<SEC-DOCUMENT>0001060955-25-000016.txt : 20250221
<SEC-HEADER>0001060955-25-000016.hdr.sgml : 20250221
<ACCEPTANCE-DATETIME>20250221170531
ACCESSION NUMBER:		0001060955-25-000016
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		153
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250221
DATE AS OF CHANGE:		20250221

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ICON PLC
		CENTRAL INDEX KEY:			0001060955
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				981067160

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-08704
		FILM NUMBER:		25652966

	BUSINESS ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000
		BUSINESS PHONE:		00 353 1 291 2000

	MAIL ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ICON PLC  /ADR/
		DATE OF NAME CHANGE:	20010213
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>iclr-20241231.htm
<DESCRIPTION>20-F
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:56d7542f-319d-475c-a76f-1ff45be39275,g:fef64a75-6c12-4b8b-a2b6-5a3facaa93b8,d:70380bb88cac48169f2186a4a94094c5-->
<html xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:iclr="http://www.iconplc.com/20241231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>iclr-20241231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-40">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-41">2024</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-42">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-43">0001060955</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="f-159">http://fasb.org/us-gaap/2024#RestructuringCosts</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="us-gaap:GovernmentAssistanceLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration" id="f-727">http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-3" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-941">http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-942">http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-253" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-1226">P4Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="iclr-20241231.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="eurPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="employee"><xbrli:measure>iclr:Employee</xbrli:measure></xbrli:unit><xbrli:unit id="location"><xbrli:measure>iclr:Location</xbrli:measure></xbrli:unit><xbrli:unit id="country"><xbrli:measure>iclr:Country</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="instrument"><xbrli:measure>iclr:instrument</xbrli:measure></xbrli:unit><xbrli:unit id="vote"><xbrli:measure>iclr:vote</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>iclr:segment</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherGeographicLocationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iclr:ComputerEquipmentAndCapitalizedSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iclr:ComputerEquipmentAndCapitalizedSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:KCRS.AGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-19</xbrli:startDate><xbrli:endDate>2024-08-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:KCRS.AGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:KCRS.AGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:KCRS.AGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-19</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:KCRS.AGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:KCRS.AGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:HumanFirstIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-09</xbrli:startDate><xbrli:endDate>2024-01-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:HumanFirstIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:HumanFirstIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-02</xbrli:startDate><xbrli:endDate>2023-10-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:OncacareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:OncacareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-20</xbrli:startDate><xbrli:endDate>2023-04-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:KCRS.AGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:KCRS.AGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:HumanFirstIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-09</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-02</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesDueMay2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesDueMay2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesDueMay2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesDueMay2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesDueMay2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesDueMay2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesDueMay2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesDueMay2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesDueMay2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesDueMay2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-08</xbrli:startDate><xbrli:endDate>2024-05-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CreditRatingStandardPoorsAxis">srt:StandardPoorsBBRatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CreditRatingStandardPoorsAxis">srt:StandardPoorsBBPlusRatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CreditRatingStandardPoorsAxis">srt:StandardPoorsBBBMinusRatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CreditRatingStandardPoorsAxis">srt:StandardPoorsBBBRatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CreditRatingStandardPoorsAxis">srt:StandardPoorsBBBPlusRatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-23</xbrli:startDate><xbrli:endDate>2024-07-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">iclr:February2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">iclr:October2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:WorkforceReductionAndOfficeConsolidationProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:WorkforceReductionAndOfficeConsolidationProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:WorkforceReductionAndOfficeConsolidationProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:PersonnelRelatedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:PersonnelRelatedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:FacilityLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:FacilityLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2025To2038Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2025To2038Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear20392043Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear20392043Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:TaxOfBusinessAcquiredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:IncomeTaxBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:IncomeTaxBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-02-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:EmployeeStockPlanTwentyZeroEightPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-02-14</xbrli:startDate><xbrli:endDate>2017-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:EmployeeStockPlanTwentyZeroEightPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-02-14</xbrli:startDate><xbrli:endDate>2017-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:OptionPlans2008Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-02-14</xbrli:startDate><xbrli:endDate>2017-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">iclr:AwardDateAllYearsExcluding2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1997-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">iclr:AwardDateAllYearsExcluding2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1997-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">iclr:AwardDateAllYearsExcluding2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1997-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:The2020LegacyPRAPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:The2018LegacyPRAPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:RestrictedStockUnitsTwentyThirteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-05-11</xbrli:startDate><xbrli:endDate>2015-05-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:RestrictedStockUnitsTwentyThirteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-25</xbrli:startDate><xbrli:endDate>2024-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:RestrictedStockUnitsTwentyThirteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsRestrictedStockUnitsTwentyNineteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsRestrictedStockUnitsTwentyNineteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iclr:NonexecutiveDirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceBasedGrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:CorvusPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:CorvusPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:CorvusPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:CorvusPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">iclr:February2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001060955</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-18</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i70380bb88cac48169f2186a4a94094c5_1"></div><div style="min-height:31.5pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">______________________________________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">20-F</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentRegistrationStatement" format="ixt:fixed-false" id="f-2">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Registration statement pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="f-3">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Annual report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the fiscal year ended: <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-4"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-5">December&#160;31</ix:nonNumeric>, 2024</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-6">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentShellCompanyReport" format="ixt:fixed-false" id="f-7">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> Shell company report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">_____________________________________</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-8">333-08704</ix:nonNumeric> </span></div><div style="margin-top:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.717%"><tr><td style="width:1.0%"/><td style="width:28.928%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.930%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ICON PUBLIC LIMITED COMPANY</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Exact name of Registrant as Specified in its Charter)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-9">ICON PLC</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Translation of Registrant&#8217;s name into English)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="f-10">Ireland</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Jurisdiction of Incorporation or Organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-11">South County Business Park</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-12">Leopardstown</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-13">Dublin 18</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-14">D18 X5R3</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="f-15">Ireland</ix:nonNumeric>.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.717%"><tr><td style="width:1.0%"/><td style="width:28.928%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.930%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of principal executive offices)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-2" name="dei:ContactPersonnelName" id="f-16">Nigel Clerkin</ix:nonNumeric>, Chief Financial Officer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-2" name="dei:EntityAddressAddressLine1" id="f-17">South County Business Park</ix:nonNumeric>, <ix:nonNumeric contextRef="c-2" name="dei:EntityAddressAddressLine2" id="f-18">Leopardstown</ix:nonNumeric>, <ix:nonNumeric contextRef="c-2" name="dei:EntityAddressCityOrTown" id="f-19">Dublin 18</ix:nonNumeric>, <ix:nonNumeric contextRef="c-2" name="dei:EntityAddressPostalZipCode" id="f-20">D18 X5R3</ix:nonNumeric>, <ix:nonNumeric contextRef="c-2" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="f-21">Ireland</ix:nonNumeric>.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-2" name="dei:ContactPersonnelEmailAddress" id="f-22">Nigel.Clerkin@iconplc.com</ix:nonNumeric> | +<ix:nonNumeric contextRef="c-2" name="dei:CountryRegion" id="f-23">353</ix:nonNumeric>-<ix:nonNumeric contextRef="c-2" name="dei:CityAreaCode" id="f-24">1</ix:nonNumeric>-<ix:nonNumeric contextRef="c-2" name="dei:LocalPhoneNumber" id="f-25">291-2000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">_____________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Name, telephone number, email and/or facsimile number and address of Company contact person) </span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered or to be registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.967%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.297%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;Trading symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-26">ORDINARY SHARES, PAR VALUE &#8364;0.06 EACH</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-27">ICLR</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-28">NASDAQ Global Select Market</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities registered or to be registered pursuant to section 12(g) of the Act:</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">NONE</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:&#160;</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">NONE&#160;</span></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate the number of outstanding shares of each of the issuer&#8217;s classes of capital or common stock as of the close of the period covered by the annual report: <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-29">80,756,860</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> O</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">rdinary Shares.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as determined in Rule 405 of the Securities Act. <ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-30">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> &#160; &#160; No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#160; &#160; <ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-31">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-32">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> &#160; &#160; No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-33">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> &#160; &#160; No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non- accelerated filer or an emerging growth company.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-34">Large accelerated filer</ix:nonNumeric>  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Accelerated filer </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Non-accelerated filer </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-35">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="f-36">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">  &#160;&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">in the filing reflect the correction of an error to previously issued financial statements. <ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false" id="f-37">&#9744;</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive- based</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAccountingStandard" id="f-38">U.S. GAAP</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; International Financial Reporting Standards as issued &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;     &#160;&#160;&#160;&#160;Other </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-indent:164.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> by the International Accounting Standards Board </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">If &#8220;Other&#8221; has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow. Item 17 </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> Item 18 </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:7.9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-39">&#9746;</ix:nonNumeric></span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:90.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.685%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_10">General Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_10">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_13">Cautionary Statement Regarding Forward-looking Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_13">1</a></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART I</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:90.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.685%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_19">Item 1. Identity of Directors, Senior Management and Advisors</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_19">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_22">Item 2. Offer Statistics and Expected Timetable</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_22">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_25">Item 3. Key Information</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_25">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_49">Item 4. Information on the Company</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_49">24</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_52">Item 4A. Unresolved Staff Comments</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_52">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_55">Item 5. Operating and Financial Review and Prospects</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_55">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_58">Item 6. Directors, Senior Management and Employees</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_58">68</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_61">Item 7. Major Shareholders and Related Party Transactions</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_61">81</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_64">Item 8. Financial Information</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_64">82</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_67">Item 9. The Offer and Listing</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_67">82</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_70">Item 10. Additional Information</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_70">83</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_73">Item 11. Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_73">91</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_76">Item 12. Description of Securities Other than Equity Securities</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_76">92</a></span></div></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART II&#160;</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:90.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.685%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_82">Item 13. Defaults, Dividend Arrearages and Delinquencies</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_82">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_85">Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_85">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_88">Item 15. Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_88">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_91">Item 16. Reserved</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_91">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_94">Item 16A. Audit Committee Financial Expert</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_94">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_97">Item 16B. Code of Ethical Conduct</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_97">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_100">Item 16C. Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_100">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_103">Item 16D. Exemptions from the Listing Standards for Audit Committees</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_103">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_106">Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_106">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_109">Item 16F. Changes in Registrant&#8217;s Certifying Accountant</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_109">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_112">Item 16G. Corporate Governance</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_112">96</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_115">Item 16H. Mine Safety Disclosure</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_115">96</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_118">Item 16I. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_118">96</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_121">Item 16J. Insider Trading Policies  </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_118">96</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_124">Item 16K. Cybersecurity </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_130">97</a></span></div></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PART III</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:90.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.685%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_130">Item 17. Financial Statements</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_130">97</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_133">Item 18. Financial Statements</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_133">97</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_256">Item 19. Exhibits</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_256">140</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_259">Signatures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_259">141</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">General Information</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As used herein, &#8220;ICON plc&#8221;, &#8220;ICON&#8221;, "ICON Group", the &#8220;Company&#8221; and &#8220;we&#8221;, "our" or &#8220;us&#8221; refer to ICON public limited company and its consolidated subsidiaries, unless the context requires otherwise.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unless otherwise indicated, ICON plc&#8217;s financial statements and other financial data contained in this Form 20-F are presented in United States dollars (&#8220;$&#8221;) and are prepared in accordance with generally accepted accounting principles in the United States (&#8220;U.S. GAAP&#8221;).</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In this Form 20-F, references to "U.S. dollars", "U.S.$" or "$" are to the lawful currency of the United States, references to &#8220;euro&#8221; or &#8220;&#8364;&#8221; are to the European single currency adopted by twenty members of the European Union, references to "pound sterling", "sterling", "&#163;", "pence" or "p" are to the lawful currency of the United Kingdom. ICON publishes its consolidated financial statements in U.S. dollars.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_13"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cautionary Statement Regarding Forward-looking Statements</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Statements included herein which are not historical facts are forward-looking statements. Such forward-looking statements are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 (the &#8220;PSLRA&#8221;).&#160;Forward-looking statements may be identified by the use of future tense or other forward looking words such as &#8220;believe&#8221;, &#8220;expect&#8221;, &#8220;anticipate&#8221;, &#8220;should&#8221;, &#8220;may&#8221;, &#8220;strategy&#8221;, or other variations or comparable terminology. The forward looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, our results could be materially adversely affected. The risks and uncertainties include, but are not limited to, dependence on the pharmaceutical industry and certain clients, the need to regularly win projects and then to execute them efficiently and correctly, the challenges presented by rapid growth, competition and the continuing consolidation of the industry, the dependence on certain key executives, changes in the regulatory environment, exchange rate fluctuations, inflation and rising labor costs, and other factors identified in the Company&#8217;s United States Securities and Exchange Commission filings and in the &#8220;Risk Factors&#8221; included on pages</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> 3 through 23.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The Company has no obligation under the PSLRA to update any forward looking statements and does not intend to do so.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Part I</span></div><div style="text-align:justify"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_19"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 1. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; Identity of Directors, Senior Management and Advisers.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Not applicable.</span></div><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_22"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; Offer Statistics and Expected Timetable.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Not applicable.</span></div><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_25"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">.&#160; Key Information.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">[Reserved]</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">  Capitalization and indebtedness</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table presents our capitalization as of December&#160;31, 2024 and December&#160;31, 2023:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,446,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,806,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less debt issuance costs and debt discount</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,290)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,624)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Debt, Net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,426,160</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,775,589</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share capital</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,020,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,942,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other undenominated capital </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(229,929)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(143,506)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,724,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,433,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Shareholders&#8217; Equity</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,522,999</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,240,743</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Capitalization</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12,949,159</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13,016,332</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed the acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of PRA Health Sciences ("the Acquisition" and "the Merger"). In conjunction with the completion of the merger, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515 million and a senior secured revolving loan facility in an initial aggregate principal amount of $300 million (the "Senior Secured Credit Facilities"). </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the Senior Secured Credit Facilities, the Company, issued </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$500&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in aggregate principal amount of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.875%</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> senior secured notes in a private offering (the "2026 Notes"). </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 2, 2023, the Company agreed with its lenders to increase the aggregate principal amount of the senior secured revolving loan facility from $300&#160;million to $500&#160;million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 8, 2024, ICON Investments Six Designated Activity Company (the "Issuer"), a wholly-owned subsidiary of ICON plc, issued $2&#160;billion senior secured notes ("the New Notes"). The New Notes were issued in aggregate principal amounts of: $750&#160;million 5.809% Senior Secured Notes due 2027 (the "2027 Notes"), $750&#160;million 5.849% Senior Secured Notes due 2029 (the "2029 Notes") and $500&#160;million 6.000% Senior Secured Notes due 2034 (the "2034 Notes"). </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The proceeds from the issuance were used to repay a portion of the senior secured term loan outstanding under the Senior Secured Credit Facilities and to pay fees, costs and expenses related to the offering.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2024,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> $4,568.6 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">of the senior secured term loan facility has been repaid through cash flow ($2,581.8 million) and refinancing ($1,986.8 million) in the period since the completion of the Merger. As at December&#160;31, 2024, $500.0&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">remained undrawn under the senior secured revolving loan facility. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.    Reasons for the offer and use of proceeds</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D.    Risk Factors</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Various risk factors that are relevant to our business and the services we provide are outlined below. The occurrence of any of these events may materially and adversely affect our business operations, financial condition and results of operations and future prospects.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_28"></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Summary of Risk Factors</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Below is a summary of some of the principal risks that could adversely affect our business, operations and financial results:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Business and Operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The potential loss or delay of our large contracts, or of multiple contracts, could adversely affect our results.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">If we do not generate new business awards, or if new business awards are delayed, terminated, reduced in scope or fail to go to contract, our business, financial conditions, results of operations or cash flows may be materially adversely affected. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We depend on a limited number of customers and a loss of, or significant decrease in, business o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">r an inability to pay outstanding invoices by one or more of them could affect our business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The inability of biotechnology customers to raise adequate financing or funding could affect our business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our financial results may be adversely impacted if we underprice our contracts, overrun our cost estimates or fail to receive approval for, or experience delays in, documenting change orders.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">If we are unable to successfully develop and market new services or enter new markets, our growth, results of operations or financial condition could be adversely affected. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">If we fail to attract or retain key personnel, our performance may suffer.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We may face challenges retaining employees which could cause disruption to our day-to-day activities which may result in additional costs to the business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our ability to perform clinical trials is dependent upon the ability to recruit suitable willing patients.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our ability to perform clinical trials is dependent upon our ability to recruit suitable willing investigators.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Clim</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ate change, extreme weather events, earthquakes and other natural disasters could adversely affect our business. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">A disease outbreak, epidemic or pandemic could adversely affect our business performance. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our business depends on the continued effectiveness and availability of our information systems, including the information systems we use to provide our services to our clients, and any system failures of, security breaches of or cyber attacks to these systems may materially limit our operations or have a material adverse effect on our results of operations. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Upgrading the information systems that support our operating processes and evolving the technology platform for our services pose risks to our business. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Failure to meet productivity objectives under our business improvement objectives could adversely impact our competitiveness and therefore our operating results.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We rely on our interactive response technologies to provide accurate information regarding the randomization of patients and the dosage required for patients enrolled in the trials. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">A failure to identify and successfully close and integrate strategic acquisition targets could adversely impact our ongoing business and financial results.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Improper performance or delays in performance of our services could adversely impact our reputation and our financial results.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our relationships with existing or potential customers who are in competition with each other may adversely impact the degree to which other customers or potential customers use our services, which may adversely affect our results of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We have only a limited ability to protect our intellectual property rights and these rights are important to our success.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The biopharmaceutical industry has a history of patent and other intellectual property litigation and we might be involved in </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">costly intellectual property lawsuits.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We act as authorized representative or legal representative for some clients pursuant to certain jurisdictional requirements for sponsors of clinical trials to appoint an authorized representative or legal representative with a local presence within the relevant jurisdiction. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We rely on third parties to provide certain data and other information to us. Our suppliers or providers might increase our cost to obtain, restrict our use of, or refuse to license data, which could lead to our inability to access certain data or provide certain services and, as a result, materially and adversely affect our operating results and financial condition.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We rely on third parties for important products, services and licenses to certain technology and intellectual property rights. If there was failure in delivery by these parties, we might not be able to continue to obtain such products, services and licenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Industry</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Outsourcing trends in the pharmaceutical, biotechnology and medical device industries and changes in spending on research and development could adversely affect our operating results and growth rates.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Large pharmaceutical companies are increasingly consolidating their vendor base and entering strategic partnership arrangements with a limited number of outsource providers.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Increased collaboration amongst pharmaceutical companies in research and development activities may lead to fewer research opportunities.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We operate in a highly competitive and dynamic market.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We may be adversely affected by industry, customer or therapeutic concentration.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Financial Results and Financial Position</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our quarterly results are dependent upon a number of factors and can fluctuate from quarter to quarter. They may fall short of prior periods, our projections or the expectations of securities analysts or investors, which may adversely affect the market price of our stock.  </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our exposure to exchange rate fluctuations could adversely af</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">fect our future results of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Inflation and rising labor costs could adversely affect our future results of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our effective tax rate may fluctuate from quarter-to-quarter, which may adversely affect our results of operations. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our unsatisfied performance obligation may not convert to revenue and the rate of conversion may slow.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The Company is exposed to various risks in relation to our cash and cash equivalents.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Changes in accounting standards may adversely affect our financial statements. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Impairment of goodwill and intangible assets may adversely impact future results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Indebtedness</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We incurred substantial additional indebtedness, which could impair our flexibility and access to capital and could adversely affect the Company&#8217;s business, financial condition or results of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Covenants in our credit agreement and the indentures governing the 2026 Notes and the New Notes may restrict our business and operations. Our financial condition and results of operations could be adversely affected if we do not comply with those covenants.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Interest rate fluctuations may materially adversely affect our results of operations and financial conditions due to the variable interest rate on our senior secured term loan facility, our revolving credit facility or in respect of any future issuances of de</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bt.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our financial results and ability to access cost effective debt may be adversely impacted if we do not maintain our credit rating.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Political, Legal or Regulatory Environment</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We may lose business opportunities as a result of health care reform and the expansion of managed care organiz</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Healthcare reform legislation, other changes in the healthcare industry and in healthcare spending could adversely affect our business model, financial condition or results of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our international operations expose us to risks as a result of changes in global political conditions which could adversely affect our results of operations. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We may lose business as a result of changes in the regulatory environment.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Failure to comply with the regulations and requirements of the U.S. Food and Drug Administration and other regulatory authorities could result in substantial penalties and/or loss of business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We are subject to political, regulatory, operational and legal risks associated with our international operations. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We operate in many different jurisdictions and we could be adversely affected by violations of anti-corruption laws, including the United States Foreign Corrupt Practices Act of 1977 ("FCPA"), UK Bribery Act of 2010 ("Bribery Act") and similar anti-corruption laws in other jurisdictions as well as</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> laws and regulations relating to trade compliance and economic sanctions.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Current and proposed laws and regulations regarding the protection of personal data could result in increased risks of liability or increased costs to us or could limit our service offerings.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Our employees may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements, which could have a material adverse effect on our business. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The failure to comply with our government contracts or applicable laws and regulations could result in, among other things, fines or other liabilities, and changes in procurement regulations could adversely impact our business, results of operations or cash flows.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Liability claims brought against us could result in payment of substantial damages, costs and liabilities and decrease our profitability. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Environmental, social and governance matters may impact our business and reputation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Common Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Volatility in the market price of our common stock could lead to losses by investors.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">An investor's return may be reduced if we lose our foreign private issuer status. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">We do not expect to pay any cash dividends for the foreseeable future.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">A future transfer of ICON ordinary shares, other than one effected by means of the transfer of book entry interests in the Depositary Trust Company ("DTC"), may be subject to Irish stamp duty.</span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_31"></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Business and Operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">The potential loss or delay of our large contracts, or of multiple contracts, could adversely affect our results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our clients may discontinue using our services completely or cancel some projects either without notice or upon short notice. The termination or delay of a large contract, or of multiple contracts, could have a material adverse effect on our revenue and profitability. Historically, clients have canceled or discontinued projects and may in the future cancel their contracts with us for reasons including, amongst others:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">cost reductions or change in prioritization of resources;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">the failure of products being tested to satisfy safety or efficacy requirements;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">unexpected or undesired clinical results of the product;&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">a decision that a particular study is no longer necessary or viable;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">poor project performance, quality concerns, insufficient patient enrollment or investigator recruitment; and&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">production problems resulting in shortages of the drug.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a result, contract terminations, delays or other changes are part of our clinical services business. In the event of termination, our contracts often provide for fees for winding down the trial but these fees may not be sufficient for us to maintain our margins, and termination may result in lower resource utilization rates. In addition, we may not realize the full benefits of our unsatisfied performance obligation of contractually committed services if our clients cancel, delay or reduce their commitments under our contracts with them.  Therefore, the loss, early termination or delay of a large contract or contracts could adversely affect our revenues and profitability.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">If we do not generate new business awards, or if new business awards are delayed, terminated, reduced in scope or fail to go to contract, our business, financial conditions, results of operations or cash flows may be materially adversely affected. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our business is dependent on our ability to generate new business awards from new and existing customers and maintain and execute existing customer contracts. If we were unable to generate new business awards on a timely basis and contract, execute and deliver those awards, that could have a material impact on our business, financial condition, results of operations or cash flows. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We depend on a limited number of customers and a loss of, or significant decrease in, business o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">r an inability to pay outstanding invoices by one or more of them could affect our business.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Wh</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ile no customers individually contributed more than 10% of our revenues during th</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">e years ended December&#160;31, 2024 and December&#160;31, 2023, our top five customers represented </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25.0%</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26.8%</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> of our revenues respectively, our largest customer represented </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.7%</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8.9%</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> of our revenues, respectively, and our top twenty five customers represented </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">62.2% and 62.9%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">of our revenues, respectively. The loss of, or a significant decrease in, business from one or more of these key customer</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s, or an inability to pay outstanding invoices due to us, could have a material adverse impact on our results of operations and financial results. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:107%">The inability of biotechnology customers to raise adequate financing or funding could affect our business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A portion of our revenue is generated from sales and services to the biotechnology industry. The clients we serve are commonly subject to financial pressures, including, but not limited to, the ability to obtain adequate financing or generate sufficient funding. To the extent our clients face such pressures, or they change how they utilize our offerings, the demand for our services, or the prices our clients are willing to pay for those services, may decline. Any such decline could have a material adverse effect on our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:107%">Our financial results may be adversely impacted if we underprice our contracts, overrun our cost estimates or fail to receive approval for, or experience delays in, documenting change orders.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Many of our contracts are long-term contracts for services. As a result, variations in the timing and progress of large contracts may materially adversely affect our financial results. Revenue recognized on these service contracts are based on an assessment of progress towards completion being the cost of time and other third party costs as a percentage of total estimated time and other third party costs to deliver our services. Estimating time and costs to complete requires judgment and includes consideration of the complexity of the study, the number of sites where trials are to be conducted and the number of patients to be recruited. We regularly review the estimated hours on each contract to determine if the budget accurately reflects the agreed tasks to be performed, taking into account the state of progress at the time of review. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We bear the risk of cost overruns unless the scope of activity and/or the assumptions upon which budget is built are revised via a change order and we are able to negotiate a contract modification. We endeavor to ensure that any changes in scope are appropriately monitored and change orders or contract modifications are promptly negotiated and documented.&#160;If we fail to successfully negotiate change orders for changes in the resources required or the scope of the work to be performed, it could materially adversely affect our operations and financial results.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to successfully develop and market new services or enter new markets, our growth, results of operations or financial condition could be adversely affected. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A key element of our growth strategy is the successful development and marketing of new services or entering new markets that complement or expand our existing business.  As we develop new services or enter new markets, we may not have or be able to adequately build the competencies necessary to perform such services satisfactorily, may not receive market acceptance for such services or may face increased competition. If we are unable to succeed in developing new services, entering new markets or attracting a client base for our new services or in new markets, we will be unable to implement this element of our growth strategy, and our future business, reputation, results of operations or financial condition could be adversely impacted. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">If we fail to attract or retain key personnel, our performance may suffer.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our business, future success and ability to continue to expand operations depends upon our ability to attract, hire, train and retain qualified professional, scientific and technical operating people. We compete for qualified professionals with other Contract Research Organizations (&#8220;CROs&#8221;), temporary staffing agencies and the in-house departments of pharmaceutical, biotechnology and medical device companies. An inability to attract and retain a sufficient number of high caliber clinical research professionals (in particular, key personnel and executives) at an acceptable cost would impact our ability to provide our services, our future performance and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We may face challenges retaining employees which could cause disruption to our day-to-day activities which may result in additional costs to the business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is an award-winning workplace that enables employees to make a difference to patients&#8217; lives by being part of a world-class contract research organization that helps deliver new medicines &amp; medical devices that are benefiting patients worldwide. The attraction, development and retention of our talent is critical to the success of the Company, and we continue to strengthen processes around these areas to minimize retention risk. The Company, led by the Chief Human Resource Officer, is taking meaningful action to retain employees. Through our annual Talent Review process, we have identified opportunities for improvement as it relates to employee retention. Our People Plans have set specific goals for each functional area in terms of three critical areas: talent attraction, development and retention. However, we can provide no assurances that our efforts in this respect will be successful.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our ability to perform clinical trials is dependent upon the ability to recruit suitable willing patients.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The successful completion of clinical trials is dependent upon the ability to recruit suitable and willing patients on which to test the drug under study. The availability of suitable patients for enrollment in studies is dependent upon many factors including, amongst others, the size of the patient population, the design of the study protocol, eligibility criteria, the referral practices of physicians, the perceived risks and benefits of the drug under study and the availability of alternative medication, including medication undergoing separate clinical trials.&#160;Insufficient or inappropriate patient enrollment may result in the termination or delay of a study which could have a material adverse impact on our results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">T</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">he Company is focused on continuing to develop its expertise in patient recruitment through Accellacare, a global clinical research network, offering patients easier and faster access to innovative treatments and offering customers the option to deploy decentralized trials. The focus is on making it easier for the site and the patient to actively participate in a trial to ensure increased predictability, enrollment and retention. Our site and patient solutions group includes upfront planning of site and patient management including identification, enrollment and engagement.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Improved site selection is achieved through:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">leading technology to identify where the patients are that match the protocol;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">assessment of the qualification of sites based on real data; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">partnerships with leading technology vendors and developing the capability to enable Electronic Medical Record ('EMR') interrogation into clinical insights such as sub-populations and larger pre-screened pools where the technology and regulations are enabled.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our ability to perform clinical trials is dependent upon our ability to recruit suitable willing investigators.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We contract with physicians located in hospitals, clinics or other similar sites, who serve as investigators in conducting clinical trials to test new drugs on their patients. Investigators supervise administration of the study drug to patients during the course of the clinical trial. The successful conduct of a clinical trial is dependent upon the integrity, experience and capabilities of the investigators conducting the trial. Insufficient investigator recruitment, which in turn may lead to insufficient or inappropriate patient enrollment, may result in the termination or delay of a study which could have a material adverse impact on our results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Climate change, extreme weather events, earthquakes and other natural disasters could adversely affect our business. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In recent years, extreme weather events and changing weather patterns such as storms, flooding, droughts and temperature changes have become more common. As a result, we are potentially exposed to varying natural disaster or extreme weather risks such as hurricanes, tornadoes, droughts, floods, wildfires or other events that may result from the impact of climate change on the environment. As a result, we could experience increased costs, business interruptions, destruction of facilities, and loss of life, all of which could have a material adverse effect on our business, financial condition, or results of operations. The potential impacts of climate change may also include increased operating costs associated with additional regulatory requirements and investments in reducing energy, water use and greenhouse gas emissions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">A disease outbreak, epidemic or pandemic could adversely affect our business performance. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A disease outbreak, such as influenza or coronavirus, could negatively impact our operations. We could experience restrictions on our ability to travel, or the ability of patients or other service providers to travel, to monitor our clinical trials and to ensure laboratory samples are collected and analyzed on time as a result of an outbreak. The potential impact of an epidemic or pandemic may also result in increased operating costs and result in a requirement to increase investment in impact prevention in addition to adversely affecting the economies and financial markets worldwide, resulting in an economic downturn that could impact our business, financial condition and results of operations.   </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our business depends on the continued effectiveness and availability of our information systems, including the information systems we use to provide our services to our clients, and any system failures of, security breaches of or cyber attacks to these systems may materially limit our operations or have a material adverse effect on our results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due to the global nature of our business and our reliance on information systems to provide our services, we use web-enabled and other integrated information systems in delivering our services. We continue to increase the use of technology. The systems may be either developed internally or provided in conjunction with third parties. We also provide access to similar information systems to certain clients in connection with the services we provide them. As the use, scope and complexity of our information systems continue to grow, we are exposed to, and will increasingly be exposed to, the risks inherent in the development, integration and ongoing operation of evolving information systems, including:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">disruption or failure of data centers, telecommunications facilities or other key infrastructure platforms;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">security breaches, cyber attacks or other failures (such as inappropriate software updates) or malfunctions in our application or information systems or their associated hardware or other systems that we have access to, or that we rely upon, or that have access to our systems; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">security breaches, cyber attacks or malfunctions with key suppliers or partners who we rely on to provide services to customers;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">use of Artificial Intelligence (&#8220;AI&#8221;) resulting in inappropriate interpretation of data; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">excessive costs, excessive delays or other deficiencies in, or problems with, systems development and deployment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The materialization of any of these risks may impede our ability to provide services, the processing of data, the delivery of databases and services and the day-to-day management of our business and could result in the corruption, loss or unauthorized disclosure of proprietary, confidential or other data, as well as reputational harm. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, as AI powered cyber threats evolve, our cybersecurity program strives to keep pace through the development of advanced detection and mitigation mechanisms. However, the dynamic nature of AI-driven attacks poses an ongoing challenge, as staying one step ahead requires constant adaptation and innovation in defensive strategies to effectively protect the organization against emerging threats.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">While we have cybersecurity controls and disaster recovery plans in place, they might not adequately protect us in the event of a system failure, security breach or cyber attack. To date, no cyber attacks have had a material impact on our results of operations or financial reporting. Additionally, despite any precautions we take, damage from fire, floods, hurricanes, power loss, telecommunications failures, computer viruses, information system security breaches, cyber attacks and similar events that impact our various computer facilities could result in interruptions in the flow of data to our servers and from our servers to our clients. Corruption or loss of data may result in the need to repeat a trial at no cost to the client, but at significant cost to us, or result in the termination of one or more contracts, legal proceedings or claims against us or damage to our reputation. Additionally, significant delays in system enhancements or inadequate performance of new or upgraded systems once completed could damage our reputation and harm our business. Long-term disruptions in the infrastructure caused by events such as security breaches, cyber attacks, natural disasters, the outbreak of war, the escalation of hostilities and acts of terrorism, particularly involving cities in which we have offices, could adversely affect our business.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unauthorized disclosure of sensitive or confidential data, whether through system failure or employee negligence, fraud or misappropriation, could damage our reputation and cause us to lose clients. Similarly, despite investing in information and cybersecurity controls, there is a risk that unauthorized access to our information systems or those we develop for our clients, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">whether by our employees or third parties, including a cyber attack by computer programmers and hackers who may attack ICON systems, develop and deploy viruses, worms, ransomware or other malicious software programs, could result in negative publicity, significant remediation costs, legal liability, loss of customers and damage to our reputation and could have a material adverse effect on our results of operations and financial results. In addition, our liability insurance might not be sufficient in type, cover provided or amount to adequately cover us against claims related to security breaches, cyber attacks and other related breaches. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We may also face cybersecurity risks due to hybrid work arrangements, which could create opportunities for cybercriminals to exploit vulnerabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Upgrading the information systems that support our operating processes and evolving the technology platform for our services pose risks to our business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Continued efficient operation of our business requires that we implement standardized global business processes and evolve our information systems to enable this. We have continued to undertake significant programs to optimize business processes. A failure to effectively manage the implementation and adapt to new processes designed in these new or upgraded systems in a timely and cost-effective manner may result in disruption to our business and negatively affect our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have entered into agreements with certain vendors to provide systems development and integration services that develop or license to us the IT platform for programs to optimize our business processes. If such vendors fail to perform as required or if there are substantial delays in developing, implementing and updating the IT platform, our customer delivery may be impaired and we may have to make substantial further investments, internally or with third parties, to achieve our objectives. Additionally, our progress may be limited by parties with existing or claimed patents who seek to prevent us from using preferred technology or seek license payments from us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Meeting our objectives is dependent on a number of factors which may not take place as we anticipate, including obtaining adequate technology-enabled services, creating IT-enabled services that our customers will find desirable and implementing our business model with respect to these services. We are continuing to develop opportunities for automation across ICON using state of the art automation tools including Robotic Process Automation (RPA), the development of new applications and capabilities, and enabling deeper integration across our digital ecosystem. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">ICON has a dedicated Artificial Intelligence Centre of Excellence. By leveraging innovative AI and ML ('machine learning'), we accelerate trials, optimize resources, and ensure strict compliance, all while upholding the highest standards of ethical governance and data privacy. Our focus is to expedite our ability to:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">find signals quickly;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">connect information intelligently;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">predict outcomes; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">tak</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">e proactive action to accelerate processes or mitigate emerging risks.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Regulations relating to the use of AI and the interpretation of those regulations by regulators, courts and others are in the early stages of development and evolving, which may make it difficult to identify adequate compliance requirements or suitable governance practices to meet those requirements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">To remain competitive within our industry and keep pace with the rapid evolution of the technological landscape, it is critical that we continue to innovate and expand the capabilities of our current technologies. Increased requirements for investment in information technology or failure to comply with regulations may negatively impact our financial condition, including profitability. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Failure to meet productivity objectives under our business improvement objectives could adversely impact our competitiveness and therefore our operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continue to pursue business transformation initiatives to embed technology and innovation and deliver operational efficiencies. As part of these initiatives, we seek to improve our productivity, flexibility, quality, functionality and cost savings by our on-going investment in global technologies, continuous improvement of our business processes and functions to deliver economies of scale. These initiatives may not deliver their intended gains or be completed in a timely manner which may adversely impact our competitiveness and our ability to meet our growth objectives and therefore, could adversely affect our business and operating results, including profitability. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We rely on our interactive response technologies to provide accurate information regarding the randomization of patients and the dosage required for patients enrolled in the trials. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We develop and maintain computer run and web based interactive response technologies to automatically manage the randomization of patients in trials, assign the study drug and adjust the dosage when required for patients enrolled in trials we support. An error in the design, programming or validation of these systems could lead to inappropriate assignment or dosing of patients, which could give rise to patient safety issues and invalidation of the trial and/or liability claims against the Company, amongst other things, any of which could have a material effect on our financial condition and operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">A failure to identify and successfully close and integrate strategic acquisition targets could adversely impact our ongoing business and financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have made a number of acquisitions, including the Merger, and continue to review new acquisition opportunities. If we are unable to identify suitable acquisition targets, complete an acquisition or successfully integrate an acquired company or business, our business may be disrupted. The success of an acquisition will depend upon, among other things, our ability to:</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">effectively and quickly assimilate the operations and services or products of the acquired company or business;&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">integrate acquired personnel;&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">retain and motivate key employees;&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">retain customers; and&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">minimize the diversion of management's attention from other business concerns.</span></div><div style="padding-left:33.75pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the event that the operations of an acquired company or business do </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">not meet our performance expectations, we may have to restructure the acquired company or business or write-off the value of some, or all, of the assets of the acquired company or business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Improper performance or delays in performance of our services could adversely impact our reputation and our financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The performance of clinical development services is complex and time-consuming. We, or vendors we engage, may make mistakes in conducting a clinical trial that could negatively impact or damage the usefulness of the clinical trial or cause the results to be reported improperly. If the clinical trial results are compromised, we could be subject to significant costs or liability, which could have an adverse impact on our ability to perform our services. Large clinical trials are costly, and while we endeavor to contractually limit our exposure to such risks, improper performance of our services or delays as a result of our performance could have an adverse effect on our financial condition, damage our reputation and result in the cancellation of current contracts or failure to obtain new contracts from affected or other clients. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our relationships with existing or potential customers who are in competition with each other may adversely impact the degree to which other customers or potential customers use our services, which may adversely affect our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The biopharmaceutical industry is highly competitive, with biopharmaceutical companies each seeking to persuade payers, providers and patients that their drug therapies are better and more cost-effective than competing therapies marketed or being developed by competing companies. In addition to the adverse competitive interests that biopharmaceutical companies have with each other, biopharmaceutical companies also have adverse interests with respect to drug selection and reimbursement with other participants in the healthcare industry, including payers and providers. Biopharmaceutical companies also compete to be first to market with new drug therapies. We regularly provide services to biopharmaceutical companies who compete with each other and we sometimes provide services to such customers regarding competing drugs in development. Our existing or future relationships with our biopharmaceutical customers may therefore deter other biopharmaceutical customers from using our services or may result in our customers seeking to place limits on our ability to serve other biopharmaceutical industry participants. In addition, our further expansion into the broader healthcare market may adversely impact our relationships with biopharmaceutical customers and such customers may elect not to use our services, reduce the scope of services that we provide to them or seek to place restrictions on our ability to serve customers in the broader healthcare market with interests that are adverse to theirs. Any loss of customers or reductions in the level of revenues from a customer could have a material adverse effect on our results of operations, business and prospects.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We have only a limited ability to protect our intellectual property rights and these rights are important to our success.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our success depends, in part, upon our ability to develop, use and protect our proprietary methodologies, analytics, systems, technologies and other intellectual property. Existing laws of the various countries in which we provide services or solutions offer only limited protection of our intellectual property rights and the protection in some countries may be very limited. We rely upon a combination of trade secrets, confidentiality policies, non-disclosure, invention assignment and other contractual arrangements and patent, copyright and trademark laws, to protect our intellectual property rights. These laws are subject to change at any time and certain agreements may not be fully enforceable, which could further restrict our ability to protect our innovations. Intellectual property rights may not prevent competitors from independently developing services similar to, or duplicative of, ours. Further, the steps we take in this regard might not be adequate to prevent or deter infringement or other misappropriation of our intellectual property by competitors, former employees or other third parties and we might not be able to detect unauthorized use of, or take appropriate and timely steps to enforce our intellectual property rights. Enforcing our rights might also require considerable time, money and oversight and we may not be successful in enforcing our rights.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">The biopharmaceutical industry has a history of patent and other intellectual property litigation and we might be involved in costly intellectual property lawsuits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The biopharmaceutical industry has a history of intellectual property litigation, and these lawsuits will likely continue in the future. Accordingly, we may face patent infringement legal proceedings by companies that have patents for similar business processes or other legal proceedings alleging infringement of their intellectual property rights. Legal proceedings relating to intellectual property could be expensive, take significant time and divert management&#8217;s attention from other business concerns, regardless of the outcome of the litigation. If we do not prevail in an infringement lawsuit brought against us, we might have to pay damages and we could be required to stop the infringing activity or obtain a license to use technology on unfavorable terms. Any infringement or other legal processing related to intellectual property could have a material adverse effect on our operations and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">We act as authorized representative or legal representative for some clients pursuant to certain jurisdictional requirements for sponsors of clinical trials to appoint an authorized representative or legal representative with a local presence within the relevant jurisdiction. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We act as authorized representative pursuant to Medical Devices Regulation 2017/745 (&#8220;MDR&#8221;) for certain clients who are located outside of the European Union. As authorized representative, we act on behalf of medical device manufacturers in relation to specified tasks with regard to their obligations under MDR. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also act as legal representative pursuant to European Clinical Trials Directive (2021/20/EC) (&#8220;CTD&#8221;), EU Clinical Trials Regulation (No.536/2014) (&#8220;CTR&#8221;) and MDR for certain clients who are located outside of the European Union with respect to clinical trials being carried out by those clients in the European Union. We also perform similar legal representative services for certain clients in other non-EU jurisdictions, where the client is located outside the relevant local jurisdiction, ICON has an established local legal entity in that jurisdiction and analogous local regulations have a similar requirement for a local legal representative for clinical trials being carried out in those jurisdictions. As legal representative, we are responsible for ensuring compliance with the client&#8217;s obligations pursuant to CTD, CTR and MDR or analogous local legislation and we are the addressee for all communications with the client provided for under CTD, CTR and MDR or analogous local legislation.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We provide these services subject to certain terms and conditions which are contained in our agreements with clients pertaining to these services. We aim to reduce any potential liability associated with these activities by seeking contractual indemnification from our clients and by maintaining an appropriate level of insurance cover. However, there is no guarantee that the specific insurance will be available or that a client will fulfill its obligations in relation to their indemnity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We rely on third parties to provide certain data and other information to us. Our suppliers or providers might</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"> increase our cost to obtain, restrict our use of, or refuse to license data, which could lead to our inability to access certain data or provide certain services and, as a result, materially and adversely affect our operating results and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our services are derived from, or include, the use of data we collect from third parties. We have several data suppliers that provide us with a broad scope of information that we collect, use in our business and sell.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We generally enter into long-term contractual arrangements with many of our data suppliers. At the time we enter into a new data supply contract or renew an existing contract, suppliers may increase our cost to obtain and use the data provided by such supplier, increase restrictions on our ability to use or sell such data, or altogether refuse to license the data to us. Also, our data suppliers may fail to meet or adhere to our quality control standards or fail to deliver the data to us. Although no single supplier is material to our business, if suppliers that collectively provide a significant amount of the data we receive or use were to increase our costs to obtain or use such data, further restrict our access to or use of such data, fail to meet or adhere to our quality control standards, refuse to provide or fail to deliver data to us, our ability to provide data-dependent services to our clients may be adversely impacted, which could have a material adverse effect on our business, results of operations, financial condition or cash flow.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We rely on third parties for important products, services and licenses to certain technology and intellectual property rights. If there was failure in delivery by these parties, we might not be able to continue to obtain such products, services and licenses.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We depend on certain third parties to provide us with products and services critical to our business. Such services include, among others, suppliers of drugs for patients participating in trials, suppliers of kits for use in our laboratories, suppliers of reagents for use in our testing equipment and providers of maintenance services for our equipment. The failure of any of these third parties to adequately provide the required products or services, or to do so in compliance with applicable regulatory requirements, could have a material adverse effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Some of our services rely on intellectual property, technology and other similar property owned and/or controlled by third parties. Our licenses to this property and technology could terminate or expire and we might not be able to replace these licenses in a timely manner. Also, we might not be able to renew these licenses on similar terms and conditions. Failure to renew these licenses, or renewals of these licenses on less advantageous terms, could have a material adverse effect on our business, results of operations, financial condition or cash flow.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_34"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Industry</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Outsourcing trends in the pharmaceutical, biotechnology and medical device industries and changes in spending on research and development could adversely affect our operating results and growth rates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are dependent upon the ability and willingness of the pharmaceutical, biotechnology and medical device companies to continue to spend on research and development and to outsource the services that we provide. We are therefore subject to risks, uncertainties and trends that affect companies in these industries that we do not control. We have benefited to date from the tendency of pharmaceutical, biotechnology and medical device companies to outsource clinical research projects. Any downturn in these industries or reduction in spending or outsourcing could materially adversely affect our business. The following could each result in such a downturn:</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">if pharmaceutical, biotechnology or medical device companies expanded upon their in-house clinical or development capabilities, they would be less likely to utilize our services;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">if governmental regulations were changed, it could affect the ability of our clients to operate profitably, which may lead to a decrease in research spending and therefore this could have a material adverse effect on our business; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">if unfavorable economic conditions or disruptions in the credit and capital markets negatively impact our customers, this could result in delays or reprioritization of their research spending.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Large pharmaceutical companies are increasingly consolidating their vendor base and entering strategic partnership arrangements with a limited number of outsource providers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Large pharmaceutical companies continually seek to drive efficiencies in their development processes to both reduce costs associated with the development of new drug candidates and accelerate time to market. As a result, large pharmaceutical companies, in particular, are increasingly looking to consolidate the number of outsource providers with which they engage, with many entering strategic partnership arrangements with a limited number of outsource providers.&#160;The failure to enter strategic partnership arrangements with customers or the loss of existing customers as a result of them entering strategic partnership arrangements with our competitors could have a material adverse impact on our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Increased collaboration amongst pharmaceutical companies in research and development activities may lead to fewer research opportunities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain pharmaceutical companies have begun to collaborate in seeking to develop new drug candidates. Increased collaboration amongst pharmaceutical companies may lead to fewer research opportunities, which in turn may lead to fewer outsource opportunities for companies within the CRO industry. A reduction in outsource opportunities as a result of this increased collaboration could have a material adverse impact on our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We operate in a highly competitive and dynamic market.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CRO industry is highly competitive. In particular, we compete with other large global CROs for strategic relationships with large pharmaceutical companies. If we are unable to retain and renew existing strategic relationships and win new strategic relationships, there could be a material adverse impact on our results. Similarly, we compete with other CROs for work, which comes outside of these strategic relationships, and we may also compete with the Research and Development capabilities of our customers; being unable to win work outside of the strategic relationships could have a material adverse impact on our results.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The type and depth of services provided by CROs has changed in recent years. Failure to develop and market new services or expand existing service offerings could adversely affect our business and operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">New entrants may also enter the market which would further increase competition and could adversely affect our business and operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We may be adversely affected by industry, customer or therapeutic concentration.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We provide services to biopharmaceutical, biotechnology, medical device and government organizations and our revenue is dependent on expenditures by these customers. Our business could therefore be adversely impacted by mergers, consolidation, business failures, policy decisions, distress in financial markets or other factors resulting in a decrease in the number of potential customers or therapeutic products being developed through the drug development process. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There has been consolidation in the biopharmaceutical market in recent years, including the acquisition of biotechnology companies by pharmaceutical companies. If the number of our potential customers were to decline in the future, they may be able to negotiate price discounts or other terms for services that are less favorable to us than they have been historically. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_37"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Financial Results and Financial Position</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our quarterly results are dependent upon a number of factors and can fluctuate from quarter to quarter. They may fall short of prior periods, our projections or the expectations of securities analysts or investors, which may adversely affect the market price of our stock.  </span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our results of operations in any quarter can fluctuate or differ from expected or forecast results depending upon or due to, among other things, the number and scope of ongoing client projects, the commencement, postponement, variation,&#160;cancellation or termination of projects in a quarter, the mix of activity, cost overruns, employee hiring, employee attrition and other factors. Our revenue in any period is directly related to the number of employees who were working on billable projects together with investigator activity during that period. We may be unable to compensate for periods of under-utilization during one part of a fiscal period by earning revenue during another part of that period. We believe that operating results for any particular quarter are not necessarily a meaningful indicator of future results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Also, if in future quarters, we are unable to continue to deliver operational efficiencies and our expenses grow faster than our revenues, our operating margins, profitability and overall financial condition may be materially adversely impacted.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our exposure to exchange rate fluctuations could adversely affect our future results of operations </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our contracts with clients are sometimes denominated in currencies other than the currency in which we incur expenses related to such contracts. Where expenses are incurred in currencies other than those in which contracts are priced, fluctuations in the relative value of those currencies could have a material adverse effect on our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, we are also subject to translation exposures as our consolidated financial results are presented in U.S. dollars, while the local results of a certain number of our subsidiaries are prepared in currencies other than U.S. dollars, including, amongst others, the pound sterling and the euro. Accordingly, changes in exchange rates between the U.S. dollar and those other currencies will affect the translation of subsidiary companies' financial results into U.S. dollars in reporting our consolidated financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Inflation and rising labor costs could adversely affect our future results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inflation and rising labor costs may result in significant increases to the cost of our services, which we may not be able to recover from our customers. Our contracts with clients are often fixed price or fixed price-per-unit contracts. If macroeconomic forces, such as inflation, cause the cost of inputs required to deliver these contracts to increase significantly, we may be unable to pass along these costs to our customers. A sustained increase in these costs may require us to increase the price of future service offerings. These actions could adversely affect our future revenue, gross margin, or both.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Our effective tax rate may fluctuate from quarter-to-quarter, which may adversely affect our results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our quarterly effective tax rate has depended and will continue to depend on the geographic distribution of our taxable earnings amongst the multiple tax jurisdictions (such as Ireland, United States and United Kingdom) in which we operate and the tax laws in those jurisdictions. Changes in the geographic mix of our results of operations amongst these jurisdictions may have a significant impact on our effective tax rate from quarter-to-quarter. Changes in tax law in one or more jurisdictions could also have a significant impact on our tax rate and results. In addition, as we operate in multiple tax jurisdictions, we may be subject to audits in certain jurisdictions. These audits may involve complex issues which could require an extended time period before being resolved. The resolution of audit issues may lead to additional taxes, interest as well as fines and/or penalties being imposed which could have a material adverse impact on our effective tax rate and our consolidated financial results. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In terms of recent legislative changes which could potentially impact our effective tax rate, on August 16, 2022, the U.S. government enacted the Inflation Reduction Act of 2022 ("IRA"). The IRA introduced a 15% minimum tax on book income of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">certain large corporations, a 1% excise tax on net stock repurchases, and several tax incentives to promote clean energy, with those tax changes becoming effective in 2023. While these changes did not have any impact on the Company for the year ended December&#160;31, 2024, we are continuing to monitor any potential future tax impacts in this regard. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We cannot predict the impact of any executive orders or regulatory changes that may become effective or enacted by the new administration in the United States.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In terms of a global minimum tax rate, the Organization for Economic Co-operation and Development's ("OECD") Global Anti-Base Erosion ("GloBE") Model Rules proposed a global minimum tax rate of 15% and recommended that it be effective from 2024. European Union member states adopted a global minimum tax in December 2022 and member states were obliged to implement the rules by December 31, 2023, which impact large multinational groups with a consolidated revenue of over &#8364;750 million. Although there is no assurance that every country in which ICON has a presence will implement GloBE, where a particular jurisdiction has a minimum effective tax rate of less than 15%, the head office location may be obliged to pay a top-up tax. Ireland has also implemented global minimum tax legislation which has been in force from 1 January 2024. The global tax environment is becoming increasingly complex and management continues to review the impact of a global minimum tax on the Company&#8217;s financial performance. Further, regulatory or policy changes in geographies in which we operate may </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">have a material impact on our results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our unsatisfied performance obligation may not convert to revenue and the rate of conversion may slow.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our unsatisfied performance obligation is the amount of awards that has not yet converted to revenue. This value is not necessarily a meaningful predictor of future results due to the potential for the cancellation or delay of projects included in the unsatisfied performance obligation.&#160;No assurances can be given that we will be able to realize this unsatisfied performance obligation in full as revenue. A failure to realize these awards could have a material adverse impact on our results of operations. In addition, as the length and complexity of projects increases, the rate at which awards convert to revenue may be slower than in the past. A significant reduction in the rate of conversion could have a material impact on our results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">The Company is exposed to various risks in relation to our cash and cash equivalents.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s treasury function manages our available cash resources and invests significant cash balances in various financial institutions to try to ensure optimum returns for our surplus cash balances.&#160;These balances are classified as cash and cash equivalents. Cash and cash equivalents comprise cash and highly liquid investments with maturities of three months or less.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;Given the global nature of our business, we are exposed to various risks in relation to these balances including liquidity risk, credit risk associated with the counterparties with whom we invest, interest rate risk on floating rate securities, sovereign risk (our principle sovereign risk relates to investments in U.S. Treasury funds) and other factors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Although we have not recognized any significant losses to date on our cash and cash equivalents, any significant declines in their market values could have a material adverse effect on our financial position and operating results.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Changes in accounting standards may adversely affect our financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We prepare our financial statements in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP") which are revised on an on-going basis by the authoritative bodies. It is possible that future accounting standard updates may require changes to the accounting treatment that we apply in preparation of our financial statements. These changes may also require significant changes to our reporting systems. These updates may result in unexpected variability i</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">n the timing of recognition of revenue or expenses and therefore in our operating results. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Impairment of goodwill and intangible assets may adversely impact future results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We record intangible assets, including goodwill, on our balance sheet on acquisitions of businesses. The initial identification and valuation of these intangible assets and the determination of the estimated useful lives at the time of  acquisition involve use of judgments and estimates. These estimates are based on, among other factors, projections  of cash flows that arise from identifiable intangible assets of acquired businesses and discount rates based on an analysis of our weighted average cost of capital, adjusted for specific risks associated with the assets. Disruptions in global financial markets and deterioration of economic conditions could, among other things, impact the discount rate. Other assumptions used in the valuations and actual cash flows arising from a particular intangible asset could vary from projected cash flows, which could imply different carrying values from those established at the dates of acquisition and which could result in impairment of such assets. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If the future growth and operating results of our business are not as strong as anticipated, overall macroeconomic or industry conditions deteriorate and/or our market capitalization declines, this could impact the assumptions used in establishing the carrying value of goodwill or intangible assets. Should disruption in the global financial markets and deterioration of economic conditions have a prolonged impact on our industry, triggering events may arise resulting in intangible asset, or goodwill </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">impairments. To the extent intangible assets, or goodwill are impaired, their carrying value will be written down to their implied fair values and a charge will be made to our net income. Such an impairment charge could materially and adversely affect our operating results.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_40"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Indebtedness</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We incurred substantial additional indebtedness, which could impair our flexibility and access to capital and could adversely affect the Company&#8217;s business, financial condition or results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Following completion of the Merger and the other transactions contemplated by the Merger Agreement, the Company has a substantial amount of debt. ICON borrowed approximately $6,015.0 million in order to pay PRA stockholders the cash consideration due to them as merger consideration under the Merger Agreement, pay related fees and transaction costs in connection with the transactions, and refinance existing indebtedness. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 8, 2024, ICON Investments Six Designated Activity Company (the "Issuer"), a wholly-owned subsidiary of ICON </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">plc, issued $2 billion senior secured notes ("the New Notes"). The New Notes were issued in aggregate principal amounts of: $750 million 5.809% Senior Secured Notes due 2027 (the "2027 Notes"), $750 million 5.849% Senior Secured Notes due 2029 (the "2029 Notes") and $500 million 6.000% Senior Secured Notes due 2034 (the "2034 Notes"). The proceeds from the issuance were used to repay a portion of the senior secured term loan outstanding under the Senior Secured Credit Facilities and to pay fees, costs and expenses related to the offering. As of December&#160;31, 2024 we had outstanding </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$3,446.5&#160;million of debt.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> This level of borrowings could adversely affect the Company in a number of ways, including, but not limited to, causing us to incur substantial fees from time to time in connection with debt amendments or refinancing, making it more difficult for the Company to satisfy its obligations with respect to its debt or to its trade or other creditors, requiring a substantial portion of the Company&#8217;s cash flows from operations for the payment of interest on the Company&#8217;s debt, reducing the Company&#8217;s flexibility to respond to changing business and economic conditions, and reducing funds available for the Company&#8217;s investments in research and development, capital expenditures and other activities. If ICON cannot service its debt, it may have to take actions such as selling assets, seeking additional debt or equity, or reducing or delaying capital expenditures, strategic acquisitions, investments and alliances.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Covenants in our credit agreement and the indentures governing t</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">he 2026 Notes and the New Notes may restrict our business and operations. Our financial condition and results of operations could be adversely affected </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">if we do not comply with those covenants.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Senior Secured Credit Facilities and the indentures governing the 2026 Notes and the New Notes include certain customary covenants that limit our ability to, amongst other things, subject to certain exceptions:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.15pt">make dividends, investments and other restricted payments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.15pt">enter into sale and leaseback transactions;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">engage in share buybacks;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.15pt">incur or assume liens or additional debt;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.15pt">engage in mergers or reorganizations; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.15pt">enter into certain types of transactions with affiliates.</span></div><div style="text-indent:43.2pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">              On December 8, 2023, ICON notified the holders of the</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> 2026 Notes o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">f the upgrade of the instrument rating to investment grade and the consequent suspension of certain of the covenants under the Indenture governing the 2026 Notes. The suspension of these covenants remains in place and will continue so long as the instrument remains at investment grade.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The revolving credit facility also includes a financial covenant that requires us to comply with a maximum consolidated leverage ratio. Our ability to comply with this financial covenant may be affected by events beyond our control.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Interest rate fluctuations may materially adversely affect our results of operations and financial conditions due to the variable interest rate on our senior secured term loan facility, our revolving credit facility or in respect of any future issuances of debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the principal amount, with the remaining balance due at final maturity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">On March 14, 2024, the parties to the credit agreement entered into a Third Amendment (the &#8220;Third Amendment&#8221;) in connection with the repricing of the senior secured term loan facility and the senior secured revolving credit facility.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR plus an applicable margin which is dependent on the Company's net leverage ratio. At December&#160;31, 2024, the applicable margin is 2.0% (which reflects the Third Amendment). The senior secured term loan facility is subject to a floor of 0.50%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reflecting the Third Amendment, the interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 0.45%, 0.10% or &#8211;% based on the Company&#8217;s current corporate family rating assigned by S&amp;P of BB (or lower), BB+ or BBB- (or higher), respectively, or (ii) Term SOFR plus an applicable margin of 1.45%, 1.10%, 0.85%, 0.65%, or 0.50% based on the Company&#8217;s current corporate family rating assigned by S&amp;P of BB (or lower), BB+, BBB-, BBB or BBB+ (or higher), respectively. In addition, lenders under the revolving loan facility are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2024, $nil (December&#160;31, 2023: $55.0&#160;million) was outstanding under the revolving loan facility while there was also $nil (December&#160;31, 2023: $3.7&#160;million) in letters of credit given to landlords to guarantee lease arrangements under the senior secured revolving loan facility.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">As the Company has variable rate debt, fluctuations in interest rates affect our business. We attempt to minimize interest rate risk by issuing fixed term debt to provide a mix of fixed and floating rate debt in the Company debt portfolio. Although the Company manages it interest rate exposure (at </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">December&#160;31, 2024, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">73%</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> of the Company's outstanding debt was at a fixed interest rate (December&#160;31, 2023: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">13%)</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">, significant changes in rates at which the Company can borrow </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">could have a material adverse effect on our financial position and operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our financial results and ability to access cost effective debt may be adversely impacted if we do not maintain our credit rating.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In Quarter Four, 2023, S&amp;P Global Ratings ('S&amp;P') upgraded ICON to an investment grade credit rating of BBB- with a stable outlook. Further Moody's Investors Service upgraded all of ICON plc&#8217;s instrument ratings to Baa3 with a stable outlook. In Quarter Four, 2024 S&amp;P affirmed ICON issuer ratings of BBB- and Moody's Investors Service changed the outlook from stable to positive. Our financial results and ability to access cost effective debt may be adversely impacted if we do not maintain our credit rating.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_43"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Political, Legal or Regulatory Environment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We may lose business opportunities as a result of healthcare reform and the expansion of managed care organizations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Numerous governments, including the U.S. government, have undertaken efforts to control growing healthcare costs through legislation, regulation and voluntary agreements with medical care providers and drug companies. If these efforts are successful, pharmaceutical, biotechnology and medical device companies may react by spending less on research and development and therefore this could have a material adverse effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to healthcare reform proposals, the expansion of managed care organizations in the health care market may result in reduced spending on research and development. Managed care organizations' efforts to cut costs by limiting expenditures on pharmaceuticals and medical devices could result in pharmaceutical, biotechnology and medical device companies spending less on research and development. If this were to occur, we would have fewer business opportunities and our revenues could decrease, possibly materially.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Healthcare reform legislation, other changes in the healthcare industry and in healthcare spending could adversely affect our business model, financial condition or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our results of operations and financial conditions could be affected by changes in healthcare spending and policy.&#160; The healthcare industry is subject to changing political, regulatory and other influences. It is possible that legislation will be introduced and passed in the United States repealing, modifying or invalidating the current healthcare reform legislation, in whole or in part, and signed into law. Because of the continued uncertainty about the implementation of the current healthcare reform legislation, including the potential for further legal challenges or repeal of that legislation, we cannot quantify or predict with any certainty the likely impact of the&#160;current&#160;healthcare&#160;reform legislation&#160;or its repeal on the healthcare sector, on our customers and ultimately on our financial condition or results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As previously noted, on August 16, 2022, the U.S. government enacted the IRA, which among other things, authorizes the U.S. Department of Health and Human Services to establish prices for certain single-source drugs and biologics within the Medicare program, commencing in 2026. Furthermore, the IRA contains provisions which impose rebate obligations on manufacturers if price increases outpace inflation. While the full impact of these IRA provisions on our customers in the biopharmaceutical industry remains uncertain, any resultant pressure on our customers&#8217; operating results could lead to a reduction in research and development spend and related outsourcing activities, which could have an adverse impact on our operating results and financial condition. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We cannot predict the impact of any executive orders or regulatory changes that may become effective or enacted by the new administration in the United States.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Our international operations expose us to risks as a result of changes in global political conditions which could adversely affect our results of operations. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Political and/or financial instability and armed conflict in various regions of the world, including, but not limited to, Ukraine, Israel and the conflict area in the Middle East, can lead to sanctions, economic uncertainty and currency exchange rate fluctuations and may interrupt our operations in those areas, which may adversely impact our results of operations. The current conflict in Ukraine has led to, among other things, hardship and the imposition of international economic sanctions aimed at the region. While the situation is subject to change, there remains the possibility of additional and harsher sanctions if the conflict intensifies. If that were to happen, our operations in the region may be severely curtailed or eliminated, which could adversely affect our results of operations. In addition, if the current unrest broadens or further escalates, our operations may be severely curtailed, which could adversely affect our results of operations. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continue to monitor developments in Israel and the conflict area in the Middle East. Further broadening or escalation of the conflict, or the imposition of international economic sanctions, could adversely affect our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We may lose business as a result of changes in the regulatory environment</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Various regulatory bodies throughout the world may enact legislation, rules and guidance which could introduce changes to the regulatory environment for drug development and research. The adoption and implementation of such legislation, rules and guidance is difficult to predict and therefore could have a material adverse effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Failure to comply with the regulations and requirements of the U.S. Food and Drug Administration and other regulatory authorities could result in substantial penalties and/or loss of business</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The U.S. Food and Drug Administration, ("FDA"), and other regulatory and government authorities and agencies inspect and audit us from time to time to ensure that we comply with their regulations and guidelines, including environmental, health and safety matters, and other requirements imposed in connection with the performance of government contracts.&#160; We must comply with the applicable regulatory requirements governing the conduct of clinical trials and contracting with the government in all countries in which we operate. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If we, or vendors we engage, fail to comply with any of these requirements we could suffer some or all of:&#160;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">termination of or delay in any research;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">disqualification of data;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">denial of the right to conduct business;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">criminal penalties;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">financial penalties;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">other enforcement actions including debarment from government contracts;</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">loss of clients and/or business; and</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">litigation from clients and/or patients and/or regulatory authorities and/or other affected third parties, and resulting material penalties, damages and costs.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span id="i6d31e028988a41e9872b3ec5a12ab11d_28598"></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We are subject to political, regulatory, operational and legal risks associated with our international operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are one of a small group of organizations with the capability and expertise to conduct clinical trials on a global basis. We believe that this capability to provide our services globally in most major and developing pharmaceutical markets enhances our ability to compete for new business from large multinational pharmaceutical, biotechnology and medical device companies. We have expanded geographically in the past and intend to continue expanding in regions that have the potential to increase our client base or increase our investigator and patient populations. However, emerging market operations may present several risks, including civil disturbances, health concerns, cultural differences such as employment, regulatory and business practices, compliance with economic sanctions laws and regulations, volatility in gross domestic product, economic and governmental instability, the potential for nationalization of private assets and the imposition of exchange controls. In addition, operating globally means the Company faces the challenges associated with coordinating its services across different countries, time zones and cultures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Changes in the political and regulatory environment in the markets in which we operate such as price or exchange controls or tariffs could impact our revenue and profitability and could lead to penalties, sanctions and reputational damages if we are not compliant with those regulations. Political uncertainty and a lack of institutional continuity in some of the emerging, developing or other countries in which we operate could affect the orderly operation of markets in these economies.&#160;In addition, in countries with a large and complicated structure of government and administration, national, regional, local and other governmental bodies may issue inconsistent decisions and opinions that could increase our cost of regulatory compliance and/or have a material adverse effect on our business. The ongoing conflict in Ukraine has resulted in an increasingly complex economic sanctions and export controls environment applicable to our business operations in the region (including Russia and Belarus) as a result of additional trade compliance measures enacted by the United States, United Kingdom and European Union member states.  These economic sanctions and export controls restrict our ability to do business with sanctioned entities, require additional compliance resources, and could have a material adverse effect on the results of our operations. We continue to monitor developments in other regions, including the Middle East and China, and will assess any impact of trade compliance measures, or other restrictions, on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Uncertainty of the legal environment in some emerging countries could also limit our ability to enforce our rights.&#160;In certain emerging and developing countries, we enjoy less comprehensive protection for some of our rights, including intellectual property rights, which could undermine our competitive position. Proceedings to enforce our future patent rights, if any, in foreign jurisdictions could result in substantial cost and divert our efforts and attention from other aspects of our business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If any of the above risks or similar risks associated with our international operations were to materialize, our results of operations and financial condition could be materially adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We operate in many different jurisdictions and we could be adversely affected by violations of anti-corruption laws, including the United States Foreign Corrupt Practices Act of 1977 ("FCPA"), UK Bribery Act of 2010 ("UK Bribery Act") and similar anti-corruption laws in other jurisdictions as well as laws and regulations relating to trade compliance and economic sanctions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The FCPA, UK Bribery Act and similar anti-corruption laws in other jurisdictions prohibit us and our officers, directors, employees and third parties acting on our behalf, including agents, from corruptly offering, promising, authorizing, or providing anything of value to a "foreign official" for the purposes of influencing official decisions or obtaining or retaining business or otherwise obtaining favorable treatment. In addition, the FCPA imposes certain books, records and accounting control obligations on public companies and other issuers. The UK Bribery Act also prohibits "commercial" bribery and accepting bribes. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our global business operations also must be conducted in compliance with applicable export controls and economic sanctions laws and regulations, including those administered by the U.S. Department of the Treasury&#8217;s (the &#8220;U.S. Treasury&#8221;) Office of Foreign Assets Control, the U.S. Department of State, the U.S. Department of Commerce, the United Nations Security Council, the European Union, His Majesty&#8217;s Treasury and other relevant trade compliance authorities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our internal policies mandate compliance with these anti-corruption and trade compliance laws and regulations. We also operate in many jurisdictions in which bribery or corruption can be common and compliance with anti-bribery laws may conflict with local customs and practices. Despite our training and compliance program safeguards, we cannot assure that our internal control policies, procedures and safeguards will protect us from acts in violation of anti-corruption and trade compliance laws and regulations committed by employees or other third parties associated with us and our continued expansion, including in developing countries, could increase such risk in the future. Violations of anti-corruption, economic sanctions and trade control laws and regulations, or even allegations of such violations, could disrupt our business and result in a material adverse effect on our financial condition, results of operations, cash flows and reputation. For example, violations of anti-corruption and trade compliance laws can result in restatements of, or irregularities in, our financial statements, disgorgement of profits, related stockholder lawsuits as well as severe criminal or civil sanctions. In some cases, companies that violate anti-corruption and trade compliance laws might be debarred by the U.S. government and/or lose their U.S. export privileges. In addition, the U.S. government or other governments may seek to hold us liable based on successor liability for violations of anti-corruption and trade compliance laws committed by companies that we acquire or in which we invest. Changes in anti-corruption and trade compliance laws or enforcement priorities could also result in increased compliance requirements and related costs which could materially adversely affect our business, financial condition, results of operations and cash flows. The increase in economic sanctions and trade controls, particularly relating to our ongoing operations in Russia, Ukraine and Belarus, has increased the amount of resources necessary to ensure compliance in this area.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Current and proposed laws and regulations regarding the protection of personal data could result in increased risks of liability or increased costs to us or could limit our service offerings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has a strong privacy posture, driven by the implementation of a core privacy governance strategy and the adoption of policies and procedures designed to help ensure that ICON, including our employees and contractors, can comply with applicable data protection laws (including, but not limited to, the General Data Protection Regulation (&#8220;GDPR&#8221;) (EU) 2016/679). Notwithstanding these measures, failure to comply with applicable data protection laws may occur and could result in increased risk of liability or increased costs to us or could limit our service offerings. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">Administrative fines:</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The GDPR introduced a regime of administrative fines for data protection infringements and provided for a tiered penalty structure based on the nature of the infringement. The EU supervisory authorities for the GDPR can directly impose fines on organizations found to be in breach of the GDPR. Lower tier administrative fines allow for fines of up to 2% of worldwide turnover of the group in the preceding financial year. Higher tier administrative fines allow for fines of up to 4% of worldwide turnover of the group in the preceding financial year. Higher tier administrative fines are more likely to be levied for major infringements of the GDPR and core data protection principles (e.g. transparency, data retention, accountability). </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">Penalties:</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The GDPR also permits Member States to implement rules on other penalties applicable to infringements of the GDPR, in particular, for infringements which are not subject to administrative fines under the GDPR itself. Therefore, Member States may legislate for further fines or penalties that may be criminal in nature. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Any fines levied under the GDPR must be effective, proportionate, and dissuasive. Supervisory authorities have been strengthening enforcement activities across the EU in recent years in respect of breaches of GDPR. The risk of fines and penalties under the GDPR carries increased risk of liability to ICON and can result in increased costs and disruption to the delivery of our services. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">Right to compensation of data subjects:</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> In addition to the risk of administrative and criminal penalties, the GDPR also provides that any person who has suffered material or non-material damage as a result of an infringement of the GDPR shall have the right to receive compensation for the damage suffered, from the controller or processor responsible for the infringement. The level of award of damages is set by the competent court in the applicable EU Member State. This carries increased risk of liability for ICON. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;text-decoration:underline">Corrective Powers of the supervisory authorities:</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">  Each supervisory authority across the Member States of the EU also has corrective powers. Supervisory authorities have the power to order ICON to bring processing operations into compliance with the provisions of the GDPR in a specified manner within a specified time period, or to impose a temporary or definitive limitation including a ban on processing, and to order the suspension of data flows to a recipient in a third country or to an international organization. Supervisory authorities also have powers to conduct audits and investigations of ICON and instruct ICON to take certain actions. The exercise of these powers by supervisory authorities has the potential to increase costs for ICON and cause disruption to the business and delivery of our services. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The foundational principles of the GDPR have helped shape the development of many other privacy laws globally. Internationally, data protection laws continue to be introduced at a rapid rate, with greater protections afforded to personal data than ever before, and greater risk of liability to organizations processing that personal data. As a global organization, ICON must ensure that our privacy posture continues to adapt to these new laws and regulations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From a US perspective, the confidentiality, collection, use and disclosure of personal data, including clinical trial patient-specific information, is regulated at the federal and state level. The Federal Trade Commission, or FTC, is an independent U.S. law enforcement agency charged with protecting consumers and enhancing competition across broad sectors of the economy. The FTC&#8217;s authority with respect to data privacy and security comes from Section 5 of the FTC Act. The FTC uses its broad grant of authority to regulate data privacy and security, using including, but not limited to, requiring the implementation of comprehensive privacy and security programs, biennial assessments by independent experts, monetary redress to consumers, and provision of robust notice and choice mechanisms to consumers. Similar laws exist at the state level, which are used by state attorneys general to enforce against privacy and security-related acts or practices deemed to be unfair or deceptive.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">More than 15 US states have adopted a comprehensive consumer privacy law or a consumer health data privacy law that regulates how certain businesses collect, use, and disclose the personal information of consumers residing in the state.  In general, these laws provide for certain consumer privacy rights and impose transparency standards for business data collection and processing practices. These laws have broad exemptions for personal information that constitutes protected health information under the Health Insurance Portability and Accountability Act of 1996 ("HIPAA") and de-identified health data as defined under HIPAA. As a result, we do not expect to have compliance obligations under these laws with respect to most patient information we collect and process. However, we are required to comply with these consumer privacy laws insofar as we collect other categories of consumers&#8217; personal information, which could include, for example, information about website visitors. These state consumer privacy laws are generally enforced by the respective state Attorney General. California&#8217;s law also includes a private right of action for certain data breaches. Dozens of other states are currently considering similar consumer privacy laws, which could impact our operations if enacted.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The US federal administrative simplification regulations under HIPAA require individuals&#8217; written authorization, in addition to any required informed consent, before protected health information may be used for research (unless an institutional review board has waived the authorization requirement or another exception applies). </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are directly regulated by HIPAA as a &#8220;business associate&#8221; because we obtain individually identifiable health information from &#8220;covered entity&#8221; third parties that are subject to such regulations. We can be directly liable to the covered entity contractually for mishandling protected health information and, under HIPAA&#8217;s enforcement scheme, we can be subject to up to approximately $2.1 million per year in civil money penalties for multiple violations of the same HIPAA requirement in 2024. The per violation penalties and calendar year cap on penalties are adjusted annually for inflation under the Federal Civil Penalties Inflation Adjustment Act.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additional legislation or regulation of this type might, among other things, require us to implement new security measures and processes which may require substantial expenditures or limit our ability to offer some of our services. Additionally, if we violate applicable laws, regulations or duties relating to the use, processing or security of personal data, we could be subject to civil liability or criminal prosecution, be forced to alter our business practices or suffer reputational harm. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Our employees may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements, which could have a material adverse effect on our business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are exposed to the risk of employee fraud or other misconduct. Misconduct by employees could include intentional failures to comply with governmental regulations, comply with federal and state healthcare fraud and abuse laws and regulations, report financial information or data accurately or disclose unauthorized activities to us. In particular, sales, marketing and business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Employee misconduct could also involve the improper use of information obtained in the course of clinical studies or data or documentation fraud or manipulation, which could result in regulatory sanctions and serious harm to our reputation. It is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent misconduct may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business and results of operations, including the imposition of significant fines or other sanctions.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">The failure to comply with our government contracts or applicable laws and regulations could result in, among other things, fines or other liabilities, and changes in procurement regulations could adversely impact our business, results of operations or cash flows.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues from our government customers are derived from sales to federal, state and local governmental departments and agencies through various contracts. Sales to public segment customers are highly regulated. Noncompliance with contract provisions, government procurement regulations or other applicable laws or regulations (including but not limited to the False Claims Act) could result in civil, criminal and administrative liability, including substantial monetary fines or damages, termination of government contracts or other public segment customer contracts, and suspension, debarment or ineligibility from doing business with the government and other customers in the public segment. In addition, contracts in the public segment are generally terminable at any time for convenience of the contracting agency or upon default. The effect of any of these possible actions by any governmental department or agency could adversely affect our business, results of operations or cash flows. In addition, the adoption of new or modified procurement regulations and other requirements may increase our compliance costs and reduce our gross margins, which could have a negative effect on our business, results of operations or cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Liability claims brought against us could result in payment of substantial damages, costs and liabilities and decrease our profitability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">We may face legal claims involving stockholders, consumers, clinical trial subjects, competitors, regulators and other parties. See </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">'Legal Proceedings'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> in Part A, Item 8 of this Form 20-F. Litigation and other legal proceedings are inherently uncertain, and adverse rulings could occur, including monetary damages, or an injunction stopping us from engaging in business practices, or requiring other remedies, including, but not limited to, compulsory licensing of patents. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Customer Claims</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If we breach the terms of an agreement with a customer (for example if we fail to comply with the agreement, all applicable regulations or Good Clinical Practice) this could result in claims against us for substantial damages which could have a material adverse effect on our business. As we provide staff to deliver our services, there is a risk that our management, quality and control structures fail to quickly detect a failure by one or more employees or contractors to comply with all applicable regulations and Good Clinical Practice and our internal requirements and standard operating procedures thereby exposing us to the risk of claims by customers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Claims relating to Investigators</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We contract with physicians who serve as investigators in conducting clinical trials to test new drugs on their patients. These patients will generally have underlying health conditions and this testing creates the risk of liability for personal injury to the patient or the risk of a serious adverse event occurring. Although investigators are generally required by law to maintain their own liability insurance, we could be named in lawsuits and incur expenses arising from any professional malpractice or other actions brought against the investigators with whom we contract.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Indemnification from Customers</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indemnifications provided by our customers&#160;against the risk of liability for personal injury to or death of the patients arising from a study drug vary from customer to customer and from trial to trial and may not be sufficient in scope or amount, or our customer&#160;may not have the financial ability to fulfill their indemnification obligations. Furthermore, we would be liable for our own negligence and negligence of our employees which could lead to litigation from customers or action or enforcement by regulatory authorities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Insurance</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We maintain what we believe is an appropriate level of worldwide Professional Liability/Error and Omissions Insurance. In the future we may be unable to maintain or continue our current insurance coverage on the same or similar terms. If we are liable for a claim or settlement that is beyond the level of insurance coverage, we may be responsible for paying all or part of any award or settlement amount. Also, the insurance policies contain exclusions which mean that the policy will not respond or provide cover in certain circumstances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Claims to Date</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To date, we have not been subject to any liability claims that are expected to have a material effect on our business; however, there can be no assurance that we will not become subject to such claims in the future or that such claims will not have a material effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Environmental, social and governance matters may impact our business and reputation.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Increasingly, in addition to the importance of their financial performance, companies are being judged by their performance on a variety of environmental, social and governance (ESG) matters, which are considered to contribute to the long-term sustainability of companies&#8217; performance. A variety of organizations measure the performance of companies on such ESG topics, and the results of these assessments are widely publicized. Customers may have specific ESG related requirements or targets and if we fail to meet these targets, we may lose business. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, investment in funds that specialize in companies that perform well in such assessments are increasingly popular, and major institutional investors have publicly emphasized the importance of such ESG measures to their investment decisions. Topics taken into account in such assessments include, among others, the Company&#8217;s efforts and impacts on climate change and human rights, ethics and compliance with law, and the role of the Company&#8217;s board of directors in supervising various sustainability issues. We actively manage a broad range of such ESG matters, taking into consideration their expected impact on the sustainability of our business over time, and the potential impact of our business on society and the environment. However, in light of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">stakeholders&#8217; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">increased focus on ESG matters and the lack of clear consensus and guidelines on the issues, there can be no certainty that we will manage such issues successfully, or that we will successfully meet society&#8217;s perceived expectations as to our proper role. Any failure or perceived failure by us in this regard could have a material adverse effect on our reputation and on our business, share price, financial condition, or results of operations, including the sustainability of our business over time.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Increasing focus on ESG matters has resulted in, and is expected to continue to result in, the adoption of legal and regulatory requirements designed to mitigate the effects of climate change on the environment, as well as legal and regulatory requirements requiring climate, human rights and supply chain-related disclosures. If new laws or regulations are more stringent than current legal or regulatory requirements, we may experience increased compliance burdens and costs to meet such obligations. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, our selection of voluntary disclosure frameworks and standards, and the interpretation or application of those frameworks and standards, may change from time to time or may not meet the expectations of investors or other stakeholders. Our ability to achieve our ESG expectations and commitments is subject to numerous risks, many of which are outside of our control. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_46"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Related to Our Common Stock</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Volatility in the market price of our common stock could lead to losses by investors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The market price of our common stock has experienced volatility in the past and may experience volatility in the future which could lead to losses for investors. Factors impacting volatility in the market price of our common stock include, amongst others:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">general market and economic conditions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">our results of operations; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">issuance of new or changed securities analysts&#8217; reports or recommendations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">developments impacting the industry or our competitors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">declines in the market prices of stocks generally;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">strategic actions by us or our competitors; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.81pt">announcements by us or our competitors of significant contracts, new products, acquisitions, joint marketing relationships, joint ventures, other strategic relationships or capital commitments;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:14.85pt">the public's reaction to press releases, other public announcements by us or third parties, including our filings with the SEC;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">guidance, if any, that we provide to the public, any changes in this guidance or failure to meet this guidance;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">changes in the credit rating of our debt;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">sale, or anticipated sale, of large blocks of our stock;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">additions or departures of key personnel;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">regulatory or political developments;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">our performance on ESG matters;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">litigation and governmental investigations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">changing economic conditions;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">exchange rate fluctuations; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:14.85pt">changes in accounting principles; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">other events or factors, including those resulting from natural disasters, war, acts of terrorism or responses to those events.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, stock markets have from time to time experienced significant price and volume fluctuations unrelated to the operating performance of particular companies. Future fluctuations in stock markets may lead to volatility in the market price of our common stock which could lead to losses by investors.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">An investor's return may be reduced if we lose our foreign private issuer status.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are a &#8220;foreign private issuer,&#8221; as such term is defined in Rule 405 under the U.S. Securities Act 1933, and, therefore, we are not required to file quarterly reports on Form 10-Q or current reports on Form 8-K with the SEC. In addition, the proxy rules and Section 16 reporting and short-swing profit recapture rules are not applicable to us. If we lose our status as a foreign private issuer by our election or otherwise and we become subject to the full reporting regime of the United States securities laws, we will be subject to additional reporting obligations and proxy solicitation obligations under the Exchange Act and our officers, directors and 10% shareholders would become subject to the short-swing profit rules. The imposition of these reporting rules would increase our costs and the obligations of those affected by the short-swing rules.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">We do not expect to pay any cash dividends for the foreseeable future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We currently do not expect to declare dividends on our common stock and have not done so in the past. We continue to anticipate that our earnings will be used to provide working capital, to support operations, to make debt repayments and to finance the growth and development of our business. They may also be used to continue our share repurchase program. Any determination to declare or pay dividends in the future will be at the discretion of our board of directors, subject to relevant laws and dependent on a number of factors, including our earnings, capital requirements and overall financial condition. Therefore, the only opportunity for stockholders to achieve a return on their investment may be if the market price of our common stock appreciates and shares are sold at a profit. The market price for our common stock may not appreciate and may fall below the price stockholders paid for such common stock. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">A future transfer of ICON ordinary shares, other than one effected by means of the transfer of book entry interests in the Depositary Trust Company (DTC), may be subject to Irish stamp duty.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Transfers of ICON ordinary shares effected by means of the transfer of book entry interests in the DTC should not be subject to Irish stamp duty where ICON ordinary shares are traded through DTC, either directly or through brokers that hold such shares on behalf of customers through DTC. However, if ICON ordinary shares are held as of record rather than beneficially through DTC, any transfer of ICON ordinary shares could be subject to Irish stamp duty (currently at the rate of 1% of the higher of the price paid or the market value of the shares acquired). Payment of Irish stamp duty is generally a legal obligation of the transferee. The potential for Irish stamp duty to arise could adversely affect the price of ICON ordinary shares.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 4. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; Information on the Company.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">History and development</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON public limited company (&#8220;ICON plc&#8221;) is a contract research organization (&#8220;CRO&#8221;), founded in Dublin, Ireland in 1990. For over thirty years we have grown significantly to becom</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">e a global provider of outsour</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ced development and services to pharmaceutical, biotechnology, medical device and government and public health organizations. Our mission is to improve the lives of patients by accelerating the development of our customers&#8217; drugs and devices through innovative solutions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are a public limited company in Ireland and operate under the Irish Companies Acts. Our principal executive office is located at: South County Business Park, Leopardstown, Dublin 18, Republic of Ireland. The contact telephone number of this office is +353 1 2912000. Our website is www.iconplc.com. Additionally, the SEC maintains a website (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our service offering includes clinical development, functional outsourcing and laboratory services. Our clinical development services include all phases of development (Phases I-IV), peri and post approval, data solutions and site and patient access services. Our laboratory services include a range of high value testing services, including bionanalytical, biomarker, vaccine, good manufacturing practice ('GMP') and central laboratory services. We also offer full-service and functional service partnerships to our customers.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Since ICON was founded, the Company has expanded through organic growth, together with a number of strategic acquisitions to enhance its expertise and capabilities in certain areas of the clinical development process and to broaden the service portfolio and add scale to existing services. Recent investments, which continue to strengthen our service offerings to meet the needs of our customers include: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On August 19, 2024, the Company acquired the KCR S.A Group ("KCR"), a CRO offering full service and functional services partnership ("FSP") clinical trial services. On January 9, 2024, the Company acquired HumanFirst, Inc. ("HumanFirst"), a life sciences technology company. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On October 2, 2023, the Company acquired 100% of the equity of BioTel Research, LLC which comprised the business formerly known as Philips Pharma Solutions, a leading provider of medical imaging and cardiac safety monitoring services. On April 20, 2023, the Company completed the purchase of the majority investor's 51% voting share capital of Oncacare Limited (such that Oncacare and its subsidiaries became wholly-owned subsidiaries of the ICON Group), a global network of oncology research sites that provide a unique patient recruitment and delivery solution for the clinical research industry.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed the acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of PRA Health Sciences ("the Acquisition" and "the Merger"). Upon completion of the Acquisition, PRA became a wholly owned subsidiary within the ICON Group. The Acquisition has transformed the scale and capabilities of the Company. The combined Company leverages its enhanced operations to transform clinical trials and accelerate biopharma customers&#8217; commercial success through the development of much needed medicines and medical devices. The combined Company retained the name ICON and brought together approximately 38,000 (as at the Merger date) employees across the globe, creating one of the world&#8217;s most advanced healthcare intelligence and clinical research organizations. The total value of the Merger consideration was $12.0&#160;billion and has resulted in the recognition of goodwill of $8.1&#160;billion, intangible assets of $4.9&#160;billion and an associated deferred tax liability of $1.1&#160;billion. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In conjunction with the completion of the Merger, on July 1, 2021, ICON entered into a 'Credit agreement' providing for a senior secured term loan facility of $5,515 million and a senior secured revolving loan facility in an initial aggregate principal amount of $300 million (the "Senior Secured Credit Facilities"). The proceeds of the senior secured term loan facility were used to repay the outstanding amount of (i) PRA&#8217;s existing credit facilities and (ii) the Company's private placement notes outstanding and fund, in part, the Merger. The senior secured term loan facility will mature in July 2028 and the revolving loan facility will mature in July 2026. As of December&#160;31, 2024, $4,568.6 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">of the senior secured term loan facility has been repaid through cash flow ($2,581.8 million) and refinancing ($1,986.8 million - refer to the New Notes below) in the period since the completion of the Merger. At December&#160;31, 2024, $946.4&#160;million was outsta</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">nding under the senior secured term loan facility (December&#160;31, 2023: $3,251.2&#160;million). As at December&#160;31, 2024, $nil (December&#160;31, 2023: $55.0&#160;million) was drawn under the senior secured revolving loan facility</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> while there was also</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> $nil</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> (</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">: $3.7&#160;million) in letters of credit given to landlords to guarantee lease arrangements under the senior secured revolving loan facility.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">With approximately</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> 41,900 em</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ployees across the globe</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, ICON has established relationships with a majority of the world&#8217;s top pharmaceutical and biotech companies. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe the Company now has the expertise, technology, and data assets to lead the industry into a new paradigm for bringing clinical research to more patients and enabling expanded capabilities for customers.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_1948"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><img src="iclr-20241231_g1.jpg" alt="Growth and Acquisitions 5.jpg" style="height:485px;margin-bottom:5pt;vertical-align:text-bottom;width:873px"/></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_1977"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:107%">Share repurchase program</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">On February 20, 2024, the Company's Board of Directors authorized a new buyback program of up to $500.0&#160;million of the outstanding ordinary shares of the Company. On October 22, 2024, the Company's Board of Directors authorized an additional buyback program of up to $250.0&#160;million of the outstanding ordinary shares of the Company. During the year ended December&#160;31, 2024, 2,179,699 ordinary shares were redeemed by the Company for a total consideration of $500.0&#160;million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">A resolution was passed at the Company&#8217;s Annual General Meeting (&#8220;AGM&#8221;) on July 23, 2024, which renewed the authorization for the Directors to purchase (buyback) up to 10% of the outstanding shares in the Company. All ordinary shares that were repurchased under the buyback program were canceled in accordance with the constitution of the Company and the nominal value of these shares transferred to other undenominated capital as required by Irish Company law.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:107%">The New Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">On May 8, 2024, ICON Investments Six Designated Activity Company (the "Issuer"), a wholly-owned subsidiary of ICON plc, issued $2 billion of Senior Secured Notes ("the New Notes"). The New Notes were issued in aggregate principal amounts of: $750 million 5.809% Senior Secured Notes due 2027 (the "2027 Notes"), $750 million 5.849% Senior Secured Notes due 2029 (the "2029 Notes") and $500 million 6.000% Senior Secured Notes due 2034 (the "2034 Notes"). The proceeds from the issuance were used to repay a portion of the senior secured term loan outstanding under the Senior Secured Credit Facilities and to pay fees, costs and expenses related to the offering. On July 10, 2024, the New Notes were admitted to the Official List (the &#8220;Official List&#8221;) of The International Stock Exchange (the &#8220;Exchange&#8221;).</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:107%">Repricing - senior secured term loan facility and senior secured revolving credit facility</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">On March 14, 2024, the parties to the Credit Agreement entered into the Third Amendment to the Credit Agreement (the &#8220;Third Amendment&#8221;) in connection with the repricing of the senior secured term loan facility and the senior secured revolving credit facility.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">With respect to the senior secured term loan facility, the repricing culminated in a margin reduction of 25 basis points, from 2.25% (based on the then-current first lien net leverage ratio) to 2.0%; and the elimination of the credit adjustment spread. The combination of the above resulted in an overall reduction of 51 basis points on the senior secured term loan facility (assuming quarterly refixing).</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">With respect to the senior secured revolving credit facility, the repricing culminated in a margin reduction of 0.40%, from 1.25% (based on the then-current S&amp;P corporate family rating) to 0.85%, which is subject to change pursuant to a pricing grid based on the current corporate family rating assigned by S&amp;P; and the elimination of the credit adjustment spread. There were also concurrent fee adjustments to the senior secured revolving credit facility; the commitment fee on drawings was reduced from 0.4375% to 0.2975%, (based on our current corporate family rating from S&amp;P) while the utilization fee increased by 15 basis points, dependent on amount utilized. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:107%">Senior Secured Credit Facilities repayment</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">During the year ended December&#160;31, 2024, the Company made mandatory and voluntary principal repayments of $2,304.8 million (December&#160;31, 2023: mandatory and voluntary principal repayments of $950.0 million) of the senior secured term loan facility. The voluntary repayments made during the year ended December&#160;31, 2024 resulted in an accelerated charge associated with previously capitalized fees of $16.9 million.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In addition, during the year ended December&#160;31, 2024, the Company drew $318.0&#160;million (December&#160;31, 2023: $370.0&#160;million) of the senior secured revolving loan facility and repaid $373.0&#160;million (December&#160;31, 2023: $315.0&#160;million). At December&#160;31, 2024, $nil was drawn under the senior secured revolving loan facility </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(December&#160;31, 2023: $55.0&#160;million)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">. Refer to note 13. Bank credit lines, loan facilities and notes for further details on the Company's Senior Secured Credit Facilities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Foreign exchange</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The Company prepares its financial statements in United States dollars while the local results of a certain number of our subsidiaries are prepared in currencies other than United States dollars, including, amongst others, the pound sterling and the euro. In addition, the Company's contracts with clients are sometimes denominated in currencies other than the United States dollar. Finally, the Company is exposed to a wider variety of currencies in the expenses line due to most expenses being incurred in the local currencies of where our global operations are based. Accordingly, changes in exchange rates between the United States dollar and those other currencies could have a material adverse effect on the Company&#8217;s financial results. In the year ended December&#160;31, 2024, the Company recorded foreign currency gains of $18.1&#160;million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Changes in Board of Directors composition &amp; Executive Leadership</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">On July 23, 2024, Ms. Joan Garahy retired from the Board of Directors and Ms. Anne Whitaker was appointed to the Board of Directors. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">Mr. Nigel Clerkin commenced employment with the Company in October 2024 and effective October 31, 2024 took over from Mr. Brendan Brennan as Chief Financial Officer.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Business Overview</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is a global provider of outsourced development and commercialization services to pharmaceutical, biotechnology, medical device, and government and public health organizations.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We offer a full range of clinical, consulting and commercial services that range from clinical development strategy, planning and trial design, to full study execution, and post-market commercialization.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON provides its services across a range of clinical outsourcing operating models including strategic partnerships, preferred provider, full-service delivery to functional service provision and stand-alone services. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process, from compound selection to Phase I-IV clinical studies. We earn revenue by providing a number of different services to our customers. Those services are integral components of the clinical development process and include clinical trial management, consulting, contract staffing, data solutions and laboratory services. </span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span><img src="iclr-20241231_g2.jpg" alt="Services chart 2024_Simple2.jpg" style="height:327px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our vision is to be the healthcare intelligence partner of choice by delivering industry leading solutions and best in class performance in clinical development. We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in the major therapeutic areas on a global basis and have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated full-service solution. In order to achieve this vision, we continue to invest in technology and data analytics capabilities. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON maintains a sustained focus on research and development. We continue to enhance our portfolio of data solutions and decentralized clinical trial technology through the development of industry-leading technologies and processes to support our clients. ICON is leading the industry transformation through four key levers: transforming clinical trials, site and patient centricity, healthcare intelligence and applied innovation, and seamless, integrated service delivery.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2024, we employed approxi</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">mately 41,900 employees in 106 locations in 55 countri</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">es. During the year ended December&#160;31, 2024, we derived </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">36.0%, 52.6% and 11.4% of our revenue in the United States, Europe and Rest of World, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">The ICON strategy</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have achieved strong growth since our foundation in 1990, as a global provider of outsourced development and commercialization services to pharmaceutical, biotechnology, medical device and government and public health organizations.  We focus our innovation on those factors that are critical to our clients - reducing time to market, reducing cost and increasing quality. Our global team has extensive experience in a broad range of therapeutic areas. ICON has been recognized as one of the world's leading Contract Research Organizations (''CROs") through a number of high-profile industry awards (see www.iconplc.com/awards).  </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">As our market has evolved, biopharmaceutical companies are tackling productivity challenges, budget constraints and greater demands to demonstrate product value; all of which are placing increased pressure on their revenues and levels of profitability. However, these trends have generally been positive for CROs, as increased outsourcing has been adopted by these companies as they seek to create greater efficiencies in their development processes, convert previously fixed costs to variable, and accelerate time to market for new treatments. We believe innovation in the biopharma sector has been fueled by recent advances in technology, improving scientific profiles of drug targets, and increasing the pipeline of quality assets that can be investigated for further development.  This provides biopharma companies an opportunity to strengthen their development pipeline with promising drug candidates, particularly those that are facing challenging patent expiries to their current marketed products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe regulatory and reimbursement pressures will increase the emphasis on late stage (post marketing) research, while increasing requirements to demonstrate the economic value of new treatments. As a result, we believe outcomes and comparative effectiveness research will most likely be required in order to secure on-going product reimbursement. Furthermore, we believe advances in molecular biology and genetics will drive further growth in innovation in the long term which in turn should create further growth opportunities for both biopharma companies and their outsourced development partners.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We expect that continued outsourcing will be a core strategy of clients in the near and mid term as they respond to the increased pressures on their revenues and profitability. Larger clients were the first to form strategic partnerships with global CROs in an effort to reduce the number of outsource partners with whom they engage and to reduce inefficiencies in their current clinical development models. More recently we have seen the increasing adoption of this reduced partner model with mid-tier pharmaceutical and biotechnology firms as they also seek to drive development efficiencies. As outsourcing penetration increases, we believe clients may seek a greater level of integration of service offerings from CROs, although some will continue to purchase services on a stand-alone basis. Creating greater connectivity and &#8220;seamlessness&#8221; between our services and the sharing of real-time clinical, operational and &#8220;real world&#8221; data with clients will therefore become increasingly important for CROs. ICON will seek to benefit from this increased outsourcing by clients to grow our business by increasing market share with our existing client base and adding new clients within the Phase I-IV outsourced development services market; the aim being to ensure we will be considered for all major Phase I-IV projects.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Delivery of our mission and strategy is focused on our four strategic pillars, being (i) Patient Access &amp; Engagement (ii) Career Development &amp; Employer of choice (iii) Enduring Customer Partnerships and (iv) Healthcare Intelligence &amp; Applied Innovation. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><img src="iclr-20241231_g3.jpg" alt="ICON_2025 Corporate Mission.jpg" style="height:339px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Patient Access &amp; Engagement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has a focused patient, site and data strategy, which is helping us to improve site identification, study placement and patient recruitment and retention. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Accellacare is ICON's global clinical research network offering customers a wide range of stand-alone and integrated solutions at site or in patients' homes as part of decentralized trials. Our patient centric approach accelerates study start-up and increases patient recruitment and retention for the pharmaceutical, biotechnology and medical device industries. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Accellacare In-Home Services takes study visits directly to patients where they live, work, study or play in all phases and therapeutic areas of clinical trials. By bringing trial visits directly to patients, we ease the burden of participating in clinical research to increase patient recruitment and retention. Accellacare In-Home Services has experience in more t</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">han 500 </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">clinical trials, tailoring our services to fit each study's specific requirements across more than 55 countries. This cohesive approach is leading to higher patient recruitment and retention rates. Accellacare is also achieving faster study start-up for its customers through efficiencies gained in central process management including budget and contracting, which can otherwise be a source of delay. This combined with a finely tuned feasibility approach allows the network to identify and recruit more patients to studies, in a wide range of therapeutic areas, in a shorter time frame. Accellacare is an important part of the integrated patient, site and data strategy, helping us to improve patient recruitment and retention. Through Accellacare, we are committed to delivering on the promise of patient centricity in clinical research whilst also providing investigators with innovative treatments for their patients with a quality-focused clinical research infrastructure supported by experienced professionals globally.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Accellacare Site Network encompasses 21 owned/embedded sites across the US, UK and Spain as well as a number of collaboration agreements with other sites. Accell</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">acare offers a quality focused clinical research infrastructure delivering value and benefits to sponsors. Accellacare supports customers with faster start-up and the time from site selection to site initiation visit when compared to other sites. Furthermore, Accellacare ac</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">hieves on average more patients per sit</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">e when compared to other sites.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In 2024, Accellacare Site Network further optimized its site partnerships and focused on enhancing capabilities within its US locations with a continued focus on Central nervous system (CNS) capabilities. This included onboarding two new CNS specialist sites in California. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In 2024, the Elite Sites, ICON's dedicated program for top-tier site networks, was designed to offer an infrastructure for those networks who have set themselves apart. These networks have been selected for their high-performance quality, consistency with faster start-up, and ability to meet or exceed recruitment commitments. With the use of ICON&#8217;s Elite Site program, the aim is for clients to increase reliability with delivery, reduce site or country footprint, shorten overall study timelines and ultimately get drugs to market faster. ICON Elite Sites have been selected to align with a few key therapeutic areas &#8211; Oncology, Neurosciences, and Gastrointestinal/ Non-alcoholic steatohepatitis (NASH) in which these networks have shown the ability to be true differentiators for our clients and study teams. The ICON Elite Sites program has a global reach, including 3 networks presently, and will continue to expand to best support our clients. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Finding and engaging suitable patients to conduct clinical trials is one of the biggest issues facing the drug development industry today.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Th</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">e performance of investigative sites that do take part in research is uneven, hard to predict and many trials do not meet the initial recruitment goals. The current market challenge in patient enrollment creates an opportunity for ICON to differentiate its service offering and we are working to reduce patient recruitment times through enhanced site and investigator selection based on key performance metrics and through use of our proprietary FIRECREST technology which is used to train and support sites during the development process. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON's site networks enhance our ability to enroll patients onto the clinical studies we perform. We have also developed strategic alliances with investigator site groups and healthcare systems in all major global research markets. In partnership with others, we are pioneering patient recruitment solutions that leverage cognitive computing to transform clinical trial matching and allow a data-driven approach to deliver the right patients for trials. One Search is our intuitive, integrated workflow and interrogation tool that enables access to multiple data sources and provides the visualization and tools necessary for optimum&#160;site identification&#160;based on ICON and industry data of capability, experience and performance. Scoring on enrollment performance, speed of start-up and quality supports better site selection.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Career development and employer of choice</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is an award-winning workplace that enables our employees to make a difference to patients&#8217; lives by being part of a world-class clinical research organization that helps deliver new medicines &amp; medical devices that are benefiting patients worldwide. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our global team of over </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">41,900</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> is united in purpose, working together in an inclusive environment to help solve some of the world&#8217;s most complex healthcare challenges. We value integrity, inclusion, collaboration and agility, which together form our &#8216;Own it&#8217; culture that fosters innovative ideas and a vibrant workplace. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our success depends on the knowledge, skills and calibre of our people. That&#8217;s why we are committed to developing a continuous learning culture &#8211; one where we challenge employees with engaging work and where every experience adds to their professional development. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Through our industry leading learning management system, internally developed professional development programs and partnerships with leading academic institutions, employees are encouraged to broaden their scientific, technical and business knowledge. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Employees also have access to tools that will help them develop the skills to support their career aspirations. With a strong emphasis on personal and professional development, ICON equips employees with the skills, knowledge and expertise to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">navigate and succeed in a dynamic work environment. At ICON, we provide growth opportunities for every stage of an employee&#8217;s career, empowering them to progress and reach new heights. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We offer competitive total rewards packages that are designed with employee health, wealth and well-being in mind. Fair and equitable pay is core to our reward ethos, and we celebrate and reward high performance. Our benefits are focused on well-being and work-life balance for employees and their family.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From training and development programs to mentorship and coaching, we're committed to helping our employees reach their full potential.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Enduring customer partnerships</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continue to focus on expanding and deepening our partnerships with existing customers, while also developing new customer relationships. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Strategic client relationships will increasingly manifest themselves in many different forms. Many of these relationships will require innovative forms of collaboration across ICON service areas and departments and will therefore require increased flexibility to offer services on both a standalone functional basis and as part of a fully integrated service solution. To support this objective, we continue to evolve our collaboration and delivery models, invest in technology that will enable closer data integration across our service areas and enhance our project and program management capabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To meet the evolving needs of both our existing and new clients we continue to enhance our capabilities through both organic service developmen</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">t and targeted acquisitions. In addition, we continue to enhance our scientific and therapeutic expertise to support our customers in specific areas including oncology, orphan and rare diseases, CNS, dermatology, infectious disease and women's health. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has extensive experience in vaccine clinical development for commercial businesses, governments and NGOs. This experience enabled us to play a significant role in the search for vaccines and treatments for COVID-19. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continue to target growth in under-penetrated CRO market segments. Penetration within medical device companies has lagged that of bio-pharma firms but is beginning to accelerate. EU regulatory reform enacted in 2017 is a further catalyst to growth in this segment as it included stricter requirements to perform clinical evaluations and post-sale surveillance. In early 2020, ICON acquired MedPass which has further enhanced our value offering in this area.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also invested significantly in our site and patient network (Accellacare), and consider our expertise and offering in this area as one of our strategic pillars.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Healthcare intelligence and applied innovation</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Innovation at ICON is focused on the factors that are critical to our clients. We develop integrated technologies to significantly enhance the efficiency and productivity of clients&#8217; drug and device development programs, providing true transparency across all areas of a study.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is focused on applying innovation that can help our customers improve their development outcomes. We are focusing this innovation in three critical areas: improving clinical trial design and execution; faster and more predictable patient recruitment; and evolving clinical trials to be more patient centric which includes data collection and analysis directly from patient&#8217;s digital devices. Our approach to developing solutions to these challenges incorporates partnering with best-in-class technology providers but is also supported by a suite of differentiated ICON proprietary technologies.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Through an informatics strategy built around key platforms including ICONIK and Health Cloud, we have continued to invest in building our capabilities in the gathering, analysis and application of real world patient data within both the clinical trial and post-trial observational study environments. ICONIK and Health Cloud enable ICON to deliver services such as Risk Based Monitoring (RBM) which uses near-real time clinical data to drive monitoring visit schedules, enabling better decision making and the successful implementation of clinical trial strategies that significantly improve efficiency in clinical trials thereby reducing overall cost and time to market whilst better protecting patient safety.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">ICON&#8217;s proprietary One Search tool helps to efficiently and effectively identify optimum trial sites. It synthesizes multiple data sources, applying AI machine learning and rich data visualization for optimum site identification, resulting in improved study start-up and site cycle times, significant reductions in the percentage of low performing sites and increasing the percentage of studies meeting planned First Patient In (FPI).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">FIRECREST is ICON&#8217;s proprietary comprehensive site performance management system. It is a web-based solution which enables accurate study information, including protocol information, training manuals and case report forms, to be rolled out quickly and simultaneously to investigative sites. It allows site behavior to be tracked to ensure training is understood, procedures are being followed and that timelines and study parameters are met. It can significantly reduce the number of data </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">queries originated from investigator sites. FIRECREST is now integrated into the ICON Safety Reporting Solution and provides a Site Question Management Tool. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The ICON Patient Engagement Platform was developed to support improved patient experience and enrollment in clinical trials. The web-based patient engagement platform, provides patients with study specific information and connectivity with the nearest investigative site. The solution supplements patient recruitment outreach by sites and increases visibility of potential study participants for sponsors and sites. An easy to navigate, user friendly interface guides the patient to new and ongoing studies in their particular indication and a pre-qualification questionnaire helps to determine if the study is a right fit for them. If the patient decides to register interest, they are given the option to select their nearest investigative site. This establishes connection with the site and the patient can then choose to contact the site or ask to be contacted for pre-screening.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We positively impact patients&#8217; lives by understanding their journeys and how they can benefit from drugs currently in development and on the market. We do this by developing a holistic, global data environment across pharmaceutical and biotech companies (development to commercial) that gives insights into patients, and how best to serve them. Alongside the application of these technology solutions we are also focused on innovation through the redesign and where appropriate the automation of current clinical trial processes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Operational excellence, quality and delivery</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Quality is the foundation of our success. The quality of our work is vital to our mission of bringing better medications to patients around the world. We are committed to maintaining, supporting, checking and improving our quality systems to meet or exceed the quality standards demanded by our clients, patients and regulatory authorities. We focus our innovation on the factors that are critical to our clients &#8211; reducing time to market, reducing cost and increasing quality &#8211; and our global team of experts has extensive experience in a broad range of therapeutic areas.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Quality project execution underpins all that we do and we have an ongoing focus on developing our people and&#160;processes to continue to&#160;enhance our service delivery. We also deploy supporting technologies which we believe will enable faster and deeper insights into the quality of trial data.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are focused on operational excellence across our support functions, and we operate a global business support infrastructure across functions including finance, information technology, facilities, human resources, legal and quality assurance. This enables us to enhance the service levels across these support areas whilst driving down the costs of the service provision.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Capabilities and service offerings</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe ICON is the world&#8217;s largest pure-play contract research organization. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. We develop new innovations, drive emerging therapies forward and improve patient lives. Our focus is on delivering Healthcare Intelligence to customers to address the full spectrum of clinical development challenges, not just point-of-service delivery. The synthesis of our experience, expertise, best practices, technology and data provides patient centric processes, commercially optimized for global success, and is driving transformation of trials to improve R&amp;D return on investment.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">With an expansive portfolio of integrated clinical, commercialization and consulting services, global presence, depth in therapeutic expertise, and data-driven healthcare technology, we deliver globally scaled expertise &amp; solutions for all customers and patients. Solutions span the Clinical Development lifecycle from compound selection to Phase I-IV clinical studies and post approval outcome research and market access consulting solutions, and can be adapted to suit local trials or large global programs:</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><img src="iclr-20241231_g4.jpg" alt="ICON Services Overview.jpg" style="height:942px;margin-bottom:5pt;vertical-align:text-bottom;width:665px"/></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Industry overview</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CRO industry provides independent product development solutions and services for the pharmaceutical, biotechnology and medical device industries. Companies in these industries outsource services to CROs in order to manage the drug and device development process more efficiently as well as bring drugs, biologics, patent-protected medicinal product and medical devices to market faster to enhance patient well-being and maximize their return on investment. The CRO industry has evolved since the 1970s from a small number of companies that provided limited clinical development services to a larger number of CROs that offer a range of services that encompass the entire research and development process, including pre-clinical development, clinical trials management, clinical data management, study design, bio statistical analyses, post market surveillance, regulatory affairs, central laboratory and market access services. CROs are required to provide services in accordance with good clinical and laboratory practices, as governed by the applicable regulatory authorities.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CRO industry is highly fragmented, consisting of several hundred small, limited-service providers, medium sized CROs and a small number of large CROs with global operations. Although there are few barriers to entry for small, specialist service providers, we believe there are significant barriers to becoming a CRO with global capabilities and expertise. These barriers include the infrastructure and experience necessary to serve the global demands of clients (sponsors), the ability to recruit sites and patients globally, the management of complex clinical trials, the ability to offer customers a variety of delivery models, broad therapeutic expertise and the development and maintenance of the complex information technology systems required to integrate these capabilities. In recent years, the CRO industry has experienced consolidation, resulting in the emergence of a select group of CROs that have the capital, technical resources, integrated global capabilities, data and expertise to manage the development programs of pharmaceutical, biotechnology and medical device companies. We believe that large and medium-sized pharmaceutical companies are selecting a limited number of CRO service providers with which they deal rather than utilizing many, in order to form strategic partnerships with global CROs in an effort to drive incremental development efficiencies and leverage the scientific and medical expertise. We believe that this trend will continue to concentrate the market share among the larger CROs with a track record of quality, speed, flexibility, responsiveness, global capabilities and access to patients and overall development experience and expertise.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">New drug development overview </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> ethical pharmaceuticals and biologics</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Before a new drug or biologic may be marketed, it must undergo extensive testing and regulatory review to determine that it is safe and effective. The following discussion primarily relates to the US FDA approval process for such products. Similar procedures must be followed for product development with other global regulatory agencies. The stages of this development process are as follows: </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Preclinical Research</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> &#8220;In vitro&#8221; (test tube) and animal studies must be conducted in accordance with applicable regulations to establish the relative toxicity of the drug over a wide range of doses and to detect any potential to cause birth defects, affect vital organs, cause mutations or cancer. Many of these tests must be performed before a new investigational therapy can progress into human studies. If results warrant continuing development of the drug or biologic, the sponsor or owner of the asset will file for an Investigational New Drug Application, or ("IND"), which must be approved by the FDA before starting the proposed clinical trials.  However, preclinical studies will continue to be conducted in parallel with the clinical trials, some of which can take up to 3 years to complete. ICON can provide expert advice for preclinical programs, but does not conduct preclinical research as a service to its customers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Clinical trials (approximately 3.5 to 7 years)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Exploratory development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Phase I</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"> (approximately 6 months to 1 year)</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> consists of basic safety and tolerability testing in small numbers of human subjects, initially in healthy volunteers, and includes studies which may show the drug is having an effect on the body, if it is safe, how it is affected by other drugs, where it goes in the body, how long it remains active and how it is broken down by and eliminated from the body. After single and multiple dose studies have been conducted, the asset can progress into Phase II, however, Phase I studies will continue to be done to help support the development of the asset in new populations such as children or the elderly.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Phase II</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"> (approximately 2 to 3 years</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">) includes basic efficacy and dose-range testing in a limited patient population (usually) 100 to 200 patients to help provide preliminary safety and evidence that the drug is likely to be effective in the target disease. If the Phase II results are satisfactory the sponsor may decide to proceed to Phase III studies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Confirmatory development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Phase III </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">(2 years or greater)</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">consists of efficacy and safety studies in several hundred to a few thousand patients at multiple investigational sites (hospitals and clinics), often in multiple geographies. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">FDA approval, through submission of an IND, is necessary for most clinical trials, regardless of the phase of development. In addition, parallel independent committee approval is also required.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">NDA or BLA Preparation and Submission.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Upon completion of Phase III trials, the sponsor assembles the statistically analyzed data from all phases of development into a single large submission along with the Chemistry, Manufacturing and Controls (CMC) and preclinical data and the proposed labelling into the New Drug Application (NDA), or Biologics License Application (BLA) and submits them for assessment and approval by the relevant division of the FDA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Expanded Access Programs (EAPs).</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Sometimes an investigational drug may be provided to subjects outside of a clinical trial, also called compassionate use. EAPs refer to the regulated use of a study drug outside of a clinical trial by patients with serious or life-threatening conditions where there is no alternative therapy available. In this context the FDA may allow the sponsor to make the study drug available to a larger number of patients for treatment use. </span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">FDA review and approval of NDA or BLA (1 to 1.5 years).</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Data from all phases of development is scrutinized to confirm that the applicant company has complied with all applicable regulations, safety and efficacy of the product has been demonstrated, and that the benefit to risk ratio for the drug or biologic is positive for the specific use (or &#8220;indication&#8221;) under study. The FDA may refuse to accept the NDA or BLA if the application has administrative or content criteria which do not meet FDA standards. The FDA may also deny approval of the drug or biologic product if applicable regulatory requirements are not satisfied, if the drug has not adequately shown to be effective or if there are safety concerns. Often a company will be required to conduct specific studies after the approval of a drug. These are called post approval requirements or commitments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Post-market surveillance, Phase IV studies and health outcomes.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Once approved by the FDA, it requires the drug or biologic license holder to collect and periodically report to them additional safety (and perhaps efficacy) data on the drug or biologic for as long as the manufacturer markets it (post-market surveillance, including pharmacovigilance). If the product is marketed outside the U.S., these reports must include data from all countries in which the drug is sold. Additional studies (Phase III and Phase IV) may be undertaken by the manufacturer after initial approval to find new uses for the drug, to test new dosage formulations, or to confirm selected non-clinical benefits, e.g., increased cost-effectiveness or improved quality of life. Additionally, the FDA and other regulatory agencies may require license holders of drugs or biologics to prepare risk management plans that are aimed at assessing areas of product risk and actively managing such risks throughout the product lifecycle.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Key trends affecting the CRO industry</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CROs derive substantially all their revenue from the research and development expenditures of pharmaceutical, biotechnology and medical device companies. We believe that the following trends create further potential growth opportunities for global CROs, although there is no assurance that growth will materialize.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Continued innovation and development of enabling technologies</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Innovation driving new drug development activity </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">New technologies together with improved understanding of disease pathology (driven by scientific advances such as the mapping of the human genome) have increased the number of new drug candidates being investigated in early development. This has greatly broadened the number of biological mechanisms being targeted, which increasingly include rare or orphan diseases that currently have no effective treatments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These developments should lead to increased activity in both preclinical and Phase I development and in turn lead to more treatments in Phase II-III clinical trials. As the number of trials that need to be performed increases and these trials become focused in indications where finding suitable patients is increasingly challenging, we believe that drug developers will increasingly rely on CROs to manage these trials to leverage their global expertise and to continue to focus their own competences on drug discovery and sales and marketing of commercialized products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Decentralized and hybrid trials</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Decentralized (DCT) and hybrid trials have existed for quite some time, but the coronavirus pandemic accelerated the demand when the pharma industry was challenged to move to remote models to protect patient safety and ensure data integrity for COVID-19 vaccine trials and other ongoing trials. The pandemic provided an opportunity to move many technologies and remote patient care solutions from pilot phase to actively supporting patients and clinical research. . </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As an industry, we have an opportunity to make decentralized and hybrid approaches a standard moving forward. The ways the industry has been conducting clinical research in a traditional site-based approach need to evolve so we can implement tools, techniques and processes in everyday research to bring about a more patient-centric approach. Each new element needs to be evaluated to assess the impact for the individual patients and study sites. Recent experiences in the industry have shown:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Using fewer countries and fewer sites can reduce costs, decrease timelines for start-up and minimize the risk of disruption during and post pandemic. </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Hybrid studies, utilizing digital health, in-home health, and telehealth, can reduce the number and frequency of onsite patient visits and therefore reduce patient burden.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Home-based patient visits and direct-to-patient contacts can increase patient satisfaction, compliance and retention, providing greater trial resilience. </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Harmonizing data from disparate data sources will provide real-time access and consistent data visibility, helping to improve safety monitoring and enabling the visualization of data trends. </span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Regulatory easement during the pandemic resulted in a number of positive changes to clinical trial procedures, enabling studies to continue and in some cases progress at a faster pace, and improvements to the process of CTA and IND approvals. Regulatory authorities have been clear that regulatory easement related to the pandemic will not be extended. However, many regulatory authorities have instead released guidance or position statements on the use of DCT elements, such as technology and off-site conduct, more generally in clinical trials, benefiting the patient and healthcare advancement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Ultimately, we are trying to increase the speed at which drugs can meet approval guidelines and help treatable populations. By using decentralized tools, technologies and processes, we will reduce the burden on patients, increase satisfaction and provide them with the same standard of care during a virtual or home visit that they would receive in a clinic, thereby fulfilling the promise of clinical research as a care option. While reduced costs may not be seen in the early phase of adoption (in fact investment required may be higher initially due to technology implementation), choosing the right solution for the specific study characteristics has the potential to increase patient recruitment and retention, which can result in reduced overall research costs and quicker time to market. To find the best clinical trial design to suit their needs, sponsors will need to take patient centricity into consideration from the outset and at every step along the way, because what benefits the patient will ultimately benefit the sponsor in outcomes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">New technology enabling more efficient development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Technology innovation is playing an increasingly important role in helping to support more efficient drug development. Leveraging differentiated technology solutions and data collaborations drives better execution in clinical trials. Larger CROs have been at the forefront of this innovation developing technology solutions that support the integration of trial data across multiple systems, data repositories that enable sponsors to get real time clinical insights on the performance of their drugs and tools that support better trial designs and operation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The emergence of modern healthcare technologies ("mHealth") that build on the global prevalence of mobile and digital technologies also have an influence on drug development. It is now possible to capture health data using mobile devices and wearables. This enables sponsors to gather new clinical and &#8220;real-world&#8221; patient insights and will also be used to enhance patient engagement and adherence throughout the development process. As these devices mature it will also be possible to complete more &#8220;decentralized and hybrid trials&#8221; based on remote monitoring of patients in their home environment which may drive further efficiencies in the trial process.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Social media is also becoming an important platform for life sciences companies to strengthen patient engagement programs and collaborate with other stakeholders in the healthcare system. Many patients with specific diseases are forming patient groups and actively collaborating using social media. These groups represent an important potential source of patients for new clinical studies but can also provide valuable insights into effectiveness and safety of new treatments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As the influence of technology on drug development grows, it broadens the potential number of partners that CROs will work with in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Expanded use of new patient data sources  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pharmaceutical companies are looking to access a variety of new healthcare data sources containing medical and prescribing records to help improve development programs and to get better evidence of the value their treatments are bringing to patients once they are launched in the market. The larger global CROs have significant data management experience which can be leveraged to support these efforts and have invested in analytics capabilities to help deliver better insights for customers during the product lifecycle. Global CROs are also forging collaborations to access specific data sets that can provide further patient insights to support better matching of patients and sites to the clinical trial process. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Improving productivity and operating efficiencies</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Continuing focus on productivity within research and development programs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pharmaceutical and biotechnology companies continue to seek ways to improve the productivity and overall efficiency of their development efforts and increasingly see the use of CROs as a strategic partner in these efforts. They are leveraging the expertise of CROs to help identify the most promising drug candidates in early development and discontinue developing those that have safety issues, limited efficacy or that will have significant reimbursement challenges. These companies are also initiating programs to drive more efficiency in their development programs. One example of this has been the efforts to achieve a more seamless transition across development phases, particularly across Phase I-III trials. In parallel, regulatory initiatives such as the 21st Century Cures Act and the emergence of clinical trial techniques such as adaptive trial design, risk based clinical trial monitoring, decentralized and hybrid trials are enhancing development, allowing effective treatments to get to patients quicker at reduced development costs. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Cost containment pressures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Over the past several years, drug companies have sought more efficient ways of conducting business due to margin pressures stemming from patent expirations of their commercialized products, greater acceptance of generic drugs, pricing pressures caused by the impact of managed care, purchasing alliances and regulatory consideration of the economic benefit of new drugs. Consequently, drug companies are centralizing research and development, streamlining their internal structures and outsourcing certain functions to CROs, thereby converting previously fixed costs to variable costs. Larger companies (and more recently medium sized companies) are actively entering into strategic partnerships with a limited number of CROs in an effort to drive increased efficiencies. The CRO industry and, in particular, large CROs with global capabilities, considerable scientific knowledge and expertise are often able to perform the needed services with greater focus and at a lower cost than the client could perform internally, although CRO companies themselves are facing increased cost containment pressures as drug companies seek to further reduce their cost base.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">Global trends influencing the CRO industry</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Pressure to accelerate time to markets and globalization of the marketplace</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reducing product development time maximizes the client&#8217;s potential period of patent exclusivity, which in turn maximizes potential economic returns. We believe that clients are increasingly using CROs that have the appropriate expertise and innovation to improve the speed of product development to assist them in improving economic returns. In addition, applying for regulatory approval in multiple markets and for multiple indications simultaneously, rather than sequentially, reduces product development time and thereby maximizes economic returns. We believe that CROs with global capabilities, considerable knowledge and experience in a broad range of therapeutic areas are key resources to support a global regulatory approval strategy. Alongside this, the increasing need to access pools of new patients is leading to the conduct of clinical trials in new &#8220;emerging regions&#8221; such as Eastern Europe, Latin America, Asia-Pacific and South America. We believe that having access to both traditional and emerging clinical research markets gives global CROs a competitive advantage.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Progress within the biotechnology sector</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The nature of the drugs being developed is continuing to change. Biotechnology is enabling the development of targeted drugs with diagnostic tests to determine whether a drug will be effective given a patient&#8217;s genomic profile. An increasing proportion of research and development expenditure is being spent on the development of highly technical drugs to treat very specific therapeutic areas in sectors of unmet medical need. Much of this discovery expertise is found in biotechnology firms. We believe that it is to these organizations that the large pharmaceutical companies will look for an increasing proportion of their innovation, and consequently, new drug pipelines. Whether it is through licensing agreements, joint ventures or equity investment, we believe we may see the emergence of more strategic relationships between small discovery firms and the larger pharmaceutical groups. As the majority of these biotechnology companies do not have a clinical development infrastructure, we believe that the services offered by CROs will continue to be in demand from such companies providing they have the necessary funding. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Increasing number of large long-term studies and an increasing requirement to show the economic value of new treatments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe that to establish competitive claims and demonstrate product value, to obtain reimbursement authorization from bodies such as the FDA in the US, and the National Institute for Health and Clinical Excellence in the UK, and to encourage drug prescription by physicians in some large and competitive categories, more clients need to conduct outcome studies to demonstrate, for example, that mortality rates are reduced by certain drugs. To verify such outcomes, very large patient numbers are required, and they must be monitored over long time periods. We believe that as these types of studies increase there will be a commensurate increase in demand for the services of CROs who have the ability to quickly assemble large patient populations, globally if necessary, to manage this complex process throughout its duration.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The rising costs of healthcare in most developed countries also means there is an increasing pressure to show that new medical treatments are more cost effective and deliver better patient outcomes than existing treatment regimes. This also means that sponsors need to increasingly generate outcome data both as part of the product approval submissions and as part of post-approval research programs. This is creating opportunities for CROs who can offer support in developing and interpreting this data.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">A focus on long-term product safety</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The clinical trial approval process can only detect major and common adverse side effects of drugs; less common but no less serious side effects may only become apparent after many years of use. As a result, there is an increase in the number of drugs given &#8220;conditional approvals&#8221; where further &#8216;post-approval&#8217; studies are being mandated. In addition, prudent sponsors undertake similar studies to detect early warning signs of any potential problems with their products. Such studies may take the form of prospective long-term safety studies, simpler observational studies or registries where patients meeting specific criteria for disease or drug use are followed for long periods to detect any safety issues. CROs are well positioned to perform these studies on behalf of sponsors. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Increasing regulatory demands</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Regulatory agencies increasingly require more data to support new drug approvals and are seeking more evidence that new drugs are safer and more effective than existing products. As a result, the complexity of clinical trials, the number of procedures required to be conducted in these trials and the size of regulatory submissions are driving the demand for services provided by CROs. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON Cares</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our mission is to improve the lives of patients by accelerating the development of our customers&#8217; drugs and devices through innovative solutions. We are passionate about providing innovative solutions for customers, we are better together working as one team and care about the success of our people, and we care about doing the right thing. We are advancing clinical research while offering customers broader and deeper experience, scale, and focus, complemented by continuity of delivery and speed to market. Our business model is described in the preceding sections. Consistent with our values, we seek to not only operate in compliance with applicable laws but also to positively influence our global workforce, the communities that we operate in, the environment and society as a whole. Doing so makes us a stronger, more resilient organization by every measure.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our core values underpin our mission and drive a culture and mind-set of ownership at ICON. "Own it at ICON", is a statement of values that has remained at the very heart of ICON&#8217;s culture, encouraging our people to seize the opportunity and bring flexibility, innovation, and determination to every situation. We believe our culture of ownership personifies who we are as a company &#8212; it also helps us apply our expertise, collaborate to get things done, and succeed at our mission.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Our values also underpin how we work together to deliver on our mission to improve the lives of patients by accelerating the development of our customers&#8217; drugs and devices through innovative solutions. These values and our Code of Ethical Conduct, which underpins these values, form the core of what we do, and how we do it. It applies to all of our officers, directors, employees, consultants and agents globally. All employees and temporary workers are mandated to complete annual global ethics training.</span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                 </span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">At ICON, we care about conducting business sustainably. We care about our people, patients, and the communities in which we live. We care about doing the right thing and we are committed to working to the highest ethical standards and demonstrating our commitment to honesty, transparency, and quality. As a testament to our commitment, we launched our &#8220;ICON Cares&#8221; program at the start of 2023 which incorporates all our </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Environment, Social and Governance (&#8220;ESG&#8221;) </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> initiatives into one program. ICON&#8217;s Environment, Social, and Governance Committee (&#8220;ESG Committee&#8221;) brings together all these initiatives and efforts under one umbrella to ensure consistency, enhance monitoring, reveal areas for development and facilitate reporting to the Board. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Nominating, Sustainability, and Governance Committee of the ICON plc Board has oversight responsibilities in respect to ESG-related strategies and initiatives. The Chief Administrative Officer and General Counsel (&#8220;CAO&#8221;) chairs the ESG Committee and reports on ESG matters to the Nominating, Sustainability and Governance Committee quarterly and reports to the Board at least annually whilst also providing periodic ESG updates to the executive leadership team. ICON&#8217;s ESG program office reports to the CAO and delivers centralized reporting and tracking of ESG initiatives. The Audit Committee has oversight responsibilities in respect to ESG-related reporting in the ICON financial statements. The Chief Financial Officer (&#8220;CFO&#8221;) reports to the Audit Committee on ESG-related reporting matters. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The ESG Committee is focused on developing our strategy and initiatives relating to the environment, social matters, health and safety, community engagement, corporate governance, sustainability, and other public policy matters relevant to the Company. The ESG Committee is a cross-functional management committee of the Company including representation from facilities, health and safety, corporate communications, finance, legal, investor relations, procurement, commercial, marketing, and human resources departments. The Committee meets regularly to assist and support executive management and the Nominating, Sustainability and Governance Committee of the Company in:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">determining and setting the strategy relating to ESG matters;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">developing, implementing and monitoring initiatives and policies based on that strategy; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">communicating these strategies, initiatives, and their results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are committed to building and developing our ESG strategies and reporting. In 2020 we launched our ESG page on the ICON website and have an internal ICON Cares ESG page on our MyICON intranet portal to engage with our employees and provide information and updates relating to ESG matters and our commitment to sustainability. In 2021, as a testament to our commitment to managing ICON responsibly and sustainably, we became a participant in the United Nations Global Compact (&#8220;UNGC&#8221;), a set of Ten Principles covering the areas of human rights, labor, environment, and anti-corruption. In</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> our 2023 ESG report, released in 2024, we reported under the Global Reporting Initiative (GRI, 2021) standards, the Task Force on Climate-Related Financial Disclosures (&#8220;TCFD&#8221;) and the Sustainability Accounting Standards Board (&#8220;SASB&#8221;) index. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our report summarizes our current policies, priorities, commitments, achievements, and progress in respect to ESG matters.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> During 2025, ICON received a silver medal from EcoVadis and increased our score from 70/100 in 2024 to 72/100 in 2025, in recognition of our environment, social and governance efforts throughout ICON. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The global landscape in respect to regulatory and legislative requirements relating to ESG reporting and disclosure requirements is rapidly evolving, and we are monitoring potential requirements so that we are positioned to adhere to any additional requirements in due course. This includes mandatory reporting under the Corporate Sustainability Reporting Disclosure (&#8220;CSRD&#8221;) from the EU and the SEC Climate Risk Disclosure Rule which is</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> pending finalization. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Building a sustainable future &#8211; our commitment to the United Nations Sustainable Development Goals</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a global company, we maintain an ethical and sustainable presence in hundreds of locations worldwide. At its core, ICON&#8217;s mission is to improve health and lives. We are also committed to contributing to the 2030 United Nations Sustainable Development Goals (SDGs) and are proud that our work contributes to their advancement.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our research, our work with customers and patients and our on-the-ground efforts to meet the needs across our communities align with the SDGs. We focus these efforts on a subset of themes where we have identified the greatest opportunity to effect change:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">SDG 3 &#8211; Good health and well-being</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">SDG 9 &#8211; Industry, innovation and infrastructure</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">SDG 10 &#8211; Reduced inequalities</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">SDG 12 &#8211; Responsible consumption and production</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">SDG 13 &#8211; Climate action </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">SDG 17 &#8211; Partnerships for the goals</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Further details on the ways ICON contributes to these SDGs and their targets are set out in our ICON Cares Report.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Environment: Conducting business sustainably</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is committed to delivering excellence in care to our communities. To improve our overall sustainability, this commitment means tracking and improving our environmental performance across all business activities. We achieve this by pursuing sustainability strategies that recognize the impact of our operations as a CRO on the environment, addressing greenhouse gas (&#8220;GHG&#8221;) emissions, energy use, waste generation and procurement-related activities. Our employees, directors, officers, contractors, temporary workers, and suppliers are expected to support our sustainability objectives. Similarly, ICON endeavors to support our customers sustainability objectives.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Our Global Environmental Management Policy and Environmental Management Plan are part of our ICON Cares program for managing environmental sustainability initiatives. The implementation of the policy and plan is led by our facilities team, reporting to our CAO. The CAO is responsible for reporting on the ICON Cares program and environmental initiatives and progress to the ICON executive leadership team and Nominating, Sustainability and Governance Committee and the Board.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">ICON set environmental goals around the use of renewable energy and carbon emissions in 2019 and we are working towards achieving these goals which are as follows: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:14.85pt">100% renewable electricity by 2025.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:14.85pt">20% reduction in kilowatt hours (&#8220;kWh&#8221;) of electricity by 2030.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In October 2024, the Science Based Target initiative (&#8220;SBTi&#8221;) validated ICON&#8217;s near- and long-term science-based emissions reduction targets. The SBTi has also verified ICON&#8217;s net-zero science-based target (&#8220;SBT&#8221;) by 2050. The SBTi is a corporate climate action organization that enables companies and financial institutions worldwide to play their part in combating the climate crisis. ICON&#8217;s SBTi validated targets:</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Near-term targets:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:14.85pt">Reduce absolute scope 1 and 2 GHG emissions 61.2% by FY2028 from a FY2019 base year.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:14.85pt">Reduce absolute scope 3 GHG emissions 20.0% by FY2028 from a FY2022 base year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Long-term targets:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:14.85pt">Reduce absolute scope 1 and 2 GHG emissions 90.0% by FY2050 from a FY2019 base year.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:14.85pt">Reduce absolute scope 3 GHG emissions 90.0% by FY2050 from a FY2022 base year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Net-zero target:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:14.85pt">Reach net-zero greenhouse gas emissions across the value chain by FY2050.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have programs in place to manage and minimize climate impacts of business activities. To continue to improve processes and reduce our environmental impact, we track, calculate, and report our Scope 1, Scope 2 and Scope 3 GHG footprint. We apply the GHG Protocol Corporate Standard, which is the global corporate accounting and reporting standard for calculating carbon emissions. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In Quarter One 2025, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">external verification of our 2024 Scope 1 and 2 GHG emissions data will be conducted. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> 202</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, we </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">uploaded our 2022 and 2023 Scope 3 emissions into a software platform and have collected our</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> full Scope 3 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">GHG emissions for 2024 utilizing the platform</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. We are currently analyzing the Scope 3 data with a view to annual public reporting in due course.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In respect to ICON&#8217;s carbon emissions for the year ended 2023, ICON&#8217;s combined Scope 1 and 2 GHG emissions have decreased since 2018. We recognize that although the combined Scopes 1 and 2 emissions have fallen year-on-year, ICON&#8217;s Scope 1 emissions have increased slightly each year up to the year ended 2023. To reach our net-zero goal, our decarbonization strategy is currently focused on reducing Scope 2 emissions, the largest contributor to our Scope 1 and 2 footprint. Following on from our Scope 2 emissions reduction efforts, we plan to launch efforts that target our Scope 1 emissions in the coming years.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2020, following pandemic-related closures and a reduction in business travel, our Scope 3, business travel GHG emissions declined significantly. Since 2021 up to the year ended 2023, as more normal business travel operations resumed, we have seen an overall increase in our total GHG emissions driven by an increase in business travel (Scope 3).</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Although emissions have increased, up to the year ended 2023, we remain below our 2018 pre-COVID overall GHG emissions and are committed to continue our work towards reducing emissions. Additionally, our emissions intensity has decreased substantially as our business has grown. Since 2018, up to the year ended 2023, our emissions intensity per million in revenue and our emissions intensity per FTE employee has decreased.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Moving forward, ICON expects to see further emission reductions relative to revenue and the number of employees due to a reduction in offices, strategic energy efficiency projects and a flexible work policy that allows eligible employees to work from home 40% of the time.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON participates in CDP (formerly the Carbon Disclosure Project) on an annual basis. CDP is a globally recognized organization that allows companies to measure and manage their environmental impacts. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We received a B- score from CDP for 2024 on our 2023 Climate Change response. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are focused on reducing energy use and increasing renewable energy use across our global operations as specific environmental goals; in 2023, 81.54% of our electricity consumed came from renewable sources (through a combination of switching direct tariffs and purchases through renewable energy credits (&#8220;RECs&#8221;)). Waste reduction is embedded into our environmental policies and practices and is one of the objectives of ICON&#8217;s Environmental Management Policy. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON leases most of our offices and facilities, and therefore we work closely with our landlords and leasing agents to implement measures to ensure we operate in an environmentally sustainable manner. In 2024, we continued with our real estate harmonization efforts and aligning ourselves to new working styles &amp; business needs. This resulted in downsizing or closing 16 locations and relocating 4 locations to new buildings, all of which are BREEAM or LEED certified, overall helping to reduce our environmental footprint. Experts from our real estate team factor environmental considerations into decisions around new office locations or building improvements. We&#8217;ve also implemented a series of measures globally to reduce the local footprint of our offices while promoting comfort and efficiency. These include:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Installing energy-efficient LED lighting.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Using motion detectors.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Purchasing recycled office supplies. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Reducing paper consumption by promoting paperless office processes and defaulting double-sided output.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Building recycling areas into business centers and kitchens/canteens. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Planting green spaces to improve internal air quality.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Selecting building materials and vendors for their low environmental impact.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">As part of our onboarding process, we require our suppliers to abide by our Global Supplier Code of Conduct which outlines our expectations around conducting business in a sustainable manner. The code requires suppliers to comply with all applicable environmental laws and regulations and to have systems in place with regards to waste management and sustainable use of resources.  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">Social: The power of our people</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are dedicated to making a positive impact on the communities where we work and live. Our community efforts are aligned with a broader vision for social impact and we are committed to furthering the United Nations Sustainable Development Goals (&#8220;SDGs&#8221;). </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Since 2012, ICON&#8217;s annual employee-nominated charity donation program has supported over 100 charities worldwide, donating $10,000 to each organization. These charities address a range of critical issues, such as fostering a more inclusive society, improving child welfare, and supporting patients battling chronic diseases. The chosen organizations reflect ICON&#8217;s corporate mission, align with our ICON Cares program. In 2024, through ICON&#8217;s Charity Matching Program, which bolsters our colleagues&#8217; fundraising efforts and fosters partnership across and within teams, 46 organizations were supported. This program aligns with the ICON Cares social pillar, as well as our company values of integrity, collaboration, agility and inclusion.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our community engagement activities are focused on two core areas:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">Supporting education and building closer ties between industry and academia; and</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:32.85pt">Improving the welfare of people in the communities in which we live.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Supporting education and building closer ties between industry and academia </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A core area of community support includes building ties between industry and academia to inspire the next generation of leaders in business and science. Our existing partnerships continued with the following organizations:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:32.85pt">The ICON-McKeon Research Fellowship in Motor Neuron Disease (&#8220;MND&#8221;) </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">in honor of Mr. Declan McKeon, former Board member, acting Chairman, Lead Independent Director and Chair of the ICON Audit committee. The ICON-McKeon Research Fellow in MND carries out research in the areas of machine-learning and artificial intelligence to derive insights from multimodal clinical, imaging neuro-electric signaling, in the context of the neurodegenerative disease of ALS. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:32.85pt">Partnership with Trinity Centre for People with Intellectual Disabilities (&#8220;TCPID&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">) - TCPID situated within the School of Education, Trinity College Dublin, aims to promote the inclusion of people with intellectual disabilities in education and society. The Centre provides people who have intellectual disabilities with the opportunity to participate in a higher education program designed to enhance their capacity to fully participate in society as independent adults. The 2-year education program includes work placements and internships to enable students to experience and participate in the work environment. In 2024, we were delighted to offer a permanent position to our first graduate of TCPID and we created a 6-month internship for an additional graduate. We also continued to host a student visit from TCPID students to our global headquarters in Dublin, where they enjoyed learning about the different phases of a clinical trial and also experienced a working laboratory during a tour of the facility. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:32.85pt">Partnership with Junior Achievement to inspire schoolchildren</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Junior Achievement encourages young people to remain in education and teaches them the skills they need to succeed in a changing world. ICON volunteers take time out of their working day to deliver Junior Achievement programs, teaching primary and secondary-level students valuable business, STEM (Science, Technology, Engineering &amp; Mathematics) and entrepreneurship skills that will serve them throughout their professional lives. Our strong partnership with JA Ireland has been in place since 2018 and we were delighted to extend our Junior Achievement partnership to India and Spain in 2024 and to relaunch the program in the UK. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Improving the welfare of people in the communities in which we live</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Through volunteering, donations and other charitable initiatives, our employees across the world are making a positive difference to their communities. We support causes that are important to our employees and have several programs that support the welfare of people in our local communities. In November 2024, 380 ICON colleagues from across the globe united in person and virtually to take part in Run in the Dark for the fifth consecutive year. Team ICON raised $10,000 to support Mark Pollock's Collaborative Cures foundation whose mission is to bring people together to cure paralysis in our lifetime. A team of over 125 ICON cyclists from 24 countries also participated in our eighth annual ICON cycle challenge, which covered a minimum of 389km from Bratislava, Slovakia to Budapest, Hungary, across 3 days and which raised over &#8364;13,000 through JustGiving donations and the ICON Cares Charity matching program for My Name&#8217;5 Doddie Foundation, a charity in support of accelerating the development of new treatments for motor neuron disease (&#8220;MND&#8221;) and, ultimately, finding a cure.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Talent and People </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our people are core to our ability to deliver our services and drive better patient outcomes. Through industry-leading talent management practices, a sincere attention to our employees&#8217; needs, well-being and health and safety, we continue to power the potential of together. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">At the core of our strategy is our people </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">People have long been central to our mission to improve the lives of patients by accelerating the development of our customers&#8217; drugs and devices through innovative solutions. We encourage our people to bring flexibility, innovation, and determination to every situation. By doing so, our people can build exciting and rewarding careers, and deliver results to bring life-changing medicines to market and to maintain our success as an industry leader.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Learning and development of our staff is a key focus for us</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">O</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ur leadership and talent programs contribute to the enhanced retention of our employees, better project deliverables for our customers and the enhanced financial performance of the business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We aim to be an industry leader where talented people come to do important work and where our employees can shape the future of healthcare, grow their careers, and reach their full potential. We have long held a deep commitment to cultivating strong people practices. This includes competitive total rewards packages along with a focus on continuous learning. We nurture a culture of development and aim to boost engagement by supporting our people&#8217;s growth, both personally and professionally. We are dedicated to finding opportunities for our employees to grow and develop.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our success depends on the knowledge, capabilities, and quality of our people. To improve their skills, we are committed to providing continuous learning. This commitment is underpinned by clearly defined competencies, which offer employees a clear path along which to develop skills and advance their careers. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To support employees at every stage of their career journeys, training and development programs are aimed at advancing scientific, technical, and business knowledge as well as behavioral competencies. Programs include Corporate and Functional Onboarding for all ICON employees tailored CRA academies; Data Management and Biostats &amp; Programming Academies; a Commercial Skills Academy; a range of project management curricula, therapeutic-focused programs, and People Leader development programs. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are focused on retaining the best talent by ensuring employees are aware of what career opportunities exist at ICON. We have invested in our career platforms to ensure employees understand the career opportunities that are available across the organization, providing them with a platform in our HR system to share and capture their skills, interests and career aspirations which enables People Leaders and employees to have better conversations on careers as part of our performance management process. This allows us to get a better understanding of the skills that exist today across the organization, within service lines and teams so we can better serve our customers.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">O</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ur People Leader development program focuses on providing our People Leaders with the relevant skills to effectively manage themselves, their team and their business, including leveraging psychometrics to raise awareness of their behavioral preferences and the preference of others. ICON also invests in Harvard Manage Mentor, an online learning platform providing People Leaders with access to learning available at any time with topics ranging from change management, retaining employees and developing employees.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We provide our people with a personalized and flexible learning experience, delivered through a combination of in-person and technology-driven programs that suit their learning styles and can flex to suit their schedules. Through our industry leading Career Hub, ICON employees are encouraged to broaden their scientific, technical, leadership, and business knowledge. By tapping into development programs and partnerships with leading academic institutions, team members can use the hub to develop competencies that advance their careers. We also collaborate with UCD Smurfit School Executive Development to deliver customized leadership development programs for global employees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">As an organization we are keen to hear directly from our employees</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To attract and retain the best talent, we must listen and respond to employees&#8217; needs. This extends to every aspect of our work, from recruitment and onboarding, to training, engagement, enablement, and reward. We pursue best-in-class approaches to building employee engagement and these include, among others:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Comprehensive global employee surveys, which measure how people feel about their work and whether they feel they have the tools to do their jobs well. Feedback from these studies informs detailed action plans at the group, function, and team level.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Pulse check surveys, which are smaller-scale studies designed to measure employee sentiment on specific topics and initiatives.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Fostering an environment of inclusion and belonging where everyone is valued.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Stay interviews to help managers understand why staff stay and to uncover what might put them at risk of departing.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Skip-level meetings to develop trust and rapport between senior leaders and employees.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our listening strategy supports our efforts to reduce employee turnover, which we monitor closely through analytics. Qualitative information is collected through formal exit interviews and, where we believe they&#8217;ll make an impact, we intervene via retention plans and related efforts.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Employee well-being </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s commitment to improving health and enriching lives extends beyond the work we do with our customers. Employees worldwide have access to tools and resources designed to support all facets of their well-being, from physical to financial to psychological and beyond.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our global Employee Assistance Program (&#8220;EAP&#8221;) ensures that all employees, and their families, have access to </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">professional mental health, financial and relationship support on a confidential basis</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Employees can also access a wide range of tools, information and support services online in local languages.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Health and safety</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At ICON, the health and safety of our employees, customers and clinical trial patients are our most important priorities. We take guidance from global and regional health authorities and governments to protect the safety and welfare of employees, as well as abide by government directives. Our global health and safety management system ensures we deliver on all local and national requirements. Our priority objectives are the safety of our staff, clinical trial patients, protecting the environment, maintaining business continuity, and ensuring all sensitive health and safety data is protected.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are committed to providing a safe working environment for our people. We achieve this goal by working in ways that protect the safety, health, and welfare of all our employees, clinical trial patients, and visitors. Risk assessment is the basis of the safety management system, and we work to identify, mitigate, and monitor existing and emerging health or environment risks that may be associated with our business activities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">Fair employment practices</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We are committed to being a workplace where all employees are included and feel a sense of belonging.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> As a global, values-driven organization, we acknowledge and celebrate our differences. Respecting viewpoints and experiences is foundational to our interactions with each other and with our patients, customers and suppliers. Moreover, we strive to build teams that reflect the various geographies and communities in which we live and work and the patients we serve.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We recognize the critical importance of ensuring all types of patients who will eventually receive therapies are represented on clinical trials, as well as offering clinical trials as a care option for those who may not otherwise have access to medical treatment. </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">We have a strong focus on talent management, succession planning and talent development to ensure we work towards building strong talent pipelines with the best candidate appointed, based on a fair and unbiased selection process where merit, experience and performance form the basis for hiring and promotion decisions.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Establishing a truly inclusive workplace requires offering fair pay. Using best-in-class methodology, we regularly review salary ranges to establish fair pay among employees regardless of gender, race or ethnicity. We also consider legitimate business factors that explain differences, such as performance, tenure and experience. ICON has made and will continue to make significant investments in organizational design structures, tools and education that uphold and support our pay principles.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are committed to ensuring fair employment practices. For every jurisdiction in which we operate, we act in compliance with relevant laws relating to labor rights and labor relations as well as market competitive benefits. We believe in fair and equal treatment for all our people, without regard to gender, race, ethnicity, sexual orientation, marital status, physical or mental disability, age, pregnancy, veteran status, nationality, religion, or any other legally protected status. We do not tolerate our employees being subjected to physical, sexual, racial, psychological, verbal, or any other form of harassment. We encourage our employees to report any issues of harassment or discrimination. We prohibit retaliation against any employee who rejects, protests, or complains about unlawful discrimination or harassment. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Human rights</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is committed to human rights and in 2021, ICON became a participant in the UN Global Compact (&#8220;UNGC&#8221;), signaling our commitment to uphold the UNGC&#8217;s 10 Principles, including those related to human rights across our global operations. Our business model and our policies, including our Global Code of Ethical Conduct and Global Supplier Code of Conduct, are intended to fully comply with applicable human rights legislation in the countries where we operate. Our zero-tolerance policy on forced labor, slavery, and human trafficking is defined clearly in these policies, which are available to employees, suppliers, customers, and the public.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are opposed to forced labor, slavery, and human trafficking. We will not knowingly support or conduct business with any organization involved in such activities. We do not employ anyone below the minimum employment age in the jurisdictions in which we operate.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Global Supplier Code of Conduct incorporates the Pharmaceutical Supply Chain Initiative (&#8220;PSCI&#8221;) principles for responsible supply chain management, including for labor. Before doing business with ICON, suppliers must certify that they will comply with the ICON Global Supplier Code of Conduct or their own materially equivalent internal code, which includes human rights protections. We perform pre-engagement due diligence on our suppliers, including in relation to labor issues, which we support through periodic re-screening. We hold our suppliers accountable for meeting their contractual obligations. Contract non-compliance can result in termination of the business relationship with the supplier and exclusion from future business.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Ethics and Compliance</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">             ICON&#8217;s commitment to ethics and integrity is embedded in our company values. We act with integrity and integrate ethical principles into our business practices and culture. ICON&#8217;s Global Code of Ethical Conduct (&#8220;the Code&#8221;) establishes our core principles and standards for honest, fair, and ethical behavior. This Code addresses the core values expected of our people in our internal interactions with each other as well as in external dealings with patients, customers, healthcare professionals, regulators, investors, vendors and other third parties.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Ethics and Compliance program is designed to protect the interests of the company and its shareholders by preventing, detecting, investigating and responding to potential misconduct and violations. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Ethics &amp; Compliance team (&#8220;E&amp;C&#8221;) provides day-to-day independent oversight for the program. The team works collaboratively with risk and compliance functions and leadership across the business to align on and optimize its reach and impact. The program is overseen by the CAO, who, reports on the program to ICON&#8217;s executive leadership team, the Nominating, Sustainability and Governance Committee and the Board. The program supports all functional areas globally and is dedicated to the implementation of standardized global policies, procedures, training, guidance, communications, monitoring, investigations, issue management, assessing compliance-related risk and mitigations, and reporting to ensure the overall compliance program is effectively functioning. Where appropriate, the program also implements regional and/or country specific policies, procedure, training and guidance.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON uses Ethics Line, a system for employees and third parties to confidentially report ethics and compliance questions, as well as concerns, and to track reports through follow-up and resolution. An independent company administers this hotline, which is available all hours of every day and can accommodate calls in over 75 languages. These tools also provide visibility into our risks while highlighting opportunities to address them. ICON&#8217;s Ethics and Compliance program will continue to grow and evolve in response to changes in our business and in the global business climate.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All personnel are required to receive ethics and compliance training during initial onboarding and complete annual refresher sessions. Training modules explain the channels available for reporting suspected unethical or illegal practices. The training supports our values and our ways of working and incorporates the key principles of our policies and codes and includes interactive scenarios where applicable.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At ICON, we promote a Speak Up culture that encourages compliance, openness, and accountability without retaliation. The Speak Up Policy aims to support our culture and values and seeks to encourage the prompt reporting or surfacing of concerns or violations about values, ethics or other standards without fear of retaliation. Reported ethics concerns and other ethics and compliance-related data are reported via the CAO to the Board as appropriate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Anti-bribery and Corruption</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is guided by the foundational principle that we do not tolerate bribery or any other form of corruption or fraud. Our anti-bribery and anti-corruption (&#8220;ABAC&#8221;) program is a core element of our Ethics and Compliance program. ICON and all ICON directors, employees, consultants, agents and all third parties acting on ICON's behalf must act in compliance with international laws and regulations relating to bribery, corruption, and illicit payments, including but not limited to the US Foreign Corrupt Practices Act and the UK Bribery Act 2010.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON maintains the ISO 37001:2016 certification for our Anti-Bribery Management System, which establishes the framework for the controls that prevent, detect and mitigate the risk of bribery. Our program is designed to ensure our compliance with anti-corruption laws, including due diligence, training, policies, procedures, and internal controls.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Bribery and corruption remain a business risk as we conduct our business across the globe and enter partnerships and collaborations. There is no certainty that all employees and third-party business partners (including our vendors, suppliers, agents, contractors, and other partners) will comply with anti-bribery laws. When working with third parties, we are committed to working with only those who embrace high standards of ethical behavior consistent with our own. Bribery and corruption risks are a focus of our third-party diligence and management process. We hold our suppliers accountable for meeting their contractual obligations with ICON, including commitments that are made with regard to our Global Supplier Code of Conduct and regulatory compliance. Contract non-compliance can result in termination of the business relationship with the supplier and exclusion from future business with ICON. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON's internal audit teams conduct ABAC program audits. Internal Audit focuses on testing for compliance and design effectiveness of the overall ABAC program. Internal Audit incorporates an assessment of ABAC measures in audits, as appropriate. In this approach, bribery and corruption risks are incorporated into the risk assessment and scoping process of each audit.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Privacy and Information Security </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Data privacy and information security are fundamental to our business and key to retaining customers, building investors&#8217; trust, protecting data subjects who entrust their personal information to us, and complying with global and regional regulations. We recognize and respect that our customers, employees, participants, and all those who do business with us expect that we will protect their personal information in accordance with our legal obligations and policy commitments. ICON&#180;s commitment to privacy and information security is demonstrated through the implementation of robust privacy and information security programs.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s Global Data Protection program is overseen by the CAO. This program governs ICON&#8217;s and its employees&#8217; obligations concerning the processing of personal data. The program consists of a Global Data Protection Officer (&#8220;DPO&#8221;), a team of privacy lawyers and specialists and corporate policies and procedures regulating how we address our data protection obligations in the countries we operate in, including our obligations under the EU General Data Protection Regulation (&#8220;GDPR&#8221;)  e.g. fulfillment of data subject rights, data protection impact assessments, our obligations to maintain records of processing activities (&#8220;ROPAs&#8221;) and management of personal data incidents and breaches in accordance with data protection laws. ICON&#180;s Global Data Protection program supports compliance with fundamental data protection principles including transparency, data minimization, accountability and security. ICON has embedded privacy by design considerations in product and process development and implements a robust set of technical and organizational measures to protect personal information processed by ICON.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">ICON&#8217;s Personal Data Incident and Breach Response Policy and Process governs the management of personal data incidents and breaches within ICON. The policy requires incidents to be reported to ICON&#8217;s DPO and Privacy Team, who manage them in collaboration with relevant internal stakeholders (e.g., IT Security, Quality &amp; Compliance), to ensure we comply with our legal and contractual obligations, including our reporting obligations. ICON&#8217;s data protection policies and procedures are independently audited as part of ICON maintaining an ISO 27701 certification that it initially achieved in 2023.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our people and partners play a critical role in safeguarding data. ICON has training in place for all employees and contingent workers on information security and privacy practices so that they understand their responsibilities with respect to data security and privacy. ICON has also established a robust Privacy and Security Champion (&#8220;PSC&#8221;) network. The PSC network acts as an extension of the Privacy and Information Security teams. In line with the PSC charter, champions provide a key touch point in relevant business units, bolster awareness of ICON&#8217;s respective privacy and security programs and provide direct support in response to priorities dictated by ICON&#8217;s Privacy and Security Council (chaired by ICON&#8217;s DPO and the Vice President of Cyber &amp; Information Security ).</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For information about our cybersecurity program see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Item 16K Cybersecurity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Sustainable procurement</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CON maintains policies and processes to support responsible, sustainable, and ethical business practices. Our goal is to source from suppliers whose values align with our own, and who are socially and environmentally responsible and conscious.  In 2024 we launched a Sustainable Procurement Policy that outlines our expectations for suppliers relating to sustainability. This policy applies to all suppliers and aims to ensure ICON maintains a responsible and sustainable supply chain.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We manage our suppliers through our Global Procurement department. The onboarding of all new suppliers is completed through a robust centrally managed due diligence process. Environmental sustainability, bribery, and corruption risks are a focus of our third-party assessment and management process. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON performs pre-engagement due diligence on our suppliers. This includes screening of sanctions lists, debarment, and adverse media. Suppliers are continuously monitored against sanctions and debarment lists and are periodically re-screened. Suppliers deemed higher risk are subject to enhanced due diligence and controls, which may include periodic training, auditing, and assessments. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As part of our onboarding process, we require our suppliers to abide by our Global Supplier Code of Conduct which incorporates the Pharmaceutical Supply Chain Initiative (&#8220;PSCI&#8221;) principles for Responsible Supply Chain Management and sets out our standards and expectations regarding:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Ethics and compliance</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Labor and human rights</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Health and safety</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Environmental stewardship</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Global Supplier Code of Conduct also outlines channels to report concerns or grievances related to our suppliers, such as our Ethics Line. We operate a strict anti-retaliation policy and expect suppliers to do the same. We hold our suppliers accountable for meeting their contractual obligations, including commitments relating to the Global Supplier Code of Conduct and regulatory compliance. Contract non-compliance can result in termination of the business relationship and exclusion from future business with our company.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To further support the development of our sustainable procurement program, ICON has engaged with EcoVadis, CDP and Supplier IO to help assess our key suppliers and gather data around sustainability maturity and GHG emissions. This data allows us to factor sustainability related factors into our supplier selection activities and embed sustainability into our procurement practices.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Sales and Marketing</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our marketing strategy is focused on building a differentiated brand position for ICON and supporting our business development efforts to develop and build relationships with pharmaceutical, biotechnology, medical device, and government and public health organizations. Our marketing activities are coordinated centrally to ensure a consistent and differentiated market positioning for ICON and to ensure all marketing efforts align to the overall strategic objectives of the business. Our business development teams are located throughout the Americas, Europe and Asia Pacific regions. Business development activities are carried out by account executives with assigned territories and global account directors supporting our large accounts. Specialized business development teams focus on growing each of our business areas. Collectively, our business development team, senior executives and project team leaders share responsibility for the maintenance of key client relationships. Our aim is to develop deeper relationships within our client base to gain repeat business and enable us new opportunities to penetrate into other therapeutic indications and adjacent service lines.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Competition</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CRO industry is fragmented, consisting of many small, niche service providers, a declining number of medium-sized providers and a smaller number of large CROs, including ICON, that are differentiated by the scale of their global operations, breadth of service portfolios and supporting technology infrastructure. The need to conduct complex research and access patients on a global basis is driving market share to these global CROs. When competing for large development programs, ICON competes primarily with IQVIA, PAREXEL, the PPD clinical research services brand of Thermo Fisher Scientific Inc., Fortrea and Syneos Health. In some specific markets, for example biotech and mid-tier pharma, ICON may also compete against mid-tier CROs. Competition also exists for acquisition candidates in addition to competition for customers.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">CROs generally compete on the basis of operational experience, the ability to recruit patients on a global basis, the depth of therapeutic and scientific expertise, the strength of project teams, price and increasingly on the ability to apply new innovation that can drive significant time and cost savings throughout the development process. An evolving area of competition is the need to provide services that can help generate the evidence of the economic value of new treatments that payers and regulators require. This requires access to new data sources which includes information to support the identification of suitable investigator sites and patient populations as well as data on the value delivered by new products following marketing approval. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe that we compete favorably in all these areas and we continue to invest in our capabilities to ensure that we remain competitive in the future.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Customers</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, revenue was earned from a wide range of customers and 25.0% of our revenues were derived from our top five customers, with no one customer individually contributing more than 10% of our revenues during the period. Our largest customer represented a strategic partnership with a large global pharmaceutical company and contributed 7.7% of revenue for the year.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, 26.8% of our revenues were derived from our top five customers, with no one customer individually contributing more than 10% of our revenues during the period. Our largest customer represented a strategic partnership with a large global pharmaceutical company and contributed 8.9% of revenue for the year ended December&#160;31, 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, 28.3% of our revenues were derived from our top five customers, with no one customer individually contributing more than 10% of our revenues during the period. Our largest customer represented a strategic partnership with a large global pharmaceutical company and contributed 8.8% of revenue for the year ended December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The loss of, or a significant decrease in business from one or more of our key customers could have a material adverse impact on our results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Unsatisfied Performance Obligation</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our unsatisfied performance obligation consists of contracted revenue yet to be earned from projects awarded by clients. At December&#160;31, 2024, we had contracted unsatisfied performance obligation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s of $15.9 billion.&#160;We</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> believe that our unsatisfied performance obligation as of any date is not necessarily a meaningful predictor of future results due to the potential for cancellation or delay of the projects included in the unsatisfied performance obligation, and no assurances can be given on the extent to which we will be able to realize this unsatisfied performance obligation as revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Information Systems</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Having access to accurate and timely information is critical in the management, delivery and quality of all aspects of drug development. ICON invests in technologies that align with modern healthcare delivery. Our strategy of using technology to enhance our global processes is evident from our deployment of leading global platforms such as Veeva (SOP document management system), Cornerstone (training delivery solution), ServiceNow (workflow and automation platform), SailPoint (identity management and governance), PEGA (safety reporting), ARGUS (pharmacovigilance), Salesforce (CRM) and Medidata (Clinical systems). </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON uses an extensive range of both on premise and cloud-based applications to support its services, including:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Clinical Operations</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In Clinical Operations, we have deployed a suite of software applications that assist in the management and tracking of our clinical trial activities. These software applications are both internally developed and commercially available applications from external vendors. These include a clinical trial management application ('CTMS') that tracks all relevant data in a trial and automates all management and reporting processes. The Electronic Trial Master File ('eTMF') is delivered via ICON's proprietary software ICOMaster and/or the Wingspan and PhlexGlobal software platforms. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Clinical Data Science and Biometrics</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In our Clinical Data Science function, we have leading clinical data management solutions including Electronic Data Capture (EDC), Biostatistics and Clinical Data Warehouse solutions from external vendors. This allows us to guarantee the integrity of client data and provide consolidated information across client studies.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Decentralized Trials</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON's Digital Platform (IDP) enables the delivery of Decentralized and Hybrid Clinical Trial services, maximizing patient recruitment and retention and at the same time expanding access to remote patient populations. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Site Performance Management and Patient Engagement</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">FIRECREST&#8217;s digital suite employs videos and visual aids to assist in the explanation of complex scientific concepts and medical terms found in trial protocols. FIRECREST eConsent solution provides sites and Sponsors with an audit-ready, on-site and remotely accessible system that automatically captures dates and signatures and is configured to mitigate against the common inspection findings which hamper the traditional paper-based consenting process.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Compliance and Safety </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON provides its Pharmacovigilance Services using Oracle&#8217;s ARGUS safety database. The system is FDA regulated, 21 CFR Part 11 compliant and generates all the standard regulatory required reports, as well the periodic reports required to support operations. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Population Pharmacokinetics and Pharmacokinetic Pharmacodynamic Modelling</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON supports Population Pharmacokinetics and Pharmacokinetic Pharmacodynamic modeling using its proprietary software NONMEM&#174;.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Laboratory and Imaging</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON's Laboratory uses a comprehensive suite of software, including a laboratory information management system (LIMS), a kit / sample management system and a web interface system to allow clients to review results online. Sample Inventory Management System (SIMS) is an interactive reporting module for use by sponsors and study teams. It provides detailed sample inventory reports and summaries of sample status and location with drill down capabilities. It helps locate samples more rapidly, particularly at critical study junctures. ICON provides imaging and cardio safety services using its internally developed Medical Image Review and Analysis system ('MIRA') &amp; Maestro platforms and uses Medidata&#8217;s Rave Commercial Imaging for collecting, managing and processing data to support its imaging capabilities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Centralized Patient Randomization</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON provides interactive response technology (IXR) to enable centralized patient randomization, drug inventory management and patient diary collection, providing our clients with a fully flexible multi-channel data retrieval solution which can be utilized via telephone, internet browser or a mobile device. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Healthcare Data Analytics </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Integrated Dataverse (IDV&#174;) is a comprehensive and longitudinal source of healthcare data in the industry, bringing together vast claims resources: medical, hospital, and prescription, with rich point-of-sale prescription data, non-retail invoice data, and demographic data. This provides data, applications, analytics, and consulting to help companies gain deep insight into the pharmaceutical market. We transform data into decisions and give deeper insight into the relationships that sponsor brands have with the market by allowing a holistic view of the impacts of payer, prescriber, and patient behavior. Our proprietary Tokenization technology Synoma&#174; simplifies the anonymization, exchange and connection of industry data sources to provide an integrated view of a patient&#8217;s data.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Finance Operations and Investigator Payments</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s global finance operations utilize Oracle&#8217;s eBusiness suite, with Hyperion reporting, to serve the organization&#8217;s financial and project accounting requirements. Workday is used to fulfill our Human Resource people management requirements. Our business development and contracting teams use Salesforce CRM. Our Investigator Payment team uses Accelerated Payment Entitlements Calculation System ('APECS') for timely and accurate payments to sites for the work performed in the care and management of patients as they participate within clinical trials.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accelerating Clinical Research with AI</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has a dedicated AI Centre of Excellence. By leveraging innovative AI and ML, we accelerate trials, optimize resources, and ensure strict compliance, all while upholding the highest standards of ethical governance and data privacy. Our focus is to expedite our ability to:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">find signals quickly;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">connect information intelligently;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">predict outcomes; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">take proactive action to accelerate processes or mitigate emerging risks.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Examples of ICON&#8217;s AI implementations include:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:32.85pt">OneView</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> empowers sponsors to see and analyze their data from multiple sources within a trusted secure environment. With OneView, smart grouping algorithms make it easy to transform this data into powerful interactive dashboards uncovering insights and enabling intelligent decisions for sponsors and project teams.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:32.85pt">OneSearch</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for optimised site identification, an intuitive, integrated workflow and interrogation tool from ICON, enables access to multiple data sources and provides the visualization and tools necessary for optimum site identification based on ICON and industry data of capability, experience and performance. Scoring on enrollment performance, speed of start-up and quality supports better site selection.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:32.85pt">EXACT&#8482; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">system is used to simplify and automate the production of multiple Clinical Data Interchange Standards Consortium (CDISC) guidelines as well as tables, figures and listings in trial reports.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:32.85pt">Cassandra</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> &#8211; AI capability which predicts the needs for FDA &amp; European Medical Agency "EMA"  post marketing studies.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:32.85pt">ICONex </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211; AI Powered capability which enables key opinion leaders and their networks to be more easily identified.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:32.85pt">iSubmit</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> simplifies eTMF document management with automated filing and compliance checks. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:32.85pt">Mapi Research Trust COA </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">stays updated with the latest clinical outcome assessments (COAs) using AI-driven intelligence in near real-time. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:32.85pt">FORWARD+</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> optimizes resource demand, allocation, and forecasting for smoother trial execution. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:32.85pt">Study Start-up Site Contracts</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> streamlines contract drafting, reducing negotiation cycles and accelerating site activation. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:32.85pt">Operational Metrics AI</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> (OMR) leverages generative AI to transform how teams interact with operational data for faster, more intuitive insights and transparency of the Clinical Research Process. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:32.85pt">Site Enablement </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- Clinical Archive Record Distribution (CARD) simplifies the delivery of data to sites at the end of a study with automated file distribution and compliance checks. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Using Informatics to Provide Accurate and Timely Access to Data </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s informatics strategy is built around key platforms to provide access to accurate and timely information. These solutions allow healthcare companies to manage, optimize and execute their clinical and commercial strategies in an orchestrated manner while addressing their regulatory obligations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Key areas where ICON has made strategic investments to enhance the clinical project delivery process and to provide our sponsors with value-add in the following areas:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:32.85pt">Data Analytics, Decentralized Trials &amp; Risk-based Monitoring (RBM) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211; using Medidata&#8217;s Clinical Data Studio to enable the management, reporting, analysis and visualization of all data relating to drug development. This platform collects, manage and standardize study data from multiple sources, including EDC, patient engagement, Electronic Medical Records (EMR) / Electronic Health Record ('EHR'), mobile health, Telehealth, Wearables, Central Laboratories to provide a single view of study information. This enables ICON to deliver services such as Risk Based Monitoring (RBM) using near-real time clinical data to drive monitoring visit schedules, enabling better decision making and the successful implementation of clinical trial strategies that significantly improve efficiency in clinical trials thereby reducing overall cost and time to market whilst better protecting patient safety.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:32.85pt">Efficiencies in Study Reporting </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">-  Enhancements to our ICONIK platform resulting in the standardization of study-specific data derivations for safety monitoring and clinical decision making in trials. The development of new data visualizations, to meet study-specific needs for risk-based, safety and adaptive monitoring, has improved the efficiency of study-specific delivery to sponsors.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:32.85pt">EMR </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- ICON created and implemented a strategy to use real patient data through EMR systems to support clinical development, including study design, feasibility, site identification, and patient recruitment.  Specifically for oncology trials, ICON has partnered with the TransMed Consortium to conduct top-level feasibility and site identification assessments based on detailed protocol inclusion and exclusion criteria, and to support patient identification and recruitment to current clinical trials.  </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:32.85pt">Decentralized Trials</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> - Automated, Real-time, Centralized, Accessible, Discoverable, Explorable &amp; Scalable Data (ARCADES), produces solutions for wearable devices, virtual/hybrid trials, robotic process automation, enhanced operational execution, and excellence through forecasting and prediction algorithms. This greatly reduces site and patient burden, while providing real-time access and oversight of our performance to our clients. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:32.85pt">ICON&#8217;s Digital Engagement Platform ('IDP')-</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> ICON is investing in Digitisation through the release of our Digital Engagement Platform which provides single access to enable stakeholders to access and use all services for a trial. The unified data aggregation layer pulls data from various different sources and provide automated data feeds directly to sponsor systems. Insights will be derived from a variety of Artificial Intelligence (AI) tools and techniques including Machine Learning (ML), Deep Learning, Natural Language Processing, Fuzzy Logic, and Anomaly detection. Decision Support will provide the detailed analysis&#8212;and potentially recommendations from statistically based models&#8212;to enable informed decision-making. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Underpinning Technology Delivery with Robust IT Infrastructure &amp; Governance</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON uses a range of enterprise applications that enable the delivery of our business services in a global environment. The focus is to provide ease of access and capture of study information for our staff and clients globally. We use a combination of proprietary applications and leading commercial business applications from vendors including Microsoft, Amazon, Oracle, Dell, SAS, Veeva, Dassault, Salesforce and BOX. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">With data at the core of ICON&#8217;s innovation efforts, we have built an Enterprise Control Tower: ARCADES which leverages the latest technology around data acquisition, consolidation, analytics, machine learning, artificial intelligence, and the cloud. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">IT expenditure is authorized by strict IT governance policies requiring senior level approval of all strategic IT expenditure based on defined business strategy and measurable business benefits. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A global corporate intranet portal serves as the gateway to access authorized data and applications for our internal staff, as well as providing an internal platform for company-wide communication. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our IT systems are operated from three data centre hubs in Europe, North America and Asia. These hubs reside within purpose-built data centre facility locations. ICON employs industry standard networking technology to facilitate connectivity across our offices. Our IT network provides global connectivity for our applications and allows collaboration and communication using tools like Microsoft Teams, M365, SharePoint and Box. Mobile staff can access systems via secure remote access portals. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:107%">Cybersecurity</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For information on Cybersecurity refer to </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Item 16K Cybersecurity. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Contractual Arrangements</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are generally awarded projects based upon our responses to requests for proposals received from companies in the pharmaceutical, biotechnology and medical device industries, or through strategic partnership agreements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues on long term contracts are recognized based on an assessment of progress towards completion. Payment terms usually provide either for payments based on the delivery of certain identified milestones, units delivered or monthly payments, according to a contracted payment schedule over the life of the contract. Where there are changes in the scope of a trial or in the services to be provided by us, a change order or amendment is issued which may result either in an increase or decrease in the contract value. We also contract on a "fee-for-service" or "time and materials" basis.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Contract periods may range from several weeks to several years depending on the nature of the work to be performed. In many cases, an upfront portion of the contract fee is paid at the time the study or trial is started. The balance of the contract fee is generally payable in installments over the study or trial duration and may be based on the completion of certain performance targets or "milestones", on units delivered, or on a fixed monthly payment sched</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ule. Installment payments may be based on key metrics for example target patient enrollment progress or delivery of the study database. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The progress towards completion for clinical service contracts is measured based on total project costs (fees are therefore inclusive of third party costs). Reimbursable costs include payments to investigators, travel and accommodation costs and various other expenses incurred over the course of the clinical trial which are fully reimbursable by the client. Reimbursable expenses are included within the contract and are invoiced on a monthly basis based on actual expenses incurred. Expenses incurred are determined by reference to activity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As the currency in which contracts are priced can be different from the currencies in which costs relating to those contracts are incurred, we usually negotiate currency fluctuation clauses in our contracts which allow for price adjustments if changes in the relative value of those currencies exceed predetermined tolerances.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Most of our contracts are terminable immediately by the client with justifiable cause or with 30 to 90 days&#8217; notice without cause. In the event of termination, we are usually entitled to all sums owed for work performed and expenses incurred through the notice of termination and all costs associated with termination of the study. Termination or delay in performance of a contract occurs for various reasons, including, but not limited to, unexpected or undesired results, production problems resulting in shortages of the drug, adverse patient reactions to the drug, the client's decision to de-emphasize a particular trial, inadequate patient enrollment or investigator recruitment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Risk Management </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Chief Executive Officer and other members of the executive management team are responsible for day-to-day risk management of the Company and our Board oversees management's activities through both the full Board and its committees. Our Chief Executive Officer and other members of the executive management team are members of ICON&#8217;s Quality and Risk Forum, which reviews risk. Our executive management team regularly reports to the Board and its Committees to ensure effective and efficient oversight of our activities and to assist in proper risk management and the ongoing evaluation of management controls. The Board oversees general business and market risk management, our Audit Committee oversees risk management with respect to financial statements, accounting and financial controls, our Compensation and Organization Committee oversees risk management with respect to our compensation plans, policies and procedures and our Nominating, Sustainability and Governance Committee oversees risks relating to ESG matters. Internal audit reports functionally and administratively to our Chief Financial Officer and directly to the Audit Committee. With respect to non-financial risk management, including cybersecurity, legal compliance, privacy and enterprise risk, the Board and its Committees receive updates from the appropriate executives on the primary risks facing the Company and the measures the Company is taking to mitigate such risks. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Government Regulation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The clinical development of new drugs is highly regulated by government agencies. The international standards for the conduct of clinical studies include:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Good Clinical Practice ("GCP&#8221;), which stipulates procedures designed to ensure the quality and integrity of data obtained from clinical testing and to protect the rights and safety of clinical subjects. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Good Manufacturing Practice (GMP) is the aspect of quality assurance that ensures that medicinal products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the product specification.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Good Distribution Practice (GDP) ensures that the quality of a pharmaceutical product is maintained by means of adequate control of the numerous activities which occur throughout the distribution process by ensuring that products are appropriately stored, transported and handled.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The US FDA and other national regulators have promulgated regulations and guidelines that pertain to applications to initiate trials of products, the approval and conduct of studies, report and record retention, informed consent, applications for the approval of drugs and post-marketing requirements. Pursuant to these regulations and guidelines, service providers that assume the obligations of a drug sponsor are required to comply with applicable regulations and are subject to regulatory action for failure to comply with such regulations and guidelines. In the United States and Europe, the trend has been in the direction of increased regulation and enforcement by the applicable regulatory authority. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In providing services in the United States, we are obligated to comply with FDA requirements governing such activities. These include ensuring that the study is approved by an appropriate Independent Review Board (&#8220;IRB&#8221;) and Ethics Committee, obtaining patient informed consents, verifying qualifications of investigators, reporting patients&#8217; adverse reactions to drugs and maintaining thorough and accurate records. We must maintain critical documents for each study for specified periods, and such documents may be reviewed by the study sponsor and the FDA.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The services we provide outside the United States are ultimately subject to similar regulation by the relevant national regulatory authority. In addition, our activities in Europe are in compliance with the European Medicines Agency processes.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We must retain records for each study for specified periods for inspection by the client and by the applicable regulatory authority during audits. If we fail to comply with applicable regulations and guidelines, it could result in a material adverse effect. In addition, our failure to comply with applicable regulations and guidelines, depending on the extent of the failure, could result in fines, debarment, termination or suspension of ongoing research, the disqualification of data or litigation by clients, any of which could also result in a material adverse effect.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Potential Liability and Insurance</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The nature of our business exposes us to potential liability including, but not limited to, potential liability for (i) breach of contract or negligence claims by our customers; and, (ii) third party (such as patients) claims in respect of our performance of services.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, although we do not believe we are legally responsible for acts of third party investigators (physicians running trials), we could be subject to claims arising as a result of the actions of these investigators.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We try to reduce this potential liability by:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Seeking contractual indemnification from customers in relation to certain activities. The terms and scope of indemnification varies from customer to customer and project to project and the performance of these indemnities is not secured. As a result, we bear the risk that indemnification may not be relevant or sufficient or that the indemnifying party may not have the financial ability to fulfill its indemnification obligations. This indemnification does not protect us against our own acts or omissions such as our negligence or where our performance does not reach the required contractual, industry or regulatory standard.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Maintaining worldwide professional liability insurance. While we maintain the types and amounts of insurance we view as customary in the industries and countries in which we operate, there is no guarantee that we will continue to be able to maintain such insurance coverage on terms acceptable to us, if at all, or that the relevant policy will respond and provide cover when we want it to.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We could be materially adversely affected if ICON is required to pay damages or bear the costs of defending or settling any claim which a) is outside the scope of or in excess of a contractual indemnification provision, b) an indemnifying party does not fulfill its indemnification obligations, c) the claim is in excess of the level of our insurance coverage or d) the relevant circumstances are not covered by our insurance policies.</span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span id="i6f25ed905b654d7bbdfcf53e85d92c03_118797"></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Organizational Structure </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Details of the Company&#8217;s significant subsidiaries or entities under the Company's control at December&#160;31, 2024 are as follows:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research S.A.</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Argentina</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research S.A.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Argentina</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Pty Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research PTY Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medpass International Pty Ltd</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">KCR CRO Pty Ltd </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Australia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Austria GmbH </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Austria</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research Austria GmbH</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Austria</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IMP-Logistics Bel, FLLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Belarus</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Belgium B.V. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Belgium</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Bermuda,&#160;Ltd.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bermuda</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Pesquisas Cl&#237;nicas Ltda. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Ltda.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS do Brasil Servi&#231;os de Pesquisas Ltda.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS China Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">British Virgin Islands</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Bulgaria EOOD</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bulgaria</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research EOOD</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bulgaria</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">KCR CRO Ltd.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bulgaria</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Services de Recherche Pharmaceutique Srl</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3065613 Nova Scotia Company</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Canada) Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates ULC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oxford Outcomes LTD.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada                   <br/>(British Columbia)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Life Sciences Canada Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canada- Ontario</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Chile Limitada</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chile</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences Chile SpA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chile</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences China, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Beijing No.2) Co., Ltd </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Beijing) Co., Ltd </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences Colombia Ltda.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Colombia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research Pharmaceutical Services Costa Rica, LTDA.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Costa Rica</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Research Ltd. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Croatia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharm Research Associates d.o.o. za klinicka ispitivanja</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Croatia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Czech Republic s.r.o. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Czech Republic</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research s.r.o.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Czech Republic</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">KCR Czech Republic a.s., in liquidation </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Czech Republic</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Denmark ApS</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Denmark</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International Nordic Countries A/S</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Denmark</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Egypt Limited Liability Company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Egypt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Estonia O&#220;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estonia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">KCR Baltics O&#220;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estonia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Finland Oy</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International Finland Oy</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services France S.A.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research S.A.R.L. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mapi Research Trust</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oncacare France SAS</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IMP Logistics Georgia LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Georgia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Georgia LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Georgia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">KCR LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Georgia </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Germany GmbH</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oncacare (Germany) GmbH </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Averion Europe GmbH i.L</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">KCR Placement GmbH (in liquidation)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">KCR CRO GmbH </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Germany </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Greece A.E.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Greece</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Guatemala, S.A.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guatemala</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences (Hong Kong) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hong Kong</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Hong Kong Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hong Kong</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Hungary Research and Development Ltd. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hungary</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Limited Liability Company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hungary</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Iceland ehf.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Iceland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates India Private Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">India</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research India Private Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">India</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Property Development (Ireland) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Holdings Clinical Research International Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Investments Five Unlimited Company </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Investments Four Unlimited Company </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Holdings Unlimited Company </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON (LR) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Global Holdings Unlimited Company </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Property Holdings (Ireland) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Operational Financing Unlimited Company </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Operational Holdings Unlimited Company </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oncacare Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Investments Six Designated Activity Company</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Holdings (Ireland) Unlimited Company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Global Treasury Unlimited Company</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Israel Ltd.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Israel Ltd.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Italy S.r.l.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oncacare Italy S.r.l</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research GK</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Investments Limited </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Jersey</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences Kenya Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kenya</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Latvia SIA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Latvia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">UAB RPS Lithuania</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lithuania</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Luxembourg S.&#224; r.l.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Luxembourg</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Malaysia Sdn. Bhd.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Malaysia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON CRO Malaysia Sdn. Bhd.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Malaysia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research M&#233;xico, S. de R.L. de C.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research Servicios, S. de R.L. de C.V.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research M&#233;xico, S.A. de C.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Mexico S. de R.L. de C. V.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mexico</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International B.V. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services Netherlands B.V.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Group B.V.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA International Operations B.V.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Netherlands</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates New Zealand Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New Zealand</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (New Zealand) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New Zealand</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research Norway AS</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Norway</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Panama Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Panama</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Per&#250; S.A.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Peru</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Per&#250; S.A.C.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Peru</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research Philippines,&#160;Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Philippines</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Services Philippines, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Philippines</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Sp. z o.o.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Symphony Clinical Research Sp z.o.o.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Poland Sp z o.o.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Curandus Sp z o.o.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Poland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">KCR S.A. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Poland </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">KCR Placement Sp z o.o.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Poland </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA International Portugal, Unipessoal, Lda.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Portugal</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research Pharmaceutical Services Puerto Rico,&#160;Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Puerto Rico</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Romania S.R.L.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Romania</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research S.R.L. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Romania</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Joint Stock Company IMP Logistics </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Russia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Rus) LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Russia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">KCR LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Russia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research doo Beograd</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Serbia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates doo Beograd</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Serbia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Singapore Pte. Ltd.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Pte) Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mapi Life Sciences Singapore Pte. Ltd.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates SK s.r.o.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Slovakia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Slovakia, s.r.o.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Slovakia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">KCR s.r.o. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Slovakia </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Pharmaceutical S A (Proprietary) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South Africa</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research South Africa (Proprietary) Limited </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South Africa</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare South Africa (PTY) LTD</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South Africa </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mapi Korea Yuhan Hoesa/ Mapi Korea LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Korea Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Korea Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS ReSearch Ib&#233;rica, S.L.U.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oncacare (Spain), S.L.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Spain, S.L.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Espa&#241;a, S.L. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Espa&#241;a, S.A.U.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">KCR CRO, S.L.U.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare Espa&#241;a S.L.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Spain </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA International Sweden AB</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sweden</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International Sweden AB</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sweden</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International Switzerland GmbH</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Switzerland) GmbH</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Switzerland AG</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Taiwan Limited </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taiwan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Taiwan,&#160;Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taiwan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (Thailand) Limited </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thailand</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Research (Thailand) Co.,&#160;Ltd.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thailand</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Ankara Klinik Arastirma Dis Ticaret Anonim Sirketi</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Turkey</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pra Turkey Sa&#287;lik Ara&#351;tirma Ve Geli&#351;tirme Limited &#350;irketi </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Turkey</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">KCR CRO Ltd. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ukraine</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IMP-Logistics Ukraine LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ukraine</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS Ukraine LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ukraine</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Ukraine LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ukraine</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">KCR Ukraine LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ukraine</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare UK Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) No. 4 Limited </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) No. 5 Limited </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Holdings (U.K.) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MeDiNova Lakeside Clinical Research Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MeDiNova Merc (UK) Limited </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">VSK (Kenilworth) Limited </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Improving Treatments Limited </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aptiv Solutions (UK) Ltd </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS International UK Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON (LR) Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) No. 2 Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) No. 3 Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Development Solutions Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Investments (UK) Ltd</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IMP Logistics UK Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medeval Group Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OncaCare (U.K.) Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharm Research Associates (UK) Limited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sterling Synergy Systems Limited</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research (U.K.) No. 6 Limited </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United Kingdom </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Global S.A.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Uruguay</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Latin America S.A</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Uruguay</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">KCR U.S., Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA - Delaware </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Human Behind Every Number, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA - MA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Early Phase Services, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA - Texas</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ClinStar LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- California</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nextrials, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- California</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates CIS, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- California</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Eastern Europe, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- California</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Addplan, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beacon Bioscience, Inc </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">C4 MedSolutions, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Care Innovations, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Care Innovations, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CHC Group, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CRI NewCo,&#160;Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CRI Worldwide, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CRN Holdings, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CRN NORTH AMERICA, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Global Pharmaceutical Strategies Group, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Investments, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Laboratory Services, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Tennessee, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON US Holdings Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MMMM Consulting, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MMMM Group, LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MolecularMD Corp.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Parallel 6, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Early Development Research, Inc. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Health Sciences, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Holdings,&#160;Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA Receivables, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PriceSpective LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PubsHub LLC </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services,&#160;Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Source Healthcare Analytics, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Symphony Health Solutions Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research, LP</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International Medical Technical Consultants, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oncacare, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRA International, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Roy RPS Holdings LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Global Holdings,&#160;LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Parent Holding LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sunset Hills, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Delaware</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clinical Resource Network, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Illinois</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Christie Clinic, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Illinois</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CRI International, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- New Jersey</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DOCS Global, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- New Jersey</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Managed Care Strategic Solutions, L.L.C. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- New Jersey</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare US Inc. </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- North Carolina</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Charlotte, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- North Carolina</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Company</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Country</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Group ownership</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Hickory, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- North Carolina</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Raleigh, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- North Carolina</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Rocky Mount, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- North Carolina</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Salisbury, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- North Carolina</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Wilmington, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- North Carolina</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Winston-Salem, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- North Carolina</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Complete Healthcare Communications LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Pennsylvania</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Complete Publication Solutions, LLC </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Pennsylvania</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Charleston, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- South Carolina</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accellacare of Bristol, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Tennessee</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lifetree Clinical Research, LC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Utah</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates,&#160;Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Virginia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Government and Public Health Solutions, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">USA- Virginia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ICON Clinical Research Vietnam LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vietnam</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 19pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 12.25pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mapi Research Trust is an association, its members are ICON Subsidiary entities</span></div><div style="margin-top:5pt;padding-left:5.04pt;text-align:justify;text-indent:-5.04pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pharmaceutical Research Associates doo Belgrade changed its name to ICON Clinical doo Beograd, with effect from January 17, 2025.</span></div><div style="margin-top:5pt;padding-left:5.04pt;text-align:justify;text-indent:-5.04pt"><span><br/></span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D.    Description of Property</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our principal executive offices are </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">located in South County Business Park, Leopardstown, Dublin, Republic of Ireland, where we own an office facility of approximately 15,000 squ</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">are meters. We lease all other properties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We maintain forty-nine offices in Europe; nine of our offices are in the UK, five in Spain, three in each of the Netherlands, Germany, Poland and Ukraine, two in each of France, Hungary, Ireland, Russia, Sweden and Bulgaria and one in each of Turkey, Belarus, Belgium, Czech Republic, Georgia, Israel, Italy, Latvia, Romania, Estonia and Slovakia. We maintain thirty-two offices in North America; twenty-eight in the United States, two in Canada and two in Mexico. We have seventeen offices in Asia; six in China (including one in Hong Kong), three in India, two in each of Japan and Singapore, and one in each of South Korea, Taiwan, Thailand and the Philippines. We have two offices in Australia. We have five offices in South America: one in each of Argentina, Brazil, Chile, Colombia and Peru. We maintain one office in South Africa.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_52"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 4A. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Unresolved Staff Comments.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_55"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 5. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; Operating and Financial Review and Prospects.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Management's discussion and analysis of financial condition and results of operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis should be read in conjunction with our consolidated financial statements, accompanying notes and other financial information, appearing in Item 18. The consolidated financial statements have been prepared in accordance with U.S. GAAP. The information included in the discussion and analysis below provides details on the information for the years ended December&#160;31, 2024 and December&#160;31, 2023. Information related to the year ended December&#160;31, 2022 has not been included. It can be found in the Company's filing of the form 20-F for the year ended December&#160;31, 2023.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are a CRO providing outsourced development services on a global basis to pharmaceutical, biotechnology, medical device and government and public health organizations. We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process - from compound selection to Phase I-IV clinical studies. Our vision is to be the healthcare intelligence partner of choice by delivering industry leading solutions and best in class performance in clinical development.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in the major therapeutic areas on a global basis and have the operational flexibility to provide develop</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ment services on a stand-alone basis or as part of an integrated &#8220;full service&#8221; solution. At December&#160;31, 2024, we employed approximately 41,900 employees, in 106 locations in 55 countries. During the</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> year ended December&#160;31, 2024 we derived 36.0%, 52.6% and 11.4% of our revenue in the United States, Europe, and the rest of the world, respectively (During the year ended December&#160;31, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">40.4%, 48.7% and 10.9% respectively).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue consists of fees earned under contracts with third-party clients. In most cases, a portion of the contract fee is paid at the time the study or trial is started, with the balance of the contract fee generally payable in installments over the study or trial duration, based on the delivery of certain performance targets or milestones. Revenue from long term contracts is recognized on a proportional performance method based on the relationship between cost incurred and the total estimated costs of the trial or on a fee-for-service basis according to the particular circumstances of the contract. As is customary in the CRO industry, we contract with third party investigators in connection with clinical trials. Investigator costs and certain other third party costs are included in our assessment of progress towards completion and costs incurred in measuring revenue. Where these costs are reimbursed by clients, they are included in the total contract value recognized over time, based on our assessment of progress towards completion.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As the nature of our business involves the management of projects, the majority of which have a duration of one to four years, the commencement or completion of projects in a fiscal year can have a material impact on revenues earned with the relevant clients in such years. In addition, as we typically work with some, but not all divisions of a client, fluctuations in the number and status of available projects within such divisions can also have a material impact on revenues earned from such clients from year to year.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Termination or delay in the performance of an individual contract may occur for various reasons, including, but not limited to, unexpected or undesired results, production problems resulting in shortages of the drug, adverse patient reactions to the drug, the client&#8217;s decision to de-emphasize a particular trial or inadequate patient enrollment or investigator recruitment. In the event of termination, the Company is usually entitled to all sums owed for work performed through the notice of termination and certain costs associated with the termination of the study. In addition, contracts generally contain provisions for renegotiation in the event of changes in the scope, nature, duration, or volume of services of the contract.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our unsatisfied performance obligation comprises our assessment of contracted revenue yet to be earned from projects awarded by clients. At December&#160;31, 2024, we had unsatisfied performance obligations of $15.9 billion </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">see note 4. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">for further details).&#160;We believe that our unsatisfied performance obligation as of any date is not necessarily a meaningful predictor of future results, due to the potential for cancellation or delay of the projects included in the unsatisfied performance obligation, and no assurances can be given on the extent to which we will be able to realize the unsatisfied performance obligation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Although we are domiciled in Ireland, we report our results in U.S. dollars. As a consequence, the results of our non-U.S. based operations, when translated into U.S. dollars, could be materially affected by fluctuations in exchange rates between the U.S. dollar and the currencies of those operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to translation exposures, we are also subject to transaction exposures where the currency in which contracts are priced can be different from the currencies in which costs relating to those contracts are incurred. Our operations in the United States are not materially exposed to such currency differences as the majority of our revenues and costs are in U.S. dollars. However, outside of the United States the multinational nature of our activities means that contracts are usually priced in a single currency, most often U.S. dollars or euro, while costs arise in a number of currencies, depending, among other things, on which of our offices provide staff for the contract and the location of investigator sites. Although many such contracts benefit from some degree of natural hedging, due to the matching of contract revenues and costs in the same currency, where costs are incurred in currencies other than those in which contracts are priced, fluctuations in the relative value of those currencies could have a material effect on our results of operations. We regularly review our currency exposures. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As we conduct operations on a global basis, our effective tax rate has depended, and will depend, on the geographic distribution of our revenue and earnings among locations with varying tax rates. Our results therefore may be affected by changes in the tax rates of the various jurisdictions. In particular, as the geographic mix of our results of operations among various tax jurisdictions changes, our effective tax rate may vary significantly from period to period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.&#160;&#160;&#160;&#160;Operating Results</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth, for the periods indicated, certain financial data as a percentage of revenue and the percentage change in these items compared to the prior comparable period. The trends illustrated in the following table may not be indicative of future results.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.691%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 to 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage of Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage<br/>Increase/(Decrease)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration related </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations </span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Year ended December&#160;31, 2024 compared to year ended December&#160;31, 2023</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:35.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.735%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.735%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.735%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.739%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,281,676&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,120,176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue for the year ended December&#160;31, 2024 increased by $161.5 million, or 2.0%, to $8,281.7 million, compared to $8,120.2 million for the year ended December&#160;31, 2023. Revenue increased by 2.0% in constant currency terms. The increase in revenues in the year ended December&#160;31, 2024 is due to the Company's acquisitions and continued organic growth.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024 the Company derived 36.0%, 52.6% and 11.4% of our revenue in the United States, Europe and Rest of World respectively. Revenues from our top five customers amounted to $2,071.4 million in the year ended December&#160;31, 2024 compared to $2,174.8 million in the year ended December&#160;31, 2023 or 25.0% and 26.8% respectively. New customer accounts are continually added across the full portfolio of large pharma customer, mid-tier pharma customers and biotech customers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue in Ireland increased by $415.9 million in the year ended December&#160;31, 2024, to $2,793.0 million, compared to $2,377.1 million for the year ended December&#160;31, 2023.&#160;Revenue in Ireland during the year ended December&#160;31, 2024 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">increased by 17.5% compared to an overall increase in Group revenue of 2.0%.&#160;Revenue in Ireland is principally a function of our global contracting model (see</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">note 22.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Business Segment and Geographical Information </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">for further details).</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue in the Rest of Europe decreased by $14.1 million or 0.9%, to $1,560.7 million in the year ended December&#160;31, 2024, compared to $1,574.8 million for the year ended December&#160;31, 2023. Revenue in the U.S. decreased by $298.5 million or 9.1%, to $2,985.3 million, compared to $3,283.8 million for the year ended December&#160;31, 2023. Revenue in our Rest of World (&#8216;Other&#8217;) region increased by $58.1 million or 6.6%, to $942.6 million, compared to $884.5 million for the year ended December&#160;31, 2023. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Refer to  note 22. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business Segment and Geographical Information</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, which details the Company's Global transfer pricing model.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Direct costs</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:51.252%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,845,319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,719,949&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Direct costs for the year ended December&#160;31, 2024 increased by $125.4 million, or 2.2%, to $5,845.3 million, compared to $5,719.9 million for the year ended December&#160;31, 2023. Direct costs consist primarily of investigator and other reimbursable costs, compensation, associated fringe benefits and share based compensation expense for project-related employees and other direct project driven costs. The increase in direct costs arose due to an increase in third party investigator/other reimbursable costs and laboratories partially offset by decreases in personnel related costs, travel and other direct project driven costs. As a percentage of revenue, direct costs have increased to 70.6% of revenue during the year ended December&#160;31, 2024 compared to 70.4% for the year ended December&#160;31, 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Selling, general and administrative </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:51.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.760%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">728,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">768,559&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40,211)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Selling, general and administrative expenses for the year ended December&#160;31, 2024 decreased by $40.2 million, or 5.2%, to $728.3 million, compared to $768.6 million for the year ended December&#160;31, 2023. Selling, general and administrative expenses comprise primarily of compensation, related fringe benefits and routine share based compensation expense for non-project-related employees, recruitment expenditures, professional service costs, advertising costs and all costs related to facilities and information systems. As a percentage of revenue, selling, general and administrative expenses decreased to 8.8% of revenue during the year ended December&#160;31, 2024, compared to 9.4% of revenue for the year ended December&#160;31, 2023. The decrease in costs for the year ended December&#160;31, 2024 primarily reflects decreases in personnel costs, facilities costs, favorable foreign exchange movements ($31.0 million) offset by increases in general overhead, professional fees and marketing costs.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Depreciation and amortization </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:51.041%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.852%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.852%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.855%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138,209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126,096&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">459,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(109,563)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Depreciation expense for the year ended December&#160;31, 2024 increased by $12.1 million or 9.6%, to $138.2 million, compared to $126.1 million for the year ended December&#160;31, 2023. The depreciation charge reflects the investments in facilities, information systems and equipment. As a percentage of revenue, the depreciation expense increased to 1.7% of revenues, for the year ended December&#160;31, 2024 compared to 1.6% for the year December&#160;31, 2023.&#160;The depreciation charge has increased mainly due to additional investment in technology assets. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization expense for the year ended December&#160;31, 2024 decreased by $109.6 million or 23.8%, to $350.3 million, compared to $459.9 million for the year ended December&#160;31, 2023. The amortization expense represents the amortization of intangible assets acquired in connection with business combinations. As a percentage of revenue, the amortization expense decreased to 4.2% for the year ended December&#160;31, 2024, compared to 5.7% of revenue for the year ended December&#160;31, 2023. The decrease in amortization is due to the order backlog and trade name intangible assets recognized in connection with the PRA merger amounting to </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$500.0 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$202.0 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> respectively as of the date of acquisition, becoming fully amortized on July 1, 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Restructuring, transaction and integration related expenses</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:51.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration related </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,602)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024, the Company incurred $29.6 million for transaction and integration related expenses. The charge includes costs associated with ongoing integration activities related to our recent acquisitions. Such costs include professional fees, legal costs and related integration costs </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">offset by the remeasurement of liability-classified contingent consideration</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has also undertaken a restructuring program aimed at realigning its workforce as well as reviewing its global office footprint and optimizing its locations to best fit the requirements of the Company. This program has resulted in a charge of $92.1 million in the year ended December&#160;31, 2024. In the year ended December&#160;31, 2023, a restructuring charge of $45.4 million was recognized. The restructuring plan reflects a workforce reduction of $74.5&#160;million (December&#160;31, 2023: $34.1&#160;million) and an office consolidation program to optimize the Company's office footprint of $17.6&#160;million (December&#160;31, 2023: $11.3&#160;million).</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We expect to incur some additional expenses associated with the Merger; however, the timing and the amount of these expenses depends on various factors including the execution of integration activities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Income from operations</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:51.322%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.760%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,097,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">956,152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,660&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations increased by $141.7 million, or 14.8%, to $1,097.8 million, compared to $956.2 million for the year ended December&#160;31, 2023. As a percentage of revenue, income from operations increased to 13.3% of revenues compared to 11.8% of revenues for year ended December&#160;31, 2023. Excluding amortization of intangible assets, Income from operations increased by $32.1 million, or 2.3%, to $1,448.1 million, compared to $1,416.0 million for the year ended December&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Excluding amortization of intangible assets, Income from operations in Ireland increased to $919.1 million compared to $885.9 million for the year ended December&#160;31, 2023.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the Rest of Europe region, excluding amortization of intangible assets, income from operations increased to $216.8 million compared to $154.6 million for the year ended December&#160;31, 2023. As a percentage of  revenue, excluding amortization of intangible assets, income from operations in the Rest of Europe region increased to 13.9% compared to 9.8% for the year ended December&#160;31, 2023.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the U.S. region, excluding amortization of intangible assets, income from operations decreased by $73.5 million, to $241.5 million, compared to $315.0 million for the year ended December&#160;31, 2023. As a percentage of revenue, excluding amortization of intangible assets, income from operations in the U.S. region decreased to 8.1% compared to 9.6% for the year ended December&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In other regions, excluding amortization of intangible assets, income from operations increased by $10.2 million to $70.7 million compared to $60.5 million for the year ended December&#160;31, 2023. As a percentage of revenue, excluding amortization of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">intangible assets, income from operations in the other regions increased to 7.5% compared to 6.8% for the year ended December&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Interest income and expense</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:35.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,609&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,014&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,595&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(237,237)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(336,699)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest expense decreased to $237.2 million compared to $336.7 million for the year ended December&#160;31, 2023. The decrease in the period reflects significant repayments of the Company's loan facilities in 2023 and 2024, the repricing of the senior secured term loan facility and senior secured revolving credit facility in March 2024, the impact of reduced interest rates on the New Notes issued in May 2024 and the closure of the 2022 Swap and 2022 Caps. Interest income for the year ended December&#160;31, 2024 increased to $8.6 million, compared to $5.0 million for the year ended December&#160;31, 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Income tax expense</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:35.370%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31,</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,710&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,961&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">561.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective income tax rate </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Income tax expense increased to $77.7 million compared to $11.7 million for the year ended December&#160;31, 2023.&#160;The Company&#8217;s effective tax rate for the year ended December&#160;31, 2024 was 8.9%&#160;compared to 1.9% for the year ended December&#160;31, 2023 primarily due to changes in various tax laws and the level of deferred tax benefit associated with the amortization of intangible assets. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">With the exception of the foregoing, the Company&#8217;s effective tax rate remains principally a function of the distribution of pre-tax profits amongst the territories in which it operates.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B. &#160;&#160;&#160;&#160;Liquidity and Capital Resources</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The CRO industry is generally not capital intensive. The Company&#8217;s principal operating cash needs are payment of salaries, office rents, travel expenditures and payments to investigators. Investing activities primarily reflect capital expenditures for facilities and information systems enhancements, the purchase and sale of short term investments and acquisitions. Financing activities primarily reflect the servicing of the Company's external debt and transactions pertaining to its ordinary shares.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our clinical research and development contracts are generally fixed price with some variable components and range in duration from a few weeks to several years. Revenue from contracts is generally recognized as income on the basis of the relationship between costs incurred and the total estimated contract costs. The cash flow from contracts typically consists of a down payment at the time the contract is entered into, with the balance paid in installments over the contract duration, in some cases on the achievement of certain milestones. Therefore, cash receipts do not correspond to costs incurred and revenue recognized on contracts. In the Company's opinion, working capital is sufficient to meet the Company's present requirements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash and cash equivalents and net borrowings</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:25.107%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.203%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Drawn<br/>down)/<br/>repaid</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net cash inflow/</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(outflow)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other non-cash adjustments</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of exchange rates</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="18" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">378,102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182,679&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,996)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">538,785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Credit Facilities, 2026 Notes &amp; New Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,775,589)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,426,160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash and cash equivalents and borrowings </span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(3,397,487)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">360,283</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">195,358</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(23,533)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(21,996)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(2,887,375)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Net cash and cash equivalents and borrowings is a useful measure that assists understanding of the Company&#8217;s liquidity and capital resources, which is relevant to the Company&#8217;s strategy. The Company&#8217;s cash and cash equivalents at December&#160;31, 2024 amounted to $538.8 million compared $378.1 million at December&#160;31, 2023.&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Refer to note 13. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Bank credit lines, loan facilities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and notes for details on the Company's outstanding debt. Refer to note 15. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for further details on the Company's contractual liabilities for lease arrangements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Cash flows</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Net cash from operating activities</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">Net cash provided by operating activities increased by $125.7 million to $1,286.7 million for the year ended December&#160;31, 2024 as compared to net cash provided by operating activities of $1,161.0 million for the year ended December&#160;31, 2023. The increase in net cash provided by operating activities of $125.7 million is primarily due to  changes in working capital, which is discussed further below, in addition to reduced interest, changes in timing of income tax payments offset by restructuring outflows.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The change in working capital is primarily attributable to an increase in cash inflows from accounts receivable of $432.6 million, a decrease in cash inflows from unbilled revenue of $344.6 million and a decrease in cash inflows from unearned revenue of $172.3 million. These changes result from differences in timing of revenue recognition, cash collection and billing on clinical trials. The number of days&#8217; revenue outstanding at December&#160;31, 2024 was&#160;47 days (September 30, 2024: 52 days, June 30, 2024: 51 days, March 31, 2024: 49 days, December&#160;31, 2023: 47 days, September 30, 2023: 49 days, June 30, 2023: 52 days). A decrease in the number of days&#8217; revenue outstanding during a period will result in cash inflows to the Company while an increase in days revenue outstanding will lead to cash outflows. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Cash generated from working capital and days&#8217; revenue outstanding may be positively or negatively impacted by, amongst others, the scheduling of contractual milestones over a study or trial duration, the achievement of a particular milestone during the period, the timing of receipt of invoices from third parties for reimbursable costs and the timing of cash receipts from customers. Contract fees are generally payable in installments based on the achievement of certain performance targets or &#8220;milestones&#8221; (e.g. target patient enrollment rates, clinical testing sites initiated or case report forms completed), such milestones being specific to the terms of each individual contract, while revenues on contracts are recognized as contractual obligations are performed.&#160;Further, credit terms negotiated between the Company and its customers, and movement in exchange rates also impact cash inflows and days' revenue outstanding.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Net cash used in investing activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Net cash used in investing activities was $266.8 million for the year ended December&#160;31, 2024 compared to net cash used in investing activities of $226.7 million for the year ended December&#160;31, 2023. Net cash used in investing activities for the year ended December&#160;31, 2024 was primarily related to cash outflows of $168.1 million for capital expenditures made mainly relating to investment in facilities and IT infrastructure, $84.2 million in relation to the acquisitions of HumanFirst and KCR Group and $14.5 million in relation to investments in equity. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Net cash used in financing activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Net cash used in financing activities amounted to $837.2 million for the year ended December&#160;31, 2024 compared with net cash used in financing activities of $844.0 million for the year ended December&#160;31, 2023. In the year ended December&#160;31, 2024, the Company made a net repayment of $360.3 million on external financing (See the</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%"> Consolidated Statements of Cash Flows</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> for further details). In addition, see note 13.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%"> Bank credit lines, loan facilities and notes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> for further details on the New Notes issued in May 2024 and the use of proceeds. Further, the Company repurchased 2,179,699</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">ordinary shares for a total consideration of $500.0 million. These outflows were offset by $36.2 million received by the Company from the exercise of equity options issued as compensation. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Net cash inflow</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a result of these cash flows, cash and cash equivalents increased by $160.7 million for the year ended December&#160;31, 2024 compared to an increase of $89.3 million for the year ended December&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C. &#160;&#160;&#160;&#160;Research and development, patents and licenses</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plays a critical role in new drug development by undertaking activities in each of the different stages of the drug development process. Clinical trials result in an advancement in the field of medical science as they establish the safety and efficacy of new drugs, thus resolving scientific uncertainty. As one of a number of world leaders in clinical research and commercialization, ICON is a trusted partner for pharmaceutical and medical device companies in helping them to accelerate the development of drugs and devices that save lives and improve the quality of life. ICON's role in ensuring that the trial design is scientifically valid is a crucial part of the design and involves scientists, medical doctors and biostatisticians. ICON works with the sponsors in designing the conduct of the clinical research trial. ICON's role of conducting clinical trials is an integral part of the research and development process leading ultimately to a decision as to whether or not each drug is safe for human consumption, has the desired effect on targeted diseases and the best means of delivering that drug to the patient. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D. &#160;&#160;&#160;&#160;Trend information</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other than as disclosed elsewhere in this annual report, we are not aware of any trends, uncertainties, demands, or commitments or events since December&#160;31, 2024 that are reasonably likely to have a material adverse effect on our revenues, income, profitability, liquidity or capital resources, or that would cause the reported financial information in this annual report to be not necessarily indicative of future operating results or financial conditions. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">E. &#160;&#160;&#160;&#160;Critical Accounting Estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note 2 to the audited consolidated financial statements provided elsewhere in this Form 20-F describes the significant accounting policies used in the preparation of the consolidated financial statements. The preparation of our consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the period. We base our estimates and judgments on historical experience and on the other factors that we believe are reasonable under current circumstances. Actual results may differ from these estimates if these assumptions prove to be incorrect or if conditions develop other than as assumed for the purposes of such estimates. The following is a discussion of the critical accounting estimates and judgments used by management. The application of these critical accounting estimates is discussed with the Audit Committee of the Board of Directors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition - Clinical Trial Services</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Clinical trial services are a single performance obligation satisfied over time i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. We have concluded that ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research project. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/reimbursable expenses) adjusted to reflect a realizable contract value. An assessment of the realizable contract value is judgmental in nature. The realizable value assessment is updated at each reporting period, having regard to (i) contract terms and (ii) customer experience.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue is recognized on a percentage completion basis as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs (inclusive of third party costs) at each reporting period. Measurement of the progress towards completion involves judgment and estimation. Assessment of completion requires an evaluation of labor and related time cost incurred at the reporting date and third party costs incurred at the reporting date. The assessment of third party costs incurred (principally investigator costs) requires a review of activity performed and recorded by the third party services providers. The timing of payments to third parties in respect of cost incurred reflect invoicing by third parties. The timing difference between the activity performed and receipt of invoices from third parties may result in significant accrued amounts at reporting periods.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assessment of progress towards completion also requires an up to date evaluation of the forecast costs to complete in respect of these projects. Given the long-term nature of the clinical trials, and the complex nature of those trials, the forecast costs to complete (being internal direct costs and costs that will be incurred by third parties (principally investigators)) is judgmental. Forecast time (and related costs) is determined by reference to (i) contract terms and (ii) past experience. Forecast third party costs to complete are determined by project by reference to (i) contract terms and (ii) past experience. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Recoverability of Goodwill and Long-Lived Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company assesses its goodwill for impairment annually or when events or circumstances indicate a possible impairment. The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also choose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If the Company elects to perform a qualitative assessment, events and circumstances considered for each reporting unit may include: (i) current year results, (ii) financial performance versus management&#8217;s annual and multi-year strategic plans, (iii) changes in the reporting unit carrying value since prior year, (iv) industry and market conditions in which the reporting unit operates, (v) macroeconomic conditions, including discount rate changes, and (vi) changes in products or services offered by the reporting unit. Based on the results of the qualitative assessment, if the Company concludes that it is not more likely than not that the fair value of the reporting unit is less than its carrying values of the reporting unit, then no quantitative assessment is performed.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A quantitative assessment includes the estimation of the fair value of each reporting unit as compared to the carrying value of the reporting unit. The Company estimates the fair value of a reporting unit using both income-based and market-based valuation methods. The income-based approach is based on the reporting unit's forecasted future cash flows that are discounted to the present value using the reporting unit's weighted average cost of capital. For the market-based approach, the Company may utilize a number of factors such as publicly available information regarding the market capitalization of the Company as well as operating results, business plans, market multiples, and present value techniques. Based upon the range of estimated values developed from the income and market-based methods, the Company determines the estimated fair value for the reporting unit. If the estimated fair value of the reporting unit exceeds the carrying value, the goodwill is not impaired and no further review is required.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The income-based fair value methodology requires management's assumptions and judgments regarding economic conditions in the markets in which the Company operates and conditions in the capital markets, many of which are outside of management's control. At the reporting unit level, fair value estimation requires management's assumptions and judgments regarding the effects of overall economic conditions on the specific reporting unit, along with assessment of the reporting unit's strategies and forecasts of future cash flows, terminal growth rates and discount rates.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the market-based fair value methodology, judgment may be required in evaluating market multiples and recent transactions. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company completed its most recent annual goodwill impairment testing as of September 30, 2024, a date which is consistent with the prior year. For the years ended December&#160;31, 2024 and 2023, the Company determined that there was no impairment of goodwill.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other long lived assets</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company assesses long-lived assets (such as intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset group might not be recoverable. If indicators of impairment are present, we evaluate the carrying value of long-lived asset in relation to estimates of future undiscounted cash flows. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Taxation</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Given the global nature of our business and the multiple taxing jurisdictions in which we operate, the determination of the Company&#8217;s provision for income taxes requires significant judgments and estimates, the ultimate tax outcome of which may not be certain. Although we believe our estimates are reasonable, the final outcome of these matters may be different than those reflected in our historical income tax provisions and accruals.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The provision for income taxes includes federal, state, local and foreign taxes. We apply the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. We account for the impact of Global Intangible Low-Taxed Income ("GILTI") in the period it arises and therefore have not provided for deferred taxes in respect of this item. Recognition of deferred income tax assets is based on management&#8217;s belief that it is more likely than not that the income tax benefit associated with certain temporary differences, income tax operating loss, capital loss carryforwards, and income tax credits, would be realized. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. We recognize the effect of income tax positions only if those positions will more likely than not be sustained. We determined the amount of the valuation allowance based, in part, on our assessment of future taxable income and in light of our ongoing income tax strategies. If our estimate of future taxable income or tax strategies changes at any time in the future, we would record an adjustment to our valuation allowance. Recording such an adjustment could have a material effect on our financial condition or results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">F. &#160;&#160;&#160;&#160;Summarized financial information of issuers and guarantors</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In connection with the offering of the New Notes by one of our subsidiaries, ICON Investments Six Designated Activity Company (the "Issuer"), disclosures required by Rule 13-01 (a)(1) through (3) of Regulation S-X are provided below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The New Notes are guaranteed on a senior secured basis by ICON and its existing and future wholly owned subsidiaries organized in the United States, Ireland and the Grand Duchy of Luxembourg (&#8220;Luxembourg&#8221;), in each case that guarantee the obligations under our Senior Secured Credit Facilities and the 2026 Notes (the &#8220;Subsidiary Guarantors&#8221; and, collectively with ICON, the &#8220;Guarantors&#8221;). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The New Notes are the senior secured obligations of the Issuer and the Guarantors and the New Notes rank equally in right of payment to all of the Issuer&#8217;s and Guarantors&#8217; existing and future senior debt (including the Senior Secured Credit Facilities and the 2026 Notes) and senior in right of payment to all of the Issuer&#8217;s and Guarantors&#8217; existing and future </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">subordinated debt. The New Notes and the guarantees are secured on a first-lien basis by substantially all of the existing and future assets of the Issuer and the guarantors that also secure the Issuer&#8217;s and the guarantors&#8217; obligations under the Senior Secured Credit Facilities and the 2026 Notes on a pari passu basis, subject to permitted liens, and the liens on the collateral securing the New Notes (the &#8220;Collateral&#8221;) rank equally in priority with the liens on the collateral securing borrowings and guarantees under the Senior Secured Credit Facilities, the 2026 Notes and any other future pari passu first lien indebtedness. The New Notes and the guarantees are effectively senior to any of the Issuer&#8217;s and the guarantors&#8217; existing and future unsecured indebtedness to the extent of the value of the assets securing the New Notes and the guarantees. The New Notes and the guarantees are structurally subordinated to all existing and future indebtedness and other liabilities of ICON&#8217;s subsidiaries that will not guarantee the New Notes, which includes all of ICON&#8217;s subsidiaries organized outside the United States, Ireland and Luxembourg and any other subsidiaries that do not guarantee the Senior Secured Credit Facilities or the 2026 Notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The New Notes are, jointly and severally, unconditionally, guaranteed on a senior secured basis by ICON and its existing and future wholly owned subsidiaries organized in a covered jurisdiction that guarantee the obligations under the Senior Secured Credit Facilities and the 2026 Notes. The obligations of each Guarantor under its note guarantee are limited as necessary to prevent the relevant note guarantee from constituting a fraudulent conveyance, fraudulent transfer or unlawful financial assistance under applicable law, or otherwise to reflect limitations under applicable law. By virtue of these limitations, the obligations of a Guarantor under its note guarantee could be significantly less than amounts payable with respect to the notes of any series or a Guarantor may have effectively no obligations under its respective note guarantee. ICON may, at any time, cause a subsidiary to become a Guarantor by executing and delivering a supplemental indenture providing for the Guarantee of payment of the applicable series of notes by such subsidiary on the basis provided in the applicable indenture.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Any Guarantor will be automatically and unconditionally released from all obligations under its note guarantee, and such note guarantee shall thereupon terminate and be discharged and of no further force and effect:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">concurrently with any sale, exchange, disposition or transfer (by merger or otherwise) described in the preliminary prospectus supplement for the offering of New Notes, of any capital stock, or all or substantially all assets of such Guarantor following which such Guarantor is no longer a subsidiary of ICON or ceases to be organized in a covered jurisdiction;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">as to all Guarantors (other than ICON), at the time of any collateral release event;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">upon legal defeasance, covenant defeasance or satisfaction and discharge of the indenture governing the New Notes; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">upon the merger, amalgamation or consolidation of any Guarantor into ICON, the Issuer or another Guarantor or upon the liquidation, dissolution or winding up of such Guarantor;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">the release of such Guarantor from its guarantee under the Senior Secured Credit Facilities (except in the case of a release from the repayment in full of the Senior Secured Credit Facilities); or</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">upon such Guarantor becoming an excluded subsidiary.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Summarized Combined Financial Information </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Summarized financial information (the "SFI"), as defined under Rule 1-02 (bb) of Regulation S-X, is provided below for the Issuer and Guarantor entities, collectively, the "Obligor Group" as of December&#160;31, 2024 and December&#160;31, 2023, and for the  year ended December&#160;31, 2024 and December&#160;31, 2023. The SFI is presented on a combined basis with intercompany transactions and balances among the entities included in the Obligor Group eliminated. The Obligor Group SFI excludes investments in non-guarantor entities. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,474,880&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,444,520&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total costs and expenses  (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,647,712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,683,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations (a)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">827,168&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">761,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (a) (b)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">699,018&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">356,467&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) Includes amortization of intangible assets of $344.4&#160;million for the year ended December&#160;31, 2024 and $452.8&#160;million for the year ended December&#160;31, 2023.</span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b) Includes net intercompany interest expense of $144.4&#160;million for the year ended December&#160;31, 2024 and $130.0&#160;million for the year ended December&#160;31, 2023.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,207,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,941,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current assets (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,996,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,347,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intercompany receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,309,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,052,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">67,513,307</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">65,341,392</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,561,140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,514,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,380,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,799,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intercompany payables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,029,580&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,618,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11,971,290</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11,933,055</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c) Non-current assets include each Guarantor's investment in obligor subsidiaries, on a combined aggregated basis.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the context of security for the New Notes, the combined financial information of entities whose securities are pledged as collateral (the "Pledgor Group") was determined to be materially consistent with the consolidated financial information of the ICON group (ICON and all of its subsidiaries) for the periods presented above, and as such, summarized combined financial information has not been presented for the Pledgor Group.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_58"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 6. Directors, Senior Management and Employees.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Directors and Senior Management</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table and accompanying biographies set forth certain information concerning each of ICON plc&#8217;s Directors, officers and other key employees as</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> of February&#160;21, 2025.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:33.504%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:55.352%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Position</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ciaran Murray</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chair and Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. Steve Cutler (1)(5)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Executive Officer and Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nigel Clerkin (1)(5)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Barry Balfe (6)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Operating Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&#243;n&#225;n Murphy (2)(3)(5)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lead Independent Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. John Climax</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eugene McCague (3)(4)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Julie O'Neill (2)(3)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. Linda Grais (2)(4) </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Anne Whitaker (4)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diarmaid Cunningham</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Administrative Officer, General Counsel &amp; Company Secretary</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Named Executive Officer of the Company.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Member of Compensation and Organization Committee.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Member of Audit Committee.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Member of Nominating, Sustainability and Governance Committee.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Member of Execution Committee.</span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Named Executive Officer of the Company following his appointment as Chief Operating Officer, effective January 1, 2025.</span></div><div style="padding-left:27pt"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Ciaran Murray</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Ciaran Murray graduated with a Bachelor of Commerce degree from University College Dublin in 1982. Mr. Murray subsequently qualified as a chartered accountant with PwC.&#160;Following qualification, Mr. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Murray gained extensive global experience working as an executive in the fast moving consumer goods and technology sectors in Ireland, Italy, the UK and the US.&#160;Mr. Murray has been the Chair of ICON plc since March 2017 and an outside Director since May 2018. Mr. Murray served as Chief Executive Officer from October 2011 until March 2017 and was Chief Financial Officer from joining ICON plc in 2005 until his appointment as Chief Executive Officer in 2011.&#160;During his time with ICON plc, Mr. Murray was recognized for his leadership of ICON and the CRO industry.&#160; Mr. Murray served as Chair of the Association of Clinical Research Organizations (ACRO) which represents the CRO industry globally. In addition, Mr. Murray was named as a leader in CRO Innovation by PharmaVOICE100, a listing of the most influential people in the bio pharma industry.&#160;University College Dublin awarded Mr. Murray an honorary degree of Doctor of Laws in 2013 for his support of third level research and innovation in Ireland. In 2018, the Royal Dublin Society awarded Mr. Murray the RDS Gold Medal for Enterprise for making an exceptional impact on Irish industry and commerce. Mr. Murray is also a member of the advisory Board of UCD Smurfit Business School. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Dr. Steve Cutler </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. Steve Cutler was appointed Chief Executive Officer of ICON plc in March 2017, having previously served as Chief Operating Officer from January 2014. Dr. Cutler served as Group President of Clinical Research Services since November 2011 until his appointment as Chief Operating Officer.&#160;Dr. Cutler was appointed to the Board of ICON plc in November 2015. Prior to joining the Company, Dr. Cutler held the position of Chief Executive Officer of Kendle, having previously served as Chief Operating Officer.&#160;Prior to Kendle, Dr. Cutler spent 14 years with Quintiles where he served as Senior Vice President, Global Project Management; Senior Vice President, Clinical, Medical and Regulatory; Senior Vice President, Project Management - Europe; and Vice President, Oncology - Europe, as well as regional leadership positions in South Africa and Australia. Prior to joining Quintiles, Dr. Cutler held positions with Sandoz in Australia and Europe. Dr. Cutler holds a B.Sc. and a Ph.D. from the University of Sydney and a Masters of Business Administration from the University of Birmingham (UK).</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Nigel Clerkin</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Nigel Clerkin was appointed as Chief Financial Officer of the Company in October 2024. Mr. Clerkin commenced his career with KPMG Dublin, before joining Elan Corporation where he held a number of roles of increasing responsibility over a fifteen-year career, culminating in the role of Group Chief Financial Officer in 2011, which he held until 2014. Mr. Clerkin then moved to be Chief Financial Officer at ConvaTec, a global medical and technologies company, before becoming UDG </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Healthcare&#8217;s Chief Financial Officer in 2018. During his tenure with UDG Healthcare, Mr. Clerkin led substantial change and improvement programs and oversaw strong financial growth across multiple business lines. Most recently, Mr. Clerkin was Chief Financial Officer at LetsGetChecked, a global provider of at-home healthcare services. Mr. Clerkin holds a Bachelor of Science (Accounting) degree and a Master of Accounting degree from Queen&#8217;s University Belfast and is also a qualified chartered accountant and a fellow of Chartered Accountants Ireland.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Barry Balfe</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Mr. Barry Balfe was appointed Chief Operating Officer effective January 2025. Mr. Balfe previously served as President of ICON Pharma Development Solutions.  Mr. Balfe has been with ICON for over 20 years and has held a number of leadership roles across both full service and functional solutions at ICON where he has successfully grown business and has developed and led a number of new strategic partnerships with some of the world's largest pharmaceutical companies. Earlier roles have included EVP, Global Business Development. As part of the FSP leadership team, Mr. Balfe served as Senior Vice-President, Global Program Management where he oversaw operational design, planning &amp; delivery within the resourcing &amp; FSP businesses. Mr. Balfe initially joined ICON&#8217;s Business Development team in 2003, before taking on the leadership of ICON's U.S. FSP business in early 2007 and subsequently overseeing European FSP operations. Mr. Balfe holds a Bachelor of Science degree in chemistry, having studied at Dublin City University and Ecole Nationale Sup&#233;rieure de Chimie de Toulouse. Mr. Balfe subsequently studied pharmacoepidemiology and pharmacovigilance at London School of Hygiene and Tropical Medicine, the University of London; and completed the Stanford Executive Program, Stanford Graduate School of Business in 2023.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">R&#243;n&#225;n Murphy </span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. R&#243;n&#225;n Murphy has served as an outside Director of the Company since October 2016.&#160;He was appointed as Lead Independent Director in January 2019. Mr. Murphy is the former Senior Partner of PwC Ireland. He was elected Senior Partner in 2007 and was re-elected for a further four year term in 2011. Following completion of the maximum two terms, Mr. Murphy retired from the firm in 2015. Mr. Murphy was also a member of the PwC EMEA Leadership Board for a five year period from 2010 to 2015. Mr. Murphy joined PwC in 1980 and was admitted to the Partnership in 1992. Mr. Murphy is presently Chairman of Greencoat Renewables PLC and a non-executive director of Norbrook Holdings Limited. Mr. Murphy previously served as a council member of the ESRI, as Chair of Business in the Community Ireland and as a non-executive Director of Davy Stockbrokers. He is also a founding Board Member of the British Irish Chamber of Commerce. Mr. Murphy completed a Bachelor of Commerce and Masters in Business Studies at University College Dublin before qualifying as a chartered accountant in 1982.&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Dr. John Climax</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. John Climax, one of the Company&#8217;s co-founders, served as Chairman of the Board of the Company from November 2002 to December 2009 and as Chief Executive Officer from June 1990 to October 2002. Since January 2010 he has held a position as an outside Director and Emeritus Chair of the Company. In 2004 he established the Human Dignity Foundation, a Swiss charity dedicated to protecting vulnerable children from sexual exploitation and abuse. Dr. Climax has over 30 years of experience in the clinical research industry. Dr. Climax received his primary degree in Pharmacy from the University of Singapore, his Masters in Applied Pharmacology from the University of Wales and his Doctorate in Clinical Pharmacology from the National University of Ireland. He has authored a significant number of papers and presentations and is a holder of numerous active patents. Dr. Climax is an adjunct Professor at the Royal College of Surgeons in Ireland. He is currently Executive Chairman of DS Biopharma and Chairman and CEO of Afimmune, both of which are private companies.</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Eugene McCague</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Eugene McCague was appointed as an outside Director of the Company in October 2017. Mr. McCague was a corporate partner of Arthur Cox, one of Ireland&#8217;s premier law firms, from 1988 until June 2017. During his time with Arthur Cox, Mr. McCague served as both managing partner and chairman of Arthur Cox and also advised a wide range of public and private companies on mainstream corporate work, mergers and acquisitions, corporate restructurings and corporate governance. In addition to his distinguished legal career, Mr. McCague also has extensive board experience with commercial, government and educational organizations. Mr. McCague currently serves on the board of the Irish branch of AON Insurance. Mr. McCague&#8217;s previous board roles include the Health Service Executive, the Irish state body which administers public health service in Ireland, chairman of the governing body of the Dublin Institute of Technology, chairman of the Dublin Institute of Technology Foundation, chairman of the governing authority of University College Dublin, director of Fly Leasing Limited and chairman of Ibec, Ireland&#8217;s leading business representative association. Mr. McCague was also president of the Dublin Chamber of Commerce in 2006. Mr. McCague holds a Bachelor of Civil Law degree and a diploma in European Law from University College Dublin.&#160;</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Julie O&#8217;Neill</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ms. Julie O&#8217;Neill has served as an outside Director of ICON plc since July 2019. Ms. O&#8217;Neill was formerly Executive Vice President, Global Operations of Alexion Pharmaceuticals, Inc., where she was responsible for global manufacturing operations and expanding and improving supply chain and quality operations in the US, Europe, and Asia. Before joining Alexion, Ms. O&#8217;Neill was Vice President of Operations and General Manager for Ireland at Gilead Sciences and earlier in her career, Ms. O'Neill held leadership positions in operations, manufacturing and quality functions at Burnil Pharmacies and Helsinn Birex Pharmaceuticals. Ms. O&#8217;Neill serves as a Board Member of DBV Technologies, Hookipa Pharma Inc., and Advancion (formerly Angus Chemical Company). Ms. O&#8217;Neill also chairs the board of Ireland&#8217;s National Institute for Bioprocessing Research and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Training ('NIBRT'). Ms. O&#8217;Neill holds a Bachelor of Science in Pharmacy from Trinity College Dublin, a Masters of Business Administration from University College Dublin and is a Chartered Director of The Institute of Directors in Ireland.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Dr. Linda Grais </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. Linda Grais has served as an outside Director of ICON plc since July 2021 having previously served as a member of the PRA Health Sciences board from October 2015 to July 2021. Dr. Grais served as a member of the board of directors of Ocera Therapeutics, Inc. from January 2008 through December 2017, as President and Chief Executive Officer of Ocera Therapeutics, Inc. from June 2012 to December 2017 and as member of the board of directors of Arca Biopharma, Inc from 2007 to 2024. Prior to her employment by Ocera, Dr. Grais served as a managing member at InterWest Partners, a venture capital firm from May 2005 until February 2011. From July 1998 to July 2003, Dr. Grais was a founder and executive vice president of SGX Pharmaceuticals Inc., a drug discovery company focusing on new treatments for cancer. Prior to that, she was a corporate attorney at Wilson Sonsini Goodrich &amp; Rosati, where she practiced in such areas as venture financings, public offerings and strategic partnerships. Before practicing law, Dr. Grais worked as an assistant clinical professor of Internal Medicine and Critical Care at the University of California, San Francisco. Dr. Linda Grais currently serves on the board of directors of Corvus Pharmaceuticals and is a member of its audit committee. Dr. Grais received a B.A. from Yale University, an M.D. from Yale Medical School and a J.D. from Stanford Law School.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Anne Whitaker </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ms. Anne Whitaker was appointed as an outside Director of ICON plc in July 2024. Ms. Whitaker is an experienced executive with more than 30 years of experience in the life sciences industry across large pharmaceutical, biotech, and specialty pharmaceutical companies. Ms. Whitaker has extensive leadership experience, having been a CEO for three clinical-stage biotech businesses (Aerami Therapeutics, Synta Pharmaceuticals and Novoclem Therapeutics) complemented by substantial bigger pharma - most notably Bausch Health, Sanofi, and GSK. Ms. Whitaker held senior executive commercial roles with GSK at local US and global levels and was responsible for running Sanofi&#8217;s North America operations. Ms.Whitaker serves as the Chair of QurAlis and as a non-executive director of Nykode Therapeutics, Trinity Life Sciences, Byrn Pharma, Bespak, and is a Member of the Board of Trustees of the University of North Alabama. Ms. Whitaker previously served on the boards of Curio Digital Therapeutics, Ergomed plc, UDG Healthcare, Cree, Mallinckrodt, KNOW Bio, Novoclem Therapeutics, Vectura Group and Synta Pharmaceuticals. Ms. Whitaker holds a BSc in Chemistry and Business from the University of North Alabama.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Diarmaid Cunningham</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Diarmaid Cunningham is Chief Administrative Officer, General Counsel and Company Secretary. Mr. Cunningham joined the Company as General Counsel in November 2009. From 2009 until 2013, Mr. Cunningham was based in the Company&#8217;s global headquarters in Dublin.  In 2013, Mr. Cunningham was seconded to the Company&#8217;s U.S. headquarters in Pennsylvania and that secondment ended in 2018 when Mr. Cunningham returned to Dublin. In July 2016, Mr. Cunningham&#8217;s role expanded to include Chief Administrative Officer in addition to General Counsel which added responsibility for the Company&#8217;s Quality Assurance, Client Contracts Services, Facilities and Procurement groups in addition to his responsibility for the Company&#8217;s Legal group. In 2023, Symphony Health (ICON's data business) moved to report to Mr. Cunningham and was also added to his group. Mr. Cunningham graduated with a Bachelor of Business and Legal Studies from University College Dublin in 1997, qualified as a lawyer in 2001 and completed the Stanford Executive Program at Stanford University in California in 2015.  Mr. Cunningham served as Secretary to the Board of the Association of Clinical Research Organizations (ACRO) in 2013, 2014, 2020 and 2021. ACRO represents the CRO industry globally to key stakeholders including pharmaceutical, biotech and medical device companies, regulators, legislators and patient groups. Prior to joining the Company, Mr. Cunningham spent 10 years with A&amp;L Goodbody, one of Ireland's premier corporate law firms. In January 2021, Mr. Cunningham was appointed as a non-executive director of the Irish charity The Jack &amp; Jill Foundation. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Compensation Discussion &amp; Analysis </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Remuneration policy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Compensation and Organization Committee seeks to achieve the following goals with the Company&#8217;s executive compensation programs: to attract, motivate and retain key executives and to reward executives for value creation. The Committee seeks to foster a performance-oriented environment by ensuring that a significant portion of each executive&#8217;s cash and equity compensation is based on the achievement of performance targets that are important to the Company, its shareholders and other stakeholders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s executive compensation program has three main elements: base salary, a bonus plan and equity incentives in the form of share related awards granted under the Company&#8217;s equity incentive plans. All elements of key executives&#8217; compensation are determined by the Compensation and Organization Committee based on the achievement of the Group&#8217;s and individual performance objectives and the CEO makes recommendations to the Committee regarding the  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">performance assessment and the compensation package of the other key executives. Base salary, bonus awards and Directors&#8217; fees were determined by the Compensation and Organization Committee in U.S. dollars, euro or British pound sterling.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Outside Directors&#8217; remuneration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Outside Directors are remunerated by way of Directors&#8217; fees and are also eligible for participation in the share equity incentive schemes. Up to April 1, 2024, each outside Director (excluding the Board Chairman) was paid an annual retainer of $90,000 and additional fees for Board Committee service. With effect from April 1, 2024, the annual retainer was increased to $100,000.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Murray&#8217;s Executive Chairman term expired on May 12, 2018 and he transitioned to the outside Director role of Chair. The current arrangement with the Chair provides for payment of &#8364;330,000 (translated at average rate for the year: $358,182) annually.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. R&#243;n&#225;n Murphy was appointed as Lead Independent Director with effect from January 1, 2019 and receives an additional annual fee of $40,000 for this role.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Outside Directors are not eligible for performance related bonuses and no pension contributions are made on their behalf. The Compensation and Organization Committee sets outside Directors' remuneration.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Executive Directors&#8217; and Key Executive Officers&#8217; remuneration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash compensation comprised of a base salary and a bonus incentive. The Committee targets total cash compensation with regard to healthcare/biopharmaceutical companies of similar market capitalization and peer CRO companies, adjusted upward or downward based on individual performance and experience and level of responsibility. The Compensation and Organization Committee believes that the higher the executive&#8217;s level of responsibility within the Company, the greater the percentage of the executive&#8217;s compensation that should be tied to the Company&#8217;s performance. Target bonus incentive for executive officers range between 85% and 135% of salary, based on Group and individual performance. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No bonus was awarded to Dr. Steve Cutler, Chief Executive Officer, Mr. Nigel Clerkin, Chief Financial Officer or Mr. Brendan Brennan, former Chief Financial Officer, for the year ended December 31, 2024. This was approved by the Compensation and Organization Committee.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The Company&#8217;s executives are eligible to receive equity incentives, including stock options, Restricted Share Units and Performance Share Units, granted under the Company&#8217;s equity incentive plans. If executives receive equity incentive grants, they are normally approved annually at the first scheduled meeting of the Committee in the fiscal year. The grant date and value is determined by the Committee and the number of units granted is determined based on the closing price of the Company's shares on the day of grant. Newly hired executives may receive sign-on grants. In addition, the Committee may, at its discretion, issue additional equity incentive awards to executives if the Committee determines such awards are necessary to ensure appropriate incentives are in place.  The equity awards granted to each participant are determined by the Committee at the start of each year based on peer group data, advice from independent compensation consultants, and Committee judgment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During 2024, Performance Share Units (&#8220;PSUs&#8221;) which were awarded in 2021, subject to vesting, vested for Dr. Steve Cutler, Chief Executive Officer, in the amount of 4,452 from a potential grant of 20,708. The percentage granted reflects service and the Company's achievements of diluted non-GAAP specified EPS targets over the three year period from 2021 - 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During 2024, Performance Share Units (&#8220;PSUs&#8221;) which were awarded in 2021, subject to vesting, vested for Brendan Brennan, then Chief Financial Officer, in the amount of 1,050 from a potential grant of 4,888. The percentage granted reflects service and the Company's achievements of diluted non-GAAP specified EPS targets over the three year period from 2021 - 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All executive officers are eligible to participate in applicable pension plans. The Company&#8217;s contributions are generally a fixed percentage of their annual compensation, supplementing contributions by the executive. The Company has the discretion to make additional contributions if deemed appropriate by the Committee. The Company&#8217;s contributions are determined at the peer group median of comparable Irish companies and peer CRO companies. Contributions to this plan are recorded as an expense in the Consolidated Statement of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Third party Agreements and Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has not identified any arrangements or agreements relating to compensation or other payments provided by a third party to ICON&#8217;s directors or director nominees in connection with their candidacy or board service as required to be disclosed pursuant to NASDAQ Rule&#160;5250(b)(3).</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Executive Compensation</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary compensation table - Year ended December&#160;31, 2024</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:18.487%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.380%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.000%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.000%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.472%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.477%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name &amp; principal<br/>position</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Salary</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Bonus</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension<br/>contribution</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All other compensation</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based<br/>compensation</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Director&#8217;s Fees</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>compensation</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler<br/>Chief Executive Officer</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,082&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,521&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nigel Clerkin,<br/>Chief Financial Officer*</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brendan Brennan,<br/>Former Chief Financial Officer**</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(586)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,977</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">207</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">76</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,260</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,601</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4,905</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*    Mr. Nigel Clerkin commenced employment with the Company in October 2024 and effective October 31, 2024 took over from Mr. Brendan Brennan as CFO.</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">**  Mr. Brendan Brennan resigned on October 31, 2024. All unvested options, Restricted Share Units and Performance Share Units were forfeited on Mr. Brennan ceasing to be an ICON plc employee on October 31, 2024 resulting in a credit to share based compensation of $0.6 million. Included within this credit, is a charge of $0.2 million related to awards which vested during the period.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary compensation table - Year ended December&#160;31, 2023</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.458%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.311%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.458%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.464%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name &amp; principal<br/>position</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Salary </span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Bonus</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pension<br/>contribution</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All other compensation</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based<br/>compensation</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Director&#8217;s Fees</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>compensation</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler<br/>Chief Executive Officer</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,244&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brendan Brennan,<br/>Chief Financial Officer</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,062&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,778</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,578</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">198</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">62</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,616</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,646</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">44</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,306</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Director Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary compensation table - Year ended December&#160;31, 2024</span></div><div><span><br/></span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:19.401%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.199%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Salary</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Company<br/>pension&#160; contribution</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All other compensation</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based<br/>compensation</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Director&#8217;s fees</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>Compensation</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ciaran Murray</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">658&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,521&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&#243;n&#225;n Murphy</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. John Climax</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Joan Garahy*</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eugene McCague</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Julie O'Neill</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Linda Grais</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Anne Whitaker**</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,234</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">130</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">31</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,395</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4,525</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,168</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-left:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7,088</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-right:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*  Ms. Joan Garahy retired from the Board on July 23, 2024.  </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">** Ms. Anne Whitaker was appointed to the Board on July 23, 2024. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary compensation table - Year ended December&#160;31, 2023</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:19.401%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.076%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.199%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Salary </span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Company<br/>pension&#160; contribution</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All other compensation</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based<br/>compensation</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Director&#8217;s fees</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>Compensation</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$&#8217;000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ciaran Murray</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,228&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,544&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,656&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,244&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&#243;n&#225;n Murphy</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. John Climax</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Joan Garahy</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eugene McCague</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Julie O'Neill</span></td><td colspan="3" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Linda Grais</span></td><td colspan="3" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-left:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-left:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-left:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,191</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">125</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,228</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-left:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,544</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-left:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,156</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,113</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-left:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,813</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-right:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Disclosure of Compensation Agreements</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Employment Contracts, Termination of Employment and Change in Control Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company does not have any termination or change of control agreements with its named executive officers other than as set out below and in the agreements relating to their equity incentives which provide for accelerated vesting on change of control.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Directors&#8217; and Executive Officers&#8217; service agreements and letters of engagement</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following information reflects the agreements in effect as of December&#160;31, 2024 or date of resignation /  retirement if earlier.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Ciaran Murray</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Ciaran Murray has served as Chair of the Board of Directors since May 2018 having served as Executive Chairman of the Board of Directors from March 2017 until May 2018. Mr. Murray served as Chief Executive Officer of the Company from October 2011 until March 2017. Mr. Murray has served as a Director of the Company since September 2011. He previously served as Chief Financial Officer of the Company from October 2005 until October 2011. Mr. Murray entered into an agreement with the Company in respect of his role as Executive Chairman which was effective from March 2017. Mr. Murray&#8217;s Executive Chairman term expired on May 12, 2018 and he transitioned to Chair.  The current arrangement with Mr. Murray provides for the payment to him of fees of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8364;330,000 (translated at average rate for the year: $358,182) per</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> annum in respect of his position as Chairman. His previous service agreement as Executive Chairman included termination provisions and also includes certain post-termination clauses including non-disclosure, non-competition and non-solicitation provisions which still apply. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">He was previously granted and held at February&#160;21, 2025 946 Restricted Share Units, which vest in May 2025.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Dr. Steve Cutler</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. Steve Cutler has served as Chief Executive Officer since March 2017 having served as Chief Operating Officer of the Company from January 2014 until March 2017. Prior to his appointment as Chief Operating Officer he served as Group President Clinical Research Services since November 2011. He has served as an Executive Director of the Company since November 2015. The Chief Executive Officer service agreement with Dr. Cutler is terminable on 12 months&#8217; notice by either party. Under the terms of this agreement Dr. Cutler is entitled to receive an annual salary of $1,247,000 effective from April 1, 2024 and a bonus to be agreed by the Compensation and Organization Committee.  He is also entitled to receive a pension </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">contribution, a car allowance of $12,000 and medical insurance coverage for himself and his dependents. He was previously granted and held at February&#160;21, 2025 239,822 ordinary share options at exercise prices ranging from $83.47 to $325.51 per share, 22,037 Restricted Share Units which vest on various dates between March 2025 and March 2027 and 32,022 (up to a maximum of 64,044) Performance Share Units which vest between March 2025 and March 2027 subject to the fulfillment of certain performance conditions. His Chief Executive Officer service agreement requires him to devote his full time and attention </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">to his duties for the Company excepting certain outside director positions authorized by the Company. The agreement with Dr. Cutler includes termination and change of control provisions and also includes certain post-termination clauses including non-disclosure, non-competition and non-solicitation provisions. Dr. Cutler has a separate agreement with the Company in respect to his role as a director of ICON plc. Under the terms of this agreement he is entitled to receive an annual fee of $44,000.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Nigel Clerkin</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Mr. Nigel Clerkin commenced employment with the Company in October 2024 and effective October 31, 2024 took over as Chief Financial Officer. The service agreement with Mr. Clerkin is terminable on 12 months' notice by either party. Under the terms of this agreement Mr. Clerkin is entitled to receive an annual salary of $618,678 (&#8364;570,000) and a bonus to be agreed by the Compensation and Organization Committee. He is also entitled to receive a car allowance of &#8364;15,000, medical insurance coverage for himself and his dependents and in lieu of the Company's pension contribution an allowance equal to 12.5% of his annual salary. On appointment, he was granted, and held at February&#160;21, 2025 8,336 Restricted Share Units, which vest on various dates between October 2025 and October 2027. His service agreement requires him to devote his full time and attention to his duties for the Company except where the Company confirms in writing that engagement or interest in another business or occupation will not prevent him from properly performing his duties. The agreement with Mr. Clerkin includes termination and change of control provisions and also includes certain post-termination clauses including non-disclosure, non-competition and non-solicitation provisions.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Brendan Brennan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Brendan Brennan served as Chief Financial Officer from February 2012 to October 2024, having previously served as acting Chief Financial Officer since October 2011.&#160;Mr. Brennan resigned as Chief Financial Officer effective as at October 31, 2024. The service agreement with Mr. Brennan was terminable on 12 months&#8217; notice by either party. Under the terms of this agreement Mr. Brennan was entitled to receive an annual salary of $618,584 (&#8364;569,913) effective from April 1, 2024 and a bonus to be agreed by the Compensation and Organization Committee.  He was also entitled to receive a pension contribution, a car allowance of &#8364;20,000 and medical insurance coverage for himself and his dependents. All unvested options, Restricted Share Units and Performance Share Units were forfeited on Mr. Brennan ceasing to be an ICON plc employee on October 31, 2024. The agreement with Mr. Brennan included termination and change of control provisions and also includes certain post-termination clauses including non-disclosure, non-competition and non-solicitation provisions.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">R&#243;n&#225;n Murphy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. R&#243;n&#225;n Murphy has served as Lead Independent Director from January 2019 having served as an outside Director of the Company since October 2016. The current arrangements with Mr. Murphy provide for the payment to him of Directors fees of $177,500 per annum. He was previously granted and held at February&#160;21, 2025 8,084 ordinary share options at an exercise prices ranging from $90.03 to $125.74 and 694 Restricted Share Units, which vest in May 2025.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Dr. John Climax</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. John Climax, one of the Company&#8217;s co-founders, served as Chairman of the Board of the Company from November 2002 to December 2009. He also served as Chief Executive Officer of the Company from June 1990 to October 2002 and is currently an outside Director of the Company. The current arrangements with Dr. Climax provide for the payment to him of Directors fees of $100,000 per annum. He was previously granted and held at February&#160;21, 2025 12,698 ordinary share options at exercise prices ranging from $90.03 to $125.74 per share and 694 Restricted Share Units, which vest in May 2025.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Eugene McCague</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. Eugene McCague</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">has served as an outside Director of the Company since October 2017. The current arrangements with Mr. McCague provide for the payment to him of Directors fees of $132,500 per annum. He was previously granted and held at February&#160;21, 2025 3,255 ordinary share options at an exercise price of $125.74 and 694 Restricted Share Units, which vest in May 2025.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Julie O'Neill</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ms. Julie O'Neill has served as an outside Director of the Company since July 2019. The current arrangements with Ms. O'Neill provide for the payment to her of Directors fees of $125,000 per annum. She was previously granted and held at February&#160;21, 2025 694 Restricted Share Units, which vest in May 2025.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Dr. Linda Grais</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dr. Linda Grais has served as an outside Director of the Company since July 2021 having served as a member of the PRA Health Sciences, Inc. board since October 2015. The current arrangements with Dr. Grais provide for the payment to her of Director fees of $132,500 per annum. She was previously granted and held at February&#160;21, 2025 694 Restricted Share Units, which vest in May 2025. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Anne Whitaker </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ms. Anne Whitaker has served as an outside Director of the Company since July 2024. The arrangements with Ms. Whitaker provide for the payment to her of Directors fees of $112,500 per annum effective from July 23, 2024. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Joan Garahy</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ms. Joan Garahy served as an outside Director of the Company from November 2017 until July 23, 2024 when she retired from the Board of Directors at the AGM. She was previously granted and held on her retirement on July 23, 2024 5,005 ordinary share options at an exercise price of $125.74 and has 18 months from her retirement date to exercise her outstanding options in accordance with the terms and conditions of the grant.  All unvested Restricted Share Units were forfeited on retirement from the Board of Directors.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Board Practices</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Board of Directors</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The business of the Company is managed by the Directors who may exercise all the powers of the Company which are not required by the Companies Act 2014 of Ireland or by the Constitution of the Company to be exercised by the Company in general meeting.  A meeting of Directors, at which a quorum is present, may exercise all powers exercisable by the Directors. The Directors may delegate (with power to sub-delegate) to any Director holding any executive office and to any Committee consisting of one or more Directors, together with such other persons as may be appointed to such Committee by the Directors, provided that a majority of the members of each Committee appointed by the Directors shall at all times consist of Directors and that no resolution of any such Committee shall be effective unless two of the members of the Committee present at the meeting at which it was passed are Directors.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board comprises one executive and seven outside Directors at the date of this report.&#160;The outside Directors bring independent judgment to bear on issues of strategy, performance, resources, key appointments and standards.&#160;The Company considers all of its outside Directors to be of complementary skills, experience and knowledge and each outside Director has specific skills, experience and knowledge that are valuable to the Company. The Board members between them have strong financial, pharmaceutical, CRO, scientific, medical and other skills and knowledge which are harnessed to address the challenges facing the Group. The Board meets regularly throughout the year and all Directors have full and timely access to the information necessary for them to discharge their duties. The Directors have access to the advice and services of the Company Secretary and may seek external independent professional advice where required. The Board considers its current size (8 Directors) to be adequate but continues to look for suitable qualified potential candidates to join the Board.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As set out below, certain other matters are delegated to Board Committees and all Board Committees report to the Board. The Company maintains what it considers an appropriate level of insurance cover in respect of legal action against its Directors. The Board, through the Nominating, Sustainability and Governance Committee, engages in succession planning for the Board and in so doing considers the strength and depth of the Board and the levels of knowledge, skills and experience of the Directors necessary for the Company to achieve its objectives. The Board meets at least four times each year. During the year ended December&#160;31, 2024 the Board held five board meetings. All Directors allocated sufficient time to the Company during the year ended December&#160;31, 2024 to effectively discharge their responsibilities to the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Corporate Governance Guidelines</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board of Directors adopted Corporate Governance Guidelines ("the Guidelines") on October 22, 2024 as a flexible framework for the conduct of the Board's business. The Guidelines reflect the Board's commitment to a system of governance that enhances corporate responsibility and accountability. The Guidelines cover the role of the Board, role of the Chair, the composition of the Board, the structure, operations, duties and responsibilities of the Board. The Nominating, Sustainability and Governance Committee will review the Guidelines annually and recommend any changes for approval by the Board. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Directors&#8217; retirement and re-election</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company&#8217;s Constitution provides that, unless otherwise determined by the Company at a general meeting, the number of Directors shall not be more than 15 nor less than 3. The Constitution also provides that one third of the Directors who are subject to retirement by rotation, rounded down to the next whole number if it is a fractional number, shall retire from office at each annual general meeting. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Board of Directors adopted a Non-Executive Director Policy for Service on April 24, 2018, amended it on April 21, 2020 and terminated it, effective October 22, 2024, on the adoption of the Guidelines. The Non-Executive Director Policy for Service provided that, subject to individual waiver by the Board, an outside Director of ICON plc shall serve on the Board of the Directors for an initial term which expired at the fourth annual general meeting after their appointment. Each outside director could serve a further term of 3 years, subject to the Board&#8217;s approval. After the second 3 year term the Board could request that the outside Director serve up to 3 further terms of 1 year each. After a third 1 year term the Board could request that the outside director serve for further 1 year terms in the event that the Board has particular requirement or desire for the outside director&#8217;s skill, knowledge or experience. For an outside Director who previously served as an executive of the Company, the initial 3 year term referred to in this policy was deemed to commence on the date that he/she is determined to be independent as per the NASDAQ Rules. This policy did not apply to Dr. John Climax as he is a founder of the Company.   As each director is currently subject to annual election by shareholders, as detailed below, the Non-Executive Director Policy for Service was terminated and there are no term limits for the Board. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Notwithstanding the Company&#8217;s Constitution, the Board has a current policy, since July 2022 and as reflected in the Guidelines, that all Directors shall seek re-election by the shareholders on an annual basis and if a director fails to obtain the requisite shareholder votes to be re-elected in accordance with the Constitution, their appointment shall terminate automatically and with immediate effect.  The Nominating, Sustainability and Governance Committee, in its annual review of Board composition, shall consider the issue of continuing director tenure and take appropriate steps to ensure that the membership of the Board contains the skills, knowledge and experience of Directors needed at that time, is periodically refreshed and takes those matters into account when recommending nominees to the Board for re-election to the Board at the annual meetings of shareholders. The Board decides whether or not to recommend for re-election each Director standing for re-election by the shareholders. At the AGM of the Company held in 2024, Ms. Joan Garahy, an independent outside director, decided not to stand for re-election and retired from the Board at the AGM, all other Directors offered themselves for re-election and the same approach will be followed for 2025. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Lead Independent Director </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Board of Directors adopted a Lead Independent Director Charter on February 14, 2017 and terminated it, effective October 22, 2024, on the adoption of the Guidelines which contain similar provisions to the charter.  The Guidelines provide that when considered desirable by the Board, including when the Chairperson is not an independent Director or may not be considered independent by the Company&#8217;s stakeholders, the Board will elect one of the Board&#8217;s independent Directors to serve as the Lead Independent Director. Where the Chairperson is not independent, the Lead Independent Director is responsible for coordinating the activities of the independent Directors and shall perform such other duties as described in the Guidelines. Mr. R&#243;n&#225;n Murphy was appointed as Lead Independent Director with effect from January 1, 2019. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Board Committees</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Board has delegated some of its responsibilities to Board Committees. There are currently four Committees. These are the Audit Committee, the Compensation and Organization Committee, the Nominating, Sustainability and Governance Committee and the Execution Committee. Each Committee has been charged with specific responsibilities and each has written terms of reference that are reviewed periodically. Minutes of Committee meetings are available to all members of the Board. The Company Secretary is available to act as secretary to each of the Board Committees if required. Appropriate key executives are regularly invited to attend meetings of the Board Committees. During 2024, the Audit Committee, Compensation and Organization Committee and Nominating, Sustainability and Governance Committee each completed a self-evaluation of the performance of the Committee and each Committee was satisfied with their performance. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Audit Committee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Audit Committee meets a minimum of four times a year. It reviews the quarterly and annual financial statements, the effectiveness of the system of internal control and recommends the appointment and removal of the external auditors. It monitors the adequacy of internal accounting practices and addresses all issues raised and recommendations made by the external auditors.  The Audit Committee pre-approves all audit and non-audit services provided to the Company by its external auditors on a quarterly basis. The Audit Committee, on a case by case basis, may approve additional services not covered by the quarterly pre-approval, as the need for such services arises. The Audit Committee reviews all services which are provided by the external auditor to review the independence and objectivity of the external auditor, taking into consideration relevant professional and regulatory requirements. The Chief Financial Officer, the Head of Internal Audit, the Chief Administrative Officer and General Counsel and the external auditors normally attend all meetings of the Audit Committee and have direct access to the Committee Chairperson at all times. The Audit Committee Charter was updated in February 2024 to include specific responsibilities in respect to the oversight and monitoring of the external reporting on environmental, social and governance (ESG) matters included in the financial statements and data quality related to such reporting in coordination with the Nominating, Sustainability and Governance Committee. The Audit Committee is currently comprised of three independent Directors: Mr. R&#243;n&#225;n Murphy (Chairperson), Mr. Eugene McCague and Ms. Julie O'Neill. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Compensation and Organization Committee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Compensation and Organization Committee is responsible for senior executive remuneration. The Committee aims to ensure that remuneration packages are competitive so that individuals are appropriately rewarded relative to their responsibility, experience and value to the Company.  Annual bonuses for the executive Directors and senior executive management are determined by the Committee based on the achievement of the Company&#8217;s objectives. The Committee also oversees succession planning for the Company&#8217;s senior management and also oversees the Company&#8217;s overall compensation strategy and programs which management approve and implement. The Compensation and Organization Committee is currently comprised of the following independent Directors:  Dr. Linda Grais (Chairperson), Mr. R&#243;n&#225;n Murphy and Ms. Julie O'Neill. On July 23, 2024, Ms. Joan Garahy, on her retirement from the Board, stepped down as a member of the Committee, Dr. Linda Grais was appointed Chairperson and Ms. Julie O'Neill joined the Committee. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Nominating, Sustainability and Governance Committee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Nominating, Sustainability and Governance Committee is responsible for Board succession, oversight of the Board and committee composition and performance and oversight of the Company's corporate governance and business ethics initiatives and strategies and activities in respect to environmental, social and governance (ESG) matters.  The Committee reviews the membership of the Board of the Company and Board Committees on an ongoing basis. As part of this, it regularly evaluates the balance of skills, knowledge, experience on the Board and then, based on this evaluation, identifies and, if appropriate, recommends individuals to join the Board of the Company.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> In selecting candidates for recommendation to the Board, the Committee makes proposals based on merit while seeking to achieve a mix of Board members that enhances the skills and experience on the Board, including with respect to professional skills, relevant industry experience, specialized expertise, and international experience</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">. When conducting a formal search for new director candidates, the Committee endeavors to include candidates with a broad range of backgrounds, skills, experiences and perspectives </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">on the initial list of candidates from which new director nominees are chosen. The Committee uses external search consultants as needed to assist it in identifying potential new outside Directors. Any external search consultants engaged to assist in the search shall also be instructed to endeavor to include such candidates on the initial list. Once potential suitable candidates are identified either by the external search consultants or by members of the Nominating, S</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">ustainability and Governance Committee, the Committee then discusses and considers the skills, knowledge and experience of the potential candidate. The Committee will assess if the Board of the Company requires and would benefit from the potential candidate&#8217;s skills, knowledge and experience and, if it decides the potential candidate is suitable, the Committee would recommend to the Board of the Company that the potential candidate be appointed.  The Board of the Company then decides whether or not to appoint the candidate. The Nominating, Sustainability and Governance Committee currently comprises the following independent Directors: Mr. Eugene McCague (Chairperson), Dr. Linda Grais and Ms. Anne Whitaker. On July 23, 2024, Ms. Joan Garahy and Ms. Julie O'Neill stepped down as members of the Committee and Dr. Linda Grais and Ms. Anne Whitaker joined the Committee. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Execution Committee</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The primary function of the Execution Committee is to exercise the powers and authority of the Board in intervals between meetings of the Board only on matters that are not delegated to another committee of the Board or otherwise reserved to the full Board within the limits set out in the Charter of the Execution Committee. The Execution Committee exercises business judgment to act in what the Committee members reasonably believe to be in the best interest of the Company and its shareholders. All powers exercised by the Execution Committee are ratified at board meetings. This Committee convenes as often as it determines to be necessary or appropriate.The Execution Committee is currently comprised of the following Directors and Officers: Dr. Steve Cutler (Chairperson), Mr. R&#243;n&#225;n Murphy and Mr. Nigel Clerkin. On July 23, 2024, Mr. Brendan Brennan stepped down as a member of the Committee and Mr. Diarmaid Cunningham joined the Committee. On February 18, 2025, Mr. Diarmaid Cunningham stepped down as a member of the Committee and Mr. Nigel Clerkin joined the Committee. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Attendance at Board and Committee meetings</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Attendance at Board and Committee meetings by the Directors who held office during 2024 are set out as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:27.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.369%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.369%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.369%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Directors&#8217; Attendance Table</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Board</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Audit</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensation<br/>and<br/>Organization</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nominating, Sustainability<br/>and<br/>Governance</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Execution Committee <br/>(2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Director</span></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of meetings attended / number of meetings eligible to attend as a Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ciaran Murray (1)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&#243;n&#225;n Murphy (1)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/4</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/4</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. John Climax (1)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Joan Garahy (1) (3) </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eugene McCague (1)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/4</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/4</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Julie O'Neill (1)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/4</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1/1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3/3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Linda Grais (1)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/5</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4/4</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1/1</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Anne Whitaker (1) (4) </span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3/3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1/1</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Independent Director as defined under NASDAQ Rule 5605(a)(2). </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">All decisions by the Execution Committee were made by written resolution and therefore no meetings were held.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Ms. Joan Garahy retired from the Board on July 23, 2024.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Ms. Anne Whitaker was appointed to the Board on July 23, 2024. </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:174%">D.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:174%;padding-left:9.01pt">Employees</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022, we employed approximately 41,900, 41,100 and 41,100 people, respectively. Our employees are not unionized and we believe we have a satisfactory relationship with our employees.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">E.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.5pt">Share Ownership</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Shares</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth certain information as of February&#160;21, 2025 regarding beneficial ownership of our ordinary shares by all of our current Directors and executive officers. Unless otherwise indicated below, to our knowledge, all persons listed below have sole voting and investment power with respect to their ordinary shares, except to the extent authority is shared by spouses under applicable law.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of Owner or<br/>Identity of Group</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of<br/>Shares (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of total<br/>Shares</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ciaran Murray</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nigel Clerkin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&#243;n&#225;n Murphy&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. John Climax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">427,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eugene McCague </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Julie O'Neill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Linda Grais </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Anne Whitaker </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">As used in these tables, each person has the sole or shared power to vote or direct the voting of a security, or the sole or shared investment power with respect to a security (i.e. the power to dispose, or direct the disposition, of a security). A person is deemed as of any date to have "beneficial ownership" of any security if that such person has the right to acquire such security within 60 days after such date.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Restricted Share Units and Performance Share Units</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth certain information as of February&#160;21, 2025 regarding beneficial ownership of Restricted Share Units (&#8220;RSUs&#8221;) and Performance Share Units (&#8220;PSUs&#8221;) which have been issued to our current Directors and executive officers.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of Owner or<br/>Identity of Group</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of<br/>RSUs </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Vesting Date</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSUs </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Vesting Date</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ciaran Murray</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">946</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2025</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" rowspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,565&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2025</span></td></tr><tr style="height:15pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2026</span></td></tr><tr style="height:15pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2027</span></td></tr><tr style="height:15pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,082&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nigel Clerkin</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,778</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,778</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 31, 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,780</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&#243;n&#225;n Murphy </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">694</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. John Climax</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">694</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2025</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eugene McCague</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">694</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Julie O'Neill</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">694</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2025</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Linda Grais </span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">694</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 22, 2025</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:7.02pt">Of the issued PSUs, performance conditions will determine how many vest. If performance targets are exceeded, additional PSUs will be issued and will vest in accordance with the terms of the relevant PSU award. The PSUs vest based on service and specified EPS targets over the periods 2022 &#8211; 2024, 2023 &#8211; 2025 and 2024 - 2026. Depending on the actual amount of EPS from 2022 to 2026, up to a maximum of 32,022 additional PSUs may also be granted to Dr. Steve Cutler. </span></div><div style="padding-left:27pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Share Options</span></div><div><span><br/></span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth certain information as of February&#160;21, 2025 regarding options to acquire ordinary shares of the Company by all of our current Directors and executive officers.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.740%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.355%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of Owner or<br/>Identity of Group</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exercise price</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Expiration Date</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" rowspan="7" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. Steve Cutler&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,784&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$83.47&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$115.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2026</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$140.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2027</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$159.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2028</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$174.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2029</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$231.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2030</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$233.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2031</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$325.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 3, 2032</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&#243;n&#225;n Murphy </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,079&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$90.03&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 19, 2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 18, 2026</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dr. John Climax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,693&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$90.03&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 19, 2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125.74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 18, 2026</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eugene McCague</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,255&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$125.74&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 18, 2026</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) The title of securities covered by all of the above options are non-qualified.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Equity Incentive Plans</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 23, 2013, the Company adopted the 2013 Employees Restricted Share Unit (the &#8220;2013 RSU Plan&#8221;) pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may select any employee, or any Director holding a salaried office or employment with the Company, or a Subsidiary to receive an award under the plan.&#160;On May 11, 2015, the 2013 RSU Plan was amended and restated in order to increase the number of ordinary shares that could be issued under the RSU Plan by 2.5 million shares and on November 6, 2024 the 2013 RSU Plan was amended and restated in order to increase the number of ordinary shares that can be issued under the RSU Plan by a further 2.5 million shares. Accordingly, an aggregate of 6.6 million ordinary shares have been reserved for issuance under the 2013 RSU Plan. The shares are awarded at par value and vest over a service period. Awards under the 2013 RSU Plan may be settled in cash or shares at the option of the Company. No awards may be granted under the 2013 RSU Plan after November 6, 2034.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 30 2019, the Company approved the 2019 Consultants and Directors Restricted Share Unit Plan (the &#8220;2019 Consultants RSU Plan&#8221;), which was effective as of May 16, 2019, pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may select any consultant, adviser or Non-Executive Director retained by the Company, or a Subsidiary to receive an award under the plan. 250,000 ordinary shares have been reserved for issuance under the 2019 Consultants RSU Plan. The awards are at par value and vest over a service period. Awards granted to Non-Executive Directors vest over twelve months. No awards may be granted under the 2019 Consultants RSU Plan after May 16, 2029.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 21, 2008, the Company adopted the Employee Share Option Plan 2008 (the &#8220;2008 Employee Plan&#8221;) pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may grant options to any employee, or any Director holding a salaried office or employment with the Company or a Subsidiary for the purchase of ordinary shares. On the same date, the Company also adopted the Consultants Share Option Plan 2008 (the &#8220;2008 Consultants Plan&#8221;), pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may grant options to any consultant, adviser or Non-Executive Director retained by the Company or any Subsidiary for the purchase of ordinary shares.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 14, 2017, both the 2008 Employee Plan and the 2008 Consultants Plan (together the &#8220;2008 Option Plans&#8221;) were amended and restated in order to increase the number of options&#160;that can be issued under the 2008 Consultants Plan from 0.4 million to 1.0 million and to extend the date for options to be granted under the 2008 Option Plans. An aggregate of 6.0 million ordinary shares have been reserved under the 2008 Employee Plan as reduced by any shares issued or to be issued pursuant to options granted under the 2008 Consultants Plan under which a limit of 1.0 million shares applies.&#160;Further, the maximum number of ordinary shares with respect to which options may be granted under the 2008 Employee Option Plan, during any calendar year to any employee shall be 0.4 million ordinary shares. There is no individual limit under the 2008 Consultants Plan. No options may be granted under the 2008 Option Plans after February 14, 2027.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each option granted under the 2008 Option Plans will be a nonqualified stock option, or NSO and not an incentive stock option as described in Section 422&#160;of the Internal Revenue Code. Each grant of an option under the 2008 Options Plans will be evidenced by a Stock Option Agreement between the optionee and the Company. The exercise price will be specified in each Stock Option Agreement, however, option prices will not be less than 100% of the fair market value of an ordinary share on the date the option is granted.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share option awards are granted with an exercise price equal to the market price of the Company&#8217;s shares at date of grant. Share options typically vest over a period of four to five years from date of grant and expire eight years from date of grant. Share options granted to Non-Executive Directors during 2018 vest over 12 months and expire eight years from the date of grant. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Legacy PRA Equity Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following represent the legacy PRA equity incentive plans, which still have equity outstanding but have been terminated as of July 1, 2021 as to grants of future awards.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, effective on July 1, 2021, each outstanding stock option and restricted stock unit under the PRA Plans was assumed by the Company and converted into a stock option or Restricted Share Unit exercisable for or payable in Ordinary Shares based on the ratio of the average trading price per Ordinary Share for the ten days prior to July 1, 2021, and the corresponding value of the merger consideration for each PRA Share. Accordingly, the plans as detailed below were assumed by the Company.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PRA Health Sciences, Inc. 2020 Stock Incentive Plan was amended and restated and assumed by the Company effective as of July 1, 2021. The 2020 Stock Incentive Plan (&#8220;the 2020 Plan&#8221;), was approved by the PRA stockholders at their annual meeting on May 18, 2020. The 2020 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2020 Plan authorized the issuance of 2.5 million shares of common stock plus all shares that remained available under the prior plan on May 18, 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The PRA Health Sciences, Inc. 2018 Stock Incentive Plan was amended and restated and assumed by the Company effective as of July 1, 2021. The 2018 Stock Incentive Plan (the &#8220;2018 Plan&#8221;), was approved by the PRA stockholders at their annual meeting on May 31, 2018. The 2018 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2018 Plan authorized the issuance of 2 million shares of common stock plus all shares that remained available under the 2014 Plan on May 31, 2018 (which included shares carried over from the 2013 Plan).</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The PRA Health Sciences, Inc. 2014 Omnibus Incentive Plan was amended and restated and assumed by the Company effective as of July 1, 2021 (the &#8220;2014 Plan&#8221;). On November 23, 2014, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2014 Plan for Key PRA Employees. The 2014 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">F.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:10.01pt">Disclosure of a registrant's action to recover erroneously awarded compensation </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_61"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 7. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Major Shareholders and Related Party Transactions.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Major Shareholders</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table sets forth certain information regarding beneficial ownership of ICON's ordinary shares as of February&#160;21, 2025&#160;(i) by each person that beneficially owns more than 5% of the outstanding ordinary shares, based upon information known to us and publicly available information; and (ii) by all of our current Directors, officers and other key employees as a group. Unless otherwise indicated below, to our knowledge, all persons listed below have sole voting and investment power with respect to their ordinary shares, except to the extent authority is shared by spouses under applicable law. None of the persons listed below have voting rights that differ from any other person listed below.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.059%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.234%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.234%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.234%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.651%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.234%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.654%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024 (4)</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 (5)</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 (6)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of Owner or Identity of Group</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of Shares (1)</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of Class</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of Shares (1)</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of Class</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No. of Shares (1)</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent of Class</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">WCM Investment Management (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,334,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,869,881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,885,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All Directors, officers and other key employees as a group (3)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">935,499&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">987,551&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,116,311&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">As used in this table, each person has the sole or shared power to vote or direct the voting of a security, or the sole or shared investment power with respect to a security (i.e., the power to dispose, or direct the disposition, of a security). A person is deemed as of any date to have "beneficial ownership" of any security if that such person has the right to acquire such security within 60 days after such date.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Neither the Company nor any of its officers, Directors or affiliates holds any voting power in this entity.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Includes 298,120 ordinary shares issuable upon the exercise of stock options granted by the Company, 45,458 RSUs awarded by the Company to Directors, officers and other key employees and 85,062 PSUs awarded by the Company to Directors, officers and other key employees. Of the PSUs, performance conditions determine how many of them will vest and, if performance targets are exceeded, additional PSUs will be issued and vest in accordance with the terms of the relevant PSU award, the figure included is the maximum amount of PSUs that may be issued.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">This information is based on the Schedule 13F-HR/A filed with the SEC by WCM Investment Management on February 11, 2025 for shares held on December 31, 2024.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">This information is based on the Schedule 13G, Amendment No. 9 filed with the SEC by WCM Investment Management on January 30, 2024 for shares held on December 31, 2023.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">This information is based on the Schedule 13G, Amendment No. 8 filed with the SEC by WCM Investment Management on February 10, 2023 for shares held on December 31, 2022.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc, is not directly or indirectly, owned or controlled by another corporation or by any government. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Related Party Transactions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">During the year, subsidiaries of the Company earned revenue of $0.3 million (December&#160;31, 2023: $0.2 million) from Corvus Pharmaceuticals. Dr. Linda Grais serves as a Director and shareholder</span><span style="color:#0094ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">of Corvus Pharmaceuticals. At December&#160;31, 2024, $0.1 million (December&#160;31, 2023: $0.1 million) was noted as due from Corvus Pharmaceuticals. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">During the year, subsidiaries of the Company earned revenu</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">e of $nil (December&#160;31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$0.05 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">) from Afimmune Limited. Dr. John Climax is Chief Executive Officer and a Director and shareholder of Afimmune Limited. At December&#160;31, 2024, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$0.1 million was no</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">ted as due from Afimmune Limited (December&#160;31, 2023: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$0.05 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">).&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On July 24, 2020, a subsidiary of the Company, ICON Clinical Research Limited, entered into an agreement to jointly establish a new company, Oncacare Limited ("Oncacare"), a specialized oncology site network in the US and EMEA regions, with a third party. The Company invested $4.9&#160;million to obtain a 49% interest in the voting share capital of Oncacare. On April 20, 2023, the Company completed the purchase of the majority investor&#8217;s 51% majority voting share capital of Oncacare. The consideration paid by ICON to purchase the 51% majority voting share capital was $5.1&#160;million. As a result of this transaction (the "Oncacare acquisition"), Oncacare and its subsidiaries became wholly owned subsidiaries of the ICON Group. Prior to the Oncacare acquisition, the Company recorded losses of $0.4&#160;million and $3.1&#160;million representing its pro rata share of the losses in Oncacare during the year ended December&#160;31, 2023 and December&#160;31, 2022, respectively. The Oncacare acquisition also resulted in goodwill of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$13.4 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> and gave rise to an acquisition-related gain of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$6.2 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.    Interests of experts and counsel</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_64"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 8. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; Financial Information.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Consolidated Statements and Other Financial Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See Item 18.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We do not expect any current litigation to have a materially adverse effect on our financial condition or results of operations. However, from time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 10, 2025, a shareholder of the Company filed a purported class action litigation against the Company, its Chief Executive Officer and its former Chief Financial Officer in the United States District Court for the Eastern District of New York.  The shareholder purports to bring claims on behalf of all purchasers of ordinary shares of the Company during the period July 27, 2023, through October 23, 2024, pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, alleging misleading statements regarding the Company&#8217;s financial performance and future business prospects.  The Company intends to defend the litigation vigorously.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Dividend Policy</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have not paid cash dividends on our ordinary shares and do not currently intend to pay cash dividends on our ordinary shares in the foreseeable future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Significant Changes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no significant changes to our business that we believe could reasonably be expected to have a material adverse effect on our business, results of operations and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_67"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 9. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#160; The Offer and Listing.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Offer and listing details</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s ordinary shares are traded on the NASDAQ Global Select Market under the symbol &#8220;ICLR&#8221;.&#160;ICON plc&#8217;s American Depositary Receipt ("ADR") program was terminated on January 31, 2013 and ICON plc&#8217;s ordinary shares began directly trading on NASDAQ on February 4, 2013.&#160;Prior to that date, ICON plc&#8217;s American Depositary Shares ("ADSs") were traded on NASDAQ and ICON plc&#8217;s Depository for the ADSs was The Bank of New York Mellon.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Plan of distribution</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Markets</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NASDAQ.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Selling shareholders</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">E.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.5pt">Dilution </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">F.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:10.01pt">Expenses of the issue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_70"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"> Additional Information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Share Capital</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Memorandum and articles of association </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Constitution </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We hereby incorporate by reference our Constitution, as amended, located under the heading &#8220;Constitution of the Company&#8221; in Exhibit 3.1.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following is a summary of certain provisions of the current Constitution of the Company. This summary does not purport to be complete and is qualified in its entirety by reference to the complete text of the Constitution of the Company, which are included as an exhibit to this annual report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Objects</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is incorporated under the name ICON&#160;plc, and is registered in Ireland under registered number&#160;145835. The Company's objects, which are detailed in the Constitution of the Company, are broad and include, but are not limited to the carrying on the business of an investment holding company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Directors</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Subject to certain exceptions, Directors may not vote on matters in which they have a material interest. Any Director who holds any executive office, serves on any Committee or otherwise performs services, which, in the opinion of the Directors, are outside the scope of the ordinary duties of a Director, may be paid such extra remuneration as the Directors may determine. The Directors may exercise all the powers of the Company to borrow money. These powers may be amended by special resolution of the shareholders.  There is no requirement for Directors to hold shares set out in the Constitution. The Directors are not required to retire at any particular age. The Constitution provides that one-third of the Directors must retire and offer themselves for re-election at each Annual General Meeting ("AGM") of the Company and that the Directors to retire by rotation are those who have been longest in office since their last appointment or reappointment. However in July 2022, the Board of Directors unanimously agreed that all of the Directors will retire and stand for re-election annually at each AGM and this is reflected in the Corporate Governance Guidelines adopted on October 22, 2024. All of the shareholders entitled to attend and vote at the AGM may vote on the re-election of Directors.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Rights, Preferences and Dividends Attaching to Shares </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has only one class of shares, Ordinary Shares with a par value of &#8364;0.06 per share. All such Ordinary Shares rank equally with respect to voting, payment of dividends and on any winding-up of the Company. Any dividend, interest or other sum payable to a shareholder that remains unclaimed for one year after having been declared may be invested by the Directors for the benefit of the Company until claimed. If the Directors so resolve, any dividend which has remained unclaimed for 12 years from the date of its declaration shall be forfeited and cease to remain owing by the Company. In the event of the Company being wound up, if the assets available for distribution among the Members shall be more than sufficient to repay the whole of the share capital paid up or credited as paid up at the commencement of the winding up, the excess shall be distributed among the Members in proportion to the capital at the commencement of the winding up paid up or credited as paid up on the said Ordinary Shares held by them respectively. An Ordinary Share shall be deemed to be a redeemable share in certain circumstances. The liability of shareholders to invest additional capital is limited to the amounts remaining unpaid on the shares held by them.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Action Necessary to Change the Rights of Shareholders </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The rights attaching to shares in the Company may be varied by special resolutions passed at class meetings of that class of shareholders of the Company.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Annual and General Meetings</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The AGM shall be held in such place and at such time as shall be determined by the board, but no more than 15&#160;months shall pass between the dates of consecutive AGMs. Directors may call an Extraordinary General Meeting (&#8220;EGM&#8221;) at any time. The members, in accordance with the Constitution of the Company and Irish Company law, may also requisition EGMs. Notice of the AGM or an EGM passing any special resolution must be given at least 21&#160;clear days prior to the scheduled date and, in the case of any other general meeting, not less than 14 clear days&#8217; notice. All holders of Ordinary Shares are entitled to attend, speak at and vote at general meetings of the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Limitations on the Right to Own Shares </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There are no limitations on the right to own shares in the Constitution of the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Disclosure of Share Ownership </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under Irish law, the Company can require parties to disclose their interests in shares. The Constitution of the Company entitle the Directors to require parties to provide details regarding their identity and the nature and extent of any interest which such parties hold in Ordinary Shares. Under Irish law, if a party acquires or disposes of Ordinary Shares so as to bring their interest above or below 3% of the total issued share capital of the Company, they must notify the Company of that. The Company would also need to be notified of the acquisition by an existing substantial (i.e. 3% plus) shareholder, of every movement of one whole percentage integer (e.g. 3.9% to 4.1% but not 4.1% to 4.9%) or more.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other Provisions of the Constitution</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There are no provisions in the Constitution of the Company:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(i) delaying or prohibiting a change in the control of the Company, but which operate only with respect to a merger, acquisition or corporate restructuring;</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(ii) discriminating against any existing or prospective holder of shares as a result of such shareholder owning a substantial number of shares; or</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(iii) governing changes in capital, in each case, where such provisions are more stringent than those required by law.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Material Contracts </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following is a summary of each contract (not being a contract entered into in the ordinary course of business) that has been entered into: (a) within the two years immediately preceding the date of this Form 20-F which are, or may be, material to us; or (b) at any time which contain obligations or entitlements which is, or may be, material to us as at the date of this Form 20-F:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Credit Facilities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 24, 2021, we entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with PRA Health Sciences, Inc. (&#8220;PRA&#8221;), ICON US Holdings Inc., a Delaware corporation and subsidiary of ICON (&#8220;US HoldCo&#8221;), and Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON and US HoldCo (&#8220;Merger Subsidiary&#8221;).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In conjunction with the completion of the Merger Agreement, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515 million and a senior secured revolving loan facility in an initial aggregate principal amount of $300 million (the "Senior Secured Credit Facilities"). On May 2, 2023, the Company agreed with its lenders to increase the aggregate principal amount of the senior secured revolving loan facility from $300 million to $500 million. The proceeds of the senior secured term loan facility were used to repay the outstanding amount of (i) PRA&#8217;s existing credit facilities and (ii) the Company's senior secured notes and fund, in part, the Merger. The senior secured term loan facility will mature in July 2028 and the revolving loan facility will mature in July 2026.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On March 14, 2024, the parties to the credit agreement entered into a Third Amendment (the &#8220;Third Amendment&#8221;) in connection with the repricing of the senior secured term loan facility and the senior secured revolving credit facility. With respect to the senior secured term loan facility, the repricing culminated in a margin reduction of 25 basis points, from 2.25% (based on the then-current first lien net leverage ratio) to 2.0%; and the elimination of the credit adjustment spread. The combination of the above resulted in an overall reduction of 51 basis points on the senior secured term loan facility (assuming quarterly refixing). </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">With respect to the senior secured revolving credit facility, the repricing culminated in a margin reduction of 0.40%, from 1.25% (based on the then-current S&amp;P corporate family rating) to 0.85%, which is subject to change pursuant to a pricing grid based on the current corporate family rating assigned by S&amp;P; and the elimination of the credit adjustment spread. There were also concurrent fee adjustments to the senior secured revolving credit facility; the commitment fee on drawings was reduced from 0.4375% to 0.2975%, (based on our current corporate family rating from S&amp;P) while the utilization fee increased by 15 basis points, dependent on amount utilized. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR plus an applicable margin which is dependent on the Company's net leverage ratio. At </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">December&#160;31, 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">, the applicable margin is 2.0% (which reflects the Third Amendment). The senior secured term loan facility is subject to a floor of 0.50%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reflecting the Third Amendment, the interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 0.45%, 0.10% or &#8211;% based on the Company&#8217;s current corporate family rating assigned by S&amp;P of BB (or lower), BB+ or BBB- (or higher), respectively, or (ii) Term SOFR plus an applicable margin of 1.45%, 1.10%, 0.85%, 0.65%, or 0.50% based on the Company&#8217;s current corporate family rating assigned by S&amp;P of BB (or lower), BB+, BBB-, BBB or BBB+ (or higher), respectively. In addition, lenders under the revolving loan facility are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Borrowers&#8217; (as defined in the Senior Secured Credit Facility) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON&#8217;s, the Borrowers&#8217; and each of the subsidiary guarantor&#8217;s assets (subject to certain exceptions), and the Senior Secured Credit Facilities will have a first-priority lien on such assets, which will rank pari passu with the lien securing the 2026 Notes and the New Notes subject to other permitted liens. The Company is permitted to make prepayments on the senior secured term loan without penalty.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Senior Secured Credit Facilities contain customary negative covenants, including, but not limited to, restrictions on the ability of ICON and its subsidiaries to merge and consolidate with other companies, incur indebtedness, grant liens or security interests on assets, pay dividends or make other restricted payments, sell or otherwise transfer assets or enter into transactions with affiliates. In addition, the revolving credit loan facility contains a financial covenant that requires ICON to maintain a Total Net Leverage Ratio (as defined in the Senior Secured Credit Facilities) of 5.75:1.00 prior to June 30, 2023 and 4.50:1.00 on and after June 30, 2023, subject to a step-down of 0.50:1.00 following a Material Acquisition (as defined in the Senior Secured Credit Facilities), which will be tested at the end of any fiscal quarter only if amounts are drawn under the revolving credit loan facility (excluding cash collateralized and backstopped letters of credit) in excess of 30% of the revolving commitments.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Senior Secured Credit Facilities provide that, upon the occurrence of certain events of default, the obligations thereunder may be accelerated. Such events of default will include payment defaults to the lenders thereunder, material inaccuracies of representations and warranties, covenant defaults, cross-defaults to other material indebtedness, voluntary and involuntary bankruptcy proceedings, material money judgments, material pension-plan events, change of control and other customary events of default.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The New Notes</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 8, 2024, ICON Investments Six Designated Activity Company (the "Issuer"), a wholly-owned subsidiary of ICON plc, issued $2&#160;billion senior secured notes ("the New Notes"). The New Notes were issued in aggregate principal amounts of: $750&#160;million 5.809% Senior Secured Notes due 2027 (the "2027 Notes"), $750&#160;million 5.849% Senior Secured Notes due 2029 (the "2029 Notes") and $500&#160;million 6.000% Senior Secured Notes due 2034 (the "2034 Notes"). </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The Company paid an underwriting discount of $6.8&#160;million on the New Notes being: 0.250% of the principal amount of the 2027 Notes, 0.350% of the principal amount of the 2029 Notes and 0.450% of the 2034 Notes. Further, the 2034 Notes were issued at a discount of $0.5&#160;million (issued at 99.896% of par). </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The proceeds from the issuance were used to repay a portion of the senior secured term loan outstanding under the Senior Secured Credit Facilities and to pay fees, costs and expenses related to the offering.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest on the New Notes is payable on May 8 and November 8 of each year, having commenced on November 8, 2024. Unless previously redeemed, the 2027 Notes will mature on May 8, 2027, the 2029 Notes will mature on May 8, 2029 and the 2034 Notes will mature on May 8, 2034.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The New Notes are guaranteed on a senior secured basis by ICON and its existing and future wholly owned subsidiaries, in each case that guarantee the obligations under our Senior Secured Credit Facilities and the 2026 Notes. The New Notes are the senior secured obligation of the Issuer and the Guarantors and rank equally in right of payment to all of the Issuer&#8217;s and Guarantors&#8217; existing and future senior debt and senior in right of payment to all of the Issuer's and Guarantors' existing and future subordinated debt. The New Notes and the guarantees are secured on a first-lien basis by substantially all of the existing and future assets of the Issuer and the Guarantors that also secure the Issuer&#8217;s and the Guarantors&#8217; obligations under the Senior Secured Credit Facilities and the 2026 Notes on a pari passu basis, subject to permitted liens, and the liens on the collateral securing the New Notes rank equally in priority with the liens on the collateral securing borrowings and guarantees under the Senior Secured Credit Facilities, the 2026 Notes and any other future pari passu first lien indebtedness.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">D.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Exchange Controls </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Irish exchange control regulations ceased to apply from and after December 31, 1992. Except as indicated below, there are no restrictions on non-residents of Ireland dealing in domestic securities, which includes shares or depository receipts of Irish companies. Except as indicated below, dividends and redemption proceeds also continue to be freely transferable to non-resident holders of such securities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Financial Transfers Act, 1992 gives power to the Minister for Finance of Ireland to make provision for the restriction of financial transfers between Ireland and other countries and persons. Financial transfers are broadly defined, and include all transfers which would be movements of capital or payments within the meaning of the treaties governing the European Communities. The acquisition or disposal of shares issued by an Irish incorporated company and associated payments may fall within this definition. In addition, dividends or payments on redemption or purchase of shares and payments on a liquidation of an Irish incorporated company would fall within this definition.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Financial Transfers Act, 1992 prohibits financial transfers involving a number of persons, entities and bodies, which is subject to amendment on an ongoing, regular basis and currently includes, but is not limited to: certain persons, entities, bodies and activities in Belarus, Bosnia &amp; Herzegovina, Burundi, Sudan, South Sudan, the Central African Republic, Libya, Lebanon, Mali, the Democratic People's Republic of Korea, Myanmar/Burma, Tunisia, Zimbabwe, Venezuela, Syrian Arab Republic, the Republic of Guinea-Bissau, Nicaragua, Democratic Republic of Congo, Iran, Ukraine and Russia; persons associated with the Taliban, ISIL (Da&#8217;esh) and Al-Qaeda, Turkey&#8217;s unauthorized drilling activities in the Eastern Mediterranean, certain known terrorists and terrorist groups and countries that harbor certain terrorist groups, without the prior permission of the Central Bank of Ireland.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There are no restrictions under the Company&#8217;s Constitution or under Irish Law that limit the right of non-residents or foreign owners to hold the Company&#8217;s ordinary shares or vote at general meetings of the Company.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">E.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.5pt">Taxation </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">        The following discussion is</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> based on existing Irish tax law, Irish court decisions and the practice of the Revenue Commissioners of Ireland, and the convention between the United States and Ireland for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion with respect to taxes on income and capital gains (the "Treaty"). This discussion does not purport to deal with the tax consequences of owning the ordinary shares for all categories of investors, some of which may be subject to special rules. Prospective purchasers of ordinary shares are advised to consult their own tax advisors concerning the overall tax consequences arising in their own particular situations under Irish law. Each prospective investor should understand that future legislative, administrative and judicial changes could modify the tax consequences described below, possibly with retroactive effect.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">As used herein, the term "U.S. Holder" means a beneficial owner of ordinary shares that (i) owns the ordinary shares as capital assets; (ii) for U.S. federal income tax purposes, is an individual who is a U.S. citizen or resident, a U.S. corporation, an estate the income of which is subject to U.S. federal income taxation regardless of its source or a trust that (x) meets the following two tests: (A) a U.S. court is able to exercise primary supervision over the administration of the trust, and (B) one or more U.S. persons have the authority to control all substantial decisions of the trust, or (y) has elected to be treated as a U.S. person for federal income tax purposes; and for the purpose of the discussion under Irish Taxation of U.S. Holders (A) is not a resident of, or ordinarily resident in, Ireland for the purposes of Irish tax; and (B) is not engaged in trade or business in Ireland through a permanent establishment.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">AS USED HEREIN, REFERENCES TO THE ORDINARY SHARES SHALL INCLUDE SHARES HELD IN THE ACCOUNTS OF PARTICIPANTS THROUGH THE DEPOSITARY TRUST COMPANY (&#8220;THE DTC&#8221;).</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Irish Taxation</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Irish corporation tax on income</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">ICON is a public limited company incorporated and resident for tax purposes in Ireland by virtue of its place of central management and control being in Ireland.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Companies which are resident in the Republic of Ireland ("Ireland") are subject to Irish corporation tax on their total profits (wherever arising and, generally, whether or not remitted to Ireland). The question of residence, by virtue of management and control, is essentially one of fact. It is the present intention of the Company's management to continue to manage and control the Company from Ireland, so that the Company will continue to be resident in Ireland.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The standard rate of Irish corporation tax on trading income (with certain exceptions) is currently 12.5%. Corporation tax is charged at the rate of 25% on a company's non-trading income and certain types of trading income not eligible for the lower rate of 12.5% referred to above. An Irish Qualifying Domestic Top-up tax ("QDTT") and Income Inclusion rule ("IIR"), applying to businesses with consolidated group revenues of &#8364;750m or more in at least two of the four preceding fiscal years, has been in force from 1 January 2024, providing for a minimum effective tax rate of 15% on Irish profits (QDTT) and a top up to a minimum of 15% on overseas profits of subsidiaries, if applicable (IIR).</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">A research and development tax credit is available in Ireland where an Irish resident company incurs qualifying expenditure on research and development activities. Qualifying expenditure incurred in accounting periods commencing on or before 1 January 2024 results in a tax credit of 30% of that expenditure. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Capital gains arising to an Irish resident company are liable to tax at 33%. However, a capital gains tax exemption is available in Ireland for qualifying Irish resident companies in respect of disposals of certain qualifying shareholdings.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The exemption from capital gains tax on the disposal of shares by an Irish resident company will apply where certain conditions are met. These conditions principally are:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">The company claiming the exemption must hold (directly or indirectly) at least 5% of the ordinary share capital of the company in which the interest is being disposed of, throughout a continuous period of at least 12 months, in the two-year period prior to disposal;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">The shares being disposed of must be in a company, which at the date of disposal, is resident in a Member State of the European Communities or in a country with which Ireland has signed or made specific arrangements to sign a double tax agreement (together a &#8220;Relevant Territory&#8221;);</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">The shares must be in a company which is primarily a trading company or the company making the disposal together with its &#8220;5% plus subsidiaries&#8221; should be primarily a trading group; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">The shares must not derive the greater part of their value from land or mineral rights in Ireland.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Unless specifically exempted, all dividends paid by the Company, will be subject to Irish withholding tax. The current rate for dividend withholding tax is 25%.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">An individual shareholder who is neither resident nor ordinarily resident for tax purposes in Ireland but is resident in a country with which Ireland has a double tax treaty (which includes the U.S.), or in a member state of the European Communities, other than Ireland (together, a Relevant Territory), will be exempt from withholding tax provided he or she makes the requisite declaration.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Irish resident corporate shareholders will be exempt from withholding tax. Where the shareholding held by the recipient company, in the company paying the dividend is not 51% or greater, a declaration must be made to avail of the exemption.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Non-Irish resident corporate shareholders will be exempt from withholding tax on the production of the appropriate certificates and declarations where they:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">are resident in a Relevant Territory and are not controlled (directly or indirectly) by Irish residents;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">are ultimately controlled (directly or indirectly) by residents of a Relevant Territory;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">have the principal class of their shares, or shares of a 75% parent, substantially and regularly traded on one or more recognized stock exchanges in a Relevant Territory (including Ireland) or Territories; or</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">are wholly owned by two or more companies, each of whose principal class of shares is substantially and regularly traded on one or more recognized stock exchanges in a Relevant Territory (including Ireland) or Territories.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">U.S. holders of ordinary shares should note, however, that detailed documentation requirements may need to be complied with. Special arrangements are available in the case of an interest in shares held in Irish companies through a depositary or in accounts of participants through the DTC. In certain cases, the depositary or the DTC can receive and pass on a dividend from an Irish company without deducting withholding tax, provided the depositary or the DTC is a qualifying intermediary, and provided the person beneficially entitled to the distribution would meet the same conditions outlined above for </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">the withholding tax exemption to apply and has provided the qualifying intermediary with the appropriate declarations. The depositary or the DTC shall be regarded as a qualifying intermediary provided the following conditions are met:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">the depositary or the DTC is resident in a Relevant Territory;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">the depositary or the DTC have entered into a qualifying intermediary agreement with the Irish tax authorities (Irish Revenue Commissioners); and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">the depositary or the DTC have been authorized by the Irish Revenue Commissioners as a qualifying intermediary and such authorization has not expired or been revoked.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Irish income tax on dividends</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Irish resident or ordinarily resident shareholders will generally be liable to Irish income tax on dividend income at their marginal rate of income tax. This income may also be liable to Pay Related Social Insurance (&#8220;PRSI&#8221;) of up to 4.1% (4.2% from 1 October 2025) and the Universal Social Charge (&#8220;USC&#8221;) of up to 11% (up to 15.1% in total).</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Under certain circumstances, non-Irish resident shareholders will be subject to Irish income tax on dividend income. Where withholding tax of 25% has been deducted, this will fully satisfy the non-Irish resident shareholder&#8217;s tax liability. No PRSI or USC should apply in these circumstances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">However, a non-Irish resident shareholder will not have an Irish income tax liability on dividends from the Company if the holder is neither resident nor ordinarily resident in Ireland and the holder is:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">an individual resident in a Relevant Territory;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">a corporation that is ultimately controlled by person(s) resident in a Relevant Territory;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">a corporation whose principal class of shares (or its 75% or greater parent&#8217;s principal class of shares) is substantially and regularly traded on a recognized stock exchange in an EU country or in a Relevant Territory;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">a corporation resident in another EU member state or in a Relevant Territory, which is not controlled directly or indirectly by Irish residents; or</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">a corporation that is wholly owned by two or more corporations each of whose principal class of shares is substantially and regularly traded on a recognized stock exchange in an EU country or in a Relevant Territory.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">U.S. Holders who do not qualify for the above income tax exemption may be able to obtain treaty benefits under the Treaty.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Irish domicile levy</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certain non-Irish resident individuals that are domiciled in Ireland will be subject to an annual levy of &#8364;200,000 if the market value of their Irish-located property on 31 December exceeds &#8364;5,000,000, their worldwide annual income exceeds &#8364;1,000,000 and their liability to Irish income tax in that year is less than &#8364;200,000.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Irish capital gains tax on disposal of shares</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Irish resident or ordinarily resident shareholders will be liable to capital gains tax at 33% on gains arising from the disposal or part disposal of their shareholding.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">A person who is not resident or ordinarily resident in Ireland, who has not been an Irish resident within the past five years and who does not carry on a trade in Ireland through a branch or agency will not be subject to Irish capital gains tax on the disposal of ordinary shares or shares held in accounts of participants through the DTC, so long as the shares do not derive the greater part of their value from Irish land or mineral rights</span><span style="background-color:#ffffff;color:#ff0000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">There are provisions to subject a person who disposes of an interest in a company while temporarily being a non-Irish resident, to Irish capital gains tax. This treatment will apply to Irish domiciled individuals:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">who cease to be an Irish resident;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">who beneficially own the relevant assets when they cease to be a resident;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">if there are not more than 5 years of assessment between the last year of Irish tax residence prior to becoming temporarily non-resident and the tax year that he/she resumes Irish tax residency;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">who dispose of the relevant assets during this temporary non-residence; and</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">the interest disposed of represents 5% or greater of the issued share capital of the company or is worth at least &#8364;500,000.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In these circumstances the person will be deemed, for Irish capital gains tax purposes, to have sold and immediately reacquired the interest in the company on the date of his or her departure and will be subject to tax at 33% of the taxable gain.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Irish capital acquisitions tax</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Irish capital acquisitions tax (referred to as CAT) applies to gifts and inheritances. Subject to certain tax-free thresholds, gifts and inheritances are liable to tax at 33%.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Where a gift or inheritance is taken under a disposition made after December 1, 1999 it will be within the charge to CAT:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">to the extent that the property of which the gift or inheritance consists is situated in Ireland at the date of the gift or inheritance;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">where the person making the gift or inheritance is or was resident or ordinarily resident in Ireland at the date of the disposition under which the gift or inheritance is taken;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">in the case of a gift taken under a discretionary trust where the person from whom the gift is taken was resident or ordinarily resident in Ireland at the date he/she made the settlement, or at the date of the gift or, if he/she is dead at the date of the gift, at the date of his/her death; or</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">where the person receiving the gift or inheritance is resident or ordinarily resident in Ireland at the date of the gift or inheritance. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">For these purposes a non-Irish domiciled individual will not be regarded as resident or ordinarily resident in the Republic of Ireland on a particular date unless they are resident or ordinarily resident in Ireland on that date and have been resident for the 5 consecutive tax years immediately preceding the year of assessment in which the date falls.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The person who receives the gift or inheritance (&#8220;the beneficiary&#8221;) is primarily liable for CAT. In the case of an inheritance, where a beneficiary and personal representative of the deceased are both non-residents, a solicitor must be appointed to be responsible for paying inheritance tax. Taxable gifts or inheritances received by an individual since December 5, 1991 from donors in the same threshold class are aggregated and only the excess over a specified tax-free threshold is taxed. The tax-free threshold is dependent on the relationship between the donor and the beneficiary and the aggregation since December 5, 1991 of all previous gifts and inheritances, within the same tax threshold.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The tax-free threshold amounts that apply are:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">&#8364;20,000 in the case of persons who are not related to one another;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">&#8364;40,000 in the case of gifts or inheritances received from inter alia a brother or sister or from a brother or sister of a parent or from a grandparent; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%;padding-left:14.85pt">&#8364;400,000 in the case of gifts and inheritances received by a child from a parent (or by a minor child of a deceased child of a grandparent) and specified inheritances received by a parent from a child for gifts or inheritances taken on or after October 9, 2019. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Gifts and inheritances passing between spouses are exempt from CAT.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">A gift or inheritance of the ordinary shares or American Depositary Shares (ADSs) in the Company will be within the charge to CAT, notwithstanding that the person from whom or by whom the gift or inheritance is received is domiciled or resident outside Ireland.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Estate Tax Convention between Ireland and the United States generally provides for CAT paid on inheritances in Ireland to be credited against Federal Estate tax payable in the U.S. and for tax paid in the U.S. to be credited against tax payable in Ireland, based on priority rules set forth in the Estate Tax Convention. The Estate Tax Convention does not apply to CAT paid on gifts.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Irish stamp duty </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Irish stamp duty, which is a tax on certain documents, is payable on all transfers of ordinary shares (other than between spouses) whenever a document of transfer is executed. Where the transfer is attributable to a sale of shares, stamp duty will be charged at a rate of 1%, rounded to the nearest euro. The stamp duty is calculated on the amount or value of the consideration </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(i.e. purchase price) or, if the transfer is by way of a gift (subject to certain exceptions) or for consideration less than the market value, on the market value of the shares. Where the consideration for the sale is expressed in a currency other than euro, the duty will be charged on the euro equivalent calculated at the rate of exchange prevailing on the date of the transfer.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Transfers through the DTC of book entry interests in shares are not subject to Irish stamp duty.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">A transfer of ordinary shares by a shareholder to a depositary or custodian for deposit and a transfer of ordinary shares from the depositary or the custodian for the purposes of the withdrawal of the underlying ordinary shares in accordance with the terms of a deposit agreement will be subject to stamp duty at the 1% rate if the transfer relates to a sale, a contemplated sale, a gift or any other change in the beneficial ownership of such ordinary shares. However, transfers of ordinary shares into or out of the DTC are not subject to Irish stamp duty where no change in beneficial ownership of the shares has occurred and provided a contract for sale in respect of the transferring shares is not in place.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The person accountable for payment of stamp duty is normally the transferee or, in the case of a transfer by way of gift, or for a consideration less than the market value, all parties to the transfer.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Transfers of ordinary shares between associated companies (broadly, companies within a 90% group relationship and subject to the satisfaction of certain conditions) are exempt from stamp duty in Ireland. In the case of transfers of ordinary shares where no beneficial interest passes (e.g. a transfer of shares from a beneficial owner to his nominee), no stamp duty arises.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">No stamp duty shall arise on the transfer of ordinary shares where the consideration for the transfer does not exceed &#8364;1,000, provided the instrument contains a statement certifying that the transaction does not form part of a larger transaction or a series of larger transactions, in respect of which the amount of the total consideration attributable to the shares would exceed &#8364;1,000.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">F.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:10.01pt">Dividends and paying agents</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">G.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:8.5pt">Statement by experts</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">H.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Documents on Display</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are subject to the informational requirements of the Securities Exchange Act of 1934, as amended, (the &#8220;Exchange Act&#8221;) and file reports and other information with the SEC. The SEC maintains a website that contains reports, proxy and information statements and other information regarding registrants that file electronically with the SEC at http://www.sec.gov.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We &#8220;incorporate by reference&#8221; information that we file with the SEC, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is an important part of this report and more recent information automatically updates and supersedes more dated information contained or incorporated by reference in this report. Our SEC file number for Exchange Act reports is 333-08704.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As a foreign private issuer, we are exempt from certain rules under the Exchange Act, including prescribing the furnishing and content of proxy statements to shareholders and our officers, Directors and principal shareholders are exempt from the reporting and short swing profit recovery provisions contained in Section 16 of the Exchange Act. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We will provide without charge to each person, including any beneficial owner, on the written or oral request of such person, a copy of any or all documents referred to above which have been or may be incorporated by reference in this report (not including exhibits to such incorporated information that are not specifically incorporated by reference into such information). Requests for such copies should be directed to us at the following address: ICON plc, South County Business Park, Leopardstown, Dublin 18, Ireland, D18 X5R3 Attention: Corporate Governance, email: corporate.governance@iconplc.com.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">I.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:13pt">Subsidiary Information</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">J.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:10.5pt">Annual Report to Security Holders</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON is required to provide an annual report to security holders in response to the requirements of Form 6-K and will submit the annual report in electronic format. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exemptions From Corporate Governance Listing Requirements Under the NASDAQ Marketplace Rules</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NASDAQ may provide exemptions from certain NASDAQ corporate governance standards to a foreign private issuer if, among other reasons those standards are contrary to a law, rule or regulation of a public authority exercising jurisdiction over such issuer or contrary to generally accepted business practices in the issuer&#8217;s home country of domicile, provided, that, the foreign private issuer properly notifies NASDAQ and makes the required disclosure except to the extent that such exemptions would be contrary to United States federal securities laws.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The exemptions that the Company relies on, and the practices the Company adheres to, are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The Company is exempt from provisions set forth in NASDAQ Rule 5620(c), which requires each issuer (other than limited partnerships) to provide for a quorum in its by-laws for any meeting of the holders of common stock, which shall in no case be less than 33.33% of the outstanding shares of the issuer&#8217;s common voting stock. The Company&#8217;s Constitution requires that only 3 members be present, in person or by proxy, at a shareholder meeting to constitute a quorum. This quorum requirement is in accordance with Irish law and generally accepted business practices in Ireland.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The Company is exempt from provisions set forth in NASDAQ Rule 5635(c) which requires (other than for certain specified exceptions) shareholder approval prior to the establishment or material amendment of a stock option or purchase plan or other equity compensation arrangement made or materially amended, pursuant to which stock may be acquired by officers, Directors, employees or consultants. Irish law does not require shareholder approval with respect to equity compensation arrangements. Accordingly, the 2019 Consultants and Directors Restricted Share Unit Plan, the 2013 Employees Restricted Share Unit Plan and the amendments to the Employee Share Option Plan 2008 and Consultants Share Option Plan 2008 were adopted by the Board of Directors without shareholder approval.</span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The Company is exempt from provisions set forth in NASDAQ Rule 5605(b)(2), which requires independent Directors to hold regularly scheduled meetings at which only independent Directors are present. Irish law does not require independent Directors to hold regularly scheduled meetings at which only independent Directors are present. The Company holds regularly scheduled meetings which all of the Directors may attend and the Lead Independent Director may call meetings of the independent Directors and non-employee Directors of the Board, as appropriate, in accordance with the Lead Independent Director Charter.</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:4.5pt"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_73"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 11</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">. Quantitative and Qualitative Disclosures about Market Risk.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The principal market risks (i.e. risk of loss arising from adverse changes in market rates and prices) to which we are exposed include foreign currency risk and interest rate risk.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are subject to a number of foreign currency risks given the global nature of our operations. The principal foreign currency risks to which the business is subject to includes both foreign currency translation risk and foreign currency transaction risk.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Although domiciled in Ireland, we report our results in U.S. dollars. As a consequence, the results of our non-U.S. based operations, when translated into U.S. dollars, could be affected by fluctuations in exchange rates between the U.S. dollar and the currencies of those operations.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are also subject to foreign currency transaction exposures as the currency in which our contracts are priced can be different from the currencies in which costs relating to those contracts are incurred. Our operations in the United States are not materially exposed to such currency differences as the majority of revenues and costs are in U.S. dollars. However, outside the United States the multinational nature of our activities means that contracts may be priced in a single currency, most often U.S. dollars, or euro, while costs arise in a number of currencies, depending, among other things, on which of our offices provide staff for the contract and the location of investigator sites. Although many such contracts benefit from some degree of natural hedging due to the matching of contract revenues and costs in the same currency, where costs are incurred in currencies other than those in which contracts are priced, fluctuations in the relative value of those currencies could have a material effect on our results of operations. We regularly review our foreign currency exposures and enter into forward currency contracts to manage our exposure. We had no open foreign currency contracts at December&#160;31, 2024.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following significant exchange rates applied during the year:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average Rate</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Closing Rate</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Euro:USD</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0854</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0795</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0354</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1039</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pound Sterling:USD</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2809</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2382</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2516</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2731</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are exposed to interest rate risk in respect of our cash and cash equivalents and available for sale investments. Our treasury function actively manages our available cash resources and invests surplus cash balances to ensure optimum returns for the Company. Financial instruments are classified either as cash and cash equivalents or available for sale investments depending upon the maturity of the related investment. Funds may be invested in the form of floating rate notes and medium term minimum &#8220;A-&#8221; rated corporate securities. We may be subject to interest rate risk in respect of interest rate changes on amounts invested. Interest rate risk is managed by monitoring the composition of the Company&#8217;s investment portfolio on an ongoing basis having regard to current market interest rates and future trends.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">As the Company has variable rate debt, fluctuations in interest rates affect our business. We do not hedge our variable rate debt and therefore, may incur higher interest costs on any unhedged debt. Previously, we attempted to minimize interest rate risk and lower our overall borrowing costs through the utilization of interest rate caps and an interest rate swap derivative agreements. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">During the year, the Company&#8217;s exposure to interest rate fluctuations significantly reduced with the voluntary and mandatory repayments </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">f the senior secured term loan facility (refer to note 13. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:107%">Bank credit lines, loan facilities and notes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">). Given this reduction and the repricing of the Senior Secured Credit facilities, the Company </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">closed the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">2022 Caps and 2022 Swap agreements. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">At </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">December&#160;31, 2024, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">73%</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> of the Company's outstanding debt was at a fixed interest rate (December&#160;31, 2023: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">13%)</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">We regularly evaluate our debt arrangements, as well as market conditions, and we will explore the opportunity to modify our existing arrangements or pursue additional financing arrangements that may result in the issuance of new debt securities by us or our affiliates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The sensitivity analysis below represents the hypothetical change in the net interest payable of a 1% movement in market interest rates.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:21.593%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.671%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest for the year ended December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest<br/>Change 1% increase in<br/>market interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest<br/>Change 1% decrease in<br/>market interest rate</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(237,237)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(254,987)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(219,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(228,628)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(241,348)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(215,908)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*At </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2024,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> 73% of the interest costs fixed due to our 2026 Notes and New Notes. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$23.5 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> financing fees have been allocated to interest cost which are not impacted by a change in interest rate.  </span></div><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_76"></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 12</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">. Description of Securities Other than Equity Securities.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_79"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Part II</span></div><div style="text-align:justify"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_82"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 13</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">. Defaults, Dividend Arrearages and Delinquencies.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_85"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 14.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Material Modifications to the Rights of Security Holders and Use of Proceeds.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_88"></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 15.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Controls and Procedures.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">A.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Disclosure controls and procedures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">An evaluation was carried out under the supervision and with the participation of the Company's management, including the Chief Executive Officer (CEO) and the Chief Financial Officer (CFO), of the effectiveness of our disclosure controls and procedures as at December&#160;31, 2024. Based on that evaluation, the CEO and CFO have concluded that the Company's disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to the Company&#8217;s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">B.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Management's Annual Report on Internal Accounting Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reference is made</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to page 98 of this Form 20-F.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">C.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Attestation Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reference is made to page 101 of thi</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s Form 20-F.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">D.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%;padding-left:9.01pt">Changes in Internal Controls over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">There were no changes in our internal controls over financial reporting during the period covered by this Form 20-F that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_91"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Reserved.</span></div><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_94"></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16A. Audit Committee Financial Expert</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Mr. R&#243;n&#225;n Murphy acts as the Audit Committee financial expert serving on our Audit Committee and Board of Directors. The Board has determined that Mr. Murphy is independent. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_97"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16B. Code of Ethical Conduct </span></div><div style="text-align:justify;text-indent:-40.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Our Global Code of Ethical Conduct applies to all officers, directors (including a non-executive director when carrying out their duties as a director of ICON plc), and employees of ICON plc, its subsidiaries and branches. There are no waivers from the provisions of the Code of Ethical Conduct that are required to be disclosed. This Code of Ethical Conduct is available on our website at: </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;text-decoration:underline">https://investor.iconplc.com/corporate-governance/governance-documents</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_100"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16C. Principal Accountant Fees and Services</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our principal accountants for the years ended December&#160;31, 2024 and December&#160;31, 2023 were KPMG, Dublin, Ireland (Audit firm ID: <ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-44">1116</ix:nonNumeric>). The table below summarizes the fees for professional services rendered by KPMG for the audit of our annual financial statements for the years ended December&#160;31, 2024 and December&#160;31, 2023 and fees billed for other services rendered by KPMG.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="12" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of total</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Audit fees</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Audit related fees</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax compliance and the preparation of tax returns</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total audit, audit related and tax compliance fees</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,920&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,849&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other tax planning and consulting services</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax advice relating to integration of ICON and PRA</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other fees</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">5</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total non-audit service fees</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,343&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,146&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total fees</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,263</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,995</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Audit fees include annual audit and quarterly review fees for the Company and its subsidiaries and services provided in connection with statutory and regulatory filings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Audit related fees principally consist of fees for assurance and related services, such as financial due diligence services, fees for the audit of employee benefit plans and fees for pension reviews. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other tax planning and consulting services represents services across a number of areas including in relation to the Group's financing facilities and other ad hoc tax advisory and planning.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:107%;position:relative;top:-3.15pt;vertical-align:baseline">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">Tax advice relating to the integration of ICON and PRA including integration of business activities and the elimination of legal entities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:107%;position:relative;top:-3.15pt;vertical-align:baseline">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">O</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">ther fees primarily consist of permissible services in relation to environment, social and governance reporting advice. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">There were no other fees billed to the company in the &#8220;other fees&#8221; category during the year ended December&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Audit Committee pre-approves all audit and non-audit services provided to the Company by its auditors.</span></div><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_103"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16D. Exemptions from the Listing Standards for Audit Committees</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">94</span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 20, 2024, the Company's Board of Directors authorized a new buyback program of up to $500.0 million of the outstanding ordinary shares of the Company. On October 22, 2024, the Company's Board of Directors authorized an additional buyback program of up to $250.0 million of the outstanding ordinary shares of the Company. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the year ended December&#160;31, 2024, 2,179,699 ordinary shares were redeemed by the Company at an average price of $229.39 per share for a total consideration of $500.0 million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the Company had remaining authorization to repurchase up to $250.0 million of ordinary shares under the Repurchase Program.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.759%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:19.663%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total number<br/>of shares purchased</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average price paid per share</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total number<br/>of shares purchased as part of publicly announced program</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Approximate dollar value of shares that may yet be purchased under the program<br/>(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 09/18/2024 - 09/25/2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">337,070&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$296.67&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">337,070&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$400.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 10/28/2024 - 10/31/2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">409,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$228.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">409,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$556.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 11/01/2024 - 11/07/2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">479,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$221.87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">479,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$450.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 12/02/2024 - 12/19/2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">953,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$209.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">953,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$250.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,179,699&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$229.39&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,179,699&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 18, 2025, the Company's Board of Directors authorized an additional buyback program of up to $750.0 million of the outstanding ordinary shares of the Company. Along with unutilized amounts under the previous authorizations, this permits the Company to repurchase up to $1 billion worth of ordinary shares. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">No ordinary shares were redeemed by the Company during the year ended December&#160;31, 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the year ended December&#160;31, 2022, 420,530 ordinary shares were redeemed by the Company at an average price of $237.75 per share for a total consideration of $100.0 million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A resolution was passed at the Company&#8217;s Annual General Meeting (&#8220;AGM&#8221;) on July 23, 2024, which renewed the authorization for the Directors to purchase (buyback) up to 10% of the outstanding shares in the Company. All ordinary shares that were repurchased under the buyback program were canceled in accordance with the constitution of the Company and the nominal value of these shares transferred to other undenominated capital as required by Irish Company law.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the repurchase programs, a broker purchased the Company's shares from time to time on the open market or in privately negotiated transactions in accordance with agreed terms and limitations. The programs are designed to allow share repurchases during periods when the Company would ordinarily not be permitted to do so because it may be in possession of material non-public or price-sensitive information, applicable insider trading laws or self-imposed trading blackout periods. The Company's instructions to the broker were irrevocable and the trading decisions in respect of the repurchase programs were made independently of and uninfluenced by the Company. The Company confirms that on entering the share repurchase plans it had no material non-public, price-sensitive or inside information regarding the Company or its securities. Furthermore, the Company will not enter into additional plans whilst in possession of such information. The timing and actual number of shares acquired by way of the redemption will be dependent on market conditions, legal and regulatory requirements and the other terms and limitations contained in the programs. In addition, acquisitions under the programs may be suspended or discontinued in certain circumstances in accordance with the agreed terms. Therefore, there can be no assurance as to the timing or number of shares that may be acquired under the programs.</span></div><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_109"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16F. Changes in Registrant's Certifying Accountant</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">While there has been no change yet in our certifying accountant, in 2023, the Audit Committee of the Company engaged in a competitive audit tender process for the position of statutory auditor. Based on the results of this process, the Audit Committee is recommending that Ernst &amp; Young be appointed as statutory auditors and independent registered public accounting firm to the Company in respect of the financial year ending December 3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">1, 2025. Ernst &amp; Young's appointment will be subject to the passing of an ordinary resolution confirming the appointment at the Company's 2025 Annual General Meeting. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">KPMG, our current independent registered public accounting firm, who have audited the financial statements as presented in this Form 20-F are expected to resign shortly after the filing of our Form 20-F, other than for purposes of auditing </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">financial statements as presented under local accounting standards for the year ending December&#160;31, 2024, after which they will resign for all purposes.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">During the two fiscal years ended December&#160;31, 2024 and December&#160;31, 2023 and any subsequent interim period there were: (1) no disagreements with KPMG on any matter of accounting principles or pra</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">ctices, financial statement disclosure, or auditing scope or procedures, which disagreements if not resolved to their satisfaction would have caused them to make reference in connection with their opinion to the subject matter of the disagreement, and (2) no reportable events as defined under Item 16F(a)(1)(v).</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The audit reports of KPMG on the financial statements of the Company as of and for the years ended </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">December&#160;31, 2024 and</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">December&#160;31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> did not contain any adverse opinion or disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope or accounting principles.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company requested that KPMG furnish it with a letter addressed to the SEC stating whether or not it agrees with the above statements. A copy of such letter, dated February&#160;21, 2025 is filed as Exhibit 16.1 to this annual report.</span></div><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_112"></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16G. Corporate Governance</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See Item 10 "Exemptions from Corporate Governance Listing Requirements under the NASDAQ Marketplace Rules".</span></div><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_115"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16H. Mine Safety Disclosure</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_118"></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16I. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_121"></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16J. Insider Trading Policies  </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON <ix:nonNumeric contextRef="c-1" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true" id="f-45">has a Share Trading Policy</ix:nonNumeric> (the &#8220;Share Trading Policy&#8221;), which, among other things, governs the purchase, sale and other dispositions of ICON's securities by our Directors, officers and employees. Our Share Trading Policy aims to promote compliance with applicable insider trading laws, rules and regulations, and the NASDAQ listing standards.  A copy of our Share Trading Policy is filed as Exhibit 11.1 to this annual report.</span></div><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_124"></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 16K. Cybersecurity </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" id="f-46" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has a cybersecurity strategy and program designed to protect our information systems and data from an evolving cyber threat landscape. <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" id="f-47" continuedAt="f-47-1" escape="true">The cybersecurity program, overseen by the Chief Information Officer (CIO), has the support of executive leadership and the Board, and we have invested heavily in cybersecurity technologies to protect our environment. </ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" id="f-49" escape="true"><ix:continuation id="f-47-1"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" id="f-48" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-50" escape="true">The <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true" id="f-51">Chief Information Officer (CIO)</ix:nonNumeric>, who reports to the CEO, has oversight responsibility for the cybersecurity strategy and program and has over a decade experience leading cybersecurity oversight.</ix:nonNumeric> The Vice President of Cyber &amp; Information Security reports to the CIO and is responsible for the delivery of the cyber and information security strategy</ix:nonNumeric>. <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" id="f-52" escape="true">The Vice President of Cyber &amp; Information Security as well as the overall security team have many years&#8217; experience and are all appropriately qualified</ix:nonNumeric>. <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" id="f-54" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true" id="f-53">ICON&#8217;s cybersecurity processes are integrated into ICON&#8217;s overall risk management processes which are monitored by ICON&#8217;s executive leadership team and reported to the Board.</ix:nonNumeric></ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" id="f-57" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-56" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" format="ixt:fixed-true" id="f-55">The Chief Information Officer provides cybersecurity updates to the Board on a quarterly basis.</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The underlying controls of the cyber risk management program are based on recognized best practices and standards for cybersecurity and information technology, including the National Institute of Standards and Technology (&#8220;NIST&#8221;) Cybersecurity Framework (&#8220;CSF&#8221;) and the International Organization Standardization (&#8220;ISO&#8221;) 27001 Information Security Management System Requirements. ICON has an enterprise-wide assessment, performed twice annually by a third party, of the Company&#8217;s cyber risk management program against ISO 27001. We also conduct an annual independent maturity review with a third party which is based on the NIST cybersecurity framework. ICON also maintains the Cyber Essentials certification.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has a dedicated Cybersecurity Operations Center that continuously monitors for threats and unauthorized access. The Cybersecurity Operations Center is staffed by appropriately qualified cyber and information security professionals. ICON has put in place controls and processes to inform and monitor the prevention, detection, mitigation, and remediation of cybersecurity incidents. These controls and procedures are designed to ensure prompt escalation of certain cybersecurity incidents so that decisions regarding public disclosure and reporting of such incidents can be made by executive management in a timely manner. The escalation processes are based on defined prioritization and severity assessment criteria.</span></div></ix:nonNumeric></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true" id="f-58">ICON partners with leading cybersecurity experts and organizations, leveraging third-party technology and expertise.</ix:nonNumeric> ICON engages with these partners to monitor and maintain the performance and effectiveness of products and services that are deployed in ICON&#8217;s environment. We leverage the knowledge and expertise of external cybersecurity experts and vendors and employ an array of third-party tools to secure ICON&#8217;s information infrastructure and protect systems and information from </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">unauthorized access. We engage third-party services to conduct evaluations of our security controls, whether through penetration testing, independent audits or consulting on best practices to address new challenges. These evaluations include testing both the design and operational effectiveness of security controls.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has training in place for all employees and contingent workers on information security and privacy practices so that they understand their responsibilities with respect to data security and privacy. Annual training includes topics such as data protection and IT security essentials. We also annually host cyber crisis response simulations with management and other employees to practice rapid cyber incident response. We work with our customers, peers and other partners within the wider healthcare, pharmaceutical and biotech communities to continuously share and receive cyber threat intelligence through various avenues, such as the Health-ISAC. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has a Supplier Risk Management program which governs the use of approved suppliers within ICON. All suppliers must be on-boarded and approved for use in line with the Supplier Onboarding, Assessment and Management procedure. Security due diligence is conducted in line with industry good practice. As part of the onboarding assessment, the Information Security team uses an industry leading solution to risk profile of the supplier. This information is leveraged by the security team with the vendor during the assessment. <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" format="ixt:fixed-true" id="f-59">In addition, we require our third-party providers to meet appropriate security requirements, controls and responsibilities and as applicable, we investigate security incidents that have impacted our third-party providers. We rely on the third-parties we use to implement security programs commensurate with their risk, and we cannot ensure in all circumstances that their efforts will be successful.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During an acquisition process, we conduct security and privacy due diligence and risk assessments, implement policies, deliver employee training, and securely integrate IT systems.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false" id="f-60">To date, no cyber-attacks have had a material impact on operations or financial reporting.</ix:nonNumeric> For more information about the cybersecurity risks we face, please see Item </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">3.D- Risk Factors</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_127"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Part III</span></div><div style="text-align:justify"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_130"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 17. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Financial Statements.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See Item 18.</span></div><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_133"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">. Financial Statements.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following consolidated financial statements of ICON plc and its subsidiaries, and the independent registered public accounting firm's report thereon, are included in Part III, Item 18 of this Annual Report: </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.012%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_136">Management's Report on Internal Control Over Financial Reporting</a></span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_136">98</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_139">Reports of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_139">99</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_142">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_142">102</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_145">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_145">103</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_148">Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_148">104</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_151">Consolidated Statements of Shareholders' Equity</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_151">105</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_154">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_154">106</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_157">Notes to the Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i70380bb88cac48169f2186a4a94094c5_157">107</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">97</span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Management's Report on Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's internal control over financial reporting is a process designed by, or under the supervision of, the Company's executive and financial officers and effected by the Company's board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principles.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A company's internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorization of management and Directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Because of the inherent limitation due to, for example, the potential for human error or circumvention of control, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Management assessed the effectiveness of the Company's </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">internal control over financial reporting </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">as of December&#160;31, 2024. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8211; Integrated Framework 2013</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Based upon the assessment performed, we determined that, as of December&#160;31, 2024 the Company's internal control over financial reporting was effective.</span><span style="background-color:#ffffff;color:#ff0000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no changes in the Company's internal control over financial reporting during 2024 that have materially affected, or are reasonably likely to affect materially, the Group's internal control over financial reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">KPMG, an independent registered public accounting firm, has audited the consolidated financial statements of ICON plc and subsidiaries as of and for the year ended December&#160;31, 2024, included herein, and has issued an audit report on the effectiveness of our internal control over financial reporting, which is included below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">98</span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_139"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:174%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To the Shareholders and Board of Directors, </span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc:</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Opinion on the Consolidated Financial Statements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of ICON plc and subsidiaries (the Company) as of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2024 and 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, the related consolidated statements of operations, comprehensive income, shareholders&#8217; equity, and cash flows for each of the years in the three&#8209;year period ended </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2024 and 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, and the results of its operations and its cash flows for each of the years in the three&#8209;year period ended </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, in conformity with U.S. generally accepted accounting principles.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, based on criteria established in Internal Control &#8211; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated February&#160;21, 2025 expressed an unqualified opinion on the effectiveness of the Company&#8217;s internal control over financial reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Basis for Opinion</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Revenue recognition for clinical trial service contracts.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As discussed in Note 3 to the consolidated financial statements, the Company recognized revenu</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">e of US$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-61">8,281,676</ix:nonFraction>&#160;thousand </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">for the year ended </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, a portion of which relates to clinical trial service revenue. As discussed in Note 2 to the consolidated financial statements, clinical trial service revenue is recognized over time, using an input measure, being total project costs (inclusive of third-party costs, principally pass-through/ reimbursable expenses) incurred at each reporting period as a percentage of forecasted total project costs, to measure progress towards satisfying the Company&#8217;s performance obligation. The transaction price is based on the contract or latest change order value, adjusted to reflect the estimated realizable contract value.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We identified the evaluation of revenue recognition for clinical trial service revenue as a critical audit matter. Complex and subjective auditor judgment was required to evaluate the Company&#8217;s estimate of total forecast project costs and the estimated realizable contract values.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following are the primary procedures we performed to address this critical audit matter:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We evaluated the design and tested the operating effectiveness of certain internal controls related to the revenue process, including controls over total forecast project costs and estimated realizable contract values.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We tested the total forecast project costs and the realizable contract values for a selection of clinical trial service contracts, by evaluating: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-31.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:26.5pt">direct costs incurred, both during the year and cumulative over the life of the contracts. We tested the accuracy and completeness of the direct costs by comparing the amounts to source data</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-31.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:26.5pt">third-party costs incurred, both during the year and cumulative over the life of the contracts. We tested the accuracy and completeness of the third-party costs incurred by comparing the costs to invoices received</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-31.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:26.5pt">findings from interviews with operational personnel of the Company to assess progress to date, the estimate of remaining costs to be incurred and factors impacting the amount of time and costs to complete the selected contracts, including an understanding of the nature and complexity of the work to be performed</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-31.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:26.5pt">correspondence of amendments to the scope or contract value, if any, between the Company and the customer for the selected contracts as part of our evaluation of contract progress</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-31.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:26.5pt">quarterly movements in forecast project costs and project margins and investigating the reasons for those movements, and</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-31.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8211;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:26.5pt">the reasonableness of the Company&#8217;s adjustments from total contract value to arrive at realizable contract value. We confirmed total contract value with customers and compared the assumptions used to derive the adjustments from total contract value to realizable contract value to underlying records.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also evaluated the Company&#8217;s methods, assumptions and data used to accurately estimate total forecast project costs and realizable contract values, by comparing historical estimates developed at contract inception to actual results for a selection of clinical trial service contracts.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(signed) <ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-62">KPMG</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We have served as the Company&#8217;s auditor since 1990.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-63">Dublin, Ireland</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">February&#160;21, 2025</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To the Shareholders and Board of Directors</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc:</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Opinion on Internal Control Over Financial Reporting </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have audited ICON plc and subsidiaries&#8217; (the Company) internal control over financial reporting as of December&#160;31, 2024, based on criteria established in Internal Control &#8211; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December&#160;31, 2024, based on criteria established in Internal Control &#8211; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December&#160;31, 2024 and 2023, the related consolidated statements of operations, comprehensive income, shareholders&#8217; equity, and cash flows for each of the years in the three-year period ended December&#160;31, 2024, and the related notes (collectively, the consolidated financial statements), and our report dated February&#160;21, 2025, expressed an unqualified opinion on those consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Basis for Opinion </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(signed) KPMG</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dublin, Ireland</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">February&#160;21, 2025</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">101</span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_142"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON plc</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.106%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-64">538,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-65">378,102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (Note 8)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="f-66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-67">1,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for credit losses (Note 4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-68">1,401,989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-69">1,790,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled revenue (Note 4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="f-70">1,286,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="f-71">951,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:NontradeReceivablesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-72">79,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:NontradeReceivablesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-73">65,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepayments and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-74">140,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-75">132,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="f-76">83,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="f-77">91,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-78">3,530,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-79">3,411,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net (Note 9)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-80">382,879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-81">361,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill (Note 10)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-82">9,051,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-83">9,022,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net (Note 11)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-84">3,559,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-85">3,855,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating right-of-use assets (Note 15)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-86">147,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-87">140,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-88">72,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-89">78,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax asset (Note 20)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-90">74,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-91">73,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity (Note 8)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" format="ixt:num-dot-decimal" scale="3" id="f-92">57,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" format="ixt:num-dot-decimal" scale="3" id="f-93">46,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-94">16,877,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-95">16,989,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-96">173,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-97">131,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (Note 4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-98">1,614,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-99">1,654,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities (Note 12)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-100">923,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-101">915,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-102">55,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-103">13,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current bank credit lines, loan facilities and notes (Note 13)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LinesOfCreditCurrent" format="ixt:num-dot-decimal" scale="3" id="f-104">29,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LinesOfCreditCurrent" format="ixt:num-dot-decimal" scale="3" id="f-105">110,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-106">2,796,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-107">2,825,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current bank credit lines, loan facilities and notes, net (Note 13)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermLineOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-108">3,396,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermLineOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-109">3,665,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease liabilities (Note 15)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-110">140,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-111">126,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current other liabilities (Note 16)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-112">83,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-113">45,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-114">125,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-115">186,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liability (Note 20)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-116">812,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-117">899,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 17)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="3" id="f-118">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="3" id="f-119">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-120">7,354,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-121">7,749,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shareholders' Equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ordinary shares, par value <ix:nonFraction unitRef="eurPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-122"><ix:nonFraction unitRef="eurPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-123">6</ix:nonFraction></ix:nonFraction> euro cents per share;</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-124"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-125">100,000,000</ix:nonFraction></ix:nonFraction> shares authorized (Note 18),</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-126"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-127">80,756,860</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December 31, 2024 and<br/><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-128"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-129">82,495,086</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December 31, 2023.</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="f-130">6,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="f-131">6,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-132">7,020,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-133">6,942,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other undenominated capital (Note 18b)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:OtherUndenominatedCapital" format="ixt:num-dot-decimal" scale="3" id="f-134">1,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="iclr:OtherUndenominatedCapital" format="ixt:num-dot-decimal" scale="3" id="f-135">1,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss (Note 24)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-136">229,929</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-137">143,506</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-138">2,724,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-139">2,433,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Shareholders' Equity</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-140">9,522,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-141">9,240,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Liabilities and Shareholders&#8217; Equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-142">16,877,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-143">16,989,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:29.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">102</span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_145"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON plc</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:53.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-144">8,281,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-145">8,120,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-146">7,741,386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-147">5,845,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-148">5,719,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-149">5,527,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-150">728,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-151">768,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-152">778,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-153">488,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-154">585,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-155">569,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration related (Note 6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="f-156">29,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="f-157">44,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="f-158">39,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-159">Restructuring (Note 19)</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="f-160">92,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="f-161">45,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="f-162">31,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-163">7,183,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-164">7,164,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-165">6,946,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-166">1,097,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-167">956,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-168">795,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-169">8,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-170">5,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-171">2,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense (Note 13)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-172">237,237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-173">336,699</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-174">229,731</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income tax expense </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-175">869,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-176">624,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-177">567,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense (Note 20)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-178">77,710</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-179">11,749</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-180">59,411</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before share of losses from equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-181">791,474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-182">612,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-183">508,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of losses from equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="f-184">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-185">383</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-186">3,136</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-187">791,474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-188">612,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-189">505,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income per ordinary share (Note 23):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-190">9.60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-191">7.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-192">6.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-193">9.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-194">7.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-195">6.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding (Note 23):</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-196">82,482,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-197">82,101,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-198">81,532,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-199">83,032,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-200">82,717,640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-201">82,468,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">103</span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_148"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON plc</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-202">791,474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-203">612,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-204">505,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Other comprehensive income, net of tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-205">84,927</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-206">26,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-207">89,530</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remeasurement of retirement benefit obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-208">6,077</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="3" id="f-209">244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-210">12,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain / (loss) on cash flow hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-211">4,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-212">1,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-213">3,728</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-214">705,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-215">640,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-216">424,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">104</span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_151"></div><hr style="page-break-after:always"/><div style="min-height:18pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.854%"><tr><td style="width:1.0%"/><td style="width:35.043%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.013%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.013%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.646%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.910%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.013%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.018%"/><td style="width:0.1%"/></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ICON plc</span></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Ordinary Shares</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ordinary Shares</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Undenominated Capital</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-217">81,554,683</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-218">6,640</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-219">6,733,910</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-220">1,134</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-221">90,937</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-222">1,416,080</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-223">8,066,827</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Comprehensive income (net of tax):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-224">505,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-225">505,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-226">89,530</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-227">89,530</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Remeasurement of retirement benefit obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-228">12,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-229">12,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on cash flow hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-230">3,728</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-231">3,728</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Comprehensive Income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-232">424,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of share options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-233">348,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-234">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-235">35,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-236">35,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issue of restricted share units / performance share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-237">241,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-238">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-239">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-240">70,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-241">70,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-242">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-243">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-15" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-244">420,530</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-245">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-246">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-247">99,983</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-248">99,983</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share repurchase costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="iclr:ShareRepurchaseProgramBrokerCommission" scale="3" id="f-249">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="iclr:ShareRepurchaseProgramBrokerCommission" scale="3" id="f-250">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-251">81,723,555</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-252">6,649</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-253">6,840,306</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-254">1,162</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-255">171,538</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-256">1,821,384</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-257">8,497,963</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Comprehensive income (net of tax):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-258">612,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-259">612,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-260">26,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-261">26,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Remeasurement of retirement benefit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="3" id="f-262">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="3" id="f-263">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on cash flow hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-264">1,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-265">1,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Comprehensive Income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-266">640,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of share options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-267">535,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-268">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-269">50,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-270">50,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issue of restricted share units / performance share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-271">235,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-272">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-273">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-274">51,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-275">51,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-276">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-277">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-28" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-278">82,495,086</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-279">6,699</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-280">6,942,669</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-281">1,162</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-282">143,506</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-283">2,433,719</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-284">9,240,743</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Comprehensive income (net of tax):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-285">791,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-286">791,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-287">84,927</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-288">84,927</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Remeasurement of retirement benefit obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-289">6,077</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-290">6,077</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on cash flow hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-291">4,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-292">4,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Comprehensive Income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-293">705,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of share options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-35" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-294">311,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-295">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-296">36,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-297">36,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issue of restricted share units / performance share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-35" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-298">130,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-299">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="f-300">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-301">41,426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-302">41,426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-303">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-304">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-35" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-305">2,179,699</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-306">142</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" sign="-" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-307">142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-308">499,998</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-309">499,998</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share repurchase costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="iclr:ShareRepurchaseProgramBrokerCommission" scale="3" id="f-310">388</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="iclr:ShareRepurchaseProgramBrokerCommission" scale="3" id="f-311">388</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-38" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-312">80,756,860</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-313">6,586</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-314">7,020,231</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-315">1,304</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-316">229,929</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-317">2,724,807</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-318">9,522,999</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">105</span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_154"></div><hr style="page-break-after:always"/><div style="min-height:21.6pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON plc</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.984%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows provided by operating activities:</span></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-319">791,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-320">612,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-321">505,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-322">488,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-323">585,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-324">569,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment of operating right-of-use assets and related property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="iclr:ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-325">15,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="iclr:ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-326">8,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="iclr:ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-327">28,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reduction in carrying value of operating right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-328">39,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-329">41,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-330">45,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="f-331">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-332">383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-333">3,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition-related gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount" format="ixt:fixed-zero" scale="3" id="f-334">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount" format="ixt:num-dot-decimal" scale="3" id="f-335">6,160</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount" format="ixt:fixed-zero" scale="3" id="f-336">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of financing costs and debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-337">23,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-338">16,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-339">17,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-340">45,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-341">55,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-342">70,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="f-343">100,542</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="f-344">85,403</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="f-345">124,985</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized foreign exchange movements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="f-346">6,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="f-347">19,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="f-348">13,009</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-349">31,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-350">24,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-351">11,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-352">349,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-353">83,296</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-354">420,695</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:num-dot-decimal" scale="3" id="f-355">339,921</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:num-dot-decimal" scale="3" id="f-356">4,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:num-dot-decimal" scale="3" id="f-357">332,592</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-358">37,743</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-359">134,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-360">192,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other net assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-361">28,157</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-362">168,403</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-363">10,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-364">1,286,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-365">1,161,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-366">563,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows used in investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-367">168,060</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-368">140,692</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-369">142,160</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of subsidiary undertakings (net of cash acquired)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="f-370">84,159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="f-371">71,766</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:fixed-zero" scale="3" id="f-372">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Movement of available for sale investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForProceedsFromShortTermInvestments" format="ixt:fixed-zero" scale="3" id="f-373">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PaymentsForProceedsFromShortTermInvestments" scale="3" id="f-374">241</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsForProceedsFromShortTermInvestments" scale="3" id="f-375">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from investments in equity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleOfLongtermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-376">2,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProceedsFromSaleOfLongtermInvestments" format="ixt:fixed-zero" scale="3" id="f-377">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromSaleOfLongtermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-378">1,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of investments in equity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireLongtermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-379">17,261</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PaymentsToAcquireLongtermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-380">13,954</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsToAcquireLongtermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-381">5,612</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-382">266,790</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-383">226,653</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-384">145,867</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows used in financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New Notes issue costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-385">12,679</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-386">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-387">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Drawdown of credit lines and loan facilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-388">2,317,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-389">370,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-390">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of credit lines and loan facilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-391">2,677,763</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-392">1,265,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-393">875,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from exercise of equity compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-394">36,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-395">50,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-396">35,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share issue costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="f-397">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="f-398">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="f-399">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of ordinary shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-400">499,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-401">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-402">99,983</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share repurchase costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="iclr:PaymentsForBrokerCommissionShareRepurchaseCosts" scale="3" id="f-403">388</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="iclr:PaymentsForBrokerCommissionShareRepurchaseCosts" format="ixt:fixed-zero" scale="3" id="f-404">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="iclr:PaymentsForBrokerCommissionShareRepurchaseCosts" scale="3" id="f-405">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-406">837,183</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-407">844,043</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-408">864,173</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate movements on cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-409">21,996</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-410">997</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-411">16,720</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net increase/(decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-412">160,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-413">89,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-414">463,445</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-415">378,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-416">288,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-417">752,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-418">538,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-419">378,102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-420">288,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">106</span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_157"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON plc</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_160"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="c-1" name="us-gaap:NatureOfOperations" id="f-421" continuedAt="f-421-1" escape="true">Description of Business </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-421-1"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc and its subsidiaries ("the Company" or "ICON") is a contract research organization ("CRO"), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process from compound selection to Phase I-IV clinical studies. Our mission is to improve the lives of patients by accelerating the development of our customers' drugs and devices through innovative solutions.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and have the operational flexibility to provide development serv</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ices on a stand-alone basis or as part of an integrated "full-service"  or a &#8220;blended-service&#8221; solution. At December&#160;31, 2024 we had approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="employee" contextRef="c-3" decimals="0" name="dei:EntityNumberOfEmployees" format="ixt:num-dot-decimal" scale="0" id="f-422">41,900</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> employees, in <ix:nonFraction unitRef="location" contextRef="c-3" decimals="INF" name="iclr:NumberOfLocations" scale="0" id="f-423">106</ix:nonFraction> locations in <ix:nonFraction unitRef="country" contextRef="c-3" decimals="INF" name="us-gaap:NumberOfCountriesInWhichEntityOperates" scale="0" id="f-424">55</ix:nonFraction> countries. During the year ended December&#160;31, 2024, we derived <ix:nonFraction unitRef="number" contextRef="c-43" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-425">36.0</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-44" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-426">52.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-45" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-427">11.4</ix:nonFraction>% of our revenue in the United States, Europe and Rest of World, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s ordinary shares are traded on the NASDAQ Global Select Market under the symbol &#8220;ICLR&#8221;.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We began operations in 1990 and have expanded our business through internal growth, together with a number of strategic acquisitions to enhance our capabilities and expertise in certain areas of the clinical development process. We are incorporated in Ireland and our principal executive office is located at: South County Business Park, Leopardstown, Dublin 18, Republic of Ireland. The contact telephone number of this office is +353 1 2912000.</span></div></ix:continuation><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_163"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-428" continuedAt="f-428-1" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-428-1" continuedAt="f-428-2"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accounting policies noted below were applied in the preparation of the accompanying financial statements of the Company and are in conformity with accounting principles generally accepted in the United States.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-429" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Basis of consolidation</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.</span></div></ix:nonNumeric><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-430" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition, intangible assets acquired in a business combination, goodwill impairment and income taxation.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="f-431" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Disclosure of fair value of financial instruments</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on the net present value of estimated future cash flows. Debt is measured at amortized cost.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial instruments are measured at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 1: Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 2: Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 3: Inputs are generally unobservable and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="f-428-2" continuedAt="f-428-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationsPolicy" id="f-432" continuedAt="f-432-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Business combinations</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Accounting for contingent consideration, after the acquisition, depends on the classification of the contingent consideration. Equity-classified contingent consideration is not remeasured after the acquisition date and subsequent settlement is accounted for within equity. Contingent consideration, which is classified as a liability or an asset, is remeasured to fair value at each reporting date until the contingency is resolved. The changes in fair value are recognized in earnings, unless the arrangement is a derivative which has been designated as a hedging instrument in a cash flow hedging relationship, in which case, the changes are initially recognized in other comprehensive income/loss.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and any contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="f-433" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Foreign currencies and translation of subsidiaries</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's financial statements are prepared in United States dollars. The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income/loss. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Transactions in currencies other than the functional currency of the subsidiaries of the Company are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the subsidiaries of the Company are translated into the functional currency of that entity at exchange rates prevailing at the balance sheet date. Adjustments resulting from these translations are charged or credited to income. Foreign currency gains and losses on intercompany transactions classified as long-term investments are reported in other comprehensive income/loss as currency translation adjustments. <ix:nonNumeric contextRef="c-1" name="iclr:ForeignCurrencyDisclosureTableTextBlock" id="f-434" continuedAt="f-434-1" escape="true">Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022 were as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-434-1"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts (credited) / charged</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-435">18,085</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-436">12,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-437">25,997</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-438" continuedAt="f-438-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Clinical trial service revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-438-1"><ix:continuation id="f-428-3" continuedAt="f-428-4"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through / reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Laboratory services revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.    </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contracting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Consulting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Data services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the &#8220;units delivered&#8221; output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Commissions</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.</span></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-428-4" continuedAt="f-428-5"><ix:nonNumeric contextRef="c-1" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="f-439" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Reimbursable expenses</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. The Company includes reimbursed expenses in revenue and direct costs as the Company is primarily responsible for fulfilling the promise to provide the specified service, including integration of the related services into a combined output to the customer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Direct costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. Payments are made based on predetermined contractual arrangements. Timing of payments may differ from the timing of the expense.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-440" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Cash and cash equivalents</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentPolicyTextBlock" id="f-441" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Investments in debt, equity and other</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Available for sale investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies short-term investments as available for sale. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity.  Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses. Realized gains and losses are determined using specific identification.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Long term investments  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2024 and December&#160;31, 2023 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2024 and December&#160;31, 2023 qualify for the Net Asset Value ("NAV") practical expedient in ASC Topic 820, Fair value Measurements ("ASC 820"). Any increases or decreases in fair value are recognized in earnings in the period. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Investments in equity </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">which do not qualify for the NAV practical expedient are measured at cost, less impa</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">irment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Equity method investments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s investments that are not consolidated are accounted for under the equity method if the Company  exercises significant influence. These investments are classified as equity method investments on the Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of losses in equity investments in the Consolidated Statement of Operations. The Company reviews equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-428-5" continuedAt="f-428-6"><ix:nonNumeric contextRef="c-1" name="us-gaap:ReceivablesPolicyTextBlock" id="f-442" continuedAt="f-442-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Accounts receivable, net and unbilled revenue</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the   Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accounts receivable early payment discounting</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:continuation id="f-442-1" continuedAt="f-442-2"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing </span></ix:continuation><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-442-2">("ASC 860"). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-443" continuedAt="f-443-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Property, plant and equipment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, plant and equipment is stated at cost less accumulated depreciation. <ix:nonNumeric contextRef="c-1" name="iclr:ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" id="f-444" continuedAt="f-444-1" escape="true">Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;</ix:nonNumeric></span></div><ix:continuation id="f-444-1"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings &#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-46" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-445">40</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-47" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-446">2</ix:nonNumeric> - <ix:nonNumeric contextRef="c-48" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-447">8</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-49" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-448">8</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment &#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-50" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-449">5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-51" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-450">5</ix:nonNumeric> years</span></td></tr></table></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-443-1">Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter.</ix:continuation> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-451" continuedAt="f-451-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception and reassess if there are changes in terms and conditions of the contract. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December&#160;31, 2024 and December&#160;31, 2023, the Company did not account for any leases as finance leases. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Operating leases are included in operating right-of-use ("ROU") assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at the lease commencement date. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Subleases are accounted for as operating leases separately from the lease they relate to, but similar in manner as all other leases.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-428-6" continuedAt="f-428-7"><ix:continuation id="f-451-1"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ROU assets for operating leases are occasionally reduced by impairment losses. The Company uses the long-lived assets impairment guidance in ASC Subtopic 360-10, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant, and  Equipment &#8211; Overall</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="f-452" escape="true"><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Intangible assets</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are measured at fair value at the date of acquisition and amortized on a straight-line basis over their respective estimated useful lives. The Company has no indefinite-lived intangible assets. The Company evaluates its intangible assets for impairment when indicators of impairment exist. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are amortized on a straight-line basis over their estimated useful lives, as set forth in the table below:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="f-453" continuedAt="f-453-1" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-52" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-454">8</ix:nonNumeric> - <ix:nonNumeric contextRef="c-53" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-455">23</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-54" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-456">3</ix:nonNumeric> - <ix:nonNumeric contextRef="c-55" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-457">5</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-56" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-458">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-57" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-459">7</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-58" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-460">5</ix:nonNumeric> years</span></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company periodically assesses the estimated useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.</span></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" id="f-461" escape="true"><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Impairment of goodwill and long-lived assets</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill is tested for impairment annually, or more frequently, if an event or circumstance indicates that an impairment loss may have been incurred.  The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also chose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Fair value is determined through various valuation techniques including discounted cash flow models and third-party independent appraisals, as considered necessary. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DebtPolicyTextBlock" id="f-462" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Debt issuance costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Debt issuance costs relating to the Company&#8217;s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company&#8217;s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativesPolicyTextBlock" id="f-463" continuedAt="f-463-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Derivative financial instruments</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has used derivative financial instruments to reduce exposures to interest rates. Derivatives are recorded on the Consolidated Balance Sheet at fair value at each balance sheet date utilizing pricing models for non-exchange-traded contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criteria for designating a derivative as a hedge include the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income and reclassify it </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-428-7" continuedAt="f-428-8"><ix:continuation id="f-463-1"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-464" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Income taxes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the provision of income taxes in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of Global Intangible Low-Taxed Income ("GILTI") in the period it arises and has therefore not provided for deferred taxes in respect of this item.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="iclr:GovernmentGrantsPolicyTextBlock" id="f-465" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Government grants</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the grant agreements, amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="iclr:ResearchAndDevelopmentCreditsPolicyTextBlock" id="f-466" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Research and development credits</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits may be recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-467" continuedAt="f-467-1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Share-based compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC Topic 718, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Compensation &#8211; Stock Compensation </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">("ASC 718")</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Replacement awards</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-428-8"><ix:continuation id="f-467-1"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.</span></div></ix:continuation><div><span><br/></span></div><ix:continuation id="f-432-1"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Transaction and integration-related expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Transaction and integration-related expenses are the incremental costs directly attributable to completion and integration activities associated with the Company&#8217;s recent acquisitions. The costs consist of investment banking fees, advisory costs, professional fees, legal costs, retention agreements with employees, and ongoing integration activities offset by the remeasurement of liability-classified contingent consideration. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" id="f-468" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Restructuring</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Restructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company&#8217;s structure and facilitate improved long-term performance. Asset related impairment charges are taken when the fair value is less than the asset&#8217;s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-469" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Net income per ordinary share</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-470" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Impact of Recently Issued or Adopted Accounting Standards</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accounting pronouncements recently adopted</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-07, Segment Reporting &#8211; Improvements to Reportable Segment Disclosures (&#8220;ASU 2023-07&#8221;), which amends the guidance in ASC Topic 280, Segment Reporting (&#8220;Topic 280&#8221;). The amended guidance requires disclosure of significant segment expenses and other segment items on an annual and interim basis, as well as additional qualitative disclosures. Furthermore, all disclosures about a reportable segment&#8217;s profit or loss, which are currently required annually, will be mandated for interim periods. The Company adopted ASU 2023-07 effective January 1, 2024, which resulted in additional segment reporting related disclosures. Refer to note </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business Segment and Geographical Information</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:107%">Accounting pronouncements issued but not adopted as of December&#160;31, 2024</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following accounting pronouncements have been issued, but not yet adopted, as of December&#160;31, 2024:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, which requires disaggregated information about an entity&#8217;s effective tax rate reconciliation and additional discloses on income taxes paid. The new requirements are effective for annual periods beginning after December 15, 2024. The guidance is to be applied prospectively, with an option for retrospective application. The Company is currently evaluating the impact of this new guidance on disclosures within its consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which requires disaggregated disclosure of income statement expenses. The new standard requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement, as well as disclosures about selling expenses. The new requirements are effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Requirements are to be applied prospectively, with an option for retrospective application. The Company is currently evaluating the impact of this new guidance on disclosures within its consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">114</span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_166"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="f-471" continuedAt="f-471-1" escape="true">Disaggregation of Revenue</ix:nonNumeric></span></div><ix:continuation id="f-471-1" continuedAt="f-471-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-472" escape="true"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue disaggregated by customer concentration is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Top client</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-473">639,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-474">721,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-475">683,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 2-5</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-476">1,431,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-477">1,453,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-478">1,506,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 6-10</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-479">1,306,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-480">1,188,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-481">1,112,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 11-25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-482">1,774,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-483">1,743,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-484">1,585,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-485">3,129,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-486">3,012,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-487">2,853,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-488">8,281,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-489">8,120,176</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-490">7,741,386</ix:nonFraction></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There was no revenue from individual customers greater than 10% of consolidated revenue in the respective years. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our customers have similar profiles and economic characteristics, and therefore have similar degrees of risk and growth opportunities.  </span></div></ix:continuation><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_169"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">4. Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)</span></div><div><span><br/></span></div><ix:continuation id="f-471-2" continuedAt="f-471-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="f-491" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Billed services (accounts receivable)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:BilledContractReceivables" format="ixt:num-dot-decimal" scale="3" id="f-492">1,437,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:BilledContractReceivables" format="ixt:num-dot-decimal" scale="3" id="f-493">1,821,855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses (note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-494">35,664</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-495">31,533</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable (net)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:ContractsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="f-496">1,401,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="iclr:ContractsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="f-497">1,790,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="f-498">1,286,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="f-499">951,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:ContractsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="f-500">2,688,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="iclr:ContractsReceivableNet" format="ixt:num-dot-decimal" scale="3" id="f-501">2,742,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:47.420%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.773%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="12" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="f-502">1,286,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="f-503">951,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="iclr:IncreaseDecreaseInContractWithCustomerAssetGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="f-504">334,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="iclr:IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent" scale="-2" id="f-505">35.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (payments on account)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-506">1,614,758</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-507">1,654,507</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-508">39,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="iclr:IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" scale="-2" id="f-509">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-510">328,484</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-511">702,571</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="iclr:ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-512">374,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" scale="-2" id="f-513">53.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled revenue and therefore contract assets rather than accounts receivable when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right of set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Consolidated Balance Sheet.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support a clinical trial. The progress towards completion for clinical service contracts is measured </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-471-3" continuedAt="f-471-4"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">based on total project costs (including reimbursable costs). Amounts owed to investigators and others in respect of reimbursable expenses at December&#160;31, 2024 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and December&#160;31, 2023 were $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" format="ixt:num-dot-decimal" scale="6" id="f-514">369.2</ix:nonFraction>&#160;million </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" format="ixt:num-dot-decimal" scale="6" id="f-515">333.0</ix:nonFraction>&#160;million (see note 12. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other liabilities</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services as at December&#160;31, 2024 increased by $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="iclr:IncreaseDecreaseInContractWithCustomerAssetGrossCurrent" scale="6" id="f-516">334.3</ix:nonFraction> million as compared to December&#160;31, 2023. Unearned revenue decreased by $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" scale="6" id="f-517">39.7</ix:nonFraction> million over the same period resulting in a decrease of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="iclr:ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable" scale="6" id="f-518">374.1</ix:nonFraction> million in the net balance of unbilled services and unearned revenue or payments on account between December&#160;31, 2023 and December&#160;31, 2024. These fluctuations are primarily due to the timing of payments and invoicing related to the Company's clinical trial management contracts. Billings and payments are established by contractual provisions on the delivery of units/milestones including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contracts when a cost-based input method of revenue recognition is applied and revenue recognized e</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">xceeds the amount billed to the customer. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The credit loss expense recognized on the Company's receivables and unbilled services was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" format="ixt:num-dot-decimal" scale="6" id="f-519">28.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" format="ixt:num-dot-decimal" scale="6" id="f-520">24.6</ix:nonFraction>&#160;million for the years ended December&#160;31, 2024 and 2023, respectively.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:continuation id="f-471-4" continuedAt="f-471-5"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-8" name="us-gaap:RevenueRemainingPerformanceObligation" scale="9" id="f-521">15.9</ix:nonFraction> billion (December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-8" name="us-gaap:RevenueRemainingPerformanceObligation" scale="9" id="f-522">14.8</ix:nonFraction> billion) of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations. The Company expects to recognize revenue on approximately <ix:nonFraction unitRef="number" contextRef="c-74" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="f-523">47</ix:nonFraction>% of the u</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">nsatisfied performance obligation over the next <ix:nonNumeric contextRef="c-75" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durwordsen" id="f-524"><ix:nonNumeric contextRef="c-74" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durwordsen" id="f-525">twelve months</ix:nonNumeric></ix:nonNumeric> (December&#160;31, 2023:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonFraction unitRef="number" contextRef="c-75" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="f-526">52</ix:nonFraction>%)</span></ix:continuation><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-471-5">, with the remainder recognized thereafter over the duration of the customer contracts.</ix:continuation>  </span></div><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_172"></div><div style="margin-bottom:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="c-1" name="us-gaap:AllowanceForCreditLossesTextBlock" id="f-527" continuedAt="f-527-1" escape="true">Allowance for Credit Losses</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="f-528" escape="true"><ix:continuation id="f-527-1"><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company does business with most major international pharmaceutical companies. Provision for credit losses at December&#160;31, 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and December&#160;31, 2023 comprises:</span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-529">31,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-530">20,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts used during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" format="ixt:num-dot-decimal" scale="3" id="f-531">24,887</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" format="ixt:num-dot-decimal" scale="3" id="f-532">13,358</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts provided during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="iclr:AccountsReceivableCreditLossExpense" format="ixt:num-dot-decimal" scale="3" id="f-533">28,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="iclr:AccountsReceivableCreditLossExpense" format="ixt:num-dot-decimal" scale="3" id="f-534">24,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" scale="3" id="f-535">601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" scale="3" id="f-536">221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-537">35,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-538">31,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">116</span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_175"></div><hr style="page-break-after:always"/><div style="background-color:#ffffff"><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="f-539" continuedAt="f-539-1" escape="true">Business Combinations</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-539-1" continuedAt="f-539-2"><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">KCR S.A. Group Acquisition</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On August 19, 2024, the Company acquired the KCR S.A. Group ("KCR"), a CRO offering full service and functional services partnership ("FSP") clinical trial services, in exchange for consideration of $<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="f-540">92.5</ix:nonFraction>&#160;million. The acquisition of KCR has been accounted for as a business combination in accordance with ASC 805 'Business Combinations' ('ASC 805'). </span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The net cash outflow was $<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="f-541">76.4</ix:nonFraction>&#160;million comprising cash payments of $<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="f-542">88.1</ix:nonFraction>&#160;million, net of cash acquired of $<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:CashAcquiredFromAcquisition" format="ixt:num-dot-decimal" scale="6" id="f-543">11.7</ix:nonFraction>&#160;million. The fair value of contingent consideration was initially measured at the date of acquisition at $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:BusinessCombinationAssetsArisingFromContingenciesAmountRecognized" format="ixt:num-dot-decimal" scale="6" id="f-544">4.3</ix:nonFraction>&#160;million and subsequently remeasured at $<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" name="us-gaap:BusinessCombinationAssetsArisingFromContingenciesAmountRecognized" format="ixt:num-dot-decimal" scale="6" id="f-545">1.1</ix:nonFraction>&#160;million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The final purchase price allocation resulted in the recognition of goodwill of $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-546">43.4</ix:nonFraction>&#160;million and intangible assets of $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="f-547">45.1</ix:nonFraction>&#160;million. Goodwill arising in connection with the acquisition is primarily attributable to the assembled workforce of KCR and the expected synergies of the acquisition. The goodwill recognized is not deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Since August 19, 2024, KCR has earned revenue of $<ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" format="ixt:num-dot-decimal" scale="6" id="f-548">32.8</ix:nonFraction>&#160;million and net income of $<ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" format="ixt:num-dot-decimal" scale="6" id="f-549">1.8</ix:nonFraction>&#160;million which are included in the Group's Consolidated Statement of Operations for the year ended December 31, 2024. The pro-forma effect of the KCR acquisition if completed on January 1, 2023 would have resulted in revenue and net income for the fiscal year ended December 31, 2024 of $<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="6" id="f-550">8,331.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-551">792.5</ix:nonFraction>&#160;million respectively and in revenue and net income for the fiscal year ended December 31, 2023 of $<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="6" id="f-552">8,202.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="f-553">613.3</ix:nonFraction>&#160;million respectively.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">HumanFirst Inc.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 9, 2024, the Company acquired HumanFirst Inc. ("HumanFirst"), a life sciences technology company in exchange for consideration of $<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="f-554">13.3</ix:nonFraction>&#160;million. The acquisition of HumanFirst has been accounted for as a business combination in accordance with ASC 805. </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The net cash outflow was $<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="f-555">7.8</ix:nonFraction>&#160;million comprising initial cash payments of $<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="f-556">11.8</ix:nonFraction>&#160;million, net of cash acquired of $<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" name="us-gaap:CashAcquiredFromAcquisition" format="ixt:num-dot-decimal" scale="6" id="f-557">4.0</ix:nonFraction>&#160;million. Deferred consideration of $<ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-558">1.4</ix:nonFraction>&#160;million remains unpaid as of December&#160;31, 2024. </span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The final purchase price allocation resulted in the recognition of goodwill of $<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-559">2.7</ix:nonFraction>&#160;million and a developed technology intangible asset of $<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="f-560">9.9</ix:nonFraction>&#160;million. Goodwill arising in connection with the acquisition is primarily attributable to the assembled workforce of HumanFirst. The goodwill recognized is not deductible for income tax purposes.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">BioTel Research LLC Acquisition</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On October 2, 2023, the Company acquired the entire outstanding equity interests of BioTel Research LLC (&#8220;BioTel&#8221;), a leading provider of medical imaging and cardiac safety monitoring services, from BioTelemetry Inc. in exchange for initial cash consideration of $<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="f-561">68.1</ix:nonFraction> million. Cash acquired amounted to $<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-5" name="us-gaap:CashAcquiredFromAcquisition" format="ixt:num-dot-decimal" scale="6" id="f-562">1.4</ix:nonFraction>&#160;million. The final purchase price allocation resulted in the recognition of intangible assets of $<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="f-563">36.4</ix:nonFraction> million and goodwill of $<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-564">23.4</ix:nonFraction> million. Goodwill arising in connection with the acquisition is primarily attributable to the assembled workforce of BioTel and the expected synergies of the acquisition. The goodwill recognized is deductible for income tax purposes.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">PRA Health Sciences, Inc. Acquisition</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021 (the "Merger Date"), the Company completed the acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of PRA Health Sciences ("the Acquisition" and "the Merger"). The Merger was accounted for as a business combination using the acquisition method of accounting in accordance with ASC 805.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022, the Company incurred approximately $<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="us-gaap:InterestExpenseNonoperating" scale="6" id="f-565">23.5</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-5" name="us-gaap:InterestExpenseNonoperating" scale="6" id="f-566">16.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-5" name="us-gaap:InterestExpenseNonoperating" scale="6" id="f-567">17.7</ix:nonFraction> million of Merger-related financing fees which are included in the &#8220;Interest expense&#8221; line item in the Consolidated Statement of Operations. </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Oncacare Limited Acquisition</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 20, 2023, the Company completed the purchase of the majority investor's <ix:nonFraction unitRef="number" contextRef="c-90" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-568">51</ix:nonFraction>% majority voting share capital of Oncacare Limited ("Oncacare") for $<ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="f-569">5.1</ix:nonFraction>&#160;million, such that Oncacare and its subsidiaries became wholly-owned subsidiaries of the ICON Group. The Oncacare acquisition resulted in goodwill of $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-570">13.4</ix:nonFraction> million and also gave rise to an acquisition-related gain of $<ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" name="us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount" scale="6" id="f-571">6.2</ix:nonFraction> million. </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Transaction and Integration Costs</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the years ended December&#160;31, 2024, December&#160;31, 2023, and  December&#160;31, 2022, the Company incurred net Merger, transaction and integration related expenses of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="f-572">29.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="f-573">44.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="f-574">39.7</ix:nonFraction> million, respectively, which were accounted for separately from the business combination and expensed as incurred within the &#8220;Transaction and integration related&#8221; line item of the Consolidated Statement of Operations. The costs consist of investment banking fees, advisory costs, </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">117</span></div></div></div></div><hr style="page-break-after:always"/><div style="background-color:#ffffff"><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-539-2">professional fees, legal costs, retention agreements with employees, ongoing business combination and integration activities offset by the remeasurement of liability-classified contingent consideration.</ix:continuation> </span></div><div id="i70380bb88cac48169f2186a4a94094c5_178"></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-575" continuedAt="f-575-1" escape="true">Fair Value</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-575-1" continuedAt="f-575-2"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company records certain assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy that prioritizes the inputs used to measure fair value is described below. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 1 &#8212; Quoted prices in active markets for identical assets or liabilities.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 2 &#8212; Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 3 &#8212; Unobservable inputs that are supported by little or no market activity. This includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable and accounts payable approximate fair value due to the short maturities of these instruments.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, t<ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="f-577" continuedAt="f-577-1" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" id="f-576" continuedAt="f-576-1" escape="true">he fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:</ix:nonNumeric></ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-577-1" continuedAt="f-577-2"><ix:continuation id="f-576-1" continuedAt="f-576-2"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1,2</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" format="ixt:fixed-zero" scale="3" id="f-578">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-3" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" format="ixt:fixed-zero" scale="3" id="f-579">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" format="ixt:fixed-zero" scale="3" id="f-580">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-3" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" format="ixt:num-dot-decimal" scale="3" id="f-581">54,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" format="ixt:num-dot-decimal" scale="3" id="f-582">54,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-583">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-584">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-585">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-586">54,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-587">54,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">1</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Excludes investments in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">equity securities recorded at cost of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCost" scale="6" id="f-588">3.5</ix:nonFraction> million which do not qualify for the NAV practical expedient.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> As at December&#160;31, 2023, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">3</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-589">1,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="f-590">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="f-591">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="f-592">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-593">1,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" format="ixt:fixed-zero" scale="3" id="f-594">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" format="ixt:fixed-zero" scale="3" id="f-595">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" format="ixt:fixed-zero" scale="3" id="f-596">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" format="ixt:num-dot-decimal" scale="3" id="f-597">46,804</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" format="ixt:num-dot-decimal" scale="3" id="f-598">46,804</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-599">1,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-600">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-601">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-602">46,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-603">48,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="f-604">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-605">2,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="f-606">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="f-607">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-608">2,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-609">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-610">2,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-611">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-612">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-613">2,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">2</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Certain investments qualify for the NAV practical expedient in ASC 820. Investments in equity consist of interests in funds and equity securities without readily determinable fair values. To determine the classification of investments in equity, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2024 and December&#160;31, 2023 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2024 and December&#160;31, 2023 qualify for the NAV practical expedient. Any increases or decreases in fair value are recognized in net income in the period. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">3</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents the fair value of highly liquid investments with maturities greater than three months, a minimum "A-" rated fixed term deposit and are based on quoted market prices.</span></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="f-577-2" continuedAt="f-577-3"><ix:continuation id="f-576-2" continuedAt="f-576-3"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">4</span></ix:continuation></ix:continuation><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-577-3"><ix:continuation id="f-576-3">Represents the fair value of the interest rate caps and the interest rate swap.</ix:continuation></ix:continuation> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">118</span></div></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-575-2"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Non-recurring Fair Value Measurements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain assets and liabilities are carried on the Consolidated Balance Sheet at cost and are not re-measured to fair value on a recurring basis. These assets include finite-lived intangible assets that are tested for impairment when a triggering event occurs and goodwill that is tested for impairment annually or when a triggering event occurs. As of December&#160;31, 2024, assets carried on the balance sheet and not re-measured to fair value on a recurring basis totaled approximately $<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-614">12,614.7</ix:nonFraction> million (December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-615">12,878.0</ix:nonFraction> million) and are identified as Level 3 assets. These assets are comprised of goodwill of $<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:GoodwillFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-616">9,051.4</ix:nonFraction> million (December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:GoodwillFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-617">9,022.1</ix:nonFraction> million), intangible assets of $<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-618">3,559.8</ix:nonFraction> million (December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-619">3,855.9</ix:nonFraction> million) and investments in equity recorded at cost of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCost" scale="6" id="f-620">3.5</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s debt was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-621">3,469.2</ix:nonFraction>&#160;million at December&#160;31, 2024 (December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-622">3,793.5</ix:nonFraction>&#160;million). </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of the senior secured term loan facility</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, the 2026 Notes and the New Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions. The fair value of the senior secured revolving loan facility approximates its carrying value, due to the short term duration.</span></div></ix:continuation><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_181"></div><div style="margin-top:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="f-623" continuedAt="f-623-1" escape="true">Investments</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-623-1"><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Investments in equity</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company entered into subscription agreements with a number of funds. During the year ended December&#160;31, 2024, net capital totaling $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="f-624">13.1</ix:nonFraction> million (December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="f-625">14.0</ix:nonFraction> million) had been advanced under the terms of the subscription agreements. The Company determined that the interest in funds meets the definition of equity securities without readily determinable fair values. The Company therefore concluded that the interests held at December&#160;31, 2024 and December&#160;31, 2023 qualify for the NAV practical expedient in ASC 820. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There was a decrease in fair value of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" scale="6" id="f-626">3.3</ix:nonFraction> million (December&#160;31, 2023: increase in fair value $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" scale="6" id="f-627">0.2</ix:nonFraction> million) recognized in net income during the year bringing the carrying value of the subscriptions to $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="f-628">54.4</ix:nonFraction> million at December&#160;31, 2024.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2024, the Company had committed to future investments of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="iclr:CommitmentToAcquireLongTermInvestments" scale="6" id="f-629">102.2</ix:nonFraction> million in respect of these funds.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Investments in equity also include equity investments of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EquitySecuritiesFvNiCost" scale="6" id="f-630">3.5</ix:nonFraction> million </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(of which </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquireEquitySecuritiesFvNi" scale="6" id="f-631">1.5</ix:nonFraction> million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> was invested during the year ended December&#160;31, 2024) which do not qualify for the NAV practical expedient, and for which the measurement alternative has been applied.  Accordingly, these investments in equity are measured at cost, less impa</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">irment.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Available for sale investments </span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As at December&#160;31, 2024, the Company held available for sale investments amounting to $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="6" id="f-632">nil</ix:nonFraction> (December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="f-633">2.0</ix:nonFraction> million). Short-term investments comprise highly liquid investments with maturities of greater than three months and minimum "A-" rated fixed term deposits. The Company classifies its short- term investments as available for sale.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">119</span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_187"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="f-634" continuedAt="f-634-1" escape="true">Property, Plant and Equipment, net</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-634-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-635" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Property, Plant and Equipment for the years ended December&#160;31, 2024 and 2023 is as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="f-636">3,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="f-637">3,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="f-638">66,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="f-639">70,072</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CapitalizedComputerSoftwareGross" format="ixt:num-dot-decimal" scale="3" id="f-640">689,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CapitalizedComputerSoftwareGross" format="ixt:num-dot-decimal" scale="3" id="f-641">550,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="3" id="f-642">51,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="3" id="f-643">45,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-644">55,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-645">56,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LeaseholdImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="f-646">62,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LeaseholdImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="f-647">55,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:VehiclesGross" scale="3" id="f-648">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="iclr:VehiclesGross" scale="3" id="f-649">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-650">928,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-651">781,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated depreciation and asset write offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-652">546,015</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-653">419,883</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment (net)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-654">382,879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-655">361,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The depreciation expense recognized by the Company</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-656">138.2</ix:nonFraction> million, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">$<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-657">126.1</ix:nonFraction> million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-658">106.4</ix:nonFraction> million for the years ended December&#160;31, 2024, 2023, and 2022, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company regularly updates its register of property, plant and equipment and during the year ended December&#160;31, 2024 and the year ended December&#160;31, 2023, certain fully depreciated assets were written off as they were no longer used by the Company.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_190"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillDisclosureTextBlock" id="f-659" continuedAt="f-659-1" escape="true">Goodwill</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-659-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfGoodwillTextBlock" id="f-660" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in the carrying amount of goodwill for the years ended December&#160;31, 2024 and 2023 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-661">9,022,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-662">8,971,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current period acquisitions (note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-663">46,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-664">36,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange movement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-665">16,791</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-666">13,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-667">9,051,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-668">9,022,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">There were <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-669"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-670">no</ix:nonFraction></ix:nonFraction> impairment charges for the y</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">ear ended December&#160;31, 2024 or the year ended December&#160;31, 2023.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">120</span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_193"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="c-1" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="f-671" continuedAt="f-671-1" escape="true">Intangible Assets</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-671-1"><ix:continuation id="f-453-1"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Intangible Assets for the years ended December&#160;31, 2024 and 2023 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-672">4,129,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-673">4,090,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-674">543,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-675">541,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names &amp; brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-676">204,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-677">204,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-678">170,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-679">170,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-680">150,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-681">141,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-682">5,199,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-683">5,147,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-684">1,639,212</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-685">1,292,106</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net book value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-686">3,559,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-687">3,855,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The amortization expense recognized by the Company</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> was </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-688">350.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-689">459.9</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-690">463.1</ix:nonFraction> million for the years ended December&#160;31, 2024, 2023, and 2022, respe</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">ctively. The decrease in amortization in the twelve months ended December&#160;31, 2024 is due to the order backlog and trade name intangible assets recognized in connection with the PRA merger amounting to </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">$<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="iclr:DecreaseInAmortisation" scale="6" id="f-691">500.0</ix:nonFraction> million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> and </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">$<ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="iclr:DecreaseInAmortisation" scale="6" id="f-692">202.0</ix:nonFraction> million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> respectively as of the date of acquisition, becoming fully amortized on July 1, 2024.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On August 19, 2024, the Company acquired KCR. The acquisition resulted in the recognition of intangible assets of $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="f-693">45.1</ix:nonFraction> million, comprising customer relationships of $<ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="f-694">41.4</ix:nonFraction> million and order backlog of $<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="f-695">3.7</ix:nonFraction> million. These assets will be amortized over their expected useful lives of <ix:nonNumeric contextRef="c-118" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-696">13</ix:nonNumeric> years and <ix:nonNumeric contextRef="c-119" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-697">5</ix:nonNumeric> years respectively. In total, $<ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-698">1.3</ix:nonFraction> million has been amortized in the period since the date of acquisition.  Refer to note 6. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Business Combinations</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On January 9, 2024, the Company acquired HumanFirst. The acquisition resulted in the recognition of a developed technology intangible asset of $<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="f-699">9.9</ix:nonFraction> million which will be amortized over its expected useful life of <ix:nonNumeric contextRef="c-84" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-700">5</ix:nonNumeric> years. In total, $<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-701">2.0</ix:nonFraction> million has been amortized in the period since the date of acquisition. Refer to note 6. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Business Combinations</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On October 2, 2023, the Co</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">mpany acquired BioTel Research LLC (&#8220;BioTel&#8221;). The acquisition resulted in the recognition of intangible assets of $<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="f-702">36.4</ix:nonFraction> million, comprising customer relationships of $<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="f-703">12.5</ix:nonFraction> million, order backlog of $<ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="f-704">3.9</ix:nonFraction> million and developed technology assets of $<ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="f-705">20.0</ix:nonFraction> million. These assets will be amortized over their expected useful lives of between <ix:nonNumeric contextRef="c-124" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-706">3</ix:nonNumeric> years and <ix:nonNumeric contextRef="c-125" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-707">16</ix:nonNumeric> years. $<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-708">6.1</ix:nonFraction> million has been amortized during the twelve months ended December&#160;31, 2024 (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">December&#160;31, 2023: </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-709">1.5</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">)</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">. Refer to note 6. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Business Combinations</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="f-710" escape="true"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future intangible asset amortization expense for the years ended December 31, 2025 to December 31, 2029 is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-711">235,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-712">220,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="f-713">208,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="f-714">195,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="f-715">180,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:FiniteLivedIntangibleAssetsAmortizationExpenseNet" format="ixt:num-dot-decimal" scale="3" id="f-716">1,039,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">121</span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_196"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="c-1" name="us-gaap:OtherLiabilitiesDisclosureTextBlock" id="f-717" continuedAt="f-717-1" escape="true">Other Liabilities</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:OtherLiabilitiesTableTextBlock" id="f-718" escape="true"><ix:continuation id="f-717-1"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Other Liabilities for the years ended December&#160;31, 2024 and 2023 is as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General trade and overhead liabilities*</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherSundryLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-719">531,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherSundryLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-720">463,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Personnel related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-721">225,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-722">385,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-723">36,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-724">36,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedUtilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-725">8,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedUtilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-726">11,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-727">Other liabilities</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-728">91,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-729">13,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:RestructuringReserveAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-730">29,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="iclr:RestructuringReserveAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-731">4,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short term government grants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:GovernmentAssistanceLiabilityCurrent" scale="3" id="f-732">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:GovernmentAssistanceLiabilityCurrent" scale="3" id="f-733">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-734">923,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-735">915,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*includes amounts due to third parties in respect of accrued reimbursable investigator expenses of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" scale="6" id="f-736">369.2</ix:nonFraction> million at December&#160;31, 2024 and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" scale="6" id="f-737">333.0</ix:nonFraction> million at December&#160;31, 2023.</span></div></ix:continuation></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_199"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="c-1" name="us-gaap:LongTermDebtTextBlock" id="f-738" continuedAt="f-738-1" escape="true">Bank credit lines, loan facilities and notes</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-738-1" continuedAt="f-738-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="f-739" continuedAt="f-739-1" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company had the following debt outstanding as of December&#160;31, 2024 and </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate as of</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal amount as of</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-128" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-740">6.329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-129" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-741">7.860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-742">946,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-743">3,251,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes (the "2026 Notes")</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-130" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-744">2.875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-131" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-745">2.875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-746">500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-747">500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Revolving Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-132" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" format="ixt:fixed-zero" scale="-2" id="f-748">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-133" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-749">6.720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-750">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-751">55,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes (the "2027 Notes")*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-136" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-752">5.809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-137" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" format="ixt:fixed-zero" scale="3" id="f-753">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-754">750,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-755">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes (the "2029 Notes")*</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-138" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-756">5.849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-139" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" format="ixt:fixed-zero" scale="3" id="f-757">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-758">750,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-759">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes (the "2034 Notes")*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2034</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-140" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-760">6.000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-141" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" format="ixt:fixed-zero" scale="3" id="f-761">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-762">500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-763">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-764">3,446,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-765">3,806,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less current portion of debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:LongTermDebtCurrentMaturitiesGross" format="ixt:num-dot-decimal" scale="3" id="f-766">29,762</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="iclr:LongTermDebtCurrentMaturitiesGross" format="ixt:num-dot-decimal" scale="3" id="f-767">110,150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:LongTermDebtExcludingCurrentMaturitiesGross" format="ixt:num-dot-decimal" scale="3" id="f-768">3,416,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="iclr:LongTermDebtExcludingCurrentMaturitiesGross" format="ixt:num-dot-decimal" scale="3" id="f-769">3,696,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less debt issuance costs and debt discount</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="f-770">20,290</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="f-771">30,624</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-772">3,396,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-773">3,665,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*Issued May 8, 2024</span></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company incurred interest costs from various financing arrangements during the years ended December&#160;31, 2024,  December&#160;31, 2023 and December&#160;31, 2022 as set out in the table below. These costs have been charged in the interest expense line of the Consolidated Statement of Operations. In the years ending December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022, the Company expensed $<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="us-gaap:InterestExpenseNonoperating" scale="6" id="f-774">23.5</ix:nonFraction> million,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-5" name="us-gaap:InterestExpenseNonoperating" scale="6" id="f-775">16.4</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-5" name="us-gaap:InterestExpenseNonoperating" scale="6" id="f-776">17.7</ix:nonFraction> million of transaction related financing costs, inclusive of the amortization of financing fees which were previously capitalized. </span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-738-2" continuedAt="f-738-3"><ix:nonNumeric contextRef="c-1" name="iclr:DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" id="f-777" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense on drawn facilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="f-778">206,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="f-779">311,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="f-780">209,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of merger related financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-781">23,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-782">16,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-783">17,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing costs*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="iclr:InterestExpenseCreditOther" format="ixt:num-dot-decimal" scale="3" id="f-784">7,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="iclr:InterestExpenseCreditOther" format="ixt:num-dot-decimal" scale="3" id="f-785">9,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="iclr:InterestExpenseCreditOther" format="ixt:num-dot-decimal" scale="3" id="f-786">2,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total financing costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-787">237,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-788">336,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-789">229,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*Includes costs associated with the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">senior secured revolving loan facility.</span></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="f-790" escape="true"><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the contractual maturities of the Company's debt obligations were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturities of debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-791">29,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-792">529,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="f-793">779,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="f-794">857,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2029 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:LongTermDebtMaturityYearFiveAndThereafter" format="ixt:num-dot-decimal" scale="3" id="f-795">1,250,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-796">3,446,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's primary financing arrangements are its senior secured credit facilities (the "Senior Secured Credit Facilities"), which consists of a senior secured term loan and a revolving credit facility; the 2026 Notes and the New Notes.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The New Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 8, 2024, ICON Investments Six Designated Activity Company (the "Issuer"), a wholly-owned subsidiary of ICON plc, issued $<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-9" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="f-797">2</ix:nonFraction>&#160;billion senior secured notes ("the New Notes"). The New Notes were issued in aggregate principal amounts of: $<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-798">750</ix:nonFraction>&#160;million <ix:nonFraction unitRef="number" contextRef="c-143" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-799">5.809</ix:nonFraction>% Senior Secured Notes due 2027 (the "2027 Notes"), $<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-800">750</ix:nonFraction>&#160;million <ix:nonFraction unitRef="number" contextRef="c-144" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-801">5.849</ix:nonFraction>% Senior Secured Notes due 2029 (the "2029 Notes") and $<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-802">500</ix:nonFraction>&#160;million <ix:nonFraction unitRef="number" contextRef="c-145" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-803">6.000</ix:nonFraction>% Senior Secured Notes due 2034 (the "2034 Notes"). </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The Company paid an underwriting discount of $<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="6" id="f-804">6.8</ix:nonFraction>&#160;million on the New Notes being: <ix:nonFraction unitRef="number" contextRef="c-143" decimals="5" name="iclr:DebtInstrumentDiscountRate" scale="-2" id="f-805">0.250</ix:nonFraction>% of the principal amount of the 2027 Notes, <ix:nonFraction unitRef="number" contextRef="c-144" decimals="5" name="iclr:DebtInstrumentDiscountRate" scale="-2" id="f-806">0.350</ix:nonFraction>% of the principal amount of the 2029 Notes and <ix:nonFraction unitRef="number" contextRef="c-145" decimals="5" name="iclr:DebtInstrumentDiscountRate" scale="-2" id="f-807">0.450</ix:nonFraction>% of the 2034 Notes. Further, the 2034 Notes were issued at a discount of $<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="6" id="f-808">0.5</ix:nonFraction>&#160;million (issued at <ix:nonFraction unitRef="number" contextRef="c-146" decimals="5" name="us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" scale="-2" id="f-809">99.896</ix:nonFraction>% of par). </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The proceeds from the issuance were used to repay a portion of the senior secured term loan outstanding under the Senior Secured Credit Facilities and to pay fees, costs and expenses related to the offering.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest on the New Notes is payable on May 8 and November 8 of each year, having commenced on November 8, 2024. Unless previously redeemed, the 2027 Notes will mature on May 8, 2027, the 2029 Notes will mature on May 8, 2029 and the 2034 Notes will mature on May 8, 2034.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The New Notes are guaranteed on a senior secured basis by ICON and its existing and future wholly owned subsidiaries, in each case that guarantee the obligations under our Senior Secured Credit Facilities and the 2026 Notes. The New Notes are the senior secured obligation of the Issuer and the Guarantors and rank equally in right of payment to all of the Issuer&#8217;s and Guarantors&#8217; existing and future senior debt and senior in right of payment to all of the Issuer's and Guarantors' existing and future subordinated debt. The New Notes and the guarantees are secured on a first-lien basis by substantially all of the existing and future assets of the Issuer and the Guarantors that also secure the Issuer&#8217;s and the Guarantors&#8217; obligations under the Senior Secured Credit Facilities and the 2026 Notes on a pari passu basis, subject to permitted liens, and the liens on the collateral securing the New Notes rank equally in priority with the liens on the collateral securing borrowings and guarantees under the Senior Secured Credit Facilities, the 2026 Notes and any other future pari passu first lien indebtedness.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-738-3" continuedAt="f-738-4"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Credit Facilities</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On July 1, 2021, the Company completed the acquisition of PRA Health Sciences, Inc. ("PRA") by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA, the parent of the PRA Health Sciences ("the Merger"). In conjunction with the completion of the Merger, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-810">5,515</ix:nonFraction>&#160;million and a senior secured revolving loan facility in an initial aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-811">300</ix:nonFraction>&#160;million (the "Senior Secured Credit Facilities"). On May 2, 2023, the Company agreed with its lenders to increase the aggregate principal amount of the senior secured revolving loan facility from $<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-812">300</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-813">500</ix:nonFraction>&#160;million. The Senior Secured Credit Facilities and the 2026 Notes were issued at a discount of $<ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="6" id="f-814">27.6</ix:nonFraction>&#160;million.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to <ix:nonFraction unitRef="number" contextRef="c-147" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-815">1.00</ix:nonFraction>% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR plus an applicable margin which is dependent on the Company's net leverage ratio. At </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, the applicable margin is <ix:nonFraction unitRef="number" contextRef="c-151" decimals="2" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-816">2.0</ix:nonFraction>% (which reflects the Third Amendment). The senior secured term loan facility is subject to a floor of <ix:nonFraction unitRef="number" contextRef="c-152" decimals="3" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-817">0.50</ix:nonFraction>%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reflecting the Third Amendment, the interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of <ix:nonFraction unitRef="number" contextRef="c-153" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-818">0.45</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-154" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-819">0.10</ix:nonFraction>% or <ix:nonFraction unitRef="number" contextRef="c-155" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" format="ixt:fixed-zero" scale="-2" id="f-820">&#8211;</ix:nonFraction>% based on the Company&#8217;s current corporate family rating assigned by S&amp;P of BB (or lower), BB+ or BBB- (or higher), respectively, or (ii) Term SOFR plus an applicable margin of <ix:nonFraction unitRef="number" contextRef="c-156" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-821">1.45</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-157" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-822">1.10</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-158" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-823">0.85</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-159" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-824">0.65</ix:nonFraction>%, or <ix:nonFraction unitRef="number" contextRef="c-160" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-825">0.50</ix:nonFraction>% based on the Company&#8217;s current corporate family rating assigned by S&amp;P of BB (or lower), BB+, BBB-, BBB or BBB+ (or higher), respectively. In addition, lenders under the revolving loan facility are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Borrowers&#8217; (as defined in the Senior Secured Credit Facility) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON&#8217;s, the Borrowers&#8217; and each of the subsidiary guarantor&#8217;s assets (subject to certain exceptions), and the Senior Secured Credit Facilities will have a first-priority lien on such assets, which will rank pari passu with the lien securing the 2026 Notes and the New Notes subject to other permitted liens. The Company is permitted to make prepayments on the senior secured term loan without penalty.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span></div><ix:nonNumeric contextRef="c-1" name="iclr:ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock" id="f-826" escape="true"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Principal repayments, comprising mandatory and voluntary repayments, during the year ended December&#160;31, 2024 and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2023 were as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal repayments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="3" id="f-827">275,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="3" id="f-828">250,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="3" id="f-829">2,014,882</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="3" id="f-830">150,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 3</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="3" id="f-831">7,441</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="3" id="f-832">300,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 4</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="3" id="f-833">7,440</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="3" id="f-834">250,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total repayments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" format="ixt:num-dot-decimal" scale="3" id="f-835">2,304,763</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" format="ixt:num-dot-decimal" scale="3" id="f-836">950,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The voluntary repayments made during the year resulted in an accelerated charge associated with previously capitalized fees of $<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" format="ixt:num-dot-decimal" scale="6" id="f-837">16.9</ix:nonFraction>&#160;million (December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" format="ixt:num-dot-decimal" scale="6" id="f-838">7.9</ix:nonFraction>&#160;million). </span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-738-4" continuedAt="f-738-5"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">During the year ended December&#160;31, 2024, the Company drew down $<ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-5" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-839">318.0</ix:nonFraction>&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-5" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-840">370.0</ix:nonFraction>&#160;million) of the senior secured revolving loan facility and repaid $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="f-841">373.0</ix:nonFraction>&#160;million  (December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="f-842">315.0</ix:nonFraction>&#160;million) as shown below. As at December&#160;31, 2024, $nil<ix:nonFraction unitRef="usd" contextRef="c-3" xsi:nil="true" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" id="f-843"></ix:nonFraction> (December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-844">55.0</ix:nonFraction>&#160;million) was drawn under the senior secured revolving loan facility.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;</span><ix:continuation id="f-739-1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Drawdown </span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Repayment</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Closing Balance</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 1, 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-845">180,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-846">100,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-847">80,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 2, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-848">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-849">80,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-850">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 3, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-851">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-852">50,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-853">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 4, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-854">65,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-855">85,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-856">55,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total drawdown / (repayments) in 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-857">370,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-858">315,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 1, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-859">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-860">55,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-861">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 2, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-862">143,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-863">193,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="f-864">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 3, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-865">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-866">50,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="f-867">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 4, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-868">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-869">75,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="f-870">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total drawdown / (repayments) in 2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-871">318,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-872">373,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">2026 Notes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In addition to the Senior Secured Credit Facilities, on July 1, 2021, a subsidiary of the Company issued $<ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-873">500</ix:nonFraction>&#160;million in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="c-185" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-874">2.875</ix:nonFraction>% senior secured notes (the "2026 Notes") in a private offering (the &#8220;Offering&#8221;). The 2026 Notes will mature on July 15, 2026. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Fair Value of Debt</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><ix:continuation id="f-738-5" continuedAt="f-738-6"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s debt was </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-875">3,469.2</ix:nonFraction>&#160;million</span></ix:continuation><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-738-6"> at December&#160;31, 2024 and (December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-876">3,793.5</ix:nonFraction>&#160;million). The fair values of the senior secured term loan facility, the 2026 Notes and the New Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions. The fair value of the senior secured revolving loan facility approximates its carrying value due to the short term duration.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_202"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">14. <ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="f-877" continuedAt="f-877-1" escape="true">Derivatives</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-877-1" continuedAt="f-877-2"><div style="text-align:justify;text-indent:14.4pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company previously entered into interest rate cap and swap agreements for purposes of managing its exposure to interest rate fluctuations.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On November 29, 2022, the Company entered into <ix:nonFraction unitRef="instrument" contextRef="c-186" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" format="ixt-sec:numwordsen" id="f-878">two</ix:nonFraction> interest rate cap agreements ("2022 Caps") with an initial total notional value of $<ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-879">2,101</ix:nonFraction>&#160;million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Caps began accruing on December 30, 2022 and the interest rate caps were due to expire on December 31, 2024. Under the terms of the interest rate caps, the Company had paid a fixed rate of <ix:nonFraction unitRef="number" contextRef="c-186" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="f-880">0.42</ix:nonFraction>% and received a variable rate equal to the amount that the three-month SOFR rate exceeds <ix:nonFraction unitRef="number" contextRef="c-186" decimals="4" name="iclr:DerivativeVariableInterestRateReferenceRateInExcessOf" scale="-2" id="f-881">4.75</ix:nonFraction>%. </span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On November 29, 2022, the Company entered into an interest rate swap agreement ("2022 Swap") with an initial notional value of $<ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-882">1,101</ix:nonFraction>&#160;million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Swap was due to begin accruing on December 31, 2024 and the interest rate swap was due to expire on September 30, 2026. Under the terms of the interest rate swap, the Company would have paid a fixed rate of <ix:nonFraction unitRef="number" contextRef="c-187" decimals="3" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="f-883">3.4</ix:nonFraction>% and would have received a variable rate of interest equal to the three-month SOFR on the 2022 Swap.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2022 Caps and the 2022 Swap were designated as cash flow hedges. G</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ains and losses were initially reported as a component of other comprehensive income/loss and subsequently recognized in net income.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">During the year, the Company&#8217;s exposure to interest rate fluctuations significantly reduced with the voluntary and mandatory repayments </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">f the senior secured term loan facility (refer to note 13. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:107%">Bank credit lines, loan facilities and notes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">). Given this reduction and the repricing of the Senior Secured Credit facilities, the Company </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">closed the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">2022 Caps and 2022 Swap agreements. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">At </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">December&#160;31, 2024, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"><ix:nonFraction unitRef="number" contextRef="c-3" decimals="2" name="us-gaap:PercentageOfDebtHedgedByInterestRateDerivatives" scale="-2" id="f-884">73</ix:nonFraction>%</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> of the Company's outstanding debt is at a fixed interest rate (December&#160;31, 2023: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="2" name="us-gaap:PercentageOfDebtHedgedByInterestRateDerivatives" scale="-2" id="f-885">13</ix:nonFraction>%)</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">. </span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-877-2"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">During</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> the year ended December&#160;31, 2024, the Company recognized a gain of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="6" id="f-886">5.0</ix:nonFraction>&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">December&#160;31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">: $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="f-887">1.6</ix:nonFraction> million) within other comprehensive income/loss after a reclassification of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-888">13.9</ix:nonFraction>&#160;million (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">December&#160;31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">: $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:num-dot-decimal" scale="6" id="f-889">2.4</ix:nonFraction>&#160;million) from other comprehensive income/loss to the income statement.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">      <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="f-890" continuedAt="f-890-1" escape="true">The fair value of the Company&#8217;s derivative financial instruments at December&#160;31, 2024 amount to $<ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="f-891">nil</ix:nonFraction>. The fair value of the Company&#8217;s derivative financial instruments at December&#160;31, 2023 on a gross basis, are summarized in the following table:</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-890-1"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.128%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.158%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notional</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest Rate Caps</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-892">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-893">1,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-894">1,600,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest Rate Swap</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-895">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="f-896">540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-897">1,100,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-898">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-899">2,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-3" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-900">2,701,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_205"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-901" continuedAt="f-901-1" escape="true">Operating Leases</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-901-1" continuedAt="f-901-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-902" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Lease costs recorded under operating leases for the years ended December&#160;31, 2024, 2023 and 2022 were as follows:</span></div><div style="margin-top:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-903">46,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-904">46,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-905">53,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from sub-leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:SubleaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-906">1,614</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:SubleaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-907">1,103</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:SubleaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-908">1,165</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating lease costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-909">44,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-910">45,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-911">52,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Of the total cost of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="f-912">44.9</ix:nonFraction> million incurred in the year ended December&#160;31, 2024 (December&#160;31, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="f-913">45.7</ix:nonFraction> million; December&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="f-914">52.7</ix:nonFraction>&#160;million), $<ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="f-915">37.2</ix:nonFraction> million (December&#160;31, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="f-916">37.9</ix:nonFraction> million; December&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="f-917">48.3</ix:nonFraction> million) is recorded within selling, general and administration costs and $<ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="f-918">7.7</ix:nonFraction> million  (December&#160;31, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="f-919">7.8</ix:nonFraction> million; December&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="f-920">4.4</ix:nonFraction> million) is recorded within direct costs. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Right-of-use assets obtained, in exchange for lease obligations, during the years ended December&#160;31, 2024 and December&#160;31, 2023 totaled $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-921">64.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-922">37.7</ix:nonFraction> million, respectively. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2024, 2023 and 2022, impairments of operating right-of-use assets were recognized within restructuring charges for $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" scale="6" id="f-923">13.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" scale="6" id="f-924">8.7</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" scale="6" id="f-925">28.4</ix:nonFraction> million, respectively, as part of an office consolidation program (see note 19. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Charges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2024 were <ix:nonNumeric contextRef="c-3" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-926">6.56</ix:nonNumeric> years and <ix:nonFraction unitRef="number" contextRef="c-3" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-927">4.01</ix:nonFraction>%, respectively. The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2023 were <ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-928">6.72</ix:nonNumeric> years and <ix:nonFraction unitRef="number" contextRef="c-4" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-929">3.29</ix:nonFraction>%, respectively.</span></div></ix:continuation><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">126</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-930" escape="true"><ix:continuation id="f-901-2" continuedAt="f-901-3"><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable leases as of December&#160;31, 2024 were as follows:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:80.168%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Minimum rental payments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-931">42,931</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-932">38,445</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-933">31,257</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="f-934">24,156</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="f-935">17,838</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="f-936">45,047</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-937">199,674</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-938">22,806</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-939">176,868</ix:nonFraction></span></td></tr></table></div></ix:continuation></ix:nonNumeric><div style="margin-top:7pt;text-align:justify;text-indent:36pt"><ix:continuation id="f-901-3" continuedAt="f-901-4"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities are presented as current and non-current. As at </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, operating lease liabilities of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="f-940">36.8</ix:nonFraction>&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> have been included in <span style="-sec-ix-hidden:f-941"><span style="-sec-ix-hidden:f-942">Other liabilities</span></span> (December&#160;31, 2023: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-943">36.4</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-944">140.1</ix:nonFraction> million</span></ix:continuation><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-901-4"> million have been classified as Non-current Lease Liabilities (December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-945">126.3</ix:nonFraction> million).</ix:continuation> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_208"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" id="f-946" continuedAt="f-946-1" escape="true">Non-current other liabilities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="f-947" escape="true"><ix:continuation id="f-946-1"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Non-current other liabilities for the years ended December&#160;31, 2024 and 2023 is as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherSundryLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-948">83,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherSundryLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-949">45,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-950">83,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-951">45,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_211"></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">17. <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-952" continuedAt="f-952-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-952-1"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Litigation</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We do not expect any litigation to have a materially adverse effect on our financial condition or results of operations. However, from time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has several non-cancelable operating leases, primarily for facilities, that expire over the next <ix:nonNumeric contextRef="c-3" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="f-953">sixteen years</ix:nonNumeric>. These leases generally contain renewal options and require the Company to pay all executory costs such as maintenance and insurance. See note 15.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Operating leases</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for rental expense pursuant to ASC 842 for the years ended December&#160;31, 2024, 2023 and 2022 and future minimum rental commitments as of December&#160;31, 2024.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_214"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">18. <ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-954" continuedAt="f-954-1" escape="true">Share Capital</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-954-1" continuedAt="f-954-2"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Holders of ordinary shares are entitled to receive such dividends as may be recommended by the Board of Directors of the Company and approved by the shareholders and/or such interim dividends as the Board of Directors of the Company may decide. On liquidation or a winding up of the Company, the par value of the ordinary shares are repaid out of the assets available for distribution among the holders of the ordinary shares of the Company. Holders of ordinary shares have no conversion or redemption rights. On a show of hands, every holder of an ordinary share present in person or proxy at a general meeting of shareholders shall have <ix:nonFraction unitRef="vote" contextRef="c-1" decimals="INF" name="iclr:NumberOfVotes" format="ixt-sec:numwordsen" scale="0" id="f-955">one</ix:nonFraction> vote, for each ordinary share held with no individual having more than <ix:nonFraction unitRef="vote" contextRef="c-1" decimals="INF" name="iclr:NumberOfVotes" format="ixt-sec:numwordsen" scale="0" id="f-956">one</ix:nonFraction> vote. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:29.25pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.02pt">Share based payments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024, <ix:nonFraction unitRef="shares" contextRef="c-199" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-957">311,040</ix:nonFraction> options were exercised at an average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-199" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-958">116.31</ix:nonFraction> per share for total proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="f-959">36.2</ix:nonFraction> million. During the year ended December&#160;31, 2024, <ix:nonFraction unitRef="shares" contextRef="c-200" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-960">120,458</ix:nonFraction> ordinary shares were issued in respect of certain RSUs and <ix:nonFraction unitRef="shares" contextRef="c-201" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="0" id="f-961">9,975</ix:nonFraction> ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-954-2"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, <ix:nonFraction unitRef="shares" contextRef="c-202" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-962">535,705</ix:nonFraction> options were exercised at an average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-202" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-963">95.12</ix:nonFraction> per share for total proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="f-964">51.0</ix:nonFraction> million. During the year ended December&#160;31, 2023, <ix:nonFraction unitRef="shares" contextRef="c-203" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-965">188,800</ix:nonFraction> ordinary shares were issued in respect of certain RSUs and <ix:nonFraction unitRef="shares" contextRef="c-204" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="0" id="f-966">47,026</ix:nonFraction> ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the year ended December&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="c-205" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-967">348,286</ix:nonFraction> options were exercised at an average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-205" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-968">102.87</ix:nonFraction> per share for total proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="f-969">35.8</ix:nonFraction> million. During the year ended December&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="c-206" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-970">195,029</ix:nonFraction> ordinary shares were issued in respect of certain RSUs and <ix:nonFraction unitRef="shares" contextRef="c-207" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="0" id="f-971">46,087</ix:nonFraction> ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:29.25pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.02pt">Share Repurchase Program</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company can acquire up to <ix:nonFraction unitRef="number" contextRef="c-208" decimals="2" name="iclr:StockRepurchaseProgramAuthorizedPercentage" scale="-2" id="f-972">10</ix:nonFraction>% of its outstanding ordinary shares (by way of redemption), in accordance with Irish </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">law and the Company&#8217;s constitutional documents through open market share acquisitions. A resolution was passed at the Company&#8217;s Annual General Meeting (&#8220;AGM&#8221;) on July 23, 2024, which renewed the authorization for the Directors to purchase (buyback) up to <ix:nonFraction unitRef="number" contextRef="c-209" decimals="2" name="iclr:StockRepurchaseProgramAuthorizedPercentage" scale="-2" id="f-973">10</ix:nonFraction>% of the outstanding shares in the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 20, 2024, the Company's Board of Directors authorized a new buyback program of up to $<ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-6" name="srt:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="f-974">500.0</ix:nonFraction> million of the outstanding ordinary shares of the Company. On October 22, 2024, the Company's Board of Directors authorized an additional buyback program of up to $<ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-6" name="srt:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="f-975">250.0</ix:nonFraction> million of the outstanding ordinary shares of the Company. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All  ordinary  shares  that  are  redeemed  under  the  buyback  program  will  be canceled in accordance with the constitutional documents of the Company and the nominal value of these shares transferred to an undenominated capital fund as required under Irish Company law.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024, <ix:nonFraction unitRef="shares" contextRef="c-212" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-976">2,179,699</ix:nonFraction> ordinary shares were redeemed by the Company under this buyback program for a total consideration of $<ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="f-977">500.0</ix:nonFraction> million.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-213" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:fixed-zero" scale="0" id="f-978">No</ix:nonFraction> ordinary shares were redeemed by the Company during the year ended December&#160;31, 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="c-214" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-979">420,530</ix:nonFraction> ordinary shares were redeemed by the Company for total consideration of $<ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="f-980">100.0</ix:nonFraction> million.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Under the repurchase program, a broker purchased or may purchase the Company's shares from time to time on the open market or in privately negotiated transactions in accordance with agreed terms and limitations. The program was and may be in the future designed to allow share repurchases during periods when the Company would ordinarily not be permitted to do so because it may be in possession of material non-public or price-sensitive information or due to applicable insider trading laws or self-imposed trading blackout periods. The Company's instructions to the broker in such cases were or may in the future be irrevocable and the trading decisions in respect of the repurchase program were made or will be made independently of and uninfluenced by the Company. The Company confirms that on entering the share repurchase plans it had no material non-public, price-sensitive or inside information regarding the Company or its securities. Furthermore, the Company will not enter into additional plans whilst in possession of such information. The timing and actual number of shares acquired by way of the redemption will be dependent on market conditions, legal and regulatory requirements and the other terms and limitations contained in the program. In addition, acquisitions under the program may be suspended or discontinued in certain circumstances in accordance with the agreed terms. Therefore, there can be no assurance as to the timing or number of shares that may be acquired under the program.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_217"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">19. <ix:nonNumeric contextRef="c-1" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="f-981" continuedAt="f-981-1" escape="true">Restructuring Charges</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="f-981-1" continuedAt="f-981-2"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022, the Company incurred approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="f-982">92.1</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="f-983">45.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="f-984">31.1</ix:nonFraction>&#160;million of restructuring charge in the Consolidated Statements of Operations under a restructuring plan adopted following a review of operations.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The restructuring plan reflected a workforce reduction of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="f-985">74.5</ix:nonFraction>&#160;million (December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="f-986">34.1</ix:nonFraction>&#160;million, December&#160;31, 2022: $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="f-987">2.7</ix:nonFraction>&#160;million) and an office consolidation program to optimize the Company's office footprint of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherRestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="f-988">17.6</ix:nonFraction>&#160;million (December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherRestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="f-989">11.3</ix:nonFraction>&#160;million, December&#160;31, 2022: $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherRestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="f-990">28.4</ix:nonFraction>&#160;million), being the impairment of operating right-off-use assets and related property plant and equipment of $<ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-5" name="iclr:ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment" scale="6" id="f-991">15.7</ix:nonFraction> million (December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-5" name="iclr:ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment" scale="6" id="f-992">8.7</ix:nonFraction> million, December&#160;31, 2022: $<ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-5" name="iclr:ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="f-993">28.4</ix:nonFraction>&#160;million) and onerous contract costs of $<ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-5" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="f-994">1.9</ix:nonFraction>&#160;million (December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-5" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="f-995">2.6</ix:nonFraction>&#160;million, December&#160;31, 2022: $<ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-5" name="us-gaap:LossContingencyAccrualProvision" format="ixt:fixed-zero" scale="0" id="f-996">nil</ix:nonFraction>&#160;).</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="f-997" escape="true"><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="f-998">92,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="f-999">45,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="f-1000">31,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="f-1001">92,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="f-1002">45,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="3" id="f-1003">31,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-981-2" continuedAt="f-981-3"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2024, a total liability of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="f-1004">31.5</ix:nonFraction> million (December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="f-1005">7.0</ix:nonFraction> million) was recorded on the Consolidated Balance Sheet relating to restructuring activities. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="f-1006" escape="true"><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="f-1007">6,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="f-1008">6,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Charge during the year*</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="f-1009">76,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="f-1010">36,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="iclr:RestructuringReserveUtilizations" format="ixt:num-dot-decimal" scale="3" id="f-1011">51,917</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="iclr:RestructuringReserveUtilizations" format="ixt:num-dot-decimal" scale="3" id="f-1012">35,727</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="f-1013">31,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="f-1014">6,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*The charge for the year ended December&#160;31, 2024 reflects the workforce reduction of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:SeveranceCosts1" scale="6" id="f-1015">74.5</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> (December&#160;31, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">: $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:SeveranceCosts1" scale="6" id="f-1016">34.1</ix:nonFraction> million) and onerous contract costs of $<ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-5" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="f-1017">1.9</ix:nonFraction> million (December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-5" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="f-1018">2.6</ix:nonFraction> million).</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The closing provision of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="f-1019">31.5</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="f-1020">7.0</ix:nonFraction> million) reflects:</span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> (1) $<ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="f-1021">27.7</ix:nonFraction> million (December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="f-1022">4.0</ix:nonFraction> million) of personnel related liabilities as a result of the workforce reduction; all of which have been classified as short-term within Other Liabilities, and</span></div></ix:continuation><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><ix:continuation id="f-981-3" continuedAt="f-981-4"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> (2) $<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="f-1023">3.8</ix:nonFraction> million (December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="f-1024">3.0</ix:nonFraction> million) of facilities related liabilities of which $<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="us-gaap:RestructuringReserveCurrent" scale="6" id="f-1025">1.4</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-5" name="us-gaap:RestructuringReserveCurrent" scale="6" id="f-1026">1.0</ix:nonFraction> million) is included within Other Liabilities and $<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="us-gaap:RestructuringReserveNoncurrent" scale="6" id="f-1027">2.4</ix:nonFraction> million (December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-5" name="us-gaap:RestructuringReserveNoncurrent" scale="6" id="f-1028">2.0</ix:nonFraction> million)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:continuation><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="f-981-4">is included within Non-Current Other Liabilities.</ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_223"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">20. <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-1029" continuedAt="f-1029-1" escape="true">Income Taxes </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-1029-1" continuedAt="f-1029-2"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's United States and Irish based subsidiaries file income tax returns in the United States and Ireland respectively. Other foreign subsidiaries are taxed separately under the laws of their respective countries.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="iclr:IncomeBeforeIncomeTaxTableTextBlock" id="f-1030" escape="true"><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The components of income before income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1031">736,374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1032">624,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1033">432,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1034">304,546</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1035">352,532</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1036">270,440</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1037">437,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1038">352,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1039">405,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1040">869,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1041">624,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1042">567,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1029-2" continuedAt="f-1029-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="f-1043" escape="true"><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The components of income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income tax expense:</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current tax (benefit)/expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1044">118,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1045">80,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1046">53,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" sign="-" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1047">45,307</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-3" sign="-" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1048">42,428</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1049">60,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1050">105,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1051">59,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1052">70,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current tax expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1053">178,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1054">97,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1055">184,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax (benefit)/expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1056">26,663</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1057">45,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1058">6,166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1059">69,493</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1060">143,323</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1061">118,475</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1062">4,386</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1063">12,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="f-1064">344</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax benefit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1065">100,542</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1066">85,403</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1067">124,985</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1068">77,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1069">11,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1070">59,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense was allocated to the following components of other comprehensive income:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency impact on long term funding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" format="ixt:num-dot-decimal" scale="3" id="f-1071">1,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" format="ixt:num-dot-decimal" scale="3" id="f-1072">3,903</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" format="ixt:num-dot-decimal" scale="3" id="f-1073">7,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retirement benefit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="3" id="f-1074">895</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" format="ixt:fixed-zero" scale="3" id="f-1075">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" format="ixt:fixed-zero" scale="3" id="f-1076">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="3" id="f-1077">647</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="3" id="f-1078">301</ix:nonFraction></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" format="ixt:fixed-zero" id="f-1079">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity" format="ixt:num-dot-decimal" scale="3" id="f-1080">79,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity" format="ixt:num-dot-decimal" scale="3" id="f-1081">8,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity" format="ixt:num-dot-decimal" scale="3" id="f-1082">66,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ireland's statutory trading income tax rate, the rate of our country of domicile, is 12.5%. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-1083" continuedAt="f-1083-1" escape="true">The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-1083-1"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes at Irish statutory rate of 12.5% (2023:12.5%; 2022:12.5%)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-1084">108,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-1085">78,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-1086">70,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate differential from amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1087">48,240</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1088">71,223</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1089">59,330</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Global Minimum Tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount" format="ixt:num-dot-decimal" scale="3" id="f-1090">16,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount" format="ixt:fixed-zero" scale="3" id="f-1091">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount" format="ixt:fixed-zero" scale="3" id="f-1092">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign and other income taxed at higher rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="f-1093">49,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="f-1094">35,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="f-1095">52,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research &amp; development tax incentives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="f-1096">3,041</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="f-1097">3,868</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="f-1098">2,608</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Movement in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1099">5,279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1100">1,068</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="f-1101">777</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effects of change in tax rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-1102">25,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-1103">3,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="3" id="f-1104">300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Decrease)/ increase in unrecognized tax benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="iclr:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" format="ixt:num-dot-decimal" scale="3" id="f-1105">59,456</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="iclr:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" format="ixt:num-dot-decimal" scale="3" id="f-1106">54,347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="iclr:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" format="ixt:num-dot-decimal" scale="3" id="f-1107">8,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investor tax expense on foreign subsidiary earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="iclr:EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount" format="ixt:num-dot-decimal" scale="3" id="f-1108">7,995</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="iclr:EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount" format="ixt:num-dot-decimal" scale="3" id="f-1109">39,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="iclr:EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount" format="ixt:fixed-zero" scale="3" id="f-1110">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="f-1111">9,385</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="f-1112">11,487</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="f-1113">8,756</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other and non-deductible expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" format="ixt:num-dot-decimal" scale="3" id="f-1114">10,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" format="ixt:num-dot-decimal" scale="3" id="f-1115">2,413</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="f-1116">654</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1117">77,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1118">11,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1119">59,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">130</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1029-3" continuedAt="f-1029-4"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-1120" continuedAt="f-1120-1" escape="true">The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:</ix:nonNumeric></span></div><ix:continuation id="f-1120-1"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deferred tax liabilities:</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1121">2,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1122">7,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating right-of-use-assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-1123">15,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-1124">16,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1125">43,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1126">39,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets" format="ixt:num-dot-decimal" scale="3" id="f-1127">901,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets" format="ixt:num-dot-decimal" scale="3" id="f-1128">950,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in foreign subsidiaries </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" format="ixt:num-dot-decimal" scale="3" id="f-1129">34,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" format="ixt:num-dot-decimal" scale="3" id="f-1130">52,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="f-1131">3,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="f-1132">7,982</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax liabilities recognized</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1133">1,002,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1134">1,073,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss and tax credits carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-1135">164,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-1136">124,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1137">7,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1138">9,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:DeferredTaxAssetsOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1139">21,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="iclr:DeferredTaxAssetsOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1140">20,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="3" id="f-1141">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-1142">2,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" format="ixt:num-dot-decimal" scale="3" id="f-1143">14,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" format="ixt:num-dot-decimal" scale="3" id="f-1144">17,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1145">78,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="iclr:DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1146">84,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:DeferredTaxAssetContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-1147">10,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="iclr:DeferredTaxAssetContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-1148">23,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" format="ixt:num-dot-decimal" scale="3" id="f-1149">6,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" format="ixt:num-dot-decimal" scale="3" id="f-1150">8,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-1151">303,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-1152">290,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1153">38,955</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1154">42,967</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets recognized</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-1155">264,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-1156">247,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Overall net deferred tax liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1157">737,728</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1158">825,438</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2024 Ireland subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available for offset against future tax liabilities, if any, of $<ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-5" name="iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" scale="6" id="f-1159">15.6</ix:nonFraction> million.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">At December&#160;31, 2024 U.S. subsidiaries had U.S. federal and state net operating loss ("NOL") carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="f-1160">8.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="f-1161">277.8</ix:nonFraction> million, respectively. These NOLs are available for offset against future taxable income and the expiry dates are shown in the table below. The subsidiaries' ability to use the U.S. federal NOL carryforwards is limited on an annual basis due to change of ownership in 2014, 2017, 2019 and 2024 as defined by Section 382 of the Internal Revenue Code of 1986, as amended and expire between 2025 - 2037. The U.S. state NOL carryforwards are restricted by the state/entity in which they arose. As of December&#160;31, 2024, U.S subsidiaries also had disallowed interest carried forward of $<ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="f-1162">317.0</ix:nonFraction>&#160;million </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(December&#160;31, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">: $<ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:num-dot-decimal" scale="6" id="f-1163">204.0</ix:nonFraction>&#160;million) that can be carried forward indefinitely. The increase of $<ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-5" name="iclr:TaxCreditCarryForwardIncreaseDecreaseAmount" format="ixt:num-dot-decimal" scale="6" id="f-1164">113.0</ix:nonFraction>&#160;million was recognized within the income tax expense. These carryforwards are available for offset against future taxable income in the event that the U.S subsidiaries have excess capacity for interest deductions in future years. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><ix:nonNumeric contextRef="c-1" name="us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock" id="f-1165" continuedAt="f-1165-1" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expected expiry dates of the US NOLs are as follows:&#160;</span></ix:nonNumeric></div><ix:continuation id="f-1165-1"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Federal<br/>NOL's</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">State<br/>NOL's</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025-2038</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="3" id="f-1166">8,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="3" id="f-1167">262,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2039-2043</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:fixed-zero" scale="3" id="f-1168">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="3" id="f-1169">6,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:fixed-zero" scale="3" id="f-1170">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="3" id="f-1171">9,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-1172">8,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-1173">277,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, we also have general business tax credit carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" scale="6" id="f-1174">1.0</ix:nonFraction> million that are available to reduce future U.S. federal and state income taxes. The general business tax credits are non-refundable and are due to expire between the years 2026-2038.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">131</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1029-4"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">At December&#160;31, 2024 other than those in the U.S. and Ireland, we had operating loss carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future taxable income, if any, of approximately $<ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" scale="6" id="f-1175">42.4</ix:nonFraction> million. In addition, at December&#160;31, 2024 those subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward for up to <ix:nonNumeric contextRef="c-1" name="iclr:TaxCreditCarryForwardExpirationPeriod" format="ixt-sec:duryear" id="f-1176">30</ix:nonNumeric> years, available to offset against future tax liabilities, if any, of  $<ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-5" name="iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" scale="6" id="f-1177">2.7</ix:nonFraction> million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The valuation allowance at December&#160;31, 2024 was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="f-1178">39.0</ix:nonFraction> million (December&#160;31, 2023; $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="f-1179">43.0</ix:nonFraction> million). The net change in the total valuation allowance was a decrease of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="f-1180">4.0</ix:nonFraction> million during 2024 and a decrease of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="f-1181">0.4</ix:nonFraction> million during 2023. Of the total decrease of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="f-1182">4.0</ix:nonFraction> million in 2024, an increase of $<ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="f-1183">2.0</ix:nonFraction>&#160;million was in respect of an acquired entity, $<ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="f-1184">5.3</ix:nonFraction> million decrease was recognized within income tax expense and a decrease of $<ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="f-1185">0.7</ix:nonFraction> million was recognized in Other Comprehensive Income. Of the total decrease of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="f-1186">0.4</ix:nonFraction> million in 2023, $<ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="f-1187">1.1</ix:nonFraction> million was recognized within income tax expenses and an increase of $<ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="f-1188">0.7</ix:nonFraction> million was recognized in Other Comprehensive Income.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The valuation allowances at December&#160;31, 2024 and December&#160;31, 2023 were primarily related to operating losses and tax credits carried forward that, in the judgment of management, are not more likely than not to be realized. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, loss utilization, projected future taxable income and tax planning strategies in making this assessment. In respect of deferred tax assets not subject to a valuation allowance, management considers that it is more likely than not that these deferred tax assets will be realized on the basis that there will be sufficient reversals of deferred tax liabilities and taxable income in future periods.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company has recognized a deferred tax liability of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" scale="6" id="f-1189">35.0</ix:nonFraction> million (2023: $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" scale="6" id="f-1190">52.4</ix:nonFraction> million) for investments in foreign subsidiaries where the Company does not consider the earnings to be indefinitely reinvested. For the deferred tax liability not recognized in respect of temporary differences related to investments in foreign subsidiaries which are considered to be indefinitely reinvested, it is not practicable to calculate the exact unrecognized deferred tax liability. However it is not expected to be material as Ireland recently implemented a participation exemption in respect of distributions from foreign subsidiaries in EEA/treaty countries, in addition to the foreign tax credit regime at the statutory tax rate in the jurisdiction of the subsidiary, so that no material tax liability would be expected to arise in Ireland in the event these earnings were ever remitted. In addition, withholding taxes applicable to remittances from foreign subsidiaries would not be expected to be material given Ireland&#8217;s tax treaty network and the EU parent subsidiary directive.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="f-1191" escape="true"><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at start of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1192">160,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1193">217,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1194">202,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-1195">7,374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-1196">1,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-1197">16,098</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease related to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-1198">2,525</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="f-1199">918</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-1200">5,442</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-1201">2,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-1202">4,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-1203">5,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lapse of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="3" id="f-1204">65,417</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:num-dot-decimal" scale="3" id="f-1205">62,363</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="f-1206">838</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1207">101,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1208">160,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1209">217,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The relevant statute of limitations for unrecognized tax benefits totaling $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" scale="6" id="f-1210">61.6</ix:nonFraction> million could potentially expire during 2025. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in the balance of total unrecognized tax benefits at December&#160;31, 2024 were potential benefits of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="f-1211">101.6</ix:nonFraction> million, which if recognized, would affect the effective rate on income from continuing operations. The balance of total unrecognized tax benefits at December&#160;31, 2023 and December&#160;31, 2022 included potential benefits which, if recognized, would affect the effective rate of income tax from continuing operations of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="f-1212">160.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="f-1213">217.6</ix:nonFraction> million respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest and penalties recognized during the year ended December&#160;31, 2024 amounted to a net charge of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="f-1214">1.9</ix:nonFraction> million (2023: $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="f-1215">4.2</ix:nonFraction> million, 2022: $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="f-1216">7.1</ix:nonFraction> million) and are included within the income tax expense. Total accrued interest and penalties as of December&#160;31, 2024 and December&#160;31, 2023 were $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="6" id="f-1217">24.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="6" id="f-1218">27.1</ix:nonFraction> million respectively and are included in closing income taxes payable at those dates.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our major tax jurisdictions are Ireland and the United States. We may potentially be subjected to tax audits in both our major jurisdictions. In Ireland, tax periods open to audit include the years ended December&#160;31, 2020, December&#160;31, 2021, December&#160;31, 2022, December&#160;31, 2023 and December&#160;31, 2024. In the United States, tax periods open to audit include the years ended December&#160;31, 2021, December&#160;31, 2022, December&#160;31, 2023 and December&#160;31, 2024. During such audits, local tax authorities may challenge the positions taken by us in our tax returns.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">132</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span></div><div id="i70380bb88cac48169f2186a4a94094c5_232"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">21. <ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-1219" continuedAt="f-1219-1" escape="true">Equity Incentive Schemes and Stock Compensation Charges</ix:nonNumeric></span></div><ix:continuation id="f-1219-1" continuedAt="f-1219-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Share Options</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 21, 2008 the Company adopted the Employee Share Option Plan 2008 (the "2008 Employee Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any employee, or any Director holding a salaried office or employment with the Company or a Subsidiary for the purchase of ordinary shares. On the same date, the Company also adopted the Consultants Share Option Plan 2008 (the "2008 Consultants Plan"), pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any consultant, adviser or non-executive Director retained by the Company or any Subsidiary for the purchase of ordinary shares.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 14, 2017 both the 2008 Employee Plan and the 2008 Consultants Plan (together the "2008 Option Plans") were amended and restated in order to increase the number of options that can be issued under the 2008 Consultants Plan from <ix:nonFraction unitRef="shares" contextRef="c-247" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="f-1220">0.4</ix:nonFraction> million to <ix:nonFraction unitRef="shares" contextRef="c-248" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="f-1221">1.0</ix:nonFraction> million and to extend the date for options to be granted under the 2008 Option Plans. An aggregate of <ix:nonFraction unitRef="shares" contextRef="c-249" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="f-1222">6.0</ix:nonFraction> million ordinary shares have been reserved under the 2008 Employee Plan, as reduced by any shares issued or to be issued pursuant to options granted under the 2008 Consultants Plan, under which a limit of <ix:nonFraction unitRef="shares" contextRef="c-250" decimals="-5" name="iclr:LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" scale="6" id="f-1223">1.0</ix:nonFraction> million shares applies. Further, the maximum number of ordinary shares with respect to which options may be granted under the 2008 Employee Option Plan, during any calendar year to any employee shall be <ix:nonFraction unitRef="shares" contextRef="c-251" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" scale="6" id="f-1224">0.4</ix:nonFraction> million ordinary shares. There is no individual limit under the 2008 Consultants Plan. No options may be granted under the 2008 Option Plans after February 14, 2027.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each option granted under the 2008 Option Plans is an employee stock option, or Nonqualified Stock Option ("NSO"), as described in Section 422 or 423 of the Internal Revenue Code. Each grant of an option under the 2008 Options Plans is evidenced by a Stock Option Agreement between the optionee and the Company. The exercise price is specified in each Stock Option Agreement, however option prices are not less than <ix:nonFraction unitRef="number" contextRef="c-252" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="f-1225">100</ix:nonFraction>% of the fair market value of an ordinary share on the date the option is granted. Share option awards are granted with an exercise price equal to the market price of the Company's shares at date of grant. Share options typically vest over a period of <span style="-sec-ix-hidden:f-1226">four</span> to <ix:nonNumeric contextRef="c-254" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1227">five years</ix:nonNumeric> from date of grant and expire <ix:nonNumeric contextRef="c-255" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="f-1228">eight years</ix:nonNumeric> from date of grant. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">PRA  Equity Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following represent the PRA equity incentive plans, that have been terminated as of July 1, 2021, as to grants of future awards.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, effective on July 1, 2021, each stock option and restricted stock unit under the PRA Plans was assumed by the Company and converted into a stock option or Restricted Share Unit exercisable for or payable in Ordinary Shares based on the ratio of the average trading price per Ordinary Share for the ten days prior to July 1, 2021, and the corresponding value of the Merger consideration for each PRA Share. Accordingly, the plans as detailed below were assumed by the Company.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PRA Health Sciences, Inc. 2020 Stock Incentive Plan  (the "2020 Plan&#8221;), 2018 Stock Incentive Plan (the "2018 Plan"), and 2014 Omnibus Incentive Plan (the "2014 Plan") were amended and restated and assumed by the Registrant effective as of July 1, 2021. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2020 Stock Incentive Plan, was approved by the PRA stockholders at their annual meeting on May 18, 2020. The 2020 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2020 Plan authorized the issuance of <ix:nonFraction unitRef="shares" contextRef="c-256" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-1229">2.5</ix:nonFraction>&#160;million shares of common stock plus all shares that remained available under the prior plan on May 18, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2018 Stock Incentive Plan (the &#8220;2018 Plan&#8221;), was approved by the PRA stockholders at their annual meeting on May 31, 2018. The 2018 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2018 Plan authorized the issuance of <ix:nonFraction unitRef="shares" contextRef="c-257" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-1230">2.0</ix:nonFraction>&#160;million shares of common stock plus all shares that remained available under the 2014 Plan on May 31, 2018 (which included shares carried over from the 2013 Plan).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On November 23, 2014, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2014 Plan for Key PRA Employees. The 2014 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">133</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1219-2" continuedAt="f-1219-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-1231" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The following table summarizes the transactions for the Company's share option plans for the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.860%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Granted<br/>Under Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-258" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1232">1,695,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-258" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1233">110.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-259" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-1234">108,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-259" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1235">229.94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-259" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1236">348,286</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-259" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-1237">102.87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited/expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-259" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1238">77,698</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-259" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1239">143.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-260" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1240">1,378,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-260" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1241">119.86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-261" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-1242">82,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-261" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1243">232.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-261" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1244">535,705</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-261" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-1245">95.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited/expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-261" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1246">22,080</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-261" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1247">196.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-262" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1248">902,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-262" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1249">142.96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-263" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-1250">68,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-263" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1251">325.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-263" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1252">311,040</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-263" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-1253">116.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited/expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-263" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1254">37,854</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-263" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1255">238.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-264" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1256">622,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-264" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1257">170.52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested and exercisable at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-264" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-1258">426,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-264" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="f-1259">135.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average remaining contractual life of options outstanding and options exercisable at December&#160;31, 2024 was <ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1260">3.91</ix:nonNumeric> years and <ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-1261">3.06</ix:nonNumeric> years respectively (2023: <ix:nonNumeric contextRef="c-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1262">4.42</ix:nonNumeric> years and <ix:nonNumeric contextRef="c-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-1263">3.89</ix:nonNumeric> years respectively).</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The intrinsic value of options outstanding and options exercisable as of December&#160;31, 2024 was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="f-1264">34.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="6" id="f-1265">32.4</ix:nonFraction> million, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The intrinsic value of options exercised during the years ended December&#160;31, 2024, 2023, and 2022, was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="f-1266">57.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="f-1267">80.4</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="f-1268">41.9</ix:nonFraction> million, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value of Stock Options Assumptions</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average fair value of options granted during the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022 was calculated using the Black-Scholes option pricing model. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-1269" continuedAt="f-1269-1" escape="true">The weighted average fair values and assumptions were as follows:</ix:nonNumeric></span></div><ix:continuation id="f-1269-1"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:57.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-199" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1270">115.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-202" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1271">85.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-205" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1272">68.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-199" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1273">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-202" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1274">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-205" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1275">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-199" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-1276">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-202" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-1277">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-205" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-1278">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-199" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1279">4.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-202" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1280">4.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-205" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1281">1.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-199" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1282">4.3</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-202" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1283">5.0</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-205" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1284">5.0</ix:nonNumeric> years</span></td></tr></table></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected volatility is based on the historical volatility of our common stock over a period equal to the expected term of the options; the expected life represents the weighted average period of time that options granted are expected to be outstanding given consideration to vesting schedules and our historical experience of past vesting and termination patterns. The risk-free rate is based on the U.S. government zero-coupon bonds yield curve in effect at time of the grant for periods corresponding with the expected life of the option.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">134</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1219-3" continuedAt="f-1219-4"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Restricted Share Units and Performance Share Units</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 23, 2013, the Company adopted the 2013 Employees Restricted Share Unit Plan (the "2013 RSU Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may select any employee, or any Director holding a salaried office or employment with the Company, or a Subsidiary to receive an award under the plan. On May 11, 2015, the 2013 RSU Plan was amended and restated in order to increase the number of shares that can be issued under the RSU Plan by <ix:nonFraction unitRef="shares" contextRef="c-265" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="6" id="f-1285">2.5</ix:nonFraction> million shares. Further, on October 25, 2024, the 2013 RSU Plan was amended and restated effective as of November 6, 2024 in order to increase the number of shares that can be issued under the RSU Plan by a further <ix:nonFraction unitRef="shares" contextRef="c-266" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="f-1286">2.5</ix:nonFraction>&#160;million shares. Accordingly, an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-267" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="f-1287">6.6</ix:nonFraction> million ordinary shares have been reserved for issuance under the 2013 RSU Plan. The shares are awarded at par value and vest over a service period. Awards under the 2013 RSU Plan may be settled in cash or shares at the option of the Company. No awards may be granted under the 2013 RSU Plan after November 6, 2034.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 30 2019, the Company approved the 2019 Consultants and Directors Restricted Share Unit Plan (the &#8220;2019 Consultants RSU Plan&#8221;), which was effective as of May 16, 2019, pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may select any consultant, adviser or non-executive Director retained by the Company, or a Subsidiary to receive an award under the plan. <ix:nonFraction unitRef="shares" contextRef="c-268" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-1288">250,000</ix:nonFraction> ordinary shares have been reserved for issuance under the 2019 Consultants RSU Plan. The awards are at par value and vest over a service period. Awards granted to non-executive directors vest over <ix:nonNumeric contextRef="c-269" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1289">twelve months</ix:nonNumeric>. No awards may be granted under the 2019 Consultants RSU Plan after May 16, 2029.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has awarded RSUs and PSUs to certain key individuals of the Group. <ix:nonNumeric contextRef="c-1" name="iclr:ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" id="f-1290" continuedAt="f-1290-1" escape="true">The following table summarizes RSU and PSU activity for the year ended December&#160;31, 2024:</ix:nonNumeric></span></div><ix:continuation id="f-1290-1"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.599%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU Outstanding<br/>Number of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU<br/>Weighted Average<br/>Grant Date <br/>Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU Outstanding<br/>Number<br/>of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU<br/>Weighted Average<br/>Grant Date Fair Value</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-270" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1291">105,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-270" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1292">226.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-271" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1293">621,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-271" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1294">218.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-201" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1295">48,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-201" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1296">325.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-200" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1297">258,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-200" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1298">313.41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-201" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1299">9,975</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-201" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1300">177.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-200" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1301">120,458</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-200" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1302">223.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-201" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1303">124,186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-201" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1304">260.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-200" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1305">111,309</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-200" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1306">241.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-272" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1307">19,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-272" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1308">280.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-273" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1309">647,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-273" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1310">251.36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of RSUs vested for the year ended December&#160;31, 2024 totaled $<ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-1311">26.9</ix:nonFraction> million (2023: $<ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-1312">35.4</ix:nonFraction> million). The share price range for the year was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-274" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="f-1313">174.96</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="c-275" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="f-1314">265.96</ix:nonFraction> (2023: $<ix:nonFraction unitRef="usdPerShare" contextRef="c-276" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="f-1315">159.33</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="c-277" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="f-1316">265.96</ix:nonFraction>).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of PSUs vested for the year ended December&#160;31, 2024 totaled $<ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-1317">1.8</ix:nonFraction> million (2023: $<ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-1318">7.5</ix:nonFraction> million). The share price range for the year was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-278" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="f-1319">174.96</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="c-279" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="f-1320">231.08</ix:nonFraction> (2023: $<ix:nonFraction unitRef="usdPerShare" contextRef="c-280" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="f-1321">159.33</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="c-281" decimals="2" name="iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" scale="0" id="f-1322">166.51</ix:nonFraction>).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The PSUs vest based on service and specified EPS targets over the period 2022 &#8211; 2024, 2023 &#8211; 2025, and 2024 - 2026. Depending on the actual amount of EPS from 2022 to 2026, up to an additional <ix:nonFraction unitRef="shares" contextRef="c-282" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-1323">80,051</ix:nonFraction> PSUs may also be granted.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Stock compensation expense</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations for the year ended December&#160;31, 2024 is stated after charging $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-1324">45.9</ix:nonFraction> million in respect of stock compensation expense (inclusive of employer related taxes). <ix:nonNumeric contextRef="c-1" name="iclr:ScheduleOfNonCashStockCompensationExpenseTableTextBlock" id="f-1325" continuedAt="f-1325-1" escape="true">Stock compensation expense has been allocated as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-1325-1"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1326">26,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1327">26,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1328">22,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1329">19,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1330">29,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1331">47,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1332">45,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1333">55,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1334">70,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, total unrecognized stock-based compensation expense related to outstanding non-vested stock-based compensation arrangements amounted to $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="6" id="f-1335">108.1</ix:nonFraction> million, which the Company expects to recognize over a weighted average period of <ix:nonNumeric contextRef="c-1" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-1336">2.29</ix:nonNumeric> years.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">135</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1219-4"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The income tax expense for the year ended December&#160;31, 2024 reflects a net income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-1337">23.4</ix:nonFraction> million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2024 was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="f-1338">10.1</ix:nonFraction> million. The income tax expense for the year ended December&#160;31, 2023 reflects a net income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-1339">20.0</ix:nonFraction> million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="f-1340">10.9</ix:nonFraction> million. The income tax expense for the year ended December&#160;31, 2022 reflects a net income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-1341">12.9</ix:nonFraction> million in connection with stock compensation (including excess tax benefits) and the total tax benefit realized in connection with stock options exercised during 2022 was $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="f-1342">7.7</ix:nonFraction> million.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_235"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">22. <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-1343" continuedAt="f-1343-1" escape="true">Business Segment and Geographical Information</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-1343-1" continuedAt="f-1343-2"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">The Company is a CRO providing outsourced services on a global basis to pharmaceutical, biotechnology, medical device and government and public health organizations. It specializes in the strategic development, management and analysis of programs that support all stages of the clinical development process - from compound selection to Phase I-IV clinical studies. The Company has the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and has the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" or &#8220;blended-service&#8221; solution. The Company has expanded through internal growth, together with a number of strategic acquisitions to enhance its expertise and capabilities in certain areas of the clinical development process. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">The Company operates as <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-1344">one</ix:nonFraction> reportable segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries.  For each of the accounting periods presented herein, the Company determined that Chief Operating Decision Maker ('CODM') was comprised of the Chief Executive Officer and the Chief Financial Officer. As the Company is managed on a consolidated basis, the CODM evaluates performance and allocates resources based on consolidated net income. The CODM uses consolidated net income, as reported on the Consolidated Statement of Operations, to evaluate income generated from segment assets and for decisions related to the deployment of operating and capital resources.  The measure of segment assets is reported on the Consolidated Balance Sheet as total consolidated assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accounting policies of the reportable segment are the same as those described in Note 2. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. In the context of considerations around significant segment expenses, as the expense information that is regularly provided to the CODM is aligned with the respective consolidated expenses for direct costs and selling, general, and administrative expenses, as presented on the Consolidated Statement of Operations, such expense disclosures are not replicated here. Furthermore, as the Company consists of a single reportable segment, other quantitative disclosures, as required by Topic 280, are as presented on the Consolidated Statement of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues are allocated to individual entities based on where the work is performed in accordance with the Company's global transfer pricing model. Revenues and income from operations in Ireland are a function of our global contracting model and the Group&#8217;s transfer pricing model. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON Ireland acts as the Group entrepreneur under the Company&#8217;s global transfer pricing model given its role in the development and management of the Group, its ownership of key intellectual property and customer relationships, its key role in the mitigation of risks faced by the Group and its responsibility for maintaining the Company&#8217;s global network. ICON Ireland enters into the majority of the Company&#8217;s customer contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON Ireland remunerates other operating entities in the Group on the basis of an arm&#8217;s length return for the services they perform in each of their local territories. The arm&#8217;s length return for each ICON entity is established to ensure that each of ICON Ireland and the ICON entities that are involved in the conduct of services for customers, earn an appropriate return having regard to their respective functions performed, assets owned, and risks assumed in these intercompany transactions. The arm&#8217;s length return is reviewed annually to ensure that it is market appropriate. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The geographic split of revenue disclosed for each region outside Ireland is the arm&#8217;s length revenue attributable to these entities. The residual revenues of the Group, once each ICON entity has been paid its respective intercompany service fee, generally fall to be retained by ICON Ireland. As such, revenues and income from operations in Ireland are a function of this global transfer pricing model and comprise revenues of the Group after deducting the arm&#8217;s length revenues attributable to the activities performed outside Ireland.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no changes to the overall basis of segmentation or the measurement basis for the segment results since the prior year. </span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">136</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1343-2"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reportable geographic information at December&#160;31, 2024 and December&#160;31, 2023 and for the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022 is as follows:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a) <ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="f-1345" continuedAt="f-1345-1" escape="true">The distribution of revenue by geographical area was as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-1345-1"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1346">2,793,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1347">2,377,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1348">1,984,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1349">1,560,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-284" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1350">1,574,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-285" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1351">1,618,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1352">2,985,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1353">3,283,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1354">3,574,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1355">942,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-287" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1356">884,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1357">563,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1358">8,281,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1359">8,120,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1360">7,741,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b) <ix:nonNumeric contextRef="c-1" name="iclr:OperatingIncomeByGeographyTableTextBlock" id="f-1361" continuedAt="f-1361-1" escape="true">The distribution of income from operations by geographical area was as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-1361-1"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1362">919,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1363">885,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1364">673,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1365">216,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-284" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1366">154,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-285" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1367">254,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1368">241,549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1369">314,982</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1370">260,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1371">70,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-287" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1372">60,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1373">68,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sub-total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1374">1,448,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-290" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1375">1,416,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-291" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1376">1,258,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization on intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-1377">350,292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-290" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-1378">459,854</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-291" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-1379">463,087</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1380">1,097,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1381">956,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1382">795,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c) <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="f-1383" continuedAt="f-1383-1" escape="true">The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-1383-1"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-292" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1384">234,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-293" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1385">199,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-294" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1386">88,556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-295" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1387">94,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1388">145,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-296" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1389">159,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1390">62,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1391">49,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span id="i85f7edaad3fa4a85a9148d91477e5119_6-1-1-1-401854"></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1392">530,481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1393">501,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">137</span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_241"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">23. <ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-1394" continuedAt="f-1394-1" escape="true">Net Income Per Ordinary Share</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-1394-1"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There is no difference in net income used for basic and diluted net income per ordinary share.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-1395" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for basic net income per ordinary share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1396">82,482,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1397">82,101,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1398">81,532,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive share options and other awards outstanding under share based compensation programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-1399">549,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-1400">615,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-1401">936,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1402">83,032,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1403">82,717,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1404">82,468,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income per ordinary share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1405">9.60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1406">7.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1407">6.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1408">9.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1409">7.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1410">6.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="i70380bb88cac48169f2186a4a94094c5_244"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">24. <ix:nonNumeric contextRef="c-1" name="iclr:AccumulatedOtherComprehensiveIncomeLossTextBlock" id="f-1411" continuedAt="f-1411-1" escape="true">Accumulated Other Comprehensive Loss</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="f-1412" escape="true"><ix:continuation id="f-1411-1"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1413">234,075</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1414">149,148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remeasurement of retirement benefit obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1415">1,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1416">7,803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain / (loss) on cash flow hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="iclr:AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-1417">2,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="iclr:AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-1418">2,161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1419">229,929</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-1420">143,506</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="margin-top:5pt"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_247"></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">25. <ix:nonNumeric contextRef="c-1" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="f-1421" continuedAt="f-1421-1" escape="true">Supplemental Disclosure of Cash Flow Information</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="f-1422" escape="true"><ix:continuation id="f-1421-1"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-1423">196,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-1424">317,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-1425">210,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for income taxes (net of refunds)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-1426">140,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-1427">163,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-1428">116,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="margin-top:3pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">138</span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_250"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">26.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="f-1429" continuedAt="f-1429-1" escape="true">Related Parties </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-1429-1" continuedAt="f-1429-2"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">During the year, subsidiaries of the Company earned revenue of $<ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" name="us-gaap:Revenues" scale="6" id="f-1430">0.3</ix:nonFraction> million (December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="us-gaap:Revenues" scale="6" id="f-1431">0.2</ix:nonFraction> million) from Corvus Pharmaceuticals. Dr. Linda Grais serves as a Director and shareholder</span><span style="color:#0094ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">of Corvus Pharmaceuticals. At December&#160;31, 2024, $<ix:nonFraction unitRef="usd" contextRef="c-301" decimals="-3" name="us-gaap:OtherReceivables" scale="6" id="f-1432">0.1</ix:nonFraction> million (December&#160;31, 2023: $<ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-3" name="us-gaap:OtherReceivables" scale="6" id="f-1433">0.1</ix:nonFraction> million) was noted as due from Corvus Pharmaceuticals . </span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:continuation id="f-1429-2" continuedAt="f-1429-3"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">During the year, subsidiaries of the Company earned revenu</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">e of $<ix:nonFraction unitRef="usd" contextRef="c-303" decimals="-3" name="us-gaap:Revenues" format="ixt-sec:numwordsen" scale="0" id="f-1434">nil</ix:nonFraction> (December&#160;31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="c-304" decimals="-3" name="us-gaap:Revenues" scale="6" id="f-1435">0.05</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">) from Afimmune Limited. Dr. John Climax is Chief Executive Officer and a Director and shareholder of Afimmune Limited. At December&#160;31, 2024, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="c-305" decimals="-3" name="us-gaap:OtherReceivables" scale="6" id="f-1436">0.1</ix:nonFraction> million was no</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">ted as due from Afimmune Limited (December&#160;31, 2023: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="c-306" decimals="-3" name="us-gaap:OtherReceivables" scale="6" id="f-1437">0.05</ix:nonFraction> million</span></ix:continuation><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:continuation id="f-1429-3">).</ix:continuation>&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i70380bb88cac48169f2186a4a94094c5_253"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">27.  </span><ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-1438" continuedAt="f-1438-1" escape="true"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Subsequent Events</span></ix:nonNumeric></div><div><span><br/></span></div><ix:continuation id="f-1438-1"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Company has evaluated subsequent events from the Balance Sheet date th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">rough February&#160;21, 2025, t</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">he date at which the consolidated financial statements were available to be issued. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">On February 18, 2025, the Company's Board of Directors authorized an additional buyback program of up to $<ix:nonFraction unitRef="usd" contextRef="c-307" decimals="-5" name="srt:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="f-1439">750.0</ix:nonFraction>&#160;million of the outstanding ordinary shares of the Company. Along with unutilized amounts under the previous authorizations, this permits the Company to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-9" name="srt:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="f-1440">1</ix:nonFraction>&#160;billion worth of ordinary shares. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">All ordinary shares that are redeemed under the buyback program will be canceled in accordance with the constitutional documents of the Company and the nominal value of these shares transferred to an undenominated capital fund as required under Irish Company law. Repurchases under the share buyback program may be effected from time to time in open market or privately negotiated transactions in accordance with agreed terms and limitations. The timing and amount of the repurchase transactions under this program will depend on a variety of factors, including market conditions and corporate and regulatory considerations. Depending upon results of operations, market conditions and the development of the economy, as well as other factors, generally we will consider share repurchases on an opportunistic basis from time to time.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Company has determined that there ar</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">e no other items t</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">o disclose.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">139</span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_256"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 19. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Exhibits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibits of ICON plc and subsidiaries</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:81.917%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001060955/000114036121006002/nc10020781x8_ex2-1.htm">2.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Agreement and Plan of Merger, dated as of February 24, 2021, by and among ICON plc, ICON US Holdings Inc., Indigo Merger Sub, Inc and PRA Health Sciences, Inc. (incorporated by reference to exhibit 2.1 to the Form 6-K (file No. 333-08704) filed on February 24, 2021).</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit22-2024.htm">2.2*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Description of Securities Registered Under Section 12 of the Exchange Act.</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001060955/000114036121023058/nt10026444x8_ex99-1.htm">2.3</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Credit Agreement, dated as of July 1, 2021, by and among ICON Luxembourg, S.&#192; R.L., ICON Clinical Investments, LLC, Indigo Merger Sub, Inc. (which, after giving effect to the Merger on the Closing Date was succeeded by PRA Health Sciences, Inc.), ICON Public Limited Company, the other borrowers party thereto from time to time, the subsidiary guarantors party thereto from time to time, lenders party thereto Citibank, N.A., as administrative agent, and Citibank, N.A., London Branch, as collateral agent (incorporated by reference to exhibit 99.1 to the Form 6-K (File No. 333-08704) filed on July 1, 2021).</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001060955/000114036121023058/nt10026444x8_ex99-2.htm">2.4</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Indenture, dated as of July 1, 2021, by and among Indigo Merger Sub, Inc., PRA Health Sciences, Inc., the guarantors party thereto and Citibank, N.A., London Branch as trustee, notes collateral agent, paying agent, transfer agent and registrar (incorporated by reference to exhibit 99.2 to the Form 6-K (File No. 333-08704) filed on July 1, 2021).</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1060955/000106095523000007/exhibit25-2022.htm">2.5</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Amendment No. 1 to the Credit Agreement referred to at Exhibit 2.3, dated as of November 29, 2022, by and among ICON Public Limited Company and Citibank, N.A., as administrative agent. (incorporated by reference to exhibit 2.5 to the Form 20-F (File No. 333-08704) filed on February 24, 2023).</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1060955/000106095523000027/exhibit991-q22023.htm">2.6</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Second Amendment to Credit Agreement, dated as of May 2, 2023, by and among various subsidiaries of ICON plc, Citibank, N.A., as administrative agent and swingline lender, and various revolving lenders. (incorporated by reference to exhibit 99.1 to the Form 6-K (File No. 333-08704) filed on July 28, 2023).</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1060955/000106095524000028/ex991icon-amendmentno3.htm">2.7</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Third Amendment to Credit Agreement, dated as of March 14, 2024, by and among various subsidiaries of ICON plc, Citibank, N.A., as administrative agent and swingline lender, and various revolving lenders (incorporated by reference to exhibit 99.1 to the Form 6-K (File No. 333-08704) filed on April 25, 2024).</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1060955/000114036124024935/ny20027656x5_ex4-1.htm">2.8</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indenture, dated May 8, 2024, among ICON Investments Six Designated Activity Company, ICON public limited company and Citibank, N.A., as trustee (incorporated by reference to exhibit 4.1 to the Form 6-K (File No. 333-08704) filed on May 8, 2024).</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1060955/000114036124024935/ny20027656x5_ex4-2.htm">2.9</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">First Supplemental Indenture, dated May 8, 2024, among ICON Investments Six Designated Activity Company, ICON public limited company, the other guarantors party thereto, Citibank N.A., as trustee and Citibank, N.A., London Branch, as notes collateral agent, including the Forms of 5.809% Senior Secured Note due 2027, 5.849% Senior Secured Note due 2029 and 6.000% Senior Secured Note due 2034 (incorporated by reference to exhibit 4.2 to the Form 6-K (File No. 333-08704) filed on May 8, 2024).</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1060955/000115752316006157/a51386268ex99_2.htm">3.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Description of the Constitution of the Company (incorporated by reference to exhibit 99.2 to the Form 6K (File No. 333-08704) filed on July 25, 2016).</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="iconplcsharetradingpolicya.htm">11.1*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share Trading Policy.</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit121-2024.htm">12.1*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Section 302 certifications.</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit122-2024.htm">12.2*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Section 906 certifications.</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit161-2024.htm">16.1*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Letter from KPMG to the Securities and Exchange Commission, dated February&#160;21, 2025.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6f25ed905b654d7bbdfcf53e85d92c03_118797">21.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">List of Subsidiaries (incorporated by reference to Item 4 of Form 20-F filed herewith).</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="icon-ex22guarantorschedule.htm">22.1*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">List of Subsidiary Guarantors and Issuer of Guaranteed Debt Securities and Affiliates Whose Securities Collateralize Securities of ICON Investments Six Designated Activity Company.</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit231-2024.htm">23.1*</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consent of KPMG, Independent Registered Public Accounting Firm.</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="iconplcclawbackpolicyasupd.htm">97</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ICON plc Clawback Policy, adopted on July 25, 2023 and amended on February 18, 2025 relating to recovery of erroneously awarded compensation, as required by applicable listing standards adopted pursuant to 17 CFR 240.10D-1.</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.1*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interactive Data Files (Inline XBRL &#8211; Related Documents).</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101).</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* &#160; Filed herewith</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">140</span></div></div></div><div id="i70380bb88cac48169f2186a4a94094c5_259"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.506%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.271%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ICON plc</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">/s/ Nigel Clerkin</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3.9pt;padding-right:3.6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Nigel Clerkin</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Date: February&#160;21, 2025 </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">141</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.2
<SEQUENCE>2
<FILENAME>exhibit22-2024.htm
<DESCRIPTION>EX-2.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ibe85ace866f54369bd307656b4186e9d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 2.2</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Description of Securities  </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">    Registered Under Section 12 of the Exchange Act </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2024 ICON plc (&#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221;) had the following series of securities registered pursuant to Section 12(b) of the Exchange Act&#58; </font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:34.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.179%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.187%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading symbol</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ordinary shares, nominal value &#8364;0.06 per share</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ICLR</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NASDAQ Global Select Market</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="padding-left:180pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Ordinary Shares </font></div><div style="padding-left:180pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.General</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.A.1. Limitations or qualifications </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable. </font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.A.2. Other rights </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable. </font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.A.3. Type and class of securities </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Each ICON plc share has nominal value of &#8364;0.06 per share. The respective number of shares that have been issued as of December&#160;31, 2024 is given in the Consolidated Balance Sheet of the annual report on Form 20-F for the fiscal year ended December&#160;31, 2024. All ICON shares have equal voting rights and carry equal entitlements to dividends. No participation certificates, non-voting equity securities or profit-sharing certificates have been issued. </font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.A.4. Pre-emptive rights</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable. </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 10.B Memorandum and articles of association</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> 10.B.1 Shareholder Rights, Preferences and Dividends Attaching to Shares </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has only one class of shares, Ordinary Shares with a par value of &#8364;0.06 per share. All such Ordinary Shares rank equally with respect to voting, payment of dividends and on any winding-up of the Company. Any dividend, interest or other sum payable to a shareholder that remains unclaimed for one year after having been declared may be invested by the Directors for the benefit of the Company until claimed. If the Directors so resolve, any dividend which has remained unclaimed for 12 years from the date of its declaration shall be forfeited and cease to remain owing by the Company. In the event of the Company being wound up, if the assets available for distribution among the Members shall be more than sufficient to repay the whole of the share capital paid up or credited as paid up at the commencement of the winding up, the excess shall be distributed among the Members in proportion to the capital at the commencement of the winding up paid up or credited as paid up on the said Ordinary Shares held by them respectively. An Ordinary Share shall be deemed to be a redeemable share in certain circumstances. The liability of shareholders to invest additional capital is limited to the amounts remaining unpaid on the shares held by them.</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.B.2. Action Necessary to Change the Rights of Shareholders </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The rights attaching to shares in the Company may be varied by special resolutions passed at class meetings of that class of shareholders of the Company.</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.B.3  Annual and General Meetings</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The AGM shall be held in such place and at such time as shall be determined by the board, but no more than 15&#160;months shall pass between the dates of consecutive AGMs. Directors may call an Extraordinary General Meeting (&#8220;EGM&#8221;) at any time. The members, in accordance with the Constitution of the Company and Irish Company law, may also requisition EGMs. Notice of the AGM or an EGM passing any special resolution must be given at least 21&#160;clear days prior to the scheduled date and, in the case of any other general meeting, not less than 14 clear days&#8217; notice. All holders of Ordinary Shares are entitled to attend, speak at and vote at general meetings of the Company.</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.B.4 Limitations on the Right to Own Shares </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;There are no limitations on the right to own shares in the Constitution of the Company.</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.B.5 Disclosure of Share Ownership </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under Irish law, the Company can require parties to disclose their interests in shares. The Constitution of the Company entitle the Directors to require parties to provide details regarding their identity and the nature and extent of any interest which such parties hold in Ordinary Shares. Under Irish law, if a party acquires or disposes of Ordinary Shares so as to bring their interest above or below 3% of the total issued share capital of the Company, they must notify the Company of that. The Company would also need to be notified of the acquisition by an existing substantial (i.e. 3% plus) shareholder, of every movement of one whole percentage integer (e.g. 3.9% to 4.1% but not 4.1% to 4.9%) or more.</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">10.B.6 Other Provisions of the Constitution</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;There are no provisions in the Constitution of the Company&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(i) delaying or prohibiting a change in the control of the Company, but which operate only with respect to a merger, acquisition or corporate restructuring&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(ii) discriminating against any existing or prospective holder of shares as a result of such shareholder owning a substantial number of shares&#59; or</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(iii) governing changes in capital, in each case, where such provisions are more stringent than those required by law.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-11.1
<SEQUENCE>3
<FILENAME>iconplcsharetradingpolicya.htm
<DESCRIPTION>EX-11.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ib74cbe93a2c5477cb099fc271bfa91f5_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 11.1</font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><img alt="image_0.jpg" src="image_0.jpg" style="height:51px;margin-bottom:5pt;vertical-align:text-bottom;width:189px"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ICON plc Share Trading Policy </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Adopted on 13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> August 2013 and </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">amended on 25</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> April 2017, 23</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> April 2018,19</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> June 2021, 21</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> February 2023 and 18</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> February 2025</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">This Share Trading Policy provides the standards of ICON plc and its Subsidiaries (together the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">Group</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">&#8221;, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">ICON</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">&#8221;) on trading and causing the trading of ICON&#8217;s securities or securities of other publicly-traded companies while in possession of material, non-public information. The Policy has been designed to ensure that all relevant persons know their responsibilities when trading in ICON securities (and &#47; or securities of other companies while in possession of material, non-public information obtained as a result of working with ICON) and to promote transparency and market confidence in the operations of ICON.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">Various applicable securities laws and regulations (such as the rules and regulations of the Securities and Exchange Commission (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">SEC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">&#8221;) and the listing rules of NASDAQ Global Select Market (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">NASDAQ</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">&#8221;)) prohibit &#8220;insider trading&#8221;. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">Simply stated, insider trading occurs when a person uses &#8220;material non-public&#8221; information to make decisions to purchase, sell, give away or otherwise trade securities or provides that information to others outside the Company to enable such trading, sometimes referred to as &#8220;tipping&#8221;.  These terms are defined in this Policy under Section 3 below. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%;padding-left:26.84pt;text-decoration:underline">Applicability</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">This Policy applies to all members of the Board of Directors, officers and employees of ICON (collectively, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">Covered Persons</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">&#8221;). This Policy applies to all transactions by Covered Persons in ICON&#8217;s securities, including common stock, restricted share units, options and any other securities that ICON may issue, such as preferred stock, notes, bonds and convertible securities, as well as to derivative securities relating to any of ICON&#8217;s securities, whether or not issued by ICON, and to all transactions in such securities by a Covered Person&#8217;s immediate family members (parents, siblings, spouses, children) and other persons living in a Covered Person&#8217;s household, or by persons or entities over which a Covered Person exercises control.</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">The terms of this Policy apply to all share trades irrespective of whether the shares are obtained on the open market or via ICON&#8217;s employee share schemes and whether they conducted via ICON&#8217;s chosen broker or platform or via any other platform, broker, online or otherwise. </font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">The Policy also applies to all transactions in an external company&#8217;s securities that a Covered Person has material non-public information about due to a Covered Person&#8217;s involvement with </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><img alt="image_1.jpg" src="image_1.jpg" style="height:28px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">or work for ICON. This again includes common stock, restricted share units, options and any other securities that companies may issue, such as preferred stock, notes, bonds and convertible securities, as well as to derivative securities, whether or not issued by the company itself. </font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">This Policy also applies to the Company, as applicable.  From time to time, the Company may engage in transactions in its own securities, including sales of securities and repurchases.  It is the Company&#8217;s policy to comply with all applicable securities and state laws (including appropriate approvals by the Board of Directors if required) when engaging in transactions in its own securities, including any applicable restrictions on insider trading.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%;padding-left:26.84pt;text-decoration:underline">General Policy&#58; No Trading or Causing Trading While in Possession of Material Non-Public Information</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:8.23pt">No Covered Person may purchase, sell or otherwise transfer (except for the exercise of stock options so long as common stock is retained) any ICON securities while in possession of material non-public information about ICON. (The terms &#8220;material&#8221; and &#8220;non-public&#8221; are defined in Section 3(c) and (d) below.)</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:8.23pt">No Covered Person who knows of any material non-public information about ICON may communicate that information to any other person outside ICON, including family and &#47; or friends.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:8.84pt">In addition, no Covered Person may purchase or sell any security of any other company while in possession of material non-public information about that company that was obtained in the course of his or her involvement with ICON. No Covered Person who knows of any such material non-public information may communicate that information to any other person outside ICON, including family and &#47; or friends.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:8.23pt">For compliance purposes, you should never trade, tip or recommend securities (or otherwise cause the purchase, sale or other transfer of securities) while in possession of information that you have reason to believe is material and non-public (which is defined in Section 3(c) and (d) below) unless you first consult with the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">Corporate Governance team</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">, and obtain the advance approval of the General Counsel.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:8.23pt">Restricted Covered Persons (as defined in Section 5) are also prohibited from trading in ICON&#8217;s securities during blackout periods as set out in Section 5. Restricted Covered Persons that are not in possession of any material non-public information are permitted to trade in ICON&#8217;s securities only when no blackout period is in effect as set out in Section 6.</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:11.29pt">Individuals listed on the Insider List (as defined in Section 7) must &#8220;pre-clear&#8221; all trading in securities of ICON in accordance with the procedures set forth in Section 8 below and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><img alt="image_1.jpg" src="image_1.jpg" style="height:28px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">are also prohibited from engaging in the transactions set out in Section 9 unless advance approval is obtained from the General Counsel. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:8.23pt">You should exercise care when speaking with other personnel who do not have a &#8220;need to know&#8221; and when communicating with family, friends and others who are not associated with us, even if they are subject to this Policy. To avoid even the appearance of impropriety, please refrain from discussing our business or prospects or making recommendations about buying or selling our securities or the securities of other companies with which we have a relationship. The concept of unlawful tipping includes passing on information to friends, family members or acquaintances under circumstances that suggest that you were trying to help them make a profit or avoid a loss, or obtain some other benefit from the information.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:7.63pt">In an effort to prevent unauthorized disclosure of our information, you are prohibited from any unauthorized posting or responding to any posting on or in Internet message boards, chat rooms, discussion groups, or other publicly accessible forums, with respect to us. Keep in mind that any inquiries about ICON should be directed to</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%"> ICON&#8217;s Marketing team.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%;padding-left:26.84pt;text-decoration:underline">Definitions</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%;padding-left:8.23pt;text-decoration:underline">Cybersecurity</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">- the activity or process, ability or capability, or state whereby information and communications systems and the information contained within these systems are protected from and &#47; or defended against damage, unauthorized use or modification, or exploitation.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%;padding-left:8.23pt;text-decoration:underline">Cybersecurity Incident</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">- An occurrence that actually or potentially results in adverse consequences to an information system or the information that the system processes, stores, or transmits and that may require a response action to mitigate the consequences. </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">A cybersecurity incident can result from unintentional events or deliberate attacks. </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">For example, the use of stolen access credentials, malware, ransomware, phishing or other unauthorized information systems action to&#58; (i) access, steal or destroy financial assets, intellectual property, or other sensitive information belonging to ICON (including an ICON acquisition), clients or business partners&#59; or (ii) otherwise materially disrupt operations.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%;padding-left:8.84pt;text-decoration:underline">Materiality</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%"> Information is generally regarded as &#8220;material&#8221; if there is a substantial likelihood that a reasonable investor would consider the information important in making a decision to buy, hold or sell a security. If the  public dissemination of the information would, or reasonably could be expected to, affect the market price of securities (whether positively or negatively) such information should be considered material.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><img alt="image_1.jpg" src="image_1.jpg" style="height:28px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">While, depending on the circumstances, any type of information could be deemed material, information dealing with the following subjects should be assumed to be reasonably likely to be found material in particular situations&#58;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:12.51pt">significant changes in ICON&#8217;s prospects&#59;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">ii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:10.07pt">significant write-downs in assets or increases in reserves&#59;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">iii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:7.63pt">developments regarding significant litigation or government agency investigations&#59;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">iv.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:7.01pt">liquidity problems&#59;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">v.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:9.45pt">changes in earnings estimates or unusual gains or losses in major operations&#59;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">vi.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:7.01pt">success or otherwise or the status  of a clinical trial&#59;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">vii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:4.57pt">changes in management, other major personnel changes or labour negotiation&#59;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">viii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:2.13pt">changes in dividends&#59;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">ix.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:7.01pt">extraordinary borrowings&#59;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">x.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:9.45pt">gain or loss of a significant contract, customer or supplier or significant material changes in the profitability status of a current significant contract&#59;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">xi.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:7.01pt">changes in debt ratings&#59;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">xii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:4.57pt">proposals, plans or agreements, even if preliminary in nature, involving mergers, acquisitions, divestitures, recapitalizations, strategic alliances, licensing arrangements, or purchases or sales of substantial assets&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">xiii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:2.13pt">the development or release of a new product or service&#59;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">xiv.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:1.51pt">changes in a previously announced schedule for the development or release of a new product or service&#59;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">xv.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:3.95pt">a Cybersecurity Incident&#59;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">xvi.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:1.51pt">public or private offerings of securities&#59; and</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">xvii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:35.07pt">pending statistical reports (such as reports relating to treasury information, awards information or interest rate developments).</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">Material information is not limited to historical facts but may also include projections and forecasts. With respect to a future event, such as a merger, acquisition or introduction of a new product, the point at which negotiations or product development are determined to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><img alt="image_1.jpg" src="image_1.jpg" style="height:28px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">be material is determined by balancing the probability that the event will occur against the magnitude of the effect the event would have on ICON&#8217;s operations or stock price should it occur. Thus, information concerning an event that would have a large effect on stock price, such as a merger, may be material even if the possibility that the event will occur is relatively small. </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">When in doubt about whether particular non-public information is material, presume it is material. </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">If you are unsure whether information is material, you should consult the Corporate Governance team before making any decision to disclose such information (other than to persons who need to know it in the ordinary course of the Company&#8217;s business) or to trade in or recommend securities to which that information relates.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%;padding-left:8.23pt;text-decoration:underline">Non-Public Information-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%"> The fact that information has been disclosed to a few members of the public does not make it public for insider trading purposes. In order for information to be considered public, it must be widely disseminated in a manner making it generally available to investors. Typically this is done through publication in a widely-available newspaper, magazine or news website, such as Dow Jones, Reuters Economic Services, The Wall Street Journal, Associated Press, or through a broadcast on widely-available radio or television programs, publication in a widely-available newspaper, magazine or news website, or public disclosure documents filed with the SEC or that are available on the SEC&#8217;s website.  Even after a public announcement, a reasonable period of time must elapse in order for the market to absorb the information. What is a reasonable period of time is dependent on the facts and circumstances of the situation.  In order to provide clarity, this policy requires that Covered Persons should allow two full trading days to lapse following publication before such information is deemed to be public.</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;text-decoration:underline">Non-public information may include&#58;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:12.51pt">information available to a select group of analysts or brokers or institutional investors&#59;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">ii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:10.07pt">undisclosed facts that are the subject of rumours, even if the rumours are widely circulated&#59; and</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">iii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:7.63pt">information that has been entrusted to ICON on a confidential basis until a public announcement of the information has been made and enough time has elapsed for the market to respond to a public announcement of the information. An example of this may be the results of a clinical trial or news of a potential merger of our clients or other material information about clients which you may hear in the course of your employment.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><img alt="image_1.jpg" src="image_1.jpg" style="height:28px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">As with questions of materiality, if you are not sure whether information is considered non-public, you should either consult with the Corporate Governance team or assume that the information is &#8220;non-public&#8221; and treat it as confidential.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%;padding-left:8.23pt;text-decoration:underline">Compliance</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%"> ICON has appointed the General Counsel to oversee the implementation and governance of this Policy. The duties include, but are not limited to, the following&#58;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:12.51pt">assisting with implementation of this Policy&#59;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">ii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:10.07pt">circulating this Policy to all employees and ensuring that this Policy is amended as necessary to remain up-to-date with insider trading laws&#59;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">iii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:7.63pt">notifying the applicable Covered Persons as appropriate of the Company&#8217;s imposition of a special &#8220;blackout&#8221; period as described Section 5 below&#59;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">iv.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:7.01pt">maintaining the Insider List as set out in Section 7&#59;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">v.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:9.45pt">setting up procedures for pre-clearing all trading in securities of ICON by persons on the Insider List in accordance with the procedures set forth in Section 8 below&#59; and</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">vi.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:7.01pt">reviewing requests from individuals listed on the insider list to engage in transactions set out in Section 9 below.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">The Compliance duties of the General Counsel set out in this Policy may also be fulfilled by the Chief Financial Officer or the Chief Executive Officer when the General Counsel is absent or unavailable.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">If any person has any doubt as to whether information in his or her possession is material and non-public, such person shall not disclose that information without first contacting the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">Corporate Governance team</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%"> who will liaise with the General Counsel as required. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%;padding-left:26.84pt;text-decoration:underline">Violations of Insider Trading Laws</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">Penalties for trading on or communicating material non-public information can be severe, both for individuals involved in such unlawful conduct and their employers and supervisors, and may include jail terms, criminal fines, civil penalties and civil enforcement injunctions. Given the severity of the potential penalties, compliance with this Policy is absolutely mandatory.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">In addition, a person who &#8220;tips&#8221; others may also be liable for transactions by the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:135%">tippees</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%"> to whom he or she has disclosed material non-public information. Tippers can be subject to the same penalties and sanctions as the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:135%">tippees</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">, and large penalties have been imposed even when the tipper did not profit from the transaction.  Similarly, aiding and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><img alt="image_1.jpg" src="image_1.jpg" style="height:28px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">abetting claims for securities fraud violations may be brought against secondary actors for providing knowing and substantial assistance to a primary securities law violator.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">The SEC can also seek substantial penalties from any person who, at the time of an insider trading violation, &#8220;directly or indirectly controlled the person who committed such violation,&#8221; which could apply to ICON and&#47;or management and supervisory personnel.  Civil plaintiffs may also bring control person claims against management or directors in private litigation.</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">Non-compliance with insider trading laws and &#47; or this Policy is also a non-compliance with ICON&#8217;s Global Code of Ethical Conduct. Employees who violate this Policy may be subject to disciplinary action by ICON, including dismissal for cause. Any exceptions to the above requirements, if permitted, may only be granted by the General Counsel in writing and must be provided before any activity contrary to these requirements takes place. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%;padding-left:26.29pt;text-decoration:underline">Blackout Periods</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">All Covered Persons who are (i) directors, officers or employees at the level of Vice President and above or (ii) designated by the General Counsel, and (iii) immediate family members (parents, siblings, spouses, children) and other persons living in such persons household  and (iv) any persons or entities each of them controls (collectively, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">Restricted Covered Persons</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">&#8221;) are prohibited from trading in ICON&#8217;s securities during blackout periods.  </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%;padding-left:8.23pt;text-decoration:underline">Quarterly Blackout Periods</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%"> Trading in ICON&#8217;s securities is prohibited during the period beginning at the close of the market on the nineteenth day of the last month of each fiscal quarter and ending at the close of the market on the second full trading day following the date ICON&#8217;s financial results are publicly disclosed. During these periods, Restricted Covered Persons may generally be presumed to possess material non-public information about ICON&#8217;s financial results.  </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">ICON&#8217;s fiscal quarters are&#58; Q1&#58; January - March, Q2&#58; April - June, Q3&#58; July - September, Q4&#58; October - December.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">&#160;&#160;&#160;&#160;The specific dates of the blackout periods are available from the MyICON homepage. </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%;padding-left:8.23pt;text-decoration:underline">Special Blackout Periods</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%"> From time to time, other types of material non-public information regarding ICON (such as negotiation of mergers, acquisitions or dispositions, the identification of a significant Cybersecurity risk or Incident or new product developments) may be pending and not be publicly disclosed. Until such material non-public information is publicly disclosed, ICON may impose special blackout periods during which Covered Persons with knowledge of or access to such material non-public information are prohibited from trading in ICON&#8217;s securities. </font></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">If ICON imposes a special blackout period, it will notify the Covered Persons affected.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><img alt="image_1.jpg" src="image_1.jpg" style="height:28px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%;padding-left:8.84pt;text-decoration:underline">Option and Restricted Share Unit Agreements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">- </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">A Close Period, for the purposes of interpretation of Option and Restricted Share Unit Plans, Agreements and terms and conditions, refers to any period where the relevant Covered Person is subject to either a quarterly blackout period or special blackout period.  </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%;padding-left:8.23pt;text-decoration:underline">Exception</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%"> The prohibition on trading in ICON securities while in possession of material non-public information does not apply to transactions under a written plan, contract, instruction, or arrangement under Rule 10b5-1 (an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">Approved 10b5-1 Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">&#8221;) that&#58;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:12.51pt">has been reviewed and approved by the General Counsel prior to adoption of the plan (or, if revised or amended, such revisions or amendments have been reviewed and approved by the General Counsel prior to adoption of such revisions or amendments)&#59;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">ii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:10.07pt">requires a &#8220;cooling off&#8221; period before any transactions may be initiated for at least 30 days after adoption of the plan or any revisions or amendments to the plan&#59; and, if the Covered Person is a director of ICON plc, an executive officer of ICON</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:135%;position:relative;top:-3.85pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">, or otherwise designated by the General Counsel, no transactions may be initiated until at least 90 days or (if later) two business days following disclosure of ICON&#8217;s financial results (for ICON's financial quarter in which the plan was adopted) in a Form 20-F or 6-K (but not more than 120 days) after adoption of (or any revisions or amendments to) the plan&#59;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">iii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:7.63pt">was entered into in good faith by the Covered Person at a time when the Covered Person was not in possession of material non-public information about ICON&#59; and, if the Covered Person is a director of ICON plc, an executive officer of ICON</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:135%;position:relative;top:-3.85pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">, or otherwise designated by the General Counsel,  the plan (and any revisions or amendments) includes a representation certifying that the Covered Person was not aware of material non-public information and that it was adopted in good faith and not as part of a plan or scheme to evade Rule 10b5-1&#59;</font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">iv.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:7.01pt">gives a third party the discretionary authority to execute such purchases and sales, outside the control of the Covered Person, so long as such third party does not possess any material non-public information about ICON&#59; or explicitly specifies the security or securities to be purchased or sold, the number of shares, the prices and&#47;or dates of transactions, or other formula(s) describing such transactions&#59; and</font></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">v.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:9.45pt">otherwise satisfies the requirements of Rule 10b5-1(c), including the limitations on overlapping and single-trade plans.</font></div><div style="border-bottom:0.54pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:144pt"></div><div style="margin-bottom:12pt;padding-left:14.2pt;text-indent:-7.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.1pt;font-weight:400;line-height:120%;position:relative;top:-4.89pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Within the meaning of NASDAQ Listing Rule 5608 and Exchange Act Rule 10D-1, including any &#8220;officer&#8221; under Exchange Act Rule 16a-1(f).</font></div><div style="margin-bottom:12pt;padding-left:14.2pt;text-indent:-7.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.1pt;font-weight:400;line-height:120%;position:relative;top:-4.89pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Within the meaning of NASDAQ Listing Rule 5608 and Exchange Act Rule 10D-1, including any &#8220;officer&#8221; under Exchange Act Rule 16a-1(f).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><img alt="image_1.jpg" src="image_1.jpg" style="height:28px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify"><font><br></font></div><div style="padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%;padding-left:26.29pt;text-decoration:underline">Trading Windows</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">In general, Covered Persons who are not Restricted Covered Persons, who have not been notified that they are subject to a special blackout period and are not otherwise in possession of material non-public information are permitted to trade in ICON&#8217;s securities without restriction.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">Restricted Covered Persons that are not in possession of any material non-public information are permitted to trade in ICON&#8217;s securities only when no blackout period is in effect. Generally, this means that Restricted Covered Persons that are not in possession of any material non-public information can trade only during the period beginning on the third full trading day following the date ICON&#8217;s financial results are publicly disclosed and ending at the close of the market on the nineteenth day of the last month of each fiscal quarter. However, even during a trading window, a Restricted Covered Person who is in possession of any material non-public information would not be permitted to trade in ICON&#8217;s securities until the information has been made publicly available or is no longer material. In addition, ICON may close this trading window for Restricted Covered Persons if a special blackout period under Section 5(b) above is imposed and will re-open the trading window once the special blackout period has ended. The fact that a special blackout period has been designated must also be kept confidential and must not be disclosed.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%;padding-left:26.84pt;text-decoration:underline">ICON Insider List</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">For purposes of this policy, ICON maintains an Insider List which includes the following individuals&#58;</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">I.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:11.9pt">all directors of ICON plc&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">II.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:8.85pt">all officers and employees of ICON who are members of ICON plc Leadership Team (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">ILT</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">&#8221;)&#59; and</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">III.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:5.8pt">other key employees and officers designated by the General Counsel.</font></div><div style="padding-left:35.45pt;text-align:justify"><font><br></font></div><div style="padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">Individuals listed on the Insider List are subject to the additional obligations and restrictions as set out in Section 8 and Section 9.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">ICON notifies each director, officer or employee when they are placed on the Insider List and they are required to acknowledge the additional obligations and restrictions that are set out in this Share Trading Policy.</font></div><div style="padding-left:35.45pt;text-align:justify"><font><br></font></div><div style="padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%;padding-left:26.29pt;text-decoration:underline">Pre-clearance of Securities Transactions</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:35.7pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">ICON requires all persons on the Insider List to refrain from trading, even during a trading window, without first pre-clearing all transactions in ICON&#8217;s securities, because </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><img alt="image_1.jpg" src="image_1.jpg" style="height:28px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:35.7pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">they are likely to be exposed to material non-public information on a regular basis. These pre-clearance procedures also apply to transactions by such person&#8217;s immediate family members (parents, siblings, spouses, children) and other persons living in such person&#8217;s household and by persons and entities over which such person exercises control. These pre-clearance procedures do not override the general prohibition on trading while in possession of material non-public information.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:35.7pt;text-align:justify;text-indent:-17.85pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:8.08pt">No person listed on the Insider List may, directly or indirectly, purchase or sell (or otherwise make any transfer, gift, pledge or loan of, except for the exercise of stock options so long as the common stock is retained) any ICON security at any time without first obtaining prior approval from the General Counsel. </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:8.23pt">Any person on the Insider List seeking to trade should contact the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">Corporate Governance team</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%"> in order to request the requisite permissions from the General Counsel.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:8.84pt">The date each request is received and the date and time each request is approved or disapproved shall be recorded. Unless revoked, a grant of permission will normally remain valid until the close of trading two trading days following the day on which it was granted. If the transaction does not occur during that period, pre-clearance of the transaction must be re-requested.  </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:8.23pt">The General Counsel must obtain approval to trade from either the Chief Financial Officer or the Chief Executive Officer.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:8.23pt">Notwithstanding the foregoing, pre-clearance is not required for purchases and sales of securities under an Approved 10b5-1 Plan. With respect to any purchase or sale under an Approved 10b5-1 Plan, the third party effecting transactions on behalf of the Covered Person should be instructed to send duplicate confirmations of all such transactions to the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">Corporate Governance team</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:135%;padding-left:26.29pt;text-decoration:underline">Prohibited Transactions</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">Certain types of transactions increase ICON&#8217;s exposure to legal risks and may create the appearance of improper or inappropriate conduct. Therefore, persons on the Insider List may not engage in any of the following transactions, even if they do not possess material non-public information, unless advance approval is obtained from the General Counsel.  These prohibitions also apply to transactions by such person&#8217;s immediate family members (parents, siblings, spouses, children) and by other persons living in such person&#8217;s household and by entities over which such person exercises control.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:39.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:8.23pt;text-decoration:underline">Short-term trading-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%"> Persons on the Insider List who purchase ICON securities in the open market may not sell any of the ICON securities of the same class during the six months following the transaction. Persons on the Insider List who sell ICON securities in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><img alt="image_1.jpg" src="image_1.jpg" style="height:28px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:39.3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">the open market may not purchase any ICON securities of the same class during the six months following the transaction.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:39.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:8.23pt;text-decoration:underline">Short sales of stock-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%"> &#8220;Short&#8221; sales of stock are transactions where you borrow stock, sell it, and then buy stock at a later date to replace the borrowed shares. Short sales of our securities by persons on the Insider List are prohibited.  These also include hedging or monetization transactions (such as zero-cost collars and forward sale contracts) that involve the establishment of a short position. See &#8220;Hedging transactions&#8221; below for more information.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:39.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:8.84pt;text-decoration:underline">Publicly traded options-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%"> A put is an option or right to sell a specific stock at a specific price before a set date, and a call is an option or right to buy a specific stock at a specific price before a set date. Any transactions in put options, call options or other derivative securities by persons on the Insider List are prohibited by this Policy.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:39.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:8.23pt;text-decoration:underline">Trading on margin-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%"> Persons on the Insider List may not hold ICON securities in a margin account or pledge ICON securities as collateral for a loan.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:39.3pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%">e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%;padding-left:8.23pt;text-decoration:underline">Hedging transactions-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:135%"> Hedging or monetization transactions can be accomplished through the use of various financial instruments, including prepaid variable forwards, equity swaps, collars and exchange funds. Persons on the Insider List may not enter into hedging or monetization transactions or similar arrangements with respect to ICON securities.</font></div><div style="padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:135%">If you have a managed account (where another person has been given discretion or authority to trade without your prior approval), you must not advise your broker or investment adviser to trade in our securities at any time or to trade in securities of  any other company while in possession of material non-public information about that company that was obtained in the course of his or her involvement with ICON. In such managed accounts, you must exercise no discretion to direct investments in the fund.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div><div><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>4
<FILENAME>exhibit121-2024.htm
<DESCRIPTION>EX-12.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="if075513e4ec24442945b991110cd2112_1"></div><div style="min-height:36.72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.85pt;padding-right:5.45pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:111%">Exhibit 12.1</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:1.85pt;padding-left:179.45pt;padding-right:179.45pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Certification of Chief Financial Officer</font></div><div style="margin-top:0.45pt;padding-left:193.95pt;padding-right:193.95pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:121%">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:1.85pt;padding-left:5.5pt;padding-right:390.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">I, Nigel Clerkin, certify that&#58;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:196.15pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1. I have reviewed this annual report on Form 20-F of ICON plc (&#34;the registrant&#34;).</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.7pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.65pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.65pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">a)     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.55pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.7pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">c)   Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.75pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">d)    Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting.</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.65pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">Dated&#58; February&#160;21, 2025</font></div><div style="padding-right:3.6pt;text-align:justify"><font><br></font></div><div style="padding-left:4.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Nigel Clerkin      </font></div><div style="margin-top:3.9pt;padding-left:4.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nigel Clerkin</font></div><div style="margin-top:3.9pt;padding-left:4.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="if075513e4ec24442945b991110cd2112_4"></div><hr style="page-break-after:always"><div style="min-height:36.72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.85pt;padding-left:177.95pt;padding-right:177.95pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Certification of Chief Executive Officer</font></div><div style="margin-top:0.45pt;padding-left:193.95pt;padding-right:193.95pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:121%">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:1.85pt;padding-left:5.5pt;padding-right:411.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">I, Steve Cutler, certify that&#58;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:196.15pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1. I have reviewed this annual report on Form 20-F of ICON plc (&#34;the registrant&#34;).</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.7pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.65pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.65pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">a)     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.55pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.7pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">c)    Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:41.5pt;padding-right:3.75pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">d)    Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting.</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.65pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">Dated&#58; February&#160;21, 2025</font></div><div><font><br></font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:8.15pt;padding-right:452.8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Steve Cutler              </font></div><div style="margin-top:3.9pt;padding-left:8.15pt;padding-right:465pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Steve Cutler</font></div><div style="margin-top:3.9pt;padding-left:8.15pt;padding-right:423.15pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Executive Officer</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>5
<FILENAME>exhibit122-2024.htm
<DESCRIPTION>EX-12.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i3b0dc226d083461fa81421f3cab09609_1"></div><div style="min-height:36.72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.85pt;padding-right:5.45pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:111%">Exhibit 12.2</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:1.85pt;padding-left:157.05pt;padding-right:157.05pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Certification Pursuant to 18 U.S.C. Section 1350,</font></div><div style="margin-top:0.45pt;padding-left:108.52pt;padding-right:108.52pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div><font><br></font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">In connection with the Annual Report of ICON plc (the &#34;Company&#34;) on Form 20-F for the year ending December&#160;31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the &#34;Report&#34;), I, Nigel Clerkin, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">(2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date&#58; February&#160;21, 2025</font></div><div style="margin-top:0.2pt"><font><br></font></div><div><font><br></font></div><div style="padding-left:4.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Nigel Clerkin      </font></div><div style="margin-top:3.9pt;padding-left:4.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nigel Clerkin</font></div><div style="margin-top:3.9pt;padding-left:4.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:1.85pt;padding-left:5.5pt;padding-right:12.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of the report or as a separate disclosure document. A signed original of this written statement required by section 906 has been provided to ICON plc and will be retained by ICON plc and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i3b0dc226d083461fa81421f3cab09609_4"></div><hr style="page-break-after:always"><div style="min-height:36.72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.85pt;padding-left:157.05pt;padding-right:157.05pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Certification Pursuant to 18 U.S.C. Section 1350,</font></div><div style="margin-top:0.45pt;padding-left:108.52pt;padding-right:108.52pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div><font><br></font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.65pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">In connection with the Annual Report of ICON plc (the &#34;Company&#34;) on Form 20-F for the year ending December&#160;31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the &#34;Report&#34;), I, Steve Cutler, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="margin-top:0.8pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:40.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5.5pt;padding-right:3.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">(2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div><div style="padding-left:5.5pt"><font><br></font></div><div style="padding-left:5.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date&#58; February&#160;21, 2025</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:8.15pt;padding-right:452.8pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Steve Cutler               </font></div><div style="margin-top:3.9pt;padding-left:8.15pt;padding-right:465pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Steve Cutler</font></div><div style="margin-top:3.9pt;padding-left:8.15pt;padding-right:423.15pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:111%">Chief Executive Officer</font></div><div style="margin-top:0.75pt"><font><br></font></div><div style="margin-top:1.85pt;padding-left:5.5pt;padding-right:3.6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:121%">The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of the report or as a separate disclosure document. A signed original of this written statement required by section 906 has been provided to ICON plc and will be retained by ICON plc and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-16.1
<SEQUENCE>6
<FILENAME>exhibit161-2024.htm
<DESCRIPTION>EX-16.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ice3cf32340274506a6e90a65ceb96067_1"></div><div style="min-height:156.24pt;width:100%"><div style="margin-top:3.85pt;padding-right:5.45pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:111%">Exhibit 16.1</font></div></div><div style="margin-bottom:20pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">February&#160;21, 2025</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Securities and Exchange Commission<br>Washington, D.C. 20549</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Ladies and Gentlemen&#58;</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are currently principal accountants for ICON plc and, under the date of February&#160;21, 2025, we reported on the consolidated financial statements of ICON plc as of and for the years ended December&#160;31, 2024 and 2023 and the effectiveness of internal control over financial reporting as of December&#160;31, 2024. In 2024 we were notified that ICON plc intend to appoint Ernst &#38; Young Chartered Accountants as its principal accountant for the year ending December&#160;31, 2025 and that the auditor-client relationship with KPMG will cease upon completion of the audit of ICON plc's consolidated financial statements as of and for the year ended December&#160;31, 2024, and the effectiveness of internal control over financial reporting as of December&#160;31, 2024, and the issuance of our reports thereon. We have read ICON plc&#8217;s statements included under Item 16F of its Form 20-F dated February&#160;21, 2025, and we agree with such statements, except that we are not in a position to agree or disagree with ICON plc&#8217;s statement that the appointment will be subject to the passing of an ordinary resolution confirming the appointment at the Company's 2025 Annual General Meeting.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Very truly yours,</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#47;s&#47; KPMG</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-22.1
<SEQUENCE>7
<FILENAME>icon-ex22guarantorschedule.htm
<DESCRIPTION>EX-22.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i166210fb811c44c5a73a663c21e62d48_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 22.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUBSIDIARY GUARANTORS AND ISSUER OF GUARANTEED SECURITIES AND AFFILIATES WHOSE SECURITIES COLLATERALIZE SECURITIES OF </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICON INVESTMENTS SIX DESIGNATED ACTIVITY COMPANY</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following subsidiaries of ICON plc, (the &#8220;Company&#8221;) are guarantors of ICON Investments Six Designated Activity Company&#8217;s (the &#8220;Issuer&#8221;) 5.809% Senior Secured Notes due 2027, 5.849% Senior Secured Notes due 2029 and 6.000% Senior Secured Notes due 2034</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; </font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.354%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NAME OF SUBSIDIARY</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Global Treasury Unlimited Company</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland </font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Holdings Unlimited Company </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research Property Development (Ireland) Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Operational Holdings Unlimited Company</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Operational Financing Unlimited Company</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Global Holdings Unlimited Company</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Luxembourg S.&#224; r.l.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Early Phase Services, LLC </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beacon Bioscience, Inc. </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Laboratory Services, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MolecularMD Corp.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON US Holdings Inc. </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PriceSpective LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DOCS Global, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare US Inc. </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Carolina</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Resource Network, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Illinois</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Investments LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PRA Health Sciences, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Source Healthcare Analytics, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Symphony Health Solutions Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virginia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PRA Holdings, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PRA International, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RPS Global Holdings, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RPS Parent Holding LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Roy RPS Holdings LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CRN Holdings, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All issued and outstanding equity securities of the following subsidiaries of the Company, subject to the limitations set forth below, collateralize the Issuer&#8217;s 5.809% Senior Secured Notes due 2027, 5.849% Senior Secured Notes due 2029 and 6.000% Senior Secured Notes due 2034&#58; </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.188%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.184%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NAME (STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OWNER</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PERCENT PLEDGED</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Investments Six Designated Activity Company (Ireland)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON plc</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research Limited (Ireland)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Operational Holdings Unlimited Company</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Holdings Unlimited Company (Ireland)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Operational Financing Unlimited Company</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Operational Holdings Unlimited Company (Ireland)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Operational Financing Unlimited Company </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ICON Operational Financing Unlimited Company (Ireland)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Global Holdings Unlimited Company </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Global Holdings Unlimited Company (Ireland)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON plc</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research Property Holdings (Ireland) Limited (Ireland)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON plc</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON (LR) Limited (Ireland)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Holdings Clinical Research International Limited (Ireland)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Holdings Unlimited Company</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare Limited (Ireland)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Holdings Unlimited Company</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Global Treasury Unlimited Company (Ireland)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Global Treasury Unlimited Company (Ireland)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON plc</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Luxembourg S.&#224; r.l. (Luxembourg)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Early Phase Services, LLC (f&#47;k&#47;a Healthcare Discoveries, LLC) (Texas)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beacon Bioscience, Inc. (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research LLC (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON US Holdings Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Laboratory Services, Inc. (f&#47;k&#47;a ICON Central Laboratories, Inc.) (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON US Holdings Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MolecularMD Corp. (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Laboratory Services, Inc. (f&#47;k&#47;a ICON Central Laboratories, Inc.)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ICON US Holdings Inc. (Delaware)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Operational Financing Unlimited Company</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PriceSpective LLC (Delaware)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CRN Holdings, LLC (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ICON Clinical Investments, LLC (Delaware)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Luxembourg S.&#224; r.l</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical Resource Network, LLC (d&#47;b&#47;a Symphony Clinical Research) (Illinois)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CRN Holdings, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DOCS Global, Inc. (New Jersey)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare US Inc. (North Carolina)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RPS Bermuda,&#160;Ltd. (Bermuda)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services, Inc. </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services de Recherche Pharmaceutique Srl (Canada)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PRA Health Sciences Colombia Ltda. (Colombia)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Hungary Research and Development Ltd. (Hungary)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Italy S.r.l. (Italy)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65%</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.188%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.184%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Mexico S. de R.L. de C. V. (Mexico)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Mexico S. de R.L. de C. V. (Mexico)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PRA International, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services Netherlands B.V. (Netherlands)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RPS Per&#250; S.A.C. (Peru)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research Pharmaceutical Services Puerto Rico,&#160;Inc. (Puerto Rico)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Romania S.R.L. (Romania)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates Espa&#241;a, S.A.U. (Spain)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PRA International Sweden AB (Sweden)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RPS Research (Thailand) Co.,&#160;Ltd. (Thailand)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sterling Synergy Systems Limited (United Kingdom)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ClinStar LLC (California)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nextrials, Inc. (California)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Care Innovations, Inc. (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CRI NewCo, Inc. (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Medical Technical Consultants, LLC (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Parallel 6, Inc. (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PRA Early Development Research, Inc. (f&#47;k&#47;a Pharma Bio-Research USA, Inc.) (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PRA Health Sciences, Inc. (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON US Holdings Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PRA Holdings, Inc. (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PRA Health Sciences, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PRA Receivables, LLC (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services, Inc. (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Roy RPS Holdings, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services, LLC (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ReSearch Pharmaceutical Services, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Source Healthcare Analytics, LLC (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Symphony Health Solutions Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sunset Hills, LLC (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Symphony Health Solutions Corporation (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates, Inc. (Virginia)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PRA International, LLC     </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PRA International, LLC (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PRA Holdings, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Roy RPS Holdings LLC (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RPS Parent Holding LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RPS Global Holdings, LLC (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PRA Holdings, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RPS Parent Holding LLC (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RPS Global Holdings, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Government and Public Health Solutions, Inc. (Virginia)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON US Holdings Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare of Bristol, LLC (Tennessee)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare US Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare of Charleston, LLC (South Carolina)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare US Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare of Charlotte, LLC (North Carolina)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare US Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare of Christie Clinic, LLC (Illinois)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare US Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare of Hickory, LLC (North Carolina)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare US Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.188%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.184%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare of Raleigh, LLC (North Carolina)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare US Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare of Rocky Mount, LLC (North Carolina)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare US Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare of Salisbury, LLC (North Carolina)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare US Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare of Wilmington, LLC (North Carolina)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare US Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare of Winston-Salem, LLC (North Carolina)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accellacare US Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Averion Europe GmbH (Germany)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHC Group, LLC (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PubsHub LLC (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global Pharmaceutical Strategies Group, LLC (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MMMM Group, LLC (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Tennessee, LLC (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADDPLAN, Inc. (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ICON Clinical Research LP (Delaware)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ICON Clinical Research LP (Delaware)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Tennessee, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CRN North America, LLC (d&#47;b&#47;a Symphony Clinical Staffing) (Delaware)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CRN Holdings, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Symphony Clinical Research Sp. Z O O. (Poland)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CRN Holdings, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research Holdings (U.K.) Limited (United Kingdom)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceutical Research Associates, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oncacare Limited (Ireland)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Clinical Research Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ICON Clinical Research Holdings (Ireland) Unlimited Company (Ireland)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ICON Holdings Unlimited Company</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</font></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>8
<FILENAME>exhibit231-2024.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i598e0c5deceb41cdb3ab70c85396ec36_1"></div><div style="min-height:45pt;width:100%"><div style="margin-top:63pt"><font><br></font></div></div><div style="margin-top:3.85pt;padding-right:5.45pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:111%">Exhibit 23.1</font></div><div style="margin-bottom:0.1pt;padding-right:5.45pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consent of Independent Registered Public Accounting Firm</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">We consent to the incorporation by reference in the registration statements (No. 333-282826, 333-231527, 333-204153, 333-190068, 333-152802, 333-257578 and 333-254891) on Form S-8 and registration statement (No. 333-278943) on Form F-3 of our reports dated February&#160;21, 2025 with respect to the consolidated financial statements of ICON plc and the effectiveness of internal control over financial reporting.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%;text-decoration:underline">&#47;s&#47; KPMG             </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:139%">Dublin, Ireland</font></div><div style="margin-bottom:0.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">February&#160;21, 2025</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97
<SEQUENCE>9
<FILENAME>iconplcclawbackpolicyasupd.htm
<DESCRIPTION>EX-97
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ida6e771a005f429589e786e7df526fa8_1"></div><div style="min-height:72pt;width:100%"><div style="margin-top:3.85pt;padding-right:5.45pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:111%">Exhibit 97</font></div></div><div style="margin-bottom:40pt;margin-top:12pt;text-align:center"><img alt="image_01.jpg" src="image_01.jpg" style="height:51px;margin-bottom:5pt;vertical-align:text-bottom;width:189px"></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ICON plc Clawback Policy</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Adopted on 25 July 2023 and amended on 18 February 2025</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Clawback Policy (this&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Policy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) provides the standards for the recoupment of certain erroneously awarded executive compensation in the event of an accounting restatement due to the material noncompliance of ICON plc (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ICON</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) with any reporting requirement under the securities laws.  This Policy has been designed to ensure that ICON is in compliance with the requirements of Section 10D of the Securities Exchange Act of 1934, as amended (the&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exchange Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), Rule 10D-1 promulgated by the Securities and Exchange Commission under the Exchange Act and the listing rules of the NASDAQ Global Select Market (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NASDAQ</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  This Policy applies with respect to all incentive compensation, including annual cash incentives and restricted share units subject to performance conditions, received by current and former executive officers of ICON, each as provided below.</font></div><div style="margin-bottom:6pt;margin-top:15pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Persons Covered</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Policy applies to all current or former executive officers of ICON within the meaning of NASDAQ Listing Rule 5608 and Exchange Act Rule 10D-1. This Policy will also apply to other members of senior management of ICON designated by the Board of Directors of ICON (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) from time to time.  Each executive officer or other individual to whom this Policy applies is referred to as a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Covered Executive</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:6pt;margin-top:15pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Compensation</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Policy applies with respect to compensation, including annual cash incentives and restricted share units subject to performance conditions, that is granted, earned or vested based wholly or in part upon the attainment of a financial reporting measure within the meaning of NASDAQ Listing Rule 5608, including the attainment of earnings per share (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Incentive-Based Compensation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  Incentive-Based Compensation does not include stock options or restricted stock units that vest (without any performance condition) upon completion of a specified employment period or bonus awards that are discretionary or based on subjective goals unrelated to financial performance.</font></div><div style="margin-bottom:6pt;margin-top:15pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Effective Date</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Policy is effective as of 2 October 2023 (the&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and applies to all Incentive-Based Compensation received on or after the Effective Date by any Covered Executive at any time during the performance period that is covered by the Incentive-Based Compensation.  For purposes of this Policy, Incentive-Based Compensation is &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">received</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; in ICON&#8217;s fiscal period during which the financial reporting measure specified for the compensation has been attained.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:15pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Restatement</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Incentive-Based Compensation may be subject to recovery under this Policy in the event ICON is required to prepare an accounting restatement due to the material noncompliance of ICON with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Restatement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:6pt;margin-top:15pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Recovery Period</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Incentive-Based Compensation received by a Covered Executive on or after the Effective Date is subject to recovery under this Policy if the Covered Executive served in any position as a Covered Executive at any time during the performance period, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">and</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Incentive-Based Compensation is received after the beginning of the Covered Executive&#8217;s service as a Covered Executive and during the last three completed fiscal years immediately preceding the date that ICON is required to prepare a Restatement (the&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Recovery Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). The date that ICON is required to prepare a Restatement is the earlier of (x)&#160;the date the Board, a committee of the Board, or the officer or officers of ICON authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that ICON is required to prepare a Restatement, or (y)&#160;the date a court, regulator or other legally authorized body directs ICON to prepare a Restatement.</font></div><div style="margin-bottom:6pt;margin-top:15pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Recovery Amount</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event ICON is required to prepare a Restatement, ICON will recover reasonably promptly the amount of Incentive-Based Compensation received during the Recovery Period that exceeds the amount of the Incentive-Based Compensation that would have been received had it been determined based on the Restatement, without regard to taxes paid (the&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Recovery Amount</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  For any Incentive-Based Compensation based on share price or total shareholder return, and where the Recovery Amount is not subject to mathematical recalculation directly from the information in the Restatement, the Recovery Amount will instead be determined based on a reasonable estimate of the effect of the Restatement on the share price or total shareholder return.</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ICON will recover the Recovery Amount in compliance with this Policy except to the extent that the Compensation &#38; Organisation Committee of the Board (the&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Committee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) has determined that recovery would be impracticable </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">and</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (i)&#160;the direct expense paid to a third party to assist in enforcing this Policy would exceed the amount to be recovered and ICON has made a reasonable attempt to recover the Recovery Amount, (ii)&#160;recovery would violate home country law adopted prior to November 28, 2022, or (iii)&#160;recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to ICON employees, to fail to meet the requirements of 26 U.S.C. 401(a)(13 or 26 U.S. C. 411(a) and the regulations thereunder.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:15pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Administration</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Board and, if designated by the Board, the Committee will administer and will have full authority to interpret and to enforce this Policy consistent with the requirements of NASDAQ Listing Rule 5608 and Exchange Act Rule 10D-1 and to determine the method for recovering Incentive-Based Compensation subject to recovery under this Policy.  Any determinations made by the Board or Committee in accordance with this Policy shall be final and binding on all persons.</font></div><div style="margin-bottom:6pt;margin-top:15pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Miscellaneous </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:8.23pt">ICON may not indemnify any Covered Executive against the loss of Incentive-Based Compensation.</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:8.23pt">This Policy will be binding on and enforceable against all Covered Executives and each of their beneficiaries, heirs, executors, administrators and legal representatives. </font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:8.84pt">The Board may amend, modify or terminate this Policy in whole or in part and at any time.</font></div><div style="margin-bottom:6pt;margin-top:15pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Non-Exclusivity</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ICON intends that this Policy will be applied to the fullest extent of the law and may require that any employment agreement, equity award agreement, or similar agreement require a Covered Executive to agree to abide by the terms of this Policy as a condition to the grant of any right or benefit thereunder. Any right of recovery under this Policy is in addition to, and not in lieu of, any other remedies or rights of recoupment or recovery that may be available pursuant to the terms of any similar clawback or recovery policy or in any employment agreement, equity award agreement, or similar agreement, or any other rights or remedies available under applicable law.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>iclr-20241231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:56d7542f-319d-475c-a76f-1ff45be39275,g:fef64a75-6c12-4b8b-a2b6-5a3facaa93b8-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iclr="http://www.iconplc.com/20241231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.iconplc.com/20241231">
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/cyd-af-sub/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iclr-20241231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iclr-20241231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iclr-20241231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iclr-20241231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.iconplc.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.iconplc.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>9952151 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>9952152 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>9952153 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>9952154 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY">
        <link:definition>9952155 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>9952156 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Descriptionofbusiness" roleURI="http://www.iconplc.com/role/Descriptionofbusiness">
        <link:definition>9952157 - Disclosure - Description of business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantaccountingpolicies" roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies">
        <link:definition>9952158 - Disclosure - Summary of Significant accounting policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DisaggregationofRevenue" roleURI="http://www.iconplc.com/role/DisaggregationofRevenue">
        <link:definition>9952159 - Disclosure - Disaggregation of Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Accountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilities" roleURI="http://www.iconplc.com/role/Accountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilities">
        <link:definition>9952160 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AllowancesforCreditLosses" roleURI="http://www.iconplc.com/role/AllowancesforCreditLosses">
        <link:definition>9952161 - Disclosure - Allowances for Credit Losses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinations" roleURI="http://www.iconplc.com/role/BusinessCombinations">
        <link:definition>9952162 - Disclosure - Business Combinations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValue" roleURI="http://www.iconplc.com/role/FairValue">
        <link:definition>9952163 - Disclosure - Fair Value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.iconplc.com/role/Investments">
        <link:definition>9952164 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentnet" roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnet">
        <link:definition>9952165 - Disclosure - Property, Plant and Equipment, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Goodwill" roleURI="http://www.iconplc.com/role/Goodwill">
        <link:definition>9952166 - Disclosure - Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssets" roleURI="http://www.iconplc.com/role/IntangibleAssets">
        <link:definition>9952167 - Disclosure - Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLiabilities" roleURI="http://www.iconplc.com/role/OtherLiabilities">
        <link:definition>9952168 - Disclosure - Other Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BankCreditLinesLoanFacilitiesandNotes" roleURI="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotes">
        <link:definition>9952169 - Disclosure - Bank Credit Lines, Loan Facilities and Notes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Derivatives" roleURI="http://www.iconplc.com/role/Derivatives">
        <link:definition>9952170 - Disclosure - Derivatives</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeases" roleURI="http://www.iconplc.com/role/OperatingLeases">
        <link:definition>9952171 - Disclosure - Operating Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Noncurrentotherliabilities" roleURI="http://www.iconplc.com/role/Noncurrentotherliabilities">
        <link:definition>9952172 - Disclosure - Non-current other liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.iconplc.com/role/CommitmentsandContingencies">
        <link:definition>9952173 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareCapital" roleURI="http://www.iconplc.com/role/ShareCapital">
        <link:definition>9952174 - Disclosure - Share Capital</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCharges" roleURI="http://www.iconplc.com/role/RestructuringCharges">
        <link:definition>9952175 - Disclosure - Restructuring Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.iconplc.com/role/IncomeTaxes">
        <link:definition>9952176 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationCharges" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges">
        <link:definition>9952177 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformation" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation">
        <link:definition>9952178 - Disclosure - Business Segment and Geographical Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerOrdinaryShare" roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShare">
        <link:definition>9952179 - Disclosure - Net Income Per Ordinary Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLoss" roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveLoss">
        <link:definition>9952180 - Disclosure - Accumulated Other Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalDisclosureofCashFlowInformation" roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation">
        <link:definition>9952181 - Disclosure - Supplemental Disclosure of Cash Flow Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedParties" roleURI="http://www.iconplc.com/role/RelatedParties">
        <link:definition>9952182 - Disclosure - Related Parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.iconplc.com/role/SubsequentEvents">
        <link:definition>9952183 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantaccountingpoliciesPolicies" roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies">
        <link:definition>9955511 - Disclosure - Summary of Significant accounting policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantaccountingpoliciesTables" roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables">
        <link:definition>9955512 - Disclosure - Summary of Significant accounting policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DisaggregationofRevenueTables" roleURI="http://www.iconplc.com/role/DisaggregationofRevenueTables">
        <link:definition>9955513 - Disclosure - Disaggregation of Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables" roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables">
        <link:definition>9955514 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AllowancesforCreditLossesTables" roleURI="http://www.iconplc.com/role/AllowancesforCreditLossesTables">
        <link:definition>9955515 - Disclosure - Allowances for Credit Losses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueTables" roleURI="http://www.iconplc.com/role/FairValueTables">
        <link:definition>9955516 - Disclosure - Fair Value (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentnetTables" roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables">
        <link:definition>9955517 - Disclosure - Property, Plant and Equipment, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTables" roleURI="http://www.iconplc.com/role/GoodwillTables">
        <link:definition>9955518 - Disclosure - Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsTables" roleURI="http://www.iconplc.com/role/IntangibleAssetsTables">
        <link:definition>9955519 - Disclosure - Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLiabilitiesTables" roleURI="http://www.iconplc.com/role/OtherLiabilitiesTables">
        <link:definition>9955520 - Disclosure - Other Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BankCreditLinesLoanFacilitiesandNotesTables" roleURI="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesTables">
        <link:definition>9955521 - Disclosure - Bank Credit Lines, Loan Facilities and Notes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesTables" roleURI="http://www.iconplc.com/role/DerivativesTables">
        <link:definition>9955522 - Disclosure - Derivatives (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesTables" roleURI="http://www.iconplc.com/role/OperatingLeasesTables">
        <link:definition>9955523 - Disclosure - Operating Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncurrentotherliabilitiesTables" roleURI="http://www.iconplc.com/role/NoncurrentotherliabilitiesTables">
        <link:definition>9955524 - Disclosure - Non-current other liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringchargesTables" roleURI="http://www.iconplc.com/role/RestructuringchargesTables">
        <link:definition>9955525 - Disclosure - Restructuring charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.iconplc.com/role/IncomeTaxesTables">
        <link:definition>9955526 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesTables" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables">
        <link:definition>9955527 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformationTables" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables">
        <link:definition>9955528 - Disclosure - Business Segment and Geographical Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerOrdinaryShareTables" roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables">
        <link:definition>9955529 - Disclosure - Net Income Per Ordinary Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossTables" roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossTables">
        <link:definition>9955530 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalDisclosureofCashFlowInformationTables" roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables">
        <link:definition>9955531 - Disclosure - Supplemental Disclosure of Cash Flow Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofbusinessDetails" roleURI="http://www.iconplc.com/role/DescriptionofbusinessDetails">
        <link:definition>9955532 - Disclosure - Description of business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails" roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails">
        <link:definition>9955533 - Disclosure - Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails">
        <link:definition>9955534 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails">
        <link:definition>9955535 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DisaggregationofRevenueDetails" roleURI="http://www.iconplc.com/role/DisaggregationofRevenueDetails">
        <link:definition>9955536 - Disclosure - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails" roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails">
        <link:definition>9955537 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Accounts Receivables and Unbilled Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails" roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails">
        <link:definition>9955538 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Unbilled Services and Unearned Revenue or Payments on Account (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails" roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails">
        <link:definition>9955539 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails_1" roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails_1">
        <link:definition>9955539 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AllowancesforCreditLossesDetails" roleURI="http://www.iconplc.com/role/AllowancesforCreditLossesDetails">
        <link:definition>9955540 - Disclosure - Allowances for Credit Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsNarrativeKCRAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativeKCRAcquisitionDetails">
        <link:definition>9955541 - Disclosure - Business Combinations - Narrative, KCR Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsNarrativeHumanFirstAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativeHumanFirstAcquisitionDetails">
        <link:definition>9955542 - Disclosure - Business Combinations - Narrative, HumanFirst Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsNarrativeBiotelAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails">
        <link:definition>9955543 - Disclosure - Business Combinations - Narrative, Biotel Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsNarrativePRAAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails">
        <link:definition>9955544 - Disclosure - Business Combinations - Narrative, PRA Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsNarrativeOncacareAcquisitionDetails" roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails">
        <link:definition>9955545 - Disclosure - Business Combinations - Narrative, Oncacare Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsTransactionandIntegrationCostsDetails" roleURI="http://www.iconplc.com/role/BusinessCombinationsTransactionandIntegrationCostsDetails">
        <link:definition>9955546 - Disclosure - Business Combinations - Transaction and Integration Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" roleURI="http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails">
        <link:definition>9955547 - Disclosure - Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvalueNarrativeDetails" roleURI="http://www.iconplc.com/role/FairvalueNarrativeDetails">
        <link:definition>9955548 - Disclosure - Fair value - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNarrativeDetails" roleURI="http://www.iconplc.com/role/InvestmentsNarrativeDetails">
        <link:definition>9955549 - Disclosure - Investments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentnetDetails" roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails">
        <link:definition>9955550 - Disclosure - Property, Plant and Equipment, net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentnetNarrativeDetails" roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetNarrativeDetails">
        <link:definition>9955551 - Disclosure - Property, Plant and Equipment, net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillScheduleofGoodwillDetails" roleURI="http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails">
        <link:definition>9955552 - Disclosure - Goodwill - Schedule of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillNarrativeDetails" roleURI="http://www.iconplc.com/role/GoodwillNarrativeDetails">
        <link:definition>9955553 - Disclosure - Goodwill - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails" roleURI="http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails">
        <link:definition>9955554 - Disclosure - Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNarrativeDetails" roleURI="http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails">
        <link:definition>9955555 - Disclosure - Intangible Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" roleURI="http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails">
        <link:definition>9955556 - Disclosure - Intangible Assets - Future Intangible Asset Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherLiabilitiesDetails" roleURI="http://www.iconplc.com/role/OtherLiabilitiesDetails">
        <link:definition>9955557 - Disclosure - Other Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails" roleURI="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails">
        <link:definition>9955558 - Disclosure - Bank Credit Lines, Loan Facilities and Notes - Schedule of Long-term Debt Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BankCreditLinesLoanFacilitiesandNotesNarrativeDetails" roleURI="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails">
        <link:definition>9955559 - Disclosure - Bank Credit Lines, Loan Facilities and Notes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BankCreditLinesLoanFacilitiesandNotesScheduleofFinanceCostDetails" roleURI="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofFinanceCostDetails">
        <link:definition>9955560 - Disclosure - Bank Credit Lines, Loan Facilities and Notes - Schedule of Finance Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BankCreditLinesLoanFacilitiesandNotesScheduleofMaturitiesofLongtermDebtDetails" roleURI="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMaturitiesofLongtermDebtDetails">
        <link:definition>9955561 - Disclosure - Bank Credit Lines, Loan Facilities and Notes - Schedule of Maturities of Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BankCreditLinesLoanFacilitiesandNotesScheduleofPrincipalpaymentsDetails" roleURI="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofPrincipalpaymentsDetails">
        <link:definition>9955562 - Disclosure - Bank Credit Lines, Loan Facilities and Notes - Schedule of Principal payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails" roleURI="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails">
        <link:definition>9955563 - Disclosure - Bank Credit Lines, Loan Facilities and Notes - Schedule of Movement on Debt Instrument (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesNarrativeDetails" roleURI="http://www.iconplc.com/role/DerivativesNarrativeDetails">
        <link:definition>9955564 - Disclosure - Derivatives - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails" roleURI="http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails">
        <link:definition>9955565 - Disclosure - Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesScheduleofLeaseCostsDetails" roleURI="http://www.iconplc.com/role/OperatingLeasesScheduleofLeaseCostsDetails">
        <link:definition>9955566 - Disclosure - Operating Leases - Schedule of Lease Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesOperatingLeasesNarrativeDetails" roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails">
        <link:definition>9955567 - Disclosure - Operating Leases Operating Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails">
        <link:definition>9955568 - Disclosure - Operating Leases Operating Leases - Operating Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1" roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1">
        <link:definition>9955568 - Disclosure - Operating Leases Operating Leases - Operating Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NoncurrentotherliabilitiesDetails" roleURI="http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails">
        <link:definition>9955569 - Disclosure - Non-current other liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesNarrativeDetails" roleURI="http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails">
        <link:definition>9955570 - Disclosure - Commitments and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareCapitalDetails" roleURI="http://www.iconplc.com/role/ShareCapitalDetails">
        <link:definition>9955571 - Disclosure - Share Capital (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringchargesNarrativeDetails" roleURI="http://www.iconplc.com/role/RestructuringchargesNarrativeDetails">
        <link:definition>9955572 - Disclosure - Restructuring charges - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringchargesScheduleofRestructuringChargesDetails" roleURI="http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringChargesDetails">
        <link:definition>9955573 - Disclosure - Restructuring charges - Schedule of Restructuring Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringchargesScheduleofRestructuringReservebyTypeofCostDetails" roleURI="http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringReservebyTypeofCostDetails">
        <link:definition>9955574 - Disclosure - Restructuring charges - Schedule of Restructuring Reserve by Type of Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails">
        <link:definition>9955575 - Disclosure - Income Taxes - Components of Income Before Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails">
        <link:definition>9955576 - Disclosure - Income Taxes - Components of Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails">
        <link:definition>9955577 - Disclosure - Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>9955578 - Disclosure - Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>9955579 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesExpectedExpiryDatesofNOLsDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails">
        <link:definition>9955580 - Disclosure - Income Taxes - Expected Expiry Dates of NOL's (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails" roleURI="http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails">
        <link:definition>9955581 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails">
        <link:definition>9955582 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails">
        <link:definition>9955583 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails">
        <link:definition>9955584 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails">
        <link:definition>9955585 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails" roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails">
        <link:definition>9955586 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformationNarrativeDetails" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails">
        <link:definition>9955587 - Disclosure - Business Segment and Geographical Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails">
        <link:definition>9955588 - Disclosure - Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails">
        <link:definition>9955589 - Disclosure - Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails" roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails">
        <link:definition>9955590 - Disclosure - Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails">
        <link:definition>9955591 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails" roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails">
        <link:definition>9955592 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails" roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails">
        <link:definition>9955593 - Disclosure - Accumulated Other Comprehensive Loss - Schedule of Accumulated Other Comprehensive income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalDisclosureofCashFlowInformationDetails" roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails">
        <link:definition>9955594 - Disclosure - Supplemental Disclosure of Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartiesDetails" roleURI="http://www.iconplc.com/role/RelatedPartiesDetails">
        <link:definition>9955595 - Disclosure - Related Parties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.iconplc.com/role/SubsequentEventsDetails">
        <link:definition>9955596 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="iclr_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iclr_OtherUndenominatedCapital" abstract="false" name="OtherUndenominatedCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" abstract="false" name="IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_OtherUndenominatedCapitalMember" abstract="true" name="OtherUndenominatedCapitalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_ShareRepurchaseProgramBrokerCommission" abstract="false" name="ShareRepurchaseProgramBrokerCommission" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment" abstract="false" name="ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_PaymentsForBrokerCommissionShareRepurchaseCosts" abstract="false" name="PaymentsForBrokerCommissionShareRepurchaseCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" abstract="false" name="AccumulatedOtherComprehensiveIncomeLossTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iclr_GovernmentGrantsPolicyTextBlock" abstract="false" name="GovernmentGrantsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iclr_ResearchAndDevelopmentCreditsPolicyTextBlock" abstract="false" name="ResearchAndDevelopmentCreditsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iclr_ForeignCurrencyDisclosureTableTextBlock" abstract="false" name="ForeignCurrencyDisclosureTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" abstract="false" name="ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock" abstract="false" name="ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="iclr_IncomeBeforeIncomeTaxTableTextBlock" abstract="false" name="IncomeBeforeIncomeTaxTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" abstract="false" name="ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" abstract="false" name="ScheduleOfNonCashStockCompensationExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iclr_OperatingIncomeByGeographyTableTextBlock" abstract="false" name="OperatingIncomeByGeographyTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="iclr_OtherGeographicLocationsMember" abstract="true" name="OtherGeographicLocationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_NumberOfLocations" abstract="false" name="NumberOfLocations" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iclr_ComputerEquipmentAndCapitalizedSoftwareMember" abstract="true" name="ComputerEquipmentAndCapitalizedSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_TopClientMember" abstract="true" name="TopClientMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_Clients25Member" abstract="true" name="Clients25Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_Clients610Member" abstract="true" name="Clients610Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_Clients1125Member" abstract="true" name="Clients1125Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_OtherCustomersMember" abstract="true" name="OtherCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_ContractAssetsAbstract" abstract="true" name="ContractAssetsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iclr_ContractsReceivableGross" abstract="false" name="ContractsReceivableGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ContractsReceivableNet" abstract="false" name="ContractsReceivableNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent" abstract="false" name="IncreaseDecreaseInContractWithCustomerAssetGrossCurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent" abstract="false" name="IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" abstract="false" name="IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" abstract="false" name="IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" abstract="false" name="AdvancePaymentsNettedAgainstUnbilledContractsReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable" abstract="false" name="ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" abstract="false" name="ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" abstract="false" name="OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_AccountsReceivableCreditLossExpense" abstract="false" name="AccountsReceivableCreditLossExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" abstract="false" name="AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_KCRS.AGroupMember" abstract="true" name="KCRS.AGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_HumanFirstIncMember" abstract="true" name="HumanFirstIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_BiotelResearchLLCMember" abstract="true" name="BiotelResearchLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_PRAHealthSciencesIncMember" abstract="true" name="PRAHealthSciencesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_OncacareMember" abstract="true" name="OncacareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_InterestRateCapAndInterestRateSwapMember" abstract="true" name="InterestRateCapAndInterestRateSwapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_CommitmentToAcquireLongTermInvestments" abstract="false" name="CommitmentToAcquireLongTermInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_VehiclesGross" abstract="false" name="VehiclesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_DecreaseInAmortisation" abstract="false" name="DecreaseInAmortisation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" abstract="false" name="FiniteLivedIntangibleAssetsAmortizationExpenseNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_RestructuringReserveAndOtherLiabilitiesCurrent" abstract="false" name="RestructuringReserveAndOtherLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_TermLoanFacilityMember" abstract="true" name="TermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_SeniorSecuredNotesMember" abstract="true" name="SeniorSecuredNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_SeniorSecuredRevolvingLoanFacilityMember" abstract="true" name="SeniorSecuredRevolvingLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_SeniorSecuredNotesDueMay2027Member" abstract="true" name="SeniorSecuredNotesDueMay2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_SeniorSecuredNotesDueMay2029Member" abstract="true" name="SeniorSecuredNotesDueMay2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_SeniorSecuredNotesDueMay2034Member" abstract="true" name="SeniorSecuredNotesDueMay2034Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_LongTermDebtCurrentMaturitiesGross" abstract="false" name="LongTermDebtCurrentMaturitiesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_LongTermDebtExcludingCurrentMaturitiesGross" abstract="false" name="LongTermDebtExcludingCurrentMaturitiesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" abstract="true" name="SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_VariableRateComponentAxis" abstract="true" name="VariableRateComponentAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="iclr_VariableRateComponentDomain" abstract="true" name="VariableRateComponentDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_VariableRateComponentOneMember" abstract="true" name="VariableRateComponentOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_VariableRateComponentTwoMember" abstract="true" name="VariableRateComponentTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_DebtInstrumentDiscountRate" abstract="false" name="DebtInstrumentDiscountRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="iclr_InterestExpenseCreditOther" abstract="false" name="InterestExpenseCreditOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_LongTermDebtMaturityYearFiveAndThereafter" abstract="false" name="LongTermDebtMaturityYearFiveAndThereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_DerivativeVariableInterestRateReferenceRateInExcessOf" abstract="false" name="DerivativeVariableInterestRateReferenceRateInExcessOf" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iclr_PerformanceShareUnitMember" abstract="true" name="PerformanceShareUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_BuybackProgramMember" abstract="true" name="BuybackProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_February2024Member" abstract="true" name="February2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_October2024Member" abstract="true" name="October2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_NumberOfVotes" abstract="false" name="NumberOfVotes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="iclr_StockRepurchaseProgramAuthorizedPercentage" abstract="false" name="StockRepurchaseProgramAuthorizedPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="iclr_WorkforceReductionAndOfficeConsolidationProgramMember" abstract="true" name="WorkforceReductionAndOfficeConsolidationProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_PersonnelRelatedLiabilitiesMember" abstract="true" name="PersonnelRelatedLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_FacilityLiabilityMember" abstract="true" name="FacilityLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_RestructuringReserveUtilizations" abstract="false" name="RestructuringReserveUtilizations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" abstract="true" name="ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iclr_RestOfEuropeAndOtherCountriesMember" abstract="true" name="RestOfEuropeAndOtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" abstract="true" name="ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iclr_ReconciliationOfProvisionOfIncomeTaxesTable" abstract="true" name="ReconciliationOfProvisionOfIncomeTaxesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" abstract="true" name="ReconciliationOfProvisionOfIncomeTaxesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iclr_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" abstract="false" name="DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_DeferredTaxAssetsOperatingLeaseLiability" abstract="false" name="DeferredTaxAssetsOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities" abstract="false" name="DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_DeferredTaxAssetContractWithCustomerLiability" abstract="false" name="DeferredTaxAssetContractWithCustomerLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_OtherCountriesMember" abstract="true" name="OtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_IncomeTaxBenefitMember" abstract="true" name="IncomeTaxBenefitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_TaxOfBusinessAcquiredMember" abstract="true" name="TaxOfBusinessAcquiredMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" abstract="false" name="DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_TaxCreditCarryForwardIncreaseDecreaseAmount" abstract="false" name="TaxCreditCarryForwardIncreaseDecreaseAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_TaxCreditCarryForwardExpirationPeriod" abstract="false" name="TaxCreditCarryForwardExpirationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="iclr_TaxYear2025To2038Member" abstract="true" name="TaxYear2025To2038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_TaxYear20392043Member" abstract="true" name="TaxYear20392043Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" abstract="true" name="CompensationRelatedCostsShareBasedPaymentsDisclosureTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="iclr_ConsultantsStockPlan2008PlanMember" abstract="true" name="ConsultantsStockPlan2008PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_EmployeeStockPlanTwentyZeroEightPlanMember" abstract="true" name="EmployeeStockPlanTwentyZeroEightPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_OptionPlans2008Member" abstract="true" name="OptionPlans2008Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_RestrictedStockUnitsTwentyThirteenMember" abstract="true" name="RestrictedStockUnitsTwentyThirteenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" abstract="true" name="ConsultantsRestrictedStockUnitsTwentyNineteenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_PerformanceBasedGrantsMember" abstract="true" name="PerformanceBasedGrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_AwardDateAllYearsExcluding2018Member" abstract="true" name="AwardDateAllYearsExcluding2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_The2020LegacyPRAPlanMember" abstract="true" name="The2020LegacyPRAPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_The2018LegacyPRAPlanMember" abstract="true" name="The2018LegacyPRAPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_NonexecutiveDirectorMember" abstract="true" name="NonexecutiveDirectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" abstract="true" name="CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" abstract="false" name="LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="iclr_StockOptionAndAwardPlansMember" abstract="true" name="StockOptionAndAwardPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_RestOfEuropeMember" abstract="true" name="RestOfEuropeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax" abstract="false" name="AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="iclr_CorvusPharmaceuticalsMember" abstract="true" name="CorvusPharmaceuticalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_AfimmuneLimitedMember" abstract="true" name="AfimmuneLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="iclr_February2025Member" abstract="true" name="February2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>iclr-20241231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:56d7542f-319d-475c-a76f-1ff45be39275,g:fef64a75-6c12-4b8b-a2b6-5a3facaa93b8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="iclr-20241231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_2d7a106c-9ac5-4eb3-bea2-4ab8c52b262d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a2b22859-0690-406e-a2be-0cd7d34ac5e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2d7a106c-9ac5-4eb3-bea2-4ab8c52b262d" xlink:to="loc_us-gaap_LiabilitiesCurrent_a2b22859-0690-406e-a2be-0cd7d34ac5e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f45d2c47-faf8-48e3-a00e-303d8cadcdb6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2d7a106c-9ac5-4eb3-bea2-4ab8c52b262d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f45d2c47-faf8-48e3-a00e-303d8cadcdb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_9193bb04-4d0f-467f-ab9a-57aae863a2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2d7a106c-9ac5-4eb3-bea2-4ab8c52b262d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_9193bb04-4d0f-467f-ab9a-57aae863a2fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_b922a694-3767-40ac-961e-2a26cf7e8482" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2d7a106c-9ac5-4eb3-bea2-4ab8c52b262d" xlink:to="loc_us-gaap_CommitmentsAndContingencies_b922a694-3767-40ac-961e-2a26cf7e8482" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_8fdc0663-5145-4278-ac15-94c45f0f9993" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2d7a106c-9ac5-4eb3-bea2-4ab8c52b262d" xlink:to="loc_us-gaap_LongTermLineOfCredit_8fdc0663-5145-4278-ac15-94c45f0f9993" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_696d5df3-e89c-441c-9904-84396861be4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2d7a106c-9ac5-4eb3-bea2-4ab8c52b262d" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_696d5df3-e89c-441c-9904-84396861be4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_9ba3e2a9-477a-44c3-93c4-c4adf64abf14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2d7a106c-9ac5-4eb3-bea2-4ab8c52b262d" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_9ba3e2a9-477a-44c3-93c4-c4adf64abf14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a6390c12-025b-4e04-8f5b-2566220b4603" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d0560f7a-3fac-431f-ad7b-b2915fcc50f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a6390c12-025b-4e04-8f5b-2566220b4603" xlink:to="loc_us-gaap_CommonStockValue_d0560f7a-3fac-431f-ad7b-b2915fcc50f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_575581ce-25ca-442d-8d4c-6132d57453c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a6390c12-025b-4e04-8f5b-2566220b4603" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_575581ce-25ca-442d-8d4c-6132d57453c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapital_5565937a-7749-4e5b-a152-606aedf9a2bd" xlink:href="iclr-20241231.xsd#iclr_OtherUndenominatedCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a6390c12-025b-4e04-8f5b-2566220b4603" xlink:to="loc_iclr_OtherUndenominatedCapital_5565937a-7749-4e5b-a152-606aedf9a2bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c45fe33a-1e92-46b7-a525-212512332e92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a6390c12-025b-4e04-8f5b-2566220b4603" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c45fe33a-1e92-46b7-a525-212512332e92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2fd2e556-70c3-4fca-88af-231fcf8247c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a6390c12-025b-4e04-8f5b-2566220b4603" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2fd2e556-70c3-4fca-88af-231fcf8247c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_35cb4cb0-a99e-4fe9-a4f9-69c34260a67c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_7e855703-ab69-4243-82c5-527387493555" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_35cb4cb0-a99e-4fe9-a4f9-69c34260a67c" xlink:to="loc_us-gaap_IncomeTaxesReceivable_7e855703-ab69-4243-82c5-527387493555" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_5e8728e5-140e-4fb0-8e7c-9fb7c5ba8ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_35cb4cb0-a99e-4fe9-a4f9-69c34260a67c" xlink:to="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_5e8728e5-140e-4fb0-8e7c-9fb7c5ba8ab4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_c0887954-360c-4b2b-beaf-c75974dfcde5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_35cb4cb0-a99e-4fe9-a4f9-69c34260a67c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_c0887954-360c-4b2b-beaf-c75974dfcde5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f6261c52-9a76-4b70-8b26-e071ce2223fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_35cb4cb0-a99e-4fe9-a4f9-69c34260a67c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f6261c52-9a76-4b70-8b26-e071ce2223fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_281092cb-e717-45f1-ac08-23cd3444cd23" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_35cb4cb0-a99e-4fe9-a4f9-69c34260a67c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_281092cb-e717-45f1-ac08-23cd3444cd23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8c293dbe-495a-404a-861e-f67c5f170ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_35cb4cb0-a99e-4fe9-a4f9-69c34260a67c" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8c293dbe-495a-404a-861e-f67c5f170ff1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontradeReceivablesCurrent_5786531a-16d8-4a29-9aea-ba3d5190c306" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NontradeReceivablesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_35cb4cb0-a99e-4fe9-a4f9-69c34260a67c" xlink:to="loc_us-gaap_NontradeReceivablesCurrent_5786531a-16d8-4a29-9aea-ba3d5190c306" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e4523309-81f4-41fb-b708-ac06c48a8e74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c6abb21a-3617-4722-b4a1-1b8735abea95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e4523309-81f4-41fb-b708-ac06c48a8e74" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c6abb21a-3617-4722-b4a1-1b8735abea95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5404fcb4-73cc-4e71-b607-6e1ad1be616a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e4523309-81f4-41fb-b708-ac06c48a8e74" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5404fcb4-73cc-4e71-b607-6e1ad1be616a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4595daf6-0fca-4ec6-98d4-a02c9a75dcaf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e4523309-81f4-41fb-b708-ac06c48a8e74" xlink:to="loc_us-gaap_Goodwill_4595daf6-0fca-4ec6-98d4-a02c9a75dcaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_7e676322-a9e8-4e14-9d9d-8647356f756d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e4523309-81f4-41fb-b708-ac06c48a8e74" xlink:to="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_7e676322-a9e8-4e14-9d9d-8647356f756d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_509010aa-ebbb-4e0d-9ef2-900c0acdf4df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e4523309-81f4-41fb-b708-ac06c48a8e74" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_509010aa-ebbb-4e0d-9ef2-900c0acdf4df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_63ddd31d-fba4-4e6b-8966-3d3c4f8f29e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e4523309-81f4-41fb-b708-ac06c48a8e74" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_63ddd31d-fba4-4e6b-8966-3d3c4f8f29e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d3d06307-d364-457b-9b71-64353c31bb46" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e4523309-81f4-41fb-b708-ac06c48a8e74" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d3d06307-d364-457b-9b71-64353c31bb46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_02c37bab-7ad3-4535-bd52-fe483bcb1312" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e4523309-81f4-41fb-b708-ac06c48a8e74" xlink:to="loc_us-gaap_AssetsCurrent_02c37bab-7ad3-4535-bd52-fe483bcb1312" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e58b363f-c3e6-42fb-986f-a94137297c10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_c32dc9cd-e5fb-455c-b62c-2a74d402caf8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e58b363f-c3e6-42fb-986f-a94137297c10" xlink:to="loc_us-gaap_AccountsPayableCurrent_c32dc9cd-e5fb-455c-b62c-2a74d402caf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_c8a98b18-e919-4126-a3ea-e036eec97dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e58b363f-c3e6-42fb-986f-a94137297c10" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_c8a98b18-e919-4126-a3ea-e036eec97dc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_82a1916f-0478-42b1-b49b-b41855fa82ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e58b363f-c3e6-42fb-986f-a94137297c10" xlink:to="loc_us-gaap_LinesOfCreditCurrent_82a1916f-0478-42b1-b49b-b41855fa82ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b756ffbb-95ab-4fd9-ab75-9e9771f3bb8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e58b363f-c3e6-42fb-986f-a94137297c10" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b756ffbb-95ab-4fd9-ab75-9e9771f3bb8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_b672b920-9dbd-4a8a-85a1-69ef6049b723" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e58b363f-c3e6-42fb-986f-a94137297c10" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_b672b920-9dbd-4a8a-85a1-69ef6049b723" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b3062f33-d5b4-4515-8374-629e348d70cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4e6a09ac-6cf3-4099-af61-dd7169da7c01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b3062f33-d5b4-4515-8374-629e348d70cd" xlink:to="loc_us-gaap_Liabilities_4e6a09ac-6cf3-4099-af61-dd7169da7c01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_26099c5b-4322-4522-b278-844019856ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b3062f33-d5b4-4515-8374-629e348d70cd" xlink:to="loc_us-gaap_StockholdersEquity_26099c5b-4322-4522-b278-844019856ba6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="iclr-20241231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_d1accb3e-fe86-452e-8af5-2435a3b0cfae" xlink:href="iclr-20241231.xsd#iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_7d1afb33-bc13-4876-9ca2-fa970169b5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_d1accb3e-fe86-452e-8af5-2435a3b0cfae" xlink:to="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_7d1afb33-bc13-4876-9ca2-fa970169b5d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ed702098-378a-4c8d-8a4a-28eca36e7cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_d1accb3e-fe86-452e-8af5-2435a3b0cfae" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ed702098-378a-4c8d-8a4a-28eca36e7cf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_6312e8d1-58c9-4a75-b12c-a4d106d0921c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_321ba061-ba2f-4cab-8a6f-f2f10af84d52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_6312e8d1-58c9-4a75-b12c-a4d106d0921c" xlink:to="loc_us-gaap_InvestmentIncomeInterest_321ba061-ba2f-4cab-8a6f-f2f10af84d52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ed960f86-4d1c-4c98-87a4-3c8831618134" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_6312e8d1-58c9-4a75-b12c-a4d106d0921c" xlink:to="loc_us-gaap_OperatingIncomeLoss_ed960f86-4d1c-4c98-87a4-3c8831618134" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_c7053cf4-c43d-4fd2-857c-1f535956c53f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_6312e8d1-58c9-4a75-b12c-a4d106d0921c" xlink:to="loc_us-gaap_InterestExpenseNonoperating_c7053cf4-c43d-4fd2-857c-1f535956c53f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_52aedc8e-37bc-455b-b311-e0e3bcc9bfa2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c677fd01-2035-421f-865b-967616e93c32" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_52aedc8e-37bc-455b-b311-e0e3bcc9bfa2" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c677fd01-2035-421f-865b-967616e93c32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_7572b4db-de4a-4b1c-9f9f-1ed0e4ce7bac" xlink:href="iclr-20241231.xsd#iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_52aedc8e-37bc-455b-b311-e0e3bcc9bfa2" xlink:to="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_7572b4db-de4a-4b1c-9f9f-1ed0e4ce7bac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_df10fe3a-68bf-43b8-be60-0637abefa57a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_90be371c-acb0-4248-aebb-84489f8d41d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_df10fe3a-68bf-43b8-be60-0637abefa57a" xlink:to="loc_us-gaap_RestructuringCosts_90be371c-acb0-4248-aebb-84489f8d41d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4bb26401-8ee1-4901-99f4-1a99c864a7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_df10fe3a-68bf-43b8-be60-0637abefa57a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4bb26401-8ee1-4901-99f4-1a99c864a7f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_019023ad-bee9-458e-a941-6b2f111f1ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_df10fe3a-68bf-43b8-be60-0637abefa57a" xlink:to="loc_us-gaap_DepreciationAndAmortization_019023ad-bee9-458e-a941-6b2f111f1ec9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_c43399ac-7aaf-4e98-9631-bc8f8d792427" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_df10fe3a-68bf-43b8-be60-0637abefa57a" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_c43399ac-7aaf-4e98-9631-bc8f8d792427" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_5729a96b-b7a0-464a-978b-9d3d7d6c51f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_df10fe3a-68bf-43b8-be60-0637abefa57a" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_5729a96b-b7a0-464a-978b-9d3d7d6c51f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_070af686-5819-4a25-ae0a-f760b6b71cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_5ded03d1-4e82-4001-8342-471a04269e31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_070af686-5819-4a25-ae0a-f760b6b71cd9" xlink:to="loc_us-gaap_CostsAndExpenses_5ded03d1-4e82-4001-8342-471a04269e31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3992e481-98ea-4bc7-b316-6c96105cda35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_070af686-5819-4a25-ae0a-f760b6b71cd9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3992e481-98ea-4bc7-b316-6c96105cda35" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="iclr-20241231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_977d8c66-0062-44dd-8fa6-9282da7ee8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_06dd5840-401a-4fb9-95eb-5967cac29b91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_977d8c66-0062-44dd-8fa6-9282da7ee8a4" xlink:to="loc_us-gaap_ProfitLoss_06dd5840-401a-4fb9-95eb-5967cac29b91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_00147c6b-f8c6-415a-941c-0e0196e56983" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_977d8c66-0062-44dd-8fa6-9282da7ee8a4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_00147c6b-f8c6-415a-941c-0e0196e56983" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_9edbdc6c-f5df-41eb-92db-5d3d89a18d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_977d8c66-0062-44dd-8fa6-9282da7ee8a4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_9edbdc6c-f5df-41eb-92db-5d3d89a18d8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_8c4ea592-17f3-4dc9-8fda-dbc474047cac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_977d8c66-0062-44dd-8fa6-9282da7ee8a4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_8c4ea592-17f3-4dc9-8fda-dbc474047cac" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="iclr-20241231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f7ba81e2-235b-48d7-a910-cb596db74efc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_029c5e9e-890a-41e4-8904-a1032d3b269e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f7ba81e2-235b-48d7-a910-cb596db74efc" xlink:to="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_029c5e9e-890a-41e4-8904-a1032d3b269e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_1d6984d7-0581-4ff7-ab74-77e3022dd033" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f7ba81e2-235b-48d7-a910-cb596db74efc" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_1d6984d7-0581-4ff7-ab74-77e3022dd033" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c1fb8bf0-f01f-48e0-8a3d-2cfdb5b56bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f7ba81e2-235b-48d7-a910-cb596db74efc" xlink:to="loc_us-gaap_ProfitLoss_c1fb8bf0-f01f-48e0-8a3d-2cfdb5b56bb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_3dbc5e5f-d169-4432-9213-d058319d2d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f7ba81e2-235b-48d7-a910-cb596db74efc" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_3dbc5e5f-d169-4432-9213-d058319d2d1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_e3f22228-caa9-48aa-915c-fbedf252ffc5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f7ba81e2-235b-48d7-a910-cb596db74efc" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_e3f22228-caa9-48aa-915c-fbedf252ffc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment_916e9ba9-93cd-43a7-9533-3dd449bd525c" xlink:href="iclr-20241231.xsd#iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f7ba81e2-235b-48d7-a910-cb596db74efc" xlink:to="loc_iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment_916e9ba9-93cd-43a7-9533-3dd449bd525c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_d84aa84a-5090-4848-8caf-8864c5d52f79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f7ba81e2-235b-48d7-a910-cb596db74efc" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_d84aa84a-5090-4848-8caf-8864c5d52f79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_d24e196a-a8b8-4f63-97ae-b0dfc899d2e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f7ba81e2-235b-48d7-a910-cb596db74efc" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_d24e196a-a8b8-4f63-97ae-b0dfc899d2e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_9d289c95-9c47-40f0-ae45-5e8f0a48b090" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f7ba81e2-235b-48d7-a910-cb596db74efc" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_9d289c95-9c47-40f0-ae45-5e8f0a48b090" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6cc1f45c-f505-4300-9784-55f117655174" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f7ba81e2-235b-48d7-a910-cb596db74efc" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6cc1f45c-f505-4300-9784-55f117655174" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_9db82721-a1f9-40cf-98c4-cfb06b32dee9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f7ba81e2-235b-48d7-a910-cb596db74efc" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_9db82721-a1f9-40cf-98c4-cfb06b32dee9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ca6576d5-4647-4ec0-adf3-bd7f7d05bc18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f7ba81e2-235b-48d7-a910-cb596db74efc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ca6576d5-4647-4ec0-adf3-bd7f7d05bc18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7eead4dc-6fc5-4ac1-91d5-1c2fabe4ead0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f7ba81e2-235b-48d7-a910-cb596db74efc" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7eead4dc-6fc5-4ac1-91d5-1c2fabe4ead0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_3897d350-d370-4569-8cf5-9d667507dc9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f7ba81e2-235b-48d7-a910-cb596db74efc" xlink:to="loc_us-gaap_ShareBasedCompensation_3897d350-d370-4569-8cf5-9d667507dc9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_b8bdd9e6-9026-4a2d-b2c1-32920614f9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f7ba81e2-235b-48d7-a910-cb596db74efc" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_b8bdd9e6-9026-4a2d-b2c1-32920614f9ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_91469314-789e-4224-a29c-2363251fd1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7a6a59b7-080f-42af-a049-de5b6004588f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_91469314-789e-4224-a29c-2363251fd1fe" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7a6a59b7-080f-42af-a049-de5b6004588f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bae90337-1408-4f2f-a665-03e89516fe97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_91469314-789e-4224-a29c-2363251fd1fe" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bae90337-1408-4f2f-a665-03e89516fe97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_260989a0-0480-4c6d-87e1-d242a4dd8f95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_91469314-789e-4224-a29c-2363251fd1fe" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_260989a0-0480-4c6d-87e1-d242a4dd8f95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_627e01e7-6b2f-4563-a137-c10833174319" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_91469314-789e-4224-a29c-2363251fd1fe" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_627e01e7-6b2f-4563-a137-c10833174319" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_72684478-f756-462c-9b6b-bd89231d75c2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_4602157b-5269-4081-8a7a-3db4e4c5ce94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_72684478-f756-462c-9b6b-bd89231d75c2" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_4602157b-5269-4081-8a7a-3db4e4c5ce94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d6083958-5e15-4a20-955c-ba2126bc53dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_72684478-f756-462c-9b6b-bd89231d75c2" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d6083958-5e15-4a20-955c-ba2126bc53dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_ddf20ae1-e2df-4561-bbb0-52e7ab538800" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_72684478-f756-462c-9b6b-bd89231d75c2" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_ddf20ae1-e2df-4561-bbb0-52e7ab538800" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_c4515f3f-0371-4cfd-89b9-4bd71900c91a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_72684478-f756-462c-9b6b-bd89231d75c2" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_c4515f3f-0371-4cfd-89b9-4bd71900c91a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_a96d8620-a0d6-4226-9be2-f1aec9e93c56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_72684478-f756-462c-9b6b-bd89231d75c2" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_a96d8620-a0d6-4226-9be2-f1aec9e93c56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PaymentsForBrokerCommissionShareRepurchaseCosts_b3f91f7f-2086-4ecf-9ad0-794026aba014" xlink:href="iclr-20241231.xsd#iclr_PaymentsForBrokerCommissionShareRepurchaseCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_72684478-f756-462c-9b6b-bd89231d75c2" xlink:to="loc_iclr_PaymentsForBrokerCommissionShareRepurchaseCosts_b3f91f7f-2086-4ecf-9ad0-794026aba014" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_447b37bc-97da-48e8-8326-dad9e2301c44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_72684478-f756-462c-9b6b-bd89231d75c2" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_447b37bc-97da-48e8-8326-dad9e2301c44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0c5e2dad-7b5e-4e7f-91b9-7b4d7bd06238" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments_0e8f9679-63ec-422b-8d95-ebbc50e92994" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0c5e2dad-7b5e-4e7f-91b9-7b4d7bd06238" xlink:to="loc_us-gaap_PaymentsToAcquireLongtermInvestments_0e8f9679-63ec-422b-8d95-ebbc50e92994" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_0425bc67-6b25-4325-b04e-dfdc495e86e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0c5e2dad-7b5e-4e7f-91b9-7b4d7bd06238" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_0425bc67-6b25-4325-b04e-dfdc495e86e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b8c0750c-7b84-4e4c-a670-c9041a4496d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0c5e2dad-7b5e-4e7f-91b9-7b4d7bd06238" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b8c0750c-7b84-4e4c-a670-c9041a4496d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_142b7bdb-ca37-4af0-8dd6-cae7a317aff0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0c5e2dad-7b5e-4e7f-91b9-7b4d7bd06238" xlink:to="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_142b7bdb-ca37-4af0-8dd6-cae7a317aff0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromShortTermInvestments_fe956c13-11e7-4c8f-a780-1a87b171706a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0c5e2dad-7b5e-4e7f-91b9-7b4d7bd06238" xlink:to="loc_us-gaap_PaymentsForProceedsFromShortTermInvestments_fe956c13-11e7-4c8f-a780-1a87b171706a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableNet_09a3246d-b33b-4145-b0bc-4353b283fbb4" xlink:href="iclr-20241231.xsd#iclr_ContractsReceivableNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableGross_b9d16a1c-9af1-4586-b3b3-15d137a126ec" xlink:href="iclr-20241231.xsd#iclr_ContractsReceivableGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ContractsReceivableNet_09a3246d-b33b-4145-b0bc-4353b283fbb4" xlink:to="loc_iclr_ContractsReceivableGross_b9d16a1c-9af1-4586-b3b3-15d137a126ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_79d77f88-5a1b-4da3-a66e-50fd345bd366" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ContractsReceivableNet_09a3246d-b33b-4145-b0bc-4353b283fbb4" xlink:to="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_79d77f88-5a1b-4da3-a66e-50fd345bd366" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableGross_d7de7c6d-6146-4900-80ff-5f01b4be0ba0" xlink:href="iclr-20241231.xsd#iclr_ContractsReceivableGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BilledContractReceivables_b789dcfc-45e2-468e-98bd-583ee4304ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BilledContractReceivables"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ContractsReceivableGross_d7de7c6d-6146-4900-80ff-5f01b4be0ba0" xlink:to="loc_us-gaap_BilledContractReceivables_b789dcfc-45e2-468e-98bd-583ee4304ec9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_3d82c8f8-1185-4d4b-a7dc-794e7cb1df4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ContractsReceivableGross_d7de7c6d-6146-4900-80ff-5f01b4be0ba0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_3d82c8f8-1185-4d4b-a7dc-794e7cb1df4d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable_a0b17303-2eb8-44f4-ac8c-3a32e841cd2b" xlink:href="iclr-20241231.xsd#iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_6cb884c3-3f55-4a6d-a42e-e98b243e13eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable_a0b17303-2eb8-44f4-ac8c-3a32e841cd2b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_6cb884c3-3f55-4a6d-a42e-e98b243e13eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_758cc13e-1671-4d0e-a6e0-0be5d1914851" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable_a0b17303-2eb8-44f4-ac8c-3a32e841cd2b" xlink:to="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_758cc13e-1671-4d0e-a6e0-0be5d1914851" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable_f45d5181-42f6-43a5-9237-48623d473f57" xlink:href="iclr-20241231.xsd#iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_61e64ba6-06fb-4ac1-82b8-e5ab02a108dc" xlink:href="iclr-20241231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable_f45d5181-42f6-43a5-9237-48623d473f57" xlink:to="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_61e64ba6-06fb-4ac1-82b8-e5ab02a108dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent_e918be85-41e5-4593-862f-79e90ab99d88" xlink:href="iclr-20241231.xsd#iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable_f45d5181-42f6-43a5-9237-48623d473f57" xlink:to="loc_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent_e918be85-41e5-4593-862f-79e90ab99d88" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_862daed7-3f71-4569-8995-336ced5e717b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_d2d281d1-ec41-42ef-a29f-d3748179870b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_862daed7-3f71-4569-8995-336ced5e717b" xlink:to="loc_us-gaap_DerivativeLiabilities_d2d281d1-ec41-42ef-a29f-d3748179870b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_f4672b7f-ec50-4648-8f1f-1d01d1bf68e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_5e21ae5c-fc6d-4386-9f49-16794fc3351e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_f4672b7f-ec50-4648-8f1f-1d01d1bf68e3" xlink:to="loc_us-gaap_DerivativeLiabilities_5e21ae5c-fc6d-4386-9f49-16794fc3351e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#PropertyPlantandEquipmentnetDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_0e14e4d6-7688-4d3d-b0a8-71008a216cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_6a5e6938-d900-494b-8a3c-7d2cadb39bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Land"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_0e14e4d6-7688-4d3d-b0a8-71008a216cc8" xlink:to="loc_us-gaap_Land_6a5e6938-d900-494b-8a3c-7d2cadb39bd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_1e5f5af0-eb5b-4b50-85e4-e2fc9cdfc692" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_0e14e4d6-7688-4d3d-b0a8-71008a216cc8" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_1e5f5af0-eb5b-4b50-85e4-e2fc9cdfc692" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_5adbdd2a-d522-43c0-b9d3-b586e1434001" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_0e14e4d6-7688-4d3d-b0a8-71008a216cc8" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_5adbdd2a-d522-43c0-b9d3-b586e1434001" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_ad523cab-0d26-4e39-a68b-dbaaa9cab3b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_0e14e4d6-7688-4d3d-b0a8-71008a216cc8" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_ad523cab-0d26-4e39-a68b-dbaaa9cab3b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_e6bc572b-e00b-4f49-afcd-e8f5867288dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_0e14e4d6-7688-4d3d-b0a8-71008a216cc8" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_e6bc572b-e00b-4f49-afcd-e8f5867288dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_743c9aa2-63c6-4cc6-a870-f4af212fdf39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_0e14e4d6-7688-4d3d-b0a8-71008a216cc8" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_743c9aa2-63c6-4cc6-a870-f4af212fdf39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VehiclesGross_ecec046b-15a8-4ea6-ab86-2dc894d4b7ef" xlink:href="iclr-20241231.xsd#iclr_VehiclesGross"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_0e14e4d6-7688-4d3d-b0a8-71008a216cc8" xlink:to="loc_iclr_VehiclesGross_ecec046b-15a8-4ea6-ab86-2dc894d4b7ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_297f2eb0-bba3-4bc5-9a00-be41248bcab1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_8c7669e6-ea76-4913-b4f8-bfdd99e3b040" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_297f2eb0-bba3-4bc5-9a00-be41248bcab1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_8c7669e6-ea76-4913-b4f8-bfdd99e3b040" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b8b620eb-bca8-4cfb-9eeb-355ce240cc43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_297f2eb0-bba3-4bc5-9a00-be41248bcab1" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b8b620eb-bca8-4cfb-9eeb-355ce240cc43" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8ffab6bf-e9d2-48c2-b6d6-0a59d4f3a7d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ba6a021f-eaa7-4006-9e00-03e8ce8aa533" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8ffab6bf-e9d2-48c2-b6d6-0a59d4f3a7d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ba6a021f-eaa7-4006-9e00-03e8ce8aa533" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_62754127-2bc3-4ca4-85ef-ef3722c6aa4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8ffab6bf-e9d2-48c2-b6d6-0a59d4f3a7d2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_62754127-2bc3-4ca4-85ef-ef3722c6aa4f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_db2789c5-143d-4475-9e02-011bb9443827" xlink:href="iclr-20241231.xsd#iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c5bc4838-ac2d-451f-8c8a-d00a5e7b53b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_db2789c5-143d-4475-9e02-011bb9443827" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c5bc4838-ac2d-451f-8c8a-d00a5e7b53b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_3a2480a0-923a-471d-9317-8283fdfca561" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_db2789c5-143d-4475-9e02-011bb9443827" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_3a2480a0-923a-471d-9317-8283fdfca561" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7b02ee95-45a3-453c-be93-10721050845e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_db2789c5-143d-4475-9e02-011bb9443827" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7b02ee95-45a3-453c-be93-10721050845e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_186021be-2da0-428a-8b53-77e6df2c9867" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_db2789c5-143d-4475-9e02-011bb9443827" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_186021be-2da0-428a-8b53-77e6df2c9867" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_a0a4359c-5f52-449f-aaf7-8c871571d33e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_db2789c5-143d-4475-9e02-011bb9443827" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_a0a4359c-5f52-449f-aaf7-8c871571d33e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OtherLiabilitiesDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#OtherLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/OtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_09028bd1-883f-4f79-bdb8-665bb02196fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_6f64f756-ec49-4b16-805d-cd510a2de172" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_09028bd1-883f-4f79-bdb8-665bb02196fe" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_6f64f756-ec49-4b16-805d-cd510a2de172" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_82031f34-ca36-412a-abd4-581181df5653" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_09028bd1-883f-4f79-bdb8-665bb02196fe" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_82031f34-ca36-412a-abd4-581181df5653" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_82905586-18da-4b64-ad45-b1307cee1041" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_09028bd1-883f-4f79-bdb8-665bb02196fe" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_82905586-18da-4b64-ad45-b1307cee1041" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedUtilitiesCurrent_50deb320-2ad9-4de9-9d51-b3ca7dc7a9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedUtilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_09028bd1-883f-4f79-bdb8-665bb02196fe" xlink:to="loc_us-gaap_AccruedUtilitiesCurrent_50deb320-2ad9-4de9-9d51-b3ca7dc7a9fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_b93940cf-45f4-4957-b959-9d59f641ff1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_09028bd1-883f-4f79-bdb8-665bb02196fe" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_b93940cf-45f4-4957-b959-9d59f641ff1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestructuringReserveAndOtherLiabilitiesCurrent_78f273a4-7686-4a14-9386-903e8df7ffce" xlink:href="iclr-20241231.xsd#iclr_RestructuringReserveAndOtherLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_09028bd1-883f-4f79-bdb8-665bb02196fe" xlink:to="loc_iclr_RestructuringReserveAndOtherLiabilitiesCurrent_78f273a4-7686-4a14-9386-903e8df7ffce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceLiabilityCurrent_e4ceeacb-8657-4196-a74d-24f8a5ab3dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GovernmentAssistanceLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_09028bd1-883f-4f79-bdb8-665bb02196fe" xlink:to="loc_us-gaap_GovernmentAssistanceLiabilityCurrent_e4ceeacb-8657-4196-a74d-24f8a5ab3dc7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_53fef199-fced-4703-9690-a1a3f2586a08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_bb95e068-597a-4bbc-a42a-46edb5abc718" xlink:href="iclr-20241231.xsd#iclr_LongTermDebtExcludingCurrentMaturitiesGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_53fef199-fced-4703-9690-a1a3f2586a08" xlink:to="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_bb95e068-597a-4bbc-a42a-46edb5abc718" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_04e7a0b0-402c-45e5-962d-c8c8b9117ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_53fef199-fced-4703-9690-a1a3f2586a08" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_04e7a0b0-402c-45e5-962d-c8c8b9117ad3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_4a02d094-c98a-4fd4-a5cb-f40a253228aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtCurrentMaturitiesGross_3cafe634-3c89-42a6-a91a-906879562ee8" xlink:href="iclr-20241231.xsd#iclr_LongTermDebtCurrentMaturitiesGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_4a02d094-c98a-4fd4-a5cb-f40a253228aa" xlink:to="loc_iclr_LongTermDebtCurrentMaturitiesGross_3cafe634-3c89-42a6-a91a-906879562ee8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_97885e26-e254-46d5-b6db-ab5788581a32" xlink:href="iclr-20241231.xsd#iclr_LongTermDebtExcludingCurrentMaturitiesGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_4a02d094-c98a-4fd4-a5cb-f40a253228aa" xlink:to="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_97885e26-e254-46d5-b6db-ab5788581a32" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofFinanceCostDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BankCreditLinesLoanFacilitiesandNotesScheduleofFinanceCostDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofFinanceCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_d266b94d-b120-45be-9dd3-12beba8c5e07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestExpenseCreditOther_a957a9c4-534d-4dc6-a1f5-767db5aa7604" xlink:href="iclr-20241231.xsd#iclr_InterestExpenseCreditOther"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseNonoperating_d266b94d-b120-45be-9dd3-12beba8c5e07" xlink:to="loc_iclr_InterestExpenseCreditOther_a957a9c4-534d-4dc6-a1f5-767db5aa7604" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_34238683-d2ee-4e35-b8f7-d2af0d64ae12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseNonoperating_d266b94d-b120-45be-9dd3-12beba8c5e07" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_34238683-d2ee-4e35-b8f7-d2af0d64ae12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_128fda28-b305-438a-95bb-1761871efb12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseNonoperating_d266b94d-b120-45be-9dd3-12beba8c5e07" xlink:to="loc_us-gaap_InterestExpenseDebt_128fda28-b305-438a-95bb-1761871efb12" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BankCreditLinesLoanFacilitiesandNotesScheduleofMaturitiesofLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMaturitiesofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_f7223931-a43a-4ebe-b311-eeeafb1b2fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_cd07b1d1-2a56-4cfd-a455-9615143f773b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_f7223931-a43a-4ebe-b311-eeeafb1b2fa3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_cd07b1d1-2a56-4cfd-a455-9615143f773b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ed4e637e-818a-4ae7-a0c3-bab7736bb477" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_f7223931-a43a-4ebe-b311-eeeafb1b2fa3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ed4e637e-818a-4ae7-a0c3-bab7736bb477" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_21d1cadf-6682-423e-915a-f302a1747a01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_f7223931-a43a-4ebe-b311-eeeafb1b2fa3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_21d1cadf-6682-423e-915a-f302a1747a01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter_166ba504-ce6e-4446-a7bf-3e8bdecaa0c2" xlink:href="iclr-20241231.xsd#iclr_LongTermDebtMaturityYearFiveAndThereafter"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_f7223931-a43a-4ebe-b311-eeeafb1b2fa3" xlink:to="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter_166ba504-ce6e-4446-a7bf-3e8bdecaa0c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2396f19f-e550-4950-9d70-13d4fbfac963" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_f7223931-a43a-4ebe-b311-eeeafb1b2fa3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2396f19f-e550-4950-9d70-13d4fbfac963" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesScheduleofLeaseCostsDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#OperatingLeasesScheduleofLeaseCostsDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesScheduleofLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_f0d7a630-07c9-413f-bd0c-38323dabcc21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_b81ebe60-cb9a-4ba6-bdc8-18e18615a926" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_f0d7a630-07c9-413f-bd0c-38323dabcc21" xlink:to="loc_us-gaap_SubleaseIncome_b81ebe60-cb9a-4ba6-bdc8-18e18615a926" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_f4711231-adc6-4e16-aea1-94fe2377d6fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_f0d7a630-07c9-413f-bd0c-38323dabcc21" xlink:to="loc_us-gaap_OperatingLeaseCost_f4711231-adc6-4e16-aea1-94fe2377d6fc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6c9590fe-f4ed-46fd-9b86-a386f015cd71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_605305fc-fa34-4e20-a203-9294f5477809" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6c9590fe-f4ed-46fd-9b86-a386f015cd71" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_605305fc-fa34-4e20-a203-9294f5477809" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_1ebf0af7-b3f7-4a72-b7b3-4d6f485d0f09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6c9590fe-f4ed-46fd-9b86-a386f015cd71" xlink:to="loc_us-gaap_OperatingLeaseLiability_1ebf0af7-b3f7-4a72-b7b3-4d6f485d0f09" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1" xlink:type="simple" xlink:href="iclr-20241231.xsd#OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_30e980cf-7648-4137-8c33-cc0a77ec0517" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_23a8843b-3fe7-4cbc-9653-137b93fcb853" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_30e980cf-7648-4137-8c33-cc0a77ec0517" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_23a8843b-3fe7-4cbc-9653-137b93fcb853" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5ce0f4de-e149-4d17-88da-6c0c123a1adf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_30e980cf-7648-4137-8c33-cc0a77ec0517" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5ce0f4de-e149-4d17-88da-6c0c123a1adf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_18ed7097-6150-41e3-947f-5e5303793c09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_30e980cf-7648-4137-8c33-cc0a77ec0517" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_18ed7097-6150-41e3-947f-5e5303793c09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2c642240-b00e-4e43-8787-da363668842b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_30e980cf-7648-4137-8c33-cc0a77ec0517" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2c642240-b00e-4e43-8787-da363668842b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_59392c8a-dd1b-49d0-a60a-9935e70c722a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_30e980cf-7648-4137-8c33-cc0a77ec0517" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_59392c8a-dd1b-49d0-a60a-9935e70c722a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_18215286-010f-4208-b765-2e33f1f6f500" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_30e980cf-7648-4137-8c33-cc0a77ec0517" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_18215286-010f-4208-b765-2e33f1f6f500" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#NoncurrentotherliabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_cc23f3bf-6a68-4da8-9e50-f6526d36c379" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_8cc1a42d-e54a-40f9-8835-930d505a7295" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_cc23f3bf-6a68-4da8-9e50-f6526d36c379" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_8cc1a42d-e54a-40f9-8835-930d505a7295" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_ae78b60f-ec1f-4434-bdc5-2b6fdefad2d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_366acd2c-ca66-4c44-ad81-552f368b9d40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_ae78b60f-ec1f-4434-bdc5-2b6fdefad2d1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_366acd2c-ca66-4c44-ad81-552f368b9d40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e4659ee0-6832-46fc-9b48-62685603c74b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_ae78b60f-ec1f-4434-bdc5-2b6fdefad2d1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e4659ee0-6832-46fc-9b48-62685603c74b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_58162822-fd18-4d42-84ee-58354a5f6e64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_ae78b60f-ec1f-4434-bdc5-2b6fdefad2d1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_58162822-fd18-4d42-84ee-58354a5f6e64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_dcdbb551-4664-462d-8940-427998592801" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_ae78b60f-ec1f-4434-bdc5-2b6fdefad2d1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_dcdbb551-4664-462d-8940-427998592801" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9bf3277d-9ed0-4b1b-bd0f-412cc472ce9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_a4f2d808-78ed-44b2-94a0-822bcb642df0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_9bf3277d-9ed0-4b1b-bd0f-412cc472ce9e" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_a4f2d808-78ed-44b2-94a0-822bcb642df0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d9aa4993-345f-45f5-aca2-a1cc560e8202" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_9bf3277d-9ed0-4b1b-bd0f-412cc472ce9e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d9aa4993-345f-45f5-aca2-a1cc560e8202" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0583e4dd-8c71-4bee-8dd1-90ff3e111df7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_8473a203-803c-44ff-9fc9-c299579a753b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0583e4dd-8c71-4bee-8dd1-90ff3e111df7" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_8473a203-803c-44ff-9fc9-c299579a753b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_cb30a7ef-c244-49b5-bfdd-920f8a65e4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0583e4dd-8c71-4bee-8dd1-90ff3e111df7" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_cb30a7ef-c244-49b5-bfdd-920f8a65e4f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount_dfb2bf02-1e54-4dc4-96f7-1b10995edd33" xlink:href="iclr-20241231.xsd#iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0583e4dd-8c71-4bee-8dd1-90ff3e111df7" xlink:to="loc_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount_dfb2bf02-1e54-4dc4-96f7-1b10995edd33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_142ec0f9-b84f-4558-93bb-ea53c39c8b11" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0583e4dd-8c71-4bee-8dd1-90ff3e111df7" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_142ec0f9-b84f-4558-93bb-ea53c39c8b11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_d80ec375-9705-4255-aad1-562de6d7a275" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0583e4dd-8c71-4bee-8dd1-90ff3e111df7" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_d80ec375-9705-4255-aad1-562de6d7a275" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_4879c534-3482-401c-abf6-52307d2a045a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0583e4dd-8c71-4bee-8dd1-90ff3e111df7" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_4879c534-3482-401c-abf6-52307d2a045a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount_50cda9a0-0e29-4bf6-8bc8-2ad4aa7c18f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0583e4dd-8c71-4bee-8dd1-90ff3e111df7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount_50cda9a0-0e29-4bf6-8bc8-2ad4aa7c18f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_97fe2452-efeb-4b51-aff7-b9e78aec8c77" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0583e4dd-8c71-4bee-8dd1-90ff3e111df7" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_97fe2452-efeb-4b51-aff7-b9e78aec8c77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount_5b922749-93e4-47f9-bc1d-9e326b3a10bf" xlink:href="iclr-20241231.xsd#iclr_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0583e4dd-8c71-4bee-8dd1-90ff3e111df7" xlink:to="loc_iclr_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount_5b922749-93e4-47f9-bc1d-9e326b3a10bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_18d0b67e-aa65-4190-bdc5-61b5d70b8cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0583e4dd-8c71-4bee-8dd1-90ff3e111df7" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_18d0b67e-aa65-4190-bdc5-61b5d70b8cd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_6736db05-673f-440a-b217-b79218fca173" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0583e4dd-8c71-4bee-8dd1-90ff3e111df7" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_6736db05-673f-440a-b217-b79218fca173" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_74406707-33c8-4953-916d-c0a3b6c337df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_82040c42-fd48-4344-aa7c-295f4d0d87c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_74406707-33c8-4953-916d-c0a3b6c337df" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_82040c42-fd48-4344-aa7c-295f4d0d87c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_748d44ce-42ce-415c-931b-c97a53b7e53f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_74406707-33c8-4953-916d-c0a3b6c337df" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_748d44ce-42ce-415c-931b-c97a53b7e53f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_3ecee177-fff5-400b-b31a-f9f9e0e10dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_4427b848-edfd-4249-b233-4a1c39b8e646" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_3ecee177-fff5-400b-b31a-f9f9e0e10dd3" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_4427b848-edfd-4249-b233-4a1c39b8e646" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_c5e72047-869d-44e6-8369-b43f5ac938fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_3ecee177-fff5-400b-b31a-f9f9e0e10dd3" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_c5e72047-869d-44e6-8369-b43f5ac938fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_d32b52bb-8c59-4864-a2f8-568427ea7cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_b193aebf-0f31-4a9b-b988-c276cd2c7256" xlink:href="iclr-20241231.xsd#iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d32b52bb-8c59-4864-a2f8-568427ea7cdb" xlink:to="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_b193aebf-0f31-4a9b-b988-c276cd2c7256" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_ebdbd9ee-5e79-4ec6-bc1b-f5aadc6f1476" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d32b52bb-8c59-4864-a2f8-568427ea7cdb" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_ebdbd9ee-5e79-4ec6-bc1b-f5aadc6f1476" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability_01e3e8fc-c6f6-4984-9744-37aa99ca3c17" xlink:href="iclr-20241231.xsd#iclr_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d32b52bb-8c59-4864-a2f8-568427ea7cdb" xlink:to="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability_01e3e8fc-c6f6-4984-9744-37aa99ca3c17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_a345ca56-32a0-4a6f-bd8f-24ec4456c6ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d32b52bb-8c59-4864-a2f8-568427ea7cdb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_a345ca56-32a0-4a6f-bd8f-24ec4456c6ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities_25d28806-020a-4df1-99ce-151aaa32d882" xlink:href="iclr-20241231.xsd#iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d32b52bb-8c59-4864-a2f8-568427ea7cdb" xlink:to="loc_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities_25d28806-020a-4df1-99ce-151aaa32d882" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetContractWithCustomerLiability_106cbbf5-7865-443f-bbb5-e7dab851f3e4" xlink:href="iclr-20241231.xsd#iclr_DeferredTaxAssetContractWithCustomerLiability"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d32b52bb-8c59-4864-a2f8-568427ea7cdb" xlink:to="loc_iclr_DeferredTaxAssetContractWithCustomerLiability_106cbbf5-7865-443f-bbb5-e7dab851f3e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_94552f31-bae1-4f36-8182-01697e7f721b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d32b52bb-8c59-4864-a2f8-568427ea7cdb" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_94552f31-bae1-4f36-8182-01697e7f721b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_aa6967f3-32f1-4d1b-af3e-c9c475e4235e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d32b52bb-8c59-4864-a2f8-568427ea7cdb" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_aa6967f3-32f1-4d1b-af3e-c9c475e4235e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_0e8b5e43-dc9b-4db9-ad6f-5e0987ef6c49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_d2e1b155-0360-4c9b-94d1-4f6c04d23989" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_0e8b5e43-dc9b-4db9-ad6f-5e0987ef6c49" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_d2e1b155-0360-4c9b-94d1-4f6c04d23989" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_e35dbb77-bf82-4964-83d7-9aaa0e4ef1db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_0e8b5e43-dc9b-4db9-ad6f-5e0987ef6c49" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_e35dbb77-bf82-4964-83d7-9aaa0e4ef1db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_ae3d4023-b2b7-436d-a41a-a68389aaa223" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_0e8b5e43-dc9b-4db9-ad6f-5e0987ef6c49" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_ae3d4023-b2b7-436d-a41a-a68389aaa223" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_6cd35b0c-e288-4b4b-b77f-e0a993b57991" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_0e8b5e43-dc9b-4db9-ad6f-5e0987ef6c49" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_6cd35b0c-e288-4b4b-b77f-e0a993b57991" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_c97c88ff-2556-496e-b04b-e908d3008fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_0e8b5e43-dc9b-4db9-ad6f-5e0987ef6c49" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_c97c88ff-2556-496e-b04b-e908d3008fa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_c185d471-f8bc-4683-8537-6efcc556b774" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_0e8b5e43-dc9b-4db9-ad6f-5e0987ef6c49" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_c185d471-f8bc-4683-8537-6efcc556b774" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#IncomeTaxesExpectedExpiryDatesofNOLsDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_cd423cca-3e7f-471b-baf7-75ce67acf483" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_36c1ffdc-a1f1-4f6a-aca5-9eb253e11f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_cd423cca-3e7f-471b-baf7-75ce67acf483" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_36c1ffdc-a1f1-4f6a-aca5-9eb253e11f0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_1ee0e875-79d4-4ecd-bb6b-426d209128a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_cd423cca-3e7f-471b-baf7-75ce67acf483" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_1ee0e875-79d4-4ecd-bb6b-426d209128a2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_367c34f8-fc9d-4bca-8807-9e6129a1b0be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_06db8357-d7c8-433d-af8b-fc3994cea5a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_367c34f8-fc9d-4bca-8807-9e6129a1b0be" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_06db8357-d7c8-433d-af8b-fc3994cea5a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_34e78616-dd5d-4e48-9196-bcab7f854df5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_367c34f8-fc9d-4bca-8807-9e6129a1b0be" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_34e78616-dd5d-4e48-9196-bcab7f854df5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails"/>
  <link:calculationLink xlink:role="http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7f5e8f8b-9d36-4dfa-a168-742fed3a6dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax_c88403ba-0df4-43ff-a724-d3d1dcb8ef70" xlink:href="iclr-20241231.xsd#iclr_AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7f5e8f8b-9d36-4dfa-a168-742fed3a6dfe" xlink:to="loc_iclr_AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax_c88403ba-0df4-43ff-a724-d3d1dcb8ef70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_fdba4051-0cf3-4ff1-b48b-066d88efa9f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7f5e8f8b-9d36-4dfa-a168-742fed3a6dfe" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_fdba4051-0cf3-4ff1-b48b-066d88efa9f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1c1f6aec-492d-44d8-8cb8-b805fd9e2c83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7f5e8f8b-9d36-4dfa-a168-742fed3a6dfe" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1c1f6aec-492d-44d8-8cb8-b805fd9e2c83" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>iclr-20241231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:56d7542f-319d-475c-a76f-1ff45be39275,g:fef64a75-6c12-4b8b-a2b6-5a3facaa93b8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.iconplc.com/role/Cover" xlink:type="simple" xlink:href="iclr-20241231.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_c71969e6-78d0-4b73-b657-9251423d998b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_DocumentInformationTable_c71969e6-78d0-4b73-b657-9251423d998b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_630ba178-f630-4b77-ac7c-99be729bcf78" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_c71969e6-78d0-4b73-b657-9251423d998b" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_630ba178-f630-4b77-ac7c-99be729bcf78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_630ba178-f630-4b77-ac7c-99be729bcf78_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_630ba178-f630-4b77-ac7c-99be729bcf78" xlink:to="loc_dei_AddressTypeDomain_630ba178-f630-4b77-ac7c-99be729bcf78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_a6186e38-d065-40f3-a4b0-e7dca0eac890" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_630ba178-f630-4b77-ac7c-99be729bcf78" xlink:to="loc_dei_AddressTypeDomain_a6186e38-d065-40f3-a4b0-e7dca0eac890" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember_a1002828-756f-4bb1-824a-214bc01b828d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AddressTypeDomain_a6186e38-d065-40f3-a4b0-e7dca0eac890" xlink:to="loc_dei_BusinessContactMember_a1002828-756f-4bb1-824a-214bc01b828d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_8a8dbc6a-0c85-4d10-9243-49765ab1e750" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_DocumentType_8a8dbc6a-0c85-4d10-9243-49765ab1e750" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement_0d56d708-5d84-47cb-8e94-26b4aeb73ba9" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_DocumentRegistrationStatement_0d56d708-5d84-47cb-8e94-26b4aeb73ba9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_51e24349-29a6-422a-a9cd-7178ff792cc4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_DocumentAnnualReport_51e24349-29a6-422a-a9cd-7178ff792cc4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8702d968-aaf8-43c6-ab88-f1cd61b666f2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_DocumentPeriodEndDate_8702d968-aaf8-43c6-ab88-f1cd61b666f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_b3ad6f89-dc27-494a-b18e-59ae4546af99" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_CurrentFiscalYearEndDate_b3ad6f89-dc27-494a-b18e-59ae4546af99" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_e71e2eeb-49a6-44bd-a993-c97ea279fac1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_DocumentTransitionReport_e71e2eeb-49a6-44bd-a993-c97ea279fac1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport_27c46f62-e434-4e93-a4f5-3353f6b17c06" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_DocumentShellCompanyReport_27c46f62-e434-4e93-a4f5-3353f6b17c06" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e599f5a6-5f15-4065-8625-3f3c4a0f4646" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityFileNumber_e599f5a6-5f15-4065-8625-3f3c4a0f4646" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_6ddcfeef-a826-4167-8a1c-e2308dfe38b1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityRegistrantName_6ddcfeef-a826-4167-8a1c-e2308dfe38b1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_1acc8335-b750-4fa7-bf65-59824a420b55" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityIncorporationStateCountryCode_1acc8335-b750-4fa7-bf65-59824a420b55" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_da2f8899-5380-4f64-a259-e10f5b8733d2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityAddressAddressLine1_da2f8899-5380-4f64-a259-e10f5b8733d2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_0f680317-cf2c-4f6b-8ffc-8f45fb4a0de0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityAddressAddressLine2_0f680317-cf2c-4f6b-8ffc-8f45fb4a0de0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_9618cfc3-6a7c-4e6f-a9ee-2c0dbca52d30" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityAddressCityOrTown_9618cfc3-6a7c-4e6f-a9ee-2c0dbca52d30" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_77e99273-bd36-49ff-a5a6-ed14c5f7a28a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityAddressPostalZipCode_77e99273-bd36-49ff-a5a6-ed14c5f7a28a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_c0b57b56-281c-42b2-9e13-eab9a6e45a50" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityAddressCountry_c0b57b56-281c-42b2-9e13-eab9a6e45a50" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName_139e45b2-ad3d-4a7d-9708-23e15753fb7d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_ContactPersonnelName_139e45b2-ad3d-4a7d-9708-23e15753fb7d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelEmailAddress_993c1e14-67f9-4855-9a7e-faf662e9cf8e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelEmailAddress"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_ContactPersonnelEmailAddress_993c1e14-67f9-4855-9a7e-faf662e9cf8e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_1d1a763b-0819-437c-8037-7ac57cb6815a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_CountryRegion_1d1a763b-0819-437c-8037-7ac57cb6815a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b2462b9a-3046-456d-b984-9f19e51c7982" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_CityAreaCode_b2462b9a-3046-456d-b984-9f19e51c7982" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_224e11b4-cd4e-4f66-8a4a-60c937ca768c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_LocalPhoneNumber_224e11b4-cd4e-4f66-8a4a-60c937ca768c" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_5539f058-4e6b-4b53-a313-b172415251f5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_Security12bTitle_5539f058-4e6b-4b53-a313-b172415251f5" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d45a1733-cf10-4b8d-bbb3-eea5eb379189" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_TradingSymbol_d45a1733-cf10-4b8d-bbb3-eea5eb379189" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4c3ab8e3-5b29-4cd0-ad87-1b0eeead807b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_SecurityExchangeName_4c3ab8e3-5b29-4cd0-ad87-1b0eeead807b" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_0237ad9c-0eb0-4ece-9e17-5ed8ec3b35e2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_0237ad9c-0eb0-4ece-9e17-5ed8ec3b35e2" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_2310c0d5-d413-4e3c-8ff7-b76d432f0848" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_2310c0d5-d413-4e3c-8ff7-b76d432f0848" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_718c3513-175b-4ff9-bb97-e480d6d2d77e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityVoluntaryFilers_718c3513-175b-4ff9-bb97-e480d6d2d77e" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_3c6544fd-0b34-4182-9f48-822382c3af83" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityCurrentReportingStatus_3c6544fd-0b34-4182-9f48-822382c3af83" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ad312e99-9cd4-49db-8985-36ec31c4c0d0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityInteractiveDataCurrent_ad312e99-9cd4-49db-8985-36ec31c4c0d0" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_f07fc0fe-920e-4148-8564-3ebe51ea9da8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityFilerCategory_f07fc0fe-920e-4148-8564-3ebe51ea9da8" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d451109c-10f9-4bc2-b924-c8f76dacd459" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityEmergingGrowthCompany_d451109c-10f9-4bc2-b924-c8f76dacd459" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_f93e67df-7859-45b6-8c29-05f9ad464669" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_IcfrAuditorAttestationFlag_f93e67df-7859-45b6-8c29-05f9ad464669" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_565f604d-e220-42c2-8a3a-ed3a110e2d0d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_565f604d-e220-42c2-8a3a-ed3a110e2d0d" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard_61a38bfa-7cfd-4cb9-81a2-2d9d039fce42" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_DocumentAccountingStandard_61a38bfa-7cfd-4cb9-81a2-2d9d039fce42" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_96a93d57-f23b-4bd9-9ebd-41feae80d85e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityShellCompany_96a93d57-f23b-4bd9-9ebd-41feae80d85e" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ec5a7131-1297-4f1b-a9f4-d59d5f296f34" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_AmendmentFlag_ec5a7131-1297-4f1b-a9f4-d59d5f296f34" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_d9d7eb81-b017-4e86-b90e-078235666d64" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_DocumentFiscalYearFocus_d9d7eb81-b017-4e86-b90e-078235666d64" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_870df72a-12ab-47f2-b1e3-5c3d62a3e14a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_DocumentFiscalPeriodFocus_870df72a-12ab-47f2-b1e3-5c3d62a3e14a" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_63d911d0-4239-4f64-8024-fbcab2b8a232" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityCentralIndexKey_63d911d0-4239-4f64-8024-fbcab2b8a232" xlink:type="arc" order="37"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="iclr-20241231.xsd#CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_91e3a4b4-e229-40e2-98fa-01108df20604" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8ca5073c-a063-40bc-a976-dc819846d694" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_91e3a4b4-e229-40e2-98fa-01108df20604" xlink:to="loc_us-gaap_StatementTable_8ca5073c-a063-40bc-a976-dc819846d694" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b7a5f4d1-259d-4277-9ee2-0ccf3b3b897d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8ca5073c-a063-40bc-a976-dc819846d694" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b7a5f4d1-259d-4277-9ee2-0ccf3b3b897d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b7a5f4d1-259d-4277-9ee2-0ccf3b3b897d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b7a5f4d1-259d-4277-9ee2-0ccf3b3b897d" xlink:to="loc_us-gaap_EquityComponentDomain_b7a5f4d1-259d-4277-9ee2-0ccf3b3b897d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3e12b56d-2e67-48ce-964e-5d35ea17fbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b7a5f4d1-259d-4277-9ee2-0ccf3b3b897d" xlink:to="loc_us-gaap_EquityComponentDomain_3e12b56d-2e67-48ce-964e-5d35ea17fbdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7897eb22-802d-408a-b5ef-350bee45e979" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3e12b56d-2e67-48ce-964e-5d35ea17fbdf" xlink:to="loc_us-gaap_CommonStockMember_7897eb22-802d-408a-b5ef-350bee45e979" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_165f63d7-3b31-4684-9261-1fbdb0f2a928" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3e12b56d-2e67-48ce-964e-5d35ea17fbdf" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_165f63d7-3b31-4684-9261-1fbdb0f2a928" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapitalMember_7eaafe58-3d78-438e-808c-f858f699901d" xlink:href="iclr-20241231.xsd#iclr_OtherUndenominatedCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3e12b56d-2e67-48ce-964e-5d35ea17fbdf" xlink:to="loc_iclr_OtherUndenominatedCapitalMember_7eaafe58-3d78-438e-808c-f858f699901d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fc3072fa-dc6d-4188-aa5c-bcde07c002a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3e12b56d-2e67-48ce-964e-5d35ea17fbdf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fc3072fa-dc6d-4188-aa5c-bcde07c002a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_3d682548-2fea-476b-b835-5fc13c946b93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3e12b56d-2e67-48ce-964e-5d35ea17fbdf" xlink:to="loc_us-gaap_RetainedEarningsMember_3d682548-2fea-476b-b835-5fc13c946b93" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_91e3a4b4-e229-40e2-98fa-01108df20604" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_62dbcd39-c06c-4ee5-b580-3a898cbafffa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_CommonStockSharesIssued_62dbcd39-c06c-4ee5-b580-3a898cbafffa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c75a6e2d-1319-49ac-84bc-913415356c23" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_StockholdersEquity_c75a6e2d-1319-49ac-84bc-913415356c23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_baf0c19e-3f25-49a6-90f5-7d0250cf84bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_baf0c19e-3f25-49a6-90f5-7d0250cf84bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d59af5eb-ec73-4494-b30a-4696822c900c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_baf0c19e-3f25-49a6-90f5-7d0250cf84bf" xlink:to="loc_us-gaap_NetIncomeLoss_d59af5eb-ec73-4494-b30a-4696822c900c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d3287714-bf55-4ac5-ad92-5db436567e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_baf0c19e-3f25-49a6-90f5-7d0250cf84bf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d3287714-bf55-4ac5-ad92-5db436567e8a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_d760f3d5-646c-4889-8b44-434f1d791fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_baf0c19e-3f25-49a6-90f5-7d0250cf84bf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_d760f3d5-646c-4889-8b44-434f1d791fe0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_6766a217-05e3-401b-9490-f5b7ae8507c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_baf0c19e-3f25-49a6-90f5-7d0250cf84bf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_6766a217-05e3-401b-9490-f5b7ae8507c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_c10319d1-89e4-4f1d-9648-faec4f42c316" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_baf0c19e-3f25-49a6-90f5-7d0250cf84bf" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_c10319d1-89e4-4f1d-9648-faec4f42c316" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_508351f2-f63c-4315-a18d-8b1cfa4819be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_508351f2-f63c-4315-a18d-8b1cfa4819be" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_03060416-d80f-4d2d-9943-eeaf168439e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_03060416-d80f-4d2d-9943-eeaf168439e4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0e93aa31-33fb-4cbd-bde0-a66db8eb99cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0e93aa31-33fb-4cbd-bde0-a66db8eb99cc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_c48b3077-acdd-4a3f-8774-f9cdc4ae69ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_c48b3077-acdd-4a3f-8774-f9cdc4ae69ac" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c3a9ff1c-91ee-4646-a5ee-d1c8ebd57f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c3a9ff1c-91ee-4646-a5ee-d1c8ebd57f9f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_f77e3060-bc50-4480-9bd1-0cc54515ad94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_f77e3060-bc50-4480-9bd1-0cc54515ad94" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_af85927d-27fd-4975-8f01-5dd125238021" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_af85927d-27fd-4975-8f01-5dd125238021" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_36626b49-6947-4912-8c2a-7ee8bd48a88d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_36626b49-6947-4912-8c2a-7ee8bd48a88d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareRepurchaseProgramBrokerCommission_ef828780-6c4c-4eda-9553-f9d33b473443" xlink:href="iclr-20241231.xsd#iclr_ShareRepurchaseProgramBrokerCommission"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_iclr_ShareRepurchaseProgramBrokerCommission_ef828780-6c4c-4eda-9553-f9d33b473443" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e0497765-0686-4f18-bab5-fae61e4acc6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0fd9b9f3-ead4-48fd-ad16-f4d67d30f0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DescriptionofbusinessDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#DescriptionofbusinessDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/DescriptionofbusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_400a3a53-2712-4a39-a95c-5f622e9eafa8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_d759ace2-cc9b-45d7-9291-69ab38deb15f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_400a3a53-2712-4a39-a95c-5f622e9eafa8" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_d759ace2-cc9b-45d7-9291-69ab38deb15f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_cd5e112f-c88d-4b40-a95d-66f37d4ce9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_d759ace2-cc9b-45d7-9291-69ab38deb15f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_cd5e112f-c88d-4b40-a95d-66f37d4ce9e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_cd5e112f-c88d-4b40-a95d-66f37d4ce9e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_cd5e112f-c88d-4b40-a95d-66f37d4ce9e5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_cd5e112f-c88d-4b40-a95d-66f37d4ce9e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_32fff8d1-aadf-4ab0-b70b-aa33771d6066" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_cd5e112f-c88d-4b40-a95d-66f37d4ce9e5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_32fff8d1-aadf-4ab0-b70b-aa33771d6066" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_912df437-77cf-4718-9464-04fcc42cba78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_32fff8d1-aadf-4ab0-b70b-aa33771d6066" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_912df437-77cf-4718-9464-04fcc42cba78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_2bd68802-01dc-4306-a139-d9cc593e107d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_d759ace2-cc9b-45d7-9291-69ab38deb15f" xlink:to="loc_srt_StatementGeographicalAxis_2bd68802-01dc-4306-a139-d9cc593e107d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2bd68802-01dc-4306-a139-d9cc593e107d_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_2bd68802-01dc-4306-a139-d9cc593e107d" xlink:to="loc_srt_SegmentGeographicalDomain_2bd68802-01dc-4306-a139-d9cc593e107d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ee824f20-7be4-4483-9379-2fb64a2b5762" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_2bd68802-01dc-4306-a139-d9cc593e107d" xlink:to="loc_srt_SegmentGeographicalDomain_ee824f20-7be4-4483-9379-2fb64a2b5762" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_80123106-1ba4-457a-9ac1-8dfddfa063cf" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ee824f20-7be4-4483-9379-2fb64a2b5762" xlink:to="loc_country_US_80123106-1ba4-457a-9ac1-8dfddfa063cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_324955b7-579b-4741-8b3a-8bc2c5b2ae7c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ee824f20-7be4-4483-9379-2fb64a2b5762" xlink:to="loc_srt_EuropeMember_324955b7-579b-4741-8b3a-8bc2c5b2ae7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherGeographicLocationsMember_e7add09e-e69f-43e9-8161-caaaa26db2cd" xlink:href="iclr-20241231.xsd#iclr_OtherGeographicLocationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ee824f20-7be4-4483-9379-2fb64a2b5762" xlink:to="loc_iclr_OtherGeographicLocationsMember_e7add09e-e69f-43e9-8161-caaaa26db2cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ac85212d-b245-44ea-b64e-a4aa5978b64f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_d759ace2-cc9b-45d7-9291-69ab38deb15f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ac85212d-b245-44ea-b64e-a4aa5978b64f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ac85212d-b245-44ea-b64e-a4aa5978b64f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ac85212d-b245-44ea-b64e-a4aa5978b64f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ac85212d-b245-44ea-b64e-a4aa5978b64f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_43866c54-1fa5-4eec-b016-141e9092c9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ac85212d-b245-44ea-b64e-a4aa5978b64f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_43866c54-1fa5-4eec-b016-141e9092c9d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_ebc7b30d-d3a4-42a0-b845-4ed83dbbbd6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_43866c54-1fa5-4eec-b016-141e9092c9d7" xlink:to="loc_us-gaap_SalesRevenueNetMember_ebc7b30d-d3a4-42a0-b845-4ed83dbbbd6a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityNumberOfEmployees_f2479702-662a-40e5-8d91-e8d487780cb9" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityNumberOfEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_400a3a53-2712-4a39-a95c-5f622e9eafa8" xlink:to="loc_dei_EntityNumberOfEmployees_f2479702-662a-40e5-8d91-e8d487780cb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfLocations_ce4683b3-862a-4d29-95c2-026440209862" xlink:href="iclr-20241231.xsd#iclr_NumberOfLocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_400a3a53-2712-4a39-a95c-5f622e9eafa8" xlink:to="loc_iclr_NumberOfLocations_ce4683b3-862a-4d29-95c2-026440209862" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_20d1479c-c6d2-4628-8019-b44645bfad05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_400a3a53-2712-4a39-a95c-5f622e9eafa8" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_20d1479c-c6d2-4628-8019-b44645bfad05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_d3b7405d-9e7f-41ee-951f-144cf4a95206" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_400a3a53-2712-4a39-a95c-5f622e9eafa8" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_d3b7405d-9e7f-41ee-951f-144cf4a95206" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ceb08422-ded4-440e-b13f-7dae15454b69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_170f0c41-b55b-4b2b-b1a4-72cbe4072731" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ceb08422-ded4-440e-b13f-7dae15454b69" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_170f0c41-b55b-4b2b-b1a4-72cbe4072731" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c5a2b77a-5a66-4e89-ad94-001eb467506d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_170f0c41-b55b-4b2b-b1a4-72cbe4072731" xlink:to="loc_srt_RangeAxis_c5a2b77a-5a66-4e89-ad94-001eb467506d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c5a2b77a-5a66-4e89-ad94-001eb467506d_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c5a2b77a-5a66-4e89-ad94-001eb467506d" xlink:to="loc_srt_RangeMember_c5a2b77a-5a66-4e89-ad94-001eb467506d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_582f1e0f-27dc-46d0-9ab7-2bb1c713a0e1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c5a2b77a-5a66-4e89-ad94-001eb467506d" xlink:to="loc_srt_RangeMember_582f1e0f-27dc-46d0-9ab7-2bb1c713a0e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3402215a-7551-4d1f-974a-964843eb6a69" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_582f1e0f-27dc-46d0-9ab7-2bb1c713a0e1" xlink:to="loc_srt_MinimumMember_3402215a-7551-4d1f-974a-964843eb6a69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_304cf3b5-994b-446d-838f-a2594f609be0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_582f1e0f-27dc-46d0-9ab7-2bb1c713a0e1" xlink:to="loc_srt_MaximumMember_304cf3b5-994b-446d-838f-a2594f609be0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3f683c9c-f045-4e53-8f1d-684823f712ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_170f0c41-b55b-4b2b-b1a4-72cbe4072731" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3f683c9c-f045-4e53-8f1d-684823f712ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3f683c9c-f045-4e53-8f1d-684823f712ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3f683c9c-f045-4e53-8f1d-684823f712ac" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3f683c9c-f045-4e53-8f1d-684823f712ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_afaf5889-f309-41d4-82ef-c9f3a2231a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3f683c9c-f045-4e53-8f1d-684823f712ac" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_afaf5889-f309-41d4-82ef-c9f3a2231a4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_80aac3be-874e-481b-a6a9-66f266da09f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_afaf5889-f309-41d4-82ef-c9f3a2231a4d" xlink:to="loc_us-gaap_BuildingMember_80aac3be-874e-481b-a6a9-66f266da09f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_be136762-9bcc-4585-81dd-581de4896a5b" xlink:href="iclr-20241231.xsd#iclr_ComputerEquipmentAndCapitalizedSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_afaf5889-f309-41d4-82ef-c9f3a2231a4d" xlink:to="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_be136762-9bcc-4585-81dd-581de4896a5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_bf5796dc-5c65-43d0-a4a6-073570746c52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_afaf5889-f309-41d4-82ef-c9f3a2231a4d" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_bf5796dc-5c65-43d0-a4a6-073570746c52" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_dc90d105-d7c1-4f53-9e61-79717c302f07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_afaf5889-f309-41d4-82ef-c9f3a2231a4d" xlink:to="loc_us-gaap_EquipmentMember_dc90d105-d7c1-4f53-9e61-79717c302f07" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_5f67779a-30b7-4489-ae2e-e98cbd2f8823" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_afaf5889-f309-41d4-82ef-c9f3a2231a4d" xlink:to="loc_us-gaap_VehiclesMember_5f67779a-30b7-4489-ae2e-e98cbd2f8823" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_76a9620b-ad8b-483a-9897-ee86156444e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ceb08422-ded4-440e-b13f-7dae15454b69" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_76a9620b-ad8b-483a-9897-ee86156444e7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_abe86efb-7051-4538-ae3d-1ee2fdcf9da5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_5f8c8100-301f-4ced-ae28-4bcf8d27cafe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_abe86efb-7051-4538-ae3d-1ee2fdcf9da5" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_5f8c8100-301f-4ced-ae28-4bcf8d27cafe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dbfe4670-da7c-41c7-b0bf-0f15a7ca83da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_5f8c8100-301f-4ced-ae28-4bcf8d27cafe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dbfe4670-da7c-41c7-b0bf-0f15a7ca83da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dbfe4670-da7c-41c7-b0bf-0f15a7ca83da_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dbfe4670-da7c-41c7-b0bf-0f15a7ca83da" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dbfe4670-da7c-41c7-b0bf-0f15a7ca83da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c31946ef-6df2-4c36-8afe-efb738abee84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dbfe4670-da7c-41c7-b0bf-0f15a7ca83da" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c31946ef-6df2-4c36-8afe-efb738abee84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_077e796e-4887-442c-a8ea-f9ad046556de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c31946ef-6df2-4c36-8afe-efb738abee84" xlink:to="loc_us-gaap_CustomerRelationshipsMember_077e796e-4887-442c-a8ea-f9ad046556de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_d8344429-26ac-4ba7-946d-66d59bec94fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c31946ef-6df2-4c36-8afe-efb738abee84" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_d8344429-26ac-4ba7-946d-66d59bec94fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_fdb230ae-e74e-4698-9396-998b5b16291d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c31946ef-6df2-4c36-8afe-efb738abee84" xlink:to="loc_us-gaap_TradeNamesMember_fdb230ae-e74e-4698-9396-998b5b16291d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_c4950cce-fece-4e53-8f74-a76487ebe103" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DatabasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c31946ef-6df2-4c36-8afe-efb738abee84" xlink:to="loc_us-gaap_DatabasesMember_c4950cce-fece-4e53-8f74-a76487ebe103" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_c045acad-c706-439d-995b-689df2cabf23" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c31946ef-6df2-4c36-8afe-efb738abee84" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_c045acad-c706-439d-995b-689df2cabf23" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_49e0c4c5-de29-4961-8a2e-02c46c319c08" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_5f8c8100-301f-4ced-ae28-4bcf8d27cafe" xlink:to="loc_srt_RangeAxis_49e0c4c5-de29-4961-8a2e-02c46c319c08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_49e0c4c5-de29-4961-8a2e-02c46c319c08_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_49e0c4c5-de29-4961-8a2e-02c46c319c08" xlink:to="loc_srt_RangeMember_49e0c4c5-de29-4961-8a2e-02c46c319c08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e0e451aa-9272-4f11-9220-648d8a9bf7e6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_49e0c4c5-de29-4961-8a2e-02c46c319c08" xlink:to="loc_srt_RangeMember_e0e451aa-9272-4f11-9220-648d8a9bf7e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6fa3aac3-43dc-4441-b0f5-21a8d398e9cb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e0e451aa-9272-4f11-9220-648d8a9bf7e6" xlink:to="loc_srt_MinimumMember_6fa3aac3-43dc-4441-b0f5-21a8d398e9cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c3119209-998a-4597-8659-bdc5aa37105b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e0e451aa-9272-4f11-9220-648d8a9bf7e6" xlink:to="loc_srt_MaximumMember_c3119209-998a-4597-8659-bdc5aa37105b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_4b7c5724-00d3-41d2-899e-a7cfe0d29148" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_abe86efb-7051-4538-ae3d-1ee2fdcf9da5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_4b7c5724-00d3-41d2-899e-a7cfe0d29148" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DisaggregationofRevenueDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#DisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/DisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_149ec4eb-3f53-42b0-9524-ebbf512a9e76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1e73263d-8378-4392-b12a-e04faddc8f94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_149ec4eb-3f53-42b0-9524-ebbf512a9e76" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1e73263d-8378-4392-b12a-e04faddc8f94" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_d5457262-2693-4f1f-bbd3-d3803dbda55c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1e73263d-8378-4392-b12a-e04faddc8f94" xlink:to="loc_srt_MajorCustomersAxis_d5457262-2693-4f1f-bbd3-d3803dbda55c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_d5457262-2693-4f1f-bbd3-d3803dbda55c_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_d5457262-2693-4f1f-bbd3-d3803dbda55c" xlink:to="loc_srt_NameOfMajorCustomerDomain_d5457262-2693-4f1f-bbd3-d3803dbda55c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_7a8ef64d-0d37-414b-881b-f4370105b5c2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_d5457262-2693-4f1f-bbd3-d3803dbda55c" xlink:to="loc_srt_NameOfMajorCustomerDomain_7a8ef64d-0d37-414b-881b-f4370105b5c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TopClientMember_5427fe51-272b-482a-a949-7f2b01d956a8" xlink:href="iclr-20241231.xsd#iclr_TopClientMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_7a8ef64d-0d37-414b-881b-f4370105b5c2" xlink:to="loc_iclr_TopClientMember_5427fe51-272b-482a-a949-7f2b01d956a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients25Member_f2a6215b-5393-4446-93b7-7f3893185771" xlink:href="iclr-20241231.xsd#iclr_Clients25Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_7a8ef64d-0d37-414b-881b-f4370105b5c2" xlink:to="loc_iclr_Clients25Member_f2a6215b-5393-4446-93b7-7f3893185771" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients610Member_17296a58-4e68-4a5b-b838-8ead7b536f90" xlink:href="iclr-20241231.xsd#iclr_Clients610Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_7a8ef64d-0d37-414b-881b-f4370105b5c2" xlink:to="loc_iclr_Clients610Member_17296a58-4e68-4a5b-b838-8ead7b536f90" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients1125Member_76afa3a7-a990-4826-bbef-2ccc9fef8e86" xlink:href="iclr-20241231.xsd#iclr_Clients1125Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_7a8ef64d-0d37-414b-881b-f4370105b5c2" xlink:to="loc_iclr_Clients1125Member_76afa3a7-a990-4826-bbef-2ccc9fef8e86" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCustomersMember_41668113-0838-4989-81be-00fd93e93973" xlink:href="iclr-20241231.xsd#iclr_OtherCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_7a8ef64d-0d37-414b-881b-f4370105b5c2" xlink:to="loc_iclr_OtherCustomersMember_41668113-0838-4989-81be-00fd93e93973" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f2f592dd-9890-4ed2-97bd-a84db9e59fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_149ec4eb-3f53-42b0-9524-ebbf512a9e76" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f2f592dd-9890-4ed2-97bd-a84db9e59fa2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_5cb723a0-c5c9-4a4c-a420-3745da3088cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_5cb723a0-c5c9-4a4c-a420-3745da3088cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_6ab6c96f-0106-4752-ba43-0b4fcca93768" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_5cb723a0-c5c9-4a4c-a420-3745da3088cd" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_6ab6c96f-0106-4752-ba43-0b4fcca93768" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_adcaf291-861f-4c17-b3de-bd59092371b9" xlink:href="iclr-20241231.xsd#iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_adcaf291-861f-4c17-b3de-bd59092371b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent_68828cc6-3f41-4e4c-a3f2-a9c728f35934" xlink:href="iclr-20241231.xsd#iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent_68828cc6-3f41-4e4c-a3f2-a9c728f35934" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_026a6c29-37fa-4ab6-8242-d28f4a3ff781" xlink:href="iclr-20241231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_026a6c29-37fa-4ab6-8242-d28f4a3ff781" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable_63b7ae83-8d32-48b9-84b0-5ade3105a328" xlink:href="iclr-20241231.xsd#iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable_63b7ae83-8d32-48b9-84b0-5ade3105a328" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_be0e2ac9-b351-4be6-8a98-bd8224e91f94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_be0e2ac9-b351-4be6-8a98-bd8224e91f94" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_5ed4b423-5a2e-4812-baaa-bfe49474e048" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_5ed4b423-5a2e-4812-baaa-bfe49474e048" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_3fedc69a-9897-417a-85d6-6b4c914b681f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_3fedc69a-9897-417a-85d6-6b4c914b681f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_67d187fc-7b56-4689-bf3a-023879225858" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_67d187fc-7b56-4689-bf3a-023879225858" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails_1" xlink:type="simple" xlink:href="iclr-20241231.xsd#AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails_1"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_5cb723a0-c5c9-4a4c-a420-3745da3088cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_5cb723a0-c5c9-4a4c-a420-3745da3088cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_adcaf291-861f-4c17-b3de-bd59092371b9" xlink:href="iclr-20241231.xsd#iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_adcaf291-861f-4c17-b3de-bd59092371b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent_68828cc6-3f41-4e4c-a3f2-a9c728f35934" xlink:href="iclr-20241231.xsd#iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent_68828cc6-3f41-4e4c-a3f2-a9c728f35934" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_026a6c29-37fa-4ab6-8242-d28f4a3ff781" xlink:href="iclr-20241231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_026a6c29-37fa-4ab6-8242-d28f4a3ff781" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable_63b7ae83-8d32-48b9-84b0-5ade3105a328" xlink:href="iclr-20241231.xsd#iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable_63b7ae83-8d32-48b9-84b0-5ade3105a328" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_be0e2ac9-b351-4be6-8a98-bd8224e91f94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_be0e2ac9-b351-4be6-8a98-bd8224e91f94" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_5ed4b423-5a2e-4812-baaa-bfe49474e048" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_5ed4b423-5a2e-4812-baaa-bfe49474e048" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_3fedc69a-9897-417a-85d6-6b4c914b681f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_3fedc69a-9897-417a-85d6-6b4c914b681f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_67d187fc-7b56-4689-bf3a-023879225858" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_67d187fc-7b56-4689-bf3a-023879225858" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativeKCRAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BusinessCombinationsNarrativeKCRAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsNarrativeKCRAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2cd85840-c35d-4ef4-862c-a01aa55ffce4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2cd85840-c35d-4ef4-862c-a01aa55ffce4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_92115703-c46a-4825-93ae-7ffa519930ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2cd85840-c35d-4ef4-862c-a01aa55ffce4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_92115703-c46a-4825-93ae-7ffa519930ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92115703-c46a-4825-93ae-7ffa519930ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_92115703-c46a-4825-93ae-7ffa519930ad" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92115703-c46a-4825-93ae-7ffa519930ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_79fd5021-2577-485d-9579-6ae86d36cb74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_92115703-c46a-4825-93ae-7ffa519930ad" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_79fd5021-2577-485d-9579-6ae86d36cb74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_KCRS.AGroupMember_b58fd3ca-2779-475b-8612-6f1676993d1b" xlink:href="iclr-20241231.xsd#iclr_KCRS.AGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_79fd5021-2577-485d-9579-6ae86d36cb74" xlink:to="loc_iclr_KCRS.AGroupMember_b58fd3ca-2779-475b-8612-6f1676993d1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_dc4fd476-3e1d-4eb6-b053-b64e7310f181" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_dc4fd476-3e1d-4eb6-b053-b64e7310f181" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_cc91c792-d429-4941-9827-299bacae6931" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_cc91c792-d429-4941-9827-299bacae6931" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_98ed4e2e-50fc-4a88-84c8-d757880e3cee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_98ed4e2e-50fc-4a88-84c8-d757880e3cee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_3982a4ce-f18c-48f0-ae26-75200a4efc01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_3982a4ce-f18c-48f0-ae26-75200a4efc01" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAssetsArisingFromContingenciesAmountRecognized_0965e218-7885-48b0-b831-5a814e47de17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAssetsArisingFromContingenciesAmountRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:to="loc_us-gaap_BusinessCombinationAssetsArisingFromContingenciesAmountRecognized_0965e218-7885-48b0-b831-5a814e47de17" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a60e944c-0b4e-4eb0-b546-52a2bd518f91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:to="loc_us-gaap_Goodwill_a60e944c-0b4e-4eb0-b546-52a2bd518f91" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_3679fe68-a74b-41cd-8639-6e66117815e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_3679fe68-a74b-41cd-8639-6e66117815e8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_25695d38-b434-480a-9e1b-bbd80a21cac0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_25695d38-b434-480a-9e1b-bbd80a21cac0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_c8f38054-0f9e-40b2-af4d-cd01831ad238" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_c8f38054-0f9e-40b2-af4d-cd01831ad238" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_39bfede4-19f9-492c-82d8-7e16fcfb64b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_39bfede4-19f9-492c-82d8-7e16fcfb64b1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_a1a14358-a659-4e0c-baf3-8d319e336e15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_a1a14358-a659-4e0c-baf3-8d319e336e15" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativeHumanFirstAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BusinessCombinationsNarrativeHumanFirstAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsNarrativeHumanFirstAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_174916d4-fa54-48d7-bcde-8e4cd10f3b21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5ad291d2-7ac7-48a9-8242-ad0040e374a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_174916d4-fa54-48d7-bcde-8e4cd10f3b21" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5ad291d2-7ac7-48a9-8242-ad0040e374a2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b88cc3ad-453a-4e4c-9a64-9e2e2b0af2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5ad291d2-7ac7-48a9-8242-ad0040e374a2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b88cc3ad-453a-4e4c-9a64-9e2e2b0af2ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b88cc3ad-453a-4e4c-9a64-9e2e2b0af2ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b88cc3ad-453a-4e4c-9a64-9e2e2b0af2ef" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b88cc3ad-453a-4e4c-9a64-9e2e2b0af2ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2a0fc199-be07-4f74-a984-8d967aef7977" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b88cc3ad-453a-4e4c-9a64-9e2e2b0af2ef" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2a0fc199-be07-4f74-a984-8d967aef7977" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_HumanFirstIncMember_651b9f79-60cd-401b-9a3e-57835d6ddef8" xlink:href="iclr-20241231.xsd#iclr_HumanFirstIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2a0fc199-be07-4f74-a984-8d967aef7977" xlink:to="loc_iclr_HumanFirstIncMember_651b9f79-60cd-401b-9a3e-57835d6ddef8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e9fe9b09-b68d-488e-9b07-ce629485f51f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_174916d4-fa54-48d7-bcde-8e4cd10f3b21" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e9fe9b09-b68d-488e-9b07-ce629485f51f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_bb99c409-079e-4377-9a94-e71f7ac9f00d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_174916d4-fa54-48d7-bcde-8e4cd10f3b21" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_bb99c409-079e-4377-9a94-e71f7ac9f00d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_00ccbc77-63fc-4d09-84b3-3e4a280539cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_174916d4-fa54-48d7-bcde-8e4cd10f3b21" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_00ccbc77-63fc-4d09-84b3-3e4a280539cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_cdc160cd-08b4-414f-b19a-a4fad52fa624" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_174916d4-fa54-48d7-bcde-8e4cd10f3b21" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_cdc160cd-08b4-414f-b19a-a4fad52fa624" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_70f5fa4a-94ee-46d8-9c04-af3085704ede" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_174916d4-fa54-48d7-bcde-8e4cd10f3b21" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_70f5fa4a-94ee-46d8-9c04-af3085704ede" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7d6e1d84-b6b8-4c42-ab59-aba9471be76e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_174916d4-fa54-48d7-bcde-8e4cd10f3b21" xlink:to="loc_us-gaap_Goodwill_7d6e1d84-b6b8-4c42-ab59-aba9471be76e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1c7a7c19-d533-4dd0-9d13-a2b4a8c6803d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_174916d4-fa54-48d7-bcde-8e4cd10f3b21" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1c7a7c19-d533-4dd0-9d13-a2b4a8c6803d" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BusinessCombinationsNarrativeBiotelAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_278a17ed-94c4-4f05-8458-babb634d98ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7bd0550c-f723-42c2-8489-64a10883308e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_278a17ed-94c4-4f05-8458-babb634d98ce" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7bd0550c-f723-42c2-8489-64a10883308e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5b51be65-05ea-4d3f-ab30-7bf68b101a02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7bd0550c-f723-42c2-8489-64a10883308e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5b51be65-05ea-4d3f-ab30-7bf68b101a02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5b51be65-05ea-4d3f-ab30-7bf68b101a02_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5b51be65-05ea-4d3f-ab30-7bf68b101a02" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5b51be65-05ea-4d3f-ab30-7bf68b101a02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77cca73c-1185-48ca-9a6a-57703e419693" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5b51be65-05ea-4d3f-ab30-7bf68b101a02" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77cca73c-1185-48ca-9a6a-57703e419693" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BiotelResearchLLCMember_8f70dcd1-8a72-420a-8496-62f4b409e090" xlink:href="iclr-20241231.xsd#iclr_BiotelResearchLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77cca73c-1185-48ca-9a6a-57703e419693" xlink:to="loc_iclr_BiotelResearchLLCMember_8f70dcd1-8a72-420a-8496-62f4b409e090" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_c1e5f71f-557d-4c25-ae97-220dbcc33700" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_278a17ed-94c4-4f05-8458-babb634d98ce" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_c1e5f71f-557d-4c25-ae97-220dbcc33700" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_d97f14c5-effe-4e70-bb8c-7a4fa29f1dba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_278a17ed-94c4-4f05-8458-babb634d98ce" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_d97f14c5-effe-4e70-bb8c-7a4fa29f1dba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_f7e337bb-6cbd-4463-9f98-98966c679fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_278a17ed-94c4-4f05-8458-babb634d98ce" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_f7e337bb-6cbd-4463-9f98-98966c679fcd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0afa2eb0-bfd1-4b8d-8ecf-dcc559a5fc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_278a17ed-94c4-4f05-8458-babb634d98ce" xlink:to="loc_us-gaap_Goodwill_0afa2eb0-bfd1-4b8d-8ecf-dcc559a5fc9b" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BusinessCombinationsNarrativePRAAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c0b1f895-ee8f-4791-994c-4795810a0069" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb85033b-87c4-4782-8338-63b110c7c503" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c0b1f895-ee8f-4791-994c-4795810a0069" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb85033b-87c4-4782-8338-63b110c7c503" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_61e974d3-a733-4b83-85bb-e20185c3e7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb85033b-87c4-4782-8338-63b110c7c503" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_61e974d3-a733-4b83-85bb-e20185c3e7b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_61e974d3-a733-4b83-85bb-e20185c3e7b3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_61e974d3-a733-4b83-85bb-e20185c3e7b3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_61e974d3-a733-4b83-85bb-e20185c3e7b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_598da221-e43a-4929-95d6-0192332c62e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_61e974d3-a733-4b83-85bb-e20185c3e7b3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_598da221-e43a-4929-95d6-0192332c62e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_1099154c-f540-4e6d-a90e-d970ca7de4d0" xlink:href="iclr-20241231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_598da221-e43a-4929-95d6-0192332c62e3" xlink:to="loc_iclr_PRAHealthSciencesIncMember_1099154c-f540-4e6d-a90e-d970ca7de4d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_8d553675-229a-41ef-a5af-6a8a7566873f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c0b1f895-ee8f-4791-994c-4795810a0069" xlink:to="loc_us-gaap_InterestExpenseNonoperating_8d553675-229a-41ef-a5af-6a8a7566873f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BusinessCombinationsNarrativeOncacareAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_02617e9d-383a-4a2d-9120-baa5ce62b407" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b8df34e1-27be-4b88-9c6a-40c033833719" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02617e9d-383a-4a2d-9120-baa5ce62b407" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b8df34e1-27be-4b88-9c6a-40c033833719" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_32c2ae2e-7222-46f8-a2ce-679bc1f2122b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b8df34e1-27be-4b88-9c6a-40c033833719" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_32c2ae2e-7222-46f8-a2ce-679bc1f2122b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_32c2ae2e-7222-46f8-a2ce-679bc1f2122b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_32c2ae2e-7222-46f8-a2ce-679bc1f2122b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_32c2ae2e-7222-46f8-a2ce-679bc1f2122b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fc0e58cc-1b43-4eaa-8961-3eb736a1fc59" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_32c2ae2e-7222-46f8-a2ce-679bc1f2122b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fc0e58cc-1b43-4eaa-8961-3eb736a1fc59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_4166d1da-fc56-4ede-9229-3ac9d8ea60e7" xlink:href="iclr-20241231.xsd#iclr_OncacareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fc0e58cc-1b43-4eaa-8961-3eb736a1fc59" xlink:to="loc_iclr_OncacareMember_4166d1da-fc56-4ede-9229-3ac9d8ea60e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_8c8970ff-2dcf-49f3-8278-53fe5aa5646d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02617e9d-383a-4a2d-9120-baa5ce62b407" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_8c8970ff-2dcf-49f3-8278-53fe5aa5646d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8d087edc-da56-406c-909a-bf15727e73fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02617e9d-383a-4a2d-9120-baa5ce62b407" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8d087edc-da56-406c-909a-bf15727e73fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a240769e-72a5-471d-b044-34d1559f9f99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02617e9d-383a-4a2d-9120-baa5ce62b407" xlink:to="loc_us-gaap_Goodwill_a240769e-72a5-471d-b044-34d1559f9f99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_2d8117b9-4ddf-44dd-ab99-679d34e553b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02617e9d-383a-4a2d-9120-baa5ce62b407" xlink:to="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_2d8117b9-4ddf-44dd-ab99-679d34e553b1" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6cb17c7b-a1d0-4a6e-8e8e-2360cd9f5c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_897ecb63-1967-4974-8de8-553610dba8c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6cb17c7b-a1d0-4a6e-8e8e-2360cd9f5c4f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_897ecb63-1967-4974-8de8-553610dba8c9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6785670e-2567-4feb-9f4c-74817c4d20af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_897ecb63-1967-4974-8de8-553610dba8c9" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6785670e-2567-4feb-9f4c-74817c4d20af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6785670e-2567-4feb-9f4c-74817c4d20af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6785670e-2567-4feb-9f4c-74817c4d20af" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6785670e-2567-4feb-9f4c-74817c4d20af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b89b74ce-53ca-4263-af6b-5b203b9acd52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6785670e-2567-4feb-9f4c-74817c4d20af" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b89b74ce-53ca-4263-af6b-5b203b9acd52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1d6d14ad-8bd9-4c66-bfea-057c3e342041" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b89b74ce-53ca-4263-af6b-5b203b9acd52" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1d6d14ad-8bd9-4c66-bfea-057c3e342041" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_3b8785ff-bbb0-4344-82bb-317b2c695a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b89b74ce-53ca-4263-af6b-5b203b9acd52" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_3b8785ff-bbb0-4344-82bb-317b2c695a6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_f372e9ea-2dfa-4243-b929-751274abfd77" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b89b74ce-53ca-4263-af6b-5b203b9acd52" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_f372e9ea-2dfa-4243-b929-751274abfd77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_9aecd18f-a93f-4b10-966d-058dd394a2f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b89b74ce-53ca-4263-af6b-5b203b9acd52" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_9aecd18f-a93f-4b10-966d-058dd394a2f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_18e2d94d-4722-4f34-b44e-79b19b33a962" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_897ecb63-1967-4974-8de8-553610dba8c9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_18e2d94d-4722-4f34-b44e-79b19b33a962" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_18e2d94d-4722-4f34-b44e-79b19b33a962_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_18e2d94d-4722-4f34-b44e-79b19b33a962" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_18e2d94d-4722-4f34-b44e-79b19b33a962_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_be6143a5-cc44-4f8b-b7f1-0fd94822de5e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_18e2d94d-4722-4f34-b44e-79b19b33a962" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_be6143a5-cc44-4f8b-b7f1-0fd94822de5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestRateCapAndInterestRateSwapMember_28712aec-2114-48ec-a8c6-58bfd4180aae" xlink:href="iclr-20241231.xsd#iclr_InterestRateCapAndInterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_be6143a5-cc44-4f8b-b7f1-0fd94822de5e" xlink:to="loc_iclr_InterestRateCapAndInterestRateSwapMember_28712aec-2114-48ec-a8c6-58bfd4180aae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_429845ac-bf16-4452-bdb5-27db317d4991" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_897ecb63-1967-4974-8de8-553610dba8c9" xlink:to="loc_us-gaap_HedgingDesignationAxis_429845ac-bf16-4452-bdb5-27db317d4991" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_429845ac-bf16-4452-bdb5-27db317d4991_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_429845ac-bf16-4452-bdb5-27db317d4991" xlink:to="loc_us-gaap_HedgingDesignationDomain_429845ac-bf16-4452-bdb5-27db317d4991_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2a347cb8-854f-4fd9-b585-f8906bc9b3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_429845ac-bf16-4452-bdb5-27db317d4991" xlink:to="loc_us-gaap_HedgingDesignationDomain_2a347cb8-854f-4fd9-b585-f8906bc9b3c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_241fb870-e27d-467f-9203-c40766280389" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_2a347cb8-854f-4fd9-b585-f8906bc9b3c0" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_241fb870-e27d-467f-9203-c40766280389" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_49ed4147-2ada-464c-92d6-09999350a2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_897ecb63-1967-4974-8de8-553610dba8c9" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_49ed4147-2ada-464c-92d6-09999350a2c4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_49ed4147-2ada-464c-92d6-09999350a2c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_49ed4147-2ada-464c-92d6-09999350a2c4" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_49ed4147-2ada-464c-92d6-09999350a2c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b4164730-4660-47fc-9f5f-1de71f6f0b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_49ed4147-2ada-464c-92d6-09999350a2c4" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b4164730-4660-47fc-9f5f-1de71f6f0b7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_8a185fd8-5971-421d-9a64-d2706b82e922" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_b4164730-4660-47fc-9f5f-1de71f6f0b7e" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_8a185fd8-5971-421d-9a64-d2706b82e922" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_dc909cc3-b515-4ad3-a89a-79cce217c9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6cb17c7b-a1d0-4a6e-8e8e-2360cd9f5c4f" xlink:to="loc_us-gaap_AssetsAbstract_dc909cc3-b515-4ad3-a89a-79cce217c9fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_5f8ec453-1c42-4cbf-88fb-1050deb97133" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_dc909cc3-b515-4ad3-a89a-79cce217c9fe" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_5f8ec453-1c42-4cbf-88fb-1050deb97133" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_6b094d7f-6fed-493c-b77b-5d10af61524b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_dc909cc3-b515-4ad3-a89a-79cce217c9fe" xlink:to="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_6b094d7f-6fed-493c-b77b-5d10af61524b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_313321d8-ba24-49a6-8873-ae848ac484d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_dc909cc3-b515-4ad3-a89a-79cce217c9fe" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_313321d8-ba24-49a6-8873-ae848ac484d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_bfb63d2e-0551-41aa-9e1f-84bbbc5170ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6cb17c7b-a1d0-4a6e-8e8e-2360cd9f5c4f" xlink:to="loc_us-gaap_LiabilitiesAbstract_bfb63d2e-0551-41aa-9e1f-84bbbc5170ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_8cbdf234-4e0b-4b26-b19f-d2fe188f491e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_bfb63d2e-0551-41aa-9e1f-84bbbc5170ca" xlink:to="loc_us-gaap_DerivativeLiabilities_8cbdf234-4e0b-4b26-b19f-d2fe188f491e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_1dcf15de-9053-4ccd-bfc4-eb080d87257b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_bfb63d2e-0551-41aa-9e1f-84bbbc5170ca" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_1dcf15de-9053-4ccd-bfc4-eb080d87257b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost_ea850f9c-f4d6-456e-bc6b-c06245d929c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6cb17c7b-a1d0-4a6e-8e8e-2360cd9f5c4f" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCost_ea850f9c-f4d6-456e-bc6b-c06245d929c1" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/FairvalueNarrativeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#FairvalueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/FairvalueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_00c04adc-f0b5-45e3-b0a2-cba46b76914b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f6f54f6-54ee-41f3-8bd8-c19ea49d1ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_00c04adc-f0b5-45e3-b0a2-cba46b76914b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f6f54f6-54ee-41f3-8bd8-c19ea49d1ae7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b7b8d17f-0698-4161-8dcd-a8bc53c23722" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f6f54f6-54ee-41f3-8bd8-c19ea49d1ae7" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b7b8d17f-0698-4161-8dcd-a8bc53c23722" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b7b8d17f-0698-4161-8dcd-a8bc53c23722_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b7b8d17f-0698-4161-8dcd-a8bc53c23722" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b7b8d17f-0698-4161-8dcd-a8bc53c23722_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_38662aa0-55a1-4048-a431-187cce9d094e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b7b8d17f-0698-4161-8dcd-a8bc53c23722" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_38662aa0-55a1-4048-a431-187cce9d094e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_d1e7cf59-43e0-4171-be97-1221e53b54fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_38662aa0-55a1-4048-a431-187cce9d094e" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_d1e7cf59-43e0-4171-be97-1221e53b54fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_486f1b9a-5475-4a8a-bb5c-014c8f0fa53a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f6f54f6-54ee-41f3-8bd8-c19ea49d1ae7" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_486f1b9a-5475-4a8a-bb5c-014c8f0fa53a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_486f1b9a-5475-4a8a-bb5c-014c8f0fa53a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_486f1b9a-5475-4a8a-bb5c-014c8f0fa53a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_486f1b9a-5475-4a8a-bb5c-014c8f0fa53a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_253cb33f-3ff3-4844-8a1c-5222320105c2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_486f1b9a-5475-4a8a-bb5c-014c8f0fa53a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_253cb33f-3ff3-4844-8a1c-5222320105c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7da53588-5f25-49d6-baae-a65854d0aca1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_253cb33f-3ff3-4844-8a1c-5222320105c2" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7da53588-5f25-49d6-baae-a65854d0aca1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_9dc90b7f-15ed-41e8-8011-669e79699683" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_00c04adc-f0b5-45e3-b0a2-cba46b76914b" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_9dc90b7f-15ed-41e8-8011-669e79699683" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillFairValueDisclosure_de7ee870-963f-4d1c-82cc-903b6a51587f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_00c04adc-f0b5-45e3-b0a2-cba46b76914b" xlink:to="loc_us-gaap_GoodwillFairValueDisclosure_de7ee870-963f-4d1c-82cc-903b6a51587f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_f25febda-cd71-49cb-8d57-cb6b0ea5fed9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_00c04adc-f0b5-45e3-b0a2-cba46b76914b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_f25febda-cd71-49cb-8d57-cb6b0ea5fed9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost_05f0856c-fd59-4085-903c-34d76c4701ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_00c04adc-f0b5-45e3-b0a2-cba46b76914b" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCost_05f0856c-fd59-4085-903c-34d76c4701ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_0cef4415-5352-4272-8f9e-d548bc0f217d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_00c04adc-f0b5-45e3-b0a2-cba46b76914b" xlink:to="loc_us-gaap_LongTermDebtFairValue_0cef4415-5352-4272-8f9e-d548bc0f217d" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b6c930ce-df61-4791-b27e-c0720c4a12d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_24159bf9-89d6-4576-a0fc-9ebcf5e51915" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b6c930ce-df61-4791-b27e-c0720c4a12d8" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_24159bf9-89d6-4576-a0fc-9ebcf5e51915" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_92b781bc-bd87-479d-9cd2-8b4c439a5f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_24159bf9-89d6-4576-a0fc-9ebcf5e51915" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_92b781bc-bd87-479d-9cd2-8b4c439a5f3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_92b781bc-bd87-479d-9cd2-8b4c439a5f3a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_92b781bc-bd87-479d-9cd2-8b4c439a5f3a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_92b781bc-bd87-479d-9cd2-8b4c439a5f3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9fb058fa-e98a-426b-8f94-cd0ce3092d01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_92b781bc-bd87-479d-9cd2-8b4c439a5f3a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9fb058fa-e98a-426b-8f94-cd0ce3092d01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3c853440-4734-4ac5-b4c5-688e47e1f224" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9fb058fa-e98a-426b-8f94-cd0ce3092d01" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3c853440-4734-4ac5-b4c5-688e47e1f224" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_345a626f-e30b-490b-a5b7-6163ad043cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9fb058fa-e98a-426b-8f94-cd0ce3092d01" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_345a626f-e30b-490b-a5b7-6163ad043cf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_9a126f38-d09a-4640-ab56-7f09d429d6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9fb058fa-e98a-426b-8f94-cd0ce3092d01" xlink:to="loc_us-gaap_TradeNamesMember_9a126f38-d09a-4640-ab56-7f09d429d6d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_f15d7d4b-a1d9-49a3-915d-4f509fa791b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DatabasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9fb058fa-e98a-426b-8f94-cd0ce3092d01" xlink:to="loc_us-gaap_DatabasesMember_f15d7d4b-a1d9-49a3-915d-4f509fa791b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_468ed026-0e49-46c5-9480-7d15ddd0fe0a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9fb058fa-e98a-426b-8f94-cd0ce3092d01" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_468ed026-0e49-46c5-9480-7d15ddd0fe0a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_23d96c10-7513-46fe-b300-3af874b2f600" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b6c930ce-df61-4791-b27e-c0720c4a12d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_23d96c10-7513-46fe-b300-3af874b2f600" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ff92bb3c-33fb-4116-ad0f-79fe83052e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b6c930ce-df61-4791-b27e-c0720c4a12d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ff92bb3c-33fb-4116-ad0f-79fe83052e9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bc90b78e-331f-4f60-be3c-670b85604b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b6c930ce-df61-4791-b27e-c0720c4a12d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bc90b78e-331f-4f60-be3c-670b85604b4b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#IntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_961e881e-d235-49fc-afbd-7247e84ca44f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_a5d7e415-04be-49be-a418-b8122066ad72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_961e881e-d235-49fc-afbd-7247e84ca44f" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_a5d7e415-04be-49be-a418-b8122066ad72" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8239fd39-a9b3-41b6-a66e-9189bdb1f2c2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_a5d7e415-04be-49be-a418-b8122066ad72" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8239fd39-a9b3-41b6-a66e-9189bdb1f2c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8239fd39-a9b3-41b6-a66e-9189bdb1f2c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8239fd39-a9b3-41b6-a66e-9189bdb1f2c2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8239fd39-a9b3-41b6-a66e-9189bdb1f2c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c3e0669-a85d-425f-95ff-160c653efbe2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8239fd39-a9b3-41b6-a66e-9189bdb1f2c2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c3e0669-a85d-425f-95ff-160c653efbe2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_HumanFirstIncMember_82b61fdf-38b7-4998-9d5e-5ad255371e80" xlink:href="iclr-20241231.xsd#iclr_HumanFirstIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c3e0669-a85d-425f-95ff-160c653efbe2" xlink:to="loc_iclr_HumanFirstIncMember_82b61fdf-38b7-4998-9d5e-5ad255371e80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_KCRS.AGroupMember_34bfd530-5bbf-40af-bc21-4cf486dcf746" xlink:href="iclr-20241231.xsd#iclr_KCRS.AGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c3e0669-a85d-425f-95ff-160c653efbe2" xlink:to="loc_iclr_KCRS.AGroupMember_34bfd530-5bbf-40af-bc21-4cf486dcf746" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BiotelResearchLLCMember_55bc908c-62cb-478f-ae95-54c359bf9ebc" xlink:href="iclr-20241231.xsd#iclr_BiotelResearchLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c3e0669-a85d-425f-95ff-160c653efbe2" xlink:to="loc_iclr_BiotelResearchLLCMember_55bc908c-62cb-478f-ae95-54c359bf9ebc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9a9c35b1-1656-49fd-bc05-310c12ec1e92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_a5d7e415-04be-49be-a418-b8122066ad72" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9a9c35b1-1656-49fd-bc05-310c12ec1e92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9a9c35b1-1656-49fd-bc05-310c12ec1e92_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9a9c35b1-1656-49fd-bc05-310c12ec1e92" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9a9c35b1-1656-49fd-bc05-310c12ec1e92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03a2ebb1-b9d9-4acf-a30f-b587e065b25f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9a9c35b1-1656-49fd-bc05-310c12ec1e92" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03a2ebb1-b9d9-4acf-a30f-b587e065b25f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_5b89a72c-522b-421c-80b5-4f5e8e5916c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03a2ebb1-b9d9-4acf-a30f-b587e065b25f" xlink:to="loc_us-gaap_CustomerRelationshipsMember_5b89a72c-522b-421c-80b5-4f5e8e5916c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_059673de-2ea8-4750-ad6f-730a5733a1cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03a2ebb1-b9d9-4acf-a30f-b587e065b25f" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_059673de-2ea8-4750-ad6f-730a5733a1cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_2a9e1ce6-ebf8-48ce-a538-60cf983ed23e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03a2ebb1-b9d9-4acf-a30f-b587e065b25f" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_2a9e1ce6-ebf8-48ce-a538-60cf983ed23e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_1f8b5021-34d2-4e9a-afb5-d7ddbb4c29ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03a2ebb1-b9d9-4acf-a30f-b587e065b25f" xlink:to="loc_us-gaap_TradeNamesMember_1f8b5021-34d2-4e9a-afb5-d7ddbb4c29ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_edc4481d-78e8-46bd-a373-695da6d75e2b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_a5d7e415-04be-49be-a418-b8122066ad72" xlink:to="loc_srt_RangeAxis_edc4481d-78e8-46bd-a373-695da6d75e2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_edc4481d-78e8-46bd-a373-695da6d75e2b_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_edc4481d-78e8-46bd-a373-695da6d75e2b" xlink:to="loc_srt_RangeMember_edc4481d-78e8-46bd-a373-695da6d75e2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d82735f0-d740-4e65-91b9-67e392fb9481" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_edc4481d-78e8-46bd-a373-695da6d75e2b" xlink:to="loc_srt_RangeMember_d82735f0-d740-4e65-91b9-67e392fb9481" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_55d22e1b-caab-4888-8e6e-87af576c487e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d82735f0-d740-4e65-91b9-67e392fb9481" xlink:to="loc_srt_MinimumMember_55d22e1b-caab-4888-8e6e-87af576c487e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_52f5a764-c46c-43a4-83c8-c3bb0e205e5a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d82735f0-d740-4e65-91b9-67e392fb9481" xlink:to="loc_srt_MaximumMember_52f5a764-c46c-43a4-83c8-c3bb0e205e5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_478cf0a1-c795-4cac-abb6-693793846a57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_961e881e-d235-49fc-afbd-7247e84ca44f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_478cf0a1-c795-4cac-abb6-693793846a57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DecreaseInAmortisation_645e620c-4638-417b-98ce-78d354f6d22d" xlink:href="iclr-20241231.xsd#iclr_DecreaseInAmortisation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_961e881e-d235-49fc-afbd-7247e84ca44f" xlink:to="loc_iclr_DecreaseInAmortisation_645e620c-4638-417b-98ce-78d354f6d22d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_94ce20da-4319-4e89-a17f-a49292a6a854" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_961e881e-d235-49fc-afbd-7247e84ca44f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_94ce20da-4319-4e89-a17f-a49292a6a854" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7c933334-da65-4058-bbc5-db414f12c7af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_961e881e-d235-49fc-afbd-7247e84ca44f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7c933334-da65-4058-bbc5-db414f12c7af" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4b1effd4-3961-4150-b689-f22a9f02222c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_96d3144d-a74e-4064-8f30-4929dc906ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b1effd4-3961-4150-b689-f22a9f02222c" xlink:to="loc_us-gaap_DebtInstrumentTable_96d3144d-a74e-4064-8f30-4929dc906ed4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_70687bf7-cccf-4b70-b4b7-b07f37087952" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_96d3144d-a74e-4064-8f30-4929dc906ed4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_70687bf7-cccf-4b70-b4b7-b07f37087952" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_70687bf7-cccf-4b70-b4b7-b07f37087952_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_70687bf7-cccf-4b70-b4b7-b07f37087952" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_70687bf7-cccf-4b70-b4b7-b07f37087952_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1622419f-6fd0-48dc-b1e9-1b5da9a1558f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_70687bf7-cccf-4b70-b4b7-b07f37087952" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1622419f-6fd0-48dc-b1e9-1b5da9a1558f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_ed3a649d-300f-4b2c-99a1-c96d7e20814a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1622419f-6fd0-48dc-b1e9-1b5da9a1558f" xlink:to="loc_us-gaap_SecuredDebtMember_ed3a649d-300f-4b2c-99a1-c96d7e20814a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorSubordinatedNotesMember_1911e5ee-6290-48f3-85a2-80e966e50944" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorSubordinatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1622419f-6fd0-48dc-b1e9-1b5da9a1558f" xlink:to="loc_us-gaap_SeniorSubordinatedNotesMember_1911e5ee-6290-48f3-85a2-80e966e50944" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_412d9205-dc39-4a93-a6e3-bda6e5436998" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1622419f-6fd0-48dc-b1e9-1b5da9a1558f" xlink:to="loc_us-gaap_LineOfCreditMember_412d9205-dc39-4a93-a6e3-bda6e5436998" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_af94bb44-2a83-434d-89df-c52f3330d36e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_96d3144d-a74e-4064-8f30-4929dc906ed4" xlink:to="loc_us-gaap_DebtInstrumentAxis_af94bb44-2a83-434d-89df-c52f3330d36e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_af94bb44-2a83-434d-89df-c52f3330d36e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_af94bb44-2a83-434d-89df-c52f3330d36e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_af94bb44-2a83-434d-89df-c52f3330d36e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a9fb0816-3c84-4fc2-911b-edfe60bde01e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_af94bb44-2a83-434d-89df-c52f3330d36e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a9fb0816-3c84-4fc2-911b-edfe60bde01e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember_9fff8a29-3567-4188-ba84-5e6906f9df32" xlink:href="iclr-20241231.xsd#iclr_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9fb0816-3c84-4fc2-911b-edfe60bde01e" xlink:to="loc_iclr_TermLoanFacilityMember_9fff8a29-3567-4188-ba84-5e6906f9df32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesMember_fe60fc7d-2deb-40aa-b673-62c36137f428" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9fb0816-3c84-4fc2-911b-edfe60bde01e" xlink:to="loc_iclr_SeniorSecuredNotesMember_fe60fc7d-2deb-40aa-b673-62c36137f428" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_aa1d574b-a8be-4f89-8912-74b537f3ca71" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredRevolvingLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9fb0816-3c84-4fc2-911b-edfe60bde01e" xlink:to="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_aa1d574b-a8be-4f89-8912-74b537f3ca71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesDueMay2027Member_b5c8f3db-6e25-4d00-ba2b-88911e1820a5" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredNotesDueMay2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9fb0816-3c84-4fc2-911b-edfe60bde01e" xlink:to="loc_iclr_SeniorSecuredNotesDueMay2027Member_b5c8f3db-6e25-4d00-ba2b-88911e1820a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesDueMay2029Member_90bd2af8-8e43-4e5c-adbb-7d17cbf4acce" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredNotesDueMay2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9fb0816-3c84-4fc2-911b-edfe60bde01e" xlink:to="loc_iclr_SeniorSecuredNotesDueMay2029Member_90bd2af8-8e43-4e5c-adbb-7d17cbf4acce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesDueMay2034Member_66fff234-4d56-49c3-b8e4-6cc2b6b77fca" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredNotesDueMay2034Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9fb0816-3c84-4fc2-911b-edfe60bde01e" xlink:to="loc_iclr_SeniorSecuredNotesDueMay2034Member_66fff234-4d56-49c3-b8e4-6cc2b6b77fca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f2076302-9fb9-4f57-92f3-a2f1b163e085" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_96d3144d-a74e-4064-8f30-4929dc906ed4" xlink:to="loc_us-gaap_CreditFacilityAxis_f2076302-9fb9-4f57-92f3-a2f1b163e085" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f2076302-9fb9-4f57-92f3-a2f1b163e085_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_f2076302-9fb9-4f57-92f3-a2f1b163e085" xlink:to="loc_us-gaap_CreditFacilityDomain_f2076302-9fb9-4f57-92f3-a2f1b163e085_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5f487dd8-4eac-4b96-b7cd-c81af8476032" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_f2076302-9fb9-4f57-92f3-a2f1b163e085" xlink:to="loc_us-gaap_CreditFacilityDomain_5f487dd8-4eac-4b96-b7cd-c81af8476032" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_3b479e66-de22-4f7f-91b0-65e43eb2c9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_5f487dd8-4eac-4b96-b7cd-c81af8476032" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_3b479e66-de22-4f7f-91b0-65e43eb2c9ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c2788f8d-9b97-48e0-9ee2-8a915f07ddd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b1effd4-3961-4150-b689-f22a9f02222c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c2788f8d-9b97-48e0-9ee2-8a915f07ddd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_58137873-2840-4a08-8f06-7cd36eee5b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b1effd4-3961-4150-b689-f22a9f02222c" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_58137873-2840-4a08-8f06-7cd36eee5b2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtCurrentMaturitiesGross_80a9c3fa-aac2-4105-b4f6-4312e760e6f1" xlink:href="iclr-20241231.xsd#iclr_LongTermDebtCurrentMaturitiesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b1effd4-3961-4150-b689-f22a9f02222c" xlink:to="loc_iclr_LongTermDebtCurrentMaturitiesGross_80a9c3fa-aac2-4105-b4f6-4312e760e6f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_45e92ec8-52cc-470d-901b-69d28e56eb1f" xlink:href="iclr-20241231.xsd#iclr_LongTermDebtExcludingCurrentMaturitiesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b1effd4-3961-4150-b689-f22a9f02222c" xlink:to="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_45e92ec8-52cc-470d-901b-69d28e56eb1f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_6e09a601-8a6c-4c76-af63-55d39c8bc685" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b1effd4-3961-4150-b689-f22a9f02222c" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_6e09a601-8a6c-4c76-af63-55d39c8bc685" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_2fedcfc1-a766-4d08-a9d2-e2f1aa9c608f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b1effd4-3961-4150-b689-f22a9f02222c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_2fedcfc1-a766-4d08-a9d2-e2f1aa9c608f" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_446bd3f3-29f4-4a8a-8041-19c4ea4d20fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_DebtInstrumentTable_446bd3f3-29f4-4a8a-8041-19c4ea4d20fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_59ab2fed-2770-4cd1-932a-79ce90a49992" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_446bd3f3-29f4-4a8a-8041-19c4ea4d20fa" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_59ab2fed-2770-4cd1-932a-79ce90a49992" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_59ab2fed-2770-4cd1-932a-79ce90a49992_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_59ab2fed-2770-4cd1-932a-79ce90a49992" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_59ab2fed-2770-4cd1-932a-79ce90a49992_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9d2d8753-0b32-4fcf-8047-c606a050c223" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_59ab2fed-2770-4cd1-932a-79ce90a49992" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9d2d8753-0b32-4fcf-8047-c606a050c223" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_6e189b04-f732-44ec-b227-935455f9d9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9d2d8753-0b32-4fcf-8047-c606a050c223" xlink:to="loc_us-gaap_SecuredDebtMember_6e189b04-f732-44ec-b227-935455f9d9aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorSubordinatedNotesMember_0cb90d5e-e2cb-4f7e-99e4-d1734127f3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorSubordinatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9d2d8753-0b32-4fcf-8047-c606a050c223" xlink:to="loc_us-gaap_SeniorSubordinatedNotesMember_0cb90d5e-e2cb-4f7e-99e4-d1734127f3f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_96446810-b41c-4346-bb94-a16799314b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9d2d8753-0b32-4fcf-8047-c606a050c223" xlink:to="loc_us-gaap_LineOfCreditMember_96446810-b41c-4346-bb94-a16799314b6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_44400f08-093a-4b8e-a261-aaa5e11fda57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_446bd3f3-29f4-4a8a-8041-19c4ea4d20fa" xlink:to="loc_us-gaap_DebtInstrumentAxis_44400f08-093a-4b8e-a261-aaa5e11fda57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_44400f08-093a-4b8e-a261-aaa5e11fda57_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_44400f08-093a-4b8e-a261-aaa5e11fda57" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_44400f08-093a-4b8e-a261-aaa5e11fda57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_69c49586-d896-4f6a-8adb-64487b2f30bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_44400f08-093a-4b8e-a261-aaa5e11fda57" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_69c49586-d896-4f6a-8adb-64487b2f30bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember_441e22ea-e668-4001-9eab-b79c951fdc2d" xlink:href="iclr-20241231.xsd#iclr_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69c49586-d896-4f6a-8adb-64487b2f30bf" xlink:to="loc_iclr_TermLoanFacilityMember_441e22ea-e668-4001-9eab-b79c951fdc2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_c922d78c-bef0-4c5a-ae22-69a714290750" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredRevolvingLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69c49586-d896-4f6a-8adb-64487b2f30bf" xlink:to="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_c922d78c-bef0-4c5a-ae22-69a714290750" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_99708579-b9b0-45e0-9faf-2e32525ffefb" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69c49586-d896-4f6a-8adb-64487b2f30bf" xlink:to="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_99708579-b9b0-45e0-9faf-2e32525ffefb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesMember_02ff990c-63a9-4c3f-ac05-f9d741c60d7a" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69c49586-d896-4f6a-8adb-64487b2f30bf" xlink:to="loc_iclr_SeniorSecuredNotesMember_02ff990c-63a9-4c3f-ac05-f9d741c60d7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesDueMay2027Member_e89f9fb6-fa34-4f1f-b885-8df291cd5837" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredNotesDueMay2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69c49586-d896-4f6a-8adb-64487b2f30bf" xlink:to="loc_iclr_SeniorSecuredNotesDueMay2027Member_e89f9fb6-fa34-4f1f-b885-8df291cd5837" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesDueMay2029Member_4ad3f3c2-9031-44c9-bbd9-772f4f3d1eb7" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredNotesDueMay2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69c49586-d896-4f6a-8adb-64487b2f30bf" xlink:to="loc_iclr_SeniorSecuredNotesDueMay2029Member_4ad3f3c2-9031-44c9-bbd9-772f4f3d1eb7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesDueMay2034Member_26bf71a3-d1d1-46fa-9300-494b012ae483" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredNotesDueMay2034Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69c49586-d896-4f6a-8adb-64487b2f30bf" xlink:to="loc_iclr_SeniorSecuredNotesDueMay2034Member_26bf71a3-d1d1-46fa-9300-494b012ae483" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_409c43c9-a22e-47ca-8e62-af5d38adcd11" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_446bd3f3-29f4-4a8a-8041-19c4ea4d20fa" xlink:to="loc_us-gaap_CreditFacilityAxis_409c43c9-a22e-47ca-8e62-af5d38adcd11" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_409c43c9-a22e-47ca-8e62-af5d38adcd11_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_409c43c9-a22e-47ca-8e62-af5d38adcd11" xlink:to="loc_us-gaap_CreditFacilityDomain_409c43c9-a22e-47ca-8e62-af5d38adcd11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_cf05179a-343f-4734-bcb3-de2272f035d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_409c43c9-a22e-47ca-8e62-af5d38adcd11" xlink:to="loc_us-gaap_CreditFacilityDomain_cf05179a-343f-4734-bcb3-de2272f035d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_08e68766-3da7-4128-84de-701f3f3ae36c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_cf05179a-343f-4734-bcb3-de2272f035d2" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_08e68766-3da7-4128-84de-701f3f3ae36c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentAxis_704697cb-52a9-41a9-bb93-cc1b6f436456" xlink:href="iclr-20241231.xsd#iclr_VariableRateComponentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_446bd3f3-29f4-4a8a-8041-19c4ea4d20fa" xlink:to="loc_iclr_VariableRateComponentAxis_704697cb-52a9-41a9-bb93-cc1b6f436456" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentDomain_704697cb-52a9-41a9-bb93-cc1b6f436456_default" xlink:href="iclr-20241231.xsd#iclr_VariableRateComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_iclr_VariableRateComponentAxis_704697cb-52a9-41a9-bb93-cc1b6f436456" xlink:to="loc_iclr_VariableRateComponentDomain_704697cb-52a9-41a9-bb93-cc1b6f436456_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentDomain_6b3aedbb-9629-4e50-9709-dbe79b971993" xlink:href="iclr-20241231.xsd#iclr_VariableRateComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_iclr_VariableRateComponentAxis_704697cb-52a9-41a9-bb93-cc1b6f436456" xlink:to="loc_iclr_VariableRateComponentDomain_6b3aedbb-9629-4e50-9709-dbe79b971993" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentOneMember_301a0207-63ad-4deb-a70a-c9256c2debd5" xlink:href="iclr-20241231.xsd#iclr_VariableRateComponentOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_VariableRateComponentDomain_6b3aedbb-9629-4e50-9709-dbe79b971993" xlink:to="loc_iclr_VariableRateComponentOneMember_301a0207-63ad-4deb-a70a-c9256c2debd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentTwoMember_237de05a-d3a4-4ef3-afc9-c64862790df0" xlink:href="iclr-20241231.xsd#iclr_VariableRateComponentTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_VariableRateComponentDomain_6b3aedbb-9629-4e50-9709-dbe79b971993" xlink:to="loc_iclr_VariableRateComponentTwoMember_237de05a-d3a4-4ef3-afc9-c64862790df0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_74614ae4-27dd-478e-b4e0-026c75e37dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_446bd3f3-29f4-4a8a-8041-19c4ea4d20fa" xlink:to="loc_us-gaap_VariableRateAxis_74614ae4-27dd-478e-b4e0-026c75e37dcb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_74614ae4-27dd-478e-b4e0-026c75e37dcb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_74614ae4-27dd-478e-b4e0-026c75e37dcb" xlink:to="loc_us-gaap_VariableRateDomain_74614ae4-27dd-478e-b4e0-026c75e37dcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_4e18a53c-e02b-4dcc-b607-bf0fe4650229" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_74614ae4-27dd-478e-b4e0-026c75e37dcb" xlink:to="loc_us-gaap_VariableRateDomain_4e18a53c-e02b-4dcc-b607-bf0fe4650229" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_1cb36dfb-d537-4e3a-82a6-41b1d1721156" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_4e18a53c-e02b-4dcc-b607-bf0fe4650229" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_1cb36dfb-d537-4e3a-82a6-41b1d1721156" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_528cd462-117a-4a0e-8aa2-bf917bce99d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_4e18a53c-e02b-4dcc-b607-bf0fe4650229" xlink:to="loc_us-gaap_BaseRateMember_528cd462-117a-4a0e-8aa2-bf917bce99d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2f31b431-5c0a-4253-aa95-a7779c2243be" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_446bd3f3-29f4-4a8a-8041-19c4ea4d20fa" xlink:to="loc_srt_RangeAxis_2f31b431-5c0a-4253-aa95-a7779c2243be" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2f31b431-5c0a-4253-aa95-a7779c2243be_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2f31b431-5c0a-4253-aa95-a7779c2243be" xlink:to="loc_srt_RangeMember_2f31b431-5c0a-4253-aa95-a7779c2243be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_023840f1-a352-4914-9f32-df50edc9b5b8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2f31b431-5c0a-4253-aa95-a7779c2243be" xlink:to="loc_srt_RangeMember_023840f1-a352-4914-9f32-df50edc9b5b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_48dce2bc-a65f-4408-8b1d-565bc49275e2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_023840f1-a352-4914-9f32-df50edc9b5b8" xlink:to="loc_srt_MaximumMember_48dce2bc-a65f-4408-8b1d-565bc49275e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fc8af24b-f598-4699-9f3f-afb07b2ac452" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_023840f1-a352-4914-9f32-df50edc9b5b8" xlink:to="loc_srt_MinimumMember_fc8af24b-f598-4699-9f3f-afb07b2ac452" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CreditRatingStandardPoorsAxis_cc61835a-e3d4-441b-9129-8d9cb8a759b4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CreditRatingStandardPoorsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_446bd3f3-29f4-4a8a-8041-19c4ea4d20fa" xlink:to="loc_srt_CreditRatingStandardPoorsAxis_cc61835a-e3d4-441b-9129-8d9cb8a759b4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExternalCreditRatingStandardPoorsMember_cc61835a-e3d4-441b-9129-8d9cb8a759b4_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ExternalCreditRatingStandardPoorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CreditRatingStandardPoorsAxis_cc61835a-e3d4-441b-9129-8d9cb8a759b4" xlink:to="loc_srt_ExternalCreditRatingStandardPoorsMember_cc61835a-e3d4-441b-9129-8d9cb8a759b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExternalCreditRatingStandardPoorsMember_78d40d34-a2ed-438a-8dc2-64ee939e3a0d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ExternalCreditRatingStandardPoorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CreditRatingStandardPoorsAxis_cc61835a-e3d4-441b-9129-8d9cb8a759b4" xlink:to="loc_srt_ExternalCreditRatingStandardPoorsMember_78d40d34-a2ed-438a-8dc2-64ee939e3a0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsBBRatingMember_3ce3f5dd-3253-4720-a6eb-794205967c08" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StandardPoorsBBRatingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ExternalCreditRatingStandardPoorsMember_78d40d34-a2ed-438a-8dc2-64ee939e3a0d" xlink:to="loc_srt_StandardPoorsBBRatingMember_3ce3f5dd-3253-4720-a6eb-794205967c08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsBBPlusRatingMember_aabb9f37-f78a-411f-8aa4-2158513cbc13" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StandardPoorsBBPlusRatingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ExternalCreditRatingStandardPoorsMember_78d40d34-a2ed-438a-8dc2-64ee939e3a0d" xlink:to="loc_srt_StandardPoorsBBPlusRatingMember_aabb9f37-f78a-411f-8aa4-2158513cbc13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsBBBMinusRatingMember_76b8a569-8f74-42b0-8f00-419c0fa29b07" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StandardPoorsBBBMinusRatingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ExternalCreditRatingStandardPoorsMember_78d40d34-a2ed-438a-8dc2-64ee939e3a0d" xlink:to="loc_srt_StandardPoorsBBBMinusRatingMember_76b8a569-8f74-42b0-8f00-419c0fa29b07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsBBBRatingMember_7db7068f-772e-4957-b307-6fc96c19393d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StandardPoorsBBBRatingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ExternalCreditRatingStandardPoorsMember_78d40d34-a2ed-438a-8dc2-64ee939e3a0d" xlink:to="loc_srt_StandardPoorsBBBRatingMember_7db7068f-772e-4957-b307-6fc96c19393d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsBBBPlusRatingMember_17b47156-4767-4d20-af00-4efee1248e4d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StandardPoorsBBBPlusRatingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ExternalCreditRatingStandardPoorsMember_78d40d34-a2ed-438a-8dc2-64ee939e3a0d" xlink:to="loc_srt_StandardPoorsBBBPlusRatingMember_17b47156-4767-4d20-af00-4efee1248e4d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_82e396d2-e645-42b7-a6b2-f85db691af97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_82e396d2-e645-42b7-a6b2-f85db691af97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_b5d2e20c-b011-443e-8e79-6730777132a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_b5d2e20c-b011-443e-8e79-6730777132a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1ba966ef-3305-40c4-b402-dfca76bcad43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1ba966ef-3305-40c4-b402-dfca76bcad43" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_f886d0fc-d0c8-46d3-8f9a-ab34a5c26fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_f886d0fc-d0c8-46d3-8f9a-ab34a5c26fb8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DebtInstrumentDiscountRate_e0bec03d-9670-4a32-bfe8-23aa34682b2d" xlink:href="iclr-20241231.xsd#iclr_DebtInstrumentDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_iclr_DebtInstrumentDiscountRate_e0bec03d-9670-4a32-bfe8-23aa34682b2d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_d073ba09-88ea-4c42-b3e2-06b5a9cdd9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_d073ba09-88ea-4c42-b3e2-06b5a9cdd9cf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3826f27c-8a5f-47d5-a1ed-94559e66f739" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3826f27c-8a5f-47d5-a1ed-94559e66f739" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_912fce9e-7adc-441b-9847-d7d3da2c5d67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_912fce9e-7adc-441b-9847-d7d3da2c5d67" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_c161f626-ec98-4e99-8f16-cf96d92cfb64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_c161f626-ec98-4e99-8f16-cf96d92cfb64" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_092e9527-511e-4276-a4b3-a797fefc9a45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_092e9527-511e-4276-a4b3-a797fefc9a45" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_04539cb2-ed30-4bdd-83f7-c6e52e52b1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_04539cb2-ed30-4bdd-83f7-c6e52e52b1c5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_18d27802-553d-4f55-a851-9c76820d8289" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_18d27802-553d-4f55-a851-9c76820d8289" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_e4dd5861-708a-4854-9e1a-85890902078f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_LongTermDebtFairValue_e4dd5861-708a-4854-9e1a-85890902078f" xlink:type="arc" order="12"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofPrincipalpaymentsDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BankCreditLinesLoanFacilitiesandNotesScheduleofPrincipalpaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofPrincipalpaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7c87fd50-c36f-460f-a323-ad1bb205cc02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3732faf1-0515-4f6b-9330-851c4ba7afbf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c87fd50-c36f-460f-a323-ad1bb205cc02" xlink:to="loc_us-gaap_DebtInstrumentTable_3732faf1-0515-4f6b-9330-851c4ba7afbf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7f76ee4e-3c4a-4dfe-901e-c01c965b6a34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3732faf1-0515-4f6b-9330-851c4ba7afbf" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7f76ee4e-3c4a-4dfe-901e-c01c965b6a34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7f76ee4e-3c4a-4dfe-901e-c01c965b6a34_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7f76ee4e-3c4a-4dfe-901e-c01c965b6a34" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7f76ee4e-3c4a-4dfe-901e-c01c965b6a34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a0d5fa9f-bfe1-4d90-b460-86861798ef3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7f76ee4e-3c4a-4dfe-901e-c01c965b6a34" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a0d5fa9f-bfe1-4d90-b460-86861798ef3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_71a04da7-2e9c-4d8f-97d8-4ccf9a0c9d60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a0d5fa9f-bfe1-4d90-b460-86861798ef3c" xlink:to="loc_us-gaap_SecuredDebtMember_71a04da7-2e9c-4d8f-97d8-4ccf9a0c9d60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_fb46e4f1-02d8-4a09-8842-8e5b8a80c088" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_3732faf1-0515-4f6b-9330-851c4ba7afbf" xlink:to="loc_us-gaap_DebtInstrumentAxis_fb46e4f1-02d8-4a09-8842-8e5b8a80c088" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fb46e4f1-02d8-4a09-8842-8e5b8a80c088_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_fb46e4f1-02d8-4a09-8842-8e5b8a80c088" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fb46e4f1-02d8-4a09-8842-8e5b8a80c088_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e12e3f40-ecda-478f-aefa-f05bd90f2509" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_fb46e4f1-02d8-4a09-8842-8e5b8a80c088" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e12e3f40-ecda-478f-aefa-f05bd90f2509" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember_5022d9fe-f6e2-4edc-be90-f8b48b419fed" xlink:href="iclr-20241231.xsd#iclr_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e12e3f40-ecda-478f-aefa-f05bd90f2509" xlink:to="loc_iclr_TermLoanFacilityMember_5022d9fe-f6e2-4edc-be90-f8b48b419fed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_14c8af0b-cab9-408c-8d85-a703b033e1b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c87fd50-c36f-460f-a323-ad1bb205cc02" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_14c8af0b-cab9-408c-8d85-a703b033e1b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment_1b870c2c-16c3-4a26-8b3f-c25e4759b2e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c87fd50-c36f-460f-a323-ad1bb205cc02" xlink:to="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment_1b870c2c-16c3-4a26-8b3f-c25e4759b2e4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a10048a1-747f-4ec1-9c29-2b50c7e3a35b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6218f375-b446-4969-8fca-a94f19df90f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a10048a1-747f-4ec1-9c29-2b50c7e3a35b" xlink:to="loc_us-gaap_DebtInstrumentTable_6218f375-b446-4969-8fca-a94f19df90f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_eca07726-b9a7-4e23-9409-7acf7614c18b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6218f375-b446-4969-8fca-a94f19df90f6" xlink:to="loc_us-gaap_CreditFacilityAxis_eca07726-b9a7-4e23-9409-7acf7614c18b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_eca07726-b9a7-4e23-9409-7acf7614c18b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_eca07726-b9a7-4e23-9409-7acf7614c18b" xlink:to="loc_us-gaap_CreditFacilityDomain_eca07726-b9a7-4e23-9409-7acf7614c18b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_01828d9b-5b37-4dd7-a873-10c3bc706c63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_eca07726-b9a7-4e23-9409-7acf7614c18b" xlink:to="loc_us-gaap_CreditFacilityDomain_01828d9b-5b37-4dd7-a873-10c3bc706c63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_86448994-6cd9-4292-b166-f603331aebb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_01828d9b-5b37-4dd7-a873-10c3bc706c63" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_86448994-6cd9-4292-b166-f603331aebb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cb7a8086-a7a3-43e2-94b7-0a75d70e00fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6218f375-b446-4969-8fca-a94f19df90f6" xlink:to="loc_us-gaap_DebtInstrumentAxis_cb7a8086-a7a3-43e2-94b7-0a75d70e00fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cb7a8086-a7a3-43e2-94b7-0a75d70e00fb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_cb7a8086-a7a3-43e2-94b7-0a75d70e00fb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cb7a8086-a7a3-43e2-94b7-0a75d70e00fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0c62e5c4-602e-4d65-9887-479fdca18f90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_cb7a8086-a7a3-43e2-94b7-0a75d70e00fb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0c62e5c4-602e-4d65-9887-479fdca18f90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_a567bf6f-cb88-4135-bb69-a1c330e89316" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredRevolvingLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c62e5c4-602e-4d65-9887-479fdca18f90" xlink:to="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_a567bf6f-cb88-4135-bb69-a1c330e89316" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6c608a73-0e77-44dc-8efd-12cb25086763" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6218f375-b446-4969-8fca-a94f19df90f6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6c608a73-0e77-44dc-8efd-12cb25086763" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6c608a73-0e77-44dc-8efd-12cb25086763_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6c608a73-0e77-44dc-8efd-12cb25086763" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6c608a73-0e77-44dc-8efd-12cb25086763_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_32485fe6-8492-429c-9c49-7eb9aedcec2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6c608a73-0e77-44dc-8efd-12cb25086763" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_32485fe6-8492-429c-9c49-7eb9aedcec2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_4912ac74-fcbb-4375-abf6-21ec9fb41ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_32485fe6-8492-429c-9c49-7eb9aedcec2b" xlink:to="loc_us-gaap_LineOfCreditMember_4912ac74-fcbb-4375-abf6-21ec9fb41ed9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_f312f4ac-1746-4759-846f-60e31b90d617" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a10048a1-747f-4ec1-9c29-2b50c7e3a35b" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_f312f4ac-1746-4759-846f-60e31b90d617" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_74f2469e-9158-478d-b249-3c72843fe93b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a10048a1-747f-4ec1-9c29-2b50c7e3a35b" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_74f2469e-9158-478d-b249-3c72843fe93b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_7d04ad3d-6b8c-444b-85b6-d96f15bab417" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a10048a1-747f-4ec1-9c29-2b50c7e3a35b" xlink:to="loc_us-gaap_LongTermDebt_7d04ad3d-6b8c-444b-85b6-d96f15bab417" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DerivativesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#DerivativesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/DerivativesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_db5f746d-61a1-41b7-8815-47f901cd09f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_86e234d3-ce03-46a6-92af-b772d60a3b65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_db5f746d-61a1-41b7-8815-47f901cd09f3" xlink:to="loc_us-gaap_DerivativeTable_86e234d3-ce03-46a6-92af-b772d60a3b65" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ac0ebdaa-d687-4b02-a8fd-7e43ec596eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_86e234d3-ce03-46a6-92af-b772d60a3b65" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ac0ebdaa-d687-4b02-a8fd-7e43ec596eb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ac0ebdaa-d687-4b02-a8fd-7e43ec596eb1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ac0ebdaa-d687-4b02-a8fd-7e43ec596eb1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ac0ebdaa-d687-4b02-a8fd-7e43ec596eb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9a6f1800-038c-41ee-a6b8-9059773a8c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ac0ebdaa-d687-4b02-a8fd-7e43ec596eb1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9a6f1800-038c-41ee-a6b8-9059773a8c8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_d928b1bb-30ab-4024-9f1c-a5c6c2f29e07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9a6f1800-038c-41ee-a6b8-9059773a8c8f" xlink:to="loc_us-gaap_InterestRateCapMember_d928b1bb-30ab-4024-9f1c-a5c6c2f29e07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_2b4f1589-6a5b-4629-935f-220e7009f4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9a6f1800-038c-41ee-a6b8-9059773a8c8f" xlink:to="loc_us-gaap_InterestRateSwapMember_2b4f1589-6a5b-4629-935f-220e7009f4ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestRateCapAndInterestRateSwapMember_3408b1ea-7a92-4eaa-9c25-660d7d020c9d" xlink:href="iclr-20241231.xsd#iclr_InterestRateCapAndInterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9a6f1800-038c-41ee-a6b8-9059773a8c8f" xlink:to="loc_iclr_InterestRateCapAndInterestRateSwapMember_3408b1ea-7a92-4eaa-9c25-660d7d020c9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0cafe30b-e7db-4b85-824a-2cd671133f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_86e234d3-ce03-46a6-92af-b772d60a3b65" xlink:to="loc_us-gaap_HedgingDesignationAxis_0cafe30b-e7db-4b85-824a-2cd671133f4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0cafe30b-e7db-4b85-824a-2cd671133f4a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_0cafe30b-e7db-4b85-824a-2cd671133f4a" xlink:to="loc_us-gaap_HedgingDesignationDomain_0cafe30b-e7db-4b85-824a-2cd671133f4a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_36e9e6be-4024-4810-8712-f129e1dd658d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_0cafe30b-e7db-4b85-824a-2cd671133f4a" xlink:to="loc_us-gaap_HedgingDesignationDomain_36e9e6be-4024-4810-8712-f129e1dd658d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c32147d6-a90e-4ed4-876d-426a2d94e319" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_36e9e6be-4024-4810-8712-f129e1dd658d" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c32147d6-a90e-4ed4-876d-426a2d94e319" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_0374cc4b-05b7-40f1-8741-7d9757ce4d38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_86e234d3-ce03-46a6-92af-b772d60a3b65" xlink:to="loc_us-gaap_VariableRateAxis_0374cc4b-05b7-40f1-8741-7d9757ce4d38" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_0374cc4b-05b7-40f1-8741-7d9757ce4d38_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_0374cc4b-05b7-40f1-8741-7d9757ce4d38" xlink:to="loc_us-gaap_VariableRateDomain_0374cc4b-05b7-40f1-8741-7d9757ce4d38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_70bb17db-8efe-40ad-911d-80617807af6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_0374cc4b-05b7-40f1-8741-7d9757ce4d38" xlink:to="loc_us-gaap_VariableRateDomain_70bb17db-8efe-40ad-911d-80617807af6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_4338513b-ebac-4630-8230-0d876432481f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_70bb17db-8efe-40ad-911d-80617807af6a" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_4338513b-ebac-4630-8230-0d876432481f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c0154e3a-f2d1-480d-89e4-00fcbc856897" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_86e234d3-ce03-46a6-92af-b772d60a3b65" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c0154e3a-f2d1-480d-89e4-00fcbc856897" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c0154e3a-f2d1-480d-89e4-00fcbc856897_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c0154e3a-f2d1-480d-89e4-00fcbc856897" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c0154e3a-f2d1-480d-89e4-00fcbc856897_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5cd6fa57-2bbe-4265-bda1-8c67a48ec9a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c0154e3a-f2d1-480d-89e4-00fcbc856897" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5cd6fa57-2bbe-4265-bda1-8c67a48ec9a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a6318002-2d05-4208-bca7-cb971fb5acd5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5cd6fa57-2bbe-4265-bda1-8c67a48ec9a3" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a6318002-2d05-4208-bca7-cb971fb5acd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_04c4ee7f-23c1-44a7-8771-ba6bcbeb7882" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_db5f746d-61a1-41b7-8815-47f901cd09f3" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_04c4ee7f-23c1-44a7-8771-ba6bcbeb7882" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_b2a1071b-8151-489c-927e-e749271c74e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_db5f746d-61a1-41b7-8815-47f901cd09f3" xlink:to="loc_us-gaap_DerivativeNotionalAmount_b2a1071b-8151-489c-927e-e749271c74e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_2c8c0b80-0517-40cd-a148-63728401d963" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_db5f746d-61a1-41b7-8815-47f901cd09f3" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_2c8c0b80-0517-40cd-a148-63728401d963" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf_36b57ce4-99d6-4131-94d4-f1494fbb16b7" xlink:href="iclr-20241231.xsd#iclr_DerivativeVariableInterestRateReferenceRateInExcessOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_db5f746d-61a1-41b7-8815-47f901cd09f3" xlink:to="loc_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf_36b57ce4-99d6-4131-94d4-f1494fbb16b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PercentageOfDebtHedgedByInterestRateDerivatives_8cedcc62-3c82-4af5-a737-81f914a1cc6f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PercentageOfDebtHedgedByInterestRateDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_db5f746d-61a1-41b7-8815-47f901cd09f3" xlink:to="loc_us-gaap_PercentageOfDebtHedgedByInterestRateDerivatives_8cedcc62-3c82-4af5-a737-81f914a1cc6f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_405dd711-2a2c-4d20-a6bc-f08b5893b147" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_db5f746d-61a1-41b7-8815-47f901cd09f3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_405dd711-2a2c-4d20-a6bc-f08b5893b147" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_a93f57e8-6ffe-44a2-93a6-5503d5df3bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_db5f746d-61a1-41b7-8815-47f901cd09f3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_a93f57e8-6ffe-44a2-93a6-5503d5df3bcd" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_bfb20cde-405d-4f03-aab7-80deedf2224a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_516e073e-ce39-4aef-af8c-8bc01342c7f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_bfb20cde-405d-4f03-aab7-80deedf2224a" xlink:to="loc_us-gaap_DerivativeTable_516e073e-ce39-4aef-af8c-8bc01342c7f5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c26f76aa-ba16-4114-a9cb-fdfd7c2761a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_516e073e-ce39-4aef-af8c-8bc01342c7f5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c26f76aa-ba16-4114-a9cb-fdfd7c2761a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c26f76aa-ba16-4114-a9cb-fdfd7c2761a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c26f76aa-ba16-4114-a9cb-fdfd7c2761a5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c26f76aa-ba16-4114-a9cb-fdfd7c2761a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5d14bffb-a411-40a3-92b8-4e6b7f2b2a26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c26f76aa-ba16-4114-a9cb-fdfd7c2761a5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5d14bffb-a411-40a3-92b8-4e6b7f2b2a26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_cfa8287f-9ba4-4d1e-81ef-f2ed0608bce4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5d14bffb-a411-40a3-92b8-4e6b7f2b2a26" xlink:to="loc_us-gaap_InterestRateCapMember_cfa8287f-9ba4-4d1e-81ef-f2ed0608bce4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6d03cadd-50b5-48c4-8eb4-0fe5815a818e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5d14bffb-a411-40a3-92b8-4e6b7f2b2a26" xlink:to="loc_us-gaap_InterestRateSwapMember_6d03cadd-50b5-48c4-8eb4-0fe5815a818e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestRateCapAndInterestRateSwapMember_ba3fda9a-7b6f-4020-a920-30027281181c" xlink:href="iclr-20241231.xsd#iclr_InterestRateCapAndInterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5d14bffb-a411-40a3-92b8-4e6b7f2b2a26" xlink:to="loc_iclr_InterestRateCapAndInterestRateSwapMember_ba3fda9a-7b6f-4020-a920-30027281181c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_e8664e98-b589-4d2a-83e9-0d9c739fbc56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_516e073e-ce39-4aef-af8c-8bc01342c7f5" xlink:to="loc_us-gaap_HedgingDesignationAxis_e8664e98-b589-4d2a-83e9-0d9c739fbc56" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_e8664e98-b589-4d2a-83e9-0d9c739fbc56_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_e8664e98-b589-4d2a-83e9-0d9c739fbc56" xlink:to="loc_us-gaap_HedgingDesignationDomain_e8664e98-b589-4d2a-83e9-0d9c739fbc56_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5ce7a1d2-852a-4296-a372-a3c354ef8103" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_e8664e98-b589-4d2a-83e9-0d9c739fbc56" xlink:to="loc_us-gaap_HedgingDesignationDomain_5ce7a1d2-852a-4296-a372-a3c354ef8103" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6956ffc7-cd6e-482e-a58b-df43f0533dae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5ce7a1d2-852a-4296-a372-a3c354ef8103" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6956ffc7-cd6e-482e-a58b-df43f0533dae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bdbb21c8-6d20-41f0-b4b8-93fd912fba14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_516e073e-ce39-4aef-af8c-8bc01342c7f5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bdbb21c8-6d20-41f0-b4b8-93fd912fba14" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bdbb21c8-6d20-41f0-b4b8-93fd912fba14_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bdbb21c8-6d20-41f0-b4b8-93fd912fba14" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bdbb21c8-6d20-41f0-b4b8-93fd912fba14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98504d0f-6c54-4c58-b473-480109175c37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bdbb21c8-6d20-41f0-b4b8-93fd912fba14" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98504d0f-6c54-4c58-b473-480109175c37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_4c0ef437-f791-4f7d-8eb5-54a2b9e4fd61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98504d0f-6c54-4c58-b473-480109175c37" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_4c0ef437-f791-4f7d-8eb5-54a2b9e4fd61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_d0cdb412-4071-4985-bb3e-cdc0b422ebd0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bfb20cde-405d-4f03-aab7-80deedf2224a" xlink:to="loc_us-gaap_DerivativeAssets_d0cdb412-4071-4985-bb3e-cdc0b422ebd0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_9fe3ab0a-1d93-439e-a741-e302ad7a591d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bfb20cde-405d-4f03-aab7-80deedf2224a" xlink:to="loc_us-gaap_DerivativeLiabilities_9fe3ab0a-1d93-439e-a741-e302ad7a591d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_c726c83c-9fdd-4338-8c38-f758f44892aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_bfb20cde-405d-4f03-aab7-80deedf2224a" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_c726c83c-9fdd-4338-8c38-f758f44892aa" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#OperatingLeasesOperatingLeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_8b7b30f2-3400-4df1-b89a-4e6b9e6fac9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3d433251-c355-47f0-9f61-853e3e100c65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8b7b30f2-3400-4df1-b89a-4e6b9e6fac9f" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3d433251-c355-47f0-9f61-853e3e100c65" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_80eab4e0-75eb-454b-8c26-504b5c62059b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3d433251-c355-47f0-9f61-853e3e100c65" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_80eab4e0-75eb-454b-8c26-504b5c62059b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_80eab4e0-75eb-454b-8c26-504b5c62059b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_80eab4e0-75eb-454b-8c26-504b5c62059b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_80eab4e0-75eb-454b-8c26-504b5c62059b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_99719708-1425-4343-b5f2-508ad02a21d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_80eab4e0-75eb-454b-8c26-504b5c62059b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_99719708-1425-4343-b5f2-508ad02a21d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ba3eb22e-86b1-44f7-b11b-92b49d3bd14a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_99719708-1425-4343-b5f2-508ad02a21d2" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ba3eb22e-86b1-44f7-b11b-92b49d3bd14a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_51f6fccf-d5d0-4043-9f9f-746021ab7beb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_99719708-1425-4343-b5f2-508ad02a21d2" xlink:to="loc_us-gaap_CostOfSalesMember_51f6fccf-d5d0-4043-9f9f-746021ab7beb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_269c5639-1992-498d-a717-0a6b382afde0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8b7b30f2-3400-4df1-b89a-4e6b9e6fac9f" xlink:to="loc_us-gaap_LeaseCost_269c5639-1992-498d-a717-0a6b382afde0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_cc7d2b35-2cfc-42e9-ae82-cdbe7c2bcc28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8b7b30f2-3400-4df1-b89a-4e6b9e6fac9f" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_cc7d2b35-2cfc-42e9-ae82-cdbe7c2bcc28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_49ad855c-f4e6-4969-b85b-19be41c95c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8b7b30f2-3400-4df1-b89a-4e6b9e6fac9f" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_49ad855c-f4e6-4969-b85b-19be41c95c8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_28b26e22-cb05-41e0-97cc-5ba7494cecf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8b7b30f2-3400-4df1-b89a-4e6b9e6fac9f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_28b26e22-cb05-41e0-97cc-5ba7494cecf1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_39b3ab06-ea97-4908-aae5-beaf40bc0d27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8b7b30f2-3400-4df1-b89a-4e6b9e6fac9f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_39b3ab06-ea97-4908-aae5-beaf40bc0d27" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_05c6adbb-f837-4655-a055-0df5192a4ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8b7b30f2-3400-4df1-b89a-4e6b9e6fac9f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_05c6adbb-f837-4655-a055-0df5192a4ba0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_24038e43-4530-4277-8216-8455ea2a0ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8b7b30f2-3400-4df1-b89a-4e6b9e6fac9f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_24038e43-4530-4277-8216-8455ea2a0ceb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c30bc1c4-7809-40de-9f25-ac2ac3cbc09f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8b7b30f2-3400-4df1-b89a-4e6b9e6fac9f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c30bc1c4-7809-40de-9f25-ac2ac3cbc09f" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ShareCapitalDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#ShareCapitalDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/ShareCapitalDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_082a6e61-7651-44ee-bc21-f935db50a8e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_082a6e61-7651-44ee-bc21-f935db50a8e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a8ca305f-d05d-4fc7-8b4c-cfc0f21e616b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_082a6e61-7651-44ee-bc21-f935db50a8e7" xlink:to="loc_us-gaap_AwardTypeAxis_a8ca305f-d05d-4fc7-8b4c-cfc0f21e616b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8ca305f-d05d-4fc7-8b4c-cfc0f21e616b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a8ca305f-d05d-4fc7-8b4c-cfc0f21e616b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a8ca305f-d05d-4fc7-8b4c-cfc0f21e616b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d74136c9-ffab-4769-928b-171adc30ba7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a8ca305f-d05d-4fc7-8b4c-cfc0f21e616b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d74136c9-ffab-4769-928b-171adc30ba7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_95f6e6f9-7bd1-4a3a-9a2f-5aae167dc690" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d74136c9-ffab-4769-928b-171adc30ba7f" xlink:to="loc_us-gaap_EmployeeStockOptionMember_95f6e6f9-7bd1-4a3a-9a2f-5aae167dc690" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_892ac4a4-e3f8-4137-8b49-839d05e53f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d74136c9-ffab-4769-928b-171adc30ba7f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_892ac4a4-e3f8-4137-8b49-839d05e53f2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_657b0f7a-2477-42d5-9633-33dd176b7261" xlink:href="iclr-20241231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d74136c9-ffab-4769-928b-171adc30ba7f" xlink:to="loc_iclr_PerformanceShareUnitMember_657b0f7a-2477-42d5-9633-33dd176b7261" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramAxis_50b6bb62-f56a-4229-b648-ff9f9f2a42e5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_082a6e61-7651-44ee-bc21-f935db50a8e7" xlink:to="loc_srt_ShareRepurchaseProgramAxis_50b6bb62-f56a-4229-b648-ff9f9f2a42e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramDomain_50b6bb62-f56a-4229-b648-ff9f9f2a42e5_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ShareRepurchaseProgramAxis_50b6bb62-f56a-4229-b648-ff9f9f2a42e5" xlink:to="loc_srt_ShareRepurchaseProgramDomain_50b6bb62-f56a-4229-b648-ff9f9f2a42e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramDomain_7d2aa806-c636-4a89-a052-975f517d3039" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ShareRepurchaseProgramAxis_50b6bb62-f56a-4229-b648-ff9f9f2a42e5" xlink:to="loc_srt_ShareRepurchaseProgramDomain_7d2aa806-c636-4a89-a052-975f517d3039" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BuybackProgramMember_24054145-32d8-43e2-a302-b657bb60029b" xlink:href="iclr-20241231.xsd#iclr_BuybackProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ShareRepurchaseProgramDomain_7d2aa806-c636-4a89-a052-975f517d3039" xlink:to="loc_iclr_BuybackProgramMember_24054145-32d8-43e2-a302-b657bb60029b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_February2024Member_7e47ce21-36d2-47f8-b22f-437efc8bdf48" xlink:href="iclr-20241231.xsd#iclr_February2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ShareRepurchaseProgramDomain_7d2aa806-c636-4a89-a052-975f517d3039" xlink:to="loc_iclr_February2024Member_7e47ce21-36d2-47f8-b22f-437efc8bdf48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_October2024Member_933c7b17-099d-40b7-9dd8-fc27e9ed5cd3" xlink:href="iclr-20241231.xsd#iclr_October2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ShareRepurchaseProgramDomain_7d2aa806-c636-4a89-a052-975f517d3039" xlink:to="loc_iclr_October2024Member_933c7b17-099d-40b7-9dd8-fc27e9ed5cd3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5bb0af7e-20fe-4469-ae2f-b374e5d924ed" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_082a6e61-7651-44ee-bc21-f935db50a8e7" xlink:to="loc_srt_RangeAxis_5bb0af7e-20fe-4469-ae2f-b374e5d924ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5bb0af7e-20fe-4469-ae2f-b374e5d924ed_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5bb0af7e-20fe-4469-ae2f-b374e5d924ed" xlink:to="loc_srt_RangeMember_5bb0af7e-20fe-4469-ae2f-b374e5d924ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ba41b06c-51f4-4ac2-9fb0-d6a45aea9645" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5bb0af7e-20fe-4469-ae2f-b374e5d924ed" xlink:to="loc_srt_RangeMember_ba41b06c-51f4-4ac2-9fb0-d6a45aea9645" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3d70ebbe-2af6-4828-9ce0-e43e1333de03" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ba41b06c-51f4-4ac2-9fb0-d6a45aea9645" xlink:to="loc_srt_MaximumMember_3d70ebbe-2af6-4828-9ce0-e43e1333de03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfVotes_c38b0e67-7ca3-4353-93eb-17fff89a7882" xlink:href="iclr-20241231.xsd#iclr_NumberOfVotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:to="loc_iclr_NumberOfVotes_c38b0e67-7ca3-4353-93eb-17fff89a7882" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e3257c3f-e54a-4880-8916-a6dc70560e87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e3257c3f-e54a-4880-8916-a6dc70560e87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_8de88dbf-d642-49bc-843e-ffca49e72d95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_8de88dbf-d642-49bc-843e-ffca49e72d95" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_81844344-9fb4-45ff-a97e-bb311ad35f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_81844344-9fb4-45ff-a97e-bb311ad35f2d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_83b296d4-a151-4d93-8e49-fefac1aa4973" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_83b296d4-a151-4d93-8e49-fefac1aa4973" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_46ec0ba9-68ef-4aa5-ac0c-837f0aaa3f54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_46ec0ba9-68ef-4aa5-ac0c-837f0aaa3f54" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockRepurchaseProgramAuthorizedPercentage_23079766-af56-4611-b48e-10fd09cf811d" xlink:href="iclr-20241231.xsd#iclr_StockRepurchaseProgramAuthorizedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:to="loc_iclr_StockRepurchaseProgramAuthorizedPercentage_23079766-af56-4611-b48e-10fd09cf811d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1_a138a5b2-dfb3-4371-be57-5c3697d54e87" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:to="loc_srt_StockRepurchaseProgramAuthorizedAmount1_a138a5b2-dfb3-4371-be57-5c3697d54e87" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_81bae575-5899-4e06-8026-39e051669454" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_81bae575-5899-4e06-8026-39e051669454" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_c2641b91-c25c-409f-b683-580a71895bad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_c2641b91-c25c-409f-b683-580a71895bad" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#RestructuringchargesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_f319174e-7b08-401d-a974-3307893392ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9318492f-c7aa-42a3-aaf8-c443608d5c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f319174e-7b08-401d-a974-3307893392ad" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9318492f-c7aa-42a3-aaf8-c443608d5c5b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_4a7d0ec2-17df-494a-8c5a-d55d1c1e8a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9318492f-c7aa-42a3-aaf8-c443608d5c5b" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_4a7d0ec2-17df-494a-8c5a-d55d1c1e8a1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_4a7d0ec2-17df-494a-8c5a-d55d1c1e8a1f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_4a7d0ec2-17df-494a-8c5a-d55d1c1e8a1f" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_4a7d0ec2-17df-494a-8c5a-d55d1c1e8a1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_8714f8e7-542f-45c7-b5e5-66fc55bfa800" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_4a7d0ec2-17df-494a-8c5a-d55d1c1e8a1f" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_8714f8e7-542f-45c7-b5e5-66fc55bfa800" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_WorkforceReductionAndOfficeConsolidationProgramMember_022291e2-9df3-4455-8ac1-715f9ac18150" xlink:href="iclr-20241231.xsd#iclr_WorkforceReductionAndOfficeConsolidationProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_8714f8e7-542f-45c7-b5e5-66fc55bfa800" xlink:to="loc_iclr_WorkforceReductionAndOfficeConsolidationProgramMember_022291e2-9df3-4455-8ac1-715f9ac18150" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PersonnelRelatedLiabilitiesMember_b4c55cde-e10b-460e-98f4-5fc0984476a5" xlink:href="iclr-20241231.xsd#iclr_PersonnelRelatedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_8714f8e7-542f-45c7-b5e5-66fc55bfa800" xlink:to="loc_iclr_PersonnelRelatedLiabilitiesMember_b4c55cde-e10b-460e-98f4-5fc0984476a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_FacilityLiabilityMember_3f8d69d2-234a-42e8-9ac4-f00c9dc6599d" xlink:href="iclr-20241231.xsd#iclr_FacilityLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_8714f8e7-542f-45c7-b5e5-66fc55bfa800" xlink:to="loc_iclr_FacilityLiabilityMember_3f8d69d2-234a-42e8-9ac4-f00c9dc6599d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_3a1a5439-0c73-4759-93b9-6508b02a9184" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f319174e-7b08-401d-a974-3307893392ad" xlink:to="loc_us-gaap_RestructuringCosts_3a1a5439-0c73-4759-93b9-6508b02a9184" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_6832efed-4ba1-44dd-96ef-226d39ec7eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f319174e-7b08-401d-a974-3307893392ad" xlink:to="loc_us-gaap_SeveranceCosts1_6832efed-4ba1-44dd-96ef-226d39ec7eb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_8188db1f-c93e-42ad-8079-25113eac9ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f319174e-7b08-401d-a974-3307893392ad" xlink:to="loc_us-gaap_OtherRestructuringCosts_8188db1f-c93e-42ad-8079-25113eac9ba8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment_f3a2b82f-8c38-4333-966c-d5c4ef094f43" xlink:href="iclr-20241231.xsd#iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f319174e-7b08-401d-a974-3307893392ad" xlink:to="loc_iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment_f3a2b82f-8c38-4333-966c-d5c4ef094f43" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_1e37c110-aef1-462a-a85d-a4a3b8907699" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f319174e-7b08-401d-a974-3307893392ad" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_1e37c110-aef1-462a-a85d-a4a3b8907699" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_4264959c-a397-47a6-9f54-efae27b4f50b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f319174e-7b08-401d-a974-3307893392ad" xlink:to="loc_us-gaap_RestructuringReserve_4264959c-a397-47a6-9f54-efae27b4f50b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_a3c0a3bb-3562-4bb2-84b0-23c9a71177f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f319174e-7b08-401d-a974-3307893392ad" xlink:to="loc_us-gaap_RestructuringReserveCurrent_a3c0a3bb-3562-4bb2-84b0-23c9a71177f4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_6600e80e-ef33-4704-a41e-56a48afaac78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f319174e-7b08-401d-a974-3307893392ad" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_6600e80e-ef33-4704-a41e-56a48afaac78" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_f749875e-2747-4fab-b954-fb4c1e486723" xlink:href="iclr-20241231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_715dff7d-fdc8-4c71-bf74-8d9d215cbc72" xlink:href="iclr-20241231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_f749875e-2747-4fab-b954-fb4c1e486723" xlink:to="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_715dff7d-fdc8-4c71-bf74-8d9d215cbc72" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_63bd0ffc-af76-4597-9335-6b22ebc31b33" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_715dff7d-fdc8-4c71-bf74-8d9d215cbc72" xlink:to="loc_srt_StatementGeographicalAxis_63bd0ffc-af76-4597-9335-6b22ebc31b33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_63bd0ffc-af76-4597-9335-6b22ebc31b33_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_63bd0ffc-af76-4597-9335-6b22ebc31b33" xlink:to="loc_srt_SegmentGeographicalDomain_63bd0ffc-af76-4597-9335-6b22ebc31b33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_098624a4-4eda-4895-be6d-dae7c7ad220a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_63bd0ffc-af76-4597-9335-6b22ebc31b33" xlink:to="loc_srt_SegmentGeographicalDomain_098624a4-4eda-4895-be6d-dae7c7ad220a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_bd4af815-1af0-404b-91d5-fd83edce335c" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_098624a4-4eda-4895-be6d-dae7c7ad220a" xlink:to="loc_country_IE_bd4af815-1af0-404b-91d5-fd83edce335c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_c9fc9cce-ba6c-470e-9922-955d97c9c6ea" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_098624a4-4eda-4895-be6d-dae7c7ad220a" xlink:to="loc_country_US_c9fc9cce-ba6c-470e-9922-955d97c9c6ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeAndOtherCountriesMember_02834b80-66f3-4f40-9252-904605da0dc4" xlink:href="iclr-20241231.xsd#iclr_RestOfEuropeAndOtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_098624a4-4eda-4895-be6d-dae7c7ad220a" xlink:to="loc_iclr_RestOfEuropeAndOtherCountriesMember_02834b80-66f3-4f40-9252-904605da0dc4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_46dce1d7-97f4-4847-8550-e7bf95b888d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_f749875e-2747-4fab-b954-fb4c1e486723" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_46dce1d7-97f4-4847-8550-e7bf95b888d2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_b6880684-39c0-4fdd-893d-a909105baf1e" xlink:href="iclr-20241231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_5adb1516-e14a-478a-b4a6-7e2af00face7" xlink:href="iclr-20241231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_b6880684-39c0-4fdd-893d-a909105baf1e" xlink:to="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_5adb1516-e14a-478a-b4a6-7e2af00face7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d1420c4d-28a5-491c-9413-cd5138defb7a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_5adb1516-e14a-478a-b4a6-7e2af00face7" xlink:to="loc_srt_StatementGeographicalAxis_d1420c4d-28a5-491c-9413-cd5138defb7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d1420c4d-28a5-491c-9413-cd5138defb7a_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_d1420c4d-28a5-491c-9413-cd5138defb7a" xlink:to="loc_srt_SegmentGeographicalDomain_d1420c4d-28a5-491c-9413-cd5138defb7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4eaf3cf5-34f0-4284-ae40-529569c8f508" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_d1420c4d-28a5-491c-9413-cd5138defb7a" xlink:to="loc_srt_SegmentGeographicalDomain_4eaf3cf5-34f0-4284-ae40-529569c8f508" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_60e886a4-d17a-4ab3-98f1-6644937a47b0" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4eaf3cf5-34f0-4284-ae40-529569c8f508" xlink:to="loc_country_IE_60e886a4-d17a-4ab3-98f1-6644937a47b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e016d53d-df9d-4796-b2b1-749c1aeeb7fb" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4eaf3cf5-34f0-4284-ae40-529569c8f508" xlink:to="loc_country_US_e016d53d-df9d-4796-b2b1-749c1aeeb7fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeAndOtherCountriesMember_86d26cf6-8839-4dc7-92db-1cf3f7eedbd1" xlink:href="iclr-20241231.xsd#iclr_RestOfEuropeAndOtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4eaf3cf5-34f0-4284-ae40-529569c8f508" xlink:to="loc_iclr_RestOfEuropeAndOtherCountriesMember_86d26cf6-8839-4dc7-92db-1cf3f7eedbd1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_951345b3-274a-48d1-a09b-01215b9da2bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_b6880684-39c0-4fdd-893d-a909105baf1e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_951345b3-274a-48d1-a09b-01215b9da2bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7057bd85-3464-456f-b71e-350fb3a1c1a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_951345b3-274a-48d1-a09b-01215b9da2bf" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7057bd85-3464-456f-b71e-350fb3a1c1a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b5c3368a-a8ef-4c44-b0c0-089bce793c93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7057bd85-3464-456f-b71e-350fb3a1c1a3" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b5c3368a-a8ef-4c44-b0c0-089bce793c93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_69575b1f-0c22-4b10-8dae-baaa53acde3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_951345b3-274a-48d1-a09b-01215b9da2bf" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_69575b1f-0c22-4b10-8dae-baaa53acde3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_77220b73-9d22-45a8-a22c-ff43ad8c4bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_69575b1f-0c22-4b10-8dae-baaa53acde3f" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_77220b73-9d22-45a8-a22c-ff43ad8c4bd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_73bb3b22-422e-4297-ae0e-63d3aecb4a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_951345b3-274a-48d1-a09b-01215b9da2bf" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_73bb3b22-422e-4297-ae0e-63d3aecb4a7f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_783ca866-1f2e-418c-9a18-2c430a703cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_b6880684-39c0-4fdd-893d-a909105baf1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_783ca866-1f2e-418c-9a18-2c430a703cb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_d2b3b965-0919-46d2-9945-4a27060b02c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_783ca866-1f2e-418c-9a18-2c430a703cb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_d2b3b965-0919-46d2-9945-4a27060b02c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_69172d6f-d6ce-4441-bb9d-be72458da3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_783ca866-1f2e-418c-9a18-2c430a703cb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_69172d6f-d6ce-4441-bb9d-be72458da3d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_4dd11399-758e-4511-a368-737acc164d77" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_783ca866-1f2e-418c-9a18-2c430a703cb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_4dd11399-758e-4511-a368-737acc164d77" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_bc53badf-1d3c-4096-bbd9-3641c1a9a97b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_b6880684-39c0-4fdd-893d-a909105baf1e" xlink:to="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_bc53badf-1d3c-4096-bbd9-3641c1a9a97b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_115a5e36-ef01-4db8-8c6e-885a6680271c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_115a5e36-ef01-4db8-8c6e-885a6680271c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d9eeac92-c226-4db4-bcfa-8a6e67776c71" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_115a5e36-ef01-4db8-8c6e-885a6680271c" xlink:to="loc_srt_StatementGeographicalAxis_d9eeac92-c226-4db4-bcfa-8a6e67776c71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d9eeac92-c226-4db4-bcfa-8a6e67776c71_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_d9eeac92-c226-4db4-bcfa-8a6e67776c71" xlink:to="loc_srt_SegmentGeographicalDomain_d9eeac92-c226-4db4-bcfa-8a6e67776c71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f1b34b2e-978c-4be2-8e4d-6e30c12cf73c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_d9eeac92-c226-4db4-bcfa-8a6e67776c71" xlink:to="loc_srt_SegmentGeographicalDomain_f1b34b2e-978c-4be2-8e4d-6e30c12cf73c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_2b316a14-6eb4-44b3-bfdf-d3a7aab3b08f" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f1b34b2e-978c-4be2-8e4d-6e30c12cf73c" xlink:to="loc_country_IE_2b316a14-6eb4-44b3-bfdf-d3a7aab3b08f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_4aa3ae0a-cc7b-4721-84ad-dca2a998a291" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f1b34b2e-978c-4be2-8e4d-6e30c12cf73c" xlink:to="loc_country_US_4aa3ae0a-cc7b-4721-84ad-dca2a998a291" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_7bbdf9fc-c575-4b4a-96a0-ca188f0d7cdc" xlink:href="iclr-20241231.xsd#iclr_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f1b34b2e-978c-4be2-8e4d-6e30c12cf73c" xlink:to="loc_iclr_OtherCountriesMember_7bbdf9fc-c575-4b4a-96a0-ca188f0d7cdc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_54c5cdb9-77bf-4aa3-b2c0-4a00f4bbdb0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_115a5e36-ef01-4db8-8c6e-885a6680271c" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_54c5cdb9-77bf-4aa3-b2c0-4a00f4bbdb0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_54c5cdb9-77bf-4aa3-b2c0-4a00f4bbdb0e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_54c5cdb9-77bf-4aa3-b2c0-4a00f4bbdb0e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_54c5cdb9-77bf-4aa3-b2c0-4a00f4bbdb0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_88df4e29-f62d-4ad4-8ab3-ccffc9949615" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_54c5cdb9-77bf-4aa3-b2c0-4a00f4bbdb0e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_88df4e29-f62d-4ad4-8ab3-ccffc9949615" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_dd73ab40-10f4-4d38-b7e9-211ba344509c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_88df4e29-f62d-4ad4-8ab3-ccffc9949615" xlink:to="loc_us-gaap_ForeignCountryMember_dd73ab40-10f4-4d38-b7e9-211ba344509c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_7c197321-a95d-4344-aa4c-35ced77201f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_88df4e29-f62d-4ad4-8ab3-ccffc9949615" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_7c197321-a95d-4344-aa4c-35ced77201f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_08d24b30-9aff-4609-ab1d-cea140ee66f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_115a5e36-ef01-4db8-8c6e-885a6680271c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_08d24b30-9aff-4609-ab1d-cea140ee66f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_08d24b30-9aff-4609-ab1d-cea140ee66f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_08d24b30-9aff-4609-ab1d-cea140ee66f9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_08d24b30-9aff-4609-ab1d-cea140ee66f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_5d31e027-86fb-478a-bb01-05c8440b4ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_08d24b30-9aff-4609-ab1d-cea140ee66f9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_5d31e027-86fb-478a-bb01-05c8440b4ad3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeMember_fe698d57-e899-4e75-8e9b-1a27d69165fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_5d31e027-86fb-478a-bb01-05c8440b4ad3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeMember_fe698d57-e899-4e75-8e9b-1a27d69165fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0a3ae8e7-46f1-4083-a6be-91c446d248de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_115a5e36-ef01-4db8-8c6e-885a6680271c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0a3ae8e7-46f1-4083-a6be-91c446d248de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0a3ae8e7-46f1-4083-a6be-91c446d248de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0a3ae8e7-46f1-4083-a6be-91c446d248de" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0a3ae8e7-46f1-4083-a6be-91c446d248de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_57738f73-1967-4083-a7fe-095161f7e9f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0a3ae8e7-46f1-4083-a6be-91c446d248de" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_57738f73-1967-4083-a7fe-095161f7e9f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeTaxBenefitMember_4b9f24a5-9884-4dd6-949b-a381a9b19134" xlink:href="iclr-20241231.xsd#iclr_IncomeTaxBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_57738f73-1967-4083-a7fe-095161f7e9f9" xlink:to="loc_iclr_IncomeTaxBenefitMember_4b9f24a5-9884-4dd6-949b-a381a9b19134" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxOfBusinessAcquiredMember_24b57a10-b81a-464d-b712-d49e44a205c5" xlink:href="iclr-20241231.xsd#iclr_TaxOfBusinessAcquiredMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_57738f73-1967-4083-a7fe-095161f7e9f9" xlink:to="loc_iclr_TaxOfBusinessAcquiredMember_24b57a10-b81a-464d-b712-d49e44a205c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_62c5d592-f0dd-431a-9d82-518cf5112359" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_115a5e36-ef01-4db8-8c6e-885a6680271c" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_62c5d592-f0dd-431a-9d82-518cf5112359" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_62c5d592-f0dd-431a-9d82-518cf5112359_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_62c5d592-f0dd-431a-9d82-518cf5112359" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_62c5d592-f0dd-431a-9d82-518cf5112359_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_e81f8576-f6ce-40f9-9aec-6ea5e474e4bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_62c5d592-f0dd-431a-9d82-518cf5112359" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_e81f8576-f6ce-40f9-9aec-6ea5e474e4bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_da26e55b-f4d0-4651-810b-54c4c1bf3562" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_e81f8576-f6ce-40f9-9aec-6ea5e474e4bc" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_da26e55b-f4d0-4651-810b-54c4c1bf3562" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_c04729b3-af3d-4e99-8b53-96b17830286f" xlink:href="iclr-20241231.xsd#iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_c04729b3-af3d-4e99-8b53-96b17830286f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_2d960d56-f302-427b-ab70-0e51ec1abf01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_2d960d56-f302-427b-ab70-0e51ec1abf01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_d83cd2ad-2219-41bb-b3b5-14bd0807e7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_d83cd2ad-2219-41bb-b3b5-14bd0807e7f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxCreditCarryForwardIncreaseDecreaseAmount_87863711-4e2d-4ede-a3e3-6b5cbe31ca62" xlink:href="iclr-20241231.xsd#iclr_TaxCreditCarryForwardIncreaseDecreaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_iclr_TaxCreditCarryForwardIncreaseDecreaseAmount_87863711-4e2d-4ede-a3e3-6b5cbe31ca62" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_5b0301ff-3d33-4653-a39d-5709927b3d71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_5b0301ff-3d33-4653-a39d-5709927b3d71" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_7f29566f-f3f6-46d8-85f9-9332fe3d0bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_7f29566f-f3f6-46d8-85f9-9332fe3d0bf3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxCreditCarryForwardExpirationPeriod_766fea31-39d9-48a3-98f4-e0880081f829" xlink:href="iclr-20241231.xsd#iclr_TaxCreditCarryForwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_iclr_TaxCreditCarryForwardExpirationPeriod_766fea31-39d9-48a3-98f4-e0880081f829" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7718debe-3a16-4202-9fed-0c38bcfc42aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7718debe-3a16-4202-9fed-0c38bcfc42aa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_85858091-4e00-4ea2-9832-a4c7352be654" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_85858091-4e00-4ea2-9832-a4c7352be654" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_a8e0cdec-30d4-4fc5-aec8-4709960f45e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_a8e0cdec-30d4-4fc5-aec8-4709960f45e0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_942cb11b-ff83-495e-a996-a0979aed7e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_942cb11b-ff83-495e-a996-a0979aed7e2b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_db8192d2-bdd2-422e-b09f-108c3f402bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_db8192d2-bdd2-422e-b09f-108c3f402bdb" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_11fd069e-6e9d-4c06-afdf-935793f2b64c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_11fd069e-6e9d-4c06-afdf-935793f2b64c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_6ab14a61-9192-45a0-be82-216a4caa51f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_6ab14a61-9192-45a0-be82-216a4caa51f7" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#IncomeTaxesExpectedExpiryDatesofNOLsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_381ed4c2-1c55-4356-992b-2427e5ae5904" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_76c09773-bf64-4996-932b-80059aa6646d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_381ed4c2-1c55-4356-992b-2427e5ae5904" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_76c09773-bf64-4996-932b-80059aa6646d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_72b2124f-876b-4334-8f39-ceb91c3bc4b8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_76c09773-bf64-4996-932b-80059aa6646d" xlink:to="loc_srt_StatementGeographicalAxis_72b2124f-876b-4334-8f39-ceb91c3bc4b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_72b2124f-876b-4334-8f39-ceb91c3bc4b8_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_72b2124f-876b-4334-8f39-ceb91c3bc4b8" xlink:to="loc_srt_SegmentGeographicalDomain_72b2124f-876b-4334-8f39-ceb91c3bc4b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1510de63-5c86-46f8-a16e-105548c91945" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_72b2124f-876b-4334-8f39-ceb91c3bc4b8" xlink:to="loc_srt_SegmentGeographicalDomain_1510de63-5c86-46f8-a16e-105548c91945" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_c7f27f15-aa0e-4aab-9b6f-5136ef7bed0d" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1510de63-5c86-46f8-a16e-105548c91945" xlink:to="loc_country_US_c7f27f15-aa0e-4aab-9b6f-5136ef7bed0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_39489fe5-5a01-49fe-abe5-8d9d3bee6aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_76c09773-bf64-4996-932b-80059aa6646d" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_39489fe5-5a01-49fe-abe5-8d9d3bee6aa5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_39489fe5-5a01-49fe-abe5-8d9d3bee6aa5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_39489fe5-5a01-49fe-abe5-8d9d3bee6aa5" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_39489fe5-5a01-49fe-abe5-8d9d3bee6aa5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_b3a224e4-f189-4a33-b9ce-badeceeedcdb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_39489fe5-5a01-49fe-abe5-8d9d3bee6aa5" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_b3a224e4-f189-4a33-b9ce-badeceeedcdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_50626858-a155-46c1-bbbf-bc53952821e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_b3a224e4-f189-4a33-b9ce-badeceeedcdb" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_50626858-a155-46c1-bbbf-bc53952821e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_08786c55-4203-45e2-8fd1-4fc398beab65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_76c09773-bf64-4996-932b-80059aa6646d" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_08786c55-4203-45e2-8fd1-4fc398beab65" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_08786c55-4203-45e2-8fd1-4fc398beab65_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_08786c55-4203-45e2-8fd1-4fc398beab65" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_08786c55-4203-45e2-8fd1-4fc398beab65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_00899fbe-6e8c-48ab-b613-860e4aae8032" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_08786c55-4203-45e2-8fd1-4fc398beab65" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_00899fbe-6e8c-48ab-b613-860e4aae8032" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_67b8ecab-9d23-4379-bb32-d74b7b0b56d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_00899fbe-6e8c-48ab-b613-860e4aae8032" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_67b8ecab-9d23-4379-bb32-d74b7b0b56d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_e72c5769-bc17-49e6-91ee-4d4a4553b16c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_76c09773-bf64-4996-932b-80059aa6646d" xlink:to="loc_us-gaap_TaxPeriodAxis_e72c5769-bc17-49e6-91ee-4d4a4553b16c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_e72c5769-bc17-49e6-91ee-4d4a4553b16c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_e72c5769-bc17-49e6-91ee-4d4a4553b16c" xlink:to="loc_us-gaap_TaxPeriodDomain_e72c5769-bc17-49e6-91ee-4d4a4553b16c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_adc8afa3-9fe9-4404-a2db-ee9fa5ea1167" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_e72c5769-bc17-49e6-91ee-4d4a4553b16c" xlink:to="loc_us-gaap_TaxPeriodDomain_adc8afa3-9fe9-4404-a2db-ee9fa5ea1167" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2025To2038Member_dbdc0d9e-210b-4c40-b9a6-a7f39b8f7959" xlink:href="iclr-20241231.xsd#iclr_TaxYear2025To2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_adc8afa3-9fe9-4404-a2db-ee9fa5ea1167" xlink:to="loc_iclr_TaxYear2025To2038Member_dbdc0d9e-210b-4c40-b9a6-a7f39b8f7959" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear20392043Member_762363d7-61b9-4a37-b339-3ff869587974" xlink:href="iclr-20241231.xsd#iclr_TaxYear20392043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_adc8afa3-9fe9-4404-a2db-ee9fa5ea1167" xlink:to="loc_iclr_TaxYear20392043Member_762363d7-61b9-4a37-b339-3ff869587974" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_18ee5ba6-0ca4-47d9-8eb1-86bbb9bdf441" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_381ed4c2-1c55-4356-992b-2427e5ae5904" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_18ee5ba6-0ca4-47d9-8eb1-86bbb9bdf441" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_b3ecc409-0d8a-498e-91dc-565192df5de6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_381ed4c2-1c55-4356-992b-2427e5ae5904" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_b3ecc409-0d8a-498e-91dc-565192df5de6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1d2b7034-ce13-4f6f-ab95-00b8a98ba7c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_381ed4c2-1c55-4356-992b-2427e5ae5904" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1d2b7034-ce13-4f6f-ab95-00b8a98ba7c0" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:href="iclr-20241231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_9e98ae29-7e8e-437e-89b0-56f174661a86" xlink:href="iclr-20241231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_9e98ae29-7e8e-437e-89b0-56f174661a86" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9a600aec-928d-470f-8d6c-4c566e1b2fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_9e98ae29-7e8e-437e-89b0-56f174661a86" xlink:to="loc_us-gaap_AwardTypeAxis_9a600aec-928d-470f-8d6c-4c566e1b2fd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a600aec-928d-470f-8d6c-4c566e1b2fd8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9a600aec-928d-470f-8d6c-4c566e1b2fd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a600aec-928d-470f-8d6c-4c566e1b2fd8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67f3a34f-eb1c-43f5-8017-d5ca7bf25587" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9a600aec-928d-470f-8d6c-4c566e1b2fd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67f3a34f-eb1c-43f5-8017-d5ca7bf25587" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsStockPlan2008PlanMember_a2e1453e-25a7-4e23-9583-5cbacee21938" xlink:href="iclr-20241231.xsd#iclr_ConsultantsStockPlan2008PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67f3a34f-eb1c-43f5-8017-d5ca7bf25587" xlink:to="loc_iclr_ConsultantsStockPlan2008PlanMember_a2e1453e-25a7-4e23-9583-5cbacee21938" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_26dd4930-37ef-4a8d-bd69-25ce8e1220da" xlink:href="iclr-20241231.xsd#iclr_EmployeeStockPlanTwentyZeroEightPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67f3a34f-eb1c-43f5-8017-d5ca7bf25587" xlink:to="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_26dd4930-37ef-4a8d-bd69-25ce8e1220da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OptionPlans2008Member_5873529b-eb4e-4e5c-b092-b9bd0c309f62" xlink:href="iclr-20241231.xsd#iclr_OptionPlans2008Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67f3a34f-eb1c-43f5-8017-d5ca7bf25587" xlink:to="loc_iclr_OptionPlans2008Member_5873529b-eb4e-4e5c-b092-b9bd0c309f62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_8e8ac3c3-7e0a-4fdd-b25d-47ff1758a344" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67f3a34f-eb1c-43f5-8017-d5ca7bf25587" xlink:to="loc_us-gaap_EmployeeStockOptionMember_8e8ac3c3-7e0a-4fdd-b25d-47ff1758a344" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestrictedStockUnitsTwentyThirteenMember_11aee2b6-fd15-4c52-affd-e0c0aa088a5b" xlink:href="iclr-20241231.xsd#iclr_RestrictedStockUnitsTwentyThirteenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67f3a34f-eb1c-43f5-8017-d5ca7bf25587" xlink:to="loc_iclr_RestrictedStockUnitsTwentyThirteenMember_11aee2b6-fd15-4c52-affd-e0c0aa088a5b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_e08c2816-7e2f-4c79-bdc3-9379ed27b472" xlink:href="iclr-20241231.xsd#iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67f3a34f-eb1c-43f5-8017-d5ca7bf25587" xlink:to="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_e08c2816-7e2f-4c79-bdc3-9379ed27b472" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e1318f12-350b-4fe7-90f9-f69a4bc5e92b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67f3a34f-eb1c-43f5-8017-d5ca7bf25587" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e1318f12-350b-4fe7-90f9-f69a4bc5e92b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_7c5a0aa0-3799-4e6a-9ab8-5eede1696792" xlink:href="iclr-20241231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67f3a34f-eb1c-43f5-8017-d5ca7bf25587" xlink:to="loc_iclr_PerformanceShareUnitMember_7c5a0aa0-3799-4e6a-9ab8-5eede1696792" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceBasedGrantsMember_c8774271-1aaa-465f-b2e2-2a57b3e0582c" xlink:href="iclr-20241231.xsd#iclr_PerformanceBasedGrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67f3a34f-eb1c-43f5-8017-d5ca7bf25587" xlink:to="loc_iclr_PerformanceBasedGrantsMember_c8774271-1aaa-465f-b2e2-2a57b3e0582c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_60bb47a4-3749-475b-8a40-ac3a56dd721b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_9e98ae29-7e8e-437e-89b0-56f174661a86" xlink:to="loc_us-gaap_AwardDateAxis_60bb47a4-3749-475b-8a40-ac3a56dd721b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_60bb47a4-3749-475b-8a40-ac3a56dd721b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardDateAxis_60bb47a4-3749-475b-8a40-ac3a56dd721b" xlink:to="loc_us-gaap_AwardDateDomain_60bb47a4-3749-475b-8a40-ac3a56dd721b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_2748e620-94e3-4d61-968d-d3d1caf56c05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardDateAxis_60bb47a4-3749-475b-8a40-ac3a56dd721b" xlink:to="loc_us-gaap_AwardDateDomain_2748e620-94e3-4d61-968d-d3d1caf56c05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AwardDateAllYearsExcluding2018Member_7b2b82e1-7c3b-4b7a-a715-4a5a8cc28922" xlink:href="iclr-20241231.xsd#iclr_AwardDateAllYearsExcluding2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_2748e620-94e3-4d61-968d-d3d1caf56c05" xlink:to="loc_iclr_AwardDateAllYearsExcluding2018Member_7b2b82e1-7c3b-4b7a-a715-4a5a8cc28922" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3662af9d-86f4-4c04-a7c8-54761959c660" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_9e98ae29-7e8e-437e-89b0-56f174661a86" xlink:to="loc_srt_RangeAxis_3662af9d-86f4-4c04-a7c8-54761959c660" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3662af9d-86f4-4c04-a7c8-54761959c660_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3662af9d-86f4-4c04-a7c8-54761959c660" xlink:to="loc_srt_RangeMember_3662af9d-86f4-4c04-a7c8-54761959c660_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c27d77ec-9b9c-4672-afe4-b16081c61c95" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3662af9d-86f4-4c04-a7c8-54761959c660" xlink:to="loc_srt_RangeMember_c27d77ec-9b9c-4672-afe4-b16081c61c95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_91fc57fc-f586-4419-8470-4180f9be54d2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c27d77ec-9b9c-4672-afe4-b16081c61c95" xlink:to="loc_srt_MinimumMember_91fc57fc-f586-4419-8470-4180f9be54d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a7749c83-d44f-4e1c-b0f5-dbacee68dc64" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c27d77ec-9b9c-4672-afe4-b16081c61c95" xlink:to="loc_srt_MaximumMember_a7749c83-d44f-4e1c-b0f5-dbacee68dc64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_38c565ed-0bd9-4f17-a7a2-28f18c47ae3d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_9e98ae29-7e8e-437e-89b0-56f174661a86" xlink:to="loc_us-gaap_PlanNameAxis_38c565ed-0bd9-4f17-a7a2-28f18c47ae3d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_38c565ed-0bd9-4f17-a7a2-28f18c47ae3d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_38c565ed-0bd9-4f17-a7a2-28f18c47ae3d" xlink:to="loc_us-gaap_PlanNameDomain_38c565ed-0bd9-4f17-a7a2-28f18c47ae3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_30f55a18-2156-4c44-8f4a-db761587eb95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_38c565ed-0bd9-4f17-a7a2-28f18c47ae3d" xlink:to="loc_us-gaap_PlanNameDomain_30f55a18-2156-4c44-8f4a-db761587eb95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2020LegacyPRAPlanMember_b5cff786-e8a9-4fa9-980d-582c9d9d10d4" xlink:href="iclr-20241231.xsd#iclr_The2020LegacyPRAPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_30f55a18-2156-4c44-8f4a-db761587eb95" xlink:to="loc_iclr_The2020LegacyPRAPlanMember_b5cff786-e8a9-4fa9-980d-582c9d9d10d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2018LegacyPRAPlanMember_b5ed21fb-306c-4b37-9871-32b7f2ac80d7" xlink:href="iclr-20241231.xsd#iclr_The2018LegacyPRAPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_30f55a18-2156-4c44-8f4a-db761587eb95" xlink:to="loc_iclr_The2018LegacyPRAPlanMember_b5ed21fb-306c-4b37-9871-32b7f2ac80d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_22c50c33-c21d-4e0f-b778-cd6b6e2303f0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_9e98ae29-7e8e-437e-89b0-56f174661a86" xlink:to="loc_srt_TitleOfIndividualAxis_22c50c33-c21d-4e0f-b778-cd6b6e2303f0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_22c50c33-c21d-4e0f-b778-cd6b6e2303f0_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_22c50c33-c21d-4e0f-b778-cd6b6e2303f0" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_22c50c33-c21d-4e0f-b778-cd6b6e2303f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a54792cf-40ff-49e1-be11-86d822f9ab60" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_22c50c33-c21d-4e0f-b778-cd6b6e2303f0" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a54792cf-40ff-49e1-be11-86d822f9ab60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NonexecutiveDirectorMember_0b0c95e5-0813-402c-866c-9020195337d5" xlink:href="iclr-20241231.xsd#iclr_NonexecutiveDirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a54792cf-40ff-49e1-be11-86d822f9ab60" xlink:to="loc_iclr_NonexecutiveDirectorMember_0b0c95e5-0813-402c-866c-9020195337d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_6e1c6a72-2d6d-41c2-8ec6-b9433c23b8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_6e1c6a72-2d6d-41c2-8ec6-b9433c23b8ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_1287f74f-cb60-4ce3-95a5-b4329de1574e" xlink:href="iclr-20241231.xsd#iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_1287f74f-cb60-4ce3-95a5-b4329de1574e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_5d0db95f-847e-4868-b076-7f2eaf342fec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_5d0db95f-847e-4868-b076-7f2eaf342fec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_afe50aaf-dba0-459a-88c2-7a4664c90bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_afe50aaf-dba0-459a-88c2-7a4664c90bf1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8f347ad3-fad4-4d7b-95bc-08ff7abdef2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8f347ad3-fad4-4d7b-95bc-08ff7abdef2c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_33415ed2-d67d-44cd-af2d-f805cab42ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_33415ed2-d67d-44cd-af2d-f805cab42ecc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0eb2cd86-847a-429b-b68d-9c04b32b721d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0eb2cd86-847a-429b-b68d-9c04b32b721d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_d2508081-e4ab-4328-9470-3137c974d5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_d2508081-e4ab-4328-9470-3137c974d5b3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_fae0bbac-ae56-4540-9e21-dd95579ca990" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_fae0bbac-ae56-4540-9e21-dd95579ca990" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_144b9962-9718-4f66-a084-006bbe79e0ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_144b9962-9718-4f66-a084-006bbe79e0ef" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_be0ee5db-8719-4719-bd53-11e7519c224e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_be0ee5db-8719-4719-bd53-11e7519c224e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_dc20d9ba-d55a-4061-a2aa-1d9b668b675c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_dc20d9ba-d55a-4061-a2aa-1d9b668b675c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_65dcfbb6-0114-468e-80c5-1515fa8bc475" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_65dcfbb6-0114-468e-80c5-1515fa8bc475" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_4e694372-5d0d-4013-9515-bc71ebd65741" xlink:href="iclr-20241231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_4e694372-5d0d-4013-9515-bc71ebd65741" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_326168de-e5fd-4186-ab1e-f88935e2f69c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_326168de-e5fd-4186-ab1e-f88935e2f69c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_cc2d6e88-7734-41ac-97be-b8b8c47198eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_ShareBasedCompensation_cc2d6e88-7734-41ac-97be-b8b8c47198eb" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4edbded7-30c5-467e-9e9c-03ed9f19bb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4edbded7-30c5-467e-9e9c-03ed9f19bb7f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_3a563630-1ba7-46eb-bd0f-fe8bb2a34ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_3a563630-1ba7-46eb-bd0f-fe8bb2a34ab1" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_127ee9f4-89dd-41b2-9d84-2a8328a81be0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_127ee9f4-89dd-41b2-9d84-2a8328a81be0" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_5047d56d-1e8c-4248-8e0e-8b8ce0e57e81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_5047d56d-1e8c-4248-8e0e-8b8ce0e57e81" xlink:type="arc" order="19"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71f57f2d-43c9-45cc-80cd-e50dde2c1d40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_88b462ee-9f72-4704-b7ce-45e3386dce3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71f57f2d-43c9-45cc-80cd-e50dde2c1d40" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_88b462ee-9f72-4704-b7ce-45e3386dce3c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e02abc22-2fe8-48a3-a1c4-8dbf2923d437" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_88b462ee-9f72-4704-b7ce-45e3386dce3c" xlink:to="loc_us-gaap_AwardTypeAxis_e02abc22-2fe8-48a3-a1c4-8dbf2923d437" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e02abc22-2fe8-48a3-a1c4-8dbf2923d437_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e02abc22-2fe8-48a3-a1c4-8dbf2923d437" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e02abc22-2fe8-48a3-a1c4-8dbf2923d437_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8cf4049b-1e1e-46ae-b137-08e32ca8e3b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e02abc22-2fe8-48a3-a1c4-8dbf2923d437" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8cf4049b-1e1e-46ae-b137-08e32ca8e3b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockOptionAndAwardPlansMember_9496e3ab-ba0c-493b-b8c6-f1b087f9f377" xlink:href="iclr-20241231.xsd#iclr_StockOptionAndAwardPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8cf4049b-1e1e-46ae-b137-08e32ca8e3b6" xlink:to="loc_iclr_StockOptionAndAwardPlansMember_9496e3ab-ba0c-493b-b8c6-f1b087f9f377" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6f46fd17-2f4d-4f38-8d84-5f39b89c21eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71f57f2d-43c9-45cc-80cd-e50dde2c1d40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6f46fd17-2f4d-4f38-8d84-5f39b89c21eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6c4ba641-75dc-4bfc-a863-f503bd8a3987" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6f46fd17-2f4d-4f38-8d84-5f39b89c21eb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6c4ba641-75dc-4bfc-a863-f503bd8a3987" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a99f26d3-f711-48b1-a9e8-3f1af12e5f04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6f46fd17-2f4d-4f38-8d84-5f39b89c21eb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a99f26d3-f711-48b1-a9e8-3f1af12e5f04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_dd053709-56da-4a02-be93-6342f5a5b32b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6f46fd17-2f4d-4f38-8d84-5f39b89c21eb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_dd053709-56da-4a02-be93-6342f5a5b32b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_0cb2600b-c43b-43f3-a27b-2e995677251c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6f46fd17-2f4d-4f38-8d84-5f39b89c21eb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_0cb2600b-c43b-43f3-a27b-2e995677251c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6de8277d-95f1-4e2a-a962-333e33f95762" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_243ca285-777f-4a56-9016-43aeb95f73ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71f57f2d-43c9-45cc-80cd-e50dde2c1d40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_243ca285-777f-4a56-9016-43aeb95f73ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_619e4c2f-8939-4c46-9b6f-28dfd2e3da21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71f57f2d-43c9-45cc-80cd-e50dde2c1d40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_619e4c2f-8939-4c46-9b6f-28dfd2e3da21" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_49f796e6-e269-4f3d-be44-82ffc71ae49a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_619e4c2f-8939-4c46-9b6f-28dfd2e3da21" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_49f796e6-e269-4f3d-be44-82ffc71ae49a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_90bb8ff7-48c4-47e3-9232-034a0a60dbee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_619e4c2f-8939-4c46-9b6f-28dfd2e3da21" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_90bb8ff7-48c4-47e3-9232-034a0a60dbee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a1a14c36-4b27-4d89-baee-db1db41e03f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_619e4c2f-8939-4c46-9b6f-28dfd2e3da21" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a1a14c36-4b27-4d89-baee-db1db41e03f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_e23291b3-491e-48e2-99bd-1c5a4b9fc1de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_619e4c2f-8939-4c46-9b6f-28dfd2e3da21" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_e23291b3-491e-48e2-99bd-1c5a4b9fc1de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9d7b169a-7f72-48e6-9514-60b51f1aafac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_d874015b-7e6f-44f8-9f50-26cda9ac6c91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71f57f2d-43c9-45cc-80cd-e50dde2c1d40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_d874015b-7e6f-44f8-9f50-26cda9ac6c91" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dacce0ac-69e2-4983-93cc-2508a7d84deb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_044aaabc-3936-490a-835d-bd022b9d5924" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dacce0ac-69e2-4983-93cc-2508a7d84deb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_044aaabc-3936-490a-835d-bd022b9d5924" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b1101c2b-d17e-431a-8927-b727bfae4d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_044aaabc-3936-490a-835d-bd022b9d5924" xlink:to="loc_us-gaap_AwardTypeAxis_b1101c2b-d17e-431a-8927-b727bfae4d0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b1101c2b-d17e-431a-8927-b727bfae4d0e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b1101c2b-d17e-431a-8927-b727bfae4d0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b1101c2b-d17e-431a-8927-b727bfae4d0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_44cf96a5-168d-4cf7-a5d6-e61c70ed6bec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b1101c2b-d17e-431a-8927-b727bfae4d0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_44cf96a5-168d-4cf7-a5d6-e61c70ed6bec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9017d326-5382-4f37-8395-689da8a0940a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_44cf96a5-168d-4cf7-a5d6-e61c70ed6bec" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9017d326-5382-4f37-8395-689da8a0940a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ab3051e7-0757-40a4-9127-853481a8d84c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dacce0ac-69e2-4983-93cc-2508a7d84deb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ab3051e7-0757-40a4-9127-853481a8d84c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_583dad55-5f3e-4258-af4a-b96069f5d60c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dacce0ac-69e2-4983-93cc-2508a7d84deb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_583dad55-5f3e-4258-af4a-b96069f5d60c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_36ff31ea-356c-4edb-af56-6a5eb2968e28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_583dad55-5f3e-4258-af4a-b96069f5d60c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_36ff31ea-356c-4edb-af56-6a5eb2968e28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f95b2921-0de3-4ec4-a65d-f16ee7f7db75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_583dad55-5f3e-4258-af4a-b96069f5d60c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f95b2921-0de3-4ec4-a65d-f16ee7f7db75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6d22f51c-a0d4-4ad7-a56d-7cd0ce034587" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_583dad55-5f3e-4258-af4a-b96069f5d60c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6d22f51c-a0d4-4ad7-a56d-7cd0ce034587" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_04f8b288-6b96-4242-91fd-bfcf3de4c935" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_583dad55-5f3e-4258-af4a-b96069f5d60c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_04f8b288-6b96-4242-91fd-bfcf3de4c935" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1671ab7f-b147-4a54-943d-d80a0ec5264a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e57b7a49-e77e-4e1d-a332-5dfa57a46508" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1671ab7f-b147-4a54-943d-d80a0ec5264a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e57b7a49-e77e-4e1d-a332-5dfa57a46508" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6857aae0-c08a-4850-98d8-2a928ff2afcd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e57b7a49-e77e-4e1d-a332-5dfa57a46508" xlink:to="loc_us-gaap_AwardTypeAxis_6857aae0-c08a-4850-98d8-2a928ff2afcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6857aae0-c08a-4850-98d8-2a928ff2afcd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6857aae0-c08a-4850-98d8-2a928ff2afcd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6857aae0-c08a-4850-98d8-2a928ff2afcd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2cc7fbaf-a726-4c2b-843a-88aee23597e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6857aae0-c08a-4850-98d8-2a928ff2afcd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2cc7fbaf-a726-4c2b-843a-88aee23597e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_da06b986-1ff1-4f6e-8f42-afd4dbe5268a" xlink:href="iclr-20241231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2cc7fbaf-a726-4c2b-843a-88aee23597e8" xlink:to="loc_iclr_PerformanceShareUnitMember_da06b986-1ff1-4f6e-8f42-afd4dbe5268a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_428ed8cd-036c-4368-a530-5106fb16c8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2cc7fbaf-a726-4c2b-843a-88aee23597e8" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_428ed8cd-036c-4368-a530-5106fb16c8b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6d4e35ff-d023-47ef-89f1-209924473da0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1671ab7f-b147-4a54-943d-d80a0ec5264a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6d4e35ff-d023-47ef-89f1-209924473da0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_34b6538f-854c-4f37-8c6a-364b59322aed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6d4e35ff-d023-47ef-89f1-209924473da0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_34b6538f-854c-4f37-8c6a-364b59322aed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9fd98c4c-15f5-447c-b22d-e433c6254816" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6d4e35ff-d023-47ef-89f1-209924473da0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9fd98c4c-15f5-447c-b22d-e433c6254816" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0593077b-f883-46f7-a334-a72788dc3358" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6d4e35ff-d023-47ef-89f1-209924473da0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0593077b-f883-46f7-a334-a72788dc3358" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_05cc92d9-2151-43bd-bcb3-4821e6613c93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6d4e35ff-d023-47ef-89f1-209924473da0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_05cc92d9-2151-43bd-bcb3-4821e6613c93" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b075a438-27dc-4c50-930a-653a745e327b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c44a9f3-d941-4579-960f-b29bb424e1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1671ab7f-b147-4a54-943d-d80a0ec5264a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c44a9f3-d941-4579-960f-b29bb424e1cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5c9085e1-7e9d-427d-9c3d-26c82720ba7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c44a9f3-d941-4579-960f-b29bb424e1cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5c9085e1-7e9d-427d-9c3d-26c82720ba7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bca39b6e-beca-47ce-9bb7-5ca7ebd995d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c44a9f3-d941-4579-960f-b29bb424e1cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bca39b6e-beca-47ce-9bb7-5ca7ebd995d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e4403c1c-065e-4e0b-b2cc-1c4842cdf177" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c44a9f3-d941-4579-960f-b29bb424e1cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e4403c1c-065e-4e0b-b2cc-1c4842cdf177" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_69e6850f-31ec-4220-b718-954c353b2b69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c44a9f3-d941-4579-960f-b29bb424e1cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_69e6850f-31ec-4220-b718-954c353b2b69" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_aa254cb3-e700-4f21-9f31-1bbe60ad1d31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6394b714-febf-4af5-8031-843a00e62dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_391ab7e1-b745-47db-868b-9c9c6907d8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6394b714-febf-4af5-8031-843a00e62dfd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_391ab7e1-b745-47db-868b-9c9c6907d8e2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b823719d-3a40-4da4-92eb-7ff580fad7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_391ab7e1-b745-47db-868b-9c9c6907d8e2" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b823719d-3a40-4da4-92eb-7ff580fad7dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b823719d-3a40-4da4-92eb-7ff580fad7dd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b823719d-3a40-4da4-92eb-7ff580fad7dd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b823719d-3a40-4da4-92eb-7ff580fad7dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_912acb56-9df4-4f6c-8bac-c7685ce9172f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b823719d-3a40-4da4-92eb-7ff580fad7dd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_912acb56-9df4-4f6c-8bac-c7685ce9172f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_a49344b3-aef8-4898-a06b-9a7060701fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_912acb56-9df4-4f6c-8bac-c7685ce9172f" xlink:to="loc_us-gaap_CostOfSalesMember_a49344b3-aef8-4898-a06b-9a7060701fd8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3381d8f1-432a-4b71-9769-7004000259f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_912acb56-9df4-4f6c-8bac-c7685ce9172f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3381d8f1-432a-4b71-9769-7004000259f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c865b7c4-0f60-45fc-899a-7e76112e0c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6394b714-febf-4af5-8031-843a00e62dfd" xlink:to="loc_us-gaap_ShareBasedCompensation_c865b7c4-0f60-45fc-899a-7e76112e0c6a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_09f2e1fc-7ffc-4b6e-bb7f-3e43087934b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_32258760-ce77-4dde-bc74-df30c8848a14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_09f2e1fc-7ffc-4b6e-bb7f-3e43087934b5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_32258760-ce77-4dde-bc74-df30c8848a14" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_230161a0-6707-486e-b207-8f364f3ea3dd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_32258760-ce77-4dde-bc74-df30c8848a14" xlink:to="loc_srt_StatementGeographicalAxis_230161a0-6707-486e-b207-8f364f3ea3dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_230161a0-6707-486e-b207-8f364f3ea3dd_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_230161a0-6707-486e-b207-8f364f3ea3dd" xlink:to="loc_srt_SegmentGeographicalDomain_230161a0-6707-486e-b207-8f364f3ea3dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8a5fbd7a-bc2a-424e-8bca-60f11d800f34" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_230161a0-6707-486e-b207-8f364f3ea3dd" xlink:to="loc_srt_SegmentGeographicalDomain_8a5fbd7a-bc2a-424e-8bca-60f11d800f34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_735499f6-005c-4029-bf6e-e3a5417b3d49" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8a5fbd7a-bc2a-424e-8bca-60f11d800f34" xlink:to="loc_country_IE_735499f6-005c-4029-bf6e-e3a5417b3d49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_82ef508e-7537-4481-b4c4-06a95c2328f0" xlink:href="iclr-20241231.xsd#iclr_RestOfEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8a5fbd7a-bc2a-424e-8bca-60f11d800f34" xlink:to="loc_iclr_RestOfEuropeMember_82ef508e-7537-4481-b4c4-06a95c2328f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d82c702b-e46a-4756-a7b3-824974621ef5" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8a5fbd7a-bc2a-424e-8bca-60f11d800f34" xlink:to="loc_country_US_d82c702b-e46a-4756-a7b3-824974621ef5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_47e4e333-ab80-4952-8a23-1516cbd395b0" xlink:href="iclr-20241231.xsd#iclr_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8a5fbd7a-bc2a-424e-8bca-60f11d800f34" xlink:to="loc_iclr_OtherCountriesMember_47e4e333-ab80-4952-8a23-1516cbd395b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f14af1ac-6976-4233-992b-6f68fab96c89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_09f2e1fc-7ffc-4b6e-bb7f-3e43087934b5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f14af1ac-6976-4233-992b-6f68fab96c89" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_7cc2bbe5-129c-47ea-aae1-162f58d9ff9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90c49366-4abb-44b4-9f19-813f5ab9bd98" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7cc2bbe5-129c-47ea-aae1-162f58d9ff9a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90c49366-4abb-44b4-9f19-813f5ab9bd98" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6e310de6-52d0-4f9c-ba05-1d0058271a22" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90c49366-4abb-44b4-9f19-813f5ab9bd98" xlink:to="loc_srt_StatementGeographicalAxis_6e310de6-52d0-4f9c-ba05-1d0058271a22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6e310de6-52d0-4f9c-ba05-1d0058271a22_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_6e310de6-52d0-4f9c-ba05-1d0058271a22" xlink:to="loc_srt_SegmentGeographicalDomain_6e310de6-52d0-4f9c-ba05-1d0058271a22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7bdc8b34-f116-4531-9146-22ac6b991274" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_6e310de6-52d0-4f9c-ba05-1d0058271a22" xlink:to="loc_srt_SegmentGeographicalDomain_7bdc8b34-f116-4531-9146-22ac6b991274" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_77df67cb-39eb-42d5-baae-5f83b2630928" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7bdc8b34-f116-4531-9146-22ac6b991274" xlink:to="loc_country_IE_77df67cb-39eb-42d5-baae-5f83b2630928" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_bc8d9fe5-cd68-43e4-b405-6b7e250f686c" xlink:href="iclr-20241231.xsd#iclr_RestOfEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7bdc8b34-f116-4531-9146-22ac6b991274" xlink:to="loc_iclr_RestOfEuropeMember_bc8d9fe5-cd68-43e4-b405-6b7e250f686c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_7a51fe6a-5010-4379-af39-209bc2ad3ef7" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7bdc8b34-f116-4531-9146-22ac6b991274" xlink:to="loc_country_US_7a51fe6a-5010-4379-af39-209bc2ad3ef7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_8d6bc909-6baa-4c9d-8021-192c60b797df" xlink:href="iclr-20241231.xsd#iclr_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7bdc8b34-f116-4531-9146-22ac6b991274" xlink:to="loc_iclr_OtherCountriesMember_8d6bc909-6baa-4c9d-8021-192c60b797df" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_43d5c019-1368-45f2-8758-0043cd05dc9d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90c49366-4abb-44b4-9f19-813f5ab9bd98" xlink:to="loc_srt_ConsolidationItemsAxis_43d5c019-1368-45f2-8758-0043cd05dc9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_43d5c019-1368-45f2-8758-0043cd05dc9d_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_43d5c019-1368-45f2-8758-0043cd05dc9d" xlink:to="loc_srt_ConsolidationItemsDomain_43d5c019-1368-45f2-8758-0043cd05dc9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c74b8684-1448-4845-96f3-7841a58314dd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_43d5c019-1368-45f2-8758-0043cd05dc9d" xlink:to="loc_srt_ConsolidationItemsDomain_c74b8684-1448-4845-96f3-7841a58314dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_89ff1b2b-cce3-4e84-83b2-b7b9da60291c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_c74b8684-1448-4845-96f3-7841a58314dd" xlink:to="loc_us-gaap_OperatingSegmentsMember_89ff1b2b-cce3-4e84-83b2-b7b9da60291c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5d9d5ec9-6a6b-4cc3-8369-8bf6ab3b332a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7cc2bbe5-129c-47ea-aae1-162f58d9ff9a" xlink:to="loc_us-gaap_OperatingIncomeLoss_5d9d5ec9-6a6b-4cc3-8369-8bf6ab3b332a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ac5eab6e-9ca4-4101-acf3-9436d1da8f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7cc2bbe5-129c-47ea-aae1-162f58d9ff9a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ac5eab6e-9ca4-4101-acf3-9436d1da8f2f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_685c30cd-02a4-4c3f-9087-c102e3368530" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5b473a00-8e0f-488e-b360-e1b6078d3aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_685c30cd-02a4-4c3f-9087-c102e3368530" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5b473a00-8e0f-488e-b360-e1b6078d3aa8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d07a8e2d-0f0c-4f57-8678-74ce809439c7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5b473a00-8e0f-488e-b360-e1b6078d3aa8" xlink:to="loc_srt_StatementGeographicalAxis_d07a8e2d-0f0c-4f57-8678-74ce809439c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d07a8e2d-0f0c-4f57-8678-74ce809439c7_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_d07a8e2d-0f0c-4f57-8678-74ce809439c7" xlink:to="loc_srt_SegmentGeographicalDomain_d07a8e2d-0f0c-4f57-8678-74ce809439c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_55158803-0ad1-4dc4-a17b-c0bf86889c73" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_d07a8e2d-0f0c-4f57-8678-74ce809439c7" xlink:to="loc_srt_SegmentGeographicalDomain_55158803-0ad1-4dc4-a17b-c0bf86889c73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_4ddc6578-c5f7-44ac-8bab-87bcfe0e46d0" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_55158803-0ad1-4dc4-a17b-c0bf86889c73" xlink:to="loc_country_IE_4ddc6578-c5f7-44ac-8bab-87bcfe0e46d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_d756ea91-b24e-4e72-92c4-2a7726adc41c" xlink:href="iclr-20241231.xsd#iclr_RestOfEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_55158803-0ad1-4dc4-a17b-c0bf86889c73" xlink:to="loc_iclr_RestOfEuropeMember_d756ea91-b24e-4e72-92c4-2a7726adc41c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_c1537fdb-b388-4895-8d34-c5a18e0e7e12" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_55158803-0ad1-4dc4-a17b-c0bf86889c73" xlink:to="loc_country_US_c1537fdb-b388-4895-8d34-c5a18e0e7e12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_0871aa0a-1f2a-4cfe-8ce7-2efeca4257fe" xlink:href="iclr-20241231.xsd#iclr_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_55158803-0ad1-4dc4-a17b-c0bf86889c73" xlink:to="loc_iclr_OtherCountriesMember_0871aa0a-1f2a-4cfe-8ce7-2efeca4257fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_fed06f5b-7da0-43bd-ba03-3b7441691aee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_685c30cd-02a4-4c3f-9087-c102e3368530" xlink:to="loc_us-gaap_NoncurrentAssets_fed06f5b-7da0-43bd-ba03-3b7441691aee" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RelatedPartiesDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#RelatedPartiesDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/RelatedPartiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_463972cd-fea7-4f16-a3bf-bd54b28b3379" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8dffb159-2e98-4e1e-8c7c-61d625c3547b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_463972cd-fea7-4f16-a3bf-bd54b28b3379" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8dffb159-2e98-4e1e-8c7c-61d625c3547b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_c2136821-06d4-4410-86f6-3bbcb500bf26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8dffb159-2e98-4e1e-8c7c-61d625c3547b" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_c2136821-06d4-4410-86f6-3bbcb500bf26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_c2136821-06d4-4410-86f6-3bbcb500bf26_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_c2136821-06d4-4410-86f6-3bbcb500bf26" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_c2136821-06d4-4410-86f6-3bbcb500bf26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_2f5dfc04-1ff9-4532-85c7-8ef4e00866e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_c2136821-06d4-4410-86f6-3bbcb500bf26" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_2f5dfc04-1ff9-4532-85c7-8ef4e00866e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CorvusPharmaceuticalsMember_8c6defa7-36b8-49e6-bdbe-ced5f61b066c" xlink:href="iclr-20241231.xsd#iclr_CorvusPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_2f5dfc04-1ff9-4532-85c7-8ef4e00866e8" xlink:to="loc_iclr_CorvusPharmaceuticalsMember_8c6defa7-36b8-49e6-bdbe-ced5f61b066c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AfimmuneLimitedMember_3c59aebb-9267-4acf-9bf6-95582f11a681" xlink:href="iclr-20241231.xsd#iclr_AfimmuneLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_2f5dfc04-1ff9-4532-85c7-8ef4e00866e8" xlink:to="loc_iclr_AfimmuneLimitedMember_3c59aebb-9267-4acf-9bf6-95582f11a681" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_526dbf18-bd38-4b3a-a1dc-2d9b5992d869" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8dffb159-2e98-4e1e-8c7c-61d625c3547b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_526dbf18-bd38-4b3a-a1dc-2d9b5992d869" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_526dbf18-bd38-4b3a-a1dc-2d9b5992d869_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_526dbf18-bd38-4b3a-a1dc-2d9b5992d869" xlink:to="loc_us-gaap_RelatedPartyDomain_526dbf18-bd38-4b3a-a1dc-2d9b5992d869_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c86fa34c-fe4d-4e74-bc18-7a89e39bb636" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_526dbf18-bd38-4b3a-a1dc-2d9b5992d869" xlink:to="loc_us-gaap_RelatedPartyDomain_c86fa34c-fe4d-4e74-bc18-7a89e39bb636" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOfCommonParentMember_9e3b51fc-0516-4d66-90fb-3d1581d44f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOfCommonParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_c86fa34c-fe4d-4e74-bc18-7a89e39bb636" xlink:to="loc_us-gaap_SubsidiaryOfCommonParentMember_9e3b51fc-0516-4d66-90fb-3d1581d44f2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_339f0f6d-da98-411a-8e59-600b7e94ebc7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_463972cd-fea7-4f16-a3bf-bd54b28b3379" xlink:to="loc_us-gaap_Revenues_339f0f6d-da98-411a-8e59-600b7e94ebc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_3b93fc20-917f-40a9-9928-ca6aa4751480" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_463972cd-fea7-4f16-a3bf-bd54b28b3379" xlink:to="loc_us-gaap_OtherReceivables_3b93fc20-917f-40a9-9928-ca6aa4751480" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.iconplc.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_973bbe11-1c82-44db-992b-9e083f33fae6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_611e4670-1b1d-4bb4-a8fa-59d5b92f7c25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_973bbe11-1c82-44db-992b-9e083f33fae6" xlink:to="loc_us-gaap_SubsequentEventTable_611e4670-1b1d-4bb4-a8fa-59d5b92f7c25" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b7b372bd-9a9c-4b8d-b6f7-900920da050e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_611e4670-1b1d-4bb4-a8fa-59d5b92f7c25" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b7b372bd-9a9c-4b8d-b6f7-900920da050e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b7b372bd-9a9c-4b8d-b6f7-900920da050e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b7b372bd-9a9c-4b8d-b6f7-900920da050e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b7b372bd-9a9c-4b8d-b6f7-900920da050e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b94da792-bdbb-4fe5-b53c-9a564b6f2406" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b7b372bd-9a9c-4b8d-b6f7-900920da050e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b94da792-bdbb-4fe5-b53c-9a564b6f2406" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_05f3f050-4ef4-49f9-8c0c-e3c3e73e1b14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b94da792-bdbb-4fe5-b53c-9a564b6f2406" xlink:to="loc_us-gaap_SubsequentEventMember_05f3f050-4ef4-49f9-8c0c-e3c3e73e1b14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramAxis_27840699-dd28-4c03-8368-545259d40222" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_611e4670-1b1d-4bb4-a8fa-59d5b92f7c25" xlink:to="loc_srt_ShareRepurchaseProgramAxis_27840699-dd28-4c03-8368-545259d40222" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramDomain_27840699-dd28-4c03-8368-545259d40222_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ShareRepurchaseProgramAxis_27840699-dd28-4c03-8368-545259d40222" xlink:to="loc_srt_ShareRepurchaseProgramDomain_27840699-dd28-4c03-8368-545259d40222_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramDomain_6fbf6e1c-195f-4ae4-b67d-434e38c76565" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ShareRepurchaseProgramAxis_27840699-dd28-4c03-8368-545259d40222" xlink:to="loc_srt_ShareRepurchaseProgramDomain_6fbf6e1c-195f-4ae4-b67d-434e38c76565" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_February2025Member_195b72d1-04f6-4b67-bacc-8366cfff01bd" xlink:href="iclr-20241231.xsd#iclr_February2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ShareRepurchaseProgramDomain_6fbf6e1c-195f-4ae4-b67d-434e38c76565" xlink:to="loc_iclr_February2025Member_195b72d1-04f6-4b67-bacc-8366cfff01bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1_a9db6212-730e-442b-b51b-eff7923d1730" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_973bbe11-1c82-44db-992b-9e083f33fae6" xlink:to="loc_srt_StockRepurchaseProgramAuthorizedAmount1_a9db6212-730e-442b-b51b-eff7923d1730" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="loc_us-gaap_RestructuringCosts" xlink:type="arc" order="691"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>iclr-20241231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:56d7542f-319d-475c-a76f-1ff45be39275,g:fef64a75-6c12-4b8b-a2b6-5a3facaa93b8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_57419880-2ae0-44b2-822d-7bc1cbe4e4f2_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_5d6166aa-a101-4f59-bf2e-00ba3a5bc504_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_e0522b72-2365-408b-9eed-be77c5e55a8a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Taxes at Irish statutory rate of 12.5% (2023:12.5%; 2022:12.5%)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_8a5911ff-4664-479d-b3a9-81f5356f9331_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0bf67b09-2fee-4f7e-baf1-6987b5a0935a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a09bf300-9603-4030-a178-73275080a09f_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase/(decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_d6e2c189-4cda-4256-ba45-1d785db1ab80_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Operating Lease Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2265593a-45a5-44f1-ab57-f5780390b09b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Asset, Indefinite-Lived [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Asset, Indefinite-Lived [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_9e6f6388-de04-4bde-aba3-44d419886510_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_1987450a-0fa7-4927-aba8-15187f6acc00_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of share capital acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_1a71f143-7eff-4686-ad47-5e9a32fd92fb_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_f704019a-d2be-41fb-91c0-3fd05b63e766_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax benefit related to stock compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RestructuringReserveAndOtherLiabilitiesCurrent_94b79d8a-2bca-401f-8853-a468c6c0fd9a_terseLabel_en-US" xlink:label="lab_iclr_RestructuringReserveAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring liabilities</link:label>
    <link:label id="lab_iclr_RestructuringReserveAndOtherLiabilitiesCurrent_label_en-US" xlink:label="lab_iclr_RestructuringReserveAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve And Other Liabilities, Current</link:label>
    <link:label id="lab_iclr_RestructuringReserveAndOtherLiabilitiesCurrent_documentation_en-US" xlink:label="lab_iclr_RestructuringReserveAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restructuring Reserve And Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestructuringReserveAndOtherLiabilitiesCurrent" xlink:href="iclr-20241231.xsd#iclr_RestructuringReserveAndOtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RestructuringReserveAndOtherLiabilitiesCurrent" xlink:to="lab_iclr_RestructuringReserveAndOtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable_818a7598-a106-4a7e-9503-80ef6dd247f4_negatedTotalLabel_en-US" xlink:label="lab_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Change in net balance</link:label>
    <link:label id="lab_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable_1b10e724-9ea5-4aac-ab6c-7ff97ac1cc65_negatedLabel_en-US" xlink:label="lab_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Decrease in net balance</link:label>
    <link:label id="lab_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable_label_en-US" xlink:label="lab_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Advance Payments Netted Against Unbilled Contracts Receivable</link:label>
    <link:label id="lab_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable_documentation_en-US" xlink:label="lab_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Change in Advance Payments Netted Against Unbilled Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:href="iclr-20241231.xsd#iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:to="lab_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_1318a7ba-0b12-4683-a23b-1d5084d235ad_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flow hedge</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_c1c125f0-eb25-4e0a-92d7-a933cbc62e09_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments to acquire equity securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireEquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:to="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_b0a31170-ac4d-44a6-8828-0f487352fbd5_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DeferredTaxAssetContractWithCustomerLiability_fc3f3b8f-0ab8-4432-8465-d7cee85cc865_terseLabel_en-US" xlink:label="lab_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unearned revenue</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetContractWithCustomerLiability_label_en-US" xlink:label="lab_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Asset, Contract With Customer, Liability</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetContractWithCustomerLiability_documentation_en-US" xlink:label="lab_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Asset, Contract With Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:href="iclr-20241231.xsd#iclr_DeferredTaxAssetContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:to="lab_iclr_DeferredTaxAssetContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_3915a9d8-20a1-4c6d-8993-e17f0129f100_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income per ordinary share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_95e4191a-c843-45d5-b474-3aa45a4425e1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary shares issued in respect of certain RSUs previously awarded by the Company (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_7130a298-96f2-4ce5-ab85-b2e33af56e0b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_4cc6fc24-0b4f-4a55-808f-40f26c31b133_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from exercise of equity compensation</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_3ee5473e-462a-4735-9191-78165e3fcb10_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total proceeds from exercise of stock options by employees</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TaxYear2025To2038Member_4e7d9f59-1a3a-4bbd-a83f-9507fd2054ca_terseLabel_en-US" xlink:label="lab_iclr_TaxYear2025To2038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025-2038</link:label>
    <link:label id="lab_iclr_TaxYear2025To2038Member_label_en-US" xlink:label="lab_iclr_TaxYear2025To2038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Year 2025 to 2038 [Member]</link:label>
    <link:label id="lab_iclr_TaxYear2025To2038Member_documentation_en-US" xlink:label="lab_iclr_TaxYear2025To2038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Year 2025 to 2038</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2025To2038Member" xlink:href="iclr-20241231.xsd#iclr_TaxYear2025To2038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TaxYear2025To2038Member" xlink:to="lab_iclr_TaxYear2025To2038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeMember_ffa3c0ad-bbef-4de1-906e-6416cb6a3d0b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_OtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent_94b9a41f-b71d-4308-935b-a516bc2e229f_terseLabel_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage change in unbilled services (unbilled revenue)</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent_label_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Contract With Customer, Asset, Gross, Current, Percent</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent_documentation_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Contract With Customer, Asset, Gross, Current, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent" xlink:href="iclr-20241231.xsd#iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent" xlink:to="lab_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_f804ff29-120f-420a-a44c-4a73d38a9130_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_dc28c58c-5e27-43bc-ad3f-5ace4c82edbc_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_eea88511-5130-40af-b5fb-d9da1532f4c4_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_4503a0f5-929c-4b42-bc2a-578535d7d249_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_c4f71a28-60bc-417d-b157-380c39e94ed8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of dilutive share options and other awards outstanding under share based compensation programs (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_a646be8e-f890-45b4-bb53-b83095875f01_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_4428a92a-8fd3-49c9-a3e5-b5422ce386b7_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_ed438a7e-4a8b-4b13-97cb-702e796f1b6b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total cost</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_9d6d2305-dfb7-4389-874c-3b89bbde5349_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_7da066a5-5b3a-480c-8084-15ccabda5599_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_243e266d-cb7b-48a4-80ec-2690d273a621_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_5bd5ff3f-d9f0-4554-8278-3411f955dbb5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TaxOfBusinessAcquiredMember_cacdfd99-fa75-4b26-802c-33924f16f9ab_terseLabel_en-US" xlink:label="lab_iclr_TaxOfBusinessAcquiredMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax of business acquired</link:label>
    <link:label id="lab_iclr_TaxOfBusinessAcquiredMember_label_en-US" xlink:label="lab_iclr_TaxOfBusinessAcquiredMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax of Business Acquired [Member]</link:label>
    <link:label id="lab_iclr_TaxOfBusinessAcquiredMember_documentation_en-US" xlink:label="lab_iclr_TaxOfBusinessAcquiredMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax of Business Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxOfBusinessAcquiredMember" xlink:href="iclr-20241231.xsd#iclr_TaxOfBusinessAcquiredMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TaxOfBusinessAcquiredMember" xlink:to="lab_iclr_TaxOfBusinessAcquiredMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_0581df05-87e5-43b0-bf41-c5ff1d7c9f84_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Secured Term Loan</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_992c7c11-ed90-4c2e-8706-2e45825da90d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_7e234a80-686f-45ba-bcab-8960ae88cca8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested and exercisable at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_39ced256-3c5e-4617-b690-9de2fee5cf68_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rate differential from amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_4fc95d50-5cdc-4bf0-9ff8-1a4a545e2297_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_58b0ab43-137c-4b1d-bbcf-5b6ebf412bf9_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_7d96e1b2-2935-4ccb-b20b-a0b5fef8e6ac_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_c04e3354-6f69-45e1-bbc7-73c694c1d250_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_dbeb12f1-1291-4390-ab9a-4467e6b25c6b_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Unrecognized Tax Benefit, Reasonably Possible [Table]</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Unrecognized Tax Benefit, Reasonably Possible [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_1aa2cfe1-60a9-4124-935d-b1328e296409_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ForeignCurrencyDisclosureTableTextBlock_6fcdd3c4-4bc6-4b28-8a9e-77291f948a4d_terseLabel_en-US" xlink:label="lab_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments resulting from foreign currency translations</link:label>
    <link:label id="lab_iclr_ForeignCurrencyDisclosureTableTextBlock_label_en-US" xlink:label="lab_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Disclosure [Table Text Block]</link:label>
    <link:label id="lab_iclr_ForeignCurrencyDisclosureTableTextBlock_documentation_en-US" xlink:label="lab_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Foreign Currency Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:href="iclr-20241231.xsd#iclr_ForeignCurrencyDisclosureTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:to="lab_iclr_ForeignCurrencyDisclosureTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_2f21c88b-2b67-488a-891c-8dc7f379f916_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_21a19e4f-a10b-4867-b01e-28638d8b210c_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_1a315d49-9828-47ec-b47d-7a75dff73c92_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">New Notes issue costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_49598ef3-09f2-4f57-803f-62c72c9efd1a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_31ce251f-a502-4ee5-a32a-8f84309a58c3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_167c3971-2023-4058-a7d0-775c41230c32_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of stock compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_ca32456b-ef83-4e79-99be-4684ac43e5cf_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_February2025Member_aed0b3ad-c75b-4b31-9c2a-8e6baf8752d7_terseLabel_en-US" xlink:label="lab_iclr_February2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">February 2025</link:label>
    <link:label id="lab_iclr_February2025Member_label_en-US" xlink:label="lab_iclr_February2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">February 2025 [Member]</link:label>
    <link:label id="lab_iclr_February2025Member_documentation_en-US" xlink:label="lab_iclr_February2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">February 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_February2025Member" xlink:href="iclr-20241231.xsd#iclr_February2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_February2025Member" xlink:to="lab_iclr_February2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_86231f80-86fc-41d1-9d89-6e589e35b1d9_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Goodwill (Note 10)</link:label>
    <link:label id="lab_us-gaap_Goodwill_078f4641-42a2-4aa9-9e8a-2e5cf989a71f_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_f57be82b-a265-4a84-ba94-506533d4a7ea_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Opening balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_7263ed4a-03bc-4ea8-95be-01649aff9815_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Closing balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_b3720836-bde5-4cf2-80b7-e6a179dc19ae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Allowance for credit losses (note 5)</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_69c732f9-d499-46c6-b8fe-036c2977e762_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Opening provision</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_5f8d4dd9-6673-44e3-83ec-08f2d58d9543_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Closing provision</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0a516e43-2dd6-46a3-b366-3a85ffdb804c_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income, net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_38ff23f4-c4d2-4632-b176-8b50cc6202ae_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Comprehensive income (net of tax):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StockRepurchaseProgramAuthorizedAmount1_9a04a898-3a2d-4b2c-a596-83538b452250_terseLabel_en-US" xlink:label="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_srt_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Authorized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_859aba41-5ebf-4375-8a67-3212a04abd4a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_73fce067-2cb4-4b5f-a795-51b32a15a20f_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_dc29e12c-f322-4133-b19d-7f8d726b1f11_terseLabel_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Table]</link:label>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_label_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Table]</link:label>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_documentation_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:href="iclr-20241231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:to="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_3543a3d8-09ca-4afc-b8cc-bb7be34aa1c0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AccountsReceivableCreditLossExpense_749e1960-7e8a-472e-9050-cf0f5c1edb21_terseLabel_en-US" xlink:label="lab_iclr_AccountsReceivableCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amounts provided during the year</link:label>
    <link:label id="lab_iclr_AccountsReceivableCreditLossExpense_label_en-US" xlink:label="lab_iclr_AccountsReceivableCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Credit Loss Expense</link:label>
    <link:label id="lab_iclr_AccountsReceivableCreditLossExpense_documentation_en-US" xlink:label="lab_iclr_AccountsReceivableCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Credit Loss Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccountsReceivableCreditLossExpense" xlink:href="iclr-20241231.xsd#iclr_AccountsReceivableCreditLossExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AccountsReceivableCreditLossExpense" xlink:to="lab_iclr_AccountsReceivableCreditLossExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentRegistrationStatement_c92e4f18-0b57-4df5-9131-f3ae57265ccc_terseLabel_en-US" xlink:label="lab_dei_DocumentRegistrationStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Registration Statement</link:label>
    <link:label id="lab_dei_DocumentRegistrationStatement_label_en-US" xlink:label="lab_dei_DocumentRegistrationStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Registration Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentRegistrationStatement" xlink:to="lab_dei_DocumentRegistrationStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_b20b0706-73e0-4d12-a3ff-8161ca4388b1_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_49741ba4-014f-487c-87fd-79b492a8b30e_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_419eaa69-8ac7-47ea-9820-ab7bc4f257e9_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_d6a6dac9-c6bb-4aac-bef1-203dbfe74d26_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repayment of credit lines and loan facilities</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_f075ee07-771c-4dfc-829c-5d4c2fd78fc8_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_54b363f6-4feb-43c0-9d2b-5bd8cfbde3bf_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Overall net deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_d7147c77-8dda-4c57-8917-93020b389d49_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Distribution of Net Revenue by Geographical Area</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_ea82512b-eda5-48b3-b0cd-0f13ad1b4d83_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange movement</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_eb601afa-0832-42ed-be22-56470c4d9029_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_95982582-517a-49d4-a535-067eb508105e_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, net (Note 9)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_7fdbb8f7-34c4-438f-acb7-396766555017_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment (net)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_e869ea63-7395-4c62-8a92-d6cd4bd26adb_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_64d84bba-1d27-4630-af79-fd33b02dd7f9_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_79217fb7-0631-411b-ad9e-8f8fa5665650_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-lived assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_e4631706-7fd2-45eb-b656-a740083928c5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary shares, par value (in EUR per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e239e377-69c3-463a-83ea-f7a62cf51c5b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_4270ca05-750c-44bf-9f78-4d0a357a8087_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currencies and translation of subsidiaries</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_4145888b-4307-47fe-b4ad-60afce493e96_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Secured Revolving Loan</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ddafe9da-ac22-4bac-9f9f-511bd1ec0684_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows used in investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_035d97c6-8b5a-47ff-be82-e468b964be9d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_08bab869-fc49-47e6-b62f-c4623bfa1dcf_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f044eb27-955f-4f5a-86a1-5d92dd5fb4af_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_95d2ad77-ad47-4810-beaa-583b5647885c_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_6c34197e-2e61-44ab-af50-60483991fcbd_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Remeasurement of retirement benefit obligations</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TaxCreditCarryForwardExpirationPeriod_09f795d9-5743-4db0-88d2-a02a9bc47175_terseLabel_en-US" xlink:label="lab_iclr_TaxCreditCarryForwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credit carry forward, expiration period</link:label>
    <link:label id="lab_iclr_TaxCreditCarryForwardExpirationPeriod_label_en-US" xlink:label="lab_iclr_TaxCreditCarryForwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carry forward Expiration Period</link:label>
    <link:label id="lab_iclr_TaxCreditCarryForwardExpirationPeriod_documentation_en-US" xlink:label="lab_iclr_TaxCreditCarryForwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Credit Carry forward Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxCreditCarryForwardExpirationPeriod" xlink:href="iclr-20241231.xsd#iclr_TaxCreditCarryForwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TaxCreditCarryForwardExpirationPeriod" xlink:to="lab_iclr_TaxCreditCarryForwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_08d4f40d-e9bb-467d-9277-73be9bf29b3e_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Laboratory equipment &#160;</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_48b82be5-ad58-4085-8d31-d61604536809_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ContractsReceivableNet_4b4371dc-784c-441b-bddd-e5f829e8f60e_totalLabel_en-US" xlink:label="lab_iclr_ContractsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable and unbilled revenue, net</link:label>
    <link:label id="lab_iclr_ContractsReceivableNet_label_en-US" xlink:label="lab_iclr_ContractsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contracts Receivable, Net</link:label>
    <link:label id="lab_iclr_ContractsReceivableNet_documentation_en-US" xlink:label="lab_iclr_ContractsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contracts Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableNet" xlink:href="iclr-20241231.xsd#iclr_ContractsReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ContractsReceivableNet" xlink:to="lab_iclr_ContractsReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_c41c0bec-9492-404b-826a-9d3275979541_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_cff3ac99-aa46-4c1c-97ab-dc6422b54aa2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise of share options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_25a601a2-fe14-411b-b3d7-77bece7f0255_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Options exercised by employees (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_168fa84b-ffe1-40ad-b69d-794531364a8b_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_975d92fd-d4d6-470b-a421-afecbef5d1f4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_57d7375d-c15f-4999-8eee-ef42d8017e74_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Identifiable intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_bf9865a8-192b-415d-90e8-0db0459026cb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_80eac4c7-3e2d-4eca-bbcc-c14748c258d4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_6c025286-3343-424d-911f-932ed3bf7a70_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]</link:label>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_label_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]</link:label>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_documentation_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:href="iclr-20241231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:to="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_eef717ee-b6c6-4df9-81dd-a3ba64b53a00_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Lapse of statute of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherUndenominatedCapitalMember_78123649-9625-4fad-ab27-315849174c4e_terseLabel_en-US" xlink:label="lab_iclr_OtherUndenominatedCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Undenominated Capital</link:label>
    <link:label id="lab_iclr_OtherUndenominatedCapitalMember_label_en-US" xlink:label="lab_iclr_OtherUndenominatedCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Undenominated Capital [Member]</link:label>
    <link:label id="lab_iclr_OtherUndenominatedCapitalMember_documentation_en-US" xlink:label="lab_iclr_OtherUndenominatedCapitalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other undenominated capital.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapitalMember" xlink:href="iclr-20241231.xsd#iclr_OtherUndenominatedCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherUndenominatedCapitalMember" xlink:to="lab_iclr_OtherUndenominatedCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_66e45eb8-e3c5-4cf0-9af5-e6c517c798d8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0795e94a-e152-46ea-b1bb-5419590a0584_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_3cedb2b3-d0c0-4f1a-a91a-212919750b26_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_929ca9a1-254b-40ad-ae14-675bc98cc976_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_2d1ce7af-7c49-4421-ab0b-73484aa7ecfd_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_64f69631-67e1-478b-9232-a1ad41e98392_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount_d8b5e4f2-b8f4-4046-947e-78ce4e22e20b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Global Minimum Tax</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, GILTI, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ContactPersonnelName_1970e285-0381-4cdd-9e75-c015fb0cd521_terseLabel_en-US" xlink:label="lab_dei_ContactPersonnelName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contact Personnel Name</link:label>
    <link:label id="lab_dei_ContactPersonnelName_label_en-US" xlink:label="lab_dei_ContactPersonnelName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contact Personnel Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelName" xlink:to="lab_dei_ContactPersonnelName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveNoncurrent_3c20f28b-e2c4-47f6-bd85-eb39719e7421_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring reserve, noncurrent</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveNoncurrent" xlink:to="lab_us-gaap_RestructuringReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_bfeec4e4-0398-405c-92e5-1baab0bf998f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_581a0fd8-0163-4a01-b83a-e7d15ea30119_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_b0b48e15-3077-4c7d-babc-9521d122acc2_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c8a1c407-df04-4b12-8672-4a7a4b32bc6f_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_41b01cfb-50b4-4d05-9093-3122f36801be_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BilledContractReceivables_7414b822-0b1d-4dbb-a145-e02e78e021a3_terseLabel_en-US" xlink:label="lab_us-gaap_BilledContractReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Billed services (accounts receivable)</link:label>
    <link:label id="lab_us-gaap_BilledContractReceivables_label_en-US" xlink:label="lab_us-gaap_BilledContractReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Billed Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BilledContractReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BilledContractReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BilledContractReceivables" xlink:to="lab_us-gaap_BilledContractReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_5bfc4642-89bc-4874-b5e4-d432fdbbd032_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Rate Caps</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_47dbc3dd-6ffc-41b5-8f31-b905337d1a3f_terseLabel_en-US" xlink:label="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Plan, 2008 Plan</link:label>
    <link:label id="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_label_en-US" xlink:label="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Plan, 2008 Plan [Member]</link:label>
    <link:label id="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_documentation_en-US" xlink:label="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Stock Plan, 2008 Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:href="iclr-20241231.xsd#iclr_EmployeeStockPlanTwentyZeroEightPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:to="lab_iclr_EmployeeStockPlanTwentyZeroEightPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_2f681d1a-298a-4e29-9f85-610e27cc50f6_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Direct costs</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c37b8412-2045-4c11-af83-e6af762bb1bc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary shares which have been reserved for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_6216863f-2c0c-4a69-9bdc-cf1ea6794cc2_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_c5dc0a09-9099-4bec-82eb-2b1cac2a7272_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_28fb1c26-0c02-44de-b52f-ec453454e2ee_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_fe51c5ff-c537-41a0-9b78-fb3267090953_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_01db1d04-208a-4ad4-a4bb-1e78d5dc98dc_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average contractual term of options outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_9f068813-8fcb-41e5-adc4-4987886ba8c8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b12f5584-793e-487d-bcaf-b5ed4bc47391_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividend yield (in percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_cd4d6a24-ef2a-4185-bbc1-9b892a10ab58_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_d8262cb8-4446-46c9-a493-4b50aae27021_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments_fdf24b48-5faf-4fa4-9c4f-98e74f079502_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from investments in equity</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfLongtermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_6e4eea98-d6d6-492c-b49b-922b5dc9b13d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business combination, net income (loss) of acquiree since acquisition date, actual</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_2707c55b-1047-45ff-9b30-33da12c02928_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accounts Receivables and Unbilled Revenue, and Unbilled Services and Unearned Revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_2c4a6ea7-b3f7-478d-af07-92bcecb57688_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Principal repayments</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_d390a49e-45f7-4891-8724-73d8cbbf2188_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Future Intangible Asset Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_3a7139d0-b0c0-468c-aea0-719c3352df65_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_bbb2a70b-5a9b-4eed-8e69-1a2eeb6e8bf1_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_d3d6ae42-2fd1-4230-979a-ca7424449402_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_f22093fa-acca-4826-a51b-3385963840b9_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Office furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_b6952d56-988f-4111-8e6f-b3e02169fe0f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net (Note 11)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_dc661a64-fb68-43d3-9184-d74e5995cf62_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net book value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_ea80c725-3d98-480f-a1b2-938c3cf74bd4_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_e0dfa4d3-d179-403f-bc0a-1fdd4622d945_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Canceled/expired (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_b4c586a3-c8e3-4081-bb79-c9159caaff6b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Weighted Average Fair Values and Assumptions Used</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_ee740f26-c831-4dbf-a1f5-d23f74b09001_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net operating lease costs</link:label>
    <link:label id="lab_us-gaap_LeaseCost_9add91d8-53a1-4be7-8188-b23418219ca3_verboseLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net operating lease costs</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_82a5369e-f4d7-4cd1-bd6a-5609d5f310af_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_d2e8f398-9a52-41ff-9504-ce9307c3842f_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable_c9002ffb-ffcd-4751-8734-218d8fa06a9f_totalLabel_en-US" xlink:label="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net balance</link:label>
    <link:label id="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable_label_en-US" xlink:label="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advance Payments Netted Against Unbilled Contracts Receivable</link:label>
    <link:label id="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable_documentation_en-US" xlink:label="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Advance Payments Netted Against Unbilled Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:href="iclr-20241231.xsd#iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:to="lab_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_9f508bd3-495f-498a-bed5-01040c2a8539_terseLabel_en-US" xlink:label="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ireland subsidiaries additional tax credit carryforward for income tax</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_documentation_en-US" xlink:label="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:href="iclr-20241231.xsd#iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:to="lab_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_790904fa-1c96-4422-bbf4-8fd05e576852_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_55ede9aa-f60e-44d7-ac73-44ef981d7099_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_fe9c6cb5-0206-4f35-bbc8-cd28dc2a732b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill impairment charge</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_29d46d6c-c349-4e40-848b-d6d453a9bf23_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title and Position [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title and Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ShareRepurchaseProgramBrokerCommission_5ad6c42e-9e3c-4ee2-947a-20cf114bb8a4_negatedTerseLabel_en-US" xlink:label="lab_iclr_ShareRepurchaseProgramBrokerCommission" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Share repurchase costs</link:label>
    <link:label id="lab_iclr_ShareRepurchaseProgramBrokerCommission_label_en-US" xlink:label="lab_iclr_ShareRepurchaseProgramBrokerCommission" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Broker Commission</link:label>
    <link:label id="lab_iclr_ShareRepurchaseProgramBrokerCommission_documentation_en-US" xlink:label="lab_iclr_ShareRepurchaseProgramBrokerCommission" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Broker Commission</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareRepurchaseProgramBrokerCommission" xlink:href="iclr-20241231.xsd#iclr_ShareRepurchaseProgramBrokerCommission"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ShareRepurchaseProgramBrokerCommission" xlink:to="lab_iclr_ShareRepurchaseProgramBrokerCommission" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_b25cb010-0216-44f0-8c04-136712d43c8b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_b2c6c046-8498-49d9-acc8-d0518eab579b_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_830e2907-6303-4eae-9a9d-5ac435e84e87_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bank credit lines, loan facilities and notes</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_e30ed657-586e-481a-a924-e31568d1ec9a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_300d57bc-445d-4a56-b60f-154ae8da945f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_2f2e73b7-c556-4b3d-ad33-8c4410735e7e_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State NOL's</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_8a86ed33-53ce-46d7-a1fa-798d251c54fe_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unearned revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_a302f6ef-6a26-46d7-9f1a-cc936224cf2b_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current tax expense</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock_6e9ca755-99a3-40e6-b9f5-6d79f9c7446d_terseLabel_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock_label_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income Loss [Text Block]</link:label>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock_documentation_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of the components of accumulated other comprehensive income (loss).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:href="iclr-20241231.xsd#iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:to="lab_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_4e5fd4e5-ecad-479d-911a-53ac3b568b70_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable - weighted average remaining contractual life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NontradeReceivablesCurrent_481e4997-8c23-46c8-bd1e-01722c61ad64_terseLabel_en-US" xlink:label="lab_us-gaap_NontradeReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_NontradeReceivablesCurrent_label_en-US" xlink:label="lab_us-gaap_NontradeReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nontrade Receivables, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontradeReceivablesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NontradeReceivablesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NontradeReceivablesCurrent" xlink:to="lab_us-gaap_NontradeReceivablesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_4ccee3b8-6946-4c59-ad2d-d4f7032f8a91_terseLabel_en-US" xlink:label="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Computer equipment and software</link:label>
    <link:label id="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_label_en-US" xlink:label="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer Equipment and Capitalized Software [Member]</link:label>
    <link:label id="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_documentation_en-US" xlink:label="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Computer Equipment and Capitalized Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:href="iclr-20241231.xsd#iclr_ComputerEquipmentAndCapitalizedSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:to="lab_iclr_ComputerEquipmentAndCapitalizedSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_19777941-76b2-4bd9-8b9d-202bb44c0179_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_dd531e18-4ce1-4ad5-abd5-e791042df5f6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, redemption price, percentage of principal amount redeemed</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_1e9b7c63-7114-4204-8f0a-f7d3ec41f2af_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Amounts (credited) / charged</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_411cdea4-0465-40e1-8cea-cf507f250f58_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_2a42edf2-47b3-4fed-b551-5d91a78eead7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense was allocated to the following components of other comprehensive income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ExternalCreditRatingStandardPoorsMember_a82e2901-2d4e-492f-98f4-3781394cdcf3_terseLabel_en-US" xlink:label="lab_srt_ExternalCreditRatingStandardPoorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">External Credit Rating, Standard &amp; Poor's [Domain]</link:label>
    <link:label id="lab_srt_ExternalCreditRatingStandardPoorsMember_label_en-US" xlink:label="lab_srt_ExternalCreditRatingStandardPoorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">External Credit Rating, Standard &amp; Poor's [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExternalCreditRatingStandardPoorsMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ExternalCreditRatingStandardPoorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ExternalCreditRatingStandardPoorsMember" xlink:to="lab_srt_ExternalCreditRatingStandardPoorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_e4933d88-c736-4fa6-8f8f-b4c92e27320d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_ad8fbef3-a015-4f62-ad76-c0229b07fcc2_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Research &amp; development tax incentives</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_064e0c11-d7ba-448b-916d-16b06e546833_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_VehiclesGross_d5b4ce27-79dc-4b5f-91fb-a575df02fd07_terseLabel_en-US" xlink:label="lab_iclr_VehiclesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Motor vehicles</link:label>
    <link:label id="lab_iclr_VehiclesGross_label_en-US" xlink:label="lab_iclr_VehiclesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vehicles, Gross</link:label>
    <link:label id="lab_iclr_VehiclesGross_documentation_en-US" xlink:label="lab_iclr_VehiclesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vehicles, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VehiclesGross" xlink:href="iclr-20241231.xsd#iclr_VehiclesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_VehiclesGross" xlink:to="lab_iclr_VehiclesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3d8698e6-3626-47ed-893c-3f178815b28d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of stock units vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_7aa76cab-f613-4b72-8821-4ffb4b8c2097_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_NumberOfVotes_7b7a31a2-fd8c-434d-b6da-82ae96983afe_terseLabel_en-US" xlink:label="lab_iclr_NumberOfVotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of votes</link:label>
    <link:label id="lab_iclr_NumberOfVotes_label_en-US" xlink:label="lab_iclr_NumberOfVotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Votes</link:label>
    <link:label id="lab_iclr_NumberOfVotes_documentation_en-US" xlink:label="lab_iclr_NumberOfVotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Votes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfVotes" xlink:href="iclr-20241231.xsd#iclr_NumberOfVotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_NumberOfVotes" xlink:to="lab_iclr_NumberOfVotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_c5ba1916-06fb-4e98-bdf3-171bad1b28f9_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Income tax expense (Note 20)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_1697dfb0-24e0-4c52-8b27-6cc08858cc33_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_6f33bb54-fb2c-4607-8247-63929c4b0720_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_2ec7971e-8269-4436-af31-7e7139105b99_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repayments of senior debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:to="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_8177914c-c705-42ac-a2a4-e66467d3e29e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Available for sale investments (Note 8)</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_76c4255a-0deb-49e8-a1f7-0b8e1c658961_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Available for sale investments</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_8125a826-998e-4d9c-bf70-4ea955186885_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_bc0f6d01-05a0-4b7e-974a-42b419b4a3d2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized share-based compensation cost, period of recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_The2018LegacyPRAPlanMember_dc96467a-6f4e-467d-8c2c-7fd4a02560e4_terseLabel_en-US" xlink:label="lab_iclr_The2018LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">The 2018 Legacy PRA Plan</link:label>
    <link:label id="lab_iclr_The2018LegacyPRAPlanMember_label_en-US" xlink:label="lab_iclr_The2018LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The 2018 Legacy PRA Plan [Member]</link:label>
    <link:label id="lab_iclr_The2018LegacyPRAPlanMember_documentation_en-US" xlink:label="lab_iclr_The2018LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The 2018 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2018LegacyPRAPlanMember" xlink:href="iclr-20241231.xsd#iclr_The2018LegacyPRAPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_The2018LegacyPRAPlanMember" xlink:to="lab_iclr_The2018LegacyPRAPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_05407b66-23c3-4ea3-afa3-d391c3fdf08d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductInformationLineItems_5d9bb737-b9d6-4a7a-98fb-a6d766576b79_terseLabel_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductInformationLineItems_label_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductInformationLineItems" xlink:to="lab_us-gaap_ProductInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e7d693c9-ae69-4746-8421-68033a84054e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf_3810a276-6044-41e4-9128-32e3c178d169_terseLabel_en-US" xlink:label="lab_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative, variable interest rate, reference rate in excess of</link:label>
    <link:label id="lab_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf_label_en-US" xlink:label="lab_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Variable Interest Rate, Reference Rate In Excess Of</link:label>
    <link:label id="lab_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf_documentation_en-US" xlink:label="lab_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Derivative, Variable Interest Rate, Reference Rate In Excess Of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf" xlink:href="iclr-20241231.xsd#iclr_DerivativeVariableInterestRateReferenceRateInExcessOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf" xlink:to="lab_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_a061f3c3-2f02-4a62-957e-a4a263aa523e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_2d7e3daf-2525-489a-b662-f65d04e04b11_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional number of ordinary shares which have been reserved for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_05f8996a-183a-4744-a050-15409c19eb1b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_f37090fd-6ab2-4f4b-b77d-2305b6e83214_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_822328ee-c000-4ff6-90c5-72786f063a86_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Personnel related liabilities</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_90a5e97f-e39e-4d10-ae32-74b34a5d9fc0_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Charge during the year*</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7b83bdb5-d981-439d-8ffa-9b19ee5ec143_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentShellCompanyReport_e2230689-a104-45f8-afc9-d49c281875db_terseLabel_en-US" xlink:label="lab_dei_DocumentShellCompanyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Shell Company Report</link:label>
    <link:label id="lab_dei_DocumentShellCompanyReport_label_en-US" xlink:label="lab_dei_DocumentShellCompanyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Shell Company Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentShellCompanyReport" xlink:to="lab_dei_DocumentShellCompanyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_ab39bf2a-6ccc-4521-aff4-245d0e7ac972_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StandardPoorsBBBMinusRatingMember_d46ac3d5-7e95-4bf3-a06d-915e60112df4_terseLabel_en-US" xlink:label="lab_srt_StandardPoorsBBBMinusRatingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Standard &amp; Poor's, BBB- Rating</link:label>
    <link:label id="lab_srt_StandardPoorsBBBMinusRatingMember_label_en-US" xlink:label="lab_srt_StandardPoorsBBBMinusRatingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard &amp; Poor's, BBB- Rating [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsBBBMinusRatingMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StandardPoorsBBBMinusRatingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StandardPoorsBBBMinusRatingMember" xlink:to="lab_srt_StandardPoorsBBBMinusRatingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_b83b8862-9139-46e5-a508-fd5ee8b7478e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, remaining performance obligation, expected timing of satisfaction, period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_acb24bef-33b8-4bbd-88d2-7c7b9816d544_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Alternative minimum tax credit carry forwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_252cb7dd-5e7f-4688-913b-97dc6115e3d6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assumptions:</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_e5bb4f73-e589-4720-b2a7-e115a1a19bd1_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_19a93d5f-88d3-48a4-bf79-28d7659a28e6_terseLabel_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Table]</link:label>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_label_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Table]</link:label>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_documentation_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:href="iclr-20241231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:to="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_c017b5f8-141d-49a8-9751-5e71fda0a6fd_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7c0761ba-77ec-4cbe-aeb0-d924cc1d1703_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_75eda160-3830-4546-a2c7-f2be2eee0e18_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cd4fd92f-bbeb-4438-948b-e60aa51cd79c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7ade55cd-c948-47e9-8a53-588cdfd31fc3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2e6459fd-1c2a-4ae7-8840-75118fa85149_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0015fdbc-ec1b-410a-87a9-7fc02795016c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_af8b2a39-0a91-4719-99c0-26dc8b9c53f9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating right-of-use assets (Note 15)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_CorvusPharmaceuticalsMember_d21095a3-f731-4842-9a86-9281ebd0197b_terseLabel_en-US" xlink:label="lab_iclr_CorvusPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corvus Pharmaceuticals</link:label>
    <link:label id="lab_iclr_CorvusPharmaceuticalsMember_label_en-US" xlink:label="lab_iclr_CorvusPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corvus Pharmaceuticals [Member]</link:label>
    <link:label id="lab_iclr_CorvusPharmaceuticalsMember_documentation_en-US" xlink:label="lab_iclr_CorvusPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Corvus Pharmaceuticals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CorvusPharmaceuticalsMember" xlink:href="iclr-20241231.xsd#iclr_CorvusPharmaceuticalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_CorvusPharmaceuticalsMember" xlink:to="lab_iclr_CorvusPharmaceuticalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2d25f728-0179-459d-9aa4-eabb407a52ce_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_42aad350-1e3e-4afc-ace4-d8745f69d11b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OncacareMember_2f157dff-d12b-41a6-9178-66cf7b915411_terseLabel_en-US" xlink:label="lab_iclr_OncacareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Oncacare</link:label>
    <link:label id="lab_iclr_OncacareMember_label_en-US" xlink:label="lab_iclr_OncacareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Oncacare [Member]</link:label>
    <link:label id="lab_iclr_OncacareMember_documentation_en-US" xlink:label="lab_iclr_OncacareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Oncacare</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember" xlink:href="iclr-20241231.xsd#iclr_OncacareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OncacareMember" xlink:to="lab_iclr_OncacareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_077e4ac6-3d29-4108-9cb0-bf06e45a881e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_0f9313f8-c0aa-4292-989d-27663d220a79_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Clients1125Member_ab9fcdbb-5b8e-4efa-b476-5c22458cb668_terseLabel_en-US" xlink:label="lab_iclr_Clients1125Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Clients 11-25</link:label>
    <link:label id="lab_iclr_Clients1125Member_label_en-US" xlink:label="lab_iclr_Clients1125Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Clients 11-25 [Member]</link:label>
    <link:label id="lab_iclr_Clients1125Member_documentation_en-US" xlink:label="lab_iclr_Clients1125Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Clients 11-25 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients1125Member" xlink:href="iclr-20241231.xsd#iclr_Clients1125Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Clients1125Member" xlink:to="lab_iclr_Clients1125Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_b3a6334c-e462-4848-9953-15f52bcfee53_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Income Per Ordinary Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ContractsReceivableGross_d3863c05-4f62-43a5-8263-01e432961726_totalLabel_en-US" xlink:label="lab_iclr_ContractsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable (net)</link:label>
    <link:label id="lab_iclr_ContractsReceivableGross_label_en-US" xlink:label="lab_iclr_ContractsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contracts Receivable, Gross</link:label>
    <link:label id="lab_iclr_ContractsReceivableGross_documentation_en-US" xlink:label="lab_iclr_ContractsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableGross" xlink:href="iclr-20241231.xsd#iclr_ContractsReceivableGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ContractsReceivableGross" xlink:to="lab_iclr_ContractsReceivableGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_92a10497-6aa3-4f22-ab2c-7c406b6aa7cc_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_66f4ed32-d4e7-4ae7-af3e-02fe9023e0bc_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise of share options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_c33a67d2-5b8f-42fc-8085-fbe33194796d_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_8b2e66a0-ca7f-4205-b72b-90795ee279fb_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Gain / (loss) on cash flow hedge</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_9cfd7568-78d3-482a-a8f3-0d72c093e51c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain on cash flow hedge</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_39483c06-0188-41c8-8228-2ec7a6e1b2d8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_d04f1d3d-83da-4671-be05-e193256c06c8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_13b340bf-eefe-424e-af92-d38bd05777a1_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsGross" xlink:to="lab_us-gaap_LeaseholdImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_cbc2b005-0678-452e-8c31-69b007845cfb_terseLabel_en-US" xlink:label="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amounts due to third parties for reimbursable expenses</link:label>
    <link:label id="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_label_en-US" xlink:label="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses</link:label>
    <link:label id="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_documentation_en-US" xlink:label="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:href="iclr-20241231.xsd#iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:to="lab_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAccountingStandard_45568af1-7e24-410c-b7f2-efcf591d1823_terseLabel_en-US" xlink:label="lab_dei_DocumentAccountingStandard" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Accounting Standard</link:label>
    <link:label id="lab_dei_DocumentAccountingStandard_label_en-US" xlink:label="lab_dei_DocumentAccountingStandard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Accounting Standard</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAccountingStandard" xlink:to="lab_dei_DocumentAccountingStandard" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_fd4dac0a-2726-4060-9f4b-05f5b4217058_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AfimmuneLimitedMember_04aaabbb-4cef-4a60-b9e4-0be69585a3a7_terseLabel_en-US" xlink:label="lab_iclr_AfimmuneLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Afimmune Limited</link:label>
    <link:label id="lab_iclr_AfimmuneLimitedMember_label_en-US" xlink:label="lab_iclr_AfimmuneLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Afimmune Limited [Member]</link:label>
    <link:label id="lab_iclr_AfimmuneLimitedMember_documentation_en-US" xlink:label="lab_iclr_AfimmuneLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Afimmune Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AfimmuneLimitedMember" xlink:href="iclr-20241231.xsd#iclr_AfimmuneLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AfimmuneLimitedMember" xlink:to="lab_iclr_AfimmuneLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_0d3ceff4-0a62-44d6-a170-3667f4db43cb_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Drawdown of credit lines and loan facilities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AwardDateAllYearsExcluding2018Member_412a3cd3-eae0-4580-b157-9892b5a06a90_terseLabel_en-US" xlink:label="lab_iclr_AwardDateAllYearsExcluding2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award date, prior to 2018</link:label>
    <link:label id="lab_iclr_AwardDateAllYearsExcluding2018Member_label_en-US" xlink:label="lab_iclr_AwardDateAllYearsExcluding2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Date, All Years Excluding 2018 [Member]</link:label>
    <link:label id="lab_iclr_AwardDateAllYearsExcluding2018Member_documentation_en-US" xlink:label="lab_iclr_AwardDateAllYearsExcluding2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Award Date, Prior to 2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AwardDateAllYearsExcluding2018Member" xlink:href="iclr-20241231.xsd#iclr_AwardDateAllYearsExcluding2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AwardDateAllYearsExcluding2018Member" xlink:to="lab_iclr_AwardDateAllYearsExcluding2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount_a9efcb59-ea6e-4f23-a7be-a6fb3d238dc7_terseLabel_en-US" xlink:label="lab_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investor tax expense on foreign subsidiary earnings</link:label>
    <link:label id="lab_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount_label_en-US" xlink:label="lab_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deferred Tax Provision On Unrepatriated Earnings, Amount</link:label>
    <link:label id="lab_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount_documentation_en-US" xlink:label="lab_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deferred Tax Provision On Unrepatriated Earnings, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount" xlink:href="iclr-20241231.xsd#iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount" xlink:to="lab_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_October2024Member_48ed9453-6d59-4665-b824-6b5e4db6439a_terseLabel_en-US" xlink:label="lab_iclr_October2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">October 2024</link:label>
    <link:label id="lab_iclr_October2024Member_label_en-US" xlink:label="lab_iclr_October2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">October 2024 [Member]</link:label>
    <link:label id="lab_iclr_October2024Member_documentation_en-US" xlink:label="lab_iclr_October2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">October 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_October2024Member" xlink:href="iclr-20241231.xsd#iclr_October2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_October2024Member" xlink:to="lab_iclr_October2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e80418f7-2319-4fb0-a481-eb47340a4d72_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_7bf978c5-f296-468f-9558-b4bbc2ffe2db_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share of losses from equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_055c81ea-dc9d-4f95-ada2-2243c8f7e20a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Loss on equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_b3bc381d-1731-4487-9ef1-20ec9ce6bc78_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested and exercisable at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_814643be-502f-49c9-83fd-b314f40cd671_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income before income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_6b0b8b26-9e30-49dd-a907-99ceaee83a29_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other and non-deductible expenses</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember_a4101564-56c1-434b-8a24-a3f15cfb24b8_terseLabel_en-US" xlink:label="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Secured Revolving Loan</link:label>
    <link:label id="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember_label_en-US" xlink:label="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Secured Revolving Loan Facility [Member]</link:label>
    <link:label id="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember_documentation_en-US" xlink:label="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Secured Revolving Loan Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredRevolvingLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:to="lab_iclr_SeniorSecuredRevolvingLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DecreaseInAmortisation_7373d8b2-27ad-4b69-90b6-29c86f2995fd_terseLabel_en-US" xlink:label="lab_iclr_DecreaseInAmortisation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease in amortisation</link:label>
    <link:label id="lab_iclr_DecreaseInAmortisation_label_en-US" xlink:label="lab_iclr_DecreaseInAmortisation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease In Amortisation</link:label>
    <link:label id="lab_iclr_DecreaseInAmortisation_documentation_en-US" xlink:label="lab_iclr_DecreaseInAmortisation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Decrease In Amortisation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DecreaseInAmortisation" xlink:href="iclr-20241231.xsd#iclr_DecreaseInAmortisation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DecreaseInAmortisation" xlink:to="lab_iclr_DecreaseInAmortisation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_231cf725-982f-4abb-82df-3565b377d5b1_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_6ecc5ffa-1f33-47dd-8c24-f8b4f8325ae9_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</link:label>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_label_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</link:label>
    <link:label id="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_documentation_en-US" xlink:label="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:href="iclr-20241231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:to="lab_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_51f1793b-497e-4648-9eb7-19faefd4c585_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance for deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_10d3b5e6-c54c-4cab-af71-c1d27289318c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance for deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_0824c268-283b-4df5-b2e2-38afaeba396f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accelerated charge on repayments</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c46237ef-890f-4f22-92b9-faca43aa71d4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_f4f16ced-b63b-4e8e-b8cb-f0af483ffd13_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ContractAssetsAbstract_e3bb2846-af31-412f-aa90-728548fcc027_terseLabel_en-US" xlink:label="lab_iclr_ContractAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract Assets [Abstract]</link:label>
    <link:label id="lab_iclr_ContractAssetsAbstract_label_en-US" xlink:label="lab_iclr_ContractAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract Assets [Abstract]</link:label>
    <link:label id="lab_iclr_ContractAssetsAbstract_documentation_en-US" xlink:label="lab_iclr_ContractAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractAssetsAbstract" xlink:href="iclr-20241231.xsd#iclr_ContractAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ContractAssetsAbstract" xlink:to="lab_iclr_ContractAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_b0abf81c-03ce-4621-b6df-7b59a6aca724_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of option price for fair value of ordinary share (in percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock_4bcb81b7-d11d-4ae3-9752-71ff4c0e11d4_terseLabel_en-US" xlink:label="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Financing Cost</link:label>
    <link:label id="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock_label_en-US" xlink:label="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Financing Cost [Table Text Block]</link:label>
    <link:label id="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock_documentation_en-US" xlink:label="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Financing Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:href="iclr-20241231.xsd#iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:to="lab_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCost_81fa73aa-b3ef-431e-a110-face54d5649e_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity securities, FV-NI, cost</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCost_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiCost" xlink:to="lab_us-gaap_EquitySecuritiesFvNiCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_327daa75-a999-4160-b405-f37695b4a531_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_c41c18fb-61b1-4333-98de-dfd44e78b5e8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PercentageOfDebtHedgedByInterestRateDerivatives_02ce1da2-b5ae-4f8f-91fc-ec5f600e2e47_terseLabel_en-US" xlink:label="lab_us-gaap_PercentageOfDebtHedgedByInterestRateDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of debt hedged by interest rate derivatives</link:label>
    <link:label id="lab_us-gaap_PercentageOfDebtHedgedByInterestRateDerivatives_label_en-US" xlink:label="lab_us-gaap_PercentageOfDebtHedgedByInterestRateDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of Debt Hedged by Interest Rate Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PercentageOfDebtHedgedByInterestRateDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PercentageOfDebtHedgedByInterestRateDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PercentageOfDebtHedgedByInterestRateDerivatives" xlink:to="lab_us-gaap_PercentageOfDebtHedgedByInterestRateDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GovernmentAssistanceLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration_0c2bdbbc-e2ca-4440-9fe2-a1953b784393_terseLabel_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Government Assistance, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_GovernmentAssistanceLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Government Assistance, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GovernmentAssistanceLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GovernmentAssistanceLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_GovernmentAssistanceLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_2929b5e4-fe74-4174-83fb-6c844da98b9a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_5cb7b0dc-8b0f-456e-bdb8-833246d603a3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary Shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_f4155c9a-686a-4643-aca7-1c40d609f7c4_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of goodwill and long-lived assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5ab203ab-960b-4e90-b358-1927a7877c0f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_acb4a82e-c847-4ea6-a896-0a50fab15467_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Secured Revolving Loan</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock_b02eeacf-4ce2-4bd5-8bd0-d394f6693a32_terseLabel_en-US" xlink:label="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Components of Income Before Provision for Income Taxes</link:label>
    <link:label id="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock_label_en-US" xlink:label="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Before Income Tax [Table Text Block]</link:label>
    <link:label id="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock_documentation_en-US" xlink:label="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income Before Income Tax, Table</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:href="iclr-20241231.xsd#iclr_IncomeBeforeIncomeTaxTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:to="lab_iclr_IncomeBeforeIncomeTaxTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_f8ad0f44-90ce-4f24-b230-c68a32bd89e3_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_5a32c24a-99de-4b46-9087-433ae60c9b35_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Share issuance costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_ca68d17a-4aa7-4dcb-8340-61104d0e0130_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_20172586-01af-44e7-84eb-3d033cd1df0b_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_94079142-7f5d-4ea8-b678-4d734c837fbe_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total accrued interest and penalties</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_a61cc2d2-ad61-4f91-b711-fed4e21971b5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other restructuring costs</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringCosts" xlink:to="lab_us-gaap_OtherRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorSubordinatedNotesMember_a8d038af-22d0-42f0-9d48-1cd278155f49_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorSubordinatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Secured Notes (the "2026 Notes")</link:label>
    <link:label id="lab_us-gaap_SeniorSubordinatedNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorSubordinatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Subordinated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorSubordinatedNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorSubordinatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorSubordinatedNotesMember" xlink:to="lab_us-gaap_SeniorSubordinatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities_7d95e749-7afc-4061-a9d4-5fadf78d628a_terseLabel_en-US" xlink:label="lab_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities_label_en-US" xlink:label="lab_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Other Liabilities</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities_documentation_en-US" xlink:label="lab_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities" xlink:href="iclr-20241231.xsd#iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities" xlink:to="lab_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7cd463ac-6445-41de-8d41-752f6f7f6dcc_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Capital</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_d45972a8-472c-4404-be15-d60a1ac04f49_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Segment and Geographical Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_ffea7182-9346-4476-a9c8-035eb6b63c3d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StandardPoorsBBPlusRatingMember_3ca18dda-547b-4e5e-b900-54bb1df53956_terseLabel_en-US" xlink:label="lab_srt_StandardPoorsBBPlusRatingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Standard &amp; Poor's, BB+ Rating</link:label>
    <link:label id="lab_srt_StandardPoorsBBPlusRatingMember_label_en-US" xlink:label="lab_srt_StandardPoorsBBPlusRatingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard &amp; Poor's, BB+ Rating [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsBBPlusRatingMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StandardPoorsBBPlusRatingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StandardPoorsBBPlusRatingMember" xlink:to="lab_srt_StandardPoorsBBPlusRatingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_dd2c31e4-fda8-4d5d-b67c-246e7054d9e8_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits at start of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_2d4a4b79-c38f-45f3-b813-b05858671ec1_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits at end of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_cc1a6766-2490-4bb8-8eff-44bb73a611d4_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographic Concentration Risk</link:label>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicConcentrationRiskMember" xlink:to="lab_us-gaap_GeographicConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_43b2ed9e-c4d0-4f30-a324-88224631c63b_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal NOL's</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_ee0420c7-46fa-4082-a8ae-41d24551ab5e_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_cb79917a-b425-4be1-8c13-a03a5a41a8e0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_2f3ef3ca-df00-4331-ab98-5e62faca6c61_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_749640db-7591-47b2-8d83-183a0deeb464_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of countries in which company operates</link:label>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Countries in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_dd906786-a2d4-437c-852a-5994baadd059_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_0cca887e-bae0-47ff-98e3-7960826f0206_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of credit facility, remaining borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_ce171c45-ef8e-4cd3-b443-d58ea8cf240b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repurchase of ordinary shares</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_4ec509e6-e9b9-471f-93ae-2d73f0f5c0ed_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_cedb1fdb-4d02-4b61-aa50-eadd0bab4d40_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments in foreign subsidiaries</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Undistributed Foreign Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_4a5243c6-1bdd-487a-aae6-28d2c4d6d92a_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_ea901f3f-3239-4de5-b8cc-f658e8aacff4_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net and unbilled revenue</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_53484aa5-7bf1-41a4-a835-ceab6373d82b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_a20ee09b-1cdd-482a-ad96-b07b96ea1847_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effects of change in tax rates</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_c58acea8-f4b5-4322-9f88-16e5ac277e66_terseLabel_en-US" xlink:label="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consultants Restricted Stock Units 2019</link:label>
    <link:label id="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_label_en-US" xlink:label="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consultants Restricted Stock Units Twenty Nineteen [Member]</link:label>
    <link:label id="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_documentation_en-US" xlink:label="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Consultants Restricted Stock Units Twenty Nineteen [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:href="iclr-20241231.xsd#iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:to="lab_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0cc38527-57ab-42a2-ba08-012be0b03aca_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_5db57da5-78bb-488e-aac3-13ff18495103_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_WorkforceReductionAndOfficeConsolidationProgramMember_5ee9fe95-6799-4146-a653-237670c5bc00_terseLabel_en-US" xlink:label="lab_iclr_WorkforceReductionAndOfficeConsolidationProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Workforce reduction and onerous contract cost</link:label>
    <link:label id="lab_iclr_WorkforceReductionAndOfficeConsolidationProgramMember_label_en-US" xlink:label="lab_iclr_WorkforceReductionAndOfficeConsolidationProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Workforce Reduction And Office Consolidation Program [Member]</link:label>
    <link:label id="lab_iclr_WorkforceReductionAndOfficeConsolidationProgramMember_documentation_en-US" xlink:label="lab_iclr_WorkforceReductionAndOfficeConsolidationProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Workforce Reduction And Office Consolidation Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_WorkforceReductionAndOfficeConsolidationProgramMember" xlink:href="iclr-20241231.xsd#iclr_WorkforceReductionAndOfficeConsolidationProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_WorkforceReductionAndOfficeConsolidationProgramMember" xlink:to="lab_iclr_WorkforceReductionAndOfficeConsolidationProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_20a5b9a7-0b65-4bfb-b2ad-482adc47b5c3_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_27c276f5-d287-4f79-b929-016bc1e2143a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, remaining performance obligation (in percent)</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_1506a779-b30c-492b-90b4-f2841da344ab_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income per ordinary share (Note 23):</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_469711cf-0441-4b34-8bc7-548593ee3522_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_PerformanceShareUnitMember_1fc0f891-f90b-4c83-b31d-ad92a474ccda_terseLabel_en-US" xlink:label="lab_iclr_PerformanceShareUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance Share Unit (PSUs)</link:label>
    <link:label id="lab_iclr_PerformanceShareUnitMember_label_en-US" xlink:label="lab_iclr_PerformanceShareUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Share Unit [Member]</link:label>
    <link:label id="lab_iclr_PerformanceShareUnitMember_documentation_en-US" xlink:label="lab_iclr_PerformanceShareUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Performance Share Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember" xlink:href="iclr-20241231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_PerformanceShareUnitMember" xlink:to="lab_iclr_PerformanceShareUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_dce64de3-2815-4281-b420-be1f67163772_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_6d64e958-c108-4247-8927-769851105116_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Share repurchase program, number of shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_d5a179b9-cf62-4800-8e7e-2b421473145f_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary shares redeemed (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_88f0722c-9e1f-44ac-998a-3a87694f5d57_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_8ad0c689-62c3-4614-917c-40b631539a13_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_f2b75da8-a1e0-4307-b93c-930df65135c4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax benefit</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_a893af78-f1fb-4b02-a90c-43b0ee0977b6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_54adcbca-884a-4d28-a360-5569727fd11b_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_954be6d0-e3c8-4256-98c0-0162a1083601_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_e26be9c5-872c-4a52-a250-bcce0b1ecdab_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock_b1a15ef7-1d76-498b-8228-37ddc3814c5a_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Non-cash Stock Compensation Expense</link:label>
    <link:label id="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock_label_en-US" xlink:label="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Non Cash Stock Compensation Expense [Table Text Block]</link:label>
    <link:label id="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock_documentation_en-US" xlink:label="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Non Cash Stock Compensation Expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:href="iclr-20241231.xsd#iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:to="lab_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_39e05589-67b3-4d6f-b27a-ea9a8a76a18a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_daa48d69-53f4-4e77-994d-e09d4600f10e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_d4776977-cee3-4d86-b13e-55658a50ebcf_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental Disclosure of Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VehiclesMember_a94d356e-463e-439b-8ead-e204520c1b4e_terseLabel_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Motor vehicles</link:label>
    <link:label id="lab_us-gaap_VehiclesMember_label_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vehicles [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VehiclesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VehiclesMember" xlink:to="lab_us-gaap_VehiclesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4f5b426a-84bd-48a8-bea2-a71c266e9d88_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_c8def453-96f1-4cd1-a38c-bba7fbb2e2c4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RestOfEuropeMember_3d85b5b0-5d74-4211-8ea2-0351bd151a1c_terseLabel_en-US" xlink:label="lab_iclr_RestOfEuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rest of Europe</link:label>
    <link:label id="lab_iclr_RestOfEuropeMember_label_en-US" xlink:label="lab_iclr_RestOfEuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rest Of Europe [Member]</link:label>
    <link:label id="lab_iclr_RestOfEuropeMember_documentation_en-US" xlink:label="lab_iclr_RestOfEuropeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Rest Of Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember" xlink:href="iclr-20241231.xsd#iclr_RestOfEuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RestOfEuropeMember" xlink:to="lab_iclr_RestOfEuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_InterestExpenseCreditOther_99a5d8ce-6f14-461e-8268-c91239d213a8_terseLabel_en-US" xlink:label="lab_iclr_InterestExpenseCreditOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other financing costs</link:label>
    <link:label id="lab_iclr_InterestExpenseCreditOther_label_en-US" xlink:label="lab_iclr_InterestExpenseCreditOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense (Credit), Other</link:label>
    <link:label id="lab_iclr_InterestExpenseCreditOther_documentation_en-US" xlink:label="lab_iclr_InterestExpenseCreditOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Expense (Credit), Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestExpenseCreditOther" xlink:href="iclr-20241231.xsd#iclr_InterestExpenseCreditOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_InterestExpenseCreditOther" xlink:to="lab_iclr_InterestExpenseCreditOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_77a2eba8-7c06-4498-a0b6-7fbc6e8bad6c_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Technology assets</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_df193ee8-2900-40b5-8b54-3ef5c2bd2d9a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_0d0c7d33-aa4d-4762-a95f-5c8737327599_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_471b8d15-325c-4436-9973-fb71f4da3856_terseLabel_en-US" xlink:label="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior secured credit facility and senior secured notes</link:label>
    <link:label id="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_label_en-US" xlink:label="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Secured Credit Facility And Senior Secured Notes [Member]</link:label>
    <link:label id="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_documentation_en-US" xlink:label="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Secured Credit Facility And Senior Secured Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:to="lab_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_7c6e59d6-da28-49d5-ae06-63a20d9f6bc0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transaction and integration related (Note 6)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_7fb6f9c1-391e-4206-8c2b-9fd2ac60cd1f_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Integration related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_079cfbd5-b856-4d6a-b6dc-b1782b944174_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_55daf4fb-f65e-4d3e-8e12-0ebc50e6c418_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_20f39365-f168-4ebf-9b2a-6012543b9fd0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other net assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_08b9234b-ba62-48ca-819d-fca41fe3aaed_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a09a6b9d-939e-4caf-a6d6-20093ff5e609_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_72103db3-6bbe-41e8-885f-d330878357ae_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current tax (benefit)/expense:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermLineOfCredit_4288f19d-90c6-4475-8dd4-f232c09a3550_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermLineOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Non-current bank credit lines, loan facilities and notes, net (Note 13)</link:label>
    <link:label id="lab_us-gaap_LongTermLineOfCredit_label_en-US" xlink:label="lab_us-gaap_LongTermLineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Line of Credit, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermLineOfCredit" xlink:to="lab_us-gaap_LongTermLineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_ba8aafe3-a45b-4fd4-9bd6-534dd0970bff_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Acquisition-related gain</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_d3a18d51-4d78-4fe2-ad88-829cef34b641_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisition related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Bargain Purchase, Gain Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:to="lab_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_4e59d9e6-c2b1-4033-be1e-fdecb278ad32_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated Useful Life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2868a537-ce63-4cce-98b4-4ad57fd910f0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options Granted Under Plans</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_34e898f0-9f04-4df0-9f7c-39613e4e604c_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_c623a8ac-4f4f-4cdb-94ba-597ff50689ed_terseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash acquired from acquisition</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StandardPoorsBBBRatingMember_ac78bf13-44b1-40bc-a2e5-5dff7265935d_terseLabel_en-US" xlink:label="lab_srt_StandardPoorsBBBRatingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Standard &amp; Poor's, BBB Rating</link:label>
    <link:label id="lab_srt_StandardPoorsBBBRatingMember_label_en-US" xlink:label="lab_srt_StandardPoorsBBBRatingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard &amp; Poor's, BBB Rating [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsBBBRatingMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StandardPoorsBBBRatingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StandardPoorsBBBRatingMember" xlink:to="lab_srt_StandardPoorsBBBRatingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_542bcd6e-298b-4e7a-b75b-46a116898942_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_c46158a4-d1ca-4910-9e45-e39ee9d56e06_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total derivatives designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_PersonnelRelatedLiabilitiesMember_b7d0a7d8-c969-4685-bdc3-1c6ef76bea2d_terseLabel_en-US" xlink:label="lab_iclr_PersonnelRelatedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Personnel related liabilities</link:label>
    <link:label id="lab_iclr_PersonnelRelatedLiabilitiesMember_label_en-US" xlink:label="lab_iclr_PersonnelRelatedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Personnel Related Liabilities [Member]</link:label>
    <link:label id="lab_iclr_PersonnelRelatedLiabilitiesMember_documentation_en-US" xlink:label="lab_iclr_PersonnelRelatedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Personnel Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PersonnelRelatedLiabilitiesMember" xlink:href="iclr-20241231.xsd#iclr_PersonnelRelatedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_PersonnelRelatedLiabilitiesMember" xlink:to="lab_iclr_PersonnelRelatedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_SeniorSecuredNotesDueMay2029Member_4d19d69f-1bcc-4ea6-9f16-9af198544338_terseLabel_en-US" xlink:label="lab_iclr_SeniorSecuredNotesDueMay2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Secured Notes (the "2029 Notes")*</link:label>
    <link:label id="lab_iclr_SeniorSecuredNotesDueMay2029Member_label_en-US" xlink:label="lab_iclr_SeniorSecuredNotesDueMay2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Secured Notes Due May 2029 [Member]</link:label>
    <link:label id="lab_iclr_SeniorSecuredNotesDueMay2029Member_documentation_en-US" xlink:label="lab_iclr_SeniorSecuredNotesDueMay2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Secured Notes Due May 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesDueMay2029Member" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredNotesDueMay2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_SeniorSecuredNotesDueMay2029Member" xlink:to="lab_iclr_SeniorSecuredNotesDueMay2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_c95f6596-e3bf-4806-b8f4-f6aaf5609d1c_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Laboratory equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1a7753eb-45cd-43cd-af0d-8cf7c4285bed_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average number of ordinary shares outstanding (Note 23):</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_7786188c-6112-4bf1-b357-9f4f3aad6748_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_79d45c23-5fc8-4f26-82d3-4d1354874f00_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Direct costs</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_33c1a91a-b61f-4f80-a10b-1b9970131865_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_933b3416-5c13-45a7-b602-869651b222ba_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_aaaa24c3-2221-413c-a9a2-72fae42a0bf2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current other liabilities (Note 16)</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_5c598cc4-0b63-4564-844e-dd7f2a55acb9_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DatabasesMember_7290ab8d-0aff-499b-91e8-3d2f6c442de1_terseLabel_en-US" xlink:label="lab_us-gaap_DatabasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Patient database</link:label>
    <link:label id="lab_us-gaap_DatabasesMember_label_en-US" xlink:label="lab_us-gaap_DatabasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Database Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DatabasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DatabasesMember" xlink:to="lab_us-gaap_DatabasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_f5df1b3f-0eb7-437d-bab7-7ffac5a5d26b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_c8558184-6bd1-4cd2-a687-915b5eb265f4_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies (Note 17)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_9c9e55c9-d245-454d-8ac4-73373ece6215_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_3a0402cc-d881-4d55-9dd0-111b10f8fd35_terseLabel_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Line Items]</link:label>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_label_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Line Items]</link:label>
    <link:label id="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_documentation_en-US" xlink:label="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Compensation Related Costs Share Based Payments Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:href="iclr-20241231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:to="lab_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_February2024Member_42b42b2d-aed5-4b5f-a023-3c33a25adf35_terseLabel_en-US" xlink:label="lab_iclr_February2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">February 2024</link:label>
    <link:label id="lab_iclr_February2024Member_label_en-US" xlink:label="lab_iclr_February2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">February 2024 [Member]</link:label>
    <link:label id="lab_iclr_February2024Member_documentation_en-US" xlink:label="lab_iclr_February2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">February 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_February2024Member" xlink:href="iclr-20241231.xsd#iclr_February2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_February2024Member" xlink:to="lab_iclr_February2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_c9f0789e-94ca-41a2-87dc-6fc771bbc077_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Reconciliation of Consolidated Reported Provision for Income Taxes and Statutory Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_f25fcdbd-c29f-44b5-9b65-fc9ba59ed1e7_negatedTerseLabel_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Change in unearned revenue (payments on account)</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_label_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Contracts With Customers, Liability, Current</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_documentation_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Contracts With Customers, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:href="iclr-20241231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:to="lab_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_295bd208-fdc4-48ac-ba10-6ef355dc0b62_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Description of business</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b16c4f9e-5602-4624-98d9-d8023e3ca0ac_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4e354eb5-9b16-4049-b365-3faa2a71fdaa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_4c21b5c7-adcd-478c-a255-6d529e763826_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_6cd26311-dfbe-438a-9d5e-96b68879af81_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_c0d13f6f-358d-48ac-8df5-62abdddd5f9b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Distribution of Net Revenue by Geographical Area</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_7a389c3a-9cf3-4bfc-9526-ee5ccf0333ad_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_The2020LegacyPRAPlanMember_0a0edcb8-655a-4df1-869a-24998e96a7f6_terseLabel_en-US" xlink:label="lab_iclr_The2020LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">The 2020 Legacy PRA Plan</link:label>
    <link:label id="lab_iclr_The2020LegacyPRAPlanMember_label_en-US" xlink:label="lab_iclr_The2020LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The 2020 Legacy PRA Plan [Member]</link:label>
    <link:label id="lab_iclr_The2020LegacyPRAPlanMember_documentation_en-US" xlink:label="lab_iclr_The2020LegacyPRAPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The 2020 Legacy PRA Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2020LegacyPRAPlanMember" xlink:href="iclr-20241231.xsd#iclr_The2020LegacyPRAPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_The2020LegacyPRAPlanMember" xlink:to="lab_iclr_The2020LegacyPRAPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_22454a6a-2e95-4569-a334-7609c8cea29b_terseLabel_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Line Items]</link:label>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_label_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Line Items]</link:label>
    <link:label id="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_documentation_en-US" xlink:label="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reconciliation of Provision of Income Taxes [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:href="iclr-20241231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:to="lab_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_7aa99d10-cb1b-4859-9ea6-b2ee5f04272c_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_dc3fdbf8-0602-4bce-b57b-163dc8a12e12_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ConsultantsStockPlan2008PlanMember_23bccdb9-9a8f-4748-a5aa-282deddf807b_terseLabel_en-US" xlink:label="lab_iclr_ConsultantsStockPlan2008PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consultants Stock Plan, 2008 Plan</link:label>
    <link:label id="lab_iclr_ConsultantsStockPlan2008PlanMember_label_en-US" xlink:label="lab_iclr_ConsultantsStockPlan2008PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consultants Stock Plan, 2008 Plan [Member]</link:label>
    <link:label id="lab_iclr_ConsultantsStockPlan2008PlanMember_documentation_en-US" xlink:label="lab_iclr_ConsultantsStockPlan2008PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Consultants Stock Plan, 2008 Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsStockPlan2008PlanMember" xlink:href="iclr-20241231.xsd#iclr_ConsultantsStockPlan2008PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ConsultantsStockPlan2008PlanMember" xlink:to="lab_iclr_ConsultantsStockPlan2008PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_69548e61-b748-4e75-9073-114b4d8de4e7_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_b27b88d9-7e27-44cd-b964-faafe5a70652_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_eb9636e7-573d-4715-afdb-d76d77499674_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_7fbe1e18-b33a-4cdf-b3a5-62134d9a1483_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a2804e29-7528-448c-a04e-539a8b982640_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rate movements on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_88fe2b69-feed-49e9-9bae-1e7f6c23e6fe_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefit, potentially expire in 2021</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_a0ad3f23-b1b7-4348-bccc-2e273bba3659_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cancelable operating leases for facilities expiration period</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c4e0a18c-a7cf-437e-8917-69b9d16a16a8_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options exercisable, intrinsic value (in USD)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateDomain_11009bb5-2fac-41e9-9cba-8edbed35eb15_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AwardDateDomain_label_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateDomain" xlink:to="lab_us-gaap_AwardDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_d7cc053a-ebcf-440d-a1ec-e548b1dc590a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_634fbd07-259a-42e9-8bda-e9adb6eed30f_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment in debt, equity and other</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_3c1fd3b4-e914-494c-9292-7e11251cae21_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_SeniorSecuredNotesDueMay2027Member_9e635022-851d-4c95-a901-c30c7cddcc3a_terseLabel_en-US" xlink:label="lab_iclr_SeniorSecuredNotesDueMay2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Secured Notes (the "2027 Notes")*</link:label>
    <link:label id="lab_iclr_SeniorSecuredNotesDueMay2027Member_label_en-US" xlink:label="lab_iclr_SeniorSecuredNotesDueMay2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Secured Notes Due May 2027 [Member]</link:label>
    <link:label id="lab_iclr_SeniorSecuredNotesDueMay2027Member_documentation_en-US" xlink:label="lab_iclr_SeniorSecuredNotesDueMay2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Secured Notes Due May 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesDueMay2027Member" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredNotesDueMay2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_SeniorSecuredNotesDueMay2027Member" xlink:to="lab_iclr_SeniorSecuredNotesDueMay2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_fe8052ef-54c6-4fd6-8179-9e76318a1db9_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Buildings</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_5aaf49be-a9ad-4b85-a475-aac36bda98ca_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Decrease related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_VariableRateComponentDomain_b67c3f0a-2839-4fbd-a716-64b599101883_terseLabel_en-US" xlink:label="lab_iclr_VariableRateComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate Component [Domain]</link:label>
    <link:label id="lab_iclr_VariableRateComponentDomain_label_en-US" xlink:label="lab_iclr_VariableRateComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate Component [Domain]</link:label>
    <link:label id="lab_iclr_VariableRateComponentDomain_documentation_en-US" xlink:label="lab_iclr_VariableRateComponentDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Variable Rate Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentDomain" xlink:href="iclr-20241231.xsd#iclr_VariableRateComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_VariableRateComponentDomain" xlink:to="lab_iclr_VariableRateComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillFairValueDisclosure_9bf88f22-6a0e-4365-9c68-a3f4ea530b41_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_GoodwillFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillFairValueDisclosure" xlink:to="lab_us-gaap_GoodwillFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments_da3e89f5-d0c3-4054-a382-cbcd50ad65e4_terseLabel_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange</link:label>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments_label_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Allowance For Doubtful Accounts Foreign Currency Translation Adjustments</link:label>
    <link:label id="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments_documentation_en-US" xlink:label="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Allowance For Doubtful Accounts Foreign Currency Translation Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:href="iclr-20241231.xsd#iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:to="lab_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_NonexecutiveDirectorMember_0c7ca6df-45aa-45c9-aeff-9be87e6f9451_terseLabel_en-US" xlink:label="lab_iclr_NonexecutiveDirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-executive director</link:label>
    <link:label id="lab_iclr_NonexecutiveDirectorMember_label_en-US" xlink:label="lab_iclr_NonexecutiveDirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-executive Director [Member]</link:label>
    <link:label id="lab_iclr_NonexecutiveDirectorMember_documentation_en-US" xlink:label="lab_iclr_NonexecutiveDirectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-executive Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NonexecutiveDirectorMember" xlink:href="iclr-20241231.xsd#iclr_NonexecutiveDirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_NonexecutiveDirectorMember" xlink:to="lab_iclr_NonexecutiveDirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3c8c24f6-05ba-41d9-b039-74bed78e300f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss (Note 24)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fa292fbf-564f-4f2f-b7fa-40d7e9fa1d43_totalLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">&#160;Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_61e68721-2bc5-478b-9ec5-dc6b35f9cbf0_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7c7cef6b-bd2b-48bf-bfa5-a96841e9f24e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6c8a0c70-42aa-4b34-9f7b-27cc184038b1_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average number of ordinary shares outstanding for basic net income per ordinary share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_876709a8-5815-4339-bafd-ef707840c65c_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent_611513eb-cc3f-481f-8815-ef6b53d4d821_terseLabel_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in unbilled services (unbilled revenue)</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent_label_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Contract With Customer, Asset, Gross, Current</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent_documentation_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Contract With Customer, Asset, Gross, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent" xlink:href="iclr-20241231.xsd#iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent" xlink:to="lab_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_457d2498-c8cc-49c4-8861-14ccbc0c2824_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Revenue</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_6d209c2e-d03e-4b00-976c-828e35504ad5_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Canceled/expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_fe0487a5-c5cb-499c-8083-4bdcbda53620_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filler Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_eedaad7d-7655-4ba3-ac70-189eddeeb586_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bad debt expense</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:to="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_62e98f93-c120-4d86-8e89-3c9524353fe2_terseLabel_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating loss and tax credits carryforwards</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_label_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets Operating Loss And Tax Credits Carryforwards</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_documentation_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets Operating Loss And Tax Credits Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:href="iclr-20241231.xsd#iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:to="lab_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_d80d6a72-da52-4a1a-981d-3dd90c23157a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, remaining performance obligation, amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_04d20f55-a409-4d3b-9291-e2b651b19229_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring reserve, current</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveCurrent" xlink:to="lab_us-gaap_RestructuringReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_835c5085-9a48-4dc1-808f-c7dd3877272e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current period acquisitions (note 6)</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_f1a23185-0be6-4d07-8601-735cf45f784e_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_PerformanceBasedGrantsMember_8e386950-4eec-44f0-9f98-b9caf219a797_terseLabel_en-US" xlink:label="lab_iclr_PerformanceBasedGrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PSUs Based on Service and EPS Targets</link:label>
    <link:label id="lab_iclr_PerformanceBasedGrantsMember_label_en-US" xlink:label="lab_iclr_PerformanceBasedGrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Based Grants [Member]</link:label>
    <link:label id="lab_iclr_PerformanceBasedGrantsMember_documentation_en-US" xlink:label="lab_iclr_PerformanceBasedGrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Performance Based Grants [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceBasedGrantsMember" xlink:href="iclr-20241231.xsd#iclr_PerformanceBasedGrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_PerformanceBasedGrantsMember" xlink:to="lab_iclr_PerformanceBasedGrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_58c41163-0ca4-4751-85cf-a5f06d1799b0_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Lease Costs</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_128dbde4-c3ae-48a2-8a34-18b8efc7ae8d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities (Note 12)</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_35865f62-b836-43d2-b4d8-086b301fcbc3_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_49336d59-b3dc-4c95-83e8-510b6e9a1454_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total unrecognized tax benefits net of potential benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_260dab31-64d5-4968-8afe-9eba2acf7a0d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TaxCreditCarryForwardIncreaseDecreaseAmount_8ea00319-e8a6-4ac7-90d6-ecc7d7951a51_terseLabel_en-US" xlink:label="lab_iclr_TaxCreditCarryForwardIncreaseDecreaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) tax credit carry forward</link:label>
    <link:label id="lab_iclr_TaxCreditCarryForwardIncreaseDecreaseAmount_label_en-US" xlink:label="lab_iclr_TaxCreditCarryForwardIncreaseDecreaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carry forward Increase (Decrease) , Amount</link:label>
    <link:label id="lab_iclr_TaxCreditCarryForwardIncreaseDecreaseAmount_documentation_en-US" xlink:label="lab_iclr_TaxCreditCarryForwardIncreaseDecreaseAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Credit Carry forward Increase (Decrease) , Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxCreditCarryForwardIncreaseDecreaseAmount" xlink:href="iclr-20241231.xsd#iclr_TaxCreditCarryForwardIncreaseDecreaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TaxCreditCarryForwardIncreaseDecreaseAmount" xlink:to="lab_iclr_TaxCreditCarryForwardIncreaseDecreaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_aa59dae9-b6c4-4c07-9d0a-a1cf80191d23_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income per Ordinary Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8ff314e6-3607-4cee-9165-0b76655c3948_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_VariableRateComponentAxis_513a361a-0122-4b04-8e8d-829585b877d5_terseLabel_en-US" xlink:label="lab_iclr_VariableRateComponentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate Component [Axis]</link:label>
    <link:label id="lab_iclr_VariableRateComponentAxis_label_en-US" xlink:label="lab_iclr_VariableRateComponentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate Component [Axis]</link:label>
    <link:label id="lab_iclr_VariableRateComponentAxis_documentation_en-US" xlink:label="lab_iclr_VariableRateComponentAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Variable Rate Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentAxis" xlink:href="iclr-20241231.xsd#iclr_VariableRateComponentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_VariableRateComponentAxis" xlink:to="lab_iclr_VariableRateComponentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_38344a87-8f30-40ec-9986-4a12c196fa31_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credit carry forward</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_3f845485-1930-499c-afb2-7cf42d25dc54_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_d8060f85-ff8e-4ea7-9a2c-62a56329e091_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for income taxes (net of refunds)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GovernmentAssistanceLiabilityCurrent_a8859e05-1f5f-4cf1-8f24-a555f3490b94_terseLabel_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short term government grants</link:label>
    <link:label id="lab_us-gaap_GovernmentAssistanceLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Government Assistance, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GovernmentAssistanceLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GovernmentAssistanceLiabilityCurrent" xlink:to="lab_us-gaap_GovernmentAssistanceLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_e6046ed8-66e9-4269-ae58-f5bd04e115f9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_b9e41b5e-b341-44e9-85ce-b6a29bd7361f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesTableTextBlock_d17a5717-b85b-40ad-a3d7-d10f6cb00a57_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1a0005d0-d94b-4c7c-a7e5-727e8bf58d17_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax (benefit)/expense:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_76a0c32b-2bf6-4e15-8283-2ae4f803c03a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_e582ad5d-2e3d-4380-90b2-f7e317ad33f0_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_e4524040-4215-4f0a-b766-f4b3f71fab39_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_label_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="lab_dei_EntityAddressesAddressTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f8aa76a6-9e8a-4f99-98b7-fb7b4f072f1c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_633a4067-8856-4ddb-8146-41b3d8147667_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_cd779939-b863-4955-9d74-04661c8a4f8a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary shares, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e54585fa-e213-4bda-b2f0-dcea4b0575db_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_f266fe04-804a-493d-92fc-9077d34d84db_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease costs</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_a4932711-eeea-4b99-b63a-7e8fe4112bc7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock units to be granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_440f2cf3-0019-4b17-8c26-c553b6e7a601_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities (Note 15)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_9fb1c6ea-3f33-4e8d-b80e-cf58b2fa5c9f_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating lease, liability, noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_633e89da-016c-4004-976c-1e3e43eb6283_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unearned revenue (Note 4)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_712ef05a-c801-4bf4-99de-625ea37dd783_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unearned revenue (payments on account)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_ac97f26b-9ba7-4f96-9ce2-841a4e986188_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_40dc4585-a811-4465-bca9-05e0e433f8c0_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ResearchAndDevelopmentCreditsPolicyTextBlock_87ef3424-5836-4f5c-b8b8-107b2129ff33_terseLabel_en-US" xlink:label="lab_iclr_ResearchAndDevelopmentCreditsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development credits</link:label>
    <link:label id="lab_iclr_ResearchAndDevelopmentCreditsPolicyTextBlock_label_en-US" xlink:label="lab_iclr_ResearchAndDevelopmentCreditsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development Credits [Policy Text Block]</link:label>
    <link:label id="lab_iclr_ResearchAndDevelopmentCreditsPolicyTextBlock_documentation_en-US" xlink:label="lab_iclr_ResearchAndDevelopmentCreditsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research and Development Credits [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ResearchAndDevelopmentCreditsPolicyTextBlock" xlink:href="iclr-20241231.xsd#iclr_ResearchAndDevelopmentCreditsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ResearchAndDevelopmentCreditsPolicyTextBlock" xlink:to="lab_iclr_ResearchAndDevelopmentCreditsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_d39d45de-22a3-4f10-b0ce-cab9d2f7bfc7_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TermLoanFacilityMember_37876333-012c-42eb-8252-ff9a299e243a_terseLabel_en-US" xlink:label="lab_iclr_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Secured Term Loan</link:label>
    <link:label id="lab_iclr_TermLoanFacilityMember_label_en-US" xlink:label="lab_iclr_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:label id="lab_iclr_TermLoanFacilityMember_documentation_en-US" xlink:label="lab_iclr_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Loan Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember" xlink:href="iclr-20241231.xsd#iclr_TermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TermLoanFacilityMember" xlink:to="lab_iclr_TermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_500f1448-e5e6-4214-9660-27332eddbb27_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income per ordinary share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_cd610533-228b-4417-b206-276977531604_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StandardPoorsBBBPlusRatingMember_01c520eb-74d7-4531-935d-2624b8d273a3_terseLabel_en-US" xlink:label="lab_srt_StandardPoorsBBBPlusRatingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Standard &amp; Poor's, BBB+ Rating</link:label>
    <link:label id="lab_srt_StandardPoorsBBBPlusRatingMember_label_en-US" xlink:label="lab_srt_StandardPoorsBBBPlusRatingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard &amp; Poor's, BBB+ Rating [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsBBBPlusRatingMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StandardPoorsBBBPlusRatingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StandardPoorsBBBPlusRatingMember" xlink:to="lab_srt_StandardPoorsBBBPlusRatingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_5207e098-715b-486b-bf05-d3cc61173927_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_5e2e62a2-de38-464d-a31b-4fd546226302_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_7201c28b-aed2-441b-9dc9-66e14576a02f_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade names &amp; brands</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_cf5b8711-e899-43b2-94b5-7e606c38d3a3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pro forma net income (loss)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_LongTermDebtCurrentMaturitiesGross_ffa279a5-0949-4cdb-a52c-cbb05984a2db_negatedTerseLabel_en-US" xlink:label="lab_iclr_LongTermDebtCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less current portion of debt</link:label>
    <link:label id="lab_iclr_LongTermDebtCurrentMaturitiesGross_label_en-US" xlink:label="lab_iclr_LongTermDebtCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Current Maturities, Gross</link:label>
    <link:label id="lab_iclr_LongTermDebtCurrentMaturitiesGross_documentation_en-US" xlink:label="lab_iclr_LongTermDebtCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Long-term Debt, Current Maturities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtCurrentMaturitiesGross" xlink:href="iclr-20241231.xsd#iclr_LongTermDebtCurrentMaturitiesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_LongTermDebtCurrentMaturitiesGross" xlink:to="lab_iclr_LongTermDebtCurrentMaturitiesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_3306d0d3-e081-452e-bc04-89759b999eb8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notional</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OperatingIncomeByGeographyTableTextBlock_4ca4bc60-1a06-4194-b3ce-59ca9276d0fe_terseLabel_en-US" xlink:label="lab_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Distribution of Income from Operations by Geographical Area</link:label>
    <link:label id="lab_iclr_OperatingIncomeByGeographyTableTextBlock_label_en-US" xlink:label="lab_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income by Geography [Table Text Block]</link:label>
    <link:label id="lab_iclr_OperatingIncomeByGeographyTableTextBlock_documentation_en-US" xlink:label="lab_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Income by Geography.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:href="iclr-20241231.xsd#iclr_OperatingIncomeByGeographyTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:to="lab_iclr_OperatingIncomeByGeographyTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax_29df53e0-7425-4e7b-bf22-49aa994f112a_terseLabel_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain / (loss) on cash flow hedge</link:label>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Loss, Cash Flow Hedge, Gain / (Loss), Reclassification, after Tax</link:label>
    <link:label id="lab_iclr_AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax_documentation_en-US" xlink:label="lab_iclr_AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Loss, Cash Flow Hedge, Loss, Reclassification, After Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="iclr-20241231.xsd#iclr_AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_iclr_AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_4edb219d-ea57-41f8-9422-a31dc2fa5ed1_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_7c4890c4-f9f1-41f7-9338-171cb232a4eb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGrossCurrent_b01ef365-17fe-4016-86b9-b40ee4750336_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unbilled services (unbilled revenue)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGrossCurrent_2b706f2e-8981-4263-bf5d-0d7aefc848d0_netLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Unbilled services (unbilled revenue)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGrossCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_fdacdd3f-bf93-4ded-93ac-77c0925035d9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options outstanding, intrinsic value (in USD)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_SeniorSecuredNotesMember_bbe7f648-ef38-4bda-a1bf-a1171458149e_terseLabel_en-US" xlink:label="lab_iclr_SeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Secured Notes (the "2026 Notes")</link:label>
    <link:label id="lab_iclr_SeniorSecuredNotesMember_label_en-US" xlink:label="lab_iclr_SeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Secured Notes [Member]</link:label>
    <link:label id="lab_iclr_SeniorSecuredNotesMember_documentation_en-US" xlink:label="lab_iclr_SeniorSecuredNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Secured Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesMember" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_SeniorSecuredNotesMember" xlink:to="lab_iclr_SeniorSecuredNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_b6a26240-fb09-47c0-89bc-993ed98cf38a_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_88c4c5de-2ee4-4b11-9a1a-37f2972db945_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c431c4ae-39b2-4432-aa32-2b54dd186ef9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_60337b72-fc6d-4e79-9600-54cd3d3840bb_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net change in the total valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateAxis_2decc80e-1e94-4096-bb95-d15ad310a572_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardDateAxis_label_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateAxis" xlink:to="lab_us-gaap_AwardDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_b0309cea-5fe6-48e4-ac6a-538f61a34023_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Provision for Credit Losses</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_1ea282bd-c6d2-4e22-88fc-d716e05792f7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_cda2d5f4-6c28-4d4a-9719-52c685424266_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock_eae8fdb6-5d8c-4dc7-a4ea-3e9ab3567111_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current other liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Noncurrent [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrderOrProductionBacklogMember_2bef0d61-f978-4cec-948b-ec82db898094_terseLabel_en-US" xlink:label="lab_us-gaap_OrderOrProductionBacklogMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Order backlog</link:label>
    <link:label id="lab_us-gaap_OrderOrProductionBacklogMember_label_en-US" xlink:label="lab_us-gaap_OrderOrProductionBacklogMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Order or Production Backlog [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrderOrProductionBacklogMember" xlink:to="lab_us-gaap_OrderOrProductionBacklogMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_87e352c4-2563-443b-9153-ffa13773bfd0_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9b32a802-9892-4ab8-8d39-3ff2de841478_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_b5bae742-8aea-49a9-8b7c-b1e2b708cfc3_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Carrying value of long-term investments in equity</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_9e3f902f-9bb3-41c0-8522-29fabf59c3d8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_0cf4426a-adef-4727-aca1-bc441d98b995_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_91ccb5bf-1715-4621-b70b-3e9c31670018_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of fair value of financial instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent_4f654d8e-20eb-4846-a503-18019a47fa2e_terseLabel_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage change in net balance</link:label>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent_label_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent</link:label>
    <link:label id="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent_documentation_en-US" xlink:label="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:href="iclr-20241231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:to="lab_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8e00426e-d88d-47e5-a852-d69865ada79a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares vested (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_3409ab6b-f953-448a-9836-ea08c6a0a163_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of interest rate derivatives held</link:label>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_label_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Interest Rate Derivatives Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:to="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_64504f46-2b46-4087-a56c-e356d68d267a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_2d882b83-bda8-4f2c-85da-708e31339887_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0d244883-4cf6-4064-8c31-17ace662f099_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis spread on variable rate (in percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ContactPersonnelEmailAddress_b8d7bcdc-cbfd-4ca6-b10d-7be558d26137_terseLabel_en-US" xlink:label="lab_dei_ContactPersonnelEmailAddress" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contact Personnel Email Address</link:label>
    <link:label id="lab_dei_ContactPersonnelEmailAddress_label_en-US" xlink:label="lab_dei_ContactPersonnelEmailAddress" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contact Personnel Email Address</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelEmailAddress" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelEmailAddress"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelEmailAddress" xlink:to="lab_dei_ContactPersonnelEmailAddress" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireLongtermInvestments_1acdb053-22e8-4bab-9725-247503824c45_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of investments in equity</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireLongtermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_6dfb82a6-b2e3-4eab-8f76-75fe63289130_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b583de4c-9367-446e-a9ca-1bdae775c6c6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Average exercise price of option per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_65e21fe8-b82e-41f9-8cd4-0a1f828edd12_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Exercised (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f6dd28a4-8d72-47ef-9612-d0e9b8634af3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding number of shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_0a0ba2aa-e669-4fd0-bc3a-dab3fce6083f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value, nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetAbstract_018227bd-81d2-4ca1-9398-42a068b28b5e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract" xlink:to="lab_us-gaap_AccountsReceivableNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_AuditInformationAbstract_label_en-US" xlink:label="lab_iclr_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_iclr_AuditInformationAbstract_documentation_en-US" xlink:label="lab_iclr_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AuditInformationAbstract" xlink:href="iclr-20241231.xsd#iclr_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_AuditInformationAbstract" xlink:to="lab_iclr_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9304ec84-7119-4c95-957a-e9a1f29aca2a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_162f4f0f-e174-4367-a5ea-a71e741d2d68_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary shares, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_bdbed5b3-a4bc-4b15-945d-291e56e03c82_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_16d0e942-9c7c-410e-954a-170dbb6fa466_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_NumberOfLocations_847134e0-86a5-4959-810f-fdb8bafc989f_terseLabel_en-US" xlink:label="lab_iclr_NumberOfLocations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of locations in which company operates</link:label>
    <link:label id="lab_iclr_NumberOfLocations_label_en-US" xlink:label="lab_iclr_NumberOfLocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Locations</link:label>
    <link:label id="lab_iclr_NumberOfLocations_documentation_en-US" xlink:label="lab_iclr_NumberOfLocations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Locations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfLocations" xlink:href="iclr-20241231.xsd#iclr_NumberOfLocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_NumberOfLocations" xlink:to="lab_iclr_NumberOfLocations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6131fb58-56f3-4e00-bd69-0977c76a0a68_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_59dfe6c3-2f20-462f-aae7-30829f358e5b_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Percentage of company revenue (in percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_f87e78cc-d172-428a-8f1a-dbff60f262ae_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income before income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_d511065f-4e8b-44af-91e1-730e297255b9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_c7a615bd-6ac5-4894-a8c5-5722e2f1ed4c_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d0421d80-bdb8-4811-8ccf-10e63c5ec5a1_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less accumulated depreciation and asset write offs</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_71f37623-1df0-4f92-889f-f4e8b330c75d_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reimbursable expenses and Direct costs</link:label>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Clients610Member_4fe40190-db61-478b-9e29-8e82ee39fe75_terseLabel_en-US" xlink:label="lab_iclr_Clients610Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Clients 6-10</link:label>
    <link:label id="lab_iclr_Clients610Member_label_en-US" xlink:label="lab_iclr_Clients610Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Clients 6-10 [Member]</link:label>
    <link:label id="lab_iclr_Clients610Member_documentation_en-US" xlink:label="lab_iclr_Clients610Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Clients 6-10 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients610Member" xlink:href="iclr-20241231.xsd#iclr_Clients610Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Clients610Member" xlink:to="lab_iclr_Clients610Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_261b1eda-f8b6-41d6-ad81-c771ca3a64e2_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_9ae9126f-c68e-4ec3-b9b0-cba1504979fb_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary shares, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e8c5fbcb-8b47-42bb-87e0-0c401e1be4de_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments to acquire businesses, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_4075e8d4-3867-498d-b0a9-d2fa01516697_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCosts_2de4096c-103a-42de-945a-5c928e32b37e_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restructuring (Note 19)</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_c78ce4b3-ecbb-4346-882e-4467b6c0e76d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts" xlink:to="lab_us-gaap_RestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_09c88ee8-6f69-421e-b611-ee3ca43f37af_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_35c833c0-e181-432a-9b3b-c834b268d297_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Supplemental Disclosure of Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_4a84efcc-da9a-4999-8a72-364bc2ad3e0b_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_6dc304d8-de2a-4b2b-a96b-6cb6ff181d03_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_95780536-60da-4979-808b-bf05e27ae7d0_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest expense (Note 13)</link:label>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_cd0cdb60-a6c3-481f-8599-dc2da0efe1b5_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_a671eb94-a2ef-4d14-ad1e-6ae46127e9cd_totalLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total financing costs</link:label>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_label_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseNonoperating" xlink:to="lab_us-gaap_InterestExpenseNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_dc1ced98-bd91-4d88-b8e9-ff1c821ae26d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax (benefit)/expense</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_GovernmentGrantsPolicyTextBlock_6dddc534-6c39-4fa7-bb5e-fb0c932f2044_terseLabel_en-US" xlink:label="lab_iclr_GovernmentGrantsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Government grants</link:label>
    <link:label id="lab_iclr_GovernmentGrantsPolicyTextBlock_label_en-US" xlink:label="lab_iclr_GovernmentGrantsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Government Grants [Policy Text Block]</link:label>
    <link:label id="lab_iclr_GovernmentGrantsPolicyTextBlock_documentation_en-US" xlink:label="lab_iclr_GovernmentGrantsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Government Grants, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GovernmentGrantsPolicyTextBlock" xlink:href="iclr-20241231.xsd#iclr_GovernmentGrantsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_GovernmentGrantsPolicyTextBlock" xlink:to="lab_iclr_GovernmentGrantsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_c7568620-b484-471c-babb-2b882f0c916d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1160c205-2d1e-4a11-998c-deecd813a33e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_30d6768c-ca8d-4dcc-879d-dba27258b47c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_14423a01-3d95-42e0-a4ce-981641945bf6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash tax benefit related to stock options exercised</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_63513147-c34e-4a3b-b8f3-87097c1d9ca2_negatedLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Amounts used during the year</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyAbstract_d0857e41-2e1b-4163-b11c-7b73126afea5_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency [Abstract]</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyAbstract_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyAbstract" xlink:to="lab_us-gaap_ForeignCurrencyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_d4e2c256-553f-4c67-bde4-c6b0f5283437_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_dff0e40c-4821-4b74-9ab9-9535884a5d0e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net of allowance for credit losses (Note 4)</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_895d9177-53c3-44f3-91e6-3ee21acb4c51_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum number of shares per employee (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6225aad0-7683-4ce8-b6cc-75ee9cd3ecf7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_a7068796-c729-41c4-a2e7-dc2df2765030_totalLabel_en-US" xlink:label="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income before share of losses from equity method investments</link:label>
    <link:label id="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_label_en-US" xlink:label="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) From Continuing Operations Before Equity Method Investments, Noncontrolling Interest</link:label>
    <link:label id="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_documentation_en-US" xlink:label="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income (Loss) From Continuing Operations Before Equity Method Investments, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:href="iclr-20241231.xsd#iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:to="lab_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_7c95df64-3e58-4f52-b6b0-36fbb2d0403e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_d123a5a4-f8bd-4473-a23f-20acefe903f3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Retirement benefit obligations</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_a12c2a07-b235-4fa9-a389-44582a96463b_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_53f53a1d-a2ba-458b-ab4b-2925c7383ed0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c2a19c71-330c-424b-bf86-152c29ecfb4b_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Shares vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_PaymentsForBrokerCommissionShareRepurchaseCosts_df3d5154-8b8d-48ce-979e-612dfd95d9ea_negatedLabel_en-US" xlink:label="lab_iclr_PaymentsForBrokerCommissionShareRepurchaseCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Share repurchase costs</link:label>
    <link:label id="lab_iclr_PaymentsForBrokerCommissionShareRepurchaseCosts_label_en-US" xlink:label="lab_iclr_PaymentsForBrokerCommissionShareRepurchaseCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments For Broker Commission Share Repurchase Costs</link:label>
    <link:label id="lab_iclr_PaymentsForBrokerCommissionShareRepurchaseCosts_documentation_en-US" xlink:label="lab_iclr_PaymentsForBrokerCommissionShareRepurchaseCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments For Broker Commission Share Repurchase Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PaymentsForBrokerCommissionShareRepurchaseCosts" xlink:href="iclr-20241231.xsd#iclr_PaymentsForBrokerCommissionShareRepurchaseCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_PaymentsForBrokerCommissionShareRepurchaseCosts" xlink:to="lab_iclr_PaymentsForBrokerCommissionShareRepurchaseCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_fe715398-f50c-4582-b310-7a824b5e1e2f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk free interest rate (in percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment_0b184335-4e2e-4af8-ac8d-9aa35a5cb904_terseLabel_en-US" xlink:label="lab_iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of operating right-of-use assets and related property, plant and equipment</link:label>
    <link:label id="lab_iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment, Operating Right-Of-Use Assets And Related Property, Plant And Equipment</link:label>
    <link:label id="lab_iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment_documentation_en-US" xlink:label="lab_iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Impairment, Operating Right-Of-Use Assets And Related Property, Plant And Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment" xlink:href="iclr-20241231.xsd#iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment" xlink:to="lab_iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_a3cd7092-68bf-4da9-88d9-c7cd4de6687f_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_f7040bab-14fa-44fb-a83c-e02e6fe2aac9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Amortization on intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_9a688a19-0e75-419c-bcb3-a16a26376690_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_ac8dff39-0f8c-4f3d-b20e-23cf88b71d5f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_e37e632f-7a5f-4786-bbb0-65d05c545af8_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_8a3d1ff9-0a3b-4251-8a28-08a1dd0d3f03_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt discount paid</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_c1e4f625-72bf-4def-8c7f-1b58d647247b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_f8e443bc-5cbc-444b-aff7-815f64fea066_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_8d012364-32f3-4093-b2ea-b7b138c0c5cb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Lease imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_StockRepurchaseProgramAuthorizedPercentage_5a42ffa6-e9df-440d-9506-d66ed9607d5b_terseLabel_en-US" xlink:label="lab_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase program, authorized percentage (in percent)</link:label>
    <link:label id="lab_iclr_StockRepurchaseProgramAuthorizedPercentage_label_en-US" xlink:label="lab_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program Authorized Percentage</link:label>
    <link:label id="lab_iclr_StockRepurchaseProgramAuthorizedPercentage_documentation_en-US" xlink:label="lab_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program Authorized Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:href="iclr-20241231.xsd#iclr_StockRepurchaseProgramAuthorizedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:to="lab_iclr_StockRepurchaseProgramAuthorizedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78464867-facd-411b-bd51-cded5327d6d0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a1ea796a-17ae-4233-98bf-bd9de1d01e72_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issue of restricted share units / performance share units (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CountryRegion_c1cc9e61-5afa-4957-b660-d588a85e9fac_terseLabel_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Country Region</link:label>
    <link:label id="lab_dei_CountryRegion_label_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Country Region</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CountryRegion" xlink:to="lab_dei_CountryRegion" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_970343f0-d3b3-45b2-8150-376eb67b95bb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax asset (Note 20)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2adba555-fc0a-4745-b380-86ba08142246_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_87a3a8f9-1136-45e0-9225-42c31d71fcfe_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_310f9ed4-7034-41ed-ab2b-792a9789e5b7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_25c7f098-5c09-4846-bde1-6d625d52045b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Unbilled revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BiotelResearchLLCMember_f154423f-7114-4e09-b8ff-e046fa482a06_terseLabel_en-US" xlink:label="lab_iclr_BiotelResearchLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Biotel Research LLC</link:label>
    <link:label id="lab_iclr_BiotelResearchLLCMember_label_en-US" xlink:label="lab_iclr_BiotelResearchLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Biotel Research LLC [Member]</link:label>
    <link:label id="lab_iclr_BiotelResearchLLCMember_documentation_en-US" xlink:label="lab_iclr_BiotelResearchLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Biotel Research LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BiotelResearchLLCMember" xlink:href="iclr-20241231.xsd#iclr_BiotelResearchLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BiotelResearchLLCMember" xlink:to="lab_iclr_BiotelResearchLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAssetsArisingFromContingenciesAmountRecognized_3dda65fc-7f1a-45f0-93d7-5f2bc0c5c2c2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAssetsArisingFromContingenciesAmountRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAssetsArisingFromContingenciesAmountRecognized_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAssetsArisingFromContingenciesAmountRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Assets Arising from Contingencies, Amount Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAssetsArisingFromContingenciesAmountRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAssetsArisingFromContingenciesAmountRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAssetsArisingFromContingenciesAmountRecognized" xlink:to="lab_us-gaap_BusinessCombinationAssetsArisingFromContingenciesAmountRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross_a8a36b0d-bbc1-45eb-ab3d-ad2ff99b1ce6_terseLabel_en-US" xlink:label="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross_label_en-US" xlink:label="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Excluding Current Maturities, Gross</link:label>
    <link:label id="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross_documentation_en-US" xlink:label="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Long-term Debt, Excluding Current Maturities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:href="iclr-20241231.xsd#iclr_LongTermDebtExcludingCurrentMaturitiesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:to="lab_iclr_LongTermDebtExcludingCurrentMaturitiesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_CommitmentToAcquireLongTermInvestments_dbf1d667-e15d-4c2d-86e0-95de336cd9ee_terseLabel_en-US" xlink:label="lab_iclr_CommitmentToAcquireLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitment to acquire future long-term investments</link:label>
    <link:label id="lab_iclr_CommitmentToAcquireLongTermInvestments_label_en-US" xlink:label="lab_iclr_CommitmentToAcquireLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitment To Acquire Long-Term Investments</link:label>
    <link:label id="lab_iclr_CommitmentToAcquireLongTermInvestments_documentation_en-US" xlink:label="lab_iclr_CommitmentToAcquireLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Commitment To Acquire Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CommitmentToAcquireLongTermInvestments" xlink:href="iclr-20241231.xsd#iclr_CommitmentToAcquireLongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_CommitmentToAcquireLongTermInvestments" xlink:to="lab_iclr_CommitmentToAcquireLongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_358e5619-323d-4a90-80c2-eb6432adba25_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of recently issued or adopted accounting standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_c7dafb9f-4141-4ca8-ba40-6396d97c1d75_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title and Position [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title and Position [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d8267883-228b-455f-9ad8-7694b668661e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_4b3d73f0-5b12-4cbc-81ae-fa21dac6507d_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_1ef57b43-a06c-4855-9330-5050b9a965e3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reduction in carrying value of operating right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_8efa35a7-2437-4331-9b73-01d5667ace46_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RestrictedStockUnitsTwentyThirteenMember_fb90594d-4d3d-4915-8630-d705bc7c8677_terseLabel_en-US" xlink:label="lab_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Units 2013</link:label>
    <link:label id="lab_iclr_RestrictedStockUnitsTwentyThirteenMember_label_en-US" xlink:label="lab_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units Twenty Thirteen [Member]</link:label>
    <link:label id="lab_iclr_RestrictedStockUnitsTwentyThirteenMember_documentation_en-US" xlink:label="lab_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restricted Stock Units Twenty Thirteen [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:href="iclr-20241231.xsd#iclr_RestrictedStockUnitsTwentyThirteenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:to="lab_iclr_RestrictedStockUnitsTwentyThirteenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_7ef7a0c3-6552-4052-a458-136422b9fdcf_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_706977be-e920-4802-a6bf-b611b200cc53_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reporting segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability_3f7bcffd-7b5d-4eec-911d-297bad52702c_terseLabel_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability_label_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Lease, Liability</link:label>
    <link:label id="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability_documentation_en-US" xlink:label="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:href="iclr-20241231.xsd#iclr_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:to="lab_iclr_DeferredTaxAssetsOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_ef8173c7-d8fe-4732-9d2e-90b63da296ea_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_138a11cf-5ddd-4e38-91e5-03aa941e2bba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unrealized foreign exchange movements</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrealized Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_481acec2-150b-4e7b-8529-a18d5d14e09f_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_be32a365-cdeb-48fc-95e6-5a8de8bcac5f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_d9ba2cab-4ae0-40a2-8793-07c6dcca1175_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityNumberOfEmployees_6c1e462a-7834-47c8-b879-f05068e0472b_terseLabel_en-US" xlink:label="lab_dei_EntityNumberOfEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of employees</link:label>
    <link:label id="lab_dei_EntityNumberOfEmployees_label_en-US" xlink:label="lab_dei_EntityNumberOfEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Number of Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityNumberOfEmployees" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityNumberOfEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityNumberOfEmployees" xlink:to="lab_dei_EntityNumberOfEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_1d4f1439-304f-49e6-9cec-f989a43af3fd_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets recognized</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_7796da08-2469-4e33-b02d-0ec45873262e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measured at Net Asset Value Per Share [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:to="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_3abe1f3c-a0bd-4d6f-be5f-20457df02b8d_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments in equity (Note 8)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities, FV-NI and without Readily Determinable Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:to="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_12fb84f6-4733-479a-94f8-c975805faea3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, interest rate (in percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_ff513b3f-ce15-4dec-a840-9324f02026dc_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_VariableRateComponentTwoMember_f487b25b-9a62-4800-a142-2bdf790a7a22_terseLabel_en-US" xlink:label="lab_iclr_VariableRateComponentTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable rate component two</link:label>
    <link:label id="lab_iclr_VariableRateComponentTwoMember_label_en-US" xlink:label="lab_iclr_VariableRateComponentTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate Component Two [Member]</link:label>
    <link:label id="lab_iclr_VariableRateComponentTwoMember_documentation_en-US" xlink:label="lab_iclr_VariableRateComponentTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Variable Rate Component Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentTwoMember" xlink:href="iclr-20241231.xsd#iclr_VariableRateComponentTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_VariableRateComponentTwoMember" xlink:to="lab_iclr_VariableRateComponentTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_4eedc204-e900-45dc-94ba-c16191eaa75c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in equity securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:to="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_831fc952-3efb-4451-a684-33e5e1218613_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CreditRatingStandardPoorsAxis_ca48c35a-e02c-4b19-a5d0-4e07c993ae8d_terseLabel_en-US" xlink:label="lab_srt_CreditRatingStandardPoorsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Rating, Standard &amp; Poor's [Axis]</link:label>
    <link:label id="lab_srt_CreditRatingStandardPoorsAxis_label_en-US" xlink:label="lab_srt_CreditRatingStandardPoorsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Rating, Standard &amp; Poor's [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CreditRatingStandardPoorsAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CreditRatingStandardPoorsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CreditRatingStandardPoorsAxis" xlink:to="lab_srt_CreditRatingStandardPoorsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_3ac603d1-c6e8-4504-81f6-32066a1a7cde_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_Clients25Member_3dbc8cf2-88a6-48e5-a80e-680cf5822a74_terseLabel_en-US" xlink:label="lab_iclr_Clients25Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Clients 2-5</link:label>
    <link:label id="lab_iclr_Clients25Member_label_en-US" xlink:label="lab_iclr_Clients25Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Clients 2-5 [Member]</link:label>
    <link:label id="lab_iclr_Clients25Member_documentation_en-US" xlink:label="lab_iclr_Clients25Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Clients 2-5 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients25Member" xlink:href="iclr-20241231.xsd#iclr_Clients25Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_Clients25Member" xlink:to="lab_iclr_Clients25Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_677fa9b3-3667-4fa5-b556-f1f985f3d499_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_7d83eb24-acda-4e80-a6ce-2cf44d05e9ca_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock_8df60d49-8c1e-45dc-ae8d-bcfa254117b9_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated useful lives of assets</link:label>
    <link:label id="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock_label_en-US" xlink:label="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Useful Lives For Property Plant Equipment [Table Text Block]</link:label>
    <link:label id="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock_documentation_en-US" xlink:label="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule Of Useful Lives For Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:href="iclr-20241231.xsd#iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:to="lab_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherUndenominatedCapital_2d0daaa0-3e76-490e-a9a4-5119dd03eb73_terseLabel_en-US" xlink:label="lab_iclr_OtherUndenominatedCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other undenominated capital (Note 18b)</link:label>
    <link:label id="lab_iclr_OtherUndenominatedCapital_label_en-US" xlink:label="lab_iclr_OtherUndenominatedCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Undenominated Capital</link:label>
    <link:label id="lab_iclr_OtherUndenominatedCapital_documentation_en-US" xlink:label="lab_iclr_OtherUndenominatedCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other undenominated capital.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapital" xlink:href="iclr-20241231.xsd#iclr_OtherUndenominatedCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherUndenominatedCapital" xlink:to="lab_iclr_OtherUndenominatedCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_f1bb78b2-f70c-492e-9f78-adbb2917afee_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_4fa10acf-409a-4891-84e7-78b2cce192be_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Movement in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_264acd0c-576e-49ff-8a14-4d46a04c7e0f_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_24dc7775-cf9a-4294-b531-d2ab81b6c2d8_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_c76e2437-1b8f-4f75-b1e0-55741ad3d4fe_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_3227fe4f-d5b4-4c93-a1b5-1838f538524d_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_6509765d-40a1-4474-aa74-92d8980f4c2f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of operating right-of-use assets and related property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:to="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_45ad33aa-dc42-4d06-93b8-7fc271490b85_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount_952da44c-6023-42f0-ae50-f1aac05fce51_terseLabel_en-US" xlink:label="lab_iclr_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(Decrease)/ increase in unrecognized tax benefits</link:label>
    <link:label id="lab_iclr_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount_label_en-US" xlink:label="lab_iclr_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Unrecognized Tax Benefits, Amount</link:label>
    <link:label id="lab_iclr_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount_documentation_en-US" xlink:label="lab_iclr_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Unrecognized Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" xlink:href="iclr-20241231.xsd#iclr_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" xlink:to="lab_iclr_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_7bc45fe6-92af-417c-94ab-afac6d3eee24_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b4cf699c-f416-4c3c-8015-6033f22c5fb8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RestOfEuropeAndOtherCountriesMember_7dfecf3b-c89c-4e27-a3f4-a88281460ea9_terseLabel_en-US" xlink:label="lab_iclr_RestOfEuropeAndOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_iclr_RestOfEuropeAndOtherCountriesMember_label_en-US" xlink:label="lab_iclr_RestOfEuropeAndOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rest Of Europe And Other Countries [Member]</link:label>
    <link:label id="lab_iclr_RestOfEuropeAndOtherCountriesMember_documentation_en-US" xlink:label="lab_iclr_RestOfEuropeAndOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Rest Of Europe And Other Countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeAndOtherCountriesMember" xlink:href="iclr-20241231.xsd#iclr_RestOfEuropeAndOtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RestOfEuropeAndOtherCountriesMember" xlink:to="lab_iclr_RestOfEuropeAndOtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_1d98474a-4189-4c36-9857-20e7661f563a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_0ec9d3e8-2d8b-4a7a-b4b7-ce2c45d937ec_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets obtained in exchange for lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOfCommonParentMember_1d8f5fc9-6516-4168-9a19-4007214ba441_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOfCommonParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiaries</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOfCommonParentMember_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOfCommonParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiary of Common Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOfCommonParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOfCommonParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOfCommonParentMember" xlink:to="lab_us-gaap_SubsidiaryOfCommonParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_DebtInstrumentDiscountRate_ad893048-5374-431c-8f49-d7da91d5cee5_terseLabel_en-US" xlink:label="lab_iclr_DebtInstrumentDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, discount rate on underwriting (in percent)</link:label>
    <link:label id="lab_iclr_DebtInstrumentDiscountRate_label_en-US" xlink:label="lab_iclr_DebtInstrumentDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Discount Rate</link:label>
    <link:label id="lab_iclr_DebtInstrumentDiscountRate_documentation_en-US" xlink:label="lab_iclr_DebtInstrumentDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DebtInstrumentDiscountRate" xlink:href="iclr-20241231.xsd#iclr_DebtInstrumentDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_DebtInstrumentDiscountRate" xlink:to="lab_iclr_DebtInstrumentDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5a3e907a-7147-44c5-8033-f081bd7c09fc_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_534af346-6567-49e9-a936-738cca5c4e8b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_KCRS.AGroupMember_27cfc3b9-8e66-4366-b447-60d97d135eff_terseLabel_en-US" xlink:label="lab_iclr_KCRS.AGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">KCR S.A Group</link:label>
    <link:label id="lab_iclr_KCRS.AGroupMember_label_en-US" xlink:label="lab_iclr_KCRS.AGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">KCR S.A Group [Member]</link:label>
    <link:label id="lab_iclr_KCRS.AGroupMember_documentation_en-US" xlink:label="lab_iclr_KCRS.AGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">KCR S.A Group</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_KCRS.AGroupMember" xlink:href="iclr-20241231.xsd#iclr_KCRS.AGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_KCRS.AGroupMember" xlink:to="lab_iclr_KCRS.AGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_f632cdda-99f5-4329-9f5c-fcfb04b454e2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_4cbb6164-3423-432c-9952-58b8e77ad2a5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_062f08bf-e452-404e-81cc-640c6d6959da_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_label_en-US" xlink:label="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Effects Allocated Directly to Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity" xlink:to="lab_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_8a7c4f98-6fdd-4680-85e8-ace76b54f72a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_bf32b3a2-e84c-4b28-a721-89f450c31fa5_negatedLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Income from sub-leases</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_d2fa8bf7-e8a5-4e0d-a922-8d0eaa99af66_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business combination, consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_9194dad0-c5ef-471f-933e-be7f26770179_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_eaabd085-e754-4bde-afba-f8e933e20d5c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative financial instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_ae2ff7c3-cdf2-4491-9563-4250a316daf6_terseLabel_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share price of equity instruments other than options, vested in period (in USD per share)</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_label_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share</link:label>
    <link:label id="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_documentation_en-US" xlink:label="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:href="iclr-20241231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:to="lab_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_b0de44e2-5f1b-4b8b-819a-095f0406c26c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less debt issuance costs and debt discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_290abe6d-8444-402c-b753-fdbcb0566ba1_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Office furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesGross" xlink:to="lab_us-gaap_FurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_3fca2078-9ca7-451a-9a95-3052805e2a0a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative, fixed interest rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFixedInterestRate" xlink:to="lab_us-gaap_DerivativeFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_a7505c8e-075f-41d2-b9ad-90473df98abb_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAnnualPrincipalPayment_37684354-27bb-4cab-aca4-4cfd8c278987_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Total repayments</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAnnualPrincipalPayment_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Annual Principal Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:to="lab_us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivables_ba823e55-d22c-4489-b237-d2e7bb4f0aaa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivables_label_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivables" xlink:to="lab_us-gaap_OtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_cb5051a7-cd7f-4377-a02b-f3ea7b9842c2_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_00dc638f-d404-4394-ab9f-003aed31555a_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current bank credit lines, loan facilities and notes (Note 13)</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditCurrent" xlink:to="lab_us-gaap_LinesOfCreditCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_52e329b7-fdca-489d-aa9e-05c2c816b6dc_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary shares issued in respect of certain PSUs previously awarded by the Company (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_8e32cc58-ede9-4c5a-bfc8-b99148240093_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_28c3f02d-c8d1-46f8-aa8a-2e451dabcb9b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pro forma revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_InterestRateCapAndInterestRateSwapMember_fd36b5c0-f3b5-49d6-9bc3-f3cd93976244_terseLabel_en-US" xlink:label="lab_iclr_InterestRateCapAndInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total derivatives designated as hedging instruments</link:label>
    <link:label id="lab_iclr_InterestRateCapAndInterestRateSwapMember_label_en-US" xlink:label="lab_iclr_InterestRateCapAndInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Cap And Interest Rate Swap [Member]</link:label>
    <link:label id="lab_iclr_InterestRateCapAndInterestRateSwapMember_documentation_en-US" xlink:label="lab_iclr_InterestRateCapAndInterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Rate Cap And Interest Rate Swap</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestRateCapAndInterestRateSwapMember" xlink:href="iclr-20241231.xsd#iclr_InterestRateCapAndInterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_InterestRateCapAndInterestRateSwapMember" xlink:to="lab_iclr_InterestRateCapAndInterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_faf62f00-d2d6-4ad3-9752-e83fe811c08d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_94ec9f58-f185-4ad8-ab91-ddf6073b6962_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_23f133e0-d463-45ea-84b7-68e519941e6c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Tax Effects of Temporary Differences that Give Rise to Significant Portions of Deferred Tax Assets and Deferred Tax Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_c41e9508-9cfa-4af7-b2c1-14cdac92cde3_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shareholders' Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_e0a1860d-3d33-4c60-ac65-fd32f66b8b03_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Other Finite-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_RestructuringReserveUtilizations_ae9e25c7-b7f2-437c-925f-7b6c1bfdf174_negatedLabel_en-US" xlink:label="lab_iclr_RestructuringReserveUtilizations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Utilization</link:label>
    <link:label id="lab_iclr_RestructuringReserveUtilizations_label_en-US" xlink:label="lab_iclr_RestructuringReserveUtilizations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve Utilizations</link:label>
    <link:label id="lab_iclr_RestructuringReserveUtilizations_documentation_en-US" xlink:label="lab_iclr_RestructuringReserveUtilizations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restructuring Reserve Utilizations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestructuringReserveUtilizations" xlink:href="iclr-20241231.xsd#iclr_RestructuringReserveUtilizations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_RestructuringReserveUtilizations" xlink:to="lab_iclr_RestructuringReserveUtilizations" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_77f19715-db4b-4fb6-b7f3-b2e9c330d690_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TaxYear20392043Member_9492c1bd-c77a-46a0-87fe-6dd7586cf45f_terseLabel_en-US" xlink:label="lab_iclr_TaxYear20392043Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2039-2043</link:label>
    <link:label id="lab_iclr_TaxYear20392043Member_label_en-US" xlink:label="lab_iclr_TaxYear20392043Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Year 2039 - 2043 [Member]</link:label>
    <link:label id="lab_iclr_TaxYear20392043Member_documentation_en-US" xlink:label="lab_iclr_TaxYear20392043Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Year 2039 - 2043</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear20392043Member" xlink:href="iclr-20241231.xsd#iclr_TaxYear20392043Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TaxYear20392043Member" xlink:to="lab_iclr_TaxYear20392043Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_044e82d9-4eae-4f82-9e6c-f4df3ce75bf4_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Buildings &#160;</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_b82527e3-41af-4540-8884-8dc645aba8d3_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_df868174-c4b2-4027-aaa3-ddd57e79e76f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromShortTermInvestments_8206451e-29c6-4c55-b933-bdeddc4d9cf5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Movement of available for sale investments</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for (Proceeds from) Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:to="lab_us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_676aa3e5-52d4-43b3-885e-cc5ca735cfbd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_f494a827-7a00-46c0-83b6-320de290ffea_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized share-based compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AddressTypeDomain_cb416f4b-07b1-4ec5-89ea-5f6a99ddd9c3_terseLabel_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:label id="lab_dei_AddressTypeDomain_label_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain" xlink:to="lab_dei_AddressTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_PRAHealthSciencesIncMember_d10ce767-05b8-417d-9471-1ada7e5fbcaa_terseLabel_en-US" xlink:label="lab_iclr_PRAHealthSciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PRA Health Sciences, Inc</link:label>
    <link:label id="lab_iclr_PRAHealthSciencesIncMember_label_en-US" xlink:label="lab_iclr_PRAHealthSciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PRA Health Sciences, Inc [Member]</link:label>
    <link:label id="lab_iclr_PRAHealthSciencesIncMember_documentation_en-US" xlink:label="lab_iclr_PRAHealthSciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PRA Health Sciences, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember" xlink:href="iclr-20241231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_PRAHealthSciencesIncMember" xlink:to="lab_iclr_PRAHealthSciencesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_2598e574-2e52-46d0-b861-dd18de8d654d_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_ec0b4369-1a18-4bd2-bbfe-8efed306bc75_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-U.S subsidiaries operating loss carryforwards for income tax</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_5008561b-586b-44ed-95e7-bbbb4361822e_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards, not subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_33467b97-129e-4f6d-8353-6d999d495321_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_01322c16-8bfb-4271-acd1-95ff70a18ad4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liability (Note 20)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1ca96b28-e9b0-4d95-8a6e-bb4cd3dd86ab_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility (in percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherCountriesMember_882e2e4a-980b-4254-9f0a-43a1e1271586_terseLabel_en-US" xlink:label="lab_iclr_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_iclr_OtherCountriesMember_label_en-US" xlink:label="lab_iclr_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:label id="lab_iclr_OtherCountriesMember_documentation_en-US" xlink:label="lab_iclr_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember" xlink:href="iclr-20241231.xsd#iclr_OtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherCountriesMember" xlink:to="lab_iclr_OtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_4181b75b-8e69-43dc-a416-36d16724b92e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c995cd26-014d-4bd2-a878-d0ddbcb5a5c4_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Value of intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ShareRepurchaseProgramDomain_5d1422b0-bd1b-40e5-b091-71ba1d682de7_terseLabel_en-US" xlink:label="lab_srt_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_srt_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_srt_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ShareRepurchaseProgramDomain" xlink:to="lab_srt_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_d2e37b5f-0482-4bc6-9122-cfa2b25358c5_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_10c5be81-193a-4a56-ae5f-10ec8014f3e3_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Share issue costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e656db36-4ec5-427a-8db3-2dd291c40f6d_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_VariableRateComponentOneMember_751470bb-5096-41e4-a51f-1c3168af96c1_terseLabel_en-US" xlink:label="lab_iclr_VariableRateComponentOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable rate component one</link:label>
    <link:label id="lab_iclr_VariableRateComponentOneMember_label_en-US" xlink:label="lab_iclr_VariableRateComponentOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate Component One [Member]</link:label>
    <link:label id="lab_iclr_VariableRateComponentOneMember_documentation_en-US" xlink:label="lab_iclr_VariableRateComponentOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Variable Rate Component One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentOneMember" xlink:href="iclr-20241231.xsd#iclr_VariableRateComponentOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_VariableRateComponentOneMember" xlink:to="lab_iclr_VariableRateComponentOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_94f283ce-764c-496c-97e6-378907866b2e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issue of restricted share units / performance share units</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_2f76c265-80fa-4ed0-a4a7-37aaf323cb79_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase related to current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_cc9d8bb1-143c-4040-bec7-47d49ca2d642_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareGross_90676d6c-cbe3-4e2c-abbf-93b166b096f8_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Computer equipment and software</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareGross_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Computer Software, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareGross" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_14e854bb-618f-4bcb-b924-6c6f0dd24f26_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_978f9fb0-e411-4279-b26c-dafd3ed1a29a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General trade and overhead liabilities</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_4422c1c4-b3b6-40d9-b642-0c2bc2861f80_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_BusinessContactMember_3345a38f-b440-4ad0-8fe5-ff0e38c377c0_terseLabel_en-US" xlink:label="lab_dei_BusinessContactMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Contact</link:label>
    <link:label id="lab_dei_BusinessContactMember_label_en-US" xlink:label="lab_dei_BusinessContactMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Contact [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_BusinessContactMember" xlink:to="lab_dei_BusinessContactMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter_19bd5ecf-c7d6-4a45-9f81-c43c9ccae9ad_terseLabel_en-US" xlink:label="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029 and thereafter</link:label>
    <link:label id="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter_label_en-US" xlink:label="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Five And Thereafter</link:label>
    <link:label id="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter_documentation_en-US" xlink:label="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Five And Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:href="iclr-20241231.xsd#iclr_LongTermDebtMaturityYearFiveAndThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:to="lab_iclr_LongTermDebtMaturityYearFiveAndThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_9e911151-6eee-4d9f-bab1-9a703b58ee6a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_3d04e0e2-27e3-4972-a998-09b64fbb0d87_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_79040a07-29c8-47b5-846c-4ba98fc7115d_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_b5f3bd4d-afbc-4d3c-8a3d-0dc12f5ee644_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_d7252986-46ac-43d8-889b-2a27f9f3f7b0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_country_IE_539198e7-5aa6-46d9-b379-f78b5eece683_terseLabel_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ireland</link:label>
    <link:label id="lab_country_IE_label_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IRELAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IE" xlink:to="lab_country_IE" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_9a4c22cc-895d-44e0-a4a2-4eebfb12b5b3_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense on drawn facilities</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_8084d740-95b3-4ef9-b9cd-aa9efbc0edf5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_40a2466b-99a0-4ce8-b7e7-2d540c467e18_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant accounting policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_7fb811fd-bd20-4398-ba1c-5221d1591b48_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_StockOptionAndAwardPlansMember_6a762938-80f6-4e03-ac08-3e8d6742c0a8_terseLabel_en-US" xlink:label="lab_iclr_StockOptionAndAwardPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Option and Award Plans</link:label>
    <link:label id="lab_iclr_StockOptionAndAwardPlansMember_label_en-US" xlink:label="lab_iclr_StockOptionAndAwardPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Option And Award Plans [Member]</link:label>
    <link:label id="lab_iclr_StockOptionAndAwardPlansMember_documentation_en-US" xlink:label="lab_iclr_StockOptionAndAwardPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Option And Award Plans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockOptionAndAwardPlansMember" xlink:href="iclr-20241231.xsd#iclr_StockOptionAndAwardPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_StockOptionAndAwardPlansMember" xlink:to="lab_iclr_StockOptionAndAwardPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_f60a7bfc-7ec2-406c-a0b1-6f2370a97c23_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_bc28e0ae-8a7b-40b8-a66b-f58ceef974fb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_25dd9242-176b-4c55-85f4-efeac820ae1d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_549c6a6c-df78-4129-b616-cea9d113bc0d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_49409a11-5ea8-41ee-ace1-bdfcc141af41_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_83b4c890-2781-448d-9550-1e283d3fbc6b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_9c8c148f-956b-420a-9acc-5b3b76d154e1_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_44f949ef-20b4-4f84-b6b7-27f3aa8e8823_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense:</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_798795f2-0234-42a9-a28d-3c4d29ea69ed_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_04552247-67c8-45a9-990c-51e64da31ba6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business combination, revenue of acquiree since acquisition date, actual</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_691cb680-1ce3-4c3d-b3dd-a9d248610942_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ea9eaeac-ca22-456b-8d0c-057d745b0829_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average fair value (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_1e226c3e-61f9-46ce-8aa8-a9f1265c9a36_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt securities, available for sale, cumulative amount advanced under subscription agreements</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_97a2ec45-9088-4127-bd16-4fcf98ade276_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Well Known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncomeTaxBenefitMember_842938bb-2baf-407d-9d2e-e14ca25a55fa_terseLabel_en-US" xlink:label="lab_iclr_IncomeTaxBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_iclr_IncomeTaxBenefitMember_label_en-US" xlink:label="lab_iclr_IncomeTaxBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Benefit [Member]</link:label>
    <link:label id="lab_iclr_IncomeTaxBenefitMember_documentation_en-US" xlink:label="lab_iclr_IncomeTaxBenefitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income Tax Benefit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeTaxBenefitMember" xlink:href="iclr-20241231.xsd#iclr_IncomeTaxBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncomeTaxBenefitMember" xlink:to="lab_iclr_IncomeTaxBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_d04a4481-b47e-4077-8472-86473edfd7d1_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_bdfe63b0-1560-40e0-b3ab-5794b0a968a1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_8d421560-0f9e-4bd9-a729-28611adfccba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repurchase of ordinary shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_8ea03107-2f69-428c-b18f-a903d94c6303_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary shares redeemed, value</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4bd93937-b484-4d3b-8eef-16374384a183_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_ca04cb16-af17-452b-86cf-9731d24a0d55_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAbstract" xlink:to="lab_us-gaap_NetIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_c3846d89-78e4-4746-b335-16bf06fb0e86_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Expected Expiry Dates of NOL's</link:label>
    <link:label id="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Summary of Operating Loss Carryforwards [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:to="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4386160c-67f1-465c-9822-b90c49384060_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_bf0b5d9a-6962-4ef2-89e5-1298e09e4b81_terseLabel_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtPolicyTextBlock" xlink:to="lab_us-gaap_DebtPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_665ef3bb-52df-4f5a-9256-9d702747f34f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average discount rate (in percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_7b029bc6-b989-48cc-b556-1c19cbc25047_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_ffb218be-5264-4793-bf3b-e6d951654872_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_c8584abf-0f9d-4ec5-9e53-f499d6926033_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_2f51e137-d19b-4c2e-9fb3-f78fe7c645a5_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt at fair value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_4f6e8da5-0d49-48bc-813a-47b62900c60e_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_eac4fb67-d50b-4b33-807a-cacbac3316a8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of subsidiary undertakings (net of cash acquired)</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_4e483a2f-5a8d-4de8-8e0f-91fa22ed8032_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase of subsidiary undertakings (net of cash acquired)</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_87763f3f-8906-4ee1-acb0-6683ea066f98_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair value of cash consideration</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_c1feca71-3260-4ad0-b0f5-0705abb1dc55_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4c528d2a-cf61-4e81-825a-3e65dda5f80c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock_14fbd46b-0cfa-4fa8-ac0e-b74e1cb91060_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Principal Payments on Debt Instrument</link:label>
    <link:label id="lab_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock_label_en-US" xlink:label="lab_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Principal Payments on Debt Instrument [Table Text Block]</link:label>
    <link:label id="lab_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock_documentation_en-US" xlink:label="lab_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Principal Payments on Debt Instrument</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock" xlink:href="iclr-20241231.xsd#iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock" xlink:to="lab_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_da99c68a-b09f-4495-b3e3-86dd9ea2cd60_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_25510058-ada8-4bd6-9045-ca6e68a8f57c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign and other income taxed at higher rates</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_3de51b32-f88a-4eb9-b45e-c056fb369385_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherCustomersMember_7cb33f26-14a6-4e26-8840-49470cc8ce7b_terseLabel_en-US" xlink:label="lab_iclr_OtherCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_iclr_OtherCustomersMember_label_en-US" xlink:label="lab_iclr_OtherCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Customers [Member]</link:label>
    <link:label id="lab_iclr_OtherCustomersMember_documentation_en-US" xlink:label="lab_iclr_OtherCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCustomersMember" xlink:href="iclr-20241231.xsd#iclr_OtherCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherCustomersMember" xlink:to="lab_iclr_OtherCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_03091826-f426-42e8-a9c2-32810de1429c_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_1e088c8b-a94b-4bb0-b3bb-e1b251696e2d_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_ad085e0e-6b28-4ee6-aea3-8652ceeefeef_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3faee61b-6d0b-4cf0-bb52-98087dad42ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Cost [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Cost [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_95eec847-10a3-47bb-9788-477282ec0dac_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_d4b6d62b-9c84-4d66-8d6d-de3e33b47d85_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_21b07b5b-65da-49cb-ade9-c0f4fdfd63a0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">80,756,860 shares issued and outstanding at December 31, 2024 and&#8232;82,495,086 shares issued and outstanding at December 31, 2023.</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_660bf028-f054-4259-95cc-1ecf776ca488_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="lab_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_e146d767-a8a9-440f-8423-51a2f1270bcc_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_de3a0303-22c2-4a35-91a9-85b5b58217cd_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_8e788d4b-69fd-4c63-acb5-c34f5896cc47_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_HumanFirstIncMember_187917ba-5343-4330-a969-f0c4d8ff4af5_terseLabel_en-US" xlink:label="lab_iclr_HumanFirstIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">HumanFirst Inc</link:label>
    <link:label id="lab_iclr_HumanFirstIncMember_label_en-US" xlink:label="lab_iclr_HumanFirstIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">HumanFirst Inc [Member]</link:label>
    <link:label id="lab_iclr_HumanFirstIncMember_documentation_en-US" xlink:label="lab_iclr_HumanFirstIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">HumanFirst Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_HumanFirstIncMember" xlink:href="iclr-20241231.xsd#iclr_HumanFirstIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_HumanFirstIncMember" xlink:to="lab_iclr_HumanFirstIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock_9bf637bd-48fa-4825-987b-bb5738a5e24f_terseLabel_en-US" xlink:label="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of RSU and PSU Activity</link:label>
    <link:label id="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block]</link:label>
    <link:label id="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock_documentation_en-US" xlink:label="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:href="iclr-20241231.xsd#iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:to="lab_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StandardPoorsBBRatingMember_1cf9fa0f-d046-48d3-9e7a-d164da387f5f_terseLabel_en-US" xlink:label="lab_srt_StandardPoorsBBRatingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Standard &amp; Poor's, BB Rating</link:label>
    <link:label id="lab_srt_StandardPoorsBBRatingMember_label_en-US" xlink:label="lab_srt_StandardPoorsBBRatingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard &amp; Poor's, BB Rating [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsBBRatingMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StandardPoorsBBRatingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StandardPoorsBBRatingMember" xlink:to="lab_srt_StandardPoorsBBRatingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_28bc021b-94a9-4c0d-834c-65a7e8f0f32b_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_8ce19727-1b94-495b-8514-9a880425cec4_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0e781872-04ba-4d18-b2f0-67e96a88b22f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows used in financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_TopClientMember_a6eaf891-5243-423f-9d3a-4f4e5c902865_terseLabel_en-US" xlink:label="lab_iclr_TopClientMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Top client</link:label>
    <link:label id="lab_iclr_TopClientMember_label_en-US" xlink:label="lab_iclr_TopClientMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Top Client [Member]</link:label>
    <link:label id="lab_iclr_TopClientMember_documentation_en-US" xlink:label="lab_iclr_TopClientMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Top Client [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TopClientMember" xlink:href="iclr-20241231.xsd#iclr_TopClientMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_TopClientMember" xlink:to="lab_iclr_TopClientMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_5b0d6a55-f6c5-4096-9a79-26e30c44eaf3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_b898da9c-60e5-4354-b671-cf72011faf9a_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred tax liabilities recognized</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_8c7a426a-d42d-4a3a-8365-f8bce2f498cb_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_545e77b7-c62e-412c-b9d7-3cff80d9edb1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_d4c44887-224e-482a-b34a-e9cf091f53db_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nature of Operation, Product Information, Concentration of Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nature of Operation, Product Information, Concentration of Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_us-gaap_ScheduleOfProductInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_d097f436-f341-41e6-a170-2736a0273b4c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_7bdb9bb5-8362-4f0b-a7b4-a8da25021cf9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_fa0587f2-9fd6-4268-b785-df93e90a6644_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ShareRepurchaseProgramAxis_8639e128-dd89-445e-bcca-bc19951362eb_terseLabel_en-US" xlink:label="lab_srt_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_srt_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_srt_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ShareRepurchaseProgramAxis" xlink:to="lab_srt_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_379437ba-68ff-4073-ba54-a99a76f335f3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_SeniorSecuredNotesDueMay2034Member_e48240cc-bdbe-4dcc-abc9-7301d196d322_terseLabel_en-US" xlink:label="lab_iclr_SeniorSecuredNotesDueMay2034Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Secured Notes (the "2034 Notes")*</link:label>
    <link:label id="lab_iclr_SeniorSecuredNotesDueMay2034Member_label_en-US" xlink:label="lab_iclr_SeniorSecuredNotesDueMay2034Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Secured Notes Due May 2034 [Member]</link:label>
    <link:label id="lab_iclr_SeniorSecuredNotesDueMay2034Member_documentation_en-US" xlink:label="lab_iclr_SeniorSecuredNotesDueMay2034Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Secured Notes - 2034</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesDueMay2034Member" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredNotesDueMay2034Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_SeniorSecuredNotesDueMay2034Member" xlink:to="lab_iclr_SeniorSecuredNotesDueMay2034Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_975d05a8-5740-4383-9030-3d28d764ac11_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6cd28918-8f1c-4309-ac51-5e076ac7e5ca_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_FacilityLiabilityMember_324b18b0-1ef1-4094-ba44-eff4ad958dbf_terseLabel_en-US" xlink:label="lab_iclr_FacilityLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Facility liability</link:label>
    <link:label id="lab_iclr_FacilityLiabilityMember_label_en-US" xlink:label="lab_iclr_FacilityLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Facility Liability [Member]</link:label>
    <link:label id="lab_iclr_FacilityLiabilityMember_documentation_en-US" xlink:label="lab_iclr_FacilityLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Facility Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_FacilityLiabilityMember" xlink:href="iclr-20241231.xsd#iclr_FacilityLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_FacilityLiabilityMember" xlink:to="lab_iclr_FacilityLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_993af5c1-028c-4933-8b45-4fc084de9700_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_76054b54-983f-46cd-a5fc-3e7b0017de8e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remeasurement of retirement benefit obligations</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_4a726d20-f709-4973-93b0-1ad9c6b3145f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Remeasurement of retirement benefit obligations</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_4e72aa87-f8c9-43fb-89c2-960ea2426471_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Sundry Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_71c83128-f95b-46c5-823f-9fbf132defeb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_51bb96c0-f9fc-4296-8eea-4f5d1d33474f_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Transaction and integration-related expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_a519972f-81c5-4255-9ec3-c93412e8f082_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_10ef0244-bfcd-452a-afb1-e6828b7ef08e_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Incentive Schemes and Stock Compensation Charges</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedUtilitiesCurrent_3b11daec-e62e-4d13-aa13-4e81cf1f7dde_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedUtilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Facility related liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedUtilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedUtilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Utilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedUtilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedUtilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedUtilitiesCurrent" xlink:to="lab_us-gaap_AccruedUtilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_7ff3a1fa-0df5-4892-ad42-1b4d5b28ff57_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_BuybackProgramMember_b2ba13c2-5ce8-4401-b500-88f82bd60a7f_terseLabel_en-US" xlink:label="lab_iclr_BuybackProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Buyback program</link:label>
    <link:label id="lab_iclr_BuybackProgramMember_label_en-US" xlink:label="lab_iclr_BuybackProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Buyback Program [Member]</link:label>
    <link:label id="lab_iclr_BuybackProgramMember_documentation_en-US" xlink:label="lab_iclr_BuybackProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Buyback Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BuybackProgramMember" xlink:href="iclr-20241231.xsd#iclr_BuybackProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_BuybackProgramMember" xlink:to="lab_iclr_BuybackProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_18677cf4-7ff3-4c39-b7b7-e04860a8dc0e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_838427f8-530f-4309-a2d0-c161091ba23a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_8e5dd71d-9ecd-4f59-acfd-f81ee9f1abec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Transactions for Company's Share Option Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_906fb6eb-4db3-49a4-99a0-1916a77cd2bd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options exercised during period, intrinsic value (in USD)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_4a3abe67-3fd2-4bcb-a2c1-de942ebcd0d5_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_7c90711a-5097-401e-8e39-e05ebc805362_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest and penalties recognized as an expense</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_e8746e21-dcfb-4a9f-9f6a-98c1b59225fd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_b36a1382-c4a5-4ec6-9295-558f6ec1964a_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_70a9cc52-5d39-4c3a-91ef-5656dbeeb134_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_dc0a6885-7376-49ca-9aec-b015be0deff4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossesTextBlock_6451b001-d488-444c-b098-2e88c3c8684f_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossesTextBlock_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Allowance for Credit Losses [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForCreditLossesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossesTextBlock" xlink:to="lab_us-gaap_AllowanceForCreditLossesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_ce1b2a68-d505-4d74-9cd6-7758efd028a3_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Country</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Tax Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_2f8dc4f5-3035-4c93-9117-fb68c6f91b9a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating right-of-use-assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_423a5334-f851-41f4-b84f-7664d621be24_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_2fc6295a-d0a5-4815-9fec-b154e7d64878_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_dc9b4e70-7f3a-4966-9f28-479e589a14bd_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_c1ff8228-a1dd-49b0-b64b-ab9d5d020ebe_terseLabel_en-US" xlink:label="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Limit of shares issued or to be issued pursuant to options granted (in shares)</link:label>
    <link:label id="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_label_en-US" xlink:label="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Limit Of Shares Issued Or To Be Issued Pursuant To Options Granted</link:label>
    <link:label id="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_documentation_en-US" xlink:label="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Limit of Shares Issued or To Be Issued Pursuant to Options Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:href="iclr-20241231.xsd#iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:to="lab_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_9ba73a98-6bb0-4dc4-9f2f-11d44893881a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_fc420355-a170-4b15-8d09-0a0a50289e48_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Severance costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OtherGeographicLocationsMember_f7b580af-465c-49e3-b445-ded18926c1d2_terseLabel_en-US" xlink:label="lab_iclr_OtherGeographicLocationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_iclr_OtherGeographicLocationsMember_label_en-US" xlink:label="lab_iclr_OtherGeographicLocationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Geographic Locations [Member]</link:label>
    <link:label id="lab_iclr_OtherGeographicLocationsMember_documentation_en-US" xlink:label="lab_iclr_OtherGeographicLocationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Geographic Locations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherGeographicLocationsMember" xlink:href="iclr-20241231.xsd#iclr_OtherGeographicLocationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OtherGeographicLocationsMember" xlink:to="lab_iclr_OtherGeographicLocationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_c8638581-27cb-44a0-91a5-16989588226d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_761fee9d-4ed7-42e9-9e62-ad10c5050ef1_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_ba00278f-8c34-47a6-9e48-637e22cddbf1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_82e3490c-60cb-4437-81ad-81f33c874caf_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_4047f10e-8ae2-45f4-a1d5-ce316cd7d7c1_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_941a5ad9-d2c1-4f80-b968-f41ff2a13ede_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Onerous contract provision</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency Accrual, Provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualProvision" xlink:to="lab_us-gaap_LossContingencyAccrualProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_914f1e67-eda9-4e8e-94be-945780dac7a5_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Base rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d881c65e-e407-489b-9ac0-05d06ce1c39e_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4b67f422-1164-46ad-ba2e-bccac3879f32_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5658c082-1e0e-4872-aff9-7290e88204bf_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at ending of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7ebb9fa3-9512-4b5d-991b-a99c3d55ca45_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent_526363bb-c431-438f-a407-06c32ae87759_terseLabel_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage change in unearned revenue (payments on account)</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent_label_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Contract With Customer, Liability, Gross, Current, Percent</link:label>
    <link:label id="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent_documentation_en-US" xlink:label="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Contract with Customer, Liability, Gross, Current, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:href="iclr-20241231.xsd#iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:to="lab_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1b4fa810-b975-4342-9cda-e7543222dcea_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepayments and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_264a0827-b39a-46d4-b794-8d5d9f012ee7_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_2b59664a-3659-47e7-aed0-0ef474a4d8fe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_55fc697d-e000-4651-84ab-a693531d2c12_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_cd2981a2-9473-4302-94c4-d3d0b856ffeb_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_282db005-35ac-4b21-b739-5bbced28041f_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_54d111eb-46b4-463d-8da0-f791a16a21fd_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_9790c719-84c8-4eaa-ad95-30c3f0989868_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_15fd9ee4-2863-46d6-912b-9b53e6831461_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of financing costs and debt discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_fbc00e0d-849f-4abc-8d6a-8773f5ce7dee_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amortization of merger related financing fees</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_185bc58a-97d1-4e45-972f-3b0abd8df36d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_9b267e13-f39a-4692-af8e-afd9061432f3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_0260e529-1b24-4e33-a6cb-a415de560023_totalLabel_en-US" xlink:label="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_label_en-US" xlink:label="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite Lived Intangible Assets, Amortization Expense, Net</link:label>
    <link:label id="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_documentation_en-US" xlink:label="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Finite Lived Intangible Assets, Amortization Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:href="iclr-20241231.xsd#iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:to="lab_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_0354ce7d-2340-4072-843f-6e034218bd15_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_6a6ec095-de32-4ac4-987c-9646eb5c6223_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency impact on long term funding</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6210c3f-e0ac-46f0-9db3-8aa7ed5afdc0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_7181f766-a3c9-4680-a1e1-b7aa3c4c85f6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Components of Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_iclr_OptionPlans2008Member_259c2a08-891a-4f80-acc0-7c2f4b23bc22_terseLabel_en-US" xlink:label="lab_iclr_OptionPlans2008Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Option Plans 2008</link:label>
    <link:label id="lab_iclr_OptionPlans2008Member_label_en-US" xlink:label="lab_iclr_OptionPlans2008Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Option Plans 2008 [Member]</link:label>
    <link:label id="lab_iclr_OptionPlans2008Member_documentation_en-US" xlink:label="lab_iclr_OptionPlans2008Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Option Plans 2008 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OptionPlans2008Member" xlink:href="iclr-20241231.xsd#iclr_OptionPlans2008Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_iclr_OptionPlans2008Member" xlink:to="lab_iclr_OptionPlans2008Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_59af1737-ab67-421d-b544-f6dde2e007a8_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_f72ecd95-98d9-412b-99f0-52cb9a13088d_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Opening provision</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_92abbfa2-c8c6-4037-a8a6-f0952a7ba925_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending provision</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_6addbd77-0d50-4e30-8ba4-3bb24b630111_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards, subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_1370d61f-cb37-4d34-9e89-1a1d69f7877d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>iclr-20241231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:56d7542f-319d-475c-a76f-1ff45be39275,g:fef64a75-6c12-4b8b-a2b6-5a3facaa93b8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.iconplc.com/role/Cover" xlink:type="simple" xlink:href="iclr-20241231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_001158c4-c9c6-4671-b64e-201842096385" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_c71969e6-78d0-4b73-b657-9251423d998b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_001158c4-c9c6-4671-b64e-201842096385" xlink:to="loc_dei_DocumentInformationTable_c71969e6-78d0-4b73-b657-9251423d998b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_630ba178-f630-4b77-ac7c-99be729bcf78" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_c71969e6-78d0-4b73-b657-9251423d998b" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_630ba178-f630-4b77-ac7c-99be729bcf78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_a6186e38-d065-40f3-a4b0-e7dca0eac890" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_630ba178-f630-4b77-ac7c-99be729bcf78" xlink:to="loc_dei_AddressTypeDomain_a6186e38-d065-40f3-a4b0-e7dca0eac890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember_a1002828-756f-4bb1-824a-214bc01b828d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AddressTypeDomain_a6186e38-d065-40f3-a4b0-e7dca0eac890" xlink:to="loc_dei_BusinessContactMember_a1002828-756f-4bb1-824a-214bc01b828d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_c71969e6-78d0-4b73-b657-9251423d998b" xlink:to="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_8a8dbc6a-0c85-4d10-9243-49765ab1e750" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_DocumentType_8a8dbc6a-0c85-4d10-9243-49765ab1e750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement_0d56d708-5d84-47cb-8e94-26b4aeb73ba9" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_DocumentRegistrationStatement_0d56d708-5d84-47cb-8e94-26b4aeb73ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_51e24349-29a6-422a-a9cd-7178ff792cc4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_DocumentAnnualReport_51e24349-29a6-422a-a9cd-7178ff792cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8702d968-aaf8-43c6-ab88-f1cd61b666f2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_DocumentPeriodEndDate_8702d968-aaf8-43c6-ab88-f1cd61b666f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_b3ad6f89-dc27-494a-b18e-59ae4546af99" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_CurrentFiscalYearEndDate_b3ad6f89-dc27-494a-b18e-59ae4546af99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_e71e2eeb-49a6-44bd-a993-c97ea279fac1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_DocumentTransitionReport_e71e2eeb-49a6-44bd-a993-c97ea279fac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport_27c46f62-e434-4e93-a4f5-3353f6b17c06" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_DocumentShellCompanyReport_27c46f62-e434-4e93-a4f5-3353f6b17c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e599f5a6-5f15-4065-8625-3f3c4a0f4646" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityFileNumber_e599f5a6-5f15-4065-8625-3f3c4a0f4646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_6ddcfeef-a826-4167-8a1c-e2308dfe38b1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityRegistrantName_6ddcfeef-a826-4167-8a1c-e2308dfe38b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_1acc8335-b750-4fa7-bf65-59824a420b55" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityIncorporationStateCountryCode_1acc8335-b750-4fa7-bf65-59824a420b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_da2f8899-5380-4f64-a259-e10f5b8733d2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityAddressAddressLine1_da2f8899-5380-4f64-a259-e10f5b8733d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_0f680317-cf2c-4f6b-8ffc-8f45fb4a0de0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityAddressAddressLine2_0f680317-cf2c-4f6b-8ffc-8f45fb4a0de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_9618cfc3-6a7c-4e6f-a9ee-2c0dbca52d30" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityAddressCityOrTown_9618cfc3-6a7c-4e6f-a9ee-2c0dbca52d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_77e99273-bd36-49ff-a5a6-ed14c5f7a28a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityAddressPostalZipCode_77e99273-bd36-49ff-a5a6-ed14c5f7a28a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_c0b57b56-281c-42b2-9e13-eab9a6e45a50" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityAddressCountry_c0b57b56-281c-42b2-9e13-eab9a6e45a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName_139e45b2-ad3d-4a7d-9708-23e15753fb7d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_ContactPersonnelName_139e45b2-ad3d-4a7d-9708-23e15753fb7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelEmailAddress_993c1e14-67f9-4855-9a7e-faf662e9cf8e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelEmailAddress"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_ContactPersonnelEmailAddress_993c1e14-67f9-4855-9a7e-faf662e9cf8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_1d1a763b-0819-437c-8037-7ac57cb6815a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_CountryRegion_1d1a763b-0819-437c-8037-7ac57cb6815a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b2462b9a-3046-456d-b984-9f19e51c7982" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_CityAreaCode_b2462b9a-3046-456d-b984-9f19e51c7982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_224e11b4-cd4e-4f66-8a4a-60c937ca768c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_LocalPhoneNumber_224e11b4-cd4e-4f66-8a4a-60c937ca768c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_5539f058-4e6b-4b53-a313-b172415251f5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_Security12bTitle_5539f058-4e6b-4b53-a313-b172415251f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d45a1733-cf10-4b8d-bbb3-eea5eb379189" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_TradingSymbol_d45a1733-cf10-4b8d-bbb3-eea5eb379189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4c3ab8e3-5b29-4cd0-ad87-1b0eeead807b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_SecurityExchangeName_4c3ab8e3-5b29-4cd0-ad87-1b0eeead807b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_0237ad9c-0eb0-4ece-9e17-5ed8ec3b35e2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_0237ad9c-0eb0-4ece-9e17-5ed8ec3b35e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_2310c0d5-d413-4e3c-8ff7-b76d432f0848" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_2310c0d5-d413-4e3c-8ff7-b76d432f0848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_718c3513-175b-4ff9-bb97-e480d6d2d77e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityVoluntaryFilers_718c3513-175b-4ff9-bb97-e480d6d2d77e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_3c6544fd-0b34-4182-9f48-822382c3af83" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityCurrentReportingStatus_3c6544fd-0b34-4182-9f48-822382c3af83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ad312e99-9cd4-49db-8985-36ec31c4c0d0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityInteractiveDataCurrent_ad312e99-9cd4-49db-8985-36ec31c4c0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_f07fc0fe-920e-4148-8564-3ebe51ea9da8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityFilerCategory_f07fc0fe-920e-4148-8564-3ebe51ea9da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d451109c-10f9-4bc2-b924-c8f76dacd459" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityEmergingGrowthCompany_d451109c-10f9-4bc2-b924-c8f76dacd459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_f93e67df-7859-45b6-8c29-05f9ad464669" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_IcfrAuditorAttestationFlag_f93e67df-7859-45b6-8c29-05f9ad464669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_565f604d-e220-42c2-8a3a-ed3a110e2d0d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_565f604d-e220-42c2-8a3a-ed3a110e2d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard_61a38bfa-7cfd-4cb9-81a2-2d9d039fce42" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_DocumentAccountingStandard_61a38bfa-7cfd-4cb9-81a2-2d9d039fce42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_96a93d57-f23b-4bd9-9ebd-41feae80d85e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityShellCompany_96a93d57-f23b-4bd9-9ebd-41feae80d85e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ec5a7131-1297-4f1b-a9f4-d59d5f296f34" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_AmendmentFlag_ec5a7131-1297-4f1b-a9f4-d59d5f296f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_d9d7eb81-b017-4e86-b90e-078235666d64" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_DocumentFiscalYearFocus_d9d7eb81-b017-4e86-b90e-078235666d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_870df72a-12ab-47f2-b1e3-5c3d62a3e14a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_DocumentFiscalPeriodFocus_870df72a-12ab-47f2-b1e3-5c3d62a3e14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_63d911d0-4239-4f64-8024-fbcab2b8a232" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9526375b-36c8-4ed5-8a8f-c43026ee58a5" xlink:to="loc_dei_EntityCentralIndexKey_63d911d0-4239-4f64-8024-fbcab2b8a232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AuditInformation" xlink:type="simple" xlink:href="iclr-20241231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AuditInformationAbstract_23ed968e-58ec-4c05-9f68-84ac7eff12d3" xlink:href="iclr-20241231.xsd#iclr_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_fdbfde99-a334-47aa-b877-f2d7bb5f40d1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_AuditInformationAbstract_23ed968e-58ec-4c05-9f68-84ac7eff12d3" xlink:to="loc_dei_AuditorFirmId_fdbfde99-a334-47aa-b877-f2d7bb5f40d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_357b66f6-0198-416f-8054-84130830cc05" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_AuditInformationAbstract_23ed968e-58ec-4c05-9f68-84ac7eff12d3" xlink:to="loc_dei_AuditorName_357b66f6-0198-416f-8054-84130830cc05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_1fe21b1e-7d5d-467a-b49a-cbd2368d1a11" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_AuditInformationAbstract_23ed968e-58ec-4c05-9f68-84ac7eff12d3" xlink:to="loc_dei_AuditorLocation_1fe21b1e-7d5d-467a-b49a-cbd2368d1a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="iclr-20241231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_f7df5c8c-9693-473d-aa91-30dcd36cafeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_a32485cb-3154-40bd-8b9c-51621a679432" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f7df5c8c-9693-473d-aa91-30dcd36cafeb" xlink:to="loc_us-gaap_AssetsAbstract_a32485cb-3154-40bd-8b9c-51621a679432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_6f78e875-96d8-466c-b008-4b48f8aa3e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a32485cb-3154-40bd-8b9c-51621a679432" xlink:to="loc_us-gaap_AssetsCurrentAbstract_6f78e875-96d8-466c-b008-4b48f8aa3e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_aac0e852-bdc5-4d3e-9080-3d52674e4fec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6f78e875-96d8-466c-b008-4b48f8aa3e2a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_aac0e852-bdc5-4d3e-9080-3d52674e4fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_de7624b3-acb3-4cf1-8936-b9080535ba19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6f78e875-96d8-466c-b008-4b48f8aa3e2a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_de7624b3-acb3-4cf1-8936-b9080535ba19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_dd9e3402-bda2-4fc6-8e47-31c457832aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6f78e875-96d8-466c-b008-4b48f8aa3e2a" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_dd9e3402-bda2-4fc6-8e47-31c457832aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_f8a991d5-03bb-4344-aa6d-7cd741a05218" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6f78e875-96d8-466c-b008-4b48f8aa3e2a" xlink:to="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_f8a991d5-03bb-4344-aa6d-7cd741a05218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontradeReceivablesCurrent_fc8cda10-129a-4424-b531-0b494083cc2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NontradeReceivablesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6f78e875-96d8-466c-b008-4b48f8aa3e2a" xlink:to="loc_us-gaap_NontradeReceivablesCurrent_fc8cda10-129a-4424-b531-0b494083cc2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_215f5e78-5fa5-4b1a-8c9a-0df2447aba02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6f78e875-96d8-466c-b008-4b48f8aa3e2a" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_215f5e78-5fa5-4b1a-8c9a-0df2447aba02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_3ac3ea7a-d2eb-4bb5-b810-550cebb8955f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6f78e875-96d8-466c-b008-4b48f8aa3e2a" xlink:to="loc_us-gaap_IncomeTaxesReceivable_3ac3ea7a-d2eb-4bb5-b810-550cebb8955f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_fa5ea1db-d0ac-4f43-a886-d07c83fb81ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6f78e875-96d8-466c-b008-4b48f8aa3e2a" xlink:to="loc_us-gaap_AssetsCurrent_fa5ea1db-d0ac-4f43-a886-d07c83fb81ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_031660e6-417a-4a9f-99d1-fbd371a5d7d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a32485cb-3154-40bd-8b9c-51621a679432" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_031660e6-417a-4a9f-99d1-fbd371a5d7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3edf7295-ea4b-4c30-a743-b32b7232b5e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_031660e6-417a-4a9f-99d1-fbd371a5d7d0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3edf7295-ea4b-4c30-a743-b32b7232b5e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d931f07f-d2a4-4ab7-a3f0-831f8ec5304a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_031660e6-417a-4a9f-99d1-fbd371a5d7d0" xlink:to="loc_us-gaap_Goodwill_d931f07f-d2a4-4ab7-a3f0-831f8ec5304a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8bde8e4e-89b6-422e-be3a-6613ac217f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_031660e6-417a-4a9f-99d1-fbd371a5d7d0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8bde8e4e-89b6-422e-be3a-6613ac217f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_77c8ba8d-c6d6-4374-a62b-b43f84114914" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_031660e6-417a-4a9f-99d1-fbd371a5d7d0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_77c8ba8d-c6d6-4374-a62b-b43f84114914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5cc6eab9-5ea3-4da9-a1d6-2e1713ff3b51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_031660e6-417a-4a9f-99d1-fbd371a5d7d0" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5cc6eab9-5ea3-4da9-a1d6-2e1713ff3b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_d556cd42-65e5-401a-85e1-8309bd21796f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_031660e6-417a-4a9f-99d1-fbd371a5d7d0" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_d556cd42-65e5-401a-85e1-8309bd21796f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_0aa2a50f-6620-4b11-bae4-6b7092bdf61c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_031660e6-417a-4a9f-99d1-fbd371a5d7d0" xlink:to="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_0aa2a50f-6620-4b11-bae4-6b7092bdf61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_4a215796-d0e9-4f6d-8d97-2fb244d3788c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a32485cb-3154-40bd-8b9c-51621a679432" xlink:to="loc_us-gaap_Assets_4a215796-d0e9-4f6d-8d97-2fb244d3788c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_386005a8-3486-4f55-a59a-464a2e62e45a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f7df5c8c-9693-473d-aa91-30dcd36cafeb" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_386005a8-3486-4f55-a59a-464a2e62e45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_23f5a767-0e01-4f1f-abbc-11c51163e3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_386005a8-3486-4f55-a59a-464a2e62e45a" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_23f5a767-0e01-4f1f-abbc-11c51163e3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_3c4b5e39-b408-4ea4-bced-855161e907ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23f5a767-0e01-4f1f-abbc-11c51163e3a8" xlink:to="loc_us-gaap_AccountsPayableCurrent_3c4b5e39-b408-4ea4-bced-855161e907ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_aba4bed5-673d-4875-8cb7-2df4eb02bcdd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23f5a767-0e01-4f1f-abbc-11c51163e3a8" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_aba4bed5-673d-4875-8cb7-2df4eb02bcdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_1b811062-ffc1-4f3b-9fb5-db0196e9a3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23f5a767-0e01-4f1f-abbc-11c51163e3a8" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_1b811062-ffc1-4f3b-9fb5-db0196e9a3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_718963c5-f0d0-4ddd-98a7-c8352f62d04f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23f5a767-0e01-4f1f-abbc-11c51163e3a8" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_718963c5-f0d0-4ddd-98a7-c8352f62d04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_61ea6c4a-8822-4c77-bfaf-e3009181d186" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23f5a767-0e01-4f1f-abbc-11c51163e3a8" xlink:to="loc_us-gaap_LinesOfCreditCurrent_61ea6c4a-8822-4c77-bfaf-e3009181d186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_91adf8c9-7156-4933-8e77-fd074a26a933" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23f5a767-0e01-4f1f-abbc-11c51163e3a8" xlink:to="loc_us-gaap_LiabilitiesCurrent_91adf8c9-7156-4933-8e77-fd074a26a933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_8d02a891-8c85-4af7-9cba-8756de55d2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_386005a8-3486-4f55-a59a-464a2e62e45a" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_8d02a891-8c85-4af7-9cba-8756de55d2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_51062761-a344-487b-947b-626d95c74594" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_8d02a891-8c85-4af7-9cba-8756de55d2ef" xlink:to="loc_us-gaap_LongTermLineOfCredit_51062761-a344-487b-947b-626d95c74594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_83407b29-cac2-41d7-973b-5d6e1d741fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_8d02a891-8c85-4af7-9cba-8756de55d2ef" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_83407b29-cac2-41d7-973b-5d6e1d741fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_64a62c9e-7138-4ff1-9030-8487564033e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_8d02a891-8c85-4af7-9cba-8756de55d2ef" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_64a62c9e-7138-4ff1-9030-8487564033e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_4dc9ae0e-13e1-4589-9dc3-ad03a0016f95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_8d02a891-8c85-4af7-9cba-8756de55d2ef" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_4dc9ae0e-13e1-4589-9dc3-ad03a0016f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_89b80c91-d5f4-4463-9661-2080abb40cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_8d02a891-8c85-4af7-9cba-8756de55d2ef" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_89b80c91-d5f4-4463-9661-2080abb40cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_2dca0ac5-6583-44da-ac31-deab8e99271f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_8d02a891-8c85-4af7-9cba-8756de55d2ef" xlink:to="loc_us-gaap_CommitmentsAndContingencies_2dca0ac5-6583-44da-ac31-deab8e99271f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_62e2e416-b026-4763-87f7-67bdf72aedf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_386005a8-3486-4f55-a59a-464a2e62e45a" xlink:to="loc_us-gaap_Liabilities_62e2e416-b026-4763-87f7-67bdf72aedf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_523f1b89-3c31-4c89-9ddf-3885447c092c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_386005a8-3486-4f55-a59a-464a2e62e45a" xlink:to="loc_us-gaap_StockholdersEquityAbstract_523f1b89-3c31-4c89-9ddf-3885447c092c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_a4b672ad-4288-44e6-9f66-0c62e618fced" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_523f1b89-3c31-4c89-9ddf-3885447c092c" xlink:to="loc_us-gaap_CommonStockValue_a4b672ad-4288-44e6-9f66-0c62e618fced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d342c902-8ac6-4f60-89c2-681019c39d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_523f1b89-3c31-4c89-9ddf-3885447c092c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d342c902-8ac6-4f60-89c2-681019c39d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapital_b1758985-0394-4cdb-a8aa-6331520ee232" xlink:href="iclr-20241231.xsd#iclr_OtherUndenominatedCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_523f1b89-3c31-4c89-9ddf-3885447c092c" xlink:to="loc_iclr_OtherUndenominatedCapital_b1758985-0394-4cdb-a8aa-6331520ee232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b8d5b5ae-7805-46ff-9cc2-b4f44130afc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_523f1b89-3c31-4c89-9ddf-3885447c092c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b8d5b5ae-7805-46ff-9cc2-b4f44130afc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_222b5680-4338-487e-a33b-e0e2abb16fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_523f1b89-3c31-4c89-9ddf-3885447c092c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_222b5680-4338-487e-a33b-e0e2abb16fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4de4bc76-af84-4720-b65d-8cdba38e07ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_523f1b89-3c31-4c89-9ddf-3885447c092c" xlink:to="loc_us-gaap_StockholdersEquity_4de4bc76-af84-4720-b65d-8cdba38e07ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_0ad3f49c-aaf4-4947-8d1b-6952c81e0bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_386005a8-3486-4f55-a59a-464a2e62e45a" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_0ad3f49c-aaf4-4947-8d1b-6952c81e0bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="iclr-20241231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_608be811-93a8-4103-8bf0-60d9e48e3b70" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_8beb6862-c450-433f-a925-828498216b54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_608be811-93a8-4103-8bf0-60d9e48e3b70" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_8beb6862-c450-433f-a925-828498216b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_4e83ffe3-4309-4e16-9af7-b56eb4d252e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_608be811-93a8-4103-8bf0-60d9e48e3b70" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_4e83ffe3-4309-4e16-9af7-b56eb4d252e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_120fc962-5f4b-4e5b-a33f-0bc1507d3480" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_608be811-93a8-4103-8bf0-60d9e48e3b70" xlink:to="loc_us-gaap_CommonStockSharesIssued_120fc962-5f4b-4e5b-a33f-0bc1507d3480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a70f7486-9ce9-4018-996b-adea37ac183d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_608be811-93a8-4103-8bf0-60d9e48e3b70" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a70f7486-9ce9-4018-996b-adea37ac183d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="iclr-20241231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_4a784b72-eb56-448c-8bea-6e77cbada651" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_605f479e-881c-44ee-bcb4-a906c151996b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a784b72-eb56-448c-8bea-6e77cbada651" xlink:to="loc_us-gaap_RevenuesAbstract_605f479e-881c-44ee-bcb4-a906c151996b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2fb2a327-29d7-4d9b-978e-cd600362d0a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_605f479e-881c-44ee-bcb4-a906c151996b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2fb2a327-29d7-4d9b-978e-cd600362d0a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_47728821-37a1-4624-a8e1-c3258a761a08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a784b72-eb56-448c-8bea-6e77cbada651" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_47728821-37a1-4624-a8e1-c3258a761a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_152822bc-d3df-44be-a602-006a2984d860" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_47728821-37a1-4624-a8e1-c3258a761a08" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_152822bc-d3df-44be-a602-006a2984d860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7189c097-2933-4aea-8b17-403b144371c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_47728821-37a1-4624-a8e1-c3258a761a08" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7189c097-2933-4aea-8b17-403b144371c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_3c487db8-ebf9-444c-b48d-639cad4f2d91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_47728821-37a1-4624-a8e1-c3258a761a08" xlink:to="loc_us-gaap_DepreciationAndAmortization_3c487db8-ebf9-444c-b48d-639cad4f2d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_1bda975e-53cb-4318-9728-e670ccf8f834" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_47728821-37a1-4624-a8e1-c3258a761a08" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_1bda975e-53cb-4318-9728-e670ccf8f834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_852645cc-70c1-486f-83fd-b31870c00594" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_47728821-37a1-4624-a8e1-c3258a761a08" xlink:to="loc_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_852645cc-70c1-486f-83fd-b31870c00594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_36219faf-ac88-4699-956e-b2866f51c0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_47728821-37a1-4624-a8e1-c3258a761a08" xlink:to="loc_us-gaap_RestructuringCosts_36219faf-ac88-4699-956e-b2866f51c0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_795e5a2b-55ac-4bbb-bb50-5cc19dd11641" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_47728821-37a1-4624-a8e1-c3258a761a08" xlink:to="loc_us-gaap_CostsAndExpenses_795e5a2b-55ac-4bbb-bb50-5cc19dd11641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0a3983c8-6205-4546-932b-2387cb9039c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a784b72-eb56-448c-8bea-6e77cbada651" xlink:to="loc_us-gaap_OperatingIncomeLoss_0a3983c8-6205-4546-932b-2387cb9039c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_31b0c16b-aa82-4d58-a8a0-c5129eea0816" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a784b72-eb56-448c-8bea-6e77cbada651" xlink:to="loc_us-gaap_InvestmentIncomeInterest_31b0c16b-aa82-4d58-a8a0-c5129eea0816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_7f19c1f4-8a6b-4127-b337-08b49797cef5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a784b72-eb56-448c-8bea-6e77cbada651" xlink:to="loc_us-gaap_InterestExpenseNonoperating_7f19c1f4-8a6b-4127-b337-08b49797cef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_8ff87bf4-3879-4fd4-8b09-046061a7c4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a784b72-eb56-448c-8bea-6e77cbada651" xlink:to="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_8ff87bf4-3879-4fd4-8b09-046061a7c4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b087a352-90fa-41da-9e72-cef481f9c206" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a784b72-eb56-448c-8bea-6e77cbada651" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b087a352-90fa-41da-9e72-cef481f9c206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_11f0c054-05a2-434d-9c72-77ff229ca228" xlink:href="iclr-20241231.xsd#iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a784b72-eb56-448c-8bea-6e77cbada651" xlink:to="loc_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest_11f0c054-05a2-434d-9c72-77ff229ca228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_505733bc-69ab-462c-9c61-ee17612badf5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a784b72-eb56-448c-8bea-6e77cbada651" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_505733bc-69ab-462c-9c61-ee17612badf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5e6d2282-0b32-4dfd-8d95-a81dbf4955b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a784b72-eb56-448c-8bea-6e77cbada651" xlink:to="loc_us-gaap_NetIncomeLoss_5e6d2282-0b32-4dfd-8d95-a81dbf4955b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_da5107e9-acf7-4a1b-997d-87e24120c87d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a784b72-eb56-448c-8bea-6e77cbada651" xlink:to="loc_us-gaap_EarningsPerShareAbstract_da5107e9-acf7-4a1b-997d-87e24120c87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ab09d80a-1eda-4c93-b08f-8e173f92b8fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_da5107e9-acf7-4a1b-997d-87e24120c87d" xlink:to="loc_us-gaap_EarningsPerShareBasic_ab09d80a-1eda-4c93-b08f-8e173f92b8fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0b19ec3d-a48a-4324-93a4-fc0561e2c1af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_da5107e9-acf7-4a1b-997d-87e24120c87d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0b19ec3d-a48a-4324-93a4-fc0561e2c1af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_035cdd25-c188-4a72-8981-bae93158e0bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4a784b72-eb56-448c-8bea-6e77cbada651" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_035cdd25-c188-4a72-8981-bae93158e0bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d958e605-d9f8-4e51-9579-03dc2c93e671" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_035cdd25-c188-4a72-8981-bae93158e0bb" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d958e605-d9f8-4e51-9579-03dc2c93e671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c43e49d9-7ecf-41c7-af77-186b71c3bbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_035cdd25-c188-4a72-8981-bae93158e0bb" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c43e49d9-7ecf-41c7-af77-186b71c3bbb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="iclr-20241231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ef06243f-b368-40e4-a347-e9b9a5b46e18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract_2657a34f-3620-4ce3-af61-4917c67c61c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ef06243f-b368-40e4-a347-e9b9a5b46e18" xlink:to="loc_us-gaap_NetIncomeLossAbstract_2657a34f-3620-4ce3-af61-4917c67c61c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b16d42db-1fac-45bb-b32a-de584e92b6a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_2657a34f-3620-4ce3-af61-4917c67c61c4" xlink:to="loc_us-gaap_ProfitLoss_b16d42db-1fac-45bb-b32a-de584e92b6a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f0456a56-ab5d-468f-a1d7-2d20596038e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ef06243f-b368-40e4-a347-e9b9a5b46e18" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f0456a56-ab5d-468f-a1d7-2d20596038e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_69307c1c-2fc5-4ebb-9135-6d2b8e45f42d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f0456a56-ab5d-468f-a1d7-2d20596038e0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_69307c1c-2fc5-4ebb-9135-6d2b8e45f42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_e2e230cb-b3f3-4423-889d-53feb8a2af72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f0456a56-ab5d-468f-a1d7-2d20596038e0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_e2e230cb-b3f3-4423-889d-53feb8a2af72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_451a91a7-a0dd-478b-8d3c-529d790df944" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f0456a56-ab5d-468f-a1d7-2d20596038e0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_451a91a7-a0dd-478b-8d3c-529d790df944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_dbb053a0-d90e-4a8f-9993-d183e3617174" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ef06243f-b368-40e4-a347-e9b9a5b46e18" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_dbb053a0-d90e-4a8f-9993-d183e3617174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="iclr-20241231.xsd#CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_a8426bba-04e2-4005-bfba-132aceb05509" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8ca5073c-a063-40bc-a976-dc819846d694" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_a8426bba-04e2-4005-bfba-132aceb05509" xlink:to="loc_us-gaap_StatementTable_8ca5073c-a063-40bc-a976-dc819846d694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b7a5f4d1-259d-4277-9ee2-0ccf3b3b897d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8ca5073c-a063-40bc-a976-dc819846d694" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b7a5f4d1-259d-4277-9ee2-0ccf3b3b897d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3e12b56d-2e67-48ce-964e-5d35ea17fbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b7a5f4d1-259d-4277-9ee2-0ccf3b3b897d" xlink:to="loc_us-gaap_EquityComponentDomain_3e12b56d-2e67-48ce-964e-5d35ea17fbdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7897eb22-802d-408a-b5ef-350bee45e979" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3e12b56d-2e67-48ce-964e-5d35ea17fbdf" xlink:to="loc_us-gaap_CommonStockMember_7897eb22-802d-408a-b5ef-350bee45e979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_165f63d7-3b31-4684-9261-1fbdb0f2a928" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3e12b56d-2e67-48ce-964e-5d35ea17fbdf" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_165f63d7-3b31-4684-9261-1fbdb0f2a928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherUndenominatedCapitalMember_7eaafe58-3d78-438e-808c-f858f699901d" xlink:href="iclr-20241231.xsd#iclr_OtherUndenominatedCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3e12b56d-2e67-48ce-964e-5d35ea17fbdf" xlink:to="loc_iclr_OtherUndenominatedCapitalMember_7eaafe58-3d78-438e-808c-f858f699901d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fc3072fa-dc6d-4188-aa5c-bcde07c002a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3e12b56d-2e67-48ce-964e-5d35ea17fbdf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fc3072fa-dc6d-4188-aa5c-bcde07c002a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_3d682548-2fea-476b-b835-5fc13c946b93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3e12b56d-2e67-48ce-964e-5d35ea17fbdf" xlink:to="loc_us-gaap_RetainedEarningsMember_3d682548-2fea-476b-b835-5fc13c946b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_91e3a4b4-e229-40e2-98fa-01108df20604" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8ca5073c-a063-40bc-a976-dc819846d694" xlink:to="loc_us-gaap_StatementLineItems_91e3a4b4-e229-40e2-98fa-01108df20604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_91e3a4b4-e229-40e2-98fa-01108df20604" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_62dbcd39-c06c-4ee5-b580-3a898cbafffa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_CommonStockSharesIssued_62dbcd39-c06c-4ee5-b580-3a898cbafffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c75a6e2d-1319-49ac-84bc-913415356c23" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_StockholdersEquity_c75a6e2d-1319-49ac-84bc-913415356c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_baf0c19e-3f25-49a6-90f5-7d0250cf84bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_baf0c19e-3f25-49a6-90f5-7d0250cf84bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d59af5eb-ec73-4494-b30a-4696822c900c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_baf0c19e-3f25-49a6-90f5-7d0250cf84bf" xlink:to="loc_us-gaap_NetIncomeLoss_d59af5eb-ec73-4494-b30a-4696822c900c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d3287714-bf55-4ac5-ad92-5db436567e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_baf0c19e-3f25-49a6-90f5-7d0250cf84bf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d3287714-bf55-4ac5-ad92-5db436567e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_d760f3d5-646c-4889-8b44-434f1d791fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_baf0c19e-3f25-49a6-90f5-7d0250cf84bf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_d760f3d5-646c-4889-8b44-434f1d791fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_6766a217-05e3-401b-9490-f5b7ae8507c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_baf0c19e-3f25-49a6-90f5-7d0250cf84bf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_6766a217-05e3-401b-9490-f5b7ae8507c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_c10319d1-89e4-4f1d-9648-faec4f42c316" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_baf0c19e-3f25-49a6-90f5-7d0250cf84bf" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_c10319d1-89e4-4f1d-9648-faec4f42c316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_508351f2-f63c-4315-a18d-8b1cfa4819be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_508351f2-f63c-4315-a18d-8b1cfa4819be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_03060416-d80f-4d2d-9943-eeaf168439e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_03060416-d80f-4d2d-9943-eeaf168439e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0e93aa31-33fb-4cbd-bde0-a66db8eb99cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0e93aa31-33fb-4cbd-bde0-a66db8eb99cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_c48b3077-acdd-4a3f-8774-f9cdc4ae69ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_c48b3077-acdd-4a3f-8774-f9cdc4ae69ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c3a9ff1c-91ee-4646-a5ee-d1c8ebd57f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c3a9ff1c-91ee-4646-a5ee-d1c8ebd57f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_f77e3060-bc50-4480-9bd1-0cc54515ad94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_f77e3060-bc50-4480-9bd1-0cc54515ad94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_af85927d-27fd-4975-8f01-5dd125238021" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_af85927d-27fd-4975-8f01-5dd125238021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_36626b49-6947-4912-8c2a-7ee8bd48a88d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_36626b49-6947-4912-8c2a-7ee8bd48a88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareRepurchaseProgramBrokerCommission_ef828780-6c4c-4eda-9553-f9d33b473443" xlink:href="iclr-20241231.xsd#iclr_ShareRepurchaseProgramBrokerCommission"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_iclr_ShareRepurchaseProgramBrokerCommission_ef828780-6c4c-4eda-9553-f9d33b473443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e0497765-0686-4f18-bab5-fae61e4acc6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_CommonStockSharesIssued_e0497765-0686-4f18-bab5-fae61e4acc6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0fd9b9f3-ead4-48fd-ad16-f4d67d30f0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7e3665a9-4b20-4a07-94c2-2e2c298aa9f3" xlink:to="loc_us-gaap_StockholdersEquity_0fd9b9f3-ead4-48fd-ad16-f4d67d30f0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="iclr-20241231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_06d181cb-e92a-4eb3-abb6-cf018b48df5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4d2920d7-5d3c-4e82-aa07-ba30db75d260" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_06d181cb-e92a-4eb3-abb6-cf018b48df5a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4d2920d7-5d3c-4e82-aa07-ba30db75d260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a2b58c08-ae47-4bca-a6fa-fcb73501d898" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4d2920d7-5d3c-4e82-aa07-ba30db75d260" xlink:to="loc_us-gaap_ProfitLoss_a2b58c08-ae47-4bca-a6fa-fcb73501d898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7ca71605-4c32-4f09-8d6d-8e66f139e451" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4d2920d7-5d3c-4e82-aa07-ba30db75d260" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7ca71605-4c32-4f09-8d6d-8e66f139e451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b4d28779-ee28-4d46-a973-d0826fb5719b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7ca71605-4c32-4f09-8d6d-8e66f139e451" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b4d28779-ee28-4d46-a973-d0826fb5719b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment_eb9c1b3b-dd5a-41d7-ada0-1dbce697f7aa" xlink:href="iclr-20241231.xsd#iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7ca71605-4c32-4f09-8d6d-8e66f139e451" xlink:to="loc_iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment_eb9c1b3b-dd5a-41d7-ada0-1dbce697f7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_daa73d30-66f2-48b3-bb32-045ad3901451" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7ca71605-4c32-4f09-8d6d-8e66f139e451" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_daa73d30-66f2-48b3-bb32-045ad3901451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_108d6e40-8b04-4a09-89c3-9071c92fb125" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7ca71605-4c32-4f09-8d6d-8e66f139e451" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_108d6e40-8b04-4a09-89c3-9071c92fb125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_2200ad7b-dc0b-4641-843e-aa98f0a1bfe7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7ca71605-4c32-4f09-8d6d-8e66f139e451" xlink:to="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_2200ad7b-dc0b-4641-843e-aa98f0a1bfe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_971bd361-ee7d-4d98-9bb9-3c8aff795ded" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7ca71605-4c32-4f09-8d6d-8e66f139e451" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_971bd361-ee7d-4d98-9bb9-3c8aff795ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_61a3631d-6909-4102-bf72-08b455442693" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7ca71605-4c32-4f09-8d6d-8e66f139e451" xlink:to="loc_us-gaap_ShareBasedCompensation_61a3631d-6909-4102-bf72-08b455442693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_2c0ff9e2-9bb7-4850-b5d4-3f84f155817d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7ca71605-4c32-4f09-8d6d-8e66f139e451" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_2c0ff9e2-9bb7-4850-b5d4-3f84f155817d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_b05c85c1-ff77-4070-aa45-47bbcafc283f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7ca71605-4c32-4f09-8d6d-8e66f139e451" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_b05c85c1-ff77-4070-aa45-47bbcafc283f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_89be7aa1-df1b-445a-955a-4e738956283e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7ca71605-4c32-4f09-8d6d-8e66f139e451" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_89be7aa1-df1b-445a-955a-4e738956283e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fece9138-b17c-4e93-b380-c0c08a7859ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4d2920d7-5d3c-4e82-aa07-ba30db75d260" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fece9138-b17c-4e93-b380-c0c08a7859ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9b973824-c0bd-4bb4-8207-43fe2d3f162b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fece9138-b17c-4e93-b380-c0c08a7859ba" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9b973824-c0bd-4bb4-8207-43fe2d3f162b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_c6d1549a-6e13-4e59-9514-f2fcd66ddae5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fece9138-b17c-4e93-b380-c0c08a7859ba" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_c6d1549a-6e13-4e59-9514-f2fcd66ddae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_46de8379-5406-4a29-bf20-3ccf5038abaf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fece9138-b17c-4e93-b380-c0c08a7859ba" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_46de8379-5406-4a29-bf20-3ccf5038abaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_57767791-cf56-4eba-be41-5f4563b8f8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_fece9138-b17c-4e93-b380-c0c08a7859ba" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_57767791-cf56-4eba-be41-5f4563b8f8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e2e01c0-e098-45c1-b5c9-445ad802f45e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4d2920d7-5d3c-4e82-aa07-ba30db75d260" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e2e01c0-e098-45c1-b5c9-445ad802f45e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b7e86bae-09f9-428f-b11d-259d803da97c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_06d181cb-e92a-4eb3-abb6-cf018b48df5a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b7e86bae-09f9-428f-b11d-259d803da97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ff57f9af-96b5-49c7-865f-f79484745d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b7e86bae-09f9-428f-b11d-259d803da97c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ff57f9af-96b5-49c7-865f-f79484745d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_966fd4bb-2c90-46f5-afde-a444daf309ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b7e86bae-09f9-428f-b11d-259d803da97c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_966fd4bb-2c90-46f5-afde-a444daf309ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromShortTermInvestments_8c2c5f71-88ef-4fa6-abd5-c3d299a20463" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b7e86bae-09f9-428f-b11d-259d803da97c" xlink:to="loc_us-gaap_PaymentsForProceedsFromShortTermInvestments_8c2c5f71-88ef-4fa6-abd5-c3d299a20463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_ced3b25e-61eb-4c6f-af1d-68887550ada8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfLongtermInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b7e86bae-09f9-428f-b11d-259d803da97c" xlink:to="loc_us-gaap_ProceedsFromSaleOfLongtermInvestments_ced3b25e-61eb-4c6f-af1d-68887550ada8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLongtermInvestments_56a6eddb-fa2a-41fd-b4d3-db4ce6e007be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireLongtermInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b7e86bae-09f9-428f-b11d-259d803da97c" xlink:to="loc_us-gaap_PaymentsToAcquireLongtermInvestments_56a6eddb-fa2a-41fd-b4d3-db4ce6e007be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_12a2b518-4eb2-4aa9-a13c-0920a5b159ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b7e86bae-09f9-428f-b11d-259d803da97c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_12a2b518-4eb2-4aa9-a13c-0920a5b159ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_076aa2d9-cacd-49b8-bea9-cd90445fc249" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_06d181cb-e92a-4eb3-abb6-cf018b48df5a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_076aa2d9-cacd-49b8-bea9-cd90445fc249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_e49d1e32-b054-4e09-a58a-f86599b3b629" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_076aa2d9-cacd-49b8-bea9-cd90445fc249" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_e49d1e32-b054-4e09-a58a-f86599b3b629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_2a4e9932-c246-4b03-8d00-630944597f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_076aa2d9-cacd-49b8-bea9-cd90445fc249" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_2a4e9932-c246-4b03-8d00-630944597f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_4b5e1a99-e580-4d6b-a98f-0a1332df4638" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_076aa2d9-cacd-49b8-bea9-cd90445fc249" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_4b5e1a99-e580-4d6b-a98f-0a1332df4638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_98b81bbb-c0f4-49ae-99e2-5f8ad6d5916b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_076aa2d9-cacd-49b8-bea9-cd90445fc249" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_98b81bbb-c0f4-49ae-99e2-5f8ad6d5916b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_c4e40a0b-bec2-4ecd-960d-d2ab9a9f494f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_076aa2d9-cacd-49b8-bea9-cd90445fc249" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_c4e40a0b-bec2-4ecd-960d-d2ab9a9f494f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8faafa9a-17b8-4981-ac09-bc6cbd1b82dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_076aa2d9-cacd-49b8-bea9-cd90445fc249" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8faafa9a-17b8-4981-ac09-bc6cbd1b82dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PaymentsForBrokerCommissionShareRepurchaseCosts_270852b8-ed56-4ce5-87fe-d737e5e84c98" xlink:href="iclr-20241231.xsd#iclr_PaymentsForBrokerCommissionShareRepurchaseCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_076aa2d9-cacd-49b8-bea9-cd90445fc249" xlink:to="loc_iclr_PaymentsForBrokerCommissionShareRepurchaseCosts_270852b8-ed56-4ce5-87fe-d737e5e84c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9a5cdf4d-0612-421b-a779-9300970db310" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_076aa2d9-cacd-49b8-bea9-cd90445fc249" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9a5cdf4d-0612-421b-a779-9300970db310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_15d8d02c-4078-4512-ba8c-0f8e3b913230" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_06d181cb-e92a-4eb3-abb6-cf018b48df5a" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_15d8d02c-4078-4512-ba8c-0f8e3b913230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bd5ac962-39a5-41b9-a253-b353cd5f1f21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_06d181cb-e92a-4eb3-abb6-cf018b48df5a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bd5ac962-39a5-41b9-a253-b353cd5f1f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2a46c187-c01a-4bd4-8a3b-3030e96efa26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_06d181cb-e92a-4eb3-abb6-cf018b48df5a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2a46c187-c01a-4bd4-8a3b-3030e96efa26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3e236bb9-befc-4165-890f-b7e9e67972bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_06d181cb-e92a-4eb3-abb6-cf018b48df5a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3e236bb9-befc-4165-890f-b7e9e67972bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/Descriptionofbusiness" xlink:type="simple" xlink:href="iclr-20241231.xsd#Descriptionofbusiness"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Descriptionofbusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2e6f980a-9544-4e71-914e-0848b84eea8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_87ee499b-162c-460c-b08c-ee292ed87470" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2e6f980a-9544-4e71-914e-0848b84eea8c" xlink:to="loc_us-gaap_NatureOfOperations_87ee499b-162c-460c-b08c-ee292ed87470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies" xlink:type="simple" xlink:href="iclr-20241231.xsd#SummaryofSignificantaccountingpolicies"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_98573fec-8c87-4707-83aa-d341eb9628b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1688ff42-7ace-4ccb-8035-8cab50918c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_98573fec-8c87-4707-83aa-d341eb9628b9" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1688ff42-7ace-4ccb-8035-8cab50918c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DisaggregationofRevenue" xlink:type="simple" xlink:href="iclr-20241231.xsd#DisaggregationofRevenue"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DisaggregationofRevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2db6c48b-5502-4aeb-b44f-b160aae7335c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_60c1ba14-c964-4dc5-af25-d29d69b6ed70" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2db6c48b-5502-4aeb-b44f-b160aae7335c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_60c1ba14-c964-4dc5-af25-d29d69b6ed70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/Accountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilities" xlink:type="simple" xlink:href="iclr-20241231.xsd#Accountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilities"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Accountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8d7f3895-1826-4053-b4ce-3e9ddeb7eec6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_ce0595bb-8174-47aa-a728-4ea349a2e1d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8d7f3895-1826-4053-b4ce-3e9ddeb7eec6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_ce0595bb-8174-47aa-a728-4ea349a2e1d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AllowancesforCreditLosses" xlink:type="simple" xlink:href="iclr-20241231.xsd#AllowancesforCreditLosses"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AllowancesforCreditLosses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_94061da4-cff6-4f24-b568-0bf59b4e164b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesTextBlock_06dfbe8d-8bf5-420d-8887-7ba37fc95994" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForCreditLossesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_94061da4-cff6-4f24-b568-0bf59b4e164b" xlink:to="loc_us-gaap_AllowanceForCreditLossesTextBlock_06dfbe8d-8bf5-420d-8887-7ba37fc95994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinations" xlink:type="simple" xlink:href="iclr-20241231.xsd#BusinessCombinations"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessCombinations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_6f5a5c3a-d147-4ea3-ba8c-f66dec69335e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_6ae0726f-dfb7-4aac-b53f-60930b89766e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_6f5a5c3a-d147-4ea3-ba8c-f66dec69335e" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_6ae0726f-dfb7-4aac-b53f-60930b89766e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/FairValue" xlink:type="simple" xlink:href="iclr-20241231.xsd#FairValue"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/FairValue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_629c6f92-f720-40b7-91a6-7c5282757c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_a03c2fad-3584-45fd-a568-ac800b59939f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_629c6f92-f720-40b7-91a6-7c5282757c9c" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_a03c2fad-3584-45fd-a568-ac800b59939f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/Investments" xlink:type="simple" xlink:href="iclr-20241231.xsd#Investments"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e2a5e387-3fe3-40fd-8599-96d93b0209f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_8f2a869d-0c2a-41d8-af1b-3277fd167310" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e2a5e387-3fe3-40fd-8599-96d93b0209f5" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_8f2a869d-0c2a-41d8-af1b-3277fd167310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnet" xlink:type="simple" xlink:href="iclr-20241231.xsd#PropertyPlantandEquipmentnet"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/PropertyPlantandEquipmentnet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_fe85d72d-113e-418e-94ac-5e73d6b720a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_c151e74f-37d4-49cf-acb3-bb6d0474b146" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_fe85d72d-113e-418e-94ac-5e73d6b720a9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_c151e74f-37d4-49cf-acb3-bb6d0474b146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/Goodwill" xlink:type="simple" xlink:href="iclr-20241231.xsd#Goodwill"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Goodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_636edb70-0d32-4c41-ae24-1af586d2c110" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock_c281bb3c-d19b-49eb-95d1-f5dd43a25263" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_636edb70-0d32-4c41-ae24-1af586d2c110" xlink:to="loc_us-gaap_GoodwillDisclosureTextBlock_c281bb3c-d19b-49eb-95d1-f5dd43a25263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssets" xlink:type="simple" xlink:href="iclr-20241231.xsd#IntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0fd1dd35-9b49-4a92-8363-2d55735bfe6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_876a5d85-755b-44e8-a906-51654861dc34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0fd1dd35-9b49-4a92-8363-2d55735bfe6a" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_876a5d85-755b-44e8-a906-51654861dc34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OtherLiabilities" xlink:type="simple" xlink:href="iclr-20241231.xsd#OtherLiabilities"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OtherLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_f6e7baf9-f50b-416c-af4b-29819d28233a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_3424101a-accb-44f2-a5e1-940ab4ed29a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_f6e7baf9-f50b-416c-af4b-29819d28233a" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_3424101a-accb-44f2-a5e1-940ab4ed29a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotes" xlink:type="simple" xlink:href="iclr-20241231.xsd#BankCreditLinesLoanFacilitiesandNotes"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a694f90e-3953-4337-8a6a-bd5e8e5abdb7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_47a3c5c6-2fc3-432e-88c0-a76ca7adcb97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a694f90e-3953-4337-8a6a-bd5e8e5abdb7" xlink:to="loc_us-gaap_LongTermDebtTextBlock_47a3c5c6-2fc3-432e-88c0-a76ca7adcb97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/Derivatives" xlink:type="simple" xlink:href="iclr-20241231.xsd#Derivatives"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Derivatives" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5072aa29-3f5a-44a1-a2bc-cca3cc2ea862" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_f93f9ef9-82db-4f83-bbe0-6efd5186b2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5072aa29-3f5a-44a1-a2bc-cca3cc2ea862" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_f93f9ef9-82db-4f83-bbe0-6efd5186b2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeases" xlink:type="simple" xlink:href="iclr-20241231.xsd#OperatingLeases"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OperatingLeases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_89d4261f-df78-4038-b229-49aaf89a6585" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_86868d52-e376-4c96-8cff-ad143c1a62e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_89d4261f-df78-4038-b229-49aaf89a6585" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_86868d52-e376-4c96-8cff-ad143c1a62e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/Noncurrentotherliabilities" xlink:type="simple" xlink:href="iclr-20241231.xsd#Noncurrentotherliabilities"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/Noncurrentotherliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_e67a491b-51c1-43fe-803a-197b1f8f0987" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock_5c3c19a9-77cc-40a3-ae51-73ec16ccb06a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_e67a491b-51c1-43fe-803a-197b1f8f0987" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock_5c3c19a9-77cc-40a3-ae51-73ec16ccb06a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="iclr-20241231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f6f3cb15-bb14-4f79-9215-2d9e68a288f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5b03224f-87da-4448-8bc6-fa619c32a3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f6f3cb15-bb14-4f79-9215-2d9e68a288f5" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5b03224f-87da-4448-8bc6-fa619c32a3e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ShareCapital" xlink:type="simple" xlink:href="iclr-20241231.xsd#ShareCapital"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/ShareCapital" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ed1fb2b5-c46a-4499-8753-7f8fea57043e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1e428281-1ba0-48e7-9ad1-0eda7fd097aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ed1fb2b5-c46a-4499-8753-7f8fea57043e" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1e428281-1ba0-48e7-9ad1-0eda7fd097aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RestructuringCharges" xlink:type="simple" xlink:href="iclr-20241231.xsd#RestructuringCharges"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RestructuringCharges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_e96068dd-29cb-4df2-a665-9f7c008510ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_8fe43941-8bd7-4afb-bb36-7bc340fde182" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_e96068dd-29cb-4df2-a665-9f7c008510ae" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_8fe43941-8bd7-4afb-bb36-7bc340fde182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxes" xlink:type="simple" xlink:href="iclr-20241231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_02f9f51a-12f3-41d0-8a7e-57f60c5aa85b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_f9a41af1-2580-47ad-95ca-5c41e8012610" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_02f9f51a-12f3-41d0-8a7e-57f60c5aa85b" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_f9a41af1-2580-47ad-95ca-5c41e8012610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges" xlink:type="simple" xlink:href="iclr-20241231.xsd#EquityIncentiveSchemesandStockCompensationCharges"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7c6f101a-d469-4686-80dc-3a0936ffeaad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_95480feb-18c6-44d0-8390-c2daa16f3952" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7c6f101a-d469-4686-80dc-3a0936ffeaad" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_95480feb-18c6-44d0-8390-c2daa16f3952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation" xlink:type="simple" xlink:href="iclr-20241231.xsd#BusinessSegmentandGeographicalInformation"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_fafcf9e2-bcb0-43e5-8263-1c00cf034e82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_461263b7-b62b-462f-90fb-bbf8d6c6fe55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fafcf9e2-bcb0-43e5-8263-1c00cf034e82" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_461263b7-b62b-462f-90fb-bbf8d6c6fe55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShare" xlink:type="simple" xlink:href="iclr-20241231.xsd#NetIncomePerOrdinaryShare"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NetIncomePerOrdinaryShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_dd3931a0-2c11-4435-af27-49c992193102" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_648ee52a-1453-4512-8e9f-170dbfbff5c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_dd3931a0-2c11-4435-af27-49c992193102" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_648ee52a-1453-4512-8e9f-170dbfbff5c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="iclr-20241231.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_7a83b253-784c-4c9f-91b0-6bade99b9029" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock_49480f92-78c4-4152-ab51-0dfc1eae1be9" xlink:href="iclr-20241231.xsd#iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_7a83b253-784c-4c9f-91b0-6bade99b9029" xlink:to="loc_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock_49480f92-78c4-4152-ab51-0dfc1eae1be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation" xlink:type="simple" xlink:href="iclr-20241231.xsd#SupplementalDisclosureofCashFlowInformation"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_6638d204-341d-4af8-884c-edcfda9e6f18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_1f8a048d-a464-49c1-9c5a-02bb51c709e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_6638d204-341d-4af8-884c-edcfda9e6f18" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_1f8a048d-a464-49c1-9c5a-02bb51c709e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RelatedParties" xlink:type="simple" xlink:href="iclr-20241231.xsd#RelatedParties"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RelatedParties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_c6e81464-102f-456a-a9bc-8349d9da0ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_c83a415f-08bc-4d40-922d-0c65198921c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_c6e81464-102f-456a-a9bc-8349d9da0ab8" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_c83a415f-08bc-4d40-922d-0c65198921c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SubsequentEvents" xlink:type="simple" xlink:href="iclr-20241231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_2430848c-9ea7-4e58-b9ef-c34a3841af6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_17a362f2-de7c-49cb-a47d-4e5c98e36d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_2430848c-9ea7-4e58-b9ef-c34a3841af6a" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_17a362f2-de7c-49cb-a47d-4e5c98e36d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" xlink:type="simple" xlink:href="iclr-20241231.xsd#SummaryofSignificantaccountingpoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_a935977f-5243-4e70-af0a-0defe24c17fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_a935977f-5243-4e70-af0a-0defe24c17fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_0c1651aa-7f93-465c-94c7-969885dce93e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_us-gaap_UseOfEstimates_0c1651aa-7f93-465c-94c7-969885dce93e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_849e23fa-fe74-46df-af4f-c91eb023c862" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_849e23fa-fe74-46df-af4f-c91eb023c862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_3cab1257-61a7-407d-94ae-3c2b262b2b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_3cab1257-61a7-407d-94ae-3c2b262b2b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_062db99b-f989-4a8b-a199-67115a4eb243" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_062db99b-f989-4a8b-a199-67115a4eb243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_c14cfa65-8746-4d98-9cfc-dc894a2b5f14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_c14cfa65-8746-4d98-9cfc-dc894a2b5f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_a42380b5-535e-4171-b4e2-7ea18c16ea86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_a42380b5-535e-4171-b4e2-7ea18c16ea86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_6ed5bae4-59d2-429e-a673-0e5e35fc5eea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_6ed5bae4-59d2-429e-a673-0e5e35fc5eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_bf856124-7f68-4fe3-ac23-50ec41f0dea0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_bf856124-7f68-4fe3-ac23-50ec41f0dea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_6b6a5535-65fb-4d51-b36d-f32486a6057a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_6b6a5535-65fb-4d51-b36d-f32486a6057a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_fb38f3da-f248-4cb2-b057-7fdddc62f028" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_fb38f3da-f248-4cb2-b057-7fdddc62f028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_ffdeac1c-95dd-41f8-8e84-3e962c3f003b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_ffdeac1c-95dd-41f8-8e84-3e962c3f003b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_3c2fca61-3e15-44ae-985c-c86b30e7552c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_3c2fca61-3e15-44ae-985c-c86b30e7552c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_20ea3fa1-26cc-43d7-a0f9-47a54a572bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_20ea3fa1-26cc-43d7-a0f9-47a54a572bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock_c8008f56-c3f9-4af2-83de-79195930a08f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_us-gaap_DebtPolicyTextBlock_c8008f56-c3f9-4af2-83de-79195930a08f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_74bdc3b3-5ea3-43be-b26f-8e6b04904e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_74bdc3b3-5ea3-43be-b26f-8e6b04904e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_b064fa3d-7290-43a7-8245-6febadd5769a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_b064fa3d-7290-43a7-8245-6febadd5769a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_GovernmentGrantsPolicyTextBlock_3f59eec6-cf53-4791-888d-63b7e9260ebd" xlink:href="iclr-20241231.xsd#iclr_GovernmentGrantsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_iclr_GovernmentGrantsPolicyTextBlock_3f59eec6-cf53-4791-888d-63b7e9260ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ResearchAndDevelopmentCreditsPolicyTextBlock_f3a0634b-9229-41a5-a089-00220d8ef063" xlink:href="iclr-20241231.xsd#iclr_ResearchAndDevelopmentCreditsPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_iclr_ResearchAndDevelopmentCreditsPolicyTextBlock_f3a0634b-9229-41a5-a089-00220d8ef063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_601ff811-c8fd-46b5-9d5f-7ed37b6d605d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_601ff811-c8fd-46b5-9d5f-7ed37b6d605d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_4ecf6214-f25a-4a66-9021-b8d88e68e17d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_4ecf6214-f25a-4a66-9021-b8d88e68e17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_3ddbac1f-5cf3-4a3b-abbe-86355b5900a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy_3ddbac1f-5cf3-4a3b-abbe-86355b5900a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_084d7156-dce3-4c39-8928-9539fd2992fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_084d7156-dce3-4c39-8928-9539fd2992fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_aa0cdc12-8eeb-45ec-af12-8fcb88990aae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3c782bb-649a-44da-9f3b-4c8c830d6caa" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_aa0cdc12-8eeb-45ec-af12-8fcb88990aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables" xlink:type="simple" xlink:href="iclr-20241231.xsd#SummaryofSignificantaccountingpoliciesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4894deb5-74bc-4507-b893-d2a0c18b86f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ForeignCurrencyDisclosureTableTextBlock_f4bf93e2-8ec5-4194-b8c2-6a424abe3156" xlink:href="iclr-20241231.xsd#iclr_ForeignCurrencyDisclosureTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4894deb5-74bc-4507-b893-d2a0c18b86f2" xlink:to="loc_iclr_ForeignCurrencyDisclosureTableTextBlock_f4bf93e2-8ec5-4194-b8c2-6a424abe3156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock_23be2f71-0571-4ba8-930a-eb28b2c85dc1" xlink:href="iclr-20241231.xsd#iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4894deb5-74bc-4507-b893-d2a0c18b86f2" xlink:to="loc_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock_23be2f71-0571-4ba8-930a-eb28b2c85dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_9538d507-869f-4aa8-825c-c60172cc1e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4894deb5-74bc-4507-b893-d2a0c18b86f2" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_9538d507-869f-4aa8-825c-c60172cc1e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DisaggregationofRevenueTables" xlink:type="simple" xlink:href="iclr-20241231.xsd#DisaggregationofRevenueTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DisaggregationofRevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3a07bc7c-ee6d-48c0-9d89-105ea8595d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_c34fef9a-d72e-436b-944a-029eed2478b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3a07bc7c-ee6d-48c0-9d89-105ea8595d1f" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_c34fef9a-d72e-436b-944a-029eed2478b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables" xlink:type="simple" xlink:href="iclr-20241231.xsd#AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_dddc84ef-e5b3-4adf-b278-68423ea8e881" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_6302b54e-cfe9-455b-a262-a4fb12a4e77a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_dddc84ef-e5b3-4adf-b278-68423ea8e881" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_6302b54e-cfe9-455b-a262-a4fb12a4e77a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AllowancesforCreditLossesTables" xlink:type="simple" xlink:href="iclr-20241231.xsd#AllowancesforCreditLossesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AllowancesforCreditLossesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_069d7a0e-daca-4d1d-b843-4d46eafca7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_fae149a8-fd9e-48ea-b292-46f67d21f7be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_069d7a0e-daca-4d1d-b843-4d46eafca7f4" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_fae149a8-fd9e-48ea-b292-46f67d21f7be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/FairValueTables" xlink:type="simple" xlink:href="iclr-20241231.xsd#FairValueTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/FairValueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a75a77f6-2d5a-433e-98e7-0bef19290064" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_969d12ef-b139-494c-9579-cf3ac5538278" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a75a77f6-2d5a-433e-98e7-0bef19290064" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_969d12ef-b139-494c-9579-cf3ac5538278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_ff78f0f2-c136-4626-b55f-2b528e9e37b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a75a77f6-2d5a-433e-98e7-0bef19290064" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_ff78f0f2-c136-4626-b55f-2b528e9e37b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables" xlink:type="simple" xlink:href="iclr-20241231.xsd#PropertyPlantandEquipmentnetTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_e1b1345d-66af-45f4-8e40-f59f67a79a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_9529819c-81b0-4506-8373-157c87b5e1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_e1b1345d-66af-45f4-8e40-f59f67a79a2a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_9529819c-81b0-4506-8373-157c87b5e1dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/GoodwillTables" xlink:type="simple" xlink:href="iclr-20241231.xsd#GoodwillTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/GoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_11ed4fe7-8b3a-41f0-9900-04a797902f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_dd8e12a8-964c-449f-a594-0af050c8b98f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_11ed4fe7-8b3a-41f0-9900-04a797902f2e" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_dd8e12a8-964c-449f-a594-0af050c8b98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsTables" xlink:type="simple" xlink:href="iclr-20241231.xsd#IntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_03200f61-f1ff-4c73-bfa1-dca4cf1788c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_52c603b4-da46-465a-a5d1-ae37bfd055e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_03200f61-f1ff-4c73-bfa1-dca4cf1788c6" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_52c603b4-da46-465a-a5d1-ae37bfd055e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_27c9977e-265c-4c18-8c51-70d493465017" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_03200f61-f1ff-4c73-bfa1-dca4cf1788c6" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_27c9977e-265c-4c18-8c51-70d493465017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OtherLiabilitiesTables" xlink:type="simple" xlink:href="iclr-20241231.xsd#OtherLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OtherLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_9af6734a-2240-4a31-b928-3a86ffe9b24f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesTableTextBlock_4d87dd77-885c-4348-98f9-bacd21bc7c53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_9af6734a-2240-4a31-b928-3a86ffe9b24f" xlink:to="loc_us-gaap_OtherLiabilitiesTableTextBlock_4d87dd77-885c-4348-98f9-bacd21bc7c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesTables" xlink:type="simple" xlink:href="iclr-20241231.xsd#BankCreditLinesLoanFacilitiesandNotesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_11b939a8-0404-487a-a70f-7df3dc330a91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_de9f679d-7b21-4197-b0a6-79094de5f6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_11b939a8-0404-487a-a70f-7df3dc330a91" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_de9f679d-7b21-4197-b0a6-79094de5f6e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock_7c473a58-af97-4a7e-801b-c0629d4152b2" xlink:href="iclr-20241231.xsd#iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_11b939a8-0404-487a-a70f-7df3dc330a91" xlink:to="loc_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock_7c473a58-af97-4a7e-801b-c0629d4152b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_5d545a14-0124-4e7c-a1a4-69b1e3d4c710" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_11b939a8-0404-487a-a70f-7df3dc330a91" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_5d545a14-0124-4e7c-a1a4-69b1e3d4c710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock_0c3fd7f7-2a34-4d6e-859c-7ea64fcbc972" xlink:href="iclr-20241231.xsd#iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_11b939a8-0404-487a-a70f-7df3dc330a91" xlink:to="loc_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock_0c3fd7f7-2a34-4d6e-859c-7ea64fcbc972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DerivativesTables" xlink:type="simple" xlink:href="iclr-20241231.xsd#DerivativesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DerivativesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_57bb2c74-762b-43c3-b38a-f83b840bc3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_53d9b1ce-b4eb-4ab4-b00e-f01909bb24ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_57bb2c74-762b-43c3-b38a-f83b840bc3d0" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_53d9b1ce-b4eb-4ab4-b00e-f01909bb24ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesTables" xlink:type="simple" xlink:href="iclr-20241231.xsd#OperatingLeasesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_8bffc304-6094-4c5f-9687-bf8c5a0d43e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_52d39c78-6044-4b65-9099-30fa0f0af17e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8bffc304-6094-4c5f-9687-bf8c5a0d43e4" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_52d39c78-6044-4b65-9099-30fa0f0af17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_271bbdd6-cf65-4d32-b000-e450287717ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8bffc304-6094-4c5f-9687-bf8c5a0d43e4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_271bbdd6-cf65-4d32-b000-e450287717ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentotherliabilitiesTables" xlink:type="simple" xlink:href="iclr-20241231.xsd#NoncurrentotherliabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NoncurrentotherliabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_c633fb21-9a3f-4fc9-827a-b8662ec19e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_17c2fa5f-873a-4889-8801-19b611ae2142" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_c633fb21-9a3f-4fc9-827a-b8662ec19e2a" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_17c2fa5f-873a-4889-8801-19b611ae2142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RestructuringchargesTables" xlink:type="simple" xlink:href="iclr-20241231.xsd#RestructuringchargesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RestructuringchargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d7354e91-38e8-42ff-9b48-a78610c9bc3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_5b967ac1-26b0-4494-9484-da5eaf43c646" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d7354e91-38e8-42ff-9b48-a78610c9bc3b" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_5b967ac1-26b0-4494-9484-da5eaf43c646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_b2a4aacb-52d1-40f2-966f-23bcef76e3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d7354e91-38e8-42ff-9b48-a78610c9bc3b" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_b2a4aacb-52d1-40f2-966f-23bcef76e3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="iclr-20241231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_38b34d6c-8865-4a87-83fd-292c05c15110" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeBeforeIncomeTaxTableTextBlock_2b178146-c8ad-4abe-8aaa-fa8299943fc4" xlink:href="iclr-20241231.xsd#iclr_IncomeBeforeIncomeTaxTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_38b34d6c-8865-4a87-83fd-292c05c15110" xlink:to="loc_iclr_IncomeBeforeIncomeTaxTableTextBlock_2b178146-c8ad-4abe-8aaa-fa8299943fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_f5c22a8f-a1a1-4e45-b49c-982d44d68fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_38b34d6c-8865-4a87-83fd-292c05c15110" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_f5c22a8f-a1a1-4e45-b49c-982d44d68fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_cb205603-a14e-4d1f-9e0e-5824b7ce7804" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_38b34d6c-8865-4a87-83fd-292c05c15110" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_cb205603-a14e-4d1f-9e0e-5824b7ce7804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_ab68ea9c-6911-4851-bb6a-aaedbd4b5c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_38b34d6c-8865-4a87-83fd-292c05c15110" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_ab68ea9c-6911-4851-bb6a-aaedbd4b5c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_a85800bb-7726-4392-a2a8-c6669d8bd90b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_38b34d6c-8865-4a87-83fd-292c05c15110" xlink:to="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_a85800bb-7726-4392-a2a8-c6669d8bd90b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_9b967706-228b-4cde-938a-b6d21a9e2e78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_38b34d6c-8865-4a87-83fd-292c05c15110" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_9b967706-228b-4cde-938a-b6d21a9e2e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables" xlink:type="simple" xlink:href="iclr-20241231.xsd#EquityIncentiveSchemesandStockCompensationChargesTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0eb0e311-1e7c-456c-9997-88280e0f6f44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_06fabaf1-25ab-45e0-b967-c6dd8160bbe3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0eb0e311-1e7c-456c-9997-88280e0f6f44" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_06fabaf1-25ab-45e0-b967-c6dd8160bbe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_ff19132c-7f50-4f45-b334-d7edb930db0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0eb0e311-1e7c-456c-9997-88280e0f6f44" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_ff19132c-7f50-4f45-b334-d7edb930db0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock_d88ac2e6-11ea-4d75-b74c-0ae70bc107a5" xlink:href="iclr-20241231.xsd#iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0eb0e311-1e7c-456c-9997-88280e0f6f44" xlink:to="loc_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock_d88ac2e6-11ea-4d75-b74c-0ae70bc107a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock_21e89b4d-4d3b-4626-a9a5-cacd966ca76f" xlink:href="iclr-20241231.xsd#iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0eb0e311-1e7c-456c-9997-88280e0f6f44" xlink:to="loc_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock_21e89b4d-4d3b-4626-a9a5-cacd966ca76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables" xlink:type="simple" xlink:href="iclr-20241231.xsd#BusinessSegmentandGeographicalInformationTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_789d9005-8c73-4668-83a0-0c5256fd0dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_bcceff53-7979-4902-b7f0-d55116222843" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_789d9005-8c73-4668-83a0-0c5256fd0dc2" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_bcceff53-7979-4902-b7f0-d55116222843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OperatingIncomeByGeographyTableTextBlock_affeca2d-e81d-425a-89e7-a198984125eb" xlink:href="iclr-20241231.xsd#iclr_OperatingIncomeByGeographyTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_789d9005-8c73-4668-83a0-0c5256fd0dc2" xlink:to="loc_iclr_OperatingIncomeByGeographyTableTextBlock_affeca2d-e81d-425a-89e7-a198984125eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_53f03848-51b0-497d-b160-aa63dcc111e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_789d9005-8c73-4668-83a0-0c5256fd0dc2" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_53f03848-51b0-497d-b160-aa63dcc111e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables" xlink:type="simple" xlink:href="iclr-20241231.xsd#NetIncomePerOrdinaryShareTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4162693e-fe05-4112-8629-50213c6b2052" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_26baecd8-3262-4b2a-aa90-ff1630daf9c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4162693e-fe05-4112-8629-50213c6b2052" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_26baecd8-3262-4b2a-aa90-ff1630daf9c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="iclr-20241231.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_6bfe1a43-c516-4393-964f-7d0cf3c9bb57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_3071f91f-c2c7-4867-80b2-16350dd61d60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_6bfe1a43-c516-4393-964f-7d0cf3c9bb57" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_3071f91f-c2c7-4867-80b2-16350dd61d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables" xlink:type="simple" xlink:href="iclr-20241231.xsd#SupplementalDisclosureofCashFlowInformationTables"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_5a7b45dd-d29a-460c-a2a5-d0f423248899" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_06e858e2-ee45-4a62-9364-686e439c4ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_5a7b45dd-d29a-460c-a2a5-d0f423248899" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_06e858e2-ee45-4a62-9364-686e439c4ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DescriptionofbusinessDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#DescriptionofbusinessDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DescriptionofbusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a336ead6-7bc4-46b8-87e9-ea9de22f50a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_d759ace2-cc9b-45d7-9291-69ab38deb15f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a336ead6-7bc4-46b8-87e9-ea9de22f50a0" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_d759ace2-cc9b-45d7-9291-69ab38deb15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_cd5e112f-c88d-4b40-a95d-66f37d4ce9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_d759ace2-cc9b-45d7-9291-69ab38deb15f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_cd5e112f-c88d-4b40-a95d-66f37d4ce9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_32fff8d1-aadf-4ab0-b70b-aa33771d6066" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_cd5e112f-c88d-4b40-a95d-66f37d4ce9e5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_32fff8d1-aadf-4ab0-b70b-aa33771d6066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_912df437-77cf-4718-9464-04fcc42cba78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_32fff8d1-aadf-4ab0-b70b-aa33771d6066" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_912df437-77cf-4718-9464-04fcc42cba78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_2bd68802-01dc-4306-a139-d9cc593e107d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_d759ace2-cc9b-45d7-9291-69ab38deb15f" xlink:to="loc_srt_StatementGeographicalAxis_2bd68802-01dc-4306-a139-d9cc593e107d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ee824f20-7be4-4483-9379-2fb64a2b5762" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_2bd68802-01dc-4306-a139-d9cc593e107d" xlink:to="loc_srt_SegmentGeographicalDomain_ee824f20-7be4-4483-9379-2fb64a2b5762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_80123106-1ba4-457a-9ac1-8dfddfa063cf" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ee824f20-7be4-4483-9379-2fb64a2b5762" xlink:to="loc_country_US_80123106-1ba4-457a-9ac1-8dfddfa063cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_324955b7-579b-4741-8b3a-8bc2c5b2ae7c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ee824f20-7be4-4483-9379-2fb64a2b5762" xlink:to="loc_srt_EuropeMember_324955b7-579b-4741-8b3a-8bc2c5b2ae7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherGeographicLocationsMember_e7add09e-e69f-43e9-8161-caaaa26db2cd" xlink:href="iclr-20241231.xsd#iclr_OtherGeographicLocationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ee824f20-7be4-4483-9379-2fb64a2b5762" xlink:to="loc_iclr_OtherGeographicLocationsMember_e7add09e-e69f-43e9-8161-caaaa26db2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ac85212d-b245-44ea-b64e-a4aa5978b64f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_d759ace2-cc9b-45d7-9291-69ab38deb15f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ac85212d-b245-44ea-b64e-a4aa5978b64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_43866c54-1fa5-4eec-b016-141e9092c9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ac85212d-b245-44ea-b64e-a4aa5978b64f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_43866c54-1fa5-4eec-b016-141e9092c9d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_ebc7b30d-d3a4-42a0-b845-4ed83dbbbd6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_43866c54-1fa5-4eec-b016-141e9092c9d7" xlink:to="loc_us-gaap_SalesRevenueNetMember_ebc7b30d-d3a4-42a0-b845-4ed83dbbbd6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_400a3a53-2712-4a39-a95c-5f622e9eafa8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_d759ace2-cc9b-45d7-9291-69ab38deb15f" xlink:to="loc_us-gaap_ProductInformationLineItems_400a3a53-2712-4a39-a95c-5f622e9eafa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityNumberOfEmployees_f2479702-662a-40e5-8d91-e8d487780cb9" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityNumberOfEmployees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_400a3a53-2712-4a39-a95c-5f622e9eafa8" xlink:to="loc_dei_EntityNumberOfEmployees_f2479702-662a-40e5-8d91-e8d487780cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfLocations_ce4683b3-862a-4d29-95c2-026440209862" xlink:href="iclr-20241231.xsd#iclr_NumberOfLocations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_400a3a53-2712-4a39-a95c-5f622e9eafa8" xlink:to="loc_iclr_NumberOfLocations_ce4683b3-862a-4d29-95c2-026440209862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_20d1479c-c6d2-4628-8019-b44645bfad05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_400a3a53-2712-4a39-a95c-5f622e9eafa8" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_20d1479c-c6d2-4628-8019-b44645bfad05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_d3b7405d-9e7f-41ee-951f-144cf4a95206" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_400a3a53-2712-4a39-a95c-5f622e9eafa8" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_d3b7405d-9e7f-41ee-951f-144cf4a95206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b90138da-a5f7-4c42-8841-57bd10e60dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyAbstract_0c916997-d23c-4112-8ad3-6140331e2828" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b90138da-a5f7-4c42-8841-57bd10e60dbc" xlink:to="loc_us-gaap_ForeignCurrencyAbstract_0c916997-d23c-4112-8ad3-6140331e2828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_afce3452-e2db-432d-ab5f-d2d6cc2d1ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignCurrencyAbstract_0c916997-d23c-4112-8ad3-6140331e2828" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_afce3452-e2db-432d-ab5f-d2d6cc2d1ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5d180cc8-eea4-45a0-8dba-1c2b2d06408c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_81707ba8-9f69-42b8-a5a8-df639f64894d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5d180cc8-eea4-45a0-8dba-1c2b2d06408c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAbstract_81707ba8-9f69-42b8-a5a8-df639f64894d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_170f0c41-b55b-4b2b-b1a4-72cbe4072731" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_81707ba8-9f69-42b8-a5a8-df639f64894d" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_170f0c41-b55b-4b2b-b1a4-72cbe4072731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c5a2b77a-5a66-4e89-ad94-001eb467506d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_170f0c41-b55b-4b2b-b1a4-72cbe4072731" xlink:to="loc_srt_RangeAxis_c5a2b77a-5a66-4e89-ad94-001eb467506d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_582f1e0f-27dc-46d0-9ab7-2bb1c713a0e1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c5a2b77a-5a66-4e89-ad94-001eb467506d" xlink:to="loc_srt_RangeMember_582f1e0f-27dc-46d0-9ab7-2bb1c713a0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3402215a-7551-4d1f-974a-964843eb6a69" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_582f1e0f-27dc-46d0-9ab7-2bb1c713a0e1" xlink:to="loc_srt_MinimumMember_3402215a-7551-4d1f-974a-964843eb6a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_304cf3b5-994b-446d-838f-a2594f609be0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_582f1e0f-27dc-46d0-9ab7-2bb1c713a0e1" xlink:to="loc_srt_MaximumMember_304cf3b5-994b-446d-838f-a2594f609be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3f683c9c-f045-4e53-8f1d-684823f712ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_170f0c41-b55b-4b2b-b1a4-72cbe4072731" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3f683c9c-f045-4e53-8f1d-684823f712ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_afaf5889-f309-41d4-82ef-c9f3a2231a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3f683c9c-f045-4e53-8f1d-684823f712ac" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_afaf5889-f309-41d4-82ef-c9f3a2231a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_80aac3be-874e-481b-a6a9-66f266da09f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_afaf5889-f309-41d4-82ef-c9f3a2231a4d" xlink:to="loc_us-gaap_BuildingMember_80aac3be-874e-481b-a6a9-66f266da09f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_be136762-9bcc-4585-81dd-581de4896a5b" xlink:href="iclr-20241231.xsd#iclr_ComputerEquipmentAndCapitalizedSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_afaf5889-f309-41d4-82ef-c9f3a2231a4d" xlink:to="loc_iclr_ComputerEquipmentAndCapitalizedSoftwareMember_be136762-9bcc-4585-81dd-581de4896a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_bf5796dc-5c65-43d0-a4a6-073570746c52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_afaf5889-f309-41d4-82ef-c9f3a2231a4d" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_bf5796dc-5c65-43d0-a4a6-073570746c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_dc90d105-d7c1-4f53-9e61-79717c302f07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_afaf5889-f309-41d4-82ef-c9f3a2231a4d" xlink:to="loc_us-gaap_EquipmentMember_dc90d105-d7c1-4f53-9e61-79717c302f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_5f67779a-30b7-4489-ae2e-e98cbd2f8823" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VehiclesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_afaf5889-f309-41d4-82ef-c9f3a2231a4d" xlink:to="loc_us-gaap_VehiclesMember_5f67779a-30b7-4489-ae2e-e98cbd2f8823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ceb08422-ded4-440e-b13f-7dae15454b69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_170f0c41-b55b-4b2b-b1a4-72cbe4072731" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ceb08422-ded4-440e-b13f-7dae15454b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_76a9620b-ad8b-483a-9897-ee86156444e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ceb08422-ded4-440e-b13f-7dae15454b69" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_76a9620b-ad8b-483a-9897-ee86156444e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_46cb024f-f41d-4c55-9d4d-b323f290a8c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_5f8c8100-301f-4ced-ae28-4bcf8d27cafe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_46cb024f-f41d-4c55-9d4d-b323f290a8c4" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_5f8c8100-301f-4ced-ae28-4bcf8d27cafe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dbfe4670-da7c-41c7-b0bf-0f15a7ca83da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_5f8c8100-301f-4ced-ae28-4bcf8d27cafe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dbfe4670-da7c-41c7-b0bf-0f15a7ca83da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c31946ef-6df2-4c36-8afe-efb738abee84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dbfe4670-da7c-41c7-b0bf-0f15a7ca83da" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c31946ef-6df2-4c36-8afe-efb738abee84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_077e796e-4887-442c-a8ea-f9ad046556de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c31946ef-6df2-4c36-8afe-efb738abee84" xlink:to="loc_us-gaap_CustomerRelationshipsMember_077e796e-4887-442c-a8ea-f9ad046556de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_d8344429-26ac-4ba7-946d-66d59bec94fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c31946ef-6df2-4c36-8afe-efb738abee84" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_d8344429-26ac-4ba7-946d-66d59bec94fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_fdb230ae-e74e-4698-9396-998b5b16291d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c31946ef-6df2-4c36-8afe-efb738abee84" xlink:to="loc_us-gaap_TradeNamesMember_fdb230ae-e74e-4698-9396-998b5b16291d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_c4950cce-fece-4e53-8f74-a76487ebe103" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DatabasesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c31946ef-6df2-4c36-8afe-efb738abee84" xlink:to="loc_us-gaap_DatabasesMember_c4950cce-fece-4e53-8f74-a76487ebe103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_c045acad-c706-439d-995b-689df2cabf23" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c31946ef-6df2-4c36-8afe-efb738abee84" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_c045acad-c706-439d-995b-689df2cabf23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_49e0c4c5-de29-4961-8a2e-02c46c319c08" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_5f8c8100-301f-4ced-ae28-4bcf8d27cafe" xlink:to="loc_srt_RangeAxis_49e0c4c5-de29-4961-8a2e-02c46c319c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e0e451aa-9272-4f11-9220-648d8a9bf7e6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_49e0c4c5-de29-4961-8a2e-02c46c319c08" xlink:to="loc_srt_RangeMember_e0e451aa-9272-4f11-9220-648d8a9bf7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6fa3aac3-43dc-4441-b0f5-21a8d398e9cb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e0e451aa-9272-4f11-9220-648d8a9bf7e6" xlink:to="loc_srt_MinimumMember_6fa3aac3-43dc-4441-b0f5-21a8d398e9cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c3119209-998a-4597-8659-bdc5aa37105b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e0e451aa-9272-4f11-9220-648d8a9bf7e6" xlink:to="loc_srt_MaximumMember_c3119209-998a-4597-8659-bdc5aa37105b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_abe86efb-7051-4538-ae3d-1ee2fdcf9da5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_5f8c8100-301f-4ced-ae28-4bcf8d27cafe" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_abe86efb-7051-4538-ae3d-1ee2fdcf9da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_4b7c5724-00d3-41d2-899e-a7cfe0d29148" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_abe86efb-7051-4538-ae3d-1ee2fdcf9da5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_4b7c5724-00d3-41d2-899e-a7cfe0d29148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DisaggregationofRevenueDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#DisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_95b1026d-e4cd-4ea2-9887-4a46dfdb8166" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1e73263d-8378-4392-b12a-e04faddc8f94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_95b1026d-e4cd-4ea2-9887-4a46dfdb8166" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1e73263d-8378-4392-b12a-e04faddc8f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_d5457262-2693-4f1f-bbd3-d3803dbda55c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1e73263d-8378-4392-b12a-e04faddc8f94" xlink:to="loc_srt_MajorCustomersAxis_d5457262-2693-4f1f-bbd3-d3803dbda55c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_7a8ef64d-0d37-414b-881b-f4370105b5c2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_d5457262-2693-4f1f-bbd3-d3803dbda55c" xlink:to="loc_srt_NameOfMajorCustomerDomain_7a8ef64d-0d37-414b-881b-f4370105b5c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TopClientMember_5427fe51-272b-482a-a949-7f2b01d956a8" xlink:href="iclr-20241231.xsd#iclr_TopClientMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_7a8ef64d-0d37-414b-881b-f4370105b5c2" xlink:to="loc_iclr_TopClientMember_5427fe51-272b-482a-a949-7f2b01d956a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients25Member_f2a6215b-5393-4446-93b7-7f3893185771" xlink:href="iclr-20241231.xsd#iclr_Clients25Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_7a8ef64d-0d37-414b-881b-f4370105b5c2" xlink:to="loc_iclr_Clients25Member_f2a6215b-5393-4446-93b7-7f3893185771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients610Member_17296a58-4e68-4a5b-b838-8ead7b536f90" xlink:href="iclr-20241231.xsd#iclr_Clients610Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_7a8ef64d-0d37-414b-881b-f4370105b5c2" xlink:to="loc_iclr_Clients610Member_17296a58-4e68-4a5b-b838-8ead7b536f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_Clients1125Member_76afa3a7-a990-4826-bbef-2ccc9fef8e86" xlink:href="iclr-20241231.xsd#iclr_Clients1125Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_7a8ef64d-0d37-414b-881b-f4370105b5c2" xlink:to="loc_iclr_Clients1125Member_76afa3a7-a990-4826-bbef-2ccc9fef8e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCustomersMember_41668113-0838-4989-81be-00fd93e93973" xlink:href="iclr-20241231.xsd#iclr_OtherCustomersMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_7a8ef64d-0d37-414b-881b-f4370105b5c2" xlink:to="loc_iclr_OtherCustomersMember_41668113-0838-4989-81be-00fd93e93973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_149ec4eb-3f53-42b0-9524-ebbf512a9e76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1e73263d-8378-4392-b12a-e04faddc8f94" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_149ec4eb-3f53-42b0-9524-ebbf512a9e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f2f592dd-9890-4ed2-97bd-a84db9e59fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_149ec4eb-3f53-42b0-9524-ebbf512a9e76" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f2f592dd-9890-4ed2-97bd-a84db9e59fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_28503d6c-d15e-448b-8295-2ca69f900a43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractAssetsAbstract_ced31558-d56f-435f-841d-8b37504d9716" xlink:href="iclr-20241231.xsd#iclr_ContractAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_28503d6c-d15e-448b-8295-2ca69f900a43" xlink:to="loc_iclr_ContractAssetsAbstract_ced31558-d56f-435f-841d-8b37504d9716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BilledContractReceivables_b0d04aa5-0450-4786-912b-ac56e7888c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BilledContractReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ContractAssetsAbstract_ced31558-d56f-435f-841d-8b37504d9716" xlink:to="loc_us-gaap_BilledContractReceivables_b0d04aa5-0450-4786-912b-ac56e7888c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_f6baf71b-dfd3-4938-82ca-d6b67e958364" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ContractAssetsAbstract_ced31558-d56f-435f-841d-8b37504d9716" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_f6baf71b-dfd3-4938-82ca-d6b67e958364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableGross_148db497-c971-4148-842d-db3fd9e28ea5" xlink:href="iclr-20241231.xsd#iclr_ContractsReceivableGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ContractAssetsAbstract_ced31558-d56f-435f-841d-8b37504d9716" xlink:to="loc_iclr_ContractsReceivableGross_148db497-c971-4148-842d-db3fd9e28ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_b02a2e5b-11d1-4c6a-8ca7-a30eb78e9d60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ContractAssetsAbstract_ced31558-d56f-435f-841d-8b37504d9716" xlink:to="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_b02a2e5b-11d1-4c6a-8ca7-a30eb78e9d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ContractsReceivableNet_1a8f1b58-b339-476e-8b41-02b039f572e7" xlink:href="iclr-20241231.xsd#iclr_ContractsReceivableNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ContractAssetsAbstract_ced31558-d56f-435f-841d-8b37504d9716" xlink:to="loc_iclr_ContractsReceivableNet_1a8f1b58-b339-476e-8b41-02b039f572e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_54baa6a2-f0d6-42f2-baa9-b3f9b2fb1b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_0420fc9d-d1c6-4ebc-ae78-146dd981d97f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetGrossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_54baa6a2-f0d6-42f2-baa9-b3f9b2fb1b2a" xlink:to="loc_us-gaap_ContractWithCustomerAssetGrossCurrent_0420fc9d-d1c6-4ebc-ae78-146dd981d97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent_39c155d0-d796-46c7-8166-ad37599cf795" xlink:href="iclr-20241231.xsd#iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_54baa6a2-f0d6-42f2-baa9-b3f9b2fb1b2a" xlink:to="loc_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent_39c155d0-d796-46c7-8166-ad37599cf795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent_83960b8b-2865-422a-aa24-5d206d13a2f0" xlink:href="iclr-20241231.xsd#iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_54baa6a2-f0d6-42f2-baa9-b3f9b2fb1b2a" xlink:to="loc_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent_83960b8b-2865-422a-aa24-5d206d13a2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_8e1b3d2a-59b7-459b-bd9b-5868b7ea188f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_54baa6a2-f0d6-42f2-baa9-b3f9b2fb1b2a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_8e1b3d2a-59b7-459b-bd9b-5868b7ea188f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_ea2d1815-ec3f-4cd1-9a9a-3b36c9a24822" xlink:href="iclr-20241231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_54baa6a2-f0d6-42f2-baa9-b3f9b2fb1b2a" xlink:to="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_ea2d1815-ec3f-4cd1-9a9a-3b36c9a24822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent_0bc5932a-675f-4fbe-8341-6e133dafc285" xlink:href="iclr-20241231.xsd#iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_54baa6a2-f0d6-42f2-baa9-b3f9b2fb1b2a" xlink:to="loc_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent_0bc5932a-675f-4fbe-8341-6e133dafc285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable_1b222949-506e-4428-a565-6660dfebb586" xlink:href="iclr-20241231.xsd#iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_54baa6a2-f0d6-42f2-baa9-b3f9b2fb1b2a" xlink:to="loc_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable_1b222949-506e-4428-a565-6660dfebb586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable_52df15a7-0639-4559-98c0-4656314927eb" xlink:href="iclr-20241231.xsd#iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_54baa6a2-f0d6-42f2-baa9-b3f9b2fb1b2a" xlink:to="loc_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable_52df15a7-0639-4559-98c0-4656314927eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent_d9b0a33c-e531-4cba-9c52-9f51d51121c5" xlink:href="iclr-20241231.xsd#iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_54baa6a2-f0d6-42f2-baa9-b3f9b2fb1b2a" xlink:to="loc_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent_d9b0a33c-e531-4cba-9c52-9f51d51121c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d3e5ba1e-c706-4c38-bc95-d2c87600959b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_5cb723a0-c5c9-4a4c-a420-3745da3088cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d3e5ba1e-c706-4c38-bc95-d2c87600959b" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_5cb723a0-c5c9-4a4c-a420-3745da3088cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_6ab6c96f-0106-4752-ba43-0b4fcca93768" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_5cb723a0-c5c9-4a4c-a420-3745da3088cd" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_6ab6c96f-0106-4752-ba43-0b4fcca93768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_5cb723a0-c5c9-4a4c-a420-3745da3088cd" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_adcaf291-861f-4c17-b3de-bd59092371b9" xlink:href="iclr-20241231.xsd#iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_adcaf291-861f-4c17-b3de-bd59092371b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent_68828cc6-3f41-4e4c-a3f2-a9c728f35934" xlink:href="iclr-20241231.xsd#iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent_68828cc6-3f41-4e4c-a3f2-a9c728f35934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_026a6c29-37fa-4ab6-8242-d28f4a3ff781" xlink:href="iclr-20241231.xsd#iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent_026a6c29-37fa-4ab6-8242-d28f4a3ff781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable_63b7ae83-8d32-48b9-84b0-5ade3105a328" xlink:href="iclr-20241231.xsd#iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable_63b7ae83-8d32-48b9-84b0-5ade3105a328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_be0e2ac9-b351-4be6-8a98-bd8224e91f94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_be0e2ac9-b351-4be6-8a98-bd8224e91f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_5ed4b423-5a2e-4812-baaa-bfe49474e048" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_5ed4b423-5a2e-4812-baaa-bfe49474e048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_3fedc69a-9897-417a-85d6-6b4c914b681f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_3fedc69a-9897-417a-85d6-6b4c914b681f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_67d187fc-7b56-4689-bf3a-023879225858" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_4075a275-d4b5-4d69-9b58-a96b05e9b876" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_67d187fc-7b56-4689-bf3a-023879225858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AllowancesforCreditLossesDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#AllowancesforCreditLossesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AllowancesforCreditLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_a78570fc-d4d2-4a09-8c3a-3a731767a53d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_3c7f54f0-d506-417b-bb2b-3624b35e7441" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_a78570fc-d4d2-4a09-8c3a-3a731767a53d" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_3c7f54f0-d506-417b-bb2b-3624b35e7441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_ee9859d5-cac9-432a-985c-74b33602495d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_3c7f54f0-d506-417b-bb2b-3624b35e7441" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_ee9859d5-cac9-432a-985c-74b33602495d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_f5948250-63e3-4e8e-98c3-0c65a51d6d82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_3c7f54f0-d506-417b-bb2b-3624b35e7441" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_f5948250-63e3-4e8e-98c3-0c65a51d6d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccountsReceivableCreditLossExpense_047ae372-ea25-4675-87d1-891444141c71" xlink:href="iclr-20241231.xsd#iclr_AccountsReceivableCreditLossExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_3c7f54f0-d506-417b-bb2b-3624b35e7441" xlink:to="loc_iclr_AccountsReceivableCreditLossExpense_047ae372-ea25-4675-87d1-891444141c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments_5234bec7-0855-470b-ac21-39dc294fcbd7" xlink:href="iclr-20241231.xsd#iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_3c7f54f0-d506-417b-bb2b-3624b35e7441" xlink:to="loc_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments_5234bec7-0855-470b-ac21-39dc294fcbd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_295184bd-93f7-4cce-9a6b-41dd57a0d571" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_3c7f54f0-d506-417b-bb2b-3624b35e7441" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_295184bd-93f7-4cce-9a6b-41dd57a0d571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativeKCRAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BusinessCombinationsNarrativeKCRAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsNarrativeKCRAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_a2599cc0-d9b1-469a-abc7-6be02c1eb7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2cd85840-c35d-4ef4-862c-a01aa55ffce4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_a2599cc0-d9b1-469a-abc7-6be02c1eb7bc" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2cd85840-c35d-4ef4-862c-a01aa55ffce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_92115703-c46a-4825-93ae-7ffa519930ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2cd85840-c35d-4ef4-862c-a01aa55ffce4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_92115703-c46a-4825-93ae-7ffa519930ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_79fd5021-2577-485d-9579-6ae86d36cb74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_92115703-c46a-4825-93ae-7ffa519930ad" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_79fd5021-2577-485d-9579-6ae86d36cb74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_KCRS.AGroupMember_b58fd3ca-2779-475b-8612-6f1676993d1b" xlink:href="iclr-20241231.xsd#iclr_KCRS.AGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_79fd5021-2577-485d-9579-6ae86d36cb74" xlink:to="loc_iclr_KCRS.AGroupMember_b58fd3ca-2779-475b-8612-6f1676993d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2cd85840-c35d-4ef4-862c-a01aa55ffce4" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_dc4fd476-3e1d-4eb6-b053-b64e7310f181" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_dc4fd476-3e1d-4eb6-b053-b64e7310f181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_cc91c792-d429-4941-9827-299bacae6931" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_cc91c792-d429-4941-9827-299bacae6931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_98ed4e2e-50fc-4a88-84c8-d757880e3cee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_98ed4e2e-50fc-4a88-84c8-d757880e3cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_3982a4ce-f18c-48f0-ae26-75200a4efc01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_3982a4ce-f18c-48f0-ae26-75200a4efc01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAssetsArisingFromContingenciesAmountRecognized_0965e218-7885-48b0-b831-5a814e47de17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAssetsArisingFromContingenciesAmountRecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:to="loc_us-gaap_BusinessCombinationAssetsArisingFromContingenciesAmountRecognized_0965e218-7885-48b0-b831-5a814e47de17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a60e944c-0b4e-4eb0-b546-52a2bd518f91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:to="loc_us-gaap_Goodwill_a60e944c-0b4e-4eb0-b546-52a2bd518f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_3679fe68-a74b-41cd-8639-6e66117815e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_3679fe68-a74b-41cd-8639-6e66117815e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_25695d38-b434-480a-9e1b-bbd80a21cac0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_25695d38-b434-480a-9e1b-bbd80a21cac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_c8f38054-0f9e-40b2-af4d-cd01831ad238" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_c8f38054-0f9e-40b2-af4d-cd01831ad238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_39bfede4-19f9-492c-82d8-7e16fcfb64b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_39bfede4-19f9-492c-82d8-7e16fcfb64b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_a1a14358-a659-4e0c-baf3-8d319e336e15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f495d86a-b47d-46a5-90d2-8104d9aba5a9" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_a1a14358-a659-4e0c-baf3-8d319e336e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativeHumanFirstAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BusinessCombinationsNarrativeHumanFirstAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsNarrativeHumanFirstAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_b9ea0aad-bd3e-4179-a1b6-409d7b542a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5ad291d2-7ac7-48a9-8242-ad0040e374a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b9ea0aad-bd3e-4179-a1b6-409d7b542a7f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5ad291d2-7ac7-48a9-8242-ad0040e374a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b88cc3ad-453a-4e4c-9a64-9e2e2b0af2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5ad291d2-7ac7-48a9-8242-ad0040e374a2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b88cc3ad-453a-4e4c-9a64-9e2e2b0af2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2a0fc199-be07-4f74-a984-8d967aef7977" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b88cc3ad-453a-4e4c-9a64-9e2e2b0af2ef" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2a0fc199-be07-4f74-a984-8d967aef7977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_HumanFirstIncMember_651b9f79-60cd-401b-9a3e-57835d6ddef8" xlink:href="iclr-20241231.xsd#iclr_HumanFirstIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2a0fc199-be07-4f74-a984-8d967aef7977" xlink:to="loc_iclr_HumanFirstIncMember_651b9f79-60cd-401b-9a3e-57835d6ddef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_174916d4-fa54-48d7-bcde-8e4cd10f3b21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5ad291d2-7ac7-48a9-8242-ad0040e374a2" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_174916d4-fa54-48d7-bcde-8e4cd10f3b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e9fe9b09-b68d-488e-9b07-ce629485f51f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_174916d4-fa54-48d7-bcde-8e4cd10f3b21" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e9fe9b09-b68d-488e-9b07-ce629485f51f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_bb99c409-079e-4377-9a94-e71f7ac9f00d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_174916d4-fa54-48d7-bcde-8e4cd10f3b21" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_bb99c409-079e-4377-9a94-e71f7ac9f00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_00ccbc77-63fc-4d09-84b3-3e4a280539cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_174916d4-fa54-48d7-bcde-8e4cd10f3b21" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_00ccbc77-63fc-4d09-84b3-3e4a280539cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_cdc160cd-08b4-414f-b19a-a4fad52fa624" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_174916d4-fa54-48d7-bcde-8e4cd10f3b21" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_cdc160cd-08b4-414f-b19a-a4fad52fa624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_70f5fa4a-94ee-46d8-9c04-af3085704ede" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_174916d4-fa54-48d7-bcde-8e4cd10f3b21" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_70f5fa4a-94ee-46d8-9c04-af3085704ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7d6e1d84-b6b8-4c42-ab59-aba9471be76e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_174916d4-fa54-48d7-bcde-8e4cd10f3b21" xlink:to="loc_us-gaap_Goodwill_7d6e1d84-b6b8-4c42-ab59-aba9471be76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1c7a7c19-d533-4dd0-9d13-a2b4a8c6803d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_174916d4-fa54-48d7-bcde-8e4cd10f3b21" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1c7a7c19-d533-4dd0-9d13-a2b4a8c6803d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BusinessCombinationsNarrativeBiotelAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_d907c167-6b71-484c-a078-8b50e6f5d062" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7bd0550c-f723-42c2-8489-64a10883308e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_d907c167-6b71-484c-a078-8b50e6f5d062" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7bd0550c-f723-42c2-8489-64a10883308e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5b51be65-05ea-4d3f-ab30-7bf68b101a02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7bd0550c-f723-42c2-8489-64a10883308e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5b51be65-05ea-4d3f-ab30-7bf68b101a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77cca73c-1185-48ca-9a6a-57703e419693" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5b51be65-05ea-4d3f-ab30-7bf68b101a02" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77cca73c-1185-48ca-9a6a-57703e419693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BiotelResearchLLCMember_8f70dcd1-8a72-420a-8496-62f4b409e090" xlink:href="iclr-20241231.xsd#iclr_BiotelResearchLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_77cca73c-1185-48ca-9a6a-57703e419693" xlink:to="loc_iclr_BiotelResearchLLCMember_8f70dcd1-8a72-420a-8496-62f4b409e090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_278a17ed-94c4-4f05-8458-babb634d98ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7bd0550c-f723-42c2-8489-64a10883308e" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_278a17ed-94c4-4f05-8458-babb634d98ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_c1e5f71f-557d-4c25-ae97-220dbcc33700" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_278a17ed-94c4-4f05-8458-babb634d98ce" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_c1e5f71f-557d-4c25-ae97-220dbcc33700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_d97f14c5-effe-4e70-bb8c-7a4fa29f1dba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_278a17ed-94c4-4f05-8458-babb634d98ce" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_d97f14c5-effe-4e70-bb8c-7a4fa29f1dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_f7e337bb-6cbd-4463-9f98-98966c679fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_278a17ed-94c4-4f05-8458-babb634d98ce" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_f7e337bb-6cbd-4463-9f98-98966c679fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0afa2eb0-bfd1-4b8d-8ecf-dcc559a5fc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_278a17ed-94c4-4f05-8458-babb634d98ce" xlink:to="loc_us-gaap_Goodwill_0afa2eb0-bfd1-4b8d-8ecf-dcc559a5fc9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BusinessCombinationsNarrativePRAAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_5ed7740c-e6d4-4bbb-8609-01ab74a3a5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb85033b-87c4-4782-8338-63b110c7c503" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_5ed7740c-e6d4-4bbb-8609-01ab74a3a5f8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb85033b-87c4-4782-8338-63b110c7c503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_61e974d3-a733-4b83-85bb-e20185c3e7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb85033b-87c4-4782-8338-63b110c7c503" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_61e974d3-a733-4b83-85bb-e20185c3e7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_598da221-e43a-4929-95d6-0192332c62e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_61e974d3-a733-4b83-85bb-e20185c3e7b3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_598da221-e43a-4929-95d6-0192332c62e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PRAHealthSciencesIncMember_1099154c-f540-4e6d-a90e-d970ca7de4d0" xlink:href="iclr-20241231.xsd#iclr_PRAHealthSciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_598da221-e43a-4929-95d6-0192332c62e3" xlink:to="loc_iclr_PRAHealthSciencesIncMember_1099154c-f540-4e6d-a90e-d970ca7de4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c0b1f895-ee8f-4791-994c-4795810a0069" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb85033b-87c4-4782-8338-63b110c7c503" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_c0b1f895-ee8f-4791-994c-4795810a0069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_8d553675-229a-41ef-a5af-6a8a7566873f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c0b1f895-ee8f-4791-994c-4795810a0069" xlink:to="loc_us-gaap_InterestExpenseNonoperating_8d553675-229a-41ef-a5af-6a8a7566873f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BusinessCombinationsNarrativeOncacareAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_eebfe413-90b5-480e-9530-a532a7ecd612" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b8df34e1-27be-4b88-9c6a-40c033833719" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_eebfe413-90b5-480e-9530-a532a7ecd612" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b8df34e1-27be-4b88-9c6a-40c033833719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_32c2ae2e-7222-46f8-a2ce-679bc1f2122b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b8df34e1-27be-4b88-9c6a-40c033833719" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_32c2ae2e-7222-46f8-a2ce-679bc1f2122b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fc0e58cc-1b43-4eaa-8961-3eb736a1fc59" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_32c2ae2e-7222-46f8-a2ce-679bc1f2122b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fc0e58cc-1b43-4eaa-8961-3eb736a1fc59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OncacareMember_4166d1da-fc56-4ede-9229-3ac9d8ea60e7" xlink:href="iclr-20241231.xsd#iclr_OncacareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fc0e58cc-1b43-4eaa-8961-3eb736a1fc59" xlink:to="loc_iclr_OncacareMember_4166d1da-fc56-4ede-9229-3ac9d8ea60e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_02617e9d-383a-4a2d-9120-baa5ce62b407" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b8df34e1-27be-4b88-9c6a-40c033833719" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_02617e9d-383a-4a2d-9120-baa5ce62b407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_8c8970ff-2dcf-49f3-8278-53fe5aa5646d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02617e9d-383a-4a2d-9120-baa5ce62b407" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_8c8970ff-2dcf-49f3-8278-53fe5aa5646d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8d087edc-da56-406c-909a-bf15727e73fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02617e9d-383a-4a2d-9120-baa5ce62b407" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8d087edc-da56-406c-909a-bf15727e73fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a240769e-72a5-471d-b044-34d1559f9f99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02617e9d-383a-4a2d-9120-baa5ce62b407" xlink:to="loc_us-gaap_Goodwill_a240769e-72a5-471d-b044-34d1559f9f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_2d8117b9-4ddf-44dd-ab99-679d34e553b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_02617e9d-383a-4a2d-9120-baa5ce62b407" xlink:to="loc_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount_2d8117b9-4ddf-44dd-ab99-679d34e553b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessCombinationsTransactionandIntegrationCostsDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BusinessCombinationsTransactionandIntegrationCostsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessCombinationsTransactionandIntegrationCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_049de130-0ce2-4ba2-8ae1-7615bd7d786f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_676a61b8-d887-413e-83aa-17c79168fe7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_049de130-0ce2-4ba2-8ae1-7615bd7d786f" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_676a61b8-d887-413e-83aa-17c79168fe7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8e78ab99-a422-4644-b0cf-3cc74a462084" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_897ecb63-1967-4974-8de8-553610dba8c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8e78ab99-a422-4644-b0cf-3cc74a462084" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_897ecb63-1967-4974-8de8-553610dba8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6785670e-2567-4feb-9f4c-74817c4d20af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_897ecb63-1967-4974-8de8-553610dba8c9" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6785670e-2567-4feb-9f4c-74817c4d20af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b89b74ce-53ca-4263-af6b-5b203b9acd52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6785670e-2567-4feb-9f4c-74817c4d20af" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b89b74ce-53ca-4263-af6b-5b203b9acd52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1d6d14ad-8bd9-4c66-bfea-057c3e342041" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b89b74ce-53ca-4263-af6b-5b203b9acd52" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1d6d14ad-8bd9-4c66-bfea-057c3e342041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_3b8785ff-bbb0-4344-82bb-317b2c695a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b89b74ce-53ca-4263-af6b-5b203b9acd52" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_3b8785ff-bbb0-4344-82bb-317b2c695a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_f372e9ea-2dfa-4243-b929-751274abfd77" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b89b74ce-53ca-4263-af6b-5b203b9acd52" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_f372e9ea-2dfa-4243-b929-751274abfd77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_9aecd18f-a93f-4b10-966d-058dd394a2f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b89b74ce-53ca-4263-af6b-5b203b9acd52" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_9aecd18f-a93f-4b10-966d-058dd394a2f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_18e2d94d-4722-4f34-b44e-79b19b33a962" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_897ecb63-1967-4974-8de8-553610dba8c9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_18e2d94d-4722-4f34-b44e-79b19b33a962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_be6143a5-cc44-4f8b-b7f1-0fd94822de5e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_18e2d94d-4722-4f34-b44e-79b19b33a962" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_be6143a5-cc44-4f8b-b7f1-0fd94822de5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestRateCapAndInterestRateSwapMember_28712aec-2114-48ec-a8c6-58bfd4180aae" xlink:href="iclr-20241231.xsd#iclr_InterestRateCapAndInterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_be6143a5-cc44-4f8b-b7f1-0fd94822de5e" xlink:to="loc_iclr_InterestRateCapAndInterestRateSwapMember_28712aec-2114-48ec-a8c6-58bfd4180aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_429845ac-bf16-4452-bdb5-27db317d4991" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_897ecb63-1967-4974-8de8-553610dba8c9" xlink:to="loc_us-gaap_HedgingDesignationAxis_429845ac-bf16-4452-bdb5-27db317d4991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2a347cb8-854f-4fd9-b585-f8906bc9b3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_429845ac-bf16-4452-bdb5-27db317d4991" xlink:to="loc_us-gaap_HedgingDesignationDomain_2a347cb8-854f-4fd9-b585-f8906bc9b3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_241fb870-e27d-467f-9203-c40766280389" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_2a347cb8-854f-4fd9-b585-f8906bc9b3c0" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_241fb870-e27d-467f-9203-c40766280389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_49ed4147-2ada-464c-92d6-09999350a2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_897ecb63-1967-4974-8de8-553610dba8c9" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_49ed4147-2ada-464c-92d6-09999350a2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_b4164730-4660-47fc-9f5f-1de71f6f0b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_49ed4147-2ada-464c-92d6-09999350a2c4" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_b4164730-4660-47fc-9f5f-1de71f6f0b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_8a185fd8-5971-421d-9a64-d2706b82e922" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_b4164730-4660-47fc-9f5f-1de71f6f0b7e" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_8a185fd8-5971-421d-9a64-d2706b82e922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6cb17c7b-a1d0-4a6e-8e8e-2360cd9f5c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_897ecb63-1967-4974-8de8-553610dba8c9" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6cb17c7b-a1d0-4a6e-8e8e-2360cd9f5c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_dc909cc3-b515-4ad3-a89a-79cce217c9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6cb17c7b-a1d0-4a6e-8e8e-2360cd9f5c4f" xlink:to="loc_us-gaap_AssetsAbstract_dc909cc3-b515-4ad3-a89a-79cce217c9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_5f8ec453-1c42-4cbf-88fb-1050deb97133" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dc909cc3-b515-4ad3-a89a-79cce217c9fe" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_5f8ec453-1c42-4cbf-88fb-1050deb97133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_6b094d7f-6fed-493c-b77b-5d10af61524b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dc909cc3-b515-4ad3-a89a-79cce217c9fe" xlink:to="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_6b094d7f-6fed-493c-b77b-5d10af61524b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_313321d8-ba24-49a6-8873-ae848ac484d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dc909cc3-b515-4ad3-a89a-79cce217c9fe" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_313321d8-ba24-49a6-8873-ae848ac484d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_bfb63d2e-0551-41aa-9e1f-84bbbc5170ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6cb17c7b-a1d0-4a6e-8e8e-2360cd9f5c4f" xlink:to="loc_us-gaap_LiabilitiesAbstract_bfb63d2e-0551-41aa-9e1f-84bbbc5170ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_8cbdf234-4e0b-4b26-b19f-d2fe188f491e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_bfb63d2e-0551-41aa-9e1f-84bbbc5170ca" xlink:to="loc_us-gaap_DerivativeLiabilities_8cbdf234-4e0b-4b26-b19f-d2fe188f491e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_1dcf15de-9053-4ccd-bfc4-eb080d87257b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_bfb63d2e-0551-41aa-9e1f-84bbbc5170ca" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_1dcf15de-9053-4ccd-bfc4-eb080d87257b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost_ea850f9c-f4d6-456e-bc6b-c06245d929c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6cb17c7b-a1d0-4a6e-8e8e-2360cd9f5c4f" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCost_ea850f9c-f4d6-456e-bc6b-c06245d929c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/FairvalueNarrativeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#FairvalueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/FairvalueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_119d7f36-f62b-4fc4-b016-943d9c0e5037" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f6f54f6-54ee-41f3-8bd8-c19ea49d1ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_119d7f36-f62b-4fc4-b016-943d9c0e5037" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f6f54f6-54ee-41f3-8bd8-c19ea49d1ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b7b8d17f-0698-4161-8dcd-a8bc53c23722" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f6f54f6-54ee-41f3-8bd8-c19ea49d1ae7" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b7b8d17f-0698-4161-8dcd-a8bc53c23722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_38662aa0-55a1-4048-a431-187cce9d094e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_b7b8d17f-0698-4161-8dcd-a8bc53c23722" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_38662aa0-55a1-4048-a431-187cce9d094e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_d1e7cf59-43e0-4171-be97-1221e53b54fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_38662aa0-55a1-4048-a431-187cce9d094e" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_d1e7cf59-43e0-4171-be97-1221e53b54fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_486f1b9a-5475-4a8a-bb5c-014c8f0fa53a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f6f54f6-54ee-41f3-8bd8-c19ea49d1ae7" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_486f1b9a-5475-4a8a-bb5c-014c8f0fa53a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_253cb33f-3ff3-4844-8a1c-5222320105c2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_486f1b9a-5475-4a8a-bb5c-014c8f0fa53a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_253cb33f-3ff3-4844-8a1c-5222320105c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7da53588-5f25-49d6-baae-a65854d0aca1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_253cb33f-3ff3-4844-8a1c-5222320105c2" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7da53588-5f25-49d6-baae-a65854d0aca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_00c04adc-f0b5-45e3-b0a2-cba46b76914b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f6f54f6-54ee-41f3-8bd8-c19ea49d1ae7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_00c04adc-f0b5-45e3-b0a2-cba46b76914b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_9dc90b7f-15ed-41e8-8011-669e79699683" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_00c04adc-f0b5-45e3-b0a2-cba46b76914b" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_9dc90b7f-15ed-41e8-8011-669e79699683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillFairValueDisclosure_de7ee870-963f-4d1c-82cc-903b6a51587f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_00c04adc-f0b5-45e3-b0a2-cba46b76914b" xlink:to="loc_us-gaap_GoodwillFairValueDisclosure_de7ee870-963f-4d1c-82cc-903b6a51587f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_f25febda-cd71-49cb-8d57-cb6b0ea5fed9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_00c04adc-f0b5-45e3-b0a2-cba46b76914b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure_f25febda-cd71-49cb-8d57-cb6b0ea5fed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost_05f0856c-fd59-4085-903c-34d76c4701ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_00c04adc-f0b5-45e3-b0a2-cba46b76914b" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCost_05f0856c-fd59-4085-903c-34d76c4701ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_0cef4415-5352-4272-8f9e-d548bc0f217d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_00c04adc-f0b5-45e3-b0a2-cba46b76914b" xlink:to="loc_us-gaap_LongTermDebtFairValue_0cef4415-5352-4272-8f9e-d548bc0f217d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#InvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/InvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_effeb0bc-bc1c-4457-a5e1-ad414453cf27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_787a9227-cb6b-44c7-b42c-186935ef60b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_effeb0bc-bc1c-4457-a5e1-ad414453cf27" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_787a9227-cb6b-44c7-b42c-186935ef60b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_478c116e-6532-4a62-af2c-95cb55d49d39" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_effeb0bc-bc1c-4457-a5e1-ad414453cf27" xlink:to="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_478c116e-6532-4a62-af2c-95cb55d49d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_ab1205c8-24cd-4300-ab56-91a338e84a80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_effeb0bc-bc1c-4457-a5e1-ad414453cf27" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_ab1205c8-24cd-4300-ab56-91a338e84a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CommitmentToAcquireLongTermInvestments_fada49f4-e8ae-45f9-8a17-902a58fcd201" xlink:href="iclr-20241231.xsd#iclr_CommitmentToAcquireLongTermInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_effeb0bc-bc1c-4457-a5e1-ad414453cf27" xlink:to="loc_iclr_CommitmentToAcquireLongTermInvestments_fada49f4-e8ae-45f9-8a17-902a58fcd201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCost_bedb27a7-dc74-4559-a9a4-411c33848919" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_effeb0bc-bc1c-4457-a5e1-ad414453cf27" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCost_bedb27a7-dc74-4559-a9a4-411c33848919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_8183c519-46e1-4652-a553-b20f27a40fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireEquitySecuritiesFvNi"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_effeb0bc-bc1c-4457-a5e1-ad414453cf27" xlink:to="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_8183c519-46e1-4652-a553-b20f27a40fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_ac9411a4-697f-4f3d-850d-fd2f9b452daf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_effeb0bc-bc1c-4457-a5e1-ad414453cf27" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_ac9411a4-697f-4f3d-850d-fd2f9b452daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#PropertyPlantandEquipmentnetDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c2ef663e-0c9f-4f86-9b7c-837249670e11" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_2a02483e-1db0-404c-ab0d-0894bbca94aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c2ef663e-0c9f-4f86-9b7c-837249670e11" xlink:to="loc_us-gaap_Land_2a02483e-1db0-404c-ab0d-0894bbca94aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_68b556cd-adf9-48fd-9d50-2096ec241ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c2ef663e-0c9f-4f86-9b7c-837249670e11" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_68b556cd-adf9-48fd-9d50-2096ec241ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_257dabd5-4ba8-47fc-98c1-c20a9a397cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c2ef663e-0c9f-4f86-9b7c-837249670e11" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_257dabd5-4ba8-47fc-98c1-c20a9a397cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_a33cc1bf-0b15-4061-b66a-9a74161709c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c2ef663e-0c9f-4f86-9b7c-837249670e11" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_a33cc1bf-0b15-4061-b66a-9a74161709c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_e7bc0cbc-c4c6-4e7c-b366-3840728202fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c2ef663e-0c9f-4f86-9b7c-837249670e11" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_e7bc0cbc-c4c6-4e7c-b366-3840728202fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_47176367-a925-42d1-8361-06a4593daa25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c2ef663e-0c9f-4f86-9b7c-837249670e11" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_47176367-a925-42d1-8361-06a4593daa25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VehiclesGross_1133d570-8d69-4351-8781-3087438f5a1b" xlink:href="iclr-20241231.xsd#iclr_VehiclesGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c2ef663e-0c9f-4f86-9b7c-837249670e11" xlink:to="loc_iclr_VehiclesGross_1133d570-8d69-4351-8781-3087438f5a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_f8bd7469-f6be-4cf0-87c1-941668f9dac5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c2ef663e-0c9f-4f86-9b7c-837249670e11" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_f8bd7469-f6be-4cf0-87c1-941668f9dac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_457945ef-ee5d-455f-a8a4-2221d437d63a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c2ef663e-0c9f-4f86-9b7c-837249670e11" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_457945ef-ee5d-455f-a8a4-2221d437d63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_45498e61-f4e7-4a31-b800-17d1a71d2eac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c2ef663e-0c9f-4f86-9b7c-837249670e11" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_45498e61-f4e7-4a31-b800-17d1a71d2eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/PropertyPlantandEquipmentnetNarrativeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#PropertyPlantandEquipmentnetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/PropertyPlantandEquipmentnetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_78cf2889-864a-4a49-bbfa-2002c7958788" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_3827c284-2eed-44f4-8318-8fe49b6ce5b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_78cf2889-864a-4a49-bbfa-2002c7958788" xlink:to="loc_us-gaap_Depreciation_3827c284-2eed-44f4-8318-8fe49b6ce5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#GoodwillScheduleofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d0bb7e65-5ac4-4535-8eea-125730d6a3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_1c2ed937-14ab-432e-bfe3-30a63c56b3fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d0bb7e65-5ac4-4535-8eea-125730d6a3a8" xlink:to="loc_us-gaap_GoodwillRollForward_1c2ed937-14ab-432e-bfe3-30a63c56b3fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_45eae6f5-ad63-4e6b-9683-69aa97bdbb8b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1c2ed937-14ab-432e-bfe3-30a63c56b3fb" xlink:to="loc_us-gaap_Goodwill_45eae6f5-ad63-4e6b-9683-69aa97bdbb8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_29e7f334-a183-4409-a38b-d0a98bbf3fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1c2ed937-14ab-432e-bfe3-30a63c56b3fb" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_29e7f334-a183-4409-a38b-d0a98bbf3fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_cfae0eef-a424-496a-ab49-57fdbcd41920" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1c2ed937-14ab-432e-bfe3-30a63c56b3fb" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_cfae0eef-a424-496a-ab49-57fdbcd41920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e00b7e03-4100-4214-9727-14f580d3c48e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_1c2ed937-14ab-432e-bfe3-30a63c56b3fb" xlink:to="loc_us-gaap_Goodwill_e00b7e03-4100-4214-9727-14f580d3c48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/GoodwillNarrativeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#GoodwillNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/GoodwillNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_075b68ee-201e-4246-b6fe-b0c06fa8636a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_8cca81f4-b0fc-4a0f-adf1-a67b30fb3501" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_075b68ee-201e-4246-b6fe-b0c06fa8636a" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_8cca81f4-b0fc-4a0f-adf1-a67b30fb3501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7f6044f1-db2b-43e6-91d8-26136ab06d34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_24159bf9-89d6-4576-a0fc-9ebcf5e51915" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7f6044f1-db2b-43e6-91d8-26136ab06d34" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_24159bf9-89d6-4576-a0fc-9ebcf5e51915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_92b781bc-bd87-479d-9cd2-8b4c439a5f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_24159bf9-89d6-4576-a0fc-9ebcf5e51915" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_92b781bc-bd87-479d-9cd2-8b4c439a5f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9fb058fa-e98a-426b-8f94-cd0ce3092d01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_92b781bc-bd87-479d-9cd2-8b4c439a5f3a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9fb058fa-e98a-426b-8f94-cd0ce3092d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3c853440-4734-4ac5-b4c5-688e47e1f224" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9fb058fa-e98a-426b-8f94-cd0ce3092d01" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3c853440-4734-4ac5-b4c5-688e47e1f224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_345a626f-e30b-490b-a5b7-6163ad043cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9fb058fa-e98a-426b-8f94-cd0ce3092d01" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_345a626f-e30b-490b-a5b7-6163ad043cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_9a126f38-d09a-4640-ab56-7f09d429d6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9fb058fa-e98a-426b-8f94-cd0ce3092d01" xlink:to="loc_us-gaap_TradeNamesMember_9a126f38-d09a-4640-ab56-7f09d429d6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_f15d7d4b-a1d9-49a3-915d-4f509fa791b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DatabasesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9fb058fa-e98a-426b-8f94-cd0ce3092d01" xlink:to="loc_us-gaap_DatabasesMember_f15d7d4b-a1d9-49a3-915d-4f509fa791b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_468ed026-0e49-46c5-9480-7d15ddd0fe0a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9fb058fa-e98a-426b-8f94-cd0ce3092d01" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_468ed026-0e49-46c5-9480-7d15ddd0fe0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b6c930ce-df61-4791-b27e-c0720c4a12d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_24159bf9-89d6-4576-a0fc-9ebcf5e51915" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b6c930ce-df61-4791-b27e-c0720c4a12d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_23d96c10-7513-46fe-b300-3af874b2f600" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b6c930ce-df61-4791-b27e-c0720c4a12d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_23d96c10-7513-46fe-b300-3af874b2f600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ff92bb3c-33fb-4116-ad0f-79fe83052e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b6c930ce-df61-4791-b27e-c0720c4a12d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ff92bb3c-33fb-4116-ad0f-79fe83052e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bc90b78e-331f-4f60-be3c-670b85604b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b6c930ce-df61-4791-b27e-c0720c4a12d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bc90b78e-331f-4f60-be3c-670b85604b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#IntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cc5d63bd-f0db-4240-bc87-592f55d25abf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_a5d7e415-04be-49be-a418-b8122066ad72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cc5d63bd-f0db-4240-bc87-592f55d25abf" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_a5d7e415-04be-49be-a418-b8122066ad72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8239fd39-a9b3-41b6-a66e-9189bdb1f2c2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_a5d7e415-04be-49be-a418-b8122066ad72" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8239fd39-a9b3-41b6-a66e-9189bdb1f2c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c3e0669-a85d-425f-95ff-160c653efbe2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8239fd39-a9b3-41b6-a66e-9189bdb1f2c2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c3e0669-a85d-425f-95ff-160c653efbe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_HumanFirstIncMember_82b61fdf-38b7-4998-9d5e-5ad255371e80" xlink:href="iclr-20241231.xsd#iclr_HumanFirstIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c3e0669-a85d-425f-95ff-160c653efbe2" xlink:to="loc_iclr_HumanFirstIncMember_82b61fdf-38b7-4998-9d5e-5ad255371e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_KCRS.AGroupMember_34bfd530-5bbf-40af-bc21-4cf486dcf746" xlink:href="iclr-20241231.xsd#iclr_KCRS.AGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c3e0669-a85d-425f-95ff-160c653efbe2" xlink:to="loc_iclr_KCRS.AGroupMember_34bfd530-5bbf-40af-bc21-4cf486dcf746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BiotelResearchLLCMember_55bc908c-62cb-478f-ae95-54c359bf9ebc" xlink:href="iclr-20241231.xsd#iclr_BiotelResearchLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c3e0669-a85d-425f-95ff-160c653efbe2" xlink:to="loc_iclr_BiotelResearchLLCMember_55bc908c-62cb-478f-ae95-54c359bf9ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9a9c35b1-1656-49fd-bc05-310c12ec1e92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_a5d7e415-04be-49be-a418-b8122066ad72" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9a9c35b1-1656-49fd-bc05-310c12ec1e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03a2ebb1-b9d9-4acf-a30f-b587e065b25f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_9a9c35b1-1656-49fd-bc05-310c12ec1e92" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03a2ebb1-b9d9-4acf-a30f-b587e065b25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_5b89a72c-522b-421c-80b5-4f5e8e5916c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03a2ebb1-b9d9-4acf-a30f-b587e065b25f" xlink:to="loc_us-gaap_CustomerRelationshipsMember_5b89a72c-522b-421c-80b5-4f5e8e5916c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrderOrProductionBacklogMember_059673de-2ea8-4750-ad6f-730a5733a1cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrderOrProductionBacklogMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03a2ebb1-b9d9-4acf-a30f-b587e065b25f" xlink:to="loc_us-gaap_OrderOrProductionBacklogMember_059673de-2ea8-4750-ad6f-730a5733a1cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_2a9e1ce6-ebf8-48ce-a538-60cf983ed23e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03a2ebb1-b9d9-4acf-a30f-b587e065b25f" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_2a9e1ce6-ebf8-48ce-a538-60cf983ed23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_1f8b5021-34d2-4e9a-afb5-d7ddbb4c29ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03a2ebb1-b9d9-4acf-a30f-b587e065b25f" xlink:to="loc_us-gaap_TradeNamesMember_1f8b5021-34d2-4e9a-afb5-d7ddbb4c29ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_edc4481d-78e8-46bd-a373-695da6d75e2b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_a5d7e415-04be-49be-a418-b8122066ad72" xlink:to="loc_srt_RangeAxis_edc4481d-78e8-46bd-a373-695da6d75e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d82735f0-d740-4e65-91b9-67e392fb9481" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_edc4481d-78e8-46bd-a373-695da6d75e2b" xlink:to="loc_srt_RangeMember_d82735f0-d740-4e65-91b9-67e392fb9481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_55d22e1b-caab-4888-8e6e-87af576c487e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d82735f0-d740-4e65-91b9-67e392fb9481" xlink:to="loc_srt_MinimumMember_55d22e1b-caab-4888-8e6e-87af576c487e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_52f5a764-c46c-43a4-83c8-c3bb0e205e5a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d82735f0-d740-4e65-91b9-67e392fb9481" xlink:to="loc_srt_MaximumMember_52f5a764-c46c-43a4-83c8-c3bb0e205e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_961e881e-d235-49fc-afbd-7247e84ca44f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_a5d7e415-04be-49be-a418-b8122066ad72" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_961e881e-d235-49fc-afbd-7247e84ca44f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_478cf0a1-c795-4cac-abb6-693793846a57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_961e881e-d235-49fc-afbd-7247e84ca44f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_478cf0a1-c795-4cac-abb6-693793846a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DecreaseInAmortisation_645e620c-4638-417b-98ce-78d354f6d22d" xlink:href="iclr-20241231.xsd#iclr_DecreaseInAmortisation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_961e881e-d235-49fc-afbd-7247e84ca44f" xlink:to="loc_iclr_DecreaseInAmortisation_645e620c-4638-417b-98ce-78d354f6d22d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_94ce20da-4319-4e89-a17f-a49292a6a854" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_961e881e-d235-49fc-afbd-7247e84ca44f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_94ce20da-4319-4e89-a17f-a49292a6a854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7c933334-da65-4058-bbc5-db414f12c7af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_961e881e-d235-49fc-afbd-7247e84ca44f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7c933334-da65-4058-bbc5-db414f12c7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d21ab12c-3b02-4434-8540-b71d51b0ba59" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f6cb6155-5e01-4cf9-b25b-f9bb16e8a8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d21ab12c-3b02-4434-8540-b71d51b0ba59" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f6cb6155-5e01-4cf9-b25b-f9bb16e8a8e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f8034ecf-79db-4663-8bb8-da1a9ef8cfc5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d21ab12c-3b02-4434-8540-b71d51b0ba59" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f8034ecf-79db-4663-8bb8-da1a9ef8cfc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_cf39d170-9c33-4293-b2c7-290ffed73100" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d21ab12c-3b02-4434-8540-b71d51b0ba59" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_cf39d170-9c33-4293-b2c7-290ffed73100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_7b475bcb-9ab1-4baf-9800-0a9ebe3bb211" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d21ab12c-3b02-4434-8540-b71d51b0ba59" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_7b475bcb-9ab1-4baf-9800-0a9ebe3bb211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_cc77d6a2-fb45-48b8-b40b-870a0038cc67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d21ab12c-3b02-4434-8540-b71d51b0ba59" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_cc77d6a2-fb45-48b8-b40b-870a0038cc67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_d0c59380-de7f-4785-8a2d-bfc5be23f80d" xlink:href="iclr-20241231.xsd#iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d21ab12c-3b02-4434-8540-b71d51b0ba59" xlink:to="loc_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet_d0c59380-de7f-4785-8a2d-bfc5be23f80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OtherLiabilitiesDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#OtherLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_ea55cfd0-bfd8-4304-b4e4-996869e2d6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_79bb5974-b9dd-45aa-939d-330f4278a201" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_ea55cfd0-bfd8-4304-b4e4-996869e2d6e6" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_79bb5974-b9dd-45aa-939d-330f4278a201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_fd43b49f-c181-4e2e-95bb-17104ce00549" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_ea55cfd0-bfd8-4304-b4e4-996869e2d6e6" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_fd43b49f-c181-4e2e-95bb-17104ce00549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_04c538e3-94d6-4a64-a9ae-ede657205b84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_ea55cfd0-bfd8-4304-b4e4-996869e2d6e6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_04c538e3-94d6-4a64-a9ae-ede657205b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedUtilitiesCurrent_492746af-fe84-403e-8f43-411315d59742" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedUtilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_ea55cfd0-bfd8-4304-b4e4-996869e2d6e6" xlink:to="loc_us-gaap_AccruedUtilitiesCurrent_492746af-fe84-403e-8f43-411315d59742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration_8356ace2-d54f-4bbe-9515-508577e14fca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GovernmentAssistanceLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_ea55cfd0-bfd8-4304-b4e4-996869e2d6e6" xlink:to="loc_us-gaap_GovernmentAssistanceLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration_8356ace2-d54f-4bbe-9515-508577e14fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d8536bd4-bd2e-4fb8-bd61-c52fed6c12ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_ea55cfd0-bfd8-4304-b4e4-996869e2d6e6" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d8536bd4-bd2e-4fb8-bd61-c52fed6c12ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestructuringReserveAndOtherLiabilitiesCurrent_cfc61282-13e9-4a21-a118-f524db2d3df7" xlink:href="iclr-20241231.xsd#iclr_RestructuringReserveAndOtherLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_ea55cfd0-bfd8-4304-b4e4-996869e2d6e6" xlink:to="loc_iclr_RestructuringReserveAndOtherLiabilitiesCurrent_cfc61282-13e9-4a21-a118-f524db2d3df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceLiabilityCurrent_b90edd7b-0340-46e3-98ed-b0dd8213aa7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GovernmentAssistanceLiabilityCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_ea55cfd0-bfd8-4304-b4e4-996869e2d6e6" xlink:to="loc_us-gaap_GovernmentAssistanceLiabilityCurrent_b90edd7b-0340-46e3-98ed-b0dd8213aa7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_bdd6bcb1-252a-463d-b7b3-2b56449da263" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_ea55cfd0-bfd8-4304-b4e4-996869e2d6e6" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_bdd6bcb1-252a-463d-b7b3-2b56449da263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_f6b87826-f7c7-4722-ad0b-29beed0f6f91" xlink:href="iclr-20241231.xsd#iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_ea55cfd0-bfd8-4304-b4e4-996869e2d6e6" xlink:to="loc_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses_f6b87826-f7c7-4722-ad0b-29beed0f6f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_35381055-5bad-40ef-8a7b-599c115fd7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_96d3144d-a74e-4064-8f30-4929dc906ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_35381055-5bad-40ef-8a7b-599c115fd7e4" xlink:to="loc_us-gaap_DebtInstrumentTable_96d3144d-a74e-4064-8f30-4929dc906ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_70687bf7-cccf-4b70-b4b7-b07f37087952" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_96d3144d-a74e-4064-8f30-4929dc906ed4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_70687bf7-cccf-4b70-b4b7-b07f37087952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1622419f-6fd0-48dc-b1e9-1b5da9a1558f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_70687bf7-cccf-4b70-b4b7-b07f37087952" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1622419f-6fd0-48dc-b1e9-1b5da9a1558f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_ed3a649d-300f-4b2c-99a1-c96d7e20814a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1622419f-6fd0-48dc-b1e9-1b5da9a1558f" xlink:to="loc_us-gaap_SecuredDebtMember_ed3a649d-300f-4b2c-99a1-c96d7e20814a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorSubordinatedNotesMember_1911e5ee-6290-48f3-85a2-80e966e50944" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorSubordinatedNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1622419f-6fd0-48dc-b1e9-1b5da9a1558f" xlink:to="loc_us-gaap_SeniorSubordinatedNotesMember_1911e5ee-6290-48f3-85a2-80e966e50944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_412d9205-dc39-4a93-a6e3-bda6e5436998" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1622419f-6fd0-48dc-b1e9-1b5da9a1558f" xlink:to="loc_us-gaap_LineOfCreditMember_412d9205-dc39-4a93-a6e3-bda6e5436998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_af94bb44-2a83-434d-89df-c52f3330d36e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_96d3144d-a74e-4064-8f30-4929dc906ed4" xlink:to="loc_us-gaap_DebtInstrumentAxis_af94bb44-2a83-434d-89df-c52f3330d36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a9fb0816-3c84-4fc2-911b-edfe60bde01e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_af94bb44-2a83-434d-89df-c52f3330d36e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a9fb0816-3c84-4fc2-911b-edfe60bde01e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember_9fff8a29-3567-4188-ba84-5e6906f9df32" xlink:href="iclr-20241231.xsd#iclr_TermLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9fb0816-3c84-4fc2-911b-edfe60bde01e" xlink:to="loc_iclr_TermLoanFacilityMember_9fff8a29-3567-4188-ba84-5e6906f9df32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesMember_fe60fc7d-2deb-40aa-b673-62c36137f428" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9fb0816-3c84-4fc2-911b-edfe60bde01e" xlink:to="loc_iclr_SeniorSecuredNotesMember_fe60fc7d-2deb-40aa-b673-62c36137f428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_aa1d574b-a8be-4f89-8912-74b537f3ca71" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredRevolvingLoanFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9fb0816-3c84-4fc2-911b-edfe60bde01e" xlink:to="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_aa1d574b-a8be-4f89-8912-74b537f3ca71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesDueMay2027Member_b5c8f3db-6e25-4d00-ba2b-88911e1820a5" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredNotesDueMay2027Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9fb0816-3c84-4fc2-911b-edfe60bde01e" xlink:to="loc_iclr_SeniorSecuredNotesDueMay2027Member_b5c8f3db-6e25-4d00-ba2b-88911e1820a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesDueMay2029Member_90bd2af8-8e43-4e5c-adbb-7d17cbf4acce" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredNotesDueMay2029Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9fb0816-3c84-4fc2-911b-edfe60bde01e" xlink:to="loc_iclr_SeniorSecuredNotesDueMay2029Member_90bd2af8-8e43-4e5c-adbb-7d17cbf4acce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesDueMay2034Member_66fff234-4d56-49c3-b8e4-6cc2b6b77fca" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredNotesDueMay2034Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9fb0816-3c84-4fc2-911b-edfe60bde01e" xlink:to="loc_iclr_SeniorSecuredNotesDueMay2034Member_66fff234-4d56-49c3-b8e4-6cc2b6b77fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f2076302-9fb9-4f57-92f3-a2f1b163e085" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_96d3144d-a74e-4064-8f30-4929dc906ed4" xlink:to="loc_us-gaap_CreditFacilityAxis_f2076302-9fb9-4f57-92f3-a2f1b163e085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5f487dd8-4eac-4b96-b7cd-c81af8476032" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_f2076302-9fb9-4f57-92f3-a2f1b163e085" xlink:to="loc_us-gaap_CreditFacilityDomain_5f487dd8-4eac-4b96-b7cd-c81af8476032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_3b479e66-de22-4f7f-91b0-65e43eb2c9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_5f487dd8-4eac-4b96-b7cd-c81af8476032" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_3b479e66-de22-4f7f-91b0-65e43eb2c9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4b1effd4-3961-4150-b689-f22a9f02222c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_96d3144d-a74e-4064-8f30-4929dc906ed4" xlink:to="loc_us-gaap_DebtInstrumentLineItems_4b1effd4-3961-4150-b689-f22a9f02222c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c2788f8d-9b97-48e0-9ee2-8a915f07ddd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b1effd4-3961-4150-b689-f22a9f02222c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c2788f8d-9b97-48e0-9ee2-8a915f07ddd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_58137873-2840-4a08-8f06-7cd36eee5b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b1effd4-3961-4150-b689-f22a9f02222c" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_58137873-2840-4a08-8f06-7cd36eee5b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtCurrentMaturitiesGross_80a9c3fa-aac2-4105-b4f6-4312e760e6f1" xlink:href="iclr-20241231.xsd#iclr_LongTermDebtCurrentMaturitiesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b1effd4-3961-4150-b689-f22a9f02222c" xlink:to="loc_iclr_LongTermDebtCurrentMaturitiesGross_80a9c3fa-aac2-4105-b4f6-4312e760e6f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_45e92ec8-52cc-470d-901b-69d28e56eb1f" xlink:href="iclr-20241231.xsd#iclr_LongTermDebtExcludingCurrentMaturitiesGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b1effd4-3961-4150-b689-f22a9f02222c" xlink:to="loc_iclr_LongTermDebtExcludingCurrentMaturitiesGross_45e92ec8-52cc-470d-901b-69d28e56eb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_6e09a601-8a6c-4c76-af63-55d39c8bc685" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b1effd4-3961-4150-b689-f22a9f02222c" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_6e09a601-8a6c-4c76-af63-55d39c8bc685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_2fedcfc1-a766-4d08-a9d2-e2f1aa9c608f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4b1effd4-3961-4150-b689-f22a9f02222c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_2fedcfc1-a766-4d08-a9d2-e2f1aa9c608f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_49a5002f-38cd-4f5f-a7cc-c0c867c3fdae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_446bd3f3-29f4-4a8a-8041-19c4ea4d20fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_49a5002f-38cd-4f5f-a7cc-c0c867c3fdae" xlink:to="loc_us-gaap_DebtInstrumentTable_446bd3f3-29f4-4a8a-8041-19c4ea4d20fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_59ab2fed-2770-4cd1-932a-79ce90a49992" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_446bd3f3-29f4-4a8a-8041-19c4ea4d20fa" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_59ab2fed-2770-4cd1-932a-79ce90a49992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9d2d8753-0b32-4fcf-8047-c606a050c223" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_59ab2fed-2770-4cd1-932a-79ce90a49992" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9d2d8753-0b32-4fcf-8047-c606a050c223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_6e189b04-f732-44ec-b227-935455f9d9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9d2d8753-0b32-4fcf-8047-c606a050c223" xlink:to="loc_us-gaap_SecuredDebtMember_6e189b04-f732-44ec-b227-935455f9d9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorSubordinatedNotesMember_0cb90d5e-e2cb-4f7e-99e4-d1734127f3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorSubordinatedNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9d2d8753-0b32-4fcf-8047-c606a050c223" xlink:to="loc_us-gaap_SeniorSubordinatedNotesMember_0cb90d5e-e2cb-4f7e-99e4-d1734127f3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_96446810-b41c-4346-bb94-a16799314b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9d2d8753-0b32-4fcf-8047-c606a050c223" xlink:to="loc_us-gaap_LineOfCreditMember_96446810-b41c-4346-bb94-a16799314b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_44400f08-093a-4b8e-a261-aaa5e11fda57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_446bd3f3-29f4-4a8a-8041-19c4ea4d20fa" xlink:to="loc_us-gaap_DebtInstrumentAxis_44400f08-093a-4b8e-a261-aaa5e11fda57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_69c49586-d896-4f6a-8adb-64487b2f30bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_44400f08-093a-4b8e-a261-aaa5e11fda57" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_69c49586-d896-4f6a-8adb-64487b2f30bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember_441e22ea-e668-4001-9eab-b79c951fdc2d" xlink:href="iclr-20241231.xsd#iclr_TermLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69c49586-d896-4f6a-8adb-64487b2f30bf" xlink:to="loc_iclr_TermLoanFacilityMember_441e22ea-e668-4001-9eab-b79c951fdc2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_c922d78c-bef0-4c5a-ae22-69a714290750" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredRevolvingLoanFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69c49586-d896-4f6a-8adb-64487b2f30bf" xlink:to="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_c922d78c-bef0-4c5a-ae22-69a714290750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_99708579-b9b0-45e0-9faf-2e32525ffefb" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69c49586-d896-4f6a-8adb-64487b2f30bf" xlink:to="loc_iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember_99708579-b9b0-45e0-9faf-2e32525ffefb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesMember_02ff990c-63a9-4c3f-ac05-f9d741c60d7a" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69c49586-d896-4f6a-8adb-64487b2f30bf" xlink:to="loc_iclr_SeniorSecuredNotesMember_02ff990c-63a9-4c3f-ac05-f9d741c60d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesDueMay2027Member_e89f9fb6-fa34-4f1f-b885-8df291cd5837" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredNotesDueMay2027Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69c49586-d896-4f6a-8adb-64487b2f30bf" xlink:to="loc_iclr_SeniorSecuredNotesDueMay2027Member_e89f9fb6-fa34-4f1f-b885-8df291cd5837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesDueMay2029Member_4ad3f3c2-9031-44c9-bbd9-772f4f3d1eb7" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredNotesDueMay2029Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69c49586-d896-4f6a-8adb-64487b2f30bf" xlink:to="loc_iclr_SeniorSecuredNotesDueMay2029Member_4ad3f3c2-9031-44c9-bbd9-772f4f3d1eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredNotesDueMay2034Member_26bf71a3-d1d1-46fa-9300-494b012ae483" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredNotesDueMay2034Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_69c49586-d896-4f6a-8adb-64487b2f30bf" xlink:to="loc_iclr_SeniorSecuredNotesDueMay2034Member_26bf71a3-d1d1-46fa-9300-494b012ae483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_409c43c9-a22e-47ca-8e62-af5d38adcd11" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_446bd3f3-29f4-4a8a-8041-19c4ea4d20fa" xlink:to="loc_us-gaap_CreditFacilityAxis_409c43c9-a22e-47ca-8e62-af5d38adcd11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_cf05179a-343f-4734-bcb3-de2272f035d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_409c43c9-a22e-47ca-8e62-af5d38adcd11" xlink:to="loc_us-gaap_CreditFacilityDomain_cf05179a-343f-4734-bcb3-de2272f035d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_08e68766-3da7-4128-84de-701f3f3ae36c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_cf05179a-343f-4734-bcb3-de2272f035d2" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_08e68766-3da7-4128-84de-701f3f3ae36c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentAxis_704697cb-52a9-41a9-bb93-cc1b6f436456" xlink:href="iclr-20241231.xsd#iclr_VariableRateComponentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_446bd3f3-29f4-4a8a-8041-19c4ea4d20fa" xlink:to="loc_iclr_VariableRateComponentAxis_704697cb-52a9-41a9-bb93-cc1b6f436456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentDomain_6b3aedbb-9629-4e50-9709-dbe79b971993" xlink:href="iclr-20241231.xsd#iclr_VariableRateComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_VariableRateComponentAxis_704697cb-52a9-41a9-bb93-cc1b6f436456" xlink:to="loc_iclr_VariableRateComponentDomain_6b3aedbb-9629-4e50-9709-dbe79b971993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentOneMember_301a0207-63ad-4deb-a70a-c9256c2debd5" xlink:href="iclr-20241231.xsd#iclr_VariableRateComponentOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_VariableRateComponentDomain_6b3aedbb-9629-4e50-9709-dbe79b971993" xlink:to="loc_iclr_VariableRateComponentOneMember_301a0207-63ad-4deb-a70a-c9256c2debd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_VariableRateComponentTwoMember_237de05a-d3a4-4ef3-afc9-c64862790df0" xlink:href="iclr-20241231.xsd#iclr_VariableRateComponentTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_VariableRateComponentDomain_6b3aedbb-9629-4e50-9709-dbe79b971993" xlink:to="loc_iclr_VariableRateComponentTwoMember_237de05a-d3a4-4ef3-afc9-c64862790df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_74614ae4-27dd-478e-b4e0-026c75e37dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_446bd3f3-29f4-4a8a-8041-19c4ea4d20fa" xlink:to="loc_us-gaap_VariableRateAxis_74614ae4-27dd-478e-b4e0-026c75e37dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_4e18a53c-e02b-4dcc-b607-bf0fe4650229" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_74614ae4-27dd-478e-b4e0-026c75e37dcb" xlink:to="loc_us-gaap_VariableRateDomain_4e18a53c-e02b-4dcc-b607-bf0fe4650229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_1cb36dfb-d537-4e3a-82a6-41b1d1721156" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_4e18a53c-e02b-4dcc-b607-bf0fe4650229" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_1cb36dfb-d537-4e3a-82a6-41b1d1721156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_528cd462-117a-4a0e-8aa2-bf917bce99d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_4e18a53c-e02b-4dcc-b607-bf0fe4650229" xlink:to="loc_us-gaap_BaseRateMember_528cd462-117a-4a0e-8aa2-bf917bce99d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2f31b431-5c0a-4253-aa95-a7779c2243be" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_446bd3f3-29f4-4a8a-8041-19c4ea4d20fa" xlink:to="loc_srt_RangeAxis_2f31b431-5c0a-4253-aa95-a7779c2243be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_023840f1-a352-4914-9f32-df50edc9b5b8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2f31b431-5c0a-4253-aa95-a7779c2243be" xlink:to="loc_srt_RangeMember_023840f1-a352-4914-9f32-df50edc9b5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_48dce2bc-a65f-4408-8b1d-565bc49275e2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_023840f1-a352-4914-9f32-df50edc9b5b8" xlink:to="loc_srt_MaximumMember_48dce2bc-a65f-4408-8b1d-565bc49275e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fc8af24b-f598-4699-9f3f-afb07b2ac452" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_023840f1-a352-4914-9f32-df50edc9b5b8" xlink:to="loc_srt_MinimumMember_fc8af24b-f598-4699-9f3f-afb07b2ac452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CreditRatingStandardPoorsAxis_cc61835a-e3d4-441b-9129-8d9cb8a759b4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CreditRatingStandardPoorsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_446bd3f3-29f4-4a8a-8041-19c4ea4d20fa" xlink:to="loc_srt_CreditRatingStandardPoorsAxis_cc61835a-e3d4-441b-9129-8d9cb8a759b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExternalCreditRatingStandardPoorsMember_78d40d34-a2ed-438a-8dc2-64ee939e3a0d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ExternalCreditRatingStandardPoorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CreditRatingStandardPoorsAxis_cc61835a-e3d4-441b-9129-8d9cb8a759b4" xlink:to="loc_srt_ExternalCreditRatingStandardPoorsMember_78d40d34-a2ed-438a-8dc2-64ee939e3a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsBBRatingMember_3ce3f5dd-3253-4720-a6eb-794205967c08" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StandardPoorsBBRatingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ExternalCreditRatingStandardPoorsMember_78d40d34-a2ed-438a-8dc2-64ee939e3a0d" xlink:to="loc_srt_StandardPoorsBBRatingMember_3ce3f5dd-3253-4720-a6eb-794205967c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsBBPlusRatingMember_aabb9f37-f78a-411f-8aa4-2158513cbc13" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StandardPoorsBBPlusRatingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ExternalCreditRatingStandardPoorsMember_78d40d34-a2ed-438a-8dc2-64ee939e3a0d" xlink:to="loc_srt_StandardPoorsBBPlusRatingMember_aabb9f37-f78a-411f-8aa4-2158513cbc13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsBBBMinusRatingMember_76b8a569-8f74-42b0-8f00-419c0fa29b07" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StandardPoorsBBBMinusRatingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ExternalCreditRatingStandardPoorsMember_78d40d34-a2ed-438a-8dc2-64ee939e3a0d" xlink:to="loc_srt_StandardPoorsBBBMinusRatingMember_76b8a569-8f74-42b0-8f00-419c0fa29b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsBBBRatingMember_7db7068f-772e-4957-b307-6fc96c19393d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StandardPoorsBBBRatingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ExternalCreditRatingStandardPoorsMember_78d40d34-a2ed-438a-8dc2-64ee939e3a0d" xlink:to="loc_srt_StandardPoorsBBBRatingMember_7db7068f-772e-4957-b307-6fc96c19393d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsBBBPlusRatingMember_17b47156-4767-4d20-af00-4efee1248e4d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StandardPoorsBBBPlusRatingMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ExternalCreditRatingStandardPoorsMember_78d40d34-a2ed-438a-8dc2-64ee939e3a0d" xlink:to="loc_srt_StandardPoorsBBBPlusRatingMember_17b47156-4767-4d20-af00-4efee1248e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_446bd3f3-29f4-4a8a-8041-19c4ea4d20fa" xlink:to="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_82e396d2-e645-42b7-a6b2-f85db691af97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_82e396d2-e645-42b7-a6b2-f85db691af97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_b5d2e20c-b011-443e-8e79-6730777132a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_b5d2e20c-b011-443e-8e79-6730777132a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1ba966ef-3305-40c4-b402-dfca76bcad43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1ba966ef-3305-40c4-b402-dfca76bcad43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_f886d0fc-d0c8-46d3-8f9a-ab34a5c26fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_f886d0fc-d0c8-46d3-8f9a-ab34a5c26fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DebtInstrumentDiscountRate_e0bec03d-9670-4a32-bfe8-23aa34682b2d" xlink:href="iclr-20241231.xsd#iclr_DebtInstrumentDiscountRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_iclr_DebtInstrumentDiscountRate_e0bec03d-9670-4a32-bfe8-23aa34682b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_d073ba09-88ea-4c42-b3e2-06b5a9cdd9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_d073ba09-88ea-4c42-b3e2-06b5a9cdd9cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3826f27c-8a5f-47d5-a1ed-94559e66f739" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3826f27c-8a5f-47d5-a1ed-94559e66f739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_912fce9e-7adc-441b-9847-d7d3da2c5d67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_912fce9e-7adc-441b-9847-d7d3da2c5d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_c161f626-ec98-4e99-8f16-cf96d92cfb64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_c161f626-ec98-4e99-8f16-cf96d92cfb64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_092e9527-511e-4276-a4b3-a797fefc9a45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_092e9527-511e-4276-a4b3-a797fefc9a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_04539cb2-ed30-4bdd-83f7-c6e52e52b1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_04539cb2-ed30-4bdd-83f7-c6e52e52b1c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_18d27802-553d-4f55-a851-9c76820d8289" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_18d27802-553d-4f55-a851-9c76820d8289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_e4dd5861-708a-4854-9e1a-85890902078f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2cd66f12-2453-4538-be8e-a218b5ecc0d8" xlink:to="loc_us-gaap_LongTermDebtFairValue_e4dd5861-708a-4854-9e1a-85890902078f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofFinanceCostDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BankCreditLinesLoanFacilitiesandNotesScheduleofFinanceCostDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofFinanceCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_bffe6052-e355-4283-be45-4a668facfd3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_0832531b-8276-4a93-baf0-9562e1c96213" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bffe6052-e355-4283-be45-4a668facfd3f" xlink:to="loc_us-gaap_InterestExpenseDebt_0832531b-8276-4a93-baf0-9562e1c96213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_3d88d21a-c223-4a6d-817d-2dbab176e1ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bffe6052-e355-4283-be45-4a668facfd3f" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_3d88d21a-c223-4a6d-817d-2dbab176e1ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestExpenseCreditOther_19d64cf8-e018-4141-b30f-11864a662a0e" xlink:href="iclr-20241231.xsd#iclr_InterestExpenseCreditOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bffe6052-e355-4283-be45-4a668facfd3f" xlink:to="loc_iclr_InterestExpenseCreditOther_19d64cf8-e018-4141-b30f-11864a662a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_972fdb73-8b48-46a5-9ca3-eb968630fe87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bffe6052-e355-4283-be45-4a668facfd3f" xlink:to="loc_us-gaap_InterestExpenseNonoperating_972fdb73-8b48-46a5-9ca3-eb968630fe87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BankCreditLinesLoanFacilitiesandNotesScheduleofMaturitiesofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMaturitiesofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f29fafa4-ac86-4e3b-bab8-9b01f2bf48e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c62f6201-b42b-4633-98bb-59f5975094c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f29fafa4-ac86-4e3b-bab8-9b01f2bf48e8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c62f6201-b42b-4633-98bb-59f5975094c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_620b27fd-bfaa-4112-96eb-38282addbb2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f29fafa4-ac86-4e3b-bab8-9b01f2bf48e8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_620b27fd-bfaa-4112-96eb-38282addbb2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_696b6f31-7394-4354-a26e-60e5e8422207" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f29fafa4-ac86-4e3b-bab8-9b01f2bf48e8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_696b6f31-7394-4354-a26e-60e5e8422207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_6d3dcf97-da54-4ca2-ad53-80954180f97c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f29fafa4-ac86-4e3b-bab8-9b01f2bf48e8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_6d3dcf97-da54-4ca2-ad53-80954180f97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter_af66e98f-ef50-434a-95a1-039d8071a6dd" xlink:href="iclr-20241231.xsd#iclr_LongTermDebtMaturityYearFiveAndThereafter"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f29fafa4-ac86-4e3b-bab8-9b01f2bf48e8" xlink:to="loc_iclr_LongTermDebtMaturityYearFiveAndThereafter_af66e98f-ef50-434a-95a1-039d8071a6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_d278037e-217d-4077-9c65-e9572c34ee60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f29fafa4-ac86-4e3b-bab8-9b01f2bf48e8" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_d278037e-217d-4077-9c65-e9572c34ee60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofPrincipalpaymentsDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BankCreditLinesLoanFacilitiesandNotesScheduleofPrincipalpaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofPrincipalpaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6efdf021-8000-49b4-af5a-1d84f9530a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3732faf1-0515-4f6b-9330-851c4ba7afbf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6efdf021-8000-49b4-af5a-1d84f9530a0b" xlink:to="loc_us-gaap_DebtInstrumentTable_3732faf1-0515-4f6b-9330-851c4ba7afbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7f76ee4e-3c4a-4dfe-901e-c01c965b6a34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3732faf1-0515-4f6b-9330-851c4ba7afbf" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7f76ee4e-3c4a-4dfe-901e-c01c965b6a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a0d5fa9f-bfe1-4d90-b460-86861798ef3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7f76ee4e-3c4a-4dfe-901e-c01c965b6a34" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a0d5fa9f-bfe1-4d90-b460-86861798ef3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_71a04da7-2e9c-4d8f-97d8-4ccf9a0c9d60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a0d5fa9f-bfe1-4d90-b460-86861798ef3c" xlink:to="loc_us-gaap_SecuredDebtMember_71a04da7-2e9c-4d8f-97d8-4ccf9a0c9d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_fb46e4f1-02d8-4a09-8842-8e5b8a80c088" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3732faf1-0515-4f6b-9330-851c4ba7afbf" xlink:to="loc_us-gaap_DebtInstrumentAxis_fb46e4f1-02d8-4a09-8842-8e5b8a80c088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e12e3f40-ecda-478f-aefa-f05bd90f2509" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_fb46e4f1-02d8-4a09-8842-8e5b8a80c088" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e12e3f40-ecda-478f-aefa-f05bd90f2509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TermLoanFacilityMember_5022d9fe-f6e2-4edc-be90-f8b48b419fed" xlink:href="iclr-20241231.xsd#iclr_TermLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e12e3f40-ecda-478f-aefa-f05bd90f2509" xlink:to="loc_iclr_TermLoanFacilityMember_5022d9fe-f6e2-4edc-be90-f8b48b419fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7c87fd50-c36f-460f-a323-ad1bb205cc02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3732faf1-0515-4f6b-9330-851c4ba7afbf" xlink:to="loc_us-gaap_DebtInstrumentLineItems_7c87fd50-c36f-460f-a323-ad1bb205cc02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_14c8af0b-cab9-408c-8d85-a703b033e1b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c87fd50-c36f-460f-a323-ad1bb205cc02" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_14c8af0b-cab9-408c-8d85-a703b033e1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment_1b870c2c-16c3-4a26-8b3f-c25e4759b2e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7c87fd50-c36f-460f-a323-ad1bb205cc02" xlink:to="loc_us-gaap_DebtInstrumentAnnualPrincipalPayment_1b870c2c-16c3-4a26-8b3f-c25e4759b2e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7e96a855-319d-412b-8624-8bbcb28f02ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6218f375-b446-4969-8fca-a94f19df90f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7e96a855-319d-412b-8624-8bbcb28f02ef" xlink:to="loc_us-gaap_DebtInstrumentTable_6218f375-b446-4969-8fca-a94f19df90f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_eca07726-b9a7-4e23-9409-7acf7614c18b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6218f375-b446-4969-8fca-a94f19df90f6" xlink:to="loc_us-gaap_CreditFacilityAxis_eca07726-b9a7-4e23-9409-7acf7614c18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_01828d9b-5b37-4dd7-a873-10c3bc706c63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_eca07726-b9a7-4e23-9409-7acf7614c18b" xlink:to="loc_us-gaap_CreditFacilityDomain_01828d9b-5b37-4dd7-a873-10c3bc706c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_86448994-6cd9-4292-b166-f603331aebb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_01828d9b-5b37-4dd7-a873-10c3bc706c63" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_86448994-6cd9-4292-b166-f603331aebb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cb7a8086-a7a3-43e2-94b7-0a75d70e00fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6218f375-b446-4969-8fca-a94f19df90f6" xlink:to="loc_us-gaap_DebtInstrumentAxis_cb7a8086-a7a3-43e2-94b7-0a75d70e00fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0c62e5c4-602e-4d65-9887-479fdca18f90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_cb7a8086-a7a3-43e2-94b7-0a75d70e00fb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0c62e5c4-602e-4d65-9887-479fdca18f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_a567bf6f-cb88-4135-bb69-a1c330e89316" xlink:href="iclr-20241231.xsd#iclr_SeniorSecuredRevolvingLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c62e5c4-602e-4d65-9887-479fdca18f90" xlink:to="loc_iclr_SeniorSecuredRevolvingLoanFacilityMember_a567bf6f-cb88-4135-bb69-a1c330e89316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6c608a73-0e77-44dc-8efd-12cb25086763" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6218f375-b446-4969-8fca-a94f19df90f6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6c608a73-0e77-44dc-8efd-12cb25086763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_32485fe6-8492-429c-9c49-7eb9aedcec2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6c608a73-0e77-44dc-8efd-12cb25086763" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_32485fe6-8492-429c-9c49-7eb9aedcec2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_4912ac74-fcbb-4375-abf6-21ec9fb41ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_32485fe6-8492-429c-9c49-7eb9aedcec2b" xlink:to="loc_us-gaap_LineOfCreditMember_4912ac74-fcbb-4375-abf6-21ec9fb41ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a10048a1-747f-4ec1-9c29-2b50c7e3a35b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6218f375-b446-4969-8fca-a94f19df90f6" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a10048a1-747f-4ec1-9c29-2b50c7e3a35b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_f312f4ac-1746-4759-846f-60e31b90d617" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a10048a1-747f-4ec1-9c29-2b50c7e3a35b" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_f312f4ac-1746-4759-846f-60e31b90d617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_74f2469e-9158-478d-b249-3c72843fe93b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a10048a1-747f-4ec1-9c29-2b50c7e3a35b" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_74f2469e-9158-478d-b249-3c72843fe93b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_7d04ad3d-6b8c-444b-85b6-d96f15bab417" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a10048a1-747f-4ec1-9c29-2b50c7e3a35b" xlink:to="loc_us-gaap_LongTermDebt_7d04ad3d-6b8c-444b-85b6-d96f15bab417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DerivativesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#DerivativesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DerivativesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_be4a3153-5637-49e2-b51f-bf2f0aa7c477" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_86e234d3-ce03-46a6-92af-b772d60a3b65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_be4a3153-5637-49e2-b51f-bf2f0aa7c477" xlink:to="loc_us-gaap_DerivativeTable_86e234d3-ce03-46a6-92af-b772d60a3b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ac0ebdaa-d687-4b02-a8fd-7e43ec596eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_86e234d3-ce03-46a6-92af-b772d60a3b65" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ac0ebdaa-d687-4b02-a8fd-7e43ec596eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9a6f1800-038c-41ee-a6b8-9059773a8c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ac0ebdaa-d687-4b02-a8fd-7e43ec596eb1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9a6f1800-038c-41ee-a6b8-9059773a8c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_d928b1bb-30ab-4024-9f1c-a5c6c2f29e07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9a6f1800-038c-41ee-a6b8-9059773a8c8f" xlink:to="loc_us-gaap_InterestRateCapMember_d928b1bb-30ab-4024-9f1c-a5c6c2f29e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_2b4f1589-6a5b-4629-935f-220e7009f4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9a6f1800-038c-41ee-a6b8-9059773a8c8f" xlink:to="loc_us-gaap_InterestRateSwapMember_2b4f1589-6a5b-4629-935f-220e7009f4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestRateCapAndInterestRateSwapMember_3408b1ea-7a92-4eaa-9c25-660d7d020c9d" xlink:href="iclr-20241231.xsd#iclr_InterestRateCapAndInterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9a6f1800-038c-41ee-a6b8-9059773a8c8f" xlink:to="loc_iclr_InterestRateCapAndInterestRateSwapMember_3408b1ea-7a92-4eaa-9c25-660d7d020c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0cafe30b-e7db-4b85-824a-2cd671133f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_86e234d3-ce03-46a6-92af-b772d60a3b65" xlink:to="loc_us-gaap_HedgingDesignationAxis_0cafe30b-e7db-4b85-824a-2cd671133f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_36e9e6be-4024-4810-8712-f129e1dd658d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_0cafe30b-e7db-4b85-824a-2cd671133f4a" xlink:to="loc_us-gaap_HedgingDesignationDomain_36e9e6be-4024-4810-8712-f129e1dd658d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c32147d6-a90e-4ed4-876d-426a2d94e319" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_36e9e6be-4024-4810-8712-f129e1dd658d" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c32147d6-a90e-4ed4-876d-426a2d94e319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_0374cc4b-05b7-40f1-8741-7d9757ce4d38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_86e234d3-ce03-46a6-92af-b772d60a3b65" xlink:to="loc_us-gaap_VariableRateAxis_0374cc4b-05b7-40f1-8741-7d9757ce4d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_70bb17db-8efe-40ad-911d-80617807af6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_0374cc4b-05b7-40f1-8741-7d9757ce4d38" xlink:to="loc_us-gaap_VariableRateDomain_70bb17db-8efe-40ad-911d-80617807af6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_4338513b-ebac-4630-8230-0d876432481f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_70bb17db-8efe-40ad-911d-80617807af6a" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_4338513b-ebac-4630-8230-0d876432481f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c0154e3a-f2d1-480d-89e4-00fcbc856897" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_86e234d3-ce03-46a6-92af-b772d60a3b65" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c0154e3a-f2d1-480d-89e4-00fcbc856897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5cd6fa57-2bbe-4265-bda1-8c67a48ec9a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c0154e3a-f2d1-480d-89e4-00fcbc856897" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5cd6fa57-2bbe-4265-bda1-8c67a48ec9a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a6318002-2d05-4208-bca7-cb971fb5acd5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5cd6fa57-2bbe-4265-bda1-8c67a48ec9a3" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a6318002-2d05-4208-bca7-cb971fb5acd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_db5f746d-61a1-41b7-8815-47f901cd09f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_86e234d3-ce03-46a6-92af-b772d60a3b65" xlink:to="loc_us-gaap_DerivativeLineItems_db5f746d-61a1-41b7-8815-47f901cd09f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_04c4ee7f-23c1-44a7-8771-ba6bcbeb7882" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_db5f746d-61a1-41b7-8815-47f901cd09f3" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_04c4ee7f-23c1-44a7-8771-ba6bcbeb7882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_b2a1071b-8151-489c-927e-e749271c74e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_db5f746d-61a1-41b7-8815-47f901cd09f3" xlink:to="loc_us-gaap_DerivativeNotionalAmount_b2a1071b-8151-489c-927e-e749271c74e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_2c8c0b80-0517-40cd-a148-63728401d963" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_db5f746d-61a1-41b7-8815-47f901cd09f3" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_2c8c0b80-0517-40cd-a148-63728401d963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf_36b57ce4-99d6-4131-94d4-f1494fbb16b7" xlink:href="iclr-20241231.xsd#iclr_DerivativeVariableInterestRateReferenceRateInExcessOf"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_db5f746d-61a1-41b7-8815-47f901cd09f3" xlink:to="loc_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf_36b57ce4-99d6-4131-94d4-f1494fbb16b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PercentageOfDebtHedgedByInterestRateDerivatives_8cedcc62-3c82-4af5-a737-81f914a1cc6f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PercentageOfDebtHedgedByInterestRateDerivatives"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_db5f746d-61a1-41b7-8815-47f901cd09f3" xlink:to="loc_us-gaap_PercentageOfDebtHedgedByInterestRateDerivatives_8cedcc62-3c82-4af5-a737-81f914a1cc6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_405dd711-2a2c-4d20-a6bc-f08b5893b147" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_db5f746d-61a1-41b7-8815-47f901cd09f3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_405dd711-2a2c-4d20-a6bc-f08b5893b147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_a93f57e8-6ffe-44a2-93a6-5503d5df3bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_db5f746d-61a1-41b7-8815-47f901cd09f3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_a93f57e8-6ffe-44a2-93a6-5503d5df3bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_554b844c-138e-432c-a507-8ad13c7f93c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_516e073e-ce39-4aef-af8c-8bc01342c7f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_554b844c-138e-432c-a507-8ad13c7f93c9" xlink:to="loc_us-gaap_DerivativeTable_516e073e-ce39-4aef-af8c-8bc01342c7f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c26f76aa-ba16-4114-a9cb-fdfd7c2761a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_516e073e-ce39-4aef-af8c-8bc01342c7f5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c26f76aa-ba16-4114-a9cb-fdfd7c2761a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5d14bffb-a411-40a3-92b8-4e6b7f2b2a26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c26f76aa-ba16-4114-a9cb-fdfd7c2761a5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5d14bffb-a411-40a3-92b8-4e6b7f2b2a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_cfa8287f-9ba4-4d1e-81ef-f2ed0608bce4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5d14bffb-a411-40a3-92b8-4e6b7f2b2a26" xlink:to="loc_us-gaap_InterestRateCapMember_cfa8287f-9ba4-4d1e-81ef-f2ed0608bce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6d03cadd-50b5-48c4-8eb4-0fe5815a818e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5d14bffb-a411-40a3-92b8-4e6b7f2b2a26" xlink:to="loc_us-gaap_InterestRateSwapMember_6d03cadd-50b5-48c4-8eb4-0fe5815a818e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_InterestRateCapAndInterestRateSwapMember_ba3fda9a-7b6f-4020-a920-30027281181c" xlink:href="iclr-20241231.xsd#iclr_InterestRateCapAndInterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5d14bffb-a411-40a3-92b8-4e6b7f2b2a26" xlink:to="loc_iclr_InterestRateCapAndInterestRateSwapMember_ba3fda9a-7b6f-4020-a920-30027281181c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_e8664e98-b589-4d2a-83e9-0d9c739fbc56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_516e073e-ce39-4aef-af8c-8bc01342c7f5" xlink:to="loc_us-gaap_HedgingDesignationAxis_e8664e98-b589-4d2a-83e9-0d9c739fbc56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5ce7a1d2-852a-4296-a372-a3c354ef8103" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_e8664e98-b589-4d2a-83e9-0d9c739fbc56" xlink:to="loc_us-gaap_HedgingDesignationDomain_5ce7a1d2-852a-4296-a372-a3c354ef8103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6956ffc7-cd6e-482e-a58b-df43f0533dae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5ce7a1d2-852a-4296-a372-a3c354ef8103" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_6956ffc7-cd6e-482e-a58b-df43f0533dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bdbb21c8-6d20-41f0-b4b8-93fd912fba14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_516e073e-ce39-4aef-af8c-8bc01342c7f5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bdbb21c8-6d20-41f0-b4b8-93fd912fba14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98504d0f-6c54-4c58-b473-480109175c37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bdbb21c8-6d20-41f0-b4b8-93fd912fba14" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98504d0f-6c54-4c58-b473-480109175c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_4c0ef437-f791-4f7d-8eb5-54a2b9e4fd61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_98504d0f-6c54-4c58-b473-480109175c37" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_4c0ef437-f791-4f7d-8eb5-54a2b9e4fd61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_bfb20cde-405d-4f03-aab7-80deedf2224a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_516e073e-ce39-4aef-af8c-8bc01342c7f5" xlink:to="loc_us-gaap_DerivativeLineItems_bfb20cde-405d-4f03-aab7-80deedf2224a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_d0cdb412-4071-4985-bb3e-cdc0b422ebd0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bfb20cde-405d-4f03-aab7-80deedf2224a" xlink:to="loc_us-gaap_DerivativeAssets_d0cdb412-4071-4985-bb3e-cdc0b422ebd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_9fe3ab0a-1d93-439e-a741-e302ad7a591d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bfb20cde-405d-4f03-aab7-80deedf2224a" xlink:to="loc_us-gaap_DerivativeLiabilities_9fe3ab0a-1d93-439e-a741-e302ad7a591d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_c726c83c-9fdd-4338-8c38-f758f44892aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_bfb20cde-405d-4f03-aab7-80deedf2224a" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_c726c83c-9fdd-4338-8c38-f758f44892aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesScheduleofLeaseCostsDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#OperatingLeasesScheduleofLeaseCostsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesScheduleofLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ef899446-9f3e-47d5-9162-149eca448cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_4866a7da-b297-4202-becb-9800f982790c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ef899446-9f3e-47d5-9162-149eca448cfe" xlink:to="loc_us-gaap_OperatingLeaseCost_4866a7da-b297-4202-becb-9800f982790c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_4eb1d60e-90b4-4eab-a8e2-4751f8903a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ef899446-9f3e-47d5-9162-149eca448cfe" xlink:to="loc_us-gaap_SubleaseIncome_4eb1d60e-90b4-4eab-a8e2-4751f8903a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_4fef02bb-a169-4190-9b84-90db84c17fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ef899446-9f3e-47d5-9162-149eca448cfe" xlink:to="loc_us-gaap_LeaseCost_4fef02bb-a169-4190-9b84-90db84c17fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#OperatingLeasesOperatingLeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_653a41d6-8f29-472d-9310-2557ecc2db8b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3d433251-c355-47f0-9f61-853e3e100c65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_653a41d6-8f29-472d-9310-2557ecc2db8b" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3d433251-c355-47f0-9f61-853e3e100c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_80eab4e0-75eb-454b-8c26-504b5c62059b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3d433251-c355-47f0-9f61-853e3e100c65" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_80eab4e0-75eb-454b-8c26-504b5c62059b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_99719708-1425-4343-b5f2-508ad02a21d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_80eab4e0-75eb-454b-8c26-504b5c62059b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_99719708-1425-4343-b5f2-508ad02a21d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ba3eb22e-86b1-44f7-b11b-92b49d3bd14a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_99719708-1425-4343-b5f2-508ad02a21d2" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ba3eb22e-86b1-44f7-b11b-92b49d3bd14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_51f6fccf-d5d0-4043-9f9f-746021ab7beb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_99719708-1425-4343-b5f2-508ad02a21d2" xlink:to="loc_us-gaap_CostOfSalesMember_51f6fccf-d5d0-4043-9f9f-746021ab7beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_8b7b30f2-3400-4df1-b89a-4e6b9e6fac9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_3d433251-c355-47f0-9f61-853e3e100c65" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_8b7b30f2-3400-4df1-b89a-4e6b9e6fac9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_269c5639-1992-498d-a717-0a6b382afde0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8b7b30f2-3400-4df1-b89a-4e6b9e6fac9f" xlink:to="loc_us-gaap_LeaseCost_269c5639-1992-498d-a717-0a6b382afde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_cc7d2b35-2cfc-42e9-ae82-cdbe7c2bcc28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8b7b30f2-3400-4df1-b89a-4e6b9e6fac9f" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_cc7d2b35-2cfc-42e9-ae82-cdbe7c2bcc28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_49ad855c-f4e6-4969-b85b-19be41c95c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8b7b30f2-3400-4df1-b89a-4e6b9e6fac9f" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_49ad855c-f4e6-4969-b85b-19be41c95c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_28b26e22-cb05-41e0-97cc-5ba7494cecf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8b7b30f2-3400-4df1-b89a-4e6b9e6fac9f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_28b26e22-cb05-41e0-97cc-5ba7494cecf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_39b3ab06-ea97-4908-aae5-beaf40bc0d27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8b7b30f2-3400-4df1-b89a-4e6b9e6fac9f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_39b3ab06-ea97-4908-aae5-beaf40bc0d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_05c6adbb-f837-4655-a055-0df5192a4ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8b7b30f2-3400-4df1-b89a-4e6b9e6fac9f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_05c6adbb-f837-4655-a055-0df5192a4ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_24038e43-4530-4277-8216-8455ea2a0ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8b7b30f2-3400-4df1-b89a-4e6b9e6fac9f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_24038e43-4530-4277-8216-8455ea2a0ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c30bc1c4-7809-40de-9f25-ac2ac3cbc09f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_8b7b30f2-3400-4df1-b89a-4e6b9e6fac9f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c30bc1c4-7809-40de-9f25-ac2ac3cbc09f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_13756e9c-92dd-4663-ae0c-3b013b59448d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_6c7ed218-c7bb-4eda-b1ea-e30f33a158b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_13756e9c-92dd-4663-ae0c-3b013b59448d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_6c7ed218-c7bb-4eda-b1ea-e30f33a158b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_cc3f731b-90f5-4b91-bd89-fe59e72c28e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_13756e9c-92dd-4663-ae0c-3b013b59448d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_cc3f731b-90f5-4b91-bd89-fe59e72c28e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e1d766ce-2215-4a15-be62-6959d4265d76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_13756e9c-92dd-4663-ae0c-3b013b59448d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e1d766ce-2215-4a15-be62-6959d4265d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ae4f588d-542e-4e21-89b5-47455f3559cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_13756e9c-92dd-4663-ae0c-3b013b59448d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ae4f588d-542e-4e21-89b5-47455f3559cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_3f1b7751-3b44-47b3-86f9-831b1534eac5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_13756e9c-92dd-4663-ae0c-3b013b59448d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_3f1b7751-3b44-47b3-86f9-831b1534eac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_fd15316e-e3ad-425b-bf63-8524b5a6e53f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_13756e9c-92dd-4663-ae0c-3b013b59448d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_fd15316e-e3ad-425b-bf63-8524b5a6e53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_eeeb5993-2dbb-4efa-9e4f-df3fe36ccd64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_13756e9c-92dd-4663-ae0c-3b013b59448d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_eeeb5993-2dbb-4efa-9e4f-df3fe36ccd64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ff83c866-13f1-49b1-85b1-b5d6162c8288" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_13756e9c-92dd-4663-ae0c-3b013b59448d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ff83c866-13f1-49b1-85b1-b5d6162c8288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c60caf01-8b85-487e-9d11-f22ae60ef5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_13756e9c-92dd-4663-ae0c-3b013b59448d" xlink:to="loc_us-gaap_OperatingLeaseLiability_c60caf01-8b85-487e-9d11-f22ae60ef5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#NoncurrentotherliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_d97fe61c-8ad3-4ca3-8d87-888a5256a5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_e4c3f142-86d9-4238-bdd1-d6cfa8bfe6a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d97fe61c-8ad3-4ca3-8d87-888a5256a5b4" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_e4c3f142-86d9-4238-bdd1-d6cfa8bfe6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_25077d85-d1a9-49e2-a16f-11d205d84962" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d97fe61c-8ad3-4ca3-8d87-888a5256a5b4" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_25077d85-d1a9-49e2-a16f-11d205d84962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4cc77aea-9e76-4607-a0af-b0a5e52f60b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_3d1c2ab0-0037-4a04-a801-69c124334b19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4cc77aea-9e76-4607-a0af-b0a5e52f60b1" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_3d1c2ab0-0037-4a04-a801-69c124334b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/ShareCapitalDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#ShareCapitalDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/ShareCapitalDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_24b63e5b-36cc-4772-9b0e-853bdba848f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_082a6e61-7651-44ee-bc21-f935db50a8e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_24b63e5b-36cc-4772-9b0e-853bdba848f0" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_082a6e61-7651-44ee-bc21-f935db50a8e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a8ca305f-d05d-4fc7-8b4c-cfc0f21e616b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_082a6e61-7651-44ee-bc21-f935db50a8e7" xlink:to="loc_us-gaap_AwardTypeAxis_a8ca305f-d05d-4fc7-8b4c-cfc0f21e616b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d74136c9-ffab-4769-928b-171adc30ba7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a8ca305f-d05d-4fc7-8b4c-cfc0f21e616b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d74136c9-ffab-4769-928b-171adc30ba7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_95f6e6f9-7bd1-4a3a-9a2f-5aae167dc690" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d74136c9-ffab-4769-928b-171adc30ba7f" xlink:to="loc_us-gaap_EmployeeStockOptionMember_95f6e6f9-7bd1-4a3a-9a2f-5aae167dc690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_892ac4a4-e3f8-4137-8b49-839d05e53f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d74136c9-ffab-4769-928b-171adc30ba7f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_892ac4a4-e3f8-4137-8b49-839d05e53f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_657b0f7a-2477-42d5-9633-33dd176b7261" xlink:href="iclr-20241231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d74136c9-ffab-4769-928b-171adc30ba7f" xlink:to="loc_iclr_PerformanceShareUnitMember_657b0f7a-2477-42d5-9633-33dd176b7261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramAxis_50b6bb62-f56a-4229-b648-ff9f9f2a42e5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_082a6e61-7651-44ee-bc21-f935db50a8e7" xlink:to="loc_srt_ShareRepurchaseProgramAxis_50b6bb62-f56a-4229-b648-ff9f9f2a42e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramDomain_7d2aa806-c636-4a89-a052-975f517d3039" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ShareRepurchaseProgramAxis_50b6bb62-f56a-4229-b648-ff9f9f2a42e5" xlink:to="loc_srt_ShareRepurchaseProgramDomain_7d2aa806-c636-4a89-a052-975f517d3039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_BuybackProgramMember_24054145-32d8-43e2-a302-b657bb60029b" xlink:href="iclr-20241231.xsd#iclr_BuybackProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ShareRepurchaseProgramDomain_7d2aa806-c636-4a89-a052-975f517d3039" xlink:to="loc_iclr_BuybackProgramMember_24054145-32d8-43e2-a302-b657bb60029b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_February2024Member_7e47ce21-36d2-47f8-b22f-437efc8bdf48" xlink:href="iclr-20241231.xsd#iclr_February2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ShareRepurchaseProgramDomain_7d2aa806-c636-4a89-a052-975f517d3039" xlink:to="loc_iclr_February2024Member_7e47ce21-36d2-47f8-b22f-437efc8bdf48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_October2024Member_933c7b17-099d-40b7-9dd8-fc27e9ed5cd3" xlink:href="iclr-20241231.xsd#iclr_October2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ShareRepurchaseProgramDomain_7d2aa806-c636-4a89-a052-975f517d3039" xlink:to="loc_iclr_October2024Member_933c7b17-099d-40b7-9dd8-fc27e9ed5cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5bb0af7e-20fe-4469-ae2f-b374e5d924ed" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_082a6e61-7651-44ee-bc21-f935db50a8e7" xlink:to="loc_srt_RangeAxis_5bb0af7e-20fe-4469-ae2f-b374e5d924ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ba41b06c-51f4-4ac2-9fb0-d6a45aea9645" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5bb0af7e-20fe-4469-ae2f-b374e5d924ed" xlink:to="loc_srt_RangeMember_ba41b06c-51f4-4ac2-9fb0-d6a45aea9645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3d70ebbe-2af6-4828-9ce0-e43e1333de03" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ba41b06c-51f4-4ac2-9fb0-d6a45aea9645" xlink:to="loc_srt_MaximumMember_3d70ebbe-2af6-4828-9ce0-e43e1333de03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_082a6e61-7651-44ee-bc21-f935db50a8e7" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NumberOfVotes_c38b0e67-7ca3-4353-93eb-17fff89a7882" xlink:href="iclr-20241231.xsd#iclr_NumberOfVotes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:to="loc_iclr_NumberOfVotes_c38b0e67-7ca3-4353-93eb-17fff89a7882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e3257c3f-e54a-4880-8916-a6dc70560e87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e3257c3f-e54a-4880-8916-a6dc70560e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_8de88dbf-d642-49bc-843e-ffca49e72d95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_8de88dbf-d642-49bc-843e-ffca49e72d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_81844344-9fb4-45ff-a97e-bb311ad35f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_81844344-9fb4-45ff-a97e-bb311ad35f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_83b296d4-a151-4d93-8e49-fefac1aa4973" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_83b296d4-a151-4d93-8e49-fefac1aa4973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_46ec0ba9-68ef-4aa5-ac0c-837f0aaa3f54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_46ec0ba9-68ef-4aa5-ac0c-837f0aaa3f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockRepurchaseProgramAuthorizedPercentage_23079766-af56-4611-b48e-10fd09cf811d" xlink:href="iclr-20241231.xsd#iclr_StockRepurchaseProgramAuthorizedPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:to="loc_iclr_StockRepurchaseProgramAuthorizedPercentage_23079766-af56-4611-b48e-10fd09cf811d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1_a138a5b2-dfb3-4371-be57-5c3697d54e87" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:to="loc_srt_StockRepurchaseProgramAuthorizedAmount1_a138a5b2-dfb3-4371-be57-5c3697d54e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_81bae575-5899-4e06-8026-39e051669454" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_81bae575-5899-4e06-8026-39e051669454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_c2641b91-c25c-409f-b683-580a71895bad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_eb6947bb-b325-43a0-a652-7e7da4b5269d" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_c2641b91-c25c-409f-b683-580a71895bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#RestructuringchargesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c8f70b10-97c7-4e51-bfa5-b742a7e87cce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9318492f-c7aa-42a3-aaf8-c443608d5c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c8f70b10-97c7-4e51-bfa5-b742a7e87cce" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9318492f-c7aa-42a3-aaf8-c443608d5c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_4a7d0ec2-17df-494a-8c5a-d55d1c1e8a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9318492f-c7aa-42a3-aaf8-c443608d5c5b" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_4a7d0ec2-17df-494a-8c5a-d55d1c1e8a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_8714f8e7-542f-45c7-b5e5-66fc55bfa800" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_4a7d0ec2-17df-494a-8c5a-d55d1c1e8a1f" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_8714f8e7-542f-45c7-b5e5-66fc55bfa800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_WorkforceReductionAndOfficeConsolidationProgramMember_022291e2-9df3-4455-8ac1-715f9ac18150" xlink:href="iclr-20241231.xsd#iclr_WorkforceReductionAndOfficeConsolidationProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_8714f8e7-542f-45c7-b5e5-66fc55bfa800" xlink:to="loc_iclr_WorkforceReductionAndOfficeConsolidationProgramMember_022291e2-9df3-4455-8ac1-715f9ac18150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PersonnelRelatedLiabilitiesMember_b4c55cde-e10b-460e-98f4-5fc0984476a5" xlink:href="iclr-20241231.xsd#iclr_PersonnelRelatedLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_8714f8e7-542f-45c7-b5e5-66fc55bfa800" xlink:to="loc_iclr_PersonnelRelatedLiabilitiesMember_b4c55cde-e10b-460e-98f4-5fc0984476a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_FacilityLiabilityMember_3f8d69d2-234a-42e8-9ac4-f00c9dc6599d" xlink:href="iclr-20241231.xsd#iclr_FacilityLiabilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_8714f8e7-542f-45c7-b5e5-66fc55bfa800" xlink:to="loc_iclr_FacilityLiabilityMember_3f8d69d2-234a-42e8-9ac4-f00c9dc6599d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_f319174e-7b08-401d-a974-3307893392ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9318492f-c7aa-42a3-aaf8-c443608d5c5b" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_f319174e-7b08-401d-a974-3307893392ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_3a1a5439-0c73-4759-93b9-6508b02a9184" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f319174e-7b08-401d-a974-3307893392ad" xlink:to="loc_us-gaap_RestructuringCosts_3a1a5439-0c73-4759-93b9-6508b02a9184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_6832efed-4ba1-44dd-96ef-226d39ec7eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f319174e-7b08-401d-a974-3307893392ad" xlink:to="loc_us-gaap_SeveranceCosts1_6832efed-4ba1-44dd-96ef-226d39ec7eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_8188db1f-c93e-42ad-8079-25113eac9ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f319174e-7b08-401d-a974-3307893392ad" xlink:to="loc_us-gaap_OtherRestructuringCosts_8188db1f-c93e-42ad-8079-25113eac9ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment_f3a2b82f-8c38-4333-966c-d5c4ef094f43" xlink:href="iclr-20241231.xsd#iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f319174e-7b08-401d-a974-3307893392ad" xlink:to="loc_iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment_f3a2b82f-8c38-4333-966c-d5c4ef094f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_1e37c110-aef1-462a-a85d-a4a3b8907699" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f319174e-7b08-401d-a974-3307893392ad" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_1e37c110-aef1-462a-a85d-a4a3b8907699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_4264959c-a397-47a6-9f54-efae27b4f50b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f319174e-7b08-401d-a974-3307893392ad" xlink:to="loc_us-gaap_RestructuringReserve_4264959c-a397-47a6-9f54-efae27b4f50b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_a3c0a3bb-3562-4bb2-84b0-23c9a71177f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f319174e-7b08-401d-a974-3307893392ad" xlink:to="loc_us-gaap_RestructuringReserveCurrent_a3c0a3bb-3562-4bb2-84b0-23c9a71177f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_6600e80e-ef33-4704-a41e-56a48afaac78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f319174e-7b08-401d-a974-3307893392ad" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_6600e80e-ef33-4704-a41e-56a48afaac78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringChargesDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#RestructuringchargesScheduleofRestructuringChargesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7d1834b6-5132-4eea-bc8e-3d7dbfbf141e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_8e96f8e3-c75f-40f9-904a-c4b57196918a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7d1834b6-5132-4eea-bc8e-3d7dbfbf141e" xlink:to="loc_us-gaap_RestructuringCosts_8e96f8e3-c75f-40f9-904a-c4b57196918a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#RestructuringchargesScheduleofRestructuringReservebyTypeofCostDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_62a31923-71b0-4aab-9a8f-90b5d31740e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_380bd3fa-d7ae-4e3a-af87-5cf6224addf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_62a31923-71b0-4aab-9a8f-90b5d31740e0" xlink:to="loc_us-gaap_RestructuringReserveRollForward_380bd3fa-d7ae-4e3a-af87-5cf6224addf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_d4d31522-8e71-4441-9e6a-0d9d57b12e28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_380bd3fa-d7ae-4e3a-af87-5cf6224addf1" xlink:to="loc_us-gaap_RestructuringReserve_d4d31522-8e71-4441-9e6a-0d9d57b12e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_d8126661-9ec5-4640-acd4-9b126e7bbc27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_380bd3fa-d7ae-4e3a-af87-5cf6224addf1" xlink:to="loc_us-gaap_RestructuringCharges_d8126661-9ec5-4640-acd4-9b126e7bbc27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestructuringReserveUtilizations_3d04e500-ab9c-486e-9c63-bbf0f61a9481" xlink:href="iclr-20241231.xsd#iclr_RestructuringReserveUtilizations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_380bd3fa-d7ae-4e3a-af87-5cf6224addf1" xlink:to="loc_iclr_RestructuringReserveUtilizations_3d04e500-ab9c-486e-9c63-bbf0f61a9481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_8be8e96e-4920-4417-9410-b4d2ec591fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_380bd3fa-d7ae-4e3a-af87-5cf6224addf1" xlink:to="loc_us-gaap_RestructuringReserve_8be8e96e-4920-4417-9410-b4d2ec591fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_88d9b957-56d4-475b-b22c-fab8bdb1c39b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_715dff7d-fdc8-4c71-bf74-8d9d215cbc72" xlink:href="iclr-20241231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_88d9b957-56d4-475b-b22c-fab8bdb1c39b" xlink:to="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_715dff7d-fdc8-4c71-bf74-8d9d215cbc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_63bd0ffc-af76-4597-9335-6b22ebc31b33" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_715dff7d-fdc8-4c71-bf74-8d9d215cbc72" xlink:to="loc_srt_StatementGeographicalAxis_63bd0ffc-af76-4597-9335-6b22ebc31b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_098624a4-4eda-4895-be6d-dae7c7ad220a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_63bd0ffc-af76-4597-9335-6b22ebc31b33" xlink:to="loc_srt_SegmentGeographicalDomain_098624a4-4eda-4895-be6d-dae7c7ad220a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_bd4af815-1af0-404b-91d5-fd83edce335c" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_098624a4-4eda-4895-be6d-dae7c7ad220a" xlink:to="loc_country_IE_bd4af815-1af0-404b-91d5-fd83edce335c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_c9fc9cce-ba6c-470e-9922-955d97c9c6ea" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_098624a4-4eda-4895-be6d-dae7c7ad220a" xlink:to="loc_country_US_c9fc9cce-ba6c-470e-9922-955d97c9c6ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeAndOtherCountriesMember_02834b80-66f3-4f40-9252-904605da0dc4" xlink:href="iclr-20241231.xsd#iclr_RestOfEuropeAndOtherCountriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_098624a4-4eda-4895-be6d-dae7c7ad220a" xlink:to="loc_iclr_RestOfEuropeAndOtherCountriesMember_02834b80-66f3-4f40-9252-904605da0dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_f749875e-2747-4fab-b954-fb4c1e486723" xlink:href="iclr-20241231.xsd#iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_715dff7d-fdc8-4c71-bf74-8d9d215cbc72" xlink:to="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_f749875e-2747-4fab-b954-fb4c1e486723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_46dce1d7-97f4-4847-8550-e7bf95b888d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_f749875e-2747-4fab-b954-fb4c1e486723" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_46dce1d7-97f4-4847-8550-e7bf95b888d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_eee25107-8f05-4c46-8040-19e4dd86ccce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_5adb1516-e14a-478a-b4a6-7e2af00face7" xlink:href="iclr-20241231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_eee25107-8f05-4c46-8040-19e4dd86ccce" xlink:to="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_5adb1516-e14a-478a-b4a6-7e2af00face7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d1420c4d-28a5-491c-9413-cd5138defb7a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_5adb1516-e14a-478a-b4a6-7e2af00face7" xlink:to="loc_srt_StatementGeographicalAxis_d1420c4d-28a5-491c-9413-cd5138defb7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4eaf3cf5-34f0-4284-ae40-529569c8f508" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_d1420c4d-28a5-491c-9413-cd5138defb7a" xlink:to="loc_srt_SegmentGeographicalDomain_4eaf3cf5-34f0-4284-ae40-529569c8f508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_60e886a4-d17a-4ab3-98f1-6644937a47b0" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4eaf3cf5-34f0-4284-ae40-529569c8f508" xlink:to="loc_country_IE_60e886a4-d17a-4ab3-98f1-6644937a47b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e016d53d-df9d-4796-b2b1-749c1aeeb7fb" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4eaf3cf5-34f0-4284-ae40-529569c8f508" xlink:to="loc_country_US_e016d53d-df9d-4796-b2b1-749c1aeeb7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeAndOtherCountriesMember_86d26cf6-8839-4dc7-92db-1cf3f7eedbd1" xlink:href="iclr-20241231.xsd#iclr_RestOfEuropeAndOtherCountriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4eaf3cf5-34f0-4284-ae40-529569c8f508" xlink:to="loc_iclr_RestOfEuropeAndOtherCountriesMember_86d26cf6-8839-4dc7-92db-1cf3f7eedbd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_b6880684-39c0-4fdd-893d-a909105baf1e" xlink:href="iclr-20241231.xsd#iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesTable_5adb1516-e14a-478a-b4a6-7e2af00face7" xlink:to="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_b6880684-39c0-4fdd-893d-a909105baf1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_951345b3-274a-48d1-a09b-01215b9da2bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_b6880684-39c0-4fdd-893d-a909105baf1e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_951345b3-274a-48d1-a09b-01215b9da2bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7057bd85-3464-456f-b71e-350fb3a1c1a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_951345b3-274a-48d1-a09b-01215b9da2bf" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7057bd85-3464-456f-b71e-350fb3a1c1a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b5c3368a-a8ef-4c44-b0c0-089bce793c93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7057bd85-3464-456f-b71e-350fb3a1c1a3" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b5c3368a-a8ef-4c44-b0c0-089bce793c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_69575b1f-0c22-4b10-8dae-baaa53acde3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_951345b3-274a-48d1-a09b-01215b9da2bf" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_69575b1f-0c22-4b10-8dae-baaa53acde3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_77220b73-9d22-45a8-a22c-ff43ad8c4bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_69575b1f-0c22-4b10-8dae-baaa53acde3f" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_77220b73-9d22-45a8-a22c-ff43ad8c4bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_73bb3b22-422e-4297-ae0e-63d3aecb4a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_951345b3-274a-48d1-a09b-01215b9da2bf" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_73bb3b22-422e-4297-ae0e-63d3aecb4a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_783ca866-1f2e-418c-9a18-2c430a703cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_b6880684-39c0-4fdd-893d-a909105baf1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_783ca866-1f2e-418c-9a18-2c430a703cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_d2b3b965-0919-46d2-9945-4a27060b02c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_783ca866-1f2e-418c-9a18-2c430a703cb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_d2b3b965-0919-46d2-9945-4a27060b02c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_69172d6f-d6ce-4441-bb9d-be72458da3d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_783ca866-1f2e-418c-9a18-2c430a703cb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_69172d6f-d6ce-4441-bb9d-be72458da3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_4dd11399-758e-4511-a368-737acc164d77" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxAbstract_783ca866-1f2e-418c-9a18-2c430a703cb2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_4dd11399-758e-4511-a368-737acc164d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_bc53badf-1d3c-4096-bbd9-3641c1a9a97b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems_b6880684-39c0-4fdd-893d-a909105baf1e" xlink:to="loc_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity_bc53badf-1d3c-4096-bbd9-3641c1a9a97b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_62385955-f418-413a-a3de-1e811b34250f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_51e71237-3a2f-4c53-9c28-8802d82d954b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_62385955-f418-413a-a3de-1e811b34250f" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_51e71237-3a2f-4c53-9c28-8802d82d954b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_0ee813d1-6552-47c3-a6ec-49ecdab3a7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_62385955-f418-413a-a3de-1e811b34250f" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization_0ee813d1-6552-47c3-a6ec-49ecdab3a7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount_3e49d0ed-4e2d-478a-b3c1-d68fa9213548" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_62385955-f418-413a-a3de-1e811b34250f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount_3e49d0ed-4e2d-478a-b3c1-d68fa9213548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_5ea53be7-d076-4453-b5f0-f74924aefcae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_62385955-f418-413a-a3de-1e811b34250f" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_5ea53be7-d076-4453-b5f0-f74924aefcae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_72330e1e-4006-44fc-9ac3-3b8c7750e98a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_62385955-f418-413a-a3de-1e811b34250f" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_72330e1e-4006-44fc-9ac3-3b8c7750e98a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_29ab9f4b-0306-45a9-9e51-22c6123b1984" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_62385955-f418-413a-a3de-1e811b34250f" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_29ab9f4b-0306-45a9-9e51-22c6123b1984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_4783d024-ad97-452c-853a-f818598f38cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_62385955-f418-413a-a3de-1e811b34250f" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_4783d024-ad97-452c-853a-f818598f38cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount_b76e10bf-a66a-4666-a050-c0da8b48eb3e" xlink:href="iclr-20241231.xsd#iclr_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_62385955-f418-413a-a3de-1e811b34250f" xlink:to="loc_iclr_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount_b76e10bf-a66a-4666-a050-c0da8b48eb3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount_5ad70164-7907-4325-9d44-a2ac78445d25" xlink:href="iclr-20241231.xsd#iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_62385955-f418-413a-a3de-1e811b34250f" xlink:to="loc_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount_5ad70164-7907-4325-9d44-a2ac78445d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_54488b05-840d-4f4f-91e2-1edf15f812ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_62385955-f418-413a-a3de-1e811b34250f" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_54488b05-840d-4f4f-91e2-1edf15f812ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_894c4b86-0e6c-4cbc-a7c7-a56d58ca0ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_62385955-f418-413a-a3de-1e811b34250f" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_894c4b86-0e6c-4cbc-a7c7-a56d58ca0ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3b697360-0483-4ea8-a06d-bf494532fc11" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_62385955-f418-413a-a3de-1e811b34250f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3b697360-0483-4ea8-a06d-bf494532fc11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9c97ecb0-d112-460d-8b4d-81fbdb60d571" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4f8d87ec-881d-4357-8ee6-3cde6489a38e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9c97ecb0-d112-460d-8b4d-81fbdb60d571" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4f8d87ec-881d-4357-8ee6-3cde6489a38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_7f9ece92-7790-477c-8733-6c9534e216eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4f8d87ec-881d-4357-8ee6-3cde6489a38e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_7f9ece92-7790-477c-8733-6c9534e216eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_e15627be-64c7-41c1-acf2-5e1ea5ca6e76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4f8d87ec-881d-4357-8ee6-3cde6489a38e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_e15627be-64c7-41c1-acf2-5e1ea5ca6e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_40ddd051-0b7c-4561-968b-aa204c9bfd54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4f8d87ec-881d-4357-8ee6-3cde6489a38e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_40ddd051-0b7c-4561-968b-aa204c9bfd54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_88abf0d0-27cd-4d09-a0c5-eca979344f57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4f8d87ec-881d-4357-8ee6-3cde6489a38e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_88abf0d0-27cd-4d09-a0c5-eca979344f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_2ff65b2a-c46b-4dd0-aa1c-641959f535f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4f8d87ec-881d-4357-8ee6-3cde6489a38e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_2ff65b2a-c46b-4dd0-aa1c-641959f535f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_b1a3367f-6fdc-402a-8073-08312096f1d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4f8d87ec-881d-4357-8ee6-3cde6489a38e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_b1a3367f-6fdc-402a-8073-08312096f1d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_0120b3c5-0dc5-4661-b20b-6e643a42faa0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4f8d87ec-881d-4357-8ee6-3cde6489a38e" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_0120b3c5-0dc5-4661-b20b-6e643a42faa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_84eb2498-3ffd-4c7a-b387-de884f43c974" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9c97ecb0-d112-460d-8b4d-81fbdb60d571" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_84eb2498-3ffd-4c7a-b387-de884f43c974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_e792beee-5dbf-428a-9636-278e27ac2a18" xlink:href="iclr-20241231.xsd#iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_84eb2498-3ffd-4c7a-b387-de884f43c974" xlink:to="loc_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards_e792beee-5dbf-428a-9636-278e27ac2a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_0433c303-bc73-4105-b26e-c2c46b99af26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_84eb2498-3ffd-4c7a-b387-de884f43c974" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_0433c303-bc73-4105-b26e-c2c46b99af26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability_3bff687e-d486-496b-bb8d-c5e740ab7020" xlink:href="iclr-20241231.xsd#iclr_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_84eb2498-3ffd-4c7a-b387-de884f43c974" xlink:to="loc_iclr_DeferredTaxAssetsOperatingLeaseLiability_3bff687e-d486-496b-bb8d-c5e740ab7020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_bf48c92b-be47-4f2e-ae27-ff7a00d438c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_84eb2498-3ffd-4c7a-b387-de884f43c974" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_bf48c92b-be47-4f2e-ae27-ff7a00d438c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_59be22c5-8775-43e9-aaeb-1ef216c38d40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_84eb2498-3ffd-4c7a-b387-de884f43c974" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_59be22c5-8775-43e9-aaeb-1ef216c38d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities_397bcd11-3807-4f5d-badc-4be4576d3e55" xlink:href="iclr-20241231.xsd#iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_84eb2498-3ffd-4c7a-b387-de884f43c974" xlink:to="loc_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities_397bcd11-3807-4f5d-badc-4be4576d3e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetContractWithCustomerLiability_c72d00a5-dcb3-4372-a5db-b5febf93779b" xlink:href="iclr-20241231.xsd#iclr_DeferredTaxAssetContractWithCustomerLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_84eb2498-3ffd-4c7a-b387-de884f43c974" xlink:to="loc_iclr_DeferredTaxAssetContractWithCustomerLiability_c72d00a5-dcb3-4372-a5db-b5febf93779b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_8905c6c8-f358-4b23-814d-b3f2f9208d52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_84eb2498-3ffd-4c7a-b387-de884f43c974" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_8905c6c8-f358-4b23-814d-b3f2f9208d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_b1a11f6e-1dc9-4b82-887c-ce890bac6697" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_84eb2498-3ffd-4c7a-b387-de884f43c974" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_b1a11f6e-1dc9-4b82-887c-ce890bac6697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_154d1e18-b2c9-45e6-afd0-dcf2f8825123" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_84eb2498-3ffd-4c7a-b387-de884f43c974" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_154d1e18-b2c9-45e6-afd0-dcf2f8825123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_4d67eb1c-77e0-4565-8595-a458400813bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_84eb2498-3ffd-4c7a-b387-de884f43c974" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_4d67eb1c-77e0-4565-8595-a458400813bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_74ee8798-b9dd-4ec2-8409-310e4ac60406" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_84eb2498-3ffd-4c7a-b387-de884f43c974" xlink:to="loc_us-gaap_DeferredTaxLiabilities_74ee8798-b9dd-4ec2-8409-310e4ac60406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6fa396a0-39b3-4d02-8450-9939d8935084" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_115a5e36-ef01-4db8-8c6e-885a6680271c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6fa396a0-39b3-4d02-8450-9939d8935084" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_115a5e36-ef01-4db8-8c6e-885a6680271c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d9eeac92-c226-4db4-bcfa-8a6e67776c71" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_115a5e36-ef01-4db8-8c6e-885a6680271c" xlink:to="loc_srt_StatementGeographicalAxis_d9eeac92-c226-4db4-bcfa-8a6e67776c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f1b34b2e-978c-4be2-8e4d-6e30c12cf73c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_d9eeac92-c226-4db4-bcfa-8a6e67776c71" xlink:to="loc_srt_SegmentGeographicalDomain_f1b34b2e-978c-4be2-8e4d-6e30c12cf73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_2b316a14-6eb4-44b3-bfdf-d3a7aab3b08f" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f1b34b2e-978c-4be2-8e4d-6e30c12cf73c" xlink:to="loc_country_IE_2b316a14-6eb4-44b3-bfdf-d3a7aab3b08f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_4aa3ae0a-cc7b-4721-84ad-dca2a998a291" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f1b34b2e-978c-4be2-8e4d-6e30c12cf73c" xlink:to="loc_country_US_4aa3ae0a-cc7b-4721-84ad-dca2a998a291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_7bbdf9fc-c575-4b4a-96a0-ca188f0d7cdc" xlink:href="iclr-20241231.xsd#iclr_OtherCountriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f1b34b2e-978c-4be2-8e4d-6e30c12cf73c" xlink:to="loc_iclr_OtherCountriesMember_7bbdf9fc-c575-4b4a-96a0-ca188f0d7cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_54c5cdb9-77bf-4aa3-b2c0-4a00f4bbdb0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_115a5e36-ef01-4db8-8c6e-885a6680271c" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_54c5cdb9-77bf-4aa3-b2c0-4a00f4bbdb0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_88df4e29-f62d-4ad4-8ab3-ccffc9949615" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_54c5cdb9-77bf-4aa3-b2c0-4a00f4bbdb0e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_88df4e29-f62d-4ad4-8ab3-ccffc9949615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_dd73ab40-10f4-4d38-b7e9-211ba344509c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_88df4e29-f62d-4ad4-8ab3-ccffc9949615" xlink:to="loc_us-gaap_ForeignCountryMember_dd73ab40-10f4-4d38-b7e9-211ba344509c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_7c197321-a95d-4344-aa4c-35ced77201f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_88df4e29-f62d-4ad4-8ab3-ccffc9949615" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_7c197321-a95d-4344-aa4c-35ced77201f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_08d24b30-9aff-4609-ab1d-cea140ee66f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_115a5e36-ef01-4db8-8c6e-885a6680271c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_08d24b30-9aff-4609-ab1d-cea140ee66f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_5d31e027-86fb-478a-bb01-05c8440b4ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_08d24b30-9aff-4609-ab1d-cea140ee66f9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_5d31e027-86fb-478a-bb01-05c8440b4ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeMember_fe698d57-e899-4e75-8e9b-1a27d69165fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_5d31e027-86fb-478a-bb01-05c8440b4ad3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeMember_fe698d57-e899-4e75-8e9b-1a27d69165fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0a3ae8e7-46f1-4083-a6be-91c446d248de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_115a5e36-ef01-4db8-8c6e-885a6680271c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0a3ae8e7-46f1-4083-a6be-91c446d248de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_57738f73-1967-4083-a7fe-095161f7e9f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0a3ae8e7-46f1-4083-a6be-91c446d248de" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_57738f73-1967-4083-a7fe-095161f7e9f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_IncomeTaxBenefitMember_4b9f24a5-9884-4dd6-949b-a381a9b19134" xlink:href="iclr-20241231.xsd#iclr_IncomeTaxBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_57738f73-1967-4083-a7fe-095161f7e9f9" xlink:to="loc_iclr_IncomeTaxBenefitMember_4b9f24a5-9884-4dd6-949b-a381a9b19134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxOfBusinessAcquiredMember_24b57a10-b81a-464d-b712-d49e44a205c5" xlink:href="iclr-20241231.xsd#iclr_TaxOfBusinessAcquiredMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_57738f73-1967-4083-a7fe-095161f7e9f9" xlink:to="loc_iclr_TaxOfBusinessAcquiredMember_24b57a10-b81a-464d-b712-d49e44a205c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_62c5d592-f0dd-431a-9d82-518cf5112359" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_115a5e36-ef01-4db8-8c6e-885a6680271c" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_62c5d592-f0dd-431a-9d82-518cf5112359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_e81f8576-f6ce-40f9-9aec-6ea5e474e4bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_62c5d592-f0dd-431a-9d82-518cf5112359" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_e81f8576-f6ce-40f9-9aec-6ea5e474e4bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_da26e55b-f4d0-4651-810b-54c4c1bf3562" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_e81f8576-f6ce-40f9-9aec-6ea5e474e4bc" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_da26e55b-f4d0-4651-810b-54c4c1bf3562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable_115a5e36-ef01-4db8-8c6e-885a6680271c" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_c04729b3-af3d-4e99-8b53-96b17830286f" xlink:href="iclr-20241231.xsd#iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration_c04729b3-af3d-4e99-8b53-96b17830286f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_2d960d56-f302-427b-ab70-0e51ec1abf01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_2d960d56-f302-427b-ab70-0e51ec1abf01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_d83cd2ad-2219-41bb-b3b5-14bd0807e7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_d83cd2ad-2219-41bb-b3b5-14bd0807e7f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxCreditCarryForwardIncreaseDecreaseAmount_87863711-4e2d-4ede-a3e3-6b5cbe31ca62" xlink:href="iclr-20241231.xsd#iclr_TaxCreditCarryForwardIncreaseDecreaseAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_iclr_TaxCreditCarryForwardIncreaseDecreaseAmount_87863711-4e2d-4ede-a3e3-6b5cbe31ca62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_5b0301ff-3d33-4653-a39d-5709927b3d71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax_5b0301ff-3d33-4653-a39d-5709927b3d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_7f29566f-f3f6-46d8-85f9-9332fe3d0bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_7f29566f-f3f6-46d8-85f9-9332fe3d0bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxCreditCarryForwardExpirationPeriod_766fea31-39d9-48a3-98f4-e0880081f829" xlink:href="iclr-20241231.xsd#iclr_TaxCreditCarryForwardExpirationPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_iclr_TaxCreditCarryForwardExpirationPeriod_766fea31-39d9-48a3-98f4-e0880081f829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7718debe-3a16-4202-9fed-0c38bcfc42aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7718debe-3a16-4202-9fed-0c38bcfc42aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_85858091-4e00-4ea2-9832-a4c7352be654" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_85858091-4e00-4ea2-9832-a4c7352be654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_a8e0cdec-30d4-4fc5-aec8-4709960f45e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_a8e0cdec-30d4-4fc5-aec8-4709960f45e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_942cb11b-ff83-495e-a996-a0979aed7e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_942cb11b-ff83-495e-a996-a0979aed7e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_db8192d2-bdd2-422e-b09f-108c3f402bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_db8192d2-bdd2-422e-b09f-108c3f402bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_11fd069e-6e9d-4c06-afdf-935793f2b64c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_11fd069e-6e9d-4c06-afdf-935793f2b64c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_6ab14a61-9192-45a0-be82-216a4caa51f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_320e62be-2d8e-4f8d-a4bf-4fbc01e01b50" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_6ab14a61-9192-45a0-be82-216a4caa51f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#IncomeTaxesExpectedExpiryDatesofNOLsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_88da1067-c7c9-402d-9079-67a79b73fa4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_76c09773-bf64-4996-932b-80059aa6646d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_88da1067-c7c9-402d-9079-67a79b73fa4c" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_76c09773-bf64-4996-932b-80059aa6646d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_72b2124f-876b-4334-8f39-ceb91c3bc4b8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_76c09773-bf64-4996-932b-80059aa6646d" xlink:to="loc_srt_StatementGeographicalAxis_72b2124f-876b-4334-8f39-ceb91c3bc4b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1510de63-5c86-46f8-a16e-105548c91945" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_72b2124f-876b-4334-8f39-ceb91c3bc4b8" xlink:to="loc_srt_SegmentGeographicalDomain_1510de63-5c86-46f8-a16e-105548c91945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_c7f27f15-aa0e-4aab-9b6f-5136ef7bed0d" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1510de63-5c86-46f8-a16e-105548c91945" xlink:to="loc_country_US_c7f27f15-aa0e-4aab-9b6f-5136ef7bed0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_39489fe5-5a01-49fe-abe5-8d9d3bee6aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_76c09773-bf64-4996-932b-80059aa6646d" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_39489fe5-5a01-49fe-abe5-8d9d3bee6aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_b3a224e4-f189-4a33-b9ce-badeceeedcdb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_39489fe5-5a01-49fe-abe5-8d9d3bee6aa5" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_b3a224e4-f189-4a33-b9ce-badeceeedcdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_50626858-a155-46c1-bbbf-bc53952821e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_b3a224e4-f189-4a33-b9ce-badeceeedcdb" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_50626858-a155-46c1-bbbf-bc53952821e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_08786c55-4203-45e2-8fd1-4fc398beab65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_76c09773-bf64-4996-932b-80059aa6646d" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_08786c55-4203-45e2-8fd1-4fc398beab65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_00899fbe-6e8c-48ab-b613-860e4aae8032" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_08786c55-4203-45e2-8fd1-4fc398beab65" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_00899fbe-6e8c-48ab-b613-860e4aae8032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_67b8ecab-9d23-4379-bb32-d74b7b0b56d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_00899fbe-6e8c-48ab-b613-860e4aae8032" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_67b8ecab-9d23-4379-bb32-d74b7b0b56d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_e72c5769-bc17-49e6-91ee-4d4a4553b16c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_76c09773-bf64-4996-932b-80059aa6646d" xlink:to="loc_us-gaap_TaxPeriodAxis_e72c5769-bc17-49e6-91ee-4d4a4553b16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_adc8afa3-9fe9-4404-a2db-ee9fa5ea1167" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_e72c5769-bc17-49e6-91ee-4d4a4553b16c" xlink:to="loc_us-gaap_TaxPeriodDomain_adc8afa3-9fe9-4404-a2db-ee9fa5ea1167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear2025To2038Member_dbdc0d9e-210b-4c40-b9a6-a7f39b8f7959" xlink:href="iclr-20241231.xsd#iclr_TaxYear2025To2038Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_adc8afa3-9fe9-4404-a2db-ee9fa5ea1167" xlink:to="loc_iclr_TaxYear2025To2038Member_dbdc0d9e-210b-4c40-b9a6-a7f39b8f7959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_TaxYear20392043Member_762363d7-61b9-4a37-b339-3ff869587974" xlink:href="iclr-20241231.xsd#iclr_TaxYear20392043Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_adc8afa3-9fe9-4404-a2db-ee9fa5ea1167" xlink:to="loc_iclr_TaxYear20392043Member_762363d7-61b9-4a37-b339-3ff869587974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_381ed4c2-1c55-4356-992b-2427e5ae5904" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_76c09773-bf64-4996-932b-80059aa6646d" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_381ed4c2-1c55-4356-992b-2427e5ae5904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_18ee5ba6-0ca4-47d9-8eb1-86bbb9bdf441" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_381ed4c2-1c55-4356-992b-2427e5ae5904" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_18ee5ba6-0ca4-47d9-8eb1-86bbb9bdf441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_b3ecc409-0d8a-498e-91dc-565192df5de6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_381ed4c2-1c55-4356-992b-2427e5ae5904" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_b3ecc409-0d8a-498e-91dc-565192df5de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1d2b7034-ce13-4f6f-ab95-00b8a98ba7c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_381ed4c2-1c55-4356-992b-2427e5ae5904" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1d2b7034-ce13-4f6f-ab95-00b8a98ba7c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_30884e9e-61d3-419c-a8e8-c92983a37c70" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2e50c756-18c1-4008-8763-2c7d5478f3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_30884e9e-61d3-419c-a8e8-c92983a37c70" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2e50c756-18c1-4008-8763-2c7d5478f3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_a1de82c1-0ff1-47aa-b174-682be5a71d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2e50c756-18c1-4008-8763-2c7d5478f3e0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_a1de82c1-0ff1-47aa-b174-682be5a71d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_e4144eea-5d90-47d3-b587-e4c12eeeb3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2e50c756-18c1-4008-8763-2c7d5478f3e0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_e4144eea-5d90-47d3-b587-e4c12eeeb3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_b59a04c6-cd44-4d67-9469-b5f9ac69128b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2e50c756-18c1-4008-8763-2c7d5478f3e0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_b59a04c6-cd44-4d67-9469-b5f9ac69128b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_b132ac49-8d0f-4435-b46e-2beaf1ed354e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2e50c756-18c1-4008-8763-2c7d5478f3e0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_b132ac49-8d0f-4435-b46e-2beaf1ed354e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_e88b829e-e13f-458f-8640-7897f100073e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2e50c756-18c1-4008-8763-2c7d5478f3e0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_e88b829e-e13f-458f-8640-7897f100073e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_6ebec14a-b5a1-4950-b353-bbad2da80f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_2e50c756-18c1-4008-8763-2c7d5478f3e0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_6ebec14a-b5a1-4950-b353-bbad2da80f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_09e83e28-11b3-46c7-b525-514b8e6b712c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_9e98ae29-7e8e-437e-89b0-56f174661a86" xlink:href="iclr-20241231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_09e83e28-11b3-46c7-b525-514b8e6b712c" xlink:to="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_9e98ae29-7e8e-437e-89b0-56f174661a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9a600aec-928d-470f-8d6c-4c566e1b2fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_9e98ae29-7e8e-437e-89b0-56f174661a86" xlink:to="loc_us-gaap_AwardTypeAxis_9a600aec-928d-470f-8d6c-4c566e1b2fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67f3a34f-eb1c-43f5-8017-d5ca7bf25587" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9a600aec-928d-470f-8d6c-4c566e1b2fd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67f3a34f-eb1c-43f5-8017-d5ca7bf25587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsStockPlan2008PlanMember_a2e1453e-25a7-4e23-9583-5cbacee21938" xlink:href="iclr-20241231.xsd#iclr_ConsultantsStockPlan2008PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67f3a34f-eb1c-43f5-8017-d5ca7bf25587" xlink:to="loc_iclr_ConsultantsStockPlan2008PlanMember_a2e1453e-25a7-4e23-9583-5cbacee21938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_26dd4930-37ef-4a8d-bd69-25ce8e1220da" xlink:href="iclr-20241231.xsd#iclr_EmployeeStockPlanTwentyZeroEightPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67f3a34f-eb1c-43f5-8017-d5ca7bf25587" xlink:to="loc_iclr_EmployeeStockPlanTwentyZeroEightPlanMember_26dd4930-37ef-4a8d-bd69-25ce8e1220da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OptionPlans2008Member_5873529b-eb4e-4e5c-b092-b9bd0c309f62" xlink:href="iclr-20241231.xsd#iclr_OptionPlans2008Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67f3a34f-eb1c-43f5-8017-d5ca7bf25587" xlink:to="loc_iclr_OptionPlans2008Member_5873529b-eb4e-4e5c-b092-b9bd0c309f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_8e8ac3c3-7e0a-4fdd-b25d-47ff1758a344" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67f3a34f-eb1c-43f5-8017-d5ca7bf25587" xlink:to="loc_us-gaap_EmployeeStockOptionMember_8e8ac3c3-7e0a-4fdd-b25d-47ff1758a344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestrictedStockUnitsTwentyThirteenMember_11aee2b6-fd15-4c52-affd-e0c0aa088a5b" xlink:href="iclr-20241231.xsd#iclr_RestrictedStockUnitsTwentyThirteenMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67f3a34f-eb1c-43f5-8017-d5ca7bf25587" xlink:to="loc_iclr_RestrictedStockUnitsTwentyThirteenMember_11aee2b6-fd15-4c52-affd-e0c0aa088a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_e08c2816-7e2f-4c79-bdc3-9379ed27b472" xlink:href="iclr-20241231.xsd#iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67f3a34f-eb1c-43f5-8017-d5ca7bf25587" xlink:to="loc_iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember_e08c2816-7e2f-4c79-bdc3-9379ed27b472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e1318f12-350b-4fe7-90f9-f69a4bc5e92b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67f3a34f-eb1c-43f5-8017-d5ca7bf25587" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e1318f12-350b-4fe7-90f9-f69a4bc5e92b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_7c5a0aa0-3799-4e6a-9ab8-5eede1696792" xlink:href="iclr-20241231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67f3a34f-eb1c-43f5-8017-d5ca7bf25587" xlink:to="loc_iclr_PerformanceShareUnitMember_7c5a0aa0-3799-4e6a-9ab8-5eede1696792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceBasedGrantsMember_c8774271-1aaa-465f-b2e2-2a57b3e0582c" xlink:href="iclr-20241231.xsd#iclr_PerformanceBasedGrantsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67f3a34f-eb1c-43f5-8017-d5ca7bf25587" xlink:to="loc_iclr_PerformanceBasedGrantsMember_c8774271-1aaa-465f-b2e2-2a57b3e0582c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_60bb47a4-3749-475b-8a40-ac3a56dd721b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_9e98ae29-7e8e-437e-89b0-56f174661a86" xlink:to="loc_us-gaap_AwardDateAxis_60bb47a4-3749-475b-8a40-ac3a56dd721b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_2748e620-94e3-4d61-968d-d3d1caf56c05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateAxis_60bb47a4-3749-475b-8a40-ac3a56dd721b" xlink:to="loc_us-gaap_AwardDateDomain_2748e620-94e3-4d61-968d-d3d1caf56c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AwardDateAllYearsExcluding2018Member_7b2b82e1-7c3b-4b7a-a715-4a5a8cc28922" xlink:href="iclr-20241231.xsd#iclr_AwardDateAllYearsExcluding2018Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_2748e620-94e3-4d61-968d-d3d1caf56c05" xlink:to="loc_iclr_AwardDateAllYearsExcluding2018Member_7b2b82e1-7c3b-4b7a-a715-4a5a8cc28922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3662af9d-86f4-4c04-a7c8-54761959c660" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_9e98ae29-7e8e-437e-89b0-56f174661a86" xlink:to="loc_srt_RangeAxis_3662af9d-86f4-4c04-a7c8-54761959c660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c27d77ec-9b9c-4672-afe4-b16081c61c95" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3662af9d-86f4-4c04-a7c8-54761959c660" xlink:to="loc_srt_RangeMember_c27d77ec-9b9c-4672-afe4-b16081c61c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_91fc57fc-f586-4419-8470-4180f9be54d2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c27d77ec-9b9c-4672-afe4-b16081c61c95" xlink:to="loc_srt_MinimumMember_91fc57fc-f586-4419-8470-4180f9be54d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a7749c83-d44f-4e1c-b0f5-dbacee68dc64" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c27d77ec-9b9c-4672-afe4-b16081c61c95" xlink:to="loc_srt_MaximumMember_a7749c83-d44f-4e1c-b0f5-dbacee68dc64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_38c565ed-0bd9-4f17-a7a2-28f18c47ae3d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_9e98ae29-7e8e-437e-89b0-56f174661a86" xlink:to="loc_us-gaap_PlanNameAxis_38c565ed-0bd9-4f17-a7a2-28f18c47ae3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_30f55a18-2156-4c44-8f4a-db761587eb95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_38c565ed-0bd9-4f17-a7a2-28f18c47ae3d" xlink:to="loc_us-gaap_PlanNameDomain_30f55a18-2156-4c44-8f4a-db761587eb95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2020LegacyPRAPlanMember_b5cff786-e8a9-4fa9-980d-582c9d9d10d4" xlink:href="iclr-20241231.xsd#iclr_The2020LegacyPRAPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_30f55a18-2156-4c44-8f4a-db761587eb95" xlink:to="loc_iclr_The2020LegacyPRAPlanMember_b5cff786-e8a9-4fa9-980d-582c9d9d10d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_The2018LegacyPRAPlanMember_b5ed21fb-306c-4b37-9871-32b7f2ac80d7" xlink:href="iclr-20241231.xsd#iclr_The2018LegacyPRAPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_30f55a18-2156-4c44-8f4a-db761587eb95" xlink:to="loc_iclr_The2018LegacyPRAPlanMember_b5ed21fb-306c-4b37-9871-32b7f2ac80d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_22c50c33-c21d-4e0f-b778-cd6b6e2303f0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_9e98ae29-7e8e-437e-89b0-56f174661a86" xlink:to="loc_srt_TitleOfIndividualAxis_22c50c33-c21d-4e0f-b778-cd6b6e2303f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a54792cf-40ff-49e1-be11-86d822f9ab60" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_22c50c33-c21d-4e0f-b778-cd6b6e2303f0" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a54792cf-40ff-49e1-be11-86d822f9ab60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_NonexecutiveDirectorMember_0b0c95e5-0813-402c-866c-9020195337d5" xlink:href="iclr-20241231.xsd#iclr_NonexecutiveDirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_a54792cf-40ff-49e1-be11-86d822f9ab60" xlink:to="loc_iclr_NonexecutiveDirectorMember_0b0c95e5-0813-402c-866c-9020195337d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:href="iclr-20241231.xsd#iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable_9e98ae29-7e8e-437e-89b0-56f174661a86" xlink:to="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_6e1c6a72-2d6d-41c2-8ec6-b9433c23b8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_6e1c6a72-2d6d-41c2-8ec6-b9433c23b8ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_1287f74f-cb60-4ce3-95a5-b4329de1574e" xlink:href="iclr-20241231.xsd#iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted_1287f74f-cb60-4ce3-95a5-b4329de1574e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_5d0db95f-847e-4868-b076-7f2eaf342fec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_5d0db95f-847e-4868-b076-7f2eaf342fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_afe50aaf-dba0-459a-88c2-7a4664c90bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_afe50aaf-dba0-459a-88c2-7a4664c90bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8f347ad3-fad4-4d7b-95bc-08ff7abdef2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8f347ad3-fad4-4d7b-95bc-08ff7abdef2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_33415ed2-d67d-44cd-af2d-f805cab42ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_33415ed2-d67d-44cd-af2d-f805cab42ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0eb2cd86-847a-429b-b68d-9c04b32b721d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0eb2cd86-847a-429b-b68d-9c04b32b721d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_d2508081-e4ab-4328-9470-3137c974d5b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_d2508081-e4ab-4328-9470-3137c974d5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_fae0bbac-ae56-4540-9e21-dd95579ca990" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_fae0bbac-ae56-4540-9e21-dd95579ca990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_144b9962-9718-4f66-a084-006bbe79e0ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_144b9962-9718-4f66-a084-006bbe79e0ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_be0ee5db-8719-4719-bd53-11e7519c224e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_be0ee5db-8719-4719-bd53-11e7519c224e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_dc20d9ba-d55a-4061-a2aa-1d9b668b675c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_dc20d9ba-d55a-4061-a2aa-1d9b668b675c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_65dcfbb6-0114-468e-80c5-1515fa8bc475" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_65dcfbb6-0114-468e-80c5-1515fa8bc475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_4e694372-5d0d-4013-9515-bc71ebd65741" xlink:href="iclr-20241231.xsd#iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare_4e694372-5d0d-4013-9515-bc71ebd65741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_326168de-e5fd-4186-ab1e-f88935e2f69c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_326168de-e5fd-4186-ab1e-f88935e2f69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_cc2d6e88-7734-41ac-97be-b8b8c47198eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_ShareBasedCompensation_cc2d6e88-7734-41ac-97be-b8b8c47198eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4edbded7-30c5-467e-9e9c-03ed9f19bb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4edbded7-30c5-467e-9e9c-03ed9f19bb7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_3a563630-1ba7-46eb-bd0f-fe8bb2a34ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_3a563630-1ba7-46eb-bd0f-fe8bb2a34ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_127ee9f4-89dd-41b2-9d84-2a8328a81be0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_127ee9f4-89dd-41b2-9d84-2a8328a81be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_5047d56d-1e8c-4248-8e0e-8b8ce0e57e81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems_9603b7d6-431e-422f-bf88-29ec04b50994" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_5047d56d-1e8c-4248-8e0e-8b8ce0e57e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_22509384-8bb7-4581-b8d5-f7d49c1d1c86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_88b462ee-9f72-4704-b7ce-45e3386dce3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_22509384-8bb7-4581-b8d5-f7d49c1d1c86" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_88b462ee-9f72-4704-b7ce-45e3386dce3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e02abc22-2fe8-48a3-a1c4-8dbf2923d437" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_88b462ee-9f72-4704-b7ce-45e3386dce3c" xlink:to="loc_us-gaap_AwardTypeAxis_e02abc22-2fe8-48a3-a1c4-8dbf2923d437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8cf4049b-1e1e-46ae-b137-08e32ca8e3b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e02abc22-2fe8-48a3-a1c4-8dbf2923d437" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8cf4049b-1e1e-46ae-b137-08e32ca8e3b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_StockOptionAndAwardPlansMember_9496e3ab-ba0c-493b-b8c6-f1b087f9f377" xlink:href="iclr-20241231.xsd#iclr_StockOptionAndAwardPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8cf4049b-1e1e-46ae-b137-08e32ca8e3b6" xlink:to="loc_iclr_StockOptionAndAwardPlansMember_9496e3ab-ba0c-493b-b8c6-f1b087f9f377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71f57f2d-43c9-45cc-80cd-e50dde2c1d40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_88b462ee-9f72-4704-b7ce-45e3386dce3c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71f57f2d-43c9-45cc-80cd-e50dde2c1d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6f46fd17-2f4d-4f38-8d84-5f39b89c21eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71f57f2d-43c9-45cc-80cd-e50dde2c1d40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6f46fd17-2f4d-4f38-8d84-5f39b89c21eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6c4ba641-75dc-4bfc-a863-f503bd8a3987" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6f46fd17-2f4d-4f38-8d84-5f39b89c21eb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6c4ba641-75dc-4bfc-a863-f503bd8a3987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a99f26d3-f711-48b1-a9e8-3f1af12e5f04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6f46fd17-2f4d-4f38-8d84-5f39b89c21eb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a99f26d3-f711-48b1-a9e8-3f1af12e5f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_dd053709-56da-4a02-be93-6342f5a5b32b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6f46fd17-2f4d-4f38-8d84-5f39b89c21eb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_dd053709-56da-4a02-be93-6342f5a5b32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_0cb2600b-c43b-43f3-a27b-2e995677251c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6f46fd17-2f4d-4f38-8d84-5f39b89c21eb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_0cb2600b-c43b-43f3-a27b-2e995677251c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6de8277d-95f1-4e2a-a962-333e33f95762" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6f46fd17-2f4d-4f38-8d84-5f39b89c21eb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6de8277d-95f1-4e2a-a962-333e33f95762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_243ca285-777f-4a56-9016-43aeb95f73ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71f57f2d-43c9-45cc-80cd-e50dde2c1d40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_243ca285-777f-4a56-9016-43aeb95f73ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_619e4c2f-8939-4c46-9b6f-28dfd2e3da21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71f57f2d-43c9-45cc-80cd-e50dde2c1d40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_619e4c2f-8939-4c46-9b6f-28dfd2e3da21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_49f796e6-e269-4f3d-be44-82ffc71ae49a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_619e4c2f-8939-4c46-9b6f-28dfd2e3da21" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_49f796e6-e269-4f3d-be44-82ffc71ae49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_90bb8ff7-48c4-47e3-9232-034a0a60dbee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_619e4c2f-8939-4c46-9b6f-28dfd2e3da21" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_90bb8ff7-48c4-47e3-9232-034a0a60dbee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a1a14c36-4b27-4d89-baee-db1db41e03f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_619e4c2f-8939-4c46-9b6f-28dfd2e3da21" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a1a14c36-4b27-4d89-baee-db1db41e03f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_e23291b3-491e-48e2-99bd-1c5a4b9fc1de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_619e4c2f-8939-4c46-9b6f-28dfd2e3da21" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_e23291b3-491e-48e2-99bd-1c5a4b9fc1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9d7b169a-7f72-48e6-9514-60b51f1aafac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_619e4c2f-8939-4c46-9b6f-28dfd2e3da21" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9d7b169a-7f72-48e6-9514-60b51f1aafac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_d874015b-7e6f-44f8-9f50-26cda9ac6c91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_71f57f2d-43c9-45cc-80cd-e50dde2c1d40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_d874015b-7e6f-44f8-9f50-26cda9ac6c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_033f69c1-65a1-46ae-a03d-4b82500e9ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_044aaabc-3936-490a-835d-bd022b9d5924" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_033f69c1-65a1-46ae-a03d-4b82500e9ac0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_044aaabc-3936-490a-835d-bd022b9d5924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b1101c2b-d17e-431a-8927-b727bfae4d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_044aaabc-3936-490a-835d-bd022b9d5924" xlink:to="loc_us-gaap_AwardTypeAxis_b1101c2b-d17e-431a-8927-b727bfae4d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_44cf96a5-168d-4cf7-a5d6-e61c70ed6bec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b1101c2b-d17e-431a-8927-b727bfae4d0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_44cf96a5-168d-4cf7-a5d6-e61c70ed6bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9017d326-5382-4f37-8395-689da8a0940a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_44cf96a5-168d-4cf7-a5d6-e61c70ed6bec" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9017d326-5382-4f37-8395-689da8a0940a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dacce0ac-69e2-4983-93cc-2508a7d84deb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_044aaabc-3936-490a-835d-bd022b9d5924" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dacce0ac-69e2-4983-93cc-2508a7d84deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ab3051e7-0757-40a4-9127-853481a8d84c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dacce0ac-69e2-4983-93cc-2508a7d84deb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ab3051e7-0757-40a4-9127-853481a8d84c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_583dad55-5f3e-4258-af4a-b96069f5d60c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_dacce0ac-69e2-4983-93cc-2508a7d84deb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_583dad55-5f3e-4258-af4a-b96069f5d60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_36ff31ea-356c-4edb-af56-6a5eb2968e28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_583dad55-5f3e-4258-af4a-b96069f5d60c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_36ff31ea-356c-4edb-af56-6a5eb2968e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f95b2921-0de3-4ec4-a65d-f16ee7f7db75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_583dad55-5f3e-4258-af4a-b96069f5d60c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f95b2921-0de3-4ec4-a65d-f16ee7f7db75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6d22f51c-a0d4-4ad7-a56d-7cd0ce034587" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_583dad55-5f3e-4258-af4a-b96069f5d60c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6d22f51c-a0d4-4ad7-a56d-7cd0ce034587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_04f8b288-6b96-4242-91fd-bfcf3de4c935" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_583dad55-5f3e-4258-af4a-b96069f5d60c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_04f8b288-6b96-4242-91fd-bfcf3de4c935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_64d18dbe-281d-4a5c-93d1-3310db7a6c68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e57b7a49-e77e-4e1d-a332-5dfa57a46508" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_64d18dbe-281d-4a5c-93d1-3310db7a6c68" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e57b7a49-e77e-4e1d-a332-5dfa57a46508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6857aae0-c08a-4850-98d8-2a928ff2afcd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e57b7a49-e77e-4e1d-a332-5dfa57a46508" xlink:to="loc_us-gaap_AwardTypeAxis_6857aae0-c08a-4850-98d8-2a928ff2afcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2cc7fbaf-a726-4c2b-843a-88aee23597e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6857aae0-c08a-4850-98d8-2a928ff2afcd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2cc7fbaf-a726-4c2b-843a-88aee23597e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_PerformanceShareUnitMember_da06b986-1ff1-4f6e-8f42-afd4dbe5268a" xlink:href="iclr-20241231.xsd#iclr_PerformanceShareUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2cc7fbaf-a726-4c2b-843a-88aee23597e8" xlink:to="loc_iclr_PerformanceShareUnitMember_da06b986-1ff1-4f6e-8f42-afd4dbe5268a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_428ed8cd-036c-4368-a530-5106fb16c8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2cc7fbaf-a726-4c2b-843a-88aee23597e8" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_428ed8cd-036c-4368-a530-5106fb16c8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1671ab7f-b147-4a54-943d-d80a0ec5264a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e57b7a49-e77e-4e1d-a332-5dfa57a46508" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1671ab7f-b147-4a54-943d-d80a0ec5264a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6d4e35ff-d023-47ef-89f1-209924473da0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1671ab7f-b147-4a54-943d-d80a0ec5264a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6d4e35ff-d023-47ef-89f1-209924473da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_34b6538f-854c-4f37-8c6a-364b59322aed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6d4e35ff-d023-47ef-89f1-209924473da0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_34b6538f-854c-4f37-8c6a-364b59322aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9fd98c4c-15f5-447c-b22d-e433c6254816" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6d4e35ff-d023-47ef-89f1-209924473da0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9fd98c4c-15f5-447c-b22d-e433c6254816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0593077b-f883-46f7-a334-a72788dc3358" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6d4e35ff-d023-47ef-89f1-209924473da0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0593077b-f883-46f7-a334-a72788dc3358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_05cc92d9-2151-43bd-bcb3-4821e6613c93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6d4e35ff-d023-47ef-89f1-209924473da0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_05cc92d9-2151-43bd-bcb3-4821e6613c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b075a438-27dc-4c50-930a-653a745e327b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6d4e35ff-d023-47ef-89f1-209924473da0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b075a438-27dc-4c50-930a-653a745e327b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c44a9f3-d941-4579-960f-b29bb424e1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1671ab7f-b147-4a54-943d-d80a0ec5264a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c44a9f3-d941-4579-960f-b29bb424e1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5c9085e1-7e9d-427d-9c3d-26c82720ba7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c44a9f3-d941-4579-960f-b29bb424e1cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5c9085e1-7e9d-427d-9c3d-26c82720ba7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bca39b6e-beca-47ce-9bb7-5ca7ebd995d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c44a9f3-d941-4579-960f-b29bb424e1cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bca39b6e-beca-47ce-9bb7-5ca7ebd995d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e4403c1c-065e-4e0b-b2cc-1c4842cdf177" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c44a9f3-d941-4579-960f-b29bb424e1cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e4403c1c-065e-4e0b-b2cc-1c4842cdf177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_69e6850f-31ec-4220-b718-954c353b2b69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c44a9f3-d941-4579-960f-b29bb424e1cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_69e6850f-31ec-4220-b718-954c353b2b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_aa254cb3-e700-4f21-9f31-1bbe60ad1d31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4c44a9f3-d941-4579-960f-b29bb424e1cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_aa254cb3-e700-4f21-9f31-1bbe60ad1d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a24190e7-7a27-47a5-9e29-fd7906641021" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_391ab7e1-b745-47db-868b-9c9c6907d8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a24190e7-7a27-47a5-9e29-fd7906641021" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_391ab7e1-b745-47db-868b-9c9c6907d8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b823719d-3a40-4da4-92eb-7ff580fad7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_391ab7e1-b745-47db-868b-9c9c6907d8e2" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b823719d-3a40-4da4-92eb-7ff580fad7dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_912acb56-9df4-4f6c-8bac-c7685ce9172f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b823719d-3a40-4da4-92eb-7ff580fad7dd" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_912acb56-9df4-4f6c-8bac-c7685ce9172f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_a49344b3-aef8-4898-a06b-9a7060701fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_912acb56-9df4-4f6c-8bac-c7685ce9172f" xlink:to="loc_us-gaap_CostOfSalesMember_a49344b3-aef8-4898-a06b-9a7060701fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3381d8f1-432a-4b71-9769-7004000259f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_912acb56-9df4-4f6c-8bac-c7685ce9172f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3381d8f1-432a-4b71-9769-7004000259f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6394b714-febf-4af5-8031-843a00e62dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_391ab7e1-b745-47db-868b-9c9c6907d8e2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6394b714-febf-4af5-8031-843a00e62dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c865b7c4-0f60-45fc-899a-7e76112e0c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6394b714-febf-4af5-8031-843a00e62dfd" xlink:to="loc_us-gaap_ShareBasedCompensation_c865b7c4-0f60-45fc-899a-7e76112e0c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BusinessSegmentandGeographicalInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_2f282e7d-6822-49bc-9706-a71d97b5f350" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_297a273e-42b7-475b-9a6b-0b41cff69bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2f282e7d-6822-49bc-9706-a71d97b5f350" xlink:to="loc_us-gaap_NumberOfOperatingSegments_297a273e-42b7-475b-9a6b-0b41cff69bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b4ad2a05-689b-4f7a-a0e8-6dd96b6509a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_32258760-ce77-4dde-bc74-df30c8848a14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b4ad2a05-689b-4f7a-a0e8-6dd96b6509a4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_32258760-ce77-4dde-bc74-df30c8848a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_230161a0-6707-486e-b207-8f364f3ea3dd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_32258760-ce77-4dde-bc74-df30c8848a14" xlink:to="loc_srt_StatementGeographicalAxis_230161a0-6707-486e-b207-8f364f3ea3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8a5fbd7a-bc2a-424e-8bca-60f11d800f34" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_230161a0-6707-486e-b207-8f364f3ea3dd" xlink:to="loc_srt_SegmentGeographicalDomain_8a5fbd7a-bc2a-424e-8bca-60f11d800f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_735499f6-005c-4029-bf6e-e3a5417b3d49" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8a5fbd7a-bc2a-424e-8bca-60f11d800f34" xlink:to="loc_country_IE_735499f6-005c-4029-bf6e-e3a5417b3d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_82ef508e-7537-4481-b4c4-06a95c2328f0" xlink:href="iclr-20241231.xsd#iclr_RestOfEuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8a5fbd7a-bc2a-424e-8bca-60f11d800f34" xlink:to="loc_iclr_RestOfEuropeMember_82ef508e-7537-4481-b4c4-06a95c2328f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d82c702b-e46a-4756-a7b3-824974621ef5" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8a5fbd7a-bc2a-424e-8bca-60f11d800f34" xlink:to="loc_country_US_d82c702b-e46a-4756-a7b3-824974621ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_47e4e333-ab80-4952-8a23-1516cbd395b0" xlink:href="iclr-20241231.xsd#iclr_OtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8a5fbd7a-bc2a-424e-8bca-60f11d800f34" xlink:to="loc_iclr_OtherCountriesMember_47e4e333-ab80-4952-8a23-1516cbd395b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_09f2e1fc-7ffc-4b6e-bb7f-3e43087934b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_32258760-ce77-4dde-bc74-df30c8848a14" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_09f2e1fc-7ffc-4b6e-bb7f-3e43087934b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f14af1ac-6976-4233-992b-6f68fab96c89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_09f2e1fc-7ffc-4b6e-bb7f-3e43087934b5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f14af1ac-6976-4233-992b-6f68fab96c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_1f144ab9-3a7b-4b6e-b370-c14c35e1d9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90c49366-4abb-44b4-9f19-813f5ab9bd98" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1f144ab9-3a7b-4b6e-b370-c14c35e1d9c5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90c49366-4abb-44b4-9f19-813f5ab9bd98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6e310de6-52d0-4f9c-ba05-1d0058271a22" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90c49366-4abb-44b4-9f19-813f5ab9bd98" xlink:to="loc_srt_StatementGeographicalAxis_6e310de6-52d0-4f9c-ba05-1d0058271a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7bdc8b34-f116-4531-9146-22ac6b991274" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_6e310de6-52d0-4f9c-ba05-1d0058271a22" xlink:to="loc_srt_SegmentGeographicalDomain_7bdc8b34-f116-4531-9146-22ac6b991274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_77df67cb-39eb-42d5-baae-5f83b2630928" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7bdc8b34-f116-4531-9146-22ac6b991274" xlink:to="loc_country_IE_77df67cb-39eb-42d5-baae-5f83b2630928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_bc8d9fe5-cd68-43e4-b405-6b7e250f686c" xlink:href="iclr-20241231.xsd#iclr_RestOfEuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7bdc8b34-f116-4531-9146-22ac6b991274" xlink:to="loc_iclr_RestOfEuropeMember_bc8d9fe5-cd68-43e4-b405-6b7e250f686c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_7a51fe6a-5010-4379-af39-209bc2ad3ef7" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7bdc8b34-f116-4531-9146-22ac6b991274" xlink:to="loc_country_US_7a51fe6a-5010-4379-af39-209bc2ad3ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_8d6bc909-6baa-4c9d-8021-192c60b797df" xlink:href="iclr-20241231.xsd#iclr_OtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7bdc8b34-f116-4531-9146-22ac6b991274" xlink:to="loc_iclr_OtherCountriesMember_8d6bc909-6baa-4c9d-8021-192c60b797df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_43d5c019-1368-45f2-8758-0043cd05dc9d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90c49366-4abb-44b4-9f19-813f5ab9bd98" xlink:to="loc_srt_ConsolidationItemsAxis_43d5c019-1368-45f2-8758-0043cd05dc9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c74b8684-1448-4845-96f3-7841a58314dd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_43d5c019-1368-45f2-8758-0043cd05dc9d" xlink:to="loc_srt_ConsolidationItemsDomain_c74b8684-1448-4845-96f3-7841a58314dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_89ff1b2b-cce3-4e84-83b2-b7b9da60291c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_c74b8684-1448-4845-96f3-7841a58314dd" xlink:to="loc_us-gaap_OperatingSegmentsMember_89ff1b2b-cce3-4e84-83b2-b7b9da60291c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_7cc2bbe5-129c-47ea-aae1-162f58d9ff9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_90c49366-4abb-44b4-9f19-813f5ab9bd98" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_7cc2bbe5-129c-47ea-aae1-162f58d9ff9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5d9d5ec9-6a6b-4cc3-8369-8bf6ab3b332a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7cc2bbe5-129c-47ea-aae1-162f58d9ff9a" xlink:to="loc_us-gaap_OperatingIncomeLoss_5d9d5ec9-6a6b-4cc3-8369-8bf6ab3b332a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ac5eab6e-9ca4-4101-acf3-9436d1da8f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7cc2bbe5-129c-47ea-aae1-162f58d9ff9a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ac5eab6e-9ca4-4101-acf3-9436d1da8f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3a7423b2-4ca0-40b5-8f52-9adc29370a23" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5b473a00-8e0f-488e-b360-e1b6078d3aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3a7423b2-4ca0-40b5-8f52-9adc29370a23" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5b473a00-8e0f-488e-b360-e1b6078d3aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d07a8e2d-0f0c-4f57-8678-74ce809439c7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5b473a00-8e0f-488e-b360-e1b6078d3aa8" xlink:to="loc_srt_StatementGeographicalAxis_d07a8e2d-0f0c-4f57-8678-74ce809439c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_55158803-0ad1-4dc4-a17b-c0bf86889c73" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_d07a8e2d-0f0c-4f57-8678-74ce809439c7" xlink:to="loc_srt_SegmentGeographicalDomain_55158803-0ad1-4dc4-a17b-c0bf86889c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_4ddc6578-c5f7-44ac-8bab-87bcfe0e46d0" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_55158803-0ad1-4dc4-a17b-c0bf86889c73" xlink:to="loc_country_IE_4ddc6578-c5f7-44ac-8bab-87bcfe0e46d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_RestOfEuropeMember_d756ea91-b24e-4e72-92c4-2a7726adc41c" xlink:href="iclr-20241231.xsd#iclr_RestOfEuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_55158803-0ad1-4dc4-a17b-c0bf86889c73" xlink:to="loc_iclr_RestOfEuropeMember_d756ea91-b24e-4e72-92c4-2a7726adc41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_c1537fdb-b388-4895-8d34-c5a18e0e7e12" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_55158803-0ad1-4dc4-a17b-c0bf86889c73" xlink:to="loc_country_US_c1537fdb-b388-4895-8d34-c5a18e0e7e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_OtherCountriesMember_0871aa0a-1f2a-4cfe-8ce7-2efeca4257fe" xlink:href="iclr-20241231.xsd#iclr_OtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_55158803-0ad1-4dc4-a17b-c0bf86889c73" xlink:to="loc_iclr_OtherCountriesMember_0871aa0a-1f2a-4cfe-8ce7-2efeca4257fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_685c30cd-02a4-4c3f-9087-c102e3368530" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5b473a00-8e0f-488e-b360-e1b6078d3aa8" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_685c30cd-02a4-4c3f-9087-c102e3368530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_fed06f5b-7da0-43bd-ba03-3b7441691aee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_685c30cd-02a4-4c3f-9087-c102e3368530" xlink:to="loc_us-gaap_NoncurrentAssets_fed06f5b-7da0-43bd-ba03-3b7441691aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1eb42ba7-9de6-4dec-a23a-1d6bbeeb2607" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f957e268-4dc9-4444-838b-1d489bedcdb0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1eb42ba7-9de6-4dec-a23a-1d6bbeeb2607" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f957e268-4dc9-4444-838b-1d489bedcdb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_551171bf-6416-4446-966c-1d7b56db8cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1eb42ba7-9de6-4dec-a23a-1d6bbeeb2607" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_551171bf-6416-4446-966c-1d7b56db8cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b94f6d50-bb03-493f-a4a3-245ea664f1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1eb42ba7-9de6-4dec-a23a-1d6bbeeb2607" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b94f6d50-bb03-493f-a4a3-245ea664f1ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_869fab02-fd07-463a-ae23-1766ba9b984d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_6cf626b8-f2c7-4cd8-8ec4-c3ed85d43608" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_869fab02-fd07-463a-ae23-1766ba9b984d" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_6cf626b8-f2c7-4cd8-8ec4-c3ed85d43608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_36073c32-2277-4bed-ae46-a6ecbe1f6176" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_6cf626b8-f2c7-4cd8-8ec4-c3ed85d43608" xlink:to="loc_us-gaap_EarningsPerShareBasic_36073c32-2277-4bed-ae46-a6ecbe1f6176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5548562a-6bd7-49a6-a13a-99204be3ae85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_6cf626b8-f2c7-4cd8-8ec4-c3ed85d43608" xlink:to="loc_us-gaap_EarningsPerShareDiluted_5548562a-6bd7-49a6-a13a-99204be3ae85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_a73f95ee-0d39-43e4-b312-cda28209ba18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_a5372f87-e2d6-46eb-b027-27680be7ddcf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_a73f95ee-0d39-43e4-b312-cda28209ba18" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_a5372f87-e2d6-46eb-b027-27680be7ddcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_c4111f0f-337a-4b08-8c07-c8fc52d7827f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_a73f95ee-0d39-43e4-b312-cda28209ba18" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_c4111f0f-337a-4b08-8c07-c8fc52d7827f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax_0951ae71-80c9-4b68-88ee-6f7469fdf7cf" xlink:href="iclr-20241231.xsd#iclr_AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_a73f95ee-0d39-43e4-b312-cda28209ba18" xlink:to="loc_iclr_AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax_0951ae71-80c9-4b68-88ee-6f7469fdf7cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e82bd2bc-3645-45df-a2dd-0efa171cce54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_a73f95ee-0d39-43e4-b312-cda28209ba18" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e82bd2bc-3645-45df-a2dd-0efa171cce54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#SupplementalDisclosureofCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_e97dc3dc-8702-4bd0-b956-5c2874a2a577" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_4ca064f4-d7b3-434f-aef3-cfe2c595c710" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_e97dc3dc-8702-4bd0-b956-5c2874a2a577" xlink:to="loc_us-gaap_InterestPaidNet_4ca064f4-d7b3-434f-aef3-cfe2c595c710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_6eca3a43-8265-42c4-8fac-cabd910373f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_e97dc3dc-8702-4bd0-b956-5c2874a2a577" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_6eca3a43-8265-42c4-8fac-cabd910373f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/RelatedPartiesDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#RelatedPartiesDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/RelatedPartiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_e06674c1-720c-4bcb-bebf-57629b8067dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8dffb159-2e98-4e1e-8c7c-61d625c3547b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_e06674c1-720c-4bcb-bebf-57629b8067dd" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8dffb159-2e98-4e1e-8c7c-61d625c3547b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_c2136821-06d4-4410-86f6-3bbcb500bf26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8dffb159-2e98-4e1e-8c7c-61d625c3547b" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_c2136821-06d4-4410-86f6-3bbcb500bf26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_2f5dfc04-1ff9-4532-85c7-8ef4e00866e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_c2136821-06d4-4410-86f6-3bbcb500bf26" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_2f5dfc04-1ff9-4532-85c7-8ef4e00866e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_CorvusPharmaceuticalsMember_8c6defa7-36b8-49e6-bdbe-ced5f61b066c" xlink:href="iclr-20241231.xsd#iclr_CorvusPharmaceuticalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_2f5dfc04-1ff9-4532-85c7-8ef4e00866e8" xlink:to="loc_iclr_CorvusPharmaceuticalsMember_8c6defa7-36b8-49e6-bdbe-ced5f61b066c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_AfimmuneLimitedMember_3c59aebb-9267-4acf-9bf6-95582f11a681" xlink:href="iclr-20241231.xsd#iclr_AfimmuneLimitedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_2f5dfc04-1ff9-4532-85c7-8ef4e00866e8" xlink:to="loc_iclr_AfimmuneLimitedMember_3c59aebb-9267-4acf-9bf6-95582f11a681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_526dbf18-bd38-4b3a-a1dc-2d9b5992d869" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8dffb159-2e98-4e1e-8c7c-61d625c3547b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_526dbf18-bd38-4b3a-a1dc-2d9b5992d869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c86fa34c-fe4d-4e74-bc18-7a89e39bb636" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_526dbf18-bd38-4b3a-a1dc-2d9b5992d869" xlink:to="loc_us-gaap_RelatedPartyDomain_c86fa34c-fe4d-4e74-bc18-7a89e39bb636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOfCommonParentMember_9e3b51fc-0516-4d66-90fb-3d1581d44f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOfCommonParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_c86fa34c-fe4d-4e74-bc18-7a89e39bb636" xlink:to="loc_us-gaap_SubsidiaryOfCommonParentMember_9e3b51fc-0516-4d66-90fb-3d1581d44f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_463972cd-fea7-4f16-a3bf-bd54b28b3379" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8dffb159-2e98-4e1e-8c7c-61d625c3547b" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_463972cd-fea7-4f16-a3bf-bd54b28b3379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_339f0f6d-da98-411a-8e59-600b7e94ebc7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_463972cd-fea7-4f16-a3bf-bd54b28b3379" xlink:to="loc_us-gaap_Revenues_339f0f6d-da98-411a-8e59-600b7e94ebc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_3b93fc20-917f-40a9-9928-ca6aa4751480" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_463972cd-fea7-4f16-a3bf-bd54b28b3379" xlink:to="loc_us-gaap_OtherReceivables_3b93fc20-917f-40a9-9928-ca6aa4751480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.iconplc.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="iclr-20241231.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.iconplc.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_ec4483dd-f021-4d27-8cbd-1f2d95de1384" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_611e4670-1b1d-4bb4-a8fa-59d5b92f7c25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_ec4483dd-f021-4d27-8cbd-1f2d95de1384" xlink:to="loc_us-gaap_SubsequentEventTable_611e4670-1b1d-4bb4-a8fa-59d5b92f7c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b7b372bd-9a9c-4b8d-b6f7-900920da050e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_611e4670-1b1d-4bb4-a8fa-59d5b92f7c25" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b7b372bd-9a9c-4b8d-b6f7-900920da050e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b94da792-bdbb-4fe5-b53c-9a564b6f2406" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b7b372bd-9a9c-4b8d-b6f7-900920da050e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b94da792-bdbb-4fe5-b53c-9a564b6f2406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_05f3f050-4ef4-49f9-8c0c-e3c3e73e1b14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b94da792-bdbb-4fe5-b53c-9a564b6f2406" xlink:to="loc_us-gaap_SubsequentEventMember_05f3f050-4ef4-49f9-8c0c-e3c3e73e1b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramAxis_27840699-dd28-4c03-8368-545259d40222" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_611e4670-1b1d-4bb4-a8fa-59d5b92f7c25" xlink:to="loc_srt_ShareRepurchaseProgramAxis_27840699-dd28-4c03-8368-545259d40222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramDomain_6fbf6e1c-195f-4ae4-b67d-434e38c76565" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ShareRepurchaseProgramAxis_27840699-dd28-4c03-8368-545259d40222" xlink:to="loc_srt_ShareRepurchaseProgramDomain_6fbf6e1c-195f-4ae4-b67d-434e38c76565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_iclr_February2025Member_195b72d1-04f6-4b67-bacc-8366cfff01bd" xlink:href="iclr-20241231.xsd#iclr_February2025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ShareRepurchaseProgramDomain_6fbf6e1c-195f-4ae4-b67d-434e38c76565" xlink:to="loc_iclr_February2025Member_195b72d1-04f6-4b67-bacc-8366cfff01bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_973bbe11-1c82-44db-992b-9e083f33fae6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_611e4670-1b1d-4bb4-a8fa-59d5b92f7c25" xlink:to="loc_us-gaap_SubsequentEventLineItems_973bbe11-1c82-44db-992b-9e083f33fae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1_a9db6212-730e-442b-b51b-eff7923d1730" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_973bbe11-1c82-44db-992b-9e083f33fae6" xlink:to="loc_srt_StockRepurchaseProgramAuthorizedAmount1_a9db6212-730e-442b-b51b-eff7923d1730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>iclr-20241231_g1.jpg
<TEXT>
begin 644 iclr-20241231_g1.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X2^J17AI9@  34T *@    @ !@ +  (
M   F   (8@$2  ,    !  $   $Q  (    F   (B $R  (    4   (KH=I
M  0    !   (PNH<  <   @,    5@  $48<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     %=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P
M,3$N,38S.#0 5VEN9&]W<R!0:&]T;R!%9&ET;W(@,3 N,"XQ,# Q,2XQ-C,X
M-  R,#(U.C R.C$W(#$V.C(X.C V   &D ,  @   !0  !$<D 0  @   !0
M !$PDI$  @    ,P,   DI(  @    ,P,   H $  P    $  0  ZAP !P
M" P   D0     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M,C R-3HP,CHQ-R Q-CHR-3HT-  R,#(U.C R.C$W(#$V.C(U.C0T      8!
M P #     0 &   !&@ %     0  $90!&P %     0  $9P!*  #     0 "
M   " 0 $     0  $:0" @ $     0  '?T         8     $   !@
M ?_8_]L 0P (!@8'!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=&AP<("0N
M)R B+",<'"@W*2PP,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8#0T8,B$<
M(3(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R_\  $0@ C@$  P$A  (1 0,1 ?_$ !\   $% 0$! 0$!
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MP>VD']L7']R+\C_C2_VQ<?W(OR/^-%A^V8O]KW']V/\ (_XT?VM<?W8_R/\
MC18/:L7^UKC^['^1_P :7^U9_P"['^1_QI6'[5B_VI/_ '8_R/\ C2_VG/\
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MH"R#RH_[@H\I/[HH"R%"(#D*/RIU PHH ** "B@ HH ** "B@ HH ** "B@
MHH ** "B@""]C\ZPN(O*$N^)E\LG&_(/&?>LJWT6UG5DN=*$*$?\]B2>V" ?
M3'>FF93@I25T7['2;'3B3:0^62NW[[-Q^)J[2+C%15D17$\=K;O/,Q6-!EB%
M)P/H.:=%-'-'YD;97)&<8Z'!_44%%:SO)KB:5);9857[C"8/O^9AT'3@*?\
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MC[)FO]Z7^$Y[X5?\C;+_ ->C_P#H2U[/2J;FN6?P/F%%0>@%% !10 44 %%
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M %,#XI?\C>/^O9/YM74?%?\ Y%NP_P"OD?\ H#4_Y3EE_P OQGAK_DD&H?\
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M!YTSQ)%?1ZE#<F-7/EB-UR"-O4C'<4>)O!K:SXKFNO[2AADEV8B,;MC"@?>
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M()W# ZG- ""1&8J'4D#) /2@NH."P!QGKVH 0RQJP5I$!/0%ASU/]#^1IQ8
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M%XV;<4&G(HZ = W3@<4V;X3:C/9O:2>*\P.<E!IR #G/'S<<CM1[1=@^JO\
MF+,'PTUFV&(?%P08(Q_9D9 !)..6Z?,>/>E'PVUL2R2#QA\\@PY_LR/G_P >
M]>:/:+L'U9_S&))\"/-D9W\2LS,<DFRZ_P#C]-_X4*O_ $,9_P# +_[.J]MY
M$?4?,/\ A0J_]#&?_ +_ .SH_P"%"K_T,9_\ O\ [.CVWD'U%=P_X4*O_0QG
M_P  O_LZ/^%"K_T,9_\  +_[.CVWD'U%=S__V0#_X3'D:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@8F5G:6X])^^[OR<@:60])U<U
M33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"<_/@T*/'@Z>&UP;65T82!X;6QN<SIX
M/2)A9&]B93IN<SIM971A+R(^/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O
M=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M;G,C(CX\<F1F.D1E
M<V-R:7!T:6]N(')D9CIA8F]U=#TB=75I9#IF868U8F1D-2UB83-D+3$Q9&$M
M860S,2UD,S-D-S4Q.#)F,6(B('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+R(^/'AM<#I#<F5A=&]R5&]O;#Y7:6YD;W=S(%!H;W1O
M($5D:71O<B Q,"XP+C$P,#$Q+C$V,S@T/"]X;7 Z0W)E871O<E1O;VP^/'AM
M<#I#<F5A=&5$871E/C(P,C4M,#(M,3=4,38Z,C4Z-#0\+WAM<#I#<F5A=&5$
M871E/CPO<F1F.D1E<V-R:7!T:6]N/CPO<F1F.E)$1CX\+W@Z>&UP;65T83X-
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(#P_>'!A8VME="!E;F0])W<G/S[_VP!#  ," @," @,# P,$ P,$!0@%
M!00$!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4
M%13_VP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!3_P  1" A:#P@# 2(  A$! Q$!
M_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($
M P4%! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R
M@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ
M<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#
MQ,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$!
M 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W
M  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8
M&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ
M@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*
MTM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z**
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!OX4?A7/?\)[H
M7_/\?^_,G_Q-'_">Z%_S_'_OS)_\33L8^VI_S+[SH?PH_"N>_P"$]T+_ )_C
M_P!^9/\ XFC_ (3W0O\ G^/_ 'YD_P#B:+![:G_,OO.A_"C\*Y[_ (3W0O\
MG^/_ 'YD_P#B:/\ A/="_P"?X_\ ?F3_ .)HL'MJ?\R^\Z'\*/PKGO\ A/="
M_P"?X_\ ?F3_ .)H_P"$]T+_ )_C_P!^9/\ XFBP>VI_S+[SH?PH_"N>_P"$
M]T+_ )_C_P!^9/\ XFE_X3S0STO3_P!^9/\ XFBP>VI_S+[SH/PH_"N?_P"$
M[T/_ )_3_P!^9/\ XFC_ (3O0_\ G]/_ 'YD_P#B:+#]K3_F7WG0?A1^%<__
M ,)WH?\ S^G_ +\R?_$T?\)WH?\ S^G_ +\R?_$T6#VM/^9?>=!^%'X5S_\
MPG>A_P#/Z?\ OS)_\31_PG>A_P#/Z?\ OS)_\318/:T_YE]YT'X4?A7/_P#"
M=Z'_ ,_I_P"_,G_Q-'_"=Z'_ ,_I_P"_,G_Q-%@]K3_F7WG0?A1^%<__ ,)W
MH?\ S^G_ +\R?_$T?\)WH?\ S^G_ +\R?_$T6#VM/^9?>=!^%'X5S_\ PG>A
M_P#/Z?\ OS)_\31_PG>A_P#/Z?\ OS)_\318/:T_YE]YT'X4?A7/_P#"=Z'_
M ,_I_P"_,G_Q-'_"=Z'_ ,_I_P"_,G_Q-%@]K3_F7WG0?A1^%<__ ,)WH?\
MS^G_ +\R?_$T?\)WH?\ S^G_ +\R?_$T6#VM/^9?>=!^%'X5S_\ PG>A_P#/
MZ?\ OS)_\31_PG>A_P#/Z?\ OS)_\318/:T_YE]YT'X4?A7/_P#"=Z'_ ,_I
M_P"_,G_Q-'_"=Z'_ ,_I_P"_,G_Q-%A>VI_S+[SH/PH_"N?_ .$[T/\ Y_3_
M -^9/_B:/^$[T/\ Y_3_ -^9/_B:+![:G_,OO.@_"C\*Y_\ X3O0_P#G]/\
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M )_?_(3_ .%+_P )MHO_ #^?^0G_ ,*+,/:T_P"9?>;O-'-87_";:+_S^?\
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M_P#D)_\ "BS#VM/^9?>;G-'-8?\ PF>C_P#/W_Y"?_"C_A,]'_Y^_P#R$_\
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ME?\ /W_Y"?\ PI?^$OTK_G[_ /(3_P"%%F'M(?S(V<^]&?>L;_A,-)_Y^_\
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M_P"$HTS_ )^/_'&_PHLP]I#N:W%'%9/_  E&F?\ /Q_XXW^%'_"4:9_S\?\
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MX2+3_P#GX_\ '6_PH_X2+3_^?C_QUO\ "BS'S1[FEM%&T5F_\)%I_P#S\?\
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M_A(=/_Y[_P#CC?X468<T>YI;11M%9O\ PD.G_P#/?_QQO\*/^$AT_P#Y[_\
MCC?X468<T>YI;11M%9O_  D.G_\ /?\ \<;_  H_X2'3_P#GO_XXW^%%F'-'
MN:6T4;16=_PD%A_SW_\ '6_PH_X2"P_Y[_\ CK?X468<T>YH[11M%9W_  D%
MA_SW_P#'6_PH_P"$@L/^>_\ XZW^%%F'-'N:.T4;16=_PD%A_P ]_P#QUO\
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M>YH;11M%9_\ ;EC_ ,]?_'&_PH_MRQ_YZ_\ CC?X4#YH]S0VBC:*S_[<L?\
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M_GK_ ..G_"C^UK3_ )Z_^.G_  H#FCW+U%4?[6M/^>O_ (Z?\*/[6M/^>O\
MXZ?\* YH]R]15'^UK3_GK_XZ?\*/[6M/^>O_ (Z?\* YEW+U%4?[6M/^>O\
MXZ?\*/[6M/\ GK_XZ?\ "@.9=R]15'^UK3_GK_XZ?\*/[6M/^>O_ (Z?\* Y
MEW+U%4?[6M/^>O\ XZ?\*/[6M/\ GK_XZ?\ "@.9=R]15'^UK3_GK_XZ?\*/
M[6M/^>O_ (Z?\* YEW+U%4?[6M/^>O\ XZ?\*/[6M/\ GK_XZ?\ "@.9=R]1
M5'^UK3_GK_XZ?\*/[6M/^>O_ (Z?\* YEW+U%4?[6M/^>O\ XZ?\*/[6M/\
MGK_XZ?\ "@.:/<O451_M6T_YZ_\ CI_PI?[4M?\ GK_XZ?\ "@.:/<NT52_M
M2U_YZ_\ CI_PH_M2U_YZ_P#CI_PH#FCW+M%4O[4M?^>O_CI_PH_M2U_YZ_\
MCI_PH#FCW+M%4O[4M?\ GK_XZ?\ "C^U+7_GK_XZ?\* YH]R[15+^U+7_GK_
M ..G_"C^U+7_ )Z_^.G_  H#FCW+M%4O[4M?^>O_ (Z?\*/[4M?^>O\ XZ?\
M* YH]R[15+^U+7_GK_XZ?\*/[4M?^>O_ (Z?\* YH]R[15+^U+7_ )Z_^.G_
M  H_M2U_YZ_^.G_"@.:/<NT52_M2U_YZ_P#CI_PH_M2U_P">O_CI_P * YH]
MR[15+^U+7_GK_P".G_"C^U+7_GK_ ..G_"@.:/<NT52_M2U_YZ_^.G_"C^U+
M7_GK_P".G_"@.:/<NT52_M2U_P">O_CI_P */[4M?^>O_CI_PH#FCW+M%4O[
M4M?^>O\ XZ?\*/[4M?\ GK_XZ?\ "@.:/<NT52_M2U_YZ_\ CI_PH_M2U_YZ
M_P#CI_PH#FCW+M%4O[4M?^>O_CI_PH_M2U_YZ_\ CI_PH#FCW+M%4O[4M?\
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M@;I*@_X$*!W1/13%D1_NN#]#FGT#"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** /G^BBBN@^2"BBB@ HHHH **** "E
M6DI5H!"T444%!1110 4444 %%%% !1110 4444 %%%% !1110 44450!1114
MDA1110 4444 %*O6DI5ZT AU%%%!04444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4J]:2E7K0 ZBBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH+"BBB@!U%%%! 4444 %
M%%% !1110-!11104%%%% !1110 4444 **=313J "BBB@ HHHH **** "BBB
M@ HHHH **** 'T444 %%%% !1110-!11104%%%% F%%%%!(4444 %.IM.J6-
M!1113104444P"BBB@ HHHH **** '+2TBTM2P"BBBJ **** "BBB@ HHHH *
M***!H*<M-IRTF#%HHHI(044450@HHHH*04444#"BBB@!5I:1:6I8!1112 **
M**L HHHH ?1114 %%%% !11130T%.6FTY:;&Q:***DD**** "BBB@:"BBB@H
M****I %.IM.I, HHHI %%%% !1110 4444 %%%%6 ^BBBH+"BBB@D****!!3
MEIM.6@:%HHHH*"BBB@ IU-IU !1110 4444 %%%% !1110 4444 .6EI%I:
M"BBB@ HHHH ****!H****"@IRTVG+0)BT444"04444%!1110 4ZFTZ@ HHHH
M **** "BBB@!RTM(M+0 4444 %%%% !1110 ^BBBH$%%%%6,**** 04444%!
M1110 4444 %.IM.H **** "BBB@ HHHH **** "BBB@ HHHH <M+2+2T %%%
M% !1110 4J]:2E7K0-#J***GJ4%%%%4 4444""E6DI5H8D+1114E!1110 44
M44 %%%%4 4444 %%%% #EI:1:6I **** "BBB@ HHHIH HHHI@%%%% T%%%%
M!04444 %/IE/H8F%%%%20%%%%!2"BBBJ*"BBB@ HHHH **** %6EI%I:D HH
MHH **** "BBB@ HHHIH IRTVG+38"T445(!1110 4444 %%%% !1110 4444
M %%%% PHHHH$%%%% !1110 ^BBB@ HHHH **** 04444%!1110 4444 %%%%
M !1110 4444 %%%% !11102*M+2+2T#"BBB@84444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 /HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ _SUJ5+J:/
MI(X]LG%144!KT+T>KSKUVO\ [PJU%K,;??1E]QR*QZ*1HIR74Z2*XBF^XZM[
M9J85RP.WGI^-6H-4FAP,[U_NM_C2-55[G0452MM2AGX)V/Z-5RD;)W%HHHH&
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\_P!%%%=!\D%%%% !
M1110 4444 %*M)2K0"%HHHH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHJ@"BBBD2%%%%( HHHH *5>M)2KUH!#J***"@HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I5ZTE*O6@!U%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11106%%%% #
MJ***" HHHH **** "BBB@:"BBB@H**** "BBB@ HHHH 44ZFBG4 %%%% !11
M10 4444 %%%% !1110 4444 /HHHH **** "BBB@:"BBB@H****!,****"0H
MHHH *=3:=4L:"BBBFB@HHHI@%%%% !1110 4444 .6EI%I:E@%%%%4 4444
M%%%% !1110 4444#04Y:;3EI,&+11120@HHHJA!11104@HHHH&%%%% "K2TB
MTM2P"BBBD 44458!1110 ^BBBH **** "BBBFAH*<M-IRTV-BT445)(4444
M%%%% T%%%%!044452 *=3:=28!1112 **** "BBB@ HHHH ****L!]%%%06%
M%%%!(4444""G+3:<M T+11104%%%% !3J;3J "BBB@ HHHH **** "BBB@ H
MHHH <M+2+2T %%%% !1110 4444#04444#"G+3:<M ,6BBB@2"BBB@84444
M%.IM.H **** "BBB@ HHHH <M+2+2T %%%% !1110 4444 /HHHJ "BBBK *
M***!H****"@HHHH **** "G4VG4 %%%% !1110 4444 %%%% !1110 4444
M.6EI%I: "BBB@ HHHH *5>M)2KUH&AU%%%3U*"BBBJ ****!,*5:2E6AB0M%
M%%24%%%% !1110 44450!1110 4444 .6EI%I:E@%%%% !1110 4444T 444
M4P"BBB@:"BBB@84444 %/IE/H8,****D@****"D%%%%4,**** "BBB@ HHHH
M 5:6D6EJ6 4444 %%%% !1110 4444T 4Y:;3EIL!:***D HHHH **** "BB
MB@ HHHH **** "BBB@I!1110)A1110(**** 'T444 %%%% !1110-!11104%
M%%% !1110 4444 %%%% !1110 4444 %%%%!+%6EI%I:!H****!A1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 ^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "K-M?S6W1MR?W6JM12&FUL=!:W\=TN </\ W:M=
M*Y89!R.O\JT+/5BAV3?,O9Q_6E8Z(U.C-F@<4B,'4%3D'TIU(W"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#Y_HHHKH/D@HHHH **** "BBB@ I5I*5:
M 0M%%%!04444 %%%% !1110 4444 %%%% !1110 4444 %%%%4 4444B0HHH
MI %%%% !2KUI*5>M (=11104%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %*O6DI5ZT .HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ****"PHHHH =11100%%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M'T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% %BUO9+1OEY4]5/]/>MRUN4NH]R'\#VKFZDM[A[:3<AP>X
M]:3-85&MSIMU%5[2[2ZCRO##JOI5BI.K<6BBB@84444 %%%% !1110 4444
M%%%% 'S_ $445T'R04444 %%%% !1110 4JTE*M (6BBB@H**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBBJ ****1(4444@"BBB@ I5ZTE*O6@$.HH
MHH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "E7K24J]: '4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%%!84444 .HHHH("BBB@ HHHH ****!H****"@HHHH ****
M "BBB@!13J:*=0 4444 %%%% !1110 4444 %%%% !1110 ^BBB@ HHHH **
M**!H****"@HHHH$PHHHH)"BBB@ IU-IU2QH****:*"BBBF 4444 %%%% !11
M10 Y:6D6EJ6 44450!1110 4444 %%%% !1110-!3EIM.6DP8M%%%)""BBBJ
M$%%%%!2"BBB@84444 *M+2+2U+ ****0!1115@%%%% #Z***@ HHHH ****:
M&@IRTVG+38V+1114DA1110 4444#04444%!1115( IU-IU)@%%%%( HHHH *
M*** "BBB@ HHHJP'T445!84444$A1110(*<M-IRT#0M%%%!04444 %.IM.H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M?#.UO('4X/\ /VKH;6Y6ZCW+P>X]*YNIK6Y:UE#+T[KZBDS2$G'1G1[J44R*
M19HU=3D&GU)V"T444 %%%% !1110 4444 %%%% 'S_11170?)!1110 4444
M%%%% !2K24JT A:***"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M*H HHHI$A1112 **** "E7K24J]: 0ZBBB@H**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *5>M)2KUH =1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444%A1110 ZBBB@
M@**** "BBB@ HHHH&@HHHH*"BBB@ HHHH **** %%.IHIU !1110 4444 %%
M%% !1110 4444 %%%% #Z*** "BBB@ HHHH&@HHHH*"BBB@3"BBB@D**** "
MG4VG5+&@HHHIHH****8!1110 4444 %%%% #EI:1:6I8!1115 %%%% !1110
M 4444 %%%% T%.6FTY:3!BT444D(****H04444%(****!A1110 JTM(M+4L
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M** "BBB@ HHHH*04444"84444""BBB@!]%%% !1110 4444#04444%!1110
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M**"0HHHH *=3:=4L:"BBBFB@HHHI@%%%% !1110 4444 .6EI%I:E@%%%%4
M4444 %%%% !1110 4444#04Y:;3EI,&+11120@HHHJA!11104@HHHH&%%%%
M"K2TBTM2P"BBBD 44458!1110 ^BBBH **** "BBBFAH*<M-IRTV-BT445)(
M4444 %%%% T%%%%!044452 *=3:=28!1112 **** "BBB@ HHHH ****L!]%
M%%06%%%%!(4444""G+3:<M T+11104%%%% !3J;3J "BBB@ HHHH **** "B
MBB@ HHHH <M+2+2T %%%% !1110 4444#04444#"G+3:<M ,6BBB@2"BBB@8
M4444 %.IM.H **** "BBB@ HHHH <M+2+2T %%%% !1110 4444 /HHHJ "B
MBBK ****!H****"@HHHH **** "G4VG4 %%%% !1110 4444 %%%% !1110
M4444 .6EI%I: "BBB@ HHHH *5>M)2KUH&AU%%%3U*"BBBJ ****!,*5:2E6
MAB0M%%%24%%%% !1110 44450!1110 4444 .6EI%I:E@%%%% !1110 4444
MT 4444P"BBB@:"BBB@84444 %/IE/H8,****D@****"D%%%%4,**** "BBB@
M HHHH 5:6D6EJ6 4444 %%%% !1110 4444T 4Y:;3EIL!:***D HHHH ***
M* "BBB@ HHHH **** "BBB@I!1110)A1110(**** 'T444 %%%% !1110-!1
M1104%%%% !1110 4444 %%%% !1110 4444 %%%%!+%6EI%I:!H****!A111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 ^BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I\$S6\JR*<$?
MK3*,T =-%()HU=>A%2UE:/<<-"3R.5K4J#NB^9"T444%!1110 4444 %%%%
M'S_11170?)!1110 4444 %%%% !2K24JT A:***"@HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH ****H HHHI$A1112 **** "E7K24J]: 0ZBBB@H***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *5>M)2KUH =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444%A1110 ZBBB@@**** "BBB@ HHHH&@HHHH*"BBB@ HHHH ****
M%%.IHIU !1110 4444 %%%% !1110 4444 %%%% #Z*** "BBB@ HHHH&@HH
MHH*"BBB@3"BBB@D**** "G4VG5+&@HHHIHH****8!1110 4444 %%%% #EI:
M1:6I8!1115 %%%% !1110 4444 %%%% T%.6FTY:3!BT444D(****H04444%
M(****!A1110 JTM(M+4L HHHI %%%%6 4444 /HHHJ "BBB@ HHHIH:"G+3:
M<M-C8M%%%22%%%% !1110-!11104%%%%4@"G4VG4F 4444@"BBB@ HHHH **
M** "BBBK ?1114%A11102%%%% @IRTVG+0-"T444%!1110 4ZFTZ@ HHHH *
M*** "BBB@ HHHH **** '+2TBTM !1110 4444 %%%% T%%%% PIRTVG+0#%
MHHHH$@HHHH&%%%% !3J;3J "BBB@ HHHH **** '+2TBTM !1110 4444 %%
M%% #Z***@ HHHJP"BBB@:"BBB@H**** "BBB@ IU-IU !1110 4444 %%%%
M!1110 4444 %%%% #EI:1:6@ HHHH **** "E7K24J]:!H=1114]2@HHHJ@"
MBBB@3"E6DI5H8D+1114E!1110 4444 %%%%4 4444 %%%% #EI:1:6I8!111
M0 4444 %%%%- %%%%, HHHH&@HHHH&%%%% !3Z93Z&#"BBBI("BBB@I!1115
M#"BBB@ HHHH **** %6EI%I:E@%%%% !1110 4444 %%%%- %.6FTY:; 6BB
MBI **** "BBB@ HHHH **** "BBB@ HHHH*04444"84444""BBB@!]%%% !1
M110 4444#04444%!1110 4444 %%%% !1110 4444 %%%% !11102Q5I:1:6
M@:"BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 /HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %7-*F\NZ"]G&*ITZ-O+D1AU4YI,J+LSJ.]+38VW
M*#3JD[@HHHH **** "BBB@#Y_HHHKH/D@HHHH **** "BBB@ I5I*5: 0M%%
M%!04444 %%%% !1110 4444 +^M>)_$#]IBU\!^+M0T&30)KQK,H#.MR%#;D
M5^A4X^]^E>UU\-_M$?\ )9/$?^_#_P"B(ZVI14G9G@YQBJN%HJ=%V;9ZQ_PV
M/9X/_%+W&?\ K\'_ ,17T-8W7VVRM[@+L$T:R!<YQD XS^-?FW7Z.:%_R!-/
M_P"O>/\ ]!%55BHVLCDR7'5\6Y^UE>Q>HHKS/XU_&6#X6Z7'#;1I=Z[=J6M[
M=C\L:C(\Q_;.<#^(@CL2,$G)V1]%6K4\/!U*CT1UWB[QUH7@6Q^UZWJ,5FA^
MY&Q+22'T5!R?RKQ/Q%^V%8QL4T+0IKD9XFOY%C'X*N<_]]#Z5\VZYKNH>)-4
MGU#4[J2]O)FR\LAZ^P]![#@51KMC2BMSX3$Y]B*LOW*Y4>[S?M?>*&D'E:-I
M,<>>5=9G;'L=XS^5:NC_ +8MXDRC5/#EO-$>KV=P4(]P&5L_B1]:\"C\/ZK/
M&)8]-O'C89$BV[E?Y5192K%2-I'!!&"*KV<.QP?VECH._._N/NOP'\</"GQ
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M496N?:'PK_:$MOBAXF;1HM%DL&6W>?S7N X^4J,8"C^]7KM?'/[)W_)49?\
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M9_$S]H;Q)\0?-M(I/[&T9N/LEJWS2#TE?^+Z  5ZO^QK_P @'Q,/^GF'_P!
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MVU.0[F_[9IPO_?9K"M_VT/%:M^_T71I%S]U$E0X^ID;GWQ7SYV/7U]_4^O\
M*O3]!_9M\?>(])AU&WT98+>9!)$+FX2-W4\@A2<CK_%7=[.$5J?!0S',L3.]
M.3?H?2OP7_:&7XM:Q/I3:%)IUU;VQN7F6X$L6T,JD?=!!)<8'L>:]D6OG_\
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MEV/OCP[XHTKQ;9RW>CWL>H6L4S6YGAR4+KC(![]1R.*UZ\/_ &/_ /DCZ_\
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M HHHIH HHHI@%%%% T%%%% PHHHH *?3*?0P84445) 4444%(****H84444
M%%%% !1110 JTM(M+4L HHHH **** "BBB@ HHHIH IRTVG+38"T445(!111
M0 4444 %%%% !1110 4444 %%%%!2"BBB@3"BBB@04444 /HHHH **** "BB
MB@:"BBB@H**** "BBB@ HHHH **** "BBB@ HHHH ****"6*M+2+2T#04444
M#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@!]%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M49Q0!T-@WF6<1]!M_+BK-9^C.3;,I_A;^E:-0=T=4@HHHH*"BBB@ HHHH ^?
MZ***Z#Y(**** "BBB@ HHHH *5:2E6@$+11104%%%% !1110 4444 %%%% !
M7PW^T1_R63Q'_OP_^B(Z^Y*^&_VB/^2R>(_]^'_T1'731^)GR_$'^[Q]3SFO
MT<T+_D":?_U[Q_\ H(K\XZ_1S0O^0)I__7O'_P"@BJK]#S^'-ZB':QJUOH.D
MWFI7CB.UM86FD8_W5&3]?I]/6OS[\9>*KWQKXDOM8OI&>:YD+!6.?+3.%0>R
MC _"OJ_]JC7CI/PO:S1B)-2NHX,+UVKF0X_% /QKXV_+\*JC'2YGQ!B'*I&A
M'9:FCX<\/WOBK7++2=.B\Z\NI!'&O8>I;V R3Z &OM/X9_ WP_\ #NRA=K>/
M4M9V_O=0N$W$'K^[!SL'T /O7DG['_AE+G5-<UZ5<FVC2TA)' +G<Y'N B_@
MQKZBJ*LM;'=DF IJE]8J*[?3L)^'X=/RKBOB/\)-!^)&G31WEK'!J6T^3J,2
M;98VP2,G^)>N5/'7N<CM:.QX[5SIM.Z/I:E&%:+A-*Q^=?BSPO?>"_$%[HVI
M($O+5]K[3E6! *L/8@@CZU1T[4+C2M0MKVUE,%S;R+-%*IY1U(*D?C7V]X]^
M!?AWXB>)(=8U1KI)XX?):.V<1K* 3@OE2>,]B*T-!^#'@GPWL^Q^'+-Y$Z27
M2&=L^N7W8/TKJ]LK:GQ?]@UO:N4':*V-GP3XFC\8^$=)UJ(!1>6ZRL@_@?HZ
M_@P(_"IO%GB2U\'^&]1UF\YM[.%I2HZN1T0>[$@"M..-(8U2-%1%& JC %>&
M?M<Z\UCX'TW2T8JVH7>]_P#:CC7)'_?31G\*YHKFEH?68BJ\+AG-N[2/EWQ-
MXAO?%FO7VKZA)YEW=RF1SG('HH]@, >P%0:-H]YX@U6UTZP@:YO+F18HHD'+
M,>G]?PR?6J?<_6OHS]D'PC'<:AK'B29 [6RBSM]PZ,V&=A[@!1]'->A*7(C\
MVPE"6-Q$8/KN>D_"_P#9XT#P/9P7&IV\.LZWC,EQ,N^*)O2-6^7CIN(R?;H/
M5U4*H55"@<!0,8I:*\Z4F]S]1HX>EAX\E-62,[7/#NE^)K-K75=/MM0@8$;+
MB,-CW!/(^HY]Z^3OCU\!1\/U.NZ&9)-!9PLD+%F>T8]#N[IG R>02!DYS7V%
M5+6]'MO$.CWNF7D8DMKR)H)%/HP(_P _0>E5&;BSCQV IXND[Q][H?F_[=/P
M]^H'Y5]&?LF_$)X=0NO"-Y.3#,#/8*QX1P"9$'L0"V/]EJ\!U[29=!UO4--G
M.9K.XDMW(& 65BI/Z5<\$Z\?"_B_1M6!P+.ZCF?GJH8;E/U&1^-=TH\T3\[P
M=:>#Q*DNCLS]$S7SW^V+_P BSX>_Z^W_ /0*^@U8.H93N5N01T-?/G[8O_(L
M^'O^OM__ $"N*G\2/T'-;/!5&MK'RK2^W3/'^?TH'8=\_P"?Z5=OM'N].M;"
MYN(F6"^A,]N_9U#LAY]<H:]#J?EUI6NCZ!_93^)_V>X;P=J,V(IBTM@S'[K=
M7B!]_O#W##O7T_SQGK7YLV-]<:9>07EM,\-S!(LL<J?>5@<@CW'%?>OPH^(4
M'Q(\&VNJ*52[7]U>0JW^KF7&['L<@CV-<=:%M3[W(\=[6'U:3U6WH=9=?\>T
MO^XU?FO7Z47?_'M+_N-_*OS7IX?9G+Q%_P NSV?]D[_DJ,O_ &#IO_0HZ^QJ
M^.?V3O\ DJ,O_8.F_P#0HZ^QJFM\1Z>0_P"Y_-G)^.OA=X>^(S6;:[:R7+68
M<0[)GCV[L;OND9^Z*^-?C-H>B^&/B)J>DZ#'Y5A:;(\>:9/G*@OR2>A./PKZ
M._:(^+>O?#B&SL])L8D74(FVZI(=QC<'!54Q@-@J<DXY/'!KP[X-_"+4_BGX
MB74]22?^PUF,UW>S$DW#9RT:L?O,2>6[9)ZD"KI^ZKMGFYM[/$UEAJ-/W[ZN
MW0^K/A+I[Z7\,_#-M(-LBV$3,/0LH8C\,UUM(JK&H55"JO 51@ >F.WTKS3X
MW?&2#X5Z/&ENBW6N7BG[- V=J*.#(^.< ]!QD@^^.=+F>A]5*I#"4$ZCLHH]
M(GN(K6)I9I%BC7EF=MH'XGBN>NOB;X0L_,$WBC1D=.&4W\6X?@&S7PEXH\::
MYXRO6N-9U.XOY-Q(61SY:<_PH/E4>PK$_P \UT>P[GRE3B)W_=T]/,_0RS^(
MGA74&5+;Q-I,[GD)'?1%OR#9KH$=9$5D8,C#(9>017YI9YKI_!OQ(\1^ [I)
MM&U.:WC!&ZUD8O"X]&3H?KUY[4.AIH52XAN[5H'Z#T5P_P (_BE9?%+PX+V%
M1;:A 52[M,Y\M^H(]5;!P?J.U=P.@_G7+)<KL?7TJD:T%4@[IA2KUI*5>M(U
M'5A>._\ D2/$/_8.N?\ T4];M87CO_D2/$/_ &#KG_T4]5'<PK_PI>C/SLKW
M+]D#_DI6I?\ 8(E_]'05X;7N7[('_)2M2_[!$O\ Z.@KT*GPL_,<L_WZGZGU
M]115;4M3M=%T^YO[Z=;:TMT,LLTGW44<DG\/K[5YO8_5&U%7;L6:S]6\1:5H
M*AM3U.STY#T:\N$B'YL17RI\5_VGM4\132:?X6DETG2URINLXN)QZ@\E >VW
MGU]!X=<W,UY.\T\TEQ,YRTDK%F;W)-=,:-]SY7%9_3IR<*4>;SZ'Z#0_%#P=
M<2^7'XJT5Y,X"B_BR?IEN:Z"UO(+Z!9K::.XA;E9(F#*WT()K\U:U?#OBS6/
M"=ZEUH^I7.GS*028)"H;ZKR&'L01ZU7L.S..GQ%*_P"\AIY'Z-T5X/\ !7]I
M&+QA<0Z)XE$5IJ\A"072#;#='^Z1G"L3Z<-G'!P#[Q7-*+B['UN%Q-/%14Z;
MO^8445^:EW_Q]2_[[?SJZ<.<\_,<Q_L_E7+>Y^E=)NVY)X&,\XQ^IKXI_9T\
M::7X!\0:]K&K2^7;QZ6RHB_?E<RQX11W)_ID\ UB?$GXU>(OB1>.+BX>QTOI
M'IMNY$>/]LC[Y]2>/3'2J]B[V.'^W:2H*K)>\^A]GWGQ&\)Z?(8[KQ-I$#YQ
MMDOHP1]06XK4TO7M,UR,R:;J-KJ$8^\]K,LJC_ODFOS=^G3I5K3=2NM(O([N
MRN9;.YC.4F@<JX^A%:>PTW//CQ%-2]ZGI^)^D]%>%_L[_'&Y\=;] U^17UF%
M/,@NL;3<H."&'3>O!X R.?X:]S'0#ICBN:47%V/KL-B(8JFJM-BTG7OC]:CN
MKJ&RM9KBXE6"")"\DDAPJJ!DD^P //:OD#XO?M):MXLO)]/\.3S:3HB_*98S
MLFN?4ENJK[#!XR3S50@YF.,QU+ QO/5OH?5FK>,M \/R&/4];T[3I!UCNKI(
MV_)B#^5+H_C'0=?E$>EZUIVHR]?+M;I)&X]0IS7YSLQD9F9BS$Y+,<D^YI8Y
M'AD22-VCD4@JRG##W!Z_D:Z/8>9\PN))\W\/0_3#]1VS17R9\&?VD+W3)$T+
MQ7=F[TV13'#J,Q)E@./XS_$G^T>F1V%> =.*B-%[';4S^G&$94X\U_.UC],J
M*^2?V._^1XUO_L'?^U4KZVK&<>5VN>U@,7]=H*M:UPHHHJ#T KR[]IG_ )(S
MKG^_;_\ H]*]#U[_ ) >H_\ 7M)_Z :_-MNM;TH<SN?.9SCOJL/96OS(*^J/
MV-?^0#XF_P"OF'_T!J^5Z*[)1YU8^&P6*^I5U6M?R/TRHKY _8^_Y*9J?_8(
ME_\ 1T%?1?QJ_P"24^*O^O!_Y5P2A:7+<_2L+C_K.%>)Y;6Z>AVE%?F;7KWP
MU^+@^&7PMUR&Q=6UV_O=MLK $0H(QNE(_$ 9ZD]\&M'1LM&>+0X@A4ERSA9*
M_4^OM;\6Z'X=*_VKK%CII;[JWEPD1;_=#$9J72?$FE:^K-IFJ6>HJHR6L[A)
M<#UX)K\Y;Z^N=2O);J\GDNKJ5MTDTSEW=NY)/)-;_P ,]+O]<\?:)I^FW5Q9
M75Q<JGVBV=DDC3J[ @]E!/Y57L4EN84^()U*JBJ>C9^AH_6G?YXZU3U+4K30
M]-N+Z]F6WL[6,RS2R$X15Y)[GL>G7\J^,/BQ^T-KOCR^N+73;F?2=!#%8[>%
M@DLR_P!Z1AW/=<X'3GJ<84W-GT..S"G@8IS6KZ'V'JGC+0-%D*:CKFFV#@X*
MW5W'&<^^2*S8_BMX*DD:-?%FB!EZYOX@/S+8K\],D\DY/KZT5T>P75GS+XCJ
M-Z4_Q/TGTO7M,UI"VG:A:WRCDFUG20?H35ZOS/M;J>QN$N+::2WN(SE)(6*N
MI]01SGZ5],_ #]HB^U35[7PSXIG^U-<$16>H,,2%^@CD(X.> &ZY.#UR,Y46
MMF>C@\^AB)*%6-FSZ7HH_P /Z4CL$4LQ"J <G...YSV_^N:Y]3ZK97Z"U2U/
M7-.T2,2:C?VMA&W1KJ=8U/XL0*^9/C'^U#>7%[/I/@V?[-:1EDEU14'F2D<?
MNL\*,_Q=?3%?/-]J%UJER]S>7,MW<.<O-,[.S'W)Y-=,:-]6?*8O/J5&7)27
M,_P/T%7XJ>#/,*#Q;HF0,@_VA$ ?Q+8K?T_5;'5H/-LKRWOH1U>WE5Q^8)%?
MFI5S2=8O]"O$N].O9["Y3D36\C1M^8(_*J]AV9PPXCG?]Y35C]*:*^>O@-^T
M9-XFOH/#GBB1/[2D(6UU# 03D#[C@<;_ $P!NX'7%?0OX8-<LHN.A];A<52Q
ME/GIL\#_ &Q_^1&T3_L)#_T4]?(WI7US^V/_ ,B-HG_82'_HIZ^1O2NZC\"/
MS[/O]]EZ(^UOV4?^216__7Y/_,5[%7CO[*/_ "2*W_Z_)_YBNJ^+7Q4T_P"%
M?AMKVXVSZA,"EG9YYE?'4^BCJ3^'I7))-S:1]O@ZL*.!A.H]$CN**_-GQ)XB
MU#Q9K5UJVJ7#7-[=/O=V_0 =@!P!Z5L?#?X<ZI\3?$<>E::NQ!A[BZ<?N[>/
MNS>OL.YQ[D:^Q25V>+'B!U:G)3HWOMKO^!^AU%8'@CP3I?P_\/V^CZ3!Y4$8
MR\C\R2O@9=SW8\?08':M^N;KHS["#DXKG5GV"BBB@I[!15#7O^0'J/\ U[2_
M^@&OS6K6%/F/!S+,_P"SW%<M[GZ<5G:SXCTKP["LNJZG9Z;$WW7O)UB!^F2,
M_A7Q=\#_ (EVWPOTWQ;J3A9K^6WAALK<G_62EFP3WVKU/X=SSYUX@\1:CXJU
M:XU/5+N2]O)FW-)(<^X4#LHZ #@5I[%WW/,J<01C13C#WGNNQ^B&C^+M"\1.
M$TK6=/U%NNVUNDD/Y*2?SK9K\T=%@N[K6+*"P,BWTTR1P&)BK^86 7!!R#D]
MO:OTAT6PDTO1[&SDN9+R6W@2)[F9B[RL% +L3SDD$_4FLZD%![GJ97F3S#FO
M"UOQ+M07VH6NEVK7%Y<Q6D"]99W"*/Q->/?';]H*'X<[]&T58[KQ$Z L9.8[
M52.-WJY&,#H.I]#\A>)/%6K^+]0>]UC4;C4+ECG?,V0OLJ]!]  *=.DY:LPQ
M^=TL++V=-<TEOY'W]_PM/P:)A%_PEFA[\=/[0A_+[V.];VGZK9:M#Y]C=P7D
M.2/,MY%D7\P2*_,[]/K5[1]<U'P]>I>:9?3V%RO2:WD9"/K@CCZUK['LSR8<
M23O^\IZ'Z6TE?._P+_:4?Q->0>'_ !4R)J4Q$=K?JH5)V(P$D X#$]", YQP
M<9^B*YI1<78^NPN*I8RGSTV%%'IFO$OCK^T/%\/9'T/0UCNO$.T>9(XW16F1
MGD?Q/Z \<C/H2,7)V1>)Q-+"P<ZCLCVBZNX+&!YKF>.VA7EI)7"J/Q-<[-\4
MO!MM((Y/%FBI)G&W^T(CM^OS<?C7P'XF\8:UXPOFN]:U.XU"9CD&=R53V51\
MJCV  ZUD5TJA=:GQ]3B1M_NJ>GF?I1I'BK1->.-,UC3]2/\ TZ722_R)K5K\
MQ(IG@E22-VCD0AE9"0PQW!'0U[C\'_VFM8\*WMOIWB>XFU?1'(3[1,2]Q;\_
M>W=74=P>1C([ Q*@UJF=6%X@A5DH5HVN?95%16MU%?6L-Q!*L\$R"2.6-MRN
MIY# ]P>M2].?3GUKG]3ZZ+3V"FR,L:%V8*J\EF. /SXKS#XR_';3/A3;_9%C
M&HZ_*FZ*S#?+&#G#R'' X/ Y..W4?'7C/XF>)/']T\VM:K-<QDY6V5MD"_[J
M#"_U]:VA3<CP<=G5'!OD7O2_(^\;SXF^$-.D,=SXIT>&13@QM?1;U_ -D5>T
MGQAH.O2B/3=;TW4)&'"V=W'+^@-?FQZ_X4JL58%25(Y##.1^1K7V"[GA+B2I
M?6FK'Z>_SHKX8^&O[1WBKP'<0P75S)K>D!ANM;M]SJ.G[MSRN/0Y7VYS7V5X
M*\:Z3\0/#\&KZ-/Y]K)\I4\-&X RC#L1D?F#T-8RIN!]+@<SHX[2+M)=#=HH
MKY2_;1_Y#OAC_KVF_P#0UJ81YG8Z<=BOJ=%UK7/JVER%4DG ZDU^8'IZ_P"?
M\_E7M7QR^-]QXHBMO#6BW31Z%9P)'</"?^/N0* 1[H#P!T8@DYXK9T'>R9X%
M/B*G*$I3A9^NY]9R?$KPE#>&UD\4:,ET#@PM?1!E/IC=U_6M^WN8;R!)K>6.
M:%QE9(V#*1ZY%?F&>/?CGK_6OJ#]C'2+]_[?U1[JX&F(%M8[;S"(GE.&9BN<
M;E4* ?1S1*CR*]PP.=SQ5=494]_ZU/J&D+!022  ,ECC 'XUSWC[QWIGPY\-
MW.M:F["&,A8XDQYDTASM103C)Y]L ^E?#OQ*^-'B3XF7CF]NWMM+#9ATVW8B
M%1VW?WSCNWZ=*SC3<]3U<PS2E@/=EK+LC[?O/B9X0T^8Q77BC1X)0<&.2_C!
M'U&[C\:U])US3M=A:73=0M=0A'!DM)UD49]U)%?F9_GO5_1M<U'P]J$5]I=[
M/87<; K-;N4(^I';VZ'TK;V&FY\[3XDES7E3T/K_ /;#_P"26V?;_B:1?^BI
M:^,F[UZ]X[^/%Q\2/A7!H>LQ#^W;:^CG%Q$FU+B-4D!) X5@6'3@\<#I7D'K
M6M.+BK'BYOB:>+Q'M:>S2/M/]D/_ ))3-_V$IO\ T&.O;J\1_9#_ .24S?\
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MHH$PI5I*5:&)"T445)04444 %%%% !1115 %%%% !1110 Y:6D6EJ6 4444
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M&OF@=1[8/X"M*7P(\?.O]\E?R/KS]D:W$?PWOY< -+J<OS=]OEQ #]#7M_\
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MK$]X<M+2+2T %%%% !1110 4444#04444#"G+3:<M ,6BBB@2"BBB@84444
M%.IM.H **** "BBB@ HHHH <M+2+2T %%%% !1110 4444 /HHHJ "BBBK *
M***!H****"@HHHH **** "G4VG4 %%%% !1110 4444 %%%% !1110 4444
M.6EI%I: "BBB@ HHHH *5>M)2KUH&AU%%%3U*"BBBJ ****!,*5:2E6AB0M%
M%%24%%%% !1110 44450!1110 4444 .6EI%I:E@%%%% !1110 4444T 444
M4P"BBB@:"BBB@84444 %/IE/H8,****D@****"D%%%%4,**** "BBB@ HHHH
M 5:6D6EJ6 4444 %%%% !1110 4444T 4Y:;3EIL!:***D HHHH **** "BB
MB@ HHHH **** "BBB@I!1110)A1110(**** 'T444 %%%% !1110-!11104%
M%%% !1110 4444 %%%% !1110 4444 %%%%!+%6EI%I:!H****!A1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 ^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!Y_BH8C$1C3=U%'T+^Q;_P CYKG_ &#3_P"C4K[#[BOCS]BW_D?-<_[!I_\
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MQ/H1RTM(M+0 4444 %%%% !1110-!1110,*<M-IRT Q:***!(****!A1110
M4ZFTZ@ HHHH **** "BBB@!RTM(M+0 4444 %%%% !1110 ^BBBH ****L H
MHHH&@HHHH*"BBB@ HHHH *=3:=0 4444 %%%% !1110 4444 %%%% !1110
MY:6D6EH **** "BBB@ I5ZTE*O6@:'4445/4H****H HHHH$PI5I*5:&)"T4
M45)04444 %%%% !1115 %%%% !1110 Y:6D6EJ6 4444 %%%% !11130!111
M3 ****!H****!A1110 4^F4^A@PHHHJ2 HHHH*044450PHHHH **** "BBB@
M!5I:1:6I8!1110 4444 %%%% !11130!3EIM.6FP%HHHJ0"BBB@ HHHH ***
M* "BBB@ HHHH ****"D%%%% F%%%% @HHHH ?1110 4444 %%%% T%%%%!04
M444 %%%% !1110 4444 %%%% !1110 4444$L5:6D6EH&@HHHH&%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% #Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH TM$7]Y*
MWHM;%9FAK^[D/J<5IU!V4_A0M%%%!H%%%% !1110!\_T445T'R04444 %%%%
M !1110 4JTE*M (6BBB@H**** "BBB@ HHHH **** "OAO\ :(_Y+)XC_P!^
M'_T1'7W+^E>)_$#]F>V\>>+]0UY]?FLVO"A,"VH8+M14ZEAG[OZUM2DHN[/!
MSC"U<514**NTSY K]'-"_P"0)I__ %[Q_P#H(KP'_ACBSP?^*HN,_P#7F/\
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M.&.I\DM&NI^:OTR.>.H(Y_/_  KU+PO^TEXV\+V4=H+NWU.",;4&H0F1E X
MW!@Q_$U[AXR_95\,>(IY;G29YM N)#G9 HDM\^R$@CZ X]!7G-[^Q[XBC9OL
MFMZ7<+_"9O-B)_ *U=?M(2W/BO[-S#!R_<O[GN8&M_M2>.M8MWAAFLM*W\;[
M& [Q[ N6Q]1CKUKR:ZN9KRXEN)I6FFE8N\DC;F9B<DD_C7NUI^Q[XED9/M6M
M:5"O\7DF5R!]"JY_2O0/!O[)WAS0[A+G6KV?7I5.X0E/(A_%026_[Z ]0:7/
M".P/+\QQC_?77FSS;]F?X4W7B+Q);>)[V!DT?3I/,MRZ\3SJ?EP#_"I^8GU
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MEN(_+<#!((8]1@'Z"O0ZY7;H?=89U72C[96D%%%%2;RV*&O?\@/4?^O:7_T
MU^:U?IC?6OVZRGMBQ19HVC+#J,C&?UKYT_X8OLN,^*KC\+)3[?WZZ*4XQO<^
M4SK U\9*,J,;V//_ -DW_DK"_P#7C-_-:^T:\=^%O[.=M\,/%/\ ;46N2Z@_
MD/#Y+VP0?-CON/I7L?\ C45)*4KH[\IPU3"8?V=56=PIMU:Q7UK+;7$:S6\R
MF.2-QE74@@@CN",C'O3J=6&S/;LI)I]3X(^-'PDOOA;XB=!&9=%NG9K*ZZC;
MU\MO]I1U_ ]ZX*SOI]/NHKJUF>WN(6$D4\;%65AR"&!R.?3TK])]:T/3_$6G
M2V&J64-_92C#P3H'4_@>A]QS7@OBO]CG2+Z62;0-8N-,9CN%M=)Y\8]@WRL!
M]=QKMA65K2/@\=D56-3VF%U78\IT[]J;Q[I]B+=KRUO"HVK/<VJF0>^5('XD
M$GZYKS[Q=XVUOQYJG]H:Y?R7LX&U,X"QJ>R*. /\:]@N/V-_%2N/(UG1Y4_B
M:1I4XX[>616WH/[&-PTRMK?B.-(P?FBL8"Q;Z.V /^^3]*TYJ<=3AE@\TQ"Y
M)IV\WH?/WA?POJ7C+7+72=)M6N;RX<*J+T4=V;T4 9)K[^^&_@:U^'7@[3]$
MM2LAA7=-,HQYLIY=_H3T]  .U,\!_#/P]\-=/-KHED(G< 374I#3S$=-[=_H
M ![5U/\ GGK7/4J<VB/J\KRM8&+G-WD_P&S0QW,+PRHLD4@*NCC(8'@@_4$U
M\)?&WX-WOPOUZ1X(I)_#]R^;2ZQG;GGRG/9QVSPP%?=]5=4TFRUS3YK'4+6*
M\LIAME@G7<C#W'ZY]JB$W Z\QR^&/A9Z274_,_=CW[[A_/\ STKMM-^-GCK1
M[+[);>)[X0* %61Q(0!V!8$C@CI7T#XP_8]T74YI9_#^J3:,S'<+:XC\^('T
M!SD#ZDUPDO[&_BM9 (]8T=H\_,SO*I'_ )#(KK]I"6Y\,\KS'"RM33^3/$M:
M\0:EXEOWO=6O[C4;MA@S7$A=B!T&3VI=!\/ZAXHU:VTO2K1[R]N&V1PQCKP>
M2>P R<]N37T1H7[%]TTJMK/B2*.('YHK&W+$CT#-@#_OD_2O=_ 'PK\.?#6S
M:+1;+9.XQ+>3$//)_O-V'L ![5,JT8JT3HPV1XK$5.;$>ZOQ&_"CX>P?#+P5
M9Z-$PEN,F:ZF7I),V-Q^@P%'?"C/-==)&DT;QNBR(ZE2C#(.01@CO_\ K]:=
M17%=WN?H5.C&G35*.R/A[X[_  /O/AOJ\VI:="T_AFXDW12J"?LQ//E.>H]%
M8]1C/.:\B^G]*_3JXMXKJWDAGC2:&12CQR#<K ]B._TQS7BGC;]DSPKXBFDN
M-'GF\.W+'.R)?-M\_P"X2-OT! KKA65O>/B\?D,W-U,+K?IV]#YB\/\ Q@\:
M>%K-;33/$5[!:H-J02,)50>@5U( ]A65XF\<Z_XRF1];U>[U+8<HLTI*H?55
MP%%>RWW[&?B>.0_8]<TF=,_>N/-B./<!7_F:O:/^Q?JDDJG5/$=G#$.JV<#R
MD^P+;1S[UIST]SR?[/S.:]G9M=KGSG!!)=31PPQM+-(VU8XU+%F)X '<^F/>
MOLC]G+X&MX#M?[?UV$+K]RI6*%C_ ,>L9ZCC^(]R.@X[FNP^'7P,\+?#5EGL
M;4WNI@?\A"](>0?[G&$_  ^]>A5A4J\RLCZ/*\E^KM5:^LNW8/KU[U\I?MH_
M\AWPQ_U[3?\ H:U]6UY=\8O@7!\7K[3;B;5Y---E&\85(!)OW$'NP]*B%HRN
MSU\TP]3%865.DM6?"5?H5\$O^22^%/\ KPCKQ_\ X8LL\_\ (UW!Z$_Z$/\
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M1110 4444#04444#"G+3:<M ,6BBB@2"BBB@84444 %.IM.H **** "BBB@
MHHHH <M+2+2T %%%% !1110 4444 /HHHJ "BBBK ****!H****"@HHHH **
M** "G4VG4 %%%% !1110 4444 %%%% !1110 4444 .6EI%I: "BBB@ HHHH
M *5>M)2KUH&AU%%%3U*"BBBJ ****!,*5:2E6AB0M%%%24%%%% !1110 444
M50!1110 4444 .6EI%I:E@%%%% !1110 4444T 4444P"BBB@:"BBB@84444
M %/IE/H8,****D@****"D%%%%4,**** "BBB@ HHHH 5:6D6EJ6 4444 %%%
M% !1110 4444T 4Y:;3EIL!:***D HHHH **** "BBB@ HHHH **** "BBB@
MI!1110)A1110(**** 'T444 %%%% !1110-!11104%%%% !1110 4444 %%%
M% !1110 4444 %%%%!+%6EI%I:!H****!A1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 ^
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH ***4<\=Z!FYI*;;-#_ 'LFKM1P+Y4*
M+Z"I:@[HJR"BBB@84444 %%%% 'S_11170?)!1110 4444 %%%% !2K24JT
MA:***"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****H HHHJ20HHHH
M **** "E7K24J]: 0ZBBB@H**** "BBB@ HHHH **** "BBB@ HHHH ****
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MCBBC&%51T JQ7!)\SN?I&$PZPU&-)= HHHJ3L"BBB@:"BBB@H**** "BBB@
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MHHJP'T445!84444$A1110(*<M-IRT#0M%%%!04444 %.IM.H **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTY:3!BT444D(****H04444%(****!A1110 JTM(M+4L HHHI %%%%6 4444
M/HHHJ "BBB@ HHHIH:"G+3:<M-C8M%%%22%%%% ;E'4M$T[65":AI]K?*.BW
M,"R#]0:SO^%?^%^/^*;TG/\ UXQ<?^.UOT4[F?LJ<M7$J6.E66EQLMC9V]FK
M=5@A"?H *MT447-8Q45H%%%%-%!3J;3J3 ****0!1110 4444 %%%% !1115
M@/HHHJ"PHHHH)"BBB@04Y:;3EH&A:***"@HHHH *=3:=0 4444 %%%% !111
M0 4444 %%%% #EI:1:6@ HHHH **** "BBB@:"BBB@84Y:;3EH!BT444"044
M44#"BBB@ IU-IU !1110 4444 %%%% #EI:1:6@ HHHH **** "BBB@!]%%%
M0 44458!1110-!11104%%%% !1110 4ZFTZ@ HHHH **** "BBB@ HHHH **
M** "BBB@!RTM(M+0 4444 %%%% !2KUI*5>M T.HHHJ>I044450!1110)A2K
M24JT,2%HHHJ2@HHHH **** "BBBJ **** "BBB@!RTM(M+4L HHHH **** "
MBBBF@"BBBF 4444#04444#"BBB@ I],I]#!A1114D!11104@HHHJAA1110 4
M444 %%%% "K2TBTM2P"BBB@ HHHH **** "BBBF@"G+3:<M-@+1114@%%%%
M!1110 4444 %%%% !1110 4444%(****!,****!!1110 ^BBB@ HHHH ****
M!H****"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH)8JTM(M+0-!1110,
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** 'T444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !R>!
MUKI+.'[/;HG<#FLC2K?SKC<1\J<GZ]JW5I,Z:4;*XM%%%2;A1110 4444 %%
M%% 'S_11170?)!1110 4444 %%%% !2K24JT A:***"@HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ****H HHHI$A1112 **** "E7K24J]: 0ZBBB@H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *5>M)2KUH =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444%A1110 ZBBB@@**** "BBB@ HHHH&@HHHH*"BBB@ HHHH **
M** %%.IHIU !1110 4444 %%%% !1110 4444 %%%% #Z*** "BBB@ HHHH&
M@HHHH*"BBB@3"BBB@D**** "G4VG5+&@HHHIHH****8!1110 4444 %%%% #
MEI:1:6I8!1115 %%%% !1110 4444 %%%% T%.6FTY:3!BT444D(****H044
M44%(****!A1110 JTM(M+4L HHHI %%%%6 4444 /HHHJ "BBB@ HHHIH:"G
M+3:<M-C8M%%%22%%%% !1110-!11104%%%%4@"G4VG4F 4444@"BBB@ HHHH
M **** "BBBK ?1114%A11102%%%% @IRTVG+0-"T444%!1110 4ZFTZ@ HHH
MH **** "BBB@ HHHH **** '+2TBTM !1110 4444 %%%% T%%%% PIRTVG+
M0#%HHHH$@HHHH&%%%% !3J;3J "BBB@ HHHH **** '+2TBTM !1110 4444
M %%%% #Z***@ HHHJP"BBB@:"BBB@H**** "BBB@ IU-IU !1110 4444 %%
M%% !1110 4444 %%%% #EI:1:6@ HHHH **** "E7K24J]:!H=1114]2@HHH
MJ@"BBB@3"E6DI5H8D+1114E!1110 4444 %%%%4 4444 %%%% #EI:1:6I8!
M1110 4444 %%%%- %%%%, HHHH&@HHHH&%%%% !3Z93Z&#"BBBI("BBB@I!1
M115#"BBB@ HHHH **** %6EI%I:E@%%%% !1110 4444 %%%%- %.6FTY:;
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MUH&AU%%%3U*"BBBJ ****!,*5:2E6AB0M%%%24%%%% !1110 44450!1110
M4444 .6EI%I:E@%%%% !1110 4444T 4444P"BBB@:"BBB@84444 %/IE/H8
M,****D@****"D%%%%4,**** "BBB@ HHHH 5:6D6EJ6 4444 %%%% !1110
M4444T 4Y:;3EIL!:***D HHHH **** "BBB@ HHHH **** "BBB@I!1110)A
M1110(**** 'T444 %%%% !1110-!11104%%%% !1110 4444 %%%% !1110
M4444 %%%%!+%6EI%I:!H****!A1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 ^BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BB@ L<#J>* )+>%KB544<G]*Z."%8(E1>B\56TZS^S1<_P"L
M;[W^%7*EG73CRH6BBBD:A1110 4444 %%%% !1110!\_T445T'R04444 %%%
M% !1110 4JTE*M (6BBB@H**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBBJ ****1(4444@"BBB@ I5ZTE*O6@$.HHHH*"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "E7K24J]: '4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%!84444 .HH
MHH("BBB@ HHHH ****!H****"@HHHH **** "BBB@!13J:*=0 4444 %%%%
M!1110 4444 %%%% !1110 ^BBB@ HHHH ****!H****"@HHHH$PHHHH)"BBB
M@ IU-IU2QH****:*"BBBF 4444 %%%% !1110 Y:6D6EJ6 44450!1110 44
M44 %%%% !1110-!3EIM.6DP8M%%%)""BBBJ$%%%%!2"BBB@84444 *M+2+2U
M+ ****0!1115@%%%% #Z***@ HHHH ****:&@IRTVG+38V+1114DA1110 44
M44#04444%!1115( IU-IU)@%%%%( HHHH **** "BBB@ HHHJP'T445!8444
M4$A1110(*<M-IRT#0M%%%!04444 %.IM.H **** "BBB@ HHHH **** "BBB
M@!RTM(M+0 4444 %%%% !1110-!1110,*<M-IRT Q:***!(****!A1110 4Z
MFTZ@ HHHH **** "BBB@!RTM(M+0 4444 %%%% !1110 ^BBBH ****L HHH
MH&@HHHH*"BBB@ HHHH *=3:=0 4444 %%%% !1110 4444 %%%% !1110 Y:
M6D6EH **** "BBB@ I5ZTE*O6@:'4445/4H****H HHHH$PI5I*5:&)"T445
M)04444 %%%% !1115 %%%% !1110 Y:6D6EJ6 4444 %%%% !11130!1113
M****!H****!A1110 4^F4^A@PHHHJ2 HHHH*044450PHHHH **** "BBB@!5
MI:1:6I8!1110 4444 %%%% !11130!3EIM.6FP%HHHJ0"BBB@ HHHH ****
M"BBB@ HHHH ****"D%%%% F%%%% @HHHH ?1110 4444 %%%% T%%%%!0444
M4 %%%% !1110 4444 %%%% !1110 4444$L5:6D6EH&@HHHH&%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% #Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH .>W7^=;&F:?Y?[V0?-V'I3--T
M[&)9?JJUJK29TTX6U"EHHJ3<**** "BBB@ HHHH **** "BBB@#Y_HHHKH/D
M@HHHH **** "BBB@ I5I*5: 0M%%%!04444 %%%% !1110 4444 %%%% !11
M10 4444 %%%%4 4444B0HHHI %%%% !2KUI*5>M (=11104%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %*O6DI5ZT
M .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****"
MPHHHH =11100%%%% !1110 4444#04444%!1110 4444 %%%% "BG4T4Z@ H
MHHH **** "BBB@ HHHH **** "BBB@!]%%% !1110 4444#04444%!1110)A
M11102%%%% !3J;3JEC04444T4%%%%, HHHH **** "BBB@!RTM(M+4L HHHJ
M@"BBB@ HHHH **** "BBB@:"G+3:<M)@Q:***2$%%%%4(****"D%%%% PHHH
MH 5:6D6EJ6 4444@"BBBK **** 'T445 !1110 4444T-!3EIM.6FQL6BBBI
M)"BBB@ HHHH&@HHHH*"BBBJ0!3J;3J3 ****0!1110 4444 %%%% !1115@/
MHHHJ"PHHHH)"BBB@04Y:;3EH&A:***"@HHHH *=3:=0 4444 %%%% !1110
M4444 %%%% #EI:1:6@ HHHH **** "BBB@:"BBB@84Y:;3EH!BT444"04444
M#"BBB@ IU-IU !1110 4444 %%%% #EI:1:6@ HHHH **** "BBB@!]%%%0
M44458!1110-!11104%%%% !1110 4ZFTZ@ HHHH **** "BBB@ HHHH ****
M "BBB@!RTM(M+0 4444 %%%% !2KUI*5>M T.HHHJ>I044450!1110)A2K24
MJT,2%HHHJ2@HHHH **** "BBBJ **** "BBB@!RTM(M+4L HHHH **** "BB
MBF@"BBBF 4444#04444#"BBB@ I],I]#!A1114D!11104@HHHJAA1110 444
M4 %%%% "K2TBTM2P"BBB@ HHHH **** "BBBF@"G+3:<M-@+1114@%%%% !1
M110 4444 %%%% !1110 4444%(****!,****!!1110 ^BBB@ HHHH ****!H
M****"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH)8JTM(M+0-!1110,**
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** 'T444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%26\#W#[47)_04#5^A'@MP!D]
ML=:V-/TSR_WDO+=E]*FL]/2U^8_-)_>_PJW4G1"G;5BXH%%+2-PHHHH ****
M "BBB@ HHHH **** "BBB@#Y_HHHKH/D@HHHH **** "BBB@ I5I*5: %HHH
MH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHJ@"BBBI)"BBB@ HHH
MH *5>M)2KUH =11104%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %*O6DI5ZT .HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH ****"PHHHH =11100%%%% !1110 4444#0
M4444%!1110 4444 %%%% "BG4T4Z@ HHHH **** "BBB@ HHHH **** "BBB
M@!]%%% !1110 4444#04444%!1110)A11102%%%% !3J;3JEC04444T4%%%%
M, HHHH **** "BBB@!RTM(M+4L HHHJ@"BBB@ HHHH **** "BBB@:"G+3:<
MM)@Q:***2$%%%%4(****"D%%%% PHHHH 5:6D6EJ6 4444@"BBBK **** 'T
M445 !1110 4444T-!3EIM.6FQL6BBBI)"BBB@ HHHH&@HHHH*"BBBJ0!3J;3
MJ3 ****0!1110 4444 %%%% !1115@/HHHJ"PHHHH("BBB@ IRTVG+0-"T44
M4%!1110 4ZFTZ@ HHHH **** "BBB@ HHHH **** '+2TBTM !1110 4444
M%%%% T%%%% PIRTVG+0#%HHHH$@HHHH&%%%% !3J;3J "BBB@ HHHH ****
M'+2TBTM !1110 4444 %%%% #Z***@ HHHJP"BBB@:"BBB@H**** "BBB@ I
MU-IU !1110 4444 %%%% !1110 4444 %%%% #EI:1:6@ HHHH **** "E7K
M24J]:!H=1114]2@HHHJ@"BBB@3"E6DI5H8D+1114E!1110 4444 %%%%4 44
M44 %%%% #EI:1:6I8!1110 4444 %%%%- %%%%, HHHH&@HHHH&%%%% !3Z9
M3Z&#"BBBI("BBB@I!1115#"BBB@ HHHH **** %6EI%I:E@%%%% !1110 44
M44 %%%%- %.6FTY:; 6BBBI **** "BBB@ HHHH **** "BBB@ HHHH*0444
M4"84444""BBB@!]%%% !1110 4444#04444%!1110 4444 %%%% !1110 44
M44 %%%% !11102Q5I:1:6@:"BBB@84444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 /HHHH
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M_OM__B:/^%::I_SVM/\ OM__ (FCF0?5JO\ *<K176?\*UU3_GM:_P#?;?\
MQ-'_  K75/\ GM:_]]M_\31S(/JU7^4Y.BNL_P"%:ZI_SVM?^^V_^)H_X5KJ
MG_/:U_[[;_XFCF0?5JO\IR=%=9_PK75/^>UK_P!]M_\ $T?\*UU3_GM:_P#?
M;?\ Q-',@^K5?Y3DZ*ZS_A6NJ?\ /:U_[[;_ .)H_P"%:ZI_SVM?^^V_^)HY
MD'U:K_*<G176?\*UU3_GM:_]]M_\31_PK75/^>UK_P!]M_\ $T<R#ZM5_E.3
MHKK/^%:ZI_SVM?\ OMO_ (FC_A6NJ?\ /:U_[[;_ .)HYD'U:K_*<G176?\
M"M=4_P">UK_WVW_Q-'_"M=4_Y[6O_?;?_$T<R#ZM5_E.3HKK/^%:ZI_SVM?^
M^V_^)H_X5KJG_/:U_P"^V_\ B:.9!]6J_P IR=%=9_PK75/^>UK_ -]M_P#$
MT?\ "M=4_P">UK_WVW_Q-',@^K5?Y3DZ*ZS_ (5KJG_/:U_[[;_XFC_A6NJ?
M\]K7_OMO_B:.9!]7J_RG)T5UG_"M=3_Y[VO_ 'VW_P 31_PK74_^>]K_ -]M
M_P#$T<R+^KU?Y3DZ*ZS_ (5KJ?\ SWM?^^V_^)H_X5KJ?_/>U_[[;_XFCF0?
M5ZO\IRM%=7_PK;4_^>UK_P!]M_\ $T?\*VU/_GK:_P#?;?\ Q-',B?J]7^4Y
M2BNK_P"%;ZG_ ,];7_OMO_B:/^%;ZG_SUM?^^V_^)HYD+ZM5_E.4HKJ_^%;Z
MG_SUM?\ OMO_ (FC_A6^I_\ /6U_[[;_ .)HYD'U:K_*<I175_\ "M]3_P">
MMK_WVW_Q-'_"MM3_ .>UK_WVW_Q-',AK#U?Y3E**ZO\ X5MJ?_/:U_[[;_XF
MC_A6VI_\]K7_ +[;_P")HYD/ZO5_E.4HKJ_^%;:G_P ]K7_OMO\ XFC_ (5M
MJ?\ SVM?^^V_^)HYD/ZO5_E.4HKJ_P#A6VI_\]K7_OMO_B:/^%;:G_SVM?\
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M@>H_\];?_OIO_B:5T'L:G\IS=%=)_P ('J/_ #UM_P#OIO\ XFC_ (0/4?\
MGK;_ /?3?_$TKH/8U/Y3FZ*Z3_A ]1_YZV__ 'TW_P 31_P@>H_\];?_ +Z;
M_P")HNAJC4['-TY:Z+_A ]1_YZV__?3?_$T?\()J _Y:V_\ WTW_ ,33NA^Q
MJ=CGJ*Z+_A!=0_YZV_\ WTW_ ,31_P (+J'_ #UM_P#OIO\ XFE=$^QJ=CG:
M*Z/_ (034/\ GK;_ /?3?_$TG_""ZA_SUM_^^F_^)HN@]C4['.T5T7_""ZA_
MSVM_^^F_^)H_X074/^>MO_WTW_Q-%T-4:G8YVBNC_P"$$U#_ )ZV_P#WTW_Q
M-'_"":A_SUM_^^F_^)HNA^QJ=CG**Z/_ (034/\ GK;_ /?3?_$T?\()J'_/
M6W_[Z;_XFG=![&IV.<IU=#_P@NH?\];?_OIO_B:7_A!M0_YZV_\ WTW_ ,31
M=![&IV.=HKHO^$&U#_GK;_\ ?3?_ !-'_"#:A_SUM_\ OIO_ (FE=![&IV.=
MHKHO^$&U#_GK;_\ ?3?_ !-'_"#:A_SUM_\ OIO_ (FBZ#V-3L<[171?\(-J
M'_/6W_[Z;_XFC_A!M0_YZV__ 'TW_P 31=![&IV.=HKHO^$&U#_GK;_]]-_\
M31_P@VH?\];?_OIO_B:+H/8U.QSM%=%_P@VH?\];?_OIO_B:/^$'U#_GK;_]
M]-_\3570>QJ=C HKH?\ A![_ /YZV_\ WTW_ ,31_P (/?\ _/6W_P"^F_\
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MH/93[&'16Y_PB-[_ ,](?^^F_P */^$1O?\ GI#_ -]-_A1=![&?8PZ*W/\
MA$;W_GI#_P!]-_A1_P (C>_\](?^^F_PHN@]C/L8=%;G_"(WO_/2'_OIO\*/
M^$1O?^>D/_?3?X470>QGV,5:6MH>$;W_ )Z0_P#?3?X4O_"(WG_/2'_OIO\
M"BZ#V,^QB45M_P#"(WG_ #TA_P"^F_PH_P"$1O/^>D/_ 'TW^%%T'L9]C$HK
M;_X1&\_YZ0_]]-_A1_PB-Y_STA_[Z;_"BZ#V,^QB45M_\(C>?\](?^^F_P *
M/^$2O/\ GI#_ -]-_A0'LI]C'HK:_P"$3O/[\/\ WTW^%'_"*7G]^'_OIO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 444E "T444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^0_\
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MR#P2""""00:^9/VCOC%\%/BM\-=1M++6()O$-K$)-+D72[B-Q(N#Y8=H@ K
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MOJ'P-KLWBCP/X?UFX18I]1T^WNY(X^%1GC5R!GMDGK7YO_MB?\G(>,/K:?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[%E]&M6Q2FL+&E37=:_H?+'_  4-S_PL#POG_H&-_P"C37OW[$G_ ";SH?\
MUWNO_1[URW[67[-_BOXU>*]$U'P_+IR6]I9M!)]MG:-MQ<G@!&R,$5ZG^S?\
M.=6^%7PFTSPYK36[:A;RSO(;5R\>'E9Q@D#L?2B4E[)*YK@\)6AG5;$2@U%K
M?H?/_P#P4:&+?P+_ +][_*&NN_X)[\_!O6O^P]-_Z3V]:_[77P'\2_&V'PPO
MAV2Q0Z<UP9OMLK1_?\K;MPK<_(>U=!^RE\(=<^"_P^U'1?$#6;W=QJDEY&;*
M5I$\LPPH,DJN#E&XQZ4.2]C8=/"5EGLL1R/DY=^FQ\$?M&6TEK\<_'$;CEM4
ME<?1CN'Z,/\ .*_4#PGXHT[Q%X/TS6[6\AFL+FT6X6X5L)M*Y.?3&#D'H017
MSQ^T_P#LBWGQ4\1-XK\+75O;:U-&J7EG=$K'<;%VK(K@'#!0JX/! '(QSXQX
M1_8E^*>H,=.U&[MO#NC2L/M :],JNO'(BC.&/H&(Z=15R<*D%>6QYF%ACLIQ
MM;DH.<9O1K;YGF'[1WBRQ\<?&[Q5K.FS+<V,UPD<4RG*R".-(MRGN#LR/8BO
MOFX\-S^+OV28-)M8C/=W7A&);>)>KRBU4HOXL /QKYW^(O[!NOOKEO'X.FT_
M^R(K2*-I=2N76:689\QV 0CDFOLGP#H=SX:\">'=(NV1KNPTZWM9?+.4+I&J
MM@^F0:FK--1Y3IR; XF.)Q/UF%N=;]-3\O/@7IWA35OBCI&F^-DQH-XSV\C2
M3-$(I&7$;,RD$#=@9)P-W/%?:7C+]ECX)>!?"NI>(=4TBYCTZP@:>0KJ,Q9L
M#A5RXRQ. !GDD"N2^//[#LWBKQ!=^(/ ]Y:V<UY(TUSI=XS)%O/+-$P!QN/.
MTC )."!P/*(OV-_C+K*0:;?-#%I\)'E?;-5\R&/W55W$<>@[UHY1G9J5CR:.
M#KY<IT)X3VKOI+?_ #/5O@79_L]>)/'FD-X3L-6M?$T#M<6L-T;EOF0%BQ(9
MD' ZL<'..^*^PH_NUXA^SG^S/IOP+M;B[FNEU7Q'>)Y<UZ$V+''D'RXUR2!D
M DGDX'3I7N"]*Y:C3>CN?=931J4<.O:P4)/HE8=1116)[04444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% "4M%% !1110 4E+10 E+110 E+110 E+110 4444 %%%% !1
M110 E+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !6/XL\5:3X+T.ZUC6[Z+3M-M5WRW$QPHYP!ZDDD
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MK1L5&49KFB[CJ***184444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1124 +15?[9;M=&V$T9N%7>80PW;?7'I4Z]* %HHIK8[T .HJK:
MW]M?;Q;W,4^PX;RW#;?KBK(H 6BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5G'*)%T^XN(8D=?[LC1Q!B.?X2AK[$\,^&]+\(:#9:+HNGV^EZ38QB&VL[5
MD<2#H !_D]3R:!&FO2EHHH&%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MNBC351M,^6S[-*V5TJ<Z*3;=M3]"/^&S?@__ -#<W_@LN_\ XU1_PV;\'_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML\WRI&3=M\@XSMSC)QGK6-_P\>;_ *)\/_!U_P#<]?,/QJ_Y+)X\_P"P_?\
M_I1)7&5ZD:--J[1^+XCB',J=:<54LDVMEW]#[1_X>/-_T3X?^#K_ .YZ/^'C
MS?\ 1/A_X.O_ +GKXNHJO84^QS_ZR9G_ ,_?P7^1]H_\/'F_Z)\/_!U_]ST?
M\/'F_P"B?#_P=?\ W/7Q=11["GV#_63,_P#G[^"_R/M'_AX\W_1/A_X.O_N>
MC_AX\W_1/A_X.O\ [GKXNHH]A3[!_K)F?_/W\%_D?:/_  \>;_HGP_\ !U_]
MST?\/'F_Z)\/_!U_]SU\744>PI]@_P!9,S_Y^_@O\C]'_P!GS]K0_';QI>:
M?"W]B?9]/>^^T?VA]HW;9(TV;?*7'^LSG/;I7T-'G;SZU^>W_!/G_DM&K_\
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M_22>HG\+/4RO_?:7JC]01TI:0=*6O%/Z!%HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %)2TE $5U_J7^E?B[Z?2OVBNO]2_
MTK\7?3Z5WX7J?FW&.U'YA1117<?F84444 %%%% !1110 5].?\$^/^2U:O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E+24 177^I?Z5^+
MOI]*_:*Z_P!2_P!*_%WT^E=^%ZGYMQCM1^84445W'YF%%%% !1110 4444 %
M?3G_  3X_P"2U:M_V 9O_2BWKYCKZ<_X)\?\EJU;_L S?^E%O657X&>YD?\
MR,J/J?H5Z4HI/2E%>+U/WD6BBBJ **** "D;M]:6D;M]: /R+^-7_)9/'G_8
M?O\ _P!*)*XRNS^-7_)9/'G_ &'[_P#]*)*XRO<CLO0_G/%?[Q4]7^84444S
MF"BBB@ HHHH **** /IS_@GQ_P EIU?_ + $_P#Z46]?H6OW17YZ?\$^/^2T
MZO\ ]@"?_P!*+>OT+7[HKR\3_$/V?A7_ )%L?5BT445S'UP4444 %(:6D-)[
M )VK\B_C5_R63QY_V'K_ /\ 2B2OUT[5^1?QJ_Y+)X\_[#U__P"E$E=N%W9^
M?<8_[O2]7^1QM%%%>B?E84444 %%%% !1110 5[+^QY_R<9X0_WKK_TDGKQJ
MO9?V//\ DXSPA_O77_I)/43^%GJ97_OM+U1^H(Z4M(.E+7BG] BT444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2TE $5
MU_J7^E?B[Z?2OVBNO]2_TK\7?3Z5WX7J?FW&.U'YA1117<?F84444 %%%% !
M1110 5].?\$^/^2U:M_V 9O_ $HMZ^8Z^G/^"?'_ "6K5O\ L S?^E%O657X
M&>YD?_(RH^I^A7I2BD]*45XO4_>1:***H HHHH *1NWUI:1NWUH _(OXU?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E
M+24 177^I?Z5^+OI]*_:*Z_U+_2OQ=]/I7?A>I^;<8[4?F%%%%=Q^9A1110
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M2TE $5U_J7^E?B[Z?2OVBNO]2_TK\7?3Z5WX7J?FW&.U'YA1117<?F84444
M%%%% !1110 5].?\$^/^2U:M_P!@&;_THMZ^8Z^G/^"?'_):M6_[ ,W_ *46
M]95?@9[F1_\ (RH^I^A7I2BD]*45XO4_>1:***H HHHH *1NWUI:1NWUH _(
MOXU?\ED\>?\ 8?O_ /THDKC*[/XU?\ED\>?]A^__ /2B2N,KW([+T/YSQ7^\
M5/5_F%%%%,Y@HHHH **** "BBB@#Z<_X)\?\EIU?_L 3_P#I1;U^A:_=%?GI
M_P $^/\ DM.K_P#8 G_]*+>OT+7[HKR\3_$/V?A7_D6Q]6+1117,?7!1110
M4AI:0TGL G:OR+^-7_)9/'G_ &'K_P#]*)*_73M7Y%_&K_DLGCS_ +#U_P#^
ME$E=N%W9^?<8_P"[TO5_D<;1117HGY6%%%% !1110 4444 %>R_L>?\ )QGA
M#_>NO_22>O&J]E_8\_Y.,\(?[UU_Z23U$_A9ZF5_[[2]4?J".E+2#I2UXI_0
M(M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 >&_M;_M.0?LM> ]+\0MH/\ PDEQJ&HK81V
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M77^I?Z5^+OI]*_:*Z_U+_2OQ=]/I7?A>I^;<8[4?F%%%%=Q^9A1110 4444
M%%%% !7TY_P3X_Y+5JW_ & 9O_2BWKYCKZ<_X)\?\EJU;_L S?\ I1;UE5^!
MGN9'_P C*CZGZ%>E**3TI17B]3]Y%HHHJ@"BBB@ I&[?6EI&[?6@#\B_C5_R
M63QY_P!A^_\ _2B2N,KL_C5_R63QY_V'[_\ ]*)*XRO<CLO0_G/%?[Q4]7^8
M4444SF"BBB@ HHHH **** /IS_@GQ_R6G5_^P!/_ .E%O7Z%K]T5^>G_  3X
M_P"2TZO_ -@"?_THMZ_0M?NBO+Q/\0_9^%?^1;'U8M%%%<Q]<%%%% !2&EI#
M2>P"=J_(OXU?\ED\>?\ 8>O_ /THDK]=.U?D7\:O^2R>//\ L/7_ /Z425VX
M7=GY]QC_ +O2]7^1QM%%%>B?E84444 %%%% !1110 5[+^QY_P G&>$/]ZZ_
M]))Z\:KV7]CS_DXSPA_O77_I)/43^%GJ97_OM+U1^H(Z4M(.E+7BG] BT444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M44 %(W;ZTM(W;ZT ?D7\:O\ DLGCS_L/W_\ Z425QE=G\:O^2R>//^P_?_\
MI1)7&5[D=EZ'\YXK_>*GJ_S"BBBF<P4444 %%%% !1110!].?\$^/^2TZO\
M]@"?_P!*+>OT+7[HK\]/^"?'_):=7_[ $_\ Z46]?H6OW17EXG^(?L_"O_(M
MCZL6BBBN8^N"BBB@ I#2TAI/8!.U?D7\:O\ DLGCS_L/7_\ Z425^NG:OR+^
M-7_)9/'G_8>O_P#THDKMPN[/S[C'_=Z7J_R.-HHHKT3\K"BBB@ HHHH ****
M "O9?V//^3C/"'^]=?\ I)/7C5>R_L>?\G&>$/\ >NO_ $DGJ)_"SU,K_P!]
MI>J/U!'2EI!TI:\4_H$6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ J*X_P!2_P!*EJ*X_P!2_P!*<=T1
M4^!GXN>GTHH]/I17MK9'\XU/XDO4****9F%%%% !1110 4444 ?3G_!/C_DM
M.K_]@"?_ -*+>OT+7[HK\]/^"?'_ "6G5_\ L 3_ /I1;U^A:_=%>7B?XA^S
M\*_\BV/JQ:***YCZX**** "DI:2@"*Z_U+_2OQ=]/I7[177^I?Z5^+OI]*[\
M+U/S;C':C\PHHHKN/S,**** "BBB@ HHHH *^G/^"?'_ "6K5O\ L S?^E%O
M7S'7TY_P3X_Y+5JW_8!F_P#2BWK*K\#/<R/_ )&5'U/T*]*44GI2BO%ZG[R+
M1115 %%%% !2-V^M+2-V^M 'Y%_&K_DLGCS_ +#]_P#^E$E<979_&K_DLGCS
M_L/W_P#Z425QE>Y'9>A_.>*_WBIZO\PHHHIG,%%%% !1110 4444 ?3G_!/C
M_DM.K_\ 8 G_ /2BWK]"U^Z*_/3_ ()\?\EIU?\ [ $__I1;U^A:_=%>7B?X
MA^S\*_\ (MCZL6BBBN8^N"BBB@ I#2TAI/8!.U?D7\:O^2R>//\ L/7_ /Z4
M25^NG:OR+^-7_)9/'G_8>O\ _P!*)*[<+NS\^XQ_W>EZO\CC:***]$_*PHHH
MH **** "BBB@ KV7]CS_ ).,\(?[UU_Z23UXU7LO['G_ "<9X0_WKK_TDGJ)
M_"SU,K_WVEZH_4$=*6D'2EKQ3^@1:*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGTKOPO4_-N,=J/S"BBBNX_,PHHHH **** "BBB@ KZ<_X)\?\EJU;_L S?\
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M#_>NO_22>HG\+/4RO_?:7JC]01TI:0=*6O%/Z!%HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *BN/\
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M+^QY_P G&>$/]ZZ_]))ZB?PL]3*_]]I>J/U!'2EI!TI:\4_H$6BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0KTI12>E**\7J?O(M%%%4 4444 %(W;ZTM(W;ZT ?D7\:O\ DLGCS_L/W_\
MZ425QE=G\:O^2R>//^P_?_\ I1)7&5[D=EZ'\YXK_>*GJ_S"BBBF<P4444 %
M%%% !1110!].?\$^/^2TZO\ ]@"?_P!*+>OT+7[HK\]/^"?'_):=7_[ $_\
MZ46]?H6OW17EXG^(?L_"O_(MCZL6BBBN8^N"BBB@ I#2TAI/8!.U?D7\:O\
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MBYZ?2BCT^E%>VMD?SC4_B2]0HHHIF84444 %%%% !1110!].?\$^/^2TZO\
M]@"?_P!*+>OT+7[HK\]/^"?'_):=7_[ $_\ Z46]?H6OW17EXG^(?L_"O_(M
MCZL6BBBN8^N"BBB@ I*6DH BNO\ 4O\ 2OQ=]/I7[177^I?Z5^+OI]*[\+U/
MS;C':C\PHHHKN/S,**** "BBB@ HHHH *^G/^"?'_):M6_[ ,W_I1;U\QU].
M?\$^/^2U:M_V 9O_ $HMZRJ_ SW,C_Y&5'U/T*]*44GI2BO%ZG[R+1115 %%
M%% !2-V^M+2-V^M 'Y%_&K_DLGCS_L/W_P#Z425QE=G\:O\ DLGCS_L/W_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM?NBO+Q/\0_9^%?^1;'U8M%%%<Q]<%%%% !2&EI#2>P"=J_(OXU?\ED\>?\
M8>O_ /THDK]=.U?D7\:O^2R>//\ L/7_ /Z425VX7=GY]QC_ +O2]7^1QM%%
M%>B?E84444 %%%% !1110 5[+^QY_P G&>$/]ZZ_]))Z\:KV7]CS_DXSPA_O
M77_I)/43^%GJ97_OM+U1^H(Z4M(.E+7BG] BT444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+<?_ !^C_AX)\1O^@5X:_P# 6X_^/U\R44>QAV#^W<Q_Y^L^F_\ AX)\1O\
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MI:2@"*Z_U+_2OQ=]/I7[177^I?Z5^+OI]*[\+U/S;C':C\PHHHKN/S,****
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MB@ I#2TAI/8!.U?D7\:O^2R>//\ L/7_ /Z425^NG:OR+^-7_)9/'G_8>O\
M_P!*)*[<+NS\^XQ_W>EZO\CC:***]$_*PHHHH **** "BBB@ KV7]CS_ ).,
M\(?[UU_Z23UXU7LO['G_ "<9X0_WKK_TDGJ)_"SU,K_WVEZH_4$=*6D'2EKQ
M3^@1:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **:WK6!HOC[PSXFU*?3M'\1:3JM_;@M-:V-[
M%-+$ P4ED5B0 2!R.I% '0T4U>E.H **H:UKFG>'K%[W5=0M=,LH_OW%Y,L4
M:_5F( J'0O$VC^*+4W.C:K8ZO; X,UC<I,@XSC<I(_\ UT :M%(*6@ HHHH
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MX\*>!/#NB74ZW-UIFG6]E+.A)61XXE1F!/."5)YYYH$;]%%% PHHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P!)[>N;$?PSZ_A7_D8KT9]0T445Y9^S!1110 4444 %</\ '/\ Y(MX]_[
M%_\ ^D[UW%</\<_^2+>/?^P!?_\ I.]5'='/B?X$_1_D?D?1117MG\XA1110
M,**** "BBB@ HHHIB/L__@G#_KOB#]-/_P#;FOM@5\3_ /!.'_7?$'Z:?_[<
MU]L"O(K?&S]RX>_Y%M+Y_F+1116!](%%%% !24M)0!%=?ZE_I7XN^GTK]HKK
M_4O]*_%WT^E=^%ZGYMQCM1^84445W'YF%%%% !1110 4444 %?9__!.'_CX\
M?_33_P#VYKXPK[/_ ."</_'QX_\ II__ +<UA7^!GT_#?_(RI_,^US]X4M(?
MO"EKR3]N%HHHH **** "HKC_ %+_ $J6HKC_ %+_ $IQW1%3X&?BYZ?2BCT^
ME%>VMD?SC4_B2]0HHHIF84444 %%%% !1110!].?\$^/^2TZO_V )_\ THMZ
M_0M?NBOST_X)\?\ ):=7_P"P!/\ ^E%O7Z%K]T5Y>)_B'[/PK_R+8^K%HHHK
MF/K@HHHH *2EI* (KK_4O]*_%WT^E?M%=?ZE_I7XN^GTKOPO4_-N,=J/S"BB
MBNX_,PHHHH **** "BBB@ KZ<_X)\?\ ):M6_P"P#-_Z46]?,=?3G_!/C_DM
M6K?]@&;_ -*+>LJOP,]S(_\ D94?4_0KTI12>E**\7J?O(M%%%4 4444 %(W
M;ZTM(W;ZT ?D7\:O^2R>//\ L/W_ /Z425QE=G\:O^2R>//^P_?_ /I1)7&5
M[D=EZ'\YXK_>*GJ_S"BBBF<P4444 %%%% !1110!].?\$^/^2TZO_P!@"?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EICC].: /$
MOVJOVG_#G[-O@.ZO;RZBN/$]W"ZZ1HZG=+/*00KLHY$2GEFXZ8') KQ?_@G5
M^TQX_P#VA;WQXGC?5(-272H[%K00VD4&TRF</GRU&?\ 5KU':O&/$G_!/K7=
M/\"_$WXG?%?Q+)JFMVFD:AJ-CIUO=//)YJ0NT;W%PX^;;Q\BY&0,M@$5J_\
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M .1E3^9]KG[PI:0_>%+7DG[<+1110 4444 %17'^I?Z5+45Q_J7^E..Z(J?
MS\7/3Z44>GTHKVULC^<:G\27J%%%%,S"BBB@ HHHH **** /IS_@GQ_R6G5_
M^P!/_P"E%O7Z%K]T5^>G_!/C_DM.K_\ 8 G_ /2BWK]"U^Z*\O$_Q#]GX5_Y
M%L?5BT445S'UP4444 %)2TE $5U_J7^E?B[Z?2OVBNO]2_TK\7?3Z5WX7J?F
MW&.U'YA1117<?F84444 %%%% !1110 5].?\$^/^2U:M_P!@&;_THMZ^8Z^G
M/^"?'_):M6_[ ,W_ *46]95?@9[F1_\ (RH^I^A7I2BD]*45XO4_>1:***H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=])8_9[N17<E%1MV5XP1(/RKUBOCG_@E7_R;)==O^*@N_P#T5!7V-0,****
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M_!__ *&YO_!9=_\ QJOS$HH^K0\P_P!;\=_)'[G_ )GZ=_\ #9OP?_Z&YO\
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M=?ZE_I7XN^GTKOPO4_-N,=J/S"BBBNX_,PHHHH **** "BBB@ KZ<_X)\?\
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MR.-HHHKT3\K"BBB@ HHHH **** "O9?V//\ DXSPA_O77_I)/7C5>R_L>?\
M)QGA#_>NO_22>HG\+/4RO_?:7JC]01TI:0=*6O%/Z!%HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'Q(_9WT[QE_PE%S;^,=8T_\ M+3]/\I/L>UQNACD)^;+KM)8$;2_1MN6W_\
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MGIPP!YSTKK5Y&:_(3X"WU[^R?^WN_@JTO[B71+G6?^$?N$D8#[3;SD"V>08
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MR:K\2O\ L%-_Z&M>VUXK^VA#)<?LN?$>*&-I96TI@JH"6/SKT H ^6O^"/\
M_P B[\3?^ONP_P#0)Z_0^OSW_P""1VG76G>'?B2+JTFMF:ZL2JSQE"<)/ZU[
M!^WM\>_'?P$\(^%;[P&D+W>H7TL%SYUG]I_=K&&&!VY- D?5%?)7_!4#_DU6
M_P#^PM9?^A-7L/[+OC[7OBA\!?"7BCQ.$&NZC!*]T(X?)7<LTB#"=OE45Y'_
M ,%-K2XOOV6[Z*VADN)/[5LVV1(6; 9L\ 4 S(_X)4_\FQW7_8P77_HJ"OL>
MOC__ ():V5S8?LT7,5U!);R_V_='9*A0X,4'.#7V!0,**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FMQS3J:
MW7F@!.*4?6O&/VJ?C%K7P3\ Z;KFA6]C<7=QJ<=DZ:A&[IL:*5S@(ZG=F,=^
MF:^6E_X*!_$;MI?AK'_7K<?_ !^MXT935T?/XS/,'@*WL:S:?IW/T,S[T9]Z
M_/3_ (>"?$;_ *!7AK_P%N/_ (_1_P /!/B-_P! KPU_X"W'_P ?JOJ\SB_U
MHR[^9_<?H7GWHS[U^>G_  \$^(W_ $"O#7_@+<?_ !^C_AX)\1O^@5X:_P#
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M_P"/U^?=%>E]7@?DW^M68>7W'Z"?\/"?A_\ ] /Q)_X#V_\ \?H_X>$_#_\
MZ ?B3_P'M_\ X_7Y]T4OJ\!?ZU9AY?<?H)_P\)^'_P#T _$G_@/;_P#Q^C_A
MX3\/_P#H!^)/_ >W_P#C]?GW11]7@'^M68>7W'Z"?\/"?A__ - /Q)_X#V__
M ,?H_P"'A/P__P"@'XD_\![?_P"/U^?=%'U> ?ZU9AY?<?H)_P /"?A__P!
M/Q)_X#V__P ?I&_X*$?#XKSHGB;\+>W_ /C]?GY11]7@'^M68^7W'Z]_"[XB
M:=\5/!&G>)])@NK:QOO,V0WBJLJ[)&C.0K,.J'&">,5U@KQ#]C'_ )-Q\*_[
MUY_Z635[?7G32C)I'ZU@ZDJV'A4ENTA:***@[ HHHH *0TM(>U 'B'[:'_)N
M/BOZVG_I7#7YCU^G'[:'_)N/BOZVG_I7#7YCUZ6&^$_(^+O]\AZ!11176?#!
M1110 4444 %%%% !7Z#_ /!/3_DC>M_]A^;_ -)[>OSXK]!_^">G_)&];_[#
M\W_I/;US8C^&?7\*_P#(Q7HSZAHHHKRS]F"BBB@ HHHH *\0_;0_Y-Q\5_6T
M_P#2N&O;Z\0_;0_Y-Q\5_6T_]*X:TI_$CSLQ_P!SJ^C/S&HHHKV3^>@HHHH&
M%%%% !1110 4444UN(_0?_@GI_R1O6_^P_-_Z3V]?4-?+W_!/3_DC>M_]A^;
M_P!)[>OJ&O&J_P 1G[WDG_(NH?X0HHHK(]L**** "D/:EI#VH X?XY?\D7\?
M?]@"_P#_ $G>OR0K];_CE_R1?Q]_V +_ /\ 2=Z_)"O0POPL_*^,?X]'T?YA
M1117:?GP4444 %%%% !1110 5^@__!/3_DC>M_\ 8?F_])[>OSXK]!_^">G_
M "1O6_\ L/S?^D]O7-B/X9]?PK_R,5Z,^H:***\L_9@HHHH **** "N'^.?_
M "1;Q[_V +__ -)WKN*X?XY_\D6\>_\ 8 O_ /TG>JCNCGQ/\"?H_P C\CZ*
M**]L_G$****!A1110 4444 %%%%,1]G_ /!.'_7?$'Z:?_[<U]L"OB?_ ()P
M_P"N^(/TT_\ ]N:^V!7D5OC9^Y</?\BVE\_S%HHHK ^D"BBB@ I*6DH BNO]
M2_TK\7?3Z5^T5U_J7^E?B[Z?2N_"]3\VXQVH_,****[C\S"BBB@ HHHH ***
M* "OL_\ X)P_\?'C_P"FG_\ MS7QA7V?_P $X?\ CX\?_33_ /VYK"O\#/I^
M&_\ D94_F?:Y^\*6D/WA2UY)^W"T444 %%%% !45Q_J7^E2U%<?ZE_I3CNB*
MGP,_%ST^E%'I]**]M;(_G&I_$EZA1113,PHHHH **** "BBB@#Z<_P""?'_)
M:=7_ .P!/_Z46]?H6OW17YZ?\$^/^2TZO_V )_\ THMZ_0M?NBO+Q/\ $/V?
MA7_D6Q]6+1117,?7!1110 4E+24 177^I?Z5^+OI]*_:*Z_U+_2OQ=]/I7?A
M>I^;<8[4?F%%%%=Q^9A1110 4444 %%%% !7TY_P3X_Y+5JW_8!F_P#2BWKY
MCKZ<_P""?'_):M6_[ ,W_I1;UE5^!GN9'_R,J/J?H5Z4HI/2E%>+U/WD6BBB
MJ **** "D;M]:6D;M]: /R+^-7_)9/'G_8?O_P#THDKC*[/XU?\ )9/'G_8?
MO_\ THDKC*]R.R]#^<\5_O%3U?YA1113.8**** "BBB@ HHHH ^G/^"?'_):
M=7_[ $__ *46]?H6OW17YZ?\$^/^2TZO_P!@"?\ ]*+>OT+7[HKR\3_$/V?A
M7_D6Q]6+1117,?7!1110 4AI:0TGL G:OR+^-7_)9/'G_8>O_P#THDK]=.U?
MD7\:O^2R>//^P]?_ /I1)7;A=V?GW&/^[TO5_D<;1117HGY6%%%% !1110 4
M444 %>R_L>?\G&>$/]ZZ_P#22>O&J]E_8\_Y.,\(?[UU_P"DD]1/X6>IE?\
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M</\ Q\>/_II__MS6%?X&?3\-_P#(RI_,^US]X4M(?O"EKR3]N%HHHH ****
M"HKC_4O]*EJ*X_U+_2G'=$5/@9^+GI]**/3Z45[:V1_.-3^)+U"BBBF9A111
M0 4444 %%%% 'TY_P3X_Y+3J_P#V )__ $HMZ_0M?NBOST_X)\?\EIU?_L 3
M_P#I1;U^A:_=%>7B?XA^S\*_\BV/JQ:***YCZX**** "DI:2@"*Z_P!2_P!*
M_%WT^E?M%=?ZE_I7XN^GTKOPO4_-N,=J/S"BBBNX_,PHHHH **** "BBB@ K
MZ<_X)\?\EJU;_L S?^E%O7S'7TY_P3X_Y+5JW_8!F_\ 2BWK*K\#/<R/_D94
M?4_0KTI12>E**\7J?O(M%%%4 4444 %(W;ZTM(W;ZT ?D7\:O^2R>//^P_?_
M /I1)7&5V?QJ_P"2R>//^P_?_P#I1)7&5[D=EZ'\YXK_ 'BIZO\ ,****9S!
M1110 4444 %%%% 'TY_P3X_Y+3J__8 G_P#2BWK]"U^Z*_/3_@GQ_P EIU?_
M + $_P#Z46]?H6OW17EXG^(?L_"O_(MCZL6BBBN8^N"BBB@ I#2TAI/8!.U?
MD7\:O^2R>//^P]?_ /I1)7ZZ=J_(OXU?\ED\>?\ 8>O_ /THDKMPN[/S[C'_
M '>EZO\ (XVBBBO1/RL**** "BBB@ HHHH *]E_8\_Y.,\(?[UU_Z23UXU7L
MO['G_)QGA#_>NO\ TDGJ)_"SU,K_ -]I>J/U!'2EI!TI:\4_H$6BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#_K=@?Y9?<O\S]/LT9K\P?\ ALCXP_\ 0X'_ ,%MI_\ &:/^&R/C#_T.!_\
M!;:?_&:/JT^Z#_6[ _RR^Y?YGZ?9HS7Y@_\ #9'QA_Z' _\ @MM/_C-'_#9'
MQA_Z' _^"VT_^,T?5I]T'^MV!_EE]R_S/T^S1[U^8/\ PV1\8?\ H<#_ ."V
MT_\ C-'_  V1\8?^AP/_ (+K3_XS1]6GW#_6[ _RR^Y?YGZ>_P J<#7Y?_\
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M>//^P]?_ /I1)7ZZ=J_(OXU?\ED\>?\ 8>O_ /THDKMPN[/S[C'_ '>EZO\
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MDDD "MZO@7_@KGXVN=+^'/@?PM!*T<6L:A<7LX4D;EMD0 ''5=UP#@]U![4
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M**[C\S"BBB@ HHHH **** "OIS_@GQ_R6K5O^P#-_P"E%O7S'7TY_P $^/\
MDM6K?]@&;_THMZRJ_ SW,C_Y&5'U/T*]*44GI2BO%ZG[R+1115 %%%% !2-V
M^M+2-V^M 'Y%_&K_ )+)X\_[#]__ .E$E<979_&K_DLGCS_L/W__ *425QE>
MY'9>A_.>*_WBIZO\PHHHIG,%%%% !1110 4444 ?3G_!/C_DM.K_ /8 G_\
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M^?'[5G["OP\^&?[*-SK?A[2'MO%WANWM9I]2^TR.U]EXXY_,5F*<[BXP!@J
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M26VA<Y'U=_P3R_95UG]G_P (ZSKWBV(6OBCQ#Y2G3MRO]BMX]Q1689^=RV6
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'YZ?\%"/^2U:1_V (/\ THN*^8J^G?\ @H1_R6K2/^P!!_Z47%?,5>Q2_AH_
M!\\;_M*MZA1116IX=V%%%% 784444!=A1110%V':OVCM_P#4)]*_%SM7[1V_
M^H3Z5PXKH?IG!WPUOD2T445P'Z0%%%% !1110 5^>G_!0C_DM6D?]@"#_P!*
M+BOT+K\]/^"A'_):M(_[ $'_ *47%=.'^,^1XI_Y%LO5'S%1117J'XP%%%%
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MI8;X3\CXN_WR'H%%%%=9\,%%%% !1110 4444 %?H/\ \$]/^2-ZW_V'YO\
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MKRS]F"BBB@ HHHH *X?XY_\ )%O'O_8 O_\ TG>NXKA_CG_R1;Q[_P!@"_\
M_2=ZJ.Z.?$_P)^C_ "/R/HHHKVS^<0HHHH&%%%% !1110 4444Q'V?\ \$X?
M]=\0?II__MS7VP*^)_\ @G#_ *[X@_33_P#VYK[8%>16^-G[EP]_R+:7S_,6
MBBBL#Z0**** "DI:2@"*Z_U+_2OQ=]/I7[177^I?Z5^+OI]*[\+U/S;C':C\
MPHHHKN/S,**** "BBB@ HHHH *^S_P#@G#_Q\>/_ *:?_P"W-?&%?9__  3A
M_P"/CQ_]-/\ _;FL*_P,^GX;_P"1E3^9]KG[PI:0_>%+7DG[<+1110 4444
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MCW#&L<6N:''&@VJJZS.  /0"*@6I^LUK;16=M%!!%'#!$H2..)0JHH&  !T
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MG3[J&*T6#3Y;0.CJQ8XD8[L$#I7T]10(1:6BB@84444 %%%% !1110 4444
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MIUG!:VD$=K:PH(XH(4")&@& JJ.  .,#TJ>BB@ HHHH **** "BBB@ HHHH
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M_DLG@/\ [#]A_P"E,=3*G#E>B.G#9GC95Z<76E9M=?,_7%>W%/6D%*M>.?O
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MA\:/F^(O^1;4^7YGQA1117K=3\-"BBB@84444 %%%% !1113 _7#X'_\D7\
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M!A1110 4444 %%%%,1]G_P#!.'_7?$'Z:?\ ^W-?; KXG_X)P_Z[X@_33_\
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MI2T@Z4M>*?T"+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.H:5=FX$]O\ 8K:/=MMI77YDC5A\R@\'M2>'G%7;-Z'%&#Q%6-&$97EILO\
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M1176?#!1110 4444 %%%% !7Z#_\$]/^2-ZW_P!A^;_TGMZ_/BOT'_X)Z?\
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M^C_(_(^BBBO;/YQ"BBB@84444 %%%% !1113$?9__!.'_7?$'Z:?_P"W-?;
MKXG_ ."</^N^(/TT_P#]N:^V!7D5OC9^Y</?\BVE\_S%HHHK ^D"BBB@ I*6
MDH BNO\ 4O\ 2OQ=]/I7[177^I?Z5^+OI]*[\+U/S;C':C\PHHHKN/S,****
M "BBB@ HHHH *^S_ /@G#_Q\>/\ Z:?_ .W-?&%?9_\ P3A_X^/'_P!-/_\
M;FL*_P #/I^&_P#D94_F?:Y^\*6D/WA2UY)^W"T444 %%%% !45Q_J7^E2U%
M<?ZE_I3CNB*GP,_%ST^E%'I]**]M;(_G&I_$EZA1113,PHHHH **** "BBB@
M#Z<_X)\?\EIU?_L 3_\ I1;U^A:_=%?GI_P3X_Y+3J__ & )_P#THMZ_0M?N
MBO+Q/\0_9^%?^1;'U8M%%%<Q]<%%%% !24M)0!%=?ZE_I7XN^GTK]HKK_4O]
M*_%WT^E=^%ZGYMQCM1^84445W'YF%%%% !1110 4444 %?3G_!/C_DM6K?\
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MX>"?$;_H%>&O_ 6X_P#C]'U>8?ZT9=_,_N/T+S[T=:_/3_AX)\1O^@5X:_\
M 6X_^/U[#^RU^U)XK^-?Q"U#0]>LM'MK6#2Y+Q&L(94D+K+$F"6E8;<2'/'7
M'-3*C**NSHP_$&!Q56-"FWS2VT/JGTIU-6G5@?2BT444 %%%% !36IU,:@!/
M,7NRY^M*)$_O+^=?D;\:O^2R>//^P_?_ /I1)7&5VQPW,KW/SJMQ<J565/V.
MSMO_ , _:;S$_O+^='F)_>7\Z_%FBJ^J_P!XR_UR7_/C\?\ @'[3>8G]Y?SH
M\Q/[R_G7XLT4?5?[P?ZY+_GQ^/\ P#]IO,3^\OYT>8G]Y?SK\6:*/JO]X/\
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MX=D?FO\ :F._Y_2^]_YGM'_#9'QA_P"AQ/\ X+K3_P",T?\ #9'QA_Z'$_\
M@NM/_C->+T4>SAV0?VICO^?TOO?^9[1_PV1\8?\ H<3_ ."ZT_\ C-'_  V1
M\8?^AQ/_ (+K3_XS7B]%'LX=D']J8[_G]+[W_F>T?\-D?&'_ *'$_P#@NM/_
M (S1_P -D?&'_H<3_P""ZT_^,UXO11[.'9!_:F._Y_2^]_YGM'_#9'QA_P"A
MQ/\ X+K3_P",UZ7^S;^TM\2O'WQK\.:%KWB3^T-*NS<">W-E;1[]MM*Z_,D:
ML/F4'@]J^3*]F_8[R?VC?"&/[UU_Z23UG.G'E>B/2RW,L94QE*$ZLFFUU/T^
M5<4]:;UZ?2E6O)/W =1110 4444 %(W;ZTM(W;ZT ?D7\:O^2R>//^P_?_\
MI1)7&5V?QJ_Y+)X\_P"P_?\ _I1)7&5[D=D?SGBO]XJ?XG^84444SF"BBB@
MHHHH ****!'LW['?_)QOA#_>NO\ TDGK]01WK\OOV._^3C?"'^]=?^DD]?J"
M.]>=B?B/V#A+_<9>HM%%%<9]L%%%% !33UIU-/6@!5K\O?VQ/^3CO%_UM/\
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MKU#\8"BBB@ HHHH **** "NS^"O_ "63P'_V'[#_ -*8ZXRNS^"O_)9/ ?\
MV'[#_P!*8Z4OA9TX7_>*?^)?F?KF.]+2"EKPS^C!:*** "BBB@ HHHH _/3_
M (*$?\EJTC_L 0?^E%Q7S%7T[_P4(_Y+5I'_ & (/_2BXKYBKV*/\-'X-GG_
M ",JWJ%%%%:GAA1110 4444 %%%% !VK]H[?_4)]*_%SM7[1V_\ J$^E<.*Z
M'Z9P=\-;Y$M%%%<!^DA1110 4444 %?GI_P4(_Y+5I'_ & (/_2BXK]"Z_/3
M_@H1_P EJTC_ + $'_I1<5TX?XSY'BG_ )%LO5'S%1117J'XP%%%% !1110
M4444 %':BCM2ELS2E_$CZH_:*W_U*?[M2U%;_P"I3_=J6O$>[/Z.I_ O06BB
MBD6%%%% !1110!\3?\%'O^/CX?\ ^[J'_MM7QA7V?_P4>_X^/A__ +NH?^VU
M?&%>O0_AH_$.)/\ D95/E^04445L?,A1110 4444 %%%% !VK]H[?_4)]*_%
MSM7[1V_^H3Z5PXKH?IG!WPUOD2T445P'Z2%%%% !1110 5\3?\%'O^/CX?\
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MR?@G4****0PHHHH **** "BBB@.I^G/[%_\ R;CX5_WKS_TLFKV^O$/V+_\
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M^C_(_(^BBBO;/YQ"BBB@84444 %%%% !1113$?9__!.'_7?$'Z:?_P"W-?;
MKXG_ ."<7^N^('TT_P#]N:^V!7D5OC9^Y</?\BVE\_S%HHHK ^D"BBB@ I*6
MDH BNO\ 4O\ 2OQ=]/I7[177^I?Z5^+OI]*[\+U/S;C':C\PHHHKN/S,****
M "BBB@ HHHH *^S_ /@G#_Q\>/\ Z:?_ .W-?&%?9_\ P3A_X^/'_P!-/_\
M;FL*_P #/I^&_P#D94_F?:Y^\*6D/WJ6O)/VX6BBB@ HHHH *BN/]2_TJ6HK
MC_4O]*<=T14^!GXN>GTHH]/I17MK9'\XU/XDO4****9F%%%% !1110 4444
M?3G_  3X_P"2TZO_ -@"?_THMZ_0M?NBOST_X)\?\EIU?_L 3_\ I1;U^A:_
M=%>7B?XA^S\*_P#(MCZL6BBBN8^N"BBB@ I*6DH BNO]2_TK\7?3Z5^T5U_J
M7^E?B[Z?2N_"]3\VXQVH_,****[C\S"BBB@ HHHH **** "OIS_@GQ_R6K5O
M^P#-_P"E%O7S'7TY_P $^/\ DM6K?]@&;_THMZRJ_ SW,C_Y&5'U/T*]*44G
MI2BO%ZG[R+1115 %%%% !2-V^M+2-V^M 'Y%_&K_ )+)X\_[#]__ .E$E<97
M9_&K_DLGCS_L/W__ *425QE>Y'9>A_.>*_WBIZO\PHHHIG,%%%% !1110 44
M44 ?3G_!/C_DM.K_ /8 G_\ 2BWK]"U^Z*_/3_@GQ_R6G5_^P!/_ .E%O7Z%
MK]T5Y>)_B'[/PK_R+8^K%HHHKF/K@HHHH *0TM(:3V 3M7Y%_&K_ )+)X\_[
M#U__ .E$E?KI7Y%_&K_DLGCS_L/7_P#Z425VX7=GY]QC_N]+U?Y'&T445Z)^
M5A1110 4444 %%%% !7LO['G_)QGA#_>NO\ TDGKQJO9?V//^3C/"'^]=?\
MI)/43^%GJ97_ +[2]4?J".E+2+TIU>*?T"%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &1XJN-6M?#]]-H5M%
M>:ND>;:"<X1WST;YEXQGN*\C_P"$M^._;P5H?_?Y/_DJO<Z* /#/^$M^/'_0
ME:'_ -_D_P#DJD/BWX[_ /0E:'_W^3_Y*KW2D- 'A+^*?CL^0?!>A\CG]\G_
M ,DU\Q_\,2>,CG&B7>/^PA:#_P!FK]$:!]*N,Y1V.'$X'#XRWMX\UMC\[_\
MAB/QE_T!+O\ \&-I_P#%4?\ #$?C+_H"7?\ X,;3_P"*K]$?PH_"K]M/N<']
MAY?_ ,^D?G=_PQ'XR_Z EW_X,;3_ .*H_P"&(_&7_0$N_P#P8VG_ ,57Z(_A
M1^%'MI]P_L/+_P#GTC\[O^&(_&7_ $!+O_P8VG_Q5'_#$?C+_H"7?_@QM/\
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MWB;5]=N]!FCNM3O)KR9(;^U$:O(Y=@H+D[<GC)/%9G_#$?C+_H"7?_@QM/\
MXJOT/V[LTH^E;>UEW/$EDV G)RE23;U/SO\ ^&(_&7_0$N__  8VG_Q5'_#$
M?C+_ * EW_X,;3_XJOT1_"C\*/;3[D_V'E__ #Z1^=W_  Q'XR_Z EW_ .#&
MT_\ BJ/^&(_&7_0$N_\ P8VG_P 57Z(_A1^%'MI]P_L/+_\ GTC\[O\ AB/Q
ME_T!+O\ \&-I_P#%4?\ #$?C+_H"7?\ X,;3_P"*K]$?PH_"CVT^X?V'E_\
MSZ1^=W_#$?C+_H"7?_@QM/\ XJC_ (8C\9?] 2[_ /!C:?\ Q5?HC^%(RY[4
M>VGW#^Q,O7_+I'Q3\'?@-\2_@CXHN=<T/PVEU>7%FUFR:A>V[Q["\;D@)*AW
M90=3C&:]D7Q9\=QG'@O0S_VV3_Y*KW'IFG"LY2<G=GJ8?#TL+3]E1C9'AO\
MPEOQX_Z$K0_^_P G_P E4?\ "6_'C_H2M#_[_)_\E5[G14G2>&?\);\>/^A*
MT/\ [_)_\E4?\);\>/\ H2M#_P"_R?\ R57N=% 'AG_"6_'C_H2M#_[_ "?_
M "51_P )=\=_^A*T/_O\G_R57N=-:@#PS_A+/CL<_P#%%Z'T_P">R?\ R57S
MKXH_9$\=>+O$VKZY=:%-'=:G>37DR0W]J(U>1R[!07)VY/&2>,5]]MSQT[TY
M1UK2,G#8XL5@Z&,2C7C=(_.__AB/QE_T!+O_ ,&-I_\ %4?\,1^,O^@)=_\
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M_P#!C:?_ !5'_#$?C+_H"7?_ (,;3_XJOT1_"C\*/;3[A_8>7_\ /I'YW?\
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M\>/^A*T/_O\ )_\ )5>YT4 >&?\ "6_'C_H2M#_[_)_\E4?\);\>/^A*T/\
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M57N=% 'AG_"6_'C_ *$K0_\ O\G_ ,E4?\);\=_^A*T/_O\ )_\ )5>YTUJ
M/BGXQ? 3XF?&[Q/;:[KGAJ.TNX+1;)4T^]MTC**[N"0\KG.9#W[#BN%_X8C\
M9_\ 0$N__!C:?_%5^A_3Z4J_2M54E%63/(K93@J\W4J4TY/<_.__ (8C\9?]
M 2[_ /!C:?\ Q5'_  Q'XR_Z EW_ .#&T_\ BJ_1'\*/PI^VGW,?[#R__GTC
M\[O^&(_&7_0$N_\ P8VG_P 51_PQ'XR_Z EW_P"#&T_^*K]$?PH_"CVT^X?V
M'E__ #Z1^=W_  Q'XR_Z EW_ .#&T_\ BJ/^&(_&7_0$N_\ P8VG_P 57Z(_
MA1^%'MI]P_L/+_\ GTC\[O\ AB/QE_T!+O\ \&-I_P#%4?\ #$?C/_H"7?\
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M!+O_ ,&-I_\ %5^B/X4?A1[:?</[#R__ )](_.[_ (8C\9?] 2[_ /!C:?\
MQ5)_PQ+XQW '1;O/_80M/_BJ_1+\*0]:?M9=QK)<OBTU21X7'XJ^.R* /!6A
M_P#?Y#_[=4__ (2WX[_]"5H?_?Y/_DJO<J*P/;2Y59'AO_"6_'C_ *$K0_\
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MM/N']AY?_P ^D?G=_P ,1^,O^@)=_P#@QM/_ (JC_AB/QE_T!+O_ ,&-I_\
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M?HC^%'X4>VGW#^P\O_Y](_.[_AB/QE_T!+O_ ,&-I_\ %4?\,1^,O^@)=_\
M@QM/_BJ_1'\*/PH]M/N']AY?_P ^D?G=_P ,1^,O^@)=_P#@QM/_ (JC_AB/
MQEQ_Q);OK_T$;3_XJOT1_"BCVT^X?V'E_P#SZ1\[>$[SXV^$?"^D:'9>#M)D
ML],LX;*%YYXS(4C0("Q%R!NPO. .:UQXL^._;P5H?_?Y/_DJO<32K61[<8J*
M48Z)'AO_  EOQX_Z$K0_^_R?_)5'_"6_'C_H2M#_ ._R?_)5>YT4BCPS_A+?
MCQ_T)6A_]_D_^2J/^$M^/'_0E:'_ -_D_P#DJO<Z* /#/^$M^/'_ $)6A_\
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MC\*7MI]P_L/+_P#GTC\[O^&(_&7_ $!+O_P8VG_Q5'_#$?C+_H"7?_@QM/\
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M_P -VNAZ[X5LK2UM[M;Q'T^ZA1RZQR)@EYW&W$A[9SBO'_\ AB/QE_T!;O\
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M^"=.\,:1X1TVYL++S/+EO+B)I3OD:0[BMPHZN<84<8KJO^$M^/'_ $)6A_\
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M_0$N_P#P8VG_ ,51_P ,1^,O^@)=_P#@QM/_ (JOT1_"C\*KVT^YR?V'E_\
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M(4"M?:S[GC?V)E__ #Z1^=__  Q'XR_Z EW_ .#&T_\ BJ/^&(_&7_0$N_\
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M^_R?_)5>YT4 >&?\);\>/^A*T/\ [_)_\E4A\6_'?_H2M#_[_)_\E5[I36H
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M1^%'MI]P_L/+_P#GTC\[O^&(_&7_ $!+O_P8VG_Q5'_#$?C+_H"7?_@QM/\
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M*IW_  EWQX_Z$K0_^_R?_)5>X\4M9GK'AO\ PEOQX_Z$K0_^_P G_P E4?\
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MCQ_T)6A_]_D_^2J/^$M^/'_0E:'_ -_D_P#DJO<Z* /#/^$M^/'_ $)6A_\
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MA1^%'MI]P_L/+_\ GTC\[O\ AB/QE_T!+O\ \&-I_P#%4?\ #$?C+_H"7?\
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MR37$@1%'J23@5F^'?&GA_P 7+,^A:[INM)"0)&T^[CN A/3<4)Q0!MT4BTM
M!1110 4444 %%%% !1110 451UC6+#0;&2]U*]M].LX_OW-U*L<:9X&68@#K
M5#P[XV\/>+EE;0M>TS6EC'SG3KR.<)]=A.* -VBF?H:YYOB%X5371H;>)M'&
ML[O+_LXZA%]I+>GEEMV?PH Z2BD7I6#XD\>>&?",T46O>(=*T668;HDU"]B@
M9QG&5#L,\^E &_14%O<Q7EO'-!(LT,@#))&=RL",@@CJ#6/>>/?#.FW4MK>>
M(])M+F)MKPSWT2.A]"I8$&@#?HKF3\3/" ;_ )&O1,?]A&'_ .*KH;:XCNH$
MFAD66*0!DD0Y5E(R"#W&* ):*** "BBB@ HHHH **** "BBJNI:E::/9R7=_
M=0V5I&,R3W$@C1 3CEB0!S0!:HKG_#OCKPWXP:1-!\0Z5K9C'[Q=-O8[C8..
MNQCCJ/SK=[?Y- #Z*YNZ^(GA6QUP:+=>)]'M]89@BZ?-?Q+<%CT C+!L_A71
MKTH 6BL+Q+XX\.>#O)_M_7],T03?ZO\ M&\CM]^/3>PS6M8WEOJ%K'<VL\=U
M;2J'CFA<.CJ>A4C@CZ4 3T55U+4;72;.2[O;F&SM8AF2XN'"(@SC)8G K+\.
M^./#OC#SCH&OZ7K8B_UG]GWD=QL^NPG';\Z -ZBD%+0 4444 %%%% !1110
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MK4^J:UI^@VHN-3OK;3K<L%\ZZE6)-QZ#+$#/6@#0HKF5^)GA#K_PE>A\\_\
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M)+D=1L5BU '344T9-8/B/Q]X9\(SQ0Z[XCTG199ANBCU"^B@9QG&5#L,\^E
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M32=:OK^ST_5+._N]/<17EO;7"226SDG"R*I)0_*>#UP:U%Z4 .HHHH ****
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M\_\ 2V>OHB@ HHHH **** "BBB@ HHHH BN9&CAD=(VE=5)6-2 6/H"2!^9
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M%Z!-JGC'4M0DBM=(N[PM;6-JH!41^3(05R64#<0%0<9)-8$/@^S_ &3?VYO
MGASX>7%Q:>%?'5I)_:?AEIGEBA9?, F4,V0 45@3E@%D&=IP/I7]I']ISPO^
MS?X:CN]4W:IXAOLII6@6A_TB]DS@?[B9(!<_0!CP?*?V7O@%XOUSXCWGQW^,
M/R^.-2B9-(T7&$T:U8%0"O\ "^QF4+G*AFW9=FP#/KA>E.IJ_=]*=0 4444
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MG:58(3F9XY9/,D(!(C58F)('ID@$L/"_^"57_)L=U_V,%U_Z*@K[&H&?FO\
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M0,^!_P#@GCH_B'P_^T%\>M/\6ZJNN>);>2T74=05RRS3[YBY!(!QDX' X P
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M9\*_'7PJGAOQA92ZAI"W*78ABN'A/F*&"G<A!Z,W>OFKX:_\I3?BO_V)T/\
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M#X7T\^$?!E]XW\5:Q=-9:?86R,8T<(6,DI7D( /8>K+UKY'_ &<]+^(6F_\
M!0>X?XH:C!?^+KSPS+>3QVK9AM$?84MT[ (.,#(SGEB2Q_1<5\8V?_*4R]_[
M$\?^@I0!]#?M(>+]8\ _ GQUXBT%7.KZ=I,\]LZ*&,3!<>;@\'8"7_X#7S'^
MRK^Q]\)?BI^SUI'B?Q1IK>,/$7B2*2ZU'6;F]E:>.<R,"B$-\K(>#G)+ Y[
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M +=^(7B6;[;KNJL=_P"\)+>4KGEE#,Q+?Q,<\  #RK]@C='\=_VHXY@5NO\
MA*PSJWWL&YON:!(YOX]?#G1?V%_B)X"^*OP\2X\/>&-1U6/1?$VB0SO);3PN
M&?>%=FP0J28&< JNW;DY^I?VB?C!JWP:\"VVI>'O"5_XU\0:E?II>G:78(6)
MF>.2022;02$58F)P/0':"6'A7_!5B1%_9ITY&_UDOB.U2-<<EO)N#@?@#^5?
M8.EPR6^FVD4S;IHXD1V]6"@$T#/SE^$MC\3;?_@H?X+O?BO=V\GBG5= N=0^
MP63$PZ= T5RB6R\D#;L8G:6&7)+,22?L;]K+XJ7OP9_9]\8^*]+*KJMI;)#9
MLR[MDTTJ0H^.^TR!O3CFO#?&O_*4SP#_ -B=)_Z#>U]*?'+X5VOQL^$_B;P3
M>3M:Q:M:^6EPHSY4J,LD3X[@2(AQZ T"Z'S+^SA^PO\ #OQ3\']&\4_$739_
M&OB_Q991ZO?:E?WT^]//02*J%7'(5EW,26)SSC %K]D/7-0^$?[0'Q)_9ZNM
M6N=7T+088]5\/2WC;I+:V<1,8,^@6XCP  ,HY &<5B?"GXI?M#_ /PE8?#76
M_@E>^.9]'06&E:[I-^([:2%>(1(^QE"JN &.P[0 R@AB>7_9M\/^+;3_ (**
M>++CQG>6]SXKG\--J.KPV"_Z/:-+]F\NV4Y.Y8XWB0-GG'4]2 C]#EZ4M)2T
M#"BBB@ HHHH **** "N5^*5[XCT_X=^([CP?8?VEXJCL)CI=J6C4/<[2(R=[
M*N Q!()&0".]=53&'<=: /CCX!?L&^$[[P#%KGQCT&X\3_$36B]SJLVJWTKO
M Q8@1J8Y,?=VDMDG/<  ##_9?LI_@5^V=\0O@OX?U&ZU#P"NE+K-M87$IE.F
MRGR'QD]!B=@>[9C)Y!KUC]IW]K>S^#DUMX/\*6#>+_BGJV(]-T&U4R>0SCY9
M)PO('(8)D,V.JCY@G[(?[->I?!VSUGQ?XWOAK?Q.\5/]IU>]8AA;JQW?9T8<
M'#<L1P2% X0$@'D?C#P_%^V)^VMKG@;Q'=7,OPW^'EBDLFEV\[1)?7K;-WF%
M<$<NRD@Y AP,;V-4/VE_A)HG[%>K>$OC+\++:X\.VD&J0Z;X@T2UG=K>^LY,
ML?E=C@_N]N!W9& # D]'^Q_NA_;'_::CG&)VU&)T#==GG3$'Z8*UT_\ P4XF
MCA_91U57(#R:G9)'GNWF9_D#^M %S]KCP#X^^/-[\.O!_AA;NW^&NK77G^*-
M8T^XBC?[.=ICC +!BI7S"1M*DE,YQBN?^-_[!_P?T7X+^(=0\/:&?"NN:%IT
MVH6>MVMY.)8Y8(S(&<ER&!*<G&1DD8/-?2W@.5-!^%_AN34KA+2.ST>V-S-<
M,$2()"N]F)(  P<D\"OCKXG_ !-\2?MX>*+GX7?"IIM.^&5I,H\2^,Y(V5+E
M0=WD1 @$J2!A>KD#.U 2P(]'^ O[0VM+^PC%\3/$I;4-6T?2KW]_.?\ C^>W
MDDBA).<DN4168]6W&N!_95_9#\'_ !D^%4/Q)^+5E<>-_%_C$RWLUS?7<T8@
MB+LJ+'Y;+@E5#9_A!"KM Y]0_:N\!Z;\.?V&/&'A7PU:?9M*TO288((4Y;8L
M\19F/<GYF8]R2>]=Y^R-(DG[,?PP,;*R_P!@VH)7ID1C(_/- 'AO[)]]?? K
M]H[Q]^S]<:I>:GX8M+6/6O#+WKAFMX6V-)"".<?OAZ#]R[8&XU]GKTKXKE4W
M?_!5"$P$'[+X1)N,=@5('_H<=?:BT A:***!A1110 4444 %%%% &)XUO-8T
M_P (ZW<>'K)=2UZ*QFDT^S9U19[@(3$A9F"@%MHR2!@GFODG]GG]AO1?$7A*
M7Q;\=-#N/$OQ)UVXFN+]-6O&;[(N]U1%\F3:<J%;/.-P5<;<5]GM7@/[3G[6
M.D? >UMM"TJS;Q5\2-5VQ:3X;M%:21G<X1Y0@)"9Z*/F<\+W90#Q+X':,W[.
M7[=&L_"7PE?74_@#6M(.JG2)IFF73)MI88+'@_*1GDE9$W;BH83_ !>TL_M7
M_MI+\(]7O+I/AYX*TM=5U73;69HQ?7+",@,RX/\ R\1+UR LF"I;(]+_ &1_
MV;]<^'U]KOQ+^)-V-6^*GBP>9?29#"PA)!^SJ0<9^5 =OR@(BKPN3P7[/6Z'
M_@HC\?8YQMG-A"Z*V<[/]'(_#!7'MB@# _:F^!.A_LDZ;H?QH^$5G-X5U#0[
M^"#5=-M[F1[;4+.1@I1U=FZML4XZ[B?O*&KU+]K#0_'WQ\\'?#CP_P##Y+R+
MP5XJNX)_$>L6L\4<MO8.(V4;2X9E*O(Y"@@^6JD_-@Z'_!1F:./]CWQVKD!Y
M&T](\CJWV^W./R#5ZA\!5;2OV?\ X<K>2K$;?PQIJS/(0 -MI'N)/;&#GZ&@
M1XA\1O\ @GW\%K?X5ZK!I>@_\(_J=A8R3VNOK>3&>*:./*RR$N0PRN6&.A;&
MT\CH?^"?_P 3-?\ B?\ LTZ)J'B2>:]U&QN)].6^N"3)=1Q$;'9CRS8.TGJ=
MAZG)KRCXP_&;Q)^V=XHO?@[\&7:+P>K>7XI\;D'[/Y))W0PD?>5L$#!S)@@8
MC#.?K[X5?#71?A!\/]%\(>'X3#I>EP")"WWY6)W/(_J[L68^['  XH&?#_[5
M?Q0^,7QN\&_$6Q\-^'9_ _PJ\.)<IJ6LZENCN=:$+%6BA_Z9LPQA>, [GYV'
MZ?\ V*/^35?AK_V"E_\ 0VJU^V+_ ,FN_$W_ + D_P#*JO[%/_)JGPT_[!2_
M^AM0+J>VT444#"BBB@ HHHH **** "L_7KF]L]&OY].M/[0U&*WDDMK3>J>=
M*%)5-S$ 9.!DD#GDUH4E 'Q3^S[^Q3:^.-*U?QO^T%HD_B'XAZW>SM+:ZC=D
MQV<(8A%189-O/+#!(4%0H&.</X?^&T_9>_;ZTKX;>![RY'@?QCH\FHW6A23O
M-'82JEPP92Q];<?,Q+;9",GY:^@/VF_VJ?#_ .SSH]O:B%O$/C;4\)I'ANSR
MT\[D[59PN2L>[C.,L?E4$YQQ/[)G[.WB70_%&L?&'XK3"]^)WB1<+:X!72K<
MXQ$,<!]JJN!]U5"Y.6) .)_:(MY_VF/VOO#?P/NK^ZMO NAZ=_;FOVEK,4:[
MDQN1&(YP \ &>GFL1R :S?VJ_P!FGP[^S7X+MOC#\'[67P9XC\*7$#7$=K<2
MR0WEM)*D3+(KLV>67/JI;<#P1L_#/=#_ ,%4OBQYWRB3PE!Y&[^(>7IF<?BK
M_E7KO[=DT<'[)?Q&:8A5-E&HW>IN(@OZD4".2_:8F^(7Q^^!O@.V^%MK<V^F
M>-'M+C6=0M[B-);*PE17*G+JS<O\P3/$; \-@NUC_@G3\$9OA_/HEMH$FFWR
M6S"+Q";V5KJ*4#B9B7V,01DKC;R0 *](_9.@EL?V8?A@+AL$>';.3<W&%:)6
M4_3:17S]\<OCYXA_:>\47_P4^!Q-Q9R9M_$WC1<_9+6W)*R1Q./O!N5+ _/A
ME3(RP!G3_P#!/SXK>+/'_P"RU?W.HB;Q#K/A^\NM-T^6>0![Y8X8Y8D:1R!G
M=)Y>XD !5R>":P?V??V*;7QOI.K>-OV@M$G\0_$/6KR9I;34;LF.SA#8546*
M3;SRPY(4% H7'/TW\$_A#HGP+^&ND>#= 1C9V$?[RXD \RYF8YDF<_WF//H!
M@#@"N'_:;_:I\/\ [/.CV]J(6\0^-M3PFD>&[/+3SN3M5G"Y*Q[N,XRQ^503
MG !\_P#P_P##D?[+O[?6E_#;P1>70\#>,='DU&ZT*2=IH["54N&5E+$G@VP^
M9B6VRD9X6OO)?NBOE?\ 9+_9U\2Z)XHUGXP_%:87OQ.\2)A;; *Z3;'&(EP<
M!]H1<#[JJ%R<L3]3KTZ8H$AU%%% PHHHH **** "BBB@"&[DDAMY)(HFGD52
MRQJ0"Q X )('/N0/>OBSX#_L;S?$Z\\2>/OVB]!FU;QOJ>H2)!I5Y>EK:QME
MQM\OR9,$$E@!D@!1@9))^V:\9_:4_:@\+_LX>'8I]2W:KXDOE*Z5X?M&_P!(
MO),X7/\ <3/!<CV 9L @'S98^$;7]D_]NSP3X6^'L]S;^$?'-E(^H^&S,TL4
M# 2 2J&;(P8U8$Y8!9!G!P.A_:OEO?CU^TU\/_@"FI75AX3DLVUOQ%]CEVO<
M(HD*1-QV$0QG(S,K8RJXZ3]EG]G_ ,67WC[4/CG\7\-\0-7B,>G:/LPNBVK#
M:% .=KE/EV]54MNR[MCF['=#_P %4KXSY E\)CR-V?F'EIG;[95_UH H?M2?
MLE^$_@?\,Y/BC\(+6?P1XR\'F.[2:QNI9%N8 ZI(D@D9@<*Q)/\ $ RL&#<=
MU\=/%'Q'^/7[*OA2]^$]C<+?^,%M&U.>UN(XI+"T="9PI9U)(D"I\F3MW].M
M>F_M>3QP?LP_$YI2 IT&Z4;O[Q0A?U(K(_8<MY;7]D_X;I.3YAT]G&?[K32,
MO_CI%!)RD/\ P3C^",?@,:!+X<EDOS;[&U_[7*+PRX_UO#; <\[=NWM@BL;_
M ()P_$+Q#XK^#_B/0]9OY->'A;69=,L-2D8DSP;%94WDDG:2<'G"LHZ 5D?'
MW]I#Q!\;O%%[\$O@2/[2U>Y#6^O^*XV/V32X"=L@609R<9!<=,[4R_*_17[/
MWP/T3]GKX8:;X/T0FX6',]W?.H5[RY8#S)F'.,X  R<*JC)QF@9\_?!W]B^7
MQOX@\5^.?VA=-@\4^,-4OV2SM&O&EL[.S"C:(PA ZL5 8?*(U( R37-? G3X
M?@3^WAXH^%?@B[GE\ W^D'4[C1FF::+3+D(C J225^\%Y))650<[5(^KOC5\
M-=3^*_@]=#TOQGK/@68W*3R:GH4IBN6158>6&!! )8$X/.W'>OC[X/:?JO[#
M_P"TWI?PWU<67BCP_P#$.3?:^*3;>5J8G)*B.5MS%E#X!7./W@<8.5H&??Z]
M/2G4V,[EIU !1110 4444 %%%% !3),CD=OI3Z* /B;X/?LCWWQD\:>,OB%^
MT/X?N;S7;G4GMM)T&[O0]M9V:JI4KY$A4KSL W8_=LQ!+;JYGQ+X%T_]D/\
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M%RMH7F.V=0$EU=[#'QW\V/&?[PK]"EH$A:***!A1110 4444 %%%% !1110
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M+?B3Q?H6D:E^S5XDT'3M0O[>UN=5GU"1H[**215>9@;1<J@)8_,.!U%?6%%
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M9:XOEZA?W6Y) S1D JI:*(G(V@(0I)8[?MN/H<^M/HH **** "BBB@ HHHH
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M3\-:]X):,>//!>IKJ^D+,P43[2I>(,> Q,<3 DXRF#UR/*_''[47Q?\ BAX
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M&":YCX7_ +0/Q"^#_@^Q\,>%/V0O$FEZ3:CA4U"3?*V &ED;['EW.!ECSVZ
M"OO*B@#R;X7^*M8^/GPGU=?'/@&]\ R:E]ITJ?1+^8S2/;M&%+Y:).&#L,;2
M/EZ]J^9?A#XV^*'[%.CW_P -?$?PQ\1_$#PU974LOA_7O"MJURDD4LC-Y<@
M.PEB3@_,"S#YA@U]YT4 ?(W[+OPR\<^,OC5XJ^/'Q)T-O#&HZK:KINB>'[C/
MG65H-OS2 \JV$ ^8!B6D.U00*^M=W'_UJDHH ^1OV _AWXG^'[?%@>)-!U#0
MQJ/B1[FS^W0&+SXOF^=,]1SUKH?VSOA%X[\7VO@[QO\ #6X>3Q9X-OOMRZ/Y
MQCCU.+<CE"-P5BICX4D9#N <XS],44 ?&/B3]L#XG^.O"UUX=\&? 7QQI7CF
M^A%L;C5K-H;+3W<8,GG.H#;<DJ7" \'H"#['^R#\ Y/V<?@GIWA:[N8[O6)I
MI-0U*6#_ %7VF0*&5"1DJJHBY/7;GC.![710(****!A1110 4444 %%%% !7
MR3_P40U3XGZC\/=-\&_#?PWK>K+KC2?VO?:/ [F.V4 >064<>86Y_P!E".0Q
MKZVHH ^ ?@_\;_'_ ,#O!-EX8\*?LA^)K*P@&99#J#F:ZE(&Z65OL0W.V!D]
M.     /J?X)?$3Q#\:_ ^KW'C;X<7WP]E^TR6/\ 9.I3M,US 8D)E!,4?RDN
MRXP?NGGM7J]% CX*^%>M_$C]A7^W? >I_#GQ!\1? ?VV2^T'7/"]NUPZ)(<"
M*5 #M).W@X(8MC>&4UVG[//P]\=_%;]H;5?CU\1_#LWA"*.P_LGPSX>O-PNK
M: D@R2*>5.&E&& ),KG:H"Y^P:*!C%SC^HKY0_8W^'OB7P;\9_VCM1US0K[2
M;#6O%+76FW%W R)>0_:;UM\9/WEQ(AX[,*^LJ* .%\;_  -^'WQ+U:+4_%?@
MW1O$6HPPBVCNM1LTFD6(,S! 2/N@NQQ_M&OE;]NK]DKP_P#\*5@_X5;\+[+_
M (27^UH-W_"/Z8OVCR-DN_[@SMSM_2ON.B@#D?AQ\-?#'PRT,V/A?P_8>';6
M=EGGM]/MQ"KR[%4LP'?  S[5UJTM% !1110 4444 %%%% !1110!\O\ [?VN
M_$I/A3;^&/AGX>UG5M0\0220:A?:/ \CVEJH7<N4!*F0N%]U$GX>*? WXN>/
M_P!G_P "VGAKPQ^R3XFB5 &N[V2_D\Z]FQ@RR'[&23Z#HHP!P*_0NB@#R/X!
M?%CQ9\7M%U:Y\7_#/4?AO+;3K!%9ZE.TYND9<EQNBCXSQT-?-OP_D^('[!OB
M+Q5X8'P]UOX@_"[5+^35=&U#PS ;F>R+[5\F5 ./E5!S@97*YW$#[NHH ^-_
M@IX'\>?';]I9/CAX_P#"]UX)T30[%].\,Z#J2LEY\P=6EE0@$?+)+G<!DNFW
M(3)^Q??.:?10!\G?LQ_#_P 2^%_VIOV@M<U;0[[3M'UB^@DTZ^N(&2*Z4/*2
M8V/WL!E_.NS_ &RO@[XN^+?POMO^$#U>YTSQ;HM\FI6<4-T8%O-JL&A9MP7)
MR&!;C*X. 21[]10!\<_\-F?%&;PR-(B_9[\:?\+#,'EL)+%UTH3?=\[SB,^5
MGD#\-Y^]7H/[&?[/6J? GP+J]UXINH[WQQXGOFU36)(6#)&[9*Q @ ,5+.Q(
M&-SL!P :^A:* $6EHHH **** "BBB@ HHHH *^=?VY/$GQ&TOX.OH_PRT+5]
M6U[7)OL<UUH\+R2V-M@F1P5&59N$#=@S$<@5]%44 ?G/^SW\2_'_ .SGX&M]
M!\/?LG>)I+J0*VHZM)?2B>^F'5V_T,X49.U.B@X&>2?K3]GOXS>,OB]#KC^+
M_A;JGPR?3V@%LFI7#3?;-X??MW0QXV;5SC/WQTKV2B@1\,>'+/Q[^PW\2/&L
M&G^ -8\?_"?Q+>OK%DWAJ$SW6F3'&Y'C X 7"\\$(I!SN6M;X:^$_'O[2W[2
MVC_%SQMX1O? ?@SPC;/#H.BZPACO+B=@P:9XV *X)W9( ^6,#=AC7VC10,97
MRC\%/A_XET3]N3XU>)K_ $.^L_#VJ6-O'8ZG- RP7#*L 8(YX8@JWY5]8T4
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M5]7<T^B@#Y _8_\ ASXJL_VA?CUX[\6:%?:-_:^J?9]*>^@:+S[7SIF!0MU
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M-02HR!_C7RE:_#[Q*O\ P48NO%YT.^'A=_"PM5U<P'[,9L*-F_IG@\5]8T4
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M7Q1_8HEUWP3XM\!>*OB;X4>^DO=&\3>'H6O'*N1E)AD[,X!PQ!#%L;P01N>
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MZ<%2*%+FY9'M21PH @/R_P"S7V\OW:=10 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?RBYCO/[6M/^?J'_ +^#_&C^UK3_ )^H?^_@_P :X.BC^TI?RAS'>?VM:?\
M/U#_ -_!_C1_:UI_S]0_]_!_C7!T4?VE+^4.8[S^UK3_ )^H?^_@_P :/[6M
M/^?J'_OX/\:X.BC^TI?RAS'>?VM:?\_4/_?P?XT?VM:?\_4/_?P?XUP=%']I
M2_E#F.\_M:T_Y^H?^_@_QH_M:T_Y^H?^_@_QK@Z*/[2E_*',=Y_:UI_S]0_]
M_!_C1_:UI_S]0_\ ?P?XUP=%']I2_E#F.\_M:T_Y^H?^_@_QH_M6S_Y^H?\
MOX/\:X.BC^TI?RAS'>?VI:=?M4/_ '\%6HV$BAE(93R"#G-><UWNE_\ (-M?
M^N2_R%=N%Q3Q$I)K8:E<MT445Z104444 %%%% !1110 4444 %%%% !1110
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M<?8];_MS3O\ G_M?^_R_XT?VYIW_ #_VO_?Y?\:\DHHY0^N/L>M_VYIW_/\
MVO\ W^7_ !J2WU*UO',<%U#,X&XK'(&./7BO(*Z?X??\AF;_ *X-_P"A+2<;
M&E/%.<E&QV4FOZ9#(\<FHVD<BDAE:=001U!YH'B32>?^)I9_^!"?XUXSXB_Y
M&#4_^OJ7_P!#-9]-0N:NNT[6/=O^$DTG_H*6?_@0G^-'_"2:3_T%+/\ \"$_
MQKPFBG[,7UA]CW;_ (232?\ H*6?_@0G^-'_  DFD_\ 04L__ A/\:\)HH]F
M'UA]CW;_ (232?\ H*6?_@0G^-'_  DFD_\ 04L__ A/\:\)HH]F'UA]CW;_
M (232?\ H*6?_@0G^-'_  DFD_\ 04L__ A/\:\)HH]F'UA]CW;_ (232?\
MH*6?_@0G^-'_  DFD_\ 04L__ A/\:\)HH]F'UA]CW;_ (232?\ H*6?_@0G
M^-'_  DFD_\ 04L__ A/\:\)HH]F'UA]CW;_ (232?\ H*6?_@0G^-'_  DF
MD_\ 04L__ A/\:\)HH]F'UA]CW;_ (232?\ H*6?_@0G^-'_  DFD_\ 04L_
M_ A/\:\)HH]F'UA]CWNUU>QOI#';7EO<.!N*PRACCUX_#\Z<VI6L;%6N80P.
M""XR#Z5YG\+>?$%Q_P!>K?\ H:5KZC_R$+K_ *ZM_,UYV,K/#6LKW.B$^:/-
M8[3^UK3_ )^H?^_@_P :/[6M/^?J'_OX/\:X.BO+_M*7\I7,=Y_:UI_S]0_]
M_!_C1_:UI_S]0_\ ?P?XUP=%']I2_E#F.\_M:T_Y^H?^_@_QH_M:T_Y^H?\
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MB_[[%']H6O\ SWB_[[%<=17I^Q7<Y/K;['8_VA:_\]XO^^Q1_:%K_P ]XO\
MOL5QU%'L5W#ZV^QV/]H6O_/>+_OL4?VA:_\ />+_ +[%<=11[%=P^MOL=C_:
M%K_SWB_[[%']H6O_ #WB_P"^Q7'44>Q7</K;['8_VA:_\]XO^^Q1_:%K_P ]
MXO\ OL5QU%'L5W#ZV^QV/]H6O_/>+_OL4?VA:_\ />+_ +[%<=11[%=P^MOL
M=C_:%K_SWB_[[%']H6O_ #WB_P"^Q7'44>Q7</K;['8_VA:_\]XO^^Q1_:%K
M_P ]XO\ OL5QU%'L5W#ZV^QV/]H6O_/>+_OL4Y+RWE<*DL;L>BJP)-<95W1?
M^0G#_P "_D:F5))7N5#%.4DK'0S:M96TACENX(I%ZJ\@!'?IFF'7-./_ "_V
MO_?Y?\:\^\9?\C)>?\ _] 6L6LE'2X3Q3C)QML>M_P!N:=_S_P!K_P!_E_QH
M_MS3O^?^U_[_ "_XUY)13Y3/ZX^QZW_;FG?\_P#:_P#?Y?\ &C^W-._Y_P"U
M_P"_R_XUY)11RA]<?8];_MS3O^?^U_[_ "_XT?VYIW_/_:_]_E_QKR2BCE#Z
MX^QZW_;FG?\ /_:_]_E_QH_MS3O^?^U_[_+_ (UY)11RA]<?8];_ +<T[_G_
M +7_ +_+_C1_;FG?\_\ :_\ ?Y?\:\DHHY0^N/L>M_VYIW_/_:_]_E_QH_MS
M3O\ G_M?^_R_XUY)11RA]<?8];_MS3O^?^U_[_+_ (T?VYIW_/\ VO\ W^7_
M !KR2BCE#ZX^QZW_ &YIW_/_ &O_ '^7_&C^W-.Z?;[7_O\ +_C7DE%+E#ZX
M^QZXNL6$LBHE];NS'"JLJDDG\:DN-2M+20)/<PPN1D+)(%..F>3[&O*]%_Y#
M-A_UWC_]"%;?Q"_Y#4/_ %[K_P"A-2Y=;&RQ#=-SL=I_;FG?\_\ :_\ ?Y?\
M:/[<T[_G_M?^_P O^->2457*8_7'V/6_[<T[_G_M?^_R_P"-']N:=_S_ -K_
M -_E_P :\DHHY0^N/L>M_P!N:=_S_P!K_P!_E_QH_MS3O^?^U_[_ "_XUY)1
M1RA]<?8];_MS3O\ G_M?^_R_XT?VYIW_ #_VO_?Y?\:\DHHY0^N/L>M_VYIW
M_/\ VO\ W^7_ !H_MS3O^?\ M?\ O\O^->244<H?7'V/6_[<T[_G_M?^_P O
M^-']N:=_S_VO_?Y?\:\DHHY0^N/L>M_VYIW_ #_VO_?Y?\:/[<T[_G_M?^_R
M_P"->244<H?7'V/6_P"W-._Y_P"U_P"_R_XT?VYIW_/_ &O_ '^7_&O)**.4
M/KC['K?]N:=_S_VO_?Y?\:5=8L))%1+VW=F. JRJ23^=>1U=T7_D-6'_ %\1
M_P#H0I<HXXMR:5CU*XU*ULY D]S#"Y&0LD@4XZ9Y/UJ/^W-._P"?^U_[_+_C
M7%_$+_D-0_\ 7NO_ *$U<Q242ZF*<)N-CUO^W-._Y_[7_O\ +_C1_;FG?\_]
MK_W^7_&O)**KE,_KC['K?]N:=_S_ -K_ -_E_P :/[<T[_G_ +7_ +_+_C7D
ME%'*'UQ]CUO^W-._Y_[7_O\ +_C1_;FG?\_]K_W^7_&O)**.4/KC['K?]N:=
M_P _]K_W^7_&C^W-._Y_[7_O\O\ C7DE%'*'UQ]CUO\ MS3O^?\ M?\ O\O^
M-']N:=_S_P!K_P!_E_QKR2BCE#ZX^QZW_;FG?\_]K_W^7_&C^W-._P"?^U_[
M_+_C7DE%'*'UQ]CUO^W-._Y_[7_O\O\ C1_;FG?\_P#:_P#?Y?\ &O)**.4/
MKC['K?\ ;FG?\_\ :_\ ?Y?\:/[<T[I]OM?^_P O^->244N4/KC['KBZQ82R
M*B7UN[,<*JRJ22?QJ:XO8+3'G31P[N%\Q@,_G7E.B_\ (9L/^N\?_H0KKO'W
MWK#_ ('_ .RU48<TE$WCB&Z;G8Z(:U8'G[;;_P#?U?\ &E_MJP_Y_;?_ +^K
M_C7E]%=OU17W.;Z\^QZA_;-A_P _UO\ ]_5_QH_MFP_Y_K?_ +^K_C7E]%/Z
MFNX?7I?RGJ']LV'_ #_6_P#W]7_&C^V;#_G^M_\ OZO^->7T4?4UW#Z]+^4]
M0_MFP_Y_K?\ [^K_ (T?VS8?\_UO_P!_5_QKR^BCZFNX?7I?RGJ']LV'_/\
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M;_MS3O\ G_M?^_R_XT?VYIW_ #_VO_?Y?\:\DHHY0^N/L>M_VYIW_/\ VO\
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MQ_M"U_Y[Q?\ ?8I/[0M<_P"OB_[[%<?12]CYA]:?8[F-@R[E.0>A%.JKI_\
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M._Y_[7_O\O\ C7DE%7RG%]<?8];_ +<T[_G_ +7_ +_+_C1_;FG?\_\ :_\
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MW_;FG?\ /_:_]_E_QI4UBPED5$O;=F8X"K*I))].:\CJ[HO_ "&;#_KXC_\
M0A2Y2HXMMI6/7%'%17-Y!:)OGFC@3IND8*/U-3=JY?XA?\@:'_KN/_06J%JS
MT)RY8N1LC7-.&<7]K_W^7_&C^W-._P"?^U_[_+_C7DE%7RGF_7'V/6_[<T[_
M )_[7_O\O^-']N:=_P _]K_W^7_&O)**?*'UQ]CUO^W-._Y_[7_O\O\ C1_;
MFG?\_P#:_P#?Y?\ &O)**.4/KC['K?\ ;FG?\_\ :_\ ?Y?\:/[<T[_G_M?^
M_P O^->244<H?7'V/6_[<T[_ )_[7_O\O^-']N:=_P _]K_W^7_&O)**.4/K
MC['K?]N:=_S_ -K_ -_E_P :/[<T[_G_ +7_ +_+_C7DE%'*'UQ]CUO^W-._
MY_[7_O\ +_C1_;FG?\_]K_W^7_&O)**.4/KC['K?]N:=_P _]K_W^7_&C^W-
M._Y_[7_O\O\ C7DE%'*'UQ]CUO\ MS3O^?\ M?\ O\O^-)_;FFYYO[7_ +_+
M_C7DM'>CE#ZX[['M$<BR1AT8.C<AE.0:=5#0_P#D"V'/_+O'_P"@BKXK(]-.
MZN+11104%%%% !1110 4444 %%%% !1110 4E+2&@"%KB)6P74'ZT?:H?^>B
M_F*Q;C_CXD_WC_.F<U\O/-YQDTHF/M#=^U0_\]5_.C[5#_SU7\ZPZ*C^V)_R
MH7M#<^U0_P#/5?SH^U0_\]5_.L.BC^V)_P J#VAN?:H?^>J_G1]JA_YZK^=8
M=%']L3_E0>T-S[5#_P ]5_.C[5#_ ,]5_.L.BC^V)_RH/:&Y]JA_YZK^='VJ
M'_GJOYUAT4?VQ/\ E0>T-S[5#_SU7\Z/M4/_ #U7\ZPZ*/[8G_*@]H;GVJ'_
M )ZK^='VJ'_GJOYUAT4?VQ/^5![0W/M4/_/5?SH^U0_\]%_,5ATG-']L3VY!
M^T-^.9)#A6!^AJ2LC23_ *0?]W^HK7_E7NX/$/$TO:-6-(RYE<KW&H6UHP2:
MXBB;&0KN <?B:B_MJP_Y_;<?]M5_QKD?'/\ R%XO^N(_]":N=KW:>&4XJ5]S
MSJF+<)N-MCU#^V;#_G^M_P#OZO\ C1_;-A_S_6__ ']7_&O+Z*U^IKN9_7I?
MRGJ']LV'_/\ 6_\ W]7_ !H_MFP_Y_K?_OZO^->7T4?4UW#Z]+^4]0_MFP_Y
M_K?_ +^K_C1_;-A_S_6__?U?\:\OHH^IKN'UZ7\IZA_;-A_S_6__ ']7_&C^
MV;#_ )_K?_OZO^->7T4?4UW#Z]+^4]0_MFP_Y_K?_OZO^-']LV'_ #_6_P#W
M]7_&O+Z*/J:[A]>E_*>H?VS8?\_UO_W]7_&C^V;#_G^M_P#OZO\ C7E]%'U-
M=P^O2_E/4/[9L/\ G^M_^_J_XT?VS8?\_P!;_P#?U?\ &O+Z*/J:[A]>E_*>
MH?VS8?\ /];_ /?U?\:/[:L/^?VW_P"_J_XUY?12^IKN'UZ7\IZC'JUE)(J)
M>0,S<!1(N35P5Y;I/_(5LO\ KNG_ *$*]27I7)6I>R:5SMP]9UDVT+1117.=
M04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7$?$C[VG_P#;
M3_V6NWKB/B1][3_^VG_LM5'<YL1_#9Q=%%%;GA] HHHI %%%% !1110 4444
M %%%% !1110 4444 %%%% +='L_\'X5XQ7L_\'X5XQ41/1Q>T0HHHJSS@HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *[3X<?>U#_ +9_^S5Q==I\./O:
MA_VS_P#9JF6QTX;^(C:\6?\ (.B_ZZC^1KE*ZOQ9_P @Z+_KJ/Y&N4KY+,/X
M[/7EN%%%%><0%%%% !1110 4444 %%%% !1110 4444 %%%% !7?:7_R#;7_
M *Y+_(5P-=]I?_(-M?\ KDO\A7L9;\<O0T@6J***^@- HHHH **** "BBB@
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MBBB@ HHHH ****!H[+X5_P#(PW'_ %ZM_P"AI6MJ7_(1NO\ KJW\S63\*_\
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M **** "KNB_\AJP_Z^(__0A5*KNB_P#(:L/^OB/_ -"%!4?B1M?$+_D-0_\
M7!?_ $)JYBNG^(7_ "&HO^N"_P#H35S%);&E?^(PHHHIF(4444 %%%% !111
M0 4444 %%%% !1110 4444 7=%_Y#5A_U\1_^A"NN\??>L?^!_\ LM<CHO\
MR&K#_KXC_P#0A77>/OO6/_ __9:NE_$1UT_X$CD:***]<\X****8!1110 44
M44 %%%% !1110 4444 %%%% !1VHH[4GLQK<Z?XC?\P[Z2?^RUQ==I\1O^8=
M])/_ &6N+KPXG;B/XC"BBBJ.<**** "BBB@ HHHH **** "BBB@ HHHH ***
M* 05Z9XD_P"7;_@7]*\SKTSQ)_R[?\"_I27Q(ZZ7\*1AT445V'-T"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH&=CI__ !X6_P#UR7^5615;3_\
MCPM_^N2_RJR*\U[GT$=D+1112*"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ KA/'7_(8B_ZX+_Z$U=W7">.O^0Q%_P!<%_\ 0FKKPO\ $.+&?PF<Y111
M7L'@A1110 4444 %%%% !1110 4444 %%%% !1110 4=J*.U3+9C6YZY_"*\
MP\9?\C)>?\ _] 6O3_X17F'C+_D9+S_@'_H"UX,=SV\5_#1BT445J>2%%%%
M!1110 4444 %%%% !1110 4444 %%%% !5W1?^0U8?\ 7Q'_ .A"J57=%_Y#
M5A_U\1_^A"DRH?$CUQJY?XA?\@6'_KNO_H+5U#5R_P 0O^0+#_UW7_T%JR6Y
M[>(_A2//J***V/!"BBB@84444 %%%% !1110 4444 %%%% !1110 4=Z*.]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJA!1110 4444 %%%% !1110 4444 %%%% !1110-;G9?"O\ Y&"X_P"O5O\
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M9+S_ (!_Z M8M;7C+_D9+S_@'_H"UBUS+8BK\;"BBBF9!1110 4444 %%%%
M!1110 4444 %%%% !1110!=T7_D-6'_7Q'_Z$*V_B%_R&H?^O=?_ $)JQ-%_
MY#5A_P!?$?\ Z$*V_B%_R&H?^O=?_0FJ>IU1_@/Y'+T45\Y_MG?&WQ3\,=!\
M)>&? 7DQ^./&FJ+I6G7-PBLENN5#R88%<[I(@"00 6)''-'/&+D[(^C**^'+
M_P#9E_:;^'3:;XE\*_'&^\<:_P#:8VO-"UEY4L=I/S[?-E='0$] D;;>5PP
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M'$T*_*KJ000H Z#G&2<R6@E3;U9^J<UY!;QQRS31Q1R,B*TC!=S,0%7G'))
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M_;3_ -EJH[G-B/X;.+HHHK<\/H%%%%( I5^]24=J!'QY\0?V\_%/AOXP>*_
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M)^"?[=%I\1OB5!\//&7@+6_AGXPNT:2TLM6+,DV%+A26CB=&*@E<IM.TC=G
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MFCUN/1?B7H L6TZ\<$OJ+,JNT#  [L'?(,_+CS%/#<',6\/9I7W/N6BOC?\
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M_P#017U>4?PV88C^&BE1117T!Y84444#/GC]K+]DI/VBE\/Z[H?B.X\&>/\
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MD?P5\+-,\*Z,_A;6+.UF/C1M611!9B3SEBDM6 D$BE0-R;@0!CDDCU?]H?\
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M51"6WY/3&*M>+OB-X5^'\,$OBCQ-H_AN.=BL4FKW\5H)&]%\QAG&>U?G_P#
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M@202!1QD @X(KY6^ &@^+? 7Q&^/T&CZSX+M]8AT":2?PUX&M]06QT[4TCQ
MZ+/;^2"3YF520D'("@*0O#_#+X;?"G6/^"=/BOQ5JUEI%UXO5;Z2XUBX*M>P
MZ@LC?9X5E/S+N40_(" V\G!W&GS&7L8Q=VS[4^ W[0NG_$#X3>!M>\7ZSX?T
M+Q-XDM9KE--6Z6W\[RY) QACED+L J9;D]Z](\)_$#PQX^@N)_#'B/2?$<%N
MX2:32;Z&Z6)B,A6*,=IQV/-?EYI^F^'=87]CNQ\6-&/#UQ:7D=VL[A(W!O&
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MUZG;JSC>]@J[HO\ R&K#_KXC_P#0A5*KNB_\AJP_Z^(__0A294/B1ZXU<O\
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MXT^WEED;JSM&I)/U)-;8[UYDERMQ?0D6BBBI$6]+_P"/@_[O]16M_#63I?\
MQ\'_ '?ZBM;^&OM<J_W9?,Z8?"<+XY_Y"T/_ %P'_H35SI_S_G\?UKHO'/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]6CUG2-.O-:UZ%BUOJFNS)/+;'UC5%1%/HP7<,]>:^@Z*5NIK[2=K<VAY?\
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M?>!M(_\ /XU+"G%2BD^Y]+:'^VUX*UOXA#P;+X>\8:-K5S:27FF1ZQHK6O\
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MK@M0_P""AWP\@N-7GT[PUXY\1^&-)N3:W_BW1]",VDV[J1NWS>8" ,@_=Y#
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M#O".N>-O#/P^@_LF[L]#MS=7PB5(XT/ECYF+('Y  !7!(RIJ'X=VWC?X@?\
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MY"\@[A2E=@Z=-)'KGPP_:/\ '_B3QQI'A[QO\#M=\%VNL0F:RUW3M0BUS3U
M4L!<30(%@R!@;B>2,@#D?0=?FA\#? 'C'PW\>/!W_"D?"?Q;^'O@=KS[1XIT
MWXB1"WTH6^Y2RV\;<N^T. V6DRRXP-U?I?\ I5P;:,:T5%Z!5[0_^0I#_P "
M_D:HU>T/_D*0_P# OY&G/X632_B(YOQE_P C)>?\ _\ 0%K%K:\9?\C)>?\
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M%%BW5DTEV.-\-_!WPAX1\>>(?&FDZ1]C\2^( JZG??:IG\\#&T>6SE%Q@?=
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MU/P/X!\53QVVD>*)-7ANP3*-T#3P*H:%67YOF)P,D;@,UN?&+]JSQ;\/-?\
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MSW+XG?M7'P_XXT?P/X \&WGQ*\9ZC8+JIL+:[2QAMK1@"LDD\BE4+ C@C&"
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7_(P:G_U]2_^AFL^J6R-Y;A1115""BBB@ HHHH **** "BBB@ HHHH ****
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MHH *O:'_ ,A2'_@7\C5&KVA_\A2'_@7\C43^%FU+^(CF_&7_ ",EY_P#_P!
M6L6MKQE_R,EY_P  _P#0%K%KF6Q%7XV%%%%,R"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@"[HO\ R&K#_KXC_P#0A6W\0O\ D-0_]>Z_^A-6)HO_ "&K
M#_KXC_\ 0A6W\0O^0U#_ ->Z_P#H35/4ZH_P'\CEZ;*66-BHR^.!GO@^W^<T
MZC_]?2J.9;W/BO\ X)DVFG:MX0\?^)+V"*3QQ=>)+A-3NI4/VE5*HZH6;D+O
M,A^N<\]/>ET/X;?"/_A9'C+PKHFCQ^)K6SFO]:3364W3,D/G"-U4EHRXVL5
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MQ#H/[7GP%T73=>U.PT?4GN!?:=:7DD=O=@,,"6-6"R =.0:Z?QY^Q+X9\3?
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M^(W_ ##OI)_[+7%UVGQ&_P"8=])/_9:XNO#CL=N(_B,****HYPHHHH ****
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M_P! 6O3_ .$5YAXR_P"1DO/^ ?\ H"UX,=SV\5_#1BT445J>2%%%% !1110
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MWX'^"MUH?B+5-*DU#6[..[FT^]EA-U&T0)60JP\Q2>H)P<GTK@?B+\*?[?\
M^"C6FZ2?%_BS31J6C/J7V[3]3\NYM<"8_9X'VG9"=GW,'[S#/->D:]^P[XG\
M9Z9X,MO%'QEU#7I/"UY#+8K+HL44"P)M_=[$D!+G:H\UW<@# '))[_XN?LTZ
MGX\^+_A_XE>%?'=QX(\3Z79G3V?^S(K^*6$E^ DCJ%8B1US\PQC !&:4*U*G
M[BENGK;[N@:'@7@OX^^*_ >H?M9:]<ZOJ.O_ /",:BD6CV>IW4US!:,]S<Q*
M$1B0B ["0N 0@SC'#M:\-_$SP?\ LVV'QUC^,GBB_P#%WV.VURXTN\N5_L9X
M)BA\D6N H(5P"1P2#M5<YKW/P)^R3IGAS6?C#/KNLCQ'I?Q'N#-<V'V/[/\
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M68?QSUY;A1117G$!1110 4444 %%%% !1110 4444 %%%% !1110 5WVE_\
M(-M?^N2_R%<#7?:7_P @VU_ZY+_(5[&6_'+T-(%JBBBOH#0**** "BBB@ HH
MHH **** "BBB@ HHHH **** "FM3J:W0T">QPU%%%>DMCYZ6["BBBF(****
M"BBB@ HHHH **** "BBB@ HHHH ****!FYX9_P"7C_@/]:\SKTSPS_R\?\!_
MK7F=<DOC9O4_A0"BBB@Y0HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Z
M?X>_\AF?_KW;_P!"6N8KI_A[_P AF?\ Z]V_]"6D]C?#_P 1'%^(O^1@U/\
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M_AHQ:***U/)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J[HO_(:L/\
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M%.BKG]BZA_SX7/\ WY;_  H_L74/^?"Y_P"_+?X4!RR[%.BKG]BZA_SX7/\
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M#1S1#DEV(:*F^PW7_/O-_P!\&C[#=?\ /O-_WP:.:(<DNQ#14WV&Z_Y]YO\
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ME/LP*]%6/[/N_P#GUF_[X;_"C^S[O_GUF_[X;_"CV4^S KT58_L^[_Y]9O\
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M>'_CR_XU:TS3+FUOHY)(MJ+G)W ]C[U,I1:=F:4Z<U->ZSD?&/\ R,EY_P
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M3_R*G^-'_"&:Q_SY_P#D5/\ &BZ'[*IV92T7_D,V'_7Q'_Z$*VOB%_R&H?\
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MH_L74/\ GPN?^_+?X4!RR[%.BKG]BZA_SX7/_?EO\*/[%U#_ )\+G_ORW^%
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MK_Y$3_&CVL/YD'L:G\K^XR**U_\ A$]5_P"?7_R(G^-'_")ZK_SZ_P#D1/\
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MC_A%-4R ;7'OYB?XU+JPL_>0XT:EU[K+_P 1>FG?]M/_ &6N,KN/'EG<7?V
M002R[=^[RU+8^[UQ7)_V+J'_ #X7/_?EO\*\F.QU5XR=1Z%.BKG]BZA_SX7/
M_?EO\*/[%U#_ )\+G_ORW^%4<_++L4Z*N?V+J'_/A<_]^6_PH_L74/\ GPN?
M^_+?X4!RR[%.BKG]BZA_SX7/_?EO\*/[%U#_ )\+G_ORW^% <LNQ3HJY_8NH
M?\^%S_WY;_"C^Q=0_P"?"Y_[\M_A0'++L4Z*N?V+J'_/A<_]^6_PH_L74/\
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M/_X\+?\ ZY+_ "%615>P4K90*1@B-00?I5@5YSW/=CLA:***104444 %%%%
M!1110 4444 %%%% !1110 4444 %<)XZ_P"0Q%_UP7_T)J[NN2\6:)?:EJ4<
MMM#YD8B"D[U'.3ZGWKIP\E&I=LY,5%RIV2..HK7_ .$3U7_GU_\ (B?XT?\
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MJ^2!N1"PSN;C@5A?V3>_\^=Q_P!^F_PKZ^C**II-GA5XR=65D4Z*N?V3>_\
M/G<?]^F_PH_LF]_Y\[C_ +]-_A6_/#N8>SGV*=%7/[)O?^?.X_[]-_A1_9-[
M_P ^=Q_WZ;_"CGAW#V<^Q3HJY_9-[_SYW'_?IO\ "C^R;W_GSN/^_3?X4<\.
MX>SGV*=%7/[)O?\ GSN/^_3?X4?V3>_\^=Q_WZ;_  HYX=P]G/L4Z*N?V3>_
M\^=Q_P!^F_PH_LF]_P"?.X_[]-_A1SP[A[.?8IT5<_LF]_Y\[C_OTW^%']DW
MO_/G<?\ ?IO\*.>'</9S[%.BKG]DWO\ SYW'_?IO\*/[)O?^?.X_[]-_A1SP
M[A[.?8IT5<_LF]_Y\[C_ +]-_A1_9-[_ ,^5Q_WZ;_"CGAW#V<^PFD?\A:R_
MZ[I_Z$*]26O-]+TV\CU2S9[2=469"6:)@!\PZFO2%KS,4TY*S/6P47&+30M%
M%%<1Z(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7*>*O%-
MWHFHQP01PNC1!R9%).22.Q'I75UYY\0O^0U#_P!>Z_\ H354=6<V(DXPNA/^
M%@ZC_P \;;_OAO\ XJC_ (6#J/\ SQMO^^&_^*KF**UY4>7[>I_,=/\ \+!U
M'_GC;?\ ?#?_ !5'_"P=1_YXVW_?#?\ Q5<Q11RH/;U/YCI_^%@ZC_SQMO\
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M_P#BJ]#\1?\ (OZI_P!>LO\ Z :\*J8),]"M)Q:LSLO^%J:K_P ^]E_WP_\
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MBDC6G.4I)-GH:]*44+0.]8G<%%+10 E%+10 E%+10 E%+10 E%+10 E%+10
ME%+10 E%+10 E+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10
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M_P!\)_\ %5YI11["(>SB>MZ)XPM-?NVM[>*=75-Y,JJ!C('9O>M]:\Q^&O\
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MJP#ZY4.Y_P"$ZL?^>%Q^2_\ Q5'_  G5C_SPN/R7_P"*KAJ*/JL ^N5#N?\
MA.K'_GA<?DO_ ,51_P )U8_\\+C\E_\ BJX:BCZK /KE0[G_ (3JQ_YX7'Y+
M_P#%4?\ "=6/_/"X_)?_ (JN&HH^JP#ZY4.Y_P"$ZL?^>%Q^2_\ Q5'_  G5
MC_SPN/R7_P"*KAJ*/JL ^N5#N?\ A.K'_GA<?DO_ ,51_P )U8_\\+C\E_\
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M1[&(?6IG1_\ "26W_/.7\A_C1_PDEM_SSE_(?XUSE%'L8A]:F='_ ,));?\
M/.7\A_C1_P ));?\\Y?R'^-<Y11[&(?6IG1_\));?\\Y?R'^-'_"26W_ #SE
M_(?XUSE%'L8A]:F='_PDEM_SSE_(?XT?\));?\\Y?R'^-<Y11[&(?6IG1_\
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MK50]!_X6#I__ #PN?^^%_P#BJ/\ A8.G_P#/"Y_[X7_XJO/J*.5!]:J'H/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^N8_F:HV/_'Y!_UT7^=7O$G_ !_1_P#7,?S-9OXT=$?X,O4RJ***U.8****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M .1>U3_KUE_] ->$5[OXC_Y%[5/^O67_ - ->$5-/9GJXC=!1116IR!1110
M4444 %%%% !1110 4444 %%%% !1110 5Z'\(_\ F*_]LO\ V>O/*]#^$?\
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M1?\ 7!?_ $)JZ\+_ !#BQG\)G.4445[!X(4444 %%%% !1110 4444 %%%%
M!1110 4444 %':BCM4RV94=T>MK]T4^F+]T4^OGCZA;(****!A1110 4444
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MUFX"]>1VXKOE*244CI=[*Q]I_LR_M/:3^TCH>KRPZ1=>&]=T6=;;4]'NW#O
MS X*MA25)5UY52"K#'K[3SWX/UKX9\4?LW:E\"_V4/C=K'B?Q$?%'C3Q5;I=
MZK>Q@B$%),JJY )YE<EB!U "C'//:+X)T[X$_L,M\7/"ZW0^(VH^'(+.379[
MN662""XN(DVQ(6VQB--JH5 (P#D]*OG:T8*7<_0>BORKT_P?XU^'^A_#KQWX
M7^'P\":_<36US+XPU+XCV3IXD61-[(]O/*BYESNV@]-P(/4?2/Q>N+3]F_\
M; \-_%*ZD73O"'C/39M'UVX;B.&ZCC#Q.W;+>7$!W^20BCVE]T-2/L.C]/P_
MS_GZ\?EU9^*H/$GP\^)OQS\:/XDM+OQUK,?AW0+?PY=K:736Z'>8!,\;JD1\
MM$9@I),+#'S,#>\(^!=>^!W[7/PAC@\*6?PPA\0LT=QH>F:]<:E+/%RK"[=W
M,;9R,!/E!4GJ!2=3R%S'VC\$?VC/^%Q?$?XG>$_^$>_LC_A"M0%C]K^V^?\
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MY_SBO3JYJWQF53X@HHHK S"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8S@9QTKH*_+7XQ:_XG\>>+/V=OA1!X8N/'7AB3P+8:M+X-M]>&C+J\WV=_\
M67+$ B-80X YX;!YKNOV9=2^(GP7\0_&[1K7P[;>%_#NE^'+C6=*\#S>,K+7
MI]'OHXU*QE8Y3,D<F\M\R 8"@DG!-J?<QE1LN:Y]P_%_X@?\*H^%OBOQE]@_
MM3^PM.FU#['YWD^=Y:EMF_:VW.,9VGU[5YI\&?VAO&GQFM/A]KEA\+/L_@KQ
M)I\EW?Z__P )#"_]E3+).BP_9S&LD^?*C^90 /.Z?(:^)O /[/\ X<^('[!_
MC;XUZYKVM7GQ-U.RU2[N=>.K3J^V*1X_LDBAMKQR+$-P=23YN 0 M9?[,?\
MR<I^R0.H_P"$,O>__335Z7.[W*5&*374_6<=/_U45^8OQC\+6/[3GQB^+TWA
MSP3?^/#X:\RSNO$/C7Q3)9:5H4T:2 I9V5JJ2,F8F/S,VXIE@I8EOHO_ ()B
M^)-6\3?LGZ-+K&HW.IS6M_=VD,MW*9'2%'&Q QYVKG '88 X JU/F=C*5+EA
MS7/J^CO11WJV8QW.X7[HI],7[HI]>:?0+8****!A1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<
M)XZ_Y#$7_7!?_0FKNZX3QU_R&(O^N"_^A-77A?XAQ8S^$SG****]@\$****
M"BBB@ HHHH ****!A1110(**** "BBB@ H[44=JF6S*CNCUM?NBGTQ?NBGU\
M\?4+9!1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ I/\*6D_P * /+_ !E_R,EY_P  _P#0%K%K:\9?\C)>
M?\ _] 6L6MSY^K_$84444S(**** "BBB@ HHHH **** "BBB@ HHHH ****
M+NB_\AJP_P"OB/\ ]"%>O5Y#HO\ R&K#_KXC_P#0A7KU92/5P?P,****@] *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KSSXA?\AJ'_KW7
M_P!":O0Z\\^(7_(:A_Z]U_\ 0FJX[G)BOX1R]%%%:GBA1_G_ #Q11^7YXZ]Z
M!'P1J'@O4_V[OVAOB7H/B#Q=JVB?#3P/=+ID6CZ1,$:ZGRZ%V+ H2'B<EF5C
M@A5QR:]:_9Z_9-\2_LX?$G5FT7Q_=:G\,;FUVQ^']44S7"S]-^5VQJ5(^\H&
MX$J5&%:O-_%7AWXJ_LC?'SQQX[\$>!KGXF>!O&\PO+S3-/:3[7:W)+L>%5V
MWO(=PC92K 94@&O0_P!G_P")?Q]^+?Q0U'6O%?@Q/AY\-%M?+BT?5+=C>M,
M<%6;9)DELLS($ 15"YW-4'HRO;1^[8^:OV;M;\/^&_\ @G[\6]1\4>&O^$OT
M*#Q1FYT;[?)9?:<FQ5?WT8+)M8ALKUVX/!KZ0\9_M4:9^SS^S]\'M>TOP/)/
MHVOVMC:VND1:FQ?3H6ME=55VC9IF5<*-VTM@'/-?/'PZ^$OCBP_X)Z_%[PW<
M^#/$%OXAOO$236VDRZ5.MW<1[[$EXXBF]E&Q^5!&$;T-=U\?/AMXNUC]G?\
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MM$",'8,C\/H*:N8UK)67=DM%%%4<H5=T3_D-:?\ ]?$?_H0JE5W1/^0UI_\
MU\1_^A"@N'Q(]-\1_P#(O:I_UZR_^@&O"*]W\1_\B]JG_7K+_P"@&O"*FGLS
MU<1N@HHHK4Y _7V]?:N,A^#_ (1M?B5>_$"/2 /%U[9_8)]0^T2_O(<(-OE[
M_+'W%Y"@\5V=% T['E>E_LO_  QT7X<ZUX#L_#(A\*:S<K=W^GB^NF,\@*$-
MYAE\P<QQ\*P''N:TO&'[/_P^^('@W2?"OB'PQ:ZIHFDPI;V$4TD@DMHU55 2
M96$B\*H)#9..<UT/C[X@>'_AAX5O?$?B?4XM)T>S7,MQ+D\GHJJ/F9B> J\G
MIS7S5IW_  4Z^#M]KBV$\/B33[4OM.I7&GH8 /[Q"2M)CD]$S[=J6FQI%3EJ
M?0_PS^$?A#X-Z(^C^#M"MM"L9'\R58BTCR-C[SNY9WP./F)([5PFI?L7_!75
M];U/5[SP#8/>ZDKI<LLTRI\XPS)&'V1L>N]%# G(()KU_2=6L]>TNTU/3KJ*
M^L+R);BWN8'#QRQL 596'!!!!S5NEH1S2/+]7_9E^&6O?#_2?!.I>$K6\\.:
M0&6PMIIIC);;FW-LGW^:N3U^<^ASBN@^&?PA\(?!O0WTCP;H-OH=E(_FRK"6
M=Y6Z9>1R9'QT^8FNPHIV0<TNYPNJ? _P1K?Q/TWXAWNA1S^,=-B\BUU+SI1L
M4!U ,8;8QP[@,4)Z<\"L?XE?LP_"_P"+WB*WUWQ=X2MM6U>%%C%UYTT+.J_=
M5Q&RB3'3YL\<=.*]2HH"\CRBW_97^%=IX?\ %6AVOA.&ST;Q1)#+JMA:WEQ#
M!,T3[X]B)(!$ W:/;Z'CBO1?#?AW3_"/AW3-#TBW^R:5IMM':6D&]G\N)%"H
MNYB2<  9))..:TJ*+(5V]V%%%%,05Z'\(_\ F*_]LO\ V>O/*]#^$?\ S%?^
MV7_L]1+8VH_&>B"@=Z!0.]<YZ0M%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %(U+2-0!XIKQ(US4?^OF0_
M^/G]*\E^#/P!\/? V;Q3)H-YJ=VWB/46U.Z_M&2-]DIR2$"1H0OS'&2?K7K.
MO?\ (<U'_KYE_P#0S5&O5BERIG8NAR_Q0^'>F_%CP#K7A#5IKJVTW5H?(GEL
M75)57<#\I96 Z#J#5#0?@[X:T?X1V?PWN+>36O#$&GC3&AU)@[SPXQ\[(JC=
MT(*@8(!&"*[>C_)IV6X].I\]>#/V'? /@_Q%HFI/JOBG7['0IC<:-H6N:K]H
MT[39"P;?#%M&"#@\DC(R0>#7HWQP^"/AW]H'P%-X4\3?:HK%YX[F.XL&1)X)
M$/#1M(CJ,@LOW3E6/3.:X_7/VU_@EX=\3R^'[_Q_8IJ<4ODR>3;SS0H^<$&9
M(VBX(YR_'>O9M,U2SUO3;74-/NH+ZPNHEGM[FVD$D4L;#*NC D,I!R".H.:2
M47L2K6/)O$7[*/@'Q1\#M)^%=[:W1\.Z4D?V.YBD5;N*50?WX<)M\QMS[CMV
MG>V5Z8Y;2?V&_!FE^+O#'BN;Q/XTU;Q3H%TEQ!J^K:PMU/,B8*6\N^,KY2_,
M J*AP[9;ICZ+]?T[?K7&>"?C%X0^(WB3Q/H'AW5_[2U;PU<?9-6M_LTT7V>4
MLZ[=TB*K?-&X^4L/EYI<L1V1@?#?]G3PO\,?%GQ!U^PGU#49_&]T;K5+74Y(
MI+<9>5BD:K$I"GSF&&+'@#U)\^@_8"^&MOJ"1K?>*&\*K>?;QX-DU=VT;SQT
M?R=NXD=/O].#QQ7TG^M%/EB%D>96G[/OARS^.DWQ7BNM177Y-.&E_8_,B^Q+
M$ H!""/=G"C^,CG@=AE_%G]EKPG\6/%EIXK;4->\(^+;6+[.->\*ZC]BO'BP
M0(V?:P(P2,XW8XSCBO8:*.5-6%RHX;X/_!GPQ\#O"8\/^%[62.V>5KFYN;F0
MRW%W,<;I99#]YC@=@.!P*XO]HK]DGP?^TU>:)=>*-2UNRDT>.:.W&CSPQAA(
M59MWF1/DY08QCO7MM%/E5K#LK6/EOX6_\$Z_AO\ "7Q_HWB[1]:\4W.IZ7*9
M8(KRZMGA8E&4[@MNIZ,2,$<@?CWGP[_90\(_#7X1^+/AWI>HZU/HGB5KE[N>
MZGA>XC\^%8G\MEB55 5 1N5N?R'M%%3R):I"Y4>(77['WP^U+X+Z%\-+]-1O
MM(T-WET[4I+A4O[:5G9RZ2HBKG+M_#@X&0<#&K\(_P!F?PQ\(/$FH^)(=2U[
MQ7XIOXEMIM>\4W_VV\$(QB-6VJ ORCMDX%>M452BD[CLCK/AI_R'I<_\^S?^
MA)7I]>8?#7_D/3?]>S?^A)7I]<%;XV<\]PHHHK S"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'@/XA>(=3\6>'/A^=).EWOBGP?*\5WI<H:<Y+(CE4;S5SQEE+@9Q@\S\+?
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M@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT3_D-:?_ -?$?_H0H+A\2/3?$?\ R+VJ?]>LO_H!KPBO=_$?_(O:I_UZR_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT:?3]8M=#EN@))6^V!&MTDC.5VW$6=[KR'[8R6=PYX6Z$O@7X_>)?AW^T?\
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MX,O4RJ***U.8**** "BBB@ HHHH&%%%% !1110 4444""BBB@ J>Q_X_K?\
MZZ+_ #J"I['_ (_K?_KHO\ZF6S+A\2.S]*6D]*6O./H HHHH **** "BBB@
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MB_\ 9G\7_LVS?$2W\3:[I?B2WU_5$U&TU*S\R.XF;$@D::(H$C)RI 1WZD9
MIQYN;4B7)R65KGTQ^E%%%;'&%'>BCO294=SN%^Z*?3%^Z*?7FGT"V"BBB@84
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !7">.O^0Q%_UP7_ -":N[KA/'7_ "&(O^N"_P#H35UX
M7^(<6,_A,YRBBBO8/!"BBBD,**** "BBB@ HHHH **** "BBB@ HHHIB"CM1
M1VJ9;,J.Z/6U^Z*?3%^Z*?7SQ]0MD%%%% PHHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !36IU-:@#Q37O\ D.:C_P!?,O\ Z&:HU>U[_D.:
MC_U\R_\ H9JC7K0^$[([!1115#"BBB@ HHHH **** "BBB@ HHHH **** "B
MBBF@.L^&O_(>F_Z]F_\ 0DKTX=Z\Q^&O_(>F_P"O9O\ T)*].'>O,K?&<T]Q
M:***Q,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYU,MF7#XD=GZ4M)Z4M><?0!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %8/B;[UO_P+^E;U8/B;[UO_ ,"_I6E/XD<^(_ALPJ***[SQ.@4444 %
M%%% !1110 4444 %%%% !1110 4444 %'>BCO294=SN%^Z*?3%^Z*?7FGT"V
M"BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !7">.O\ D,1?]<%_]":N[KA/'7_(8B_ZX+_Z
M$U=>%_B'%C/X3.<HHHKV#P0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*.U%':IELRH[H];7[HI],7[HI]?/'U"V04444#"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *3_  I:3_"@#R_Q
ME_R,EY_P#_T!:Q:VO&7_ ",EY_P#_P! 6L6MSY^K_$84444S(**** "BBB@
MHHHH **** "BBB@ HHHH **** +NB_\ (:L/^OB/_P!"%>O5Y#HO_(:L/^OB
M/_T(5Z]64CU<'\#"BBBH/0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "FM3J:U 'BFO?\AS4?^OF7_P!#-4:O:]_R'-1_Z^9?_0S5
M&O6A\)V1V"BBBJ&%%%% !1110 4444 %%%% !1110 4444 %%%%- =9\-?\
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M7^=7O$G_ !_1_P#7,?S-9OXT=$?X,O4RJ***U.8**** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*\\^(7_(:A_Z]U_]":O0ZQ=:\*VVN72SS23(ZH$ C8 8!)[@^M5%V9SUX.I#
ME1Y=17H/_"O;#_GM=?\ ?:__ !-'_"O;#_GM=?\ ?:__ !-:<R/.^JU#SZBO
M0?\ A7MA_P ]KK_OM?\ XFC_ (5[8?\ /:Z_[[7_ .)HYD'U6H>?45Z#_P *
M]L/^>UU_WVO_ ,31_P *]L/^>UU_WVO_ ,31S(/JM0\^HKT'_A7MA_SVNO\
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M/\*/^$;MO^>DOYC_  JO;1,_JLSG**Z/_A&[;_GI+^8_PH_X1NV_YZ2_F/\
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M!#(CJ\A*D,,D8X.?2I;W28KZ022.X8+M^4C_  ]ZAU%S\QNJ$E3<#E:*Z/\
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MC_X1NV_YZ2_F/\*/^$;MO^>DOYC_  H]M$/JLSG*GL?^/ZW_ .NB_P ZW/\
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M17$>LMA:***!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %<)XZ_P"0Q%_UP7_T)J[NL?5_#=MK
M%RLTTDJ,J;,(1C&2>X/K6]&:ISYF<^(INI#EB><T5W/_  @MC_SWN/S7_P")
MH_X06Q_Y[W'YK_\ $UZ'UJF>7]3JG#45W/\ P@MC_P ][C\U_P#B:/\ A!;'
M_GO<?FO_ ,31]:@'U.J<-17<_P#""V/_ #WN/S7_ .)H_P"$%L?^>]Q^:_\
MQ-'UJ ?4ZIPU%=S_ ,(+8_\ />X_-?\ XFC_ (06Q_Y[W'YK_P#$T?6H!]3J
MG#45W/\ P@MC_P ][C\U_P#B:/\ A!;'_GO<?FO_ ,31]:@'U.J<-17<_P#"
M"V/_ #WN/S7_ .)H_P"$%L?^>]Q^:_\ Q-'UJ ?4ZIPU%=S_ ,(+8_\ />X_
M-?\ XFC_ (06Q_Y[W'YK_P#$T?6H!]3JG#45W/\ P@MC_P ][C\U_P#B:/\
MA!;'_GO<?FO_ ,31]:@'U.J<-1VKN?\ A!;'_GO<?FO_ ,31_P (-9<_O[C_
M +Z7_P")I/%0L-8.HG<Z-.5%+2+\HI17DGM+;46BBB@84444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2&EIK4 >8
M>,?^1DO/^ ?^@+6+7I>I>#K/5;V2ZEEG623&0C #@ =Q[55_X5[8?\][K_OM
M?_B:U4E8\JIAIRDVCSZBO0?^%>V'_/:Z_P"^U_\ B:/^%>V'_/:Z_P"^U_\
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M=SNP])TXM,=1114G6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 54OIFMT#J.<XJW5'5O\ CW7_ 'OZ&N/&
M2<*$Y1=K">Q5_M2;T4?@:3^U)?\ 9_(_XU5HKXWZ]B=^9G-S/N6_[4E_V?R/
M^-']J2_[/Y'_ !JI11]>Q'\S#FEW+?\ :DO^S^1_QH_M27_9_(_XU4HH^O8C
M^9AS2[EO^U)?]G\C_C1_:DO^S^1_QJI11]>Q'\S#FEW+?]J2_P"S^1_QH_M2
M7_9_(_XU4HH^O8C^9AS2[EO^U)?]G\C_ (T?VI+_ +/Y'_&JE%'U[$?S,.:7
M<M_VI+_L_D?\:/[4E_V?R/\ C52BCZ]B/YF'-+N6_P"U)?\ 9_(_XT?VI+_L
M_D?\:J44?7L1_,PYI=RW_:DO^S^1_P :3^U)?13^!JK28^:CZ]B/Y@YI=S?@
M;=$K=R :D%16?_'K%_NC^52BONJ;O"+\CI%HHHK084444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %4=6_X]T_WOZ&KU4=6_P"/=/\ >_H:X<=_NT_0F6QDCK0M ^\:%KX Y!:*
M** "BBB@ HHHH **** "BBB@ HHHH **** "CN**.XH6XT;EG_QZQ?[HJ>H+
M/_CUB_W14]?I%+^''T1UK8****U&%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %4=6_X]T_WOZ&KU4=6_X]T_WOZ&N''?
M[M/T)EL9(^\:%H'WC0M? '(+1110 4444 %%%% !1110 4444 %%%% !1110
M 4=Q11W%"W&C<L_^/6+_ '14]06?_'K%_NBIZ_2*7\./HCK6P4445J,****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "J.K?\>Z?[W]#5ZJ.K?\>Z?[W]#7#CO]VGZ$RV,D?>-"
MT#J:%KX Y!:*** "BBB@ HHHH **** "BBB@ HHHH **** "CN**.XH0T;EG
M_P >L7^Z*GJ"S_X]8O\ =%3U^D4OX<?1'6M@HHHK484444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA1116@!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 )2T44 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MUIU9GI(6BO-?CY^T'X)_9M\"R^*O'&IFRL@_DV]M OF7-Y*1Q%#'D;FQD]0
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M&LVM_K_B77)3!I'AW1XQ)=7;@@;L$_*FYE7/))8!5;!QSG6>ZT5\!V__  5
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MR,@'VO15+1M5M-=TFSU+3YUNK&\A2XM[A/NR1NH96'L00:MM0 ZBOA/X@?\
M!1SQSX?^+GCCP/X._9U\0_$5?"E^;&YU+0[^>4="59TCL9/+SAL L<[3571_
M^"HVH>&/$.F0?&+X"^,?A%X?U"<6T.NZ@L\L*R$\EEEMH"54?,=F]@ <*<4
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MQ.-@R?O%!Q]ZO38_NT .HHHH **** "BBB@ HHKQGQI^T5_PB/[3G@'X0_\
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M?V#_ &Y;O/\ V=]I^T^3ME>/'F;$W?<SG:.M 'I-%%% !1110 4444 %%%%
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M--Q_>C!P/J/1_P!IVZBO/^"6/P:DAD$J>7X93</58E4_D01^% 'Z10?ZF/\
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MHD$D[N1#M)&0".,3?'3QY^T;^R!8:+\2O%'Q-T3XD^"WU*WM-;\-Q^&HM/\
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MA/\ 'G1O 'Q$NI/BYX*\06DLUMX[TSP\-/.E7$:EC#>)#F)$; 523EBP.>&
MI76K?M&_M _$GQI9>%-=/P&\">'+XZ=I^J:IX66_U#79%.'G2.Z*H+<]5=>H
M(^]SMUKS]KT_$+]I3P3\-O@]=:#XVT<PS:AXOUZU+7MMIUJ%!B2*>&58Q*[
MKSO +)QUQ\R_#WQQI/[0/BWXAZA\>?VBM?\ A9K&B:_<Z;!X"T_Q+%X>MH+2
M,D*&5@#<DG*[E.[Y>2=PP >^_LR?'#XGV7[2GCGX#?%75=-\7:KHFEQZUIOB
MBPLA9/=V[-$,20H!&#^^7[N,%6&6!!%/]BTD_M4_M:9_Z&2R_P#0)Z\#_8?D
M^']G_P %%_%R?#B'48_!]UX+;^SK_5I+F275F$UH9;E6N/G*LZ2 'H?+R  <
M5[Y^Q;_R=5^UK_V,EE_Z!/0!]EFOB/\ X)3?\DM^*W_90]3_ /15O7VX>M?E
MS^PA^V3\'OV=_"OQ+\/?$'QA_P (_K%UXXU&^BMO[,O+G="5A0/NAA=1\T;C
M!.>.G(H ^I/^"DWPWT7XA?LB^.9]4LXI;W0+3^U].NV3+VTT; G8>V]-R'V;
MIP*XL_M9>)/ ?['?P.O-%TU/%7Q2\=VEAHNC6VH.RQS79C"/<SG()12 S8(R
M7'('->4?M:_MN:#^U9X/'P.^ <&I>-_$?BV:&WNM06QEMK>WM0X=_P#6JKCE
M5W,RA51F.[-:7[>7[-]EX+^"_P  +J^T*X\6^ OAC-%8>)K&Q\Q))-/=($GG
M&Q@X&8"20P(,@YQD@ ]1\7^%?VLOA'X2U#QXOQ@\/_$6?2[9[Z]\%W7A:"QM
M9(47=*D%W$PE+*H;86 SW]#3\>?M:^)+JY_9G^*7A;4GL_A5XXU)=&\0Z+<6
M\+^5<3@I%F8QF0-'(LP)5E5C".,,:\>\=_#O_@GMX3^%]UXNTVQT+Q-<?9O-
ML= TWQ=J#ZA=S$?NX3 +DR1%FPI9T 3.6KVWQE^S[;^-/^"<]QX1T3P)+\.-
M0@TIM?TGPO\ VC-?3Z;>)*UVD?GS 2>8Y)5@0-IE9>@S0!U/[7_QB\:>'/''
MP>^&OPUU8:/XN\:Z[_I-XMM#<-!ID"[KEMDR,H.&R"1G]VP%7?VGOC]XP\(^
M./ OPE^%]I8W7Q(\9&65+_5@6M-(LHAF6ZD1<%S@/M'0E#P>%/C/[#_B2?\
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M+>N?%+X,?%+7-.\#ZQ8^);K6-,O->G2RMM2L9]H26.:3:C']WG&<G=@#Y6
M/4_@7\=/B)X3_: OO@-\9;O3M>\12:9_;/A[Q9I=L+9=6M0S*ZS0 XCE&USA
M0%_=OU^4MYO\/?BM^T-\=OCY\<_A[X9\;:9X6T#PQK;0P^)+W18;V?38<RK%
M;6]OMC65F*$L\S-M"C')R9_"/BJT_:B_X*,:5XU\#R+J_@/X<^'9]/N?$<"'
M[+=7TWF+Y,4F,/A9@1@X(C<@X()Z3]AG_DX3]K+_ +'*/^4] '$>#_C+^TM;
M?'_Q1^SE<^)?#OB+Q'!!%JUM\1[S2D@^QZ<RJ9)&LHB$DDWR1(B$@!MQ9G4@
MCL/!_P 3OC3\"/VK_!/PJ^)OCBP^*7AKQU97,VFZXNB1:3=6=Q!&79#'#\A4
MX Y+']XIRN"#6\'_ /*7+QU_V3R'_P!'6M7OVG/^4@/[*G^[KG_I.M '+?#S
MXJ_M#?'3X^?'/X>^&O&VF>%M \,:V88?$E[HL%Y/IL),JQ6UO;A8UE9BA+/,
MS%54<9/-/P?\9?VEK;X_^*/V<KGQ+X=\1>(X((M6MOB/>:4D'V/3F53)(UE$
M0DDF^2)$0D -N+,ZD$=O^PS_ ,G"?M9?]CE'_*>L_P '_P#*7+QU_P!D\A_]
M'6M %GP?\3OC3\"?VK_!/PJ^)OCBP^*7AKQU974NFZXNB1:5=6=Q!&79&BA^
M0I\H')8_O <KC:=7Q1\7OBQ^T#\>O&'PS^#FOZ?\/O#_ ()\F+7_ !K>Z:FI
MSO>2 L+:VMW81D !PQ;G*'E>-V?^TX?^,_\ ]E7_ '=<_P#2=?\ "OG2\^!O
MP2\)?MG?%G1?VDM#BM;/Q9J#:_X2\1ZEJ=U86,L<LCO/"TT,L:!E,BY+]"AY
M^9=P!],:-\6/BW^S?\:? W@+XO\ B72_B1X3\;S/8Z/XPM=+32[RVOP 5@N+
M>,F,HV54%>?FR3P17,^-_BU\=/'7[;WC3X+> ?&-AX6T&WT>SU3^U[W1X;U]
M)C$2^:88R%\Z2666,8E<JJAB!7!^&?AI^RG:?M,_#WPM\%OAI9_$+Q#%=+K%
M_P"(=%\6ZA+8^'HH'22.X>022Q3,6&!%D#=M5B-PKU?X5_\ *4;XS_\ 8FZ=
M_.WH F^+?QA^+WP7TWX7?"#2]=TSX@?&SQM=7<2^*-2TY;.RM+6)BS7+6T/&
MY8F7 &1F-SAN%,UOJ?[27[/WQ,\#V_BO7W^/7@?Q+?+IVIW6D^%DL;SP_(Q
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M?YXKQ#X>^.-)_: \6_$._P#CS^T5K_PKUC1-?N--@\!:?XFB\/6L%HA.T,&
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M$W@#7OV6?!EI\.KF6;2-(M_L%W'=Q>7<0WP DN1*N2 [/*7X)&)!@XH [?\
M:B\=7WPT_9W^(WB?2V:+4],T*ZGM95ZQS>651Q_NL0?PKR7_ ()L?"'0/AO^
MROX/U?3K*'^V_$]H-6U342 TUPTA)12^,[43: O0$,>I)/T-\3/ ME\3OA[X
MD\(ZDQ2PUS3Y].F=1DJLL90L!ZC=G\*_/S]F[]L+_AB>SC^ _P"T+IM]X<?P
M^\B:-XHM;22XL[NS+LR'"*79020KHK<?*P5E;(!]R?'SX2Z%\;_A'XE\'^(;
M."ZLKZSD\J26,,UM.$;RIT]'1L,",=QT)KX.^#/[0GC7PA_P27UCQ5H6LOI_
MBGP?<_V/8ZD\,=P5B%] %&R565@(I_+&Y3@*,>M=Q\>/^"E_A'QUX7N_ ?P"
M@UCXC?$'Q';R6%B]CIMQ;Q69=2K2GS51V95)884J-N68 8+_ (D?LPZQ\'_^
M"5/B+X<V]O\ VCXEM]-35=3CMOWFZ87D5U<!<#YO+1&4$=1'GO0!]@Z?XEU&
M;X)VVOR7&=7;P\M^UQL7_7&V#EMN-OWN<8Q[5\&^.O&GQ+_:!_X)2IXXU?Q[
M]GU,P7TNO#^QK5_[9MTO9(4@^4(MOC:AWQKGY>>IKV2U_;;^$O\ PR19W.G>
M,=-U;Q)-X933[;PO93"759;XVWEB 6J_O?\ 6<;MH7'.<$$^-_#*UDO/^"+.
MIQP(TC+H^J2;5Z[4U*9G;\%!- 'J?@?XF^*?V1/V%(/B'XU\7_\ "R$_L32Y
M?#VE?V3#IOV)988DAM"\>3*JEU+2,-VU&[FH-:M?VQO"?PW7XI/XUT7Q+K$4
M*:A=?">Q\+)Y7DG!>"&Z4FX>95/W>>00&;C=R'QD-K^T+_P35T&S^&NJZ?XM
MUWPEI.AZC?:5I<ZW$\301+YD,D:L620*LC;"-Q\L@ Y%>M^*/^"C/PIL_P!G
MU_&WAOQ3I.K>*;BP']F^$?/$FH/J#KB."2V4B4*),!FP 0,J3D9 -C]HG]K+
M6/A=\$_ NM:#X3F'Q%\>W%GINB>&=>1H6M;R=5)2Z!VD>62%*Y4EB.0,D<%X
M_P!+_:Q^!7@.]^)-U\6M ^(XT:V;4=8\%2^&H+&W%NB[YQ;W<?[URBAMI<+D
M#)!.%/-?M?)\0E^$_P"SQ\:_%OA^%];\#ZU:ZYXKTC2+9]MG!+L>7".SL/*$
M:HQ+'#'/0<>B_M%?MO\ PA;]GGQ))X7\<:+XNU[Q!I4VGZ/H.EW"W5[/<W,9
M2-7MES(F"P)$BKT(^\0" 8?[6G[7VN:3^QOX*^+_ ,++^;2I=>U*P*I);PS2
M>3(LAEMF$B.H8,FPL!P5.#CKE?'K5OVJOA#\+=0^,D_Q,\-A=*6*_OOAQ!X<
MB>QBA:15>(7S/Y\I4."Q&S.UMI'&?,/V@?AGJWP@_P"":OP6\*Z["UMK-GXB
MTN6[MF^]!)-+/,T3?[2>9M/H5(Z5];?\% _^3,_BO_V"#_Z,2@#RA=1_:?\
MC9\)X_BWX7^(>B?#:TO-..KZ/X%CT"'4?M%MM\R(7-[-EEDD49_=QX 8=#TV
M-$_;R:']A/2?CCJ^AQ7'B*[!TZ+1;-RL=WJ0G>W54SE@C%#(0-Q"Y&6(S7JW
M[.?_ "9G\./^Q'L?_2%*_/K1_A+K?Q9_X)#^$DT+2Y=<N_#^O3ZY+ID&XR74
M$=U<I*JA?F)"2LV!SA3CG H ^LK7X;_M@W6@Q>+)/C+X9M/$3Q"[_P"$ ;PK
M =,5]H/V5KW<9\?PE@3ST8CFLW7/V_+R/]AW5/C'IWAR&+QAIMT-#OM&N69K
M:SU+S5B8N006B&]7 #9.Y5W9R:\<T/X=_P#!.S6/AK'XREBT+3XOLGVB;2+K
MQ5J*ZG$X4%HOLGVKS'8'*_(I!QP2.:[WX?Z]X>^$?[!>M^,M!_9O>S\%:M>-
MJ-_X&O=<GOI9]-?RXFOW-Q"YQL1'\H#;L7?N R: -W3]%_:J/@*T^(7@SXZ>
M$_C!<R(EPOA"'P]96^F78)&^*+4$D1SMYVEBF<<D5]C>%=0U#5O#6EWNK:8V
MB:K<VL4UWIKS),;29D!>$R(2K[&RNY20<9'%?F)\1OAK^R'X?^'VH_$SX0?&
MF;X6^)8].>ZL+7PSXF8W4TQ&4BDLG=K@98A2BE H.3@ U]V_L?\ B7QOXP_9
ML\!ZS\1H9(O%]Y8>9=F:/RY)%WMY,CK@;7>+RV(P.6/ H ]CIK=#]*=36Z'Z
M4UN)[,\DI*6DKZ&/PH^8E\3"BBBF0':O75^Z*\B[5ZZOW17F8S='K8':0M?'
MO[6WPF^(6B_'OX>?'SX<^%+7XAW_ (6L;C3=0\+SW7V>9X'$A6:V8@C>/-D!
MQEON *X)Q]?O7QE^T_\ M,>/?V2?VAM \2^)8M1USX :WIWV&>+3;&%WTK40
MV?,,FP.25"X1Y,,&EV@F,"O//5*>H?\ !1KX8:I8W'A#XS_#_P ;?#*'6+1[
M2\M_%FARBTFCD4J\89"9"""1N\M?7(KT#XK7VC?LX?L*^(=2^"-Y#I.CZ/H[
M7^@7EM<?VC$JRS"3>CSF42*WFL1NW##8' %>?_%7_@II^S-K?PVUO3QJLWC[
M[=:M;GPRNAW:_:RPP(V,\21A<D9.[(_AR0*\ZT+X=>)_AA_P1]\6:3XKM)M-
MU";3;J_ATVY#"6S@FNEDCC=6Y5L,6*GD;\'G- %;_@H)_P )QXZ_8N^%/C&X
M\;^18W<.C2ZKI']E0/\ ;KZ>-'6Z\X8,>PE_W:#:V[L!7N_Q6^+OQ&_9;^$/
MA;P[=^((/C%\7_%VLC1] NKK2XM*@:23&UI88&QY<0(R0P)+#)4<UY%^V0K+
M_P $Q_AG=%3]GM(/#<\[CHD8B1<G\64?C2?\%$M/\*?&SP3\*?BGI?V;XG?#
M3P=KDD?BB+P[>>>/L,P@,S;X'!!01KG#@J7&<#) !Z-XO\*_M9?"/PEJ'CQ?
MC!X?^(L^EVSWU[X+NO"T%C:R0HNZ5(+N)A*650VPL!GOZ'Z1^!_Q:TOXZ?";
MPQX\T>*2WL=<M%N1;RG+P/DK)$3W*.K+D<';GO7P#X[^'?\ P3V\)_"^Z\7:
M;8Z%XFN/LWFV.@:;XNU!]0NYB/W<)@%R9(BS84LZ )G+5]P_LK^%K/P=\ ?!
M^G6'@=OAM;&V:Z7PK)J,U^^G&:1I3&\TP#E\ON96'RLQ7MF@#4_:!U+P7IOP
M9\8?\+#U>'0_!MUILUGJ5Y*Y0K%*AC(3 +-(=V%5069B  20*_*_X&^./'GQ
MW\+>&?V3=8UV#PIX!U!GN]/\4:QILUKJ.OZ''*9+>&TCD!C+.T;$,6P%0KEO
M+*O]A?\ !3G0;F?P5\,_$^H:1/XA\ ^%O%EKJ?BG2HE+K)9CY3(Z#[RKEE(]
M).>,FN#_ ."@'Q@_9^^+?P/TW5](^(FF:A\0M*GCO/!DGA:=;O4XKPE66)HD
M.Z)&VKN\S;M*(1E@JD ^[O"/]AZ?I<&@:%=VTUOH<4>GFWMYUE:V$:!51P#E
M2% X/-;J^M?GS_P2P\1:?:W_ ,3]$\9'6+/X]ZGJ9UGQ+9Z_:-;W$EN=IA>-
M<#Y 9V8C"D&88&W::_09>E 'YN?"']JCX7_LW_M8_M/P_$3Q/_PCLFK>(K=[
M(?V?=7/F"-)0Y_<1/C&]?O8SGBJ7[<O[;OPJ_:/^"-S\*OA=<7_Q!\8^);RU
MALH+32;F(0.DZ2;OWR(Q8A"HV@_>YP!7<_LT?"3P-\3OVKOVJW\8>#/#WBQ[
M/Q':"V;7-*@O3 &2;<$,B-MSM7..N!7V'X*^#'P_^&]Y)=>$_ WAOPO=2*4D
MGT72+>S=E/8M$BD]!0!XG\2M?^+7PG^'OP?^%_PQ\.OJ_BS4K.WTJ]\47]E-
M<Z9HD-O;QK)/.ZC;N)SL5C\VT\-P#Y+\>/'G[1?[%.FZ!X^\2?%?3?C!X-EU
M6'3M6TB[\+V^D2P1R9^>*2#<2<*1ECP2ORN":W_VYOBIX@T?XV_"GX>W_P 0
M;_X0_#'Q)%<RZMXOTN1;:X::/[MNMT0?L_\ !\_3][EL@8KY _;N\/? W0OA
MA;6_@CX@>(OC-XYAO+>6YU^]\23:Y%IED2RLTDL?^CJSOL0*<-\W;C(!]'?\
M%$O"/CG6/CM^S_=Z/\1/[&L-3\2V]IHUE_8<$_\ 9%[\F;S>QW3YRO[I\*-O
MN:]6_;$^(WQ+_9Q_93T/4K#QS_:GCB#5K#3[WQ)_9%M#]L621A(?LQ5XX\C
MPHXQP:Y7]OK7M.T3Q1^RYXHU"]@L?#UGXUM9[G4KAPL,,;*C;V8\!=JL=QP
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MU\/4485?AS< #GI]HN*?_P %#_\ D=/V8?\ LIFG?^AK0!Y7^T=\/?B=J_\
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M*UDO/^"+.IQP(TC+H^J2;5Z[4U*9G;\%!- 'I&B:E\4?@-_P3LU?QC-\2_\
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M> _%WP>\<PZU^T!8WD=OH'_"#R)J4]S Q.^*?R]RJ &8J&RQW,NUE9BOK_\
MP2OU?PC;_L_W?A326OK?QSHVHS2>,;#5H&AO(=1D=E)=22=NV((#U_=G(#9
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M_M8>./@YX;\<:+\2O#O@]VTFVGTCX?R>'8[FWGMUB3R5NKV0^<DLB<ML& 2
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M4^(7_!/?Q+\9/!3MX6\66%L()HS%'<"QO4N(HY5 D5D=2K;EW*?E<="#C?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3&
MYXSBGTE '&?\*KTK_GXO!]'3_P")I/\ A5>E?\_%Y_WVG_Q-=ID48I\S,_9Q
M['%_\*KTK_GXO/\ OM/_ (FC_A5>E?\ /Q>?]]I_\37:;11BGS,/9Q['%_\
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M4^6X[,N"/6G^*?!N@^.M)DTGQ)HNG>(-+D(9['5+2.Y@<]B4D!4]3V[UMT4
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MA!J,.GP &26= <J990#M;D"/@E=I/U8O2EHH :V:X?\ X49\-_\ A*F\2_\
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M?#OA"QUD0V;_ '8'A")Y14#EF^8L6'("FOOFB@#Y _9;^%WC#7_VA/&WQO\
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M&*I7'PE\$7?A&S\*3^#?#\WA:T=9+?1)-+@:RA96+*R0%-BD$D@@#DDUU]%
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MDY9LGDT1^"?#\/BR7Q2F@:6GB:6U^Q2ZTMG&+Q[<$,(3,!O*9 .PG&0*WJ*
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M]AX)\)Z+X=TN+R-,TFRAL;6(?P11($0?DHK8HH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** /QF_X>!_'S_H??\ RD:?
M_P#&*/\ AX'\?/\ H??_ "D:?_\ &*^>./6CCUKZ7V-/^5?<?EGUS$_\_'][
M/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T
M_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_
M /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC
M_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_
M *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\
M_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]
M:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\
MI&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__
M !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!
M_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'U
MS$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCC
MUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^
MA]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I
M&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_
M (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5
M?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QB
MOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'
M\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W
M_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][
M/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T
M_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_
M /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC
M_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_
M *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\
M_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]
M:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\
MI&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__
M !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!
M_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'U
MS$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCC
MUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^
MA]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I
M&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_
M (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5
M?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QB
MOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'
M\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W
M_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][
M/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T
M_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_
M /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC
M_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_
M *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\
M_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]
M:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\
MI&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__
M !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!
M_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'U
MS$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCC
MUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^
MA]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I
M&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_
M (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5
M?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QB
MOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'
M\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W
M_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][
M/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T
M_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_
M /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC
M_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_
M *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\
M_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]
M:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\
MI&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__
M !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!
M_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'U
MS$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCC
MUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^
MA]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I
M&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_
M (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5
M?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QB
MOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'
M\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W
M_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][
M/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T
M_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_
M /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC
M_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_
M *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\
M_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]
M:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\
MI&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__
M !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!
M_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'U
MS$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCC
MUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^
MA]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I
M&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_
M (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5
M?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QB
MOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'
M\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W
M_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][
M/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T
M_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_
M /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC
M_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_
M *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\
M_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]
M:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\
MI&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__
M !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!
M_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'U
MS$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCC
MUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^
MA]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I
M&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_
M (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5
M?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QB
MOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'
M\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W
M_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][
M/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T
M_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_
M /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC
M_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_
M *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\
M_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]
M:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\
MI&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__
M !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!
M_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'U
MS$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCC
MUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^
MA]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I
M&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_
M (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5
M?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QB
MOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'
M\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W
M_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][
M/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T
M_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_
M /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC
M_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_
M *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\
M_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]
M:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\
MI&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__
M !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!
M_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'U
MS$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCC
MUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^
MA]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I
M&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_
M (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5
M?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QB
MOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'
M\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W
M_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][
M/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T
M_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_
M /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC
M_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_
M *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\
M_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]
M:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\
MI&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__
M !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!
M_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'U
MS$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCC
MUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^
MA]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I
M&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_
M (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5
M?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QB
MOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'
M\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W
M_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][
M/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T
M_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_
M /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC
M_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_
M *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\
M_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]
M:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\
MI&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__
M !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!
M_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'U
MS$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCC
MUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^
MA]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I
M&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_
M (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5
M?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QB
MOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'
M\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W
M_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][
M/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T
M_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_
M /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC
M_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_
M *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\
M_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]
M:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\
MI&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__
M !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!
M_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'U
MS$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCC
MUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^
MA]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I
M&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_
M (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5
M?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QB
MOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'
M\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W
M_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][
M/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T
M_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_
M /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC
M_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_
M *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\
M_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]
M:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\
MI&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__
M !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!
M_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'U
MS$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCC
MUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^
MA]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I
M&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_
M (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5
M?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QB
MOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'
M\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W
M_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][
M/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T
M_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_
M /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC
M_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_
M *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\
M_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]
M:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\
MI&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__
M !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!
M_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'U
MS$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCC
MUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^
MA]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I
M&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_
M (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5
M?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QB
MOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'
M\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W
M_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][
M/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T
M_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_
M /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC
M_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_
M *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\
M_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]
M:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\
MI&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__
M !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!
M_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'U
MS$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCC
MUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^
MA]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I
M&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_
M (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5
M?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QB
MOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'
M\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W
M_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][
M/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T
M_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_
M /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC
M_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_
M *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\
M_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]
M:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\
MI&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__
M !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!
M_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'U
MS$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCC
MUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^
MA]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I
M&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_
M (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5
M?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QB
MOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'
M\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W
M_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][
M/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T
M_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_
M /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC
M_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_
M *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\
M_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]
M:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\
MI&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__
M !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!
M_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'U
MS$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCC
MUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^
MA]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I
M&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_
M (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5
M?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'\?/^A]_\I&G_ /QB
MOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W_P I&G__ !BC_AX'
M\?/^A]_\I&G_ /QBOGCCUHX]:/8T_P"5?<'US$_\_'][/H?_ (>!_'S_ *'W
M_P I&G__ !BBOGCCUHH]C3_E7W!]<Q/_ #\?WL****V.(**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M ****0[,****8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH ****0[-;A1113$%%%% !1110 4444 %%%% !1112'J%%%%,04444 %%%%
M !1110 4444 %%%%(84444Q!1110 4444 %%%% !1112'9A1110%F%%%%,04
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%( HH
MHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1112'9A1113$%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444@"BBBF 4444 %%%% !1110 45+:VLU]<
M)#;PR3S,>(XD+,<<G '7C^56]4\/ZKH6!J>F7FGD]!=P/%^60*5RN65KF?11
M13)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MI#LPHHHIB"BBB@ HHHH **** "BBB@ HHHH **** "BBBD 4444P"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
MD.S"BBBF(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M ,$J8H=+EN? /BZXFO(P2MAKT:D2^PFC"[#C'5",XY'6O@;Q9X3U?P/XCO\
M0=>T^;2]7L93%<6DZX9&Z_B"""",@@@@D'-53JPJ_"R,3@ZV%_BHR:*]&^!/
MP'\4_M!>-$\/>&8$'EKYUY?W.1;VD?\ ><@'DG@* 2?H"1]V>&?^"4?@^WLX
M/^$@\:ZW?76W]\=-CAMTW?[.]9#U[GD^U14KPINS9IA\NKXJ/-!:'YF_A17Z
M7>*O^"4/A6:QE_X1OQKK%C=C)C_M6"*ZC/H&"",_C^AZ5\%?&7X-^)?@7XXN
M?"_BBU6&^C598IH7+PW,3$A98V(!*D@CD @@@@$&G3KPJ.R8L3@*^%7-46G<
MX:BOJ3]D?]C&T_:;\*:WK%SXIN-!?3KT6@BALEF#YC5MV2XQUQC%>@V?_!,O
M4+SXRS>&T\1W#>#;&QANKW7'M!')))(SXMX5W%2V$!+$X4,,@Y7,RQ%.,G%O
M8JGEV)J052,;IGPT*,5]Z?M*_P#!/;P5\'?A+K/C+2?%^L1/I<2,UOJD<,ZW
M+LZQK&"BIM+.R\X;'IWKY%^#OP7\5?';Q=#X=\*V'VJZ8!Y[F4E8+6+H9)7P
M<+]!D] &-7&M&:YD]#.M@JU&HJ;6K.%HK]*O!O\ P2C\-0V<9\6>-=6OKQN7
M71XHK:-21T!D$A;![X&?05G^._\ @E'I_P#9LLG@SQK=1WZ\Q6^N0J\;^QDB
M *\X^8(W?CG(Q^MT[VN=;RC%J/-RGYRU^L'_  33TBPOOV:UDN+*WN)/[8NA
MNEB5CTC[D5^8'Q \ Z[\+_%NH>&?$E@^G:O8OLEA;H>,JZG)W*PP01P0:_4K
M_@F5_P FT+_V&;O^4=1BY7I73.C)H\N+<9+HSX__ ."EEI!9?M*-';PQP1_V
M-:G;$@4=9.<"OE2OTI_:9_9"\5_M*?M27%S:3+H7A>UTJTCN-:N(RX+YD)CB
M0$>8^,$\@*""3R =0?\ !*?P#_987_A+O$HU''_'QFW\G=CKY7E9QG_;_'O1
M3Q%.$(IO4K$Y;B*^(J2A'2Y^85&<U[C^TY^RCXE_9EUJT6_N(]9\.Z@66RUB
MWC**S#_EG(A)*2;><98$9(/#5X=[UV0DIJZ9X56E.C)PJ+5!111S]/P_S_GT
MK0Q04<5]2?L[_L >-?C=I-MK^JW:>#O#=P%>WN+J RW-TA&0\<65^0C&&9AD
M-E=PKZ>M_P#@E1\.A9D3^*O%$MUQB2.2V6/MGY3"Q]?XJY)8FG%V;/5HY7BJ
MT>:,=#\O:*^POC__ ,$X?%OPMT6YU_PEJ?\ PFFD6RF2XMA;F*^A4?Q! 6$H
M Z[<-SPN!7Q]CCCCT]?\_P"%;0J1FKP9QU\/5P\N2I&S$HK[K^#W_!-?3OBE
M\+_#/BV3QU=:?)K%E'=M:IIJ.(]PSM#>:,_E4WP/_P"":)\82:QJ/C77-0TO
M18K^XM=-M[*-([J[ABE9!<.7#"-6VY VG(P00",Y/$TM5?8[(Y7BI<K4=SX.
MHKZC_;1_9*\._LRIX>N=&\3WFI_VQ)*B:=J$*>:BQA2\GF)@%<N@P5SSP>.,
MK]F']B?Q5^T9;_VU)=+X;\(I(8SJEQ"9)+E@?F6"/(#8/!8D*#Q\Q! OVT.3
MGOH8/!5O:^P2O(^<<45^GMY_P2E\ -I)2U\7^)(]2Q_Q\3&WDBSV/EB-21GM
MOZ?G7B?AK_@FGXCD^+M[X3\1:V;/0QILE_8^(=/M?-CN=DL2&)D+#RWQ)DJ2
M>@P6&2,EBJ4NIU3RK%0:7+>Y\7=**^E_VO/V0[3]F#3O#-S;>)9O$!UB6>)A
M+9B 1^6J'(P[9SO_ /KUXG\,?AGXA^,'C33_  OX9LC>:K>-QNR(X4'WI)&Y
MVJHY)^@Y) .\:D91YT]#AJ8>K2J^RDO>.4Q1S7Z2>#?^"46@Q:;"WBSQMJ5S
M?D9DCT:".&)?50TBN6[\D#KT%:NO_P#!*7P/-;2C1?&?B#3[@C]W)J"P72*?
M=52,G_OH5S_6Z5[)GHK)\6U?E/S&HKUC]H;]F_Q3^S?XJATG7Q%=V-XK26&J
M6N?)N5! 8#/*NN1E3TW=2"">@_9'_9IMOVFO%FM:-<Z]+H"Z=9+=B6*V$V\E
MPFT@LN,9K?VD.3GOH>:L-5=7V"7O'@^?2BOLKXN?\$XM>\)^-/!GASP9K$WB
M6XUY;R6YNKRU%M;Z?'!Y/SR,I?@F;&,9)&!DG%>T^&?^"4?@ZWTR-?$/C+7+
M_4-OS2:7'#:PAL#HKI*V.O\ %^59/$TDD[G;'*L5*3CR['YF5?\ #[*NO::7
MV[!<QD[C@??'7VKZU_::_P"">.K_  9\+7GBSPMK$GB;0;)?,O;::$1W=M&#
MS(,';(B]6(VD#)P1DCY%TVU%_J5I;%MGG3)#N49QN."0#BM8SC4BW!Z'+4P]
M7"U%&I'4_<7Q=XB\!MX1UM4U/PZ938S@!9H-V=A]\YK\,/\ /7-?H?K7_!*G
M2](T.^OQ\1+R0VMO).(_[*0!MJDX_P!;QT_6OSUM;6:]N(;>WA>:XF=8XX8U
MW.[$@*H ZDDCC\JYL+R1YFI7/3S1UINFJD.5_>14?C7WG\(/^"6^JZ]HMOJ7
MQ \1OH%Q,H<:1IL:S31 C_EI*QVAO]D*P'][M7JEU_P2I^&;6Q6U\3>+(KC'
M#RW%JZ9]2H@4G\ZIXJE%V;,893BIQYK6/RXHKZC_ &G?V$/$WP!T=O$FEZA_
MPE?A9#MN+A+<Q3V>3@-*F2"G;>#U(RJ\$_+W1O7GM[5TPJ1J*\6>;6P]3#RY
M*BLQM%?5W[,_[ /B7XZ:#:^*-;U,>%?#%PVZW9H#+=7:#^-$. J$\!B3D#(4
MC!KZ6M_^"5/PX-JRR^*O%4EQQB1);94_[Y\@D]^]83Q5.+M<[Z.5XFM%3C'1
MGY=TJ]Q7W3\;?^"7^K>$]!O=9\ :_+XD^S(TC:-?0!+EU R?*D3AV_V2JDXX
M))P?G3]E_P"!,/[0WQ2_X1&XU:70E^QS7?VJ.W$IS&5&W:67KN/?M[UI&M"4
M>:+,*F!KTZBI26K/IG]E/_@G;I_C#P[HGC?XA:D;K2]1MX[^ST+3W*>9$ZAD
M,\N 1D'.R/'^_P!17Q_\<M&LO#OQL^(&EZ?;1V6GV/B'4+:VMH1A(HDN9%15
M'8!0 /I7[@?#?P:GP[^'GAOPM'<M>QZ+IUOIZW#)L,HBC";RN3C.W.,\5\'?
MM5?L%6&BZ/\ $GXK#QE<R3O<7>M?V9]@4(#+,7\O?OZ#?C..U>?1Q%ZC<GIT
M/H<=EO+AHJC'5:O[B+_@EWJ7AS3]"^((UVZTNW+75EY0U"2-2WRS9V[S_*N:
M_P""H6I:%J'BWP&VA7.G7$:V5SYK:?)&R@^8F-VW\:\Z_9!_9#M/VG].\2W5
MUXDF\/'1Y;>,+#:+.)/,5SG)9<8V?K61^UY^R[;?LP:UX<L+?Q!-X@75+>:<
MM+:"#R]CJ,8#-G.[U[5LE#V[][4X93J_V>H^SM'N?/V,8Q16MX4\):SXW\06
M.A:!IT^K:Q>OY=O:6RDN[8)S[  $DG@#)K[O^&?_  2GGO-/AN_'GB]K&YD4
M,VFZ+"KF+(SAIG&TL.A 3''!-=52M"G\3/*P^#K8K^&KV/SZHK]-_$7_  2C
M\$W%FRZ%XSU^PO,#$FI1P74>1G.51(CZ?Q=N]?$/[0'[,_C/]G/7([3Q';1W
M6F7)(L]8L@SVT^/X<D JXZE&YP#U&"8IUZ=1V3-:^78C#KFG'0\FI:O:'IPU
M?6M/L2YC%U<1P%U&XKN<+GWZYZ]J^[?B%_P3 LO!?P]\2^(K;QW>ZC<Z3I=U
M?QV8TM09GBB9U0$2$C<5QP#UZ5=2K&FTI&-#!UL2G*DM$? =%?>'P0_X)@ZC
MXIT*VUCXB:[<>'6N4$B:-IT:M<QJ1D>;(XPC>J!6QW(.0.U\=_\ !*70)--G
M?P;XRU*UU%03'%KB1SQ2'LI>)$903WPW7H:S^M4[VN=D<JQ4H<_*?FU0.M;?
MC;P9K/P\\6:IX;\06;6&L:;,8+B!R#@CD$$<%2""".""#WK$7K75=25TSR)1
M<6XL./2OUP_X)SZ/8WG[+^CS3V5M/)]NO 7DA4D_OF]17Y']C7Z^?\$W?^36
MM&YQ_I]Y_P"CC7#C+^ST/H,D2>)U['P]_P %%[:&S_:@UF*WAC@C^P6>$C4*
M!^Z'85\R5^EOQ\_8H\2_M&_M0:[K,UZOAOPC%:6D)U*2+S)+AQ"-RPID;@#@
M%F( [;B"!>U#_@E/X"DTTI8^+O$EOJ!4XGN/L\L.>Q,8C4X]M]*GB*<(13>H
M\1EN)K5YSA'1L_,2C\:]B_:,_9@\6?LV^((;36Q'J.CWA86.LVJGR9\=58'[
MDF,$H<]3M) S7)?!?X>Q_%CXJ>&O",UZVG1ZO=BW-TD8D:/()R%)&>GK78JD
M91YDSQ)4*D*GLI+4XJEX]:^YOC3_ ,$W=.^$WPJ\2^+X_'=UJ,FD6C7(M7TU
M8Q)@@8+"0XZ^E?#'_ >HZ#I4TZD:NL6:8C"U<*U&HK7%_&CKU-?;'[/O_!.V
MP^-WPA\/^-9O&]SI,NJ+*QM$TX2B,I.\?#&49SY>>@ZU\T_'_P"%<?P2^+WB
M'P3#J+:K%I30J+QX1$9-\$<N2H)QCS,=3TI1K1G)P3U157!UJ--59+1GZ=?L
M7ZYX-M?V8_ D>IZAH<%\MM,)8[J:%9 ?M$OWMQS^=?G+^V!<65U^TMX\DTV2
MWEL6O5,3VK*8V'E)]TKQUSTKWOX"_P#!.BP^,WPE\.>,YO&]SI4FK122-9KI
MPE$>V1X\!O-&?NYZ#KTKY;^.'PVC^$/Q8\1^#H;YM3CTBX6!;MXQ&9,HK9*@
MG'WO6N:C&"J2Y9'JXZ55X6FIT[+H[[Z'ZO?L.Z'I]S^RQX DFL;::5K6;+O
MK$_Z1+ZBOS1_;.MX[;]J'X@QQ1K#$M^H"(H '[F/H!7Z>?L+?\FI_#__ *]9
MO_2B6OS>_:FT-?$_[:7BG1WF-NFH:[:VC2JN2@D6)-P&1G&[IFL<.[5IW.W,
MHIX.DEUM^1J?LA_L87?[2T-WKE_K::+X4T^[^R7#6XWWD\@5'*("-J#:X^<Y
MY.-K=F_M]?"/PO\ !/XK^'/#GA+3AIVFCPY!/("[2/-*;FY5I'9CDL0BCT
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M1 VF(OF>7&S[2?,[XQTJ5B:5EJ:O*\4KWCL?G]103FBNH\IA7TO^R-^QA?\
M[2T-UKEYK4>C>%-/N_L=RT WW<T@1'*QJ1M4;77YVS@G[K<X^>O#.DKKWB+2
MM+:4P+?7<5L90N2F]PN0._7UK]I_V7/V<[?]FGP/J?AVVUN77DOM1;4#/-;B
M$H3'''LP&.<>6#G/>N+$UG2C9;GN97@UBJMYQ]U'YR?M\_!_PM\$?B1X5\.^
M$M,&G:?_ &!'-(6=I)9Y3<3AI'8G)8A1[      5\P_6OV _:A_8CLOVEO&V
MF^(KGQ7/H+V.G+IX@BLEF#A99)-VXNI'^LQCVK\[_@#^SG;?&GXZ:K\/9M<E
MTJ&S2[9;Y+<2,WDR!/N;QC.?6E0K1=/5ZK<K,,#4CB/=CI)Z'A]'XU]S?%#_
M ()CZCX7;PS;>%O$\^OWNK:HME-]IL!!#9P>5)(]Q(RNWRKY8&,98L #DUZ;
M-_P2G\$Q^'MG_"::\-8$9W7C1V_V;=@X;R=N[;GG'F9]QUJOK5.RUW,?[*Q6
MJ:V\S\S*.*[;P7\*=8^)WQ*7P;X-7^W+J2YDB@NPABB,*,1]HDZ[$VX;VR!R
M2 ?NWP7_ ,$H=#BTZ(^+?&^H7-\1F2/1H8X8D]0&D5RW?G"]>E:5*\*?Q,YZ
M&!Q&)NX1V/S<HK].=>_X)2>!IK60:-XS\0V%R?N27R072J?4JJ1Y_,=*^(?V
MB_V:_%'[-WBF#2M=\J^T^]5GL-6M01#<J"-PP>5D7*DH2<9!R00:5/$0J.R9
M6(R[$89<\XZ=SR7'&:2KVAZ'J'B35[/2M*LYM0U*]D6&VM+9"TDKMP H]<D<
M5]Y?"O\ X)6W>H:7#??$'Q2^EW4J[CI6BQI(T1(R T[Y4D9P0%(R.&-54JQI
M?&S+#X.MBF_9JY^?]'>OTWU__@E)X'FMG&B>,_$%A<8.UK](+I0><$A4C./;
M/05\1?M#?LS^+OV;_$%O8^(4AO=/NU+6>JV6XV\^WJIR 5<#DJ<XR.2.:B%>
MG4T3-<1EV(PT>::T/2?^";UK!>?M-V45Q#'/&=,O/ED0,/NKV(K[$_X*1Z/8
M6/[,M[+;V5M XU.S^:.)5/WCW KY!_X)J_\ )T%CW_XE=Y_Z"*^R_P#@I9_R
M;!??]A2S_P#0C7'7O]81[F"BO[,J-^9^1?K17N/[+?[+.N_M,>*+BVMYGTCP
MW8@F_P!9,6\1L0=L2#(W.?KA1DGL#[M\8?\ @GSX(^"'@:^\4^)?BE=PV<'R
M10)I49ENI2#LAB4S?,[8^@ 8D@ D=TJT(RY;ZG@T\#7J4_;):'PQ12N06)7[
MN>,]<4E="//"BO7?V7?@5!^T1\4/^$2N-7DT5#8S78NHX!,<H5&W:67KNKZ)
M^)W_  3'U'PPWAFV\*^)YM?OM6U1;*;[38""&S@\J21[B1U=OE7RP,8R2P .
M37/*O",N5G?1P->M#VD(W1\-9&>E)7Z:2_\ !*7P3'X?V'QIKRZP$.Z\:.W^
MS;L'GR=N[;GG'F?B.M?G=IO@F_\ %7C@>%O"L<OB2]GNWM;$VT6TW05CMDVD
M_*I4;SDX ZX -%.M"I?E>PZ^!K8;E4UN<YBBOT2^&/\ P2IMIM*@N?'_ (MN
MH[Z0;GT_0415AYZ&:16W''7"  ]"W4Z7CK_@E+H,FGRMX.\::E:7RJ6BBUR*
M.XC=L<*SQ+&5&>K;6^AQ6?UJE>R9TK*<5R\W*?FW1BNL^*'PN\2?!WQC>>&?
M%.GM8:E;X9<'='-&20LL;?Q(<'!]00<$$#!T30]0\2:Q9Z5I5G-J&IWDH@MK
M6W0O)*[<!5'U(KJ4DU=/0\ITY1GR-:E&CZ5]_P#PK_X)6W>H:7!>_$'Q2VEW
M4J[CI.BQI(T1(X#3OE21G! 4C(X8UW'B#_@E+X(EMW&B>,_$%C/@[6OUM[I0
MW.,A8XSCVST%<KQ5).R9ZL<IQ<H\W*?F117K?[0W[,_B[]FWQ!;V'B%(;W3[
MQ2UGJMEN-O/MZJ<@%7 Y*G.,CDC!KR7GMS^8_P _Y_'IC*,ES)GESHSIS<)K
M5"4N*^R?@3_P35\7_$;2;76_&.I?\(5IMP-\5BUN9;^1.Q9"56+(Z!MS>JBO
M>9/^"4_PZ-B$C\5>*%O.\K26QC_[X\D'T_BKFEBJ<79L]*EE6*J1YE&Q^7E%
M?4'[1W[!/C+X$Z7-K^GWB>+O"L/^ON[6$QW%JO\ >EBR?D_VE8].0M?+YY /
MJ/7G]:Z(U(U%>+."MAZM&:IU(V84O'>OT*TO_@E?INI>';34C\0[M#/;+<;!
MI:'&Y V,^;[_ .>]#X _\$R[?Q=X*LM=^(VLZIH][J$0FATC2UCCDMXV&5\U
MY$?YR""4V_+T)SD##ZS22W.Z.58J32Y=SX#HKWS]L+]G/1OV:_'6F:)I'B.?
M6TO[,WI@NX%6:V3>47<RG:X8J_\ "N-O0]:[;]F;_@G[XD^-VBVOB?Q#J'_"
M*>%KGY[7]UYEW>)_?120$0]G;.[&0I!!K3VT%!3;T.>.#KRJNBHWDCY-Q7Z7
M_P#!*S2[._\ A?XS:YM(+AEUE #+$K'_ %"\9(JQKW_!*7P1+I+1Z+XP\06>
MI[2%FOE@N(2WO&J(V/\ @>?>O1/V%/@7XG_9]T+QQX<\3P1B1M62>UO;=MT%
MU"85&]">>H((8 @CZ$\-?$0J4VHL][+\OKX;%1=1:6/F'_@JE86UA\4O!J6U
MO%;JVCL2(D"C_7-S@5\15]Q_\%7/^2I>"_\ L#/_ .CVKX<KKPW\)'C9GIBY
M^H445K>%?"NK>-]>LM"T'3Y]4UB^D\JWM+="SNV"3QV  ))/  )[5TWMJ>;%
M.3LC)HZ5^@GPR_X)4W%YI\5UX\\7-87$BACINBQ*YBR,X:9\J2.APA&1P379
M^(O^"4G@B:S9="\9>(+&[P")-16"ZCSSG*HD1]/XN,5R/%4KVN>Q'*,7*/-R
MGYD4Z*-YI$C09+L% ]<GWKUG]H#]F3QG^SGK$-KXCMX[K3+IB+36++<UM/C^
M') *2 <[",D XR.3ZO\ L<_L:V?[1?AJ_P#$]QXHFT5]*U5;86L=F)EEVI')
MDL74C.XCI[UK*K!0YKZ')2P=:=?V-M3]&?@'\"/#7P'\":?I&D:?;QZAY"_V
MCJ>P>==38^=F?&2-V<+G &,=*\4^,O[>'P=U+X<^-]%TKQ$NHZVVFW=M91-I
MMPT,]QY;+'A_+*XW8.2<$#(-?6&J6!U'2[NS$IA,\+Q"5>2FY2,@>V:_+?\
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M6Y!>Q6OV62P6(?/N.=P<]-OI36(IR:2>XI9;B81E.4=(^A\@?>/)I#^=>O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR91BJU3$>SG)M/>Y\@_MX_!NQ^#?QZO8M(MUM=#URV75K6WC4". NS++$H'
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MRRQ59YER\VES[<_X*3Z+!J?[,.HW<ZJ9=-U*SN8&QG:QD\H]?]F5A[YKY?\
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M ,%+/!L?PKTN;XA7-W)XTA+0W=OI=BS>?M.%E!^6,%AC(#8!SP 0*_,/@_\
MZJ[GP?\  WX@?$#PS-K_ (:\(ZIKVDPSM;23Z? 9B)%56*[%RQ.UT/3'-=<Z
M%-P5]#QL/C\7"HY0;;?0[GQ=^TA/X;_: \4_$3X/S7GA--:5@ZWUI;22?O-C
MS#81(BAI4#<<CIGKG]@?A?K%YXB^&7A/5=0F^U7]]I%I<W$VQ5\R1X49FVJ
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M::^U"".*.XMV^95&'9OD;.,@??:OL+_@F1_R;..__$YN_P"25^7OB[X7>,?
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MZ"JQS117LV/BF[N]SZH_X)V_!JT^*7QN;5M6MDNM(\+P+?M#(,J]RS;8 1Z
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MBO4[?Q[#XBO?!DE@TT%_XA@<,MP'38(I)0'=2I?/494'@YSZU\3_ (U?!?\
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M3_BOH7A7QIX@NO$?A[7+E+ 2ZBWG3VL\A*PLDA^;!<JK!BV <C&*_1GXT?\
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M, XXKQ7_ ()MZA<:M^U5<7UW)YMW=:5?332;0NYV="QP  ,D]A6S_P %5?\
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M@101VD<=Z]O_ ."@'[46N_ GP[HF@^$IELO$6N>;(]^T:N;6W3 )0-D;V9@
M2" %;@$J1S?_  2EO(&^#OBZU4K]IBUXRN.^Q[>$+GVRC_K7E/\ P5@T^XB^
M)'@:^8-]DFTJ6"//W=Z2Y?'OB1/TK5VJ8IJ2N<ZD\/E2G2T;. _9[_;S\?\
M@OXD:6_C7Q5>:]X2N[A8M234%,S01L<&:,@%@4SNVKU (P3C'K_[6_[;'P@^
M,WPHUCP=I]IK>K7TVV>QOULUBA@N$.4<[W#@'E3A/NNW>O@#2],N=:U*TT^R
M@:ZO;N9;>""/DR2.P55'/<MBNX\4_L]?$WP.LTNM^ O$%E;P@M)='3Y'A4#N
M9$!3]:[)4:7M$WHSQ*>.Q7L94]9+SU_$]F_X)J?\G06/_8+N_P#T%:_0S]K+
MX-:E\>OA?!X/TV>.R-UJEK)<7DO(MX$8L[X_B.. HZDCD#D?GG_P35/_ !E!
M8_\ 8+N__05K]6?&GC#2/ 'AC4/$&OW\.F:/81&:XNICPJCL!W))  &220 ,
MUP8JZK:'T64QC/!2C/:[N<CHN@^$/V7O@S-'86LEGX:\.V;W5PT49EGFVC=)
M*^!\SL023P![ <?D3^TM^TAK_P"TAXY?5]2W6>BVI:/2](5R8[6(GJ>QD8 %
MF[]!@ "OUU^#?Q@\,?M(?#<Z]HT+R:9<O/976GWRJ9$()4QRH"1\R%6QG[KB
MOR._:N^!,_[/OQ>U/0HTD;0KG-[I%PV3NMF)PI;NR$%3GKMST(K3"6YWS_$<
M^;\[H0=#^'Y?@>.GBBCGO^E%>MT/C3ZQ_P""97_)S*_]@:[_ /0HZ_2WX^?%
M:W^"/PF\1>,YX1<_V;;@PVY) EF=UCB0D=B[KD]ADU^:7_!,K_DYE?\ L#7?
M_H4=?8W_  4JF>/]E_4E5MH?4K-6]QYF?Y@'\*\C$Q4JZ3/MLOJ.EETYK=7/
MB34_^"B7Q?UO2?$&FZA>Z5<V6K6<UF$CL1$UH)%9=T+(=VY03C<6Z?C7OO\
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MUZWH?(1U:1^YG[-?PUM/A/\  _PCX>MH!#+'8QSWC*!F2YD4/,Q(Z_.S 9Z
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M7I1S#V56.R>I'^W=\2C\-?V:_$KQ2^7?ZT!HMKCJ3-GS/RA64_45\1?\$_\
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M1BJU3$\LI-IWN>-_\%7?^2I^#/\ L#/_ .CVKX;%?<G_  5=X^*7@S_L#/\
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M'5/#>IK'<:?JEMF"XV!C#(5S%,G^TIPP_+N:_!^.-Y&"(K/(QP%0$EC]._\
M]>OWV^&^GW.C_#OPO97N[[9::7:PS;A@[UB56R/J#3Q4(TVI1)RBM/$PG3JM
MN/F?C1^SCI-SH/[5'@32[Q/+O++Q+!;3+G.UTFVL/S!K]G_'7BNU\">#-?\
M$E\K/9Z18S7\RH0&9(D+D#)QDA<"OR'\ ZE;:S^WM9:A9,KV5WX]DN(&3[IC
M>]=E(]L$5^GG[6DWV?\ 9J^)+8S_ ,2.Y7\T(_K2Q7O3A?J7E7[NA6:Z-GY7
M>,/VUOC#XN\5RZY'XTU#1$\W?!IVER^3:PID[4V#AP 1R^XMQG/ 'ZI_LL_%
M&_\ C-\!?"?BS5?+.J7D#QW;1J%5Y8I7A9]HX&XQ[L#INQ7X=<=,8YK]C/\
M@GC_ ,FE>#O^NM]_Z6SUKBJ<8P5EJ<N38BK5Q$E.3:L?GC^WEH]MHG[5OCJ*
MU4)'-);73*!_');1.Y_%F8_C7@%?1O\ P4*_Y.T\9?\ 7.Q_](X:^<J[:/\
M#B?/8Q6Q%1>84445N<84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.0!C6_9C_8_\,_LS1ZE>65_/KWB#4$\F?5+J)8]L0;/EQHI.T$A2V2<E1V
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M9/4I&N$7\!7&_>Z]?0<5O0P_L_>EN>?CLP^M15*FK070_;[]D7_DV;X;C/\
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M&<G&237J?P9L_AY\.Y;SX7>!1##+X?@CNK^W@;S&C>4L TTF>96\LD@\@;>
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MTW1ARL\K,<3#%U?:0NM.H5]M_P#!*7_DL?B[_L G_P!*(J^)*[#X9_%SQ?\
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M[6'*COP.)^JUU5:NC];?VG/V+M$_:4\5:)KM]XAO-#N=/M_L<BVT"R">$.7
M!)&U@6;GGKTKY$_81\+KX%_;;\2^'$=Y4T>'5-/623&YA%.L8)P ,G;G@5Y[
M/_P4,^.DVG_9?^$LMT<J5-RFEVPE/J?]7M!Z]!7D?AGXS>-/!OCJ^\9Z1K]Q
M:^*+XRFXU,HCR2F0YD)#*1EC[5RTZ-50<)/0]6OCL+.O"O3B[IW9^FW_  4T
MRO[,[]@=8M,_^/U^2H^]^E>G_$/]ICXG?%;P_P#V%XL\6W&LZ5YJS_9I+>%
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MMCU!Q7Y]?#3]JKXK?"6TCL?#?C*^@TY %2QN@EW B@YVHLP8(#_LXKLO$/\
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M5F,BL<YD<DCD[N:YY8>M45IL]&GF6#P]3FH4WKN?47_!5O\ Y*GX,_[ [_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ]B_
M9F_:9U_]FGQA-J>FP+JFCWZK'J.DRR&-9U4G:RN =KKEL'!&&88.:_0GPO\
M\%+O@WK%@DFISZQX?N<?/;W>GM*0>^#%O!'N<<=NU?DI17+4P\*CNT>KA<RK
MX6/)#5'Z_:U_P4>^!^E0R26NNZAK#+TCL]*G5FX[>:J#\R*^(/VN/VV-4_:.
MA@\/Z3I\OA_P?;RB<V\KAKB\D'W7EV\*JYX0$C)R2V%V_,%%33PU.#NC3$9K
MB,1%P;23%:DHHKL/&"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH ]"_X9U^*_P#T3'QE_P"""[_^-T?\,Z_%?_HF/C+_ ,$%W_\
M&Z_=W:*-HKQOKTNQ]Q_8-+^=GX1?\,Z_%?\ Z)CXR_\ !!=__&Z/^&=?BO\
M]$Q\9?\ @@N__C=?N[M%&T4?7I=@_L&E_.S\(O\ AG7XK_\ 1,?&7_@@N_\
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M_P#1,?&7_@@N_P#XW7[N[11M%'UZ78/[!I?SL_"+_AG7XK_]$Q\9?^""[_\
MC='_  SK\5_^B8^,O_!!=_\ QNOW=VBC:*/KTNP?V#2_G9^$7_#.OQ7_ .B8
M^,O_  07?_QNC_AG7XK_ /1,?&7_ ((+O_XW7[N[11M%'UZ78/[!I?SL_"+_
M (9U^*__ $3'QE_X(+O_ .-T?\,Z_%?_ *)CXR_\$%W_ /&Z_=W:*-HH^O2[
M!_8-+^=GX1?\,Z_%?_HF/C+_ ,$%W_\ &Z/^&=?BO_T3'QE_X(+O_P"-U^[N
MT4;11]>EV#^P:7\[/PB_X9U^*_\ T3'QE_X(+O\ ^-T?\,Z_%?\ Z)CXR_\
M!!=__&Z_=W:*-HH^O2[!_8-+^=GX1?\ #.OQ7_Z)CXR_\$%W_P#&Z/\ AG7X
MK_\ 1,?&7_@@N_\ XW7[N[11M%'UZ78/[!I?SL_"+_AG7XK_ /1,?&7_ ((+
MO_XW1_PSK\5_^B8^,O\ P07?_P ;K]W=HHVBCZ]+L']@TOYV?A%_PSK\5_\
MHF/C+_P07?\ \;H_X9U^*_\ T3'QE_X(+O\ ^-U^[NT4;11]>EV#^P:7\[/P
MB_X9U^*__1,?&7_@@N__ (W1_P ,Z_%?_HF/C+_P07?_ ,;K]W=HHVBCZ]+L
M']@TOYV?A%_PSK\5_P#HF/C+_P $%W_\;H_X9U^*_P#T3'QE_P"""[_^-U^[
MNT4;11]>EV#^P:7\[/PB_P"&=?BO_P!$Q\9?^""[_P#C='_#.OQ7_P"B8^,O
M_!!=_P#QNOW=VBC:*/KTNP?V#2_G9^$7_#.OQ7_Z)CXR_P#!!=__ !NC_AG7
MXK_]$Q\9?^""[_\ C=?N[M%&T4?7I=@_L&E_.S\(O^&=?BO_ -$Q\9?^""[_
M /C='_#.OQ7_ .B8^,O_  07?_QNOW=VBC:*/KTNP?V#2_G9^$7_  SK\5_^
MB8^,O_!!=_\ QNC_ (9U^*__ $3'QE_X(+O_ .-U^[NT4;11]>EV#^P:7\[/
MPB_X9U^*_P#T3'QE_P"""[_^-T?\,Z_%?_HF/C+_ ,$%W_\ &Z_=W:*-HH^O
M2[!_8-+^=GX1?\,Z_%?_ *)CXR_\$%W_ /&Z/^&=?BO_ -$Q\9?^""[_ /C=
M?N[M%&T4?7I=@_L&E_.S\(O^&=?BO_T3'QE_X(+O_P"-T?\ #.OQ7_Z)CXR_
M\$%W_P#&Z_=W:*-HH^O2[!_8-+^=GX1?\,Z_%?\ Z)CXR_\ !!=__&Z/^&=?
MBO\ ]$Q\9?\ @@N__C=?N[M%&T4?7I=@_L&E_.S\(O\ AG7XK_\ 1,?&7_@@
MN_\ XW1_PSK\5_\ HF/C+_P07?\ \;K]W=HHVBCZ]+L']@TOYV?A%_PSK\5_
M^B8^,O\ P07?_P ;H_X9U^*__1,?&7_@@N__ (W7[N[11M%'UZ78/[!I?SL_
M"+_AG7XK_P#1,?&7_@@N_P#XW1_PSK\5_P#HF/C+_P $%W_\;K]W=HHVBCZ]
M+L']@TOYV?A%_P ,Z_%?_HF/C+_P07?_ ,;H_P"&=?BO_P!$Q\9?^""[_P#C
M=?N[M%&T4?7I=@_L&E_.S\(O^&=?BO\ ]$Q\9?\ @@N__C='_#.OQ7_Z)CXR
M_P#!!=__ !NOW=VBC:*/KTNP?V#2_G9^$7_#.OQ7_P"B8^,O_!!=_P#QNC_A
MG7XK_P#1,?&7_@@N_P#XW7[N[11M%'UZ78/[!I?SL_"+_AG7XK_]$Q\9?^""
M[_\ C='_  SK\5_^B8^,O_!!=_\ QNOW=VBC:*/KTNP?V#2_G9^$7_#.OQ7_
M .B8^,O_  07?_QNC_AG7XK_ /1,?&7_ ((+O_XW7[N[11M%'UZ78/[!I?SL
M_"+_ (9U^*__ $3'QE_X(+O_ .-T?\,Z_%?_ *)CXR_\$%W_ /&Z_=W:*-HH
M^O2[!_8-+^=GX1?\,Z_%?_HF/C+_ ,$%W_\ &Z/^&=?BO_T3'QE_X(+O_P"-
MU^[NT4;11]>EV#^P:7\[/PB_X9U^*_\ T3'QE_X(+O\ ^-T?\,Z_%?\ Z)CX
MR_\ !!=__&Z_=W:*-HH^O2[!_8-+^=GX1?\ #.OQ7_Z)CXR_\$%W_P#&Z/\
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M_P"-U^[NT4;11]>EV#^P:7\[/PB_X9U^*_\ T3'QE_X(+O\ ^-T?\,Z_%?\
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M_&Z/^&=?BO\ ]$Q\9?\ @@N__C=?N[M%&T4?7I=@_L&E_.S\(O\ AG7XK_\
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MO2[!_8-+^=GX1?\ #.OQ7_Z)CXR_\$%W_P#&Z/\ AG7XK_\ 1,?&7_@@N_\
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M_P#&Z_=W:*-HH^O2[!_8-+^=GX1?\,Z_%?\ Z)CXR_\ !!=__&Z/^&=?BO\
M]$Q\9?\ @@N__C=?N[M%&T4?7I=@_L&E_.S\(O\ AG7XK_\ 1,?&7_@@N_\
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M_P#1,?&7_@@N_P#XW7[N[11M%'UZ78/[!I?SL_"+_AG7XK_]$Q\9?^""[_\
MC='_  SK\5_^B8^,O_!!=_\ QNOW=VBC:*/KTNP?V#2_G9^$7_#.OQ7_ .B8
M^,O_  07?_QNC_AG7XK_ /1,?&7_ ((+O_XW7[N[11M%'UZ78/[!I?SL_"+_
M (9U^*__ $3'QE_X(+O_ .-T?\,Z_%?_ *)CXR_\$%W_ /&Z_=W:*-HH^O2[
M!_8-+^=GX1?\,Z_%?_HF/C+_ ,$%W_\ &Z/^&=?BO_T3'QE_X(+O_P"-U^[N
MT4;11]>EV#^P:7\[/PB_X9U^*_\ T3'QE_X(+O\ ^-T?\,Z_%?\ Z)CXR_\
M!!=__&Z_=W:*-HH^O2[!_8-+^=GX1?\ #.OQ7_Z)CXR_\$%W_P#&Z/\ AG7X
MK_\ 1,?&7_@@N_\ XW7[N[11M%'UZ78/[!I?SL_"+_AG7XK_ /1,?&7_ ((+
MO_XW1_PSK\5_^B8^,O\ P07?_P ;K]W=HHVBCZ]+L']@TOYV?A%_PSK\5_\
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MPSK\5_\ HF/C+_P07?\ \;K]W=HHVBCZ]+L']@TOYV?A%_PSK\5_^B8^,O\
MP07?_P ;H_X9U^*__1,?&7_@@N__ (W7[N[11M%'UZ78?]@TOYV?A%_PSK\5
M_P#HF/C+_P $%W_\;H_X9U^*_P#T3'QE_P"""[_^-U^[NT4;11]>EV#^P:7\
M[/PB_P"&=?BO_P!$Q\9?^""[_P#C='_#.OQ7_P"B8^,O_!!=_P#QNOW=VBC:
M*/KTNP?V#2_G9^$7_#.OQ7_Z)CXR_P#!!=__ !NC_AG7XK_]$Q\9?^""[_\
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M_C=?N[M%&T4?7I=@_L&E_.S\(O\ AG7XK_\ 1,?&7_@@N_\ XW1_PSK\5_\
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M^B8^,O\ P07?_P ;K]W=HHVBCZ]+L']@TOYV?A%_PSK\5_\ HF/C+_P07?\
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M ,;H_P"&=?BO_P!$Q\9?^""[_P#C=?N[M%&T4?7I=@_L&E_.S\(O^&=?BO\
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MW_\ &Z/^&=?BO_T3'QE_X(+O_P"-U^[NT4;11]>EV#^P:7\[/PB_X9U^*_\
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M7I=@_L&E_.S\(O\ AG7XK_\ 1,?&7_@@N_\ XW1_PSK\5_\ HF/C+_P07?\
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M%'UZ78/[!I?SL_"+_AG7XK_]$Q\9?^""[_\ C='_  SK\5_^B8^,O_!!=_\
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M_P ;K]W=HHVBCZ]+L']@TOYV?A%_PSK\5_\ HF/C+_P07?\ \;H_X9U^*_\
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MN[11M%'UZ78/[!I?SL_"+_AG7XK_ /1,?&7_ ((+O_XW1_PSK\5_^B8^,O\
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MS\(O^&=?BO\ ]$Q\9?\ @@N__C=%?N[M%%'UZ78/[!I?SL6BBBO-/J HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
@B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>iclr-20241231_g2.jpg
<TEXT>
begin 644 iclr-20241231_g2.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X37>17AI9@  34T *@    @ "0 +  (
M   F   (A@$2  ,    !  $   $:  4    !   (K $;  4    !   (M $H
M  ,    !  ,   $Q  (    F   (O $R  (    4   (XH=I  0    !   (
M]NH<  <   @,    >@  $7H<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M         %=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P,3$N,38S.#0
M   $)P    D   0G    "5=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P
M,3$N,38S.#0 ,C R-3HP,3HQ-2 Q,3HS.3HP,P  !I #  (    4   14) $
M  (    4   19)*1  (    #,3   )*2  (    #,3   * !  ,    !  $
M .H<  <   @,   )1      <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M         #(P,C4Z,#$Z,34@,3$Z,S$Z,3, ,C R-3HP,3HQ-2 Q,3HS,3HQ
M,P     & 0,  P    $ !@   1H !0    $  !'( 1L !0    $  !'0 2@
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M 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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MJ</&7B7_ *#M_P#]_P!J?)'L8O%5OYF*/&7B7_H.7_\ W_:E'C+Q+_T'+_\
M[_M1R1[$O%5_YV._X3'Q)_T'+_\ [_-2_P#"8^)/^@Y?_P#?YJ.2/8EXNO\
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M:_V)C/\ G]^9Y/\ ;."?V7]R_P Q"?#W_/)O_!?%_P#%TF/#W_/-O_!?%_\
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M@QG)^E1R_P!A*DABU;47;RV,89,?-CY0?;-&O8/<[F%]IG_Y[2?]]FC[3/\
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M_L#P_P#]"]I/_@(M0ZLUI<T5&DU=(/[ \/\ _0O:3_X"+1_8'A__ *%[2?\
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M)3IZ_>H_LJI_,OZ^0?VS1_E?W+_,#XOT8'!M]3!_ZXI_\53/^$TT+_GGJ/\
MWZ3_ .*H_LFJ_M+^OD)YU16\7^'^8?\ "::%_P \]1_[])_\51_PFFA?\\]1
M_P"_2?\ Q5/^R*O=?U\@_MNAV?X?YA_PFFA?\\]1_P"_2?\ Q5'_  FFA?\
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MYOO^^4H_UG_N!_9-/^9A_P (SI'_ #\WW_?*4?\ ",Z1_P _-]_WRE'^L_\
M<#^R:?\ ,P_X1G2/^?F^_P"^4H_X1G2/^?F^_P"^4H_UG_N!_9-/^9CX_">E
MRYVW-[Q_LK3E\+Z1!.GFS7Q4$$C:HR*;XE?+?D!933_F9Z)'-(?$]Q 7;REL
MHG"9X#%Y 3]>!^5<A>"UCO9T?5-.5A(<JUTH(Y[C-<&,PM2NDJ:O8]GEE+8@
MS9_]!;3/_ M/\:,V?_06TS_P+3_&N#^RL5_*'LI]@S9_]!;3/_ M/\:,V?\
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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M_P".4^678/;TOYE]YW]%<!_PT'\+?^BD^$?_  >VO_QRC_AH+X7?]%)\(_\
M@]M?_CE')+L'MZ7\R^\[^BN _P"&@OA=_P!%)\(_^#VU_P#CE'_#07PN_P"B
MD^$?_![:_P#QRCDEV#V]+^=?>COZ*X#_ (:"^%W_ $4GPC_X/;7_ ..4?\-!
M?"[_ **3X1_\'MK_ /'*.278/;TOYU]Z._HK@/\ AH+X7?\ 12?"/_@]M?\
MXY1_PT%\+O\ HI/A'_P>VO\ \<HY)=@]O2_G7WH[^BN _P"&@OA=_P!%)\(_
M^#VU_P#CE'_#07PN_P"BD>$?_![:_P#QRCDEV%[>E_.OO1W]%<!_PT%\+O\
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M^.4O_"_?AA_T4?PE_P"#RU_^.4<DNP?6*/\ .OO1WE%<%_PO[X8?]%'\)?\
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M !RC_A?7PR_Z*+X3_P#!Y:__ !RCEEV#ZQ1_G7WH[NBN$_X7U\,O^BB^$_\
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M $4/PK_X.K;_ .+H_P"%[?#7_HH7A7_P=6W_ ,71R2[!]9H?SK[T=S17#?\
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M ,'5M_\ %T?\+S^&_P#T4'PK_P"#JV_^+HY)=@^LT/YU]Z.XHKA_^%Z?#?\
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MNP?6L/\ \_%]Z.UHKBO^%V?#S_H?/#/_ (.+?_XNC_A=GP\_Z'SPS_X.+?\
M^+HY)=@^MX?_ )^1^]':T5Q7_"[/AY_T/GAG_P '%O\ _%T?\+L^'G_0^>&?
M_!Q;_P#Q=')+L'UO#_\ /R/WH[6BN+_X79\//^A[\,_^#BW_ /BZ/^%V?#S_
M *'OPS_X.+?_ .+HY)=@^MX?_GY'[T=I17%_\+L^'G_0]^&?_!Q;_P#Q='_"
M[/AY_P!#YX9_\'%O_P#%T<DNP?6\/_S\C]Z.THKB_P#A=7P\_P"A\\,_^#BW
M_P#BZ/\ A=GP\_Z'OPS_ .#BW_\ BZ.278/K>'_Y^1^]':45Q?\ PNSX>?\
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M"K3J:M.J0"BBBJ =11102%%%% !1110 4JTE*M AU%%%)$A2K24JTP'4444
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MJ]: '4444$A1110 4444 %*M)2K0 ZBBB@ I5I*5:!,6BBB@D**** "BBB@
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MFTZ@!:*** !>M.IJ]:=02PHHHIH04444, HHHI .6EI%I:"6%%%% #J6DI:
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MD ..E+0 4444 %%%%!(4448/I0 ZBEHH$)2KUHH7K0 ZBBB@D**** "BBB@
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MD2)2K1BE450"T444 %%%% F%%%% @I], /I3\&I8"44N#13 %IU-6G?CCZT
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M_CU?,-%:?5Z7\I\]_K%FO_/]_@?3W_#P/QY_T+_A?_P&N/\ X]1_P\#\>?\
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MS_H7_"__ ("S_P#QZOF"BCZM2_E#_6+-O^@A_A_D?4'_  \$\=_]"]X7_P#
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M'_Q^OF"BCZM1_E#_ %BS;_H(D?3_ /P\$\>_]"_X7_\  6X_^/T?\/!/'O\
MT+_A?_P%N/\ X_7S!11]6H_RA_K%FW_01(^G_P#AX)X]_P"A?\+_ /@+<?\
MQ^C_ (>">/?^A?\ "_\ X"W'_P ?KY@HH^K4?Y0_UBS;_H(D?3__  \$\>_]
M"_X7_P# 6X_^/T?\/!/'O_0O^%__  %N/_C]?,%%'U:C_*'^L6;?]!$CZ?\
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MJM'^4/\ 63-_^@B7X'TO_P -\>.?^@!X9_\  :?_ ./4?\-\>.?^@!X9_P#
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M_P" T_\ \>KYHHH^JT?Y0_UDS?\ Z")?@?2__#?'CK_H >&/_ 6?_P"/4?\
M#?'CK_H >&/_  %G_P#CU?-%%'U6C_*'^LF;_P#01+\/\CZ7_P"&^/'7_0 \
M,?\ @+/_ /'J/^&^/'7_ $ /#'_@+/\ _'J^:**/JM'^4?\ K+F__01+\/\
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M'CK_ * 'AC_P%G_^/4O_  WSXZ_Z 'AG_P !9_\ X]7S/11]5H_RA_K+F_\
MT$2_#_(^E_\ AOGQU_T /#'_ ("S_P#QZC_AOCQU_P! #PQ_X"S_ /QZOFBB
MCZK1_E#_ %ES?_H(E^!]+_\ #?'CK_H >&/_  %G_P#CU'_#?'CK_H >&/\
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MX;_\!I__ (]7S?11]3H?R$_ZSYS_ -!,OP_R/I#_ (;M\;_] +PW_P" T_\
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M_P#T O#?_@-/_P#'J^;Z*/J=#^0/]9LX_P"@F7X?Y'TA_P -V>-_^@%X;_\
M :?_ ./4?\-V>-_^@%X;_P# :?\ ^/5\WT4?4Z'\@?ZS9Q_T$R_#_(^D/^&[
M/''_ $ _#?\ X"S_ /QZC_ANSQO_ - /PW_X"S__ !ZOF^BCZG0_D0?ZS9Q_
MT$R_#_(^D/\ ANSQO_T _#?_ ("S_P#QZD_X;K\;_P#0#\-_^ L__P >KYPH
MH^IT/Y$'^LV<_P#03+\/\CZ0_P"&Z_&__0#\-_\ @+/_ /'J/^&[/&__ $ _
M#?\ X"S_ /QZOF^BCZG0_D0?ZS9S_P!!,OP_R/I#_ANSQO\ ] /PW_X"S_\
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M]9\Y_P"@F7X?Y'TA_P -U^-_^@'X;_\  :?_ ./4?\-U^-_^@'X;_P# :?\
M^/5\WT4?4Z'\B#_6?.?^@F7X?Y'T?_PW5XV_Z /AH_\ ;K/_ /'J7_ANOQM_
MT ?#7_@+/_\ 'J^;Z*/J=#^1#_UGSG_H)E^'^1](?\-U^-O^@#X:_P# 6?\
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MT-'^?:CZO2_E)_MS,O\ G\_P/=_^&Q/%O_0&T'_P'E_^.T?\-B>+?^@-H/\
MX#R__':\'Z].:.O3FG]7I?RA_;F9?\_G^![Q_P -B>+?^@-H/_@/+_\ ':/^
M&Q/%O_0&T'_P'E_^.UX1_GI2>OMUYZ4OJ]+^4/[<S+_G\SWC_AL3Q;_T!M!_
M\!Y?_CM'_#8GBW_H#:#_ . \O_QVO!^E:GAWPQJWBS4%L='T^?4+IAGRX$S@
M>I/0#W-'L**U<47'.LSG)1A5DVSV7_AL7Q;_ - ;0?\ P'F_^.T?\-B^+?\
MH#:#_P!^)O\ X[7@[J8V96&TJ<-[&COCOZ=:/J]+^4C^W,R_Y_,]X_X;%\6_
M] ;0?^_$W_QVC_AL7Q;_ - 70/\ P'F_^.UX-D>H_,4>_;UH^KTOY0_MS,O^
M?S/>/^&Q/%O_ $!= _\  >;_ ..T?\-B>+?^@+H'_@/-_P#':\\\0?!_Q-X9
M\)6OB2_M8H]*NA&T4BS*S$2+N7Y1SR*7Q!\'O$WAGPC:^);^UACTJY$9CD6=
M2Q#C*\=>14>SP_9';+,,[C>\IZ*[TV7?;8]"_P"&Q/%O_0%T#_P'F_\ CM'_
M  V)XM_Z N@?^ \W_P =KP<<TM:?5Z7\IQ?V[F7_ #_9[O\ \-B>+?\ H"Z!
M_P" \W_QVC_AL3Q;_P! 70/_  'F_P#CM>$44?5Z7\H_[=S+_G\SW?\ X;$\
M6_\ 0%T#_P !YO\ X[1_PV)XM_Z V@?^ \W_ ,=KP?UP<X]*[/P7\(O$OQ T
MB\U/1K6*>SM7*2R23*F&"AB "<G@BIE1HQ5VD;4<VS?$3Y*524GV1Z+_ ,-B
M>+?^@-H'_@/-_P#':/\ AL3Q;_T!M _\!YO_ ([7A#*58@]0<4E/ZO2_E,?[
M=S+_ )_,]X_X;$\6_P#0&T#_ ,!YO_CM'_#8GB[_ * V@?\ @/-_\=KP>BG]
M7I?RB_MS,O\ G\SWC_AL3Q=_T!M _P# >;_X[1_PV)XN_P"@-H'_ (#S?_':
M\'HH^KTOY1_VYF7_ #^9[Q_PV)XN_P"@-H'_ (#S?_':/^&Q/%W_ $!M _\
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M_P"_$G_QRO':*/8T^Q7]J8W_ )^L]B_X:@\2?] G1?\ OQ)_\<H_X:@\2?\
M0)T7_OQ)_P#'*\=HH]C3[!_:F-_Y^L]B_P"&H/$G_0)T7_OQ)_\ '*/^&H/$
MG_0)T7_OQ)_\<KQVBE[&GV#^U,;_ ,_6>Q?\-0>)/^@3HO\ WXD_^.4?\-0>
M)/\ H$Z+_P!^)/\ XY7CM%'L8=@_M3&_\_6>Q?\ #4'B3_H$Z+_WXD_^.4?\
M-0>)/^@3HO\ WXD_^.5X[11[&GV#^U,;_P _6>Q?\-0>)/\ H$Z+_P!^)/\
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M)^F: $HI=I],?7BDH **** "BBB@ HHHH ***/QQ0 44N.])0 4444 %%%%
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M*/\ DO&D?]B[;_\ I1<U\G5Y&'_A1/US.O\ D8UO4^Q_V$_^23_'C_L%0?\
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MU+_D(77_ %U?_P!"-5ZYUL>M+=A1110(**** "BBB@ KW/P!\"=)NO#,.O\
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M&^7ZHPS7_D4?]Q%_Z3(\8I?X?SI*7^'\Z[S\^1^U5%%%?)']:A3&[T^F-WH
M_GI\2?\ (XZI_P!?LG_HPU^]OPE_Y);X0_[!%I_Z)6OP2\2?\CCJG_7[)_Z,
M-?O;\)?^26^$/^P1:?\ HE:];&_#$^*R#XW_ (4=91117DGVH5\7_P#!5O\
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MY&UG#=(L+ 9,;^45_>*.,@YYS7T_X7O_ !)X%\+ZE=_%#Q)HUY;0DE;R&#R
M4QT<'"ECC[H&>:_*>&XDMVWQ.T;_ -Y#M/YU8O-9OM1V_:KR>X"C \V1FP/0
M9/%8U,*ZDFW(][+N)H9?AXTXT?>BK:2:B_.4=K_UH?;?[&WQ<\/27/BOPJ+N
M+2Y+S49+W3%D(4/&X V+GC<,9V]>:],T_P ">,/#$.N:EXV^+-W%I,>3:S6B
MPVYB3GERZ$$XQ\H[BOS/61E8,#M(Z%>U6KC6K^[A6*:\GEB4?*CR,P7Z9-*6
M%O)N+M<,+Q/['#PHUJ3DX7M:3BM>Z6]NA]W?L7:U'KWBGXFZA%?W&IQW%^CI
M=WF/-F7YL.V !D\= !7P[XQD+^+-88DG-W(>N?XC65'<20Y\N1X\]U.*83DD
MUO3I<DW*^YX6.S5XS"4<,X6<')WO>_,[]M/O9^FG[*?CZV^)OP?T62^,=QJ6
MAO\ 996E^9E=%(63V)1NON:^'_VA?B,?B9\9M4U1)2UA%.+6TR>!$AV@^V>O
MU)KRZ.XEB7"2,HSGAB!_G_&F!MK9'^'X5%/#JG-S[G9F&?U<PP5'!SC;DM=W
M^*RLC]!OVHO$7_"+_#?X:ZQM+K97UK<.%&<J(US6I\7?A+HW[6WAWP[KOA_Q
M)!:-;C!E1?.&UN6C8!AA@:_.B2XDE7:\K.O7#'.#4]GJUYIS,UK=36Y8;28I
M"O'IQ6:PKBDXRLT>E4XFIUYU5B*'-2FHIQYM;QZIV_3YGUG\?/!GPP^ =IX8
M718%F\96=S!++)#<R%O+0@NSQ[B%+=N,_P Z^A_$EYK?QL\'Z/JWPR\<0Z*6
M(><+&) RD<HW&593GZU^7LLSW#EY7:1SU9CDU/9ZI=Z<^^UNIK=\8W1.5)_*
MG+#.27O:HSH<2PHU:JC04:4[>[%\K5MGS);]S[$_;&N$\*^!['0KOQ[JNNZS
M</&TNFSO#Y7RC)D8+&&7D\#=7R#H,=A+K5C'JDDT6FM,HN7M\>8L9/S$9!Z#
MU!JG-/)<2F261I'/5W.YC]2:9G^?K713I^SARW/G\QS#^T,3]8Y;+2RNWHN[
M9^E6@> /$>G^&=#E^%/Q#-]I 4;X=>*WL;IVVL%RA'3:,=*X_P#;<\9:38_#
MG2='NKJSNO%@O(;A$@.3&5&7;;DE5/3&:^$+/6+W3E9;6[FMU;JL4C*/T-5Y
MKB2X<O+(\CGJ[L23^=<T<*U-2;V/I<1Q1&IA)X:E1Y>=6UDVE_A3V/T3US1O
M#O[8?P9TFWTO6XK'5+18Y=A&]K>3;M9'CSG!QU],57AL_#O['?P/U/3;W6(]
M1UN]21DC4A'GE8%5V)G(5?7VK\^+34+G3Y1+:W$MM(.C1.5/YYI+B\FO)3)<
M323N>KR-N)_/K1]5?P\WN[V$^)X7^L+#KZQR\O/=V]>6V_S/N_\ 94F,_P"S
M!XL=VW2NUZS>I)0DU7_8GUC2_$WP;U_P8;V.'4VDG#0L0'V2+@. >H%?"RW$
MD:%$D=4/5=QP:6WNY;6020RR12 Y#HY4_I3EAN925]W<PP_$GL)8=^RNJ<7%
MZ_$G;RTV\S](?V:/@';? G5M;MKC7[;5-9OD5A;P (T< 8X9E)SR>]>=?L^Z
MQ:6/[7WQ)M[BXCCFO4FB@1V ,CB2-B!] #^5?$TFHW,TS2R7$KRMU=G))]><
MU''<RQR>8DC))UW*Q!_.CZLWS.4M67_K)2IK#PP^'Y8TI.27->][W6WGN?:_
MC;X.2^ ?VJ/!_BA]46\BU_6_,\@1%&@P!P3N(;GV%:GQZ^(5K\,/VKO!&O7^
M18QZ>89V"D[$D+HS>^ <_A7PU=:I=WTRS7%U-/*IR'D<L1[@DU7DF:7EV+L!
MP7.::P[NG)WLK&,^((0C4CAJ7)S3C->]>S5O+J_2Q^A7QF_9@TS]HCQ-IOC'
M1/%%O;VTT*0SM&@F25 20R$,,-@D8/\ 2N4_:V^)'AWP]X%T#X9:)>1WD\,M
MLER(W#BWBA*[0Y'&XE1Q]:^*;?6+ZSA>&WO+B")QADCD901Z$9JLTA9LDDM_
M>/6B.'::YI72V-,5Q%2JTZWU?#J$ZOQRNW?O9=+GW-^WT^?A;X+ /2]#''(_
MU)Y_SZU9M\?\._HU/4:=*.3U_P!(?K7PE)<2RKM>1W4<@,Q-'VB3RO+$C>7C
M&W/'Y4?5[0C"^SN34XB53%U\5[+^)#DM?;;7;7;;\3[P^ '@.WO/A/#>?##X
M@:A8:^ZH]S9:A+'/;0S<>8K0;. >S#G!'->B?%3Q,?!_P%UB#XC:CI5YJ]S9
M2PK#9H8UN'88541B22,CD# ZU^9]KJ%Q82>9:W$UN_9HY"I_/-)>:A<:A(7N
MIY+ASU:5BQ_S_GVJ985RES.1TT>*(X?"^QIT;2Y>7XGR^O+W^9 WWF^M)0:*
M[SX$**** "BBB@ HHHH !WKVG_@H-_R33]GK_L7Y/_1-E7BP[U[3_P %!O\
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M/]5?*TY;NY[O^M,(UZ=6G0LH4W!+FZ/;6W3\>Y]8_P#!/IBOBGQ:>2/L4/\
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M59QB%2,$CUYKYY\+^ ?$/C>65=#TFXU 1G#O&H"+[%CA0?;-?3/[..%_9_\
M$WH9;S_T0M6OV9_$NBZE\+4\/6VJQZ5KJ23+)Y;(LS,S,5D0,"&^4@=.-M3[
M25-S:5]3I674,?#!4:DN6\&]+7;36FO4^:O%'PC\8>#+4W6L:#=6MJ#AIUVR
MHOU*$@?C7(5]P^-]#^(6D>!=2L;6_P!-\6PO%(LG]H6QCN?**X*KM;:S8SR0
M*^'V!5B"NT@X*^E=-"JZJ;9\WG&6PRZI&-/FLU]JWYK1_(2BBBNH^>"BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#H_AO_P E"\,?]A.V_P#1JUY'^V-_R<AXQ_WK7_TDAKUWX:J6^(7AG:"V
M-2MR<?\ 7137D/[8CK)^T?XQ*L&&ZU&0>XM(0:=+^-\OU1AFO_(H_P"XB_\
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M_N8?ZL8S^>G_ .!Q/ **]_\ ['_91_Z*UK?_ ("2?_(E']C_ +*/_16M;_\
M 23_ .1*/K$>S^YA_JQC/YZ?_@<3P"BO?_['_91_Z*UK?_@))_\ (E']D?LH
M_P#16M;_ / 23_Y$H^L1[/[F'^K&,_GI_P#@<3P"BO?_ .Q_V4?^BM:W_P"
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M_(M'UJ'9_<P_U6QO\]/_ ,&1/":*]W_LW]EK_HK&M?\ @+)_\B4G]F_LM?\
M16-:_P# 63_Y$H^M0[/[F'^JV-_GI_\ @R)X317N_P#9O[+7_15]:_\  67_
M .1*/[-_9;_Z*OK7_@++_P#(E'UJ'9_<P_U6QO\ /3_\&1/"**]W_LW]EO\
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MN8?ZKXS_ )^4_P#P9$\&HKWG^R?V7/\ HJVM?^ LG_R+1_9/[+G_ $5;6O\
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M^YA_9%3_ )_4_P#P9'_,\E_/\C1^?Y&O6MW[-?\ T4W5O_ 23_Y&HW?LU_\
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M_E?W,/JT?^?]/_P./^9PE%=W_;W[._\ T4?4?_ 67_Y&H_M_]G?_ **-J/\
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M[//_ $4;4?\ P%E_^1Z/[;_9Y_Z*-J/_ ("R_P#R/1S/^5_<P^KP_P"?]/\
M\&1_S."HKO?[:_9Y_P"BBZC_ . LO_R-1_;7[//_ $474?\ P%E_^1J.9_RO
M[F'U>'_/^G_X,C_F<%1USBN^_MK]GK_HHNH_^ LO_P CU!<_$7]GWPF/M4>K
M:MXMD7E+98'4;NHSN2,8R,=<?-WHYG_*_N$Z%*.LL132_P :?Y:F[\$?#L=E
M?3^,]9?[#H&C123_ &J4[%=P,8!)' SGKUP.]?%WQ&\6R>//'FO^(9 5_M*\
MDN%0@ HC,=B\>BX'X5Z)\<OVF-6^+UK#HME91>'O"ELP,.F6K#YR,A2[ #.!
MT4  >^,UXQW-=-&G*+<Y[L^7SG,*->$,)A7>$7=O;FD^MNR6U]0I?X?SI*7^
M'\ZZCY1'[54445\D?UJ%%%% !1110 4444 %?%__  5<_P"3=-$XZ>)[;/\
MX"W5?:%?.W[?7@.X\??LO^+(+*U^UWVF^5J<2 9($3@RL/<1&2MJ+Y:D6SBQ
ML7/#32['XJXV\'K2K0P(8@\$=<]:!P37TA^<L=1110B0HSCI^?>BBF 9]:,T
M44@#/^<4JTE*M,3'4E%%(D7-.IE/H 7-&:2BF M)110(****!7%IW'I3*?0
M<>E''I110 #&>E.XIJ]:=2)84444Q"\>E''I244 +QZ4<>E)10 Y<>E.X]*:
MM+02Q>/2CCTI**!#AC'2EX]*1>E+0 <>E''I110 <>E''I1102''I1QZ444
M.XHHHH *48I*5>M(!W%%%%,@*./2BB@ X]*./2BB@ X]*<N/2FTJT .X]*/H
M,&BB@ I5I*5:!,6BBB@D7-)Q110,,"C HHH$+@>E.X]/TIE/H$Q?PH_"DHH$
M*,>E.X]*:.M.H .*.*** #BCBBB@EAQ1Q110(5<>E+@>E(M+0 8'I1@>E%%
M#EQZ?RI?\]O\*1:6@D/\]O\ "C_/;_"BB@0?Y[?X4?Y[?X444 '^>W^%''''
M\O\ "BB@!X_ST_PHS_GC_"DI:"0S_GC_  I=WU_.DHH ?N^OYT;OK^=)10 N
M[Z_G1N]S^=)10(7=]?SHW?7\Z2B@D7=]?SI0>:;2K0 [C_./\*./\X_PHHH
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M;]:2B@@7/M^M%)10 N:,TE% "YI5IM*M #J7\*2BI1 N?:E4TVE6J =1110
M4N:2B@3%S1FDHH%<7-.IE/J6 ?C1^-)15!<<M+].M-6G4 *>II***!,*7^&D
MJ]H>DW6O:U8:;91-->7LZ6\,:]7=F"J!ZY-#",7)V6Y^SM%%%?)']9A1110
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MV_\ \11_PR]\(/\ HF'A'_P2V_\ \13^O1[!_8=3^=?B?@]_GK1_GK7[P_\
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M'L+_ %=K?\_%^)^&U%?N3_PS+\)/^B9^$_\ P36__P 11_PS+\)/^B9^$_\
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M]@_U;K?\_%^)^((4XZ4NT^E?M]_PS5\)_P#HFOA3_P $UO\ _$4?\,U?"?\
MZ)KX4_\ !-;_ /Q%'UZ/87^K5;_GXOQ/Q!VGTHVGTK]OO^&:OA/_ -$U\*?^
M":W_ /B*3_AFGX3?]$U\*?\ @FM__B*/KT>P?ZLUO^?B_$_$3!]*-I]*_;O_
M (9K^$__ $37PI_X)[?_ .(H_P"&:_A/_P!$V\*?^">W_P#B*/KT>P?ZLUO^
M?B_$_$3:?2C:?2OV[_X9K^$__1-O"G_@GM__ (BC_AFOX3_]$V\*?^">W_\
MB*/KT>P?ZLUO^?B_$_$3::-IK]N_^&:_A/\ ]$V\*?\ @GM__B*/^&:_A/\
M]$V\*?\ @GM__B*/KT>PO]6:W_/Q?B?B)M-* ?2OVZ_X9K^$_P#T3;PI_P""
M>W_^(H_X9K^$_P#T3;PI_P"">W_^(H^O1[!_JS6_Y^+\3\1L&BOV[_X9L^%'
M_1-O"O\ X)[?_P"(H_X9L^%'_1-_"O\ X)[?_P"(H^O1["_U9K?\_%^)^(E.
M45^W/_#-GPH_Z)OX5_\ !/;_ /Q%)_PS;\*/^B;>%/\ P3V__P 11]>CV#_5
MFM_S\7XGXD45^W'_  S;\*/^B;>%?_!/;_\ Q%'_  S9\*/^B;^%?_!/;_\
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M ,11]>CV%_JO7_Y^+\3\3**_;/\ X9N^%/\ T3;PI_X)[?\ ^(H_X9N^%/\
MT3;PI_X)[?\ ^(H^O1[!_JO7_P"?B_$_$W!]*-I]*_;+_AF[X4_]$V\*?^">
MW_\ B*/^&;OA3_T3;PI_X)[?_P"(H^O1_E#_ %7K_P#/Q?B?B;M/I1M/I7[9
M?\,W?"G_ *)MX4_\$]O_ /$4?\,W?"G_ *)MX4_\$]O_ /$4?7H]@_U7K_\
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MA_JK7_Y^+\3\5J5>M?M1_P ,X?"O_HG/A?\ \%,'_P 31_PSC\*_^B<^%_\
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M7^I^(_Y^K[F?C517[*_\,[_"_P#Z)YX8_P#!3!_\31_PSO\ "_\ Z)YX8_\
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MP?\ Q-+Z]'L'^IV(_P"?J^YGXW4#K7[(_P##//PP_P"B>^&/_!3!_P#$T?\
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M1^YGY!J#FG;37Z]?\,__  S_ .A \-?^"J#_ .)I?^&?_AI_T('AK_P50?\
MQ-/Z_'^4/]2<3_S^C]S/R$VFC::_7O\ X9_^&G_0@>&O_!5!_P#$T?\ #/\
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M /"@?AK_ -"%X<_\%</_ ,31_P *!^&O_0A>'/\ P5P__$T?7X?RA_J/B?\
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M</\ \31_PH/X;?\ 0A>'/_!7#_\ $T?7X?RB_P!1<3_S^C]S/R. IV*_6_\
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M?&U%/_62K_S[7WB^O2_E/LG_ (37P_\ ]!W3?_ N/_XJC_A-?#W_ $'=-_\
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M<IK4?VY4_D0?VI/^4^Y?^$\\,_\ 0Q:5_P"!L7_Q5'_">>&?^ABTK_P-B_\
MBJ^&:*?]N5/Y$+^U9_R'W+_PGGAG_H8M)_\  V+_ .*H_P"$]\,_]#%I/_@;
M%_\ %5\-&FT_[;J?R(/[5G_(?<__  GOAG_H8M*_\#8O_BJ/^$]\,_\ 0Q:5
M_P"!L7_Q5?"]%/\ MJI_(B?[6G_(?='_  GWAG_H8M)_\#HO_BJ/^$^\,_\
M0Q:3_P"!T7_Q5?"N:*/[:J?R(/[6G_(?=7_"?>&?^ABTG_P.B_\ BJ/^$^\,
M_P#0Q:3_ .!T7_Q5?">?\YIK?YYI_P!M5/Y$3_:\_P"0^[O^$^\,?]#'I/\
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M?_%5\"44_P"UI_R"_MNI_(C[[_X6%X6_Z&71_P#P/B_^*I/^%A^%?^AFT?\
M\#XO_BJ^!&I*?]JS_D%_;=3^1'WY_P +#\*_]#-H_P#X'Q?_ !5'_"Q/"O\
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M_H9]&_\  ^+_ .*K\\**/[0E_*+^WZG_ #[7WGZ'_P#"QO"?_0SZ-_X,(O\
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M*K\T*:W6J]L^PO\ 6BK_ ,^E][/TQ_X6AX._Z&S0_P#P8P__ !5'_"T/!O\
MT-FA_P#@QA_^*K\S&I*?MGV%_K36_P"?2^]GZ:?\+0\'?]#9H?\ X,H?_BJ/
M^%H>#?\ H;-#_P#!E#_\57YETVCVK["_UIK?\^E][/TV_P"%H>#?^ALT/_P9
M0_\ Q5'_  M#P;_T-FA_^#*'_P"*K\R**?M7V%_K56_Y]+[V?IO_ ,+1\&_]
M#9H?_@RA_P#BJ3_A:7@W_H;-#_\ !E#_ /%5^9#4E/VC[!_K56_Y]+[V?IQ_
MPM'P;_T-FA_^#*'_ .*H_P"%H^#?^ALT/_P90_\ Q5?F/2-BG[07^M=;_GTO
MO9^G/_"TO!G_ $-NA_\ @RA_^*H_X6EX,_Z&W0__  90_P#Q5?F&>E(O6CVA
M/^M=;_GTOO9^GO\ PM+P;_T-NA_^#*'_ .*H_P"%I>#/^ANT+_P9P?\ Q5?F
M">M(U5S!_K96_P"?2^]GZ?\ _"T_!?\ T-V@_P#@S@_^*I/^%J>"_P#H;M"_
M\&4/_P 57Y@<T4^87^ME;_GTOO9^G_\ PM3P7_T-V@_^#.#_ .*H_P"%J>"_
M^ANT'_P9P?\ Q5?E^W2F_P">]',+_6VM_P ^E][/U"_X6IX+_P"AOT'_ ,&<
M/_Q5'_"U/!?_ $-^@_\ @S@_^*K\O?\ />DIW#_6VM_SZ7WL_4/_ (6IX*_Z
M&_0?_!G!_P#%T?\ "U/!7_0WZ#_X,X/_ (NORZ_&FMUJA?ZW5O\ GTOO9^H_
M_"U?!7_0WZ#_ .#.#_XNC_A:O@K_ *&_0?\ P9P?_%U^6]% O];JW_/I?>S]
M2/\ A:O@K_H<-!_\&<'_ ,51_P +5\%?]#AH/_@S@_\ BJ_+6BF+_6ZM_P ^
ME]Y^I/\ PM;P3_T.&@_^#.#_ .*H_P"%K^"?^APT#_P9P?\ Q5?EJ:3FGRB_
MUOK?\^5]Y^I7_"V/!/\ T.&@?^#.#_XNE_X6QX)_Z'#0/_!G!_\ %5^6F:.:
M?*+_ %PK?\^5]Y^I7_"V/!/_ $.&@?\ @S@_^+H_X6QX(_Z''0/_  :0?_%U
M^61^II&HY0_UPK?\^5]Y^IW_  MCP1_T..@?^#2#_P"*H_X6QX(_Z''0/_!I
M!_\ %U^5^31DU7(+_7"M_P ^5]Y^J'_"V/!'_0XZ!_X-(/\ XJC_ (6QX(_Z
M''0/_!I!_P#%5^5Q/^<TF?\ .:?L_,7^N-?_ )\K[V?JE_PMCP1_T..@?^#2
M#_XJC_A;'@C_ *'+P_\ ^#2#_P"*K\K#_GFF_P">M'L_,/\ 7&O_ ,^5][/U
M5_X6QX(_Z'+P_P#^#2#_ .*H_P"%L>"/^AR\/_\ @T@_^*K\JO\ /6C_ #UI
M^S7<7^N5;_GROO9^JO\ PMCP1_T.7A__ ,&D'_Q='_"VO __ $.7A_\ \&D'
M_P 77Y4'KW_.C)]:KV2[B_URK_\ /E?>S]5O^%M>!_\ H<O#_P#X-(/_ (NC
M_A;?@?\ Z'+P_P#^#2#_ .+K\J.::W6CV2[B_P!<Z_\ SY7WL_5G_A;7@;_H
M<_#_ /X-(/\ XNC_ (6UX'_Z'+P__P"#2#_XNORD;.*2G[%=Q?ZYU_\ GROO
M9^KG_"VO W_0Y^'_ /P:0?\ Q='_  MKP-_T.?A__P &D'_Q=?E$:2G[!=P_
MUTK_ //E?>S]7O\ A;7@;_H<_#__ (-(/_BZ/^%M>!O^AS\/_P#@T@_^+K\H
M**?L%W%_KI7_ .?*^]GZO_\ "V_ W_0Y^'__  :0?_%T?\+<\#?]#GX?_P#!
MI!_\77Y/-UI*/JZ[B_UTK_\ /E?>S]8O^%N>!O\ H<_#_P#X-(/_ (ND_P"%
MN>!?^AT\/?\ @T@_^+K\G6I*?U==Q?ZZU_\ GROO9^L?_"W/ O\ T.GA[_P:
M0?\ Q='_  MSP+_T.GA[_P &D'_Q=?DY3*?U9=Q?Z[5_^?*^]GZS?\+<\"_]
M#IX>_P#!I!_\71_PMSP+_P!#IX>_\&L'_P 77Y,TUJ?U9=P_UVK_ //E?>S]
M:/\ A;G@7_H=/#W_ (-8/_BZ/^%N>!?^AT\/?^#6#_XNOR7HH^JKN+_7>O\
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M-?\ Y\K[V?M%_P +N^'7_0^^&/\ P<6__P 72?\ "[OAU_T/OAG_ ,'%O_\
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M_HH7A7_P=6W_ ,71_P +V^&O_10O"O\ X.K;_P"+K\.324?48_S#_P!:*O\
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M#YO8J_R].@M%%%=1VA7F?Q\_Y$^U_P"OY/\ T7)7IE>9_'S_ )$^U_Z_D_\
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MOY _MZK_ ,^H?C_F?I2?'W[.)_YJ=<?]^)/_ )'I/^$^_9Q_Z*=/_P!^)/\
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M_P!^W_\ D>C[1^SK_P!%+O\ _OV__P CU\(T4?V%@^P?VL_^?,/Q_P S[O\
MM'[.O_12[_\ []O_ /(]-\[]G7_HI=__ -^W_P#D>OA*BC^PL'V#^UO^G$/N
M?^9]V^=^SK_T4N__ ._;_P#R/1YW[.O_ $4N_P#^_;__ "/7PE13_L/!]A?V
MK_TXA]S_ ,S[M\[]G4_\U+O_ /OVW_R/2>;^SK_T4R__ ._3?_(]?"=%']AX
M3L']J_\ 3B'W/_,^[/-_9U_Z*9?_ /?IO_D>CS/V=?\ HIE__P!^F_\ D>OA
M.BC^P\)V#^U/^G$/Q_S/NSS/V=?^BF7_ /WZ;_Y'I"_[.I_YJ9J'_?IO_D>O
MA2BG_8>$["_M1?\ /B'X_P"9]U;OV=/^BF:A_P!^F_\ D>D_XQT_Z*9J'_?I
MO_D>OA:BC^Q,)V#^U%_SXA^/^9]T_P#&.G_13-0_[]M_\CT?\8Z?]%,U#_OV
MW_R/7PM11_8F$[!_:B_Y\0^Y_P"9]TX_9T_Z*9J'_?IO_D>DV_LZ?]%-U#_O
MVW_R/7PO13_L7"]F']IK_GQ#\?\ ,^Z-O[.G_13=0_[]M_\ (](4_9S/_-3=
M0_[]-_\ (]?#%%']BX7S%_::_P"?$/Q_S/N?R_V<_P#HIFH?]^F_^1Z/+_9S
M_P"BF:A_WZ;_ .1Z^&**/[%PO9A_::_Y\0_'_,^YO*_9S_Z*;J'_ 'Z;_P"1
MZ3R?V<O^BF:A_P!^F_\ D>OAJBC^Q<+V#^TH_P#/B'X__)'W+Y'[.7_13-0_
M[]'_ .1Z/(_9R_Z*9J'_ 'Z/_P CU\-44_[%POF+^TH_\^(?<_\ ,^Y#;_LX
MG_FIFH?]^F_^1Z/LO[./_13-0_[]-_\ (]?#=%']BX7S#^TH_P#/B'W/_,^Y
M/LO[./\ T4W4/^_3?_(])]E_9Q_Z*;J'_?IO_D>OARBC^QL-_7_#!_:4?^@>
M'W/_ #/N/[+^SC_T4S4/^_3?_(]'V3]G'_HIFH?]^F_^1Z^'**?]CX;S_KY!
M_:4?^@>'W/\ S/N(V?[.!_YJ;J/_ 'Z;_P"1Z/[/_9SD8(GQ-OP[<*3&<?C_
M */7P[11_8^&\_Z^0O[1A_T#P_'_ #/NMO@%H7B_3[F[^'?C2S\32VZY>R;:
MLO4<YR,#GNN.O->.:KI-WHNI3V-] ]K=0N5DBDZJ:\.\+^+=7\%:Q;ZMHE]-
MIU_;L'26%]IXYP<=1ZYK[3\=ZM:_&_X*Z!\2;>%8M7@;[#JB(!DN/EW''8D
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M?=_U\@YL-_T#P_'_ #/IS_A7'[/'_12=6_[Y_P#N>C_A6_[//_12=5_[Y_\
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M **9K'_?/_W/7S911]4C_,_Z^0<N#_Z!H?C_ )GTG_PJG]G;_HI>L?\ ?/\
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M?7O_ !W_ .1J\XHH]G+^=_U\A_5\%_T#Q_'_ #/1O^&9?V>?^BCZ_P#^._\
MR-1_PS'^SS_T4?7_ ,E_^1J\YHHY)?SO^OD'U?!?] \?Q_S/1?\ AF/]GG_H
MI&O_ /CG_P C4?\ #,?[/'_12/$'_CG_ ,C5YU11[.7\[_KY#^KX+_H'C^/^
M9Z(?V8?V>/\ HI'B#_QS_P"1J0_LO_L\'_FI'B#_ ,<_^1J\\HHY)_SO^OD'
ML,'_ - \?Q_S/0O^&7OV=_\ HI'B#_QS_P"1J/\ AEW]G?\ Z*1X@_\ '/\
MY&KSVBCDE_._Z^0_88/_ *!X_C_F>@M^RY^SN?\ FI'B#_QS_P"1J3_AEO\
M9W_Z*3X@_)/_ )&KS^BCDG_._P"OD'L<'_T#Q_'_ #.__P"&6?V=_P#HI/B#
M_P <_P#D:D_X98_9V_Z*3XA_\<_^1JX&BCV<OYW_ %\A^QPG_0/'\?\ ,[[_
M (98_9V_Z*5XA_\ '/\ Y&I/^&5_V=O^BD^(?_'/_D:N"HH]G+^=_P!?(/98
M3_H'C^/^9WG_  RI^SM_T4KQ#_XY_P#(U)_PRI^SM_T4KQ#^:?\ R-7"44<D
M_P"=_P!?(?L\)_SXC^/^9W7_  RE^SM_T4KQ%_XY_P#(U'_#*/[.O_12O$/_
M (Y_\C5PM%')/^=_U\@]GA?^?$?Q_P SN?\ AE']G7_HI7B'_P <_P#D:D/[
M)_[.I_YJ5XB_\<_^1JX>BCDG_._Z^0_9X7_GQ'\?\SN/^&3OV=/^BE^(O_'/
M_D:C_ADW]G3_ **5XB_\<_\ D6N'HH]G+^=_U\@Y,+_SXC^/^9V__#)G[.G_
M $4KQ%^4?_R+2?\ #)?[.?\ T4OQ%_Y#_P#D6N)HHY)_SO\ KY#Y,+_SXC^/
M^9VI_9)_9S_Z*7XB_*/_ .1:0_LD?LYG_FI?B/\ \A__ "+7%T4>SG_._P"O
MD'+AO^?$?Q_S.T_X9'_9R_Z*9XC_ /(?_P BT?\ #(W[.7_13/$G_D/_ .1:
MXNBCDG_._P"OD/EPW_/B/X_YG9?\,B?LX_\ 13/$G_D/_P"1:/\ AD/]G'_H
MIGB3_P A_P#R+7&T4<D_YW_7R"V&_P"?$?Q_S.Q_X9"_9Q_Z*9XD_P#(?_R+
M2?\ #('[./\ T4SQ)_Y#_P#D6N/HHY)_SO\ KY#MA_\ GQ'\?\SK_P#AC_\
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MJ/+&U@_MD2/#^QWX=",4$OB%%?!^\-MT<'VX'Y5O5S_[9O\ R9WX8_[&-/\
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M-I/7Z4M)5H9]O_M=9A\9>'H5.(TT>/:O8?O9/\!7A->[_M??\CUH/_8'C_\
M1LM>$5PT/X<3]YQG\>04445N<84444 %%%% !1124 +17I0_9U\=-IOVY=*5
MK?RO.!$JY*XST^E<7X9\+:EXNUR+2-,MS/?29VQDXZ YY/TJ5.+O9FLJ4XM)
MK<R:*[;QE\&_%/@'2EU'6K%+:T:40AUE5OF() X^E<3_ )Z4U)25T3.$J;M-
M6844=L]NM%40%%==X:^%/B3Q;X?N];TVR6;3K4.9)6D5<;5RV/6GZ+\)?$OB
M#PO<>(+*R672X!(SRF0 @)G=QUXQ6?/'N:JE4=K1>IQU% YZ<TG'K5F0M%'/
M/!_*C^= !177>$?A5XC\<:7=ZAI%FMQ:VIQ*YD48X)_'I7)R1M%(R,,,IP?K
M24D]$4XRBDVM&-HKL?!/PE\3?$*SGNM$LEN8(7$;LT@7#8SCFM^X_9J^(,$9
M?^Q1+@9VQSH3^6:EU()V;-(T*LES1BVCR^BK>J:3>Z'?RV6H6LMG=QG#PS+M
M854]AR?;FK,=M&%%%% !11787WPG\2:=X1C\33V2KI$BJZS>8N2">#BDY);E
M1A*5^57L<?11^M'K3)"BBCGT(_ T %%%=#X,\ Z[\0-0>TT.Q>\DC&Z1NB1C
MU9CP*&TE=CC%R=HK4YZBO0?&'P'\8^"=-;4-0TY7LH^9)K:02",>K <XKSZI
MC)25XLJ=.=-VFK,**LZ7IMQK&HVUC:IYES<2+%&N<98G KTO_AF7X@?] F/_
M ,"$_P :)3C'XF5"E4J:PBV>5T5UWB[X3^*_ ]N+C6-'FM[8G'GJ0Z9]R"<?
MC47@CX9^(/B)]J_L.T6Y^S &3=(%QGIUZ]*.>-N:^@O95.;DY7?L<M14]]9R
MZ=?7%I.NV>"1HI%ZX93@C\Q4%49V8448/I2<8SGCUH 6BC!HZ].: "BCW_'I
M10 4444 %%)6EHOAW4_$3S+IMC->&%#)*8ER$4 DDGH.E%TM1I-Z(SJ*ZCP/
M\-=>^(C7:Z':K=&U"M+ND"@!LXZ]>AZ5S^H6,VEZA<V5RNRYMY6AD0'.&4D$
M<>X-+F3=AN$DE)K1E>BCK[_3FD_GZ4R1:*** "BBB@ HHHH **** "BBB@#J
M_A-(T?Q1\)%6VG^U;53CWE4'^=?-7_!0"-(?VNOB J*$!DLFPOJ;&W)/XDDU
M])_"G_DJ'A'_ +"UK_Z.2OF[_@H)_P G>>/_ />L?_2"WK)?QOE^IM5_W3_M
MY?DSYWH/W:*#]VNL\I;G]&%,;.:?4;]Z^4/U0^,OB'_P3O\ @HNI:GXG\3>(
M=1TA;^ZDN)[B[U*.&+S)&+E06 [DX'6N,TG]A']FC7=&U#5[#QS<76E:?,EO
M=7RZI'Y,+N0J*SD8Y+*!]:Y'PC\-]5_X*'?&[QOKOBKQ!>V'P]\.WS6-AI]F
MV"P!/E@*V5'"[G;&<OQ3_P!BGX&Z7\8?@=\:?A[>WUU86$OB"*..YM\;U,7S
M(3D8/*#(_E7C>Y*7NTU9WMYV/G[4ZDUR4E9WM?K8^NOV;_V5/ _[.DNL7_@^
MZO;Q=:BA$DMS<"5"B;BI0@8P=YYYKW1>E?#/_!//Q-XF\%^,OB3\$_$NH-JA
M\)SA[&9F)VIO9'"YSA#\C =BS>M?<R]*]'#N+IKE5CUL+*$J2Y%;R%HHHKH.
MH*\S^/G_ ")]K_U_)_Z+DKTRO,_CY_R)]K_U_)_Z+DKQ\X_W"MZ$5/A9X'2-
MTI:1NE?BJ/+&US_[9O\ R9WX8_[&-/\ T"[KH*Y_]LW_ ),[\,?]C&G_ *!=
MU]YP;_R-%_A?YHX<?_N=;_"S\]324II*_H$_) HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ K])_\ @G-)-!^S_P"*I+8,9TU*=X]JY.\0
M)C QSSBOS8K]*?\ @G%>'3_@#XHNE4.T&I32A2#@D0H<'\J\W'_P'ZH^FX=_
MWY>C,3]FWXQ?M >)_B_::9XFTG4)O"\CR"[FU#2_LJPH Q#*Y5<G(48R>M2?
MM-66FV_[;'PFFM51+^X6)KHH!\V)'"EO?  ^F*\]UC_@IIXW5KFVM?#.APNK
M,BS-YK%><9QOQGZ\5Y#\*?B)KOQ2_:F\)>(?$=\U]J5SJD9=F(55&" JKV4#
M& *YXX>?,ZDHJ*L]CTZF84'3AA85)5&YIW?35'W'^U)^S;X;^,7C30=7\5>,
MH?"NF06QLHHS)%')/*7SA3)P>.V":^//VJ?V0Y?V?X=,U72M5EUO0M0E,"M*
M@$L;XR Q48(/J*]*_P""GFJ7*?$#P;;"9UMX[&258P2!O\P?-]:])_;=M9-6
M_9I\!6X93/<36,89NFYHE&>?<UGAY5*:I>]I+H=&84L/B98K]W:<+.]][GFO
M@7]@/P[:^ ].\1?$GQP?#1O42188GBA2+>,JK/)D%L$=/6N'_:?_ &,XO@?X
M3L_%F@Z\^N>'I9$B=IPHD7?]Q@RC!4_A7T+XC^$7PZ_9Y^&&@7GB[0]:^(^H
M3.B1VTDCW$9F*YP(\[54>N#6Q^VO<?;?V08)ETMM&62>Q9-.;K;J2<(<>@Q]
M*(XBJZD;2NF[?\,%;+L-'"U%*FHSC&^[;^?3Y(\U\._\$W?#^K>&]$UJZ\:W
MEI;75K%=70:&,;0R X5CTZ]36)X?_8(\+>*OB1XH\.:=XTO)[?1X89!,(HV)
M>09V,>AXQR,=:]2_;%UFZTK]CGPY%:SO!]K2PBD*G!*^6"1]/\*X_P#X)?S/
M-_PG#N[2,3!EF.3W_P _A0JE?V,JW/MT'+"X'Z[2P:HK57;N^ST(-'_X)Q^%
M-0AO=+;XBFX\4VJ[I+6U\IE@Z[?,3EP.G<57\*_\$X] *G2/%'Q!2'Q3(C21
MZ?ISQ9"=G*/EF&!GC JI^Q7J5S??M;^.Y9Y7>247>\L3E\2D#ZCBGV.J7-U_
MP4DG$DK,([QH$RQR$$?0>WMTJI2KJ4H\^RN9PI8"5.G5]@O>GR6N_O\ 4\7F
M_9!\1G]H1OA='=0M(%^U?VB5^1;;&?,(]>V/6OH6+_@G?\-Y-2_L _$B[D\3
MK'O:S62WWC 'S>5C=CD=^E;WQ4^#2?&7]M<6=QJ-UIEA8:+!=W#V4ACED R
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M-4>72=)91>:G.@.#W50,<Y)'/]TUZ1J'[%?AW4+6[M?#?C7[;KMJF9+65XG
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MBX6-=H6)<#Y=V3SC^&N\N/!7AKQM]F\1:EX=AN+ZYL%B,=_ #((FP_ENIXW
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M[MP-QZ #N*=\7/V3[#PG\/Y?%_A3Q"VM:?;J)I%F*-OC+!=Z,O'&>1[&N_\
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M@ HHHH **** $KW_ /:R_P"2-? C_L#/_P"B+2O *]__ &LO^2-? C_L#/\
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MW7AZ+P?I=QK6@W>OZ8&4HEDI81Y7AB!V(-91J3C",5U.JI1I3K5)R5[)??\
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MBMXQ4%RQV//JU9UINI4=VPHHHJS(**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ I?7Z4E+Z_2@9^C/@'_DR#X9?]?MQ_Z/NZY6NJ\ _\F0?#+_K]
MN/\ T?=URM?B>>_[_4/T*7\.E_@C^0VDI:2O ,3T?P;_ ,D%^,__ &!)/_1$
M]?G]7Z ^#?\ D@OQG_[ DG_HB>OS^K]<X:_W%?UU9YF;_!0]'_Z4PHHHKZP^
M="BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /1_@9\<=6^
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M=D:QC&23T0=^M<Q116B2BK(YY2<Y.4GJPHHHIDA1110 4444 %%%% !1110
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M2?\ QJOH#[;<?\]Y/^^S36O;C_GO)_WV?\:K_7JK_P ^?Q_X ?V'@/Y9??\
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M_P  /[)P'\LO_ O^ >*_\.U_BU_S\^'/_ ^3_P"-4?\ #M?XM?\ /SX<_P#
M^3_XU7M)O[K/_'Q-_P!]FD_M"Z_Y^9O^^S3_ -=*O_/K\?\ @$_V3@/Y9?\
M@7_ /%_^':_Q:_Y^?#G_ ('R?_&J3_AVO\6O^?GPY_X'R?\ QJO:?[0NO^?F
M7_OLTS^T+K_GYF_[[-/_ %TK?\^OQ_X ?V3@/Y9?^!?\ \9_X=K_ !:_Y^?#
MG_@?)_\ &J/^':_Q:_Y^/#G_ ('R?_&J]F_M"Z_Y^9O^^S36O[G/_'S-_P!_
M#_C3_P!<ZO\ SZ_'_@"_LO ?RR_\"_X!XW_P[8^+7_/SX<_\#Y/_ (U1_P .
MV/BU_P _/AS_ ,#Y/_C5>Q_;KG_GYF_[^'_&E_M"Y_Y^)O\ OX?\:/\ 7.K_
M ,^OQ_X O[+P'\DO_ O^ >-_\.U_BU_S\^'/_ ^3_P"-4?\ #M?XM?\ /QX<
M_P# ^3_XU7L3:A=?\_,W_?PTGV^Z_P"?F;_OX?\ &G_KE6_Y]?C_ , /[+P'
M\DO_  +_ (!X]_P[7^+7_/SX<_\  ^3_ .-4?\.U_BU_S\^&_P#P/D_^-5[
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M&R?_ !JM@ZC=?\_,W_?PTS^TKO\ Y^9O^_AI_P"LU;^1?U\A?5\!_P ^Y?\
M@7_ ,K_AWK\4?^?GP_\ ^!LG_P :H_X=Z_%'_GX\/_\ @;)_\:K5_M*[_P"?
MF;_OX:/[2N_^?F;_ +^&G_K-6_D7]?(7L,!_S[E_X%_P#*_X=Z_%'_GX\/\
M_@;)_P#&J3_AWK\4?^?C0/\ P-D_^-5JMJ5W_P _4_\ W\-)_:5W_P _4_\
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M_P"_IH_M^M_*@M@/^?4O_ O^ /\ ^'>_Q0_Y^?#_ /X&R?\ QJD_X=\?$_\
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M7L)_SY?_ (%_]J>D_P###OQ$_P"?C1/_  +?_P"-T?\ ##OQ$_Y[Z)_X%O\
M_&Z\V_M:^_Y_+C_O\W^--_M:^_Y_+C_O\W^-']JU>POK^$_Y\O\ \"_^U/3/
M^&'?B+_SWT3_ ,"W_P#C=)_PP[\1?^>^B?\ @6__ ,;KS3^UK[_G]N?^_P W
M^-']K7O_ #^7'_?YO\:?]J5>PO[0PG_/E_\ @7_VIZ7_ ,,._$3_ )^-#_\
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MHG_@6_\ \;KRDZM??\_MS_W^;_&D_M>^_P"?VY_[_-_C3_M&J+^TL)_SY?\
MX%_]J>L?\,/?$3_GOHG_ (%O_P#&Z/\ AAWXB?\ /?1/_ M__C=>3_VO??\
M/[<_]_F_QI&U>^_Y_;C_ +_-_C1_:%47]IX3_GP__ O_ +4]:_X8=^(O_/?1
M/_ M_P#XW1_PP[\1?^>^B?\ @6__ ,;KR/\ MB_Q_P ?MQ_W^;_&F_VM?D_\
M?MQ_W];_ !I_VA5%_:F$_P"?#_\  O\ [4]>_P"&'/B+_P ]]$_\"W_^-T?\
M,._$3_GXT/\ \"W_ /C=>0G5[[_G]N/^_K?XTAUB_P#^?VX_[_-_C3_M"J']
MJ83_ )\/_P "_P#M3U[_ (8=^(G_ #\:)_X%O_\ &Z/^&'?B)_SWT3_P+?\
M^-UX_P#VQ?\ _/[<?]_F_P :/[8O_P#G]N/^_K?XT_K]47]J8/\ Y\/_ ,"_
M^U/8/^&'?B)_SWT3_P "W_\ C='_  P[\1/^>^B?^!;_ /QNO'FUB_\ ^?VX
M_P"_K?XTW^UK[_G\N/\ OZW^-'UZJ']JX/\ Y\/_ ,"_^U/8_P#AAWXB?\]]
M$_\  M__ (W1_P ,._$3_GOHG_@6_P#\;KQS^UK[_G\N/^_K?XT?VM?8_P"/
MVX_[^M_C3^O51?VK@_\ GP__  +_ .U/9/\ AAWXB_\ /?1/_ M__C='_##O
MQ%_Y[Z)_X%O_ /&Z\8_MB_\ ^?ZX_P"_S?XTAUB__P"?ZY_[_/\ XT_KM47]
MK8/_ )\/_P "_P#M3V?_ (8=^(O_ #WT3_P+?_XW1_PP[\1?^>^B?^!<G_QN
MO%_[8O\ _G^N?^_S_P"-']L7_P#S^W/_ '^;_&G]=JB_M;!_\^'_ .!?_:GM
M'_##OQ$_Y[Z)_P"!;_\ QNE_X8=^(G_/QH?_ (%O_P#&Z\4_MG4/^?ZX_P"_
MS?XT?VQ??\_MQ_W];_&G]<J^0?VO@_\ GP__  +_ .U/:_\ AAWXB_\ /?1/
M_ N3_P"-T?\ ##OQ%_Y[Z)_X%R?_ !NO$VUB_P#^?VX_[^M3?[8O_P#G]N?^
M_K?XT_KE7R%_:^#_ .?#_P# O_M3V[_AAWXB?\_&B?\ @7)_\;H_X8=^(O\
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MFKW0O[9P?_/A_P#@?_VI[M_PP[\1/^?C0_\ P+?_ .-TG_##OQ$_Y^-$_P#
MM_\ XW7A1UB__P"?VY_[_-_C3/[8O_\ G^N?^_S?XT?6:O<7]LX/_GP__ __
M +4]X_X8=^(G_/?1/_ M_P#XW2_\,._$7_GXT/\ \"W_ /C=>#?VQ?\ _/\
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MVTC_ ,"F_P#B*/\ AD/QS_SVTC_P*?\ ^(KX2;7M3_Z"-W_W_;_&D_M_4_\
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M?\,A^.?^>VD_^!+_ /Q%?GC_ ,)!J?\ T$KS_O\ M_C2-X@U3_H)7G_?]O\
M&CV=7^9?=_P1_P!L8;_GR_\ P+_[4_0__AD/QS_SVTG_ ,"7_P#B*/\ AD/Q
MS_SVTG_P)?\ ^(K\[3X@U3_H(W?_ '_;_&D_X2#5/^@C=_\ ?]O\:/9U?YE]
MW_!'_:^&_P"?+_\  O\ [4_1/_AD/QS_ ,]M)_\  E__ (BC_AD/QS_SVTG_
M ,"7_P#B*_.MO$&J?]!*\_[_ +?XTP^(-4_Z"5Y_W_;_ !H]G5_F_#_@E?VM
MAO\ GR__  +_ .U/T7_X9#\<_P#/;2?_  )?_P"(H_X9#\<_\]M)_P# E_\
MXBOSF_X2#5/^@E>?]_V_QII\0:IG_D)7G_?]O\:/9U?YE]W_  1_VMAO^?+_
M / O^ ?HW_PR'XY_Y[:3_P"!+_\ Q%'_  R'XY_Y[:3_ .!+_P#Q%?G$?$&J
M?]!*\_\  AO\:/\ A(=4_P"@E>?^!#_XT>SJ_P R^[_@C_M3#?\ /E_^!?\
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M*H IE/IE-$!2-2TC51(VFMUIU-;K5""BBBF2(U-IS4VM$ 4C4M(U,D;1110
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M_P#B:U?^&PO G_/'6/\ P%7_ .+H_P"&P/ G_/'6/_ 5?_BZ/]0Y_P#/B?\
M7R#_ %BR#_H+A]YD_P#"A?$O_/2P_P"_S?\ Q-(?@)XE_P">EA_W^;_XFM?_
M (; \"?\\=8_\!5_^+H_X; \"_\ /'6/_ 5?_BZ/]0Y_\^)_U\@_UBR#_H+A
M]YC_ /"@_$O_ #TL/^_S?_$T?\*#\2_\]+#_ +_-_P#$UL_\-?>!O^>&K_\
M@*G_ ,71_P -@>!?^>&K_P#@(G_Q=/\ U%G_ ,^)_P!?(7^L.0?]!</O,3_A
M0?B;_GI8?]_F_P#B:/\ A07B;_GI8?\ ?YO_ (FMK_AL'P+_ ,\=7_\  1?_
M (NE_P"&P/ O_/'5_P#P$7_XNC_46?\ SXG_ %\@_P!8<@_Z"X_>8G_"@O$W
M_/2P_P"_S?\ Q--_X4#XF_YZ6'_?YO\ XFMW_AL#P+_SQU?_ ,!%_P#BZ/\
MAL#P+_SQU?\ \!%_^+H_U%G_ ,^)_P!?(/\ 6#(/^@N/WF%_PH'Q-_STL/\
MO\W_ ,31_P *!\3?\]+#_O\ -_\ $UN_\-@>!?\ GCJ__@(O_P 71_PV!X%_
MYXZO_P" B_\ Q=/_ %&G_P ^9_U\A?ZP9!_T%Q^\P3^S_P")_P#GII__ '^;
M_P")I#^S_P")_P#GII__ '^;_P")K?\ ^&P/ O\ SQU?_P !%_\ BZ/^&P/
MO_/'5_\ P$7_ .+H_P!1Y_\ /F?]?(/[?R#_ *"X_><__P ,^^)_^>NG_P#?
MYO\ XFC_ (9]\3_\]=/_ ._S?_$UT'_#8'@7_GCJ_P#X"+_\72_\-?>!?^>.
MK_\ @*O_ ,71_J//_GS/^OD']O9!_P!!<?O.=/[/OB?_ )ZZ?_W^;_XFD_X9
M[\4?\]=/_P"_S?\ Q-=)_P ->^!O^>.K_P#@(G_Q='_#7O@;_GCJ_P#X"I_\
M73_U'G_SXG_7R#^WL@_Z"X_><W_PSWXH_P">NG_]_F_^)I/^&>O%'_/73_\
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M .@J/_@1RY_9W\4_\]=._P"_[?\ Q%)_PSOXI_YZZ=_W_;_XBNI_X:\\#_\
M/#5__ 5?_BZ/^&O/ W_/'5__  %7_P"+H_U*G_SYG_7R%_;G#_\ T%1_\".6
M_P"&=_%/_/73_P#O\W_Q%-_X9V\4_P#/73_^_P W_P 175_\->>!O^>.K?\
M@*O_ ,71_P ->>!O^>.K_P#@*O\ \71_J74_Y\S_ *^0?VWP_P#]!4?O.4_X
M9W\5?\]-/_[_ +?_ !--/[.OBK_GII__ '_;_P"(KK?^&O/ W_/'5_\ P%7_
M .+H_P"&O/ W_/'5_P#P%7_XNG_J74_Y\S_KY"_MKA__ *"H_P#@1R7_  SK
MXJ_YZ:?_ -_V_P#B*/\ AG7Q5_STT_\ [_M_\176_P##7?@;_GCJ_P#X"K_\
M72_\-<^!_P#GCJ__ ("K_P#%T?ZEU/\ GS/^OD']M</_ /05'_P(Y _LY^*S
M_P M-/\ ^_[?_$T?\,Y>*_\ GII__?\ ;_XBNP_X:Y\#?\\-6_\  5?_ (NC
M_AKKP/\ \\-7_P# 5?\ XNG_ *F5/^?,Q?VUP_\ ]!4?_ CCC^SCXK_YZ:?_
M -_V_P#B*3_AG'Q7_P ]-._[_M_\179?\-=>!_\ GAJ__@*O_P 71_PUUX'_
M .>&K_\ @*O_ ,73_P!3:G_/F8?VQP__ -!4?_ CC?\ AG'Q7_STT[_O^W_Q
M%-_X9O\ %G_/33O^_P"W_P 17:?\-=>!_P#GAJ__ ("K_P#%T?\ #77@;_GC
MJW_@*O\ \73_ -3:G_/F8?VQP_\ ]!4?_ CB_P#AF_Q9_P ]-._[_M_\12']
MF[Q9_P ]-._[_M_\17:?\-=>!?\ GCJW_@*O_P 72C]KCP,?^6&K?^ J_P#Q
M='^IM3_GS,/[8X?_ .@J/WG$_P##-OBS_GIIW_?]O_B*/^&;?%G_ #TT[_O^
MW_Q%=O\ \-<>!_\ GAJW_@*O_P 71_PUQX'_ .>&K?\ @*O_ ,73_P!3JO\
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M:>"/^>.K?^ J?_%T?ZJUO^?,A?VCP[_T%1_\"/-?^&7O&/\ SUTS_P "'_\
MB*/^&7O&/_/73/\ P(?_ .(KTK_AK3P3_P \=6_\!4_^+I?^&L_!'_/'5O\
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M/&9_Y:Z7_P"!#_\ Q%)_PROXS_YZZ7_X$/\ _$5ZE_PUAX)_YXZM_P" R_\
MQ='_  UAX)_YXZM_X#+_ /%TO]6*_P#SYD'U[AW_ *"H_P#@1Y:?V5_&?_/7
M2_\ P(?_ .(IO_#*WC3_ )ZZ7_X$/_\ $5ZI_P -8>"?^>6J_P#@,G_Q='_#
M6'@K_GCJW_@,O_Q=/_5FO_SYD+Z[P[_T%1_\"/*?^&5?&G_/72__  (?_P"(
MH_X95\:?\]=+_P# A_\ XBO5O^&K_!7_ #QU;_P&7_XNC_AJ_P %?\\=6_\
M 9?_ (NC_5FO_P ^9!]=X=_Z"H_^!'E/_#*OC3_GKI?_ ($/_P#$4G_#*?C3
M_GKI?_@0_P#\17J__#5_@K_GCJW_ (#+_P#%T?\ #5_@K_GCJW_@,O\ \73_
M -6J_P#SZD'USAW_ *"H_P#@1Y1_PRGXT_YZZ7_X$/\ _$4?\,I^-/\ GKI?
M_@0__P 17J__  U?X*_YXZM_X#+_ /%T?\-7^"O^>.K?^ R__%T?ZM5_^?4A
M?7.'?^@F/_@1Y,W[*?C3_GMI?_@0_P#\12?\,I^-/^>VE?\ @2__ ,17K?\
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M;XV_Y[:3_P"!+_\ Q%>P_P##5W@K_GCJO_@.G_Q='_#5W@K_ )XZK_X#I_\
M%T_]7:__ #YD'UCAW_H)7_@1X\?V3?&W_/;2?_ E_P#XBD_X9+\;?\]M)_\
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M.O\ GMI'_@4__P 12_\ #'_CK_GMI'_@4_\ \17N?_#5/@S_ )YZI_X#K_\
M%T?\-4^#/^>>J?\ @.O_ ,73_L/$_P#/J0N;AS_H)7_@7_ /"O\ ACWQW_SV
MTC_P*?\ ^(H_X8]\=_\ /;2/_ I__B*]U_X:I\&?\\]4_P# =?\ XNC_ (:I
M\&?\\]4_\!U_^+H_L/$_\^I!S<.?]!*_\"_X!X2?V/?'?_/;2/\ P*?_ .(I
M/^&._'G_ #VTC_P*?_XBO=_^&J?!G_//5/\ P'7_ .+H_P"&J?!G_//5/_ =
M?_BZ?]B8G_GU(5^'/^@E?^!?\ \&_P"&.O'G_/;1_P#P*?\ ^(H_X8Z\>?\
M/;1__ I__B*]Y_X:I\&?\\]4_P# =?\ XNC_ (:I\&?\\]4_\!U_^+H_L7%?
M\^I!?AO_ *"5_P"!?\ \&_X8Z\>?\]M'_P# I_\ XBF_\,<^/?\ GMH__@4_
M_P 17OG_  U3X,_YY:I_X#K_ /%T?\-4>#?^>6J?^ Z__%T?V+BO^?4@_P",
M<_Z"5_X%_P  \#_X8Y\>_P#/;1__  *?_P"(H_X8Y\>_\]M'_P# I_\ XBO?
M/^&J/!O_ #RU3_P'7_XNC_AJCP;_ ,\M4_\  =?_ (NG_8V*_P"?4@_XQO\
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M3_LK%?\ /IA[/AO_ *"%_P"!?\ ^>?\ AC'Q]_SWT;_P*?\ ^-TA_8Q\?_\
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MHO!O_/+5/_ =?_BZ/^&HO!O_ #RU3_P'7_XNC^S,5_S[8>PX:_Z"%_X%_P
M^<?^&*_B#_SVT;_P+?\ ^-TG_#%7Q!_Y[:-_X%O_ /&Z^C_^&HO!O_/+5/\
MP'7_ .+H_P"&HO!O_/+5/_ =?_BZ?]FXO_GVQ?5^&O\ H(7_ (%_P#YO_P"&
M*?B#_P ]M%_\"W_^-TA_8G^(7_/;1?\ P+?_ .-U](_\-1>#?^>6J?\ @.O_
M ,71_P -1>#?^>6J?^ Z_P#Q=/\ LW%_\^V'U?AK_H(7_@7_  #YM_X8G^(7
M_/?1?_ M_P#XW1_PQ/\ $+_GOHO_ (%O_P#&Z^DQ^U#X./\ RRU3_P !U_\
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MB/XA_P#/?1?_  +?_P"-U]*_\-1>#?\ GGJ?_@.G_P 71_PU%X-_YYZG_P"
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MNC_AI[P=_P \]2_\!T_^+H^IXS_GVP^H\-?]!'_DW_ /EUOV&?B,?^7C0_\
MP,?_ .-TW_AACXC?\_&A_P#@8_\ \;KZD_X:>\'?\\]2_P# =/\ XNC_ (:>
M\'?\\]2_\!T_^+H^J8W_ )]L/J/#7_01_P"3?\ ^6S^PO\1O^?C0_P#P,?\
M^-TG_#"_Q'_Y[Z'_ .!C_P#QNOJ4?M/>#S_RSU+_ ,!T_P#BZ/\ AIWP?_SR
MU/\ \!T_^+I_5,;_ ,^V'U#AK_H(_P#)O^ ?+/\ PPO\1_\ GOH?_@8__P ;
MH_X87^(__/?0_P#P,?\ ^-U]3?\ #3O@_P#YY:G_ . Z?_%T?\-.^#_^>6I_
M^ Z?_%T?5<;_ ,^V+^S^&?\ H(_\F_X!\L']A7XC_P#/?0__  ,?_P"-T?\
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M ,__ /R;_@'RB?V#_B2?^7C0O_ Q_P#XW2?\,'_$G_GXT+_P,?\ ^-U]7_\
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M)^)?_/QH/_@8_P#\;I/^&"/B7_S\:#_X&O\ _&Z^N/\ AICPA_SSU+_OPO\
M\71_PTQX0_YYZE_WX7_XNG[/'?R?@+^R>&/^?_\ Y-_P#Y'_ .&"/B7_ ,_&
M@_\ @:__ ,;I/^&"/B7_ ,_&@_\ @:__ ,;KZY_X:8\(?\\]2_[\+_\ %T?\
M-,>$/^>>I?\ ?A?_ (NCV>._D_ /[)X8_P"?_P#Y-_P#Y%_X8'^)G_/QH/\
MX&O_ /&Z0_L#_$S_ )^-!_\  U__ (W7UW_PTQX0_P">>I?]^%_^+H_X:8\(
M?\\]2_[\+_\ %T<F._D_ /[)X8_Y_P#_ )-_P#Y#_P"&!?B9_P _&@_^!K__
M !NC_A@7XF?\_&@_^!K_ /QNOKW_ (:6\(_\\]2_[\+_ /%T?\-+>$?^>>I?
M]^%_^+I\N/\ Y/P#^R.&/^?_ /Y-_P  ^03^P)\3/^?C0?\ P-?_ .-TG_#
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M_D_ ?]D<,_\ /_\ \F_X!\<G_@G[\3O^?C0/_ V3_P"-TG_#OWXG?\_&@?\
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MO^>>H_\ ?A?_ (NC_AI/PE_SSU'_ +\+_P#%T6QW\GX#_LWAO_G_ /\ DW_
M/B<_\$[OBF?^7GP]_P"!TG_QJD_X=V_%/_GY\/?^!TG_ ,:K[9_X:3\)?\\]
M1_[\+_\ %T?\-)^$?^>>H_\ ?A?_ (NCEQW\GX#_ +-X<_Y__P#DW_ /B4_\
M$[?BG_S\^'O_  .D_P#C5(?^"=?Q4_Y^?#W_ ('2?_&J^V_^&DO"7_//4?\
MOPO_ ,71_P -)>$O^>>H_P#?A?\ XNCEQW\GX#_LWAS_ )__ /DW_ /B/_AW
M5\5/^?GP[_X'2?\ QJFG_@G3\5/^?GP[_P"!TG_QJOM[_AI+PE_SSU'_ +\+
M_P#%TO\ PTEX2_YYZC_WX7_XNCEQW\GX#_L_AW_G_P#^3?\  /AX_P#!.CXJ
M_P#/SX=_\#I/_C5'_#N?XJ_\_/AW_P #I/\ XU7W#_PTEX2_YYZC_P!^%_\
MBJ/^&DO"?_//4?\ OPO_ ,51RX[^3\!_V?P[_P __P#R;_@'PX?^"<_Q5_Y^
M?#O_ ('2?_&J;_P[E^*W_/SX=_\  Z3_ .-5]RC]I'PF?^6>H?\ ?A?_ (JC
M_AI'PG_SSU#_ +\+_P#%TK8[^3\"OJ'#W_/_ /\ )O\ @'PU_P .Y?BM_P _
M/AW_ ,#I/_C5-_X=Q_%;_GY\._\ @=)_\:K[G_X:1\)_\\]0_P"_"_\ Q='_
M  TCX3_YYZA_WX7_ .+IVQW\GX#^H\/?\_\ _P F_P" ?"__  [A^*__ #\^
M'?\ P.D_^-4A_P""</Q7_P"?GP[_ .!TG_QJONG_ (:1\)_\\]0_[\+_ /%T
M?\-(^$_^>>H?]^%_^+HMCOY/P']1X>_Y_P#_ )-_P#X5_P"';_Q7_P"?GP[_
M .!TG_QJF_\ #M[XL?\ /SX<_P# Z3_XU7W;_P -(>$_^>>H?]^%_P#BJ/\
MAI#PG_SSU#_OPO\ \52MCOY/P#ZEP]_S_P#_ ";_ (!\)'_@F]\5_P#GZ\.?
M^!TG_P :IK?\$W?BQ_S]>'/_  /D_P#C5?=__#2'A/\ YYZC_P!^5_\ BZ/^
M&D/"?_//4/\ ORO_ ,71;'?R?@/ZGP__ ,__ /R;_@'P=_P[;^+'_/UX<_\
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M1?A3^YJ'_?E?_BJ?^V_R?@/V.1?\_O\ R;_@'YZ?\.Q?B_\ \_7AG_P82?\
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MX#]GDG_/Y?\ @1^=?_#K[XQ?\_/AG_P82_\ QFD/_!+WXQ?\_7AG_P &$O\
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M#"7_ .,TT_\ !+;XR8/^D^&#]=0E_P#C-?H]_P -%>%?^>>H?]^5_P#BJ/\
MAHGPK_SSU#_ORO\ \52_VW^3\!VR;_G\OO/B+X:?\$H=:FU*&?QSXIM;6R1L
MR6NCJ7D?H>)'  [_ ,/8<U]^_"_X3^&O@[X3MO#OA738]-TZ'YF"_,\KXP7=
MCRS''4UA0_M">%)I-I^VQ<9W/",?HU=KX?\ %VD^*+43Z;>QW2]U4_,OU!Y%
M<F(6(M>JFD>Q@99=S6PLTY>MV;-%%%<)[@444UF"]: '44SS!@=:=0 M%%%
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M+ ./2CBBBD [%%+106)12T4 )12T4 )12T4%"44M%2P$I5Q10O6D [\****
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M4M!04444F 4445(!11106%%%% !1110 Y>E%"]**E[E!3EZ4VG+TH&+1110
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M>X4445H<X4444 %%%%!2/NBBBBOSH_H8*8W>GTQN] '\]/B3_D<=4_Z_9/\
MT8:_>WX2_P#)+?"'_8(M/_1*U^"7B3_D<=4_Z_9/_1AK][?A+_R2WPA_V"+3
M_P!$K7K8WX8GQ60?&_\ "CK****\D^U"O!?VS/\ DEVG_P#87A_]$S5[U7@O
M[9G_ "2[3_\ L+P_^B9J]K)?^1C1]3Y+BW_D18O_  L^+J***_<S^- HHHH
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ME+4@%%%%(:"BBB@84444 %.IM.I,:"BBBD4%%%% !11104@IRTVG+0 M%%%
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M6@H****!A1114 *M.IJTZ@ HHHI,:"BBBD,**** "E6DI5H&A:***"@HHHH
M****!H****"A]%%%0 4444 %%%% #EZ4M(O2EH*"BBBDP"BBBI ****"PHHH
MH **** '+THH7I14O<H*<O2FTY>E Q:*** "BBB@H**** "BBB@!U+24M!84
M444 %%%%  O4TZFKU-.J!A11128(****DH**** "G+TIM.7I0-"T444#"BBB
M@ HHHH*04444#"G4VG4F M%%%( HHHH =11104%%%% PHHHH ****"@HHHJ
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MI:2D,****DH**** "E7K24J]: '4444%A1110 4444 .7I2TB]*6I*"BBB@
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MH **/\]*/\]*D!5IU(M+2 ****3&@HHHI%!1110 4JTE.6@:"BEHH&)12T4
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MD+P1_?U#_O\ _P#UJ7_AD+P1_>O_ /O_ /\ UJ]PHH_MC,/^?TOO#_57)/\
MH$A]QX=_PR#X'_O7_P#W_P#_ *U'_#(7@@?QZA_W_P#_ *U>XT4?VQF'_/Z7
MWC_U6R3_ *!(?<>'_P##(?@G^_J'_?\ _P#K4?\ #(7@C^]?_P#?_P#^M7N%
M%']L9A_S^E]X?ZK9)_T"0^X\._X9"\$?WK__ +__ /UJ/^&0O!']Z_\ ^_\
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MV^BC^U\?_P _I?>'^JV2?] D/N/$/^&1?!/]Z^_[_P#_ -:C_AD7P3_>OO\
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M;'_\_I?>'^J^2_\ 0+#[CQ+_ (9)\%>M]_W_ /\ ZU'_  R3X*];[_O_ /\
MUJ]MHH_M;'_\_I?>'^J^2_\ 0+#[CQ+_ (9)\%>M]_W_ /\ ZU'_  R3X)_O
M7W_?_P#^M7MM%']K8_\ Y_2^\/\ 5?)?^@6'W'B?_#)7@K^]??\ ?_\ ^M1_
MPR5X*_O7W_?_ /\ K5[911_:V/\ ^?TOO'_JQDO_ $"P^X\3_P"&2O!7]Z^_
M[_\ _P!:C_ADKP5_>OO^_P#_ /6KVRBC^UL?_P _I?>'^K&2_P#0+#[CQ/\
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MU>QT4?VGC?\ GZ_O#_5W*?\ H&C]QXY_PRSX._O7O_?ZC_AEGP?_ 'KW_O\
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MZWO_ '^_^M7L5%']I8S_ )^,/]7LI_Z!H_<>._\ #+?@_P!;W_O]_P#6I?\
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M_P (_P!^]_[_ %>OT4?VCB_^?C#_ %?RK_H'C]QY!_PR_P"$?[][_P!_J/\
MAE_PC_>O?^_W_P!:O7Z*/[1Q?_/QA_J_E7_0/'[CR#_AE_PC_>O/^_W_ -:C
M_AE_PAZWG_?[_P"M7K]%']HXO_GXP_U?RK_H'C]QY!_PR_X0];S_ +_?_6H_
MX9?\(>MY_P!_O_K5Z_11_:.+_P"?C#_5_*O^@>/W'D'_  R_X0];S_O]_P#6
MI1^S#X0];W_O]_\ 6KUZBC^T<7_S\8_[ RK_ *!X_<>0_P##,/A'^]>_]_O_
M *U'_#,/A'^]>_\ ?[_ZU>O44?VCB_\ GXP_L#*_^@>/W'D/_#,/A'^]>_\
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MZW?_ ']KU>BCZ]B?^?C'_8F6_P#/B/W'E'_#-OA3UN_^_M'_  S;X5_O7?\
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M +^__6KU*BCZYB/YV']CY?\ \^(_<>6_\,Z^%_6[_P"_O_UJ/^&=?"_K=_\
M?W_ZU>I44?7,1_.Q_P!CY?\ \^(_<>6_\,Z^%_6[_P"_O_UJ/^&=?"_K=_\
M?W_ZU>I44?7<1_.P_L?+_P#GS'[CRW_AG7POZW?_ ']_^M1_PSKX7];O_O[_
M /6KU*BE]<Q'\[#^Q\O_ .?,?N/+?^&=?"_K=_\ ?W_ZU'_#.OA?UN_^_O\
M]:O4J*?US$?SL/['R_\ Y\Q^X\N_X9W\,>MW_P!_O_K4?\,[^&/6[_[_ '_U
MJ]1HI?7,1_.P_L?+_P#GS'[CR[_AGCPQZW?_ ']_^M2_\,\^&/[UW_W]_P#K
M5ZA11]<Q'\[#^Q\O_P"?,?N/+_\ AGGPQ_>N_P#O[_\ 6H_X9Y\,?WKO_O[_
M /6KU"BCZYB/YV/^Q\!_SYC]QY?_ ,,\^&/[UW_W]_\ K4?\,\^&/[UW_P!_
M?_K5ZA11]<Q'\[#^Q\!_SYC]QYE#^SYX6C?+K=2C^ZTV/Z5V?A[PCI7A6W,6
MF645L"<EE'S$^YK:HK.>(JU%:<FT=%' 87#OFHTTGY(****YSO"F-WI],;O0
M!_/3XD_Y''5/^OV3_P!&&OWM^$O_ "2WPA_V"+3_ -$K7X)>)/\ D<=4_P"O
MV3_T8:_>WX2_\DM\(?\ 8(M/_1*UZV-^&)\5D'QO_"CK****\D^U"FEL4ZN:
M^(GCG3/AKX)USQ3K$OE:=I-J]S*<@%MHX49_B8X4>["FM=!-J*NS5UCQ!IOA
MVR:\U2_MM.M%.#/=2K&F<$XR3C/!XKSJ;]JCX1V\SQ2?$#15=&*L/M&<$<'M
M7X^_M#_M)>*?VA?&%WJ6K7DT.CB0BQT='(@MXA]T$#AFQU8\Y)KR/GUKU(8'
M3WGJ?+U<Z:E:E'3S/W;_ .&KOA#_ -%!T7_O_P#_ %J/^&KOA#_T4'1?^_\
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M/J,>X?VW5_D7XG[M_P##5WPA_P"B@Z+_ -__ /ZU'_#5WPA_Z*#HO_?_ /\
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MM7X2<^M'/K1]1CW#^VZO\B_$_=O_ (:N^$/_ $4'1?\ O_\ _6H_X:N^$/\
MT4'1?^__ /\ 6K\).?6CGUH^HQ[A_;=7^1?B?NW_ ,-7?"'_ **#HO\ W_\
M_K4?\-7?"'_HH.B_]_\ _P"M7X2<^M'/K1]1CW#^VZO\B_$_=O\ X:N^$/\
MT4'1?^__ /\ 6H_X:N^$/_10=%_[_P#_ -:OPDY]:.?6CZC'N']MU?Y%^)^[
M?_#5WPA_Z*#HO_?_ /\ K4?\-7?"'_HH.B_]_P#_ .M7X2<^M'/K1]1CW#^V
MZO\ (OQ/W;_X:N^$/_10=%_[_P#_ -:C_AJ[X0_]%!T7_O\ _P#UJ_"3GUHY
M]:/J,>X?VW5_D7XG[M_\-7?"'_HH.B_]_P#_ .M1_P -7?"'_HH.B_\ ?_\
M^M7X2<^M'/K1]1CW#^VZO\B_$_=O_AJ[X0_]%!T7_O\ _P#UJ/\ AJ[X0_\
M10=%_P"__P#]:OPDY]:.?6CZC'N']MU?Y%^)^[?_  U=\(?^B@Z+_P!__P#Z
MU'_#5WPA_P"B@Z+_ -__ /ZU?A)SZT<^M'U&/</[;J_R+\3]V_\ AJ[X0_\
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M#_T4'1?^_P#_ /6K\).?6CGUH^HQ[A_;=7^1?B?NW_PU=\(?^B@Z+_W_ /\
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MHO\ W_\ _K4?\-7?"'_HH.B_]_\ _P"M7X2<^M'/K1]1CW#^VZO\B_$_=O\
MX:N^$/\ T4'1?^__ /\ 6H_X:N^$/_10=%_[_P#_ -:OPDY]:.?6CZC'N']M
MU?Y%^)^[?_#5WPA_Z*#HO_?_ /\ K4?\-7?"'_HH.B_]_P#_ .M7X2<^M'/K
M1]1CW#^VZO\ (OQ/W;_X:N^$/_10=%_[_P#_ -:C_AJ[X0_]%!T7_O\ _P#U
MJ_"3GUHY]:/J,>X?VW5_D7XG[M_\-7?"'_HH.B_]_P#_ .M1_P -7?"'_HH.
MB_\ ?_\ ^M7X2<^M'/K1]1CW#^VZO\B_$_=O_AJ[X0_]%!T7_O\ _P#UJ/\
MAJ[X0_\ 10=%_P"__P#]:OPDY]:.?6CZC'N']MU?Y%^)^[?_  U=\(?^B@Z+
M_P!__P#ZU'_#5WPA_P"B@Z+_ -__ /ZU?A)SZT<^M'U&/</[;J_R+\3]V_\
MAJ[X0_\ 10=%_P"__P#]:C_AJ[X0_P#10=%_[_\ _P!:OPDY]:.?6CZC'N']
MMU?Y%^)^[?\ PU=\(?\ HH.B_P#?_P#^M1_PU=\(?^B@Z+_W_P#_ *U?A)SZ
MT<^M'U&/</[;J_R+\3]V_P#AJ[X0_P#10=%_[_\ _P!:C_AJ[X0_]%!T7_O_
M /\ UJ_"3GUHY]:/J,>X?VW5_D7XG[M_\-7?"'_HH.B_]_\ _P"M1_PU=\(?
M^B@Z+_W_ /\ ZU?A)SZT<^M'U&/</[;J_P B_$_=O_AJ[X0_]%!T7_O_ /\
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MK1SZT?48]P_MNK_(OQ/W;_X:N^$/_10=%_[_ /\ ]:C_ (:N^$/_ $4'1?\
MO_\ _6K\).?6CGUH^HQ[A_;=7^1?B?NW_P -7?"'_HH.B_\ ?_\ ^M1_PU=\
M(?\ HH.B_P#?_P#^M7X2<^M'/K1]1CW#^VZO\B_$_=O_ (:N^$/_ $4'1?\
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M7?"'_HH.B_\ ?_\ ^M7X2<^M'/K1]1CW#^VZO\B_$_=O_AJ[X0_]%!T7_O\
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M:/J,>X?VW5_D7XG[M_\ #5WPA_Z*#HO_ '__ /K4?\-7?"'_ **#HO\ W_\
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M $4'1?\ O_\ _6K\).?6CGUH^HQ[A_;=7^1?B?NW_P -7?"'_HH.B_\ ?_\
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MZT?48]P_MNK_ "+\3]V_^&KOA#_T4'1?^_\ _P#6H_X:N^$/_10=%_[_ /\
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M?^B@Z+_W_P#_ *U?A)SZT<^M'U&/</[;J_R+\3]V_P#AJ[X0_P#10=%_[_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !111_GI0,**,9I<>O% A**** "BB@\$B@84444""BBB@ HHH
MH **** "BBB@ HHI:!B44?I10(**** "BCGKBB@84444""BBB@ HHHZ9]J!A
M1110(**** "BE S2=<4AA1113$%%%% !1110 4444 %%%'K0,**7'XTE @HH
MHH **** "BBB@ HHHH **** "BBB@ HI<9Z4E !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7_DEOA#_ +!%I_Z)6O6QOPQ/BL@^-_X4=91117DGVH5\7_\ !5O_ )-UT/\
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MO"XL%U.9?FDC@A;&T+&O)/(SZ<U^=.EZ7=ZUJ5IIUC ]U?74RP0P(/FD=B
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M&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MECH_B'Q5I_BJ_P!+L1&TUC9BW\C<S-Y;X)!/.?;-<.W[:GQI;1VTX^/M3,+
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M7$TZN&A2:?-'[CCZ***ZCRPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=A1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ I\<SPR!XW:-QT9"01Z]*910,EGN9;J3?-*\KXQN=B3U]34
M5%% !1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ZS
MX3>+(O OQ0\)^([A/,M]*U6VO9$P#N6.57(P?85]B_\ !2;X3Z[XN\8:'\4?
M#D$GB#PE?:3! ;JQ0RB$J[LI./X6$@P>Q#9KX.KZ)^ ?[</CSX$:&?#\"6OB
M+PWEMNFZGEA'G&0KCD+_ +/2N>I&7,IPW1Z&'JT^25&KHG;7LT<Y^S/\!?%G
MQ:^+'A^RT[3;NWM+>\CGO-1E1DBMHXVWL=^/O?*0 ,G.*^L?VT_VZ/%OPZ^,
MTWAKX>:U9KI^FVB0WY:!9<7F^3S$SV*KL!'KFO*OB!_P4L\;^)/#=YH_AK0=
M*\%"Z4"2[TT$RC(^;:>,$Y//)X%?(EY>SZC>3W5W*]S<W$C2RS2,2SNQRS$G
MJ2>IK-4Y5)<U1:+H;2Q$,/3=/#2;;=V]ON/JKPW_ ,%+/C#I>O65UJ=[8ZM8
M12@W%C]E6/SD'WE##[I]Q7UE9?\ !4OX6S>'1=7-CK,.JE!G3U@W MM!P),X
MZY'/I7Y.4N?\FG+#4I=":698FE=<U_4]C_:D_:0U3]I?XA)KUY:C3M.LX/LN
MGZ>#N\F/)9BQ[LQ//T [5XW1173&*BN5'GU*DJLG.;NV%%%%49A1110 4444
M#/Z,Z***^4/U(**** .$^-'PGTCXT_#W5O"VLQ(T-W'^YF9<F"4?<<>X/Z$U
M^+GQQ_9_\6_ 'Q=/8:O8SI;*^;;4(E/E2+G@AAWXK]W"N?I7.>.OAWX?^).A
M2:/XDTNWU73Y,_N9USM.,94]C750Q#HZ=#Q,PRY8O]Y!VDON?J?DU\$?^"AG
MQ$^%%C!I>HNGBG2H0$2&_8^8@'8/U ]J]]MO^"M%B8$,_@F19<?,$N./PKI?
MB!_P2K\(:U=^?X8UZZT126S;W \Y!\V1@]>!Q7GG_#I'6/\ H?K(?]NCUV.6
M%GJSQ(TLSPZY(7M\G^9T7_#VC2_^A*F_[_UY=^TI^WYH_P ?_A'JO@]O"LMC
M<7$D,UO=M-N$,B2*V<>Z[U_X%77_ /#I#6/^A^LO_ 1Z/^'1^L?]#]9?^ CT
M1^JQ=T*?]J5(N,E)I_X3\]_I2XK]!9/^"1^M>6=GCVPW=MUH^*Q;S_@DSXXA
MD"P>,M%N$Q][R95Q77]9I?S'(LOQ3_Y=O\/\SX3HK[E_X=/^/_\ H:]%_P"^
M)*/^'3_C[_H:]%_[XDI_6*7\P_[/Q7\C/AJBON7_ (=/^/O^AKT7_OB2C_AT
M_P"/O^AKT7_OB2CZQ2_F#^S\5_(SX:HK[E_X=/\ C[_H:]%_[XDH_P"'3_C[
M_H:]%_[XDH^L4OY@_L_%?R,^&J*^Y?\ AT_X^_Z&O1?^^)*/^'3_ (^_Z&O1
M?^^)*/K%+^8/[/Q7\C/AJBON7_AT_P"/O^AKT7_OB2C_ (=/^/O^AKT7_OB2
MCZQ2_F#^S\5_(SX:HK[E_P"'3_C[_H:]%_[XDH_X=/\ C[_H:]%_[XDH^L4O
MY@_L_%?R,^&J*^Y?^'3_ (^_Z&O1?^^)*/\ AT_X^_Z&O1?^^)*/K%+^8/[/
MQ7\C/AJBON7_ (=/^/O^AKT7_OB2C_AT_P"/O^AKT7_OB2CZQ2_F#^S\5_(S
MX:HK[E_X=/\ C[_H:]%_[XDH_P"'3_C[_H:]%_[XDH^L4OY@_L_%?R,^&J*^
MY?\ AT_X^_Z&O1?^^)*/^'3_ (^_Z&O1?^^)*/K%+^8/[/Q7\C/AJBON7_AT
M_P"/O^AKT7_OB2C_ (=/^/O^AKT7_OB2CZQ2_F#^S\5_(SX:HK[E_P"'3_C[
M_H:]%_[XDH_X=/\ C[_H:]%_[XDH^L4OY@_L_%?R,^&J*^Y?^'3_ (^_Z&O1
M?^^)*/\ AT_X^_Z&O1?^^)*/K%+^8/[/Q7\C/AJBON7_ (=/^/O^AKT7_OB2
MC_AT_P"/O^AKT7_OB2CZQ2_F#^S\5_(SX:HK[E_X=/\ C[_H:]%_[XDH_P"'
M3_C[_H:]%_[XDH^L4OY@_L_%?R,^&J*^Y?\ AT_X^_Z&O1?^^)*/^'3_ (^_
MZ&O1?^^)*/K%+^8/[/Q7\C/AJBON7_AT_P"/O^AKT7_OB2C_ (=/^/O^AKT7
M_OB2CZQ2_F#^S\5_(SX:HK[E_P"'3_C[_H:]%_[XDH_X=/\ C[_H:]%_[XDH
M^L4OY@_L_%?R,^&J*^Y?^'3_ (^_Z&O1?^^)*/\ AT_X^_Z&O1?^^)*/K%+^
M8/[/Q7\C/AJBON7_ (=/^/O^AKT7_OB2C_AT_P"/O^AKT7_OB2CZQ2_F#^S\
M5_(SX:HK[E_X=/\ C[_H:]%_[XDH_P"'3_C[_H:]%_[XDH^L4OY@_L_%?R,^
M&J*^Y?\ AT_X^_Z&O1?^^)*/^'3_ (^_Z&O1?^^)*/K%+^8/[/Q7\C/AJBON
M7_AT_P"/O^AKT7_OB2C_ (=/^/O^AKT7_OB2CZQ2_F#^S\5_(SX:HK[E_P"'
M3_C[_H:]%_[XDH_X=/\ C[_H:]%_[XDH^L4OY@_L_%?R,^&J*^Y?^'3_ (^_
MZ&O1?^^)*/\ AT_X^_Z&O1?^^)*/K%+^8/[/Q7\C/AJBON7_ (=/^/O^AKT7
M_OB2C_AT_P"/O^AKT7_OB2CZQ2_F#^S\5_(SX:HK[E_X=/\ C[_H:]%_[XDH
M_P"'3_C[_H:]%_[XDH^L4OY@_L_%?R,^&J*^Y?\ AT_X^_Z&O1?^^)*/^'3_
M (^_Z&O1?^^)*/K%+^8/[/Q7\C/AJBON7_AT_P"/O^AKT7_OB2C_ (=/^/O^
MAKT7_OB2CZQ2_F#^S\5_(SX:HK[E_P"'3_C[_H:]%_[XDH_X=/\ C[_H:]%_
M[XDH^L4OY@_L_%?R,^&J*^Y?^'3_ (^_Z&O1?^^)*/\ AT_X^_Z&O1?^^)*/
MK%+^8/[/Q7\C/AJBON7_ (=/^/O^AKT7_OB2C_AT_P"/O^AKT7_OB2CZQ2_F
M#^S\5_(SX:HK[E_X=/\ C[_H:]%_[XDH_P"'3_C[_H:]%_[XDH^L4OY@_L_%
M?R,^&J*^Y?\ AT_X^_Z&O1?^^)*/^'3_ (^_Z&O1?^^)*/K%+^8/[/Q7\C/A
MJBON7_AT_P"/O^AKT7_OB2C_ (=/^/O^AKT7_OB2CZQ2_F#^S\5_(SX:HK[E
M_P"'3_C[_H:]%_[XDH_X=/\ C[_H:]%_[XDH^L4OY@_L_%?R,^&J*^Y?^'3_
M (^_Z&O1?^^)*/\ AT_X^_Z&O1?^^)*/K%+^8/[/Q7\C/AJBON7_ (=/^/O^
MAKT7_OB2C_AT_P"/O^AKT7_OB2CZQ2_F#^S\5_(SX:HK[E_X=/\ C[_H:]%_
M[XDH_P"'3_C[_H:]%_[XDH^L4OY@_L_%?R,^&J*^Y?\ AT_X^_Z&O1?^^)*/
M^'3_ (^_Z&O1?^^)*/K%+^8/[/Q7\C/AJBON7_AT_P"/O^AKT7_OB2C_ (=/
M^/O^AKT7_OB2CZQ2_F#^S\5_(SX:HK[E_P"'3_C[_H:]%_[XDH_X=/\ C[_H
M:]%_[XDH^L4OY@_L_%?R,^&J*^Y?^'3_ (^_Z&O1?^^)*/\ AT_X^_Z&O1?^
M^)*/K%+^8/[/Q7\C/AJBON7_ (=/^/O^AKT7_OB2C_AT_P"/O^AKT7_OB2CZ
MQ2_F#^S\5_(SX:HK[E_X=/\ C[_H:]%_[XDH_P"'3_C[_H:]%_[XDH^L4OY@
M_L_%?R,^&J*^Y?\ AT_X^_Z&O1?^^)*/^'3_ (^_Z&O1?^^)*/K%+^8/[/Q7
M\C/AJBON7_AT_P"/O^AKT7_OB2C_ (=/^/O^AKT7_OB2CZQ2_F#^S\5_(SX:
MHK[E_P"'3_C[_H:]%_[XDH_X=/\ C[_H:]%_[XDH^L4OY@_L_%?R,^&J*^Y?
M^'3_ (^_Z&O1?^^)*/\ AT_X^_Z&O1?^^)*/K%+^8/[/Q7\C/AJBON7_ (=/
M^/O^AKT7_OB2C_AT_P"/O^AKT7_OB2CZQ2_F#^S\5_(SX:HK[E_X=/\ C[_H
M:]%_[XDH_P"'3_C[_H:]%_[XDH^L4OY@_L_%?R,^&J*^Y?\ AT_X^_Z&O1?^
M^)*/^'3_ (^_Z&O1?^^)*/K%+^8/[/Q7\C/AJBON7_AT_P"/O^AKT7_OB2C_
M (=/^/O^AKT7_OB2CZQ2_F#^S\5_(SX:HK[E_P"'3_C[_H:]%_[XDH_X=/\
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M (=/^/O^AKT7_OB2C_AT_P"/O^AKT7_OB2CZQ2_F#^S\5_(SX:HK[E_X=/\
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MDH_X=/\ C[_H:]%_[XDH^L4OY@_L_%?R,^&J*^Y?^'3_ (^_Z&O1?^^)*/\
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M[E_X=/\ C[_H:]%_[XDH_P"'3_C[_H:]%_[XDH^L4OY@_L_%?R,^&J*^Y?\
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M (=/^/O^AKT7_OB2CZQ2_F#^S\5_(SX:HK[E_P"'3_C[_H:]%_[XDH_X=/\
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M"^?W?\$_6DL!2XW5\8_ GXO_ !S^)&BPZ[XDO]*T'3+D![:&/3U:>5>S$$\
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M>9?\+&U3^[#_ -\4?\+&U3^[#_WQ1[: >SD>F[:-M>9?\+&U3^[#_P!\4?\
M"QM4_NP_]\4>V@'LY'INVC;7F7_"QM4_NP_]\4?\+&U3^[#_ -\4>V@'LY'I
MNVC;7F7_  L;5/[L/_?%'_"QM4_NP_\ ?%'MH![.1Z;MHVUYE_PL;5/[L/\
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M>9?\+&U3^[#_ -\4?\+&U3^[#_WQ1[: >SD>F[:-M>9?\+&U3^[#_P!\4?\
M"QM4_NP_]\4>V@'LY'INVC;7F7_"QM4_NP_]\4?\+&U3^[#_ -\4>V@'LY'I
MNVC;7F7_  L;5/[L/_?%'_"QM4_NP_\ ?%'MH![.1Z;MHVUYE_PL;5/[L/\
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M>9?\+&U3^[#_ -\4?\+&U3^[#_WQ1[: >SD>F[:-M>9?\+&U3^[#_P!\4?\
M"QM4_NP_]\4>V@'LY'INVC;7F7_"QM4_NP_]\4?\+&U3^[#_ -\4>V@'LY'I
MNVC;7F7_  L;5/[L/_?%'_"QM4_NP_\ ?%'MH![.1Z;MHVUYE_PL;5/[L/\
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M>9?\+&U3^[#_ -\4?\+&U3^[#_WQ1[: >SD>F[:-M>9?\+&U3^[#_P!\4?\
M"QM4_NP_]\4>V@'LY'INVC;7F7_"QM4_NP_]\4?\+&U3^[#_ -\4>V@'LY'I
MNVC;7F7_  L;5/[L/_?%'_"QM4_NP_\ ?%'MH![.1Z;MHVUYE_PL;5/[L/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4^:"2WF:*12DBG:RMU!]*96)H%%%% !1DCH<'J/K110![Q1117L'GA7YZ?\
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M[(ZTU*-V='\2=+CCDM[^-0'E/EO[G&5/\ZXG^5=U\2K^-EL[-6!D5B[J.W
M_3-<+2J_&[!3^%!11161H%%%% 'O%%%%>P>>%?GG_P %;_\ 4?"O_>U3_P!M
M*_0ROSS_ ."M_P#J/A7_ +VJ?^VE=>$_C1/'S?\ W*I\OS1<_P""2_\ R+GQ
M%_Z^K/\ ] EK[_7[HKX _P""2_\ R+GQ%_Z^K/\ ] EK[_7[HJ<3_%8\I_W.
MG\_S8M%%%<QZX5R/Q*_Y </_ %\+_P"@M775R/Q*_P"0'#_U\+_Z"U95?@9<
M/B1YK1117F':%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK*Z%]9V]PH95EC5PK_> (!P?>IZ3V[=!2U\^?;!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 2VMI+?7"0PH9)7. H]:])T7
M2K7P78R7-W=;7D4;\GY?H!W-9WP[TQ(;:XU*4<_<5CV4<FN6\1ZY+KVH/,3B
M%3MB7T7/7ZUT1M3CS=3)^^^7H/\ %.L0:UJQN;>+R4V!,D<M@GD_G7H/@K5(
M]0T&! V9;<")U],=/TQ7F.FZ;/JUVMO;KN=NI]!ZFO5?#WANWT&'$>6E<8D<
MGK5T>9R<B:EDK&S2445VG,<3\2M4C6UAL%(:5F$C =0HS61X+\36NB^9#<Q;
M1,^?/7^'V(]*Z;Q3X-BUC?<P'R[S'KP^.WM7F,D302LC@HZG:P]/8UPU'*$^
M8ZH6E&QW/BOPJNI+)JNGR>>6&^10<[L#&1^ Z5PA&TX/KBNK\ ZX]IJ"6,C9
MM[C[H/\ "W8CZ]/Q%4_'&EC3==D*C$4X\Q5'0>OZYJ)I27.AQNGRLP****P-
M0HHHH ]XHHHKV#SPK\\_^"M_^H^%?^]JG_MI7Z&5^>?_  5O_P!1\*_][5/_
M &TKKPG\:)X^;_[E4^7YHN?\$E_^1<^(O_7U9_\ H$M??Z_=%? '_!)?_D7/
MB+_U]6?_ *!+7W^OW14XG^*QY3_N=/Y_FQ:***YCUPKD?B5_R X?^OA?_06K
MKJY'XE?\@.'_ *^%_P#06K*K\#+A\2/-:***\P[0HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&L_\_0_[X7_"L/R7_N-^5'DO_<;\JKFDMB;(W/\ A.-9_P"?H?\ ?"_X4?\
M"<:S_P _0_[X7_"L/R7_ +C?E1Y+_P!QORI\T^X<L3<_X3C6?^?K_P <7_"L
MO4=4NM6F$MU,97 VC/&!5?R7_N-^5'DO_<;\J3<GN.R0WU-%.\E_[C?E1Y+_
M -QORJ;,8VBG>2_]QORH\E_[C?E19@-HI_DR'@(WY5T&@>"[S5)4>9#;VP.2
MS#EA[4XQ<G9";2U9ZK1117K' %?GG_P5O_U'PK_WM4_]M*_0ROSS_P""M_\
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M#_GR_P /\P_UBRK_ *"(_C_D?1GEQ_W%_*CRX_[B_E7SG_PW-X+_ .@7J_\
MW[C_ /BJ/^&YO!?_ $"]7_[]Q_\ Q5']B9A_SY?X?YA_K%E7_01'\?\ (^C/
M+C_N+^5'EQ_W%_*OG/\ X;F\%_\ 0+U?_OW'_P#%4?\ #<W@O_H%ZO\ ]^X_
M_BJ/[$S#_GR_P_S#_6+*O^@B/X_Y'T9Y<?\ <7\J/+C_ +B_E7SG_P -S>"_
M^@7J_P#W[C_^*H_X;F\%_P#0+U?_ +]Q_P#Q5']B9A_SY?X?YA_K%E7_ $$1
M_'_(^C/+C_N+^5'EQ_W%_*OG/_AN;P7_ - O5_\ OW'_ /%4?\-S>"_^@7J_
M_?N/_P"*H_L3,/\ GR_P_P P_P!8LJ_Z"(_C_D?1GEQ_W%_*CRX_[B_E7SG_
M ,-S>"_^@7J__?N/_P"*H_X;F\%_] O5_P#OW'_\51_8F8?\^7^'^8?ZQ95_
MT$1_'_(^C/+C_N+^5'EQ_P!Q?RKYS_X;F\%_] O5_P#OW'_\51_PW-X+_P"@
M7J__ '[C_P#BJ/[$S#_GR_P_S#_6+*O^@B/X_P"1]&>7'_<7\J/+C_N+^5?.
M?_#<W@O_ *!>K_\ ?N/_ .*H_P"&YO!?_0+U?_OW'_\ %4?V)F'_ #Y?X?YA
M_K%E7_01'\?\CZ,\N/\ N+^5'EQ_W%_*OG/_ (;F\%_] O5_^_<?_P 51_PW
M-X+_ .@7J_\ W[C_ /BJ/[$S#_GR_P /\P_UBRK_ *"(_C_D?1GEQ_W%_*CR
MX_[B_E7SG_PW-X+_ .@7J_\ W[C_ /BJ/^&YO!?_ $"]7_[]Q_\ Q5']B9A_
MSY?X?YA_K%E7_01'\?\ (^C/+C_N+^5'EQ_W%_*OG/\ X;F\%_\ 0+U?_OW'
M_P#%4?\ #<W@O_H%ZO\ ]^X__BJ/[$S#_GR_P_S#_6+*O^@B/X_Y'T9Y<?\
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MCZ,\N/\ N+^5'EQ_W%_*OG/_ (;F\%_] O5_^_<?_P 51_PW-X+_ .@7J_\
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M#_GR_P /\P_UBRK_ *"(_C_D?1GEQ_W%_*CRX_[B_E7SG_PW-X+_ .@7J_\
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M_P#%4?\ #<W@O_H%ZO\ ]^X__BJ/[$S#_GR_P_S#_6+*O^@B/X_Y'T9Y<?\
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MCZ,\N/\ N+^5'EQ_W%_*OG/_ (;F\%_] O5_^_<?_P 51_PW-X+_ .@7J_\
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M#_GR_P /\P_UBRK_ *"(_C_D?1GEQ_W%_*CRX_[B_E7SG_PW-X+_ .@7J_\
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M_P#%4?\ #<W@O_H%ZO\ ]^X__BJ/[$S#_GR_P_S#_6+*O^@B/X_Y'T9Y<?\
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MCZ,\N/\ N+^5'EQ_W%_*OG/_ (;F\%_] O5_^_<?_P 51_PW-X+_ .@7J_\
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M#_GR_P /\P_UBRK_ *"(_C_D?1GEQ_W%_*CRX_[B_E7SG_PW-X+_ .@7J_\
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M_P#%4?\ #<W@O_H%ZO\ ]^X__BJ/[$S#_GR_P_S#_6+*O^@B/X_Y'T9Y<?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.?$GMWS@ ]:7IUXXS7TW\.?V=]/\<?&[QM%?*\7AK1-1D06\;%?-+2$I'GL
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MI9(Q(2!(I"M&W!ZX/YUZWXT\-? _X/\ BB-==TN$7NI;6BM2LDJ0( %W;<\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M((Z5SGA#QEXZU#PO<ZE;?#K2- BRV;6YO#;2.H&2Y'E 8Y[U\D?#3]H?Q?\
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M>K[R?O12:BG=KS;6A]I^.-<U7X9:]IF@> OAQ#<I<(O_ !,8X=L,1SC#%5[
M<ECT]:POVY%=OA3I!'_06C+;>W[F7\:\9O/VT_'MQI9M8XM-MYRNTW20MO\
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M5#):V'>$46FJ;DY?.VQMB>(:&+AC>9-.JHJ/I&^Y]-?LKL?^&<]2]!+=A?\
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MANUY]?Z]3Z$_: N'M?V==0_X21H?[3:T@679]TW6Y?N^N&_054\>:'<?%_\
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M7O>ZLHWW_-GU]\7)"G[&5D0V,Z1I()'8;[>L#]@XM_PC_BP<X%Q!C/\ N/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %'?\111W_$4 ?KM1117\
MZ']8!1110 4444 %%%% !7SK^W1_R2'3/^PU#_Z(GKZ*KYU_;H_Y)#IG_8:A
M_P#1$]>UDO\ R,*/J?/\0?\ (KQ'^$^$Z***_<#^;PHHHI@%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!?T77M1\.7PO=*O
M9M/NPI430.5;!'3(I=<\0:EXDOVO=4O9]0NV 4S7#EF(' &3[5GT5')'FY[:
M]R_:3Y>2[MVZ!1115D!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^_X91^)G_0O_ /DQ'_\ %4?\,H_$S_H7_P#R8C_^*K@?^%R>.?\ H;-7_P#
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M/YX?=+_,/KF2?\^ZO_@4?\COO^&4?B9_T+__ ),1_P#Q5'_#*/Q,_P"A?_\
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M_/#[I?YA]<R3_GW5_P# H_Y'??\ #*/Q,_Z%_P#\F(__ (JC_AE'XF?]"_\
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M\COO^&4?B9_T+_\ Y,1__%4?\,H_$S_H7_\ R8C_ /BJX'_A<GCG_H;-7_\
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M .*H_P"&4?B9_P!"_P#^3$?_ ,57 _\ "Y/'/_0V:O\ ^!C_ .-'_"Y/'/\
MT-FK_P#@8_\ C1['-/YX?=+_ ##ZYDG_ #[J_P#@4?\ ([[_ (91^)G_ $+_
M /Y,1_\ Q5'_  RC\3/^A?\ _)B/_P"*K@?^%R>.?^ALU?\ \#'_ ,:/^%R>
M.?\ H;-7_P# Q_\ &CV.:?SP^Z7^8?7,D_Y]U?\ P*/^1WW_  RC\3/^A?\
M_)B/_P"*H_X91^)G_0O_ /DQ'_\ %5P/_"Y/'/\ T-FK_P#@8_\ C1_PN3QS
M_P!#9J__ (&/_C1['-/YX?=+_,/KF2?\^ZO_ (%'_([[_AE'XF?]"_\ ^3$?
M_P 51_PRC\3/^A?_ /)B/_XJN!_X7)XY_P"ALU?_ ,#'_P :/^%R>.?^ALU?
M_P #'_QH]CFG\\/NE_F'US)/^?=7_P "C_D=]_PRC\3/^A?_ /)B/_XJC_AE
M'XF?]"__ .3$?_Q5<#_PN3QS_P!#9J__ (&/_C1_PN3QS_T-FK_^!C_XT>QS
M3^>'W2_S#ZYDG_/NK_X%'_([[_AE'XF?]"__ .3$?_Q5'_#*/Q,_Z%__ ,F(
M_P#XJN!_X7)XY_Z&S5__  ,?_&C_ (7)XY_Z&S5__ Q_\:/8YI_/#[I?YA]<
MR3_GW5_\"C_D=]_PRC\3/^A?_P#)B/\ ^*H_X91^)G_0O_\ DQ'_ /%5P/\
MPN3QS_T-FK_^!C_XT?\ "Y/'/_0V:O\ ^!C_ .-'L<T_GA]TO\P^N9)_S[J_
M^!1_R.^_X91^)G_0O_\ DQ'_ /%4?\,H_$S_ *%__P F(_\ XJN!_P"%R>.?
M^ALU?_P,?_&C_A<GCG_H;-7_ / Q_P#&CV.:?SP^Z7^8?7,D_P"?=7_P*/\
MD=]_PRC\3/\ H7__ "8C_P#BJ/\ AE'XF?\ 0O\ _DQ'_P#%5P/_  N3QS_T
M-FK_ /@8_P#C1_PN3QS_ -#9J_\ X&/_ (T>QS3^>'W2_P P^N9)_P ^ZO\
MX%'_ ".^_P"&4?B9_P!"_P#^3$?_ ,51_P ,H_$S_H7_ /R8C_\ BJX'_A<G
MCG_H;-7_ / Q_P#&C_A<GCG_ *&S5_\ P,?_ !H]CFG\\/NE_F'US)/^?=7_
M ,"C_D=]_P ,H_$S_H7_ /R8C_\ BJ/^&4?B9_T+_P#Y,1__ !5<#_PN3QS_
M -#9J_\ X&/_ (T?\+D\<_\ 0V:O_P"!C_XT>QS3^>'W2_S#ZYDG_/NK_P"!
M1_R.^_X91^)G_0O_ /DQ'_\ %4?\,H_$S_H7_P#R8C_^*K@?^%R>.?\ H;-7
M_P# Q_\ &C_A<GCG_H;-7_\  Q_\:/8YI_/#[I?YA]<R3_GW5_\  H_Y'??\
M,H_$S_H7_P#R8C_^*H_X91^)G_0O_P#DQ'_\57 _\+D\<_\ 0V:O_P"!C_XT
M?\+D\<_]#9J__@8_^-'L<T_GA]TO\P^N9)_S[J_^!1_R.^_X91^)G_0O_P#D
MQ'_\51_PRC\3/^A?_P#)B/\ ^*K@?^%R>.?^ALU?_P #'_QH_P"%R>.?^ALU
M?_P,?_&CV.:?SP^Z7^8?7,D_Y]U?_ H_Y'??\,H_$S_H7_\ R8C_ /BJ/^&4
M?B9_T+__ ),1_P#Q5<#_ ,+D\<_]#9J__@8_^-'_  N3QS_T-FK_ /@8_P#C
M1['-/YX?=+_,/KF2?\^ZO_@4?\COO^&4?B9_T+__ ),1_P#Q5'_#*/Q,_P"A
M?_\ )B/_ .*K@?\ A<GCG_H;-7_\#'_QH_X7)XY_Z&S5_P#P,?\ QH]CFG\\
M/NE_F'US)/\ GW5_\"C_ )'??\,H_$S_ *%__P F(_\ XJC_ (91^)G_ $+_
M /Y,1_\ Q5<#_P +D\<_]#9J_P#X&/\ XT?\+D\<_P#0V:O_ .!C_P"-'L<T
M_GA]TO\ ,/KF2?\ /NK_ .!1_P COO\ AE'XF?\ 0O\ _DQ'_P#%4?\ #*/Q
M,_Z%_P#\F(__ (JN!_X7)XY_Z&S5_P#P,?\ QH_X7)XY_P"ALU?_ ,#'_P :
M/8YI_/#[I?YA]<R3_GW5_P# H_Y'??\ #*/Q,_Z%_P#\F(__ (JC_AE'XF?]
M"_\ ^3$?_P 57 _\+D\<_P#0V:O_ .!C_P"-'_"Y/'/_ $-FK_\ @8_^-'L<
MT_GA]TO\P^N9)_S[J_\ @4?\COO^&4?B9_T+_P#Y,1__ !5'_#*/Q,_Z%_\
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MZ&S6/_ Q_P#&CV.:?ST_N?\ F'US)?\ GW5_\"C_ )'>_P##*/Q,_P"A?_\
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MD_Z NB_^ Y_QH_X:T\2?] 71?_ <_P"-'UW'?] Z_P# _P#[4/[+R[_H*?\
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MD_Z NB_^ Y_QH_X:T\2?] 71?_ <_P"-'UW'?] Z_P# _P#[4/[+R[_H*?\
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MD_Z NB_^ Y_QH_X:T\2?] 71?_ <_P"-'UW'?] Z_P# _P#[4/[+R[_H*?\
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MD_Z NB_^ Y_QH_X:T\2?] 71?_ <_P"-'UW'?] Z_P# _P#[4/[+R[_H*?\
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MG_X!_P#;'S,VGW2C)MIA]4-5_P!:^HU_:PUJ5@+OP[HMS%U\OR2/\:LR^"_
MO[1VFW+>'[-?"?C:WA,BV*,!;3G<6.  ,CGJ,8R.*7]IU:/O8JCRQ[I\UO7K
M;SL)Y+2K+EP5?GG_ "M<K?IJU?R/E2DJSJ6GW&DZC<V-W$T%U;RM%+$W!1E.
M"#[U6KZ!--71\HTXNSW"GPPR7$R0Q(TDKD*J*,LQ)P !]:;U('<U]0_LW>#M
M(\%> [CXDZ[:1W=W+(8=(AE4\.,C=@CJ2/O=@IQ7!CL7'!4?:-7;T2[MGIY;
M@)YCB%1B[+=OLEU_R\S@?"?[)_C[Q/:QW4MC!H]M(,K)J$HC;VRO+?I71?\
M#%'B_P#Z#&C?]_V_^)KH/$WQ UWQ9=/+?ZA*$;(^SQ,5C4>@7/\ /-87VR?_
M )[2?]]FOG?K>8SU<XQ\E&_XMGW,<HRJFN7DE+S<K?@D,_X8I\8?]!C1O^_[
M?X4?\,4^,/\ H,:-_P!_V_PI_P!LG_Y[2?\ ?1H^V3_\]I/^^C1]8S#_ )^K
M_P !_P""5_9>5?\ /J7_ (&_\AG_  Q3XP_Z#&C?]_V_PH_X8I\8?]!C1O\
MO^W^%/\ MD__ #VD_P"^C1]LG_Y[2?\ ?1H^L9A_S]7_ (#_ ,$/[+RK_GU+
M_P #?^0S_ABGQA_T&-&_[_M_A1_PQ3XP_P"@QHW_ '_;_"G_ &R?_GM)_P!]
M&C[9/_SVD_[Z-'UC,/\ GZO_  '_ ((?V7E7_/J7_@;_ ,AG_#%/C#_H,:-_
MW_;_  H_X8I\8?\ 08T;_O\ M_A3_MD__/:3_OHT?;)_^>TG_?1H^L9A_P _
M5_X#_P $/[+RK_GU+_P-_P"0S_ABGQA_T&-&_P"_[?X4?\,4^,/^@QHW_?\
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MZO\ P'_@A_9>5?\ /J7_ (&_\AG_  Q3XP_Z#&C?]_V_PH_X8I\8?]!C1O\
MO^W^%/\ MD__ #VD_P"^C1]LG_Y[2?\ ?1H^L9A_S]7_ (#_ ,$/[+RK_GU+
M_P #?^0S_ABGQA_T&-&_[_M_A1_PQ3XP_P"@QHW_ '_;_"G_ &R?_GM)_P!]
M&C[9/_SVD_[Z-'UC,/\ GZO_  '_ ((?V7E7_/J7_@;_ ,AG_#%/C#_H,:-_
MW_;_  H_X8I\8?\ 08T;_O\ M_A3_MD__/:3_OHT?;)_^>TG_?1H^L9A_P _
M5_X#_P $/[+RK_GU+_P-_P"0S_ABGQA_T&-&_P"_[?X4?\,4^,/^@QHW_?\
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MZO\ P'_@A_9>5?\ /J7_ (&_\AG_  Q3XP_Z#&C?]_V_PH_X8I\8?]!C1O\
MO^W^%/\ MD__ #VD_P"^C1]LG_Y[2?\ ?1H^L9A_S]7_ (#_ ,$/[+RK_GU+
M_P #?^0S_ABGQA_T&-&_[_M_A1_PQ3XP_P"@QHW_ '_;_"G_ &R?_GM)_P!]
M&C[9/_SVD_[Z-'UC,/\ GZO_  '_ ((?V7E7_/J7_@;_ ,AG_#%/C#_H,:-_
MW_;_  H_X8I\8?\ 08T;_O\ M_A3_MD__/:3_OHT?;)_^>TG_?1H^L9A_P _
M5_X#_P $/[+RK_GU+_P-_P"0S_ABGQA_T&-&_P"_[?X4?\,4^,/^@QHW_?\
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MZO\ P'_@A_9>5?\ /J7_ (&_\AG_  Q3XP_Z#&C?]_V_PH_X8I\8?]!C1O\
MO^W^%/\ MD__ #VD_P"^C1]LG_Y[2?\ ?1H^L9A_S]7_ (#_ ,$/[+RK_GU+
M_P #?^0S_ABGQA_T&-&_[_M_A1_PQ3XP_P"@QHW_ '_;_"G_ &R?_GM)_P!]
M&C[9/_SVD_[Z-'UC,/\ GZO_  '_ ((?V7E7_/J7_@;_ ,AG_#%/C#_H,:-_
MW_;_  H_X8I\8?\ 08T;_O\ M_A3_MD__/:3_OHT?;)_^>TG_?1H^L9A_P _
M5_X#_P $/[+RK_GU+_P-_P"0S_ABGQA_T&-&_P"_[?X4?\,4^,/^@QHW_?\
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MZO\ P'_@A_9>5?\ /J7_ (&_\AG_  Q3XP_Z#&C?]_V_PH_X8I\8?]!C1O\
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MW_IFG^3)C.QL9QD#- 68RB@C'!X/3I10 444OEL1G!Q]#0 E%'ZT4 %%&/\
M"E52W0$_3F@!**&!4X/6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M14#'=)D]AT%>/^)O!^K^#M673-7LWL[YD5Q"Y!)!SCI]#7U)XL_Y.]\,>O\
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M/ 0C.FI:NVMFOO7Y,Y"BEI*^D/E0HHHH **** "BBB@ HHHH **** "BBB@
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M=685)4L9AYQ@Y/W]%Z+N<>6THUL%B83FHJ\-7>V[['A7[*/_ "6"S_Z]9_\
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M%7OCGX7U.Z\3:;K45MNTZ#RTDEW@;3OZ$9R:V?C/J$6FW'@ZZE.(HKS+'T
MR:TPTW36'4)7^+3Y;$8B"FZ[G&WPZ_/<S5^%_@;X?Z+;S^*YFGN9L EF<#=W
M"JG/&>]87Q(^$6DV_AO_ (2/PQ.7L@ [Q;MX*_W@3R.>U=7\;_ ^I^.(=+O]
M%47@C4@QJX&5;D,#D9J6^M?^%>_!">PU61/M3P-'Y>0?F8_='TI4L14M3JJJ
MW.4K./EZ=!U,/3O4I.DE"*NI?\$P_"'PG\+:K\.[+6-1\VTE:/S9[D2D8 )S
MQ5R'X8^ _&WA>[N/#AD66!647"NY.X#.&5N.?8"I(RR_LXOCC_0V_P#0JK_L
MX_\ (J>(!V\[\/N45)UN2K651^[.R5]!4X4>>G1=->]&[=M3P":,PS21M]Y&
M*G'L<5W7P3_M"/QY936-HUTJ9$VWHB-P237%:A_Q_P!SQ@^8W\Z]]_9ODMSX
M;U9("@U#S>=W7&WY?PS7OYA5]GA92M>^GWGAX"E[3$QC>UM?N/1-4T72M#U:
M]\6RI<&YCMMDFQL@J!V7UKY4\;:E<Z[XBO=6FM9+9+R3S461<<'IU]J^B_AK
M'XSM=2U2V\2P^;8N[/%/)(K')/W5'=<5F_M!:3J%YX1@^PPQFQM7WW&" R+C
M P/2OG<!6^JXE4I-2;LKWT2['OXZC]8P[JQ3BE=VMK?N?-<$?G7$<?3>P7\S
MBOJ+QUJTGPZ^%,7]E 6\WEQP1R+CY&8<M]>IKY;C8HRNOW@<C]#7U/):VGQ@
M^%L5O:W"QSF),%NL<B>OU(_6O5S6RG1E4^!/4\S++N-6,/C:T/!?"?Q$US0_
M$5M=C4KFX5I5\V&:8LL@)YR/I_2O7_C]H%KJ#>&[]HP6>[6V=NYC;G],?K7'
M>$_@!K[>((3JT<5K80R;W=958R '.% SU]\5T?QV\66DFN:#HT<H9K>X6YGV
MXPO8#\B:QK3I5<;3>&U:3NUVL;4H5*>$J+$*R;5K]SEOCAX!T;P0NDG2H&@\
M[?OW.6SC%7_$'PWT'2?A'9Z]'!(E^RP-)+YA/WG4-Q]":['X\>"M5\96NCOI
M-O\ :S$[!@I' ;&#SVH^*>ER:/\  ];&;:9;=;>-\'(!#KD"N>CBI2IX>*G[
MSEKKK:_4WJX6,9XB7)[JCIII>W0Z*WC\+#X7I&TK'PQY)!=B^=NXYSW^]FO+
M?A_\)]%\47&JZW=2R#P]#,ZVR*Q4N@YRQ/( %=?H.DW/B#]G^"PL4\^[EMG5
M(PP&3YC=R:7X8V+ZA\,]8\-L4@U*%IK::/<"59AP3@_K7+&<L/3J\DW?FL_2
M^_KYG3*$:]2ESP5N6Z]>WIY&6OP_^'?CC1KT^'[C[+/;?*9EE?"MVR)">/<5
MR'PK^$<?B^ZOKG59BFG6<IB/E,,RL,YPQS@?XU:\,_L]ZEJ$-[)KDYT=(O\
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MWML-&5V_4^?Q]+V.(E&R7H%%%%>D< 4444 %%%% !1110 4J_>'US]/>DHH
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M[^9\WEF85<KQ4<712<HWM?;56Z-=^Y]G:AXH_9=U2^N+R\B66[N)&EED-MJ
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M=+'VK-\=_A)\&?!NI67P\0WFI7@9UBCBEVER,!G>0=!QP/2L_P"%7[0'P_\
M$'P?;P;XWO'TJ3RFAF\M'"S*6W;E= <'IU_6OCGC_(I=W'7FN;_5[#.#C*<G
M)M2YK^]=;:V.M<6XV-52C3@H*+CR*/NV>^E[Z^I]PZ#\=O@OX;\"ZOX.T74+
MK2[!X)K>.::SF?SS(A!?(4GJ2/F Z>E</^S9\</!7P[^&?B#1M;U9[6]N+F9
MX$6UEDWHT853E%('([XKY5_STS_.@X/;W((S5?V!AO9SIN<GSM-NZO=?+KU)
M_P!:\9[:E6C3@G33BDDTK/I:_3H37TBS7MPZ'*-(S ^Q-?1W[,O[1>B?#_P_
M=^$_%D4BZ)<.SQW*1F15WC#JRCD@^U?-= QZ8]2.M>OC,%1QU!T*VWEN?/Y=
MF5?+,2L5AVN;7?9I[IGW!X=^+WP'^#D.HZEX4>6:_NU^:"VCG=I,'(0&3"J,
M^I%</^T9\;/AW\6?AU8W%I9S2^)]^R%)5*26@SEMQZ,/3%?+&[K_ $.*..]>
M11R##TJ\<3[2;FG>[EKZ>A]!7XJQ=?#3P:I4XTY*UE'1>:U>O_#[CX"%GC)/
M&037W;JWQZ^"'C3P=IFB^)]1-_!!#%NMWLKL!9%0#JJ#H<]Z^#NO7_&CO7=C
M\LI9@X.<I1<+V<7;?Y,\O*\ZK92JD:4(R4[)J2;6GS1]Q>'_ (X? 'X6Q75W
MX3MV6]D3!6WL[CS7']T/*.!^->4?"OX_Z6?V@M3\;^*K@Z7975O+&H6)Y?+7
M VKA 3T]J^=.*7=[G]?\:XZ>0X:G&HG*4I35FV[NWJ>A5XHQE2=%QA"$:4N9
M1C&T;^:O^J/HN3]HO3_"?[1>K^+M(=]3\/ZAMBF4*T;O'@<JK '(/8UZQ>?$
M[]GS6O$D/C:[E7^W8\2;7MY]Q<="T8&TL/6OAP'%!;/7GZFBMD6'J\KC*46H
MJ-T[-I='H&'XHQ=%3C.$)QE)SM)749/6ZUT/HKQQ^U-'XF^,_ASQ##92+X?T
M.;,5N^!)*IX9SSP?05ZOXW^+OP*\8:KI/BS5]0NM0U+3E'V>RCBESG.0&3&W
M(/N/QKX>W?E1N]S3J9#A9>S]FY0Y%96=M'WTZZA2XHQL/:^UC&I[1J3YE>S6
MS6JVLK>A]2?M+?&CP1\2D\'W>@ZO)<76GW@EGMY+66,I&2">64 XP>A-0?M5
M?&KPA\3?!/AO3O#VIO?7=G<"6>-K66+8HC*]74 \GM7S%N]?\*3_ #T_2M*&
M2X>@Z/+*7[J]MNO?3_(QQ/$>+Q2Q"G&*]LHJ5D_L[6U^_<^I(?C=X-C_ &4H
MO!9U0_\ "2+9R1?9#;2[=QE9@"^W;T([UV.F_'7X5?$SX0Z=X;\97]QI3VUO
M!%<6RI("3$  595((.T<'GGI7Q5GWI=W^>M8U,APT[M2DGS.=T]4WVTV.BEQ
M3BZ=DX0E'D5-IIV<5M?7?\/(^T/&'QZ^$^K?!+6?!VB:A/I:+:26UE:S6<OS
MD<JVX*0 S>I!Z\5R?AGXW>#M._99O_!MQJCIXBDL[F%+7[-*069F(^<+M_6O
MEL-1GM[8IPR'#0A[/FDUSJ>K6Z^7WA4XIQE2K[5P@GR.GHG;E?SW73IY'TW^
MPMKFIV/C[4]+CMY9=,O;0R2N!\D;H<JQ/XE?^!59_;J\??VIXHTKPO!+N@TZ
M/[3<!3_RU?( /N%!_P"^A6?X+_;0N?!/@>PT*U\)6TMU:0"!;UKLJ'QG#,@3
MGKTW5\_^*O$]_P",O$%_K.J3&>^O9#+*Y]3V'H , ?2N/#Y?6K9K+'UZ:@DK
M+5.[VOY:'?BLWPV'R*&5X6LYRD[RT:45ORZ[ZGU)^SQ\<? .G_"&Y\%^,[PV
M0)FCDC>*1DGA<#.&0'!ZCM4?P1^,'PQ^%OCKQR;;49+#PW>-!_9O^C3RDA4^
M8'Y2P^8GK7R7N]?K1GN.#Z\UVU,BP]1UKSE:KNKJU[IW6F^AYU+BC%T5A[0@
MY4=(MIWM9JS=]K/[SZ*^"'[1FG?#/XA^*3J EN/#.M7TMQYT*9:(F1BC[>I!
M#'(ZUZWIGQ?^ WPWU#4O$_AZ3S-9OE9FBMH)][[CDJJN J9/-?#.>_4^_./I
M1QWZ>E+$Y#AL14=1RE&Z2DD[*5NX8/BC&8.DJ2A"7*VXN4;N+>_+KYGV!\$?
MVK- CUCQ2OB[=I,>L7AN89HXV=%4J$\MM@R"%5>?7/2NB^'_ ,9/@7\)=4O[
M;0K^[3[<#+<Z@\$TP)!XC!V[NYZ#'')KX>W#L/SHW>G'^?TK.MP[A*TIVE*,
M96ND]--NC-\/Q=CJ$(*4(2E!NTI1N]=^JW/I[X+?%_P1X!^.7CO6[W6&70]2
M60VETMK*QD9I5D(*!=P[]1VKPWXM:]9>*/B7XDU;39OM%A>7LDT$I0KN0G@X
M(!'XUR>[].G-(>IKU:&7TL/7>)BVY.*CTM9?+?\ JQX>*S:MB\+'"2BE%2<M
M+WO+?KMKI^9[=^S)\?8?@UK%]:ZK#+<:#J6WSO(4%X77.UP#U')!'^%>Z/XT
M_9NG\1?\)4YM!JV\W#.;>Y&7!SN,6-N<^W)Y]Z^'<TO'X>@%<6*R6AB:TJZG
M*$I*SY7:_KH>C@>),3@L/'"RIPJ0B[QYXWY7Y'OO[0?[2Q^(OBK1)/#T<EKI
MV@W/VJUN)0 \TP(Q(5[ 8X'N>E>MS?'?X/\ QP\,V$/CZ)M.U&U&\Q2I+\C$
M88QR1_PG'0_E7Q,>>:/2E4R/"RI4Z=-N#I[-/77?7S"EQ/CH5ZU:JHU%5MS1
MDKQTVTNMO^'/J3X\_M)>&;_P#'X#^'L.S26189;GRC'&L0.?+16Y.2.21TSZ
MT2?&_P &O^R:G@H:HX\1_8_*^R-;2\-YY8#?MV]/?O7RYN_&@-U_.JCDF%A2
MA23?NRY[WU<O,4^)<;4K5:TE'WX>SM9V47TBKZ?.Y]>?!3X^^ ;WX.#P'XZE
M>P2&.2V+-'(R3Q,Q8$,@)5AG'X UUG@7]H?X+_#_ $&_T#0[JXTW3XB6CDDM
M9Y#<NP.YL[2>,*,MCMBOA;CBES^/^?K7+6X=PM:4VYR2D^9I/2_?8[</Q=C<
M-"G%4X.4(\JDXOFY>U[_ )'T5^R#\9O#OPLO_$-EXBN&LK74Q"8[H1LZJT?F
M#:VT$C(?KCM78Z!\4?A#X"^.G]OZ#J#VNCW&G3I>S+!<R@W+2*XP"">1GH,5
M\B9'/'%&[W-=-?):&(K5*TI27.K-)Z;6[,X\+Q'B<+AZ.'C"#5)WBVG=:WM>
M^S_+J?147[1=AX/_ &D_$'B_2O,U3PWJI2&954QO)'Y<8+*& .Y63//7D=\U
MZO=?$S]GO5/%,/CJYE4Z]&5EYMY]_F*/E9HP-I88'/3@?6OAT'VQ2Y^I]\UG
M6R+#U7%QG*+45&Z=FTM+,UP_%&+H*<9PA-2DYI25U&3=[QUT_$]X^*G[0T'Q
M-^+WA?5C')8^&="O(I(5D7,C+YJM)*P&>2$48'915_\ ; ^+7A7XK7WAB3PS
MJ+:A'8Q7"SEK>6':7:/;]]1G.T]/2OG?/I_(4N<8QU]<<UUT\IPU&I1J4[KV
M2:2Z:[WTW."MGV+Q%+$4JS3]LTY/K[MK6Z):6VV/J3XK?&[P=XF_9O\ #_A/
M3=3:XU^TMK".:T:UE4*T4:AQN9=IP0><GI6_H_Q8^"OQ+\#Z?IOB>RA\)ZG;
M%)#_ &?:F#$H4J7C>)<8.3PW3/M7QWU 'IT]!1[?G7+_ &%A_9J$)RBU)R33
MUN[7Z6Z=CN7$^*=9U:E.$DXJ#BXW34=NM[Z]'\CZZ^./[2'@]OA7)X&\&W5W
MK(GB6V>]NC(1'$&!(+2?,['&!VP>V *^1?3Z>E+GZ_G25Z. R^EE]-TZ5W=W
M;>[9X^:9K7S:LJU>RLDDDK))?>%%%%>D>,%%%% !1110 4444 %%%% !1110
M 4444 7='T>\\0:I::986\EW>W4BPPPQCYG9C@ ?Y_E7UUH_AGP;^R#X=LM>
M\2(->^(%VA^SVL3 ^1D$-L[*HS@R'GJ%X)SR'[%_ANST^\\4?$+5$Q9>';-_
M+DR,J2C-*P!'41J1U'W_ './!_'GC;4?B%XLU+7]4E9[F\E,@3>66),DK&N?
MX5& /UKYC$1GF>*G@U*U*%N:V\F]5&_:V_W'VN#E3R7 PS!Q4J]5ODOJHJ.C
ME;J[[?>:_P 7OBMJ/QA\8'7M1MH+-EB6WAM[<?*D:EF )/WCECR?6O;_ (7_
M +3OAW7O!MAX ^)6C+/HXACLEOXSB,1I@1^8H(9-H &]"3QT')KY9^E*&^N*
M]+$97A<10C0<;*/PVT<?-,\C"YWC,+B9XI2YG/XDTFI+LT>V_M&?L]O\*[R'
M6M%D;4/".H,#!/PQA=LLL;,.JD#Y6'7^?B)KZY_9BUR+XQ_"OQ1\+-=E>1H;
M;SK&>3+F*/("X/81R;"/4,1VKY.U*QFTO4;JRN$\NXMI6AD0@C:RD@C!Y&"*
MYLKQ%5NI@\2[SIO?NGL_7N=>=X6@HTL?@URTJR>G\LEI*/IV\BO7K_[)/_)P
MGA+_ 'KK_P!))J\@KU_]DG_DX3PE_O77_I)-79F?^XU_\$OR9P9)_P C/#?]
M?(?^E(P_C+_R5WQM_P!AJ\_]'O7MFI_\F7^"/^PS+_Z,O*\3^,O_ "5WQM_V
M&KS_ -'O7MFI_P#)E_@C_L,R_P#HR\KP,9_ PG^*/_I+/M\M_P!ZQW^"?_I<
M3Q*BBBO4. <AVN">@Y/YU]F^+/C/\'?'>GPV6O7QO[>)Q(L<EI<KM;!&<JH[
M$]Z^,/\ /^<T?I^->7C,OIXZ4)3DXN-[6=M_O/7P.95,!&<(1C)3M=25]OGY
MGTEXFU/X MX=U;^RX%&IM:RBV/DWG^MV-LZ\?>QUXK9\/?&'X?>-?A+9^&/%
MMY+IC6]M%;W$2H^&\H* Z,JD$':#CKV]Z^5/T]Z.3^/7G-<LLGIRBHRJS;3N
MFW=I^6AV1SNK&;E&E!)JS2C9->:N?66I?&3X8/\ "O5_"6DWL^F0BVEMK6.2
MUE/F$@D/D \,WK@]>*K> /CMX$T/X/Z7H.L32W=TL!MKJP6UD;Y6<[OFQMP%
M8GKV]:^5N?Q_&C]!Z=1^51_8F&<'!RE9RYM];_<7_;^*4U448W4>79VMZ7/K
M.R^,7PO^$WA6^7P66O+ZZS*L"Q299\84NS 84>G7VKS3X$_'@?#W6-3BUM);
MC3=4F^T2RQKN>*7^_CN#W^G>O%^WZ\T8'H/RK:.48=4ZD)WES[MO73;IT,)Y
MUB95*=2"4>39)66N^GF?7-A\0_@IX)U2Y\2Z.WF:M.&Q'!#,6YZJ@8!4)KS3
MPE\;+74_CTOB_P 02_V=IWER0HJHTGDIMPH(4$Y]<#J37B7^<=J3^7UI4\HH
M04^:4I.2Y;MW:79#JYU7J.'+&,5%\UDK)ONST3X^>+]*\<_$J]U?1KAKJPEB
MA5)3&R<K&H/RL 1SGJ.U>WK\8OAK\1_AQ8Z1XJO9M,>W6(S6R)("'1<94JI!
M7V]^E?)G^?2E[@\_G6M;+*56E2I<S7L]FGJ94<VK4:M6KRI^T^)-:?G<^J?&
M/QD^'&M?![4O"VE7DVF[;?R+.VDM9,GRF5E^8*1\VT'DYYYYJ+X9_%[P!?\
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M'/\ UY1?^U:\7.?]QJ?+\T>]D7_(QI?/_P!)9\ZR?ZQOJ:^C%_Y,Q'_7X?\
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M]=H S7/45A["DI<_(K][&WMZKCR.3MVN6]+U>]T6^CO+&YDM;J/[LT;8/O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P#$T>VS3_GW#_P*7_R(?4LE_P"?M3_P&/\ \D>9_P#"J?&G_0IZS_X R_\
MQ-'_  JGQI_T*>L_^ ,O_P 37IG_  UQ\3O^@['_ . D/_Q-'_#7'Q._Z#L?
M_@)#_P#$T>VS3_GW#_P*7_R(?4LE_P"?M3_P&/\ \D>9_P#"J?&G_0IZS_X
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M . D/_Q-'_#7'Q._Z#L?_@)#_P#$T>VS3_GW#_P*7_R(?4LE_P"?M3_P&/\
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M_P#$T>VS3_GW#_P*7_R(?4LE_P"?M3_P&/\ \D>9_P#"J?&G_0IZS_X R_\
MQ-'_  JGQI_T*>L_^ ,O_P 37IG_  UQ\3O^@['_ . D/_Q-'_#7'Q._Z#L?
M_@)#_P#$T>VS3_GW#_P*7_R(?4LE_P"?M3_P&/\ \D>9_P#"J?&G_0IZS_X
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M . D/_Q-'_#7'Q._Z#L?_@)#_P#$T>VS3_GW#_P*7_R(?4LE_P"?M3_P&/\
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M_P#$T>VS3_GW#_P*7_R(?4LE_P"?M3_P&/\ \D>9_P#"J?&G_0IZS_X R_\
MQ-'_  JGQI_T*>L_^ ,O_P 37IG_  UQ\3O^@['_ . D/_Q-'_#7'Q._Z#L?
M_@)#_P#$T>VS3_GW#_P*7_R(?4LE_P"?M3_P&/\ \D>9_P#"J?&G_0IZS_X
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M . D/_Q-'_#7'Q._Z#L?_@)#_P#$T>VS3_GW#_P*7_R(?4LE_P"?M3_P&/\
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MX_\ XW1_PTUX"_Z)/I__ 'W'_P#&Z/;XS_H&?_@4?\P]GE__ $%Q_P# 9_\
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M_P#&Z/\ AIKP%_T2?3_^^X__ (W1[?&?] S_ / H_P"8>SR__H+C_P" S_\
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M'M\9_P! S_\  H_YA[/+_P#H+C_X#/\ ^1/'**]C_P"&FO 7_1)]/_[[C_\
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MX_\ @,__ )$\<HKV/_AIKP%_T2?3_P#ON/\ ^-T?\--> O\ HD^G_P#?<?\
M\;H]OC/^@9_^!1_S#V>7_P#07'_P&?\ \B>.45['_P --> O^B3Z?_WW'_\
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MW'_\;H_X::\!?]$GT_\ [[C_ /C='M\9_P! S_\  H_YA[/+_P#H+C_X#/\
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MN/\ ^-T?\--> O\ HD^G_P#?<?\ \;H]OC/^@9_^!1_S#V>7_P#07'_P&?\
M\B>.45['_P --> O^B3Z?_WW'_\ &Z/^&FO 7_1)]/\ ^^X__C='M\9_T#/_
M ,"C_F'L\O\ ^@N/_@,__D3QRBO8_P#AIKP%_P!$GT__ +[C_P#C='_#37@+
M_HD^G_\ ?<?_ ,;H]OC/^@9_^!1_S#V>7_\ 07'_ ,!G_P#(GCE%>Q_\-->
MO^B3Z?\ ]]Q__&Z/^&FO 7_1)]/_ .^X_P#XW1[?&?\ 0,__  */^8>SR_\
MZ"X_^ S_ /D3QRBO8_\ AIKP%_T2?3_^^X__ (W1_P --> O^B3Z?_WW'_\
M&Z/;XS_H&?\ X%'_ ##V>7_]!<?_  &?_P B>.45['_PTUX"_P"B3Z?_ -]Q
M_P#QNC_AIKP%_P!$GT__ +[C_P#C='M\9_T#/_P*/^8>SR__ *"X_P#@,_\
MY$\<HKV/_AIKP%_T2?3_ /ON/_XW1_PTUX"_Z)/I_P#WW'_\;H]OC/\ H&?_
M (%'_,/9Y?\ ]!<?_ 9__(GCE%>Q_P##37@+_HD^G_\ ?<?_ ,;H_P"&FO 7
M_1)]/_[[C_\ C='M\9_T#/\ \"C_ )A[/+_^@N/_ (#/_P"1/'**]C_X::\!
M?]$GT_\ [[C_ /C='_#37@+_ *)/I_\ WW'_ /&Z/;XS_H&?_@4?\P]GE_\
MT%Q_\!G_ /(GCE%>Q_\ #37@+_HD^G_]]Q__ !NC_AIKP%_T2?3_ /ON/_XW
M1[?&?] S_P# H_YA[/+_ /H+C_X#/_Y$\<HKV/\ X::\!?\ 1)]/_P"^X_\
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M=_T'(_\ P$B_^)H^I9CVA][_ ,@_MK*^\_\ P&/_ ,D=W_PA/B'_ * FH?\
M@,_^%'_"$^(?^@)J'_@,_P#A7"?\-;_$[_H.1_\ @)%_\31_PUO\3O\ H.1_
M^ D7_P 31]2S'M#[W_D']M97WG_X#'_Y([O_ (0GQ#_T!-0_\!G_ ,*/^$)\
M0_\ 0$U#_P !G_PKA/\ AK?XG?\ 0<C_ / 2+_XFC_AK?XG?]!R/_P !(O\
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M_$[_ *#D?_@)%_\ $T?\-;_$[_H.1_\ @)%_\31]2S'M#[W_ )!_;65]Y_\
M@,?_ )([O_A"?$/_ $!-0_\  9_\*/\ A"?$/_0$U#_P&?\ PKA/^&M_B=_T
M'(__  $B_P#B:/\ AK?XG?\ 0<C_ / 2+_XFCZEF/:'WO_(/[:ROO/\ \!C_
M /)'=_\ "$^(?^@)J'_@,_\ A1_PA/B'_H":A_X#/_A7"?\ #6_Q._Z#D?\
MX"1?_$T?\-;_ !._Z#D?_@)%_P#$T?4LQ[0^]_Y!_;65]Y_^ Q_^2.[_ .$)
M\0_] 34/_ 9_\*/^$)\0_P#0$U#_ ,!G_P *X3_AK?XG?]!R/_P$B_\ B:/^
M&M_B=_T'(_\ P$B_^)H^I9CVA][_ ,@_MK*^\_\ P&/_ ,D=W_PA/B'_ * F
MH?\ @,_^%'_"$^(?^@)J'_@,_P#A7"?\-;_$[_H.1_\ @)%_\31_PUO\3O\
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MB=_T'(__  $B_P#B:/\ AK?XG?\ 0<C_ / 2+_XFCZEF/:'WO_(/[:ROO/\
M\!C_ /)'=_\ "$^(?^@)J'_@,_\ A1_PA/B'_H":A_X#/_A7"?\ #6_Q._Z#
MD?\ X"1?_$T?\-;_ !._Z#D?_@)%_P#$T?4LQ[0^]_Y!_;65]Y_^ Q_^2.[_
M .$)\0_] 34/_ 9_\*/^$)\0_P#0$U#_ ,!G_P *X3_AK?XG?]!R/_P$B_\
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M'4%?.O[='_)(=,_[#4/_ *(GKZ*KYV_;F4M\(=/(&0NLPD_]^9A_45[.3?\
M(PH^I\_Q!_R*\1_A/A*BC]:*_<C^;PHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ H[_B**/?W% 'Z[4QC@TXMBOC3]J[]N;5?AG\0H?AM\
M-/#J^*?&\BH)]Z/,D$CJ"D2Q1D-(^TACR ,CKSC^;ZE2-*/-(_JJK5A1CS3/
M.?B-\*?C+^R%\:/$OCSX1Z2_BSP;XDG^T7NCQQ-<&-V9F(>)#O&UF?:Z\ -@
MUX9\ _B]\=_A1I_C#0_!7PWU"YUKQ%?_ &N2ZDTR>0VDC#!VIC'&<_,<=,@@
M'/Z$>(/CWJGP?_95LOB#\0]-^S^*8=.B^T:61Y)EOG^58@.=N6Y/4A0QYQ7Q
MAX=^,/[9/Q4\-W/Q*\,ED\*QF26&TMK6T2*2-,[Q%%(#+(HVXR"2>0#Z>55C
M&$ER2?>RZ7_(\2M"%.:]G*7>R6U_R/J/]A?]F?7_ ((Z#XB\2>.+G[3XZ\53
MK<7RF82F%%+, SC.YV:1V8@GJ!VKZG484#I7SK^Q=^U,/VFOA_>3ZC;0Z?XK
MT61(-3M8,^6VX$I,@.2JMM?@]"K#T)^BUZ5Z=#D]FN38]C#^S5*/LMA:***W
M.D*\V_:"\"R_$+X5ZYI=JGF7ZH+FU4=3)&=P4>[#<O\ P*O2::RG.1BMJ-:6
M'JQJPWBT_N.?$4(XJC.A/:2:?S/R-=3&Q5AL93@AN,'OGTIOU&#7V#^T7^RK
M=:QJ5SXF\&VZR7$Q,EYI2$*6<\EXL\9/=?RKY(U'2[W1[I[6^M)K.XC.UHIX
MV1E/H0:_<<!F%#,*2J4GKU75?UW/YPS/*L3E=9TZT=.CZ/T_RZ%6BBBO4/&"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHZ=>* "NA\ ^#[OQYXRTK
M0;)&::\F5&9?X$SEW/L ,_A3?"/@37_'6IQV&AZ7<:A<,>1&GRJ.Q9NBCW/%
M?=G[/'[/%K\(M-;4-0>.^\2W2;99E'R6Z]?+3C\V[\#H.?G\VS:EE]%ZWF]E
M^K\CZC(\DKYK7B^5JFMWT]%W?Y'M#=_I7YY_L=VEMJ_[?'QWOM559=8M;K4$
MM/.^8I']MV-MSTPH1<^AQQGG]#B/:OA+]IC]DWXFZ!\<)/C'\#;M(]<O%_XF
M&G"2.-R^T*[*)/D=7 !93SNR1GC'X1B(OW9I7LS]YQ497A4BK\KV,#_@K!XQ
MFOK/X=_#W3B9[[4;R34)+93R6_U$ QWW-),/^ U]P_#/P;;?#GX>^&_#%FBK
M;Z3I\-DK 8W;$ )/N2"3ZDFOB#X&?LE_%KXG?'VP^*OQVD6)M)=)K2PDDB=Y
MI(SF%0D>5CC1OFP>21T^8FO2/VUOB7\=-+\2:?X&^$WAFXO+'6-,W76LV=G)
M+-;R/(\;(),[(@%"G<1D;LY7 -8PDXN=>:>NB[G/3FXN>)G%ZV276QY9_P $
M]W@E_:O^.SZ-\N@--.844878;U_*_P#'-V!]:_15>E?,_P"PO^RU=?LV_#R]
M?77AE\6Z])'/J(A?>D"H#Y<(;^(KO<DCC+'!( -?3 KHPL)0I)2W.K!TY4Z*
M4M]_O%HHHKJ.T***0M0 UE^;/%96L^$]$\2+C5M(L=37L+RW27'_ 'T#67XL
M^)&C>$7:*YF::[QG[/",L/J>@_&N*;]H2'<=NC.5[$SC_"O)K9Q@\'4Y9U;2
M7:_Z&-1TY+EGJCK/^%+^ _\ H4-%_P# -/\ "D_X4MX#_P"A0T;_ ,!$_P *
MY/\ X:$B_P"@,W_?\?\ Q-'_  T)%_T!F_[_ (_^)I?ZT87_ *"'_P"3?Y')
M]7P?_/N/W+_(ZS_A2W@/_H4-&_\  1/\*/\ A2W@/_H4-&_\!$_PKD_^&A(O
M^@,W_?\ '_Q-'_#0D7_0&;_O^/\ XFC_ %HPO_00_P#R;_(/J^#_ .?<?N7^
M1UG_  I;P'_T*&C?^ B?X4?\*6\!_P#0H:-_X")_A7)_\-"1?] 9O^_X_P#B
M:/\ AH2+_H#-_P!_Q_\ $T?ZT87_ *"'_P"3?Y!]7P?_ #[C]R_R.L_X4MX#
M_P"A0T;_ ,!$_P */^%+> _^A0T;_P !$_PKD_\ AH2+_H#-_P!_Q_\ $T?\
M-"1?] 9O^_X_^)H_UHPO_00__)O\@^KX/_GW'[E_D=9_PI;P'_T*&C?^ B?X
M4?\ "EO ?_0H:-_X")_A7)_\-"1?] 9O^_X_^)H_X:$B_P"@,W_?\?\ Q-'^
MM&%_Z"'_ .3?Y!]7P?\ S[C]R_R.L_X4MX#_ .A0T;_P$3_"C_A2W@/_ *%#
M1O\ P$3_  KD_P#AH2+_ * S?]_Q_P#$T?\ #0D7_0&;_O\ C_XFC_6C"_\
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MT)%_T!F_[_C_ .)H_P"&A(O^@,W_ '_'_P 31_K1A?\ H(?_ )-_D'U?!_\
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M/J^#_P"?<?N7^1UG_"EO ?\ T*&C?^ B?X4?\*6\!_\ 0H:-_P" B?X5R?\
MPT)%_P! 9O\ O^/_ (FC_AH2+_H#-_W_ !_\31_K1A?^@A_^3?Y!]7P?_/N/
MW+_(ZS_A2W@/_H4-&_\  1/\*/\ A2W@/_H4-&_\!$_PKD_^&A(O^@,W_?\
M'_Q-'_#0D7_0&;_O^/\ XFC_ %HPO_00_P#R;_(/J^#_ .?<?N7^1UG_  I;
MP'_T*&C?^ B?X4?\*6\!_P#0H:-_X")_A7)_\-"1?] 9O^_X_P#B:/\ AH2+
M_H#-_P!_Q_\ $T?ZT87_ *"'_P"3?Y!]7P?_ #[C]R_R.L_X4MX#_P"A0T;_
M ,!$_P */^%+> _^A0T;_P !$_PKD_\ AH2+_H#-_P!_Q_\ $T?\-"1?] 9O
M^_X_^)H_UHPO_00__)O\@^KX/_GW'[E_D=9_PI;P'_T*&C?^ B?X4?\ "EO
M?_0H:-_X")_A7)_\-"1?] 9O^_X_^)H_X:$B_P"@,W_?\?\ Q-'^M&%_Z"'_
M .3?Y!]7P?\ S[C]R_R.L_X4MX#_ .A0T;_P$3_"C_A2W@/_ *%#1O\ P$3_
M  KD_P#AH2+_ * S?]_Q_P#$T?\ #0D7_0&;_O\ C_XFC_6C"_\ 00__ ";_
M "#ZO@_^?<?N7^1UG_"EO ?_ $*&C?\ @(G^%'_"EO ?_0H:-_X")_A7)_\
M#0D7_0&;_O\ C_XFC_AH2+_H#-_W_'_Q-'^M&%_Z"'_Y-_D'U?!_\^X_<O\
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M_P!:,+_T$/\ \F_R#ZO@_P#GW'[E_D=9_P *6\!_]"AHW_@(G^%'_"EO ?\
MT*&C?^ B?X5R?_#0D7_0&;_O^/\ XFC_ (:$B_Z S?\ ?\?_ !-'^M&%_P"@
MA_\ DW^0?5\'_P ^X_<O\CK/^%+> _\ H4-&_P# 1/\ "C_A2W@/_H4-&_\
M 1/\*Y/_ (:$B_Z S?\ ?\?_ !-'_#0D7_0&;_O^/_B:/]:,+_T$/_R;_(/J
M^#_Y]Q^Y?Y'6?\*6\!_]"AHW_@(G^%'_  I;P'_T*&C?^ B?X5R?_#0D7_0&
M;_O^/_B:/^&A(O\ H#-_W_'_ ,31_K1A?^@A_P#DW^0?5\'_ ,^X_<O\CK/^
M%+> _P#H4-&_\!$_PH_X4MX#_P"A0T;_ ,!$_P *Y/\ X:$B_P"@,W_?\?\
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M3_X:$B_Z S?]_P ?_$T?\-"1?] 9O^_X_P#B:/\ 6C"_]!#_ /)O\@^KX/\
MY]Q^Y?Y'6?\ "EO ?_0H:-_X")_A1_PI;P'_ -"AHW_@(G^%<G_PT)%_T!F_
M[_C_ .)H_P"&A(O^@,W_ '_'_P 31_K1A?\ H(?_ )-_D'U?!_\ /N/W+_(Z
MS_A2W@/_ *%#1O\ P$3_  H_X4MX#_Z%#1O_  $3_"N3_P"&A(O^@,W_ '_'
M_P 31_PT)%_T!F_[_C_XFC_6C"_]!#_\F_R#ZO@_^?<?N7^1UG_"EO ?_0H:
M-_X")_A1_P *6\!_]"AHW_@(G^%<G_PT)%_T!F_[_C_XFC_AH2+_ * S?]_Q
M_P#$T?ZT87_H(?\ Y-_D'U?!_P#/N/W+_(ZS_A2W@/\ Z%#1O_ 1/\*/^%+>
M _\ H4-&_P# 1/\ "N3_ .&A(O\ H#-_W_'_ ,31_P -"1?] 9O^_P"/_B:/
M]:,+_P!!#_\ )O\ (/J^#_Y]Q^Y?Y'6?\*6\!_\ 0H:-_P" B?X4?\*6\!_]
M"AHW_@(G^%<G_P -"1?] 9O^_P"/_B:/^&A(O^@,W_?\?_$T?ZT87_H(?_DW
M^0?5\'_S[C]R_P CK/\ A2W@/_H4-&_\!$_PH_X4MX#_ .A0T;_P$3_"N3_X
M:$B_Z S?]_Q_\31_PT)%_P! 9O\ O^/_ (FC_6C"_P#00_\ R;_(/J^#_P"?
M<?N7^1UG_"EO ?\ T*&C?^ B?X4?\*6\!_\ 0H:-_P" B?X5R?\ PT)%_P!
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MX#_Z%#1O_ 1/\*/^%+> _P#H4-&_\!$_PKD_^&A(O^@,W_?\?_$T?\-"1?\
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M\31_K1A?^@A_^3?Y!]7P?_/N/W+_ ".L_P"%+> _^A0T;_P$3_"C_A2W@/\
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MX_<O\CK/^%+> _\ H4-&_P# 1/\ "C_A2W@/_H4-&_\  1/\*Y/_ (:$B_Z
MS?\ ?\?_ !-'_#0D7_0&;_O^/_B:/]:,+_T$/_R;_(/J^#_Y]Q^Y?Y'6?\*6
M\!_]"AHW_@(G^%'_  I;P'_T*&C?^ B?X5R?_#0D7_0&;_O^/_B:/^&A(O\
MH#-_W_'_ ,31_K1A?^@A_P#DW^0?5\'_ ,^X_<O\CK/^%+> _P#H4-&_\!$_
MPH_X4MX#_P"A0T;_ ,!$_P *Y/\ X:$B_P"@,W_?\?\ Q-'_  T)%_T!F_[_
M (_^)H_UHPO_ $$/_P F_P @^KX/_GW'[E_D=9_PI;P'_P!"AHW_ (")_A1_
MPI;P'_T*&C?^ B?X5R?_  T)%_T!F_[_ (_^)H_X:$B_Z S?]_Q_\31_K1A?
M^@A_^3?Y!]7P?_/N/W+_ ".L_P"%+> _^A0T;_P$3_"C_A2W@/\ Z%#1O_ 1
M/\*Y/_AH2+_H#-_W_'_Q-'_#0D7_ $!F_P"_X_\ B:/]:,+_ -!#_P#)O\@^
MKX/_ )]Q^Y?Y'6?\*6\!_P#0H:-_X")_A1_PI;P'_P!"AHW_ (")_A7)_P##
M0D7_ $!F_P"_X_\ B:/^&A(O^@,W_?\ '_Q-'^M&%_Z"'_Y-_D'U?!_\^X_<
MO\CK/^%+> _^A0T;_P !$_PH_P"%+> _^A0T;_P$3_"N3_X:$B_Z S?]_P ?
M_$T?\-"1?] 9O^_X_P#B:/\ 6C"_]!#_ /)O\@^KX/\ Y]Q^Y?Y'6?\ "EO
M?_0H:-_X")_A1_PI;P'_ -"AHW_@(G^%<G_PT)%_T!F_[_C_ .)H_P"&A(O^
M@,W_ '_'_P 31_K1A?\ H(?_ )-_D'U?!_\ /N/W+_(ZS_A2W@/_ *%#1O\
MP$3_  H_X4MX#_Z%#1O_  $3_"N3_P"&A(O^@,W_ '_'_P 31_PT)%_T!F_[
M_C_XFC_6C"_]!#_\F_R#ZO@_^?<?N7^1UG_"EO ?_0H:-_X")_A1_P *6\!_
M]"AHW_@(G^%<G_PT)%_T!F_[_C_XFC_AH2+_ * S?]_Q_P#$T?ZT87_H(?\
MY-_D'U?!_P#/N/W+_(ZS_A2W@/\ Z%#1O_ 1/\*/^%+> _\ H4-&_P# 1/\
M"N3_ .&A(O\ H#-_W_'_ ,31_P -"1?] 9O^_P"/_B:/]:,+_P!!#_\ )O\
M(/J^#_Y]Q^Y?Y'6?\*6\!_\ 0H:-_P" B?X4?\*6\!_]"AHW_@(G^%<G_P -
M"1?] 9O^_P"/_B:/^&A(O^@,W_?\?_$T?ZT87_H(?_DW^0?5\'_S[C]R_P C
MK/\ A2W@/_H4-&_\!$_PH_X4MX#_ .A0T;_P$3_"N3_X:$B_Z S?]_Q_\31_
MPT)%_P! 9O\ O^/_ (FC_6C"_P#00_\ R;_(/J^#_P"?<?N7^1UG_"EO ?\
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M/_H4-&_\!$_PH_X4MX#_ .A0T;_P$3_"N3_X:$B_Z S?]_Q_\31_PT)%_P!
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M7P?_ #[C]R_R.L_X4MX#_P"A0T;_ ,!$_P */^%+> _^A0T;_P !$_PKD_\
MAH2+_H#-_P!_Q_\ $T?\-"1?] 9O^_X_^)H_UHPO_00__)O\@^KX/_GW'[E_
MD=9_PI;P'_T*&C?^ B?X4?\ "EO ?_0H:-_X")_A7)_\-"1?] 9O^_X_^)H_
MX:$B_P"@,W_?\?\ Q-'^M&%_Z"'_ .3?Y!]7P?\ S[C]R_R.L_X4MX#_ .A0
MT;_P$3_"C_A2W@/_ *%#1O\ P$3_  KD_P#AH2+_ * S?]_Q_P#$T?\ #0D7
M_0&;_O\ C_XFC_6C"_\ 00__ ";_ "#ZO@_^?<?N7^1UG_"EO ?_ $*&C?\
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M (:$B_Z S?\ ?\?_ !-'^M&%_P"@A_\ DW^0?5\'_P ^X_<O\CK/^%+> _\
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M*6\!_P#0H:-_X")_A1_PI;P'_P!"AHW_ (")_A7)_P##0D7_ $!F_P"_X_\
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M!$_PIT?P9\"POO7PCHH8=,V:$?EBN1_X:$B_Z S?]_Q_\31_PT)%_P! 9O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK>A%3X6>!T445^*'FA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P %;_\ 4?"O_>U3_P!M*_0ROSS_ ."M_P#J/A7_ +VJ?^VE=>$_C1/'S?\
MW*I\OS1<_P""2_\ R+GQ%_Z^K/\ ] EK[_7[HKX _P""2_\ R+GQ%_Z^K/\
M] EK[_7[HJ<3_%8\I_W.G\_S8M%%%<QZX5YW\<K-[KP5O7A8+F.1SZ#!7^;"
MO1*I:MI<&LZ?<65R@D@G0HP]O6N+&4'BL/.BMY*Q,ES)H^1.>,]:*Z#Q?X+U
M#PEJ,D5Q _V9G(AN,$JX[#/K[5S_ /GI7X?5I3HS=.HK-'F--.S"BBBL0"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW\._^#6#_P"+H^H0_P"?7_DO_ #V3_E_ U/^$#\._P#0%L?^_"T?\('X=_Z
MMC_WX6LO_A<_@#_H=_#O_@U@_P#BZ/\ A<_@#_H=_#O_ (-8/_BZ/J$/^?7_
M )+_ , /9/\ E_ U/^$#\._] 6Q_[\+1_P ('X=_Z MC_P!^%K+_ .%S^ /^
MAW\._P#@U@_^+H_X7/X _P"AW\._^#6#_P"+H^H0_P"?7_DO_ #V3_E_ U/^
M$#\._P#0%L?^_"T?\('X=_Z MC_WX6LO_A<_@#_H=_#O_@U@_P#BZ/\ A<_@
M#_H=_#O_ (-8/_BZ/J$/^?7_ )+_ , /9/\ E_ U/^$#\._] 6Q_[\+1_P (
M'X=_Z MC_P!^%K+_ .%S^ /^AW\._P#@U@_^+H_X7/X _P"AW\._^#6#_P"+
MH^H0_P"?7_DO_ #V3_E_ U/^$#\._P#0%L?^_"T?\('X=_Z MC_WX6LO_A<_
M@#_H=_#O_@U@_P#BZ/\ A<_@#_H=_#O_ (-8/_BZ/J$/^?7_ )+_ , /9/\
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MW\._^#6#_P"+H^H0_P"?7_DO_ #V3_E_ U/^$#\._P#0%L?^_"T?\('X=_Z
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M@#_H=_#O_@U@_P#BZ/\ A<_@#_H=_#O_ (-8/_BZ/J$/^?7_ )+_ , /9/\
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MW\._^#6#_P"+H^H0_P"?7_DO_ #V3_E_ U/^$#\._P#0%L?^_"T?\('X=_Z
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M@#_H=_#O_@U@_P#BZ/\ A<_@#_H=_#O_ (-8/_BZ/J$/^?7_ )+_ , /9/\
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MW\._^#6#_P"+H^H0_P"?7_DO_ #V3_E_ U/^$#\._P#0%L?^_"T?\('X=_Z
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M@#_H=_#O_@U@_P#BZ/\ A<_@#_H=_#O_ (-8/_BZ/J$/^?7_ )+_ , /9/\
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MW\._^#6#_P"+H^H0_P"?7_DO_ #V3_E_ U/^$#\._P#0%L?^_"T?\('X=_Z
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M@#_H=_#O_@U@_P#BZ/\ A<_@#_H=_#O_ (-8/_BZ/J$/^?7_ )+_ , /9/\
ME_ U/^$#\._] 6Q_[\+1_P ('X=_Z MC_P!^%K+_ .%S^ /^AW\._P#@U@_^
M+H_X7/X _P"AW\._^#6#_P"+H^H0_P"?7_DO_ #V3_E_ U/^$#\._P#0%L?^
M_"T?\('X=_Z MC_WX6LO_A<_@#_H=_#O_@U@_P#BZ/\ A<_@#_H=_#O_ (-8
M/_BZ/J$/^?7_ )+_ , /9/\ E_ U/^$#\._] 6Q_[\+1_P ('X=_Z MC_P!^
M%K+_ .%S^ /^AW\._P#@U@_^+H_X7/X _P"AW\._^#6#_P"+H^H0_P"?7_DO
M_ #V3_E_ U/^$#\._P#0%L?^_"T?\('X=_Z MC_WX6LO_A<_@#_H=_#O_@U@
M_P#BZ/\ A<_@#_H=_#O_ (-8/_BZ/J$/^?7_ )+_ , /9/\ E_ U/^$#\._]
M 6Q_[\+1_P ('X=_Z MC_P!^%K+_ .%S^ /^AW\._P#@U@_^+H_X7/X _P"A
MW\._^#6#_P"+H^H0_P"?7_DO_ #V3_E_ U/^$#\._P#0%L?^_"T?\('X=_Z
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M@#_H=_#O_@U@_P#BZ/\ A<_@#_H=_#O_ (-8/_BZ/J$/^?7_ )+_ , /9/\
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MW\._^#6#_P"+H^H0_P"?7_DO_ #V3_E_ U/^$#\._P#0%L?^_"T?\('X=_Z
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M@#_H=_#O_@U@_P#BZ/\ A<_@#_H=_#O_ (-8/_BZ/J$/^?7_ )+_ , /9/\
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MW\._^#6#_P"+H^H0_P"?7_DO_ #V3_E_ U/^$#\._P#0%L?^_"T?\('X=_Z
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M@#_H=_#O_@U@_P#BZ/\ A<_@#_H=_#O_ (-8/_BZ/J$/^?7_ )+_ , /9/\
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MW\._^#6#_P"+H^H0_P"?7_DO_ #V3_E_ U/^$#\._P#0%L?^_"T?\('X=_Z
MMC_WX6LO_A<_@#_H=_#O_@U@_P#BZ/\ A<_@#_H=_#O_ (-8/_BZ/J$/^?7_
M )+_ , /9/\ E_ U/^$#\._] 6Q_[\+1_P ('X=_Z MC_P!^%K+_ .%S^ /^
MAW\._P#@U@_^+H_X7/X _P"AW\._^#6#_P"+H^H0_P"?7_DO_ #V3_E_ U/^
M$#\._P#0%L?^_"T?\('X=_Z MC_WX6LO_A<_@#_H=_#O_@U@_P#BZ/\ A<_@
M#_H=_#O_ (-8/_BZ/J$/^?7_ )+_ , /9/\ E_ U/^$#\._] 6Q_[\+1_P (
M'X=_Z MC_P!^%K+_ .%S^ /^AW\._P#@U@_^+H_X7/X _P"AW\._^#6#_P"+
MH^H0_P"?7_DO_ #V3_E_ U/^$#\._P#0%L?^_"T?\('X=_Z MC_WX6LO_A<_
M@#_H=_#O_@U@_P#BZ/\ A<_@#_H=_#O_ (-8/_BZ/J$/^?7_ )+_ , /9/\
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MW\._^#6#_P"+H^H0_P"?7_DO_ #V3_E_ U/^$#\._P#0%L?^_"T?\('X=_Z
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M@#_H=_#O_@U@_P#BZ/\ A<_@#_H=_#O_ (-8/_BZ/J$/^?7_ )+_ , /9/\
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MW\._^#6#_P"+H^H0_P"?7_DO_ #V3_E_ U/^$#\._P#0%L?^_"T?\('X=_Z
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M@#_H=_#O_@U@_P#BZ/\ A<_@#_H=_#O_ (-8/_BZ/J$/^?7_ )+_ , /9/\
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MW\._^#6#_P"+H^H0_P"?7_DO_ #V3_E_ U/^$#\._P#0%L?^_"T?\('X=_Z
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M@#_H=_#O_@U@_P#BZ/\ A<_@#_H=_#O_ (-8/_BZ/J$/^?7_ )+_ , /9/\
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MW\._^#6#_P"+H^H0_P"?7_DO_ #V3_E_ U/^$#\._P#0%L?^_"T?\('X=_Z
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M@#_H=_#O_@U@_P#BZ/\ A<_@#_H=_#O_ (-8/_BZ/J$/^?7_ )+_ , /9/\
ME_ U/^$#\._] 6Q_[\+1_P ('X=_Z MC_P!^%K+_ .%S^ /^AW\._P#@U@_^
M+H_X7/X _P"AW\._^#6#_P"+H^H0_P"?7_DO_ #V3_E_ U/^$#\._P#0%L?^
M_"T?\('X=_Z MC_WX6LO_A<_@#_H=_#O_@U@_P#BZ/\ A<_@#_H=_#O_ (-8
M/_BZ/J$/^?7_ )+_ , /9/\ E_ U/^$#\._] 6Q_[\+1_P ('X=_Z MC_P!^
M%K+_ .%S^ /^AW\._P#@U@_^+H_X7/X _P"AW\._^#6#_P"+H^H0_P"?7_DO
M_ #V3_E_ U/^$#\._P#0%L?^_"T?\('X=_Z MC_WX6LO_A<_@#_H=_#O_@U@
M_P#BZ/\ A<_@#_H=_#O_ (-8/_BZ/J$/^?7_ )+_ , /9/\ E_ U/^$#\._]
M 6Q_[\+1_P ('X=_Z MC_P!^%K+_ .%S^ /^AW\._P#@U@_^+H_X7/X _P"A
MW\._^#6#_P"+H^H0_P"?7_DO_ #V3_E_ U/^$#\._P#0%L?^_"T?\('X=_Z
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M@#_H=_#O_@U@_P#BZ/\ A<_@#_H=_#O_ (-8/_BZ/J$/^?7_ )+_ , /9/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M ."?OP/T+4+#7/B-KMG#?7,%]):Z>MP@=+<(,R2A2,;B6P#U&WCK79_\$S7
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MIFOMHL.M:Y/.;73XYCM\O*YD<N 6 P "%ZY%8'A?6] _;@_9XOI=2T6.SO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG,2WUT\JIVRH)P#CN!SFN:HI*G!.ZB@Y8K5(W_"'C_Q+\/[J2Y\,Z]J&A32
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M$ U@9/4]?Y4E%7&*BK15D-)+8Z#PG\0?$_@.9Y?#GB'4]"D?&_\ L^[>$/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5Z+^SG_R7[X<_P#8P6/_ */2O.JU/"^O3>%_$FE:O;DB>QN8[F,C
M&=R,&[@C^$=0:SJ1YX2BNJ(FN:+2/W94[E!'2EKEOAO\1-%^*'@W3O$>A727
M5C>1A_D8$QM_%&WHP/!^E=.L@89[>]?DDDXMQEHT?%M.+LSGOB)H-QXH\!^)
M-'LV1;S4--N+6%I/NAWB91GVR:^#O'7COPW^Q/X*G\!^ IH=5^)VH1 ZQK^
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A%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>iclr-20241231_g3.jpg
<TEXT>
begin 644 iclr-20241231_g3.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X33^17AI9@  34T *@    @ !@ +  (
M   F   (8@$2  ,    !  $   $Q  (    F   (B $R  (    4   (KH=I
M  0    !   (PNH<  <   @,    5@  $48<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     %=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P
M,3$N,38S.#0 5VEN9&]W<R!0:&]T;R!%9&ET;W(@,3 N,"XQ,# Q,2XQ-C,X
M-  R,#(U.C Q.C$U(#$R.C(Q.C(T   &D ,  @   !0  !$<D 0  @   !0
M !$PDI$  @    ,P,   DI(  @    ,P,   H $  P    $  0  ZAP !P
M" P   D0     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M,C R-3HP,3HQ-2 Q,CHR,#HP,  R,#(U.C Q.C$U(#$R.C(P.C P      8!
M P #     0 &   !&@ %     0  $90!&P %     0  $9P!*  #     0 "
M   " 0 $     0  $:0" @ $     0  (U$         8     $   !@
M ?_8_]L 0P (!@8'!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=&AP<("0N
M)R B+",<'"@W*2PP,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8#0T8,B$<
M(3(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R_\  $0@ ?P$  P$A  (1 0,1 ?_$ !\   $% 0$! 0$!
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MG!Q[^V*VJSG>_O;FU/EM[NP45!H%% !10 44 %% !10 44 %% !10 44 %%
M!10 44 %,:-'='9 60Y4D=#C''X&B]A-7W*K:38,'S:Q@N<L0,$\@G]5'Y4?
MV/IO_/C;]O\ EF.PP/TXK3VL^YG[&GV$N[:*#2[M+>$+N1F*QKRQQZ#J:?\
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M.:/K\835=.@N=OW6=<,OT8<C\Z:;6J)E%25F<\/A-X+$N_\ LEL?W?M,N/\
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M^37_ -A1_P +?/\ T!/_ ":_^PJO9G)_:W]T/^%OG_H"?^37_P!A1_PM\_\
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M ":_^PH]F']K?W0_X6^?^@)_Y-?_ &%'_"WS_P! 3_R:_P#L*/9A_:W]T/\
MA;Y_Z G_ )-?_84H^+_(SHG'?%S_ /8T>S'_ &LOY3NM!\06/B+3_M=DS8!V
MO&XPR'T-:M9M6=CU:=15(*<>H44BPHH K:C(\6FW,D3E)%B8JP X..O-,^Q3
M?]!*[_*/_P"(IDM7>YQGQ+TJ]E\.1S1W-Q<QP3!Y48+PN"-WR@=,_K7C];0>
MA\]F4'&O=]0HJS@"B@ JW9SV\(9;B'S Q'( ) YR.>F<@Y'/'O2*BTG=EE[S
M2R8PFG8 ^^2[?-^O']/>G27^EO=B3^S (CUC#D>GH:-33GAV&+>V DFS8CR7
MD#*AZA1_#NSD?7FEAO=,C4"33?,.?F.\C(].I_.BS#GAV$2\TP3.SZ;F,_=4
M2-Q^M16]Q9I;O'-;F1B3AA@'MSZ]NG3FC47-"^Q.+W2\D?V=\FP@ N2=W;G-
M1QWEFBQ VGS+%L8D [CN!SR.O4>P(].34?/#HA1>:<!&#IP8*/FRYY/'_P!>
MJ]U-:R)^XMO*;?G[Q.%P,=_7/Z4:BE*#6B*M%,R"B@ HH ]7^$MC<PV6H7DB
MLMO.R+'D?>*[LD?F!^?I7I%<\_B/I\#%QP\4R"&]M;B:6&&YADEA.)$1P2A]
MQVJ?-2=2DGL1B>%E++*A4-L)## ;.,?7/%8S:3/)<O>6MY$ID.]9%4[G4LIV
ML<\@!2!['\VM#*I'G7NL>ME/8^'KN.ZO'NIC$Q:1B?[N. 3Q6U0RX)K1@1D8
M/2LQO#>ANQ9M'L"3U)MD_P *$V@G3A/XE<;_ ,(SH/\ T!=/_P# 9/\ "C_A
M&=!_Z NG_P#@,G^%/F9G]6H_RH/^$9T'_H"Z?_X#)_A1_P (SH/_ $!=/_\
M 9/\*.9A]6H_RH/^$9T'_H"Z?_X#)_A1_P (SH/_ $!=/_\  9/\*.9A]6H_
MRH/^$9T'_H"Z?_X#)_A1_P (SH/_ $!=/_\  9/\*.9A]6H_RH/^$9T'_H"Z
M?_X#)_A1_P (SH/_ $!=/_\  9/\*.9A]6H_RH/^$9T'_H"Z?_X#)_A1_P (
MSH/_ $!=/_\  9/\*.9A]6H_RH/^$9T'_H"Z?_X#)_A1_P (SH/_ $!=/_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?ZX97_,_N/N^BOA#_AN/Q]_T#O#_ /X#3_\ QZC_ (;C\??] [P__P" T_\
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MC[_H'>'_ /P&G_\ CU'^K>8_R?B'^N&5_P S^X^[Z*^$/^&X_'W_ $#O#_\
MX#3_ /QZC_AN/Q]_T#O#_P#X#3__ !ZC_5O,?Y/Q#_7#*_YG]Q]WT5\(?\-Q
M^/O^@=X?_P# :?\ ^/4?\-Q^/O\ H'>'_P#P&G_^/4?ZMYC_ "?B'^N&5_S/
M[C[OHKX0_P"&X_'W_0.\/_\ @-/_ /'J/^&X_'W_ $#O#_\ X#3_ /QZC_5O
M,?Y/Q#_7#*_YG]Q]WT5\(?\ #<?C[_H'>'__  &G_P#CU'_#<?C[_H'>'_\
MP&G_ /CU'^K>8_R?B'^N&5_S/[C[OHKX0_X;C\??] [P_P#^ T__ ,>H_P"&
MX_'W_0.\/_\ @-/_ /'J/]6\Q_D_$/\ 7#*_YG]Q]WT5\(?\-Q^/O^@=X?\
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M^K>8_P GXA_KAE?\S^X^[Z*^$/\ AN/Q]_T#O#__ (#3_P#QZC_AN/Q]_P!
M[P__ . T_P#\>H_U;S'^3\0_UPRO^9_<?=]%?"'_  W'X^_Z!WA__P !I_\
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M_P"@=X?_ / :?_X]1_JWF/\ )^(?ZX97_,_N/N^BOA#_ (;C\??] [P__P"
MT_\ \>H_X;C\??\ 0.\/_P#@-/\ _'J/]6\Q_D_$/]<,K_F?W'W?17PA_P -
MQ^/O^@=X?_\  :?_ ./4?\-Q^/O^@=X?_P# :?\ ^/4?ZMYC_)^(?ZX97_,_
MN/N^BOA#_AN/Q]_T#O#_ /X#3_\ QZC_ (;C\??] [P__P" T_\ \>H_U;S'
M^3\0_P!<,K_F?W'W?17PA_PW'X^_Z!WA_P#\!I__ (]1_P -Q^/O^@=X?_\
M :?_ ./4?ZMYC_)^(?ZX97_,_N/N^BOA#_AN/Q]_T#O#_P#X#3__ !ZC_AN/
MQ]_T#O#_ /X#3_\ QZC_ %;S'^3\0_UPRO\ F?W'W?17PA_PW'X^_P"@=X?_
M / :?_X]1_PW'X^_Z!WA_P#\!I__ (]1_JWF/\GXA_KAE?\ ,_N/N^BOA#_A
MN/Q]_P! [P__ . T_P#\>H_X;C\??] [P_\ ^ T__P >H_U;S'^3\0_UPRO^
M9_<?=]%?"'_#<?C[_H'>'_\ P&G_ /CU'_#<?C[_ *!WA_\ \!I__CU'^K>8
M_P GXA_KAE?\S^X^[Z*^$/\ AN/Q]_T#O#__ (#3_P#QZC_AN/Q]_P! [P__
M . T_P#\>H_U;S'^3\0_UPRO^9_<?=]%?"'_  W'X^_Z!WA__P !I_\ X]1_
MPW'X^_Z!WA__ ,!I_P#X]1_JWF/\GXA_KAE?\S^X^[Z*^$/^&X_'W_0.\/\
M_@-/_P#'J/\ AN/Q]_T#O#__ (#3_P#QZC_5O,?Y/Q#_ %PRO^9_<?=]%?"'
M_#<?C[_H'>'_ /P&G_\ CU'_  W'X^_Z!WA__P !I_\ X]1_JWF/\GXA_KAE
M?\S^X^[Z*^$/^&X_'W_0.\/_ /@-/_\ 'J/^&X_'W_0.\/\ _@-/_P#'J/\
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MX97_ #/[C[OHKX0_X;C\??\ 0.\/_P#@-/\ _'J/^&X_'W_0.\/_ /@-/_\
M'J/]6\Q_D_$/]<,K_F?W'W?17PA_PW'X^_Z!WA__ ,!I_P#X]1_PW'X^_P"@
M=X?_ / :?_X]1_JWF/\ )^(?ZX97_,_N/N^BOA#_ (;C\??] [P__P" T_\
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M/Q]_T#O#_P#X#3__ !ZC_5O,?Y/Q#_7#*_YG]Q]WT5\(?\-Q^/O^@=X?_P#
M:?\ ^/4?\-Q^/O\ H'>'_P#P&G_^/4?ZMYC_ "?B'^N&5_S/[C[OHKX0_P"&
MX_'W_0.\/_\ @-/_ /'J/^&X_'W_ $#O#_\ X#3_ /QZC_5O,?Y/Q#_7#*_Y
MG]Q]WT5\(?\ #<?C[_H'>'__  &G_P#CU'_#<?C[_H'>'_\ P&G_ /CU'^K>
M8_R?B'^N&5_S/[C[OHKX0_X;C\??] [P_P#^ T__ ,>H_P"&X_'W_0.\/_\
M@-/_ /'J/]6\Q_D_$/\ 7#*_YG]Q]WT5\(?\-Q^/O^@=X?\ _ :?_P"/4?\
M#<?C[_H'>'__  &G_P#CU'^K>8_R?B'^N&5_S/[C[OHKX0_X;C\??] [P_\
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M1_PW'X^_Z!WA_P#\!I__ (]1_JWF/\GXA_KAE?\ ,_N/N^BOA#_AN/Q]_P!
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M_7#*_P"9_<?=]%?"'_#<?C[_ *!WA_\ \!I__CU'_#<?C[_H'>'_ /P&G_\
MCU'^K>8_R?B'^N&5_P S^X^[Z*^$/^&X_'W_ $#O#_\ X#3_ /QZC_AN/Q]_
MT#O#_P#X#3__ !ZC_5O,?Y/Q#_7#*_YG]Q]WT5\(?\-Q^/O^@=X?_P# :?\
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M??\ 0.\/_P#@-/\ _'J/]6\Q_D_$/]<,K_F?W'W?17PA_P -Q^/O^@=X?_\
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M ,!I_P#X]1_JWF/\GXA_KAE?\S^X^[Z*^$/^&X_'W_0.\/\ _@-/_P#'J/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1110%PHHHH"X4444!<**** N%%%% 7"BBB@+A1110%PHHHH"X4444!<****
MN%%%% 7"BBB@+A1110%PHHHH"X4444!<**** N%%%% 7"BBB@+A1110%PHHH
MH"X4444!<**** N%%%% 7"BBB@+A1110%PHHHH"X4444!<**** N%%%% 7"B
MBB@+A1110%PHHHH"X4444!<**** N%%%% 7"BBB@+A1110%PHHHH"X4444!<
M**** N%%%% 7"BBB@+A1110%PHHHH"X4444!<**** N%%%% 7"BBB@+A1110
M%PHHHH"X4444!<**** N%%%% 7"BBB@+A1110%PHHHH"X4444!<**** N%%%
M% 7"BBB@+A1110%PHHHH"X4444!<**** N%%%% 7"BBB@+A1110%PHHHH"X4
M444!<**** N%%%% 7"BBB@+A1110%PHHHH"X4444!<**** N%%%% 7"BBB@+
MA1110%PHHHH"X4444!<**** N%%%% 7"BBB@+A1110%PHHHH"X4444!<****
M N%%%% 7"BBB@+A1110%PHHHH"X4444!<**** N%%%% 7"BBB@+A1110%PHH
MHH"X4444!<**** N%%%% 7"BBB@+A1110%PHHHH"X4444!<**** N%%%% 7"
MBBB@+A1110%PHHHH"X4444!<**** N%%%% 7"BBB@+A1110%PHHHH"X4444!
M<**** N%%%% 7"BBB@+A1110%PHHHH"X4444!<**** N%%%% 7"BBB@+A111
M0%PHHHH"X4444!<**** N%%%% 7"BBB@+A1110%PHHHH"X4444!<**** N%%
M%% 7"BBB@+A1112$%%%%, K6\.^+=;\'WGVO1=5N]*N,\O:RLF_']X#J/8\5
MDT5G*G"HK35UYFE.I.D^:#L_(^H/AI^VYJVE^5:>,K(:M; X_M"T"QSJ/5DX
M1OPV_C7U=X%^(F@?$;2QJ&@:E#?0\!T4XDB;^ZZGE3[$5^65:WA?Q9K'@O5H
MM3T34)M.O8^DD)ZC^ZPZ,O RIX.*^0S#AG#XA.6']R7X?\ ^[ROB[%85J&*]
M^/XGZO4M?.GP*_:NTWQ[]FT3Q*T6D^(6(2.?(%O>'_9)^XY_NG@GIUP/H9"#
MR*_,\5A*V#J.G6C9G[#@L=A\PI*MAY77Y>I+124M<9Z 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ****5TMQV84444Q!1110 4444 %%%% !1112'8****5Q>844450!111
M0 4444 %%%% !1110 4444 %%%% !1110 444M "459L].N]2E,5I:S74O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M! $QX?)&/KY1S^=?.0[_ (_RK]9M%4?V/9<?\L4_D*_1^(L7#"^SYZ49WO\
M%T/RCA; 5,<ZG)6E3M;X=+GY:^-M2UG6/%6IWGB&*6#69I=]U%- 875R!U3
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MQ6SHG@GQ%XDM6N=(\/ZIJMJC>4TUC92S(& !*Y5<9P1^#"L[4M/FTG4+JRN
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MIM+0]T^('CSPM^S!X-TBUL]%\Q9F\FVLK7$>[: 7D=R#TR,DY))^M?)7Q_\
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MM%N)P#B-D)_#->9_&C]E'6?AGI<^N:5>_P!N:)#S-^[*SP+_ 'BJY#*.Y!&
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M=6#R'&XVG[6G&T7U;M?T/C>BOJ'_ (8EO;?QQ;V3ZM)=>&KB.1AJ-M$!+$X
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MD,ORG%YDG*C'W5NWHCY(HKZYU?\ 8K\.ZYI,EQX+\7O<S*/E^U/%<1.>PWQ
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BDIG8XI
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MMI<J9]I@(1EQ#B:C^*/,UZGR!\6/B?JGQ3\67>JW]Q*UGYK"RM'?Y+:'/RJ
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MXDVLSLI['@#/;=D<@5\,> _^1Z\._P#81MO_ $:M?5?[>)(\.^$QG@W,I_\
M'!66;485LSPD)K34WR2M4P^3XVK!V>A\<M(\DQD=W:5F+,Q8DDYZD_ES^=??
M7[/NNW/Q,_9XEM=9D:_D6*XTR1Y"2TB;2%!/<[6 SWQFO@.ONG]C'_DA]_\
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M /9*^*_#7_(Q:5_U]1?^ABOM3]HK_DU73O\ KCI__LE?%?AK_D8M*_Z^HO\
MT,5KD5E@:S\Y&?$EWF&'73E@?9'[=7_)-_#PQ_S%%_\ 1,E<?^PSX'M[[5-<
M\5W,0EDL]MG:,X!V,P)D;V;;M7/HQ]:Z_P#;J_Y)OX>]/[4'_HF2I/V%[B-O
MAKKT(QYRZLTC 'L88@/_ $$UX<:DJ?#SY>LK?*Y]%*E"KQ/%SZ13^Y'A'[2/
MC[Q#\1/B)JEKLO!HFF7+VEI:HK&,^62IEP!@LQR<^A [5Y[X1U;Q)X%UZVUC
M14O;.^MVR'2-L,,@E6&/F4XY7O7U#X@_;@G\/Z]J6EW'@96GLKF2VD/]JX^9
M&*GCR?450_X;X.,#P(@_[BO_ -HKU\/4QL,-&A'!IQM_,M?,\'%4\MJ8N5>>
M/:G>_P ,M'?;Y'8?M,:);?$K]G^Q\6BU\J_M(8-1BX^=$E""2,GT ;)]XQ7F
M?["7_(\^(O\ L'K_ .C!TIGQ _;./COP7J_A\^#Q9#4+=H/M U+S/+R/O;?*
M&<?45)^PC_R/'B+M_P 2Y>W_ $T''2N&-#$X7)Z]/$+E5]%>^CMV/3EB<+B\
M^PU7#2YG;WG:VJ]3/_;)^)VIZQ\0+GPI#=RP:-IL4?FVT;E5FE9!)N?'W@ R
M@#MAO6O$_ OC#4/ ?BK3M;TZY>VN+696?:2!(F061O\ 9(XQ[UV/[3?_ "73
MQ9_UWC_]$1UY?7T^ P]*.6QARJSCKYZ'QV98JM/-9U')W4M-=M3[=_;DTVWN
M?AIH>I/&OVRWU-8DEQR$>)RR_B43_OFO#OV/?E^.&G>UM<#_ ,<->^?MN?\
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M&-*O= G\N*T\T.A$=NHP0K YR<;>G0DU\Z6=G-J%U#:V\;2W$[K%'&O5F8X
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MO4+,T#@JT1R.57 Z]GQT KY5^(GA(>!/B?J^@H6,-G?%(MQ!/EDADS[["O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3/85WYEDU?&8^&)A)<JMZZ'FY3G^'P&63PE6+YG?5;:GGP[_ (_RK]9]%_Y
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MN2[?\.F?8?P<^!^B?!>PO(],FN+R^O2INKRZ89?;G:H X4 LQ[GGDGBOG_\
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MI/YTI9?4EF<,8I+E4;>80S*G'*)Y>XOF<K^6ABV7_'Y;_P#71?YU]N_MQ_\
M)(M#_P"PS%_Z(GKX>C<QR*RG#*<BNP\8_&#Q?\0-+AT[Q!K4NI644HGCB>*-
M '"LH/RJ#P&/?O1CL!4Q&+H8F+25-ZAE^94L)@<3AIIMU%I;]3C3T-?=?A__
M ),LG_[ -S_[/7PI79P_&+QC;^$3X8BUR5-":!K<V8BCQY;9R,[<]S59I@:F
M.]DJ<DN65]0R7,:>7.LZB;YHM:>9TW[*N?\ A?GA7']ZY_\ 2:6OJ_\ :.^#
M=O\ &;3X+;3KVUMO%.F(9X(YB/WD+DC:V.5!9,AL'E2.Y(^4?V4_E^/OA7CO
M<CZ?Z--7I7[8OBC5O!OQFT+5-$U"?3;^/1U"S0-@X,TN01T8>Q!''2OG,PI5
MJV=0C0ERS4='TOK^!]1E-:A0R"I+$0YH.=FNNOZG%^'?V//B'JVL1VNH6,&C
M6.[;)?37,<@"^JJC$L?K@9QR*]J^.GC'1/@3\'(OA_H4JMJ=W:&S2+<#(D+Y
M\V=\="Q+8Z99N.AKP&^_:M^)U]9M;'Q$(0R[6DAM(E<@C'#!./J,&O+-2U*[
MUB^FO+ZZFO;R9MTEQ<2%W<^K,>M>G_9V-QE:,\PE'EAK:/5^9Y']J9?@*$Z>
M60ESS5N:5M%Y'J_[)?\ R7CP]_N7/_HB2NJ_;G_Y*[IG_8%A_P#1\]>%>&/%
M&J>#=:@U?1KMK'48 PBG558KN4J>&!'()'XU9\9>.M=^(.J1ZEX@U!]2O8X1
M LTB*I$89F PJ@=6:NZ67U)9I'&)KEY;6ZGG1S*G'*)9>XOG<KWZ&%TYQG'.
M*^WOV<_B!HOQ<^$\O@#7)HVU*VLVL)('(!GM]NU)(\]U& ?0J#WKX@J:SO;C
M3KJ*ZM)Y+:YB8/'-"Q5T8=P1T-;YGE\<PI<CERRB[I]F<^4YI++*[G;FA)6D
MNZ/<?%W['/C_ $75Y8M'M(M>L"_[JZCGCA8J3P75V!!^A/0<UZ_^SW^SD_PE
MNIO&'C*ZLX+VW@<0P&1?+LUQ\\KR$X#8R.. ">3G \%TO]JSXFZ79I;KXB^T
M*G1KBVB=\>[%<G\?SKE/&WQ@\9?$*/R]?U^YO;;K]F&(H..1E(P ?J03[UXU
M3!YOBJ?U>M4BHO=K=H]^ECLCP53ZUAZ<W-;)VLF=)^TA\5(/BM\1);NP+'2+
M&/[):$\>8 Q+28[;F)]\!<\\#S?1=8N?#^L6.J63^7>6<\=Q"W/#HP9<^V15
M,_YXI/T^M?34,+3H4%AH+2UCY+$8NKB<3+%3?O-W/T]T"'1?'W_"+^/4C#S1
MZ>YMF)'[M9@A<-_M#9M]LM7Y^_'#QT?B)\4-=UA)/,M//-O:D'CR8_E0C_>Q
MN_X%4.B_&?QKX=\-#P_IVO3VNCA'C6U$:$*'R6&XKN'+$]>]<5[YS7SV4Y-/
M UYU:COTCY(^GSK/H9EAZ=&E%KK*_5VW.A^'WC"X^'_C;1O$%L"\EC<+(8UQ
MF1#E73G^\I9?QK[9^*'P\T7]J/X?Z;K/AS4K==1@!>TNCT&0-T$N.5YQV)!'
M3FO@6N@\'^/O$7@&\:Z\/ZO<Z9(V PA;Y'QTW*05/Y&NO,LMGB:D<5AI<M2/
MXG#E.;4\'3GA,5'GI3Z+H^YZ+#^R+\3IM26U;1((82<&\:\B$*@]R Q; ] N
M?SS7TA:Z-X7_ &6?@O/%JS6^J7\[-*T<D:YO+HJ $53T08'T )[U\V3?M;_%
M"6'RQX@CC;_GHME!N_5/Y"O,O$GBK6/&&I/J&MZE<:G>-QYMRY8J/11G"CV
M%<-3 9CCG&.-J14$[VC>[/1IYEE>6J<\OA*51II.5K*_H4+NZDOKJ:YEP99G
M:1RJA02QR< # Y)X%0T45];%<J21\0VY-R?4/\\U^AOQ,\#S?&_X%Z;9:)>6
MZW,\5K>6[W#'RWPH.UB <9!/.#SBOSR_2NX\%?&[QO\ #VQ-CH/B"XLK,G(M
MVCCFC4DY.!(K!>?0#K7@9M@*^,=*IAY)3@[JY]/DF:8? JK1Q47*G45G;<T;
M[X::Q\*?BUX;T;6C;F[>[M;A6MG+H4:8 ') /56[#IWKW_\ ;R_Y%_PE_P!?
M,W_H"U\O>*/B9XE\:>(+/7-9U-KW5;3:(+@Q1H4VOO4 *JCACGIWJ3QI\5?%
M7Q$AM8/$6KR:G%:L6A62-%VD@ GY5';%92P&*K8C#XFK)7IWYO\ @&D,RPM#
M!XK"T8RM4:Y;]$NYRM?=/[&/_)#]0_["$_\ Z+CKX6'4=^>E=EX1^,GC+P+H
MKZ3H6NRV&G.[2M"D4; LP )RRYY %=6;X&IF&'5*FTG=/4X\DS"GEN)=:JFT
MXM:>9B>#_$]SX+\6:7KMI@W&GW*7"JQPK!3DJ?8C(_&ON?Q]X1T']JSX96%_
MHE_%%?P$RVMPX#-!(5&^"4#E<_+GK@A3@CK\ \Y.,9]#_GZ_E6YX3\<:_P"!
M=0-YH&K7.ESM@,8'(#@=-RD$-^(-8YAE<L2Z=>A/EJ0V?0Z,KS>&$53#XJ'-
M2J;KMYGHX_9'^)W]I"U_L.$0[L?:OMT7E;<]?O;\?AFOI+P[X5\,_LN?!V[E
M\0RV]_>3-YMQ\BL;JX*X6&)2.0 ,#_@3$ 9Q\UM^UO\ %%[<1CQ!&C8QYBV,
M&[Z_<(_2O-O%/C+7/&VHF^UW5+C5+KHKSN6"CT4=%'L !7#4P.99@XT\94BH
M)W?+>[^\]*GF64Y<I5,#3E*HU9.=K*_H4-5U&75]4O+Z8(LUU,\[K&H5 6;/
M [#KQVQ56BBOKHI)66R/AY2<VY/J%?<W[3G_ ";-IG_;C_(5\,UV7B+XQ>,?
M%GAV/0M7UN2\TE-@6V:.-1\G"\A0?UKQ<?@:F+KT:L&DH.[N?099F-/!X;$4
M9IMU%96_4[K]CS_DMVF_]>MQ_P"@5I_MM?\ )9(/^P5#_P"ARUXQX5\7:OX(
MUA-5T2]:POT5D6955B%/488$>M2>+_&NM^/-5&I:]?OJ-\L8B$TB*I" D@84
M =SV[U#P-1YG]=37+RV\QK,J:RAX#E?-S<WD9%O<RV=Q%<02-%/$P=)%ZJPY
M!_.OTH\%S:5\8/"_@GQC/&&O+,-<QE>B3&-X9D/L&S^*@U^:1_6NU\)_&;QG
MX&T5M*T/7YM/TYG:3R51'"ENIRRDCIV-99UE<\PC!TI*,H]7V9TY!F]/*IS]
MO%RA);+OTW.@_:9\>'QY\7-7ECD\RRTX_P!GVW/&V,D,1V.7+D'T(KSWPSK]
MUX5\1:;K-EC[587"7,>[."5(.#[<<^V:S68L2223GG/7\:2O8H86%'#K#=$K
M'@XC&5:^*EBF_>;O_D?H!XNT#P[^UE\*[6XTN_CMM0A/FV\S ,]K-C#12 '.
M#W]<*1D<'YCE_9&^)T>H?9AH<$D.[:+I+V+R<9QGE@V/;;DUYKX5\9ZYX)U#
M[=H.J7.EW)&&:!]N\#H&7HP^H(XZ5Z0W[6WQ0-N(AX@C5L8\P6,&[Z\QD?I7
MS='+\RR^]/!3C*%[I2Z'UE;-,JS2U3,(2C46C<;:^MSZ3\%^"/#?[,/PGO[O
MQ/<6]Y=W#"2\8(&\^3!$<$2L!N !;&<=6/ SCXK@\82#Q\GB>:SA=AJ/]H/:
M!!Y1_>;S'M_NG&/IC\8O%GC?7O'6H?;=>U6YU.XQA6F?Y5]E7HH]@ *P_P#/
M)Q7H9?ELZ'M*F(GS3GOY>AY>:9M#$NE3PL.2G3V[_,^\/BU\+=*_:.^&^A:M
MX0N[2&XMU:6RRNR)U; >)L#*D%!VX*D=^/G"U_9+^)]QJ MFT!((RV#<2WL'
ME@<_,=KEOR&:X/P;\2/$WP_N&F\/ZS=:86Y:-6!C<^K(P*D^Y%=X_P"UK\4'
MM3#_ ,)"@;;@R_88-_Z)C]*\^C@LTP*=+"SC*&MN:]U<]2OF.3YBU6QL)1J:
M7Y;6=O78^D]:FLOV;?V<O[#O[^.[U1K6>WMU!_UUQ*68A%Z[%+DY]!D\FO@P
MG_.*U/$?BC5_%VI/?ZUJ-SJ=XW_+:YD+D#^Z.R@>@Q657J97E[P,)NI+FE-W
M9XV<9HLQG"-*/+3@K);NP9Q@]<'->H_LY_%*/X4_$:WO;QB-)O(_L=XP&=B$
M@B0#_9(!/^SNQS7EU%>GB,/#%494*FS5CR,+B)X.M'$4]XNY]M_M"?LZM\8)
MK;QAX/NK2;49X$$L>\"*\0#Y)%D!P&Q@<\$ <C'/C/A7]CKQ_K&K10ZO9PZ#
MI^_][=2W$<QV]]JQL2Q^I'U%>>^!_C%XQ^',?E:!KMQ:6V<FU8++#]=C@@9]
M5ZXKI]6_:J^)NK6CVS>(S;1NNUFM;:*-_P#OH+N4_0BOEZ6"S?"T_JU"I%PZ
M7W2/L:V89)C:OUK$4YJ;U:5N5O\ ,^B/C]X^T/X+?"6/P'HDRMJ5Q9_88H8V
M!>&$KAY7QT+ G'3+-QT-?*'P9X^+G@W_ +"]J/\ R*M<G>WUQJ5U+=7<\EU<
MRL7DFF<N[L>I8DY)J32-6N]"U2TU&PF-O>VDJS03 9*.IR#@@CKZUZ6#RM87
M"5**E>4[W;[L\G'9P\;C:==QY80M9+HD?5?[?7^N\#_2]_\ ;>ODFNH\;?$W
MQ-\1C9GQ'JLFIFSW^1YD<:>7OV[ON*.NU?RKEZWRG!SP.$C0FTVK['-G6.AF
M.-EB:::3MN%=]\ _^2S>$#_U$(_YUP-=_P# /_DLWA#_ +"$?]:ZL<KX6K_A
M9QY?_O=+_$OS/MW]H#X4V/QB\.PZ,M_;V.OV^Z[L'E.3@85@1][8<J"<'!VG
M!Z'Y/T_]C_XDW>L+:SZ7;65KN :^DNXVB"YZ[58L<=<8Y_&O3OVV]<U#P[XJ
M\$:CI=Y-8WT$5T8YH'*LIS'W'M^??BO(I?VL/B?)9F >(E0;=OF+9P;R.G79
MP>>W2OB<HHYE#!QEA9QY)?S=/0_0\\KY14S"2QL)<T?Y>OJ?1GCK7-$_9=^"
M:^&=*O1<:]<0M';*S!99)7R'N& ^Z!R1[A5YKY__ &1_&%CX1^+]O_:$RPPZ
ME:R:>LK\!79D9>>V3'M_&O)-8UK4/$.H2WVIWMQJ%[(?GN+F4R.<=.3VJE_^
MNOH,/D\:>%J4:LKRJ?%+S/F,5GLJF+HUZ$.6%*UH^1]B?M4?L]^*?'7BZ'Q+
MX<@75@]LD$]GY@22,J6(9=Q *G/0<@@]<G'E_@K]C_QUKVJ1+K=HGAO3=V9K
MB>9)'*]]BHQY_P![ ]ZY?PQ^TC\1?"=C%9V?B2:2SB&$CO(DG('8!W4MCVSB
MJ?C+X^>/?'=JUIJ_B*X:S<;6MK95MT<=PP0#</8DUR8;"9MAZ2PT:D5%:<VM
MTO)'9BL;DF)JRQLJ<^=Z\NBC?S>Y]TS6NAZQ\%=>T#PE/#J-C:Z7<Z3"MN^]
M=ZPE-F[N>1D^IK\U>HSR/QQC_/%=AX-^+WC#X?Z;-8>'];ETZSFE,[PI%&X9
MR -WS*>RJ/PKDIYGN)I)9"&>1MY(&,D\YX Q^''%=>49;4RZ553ES*>M^OS.
M//,VI9I"BZ<>64%:W3Y'Z"^(?!TOQG_9KTK2M(NK9+JZT^SDADFR(@Z;"5.,
ME?NL..A^E?''BGX6ZS\)?B!HFDZV;=KF9H+E&M7+H4,I7J5!SE3Q[U3\$_&?
MQI\.[5[7P_K]Q8VC-DP&-)HP2>2JNI"Y]0.:I>,/B9XF\?:M::GKVJ-J%_:@
M+!*88XRG.1@(JC[W/([5S8#+<;@JDX<Z=*5_6[.K,LUP&.ITJCA)5H\JZ6LC
MZR_;H7;\-_#HS@C5 2?^V,E>,?LG_%VS^&WC*YT_5YEMM&UA4B>=SA()5)V,
M3V4AB">Q()XKSSQI\7O%WQ#T^"R\0ZU+J=K#()HHWBC0*VTC/RJ#T)_.N/\
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M]792Q_$UPU,LQ>%Q$\1E\E[V\9;7/3IYM@L7AH8;-(-\GPRC:]NS1[%^S_\
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MY<_SS7I?A7]H[XA^#K&.QL/$<TEH@PD=Y&EQ@>FYU) 'IG%?,XC+<13Q3Q>
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M^R?\%O[(L+Q;K7KA7,&\@/<7+##3%><(O''HJKG)KX8M"3?0$Y.9!R22>O\
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M,\#CL#3IU8256"LGT.-HHHKZH^,04444#"BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!UWPAC,GQ7\&!>O]M69_*=#7ZB@5^9O[/]
MB^H?&CP?$@RRWZ2_@@+G]%-?IG7Y;Q8[XFFEV_4_9N!XVPE5]Y?H**6FK3J^
M&/TH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH]0] HHHH!!1^@
M]:*W_ /AM?&'C;0M$D9DBO[V*WD9/O!&8!B/<+FLZDU2@YRV2N:TZ;JU%3AJ
MV95CI=YJ<A2SM)[MQU6&(MCC/;VJ&>WEM9#'-%)"XYVR @X^A%?H1\3OBCX9
M_9G\.Z+I]GH7FK<;EMK*T*Q@*@7<[,>I^9>3DDY)KY$^/OQH7XT>(-.OX=.;
M2X+.U\GR&E$GS%R2V0!P1M_(U\]E^:8C,)J4:-J;O[U^WD?39KD^%RVGR2Q'
M-55O=2[^9Y=1117TFA\GH@HHHH&%%%% PHHHI[;B"BBBC;4 HHHH]0]0HHHI
M!ZA1113#T"BBBC4 HHHHWV';6P4444[.]A!1114AN%%%=7\+/!4?Q$^(&C>'
M9;IK.*^E*O,BAF551F. >Y"X_'O6=2I&C"52>R5S:C2G7J1I0U<M$<I17N/[
M4_PST+X6:UX<TG0K8Q1-8M)++(Y:29]Y&YCZ\=L =A7AU8X3$QQE&-:FG9G1
MCL)/ 5Y8>J_>04445U'$%%%%,04444M ] HHHH>P!1113\@"BBBD 4444P"B
MBBCK884444>8O,*?%#)<2".*-I7;HB#)/TIE=_\  ;Q9IG@?XL:%KFL3-;Z;
M:F8RR*C.1N@D0?* 2>6%<^(J2I4ISA&[2O;N=.%I1K5H4YRY4WOV.%N+6>U8
M":&2$MR!(A7/TXJ*OI;]M[48-2\2^$YH"62736G3*E3L9P1D?A7S37/@,2\9
MAXUW&U^AU9E@U@,5/#QES)=0HHHKO/,"BBOIS]A>T@NO%OB99X4F4646 ZAA
M]\^M<&.Q:P6'E7M>W0]/+<$\PQ4,,G;FZGS'17I'[1T:0_&WQ8D:JB"Z7"J,
M ?NTKS>NFA5]O2C4VNKG+B*/U>M*DW?E;5PHHHK;K8YO4**** 04444 %%%%
M,-MPHHHHWV **** "BBB@ HHHH ****5T 4444P"BBB@-]@HHHH#R"BBNB^'
M*AOB%X85E# ZI:@@C(/[U:SJ2]G!R[*YK2I^TJ1IWW=CG:*^P?VZ+.WM?#_A
M0PP1Q$W,P)C0+_ M?'U<&78W^T,.L1RVO?\  ]+-<O>68IX9RYK6UVW"BBBO
M2/("BBIK,9O( 0"/,7@CKR*F<N6+EV+C'FDH]R&BOM?]MZRM[?X7Z&\5O'$S
M:LF610"?W$M?%%>;EN._M##^WY;:M=]CU<UR]Y9B7A^;FLD[[;A1117JGCA1
M110&V@4444#MK9!11Z5]3_L]?&+P!X+^$]QI'B+48[?5I)YW6)K&:4[64;?F
M6,CMZUYV.Q-3"TU.G3<W>UE^9Z678.GC:G)5J*FK-W?Y'RQ12TE=Z>EV>=)<
MK:"BBBG<FS"BBBF 4444>;'9[!1110+?8**** \PHHHI!Y(**^C/V5_@)H/Q
M,L;_ ,0:^\MU;V-S]F33T.Q'8(K%G8'<1\P^4$?=Y)'%>!^((4@U[4HXE"1I
M<R*B@< !C@#M@#%>?1QU*MB*F'AJX;GIU\OJX?#4\54TC.]NYGT5]O?L^6-M
M-^RWJ$KVT;R>1J'SLBY_C[U\1>OUK+!8_P"N5:M/EMR.V^YT9AECP%&C6<K^
MT5]MA****]7R/$"BBBGUL'F%%%%( HHHIC^84444!8****+-B"BBBD,****8
M@HKTC]G.))OC9X31U5T-RV589!_=O7IW[<UK#:>./#RPQ1Q*=/8GRU"Y_>&O
M)J8]0QT,'R_$KW/;IY:ZF7SQ_-\+2M;N?--%%%>MZGB!1110 45UOPFUK3_#
M?Q)\.ZGJLH@TZUO$EGD9&?:HZG:H)/X"O3?VK?B1X1^(M_X<D\)WB7<=K%.M
MP4M9(,%BFW[Z+G[K=*\ZIB:D<5"A&FW%KXNB/5I8.E4P<\2ZJ4HNRCU?XG@M
M%%%>CY'E!1112!Z;A1113\@V=F%%%% [!1110(****/,'HFV%%%%&VX>@444
M4ET[@%%%%/0 HHH_SS0 45]-_LZ_ #P]XJ^'][XRUOS-0E3SX[>Q;Y8HR@X9
ML<L?8X ]#7S(.W&/I_\ 6Z5YV'QU+$U:E*G]C?U/3Q67U<)0I5JME[172\@H
MKZG_ &>_C'X \%_">XTCQ#J,=OJTD\[K&UC-*=K*-OS+&1V/>OEFC"XJIB*M
M2G*FXJ.S[^A6+P=+#T*56%52<]TOL^NHE%%%>B>4%%%%&P:7LF%%%%%N@!11
M10 4444>@>H4444 %%%% !1112^8]0HHY[=:^XO!EA;/^QI=3&WB,HT*^.\Q
MC/\ RU[UY.8YA_9ZIOEOS.Q[>5Y8\RE47-R\D7+:]SX=HHY_SS17K^9X8444
M4:V&%%'Z5]->+O@!X>\"_LWW7B<^9J&O7EO9SK=2Y @626(E(TZ=&*Y.3]!Q
M7GXK'4L'*G&IO-V1Z6#R^MC54E3V@KL^9:*DMF6.XB9^%5P3D< 9]*^G?VH?
MC!X$^('P^TW3O"^H1W>H0ZE'/(B6<L)\L12J3ET4'EUXSWJ,1BJE&M2I1IN2
MGNUT]2L+@Z>(P]6M*JHRAM%[R]-3Y>HHHKTSRNEPHHHH"S"BBBE=""BBBF,*
M*** ] HHHI>H_4****8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H_E12T@/=/V,]!.K
M?&:&Z*Y33;.>XW8X!($>/RD-??U?+/["/A-K7P]X@\1RI@WEPEI"3_=C!9B/
M8L^/^ 5]4U^-<15E6S":7V;(_H#A3#/#Y9!RWE=C5IU%%?-'V 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% "'M7PG^W1_R5[2_^P)%_Z/GK[L/:OA/]
MNC_DKVE_]@2+_P!'SU]7PS_R,8^C_(^)XP_Y%4O5'UW\&_\ DD?@G_L"6?\
MZ(2NRKC?@W_R2/P3_P!@2S_]$)795\W7_BS]7^9]7A/]WI_X5^04445@=844
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% "-2"G44 <I\3_!\7Q \
M:YH,F,WMLR1,W191S&WX,%/X5^75Y:S6%U-;7$30W$,C1R1L,%6!P0?H<_K7
MZW-C;STKX0_;(^%[>$_'2>);.WVZ7K7,K*/E2Y ^8>VX#=[D-7W/"^-5*M+"
MRVGMZGYIQIESK48XR"UCH_0^>J***_43\:"BBBF 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:;XI.J7[W@S9[HC]]SD\'/%>J_L+?\DW\0?]A0_^B8Z^-_$G_(Q:M_U]2?\
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M;5\$6_AWX@6&MVL:Q)K<#-*J@ &:(@,WXJZ?B">]>P^"_P#DRN[_ .P#??\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA:.+K\\KIM62Y?+0]-_;N8_\)MX;&>/L#G'_ &T-?,7MC-?3G[=W_(\>'/\
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M@M7#:Q_R%KW_ *[R?^A&NX_9Y_Y+5X1QU^VC_P!!:OM\3K@)7VY?T/SO"_\
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M*SE+3S/-SG#5J^5X2O3C>,(ZM=#Z9_9#_P"2 WO_ %]77_H(KX5-?=7[(O\
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MSC_;3Q5=V4[ZOI?8]/U[]N"70=;U#3)_ B^?9W$EM(?[5QED<J?^6/J*H_\
M#?![>!%_\&W_ -HJ_P#M"?LL7WC77YO%7@LV\\M]M>ZT]I!'O?',D;'Y?FX)
M!(YR<Y)KSCP#^QSXUUK7H5\26T>@:2C@SR&XCDE=>XC",PR>F6P!Z&O%H4<B
MGAE5J:22U7,[W]+GT&)Q'$D,4Z-+6+>C45:W>]C8^(7[99\>^#-6T ^#Q8C4
M(&@^T#4]_EY_BV^4,XZ]17S3^E?8?[7GCCPYX;\(VO@728+4ZHRQ)*L<2DV=
ML@!50W\+':@ _N\GMGX\_#'^?\_E7T>11HK#N=&E[.+=[-MW\]3Y3B*59XM4
MZ]95)15KI)6\M K8\)^+-6\$ZY;ZOHE[)8:A ?DECQR#P5(/# ^AXK(%?3_[
M%'C?1;+4M2\,:I';17UXZW%A/)&-[MMQ)'O/.<*K ?[U=^95OJ^%E4=/G75>
M1Y>5X;ZUBXTE4]FWM+S+_@_]NRYACCA\4>'5N!_%=:9)L..G^J<XS_P.O5-'
M\<?"7]HQAIMQ:6MYJKQG%IJ%KY5TH YV2#J1U^1C7A7Q4_8\\5Z?XDO+KPG;
M1:QH]Q(TD4*3I%- "<["'*J0,X!'8<CFNA_9Z_9=\5^&O'FG^)?$\<>D6^G,
MTB6JW"22RN5*CE"5"\DGG/&,<Y'P^*HY2\.\5A:G).UTD];]K;GZ+A,1GGUE
M8/%TO:4[V;:TMWN>2_M%_!^/X0>-EM+&1YM(OXC<6;2G+ISAHR>^#@Y]&'4Y
MKZ=_:Y4ZC\ X[JU;_1TNK6=MO="2!^K+7A7[8GQ$T_QI\0+/3M,F6YM]%A:&
M2=#E6F9LNH]0-JC/KN]*]F^ 'C[0_C5\(Y? NNS(=3M[/[%+;L0'EA Q'+'G
MJ5 7GJ&4$]16^*>(^JX3'5E?D>O>W=F&$^JO&8W+J$DE45H]K]CX<]![?Y_K
M7>_ :UDO/C)X02)BKKJ,4G'HIW$?D#7<>*_V./B!HNK2PZ19PZ_8[\174-Q'
M"=N>-RR,"IQZ%OQKV?\ 9[_9Y_X4ZUSXP\8WEI!?PP,D<9<>59H?O.TAXW$9
M'' !/)SQ[F.SG!_5)>QGS.2LDM]?(^<RW(L>L;#VU-QC%W;:TT\SF?V]KA?.
M\%0<&3;>.?4#]R/\?RKM/!?_ "97=_\ 8!OO_:M?,W[17Q2A^*WQ&N+^RW?V
M39Q_8[,M_&JLQ,F.VXL3ZX"YY&!],^"?^3++S_L WW_M6OG<5AY87+L)3GH^
M:_I<^JP>*AC,UQM2GJN1I>=CY.^!O_)8O!W_ &%(/_0Q7O/[?'_'YX*_W+S^
M<%?,W@WQ"WA/Q=HNM!3)_9]Y#<F,'&\(X8K^(&*^Y_CY\+$_:"\"Z/J'AV\M
MY;ZUS<6<CM^ZGCD4;DW#."=JD''51TZCU\TFL+FF&Q-3X+-7/"R:G+&9/BL-
M2UFVG;JS\_\ ]?;UK[L^$L+V_P"QK<JXP?['U-OP+SD'\C7AGAC]C3Q]JVJI
M'K$-KH-@K_O+F2=)B5S_  *A.3C^\1W_ !^J-2_L.U^!/B;2_#UPMSIND:1=
MZ<KJ<C=%"589[D'@GUS7%GV/P^*5*G0ES6DF[;+YGH\-Y;B<(ZU;$1Y$X-)/
M1OY'YO=OPK[K^.'_ ":#;?\ 8/TS_P!&0U\*?PBOT#N/"LGQB_9<TG1M)O(4
MNKK2K(1RS$E!+%Y997(!(^:-E)QP:[N()1IU,-4D_=4M7VV/-X8C*K2QE&&L
MG'1=SX"LO^/RV_ZZ+_.OMW]N3_DD>B#_ *C47_HB>OE7XA_"?7/A'XDTW3M<
M^S-+<HL\;VKLRE=Y&#D#D$<_4>O'U3^W$?\ BT.B9.?^)S$?_)>>L\QK0K8_
M!5*;NFW;[S3*Z-3#Y9F%*JK225R+]A>>.3X9Z_;@CSEU5I&_W6AB _\ 037Q
MQXMMI;/Q7K5O<$F>&]FCDS_>$C _K7KG[)_Q>M/AKXRN+#5YEMM%UA4B>X;[
ML$RD[&+=E^8@^A8$\ FO4OVA/V6=0\:>()O%7@TV]Q-?8DN=/9UC5GQ_K(V/
MRG=U(/<DYY-3"M#+,VK/$Z1J;/H74HSS;)*"PGO3I:2CUMY'QY7WEX,4Z3^Q
MK.;CYL^'[R0!NX=9&0?DPKQ#X??L:^,-9UJ$^*($T#2(VW3-Y\<LTBC^%0C,
M 3ZL>/0]*]&_:X^*FD>'?!2?#W07B:ZF6..YAMF&+2!-I6,^A;"C'9<D]1F<
MUQ-/,Z]'"X5\UI7;6R+R;"U<HP^(QF+7(G%Q2>C=_(X7]A?_ )*EK'.?^)1)
M_P"CHJXC]JP8^/GBH?[5M_Z2PUVW["X_XNCK..G]D./_ "-%7%?M6<_'SQ5_
MO6W_ *2PUU4O^1_/_!_D<=77AJG_ (V>3>OTK[E_;"_Y(-I1_P"GZV_]%O7P
MUZ_2ON3]L#/_  H;2O\ K^MO_1;U6;_[_@_\1.1_\B['6_E/B72=5O-#U*VU
M#3[F2SO;9Q)%/"<,C#N#_GT[XKZ5\$_MR:SIL45OXFT2#5PH"-=V<GDRG'4E
M""K'Z%17)_LB^.-&\*_$*;3];2W%OJL:Q6]S/&I\J=3E1G^$,&8'W"UW?Q\_
M91\0:UXQO_$7A"*'4(-0D\^>Q:9(I(Y3DL5+84J3SRV02>HI9A6P5;%?5<PI
MI*VDKV_$,KH9A1P?US+:K;O9Q2_&VM_N/3=!^-GPG^.DD&C:E:P?;IV\N&RU
MJS4,6/9'Y4-Z8;=GI7SW^U)\";#X3ZGI^IZ$)$T34BT?V>1BQMY0 <!CR5(S
MC).-I]L:GPG_ &2?&S>,=*O_ !%:IH.F65S'<R,UPDDLFQ@VU C'!)&,G&.O
M/0[W[;?Q%T[5KC1_"5A.MQ<6,K75XR<B)BI5$/\ M8+DCME?6O+P<:>%S.G1
MR^HY0?Q*]TCVL=.IC,HJULSI*%1?"[6;^1\JT5ZW^S_\#8?C9>:S!-JTFE?V
M?'$X:.$2[]Y8=R,8VUR_Q?\ A_'\+_B!J7AN*\>_2T$9$\B;"V^-7Z9/][%?
M:PQU"IB7A(OWUK8_/IY?B(858UQ_=MV3_P" <91117=IT/-"BBBF 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 444^.-YI$CC1I)&(554$DD] /K0-)O8T/#?AS4/%VNV6CZ5;FYU"\E$448]
M3W)[ #))[ &OTQ^%/PZL?A=X)T_0K(!FA3=<3XYFF/+N?J>GH !VKRW]EGX
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MU?#/_(QCZ/\ (^)XP_Y%4O5'UW\&_P#DD?@G_L"6?_HA*[*N-^#?_)(_!/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %'^>]%% ';^!_C3XU^',/V?0==GM;0'/V60++%[X5@0O
M_ :Z'6/VIOB;K5F]K)XD>VB<88V=M%$Y^C!=P/T(KR>BO/EE^#J3]I.DF_0]
M.GF>-I0]G"M)1[7)KN[GO[J6YN9GN+B5B\DTCEV=CU))Y)_&K&B:U>^'=6M=
M3TV<VU_:R"6&90"48=#@@BJ-%=KA%QY6M.QYZG)2Y[Z]^ITGC3XC>(_B)/:S
M>(=4DU.2U0I"TB(I4'!(^10.PKFZ**5.G"E'DIJR\AU*DZLG.HVV^X4?I116
MAGT.K\$_%3Q5\.Y';P_K5QI\;G+P#;)$Q]2C KG]:[*__:N^)U_;-#_PD*VP
M8%2T-I$K'(QP=F1]17D5%<%3 86M+GJ4HM]['HTLRQE&'LZ=62CZLMZIJU[K
ME_+?:C=SWUY,=SSW,A=V^K-R?QJITYHHKM45&/*E9(X)2<Y<TG=G>>!?CEXV
M^'-J+70]<EALATM9U6:(?0.#M_X#BK7B_P#:&\?^.-.DL-3\0S?8I 5>"VB2
M .".C%%!([8/%><T5QO X253VCI*_HCO68XQ4O8JM+E[7=CKK3XL>++#P:_A
M2WUB2+P\R/$UBL<>-KL6<9VYY+$US.GWT^EWUO>VTAANK>59HI5 )1PV0>?0
MX[57HK>%&G3NHQ23WTW.6>(JU+>TDW;;5Z>AUGC3XJ^*OB);VL/B+5Y-3CMF
M+Q+)%&FQB "?E45R=%%52I0HP4*:LB:M:I6ESU9-ONPHHHK4R);:ZFL[B.>W
MFDMYXSN26)BK(W8AAR#[UZGI?[4WQ,TFQ2U3Q$US&@PC75O%(X_X&5R?QS7D
M]%<M;#4,3;VT%*W='9A\9B,)?V$W&_9LZ[QO\6/%WQ$5$\0ZY<ZC!&<K;X6*
M+/KL0!2>O)&:Y)OFZ_I245K2I0H14*<4EY(QJUJN(ESUI.3\SKO WQ9\6_#=
MW_X1_6I["%VR]N<20L?='!&??CZUTWB#]I[XD^)+%K*X\226]NXP_P!C@2%V
M_P"!(NX>G![UY717-+ X6<_:3I)R[V.NGF.,I4_90K24>UV=?X5^+?BWP3HM
MSI.B:S)8:=<R---;K'&V]F4*22RELD*!U[5R ]C[YZT45T0HTZ;<H*S>YRU*
M]6HE&<FTMK]#L_!GQD\9_#V!H-!\075E:]1;-MEB'^ZCJ5'X=:ZK4/VK/B=J
M%JULWB(0J>&D@M8D<\?WMN0?I7D5%<U3 82I+GE2BWZ(ZZ>98VG#V<*TDO5E
MK4M5O-:OIKV_NYKV\F.Z2>X<N[GU9C58<'//X'!_G245VJ,8KEBK(\]RE)\S
M=WW/3M+_ &EOB9HVFQV5MXKN?(C7:/.MX9GZ8^^Z,W3'4]Z\]U?5KO7-4O-1
MOI3/>W4K332D %W8DLV%P.23VJG17/2PM"A)SI046^R.FMB\1B(QA6J.26UW
M<[CP1\:O&GPZA%OH6O3VUH#G[+*%EB'T5P0O_ :W]9_:F^)FM6;VLOB1[:%Q
MAC:6\4,GX.%W _0BO***QEE^#J3]I.DF_0Z(9GC:</9PK24>UR6ZN)KRXDGN
M)7GGE8O))(Q9F8]22><_4UJ^$_&6L^!=6_M/0KY].OO+:+SD16.TXR,,".P[
M5BT5V2IPE'DDM.QP1J3C)34GS+J;'BKQ=J_C?6)-5UR\:^U"155IF55. , 8
M4 <#VK/T^_GTN^MKVUD,-U;2+-%( "4=3N!Y]"*KT41IPA#DBM-K!*I.4_:2
M>OX_>=5XT^*7BGXB1VL?B+5I-32U+-")(XUV%L _=4?W1^5<K[_SHHI4Z<*,
M>2G%)?@.K5J5Y<]63D^[.SO_ (Q>,=3\(IX7NM;EFT%(([=;'R8P/+CV[%!"
M@\;5[YXKC#^G\_?_ /7112IT:=&_LXI7WL.K6JUVG5DY6TU.I\%_$[Q3\.YG
MD\.ZW<Z:'.YH48-$Y]3&P*GZFNWNOVLOBA<Q>6OB%8<\;XK*')]>J8%>/T5S
M5,!A*LN>I2BWWL=E+,L91A[.G5DH]DV7]<U[4O$NI2W^JWUQJ-Y)]Z>ZD,CD
M=ADG@>W2G^'?$6H>$]:M=6TJY:SU"V):&=5!*$J5/!!'0D?C6;177[.'+R<J
MMV.'VM3G]IS/F[W.C\:?$+Q#\1+RWN_$6I2:G<6Z&*-Y(T4JN<D?(H'6N<HH
MIPA"G%0@K)=$.I4G6FYU'=OJS=\)>.-?\#:A]LT'5;K3)VP&\AR%?TW*?E;\
M?2O18_VM_B@L&P^((V;&/--C!N_ ;,5X[17)5P.&KOFJTHR?FCKH9AB\+'DH
M5917DV;GBSQQKWCJ^%YK^JW.J7"Y"M.^50'J%7HH^F!6'1175"G"G'D@K(XZ
ME2=67/4=WYA1116AF%6]*UB^T'4(;[3;R>QO8CF.>WD,;J3QP1S52BIE%27+
M)71492@U*+LT>OV_[67Q/M[3R!XB63@J))+*$OCIG.SD]^]<CI?Q@\9:/XFN
M_$-KX@NUUJZA,,UY*%D9H\@[?F! 'RC@ 8Q7'45Q1P&%IW4:45??0]">98V;
MBY5I/EVU>AH^(/$&H>*-9NM6U6Y-YJ%RX>:=@ 7(&.P'85T>@_&/QEX9\,MX
M>TW79;71F61#:K%&RE7)W\E<_P 1_.N+HKIE1I32C*":6RL<M/$5J<W4A-J3
MW?>XOL>O>D_4>E%%:V.?K<])\(_M%?$'P3IZ6&F^(9FLXU"QPW4<<X0#H%+@
MD?3./:J'CGXX>-OB-:_9==UV:XL<@_98E6*(X.?F5 -W/][-<+17"L#A54]J
MJ24N]E<]%YEC94_8NM+E[7=CKM6^+/BW7/"=OX9OM9DN-#MXXX8[-HXP%6/
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MI]5H<GLN1<N]K:&?US$.K[;VCYMKWUL/FD:>1Y7;<[L6+8 R3U/%7-!UV_\
M#.L6NJ:9<-:7]J_F0S*H)1NF<$$=,U0HK=QBURM:=CF4Y1DIIZHZ7QK\1O$?
MQ$N+:;Q%JDFIRVRLL321HI16()'R*!V%<U112A3A3CR05DMDBJE6I5DYU'>3
MZL]'\)?M$_$'P58QV.G>(IFLT&$ANHTGVCT!=2P'L"*H>,_C5XS^($L#:WKD
MUQ%;NLL5NBK'$K*<AMB@ D>I!KAZ*Y%@,)&?M%37-WL=CS'&2IJDZTG'M<ZS
MQI\5/%7Q$M[6'Q%J\FI16K%X5>-%VDC!QM4'H!7)T45U4Z<*,>2FK+R.2K6J
M5Y<]65WW84445IY&)Z#X,^/WCSP#8I9:1XBGCL5QMMKE$G10.@42 E1[*0*A
M\>?'#QK\1[46FNZW+/9 Y-I$BPQ-@Y!954;L=><]*X2BN'ZCA>?VGLH\W>QZ
M/]I8SV7L?:RY>U]#K_&'Q<\7>/M+@T[7]:DU&S@E$T<31QJ%<*5S\J@]&(Y]
M:Y"BBNJG2IT8\M.*2\CDJUJE:7/4DV_,[WP3\=/'/P_M5M-&U^XALE^[:S!9
MHQ[*KAMH_P!W%;>L?M3?$W6K9[>3Q*]M"RX;[);PQ,?HP7</P(KR>BN.67X.
M<_:2I1;]$=T,TQM.'LXUI*/:Y)<7$MU,\TTKS2R'<TDC%F8]R2>3^=1T45Z"
M22MV/,;<G>6IK^%O%>K>"]:AU;1+U]/U"(,JSHH; 8$$$$$'.:L>,O'FO_$+
M48K_ ,0ZE)J=U%$(4>157:F2< *H'4_4YYK HK+V-/VBK<JYEU-57JJG[+F?
M+VOI]P?7@5VGA?XR>,O!>B-H^C:Y+8::[M(UND4; EA\W++GH*XNBG4I4ZJM
M4BFO/N*E6JT&Y4I.+\M ]._'<^O^?TK;\*^-M=\#ZA]MT'5;K2[@C#- Y7>!
MT#*>&'L01QTK$HHG3A4AR32:"%6=*:J4Y-275;GL$_[6GQ1FM_*'B%(VP,R+
M90[C]?DQ^6*\PU_Q!J?BC5)=1U>^N-1O9?O3W$A=B.PYZ >@XK.HKGHX/#8=
M\U&FH^B.G$8_%XJ/+6JN2\W<*[WP3\=/'/P_M5M-%U^XALE^[:S!9HQ[*KAM
MH_W<5P5%;5:%*O%QJQ4EYZF-'$5L-+GHS<7Y.QZOK'[4GQ,UJW>WE\2O;1,N
M&^R6\43'Z,%W#\"*\LN+B6ZF>::5YI9#N:21BS,>Y)/)_.HZ*BCA:&'_ (,%
M'T5C3$8S$8IIUZCE;N[CHY'AD22-VCD0[E=3@J?4'/%>HZ'^T[\2O#]K';0>
M)IIX(QA5O(8YF_%V0L?SKRRBBOA:&)TK04O5!A\9B,*VZ%1QOV=CT7Q;^T)\
M0?&UF]GJ7B.<6;C:\%JB0*P]"44$CV->=445='#T<.N6E!17DK$5L57Q,N:O
M-R?FPHHHK;H<WDS7\,>+-9\%ZJFI:'J,^FWJ*5$L#8R#_"PZ$9 X/' KJ_%G
M[0'C[QSHL^D:WX@:]TZXQYD(M8$#8(8<K&#P5!_"O/:*YIX6A4FJDX)R76VI
MV4\9B:5-TH5)*#Z)Z'9Z#\8?&'AGPW)H&F:W)::.X<-:K%&5(DSNY*D]SW[U
MQOL>O>DHK2G1ITFY0C9O<RJ5JE51523?+L:_A7Q9JO@K6H=6T:[:QU"$%4F5
M58@,,,,,".A-3>,/'&N>/=4CU+Q!J#ZE?1Q+ )I$5"$4DA?E [LWYUA44>QI
M^T]KRKF[]05>JJ7L5+W>W0[30OC'XR\,^&6\/:;KLMKHS+(AM5BC92KD[^67
M/\1_.N,]CU[TE%.%*G3;<(V;WMU%.M5J*,:DFU':_0/\]Z[CP1\:O&GPZA%O
MH6O3VUH#G[+*%EB'T5@0O_ :X>BIJT:5>/)5BI+S'1Q%;#RYZ,W%^3/5]9_:
ME^)FMV;VTOB1[:%QM8VEO%"_X.%W*?H17EMU<37EQ)/<2O//*Q>221BS,QZD
MD\Y^IJ*BLZ.$H8>_L8*-^RL:U\9B<4[UZCEZNX=.:[SP+\<O&WPYM1::'KLL
M%D.EK.JS1#Z!P=O_  '%<'16E:C2Q$>6M%27FC.CB:V&EST)N+[H]&\8?M#>
M/_'&FR6&I^(9OL3@J\-O&D <$=&**"1VP>.:Q[3XL>++#P:_A2WUB2+P\T;Q
M-8K''C:[%G&=N>2Q-<C16,<%AH148TXV7EU[F\\?BZDG.563;TWZ=CL/A5\/
M'^*7C*W\/1:A%IMQ<1R212S*75F4;BO4'H#^1KI/&6@^./V:?% TVWUVXL_M
M40G2XTZ5XX9QRO*D8+ CG/3(->?>&O$5_P"$=>L=9TR?[-?V4HFBD]QU!]01
MD$=P2*^L-/\ VK/A_P#$30X[#XA>'/+F3 .^V%U#GH60XW*?;''3)KQ\RJ8N
ME6C)4_:4;:QLM^Y[N5T\%B*$H2J^RKIW4ME;L?.6O_%[QUXXA&GZCXBU+4(9
MV"?9(WVK*3@!2B !L^GKBOKGQ1:2?"O]D&;3-0Q#>_V4+1H\X/F3G#(,]QO/
MY&N8L?C5\!? +'4?#FA>?J2@F-[;3SYH)]'EQMZ]CTKPCXW_ ![U?XSZA DL
M0T_1+5B]M8QN6^8\>8YXW-C.., $@=23Y#HU<RK4X4Z'LJ4'=W5F_D>Y'$T<
MIHU:E3$^VK3CRI)W27FSS[0/$&H>%]8MM6TJX-IJ%JV^*=5!VG!'<$=">M:7
MC3XA>(/B'>07?B'4I-3N($,<4DB(I5<DX^10.N?RKG:*^V=*G*:J<OO+9]3\
M]5:K&G[%2?*]UT%KLK7XQ>,=/\(MX8M];ECT)H'MS9B&,J8VSN7.W/.3WKC*
M**E&G5^.*=NX4Z]6BVZ<FK]M _4=O\:***V,2]H>M7OAS5K34].G:UOK6020
MS*H)1AWP016OXV^)'B3XB26DGB+5)-3>U5EA:2-$V*V,_< '.T?E7-45BZ-.
M4U4<?>6S-XUZL8>R4GROH=9X*^*OBKX>0W4/A[5Y--BN6#RJB(P<@$ Y9">]
M<WJ%_<:I?7-[=R&:ZN96FED( +NQRS< =3S5>BA4J<9NI&*4GN["E6J3@J<Y
M-Q6ROHBUI>I7.C:E::A92F"\M)DN()0 =DB,&4\@CJ!UK=\;?$WQ/\1OL9\1
MZK)JGV,.(/,CC79OV[ON ==@_*N8HHE1I2FJDHWDMGV'&O5C3=)2?*^AUG@K
MXJ>*OAY#=0^'M7DTV*Y8/*J(C!R 0#ED)[US>H7]QJE]<WMW(9KJYE::60@
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MT52VT!1PH X  K)HJU1IQG[517-WMJ1+$5I4_8N;Y;WM?3[@HHHK<YPHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MBBUP"BC_ #S74> ?AIXC^)FJ"P\/Z;)=N"/-G(VPP@]"[GY1].2>P-95*M.C
M%SJ222[FU*C4KS5.E%R;Z+4YNW@ENIXX88VEFD8(D:*69F)P  .2<U]J?LV_
MLOCPA]E\4^*H0^MX#VE@V&6T_P!INQD].R^YZ=E\#_V9]#^%,4&HW@76/$I7
M+7<B_) 2.5B4]/\ >/)YZ XKVE5QQ7YAG/$#Q*=#"NT>K[_\ _8>'^%XX22Q
M6-5Y]%V_X(D?IWQ4E%%?$'Z2%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_0XVW_@O;_XY1_K!EO\ S\_!_P"0?ZKYM_SY_%?YGRC17U=_PP/??]#C;?\
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MS\'_ )!_JOFW_/G\5_F?*-%?5W_# ]]_T.-M_P""]O\ XY1_PP/??]#C;?\
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M^"]O_CE'^L&6_P#/S\'_ )!_JOFW_/G\5_F?*-%?5W_# ]]_T.-M_P""]O\
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M;_S]_!_Y!_JOFU[^Q_%?YGRC17U=_P ,#WW_ $.-M_X+V_\ CE'_  P/??\
M0XVW_@O;_P".4?ZP9=_S]_!B_P!5\V>]'\5_F?*-%?5W_# ]]_T.-M_X+V_^
M.4?\,#WW_0XVW_@O;_XY1_K!EO\ S\_!_P"0_P#5?-O^?/XK_,^4:*^KO^&!
M[[_H<;;_ ,%[?_'*/^&![[_H<;;_ ,%[?_'*/]8,M_Y^?@_\@_U7S;_GS^*_
MS/E&BOJ[_A@>^_Z'&V_\%[?_ !RC_A@>^_Z'&V_\%[?_ !RC_6#+?^?GX/\
MR#_5?-O^?/XK_,^4:*^KO^&![[_H<;;_ ,%[?_'*/^&![[_H<;;_ ,%[?_'*
M/]8,M_Y^?@_\@_U7S;_GS^*_S/E&BOJ[_A@>^_Z'&V_\%[?_ !RC_A@>^_Z'
M&V_\%[?_ !RC_6#+?^?GX/\ R#_5?-O^?/XK_,^4:*^KO^&![[_H<;;_ ,%[
M?_'*/^&![[_H<;;_ ,%[?_'*/]8,M_Y^?@_\@_U7S;_GS^*_S/E&BOJ[_A@>
M^_Z'&V_\%[?_ !RC_A@>^_Z'&V_\%[?_ !RC_6#+?^?GX/\ R#_5?-O^?/XK
M_,^4:*^KO^&![[_H<;;_ ,%[?_'*/^&![[_H<;;_ ,%[?_'*/]8,M_Y^?@_\
M@_U7S;_GS^*_S/E&BOJ[_A@>^_Z'&V_\%[?_ !RC_A@>^_Z'&V_\%[?_ !RC
M_6#+?^?GX/\ R#_5?-O^?/XK_,^4:*^KO^&![[_H<;;_ ,%[?_'*/^&![[_H
M<;;_ ,%[?_'*/]8,M_Y^?@_\@_U7S;_GS^*_S/E&BOJ[_A@>^_Z'&V_\%[?_
M !RC_A@>^_Z'&V_\%[?_ !RC_6#+?^?GX/\ R#_5?-O^?/XK_,^4:*^KO^&!
M[[_H<;;_ ,%[?_'*/^&![[_H<;;_ ,%[?_'*/]8,M_Y^?@_\@_U7S;_GS^*_
MS/E&BOJ[_A@>^_Z'&V_\%[?_ !RC_A@>^_Z'&V_\%[?_ !RC_6#+?^?GX/\
MR#_5?-O^?/XK_,^4:*^KO^&![[_H<;;_ ,%[?_'*/^&![[_H<;;_ ,%[?_'*
M/]8,M_Y^?@_\@_U7S;_GS^*_S/E&BOJ[_A@>^_Z'&V_\%[?_ !RC_A@>^_Z'
M&V_\%[?_ !RC_6#+?^?GX/\ R#_5?-O^?/XK_,^4:*^KO^&![[_H<;;_ ,%[
M?_'*/^&![[_H<;;_ ,%[?_'*/]8,M_Y^?@_\@_U7S;_GS^*_S/E&BOJ[_A@>
M^_Z'&V_\%[?_ !RC_A@>^_Z'&V_\%[?_ !RC_6#+?^?GX/\ R#_5?-O^?/XK
M_,^4:*^KO^&![[_H<;;_ ,%[?_'*/^&![[_H<;;_ ,%[?_'*/]8,M_Y^?@_\
M@_U7S;_GS^*_S/E&BOJ[_A@>^_Z'&V_\%[?_ !RC_A@>^_Z'&V_\%[?_ !RC
M_6#+?^?GX/\ R#_5?-O^?/XK_,^4:*^KO^&![[_H<;;_ ,%[?_'*/^&![[_H
M<;;_ ,%[?_'*/]8,M_Y^?@_\@_U7S;_GS^*_S/E&BOJ[_A@>^_Z'&V_\%[?_
M !RC_A@>^_Z'&V_\%[?_ !RC_6#+?^?GX/\ R#_5?-O^?/XK_,^4:*^KO^&!
M[[_H<;;_ ,%[?_'*/^&![[_H<;;_ ,%[?_'*/]8,M_Y^?@_\@_U7S;_GS^*_
MS/E&BOJ[_A@>^_Z'&V_\%[?_ !RC_A@>^_Z'&V_\%[?_ !RC_6#+?^?GX/\
MR#_5?-O^?/XK_,^4:*^KO^&![[_H<;;_ ,%[?_'*/^&![[_H<;;_ ,%[?_'*
M/]8,M_Y^?@_\@_U7S;_GS^*_S/E&BOJ[_A@>^_Z'&V_\%[?_ !RC_A@>^_Z'
M&V_\%[?_ !RC_6#+?^?GX/\ R#_5?-O^?/XK_,^4:*^KO^&![[_H<;;_ ,%[
M?_'*/^&![[_H<;;_ ,%[?_'*/]8,M_Y^?@_\@_U7S;_GS^*_S/E&BOJ[_A@>
M^_Z'&V_\%[?_ !RC_A@>^_Z'&V_\%[?_ !RC_6#+?^?GX/\ R#_5?-O^?/XK
M_,^4:*^KO^&![[_H<;;_ ,%[?_'*/^&![[_H<;;_ ,%[?_'*/]8,M_Y^?@_\
M@_U7S;_GS^*_S/E&BOJ[_A@>^_Z'&V_\%[?_ !RC_A@>^_Z'&V_\%[?_ !RC
M_6#+?^?GX/\ R#_5?-O^?/XK_,^4:*^KO^&![[_H<;;_ ,%[?_'*/^&![[_H
M<;;_ ,%[?_'*/]8,M_Y^?@_\@_U7S;_GS^*_S/E&BOJ[_A@>^_Z'&V_\%[?_
M !RC_A@>^_Z'&V_\%[?_ !RC_6#+?^?GX/\ R#_5?-O^?/XK_,^4:*^KO^&!
M[[_H<;;_ ,%[?_'*/^&![[_H<;;_ ,%[?_'*/]8,M_Y^?@_\@_U7S;_GS^*_
MS/E&BOJ[_A@>^_Z'&V_\%[?_ !RC_A@>^_Z'&V_\%[?_ !RC_6#+O^?GX/\
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MY^?@_P#(/]5\V_Y\_BO\SY1HKZN_X8'OO^AQMO\ P7M_\<H_X8'OO^AQMO\
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MY^?@_P#(/]5\V_Y\_BO\SY1HKZN_X8'OO^AQMO\ P7M_\<H_X8'OO^AQMO\
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MY^?@_P#(/]5\V_Y\_BO\SY1HKZN_X8'OO^AQMO\ P7M_\<H_X8'OO^AQMO\
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MY^?@_P#(/]5\V_Y\_BO\SY1HKZN_X8'OO^AQMO\ P7M_\<H_X8'OO^AQMO\
MP7M_\<H_U@RW_GY^#_R#_5?-O^?/XK_,^4:*^KO^&![[_H<;;_P7M_\ '*/^
M&![[_H<;;_P7M_\ '*/]8,M_Y^?@_P#(/]5\V_Y\_BO\SY1HKZN_X8'OO^AQ
MMO\ P7M_\<H_X8'OO^AQMO\ P7M_\<H_U@RW_GY^#_R#_5?-O^?/XK_,^4:*
M^KO^&![[_H<;;_P7M_\ '*/^&![[_H<;;_P7M_\ '*/]8,M_Y^?@_P#(/]5\
MV_Y\_BO\SY1HKZN_X8'OO^AQMO\ P7M_\<H_X8'OO^AQMO\ P7M_\<H_U@RW
M_GY^#_R#_5?-O^?/XK_,^4:*^KO^&![[_H<;;_P7M_\ '*/^&![[_H<;;_P7
MM_\ '*/]8,M_Y^?@_P#(/]5\V_Y\_BO\SY1HKZN_X8'OO^AQMO\ P7M_\<H_
MX8'OO^AQMO\ P7M_\<H_U@RW_GY^#_R#_5?-O^?/XK_,^4:*^KO^&![[_H<;
M;_P7M_\ '*/^&![[_H<;;_P7M_\ '*/]8,M_Y^?@_P#(/]5\V_Y\_BO\SY1H
MKZN_X8'OO^AQMO\ P7M_\<H_X8'OO^AQMO\ P7M_\<H_U@RW_GY^#_R#_5?-
MO^?/XK_,^4:*^KO^&![[_H<;;_P7M_\ '*/^&![[_H<;;_P7M_\ '*/]8,M_
MY^?@_P#(/]5\V_Y\_BO\SY1HKZN_X8'OO^AQMO\ P7M_\<H_X8'OO^AQMO\
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MY^?@_P#(/]5\V_Y\_BO\SY1HKZN_X8'OO^AQMO\ P7M_\<H_X8'OO^AQMO\
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M)2UYQZX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=U&ZG44 -W4;J=10 W=1NIU% #=U&ZG44 -W4;J=10 W=1NIU% #=U&ZG44
M-W4;J=10 W=1NIU% #=U&ZG44 -W4;J=10 W=1NIU% #=U&ZG44 -W4;J=10
M W=1NIU% #=U&ZG44 -W4;J=10 W=1NIU% #=U&ZG44 -W4;J=10 W=1NIU%
M #=U&ZG44 -W4;J=10 W=1NIU% #=U&ZG44 -W4;J=10 W=1NIU% #=U&ZG4
M4 -W4;J=10 W=1NIU% #=U&ZG44 -W4;J=10 W=1NIU% #=U&ZG44 -W4;J=
M10 W=1NIU% #=U&ZG44 -W4;J=10 W=1NIU% #=U&ZG44 -W4;J=10 W=1NI
MU% #=U&ZG44 -W4;J=10 W=1NIU% #=U&ZG44 -W4;J=10 W=1NIU% #=U&Z
MG44 -W4;J=10 W=1NIU% #=U&ZG44 -W4;J=10 W=1NIU% #=U&ZG44 -W4;
MJ=10 W=1NIU% #=U&ZG44 -W4;J=10 W=1NIU% #=U&ZG44 -W4;J=10 W=1
MNIU% #=U&ZG44 -W4;J=10 W=1NIU% #=U&ZG44 -W4;J=10 W=1NIU% #=U
M&ZG44 -W4;J=10 W=1NIU% #=U&ZG44 -W4;J=10 W=1NIU% #=U&ZG44 -W
M4;J=10 W=1NIU% #=U&ZG44 -W4;J=10 W=1NIU% #=U&ZG44 -W4;J=10 W
M=1NIU% #=U&ZG44 -W4;J=10 W=1NIU% #=U&ZG44 -W4;J=10 W=1NIU% #
M=U&ZG44 -W4;J=10 W=1NIU% #=U&ZG44 -W4;J=10 W=1NIU% #=U&ZG44
M-W4;J=10 W=1NIU% #=U&ZG44 -W4;J=10 W=1NIU% #=U&ZG44 -W4;J=10
M W=1NIU% #=U&ZG44 -W4;J=10 W=1NIU% #=U&ZG44 -W4;J=10 W=1NIU%
M #=U&ZG44 -W4;J=10 W=1NIU% #=U&ZG44 -W4;J=10 W=1NIU% #>M'X4Z
MBF WFBG44 -HQ3J*!"4M%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@!#2'FE/-(V-N* /A/]MSPPVD_$ZRU9480:I9+\_8R
M1DJP_!3'^=>1_"CQ@/ /Q&T#7V&8;.Y!FP,GRF!23'OM9L>]?>O[17PG/Q:^
M'\ME:E%U>S?[58LW 9P""A/HP)'IG!/2OSDNK.?3[N:UN89(+F"0QRPN"&1E
M.&4CUR#7ZWD6(IX[+_JT]XJS].C/POB7"U<MS18JFM)/F7KU1^LVGWD.H6L-
MS;2+-!,BR1R(<JRD9!!],?SJU7P)\"?VJM0^%UC'HFM6TNM>'XSB'RV'GVP]
M%W<,O/"L1CGGM7T=:_M@?#*>U\V36;BWDQGR9+"8MGTRJD?K7PF,R/&X6HXQ
M@Y1Z-*Y^EY?Q'@,;24Y5%&75/0]K;[M?!/[9?CR'Q5\3(=)M9%DM]$A,#LO(
M\]B&D'X (/J&]*[KXL?MK17>F3Z;X(M9XYY 5.JW:A=@]8TY.?0MC'H:^2II
MI+B9Y99'EFD)9I'8EF8DDG/<Y/YU]1P_DU:A5^LXE6?1=?4^*XIS^ABJ2P>$
M?-U;Z>AU_P &_#+^,/BEX9TI4+I+?1O*!_SS0[W_ /'5-?IS? +I\X'3RV_E
M7S)^QG\';C0;"?QKJT7E7&H1>7I\3#YEA)R9#_OX7'L,_P 5?3\J[HF7'4$5
MX?$6-ABL:HP=U#3Y]3Z+A;+IX3+Y2J*TJFORMH?DA_$:^^?V*R6^#(YZ:A./
MT6OA77=*ET'7=0TV==LUE</;NOHR,5_F,_A7T_\ L<_&30?"^BZAX5UR^BTN
M5[IKNUN+APD3[E563<> 05SSUW5]AQ!1J5\M3IJ^ST['PO#%:GA<V?M79.ZN
M^Y]B^E?F_P#M03+-\>/%97H)8%_$01@_J*^V/'7Q]\$^!=)EN[C7+2]F"YBL
MK*999I6[ *#P#ZG K\[?&/B>Y\:>*M5UV[54GU"Y>X9%Z+N/"_@,#WQ]:\/A
M;"58UIUY1:C:Q]'QGCJ%2A3P].2<KW=NB/H/]A'_ )'KQ'_V#E_]&"OL;Q-_
MR+NJ_P#7M)_Z":^.?V$?^1Z\1?\ 8.7_ -&"OL7Q-_R+FJ?]>TG_ *":\O/O
M^1J_^W3V^&?^1+_X$?D__P#6K[^_8SA$?P3M"/\ EI>7#'_OK']*^ ?\/Z5^
M@_['J!?@;I+#^*>X/_D9A_2OJN)VU@(KS1\1P>D\TF_)GMB]33J04M?E)^WA
M1110 4444 (>U?"?[='_ "5[2_\ L"1?^CYZ^[#VKX3_ &Z/^2O:7_V!(O\
MT?/7U?#/_(QCZ/\ (^)XP_Y%4O5'UW\&_P#DD?@G_L"6?_HA*[*N-^#?_)(_
M!/\ V!+/_P!$)795\W7_ (L_5_F?5X3_ '>G_A7Y!1116!UA1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,<\5XK\;/V
M9=$^+3-J=K(NB>(57!O(XPR3X' E3(S_ +V<CWP /;:*Z</B:N%J*K1E9HX\
M7@Z&.I.CB(\T6?FUXO\ V:/B'X/DD\[P_-J5JI^6XTP_:%8>H51O'_ @*XB;
MP3XC@D,<GA_54D&,JUG*&_(KD5^K9 /49I-B_P!T?E7V-/BS$17[VFI/[CX"
MMP/AIRO2JM+SU_R/S&\._ WQ_P"*+CRK'PKJ6<_ZRZA-NG_?4NT&OI7X._L:
M6OA^\MM8\:3PZG=QD.FE0C=;HPY&]C_K,?W<8_WA7U+M Z "EKS\9Q'C,5!T
MXVBGVW^\]3+^$L#@YJK.\Y+OM]Q#"HC5450JJ,!1T%.8?*>:DHKY4^V2MHCY
M,_:3_9=U+Q)KUQXK\(0+<W%S\][IFY8V9\8,B$D*21C(R#D9R<XKY>NOAWXJ
ML;H6\_AK5XIMVP(]C("QSCCCGKVK]5*;L7^Z/RKZW \1XC"4E2G%22^\^$S'
MA'"XZLZT)N#>Y^=OPW_99\;>/;R%[O3Y?#NE$YDO-0C*.!G^&+AF)XZX'7GL
M=KXY?L\ZOH/BRST_PCX8U&_TFWT^)/M,$#2^;+EB[.P'WB<$_@!@ "OOG '0
M48'I1_K+B_;*JDK+IT'_ *GX'ZNZ-W=[RZGR/^QK\/?$O@_QCKL^MZ'?:7!+
M8B..2[A9 S!P< D?7\J^IO$4<DVA:A%$I>1[>154#))*GBM+ '045X>,QT\9
MB/K,DD]/P/H\ORV&7X3ZI"3:UUZZGYA?\*/^('3_ (0_6,YZFU?M^'>ON']E
MSP_J7ACX.Z5I^K6,^G7L<MP6M[E"DB@S.1D>X(/XUZYM'H*,#TKT<PSJMF%%
M4:D4DNQY>5\.T<KQ#Q%.;;?<1:=117SA]8%%%%, HHHH 0]J^$_VZ/\ DKVE
M_P#8$B_]'SU]V'M7PG^W1_R5[2_^P)%_Z/GKZOAG_D8Q]'^1\3QA_P BJ7JC
MZ[^#?_)(_!/_ &!+/_T0E=E7&_!O_DD?@G_L"6?_ *(2NRKYNO\ Q9^K_,^K
MPG^[T_\ "OR"BBBL#K"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM.KS3V HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!#VKX3_;H_Y*]I?_8$
MB_\ 1\]?=A[5\)_MT?\ )7M+_P"P)%_Z/GKZOAG_ )&,?1_D?$\8?\BJ7JCZ
M[^#?_)(_!/\ V!+/_P!$)795QOP;_P"21^"?^P)9_P#HA*[*OFZ_\6?J_P S
MZO"?[O3_ ,*_(****P.L**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFBP>'?#^FZ3;9%O8VT=K%NZ[44*/T%<_%DZ:=*/VU?[CJX'IU?WTOL/3Y_\
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ML'PQ_P!#!IG_ (%Q_P#Q5'_"P?#'_0P:9_X%Q_\ Q5?'-%']D0_G)_ULJ_\
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M_P +!\,?]#!IG_@7'_\ %4?\+!\,?]#!IG_@7'_\57QS11_9$/YP_P!;*O\
MSZ7WGV-_PL'PQ_T,&F?^!<?_ ,51_P +!\,?]#!IG_@7'_\ %5\<T4?V1#^<
M/];*O_/I?>?8W_"P?#'_ $,&F?\ @7'_ /%4?\+!\,?]#!IG_@7'_P#%5\<T
M4?V1#^</];*O_/I?>?8W_"P?#'_0P:9_X%Q__%4?\+!\,?\ 0P:9_P"!<?\
M\57QS11_9$/YP_ULJ_\ /I?>?8W_  L'PQ_T,&F?^!<?_P 51_PL'PQ_T,&F
M?^!<?_Q5?'-%']D0_G#_ %LJ_P#/I?>?8W_"P?#'_0P:9_X%Q_\ Q5'_  L'
MPQ_T,&F?^!<?_P 57QS11_9$/YP_ULJ_\^E]Y]C?\+!\,?\ 0P:9_P"!<?\
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M $,&F?\ @7'_ /%5\<T4?V1#^</];*O_ #Z7WGV-_P +!\,?]#!IG_@7'_\
M%4?\+!\,?]#!IG_@7'_\57QS11_9$/YP_P!;*O\ SZ7WGV-_PL'PQ_T,&F?^
M!<?_ ,51_P +!\,?]#!IG_@7'_\ %5\<T4?V1#^</];*O_/I?>?8W_"P?#'_
M $,&F?\ @7'_ /%4?\+!\,?]#!IG_@7'_P#%5\<T4?V1#^</];*O_/I?>?8W
M_"P?#'_0P:9_X%Q__%4?\+!\,?\ 0P:9_P"!<?\ \57QS11_9$/YP_ULJ_\
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M_P +!\,?]#!IG_@7'_\ %4?\+!\,?]#!IG_@7'_\57QS11_9$/YP_P!;*O\
MSZ7WGV-_PL'PQ_T,&F?^!<?_ ,51_P +!\,?]#!IG_@7'_\ %5\<T4?V1#^<
M/];*O_/I?>?8W_"P?#'_ $,&F?\ @7'_ /%4?\+!\,?]#!IG_@7'_P#%5\<T
M4?V1#^</];*O_/I?>?8W_"P?#'_0P:9_X%Q__%4?\+!\,?\ 0P:9_P"!<?\
M\57QS11_9$/YP_ULJ_\ /I?>?8W_  L'PQ_T,&F?^!<?_P 51_PL'PQ_T,&F
M?^!<?_Q5?'-%']D0_G#_ %LJ_P#/I?>?8W_"P?#'_0P:9_X%Q_\ Q5'_  L'
MPQ_T,&F?^!<?_P 57QS11_9$/YP_ULJ_\^E]Y]C?\+!\,?\ 0P:9_P"!<?\
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M $,&F?\ @7'_ /%5\<T4?V1#^</];*O_ #Z7WGV-_P +!\,?]#!IG_@7'_\
M%4?\+!\,?]#!IG_@7'_\57QS11_9$/YP_P!;*O\ SZ7WGV-_PL'PQ_T,&F?^
M!<?_ ,51_P +!\,?]#!IG_@7'_\ %5\<T4?V1#^</];*O_/I?>?8W_"P?#'_
M $,&F?\ @7'_ /%4?\+!\,?]#!IG_@7'_P#%5\<T4?V1#^</];*O_/I?>?8W
M_"P?#'_0P:9_X%Q__%4?\+!\,?\ 0P:9_P"!<?\ \57QS11_9$/YP_ULJ_\
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M_P +!\,?]#!IG_@7'_\ %4?\+!\,?]#!IG_@7'_\57QS11_9$/YP_P!;*O\
MSZ7WGV-_PL'PQ_T,&F?^!<?_ ,51_P +!\,?]#!IG_@7'_\ %5\<T4?V1#^<
M/];*O_/I?>?8W_"P?#'_ $,&F?\ @7'_ /%4?\+!\,?]#!IG_@7'_P#%5\<T
M4?V1#^</];*O_/I?>?8W_"P?#'_0P:9_X%Q__%4?\+!\,?\ 0P:9_P"!<?\
M\57QS11_9$/YP_ULJ_\ /I?>?8W_  L'PQ_T,&F?^!<?_P 51_PL'PQ_T,&F
M?^!<?_Q5?'-%']D0_G#_ %LJ_P#/I?>?8W_"P?#'_0P:9_X%Q_\ Q5'_  L'
MPQ_T,&F?^!<?_P 57QS11_9$/YP_ULJ_\^E]Y]C?\+!\,?\ 0P:9_P"!<?\
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M $,&F?\ @7'_ /%5\<T4?V1#^</];*O_ #Z7WGV-_P +!\,?]#!IG_@7'_\
M%4?\+!\,?]#!IG_@7'_\57QS11_9$/YP_P!;*O\ SZ7WGV-_PL'PQ_T,&F?^
M!<?_ ,51_P +!\,?]#!IG_@7'_\ %5\<T4?V1#^</];*O_/I?>?8W_"P?#'_
M $,&F?\ @7'_ /%4?\+!\,?]#!IG_@7'_P#%5\<T4?V1#^</];*O_/I?>?8W
M_"P?#'_0P:9_X%Q__%4?\+!\,?\ 0P:9_P"!<?\ \57QS11_9$/YP_ULJ_\
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M_P +!\,?]#!IG_@7'_\ %4?\+!\,?]#!IG_@7'_\57QS11_9$/YP_P!;*O\
MSZ7WGV-_PL'PQ_T,&F?^!<?_ ,51_P +!\,?]#!IG_@7'_\ %5\<T4?V1#^<
M/];*O_/I?>?8W_"P?#'_ $,&F?\ @7'_ /%4?\+!\,?]#!IG_@7'_P#%5\<T
M4?V1#^</];*O_/I?>?8W_"P?#'_0P:9_X%Q__%4?\+!\,?\ 0P:9_P"!<?\
M\57QS11_9$/YP_ULJ_\ /I?>?8W_  L'PQ_T,&F?^!<?_P 51_PL'PQ_T,&F
M?^!<?_Q5?'-%']D0_G#_ %LJ_P#/I?>?8W_"P?#'_0P:9_X%Q_\ Q5'_  L'
MPQ_T,&F?^!<?_P 57QS11_9$/YP_ULJ_\^E]Y]C?\+!\,?\ 0P:9_P"!<?\
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M $,&F?\ @7'_ /%5\<T4?V1#^</];*O_ #Z7WGV-_P +!\,?]#!IG_@7'_\
M%4?\+!\,?]#!IG_@7'_\57QS11_9$/YP_P!;*O\ SZ7WGV-_PL'PQ_T,&F?^
M!<?_ ,51_P +!\,?]#!IG_@7'_\ %5\<T4?V1#^</];*O_/I?>?8W_"P?#'_
M $,&F?\ @7'_ /%4?\+!\,?]#!IG_@7'_P#%5\<T4?V1#^</];*O_/I?>?8W
M_"P?#'_0P:9_X%Q__%4?\+!\,?\ 0P:9_P"!<?\ \57QS11_9$/YP_ULJ_\
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M%%%%( HHHH ****/4 HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*OFZ_P#%GZO\SZO"?[O3_P *_(****P.L**** "BBB@ HHHH **** "BBB@
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M91BL+1]O6C9>IQE%%%=QXH4444 %%%>B?#/X4Q_$#3+N[>_>S-O*(]BQ!@>
MW7/O656K&C'GGL=6%PM7&5%2HJ[/.Z*FO+?[+=S0 [A&[(&( Z''3\*AK5-2
MV.>2<6XOH%%%%,CT"BBB@8445Z)\,_A/%\0-+O+N347L3;RB,*L6X'Y0<YW>
M]8UJL*$>:>QU8;#5<94]E15Y'G=%3ZA:BROKFW#;A%*\88@#.#C.*@K56:N<
M\HN,G%[H****-"=]@HHHIB"BBBD/0**** "BMKP9X>7Q7XFL=):8VXN69?,
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M9/\ ^OBBBBOL3\B6P4444AA1110 4444 %%%% !1110 4444 %%%% !1110
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MUE@<-EF%A4CA_:R:UTN=SJ7P(\)7D++!92V4AZ20W#G'X,2/TKQ+XD?#.\\
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MBB>QU%9&@6U:4>6Y4[@R#^3&JWQ<M8[/XC:W'&NU3*LF/=D5C^IJM\/O&S^
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MZC\%/AY8R:;)XGUF-)8E+&V2;!10IYD8'C.0>O3&?2H_$7[15VM\\6AV5O\
M9$;"S7:LQD'J I&T'L#S],\1/%5*DW3P\;VW+HY90IT(U\=4<5+9):GDNJ:'
MJ.B2!-0L;BR+?=$\3)GZ9&#^%4J^B/ _Q/L/B<LOA_7M.@CN)E)48S', ,D
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M;*")2 2 68@'L,GD_P"[7EGC7XY?\)=X5NM+CTQK">=U0NLWF*4')&=JD$G
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MOSY-KOCYSN^;;]:Y..-I&5$4N[$*JX))/I@5](?",9^#\W'\-S_-J\ \,_\
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M#KY91G0EB<%4YHQW36J/)J*/PY[T5Z1\X3V=C<ZC,8;6WFN9=I;9!&7; ZG
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MNV!WP/P_.K$&@ZG=:BUA%I]T]ZOWK<1'>HXY*XZ<]:[[]GD?\5Z^1Q]BD_\
M0DKT_P ;>+M'^%EY=7J6AO-6U9Q*R;MORJBH,M@X7Y>!CJ317Q<Z=;V,(W8L
M#E-'$858RM4Y8INY\[WGA?6-,NHH+K2[N&:1L1JT+?.?1>/FKZ$^&VGW-I\(
M&MI[::&Y,5R/)>-E?)+8&TC-<#XF^/4VM1Z4]IIOV*>UN?M$D<DF]'P"% (
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M,ZU\4XS5*DKR9R8++8U:,L5B9\E-:>;9X=?>!_$.FPM-<Z->11 99S"Q4?7
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4I;22MZ6/4OV=;IX?'%S &;RY;-L@=,JR$'\L_G5#X\6R6_Q$NF08,L,;O\
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MHY0?^^#6E^T4-OCJVX_Y<(\_]_)*S/@9_P E(T__ ')?_0#6I^T8?^*ZMO\
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M8W>,!@1CG!_'\*X3]H22VN?%MG<VTT<PDM K&-@W(=NN#Z$?E7/?#CX>7'Q
MU*>+S6L[2!-TESY>[#<;5'/4Y/Y50\=>%8O!OB"32X[\:@\2*9)!%Y>UCSMQ
MD]B#^-==&FHXJ\JG-)(\K%8F4\NM3H<E-O>_7T9SU%%%>S9Z'Q^R/I'X1_\
M)'I_]VY_FU?/_AO_ )&+2L]/M47_ *$*^@/A'_R1^;_=N?YM7@'AG_D8M)_Z
M^XO_ $-:\/"ZRKGV>9?P\%Z+\SV[]I.X8:#H\.3M:Y9R.V0A'_LQKY_KWO\
M:4.=+T7_ *[2?^@BO!%^\*Z,M_W=>IQ\1/\ V^3OT1](_ O_ ))C-_UVF_D*
M^;5KZ2^!7_),9_\ KM+_ "%?-O6LL+;VM?7J=&9_[K@_0^DOCE_R3&W_ .NT
M/\C7DWP5M5NOB-I0<96/S)/Q$;8_6O6?C?F;X76\@4D>;"QQV&*\6^&.LQ:#
MXZTB[G8) )3&['H ZE<GZ9!K'"IRPM2,=]3JS*4(YK0E/:T3WGXF> ],\:WU
MFVH:S_9WV>-@D.Y.<GEOF^@_*N._X41X:QD^*,^VZ/\ QJ?]HOPM/=0V.O6Z
M>9' I@G*C)52<JWT!+#\17A'^..O>E@Z52I13A5LD:9OBJ%#%25?#J7G=ZGU
M+\/?#>C_  ]M[R&#7H[Q+DJY$LJ#:P!!/![\?E7AE]%'#\7BL+*\1UE64J<C
M!F!XY]_TK7\!?!>X\9:"^I37K:;$SE8-T._>@ZMU'&>!]#7)>'X8[?QOID4,
MWVB)-1B5)L8#@2CYL9.,]:TH0C&=22GS/KH<N,K5*M'#1='DCS*VMSU_]I;_
M )!>B'_IL_\ Z"*S_P!F?_C_ ->_ZYP_SDK0_:6.=+T3T\Y__016=^S/_P ?
MVO?]<X?YR5SQ_P"1>_ZZGIU/^1_%^GY'GGQ._P"2@:]_U]-_2O:IO^3?0/\
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MK(\0\1@8-O5:?<.HI*6N ]X**** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P#] [P__P" T_\ \>JZO#V/E4E))6;?5&&'XKRVG1A"3=TDMO(^[Z*^$/\
MAN3Q_P#] [P__P" T_\ \>H_X;D\?_\ 0.\/_P#@-/\ _'JR_P!7,?\ RK[T
M='^MV6?S/[C[OHKX0_X;D\?_ /0.\/\ _@-/_P#'J/\ AN3Q_P#] [P__P"
MT_\ \>H_U<Q_\J^]!_K=EG\S^X^[Z*^$/^&Y/'__ $#O#_\ X#3_ /QZC_AN
M3Q__ - [P_\ ^ T__P >H_U<Q_\ *OO0?ZW99_,_N/N^BOA#_AN3Q_\ ] [P
M_P#^ T__ ,>H_P"&Y/'_ /T#O#__ (#3_P#QZC_5S'_RK[T'^MV6?S/[C[OH
MKX0_X;D\?_\ 0.\/_P#@-/\ _'J/^&Y/'_\ T#O#_P#X#3__ !ZC_5S'_P J
M^]!_K=EG\S^X^[Z*^$/^&Y/'_P#T#O#_ /X#3_\ QZC_ (;D\?\ _0.\/_\
M@-/_ /'J/]7,?_*OO0?ZW99_,_N/N^BOA#_AN3Q__P! [P__ . T_P#\>H_X
M;D\?_P#0.\/_ /@-/_\ 'J/]7,?_ "K[T'^MV6?S/[C[OHKX0_X;D\?_ /0.
M\/\ _@-/_P#'J/\ AN3Q_P#] [P__P" T_\ \>H_U<Q_\J^]!_K=EG\S^X^[
MZ*^$/^&Y/'__ $#O#_\ X#3_ /QZC_AN3Q__ - [P_\ ^ T__P >H_U<Q_\
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M(K^/5/$.J7L.?)N;J6:,,,':SDC/X&LZBE&C&%255;L*F,JU</##2^&)Z?\
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MAZ#I9T_PGIJJ=I5',8BBC/\ >V]6]>E>)7EY-J%S+<W$KSSRMO>1SRS'J?\
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M(_MBG>B):2%E8=-H8;0?I7 _$SXL7/CQEL[:)K/28VW"(D%Y3V9SV^@]^37
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M,[=X.,[1G'7 K?HJE)Q=TR)0C47+)71Q7_"E_ /_ $)?A_\ \%D'_P 12_\
M"F/ /_0E>'__  60?_$UVE%:>VJ_SO[SG^J8?_GVON1Q?_"F/ /_ $)7A_\
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M'_"F/ /_ $)7A_\ \%D'_P 37:44>VJ_SO[P^J8?^1?<CB_^%,> ?^A*\/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%%%]0"BBB@/0**** "BBB@ HHHH ****=@TZ!1112 ****
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M>]BN:7+R7T"BBBGY$A1113 ****0!1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $--/K3Z2@#Y\_:1
MT4P:QI6IKG$\+0-CH"IW#\3O/_?->-U]3?'#PZ=>\!W+QKNFL6%TF.I"@AA_
MWR6_*OEGG_/\Z^QRVI[2A;L?D'$6&=''.2VDKA1117J'RP4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$_3/6J52$GRJ2;,Y8>M"//*+2*E%%*JM(P51N8G  &2?I6ET86N[(2BM^U\
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MNGAZU1-P@VEV1SU%27-K/9SM#<0R6\RG#1R*58'W!'%1U>^QE*+B^5[A110
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MS.O 2H1J_P"T0<E9Z+N<E_G_ #_GM11_/K_G\J?##+<2K%#&TLK'"I&"6)]
M/6NE/2[.!IRDU$916_\ \(#XD\GS?["U#;_U[/G\L9K#G@DMIFBFC>*53AD=
M2"I]",<?C4QJ0J.T6F74HU:2O4C89116EI?AK5M:7=8:;=WB9QOAA9E_.J<H
MQ7-)V1,*<ZC2@KF;16_=^ ?$EG&7ET._5 ,EEA9@/<XZ5@'(+ C# X(/;]*F
M,XS^!ICJ4:M/XXM>J.R^&7P_3X@:E>6KW;67D0B7*INSDXQC(K&\9>'QX5\2
MWVE+.;@6[*/,*A<Y4'I^->D?LU_\C)JW_7J/_0ZX_P",'_)2-;_ZZ)_Z+6N&
M%:;Q4H7T2/>K86E'*J>(4??;:..HHHKTCYP***W+'P/XAU& 36VBWTD1&0ZP
MM@CU!(YJ)2C#XG8VIT:E72$6_0/!'AM?%WBBRTAIVMQ<[QYBKNQM1FZ?\!J_
M\2/!"^ ==ATY;HW?F6ZS^84"]69<8R?[OZUI?".SN=.^*FD074$EM<(TH:*5
M"K+^Y?KFM?\ :._Y'BS_ .P?'_Z,DKSO;2^MQA%Z6/=C@Z?]E3KRC[ZE8\KH
MI/KTK:TWP7K^L0B6RT>]GB/W9%A(0_0D8KT924%>6AX-.E4JOEIQ;?D8U%:&
MJ^']3T,J-0T^YL@QPIGB90?8$C!_"J"J68 #))P!C--2C)<R>A,H2IRY9JS\
MQ**O7FA:EIT(FN].NK:+H'FA9!SR!DC'_P"JJ%--25TPE"4':2L+14MI9W%]
M<+#:PR7$S<B.%"S'')P/8<_A3[[3;O2Y%CO+2:T=AN59HVC)'3(!'J#^5*ZO
MRWU%RRY>9+0KT4^WMY;J9(H8WFE8X6.-26/L!6\/AYXF,/G?V%?[?^N#;O\
MOGK42J0CI)V-88>K43=.+EZ'/45)<6\UI,T,\3P2J<-'("K ^X(XJ*M+WCH9
M\K4N5GIGBCX01>'?! \0+J3SL4B;R#$!]\J,9S[UYG_ACUKZ3^*'_)%8O^N5
MK_Z$E?-@[9Z8%>;@:LJL6YOJSW\ZP]+"U81I*RY4Q:*N:9H]_K4QBL;*XO)!
MU6WC9MOY?UK2O/ 7B.PA\V?1+Y(\;F80E@OUP.*[G4A%V<M3Q8X>M-<T8-KT
M,&BCD9!&,<?YXJ:TLKC4)A#;02W,QY$<*%F/T K3979CRN_+;4AHJVVDWR7R
MV3V5PEXV-MNT3>8<]/EQDYK3E\ ^)(81,^A7X3&3B!B1]1CC\:S=2"=F]S:.
M'K3^&#?R,&B@KM)!&"./\\5-:65QJ$PAMH);F8\B.%"S'Z 5HW;5F"BV^5+4
MAHJS+IEY;W@M9+.XCNVQB!XR)#GI\I&236M-X \206_FOH5^(L9.(&S@=_45
M$JD(VN]S:.'JSORP;MOH8%%*P8,01@@X.?6MNV\">(KRV^T0Z+?20XR'6!N1
MZ@#K^%$IQC\3L*G1J57RPBV_0PZ*ENK.>QN&@N89+>=.&BE0JR_4$9_.HJM:
M[&7*UHUJ%%3V5C<ZE<+!:6\UU,W2.%"[?D.:VIOA[XE@A\U]#OU7&>(23^6/
MYU$JD(NSD;0P]:I'FA!M>2.>HI7C:)V1U*.IPRL,$'W&.#3H()+J9(H8VFE<
M[4CC4DL3T %7H8V=[6U&459O=+O--D6.[M+BU=AE5GB9&89QT(R>:UX?A_XE
MN+?SDT*^\HC.?(;./4 \FL_:06[-XX>K-M1@W;?0Y^C\,^WK4MW9SV,[V]S!
M);3KPT<J,&7Z@BKFAZ5?:G>(UG9W%T(Y$9_)C9PH)_B/;@&JE-1BYW)IT9SJ
M*DUJ_O+FJ>"M6T30K?5;^V-K;SR^5$DORR-P3G;V'!Z\]*PJ^COV@-,O-4\+
M:9%:6DUTZW8+)#&7(&QAD@#I_C7SM=6L]E,\-Q#);S+]Z.52K+GGD$5R87$/
M$4^:6YZN:X%8&O[.%[66I%1117:>(%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% ZBF+H>P
M?LWZ3]H\0:GJ1Y6W@$2Y[EVSG\E_6OH5:\\^!/ATZ'X%MYY%Q/J#&Z;/7:0
MO_CH!_&O1J^'QM3VM>3/VW)<.\-@81:LWK]XG>EHHKA/<"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW0?C,?$'Q*TL^2UG87$'V-X)&!VRL<[O?D*O0=Z\I\>3/<>-M>=SN/VZ9?H
M[ ?H/TK$AF>WE26-BDB$,K*>01T-;PP%)T[M7DT>?6SS$QK\J:4(RT279GJW
M[0WAO^S_ !-;:M&F(KZ(*Y_Z:( /U7;^1KRJ"&2YGCAB4O+(P1$ Y8DX KZ.
M\;(GQ)^#Z:G"H-S%$+L*IX5TR)%_#YQ]<5Y=\#_#IU[QQ;3NF;;3Q]I;<.-P
MP$'X,0?P-&&K\N%ES;QT+S/ .MF,/9KW:MG_ )GI7Q$FA^'?PCMM&@*BXFC6
MS^7^+(S*WX_-^+5\Z?Y^M>F_'SQ)_;'C$6,39@TZ/RL=O,;#,?RVC\*\SK?
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M_M3X8O:S[FB22:W(;NIY_P#9C48JC'".-:CH:Y;C*F:^TP>+?-=-I]58\L^
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MYS'N3;SWXQ7@OPZ_Y'S0?^OV/_T(5M@FY8:HNUSDSFG&.8T';67+?UN?17Q
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MH>!/!'Q*DDOK6:,W4@W//8SA7R>[+R ?J,^M;8CEIXERQ$6X]#FP"G5R^-'
MS4:B^)/=F9\//BU;^/%NM)U^UM(9?++AN/(D7(R"K'@C/J0>>E>+^/=)L-$\
M57]OIEQ'<Z?N\R%H7$@52 =N03T.1ZXP:]$\0?LX7MJK2Z-J,=VO40W \MOH
M&&03^5>2:EIMUH][-97D#6US$=KQR @CW_J,9S73A(T?:2G0EH^AY>:RQBHP
MIXVGJOM>7;0^A?#]O8_"7X7KK*V:W5]+#'+*R]7=\;5W=E!8#_\ 77"K^T5X
MB^TAS9Z<8<_ZM4?E<] =W7\/PKJOAS\3M UOPO#X?\1-#;R1Q"W/VK'E31@
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M);V=C#:Y.V%T9B%]"P8<]>0!]*[+]HR\:/P?IENI8"6Z!;:<9 1N/U'Y5\\
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M_P!X$ '\/7ZUZ)NTOXS^ 7E-OY4K!@ W+6\RC^]CZ?4&OESU/U-?17[.9/\
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MJ#5]/M9+,M\QM5974>H#,<_3O7"_%*\>^^(&MR2%B5N#&-WHORC'Y5RU==#
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MUO=<OP(X4) PJ@ _,?NKSSCJ2*Y3PE^T!>:EX@MK+5;&VCM+F585D@W*8R2
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7XQ55[.;]Y?B?E6?9/+"S>(HKW'^!RM%%%>R?&A1110 4444 %%%% !1110
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M06EK&TUQ,X1$4=237MFB_&[1/$6EKI_BZP4\#>WE>9$Y'<KU!^F1[TZ3XD>
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M "/T?_7E'_Z$]<Y\,?%%GX/\60ZE?"0VZ1NI$2Y;D8'%3_%;Q=9>-/$\>H6
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MWL/ NM7=YJ"RM'+;^4/)4,<[@>Y''%;8R+GAY1CN<>4584<=3G-V29%\9/\
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M5WVKO&Z#KLDRP/XDL/PKP+7M!N_#6K7&G7D31S0-MY& P'1A['M5OPCXNO\
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M@:;<5;H2JE@/?) XKUWX_>+-6\/VNF6>G3R6<-R)#+-"=K';MPH;J.N>/:O
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_=3T(^F:S:]^,E-7B[GPM2$Z4G&HK-!1113NNYF%%%% !1110 4444 %%%%
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M]0TZA1113 ****0!1113 ****7J'H%%%%,04444>A5V%%%%(04444P"BBBD
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M[>^P6O\ S[Q?]\"C[!:_\^\7_? H_M?^Y^(?ZI/_ )_?A_P3XAHK[>^P6O\
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MXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\
MG]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B
M&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:
M_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_W
MP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S
M[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^
MU_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_J
MD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'
M_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM
M[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/
MO%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L
M%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]
M\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[G
MXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\
MG]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B
M&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:
M_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_W
MP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S
M[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^
MU_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_J
MD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'
M_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM
M[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/
MO%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L
M%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]
M\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[G
MXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\
MG]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B
M&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:
M_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_W
MP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S
M[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^
MU_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_J
MD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'
M_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM
M[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/
MO%_WP*/L%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L
M%K_S[Q?]\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]
M\"C^U_[GXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"C^U_[G
MXA_JD_\ G]^'_!/B&BOM[[!:_P#/O%_WP*/L%K_S[Q?]\"E_:_\ <_$/]4G_
M ,_OP_X)\0T5]O?8+7_GWB_[X%'V"U_Y]XO^^!3_ +7_ +GXA_JD_P#G]^'_
M  3XAHK[>^P6O_/O%_WP*/L%K_S[Q?\ ? H_M?\ N?B'^J3_ .?WX?\ !/B&
MBOM[[!:_\^\7_? H^P6O_/O%_P!\"C^U_P"Y^(?ZI/\ Y_?A_P $^(:*^WOL
M%K_S[Q?]\"C[!:_\^\7_ 'P*/[7_ +GXA_JD_P#G]^'_  3XAHK[>^P6O_/O
M%_WP*/L%K_S[Q?\ ? H_M?\ N?B'^J3_ .?WX?\ !/B&BOM[[!:_\^\7_? H
M^P6O_/O%_P!\"C^U_P"Y^(?ZI/\ Y_?A_P $^(:*^WOL%K_S[Q?]\"C[!:_\
M^\7_ 'P*/[7_ +GXA_JD_P#G]^'_  3XAHK[>^P6O_/O%_WP*/L%K_S[Q?\
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M_/[\/^"?$<<,DS;8T:1NN%!)_2M>Q\%:_J>W[-HU]*K='%NX7\S@5]F+&O\
M='Y4[:/05G+-Y?9@;0X2I_;JM_(^7]'^ ?BC4MIN([?38SU\^7<V/HN?YBO1
M?#O[.^BZ:5DU2YFU24=4'[J/\AS^M>N45PU<PQ%72]CV\-P_@</KR\S\]?PV
M,_2](L]%M4MK"TALX%Z1PH%'Y"KIZT^BO.;;U9]%&*@K15D-'6G444B@HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH 0T?C2T4 )2T44 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E&12T4 (/K
M2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 444A- "T4W[U+TH 6BFFC\: '44S[N:/KQ0 ^BF!A_>%+N']
MX4"NAU%,W#U!HX]J NA]%-HYH&.HI*-U "T4W]:/K0 ZBFJ><4Z@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BDI: "BFT<T .HI@;/6G4 +13.A]:7=Z\4 .HIN\?WA1
MN']X4"NAU%-W#^\*-R^M 70ZBF[O2CGUH&.HI*,T +13&Z4JT .HI!]*6@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HI#2<T .HIF32T .HINZ@L/:D ZBF!QZ@
M4NX?WA3%=#J*;O']X&C<OJ* NAU%-W>AHR?6@8ZBDHZ4 +13,TM #J*:M.H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **0TG)H =13>:#0 ZBFC\J,^] #J*9O'
MKBEW#^\*!<R'44W>/[P-&Y?44!=#J*9N!I5Q0,=124=* %HIF[\:7]* '44U
M:=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %)0W-)^- #J*BED2%&>1E1%&69C@ =R
M37A'Q._;?^$/PM\R&[\4Q:WJ,>0;#00+R3/<%E/EJ?9G!JHQ<MD8U*U.BKU)
M)'OE,8[>2>*_-+XD?\%5O$>H22P>"/"=EH]ORJWFL2&YG([,(T*JAZ<$N*^8
MOB%^U!\5/B@)H_$/C?5)[64;7L[63[+;D>ACBVJWX@FNR.#J2U>AXE;.L/3^
M#WC]D/&WQT^'WPY\Q/$OC/1=(FC&3;3WJ>?QUQ$"7/X"O!_&'_!3+X/>'7:/
M3'UKQ.XZ/I]CY4>?<SM&<>X!K\E**ZXX*'5W/&J9[6EI3BD?H)XI_P""LEX^
M^/PY\/H8>NVXU343)GTS&B+CZ;Z\LUS_ (*:?&75MWV5O#^C ]/L6G,V.G_/
M5W]_SKY.HKHCAJ4=D>;/,\7/>9[AK7[;'QOU[=]H^(6HQ$@C%G%!;=@/^64:
MCM_GFN0U+]H;XHZNSM>?$;Q5,K'.S^V;A4Z8X4/@=^W>O/J*U5."V1R2Q-:7
MQ3?WG07'Q"\47B2)<>)=8G1_OK)?RL&^N6JA_P ))JW_ $%+W_P(<9_6LZBK
MY49>TEW-'_A)-6/75+S\9W_QK1LOB/XMTWR_LGBG6K4Q?<\C4)DV_3##%<[1
M1RKL'M)K9GI.E_M*?%C1V'V7XD>*5"X"I)JT\BC'HKL1_C7:Z'^WA\<]#P(O
M'4UU%SF.^LK:?/7^)HRW?L?Y5X#14.G![I&T<56A\,W]Y]B:#_P5&^+&FN@U
M'2_#>L0@Y?S+26*0C)X#)+@=1_">GU->L>%?^"LFF2E$\2?#^\M<??FTF^2?
M/N$=4Q]-QK\XZ*REAJ4NAV4\TQ=/[=S]A?!W_!1+X*^+/+6?7KSP[</@"'6+
M)TQ]7CWQC\6KW7PC\2/"GCR'S?#GB32=>3&2VG7L4^/KL8X_&OP%J2WN9K.=
M)[>62">,[DEB;:RGU!['Z5SRP,7\+/3IY]5C_$BG^!_0TOWJ=7XJ?#S]MKXR
M?#8Q)9^,+G5[*/'^AZV/MB$#^'>^9%'^ZPKZC^&O_!5FSF\JW\?>$);5^C:A
MH$GF)]?)D(*C_MHWTKCEA*D=5JCV:.<X:J[2=F?H117E?PS_ &F?AE\7A#'X
M9\8:=>7LG T^>3[/=Y[@12!7/X CWKU!6W=^*Y)1<=T>U"I"HKP=R2BF^M%2
M:#J*3O2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI[\8-5WK96_AS1E/W6M;&1W YZF61AG\.U?(M%=*PM*.R/-GFF+GO,]XUO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%(U)0 ZDIK$<5YE\3?VDOAK\(?,
M7Q1XOTZQO(QSI\3F>ZZ9_P!3&&<?4C'O347)V1$ZD*:YINR/4*1J_/OXF?\
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M[E*O2K*].29=HIO-'X5)N.HI*6@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR?>O,<GT^M)17>HQCHD?/3J2J.\W=A]:.***9F%%%%,04444 %%%% !1110
M4444 %%%% !1110 4444@V"EX]*2BF JL5(*G!!R".HKWWX1_MQ?%CX0M#!!
MKY\1:0G']G:]NN4"CC"R9\Q,#H V/8]*\!HK.4(S5I(WI5JE%\U-V9^KGP:_
MX*5_#WQ\8;'Q=#-X&U5\+YET_G63-[3  I_P-0!_>-?6ND:O9:[I\%_IM[!J
M%E.N^*XMI%DCD4]"K*<$5_/=SVKO_A3\=O'/P3U07OA'Q#=:<F[=+9,WF6L_
MKYD394G'?&1V(KSZF"3^ ^DPV>3C:-=7/W@I:^(_@3_P4R\*^,!;:5\1;/\
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M65T?OJ*6O@#X$?\ !4+3]1-OI7Q2TO\ LJX.$&N:5&SV_P!98>63W*%@<_=
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M@K11\W5K5*SO4DV+QCCK2445H8:AQ1110 4444 %%%% !1110 4444 %%%%
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MC!6BCYFKB*M9WJ2;"BBBM# ****!!1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4[98'QGRY$/*,/0_49!!KLS7EM-.S/K8RC-*47H.HIO\76G4B@HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M* "BBB@ HHHH **** "BBB@ HHHH **** "E7K^M)10,])^!_P"T%XR_9_\
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MTLUQ.Y>21R<LS,>22<DD]<U7KWJ-"-'7J?G^-S"KBY:NT>P4445TGDA1110
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MA'>DHHKN]#PPHHHI""BBBF 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !12-24 *::V0OXTC\+_\
M6KX0_;K_ &W#X0%Y\.OA_J!77FS#J^M6K\V0/!AB8=)O5A]SI][E-:=-U'9'
M)B<3#"TW4G\O,N?ML?MU1^ UO? 7P\O5F\2L&BU'6(6!33^S1QGG=-UR?X.G
MWON_F7<W4M[<33W$LEQ<2N9))I&+.[$DEF)ZDDG/7FHV8OEF.YF/)]??K25[
M]*BJ2LC\YQ>,J8N?-/\ X8****V. ****8!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7US^QK^V_??!6\MO"GC">?4? LS!(ICEY=*)_B0 $M$2>4'3J
MN.0WR-0.>/:LJE.-169TX>O4P\_:4WL?T(Z+J]EK^FVNI:;=PWVGW<2S07-N
MX>.5&&0RD<$$$5?K\A/V,_VR+[X":U%X;\1S37OP_O)<NGWWTUV/,L8[H3RZ
M#KRP&<[OUMTC5+/7=-M=1T^ZBO;"[B6:"X@</'*C#<K*PZ@@@Y^E>!6I.D]=
MC]&P6-AC(<T=^J+U%-%.K ]$**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444  K] /V _VS'T
MV?3_ (7^.;_=9/B#0M4N'YB;HMK(W]T]$;M]WD8V_G_0/6L:E.-569VX7%3P
MM15(?,_H=4?-GVI]?$W[ 7[7TGQ-TN/X>^,+WS/%>GP_Z!?3-\^HP*.58GK*
M@'/=EYZAB?M5>]?/5*;IRY6?I.'Q$,3352#)**1:6LSJ"BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHH **** "BBB@ I&[?6BL?Q;XJTSP3X;U+7M:NX['2M/@:YN;B0\(BC)^I[
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MZ)ST>X8>K8XST4#@$MGYWKW<+1]G'F>[/S_-,>\34Y(/W4'M1117<>"%%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&_\ ,/!^HE%%%>L?'A1110(**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ H]_P#]5%% 'Z3?\$T_VE/[:TM_A3K]T3?V
M"--H<TK<RVX)+P9[LG++ZJ2. @K[X7N:_GW\)^*-3\$^)M,U_1;EK/5=-N$N
M;:9#C:ZG(SZCL0>",BOW(^ _Q=TWXY?"W1/%^F;4%Y#MN;?.3;W"_++&>_#
MXSU4J>A%>)BZ/)+F6S/O,FQGMJ?L9/5?D>A44@I:\\^D"BBB@ HHHH ****
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M10 4444 %%%% PHI5&>.N>*]E\"_L=_&/XB6$5_H_@74%LI "EQ?O'9*5/\
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MB.-?=F('L,GH*_#7QMXRU7X@^+-7\2:W<FZU;5+E[FXDSQN8Y"KZ*HPH'8
M5WX6CSRYGLCYW.,:Z%/V4-Y?D8=%%%>X? A1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM!_:-^&MEXIT8BWN/]1J&FL^Z2RN /FC;U!ZJV!E2.AR!ZE2+"BBB@ HHHH
M**** "BBDR* %HI*6@ HHHH **** "ORI_X*I_\ )PN@?]BM;_\ I7=U^JU?
ME3_P53_Y.%T#_L5K?_TKNZ[<'_%/"SK_ '1^J/T/_9O_ .3>OAA_V*^F?^DD
M5>CUYQ^S?_R;U\,/^Q7TS_TDBKT>N27Q,]>C_#CZ(****DV"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@!*IZMJEKHFF7FH7LR6UG:0M//-(<+'&H)9C[
M  FK;=*^)?\ @IM\=/\ A#_AY9?#S3+C9JOB,>=?;#AH[%&Z'T\QQCW6.0=Z
MTIP=2:BCEQ598>E*H^A\%?M(?&J^^/GQ:UCQ5<-(EBS_ &?3;5S_ *BU0GRU
MQV)R6/\ M,WM7F%*WOU[CTI*^EC%17*C\NJ5)5)N<MV%%%%,R"BBBF 4444
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M+BVF?J-.I&K!3CLQ:*2EJ34**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!#3'^[D
M]J<U?-'[>WQS/P:^"%Y9Z?<>3XC\2[M-LBK?/%&1^_F'^ZAV@CHTB'M5PBYR
M448UJJH4W4ELCX _;B^/C_'#XRWL=C<F7POH#/8::JGY)"#^]G'^^RC!_NJE
M?.]*?\^WMZTE?20CR1Y4?EE:M*M4=26["BBBM# **** "BBB@ HHHH ****
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M2WL?%=%>[_L/^$]&\<?M+>%M&\0:9:ZSI5Q%>&6SO(EEBD*VLK D'@X8 CW
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:&":AK31MU&=T,!_(2'_ +9U^>'85N>./&6I_$+QAK'B76)?.U/5;J2[G;/
M9F)VJ.R@84#L !6'7T=&G[."1^88W$O%5G-[= HHHK<X HHHH **** "BBB@
M I>2>:2BIEL5'='ZU?MB_P#)@UU_UX:/_P"C[:OR5K]@/VG/"6M>./V(FT?P
M_I=UK.JSZ?I)BL[*(R2OMEMV;"CKA03^%?FI_P ,K_&#H/AMXEX]-.D_PKS\
M--1B[L^CS6C4J5(<D6]$>55^M'_!,[/_  S+Q_T&+O\ E'7YV?\ #*_Q@_Z)
MKXE/_<-DQ_*OTN_X)^^"?$/P_P#V??[*\2:/>:'J/]J74WV2^A:*38P3:VT\
MX.#3Q4XR@K,,HHU(5VY1:5F?CY12\]N>M?HM\#?V+?A[\'?AHGQ&^.LD+3^2
MMRVFZ@S+:V ;[L;HIS-,<@%<$9.T*2-QZIU8TXIOJ>51PL\54:CMW/SHHK]'
M$_;#_98OKS^QY_A9';Z2V$^U2>&+'R5&>6V(Q< =<A<]<#(YY?\ :L_8J\)3
M?#A_BK\&YDET5(#>W>FVLIGMY+8#+3P,22-@#%D)(P#C;M(.4<1JE-6.F>6O
MDE.C-2MN?!=%;'@_PIJ/CCQ7I/AW2(/.U35+J.SMXFZ;W8*,GL!GDG@ &OT@
MNO@7^SU^Q;X(TW4_B/9Q^,/$=T"J?;+?[2]W(JY=8;8GRU09ZO\ W@"V2!6E
M2M&GI:[9S8;!3Q"<K\L5NV?F/17Z2:/^V#^RQXLO8]*U3X91Z-8S-L%YJ'AF
MR:",8P"?*9W7DD JIQCK7'?MU?L?^$? _@&'XF?#JW6PTSSHAJ%C;R>9:^3,
M0(YX22=HWLBE0=N'7 &#G-8CWE&<;'3/+OW;J4:BE;>QY9_P3?\ ^3IM&_Z\
M+S_T4:L?\%*L_P##4%]C_H%VA]/X35?_ ()O_P#)TNB^OV"\S_WZ-=5^W-J>
MD:+^W#HVH>(+7[=H%I_95QJ%KY0E\ZV5PTJ;#PV4##:>N:A_[Q?R.B*OEMO[
MQZW^P;\._#<7[+?BSQ>-'MF\33+J5L=4=-TZ0K!PB,WW!R<[<9[YK\VQT'%?
MM?\  7QU\-?%?P0U'6O _A\:1X+B>Z6?3Q91P;RB R_NU8J=PXY/-?G-^U=\
M5/@G\0O#^A6_PK\(?\(U?V]T\E[+_9D5KYL13"C*,=V#VK*A-NH[K<WS##TX
MX>FU)*R^\^L/"6/^'7=SZ_\ ".7O_H^6ORY-?KI^SOX#/Q1_8'T'PD+S^SQK
M&EW%FUULW^4&N) 6V]\#/&1GU%>5W/Q(_9+_ &8[P^%K7PQ_PFNK6;^1?:BF
MG0ZC*D@X;=-.R)G/!6'Y01C VD":53V<I)*^IKB\+[>%&<IJ*Y4M3\WJ*_5N
M?X$_ ;]M#X9W6N>!=-LO#^IJ6A2^TRS%E-:W.T-MN(5 5P=RDDYR#\K=Z_+;
M7M!O?#/B+4=%OX_*U'3[J2RN(AD[9HW*,O3/W@1_^NNZG652_1H\/%8*6%L[
MW3V:ZF;17Z,_ _\ 8K^'GP?^&:?$;XYR0M/Y*7;:;?LR6U@",I&Z*<S3'@%,
M$9.T*2,F2V_:T_91U;4H=#NOA=:VFD,VP:A-X8LA;Q9SEMJ$R*.>JKGD\=ZS
M>(U:@KG3'+>6,76J*+>R/SBHK[?_ &T/V+_#O@;P6GQ/^&DF?"[".6^L4G,T
M4<4I41SP/R6C)9<@DXW CC@>5_L9_LJM^TEXPOI-4N9K#PGHHC:_EM\"69V)
MV01D\#(5B6P< =,L*T5>#ASG-+ UHUE0MJ]NQ\Z45^EOBWXP?LI_LVZW<>$]
M/^']MXEU33V,%S/9Z9!>F&5<922XN7#%L]=I8 @@X(('1_#?7OV8/VO)+OP]
M8^!['2=<,32+:7&FQZ?>M&N,O'+;M@XR#MWY'7;C-8_67ORZ'8LLC*7LU6CS
M=C\KZ*]=_:H^!K_L]_&'4_"T4TUUI31I>Z;<W&-\ML^0-Q& 2K*Z$@#)7.!G
M%?6W[&_[/GA+XK?LDZ_/<^&='OO%=U+J-G8ZI?6RM+#(8@L)WD$C:Q!R.E;2
MK1C!3Z,Y*.!JUJSH;21^=E%?JG9#]E3]F>"V^'?B4^'[[7X8XUU"YU31FOYI
M9&4'=-((G"9SD)D!0PX .:^&/B3X.T3XN_M/:CX7^$.D6\.DZAJ(L]-BMI&:
M%MJ@2S@DG;'E9)/EX"8P.U13K\[>FB+KX!T8JTTVW:R/$Z*_3V3X+?L\_L4>
M#;"]^(5M;>+_ !/<K\OVZU6[FNG&-WD6S'RT09^\W3(!<DBL[PQ\?OV4_COJ
MT7A;5O %GX:EO',-M=ZII-O:*Q/"@7$#EHF/N5&1C).*CZS?6,;HW_LNUHSJ
MI2['YIT5]._MH_L@/^SGJMIK>@SSW_@G5)3%"UQ@RV<^TMY+L -P(#,C8'"L
M#]W+?,6,8KJA.-2/-$\JM1GAY\DUJ%%%%:& 4444 %%%% !1110 5T/P_P#'
M.J_#/QKHWBC1)O(U32KE;F%NS8X9&]592RD=PQ'>N>H'O2:YDTRHR<)*4=T?
MOE\*?B+I?Q8^'VA>+='<-8ZI;+,%W9:)^CQM_M(X93[J:ZZOS4_X)@?'8:3K
MNI_"[5KC$&I%K_2-YX$ZK^^A&?[R*' Z#8W]ZOTHX_2OFZU/V<^4_3\%B%BJ
M*G?7J/HI!2UB=X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^!7Q0UKP1JWAO7M1U#2_),EQ9"#R7\V".9<;Y >%D Y'4&OK*OQ/_P""BO\
MR>/\0?\ N'_^F^VH&]#])/V:?VVO"O[3GBS5=!T'0M8TJYT^R^W22:D(=C+Y
MBI@;'8YRP[8X-?0&L:DFCZ3>7\B-)':PO.RIU(52Q SWXK\M?^"1W_):?&/_
M &+Y_P#2F&OT[\<?\B5X@_[!]Q_Z+:@#XN_X>W_#G_H3_%'3LMM^?^M_G7KW
MB[]N?X?^"/@EX<^(NIQWD?\ PD432:7H*>6;Z?:Y5LC=M55/5B<#/<D _B;V
M/\\9Q7H/@?P9X]_:)\4:1X6T"TN?$.H6-DMM:V^Y5BM+1')Y9B%1 SDDD]7[
MD@46)YC[HTC_ (*_V4NI*NJ?#"XM=/9AF6TUI9IE7N=C0(&.,G&X=A[U]W_#
M/X@:9\5/ ^C>+-'CNHM,U:W%S;I>1>5+L)(RRY/IZD$<@G-?D)J7_!.?XUZ'
MK6B6MYX=CN+#4+V&TEO]-N4N5M [@&210=X50<EL8&.>U?LAX9T&R\*Z!INB
MZ;#]GT[3K6*SMHO[D<:A%7\ !2*1IT444#"BBB@ K\J?^"J?_)PN@?\ 8K6_
M_I7=U^JU?E3_ ,%4_P#DX70/^Q6M_P#TKNZ[<'_%/"SK_='ZH_0_]F__ )-Z
M^&'_ &*^F?\ I)%7H]><?LW_ /)O7PP_[%?3/_22*O1ZY)?$SUZ/\./H@HHH
MJ38**** "BBB@ HHHH **** "BBB@ HHHH **0TV@"*^O(-/LY[JYE2"W@1I
M9)9" J*HR6)/0 "OPP_:*^+4WQN^,?B7Q8[/]DNK@Q6,;@CR[5/EA&.QV@,0
M/XF8U^E7_!1CXO'X<? 6?1+.X\G5_%4ATY IPPM@-URP]BF(S_UV%?D;_#CO
M^E>O@J=KS/B\\Q/-)4(]-Q****],^3"BBBF 4444 %%%% !1110 4444 %%%
M% !1110 445I:1X<U?Q!YO\ 9>EWNI"';YGV2W>7R\YQG:#C.#^5*Z&DY:(S
M:*Z/_A77BSJ?"^M8_P"P?-_\352^\'Z[I[A+K0]1M7(SMGM9$./7D#BIYET-
M/9S[,QZ*7USQ251GL%%%%,04444 %%%/BA>:1(XT:621@JHHR6)X  [G-(8R
MBM/5_#6K^'TC.J:5?:<)"1&UY;/%OQU W#MZ5F4)W').+LPHHHIDA1110 44
M44 %%%'2@ HHHI %%%%, HHHH **** "BBB@ HHHH **** "BBB@ I1ZTE%
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M3-E59?=%WR?2,U^(^[<23UKU,%3NW-GR.>XC14%ZL****]8^-"BBBF 4444
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MJ'B2\A1W<MA$(8Y;"DD'@ CGFG6C5Y;5)*P86OAHU4Z-.3?J>L^!_A7IT?\
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M\%/_ /DY*U_[ -K_ .C9JJW^TKT,%+ERR2CUD?(W.****] ^>"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ H7J/SHHH ]Y_8I^-'_"E?COHUW=7'DZ#J
MY_LK4M[$(L<A&R1L\#8X5B?[H;UK]HXVW*#[5_/'7[5?L6_%QOC)^S]X?U.[
MN/M&L:<#I6HNS9=IH0 ';_:>,QR'W<UY&-I[31]CD>(OS4'\CW44M-44ZO+/
MKPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BD-%
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M,C\"F*2*D>T_\$CO^2T^,?\ L7S_ .E,-?IWXX_Y$KQ!_P!@^X_]%M7YB?\
M!([_ )+3XQ_[%\_^E,-?IWXX_P"1*\0?]@^X_P#1;4=1K8_G:K]4/^"2?@:U
MTWX2^*_%C1?\3#4]6^P"0\GR((D9<>F7FDR/]D5^5]?L3_P2]C6/]E>T8##/
MJ]XS>YW*/Y 4V1'<^M@>:6BBI- HHHH **** "ORI_X*I_\ )PN@?]BM;_\
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M)!,HS\JY;#;MP!^88P?G7]E_P=\*_&GBC6+?XK>(9/#NE0V@DLYHK@0>9,7
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MU#3;PVUM'I\ZQAAY(<94HQ)W'U]JWE5C&'.]CBIX2K5JNC%>\?'5%??G@?\
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M!*>HZMG@#U!X;]L#]NC1?&G@M_AQ\+H9+7PV\8MKW4C;_9TEMU "P6\?58R
M 2P4X&T#!-?#E%9QPZ3O-W.B>8RY'"E!13WMN>W?L8>/-"^&?[1?AGQ%XEU!
M-*T:UCNQ-=2JS*A:VD1>%!/+,!T[UT7[?'Q/\,?%KXX6^N>$M5CUG2ETB"V-
MQ%&Z 2+)*67#J#P&7MWKYOHK;V:]ISG+]:G]7>'Z7N%%%%:G$%%%%, HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH !7VK_P $O_BPWACXJZKX'NYL67B2
MV,ULK'@74 9N/]Z+S,_]<UKXJKH_ASXUN_AOX^\/>*;++7.D7T-ZJ9P) C@L
MA]F *GV)K*K'GIN)V82L\/6C47<_?M:=6=X?UFT\1Z+I^K6$HGL;^VCNH)1T
M>-U#*WX@@UHU\SMH?J:=U=!1110,**** "BBB@ HHHH **** "BBB@ HHHH
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M<V-LJ?\  9%=?^ UV]?,M6=C]6C)3BI+J%%%%(H**** "BBB@ HHHH ****
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M;0_+GNPHHHIB"BBB@ HHHH **** "BBB@ HHHH **** /7/V1_\ DYCX<?\
M88A[9[FOU-_:2_: ^&_P0G\/IX_T:?57U)9VL_)T^*Z\L)Y?F9WL-N=Z=.N/
M:ORR_9'_ .3F/AO_ -AF'^=?57_!6S_D(?##_KEJ7\[6O-K052O&+/J,#5E0
MP-2I%=3NC^WQ^SGC_D3[W_P06W_Q='_#?'[.>.?!U[WY_L"V]/\ ?_SFOR_-
M%:_5(=V<G]L5]^5?<>J?M._$#PW\4?C3KOB3PC9R6&@7:6ZP026ZP%2D"(_R
M*2!EE/2OT!_X)>RK;_LWZU*WW5\0W3'\+>W-?E57ZD?\$V?^35/%/_89O?\
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MM-D#'@.!YL9^NZ+8/]^OUY']*^?Q4.6H?HF45O:X5)[K0DHI!2UR'MA1110
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M@"BBBF 444&D,***7D4!82BCM10(****8!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4O4_2DHI ??7_  2D
M^(AM?$7C/P//*?+N[>/5[6,G #QD1RX]V5X?^_9K])  :_$']D3Q\?AO^T9X
M&U9G\NUDU!+"Y).%\JX_<L6]E\P-_P !%?MYRP!5@!7A8R/+4NNI^@9+6]IA
M^1_9)****XCZ **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]/\ ]=?JEKP_XU@Q'_J6+?\ ]&)7Y6]A7-AY-N5^YZF9PC'V5EO$&ZT5]6_
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M&X@)!.TG@.I"L#[8Z$U]\>/OA3^S_P#ML_9?%6E^+K?2_$DD2K-<6%S%#=2
M+A5N+>0;LJ%P&P"0OWBH%?)7["OP;^'7QV\5>)_#/C>.X.H_9([O2GMKMH'
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MLK:1#;RR9Y:2$>2Y/N6C->3CHZ*1]=D%36=/YGJXI:2EKRC[(**** "BBB@
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MXC_[&>X_])+2N/%-JG='MY1",\3:2OHS\O=>A2WUS4(HT5(X[B1550   Q
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MRZIJUT?ECC&%11U=V/"H,\L>/Q(%;4;*GH[G%C(U*F(LXV?9'-45]_\ A?\
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M<;&\4SZ?(ZWLZDHOJCZ@HHHKQC[D**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH ***2@!:*0#%+0 4444 %%%%
M!1110 4444 %%%% !7Y4_P#!5/\ Y.%T#_L5K?\ ]*[NOU6K\J?^"J?_ "<+
MH'_8K6__ *5W==N#_BGA9U_NC]4?H?\ LW_\F]?##_L5],_])(J]'KSC]F__
M )-Z^&'_ &*^F?\ I)%7H]<DOB9Z]'^''T04445)L%%%% !1110 4444 %%%
M% !1110 4E%(W*T ?*G_  4N\4?V#^S'>60/.M:G:6/_ 'RS7'_MO7Y&>M?I
M+_P5DUSR/"7P^T8-Q=7UU=E?^N4:(/\ T=7YM5[N$C:E<_/<ZGS8MKLD%%%%
M=QX(4444 %%%% !1110 4444 %%%% !1110 4444 %%'UHYH **.WO10 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%'6D 44<
M8Z<T4QV"BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %?O7\&?%1\
M<?"7P9K[-ODU+1[2ZD/^V\2EA_WT37X*5^SW[!NN?V]^RGX%D+;GMX;BU;V\
MNXE0?^.A3^->9CE[J9]3D,[59Q[H^@12T@I:\<^W"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***3I
M0!XO^V9XH_X1']F'XAWP.&FTQK >N;AEM_\ VK7XD'UZ_P Z_6K_ (*<:[_9
M/[-8M Q']J:S:VI [A1)-_[1K\E>PKV\%&T&^Y\'GL[XA1[(****] ^;"BBB
M@ HHHH **** "BBBD!^MGBW_ )1JV_\ V)%E_P"B8J_)+T^E?K;XM_Y1JV__
M &)%E_Z)BK\D^3^5<.%^VO,^AS?>E_A0H_\ U5]N_P#!*2\E3XN>+[91F"30
MQ(YS_$L\84?D[5\0\D8K]%_^"4OP]N+?3O&WC>YA*6UT\.EV<A&-VS,D^!W'
MS0C/LP[5IB6O9._4YLKBY8N+70\&_;P\.S:W^V;KNF6 WWNJ/IT*+ZR/;0QJ
M/T6OL/\ :>\<)^QC^S!H/A?P,$LM3N2NDV5R% >/Y"\]UCNY/?LTN[G&#\<_
M$#X@V?CC_@H):^(/.6338O&>G6Z3 C:T5O/##N!ST(B+?CFOT%_:Q_:@N/V8
M-)\/:DOA+_A*+?59Y;=V.H?9/(955D'^JDW;AO\ 3&WOGCCJ<W[N+5SVL/[/
M_::W-RZVOV/QOOO$&JZEJ[ZK>ZG=7>JR.9'OY[AFF9CR6+DDDG)R2>]?IK^P
M3\9+S]HOX6^+O 'C]O\ A()--ACA:XO/FDN[.=779)W9D,9^<\D.N>1D\.?^
M"MAS@_"E?_"B_P#N6C_A[<?^B5 ?]S%_]RUI456I&WL[6.;"O"X>?/[>ZZZ/
M4^2;.\O_ -EW]I1I8'DEG\(Z\\1(^5KBW20HP_[:Q9&/1S7V9_P4X\!6OC/X
M:^#/BCHQ6Z@M2EM-<1])+2X >&0G^Z'&!_UVKX3^-'Q('Q>^*'B/QA_9G]D?
MVO<"<V/G>=Y7RJI&_:N[H3]T=:_0?]D;58/VFOV+_$/PVU.99-2TNWET<-*<
ME4*^99S$>BM\H_ZX5=9./)4>ZW,L(X5O;89;2UB?GI\&_AU<?%CXJ>%_"%OO
M!U:]C@ED09:.$?-*X_W8PS?\!K[F_P""H7Q(@\.^$O!WPOTDK;13 :C=6\7
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MXEZ?&IO+:=-/N)UX,MM*K/$Q]=KCC_KJ:L_\$H5_XM[X[XR/[4AR/;R:Z?\
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M'@=UA KY@_X*DX_X:+TK/_0N6W_I1<U][?M$_'QO@'\)+;QM9>'E\3VC7%O
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M, HHHH **** "BBB@ HHHH **** "BBB@ HH^M&#2]0"BCFBF 4444 %%%%
M!1110 4444@"BBB@ HHHI@%%%% !1110 4444 %%%% &AX>\0ZGX3UNSU?1K
M^XTO5+.02V]W:R%)(V]01_DC([U]9>#O^"G_ ,4=!T^VM-9TS0O$OEC!NYX'
MM[B3U+%&"9^B#Z&OCVBLITXU/B1U4<56P_\ #E8^M/'W_!2WXL>+M+EL=*32
M/"<4@*M<:= TEQ@\'#R,P7@]54'/((-?*5Y?3ZA=375W/)=7<[M)--,Y=Y&)
MR69CR23DDD]Z@HIPIQI_"@K8FKB/XLKA1116ARA1110 4444 %%%% !1110
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M^!/@KPO\._ <W_"/2:A:L))K/Y'M+*,"...(]5W'(W#D"/ /->#?"NX@M?\
M@IU>/<;3&?%6L(-QXW,ERJ_^/$5I_P#!5BSFC^-/A2Z96^SRZ L:-V++<3%@
M/?#I^8K*W/5A&6UCHBW1PE:=/1N5OD?'FD>*]8T#7H-<T[4[RQUB"3S8[^"=
MTG5O7=G.?7ZXQ7VA\:OVU/ GQR_9=A\+>);/4Y?'[V\,GGVME'Y,-]$V#*&+
MC:L@# [02!(17PUSVZUU%E\+?&6J>&1XCLO"6M7GA\K(PU2WT^62V 0D/F4*
M5 4JV>>U=<J<).+>AY-'$5J:E&&J>ZW/T(_X)I?#72_!OPE\0?%+4T07M\\T
M,=PR@^390#+[6_VI V?^N2^]?#GQX_:"\5?'[QE>:QKNH3_V>97^P:1YO^CV
M<1/RHJX W ;<N1EB.>P'Z5?L5>)3X?\ V'=&U73[-=2NM)L]4G%B)O+\Z6.Y
MN9!&7VG:6^7YL'&[.#7BG_#VP]1\*U_\*+_[DK@IRG[64HQN?0UX48X2E3G4
MY%Y)N_W'A7[$?[1WB'X5?%KP_P"'WU&>Y\(:[?1:?=:;-(6BB>5A''.F[/EL
MK,I;&-RC!SA2/1/^"HGPGLO"OQ%\/^---@6!?$<$D5\L8PIN(=O[PC^\R.H/
MKY>>I.>R_P"'MA/_ #2D9_[&+_[EKPO]J[]LY?VGO#>AZ4?!O_"-OI=VUT+C
M^U/M?F!D*[=ODQX]<^WO6D(SE54^6QR5*F&C@Y455YWNM&?,U%':BO3ZGS7H
M%%%% @HHHH **** "BBB@ HHHH 3Z]*]V^!/[4&L_!7PC>:'I[8AGOWO&_WF
MCC0_I&*\*HVL>F[_ (#TK*HN9'10J.G*Z/Z(****^9/U@**** "BBB@ HHHH
M **** "BBB@ HHHH **** "FMTIU,>@#S/X]_M">$OV<_!Q\0>*[F4+*YBL]
M/M%#7-Y)UVQJ2. ,$L2 ,]>0#^:_Q1_X*D?%7Q?<7,'A6'3O!6F,Q$1@@6ZN
MPG(P\DF4SCNL:^QST\[_ &\/BY??%?\ :2\5":9CIGA^YDT.P@S\B) [)(P_
MWY-[9[@@= *3]D?]CW6OVIM7U.2/5(]!\-Z2R)>ZB\0FD9G!*QQ)D9; 8DDX
M4$=>AI$.]]#+N/VW/CG=SM,_Q)UA68Y(C\N->W0*@ Z#H/J>3GK/!?\ P4=^
M.GA&XA^T>);7Q);(5S:ZQ8Q,"!C(+QJDG('7=G\37V=:_P#!*#X0PV313ZWX
MOGN&'-Q]NME8'&"0!;X]^<]:^5_VP/\ @G[>_L\^'SXO\,:K<>(_"22K%=QW
M42K<V&XA49RORR(6.-P"X+*,'.: U/M+]E/]OKPM^T1>1>'=4M/^$5\:LI:.
MQDEWV]X ,DP2$ [L9)C89 Z%L$CZJ7K7\Y6E:I>:'J5IJ-A<R6E]9RI/;W$+
M;7CD4Y1@?4$#'TK][OV<OB@WQH^!_@_QE+L%WJ=BINQ&NU?M$;&*;:.P\Q'Q
M[8I#3/1VZ9KYV_:+_;D^'7[/2W&GSW9\2^*T!5="TN16>-@/^6\G(B'L<MW"
MGG$W[?7BG6/!O[*GC+4]"U.ZT?45-I$MY9R&.5%>ZB1P&7D95B#CL37XC,S2
M2%V)+,<DLQ)SWR3UY_G0#=C^B+P3KK^*/".AZS)"MO)J-A!>/"IRJ&2-7P#W
M S6Y7(_"'_DD_@K_ + EE_Z(2NNI%!112;10 M%)2T %%%)M% "T4FV@#% "
MUA>-/&^@?#SP_<:YXEU>ST32;?\ UEW>RB- <'"C/5CCA1DGL*VV&17XO?\
M!1CQ9K6M?M4>+M)O]4N[O2]*:VCL+*68F&V5K6%VV)]U2S,22.3WIB;L?HY\
M OVRO#G[1OQ4\1>&?">G71T;1[ 77]L7G[MKIS*$^2+&53!R"V&/]T8Y^AZ_
M++_@D7_R5CQQ_P!@1/\ T>E?J;2!!112;10,6BDVBEH **** "BBDVB@!:*2
MEH *^=OV[OC!XH^!_P "6\3>$+V.PU<:G;VWG2P),/+</N&UP1V%?1->-?M8
M? &?]I+X4'P?;ZU'H,GVZ&\^V2VYG&$#?+M#+UW>O:@#\Q3_ ,%*/CY_T-%C
MG_L#VW\MGTK]G%^\>>W2OS/_ .'0.K]OB=8]O^8._P#\>K],%Z]:!(?1110,
M**** "BBB@ HHHH **** "ORI_X*I_\ )PN@?]BM;_\ I7=U^JC5^5?_  52
M_P"3A=!SU_X1>W_]*[NNW"?Q3P<Z_P!T?JC]#_V;_P#DWKX8?]BOIG_I)%7H
M]><?LWD?\,\_##G_ )E?3/\ TDBKT7CU%<DOB9[%'^''T0ZBF\>HHX]14FMQ
MU%-X]11QZB@+CJ*;QZBCCU% 7'44WCU%''J* N.HIO'J*./44!<=13>/44<>
MHH"XII"<?G0<>M-W#N:-0/S(_P""KVK--\4/!6F9^6VTB2YV^\DS+_[2KX:K
MZX_X*>ZE]O\ VD[>'.?L>A6MO^<DTG_M2OD>OHL.K4D?F>92YL74]0HHHKI/
M,"BBB@ HHHH **** "BBB@ HHHH **** "BBBD #)X )/;'^'>OU"^&G_!-W
MX;7'P\\/+XMCU-?%UUIRW%Z(;XQ[)6 +A4QTC+JN?8>M?&/[%7PE/Q=_:&\-
MZ?/#YVEZ9(=6O\\@Q0D$*1W#2&-#[.:^S_CU^TDG@C]NKX<:(+L+HVGVAT_4
MQNP$DOR/O^RA+63Z UP8B4G)0@_,^CRZC2C2=>NKIM)'YN?$+P5?_#CQQKOA
M?4UQ?:3>2VDA (#[&P'''1AAA[$5S]?<O_!4CX1?V%X]T/XA64.VTUR$6-^R
MCI=0K^[8GU>(8'M#7PU751G[2"D>1C*'U>O*F%%3V%C<ZG?06=G!+=7=PZQ1
M00(7>1V. JJ.22<  #J:^F/!G_!.7XS>+M-CO9]-TSPXDH!2+6+S9)@]RD:N
M1]&P1W%5*I&'Q,SI8>K6_AQ;/F"BO=/BW^Q;\5?@UI,NKZQH*W^C0@F;4-'E
M^TQP*.2S@ .JX!.XKCMG)%>&^N>H]>GTIQG&2O%DU*,Z3M4BT-HKTGX0?LZ_
M$#XY7$J^#O#TVH6D#^7/J$S+!:PMUVM(YP6 (.T98 CBO:;[_@F7\9+6S\^(
M^'KZ7&?LT&H,)![?/&JG_OJHE5A%VDS:&#KU(\T(MH^3:*WO&W@/Q#\.-?FT
M3Q/H]UHFJP\M;7D90E<D!E/1E.#AE)![$UD6-C=:I>P6=E;RWEY<.(H;>!"[
MR.QPJJHY))(& .]:WTOT.9PDGRO<@HKZ?\%_\$YOC+XPTZ*]FT_3?#:2A62/
M6KPI*5/()2-7*?[K8([BN<^*O[#_ ,6_A%I,VJZCH,>KZ/;KNGOM%G^TK"N.
M69,+(% R2VW  Y-8JM3;LF=3P6(4>=P=CP.BC@D?Y_S^']:[KX3?!#QM\;]8
METWP;H<VKS6X4W$VY8X( >ADD8A5SAL#J=IP#6LI**N]CFC3E4ERQ5V<+17U
MLO\ P3%^,+6?GF?PVLO_ #ZG4)?,Z<<^45_4_05X1\6O@/XZ^"&H0VOC+P]<
M:2)R1;W0*RV\V.H65"5)Q@[<[AGD5G&K"3M%F]3"5Z,>:<;(X"B@+N^7K[ <
MFOI;P+_P3U^,WCC2[:_;1K+P];7 W)_;=UY,A4]&:- SI]&4'CD<C-2G&'Q,
MBEAZM;^'&Y\TT5],^-O^"=_QG\%Z=)>Q:/8^)((@7==#N_-EQ[1NJ,Q]E!/M
M7S5+#);S/#-&T,L;%7C=2K*02"".QR"/J#1&I&?PL56A4H_Q(M$=%*?0=*2M
M# U/"_AO4_&7B+3M#T:SDU#5=0G6VMK:,#<[L< <\#ZG@=>U?H-:_L8_ C]G
M7P=8:G\;_$O]HZG='_5B>>&)F !9(88/WTH7H7[[AD+G%?*_[$6NZ7X=_:D\
M!WFKND=JUS+;I)(<*LTL$D47YR.@_'/:OHO_ (*H?#77I/$GAGQY"DMUX=CL
METF<H"PM)A*[JS#L'$F,^J8/:N&K*4JJIIV1[^"IPAAIXGEYI+H]D:_CO]A7
MX6?&+X:W'BWX$:QFXA\PQV:W3W%O<NHR8#YI\R*3IC<?XAD8(8?GA<V\MG<2
MV]Q$\-Q$Y22.1=K(P)!!'8Y^G2OTT_X)D^!];^'_ ,+O&'BOQ'NTG0-8>&XL
MEO#Y8\J%)#)<\_=C8. &.,B+/3!/YV_%#7[/Q5\2_%VMZ<NS3]2U>[O;=<8V
MQ23.Z#'T(Z_XTL/)\THWND&/I0]C3KJ/+*6Z.8HHHKO/ "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ K]8?^"7FK-J'[.-Y;,<BQUZYMU&>BF*&3^<AK
M\GJ_33_@E#J8E^&_C?3RW^IU>.?&?[\(7_VE7#C%>F>]DLN7%KS3/NI:=3?J
M:./45X1^@CJ*;QZBCCU% 7'44WCU%''J* N.HIO'J*./44!<=13>/44<>HH"
MXZBF\>HHX]10%QU%-X]11QZB@+CJ*;QZBCCU% 7'44WCU%''J* N.HIO'J*.
M/44!<=13>/44<>HH"XZBF\>HHX]10%QU%-X]11QZB@+CJ*;QZBCCU% 7'44W
MCU%''J* N*>U-]:6D.,4 ?!?_!636##X+\ :7N^6XU"YN=OKY<2+G_R-^M?F
MM7WW_P %9]2\SQ+\.=.S_J+2]G_[[>%?_:=? E?087^$C\XS:7-BY!11174>
M.%%%%, HHHH **** "BBBD!^ROASX?WGQ6_85\-^$M/N8+.]U;PA8V\4USN\
MM"8(SEMH)QQV%?(B_P#!*CXAXR/%OAGG'4W&??\ Y9U\W:/^TA\4O#^EV>FZ
M;X_\066G6<*V]O;0:A(J11J,*JC/    ]JM_\-4?&#_HI/B7'_82D_QKSXT:
MT+\CW/I*N.P==1]K!MI6/KCP7_P2?:/4HI?%GCM9;!&!>UTBR*R2CN/-=L)_
MWPWX5WG[37[3/@S]F+X5_P#"L?AG-;KXCCMC8PPZ?*)!I*'(>65@3F;)) )+
M;CO;L&_/?Q!^T%\3?%5D]GJ_C_Q)?6CKM>WEU27RW'^TH;#?C7G]6J$YM.J[
MF4LPI48..$ARM]62PW$MO<)/$[).C"19%/(;KG/U]*_670=:\(_\%"OV;6T2
M^OHM/\4VZQO=+&JO-IUZ@($ZH2,QN-WU5V7(8<?DJ,]JU/#GBC5_!VK0ZKH>
MJWFC:E#_ *N[L9WAD7/4!E.<'TK6K24TK;K8X\'C/J\I1DKQENCZ/UC_ ()O
M_&K3];:RL])TW5;0R,%U*#4HEBV@X#%9"KC/7 4\$U]?_"KX3>"OV$_@/KFL
M>/;VQU75+YEEOV6,2+<2!2L-I;JX!?[S<D#)9F.%''PQ!^W;\=;?3Q:+\0+D
MP*-H:2QM'DP,=9#%N/YUY/XY^(WB?XEZL-2\5:]?:]?*NQ9+V8OY:\<*#PHX
MZ#C//6L72JU&E49VQQ6$P[<Z$&Y/OT*GB[Q))XP\5:QKD\$-K-J5W+=O!;H$
MBBWL6VJH   S@<=J^B_^"=?Q8/PY_:"M-(NIO+TOQ3#_ &7*K'"BXSNMV_WM
M^8Q_UUKY<J>QOKG3+ZWO;.>2UN[:19H9XFVM&ZD%6![$$5U3@I0<3R:-=T:R
MK=;W/UY_:DUC2/V8OV;_ !W<>'P++5/%6HW B9>"UY>$^;(/0K$KL/\ KF*_
M(#;Z< ^O3_Z]=;XV^+GC;XD6MM;>*?%.JZ_;VKF2&'4+MY5C8C!(!/!QQ7(U
ME0I.DM=SKQ^,6*J)P5HH_2+_ ()\_'?P]X[^&5S\%O%SP&XCBGAL;>Z;"ZA9
MR[B\&2>77<_'=6&/NG'D7Q8_X)G_ !&\.^(KK_A!UMO%FA,VZV\RZBMKI%/\
M#B0JI*C W \]< \#X]AF>WE26-VCD0AD="058="".ASWKVKPS^VI\;?"6GK9
M:?\ $'4'A4;5_M"*&]8>P>>-VP/K6<J4Z<G*GU-XXRA6I1IXJ+]W9H^QOV/_
M -B.?X&ZM<_$3XG7>G07UG;3"VL?-62&R0JRRS3R'Y<[-P !V@,Q))P!\=?M
M@_%[1?C-\9]0U7PU:06OAVSC6QLGAMQ";@*69YF  .7=V(SSM"Y .17)?$?X
M_P#Q$^+5NEMXL\6ZEK%FK[Q:2N$@W<8/EH%4D8Z[?7U->?\ ISS_ /7ST]S5
MTZ,N9SF]3+$XNG*DJ%"-HK[S]4->_P"4847_ &+%O_Z,2OSW_9U^,$_P+^+_
M (?\7I$UQ:6LIBO;=/O2VT@V2 =/F .X9.,J*RI/C1X[F\'#PF_BW5W\,^0M
ML-):[?[.(AR$V9Z @?E7%^V,_A_2BG1Y5*,NHL3C/:SISIZ.*1^JO[4G[-6E
M?ME>%="^('PZUW3YM8BM/*AGD)$%_!N)$;L!F.1&+XR,@L58#@CY>\$_\$T_
MBWKWB**UUZ'3_#&D"7$VH27<=RWE]VCCC8ECZ!BO/<5\^_#OXQ>-OA+=RW'A
M'Q/J&@F8YECMIB892.,O&<HQ^HKT/7/VXOCCXBL9+.[^(-[%"Z[6:RMK>UD
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MLGDW4<^_RMF_[A.,>8G7KGCI2YHWY;ZDJG.47-+1'FE%='X ^'OB3XH>)(-
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MVBGV...)2PDJ#6K=S])_V2?^4>OB/_KPUO\ ]!EK\V/AS_R43PO_ -A6U_\
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M&>"=I X^8_,?7OV4_P!EC0/V5/$UG=^+O$MCJ7Q!\1+)I^G6MJ#Y:(JF601
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M.]S]FOAQ^V_\%OB='$EAXVL=*O7P#9:X38RACT7,F$8_[K-7J'CCPAHGQ:\
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M;Q'/[EKK_(_**BE/^>,?I25ZA\HPHHHIB"BBB@ HHHH **** "BBB@ HHHH
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M3/[5O_58_P#RK49_:M_ZK'_Y5J_9O:/2C:/2CZU_=0?V1_T]E]Y^,F?VK?\
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M-H]*/K7]U!_9'_3V7WGXR?\ &5O_ %6/_P JU'_&5O\ U6/VS_:M?LT0/2C
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M_58__*M7[-[1Z4;1Z4?6O[J#^R/^GLOO/QDS^U;_ -5C_P#*M1G]JW_JL?\
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MIIQE8 B S3CWY"ANV']:] _X*I_\D&\+?]C'%_Z2W-=E^Q7<Z5I/[#>BWE_
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MXR9_:M_ZK'_Y5J,_M6_]5C_\JU?LWM'I1M'I1]:_NH/[(_Z>R^\_&3/[5O\
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M3_V,=O\ ^D]S7Y25Z>'G[2'-:Q\KF6'^K5_9\S>BW"BBBND\L**** "BBB@
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MFU_%+_L6=1_])WKH?@[(LWPD\$.G*-H=B5^A@3%<]^U)_P FU_%+_L6=1_\
M2=ZDL_!"OVN_X)UZ2FD_LA^""J[9+HWEQ*?[S&[F /\ WRJ#\*_%$=N,U^Y/
M["ZA?V3?AN  ,Z>S''O-(?\ &F1$]VZURWQ,^)GAOX0^#KWQ/XJU2/2=(M<!
MYG!9G8G"HBCEF)Z #WZ UU#=*_*S_@K)\1+[5?BUX;\&),PTG2=,%\T*D@-<
MS.X+,.A(2- .XW-ZTBSI?B;_ ,%<-0DGEM_A]X+M[>WY"7_B*0R2,#T/D1,
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M [01_? ([CBO//AS\3O$_P )?$T.O^$]8N-&U.,;?,A(*R(2"4=2"KJ2 =K
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M/S!/-)<32332-+-(Q=Y')+,QZDGN3ZU4:52I-2J]#.KC*%"C*AA+Z[L^QO\
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MKCQ-X8MXUENK>ZV/<Q1''[Y)(E"R1\Y. -HYY&<?&W7_ "/Z5^K_ .SS'?\
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MH&?<\ 9) K]R/@7\(=*^!?PNT+P7I#&:#38<2W3*%>XF8EI96'^TQ.!V&!T
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M^0XSG-($?SR=OPK]R_V&O^33?AO_ -@]O_1TE<A_P[9^ O)/A>^_\&]U^?\
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M>,8'4?L=^*HO!G[3WPYU.>3RH?[6CM&D;@*LX,!)]OWO)[=:_:#XC?!7P?\
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MG.0:=R;'YC^&=)^*W[8'Q&L-&;4]7\7:JQYNM2N9)(+"(D!Y&)R(HQ@9QU.
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MV*UO_P"E=W7ZK5^5/_!5/_DX70/^Q6M__2N[KMP?\4\+.O\ ='ZH_0_]F_\
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MF85_K#<962>W3[C[8_X*6?L^Z;X \4:3X]\/V<=CIVORR6^H6\";8UO -XD
MZ R+N) [QD_Q&O9O^"5/_)&/%_\ V'C_ .D\5;'_  418ZA^R)I5SJ6U;\W^
MGRC/_/8QN&_\=9ZR/^"5/_)&?&'_ &'C_P"D\-<SDWA]>YZ\:<:>9WAUC<_/
M7X:_#N\^+/Q:T;PA8/Y5QJVH_9S-C/E)N+228[[4#-^%?I=^T!\9/#?[!_PF
MT+PCX#T:U?6[Q&6RMICD*J@"2[N-N&=BVT#)&X[N<)BOD#_@GG;0W'[7&EO*
M?GAM[]XN/XO*=?\ T%FK;_X*B7-S-^T9I\4R[88?#ULL'HRF:<EO^^BP_P"
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MO_X)+VL$FL?$RZ;:+F.#3XDXYV,UP6Y_X E8QDXT)/S/0K4E6Q]*$MK(Z_\
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M9TSPEX>T_P /V1Y:.Q@6,R'U=OO.?=B33%8Q_@+\);'X&_"?P[X*L&$RZ9;
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M#]F+XA6.W<T6F-?+QGFW99^/^_5?B/\ 7K7MX.5Z;78^"SRGRXA2[H****]
M^<"BBB@ HHHH **** "BBB@#UC]FO]GO4?VE/'5]X8TS5K;1[BUTZ343/=1L
MZLJRQ1E0%YSF4'\#7TI_PZ>\6_\ 0]Z-_P" LO\ C7.?\$K?^3A/$'_8KW'_
M *5VE:7[>7QX^(G@/]HO5=(\.^-=:T;3([.UD2SLKQXHU9HP6(4>IKSYSJRK
M>S@SZ+#T<+#!K$5HMN]MS1_X=/>+?^AZT;_P%E_QH_X=0^+<$_\ "=:-_P"
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M84M;>*&)!'%&@1$7H% P *\K'2V1]=D$-9S^1.*6D'K2UY)]D%%%% !1110
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M;A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV/O1QPQ*#_WTT@_"ORR!QS7[5_L1^%#X1_9=\ VK+MDNK(ZBQ(Y;[0[3*?\
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MAS_T/_A?_P '-M_\72-\</ARHR/'_A?_ ,'-M_\ %T =Q13$R">]/H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "ORI_P""J?\ R<+H'_8K6_\ Z5W=?JM7Y4_\%4_^3A= _P"Q6M__ $KN
MZ[<'_%/"SK_='ZH_0_\ 9O\ ^3>OAA_V*^F?^DD5>CUYQ^S?_P F]?##_L5]
M,_\ 22*O1ZY)?$SUZ/\ #CZ(****DV"BBB@ HHHH **** "BBB@ HHHH ***
M* *.MZ5;Z[H][IMW'YMI>0/;S)_>1U*L/R)K\ ?%7AZX\(^)M7T.[XN],O)K
M*;C'SQN4;]5-?T%M7XS_ +?/@1O O[3WBC;'Y=IK BU>#_:$J_O#_P!_5EKT
M<%*TG$^6SZG>G"HNC/G@T4=LT5[)\0%%%%, HHHH **** "BBB@#[)_X)6G'
M[0NOG_J5[C_TKM*],_;%_8M^)?QL^.6H^*/#-MILVE3VEO$C7-X(GW)&%;*X
M]:\S_P""5O\ R<-K_I_PB]Q_Z5VE>@?MG?MB?%#X-_'C4O#/A;6K>QTB"TMY
M4ADL(9B&>,%OF92>M>7/G^L/DWL?5X?V']FKV][<W0\?_P"':?QJ_P"?'1?_
M  9+_A2-_P $U?C4HYLM& ]M27_"L_\ X>+_ !R_Z&>S_P#!5;?_ !%(?^"B
MOQR;C_A);(_]PJW_ /B*UMB4];'#_P )G3F/G/5=,GT75+[3[D*+FTF>"4*<
MJ&1BIP<<\@U^P/@'P)X:^(7[%O@/3O&,GE>&+?1=/U&_RVU6AMU69E=AR$.S
MYL<XSC%?C[J>I3ZQJ5Y?W3;[JZF>>5@  79BS$ <#DGI7ZG^+K^;3?\ @F/;
MRP.4=O"=E"<=U<Q(P_%6(_&EBDVHKS-LJ<4ZTK721Y-XF_X*@6?A>[CT;X<_
M#ZR@\+V($%JU[(8-\8[I#&-L0]!DG'/'2OH#P#XS\"_\%!/@AJUMJV@K8WEN
MS6UQ;3D32Z=<,F8YX)0 <'@@\9VLK#&<_C_ZDC_/_P"JOT/_ ."24C_\73C)
MRBG2V'U(NP?Y"HKT8TH<T=T;8'&U<5B/95=8ROH?!&N>&+_0?%6H>';B/S-4
MLKV33Y(XCG,R2&,@>OS BOU \#^ _ 7_  3\^!,?C#Q/8)J7C.Y6..XGC5'N
M);IU)%I QX2-0&RPZA"QS\JCXX\(:1#KG_!0/[)<(LD)\?7,I5^A\N\DD /X
MH.M>W?\ !6;5YI->^'.E@N+>&VO;H\G:S.T2CV) 0_3<?6JJMU)0IF6%4<+2
MK8E*[B[(K:7_ ,%7M;_X2%?[4\!Z>V@LX#PVMT_VE$)Y(9AM<@=L+GUK[0^
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M6U+#4H\\GV*S+$571I0;TDM0Z44'M17I'S 4444 %%%% !1110 444O]?SI
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M 'P:G['?[*MQ<>,)XK>[LXYM9U14<$),X4+ &Z,X"QQC!.6X!((-?F5^S_\
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M?<_[/X_XUBZ__P!BWXB_]"NZ^;O^"GBJO[2=N0,%M"M2?<^9,/Y 5](_L_\
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M0[?PSX=TO1[1=MII]K%:0KZ)&H5?T K\:_V'? K^/?VG/!D'E&2VTVX;5IV
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M /)O7PP_[%?3/_22*O1ZY)?$SUZ/\./H@HHHJ38**** "BBB@ HHHH ****
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MDZ(B@!0/8 "K=?,RES2;/U>C35*G&"Z(****@V"BBB@ HHHH **** "BBB@
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MZ@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M 26,%XL)/WEBFWK)@_[J]/:N-\4?M]^!_AWHMWIGP,^&MGX9NKA3&VKWUI#
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M (];:O@S]HC]H[Q-^T?XPBUC7Q%9V-HK1:?I-J28;6,D%L$_>=L LQ'.T<
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MJ^:K2YZC9^GX"C['#0B(*6BBL3T HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3M;'9EKXK_X*;?L^Z9\+_B-I7C+P_;0V.E>*1+]ILH5VK%>1[2[J!P%D5U;
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M>L_\%</^2U>#O^Q?'_I3-7DW_!.K_D\CX??]Q#_TW7-,GJ?M?7R'_P %2?\
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MQLQ]$DX'_78U^9O;^GI7T6'G[2FF?F68T/J^)E'H]0HHHKH/,"BBBF 4444
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M]%? O_!,SPUX!U2+Q#\2?'5KJ&@V+":6S6$6<#X.<2S.YPG3(&"<GYA7FO\
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MB;.FS#U*_P"D C\#C_OJM,4[4F<V514L7!,\&_X*$?$"Y\;?M+:_9/-(VGZ
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MQP:^/**P=.]15+G?'%<N&>'MN[W%/&1GBDHHK<X0I=QI**0@HHHHWW&%%%%
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MN&![BJ1$C]POV/;ZVU#]E_X92VJA8UT.WB8#^^B['/\ WTK'\:]A;I7Y>_\
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M<*#Z*/I7Z>?\$QYO'GB'X4ZYXI\9^)=:UZRU&\6VTB/6+V2Y\N*$,))(RY)
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MN58;ZOATWO+4:O>G445R'M!1110 4444 %%%% !1110 4444 %%%% !1110
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M*A452/0^\/\ @IO\ M2L_&%O\4M+M)+G2;^".UU9HD+?9ID 2.1\=%=-B9/
M*<_>%?"!/^<5]_\ [.'_  46TR'PNO@_XR6\^I6XB^RC7%@^TB:$C!2[CY9C
MCY2P#%L\@\L>XU#X2_L8^/M2?4H?$/A[1WE;S7@M]?\ L$9]A%(X"#_94+WP
M*XJ=65%<DT]#W:^%I8Z7MJ$TF]TS\XO!/@O6/B)XKTSPWX?LI-0UC4IA!;V\
M?=CU)/90 6+'@ $G &:_2K]IWX7_  V^ O[(,-EJ?AO1-0\26VG1:+IVH/9I
M]JDO77YYEDQN&#YLWI\HXZ5I6'QC_9;_ &3-(NW\&3Z9J&J2I@KH4C:E>7.
M#M-PS,JJ>#@N%ZX%? _[2G[2GB']I/QDNJ:FO]GZ/9[H]-TB-]Z6R-C<2<#<
M[8&YB.P  &!1>=>::5DA.-#+Z,HMJ4Y?<CZ%_P""4?\ R53QJ?\ J#)CM_RW
M7M^5> ?MC?\ )SWQ&_["K?\ H*UZ9_P3O^,7A#X-^/O%.H>,M;BT2TN],2"&
M66-W#OYJL1\BL>@/MQ7CG[37BK2O''Q[\;:]H=XNH:1?WYEMKI%*K(FU1D9
M/4'J*TC%^W;.:K.+R^G!/6[.;^$__)4O!W_8:LO_ $>E?>G_  5HX\/_  W'
M_3S?=>GW(:^ _AUJ5KHWQ \,7][*(+.UU2UGGE;)"1K,A9L#DX )X]*^O/\
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MR/N\DPWLZ3K2WE^0X?TIU)2UYY]*%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 U
MN@^M?E1_P4O^"O\ P@_Q:M?&NGV^S2?%$9,^Q?ECO8P ^?3>FQAZD2&OU8:O
M(/VJO@K%\>O@KKGAM$7^UXP+W2Y&P-EW&"4&3T#@M&3V$AKHH5/9U$SS,QPW
MUG#N*W6J/P_HJ2YMY;2XEAGC>&>-RLD<BX9&!P01V(.00>>*CKZ(_,WIH%%%
M%,04444 %%%% !1110 4444 =%\-_P#DH?A?_L*6O_HU:_1__@JU_P D<\(_
M]AX?^D\M?FSX'OX-+\::!>W4@BM;?4+>:60@D*BRJ6/'/ !K[>_X*&?M$?#S
MXQ?#'PYIG@[Q-!K=];:P+F:&**5"L?D2KNRZ =6 _&N*K%^V@SW<'4A'!5XR
M>KM8\+_X)_?\G=> OK?_ /I!<5WW_!4K_DXO2?\ L7+;_P!*+FO)/V-_'6A_
M#?\ :2\'^(_$FH1Z7HMD;O[1=R*S*F^TFC7A03RSJ.G>NN_;_P#BEX6^+OQK
MT[6O"&K1:SI<6AP6KW$,;H!(LT[%<. >CJ>G>B47]93Z"C./]G.#>O,?--?J
ME^V5_P F#Z-_UZZ/_*.ORN_STS7Z"?M.?M(?#CQU^Q_IG@_0_$\&H>(XK?3$
M>QCAE5@8A'Y@W% N5P>^*5>+<X6Z!E\X1H5E)V;6A/\ \$D?]9\5/II7_MY7
MQ=\?/^2Z?$;_ +&34?\ TIDKZ6_X)Q_'/P/\%V^(1\9^((=#_M(:?]E\Z*1_
M.\O[3OQL4XQYB=<=:^7/B_K5EXC^+7C;5]-G%UI]_KE]=6TZ@@2Q/.[(P!Y&
M00>13IQ?MI,,3*#P-*">J;.N_9'_ .3F/AO_ -AF#^=?3'_!63_D<OA[_P!>
M%U_Z,CKY3_9O\4:7X+^._@?7=:NUL-)L-4BGN;IU8B- >3A03^0[U[K_ ,%%
M/C1X+^,OB;P9<^#=<BUR"QL[B.Y>&.1!&S.A PZCJ >GI2G%^WB[!1G&.7U(
M7U;1]3?"2T_X7Q_P3Q30-)"3:I_8,VE+;LW2ZMR1&K'^$L4C;V#@U^3\T,D$
MSQ2HT<J$JZ.,,I!Q@CL?:OHW]CO]KJ\_9LUR[T_4[>;5/!>J2"2[M8"#+;2X
MV^?%G@G  ()&X*.?EKZD\8>#?V1?VC=2D\4R>,]/\,:I>$2730ZE'I4DKYRQ
M>&X7;N))W,%^;DDGK6<6\/*5UHSJJ1AF5&#A)*45:S/B[]D'P+>_$#]H[P+9
M6<'G1V>I0ZI=,1\J06[K*Q;V.T+[E@.]?3O_  5D\56UQK7P]\-QR9N[6WN]
M0GB Y"2M''$?SBF_*N[L?CG^S;^QSX7OX?A[)#XK\0W4?/\ 9TQN9[ENRRW>
M-B("!E5Z<D(37YZ?%KXI:Y\9_'NJ>+?$$RO?WSY$4>?+@C'"11@GA5''OR3D
MDDU'FK55.UDC*JX8/"/#J2<I/6VQZA^PS\6/^%3_ +1'AZ>XF\K2M:8Z->EC
MA=LQ41L?3$HB)/H#7VAXP_9E76/^"@GAWQ;]DSH,VG?\)!=-C"&\MBD*J.V=
M[VTGO\_OG\L8Y&CD#(65U.5*]0?45^L7@O\ X*"?#EO@OI^K:YX@A_X3:WT@
MM<Z48)=\UVB$% P3:!(Z CGHP]*6(C)2YH>AKEM6E*FZ5=V47='R5_P4B^*O
M_"P/CVV@6LWF:9X5M_L"[3D?:7P\[#W'[M#[Q&O1_P#@EU\'=$\1:EXC\?:K
M;1WNH://'9Z:DG(@=D+/+CNV"H4]OF[\U\+ZYK5WXDUK4-5U"9KC4+^XDNKB
M9NLDCL7=O?))/XU]&_L/_M46?[.?B[5+3Q##-+X3UM8Q<2VR;Y;65,[)0O\
M$N&8,!SC:1G&#<Z;C0Y8G+0Q,*F/]K6V;_X8[G]H_P#X*#?$IOB1XBT'P;>P
M^%M$TN]FT^-X[6.6YG\IV0R,TJG;N()"J 5&!DG)KQKX?_$3XF_';XO^#= U
M7Q;KNOB\UBV)M)[V1X$59%9Y/*SMPJ*S'C@ U]>_$?X1?LH?';Q)=>,1\3K#
MPW?7[?:+Q++6K:T6XD)RTC0W"%E<\YV@9)R023GD7^-W[/O['^FWB_".R;Q[
MXZFB,/\ ;-](TL<8Y^_-M5<=RL*C=_$PX(QC*')RPAJ=U6G5=7VE:LN2_?\
M0[#_ (*P+CX=^!./^8I-S_VQKR3_ ()4_P#)=O$__8NR_P#I3;UU?[<7[0'P
MT^/OP'T(Z#XI@D\36-[!?OI'DS"0J\926,%E"[E+J<YQA&Q7SM^QI\=]._9^
M^--OK^M1/)HU]:2:7?2P@LT$;O&_FX'+!6C7(ZXW8R<"JA&7U=QMJ36JTUF,
M*JDG'34?^W5&T?[5WQ!###&XMV_ VL)'Z5]*_P#!(_\ UGQ5_P"X7_[>5U/[
M1C_LM?%[PYXF\9-X@T&X\<7.DS)8W<>I313/<+"5MS) KKN(*H/G7I@'C%>-
M?\$X_CEX&^#,GQ"_X37Q!#H0U(:?]D\Z.23SO+^T[R-BMT\Q/S'I2E)U*'*E
ML53IQP^8*HYJTKO<\_\ "7BVV\#_ +?TVL7KB*TC\<7L$TC$ 1K+<RPER>P7
MS,GV!KW_ /X*N^ ;V>/P3XSMX-]A )M*NY0!^[9B)(<_[)Q+SVP/6OAWXP:U
M9^(OBUXVU?3;A;G3[_7+ZZMKA00)(WG=D< ],@@\BON3X"?MU>!_B!\.Q\/_
M (YQ1M^X%J^J7D#7%M?1K]TS8!9)1QE\8R-V5-54C*+A5BMC##U:52%7"U)6
MYGH^A^=IZG^IYK]+/^"4W@2]TKP5XU\6W4'E6FKW-O:6DC#&\6XD,C#VW2@9
M[E".U4O^&<?V.[74%U=_B'8RV'#?V7_PE$+1X'."J_ON>F"V>?>N=_:6_;Q\
M+6/P_F^'/P6MA:Z?);_8Y-8MX#:PVT!X,=M&0&RW(+D+@$E<DA@IS==>S@MS
M3#8>&7S=>M-.VR3N?/>B>*;?QM^W1I6OV<OG6.I?$*WNK:3^]"VHJ8S^*[:^
MC?\ @K9_R$OAA_URU+^=K7Q=\%=<LO#'QD\!ZSJ=PMIINGZ_87EU<,"5CBCN
M$=W. 2<*I/3/%?2W_!1KXX>"/C1=> '\&:]#K@TZ.^%T8HI4\KS#!LSO4==C
M]/2M)0:K0MT.:G6C+!UKO5NY\:>E?JCH/_*+^7_L5KG_ -&/7Y79X/8]J_0;
M1_VD/AQ:_L$R> I/$]NOBPZ!/:+IODS;_-+L57.S;T([XIXF+?*EW)RN<(.K
MS.UXL_/G_&BCCH,T5V'AA1113 **** "BBB@ HHHH ***.E #X89+B:.*)&D
MD=@JHHR6)/0#UK]P_P!EWX/Q_ [X*^'?"[1JNI+#]JU*1>=]W)\TG/\ $%.$
M![J@K\W?^">OP/;XJ?&R'7;Z'?H/A79J$K,,K)<Y_P!'C_!E+^XC([U^O"_T
MKQ\94N^1'VN1X;EBZ[Z[#E-.I!2UYA]6%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 -?)'%?C!
M^VA\)?'.N_M0?$&_TSP;X@U&PN+Y6BNK32YY(I%\J,95E4@\^E?M#13$U<_,
M'_@EK\._%?@_XX>)[O7O#&L:):R>'I8DGU#3YH(V<W5N0H9U )P"<=< ^E?I
M]112 ****!C6^[TS7RY^V!^P_HW[2T2Z[IEVF@>.K6#R8KUES;WB#E([@ 9X
MZ"0990>C  #ZEHI@?@M\3/V5?BO\);IH_$/@G5$@W$+?6,1NK9_^VD6Y1QSA
ML'KQUQYE!I5]=7;6D-G<2W2]88XV+]<=.O4BOZ-J*+D\I^*/P-_8#^*WQDU"
M![O1+CP;X?+#SM4UZ%H&V<<Q0L!)(2.G 7U<=_UL^!_P3\,_ 'P+:^%/"]LT
M=I&3+/=3$&:ZF.-TLA &6. ,8    &!7H5%%QVL-8U\;_MK?L&P_'ZX;QEX-
MFM],\<)&L=S#<'9;ZDB\#<0#LE X#$8( !Q@,/LJB@9_/QX\^!?Q"^%]Z]KX
MH\&ZSH[HS)YTUHY@?&<E)5!1QP>58CJ:Y/2=$U'7KH6^F6%UJ%PW2*UA,KG_
M ("H)Z9K^C.BBY/*?CO^SA_P3I\?_%;5[/4?&6GW7@CPBKK),]\ACO;E,C,<
M4+?,F1QOD '.0'QBOUN\*^%]+\#^&M,T#1;..PTG3;=+6VMHAPB*  /<X&2>
MI.2>:VJ*0T>*?M9?LY6?[3'PIN/#S31V.MVLHO-*OI<E(9P",/CDHZEE. <9
M# $J*_&SXH?L_P#Q!^#FK36/BSPIJ6G*CL$O/(9[6;!)+),H*MQSUR.,@=!^
M_P!13!JY_/%X+^&_BOXB:E!8^&/#NIZ[=RG"I86KRC@@$DJ, #N3@#N17UVW
M_!._7/A[^S3XU\8>*;&34_';VMLND>'],5KA[+=<Q"1W$8/F2["PPNY5!)Y.
M-OZQ447%RG\^O_"C_B/G/_" >*?QT6Y_^(K]_P#3U9=/ME8%6$2@YX(./TJW
M10-*Q^?W[9__  3MN_B+X@U#QW\,4MX]:O&:;4M!FD$*74I/,L#'"J['EE8A
M226SG(/YV>-OA)XU^'-Q+#XG\*:QH31-M+WUE)&A.>SXVL/=<BOZ%**+BL?S
MGK-J_B"2.T5[W4G!S' "\K>G"BO=/@G^PK\5_C+JEK_Q3UUX6T-WQ-K&N0M
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MF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "-3&J2B@#\F_\
M@H]\!C\-_BLOC+3+5H]!\5,T\Q5?DBOQS*OMO!$@SU)D_NU\AU^[/[07P<T_
MX[?"K6O"5]LCEN8_,LKIQG[-<KS%)QS@'@XZJ6'>OPX\1^']1\):]J.B:M;/
M9ZGI]P]K<P28W1R(=I4XX."#R.#UKW<)5YX\KW1^?9O@_85O:1^&1FT4IR.*
M2NX\$****!!1110 4444 %%%% !1112 4'UI,T44 %%%% !WYHHHH **** "
MBBBF,**** "BBBD <8]Z.1113"X4=:**/0+]A<]NU)S1126FP!2]2*2BF(*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5^5/\ P53_ .3A= _[%:W_ /2N[K]5&KYH_:4_8CT/]I+QU9>)]2\2
MW^C7%KIL>G+!:0HZLJRRR;CN]Y2/PKIP]14YWD>5F6'GB<.Z=-:W1ZE^S?\
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MMD\8'%=;7SM:HZLK]#]+P.%6$HJ'7J-%.HHK ]$**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH 1J2G44 0S1B6%HV 96&"&&01[CO7XY?MO?LWM\ _BI)/I
M=L4\(:\6NM-91\MNW'F6Y/JI.1_LLO4@U^R35YE^T/\ !'3/C_\ "W5/">HL
M()I,3V-YMW&UNE!\N0#N.2I'=68<9S73AZOLIW/*S'"+%46E\2V/PMHK;\;^
M#-7^'GBW5?#>O6;6.KZ;.UO<0MR PZ$'NI!#!OX@P/<5B5]"M5='YM*+BW%[
MA1113)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 -?I7Y7_\%'/V;3\/?&W_  L'0K01
M^'O$$Q%]'$N%MKTC+,?19<%L_P!X/V(K]4&[5S/Q+^'VD?%7P-K/A778//TS
M4X&ADVXW(>JNI/1E8*P/8J*Z*-1TIJ1YV.PJQE%PZK8_ ?U_KUHKNOC9\(=:
M^!?Q&U3PCKB9N+5M]O=*I6.Z@;[DR>S#J/X2I7L:X6OH8R4E='YI4A*G)QEN
M@HHHJC,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&;ISW04445H9!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%'X9]J0['3_  S^'.L?%KQUH_A/0H?.U+4YA"A/W8UQ
MEY']%506/L#UZ5^XWPC^&.C_  =^'VC^$M#CV6&G0A/,(P\\AY>5_P#:9B6/
MUP.,5\W?\$]?V7V^$_@L^-_$-KY?BSQ! ODPRIA[*S.&5".S/A78'IA1@$-G
M["7TKP\56]I+E6R/O\IP7U>G[2:]YBK2T45PGT 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 UA2?UI]% #5IU%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% "&FM]VGT4 ?G=_P %'/V5
M6D:;XL^%K3<0H'B"TA4]!P+L >@X?'3 8_QFOSPS7]#%];0WMI-;7$*7%O,A
MCDBD4,CJ1@J0>""#C%?D!^VU^RG<?L_^,VUC0[:5_ NKRDV<@RWV*4Y8VS$^
M@R4)ZJ#U*DUZ^%KW7)(^+SC <G[^FM'N?,U%'^>E%>H?)A1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M ,Q%->I\34445ZY\>PHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%%
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M0%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTM>*?=A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.IPRL,8(ZCZ__6IM>H?)6L%%%% @HHHI@%%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKIJ6L=3XR<)4Y.,EJ%%%%,@****8!1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MCO?#_B/3+C2-8LW\N:UN%PP]"#T92.0RD@@@@D5_0&U>6_'7]G/P7^T'H/\
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M'.U!EY7/5Y'/+N>['V'0"NL[DYI:6O);;U9]E&*BE&*T0W^+K3J**104444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!_%VKUZ>*A/1Z,^)Q>5U\-[R5UY'SG11].GUS^(XZ45VGBO30**** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% "-3>,T^DH RO$WA?2?&.BW6D:YIUMJVF72
M>7-:7<8DC<>X/YY[8XK\\?VDO^":-YIINM?^$[/?6?,DOAN[E_?1^HMY6.&&
M/X'.>.&;.*_22F-_6M:=65-Z,X<3@Z.*C:HM>Y_/?K6CW_A[5+G3=4L;C3=1
MM7,<]K=1-%+$PZJRMR/Q]:I5^Y7QL_9K\!_'S2S;^*='5[Y$VV^KVN(KRW_W
M9,<C_98%?45^<?QW_P""=OQ!^%?VC4O#2GQSX>3+%[&+;>PJ.?G@Y+ >L9;H
M20M>Q1Q4)Z2T9\7BLHK4/>A[T3Y1HI\D;PR/'(ACD0[61A@@CJ"#SD>G:F5V
MGA6ULPHHHIB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH'N%%%'2@/(*!CO7L_P._9)^(WQZDBGT/2#8:&S8?7-2S%:@=RAQ
MF4^R!@#P2.M?HU^S_P#L%^ ?@F;?5+^'_A,/%,>'&H:C$/*@8=X8<E5/HS%F
M!&01TKDJ8F%/U/6PF6U\4]%9=V?#W[._[!/CKXT26VJZW#)X/\*/MD^V7L)%
MS<J<?ZF%L'D8^=\+SD;L8K].O@U\!_!?P'T$:5X2TA+0N,W%]+^\NKIAWED/
M+?0849X KT*,8XQP.E25X]6O*KH]C[;"9?1PB]U7?<;1^M.I*YSTP%+110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 C4GJ,TZB@14U+3[75K&:SO;>*[M)T,<L$\8DC
MD4C!5E(P01V-?"'[2G_!-.RUS[3K_P *7CTN_),DOAVZDQ;2GKF"0_ZLY_A;
M*\\% .?OJFMTK2G4E3=XLY<1A:6*CRU%_F?S]^+_  ;KO@'7+C1?$>D7>B:K
M;G]Y:7D1C<=<, 1RI[,#@C&.*Q:_>3XK?!7P9\:M#.E>+]#MM6@ /E3L"D]N
MQ_BBD'S(?H<'OD<5^=OQX_X)H^+_  2;K5/A[<MXQTA26_LZ3:FH1+Z <)-C
MGE2I)/"5[%+%QGI/1GQ>+R>M1]ZE[R_$^+:*LZEIMWH]]/97]K-8WENYCEM[
MB,QR1L.H92 0?8C(JM7<G<\!Q:=@HHHIDA1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MIQV<0RU_9Q?:;8+ZF2+<!_P+!]0*\K]J[%)25XL\2=*=/22L%%%%49A1113
M****!!1110 4444 %%%% !1110 4444AV"BI;:UFO)T@MXGGGD.U(HE+.Q]
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M'''%&L4:+M5$& H'0 #M4IIU%<A[%EL-6G444#"BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6BK#3FC'J*?12+$'Z4M%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM/LS'^P<1_,C\:Z*_97_ (=\_ /_ *$,C_N,W_\ \?JY:_L'_ FR0)%X MF
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M  @9_P#!Q?\ _P ?J_KL.S,/[!Q'\R_'_(_&NBOV5_X=\_ /_H0R/^XQ?_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "&BEHH :
M5HVC%.HH 9SZYI>:=10 WGO1BG44 -QBE%+10 @%+110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4E+10 F.:0C\*=10 SGUI>:=10 WFES
M2T4 -_2E'UI:* $I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@!#2?A3J* &_2CFG44 -Y%&:=10 VEXI:* &K3J** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!#2?I3J* &\T<TZB@!O(H
MS3J* &T?A3J* &K3J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7B7_  V;\'_^AN;_ ,%EW_\ &J/^&S?@_P#]#<W_ (++O_XU1[.?8/[2P/\
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M_C5'LY]@_M+ _P#/^/\ X$CVVBO$O^&S?@__ -#<W_@LN_\ XU1_PV;\'_\
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M_P#C5'_#9OP?_P"AN;_P67?_ ,:H]G/L']I8'_G_ !_\"1[;17B7_#9OP?\
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M\'_^AN;_ ,%EW_\ &J/9S[!_:6!_Y_Q_\"1[;17B7_#9OP?_ .AN;_P67?\
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MHKQ+_ALWX/\ _0W-_P""R[_^-4?\-F_!_P#Z&YO_  67?_QJCV<^P?VE@?\
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M\-F_!_\ Z&YO_!9=_P#QJCV<^P?VE@?^?\?_  )'MM%>)?\ #9OP?_Z&YO\
MP67?_P :H_X;-^#_ /T-S?\ @LN__C5'LY]@_M+ _P#/^/\ X$CVVBO$O^&S
M?@__ -#<W_@LN_\ XU1_PV;\'_\ H;F_\%EW_P#&J/9S[!_:6!_Y_P ?_ D>
MVT5XE_PV;\'_ /H;F_\ !9=__&J/^&S?@_\ ]#<W_@LN_P#XU1[.?8/[2P/_
M #_C_P"!(]MHKQ+_ (;-^#__ $-S?^"R[_\ C5'_  V;\'_^AN;_ ,%EW_\
M&J/9S[!_:6!_Y_Q_\"1[;17B7_#9OP?_ .AN;_P67?\ \:H_X;-^#_\ T-S?
M^"R[_P#C5'LY]@_M+ _\_P"/_@2/;:*\2_X;-^#_ /T-S?\ @LN__C5'_#9O
MP?\ ^AN;_P %EW_\:H]G/L']I8'_ )_Q_P# D>VT5XE_PV;\'_\ H;F_\%EW
M_P#&J/\ ALWX/_\ 0W-_X++O_P"-4>SGV#^TL#_S_C_X$CVVBO$O^&S?@_\
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M /T-S?\ @LN__C5'LY]@_M+ _P#/^/\ X$CVVBO$O^&S?@__ -#<W_@LN_\
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M:H]G/L']I8'_ )_Q_P# D>VT5XE_PV;\'_\ H;F_\%EW_P#&J/\ ALWX/_\
M0W-_X++O_P"-4>SGV#^TL#_S_C_X$CVVBO$O^&S?@_\ ]#<W_@LN_P#XU1_P
MV;\'_P#H;F_\%EW_ /&J/9S[!_:6!_Y_Q_\  D>VT5XE_P -F_!__H;F_P#!
M9=__ !JC_ALWX/\ _0W-_P""R[_^-4>SGV#^TL#_ ,_X_P#@2/;:*\2_X;-^
M#_\ T-S?^"R[_P#C5'_#9OP?_P"AN;_P67?_ ,:H]G/L']I8'_G_ !_\"1[;
M17B7_#9OP?\ ^AN;_P %EW_\:H_X;-^#_P#T-S?^"R[_ /C5'LY]@_M+ _\
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MVE@?^?\ '_P)'MM%>)?\-F_!_P#Z&YO_  67?_QJC_ALWX/_ /0W-_X++O\
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M /&J/9S[!_:6!_Y_Q_\  D>VT5XE_P -F_!__H;F_P#!9=__ !JC_ALWX/\
M_0W-_P""R[_^-4>SGV#^TL#_ ,_X_P#@2/;:*\2_X;-^#_\ T-S?^"R[_P#C
M5'_#9OP?_P"AN;_P67?_ ,:H]G/L']I8'_G_ !_\"1[;17B7_#9OP?\ ^AN;
M_P %EW_\:H_X;-^#_P#T-S?^"R[_ /C5'LY]@_M+ _\ /^/_ ($CVVBO$O\
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M /H;F_\ !9=__&J/9S[!_:6!_P"?\?\ P)'MM%>)?\-F_!__ *&YO_!9=_\
MQJC_ (;-^#__ $-S?^"R[_\ C5'LY]@_M+ _\_X_^!(]MHKQ+_ALWX/_ /0W
M-_X++O\ ^-4?\-F_!_\ Z&YO_!9=_P#QJCV<^P?VE@?^?\?_  )'MM%>)?\
M#9OP?_Z&YO\ P67?_P :H_X;-^#_ /T-S?\ @LN__C5'LY]@_M+ _P#/^/\
MX$CVVBO$O^&S?@__ -#<W_@LN_\ XU1_PV;\'_\ H;F_\%EW_P#&J/9S[!_:
M6!_Y_P ?_ D>VT5XE_PV;\'_ /H;F_\ !9=__&J/^&S?@_\ ]#<W_@LN_P#X
MU1[.?8/[2P/_ #_C_P"!(]MHKQ+_ (;-^#__ $-S?^"R[_\ C5'_  V;\'_^
MAN;_ ,%EW_\ &J/9S[!_:6!_Y_Q_\"1[;17B7_#9OP?_ .AN;_P67?\ \:H_
MX;-^#_\ T-S?^"R[_P#C5'LY]@_M+ _\_P"/_@2/;:*\2_X;-^#_ /T-S?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M *9 O^P['#@?W7.3P PKCGA[:Q/OLNXKA4:IXQ<K[K;YGZ,4M<O\/_B+X?\
MB;H,6L>'=1CU"SDX;:<21-W1U/*M[$>_(.:Z:N)IK1GZ!3J1J14X.Z8ZBD%+
M2- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $-4->URS\-Z-
M>:IJ$ZVUA9Q-//,YP$1022?P%7V&X8KXM_;U^,4D"VGP]TR;:)$6\U-D;G;D
MF*(_4C>?HM:4X\\DCR\RQL<OPTJ\M^GJ?-_QV^,FH?&SQU<:S<[X-.BS#I]D
MQ_U$.>,C^^W5CZ\= *\ZI/\ /_UZ6O845%61^"UZ\\35=6H[MZA1113, HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *.1R!D
MBBB@#O\ X(_%[4O@KXYM=<LMT]HP\F^LAD"XASR.?XQP5/J!V)K]4_#?B"Q\
M5:)8ZOIMPMU87T*SP3+T96 (/L?8\BOQM_SUQ7V9^P3\8G6XNOAYJ<W[M@]Y
MI18\J?O2PCZ\R#Z25R8BG=<Q][POFCHUOJE1^[+;R9]M"G4Q?O'CFGUYI^L!
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%(:;0!G^)M>M?"WAW
M4]8OG\NSL+:2ZF;T1%+']!7Y"^-_%]]X^\7:MXAU)MU[J,[3R#/"@_=0>RJ
MH]@*^^/V[O'#^&_A#%HUN^RXUR[6W;!P?)0>8Y'_  (1J?9C7YV?Y_S^5>CA
MXVCS'Y3Q;C'.M##)Z1U?S"BBBNP^ "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@04444#"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** \PHHHH%H%%%% PHHHH **** "BBB@ HH
MHH **** "BBB@-+V"BBB@ HHHIBN%%%% 7"BBBD,**** "BBB@ HHHH ****
M "BBB@ HHHIAZ!1112$%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBBF'J%%%%( HHHH **** "BBB@ HHHH **** "BBB@-.H4444"N
M@HHHICL%%%%(7H%%%% PHHHH ****8!1110+S84444AA1110+S"BBBF/S"BB
MBD 4444 %%%% !1113 ****0!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5K>$?$][X+\4:5KNG2>7>Z?<QW$1[$JP.T^Q&0?4$CO631Z]J3[,J$Y4Y*
M<=T?L=X-\26OC'POI6N61W6FHVL=U%ZA74, ?<9YK:KYA_8'\<-K_P +;[0)
MWWSZ'>,L8[B&7+KG_@?FCZ 5].[J\:<>631_0>7XCZWA:=;NA:***@] ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HIKC*U@>)/'7AWP7]G_X2#7M-
MT3[1N\G^T;R.#S-N-VW>1G&X9QTR*+-[$2G&"O)V1T-%<)_PO3X=?]#YX;_\
M&UO_ /%T?\+T^'/_ $/GAO\ \&UO_P#%U7++L8_6J'\Z^\[NBN$_X7I\.?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %>M?!']FOQ3\;IC<6(32]"C?;
M+JMVK%">XC4?ZQA[$ =R.*YKX-?#F;XK?$C1?#<9>."ZEW74R#F.!1ND8>^
M0/<BOMW]I;XS0?LX^ ]&\+>#[>"RU6YA,5FJJ&6SMTP#(5/5B3P6R"=Q.<8.
M%2HTU&.Y]-E674:M*>-Q;:IP_%]CGX?V*/A7X+M87\5>)[MYI./,N[V*SC9L
M'[H(R/\ OH]!3+O]B+X8>,+.XD\*^*KR.<#Y&M[N*\A0D_Q*!N(X(^^*^'=9
MUO4/$6H2ZAJE[<:C?3',EQ=2F1V/NQ_"G:#X@U/POJ<.HZ1J%SIE]"<I<6LA
M1U_$=O;O4^SGOS:G3_:V7<W)]47)ZZ_D>B_&G]G+Q7\$9DFU.)=0T:5MD6JV
MH+19[*X/*,1S@Y!P<$X->5_GZ<\U^C/[.?QDL_VE/A[J_AOQ;;VUQJ]O#Y%]
M#MPEU"XPLH'8YR#MZ, 1C( ^&/C!\.Y_A3\1M9\-32-.EI+F"=AAI8F :-_K
M@C/;*FJIU&WRRW.7-<NI4:<,9@W>G/\ !]CC:*ZVP^$OC#5/",GBFUT"ZF\/
MQQR2MJ"A?*"(2'/7.!M;/TK2\#_ /X@?$:Q6]\/^%[R]LFY2YD*012?[K2,J
MMZ<=Q6KDD>+#"5ZDE&,'=[:,X"BNU\<?!7QS\-[?S_$?AN]T^VSC[3M$L(/H
M9(R5'XGM7$]/Y4U)2V,JE&K1ER58N+\Q:**])\)_LW_$KQM8I>:1X1OI;1E#
M)+<&.V#J>A7SF3</IFAR4=QT:%7$2Y:47)^2N>;45WGC;X$>/_AU:-=^(/"]
M[9VB#+W*!9X4]-SQLRK^)K@SG'7GZ\\41DI;"J4*M&7+4BT_/0**ZOPO\*?%
MOC71[K5="T&ZU+3K5V26X@ VHRJ&(SD<@$'\:TO GP'\??$O39-1\.>&[C4+
M"-B/M)DBAC9@>0K2,H<YX^7\Z7,ENRZ>%KU;*$&[ZK0X*BMOQ=X)U[P#JS:9
MXATJXTB^5=RQ7"$;UZ;E;HPR#R">A]*T?!?PG\8_$0$^'/#M_JL0.TSPQ;8@
M?0R-A0?QIN25FR8X>M*?LXQ;EVMJ<G17LDW['OQ>MX6E;P>VU1D[;^U<_P#?
M(ER:\N\1>&=6\):FVGZUIMUI-ZG+6]Y$8WP>A&1R*2E%[,TK8/$8=<U6FXKS
M5BE8V5QJ5[;VEI!)<W=Q(L4,,2[GD=CA54#DDD@<>M=_\3O@7XB^$.@>'[_Q
M'Y-O=:PTP2Q1P\D*QA/OL/ER=_09QZY)%7OV??AOXF\5^/O#.LZ3HUS?:9IV
MM6;7=U"!LA"RQNQ;V"\_A7U1^W'\,_%'Q&M_!X\-:+=:N;1KHS_9@#Y>X1!<
MY/?:?RK*53EFHGN8/*O;X&KB7"3DK<OGYKN?$/@/0H/%'CGP[HUT\D5MJ.HV
MUI*\) D5))54E200" >,BO:OVJ?V=?#WP+T_P[/HE]JEX^HR3)+_ &A-$X4(
M$(VA(UQ]X_D*\2AT+7=&\8Q:1#;W%EXD@O4MXH(7*317(<!54@\,'Q@^M=3\
M5-%^)NDV^G'X@R:\\+LXL_[9NWF&0!NVAG;!QMSZ\5;=Y*S.'#NG#"583IMR
M_F[>IYY117H/@O\ 9_\ B'\0K,7>A>%;RZLV&5N)=EO$X]5:1E##Z9K234=6
M>91H5:[Y:47)^1Y]17I'BO\ 9Q^)7@FQ:]U;PC>Q6JC<\MN8[E4 ZEO)9]H^
MO%>;GOQ^M)-2V'5P]6@[58N+\T%%=+X+^&OB?XBM=KX;T:YU@V80S_9P#Y>[
M.TMD]RI_*G>'?ACXK\6:]=:+H^@7M_J5I(8KF&&,D0,"5(D;HO(/)/:CF2W8
M1H59I.,6[[:,YBBO6-6_93^+&B63W5SX-NFB49/V:X@N'_[XCD9OPQ7E4\,E
MK,\,T;PS1MM>.12K*WH0>_X4HR4MBJV&KX=VK0<?56&44"O1O"?[.?Q)\;6D
M=SI/A"_EM9 'CFN=ELCJ>00967(^F:;DH[LFE0JUGRTH.3\E<\YHKUG6?V4O
MBQH-FUU=>#;IHEZ_9)X+E_\ OB-V/Z&O*KBWEM9I(9HVAFC8J\<@(93W!!Z?
ME1&2ELRJV%KX?^+!Q]58]<_9?^#VD?&SQ_?Z%K5U?6EK;Z9)>J^GR(DA=98D
M )=&&,2'MU YK!^/WP[T_P"%/Q4U?PQI4]U<V-FL+1R7CJTAWQ(YR551U8]J
M]:_X)\_\EHU?_L 3_P#I1;UR'[9W_)Q7B?\ W+7_ -)HJQN_:\I]!+#TEDD:
MZC[_ #-7/$J***W/ESZF_9A_97\+?&SX?7>NZUJ.L6EW%J,EHJ6$T2IM6.-A
MD/$QSESW]*]<_P"'?/P^'_,>\2?^!-M_\8JQ^P#_ ,D1U/U_MJ;_ -$PU\$^
M*O\ D:-8_P"OR;_T,UQ1YJDVDS]!G+!9?E^'JU,.IRFO3]&?=W_#OGX>_P#0
M>\2?^!-M_P#&*1O^"?/P^Q_R'?$G_@3;?_&*_/ZBM/9S_F/.><9?;_<U]_\
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MCPC?2VC*&26X,=L'4]"OG,FX?3-)R2W)HT*N(ERTHMOR5SS:DKO?&WP'\?\
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MC?\ 05\-?^!5Q_\ &*_0VBCZQ,/]6<O[/[S\\O\ AWW\1O\ H*^&O_ JX_\
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M_P 8K]#:*/K$P_U9R_L_O/SR_P"'??Q&_P"@KX:_\"KC_P",4?\ #OOXC?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 444=* Z,^L/\ @GCH\5QX^\3ZHRYE
MM=.2%&[#S),G'O\ NJX3]M;6YM6_:$UR"0YCT^"VM(N>B^2LI_\ 'I7KN?\
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MY ZE5CX^4 9( .>=H]:^"&HR:3^PS>WL)VS0:5JTD9]&$EP1^N*_/K_/^?\
M/:IIP4I2;.O-,?5PF"PU*B^5N-V^I]Y_LQ_M1S_&*^N/ _CFTL[F_NH)#;W
MB CO$V_/#)'TW;=QR, @'CCGYI_:@^$4/P=^*5S8:>A31;Z,7MBN2?+1F(:/
M)Z[6!'/;;GDUSWP%OI-.^-G@66/AFUFUB_!Y50_HQKZ8_P""C-M'Y?@6YR%F
M#7B 8Y*XA.?PQ^M-)4ZB2V9R2J2S/)YU:^LZ3T?6QB_L/_ O3/$$=WX_\16T
M=U:V4I@TZWN!^[$B@%IV!X.W.%[ [CU -0_%S]NSQ!)XBNM/\"I:6&CV\C1)
MJ$T7G2W.#C>H8853V&"<'/'0>_\ [/.F:;;?LJZ);WMXNG:9/IMP]U>>:L0A
M21Y#(Y<\+MW$Y/ Q7DH_9Y_9R/7XBVN/^QBM/\*SYHN;<]3VY83$X? 4:6!D
MH.2NW>S9'\ /VT-2\8>*;3PKX]M[*6#4B+:WU"&+R_WK<!)5Y4JQPH( Y(X(
M)(\M_;&^"%G\*?&UKJFB0"WT#6E=X[=!\EO,N-Z*.RD%6'U(Z+7K^F_ G]G;
M2=1M+ZV^(ULMQ;3)-&W_  D5IPRL"#T]0*3]N+QYX.\8_"W2(=#\2Z-K.H6V
MK1R>387T4\@C,,H8X1B0N=G./2JBTJBY#FQ="I4RRHL=-2E#6+3NS7_8'LH]
M2^"_B>UF+".;6)HV*G! -M"#@]C6)\3OVQ+?X.^(U\$^!O#]C<Z5H(6QEEG=
ME7>GRM$@7&-I^4LW\6>#U/0_\$^,_P#"H?$'K_;4G/\ V[P5\*>*;I[[Q-J]
MS(2TDUY-(Q)[LY)_G^M.,%.I*YGB<=6P&589T'9M;];'M8\5V_[57[16CW?B
M+R=!T(QQQR6\UT (X8E+-'O.W)>0L!W&_OBO>_VD/VFE^"(TKPEX!M=-6Z%J
MLCS; T%I%DK&B*AQN.">> ,<'=Q\*:'H=_XDU>TTO2[62]U"[D$,$$(RSL>!
MCM^)X%?6/@O_ ()\WT]@EUXM\3PZ6VTLUG81>;L7'&Z5BH!'?"D>YJIQA&W,
M].QY^78G,,33JK#0O.3UGHK'#^'_ -NKXEZ7J44^H3V&LV@8&2VGM5BW+W :
M/!!]#SSZU]%_M,Z3HOQ@_9I/C"&U"75O:0ZM93. )85;;YD9(]48@@'&5'I7
M"S?L^?L\?#UFE\1>-6U%XAE[2?5(RYY_YYP*)#Z<5ZO\5)O#]Q^R5K4GA6/R
M_#QT7_0%PX_<Y&WA_FZ>O/K6,G'FCRJQ]!@Z.+^KUZ>-J*:Y797NUYGQW^S3
M\:O$WP_\5:-X9TF6UCTS6=:MH[M98 ['?(D;;3V^4_F#7U5^V%\</%/P7@\+
MMX:EM8O[1:Y$_P!I@$OW!%MQS_MFOACX/_\ )6_!/_8<LO\ TH2OJC_@HU_Q
M[^!/]^]_E!6LXKVL3QLMQ5>&38B49N\6K>1\V>!_$EYXP^/WAO6]0*F^U#Q)
M:7,Y1=J[VN4)P,\<U]-?\%%O^01X)'/^ONN?^ QU\H?![_DKG@C_ +#EC_Z4
M)7U?_P %&#_Q*?!/_7>Z_P#08ZJ5O:1.? R<\HQ<I;MH\\_8J^!-A\1M>OO%
M&OVBWFBZ.ZQP6LHS%/<GYOF!^\J*5.WN6&<C(/=?'[]M;4_"_BJ\\->!8+..
M+3W:WN-3GC\S=(O!6)<@84Y&3G)!XQR?0/V-431_V:&O[>,23//>73(O5F4E
M0/J0BU^=C.\C,[L69CDL>I/?/XU,8JI4=^AT8BO/*<MH4\-[LJBNWU/KGX-_
MMU:ZWB2TTWQZEK=Z5=R+$=1@B$,EL6(&]@#M9!WQ@@<\XP7_ +;WP'T[P_#!
MX^\/6R6D-S.(-2MX!B/>^2LP Z9.0WJ2IZY)^0J_1+XF2G7/V'8+B]&9)/#^
MGS,TG4N/)(;\3@_C1.*IRBXA@<1/-L%7H8I\S@KI]3S?_@G,-UYX^SQ^[L?Y
MW'%;?QV_:/M/V?=8NO!?@'1K-=4:5K[4[^Y!<+-,3(PVC!9R'#9)PH*@#'W<
M7_@G+_Q^>/?^N=C_ #N*^>?VBKA[KXZ>.'D.2-5F0?13M'Z#]*2BI57<UEC*
MF#R2C.EI)MJ_8]Z^!_[;GBC5?'6E:%XPBL[[3M4N$M%NH(?*EMY';:C'!VLF
M2,\ @'.>,%O_  4"^'MAI.J:!XNLK:.WGU$R6EZ44 2L@#1N>F6V[P3Z*/2O
MEWP*Q7QMX>(."-1M^?\ MJM?:W_!0S_DGOA3I_R$V'/_ %R:FXJ%2/*8T<34
MS#)\0L2^;DLTWN>2_L0_#_PYX@\9:AKWB.>RD.EA$L;*[E0>9,V29-A.3L &
M,]W!Z@5T?QN_;;\36/C34M&\$-:6.EZ?.UO]MDA6:2X=3AF&<J%R"%XR1SGG
M ^=?A?\ "?Q%\8/$7]C^'+59I53S)KB8E88$S@,[>Y[ $^U?4FE?\$_]$TBQ
M6Y\5^.)(QP9/LD20(G'($DA;/U('TIU.3FO)W,\!+,*V"5+ T^1=97M<Q/@E
M^VUXLU#QQI&B>+EL]4T[4KF.T^U10"&:%G8*KG:=I7)Y& <=#Q@V?^"@W@/3
M]/U#PWXJL[9+>[OC):7C* #,556C8X[@;QGN-H["NC\/_#;]F_X;^(-,9_$@
M\1:S]KB2T3[>;IEGW@)E;8!<[L??&*F_X*('/@OPB1T^WR_^BZR3C[1<IZ]6
MC7_LFM#&5%.4=59W:]6>8?\ !/G_ )+1J_\ V )__2BWKD/VSO\ DXKQ/_N6
MO_I-%77_ /!/G_DM&K_]@&?_ -*+>N0_;._Y.*\3_P"Y:_\ I-%6VGM]#Q*G
M_)/P_P ;/$J***Z3X[J?H5^P",_!/4QT_P")U-_Z)AKRG6?V ?&6I:Q?WD?B
M#1 D\\DH5C," S$_W/3%>K?L _\ )$]2]1K4Q_\ (,-?*?B+]I+XFVOB#5(8
M?&6I1Q1W4J*BLN% 8@ <>F*X8*;G+E/TG$3P,,LPKQL')6TLSTK_ (=Z>-?^
MA@T/_OJ;_P"(JCKG[!OC#0=&OM2FU[1FBM())V5#+N(12V!\G7BO,_\ AIKX
MI?\ 0[:G_P!]+_A4%]^T=\2]1LY[6Y\8ZC-;SHT4B,R896&".GH36RC5ZG@R
MQ&22B^2C),\Y5MK J=N#GY>W>OT*_9Q^*FG?M&?"N_\ !/BPK>:Q;6OV:[60
MC=<P$ ).#_>!QD]F"MW%?GI[8Q_G_P#576?"GQ=KW@CX@:)JOAM'GU=+E(XK
M5 3]IW$*82!U#@[?J01R*NI'FC=[HX<HQ[P6(LM82T:\CT#3?V6_$-U\>)/A
MY*LB6]N_VB;4PGR?8<\3#MEAA<=-W'\)-?1O[47Q>T_X$_#VQ^'7@S;8ZG<6
M@@ A/-E:X(+YZ^8^&P?O?>;KC/TAJ$E[#H%YJ=EI44FO?828[:215,DJJ62%
MI/3>2,]!DFOR0\;:]K/B?Q;JVJ>())9=:N+AC="9=K*X.TIM_A"XV[>P4#M7
M/3O6EKT/J<QA3R'#RCAOBJ]>R[&Y\%_AO+\6/B5HWAI9&@AN9"]Q,HYBA0%W
M([ D# ]V&:^V/CS\=-)_9>T'2O"'@W1K-=5DM_,@MV4B"TAR5$C@<NS,KXRP
MR023G@^*_P#!/>QCD^*^NW3$%H='9%!']Z:/)_\ '<?C7#?ME7LUY^T5XH65
MB5MUM88U/\*_9XVQ^;,?QJY)3J\KV/.PM26791+%4OXDY6OV.F\*?MW?$#3M
M>AN-<-EK&DLX\^T6V6)PF>?+93]['][([8YS7I_[:/@?PYXT^&NE_$K1S"FH
MF.W<NK!6N[24#;E<Y9E+*>.B[AS@8^'Z"Q;DG)Z_E6GLTI7CH>7'.*LJ%3#X
MI<ZELWNG^)]=_L0_ O3?$$5W\0/$5M'=VEG,8=.@N #'YB@,\Y!X.W(5>H!#
M'J 1!\7/V[/$$GB*ZT_P*EI8:/;R-$FH31>=+<X.-ZAAA5/88)P<\=![_P#L
M\:7IMM^RKHMO>WBZ=IDVFW#75YYJQ"%)'D,CESPNW<3D\#%>2C]GG]G(]?B+
M:X_[&*T_PKFYE*;<]3Z^6$Q.'P%&G@9*#DKMMV;N1_ #]M#4_&'BJT\*^/;>
MRE@U(BVM]0AB\O\ >MP$E7E2K'"@@#DC@@DCRW]L;X'VGPI\;6NIZ+ +?0-:
M#/';H/DMYE(WHH[*058?4@<+7K^F_ G]G;2=1M+VV^(ULMQ;3)-&W_"16G#*
MP(/3U IO[<7CSP?XR^%FDPZ)XET;6=0MM7CD\FPOHIY!&890QPC$A<[.?I51
M:51<ISXJA5J9946-FI3AK%IW9T?_  3[_P"2+:]_V'IO_2>WKX"O/^/RX_WV
M_F:^_?\ @GW_ ,D7U[O_ ,3Z;_TGMZ^ KS_C\N/]]OYFKI_%,\S,?^1?@3]
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MW_H*U]=_!/\ Y,3N_P#L"ZQ_Z,N:UJ?!$\G)8QACL5&.UI'Q)\'O^2N>"?\
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M#Z1BJ7[NI;HSFJ_[?D\:GVZ+_ \W_8R^'_\ PG'QKTZZECWV&AH=2E+#@NI
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M?^P]-_Z3V]? -]_Q^7'^^W\S7W]_P3[_ .2,:]_V'IO_ $GMZ^ ;[_C\N/\
M?;^9JZ?Q3/,S'_D7X$_0C]NS'_"@['/ _M2WR3T_U<E>=_\ !/GXA^7=^(?
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M(<CZR%SGN"*\?K6E'ECJ>-G6*6*QDN3X8Z+Y!1116IX04444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!VOP1E:'XS>!&7D_V
M[8K^!G0'^=?K@GH*_)?X!V_VKXV>!DQG&L6K_P#?,@;^E?K17G8GXD?JO!_^
M[U6^_P"@HIU(O2EKC/T **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!#
M7YZ_\%!_^2U:1_V 8/\ THN*_0HU^>O_  4'_P"2U:1_V 8/_2BXKIP_\0^1
MXI_Y%LO5'VG\#?\ DBO@'_L 6'_I.E=Q7#_ W_DBO@'_ + %A_Z3I7<5A+=G
MTV'_ (,/1?D%%%%2= 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,U>4_P#!/OQU;:/XP\0>&+J812:K!'/:ACPTD.[<H]RKY^D9K(_:3_:H\/\
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M#G_9+8YKQZBG)*2:9&%Q%3"UHUZ;UB?>'[7?[-=W\1O+\=>#HDOM46W47EG
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MF4;0">@ ] , >P%8]%%/8SE*4Y.4G=L****9 4444#>H4444@"BBBF 4444
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MP^'AR4X]/,****U/ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110(****!A1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTZ:3\]JFJ$OPI\;PR%'\'>($=>JMIDXQ_P".5?-'N>>\)B([TW]S.5HKI_\
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MHYEW#ZO6_D?W',45T_\ PJ[QI_T*&O?^"R?_ .)H_P"%7>-/^A0U[_P63_\
MQ-',NX?5ZW\C^XYBBNG_ .%7>-/^A0U[_P %D_\ \31_PJ[QI_T*&O?^"R?_
M .)HYEW#ZO6_D?W',45T_P#PJ[QI_P!"AKW_ (+)_P#XFC_A5WC3_H4->_\
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M/^%7>-/^A0U[_P %D_\ \31S+N'U>M_(_N.8HKI_^%7>-/\ H4->_P#!9/\
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M_P#B:/\ A5WC3_H4->_\%D__ ,31S+N'U>M_(_N.8HKI_P#A5WC3_H4->_\
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M=XT_Z%#7O_!9/_\ $T<R[A]7K?R/[CF**Z?_ (5=XT_Z%#7O_!9/_P#$T?\
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M>_\ !9/_ /$T?\*N\:?]"AKW_@LG_P#B:.9=P^KUOY']QS%%=/\ \*N\:?\
M0H:]_P""R?\ ^)H_X5=XT_Z%#7O_  63_P#Q-',NX?5ZW\C^XYBBNG_X5=XT
M_P"A0U[_ ,%D_P#\31_PJ[QI_P!"AKW_ (+)_P#XFCF7</J];^1_<<Q173_\
M*N\:?]"AKW_@LG_^)H_X5=XT_P"A0U[_ ,%D_P#\31S+N'U>M_(_N.8HKI_^
M%7>-/^A0U[_P63__ !-'_"KO&G_0H:]_X+)__B:.9=P^KUOY']QS%%=/_P *
MN\:?]"AKW_@LG_\ B:/^%7>-/^A0U[_P63__ !-',NX?5ZW\C^XYBBNG_P"%
M7>-/^A0U[_P63_\ Q-'_  J[QI_T*&O?^"R?_P")HYEW#ZO6_D?W',45T_\
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M+N'U>M_(_N.8HKI_^%7>-/\ H4->_P#!9/\ _$T?\*N\:?\ 0H:]_P""R?\
M^)HYEW#ZO6_D?W',45T__"KO&G_0H:]_X+)__B:/^%7>-/\ H4->_P#!9/\
M_$T<R[A]7K?R/[CF**Z?_A5WC3_H4->_\%D__P 31_PJ[QI_T*&O?^"R?_XF
MCF7</J];^1_<<Q173_\ "KO&G_0H:]_X+)__ (FC_A5WC3_H4->_\%D__P 3
M1S+N'U>M_(_N.8HKI_\ A5WC3_H4->_\%D__ ,32CX6^-&X'A#7B3QQID_\
M\31S+N'U:M_(_N9R]%=O;_ [XB7DFQ/ OB(-C/[S3)D'YLH%==H?[(/Q8US8
MR^%VL86_Y:7MS%%CZJ7W?I2YXK=F\,OQ=1VA2D_DSQJBOKKPC_P3SUZZV2>)
M/$]EIJ]3#IT37#$>FYM@!_!A7OOP_P#V//AKX%\N5](/B"]7'^DZRPG&?:/
M3_QW/O64J\%L>[A>&,?B/C7(O,^"OA?\ _&WQ<G3^P-(D-B3A]2NCY5LOOO(
M.[KT0$CTK[<^"?[&OA;X9B#4]<6/Q/XA7#"6>/\ T:W;_IG&<Y(/\39/<;:^
MA+>W2UC2**-8HD7:J(,  =  *FKCJ5Y3T6Q]]EW#N$P+4Y+FEY[?<1JH7&!C
MC%.[4M+7,?5C13J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MSU_X*#_\EJTC_L P?^E%Q73A_P"(?(\4_P#(MEZH^T_@;_R17P#_ -@"P_\
M2=*[BN'^!O\ R17P#_V +#_TG2NXK"6[/IL/_!AZ+\@HHHJ3H"BBB@ HHHH
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M\J-O^R/RI]% 6789M_V1^5&W_9'Y4^B@++L,V_[(_*C;_LC\J?10%EV&;?\
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M\J-O^R/RI]% 6789M_V1^5&W_9'Y4^B@++L,V_[(_*C;_LC\J?10%EV&;?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS8Q!O])OY01!;CN7;N?]D<GMZU]U^%_V'/AAX>D$EU:7^O,O(_M*ZX_[YB"
M_0@U[GH.@Z;X:TV'3]*L;?3K&%=L=O:Q+&BCV J98A)6BCIPO"M:I44\;/3J
MNK^9S/P@^%6D_![P7::!I2[]@\RYNF&&N9B!ND/IG  '.  .U=LXW*12C[V*
M5NE<#;;NS]+ITH48*G!62/RE_:+^&=[\+_BQK=C- 8M/N[A[RPE481X)&)4
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MDC2OPYC<52=3$5>:IZZ(^7?^"=__ "4'Q1_V#%_]&+7W#XJ_Y%?5O^O27_T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M44E+2- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M0U^>O_!0?_DM6D?]@&#_ -*+BOT*-?GK_P %!_\ DM6D?]@&#_THN*Z</_$/
MD>*?^1;+U1]I_ W_ )(KX!_[ %A_Z3I7<5P_P-_Y(KX!_P"P!8?^DZ5W%82W
M9]-A_P"##T7Y!1114G0%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!V!(R",^U%NB*E.,%>3LCI:6N1T7XJ>#/$VI1:?I'BS1-4OY<E+6SU&&65P
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M_P"+!^-?;3V_F*W-.^,G@34[JULK3QIX?NKVXD6&&WAU2!WD=B %50^2Q)
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME!QGH0,=37YJ]^, U4>6M%MHYL12Q/#>,C[.=X[^J/VB7#'/M7P-_P %#/\
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M\F!]Z221B?KDDD^^:]&;]FGXH+I/]I'P7J?V4+NVA1YV/^N6?,R/3;FO;OV
M/AG::OKFL^,KR-9FTTBSLE=<A)'&7D^H7:H]F-?=+<*>*Z*E?D?+%'S&4\.1
MQ^&^L5YM7V_S/R-U;XI>(]6^']OX)U2Z:\TRQOEN[87!9I;<K&\?E@DYV8?[
MO0$<=ZR/ _\ R.F@?]A"W_\ 1BU]._M]_#.QT+6]%\7:?;1VK:HTEM?"- H>
M50&20XZL06!/?:*^8O __(Z:!_V$+?\ ]&+6T6I0NCYS&8>KA<P5&K*[35GY
M7T/V(./*YZ8K\[?VOOV@M2\=>,M0\)Z5>-;^&-*F-O)'"Y O)U.'9\=5#94
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M '44W=2[J %HI-U&Z@!:*3=1NH 6BDW4;J %HI-U&Z@!:*3=1NH 6BDW4;J
M%HIN:,^] #J*;GWHS[T .HIN:7=0 M%-S1GWH =13<^]&?>@!U%-S[T9]Z '
M44W/O1GWH =13<^]&?>@!U%-S[T9]Z '44W/O1GWH =13<^]&?>@!U%-S[T9
M]Z '44W/O1GWH =13<^]&?>@!U%-S[T9]Z '44W/O1GWH =13<^]&?>@!U%-
MS[T9]Z '44W/O1GWH =13<^]&?>@!U%-S[T9]Z '44W/O1GWH =13<^]&?>@
M!U%-S[T9]Z '44W/O1GWH =13<^]&Z@!U%-W4;J '44W=1NH =13=U&Z@!U%
M-W4;J '44W=1NH =13=U&Z@!U%-W4;J '44W=1NH =13=U&Z@!U%-W4;J '4
M4W=1NH =13=U&Z@!U%-W4;J '44W=1NH =13=U&Z@!U%-W4;J '44W=1NH =
M13=U&Z@!U%-W4;J '44W=1NH =13=U&Z@!U%-W4;J '44W=1NH =13<T9]Z
M'44W/O1GWH =13<^]&?>@!U%-S[T9]Z '44W/O1GWH =13<^]&?>@!U%-S[T
M9]Z '44W/O1GWH =13<^]&?>@!U%-S1NH =13=U&Z@!U%-W4;J '44W=1NH
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M-1_[ <__ *.@K]#S4XCXS?A7_D7+_$SY%_X*)_\ (G>$O^O^7_T77QU\+?\
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M#_V +#_TG2NXK"6[/IL/_!AZ+\@HHHJ3H"BBB@ HHHH **** "BBB@ HHHH
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M_P#\77Y%T4?5EW#_ %NK?\^E]Y^NG_"]OAQ_T/OAK_P;V_\ \71_PO;X<?\
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M11]67</];JO_ #Z7WGZ\?\+X^&__ $/WAG_P<6__ ,71_P +X^&__0_>&?\
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M,?\ @XMO_BZ_'NBCZK'N5_K95_Y]+[S]A/\ A?7PV_Z*!X8_\'%M_P#%T?\
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M_P!%!\+_ /@YMO\ XNC_ (7U\-/^B@^%_P#P<V__ ,77X[44?58]P_UKJ_\
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M_@ZMO_BZ_&MJ;1]57</]:*O_ #[7WG[+?\+_ /AE_P!%$\*_^#JV_P#BZ/\
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M ,'5M_\ %U^,E,H^IKN'^M%7_GVOO/V>_P"&@/AC_P!%%\*_^#JV_P#BZ/\
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MBS11]37</]9JO_/M'[3?\-"?"_\ Z*/X3_\ !W;?_%T?\-"?"_\ Z*/X3_\
M!W;?_%U^+-%'U-=Q_P"LM7_GVC]IO^&A/A?_ -%'\)_^#NV_^+H_X:$^%_\
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M^IKN'^L53_GVC]MO^&AOA9_T4GPC_P"#VV_^+I/^&AOA9_T4GPC_ .#VV_\
MCE?B511]37</]8JG_/M'[:_\-#_"S_HI7A'_ ,'MM_\ '*/^&A_A9_T4KPC_
M .#VV_\ CE?B/11]37</]8JG_/M'[<?\-#_"S_HI/A'_ ,'EK_\ '*/^&A_A
M7_T4GPC_ .#RU_\ CE?B/11]37<?^L-3_GVC]M_^&B/A7_T4GPC_ .#RU_\
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M^HKN'^LE3_GVC]R?^&COA1_T4WP?_P"#ZU_^.4?\-'?"C_HIO@__ ,'UK_\
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M_P"#^U_^.5^$]%/Z@OY@_P!8)_\ /M'[L?\ #2'PF_Z*=X-_\']K_P#'*/\
MAI#X3?\ 13O!O_@_M?\ XY7X3T4?4%_,'^L$_P#GVC]V/^&D/A-_T4[P;_X/
M[7_XY1_PTA\)O^BG>#?_  ?VO_QROPGHH^H+^8/]8)_\^T?NQ_PTA\)O^BG>
M#?\ P?VO_P <H_X:0^$W_13O!O\ X/[7_P".5^$]%'U!?S!_K!/^1'[O6G[0
M7POOV9+7XC>$[AU&2L6N6S$#UXDKH-+\?>&-<DCCT[Q%I5^\GW%M;Z*0M] &
M.:_ &BCZ@OYBEQ!+K#\3^AY6'K^M+7X'>%OBYXX\$2(V@>,-<T@)C"V>H2QH
M<= 5#8(]B,5] ?#W_@I-\7/"$T*:U<:?XQL5X:/4+989MOH)8@N#[L&^AKGG
M@YQ^%W/0I9[0EI4BU^)^N5%?)?PA_P""CWPQ^(TT%CK[3^!]5EXQJ1#VC-Z"
M<  #WD5!^E?55E>6^I6\-S:SQW-M,@>.:%PZ.IZ$$'!%<<J<H?$CW:.(I8A7
MIRN6J*:M.K,Z HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@!K=*^7/V]O#NK>(_ OAN'2=+O-4ECU)F>.RMWF91Y3#)
M"@D"OJ6D(!ZC-7&7+*YPXW"K&X>>';MS*Q^0UC\+O&?VRWSX1UT#S%ZZ;.!U
M]UK]<X.$5?:I=J_W1^5.K2I5]IT/,RG*(94I*,N:XE+116!]"-;M7*?$[X<:
M+\5O"-WX>UR R6D^&26,@202#[LB$@X8?R)!R"176T4T[:HSJ4X58N%173/S
M*^*W[(/COX<WES+I^GR^)M$4YCOM.CWRA>3AXLE@0,\C*\]<G%>(7%K+:3M#
M-$\$J\&.12&'Z?SK]HVQ5>:QMKK;YUO',%.1O0''YUUQQ+M:2N?"XCA*C4GS
MT*CBNUK_ ':H_(3P;\-?%/Q!NX[;P[H-]JK.VSS((<Q*?]N4X5![D@5]V_LS
M_LE0?"F>+Q'XDDAO_%)4^5%$=T-D&&"%/\3XR"W09('J?I14"GH!^%/J*E>4
M]%H>AEW#>&P,U5F^>2^[[B+A%.>:\K_:,^"<7QP\ OIL<T=IK-J_VC3[F0D(
MLF,%6P"=K D'&2#@X.,'UFBL$VG='T]>A3Q-.5*JKIGX]^./AOXF^&^I-8^(
MM%NM+D#%4>6,^5)C/*./E<?[I/X5F:!X;U;Q3J"6&C:;=ZK>M]V"SB:1SZG"
MC( ]>@K]E)(DD4JZ*ZG@AAG-1V]K#;1A(H8XD'144 ?I77]9TLT? RX/I\]X
MUFH]K?K<_/E?V/-9\*_!7Q)XEUVSDNO$S00KIVC6:&5X-TT89W"?>?:2-HR
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M"BBBI **** "BBB@ HHHH*04444#"BBB@ HHHH :W6DI6ZTE !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M* "BBB@ HHHH **** "FFG4TT#$HHHH*"BBB@ HHHH **** "BBB@ HHHJD
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M6UB_LW42QR_VB'"%F_VG79(?]^O;*^:DN5M'ZG2J*M3C4CLT%%%%2:A1110
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MTXR3L/)( ]^AN?M9?"?0O@S\0M)\/: DXM1H\4\LMS+YDDLC2S*78]!PBC
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M*PT/1[62]U.^E$,$*=6)YR3V  ))[ $]!7Z+?!S]B7P1X TF"X\36<'BO7V
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MH0KMZ29RU%%>O_LC:'IOB7]HSP7IFKZ?:ZIIUQ<2K-9WD*S12 02$!D8$'D
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M **** "BBB@ HHHH **** $:FTYJ;2*"BBBF 4444 %%%% !3:=3: "BBBJ
M**** "BBB@ HHHH **** "BBBI92"BBB@84444 %+RWUI**0'Z!?\$G_ !V8
M]8\<^#993MF@AU:VCS]THWE3'\=\'Y5^CM?C;_P3X\2?\(]^U1X5C9]D.I1W
M5C(?7= [*/\ OM$K]D%_2O"Q<>6KIU/T+):G/A4GT8^BD%+7$>\%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKX:_\"KC_P",4?\ #OOXC?\ 05\-?^!5Q_\ &*/9T_Y@_M3-_P#H%_$^T_\
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M1113 ****HH****0#****D HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *::=330,2BBB@H**** "BBB@ HHH
MH **** "BBBJ0!3:=3:& 4445(!1110 4444 %%%%!2"BBB@84444 %%%% #
M6ZTE*W6DH **** "CISZ<T4<]NM UNC]8?V=? \'P[^"_AC38XECN9+-+RY(
M'+32@.^3WP3M^BBOSG^/GQ@U7XP^/]1U&ZO))-)AG>/3;/<?+@A!PI"YP&8
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M **** "BBB@ HHHH **** "BBB@!&IM.:FTB@HHHI@%%%% !1110 4VG4V@
MHHHJ@"BBB@ HHHH **** "BBB@ HHHJ64@HHHH&%%%% !1110!Z=^R_?'3_V
MC/AI*#C=XAL8O^^YE3_V:OW/K\*?V;+4WG[0WPSB'_0R:>Y^BW",?T!K]UO\
M*\;&_&C[?(/X4_45:=35[4ZO-/J0HHHH **** "BBB@ HHHH **** "BBB@
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M44 %%%% !1110 4444 %%%%4@"FTZFT, HHHJ0"BBB@ HHHH ****"D%%%%
MPHHHH **** &MUI*5NM)0 4444 %'\O>BB@#]-OV./BI;?$3X0Z;IDDX;6-
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M;]M0GCEC:S$9"A588;>Z\Y/I6E>+E!V/.R+$4L/CHU:KLM2+]O'_ )."O/\
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MZJ5(_P!I3CCZFOL[]C/]EG4_AI>3^,?%T"VNN2PM!9:?N#FU1L;G<CC>P&
M?E!;/)P-J/\ X*"?#!K<R-;ZXCC'[LV:%OS$F./KWKR[XI?\%$+C4+*>R\":
M))I[R K_ &GJNUI(QZI$I*Y[@EB!CE36<G5FN6UCLP]'*,LG]8]KSM;(L?\
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MYL#F9VS(_P K$8(6,=?X3ZUE4BYSBNAZ& Q-/!X6K43_ 'CT0G_#<7QLV_\
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M"U1+$1EE(D#9;<P'0&LH*4H374]*O4HT<5A9)^ZD<!\?O^2[?$;_ +&34O\
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M]I?XM>'?C%\8)?&F@:??Z=#=06_VN'4%C#M-&-F5VLW&Q8QS@Y!]J[W]L/\
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M6JZ7=2V6HV<JSV]S"</'(IR&'/7I^E?;FB?MV?#_ .)WA.UT7XT^!?[7N;8
MK>64"3Q2/C!D"LRM$QZ?*2#VP.!$HRA+VD5<ZZ=2CB,.\/4ERM-M,^6/V?\
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M/:*<FFDE^IZ%_P $N<?\- :]U_Y%FXZ_]?5I7BW[6'_)R/Q%_P"PQ-_.MO\
M9!^/FD?L[?$S4_$NM:??:C:W6D2Z<L5B$\P.TT,FX[V P!$1U[BO/_C1XXM/
MB5\5/%'BFQ@FMK/5;Y[J*&X \Q%8YPV"1GZ5LH-5W+I8XJE:$LOA2O[RDV>S
M?\$ZO^3G]&_Z\;S_ -%&L/\ ;W_Y.R\=_6Q_](;>N<_9<^,6F_ GXNV/BW5K
M.ZO[*WMYX6AL@ID)D3:"-Q QGWK/_:2^*-A\:/C1XB\9:7:W%E8ZD;?R[>\5
M1*OEV\41W;21R8R1@]"*.5^WYNEANM#^SE2O[W-<\R_AI*6DKK/'"D:EI&H
M2BBB@ HHHH **** "BBBDR@HHHJ0$:FTYJ;5( HHHI@(U-IS4V@I!1110,**
M** "BBB@ HHHH **** &T444%!1110,*93Z90 4444 %%%% !1110 4444 %
M%%% !1110 4444 (U-IS4VD4%%%%, HHHH **** "FTZFT %%%%4 4444 %%
M%% !1110 4444 %%%%2RD%%%% PHHHH ***.](#W+]B+03XB_:F^']O_  P7
MCWC'T$,,DH_5!^=?M77Y9_\ !+/P2VM?&K7?$;INM]#THQ!L=)IW"K_XY'-7
MZFXKP\9*]1>1]_D=/EPW-W8ZBDI:X3Z$**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** $--I]% 'SI^W%X!/B[X-R:I;QLUWH,RW@"C+&(C9*/P!#_\ K\X
MO\__ *J_9O6M+MM<TF\TZ]B6>SO(7MYHFZ.C*593]037Y(?%;P#=?##XA:WX
M;NMS?8KAA#*XYEB/,;_BI4_7/I7HX:2:Y6?EG%N"Y:L,7%;Z/U.3HHHKL/ST
M**** "BBB@ HHHH ****8!1115%!1112 91114@%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !333J::!B444
M4%!1110 4444 %%%% !1110 44452 *;3J;0P"BBBI **** "BBB@ HHHH*0
M4444#"BBB@ HHHH :W6DI6ZTE !1110 4444 %%%%4BD%%%%,+(1J;3FIM2
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M#I]SXETF'5G:/2Y+N%;MT8*1"7 <@GI\N>>U9E%#V-(OE:=C]&_!OA_]G?\
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M 4444 %%%% !1110 C4VG-3:104444P"BBB@ HHHH *;3J;0 44450!1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %--.IIH&)11104%%%% !1110 4444 %%%% !1115( IM.IM# ****D
MHHHH **** "BBB@I!1110,**** "BBB@!K=:2E;K24 %%%% !1110 44452&
M@HHHIC$:FTYJ;4L HHHH&-HHHJB HHHH *:W6G4UNM "4444 %%%% !1110
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M25(!1113 ****"A&IM.:FT %%%% "-24K4E!2"BBBFAA1112 **** &4444
M%%%%/H4AE%%%(84444 %%%%4 VBBBI*&-WJ*I6[U%6B.6IN,HHHK0@**** "
MBBB@ I&I:1J &T444%A2-2TC4 )1110 4444 %%%% !1112904445("-3:<U
M-JD 4444P$:FTYJ;04@HHHH&%%%% !1110 4444 %%%% #:***"@HHHH&%,I
M],H **** "BBB@ HHHH **** "BBB@ HHHH **** $:FTYJ;2*"BBBF 4444
M %%%% !3:=3: "BBBJ **** "BBB@ HHHH **** "BBBI92"BBB@84444##_
M #R,BOT]_P"":O[.Y\(>$9OB9K5LR:OKT7DZ8D@.8;+()D^LK $'^XBD?>-?
M+'[$_P"RO<_M >.$U36;:1? NCRB2]D(*B\E&"MLC=\\%B.B\<%P:_8&SM8K
M&WBM[>)(8(4$<<<:A551P% '  '&*\G%UOL1/K<EP+<OK$UIT)H^F.M/I!ZT
MM>4?9!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*2NC\9QF!KX&HZ=:-OR"BBBJ. **** "BBBF 4445104444@&4445(!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4TTZFF@8E%%%!04444 %%%% !1110 4444 %%%%4@"FTZFT, HHHJ0"B
MBB@ HHHH ****"D%%%% PHHHH **** &MUI*5NM)0 4444 %%%% !1115(:"
MBBBF,1J;3FIM2P"BBB@8VBBBJ("BBB@ IK=:=36ZT )1110 4444 %%%% !1
M110-!2-2TC4#&T444 %%%% !1114]0&T4450!1110,****"@HHHH 1J;3FIM
M !1110 C4VG-3:"D%%%% PHHHH **** &T444%!1110 4UNM.IK=: $HHHH
M****"D%(U+2-0,;1110 4444 (U)2M24%(****!A1110 4RGTR@:"BBB@8C4
MVG-3: "BBB@ I&I:1J"N@QNM)2MUI*LS"BBB@ IE/IE !11128!1110B@IM.
MIM, HHHH *93Z90,****"@HHHH *:W6G4UNM T)11104-HHHH **** "BBB@
MH:W6DI6ZTE !1110,::2E-)04%%%% !1110 C4E*U)312"BBBAC&MUI*5NM)
M4@%%%%, HHHH*$:FTYJ;0 4444 (U)2M24%(****:&%%%%( HHHH 91110 4
M444^A2&4444AA1110 44450#:***DH8W>HJE;O45:(Y:FXRBBBM" HHHH **
M** "D:EI&H ;11106%(U+2-0 E%%% !1110 4444 %%%%)E!1114@(U-IS4V
MJ0!1113 1J;3FIM!2"BBB@84444 %%%% !1110 4444 -HHHH*"BBB@84RGT
MR@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1J;3FIM(H****8!1110
M4444 %-IU-H ****H HHHH **** "BBB@ HHHH ****E[EK4***502P &2>,
M4AV$_G],U[M^RW^REXB_:0\2*8UDTOPA9RJ-1UEEX]3%%GAY2,>H4$%NH!]/
M_9;_ ."?/B#XH36GB+Q_!=>&O"F1)'9./+O;\=1\I'[J,_WF 8C[H'##]/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?YGQS17V-_P[EU'_ *'FV_\ !:W_ ,<H_P"'<NH_]#Q;?^"UO_CE'MZ?</\
M5[,_^?7XK_,^-J*^R/\ AW)J/_0\6O\ X+6_^.4?\.X]1_Z'BU_\%K?_ !RI
M]M3[A_J]F?\ SZ_%?YGQO17V1_P[CU'_ *'BU_\ !:W_ ,<H_P"'<>H_]#Q:
M_P#@M;_XY1[:'</]7LS_ .?7XK_,^-Z*^R/^'<>H_P#0\6O_ (+6_P#CE'_#
MN/4?^AXM?_!:W_QRCVT.X?ZO9G_SZ_%?YGQO17V1_P .X]1_Z'BU_P#!:W_Q
MRC_AW'J/_0\6O_@M;_XY1[:'</\ 5[,_^?7XK_,^-Z*^R/\ AW'J/_0\6O\
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M6H_]#S;?^"UO_CE4J]/N'^K^9?\ /K\5_F?&U-K[+_X=Q:E_T/-M_P""UO\
MXY2?\.X=2_Z'JU_\%K?_ !RCV]/N'^K^9?\ /K\5_F?&M%?97_#N'4O^AZM?
M_!:W_P <H_X=PZE_T/5K_P""UO\ XY4^WI]P_P!7\R_Y]?BO\SXUHK[*_P"'
M<.I?]#U:_P#@M;_XY1_P[AU+_H>K7_P6M_\ '*/;T^X?ZOYE_P ^OQ7^9\:T
M5]E?\.X=2_Z'JU_\%K?_ !RC_AW#J7_0]6O_ (+6_P#CE'MZ?</]7\R_Y]?B
MO\SXUHK[)_X=PZE_T/-K_P""UO\ XY1_P[AU'_H>;7_P6M_\<H]M#N4N'\R_
MY]?BO\SXVHK[)_X=PZC_ -#S:_\ @M;_ ..4?\.X=1_Z'FU_\%K?_'*?MH=Q
M_P"K^8_\^_Q7^9\;45]D_P##N'4?^AYM?_!:W_QRC_AW#J/_ $/-K_X+6_\
MCE'MH=P_U?S'_GW^*_S/C:BOLG_AW#J/_0\VO_@M;_XY1_P[AU'_ *'FU_\
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M #/C2BOLO_AV_J/_ $/5K_X+6_\ CE'_  [?U'_H>K7_ ,%K?_'*?MZ?<?\
MJ_F/_/O\5_F?&;4VOLUO^";^I'_F>[7_ ,%K?_'*3_AV[J7_ $/=K_X+6_\
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M??XH^+J*^T?^':^H_P#0^6O_ (+&_P#CM'_#M?4?^A\M?_!8W_QVCV]/N/\
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M>WI]P_L',/\ GW^*/BJBOM7_ (=GZG_T/MK_ ."MO_CM+_P[/U+_ *'ZU_\
M!6W_ ,=H]O3[C619A_S[_%'Q32-7VO\ \.S]2_Z'ZU_\%;?_ !VD/_!,_4C_
M ,S]:_\ @K;_ ..T>WI]Q_V%F'_/O\4?$]%?:_\ P[-U+_H?K7_P5M_\=H_X
M=FZE_P!#]:_^"MO_ ([1[>GW#^PLP_Y]_BCXHHK[7_X=FZE_T/UK_P""MO\
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MMU7_ **'9_\ @J?_ ..T?6*?</[(QO\ )^*/A&BON[_AU;JO_10[/_P5/_\
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M*7_^.T?\.H=6_P"BC6?_ (*7_P#CM+ZU2[C_ +'QO\GXH^"J*^]?^'4.K?\
M11K/_P %+_\ QVC_ (=0ZM_T4:S_ /!2_P#\=I?6:7</['QO\GXH^"6IM??'
M_#J'5O\ HHUG_P""E_\ X[1_PZ@U;_HHUG_X*6_^.T_K5+N/^Q\;_)^*/@>B
MOOC_ (=0:M_T4:S_ /!2W_QVC_AU!JW_ $4:S_\ !2W_ ,=I_6J7</['QO\
M)^*/@9J;7WT?^"3^K-_S4>S'_<)?_P".TG_#IW5O^BD6?_@I?_X[1]:I=QK)
M\;_)^*/@:BOOG_AT[JW_ $4BS_\ !2__ ,=H_P"'3NK?]%(L_P#P4O\ _':/
MK5+N/^R,;_)^*/@:BOOG_AT[JW_12+/_ ,%+_P#QVC_AT[JW_12+/_P4O_\
M':/K5+N']D8W^3\4? U%??/_  Z=U;_HI%G_ ."E_P#X[1_PZ=U;_HI%G_X*
M7_\ CM'UJEW#^R,;_)^*/@:BOOG_ (=.ZM_T4BS_ /!2_P#\=H_X=.ZM_P!%
M(L__  4O_P#':/K5+N']D8W^3\4? U%??/\ PZ=U;_HI%G_X*7_^.T?\.G=6
M_P"BD6?_ (*7_P#CM'UJEW#^R,;_ "?BCX$HK[[_ .'3NK?]%(L__!2__P =
MI/\ ATYJW_12+/\ \%+_ /QVCZU2[C_LG&_R?BCX%HK[Z_X=-ZM_T4BS_P#!
M2_\ \=I/^'3>J_\ 12+/_P %+_\ QVCZU2[C_LC&_P GXH^!J97WY_PZ;U7_
M **19_\ @I?_ ..TG_#IO5O^BD6?_@I?_P".T?6J7</[(QG\GXH^!**^^_\
MATWJW_12;/\ \%+_ /QVC_ATWJW_ $4FS_\ !2__ ,=H^M4NX?V3C/Y/Q1\"
M45]]_P##IO5O^BDV?_@I?_X[1_PZ;U;_ **39_\ @I?_ ..T?6J7</[)QG\G
MXH^!**^^_P#ATWJW_12;/_P4O_\ ':/^'3>K?]%)L_\ P4O_ /':/K5+N']D
MXS^3\4? E%???_#IO5O^BDV?_@I?_P".T?\ #IO5O^BDV?\ X*7_ /CM'UJE
MW#^R<9_)^*/@2BOOO_ATWJW_ $4FS_\ !2__ ,=H_P"'3>K?]%(LS_W"7_\
MCM'UJEW#^R,9_)^*/@2BOOO_ (=-:M_T4>R_\%+_ /QVC_ATUJW_ $4>R_\
M!2__ ,=H^M4NX?V1C/Y/Q1\"45]]_P##IK5O^BCV7_@I?_X[1_PZ9U;_ **/
M9?\ @I?_ ..T?6J7</[(QG\GXH^ VIM??Q_X),ZMV^)%D/\ N$O_ /':3_AT
MQJ__ $4FR_\ !0__ ,=H^M4NY7]DXS^3\4? 5%??O_#IC5_^BDV7_@H?_P".
MT?\ #IC5_P#HI-E_X*'_ /CM'UJEW#^R<9_)^*/@*BOOW_ATQJ__ $4FR_\
M!0__ ,=H_P"'3&K_ /12;+_P4/\ _':/K5+N']DXS^3\4? 5%??O_#IC5_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH 0T@%%% !]**** "BBB@04444"N%%%%
M7"BBB@+A1110%PHHHH"X4444!<**** N%%%% 7"BBB@+A1110%PHHHH"X444
M4!<**** N%%%% 7"BBB@+A1110%PHYHHH*#FCFBB@ YHYHHH .:.:** #FCF
MBB@ YHYHHH .:.:** #FCFBB@ YHYHHH .:.:** #FCFBB@ YHYHHH .:.:*
M* #FCFBB@ YHYHHH .:.:** #FCFBB@ YHYHHH .:.:** #FCFBB@ YHYHHH
M .:.:** #FCFBB@ YHYHHH .:.:** #FCFBB@ YHYHHH .:.:** #FCFBB@
MYHYHHH .:.:** #FCFBB@ YHYHHH .:.:** #FC\:** #\:/QHHH /QH_&BB
M@ _&C\:** %HVBBB@ QZ4G-%% !S1S110 <T<T44 +CUHVBBB@ Q2T44 %%%
M% !1110 4444 %)110 4444 %%%% !1110 M%%% !1110 4444 %)110 444
M4 %%%% !1110 4444 +1110 4444 %%%% !1110 E&?:BB@ _"BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
'%%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>iclr-20241231_g4.jpg
<TEXT>
begin 644 iclr-20241231_g4.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^(,6$E#0U]04D]&24Q%  $!   ,2$QI
M;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S<$U31E0     245#
M('-21T(                  /;6  $     TRU(4" @
M                                               18W!R=    5
M   S9&5S8P   80   !L=W1P=    ?     48FMP=    @0    4<EA96@
M A@    49UA96@   BP    48EA96@   D     49&UN9    E0   !P9&UD
M9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'5M:0   _@    4
M;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P   @,9U120P  !#P
M  @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W
M;&5T="U086-K87)D($-O;7!A;GD  &1E<V,         $G-21T(@245#-C$Y
M-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR+C$
M                                                     %A96B
M      #S40 !     1;,6%E:(                     !865H@
M;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(        "2@   /
MA   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M     !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                    9&5S8P         N245#(#8Q
M.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M       N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@
M+2!S4D="                             &1E<V,         +%)E9F5R
M96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M     "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M
M,BXQ                                  !V:65W       3I/X %%\N
M !#/%  #[<P !!,+  -<G@    %865H@      !,"58 4    %<?YVUE87,
M         0                        */     G-I9R      0U)4(&-U
M<G8        $      4 "@ / !0 &0 > ", *  M #( -P [ $  10!* $\
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M[D(P0G)"M4+W0SI#?4/ 1 -$1T2*1,Y%$D5519I%WD8B1F=&JT;P1S5'>T?
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M^_>*^!GXJ/DX^<?Z5_KG^W?\!_R8_2G]NOY+_MS_;?___^X $T%D;V)E &2
M     04  DE$_]L A  *!P<7"!<?%!0?)!\9'R0G'!P<'"<C(" @(" C)R0E
M)24E)"<H+"TM+2PH,C(R,C(R,C(R,C(R,C(R,C(R,C(R 0L2$BH5*C(@(#(R
M,C(R,C(R,C(R,C(R/CX^,C(R,D! 0$ R,C) 0$! 0#) 0$! 0$! 0$! 0$!
M0$! 0$! 0$#_P  1" VT"; # 1$  A$! Q$!_\0!H@    <! 0$! 0
M    ! 4# @8!  <("0H+ 0 " @,! 0$! 0         !  (#! 4&!P@)"@L0
M  (! P,"! (&!P,$ @8"<P$" Q$$  4A$C%!408382)Q@10RD:$'%;%"(\%2
MT>$S%F+P)'*"\25#-%.2HK)C<\(U1">3H[,V%U1D=,/2X@@F@PD*&!F$E$5&
MI+16TU4H&O+C\\34Y/1E=865I;7%U>7U9G:&EJ:VQM;F]C='5V=WAY>GM\?7
MY_<X2%AH>(B8J+C(V.CX*3E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^A$
M @(! @,%!00%!@0( P-M 0 "$0,$(1(Q0051$V$B!G&!D3*AL? 4P='A(T(5
M4F)R\3,D-$."%I)3):)CLL('<](UXD2#%U23" D*&!DF-D4:)V1T53?RH[/#
M*"G3X_.$E*2TQ-3D]&5UA96EM<75Y?5&5F9VAI:FML;6YO9'5V=WAY>GM\?7
MY_<X2%AH>(B8J+C(V.CX.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ:JKK*VNKZ_]H
M# ,!  (1 Q$ /P#LV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5@?YH
M_9B^;?PRZ#J-;R'Q8/I^D3:E7T4+<:5IVKT_5EI-.IAC,_I",_PC=_[Z;\,'
M$&W\O/N9'Y%T&?3[CG*A5>!%3XU&0D;<[2XI0E9'1Z+E#NG8J[%6'_F;_O,G
M_&0?\1?+8<W6:WZ?C^@I?^5G^[_]A_QOAFTZ'^+X?I8_Y[_WME_V/_$%R<>3
MAZKZS\/N#U#R_P#[S0_\8T_XB,H/-W^+Z8^X?<F&1;G8J[%78J[%78J[%78J
M[%78J[%78J[%78J\NTCR1=6L\<C*.*NK'XEZ!@3WS(,@Z#'II1D#YAZCF.[]
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5B/GOS!-HWI>B0.7
M+E4 ].-.OSRR(MUNJRG'7#Y_H1?DC6)-7@:28U8.5Z ;<5/;YX)"FW39#DC<
MN]7\WZRVCVY=/MDA%/@3W^X8Q%LM1D\.-AYIIFE7/F5V*MR*[LSL=J],O)IT
M4(2S'];UK1K5K2&.-_M*H![[C,8O1XX\,0"C<#:[%78J\?\ /?\ O;+_ +'_
M (@N9,>3S6J^L_#[@SFZT]]2TU(HQ5VCBH*TZ<#_  RJZ+MI0,\8 [H_H2SR
M1Y7GTB=I)E 4H5Z@[\E/;Y9*4K:--@ECE<NYG64NV=BKL5=BKL5=BKL5>1^?
M_P#>Q_DO_$1F3#D\YJOK/P2VT\NW%ZHDCC9E/0CVVR5TT1PRD+ 5O\(W?^^F
M_#!Q!E^7GW,J\@:)/ITKM*A4%* GQJ,KF;=AI<<H$V.C/LI=P[%78J[%78J[
M%7C_ )[_ -[9?]C_ ,07,F/)YK5?6?A]P>H>7_\ >:'_ (QI_P 1&4'F[_%]
M,?</N3#(MSL5=BKL5=BKL5=BKL5>7_F;_O2G_&,?\2?,B')T&M^KX?I+,/(G
M^\47^R_XFV52YNSTOT#X_>609!S'8J[%78J[%78J[%78J[%78J[%78J[%78J
M\Z\U><+G3;EXHV 1>-!Q!ZHI_CE\8@ATF?42A(@?C9G.D7!NH(Y&^TR*Q^94
M$Y27;XSQ1!\@C,#8[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78JP7SOY7GU>=9(5!4(%Z@;\F/?
MYY=&5.IU."625Q[F1^5=/?3;9(I!1UY5%:]78_QRN1LN;@@81 /XW3?(N2[%
M78J\_P#S3_W1_L_^-,N@Z;7?P_']"8?EE_O,_P#QD/\ Q%,$^;=HOI^/Z Q[
M2/)%U:SQR,HXJZL?B7H&!/?)F0</'II1D#YAZCF.[]V*NQ5V*NQ5V*NQ5*/-
M6H/IML\L9HZ\:&E>KJ/XY*(LN-GF81)'XW8YY(\T3ZO.T<S J$+= -^2CM\\
MLE&G"TV>6252[DW\[Z/)J\"QPBK!PW4#;BP[_/(1-.3J<9R1J/>A/(GE^;1O
M5]8 <N/&A!Z<J]/GAD;:M+B..^+R_2R[*W9.Q5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*L#_ #1^S%\V_AET'4:WD/B@_P M]0BLO6]5U2O"G-@M:<^E<,Q;5HYB
M/%9 Y?I9Q_B"V_W]'_P:_P!<JHNV\6/\X?,(JUO$O!RC97%:54AA7Z,#9&0E
MR>8Z/YSN[F>)'DJK.JL.*;@L ?V<O,0Z''J)F0!/4= ]4S'>@>5ZQYSN[:>5
M$DHJNRJ.*; ,0/V<R!$//Y-1,2(!ZGH&2?F;_O,G_&0?\1?(0YN;K?I^/Z"E
M_P"5G^[_ /8?\;X9M.A_B^'Z6/\ GO\ WME_V/\ Q!<G'DX>J^L_#[@]0\O_
M .\T/_&-/^(C*#S=_B^F/N'W)AD6YA/G;S@^F-Z$&S4JS]:5Z 9;&-NJU.H,
M#PQ2.VLM4U!!,K2<3NO[SC4?+D,G8#B1CEF.(7\U30O.\]C*(KHEEKQ;D/B3
MM^'>N QMEBU,HFIL]US64T6(ROOV5?YF\,J MW&7(,8LO.6\PW_F!R(2P'\L
M7PA1[M_4Y=0#H_&GE/I^QI/,=]H#A9BQ_P F7>H]F_H<:!7QIXCZOM>DZ-JZ
M:Q$)4Z'J.X/<9013O,>09!88-YL\V76GW3Q1/1!QH.*'JBGNN71B"'4Y\\H2
M(!^[N0NJ^>;B]XQP$B@')E'Q.U-_D*^&$1IKR:F4MHKI=<O=/MHY1(PJS*W,
M!C4;C=P3T_5C0)2<LX1!OOY_M9/Y%U]]8C<3'E(K=: ?">G2G@<KD*<_2Y3D
M!OFUY[\P2:.B"%N+L3O0'X1UZU[D8Q%KJLIQ@</-WD74KC5$>6=^0KQ391TZ
M] /'&0I=+.4P3)BNC^<[NYGB1Y*JSJK#BFX+ ']G+#$.OQZB9D 3U'0/0=>U
MM-$B,K[GHJ_S'PRD"W<Y<@QBR\Y/F*_UYRL1;_5B^&@^?]3E] .D\:>4[?8M
M.OW^@N!*S?ZLOQ!A\_Z'&@4>+DQ'>_B]%\NZ\NN1>HNQ&SKX'^F4$4[O#E&0
M6PWS#Y^DG<Q6FRUX\P*LY_R?X=\M$.]U>75$FH)=-)J>GKZSF4+XDU ^:[T^
MD9+8M).2'J/$ROR=YQ_2Y]&:@E J".C#^N52C3L-/J/$],N;+LK=D[%7EFJ^
M=+NUN)$63X%D90.*?9#$4^SF0(AY^>IE&1%]3T"^?5M1U^LD(=8^PC^$?\%L
M2<: 2<F3+O&Z\D-IOG6ZTJ3C,2Z@T9'^T/I.]<3$%A#4R@?5O[WJ5K=K=()$
M-58<@?;*'H(R$A8>=^8/S EN',=K\* TY4JS?+P_7EPAWNDRZLDU!!.-4@'J
MDS4I7J3_ ,+_ &9+9J/BC?U)SY4\^-<.(;FAY;+)TW\&^?CD)1<K!JB3PR^:
M=^>=6ETJ!7A;BQ<*30';BQ[@^&0B+<K4Y#"-Q[_UL2M?S"GAB?FW.4D!"0H"
MCN?A K[9;P.NCJY &]ST1/E'5+J\N*RLY!1B*UXU[;=,$@&>GG*4M[Y%(?,5
MU=W'#ZX&VKPY*%\.70#VR8KHXF:4S7'\-E;0+R^@C(M W#D:\45OBH.Y![4P
M$#JRQ2F!Z.7N5_-MU>2\EN WHB0\*J /VN.X [8QIGGE,_5RO;9!>7;J[M^?
MU,-O3GQ4-X\>H/OA-=6K#*8O@^.STJ\U[]#VJ33U,A5:KT+2%=Q[>_AE%67>
M2R^'$2ESH?-@3>9+_77*Q%O]6+:@^?7[SEU .H\:>4[?8MDUC4-!(]5G'AZG
MQJ?I-?UXT"@Y,F+G?QW9_P"5_,JZ]&33C(OVU_B/8Y3*-.XP9O%'F\[\]_[V
MR_['_B"Y='DZ75?6?A]P9Q>7[Z?IB2Q&CB.*AH#UX#OE0%EVTI&&,$=T?T)7
MY&\RW&JSLDS\E"%@.*C?DH[ >.2E&G'TV:4Y5(]/U,@\T>95T% :<I&^PO\
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MS%]4?>/O9A^:?^Z/]G_QIE4'9:[^'X_H3#\LO]YG_P",A_XBF"?-NT7T_']
M>?\ E_\ WIA_XR)_Q(9<>3I\7U1]X^]Z%^8.AR:G&CQ#D8R:J.I#4Z?=E$#3
MN=7B,P".C"="\TS>7ZHH!4FK(P[]/H.7&-NJQ9SBV^QD(\YVFKD?6X:$;!OM
M ?J/Z\KX2.3F_F89/KC^EFEI9P/#Z<8'HL#LO0ANN5.TC&)%#DQ235],T.3E
M$G*1:[QU-.W5FIEM$NO.3'B.PW\D%K7YA_7XVBBC(Y*5+,>Q&^P]O?"(4U9-
M7Q"@$F\B?[VQ?[+_ (@V2ER<72_6/C]Q>@>>_P#>*7_8_P#$URF/-W.J^@_#
M[PP_\LO]Z7_XQG_B29;/DZS1?5\/TAD'YF_[S)_QD'_$7R$.;F:WZ?C^@I?^
M5G^[_P#8?\;X9M.A_B^'Z6*^:KDW-U*3V<K]"_#_  RR/)U^>5R/O>PZ?9BQ
MC6)=@H S&)MZ:$>$4P_\SK,&..;]H-PK[$$_PRR!=9K8[ _!K\K[DO'+'V5E
M8?[('_FG#-=%+8A@FD0"YGC1NC.JGY%@,M+J,8N0'F'N@%,Q'K7ANL1BWN)5
M78+(P'T,:9EAY/(*D?>7N>8CUCL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL58'^:/V8OFW\,N@ZC6\A\5/
M\K/]W_[#_C?&;'0_Q?#]+T#*7<NQ5X59R_HZ=6;_ '6X)'^JW]F99W>2B>"7
MN+V23S!;QIZID7C2M:C]76OMF-3TYRQ NP\7O[GZW(\G\S,W_!&N90>6E+B)
M+TG\S?\ >9/^,@_XB^40YN\UOT_']!2_\K/]W_[#_C?#-IT/\7P_2Q_SW_O;
M+_L?^(+DX\G#U7UGX?<'J'E__>:'_C&G_$1E!YN_Q?3'W#[DPR+<PK7//KZ3
M,T/I \>AY4J"*^&6B%NKRZHXSPTG7Z+M->02<$8,/M#8_>*'(V0Y7!#*+H/*
M=>M([*=XX3R13L?HW'T';,@;O/98B,B!R9)YYL',5O.VY]-4<_Y5*_Q.5Q+F
MZF!J,O*BCO(TMI=Q>E,D?JJ3]M5JP._4C?!*V[3&$A1 OSI,M>OK#1E_NHG<
M]$54K\SMMD0"6_+*&/I$^5!%>4;Z+4@TL4"Q 'CR4+\7<] .FV"0IGIY">XC
M3 O/?^]LO^Q_X@N71Y.HU7UGX?<'J'E__>:'_C&G_$1E!YN_Q?3'W#[D?D6Y
MXOJ]L="NV"[<'YI\OM+F4-P\OD'A3]Q5O+=J=:O%+[U8R/\ 1\1^\XG8,L,?
M$GOWV7L>8KTSP_R__O3#_P 9$_XD,RSR>4Q?5'WC[V6_F=IYY1S@;4X$^'<?
MK.50+L=;#E+X(S\O-=C,7U=V =22H)I53OM]."8;=)E%<)1/G+S=^C%"6[ R
MD[]&XK[^^",;9ZC4<&T>: TJ>Y\SVD_JFH(I&* 59?B_IDC42U0,LT)7\&+>
M5+F&UN!]952A!4\P"%/8[_++).OP2$9>KEYO2I[6PMU]1D@"^/%/PVWRC=WA
MC "ZC]C'=,U^UU*988[1-SLW%-@/VOL^&3((ZN%#+&9X1 ?9^IGV4NX=BKP_
M7CQN9B/]^O\ \3.98Y/*9?JE[S][UO1O,$6J1B0, :?$I-"I[YC$4]'CRB8M
MY_\ F!K2:E*J1GDL8/Q#H6;K3[AET!3IM7D$S0Z)_HNA-+IC1T^*0&0#WVX_
M?Q&0)W<S'BO'7?NQ'RAJPT>Y#R;*04;VK_:,MD+==I\GARL^YZQ+JT,2>H9%
MXTK6HS&IZ(Y !=AX_JER==N69!O(U%'_  J_AF2-@\S,^++;J6;?F#;_ %6S
MBC'171?N1AE4.;M=6.& 'F/N*%_*S_=_^P_XWPS:]#_%\/TO0,I=R\__ #3'
M]S_L_P#C3+H.FUW\/Q_0M\@:_!I\+QRN%;F6W[@JH_AC,6NERQ@*)ZIC^9;<
MK5"/]^+_ ,0?!#FW:SZ1[_T% ?E9_N__ &'_ !OAFTZ'^+X?I6_F=IYK'..E
M.#>W<?QQ@5UL.4O@BOR]U^/TOJ[L%92>-32H.^WTX)ALTF45PE'^=?,$=I \
M:L#(XXA0>QZD_1@B&[4Y1&)'4L6_+C3S/<&7]F-3O_E-L/PKEDRZ_1PN5]R!
M\]_[VR_['_B"X8\FG5?6?A]P9AK?_')'_&.']:96.;LLG]U\(_H8_P#EE_O2
M_P#QC/\ Q),G/DX>B^KX?I"W\Q]/,%P)?V9%&_\ E+M^JF,"C60J5][*O)7F
M".[@2-F D0<2I/8="/HRN0=CILHE$#J$O_,+7XS%]71@S,06XFM%&^_TX8!I
MU>45PA"_ECIYK).>E/37W[G^&&9:]%#G+X(B/\SE<@>D=S3[7]F/ S&M!Z?:
MSK*7;.Q5Y'Y__P!['^2_\1&9,.3SFJ^L_!/O*WG*WTRV2*0MR7E6@KU8G^.0
ME&RY>#41A$ _C=-O^5AVGBW_  )R/ 7)_-P1VD^;(-7?TXB2U.6XIL,!C3;C
MSQR&@\O\U3M/=2ENH<J/DNP_#+X\G09S<C[WJ>E:-:V<8:)4*T!YD D^]3F.
M27H(8XQ&U>]Y;YKOEO[J21#520 ?'BH7^&9$10>?SR$I$AZ3_P!*W_HV_P"9
M64=?B[W_ "?^9^AY_P"1/][8O]E_Q!LNER=-I?K'Q^XO8,QGI7C_ )[_ -[9
M?]C_ ,07,F/)YK5?6?A]P>GZ".5M"#_OI/\ B R@\W?XOIC[A]SR?4K<Z!=D
M+_NMPR_ZM:C\,R!N'G9CPI^XJNA6QUZ\!;]IC(_R^T?Z8G8,L4?%G\;+V3,5
MZ9V*L/\ S-_WF3_C(/\ B+Y;#FZS6_3\?T%CWY>ZVFG2-'(>*R4H3TY+7]=<
MG,6X>DRB!H]6<Z[Y@BTR)GY#E0\%!W)[92!;MLN40%_)YGY,L3>W<=.BGF?;
MCO\ KIF1(T'1:>/%(?--/S-_WI3_ (QC_B3Y&')OUOU?#])9AY$_WBB_V7_$
MVRJ7-V>E^@?'[RQ_\T_]T?[/_C3)P<+7?P_']"KY'F:"PF=?M*SD?,1K3&7-
MEIC4)'W_ ',-\N6T=Y<QI,?@8_%4]=C0?2=LL/)UF$"4@)/6;A;?0HS)Q1 H
M[ "OM\SF/S>C/#B%[!Y'Y?\ ]Z8?^,B?\2&9)Y/-XOJC[Q][TSS7YI;R^4HG
M(-7>M-Q]&8\8V[W/G.*MG:-?0>:X^4B(7!(931B/ ^.)'"N.4<XW 85YYT:#
M2I%$&Q8$LE:\?#WW_AET3;J]5CC ^GY(RSL'OM*;OPD+H/\ )%*_K;(W1;(P
M,L7N-H+R/=6\<C)<JA# <6D"D CY]*UR4FK32B#4J^+.M0CL-.0R.D-*; *E
M6]@*92++MYC' 61'Y!*?+6M6^K3!(K5$('+F GPT^2^.2D*<;#DCD-" 'GM^
MIFV5.U=BKQ_SV*7LG^Q_X@N9,>3S6J^L_#[F>^6?,,$\,,0<>IP5./>JKO\
MJRF0=QARQ( O>GFNH6[:)<D4WC?DOR!JN7C<.BF/#E[B]=L-;AOT$B.*$;U(
M!'L<QB*>DAE$A8+SGS_K::G*JQGDL8(Y#H6/6GW#+X"G2:K*)G;HS3R+IYL;
M5>6Q<F2GSZ?@!E4C9=II8<,??NR+(.:\\_,[3SRCG VIP)\.X_6<N@72ZV'*
M7P1GY>:[&8OJ[L ZDE032JG?;Z<$PVZ3**X2B?.7F[]&*$MV!E)WZ-Q7W]\$
M8VSU&HX-H\UOE.]N/,$,OU@@HP]-=@.H/+]8PR%+@E+*#Q>Y@>E7)T*Y5G!!
MC:C#V^RWX9:=PZ>$O"EOT+V"+5H94]02+PZ\JC,:GIAD!%V'D_F_5AK%R7CW
M4 (OO3^TYDQ%/.ZC)XDK'N9EK-@=.THQ-U"I7YF12?Q.5 V79Y(<&*O=]Z0_
MEE_O2_\ QC/_ !),G/DX>B^KX?I#,//?^\4O^Q_XFN51YNSU7T'X?>&'_EE_
MO2__ !C/_$DRV?)UFB^KX?I#,//?^\4O^Q_XFN51YNSU7T'X?>&'_EE_O2__
M !C/_$DRV?)UFB^KX?I#OS-_WI3_ (QC_B3XPY+K?J^'Z2S#R)_O%%_LO^)M
ME4N;L]+] ^/WEA_YF_[TI_QC'_$GRV')UFM^KX?I+,/(G^\47^R_XFV52YNS
MTOT#X_>6'_F;_O2G_&,?\2?+8<G6:WZOA^DI[I%@=0TKTUW)5Z#W$C$?B,@3
M1<O''CQ5[_O89Y4N8;6X'UE5*$%3S (4]CO\LMDZS!(1EZN7F]*GM;"W7U&2
M +X\4_#;?*-W>&, +J/V,=TS7[74IEACM$W.S<4V _:^SX9,@CJX4,L9GA$!
M]GZEOYI_[H_V?_&F,$:[^'X_H3#\LO\ >9_^,A_XBF"?-NT7T_'] 3WS)8'4
M+:2-=R5V'N-Q^K( T7,S1XXD/+_)^K#2+D-)LI!1CX5_M&9$A8=!I\GARW]S
MU.]UR&RC,K.O&E10@\OEXYC 6]!+*(B[8)H?FZ\U6=(@PHS?%\*[+U/;PRXQ
M =1BU$YR 4OS-_WI3_C&/^)/AAR8ZWZOA^DLE\LS-!I@=?M*DI'S#/3*Y<W/
MPFL=^4OTO/?+EM'>7,:3'X&/Q5/78T'TG;+CR=+A E("3UFX6WT*,R<40*.P
M K[?,YC\WHSPXA>P>1^7_P#>F'_C(G_$AF2>3S>+ZH^\?>S#\T_]T?[/_C3*
MH.RUW\/Q_0F'Y9?[S/\ \9#_ ,13!/FW:+Z?C^@//_+_ /O3#_QD3_B0RX\G
M3XOJC[Q][TSS7YI;R^4HG(-7>M-Q]&8\8V[W/G.*MG:-?0>:X^4B(7!(931B
M/ ^.)'"N.4<XW 85YYT:#2I%$&Q8$LE:\?#WW_AET3;J]5CC ^GY)II$\D&D
MRD?S$+_JL5!_6V1/-OQDC$?QW))Y)L(K^Y"3T(XDJI_:;;;[JGZ,E(TXNFB)
M2J3/_,KPZ1:R !4+(44* *EA3ME,=R[C,8XXGD-J8!Y$_P![8O\ 9?\ $&RZ
M7)T^E^L?'[B] \]"ME+_ +'_ (FN4QYNYU7T'X?>P3R'JD>F7!:5N*E"H/:M
M5/\ #+I"W4:68A+?N9)^8%ZE]:(\9#*91N/97RN HN=JY"4 1W_K0WY6?[O_
M -A_QOAFUZ'^+X?I8[YUT\V5T]>CGFI_UNOXUR<38<+4PX9'SW>D^7_,,6J1
M*W(!P!S4G<'OE!%.\Q9A,?>Q'\Q==2[XP1L&XGDY&XKT _7EL Z[5Y1+TA-?
MRUT\V\+2G;U&V_U5_M)R,RY&CA4;[V ^7_\ >F'_ (R)_P 2&7'DZ?%]4?>/
MO>X9B/5O#_,'^],W_&1_^)',L<GE,OU2]Y^][AF(]6[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%4A\T^6
M/\0!!SX<23]GE6M/<9.,J<//A\6MZ6^5O*W^'N?Q\^?']GC3C7W/CC*5K@P>
M%>]VR#(.8[%6&>8OR_&HR&6%@C-NRMT)\13+1.G5YM)QFXI=IWY8OR!G=>/<
M)4D_20*9(S:8:(_Q'Y(J\_+-9W9DEXJ3LO"O$>'V\ FV2T5G8_9^UD7F;0/T
M]$(N7"C!ZTY= 13J/'*XFG-S8O%%<MT/Y6\K?X>Y_'SY\?V>-.-?<^.&4K88
M,'A7O=I?KOD']+S-/ZO'E3X>%:44+UY#PR0G31ETOB'BO[/VLHT^U^I1)%6O
M!52O2O$4KE9W=A"/" .X(C S2'S'Y3CUZC$\9 *!QX>!'?)B5.)FP#+[V(O^
M6EPAHDB4/7=A^'$Y9QNM_)RZ$)MHOY<):L'G;F1N$ HOT^.1,W(QZ,1-RW9?
M>V:7R&.055MB,K!IV4HB0HL#U#\L6J3!(*=@_;Z17]66B;J)Z+^:?FU8?E@U
M09Y!3N$J2?I-/U83-8Z+^<?DSVRLTL4$<8HJ[ 923;MXQ$108MKOD']+S-/Z
MO'E3X>%:44+UY#PRP3IU^72^(>*_L_:RC3[7ZE$D5:\%5*]*\12N5G=V$(\(
M [@B,#-C'F;R8->=9 _ @<3\/*OA^T,LC*G S:;Q3=TJ>5_* T!F?GS9@ #Q
MXT'?N>NWW8)2M.#3^%O=LCR#G,'T_P#+?ZE*DOK5X,KTX4KQ-:?;RTSMU,-'
MPD'BY'N_:S&]LTOD,<@JK;$96#3LY1$A18'J'Y8M4F"04["3M](K^K+1-U$]
M%_-/S:L/RQ:H,\@X]PE:GZ33]6$S6.B_G'Y,]L[-+%!'&**HH!E)W=O&(B*#
M&?,'D&/4V,L9]-SNVU5)^78Y,3IP<NE$]QLD"?EC.3O(@'B.1/W4&3XW#&BE
MWAF'EWRK%H()7XG/5S^H> RLRMV6' ,7O[T\R#ENQ5X?Y@_WIF_XR/\ \2.9
M8Y/*9?JE[S][,]8_+7U6+6[!0?V'K0?(BOZLJ$W9Y-'9]/R=H_Y:B)@UPP8#
M]A*T/S)[?1B9IQZ.OJ^3/%4**#IE+MV*>8/(4>J,9(SZ;G=MJJQ\:=CE@G3K
MLNE$]QL6/+^6,]=W2GC\5?NI_')\;A?DI=X95Y<\F1:(>9/.3^8[ ?(9696[
M'#IQCWYE%^9M _3T0BY<*,'K3ET!%.H\<$339FQ>**Y;H?RMY6_P]S^/GSX_
ML\:<:^Y\<,I6PP8/"O>[9!D',2W7-"CUM/3DKL:JPZ@Y(&FC+B&046)G\K5K
MM,:>'#?[^66<;KOR/]+[&2>8O+OZ;A6'GQXL&K3ET4CI4>.5@TYV;#X@X;4?
M*WE;_#W/X^?/C^SQIQK[GQPRE;'!@\*][M.;RS2]0QR#DK=1D>3E2B)"BP34
M/RQ-28)!3L'[?2/Z9:)NGGHOYI^:E9_EA(3^]D4#OP!/ZZ8>-$=$>I^3.]+T
MJ/2D$40HH^\GQ.4DV[:$! 4&-Z[Y!_2\S3^KQY4^'A6E%"]>0\,L$Z<'+I?$
M/%?V?M3B]T#ZW:"TY4HJ)SI_)QWI7O3QR .]N5+%Q0X/(;^Y+_+/DO\ 0,IE
M]3G52E./'J0:_:/ADI2MIPZ;PC=WMW)YJFE1ZJABE%5/W@^(R -.5. F*+!+
MS\L) ?W4BD=N8(_57+N-U,M$>A^:KI_Y8FH,\@IW"=_I/],!FF&B_G'Y,[L[
M-+)!'&.*KT&5<W<1B(B@PB/\K^!!];H:_8_YORWC=2-%7\7V?M9]E+N'8JQ'
MS!Y$_3,QF]7C4 <>->@IUY#+!*G6Y=+XAXK^S]J6_P#*K/\ B_\ X3_F_)<;
M1^1_I?9^UW_*K/\ B_\ X3_F_'C7\C_2^S]J:^6_)'Z#E]7U.?PE:<>/6G?D
M<B96Y.'3>$;N_@L\S>15U=S-&W!S]H$?"WO[8QE3'-I?$-C8I);?EI.=I)%"
M_P"3R;\"%R?&XL='+J0C[K\L$D(].4J* $%>1)\:\A@XVZ6B!Y%D\>D%;7ZJ
M6K^[,7.GB.(-*]OGE=[VYXQ^G@\JM(M"\@_HB99_5Y<:_#PI6JE>O(^.3,[<
M/%I?#/%?V?M9AE3LV'Z[Y!_2\S3^KQY4^'A6E%"]>0\,M$Z=9ETOB'BO[/VL
MHT^U^I1)%6O!52O2O$4KE9W=A"/" .X///S-C03(1]LK\7R!^'^.70=+K0+'
MN1_Y9:;P5[@]_@7Y#<_P^[!,MVBAL9?!GF4NW=BK#_S-_P!YD_XR#_B+Y;#F
MZS6_3\?T%B_D_P N)KR3*QHR\.##M7G7;PR<C3@:?",HE\/THT?EC-R_O$X^
M/Q5^ZG\<'&V_DCWAF?E[RU'H*D)NQ^TYZG^@RHRMVF'",0V^:7^9O)?Z>E$O
MJ<**$IQY="37[0\<E&5-.;3>*;NMNY.-"TK]$0K!RY<:_%2E:L6Z5/CD2;<G
M%#PQPI?YI\K?XAX?'PX<OV>5>5/<>&&,J:<^#Q:WJE?RUY>_0<31%N89BU:<
M>H I2I\,$C;+#B\(5S8OJOY9EV+6[@*?V7KM](K^K+!-P)Z+?TGYMZ?^6K$@
MW$@*C]E*_K-*?=B9K#1_SC\E>'\MOJ\@D2:G%@RCATH:@5YX.-F-'1L2^S]K
M*M8T>/6(S%*-NH(Z@^(RL&G8Y,8R"BP:X_+*6,UBD4CMRJI_#EEW&Z@Z(CD5
M6Q_+%B:SR"G<)4D_2:?JP&;*.B/\1^3/+2S2S01H**HH!E3MXQ$108AK7Y<)
M=,7@;@3U0BJ_1X?CE@FZW)HQ+>.R50?EA,Q^.1 /\GDQ_$+DN-QQHCU(9OH7
ME^+0TX1[D_:8]6RHFW:XL0Q"@FF1<AV*L>\P^3HM<8.25<"G(=Q[C)B5.'FT
MXR[]4OT7\OQI<RS>KRXFH'&G:G\QR1G;1CTG >*_L3;S#Y6BUT M\+C97'7Y
M'Q&1$J<G+@&7GS[V'2_EC.#\,B$>)Y _=0Y9QNL.BEWA-]%_+A+5@\[<R.B
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M6)K/(*=PE23])I^K 9LHZ(_Q'Y,X32XTB^KA?W?'CQ]LJMVW *X>C [[\L9
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MRN.'_?3_ 'KCX:^,'?\ *XX?]]/]ZX^&OC!W_*XX?]]/]ZX^&OC!W_*XX?\
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M^5LP_P"^G^]<?#7\R.YW_*V8?]]/]ZX^&OYD=SO^5LP_[Z?[UQ\-?S([G?\
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M_E:$7^^V^\8^&OYP=Q=_RM"+_?;?>,?#7\X.XN_Y6A%_OMOO&/AK^<'<7?\
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M/U;:)FMY.PD^./\ X+J/F<;(;HSA/^C[V,ZYY?FT)^$RTK]EANK#Q4Y,&UE
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M7[/_ )9%_P"#?'A/>OYH?S!\W?7[/_ED7_@WQX3WK^:'\P?-WU^S_P"61?\
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M\W?6+3_EE7_@VQH]Z^+'^:/F[ZQ:?\LJ_P#!MC1[U\6/\T?-WUBT_P"65?\
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MR8-N+.!@:*"R36[%6\"'8JC=*TB75W].%:GN>P'B3@)IMAC,S093#Y8M-/\
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MJ[%78J[%78J[%78J[%78J[%78J[%78JM;I@53P(=BKL5=BKL52OS1_O'<?\
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M$8I!I=YCL!J\1ND $J?WP'[2_P _]< -;+FAX@XQS'-A>6NK9S^6/VI?DO\
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M/GR_9XTXT]SXY.,K<//@\*M[MZ!Y[_WBE_V/_$URF/-W.J^@_#[P\O\ +_\
MO3#_ ,9$_P")#,@\G08OJC[Q][T#\S?]YD_XR#_B+Y3#F[C6_3\?T%,//?\
MO%+_ +'_ (FN1CS;]5]!^'WA+_RR_P!YG_XR'_B*9*?-HT7T_'] >?\ F#_>
MF;_C(_\ Q(Y<.3I\OU2]Y^]+\+2]KNH7M+7C9@<U4>GX=OX?CF+UW>ID#&/H
M^#%M*\Y3Z:674%:G[)X4-?#L,L,;Y.!CU$H?WE_));6PA\PW](@1"WQL*4Z#
M<?2?UY*Z#BB(RSVY<V4^;_-!\OA(8 H8BNXV5>@H/HRN,;=AJ,_A5&*IY2\P
M_P")(WBG4%AU\&5O;&0I.#-XP(DQS1M+_16J+$.@+<?]4QL1DR;#@XX<&6O?
M]S-/,>LQZ&HG9>3_ &$'SW._8;;Y4!;M,V08AQ'X//=5\Z/J4D4I4*8F+"AZ
MUX_TR\1ITT]29D'N9KYWM!J=F9%WXTE4^W?\#E4=B[34QXX7\4H_+#3Z"2<]
MZ(OT;G^&2F7'T4.<O@B-!U#](:G,PZ!"B_)60?KP$4&6*?'DE[J^T)+^9O\
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MPQ2)QT;9QYCU)M*MWF0 LM*!NF[ =J>.4Q%EW&:9QQ,A^-V)^3=5?5KUY9
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MBKL5=BJK;?;7YC]> LH\V_/W^]TWS'_$%R,>3N,WU%CV3<=V%#.M5_WFM/\
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M8J[%78J[%78J[%78J[%4ZT+^ZNO^,#95/H[+2_Q?U6%Y-B[%4X\I_P"]</\
MKK^O(2Y-^'ZA[T]U/^]D_P!=OUXAKR<S[RAL+6[%78J[%78J[%78J[%7I_F/
M_>>3_5S%CS>BS?27F&93SK._(LQ:)E/0-M](RB;N=(=OBE5[I8O;]H_V20S?
M+B&.2!H.-+'Q9*_')./,FO'1@L4( )%?95Z"@R$8VY>?-X>T53R[K/Z<1DE
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M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL56MTP*IX$.Q5V*NQ5V*I7YH_WCN/\
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M)$^JQ+,C(%:M Q:NQ([*?#*S.G/QZ660<0K\?!CF6. [%78JOAB,[!5%6)
M\2<"0+V1E]HD^GKRE0JI-*GQP VVSQ2AO((C0?+4FN\O2*CA2O(D?:KX ^&
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M^ZN_^,0_XED)=&T?3+W(/+'1NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5.M
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M::^1=1>^@/J$L58J">M* Y"8HN5H\AG'?H6)6$R6.H$OLBRN-^WV@,N.X=3
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M*NQ5V*NQ5M14[],4LBN=%ETE/4AD)WW"BFWCU.5W;F'&8"P49Y<U>6^)5Q4
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M4UG6Y-9?G*>GV5'11[9:!3K<N4Y397Z+K\NBMRB.Q^TI^R<3&TXLQQ'9D_\
MRLYJ?W(KX\MONX_QRKPW8_G_ .C]O[&+ZUKTNM-RE.P^RH^R,M$:==ES'*=T
MQTKSO/I42PHJ%5K0L&KN2>S#QR)A;?CU4L8X17X^*26-Z]@XDC-&4U&3(MPX
M3,#89C'^9S ?%$"WB&H/NH?UY3X;MAKC_-^U+Q^85RKEZ(0=@I!HORH1DN -
M'YR5WLD>IZH^I2F=J!C3[-0-@!MN?#)@4X63(9GB*>6_YAW4(H>#>[ U_ C(
M< <T:V0[D)I_G":PDDE4(6E(9J@TVKT^(>.$QMJAJ90).VZ6ZKJ3:K*TS@!F
MI4+TV '>OADP*<?),Y#Q%-="\Y3:.O#9X^RMV^1R!C;DXM2<>W,)O<_F:[BD
M<04^+-R_"BY#PW*.N/0?:PZ]O7OG,DAY,>IRX"G52D9FRGFJ^=Y]5B:%U0*U
M*E0U=B#W8^&0$*<S)JI9!PFOQ\4BM+DVCK(M*JP85Z54UR9W<*,N$WW)OK?F
MZ76T$<BH &Y?"#6M".['QR(C3E9=0<HHTOT'SC-HPX"CQ_RMV^1P&-LL.I./
M;F$ZE_,YB/AB /B6J/NH,AX;EG7?T?M8?J6I2:FYDE-6/X#P&7 4ZJ<SD-E"
MX6MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5%Z5!]8FC0=W4?C@+;C%R \PA/.=
MP+B\F8?SE?\ @?A_AD8\G:93<BDF3:'84,YOCZ]G:R#H%=#\U;*X\RNJ%Q@?
M>$HRUU3L5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL53[0_.$ND+PH'3LI[?(Y7*
M%NPPZJ6(5S"<2_F4Q'PQ 'W:OX<1E?AN6=?W1^W]C$]1U)]3<R2FK'[@/ 9>
M!3J<F0Y#<DZT;SO-IJB-@'4;"NQ'M7*S"W-Q:R6,4=TPN?S(=Q2.,*?%FY?P
M7(^&Y$M>3R'VVQ"[NWO&,DAJQZG+@*=1*1F;*=:CYRFU&(P.J!33<!J[$'^8
M^&0$*<W)JY9!PFOQ\5'0/,TFB5"@,AW*GQ\0<91XF&#4'#[DWO\ \Q))U*Q(
M$)_:KR(^6PR QN7/7$CTBOM2W4/.,VH0F!PG$@"H#<OA(/\ -[9,0 <:>JE.
M/":_'Q2FQOGT]Q)&:,,F1;B0F8&PGESY[GN8VC8)1E*DT:M"*?S96,8#G2UD
MI"MM_P =ZEI7G*;2HQ$BH5%?M!J[FO9AA,+8X]7+&.$5^/BDMI=O9L)(S1AT
M.3(MPHR,#89?;?F0Z"DD88^(;C_ Y3X;MXZ\CF/M2_6?.\VI*8U 1#UIN3[5
MR0A3CY=9+(*&R5:-K#Z._J1@$T*_%6F_R(R9%N+BRG$;#>M:T^LN)) H(7C\
M-:4J3W)\<8QI<N4Y3916B>:9=%4I&%()Y?$#\NQ&1E&VW#J3B%"DMEOFDE,W
M1RQ?;L2:[9.G&,R3Q=;ME-G^8TD0I)&'/B#Q_@<I.-VL=>1S%_8HZG^8$MVI
M2-1&#U->3?0=L(QTPR:TR% 4Q3+G4NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5.M&_=6]U(>GI</I<T&52Z.STHVF?)A>38.Q5-/+<P@NH6/02+7[\C+DW8C
M4A[V2ZS$89Y ?YV_$Y$,<HJ1]Z"R34[%78J[%78J[%78J[%78JJVUTUHP=#1
MAT."K91D8FPR>#SZRBCQ@GQ!X_P.5<#L1JSU"5ZQYFDU0<314_E'?YG)B-.-
MDSG)MT4-(UM](+&,*>5*\J]OD1A(MACRG'R4[K5&NIO78#E4&@Z?#3W]L:8R
MR&1XD5JWF2354".% !Y?"#X$=R?' (TVY,YR"C2]?-4JQ>A1>/'A6AK2E/'!
MPI_,&N';E2403&!@XZ@@CZ,FXH-&TTU;S))JJ!'"@ \OA!\".Y/CD1&G)R9S
MD%&E^F^:I=-01H%(%?M UW^D8#&TPU!@*%)5;736C!T-&'0Y.K<:,C$V&3P>
M?644>,$^(/'^!RK@=B-6>H2O6/,TFJ#B:*G\H[_,Y,1IQLF<Y-NB'T?6GTEB
MR4(/VE/0X2+88\IQ\D]E\_,1\,8!\2U?PH,KX',.K/0(%O.4[H48(00020:[
M_(TR7 T_F9$5L@=(UM](+&,*>5*\J]OD1DB+:<>4X^2'U&_;4)#*] 32M.FP
MIA IA.?&;*&PM:9Z7YAETL<4(*]>+"HR!C;D8\QQ\E^H^8I-09'<*#&:K0'V
MZ[^V(C29YC,@FMF]6\R2:J@1PH /+X0? CN3XXB-)R9SD%&DK@F,#!QU!!'T
M9)Q@:-IIJWF2354".% !Y?"#X$=R?'(B-.3DSG(*-*NB^:GTM>! 9.PK0CY'
M 8VRQ:@X]N:,O//,DHI&H3WKR/\ # (-LM63R%)?JGF:35$]-U4"M?A!K^).
M2$::,F<Y!1I=IOFJ734$:!2!7[0-=_I& QM,-08"A27Z?J+Z<_.,T/X$>^2(
MMHA,P-ADD?GX@?%&"?9J?P.5\#L!K/+[4IUCS-)JHXFBI_*._P SDQ&G%RYS
MDVZ)/DW%=BKL5=BKL5=BKL5=BKL5=BJMYO\ W<%K'W"N_P!#L",C'F7*R[1@
M/?\ :Q3+'";P(9=Y*/.&Y0=2(V^A6-<KD[#!RE\$1@5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5.M.\SR68"$!E'2NQ^_(&+E0S&**F\Y,P^% #XDU_@,
M'"V'4>3'IYVG8NQJQZG+'#)M.K+S9) .+@/3OT.0,7)CG(YJESYO>0410OO7
ME_3'A9'4$\DB2<JP?JU>6_CUR;B7O:.U+7I-24(X4 &NU?ZGQR(%-L\IGL6M
M)UI],J  5/4'$BUAD,$PNO-[RBB*%/C6OW;#!PMTM03R0=WYBDNXS$P6AIOO
M7;Z<--4LID*05C?O8-R0T/?P.$BVJ,C'DCKWS')>H8V"T-*T!KL:^. 1IMEF
M,A32^8I%C]&B\>/#H:TI3QQI?%-4ET$[6[!T-".AR32#2?P^<F4?&@)\0:?P
M.5\+F#4>2$U'S+)>CB %4]:=3].2$::IYC) Z=J#:>W- ":4WPD6U0GP&PWJ
M6I-J3!W ! IM_F?'$"EG/CW*MINN/IJE4"D$U^*O]1@(MG#*8<D,+YUD,JFC
M$EMO?#37Q&[3R'SDRCXD!/L:?P.0X7+&H\D'J7F62]7@ %4]:=3].2$::IYC
M+9)\DXSL5=BKL5=BKL5=BKL5=BKL5=BKL5=BJ+TF+U9D'^4/PWP%L@+(8GKT
M_P!8N)6'0NU/E7+!R==E-R/O+*ORQ^U+\E_XVRG(['1?Q?!Z#E#N78J[%78J
M[%51.F%*["KL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL56MTP*IX$.Q5V*NQ5V*I7YH_WCN/\ C#)_Q Y(<V,N1?.&9CJW8JWBK.O*
M6I)K4/Z.F(5U):V<]*GK&?GV_L&5G;=D8^*.'KT0EY9/8N8Y 58=0<L!MTLH
MF)HJ&+%V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*L@T>P334^O7>T:[QIWE?L![?Y],@3>P=A@Q5ZY<NGFPO5=2?596FD-6<
MU/MX#Y#IDP*;I2XC:$PL'8JF_E;6?T+<),=UKQ<>*-L?ZY$BVV$N$L@U_2OT
M;)1=XV^.-NS(>F,3;K,^+PSY=$LR;C.Q5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*LA\OJ-*1[^3[* K$#^W(=A]W?^S*Y;
M[.STT.']X>G+WL%DD,I+-N2:D^^6+S6XH=A0S/R?,-4ADL6/QU]6"O\ ,!\2
M_2/XY4=C;D"/B1,.O,)>Z%"0=B-B,N=&136*'8J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78JY5Y;#KBE-_,K_H>V2S_P!VN1+-
M[#]E?X_[>4C<V[DQ\*(AU.Y8=ECBNQ5L&F*O0;^4:S"EXG6@28>#CO\ 3_3*
M1MLYF4<8XQ\4IRQPG8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%4;I.G'49 @V'5F_E4=3D2:;L<.,TDOFG5AJL[.GV% 2/
M_57I_7#$4C-/C.W+D$GR;CMX$)SY5U8:7.&?^[8&.3_5;^G7(R%N3AGP'?ER
M+)M0LC9.5.XZJ?%>QRL&W+G'A-(;"UNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*IA!/\ HB%[IMFH4A'BY[_1_7(\]FX'
MPP9_ //R:Y<Z9G/Y8_:E^2_\;91D=OHOXO@]!RAW+L5=BKL5=BJHG3"E=A5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*K6Z8%4\"'
M8J[%78J[%4K\T?[QW'_&&3_B!R0YL9<B^<,S'5NQ5O%7=,59AIWGWU4$-_'Z
MZ#97K25?]EW^GZ3E?#W,R1/:0M'<],N=UN'C_P F2-G/_";8;+CG3Q/*5?!W
MHZ=_RV_\D)<;/<P_+#^=_L7>CIW_ "V_\D)<;/<OY8?SO]B[T=._Y;?^2$N-
MGN7\L/YW^Q=Z.G?\MO\ R0EQL]R_EA_._P!B[T-._P"6W_DA+C9[E_+#^=_L
M7>AIW_+;_P D)<;/<OY8?SO]B[T-._Y;?^2$N-GN7\L/YW^Q=Z&G?\MO_)"7
M&SW+^6'\[_8N]#3O^6W_ )(2XV>Y?RP_G?[%WH:=_P MO_)"7&SW+^6'\[_8
MN]#3O^6W_DA+C9[E_+#^=_L7>AIW_+;_ ,D)<;/<OY8?SO\ 8N]#3O\ EM_Y
M(2XV>Y?RT?YW^Q=Z&G?\MO\ R0EQL]R_EH_SO]B[T-._Y;?^2$N-GN7\M'^=
M_L7>AIW_ "V_\D)<;/<OY:/\[_8M_5]/_P"6W_DA)C9[E_+1_G?[%WU?3_\
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ML@2.2=)Y_OUV]9ON7^F1X0V^++O7?\K!O_\ ?Q^Y/^:<'"$>-+O=_P K!O\
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M )IQX OC2[W?X_OO]_'[D_YIQX OC2[W?X_OO]_'[D_YIQX OC2[W?X_OO\
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M_P >7W^_C]R_\TX\(7QY=[O\>WW^_C]R?\TX\ 7QY=[O\>WW^_C]R?\ -./
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M\Q/O^YW^.+W_ 'Z?N7^F/ %_,3[_ +G?XXO?]^G[E_ICP!?S$^_[G?XXO?\
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M7'^_8_\ AOZ8^(O@%W_*GKC_ '['_P -_3'Q%\ N_P"5/7'^_8_^&_ICXB^
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M\-_3'Q%_+'O=_P JFG_WY'_PW],?$7\L>]W_ "J:?_?D?_#?TQ\1?RQ[W?\
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MB+^5/>[_ )53/_OQ/^&_ICXB_E3WN_Y53/\ [\3_ (;^F/B+^5/>[_E5,_\
MOQ/^&_ICXB_E3WN_Y53/_OQ/^&_ICXB_E3WN_P"54S_[\3_AOZ8^(OY4][O^
M553_ ._$_P"&_ICXB_E3WN_Y55/_ +\3_AOZ8^(OY4][O^553_[\3_AOZ8^(
MOY4][O\ E54_^_$_X;^F/B+^5/>W_P JJG_WXG_#?TQ\1?RI[W?\JJG_ -^)
M_P -_3'Q%_*GO=_RJJ?_ 'XG_#?TQ\1'Y4][O^553_[\3_AOZ8^(OY4][O\
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MB+^4/>'?\JMG_P!^)_PW],?$7\H>\._Y5;/_ +\3_AOZ8^(OY0]X=_RJV?\
MWXG_  W],?$1^4/>'?\ *K9_]^)_PW],?$7\H>\._P"56S_[\3_AOZ8^(OY0
M]X=_RJV?_?B?\-_3'Q%_*'O#O^56S_[\3_AOZ8^(OY0]X;_Y5;/_ +\3_AOZ
M8^(OY0]X=_RJZ?\ WXG_  W],?$7\H>\._Y5=/\ [\3_ (;^F/B+^4/>'?\
M*KI_]^)_PW],?$7\H>\._P"573_[\3_AOZ8^(OY0]X=_RJZ?_?B?\-_3'Q%_
M*'O#O^573_[\3_AOZ8^(OY0]X=_RJZ?_ 'XG_#?TQ\1?RA[P[_E5T_\ OQ/^
M&_ICXB_E#WAW_*KI_P#?B?\ #?TQ\1?RA[P[_E5T_P#OQ/\ AOZ8^(OY0]X=
M_P JNG_WXG_#?TQ\1?RA[P[_ )5=/_OQ/^&_ICXB_E#WAW_*KI_]^)_PW],?
M$7\H>\-_\JOG_P!^)_PW],?$7\H>\._Y5?/_ +\3_AOZ8^(OY0]X=_RJ^?\
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MV7?I"7^=O^".'C/>MEK](2_SM_P1QXSWK9=^D)?YV_X(X\1[ULN_2$O\[?\
M!''B/>MEWZ0E_G;_ ((X>(]Z++7Z1E_G;_@CCQ'O6R[](R_SM_P1QXCWK9=^
MD9?YV_X(X\1[UXB[](R_SM_P1P\1[UXB[](R_P [?\$<>(]Z\1:_2,O\[?\
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M_P#!'^N'B*\1=^DY?]^/_P $?ZX\17B+OTG+_OQ_^"/]<>(HXBU^DY?]^/\
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M9=^G+C_?LG_!M_7&E\:7\X_,N_3EQ_OV3_@V_KC2^-+^<?F7?IRX_P!^R?\
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M[_E_X-_ZX\(3XDN\_-W^(KK_ '_+_P &_P#7'A"^)+O/S:_Q%=?[_E_Y&/\
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MPA>,]Y:_Q-=_[_E_Y&/_ %QX0GC/>7?XFN_]_P O_(Q_ZX.$+QGO+7^)KO\
MW_+_ ,C'_KCPA>,]Y:_Q-=_[_E_Y&/\ UQX0GC/>7?XFN_\ ?\O_ ",?^N/"
M%XSWEK_$UW_O^7_D8_\ 7'A">,]Y:_Q/=_[_ )?^1C_UQX0O&>\N_P 3W?\
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M5K%+C@5K%+6*M'%+L5:Q2UBK6!+L5:Q2UBKCBEK%56SO'L766,E74U4C!S9
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M;8^&5\./\[[&O] _Y:&_Y%MA\,KX<?YWV.I8?\M#?\BVQ\,H\./\[['4L/\
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ML=_AFS_Y:&_Y%G'B*_EX]_V-?X9L_P#EH;_D6<>(I_+Q[_L=_ABS_P"6AO\
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MVO\ "5G_ ,M#?\BS_7'B*?!CWN_PE9_\M#?\BS_7'B*^#'O=_A&S_P"6AO\
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MVY6GRWID0 V&1/-EUI$B6:AB50H.3+U'+KX^.5'FY(Y)/8P6-BXD29JC_/\
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M >U#V.)BRA/H45#IUA9-ZOJ!J;A2P;\!O@LED!$,>U[5%U&2J#B@V44I].3
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M-AQ\?-D<^K:59R&W,2FAXE^ (!_UOM971+D&4 :I*//'D]--47%O_=DT9:U
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MV9CT1OY@?[S?[,?QP0YL\W)CWY=?[T-_QC/_ !)<LGR:,/-4UW_CII_KQ?\
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M_'&)M,X<*49)J>K_ /2O_P"C?_F7F-U^+LOX?A^AY1F2ZUZO_P!*_P#Z-_\
MF7F-U^+LOX?A^A*_RXN 8GC_ &@W+Z" /X9*;7A.R'OO.ES92&)HEY T&S;_
M "WPB(+$Y2#5-^8]1NS;GUT14>@ZGE7KT\<8@6F<C6Z/N[*'RO;^HL8=A0%C
MO4GO7L,C?$69 @%OE3S%-K,C!E58U7]D'[1(IO\ ?AE&D8YF23:[_P =-/\
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M8JR'R[KB1*;:Y_N6-0W>-O$>WCD".KGX,W#Z9<ON1VHZ.]C\7VHS]F1=U(P
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M_P"";'\P5]/\UWU>S_Y95_X)L?S!7T_S7>A9_P#+*O\ P38^.5]/\UWH6?\
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M^*/YOVM?7;3_ )95_P"#;#QE'C#^;]KOKMI_RRK_ ,&V/&5\8?S?M=]=M/\
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MM!_RRK_P;?TP\/FOCC^;]KO\;0?\LJ_\&W],'#YKXX_F_:[_ !O!_P LJ_\
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M[%78J[%78J[%78J[%78J[%78JM;I@53P(=BKL5=BKL5=BJC=6JW2\6_VLKG
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MKL*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5:W3
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M\&/\T?)W^'+;_?2?\",;*^#'^:/D[_#EM_OI/^!&-E?!C_-'R=_ARV_WTG_
MC'B*^#'^:/D[_#EM_OI/^!&/$5\&/\T?)W^'+;_?2?\  C'B*^#'^:/D[_#E
MM_OI/^!&/$5\&/\ -'R=_ANV_P!])_P(QXBO@Q_FCY._PW;?[Z3_ ($8\17P
M8_S1\G?X;MO]])_P(QXBO@Q_FCY._P -VW^^D_X$8\17P8_S1\G?X;MO]])_
MP(QXBO@Q_FCY._PW;?[Z3_@1CQ%?!C_-'R=_ANV_WTG_  (QXBO@Q_FCY-?X
M;MO]])_P(QXBO@Q_FCY._P -VW^^D_X$8\17P8_S1\G?X;MO]])_P(QXBO@Q
M_FCY._PW;?[Z3_@1CQ%?!C_-'R=_ANV_WTG_  (QXBO@Q_FCY._PW;?[Z3_@
M1CQ%?!C_ #1\G?X;MO\ ?2?\",>(KX,?YH^3O\-VW^^D_P"!&/$5\&/\T?)W
M^&[;_?*?\",>(KX,?YH^3O\ #=M_OE/^!&/$5\&/</D[_#=K_OE/^!&/$5\&
M/</D[_#=K_OE/^!&/$5\&/</D[_#5K_OE/\ @1CQ%?!CW#Y._P -6O\ OE/^
M!&/$5\&/</D[_#5K_OE/^!&/$5\&/</D[_#5K_OE/^!&/$5\&/</D[_#5K_O
ME/\ @1CQ%?!CW#Y._P -6O\ OE/^!&/$4^#'N'R=_AJU_P!\I_P(QXBO@Q[A
M\G?X:M?]\I_P(QXBOA1[@[_#-K_OE/\ @1CQ%?"CW!K_  S:_P"^4_X$8\17
MPH]P^3O\,VO^^4_X$8\17PH]P^3O\,VO^^8_^!&/$5\*/</D[_#-K_OF/_@1
MCQ%?"CW!W^&;7_?,?_ C'B*^%'N#O\,6O^^8_P#@1CQ%?"CW!W^&+7_?,?\
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M%X/]P_YJQ\ ^2_G(^?V?K=_BV+P?[A_S5CX!\E_.1\_L_6[_ !;%X/\ </\
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M\5Q>#_</^:L? /DOYN/G^/B[_%<7@_W#_FK'P#Y+^;CY_CXN_P 5Q>#?</\
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MKXT&8P.]^;GF/HX2;V2_R;_<M_KG_B*Y;GY_!QM%])]_Z QW7KMKF9ZG925
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M1$UDO^E^EF&L:;^E(P@:FX8'KX_US7PGP%WF;%XHKXI9Y6M_JKS)6O$J*_\
M!9=F-@%Q-+'A,A[OTI/Y@D,5RS#J"I^Y1F1B%Q<'4&ID^[[@R>YC778/A/7<
M>S#L<PP?#+MY 9X[)5I'E=H7#RTH.W6N73S6-G#PZ4Q-R0?FF="XCC ''[7$
M#J>WT99A!JRT:J0NH]$CS*=<]"O$-Y 1":%E''Y>'W;9J8^D[O3S'''T]VS'
MM*\N2QR*\@"JIY=0>GRS*GE!&SK,6FD#<MJ3+S>/W(_UQ^ILJP<_@Y6L^GX_
MK17_ !Z?\\?^-,A_%\?TMW^3_P S]# \V;SC.;61=;M^%=Z<6]F&:PCPY/11
M(SPI)(?*,I:C$!>Y!_5F2<P=?'1RO=3\P6,-C1(Z\NIWK09+%(RYL-1"./:/
M-D]VAO("(30LHX_+P_AF%'TG=W$QQQ]/=LQ_2O+DL<BO( JJ>74'I\LRIY01
MLZS%II W+:DQ\WC]R/\ 7'ZFRG#S^#E:SZ?C^M1M]%AU"#E& '(ZU;9N_?)'
M(8G=KC@CDC<>?QYK= TF>SDJ_P *;U%:U^[#DF)!&GQ2@=^2'\X7"R.J#JH-
M?IID\ V:]9($@=S'<RG5MXJ[%78J[%78J[%78J[%6\4NP*[%+L5=BKL5=BKL
M5;Q5V*NQ5V*NQ5V*NQ5O KL5=BKL5=BKL5=BKL4NQ5V*NQ5V*NQ5V*NQ5V*7
M8J[%78J[%78J[%6\5=BEV*NQ5V*NQ5V!78J[%78J[%78J[%78JNP)=BKL5=B
MKL5=BKL5=BKL4NQ5V*NQ5V*NQ5V*MX%=BKL5=BKL5=BKL5=BKL5=BKL5=BKL
M5=BKL4NQ5V*NQ5V*NQ5V*NQ5=@2[%78J[%78J[%78J[%78I=BK*KRV.J6Z>G
MU%-OD*',0'A.[MIQ\2(I*?\ #LW@/O&7>('#_+R=_AV;P'WC'Q OY>3:^7)B
M=P!](P>($_EY(SS5*/@3N*G(8@W:D\@Q[,EUSL595Y;_ +K_ &1_AF#EYNWT
MWT_%-LH<QV*NQ5V*NQ543IA2NPJ[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%5K=,"J>!#L5=BKL5=BJ1^</\ ><_,9F:;ZG5Z_P#N
M_B'GV;QY!V*NQ5V*NQ5V*NQ5V*NQ5V*NP*[%78J[%78J[%78JWBAV*NQ5V*N
MQ5K%6\5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL"NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5O%6UP,@W@9.Q5V*NQ5V*NQ5V*
MK\#-V*NQ5V*NQ5V*NQ5L8L@[ EV*NQ5V*NQ5V*MC%6\#)V*NQ5V*NQ5V*MXI
M=BKL5=BKL5=BKL5;P)=BKL5=BKL5=BKL5;&*6\"78J[%78J[%6L5=BK8Q5O%
M+L5=BKL51!U&5AQ+M2E*<C2F0X!W-OBRY6?FA\FU(B+4)(1Q5V '8,0,@8@]
M&T9)#8$_-#Y)J1'U^2G'FW&E*<C2GA3(\([FWQ)55GYJ*L4-1L<+ &DQ3S%<
M(*!S](!_$C*O"CW.4-3,=4#<7+7)Y.23[Y8!7)QY2,MRNAO9+<41F4>"DC 8
M@IC,QY$CXJ3N7-3N3U.28$VK6MZ]H:QL0?;(F(ES;(3,/I14VOSSBA<T]J#]
M5,@,8'1NEJ)RZH9;^1!Q#L!X<C3)\([FH9)#:S\V6>3O[EO]<_\ $5S S\_@
M[K1?2??^@)#<ZK+92R"-B!S;;J/M'L<RA 2 ON=;++*$I<)ZG[T%=ZC)>_WC
M$_J^[+8Q$>3CSR&?U%#9-J3&'7YX10.:>]#^L'*3C!Z.7'43'5#75Z]V:R,3
M\\F(B/)IG,SYE2CD,9JIH1T(PD6P!KDF'^(;BE.9^X?KIE7A1[G*_,S[T)'?
MR1UXNPJ:FC'<Y/A!:1DD.I^:B[ES4[D]3DFLFU:*^DA%%=@/ $C 8@M@R2'(
MGYNCO9(B2K,">I!._P \3$% F1R)^:G+*9CR8DD]SN<(%,22=RJVMZ]H:QL1
M\L!B)<V<9F'(HF;7IYA0N:>U!^K*QC Z-QU$Y=4ORYQ78JB[35I;,4C8@>'4
M?CE4H"7-OAFE#D6[G5I;K[;D_A^K$0 3+-*?,J4M]),*,[$>!).2$0&!F9<R
M?FW]?DIQYMQI2G(TIX4QX0OB2JK/S4,DUJD%RUN>2$@^V B^;*,C'<(UO,-P
MXIS/W ?C3*O"'<Y!U$SU2]F+FIW.7.*3:*M-5ELQ1&('AU'XY7* ES;X990Y
M%NYU:6Z^VY/X?JQ$ %EFE+F5*6]DF%&=B/ DG"(@,#,RYD_-UM>/:&J,1\L3
M$'FL9F')%R>8)Y!0N?H 'ZAD/#'<WG43/5+B>6YRUQFL4.Q5O%78J[%78J[%
M78J[%6\4NP*[%+L5=BKL5=BKL5;Q5V*NQ5V*NQ5V*NQ5V!6\5=BKL5=BKL5=
MBKL4NQ5V*NQ5V*NQ5V*NQ5V*78J[%78J[%78J[%6\5=BEV*NQ5V*NQ5V!78J
M[%78J[%78J[%78JNP)=BKL5=BKL5=BKL5=BKL4NQ5V*NQ5V*NQ5V*MX%=BKL
M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL4NQ5V*NQ5V*NQ5V*NQ5=@2[%78J[%7
M8J[%78J[%78I=BJ::-K!L#Q;=#U]O?*IPXG*PY>#W)]>I)<#U+=]OY=J?0<Q
MA0VD["8,MX%*[9[NX;C4BG4L !^K+CPAQ(G)(II=:B-+2CMS?_/[AE(CQ.7+
M)X8WW+$;BX-RQ=NIS- IT\I<1LJ>%B[%65>6_P"Z_P!D?X9@Y>;M]-]/Q3;*
M',=BKL5=BKL55$Z84KL*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5:W3 JG@0[%78J[%78JD?G#_ 'G/S&9FF^IU>O\ [OXAY]F\
M>0=BKL5=BKL5=BKL5=BKL5=BKL"NQ5V*NQ5V*NQ5V*MXH=BKL5=BKL5:Q5L8
MJ[%78J[%78J[%78J[%78J[%78J[%78%=BKL5=BKL5=BKL5=BKL5=BKL5=BKL
M5=BKL5=BKL5=BKL5=BKL5=BKL5=BK>*MC R#>!D[%78J[%78J[%78JOP,W8J
M[%78J[%78J[%7#%D&\"78J[%78J[%78J[%5V!D[%78J[%78J[%6\4NQ5V*NQ
M5V*NQ5V*MC EV*NQ5V*NQ5V*NQ5V*5V!+L5=BKL5=BK6*NQ5L8JWBEV*NQ5V
M*NQ5V*NQ5V!78J[%+L5=BKL5=BK>*78J[%5>&]D@%$9E'@I(R!B"V1F8\B1\
M5%W+FIW)ZG),";:PH=BK>!78I=BKL5=BKL5=BKL5;Q2[%78J[%78J[ KL4MX
MJ[%78J[%78J[%78J[ KL5=BKL4NQ5V*NQ5O%78J[%78J[%78J[%6\4NP*[%+
ML5=BKL5=BKL5;Q5V*NQ5V*NQ5V*NQ5V!6\5=BKL5=BKL5=BKL4NQ5V*NQ5V*
MNQ5V*NQ5V*78J[%78J[%78J[%6QBKL4NQ5V*NQ5V*NP*[%78J[%78J[%78J[
M%5V!+L5=BKL5=BKL5=BKL5=BEV*NQ5V*NQ5V*NQ5O KL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BEV*NQ5V*NQ5V*NQ5V*KA@2[%78J[%78J[%78J[%78I=
MBJY$,AH!4GM@2!;)]*TXZ8/4E?CXK7;Z??,64N+8.TQ8_#WD45!K<5V2@8J>
M@)VK\L@8$-HS1ELD.K:,]H2]>2_S=_IS(A,%P,N$QWYI5ESB.Q5V*LJ\M_W7
M^R/\,P<O-V^F^GXIME#F.Q5V*NQ5V*JB=,*5V%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78JM;I@53P(=BKL5=BKL52/SA_O.?F,S
M--]3J]?_ '?Q#S[-X\@[%78J[%78J[%78J[%78J[%78%=BKL5=BKL5=BKL5;
MQ0[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78%=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKABK8P)"[ S=BKL5
M=BKL5=BKL57#%FW@5V*NQ5V*NQ5V*N&*0W@9.Q5V*NQ5V*NQ5V*KL#)V*NQ5
MV*NQ5V*MXI=BKL5=BKL5=BKL5;P)=BKL5=BKL5=BKL5=BJ[ R=BKL5=BKL5:
MQ5V*MC%6\4NQ5V*NQ5V*NQ5V*NP*[%78I=BKL5=BKL5;Q2[%78J[%78J[%78
MJ[ K>*78J[%78J[%78J[%6\4NQ5V*NQ5V*NP*[%+>*NQ5V*NQ5V*NQ5V*NP*
M[%78J[%+L5=BKL5;Q5V*NQ5V*NQ5V*NQ5L8I=BKL"78J[%78J[%78JWBKL5=
MBKL5=BKL5=BKL5;P*[%78J[%78J[%78I=BKL5=BKL5=BKL5=BKL4NQ5V*NQ5
MV*NQ5V*MXJ[%+L5=BKL5=BKL"NQ5V*NQ5V*NQ5V*NQ5L8$MXJ[%78J[%78J[
M%78J[%+L5=BKL5=BKL5=BK>!78J[%78J[%78J[%7#%78J[%78J[%78J[%78I
M=BKL5=BKL5=BKL5=BJX8$NQ5V*NQ5V*NQ5V*NQ5V*78JR?1[9-.C]>3J?P!Z
M??F),\1H.TQ1&,<17W.IVMW]NII[-@$9!E+)"7/]*AZUEX?@V2J37>/\6CX-
M9@:D:G8[ $'^.5F!YN1'-'DQ_7-.^HO\/V6W'],R82X@Z[-CX"EN6N,[%65>
M6_[K_9'^&8.7F[?3?3\4VRAS'8J[%78J[%51.F%*["KL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL56MTP*IX$.Q5V*NQ5V*I'YP_WG
M/S&9FF^IU>O_ +OXAY]F\>0=BKL5=BKL5=BKL5=BKL5=BKL"NQ5V*NQ5V*NQ
M5V*MC%#L5=BKL5=BKCBK6*MXJ[%78J[%78J[%78J[%78J[%78J[ KL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK8P)"[ S
M=BKL5=BKL5=BKL57#%D&\"78J[%78J[%78JX8I#>!D[%78J[%78J[%78JNP)
M=BEV*NQ5V*NQ5L8I=BKL5=BKL5=BKL5;P*[%+L5=BKL5=BKL5=BJ[ R=BKL5
M=BKL5:Q5V*MC%6\4NQ5V*NQ5V*NQ5V*NP*[%78I=BKL5=BKL5;Q2[%78J[%7
M8J[%78J[ K>*78J[%78J[%78J[%6\4NQ5V*NQ5V*NP*[%6\4NQ5V*NQ5V*NQ
M5V*NP*[%78J[%+L5=BKL5;Q5V*NQ5V*NQ5V*NQ5O%78I=@2[%78J[%78J[%6
M\5=BKL5=BKL5=BKL5<,5;P*[%78J[%78J[%78J[%+L5=BKL5=BKL5=BKL4NQ
M5V*NQ5V*NQ5V*MXJ[%+L5=BKL5=BKL"NQ5V*NQ5V*NQ5V*NQ5L8$MXJ[%78J
M[%78J[%78J[%+L5=BKL5=BKL5=BKL"MXJ[%78J[%78J[%78J[%78J[%78J[%
M78J[%78I=BKL5=BKL5=BKL5;&!+>*NQ5V*NQ5V*NQ5V*NQ2[%5[2EA0DTP4F
MUF%#L5=BJYY3)U)/SP4DFUN%#L595Y;_ +K_ &1_AF#EYNWTWT_%-LH<QV*N
MQ5V*NQ543IA2NPJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%5K=,"J>!#L5=BKL5=BJ1^</\ ><_,9F:;ZG5Z_P#N_B'GV;QY!V*N
MQ5V*NQ5V*NQ5V*H^RT2:^%8T)'CT'WFF4RR"/,N5CT\\F\1^/BU>Z)-8BLB$
M#QZC[Q7&.02Y%<FGGC^H('+7%=BKL5=BKL5=BJ+N=+DM7$3K1S2@J.^PZ'*Q
M,2%AOGAE \)&Y4[NT:R<QR"C#J-CUW[9*,A(6&&2!QGAES4<DU.Q5V*NQ5&K
MHTSQ>N%_=_S5'8TZ5KE7B"^'JY0T\C'CK;OV0.6N*C+#3)-1)$2\B-SN!^O*
MY3$.;?BPRR_2+0\T)@8HVQ!((]QDP;W:I1,31Z+,+%V*JTUH\ 5F! ;=2>_R
MR(D"V2@8@$CGR4<DUNQ55M;5KM@B"K'H/]O(REPBRV0@9GACS6S0F!BC;$$@
MCW&$&]V,HF)H]%F%B[%78%5;6U:[8(@JQZ#_ &\C*7"++9"!F>&/-6M]*EN9
M#$BU=:U%1V-#O6F1,P!;9'#*<N #<>[HA,L<=V*NQ5V*IM'Y6N90&";$5'Q+
M_7,<YXCK][L!H\AWX?M'ZUEQY<N+<5:,T]J-^HG",T3U8RTF2.YC^G[DLR]P
M41>V#V!"R"A(Y#<';Z,A&0ER;LF(XS4O>A\FTNQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*NQ5L8%78&QV*NQ5V*NQ5V*NQ5<,60;P)=BKL5=BKL5=BKABD-X&3L
M5=BKL5=BK:KRV&*1NB+[3WL&XR"A(KU!V^C(1D)<FW)C.,U)0R34[%*M:VCW
MC<8P2?;(RD(\VR$#,U%N]L7L6X2"AI6E0?U8QD)<DSQG&:DH9)J=BK8Q5V*5
M5;9G4N >(ZMV&1L<F8@2.+HOL[%[YN$8J:5I4#]>"4A'FRAC.0U%#Y-J=BKL
M5;P*[%+L5=BKL55K2T:\;@@JQ[;#]>1E(1W+9"!F:BF'^%[G^3_AE_KE/C1[
MW*_*3[OM'ZT%=Z?)9_WBD?J^_+8R$N3CSQ2A]0=963WS<8Q4TK2H'Z\92$>:
MPQG(:BH9)K=BKL5=BK6*NQ5L8JWBEV*NQ5V*NQ5V*NQ5V!78J[%+L5=BKL5=
MBK>*NQ2[%78J[%78J[%78JW@2[%78J[%78J[%78JWBEV*NQ5V*NQ5V!7#%4=
M;:/-="J(2/'I^O*S,!R(X93Y!9=Z7+9[NI \>H^\81,2Y(GBE#F$+DVEV*NQ
M562R=T,H'P*:$U'^??(\0NFP0)'%T4<DUKE4N:#J<"0+730M >+"A'8X ;28
MF.Q7SV;VZJS"@857IO@$@64H&(!/7DH9)@[%78JJV]NURP1!5CT& FF<8F1H
M+9(S$2K=0:'YC$&T$5LMPL78J[%78J[%52WMVN6"(*L>@R)-,XQ,C0:DC,1*
MMU!H?F,(-H(HTMPH=@2[%78J[%78J[%6\5=BKL5=BKL5=BKL5<,5;P*[%78J
M[%78J[%78J[%+L5=BKL5=BKL5=BKL4NQ5V*NQ5V*NQ5V*MXJ[%+L5=BKL5=B
MKL5=@5%6NFR7?V%)'CV^\Y R ;8XS/D%USI$MJ*NI \>OZL F"REBE'F$'EC
M0[%78J[%6Q@2WBKL5=BKL5=BKL55(+=K@T0$GKM@)IG&)ER6RQ&$\6%".V(-
MH(KFB9-+DB3U"OP&AK4=^G?(B0)IM.(@<71"9-I=BKL5=BKL5=BK>!78J[%7
M8J[%78J[%78J[%78JKK9.R\PIX^--LCQ!LX#5TMM[=KE@B"K'H,2:1&)D:"Z
MZM&M#Q<4/7Q_5B#:90,-BH9)K=BEV*NQ5V*NQ5V*NQ5L8$MXJ[%78J[%78J[
M%78J[%+L5=BKL5=BKL5=BKL5=BK*O+?]U_LC_#,'+S=OIOI^*;90YCL5=BKL
M5=BJHG3"E=A5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*K6Z8%4\"'8J[%78J[%4C\X?[SGYC,S3?4ZO7_P!W\0\^S>/(.Q5V*NQ5
MV*NQ5V*IKY;TT:E,%;[(^)OD/[<Q\T^ .?I,7BSH\N95M<\P273E48K&IHJK
MMT^60Q8A$;\VS4ZJ4S4341RIO0_,36C<926B.S _%]V.7#Q#;FNGU1@:F;CU
MZH,6'Z0F,=ONI)XUVH/?Y99Q< N3C^'XL^''\$R_PS%7@;A.?2E._A7EE'C'
MGPES?RD;KQ!?X\TNFT9K><6[FA+*O(;BC&E<O&0&/$'"E@,9C&>I&_O3)?*)
M4MZDBH@/$.VW+Z*_QRCQ^X67-&AHGBD !U/]J6Z1HKZH3QHJK]IST&7Y,@@X
M>#3G-RV YE''RRLU1!,DCC]GH3\MSE/C$?5$AR?R@E]$Q(]R*\UH7NT -"0E
M#X?$=\A@^@_%OUHO+&OZ/WI1KUNT$[([%VV^*E":J.V9&(@QL;.OU,3&9!/$
M=M_@$>OE<0*#<2K$3T4[G]8RKQ[^D6Y7Y/A'[R0CY?@H/5=!;3P'!#QGHZ],
MLAE$]N1<?/ICB'%SB>H2O,AP'8JSS0YU2VAC?[,A>,_26S491ZI$=*/W/5Z:
M0&.$3REQ1_W3";RU-H[1GJI(S:QEQ"WF<D. F)Z,P\KJ-/C2OVIF_P"%4'_/
MZ<UF?UD_T0]%HQX48]\S]@'X^;&-3B,UQ(JBI,C #_9',^!J(]P=%FB99) ?
MSC]Z8_X82'X99T1_Y>M/F:C*?&)Y1)#F_DQ':<X@]WX*#N-$-G*(IF"J=Q)U
M%/'+!DXA8^3C2TWARX9F@?XF0:WIT4D,(:4 *IX&GV]E]]LP\<R"=NOR=OJ,
M43"%SJAMMSY>;'-)T5M2J:A47[3MT&9N3)P.GP:<YM^0',E,$\KI<U$,ZNX%
M>-*?Q.4G.1]42'+&C$_HF">[\%"^6D*72 ]02#]QRS-O$M&D%9(CW_<4PU#R
M\OJ.\TJQ\G8J#N:<COU&4PR[ 1%[!R\NE'$93D(W(U\TMU;0&TX"0$/&W1UR
M_'E$]N1<+/ICB'%=Q/4-:5H+:@"Y(2,=7;IC/*(;<RN#3'*.+E$=2C&\KB=2
M;>592.JC8_K.5^-7U"G(_)\0_=R$O+\%"^6!2YC!\3^HY/-]):-'_>1^/W%'
M6-J]U>2K&YC/)_B K^UT[95*0C 6+Y?<Y..!GEF(RX=Y;_%(K*R:^<1H*L<R
MY2$19=7CQG(>&*=GRO&IX&=!)_+3OX5KF+XQY\)IVGY.(/#XD;[OP4GU'3GT
MYS')U_ CQ&9,)B8L.MRXCB/#)"Y-H99YKF:**WXDCX3T-.R9K\ LR_'>[_6R
M,8XZ[O\ B4CL-<EL6#!B1W4FH.94L8DZS%J98S=GW)EYOLUC9)D%!(.7T[;_
M (Y3IY$@Q/1S-=C (G'^((7S%9O!(JNYD8H*&E.I.V3PR!&PK=IU>.49 $\6
MP^\H@^6$MZ">94<C[-*T^>XR'C$_3$EM_)B/US$3W?@H'5]%;3*$D,C?99>A
MR['D$W%SZ<X?,'D0JZ?H!N4]61Q''V9N_P AD9Y:- 66>+2\8XY$1CWE=?\
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M:D"WX8F>.0'?^I13R\L]1'*K./V?[:Y+Q:YA@-.)?3($]R&T>T623XWX%6%
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M/R/ZF]3U5%N%GB/*@%=B*G<'K[8P@>'A*<N8<8G'=4F%IJ+%^31LVY!&U?\
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MF6(\.._>QNVEENI!0DN3M4]_',H@ .LB92/FG-_8JM#<S$FFP RB,OYH<[)
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MXBG$;[=QD")3V.S9"6/">($R/R2&60RDL>I-3].98%.L)LVF'E^[6SF#N:*
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MT&_V.TB\2V256-"R47KN:'&<22%PS$1*^H7:3?QI&\,U0K;U';!.)NPRPY
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M6J(L?HS+R2M13J,IE#>PYD,HKAD+"M'JT-@#]71N9%.3]ONR)@9?4V#+&'T
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MK\T3 EB1X'OEIQ@N+'/('FK>9[80RU7]H5/SP8C8;-3&I>]9%Y>D< L56O\
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MC, 5$$MN3$9&\DHCR5=:14M8@C<P&(#=*_:P8_J+/. ,<:-[\_FLUNX9+:!
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M82D/<DT$[0,'4[@UR\BW!C(Q-A-++6Z3^M(!N*'C^O*98]J#EPS^OBE]BO\
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MQ5O%78I=BKL5=BKL5=@5V*NQ5V*NQ5.[VX5K2-01R#;BN_[7;,>(]1<^<@8
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MB;O0)[(<G0@>(H?U$Y".6,N1;YZ6>,7*/Z?N5?*_^],?S/\ Q$Y'-])9Z/\
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MDTV215=5)#'BM.Y^77!Q@)&*1 ('/DJW.AS6J\W0A?'8_JP#()<F<]/* LA
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MS2?5\$JM;1[L\4%32O8;?3EYD(\W"A SV"(@T2:X7DJ&GT#]>0.0!MC@E(6
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M;:#TKA*@&JR5Y4]O]O+\?"97'Y.'G\2$.#(+WVES7V-PQL9CR-0RT-=^J8)
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MT((R,9>'Z9,\F+\QZX$>80ESI4>FQ-ZI!E/V54_9]SE@F9G;DT3PC%'U?5T
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MMTP99$2BG2P$L>0D#8?H+',S73,DTVU1[&5RH+!MFH*C['?,*<CQ@?CJ[G#
M'#*5"[Y_)"V%NNH0.H ]2/XP0-V7N#XTR<CPR'<=FG%$98$5ZH[^\)1F0X#L
M5=BKL5=BKL5=BJX8LV\"NQ5V*NQ5V*NQ5PQ2&\#)V*NQ5='&9"%&Y)H,!-)
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M"/%$\4?)'^4E5H)PYHI'Q'P'$U.59_JC3EZ$ PG?+K\B@OT?9?[_ &_X!O\
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M$PY!#8][M-9ISEHQY@;A!Z!I+:2QN;CX%0&@/4D[99ER<?ICNX^FP'"?$R;
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MA_O5^@P_7[6:!*<R0P'C2G],CE/#(2/)GIH^)CGC'/G]WZE3RYH4EK,LLPX
M&@KU9CM08,V42%#=EI--*$A*>WZ2H66H"POG9ME+NI/A5C_')RAQ0'N#5CRC
M%FD3RXI#[5+4/*DT3GTUY(352*=#AAG!&[#+HI@^D6.B9W>G?HZQ="06Y O3
MLQ*[?=3*(SXYVYL\7A83'K8O[$#=_P#'/C_XR'_C?+H_WA]WZG%G_<1_K?\
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M]KO\"'_?@_X'^W'\WY+_ "8?YWV?M=_@0_[\'_ _VX_F_)?Y,/\ .^S]KO\
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M]KO\"'_?@_X'^W'\WY+_ "8?YWV?M=_@0_[\'_ _VX_F_)?Y,/\ .^S]KO\
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MO\$'_?@_X'^W'\UY+_)Q_G?9^UW^"#_OP?\  _VX_FO)?Y./\[[/VN_P0?\
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M ?++@*<*1LVRJX_-*6ZMC:R1JU4]-G)/([4Y?/O\\APMWBV*>B_EE_QSH?\
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M[E2>IR!B"VB9"09-J1%AJ$FG.)86*N.C#!5L@:9E#^;][&O$B-C_ #%37\&
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MH:)YGN- Y?5GX<Z<OA5J\:T^T#XG$BT1D8\D)J>IR:M(TTS<I&IR:@%:  ;
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M3,=SWA/YGZ#'H]U^Z 5)%Y\1T4U(-/;:N9$3;K\L:+#<L:'8J]L_*3_>(_\
M&1OU+F+/FY^+DS?*V]V*NQ5V*NQ543IA2NPJ[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%5K=,"J>!#L5=BKL5=BK#?S5_WA;_ %U_
M7ED.;3EY/#LRG7NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5/\
M4_/5[JT;0S2\HVIR7B@K0@C<*#U&0$0&TS)2#)M3L5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKU'RE
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MNCC;E3KMV(R8-M$X<+T;S3_QPX_^,4'_ !IE8YN3+Z?DPWR9^7K>84,\K^G
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MR? &DY2S:_@3SCIGUF9 LOILZM3[+)7H>O%J?<<AR+>?7%!_E)_O!+_QE?\
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M5V*NQ5V*NQ5V*NQ5V*IAY?\ ]Z8?^,J?\3&1+./-Z]Y]UC]#7=E,310TBO\
MZK>F#_7*8BW-F:(9 WEU&O1?=Q&8_IKLW_ U&1MLX=[8_P"0=8_35W>S?LEH
MPG^JOJ!?U5R4A35 V2QOR!&K:M.6ZCU2OS]0#]1.2ER:\?U%,/.&GZ5<73M>
M7$J3;<E4'B!Q%*?NF[>^ 6RF(WN7>:O,-E=:<;:*1G*J@C+))4\".K%%7IB
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M2IZD!KMW6O6E=B#X891MC#)P[)]'^95CI(9K*V*R-UJ%0?>I8T]MLCPDMOB
M<@PVPU*[U:]$\7Q7+,67H.@Z;]N(I3PR=4&@$DVS_6_/PL^*7]D/6 Y*&*,O
MS4D&GXY6(]SD2R5S"9ZKJKWVCO/. K.A-!L*,_P#_@:8 -V9-QW8=Y&\^0>7
MK9X)5<LSLP*!2*%%7NP\,G*-M$)B(2?R7YWD\KL13G$Q^)*TW\5/C^O)2C;"
M$^%E<?YD:?8L9K>U(F-:FB+N?\H$]>^V0X2W>(!R#")_-L\UV+XD>H#4#]D
M;<?E3;^W+*Z./QF[9G<_F#IVM4>]MF,@%*KQ;\>2&F5\)#?X@/,)/YQ_,+]-
MQ"UMX_3@%-C2I"_9%!L ,D(TPGDXM@PG+''=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL59MY._,E_+Z>A(OJ
M0_L[T9:]:>(]OQRLQMR(9.%D*_F3ID!]2.U(DZ\O3B4U_P!8&N0X2V>(.YA7
MF_SG+YH<%APC7[" UI7N3W.6"--$Y\2>_F!Y\@\S0I'"K@J_(\PH%.)'9CXY
M&,:;,DQ(.\C>?(/+UL\$JN69V8% I%"BKW8>&,HVL)B(23R'YCC\N7!FE#%>
M!6B $U)'B1X9*0MKA+A*KJGG -J)U"W!I52%?8D! C T)Z[X@;4DSWL,FU3\
MP=-U:DL]LSR@4%>-/&G+EN/]CD!$AM.0'HH^8/S*@UNQ:V*.DC ?9"^F.+A@
M*\JTH/#$1HK+()"D+IWGR"UTPV+*_JE)%Y +PJ[,1ORKW\,)CO;$3 %.\C>?
M(/+UL\$JN69V8% I%"BKW8>&,HVL)B(8!EKC,U_+OSE#Y7]7UE=O4X<> 4_9
MY5K5E_FRN0MOQSX4AAU9([T71!X"834VY<?4Y>-*T]\E6S"][\TZ_,/SA#YG
M:(PJXX!@>84?:ITHS>&1B*9Y)\2.U'SY!=:8+%5?U0D:\B%X51E)WY5[>& 1
MWMD9@BD%Y,_,)O+R&"5/4@-=NZUZTKL0?##*-L89.'9/H_S*L=)#-96Q61NM
M0J#[U+&GMMD>$EM\0#D&#P^8&FO$O+@EB)4D?CX*P-%'R%!EE;./Q;V4Z_,+
MSA%YF:)H Z\ U>8 ZTI3BS>&1B*9Y)\2:V'YG0WL(AU*'U>/[8"FOO1J4/N#
M@X>YF,M_4I:Q^9$4<#6VGP^BK5#,0JFAZT"UW/B3B(]ZG)M44D\E^=Y/*[$4
MYQ,?B2M-_%3X_KR4HVUPGPLKC_,C3[%C-;VI$QK4T1=S_E GKWVR'"6[Q .0
M85)YNFEO!?-0R!@0/V>(VX_*FWXY.MJ:./>V;:C^9=AJBAY[8O*OV0P0J/\
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MBPEDL4$N\A>:E\LSF20,8V4JP2A/B#N1AD+8XY<)1WYA>>$\S^FL(942I(<
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M[8\/FOBCN#O\56W_ "Q0_>V/#YKXH[@[_%5M_P L4/WMCP^:^*.X._Q5;?\
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M[8\/FOBCN#O\56W_ "Q0_>V/#YKXH[@[_%5M_P L4/WMCP^:^*.X._Q5;?\
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M[8\/FOBCN#O\56W_ "Q0_>V/#YKXH[@[_%5M_P L4/WMCP^:^*.X._Q5;?\
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M[8\/FOBCN#O\56W_ "Q0_>V/#YKXH[@[_%5M_P L4/WMCP^:^*.X._Q5;?\
M+%#][8\/FOBCN#O\56W_ "Q0_>V/#YKXH[@[_%5M_P L4/WMCP^:^*.X._Q5
M;?\ +%#][8\/FOBCN#O\56W_ "Q0_>V/#YKXH[@[_%5M_P L4/WMCP^:^*.X
M._Q5;?\ +%#][8\/FOBCN#O\56W_ "Q0_>V/#YKXH[@[_%5M_P L4/WMCP^:
M^*.X._Q5;?\ +%#][8\/FOBCN#O\56W_ "Q0_>V/#YKXH[@[_%5M_P L4/WM
MCP^:^*.X._Q5;?\ +%#][8\/FOBCN#O\56W_ "Q0_>V/#YKXH[@[_%5M_P L
M4/WMCP^:^*.X._Q5;?\ +%#][8\/FOBCN#O\56W_ "Q0_>V/#YKXH[@[_%5M
M_P L4/WMCP^:^*.X._Q5;?\ +%#][8\/FOBCN#O\56W_ "Q0_>V/#YKXH[@[
M_%5M_P L4/WMCP^:^*.X._Q5;?\ +%#][8\/FOBCN#O\56W_ "Q0_>V/#YKX
MH[@[_%5M_P L4/WMCP^:^*.X._Q5;?\ +%#][8\/FOBCN#O\56W_ "Q0_>V/
M#YKXH[@[_%5M_P L4/WMCP^:^*.X._Q5;?\ +%#][8\/FOBCN#O\56W_ "Q0
M_>V/#YKXH[@[_%5M_P L4/WMCP^:^*.X._Q5;?\ +%#][8\/FOBCN#O\56W_
M "Q0_>V/#YKXH[@[_%5M_P L4/WMCP^:^*.X._Q5;?\ +%#][8\/FOBCN#O\
M56W_ "Q0_>V/#YKXH[@[_%5M_P L4/WMCP^:^*.X._Q5;?\ +%#][8\/FOBC
MN#O\56W_ "Q0_>V/#YKXH[@[_%5M_P L4/WMCP^:^*.X._Q5;?\ +%#][8\/
MFOBCN#O\56W_ "Q0_>V/#YKXH[@[_%5M_P L4/WMCP^:^*.X._Q5;?\ +%#]
M[8\/FOBCN#O\56W_ "Q0_>V/#YKXH[@[_%5M_P L4/WMCP^:^*.X._Q5;?\
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MOV34$@@=NAR4)6PS0 W")TORU:>6+07E\GJ.P%$.X'+<*!TK3K7I@))-!E&
M@+DB;72K#SU"YMXQ#,G@ M">E0NQ4T^>"S%D(QR#;9B/DGRC^F[EHYJA(MY
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M%78JM;I@53P(=BKL5=BKL58;^:O^\+?ZZ_KRR'-IR\GAV93KW8J[%68^:O\
M>:R_XPG_ (ED(]6S+R'N8OEKC.Q5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*O;(W.
MC:.&BV;T0P([&3<G_ALQ>9=G],/@\3ZYE.L3\>=KKT/JI8&+CPH5!/'Y]<AP
MAN\0U3*_RW\L0F%KZY 8+7@&W ""I:G?^S*YGHWX8"N(HS2OS*BUB9;:6!1$
MYX)6C4KL*BE-_P /? 84SCF$C5,7_,;RPF@S@Q;1R L%_E(Z@>W3+(&W'RPX
M3L]*\]ZI#I$23RQB5@U(U;IR(ZGY 91$6YN20B+4=$O(//%J7GB "L48>!4
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M\WGF7.&[%78J[%78J[%78J[%78J[%78J[%78J[%78JGODO71H5TDK?8-4?\
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MW3;[ER$1L6W(;D L_->Y^J3VLG\I+?\  LAQ@N8T0F/Y@:(_FJ"&>T^/C4@
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MG+(]4HT[5)-,D$T3<9%K1J ]00>M1T.2(MK$JW7ZOK,VLOZL[<GIQK11L/\
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MCR3&_P#.][J"\))F*G8A0JU^?$#(B(#,Y">J!T?6YM$<R6[<6(XDT5MJ@_M
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MH)&4=>.Q7_@348D6L9F/)O5O-%SK XSR,R_R[!?N6@Q$0$RF9<U;RCIL.IW
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M>%?$/D[_ )61<_RP_P#(M<>%?$/D[_E9%S_+#_R+7'A7Q#Y._P"5D7/\L/\
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M%S_+#_R+7'A7Q#Y._P"5D7/\L/\ R+7'A7Q#Y._Y61<_RP_\BUQX5\0^3O\
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M>%?$/D[_ )61<_RP_P#(M<>%?$/D[_E9%S_+#_R+7'A7Q#Y._P"5D7/\L/\
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M%S_+#_R+7'A7Q#Y._P"5D7/\L/\ R+7'A7Q#Y._Y61<_RP_\BUQX5\0^3O\
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M>%?$/D[_ )61<_RP_P#(M<>%?$/D[_E9%S_+#_R+7'A7Q#Y._P"5D7/\L/\
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M%S_+#_R+7'A7Q#Y._P"5D7/\L/\ R+7'A7Q#Y._Y61<_RP_\BUQX5\0^3O\
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M,W^^W_X%OZ8VO"7?HF;_ 'V__ M_3&UX2[]$S?[[?_@6_IC:\)=^B9O]]O\
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M_P!]O_P+?TQM>$N_1,W^^W_X%OZ8VO"7?HF;_?;_ / M_3&UX2[]$S?[[?\
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M_OM_^!;^F-KPEWZ)F_WV_P#P+?TQM>$N_1,W^^W_ .!;^F-KPEWZ)F_WV_\
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M]$S?[[?_ (%OZ8VO"7?HF;_?;_\  M_3&UX2[]$S?[[?_@6_IC:\)=^B9O\
M?;_\"W],;7A+OT3-_OM_^!;^F-KPEWZ)F_WV_P#P+?TQM>$N_1,W^^W_ .!;
M^F-KPEWZ)F_WV_\ P+?TQM>$N_1,W^^W_P"!;^F-KPEWZ)F_WV__  +?TQM>
M$N_1,W^^W_X%OZ8VO"7?HF;_ 'V__ M_3&UX2[]$S?[[?_@6_IC:\)=^B9O]
M]O\ \"W],;7A+OT3-_OM_P#@6_IC:\)=^B9O]]O_ ,"W],;7A+OT3-_OM_\
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M[?\ X%OZ8VO"7?HF;_?;_P# M_3&UX2[]$S?[[?_ (%OZ8VO"7?HF;_?;_\
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MKDN -?BE;_RM&_\ YU_X!?Z8\ 7Q2[_E:-__ #K_ , O],> +XI=_P K1O\
M^=?^ 7^F/ %\4N_Y6C?_ ,Z_\ O],> +XI=_RM&__G7_ (!?Z8\ 7Q2[_E:-
M_P#SK_P"_P!,> +XI=_RM&__ )U_X!?Z8\ 7Q2[_ )6C?_SK_P  O],> +XI
M=_RM&_\ YU_X!?Z8\ 7Q2[_E:-__ #K_ , O],> +XI=_P K1O\ ^=?^ 7^F
M/ %\4N_Y6C?_ ,Z_\ O],> +XI=_RM&__G7_ (!?Z8\ 7Q2[_E:-_P#SK_P"
M_P!,> +XI=_RM&__ )U_X!?Z8\ 7Q2[_ )6C?_SK_P  O],> +XI=_RM&_\
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M )6C?_SK_P  O],> +XI=_RM&_\ YU_X!?Z8\ 7Q2[_E:-__ #K_ , O],>
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M_P K1O\ ^=?^ 7^F/ %\4N_Y6C?_ ,Z_\ O],> +XI=_RM&__G7_ (!?Z8\
M7Q2[_E:-_P#SK_P"_P!,> +XI=_RM&__ )U_X!?Z8\ 7Q2[_ )6C?_SK_P
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M"FPRER6)_F1IIN;;UH_[R!A*I]A]K^OT9.):L@V1>J>9UBT\WB[<HP5_UWV
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M?%+O^5HW_P#.O_ +_3'@"^*7?\K1O_YU_P" 7^F/ %\4N_Y6C?\ \Z_\ O\
M3'@"^*7?\K1O_P"=?^ 7^F/ %\4N_P"5HW_\Z_\  +_3'@"^*7?\K1O_ .=?
M^ 7^F/ %\4N_Y6C?_P Z_P# +_3'@"^*7?\ *T;_ /G7_@%_ICP!?%+O^5HW
M_P#.O_ +_3'@"^*7?\K1O_YU_P" 7^F/ %\4N_Y6C?\ \Z_\ O\ 3'@"^*7?
M\K1O_P"=?^ 7^F/ %\4N_P"5HW_\Z_\  +_3'@"^*7?\K1O_ .=?^ 7^F/ %
M\4N_Y6C?_P Z_P# +_3'@"^*7?\ *T;_ /G7_@%_ICP!?%+O^5HW_P#.O_ +
M_3'@"^*7?\K1O_YU_P" 7^F/ %\4N_Y6C?\ \Z_\ O\ 3'@"^*7?\K1O_P"=
M?^ 7^F/ %\4N_P"5HW_\Z_\  +_3'@"^*7?\K1O_ .=?^ 7^F/ %\4N_Y6C?
M_P Z_P# +_3'@"^*7?\ *T;_ /G7_@%_ICP!?%+O^5HW_P#.O_ +_3'@"^*7
M?\K1O_YU_P" 7^F/ %\4N_Y6C?\ \Z_\ O\ 3'@"^*7?\K1O_P"=?^ 7^F/
M%\4N_P"5HW_\Z_\  +_3'@"^*7?\K1O_ .=?^ 7^F/ %\4N_Y6C?_P Z_P#
M+_3'@"^*7?\ *T;_ /G7_@%_ICP!?%+O^5HW_P#.O_ +_3'@"^*7?\K1O_YU
M_P" 7^F/ %\4N_Y6C?\ \Z_\ O\ 3'@"^*7?\K1O_P"=?^ 7^F/ %\4N_P"5
MHW_\Z_\  +_3'@"^*7?\K1O_ .=?^ 7^F/ %\4N_Y6C?_P Z_P# +_3'@"^*
M7?\ *T;_ /G7_@%_ICP!?%+O^5HW_P#.O_ +_3'@"^*7?\K1O_YU_P" 7^F/
M %\4N_Y6C?\ \Z_\ O\ 3'@"^*7?\K1O_P"=?^ 7^F/ %\4N_P"5HW_\Z_\
M +_3'@"^*7?\K1O_ .=?^ 7^F/ %\4N_Y6C?_P Z_P# +_3'@"^*7?\ *T;_
M /G7_@%_ICP!?%+O^5HW_P#.O_ +_3'@"^*7?\K1O_YU_P" 7^F/ %\4N_Y6
MC?\ \Z_\ O\ 3'@"^*7?\K1O_P"=?^ 7^F/ %\4N_P"5HW_\Z_\  +_3'@"^
M*7?\K1O_ .=?^ 7^F/ %\4N_Y6C?_P Z_P# +_3'@"^*7?\ *T;_ /G7_@%_
MICP!?%+O^5HW_P#.O_ +_3'@"^*7?\K1O_YU_P" 7^F/ %\4N_Y6C?\ \Z_\
M O\ 3'@"^*7?\K1O_P"=?^ 7^F/ %\4N_P"5HW_\Z_\  +_3'@"^*7?\K1O_
M .=?^ 7^F/ %\4N_Y6C?_P Z_P# +_3'@"^*7?\ *T;_ /G7_@%_ICP!?%+O
M^5HW_P#.O_ +_3'@"^*7?\K1O_YU_P" 7^F/ %\4N_Y6C?\ \Z_\ O\ 3'@"
M^*7?\K1O_P"=?^ 7^F/ %\4N_P"5HW_\Z_\  +_3'@"^*7?\K1O_ .=?^ 7^
MF/ %\4N_Y6C?_P Z_P# +_3'@"^*7?\ *T;_ /G7_@%_ICP!?%+O^5HW_P#.
MO_ +_3'@"^*7?\K1O_YU_P" 7^F/ %\4N_Y6C?\ \Z_\ O\ 3'@"^*7?\K1O
M_P"=?^ 7^F/ %\4N_P"5HW_\Z_\  +_3'@"^*7?\K1O_ .=?^ 7^F/ %\4N_
MY6C?_P Z_P# +_3'@"^*7?\ *T;_ /G7_@%_ICP!?%+O^5HW_P#.O_ +_3'@
M"^*7?\K1O_YU_P" 7^F/ %\4N_Y6C?\ \Z_\ O\ 3'@"^*7?\K1O_P"=?^ 7
M^F/ %\4N_P"5HW_\Z_\  +_3'@"^*7?\K1O_ .=?^ 7^F/ %\4N_Y6C?_P Z
M_P# +_3'@"^*7?\ *T;_ /G7_@%_ICP!?%+O^5HW_P#.O_ +_3'@"^*7?\K1
MO_YU_P" 7^F/ %\4N_Y6C?\ \Z_\ O\ 3'@"^*7?\K1O_P"=?^ 7^F/ %\4N
M_P"5HW_\Z_\  +_3'@"^*7?\K1O_ .=?^ 7^F/ %\4N_Y6C?_P Z_P# +_3'
M@"^*7?\ *T;_ /G7_@%_ICP!?%+O^5HW_P#.O_ +_3'@"^*7?\K1O_YU_P"
M7^F/ %\4N_Y6C?\ \Z_\ O\ 3'@"^*7?\K1O_P"=?^ 7^F/ %\4N_P"5HW_\
MZ_\  +_3'@"^*7?\K1O_ .=?^ 7^F/ %\4N_Y6C?_P Z_P# +_3'@"^*7?\
M*T;_ /G7_@%_ICP!?%+O^5HW_P#.O_ +_3'@"^*7?\K1O_YU_P" 7^F/ %\4
MN_Y6C?\ \Z_\ O\ 3'@"^*7?\K1O_P"=?^ 7^F/ %\4N_P"5HW_\Z_\  +_3
M'@"^*7?\K1O_ .=?^ 7^F/ %\4N_Y6C?_P Z_P# +_3'@"^*7?\ *T;_ /G7
M_@%_ICP!?%+O^5HW_P#.O_ +_3'@"^*7?\K1O_YU_P" 7^F/ %\4N_Y6C?\
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M7A/YCZJ=6O61=Q'^Z4>X^U]/+;,J H.!D-E[%Y;T5=#MT@7JH^(^+'[1^_\
M#,8FW-B*":8&3L5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKQG\V="%C<+<(*+*/B
M_P!=>OWBGTUS(@7"RQHV]"\@:N=6LXV8U9?W;?->GX4RJ0HN3 V&29!L=BJH
MG3"E=A5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*K
M6Z8%4\"'8J[%7S_Y47]*:C$6_:E]0_15_P"&94M@Z^.Y?0&8KL'8J[%5.6X6
M+J<%II#G4U[ X+337Z3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=
M^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UI
MWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6
MG?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM
M:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&
MUIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<
M;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!
MQM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX
M'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'
M@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,
M>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^D
MQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ
M3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?
MI,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=
M^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UI
MWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6
MG?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM
M:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&
MUIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<
M;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!
MQM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX
M'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'
M@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,
M>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^D
MQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ
M3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?
MI,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=
M^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UI
MWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6
MG?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM
M:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&
MUIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<
M;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!
MQM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX
M'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'
M@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,
M>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^D
MQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ
M3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?I,>!QM:=^DQX'&UIWZ3'@<;6G?
MI,>!QM:5H[U9.]/GAM:5\+%V*NQ5A'YLV@FLN?='5OOJO\<LAS:,HV2S\F+G
ME'-'_*RM_P $"/\ C7)9&.$O2LI<EV*JB=,*5V%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78JM;I@53P(=BKL5> ?EY_O?#\V_P"(
M-F5/DZ_'S>_YBNP=BJ$O;OTOA'7]61)9 )837(LW8%=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL51=G
M></A;I^K) L2$SR;!V*L2_-#_>"3YI_Q,99#FTY.3&OR5_X^/^>?_,S)Y&K#
MU>I90Y;L55$Z84KL*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*NQ5:W3 JG@0[%78J\ _+S_>^'YM_Q!LRI\G7X^;W_ #%=@TS<17PQ
M5(W?F:GOE;:U@5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5P%<*II!IZQBK_P!@R8#&U_JPG;;[L.RJ-UIPIR3[OZ8"%!2]5Y&@ZY!D
MFL5BEN*ON??IDZIC;?UF)MMONPV%4;O3P!R3[L!"@I=E;)V*NQ5V*IM92^HO
MRVRP,"B,+%B7YH?[P2?-/^)C+(<VG)R8U^2O_'Q_SS_YF9/(U8>KU+*'+=BJ
MHG3"E=A5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MK6Z8%4\"'8J[%7@'Y>?[WP_-O^(-F5/DZ_'S>_YBNP4KK[!^6 I"396V.Q5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5+=6U^#1Q^^< GHO5C] R8
MB2PE,1YI(OYE6C&GQ@>/$4_77+/#+5XP9#INK1:HO.%@P[TZCYCJ,J(IN$A+
MDB9)1%NQ 'OM@9.CE$NZD$>V^*K\"NQ5V*NQ5V*J<DZQ?:('S-,*KD<2"H-1
MXC%5V!78J[%78J[%78JDU_YNM=.<Q2R<76E1Q<]17LI\<L$"6HY -BG.5MKL
M5=BKL5=BJ1:IYRMM+;@[U8=50<B/GVRP0):I9!%!6WYC6DYH2R?ZR_\ -).2
M.,L!F!9-!.MPH="&4]"-P<J<@&U3 KL5=BJ5:IYFM])8),_%B.0'%CMN.P/A
MDQ$EKE,1YIA;W"W*JZ&JL RGQ!W&1Y-@-JN!78J[%5%+I)#0,"? $8:6U#5-
M7BTE0\S<5)X@T)WW/8'PP@6QE(1YNTO5XM64O"W)0>)-"-]CW \<2*6,A+DC
M<BR=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BJ*TV/F_RWR00535)BS<>PPR*A
M J.6PR*4]M(# M":Y:!3 JHC [#"A"ZA:F85';MD2$@I/E3-,]*E+ J>W3+(
ML2@+E.#$#QR!9*>!78J[%4QTSH?GDPP*-R3%B7YH?[P2?-/^)C+(<VG)R8U^
M2O\ Q\?\\_\ F9D\C5AZO4LH<MV*JB=,*5V%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78JM;I@53P(=BKL5> ?EY_O?#\V_X@V94^
M3K\?-[_F*[!1N_L'Y8"D)/E;8[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%7BEN?\0W@]9B!(^Y\!V4?J&9_TAU0]<MWH<_Y=VDB\54JW\P9B?N)
MIF-XA<TX0Q3RQI%WHUTI]-^'+@YI\)4FE?EWRZ1!#CPB8E,_S(UJ&XC%NK5D
M20%EHVPXMWI3OD,8ZL\T@=E/\O?,$%A$89'I(TGPK1C7D% W IUPY(DKAF *
M\V67OFNVL9##(]'%*KQ<]14;A:=\I$"7).0 TA=7\\6VE,8V)9AU""M/I) P
MB!+&6413/5=;ATA>4S!:]!U)^0&0$;;)2$>;'C^9MJ#3C)3QXK3_ (E7+?#+
M1XX3[1_,$&L@F%JD=5.S#Z,K,2&Z,Q+DP#\Q=:AU,QK$W(H7#[,*'X?$#P.9
M&,4X6:0ER3[R)Y@@6"*V+_O?B^&C?S,W6E.GOE<XF[;L4Q0"?ZQYC@T4#UFH
M3T4;L?HRL1);Y3$>:4VGYC6ERW$\D]W&WX$Y,XR&H9@64*P<5&X/0Y4Y"6:U
MYD@T0#U6W/11NQR0B9-<IB/- :9Y\M=1)4%D(!-''6FYI0G)&!#".421^E^9
MK?5F*0OR8#D1Q8;;#N!XY$Q(9QF)<F*^9K'3I;AVN)G67X>2J#0?"*?[K;M[
MY=$FMG'F(WN6?$TS&<QC.H?F#:63<06<CKZ8J/O) ^[+AC):#F 1>C^<+;5R
M$1J.>BN*'Z.Q^_(F!#*.023S*VU*/-=\UA:R2)LP% 1VY$+7Z*Y.(LM>0T'G
M'D?0HM;E83$D**A:T+5_';,J<N%P<4!([LF\Q?E]#Z3/;*1(NX4$MR]MZY5'
M(>K?/"*V6_EW;7-@SQ3(RQD<EY#8-T_'^&.0@KA!&Q9I=W:62F20A5'4G* +
M<HFF,2_F5:(:#FP_F"BGXD'\,N\,N/XP3W2=<AUA>4+<J=1T(^8.5&--T9"7
M)YY^9_\ O2G_ !B'_$WS*Q<G"S\_@SK3;]-.LHI93Q18HZFA/55':OCF.19<
MN)J()[@B-*UZ#6.7H-RXTY;,*5K3[0'A@,2&49B7)4U35XM)4/,W%2>(-"=]
MSV!\, %IE(1YH$^<;01^MZGP%N%>+_: K2G&O0Y+@+#Q!S>7>4;]-.NHY93Q
M1>530GJC#M7QS+F+#KL9HV7H?F&ZL]9MEDFD80E_A90:E@&%*%2?'MF-$$%S
MID2&_)$^38+:"%A:.SIS-2W7EQ7;[*]J8)WU98P /2F&K:Y#HZ\IFXUZ#J3\
M@,@(VSE(1YI%%^95HYH>:C^8J*?@2?PRWPRT^,&3VEVEXHDC8,IZ$9213D V
ME@\VVIE]#U/W@8I3BWV@:=:4R? 6'B"Z2^]_,2TM6X@L].Z $?>2,D,9+6<P
M";:-Y@AUH$PM6G53LP^C(&--L9B7)=J^O0Z, 9FI7H.K'Z,1$E93$>:11_F7
M:L:$2 >)44_!B?PRSPRT^,&365\E^@DB8,IZ$9213D VB,"78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%43I
M\OIN*]]LD$%7U2V->8Z=\,@@*6F)R?Y"N(24YRQ@[%78JD-ZG!R/\]\J+8$P
MT^#T%+-M7]63 IB4LFD]1B?$Y6R68%=BKL53'3.A^>3# HW),6)?FA_O!)\T
M_P")C+(<VG)R8U^2O_'Q_P \_P#F9D\C5AZO4LH<MV*JB=,*5V%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78JM;I@53P(=BKL5> ?
MEY_O?#\V_P"(-F5/DZ_'S>_YBNP4;O[!^6 I"3Y6V.Q5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5YGYG_+^57:6V')&)/#HR_?U&9<<G>X$\)YA)
M(=>OM#/$LZ_Y,@J/N;^&3X1)JXY19=Y8_,+Z^XAN %9ME=>A/@1VRF6.N3DP
MS7L5#\R-%AMXQ<*M)'D 9JMN.+=JT[8<9Z,<T0-U/\O?+\%_$9I$K(LGPM5A
M3B%(V!IUPY)$+A@"+\T@\]MQOI".OP?\07+(<FC+]3+-(_+F%HPUP6:1A4T-
M *]LI.3N<J.$=6_,_DM]7F,[2JJ4  (^R![_ #WQC.EGBXC=HB[72K.,HWI&
M@I\/%G^\;UP#B+(\([F%^0)"E[&!W# _\ 3_  R_)R<3#]28_F+HL.F&-HEX
MERY?=C4_#XD^)R&,VSS1$>2=>3-%MX;9+UD_>*'8M5OV68=*TZ>V0G(W3;BB
M*XF):/PU^Z+WCA5-7;DW$'P4$_YTRX^D;.-'UGU)_P";-+L'@+VSQ"1=P$=?
MB'<4KE<";W;\D8UM2-_++56N(W@8U],@K_JMV^@C\<CD%,L$K%,2A4^:+ZCD
MT=S]"+4T'^Q&7?2'&^N3-O,?DNW^KNT*!'12RD5WX[T/C7*(S-N7/&*V8W^6
M'^]+_P#&(_\ $TRW+R:,'/X)=Y]_WME_V'_)M<ECY->7ZF:_F/JC6=N(U-#(
M:'_5'7^&48Q9<O-*@EGD/RG%=P_6)U#EB0H/0 ;5^_)9)ULUXL8(LK-=_+V3
MUN=G15V-"U.+>V&.3O66'?TL_M.?!?4^W0<J=.5-\QBY@6W]DM_&T3_984.(
M-*1;RC4_)%UI3<HP74='C^U]W7,P3!==+$8\EEKYTO=-/%F)I^S**G_FK\<)
M@"@9919_Y5\WIKX*D<95%2O8CQ&8TH<+FX\G&Q'\R]4::80 _"@!(_RF_LR[
M&.KBYY;TRK2_(MM#"$D0,Y'QL:UK[>&5&9<F.( ,$B9O*M]Q4_"K!3[HU#O]
M!^_,CZ@X8_=R1_YG_P"]*?\ &(?\3?(XN3//S^#(=<_XY _XQ0_K3*H_5\VZ
M7T? )=^5/^[_ /GG_P ;Y/*PP=4Q_,__ 'F3_C*/^(/D,7-GGY?% ^1-%AU>
MT99UY 2L1NPWX)_*1DIFBPQ1$AOWL3\HV":C=1Q2CDC<JBI'1&/:GAETS0<;
M&+-%F/G_ $Z/3;)(HAQ02B@J3U5SWKE.,V7*S#ACMWHG\L/]YG_XRG_B"9'+
MS98.7Q8?*Q\U7W%C\+,5'M&M3M] ^_+_ *0XQ_>29WJGD6VFA*1H%<#X&%:U
M]_',<3+F2Q ABOY::JT,Q@)^%P2!_E+_ &9;D'5QL$MZ2/4K8W=])&#0O.R5
M_P!:0C+!L/@U$7+XO1YO(%HT914HU-GJ>5?'PS%\0N=X0I@WY>W!BO$4=&#*
M?^!+?PS(R<G#PG=?^8H?ZV>7V>*\/E3?_AJXX^2<W-/#<:9K,/IJ$AD(V++Q
M*G_6[_?E?J#=<9#N3SRAY<;0E8>H)$>A%!0 COU/7^&5SEQ-V.' R3*FYV*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5'6-AZOQ-T\/')@()5[N_5 5&YZ>V$E ""L)O2<5Z';(A)3S+6#L5:
M)IBJ0S3<W+>^4MB9PWBW0XGJ>V6 VPJD#>V?U<U'V3D"*9 H7(I=BKL53'3.
MA^>3# HW),6)?FA_O!)\T_XF,LAS:<G)C7Y*_P#'Q_SS_P"9F3R-6'J]2RAR
MW8JJ)TPI785=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL
M5=BJUNF!5/ AV*NQ5X!^7G^]\/S;_B#9E3Y.OQ\WO^8KL%&[^P?E@*0D^5MC
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BJA>\O3;T_M\3Q[_%3;\<(
M07GGEWS]*\X2[8",U%: <6[5S)ECVV<*&4WZGH4[1S(2_$H>O*A7^F8SFEXO
MJ,2/=%;3[)<".GC[?3TS/'+=U1Y^EGWYG_[S)_QE'_$'S&Q<W,S\OBH?EI?1
MQ0,C.H;U">)(!W50/U8<@W1@.WQ8IY]_WME_V'_)M<NQ\G&R_4]DS!=H\A\S
M7KZU>F%FH@D])0>B_%QY?QS-B.$.MF>*5,RA\A6>GKSD!;B*DNVVWL*#*/$)
M<H8HA@_D+_>V+_9_\FVS(R<G#Q?4R'\UO]T?\]/^-,KQ-^?HF/E66.\T\6X=
M>;+(G&HY58MV^1R$]C;9CWC7O8/Y5TV&_G]&X)4$$#?C\?AO].9$S0V</'$$
MT6::AY&L=-0RRLX4?Y7ZMLH$R7+.*(1?DJUM%YO:%R-E8O\ ?MMD9D]66,#^
M%@=C+_AR^!<4$;D'_5-17[C7,@^H.&/1)G_F3S;;Q6[^G(KNZE552"?B%*GP
MI[YCQ@;<V>0 ,4_+#_>E_P#C$?\ B:9=EY.-@Y_!+O/O^]LO^P_Y-KDL?)KR
M_4RG\TK0R1QRCHK%3_LJ?\TY3B+DYQM:8?EU?K/:B,'XHR01_K,6!_'(Y!NS
MPFPL\S^>AHDHB10YI5MZ<3X=#AC#B1/+PFF3V4S3QJ[CBQ4$KX$CIE)<@;I1
MYQOYM.MS+ :,K#EM7X3M^NF3@+.[7D) L)1Y+\YG4N4=RX$E:IT4$>'SR<X5
MR:L>3BYI[YE6W>%OK/'C0T)^U7MQ[U^60C?1NG5;O.?R\C9[Q2O0*Q;Y<:?K
MIF3DY.#AYK_S&LS!=E^SJK#Z!Q_ACC.RYA1>HZ=?KJ$:RH:JPK\O$?1F(13L
M0;W>2ZXPUV_81[AW5 1X !:_A7,R/I#K9>J28_F?_O2G_&(?\3?(XN3//S^#
M(M90OI( _P!]1'[N!RH?4WR^CX!*/RLN%1I4)^)@I \>/*OZ\GE:L!YH_P#-
M&\41)%7XR_.GL%(_CD<09YSM2O\ EA_O,_\ QE/_ !!,&7FG!R^+"?)-PMM>
M1,Y"K\6Y-!NC 9D3Y.)B-%F?YE3+/:HR$$>J-P:C[+Y1CYN7FY?%?^6'^\S_
M /&4_P#$$P9>:X.7Q8;H;#0K]1)L$=D)/@05K^-<OEZ@XT?3)ZUJ-^NGQM*Y
MHJBOS\!].88%NR)K=Y=^7-F9[L/V168_2./\<R\AV==A%E#?]+/_ *.?^9N'
M^'X,?XOC^E[)F"[1XWY"_P![8O\ 9_\ )MLSLG)U>+ZF::_YCLYI?JES&S$$
M+R(6@Y4W#<@1URB,3S#ESF+X2EWF+\O8;:)YH6*\%+<6W!IV'?\ 7DHY"6$\
M( L*'Y7WSEWAJ3'QY^P:H&WSK^&'*&. ]'I&8KG.Q5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5?!'ZK!?'"%3/4
M9_14*O?]63)8A*<K9(^QL.?Q-T[#)@,24TZ98Q;Q5IE#"AZ8JD]]9>AN/L_J
MRLBF8*$!ID4IQ _UR.AZ]#E@W8<DG(IE;-V!78JF.F=#\\F&!1N28L2_-#_>
M"3YI_P 3&60YM.3DQK\E?^/C_GG_ ,S,GD:L/5ZEE#ENQ543IA2NPJ[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%5K=,"J>!#L5=BK
MP#\O/][X?FW_ !!LRI\G7X^;W_,5V"C=_8/RP%(2?*VQV*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*L1\P_E_'JC&6-O3<]=JJ3XT['_ #IE\<E.
M-/$),='Y73UWDCX^/Q5^[C_'+/%#3X!9/Y;\BQZ,PD8\Y!T-**OR'\<JE.V^
M&(13O6-(36(C#)6A[CJ".^5@TW2CQ"F)6OY9"VD6035"L&IP\#7KR_AEQR6X
MPP4>:)U[\O\ ],3M/ZO'E3X>%:44+UY#PP1R4$SP\1NV990Y3"O,_D#]*2&:
M%@KM]I6K0GQJ.F7QR4XL\7%N$/;>0[FYHMU<$Q]T5G;_ (E0#[LD9CH&(Q$\
MRB]&_+_]$SK.LM0I-%X=B"*5Y>_AD3DL4RCAX3:>>8?+T>O($D)!!JK#J,KC
M+A;IPXTBT3\O/T5,L_J\N)/P\*=01UY']662R6&F.'A-VN\Q_E\FJ.98FX.=
MV!%58^/MC')29X>+<)/'^6UQ<$">9>(\"SG_ (8#)^(.C5X)/,L\TG2H])C$
M40HH^\GQ.8Y-N9&/#LQ/7Y-/UN7TY&99@WI\@"-ZTH:BF71N+C3X9&NK<ODF
MVT**2=R7*HW'E2@-*"@\:],>,R3X0@+2C\KH"T\C]@G$_-F!'_$<GEY-6 ;I
M[KWY?_IB=I_5X\J?#PK2BA>O(>&5QR4&V>'B-VRJ^LDOT:*055A0C*0:<DBV
M W/Y:2P,6MI0!VY<E('S6M?PS)&3O<,X2.11NA?EP+5Q)<,'(-0J_9K[D]<C
M+)?)E'#6Y9SF.Y:R6(3 JP!!%"#T(PJP/5/RP61BUN_$']EQ6GR(S(&7O<.6
M#N0$'Y6S,?CD0#_)Y-^L+DO%8# 6;^7_ "U%H*D1[L?M.>I_LRB4N)RX0$%W
MF#R]'KJ<)-B-U8=5/]/;!&7"LX"3"6_+:YBJL<J\#UW9:_[$ C\<O\0.+X)[
MV2>6/),>AGU&/.7IRI0+\A_'*Y3XF^&+A6>:/)/Z?E$OJ<**$IQY="37[0\<
M8SX43Q<9M/(=+5;<6S_$H01GM4!>/T97>]MPCM3 KG\KY4:L,B\:[<JJP^X'
M,@97#. ]$?'^6(:,AY?WI(^.E0 .P%1]_P"&#Q&?@,C\K^7_ - 1&+GSJQ>M
M./4 4ZGPRJ4N)NA#@%)%J?Y9QW;EXY"G(U*E>0W\-QE@R4U2P@HJX\C^M:):
M>I3@_/GQZ_:VIR_RO'(\>]LCBL<*9^5_+_Z B,7/G5B]:<>H IU/AD92XF<(
M< I ^9_),>N'U%/"7H32H;YC^.2C/A8SQ<3&U_+:YEHLDJ\!TW9J?[$@#\<L
M\0-'@GO9MH'E^/0DX1[D[LQZL?\ /ME$I<3E0@(I%_RK_P#TGZUZO^[?5X\/
M\OE2O+\:99XFU-/@[W?6V990Y3#=!_+_ /0\ZS^KRXU^'A2M5*]>1\<OEDL.
M+##PF[1GFCR6FND2!N$@%*TJ"/<?QR,9\+.>/C8^?(-[*/3><&(?L\G(_P"!
M(IEOB#N:?"EWLL\M>68] 0A3R=OM.>]/#P&4REQ.1"' G65MKL5=BKL5=BKL
M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL
M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL
M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL
M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL51.G?
M;'TY((*OJ,#2-4 D4PD("'ALF8@$$#O@I-IV!3+6#>*NQ5V*K)(Q("#WQ5)3
M9..QRJFRT?ID+15Y"G3)!B4LN/M'YG(%DLP*[%4QTSH?GDPP*-R3%B7YH?[P
M2?-/^)C+(<VG)R8U^2O_ !\?\\_^9F3R-6'J]2RARW8JJ)TPI785=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BJUNF!5/ AV*NQ5X!
M^7G^]\/S;_B#9E3Y.OQ\WO\ F*[!3G7FI'M@2$ERML=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML58CYG\AKK#F:-N$A^U455OZ'+XSIQIXN+=)SY O+NB3S@H.@Y.]/H:@R?B
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MBKO3/@<5=Z9\#BKO3/@<558[)G[4^>&D6F-O;" ;=?')4P)5L*'8JQ+\T/\
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MCX,>X+^8G_.+O\1W/^_7^_'P8]P7\Q/^<7?XCN?]^O\ ?CX,>X+^8G_.+O\
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M_OU_OQ\&/<%_,3_G%W^([G_?K_?CX,>X+^8G_.+O\1W/^_7^_'P8]P7\Q/\
MG%W^([G_ 'Z_WX^#'N"_F)_SB[_$=S_OU_OQ\&/<%_,3_G%W^([G_?K_ 'X^
M#'N"_F)_SB[_ !'<_P"_7^_'P8]P7\Q/^<7?XCN?]^O]^/@Q[@OYB?\ .+O\
M1W/^_7^_'P8]P7\Q/^<7?XCN?]^O]^/@Q[@OYB?\XN_Q'<_[]?[\?!CW!?S$
M_P"<7?XCN?\ ?K_?CX,>X+^8G_.+O\1W/^_7^_'P8]P7\Q/^<7?XCN?]^O\
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MP7\Q/^<7?XCN?]^O]^/@Q[@OYB?\XN_Q'<_[]?[\?!CW!?S$_P"<7?XCN?\
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M 'X^#'N"_F)_SB[_ !'<_P"_7^_'P8]P7\Q/^<7?XCN?]^O]^/@Q[@OYB?\
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M-O#,[)/@'$ZO%C\27#R9&_Y<LLBJ)*H02S<:4]@*FI.8?YH5R=D=";J]NNR
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M4]"EU&(O'.\0#D<5K0FB[[,OCF?GR")WB#M^.CJ]-A,Q8D8[_CJD$^GO+<-
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M][3K9DRKN3W\N;YIHWB)J$(*^P:NWX9BZJ-$'O<[0S)!'=^EK0[46NI3J.G
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M1J>MS:KQ]9N7&O'912M*] /#(PQB')LR999/J* RUH3G2O-=QI0XHP*]E85
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M?ZP_5FFU?,/0:#D?>S#-:[=B7YH?[P2?-/\ B8RR'-IR<F-?DK_Q\?\ //\
MYF9/(U8>KU+*'+=BJHG3"E=A5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*NQ5V*NQ5V*K6Z8%4\"'8J[%7@'Y>?[WP_-O\ B#9E3Y.OQ\WO^8KL
M$K\S?[S2_P"J<R,/U!QM1]$O<\CSHWD78J[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J] _+K^
M[D_UA^K--J^8>@T'(^]F&:UV[$OS0_W@D^:?\3&60YM.3DQK\E?^/C_GG_S,
MR>1JP]7J64.6[%51.F%*["KL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL56MTP*IX$.Q5V*O /R\_WOA^;?\0;,J?)U^/F]_P Q78)7
MYF_WFE_U3F1A^H.-J/HE[GD>=&\B[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7H'Y=?W<G^
ML/U9IM7S#T&@Y'WLPS6NW8E^:'^\$GS3_B8RR'-IR<F-?DK_ ,?'_//_ )F9
M/(U8>KU+*'+=BJHG3"E=A5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*K6Z8%4\"'8J[%7@'Y>?[WP_-O^(-F5/DZ_'S>_YBNP2OS-
M_O-+_JG,C#]0<;4?1+W/(\Z-Y%V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5L"N*I_'Y'NW / "OBPKF(=1%V T<ST7?X$
MN_Y1_P $N#\S%/Y.?X*0W%NULQ1Q1AL0<R@;W#@2B8FBIY)B[%78J[%78J]
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MD:R)7Y.U*/3W8F-I)#LO 5H.^7YX&0YT'%TN00/(D^3*='O;^YGK*G&$UJ"
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M\K>6FT M<7#*/AX]=@.Y)^C#FR^)Z8L=/@\&Y3I)]'U :EJ8E'1BU/D(R!^
MS(G'@QU^.;AXI^)EXO?]RE^8?^](_P!0?K.2TOT_%CK?K^"?:G_QRA_J1_\
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M9.;J,'CU*%*MG$OD^T;U&!D)+ #NQ% !D9'QY;,X@::&_-(/RX_WH;_C&?\
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M_:O\JZ;/9EVNG+.U**6Y$ =\<TQ+Z0G3XY1OC._OMBECJ:Z7J,COLIDD5CX
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M7^.9.'()"AT#AZC"8&SU)95^9']RG^O_ ,:G,'2\S[G9Z[Z1[U21%\W685&
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MK?+IFKR XI\3O,)&;'P=:I!:-Y#]!B]YQ,8!V#'[R=J#+<FIOZ&C%HZ-Y*I
MZ"T3:BOH"D=6"]3TC;????+<E^'ZN?[6G#7B^GEO]RMYS*B^C]3[%$Y?ZO(U
M_#(8/H->;/55X@OEM][)?,]K=72H+1J+ORXGB>U*',/"8CZW8ZB,Y >&Y+-[
M.QDCD;FXCDY&M=R":?1CQ"4P1WA>$QQD'<T4D_++_=W^P_XWS)U?3X_H<+0?
MQ?#]*SR?_O?/\I/^3BX<_P!$?A]R--_>2^/WA+=:ACGU!EF)6,L 6&U/A%.H
M/?+L9(ALX^4 Y2)<OV)W<^7;O3F'U*5C'3H[ T^@BE,QAEC+ZQNYLL$X']W+
M;S*)\Z7 BLPDQ!F;C2G\P^T1[=<A@%RL<FS52J%2Y[*]@C2V"BS(#\1OM]K]
MOZ>N0EM/ULX G&/#YU_:O\JZ;/9EVNG+.U**6Y$ =\<TQ+Z0G3XY1OC._OM@
M\CB+4"6V N*D^WJ9LAO#_-_0Z4[9/\_]++?/.A2:D%DCI1 Q:I[;'^&8&GR"
M&QZNUU>$Y*(Z6@?RR_W=_L/^-\MU?3X_H:-!_%\/TH;RWJZZ?>2K(:*[,*GH
M"&-*Y/+#B@*Z,,&40R2!ZD_>KZUY$ENYVDB*\'/(U.XKN<CCU(B*/1GET9E*
MXU11'G*]33K9;-35J*#[*M-S\R,A@B92XV>JF(0\,>7V*WY?_P"\LG^NW_$%
MR.I^H>[]+/1?0?>?N#$O)_\ O7%\S_Q$YGY_I+JM+]8_'1,_S'_WH7_C&/\
MB3Y3I?I^/ZG(UWU#^K^DL3S/=4["KL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL
M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5>B>;?]X(_P#GG_Q'-/@^L_%Z
M'4_W8^"(T[R;;(Z7$;%D Y $U!/8_1D)YY48ELAI8 B8Y,<\PZ['J]RBN?\
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M\1<[6Y17 /BP'-HZ)O"A$P:G-;#BDCJ/!6('X'(& /,!M&24>1/S4DNGC;U
MQ#_S GE]^'A')B)$&^JZYOI+NGJ.S4Z<B6I]^ 1$>293,N9)]ZCDVM%7&IS7
M0XR2.P\&9B/Q.0$ .0#;+)*7,D_%:NHRHGIAV"=.'(\=^NW3'@%W2!D(%6:[
MK66UV]H>4;,II2JDJ:?1A,1+FB,C'D::>Y>1N98EZUY$GE4>^- ;*9$F^J^Z
MOY+RGJ.STZ<B6I7YX!$1Y)E,RYDGWM6U]):?W;LO^J2OZL3$'FL9F/(D+TU.
M6-BXD<,>K!C4_37 8 ] D9)#>S\U33YTEF#7-60GXS4UW[UZX) @>EG @RN>
MXZLQO/)JW@!LY0(R/B7D67YYKHY^'ZQN[>6E$O[N6WO:\P7\6CV@LXV#.1Q-
M.V]6)\*^&''$SEQE&:8Q0\,;EA5OJ,MJ.,;LJG<A6('X9L3 'F'31R&/(D?%
M9;7;VAY1LRFE*J2II]&2,1+FQC(QY&EDTS3DLY+,>I8U/WX0*03>Y5KC49;H
M<9'9E&X#,2/QR(@!R#.60RYDGXLF\L:;::G%Q8\+@5HW(CY,!7,+-*4#Y.RT
M\(9!W2]Z;:3Y:_0<OUFYE4\0>-3X[=_U9CSR^(.&(<O'@\(\<Y,/\RZH-5G:
M1?L[!?D,V&*' *=1GR>)(D)5F0XBM!=/;&J,5/BI(_5D2 >;*,C'DJ7&IRW(
MH\CL/!F)_6< @!R 9G)*7,GYH7)M:O;7TEI_=NR_ZI(_5D#$'FSC,QY$A9-<
M-<&KDL?%C4_CA KD@R,N:I:W\EG7TW9*]>)*UI\L!B)<TQF8\B1[E%W+DDFI
M.Y)R5,";1'Z3EX\/4?C_ "\C3[LCP#G0;/$ERL_-IM1E9/3+MP_DY'C]W3'A
M%W2\9JK-=UJ,4S0GDI(/B#0Y(BV )')5N;^2[IZCLU.G)BWZ\B(B/)E*9ES)
M+=SJ,MV*2.S ;T9BWZ\1 1Y!,LAES)/Q4H9V@/)"5/B#0Y(BV D1R5+F_DNO
M[QV;_68G]>1$0.3*4S+F25&.0QD,I((-01U!R1%L :5;F^DNZ>H[-3IR):GW
MX!$1Y,Y3,N9)71ZC+&OIJ[!-QQ#'COUVZ8. '>DC(0*LUW6H(Y0U!H1WR36#
M2*DU>>0<6D<CP+-3]>0X .@^3:<LCU/S0>6-3L4-X5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL51:ZO.@XB
M5P/#DU/UY5P#N'R;AED.I^90C,6-3N<L:KMP/'<8JBI-5FE'%I'*^!9B/NKE
M8@!T#:<DCM9^:$RQJ1,FHRR+Z;.Q38<2QX[=-NF0$ -Z;#D)%6:[K:M;^2SK
MZ;LE>O$E:T^6)B)<T1F8\B1[EB7+QMS#$/6O($\JGWPD [($B#?5NYNWNSRD
M9F-*58EC3Z<1$1Y+*1ESW7W.HRW8I([,!O1F+?KP" CR#*60RYDGXNM]1EM1
MQC=E4[D*Q _#$P!YA8Y#'D2/BIV]T]J>4;%3TJI(/X83$'FQC(QY;-3SM<$L
MY+,>I8U/WG"!7)!D9;E4MK^2U_NW9?\ 58C]61,0>891F8\B0IS3M.>3DL?$
MFIP@4Q),N:I:W\EG7TW9*]>)*UI\L!B)<V49F/(D>Y1=RY))J3N2<E5,";='
M(8C5201W&QQ(M0:5Y]1EN11W9AX,Q/Z\B( <@V'(9<R?FI03M;D,A*L.A4T/
MWC)$7S8"1CN&[BZ>Z/*1BQZ58DG\<  '),I&7/=5BU2:%>*R.%\ S ?=7 8
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MKL*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5:W3
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M\8[J^UC>L:<]E(U494Y,$J" 0#VKUS,QS$AS==EQF!.U"S2'MK&2Z_NT9O\
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M8#,#J$C'(\@?DAF4J:'8Y-KY*MO:/=&D:LQ\%!/ZL!D!S91B9<A;=S926O\
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MEN ?DAR*;')M;6*LKU6S2/3H9 JARV[ #D=GZGKF!"1,R/QT=KE@!BB:WO\
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MVXQ!'-T41F/%023V&YQ)I %\E2XL9+7^\1E_U@1^O(B0/)E*!CS!"R&W:>O
M%J"IH*T [_+"32!$GDV+5ROJ<3P_FH>/WX\0Y)X35]%UO8277]VC-_JJ3^K
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MC$>KT'2I/TF(D_C@)O%^.](%9_Q_-0'YA_[TC_4'ZSENE^GXM&N^OX)]J?\
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MR?ZP_5FFU?,/0:#D?>S#-:[=B7YH?[P2?-/^)C+(<VG)R8U^2O\ Q\?\\_\
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MRED %2Q[;YAB49DF?P#L90ECB(XQ[RNL;6YU6)X+Q#]DM'(P%0P^6"4HP(E
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MZUWH][2XDLYA=@DKQ:(ONXWH?>F5<41,<'Q;S&1QR\3I57S2W5/]X;;YR?\
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M'G$?1+X(G4?RY$SEH7"J=^)'3Y'(1U5#<-D]#9N)3.SM8/)L)9VJQZGH6(Z
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MTXN)'O\ N;M7+AG$]P'WEDNH3S:I&LMA(!X@A=_O!H1F'$"!J8=C,RR 2Q%
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M:J*5WS4G3R!N+OXZJ!B!(?9;7^)--_WR/^1:8^%D[_M*^/B_F_[$._Q)IO\
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M>1YT;R+L5=BKL51-MJ4MH*1NRCK16*BOT9 P$N8#9'(8\B1\5;].W'^_I/\
M@V_KD?#CW#Y,_&E_.E\RA[F^DNZ>H[-3IR):GWY(1$>37*9ES)/O4,FP9?Y<
MNH]4MVL96"L36)CX]:??]]<UV6)A+C'Q=O@D,D3BE\$KF\FW<3<?3K[@BGWY
M<,\3U<8Z68/)-[M5\LVC0$@SR_: _97_ &OQ.41_>RXN@<N5:>!C_%)"WO\
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M8MT[2)+>VN$:IF=5;TQNP4'8GY^&&<P91/0=48\1C"8/U&MDOU84L;;YR?\
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M#S91D8\EUS?27?\ >.S?ZQ+?KR(B!R92F9<R2J?I6;CP]1^%*<>3<:>%*X.
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M3R3!M7*&HV.*0:1;:Q.PH97IX<FI^O*_#'</DV^++^<?F4%EC2JM=.RB,L>
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MQ8CE/"$Q_P )G_?]O_R,_P";<I\?^C+Y.1^6_I0_TR'O_+4MDGJ_"\?=XSR
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MF;2UTJ<Q(25 !^+KN/HS'PS,Q9<O48QCEPA*<R'$=BKL55K(H)%]3['(<_\
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MP!YWWVT_FI#NKNIVO:4I>)X!1)P"J_RL=B/O...>Q$OX5S8Q<3'^)&:IJO\
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MNOAT]L/ABJ1XTKXKW(I#6=Z]BP>-BK#N,G*(EL6N$S V%:\OI=8<,Y+N:**
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M]]_B5/RIJ<FI2-;3,7216V<\J&G45PYH" XAM2--D.0\$C8(ZH;0::=;R7E
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MX@TPQ$SX))KJUS>R2$0I*D2GC&L:NHXCIT&]<H@( >H@GK=.5EED)](D .5
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M[%"\_P".7%_QE/\ QODH_P!X?=^IA/\ N8_UOUJD$)U+3>$>[12<F4=:;_\
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MTCR"JHIH />E,@9RF2([5U;!CACB)3W)Z*DFFVNK0236RM&\0JRDU!'TD^&
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MV./'&,>.?P"-L]/L]?#I C12*I85)8&GS)RJ4IXZ,C8;H0QYK$08FE#\O?\
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MBT:G@I^)W(JQW.P'ME$<DI$Q'>=^YRI8H0$92[AL.I2^QTV+4&DG(,=M'0D
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M-(+=%)8#D278"NY%?;*\F,T3*1^YNQ9AQ 1@.?O4-:_XZ/\ ST3_ (UR6/\
MN_@6O+_>_P"</T+//<+1W;$]&"E?EQ _6,.F-Q1K 1,_!$>108S-(W]VL9Y>
M'C^H'(:G>AYMFCVXCTI;Y1_N;O\ XQ'_ (B^'/SA[_U(TWTY/ZOZTBTG^^C_
M -=?^)#,J?(^XN#B^H>\)GYT8K>2$=1Q_P"(+E.G^@?'[W)U6V0_#[@G>HV
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M.%JC<S^.B-\HG]S=_P#&(_\ $7RK/SC[_P!3=IOIG_5_6DNA?[T0_P#&1/\
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MNQ5.[?5;6-0&MN3  %O485/C2F8IA(_Q?8YL<L -X?[(JGZ9M/\ EE_Y*O\
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M<:;<:=*9=& B*#C3RF9XBFDWF6*\/.>W5Y.[AF6OS4=<I&(QVC+9R3J!+>4
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M$D9+-,OCI\JRKU4U^CN/I&&<>(4C'/@(DBO,<L4\[/ :HWQ="*$]1O[Y7B!
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M_P!8?JS3:OF'H-!R/O9AFM=NQ+\T/]X)/FG_ !,99#FTY.3&OR5_X^/^>?\
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M+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\
M+^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\
MW?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_
M-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_
M "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4
M/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,
M?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V
M_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\
ME#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^
MS'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!
MMO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E
M_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O
M_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^
M ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O
M)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O
M[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=
M_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U
M+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\
M+^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\
MW?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_
M-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_
M "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4
M/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,
M?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V
M_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\
ME#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^
MS'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!
MMO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E
M_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O
M_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^
M ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O
M)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O
M[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=
M_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U
M+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\
M+^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\
MW?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_
M-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_
M "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4
M/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,
M?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V
M_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\
ME#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^
MS'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!
MMO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E
M_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O
M_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^
M ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O
M)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O
M[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=
M_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U
M+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\
M+^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\
MW?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_
M-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_
M "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4
M/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,
M?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V
M_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\
ME#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^
MS'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!
MMO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E
M_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O
M_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^
M ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O
M)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O
M[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=
M_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U
M+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\
M+^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\
MW?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_
M-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_
M "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4
M/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,
M?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V
M_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\
ME#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^
MS'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!
MMO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E
M_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O
M_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^
M ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O[_[,?S4O
M)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=_@&V_P O
M[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U+R7\E#S=
M_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\ +^_^S'\U
M+R7\E#S=_@&V_P O[_[,?S4O)?R4/-W^ ;;_ "_O_LQ_-2\E_)0\W?X!MO\
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MSIY!-(&&W:=N"CXO#,>,3(T$+[JQ>TIS%*]-Q_#)2@8<UI;;6K71XH*FE?\
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MQ5V*NQ5V*NQ5:W3 JG@0[%78J\ _+S_>^'YM_P 0;,J?)U^/F]_S%=@H7O\
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MA"MV(!_V)_IF1C_>1W_%)&Z7>8[CFX3^4?B<Q=3*S7<QDG$EV\L8>$ GP/\
MMYG&9(N+-0AN+B0$L$4#^:O]<KC*9YT$;J.@2^LTC'N0=O\ 99#3FS(_CJ@*
M.D7 CF=3^T33Y@Y7AE4B.]0HZAH\C2$J*AC6OSR&3"2=D$(W5V%K (J[D ?=
ME^8\$>%)5Y;4W5NJCKQ4C[LL,.. 'D$]$+H6FO;L7<4VH,IP8S$V4 *%M.+B
M[Y#I4_@M,KC+BR7^.2.JGYB_O?\ 8C^.1U/U?!9(^_\ ]Y5_U4_AF3D_N_@$
MGD[RU]AO];^&.FY?%8J?ENX'%D[UY#(Z:6U+%6^LW7+CP7Y[T_XED^*=U0_'
MQ3NEVNSNQ"/Q)&_PU[_/,7/(\C7P8E'^9?L+_K?PS)U/+XID[RU]AO\ 6_AC
MIN7Q6*!\M_WA_P!4_K&8^F^KX(BIZW:LDC.1\)(H?HR.>!!)4A+<PV+>*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*NQ5V*LHN&XVH(_D7^&;B7T? -G1CUM>/"P;D>OCFLC,@L+3KS-'55
M;O6F;#4C8%E)&R7;RQAX0"? _P"WEYF2+BR4(;BXD!+!% _FK_7*XRF>=!&Z
M"T6]#2MRI5_NKE&"?J/F@-7VAR22$KNK&M:]*X,F D[((1FLH(X HZ#B,OS"
MH?)D6Y(C>6P";GBOX82..&W<%Z+=!L6MN1<4K2@^61T^,QNU 4-*_P!Z9/\
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M0E8J% HQW'4_/(YIV:KJI3'4$AL6Y,H)/V5&P^>9601@;(^"3LEUGZ<K,\E
MHJ0GC[9BPX223\F*(MKZ.X8(8EH33;KEL<@D:X0FUD96PF*<0PY #EVR(K'*
MJO=>2_7+D,YC"BM1\7[709+/*SPU\5+IC'IE$XAWI5BW08#6+:K*\ED\:7L9
MDC'%E^THZ4P2 F.(;$<UYK;"V1$,T@J :*OB<CCB .*2A6MKJ*\8(R!=]BOZ
MCED91F:(I>:C?1!+CB  *KMVZ#*\@ G7N4KKJQ$]P8UV&W3L.(KDIX^*?"/Q
MLM;MO?Q0'BL891W/4XG)&.PBMJ.I6JJ%EC^PW;P.0RQ&TH\BI1=P$TP*!&&J
M*EFW&7RK%6U^:>2%O'BN$YJ KUW7QRF9C(6-CW(2_,1B[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78JB=-_O4_P!89=B^H>](1VK:?)-*S*I(--_H&9&;&3(D!)"[
M2K)K-O5E^%0#U[Y+% P/%+90*0EI +^1F.R[NWRRB$?$)/3FCFK#4X@:>D./
M_#99XL?YNR;4[S3@LBK']EZ%?IR$\>XKKR6E>XN(K ^FJ!B/M,WCELI1Q^D"
M_>O)4FBBD@:1%H21\U-1T.2D(F!D E#2Q 6RM05Y=>_?*2!P ^?ZT=':#$)9
M*, 10]=\=. 3NH7>7?[W_8G^&2TWU?!0A].2,DM+T45"_P QRK&!SD@(NVOH
M[A@AB6A--NN7QR"1KA";61E;"8IQ##D .7;(BL<JJ]UY+]<N0SF,**U'Q?M=
M!DL\K/#7Q4MS^GI=%XAWI4EN@QEPXMJLKR:]./4D9D7BZBM!T(P4,@V%$+S;
MTZU26$L]  VY[T &V'' &-GO4+8KV*21 $ 7<&M#6O3[L G$D;;+:"U*W^K2
M,O:NWR.8^6/"2$%%:G$MLB1@#E3DQIO]^790(@1Z]4E+,PV*?:K:O<)%P!-%
MW^Y<V66!D(UW?J9E"Z=I,@=684 ())]LJQX3=E "*AXWUP^P(X[5\105RT5.
M9]WZD\T'=31(IBC6IZ<^]:]LHF8@<,1\4*\_IZ71>(=Z5);H,LEPXMJLKR6^
ME'J2,R+Q=16@Z$8*&0;"B%YJ5O$#;NQ J"*'OU&0B!P$_CHK=O"EI&)9!R+?
M97M\\,8B XI;WR"JL#QZG\!0(_[)7)Q,<NU4>B\T/IUDK<GD^RG4>)\,JQP&
MYER"A5CU&*4\6C4*>XZC)C)$[&(I;4'9;&0\0KKVKN,K-8Y="CDC]=NPA"<0
M25'Q=QN>F9.>=;4.3(I%FM8)VK)J4:H6"NNV_?-B*RQ NB&?-#MHTUL0RT--
MP5RKP91W"*0;<[V2A^TQIX>V4&YGS1S1\]Q%8'TU0,1]IF\<R92CCV OWIY*
M=] DR":,4%:,O@<A.((XH_%2BY88K=$D<5^$?"/VC3J<O,8Q D>Y*E8LE^SK
MQ"\A\/3:@I_;D,=9"17/D@;I=9V_KR!#X[_QS%A'B-("8 )-<A0HX@TI04V&
M9.QG71/52AL1<3.#LBEB?D#TR,<?%(]PM:7G4X@:")>/_#8?%C_-%+:C>6:F
M0+$00U*;UIE<X"ZCU0KSW$5@?35 Q'VF;QRV4HX]@+]Z>2G?0),@FC%!6C+X
M'(3B".*/Q4HBX":8% C#5%2S;C+I5BK:_-/)"WCQ7"<U 5Z[KXY3,QD+&Q[D
M)?F(Q=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL59!)_O'] _XEFT/]
MW^.]GT6V]O']7#N.E22!N?B.U<C&,>"S^-U;L9(=1K'Z84TVI_7#C,<FU4HW
M0%A8"68QMT%?IIF-CQW+A* $;<7,5LW!H@%K3E_'I_',B4HQ-&/Q2@G2(S+Z
M9JI8;$'QZ;YCD1XAP\K"%75[0-,$0 5 Z"F3S0]5!2B+IH=+HG .U-R?\SEL
MC'%M5IY*L<$4L+R(HZ'J*\2!VR8C$Q) [U6:,H:!PWV:FORXC(X?H-_C90ML
MKF&Z;TO3 !Z'O_G]."$HR/#PJ$/'QT^<IQ#"H KVKE0K'*JM')%:_=",\"H)
M*_:[C<Y=J)@;5TYI+<ENFG(I]/F3U/\ G7"8C&/IM>2"O)8+A.2C@_\ +0_[
M68\S&0L;%!2S,-B[%4X\M?;;_5_CF?IN9]S.*^YT"25V8%:$D]3W/RR4M.22
M=EI!7FE/8 .Q!%:;?[68\\1Q[FF)%(O6+=6C25  #UH*=<OS1! D$EVGPK#
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MQ\1DLD. TDA':!/(S\:DI0U\!F3IY$FNB0I60 N?AZ<C3\<A#Z]N\J.:#O\
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MATPWM8K/+O\ >_[$_P ,&F^KX*%NG6ZB-Y6'+CT7!CB*,CO2A5L-2DG=515
MJ*\1V[Y/'D,C0KX!05*]_P!Z?]DO\,A/Z_B%/-K57].X)/8J?P&#*:G\E+>O
M0D2<_P!E@*'Z,.HCO?>I5-$0Q!Y3]D*1\\E@%7+R4+8#_HK_ .O_ ,TX(_W9
M]_ZEZ)5F$Q9!Z'Z1]*3Z'_V.^;/A\3AE\_@SYI1J%S]9D9NU=OEF%DEQ&V)0
MV4H3W6+AH4BXDBH[&G9<V.:1 C7=^IF4H>[>04+,1[DYA&9/4L+1_EXT=O\
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M[U+=_((KI">E!^-<.0U,*>:$U^W*2%NS4H?HIE&HB1*T%&Z?;F&W?EM4,?\
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MDY'W%2Q#-"U.Q5V*KX'","PY#PK3)Q(!WW2C/KD/^^O^'.7\<?YOVI6RW<3
M@14/8\B:9$SB?X?M0@LQT)CH/]\/D?U9EZ?ZF00M_P#WC_ZS?KRG)]1]Y049
MH$'*3GV4'?+]/'>^Y(5='E]:=F\>1_')X3<R?>D).%)-.^8-,$XUH^G,E>P6
MO_!',[/M(?#[V15M5NTAD(:,,=OBKU_#+,LQ$[QM)4$O@Z/Z<5!2C'ET_#*Q
MDL&H_:BTGS 8ISI']S+_ *O\#F?A^F7N_0R"39@,4YL%^JP2.=N6P_5_',_'
MZ8$][,*=M_O-)_K#]:Y&/T2]_P"I'1UM_O-)_K#]:XQ^B7O_ %+T=-_O*G^O
M_P U8R_NQ[_UKT=J(YP1,.@J#\_\QCDWC%2IZ"A:4$=JD_=D, N2A$Z<P6Z:
MO<M3[\NQGUGXI'-1>_B0D&$5'7?^S(')$?P_:BW7]UZL2@1\%K536OC@R2N(
MVH*2WYA^VO\ J#]9PZCF/<I=;?[S2?ZP_6N,?HE[_P!2]&R.=J*=F^+_ #^D
M8\\?Q7HEMO ;A@J]3F+&/$:#%,M&3ZO/P;KN/IS*PCAE3(+7OXT)!A%1U^+^
MS$Y(C^'[5MU_=>K$H$?!:U4UKXX,DKB-J"DI7F&Q3G593:*D:;+2M1W.9^4\
M $1W,BB+#CJO%G^VA%?\H=LMQUEW/,)&Z37[\Y&-*;G;,#(;)8%2AC,I"CJ3
M3( 6:5/M1FABI$X8\1^S3^N;+)*(])O9F7:;-#-RA0,.0/VJ?UQQRB?2+W4)
M;9^K:,Q05X_:'MF)#B@373FQ"N-1AN-I(P*]U_S&6>)&7U1^2;4KFQ:TF"Q[
MGJN0E PE4?@JL^K*YI-&"1L3T.6'*#]45M;=6T<?":.H0G<'VP3B!4AR5%:K
M=I#(0T88[?%7K^&799B)WC:25!+X.C^G%04HQY=/PRL9+!J/VHM9;?[S2?ZP
M_6N1C]$O?^I>B59A,78JG5S&=0BC8?:!X'Z=LV$AXD8GX,^:AKLHYB,=$%,K
MSG?A[D%L6\=G&KR LS=!6@QX1  RWM>2,TB[$Q8*@4<>HZ_?E^&?$30K9(*$
MT?[$W^I_ Y3AY2]R [1]TE_U/X''#RE[E"!L5+R*!_,/UYCP%D>] 1VH6_UF
MY*>)'_$1F1DCQ3K\<DGFU/-#:,45.1!I5C_#!(Q@: OWJK:G+ZL",0!4]!T[
MY9E-P"E2F_WE3_7_ .:LA+^['O\ UKT=H_V)O]3^!QP\I>Y0W3U+7X>S?%_G
M].//'\5Z)9"AD8!>I.V8D198IKJK!KA:=BM<S<I]8^#(H;7/[YOH_P"(C*<_
MU'\=%*M-_O*G^O\ \U99+^['O_6O1*LPF+>*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*ID-1B'^ZA]_P#9
MF7XD?YOVLK0-S()6)4<1X9CR-G;9"OI=P+>16/3H?IRS%+AD"H7ZQ;&"0^#'
MD/IR6:/#)2W:ZG,U(T;P %!_3#'+([!-JWF3^\'^J/UG)ZGG\%DBKM@MQ'7^
M4?QRZ9J<?=^M)YI5JB%)6KXD_0<P\HJ18E%Z>.$$K'H: ?/_ #.78]HR*0W(
MA:U6G9JG\<)%X_BO1*XD+D =2=LPP++%.[VU%]<<*[ ?%FPG#CG7DS.Y037L
M41HD8/NQ)_#*..(Y1^:+5]>8L(R10E=Q]V6:C<1]RE9Y@^VO^H/UG(ZCF/<I
M2R/J/GF(&*?:WJ,EJX5#0<:]!XGQS8Y\A@=NYF2H:=JKW+B.3XE;;H/X97CR
MF1J6]H!=ID8MKDIVW QQ#AG2CFI/?Q(2#"*CK\7]F1.2(_A^U;5+B[YJG[O@
MG($&M?GAE.P-J%K:CKR%923T(%/NR&H'J4JVD(1%*>Q6GW Y9A'IE[E"RUWM
MI/F/UC(Q^B7O_4O11T52TRT[5_5E> 7(("M;?[U?[-OXY9'^\^)3U='9+<RR
MEZ\5+$TZ]3B("4I7R%K2FM^B']W$*]N1+9$9 /IC^E%JGF+^]_V(_CDM3]7P
M27>8/MK_ *@_6<=1S'N4MZZ.7!A]DJ*8Y]Z/DI4] 0M*".@!K]V1TX]2A7L)
M/AG(\-O^&RS&=I_CO4)-F Q3B6,ZC$C#[2G@?IS/(\2(/P9<U#6Y@S\%^R@X
MC*\YWKNV4I=F(Q1E[9&RXL#4,*@],R)PX*20NM-6EA(H2WL=\,,T@MJNOPK%
M)\/<5(]\GJ(@'9)7>8/MK_J#]9PZCF/<I;UAOW<(_P G^ QS<H^[]2E1L+-&
M1I9*\5[#N<AC@"#*710KV5\I=0D8%2-]V.60R"Q45!4[W_>G_9+_  R,_K^(
M4\W:JP6X)/2J_J&#+M/Y*49JMVD,A#1ACM\5>OX9D99B)WC:25!+X.C^G%04
MHQY=/PRL9+!J/VHM9J(YP1,.@J#\_P#,9')O&*E3T%"TH([5)^[(8!<E#0N?
MJMP6[<S7Y5QXN&=^91:/2U%G+)*?LJ.0_P!EF2(\$C+NW^;+DD+.7-3U.:TF
MV#6!6\5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL57P.$8%AR'A6F3
MB0#ONE&?7(?]]?\ #G+^./\ -^U*V6[B8$"*A['D33(F<3_#]J$%F.A,M!N!
M#)0_M"GTYEZ>52][((.]MC:N5/;I\LHG'A-(3"PU*>Z<+RJ*[[#IW[9E8\LI
M&K2"MU'_ 'I_V2_J&#)]?Q'Z%/-&QL%NVKW&W_ C+P?WA_'1/5()D,;$-U!W
MS6R%%@F=/3M?B[M\/^?T9E\L?Q9=&Y$+6JT[-4_CA(O'\5Z)7$A<@#J3MF&!
M98IW>VHOKCA78#XLV$X<<Z\F9W*":]BB-$C!]V)/X91QQ'*/S1:OKS%A&2*$
MKN/NRS4;B/N4K/,'VU_U!^LY'4<Q[E*59A,49>V1LN+ U#"H/3,B<."DU2ZT
MU:6$BA+>QWPPS2"VJZ_"L4GP]Q4CWR>HB =DE=Y@^VO^H/UG#J.8]RENY:EK
M&/\ */ZVQE] ]_ZUZ(33+/ZXX4[#J<IQ0XS2!NK->Q1&B1@^[$G\,LXXCE'Y
MIM7UYBPC)%"5W'W99J-Q'W*5FJ_W4/\ JG_C7(Y?IC[OU*43)<)'#&63F*$=
M:4.6F0$8V+2I6FH*S#TX1R[4;^S(0R"_3'?WHMVF-ZS3 "C,#0??AQ;F2A)J
M9@,4XUQ#&D0/4*:_<N9V<4(^[]3(MWK!4@)Z?]<XSV$/QW*5#7D*RDGH0*?=
ME>H'J4H6*R:5#(*<5ZY2($CB0A\J0FVE_N(GE7[8V'MF;B],3+JR"W3K_P!0
MF*6K*_W@X,>2_3+>U!5-:@%HB1CW)/CD\\> "*G9)\P&*=68]:V=1U!K^HYL
M(;P(9=$ES7L4Y4>E:&O[1V^\?TS/Y8_>SZ(&>P,,:R@U#==NAS'ECH"3&G0:
MI)!T8_([C&.64>JVC=>0$(]*,P^(?=E^H'(]Z2D^8+%-;G_>:/\ UC^MLS9?
M1'W_ *V717EM_P!)>E)X_"_T?YG+#'Q>$_ IYK5N/7NA3H#Q'T X.+BR(ZH*
M2W^LSLGBY_7F.8\4Z\RA7GFAM&**G(@TJQ_AEDC&!H"_>GDK:G+ZL",0!4]!
MT[Y9E-P"E3UAOW<(_P G^ R&;E'W?J4M>7?[W_8G^&.F^KX*$5#<KJJM#0+3
M>/Z,NC(908\NY/-":&/1FXML:$?3E&#:5% <]_$A(,(J.N_]F$Y(C^'[5MU_
M=>K$H$?!:U4UKXX,DKB-J"DMZK_=0_ZI_P"-<.7Z8^[]2E*LPF+>*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5.?+G5OH_CFPTW5F$]S9
M,F)?FA_O!)\T_P")C+(<VG)R8U^2O_'Q_P \_P#F9D\C5AZO4LH<MV*JB=,*
M5V%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78JM;I@
M53P(=BKL5> ?EY_O?#\V_P"(-F5/DZ_'S>_YBNP4+W^[?_5/ZLKR<C[BI8AF
MA:G8J[%78J[%78J[%4187?U-P]*T[=,MQSX#:0BWU2)R28A4[]?[,O.6)_A^
MU-J5UJ[3+P4!5\%R$LQ(H;!;0MK<FU8.O495&1B;"$>^L#[2QJ'_ )NN9!S#
MF(B^]-H6_O?KA#4I0!>M<IR3XT$J\6K?"%D4.!TKU^_+!FVJ0M;676IF9>"J
M$3P'?YX)Y>(4-@MH',9"/T_4A9AE*\@W7>G\,R<>7@!%7;(%4&IQ+N(17YU_
MAD_%C_-6T->ZBU[]K8#H!TRF>0SYH)MT5[Z<314^T0:U^7],(G43'O6W17OI
MQ-%3[1!K7Y?TQ$ZB8]ZVY[WE$(J=#RK7Y_UQ,[CPK:)M)WM8ZE0T1/0^.6PD
M8#E<4A&:7>^NX6- BC=J;_CE^*?$:B*'5(*3SS_O"ZG]HD'Z<P92WL=[!&G6
M%EWDC5F\>F7^,#SB&5H2]OFO"": #H!T&4SR&;$FV]0O?KK!J4H./6N')/C-
MI)MT5[Z<314^T0:U^7],1.HF/>MNL=0:SK2A4]5/3&&0P4&D3^F!$#Z2!2>_
M7+?&KZ12;2Y92AY [UK7,4&MV*9'6%EWDC5F\>F97C \XAE:$O;YKP@F@ Z
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M%78J[%78J[%6\5:Q5U,5=BKL51T.KO$O$T8#H&%<R8YB!7/WIM3N]2>[%&V
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M"6";^F;:U(?8D_"#]&9M<,-V?1S:=%&J2/LO$5IU9CB<<0!(]RTHV$$5Y,0
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M,)0#3]K[J;;X3D'%Q;K: N91,[,.A)/WG,61LDL41>W@N$C45JHH?PRV<Q(
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MNQ5V*NQ5V*NQ5V*NQ5=%&92%'4],D!>RHW]"3?R_BO\ 7+_ EW?<RI2FTN6
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M(VD.JE?KR\I% [J/UG):@61[E*K=W8TJD<0'*GQ,<LG/PO3'YIY-1R#5D8,
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M:_ZH_IB9S&WZ%LK=2#LR)*U3WV XU^61R78$BI1.I3RVC<(AQ3:G$=<NR2E
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M16H%1]V^6$2Q_2=D\D0\K7D+M,M"/LM2F6DF<29?!*0YK6"<0QF:VI'N0WQ
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MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5&ZI>"\8,M=E
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M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%5K=,"J>!#L5=BKP#\O/\
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M034UZ[_++)Y(@GT]5M#W6KF5?310B]P,JGFL4!002B+.8PVSD=>5/OXY; U
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M[%78J[%78J[%78J[%78JF0M;?_?A_P"!/],R^&'\[[&2!N55&(0U7L>F8\@
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MH-J';Z,IEDL\2+1L\T%_\;$HW?:H.9$I0R;G8IYJBWT,4;QI4;;$]6)R0R1
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MPB'4$) "..W3(^G(.XKS0^FQQ*I>4@D=%RO$(@7+Y("*M+J*^;T_2 KT(_L
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M!5T9A.LL:[5K3Y';)X3Q"0"0DGU9N7"AY>&:_A-TP3C73Z4<<?<#]0IF=GV
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M%H',9#8/'<853*'S!+&*&A^8_I3,L:B096A[S5)+O9CMX#IE4\IGS1:'AF:
M\E-#E49&.X0F7^(I:4^'YT_MS+_,R\F7$ELTS3GDQJ<Q)2,MRQ5[[46OJ%@!
M3PRW)D,^:2;<-181^C0<?QZUQ\0\/"MK;*\-FW):5I3?(PF8&P@&E]OJ36[M
M( *M6M>FYKDHY3$\7>FU#USRY]Z\OXY7Q;VA4OKYKUN34K2FV2G,S-E2;7#4
M6$?HT''\>M<EXAX>%-MV6IO9;+T\#TQAE,.2@TB/T_+RY;?+MEGYB5VMH>WU
M)K=VD %6K6O3<URN.4Q/%WK:&D?U"6/<URHFT(B]U%KV@8#X>E,MGD,^:2;=
M?:BU]0L *>&.3(9\U)M4M-8DM!Q!!'@<E#,8+;5YJTEX*,:#P&">4SYJ3;5E
MJCV6R]/ X(93#DH-*LNO2N0:@4[ 98=1(IM1N=4>X8.: KTID)93(WW(M4N]
M8>[7@P%/;_;PSS&8HJ2I7VHM?4+ "GAD<F0SYJ3:I::O):"@-1X')0S&"VZ[
MUB2[%":#P&,\QFI*G9:BUE4*!\76N1AD,.2@TAXW],AAV-<J!I"O>7[7;!S0
M$"@XY9/(9FU)M%IYAE04V/N1EPU$@RXD%=7KW9JYKX91.9GS8DVH94K>*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*NQ5V*ISY<ZM]'\<V&FZLPGN;)DQ+\T/\ >"3YI_Q,99#FTY.3&OR5
M_P"/C_GG_P S,GD:L/5ZEE#ENQ543IA2NPJ[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%5K=,"J>!#L5=BKP#\O/\ >^'YM_Q!LRI\
MG7X^;W_,5V"A>_W;_P"J?U97DY'W%2Q#-"U.Q5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5,AH$I[#[\R_P O)E2!N;<V
MS%&ZC,>4>$T4(O1 #,M??]678/J"0H:C7U7K_,<AD^H^]!5XK:!@"TA!IN*'
MK]V6",.LOL2IZI9"R8*#4$5_7D<L. T@BDQU"$3SQJ>A45^\YE9(\4XCR9%!
MZM?M)(5!(530 ;=,HRY"37<@E7AF-] X?<I0@Y8#XD3?1>:HEV;6U!7J217P
MZY(3X8;)Z)=::B]NP:I/B">N8L,AB;8VC+]/JEQ55K^T%]_]O+\@X)[)+<MK
M/.W-CQKTJU*8F$Y&SM\5=KXVC)-3QZ^/3#J/X?<I6>8/MK_J#]9R.HYCW*4%
MI]/42O\ ,/UYCX_J'O0$3KM?6:OM3[LMS_4I2[,5")@@:)T+ BI%/ORZ,2"+
M2C-1_P!Z?]DOZAE^3Z_B/T)/-7?_ 'L^D?\ $,L/]Y^.Y/5!:G?.TC $@*2
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M'1*<PF+L53G6/[F+Y?P&9^;Z8^[]#(J>E?W4W^J/^-LCB^F7N_6H2^T^VO\
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M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BJUNF!5/
MAV*NQ5X!^7G^]\/S;_B#9E3Y.OQ\WO\ F*[!0O?[M_\ 5/ZLKR<C[BI8AFA:
MG8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%4QT'^^'R/ZLR]/]3(*=[>R+(X#L &/<^.1G,@G<\SU02C]$N6N
M^4<AY+3OF1@D9W&6XID-T/I ^"8#^4_J.5X>4O<@(&Q0O(H'\P_7F/ 61[T!
M':D&-P>'VMJ?\",OR7Q[<_V)/-<^K!S2:,$C8GH<D<H/U16U'4;1%598ZA6[
M'(9(  2CU4JGF#[:_P"H/UG):CF/<I=YA^VO^H/UG'4<Q[E+K;_>:3_6'ZUQ
MC]$O?^I>BM;3*EO4KS ;<5I].61D!#E>Z5*'4(V8<81RKM\7?[LKCD%[1^U%
MN^LRK*\B+2GVUZ]O[,>*7$9 >]7#48;C:2,"O=?\QCXD9?5'Y+:E<V+6DP6/
M<]5R$H&$JC\%5GU97-)HP2-B>ARPY0?JBMJ.HVB*JRQU"MV.0R0  E'JI2[,
M1BG-Y_O+'\_^:LSY_0/?^MD>2G-_O*O^O_S5D9?W8]_ZUZ.\N_WO^Q/\,=-]
M7P4(?1O[Y?G_  RK#]00%6%@MSO_ #G]9R<34_B4]41>WL<3L&B!->M>OOTR
MV<P";BI*G/>>I"0L?%21O7O]V0E.X[1H+;6J_P!U#_JG_C7'+],?=^I2[5?[
MJ'_5/_&N.7Z8^[]2E4O6"I 3T_ZYR4]A#\=RE0UY"LI)Z$"GW97J!ZE*MI"$
M12GL5I]P.681Z9>Y0WI,@6&2J\J$$K[8XCZ9=5"B-1B/^Z1]_P#9D/$C_-^U
M;;O9C+,A9>)'$4K7OAF29"Q7)2I:Y_?-]'_$1E>?ZC^.B"K3?[RI_K_\U99+
M^['O_6GHWJ(YP1$=!4'Y_P"8QR;QBI0%I:->-Q7KUS&A S-!%)GI;A(I 1RH
M02*]1F9B-1EU9!0&HQ'_ '2/O_LROQ(_S?M1:GK$QE>K+Q- *5KD,Q).XI!0
M&8R&\5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL
M5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL53GRYU;Z/XYL--U9A/<V3)B7YH?[P2
M?-/^)C+(<VG)R8U^2O\ Q\?\\_\ F9D\C5AZO4LH<MV*JB=,*5V%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78JM;I@53P(=BKL5>
M?EY_O?#\V_X@V94^3K\?-[_F*[!1O16-O]4_JRN?(^XJ6'YH6IV*NQ5V*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
M$6%W]3</2M.W3+<<^ VD(M]4B<DF(5.Y^+^S+SEB?X?M3:V76/A*1J$!ZTZX
M#FVJ(I%H6QO6LFY+\B/'*H3,#: :19U<)O'&%)ZGO]'AEWC5](I-H:YOC-)Z
MJ_"=J=^@RF62SQ+:*;5UEW>-2WCTRXY@><0FT+>WYNZ"@"CHHZ93/)QH)MVH
M7OUU@U*4''K7#DGQFU)MVH7OUU@U*4''K7')/C-J3;HKWTXFBI]H@UK\OZ8B
M=1,>]765^UF32A!ZJ>AP0R&"@TB1K"Q;QQJK>/7+O& ^F(";0MK?M;,7&Y/6
MO?*89#$VQM%?I9%W$2\O'M]U,N\8?S0RM!R7KR/ZA/Q909DGB8VC6U=9=WC4
MMX],O.8'G$,K0M[?F[H* *.BCIE,\G&@FT+E*$;-J'JQ+%3[)K6OS_KF1+)<
M1%-K'ON<0BIT/*M?G_7(F=QX5MVG7OU%N5*[4I6F''/@-J-E*VN#;,''497&
M7";0KWU\MUNJ<6K4FO7+<F02Z4DE7&L"0#U4#D=^ARSQK^H6MH>]U$W0"T"J
M.BC*IY.+;D%):NKWZPJ+2G 4K7KT_IC.?$ .Y;==7OUA46E. I6O7I_3&<^(
M =RVZZO?K"HM*<!2M>O3^F,Y\0 [E1TMXUL DZ!]OA->WSWS(,S':8M-J\-X
M98I&("IQXJHZ;Y9&=QD>0J@FTGM+QK1N2_2.QS!A,P-A@#2-&KHIY+$H;Q_L
MIE_C ;B(ME:!-T7?U&W-0<Q^.SQ%BW?77UMR]*5IM]%,,Y<9M2O>]Y1"*G0\
MJU^?]<D9W'A2OL]3-L"A 9#^R<,,O#MS"@JLFKT4K$@2O4C<Y,YMJB*3:$M+
MQK1N2_2.QRF$S V$(T:NBGDL2AO'^RF7^,!N(BTVET\QG8LVY.8LI<1LL5F1
M5O%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%4Y\N=6^C^.;#3=683W-DR8E^:'^\$GS3
M_B8RR'-IR<F-?DK_ ,?'_//_ )F9/(U8>KU+*'+=BJHG3"E=A5V*NQ5V*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*K6Z8%4\"'8J[%7@'Y>
M?[WP_-O^(-F5/DZ_'S>_YBNP:9>8H>^ BU8;-$86*GJ#3-!(4::EF15V*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5K%78J[%78J[%78J[%78J[%74Q5U,5=BKL5=BKL5=BKL5=BK>*M8JZF*
MNQ5V*NQ5V*NQ5V*NQ5'0ZN\2\31@.G(5S)CF(%<_>FU.[U)[L4;8#L-AD9Y#
M/FI*%RA#L5=BKL5=3%74Q5V*NQ5V*NQ5V*MXJ[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8JR'0(."%C^T?P&;73QH7WLPFN9K)B7YH?[P2?-/^)C+(<VG)R8U^2O_ !\?
M\\_^9F3R-6'J]2RARW8JJ)TPI785=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BJUNF!5/ AV*NQ5X!^7G^]\/S;_B#9E3Y.OQ\WO\
MF*[!V*I1K.FF;]XG7N/','/BOU!B0D&:M@[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[
M%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%6L5=
MBK>*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5%:?8&\;_
M ">YR_'CXRD!E2((P .@S= 4V+L*L2_-#_>"3YI_Q,99#FTY.3&OR5_X^/\
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M(?\ C(WZES69^;BY.;,,QFEB7YH?[P2?-/\ B8RR'-IR<F-?DK_Q\?\ //\
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M_>N?_C+)_P 3.9L.0]S?'D]=_,3_ '@E_P!A_P G%S7XOJ<:'-@_Y3_[UO\
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MTH7WU>O4S+%7VD_VLP\4JOW-$#2=>:=*FU&W]"V*H30'D2!P'8<0?;Z,KA(
MV6,37-C'E/R-=Z#.LI>/AN'56?<4_P!0=#OE\\@D&R4@5#\W+(?NIA]KXD/N
M.H^[?#@/1<99KYGU0Z1;23+]I1\/S8A1^)S&A'B--419>%76JS7E3([-RZU)
MW^C-H(@.95,XT:YU36;?TX@JP\?3#,./PTX[=_IIF+(1B6DT$3H/Y9R:?-'-
M-*HX,&HE=R#L*FG7!+-8H(,[3'\V?]Y4_P",J_\ $'R&#G\$8^;ORG_WD?\
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MHO\ 3'/S7)S8IYV\HS:<\ETQ4QO(2*$\OC);I3,C'D!V;(RO9Z!^8G^\$O\
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M^<KC01PB(*=>#BH^CH1]^1EC$D&(*.U#\R;R]4J"L8/7TP0?O))'T9 80$"
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MKL5=BKL5=BKL5=BKL5=BJUNF!5/ AV*NQ5X!^7G^]\/S;_B#9E3Y.OQ\WO\
MF*[!B?YE?[QG_67]>9&'FVX^;QW-HY;L5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL55+:X:U=9$-&4AE/@0:CK@(M4SU;S5<ZR@CG?DH/(#B@WH1^RH\<A
M& CR8B("498R=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BJ-T:\%A/'*>B.K'Y [Y&0L((M]"HX< C<'H<
MT[@KL5=BKQWSWYS;5W,$1I"II_QD([GV\!]/RV.+'P[N5"-,-S);6:_E_P"4
MFOI!=2BD*'D*_ML/X#N?H\<QLLZV#5.5;);YZU\:W<ED-8T'!/>G4_2?PID\
M<>$,H"@QS+F;L5>O?E?_ +R'_C(WZES69^;BY.;,,QFEB7YH?[P2?-/^)C+(
M<VG)R8U^2O\ Q\?\\_\ F9D\C5AZO4LH<MV*JB=,*5V%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78JM;I@53P(=BKL5> ?EY_O?#\
MV_X@V94^3K\?-[_F*[!B?YE?[QG_ %E_7F1AYMN/F\=S:.6[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78JSKR?^8GZ*407
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MN\A6:RWUS(>J,P7VY.:G\,&0[!9G9C?FOS)</>2%9&41N40*2 .)IT]Z9?"
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M!LF=]9:7YE57CD2W8=5HD?W@\:_,'*P90\V()"IJ_F*VT.R-E!)ZSE6C!KR
M#5J:].^P&,8&1L[* 2;6_ESJT-G:2)+(B,78A795)'!>Q..6))68LH/\J]2B
ML/7]:1$KZ=.;!:TYUI7)9@32<@M&?H[2]4G-T9@OQ<GB9E4%@=^O4'VZY&Y
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M4E_>#TE+@2,0%(X, :]-\R)V8MDMPF7FG48I]3@D1U9 8JN&!44DJ:GIMD(
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M;[D#(F0"+;ATF:X7FD;LO\RJQ'WTQX@%M"$4R241::;+>_W2,_\ J*6_5@)
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MA+O>9D<=CF<Y#L5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKU[\K_P#>0_\
M&1OU+FLS\W%R<V89C-+$OS0_W@D^:?\ $QED.;3DY,:_)7_CX_YY_P#,S)Y&
MK#U>I90Y;L55$Z84KL*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5:W3 JG@0[%78J\ _+S_>^'YM_P 0;,J?)U^/F]_S%=@Q/\RO
M]XS_ *R_KS(P\VW'S>.YM'+=BKL5=BKV'R/_ *-IG-/M4D;_ &0+ ?J&:[)O
M)Q9\WCQ/+<YL7*373=3NX$XP-($KT2M*_1E9 /-@0&1?E.*7;_\ &)O^)IE.
M;E\6&3DCK?\ X[OTM_R9.1/T?CO1_"EOYI_[V#_C&OZVR>'DRQ\F=^>M=.A0
MK*B@R%N"%A7C45)_#,3''B+3$6H^5-6/FVT=;@"M3&U!L10$'Y[Y*<> [+(<
M)8=^4_\ O6__ !B;_B:9D9^7Q;<G)0U_3?TIJK0] SJ#\N(K^&&)X8VD&@RC
MSEYH/E01VUHJK\/+<;!:T%![T.^48X<>Y:XQXN:4:IYSMO,%H4N12X /'BIH
M''2A[ ]\L&,Q.W)D(D%#>0]<33$=8X'EG;]I%J /V1X@5ZY++&^NR9BV7^4[
MO4;F1C>*%BIML >5>U-_OS'F(CDU2KHPG5;5;36%1!1?6B-!_E<&/XG,F)N'
MP+<#LFGYO?;A^3_K7(8.K'&\ZS,;WL7E7_CD_P#/.7_B3YKI_5\G%ES>.YL7
M*>QZ(_UK2/WG^^I!]"\@/P&:V6TOBXIYL4\A:ZFF(ZQP22SM^TBU '[(\0*]
M<R,D;Z[-DQ;+_*=WJ-S(QO%"Q4VV /*O:F_WYCS$1R:I5T8-YBOV\M:A,UM1
M3MV!'QJK';YYE1''$6W <09W^8&O2Z'"CP$!B_$U .W$GOF)BB)'=I@+>;>4
M-3CL;CU98VE;?@J $\SWIF;D%AOD+#.[?5]3OKD%(BEN6%1( #P[UKO7Y9BF
M,0/-IH!*/S<M5C>&0"C,'#'QX\:?KRS >;/&7G>9C>S_ ,D>>8M/B^JW0^#?
MBU.0HW4,/IS$R8R38:91O<)T/*.FZV>5L_%NO[I]Q_L6K3\,JXY1YL.(AB/F
MKRG/I<B(SF1)&XQL:[$]B-]_UYD0F"V1E;,O,>ICR-;1Q6RCDU14C^4#DQ\3
MN,QH#Q#NU <12BW\^P:Q;M#J ^([ HM?DWL1EAQF)N++@KD@/RG_ -ZW_P",
M3?\ $TR>?E\663DB9=$76M8DC?=%(=AXA57;Z21@XN&*+H)WYD\PWNGS>C9P
M$Q( *B-V5MN@IM0=-LJA$$62Q !YH;\P=*74;1;W@4E4*7!%&HU!Q;Y$X<4J
M/"F!HTK_ )6 &SDY=/4:ORX)@S<T9.:"\K?F!+J5TL#*HB:H55&ZT!(_5DIX
M@!:90H(+SEH*W>IQQ+MZP5GI\V#'[ER>.513$T$Y\Y>:#Y4$=M:*J_#RW&P6
MM!0>]#OE6.''N6,8\7-*-4\YVWF"T*7(I< 'CQ4T#CI0]@>^6#&8G;DR$2"W
M^5N@I<E[J05X'B@I6C=2?GTICFE6RY#T32Q\VW\UR ]NX@9N/]V]54G[7+V[
MY PC7/=B8BF._F;H2:;,LL8HLH)('3DM*_?49=AE8;(&V%YDMKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKV+R/\ Z+IG
M-/M4D?\ V0+4_4,UV3>3BSYO,/+^D?IVX6 MQY\OBIRZ*6Z5'AF;.7"+<@FG
MHUK^7EQ:)Z4=XRIO\(3;?K_NS,,Y0>C1Q^3"OR[_ -[XO]G_ ,FVS)R_2VSY
M)_YTTW]*ZG%"=@RJ#\JL3^&58SPQMA$T$U\Y>:3Y5].VM55?AY=-@M:"@]Z&
MN5XX<>Y8QCQ<U:QE7SY9-ZJ@2J2H([.!4$>QKN,!_=E!]!8Q^4_^];_\8F_X
MFF7Y^7Q;,G)-?-7G^32+EH;=5XJ1S)'VV(!/],KABXA98QA81'Y@6<>KV27R
MBC *U>_%Z#B?D3@Q'A/"B!HTEGE+S!]2MC%:0.\^_*0+5>1Z5->@&3G&SN64
MA9W9=Y3DO;I7^OJ #3@"%J>O*H';YYCSH?2URKHP/RO;K;:OP795DF4#V"N!
MF7,W'Y-TN3OS3_WL'_&-?UMCAY+CY,,S);7L6K?\<<?\8(OU)FNC]?Q<4<WC
MN;%RF8?EMH2:K.7E')8QRXGH6/2N8^:5!JF:3?S#^9,UC<M%"J^G&W AANQ&
MQ[[;Y5#""-V(A81/G_3H]5M$OT6CT1B?%7IL?D3@Q'A/"B!HTW^76GQZ=:O?
M.*M\1KW"(-P/G0XY39X5F;-(+0_S$DU.Y2*=$,;N H W5J_ :_.F2EBH;),*
M"S\W/[V+_4/Z\<"XTW_-K_>>/_C)_P :ME>#FQQ\T;Y6AIIR_4BHE(J2W^_*
M_%R_A]';(S^KU,9<]T$VM7EC&Z:A;F5#^U'Q(X]^5/[,EP@_265 \F.?EQK4
MD%RMLA_<NS,00*[(2-_H&798V+9S&R8?F9YAFMY#:J1Z3(I84%>I[_1D,,0=
MT0'5,]'_ ..*?^,<O_$WR$OK^3$_4E'Y6:$ETSW,@KP(5 >S=2?H[99FE6S+
M(7-^:DHN/LKZ'*E*?%QKUKXX^"*\U\-*_-FHV>K7$<L-0&/[_;CM4?%\Z5KE
MD 8C?X,H@AZ/KL=TL2?H[@ .VVZT^'C^SF%&OXF@5U8?YMUN6>U]&]MV67M*
M*< U>QWZCKOF3"-&XEMB-]GG>9C>[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7KGY3
M_P"\C_\ &5O^()FOS\_@XV3F@7_*0.Q9I]B22 E/QYY+Q_)/B-_F!KL-G;"Q
MA8,:*I ->*)2E3X[#'%$D\16 WM-?*'IC2T,PK& [./99&/\,KR?5LQES85Y
MA\XMYJ"6RQA%]12IK4]U%?\ @LR88^#=M$>%E_F75!Y'MXXK95Y-4 D?R@<F
M/B=QF/"/B'=JB.([M>5M9'G:&2"Z4$K2I&U0U:$>!%,,X^&;"R'#R8Y^75J;
M/4)(CU170_[%@,NRFXMDS84_,FE_I;5V@Z!F2O\ JB-2?P&,)<,;6)H,J\S:
MI<Z'PM]/@)0"I98V91O]D4VKW.40 EO(M<0#S4O,%B?,>G^O-&8[B-2U""I'
M#[0WWH1N,,3P2H<D@\)27\K-"2Z9[F05X$*@/9NI/T=LLS2K9ED+F_-247'V
M5]#E2E/BXU^U7QQ\$5YKX:7>9_,<#7"7=C\,@KSJM!7H#3Z37)PB:J3*(VHL
MYUK7I;33DND(]4I&Q-!2K\:[?3F+&(,J:0-Z>.WMXU\[2ONS'DWS.;$"G*&R
MKI.E2:O*L,0JS?<!W)QE+AW4FGMEO!$J16=TZ2R@ A6 J>'0\=_[=_?-82>8
M<3S8AYNT^]\S7#6ZH%2+XEJ=F#;!J_1T[;YD0(@+;(D1><S1&%BIZ@D&GMF8
M"WLB_+O_ 'OB_P!G_P FVRK+]+"?)Z'YM\C_ .))%D]3AQ7C3CRKO7^89APR
M<#1&7"LTG3[?R%$[22U9J$] 6XUH%6I\<9$Y"DGB8S^6UV;V_FE.Q='<_P"R
MD0Y?E%1#.>P3CS)YY3RY,T,$89B><C$T^)A7MUV_IE4,?&++&,;0WY=:9'86
MSWT@JPY$'^54&]/<[Y++*SPIF;-(;0_S-FN[A4E5?3=@E%&Z\C0;UW]\E+"
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MXBD#&5%4$'DA;G] X]?IR9S!D<B/_,SS$D1BAC(:1)!*W^3QK0'YUR&*/5$
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M/M4URO'/@V+&,N'FK6$*^0[)O58&5B6 '=R* +\J;G ?WA0?46,?E-_O6_\
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M?[W3?,?\17+,?(,H<F7?EUJ<=_;/82&C'D /YE<;T]QOF/E%'B:YBC:%T/\
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MU/*O+E7>O6M?'#2JUYJ4M_3UI'>G3FQ:E>M*X  % INUU6:S'&*1T'@K,H_
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MY1,R-TJA*FGS&$BTU:VXN7NF+R,68]68DD]NIP@4J(M]8GM5XQRNJ^"NP'W
MY$Q!12#)KODDNPI=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKU[\K_P#>0_\
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M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J]>_*_P#WD/\
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M^R1X9BY9F-4U3-)S>6FB63M'(*.IHP_?FA'RRL&9_ 8 R*EYC\BVLEL;JS-
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M\03-?GY_!QLG-AOD;_CI)_K2?\0?,C)]+;+DS#S?YHC\N7 *1*\S*&9V[+T
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MPG5:L=S0]:?QS)R'A%!MEL&2:AYBN=.F,<EM6VK3D@+?!_-MM]&4B (Y[L
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M6'4#VZ9=BGQ!G"5L^CL3H-HC6$2R/123W8$;M7O\LQ+XCZFF[.['M9\PP:G
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MJ*Z9K1E?905!/ARA"U^BN1 N'X[T 7%F/F74;ZT96LXTEC(WJ"6!^AQMF-
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M822!BIH P(&RC<[_ (8PD9@VH)D'H>O:G=+&DM@J2JVYK4FG8K1ES#B!_$T
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M:/)<B! P*%*.7/+:@HY%<LB(D[6R %M?E?\ [Q2_\9&_Y-ICFYK/FPS\N_\
M>^+_ &?_ ";;,G+]+;/DCOS4_P![!_QC7];9'#R8X^3)?S0_WBB_XR+_ ,FW
MRC#S80YJWY=ZG]8LC#$5]:/E0-T^(EE)IO3>F#***)C=NRU75[E^#0Q(.[L&
MX_A(:_1B1$=2I 8QK&H27>IP+,8R\<D:$Q!N/VP:?$3N*Y?$5$M@&R._-[[<
M/R?]:Y#!U1C3+RW_ ,<>3_C'-_QMD)_7\F)YL>_*<TNW_P",3?\ $TR[-R^+
M/)R0WYA:--#<R3LA])BM'['X1_3#BD*I,#LQ+,EM=BKL5=BKU[\K_P#>0_\
M&1OU+FLS\W%R<V89C-+$OS0_W@D^:?\ $QED.;3DY,:_)7_CX_YY_P#,S)Y&
MK#U>I90Y;L55$Z84KL*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5:W3 JG@0[%78J\ _+S_>^'YM_P 0;,J?)U^/F]_S%=@Q/\RO
M]XS_ *R_KS(P\VW'S>.YM'+=BKL5=BK:L5-1L1BJ?6_GJ]MUXK,:?Y05C][
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M@?##*(ES4BU&_OWU%S+*>3MU- /;M080*2!2.U3S1<ZN@BF?D@(8#BHW ([
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M>^<KN^C,,DA9#U'%=_IXURL8P-V(B HP^:+F"#ZJKTAH5X\5Z,23O2O?QP\
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M CL!XY$0$>3$1 =#YHN8(/JJO2&A7CQ7HQ).]*]_''@%VO"'H7Y7_P"\4O\
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MMD1:8:IYKNM63TYY.2 UI11N/D!D! 1Y,1$!*<M9NQ5V*NQ5Z]^5_P#O(?\
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MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK+O*?D/\
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M,//T:,C)/-4(\P64O'[4;/0?Y4+$'[P#]^40/"?QU:X[%C_Y46 B66Z?8#X
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MY._-0_Z6/^,:_K;'#R7'R9+K'_'%'_&.+_B:91'Z_FP'U._*_>RE_P",C?\
M)M,<W-9\WDV9[DM@<MAA5Z+YN;_#UA#9+L[_ !2?1\3?\,?N&8>/U2XFB.YM
MYUF8WLE_+O\ WOB_V?\ R;;*<OTM<^2<?FW_ '\?_&/_ (V.58.3#&RZ347T
MS2TFCIR6&,BN_P"RHS'JY5YM=66&Z5^9]R94$O%D) 84H:$]1F1+"*;3 ([\
MV-'2+A<J*,Q*/3]K:H/SVR.&71CC+SVT^VO^L/UYEEO+U?\ -G_>1/\ C*O_
M !!\P<'/X.-CYO(LSW*;PJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J]8_*7_>>3_C)_QJN8&?FXV3FI?EO=KJMI)9R;\:C_ &$E?XUQRBC:
MSV-K/S$N!H]G%9)WH#_JQT_6U,<0XC:8;FU?\V_]YX_^,G_&K8,'-&-$>23'
M)IE"I< 2"1$^TVY-!N-RM.^#)]2)<TET;6=,AF5K:VF]45X\:L>F^QE/;+)1
ME6Y'X^#,@JUSJZ7>K6[LCQD+P*R@*:D/Q.Q/<X!&HE%;)?\ FQ:NMPDA!X%
MH/:H)J/QR> [,L;(?RVM7@LG+;!F9E^7$"OX93E-EKGS2S\G_P#CX_YY_P#&
M^69^C+(@?)TJQZK(&ZEI0OSY5_4#DLGT_)E+D@/S,MWBO69J\652GR"@'\1D
M\)V3#DI7OE6ZL[07$C@1$*?3+/R^([#C2GXX1,$TD2%LAT_RQ::-9"]ND,K%
M5>E=ASIQ%*CQWKE)F9'A#69$F@G7D'68]3]00P+"B\=UWY$UZF@Z95EC7,VQ
MF*8IH'_'9;_C+/\ JDS(E]'P#8?I4_S4_P![!_QC7];8</)<?)AF9+<]M\IV
M*:#9+ZK"/D.;LQ"T9^FYVJ!09K)GB+B2-E">6M+L-%E+07(9W'#BTD;<JG;8
M &N2G*4N83(DL5_-32?JMPLZCX9!O_K+M^JGXY?AE8ILQE/]'_XXA_XQR_\
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MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5ZY^4_P#O(_\
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MPE!)'4D*3Q(KUWH=OHPSQ<6ZRA:90_FB;9P8X$2/]I%-"Q[?%Q[?+(>#?5'
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M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BJUNF!5/
MAV*NQ5X!^7G^]\/S;_B#9E3Y.OQ\WO\ F*[!B?YE?[QG_67]>9&'FVX^;QW-
MHY;L5=BKL5>N?E/_ +R/_P 96_X@F:_/S^#C9.;%;C\R[R-B 4H"1]G+QA#9
MP!*-<\WSZZ@28J0#R%!3>E,LC 1Y,A&DVTG\O&U6U6YCD^)JTCX^#E?M<O:O
M3*Y9>$TQ,Z*/C_*AI5)6="XZJ!\(/^M6O_"Y'Q_)'B,'N[![20PN/C4\2/?V
MS*!O=M!MFEI^5DACYSRK$?Y:<J>Q/(?QS%.;N:O$9=Y/T&30;>6*2A^-F5EZ
M%2BT/X9CY)<1:I&WG7D_R?\ XF]3]YPX<?V>5>7+_*7^7,W)DX&^4N%.+3\J
MWD%))E1S7BE*FGO\0_CE1S>3'Q&+>8/+\N@2>G+3?=6'1AF1&0DV VB_+7DV
M;S#5DHL8V+MX^ '?(3R"*)2I/[C\J7XDPS*[#JM.._A6K94,_>&'B,3TRSDA
MNHXMXY!*JU(KP;D-Z'K3\<R"=FPG9D7YCV4]HT7UB;UB0W'X%CX]/Y>N4XB#
MR%,(%4C_ "R>X@CFCD!:0*W$KQ"AEJ:MR/3Y;X/&HTCC5I?RI=DY13*[>%*"
MO@&J?U8/'\E\1*O(VB+>W :201M$Z,%8;N0WV1N/#WRS)*A[V4S09O\ F%H"
M:HJR/,L9C5R%8#X^AV^(>'OF+BEPM,#3Q_-BY2,T?3CJDR0KU=@/D.Y^@9&1
MH6@FGO"7T=K(EH-CP+*/!4HH'^?AFJJ]W"KJ\4\W:3^B+J2,"BUY)_JMN/NZ
M?1FSA+B#EQ-A?Y9\IR^8F(CHJ+]IVZ#V]S@G,064J95:_EN^GSQ21RK)PD1G
M6G%@ P)[M_#*#EL-?';7YO?;A^3_ *UQP=5QK//FG7-M:HTUQZJ%U 3TU2AX
M-O4?=CB()V"P(M*?*_D;_$$#3^KPXL5X\>5:*&Z\AXY9/)PFF<ITD>@Z5^F)
MT@Y<>9(Y4K2@)Z5'AELI<(MF32+\V>6_\.2B+GSJ@>O'CU+"E*GPR,)\8MC&
M7$G6C_EE+>QB6:01*14 CD:>^XIE<LU<F)G3+_(GEA_+[3!F5T?@4=>].=?U
MYC9)\5-4Y6Q+RQ:376H3K!+Z3?O"6X+)4>H-J-^O,B9 B+;)'9(/-D#PW<BR
MOZC@BK\0O+X1^R,N@=FR/)/]-_+"69!)<2+"#V(Y$?/=0/ORDYAT:SD0/F3R
M#-H:>J")(^[+L5^8\,G#*),HSM"^6/)\WF(DH0J+LSMX^ \3DIY!!,I4R ?E
M<)@1#<H[CJM.GSHS?JRGQO)AXC'=,\L?6+EK6XD$)0&K-0BHIM]I>M<N,Z%C
M=F9;6]3\ZZ&FM1*DDHB ;ER8 UV(INRY@8Y<)<>)IA'Y>:=/<&<6\_I<2G(\
M%DY_;I]H[4_CF5E(%6&V98I?6KRW#QCXY#(R["G)N7A[YD [-H.S+[;\JGX@
MSS+&QZ+3EOX5JOX5S&.;N#5XB1^9O)<WEZC-1XSMS7L? CMEL,@DSC*T5Y8\
MC'S! \XDXE6*A./*M%#=>0ZUR,\G":1*=)G:?E4\R_',HD'5 .5/F:C]60.?
MR8^(P_6M'DT:5H9:<AW'0@]",R8RXA;:#:!R263?E]I'Z3NU)'PQ_O&^C[/X
MY1EE0:YF@H>=]7_2MV[ _"O[M/DO]34X<<>$)@*""\M?[UP?\98_^)C)SY'W
M)ER>I_F!YDFT%8S"0"Q8&HKTIF!B@)<W'A&TH\H?F+)J$P@N0OQ[*ZBGQ>!^
M>69,5"PRE"DE_,W0UTV=98Q19020/YEI7[ZC+<,K#.!M1T/\O)-2B$\KK%&1
M4%MS3QZB@\-\,LM;*9TB;_\ +)TC,MO*LP%30"E:=:49A7(C-WH$U_Y9:.D\
MHN3( R,RB+:K50[C?W\.V.:6U+,II^9.@).6NC,H=4 $5!R;XO\ 6]_#*\4J
MV8P/1B_EKR++KJ>KR$<6_P 3=Z=:#P'CE\\@CLV2G2;2?E<9E+6\Z2D=J4^B
MH9LK\;O#'Q&"RQ&$E6%""01X$9EMR,T/_>B+_C(G_$AD9<D'D^@)F5SZ3;\E
M.WBHH#_Q(9J'">$/H#+>?4^_J</HKU^[?-KQ;6YE[6]VA98SZ2_LJNW@IJ!_
MQ$YJG#> :V*W$O\ QD?_ (D<VT>3F#DRK3OROEF027$BP@]B.1'SW4#[\H.8
M=&LY$#YC\@3:(GJ@B2,=644(]R/#)PRB3*,[4O)_D_\ Q-ZG[SAPX_L\J\N7
M^4O\N')DX%E+A3>R_*QYMI)E1MRJ4Y-3Q/Q"GXY4<WDQ.1C/F/RY)Y>D].2A
M!%58=",OA/B;(RMEFMZ=<QZ:DCW'*+A$1%Z:B@/'B.8WV_',>)'%R[VH$6RS
MR;HJ:5;-&DHD#,6+*!1:JHI]H]*9CY)<1:Y&R\J\R:"FC.J1RB;D*U4#8UI3
M9FS/A+B\G(B;3_3OROEF027$BP@]B.1'SW4#[\J.8=&!R('S'Y FT1/5!$D8
MZLHH1[D>&3AE$F49VI>3_)_^)O4_><.'']GE7ER_RE_EPY,G LI<*.'Y;2QP
M27$CA0BLZKQJ6"@G?<<:T]\AXV](XT?ING7+Z69%N*0\)#Z/IJ=@S5'/KO\
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M!LRI\G7X^;W_ #%=@Q/\RO\ >,_ZR_KS(P\VW'S>.YM'+=BKL5=BKUS\I_\
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MH%)3O\F^'(5,_@,:DQKSIYS/F%E6,%8D-5K]HMXG^&78\?"SC&D_MO.UIKL
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MQ5K%78%=BKL*NP*[%785=BKL5=BKL5=@5V*NQ5V%6\5=BK6*NQ5G.@_F D$
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M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL56MTP*IX$.Q5V*O
M/R\_WOA^;?\ $&S*GR=?CYO?\Q78,3_,K_>,_P"LOZ\R,/-MQ\WCN;1RW8J[
M%78JGWE/S6_EQR0.4;?;3^(]\JG#C82C;.9?,^DZH?5F4!^_.-N7TE00?OS$
MX)#DT\)"3^:_S"2YB-M9@JA'%FIQ^'^51ED,5;EE&'>Q;RSY@;R_,)E%13BR
M_P RY?./$&R0MFMWJ^CZN_UB8,)-N2D/\7SXU'XYC",H[!JHA)/.WG8:V!!
M"L*FN^Q8CIMV RW'CX=RSC&DQTWS3;0:6;5GI-PD7CQ;JS,1O2G?QR!@>*V)
MB;2?\O-:AT:X:2=N*F,J#1COR4_L@^&698F0V93%J&L:K%<ZA]81JQ>HC<J'
MHO&NU*]L,8U&D@;)K^9'F*#6_1^KORX\^6S+3EPI]H#PR&*)CS8P%(K6_--M
M=::ELCUE"1*5XMU7CRW(IV\<C&!$K]Z!$VA?RW\Q0:)ZWUA^/+AQV9J\>=?L
M@^.2RQ,N29BTJT?58K;4/K#M2+U';E0]&Y4VI7ODY1N-,B-E?\P]:AUFX62!
MN2B,*31AOR8_M >.#%$Q&Z("DXUOS3;76FI;(]90D2E>+=5X\MR*=O'*XP(E
M?O8B)M2_+_SA!H\;P7%5#-S#4)&X"D&F_;#EQF6X3.-L=\TI:)(OU$DI3XJ\
MOM5_R@#ET+_B9QOJS+3O-UCJ-FEK=DKQ54(HV_"E""H/AF,8$&PU&)!L)%Y?
M\WQ^6[B01 M:LVP_: '1A7\<ME#C'FS,;3?ZUHH?UZ$M7EZ='I7Y?9^BM,KJ
M?)AZF(^:-<769>4:".,"BJ  ?FU.^9$(\+;$4RG2_.MMJ5N+745)"THXJ:\>
MAVW#?KR@XR#<6LQ(W#;Z[I>AHWU2/U9#T+J2/IY_P&^/#*7-:)YI'Y,\W_H"
M5VD!:.3[?'J".A Z=SMEF2'$&<HVR%;K1EE^LAFY\N?"CTY5K_+X^],JJ=4U
M[L<\[^:QYCD4H"(T!"UZFO4G[AEV.'"V1C3&LO;&\5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK
ML5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5>O?E?_O(?^,C?
MJ7-9GYN+DYLPS&:6)?FA_O!)\T_XF,LAS:<G)C7Y*_\ 'Q_SS_YF9/(U8>KU
M+*'+=BJHG3"E=A5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*K6Z8%4\"'8J[%7@'Y>?[WP_-O^(-F5/DZ_'S>_P"8KL&)_F5_O&?]
M9?UYD8>;;CYO'<VCENQ5V*NQ5V*NQ5K K>*NPJU@5V*NPJ[%78J[%78J[%78
MJ[%6\5:Q5V*NP*[%78J[%78J[%78J[%785;Q5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5Z]^5_^\A_XR-^I<UF?
MFXN3FS#,9I8E^:'^\$GS3_B8RR'-IR<F-?DK_P ?'_//_F9D\C5AZO4LH<MV
M*JB=,*5V%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8JM;I@53P(=BKL5> ?EY_O?#\V_X@V94^3K\?-[_ )BNP8]Y\M3=64H'4 /_
M ,"P)_#+L1J39#F\2S;.8[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7L_Y=VAMK)">K%G^\
MT'X#-5F-R<2?-D^4-3$OS0_W@D^:?\3&60YM.3DQK\E?^/C_ )Y_\S,GD:L/
M5ZEE#ENQ543IA2NPJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%5K=,"J>!#L5=BKP#\O/][X?FW_$&S*GR=?CYO?\Q78+9(Q*"K"H
M(H1['%7A7F?R^V@S&,UX'>-O%?ZCOFWA/B#G1E:49:R=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MJ:>7="?7)A$G3J[?RKW/]/?*YRX1;&1I[M;P+;*$0450% \ .F:@FW"5,"&)
M?FA_O!)\T_XF,LAS:<G)C7Y*_P#'Q_SS_P"9F3R-6'J]2RARW8JJ)TPI785=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BJUNF!5/ A
MV*NQ5\^Z8_Z U%>6PCFXM_J\N)_#,L[AUP],GT%F([%V*H#6=%BUJ,Q3"H[$
M=5/B#DXR,>3(&GEVL_EO<V))B'JIV*[-]*_TKFPCF!YN2)@L=DT:>+9HG'S5
MOZ9?Q!LL+/T9+_OM_P#@3_3'B"V[]&2_[[?_ ($_TQX@MN_1DO\ OM_^!/\
M3'B"V[]&2_[[?_@3_3'B"V[]&2_[[?\ X$_TQX@MN_1DO^^W_P"!/],>(+;O
MT9+_ +[?_@3_ $QX@MN_1DO^^W_X$_TQX@MN_1DO^^W_ .!/],>(+;OT9+_O
MM_\ @3_3'B"V[]&2_P"^W_X$_P!,>(+;OT9+_OM_^!/],>(+;OT9+_OM_P#@
M3_3'B"V[]&2_[[?_ ($_TQX@MN_1DO\ OM_^!/\ 3'B"V[]&2_[[?_@3_3'B
M"V[]&2_[[?\ X$_TQX@MN_1DO^^W_P"!/],>(+;OT9+_ +[?_@3_ $QX@MN_
M1DO^^W_X$_TQX@MN_1DO^^W_ .!/],>(+;OT9+_OM_\ @3_3'B"V[]&2_P"^
MW_X$_P!,>(+;OT9+_OM_^!/],>(+;OT9+_OM_P#@3_3'B"V[]&2_[[?_ ($_
MTQX@MN_1DO\ OM_^!/\ 3'B"V[]&2_[[?_@3_3'B"V[]&2_[[?\ X$_TQX@M
MN_1DO^^W_P"!/],>(+;OT9+_ +[?_@3_ $QX@MN_1DO^^W_X$_TQX@MN_1DO
M^^W_ .!/],>(+;OT9+_OM_\ @3_3'B"V[]&2_P"^W_X$_P!,>(+;OT9+_OM_
M^!/],>(+;OT9+_OM_P#@3_3'B"V[]&2_[[?_ ($_TQX@MN_1DO\ OM_^!/\
M3'B"V[]&2_[[?_@3_3'B"V[]&2_[[?\ X$_TQX@MN_1DO^^W_P"!/],>(+;O
MT9+_ +[?_@3_ $QX@MN_1DO^^W_X$_TQX@MN_1DO^^W_ .!/],>(+;OT9+_O
MM_\ @3_3'B"V[]&2_P"^W_X$_P!,>(+;OT9+_OM_^!/],>(+;OT9+_OM_P#@
M3_3'B"V[]&2_[[?_ ($_TQX@MN_1DO\ OM_^!/\ 3'B"V[]&2_[[?_@3_3'B
M"V[]&2_[[?\ X$_TQX@MN_1DO^^W_P"!/],>(+;OT9+_ +[?_@3_ $QX@MN_
M1DO^^W_X$_TQX@MN_1DO^^W_ .!/],>(+;OT9+_OM_\ @3_3'B"V[]&2_P"^
MW_X$_P!,>(+;OT9+_OM_^!/],>(+;OT9+_OM_P#@3_3'B"V[]&2_[[?_ ($_
MTQX@MN_1DO\ OM_^!/\ 3'B"V[]&2_[[?_@3_3'B"V[]&2_[[?\ X$_TQX@M
MN_1DO^^W_P"!/],>(+;OT9+_ +[?_@3_ $QX@MN_1DO^^W_X$_TQX@MN_1DO
M^^W_ .!/],>(+;OT9+_OM_\ @3_3'B"V[]&2_P"^W_X$_P!,>(+;OT9+_OM_
M^!/],>(+;OT9+_OM_P#@3_3'B"V[]&2_[[?_ ($_TQX@MN_1DO\ OM_^!/\
M3'B"V[]&2_[[?_@3_3'B"V[]&2_[[?\ X$_TQX@MN_1DO^^W_P"!/],>(+;O
MT9+_ +[?_@3_ $QX@MN_1DO^^W_X$_TQX@MN_1DO^^W_ .!/],>(+;OT9+_O
MM_\ @3_3'B"V[]&2_P"^W_X$_P!,>(+;OT9+_OM_^!/],>(+;OT9+_OM_P#@
M3_3'B"V[]&2_[[?_ ($_TQX@MN_1DO\ OM_^!/\ 3'B"V[]&2_[[?_@3_3'B
M"V[]&2_[[?\ X$_TQX@MN_1DO^^W_P"!/],>(+;OT9+_ +[?_@3_ $QX@MN_
M1DO^^W_X$_TQX@MN_1DO^^W_ .!/],>(+;OT9+_OM_\ @3_3'B"V[]&2_P"^
MW_X$_P!,>(+;OT9+_OM_^!/],>(+;OT9+_OM_P#@3_3'B"V[]&2_[[?_ ($_
MTQX@MN_1DO\ OM_^!/\ 3'B"V[]&2_[[?_@3_3'B"V[]&2_[[?\ X$_TQX@M
MN_1DO^^W_P"!/],>(+;OT9+_ +[?_@3_ $QX@MN_1DO^^W_X$_TQX@MN_1DO
M^^W_ .!/],>(+;OT9+_OM_\ @3_3'B"V[]&2_P"^W_X$_P!,>(+;OT9+_OM_
M^!/],>(+;OT9+_OM_P#@3_3'B"V[]&2_[[?_ ($_TQX@MN_1DO\ OM_^!/\
M3'B"V[]&2_[[?_@3_3'B"V[]&2_[[?\ X$_TQX@MN_1DO^^W_P"!/],>(+;O
MT9+_ +[?_@3_ $QX@MN_1DO^^W_X$_TQX@MN_1DO^^W_ .!/],>(+;OT9+_O
MM_\ @3_3'B"V[]&2_P"^W_X$_P!,>(+;OT9+_OM_^!/],>(+;OT9+_OM_P#@
M3_3'B"V[]&2_[[?_ ($_TQX@MN_1DO\ OM_^!/\ 3'B"V[]&2_[[?_@3_3'B
M"V[]&2_[[?\ X$_TQX@MN_1DO^^W_P"!/],>(+;OT9+_ +[?_@3_ $QX@MN_
M1DO^^W_X$_TQX@MN_1DO^^W_ .!/],>(+;OT9+_OM_\ @3_3'B"V[]&2_P"^
MW_X$_P!,>(+;OT9+_OM_^!/],>(+;OT9+_OM_P#@3_3'B"V[]&2_[[?_ ($_
MTQX@MN_1DO\ OM_^!/\ 3'B"V[]&2_[[?_@3_3'B"V[]&2_[[?\ X$_TQX@M
MN_1DO^^W_P"!/],>(+;OT9+_ +[?_@3_ $QX@MN_1DO^^W_X$_TQX@MN_1DO
M^^W_ .!/],>(+;OT9+_OM_\ @3_3'B"V[]&2_P"^W_X$_P!,>(+;OT9+_OM_
M^!/],>(+;OT9+_OM_P#@3_3'B"V[]&2_[[?_ ($_TQX@MN_1DO\ OM_^!/\
M3'B"V[]&2_[[?_@3_3'B"V[]&2_[[?\ X$_TQX@MN_1DO^^W_P"!/],>(+;O
MT9+_ +[?_@3_ $QX@MN_1DO^^W_X$_TQX@MN_1DO^^W_ .!/],>(+;OT9+_O
MM_\ @3_3'B"V[]&2_P"^W_X$_P!,>(+;OT9+_OM_^!/],>(+;OT9+_OM_P#@
M3_3'B"V[]&2_[[?_ ($_TQX@MN_1DO\ OM_^!/\ 3'B"V[]&2_[[?_@3_3'B
M"V[]&2_[[?\ X$_TQX@MN_1DO^^W_P"!/],>(+;OT9+_ +[?_@3_ $QX@MN_
M1DO^^W_X$_TQX@MN_1DO^^W_ .!/],>(+;OT9+_OM_\ @3_3'B"V[]&2_P"^
MW_X$_P!,>(+;OT9+_OM_^!/],>(+;OT9+_OM_P#@3_3'B"V[]&2_[[?_ ($_
MTQX@MN_1DO\ OM_^!/\ 3'B"V[]&2_[[?_@3_3'B"V[]&2_[[?\ X$_TQX@M
MN_1DO^^W_P"!/],>(+;OT9+_ +[?_@3_ $QX@MN_1DO^^W_X$_TQX@MN_1DO
M^^W_ .!/],>(+;OT9+_OM_\ @3_3'B"V[]&2_P"^W_X$_P!,>(+;OT9+_OM_
M^!/],>(+;OT9+_OM_P#@3_3'B"V[]&2_[[?_ ($_TQX@MN_1DO\ OM_^!/\
M3'B"V[]&2_[[?_@3_3'B"V[]&2_[[?\ X$_TQX@MN_1DO^^W_P"!/],>(+;O
MT9+_ +[?_@3_ $QX@MN_1DO^^W_X$_TQX@MN_1DO^^W_ .!/],>(+;OT9+_O
MM_\ @3_3'B"V[]&2_P"^W_X$_P!,>(+;OT9+_OM_^!/],>(+;OT9+_OM_P#@
M3_3'B"V[]&2_[[?_ ($_TQX@MN_1DO\ OM_^!/\ 3'B"V[]&2_[[?_@3_3'B
M"V[]&2_[[?\ X$_TQX@MN_1DO^^W_P"!/],>(+;OT9+_ +[?_@3_ $QX@MN_
M1DO^^W_X$_TQX@MN_1DO^^W_ .!/],>(+;OT9+_OM_\ @3_3'B"V[]&2_P"^
MW_X$_P!,>(+;OT9+_OM_^!/],>(+;OT9+_OM_P#@3_3'B"V[]&2_[[?_ ($_
MTQX@MN_1DO\ OM_^!/\ 3'B"V[]&2_[[?_@3_3'B"V[]&2_[[?\ X$_TQX@M
MN_1DO^^W_P"!/],>(+;OT9+_ +[?_@3_ $QX@MN_1DO^^W_X$_TQX@MN_1DO
M^^W_ .!/],>(+;OT9+_OM_\ @3_3'B"V[]&2_P"^W_X$_P!,>(+;OT9+_OM_
M^!/],>(+;OT9+_OM_P#@3_3'B"V[]&2_[[?_ ($_TQX@MN_1DO\ OM_^!/\
M3'B"V[]&2_[[?_@3_3'B"V[]&2_[[?\ X$_TQX@MN_1DO^^W_P"!/],>(+;O
MT9+_ +[?_@3_ $QX@MN_1DO^^W_X$_TQX@MN_1DO^^W_ .!/],>(+;OT9+_O
MM_\ @3_3'B"V[]&2_P"^W_X$_P!,>(+;OT9+_OM_^!/],>(+;OT9+_OM_P#@
M3_3'B"V[]&2_[[?_ ($_TQX@MN_1DO\ OM_^!/\ 3'B"V[]&2_[[?_@3_3'B
M"V[]&2_[[?\ X$_TQX@MN_1DO^^W_P"!/],>(+;OT9+_ +[?_@3_ $QX@MN_
M1DO^^W_X$_TQX@MN_1DO^^W_ .!/],>(+;OT9+_OM_\ @3_3'B"V[]&2_P"^
MW_X$_P!,>(+;OT9+_OM_^!/],>(+;OT9+_OM_P#@3_3'B"V[]&2_[[?_ ($_
MTQX@MN_1DO\ OM_^!/\ 3'B"V[]&2_[[?_@3_3'B"V[]&2_[[?\ X$_TQX@M
MN_1DO^^W_P"!/],>(+;OT9+_ +[?_@3_ $QX@MN_1DO^^W_X$_TQX@MN_1DO
M^^W_ .!/],>(+;OT9+_OM_\ @3_3'B"V[]&2_P"^W_X$_P!,>(+;OT9+_OM_
M^!/],>(+;OT9+_OM_P#@3_3'B"V[]&2_[[?_ ($_TQX@MN_1DO\ OM_^!/\
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M!./ 5\4._P"5JV/\S_\  G'@*^*'?\K5L?YG_P"!./ 5\4._Y6K8_P S_P#
MG'@*^*'?\K5L?YG_ .!./ 5\4._Y6K8_S/\ \"<> KXH=_RM6Q_F?_@3CP%?
M%#O^5JV/\S_\"<> KXH=_P K5L?YG_X$X\!7Q0[_ )6K8_S/_P "<> KXH=_
MRM6Q_F?_ ($X\!7Q0[_E:MC_ #/_ ,"<> KXH=_RM6Q_F?\ X$X\!7Q0[_E:
MMC_,_P#P)QX"OBAW_*U;'^9_^!./ 5\4._Y6K8_S/_P)QX"OBAW_ "M6Q_F?
M_@3CP%?%#O\ E:MC_,__  )QX"OBAW_*U;'^9_\ @3CP%?%#O^5JV/\ ,_\
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MQ_F?_@3CP%?%#O\ E:MC_,__  )QX"OBAW_*U;'^9_\ @3CP%?%#O^5JV/\
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M?%#O^5JV/\S_ / G'@*^*'?\K5L?YG_X$X\!7Q0[_E:MC_,__ G'@*^*'?\
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MYG_X$X\!7Q0[_E:MC_,__ G'@*^*'?\ *U;'^9_^!./ 5\4._P"5JV/\S_\
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M_P "<> KXH=_RM6Q_F?_ ($X\!7Q0[_E:MC_ #/_ ,"<> KXH=_RM6Q_F?\
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M .!./ 5\4._Y6K8_S/\ \"<> KXH=_RM6Q_F?_@3CP%?%#O^5JV/\S_\"<>
MKXH=_P K5L?YG_X$X\!7Q0[_ )6K8_S/_P "<> KXH=_RM6Q_F?_ ($X\!7Q
M0[_E:MC_ #/_ ,"<> KXH=_RM6Q_F?\ X$X\!7Q0[_E:MC_,_P#P)QX"OBAW
M_*U;'^9_^!./ 5\4._Y6K8_S/_P)QX"OBAW_ "M6Q_F?_@3CP%?%#O\ E:MC
M_,__  )QX"OBAW_*U;'^9_\ @3CP%?%#O^5JV/\ ,_\ P)QX"OBAW_*U;'^9
M_P#@3CP%?%#O^5JV/\S_ / G'@*^*'?\K5L?YG_X$X\!7Q0[_E:MC_,__ G'
M@*^*'?\ *U;'^9_^!./ 5\4._P"5JV/\S_\  G'@*^*'?\K5L?YG_P"!./ 5
M\4._Y6K8_P S_P# G'@*^*'?\K5L?YG_ .!./ 5\4._Y6K8_S/\ \"<> KXH
M=_RM6Q_F?_@3CP%?%#O^5JV/\S_\"<> KXH=_P K5L?YG_X$X\!7Q0[_ )6K
M8_S/_P "<> KXH=_RM6Q_F?_ ($X\!7Q0[_E:MC_ #/_ ,"<> KXH=_RM6Q_
MF?\ X$X\!7Q0[_E:MC_,_P#P)QX"OBAW_*U;'^9_^!./ 5\4._Y6K8_S/_P)
MQX"OBAW_ "M6Q_F?_@3CP%?%#O\ E:MC_,__  )QX"OBAW_*U;'^9_\ @3CP
M%?%#O^5JV/\ ,_\ P)QX"OBAW_*U;'^9_P#@3CP%?%#O^5JV/\S_ / G'@*^
M*'?\K5L?YG_X$X\!7Q0[_E:MC_,__ G'@*^*'?\ *U;'^9_^!./ 5\4._P"5
MJV/\S_\  G'@*^*'?\K5L?YG_P"!./ 5\4._Y6K8_P S_P# G'@*^*'?\K5L
M?YG_ .!./ 5\4._Y6K8_S/\ \"<> KXH=_RM6Q_F?_@3CP%?%#O^5JV/\S_\
M"<> KXH=_P K5L?YG_X$X\!7Q0[_ )6K8_S/_P "<> KXH=_RM6Q_F?_ ($X
M\!7Q0[_E:MC_ #/_ ,"<> KXH=_RM6Q_F?\ X$X\!7Q0[_E:MC_,_P#P)QX"
MOBAW_*U;'^9_^!./ 5\4._Y6K8_S/_P)QX"OBAW_ "M6Q_F?_@3CP%?%#O\
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M7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P
M/^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA
M/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%
M\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\
M #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J
M83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\
M1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_
M   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\
M*F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L
M?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M
M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_
M "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_F
MK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?
M[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=
M_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _
MYJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_
MW^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P
M7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P
M/^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA
M/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%
M\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\
M #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J
M83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\
M1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_
M   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\
M*F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L
M?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M
M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_
M "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_F
MK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?
M[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=
M_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _
MYJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_
MW^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P
M7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P
M/^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA
M/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%
M\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\
M #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J
M83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\
M1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_
M   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\
M*F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L
M?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M
M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_
M "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_F
MK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?
M[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=
M_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _
MYJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_
MW^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P
M7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P
M/^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA
M/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%
M\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\
M #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J
M83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\
M1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_
M   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\
M*F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L
M?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M
M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_
M "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_F
MK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?
M[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=
M_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _
MYJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_
MW^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P
M7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P
M/^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA
M/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%
M\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\
M #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J
M83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\
M1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_
M   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\
M*F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L
M?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M
M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_
M "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_F
MK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?
M[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=
M_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _
MYJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_
MW^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P
M7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P
M/^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA
M/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\  #_FK'Q%
M\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J83_?[?\
M #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\1?!=_P J
M83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_   _YJQ\
M1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\ *F$_W^W_
M   _YJQ\1?!=_P J83_?[?\  #_FK'Q%\%W_ "IA/]_M_P  /^:L?$7P7?\
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-J[%78J[%78J[%7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
M_]C_X0WZ17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    D    <@$R  (    4
M    EH=I  0    !    K    -@ +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P($-#(#(P,34@*$UA8VEN=&]S:"D ,C Q-SHP,CHP-R Q-CHT,CHR
M.      #H $  P    '__P  H ( !     $   )0H , !     $   "A
M      8! P #     0 &   !&@ %     0   28!&P %     0   2X!*  #
M     0 "   " 0 $     0   38" @ $     0  #+P         2     $
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MF#8\&/)')RLX<$SZHB>GI_P3%]?P^JX.9T\=1IM QMI<][O;LV_S@M_<]/\
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M*J(!)@<^9 _*O/TE/&Z]6[BY_:]S]3?!_6_>_J_U7UWHWU>PK[&V]6ZABXU
M.M#<BLVO\B]CW5TL_M>K_P 5_.+T2.G_ +.C]%^SO1CEOH^CM\?YOT/2_L;%
M\O)**7%Q"_IV=3E_NOW?+[=UPR]S_.UPO__9_^T64E!H;W1O<VAO<" S+C
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M;V]L      !#<FY#8F]O;       0VYT0V)O;VP      $QB;'-B;V]L
M  !.9W1V8F]O;       16UL1&)O;VP      $EN=')B;V]L      !"8VMG
M3V)J8P    $       !21T)#     P    !29" @9&]U8D!OX
M $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^            !"<F14
M56YT1B-2;'0               !";&0@56YT1B-2;'0               !2
M<VQT56YT1B-0>&Q <L            IV96-T;W)$871A8F]O; $     4&=0
M<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L=
M     %1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R8T!9
M        $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O
M;6QO;F<         #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T
M4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0
M    $ $L     0 " 2P    !  (X0DE-!"8       X             /X
M #A"24T$#0      !    !XX0DE-!!D       0    >.$))30/S       )
M           ! #A"24TG$       "@ !          (X0DE- _4      $@
M+V9F  $ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@    $ 6@
M  8       $ -0    $ +0    8       $X0DE- _@      '   /______
M______________________\#Z     #_____________________________
M ^@     _____________________________P/H     /______________
M______________\#Z   .$))300        "   X0DE-! (       (  #A"
M24T$,        0$ .$))300M       &  $    ".$))300(       0
M 0   D    )      #A"24T$'@      !      X0DE-!!H      W4    &
M              "A   "4    "  20!# $\ 3@ @ %  ;P!S &D = !I '8
M90 @ &P ;P!G &\ ( !# $T 60!+ "@ ;@!O ', = !R &$ <  I     0
M                       !              )0    H0
M       !                         !     !        ;G5L;     (
M   &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M        3&5F=&QO;F<          $)T;VUL;VYG    H0    !29VAT;&]N
M9P   E     &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M$@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R
M:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
M5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,
M   !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M          !"=&]M;&]N9P   *$     4F=H=&QO;F<   )0     W5R;%1%
M6%0    !        ;G5L;%1%6%0    !        37-G951%6%0    !
M   &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!
M"&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC
M94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L
M:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M
M$453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M       *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M        "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M        .$))3004       $     CA"24T$#      ,V     $   ".
M)P   :P  $$T   ,O  8  '_V/_M  Q!9&]B95]#30 "_^X #D%D;V)E &2
M     ?_; (0 # @(" D(# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1
M# P,# P,# P,# P,# P,# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04
M#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,_\  $0@ )P". P$B  (1 0,1 ?_=  0 "?_$ 3\   $% 0$! 0$!
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M:[:*"6, ,:.VG?=Q_A7?U/32^M/4[.H]:R'D_HJ'&BAO(#:SM<X1_I;-UO\
MYPLD\*>$ !9W</G.<G.<H0D8XXFM-.*NI7:]S7!S7$.!D.!(,C^4MWH_UQZO
MTZUHOL=FXOY]5KI>)_.JO?-FYO[C_P!%_P"?%T'6ZZ_^8&.=C993B.88&A)J
M:YS?W7;7O7 HBI@V/!CR1R<K.'!,^J(GIZ?\$Q?7\/JN#F=/'4:;0,;:7/>[
MV[-O\X+?W/3_ #UP_7?KOGYECZ>F/.+B"0+!I:_^7N/NH;^XUGZ7_A/\&N>9
MF93,2S";8X8USVV65 ^USF?0)_U_P=7^B6Q]4_JZ.LY3K,B6X.,1ZL2#8XZM
MH:_\WV^Z[;^D_P"W?5K;P"-DZMB7.9N8X,6(<$I?.?Y?H.';?9:\ONL=98>7
M/<7./Q<\[E=Z?U[JW3G-=B93PQO^">2^HCP])_M_[;V6+M\CZT_5OH=KNGXU
M)/I';8W%K9L:X?2:]SG5-?9^_L]3^7[U0^L&-]6.I]%LZWBV,Q[FDM8]C=I?
M;]+[+?C^W]-9^_\ SC/Y_P#HR7'=7'0K3RAAQ2Q\P#EA<IB^';?U.U]6_K+C
M];H+7 59U0FZCL1QZU,_2J_\\_G_ .#LMSOK/]<A@6/P.F[;,MNEUSA+*R?S
M&-_PE[?^VZ_^$_FUPN'F9&#DUY>*_P!.^J2Q\ Q(+':.EOT7*6!A9'4<VK#H
M]UV0Z YQ_MV6//\ (:'6/2]L V=DGXCEGCCCB/UI/#Q#KVX?ZZLSJ6=F.+\S
M)LN),P]QV@G]RO\ FV?V&J&-FY6,_?B9%E+^YJ>6_P"=M/N7H7_8W]3\9@>-
MV4\3N#0_(LX#M?\ !5?VZJ?^N)Z>H_5GZV,=B65_I]IV,M:&7-'/J8]K2_\
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MH[?'^;]#TO[&Q?+R2BEQ<0OZ=G4Y?[K]WR^W=<,O<_SM<+__V3A"24T$(0
M    70    $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <
M !< 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  ( !# $, (  R #
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M                     0  ]M8  0    #3+4%$0D4
M                                              YD97-C   !+
M 'QC<')T   !J    "MW='!T   !U    !1T87)G   !Z    !AT96-H   "
M      QV=65D   "#    %YV:65W   ";    "1!,D(P   "D  !7V9!,D(R
M   "D  !7V9!,D(Q  %A^  !7V9",D$P  +!8  ".+1",D$Q  3Z%  ".+1"
M,D$R  <RR  ".+1G86UT  EK?   D)%D97-C         ")#;V%T960@1D]'
M4D$S.2 H25-/(#$R-C0W+3(Z,C P-"D
M
M                =&5X=     !#;W!Y<FEG:'0@,C P-R!!9&]B92!3>7-T
M96US+"!);F,N  !865H@        V$4  .!/  "^YG1E>'0     24-#2$1!
M5"!&3T=203,Y '-I9R      ;V9F<V1E<V,         !$0U,
M
M                                     '9I97<      F74*P)\GJD"
M#27, 'K$"0!_4N\ :0>/     6UF=#(     ! ,+   !
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MJ!FI,:I*JV*L>ZV5KJ^ORK#EL@*S'[0]M5RV?;>/N)ZYKKJ^N]"\XKWTOPC
M',$PPD7#6L1OQ87&FL>PR,7)V\KPS 7-%LX<SR+0)]$KTB[3,=0SU336-=<U
MV#79--HSVS'<+]TMWBK?)^ EX2'B'N,;Y!?E%.7^YN'GP^BFZ8CJ:^M.[#'M
M%.WW[MGOO/"?\8'R9/-&]"CU"?7K]LWWL/B4^7GZ8?M*_#;])?X6_PK__P
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M^_K6^['\C/UG_D3_(?__    M0%L B4"XP.E!&T%. 8%!M 'F@AC"2P)]@K
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M; 4S!?D&OP>$"$@)#0G2"I@+7@PE#.P-LPYZ#T$0"1#0$9<27Q,G$^\4MQ6
M%D@7$1?:&*,9:QHT&OP;Q1R-'50>'![C'ZH@<2$Y(@ BR2.2)%PE)R7T)L(G
MD2AC*38J"BK@*[@LD"UI+D0O'B_Y,-4QL#*+,V8T034<-?8VT#>J.(0Y7CHX
M.Q([ZSS%/9\^>#]20"Q!!D'@0KM#ED1Q14U&*4<%1^)(OTF=2GQ+6TP[31Q-
M_D[@3\10J%&.4G537%1%53!6&U<(5_58Y%G36L1;M5RG79I>C5^"8'9A;&)A
M8UAD3F5%9CQG,V@I:2!J%VL.; 1L^FWP;N5OVG#0<<5RNG.P=*9UG':2=XEX
M@'EX>G%[:WQE?6%^7G]<@%N!7()>@V*$:(5OAGF'A(B2B:&*L8O#C->-[(\#
MD!N1-))/DVJ4AY6EEL.7XID"FB*;0IQCG82>I9_&H.>B!Z,GI$:E9J:%IZ2H
MPZGBJP&L(*T_KEVO?+";L;NRV[/\M1VV0+=EN(NYL[K=O F].+YJOY_ U\(1
MPTW$C,7,QP[(4LF6RMO,(<UGSJW/\]$YTG[3Q-4+UE'7F-C?VB?;<-RZW@7?
M4."=X>OC.N2+Y=WG,>B&Z=WK-NR1[>[O3O"O\A+S=?3:]C[WHOD$^F3[Q?TH
M_I#___\ @ "  .FM@ & #]1,@ . ';[:@ . +*E/@ . .Y.>@ . 37VR@ 6
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M-Q?&@:N#>^T:A..1/=DQA!2/:,4V@V2-L+$B@N:,)YT(@G^*Z8C2@B")S'1
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MR48=COR0WC4!C-N/7R(RBSF.> U=B+V)";,DHD"IN:/+GKZF:918FW.C%83
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MDSA^HA\5D>Q_J@HECW"!3*SZK1&!H)XEJ/*!7H\_I0B!)H _H7*! '$\GB*
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MF?M]["U'EQ1^SAK^E9R  0@QD6>!H:#YM6R!=)+7L-&!$(2[K%F RG:KJ!J
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M.FU3KH:!%V 6JA"!'%+7I;V!/$4IH:6!?#;YG=:!XB?YFH:"?A;.F*6#F@;
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MFG9]]X0NE_=^&W36E9I^8F5LDTU^NE5ND2=_$43<CRQ_;C."C7-_X2 OC("
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M<%_NO&B.%U4"MR6,\4H,L?J,##\0K."+4C.GJ!V*U2?$H["*MALEG[N*50V
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M 3H=?4^A!R:_?.*9(Q#[? V+>\./C?EQN+-YC(-S"J,JBRQT1I*!B@%U7X'
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MCM9\DD#[C3-],3 <B]%]VQTZBRQ^G D'B+> !*<NFLZ D9E4F#N I8L\E=>
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MI[=Z"U9+I!!ZPTHMH(5[D#UFG31\6R_VFB]]+B&CE[E^'!$;EI%_7@/ICE2
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M>>2!#(CU>E> _'<Z>LJ ^63S>TF ]5(@>\J \CZ3?#> [2E8?'" VQ!=?*>
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M?S)_M9&4?QI_KH#P?PA_PW P?OE_YU[0?P> #TS7?R* .CHD?SB 8B6T?SN
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MBR]?CE2;4B(#C!^5\!+WBBN,TP:GA)R$?W\0L$]LN'/XK%EN6&BZJ)5OY%U
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MF-. NP#,CDB BF?WO;^ 9%WHN4: /E/IM-> +DG_L'B 0D >K"6 >38[I^:
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M=NFG/&/@=V6C8510=_N?LT0\>(V<2S.'>.F9"B$Y>+Z3=@U >9V(]JSL=+C
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MI+A\DD,DH6I]&#D2GBU]L"Y6FTU^4R+KF,]_#!9_ENA_]PG:DF: [ %*BH2
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MLCG"H\Z6A3#3H!:5?2=YG(.3IQV<F1Z0R!+LE?F,O@CNCK*&"@(UARR!?EX
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M:3B!M:&A:S*!@9$@;.&!68!Z;H*!.V^W<!B!(EYM<9^!!4R8<P> XSH!="V
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M;:%_\JA1;Q9_]YCQ<'%__8E1<:. !'F#<LV #FF6<^^ '%D/=12 *4?R=B>
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MA&N "X ZD+-_@76.CRY_P6JEC;U_[U]:C&J !%/3BQZ +D@OB=F 9#O1B,Z
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M&TCPI)AJ)C\PH:!L0C57GLEN9BJJG&)P:!\?FH9R0Q)<F89SX0:ZDWMWOP
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M,3Z9IR)\L37AH[-]02TFH$]]X2/*G4I^F!FYFK-_<@\1E^N ?07[C_R!/
MB.:  %AIL#R _T_!K-Z \$<5J8& ]CY@IB.!&S6WHKF!6BT2GU>!L"/4G$6"
M*!GKF9&"VP]EEJZ##P97CMF"V ! B#2 *U@HKS2&<$^#J^R%^T;<J)V%H3XN
MI4:%;C64H>&%72T!GH"%;2/=FV.%J1H5F)>&&P^ME9V%00:GC>"$. "4AVB
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M("&@@>Y[VA$ @<U\A@/ @1!^FX(-@Q)\"W=1@J1\FVQ2@D-]%&#M@?1]:%5
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M= $GA>UY77O@CZMEE'&,CF)GWV;LC2]J"%O8C!ML 5",BPQM^T4<B@=O]CC
MB3%QRRN.B)%S?1U7B$AU  U6AY)VCP&DA-)[<GI[C<ELGG!(C*=N567/BY)O
M\5KIBH]Q9$_ B99RW41QB*=T6CA&A^)UORM/ATMW#QU;AO9X00V:AC)YJ (3
M@]=]2GE&C"!SFV\IBPITQ63(B@9UV5H!B1MVSD[XB#9WS$/,AU=XT#?1AJ=Y
MOBL4AA]ZGQU?A<A[=PW7A/U\MP)U@OI^Z7@5BJ5ZD6X1B:9[,V/,B+9[PUDE
MA]Y\/$XZAPE\P$,NACE]3#=<A9=]QBK/A1=^/QU2A+5^R X(@]Q_G@+3@B&
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M&RM\C&6'UR"UBPB'UA3ZB=F'# ENACJ%&@&H@P.!'V'YEC20'%ETE$2/?U#
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MM#ESH])S\3$KH-UU,2C8G?AV>!_/FW5WRA7WF71Y'@PSE?][500?CCQ^
MAE>  %%NJQ1V'TEVJ#IVW$%HI5UWJ3DYHGMXC#$%GXUY<RC)G*MZ9!_@FAY[
M9A8RF %\?0R)E(A^/01]C0E_T0  AA*  %$XJ=%[J$DZIP%[_4$MI"Y\9SD*
MH5=\\C#HGG%]BBC"FY%^-!_YF/9^]A9SEKA_X0SADS. V03:B^R!>   A="
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M>N-]N@0@?.-_!((,<\E_Y'<M=*: "FPE=7^ *V#<=E& 155 =P^ 84E^=\&
M@3SZ>&Z E"_'>0* IB&Y>5" QQ& >>R \@1]?"B T8#"<FN'+G8#<V*&PFL;
M=%6&55_T=4*%YU1W=A2%?TC4=M6%'#QT=XV$MR]I>"2$7R&+>&N$-!&4>1B#
MLP3,>XB"6W^A<5*.>G3]<E6-C&HR<U>,G5\J=%:+K5/*=3F*Q$A$=@F)XCP
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MA6J 1P Q@Q2 (5OND+]^_E/BCT1_8TNAC>E_OT,.C+F ##I#BX6 7#%>BE6
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M]03TB()^7   @Y&  %.0FC!WFTO7F!EXBT/VEBEY;3O9E'!Z.S.6DK%["BM
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M"P [@G2 *%&FE<V. DHMD]R-LD*2D@N-5CK$D&F,Z#+*CMB,D"J_C4N,6B(
MB[F+_!B(BCF*< ZBA^B'U08BA&2$)@!J@@> 2%$ME.*3K4G1DQ*2YT)/D562
M+3J1C[.1A3*DCBJ0^RJFC*B0CR'TBQ6/+!B,B8J,H@ZXAS6)109"@^B$.P"0
M@;" 84QSK-]:6T2IJ?M<[CS/IS]?BC3<I+QB-2S/HB-D[22FGZEGI!NAG<-J
M*Q&SG'IL>0CHE]EP% &FC^9U[0  A/)],TP1JE!@'D1>IX]B0CR3I/=D=C2C
MHIMFPBRKH!=I&"2AG:1K<!O"F[-MKA'_FE!OQPE+E;1S+@(4CD5X>   A(5^
M8DN&J!AEU4/4I8YGBSP=HQ5I6C1;H+1K3RR"GCIM1223F]%O/1O7F=AQ+1)
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M7!N";&?L7R"",EGG8@N!]4M%9+"!M3P09N^!<RP@:&B!,!I7:5* [@A@<C2
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M7D>!#F\I8-R _&'[8VN ZU2J9>B V$:H:#6 PC@&:BR J"BF:VR CA==;-J
M<@;Y=)J )Y0-5E*)'X>=6:F(CGL'7+^'[VXV7W>'/6$J8B6&D5/_9+^%YT8C
M9Q^%0C>L:2.$J"A]:F>$)A=X; ^#V0=:= 2"#9+"5-B1.X9^6$20%'H/6W&.
MWFU<7D.-DV!Q80>,4%-J8[6+$D6T9B:)XS=D:#:(RRAB:8&'XA>3:UZ&Y0>N
M<X:#JY&E4YB9/H5Z5QV7GGDG6F"5Z&R674"4$%_-8!&205+I8LJ0=T5894>.
MPC<N9V.-+RA5:+>+XQ>Q:L6)F@?T<QJ%")"Z4IVA4H2@5B^?(WAC67V<X6OO
M7&B:@%]#7T*8)E)^8@*5TT4-9(J3G#<$9K&1DRA-: Z/RQ?+:D>+V@@M<L.%
MAX_^4=VI<(/P57&FD'?$6,*CK&MH6[:@PU[47I>=WE(H85Z; D308^^83#;B
M9B&5UBA'9X62^1?@:>&-IPA;<GR%IY4:;3)5D(A#;EU93WM6;X)<XVY"<)M@
M-&#W<;YC65.#<N!F;$5 =!5I2C8\=3YK[R9,=B%N.Q0#=QMO=P/7>VQSG9,$
M:7!>+H9[:P1A&GG(;(ICYFS5;?MF@5^W;V)I 5)W<+YK=41J<B-MQ36B<V]O
MZ"7V=%MQP!0"=7IRK@0W>D9VG9$)9B-FG(2J: IHR7@M:=QJWVN :Y!LT5Z6
M;3%NKU&%;L)PA4.J<%5R0S48<<%SX"6H<K9U/Q0"= EUX02+>4)Y3(]:8S%N
M[X,E96=P:7;39WQQTVI4:6%S(EV4:S)T9%"L;/1UGT+^;JYVQS2<<#=WU25D
M<35XMQ0!<L5Y$ 36>%Y[J(VJ8+]W#H&J8RYWZG6*975XM6DW9X-Y9ER?:7UZ
M#T_@:V9ZM4)?;3U[3C0N;MA[UB4N;]E\1Q07<:=\; 4U=Y-]Z(PC7KM^XH!/
M85U_(G1:8]%_56@M9?]_<5N\:!E_C$\G:B!_IT'0; E_NS//;:Q_RR4(;JM_
MVQ0_<+)_YP6B=N)__HK,7/*&L'\A7[^&57-28EB%[&='9*6%<%KX9MR$^DZ&
M:/V$AT%5:O>$%S-];*.#L"3G;:&#8A1A;^"#'@7_=DN!QXFA6WB.=WX67F&-
MCG)F81.,EF9[8W>+AUI,9<2*@TW\9_J)AD#L:@&(DS,Z:[:'MR3.;+:'#A2!
M;RJ%\P9/=<N#3(B=6E"6+'TJ7424TG&48 238&7$8GB1RUFT9-*00DV%9Q*.
MPD"6:2:-43,%:N., R2_:^>+!!2?;HZ(=@:2=5Z$<8>Q66*=Z7Q=7%N<#'#C
M7R*:&64K8:*8 EDU9 :5]DTC9DZ3]D!/:&N2##+;:C*04B2T:SJ.JQ2Y;@V*
MC0;)=06$EH;C6*"EI'NQ6YNC)W!37FB@H&2P8/*>"%C/8UZ;?$S39:Z8_4 6
M9].6GC*Y::&4A"2L:JZ1F13-;::,.@;U=+Z$M(L!<X959G[W=%-9(G+:=1-<
MKF:;=<%?[UH:=GYC#TUM=S]F(#_=> ]H]#%_>-IKBR(F>7QMQ!" >L5O$0)C
M?7YT1XDB;^5=J7U-<25@E7%:<DIC8&4V<T=E^5C>=$-H?$QB=3MJ]C\1=C1M
M1S#\=QAO:B'S=[MQ/A"G>2YR1P+8?%QW&(=/;+=EKGN>;DAG[&_:;[EJ#V/T
M</AL"5?-<BMM]$M]<U-OV#YB='5QH3"*=79S2"'&=AYTKQ#)=\9U=@,_>UQY
MEH7 :>EMF7I":[]O-6ZL;6MPNV+L;MER'E;J<#AS=DK"<8ETR3W2<M)V!# K
M<_1W)2&>=*5X%Q#H=HIXH .9>GM[QH0^9YEU8WCK:9MV9&U^:W%W46'E;0IX
M(%8);HUXZDH(;_]YL#U$<61Z9B_.<I=["B%[<TI[E1$/=6Y[] /]>;!]X(+7
M9:1\W'>D9]1]2&Q::=1]I6#G:X]]ZE4P;3!^+4E6;KQ^<#R]<#!^JR]X<6A^
MXB%><A1_&1$\='=_701F>/U_V(&+8^V$4G:!9D&$)VM<:&.#\& +:CR#IE1T
M:_B#8$B\;9R#'CQ(;QZ"WR\M<%R"JB%%<02"D1%C<Z."602_>&6!AH!E8GV+
MPG5_9.J+#VI]9R.*4%],:12)?5/3:N:(LD@Z;)^'[SOF;BR'-R[N;V^&EB$P
M<!2&+Q&$<NZ$^ 4+=^."]']H85>3('2?8]*2"&FY9AF0V5ZF:!>/AU-+:?J.
M0$?/:\.- CN7;5J+U"Z[;I^*RR$>;T&*#1&@<E.'305,=W6#E7Z58%^:D'/C
M8NB8_&D693N745X=9T*5@U+;:3.3PD=Y:PJ2#CM7;*B0<"Z1;?&/!B$0;I"-
M:A&W<=.)/06 =QN#N'WK7Y"B G-+8B:?T6B29(6=EEVO9I2;35* :)"9%$<S
M:G*6[CLC;!B4YRYO;6*3'"$$;@"0'!')<6V*R@6J=M.#U8#E>B!59'6J>H-9
M"VI;>MA<A%[L>Q9?N5,S>VMBU$=)>\EEXCIM?#IHKBRU?+1K-QWN?2UM7@U4
M?C]O!@$:?XQU'W\'=LM=*700=XM@&6CS>#1BYEV:>+QE?E(&>4MH!T9+>=MJ
MACFR>FULVBQ*>O=N_1W=>V5PS V7?*UR-P&:?FMWMWU3<[=DU'*"=,IG'&>2
M=;YI2EQP=H1K35$(=T9M1D5W> )O.#D6>+=Q#ROQ>5ARP!W.><-T, W2>TIU
M7P(+?6QZ WOK<09L6W%.<E1N$6:)<WYOKEN&='-Q)5 _=5QRE$34=CMS_SB>
M=Q9U4"NJ=]9V@QW!>$EWB X'>A)X@ )N?(M\!WJ7;LESPW :<#]TZF5W<9!U
M^5J6<JYVZ$]S<[AWTD0N=+1XN3@C=:AYC"MA=GEZ31VR=NEZ]@X[>/=[S@+4
M>[Y]^GE);.=ZY&[I;H1[?F1E;_M\!EFJ<3I\<TZJ<E]\WD.)<W%]2C>H='-]
MK2L7=4=^"QVA=:M^; YO=_U_ P,Y>PA_SG@0:S:" &W7;/>""6-X;I""!5C=
M;^^![DW\<2R!V4+Z<E.!R#<^<V"!NBK7=#B!N!V3=)6!U0Z;=RB!P@./>FR!
M7W;_:<Z)&6SG:Z>(HF*I;5:('E@N;LJ'ATUI<!Z&]D*%<5B&;#;F<G"%[BJ@
M<TJ%BQV$<YZ%: Z_=G&$+ /8>>>"FG8<:+:0)FP::I>/46'V;$^.9%>;;<R-
M5TSQ;S*,4D(G<(*+5S:@<:&*;"IQ<GF)J1UT<L:)#P[;==6&4006>7>"Q'57
M9[^716ML::^5^V%@:W.4FU<A;/>3&$R0;FV1HT'<;\^0/39G</6.ZRI*<<N-
MTQUE<@^,(P[R=5:(&01)>1N"YG2P9N2>9VK<:.N<AF#G:KZ:G5:_;$>8IDQ!
M;<N6PT&@;SR4]C8Y<&B31BHK<3R1K!U:<7N.F0\$=.^)AP1R>-*# G<!@-Q5
M6FRC@*=9&V(C@'E<GU=M@%9?QDQK@$QBVD$W@%%EX#4(@'=HHR?S@,!K(!F[
M@3QM-PJ/@9EOA  &@:YV0'5S?8A<RVM&?;E?UF#K?>5BLU9'?@AE2DMF?C-G
MU$!=?F1J531M?J9LJ2>C?OANRAG!?UYPE0K;@ 5RJ "!@(EXFW/R>IMD%6GE
M>QEFA%^P>X=HRU4]>]YJUDJ%?#9LV3^C?(YNUC/H?.YPMB=??5!R<!G'?:IS
MYPL??J!UQ0#N?X9ZL7*(>"1K+&B[>,)M'EZX>55NY51A>=AP;4G)>E1Q[S\,
M>LYS;C-^>TYTT"<H>\=V%AG,?!]W+0M;?69XW0%.?J)\AG%-=?MR0F>B=KIS
MJEW =W!T[%.*>!AU]4D3>+-V^3YY>4=W_#,5>=YXZB;Q>F1YQAG0>K-ZC N8
M?$A\#0&Q?<]^2W \=!QY%&:==05Y]US1=>!ZN%*]=J9[2$AG=UE[UCWO> !\
M93*R>*-\ZB:\>2U];1G1>6U]]@O4>TQ^]0(4?1)_]&\C<G5_Y66J<X& .EP!
M='N =%(,=5V B$?2=B: GCUW=MZ N3)<=XZ UR:->!R! QG3>$^!5@P'>G.!
M<0)I?'&!86XH<0Z&L632<C2&B%M)<T6&2%%S=#B%Y4=4=16%B#T4=>"%,S(5
M=IJ$ZB9E=RF$OQG1=U&$V PQ>;F#H0*Q>^>!TFU8;^B-:V06<1^,ZUJG<CV,
M2U#P<S>+>T;K=":*LCS$=06)]C':=<:)229!=E*(R1G+=FZ(*0Q3>1F%DP+N
M>W.!^VR3;O>4*F-P<#J315H><6"2/5"$<EV1 D:5<UR/TSR$=$Z.M3&K=16-
MJR8C=9V,WAG%=;&*\0QM>)6',0,?>Q2"'&OA;C&:Y6+C;WV9>EFP<*J7^% M
M<:N65$90<K>4PCQ0<[F323&$=(21["8*=0F06AG =1J-*PR#>"N(=@-'>L>"
M-VTFA\55@V.2ARE9(%G8AI!<C$_?A?Y?JD68A8EBNCL=A2IEO2^<A/]H>2,E
MA1-J[!5TA9EL\@@3A)MP*   @@%WY6O8A)I<?6)OA%!??5C3A 1B5$[H@[5D
M[D2^@W%G?3IK@SEJ!2\B@R-L7"+T@SEN?166@YUP0@AH@P5S00  @:)YN6J!
M@==C9&$X@<YEUE?!@;IH)$X!@99J.D/[@7EL2SG,@6-N5RZW@65P0R+(@81R
M"!6S@=!SA@BT@9UV50  @4U[5VDQ?W=J(6 D?X=L'E;:?Y-M]4TT?YAODD--
M?YYQ*SE!?Z9RP2Y:?\-T.2*B?_%UDA7-@#!VO0CV@&%Y7P!-@(%\]V@;?5=P
MY%\K?8=R7U7^?;1SN$QV?=MTX$*N??QV!#C#?AQW)BX&?DUX,2* ?H5Y*A7F
M?K)Z$ DZ?T%\1@"M?ZI^DV<U>WYW;%Y->]5X:%4S?"1Y2$O,?&5Y_D(A?)QZ
MLSA6?,Q[:2V]?0M\%")@?45\OA7\?5]]<PE^?D)^Z $.?N> %V8U>>5]Y5UX
M>EA^7U2$>L%^PDLX>QI_!D&G>V1_2S?W>Z1_EBU]>^]_XB)&?"V /Q80?#J
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MV4>@B9MD>3XIB.%G$32'B#EIH2GDA\IK_AY-AZ9N(!&-A]-O]09$A:!T @
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MKSW)B&=WIS5CAZAXH"S@AN]YGB.1AE5ZEAEQA>![D0ZUA-]] 06+@QE^^P
M@-F  %2HB3QZ%DTWB(!Z[T6%A\E[K#UPAQA\0S4@AFA\WBRTA;M]@R."A29^
M+AF%A*I^\ [K@[1_] 71@C> T0  @+*  %0'A^U_VDRSASF 644;AHJ O3T>
MA>. ^33CA4*!/2R.A*.!CR-UA!*![AF4@X^">@\7@JB"G08,@7*"<   @)"
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M_S6QBA6(Z"XSB0^(X":CB!&(^!YCAOR)!Q5AA>N'\PQX@]R&(032@AJ#0@
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M6QS\;MEY( W'<^%Z"@*S>W!\WWF:7?1WYV[Q8,-XJV0S8TYY7EE597EY]TY
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MED'ZAWY;\#CAAOI?.2^/AIQB<"4]AH)E8AGDALEG_@W>AIMJD 0-A2]OJP
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MM#AK@_9O4#!A@[1PZB@V@WQRA!\_@U)T$!5C@TYU@0NX@J%WSP.O@@9[IP
M@ !_?DX3@J9OI$<1@H=Q0C_'@EURN3@4@B9S]3 E@?IU-"@8@=)V>!]%@:]W
MNA68@9UX]PP)@4%[( 0(@0)]T0  @ "  $UH@,1U54:-@,%VBS]E@+!WG3?*
M@(QX>B_R@'-Y7R?^@%UZ31]+@#][2!7%@"1\5 Q.@!-^$P14@"-_JP  @ "
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MY##'@_" 6BFR@X" VR*&@QR!<QJO@HZ"+1(>@=R"MPI.@0*"N0-Q@)B"5
M@ "  $/#A(&#BSV[@^2$/3=G@TB$OS"D@JF$_"FB@D:%12*,@?&%JQK.@6R&
M(Q)7@,F%DPJ+@#>$G0.E@ J"=P  @ "  $-%@S6(\3UM@L")+C<[@CN)53"'
M@9Z)82F6@46)>B*0@/V)N!KG@(&)9!*$?^V'WPJ\?Y6&(0//?YB"DP  @ "
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M)TT4:O!CO4+E;'9F13B2;>UHP2US;UEK'2&'<']M111[<N-O P@7> MR#
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M8O&"PCJG92:"KS&N9T>"L"@0:16"U!W$:JF#)!*#;[^#-@@4=9R"C@$/?C:
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M=C+/?QMFNRL??V=H^R-)?\)K-AJB@!IM6A$O@(1O9PCC@.%RUP'P@3QX,
M@ !^(4<V>^UE=4"F>_AGG3G&?"5IJ#)R?(9KB2KA?/=M:2,M?6]O2!JO?=-Q
M&1%H?G%RX DT?U)V%0)%@!EZD0  @ !_3$:)>2IK$T @>6ILYSED><)NFC(N
M>CUP'RJZ>LMQIR,E>UUS-!K2>\ETPQ&X?)UV60F6?>]Y9P*E?Q=\P   @ "
M $80=L)PM#^W=R=R&SD/=Z!S:#'T>#1TD"J8>-UUP2,?>8AV_!KP>?]X2Q']
M>PQYM GJ?,!\6P+W?CI^G@  @ "  $6>=+!V23]6=2-W53C$=:IX23'#=DUY
M'2J =Q!Y_2,A=]5Z[!L3>%U[_1)#>:Y].PHZ>[M_#0- ?7V 1P  @ "  $4E
M<O![RC[W<U=\I3B <]E]7C&<=(%]Z"IR=5I^@",M=CI_+AL^=MZ !1*->'F
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MO"N;?*-WQ23M?/AXUAX??5IY^!:G?6=[/P[A?=]]"@@A?HE_  (2?U2 1
M@ "  #T0>NEY73>;>KEZES'.>JE[HRN$>L1\;R3O>RQ]0QX_>Z5^+!;J>\=_
M0@\[?*" >@AZ?:&!2@)7?JZ!E0  @ "  #RW>4!^K3==>1-_GS&H>0> :RMQ
M>26!!"3R>9Z!HAY;>BR"6A<F>F>#/ ^)>Y:#9 C&?."#.@*1?B6!O   @ "
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M,@     $ PL   $                    !                     0
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M-=Q)W5O>;-]ZX(;AD>*/XWGD8.5&YBOG#^?QZ-/IL^J3ZW'L3^TL[@GNY._
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M88" #I);3JA_YX[9/ -_NHM5*?5_=H=OYJ*"F[9DTQN!Y[%$OZR!.ZQ(K&*
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M.8RJ3@2-FHK(/WN*_(CK,2*(>H<E) J%R857M9"AQ:"BIGJ>1)W7EV::\IL
MB%&7[9@;>7B5*)5[:M:2<I+P7"2/SY!E38B-,(W;/R^*C8M6,0^'_XCI)#R%
M/89PM&.ABJA#I6V=^Z3-EG*:GJ%+AV^7E)V[>*Z4S9IP:B>2%9<V6Y6/<I0
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MU)F!1[Z/?Y4Q.O6,(Y#F+G:(W(RT(W:%7(BCIA:I1KK\F VD_[8.BA:@WK$
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MT9O+3Z&6P9?.0X22MI//-\&.I8_7+$R*LHOW(F2&D(A,F[6Q%[=$CEJL2;*
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M_H6/;/B#<83R6QR"\H1626B";X.T-^V!YX, )RR!4()$U.J'+I*(PXV&-Y#
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MJ\B"M(/7FNB"0X-9BAF!XX,'>6*!B8+':%J!3(*&5S^!'H)$1E6 ZX'\-:R
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M[*HH@UI^K:5P<X=^>J"X8X=^9YOV4X]^8I<D0]Y^59)'-(%^08UY)E-^#8B
MPK6 $<$HLJQ_A[O+HIA_"K95DFY^I+"_@H5^8JM#<LY^*Z6]8O!^%Z @4Q]^
M$IIM0Y5^!Y2Q-%]]_(\*)F%]T8E)P=!_X\G$L=5_5<.SH<U^U+V$D:]^:;<M
M@=A^)+#A<CA]ZJJ$8G9]U:0#4L1]T9UK0UI]R9;4-$5]Q9!B)FU]H8GOQ':-
MMG'XM+:,/7-/I-"*WW22E*N)K76SA)&(E7;I=(V'B'@L9#>&DWE;4\J%JWJ$
M0XB$Q'NS,VV#Y'S=)#:"_'XYPGJ,5'J?LMN+"WL9HQ>)T'N(DQF(K7OJ@RR'
MJ7QM<UJ&KWT"8S>%S7V,4P*$]GX20O^$'WZ;,RZ#3'\>)%2";7^^P+^+$X,?
ML2^)XX+*H86(PX)UD;&'OH(>@>Z&SX'Q<D:%Z('58E*%&(&U4E"$48&20H2#
MB8%N,O6"Q(%')&^![X$HOQJ*%8MTKZV(\HIDH">'X(E5D':&YXA*@-6&"8=O
M<5*%,X:E88:$<X754;&#O(4 0AB# H0J,L."2H-4)(:!@()VO86)3I/-KBF(
M-Y("GKN'+I \CRV&.HY^?[&%9HSS<%6$FXMX8+:#Y8GW41*#-XAO0;""A(;E
M,I>!T85@)*.!!H/%O J(O)O^K+"'L9E_G5"&KI<'C>*%MY2=?HN$Y9)C;U>$
M'Y U7^B#;8X#4'F"PHO+04Z"$8F.,G&!6X=<),6 B(4.NJ2(2J0FJUZ'0:#X
MG!6&/9W0C,.%1)JR?8V$=9?";GR#LI3:7S6#!9'R3_2"78\#0/N!K(P1,E"
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MKZQDD#:+^*A3@AF*3Z0Q=!R(X: N9DV'@9PI6%*&-I@.2FN$[I/E/-F#G8_
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M]9$Y;UJ.]H]I8AV- HVE5*^+&XO31U")-8G].D.'3(@M+86%;(9V(C&#;X3
MHYN7G9X=EGR5'INZB4.2O9D^>]V0B9:A;I".B90O87&,EY'%5":*L8]11NZ(
MS(S7.@J&X8IF+7J$^X@2(EN"](7!HH"73Z5OE7&4RZ)LB$J29)]1>ON0*IP3
M;<F.*9C]8,B,-I7M4YV*49+/1HB(;8^J.<V&@(R.+6F$F(F3(GZ"C(:BH827
M%:ROE'"4B*DHATZ2&:5^>A2/V:&F;/R-U)WL8!F+W9HS4PV)^)9B1AN(%9*$
M.8:&*(ZO+5*$0(K^(IR"-(=FH*"6XK/QDXV44*_:AG.1W*N:>4N/E:<D;$J-
MC*+!7X"+D9Y94H^)JYG.1;J'R94R.4>%WI"C+3R#]XP_(K2![(@+G]B6MKLO
MDM"4(K9LA<*1JK&$>*B/7JQJ:[J-4:=77P6+4Z(Z4BJ);9SR16R'C)>9.16%
MH9)8+2N#O(U/(LB!LHB2G^>C]'$@DQZ@G'*3AC*=;'/M>0R:>'4B; &7I79N
M7R*4VW?(4?.2('D61,&/;WIG-]:,RWO**RR*4WU"']:'U'[PGJ>BS7B3D?.?
MD7E"A1R<=GGI> J9CGJ#:QV6R7LZ7F"4#'P!45N177S 1%F.MWV"-Z*,&7Y2
M*R^)HW\U(!N'(8 ^G5VAT'_%D+N>H'_?A ";D7_K=QJ8MG_B:DV5_X !7:Z3
M4( S4-&0K8!=0_N.$(")-W.+>8#!*S&)!H$-(%>&@X%RG"^@]H;4CZ6=S89?
M@P::Q879=D"7\(4[:8^5183&70N2I(1?4%*0#8/M0Z:->H-Z-TJ*ZX,3*S2(
M>X+&((N%^8*)FN^@2HWJCH>=)8S=@@>:(8O =5^738J+:,J4J(F 7&.2#HB!
M3\^/?8=T0TR,[X9C-QR*8H5@*S6'[H1Z(,2%98.?F?.?PI3*C8:<II,L@0V9
MI9%\='V6S8^S: 64*(X46[Z1CHR 3TR._XK=0O",<8DU-NN)X(>9*S:'8X8<
M(/Z$S82IF.B?5)NHC)6<.IEO@#69.)<E<[F6793"9UJ3N)**6R^1'Y!=3MN.
MD8X@0J&,!(O?-L&)<(FK*S>&[(>8(2^$2X65E^N? :*"BZJ;XY^T?UR8W9S3
M<O65_9G99JZ35I<(6IZ0NY0^3F>.+I%B0DR+H(Z -I&)#(NK*S&&@XCZ(5F#
MW89CEP6>R*E1BL*;H:8%?GJ8DZ*=<B>5JY\09?F2_YND6@207Y@Z3>F-TI2U
M0>Z+19$F-E>(L(VD*R2&)HI((7R#@(<5EC2>D; >B?.;::Q(?;285JA1<7*5
M9J0O95F2M: B67R0$IP237N-@Y?@09J*]Y.?-B.(88]Q*Q:%V8MM(9B#-(>K
ME7^>7+;;B4B;-[)B?168)*W+<."5+ZD/9-F2>:1<60^/TY^C32&-0YK!05>*
MMY73-?B((I$ *PN%FHQC(:^"]X@EE'VKIG%3B'RGTW*9?&ND%7/9<#V@>741
M9#*<_G9D6%B9B'?'3#26(GDB0!.2Q7J#-$./=WOW*+J,7WV!'IR)17\[DWVJ
MA'A'AY*FQ'CE>Y6C&'F(;W6?B7HS8X"<&WKZ5\*8LGO12\.55WRB/\V2 GUX
M-"J.NGY>*-&+HG]9'NF(A8!WDG:ICW\JAI*EVW\W>JFB.']$;K*>KW]28MJ;
M3'^'5S:7\'_/2UJ4GX 1/XR14X!7-!2.$("K*.2*^H$4'RV'VX&7D7FHM879
MA::E"85?>=.A;(3D;?R=YX1G8CR:CX0/5K"70(/%2O:3^8-Q/U"0MH,<- "-
M>8+8*/:*9H*Q'VB'1X*=D'.H!HR5A+BD78N%>/^@PHIW;4"=/XEL89J9[(B&
M5BB6HH>M2H^38H;$/PZ0(X79,^:,Z(3_*0:)SX1''ZB&J8.?CZFG?9,3@^:C
MUY%V>#"@/(_;;(:<MHY"8/F99(S25:.6&HMM2BB2VXGW/LF/G8A],\>,7X<3
M*16)/(7+'^J&"825CL.G!IEU@QRC8I=-=WZ?QY4D:^6<0)+[8&Z8[9#[53&5
MI(\(2="29HT"/HZ/*8KX,ZR+Z(C_*2*(O8<I("*%@(5MC>6FJY_5@E*C!)TE
M=L:?9IIQ:S^;VI>X7]V8A)4I5+F5.9*D27&1_9 )/DN.P(UH,XJ+?8K9*2>(
M3HAO(%*%#88IC1VF<*8Y@8:BP*,/=@"?&)_9:HN;@IR67T"8*)ES5#64V997
M20>1G),>/?V.7X_<,UZ+'(RK*2.'[(F@('J$JX;,C%:F-*R/@,JBA*CB=5&>
MV*4F:>R;.J%57K67VYV<4\"4B)GC2*F1298(/;B.#9(B,S6*RHY1*1Z'FHJJ
M()J$6X=3BYZE]K+%@"JB3JZ"=,2>I:HR:6R:_Z717D67G*%\4V*41ITF2%V1
M!YBJ/8"-RI0E,Q2*AX^]*1J'6(N*(+2$&X?"B4FS:7'>?A2NTG,N<M>J971M
M9X>F.'657&2B*7;@47V>'GA 1F*:('F<.UN6)WK^,+&2-'QN)EJ.8WWG'7V*
MFW^#B*2R1'B#?7BMR'DM<D.I;WG39ONE3GIT6^BA2GLX416=27P01A:94'SH
M.S&56'W&,*R197ZP)H"-EW^A'=*)SH"MA^.Q2'\!?+FLV7\C<92HC'\^9F^D
M<G].6W.@=W^'4+.<?W_51<^8C8 C.PJ4FX!W,*B0K8#5)J&,X8$^'AV)&8&[
MAP^P985/? &K_(3X</6GLX269>BCGX0C6P"?JX/54%2;NH.718N7U(-2.N:3
M[X,0,*60"H+;)K^,08*]'EZ(>X*PAE&OI8NJ>TNK0HK$<$ZF_HG6952BZHC=
M6H*>^H@(3^^;#8=!14*7+89N.KV33H6<,)Z/:X39)MZ+GX0S'J6'U(.?A;6O
M"I&Z>J*JKI!/;Z*F;([<9+JB5HU=6?^>9HP&3X6:>8J\1/:6FHEE.I&2NX@,
M,)6.U8;")OR+ (66'N^'+(2"A/ZND)>Q>?VJ,96_;P^E[9/"9#6AU9&Z68V=
MY8_>3RN9^(X/1+26&XPR.FN2/(I2,(Z.5(B#)Q>*>(;4'RZ&G85(A$FN+YV:
M>5BIRILG;GFE@)BH8ZVA8Y8961F=<9.V3LV9A)%?1&^5IX[V.D"1R8R+,("-
MX(HQ)RJ* 8?Z'V.&)(7T@Z*MY:-R>+*I=Z"6;=FE))VA8QR@_IJ.6)R="9>A
M3F>9&Y2^1"&5/I'".@V17X[",&N-=8O4)S6)F(D,'X^%OH:(@O2MFJE.>!:I
M+J7N;4VDV*)U8IR@J)[>6"Z<L9MD3@V8PI?P0]V4Y)1@.>"1!9#+,%>-'(U-
M)SV)08GZ'[.%:H<#@DVM4*\?=XZH[JL4;-NDFZ< 8C6@8Z+C5]:<:9[;3<68
M>IK70Z:4G):U.;R0O)*1,$>,TXZ/)T.(^HK ']"%)X=G?G.[6G*D<_&V&G/E
M:7>Q"'457P*L/G8K5,:GCW=M2M"BXGC)0,">.WHE-M:9DGN&+5*4YWSO)">0
M3GY1''N+T'_&?BJZ+7CX<Z6U#'F8:2NP$7HT7K>K4GK'5(.FK7N'2IFB!WQ>
M0)N=8'T\-LF8LWXA+6&4!G\+)%R/<7_M'-B*]X#??:ZY'G\0<RVT#'\S:+ZO
M'W].7F6J;']=5$*ESG^92F2A+G_K0'B<CH!$-KR7YH"E+6^3/8$*)(N.KH%M
M'2J*.('=?1.X+(4$<K*S&H2Z:%VN+X1C7A2IA(/W4_^DZX.P2C&@3H-Y0%>;
MO(-#-K"7)X,1+7N2C(+I)+2. H+.'7&)D(+"?)VW6(K\<C>R3(HL9^6M9HE0
M7:JHO8AF4ZBD)H>?2>Z?BX;F0"R; (8H-J"6=(5M+8B1WX2^)."-4X0E';Z(
MXH.@?"JVJI"?<;2QI8]19UZLPXWX73"H&8R/4T*C@HM.2:&>YXH</_N:78CB
M-HV5TH>I+961.H9])0^,J85H'@^(,H1Q>YZV'I8I<32Q&9189NFL-I)[7,:G
MBY"14NJB]([525^>68TH/]&9T(MQ-GV518FZ+:&0K(@3)3>,%X:('E2'G84G
M>Q6UJYN<<+6PH9E29G:KN9;Y7%ZG")2/4I.B<I)621V=V) K/Z694(WS-FN4
MQ8N[+:B0+(F5)5>+EX>0'HZ''H7%>IBU2Z#P<#JP.IY'9@"K29N#6_*FCYB=
M4CFA^)7B2->=8I,U/W>8VI!W-E643HVW+:N/MHL-)7&+)XB%'KZ&M(9+>@NT
M\*9-;\.OWZ,B99FJZI_>6Y6F)YQ\4>JAD)D_2)J<_98//TZ8=I+)-D*3ZH^$
M+:V/4XQ:)86*R8E8'N:&78:[>7RTFZNF;UBOD:?'94:JGJ/H6TFETZ +4:NA
M/)Q-2&F<K)B;/RV8)934-C*3F)$1+:Z/ XUS)9:*?HH''P:&%X<5<Z?#>G0=
M:9&^#73C7[>XE'7"5BVS#W;%3.FMGG@ 0_>H*GE9.P>BM'JW,DZ=-'P8*?Z7
ML'UW(@B2-GZ^&XJ,]( (<ZC"7'GU:9B\^'HZ7[^WB7J95BVR$7L=3.BLJWO9
M0_BG/WRR.PVAQWV7,F"<07Z$*B.6NG]L(DV12( \&^Z,#X$/<VS!,G^C:6J[
MV7]T7Z"V>']?5A^Q$G]N3..KM7^M0_>F3H $.Q.@W8!J,G";8(#8*D.5WX%#
M(HF0=H&='$:+1H'^<S[ 'H5+:4:ZP82S7X6U8H0P5@JP"8/,3-:JKX.,0_2E
M2(-=.Q>?[(,V,GV:BH,6*F"5'H+Z(KV/O8+@').*EH+3<P6_2(K6:0:YWHG$
M7T2T>HC(5=&O)X?M3*NISX<U0]FD:8:+.P^?%H7B,HF9P84_*H&47X2D(OB/
M 808'.>)WX.A<J:^DY #:*6Y)HY]7N2SP(T+57JN;(NY3&:I%8J00ZNCL(EW
M.ON>7XA<,I*9"X=$*J:3J(8W(S:.2H4\'3Z)*(1A<CR]VY4(:$BX?),-7I*S
M'I$F53"MRX]:3"NH=8W 0X2C$(PX.NN=P8JJ,IF8;HD?*L:3#(>C(VN-KH8^
M'8B(C84(<>.]/)G]9_:WY)>27D>RB94V5.NM,9+S2_2GWI#F0U^B?H[L.MR=
M,(SH,J*7WHKH*N.2?HCZ(YF-)8<I'<>("867<:2\NY[D9["W7IP37?^Q_)E*
M5*FLFY:32\"G3)0/0SVA])&>.L^<J(\B,JN75HRH*P"1^HI%(\*,JX@"'?N'
MFX82<4R\3:.J9VBV[*!D7<.Q@YTH5'*L&YG_2Y2FSY<$0R"A?Y0<.L2<-9$H
M,K.6XXXZ*Q>1C(MI(^.,1HB['B:'089W<.:[\:@Y9R*VCJ1H79*Q(J"N5$6K
MLIT52W"F:IFH0PBA(99..KN;V)+J,KF6AX^0*RJ1,HQ<(_Z+]HE4'DF&^8;)
MWU]UVV_$S0UVOW%.NK9WCW+%J%5X/W0=E?%X\G5_@Y=YIW;K<2%Z:'A"7J)[
M,7F.3"Y[^GK5.:Y\P'OY)Z5]E'U#W1ESRWG RP1TXWI,N-QUY7K0II)VQGM'
ME%UWHGO8@CUX?GQV;_9Y8'T%7:5Z1GV,2VA[*WX..39\#'Y\)Y%\]G[WVO]R
M$(.3R/!S68,=MN5T@8*RI-]U>()8DN-V<H(=@/AW;X'N;M]X;H&V7+UY;X%Y
M2K=Z;H$W.,M[:(#J)W]\:("2V.MPKXS^QP5R!XNFM2-S0HIAHT=T4HD[D7EU
M9H@Y?\!V?8=";=EWE(9+6^EXK(502AEYPX1,.&QZU8-!)V][ZH(2UO9OG)9F
MQ31P_I0[LW=R1Y(FH;YS:9 RD!QTD(YH?I%UN(RH;-MVX8KK6R!X"HDK28IY
M,8=A.!YZ4X64)W5[=(.0U4INPI^CPY5P.)RQL>MQD9G5H%!RO9<9CM-S[I2)
M?71U(I( :^YV5H]\6FAWBHST20UXNHIA-^)YY8?3)XQ["H4 TZ5N%*C3PAMO
MD*4GL)1P\*&'GQ)R)9W]C;9S8)J??'QTGI=&:R%UW)/S6<EW&9"<2*%X4XT\
M-ZYYAHGJ)Z%ZL(9+TC=MC[()P,%O"ZV@KT]P:ZD^G>-QHZ3HC*5RY*"^>X]T
M)YR5:E]U:YAP63AVKI1%2$)W[Y /-X!Y+XOJ)[)Z8H=RT0UM,;L]OX=NIK8=
MKA)P K#_G+=Q-ZOIBY=R>*;W>J-SO*(!::%U 9T&6+!V1I?]1^YWC9+E-U=X
MW8W6)\!Z(8AVS_ALY\1FOG!N5KZ-K0%OK+BSF[5PW++;BJQR':T?>==S8:=5
M:/]TIJ%Z6#QU[)N*1ZAW-Y6)-S9XEX^1)\QYZXE4SOQLJLV%O85N%,;FK"1O
M9L!%FN1PD[FEB>]QT[,3>3)S%ZQL:'MT6Z6G5]]UHI[*1V]V\I?C-QMX7Y$.
M)]5YP(H+TS)\.6ZKPD9\3G!CL2Q\<W("G\I\K7-\CF5\ZW3S?0U]*W9O:W]]
M@G?:6>%]Y'D\2%M^27J:-N!^K'O9)@Q_'7U#T31Z/7@ZP%)ZF7CSKTYZ]'FC
MGA)[3GI%C-][K7KV>[Y\#WNQ:F-\A7QD6/A]!7T11ZY]A7VZ-H!^ 'Y()@Y^
M@W[JSQ!XGH&2OE-Y'H%>K7QYG($NG'AZ%8$$BWAZDH#R>HI[$(#L:5][H8#D
M6"5\.X#91Q-\TX#(-BI]9("A)@]]^H!XS19W68J2O(!W]HF,J]-XBHB3FOUY
M#H>LBBMYGH;>>6QZ,X88:&]ZV8555V9[AH2/1HI\,8/ -=Y\V8+@)A%]@8'I
MRT9V4I.0NLEW Y'"JCEWII %F8IX-8Y?B.-XTXS2>%%Y>8M,9X1Z+HG+5J]Z
MZXA&1@M[I8:V-9Y\684<)B%]"8-9R:%UBIQSN31V1IG<J+IV\Y=:F"IWBI3W
MAZEX,Y*O=T%XXY!J9J-YHXXJ5@-Z:XOG19A[+HF7-6I[Z(=#)CQ\F(2]R"-T
M[:5%M\]UIJ'QIVYV5)ZOEOEV\YN)AIAWI9A^=E5X7I5R9>%Y*9)N56YY^X]F
M135ZQHQ2-3U[AHE$)E1\-X7\QL9T<*X/MH!U(JH'IC-US:8,E=9V<*(GA91W
M*)Y9=7-WYYJ&92EXN):Y5.1YD9+D1-MZ9(\#-11[+(LL)F=[Y(<8Q85T"[;1
MM4%TMK(EI/UU7JU^E+9V ZCBA))VO*14=)-W>Y^[9'1X3IL=5%]Y*I9Q1(=Z
M Y&U-.YZV8S_)GA[GX@2Q&!SM;^%M"=T7+HWH_)U ;3ED[YUIZ^0@[-V8*H\
M<])W'Z368]AW\I]>4^YXT9G21$!YKY0V-,UZDXZB)H9[98CGPV-S;,@GLSUT
M$,(LHQITM;PFDO5U7+82@OYV%:_O<S5VTZFR8UIWJ*-84Y-XB)SG1 =Y:I9N
M-+)Z6I ))I%[-XF6QP6"V6W?MT6"4F^OIT>!WW%?ENB!C'+<AHN!171@=D&!
M W7M9:F X7=K5/R SGCB1'2 OGI8- J L'NU)'6 J7U!Q2*!#7;QM6J MG?*
MI8" ;WB3E4> 0GE&A1F &WH1=0-_]WKJ9*%_\GN_5"M_^WR10^* !'U>,\2
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ME=N"M)+>ATN"*I#L>+Z!MH\>:E&!2HU96ZB ^(N030* L8G!/J& 8H?N,(>
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MB%V'5ZHD>S"&**7H;@R%(J&O81*$)IUI4^:#1)D'1LZ":I23.A6!B) E+<"
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M>;1-FZ=PCJ^-C')QJZK-?4URTJ8';DYS_J$N7RYU0)Q'4!QVC9=,04MWV))
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MQ7AI+Q.!BWH](:B!6'Q$L!2#H'$0HB6#$W)_E >"FG/4A9V"0'4"=S:![G9
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MC<* TFDN?_Z G&N%<C& <6W.9'N 3' 95FJ 07)12$J 1'2$.FB 37:Z+,*
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MU'Y)/J"5@7[*-LB23G],+Q^/)W_1)]Z, H!9(.R(YX#@&V.&!H%E9JBE,8'
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MY8/09@N4!)/;7D>2!I*65GV0"I$U3J&.$X^N1LV,-(X:/S6*6XR -W6(B(K
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M"HH"*)MXKX=.'^5Z/(3 B5=HL*5X?IYJB**%<^)L6I^$:1MN(9QM7CIOWYE
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M=86 6&N=:XF .VV@85V -V^$5R" ,W%L30: ,7-;0IJ -W5%.#> 0W<O+CF
M4WD<))B :'K[''* @7SF?@E^F'"'=&%^?'(2:I1^>7.'8(I^FG3;5F]^NG8U
M3'I^W'>50CI_#'CH. A_0WHX+C9_>7N+)+I_J'S9'+Q_UWXL?.A\VG=]<T]\
MWWAR:9E\_7E47[-]0'H;5;M]?GKF2^I]O7NU0=-^#7QT-\Y^9'TO+BE^M7WN
M)-=^^'ZN'09_-W]R>^=[5WXA<DI[B'Z*:*%[S7[B7N!\+7\A50I\@W]A2UI\
MUW^B06I]/7_4-XU]J( "+A1^"H V).Y^6H!O'4Q^HX"N>LMZ$(2V<5)Z7X2+
M9\MZOX127BE[.80%5'![I8.V2M]\#H-G00]\AX,*-U9]!8*J+@%]=X)1)0)]
MTX(''8A^)H'&><%Y!XLR<&]Y9XJ"9PMYV8G"78AZ98CJ4^MZY(@-2G9[8(<L
M0,![Z(8\-R)\<X5&+>Q\\H1;)1!]78.#';I]NX*]>-AX.I& ;Z5XH)!O9F!Y
M&H\^7/MYKXWA4WEZ0(QX2AYZSHL&0'Q[7XEZ-O%[\(?E+=1\>(9;)1E\]83H
M'>5]8H.3> UW@Y?#;OAW^)8X9<]X?)2)7(5Y%Y*E4QMYMI"N2=5Z5(ZK0$-Z
M[8R%-LA[@8I1+;Y\$H@K)1]\GH8A'@A]&81(=V%VWYWF;FEW:)N^95MW^YEZ
M7"5XFY</4L]Y1I2+29MY\I'X0!9ZD(\\-J9[)XQQ+:Q[OHFZ)21\6(<H'B-\
MWX3;>*J,0ULZ;T"+!UZ=9<.)ZF'?7"*(^&3P4G6(#V@%2.N'*VLB/N^&8&XA
M-/6%I'$=*V^$[W0L(FB$1G=$&M:#L'IR=UV)K6(S;BJ(M&3H9-2'V6>'6T6'
M)FH(4;>&:VR02%&%L&\C/HN%!W&F-,R$:G0K*WR#U':[(IZ#1WE(&SB"RGOB
M=@V'@VCV;/N&OVL58\R&#VTC6F^%>F\940:$XW$81\6$3G,?/B^#R74@-*:#
M37<B*XB"UGDK(LZ"97LL&XZ" 'TT=-&%GF^6:^R$[G$P8N:$67*Y6:B#YW0J
M4&"#<W6B1T*# 7<A/=J"HGB2-(2"2WH"*Y*!]7MY(OB!GGSO&]F!3WYG<\V#
MZ'8P:OB#6'<]8@B"XG@\6.R"CWDH3\.".'H91L>!XGL./8>!H7OR-%N!:7S3
M*Y2!+'V[(QZ YWZI'"2 IW^8<O*":GR":AR" WT)83J!KWV$6#Z!=GWP3S2!
M-GY<1E: ]7[*/3B RW\G-#" J7^"*XV ?G_D(SZ 1(!0'&V "X# <?J!*X*W
M:4F W(*U8(B H8*I5ZB ?X*13KF 4X)V1?: )8)://2 $((P- J  H($*XA_
MZ('A(UI_N('/'*I_AX'%<1* )(C.:(5_Y8A37^5_N8?*5R)_IX<P3DQ_C8:/
M1:)_<H7J/+=_;84S,^5_;(1Y*WY_7X/+(V]_/(,R'-Y_%H*K<$=_48Z\9]-_
M&XWG7TY^]HSW5JI^ZXO?3>U^XXJY15E^W(F+/(!^X(A!,\!^Y8;N*VY^X(6I
M(WU^SX1]'0I^N(-Q;Y)^E92>9SA^;Y-77LY^59'N5D1^39!939U^58ZN11U^
M8(SX/%)^:XL:,Y]^<HDO*U]^=8=7(XA^<X6?'2U^:X08;O=][YI?9KA]W9B
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M7U*$4)5>5Z^#II.O3_B"]Y'R2"&";I :0'*![XXU.'>!:8P:,): WHGS*2F
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M0GZEH#%37(,%DR572(+!AB1:_H*">2]>98)*;"-ARH(+7S%E,8'(4@QHCX&
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M<H4W'[YX X-VBD);/)PH?VQ>8IH9=(MA8I?I:9-D+Y6-7H]F^),K4[)IPY#
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M+=)W+(CV)4!XYX:2'C=Z>X1L>E2 T5;.<(R G5JQ9L. <%Y@7/" 3F' 4P^
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M8T>"QW:$6\:"D'>85#6"3GB>3(F" 'F.1.&!KWJ /7&!7WMU-<Z!)7QC+DR
M]7U2)RZ Q'Y&(%J DG\]&NV 98 K8G*!7'P]6R&!.GS44[>!$'U=3"2 W'W3
M1). HWY)/3J :W[!-;& 2W\T+DB -7^I)T. &X D((9_^H"F&RY_W($D8;:
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M1AZ& GS3/TB%-GUS.*^$:GX5,?B#IWZV*V>"ZW]7)3&"-W_Y'S6!D("7&HJ
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M/YR'CHH/.<"&<8D_-"B%78AH+H*$+H=F*0&# X98(\.!_(55'IB!+81:&J2
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ML($5/W>0L(%U.A:.JX&P-..,KX'M+_Z*MX(J*QR(GH)3)EZ&DX)N(=.$P(*
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M>V^/2F-L<7'1/EUO>G0/,L=R@'9+)[UU:'AK'B9X0GJ6D)E8!&O4A-];;6W
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M0:Z!PW7!.U:!C'<N-3^!5WBB+Q2!('H>*1* [WN<(V: RWT0'>F OGYP&:V
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MKW1E7K99*G6?4SY=O';61Z=B5'@'/#UF\7DY,5=KB'IT)QUO]7NZ'F9T*GT
MBSI$UWA;?_!)AWD$=*I.+GFI:6-2QGI)7?Y7?GK@4KA<2WMT1U)A&7P&/!IE
M[7R;,65JN7T[)U=O7'WO'M!SO'ZCB>1"8X 6?M!'4X 9<[M,.( 6:)I1#X +
M75]6 '_Z4D1; W_E1PE@!7_4._QE"G_*,7)J!G_/)XANV7_S'RIS7H 8B,A
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MRVR]:SA=M6Y-8;9@JF_C6$!CKW&!3N!FP',91;IIW'2T/&EM%796,T9P5W@
M*J5SA'FQ(I5V?'MB&_]Y,7T'<[A8,'.W:DM;872I8.Q>FG6E5YMAVW:Q3F%E
M)7>]16-H=WC,/#YKW7GE,T9O2GL(*LURHWPP(MAUT'U:'%UXKWY[<K55YWJ"
M:75947K:8#U<P7L_5PQ@.WNV3?-CN7PR11AG/7RR/!EJS7U!,T=N8'W;*N]Q
MX7Y\(Q%U/'\C'*YX07_%<=I3ZX$H:+U7@H#U7ZE;'X#,5IA>Q8"P39YB=(">
M1.%F*8"1/ )IXH"4,U%MFX"@*Q1Q0("R(T5TP8#,'/%WY(#H<2]2/(>@:"95
M](;[7RQ9LH955D!=>(6L36%A5(4/1+YE.(1Y._QI&X/K,V9L^(-C*SYPOH+=
M(W9T7():'2IWEH'F<*I0UXW\9ZQ4IXS+7L98?HN85?E<7HIB33)@88D]1*1D
M<(@@._IH=X<$,WIL=(7H*V1P583.(Y]T"H.W'5AW5X*\<$-/MI0>9TM3EI)"
M7G17@9!Q5<%;=XZM30Q?FXT$1)!CS(MC._EG\HF^,XML"8@8*X%P 89W(\!S
MR(3:'7UW)(-L<GAP+$\!:+1Q/E+P7RMR1U;K5?%S1%KU3+)T>U[]0YQUT&,/
M.D=W6F<3,11Y!VL:*&IZOF\J(&)\>G,G&<E^'7<@<+EK^E9;9S=M=%FD7=UN
M[%S_5+9P86!R2Z)Q^6/D0L1SI6=@.;9U@&K<,-%W=&YA*&YY:7'K()I[5'5@
M&C=]&WC*;R5H#%VO9<MIZ6!87)QKRF,54Z5MKF7M2L!OHFC(0A1QHVNK.4%S
MRFZ9,)IV!7&1*'%X-W2-(,MZ3G=W&I9\.'I1;>)DD62^9+YFPF;?6[AH^FD1
M4M9K.VM:2A9M@FVB09-OT&_P..MR/W)','!TNG2G*'-W)'<-(/9Y9WEL&NE[
M<GNW;+)AAFNC8\=D 6T\6NYFA&[D4BII$'"?28QKG7)903%N+G08.+-PV'7@
M,&1SB'>R*(]V)7F)(3%XF'M>&T)ZRGTA:]Y>Y7)%8P)AK7-)6D%D='1@4:!G
M.G61225J ';%0.ULQW?_.)=OGGE','!R=WJ9*+YU/WOO(79WY7U &YYZ07Z#
M:NQ<JWBW8D)?HWDI6:QBG7FP42IEF7I42,MHDGL 0+)KC7NS.']NC'QZ,'MQ
MBWU-*.9T>7XA(;%W37[T&^MYS7^^:A1:SG\(89A=XW[V62M@_G[V4,ED(7\.
M2(9G3'\S0(9J>']A.'!MH7^C,(IPQ'_P*0USUX ](>5VSH"('"QY;(#3:6E9
M3(4O80I<:H2S6+Q?E80]4(!BT8/-2%1F*8-O0&EIAX,:.&QLVX+2,)YP)(*0
M*31S5H),(A1V9X("'&-Y&H'#:.17ZHLT8)=;(XHZ6&%>98E 4$5AM8A(2"YE
M,X=I0%1HOH:4.&ML.(7$,+!OH83T*59R[H0C(CIV%(-+')!XUX*.:'Q6J9#Y
M8#M:"H]D6!==;(W94!9@S(Q92 ]D:XK\0$-H&XFL.&IKM8A:,+]O.(<'*7!R
MFX6T(EEUTH1?'+-XHH,U:B9V-$]U831VSU-I6'5W:%=E3_9W_5MI1W-XSE]N
M/QQYOV-]-I!ZVV>&+B]\%6N7)E)]66^S'PA^I7/ &25_VW>_:)YR,59P7^AS
M*UG%5U1T*ETJ3NAU+V"C1HUV7F0</FIWHV>>-A]Y"FLG+@)ZA6Z\)F-\ G)7
M'T5]?'7>&8Q^UGE09UEN5%U;7KUOMF F5DAQ'F+[3@%RD&7>1=!T&&C&/=IU
MK6NY-<5W7&ZZ+=YY%W'))G%ZSG3;'WI\<W?:&>=]\'K!9C-K"V0*7<]LL69<
M58-N9FBR35%P,&L-14%R!&UK/7)SWV_0-81UTW) +<5WSG2\)GYYNG<\'ZA[
MB7FT&C9])GP191AH'VJ17/%J"&QI5-1L FY!3+YN$W 61,]P*''L/21R0G/)
M-5UT;76P+<5VG7>C)J%XNGF9'^5ZMGN,&HM\>'UE9#IEGG#07#9GR'(F5#MI
M_G-[3$AL1G3-1'END78D/.]PW7>"-4QS-7CP+=EUC7IH)M1WU'OA("MY_WU4
M&N1[YGZR8V=C@G;[6XUETG? 4[AH-'B(2^)JKGE31"YM*7HI/,!OI7L(-3YR
M)7OZ+>MTHGSX)P!W#GWV(&9Y8G[N&R][:W_98JUAM7T%6OAD'7U&4T9FG'V*
M2Y!I/'W20_5KY7XI/)]NCWZ(-3=Q.'[\+?]SVW]Z)RIV:G_V()MXWX!K&VY[
M H#<8A%@,(+<6G=BIH*[4N-E-X*12U!G[8);0\QJP((T/(IMF8(7-3EP;8('
M+A=S-H'[)U)UY8'K(,EX<X'0&Z-ZJX&\89Q>PXB36A!A7(?[4I%D"8=62QQF
MT8:@0ZUIQX7_/'MLRX5H-3UOQ835+BQRKX1#)W1U>H.K(/!X'(,&&\YZ9()Y
M84===XX,6<!@0HS@4D]C$HNQ2O-EZ(I]0Y-H_8EE/&]L)(A:-3]O/8=++CUR
M0H8Z)Y!U)(4G(0]WUH0)&_%Z*X,48>9\A$_<6;]\J%/&4<A\R5>]2@U\Y%O"
M0DE]05_).K9]O&/;,OE^7&?N*VE_%&P-)%A_V' U'<> JG12&(Z!;WA58)5X
MD59S6*=Y&5G*4-AYGUTU22]Z)6"[09%ZW&0_.BU[JF?-,JA\CVMH*U-]@F\1
M)'9^?'*]'@=_?796&/& 9GG/7W5TXET$5[!UOU_?4 1VI&+$2'-WE&6W0/IX
MH6BR.;]YNVNY,FEZY&[3*T1\%''[))!]174D'D!^<7@X&4=_?GLJ7F]QN&->
M5N1RTF7*3V%S_F@Y1^-U0FJL0(AVE6TD.7%W\&^D,CYY6G(R*SMZR73,)*=\
M+W=G'G)]A7GX&9)^LGQF77)NWFF85B)P.6N/3LYQIVV%1VMS+V]Z0"YTOW%R
M.3=V5'-P,B=W]'5[*T=YEW>1)-%[+7FG'K%\KGNW&>1]_GVE7)AL>&]]57=N
M"7$"3DMOK'*!1PEQ:'/Y/^IS*G5W.1%T[W;^,B-VNWB4*V-XB'HT)0AZ1GO2
M'OA[\GUF&CI]97[>6_!J:7595.IL'G923=IMZW=+1K5OUGA$/[!QQGE(./!S
MMGI6,A]UJWMX*WQWG7RC)3AY@'W+'S1[4G[I&H)\XW_R6UMHH7L05&QJ;WN/
M37=L67P-1G%N:'R*/X-P@GT6.-ERGGVL,B!TO'Y4*Y5VU'\%)61XVG^Q'VEZ
MRX!0&L!\=8#D6LUG&("34_EH^8"\32!J]H#71CMM&(#=/V-O6H#S.,QQHX$1
M,BASZX$\*[%V*H%I)8UX48&-'Y=Z6H&@&O-\&(&V6F=ELH8"4YYGLX6X3-AI
MR85?1A!K^H3O/TMN7H21.,-PSH0\,C%S/H/J*\EUGX.5);%WXH,W'[YY_X+%
M&QU[S8)E6B-D=XLZ4UEFH(I=3)YHTHE^1>UK$8B:/S=MD8?,.+QP(H<),C=R
ML89!*]QU+X5T)<UWB82?']UYMH.X&SY[D8+U6=^"\5 I4H2"EU0-2U6"-E@"
M1%N!SUP-/5B!K6 ;-H:!JF0U+Y:!P6A6*-6![6R$(HB"*G"X'*6"?G3?& F"
MT'C>6,5_ E9?49]_$UF]2I9_&UTS0Z]_%V#)/,Y_361>-B9_FF?[+V9_\FNK
M*-: 5F]I(K* R',E'.J!3';*&&>!Q7I#5[M[C%R?4-9[U%^,2?E\*6*$0Q]\
MD&6+/%Q]&&B<-=I]KFN[+T)^1F[P*-E^Y7(S(M=_BW5P'2: /7B4&+F VWN*
M5M-X=F*M4"IX]V4R279YD&>[0JYZ1VI)/ =[$&S>-:5[XF]]+RM\NG(K*-]]
MEG3C(OA^<7>8'5M_37H\&0& #7RS5?MUIVBA3XAV:FJU2/YW0VS)0D]X.F[?
M.\1Y/7#[-8!Z1',>+R5[4G5.*/=\8G>'(RA];7F['9M^<WOB&5!_57W@52]S
M5&XV3O!T16_B2))U3G&(0@-V=G,I.Y-WJ'31-6EXWG:"+RQZ%WA"*1Q[4'H*
M(V1\A'O+'>-]LGUZ&:-^M7\&5+-Q17/!3H%R7W3L2#5SDG850<)TYW<].VEV
M17AR-55WI'FP+S-Y!7L!*3MZ97Q:(Y=[O7VI'B!]#G[G&>I^+H )5$-O>WDG
M3AMPLWGA1^)R!'J908QS>GM..TEU 'P1-4EVB7S=+SUX$WV[*5IYF7Z>(\9[
M%']V'E5\@X Z&B5]NX#L4\9M\GY93;9O/'[*1YAPH'\I06%R)W]O.S-STG_"
M-45UAH =+TQW/(""*7IXZH#E(_)ZAH$['H5\#X%W&E=]6X&P4VMLF(."369M
M^H.&1UIO<8-X03YQ!X-1.R)RT8,W-4-TJX,C+UIVAX,0*99X6H+W)!=Z$X+/
M'JM[L(*+&H!]#()44S%K<8B 32QL[8?O1REN>H=>02)P&X;-.Q1R (9)-4)S
M^87-+V5U]H5**:UWYH2^)#5YMX0D'LM[9(-P&J!\S8+:4<F)0E";2U2(8%2<
M1/:'@UBC/K&&KERQ.&>&&&#&,E:%G63H+#N%*FD5)E.$PVU+(,^$;W%Y&Y>$
M-76(%Y*$"GE=4.>%?U9\2I^$^5H$1&:$>5V6/C>$ 6$U. Z#N636,B&#A6B!
M+"R#3FQ")FB#'W -(0*# 7/(&]Z"_7=9%^N"_WJN4 >",%QA2?N!VU^%0^J!
MH&*C/<R!AV6Y-\"!BFC>,?2!EVP1+""!FV]>)GJ!HW*S(2Z!NG7U'!R!Z'D*
M&#F"$WOC3RQ_,6(N25M_$V3K0W5_&&>;/6Y_2VH[-WY_C6SI,=!_U6^C+!>
M$')N)HR 3G4_(5: EW?_'%. \WJ9&'Z!1'S[3GU\=V?/2-5\EFHF0Q)\UVQK
M/21]1&Z9-TY]OG#3,;Q^.W,6+!]^J'5I)JY_%'>^(8Q_BWH#')6 $WPF&,J
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M-RN!P'L*,Q"!1'P;+OJ!&'T>*Q^ _7X;)TB H7\:(X" 1( "'\* '8"]&\V
M18$X&-R 98&A/NB!/GRH.P^ UWVY-Q^ <7ZH,PV #']K+P=__8 5*SV  X"R
M)W9_S(%$([E_E8&\'_U_D8(*&_U_UH(9&0* #X(H/R!_\(##.QM_K(%6-Q9_
M88'?,PM_#H);+Q%_&(*O*U5_.(+S)YM_((,A(^=_"8,R("Q_(8,?'"-_?H+2
M&2!_RX*6  #__P  __\  /__  !M9G0Q      ,$(0   0
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M4U?^L%UT^J]BBO*Q8YOKLF6JY;-FN-^S:,7:LV[/U;)TV-*Q>=_/L'WDS:^
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MHBL1_Z0Z)?^C13W_I$]2_ZQ87O^P7&K]L5YU^[/_XO_B24-#7U!23T9)3$4
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MW62GH]9GLI70:+R'RVG%?,=MS'?&=\YWQH;->,>7S'G(J<MZP*O,>L"KS'K
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MLHG28;I_SF/ >,QGPW;,;\1VS'G#=\V$PGC-D,%YSIG ><Z9P'G.F<!YSIG
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M<)F[XW&CN^-RK;O@=;6[V'FXNM%]N+K*?[BZQ8"XN\6 N+O%@+B[Q8"XN\6
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MP-EWL+_1>[2_R7^TO\."M;^\@[3 N(2TP+B$M,"XA+3 N(2TP+B$M,"XA+3
MN(2TP+B$M,"XA+3 N(2TP+B$M,#_F2,-_YLR(/^:/C;_FDE*_Z)05?^G5V'_
MJEYL_ZMC>/ZJ9X+YJ&N-]*-NE^Z<<J'HDWJJX8J!LMF B;O2>9+!SWB>PLUZ
MJL+)?;+"PH&RPKR$L\*VA;+"LH6RP[*%LL.RA;+#LH6RP[*%LL.RA;+#LH6R
MP[*%LL.RA;+#LH6RP[*%LL/_FB,-_YLR'_^:/C;_FTE)_Z-05/^I5U__K%YK
M_ZUB=?RL9H#VJVJ*\*EOE.JC<YWCG'FFVY* L-*'AKK)?XW"Q7R8Q<-]I<7
M@+#%NH.QQ+6&L<2PAK'%K8:QQ:V&L<6MAK'%K8:QQ:V&L<6MAK'%K8:QQ:V&
ML<6MAK'%K8:QQ:V&L<7_FB,-_YLR'_^;/C;_G4E(_Z504_^K6%[_KEYI_J]A
M<_FO97WSKFF'[:UND.>I<IG?HWFCU9A^K\N.A+G!A8K"NX"3Q[B!H,>W@JW'
MLH6OQZZ'K\>JB*_'J(BOQZB(K\>HB*_'J(BOQZB(K\>HB*_'J(BOQZB(K\>H
MB*_'J(BOQZB(K\?_FB,-_YPR'_^;/C;_GDE'_Z=04O^M6%S^KUUG_+!@<?>Q
M9'KPL6B#ZK%MC.2P<I3:J':BT)Y\KL65@;BZBX?"LH6.R*Z$FLJLAJC*JH>M
MRJ>)K<FDB:W)HHFNR:*)KLFBB:[)HHFNR:*)KLFBB:[)HHFNR:*)KLFBB:[)
MHHFNR:*)KLG_FR,-_YPR'_^</C;_GTE&_ZA04/^N65O]L5QE^K)?;O2T8W?M
MM6=_Y[9LA^"T;Y/5K'.ARJ1YK;^;?[BTDH3!JHJ*R:6(E<RBB:+,H8JKS)^*
MJ\R=BJS+G(JLRYR*K,N<BJS+G(JLRYR*K,N<BJS+G(JLRYR*K,N<BJS+G(JL
MRYR*K,O_FR,-_YTS'_^</C7_H4A%_ZI13_^P65G\LEQC^;1?:_&W8G/KN6=Z
MY;QL@=NY:Y+0L7&@Q:EWK+JA?+>NF8+ HY"&R9N,C\Z8C)S/EHVJSY:,JLZ6
MC*K-EHNKS):+J\R6BZO,EHNKS):+J\R6BZO,EHNKS):+J\R6BZO,EHNKS):+
MJ\S_FR,-_YTS'_^=/C7_HDA$_ZM13OZQ6%?ZM%M@]K=>:.^Z8F_HOV=TX<)H
M@-:^:)'+MFZ?OZYTJ[2G>K:HGW[ G9>#R9*1B<^-CY;1BY&ET8R/J-&-CJG/
MCHVJSHZ-JLZ.C:K.CHVJSHZ-JLZ.C:K.CHVJSHZ-JLZ.C:K.CHVJSHZ-JL[_
MG",,_YXS'_^=/C7_I$A#_ZU23/RR6%7XMEI=]+E=9.R_86GFQF=MW<EB?]'#
M9I#%NVR>N;1QJJZM=K6BIGN_EIY_R(F7A<^"E8_3@):?TH*5I]*%DJC0AY"I
MSX>0J<^'D*G/AY"ISX>0J<^'D*G/AY"ISX>0J<^'D*G/AY"ISX>0J<__G",,
M_YXS'_^>/S7_IDA"_Z]32ONT5U+VN%E9\;U<7^K$8&+CS&-KV-%=?LS)8X^_
MP6F=L[INJ:>S<[2;K7>]CJ9[QX*@@,Y[GHO2>:";T7N?J=!_F:G/@):ISX"6
MJ<^ EJG/@):ISX"6J<^ EJG/@):ISX"6J<^ EJG/@):ISX"6J<__G2,,_Y\S
M'O^?/S7_J$E _K%42/FV54_TNU=4[<):6.;,85C>UEMJTM=:?<7/88VXR&:<
MK,)KJ*"[;[*4M7.\AZYVQ7NJ?,QUJ8C.=*N9S72MJ\Q[I:S+?)^KS'R?J\Q\
MGZO,?)^KS'R?J\Q\GZO,?)^KS'R?J\Q\GZO,?)^KS'R?J\S_G20,_Y\S'O^@
M/S7_JDH^_+-31?>X5$KPOU5.Z,E93N#575'6X%=HR]Y9>[[778RQT&*;I,IG
MIYC$:K&+OFV[?KAQPW2U>,EPMH;)<+B7R&^[J\=VLJ_&>*NNR'BKKLAXJZ[(
M>*NNR'BKKLAXJZ[(>*NNR'BKKLAXJZ[(>*NNR'BKKLC_GB0,_Z T'O^A/S7_
MK4L\^K520?.\4D3KQ5-%XM)80=C@5T_.YEIFP^1;>;;?7(JHVE^9F]1BI8_.
M9*^"R6>Y=<5KP&[$=<1KQH3$:\B5PVK+J<)PQ+3 <KFRPG*YLL)RN;+"<KFR
MPG*YLL)RN;+"<KFRPG*YLL)RN;+"<KFRPG*YLL+_GR0+_Z$T'O^D0#/_L4TX
M][A0.^_!3SSDSE$XV-Y.0L_F5%;%[5AIN^I;>:_G78BAXUV7D]]=HX;97JUY
MU&&V;]!FO&O/<KYKT'^];-"-O&W1G;MMT:ZZ;,RWNVS,M[MLS+>[;,RWNVS,
MM[MLS+>[;,RWNVS,M[MLS+>[;,RWNVS,M[O_H"0+_Z,U'?^H02_[M$XS\[U,
M-.C)2S#:VT4TS^5+2<;N45V[\E5OL>]7?J7L6HR7Y5B9B]]9HX#:6ZQUU5VS
M;M-CMVS3;;ALTWBW;-.$MFW4D;5NU9^T;M6LLV[5K+-NU:RS;M6LLV[5K+-N
MU:RS;M6LLV[5K+-NU:RS;M6LLV[5K+/_HB4+_Z4U'?^L0RKXN$LK[<-'*-[5
M02/0Y$,ZQNY)3[SV3F.R]U)SJ/)6@IKK5(Z.Y529@]]5HGG;5ZEPV%JO:]9?
MLFC59[-HUG"R:-9YLFG7A+%JV)&P:MB;KVK8FZ]JV)NO:MB;KVK8FZ]JV)NO
M:MB;KVK8FZ]JV)NO:MB;KVK8FZ__I"4*_Z<V'/ZR1B/ROD8AX\\^&-+B.2G'
M[4) O?9(5;/]36>J^5)VG/%0@Y#K4(Z%Y5"8>^%1GW/>4Z5LVU>I9]I;K&7:
M8JUDVFFM9-IPK&7:>:MEVX.K9MN,JF;;C*IFVXRJ9MN,JF;;C*IFVXRJ9MN,
MJF;;C*IFVXRJ9MN,JF;;C*K_IB8)_ZDX&_>Y1AKHR#L2U-\M&<CL.C"]]D)%
ML_Y(6*K_36F=^$MWD?)+@H;L2XQ\YTR4<^1-FVSA4*!GWU.C9-Y7I6+>7:5A
MWF*F8=YHI6'>;Z5AWGBD8=]_HV'??Z-AWW^C8=]_HV'??Z-AWW^C8=]_HV'?
M?Z-AWW^C8=]_HV'??Z/_J2<(_[$Z$^[!.PS7VQT*R>LQ'[[V.S6T_D-(JO](
M6IW_1FF1^49UAO-&?WSN1XASZTB/:^=*E&7E3)ABY$^:7^-3G%[C5YU=XER=
M7.)AG5SC9IU<XVV<7.-TG%SC=)Q<XW2<7.-TG%SC=)Q<XW2<7.-TG%SC=)Q<
MXW2<7.-TG%SC=)S_K2@']+LZ!][3&0'+Z20/O_4T([7^/CBJ_T%)G/] 69#_
M0&:&^T%Q?/9">G/R0X%K[T2'9>U&BV#K28Y=ZDR06^E/D5GI4Y)8Z%:36.A:
MDU?H7I-7Z&225^EIDE?I:9)7Z6F25^EIDE?I:9)7Z6F25^EIDE?I:9)7Z6F2
M5^EIDE?I:9+]LR<$Y<H= ,WF%03 ]"L3M?TW)JK_.SB<_SE'D/\Y587_.V%[
M_SQK<OL]<VKW/WEC]$%]7O-#@5OQ18-8\$B$5O!+AE7O3H94[U&'4^]4AU/O
M5X=2[UR'4N]@AU+O8(=2[V"'4N]@AU+O8(=2[V"'4N]@AU+O8(=2[V"'4N]@
MAU+O8(?JP0H S]8' ,'S'P:W_3 5J?\R)9O_,36/_S%#A/\S3WK_-5IP_S=B
M:/\Y:6'].VY<^SUR6/D_=57X0G=3]T1X4O='>5'W27E0]DQZ3_9.>D_V47I.
M]E5Z3?98>DWV6'I-]EAZ3?98>DWV6'I-]EAZ3?98>DWV6'I-]EAZ3?98>DWV
M6'K,R 0 P>8' +;]( >I_R84F_\G(H[_*#"#_RH]>?\M1V__+U!F_S)87_\T
M7EG_-F)5_SEE4O\[:%#_/6E._T!J3?]":TS^1&Q,_D9L2_Y);$K^2VU)_DYM
M2?Y0;4G^4&U)_E!M2?Y0;4G^4&U)_E!M2?Y0;4G^4&U)_E!M2?Y0;4G^4&W_
MC!P+_XTI'/^+-S#_AD1%_XI,4O^-4E__C%AL_XA>=_Z"9(/Y>VR-]'1TE_%M
M?)[O9X6C[F2-I>UDEJ;M9)ZF[66EINUEK:;M9K2F[F>\I>EJP*7D;<*EWG#$
MI-IRQZ3:<L>DVG+'I-IRQZ3:<L>DVG+'I-IRQZ3:<L>DVG+'I-IRQZ3_C!P+
M_XTI'/^+-S#_AD1%_XI,4O^-4E__C%AL_XA>=_Z"9(/Y>VR-]'1TE_%M?)[O
M9X6C[F2-I>UDEJ;M9)ZF[66EINUEK:;M9K2F[F>\I>EJP*7D;<*EWG#$I-IR
MQZ3:<L>DVG+'I-IRQZ3:<L>DVG+'I-IRQZ3:<L>DVG+'I-IRQZ3_C!P+_XTI
M'/^+-S#_AD1%_XI,4O^-4E__C%AL_XA>=_Z"9(/Y>VR-]'1TE_%M?)[O9X6C
M[F2-I>UDEJ;M9)ZF[66EINUEK:;M9K2F[F>\I>EJP*7D;<*EWG#$I-IRQZ3:
M<L>DVG+'I-IRQZ3:<L>DVG+'I-IRQZ3:<L>DVG+'I-IRQZ3_C!P+_XTI'/^+
M-S#_AD1%_XI,4O^-4E__C%AL_XA>=_Z"9(/Y>VR-]'1TE_%M?)[O9X6C[F2-
MI>UDEJ;M9)ZF[66EINUEK:;M9K2F[F>\I>EJP*7D;<*EWG#$I-IRQZ3:<L>D
MVG+'I-IRQZ3:<L>DVG+'I-IRQZ3:<L>DVG+'I-IRQZ3_C!P+_XTI'/^+-S#_
MAD1%_XI,4O^-4E__C%AL_XA>=_Z"9(/Y>VR-]'1TE_%M?)[O9X6C[F2-I>UD
MEJ;M9)ZF[66EINUEK:;M9K2F[F>\I>EJP*7D;<*EWG#$I-IRQZ3:<L>DVG+'
MI-IRQZ3:<L>DVG+'I-IRQZ3:<L>DVG+'I-IRQZ3_C!P+_XTI&_^+-S#_AT1%
M_XQ+4O^/4E[_CUAK_XM>=OZ%8X+Y?FN-]7=SEO%O>Y[N:8.C[6:,INUDE:?L
M9)ZH[&6EJ.UFKJ?M9[6G[&B^I^9KP*;A;\*FVW+%I=9TQZ76=,>EUG3'I=9T
MQZ76=,>EUG3'I=9TQZ76=,>EUG3'I=9TQZ7_C1P+_XXJ&_^,-S#_B41$_Y!+
M4/^345S_DU=H_Y%==/^,8H#ZA&B+]7UPE?%U>9WN;8&D[&B*J.MFE*KK9IVJ
MZV:FJNMGKZKL:+FJYVR^J>!OP*G:<L.HU'7%J,]VQ*G/=L2ISW;$J<]VQ*G/
M=L2ISW;$J<]VQ*G/=L2ISW;$J<]VQ*G_CAP*_X\J&_^--S#_BT-#_Y-+3O^7
M45K_EU=F_Y9=<O^28GW[BV>)]H)ND_)Z=ISN<G^D[&N(J>IGDJSJ9YVMZF>G
MK>IILJSI:[RLX6^_J]ISPJO4=L.JS7C"J\AYPJS(><*LR'G"K,AYPJS(><*L
MR'G"K,AYPJS(><*LR'G"K,AYPJS_CQP*_Y J&_^.-S#_CD-"_Y5*3?^:45G_
MFU=D_YI<</^787O\D6:&]XALD?. =)OO=WVCZVZ&JNIID*[I9YROZ&BHK^AJ
MLZ[C;KRNVW+ K=1VP:W-><&MQGK KL)[P*_">\"OPGO K\)[P*_">\"OPGO
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M>4OW9'A+]V1X2_=D>$OW9'A+]V1X2_=D>$OW9'A+]V1X2_=D>$OW9'C1O $
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M[8]G?>B&;XCB?G>2W'5_G-9NB*/3;).FT&R>IL]NJ:;.;[:FS'#$IL9TQJ;
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MO;-LH;VS;*&]LVRAO;/_C14&_X\E%/^:,QW_J#X?^K-*(.^\2A[ER$@9VMI
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MA/U1MH3^4<&#_E++@_A6SX/S6=&"[ES4@NE?UH'D8MJ!XF/;@.)CVX#B8]N
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MQZ67?<>EEWW'I9=]QZ67?<>EEWW'I9=]QZ7_?Q,)_WX>$O^$*A[_DC8C_YQ
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M;T+\FF]"_)IO0OR:;T+\FF]"_)IO0OR:;T+\FF_<IP  S[<! ,3' @"YU@0
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M>D_3Y'I/T^1Z3]/D>D_3Y'I/T^1Z3]/D>D_3Y'K_APX$_YL. -JL P#0N@0
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MBEJ?VHM:G]J+6I_:BUJ?VHM:G]J+6I_:BUJ?VHO_<@X)_X83!/^6%0'TI!
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M84;A\&%&X?!A1N'P84;A\&'XD0$ UJ(  ,NP  #!O   M\D" *S4! "BZA,
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M>MF,='G:BG9XVXEV>-R(=GC<B'9XW(AV>-R(=GC<B'9XW(C_81,-_W 3"O^
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M=U*FZ'=2INAW4J;H=U*FZ'?_> @$_XL( -R9  #1I0$ R+ ! +^Y  "TPP$
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M,BC_<#$F_WPP)?^',"/_E"\C_Y<O(_^7+R/_ER\C_Y<O(_^7+R/_ER^ZMP
MK\(  *++  "4T@  A]D  'K@  !Q]  ":/\$!5__"@I7_Q /3_\4%$C_&!E"
M_QP</?\A'SC_)2(T_RDC,?\N)"[_,R4L_S@F*?\^)B?_128E_TPF(_]4)B'_
M724?_V8E'?]O)!O_>B0;_WTC&_]](QO_?2,;_WTC&_]](QO_?2.QP   I<D
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M.J-#_SNJ0_\[L4+^/+E"_3W"0?P]S4'Z/MM ^#_H0/9 \C_T0/L_\D#_/^]
M_T#K0O]!ZT+_0>M"_T'K0O]!ZT+_0>M"_T'_0QD4_SHC&O\_)1S_1"@=_T@Q
M(?]*.RG_248S_T90._]"6T'_/V=$_SUS1O\\?D;_/(A&_3V11OP]F47[/J%%
M^C^G1?D_KT3X0+=$^$' 0_=!RT/U0ME"\T/F0O!$\4'N1/I![$/_0NE$_T3D
M1O]%Y$;_1>1&_T7D1O]%Y$;_1>1&_T7_1!@4_SLC&O]#(QK_22<<_T\O'_]1
M.2?_3T0Q_TQ..O]'6$'_0V-&_4%O2/I >DGY0(5)]T&.2/9"EDCU0IY(]$.E
M1_-$K$?R1+1&\46]1O!&R47O1]9%[$?E1.E(\4/G2/I%Y4?_1^%(_TC<2O])
MW$K_2=Q*_TG<2O])W$K_2=Q*_TG_11@4_SXA&?]'(1C_4249_U8N'/]9."7_
M5T$N_U-+./U.54'Y25]']D9K2O-%=DSQ18%,\$6*2^Y&DTOM1YM*[$BB2NM(
MJDGJ2;))Z4J[2.A+QDCG3-5'Y$SD1N%,\$??3/I*W4O_2]=-_TW23O].TD[_
M3M)._T[23O].TD[_3M)._T[_1Q@3_T,?&/]-'A;_5R07_UTM&O]A-B'_7S\K
M_%M(-?=54C[R4%Q'[DQF3.M*<D[I2GU/YTJ&3N9+CT[D3)=-XTV?3>)-ITSA
M3J]+X$^Y2]]0Q4K=4-1*VE'D2MA1\$S54/I/T5#_4<Q2_U+(4_]3R%/_4\A3
M_U/(4_]3R%/_4\A3_U/_2!<3_T<<%O]3&Q3_7B,4_V4K%_]H-!W^:#TF]V1&
M,/!>3SKK5UA$YE)B3.-/;5#@3WA2WD^"4MQ0C%';4910V5&=4-A1I5#64JU0
MU5*V4--3PE#24]%0T%3A4<U5[U+*5/I4QE7^5L)6_E>^5_Y8OE?^6+Y7_EB^
M5_Y8OE?^6+Y7_EC_2A<2_TL:%/]9&Q+_9"(2_VLJ$_]O,AGY<#LA\6U#*NIG
M3#7D859 WUM?2MI6:5'65'14U%1^5M)4AU;05(]6SE685LU5H%;+5JA6RE:Q
M5LA7O%?'5\I7Q5C<5\)9[%C 6/A:O%G\6[A:^URU6_M<M5O[7+5;^URU6_M<
MM5O[7+5;^US_2Q<2_U 8$_]?&Q#_:B$/_W$H$/YV,17U=SD<['5!).5P22_>
M:U0ZV&1=1=%>95'-6F]8REAX6\=8@5S%6(I<PUF27,)9FUS 6J-<OUJL7;U;
MMUV\6\1=NES57;A=YUVV7?5?LEWX8*]>^&&L7_=AK%_W8:Q?]V&L7_=AK%_W
M8:Q?]V'_3182_U47$?]D&@[_;R -_W<G#?I\+Q'P?C<7Z'T_'N!Y2"?9=5(S
MT6U:0LIF8D_$86I9P%YS7KU=?&&[785BN5V-8KA=EF*V7IYBM5ZH8K-?LF*R
M7[]BL&#08ZY@XV.L8/)DJ6'U9:9B]&6D8_1EI&/T9:1C]&6D8_1EI&/T9:1C
M]&7_3A81_UD5#_]H&0S_=!\+_WLF"_:!+ WL@S42XX,]&-N"1R#3?% PRW58
M/\-N8$V]:&=8N&1O8+1B=V6R87]FL&&(9ZYAD6>L8IIGJV*C9ZECK6BH8[IH
MIV/*:*5DW6BC9.YIH&7Q:9YF\6F<9O%IG&;Q:9QF\6F<9O%IG&;Q:9QF\6G_
M3Q81_UP3#O]L& K_>!X)_X D"/.%*@KHB3(-WXHZ$M:'1!S.@DXLQ7Q6/+YV
M7DJW<&16L6MK8*QG<V>I9GMJIV6#:Z5EC&RC9I5LHF:?;*!FJ6R?9[5MG6?$
M;9QGV&V::.MMF&CO;99H[VV5:.]ME6CO;95H[VV5:.]ME6CO;95H[VW_4!81
M_V 2#?]P& G_>QT'_8,B!O")* ?EC2\)VX\W#-*,0QK)ATTJP8)5.;E\7$>R
M=V)4JW%H7Z9M;V>B:W9LGVE^;YQIAW";:9!QF6F:<9=II7&6:K%QE6K <9-J
MTW*2:N=RD&OL<8]K['&.:^QPCFOL<(YK['".:^QPCFOL<(YK['#_4141_V,2
M"_]S%PC_?AP%^H<A!.V-)03AD2L%V),T"LV001C%C$LGO(=3-K2"6D2M?6!1
MIGAF7:!S;&>;<'-NEVUZ<I1L@G22;(QUD6R6=8]LH76-;*UUC&R[=HIMSG:)
M;>-VB&WI=8AMZG2';>ITAVWJ=(=MZG2';>ITAVWJ=(=MZG3_5!0/_V81"O]V
M%@;_@1L$]XH> ^F0(@+>E28#TY<S"<J40!;!D$HEN(Q2-+"'64*I@E]/HGYE
M6YMY:F65=&]ND'%V=(UO?G>*;X=XB&^1>8=OG'F%;ZEZA&^W>H)OR7J!;]]Z
M@7#G>8%OYWB!;^AW@6_H=X%OZ'>!;^AW@6_H=X%OZ'?_5A,._VD0"?]X%07_
MA!D#](T< >:3'@':F2 !T)HQ!\:8/Q2]E$DBM9!1,JV,6$"EB%Y-G8-C69=^
M:&.0>FUMBG9R=(5S>7F"<H)\@'&,?7YRF'U]<J5^>W*S?GERQ'YX<MM^>7+D
M?'ERY7MZ<N9Z>G+F>GIRYGIZ<N9Z>G+F>GIRYGK_61$-_VP0"/][% 3_AQ<"
M\8\8 ..6%P#6G!P S)TO!L*</1*YF$@@L950+ZF15SVAC5Q*FHEB5I*$9F*+
M?VMLA'MO='YW=GMZ=7Y_=W6(@75UE(%S=:"!<G6N@7!VP(%O=M:!<';B?W%U
MXWYR=.1\<G3D?')TY'QR=.1\<G3D?')TY'S_7! ,_V\.!_]^$P/_B14![I(3
M -^:#0#2GQD R*$M!;Z@.Q"UG48>K9E/+:6653N=DEM(EHY@5(Z*95^'A6EJ
M?X%M<WA]<GQR>GF!;GF#A&MYCX5J>IR$:'JKA&=ZO(-F>M*#9WK@@6AYX8!J
M>.)_:GCB?VIXXG]J>.)_:GCB?VIXXG__7PT+_W(.!?^!$0+[C!$ YY4+ -:=
M!P#-HA4 PZ4J!+JD.0ZQH40<J9Y-*J&;5#B9EUI%D9-?48J08UV"C&=H>HAK
M<G*$;WMJ@7:"97]_A6-_BX9A@)F%8("HA%^ N8-?@<^"7X#A@6%^X8!B?>*
M8GWB@&)]XH!B?>* 8GWB@&)]XH#_8PL)_W8,!/^$#@'PD H V)D% -&@!0#(
MIA$ OJDH K6H-PRMID(9I:-+)YRA4C:5G5A"C9E=3X6685I^DF5E=8]I;VR+
M;7ADB'-_7H=]@UR'B8-<B)>"6XBF@5J)MW]:B<U^68CC?EJ%XWY<@^-^7(/C
M?ER#XWY<@^-^7(/C?ER#XW[_9P@(_WH+ ON("@#<DP( TYP# ,ND P#"J@P
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M/4'DICQ Y;<[0.;-.C_FY3D\X_4[/./U.SSC]3L\X_4[/./U.SSC]3O/F@
MPZ@  +JS  "OO   I,0  )?+  "+T@  @-L$ 'KK% )S[1X(:NTF#V+M+!A9
M[3$A4NTU*4OM.C!%[3\U0>Y&.#[N3CD\[U8Z._!@.3KQ;#DY\7DX./*'-S?S
MEC4W\Z<T-O2V,S;TR3,U]=TR-?7=,C7UW3(U]=TR-?7=,C7UW3+&I   O+
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M&1?_?!@5_X48%?^%&!7_A1@5_X48%?^%&!7_A1BNO@  H<8  )/-  "%TP
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M.>1'P3CC2,XXX4C>-]Y([#C;1_8[V4?^/=A&_S_51O] TT?_0--'_T#31_]
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M<6YQ['%N<>QQ;G'L<6YQ[''_6P@)_VX*!/]["P'MA0@ V8T$ -*3!0#)EQ,
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M54NNK5-*KL!22J[944FM[%)&J_I41JO]54:K_55&J_U51JO]54:K_57E?P
MU(X  ,F:  "_I   M:P  *NR  "@N   D[X! (W!%P"'PB@$@,(T#7G!/!AQ
MOT(C:;Y'+F"\3#A9NU!!4KI61TZY74Q+N69.2;EQ3DBZ?DQ(NHM+1[N:2D>[
MJTA&N[Y'1KS71D6ZZT9#N/E)0KC]2D*X_4I"N/U*0KC]2D*X_4K;AP  S94
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M)33ORB4S[^,D,^_I)#/OZ20S[^DD,^_I)#/OZ23!I   N*X  *ZW  "BOP
ME<4  (C+  !\T0  <=@  &CC P!B\Q #6_,8"%3T'PY-]"031O0I&$#U+QT[
M]34@./8[(C7V0B,S]THC,?A3(S#Y72(O^6@B+?IV(2SZA" K^Y,?*ONB'BG\
ML1TI_,,=*?S)'2G\R1TI_,D=*?S)'2G\R1VZK0  L;8  *6^  "8Q0  B\H
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M78!E^EV 9?I=@&7Z78!E^EW_4@<)_V,(!/]P"0'R>0D W'X% -:"!@#-AA8
MQ(@J [N&. RS@T,8JX!+)*5\4C&>>%@]EW1>1Y)P8U"-;&E7B6EO7(9H=U^#
M9W]A@F>(8H!GDV)^9YYC?6BK8WMGN6-Z9\UD>6CC8WEH\V)Y:/=A>6CX8'EH
M^&!Y:/A@>6CX8'EH^&#_504(_V8' _YS!P#G>P0 V($# -&&!0#)B1, P(LH
M K>*-@JOB$$5J(1*(J&!42Z:?5<ZDWE<18UU84Z(<697@VYL77]L<V)\:WME
M>FJ$9GAJCV=V:IIG=&JG9W-JMFAQ:LEH<&K?9W!K\69Q:_5D<6KV8W%J]F-Q
M:O9C<6KV8W%J]F/_5P,'_VD% O=U! #<?@  U(0" ,V) P#%C!$ O(\F ;2.
M- BLC$ 3I(E('YV&3RR6@E4XD'Y:0HEZ7TR#=F15?7-I7GAP;V1T;G=H<6Z
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MJEM/D[Q:3I/364V2Z%I+D/9;2X[[7$N.^UQ+COM<2X[[7$N.^USX<0  VX
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M.T.TYCI!L_0\0+']/D"Q_3Y L?T^0+']/D"Q_3[4AP  QY0  +V?  "TIP
MJJX  )^S  "3N   A[P  'O" P!VQ1@ <<8G!&O%,0MDQ3D47<0_'5;#1"5/
MPDDM2L%/,D;!5C9$PE\W0L)J-D+"=C5!PX0T0,.2,T#$HC$_Q+0P/L3++S[#
MY"X]P?,P.\#\,CO _#([P/PR.\#\,CO _#+,D   P9P  +>F  "NK@  I+0
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M$27WV!$E]]@1)??8$27WV!&VK   K;0  *&[  "4P0  A\8  'K+  !NT0
M8]<  %C=  !0YP  2_D' T7[$ 8__!8*.?P;#33\(1 P_282+?TL$RK^,Q0G
M_CD4)/]!%"+_2A0@_U03'O]@$AS_;A$:_WT/&?^+#AG_F@X8_Z<-%_^T#!?_
MM P7_[0,%_^T#!?_M RPLP  I+L  )?!  ")Q@  ?,P  &_1  !CV   6-T
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M1I%8_T:16/]&D5C_1I%8_T;_1P<*_U<&!?]C"0+Z:PL [6\+ -]P# #3<AL
MR7,L!,%R.@ZY;D0:LFE,)JQE5#*F85LZHEYB09]=:D2<7'%&FEQY1YA;@$>7
M6XA(E5N12)1;FDB27*1)D5NO28];ODJ.6]!*C%OE2HM;]$J*6_Y*BEO_2HI;
M_TJ*6_]*BEO_2HI;_TK_2P0(_UL%!/]G!P'O;@8 W'($ -9T!P#.=Q< Q7@J
M [QW. RT<T(7K6]+(Z=K4B^A9U@YG&1?09AA9D:58&U)DE]T2Y%>?$R/7H1-
MC5Z,38Q>EDV*7J!.B5ZL3H=>ND^&7LQ/A%[A3X1>\D^#7OU/@U[_3H)>_TZ"
M7O].@E[_3H)>_T[_3@('_U\$ OIJ! #B< $ V'4" -%X!0#)>A0 P'TH KA[
M-@JP>4 5J75)(*-Q4"R<;58WEVE<0))F8D>.8VE,BV)P3XEA=U"'87]1AF&(
M4H1ADE*#89Q3@6&H4W]AME1^8<A4?6'>5'QA\%-\8?M3>V'_4GMA_U)[8?]2
M>V'_4GMA_U+_40 &_V$" O)L  #<<P  TWD! ,U\ P#%?A( O( E ;2 - BL
M?3\2I7I''I]V3BF8<U4TDF]:/HUK7T:):&5,A65L48)D<U2 9'M6?F.$5WQD
MCE=[9)E8>62E6'=DLUAV8\19=&/:671D[5AT9/I6=&3_571D_U5T9/]5=&3_
M571D_U7_5  %_V0  >EN  #9=@  T'P  ,E_ 0#!@0X N(0C +"$,@>I@3T0
MHGY&&YM[32>5>%,RCW18/(EP742#;6),?VIH4GMH;U=X9W=:=F: 6W1FBEQR
M9Y5<<6>B7&]GKUUM9L!=;&;676QGZUML9_A:;6?]66UF_5AM9OU8;6;]6&UF
M_5C_5P $_F<  -]Q  #5>0  S'\  ,6#  "\A0L M(<@ *R', 6EACL.GH-$
M&9> 3"21?5$OBWE7.85U6T)_<F!+>6]E4W1L:UEP:W-=;FI\7VMJAF!J:I%@
M:&J>8&9JK&!E:KU@8VK38&1JZ%]D:O9=96K[7&5J^UME:OM;96K[6V5J^UO_
M6P #]VH  -QT  #2?   R8(  ,&&  "XB < L(L= *F++02BBCD,FX=#%I2%
M2B&-@E LAWY5-X%[6D![>%Y)='5C4FYR:%EI<&]?96YX8F-N@F-A;HYC7VZ;
M8UYNJ6-=;[IB7&_/8EQNYF!<;O5?76[Z7EYM^EU>;?I=7FWZ75YM^EW_7@ "
M[FP  -EW  #.@   Q88  +V*  "TC , JXX: *6/*P.>CC<*EXQ!%)"*2!^*
MAT\I@X14-'V!6#YV?EU';WMA4&AX9EAB=FQ?7G1T8UMT?F19=(MD6'288U=T
MIV)7=+AA5G7-8%5TY&!5=/-?5G+Y7E=R^5Y7<OE>5W+Y7E=R^5[_8@ !XG
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M34N-XDU)C/%/2(O]4$B*_U%(BO]12(K_44B*_U'C<   U'X  ,B)  "^D@
MM9@  *N=  "?GP  E:(# (ZD&0")I"D"@Z0U"7VC/A%VH44;;Z!+)6B>4"YA
MG%4W6IM:/U297T90F&9*39=O3$R7>TM+F(=*2IB524J8I$=)F+5&29C*1$B7
MX41&EO%&193\2$64_DA%E/Y(193^2$64_DC==P  SH0  ,./  "ZEP  L)X
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M)SBY_"<XN?PG.+G\)SBY_"?'CP  O)L  +.D  "JJP  G[   ).U  "'N
M>[P  &[!  !BR ( 7<H3 %G+(@)5RRP'3\LS#4K*.A-$RD 90,I''3W*3Q\[
MRE@@.LMB'SG+;1XXS'H=-\R)'#?-F!LVS:H:-<V_&#3.V!@TS.P8,LKW&C+)
M^1LRR?D;,LGY&S+)^1N_F   MJ,  *ZK  "CL@  E[8  (JZ  !^O@  <L,
M &;(  !<S@$ 4M0& $S9$@!)VA\"1-HH!T#:, L[VC</.-L_$C7;1Q0TW% 4
M,]Q:%#+=91,RWG(2,=Z $3#?D! OX*$/+N"T#BWARPXLX>(-*M[R#BK>] \J
MWO0/*M[T#RK>] ^YH@  L:L  *>R  ";N   CKP  ('   !TQ0  :<H  %W/
M  !3U0  2ML" $7H# % Z!<#.^D>!S;I)0HRZBP-+^HS#RSK.Q JZT,0*>Q,
M$"?M5P\F[F(.)>YP#23O?PPC\(\+(O"A"B'QLPD@\<<)'_+@"!_RY0@?\N4(
M'_+E"!_RY0BSJ@  JK(  )ZX  "1O0  @\(  ';&  !JRP  7]$  %36  !*
MW   0>$  #SS!0$W]@T$,_<5!B_X&PDK^"$*)_@G#"3Y+@PA^34-'_H]#!S[
M1@P:^U +%_Q<"A7]:@D4_7H)$_Z*"!+^F@<1_ZD&$/^Z!A#_O080_[T&$/^]
M!A#_O0:ML@  H;@  )2^  "&PP  >,@  &S-  !?T@  5-@  $K=  !!X@
M..<  #/V  (O_P,$*O\)!B;_$ <B_Q4('_\:"1S_( H8_R8*%?\M"A+_-0H.
M_SX)"O](" ;_5 @#_V(' /]Q!@#_@ 4 _XT% /^:! #_G00 _YT$ /^=! #_
MG02DN   E[X  (G#  ![R0  ;LX  &'4  !5V@  2M\  $#C   WZ   +^X
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MJ5)I8[E2:&+-4V=CY%)H8_10:&/^3VAC_TYH8_].:&/_3FAC_T[_5@ !ZV,
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M5E)PW552<.]44F_Z5%-O_U-3;_]34V__4U-O_U/V8   W&X  ,]X  #$@
MNX4  +*)  "GB0  GXL0 )F-(@"3C3 $C8LZ#(:)0A6 ATD>>H5.*'2#4S%M
M@%<Z9GY<0V![8$M:>69157AN55-W>%=2=X1647B255!XH%1/>+!23WC$44YX
MW%!-=^Y137;Y44UU_U%-=?]1377_44UU_U'I9   V'(  ,M\  #!A   MXH
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M/$*/_CU"C_X]0H_^/4*/_CW6=@  R((  +Z-  "UE   K)H  *&>  "4GP
MAJ(  '^D"0!ZI1P =:8J G"E-0AJI#T/8Z-#%UVB21]7H4XG4:!3+DR?63-)
MGF$V1IYJ-T6>=3=$GH$V1)Z.-4.>G3-#GJTR0I[ ,$&>V2]!G.PP/YKX,CZ:
M_C0^FOXT/IK^-#Z:_C30?0  PXD  +F3  "PFP  IZ   )RD  "/I@  @JD
M ':L  !PK1, ;*XC &>N+P5BK3<+7*P^$E:L1!E0JTH@2ZI/)D>I5BI$J5TM
M0JEG+4&I<BQ JGXK/ZJ,*C^JFB@^JJLG/:J^)CRIUB0\J.HE.J;V)SFF_2DY
MIOTI.:;]*3FF_2G(A0  O9$  +2:  "LH@  HJ<  )>J  "*K0  ?;   &^S
M  !FM@< 8;<9 %VW)P)9MS '4[<X#4ZV/A-)MD091+5*'4"U42 ^M5HB/+5C
M(CNU;B$ZMGL@.K:('SFVEQTXMJ@<.+:[&S>VTQHVM.@:-;/U'#2R_!TTLOP=
M-++\'32R_!W!C@  N)D  +"B  "GJ   FZT  (^P  "#LP  =K8  &JZ  !=
MOP  5<(+ %'#&P!.PR8"2<,O!T7#-@Q PST0/,-$%#G#3!8WPU06-L1>%C7$
M:18TQ'85,\6#$S/%DQ(RQ:01,<6W$##%S@\OQ.4/+L+S$2W!^A(MP?H2+<'Z
M$BW!^A*[F   LZ$  *NI  "@KP  E+,  (>V  !ZN0  ;KT  &+!  !6Q@
M3,L! $/0"0! TA< /=(B CG2*P4UTS,(,M,Z"C#30PLOU$P,+=16#"W580LL
MU6T**]9\"2K7BP@IV)T(*-BP!R;9QP8EV. &)-;N!R/5]0@CU?4((]7U""/5
M]0BUH0  KJD  *.P  "7M   BK@  'V\  !QOP  9,0  %G(  !/S0  1=(
M #O8 @ SX @ ,>(4 2[C'0,KXR4%*.0M!B;D-0<DY3X((^9(!R'F4@<?YUX&
M'N=L!AWH>P4<Z8P$&^F>!!GJL0,8Z\@#%^O= Q;KZ@(6Z^H"%NOJ A;KZ@*P
MJ0  I[   )NV  ".N@  @+X  '/"  !FQ@  6\L  %#0  !&U   /-D  #/>
M   MZ0( *O$* 2?R$P,C\QH$(/,A!1WT)P8:]"\&&/4X!A7U0083]DP%#_98
M! OW9@0*^'8#"?F' PCYF0('^:H"!OJ[ 0;ZR0$&^LD!!OK) 0;ZR0&IL
MGK8  )&[  "#OP  =<0  &C(  !<S0  4=(  $;7   \W   ,N   "KD   E
M[P  (OH  1[_!@,;_PT#&/\3!!7_&041_R %#?\G!0G_+P4&_S@$ O]$! #_
M4 , _UX" /]O @#_@ $ _X\! /^< 0#_I@$ _Z8! /^F 0#_I@&AM@  E+L
M (;   !XQ0  :LH  %W0  !1U0  1ML  #O?   RXP  *><  "'J   =]  !
M&?T  A7_  (3_P ##_\%! O_"@0'_Q $ _\6! #_'00 _R4$ /\O P#_.@,
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MK3I^5KP[?%;//'M6Y3QZ5O0[>E;^.WI6_SIZ5O\Z>E;_.GI6_SK_2@ "\%<
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M26->W$AC7^]'8U_Z161?_T1D7_]$9%__1&1?_T3\5   X&   --K  #(<@
MOW8  +9W  "M=P  I7D5 )]Z)@&8>3(&DG<\#HQT0Q>&<DH@@6]/*7QL5#%V
M:5DY<6=>/VQE9$1I8VM(9F-S2F1B?4MB8H=,86*33%]BH4Q>8J],7&+"3%MB
MV4M<8NU*7&+Y2%UB_T==8O]'76+_1UUB_T?T5@  W60  ,]N  #%=0  NWD
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M1DIQ_T=*<?]'2G'_1TIQ_T?A8P  T7   ,5Z  "[@0  LH8  *B(  ";B
MDXD$ (R+%P"'C"8!@HLR!GR*.PQVB$(4<(=('6J%325D@U(N7H%6-5A_6SQ2
M?6%"3WQI14Q\<T9+?']%2WR,1$I\FD-)?*I!27R\0$A\TC]'>^A 1GKU045Y
M_T)%>?]"17G_0D5Y_T+<:0  S74  ,%_  "WA@  KHL  *.-  "5C0  C8\
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M*3J5_BG*?   OH@  +61  "LF   HIL  )6=  ")GP  ?*(  &^E  !HIPL
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M#"Z^C0LMOIT*++ZP"2J^Q0DIO=X(*+ON"2>Z^0LGNOH+)[KZ"R>Z^@NWEP
MKZ   *>G  "<K   D*\  (.R  !VM   :K<  %VZ  !2O@  1L(  #O' P U
MR@X -,L; #'+)0$ORRT#+,PV!2K,/@4IS$<&)\U1!B;-6P4ESF@%),YU!"//
MA ,BSY4#(,^H A[/O@(=T-@"',[K AO,]@,;S/8#&\SV QO,]@.RH   JZ@
M *"M  "4L0  A[0  'JX  !MN@  8;X  %7"  !*Q@  /\H  #7.   LTP(
M)-@' "'<$  ?W!L 'MPD 1S=+@$;W3@!&MY" 1G?30$7WUD!%N!G 13A=@ 3
MX8< $>*9  [BK0 ,X\4 "N/=  GA\0 )X/$ ">#Q  G@\0"MJ   I*X  )BS
M  "*MP  ?;H  '"]  !CP0  5\4  $S)  !!S0  -M(  "W6   EVP  'M\
M !KK!@ 8[0\ %NT7 1/M'P$1[2<!#NXP 0ON.P$)[T8!!O!3  /Q8@ !\7,
M /&$  #QE@  \*D  /"[  #PTP  \-,  /#3  #PTP"GKP  F[0  (ZX  "
MO   <\   &7$  !9R0  3<T  $+1   WU0  +MH  "7>   >X@  %^4  !3Q
M   1^@( #?P) 0K\$0$'_!<! _P? 0#]* $ _3(! /T^  #]3   _5L  /UM
M  #\?@  ^X\  /N=  #ZK   ^JP  /JL  #ZK ">M0  D;D  (.]  !UP@
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M /\ [@#_ .X _P#N /\ [@#_ .X _P#_!B /_P<=#O\$' [_ " -_P K#/\
M-PO_ $0)_P!1!_\ 7 ;_ &@%_P!R!/\ >P/^ (("_ "( OH C0'Y ),!^ "8
M ?< G0'U *, ] "I /( L #Q +@ [P## .X T #M -\ [ #M .H ]P#I /\
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ML2"22< AD$G2(8Y)YB*-2/0CC$C^(XM(_R2+2/\DBTC_)(M(_R3_/  "^D<
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M,G92W#-V4N\R=5+Z,G52_S%U4O\Q=5+_,752_S'_1P  XU,  -9>  #+9
MPF<  +IG  "R904 JF89 *1G* *=9C0(EV,]$)%@11F,74L@B%I2)X186"R"
M5UXO?U9D,7U5:S-[57,S>E5[-'A5@S5W58TU=568-G-5I#9Q5;(W<%7#-VY5
MV3AN5>TW;E7Y-FU5_S5M5?\U;57_-6U5_S7X2@  X%<  -)B  #(:   OFL
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M/UA>_CY97O\^65[_/EE>_S[F5   UF(  ,EL  "_<@  MG8  *QV  "B=
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M1VW_/4=M_SW;8P  RV\  +]W  "V?@  K($  *""  "4@0  BX,  (6$$0"
MA2  >X4M W:$-@AP@SX/:X%$%F6 2AU??DXE67U3+%1[6#-/>5XX3'AF.TIX
M;SQ(>'L\2'B'.D=XE3E&>:0X1GBU-D5XRC5$=^(U0W;R-T)U^SA"=/\X0G3_
M.$)T_SC6:   QW0  +Q\  "R@P  J(8  )R&  ".A@  A8@  '^*"@!ZBQL
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M(3R5DB [E*$>.Y2R'3J4QQPZD]\;.)+P'3>0^A\VD/X@-I#^(#:0_B#$?
MN88  +"/  "FDP  FI0  (Z5  ""F   =IL  &F>  !@H 0 6Z(5 %BB(P!5
MHBT"4*(U!TRA/ M'H4,00Z!)%3^?3Q@\GU<:.I]?&CF?:AHXGW49.)^"&#>?
MD!8VGY\5-9^P%#2?Q1,TGMT2,YSO%#*;^14QFOT6,9K]%C&:_1:^A   M8X
M *R6  "AF   E9H  (F<  !^H   <J(  &6F  !9J   4*H) $VK&0!*K"4
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M !7'M  3Q\T $\7E !/$\P 2P_@!$L/X 1+#^ &OG@  J*8  )VK  "1K@
MA+$  ':T  !IM@  7;D  %&\  !%OP  .L(  "_&   GRP  'L\" !?2!P 3
MU!  $=0; !#4)  .U2X #-4Y  O510 *UE$ "=9?  ?6;@ %UG\ !-:1  +6
MI   UK@  -?/  #6X@  UNH  -;J  #6Z@"JI@  H*P  )6P  "'M   >K<
M &RY  !?O   4\   $C#   \QP  ,<L  "C/   @TP  &-8  !':   )W0$
M!>,(  /B$@ !X1L  .$E  #A,0  XST  .1,  #E6P  Y6P  .9]  #FCP
MYJ$  .>R  #GPP  Y\T  .?-  #GS0"DK0  F+(  (NU  !]N0  ;[P  &+
M  !5Q   2<@  #W,   RT   *-,  "#8   8W   $=\   KA   #Y    .T
M  #P @  [PH  .X3  #N'0  [B@  .XU  #P10  \E8  /-G  #T>0  ](H
M /69  #UI@  ]:P  /6L  #UK ";LP  CK<  (&[  !ROP  9,,  %?'  !+
MS   /M   #/5   IV0  ']T  !?A   0Y   ".<   +I    Z@   /,   #[
M    ^@   /D!  #Y"0  ^10  /D?  #Z+   _#T  /Y.  #_80  _W(  /^
M  #_C   _Y$  /^1  #_D0#_ !\,_P =#/\ ' O_ !\*_P K"/\ . ;_ $4$
M_P!2 _\ 70+_ &<!_P!Q ?\ >0#] (  ^@"& /@ C #V )$ ]0"6 /, FP#R
M *  \0"F /  K #P +, [P"\ .X R0#M -@ [0#G .T \0#L /H [ #_ .L
M_P#J /\ Z@#_ .H _P#_ !P,_P 9#/\ &0O_ !X*_P H"/\ -0?_ $(%_P!/
M _\ 6@+_ &4!_0!N ?H =P#X 'X ]0"$ /, B@#Q (\ [P"4 .T F0#L )X
M[ "D .L J@#J +$ Z0"[ .@ QP#G -4 Y@#D .8 \ #E /D Y0#_ .0 _P#B
M /\ X@#_ .( _P#_!!@,_P,4#/\ % O_ !P*_P E"/\ ,@?_ #\%_P!+!/\
M5P+Z &$!]P!K ?0 = #R 'L [P"" .T AP#K (T Z0"2 .< EP#F )P Y0"B
M .0 J #C +  X@"Y .  Q0#@ -, WP#B -X [P#= /D V@#_ -@ _P#8 /\
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MMPBJ,\4(J3/6"*8SZ JD,_4,HC/_#:$S_PV@,_\.H#/_#J S_P[_)0 %_S$
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M&8I$WAJ(1.\;AT/[&X9#_QN&0_\;AD/_&X9#_QO_-P !Z4   -Q+  #140
MR%,  ,%0  "Z3@P LE ? *M0+ 6E3C<+H$Q!$9Q*21:825(9EDA9&I1(8!N2
M2&<;D$AN&X](=!R-2'L<C$B"'(M(BAR)2),=B$B<'89(J!Z%2+4>@TC&'X)(
MVA^ 1^T@?T?Y(']'_R!^1_\@?D?_('Y'_R#^/   Y$<  -=1  #,5P  PUD
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M+FA1_BUH4?\L:%'_+&A1_RSI1P  VE8  ,Q?  #!90  N&<  *]E  "F8@
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M-UI7RC=:5^$V6E?R-5I7_#1;5O\S6U;_,UM6_S/C3P  TUT  ,9F  "\;
MLFX  *AL  ">:@  EVL) )%L&@"+;"@!AFLR!H!I.@U[9T$4=F1'&W%B3")L
M8%$H:%Y7+F1=7#)A7&,V7EMK.%Q;=#E:6WXY65N).E=;ECI66Z0Z55JT.E1:
MR#E36M\Y5%KQ-U1:^S946O\U5%K_-51:_S7@5   T&$  ,-J  "Y;P  KW$
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M,T-I^3-#:?\S0VG_,T-I_S/48@  Q6T  +IU  "Q>P  I'L  )AZ  ",>@
MA'P  'U]"0!X?AH ='\G 6]^,01J?CD*97Q $%][11=:>DH=57A/)%!W5"I,
M=5LO275B,49T;#)%='8R1'2#,41TD"]#=)\N0G2O+4)TPRQ!=-LK0'+M+3]Q
M^"X_</\N/W#_+C]P_R[/9P  P7(  +=Z  "L?@  GWX  )1_  "'?P  ?H$
M '># P!QA!0 ;84B &F%+@-DA38'7X0]#5J"0Q-5@4@94(!-'TQ_4R1(?EDH
M17UA*T-]:RM"?78J07V"*4!]CRA ?9XF/WVN)3Y]PB0^?-HC/'OM)3MY^"8[
M>/\G.WC_)SMX_R?*;0  O7<  +-_  "G@@  FX,  (^#  "#A0  =X<  '")
M  !JBPT 9HP= &*,*0%>C#(%68LZ"52*0 ]0B4852XA+&D>'41Y#AU@A089@
M(S^&:2,^AG0B/8:!(3R&CB \AIT>.X:M'3J&P1PZA=D;.(3L'3>"]QXW@?X?
M-X'^'S>!_A_$=   N7X  +"&  "BAP  EH<  (N(  " B@  <XX  &F0  !B
MD@8 79,6 %J4(P!6E"X"4I,V!DZ3/0M)DD,/19%)%$&13Q<^D%8:/)!>&SJ0
M:!HYD',:.9!_&#B0C!<WD)L6-I"L%36/OQ0UC]@3-(WK%#.,]A8RB_T7,HO]
M%S*+_1>_>P  M84  *N+  "=BP  DHP  (>.  !\D0  <)0  &27  !9F@
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M B"Q@ (?L8\!';&A 1NQM $:L,L &:_C !FN\0$8K?D"&*WY ABM^0*PE
MJ)L  )N<  "/G@  @Z(  'BF  !MJ@  8:T  %6O  !)L@  /+0  #&W   H
MN@  (+P* !Z]%@ <O2  &[TI !F],@ 8OCL %[Y$ !6^3P 4OEH $K]G !"_
M=@ -OX8 "[Z8  F^J@ 'O;\ !KS7  :\Z0 &N_, !KOS  :[\P"KG0  HZ(
M ):D  "*IP  ?ZP  '.P  !FL@  6;0  $VV  !!N0  -;P  "J_   AP@
M&<8  !'( @ (RPD !LL4  7,'@ $S"@  LPS  ',/@  S$H  ,U7  #-9@
MS78  ,V(  #-F@  S*X  ,S"  #+U@  R^4  ,OE  #+Y0"HI0  G:H  )&M
M  "$L   =[,  &FV  !<N   4+L  $2^   XP0  +<0  "/(   :S   $L\
M  K1   #U    -4$  #6#0  UQ<  -@A  #:*P  VS<  -Q$  #>4P  WF,
M -]U  #?AP  X)H  -^L  #?NP  W\L  -_+  #?RP"AJP  E:\  (BS  !Z
MM@  ;+D  %^\  !2OP  1L,  #G&   NR0  (\T  !O2   3U0  "MD   3:
M    W0   -\   #A    X@0  .,-  #E&   YR,  .DO  #K/@  [4X  .]?
M  #P<@  \(0  /&4  #QH@  \:P  /&L  #QK "8L   B[0  'ZX  !PO
M8K\  %3#  !(R   .\L  "_/   DTP  &M@  !+<   )WP   N(   #C
MY0   .<   #I    Z@   .P   #N @  \ P  /(9  #U)P  ^#<  /M(  #\
M6@  _6P  /Y\  #_B0  _Y,  /^3  #_DP#_ !P*_P 8"?\ %PC_ !T&_P I
M!?\ -@/_ $,"_P!/ ?\ 6@#_ &4 ^P!N /< =@#V 'T ]0"# /0 B #S (T
M\@"1 /$ E@#P )L [P"@ .X I@#M *T [0"U .P P #J ,X Z #? .8 [@#F
M /D Y@#_ .8 _P#F /\ Y@#_ .8 _P#_ !@*_P 5"?\ $PC_ !L'_P F!?\
M,P/_ $ "_P!, ?X 5P#Y &( ]0!K /( <P#P 'H [P"  .T A0#L (H ZP"/
M .H E #I )D Z "> .< I #F *L Y0"S .0 O0#B ,P X #< -\ ZP#> /4
MW@#] -X _P#= /\ W0#_ -T _P#_ !0*_P 1"?\ $0C_ !@'_P C!?\ +P/_
M #T"_@!( ?@ 5 #R %\ [@!H .L < #I '< YP!] .8 @P#E (@ Y ", .,
MD0#A )8 X "< -\ H@#> *D W "Q -L NP#9 ,D U@#: -4 YP#5 /, U #[
M -, _P#3 /\ TP#_ -, _P#_ A *_P *"/\ #0?_ Q<&_P$@!?\ *P/^ #@"
M]@!$ ?  4 #J %L Y0!D ., ;0#A '0 WP!Z -T @ #< (4 VP"* -D CP#8
M )0 U@"9 -4 H #4 *< T@"O -  N0#. ,< S0#6 ,P Y@#* /$ R0#[ ,@
M_P#' /\ QP#_ ,< _P#_!@@)_P,"!_\*"0;_#1(%_PT=!/T()P/T!#,![0)
M .<!3 #@ %8 W %@ -H!:0#8 G  U0)W -,#?0#2 X( T .' ,\#C #. Y$
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M#),ZJ0R1.K4,D#K%#8XZV0V,.NL/BSKX#XHY_Q").?\0B3G_$(DY_Q#_+0
MZ#8  -M   #01@  QT8  ,!"  "Z/PP LD(> *Q"+ 2F03<(H4!!#)X_2PV;
M/U,.F3]:#Y<_80^5/V@/E#]N#Y(_= ^1/WL/D#^!$(X_B1"-/Y$0BS^;$8H_
MI1&(/[(2AS_!$H4_U1.$/^D4@C_V%($^_Q2!/O\4@3[_%($^_Q3X,0  XSX
M -5(  #*3@  P4\  +I*  "S1P@ K$D: *5)* .@2#,(FD8]#9=%1A"31$X2
MD4-5$X]#7!2-0V,4C$-I%(I#<!2)0W84AT-]%89#A16$0XT5@T.7%H%#HA:
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M(FU*RR)K2>$C:TGQ(FI)_"%J2?\A:DG_(&I)_R#F00  UE   ,E9  "^7@
MM%X  *I;  "C5P  G%@. )99'@"162L#BU<T"895/ ^"4T,4?E%*&7M/4!UX
M3E8?=DU<(71-8R)R36HC<$UQ(V]->B1M38,D:TV-)6I-F29H3:8F9DVU)V5-
MR"=D3-XG8TSP)F-,^R5C3/\D8TS_)&-,_R3C1@  TU0  ,9=  "\8@  L&$
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M+T]6^"Y05?\M4%7_+5!5_RW:4P  RF   +YG  "R:P  IFH  )QI  "29@
MBV<  (5H$0" :A\ >VDJ G9H,P=Q9CL,;&5!$V=C1AEB84P?7E]1)5I>5BI6
M7%PN4UQD,5%;;3-06W<S3EN",TU;CS),6YTR2UNL,4I;OS%)6]4P25KJ,$E:
M]R]*6?\N2EG_+DI9_R[66   QV,  +MK  "O;0  HFT  )AL  ".:@  AFL
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M)3IL_R7)9P  O'$  +%W  "C=P  EW<  (QW  " >   =GH  &]\  !I?@T
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M$3.+AQ RBY8/,8NF#C&+N TPBL\,+XGE#"Z'\PXMAOP/+8;]#RV&_0^Z>@
ML(,  *&#  "5A   BH4  '^&  !UB0  :8T  %Z0  !4DP  2Y8& $>7%0!$
MER$ 0I<J 3^7,@,[ECD%.)9 "#661PHSED\+,997"S"580LOE6L++I5W"BV5
MA0DLE9,(*Y6C!RJ5M08HE,P&*)/C!B>1\@<FD/L()I#\"2:0_ FU@@  JH@
M )R(  "0B0  A8H  'N-  !PD   9)0  %B7  !.FP  1)X  #N@"0 WH!<
M-:$A #.A*@ QH3("+Z Z RR@000JH$H%*:!2!2>@7 4FH&<$):!S!"2@@ ,C
MH(\"(:"? B"?L0$>G\<!'9[@ 1V<[P(<F_D#')K[ QR:^P.PB@  HXT  )>-
M  ",CP  @9$  ':5  !KF   7YP  %2@  !)HP  /J8  #.H   JJ@D )ZL5
M "6K'P CJR@ (JLP ""K.  >JT$!':M* 1RL5  :K%\ &:QK !>L>0 5JX@
M$ZN9 !&KJP /JL$ #:G9  ZH[  .I_8 #J?X  ZG^ "LDP  GI,  ).3  "'
ME@  ?)H  '&>  !EH@  6J4  $^I  !$K   .*\  "VP   CLP  &K4# !2V
M#0 2MQ@ $+<A  ZW*@ ,MS, "[<]  FW1P (MU( !K=?  2W;0 "MWT  +:.
M  "VH   M;,  +3)  "TW   L^H  +/M  "S[0"FF0  FID  (V;  ""GP
M=Z0  &RH  !@K   5;   $FR   ]M   ,;8  ":Y   =NP  %+T   N_   #
MP0@  ,(2  #"&P  PR4  ,,N  ##.0  PT0  ,10  #$7@  Q&\  ,2   #$
MD@  Q*4  ,.X  ##RP  PMP  ,+@  #"X "BH   E:$  (FE  !^J@  <Z\
M &:R  !9M   3+<  #^Y   SO   *+X  ![!   5Q   #,<   3)    RP
M ,T"  #."@  SQ0  - =  #1)P  TC(  -,^  #53   UEP  -9O  #6@@
MUI4  -:G  #6MP  UL8  -;*  #6R@"=J   D:P  (6P  !WLP  :;8  %RX
M  !/NP  0KX  #7!   JQ   '\<  !;+   ,SP  !=(   #3    U0   -@
M  #9    VP$  -T*  #?%   X1\  .,K  #E.   Z$<  .I8  #J;   ZH$
M .J4  #JHP  ZK   .JS  #JLP"5K@  B;(  'NU  !MN   7[P  %'   !$
MPP  -\<  "O*   @S0  %=$   S6   $V@   -T   #=    WP   .$   #C
M    Y0   .<   #I    [ D  .\6  #R(P  ]#(  /="  #Z5   ^V8  /MY
M  #[B0  ^Y8  /N9  #[F0#_ !8(_P 3!_\ $P7_ !L$_P G O\ ,P'_ $
M_P!- /P 6 #Y &( ]P!K /8 <@#T 'D \P!^ /( @P#Q (@ \ ", .\ D0#N
M )8 [0"; .L H #I *< YP"N .8 N0#E ,8 Y #6 ., Z #C /8 XP#_ .(
M_P#B /\ X0#_ .$ _P#_ !,(_P .!_\ #07_ !@$_P D O\ , '_ #T ^P!)
M /8 50#S %\ \0!H .\ ;P#M '8 [ !\ .L @0#J (8 Z0"* .@ C@#G ),
MY0"8 ., G@#A *4 WP"L -X M@#< ,( VP#3 -L Y@#: /, V0#] -@ _P#8
M /\ V #_ -@ _P#_ ! (_P +!_\ #07_ !<$_P @ O\ + '\ #D ] !& .\
M40#L %L Z0!D .< ; #E ', Y !Y .( ?@#A (, X "' -X C #= )$ VP"6
M -D G #6 *( U0"J -0 LP#2 +\ T0#0 -  X@#/ /  S@#X ,T _P#, /\
MS #_ ,P _P#_  D(_P $!O\ "@7_ !0#_P > O\ * #T #4 Z@!! .8 30#C
M %< X !@ -X : #< &\ V@!U -@ >P#6 (  U0"$ -, B0#1 (X SP"3 ,X
MF0#, *  RP"H ,D L0#( +T Q@#- ,4 W@#$ .P PP#V ,( _0#! /\ P0#_
M ,$ _P#_  ('_P  !?\#!@3_! \"_P 9 ?@ (P#K "\ X@ \ -T 2 #: %,
MU@!< -, 9 #1 &L SP!R ,T =P#+ 'P R0"! ,@ A@#& (L Q0"1 ,, EP#"
M )X P "F +\ KP"] +L O #* +L VP"Y .H N #V +8!_@"V O\ M0+_ +4"
M_P#_ P %_P<  _\- 0+_#0D!^0D3 .T#' #? "@ V0 V -, 0@#/ DX RP-7
M ,@$8 #&!&< Q 5N ,(&= # !GD OP=^ +X'@P"\!XD NPB. +D(E0"X")P
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MJ@&?);8!GB7% 9PEUP&:)>D"F"7V Y<E_P.6)?\#EB7_ Y8E_P/_&@ !\"(
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M#($ZS U_.N$-?3GR#GTY_ Y\.?\.?#G_#GPY_P[K+@  W3T  ,]&  #$2@
MN4@  +%$  "K0 , I4$5 )]#) &:0B\%E4 Y")$_0@N./TH,C#Y2#8H^6 Z(
M/E\.ASYE#H4^:PZ$/G(.@CYX#H$^@ ^ /H@/?CZ2$'T^G!![/J@1>CZW$7@^
MR1)W/MX2=3[P$G4]^Q)T/?\2=#W_$G0]_Q+G-0  V$0  ,I,  "_4   LTX
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M'UY(]QY>2/\=7DC_'5Y(_QW=1@  S5(  ,!:  "S6P  IUH  )Y8  "75
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M)455_R7/5P  P6(  +1F  "E9@  FF8  )!E  "&8P  ?V4  'EF!@!S9Q4
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M'SQLAAX[;)0=.FRD&SILM1LY;,L:.&OB&C=I\1LV:/H<-F?_'#9G_QS#9@
MMV\  *=P  ":<   CG   (1P  !X<0  ;G0  &=V  !A=P8 7'D5 %EY(0!6
M>2L!4GDS!4YX.@E+>$ -1G=%$4-V2Q4_=5(8/'59&3MU8AHY=6T9.75X&#AU
MA1<W=),6-G2C%39TM!0U=,H3-'/A$S-Q\14R</H6,F_^%C)O_A:_:P  LG,
M *)S  "5=   BG0  (!U  !U=P  :GD  &%\  !:?@  5( / %& ' !/@2<
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M R*0K@(AC\,"(([; A^-[0,?C/<$'XO\!!^+_ 2P@   H(   ).   "(@0
M?H,  '.&  !IB0  78T  %*0  !)DP  /I8  #29 P NFP\ +)L: "J;)  H
MFRP )YLT 26;/ $CFT0!(9M- 2";5@$?FV$!'9MM 1R;>@ :FX@ &)J8 !>9
MJ@ 5F;X $YC6 !27Z@ 4EO4 %)7Z 125^@&IA0  FH4  (Z&  "$AP  >8H
M &Z-  !CD0  690  $V8  !#G   .)\  "ZA   DI $ ':4, !NF%P 9IB
M&*8I !:F,0 5ICH $Z9# !*F30 0IE< #:9D  NF<0 )I8  !Z60  6DH@ #
MH[4  J+*  .BWP #H>P !*'R  2A\@"BB@  E8L  (J,  !_C@  =)(  &F6
M  !>F@  4YX  $BB   ]I0  ,J@  "BJ   ?K   %JX   RP!P &L!( !; ;
M  .Q)  "L2T  +$W  "Q00  L$L  +!8  "P90  L'4  +"%  "OEP  KJD
M *Z^  "MTP  K.,  *SI  "LZ0"<D   D9$  (63  !ZEP  ;YL  &2@  !9
MI   3J@  $.L   WKP  ++$  "*S   8M0  $+<   :X    N@8  +H.  "[
M&   NR   +PI  "\,P  O#X  +U)  "]5P  OF8  +YX  "]B0  O9P  +RP
M  "[PP  N]0  +K>  "ZW@"8EP  C)D  (&=  !VH@  :J<  %^K  !4KP
M2+(  #NU   OMP  )+D  !J\   0O@  ",    #!    PP   ,0!  #%"0
MQQ(  ,@;  #))0  RB\  ,LZ  #-1@  SE8  ,]G  #/>@  SXT  ,^?  #/
ML   S[\  ,[)  #.R0"4GP  B*,  'VH  !RK@  9K(  %BT  !+MP  /KH
M #&]   FOP  &L(  !'%   (R    ,H   #,    S@   -    #1    TP
M -4'  #8$@  VAT  -PH  #>-0  X$,  .)4  #D9@  Y7L  .6.  #EG@
MY:H  .6R  #EL@"0J@  A:\  'BS  !JM0  7+@  $Z\  !!OP  ,\(  "?%
M   <R   $<P   ?0    U    -8   #7    V0   -L   #=    WP   .(
M  #D    YP8  .L2  #N'P  \"X  /(^  #U4   ]60  /9X  #WB0  ]Y4
M /><  #WG #_ !(&_P .!?\ #0/_ !@"_P D /\ ,0#_ #X _0!* /L 50#X
M %X ]@!G /0 ;@#S '4 \0!Z /  ?P#O (, [0"( .L C #I )$ Z "6 .<
MG #F *( Y "J ., L@#B +\ X0#0 -\ X@#> /( W0#^ -T _P#= /\ W0#_
M -T _P#_  T&_P *!?\ # /_ !4!_P @ /\ +0#Z #L ]@!' /0 4@#Q %L
M[P!D .T :P#K '( Z0!W .@ ? #F ($ Y "% .( B@#@ (X WP"3 -X F0#=
M *  VP"G -H L #8 +P U@#+ -0 W@#3 .\ T@#[ -( _P#2 /\ T@#_ -(
M_P#_  D&_P %!/\ "@/_ !0!_P = /L *0#R #< [P!# .P 3@#I %@ Y@!@
M .0 : #B &\ WP!T -T >0#; 'X V0"# -@ AP#6 (P U0"1 -, E@#2 )T
MT "D ,X K0#- +@ RP#' ,D V@#( .P QP#X ,8 _P#' /\ QP#_ ,< _P#_
M  (&_P  !/\ !P+_ !$!_P 9 /( )0#J #$ Y@ ^ .( 20#? %0 W !< -D
M9 #5 &L TP!Q -$ =@#/ 'L S@!_ ,P A #+ (D R@". ,@ E #& )H Q0"B
M ,, JP#! +4 OP## +X U@"] .@ O #T +L ^P"[ /\ NP#_ +L _P#_   %
M_P   _\  P'_  P ^0 3 .< '@#A "P W  Y -@ 10#3 $\ T !8 ,P 8 #*
M &< R !M ,8 <P#$ '@ PP!\ ,$ @0#  (8 OP"+ +T D0"[ )@ N@"? +@
MJ "V +, M0#! +, T@"R ., L0#P +  ^0"P /X KP#_ *\ _P#_   #_P
M ?\#  #Y  4 \  + -\ %P#8 "4 T0 S ,P /P#( $H Q !3 ,$ 6P"_ &,
MO0!I +L ;P"Z '0 N !Y +< ?@"V (, M "( +, C@"Q )4 KP"= *X IP"L
M +$ JP&_ *D"T "H ^( IP3P *4&^@"D!O\ HP?_ *,'_P#_ 0 "_PD  /$*
M  #E!P  W@$" -8 #P#/ !X R $K ,($.0"^!D0 N@=. +<(5P"U"5X LPIE
M +$*:P"P"W  K@MV *T+>P"L#(  JPR& *D-C "H#90 I@Z< *4.I@"C#[$
MHA"_ * 0T0">$N0 G!/S )L3_0":$_\ FA/_ )H3_P#_"P !\1(  .08  #:
M&@  TA8  ,P-!0#&"A8 OQ E +D4,P"T%3\ L!=) *T74@"K&%D J1A@ *<9
M9@"F&6P I1ER *,:=P"B&GT H1J# )\;B0">&Y$ G!N9 )L<HP"9'*X F!R\
M )8<S@"5'>$ DQWQ )(=_ &1'?\!D1W_ 9$=_P'[%   YQX  -LF  #1*0
MQR8  , ?  "\&0\ M1T? *\@+0"K(CH IR)$ *0C30"B(U4 H"1< )XD8@"=
M)&@ FR1N )HE<P"9)7D ER5_ )8EA@"5)8X DR66 )(FH &0)JL!CB:Y 8TF
MR@&,)M\"BB;P H@F^P.()O\#AR;_ X<F_P/O&P  X2D  -0R  #(-0  OC(
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M#6\X]PUO./\-;CC_#6XX_PWA-0  T4(  ,-*  "U20  JD<  *-$  "=00
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M&E-&_QK22@  PU4  +17  "F5P  FU8  ))4  "+40  A5(  ']3"P!Z5!H
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M(T54A2)$5)(B0U2A(4)4LB!!4\8@0%/>'T!2[Q] 4OD>0%'_'D!1_Q[(5P
MNE\  *I?  "<7P  D5\  (A>  !_7   >%X  '%?  !L80\ 9V$< &1B)@%@
M82\$7& V"%=?/ Q37D$13UQ'%DQ;3!I(6E,=15E:($-98B%"66PA05EW(4!9
MA" _6I$?/EJ@'CU:L1T\6<4=.UG='#M8[AT[5_D=.U;_'3M6_QW%6P  MF(
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M#C%PK@TP;\(-+V_:#"YM[0XN;/</+6O^$"UK_A"Y:@  J&P  )EL  "-;
M@FT  'EN  !L<   8W,  %MU  !3>   37D( $EZ%0!&>R  1'LI $%[,0(^
M>C@%.GH^"#=Z10HU>DP,,WE4##%Y7 PP>6<,+WER"RYY?PHM>8P)+'B<""MX
MK @J>,$'*G?9!REU[ @H=/<)*'/^"RAS_@NT;P  HG   )1P  "(<   ?G$
M '5S  !J=0  7WD  %9[  !.?@  18$! #^"#@ \@QH .H,D #B#+ $U@S0"
M,X,[!#&#0@4N@TD&+8-1!RN"6@<J@F0&*8)P!BB"? 4F@HH$)8&9!"2!J@,C
M@+X#(H#6 B)^ZP,A??8$(7S]!2%\_06M<P  G'0  (]T  "$=0  >W8  '%X
M  !F>P  6G\  %&"  !(A0  /X@  #6+!@ QBQ( +XP< "V,)0 LC"T *HPU
M 2B,/0(FC$0")(Q- B.,5@(AC& "((QL 1^,> $=BX8!&XN6 !J*IP 8BKL
M%XG2 !>(Z  7AO0!%X7\ 1>%_ &F>   EW@  (IY  " >@  =WL  &Q^  !A
M@@  5H8  $R)  !#C   .8\  "^2   FE < (I43 ""5'  >EB4 '98M !R6
M-0 :ECT &99& !>63P 5EEH %)9E !*6<@ 0E8$ #960  N4H0 )D[0 !Y+*
M  B1WP (D.T "9#W  F0]P"??0  D7T  (9^  !]?P  <H(  &>&  !<B@
M4HX  $>2   \E0  ,Y<  "F:   ?G   %I\$ !"@#P .H!D #: B  N@*@ *
MH#, "* \  >@1@ %H%$  Z!<  &@:0  GW@  )^(  ">F0  G:L  )O   ":
MU@  FN0  )KN  ":[@"8@P  C(,  (.$  !XAP  ;8H  &*.  !7D@  3)8
M $&:   VG@  +*$  "*C   9I0  $:<   >I!   J@T  *H7  "J(   JR@
M *LQ  "K.P  JD4  *M1  "K7@  JFT  *I]  "JC@  J:$  *BT  "FR@
MI=T  *7J  "EZ@"3B   B8D  'Z,  !SCP  9Y0  %R8  !1G   1J$  #ND
M   PJ   )JH  !RL   3KP  "K    &R    LP,  +0+  "T%   M1P  +4D
M  "V+@  MC@  +9#  "W4   MU\  +=P  "W@@  MY0  +:G  "UN@  M,P
M +3<  "TW "0CP  A)$  'F5  !NF@  8IX  %>C  !,J   0:P  #6O   J
ML@  '[0  !6V   *N    [D   "[    O    +X   "_!0  P X  ,$7  #"
M(   Q"D  ,4T  #&0   R$\  ,E@  #)<@  R88  ,B9  #(J@  Q[D  ,?)
M  #'R0"+EP  @)L  '6@  !II0  7JH  %.O  !'LP  .;8  "VX   AN@
M%KT   O    "P@   ,,   #%    Q@   ,@   #*    RP   ,X'  #/$
MTAH  -0D  #7,   VCT  -U.  #?8   X'0  ."'  #@F0  X*8  -^S  #?
MLP"'H0  ?*<  '&M  !GL@  6;4  $NX   ]NP  +[X  "/!   7Q   #,<
M  +*    S0   ,X   #0    T@   -0   #6    V0   -L   #?    X08
M .03  #G'P  Z2P  .TZ  #P3   \E\  /-S  #TA0  ])(  /2=  #TG0#_
M  P$_P ) _\ "0'_ !0 _P A /\ +P#^ #L _ !' /H 4@#W %L ]0!C /(
M:P#P '$ [0!V .L >P#J (  Z0"$ .@ B #G (T Y@"2 .0 EP#C )T X@"E
M .  K@#> +D VP#( -H W0#9 .\ V0#\ -D _P#9 /\ V0#_ -D _P#_  D$
M_P & _\ "@'_ !, _P = /L *P#W #@ ] !# /( 3@#O %@ [ !@ .D : #F
M &X Y !T .( >0#A 'T WP"! -X A@#= (H W "/ -H E #9 )L UP"B -0
MJP#2 +4 T #$ ,\ V #. .L S0#Y ,T _P#, /\ RP#_ ,L _P#_  0$_P
M O\ " '_  \ _0 : /, )@#O #, ZP _ .D 2@#F %0 X@!= -X 9 #; &L
MV0!P -@ =0#6 'H U !^ -, @P#2 (< T ", ,\ D@#- )@ R@"? ,@ J #&
M +( Q0#  ,, T@#" .8 P@#V +\ _P"^ /\ O0#_ +T _P#_   $_P   O\
M!0'_  H \P 5 .L (@#F "X X0 [ -T 1@#9 %  U0!9 -( 8 #/ &< S0!M
M ,P <@#* '< R0![ ,< ?P#& (0 Q ") ,( CP#! )4 O@"< +T I0"[ *\
MN0"\ +@ S0"V .( M #Q +( _ "R /\ L@#_ +( _P#_   #_P   ?\   #\
M  4 Z0 . .( ' #; "D U0 V -  00#, $L R0!4 ,8 7 #$ &, P@!I ,
M;@"^ ', O0!W +P ? "Z ($ N "& +< C "U )( LP"9 +( H@"P *P K@"X
M *P R0"J -T J0#M *D ]P"H /X J #_ *@ _P#_   !_P   /@   #L
MX  ' -< %0#0 ", R0 P ,4 / #! $8 O@!/ +L 5P"X %X M@!D +4 :@"S
M &\ L@!T +  >0"O 'X K@"# *P B0"K (\ J0"7 *< H "F *H I "V *(
MQ@"A -D H #I )\ ] "> /L G@#_ )X _P#_    ]    .<"  #> @  U0
M ,T #0#% !L P  H +L -0"W $  LP!* +$ 4@"N %D K %@ *L!9@"I 6L
MJ )P *<"=0"E GH I .  *,#A@"A!(T GP25 )X%G@"<!JD FP:U )D&Q0"8
M!]@ EPCI )4)]@"4"?X E K_ )0*_P#Z P  Z0T  -T5  #2%0  R!   ,((
M P"^ 1, MP4A +()+P"N"SH J@U$ *@-30"E#E4 HP]; *(080"@$&< GQ!L
M )T1<@"<$7< FQ%] )D2A "8$HL EA*3 )43G0"3$Z< DA.T ) 4Q0"/%-D
MC17K (P6^ "+%O\ BQ;_ (H6_P#N#0  X1P  -0C  #&)   O2   +<9  "T
M$0H KA0; *D7*0"E&34 H1H_ )X;2 "<&U  FAM7 )@<70"7'&, E1QH )0<
M;@"3''0 DAQZ ) =@ "/'8@ C1V0 (P=F@"*'J4 B1ZR (<>P@"&']8 A!_I
M (,?]P&"'_\!@A__ 8(?_P'I&@  VR<  ,LO  "^+@  M"L  *XG  "J( 0
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M#&$W_PS5.@  Q48  +1&  "G1@  G44  )9"  "00   BSX! (8^$0""/QX
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M%E-#AA920Y,64$.A%T]#L!=.0\,734+;%TU"[19-0?D534'_%4U!_Q7+20
MND\  *I0  "=4   DU   (M.  "$2P  ?DL  'A,!0!S310 ;TT? &M-*0)G
M3# %8DHW"5])/0Q;2$,/6$=($E9&3A141E464D9<%U%&91A/1FX93D9X&4Q'
MA!E+1Y 92D>?&4A'KAE'1L$91D;9&4=%[!A'1?@71T7_%T=%_Q?(30  MU(
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M%SE6JQ8X5KX6-U75%394ZA8V4_86-E+]%S92_Q>_60  K%H  )Q;  "06P
MAEL  'U;  !R6@  :EP  &1>  !>7P0 6F 2 %9A'0!3828!4&$N TQ@-09)
M7SL*15Y!#4)>1A$_74T4/%U4%3I<718X7&86-UUQ%3==?A0V78L3-5V:$S1<
MJA(T7+T1,US4$3):Z1(Q6?43,5C]%#%8_Q2Z70  IUT  )E>  ",7@  @E\
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M R)QY@,B</0%(6_[!B%N_@:I:   F6@  (MI  " :0  =VH  &UL  !B;P
M6'(  %!T  !(=P  /WH  #=\!P S?1, ,7T= "]])@ M?BT *WXU 2E^/ (G
M?D0#)GY, R1^50,C?E\"(GUJ B!]=P$??80!'7R3 1Q\I  ;>[8 &7K- !EY
MY  :>/(!&7?Z AEW_0*B;   DVT  (=M  !\;@  <V\  &EQ  !>=   5'@
M $M[  !#?@  .8$  #"#   HA0H )885 ".&'@ BAR8 ((<N !^'-@ =ASX
M'(=' !J'4  9AUH %X=E !6'<@ 4AH  $H:/ !"%H  -A+( #(/(  N"W@ ,
M@>\ #8#X  V ^P";<0  C7$  ()Q  !Y<@  ;W0  &1W  !:>P  3W\  $:"
M   \A0  ,X@  "J+   AC0  &8\* !:0%0 4D!T $Y E !&0+0 0D#8 #I ^
M  R02  *D%( ")!>  :0:P $D'D  H^(  ".F   C:H  (R_  "+U   BN4
M (KN  "*\0"5=@  B'8  'YV  !U>   :GL  %]_  !5@P  2X<  $"*   V
MC@  +9   ".3   :E0  $9<   B9"0 #FA,  9D<  ":)0  FBT  )HV  ":
M/P  FDH  )I6  ":8P  FG$  )F   "8D   EZ(  ):V  "5S   E.   )3K
M  "3[@"/>P  A'L  'M\  !P?P  98,  %J'  !0C   19   #J3   PE@
M)ID  !V<   3G@  "J    *B @  HPH  *,3  "C&P  I",  *0K  "E-
MI3\  *5*  "E5P  I68  *5V  "DAP  HYD  **L  "AP0  H-4  *#D  "?
MZ0"*@   @8$  ':$  !KB   8(P  %61  !*E0  /IH  #2=   IH   'Z,
M !6F   +J   !*D   "K    K    *T'  "M$   KA@  *\@  "P*   L#(
M +$]  "Q2@  LED  +)I  "R>@  L8P  +"@  "OM   KL@  *W8  "MW@"'
MAP  ?(D  '&-  !FD@  6I<  $^;  !$H   .*4  "ZH   CJP  &:T   ZP
M   %L@   +0   "U    M@   +<   "X 0  N0H  +H2  "[&P  O20  +XN
M  "_.@  P4D  ,):  ##;   PW\  ,*2  #"I   P;0  ,'"  #!QP"#CP
M>),  &R8  !AG0  5J(  $NG   _K   ,[   "BS   =M@  $;@   :Z
MO0   +T   "_    P    ,(   ##    Q0   ,<#  #)"P  RQ4  ,X?  #0
M*@  TS<  -9(  #96@  V6X  -F"  #:E   V:,  -FN  #9LP!_F0  =)X
M &FD  !>J@  4Z\  $>T   YMP  *[H  !Z\   2OP  !\(   #%    R
M ,@   #)    RP   ,P   #.    T0   -,   #7    V@0  -X/  #B&@
MY2<  .@U  #L1P  [UH  /!N  #P@0  \)   /";  #PGP#_  @#_P & ?\
M!P#_ !( _P ? /\ + #] #@ ^@!$ /@ 3@#U %@ \0!@ .X : #L &X Z@!S
M .D > #H 'P Y@"  .4 A #D (D XP". .( DP#@ )D W@"@ -L J0#9 +0
MV ## -4 U@#5 .T U #[ -  _P#. /\ S0#_ ,T _P#_  0"_P   ?\ ! #_
M  X _0 ; /D * #U #4 \@!  .\ 2P#K %4 YP!= .0 9 #B &L X !P -\
M=0#= 'D W !] -L @@#9 (8 V "+ -8 D #3 )8 T0"> ,\ I@#- +  RP"^
M ,H T0#) .< Q0#W ,( _P#" /\ P@#_ ,, _P#_   "_P   ?\   #_  D
M]0 7 /  (P#L #  Z  \ ., 1P#@ %$ W !9 -D 80#6 &< U !L -, <0#1
M '8 T !Z ,X ?@#- (, RP"( ,D C0#' ), Q0": ,, HP#! *T OP"Y +T
MS "Z .$ N #R +@ _P"X /\ N #_ +@ _P#_   "_P   /\   #U  0 [  2
M .8 'P#@ "L V@ X -8 0P#3 $P SP!5 ,P 7 #* &, R !I ,8 ;@#$ '(
MP@!W ,$ >P#  (  O@"% +T B@"[ )  N0"7 +< H "U *D LP"V +  Q@"O
M -L K@#N *X ^P"M /\ K0#_ *T _P#_   !_P   /X   #K    X@ , -H
M&0#2 "8 S0 R ,D /@#& $< PP!0 ,  6 "] %X NP!D +D :@"X &X MP!S
M +4 > "T 'P LP"! +$ AP"P (T K@"4 *P G0"I *8 IP"R *8 P0"E -4
MI #I *, ]@"C /\ HP#_ *( _P#_    ^P   .L   #A    U@ & ,P $P#&
M "  P0 L +X . "Z $( MP!+ +0 4P"R %H L !@ *X 90"M &H K !O *H
M= "I 'D J !^ *8 A "D (H HP"1 *$ F@"? *0 G@"O )P O0"; -  F@#D
M )D \0"8 /H F #_ )@ _P#]    [    .$   #3    R@   ,( "P"\ !D
MN  E +0 ,0"P #P K0!% *H 30"H %4 I@!; *0 80"B &8 H0!K *  < "?
M '4 G@!Z )P @ "; (< F0"/ )@ EP"6 *$ E "M ), NP"2 ,T D #A (\
M[P". ?@ C@'] (X!_P#Q    XPH  -40  #'#@  O@H  +D" @"T !$ KP >
M *L *@"G C8 I 1  *$$2 "?!5  G096 )L'7 ":!V( F =G )<'; "6!W$
ME0=W ),'?0"2"(0 D B, (\)E@"-":  C FL (H*NP")"LT APOB (8,\0"%
M#?L A W_ (0-_P#I#0  VQH  ,D>  "]'0  M!H  *X4  "L"P< IPD7 *(-
M) "?$#  FQ$Z )D20P"6$TL E!-2 ),36 "1$UT D!-C (X4: "-%&X C!1T
M (H4>@")%8( AQ6* (85E "$%IX @Q:K ($6N@" %\T ?A?B 'T8\@!]&/T
M?!C_ 'P8_P#C&@  TR4  ,$H  "T)P  JR4  *4A  "B&P  GQ80 )H9'@"6
M&RH DQPU ) </@".'48 C!U- (H=4P"('5D AQU? (8=9 "$'FH @QYP ($>
M=P" 'W\ ?Q^' 'T?D0!\'YP >B"H 'D@MP!X(,H =B#@ '4A\ %T(/L!="#_
M 7,@_P+=)   RBX  +HP  "M,   I"X  )XK  ":)@  ER$* )(B&0".)"4
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M!F0SB09C,Y0'83.A!V SL A>,\,(73+9"%PR[ E<,O@)6S+_"5LQ_PG..@
MNCX  *H_  ">0   E3\  (X\  "(.@  @S<  '\W"P![.!D =S@C 70X+ )P
M-S0$;C<\!FLV0@9I-DD'9S9/!V8V50AD-EL(8S9B"&$V:@E@-G()7C=\"5TW
MA@I;-Y(*6C>?"U@WK@M7-\ ,53;6#%4VZPQ5-O<,537^"U4U_PO*/P  MD(
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M%$-"J11"0KH404+1%$%!YQ-!0?430D#\$D) _Q*_20  K$L  )U,  "13
MB$P  (!+  !Y2   <DD  &Q*  !G2@D 8DL6 %]+( !;2RD"5THP!51)-@A0
M2#L+34=!#4M'1Q!(1DX21D95%$5&711#1F<50D9Q%4%'?15 1XD5/D>7%#U'
MIQ0\1[D4.T;/%#M&YA0[1?03.T3\$SQ$_Q.[3   J4T  )I.  ".3P  A$\
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M"RU7XPLL5?(-+%3Z#BQ4_P^O50  G58  )!7  "$6   >E@  '%9  !D60
M75P  %9=  !17P  3& & $AA$@!%81P 0F(E $!A+0(\83,$.6$Z!C9@0 @T
M8$<*,F!."S!@5PLO8& ++F!K"BU@> HL8(4)*V"3""M?HP@J7[4'*5[,!RA=
MXP<H7/$))UOZ"B=:_PNJ60  F5H  (Q:  " 6P  =UP  &U<  !@7P  6F
M %-B  !+90  168! $!H#0 ]:!@ .V@A #AH*0 V:# ",V@W S%H/@4O:$4&
M+6A,!RMH50<J:%\'*6AJ!BAH=@4G:(,%)F>2!"5GH@0D9K0#(V;* R)EX0,B
M8_$%(6+Y!B%A_@>D7   E%T  (=>  !\7P  <F   &EA  !=8P  5F4  $]H
M  !':@  /VT  #=O!P T;Q, ,7 < #!P)  N<"P +' S 2IP.@(H<$(#)G!*
M R5P4@,C<%P#(G!G B%P= (@<($!'F^/ 1UOH $<;K( &VW( !MLX  ;:_ !
M&FKY AII_0.>80  CV$  (-B  !X8P  ;F0  &5E  !::   4FL  $IN  !"
M<   .7,  #%U   J=PL )W@6 "5X'P D>"8 (G@N "%X-@ ?>#X 'GA& !QY
M3P ;>5@ &7EC !AX<  6>'X %'B, !-WG  1=J\ $'7$  YTW  0<^X $7+W
M !%Q_ "890  BF4  'YF  !T9P  :V@  &%J  !7;@  37$  $5T   \=P
M,WD  "M\   B?P0 &X - !F!%P 8@1\ %H$G !6!+P 3@3< $H$_ !"!20 .
M@5, #(%>  J!:@ (@7@ !H"'  5_EP #?J@  7V]  %\T@ ">^0  GON  -Z
M]0"2:0  A6H  'IJ  !P:P  9VT  %UP  !3=   27@  $![   V?@  +8$
M "2$   ;A@  $XD#  N*#0 (BA< !XH?  6*)P $BB\  HHX  &*00  BDL
M (I6  "*8P  BG$  (J   ")D   B*(  (>T  "%S   A.$  (/J  "#\ ",
M;@  @&\  '9O  !M<0  8G0  %AX  !.?   0X   #F#   PAP  )XD  !Z,
M   5C@  #)    .2!P  DQ   ),8  "3'P  DR<  )0O  "4.   E$,  )1.
M  "46P  E&D  )1X  "3B0  DIH  )&M  "0P@  C]@  ([G  ".[@"&<P
M?'0  '-U  !H>   77P  %.   !(A0  /8D  #.-   ID   ()(  !>5   -
MEP  !9D   ";    G @  )P0  "<&   G1\  )TF  ">+P  GCD  )]$  "?
M40  GU\  )]O  "?@   GI$  )VD  "=N   F\T  )O=  ";YP"">0  >7H
M &Y\  !C@0  6(4  $V*  !"CP  -Y,  "R6   BF0  &)P   Z>   &H
M *,   "E    I@   *8$  "G"P  J!0  *@;  "I(P  JBP  *LW  "L0P
MK%(  *UB  "L=   JX<  *N:  "JK0  JL   *G0  "IW !_?P  =((  &F&
M  !>BP  4Y   $>5   [F0  ,9T  ":A   ;I   $:<   :I    JP   *T
M  "N    L    +$   "R    LP8  +0.  "U%P  MQ\  +@I  "Y-0  NT(
M +Q3  "]90  O7@  +V+  "[GP  NK$  +G   "YRP![AP  <(L  &20  !9
ME@  3IL  $*@   VI0  *ZD  ""M   5KP  "K(   "U    MP   +@   "Y
M    NP   +P   "]    OP   ,    #"!P  Q!   ,<:  #))0  RS(  ,Y"
M  #15   TF@  --\  #3C@  TYX  -.J  #3LP!WD0  :Y8  &"<  !5H@
M2J<  #ZM   RL0  )[4  !JX   -NP   KT   #     P@   ,(   #$
MQ0   ,<   #)    RP   ,T   #0    TP   -@*  #<%0  X"$  .,O  #G
M00  Z54  .IJ  #K?0  [(T  .R9  #LH #_  ,!_P   /\  P#_ !  _P ;
M /X * #\ #4 ]P!! /0 3 #Q %4 [@!= .P 9 #J &H Z !P .< = #E 'D
MY !] .( @0#A (4 WP"* -T CP#; )8 V0"= -@ I0#5 +  TP"^ -( T0#-
M .@ R@#[ ,D _P#) /\ R0#_ ,H _P#_   !_P   /\   #_  H ^@ 8 /8
M) #Q #$ [0 ] .L 2 #H %$ Y0!9 .( 80#? &< W0!L -L <0#9 '8 U@!Z
M -4 ?@#3 (( T@"' -  C #/ ), S0": ,L H@#) *P QP"Y ,( RP"_ .,
MOP#V +\ _P"^ /\ O@#_ +X _P#_   !_P   /\   #X  8 \@ 4 .L ( #E
M "T X0 Y -\ 0P#< $T V !5 -0 70#1 &, S@!I ,T ;@#+ '( R@!W ,@
M>P#' '\ Q0"$ ,0 B0#" (\ P0"6 +\ GP"\ *D N "U +8 Q0"U -P M #P
M +0 _@"S /\ LP#_ +, _P#_    _P   /D   #O  ( YP . -T ' #8 "@
MTP T -  /@#- $@ R0!1 ,8 6 ## %\ P0!E ,  :@"^ &X O0!S +P =P"Z
M 'P N0"  +< A@"U (P LP"3 +$ FP"O *4 K0"P *L OP"J -4 J0#J *D
M^ "H /\ J #_ *@ _P#_    _P   .X   #D    V  * -  %@#* ", Q0 N
M ,$ .0"_ $, O !, +H 4P"W %H M0!@ +, 90"Q &H L !O *X <P"M '@
MJP!] *H @@"I (@ J "/ *8 F "D *$ HP"L *$ NP"@ ,T GP#C )X ] ">
M /X G@#_ )X _P#_    [P   .,   #7    RP $ ,0 $0"] !T N0 I +8
M,P"S #T L0!& *X 3@"K %4 J0!; *< 8 "F &4 I0!J *0 ;P"C '0 H0!Y
M *  ?@"? (4 G@", )P E ": )X F0"I )< M@"6 ,@ E0#> )0 [P"3 /H
MDP#_ )( _P#T    YP   -8   #(    P    +D "0"S !8 L  B *P +0"I
M #< I@!! *, 20"A %  GP!6 )X 7 "< &$ FP!F )H :@"9 &\ F !U )8
M>P"5 ($ E ") )( D0"0 )L CP"F (T LP", ,0 BP#9 (D Z@"( /4 B #\
M (< _P#K    W 8  ,H)  "]!P  M 4  +   0"K  \ IP ; *, )@"@ #$
MG0 [ )H 0P"9 $L EP!1 )4 5P"3 %P D@!A )$ 9@"/ &P C@!Q (T =P",
M 'X B@"& (D CP"' )D A0&D (0!L0"# <( @0/6 ( $Z !_!?0 ?P7[ 'X%
M_P#C#   T!8  , 7  "S%@  JQ0  *8.  "C!@8 H $3 )L$( "7!BL E <U
M )((/@"0"48 C@E, (P*4@"+"E@ B0I= (@*8P"'"F@ A@MN (0+=0"##'P
M@0R$ ( ,C0!^#9@ ?0VD 'L-L@!Z#<, >0[9 '<0[ !V$/< =A#^ '80_P#<
M&0  QQ\  +<A  "K(0  HA\  )T<  ":%@  F X* ),0&0"/$B4 C!,O (H4
M.0"(%4$ AA5( (053@"#%50 @199 ( 67P!^%F0 ?19K 'P6<0!Z%WD >1>!
M '<7BP!U&)8 =!BB ',8L !Q&,( <!G7 &\9ZP!N&O@ ;1K_ &T9_P#5(P
MP"<  + I  "D*0  G"<  )8E  "1(0  CQL$ (P:% "(&R  A!PJ ((=- "
M'CP ?AY# 'P>2@!['E  >1Y5 '<>6P!V'F$ =1]G ',?;@!R'W8 <"!_ &\@
MB !M(), ;"&@ &HAK@!I(<  9R'5 &8AZ0%E(?8!92'^ F4@_P+-*@  N2X
M *HO  "?,   EBX  (\L  "+*0  AR4  (0B#@" (QL ?20F 'HE+P!X)3@
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M!U,RJ =1,KD(4#'."$\QY0A/,?,(3S#\"$\P_PB_.   K#H  )X\  "2/0
MB3P  ((Z  !\.0  =S<  ',U 0!O-0X :S8: &<W) %D-BP"834S!%XU.@5<
M-4 &6C5&!E@T3 =7-%('5359"%0U80A2-6H)435T"5 V?@E.-HH*33:7"DLV
MI@I*-K<+237-"T@UXPM(-/,+2#3["TDT_PJ[.P  J3X  )H_  "/0   AD
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M#C9"WPXV0? /-D#Y#S9 _P^P1   GT<  )%(  "&2   ?4D  '1(  !M10
M948  %](  !:20  54D, %)*%P!/2B  3$HH 4E)+@-&230&0T@Z"4!(00L]
M1T<-.T=/#CE'5P\X1V /-TAJ#S9(=@\U2(,.-$B1#C-(H0TR2+(-,4?'##%'
MW@PP1N\-,$7Y#C!$_PZL1P  G$D  (Y*  "#2P  >4P  '%+  !H2@  8$L
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M!B!6_@>?40  D%,  (-4  !X50  ;E4  &56  !;6   4UH  $Q<  !%7@
M/F   #AB!@ T8A$ ,6,; "]C(P N8RH +&,Q 2EC. (H8T ")F-' R1C4 ,C
M8UD#(F-D B%C< (@8WX!'F., 1UBG $<8JT!&V'" !M@V@ ;7NP!&UWW AI=
M_0.:50  BU8  ']7  !T6   :ED  &%:  !770  3U\  $AA  !!8P  .64
M #%H   K:@L *&H5 "9J'@ D:R4 (VLM "%K-  @:SP 'FM$ !UK30 ;:U8
M&FMA !AK;0 7:WL %FJ) !1JF0 3::L $FB_ !%GV  29>L $V7V !-D_0&5
M60  AEH  'M;  !P7   9ET  %Y?  !480  2V0  $1F   \:0  -&P  "QN
M   C<00 '7(. !MS&  :<R  &',G !=S+P 5<S8 %',_ !)S2  1<U( #G-<
M  US:  +<W8 "7*%  =RE  &<:8 !7"Y  1NSP %;>, !FSO  =L^ "/7@
M@5X  '9?  !L8   8V$  %ID  !09P  1VH  #]M   V<   +G(  "9U   =
M>   %'H'  Y[$  ,>QD "GLA  E[*  (>S  !GLX  5[0@ #>TP  GM6  ![
M8@  >W   'M_  !ZCP  >:   'BS  !WR0  =MX  '7J  !T\0"(8@  ?&,
M '%D  !H90  7V<  %5J  !,;0  0G$  #ET   P=P  *'H  !]\   7?P
M#8(!  6$"@  A!,  (0:  "$(@  A"D  (4Q  "$.@  A$0  (10  "%6P
MA&D  (1Y  "#B0  @IH  (&M  " P0  ?]D  '[I  !]\0"#9P  =V@  &YH
M  !E:@  6VT  %%Q  !'=0  /'D  #-\   J?P  (8(  !B%   0AP  !HH
M  ",!0  C P  (P4  "-&P  C2(  (XI  ".,0  CCL  (Y'  "/4P  CV
M (]P  ".@0  CI,  (VE  "+N0  BM   (GB  "([@!];   =&T  &MN  !@
M<0  5G4  $MZ  !!?@  -H(  "R%   CB0  &8L  !".   (D    )(   "4
M    E04  )4+  "6$P  EQH  )<A  "8*   F3$  )D\  "920  FE<  )IG
M  ":>   FHH  )F=  "8KP  E\0  );7  "6Y0!Z<@  <7(  &9U  !;>@
M4'X  $6#   ZB   +XP  "60   ;D@  $I4   >7    F@   )P   ">
MGP   )\"  "@"0  H1$  *(7  "C'P  I"<  *4Q  "F/0  IDP  *=<  "G
M;@  IX   *:2  "FI@  I;@  *7)  "DV0!W=P  ;'H  &%_  !6A   2XD
M #^.   TDP  *9<  !Z:   4G0  ":    "B    I    *<   "H    J@
M *L   "L    K ,  *T)  "O$@  L1H  +(C  "T+@  M3P  +9-  "W8
MMG,  +6'  "UF@  M:L  +2Z  "TR !S?P  9X0  %R)  !1CP  190  #F:
M   NG@  (J(  !BF   ,J0   :P   "N    KP   +$   "S    M    +8
M  "W    N0   +H   "\ P  O@P  ,$6  ##(   Q2T  ,@\  #*3@  S&(
M ,UV  #,B0  RIL  ,FJ  #(M@!NB0  8X\  %B4  !-F@  0*   #2F   H
MJP  ':\  !*R   &M0   +@   "[    O0   +T   "_    P    ,$   ##
M    Q0   ,<   #*    S0   - %  #5$   V1T  -PK  #@/   XU   .9E
M  #G>   YXD  .B5  #HGP#_    _P   /\   #_  P _P 8 /H )@#W #(
M]0 ] /, 1P#O %$ ZP!: .@ 80#F &< Y !M .( <@#A '8 WP!Z -X ?@#=
M (, VP"' -H C #8 )( U@": -0 H@#2 *P S@"Z ,D S@#' .8 Q@#X ,8
M_P#& /\ Q@#_ ,< _P#_    _P   /\   #^  < ]P 5 /  (@#M "X Z@ Y
M .< 0P#C $T WP!6 -P 70#: &, V !I -8 ;@#4 ', T@!W -$ >P#0 (
MS@"$ ,P B0#* (\ QP"7 ,0 GP#" *D OP"U +T QP"\ -X NP#S +L _P"[
M /\ NP#_ +L _P#_    _P   /P   #U  , Z@ 1 .4 '0#@ "D VP U -@
M/P#5 $@ T@!1 ,X 6 #, %\ R@!E ,@ :@#% &\ PP!S ,$ > "_ 'P O0"!
M +P A@"Z (P N0"3 +< FP"V *4 M "P +( P "Q -4 L #M *\ _0"O /\
MKP#_ *\ _P#_    _P   /,   #G    W@ + -< &0#/ "0 S  P ,D .@#&
M $, PP!, +\ 5 "\ %H N0!@ +< 9@"V &L M0!O +0 <P"S '@ L@!] +
M@@"O (@ K@". *P EP"K *  J0"L *< N@"F ,T I0#F *0 ]P"D /\ I #_
M *0 _P#_    ]    .<   #9    T  ' ,< % #" "  O@ J +H -0"W #X
MM !' +$ 3@"O %4 K@!; *P 8 "K &4 J@!J *D ;P"H ', IP!X *4 ?0"D
M (, HP"* *$ DP"@ )P G@"G )P M "; ,< F@#> )D \0"9 /T F0#_ )D
M_P#V    Z0   -@   #,    P@ " +L #@"V !H L0 E *T +P"K #D J0!!
M *< 20"E %  HP!6 *( 6P"A &  GP!E )X :@"= &\ G !T )L >0"9 '\
MF "& )< CP"5 )@ DP"C )( L "0 ,$ CP#6 (X ZP"- /@ C0#_ (T _P#N
M    W    ,L   "_    MP   +  !P"K !0 IP ? *0 *0"A #, GP \ )T
M1 "; $H F@!1 )@ 5@"7 %L E0!@ )0 90"3 &H D@!O )  =0"/ 'L C@"#
M (P BP"* )4 B0"@ (< K0"& +P A0#1 (0 Y@"# /0 @P#\ (( _P#D
MT $  , "  "T @  K    *<   "B  P GP 8 )P (P"9 "T E@ V )0 /@"2
M $4 D !, (\ 4@"- %< C !< (L 80") &8 B !K (< <0"% '@ A !_ ((
MB "! )( ?P"= 'X J@!] +D ? #- 'L X@!Y /  >0#X 'D _0#:"0  Q0X
M +80  "J$0  H@X  )T*  "; @0 EP 1 )0 ' "0 "< C0 P (L .0") $
MAP%' (8"30"% E( @P)8 ((#70"  V( ?P-H 'X#;@!]!'4 >P1] 'H$A@!X
M!)  =P6< '4%J0!T!;D <@7, '$'X0!P!^\ < CX &\(_0#0%0  O1D  *X:
M  "B&P  FAD  )46  "1$@  D D( (P&%0")""$ A@DJ (,*,P"!"SL @ Q"
M 'X,2 !]#4X >PU4 'H-60!X#5\ =PUE '8.; !T#G, <@]\ '$0A0!O$)
M;A"< &P1J@!K$;H :1'. &@2Y !G$O, 9Q+[ &<2_P#)'   M2   *<C  "<
M(P  DR(  (T@  ")'   AQ<  (42#@"!$QL ?A0E 'P5+@!Y%C8 =Q8^ '86
M1 !T%TH <Q=0 '$750!P%UL ;A=A &T8: !K&'  :AAY &@9@@!F&8T 91F:
M &,:J !B&K@ 81K, & :X@!?&_( 7QO\ %X:_P#"(P  L"8  *$I  "6*
MC2@  (<G  "")   ?R   'T<" !Z'!8 =QP@ '0=*@!Q'C( ;QXY &X>0 !L
M'D8 :QY, &D?4@!G'U@ 9A]> &0?90!C(&T 82!V & @@ !>(8L 72&8 %LA
MI@!:(;8 62'* 5@AX0%7(?$!5R'[ E<A_P*\*   JRP  )PN  "1+@  B"T
M ((L  !]*@  >2<  '<C! !S(Q$ <",< &TD)@!J)"X :"4U &8E/ !E)4,
M8R5) &$E3@%@)50!7B5; 5TF8@%;)FH!6B9T 5@G?@%7)XD"52>6 E0HI )3
M)[0"42?( E GWP-0)_ #4";Z T\F_P2X+0  IC   )@R  "-,@  A#(  'XP
M  !X+P  ="T  '$J  !M*0P :2H8 &8J(@!C*BH 82HQ 5\J. %=*C\"6RI%
M EHJ2P)8*E$"5RM8 E4K7P-4*V<#4BQQ U$L>P-/+(<$3BV4!$TMH@1++;(%
M2BS'!4DLW@5)*^\%22OZ!DDJ_P:T,0  HC0  )4U  ")-@  @38  'HT  !T
M,P  ;S$  &LO  !G+P@ 8R\4 & P'@!=,"8!6B\N 5@O- )6+SL#5"]!!%(O
M1P11+TT$3R]4!4XP7 5,,&4%2S!N!DHQ>09(,84&1S&2!T8QH =$,;$'0S'%
M!T(PW =",.X'0B_Y!T(O_P>P-   GS<  )(Y  "&.0  ?3D  '8X  !P-@
M:S4  &8T  !B- 4 7C01 %HU&P!7-2, 5#0J E(T,0-/,S<$33,]!4LS0P9*
M,TH&2#11!T<T60=%-&((1#5L"$,U=PA!-8,)0#60"3\UGPD]-:\)/#7#"3LT
MV@D\-.T)/#/X"3PS_@FM-P  G#H  (X[  "#/0  >CT  ',\  !M.@  9S@
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M"BM _0JB00  DT(  (5$  ![10  <44  &E%  !A10  6$4  %)&  !-1P
M2$@" $1)#0!!21< /TH? #Q*)@$Y2BT"-TDS!#1).@4R24$',$E(""])4 @M
M25H(+$ED""M*< <J2GT'*DJ+!BE*F@8H2:L%)TF_!29(U@4F1^H&)4;V""5%
M_ B>1   CT4  ()'  !W2   ;D@  &5)  !=20  4TH  $U+  !'30  0TX
M #Y/"0 Z3Q, .% < #90)  S4"L!,5 Q B]0. ,M4#\%*U!&!2I03P4H4%@%
M)U!C!290;P0E4'P$)%"*!"-0F0,C3ZH#(D^^ B%.U0(@3>D$($SU!2!+_ ::
M1P  BTD  ']*  !T2P  :DP  &%,  !930  3T\  $E0  !#4@  /50  #=5
M!0 S5@\ ,588 "]6(  M5R@ *U<O 2E7-@$G5ST")5=$ R1730,B5U8"(5=A
M B!7;0(?5WH!'E>( 1U6F $<5JD!&U6] !I4U  ;4^@!&U+U AI1_ .62@
MATP  'M-  !P3@  9D\  %Y0  !540  3%,  $95   _5P  .%D  #%;   L
M70H *%T4 "9='  D7B0 (UXK "%>,@ @7CH 'EY" !U>2@ ;7E0 &EY> !E>
M:@ 77G< %EZ& !5=E0 47:< $URZ !);T@ 36>< $UCT !18^P&13@  @U
M '=1  !L4@  8E,  %I4  !250  25@  $):   [7   ,UX  "QA   D8P4
M'V4. !UE%P ;91\ &64F !AE+@ 6934 %64] !-F1@ 29E  $&9:  YE9@ ,
M97, "F6"  EDD0 (9*( !V.U  9ARP '8.$ "%_O  E?]P"+4@  ?E0  ')5
M  !H5@  7U<  %=8  !.6@  15T  #U@   V8@  +F0  "9G   >:@  %FP'
M !)M$0 0;1D #6T@  QM*  *;3  "6TX  =M00 &;4L !&U5  )M80  ;6X
M &Q\  !LC   :YT  &NP  !IQ@  :-L  &?I  !F\0"%5P  >5@  &U9  !D
M6@  7%L  %-=  !*8   06,  #AF   P:0  *&L  "!N   8<0  $',"  =U
M"@ "=A,  '8;  !U(@  =BH  '8R  !V.P  =44  '5/  !U6P  =6@  '5W
M  !TA@  =)<  '.J  !ROP  <=<  '#H  !O[P" 6P  =%P  &E=  !A7@
M6&   $]C  !&9@  /&H  #-M   J<   (G,  !IV   2>   "'L   !\"
M?0\  'T6  !^'0  ?B0  'XK  !_,P  ?ST  'Y)  !^5   ?V$  'YP  !^
M@0  ?9(  'VD  ![N   >L\  'GD  !Y[@!Z8   ;V$  &9B  !=8P  4V8
M $IJ  ! ;@  -G(  "UV   D>   &WL  !)^   *@    8,   "$ P  A0H
M (81  "&%P  AQT  (@D  "(*P  B34  (E   "(30  B5H  (EI  ")>@
MB(P  (>>  "&L0  A<<  (3<  "$Z !U90  :V8  &-G  !8:@  3FX  $1S
M   Y=P  +WL  "5_   <@0  $X0   F'   !B@   (P   ".    CP(  (\(
M  "0#@  D14  )$;  "2(@  E"H  )4U  "50@  E5   )9>  "6;P  E8(
M )25  "3J0  DKP  )'0  "0X0!Q:P  :6L  %YO  !3<P  27@  #U]   R
M@0  *(4  !V)   4C   "HX   &1    E    )8   "8    F0   )D   ":
M!0  FPL  )P2  "=&0  GR   * J  "B-@  H40  *)4  "C90  HW@  **,
M  "BGP  H;(  *##  "@T0!O<   9',  %EX  !.?0  0X(  #>'   KC
M(9   !:4   +EP   9D   "<    G@   *    "B    HP   *0   "E
MI@$  *<'  "H#@  JA<  *P?  "N*@  KS<  *](  "Q6@  L6T  +&   "Q
ME   L*8  +"V  "PPP!J>   7WT  %2"  !)B   /(X  #&3   EF   &IP
M  Z?   #H@   *4   "G    J0   *P   "M    KP   +    "R    LP
M +0   "V    N <  +L0  "]&P  OR<  ,(V  #$2   Q5X  ,1S  #$AP
MQ)@  ,.G  ##L@!F@@  6X@  %".  !$E   -YH  "N?   @I   %:@   BL
M    K@   +$   "T    M0   +<   "X    N@   +P   "^    OP   ,$
M  ##    Q@   ,D"  #."P  TA@  -4F  #:-P  WDL  .%?  #B<P  X88
M ."5  #?H #_    _P   /\   #_  @ _  5 /D (@#U "X \0 Z /  0P#L
M $T Z0!5 .8 70#C &, WP!I -P ;@#9 ', UP!X -4 ? #3 ($ T@"& -
MBP#/ )$ S@"8 ,P H #* *H R "W ,8 R0#$ .( PP#V ,( _P#" /\ PP#_
M ,, _P#_    _P   /\   #Y  4 \P 2 .T '@#H "H Y0 U ., /P#@ $@
MV0!1 -, 6 #/ %\ S0!E ,L :@#* &\ R0!T ,@ > #' 'T Q@"! ,0 AP##
M (T P@"3 ,  FP"^ *8 O "R +L P@"Y -H MP#P +8 _P"V /\ MP#_ +<
M_P#_    _P   /D   #M  $ Y@ - -X &P#: "4 U@ P -  .@#, $, R !,
M ,4 4P## %H P0!@ +\ 90"^ &H O !O +L = "Z '@ N0!] +@ @@"W (@
MM0"/ +0 EP"R *  L0"L *\ NP"M -$ K #I *L ^P"K /\ JP#_ *L _P#_
M    ^    .L   #@    U0 ) ,X %@#) "$ P@ K +\ -0"^ #\ NP!' +D
M3@"V %4 M !; +, 8 "R &4 L !J *\ ;P"N ', K0!X *P ?@"K (0 J0"*
M *@ D@"G )L I0"G *, M "B ,@ H #A *  ]0"@ /\ GP#_ )\ _P#Z
M[0   -T   #1    QP % ,  $ "X !P M0 F +( , "P #D KP!" *P 20"J
M %  J0!6 *< 6P"F &  I0!E *0 :0"C &X H@!S *$ >0"? '\ G@"& )T
MC0"; )< F@"B )@ KP"6 ,$ E0#8 )0 [P"3 /P DP#_ )( _P#P    W@
M ,\   #"    N@   +( "P"M !8 J0 A *< *P"E #0 HP \ *$ 1 "? $H
MG@!0 )P 5@"; %L F@!@ )D 9 "8 &D E@!O )4 = "4 'H D@"! )  B0"/
M )( C0"> (P J@"* +H B0#0 (D YP"( /< B #_ (@ _P#F    T@   ,$
M  "V    K@   *< !0"C !$ GP ; )T )0"; "X F0 W )< /@"5 $4 DP!+
M )( 40"0 %8 CP!; (X 8 ", &4 BP!J (H < ") '8 AP!] (8 A0"% (\
M@P": (( IP"! +8 @ #* '\ X0!^ /( ?@#\ 'X _P#9    Q0   +8   "J
M    HP   )\   ":  H E@ 5 )0 'P"1 "D CP Q (P .0"+ $  B0!& (@
M3 "& %$ A0!6 (0 6P"# &  @@!F ($ ; !_ '( ?@!Z 'P @@![ (P >0"7
M '@ I !W +, =@#% '4 W !T .X = #X ', _0#. @  NP<  *P*  "B"@
MF@D  )4%  "2  , CP . (P &0") "( A@ L (0 ,P"" #L @0!! '\ 1P!^
M $T ?0!2 'P 5P!Z %P >0!B '< : !V &\ =0!W ', @ !Q (H < "5 &\
MH@!M +  ; ## &L V0!J .H :@#T &D ^@#%#0  LQ(  *05  ":%0  DA0
M (P2  ")#0  AP4& (4!$@"! !P ?P$F 'P"+@!Z S8 > 0] '<$0P!V!4@
M= 5. ',&4P!Q!ED < 9? &\&90!M!VP ; =U &H'?@!H"(@ 9PB4 &4(H0!D
M"+$ 8PC# &()V0!A"NH 8 KU & *^P"^%@  JQH  )X<  "3'0  BQP  (4;
M  "!%P  ?Q,  'X+"0!["A8 =PL@ '4,*0!S#3$ <0TX &\./P!N#D4 ; ]*
M &L04 !I$%8 :!!< &818P!D$6H 8Q%S &$2?0!@$H< 7A.4 %T3H0!;$[$
M6A/$ %D3VP!8%.T 6!3X %@4_@"W'   IB   )@B  "-(P  A2,  '\A  !Z
M'P  =QL  '47 P!S%!  <!4; &T6) !K%BP :18T &<7.@!E%T$ 9!=& &(8
M3 !A&%( 7QA8 %T97P!<&6< 6QEP %D:>@!8&H4 5AN2 %4;H !3&Z\ 4AO"
M %$;V0!1&^P 4!OX % ;_P&R(0  H24  )0G  "(*   @"@  'HG  !U)0
M<2(  &X?  !L' L :1P7 &8=( !C'2@ 81TP %\>-@!>'CT 7!Y# %L>20!9
M'T\ 5Q]5 %8?70!5(&4 4R!N %(A> !0(8, 3R&0 $XBG@%,(JX!2R'! 4HA
MV %)(>L!22'W DD@_@*N)@  G2D  (\K  "$+   ?"T  '4L  !P*0  ;"<
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M!C4N_ :B,0  DS,  (8U  ![-@  <C8  &LV  !D-0  7S(  %HR  !5,P
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M!BH_; 8I/WD%*#^'!2<_E@0G/Z8$)C^Y!"4^T ,D/>4$)#SS!B0[^P:9.0
MBCP  'T]  !R/@  :3\  &$_  !9/P  4C\  $I   !%00  04(  #Q#!@ X
M1!  -D09 #1$(  R1"< +T0N 2U$- (K1#L#*D1#!"A$2P0G154$)D5?!"5%
M:P0D17@#(T6% R)%E0(A1:4"(42X B!$SP(?0^4"'T+R!!]!^@65/   AC\
M 'I   !O00  94(  %U"  !60P  3D,  $5%  ! 1@  .T@  #9) @ R20P
M+TH6 "U*'@ K2R4 *4LK "=+,@$E2SD")$M! B)+2@(A2U,"($M= A]+:0$>
M3'8!'4N$ 1Q+DP$;2Z0 &TJW !I)S0 :2.0!&D?R AI&^@.10   @D(  '9$
M  !K10  8D4  %I&  !21@  2D<  $))   \2P  -DT  #!.   L4 @ *%$2
M "91&@ D42$ (E$H "!2+P ?4C< '5(_ !Q21P ;4E$ &5); !A29P 74G0
M%E*" !51D0 44:( $U"U !)/S  23N( $TWQ !1-^0&-1   ?T8  ')'  !G
M2   7DD  %9)  !/2@  1TP  #].   Y4   ,E(  "Q4   D5@0 'U<- !U8
M%@ ;6!T &E@D !A8+  76#, %5D[ !191  264T $%E8  Y98P -6'  "UA^
M  I8C@ )5Y\ "%:Q  A5QP (5-T "5/M  I3]@"(2   >DD  &Y+  !C2P
M6TP  %--  !,3@  1%   #M3   U50  +E<  "=9   ?7   %U\' !-@$0 1
M8!@ #V @  U@)P ,8"\ "F W  E@/P '8$D !6!3  1@7P "7VL  %]Z  !?
MB0  7ID  %VL  !<P0  6]@  %KH  !9\ ""3   =4T  &E.  !?3P  5U
M %!1  !(4@  0%4  #=8   P6P  *%T  "%@   98P  $F4"  EH"P %9Q0
M V<;  %G(@  9RH  &<Q  !G.@  9T0  &=.  !G6@  9V8  &9U  !FA
M9I0  &6G  !DNP  8],  &+F  !A[@!]4   <%(  &52  !<4P  550  $U5
M  !$6   .UP  #)?   J8@  (F0  !IG   3:@  "FP   -N"   ;Q   &\6
M  !O'0  <"0  ' K  !P-   <#T  '!(  !P5   <&   &]O  !O?P  ;H\
M &VA  !MM0  ;,T  &KC  !J[@!W50  :U8  &%7  !95P  45D  $A<   _
M7P  -6,  "QF   D:0  '&P  !1O   ,<0  !'0   !V!0  =@L  '<2  !W
M&   >!X  'DE  !Y+0  >38  'E!  !Y30  >5H  'EH  !X>   >(H  '><
M  !WKP  =<8  '7<  !TZ@!Q6@  9EL  %Y;  !67   35\  $-C   Y9P
M+VL  "9O   =<@  %74   QW   $>@   'P   !^ 0  ?@<  '\,  " $P
M@1D  ((?  "")@  A"T  (0Y  "#10  @U,  (1A  "$<0  @X,  (*6  "!
MJ@  @;X  (#5  !_Y0!L7P  8U\  %M@  !18P  1V@  #UL   R<   *'0
M !]X   6>P  #'X   2     @P   (4   "'    B $  (D&  ")#   BA(
M (L8  ",'@  CB4  (\O  "//   CTH  )!9  "0:   D'L  (^/  ".HP
MC;<  (S+  ",VP!I9   860  %9H  !,;   07$  #9V   K>@  (7\  !>"
M   ,A0   X<   "*    C@   )    "2    DP   )0   "5 0  E@<  )<-
M  "8%   FAL  )PB  ">+@  GCT  )Y,  "?70  GV\  )^#  ">F   G:P
M )R^  ";S0!G:0  7&T  %%Q  !&=@  .GP  "^!   DA0  &(D   V-   #
MD    ),   "6    F    )L   "<    G@   )\   "@    H0   *("  "D
M"0  I1$  *@8  "J(@  K#   *Q   "M40  KF0  *YY  "MC@  K*$  *RQ
M  "LOP!B<0  5W8  $Q\  ! @0  -(<  "B-   <D0  $98   69    G
M )\   "A    I    *8   "G    J0   *H   "K    K0   *T   "O
ML04  +,.  "W%P  N2,  +LR  "\10  O5D  +YN  "_@0  OY0  +^D  "^
MKP!=>P  4H$  $>'   ZC@  +I0  "*9   7G@  "J(   "E    J    *H
M  "M    KP   +(   "S    M0   +<   "Y    N@   +P   "^    P
M ,,   #)!@  S!,  ,\@  #3,0  UT4  -E<  #8<P  UH8  -B5  #8H #_
M    _P   /\   #_  8 ^@ 2 /4 'P#R "H [@ U .@ /P#E $@ X0!0 -X
M6 #; %X V0!D -< :0#5 &X TP!S -( > #1 'T T "" ,X AP#- (T RP"4
M ,H G0#( *< QP"S ,4 QP## -\ P0#U +\ _P"^ /\ O@#_ +\ _P#_
M_P   /P   #V  ( [@ 0 .D &P#B "8 W  Q -H .P#8 $, U !, -$ 4P#.
M %H RP!? ,D 90#' &H Q@!N ,0 <P## '@ P@!] ,$ @P"_ (D O@"0 +T
MF "[ *( N@"M +@ OP"V -8 M0#O +, _P"R /\ L@#_ +, _P#_    _@
M /(   #H    X  * -@ %P#/ "$ S  L ,H -@#) #\ Q0!' ,( 3@"_ %4
MO0!: +P 8 "Z &4 N0!I +< ;@"V ', M0!X +0 ?@"S (0 L0"+ +  DP"O
M )T K0"H *P MP"J ,P J0#G *< ^@"G /\ IP#_ *< _P#_    \0   .4
M  #9    SP & ,4 $@#  !T O0 G +L ,0"Y #H MP!" +0 20"R $\ L !5
M *\ 6@"M %\ K !D *L :0"J &X J !S *< >0"F '\ I "& *, C@"A )<
MH "B )X L "= ,, G #> )L \P": /\ F@#_ )H _P#T    XP   -0   #(
M    O0 " +< #0"R !@ KP B *T *P"K #0 J@ ] *@ 1 "F $H I !0 *(
M50"@ %H GP!? )T 9 "< &D FP!N )H = "9 'H EP"! )8 B0"5 )( DP"=
M )( JP"0 +L CP#4 (X [ ". /P C@#_ (X _P#F    U0   ,4   "Z
ML    *H " "F !, HP = *$ )P"? "\ G  W )H /@"8 $4 EP!+ )4 4 "4
M %4 DP!: )( 7@"1 &, D !I (X ;P"- '4 C !] (L A0") (X B "9 (<
MI@"% +4 A #* (0 Y "# /8 @P#_ (, _P#;    Q@   +@   "M    I@
M *   @";  T F  8 )4 (0"3 "H D0 R (\ .0". $  C !& (L 2P"* %
MB0!5 (< 6@"& %\ A0!D (0 :@"# '$ @@!X (  @0!_ (H ?0"5 'P H@![
M +  >@## 'D W0!Y .\ >0#\ 'D _P#.    O    *T   "B    FP   )8
M  "2  < C@ 2 (L ' ") "0 AP M (8 - "$ #L @P!! ($ 1@"  $L ?P!0
M 'X 50!] %H >P!@ 'H 9@!Y &P > !T '8 ?0!U (8 <P"1 '( G@!Q *P
M< "^ &\ U0!O .L ;@#X &X _P#$    L0(  *0$  "9!0  D00  (P!  ")
M  $ A@ + (, %0"! !\ ?P G 'T +P![ #8 >@ \ '@ 0@!W $< =@!, '0
M40!S %8 <@!< '$ 8@!O &D ;@!Q &P >@!K (0 :0"/ &@ FP!G *D 9@"[
M &4 T0!E .< 9 #S &, ^0"[!@  J0L  )P.  "1$   B1   (0-  " "
M?P($ 'P #@!Z !@ =P A '4 *0!S #$ <0 W '  /0!N $, ;0!( &P 30!J
M %, :0!8 &< 7P!F &8 9 !N &, =P!B (( 8 &- %\!F@!= :@ 7 &Z %P!
MSP!; N, 6@+O %H#]@"S#P  HA0  )46  "*&   @A@  'P6  !Y$P  =@X
M '4'!P!S Q( < ,< &T$) !K!2P :04S &<&.0!F!C\ 90=$ &,'2@!B"%
M8 A6 %\)7 !="60 7 EL %H*=@!9"H$ 5PN- %8+F@!5"ZD 5 N[ %(+T !2
M"^0 4@SQ %$,^0"M%@  G1H  (\<  "$'@  ?1X  '8=  !R&@  ;Q<  &T2
M  !L# L :0P6 &8-'P!D#B< 8@XN & .-0!>#SL 71!! %P01P!:$4T 61%3
M %<26@!5$F$ 5!-J %(3= !1%(  3Q2, $X4F0!-%:D 2Q6[ $H4T0!*%.8
M2A3T $H4^P"H&P  F!X  (HB  " (P  >",  '$B  !L(   :!T  &8:  !D
M%@4 8A41 %\6&@!<%B, 6A8J %@7, !7%S< 51<] %080P!2&$D 41A0 $\9
M5P!.&5\ 3!IH $L:<@!)&WX 2!N* $<<F !%'*< 1!RY $,;SP!"&^4 0AOT
M $,:_ &C'P  E"(  (8E  !\)P  ="<  &TG  !G)0  8R(  & @  !='0$
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M S4K; ,T*W@#,RN% S(KDP,Q*Z,#+RNU RXKRP,N*N(#+BGQ!"\I^@29*0
MBBP  'TN  !S,   :C$  &(Q  !;,   5B\  %(L  !-+   22T! $4M"@!"
M+10 0"T< #TM(@ Z+2D!."PO 38M-0(U+3P"-"Y$ S,N3 ,R+U4#,"]?!"\P
M:@0N,'8$+3"$ RPPD@,K,*(#*C"T RDOR@,H+^$#*2[P!"DM^@26+   AR\
M 'LQ  !P,P  9S,  %\T  !8,P  4C(  $TP  !(,0  1#(  $ R!P \,A$
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M&@ I/B$ )S\H "4_+P$D/S8!(C\^ 2$_1@$@0$\!'T!: 1Y 90$=0'(!'$"
M 1M CP :0)\ &3^Q !@^QP 8/MX &#WO 1D\^ *,-@  ?C@  '$Z  !F.P
M73P  %4\  !./   1ST  $ ^   Y0   -$$  "Y"   J0P8 )T0/ "1%%P B
M11X (44E !]%+  >1C, '$8[ !M&1  91DT &$97 !=&8P 61G  %49^ !1&
MC0 319X $D6P !%$Q0 10]T $D+N !-!^ &(.0  >CP  &X]  !C/@  6C\
M %(_  !+0   1$   #Q#   V1   ,$4  "M'   D20( ($H+ !U+%  ;3!L
M&4PB !=,*0 63#  %4PX !-,00 23$H $$Q5  Y,8  -3&T "TQ[  I,B@ )
M2YH "$JL  =*P0 (2=@ "4CJ  I']0"#/0  =C\  &I!  !?0@  5D(  $Y#
M  !(0P  040  #E'   R20  +4H  "9,   ?3P  &5$' !12#P 24Q< $%,>
M  Y3)0 ,4RT "U,T  E3/0 '4T8 !E-1  137  #4V@  5)V  !2A@  498
M %&H  !0O   3],  $[E  %-[P!_00  <4,  &5$  !;10  4T8  $Q&  !%
M1P  /DD  #9+   O3@  *%   "%2   :5   $U<"  M:"@ '6A, !5H:  -:
M(0 "6BD  %HP  !:.0  6D(  %I,  !95P  660  %ER  !9@0  6)$  %BC
M  !7MP  5L\  %7C  !4[0!Y10  ;$<  &%(  !820  4$D  $E*  !"2P
M.DX  #)1   J5   (U8  !M9   56P  #%X!  5@"   80\  &$6  !B'0
M8B0  &(K  !A,P  83T  &%'  !A4P  85\  &%M  !@?   8(T  %^?  !>
ML@  7<D  %S@  !<[0!T2@  9TL  %U,  !43   34T  $9.   ]40  -50
M "Q8   E6@  '5T  !5@   -8P  !F4   !G!@  : P  &@3  !I&0  :A\
M &HF  !J+@  :C<  &I!  !J30  :ED  &IG  !I=P  :(@  &B:  !GK0
M9L,  &;;  !EZ@!N3P  8E   %E0  !24   2E$  $%5   X6   +UP  "9?
M   >8@  %F4   YH   &:@   &T   !O @  ;P@  ' .  !Q%   <AH  ',@
M  !S)P  =#   '0Z  !T1@  <U,  '-A  !S<0  <H(  '&5  !PJ   <+P
M '#4  !OY@!H4P  7E0  %94  !/50  1E@  #Q<   R8   *60  !]H   7
M:P  #6X   9Q    <P   '8   !W    > ,  'D(  !Z#@  >Q0  'P:  !]
M(   ?B@  ( Q  !_/0  ?TL  ']9  !_:0  ?GL  'V.  !\H@  >[8  'O,
M  ![W@!C6   6UD  %19  !*7   0&$  #5E   L:@  (6T  !AQ   .=0
M!7@   !Z    ?0   '\   "!    @@   (,"  "$!P  A0P  (82  "(&0
MB2   (LG  ",,P  BT(  (M1  "+80  C',  (J&  "*FP  B*\  (C$  "'
MU@!@70  65X  $]A  !$90  .6H  "]O   D=   &7@   Y\   %?P   ((
M  "$    AP   (D   "+    C    (T   "/    D 4  )$*  "2$   E!<
M )8?  "8*   F3<  )A(  "96   FFD  )E]  "8DP  F*@  ):[  "6S@!?
M8@  5&8  $EJ   ^<   ,G4  "=Z   <?P  $8,   6'    B@   (P   "/
M    DP   )4   "7    F0   )H   ";    G0   )X   "@!   H0H  *03
M  "G&@  J2<  *DX  "I2@  JUP  *QP  "KA0  JIH  *BL  "HO !::P
M3V\  $1U   X>P  +($  ""&   4BP  "(X   "3    E@   )D   "<
MG@   *$   "C    I    *8   "G    J0   *D   "K    K0   + '  "S
M$   MAP  +DJ  "Y/0  NU   +QE  "\>@  NX\  +J@  "ZK0!5=   2GH
M #Z!   RAP  )8T  !F3   ,F    )L   "?    H@   *4   "H    J@
M *P   "N    KP   +$   "S    M    +8   "W    N0   +P   # !@
MQ1$  ,D>  #++@  S40  ,]:  #1;P  T8(  -*2  #2GP#_    _P   /\
M  #]  , ^  0 .\ &@#K "8 Z@ P .@ .@#E $, X0!+ -X 4P#; %D V0!?
M -8 9 #4 &D TP!N -$ <@#/ '< S@!] ,P @P#* (D R0"1 ,< F0#& *0
MQ "P ,( P@#! -P OP#V +X _P"] /\ O #_ +L _P#_    _P   /L   #R
M    Z0 + .$ & #= "$ VP L -D -@#7 #\ TP!' ,\ 3@#, %0 R@!: ,@
M7P#& &0 Q !I ,, ;0#! '( OP!X +P ?@"Z (0 N0", +< E "U )X M "J
M +( N@"Q -  L #N +  _P"P /\ KP#_ *\ _P#_    ^    .T   #D
MU@ ' -  $P#, !X R0 G ,< ,0#& #H PP!" +\ 20"[ $\ N !5 +8 6@"T
M %\ L@!D +$ : "P &T K@!S *T >0"L '\ J@"' *D CP"H )D I@"E *4
MLP"D ,< HP#E *( ^@"A /\ H0#_ *$ _P#Y    ZP   -X   #/    Q0 #
M +\ #@"[ !D N0 C +8 + "S #4 L  ] *T 1 "K $H J0!0 *@ 50"G %H
MI0!> *0 8P"C &@ H@!M *$ <P"? 'H G@"! )T B@"< )0 F@"? )D K "8
M +X EP#; )8 \P"5 /\ E0#_ )4 _P#K    VP   ,P   "^    M@   +
M"0"L !0 J0 > *4 )P"D "\ HP X *$ /P"? $4 G0!+ )P 4 ": %0 F0!9
M )@ 7@"7 &, E0!H )0 ;@"3 '0 D0!\ )  A "/ (X C@": (P IP"+ +<
MB@#0 (H ZP") /T B0#_ (D _P#>    RP   +L   "Q    J0   *, ! ">
M  \ FP 9 )D (@"7 "L E@ R )4 .@"3 $  D0!& (\ 2P". %  C0!4 (P
M60"+ %X B0!C (@ :0"' &\ A@!W (0 ?P"$ (D @@"5 ($ H@"  +$ ?P#'
M 'X X@!^ /4 ?@#_ 'X _P#/    O0   *\   "E    G@   )@   "3  H
MD  4 (T '0"+ "4 B@ M (D - "( #L A@!! (4 1@"# $L @@!0 ($ 5 "
M %D ?P!> 'X 9 !\ &L >P!R 'D >@!Y (4 > "0 '8 G0!U *P = "_ ',
MV !S .X <P#] ', _P#$    L0   *0   ":    D@   (T   ")  0 A@ .
M (0 & "" "  @  H '\ +P!^ #8 ?  \ 'L 00!Z $8 > !+ '< 4 !V %4
M=0!: ', 8 !R &8 < !N &\ =@!N ($ ;0", &P F0!J *@ :0"Y &D SP!H
M .D : #W &@ _P"Y    J    )L   "0 @  B0   (0   "!    ?@ ( 'L
M$@!Y !H =P C '4 *@!T #$ <P W '$ / !P $( ;P!' &T 2P!L %$ :P!6
M &D 7 !H &, 9@!J &4 <P!D 'X 8P") &$ E@!@ *0 7P"T %\ R@!> .(
M7@#S %X _ "P 0  H 8  ),)  "("P  @0H  'L(  !X!   =@ # ', # !Q
M !4 ;P = &T )0!K "P :@ R &@ . !G #T 90!" &0 1P!C $T 80!2 &
M60!? %\ 70!G %P <0!; 'L 60"' %@ DP!7 *( 5@"R %4 Q@!5 -X 50#N
M %0 ]@"I"0  F@T  (L2  ""$P  >A,  '01  !P#0  ;0D  &P#!@!J  X
M:  7 &4 'P!C "< 80 M &  ,P!> #D 70 ^ %P 1 !: 4D 60%/ %@"5@!6
M ET 50-E %,#;P!2!'D 402% $\$D@!.!*$ 302Q $P$Q0!, ]H 2P3J $L$
M\P"C$   E!0  (87  !\&0  =!D  &T8  !I%@  9A(  &0.  !C" @ 8042
M %X&&@!<!R( 6@<I %@'+P!7!S4 50@Z %0(0 !3"48 40E, % *4P!."EL
M30MD $L+;@!*#'D 2 V% $<-DP!%#:( 1 VS $,,Q@!##-P 0@SL $,,]0">
M%0  CAD  ((<  !X'0  ;QX  &@=  !C'   7QD  %T6  !;$@( 6@X+ %<-
M%0!5#AT 4P\D %$0*P!0$#$ 3A W $T1/0!+$4, 2A)* $@240!'$UD 11-B
M $04; !"%7@ 016$ #\5D@ ^%:$ /!6R #L5QP Z%-T .Q3O #L4^ ":&
MBAX  'X@  !T(0  :R(  &0B  !>(   6AX  %<;  !5&0  4Q8& %$5$ !.
M%AD 3!8@ $H6)P!(%RT 1A<S $47.0!#&$  0AA' $$93@ _&58 /1I@ #P:
M:@ Z&W8 .1N# #@<D  V'*  -1NQ #0;Q0 S&MP -!KN #0:^ "6'   AR$
M 'LC  !P)0  9R4  & E  !:)   52(  %(@  !/'0  3!P" $H<# !''!4
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M 20KC $C*YP!(BJN 2$JP@$A*=D!(2GK 2$H]P*,)0  ?BD  '(K  !G+0
M7BX  %8N  !0+@  2BT  $4L  ! *P  .RP  #<L 0 T+ D ,2P2 "\L&0 M
M+2  *RTG "DM+0 H+30!)BX\ 24N10$D+TX!(R]8 2(O8P$A,&\!(#!] 1\P
MBP$>,)L!'2^M !POP0 ;+M@ '"WK 1PM]@*)*0  >RP  &\N  !D,   6S$
M %,Q  !,,0  1S   $$P   [,   -C$  #(Q   N,@8 *S(/ "DR%P G,QX
M)3,D ",S*P B-#( (#0Z 1\T0@$>-$P!'356 1PU80 ;-6X &C5[ !DUB@ 8
M-9H %S2L !8TP  5,]< %C+J !<R]@&&+   >"\  &PQ  !A,@  6#,  % S
M  !),P  0S,  #TT   V-0  ,#8  "PW   I-P, )3@+ "(X%  @.1L 'SDB
M !TY*0 <.C  &CHW !DZ0  8.DH %SI4 !4Z7P 4.VP $SMZ !([B  1.ID
M#SJJ  XYOP -.-4 $#?I !$W]0""+P  =3(  &DT  !>-0  538  $TV  !&
M-@  0#<  #HW   R.0  +3H  "@[   C/0  'SX( !P_$0 :/Q@ &#\? !9
M)@ 50"T $T U !) /0 10$< #D!1  U 7  ,0&D "D%W  E A0 (0)4 !S^G
M  8^N@ &/=  !SWD  D\\0!_,P  <34  &4W  !;.   43D  $HY  !#.0
M/3H  #<[   O/0  *CX  "5    ?0@  &40% !1%#  21A4 $$8<  U&(P ,
M1BH "D8Q  E&.@ '1D, !D9-  1&6  #1F4  D9S  !&@@  1I(  $6C  !$
MM@  0\T  $+@  !"[0![-P  ;3D  &$Z  !7.P  3CP  $<\  ! /0  .CT
M #0_   L00  )D,  "!%   ;1P  %$D!  Q,"0 (31( !DT9  1-(  "328
M 4TN  !--@  33\  $U)  !-50  36$  $UO  !-?@  3(X  $N@  !*LP
M2<D  $C@  !(ZP!V.P  :#T  %T^  !3/P  2S\  $1    ^0   -T$  #!$
M   I1@  (D@  !Q+   630  #D\   =2"  !4PX  %05  !4'   5",  %0J
M  !4,@  5#L  %1%  !440  4UT  %-J  !3>@  4XH  %*<  !1KP  4,4
M $_=  !.[ !P/P  9$$  %E"  !/0@  2$,  $)#   [1   ,T<  "Q)   D
M3   '4\  !91   04P  "%8   %9!@  60P  %H2  !;&   6QX  %PE  !<
M+0  7#8  %Q   !;2P  6U@  %MF  !;=0  6X8  %J8  !9JP  6,   %?9
M  !6Z@!K0P  7T4  %5%  !,1@  1D8  #]'   W2@  +TT  "=0   ?4P
M%U8  !!8   (6P   5X   !@!   8 D  &$.  !B%0  8QH  &0A  !D*
M9#   &0Z  !D1@  9%,  &1@  !D<   8X$  &*3  !AIP  8+P  &#3  !?
MYP!E2   6DD  %%)  !*20  0TH  #I-   R40  *50  "%8   86P  $%X
M  EA   !8P   &8   !H    :04  &H*  !K$   ;!4  &T;  !N(@  ;RD
M &\S  !O/P  ;TP  &Y:  !N:0  ;7L  &R-  !KH0  :K8  &K-  !IX0!?
M30  5DT  $]-  !(3@  /E$  #55   L60  (ET  !EA   09   "&<   %J
M    ;    &\   !P    <@   ',%  !T"@  =0\  '85  !X&P  >2,  'HK
M  !Z-P  >D0  'I3  !Y8@  >70  '>'  !VFP  =:\  '7%  !TVP!;4@
M5%(  $U2  !#50  .5H  "]>   D8@  &F<  !%K   &;@   '$   !T
M=P   'D   ![    ?    'T   !_ @  @ <  ($,  "#$P  A1H  (<B  ")
M*P  B#D  (=)  "'60  AVL  (9_  "%DP  A*@  (.\  ""T0!85@  4E<
M $A:   ]7@  ,F0  "=I   <;0  $G(   9V    >0   'P   !_    @0
M (0   "%    AP   (@   "*    BP   (T$  "."@  D!$  )(9  "5(0
MERX  )8^  "54   E6(  )5U  "4B@  DY\  )*T  "1Q@!76P  35\  $)D
M   V:0  *V\  !]T   4>0  "'T   "!    A    (<   "*    C    (\
M  "1    D@   )0   "5    EP   )@   ": 0  G <  )\/  "A&   I2(
M *8R  "D1@  I5@  *9K  "F@   I)8  *.J  "CO0!29   1VD  #QO   P
M=0  )'L  !>    +A0   (D   ",    CP   ),   "6    F@   )P   ">
M    H    *(   "C    I0   *8   "H    J@   *T!  "P"@  M1,  +@B
M  "X-   N$@  +I<  "[<0  NH8  +F:  "XJ@!-;@  070  #5Z   I@0
M'8<  !",   #D0   )4   "9    G0   *    "C    I@   *@   "J
MK    *T   "O    L0   +,   "T    M@   +D   "]    PP<  ,@6  #,
M)@  RSL  ,Y1  #09@  SWP  ,V.  #-G0#_    _P   /\   #\    \@ ,
M .\ %P#K "$ Z@ L .D -@#G #\ X0!' -L 30#5 %, T@!9 -  7P#. &,
MS !H ,L ;0#) '( QP!X ,8 ?@#$ (0 P@", ,  E@"^ *( O0"O +L P0"Z
M -P N #U +< _P"V /\ M0#_ +$ _P#_    _P   /<   #J    Y  ( -\
M% #< !X V@ G -0 ,0#/ #H RP!" ,@ 20#% $\ PP!5 ,$ 6@"_ %X O0!C
M +P : "Z &T N0!R +< > "V '\ M "' +( D "P )L L "I *X N0"M -(
MJP#N *L _P"J /\ J@#_ *< _P#_    \P   .H   #:    T@ $ ,P #P#)
M !H P0 C +\ + "^ #4 O  ] +@ 1 "V $L M !0 +( 50"P %H K@!> *T
M8P"K &@ J@!M *@ <P"G 'H I0"! *0 B@"B )4 H@"B *  L0"? ,< G@#E
M )T ^P"= /\ G0#_ )T _P#S    Y0   -,   #(    P    +L "@"S !4
ML  ? *X * "M #  K  X *D /P"F $8 I !+ *, 4 "A %4 H !9 )\ 7@">
M &, G !H )L ;@": '0 F !\ )< A "5 (X E "; )0 J@"2 +T D0#: )$
M] "0 /\ D #_ )  _P#D    TP   ,(   "X    L    *@ !0"D !  H@ :
M )\ (P"> "L G0 S )L .@"9 $$ F !& )8 2P"5 %  DP!4 )( 60"1 %X
MD !C (X :0"- &\ BP!V (H ?P"( (D AP"4 (< I "& +4 A0#. (0 [ "$
M /\ A #_ (0 _P#4    P    +,   "I    H0   )L  0"7  L E  5 )(
M'@"0 "8 CP N (\ -0"- #L BP!! (H 1@"( $L AP!0 (8 5 "% %D A !>
M (, 9 "! &H @ !R 'X >@!] (, >P"/ 'L G@!Z *X >@#$ 'D XP!X /@
M> #_ '@ _P#%    M    *<   "=    E0   (\   "+  8 B  0 (8 &0"%
M "$ A  I (, , "" #8 @  \ '\ 00!^ $8 ?0!+ 'L 3P!Z %0 >0!9 '@
M7P!V &4 =0!M ', =0!Q '\ < "* '  F !O *@ ;@"\ &T UP!M /  ; #^
M &P _P"Y    J0   )P   "1    B@   (4   "!  ( ?@ + 'P % ![ !P
M>0 C '@ *@!W #$ =@ V '0 / !S $$ <@!& '  2P!O %  ;@!5 &T 6P!K
M &$ :0!I &@ <0!F 'L 90"& &0 E !C *, 8P"U &( S0!A .< 80#W &$
M_P"O    H    )$   "(    @    'P   !Y    =0 & ', #@!Q !< ;P >
M &X )0!M "P :P Q &H -P!I #P 9P!! &8 1@!E $L 9 !0 &( 5@!A %T
M7P!E %X ;0!< '< 6P"# %H D !9 )\ 6 "O %< Q !7 -X 5P#R %< _0"G
M    EP$  (H$  " !@  > 4  ',#  !O    ;0 ! &H "0!H !( 9@ 9 &4
M( !C "8 8@ L &$ ,@!? #< 7@ \ %T 00!; $< 6@!, %D 4@!7 %D 5@!A
M %0 :@!3 '0 4@"  %$ C0!0 )L 3P"K $X O@!. -@ 30#L $X ^ "@ P
MCPD  (,,  !Y#0  <0T  &L,  !G"0  9 4  &, ! !A  L 7P 4 %T &P!;
M "( 60 H %@ +@!6 #, 50 X %0 /0!3 $, 4@!) %  3P!/ %8 30!> $P
M9P!* '( 20!^ $@ BP!' )D 1@"I $4 O !% -( 10#G $4 \P":"0  B@X
M 'X2  !S%   :Q0  &43  !@$@  70X  %L*  !:!08 6 $- %8 %@!4 !T
M4@ C %  *0!/ 2\ 3@$T $P".@!+ C\ 2@-% $@#3 !'!%0 101< $0%9@!"
M!7$ 009] $ &B@ ^!ID /0:I #P%N@ \!-  / /C #L#[P"5#P  AA0  'H7
M  !O&   9AD  %\8  !:%P  5A4  %02  !2#@  40H' $\'$ !-!Q@ 2P@?
M $D()0!(""L 1@DQ $4)-@!#"3P 0@I# $ +2@ _"U( /0Q; #P,9@ Z#7$
M.0U^ #<.BP V#IH - ZK #0-O0 S#-( ,@SE #(,\ "0%   @A@  '8:  !K
M'   8AT  %L<  !5&P  41H  $X8  !,%0  2A(" $D0"@!'#A, 1 X: $(/
M(0!!$"< /Q M #T0,P \$3H .A)! #D22  W$U  -11: #049  R%7  ,15\
M # 5B@ N%ID +16J "P4O0 K%-0 *Q3H "L3\P",&   ?AL  '(>  !G'P
M7B   %<@  !1'P  31X  $D<  !&&@  1!<  $(6!0! %0X /146 #L6'0 Y
M%B0 -Q8J #46,  T%S8 ,Q<^ #$81@ P&4X +QE8 "T:8@ L&FX *AM[ "D;
MB0 G&Y@ )ANI "4:O  D&M, )!GG "49] ")&P  >QX  &\A  !D(@  6R,
M %0C  !.(@  22$  $0@  !!'@  /AP  #L< 0 X&PH -AL3 #0;&@ R&R
M,!LF "X<+0 M'#0 +!T[ "H>0P I'DP *!]6 "8?8  E(&P )"!Y "(@B  A
M()< (""H !\?NP >']( 'A[F !\>\P"&'0  >2$  &PC  !A)0  6"8  % F
M  !*)0  124  $ D   \(P  .2$  #4A   R(0< +R$. "TA%@ K(1T *"$C
M "<A*@ F(C$ )2(Y "0C00 C)$H (214 " D7P ?)6L 'B5X !PEA@ ;)98
M&B6G !DDN@ 8(]$ &2/F !HB\P"#(   =B,  &DF  !>*   52@  $XH  !'
M*   0B@  #PG   X)P  ,R8  # F   L)@, *28+ "8F$P D)QH (B<@ "$G
M)P @*"X 'B@V !TI/P <*4@ &RE2 !HJ70 9*FD %RIW !8JA0 5*I4 %"JF
M !,IN0 2*-  $RCE !0G\P"!(@  <R8  &8H  !;*@  4BL  $LK  !$*P
M/BL  #DJ   T*@  +RH  "HK   F*P  (RP( " L$  >+1< '"T> !LM)0 9
M+BP &"XT !<N/  6+T8 %2]0 !,O6P 2+V< $3!U  \PA  .+Y, #"^D  LN
MMP ++<T #"WB  TL\ !])0  <"D  &,K  !8+0  3RT  $@N  !!+@  .RX
M #8M   P+0  *B\  "4P   A,0  '3$% !HR#0 8,Q4 %C,< !0T(@ 3-"D
M$C0Q ! T.@ .-$, #31-  LU6  *-60 "35R  @U@  &-)  !32A  0SLP $
M,LD !3+>  8Q[ !Z*   ;"P  & N  !5+P  3#   $4P   ^,   .#   #,P
M   M,0  )S,  "(T   =-0  &#<" !0X"@ 1.1( #CH9  PZ(  *.B< "3HN
M  @Z-@ '.C\ !3I*  0Z50 ".F$  3IN   Z?0  .HT  #F>   XL   .,8
M #?<   VZ@!V+   :2\  %PQ  !2,@  23,  $(S   [,P  -3,  # S   J
M-0  )#<  !\X   :.@  %#P!  T^!P )0 \ !D 6  1 '0 "0"0  4 K  !
M,P  0#P  $!&  ! 40  0%T  $!K  ! >@  0(H  #^;   ^K0  /<,  #W;
M   \Z@!R,   9#(  %@T  !.-0  1C8  #\V   Y-@  ,S8  "TW   G.0
M(#L  !L]   5/P  $$(   A$!@ "10T  $83  !'&@  1R   $<G  !'+P
M1S@  $="  !'30  1ED  $9G  !&=@  1H8  $:8  !$JP  0\   $+8  !"
MZ@!M-   8#8  %0X  !+.   0SD  #PY   W.0  ,3H  "H\   C/@  '$$
M !=#   110  "D@   -*!0  2PL  $P1  !-%P  3AT  $\D  !/*P  3C0
M $X^  !.20  3E8  $YC  !-<@  38,  $V5  !,J   2KT  $G6  !(Z0!H
M.0  6SH  % [  !'/   0#P  #H\   T/0  +3\  "5"   >10  %T<  !)*
M   *3   !$X   !1!   4@D  %,.  !4%   51H  %8@  !7)P  5R\  %8Y
M  !61   5E$  %9?  !5;@  57\  %61  !5I0  4[L  %'3  !0Z !B/0
M5CX  $P_  !$/P  /C\  #A    P0P  *$8  "!)   83   $DX   I1   $
M4P   %8   !8 0  608  %H+  !<$0  718  %X<  !?(@  8"H  %\T  !?
M/P  7TL  %]:  !>:0  7GH  %V-  !=H0  7+<  %K0  !9Y@!<0@  44,
M $E#  !#0P  /$,  #-&   K2@  (TT  !I1   25   "U8   19    7
M %\   !@    8@(  &,&  !D"P  91$  &<6  !H'   :20  &HM  !I.
M:44  &E3  !H8P  :'0  &>'  !FFP  9K   &3)  !CX0!71P  3D<  $='
M  !!1P  -TH  "Y.   E4@  '%8  !-9   )70   V    !C    90   &@
M  !J    :P   &P"  !N!@  ;PL  ' 0  !R%P  <QX  '4F  !U,0  =3T
M '1,  !T7   =&T  '.   !QE0  <*H  &_   !NV !32P  3$L  $9+   [
M3@  ,E,  "A7   >7   %&    ED   !9P   &H   !N    <    ',   !T
M    =@   '<   !Y    >@,  'P(  !^#@  @!4  ((=  "$)@  A#,  (-"
M  "#4@  @F0  (%X  " C0  ?J(  'VW  !\S0!13P  2T\  $!3   U6
M*UT  "!B   59P  "6L   !P    <P   '8   !Y    ?    'X   "
M@@   (0   "%    AP   (D   "+!   C0L  (\3  "2'   E28  )0V  "3
M1P  DEH  ))N  "1@@  CY@  (ZL  "-P !05   15@  #I=   O8@  (V@
M !=N   +<P   '<   !\    ?P   ((   "%    B    (H   ",    C@
M )    "1    DP   )4   "7    F0(  )P)  "?$@  HQL  *4I  "D/
MHE   *)C  "B>   H8T  )^B  ">M !*70  /V(  #-H   H;@  &W4   YZ
M   "@    (0   "(    BP   (X   "1    DP   )8   "8    F@   )P
M  ">    H    *(   "C    I@   *D   "L!P  L!   +0=  "U+P  LT4
M +-9  "U;0  MH(  +.7  "RJ0!%9P  .6T  "UT   A>P  %($   :'
MBP   )    "3    EP   )H   ">    H@   *0   "F    J0   *L   "L
M    K@   +$   "R    M0   +@   "\    P0(  ,@,  #.'0  S3,  ,U)
M  #/70  T7(  ,^&  #.EP#_    _P   /\   #W    \@ ( .\ % #I !X
MY  G .( ,0#A #L W !# -@ 2@#4 %  T !5 ,X 6@#+ %\ R0!C ,< : #%
M &T PP!S ,( >0#  (  O@"( +P D0"Z )T N "K +8 O@"V .  M0#Y +0
M_P"S /\ K@#_ *H _P#_    _@   /    #I    XP $ -L $ #3 !H T0 D
M ,\ +0#, #8 R  ^ ,0 10#! $P OP!1 +T 5@"[ %L N0!? +@ 8P"V &@
MM !N +, = "Q 'L KP"" *T BP"K )8 J@"D *@ M "I -, J #R *< _P"F
M /\ HP#_ )\ _P#\    \0   .$   #6    S@   ,, "P#  !8 O  @ +H
M*0"X #$ MP Y +0 00"Q $< KP!, *T 40"L %8 J@!: *D 7P"G &0 I@!I
M *0 ;P"B '4 H0!] )\ A@"= )  G "= )H K ": ,0 F@#H )H _P"9 /\
MF #_ )4 _P#M    VP   ,T   ##    MP   +$ !@"M !$ J@ ; *D ) "H
M "P IP T *4 / "B $( H !( )\ 30"= %$ G !6 )L 6@"9 %\ F !D )<
M:@"5 '  DP!X )( @ "0 (H C@"6 (P I0", +@ C0#< (P ^ ", /\ C #_
M (H _P#=    R    +L   "O    IP   *$  @"=  L FP 6 )D 'P"8 "<
MEP O )< -@"4 #P DP!" )$ 1P"0 $P CP!0 (T 50", %D BP!> (H 9 "(
M &L AP!R (4 >P"# (4 @@"0 (  G@!_ *\ @ #. (  [@!_ /\ ?P#_ '\
M_P#)    N    *P   "@    F0   ),   "0  < C0 1 (L &@"* "( B@ I
M (D , "( #< A@ \ (0 0@"# $< @@!+ ($ 4 "  %0 ?P!9 'T 7P!\ &8
M>P!M 'D =@!W (  =0"+ ', F !R *@ <P#" ', XP!S /L <@#_ '( _P"\
M    JP   )T   "4    C    (<   "$  , @0 , '\ % !^ !P ?0 D 'T
M*P!\ #$ >@ W 'D / !X $  =P!% '4 2@!T $\ <P!4 '( 6@!P &  ;P!H
M &T <0!K 'L :0"& &@ DP!G *, 9P"X &8 U@!F /, 9@#_ &8 _P"P
MGP   )(   ")    @@   'T   !Y    =P ' '0 $ !S !< <@ ? '$ )0!P
M "L ;P Q &T -@!L #L :@ _ &D 1 !H $H 9P!/ &4 50!D %L 8P!C &$
M; !? '8 7@"! %P C@!< )X 6P"Q %L R@!; .D 6@#[ %H _P"F    E0
M (D   "     >    ',   !P    ;0 # &H "@!I !, 9P 9 &8 ( !E "8
M9  L &( ,0!A #8 8  [ %\ /P!> $4 70!* %L 4 !: %< 6 !? %< 9P!5
M '( 5 !] %( B@!2 )H 40"K %$ P0!0 -X 4 #T %  _P"=    C0   ($
M  !X 0  <    &H   !F    9    &$ !@!?  T 70 5 %P &P!; "$ 6@ G
M %D + !8 #( 5@ V %4 .P!4 $  4P!& %$ 3 !0 %, 3P!; $T 9 !, &X
M2@!Z $D AP!) )8 2 "G $< NP!' -0 1@#L $8 ^0"5    AP0  'L&  !Q
M"   : @  &('  !>!0  6P(  %D  0!7  @ 5@ 0 %0 %@!3 !T 40 C %
M* !/ "T 3@ R $P -P!+ #P 2@!" $D 20!' %  1@!8 $0 80!# &P 00!W
M $$ A0!  ), /P"C #X M0 ] ,P /@#E #X ] "0!0  @0D  '4,  !K#@
M8@\  %P.  !7#   5 H  %$'  !0 P, 3P * $T $@!+ !@ 2@ > $@ ) !'
M "D 1@ N $0 ,P!# #D 0@ ^ $  1@ _ $T /0!5 #L 7P Z &D .0!V #@
M@P W )$ -@"A #4 L@ U ,@ -0#? #4 [P"+"0  ?0X  '$2  !F$P  710
M %84  !1$P  31$  $L.  !)"@  2 <% $8## !% A, 0P$: $$!(  _ B4
M/@(K #P",  [ S8 .@,\ #@$0P W!4L -093 #,&70 R!VD ,0=U # '@@ O
M!Y$ +0>@ "T&L@ M!,8 +0/< "T"ZP"'#0  >1,  &T5  !B%P  61<  %(7
M  !-%P  2!8  $44  !"$0  00T  $ *!P ^" X / @6 #H('  X""$ -@DG
M #4)+0 S"3, ,@HZ #$+00 O#$D +@Q3 "P-70 K#6D *0YV "</A  F#Y,
M) ZC "0-M  C#<@ (@S= "(,ZP"$$@  =A8  &D8  !>&@  51H  $X;  !)
M&@  1!D  $ 8   \%@  .A0  #D1 @ W$ D -0X1 #,.%P Q#QX +Q D "X0
M*@ L$3$ *Q$X "D20  H$T@ )A-2 "447  C%&@ (A5U " 5@P ?%9( 'A6C
M !T4M0 ;$\H &Q/@ !P3[@"!%0  <QD  &8;  !;'0  4AT  $L=  !%'0
M0!T  #L<   W&@  -!D  #,6   P%@0 +A4, "P5$P J%1H *!8@ "86)@ D
M%RT (Q<U "(8/0 A&$8 'QE0 !X96@ =&F8 &QIS !H;@0 9&I$ %QJB !89
MM  5&<D %1C? !88[P!^&   <!L  &,>  !8'P  3R   $@@  !"(   /"
M #<?   S'@  ,!T  "T;   J&P$ )QL( "0;$  B&Q8 (!L< !\<(P >'"L
M'1TR !L=.P :'D0 &1Y. !@?60 6'V4 %1]R !0@@  2'Y  $1^A ! >LP /
M'L@ #AW> ! <[@![&@  ;1X  & @  !5(@  32,  $4C   ^(P  .2(  #0B
M   P(0  +"   "@@   D(   (2 % !X@#  <(10 &B$: !@A(0 7(B@ %B(P
M !4C.  4(T( $R-, !$D5P 0)&, #B1P  PE?@ +)(T "B2>  DCL  ((L0
M""+:  DAZ@!X'0  :B   %TC  !2)   2B4  $(E   [)@  -B4  #$D   L
M)   *"0  ",D   ?)0  '"4" !DF"0 6)Q$ %"<8 !(G'P 1*"8 #R@M  TI
M-@ ,*3\ "RE)  HI5  (*5\ !RIL  4J>P $*HH !"F;  ,HK  ")\$  B;7
M  ,FYP!U(   9B,  %HE  !/)P  1R@  #\H   X*   ,R<  "XG   I)P
M)2<  " H   ;*0  %RH  !,L!P /+0X #"T6  HM'  )+B, !RXJ  8N,@ %
M+SL !"Y%  ,N4  !+EP  "]I   O>   +X@  "Z8   MJ@  ++X  "O5   K
MY@!Q(P  8R8  %<H  !,*0  1"H  #PK   V*@  ,"H  "LJ   G*0  (BH
M !TL   8+0  %"\   XQ!@ (,PP !3,4  ,S&@ !-"   #0G   T+P  -#@
M #1"   T30  -%D  #1F   T=0  -(4  #.6   RJ   ,;P  #'3   PYP!M
M)P  7RD  %,K  !)+   02T  #DM   S+0  +BT  "HL   D+0  'RX  !HP
M   5,@  $#0   DV!0 $. L  #D1   Y%P  .AX  #HD   Z+   .S0  #L^
M   Z20  .E8  #IC   Z<@  .H(  #J4   XIP  -[H  #;2   UY@!I*@
M6RT  $\N  !&+P  /3   #8P   Q+P  +"\  "<P   A,0  &S,  !8U   1
M-P  "CH   4\!0  /0H  #\0   _%0  0!L  $$A  !!*0  03$  $(Z  !!
M1@  05(  $!@  ! ;P  0'\  $"1  ! I0  /KD  #S1   [YP!D+@  5S
M $LR  !",P  .C,  #0S   O,@  *C,  ",T   =-P  %SD  !$[   +/@
M!4    !"!   1 @  $4-  !&$@  2!@  $D>  !))0  22T  $HV  !)00
M24X  $A<  !(:P  1WP  $>.  !'H@  1;@  $31  !"Y@!?,@  4C0  $@U
M   _-@  .#8  #,U   M-@  )C@  !\Z   8/0  $D    M"   %10   $<
M  !) @  2P8  $P*  !.#P  3Q0  %$:  !2(   4B@  %(R  !2/   44D
M %!7  !09P  3W@  $^*  !/GP  3K4  $S/  !+YP!9-P  33@  $0Y   \
M.0  -S@  #$Y   I.P  (3X  !E!   31   "T<   5*    3    $\   !1
M    4@,  %0'  !6"P  5Q$  %D6  !;'   7"0  %PM  !;-P  6D,  %I2
M  !98@  67,  %B&  !7F@  5[   %?+  !4Y0!3/   23P  $$]   [/
M-3P  "P_   D0@  '$8  !-*   ,3   !4\   !2    50   %<   !9
M6P   %T#  !>!P  8 L  &(1  !D%P  91X  &8G  !F,0  93T  &1+  !D
M7   8VX  &*   !AE0  8:L  &#%  !@X0!.0   1D   #]    Y0   ,$,
M "='   >2P  %4\   M3   %5@   %D   !<    7@   &$   !C    90
M &8   !H @  :08  &L+  !N$0  ;Q@  '$@  !Q*@  <38  '!$  !P5
M;V8  &YY  !MC@  ;*0  &N[  !KU@!+10  1$0  #Y$   T2   *TP  "%0
M   750  #%D   -=    8    &,   !F    :0   &P   !N    ;P   '$
M  !S    =    '8$  !X"0  >A$  'P8  !_(@  ?RT  'X[  !^2P  ?5X
M 'QQ  ![A@  >IP  'BS  !WRP!)20  0T@  #E,   N40  )%8  !E;   -
M8    F4   !H    ;    &\   !S    =@   '@   !Z    ?    'X   "
M    @@   (0   "&    B 8  (L-  ".%P  D2(  ) O  "00   CU(  (UG
M  ",?   BY(  (FG  "'O !(30  /5$  #-6   H7   '&$   ]G   ";
M '(   !V    >0   'T   "     @@   (4   "'    B@   (P   "-
MCP   )(   "4    E@   )D#  "=#   H!8  *0B  "C,P  HD<  *!<  "?
M<   GH8  )V;  ":K@!#5@  -UL  "QB   ?:   $VX   5T    >@   '\
M  "#    AP   (H   "-    CP   )(   "4    E@   )D   ";    G0
M )\   "A    I    *<   "K 0  KPH  +05  "W)@  M3L  +)1  "R9@
MLGL  +*/  "OH@ ]80  ,6<  "5N   8=0  "7L   ""    AP   (P   "0
M    DP   )8   "9    G    )X   "A    HP   *4   "G    J@   *P
M  "N    L    +0   "X    O0   ,0)  #+&0  RBX  ,='  #(6P  RG
M ,R#  #)E@#_    _@   /P   #X    [P $ .@ $ #F !L X0 E -\ +@#?
M #< V@ _ -4 1P#2 $T SP!2 ,P 6 #* %P R !A ,8 9@#$ &L P@!P ,
M=@"^ 'T O "% +D C@"V )H M "H +( NP"P -D K@#W +( _P"K /\ I0#_
M *( _P#\    ]P   .\   #H    V@   -0 "P#. !8 S  @ ,H *@#) #,
MQ@ [ ,( 0@"_ $D O0!. +L 4P"Y %@ MP!< +4 80"T &8 L@!K +  <0"O
M '@ K0!_ *H B0"H )0 I@"A *0 L@"B ,P H0#N *, _P"@ /\ FP#_ )@
M_P#T    Z@   -T   #,    Q0   +T !@"Z !( MP < +8 )0"U "X M  V
M +$ /0"N $, K !) *H 3@"I %( IP!7 *8 6P"D &  HP!E *$ ; "@ '(
MG@!Z )P @P": (X EP"; )8 J@"4 ,  DP#B )0 _P"5 /\ D #_ (X _P#E
M    U@   ,@   "Y    L    *L  @"H  P I0 7 *0 ( "C "@ HP P *$
M-P"> #T G !# )L 2 "9 $T F !2 )< 5@"5 %L E !@ ), 9@"1 &T CP!T
M (X ?@", (@ B@"5 (@ I "& +< A #4 (4 ]@"' /\ A0#_ (, _P#2
MP0   +$   "H    H    )L   "7  < E0 1 )0 &@"3 ", D@ J )( ,0"0
M #< C@ ] (T 0@"+ $8 B@!+ (D 4 "( %4 AP!: (4 7P"$ &8 @@!N ($
M=P!_ ($ ?0". 'L G0!Z *X > #( '@ ZP!Y /\ >0#_ '@ _P#!    L0
M *(   "9    D@   (T   ")  , A@ , (4 %0"$ !T A  D (0 *P"" #$
M@  W 'X / !] $  ? !% 'L 20!Z $X > !4 '< 6@!V &  = !H ', <0!Q
M 'L ;P"' &T E@!L *8 :P"] &L X !L /X ; #_ &P _P"S    H0   )4
M  ",    A0   (    !]    >@ ' '@ $ !W !@ =0 ? '4 )@!U "P <P Q
M '( -@!Q #L <  _ &\ 1 !M $@ ; !- &L 5 !J %L : !C &8 :P!D '8
M8P"! &$ D !@ *  7P"T %\ U0!? /4 7P#_ &  _P"F    E@   (H   "!
M    >@   '4   !Q    ;@ # &L "P!J !, :0 : &D ( !I "8 9P L &8
M,0!D #8 8P [ &( /P!A $0 8 !) %\ 3@!= %8 7 !> %H 9P!9 '$ 5P!\
M %4 BP!4 )H 4P"M %0 R@!4 .L 5 #_ %0 _P"<    C0   ($   !X
M<    &H   !G    8P   &$ !@!@  T 7@ 5 %T &P!= "$ 7  G %L + !:
M #$ 60 V %@ .@!7 #\ 5@!$ %0 2@!3 %  4@!: %  8@!. &T 30!X $L
MA@!* )8 20"G $H P !* .  2@#X $H _P"4    A0   'D   !O    9P
M &$   !=    6@   %@  @!6  D 50 0 %0 %@!3 !P 4P B %( )P!1 "P
M4  Q $\ -@!- #L 3 !  $L 1@!* $P 2 !5 $< 7@!% &D 0P!T $$ @@!
M )$ 00"D $$ N0!! -4 0 #P $  _@",    ?@   ',!  !H P  7P0  %D#
M  !5 @  4@   %    !.  4 30 + $P $@!+ !@ 2@ > $D (P!( "@ 1@ M
M $4 ,@!$ #< 0P \ $$ 0@!  $D /P!1 #T 6P [ &4 .0!Q #@ ?P V (X
M. "@ #@ LP W ,P -P#G #< ]P"'    >00  &P'  !B"0  60D  %,)  !.
M"   2@8  $@#  !'  $ 10 ' $0 #0!" !0 00 9 $  '@ _ ", /0 H #P
M+@ [ #, .0 Y #@ /P W $8 -0!/ #0 6  R &, ,0!O #  ?0 P (P +P"<
M "\ K@ N ,, +@#= "X [P""!   = D  &@+  !=#0  50X  $X.  !(#0
M1 P  $$)   _!P  /@0# #P "0 [  \ .0 5 #@ &@ V !\ -0 D #0 *@ R
M "\ ,0 U #  /  N $, +0!, "P 5@ J &$ *0!M "@ >P G (D )P"9 "8
MJ@ E +X )@#7 "8 ZP!_"   < P  &00  !9$0  4!,  $D3  !$$@  /Q$
M #L/   X#0  -@H  #4'!0 T!0H ,@,0 #$#%@ O AP +@,A "P#)@ K RP
M*00R "@$.0 G!4$ )09+ "0'50 C!V  (@=M " (>@ ?"(D '@B9 !T'J0 =
M!;P '0/3 !T!YP![#   ;1   & 3  !6%   318  $86   _%@  .A4  #84
M   S$@  ,!   "X. 0 M"P4 + D+ "H($@ H"1@ )@D= "4)(P C"BD (@HP
M "$+.  @"T$ '@Q* !T-50 ;#6$ &0YN !@.?0 6#HP %0Z< !4-K  4#+X
M% O3 !0*Y !X$   :10  %T5  !2%P  2A@  $(9   \&0  -A@  #(7   N
M%@  *Q4  "D3   G$@( )1 & ",0#  A#Q0 'P\: !X0(  <$"< &Q$O !H2
M-P 9$D  %Q-* !845  4%&  $A1M !$5>P 0%8L #A2;  P4K  +$[\ "A+4
M  L1YP!U$P  9A8  %H8  !0&@  1QL  #\<   X&P  ,QL  "X:   J&0
M)Q@  "07   A%@  'Q4# !P5"  :%1  &!46 !<6'0 5%B0 %!<L !,7-0 2
M&#X $1A(  X94@ ,&5X "QIJ  D:>  (&H< !QF7  89J  %&+P !!?1  46
MXP!R%0  8QD  %<:  !-'   1!T  #P>   U'@  ,!T  "L<   G'   (QL
M " :   =&@  &1H  !<:!0 4&PP $AL4 ! <&P .'"( #!PI  L=,0 *'3H
M"1Y$  @>3@ &'EH !!]G  ,?=0 !'X0  1Z5   =I@  '+D  !S/   ;X@!O
M&   8!L  %0=  !*'P  02   #D@   S(   +1\  "@?   D'@  (!T  !T=
M   :'0  %1X  !$@!  .( H "B$2  DA&  '(1\ !B(F  0B+@ #(S8  B-
M  $C2P  (U<  "-D   C<P  )((  ".3   BI   (;<  "#-   ?XP!K&@
M71X  %$@  !'(0  /B(  #8B   P(@  *R$  "8A   B(   'B   !L@   7
M(0  $B(   TD!  ))@D !280  ,G%@  )QT  "<C   H*P  *#,  "D]   H
M2   *%0  "AB   H<   *(   "F1   GHP  );8  "3-   DX@!H'@  6B
M $XB  !$)   .R4  #,E   M)   *"0  "0C   @(@  '2(  !@C   4)0
M#B<   HH!  %*PD  "P.   M%   +1H  "TA   N*   +C   "\Z   O1
M+E$  "U?   N;@  +7X  "Z/   NH@  ++8  "K+   IXP!D(0  5B,  $HE
M  ! )P  ."<  #$G   K)@  )B8  "(E   >)0  &B8  !4H   0*@  "BP
M  4N!   , @  #$,   S$@  -!@  #0>   U)0  -2T  #4V   U00  -4X
M #1<   S:P  ,WL  #.-   SH   ,;4  ##-   NXP!?)0  4B<  $<I   ]
M*@  -2H  "XI   I*0  )2@  " H   ;*0  %BL  !$M   +,   !C(   $T
M P  -@<  #<+   Y$   .A4  #L;   \(@  /"H  #PS   \/0  /4D  #M8
M   Z:   .G@  #F+   YG@  .;0  #?-   UY0!:*   3BL  $,L   Y+0
M,BT  "TL   H*P  (RL  !TM   8+P  $C$   LT   &-@   3@    [ @
M/ 4  #X)  ! #0  01(  $,8  !$'P  1"8  $0O  !$.@  1$4  $-4  !"
M9   0'4  $"(  ! G   0+(  #_-   ]YP!5+0  22X  #\P   V,   ,"\
M "PN   F+@  'S   !DS   3-0  ##@   8[    /0   $    !"    1 ,
M $4&  !'"@  20\  $L5  !-&P  32(  $TK  !--0  34$  $Q/  !*7P
M27$  $F$  !(F   2*X  $C)  !'Y@!0,0  13(  #LS   T,P  +S$  "DR
M   B-   &C<  !0Z   ,/0  !D    !"    10   $@   !*    3    $X#
M  !/!P  40L  %,1  !6%@  6!T  %@F  !8,   6#L  %=(  !560  4VP
M %)_  !2E   4:H  %'%  !0XP!*-@  0#8  #DV   S-0  +34  "4X   <
M.P  %#\   U"   &10   $D   !,    3@   %$   !3    50   %<   !9
M P  6P<  %T+  !?$0  8A@  &,@  !C*@  8C8  &)#  !@4P  7V8  %U[
M  !<CP  7*4  %N^  !:W0!&.@  /3H  #<Y   R.0  *3P  !]    61
M#4@   9+    3P   %(   !5    6    %H   !=    7P   &$   !C
M90(  &<&  !I"P  ;!(  &X:  !O(P  ;R\  &X\  !L3   :UX  &IS  !I
MB   :)X  &>V  !FTP!"/@  /#T  #8]   M0   (T4  !E)   .3@  !5(
M  !6    6@   %T   !@    8@   &4   !G    :0   &L   !M    <
M '(   !T!@  =PL  'H3  !\'   ?"<  'LU  !Z1   >58  'AK  !W@
M=I8  '2L  !SQ0!!0@  .T(  #%%   G2@  '$\  !%4   %60   %X   !A
M    90   &D   !L    ;P   '(   !T    =@   '@   !Z    ?    'X
M  "     A (  (8)  ")$@  C!T  (PJ  "+.@  BDP  (E@  "'=@  AHP
M (6B  "#N0!!1@  -DH  "M0   @50  %%L   =@    9@   &L   !O
M<P   '8   !Z    ?0   (    ""    A0   (<   ")    BP   (X   "0
M    DP   )8   ":!@  G1$  *(=  "A+   GS\  )Y4  "<:@  FH   )B5
M  "7J@ [3P  ,%4  "5;   880  "F@   !N    =    'D   !]    @0
M (4   "(    BP   (X   "0    DP   )4   "7    F@   )P   "?
MH@   *4   "I    K@4  +,1  "X'@  MS(  +1'  "R7@  L',  *^(  "N
MFP U6@  *6$  !QH   .;@   '8   !\    @@   (<   "+    CP   ),
M  "6    F    )L   ">    H0   *,   "F    J    *L   "N    L
M +0   "Y    OP   ,4$  #.$0  T20  ,T[  #(4P  R&@  ,A]  #(CP#[
M    ]P   /4   #R    [    .4 "P#B !< X  B -\ *P#? #0 V@ \ -8
M0P#2 $H SP!/ ,P 50#* %H QP!> ,4 8P## &@ P0!N +\ = "] 'L N@"$
M +@ C@"V )H LP"I +  O@"M -X JP#Z *H _P"A /\ G@#_ )H _P#T
M[P   .L   #?    U    ,\ !P#+ !, R0 = ,@ )@#' "\ Q0 W ,  /@"]
M $0 NP!* +D 3P"W %0 M0!9 +0 70"R &( L !H *\ ;@"M '4 JP!] *D
MAP"G )( I0"A *( M "? -( G0#T )L _P"6 /\ DP#_ )  _P#K    Y0
M -,   #&    O@   +D  @"V  T M  7 +( (0"Q "D L0 Q *X . "L #X
MJ@!$ *@ 2 "F $T I0!1 *0 5@"B %L H !A )X 9P"< &X FP!V )D ?P"7
M (L E0"8 )0 J@"2 ,4 D #J (X _P"* /\ A@#_ (4 _P#@    S@   +T
M  "R    JP   *8   "B  < H0 2 *  &P"? ", GP K )P ,@"9 #@ EP ^
M )4 0P"4 $< D@!+ )$ 3P"0 %0 CP!9 (X 8 ", &@ B@!O (D >0"' (,
MA0"1 (0 H0"" +8 @0#; (  ^P"  /\ ? #_ 'L _P#+    MP   *H   "A
M    F@   )4   "2  , D  , (T %0", !X C  E (P + "* #( B  X (<
M/0"% $$ A !& (, 2@"" $X @0!3 (  60!_ &  ?0!I 'L <@!Z 'T > ")
M '8 F0!T *P <P#, '( \0!Q /\ < #_ &\ _P"X    IP   )L   "2
MBP   (8   "#    ?P ' 'X $ !] !@ ?0 ? 'T )@![ "T >0 R '@ -P!W
M #P =@!  '4 10!S $D <@!. '$ 5 !P %H ;P!A &T ; !K '< :0"# &<
MD@!F *, 90"^ &0 Y0!C /\ 9 #_ &, _P"H    F0   (T   "%    ?@
M 'D   !T    <@ # '  "P!O !, ;@ : &X (0!N "< ;0 L &L ,@!J #8
M:0 [ &@ /P!G $0 9@!) &4 3P!C %4 8@!< &$ 90!? '( 70!^ %L C !9
M )T 5P"T %< U@!7 /< 6 #_ %D _P"=    C@   (,   !Y    <@   &L
M  !H    90   &, !@!B  T 8@ 5 &( &P!B "( 80 G &  +0!? #( 7@ V
M %T .P!; #\ 6@!% %D 2@!8 %$ 5P!8 %4 8 !4 &L 4@!Y %  AP!. )<
M3 "L $L R0!+ .X 3@#_ $X _P"3    A0   'D   !O    9@   &$   !=
M    6@   %D  @!8  D 5P 1 %< %P!7 !T 5P B %4 )P!4 "P 4@ Q %$
M-@!0 #H 3P!  $X 10!, $P 2P!3 $H 7 !( &8 1P!T $4 @@!# )( 00"F
M $  OP!  .0 0P#^ $0 _P"+    ?0   '$   !F    7@   %<   !3
M40   $\   !.  8 30 + $T $@!, !< 3  = $L (@!* "< 2  K $< , !&
M #4 1  [ $, 00!! $@ 0 !/ #\ 6  ] &( / !P #H ?@ X (T -P"A #<
MN  Y -L .@#W #H _P"$    =@   &H   !?    5@   %    !,    20
M $<   !%  ( 1  ' $, #0!" !, 0@ 8 $$ '0!  "( /@ G #T *P [ #
M.@ V #@ /0 W $0 -@!, #0 50 S %X ,@!M #$ >@ P (H +P"< "X L0 P
M ,X ,0#M #( _P!^    <    &0"  !9!   404  $H%  !%!   00(  #X
M   ]    .P $ #H "0 Y  X .  3 #< &  U !T ,P B #( )P Q "P ,  Q
M "\ .  M $  + !( "L 40 J %P *0!I "@ =P G (< )P"9 "< K  H ,0
M* #C "@ ]P!Z    ; 0  %\&  !4"   3 D  $4)   _"0  .P@  #<&   U
M!   ,P(! #( !0 P  H +P / "X %  M !D +  > "H (P I "@ *  N "<
M-  F #T )0!% ", 3P B %H (0!G "  =0 @ (4 'P"5 !\ IP ? +P 'P#9
M !\ [P!V P  9P<  %L*  !0#   2 T  $ -   Z#0  -0P  #$+   N"0
M+ @  "H& P I P8 * (+ "<!$  F !4 )  : ", 'P B "4 (  K "  ,@ ?
M #H '@!# !T 30 ; %@ &@%E !D <P 8 (( & "2 !< HP 7 +< %@#/ !8
MY@!R!@  9 H  %<-  !-$   1!$  #P1   V$0  ,1   "T/   I#@  )@P
M "0+ 0 B"00 (0<' " %"P >!1$ '046 !P%'  ;!2( &@4H !D%+P 8!3@
M%P5! !8&3  4!U< $P=D !$(<@ 0"($ #P>1  X&H@ .!;0 #@/*  \!X@!N
M"@  8 P  %00  !*$P  010  #D4   S%   +1,  "D3   E$@  (1$  !\/
M   <#@( &PP% !D+"  8"@T %@D3 !4)&  4"A\ $PHF !(*+@ 1"S< $ Q!
M  T-3  +#E@ "0]D  @/<@ '#X$ !@Z1  8-H@ %#+0 ! O)  4)W0!K#0
M71   %$3  !'%0  /18  #86   O%@  *A8  "45   A%   'A,  !L2   8
M$@( %A$$ !00!@ 1#PD #@X.  T0%@ ,$!T "Q$D  H2+  )$C4 "!,^  <3
M20 %%%0  Q1A  (5;P !%7X  !2/   3H   $K(  !''   0W0!H$   6A(
M $X5  !$%P  .A@  #,9   M&   )Q@  "(7   >%@  &Q4  !@5   5% (
M$Q0% ! 3!@ ,% @ "14,  @5$P &%AH !18A  07*  #%S$  A@[  $810
M&%$  !E>   9;0  &7T  !F-   8GP  %K$  !7'   4W0!E$P  5Q4  $L8
M  !!&@  .!L  # ;   J&@  )!H  " 9   <&   &1<  !87 0 3%@, $18$
M  P7!0 (& < !1H+  ,;$0 !&Q@  !L>   <)@  '2X  !TX   =0P  'DX
M !U<   =:P  '7L  !V,   =G@  &[$  !G&   8W@!B%0  5!@  $@:   ^
M'   -1T  "X=   G'   (AP  !X;   :&@  %QD  !48 @ 1&0( #1H#  D;
M!  %'0<  1X*   @$   (18  "$<   A(P  (BL  "(U   C0   (TP  "):
M   B:0  (GD  "&+   AG0  (;$  !_(   =W@!>&   41L  $4=   Z'P
M,A\  "L?   E'@  (!T  !P<   9&P  %AL  !(;   .'0  "AX!  4@ P !
M(@8  "0)   F#0  )Q0  "<:   H(0  *"D  "@R   H/0  *4D  "E6   G
M9P  )G@  ":)   FG0  )K$  "3*   BX@!:&P  31X  $$@   W(0  +R$
M "@A   C(   'Q\  !P>   8'@  %!X   \@   *(0  !B,   (E @  )P4
M "H(   L#   +A(  "X8   N'P  +R8  "\O   O.@  +T8  #!3   N9
M+'8  "R'   LFP  *[   "O*   HY !6'P  22$  #XC   T)   +"0  "8C
M   B(@  'B$  !H@   5(0  $",   LE   &)P   2D    L 0  +@0  # '
M   R"@  -!   #46   V'   -B0  #8L   W-P  -T(  #=/   V8   -'(
M #*%   RF0  ,:\  #'*   QY@!1(P  124  #HG   Q)P  *B8  "4E   A
M)   '2,  !<E   2)P  #"D   8K   !+@   #     S    -0(  #<%   Z
M"   / P  #X2   _&   /R   #\H   _,P  /SX  #]+   _6@  /&X  #J#
M   YE@  .:T  #C)   XYP!,)P  0"D  #8J   N*0  *"@  "0G   ?)P
M&2@  !,J   ,+0  !S    $S    -@   #@    [    /0   #\"  !!!0
M0PD  $8.  !(%0  2!P  $@D  !(+@  2#H  $A'  !(50  16D  $-^  !"
MDP  0:H  $#'  ! Y@!'*P  /"T  #,M   L+   *"H  "(J   ;+   %2\
M  TR   '-0   3@    [    /@   $$   !#    10   $@   !* P  3 8
M $X+  !1$0  4Q<  %,@  !3*0  4S4  %-"  !24   3V0  $UX  !+CP
M2J8  $K!  !)XP!",   .#$  # P   L+@  )BX  !XQ   7-   #S<   <[
M    /@   $$   !$    1P   $H   !,    3P   %$   !3    50,  %<'
M  !:#   71,  %\;  !?)   7R\  %X\  !>2P  7%P  %ER  !7B   5I\
M %6Y  !4V@ ]-   -30  # R   J,@  (34  !@Y   0/   !T    !$
M2    $L   !.    4@   %0   !7    6@   %P   !>    8    &,!  !F
M!0  :0L  &P3  !N'   ;B<  &TU  !L0P  :E0  &=J  !E@0  8YD  &*Q
M  !ASP Z.   -#<  "\V   E.0  &SX  !!#   (1P   $L   !0    5
M %<   !:    70   &    !B    90   &<   !I    ;    &X   !Q
M= 8  '@,  ![%@  ?"   'LM  !Z/   >$P  '9A  !T>   <I$  '"G  !O
MP0 Y.P  -#L  "D^   >0P  $TD   =/    4P   %<   !<    7P   &,
M  !F    :0   &P   !O    <0   ',   !V    >    'L   !]    @0
M (0%  "(#0  BQ@  (PD  "*,P  B$0  (99  "$<   @H@  (&=  !_M  Y
M/P  +D,  "-)   83P  "U4   !;    8    &0   !H    ;    '    !T
M    =P   'H   !]    ?P   ($   "$    A@   (@   "+    C@   )(
M  "6 @  F0P  )T9  "=*   FSD  )E-  "78P  EGL  )20  "2I@ S20
M*$X  !Q4   06P   F(   !H    ;0   '(   !W    >P   '\   "#
MA@   (D   ",    CP   )$   "4    E@   )D   "<    H    *0   "H
M    K0   +(+  "W&@  M2L  +-   "P5@  KFT  *N#  "JEP M5   (5L
M !5A   &:    &\   !V    ?0   ((   "'    BP   (X   "2    E0
M )@   ";    G@   *$   "C    I@   *D   "L    L    +0   "Y
MP    ,@   #2"P  V1L  -4Q  #02   RV   ,AU  #&B
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MZ.GJZ^SM[N_P\?+S]/7V]_CY^OO\_?[_;69T,0     #!"$   $
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MYN?HZ.GIZNOK[.SM[N[O[_#P\?+R\_/T]/7V]O?W^/CY^?K[^_S\_?W^_O\
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MLXKP^K8? ?:[/@_UO4,I]KU(2?>[4&SROT^ Z,E-C-O8.*C,STJ^P\9?SL#
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MOWW:C[]]VH^_?=J/OWW:C[]]VH^_?=J/OWW:C[]]VH^_?=J/OWW:];H> /+
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M@,=^RH#'?LJ QW[*@,=^RH#'?LJ QW[*@,=^RH#'][,* /:[-@?TO4 ;[L1
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M6G?_.&1N_CIL9OL\<E_X/G=:]D%Z5O5%?53T2']2\TV 4?-1@%#S5H!0\UN
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MK86I=KIUHG[$<*.4Q6^FK<-UH++"=YFRPWB4LL)ZD;/!?(ZTP'R.M,!\CK3
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M=WI*]X%Z2?>.>4GWCGE)]XYY2?>.>4GWCGE)]XYY2?>.>4GWCGE)]XYYX:0
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M337_74TU_UU--?]=337_74TU_UU--?]=337_74TU_UU-O\,  ++2  "CW
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M?:V'B(6V@H>5N'^(J+A^B+JW@(:[MH*&O+2#A;ZRA(2_L(6$P*Z%A,"NA83
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MP811Z].#4^#8A535W(A4U=R(5-7<B%35W(A4U=R(5-7<B%35W(A4U=R(_Y
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M9SW_J&8]_ZAF/?^H9CW_J&8]_ZAF/?^H9CW_J&8]_ZAFVJ,  ,RT  #!PP
MM=$  *C=  "=_PT#E/\9"XK_'Q=__R0C=?\F+VK_*#E?_RI"5_\M2E'_,5!+
M_S542/\[6$7_0%I"_T9;0/],7#[_4UP\_UM<._]D6SG_;5LX_W=:-O^#6C7_
MCEDU_XY9-?^.637_CEDU_XY9-?^.637_CEDU_XY9SJX  ,*]  "WS   J=@
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M=$[2YW=/S>=X3\WG>$_-YWA/S>=X3\WG>$_-YWA/S>=X_X8  ?26  #6IP
MS+4  ,+" 0"YT 0 K^T- *CR)0:?\S 3E?0V(HKS.C%_\SP_=/(^3&?R0%=<
M\4)A4_)':4WR3VY)\UIO1O5G;T7U=VY#]HIM0_>>:T+XM&I!^M%I1?7B:$GJ
MYVA)Y.EJ2>3I:DGDZ6I)Y.EJ2>3I:DGDZ6I)Y.EJ_XP  -J?  #-KP  P[P
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M1B?_J48G_ZE&)_^I1B?_J48G_ZE&R:X  +Z[  "RR0  I-(  );;  ")YP
M?_X" W7_" AK_PX.8O\4%5G_&!Y1_QPE2?\A*T/_)3 ]_RDT./\M-S7_,SDS
M_SDZ,/\_.R[_1CLK_TX[*?]6.RC_8#LE_VHZ(_]U.B'_@CD@_XHY(/^*.2#_
MBCD@_XHY(/^*.2#_BCD@_XHYO[@  +3%  "FSP  F-@  (G?  !\Z@ !<OX
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MAEF@W(A;F]N)6YK;B5N:VXE;FMN)6YK;B5N:VXE;FMN)_W(#!/]^!@+ZD 4
MVIX  -&J @#*M0( PL   +G+"0"QSR0$J,XT$I[,/R.5RD<TB\9-1('#4E-V
MP%9A:[U:;F"[7WA8N6A^5;IV?U2[AWY3O)I]4KRN>U&]RGE1N^9Z4[/D?52M
MXG]6I^& 5J;A@5:FX8%6IN&!5J;A@5:FX8%6IN&!_W0"!/^% @'BE@  TZ0
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M6T3<]EM$W/9;1-SV6T3<]EM$W/9;Z(T  -.>  #'K   OK@  +3$  "HS@
MG=<" )3R#P&+]1T&@_8F$7KV+1UP]C$I9?8U-%OU.#Y2]CM&2_9!347W25%"
M^%)3/_E=4SWY:E([^GI1.ON,4#G\H$\X_+5../W33#?^[4L[]_E*//;Z2CSV
M^DH\]OI*//;Z2CSV^DH\]OI*V9<  ,JH  # M0  ML   *K+  "=TP  D=L
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M>1P-_WD<LL   *7*  "5T0  AMD  'C@  !KYP  7^\  5;_  1-_P '1?\
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MW8=?AMV&8(3=AF"$W89@A-V&8(3=AF"$W89@A-V&_V('"/]R P/_A 0 X)
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M<U*AZW-2H>MS4J'K<U*AZW-2H>MS_W   _*%  #8DP  S:   ,2K  "[M
ML;P  *?% @"?S!0 F,TI!I#,-A.'RC\A?\A&,77&2SYJPT]+8,%45U? 6F!1
MOV-E3[]P9DW ?V5-P9!D3,*C8DO#N&%+P]E?2,'T84FY]61+L_-G3*_R:$RO
M\FA,K_)H3*_R:$RO\FA,K_)H_WD  -Z,  #1F@  QJ<  +VQ  "TN@  J<(
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M21@-_U07"_]?%@C_;!4&_W@4!/^#$P3_@Q,$_X,3!/^#$P3_@Q,$_X,3K[X
M *''  "2S@  @]4  '3=  !GXP  6^D  %#P  %(_@ $0/\ !SC_  HR_P -
M+?\ #R?_ !$C_P03'_\)%!O_#A08_Q05%O\9%1+_'A4,_R05"/\J%03_,A0
M_SP3 /]%$@#_3Q( _UD1 /]@$ #_8!  _V 0 /]@$ #_8!  _V 0_SL5$O\P
M'A?_)BL:_RDM'/\I,Q[_)CL@_R)&(O\B5"3_(F$G_R)O*O\A>RO_((<L_R&1
M+/\BFBS_(J,L_R.J+/\DLRS_)+LL_R7%+/\FTBS_)M\K_R?K*_\H]BO_*?\J
M_RG_*?\J_RG_*O\H_2O_*OPK_RK\*_\J_"O_*OPK_RK\*_\J_SP5$?\Q'A?_
M*"D:_RPK'/\L,![_*CDA_R=$(_\G4B;_)U\I_R9L+/\E>2W_)(4N_R6/+O\E
MF"__)J$O_R>I+_\HL"__*+DN_RG#+O\ISR[_*MTN_ROJ+?\L]2W_+?XL_RW_
M*_\N_RO^+?\L^##_+?<P_RWW,/\M]S#_+?<P_RWW,/\M_ST5$?\R'A;_*R<:
M_S H&_\P+1[_+S8A_RU")/\L3RC_+%PL_RMI+_\J=C#_*8(Q_RF,,?\JE3'_
M*YXQ_RRF,?\LKC'_+;8Q_R[ ,?\NS#'_+]DP_S#G,/\Q\R__,?TO_3+_+OLR
M_R[X,O\P\C7_,?$U_S'Q-?\Q\37_,?$U_S'Q-?\Q_SX4$?\S'1;_,"09_S0E
M&O\V*AW_-C,@_S4_)/\S3"K_,E@O_S%E,O\P<C/_+WXT_R^)-?\PDC7_,)LU
M_S&C-?\RJS3_,[,T_S.]-/\TR#3_-=8S_C;E,_LV\3+Y-_LR]SC_,?4V_S/P
M./\UZSO_-NH[_S;J._\VZCO_-NH[_S;J._\V_T 3$?\U'!;_-2 8_SHA&?\\
M)AO_/C ?_ST\)/\[2"O_.50Q_S=A-?\V;C?_-7HX_S6%./\VCSG_-Y@Y_C>@
M./TXJ#C\.; X_#FY./LZQ#?Z.](W]SSB-O0][S;Q/?HU[SS_-^T\_SGG/_\Z
MX4'_.^!!_SO@0?\[X$'_.^!!_SO@0?\[_T$3$/\W&Q;_.AT7_T$=%_]%)!G_
M1RX=_T4Y(_]$12O_0% S_SY<./\\:3O].W8\^SN!/?D\BSWW/90]]CZ<//4^
MI#ST/ZT\\T"V._)!P3OQ0L\Z[T+?.NM#[CGH0_HZYD+_/>)#_S_<1?] U4?_
M0=1'_T'41_]!U$?_0=1'_T'41_]!_T(3$/\X&Q7_0!D5_T8:%/].(A;_4"P:
M_T\V(/]-02G_24PS^T58.O=#9#_T0G% \D)\0?!"AT'N0Y!![4290.Q%H4#J
M1JI Z4:S/^A'OC_G2,P^Y4G>/N%)[3[>2/E!W$C_0]5)_T7/2_]&RDW_1\E-
M_T?)3?]'R4W_1\E-_T?)3?]'_T02#_\[&17_1A<2_T\9$O]6(1/_6BH6_UDS
M'/]6/B;X4DDQ\TU4.NY)7T'K2&Q$Z$=W1>9(@D7D28Q%XTJ51>%+GD3@3*=$
MWTVP0]U.O$/<3LM#VD[=0]9/[4733OE(T$W_2LE/_TS#4?],OE+_3;Y2_TV^
M4O]-OE+_3;Y2_TV^4O]-_T41#_] %Q/_3!40_U<8#_]?( __8B@2_V,Q%_EA
M.R'Q7$4LZU90..916T'A3F='WDYS2=M.?DK93XA)V$^22M50FDK44*-*TE&M
M2]%1N$O/4L9+S5+82\I4ZTS'4_E/PU/_4;U5_U*X5O]3M%?_4[-7_U.S5_]3
MLU?_4[-7_U.S5_]3_T<1#_]%%A'_4A(._UX7#/]F'@S_:B8._&LO$_-K.1OK
M9T,FY&%.,MU<6#[85V-'TU1M3=!3>%#-5()1RU2+4LE5E5+(59Y2QE:G4L16
MLE/#5[]3P5?14[]8YE.[6/96MUC^5[):_EBN6_U8JUS]6*I<_5BJ7/U8JES]
M6*I<_5BJ7/U8_T@0#O]*$Q#_5PX,_V06"O]L'0G_<20*]G,L#NUS-A7E<4 ?
MW6U,*]9G5CG/8%]'R5MH4<59<E;"67Q8P%F&6;Y9CUJ\6IA:NEJB6KE;K5JW
M6[E:MES*6K-=X%NP7?)<K5WZ7:A>^EZE7_I>HV#Z7:)@^EVB8/I=HF#Z7:)@
M^EVB8/I=_TD0#O].$0[_7 T*_VD4!_]R&P;^=R('\GHI"NA[,P_?>CT8UW=*
M),]Q5#7':EQ$P61E4;Q@;5FX7G=>M5Z 8+->B6"Q7I-AL%^=8:Y?J&&L8+1A
MJV#$8:EAVF&F8>]BHV+V8Z!C]F.=8_9BFV/W8IMC]V*;8_=BFV/W8IMC]V*;
M8_=B_TL/#?]2#0S_80P(_VX3!?]V&03Z?!\$[H F!N."+PK:@SP0T7Y((<EY
M4C+!<EI"NFQB3[1G:5JO9')AK&-[9:ECA&:G8XYGIF.89Z1DHV>B9*]GH62^
M9Y]ETV>=9>IHFF;R:)=F\V>59O-GE&;T9I-F]&:39O1FDV;T9I-F]&:39O1F
M_TP.#?]5"PO_90L'_W(1!/]Z%@+V@1P"Z84B ]^(*@75B#D.S(5&'L. 4"^[
M>E@_M'1?3:UO9EFH:VYCHVAV:*!G?VN>9XELG&>3;)IHGFV9:*IMEVBY;95H
MSFV3:.9MD6GO;8]I\&R.:?!KC6CQ:HUH\6J-:/%JC6CQ:HUH\6J-:/%J_TT.
M#?]9"0G_:0H%_W4/ O]^$P'RA1<!Y8H= =J-)0+0C3<,QXI$&[^&3BRW@5<\
MKWM>2JAV9%BA<FMCG&YR:IAL>F^5:X1QDVN.<I%KF7*/:Z9RCFNT<HQKR'**
M:^)RB6OL<8AK[7"':^YOAFOO;89K[VV&:^]MAFOO;89K[VV&:^]M_TX-#?]<
M!PC_; D$_W@- ?R"#P#MB!$ X(T4 -61(@'+DC4*PH]#&;J+32FRAU4YJH)<
M2*-]8E6<>&AAE71O:Y!P=G*-;G]UBFZ)=HANE7>&;J%WA&ZP=X-NPW>!;MUW
M@&[I=8!NZG. ;NMR@&WL<(!M[7" ;>UP@&WM<(!M[7" ;>UP_T\-#/]?!0?_
M;P@#_WP* /*$"@#DBPD V9$( -"5'P#'EC,(OI1!%[:03">NC%0WIHA;19Z#
M85.7?F9?D'EL:HEU<G.$<GIX@7&$>W]QCWM]<9U[>W&K>WEQOGMW<=A[=W'F
M>7AQZ'=Y<.EU>6_J<WEOZW-Y;^MS>6_K<WEOZW-Y;^MS_U ,#/]B P;_<@8"
M^G\' .2'! #8C@0 U)0& ,R9' #"FC$'NIA %+*52B2JD5,THHU90YJ)7U"2
MA&1=BX!I:8-[;W)]=W5Z>'5_?G5UBH!S=9B <76G?V]UN7]M==-_;G7D?&]T
MYGIQ<^=X<G+H=G)RZ79R<NEV<G+I=G)RZ79R<NEV_U,*"_]E 07_=@0![X("
M -J*  #4D@, SY@$ ,>=&0"^GB\%M9T^$JV:22&EEE$QG9-80):/7DV.BV-:
MAH9G9GZ!;'%U?7)Z;GIZ@&IYA8-H>I.#9GJC@F5ZM8%C>\Z 9'KC?F9XY'QH
M=^5Z:G7G>&IUYWAJ=>=X:G7G>&IUYWAJ=>=X_U8("?]I  /_>0$ X84  -:.
M  #/E0( R9P" ,&A% "YHRP$L:$[$*F?1A^AG$\NF9E6/9&57$J)D6%7@8UE
M8WB):FYNA&]Y9H%V@&& @8-?@)""7H&@@5V"LH!<@LM^7('C?5Y^Y'Q@?.5[
M8GKF>F)YYGEB>>9Y8GGF>6)YYGEB>>9Y_UH&"/]M  +U?0  VX@  -*2  #*
MF0  PZ   +NE#P"TIR@"K*<X#:2E1!N<HDTKE)]4.8R;6D>$F%]3?)1C8'*0
M:&MHC6QU8(IT?%N)?W]:BHY^68J??%F+L7M8B\IY5HKF>5B&YGE:@^9Y6X#G
M>%Q_YWA<?^=X7'_G>%Q_YWA<?^=X_U\"!O]R  'E@0  UHT  ,V6  #%G@
MO:4  +2J"0"MK"0!IJPU"IZK01B6J$HGCJ91-8:B5T)^GUQ/=9QA6VR99F=B
MEFMP6Y1S=E>3?WA6E(YW5I6?=565L7-4E<IR4Y3H<E20ZG-5C.IT5HCJ=%:'
MZG16A^IT5H?J=%:'ZG16A^IT_V0 !/YW  #=A@  T9$  ,B;  # HP  MZD
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M6DBJ_%I(JOQ:\7H  -B+  #+F   P*0  +BL  "NM   H[H  )C!  ",R ,
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MB"0M^YLC+/NQ(BO\S"$K_>@A*OO^("KZ_R J^O\@*OK_("KZ_R J^O\@PZ,
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M#P#_;0X _WH- /^*#0#_C0T _XT- /^-#0#_C0T _XT-J[P  )W$  ".RP
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M:VUN\6EM;O%I;6[Q:6UN\6EM;O%I_U,#!_]E  +S<P  VWT  -*%  #+C
MQ)   +V3$@"UEBD"K94Y#*:31!J>D$THEXU4-I")6D*)A5].@H%D6GI]:61R
M>6YM;'9V<VAU@'9E=8UV9'6<=F)VK'5@=L%T7W;><V%U['%C<^YO9'+O;65Q
M\&QE<?!L97'P;&5Q\&QE<?!L_U8 !O]H  'G=@  V($  ,Z)  #'CP  OY0
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M:%*$\VA2A/-H_V0  >1U  #6@P  RXX  ,&7  "YG0  L*,  *2F  "=J18
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MPS ):\,Y$V/"0!Y;P$4H4[]+,DV^43E(OEH]1KYE/T6_<CY$OX ]0\"1.T/
MHSI"P;@Y0<'6-T"_\CD]O/\\.KO_/CJX_T ZN/] .KC_0#JX_T ZN/] V8,
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M%2CURA0H]NH3)O3[$R7R_Q,E\O\3)?+_$R7R_Q,E\O\3OJ(  +6M  "KM0
MG[P  )'!  "$Q@  =\L  &O1  !@V   5=X  $[K  %(^@D$0OL2!SS[&0LV
M_!\/,?PF$BW]+1,I_344)OX^%2/_1Q0A_U,3'_]@$AW_<!$<_X(0&_^5#QK_
MJ@X9_\(-&?_A#!C_\@P8__(,&/_R#!C_\@P8__(,N*L  *ZT  "BO   E,(
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M2^8QN4KV,[9*_S6T2O\VLTG_-[!*_S>O2O\WKTK_-Z]*_S>O2O\W_S,2#_]
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M57YB_U-]8O]3?6+_4WUB_U-]8O]3_TD!!_]9  +X9@  WF\  -5V  #.>@
MR7P" ,%_%P"Z@2P#LH Z#JM]11ND>4XHG795-9=R6T&1;F%+C&IG4XAH;EB%
M9G9;@F: 78%FBEU_9I5>?6:A7GMFL%YY9<)>=V7<7G=E\UQW9?Q:=V7]67=D
M_E=W9/]7=V3_5W=D_U=W9/]7_TP !O]<  'O:0  VW,  -)Z  #*?@  Q(
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M7V%M^%]A;?A?_U8  _9F  #=<P  T7T  ,>%  "_B@  MXT  *Z/!P"HDB
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MH5),E+-03)3,3DJ3Z$](D?M11X[_4DF*_U1)BO]428K_5$F*_U1)BO]4ZVD
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M+#ZXYRL[M?HN.;/_,3>R_S0VLO\T-K+_-#:R_S0VLO\TTH,  ,21  "ZG
MLJ4  *BK  "=L   D;0  (2W  !XNP  ;,$  &+&"@!>QQT!6L<J!53',PQ.
MQCL42,9"&T/%22$_QE(D/<9=)#S&:20[QW<C.LB&(CG(ER YR*L?.,G$'CC(
MY1TUQ?D@,\/_(S'!_R8QP?\F,<'_)C'!_R8QP?\FR8T  +Z:  "UI   K*P
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M(>SZ"1_I_PH>Z?\+'NG_"Q[I_PL>Z?\+NJ$  +*K  "HLP  F[@  (Z]  "
MP0  <\8  &?+  !;T   4-4  $?;   ]X0  ./0' C3U$00O]A@'*_8@"2?V
M)PLC]S ,(/@Y#![Y0PP;^4X+&?I<"A;[; D5^WX(%/R2!Q/\J <2_<(&$?[B
M!1#]^P40_?T%$/W]!1#]_040_?T%M*H  *NS  ">N0  D+X  (+#  !TR
M9\T  %O2  !0V   1MT  #SB   SZ   +_@  BK_!00F_PP&(O\3!Q[_&@@:
M_R$)%O\H"1/_,0D._SL)"O]'" ;_5 <"_V0& /]W!@#_B@4 _Y\$ /^R! #_
MS@, _](# /_2 P#_T@, _](#KK(  *&Y  "3OP  A<0  ';*  !HSP  6]4
M %#;  !%X   .N0  #'H   J\  !)?L  B#_  0<_P %&/\$!A3_"@<1_Q('
M"_\8!P?_'P<"_R<' /\Q!P#_/08 _TH% /]9!0#_:P0 _WT# /^- P#_GP(
M_Z$" /^A @#_H0( _Z$"I+D  ):_  "(Q0  >,L  &K1  !<V   4-X  $3D
M   YZ   +^P  ";O   ?]@ !&O\  A7_  ,1_P $#?\ !0G_  8&_P & O\&
M!@#_# 8 _Q0& /\<!@#_)04 _S$% /\^! #_3 , _UH# /]H @#_> ( _WD"
M /]Y @#_>0( _WD"_Q$B$?\+)A'_#"42_PDG$O\#+!'_ #41_P!$#_\ 40[_
M %X,_P!K"O\ =PG_ ($(_P"*!_\ D@;_ )D&_P"?!?\ I@7_ *P$_P"S!/\
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M/)!4_SN/5/\[CU3_.X]4_SN/5/\[_SX!"/]+  /_5P  YUX  -MD  #59@$
MT64% ,EH' # :2X&N&<\$+%C1QVK7T\IIEQ7,J):8#F>66@\G%EP/II8>#^8
M6(! EUB(0)58D4"36)M!DEBG09!8M$&.6,5!C5C<0HM8\4*)6/]!B5?_08A7
M_T"'5_\_AU?_/X=7_S^'5_\__T$ !O]/  +V6P  WV,  -9I  #/:P  RVL"
M ,-M& "[;RP$LVTZ#JQJ1!JF9TTFH&-5,9MA7#J77F,_E%UK0Y)<<T607'M&
MCER$1HU<C4:+7)='B5RC1XA;L$>&6\%'A%O82(-;[D>"6_Y&@5O_18!:_T2
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MG%Q4=*Q;4W3"65)TWEA2<_584G'_5E1O_U55;O]456[_5%5N_U15;O]4_U@
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M21]JED\I8Y14,UR263Q5D%Y#4(]F2$V.<$I+CGQ*2X^*2$J/FD9)CZM%28_
M0TB/W4%&C?1$1(O_1D.)_T=$A_]'1(?_1T2'_T=$A_]'XVD  -%Y  #$A0
MNHX  +*5  "IF@  GIL  )&=  "%H   ?Z(5 'RC)P%VHC0'<*$]$&J@11EC
MGDLC7)U0+%6;5C10FET[2YEE/TF9<$!(F7P_1YF*/D>9F3Q&F:HZ19G .469
MW3="E_,Z0)7_/#Z4_SX^D_\_/I/_/SZ3_S\^D_\_W'$  ,N   "_BP  MI0
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M&"ZZ_QHMN?\;+;G_&RVY_QLMN?\;Q(P  +F8  "QH@  J:D  )VN  "1L0
MA+0  '>W  !JN@  7K\  %+$  !'R@, 0LP2 $#-( $\S2H$.,XT"#3./0LQ
MSD8-,,]1#2_/70TNT&H,+=!Y#"S1B@LKT9P**M*S"2G2T0@HT.T))L[\#"3+
M_PXCRO\/(\K_#R/*_P\CRO\/O9<  +2A  "LJ@  H:\  )6S  "'MP  >KH
M &V]  !AP@  5<8  $K+  ! T   -=8# "_="P MWAD!*M\C R??+04EX#@&
M).%#!B+A3P8AXEP&(.-K!1_D>P4>Y(X$'>6C QOFO@,:YN #&./X Q?B_P06
MX?\%%N'_!1;A_P46X?\%MZ$  *^J  "EL   F+4  (JY  !\O0  ;\   &+%
M  !7R0  3,X  $'3   WV   +=T  "CI P E[PT!(O 7 A[P( 0;\"D$&/$R
M!1;R/003\TD$$/-6! ST9@,,]7D""_6- @KUI ((]KX!!_?B 07V]P$$]?\!
M!/7_ 03U_P$$]?\!L:D  *BQ  ";M@  C;L  '^_  !QPP  9,@  %?-  !,
MT@  0=8  #;;   MX   )>0  "#O   <^P$!&?\) A;_$@,2_QD##?\A! G_
M*@,%_S4# ?]! P#_3P( _V " /]T 0#_B $ _YX! /^T  #_SP  _^,  /_C
M  #_XP  _^, J[$  )ZW  "0O   @L$  '/&  !ERP  6-   $S6  ! VP
M-M\  "SC   CYP  &^L  !?U   3_@ !#O\  @O_ @((_PD# _\0 P#_%P,
M_R # /\J @#_-P( _T8! /]8 0#_:P$ _W\  /^1  #_H@  _ZT  /^M  #_
MK0  _ZT H;<  ).]  "%P@  =<@  &?.  !9U   3-H  $#@   TY   *N@
M "'K   8[@  $?$   SZ  $(_P !!/\  @'_  ( _P " /\  P#_! , _PL"
M /\5 @#_'P( _RP! /\\ 0#_3 $ _UX  /]O  #_?@  _X<  /^'  #_AP
M_X< _P(F#_\$(P__ R(/_P D#O\ *@W_ #0,_P!""O\ 4 C_ %T'_P!I!?\
M=03_ '\#_P"' _\ CP+_ )0"_P": ?\ H '_ *<!_P"M ?\ M0#_ +X _P#*
M /\ V0#^ .@ _0#S /T _@#\ /\ ^P#_ /L _P#[ /\ ^P#_ /L _P#[ /\
M_P0E#_\((0__"" /_P(A#_\ )@[_ #(-_P _"_\ 30G_ %H(_P!G!O\ <@7_
M 'P$_P"% _\ C /_ ),"_P"8 O\ G@'_ *0!_P"K ?\ LP'_ +P _0#' /P
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M*9A,[BN63/TKE$O_+)-+_RN32O\KDTK_*Y-*_RN32O\K_S@ !O]"  +X30
MXE,  -I8  #360  T%4% ,=8&P"^6BT%MU@Z#[!511FK4D\BIU%8)Z108"NA
M4&DLGU!Q+9Y1>2Z<48 NFE&(+YE1D"^749HOEE&D,)11L#"34, PD5#5,8]0
MZS&-4/LQC$__,8M/_S&*3_\PBD__,(I/_S"*3_\P_SP !?]'  'L40  W5H
M -1?  #-8   R%T! ,!?%P"X82H#L6 X#*I=0Q>E6DPAH%A4*9Q67"^9560R
MEU5L,Y54=#245'PUDE2#-9!4C#:/5)8VC52@-HQ4K#>*5+PWB%30-X93Z#>%
M4_DWA%/_-H-3_S:#4O\U@U+_-8-2_S6#4O\U_S\ !/]+  #D5@  V5\  ,]D
M  #'9@  PF0  +IE$P"S9R<"K&8U"J5D0!2?84D?FEY1*99;63&26F VD%AG
M.(U8;SJ,6'<[BEA_.XA7B#R'6)$\A5></(-7J3V"5[@]@%?,/7Y6Y3U]5O<\
M?%;_.WQ6_SI[5O\Y>U;_.7M6_SE[5O\Y_T$  OE/  #A6P  U&0  ,MI  ##
M:P  O&H  +5J#P"N;"0!IVPS"*%J/A*;9T<=E61/)Y!A5C&,7EPWB5UC/(9;
M:SZ$6W) @EM[08%:A$%_6HU"?5J90GM:I4)Y6K1"=UK(0W99X4)U6?9!=%G_
M/W19_SYT6?\]=%G_/719_SUT6?\]_T,  O!2  #=7P  T6@  ,=M  "_<
MN&\  +!O"P"I<2$ HW$Q!IUP/ ^7;44:D6I-)8QG4R^'9%HW@V%@/G]?9T)]
M7FY$>EYV1GA>?T=W7HE'=5Z51W-=HD=Q7;!(;UW$2&U<W4=L7?1%;%W_0VQ<
M_T)M7/] ;5S_0&U<_T!M7/] _T8  >E5  #:8P  S6P  ,-Q  "[=   M',
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M25=F_TE79O])]E$  -]B  #/;@  Q'<  +I\  "R@   J(   )Z   "7@A,
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MDSQ&BJ0Z1HJV.$6*T#=#B>LX08?\.D"%_SL_A/\\/X3_/#^$_SP_A/\\W&H
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M%S:KS!8UJ>D6,Z?Z&3&F_QLPI/\=,*3_'3"D_QTPI/\=QH(  +J/  "RF
MJJ   *"D  "2I0  AJ@  'JK  !NK@  8+   %.T  !+M@P 2;<= $:W*0)"
MMS(&/K<Z"CFW0PXVMTL0-+=5$3.W8!$RMVP0,;AZ#S&XB0XPN)L-+[BO#"VX
MR LMM^8+*[3Y#BFS_Q HL?\2*+'_$BBQ_Q(HL?\2OXP  +67  "NH   I:8
M )JK  "-K0  @+   '.R  !FM   6;<  $V[  !!OP  -\,) #7$&  SQ20!
M,,4N R[%. 4KQD$&*L9,!RC'5P8GQV0&)\AR!2;(@@4DR)0$(\BH!"+)P@,@
MR.,#'\7W!1W#_P<<P?\(','_"!S!_P@<P?\(N98  +&@  "IJ   GJT  )&P
M  "#LP  =K4  &FX  !<NP  4+\  $7"   YQP  +\P  ";1!  ?U0P '=89
M !S6)0 ;US  &M@\ !G82  8V54 %]ID !7:=0 4VX< $MR< !#<M0 -W=@
M#=KR  W8_P$-UO\"#=;_ @W6_P(-UO\"LZ   *RH  "BK@  E;(  (>V  !Y
MN0  :[P  %Z_  !2PP  1\<  #O+   QSP  *-0  !_9   7W0  $^<) !'H
M%  .Z!X "^DI  GI-0 'ZD( !>M0  /L8  ![',  .N'  #JG0  ZK@  .O<
M  #J\P  ZO\  .K_  #J_P  ZO\ KJ@  *6O  "8M   BK@  'R[  !NOP
M8,,  %3'  !(S   /-   #'4   GV0  ']T  !?A   /Y   "_    CX!0 %
M^ X  ?D7  #Y(0  ^"P  /@Z  #X20  ^%L  /AN  #WA   ]IH  />Q  #W
MRP  ^.D  /CI  #XZ0  ^.D J*\  )NU  "-N0  ?[X  '#"  !BQP  5<P
M $C1   \U0  ,=H  "?>   =X@  %N8   WI   &[    _8   #^    _P
M /\%  #_#0  _Q<  /\B  #_,   _T   /]3  #_:   _WT  /^1  #_HP
M_[4  /^U  #_M0  _[4 GK4  )&Z  ""OP  <L4  &3*  !6T   2=4  #S;
M   PWP  )>,  !SG   2Z@  "^X   3P    \@   /P   #_    _P   /\
M  #_    _P(  /\+  #_&   _R4  /\V  #_20  _UX  /]Q  #_@0  _Y$
M /^1  #_D0  _Y$ _P D#?\ ( W_ " ,_P A"_\ )@K_ #((_P! !O\ 3@3_
M %L#_P!G O\ <0'_ 'L!_P"# /\ B@#_ )  _P"6 /\ G #_ *( _@"I /T
ML #\ +@ ^P#" /L SP#[ .  ^@#N /H ^@#Z /\ ^@#_ /H _P#Z /\ ^0#_
M /D _P#Y /\ _P A#?\!'0W_ !P,_P >"_\ (@K_ "\(_P ]!_\ 2P7_ %@#
M_P!D O\ ;P'_ '@!_P"  /\ AP#_ (X _P"4 /T F@#[ *  ^0"F /@ K0#W
M +4 ]@"_ /4 S0#U -T ] #L /0 ]P#T /\ ] #_ /, _P#S /\ \@#_ /(
M_P#R /\ _P0>#O\&&0W_ Q@,_P 9#/\ ( K_ "P)_P Z!_\ 2 7_ %4$_P!A
M _\ ; +_ '4!_P!] ?T A0#[ (L ^0"1 /< EP#U )T \P"D /( JP#P +,
M[P"] .X R@#N -H [0#H .T ]0#L /\ ZP#_ .H _P#H /\ YP#_ .< _P#G
M /\ _PD:#O\*% W_"!,,_P(3"_\$'@O_ 2D)_P V"/\ 0P;_ %$$_P!= _X
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M[!.D._L5HCO_%J Z_Q:?.O\6GSK_%I\Z_Q:?.O\6_RH !_\Q  /_/   [C\
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M)X9*_R>%2O\FA4K_)H5*_R:%2O\F_S8  OE"  #B30  UE8  ,Q:  #%6P
MOU8  +A7$@"Q624"JEDS":17/A*>5$@:FE)0(9=16"6446 HDE!H*9!0;RJ/
M4'<KC5!_*XQ0ARR*4) LB5":+(=0IBV%4+,MA$_&+8)/W2V 3_(M?T[_+7Y.
M_RQ^3O\K?D[_*WY._RM^3O\K_SD  >Y&  #>4P  TEP  ,A@  # 80  N5X
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M-V=8_S=G6/\W^T,  .-4  #380  QVD  +UM  "U;P  JVT  *1L 0"=;A@
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MD$=.:Y]%36NP1$QKQT)+:^-!2VKX04MI_T!+:/\_2VC_/TMH_S]+:/\_YE8
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M+D&%Q2Q!A>(K/H/V+CV!_S [@/\Q.W__,3M__S$[?_\QU6D  ,5V  "Z@0
ML8@  *6+  "9BP  CHP  (*/  !UD@  ;Y,% &J5&0!GE2@!8Y4S!5Z4.PM8
MDT(24Y)(&4Z13B!)D%4E18]=*4*/9BI!CW(J0(]^*4"/C"<_CYPF/H^N)#V/
MQ"(]CN$A.HSV)#B+_R8WB?\H-XG_*#>)_R@WB?\HSG$  ,!]  "VAP  K8\
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M!R.M_PDBJ_\*(:O_"B&K_PHAJ_\*NHL  +*6  "JG@  H*$  )*C  "%I0
M>:D  &VL  !AKP  5+$  $BT   [MP  ,+H" "J\$  IO1T )[TH "6^,@$C
MOCP"(KY& B"_40(?OUT"'K]K 1V_>P$<P(L!&L"? !G M@ 7O]0 %[WP 1:[
M_P(4NO\#%+G_!!2Y_P04N?\$M94  *V?  "FI@  FJD  (VL  " KP  <K$
M &6S  !8M@  3+@  $"[   SOP  *<,  "#'   7RP4 $<T0 !#-'  .SB<
M#<XS  O.0  *STT "L];  C/:P &T'T !="1  30I@ "T,$  ,_B  #.^  !
MS/\  LO_  ++_P "R_\ L)\  *FG  ">K   DJ\  (2R  !UM0  :+<  %NZ
M  !.O0  0L   #;$   KR   (LP  !G0   1TP  !]<   ':!P  VA0  -L?
M  #<*P  W3D  -Y'  #?5P  X&D  .!]  #AD@  X:D  .'$  #BXP  XO8
M .'Z  #A^@  X?H K*<  **M  "5L0  A[4  'BX  !JNP  7;X  %#"  !$
MQ@  -\D  "S-   AT0  &=8  !':   )W    =\   #B    Y    .4*  #F
M%@  Z"(  .HP  #L00  [U(  /!F  #P>P  \9   /*F  #RO0  \M<  /+A
M  #RX0  \N$ I:X  )BS  "*MP  ?+L  &V^  !>PP  4<<  $3+   WSP
M+-0  "'8   7W   #^    ?D    Y@   .<   #J    \    /    #P
M\0D  /07  #V)@  ^3D  /Q,  #]80  _G8  /^+  #_G0  _ZX  /^U  #_
MM0  _[4 F[0  (ZX  !_O0  ;\(  &'&  !3RP  1=$  #C5   LVP  (-\
M !;C   ,Y@  !>H   #L    [P   .\   #Q    ^    /P   #\    _
M /T   #^"@  _QP  /\O  #_1   _UD  /]M  #_?P  _XX  /^3  #_DP
M_Y, _P A"_\ '0K_ !P)_P ="/\ (P;_ # %_P ^ _\ 3 '_ %@!_P!D /\
M;@#_ '@ _P"  /\ AP#_ (T _P"2 /X F #] )T _ "C /P J0#[ +  ^@"Z
M /H Q@#Y -4 ^0#G /< ]0#U /\ ] #_ /4 _P#U /\ ]0#_ /4 _P#U /\
M_P ="_\ &@O_ !@*_P 8"/\ ( ?_ "X%_P [ _\ 20+_ %4!_P!A /\ :P#_
M '4 _0!] /L A #Z (H ^0"/ /@ E0#W )L ]@"@ /4 I@#T *X ] "W /,
MP@#R -$ \@#D /  \P#N /X [@#_ .X _P#M /\ [0#_ .T _P#M /\ _P :
M#/\ %0O_ !0*_P 3"/\ '0?_ "H%_P X _\ 10+_ %$!_P!= /T : #Y '(
M]@!Z /0 @0#S (< \0"- /  D@#O )@ [@"= .T I #M *L [ "T .L OP#J
M ,X Z0#@ .< \ #F /D Y #_ .0 _P#D /\ Y #_ .0 _P#D /\ _P05#/\#
M$0K_  X)_P 2"/\ &@?_ "8%_P T!/\ 00+_ $X!^@!9 /4 9 #Q &X [@!V
M .P ?0#J (0 Z0"* .@ CP#G )4 Y0"; .0 H0#C *D X@"Q .$ O #@ ,L
MW@#= -T ZP#; /< V0#_ -D _P#8 /\ V #_ -@ _P#8 /\ _P@1"_\("@K_
M P8(_P4,!_\'%P;_ R(%_P O!/T / +W $D!\@!5 .P 8 #H &H Y !S .,
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M _\># /[&Q<#\!8C N<2, '@$3X VA%+ -835P#2%6$ SQ=J ,T8<P#+&7H
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M#ILT_PZ:-/\.F3/_#IDS_PZ9,_\._R4 !/\K  'Q,P  XCD  -H[  #3.
MSS ' ,<S&P"_-BP#N3<[![0X1PJP.5(+K3I;#*L[9 VI.VP-ISQS#:8\>@ZD
M/( .HSR'#J(]C@^@/9</GCV@#YT]JP^;/;@0FCW)$)@]WQ&5//(2DSS_$Y([
M_Q.1.O\3D#K_$Y Z_Q.0.O\3_R@  OXR  #G.P  VT,  -)&  #*1   Q3X"
M +X^%@"W02@#L$$V"*M!0@VG04P0I$%6$J)"7A.@0F83GD)N%)Q"=12;0WP5
MF4.#%9A#BA660Y,6E4.<%I-#IQ:20[07D$+%%XY"VQ>,0N\8BD'^&8E!_QF(
M0/\9AT#_&(= _QB'0/\8_RL  ?(W  #A1   U4P  ,M/  ##3@  O4@  +='
M$0"P2B0!J4HR!Z1)/0Z?2$@3G$A1%YE'61F71V$:E4=I&I1'<!N21W<;D4=^
M'(]'AAR.2(X<C$B8'8I'HQV)1[ =AT? 'H5'UAZ#1NP>@D;\'H%%_QZ 1?\>
M@$7_'8!%_QV 1?\=_R\  .L]  #<2P  T%,  ,96  "^5@  MU   +!/# "I
M4B  HU(O!IY1.@V93T04E4U-&I),51V/3%P?C4QD((M+:R&*2W(BB$MZ(H=+
M@B*%3(HCA$N4(X)+GR. 2ZPD?TN])'U*TB1[2NHD>DK[)'E)_R-X2?\B>$G_
M(GA)_R)X2?\B_S0  .=$  #840  RUD  ,%<  "X7   L5<  *I5" "D6!T
MGEDL!)A7. N354$3CU-)&XM142"(4%@CAE!?)81/9B>"3VXH@4]V*']/?BE^
M3X<I?$^1*7I/G"EX3ZDJ=DZY*G1.SBIS3N<J<DWY*7%-_RAP3?\G<$W_)G!-
M_R9P3?\F^3@  .-*  #45@  QUX  +UA  "T80  K%T  *5;! "?71D FEXI
M Y1=-0F/6S\2BEE'&H963B&"554F?U1;*7U38BQ[4VHM>5)Q+GA2>BYV4H,O
M=%*-+W)2F2]P4J8P;E*V,&Q1RC!J4>0O:5'W+FE1_RQI4/\K:5#_*FE0_RII
M4/\J\3L  .!/  #06P  Q&(  +IF  "P90  IV(  *!@  ":8A8 E6,G 9!B
M,P>*83T0A5Y%&(%<2R!]6E(F>5A8+'977B]T5F8Q<E9M,W!6=C1N57\T;%6)
M-&I5E35H5:,U956R-6-4QS5B5.$T8E3V,F)4_S!B5/\O8E/_+F)3_RYB4_\N
M[4$  -Q3  #-7P  P68  +=J  "L:   HV8  )QD  "69A( D6@D 8QG,0:&
M9CL-@F1#%GUA21YX7T\F=%U5+'!;6S%L6F(U:EEI-V=9<CAE67LY8UF&.6%9
MDCE?6* Y75BO.5M8Q#E:5]\X6E?T-EI7_S1:5_\R6U?_,5M7_S%;5_\QZD8
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M.DEGOCA(9]DW1V;Q-T=E_S9'9/\U1V/_-4=C_S5'8_\UWU8  ,YE  # ;P
MMG8  *EW  ">=P  E'<  (EW  "#>0  ?7H4 'E\)0!U>S$$<'HZ"VMY01)E
M=T<:8'5-(EIT4BI5<E<Q4'!>-DQO9CE*;W Z26]\.4AOB3A';Y@V1F^I-$5O
MO3-$;]@Q0VWP,D)L_S)!:_\R06K_,D%J_S)!:O\RVEP  ,EJ  "]<P  LWH
M *5[  ":>P  D'L  (-\  !]?@  =X . '.!( !O@2T":H$W"&5_/@Y@?D46
M6GU*'55[4"10>E4K2WA<,$AX93-&=V\S17=[,D1XB#!#>)<O0GBH+4%XO"M
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M&C6&_APTA?\=,X3_'C.$_QXSA/\>R'$  +M\  "RA0  I8@  )B(  "-B0
M@HL  '>-  !JD0  7Y,  %>6!P!3EQ@ 49<E $Z7, -*ES@'1I9 #$&51Q ]
ME4X4.Y56%CB48!8WE&L6-Y5W%3:5A10UE903-)2E$3.4N1 RE-0/,9+N$"^0
M_1,NC_\4+8[_%2V._Q4MCO\5PG@  +>$  "NC0  H(T  )2-  "(CP  ?9$
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M 0NR_P$+LO\!LI0  *N=  "@H   DJ$  (6D  !XIP  ;*L  &"N  !4L0
M1[,  #NU   NN   )+L  !J^   1P0  !\,)  3$%@ #Q"$  L4M  '%.0
MQ44  ,53  #%8@  Q70  ,6'  #%G   Q+(  ,3/  ##Z@  P_D  ,+_  #"
M_P  PO\ K9X  *>E  ":J   C:L  ("O  !RL0  9+,  %>V  !*N   /;L
M #&]   FP0  ',0  !/(   *R@   <T   #/!0  T!   -$;  #2)@  TS(
M -1   #63P  V&   -AS  #8B0  UZ   -:Y  #6V   UNT  -7X  #5^
MU?@ JJ8  )^K  "2KP  A+(  '6U  !GN   6;H  $R]   _P   ,\,  "?'
M   <RP  $\\   K3   "U    -@   #:    W    -T'  #?$@  X1X  .0K
M  #F.0  Z4H  .I=  #K<@  [(@  .R@  #KN   Z](  .KF  #JY@  ZN8
MHJP  )6Q  "(M   >;@  &J[  !;OP  3L,  $'&   SR@  *,T  !S2   3
MUP  "=L   '>    WP   .(   #D    Y@   .@   #J    [ 8  .\4  #R
M(@  ]3(  /A$  #Z6   ^VX  /R$  #]F   _:L  /VZ  #]N@  _;H F;(
M (NV  !\N@  ;;X  %[#  !0QP  0LP  #30   HU   '-H  !'>   'X@
M .4   #H    Z@   .L   #L    [@   /    #S    ]0   /@   #["
M_A@  /\J  #_/0  _U(  /]G  #_>P  _XH  /^6  #_E@  _Y8 _P <"?\
M& C_ !<'_P 9!?\ ( 3_ "\"_P [ ?\ 20#_ %8 _P!A /\ :P#_ '0 _P![
M /\ @@#_ (@ _@"- /T D@#\ )< _ "= /L HP#Z *H ^ "R /8 O0#T ,P
M] #? /, [P#S /T \P#_ /, _P#S /\ \P#_ /, _P#S /\ _P 9"?\ %0C_
M !('_P 4!?\ '@3_ "L"_P X ?\ 1@#_ %, _P!> /T : #\ '$ ^@!X /D
M?P#X (4 ]P"* /8 CP#U )4 ] ": /, H #R *< \ "O .X N@#L ,@ ZP#:
M .L [ #K /L Z@#_ .H _P#J /\ Z@#_ .H _P#J /\ _P 6"O\ $@C_  X'
M_P .!O\ &P3_ "<"_P U ?\ 0@#^ $\ ^0!: /8 9 #T &T \@!U /$ ? #P
M (( [P"' .X C #M )( ZP"7 .H G0#H *0 Y@"L .0 M@#C ,, X@#5 .$
MZ0#@ /< X #_ .  _P#? /\ W@#_ -X _P#> /\ _P 1"?\ "PC_  @'_P -
M!?\ & 3_ ","_P P ?P /@#U $L \ !6 .T 8 #K &D Z0!Q .@ > #F 'X
MY0"$ ., B0#B (\ X0"4 -\ F@#= *$ VP"I -D LP#7 ,  U@#2 -4 Y0#4
M /, TP#] -( _P#1 /\ T #_ -  _P#0 /\ _P(*"?\ ! ?_   &_P )!/\
M%0/_ " "_P K /0 .0#J $8 YP!1 .0 7 #A &4 WP!M -T = #; 'L V0"!
M -@ A@#6 (P U "2 -( F #0 )\ S@"G ,T L0#+ +X R@#. ,D X #' .\
MQ@#[ ,0 _P## /\ P@#_ ,( _P#" /\ _P<$"/\$  ;_!0 $_PD$ _\(#P+_
M QL!]0 E .D ,@#A $  W0!, -D 5P#5 &$ TP!I -$ <0#/ '< S0!] ,L
M@P#* (D R "/ ,8 E@#% )T PP&E ,(!KP#  ;P OP/, +T$WP"[!O$ N0C^
M +<)_P"V"?\ M0K_ +4*_P"U"O\ _PT !_\*  3_$0 "_Q0  ?T3" 'U#!,
MZ@4= -T *P#7 CD T@1' ,X'4@#*"%P R IE ,4,;0#$#70 P@Y[ , 0@0"_
M$8< O1&- +P2E "Z$YP N1.D +<4KP"V%+P M!7, +(6X "O&/( K1C_ :L8
M_P&I&/\!J!C_ :@8_P*H&/\"_Q, !?\3  +_&P  \AT  .@9  #E$@< W@H3
M -0+(@#-$3, QQ9! ,(930"_&U@ O!UA +H>:0"X'W  MB!W +4@?0"S(80
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MEB%S2J,A<4JQ(F])Q")M2=TB;$GR(6M(_R!K2/\?:DC_'FI(_QYJ2/\>[C8
M -U)  #.5   P5L  +9<  "K6@  I%8  )U4  "8510 DU<D 8Y7, :)53H-
MA%-"%(!22AI]4%$>>D]7(7A/7B-V3F4D=$YM)7-.=29Q3GXF;TZ()FU.DR=K
M3J G:4VN)V=-P2=E3-HH9$SP)F-,_R1C3/\C8TO_(F-+_R)C2_\BZSP  -E.
M  #*60  OE\  +)@  "G7@  GUL  )E9  "36A  CEPA (E<+@6$6S@+@%E
M$GQ71QEX54X?=%14)'%36B=O4F$I;5)I*FM1<2MI47HK9U&$+&51D"QC49TL
M85&K+%]0OBQ=4-8L7%#O*EQ/_BA<3_\G7$__)5Q/_R5<3_\EYT(  -92  #'
M70  O&,  *YC  "D8@  FU\  )1=  ".7PL BF$> (5A*P. 8#8)?%X^$'=<
M11AS6DL>;EA1)&M75REH5EXL955E+F-5;3!A57<P7U6!,5U5C#%;5)HQ652I
M,%=4NS!54]0P55/M+E53_2Q54O\J5E+_*%92_RA64O\HY$<  -)7  #$80
MN6<  *MF  "@90  EV,  )!B  "*8P@ A64; (%F*0)\930'>&0\#G-B0Q9N
M8$D=:5Y/(V5<5"EA6ULN7EIA,5M9:C-96',T5UA^-%58BC136)<T4EBG,U!8
MN3-.5]$R3E?L,$Y6_"Y/5O\L3U;_*T]6_RM/5O\KX4P  ,];  #!90  MFH
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M*#YH^B@]9_\H/6;_*#UF_R@]9O\HTUP  ,-I  "X<@  JG0  )UT  "2=
MB'0  'QU  !U=P  ;WD' &M[&0!G>R<!8WLQ!%]Z.@I:>4 057A&%E!V3!Q+
M=5(B1W18)D1S82E"<VLI07-V*$!S@R<_<Y(E/G.B)#USM"(\<\T@.W+H(3EP
M^B(X;O\C.&W_(S=M_R,W;?\CSF(  +]N  "U=P  IG@  )EX  ".>   A'D
M '9[  !N?@  9W\  &*!$@!?@B$ 7((M EB!-@93@#T+3W]#$4I^21=&?5 <
M0GU7'T!\7R$^?&HA/7QU(#Q\@AX[?)$=.GRA&SE\M!HX?,P8-WKH&35X^1LT
M=_\<,W;_'3-V_QTS=O\=R&D  +MT  "P?   H7P  )1\  "*?0  @'X  '2
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M#BB)_PXHB?\.O7@  +.#  "EA@  EX8  (R&  "!AP  =HD  &N,  !?D
M5),  $F6   ^F00 .IH3 #B:(  VFBH -)HS C&:/ 0OFD0&+9I-!BN:5P<J
MFF(&*9IN!BB:>P4GFHH$)9J;!"29K@,CF<8#(9CC B"6]P4?E/\&'I/_!QZ3
M_P<>D_\'N($  *^+  "@BP  DXL  (B,  !\C@  <9   &64  !9EP  39L
M $.>   XH0  +:,# ">D$0 FI1T )*4G ".E,0 AI3L!(*5$ 1ZE3P$=I5H!
M'*5F !NE=  9I80 &*65 !:EJ  4I,  $Z/? !2A]0 3G_\!$I[_ A*>_P(2
MGO\"LXH  *F1  ";D0  CY$  (*3  !WE@  :YD  %^<  !3H   2*,  #RF
M   QJ0  )JL  !RN   4KPH $; 7 !"P(@ -L"P #+ W  NP0@ )L$T "+%:
M  :Q:0 $L'D  ["+  &OG@  K[0  *[0  "MZ@  K?D  :O_  &K_P !J_\
MKI0  *28  "7EP  BID  'V<  !QGP  9:,  %FF  !.J@  0JT  #:P   J
ML@  '[0  !6W   +N    KH(  "[$P  NQX  +PH  "\,P  O#\  +Q+  "]
M6@  O6H  +U]  "]D0  O*8  +N_  "ZW@  NO$  +G[  "Y_   N?P JYT
M *"?  "2H   A:,  'BG  !LJ@  8*X  %.Q  !&M   .;8  "VX   ANP
M%[X   W    $P@   ,0   #&!   QPT  ,@8  #)(P  RB\  ,L[  #,20
MSED  ,YL  #/@0  SY8  ,ZM  #.R   S>,  ,ST  #,]0  S/4 IZ4  )NH
M  "-J@  @*X  '*R  !DM   5K8  $BY   [O   +[X  "/!   8Q0  #<@
M  3+    S0   ,\   #2    TP   -4$  #8#@  VQH  -TF  #?-   X40
M .-6  #C;   Y(,  .2:  #EL0  Y<D  .3A  #DY   Y.0 H*L  ).O  "%
ML@  =K4  &>X  !8NP  2[X  #W"   OQ0  (\@  !?+   -T    ]0   #9
M    V0   -L   #>    X    .(   #E    Z ,  .L0  #N'0  \2P  /0]
M  #V4@  ]VD  />"  #WF@  ^*P  /C   #XPP  ^,, EK   (BT  !ZN
M:KL  %N_  !-Q   /L@  #',   DSP  %],   K8   "W0   .$   #D
MY    .8   #H    Z@   .P   #O    \0   /4   #X!0  _!0  /\E  #_
M-P  _TP  /]B  #_>0  _XT  /^@  #_H@  _Z( _P 7!_\ % ;_ !,%_P 5
M _\ '@'_ "L _P Y /\ 1P#_ %, _P!> /\ : #_ '  _P!W /\ ?0#^ (,
M_0"( /P C0#[ )( ^0"8 /< G@#U *4 ] "M /, M@#R ,, \@#8 /$ ZP#Q
M /H [P#_ .\ _P#N /\ [P#_ .\ _P#O /\ _P 4"/\ #@;_  T%_P . _\
M&P'_ "@ _P V /\ 1 #_ %  _@!; /P 9 #Z &T ^0!T /< >@#V (  ]0"%
M /0 B@#R (\ \ "5 .X FP#M *( [ "I .H LP#I ,  Z0#2 .@ Y@#F /8
MY0#_ .0 _P#D /\ Y #_ .4 _P#E /\ _P 1"/\ "P;_  D%_P , _\ %P'_
M "0 _P R /L /P#X $P ]@!7 /0 8 #R &D \ !P .X =P#M 'T ZP"" .D
MAP#G (P Y0"2 .0 F #C )X X0"F .  KP#? +P W0#, -P X #: /, V0#_
M -@ _P#8 /\ V #_ -D _P#9 /\ _P +!_\ !0;_  $$_P * _\ %@'_ !\
M^@ M /, .P#O $< [0!2 .H 7 #G &4 Y0!M ., <P#A 'D WP!_ -T A #;
M (D V0"/ -@ E0#6 )L U "C -, K #1 +@ T #' ,X W #, .\ RP#\ ,L
M_P#* /\ R@#_ ,H _P#* /\ _P $!_\   7_   #_P & O\ $@'^ !L [P G
M .D -0#E $( X@!. -\ 6 #< &$ V0!I -8 ;P#3 '8 T0![ ,\ @0#. (8
MS "+ ,L D@#) )@ R "@ ,8 J0#$ +0 P@## ,$ UP"_ .H O@#V +T _P"]
M /\ O #_ +P _P"\ /\ _P  !O\   3_   "_P ! ?\ "P#U !0 Y0 @ -\
M+P#: #P U0!( -( 4P#. %P RP!D ,D ; #' '( Q0!X ,, ?0#" (, P0")
M +\ CP"] )8 O "> +H IP"X +( MP#! +4 TP"T .8 L@#T +$ _P"O /\
MK@#_ *T _P"M /\ _P0 !/\   +_"  !^ @  /$# @#I  L W  9 -4 * #/
M #8 R@!# ,8 3@#" %@ P !@ +X!: "\ FX N@-U +D$>@"W!(  M@6& +0&
MC0"S!Y0 L0>< + (I@"N";( K0G  *L*TP"I"^@ IPWX *0/_P"C#_\ HP__
M *(/_P"B#_\ _P@  _\,  'S$0  YA0  -\1  #9" ( TP 0 ,P"'P#%!B\
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MF@F'.*8*AC>T"H0WQ@J"-]T*@#;R"WXV_PM]-?\+?37_"WPT_PM\-/\+\R
M .0S  #4/P  R$8  +M%  "R00  K#P  *@W!@"B.AH G#PI I@\-0:4/$ )
MD3Q)"H\\40N-/%D,BSU@#8D]9PV(/6T-ACUT#H4]? Z$/80.@CV-#H ]EP]_
M/:,/?3VQ#WL\PA!Z/-H0=SSO$'8[_A!U._\0=#K_#W0Z_P]T.O\/[RD  -\[
M  #/1P  PTT  +9+  "L2   ID0  *%  @"<0A8 ED0E I%#,0:-0SP*BD)%
M#H="31"%0E01@T);$H)"8A* 0FD3?T)P$WU">!-\0H 4>D*)%'A"E!1W0J 5
M=4&M%7-!OQ5Q0-85;T#M%6Y _15M/_\4;#__$VP__Q-L/_\3[#   -M"  #+
M30  OE(  +%1  "G3@  H$H  )M'  "62!( D4LB 8Q*+@6'23@*A$A!#X%'
M21-^1E 5?$97%GI&7A=Y1F48=T9L&75&=!ET1GP9<D:&&G!&D!IN1IP:;$6J
M&FI%O!MH1-,;9D3K&F5$^QEE0_\894/_%V5#_Q=E0_\7Z#<  -9(  #'4@
MNE8  *Q5  "C4P  G$\  )9-  "13@T C% ? (=0+ 2#3S8)?TX^#WM,1A1X
M2TT8=4I3&G-*6AQQ2F$=;TIH'FY*<!YL2GD?:DJ"'VA)C1]F29D?9$FH(&)(
MN2!@2,\@7DCI'UY'^AU>1_\<74;_&UU&_QI=1O\:Y#T  ---  #$5P  MEH
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M*$E2]R9)4O\D2E'_(TI1_R)*4?\BVDP  ,E:  "\8P  K&,  )]C  "58@
MC&$  (1?  !^80  >6,1 '5D( !Q9"P#;60U"&AB/0YD84,47U])&UM=3B%6
M7%0F4UI:*E!:8BQ.66PM3%EV+4I9@BU)69 L1UF?*T99L"E%6<8H0UCB)T-7
M]B9#5O\E0U;_)$16_R-$5O\CUE$  ,5>  "Y9@  J&8  )MF  "190  B&4
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M&C-I_QLS:?\;R&(  +MM  "L<0  G'$  )!Q  "&<0  ?7(  &]U  !G=P
M7WD  %I["P!7?!H 5'PG %%\, -->S@'27H_#$5Y11!!>4P4/GA3%SMX6Q@Y
M>&48.'AQ%S=X?18V>(L5-7B;$S1WK!(S=\(1,W;?$#%T]!(P<_\3+W'_%"YQ
M_Q4N<?\5PVD  +=S  "G=0  F'4  (QU  ""=@  >7<  &UY  !B?0  67\
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M= $?E8,!'923 1R4I0 :D[L &)/8 !B1\ $8C_\"%X[_ Q>._P07CO\$M(
M *:$  "7A   BX,  ("$  !UA@  :8D  %Z-  !3D   1Y0  #V7   RF0
M*)P  !Z>"0 ;GQ4 &I\@ !B?*@ 7GS, %I\] !6?1P 3GU( $J!? !"?;  -
MGWL #)^,  J>GP (G;0 !YS.  B;Z0 )FOH "9G_  F8_P )F/\ KXD  *"*
M  "2B0  AXD  'N+  !OC@  8Y$  %B5  !-F0  09P  #6?   KH@  (:0
M !>G   -J04 !:H0  .J'  "JB8  :HP  "J.P  JD8  *I3  "J80  JG
M *F!  "IE   J*@  *?!  "FWP  I?   *7[  "E_P  I?\ J9$  )N0  "/
MCP  @I$  ':4  !IEP  79L  %*?  !&HP  .Z8  "^I   DK   &JX  !&P
M   &L@   +,%  "T#P  M!D  +4C  "U+0  M3@  +5$  "V4@  MF(  +9T
M  "VAP  M9P  +2S  "ST   LNH  ++X  "Q_0  L?T I)<  )>6  ")F
M?9L  '"?  !DHP  6*<  $RJ  ! K@  -+$  "BS   =M0  $K@   BZ
MNP   +T   "^ 0  OPH  , 5  #!'P  PRD  ,0U  #%00  QE$  ,=C  #'
M=P  QXP  ,:C  #&O0  Q=H  ,3N  #$]0  Q/4 H)X  )*?  "%H@  >*<
M &NK  !?KP  4[,  $6U   WN   *KH  !Z\   3OP  ",(   #$    Q0
M ,<   #)    RP   ,T#  #/#0  T1D  -0D  #6,   V3X  -Q0  #>8P
MWGH  -^1  #?J   WK\  -[8  #>Y   WN0 FZ@  (ZJ  "!KP  <[,  &2U
M  !5N   1[L  #F^   LP0  '\0  !/'   (R@   ,T   #1    T0   -0
M  #6    V0   -P   #?    X@(  .4/  #H'   ZBL  .T[  #P3@  \F,
M /-[  #TD@  ]*8  /2W  #TP@  ],( E*\  (:R  !WM@  9[D  %B\  !*
MP   .\0  "W(   @RP  $\X   ;2    UP   -L   #?    WP   .$   #C
M    Y0   .<   #J    [@   /(   #V @  ^1$  /PB  #^-0  _TH  /]A
M  #_>   _XT  /^=  #_I0  _Z4 _P 3!O\ #P3_  T#_P 0 ?\ &@#_ "D
M_P W /\ 1 #_ %  _P!: /\ 9 #_ &P _P!S /T >0#[ '\ ^0"$ /@ B0#V
M (X ]0"3 /4 F0#T *  \P"H /( L0#Q +X [P#. .T Y0#L /< ZP#_ .L
M_P#K /\ [ #_ .P _P#L /\ _P .!O\ "P3_  D#_P * ?\ %P#_ "4 _P T
M /\ 0 #_ $P _0!7 /H 8 #Y &D ]P!P /0 =@#R 'P \ "! .\ A@#N (L
M[0"0 .L E@#J )T Z0"D .@ K0#F +D Y #) .( X #A /, X #_ .  _P#@
M /\ X0#_ .$ _P#A /\ _P +!O\ !@3_  ,#_P * ?\ %0#_ "$ _  O /D
M/ #V $@ ] !3 /$ 7 #O &4 [ !L .D <P#G 'D Y0!^ .0 @P#C (@ X0"-
M .  DP#? )D W0"A -P J@#9 +0 U@#$ -4 V0#3 .T TP#] -( _P#2 /\
MT0#_ -  _P#0 /\ _P $!?\   3_   "_P ( ?\ $ #Y !T \P J .\ -P#L
M $, Z0!. .8 6 #B &$ WP!H -P ;P#; '4 V0!Z -< ?P#5 (0 U "* -(
MCP#1 )8 SP"= ,P I@#* +  R "_ ,< T@#% .@ Q0#Y ,0 _P#! /\ P #_
M ,  _P#  /\ _P  !?\   /_   !_P $ /\ "@#O !8 Z0 E .0 ,@#@ #X
MW !* -@ 5 #4 %T T0!D ,\ :P#- '$ RP!V ,H ? #( ($ QP"& ,4 C ##
M )( P0": +\ HP"] *T NP"[ +H S "Y ., MP#T +4 _P"S /\ LP#_ +(
M_P"R /\ _P  !/\   +_    _P   /8  P#F !  W@ > -@ *P#2 #D S0!%
M ,H 3P#' %@ Q !@ ,( 9P#  &T O@!S +T > "[ 'T N@"# +@ B0"V )
MM0"7 +, H "Q *L KP"W *X R0"L -\ J@#O *D ^P"H /\ J #_ *< _P"G
M /\ _P   O\   'Z    [    .0   #<  @ TP 7 ,P )0#& #( P@ _ +X
M20"[ %, N !; +8 8@"T &D LP!O +$ =0"P 'H KP"  *T A@"L (T J@"5
M *D G@"G *D I0"V *,!QP"B ML H /M )\$^P">!?\ G07_ )P%_P"<!?\
M_P   ?L#  #K"P  X1   -@+  #0 @  R0 . ,( '0"] "L N  X +0#1 "Q
M!4X K@=7 *P)7@"K"F4 J0IK *@+<0"F#'< I0Q^ *0-A "B#HP H0Z4 )\0
MG0">$*@ G!&V )H1QP"9$=T EA/Q )43_P"3$_\ DQ/_ )(3_P"2$_\ _P0
M .\1  #B'   UR$  ,L?  ##%P  O@T" +H'%0"T#20 KQ(R *L4/P"G%DD
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M!7\QO09],=,&>S#J!GDP^P=X+_\'=R__!W<N_P=W+O\'[B$  -XR  #./@
MOT   +(^  "J.P  I#<  * Q 0";,A4 EC0D 9(U,0..-3L%BS9%!HDV30>'
M-U0'AC=;"(0W8@B#-V@(@3=O"( X=@E^.'X)?3B'"7LXD0EZ.)T*>#>J"G8W
MN@IT-] *<C;H"W V^0MO-?\+;S7_"FXT_PIN-/\*ZBD  -DZ  #)10  N48
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M&5A#]1=80O\66$+_%5A!_Q180?\4WCT  ,Q,  "]4P  K5,  *!2  "740
MD$X  (I+  "%300 @$X6 'U0) %X3RX%=$XW"G!,/P]L2T43:4I,%F=*4AED
M25D:8DE@&V%)9QQ?27 =74EZ'5M)A1U92)$=5TB?'55(KQU31\,=4D;>'5%&
M\QM11O\9447_&%%%_Q=11?\7VT(  ,E1  "Y5@  J58  )U5  "35   C%(
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M'3Y1_QP^4?\<SU(  ,!=  "N7P  GU\  )-?  ")7P  @5X  'A>  !Q8
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M> \Q<X8.,'.5#2]SI@PN<[H++7+4"BQP[@LJ;OT-*6W_#BAL_P\H;/\/OF@
M *YN  "=;@  D&X  (1N  ![;P  <7   &5S  !<=@  4WD  $M[  !%?0L
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M !&.G0 /CK$ #8W*  V+YP .BOH #HG_ 0Z(_P$.B/\!K7T  )Q]  ".?
M@WP  'E]  !N?P  8H(  %>&  !,B@  08T  #>0   MDP  (Y4  !F7 @ 1
MF0T #YD9  V9(P ,F2P "YDV  F90  (F4L !IE7  2990 "F7,  )B#  "8
ME0  EZ@  );   "5VP  E.\  )/[  "3_P  D_\ IH,  ):"  "*@@  @((
M '2$  !HAP  7(L  %&.  !&D@  .I4  #"8   FFP  &YT  !*@   'H@(
M *,,  "C%P  HR$  *0J  "D-   I#\  *1,  "D60  I&@  *1Y  "CBP
MHI\  *&V  "?TP  GNP  )[V  ">_0  GOT GXD  )*(  "'B   >XH  &Z-
M  !BD   5I0  $N8   _G   ,Y\  "BB   >I0  %*<   JI   !JP   *P"
M  "M"P  KA4  *X?  "O*   KS,  *\^  "P2P  L%L  +!L  "P?@  KY(
M *^I  "MQ   K.,  *KT  "J_0  JOT FH\  (^.  ""D   =9,  &B7  !<
MFP  4)\  $2C   XIP  +:H  "*M   7L   #+(   .T    M0   +<   "X
M    N08  +D0  "[&@  O"0  +TO  "^.P  OTH  ,!<  # ;P  P(0  ,":
M  "_L@  O\X  +[F  "]]   O?0 EY8  (J7  !]F@  <)\  &.C  !7J
M2ZP  #^P   RM   )K8  !FX   .N@   [T   "^    OP   ,$   ##
MQ    ,8   #("0  RA0  ,T>  #/*@  T3@  -5)  #87   V'(  -B)  #7
MH0  U[<  -;/  #6XP  UN, DI\  (6B  !YIP  ;*P  %^Q  !2M0  1+<
M #6Z   HO0  &[\   W"   #Q0   ,@   #*    RP   ,P   #.    T0
M -,   #7    V@$  -X,  #B&0  Y28  .@T  #L1P  [EP  .]T  #PBP
M\*$  /"S  #PQ   \,0 CZH  (*O  !TLP  9;8  %:Y  !'O0  -\   "G$
M   <QP  #LH   +-    T0   -4   #8    V    -H   #=    WP   .(
M  #E    Z0   .T   #P!   \Q(  /8A  #Z,0  _D4  /]<  #_<P  _X@
M /^9  #_I@  _Z8 _P .!/\ "@/_  @!_P ( /\ & #_ "8 _P T /\ 00#_
M $P _P!7 /\ 8 #^ &@ ^P!P /D =@#X 'L ]P"  /8 A0#U (H ] "/ /,
ME0#R )P \0"C .\ K #M +@ ZP#( .D WP#I /, Z #_ .@ _P#H /\ Y0#_
M .0 _P#C /\ _P *!/\ !P/_  0!_P ( /\ % #_ ", _P P /\ /0#^ $D
M^P!3 /@ 70#T &4 \0!L /  <P#N '@ [0!] .P @@#K (< Z@", .D D@#H
M )@ Y@"? .0 J #A +0 WP## -T V #= .\ W #_ -H _P#6 /\ U0#_ -0
M_P#4 /\ _P &!/\  0+_   !_P $ /\ $0#] !X ^0 L /8 .0#T $0 \0!/
M .P 60#I &( YP!I .4 ;P#C '4 X@!Z .  ?@#? (, W@"( -P C@#: )4
MV "< -4 I0#3 *\ T0"] ,\ T0#. .D RP#Z ,@ _P#& /\ Q@#_ ,< _P#'
M /\ _P  !/\   +_   !_P   /P "@#T !H [P F .P - #G $  XP!+ .
M50#< %T V@!D -@ :P#5 '$ U !V -( >P#0 (  SP"% ,P BP#* )$ R "8
M ,< H0#% *L P@"X ,$ RP"^ .( N@#U +H _P"Z /\ N@#_ +H _P"Z /\
M_P   _\   '_    _P   /$ !0#J !0 Y  A -T +@#8 #L U !& -$ 3P#.
M %@ RP!@ ,D 9@#& &P Q !R ,, =P#! 'P P "! +X AP"] (T NP"5 +D
MG0"W *< M0"T +( Q0"P -L KP#P *X _@"N /\ K0#_ *T _P"M /\ _P
M O\   #_    ]0   .<   #>  T U0 ; ,\ *0#* #4 Q@!  ,, 2@#  %,
MO0!; +L 8@"Y &@ MP!N +8 <P"T '@ LP!^ +( A "P (H KP"2 *T F@"J
M *0 J "P *8 OP"E -4 I #K *, ^0"B /\ H@#_ *$ _P"A /\ _P   ?\
M  #P    Y0   -P   #2  8 R0 5 ,, (@"^ "\ N@ [ +< 10"T $X L0!6
M *\ 70"M &0 K !J *L ;P"I '4 J !Z *< @0"E (< HP"/ *$ F "@ *(
MG@"M )T O "; -$ F@#E )@ ]0"7 /\ EP#_ )8 _P"6 /\ _P   /(   #F
M"   V@H  ,X%  #%    OP , +H &@"U "< L0 T *T /P"J $D IP!1 *4
M60"D &  H@%F *$"; "? W( G@-W )T$?@";!(4 F@6- )@%E@"7!J  E0:L
M ),&NP"2!\\ D CE (X)]@"-"O\ C K_ (P*_P","O\ ^    .H0  #=&@
MS1T  ,(8  "Z$0  M@@! +( $@"L R  J <N *0*.@"A#$0 GPY- )P050";
M$5P F1)B )@2: "7$VX E1-U )04>P"2%(( D16+ (\5E ".%9\ C!6K (H5
MNP")%<\ AQ;G (47^ "$%_\ @Q?_ ((7_P""%_\ \@L  .,=  #5)P  Q"D
M +@E  "P(0  JQH  *D1" "D$QH GQ<H )L9-0"8&S\ EAQ) )0=40"2'E@
MD!Y> (\?9 ".'VL C"!Q (L@> ")(8  B"&( (<AD0"%(9P @R&I ((AN "
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M!VHP\P=I+_\':"__!V@N_P=H+O\'Y"H  -$Z  # /P  L#\  *0^  "</
MEC@  )$U  ".,@H B30; (4V* &"-C,#?S8\!7PV1 9[-TP'>3=2"'<W60AV
M-U\(=#=F"7,W;0EQ-W8);S=^"6TWB IL-Y0*:C>A"F@WL IF-L,+9#;<"V(U
M\0MA-?\+833_"F T_PI@,_\*WS$  ,U!  "[1   JT0  )]$  "700  D3X
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M$TP__Q-,/_\3U$,  ,-/  "O3P  H$\  )5/  ",3@  A4P  ']*  !Y2P
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M=QH[6(09.EB2&#A8HQ8W5[45-E?.%#16Z10S5/H5,U/_%3)2_Q4R4O\5Q58
M +-;  "A7   DUP  (A<  !^7   =EP  &I=  !D7P  7F$  %IB"@!78QD
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M!RENGP8H;K(&)VW+!29LY@4D:OD'(VC_"2)G_PHB9_\*N&<  *1G  "49P
MAV<  'UG  !S:   :FH  %YM  !6;P  3G(  $5T   \=P4 .'@2 #9X'0 U
M>"< ,G@O 3!X-P(N>#\$+'A'!2IX4 4H>%D%)WAD!"9X< 0D=WX#(W>- R%W
MG0(@=K !'G7( 1YTY0$=<_@#'''_!!MP_P8;</\&L6L  )YL  "/:P  @VL
M 'EL  !P;0  96\  %IR  !1=0  2'@  #][   U?0  +8 ) "J %0 H@!\
M)H$H "6!,0 C@3D (8%" 2"!2P$>@54!'8%@ 1N!;  :@'H &(") !9_F@ 4
M?ZT $G[% !)]X@ 3>_8 $WK_ 1-Y_P(2>?\"JG   )EP  "+<   ?W   '5P
M  !K<@  8'0  %9X  !+?   0GX  #B!   NA   )8<  !R)"  8BA0 %XH>
M !6*)P 4BC  $XHY !&*0P 0BDT #8I9  N*90 )BG, !XF#  6)E  $B*8
M H:]  *%V  "A>T  X/[  2"_P $@O\ HW8  )-U  "&=0  ?'4  ')V  !F
M>   6WL  %!_  !%@P  .X8  #&)   GC   'HX  !21   *DP@ !)03  *3
M'0 !DR8  ),O  "3.0  DT0  )-0  "370  DVL  )-[  "2C   D9X  )"T
M  "/T   CN@  (WU  "-_0  C?X G'L  (Y[  "">@  >'L  &Q]  !@@
M580  $J(   _BP  ,X\  "J2   @E   %I<   R9   "FP   )P*  "<%
MG1T  )TF  ">+P  GCH  )Y%  ">4P  GF(  )YQ  "=@P  G98  )RK  ":
MQ0  F>,  )CU  "7_@  E_\ EH$  (F   !_@   <X(  &>&  !:B0  3XX
M $.2   XE0  +9D  "*<   8G@  #:    2C    I0   *8   "G"   IQ(
M *@:  "I(P  JBT  *HX  "J10  JU0  *MD  "J=P  J8L  *FA  "HN0
MI]@  *;N  "E^@  I?P D8<  (>'  !ZB0  ;8P  &&0  !5E   29@  #R=
M   QH   )J0  !JG   0J0  !:L   "M    KP   +$   "R    LP,  +,,
M  "T%@  MA\  +<J  "X-@  N40  +I5  "[:   NWP  +J1  "YJ@  M\8
M +;C  "U\P  M?8 CXX  (*/  !UDP  :)<  %N;  !/H   0Z4  #:I   K
MK0  '[   !.S   (M0   +@   "Y    N@   +P   "]    O@   ,    #"
M!0  Q \  ,<9  #))0  RS(  ,Y#  #/5@  T6P  -&"  #1F   T*\  -#&
M  #/W0  S^( BI<  'V:  !PGP  8Z0  %>I  !+K@  /K(  #&V   DN0
M%[L   F^    P    ,,   #$    Q0   ,<   #(    RP   ,T   #0
MTP   -@(  #<%   X"   .,O  #G00  ZE<  .IN  #KA@  ZYP  .NO  #K
MP   Z\4 AJ(  'FG  !MK0  8;(  %.V  !$N0  -+T  "7    8PP  "L8
M  #)    S0   -    #1    T@   -,   #5    V    -L   #?    XP
M .<   #K 0  \ T  /,<  #W+   ^T   /U6  #_;@  _X4  /^7  #_I@
M_ZH _P ) _\ !P'_  , _P & /\ %0#_ ", _P Q /\ /0#_ $D _P!4 /T
M7@#[ &8 ^0!L /< <@#V '@ ]0!] /0 @@#S (8 \@"+ /$ D0#O )@ [0"?
M .L J #J +, Z ## .< V@#E /  Y #_ .  _P#= /\ W #_ -L _P#9 /\
M_P & O\  0'_    _P $ /\ $@#_ "  _P M /\ .0#Z $8 ]P!0 /0 6@#R
M &( \ !I .X ;P#L '0 ZP!Z .H ?@#H (, YP"( .4 C0#C )0 X0"; -\
MI #= *\ VP"] -D T@#7 .H T@#] ,\ _P#/ /\ SP#_ ,\ _P#/ /\ _P
M O\   '_    _P   /\ #0#[ !L ^  H /( -@#O $$ [0!, .D 50#F %T
MY !E .$ :P#? '$ W0!V -L >P#9 (  V "% -4 B@#4 )  T@"8 -  H #.
M *H S "X ,D R@#$ .0 P@#X ,( _P#" /\ P@#_ ,( _P#" /\ _P   O\
M  '_    _P   /< !P#Q !8 Z@ C .4 ,0#B #P WP!' -L 4 #6 %D TP!@
M -$ 9P#/ &T S0!R ,L =P#* 'P R "! ,< A@#% (T PP"4 ,$ G "_ *8
MO "S +@ Q "W -P M@#R +4 _P"U /\ M0#_ +4 _P"U /\ _P   ?\   #_
M    ]0   .P  P#D !$ VP ? -8 *P#2 #< S@!" ,H 2P#' %0 Q !; ,(
M8@#  &@ O@!M +T <P"[ '@ N@!] +@ @@"V (D M "0 +( F "P *( K@"N
M *P O0"K -, J@#K *D _ "H /\ J #_ *@ _P"H /\ _P   ?\   #V
MZ@   .    #4  L S0 9 ,@ )0#" #$ OP \ +P 1@"Y $X M@!6 +0 70"R
M &, L !I *X ;@"M '0 JP!Y *H ?P"I (4 J ", *8 E0"D )X HP"J *$
MN "@ ,P G@#D )T ]@"= /\ G #_ )P _P"; /\ _P   /8   #K    W0
M -$   #(  0 P0 2 +L 'P"V "L LP V +  0 "M $D J@!1 *@ 6 "F %\
MI !E *, :@"B &\ H0!U *  >P"? ($ G0") )P D0": )L F "F )< M "5
M ,8 E #> ), \0"1 /T D #_ )  _P"0 /\ ^P   .T   #@!0  SP4  ,0
M  "]    MP * +$ & "M "0 J@ P *8 .P"C $0 H !, )X 5 "= %H FP!@
M )H 9@"9 &P F !Q )8 > "5 'X E "& )( CP"0 )D CP"D (T L@"+ ,0
MB@#: (@ [@"' ?H A@+_ (4"_P"% O\ \P   .4.  #4%P  Q!4  +D2  "Q
M#   K0,! *D $ "E !T H0 J )T!-0": S\ F 5( )8&3P"4!U8 DPA< )$(
M8@"0"6@ CPEN (T*=0","GP BPN$ (D+C0"'"Y@ A@ND (0+L@""#,0 @0S<
M '\.\ !^#OX ?0[_ 'P._P!\#O\ [0P  -T<  #*(@  NR(  *\?  "H&P
MHQ4  *$,!@"="18 F0TD )40+P"2$CH D!-# (T52P",%5( BA99 (D77P"'
M%V4 AAAK (48<@"#&7D @AF" ( 9BP!_&98 ?1FB 'L9L !Z&<, >!G; '8:
M\ !U&O\ =!K_ ',9_P%S&?\!YQ@  -8H  #"*P  LRL  *@I  "@)@  FR(
M )@;  "6%A  D1H? (T<*P"*'C8 AQ\_ (4@1P"$(4\ @B%5 ($B6P!_(F(
M?B-H 'TC;P![(W< >B-_ '@DB !W)), =2.@ ',CK@!Q(\  ;R/8 6TC[@%L
M(OX":R+_ FLA_P)J(?\"XB(  ,\Q  "[,@  K#,  *$R  ":+@  E"L  ) G
M  ".(@H B20: (8F)P""*#( @"D[ 7XI1 %\*DL!>RI2 7DJ6 )X*UX"=BME
M G4K; )S*W,"<BQ\ G LA@)N+)$#;"N= VHKK -H*[X#9BK5 V4J[ 1C*?P$
M8BG_!6(H_P5B*/\%W2H  ,DW  "V.0  ISD  )PX  "4-0  CC(  (HO  "'
M*P4 @RT6 '\O(P!\,"X!>3 W G<P/P-U,4<$<S%.!'$Q5 5P,5H%;C)A!6TR
M: 5K,G %:C)Y!F@R@P9F,HX&9#*;!F(QJ09@,;L'7C#2!UPPZP=;+_L'6R__
M!UHN_P=:+O\'V3(  ,0\  "Q/0  HCX  )@]  "/.P  B3@  (0V  "!,P$
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M>!5(0X051D.1%$1#H!1"0K(40$+)$S]!Y!,_0/<2/T#_$3\__Q% /O\1R4@
M +1+  "C3   E4P  (I,  "!3   >DH  '-'  !M20  :$L" &1,$@!A31\
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M$3-4G1 R4Z\.,5/%#3!2X0TN4?4/+4__$"U._Q M3O\1OE0  *E4  "850
MBU4  (!6  !W5@  ;E8  &)7  !<60  5UL  %)<! !/71, 3%X> $I>* %'
M7C #0UTW!D!</0D\6T,,.5M*#S=;4A U6UL0-%ME$#);<0\Q6WX.,%N,#"];
MG LN6JX*+%K$"2M9X DI5_4+*%;_#"A4_PTG5/\.N5<  *18  "46   AUD
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M !1OVP 5;?( %6S_ 11K_P(4:O\#IV0  )5D  "'9   >V4  '%E  !H9@
M7F@  %-L  !+;@  0G$  #ET   P=@  )WD" "![#0 >>Q@ ''LA !M[*@ 9
M>S( &'P[ !=[1  5>TX %'M9 !)[90 0>W, #7N"  MZD@ )>:0 !WBY  9W
MTP '=NL "'3[  ES_P )<_\ H&D  )!I  "":0  =VD  &YJ  !D:P  66X
M $]Q  !%=0  /'@  #)Z   I?0  ((   !># @ .A0T "X48  J$(0 (A"H
M!X0R  :$/  $A$<  X12  &$7@  A&P  (1[  "#BP  @IT  (&R  !_S0
M?N4  'WT  !]_   ?/\ F6\  (IN  !^;@  =&X  &IO  !?<@  5'4  $EY
M   ^?   -7\  "N"   BA0  &(<   ^*   %C 4  (T/  "-&   C2$  (XI
M  ".,@  CCT  (Y)  ".50  CF,  (YS  "-A   C)8  (NJ  "*PP  B.(
M (?T  "&^@  AOX DW0  (5S  ![<P  <70  &5V  !9>0  3GT  $.!   W
MA0  +8@  ".+   :C@  $)    >2    E0   )8'  "6$   EA@  )<@  "8
M*0  F#,  )@^  "82P  F5D  )EI  "9>P  F(X  )>B  "6N0  E-@  )/O
M  "2^P  DO\ C7H  ()Y  !X>0  :WL  %]_  !3@P  2(<  #R+   PCP
M)I(  !N5   2EP  !YH   "<    G@   )\   "@!@  H X  *$7  "B'P
MHR@  *0S  "D/P  I4X  *5?  "E<0  I8,  *28  "CKP  HLL  *'G  "@
M]0  H/L B8   ']_  !S@0  9H4  %F)  !-C@  09(  #66   IF@  'IT
M !.@   (H@   *4   "G    J0   *L   "L    K0   *T(  "N$0  L!H
M +(D  "S,   M#X  +5/  "V80  M'<  +.,  "SHP  LKP  +':  "Q[0
ML/4 AX8  'J(  !MBP  8)   %25  !'F0  .IX  "ZB   BIP  %ZH   NL
M    KP   +$   "R    M    +8   "X    N0   +H   "\ @  O@L  , 5
M  #"(0  Q2T  ,<]  #)4   RV4  ,M[  #+D0  R*H  ,;$  #%W   Q>@
M@H\  '63  !HEP  6YP  $^A  !"IP  -:P  "FP   =LP  $;8   2Z
MO    +X   "_    P    ,(   ##    Q@   ,@   #*    S0   -$#  #6
M#@  VAP  -TJ  #A/   Y%(  .5I  #F@   YY8  .:J  #FN@  YL8 ?IH
M '&?  !DI0  6*H  $RP   _M0  ,;D  "&\   4OP  !<(   #%    R
M ,L   #+    S0   ,X   #/    T@   -4   #:    W@   .(   #F
M[ @  / 7  #S)@  ^#L  /I2  #[:P  ^X(  /R5  #\I   _*P _P & ?\
M @#_    _P % /\ $@#_ "  _P M /\ .P#_ $8 _P!1 /T 6@#[ &( ^0!I
M /8 < #T '4 \P!Z /$ ?P#P (0 [@") .T C@#L )0 Z@"< .@ I #G *\
MY0"^ .0 U #? .T V@#_ -@ _P#9 /\ V@#_ -4 _P#1 /\ _P   ?\   #_
M    _P   /\ #@#_ !P _0 J /H -P#Y $( ]P!, /, 5@#O %X [ !F .H
M; #H '( YP!W .4 ? #D (  X@"% .$ BP#? )$ W@"8 -L H0#9 *L UP"X
M -( S0#- .< RP#Z ,L _P#+ /\ S #_ ,L _P#( /\ _P   ?\   #_
M_P   /X "@#X !@ \@ F .\ ,@#M #T Z0!( .4 40#A %H W@!A -P : #:
M &T V !S -8 > #5 'T TP"" -$ AP#/ (T S0"4 ,H G0#' *< Q "S ,$
MQ@"_ -X O@#T +X _P"^ /\ O0#_ +T _P"] /\ _P   ?\   #_    ^@
M /, !0#J !0 Y0 @ .  +0#< #D V0!# -4 3 #1 %4 S@!< ,L 8P#( &D
MQ0!N ,, <P#! '@ OP!^ +X @P"\ (D NP"0 +D F0"X *( M@"N +0 O@"R
M -0 L0#N +  _P"P /\ KP#_ +  _P"P /\ _P   /\   #^    [P   .0
M 0#<  X U0 < ,X )P#+ #, R  ] ,4 1@#  $\ O !7 +D 70"W &, M0!I
M +0 ;@"S ', L@!Y +$ ?@"O (0 K@"+ *T E "K )T J0"I *@ MP"F ,L
MI0#F *0 ^0"C /\ HP#_ *, _P"C /\ _P   /P   #O    XP   -4   #-
M  D Q0 6 ,  (@"\ "T N  X +0 00"Q $D KP!1 *T 6 "K %X J0!D *@
M:0"G &\ I@!T *4 >@"D (  H@"' *$ CP"? )D G@"D )P L0": ,0 F0#=
M )@ \P"8 /\ EP#_ )< _P"7 /\ _P   /(   #D    T@   ,@   "_  (
MN0 0 +0 ' "O "< JP R *D / "F $0 I !, *( 4P"@ %D GP!? )T 9 "<
M &H FP!O )H =0"9 'P EP"# )8 BP"4 )4 DP"@ )$ K0"/ +X C@#5 (T
M[0", /L BP#_ (H _P") /\ ]@   .@   #5    Q@   +L   "T    K@ (
M *D %0"E "$ H@ L )\ -@"< #\ F@!' )@ 3@"6 %4 E0!; ), 8 "2 &8
MD0!L )  <@"/ '@ C0"  (P B "* )( B0"= (< J@"% +H A #0 (, Z "!
M /< @ #_ '\ _P!_ /\ [@   -X,  #*$   NP\  + +  "I!P  I0   *$
M#0"= !H F@ F )< , "4 #H D0!" (\ 2@"- %  C !7 (L 7 ") &( B %H
M (<!;P"% G8 A -] (,#A@"! Y  ?P.< 'X#J0!\ [D >@/. 'D%Y0!W!O8
M=@;_ '8&_P!V!O\ Z P  -0:  #!'   LAL  *<:  "@%@  FQ$  )D'! "7
M 1( D@0@ (X&*P","#4 B0H^ (<+1@"&#$T A U3 (,.60"!#E\ @ ]F '\0
M; !]$'0 ?!%\ 'H1A0!Y$8\ =Q&; '41J0!S$;H <1'1 ' 2Z0!N$OD ;1+_
M &T2_P!M$O\ X1D  ,LC  "X)0  JB4  * C  "8(   DQT  ) 7  "/$ H
MBQ$9 (<4)@"$%C  @1<Z '\80@!^&4D ?!I0 'L:5@!Y&EP >!MB '8;:0!U
M''$ <QQY '(<@@!P'(T ;AR9 &P<IP!K'+@ :1O. &<<YP!E'/D 91O_ 60;
M_P%D&_\!W",  ,4J  "R+   I"T  )DK  "2*0  C"8  (@B  "'' 0 @QP5
M '\>(0!]("P >B$V '@B/@!V(T8 ="-, ',C4P!Q)%D <"1? &\D9@!M)6X
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M>P98,H8&5C&2!E0QH0=2,;$'4##'!T\OX0=.+_4'32[_!TTM_P=-+/\'RS<
M +4Y  "D.P  ECL  (P[  "#.@  ?3<  '@V  !T-   <30' &TU%@!J-B(
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M#SX^F@\]/JP..S[!#CD]W TY//(-.3O_#3DZ_PTZ.O\-OT(  *I$  ":10
MC44  ()&  !Y10  <D0  &Q"  !F0P  844  %U&"P!:1Q@ 5T<C %1'*P-1
M1S(&3D8Y"4M%/PM(1$4.141,$$-$4Q%!1%P1/T1E$3U$<!$\1'P0.D2*$#A$
MF0\W0ZH.-4._#31"V@TS0?$-,T#_#C,__PXS/O\.NT4  *='  "72   BDD
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M!215V 0C4^\&(E'^"")0_PDA3_\*KE   )M1  ",4@  @%,  '53  !K4P
M8U0  %E6  !26   2UH  $1<   _7@8 .UX3 #E?'0 W7R8 -5\N 3)>-0,P
M7CP$+EY#!BQ>2P8J7E0&*5Y>!B=>:@4F7G<$)%Z%!"->E ,A7:8"(%R[ AY<
MU@$>6NX#'%C]!!Q7_P8;5O\'J%0  )95  "(50  ?%8  '%7  !G5P  7U@
M %5;  !.70  1U\  #]A   W9   ,F4, "]F%P N9B$ +&8I "IF,0$H9C@!
M)F9  B1F20(C9E("(69< B!F9P$>9G0!'&6# 1MED@ 99*0 %V.Y !5BU  6
M8>T %E_\ 15>_P(47?\#HU@  ))9  "#6@  >%H  &U;  !D7   6UT  %)?
M  !)8@  0F0  #EG   Q:0  *6P$ "1M$  B;AH (&XB !]N*P =;C, '&X[
M !IN1  9;DX %VY8 !5N8P 3;7$ $6U_  YMCP ,;*  "VNU  EJS@ *:.@
M"V;Z  MF_P ,9?\!G5T  (Q=  !_7@  <UX  &E?  !A8   5V(  $YE  !$
M:   /&H  #-M   K<   (G(  !EU!@ 4=A$ $W8; !%V(P /=BL #78T  QV
M/0 *=D< "'92  =V7@ %=FL  G5Z  !UB0  =)L  '.N  !QQP  <.$  &_R
M  !N_0  ;?\ EF(  (=B  !Z8P  ;V,  &9C  !=90  4V<  $EK   ^;@
M-7$  "UT   D=@  &WD  !)\   (?@D  G\3  !_'   ?R0  '\M  !_-@
M?D   'Y+  !^5P  ?F0  'YS  !]@P  ?94  'RH  !ZP   >=X  'CP  !W
M^0  =O\ D&<  ()G  !V9P  ;&@  &)H  !7:P  36\  $-R   X=@  +WD
M "9[   <?@  $X$   F#    A@0  (<,  "'%0  AQT  (@D  "(+   B38
M (A"  "(3@  B5P  (EK  "(?   AX\  (:B  "$N0  @]8  (+O  "!^P
M@/\ BFT  'UL  !S;   :6T  %UO  !2<P  1W<  #Q[   Q?@  )X(  !V$
M   4AP  "HH   &,    CP   (\$  "0#   D!4  )$<  "2(P  DRP  ),W
M  "31   E%(  )1A  "4<P  DX8  )*:  "1L   C\P  ([I  ",^   B_\
MA'(  'IR  !P<@  9'4  %=X  !,?   0($  #2$   IB   'HP  !6/   *
MD0   I0   "6    F    )D   ": @  FPH  )P2  "=&@  GB(  )\L  "@
M.   H$<  *%7  "A:0  H7P  *"1  "?IP  GL   )W>  "<\0  F_L @7@
M 'AX  !K>@  7GX  %*"  !%AP  .(P  "V0   BE   %I<   N:   !G
M )\   "A    HP   *0   "E    I@   *<'  "H#@  J1<  *L@  "M+
MKCD  *Y*  "O70  KW$  *^%  "NG   KK0  *W0  "MYP  K/0 ?WX  '*
M  !EA   6(D  $R.   _DP  ,I@  ":<   ;H   #J,   .F    J    *L
M  "M    KP   +    "R    LP   +0   "V    N <  +H1  "]&P  OR@
M ,$W  ##2@  Q5\  ,-W  #"C@  P:4  ,&]  # U0  P.@ >H@  &V+  !@
MD   4Y4  $:;   YH   +*4  ""J   4K0  ![    "S    M@   +@   "Y
M    NP   +T   "_    P0   ,,   #%    QP   ,H   #/"@  TA@  -8F
M  #;-P  WDP  .%C  #A>@  XI$  -^G  #=NP  W-  =9,  &F7  !<G0
M3Z,  $*I   UK@  *+,  !RW   .NP   ;X   #!    Q    ,8   #&
MR    ,D   #+    S@   -$   #4    V    -T   #A    YP0  .L3  #O
M(P  \S<  /9.  #X9@  ^7X  /F2  #ZH0  ^:X _P ! /\   #_    _P "
M /\ #@#_ !T _P K /\ -P#_ $( _@!. /L 5P#X %\ ]@!F /0 ;0#S ',
M\0!X /  ?0#O (( [0"' .P C #I ), YP": .0 HP#A *X WP"\ -P T #7
M .L U@#^ -4 _P#5 /\ U #_ ,\ _P#+ /\ _P   /\   #_    _P   /\
M"P#_ !H _  G /D ,P#V #X ] !) /  4@#M %H Z@!B .< : #C &\ X !T
M -X >0#< 'X V0"$ -< B0#5 (\ U "6 -( GP#1 *D S@"V ,P R #) .(
MR #X ,< _P#' /\ R #_ ,4 _P#" /\ _P   /\   #_    _P   /D !P#T
M !8 [P B .L +P#I #H YP!# .( 30#; %4 U0!= -( 8P#/ &D S0!O ,P
M= #+ 'D R@!_ ,@ A #' (H Q@"1 ,0 F0#" *, P "P +X P "\ -D N@#Q
M +D _P"Y /\ N0#_ +D _P"W /\ _P   /\   #_    ]P   .P  P#F !$
MW@ > -H *0#8 #0 T0 ^ ,P 1P#( %  Q0!7 ,, 7@#! &0 OP!I +T ;P"\
M '0 NP!Y +H ?P"X (4 MP", +8 E "T )T L@"J +  N "N ,X K #I *P
M_0"K /\ JP#_ *L _P"K /\ _P   /\   #T    Z    -X   #4  L S0 9
M ,@ ) #" "X OP Y +T 0@"Z $H MP!2 +4 6 "S %X L0!D +  :0"N &\
MK0!T *P >@"K (  J0"' *@ CP"G )@ I0"D *, L0"A ,4 H #? )\ ]P"?
M /\ G@#_ )X _P"> /\ _P   /4   #H    V0   ,T   #$  8 O@ 3 +<
M'P"S "D L0 S *\ / "M $4 J@!, *@ 4P"F %D I0!> *, 9 "B &D H0!O
M )\ =0"> 'L G0"" )P B@": ), F0"? )< K "5 +T E #6 )( [P"1 /\
MD0#_ )$ _P"1 /\ ^@   .P   #9    R@   +\   "W    L  , *L &0"H
M "0 I0 M *, -P"A #\ GP!' )T 3@"; %0 F0!9 )@ 7P"6 &0 E0!J )0
M< "2 '8 D0!] (\ A0". (\ C ": (L IP") +< B #. (< Z "& /H A@#_
M (8 _P"& /\ \0   -\   #,    O0   +,   "L    I@ & *( $P"> !X
MFP H )D ,0"6 #H E !" )( 20"0 $\ CP!5 (T 6P", &  B@!F (D ; "(
M '( A@!Z (4 @@"$ (P @@"7 ($ I "  +, ?@#' 'T X@!\ /4 >P#_ 'H
M_P!Z /\ Z0   -,'  # "0  L@@  *@'  "A @  G0   )D "P"6 !< DP B
M )  + "- #4 BP ] (@ 1 "' $L A0!1 (0 5P"# %P @0!B (  : !_ &\
M?@!W 'P ?P![ (D >0"5 '< H0!V +$ = #$ ', W0!Q /  < #\ '  _P!P
M /\ X@P  ,H3  "W%0  J18  )\4  "8$0  DPL  )$$ P"/ !  BP < (@
M)P"% #  @@(Y ($#0 !_!$< ?05- 'P&4P![!ED >0=? '@'9@!W!VT =0AU
M '0(?@!R"(@ < B4 &X(H0!M"+  :PC$ &D(W !H"O  9PK] &8*_P!F"O\
MV1@  ,$<  "P'@  HA\  )@>  "0&P  BQ@  (@3  "'"P< A D5 ($+(0!^
M#2L >PXT 'D0/ !X$4, =A)* '034 !S$U8 <1-= ' 48P!N%&L ;11S &L5
M? !I%8< 9Q63 &84H !D%+  8A3% & 4W@!?%?, 7A7_ %X5_P!=%/\ T2
M +HC  "I)@  G"8  )$E  "*(P  A"$  ($=  !_&   ?14/ 'D7' !V&"<
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M!$XLF@1,*ZL$2BN^!$@JV01'*? $1RC_!4<H_P5')_\%P2\  *PR  ";-
MCC4  (0U  !\-   =C(  '$P  !M+P  :2X" &8N$0!C,!P 8# F 5TQ+@);
M,38#63$]!%<Q0P15,4H%5#%0!5(Q5P90,5\&3S%H!DTQ<@9+,7X&23&*!D<Q
MF 9%,*D&0S"\!D$OU@9 +NX'0"W^!T L_P= +/\'O#,  *@V  "8.   BSD
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M0   :C\  &0^  !>/0  6CX  %4_!0!20!, 4$$= $U")@%*02T#1T$T!45
M.@A"0$$*0#]'"ST_3PP[/U<,.3]@##@_:PPV/W<,-#^%"S,_DPHQ/Z0),#ZX
M"2X^T0@M/>L)+3O["BTZ_PHM.O\*L#X  )Y   ".00  @D(  '=#  !N0P
M9T,  &!"  !90@  5$0  %!% 0!,1@X 2D<: $A'(P!%1RL"0D<Q!#]&. <\
M1CX).45%"C=%30LU154,,T5?##)%:0LP178*+T6#"2Y%D@@L1:,'*T2W!RE$
MT 8H0NH')T'[""= _PDG/_\*K4$  )I#  "+10  ?T8  '1&  !K1@  8T8
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M 192_P(44O\#GDT  (Y.  " 3P  =%   &E1  !@40  6%(  %!3  !(5@
M05@  #E;   R70  *E\& "9@$0 D81H (V$B "%A*P @83( 'F$Z !UA0P ;
M84P &6%6 !=A80 686X %&!\ !%@BP /7YT #5ZP  M=R  +7.0 #5KW  U9
M_P -6/\!F5$  (E2  !\4P  <%0  &55  !=50  558  $Q8  !#6P  /%X
M #1@   L8P  )&4  !QH"0 9:!, %V@< !5H)  4:2P $VDU !%I/0 .:4<
M#&A1  IH70 (:&D !F=W  1GAP "9I<  6:K  !DP@  8]T  6'P  )@_  #
M7_\ DU8  (17  !W6   :U@  &)9  !:60  45L  $A=   ^80  -F0  "YF
M   F:0  '6P  !5N   +<0H "'$5  9Q'0 $<28  W N  )P-P  <$$  '!+
M  !P5P  <&,  &]R  !O@0  ;I(  &ZE  !MO   :]H  &GM  !H^   9_\
MC5L  ']<  !R7   9UT  %]=  !67@  3&$  $-D   X9P  ,&H  "=M   >
M<   %G(   UU   $> 8  '@/  !X%P  >1\  'DG  !Y+P  >3D  'E$  !Y
M4   >5T  'EK  !X>P  =XT  '>@  !VM@  =-,  '/M  !R^0  <?X AV
M 'IA  !N80  9&$  %MB  !190  1V@  #QK   R;P  *'(  "!U   7>
M#GH   5]    ?P(  ( *  " $@  @1D  ((@  "")P  @S   (,[  "#2
M@U4  (-D  "#=   @H<  (&:  " L   ?\P  '[H  !\^   ?/\ @68  '5F
M  !K9@  868  %9I  !+;0  0'   #5T   K>   (7L  !=^   -@   !8,
M  "&    B    (D"  "*"0  BA$  (L8  ",'P  C2<  (XP  "./@  CDP
M (];  "/;   CG\  (V4  ",J@  B\,  (GC  "(]   B/X ?&P  ')K  !H
M:P  7&X  %!R  !$=@  .7H  "U^   B@@  &(4   V(   #BP   (X   "0
M    D@   )0   "5    E@8  )8-  "7%0  F1T  )LE  "<,0  G#\  )Q/
M  "=8   G70  )R)  ";H   FK@  )G4  "7[0  E?H >7$  '!Q  !C=
M5G@  $I\   ]@0  ,84  "6*   :C@  #I$   24    E@   )D   ";
MG0   )\   "@    H0   *("  "C"0  I1(  *<:  "I)0  JC(  *I#  "K
M50  K&D  *M_  "KE0  JJT  *G'  "HX0  J/$ =W<  &IZ  !=?@  48(
M $2(   VC@  *I(  !Z6   2F@  !IT   "@    H@   *4   "G    J0
M *L   "L    K0   *X   "P    L@0  +0-  "W&   N20  +HS  "\1P
MO5P  +UR  "]B   O9\  +RW  "\T   N^4 <H   &6$  !8B0  2X\  #Z5
M   PFP  ))\  !>D   *IP   *H   "M    L    +(   "T    M@   +<
M  "Y    NP   +T   "_    P0   ,0   #)!@  S!,  - @  #4,0  V$<
M -Q=  #:=P  UY   ->F  #6N@  ULT ;8L  &&0  !4E@  1YP  #BB   K
MJ   'JT  !*R   %M0   +@   "[    O@   ,$   #"    PP   ,4   #&
M    R0   ,P   #/    T@   -8   #<    X@   .8.  #J'P  [S(  /))
M  #U8@  ]GD  /:.  #UH   ]*\ _P   /\   #_    _P   /\ "P#_ !H
M_P H /\ - #_ #\ _P!) /H 4P#T %L [P!C .P :0#K &\ Z0!U .@ >@#G
M (  Y@"% .0 BP#C )$ X@"8 .  H0#> *L W0"Y -H SP#7 .@ U #] -(
M_P#2 /\ SP#_ ,D _P#% /\ _P   /\   #_    _P   /\ "0#^ !8 ^0 D
M /< +P#V #H [P!$ .D 3@#F %8 XP!= .  9 #> &H W !P -H =0#9 'H
MV "  -8 A@#4 (P TP"3 -$ G #/ *8 S0"R ,L Q@#( .  Q@#W ,0 _P##
M /\ PP#_ +X _P"\ /\ _P   /\   #_    _0   /< ! #O !, ZP ? .<
M*@#@ #4 W@ _ -L 2 #7 %$ TP!8 -$ 7@#. &0 S !J ,H ;P#( '4 Q@!Z
M ,4 @ #$ (8 P@". ,$ E@"_ *  O0"K +L O "Y -4 MP#O +4 _P"T /\
MM #_ +0 _P"R /\ _P   /\   #\    \    .@   #@  T V0 ; -$ )0#.
M #  S  Z ,H 0P#& $L PP!2 ,  60"^ %\ O !D +H :@"Y &\ MP!T +4
M>P"T ($ LP"( +$ D "P )H K@"E *T M "K ,D J0#F *@ ^P"G /\ IP#_
M *< _P"G /\ _P   /L   #N    X0   -8   #.  @ Q  5 ,  (0"] "H
MNP T +D /0"V $4 LP!, +$ 4P"O %D K0!> *P 9 "J &D J0!O *< =0"E
M 'L I "" *( B@"A )0 GP"> )T K "< +\ FP#; )H \P"9 /\ F #_ )@
M_P"8 /\ _@   /    #>    T    ,4   "\  , M0 0 +$ &P"N "4 K  N
M *H . "H $  I@!' *, 30"A %, GP!9 )T 7@"; &0 F@!I )D ;P"7 '8
ME@!] )4 A0"3 (X D@"9 )  IP"/ +< C@#0 (T ZP", /X C #_ (P _P",
M /\ ]@   .(   #0    P0   +<   "N    J0 * *4 %0"B "  GP I )T
M,@"; #H F !" )8 2 "4 $X DP!4 )$ 60"0 %\ CP!D (T :@", '$ BP!X
M (D @0"( (H AP"4 (4 H@"$ +$ @P#& (( XP"! /< @0#_ ($ _P"  /\
M[    -8   ##    M    *H   "D    GP $ )H $ "7 !H E  D )$ +0"/
M #4 C0 ] (L 1 "* $H B !/ (< 50"& %H A !@ (, 9@"" &T @0!T '\
M?0!^ (8 ? "1 'L G@!Y *T > #  '< VP!V /( =@#_ '8 _P!U /\ X
M ,D   "X @  J@,  * "  "9    E@   )$ "0". !0 BP > (@ * "& #$
MA  X (( /P"! $8 ?P!+ 'X 40!\ %< >P!< 'H 8@!X &D =P!Q '8 >0!T
M (, <P". '$ FP!O *D ;@"\ &T U0!L .T :P#Z &H _P!J /\ U@@  , ,
M  "M$   H1   )<.  "0"P  BP<  (D  0"&  T @P 8 ($ (@!^ "P ?  T
M 'H .P!X $( =P!( '4 30!T %, <@!9 '$ 7P!P &8 ;@!N &T =P!K 8$
M:0&, &@ F0!F *@ 9 "Z &, T@!A >D 80+W & "_P!@ O\ SA$  +@5  "F
M&   FAD  ) 8  "(%P  @Q0  ( .  !_!P4 ?0(2 'H#'0!W!2< = 8O '('
M-P!Q"#X ;PE$ &X*2@!L"E  :PM7 &D,70!H#&4 9@QM &0,=@!C#($ 80R,
M %\,F0!=#*D 6PR[ %D,TP!8#>H 5PWY %<-_P!7#/\ QAD  +$<  "@'P
MDR   (D@  ""'P  ?1P  'D9  !W%   =@X* ',.%P!P$2( ;1(K &L3,P!I
M%#H 9Q5! &851P!D%DX 8Q94 &$76P!@%V( 7A=K %P7= !:%W\ 61>+ %<7
MF !5%Z@ 4Q>Z %$6TP!0%^P 3Q;\ $\6_P!/%O\ P!\  *LC  ";)   CB4
M (0F  !\)0  =R,  ',@  !P'0  ;AD% &P8$P!I&AX 9ALG &0<, !B'3<
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M!#HJS00Y*>@$.2CZ!#DG_P0Y)_\$LBP  )\P  "0,0  @S,  'DS  !P,@
M:C(  &0P  !@+@  72X  %DN!P!6+Q0 4S > %$P)@%/,2T"3#$T THQ.P1)
M,4$$1S%(!44Q3P5#,5<&03%@!C\Q:@8],78&.S&#!CDQD08W,*$%-2^T!3,O
MS 4R+N8%,BWY!C(L_P8S+/\&KC   )PS  ",-0  @#8  '8V  !M-@  9C8
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M!2 [_P8@.O\'HSL  )$]  "#/P  =S\  &Q   !C0   7$$  %5!  !-00
M1T,  $-%   _1@0 .T<0 #E'&@ W1R( -$<I 3)', (P1S<$+D<^!2Q'1@4J
M1T\%*$=8!2='8P0E1V\$(T=] R)'C (@1IP"'D:O 1U%QP$<1.(!&T+V QI!
M_P0:0/\%GSX  (Y   " 0@  <T,  &E#  !@1   6$0  %%%  !)1@  0D@
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M6P +6V< "5MU  =:A  %6I0  UFG  )8O0 "5M@  U7M  14^P %4_\ D$L
M (%,  !S30  9TX  %Y.  !63P  3T\  $=1   ^5   -E<  "]9   G7
M'UX  !=A P 08PP #6,6  MC'@ )8R8 "&,N  9C-P %8T   V-+  %B5@
M8F(  &)P  !A?P  88\  &"B  !?MP  7M0  %SJ  !;]P  6OX BT\  'Q1
M  !O4@  8U(  %I2  !34P  2U0  $)7   Y6@  ,%T  "A?   @8@  &&4
M !!G   ':@<  6L0  !K&   :R   &LH  !K,0  :SH  &I%  !J4   :EP
M &IJ  !I>@  :8H  &B=  !GL@  9LX  &7J  !C]@  8OT A50  '96  !J
M5@  8%8  %A6  !/5P  1EH  #Q=   S8   *F0  "%F   9:0  $6P   AO
M    <00  '(+  !R$P  <QH  ',A  !T*0  =#(  '0]  !T20  <U8  '-D
M  !S=   <H4  '&8  !QK0  <,@  &[F  !M]P  ;/\ ?UH  '%;  !F6P
M75L  %5;  !*7@  0&$  #9E   L:   (FP  !EO   0<@  "'0   !W
M>0   'H&  !Z#0  >Q0  'P;  !](@  ?BH  '\T  !^00  ?DX  'Y<  !^
M;0  ?7\  'R2  ![J   >\$  'GA  !X]   =_X >5\  &U@  !C8   6F
M $]B  !$9@  .6H  "]N   D<@  &G4  !%X   '>P   'T   "     @@
M (,   "$!@  A0T  (84  "'&@  B"(  (HJ  "*-P  BD4  (I4  "*9
MBG<  (F+  "(H@  A[H  (;9  "$\0  @_P =&4  &EE  !A90  56@  $EK
M   ]<   ,G0  "=X   <?   $7\   >"    A0   (<   "*    C    (X
M  "/    D 0  )$*  "2$0  E!@  )4@  "7*P  ESH  )=*  "86P  F6T
M )>#  "7FP  E;,  )/1  "2Z@  D?< <&L  &AJ  !;;0  3W$  $)V   V
M>P  *H   !Z$   3AP  !XH   "-    D0   )0   "6    F    )H   ";
M    G    )T   "?!0  H0P  *,5  "E'0  IRH  *<[  "H30  J6   *EV
M  "HC@  IJ8  *7!  "DW   I.T ;W   &)S  !5=P  27P  #N"   NAP
M(8P  !61   )E    )<   ":    G0   *    "B    I    *8   "G
MJ0   *H   "K    K0   *\(  "R$@  M1X  +@M  "X0   N50  +IK  "Y
M@@  N9H  +BQ  "WRP  M^$ :GD  %U^  !0@P  0XD  #2/   HE   &YH
M  Z>   !H0   *0   "G    J@   *P   "N    L0   +,   "U    MP
M +D   "Y    O    +\   ## @  R T  ,P;  #.+   T$,  -%<  #1=
MT8L  -*B  #1M@  T<H 980  %B*  !+D   /98  #"=   BH@  %:<   BK
M    KP   +(   "V    N    +H   "\    O@   ,    #"    Q    ,<
M  #*    S    -    #4    W    .$*  #F&@  ZBT  .Y$  #R70  \'<
M .^/  #MI   [K, _P   /\   #_    _P   /\ " #_ !@ _P D /\ , #\
M #L ^@!% /< 3@#T %< \0!> .\ 9 #M &L ZP!P .D =@#G 'L Y@"! .0
MAP#C (X X0"6 .  GP#> *D W "W -H RP#8 .< U #] -( _P#/ /\ R@#_
M ,0 _P#  /\ _P   /\   #_    _P   /\ !@#[ !0 ]P @ /$ *P#O #8
M[@!  .L 20#G %$ Y !9 .$ 7P#? &4 W !K -L < #9 '8 U@![ -0 @0#2
M (@ T0"0 ,\ F0#- *, RP"P ,D P0#' -L Q0#W ,, _P#  /\ OP#_ +D
M_P"V /\ _P   /\   #_    ^P   /(  @#M !  XP ; .$ )@#? #$ W0 [
M -H 1 #6 $P T@!3 -  60#- %\ RP!E ,D :@#' '  Q0!U ,, >P#  ((
MO@"* +P DP"Z )T N "I +8 N "U ,X M #N +, _P"R /\ L #_ *\ _P"L
M /\ _P   /\   #U    [    .,   #6  H T0 7 ,T (0#+ "L R0 U ,@
M/@#$ $8 P0!- +T 4P"Y %D MP!? +0 9 "R &H L0!O *\ =0"N 'P K "$
M *L C0"I )8 J "B *8 L "D ,0 HP#C *( ^@"A /\ H0#_ *$ _P"@ /\
M_P   /8   #G    V@   ,\   #$  4 OP 2 +L '0"Y "8 MP O +0 . "P
M $  K0!( *H 3@"I %0 IP!9 *4 7@"D &0 HP!I *$ ;P"@ '8 G@!^ )T
MA@"< )  F@"< )D J0"7 +H E@#8 )4 \@"4 /\ DP#_ ), _P"3 /\ ^0
M .8   #6    R    +P   "U    KP , *P %P"I "$ I0 J *, ,P"B #L
MGP!" )T 20"; $X F@!4 )@ 60"7 %X E0!D )0 :@"2 '  D !X (\ @ ".
M (H C "6 (L HP"* +, B #+ (@ Z0"' /T AP#_ (< _P"' /\ [P   -H
M  #'    N    *\   "H    HP ' )X $@": !P F  E )8 +@"5 #8 DP ]
M )  1 ". $H C0!/ (L 5 "* %D B0!? (< 90"& &L A0!S (, >P"" (4
M@0"0 (  G0!^ *T ?0#! 'P WP!\ /8 >P#_ 'L _P![ /\ X@   ,P   "Z
M    K    *,   "=    EP ! )( # "/ !< C0 @ (L *0") #$ AP X (4
M/P"$ $4 @@!* ($ 4 "  %4 ?@!: 'T 8 !\ &< >@!N 'D =P!X ($ =@",
M '4 F0!S *@ <@"Z '$ U !P .\ < #_ '  _P!P /\ U@   ,    "N
MH@   )@   "1    C0   (D !@"& !$ A  ; ($ ) !_ "P ?@ S 'P .@!Z
M $$ >0!& '< 3 !V %$ = !7 ', 70!R &, < !K &\ <P!M 'T ; "( &H
ME0!I *0 9P"T &8 S0!F .@ 90#Z &4 _P!D /\ S $  +8&  "F"   F0H
M (\*  "(!P  A ,  ($   !^  H ?  5 'D 'P!W "< =0 O ', -@!Q #P
M< !" &X 2 !M $X :P!3 &H 60!H &  9P!H &8 <0!D 'L 8P"& &$ D@!?
M *$ 7@"R %P R !< .0 6P#T %H _@!: /\ PPH  *X0  ">$@  D10  (<4
M  " $@  ? X  '@*  !W! 0 =0 . ', &0!P "( ;0 J &L ,@!I 3D : (_
M &8#10!E TL 8P11 &($5P!@!5X 7P5F %T%;P!<!7D 6@6% %@%D0!6!:
M5 6Q %,$QP!2!>  407Q %$%_0!1!?\ O!(  *@6  "8&0  BQL  ($;  !Z
M&@  =!@  '$4  !O$   ;@D' &P'$P!I"1T 9@HF &0++@!B##4 80T[ %\-
M0@!>#D@ 7 ]. %L050!9$%P 5Q!E %80;@!4$7D 4A&% % 1D@!.$*$ 3!"S
M $H/R@!)#^, 20_U $@._P!(#O\ MA@  *(<  "3'@  AB$  'PA  !T(
M;A\  &H<  !H&0  9A4  &42#0!B$QD 7Q4B %T5*@!;%C$ 61<X %@7/P!6
M&$4 51A+ %,84@!1&5H 4!EB $X9; !,&7< 2AF# $@9D !&&:  1!BQ $(8
MR !!%^, 01?V $$7_P!!%O\ L!T  )XA  ".(P  @B4  '@F  !P)0  :20
M &4B  !B'P  7QT  %X;"0!;&Q4 6!P? %8=)P!4'BX 4A\U %$?/ !/'T(
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M RPG_P0L)O\$I"D  ),L  "$+@  >#   &XP  !E,0  7C$  %@P  !4+P
M4"T  $PN  !)+PD 1B\5 $0P'@!","4 0#$L 3TQ,P([,3D#.3% !#@Q2 0V
M,5 %-#%9!3(Q8P0P,6\$+C%[!"PQB@,J,)H#*#"L R<OP@(E+MT")2WS R4L
M_P0F*_\$H2T  ) O  "!,@  =3,  &LT  !B-   6S0  %0T  !/,P  2S(
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M7@(>0FH!'$)W 1I"A@ 8098 %D&I !5 OP 3/]H %#[Q !0\_P$4._\"EC<
M (4Z  !X/   :ST  &$]  !8/@  43X  $H_  !$0   .T(  #9$   Q10
M+4<% "E(#P G2!@ )4@@ "-))P A22\ ($DV !Y)/@$<24< &TE1 !E)7  7
M26@ %4EU !-(A  11Y0 #D>G  Q&O  +1=8 #$3O  U"_0 -0?\!DCL  ($^
M  !T/P  :$   %U!  !500  34(  $="  ! 1   .$8  #-(   M2@  )DP
M "%."@ >3Q0 '$\< !I/(P 83RL %T\R !5/.P 43T0 $D]. !!/60 -3V4
M"D]R  A.@0 &3I$ !4VC  -,MP "2]$  TKI  5)^0 %2/\ C4   'U"  !P
M0P  9$0  %I%  !110  2D4  $1&   ]2   -$L  "Y-   H3P  (5$  !E4
M!  35@T $586  Y6'@ -5B8 "U8N  I6-@ (5C\ !E9)  165  "56   %5M
M  !5?   5(P  %.>  !2LP  4<X  %#F  !/]0  3_T B$0  'E&  !K1P
M8$@  %9(  !.2   2$D  $%*   X30  ,%   "E2   B5   &E<  !-:   *
M70@ !%T1  )=&0  72$  %TI  !=,0  73H  %U$  !=3P  75L  %QI  !<
M>   6X@  %N:  !:K@  6<D  %CF  !6]   5?P @DD  '-+  !F3   7$P
M %-,  !,3   1$T  #Q0   S4P  *U8  "-8   ;6P  %%X   M@   #8P4
M &0-  !E%   91L  &4C  !E*P  930  &4^  !E20  954  &5C  !D<@
M8X,  &.5  !BJ@  8<0  &#B  !?]0  7OT ?$X  &Y0  !B4   6%   %%0
M  !)40  /U,  #96   M6@  )%T  !M@   38P  "V4   -H    :@(  &L)
M  !L$   ;!8  &T=  !N)   ;RT  &\W  !N0@  ;D\  &Y=  !N;0  ;7X
M &R0  !KI0  :[X  &K>  !I\P  9_X =E0  &E5  !>50  5E0  $Y5  !$
M5P  .5L  #!>   F8@  '&4  !-H   *:P   VX   !P    <P   '0#  !U
M"0  =A   '<6  !X'0  >24  'HN  !Z.@  >4<  'E6  !Y90  >'<  '>+
M  !VH   =;@  '76  !S\0  <_P <%D  &1:  !<60  4UD  $E<   ]7P
M,F,  "AH   >:P  %&\   ER   "=0   '<   !Z    ?    'T   !_ @
M@ @  ($.  ""%0  A!P  (4E  "'+P  ACT  (5-  "%70  A6\  (2#  "#
MF@  @K$  ('/  "!ZP  ?_H :U\  &)>  !97@  3F$  $)E   V:0  *VX
M !]R   5=@  "7H   !]    ?P   ((   "$    A@   (@   ")    BP
M (P&  "-#   CQ0  )$;  "3)   E#(  )-#  "35   E&8  )-[  "2D@
MD:L  (_'  ".Y0  CO4 :&0  &!D  !49P  2&L  #MP   N=0  (GH  !9^
M   *@@   (4   "(    BP   (T   "0    D@   )0   "6    EP   )@
M  ": @  G D  )X1  "A&0  HR0  *0U  "C20  I%L  *5O  "DAP  HZ$
M *&\  "?W0  G?  9VH  %IM  !.<0  078  #1\   F@0  &H8   R*   !
MC@   )$   "5    F    )L   ">    H    *(   "C    I0   *<   "H
M    J@   *P#  "O#   LQ8  +8E  "V.   MDP  +AA  "W>@  MI,  +2L
M  "SQ@  L]\ 8G,  %5W  !(?0  .H,  "V)   ?C@  $I0   29    G
M )\   "B    I0   *@   "J    K    *X   "P    L@   +,   "T
MMP   +D   "]    P@D  ,88  #**0  RCX  ,Q5  #-;@  S88  ,V=  #-
MLP  S,@ 77X  %"#  !"B@  -)$  ":7   9G0  "Z(   "F    J0   *P
M  "O    L@   +4   "X    N@   +P   "_    P0   ,0   #&    R
M ,P   #0    V    -T%  #A%0  Y2@  .E   #J7   Z'<  .F-  #JH@
MZK( _P   /\   #_    _P   /\ " #_ !0 _P @ /\ + #^ #< _ !! /D
M2@#V %( ] !9 /( 8 #P &8 [@!K .P <0#J '8 Z !\ .8 @P#C (H X "2
M -T G #; *< V "V -4 R@#4 .< TP#\ -, _P#/ /\ Q0#_ +\ _P"[ /\
M_P   /\   #_    _P   /\  P#U !$ \P ; /( )P#P #( \  \ .P 10#I
M $T Y0!4 .$ 6@#< &  V0!F -4 :P#2 '$ T !V ,X ?0#, (0 R@", ,@
ME0#& *$ Q "N ,( P0#  -P O@#U +P _P"\ /\ N #_ +0 _P"Q /\ _P
M /\   #_    ]P   .X   #F  P XP 8 .  (@#> "P W0 V -< /P#/ $<
MS !. ,D 5 #& %H Q !@ ,( 90#  &L OP!P +T =P"[ 'T N0"% +< C@"U
M )D M "G +( MP"P -  K@#M *T _P"L /\ J@#_ *8 _P"D /\ _P   /P
M  #R    Z    -D   #3  < S@ 3 ,L '@#& "< P0 Q ,  .@"] $( N@!)
M +< 3P"U %4 LP!: +$ 7P"O &4 K0!J *L < "J '< J !_ *8 B "D )(
MHP"? *( KP"@ ,0 GP#B )X ^P"= /\ G0#_ )L _P"9 /\ _P   .X   #@
M    T@   ,<   "_  ( N@ - +0 &0"Q ", KP K *X - "L #P J0!# *8
M2@"D $\ H@!5 *$ 6@"? %\ G@!D )P :@"; '$ F0!Y )< @0"6 (L E "7
M )0 IP"2 +D D0#5 (\ \P"/ /\ C@#_ (X _P". /\ \0   .    #.
MOP   +8   "O    J  ( *0 % "A !T GP F )T +P"< #< F@ ^ )@ 1 "6
M $H E !/ ), 5 "1 %H D !? (X 90"- &L BP!S (D >P"( (4 A@"0 (8
MH "% +$ A #) (, Z0"" /X @@#_ (( _P"" /\ YP   -    "]    L
M *@   "A    F@ # )< #@"4 !@ D0 A )  *@". #$ C0 Y (L /P") $4
MB !+ (8 4 "% %4 @P!: (( 8 "  &8 ?P!N 'T =@!\ (  >P"+ 'H F0!Y
M *D > "^ '< W0!V /8 =@#_ '8 _P!V /\ V0   ,,   "Q    I    )L
M  "4    CP   (L "0"( !, A@ < (0 )0"# "P @@ T (  .@!^ $  ?0!&
M 'L 2P!Z %  > !6 '< 6P!U &( = !I '( <0!P 'L < "' &\ E !M *,
M; "V &L T0!J .T :@#_ &H _P!J /\ S    +8   "F    F@   )    ")
M    A@   (( ! !_  T ?  7 'H ( !Y "@ =P O '8 -0!T #P <@!! '$
M1P!O $P ;@!1 &T 5P!K %X :0!E &< ;0!F '< 90"# &0 D !B )\ 80"P
M &  QP!? .0 7P#Y %\ _P!? /\ P@   *T   ">!   D 8  (<%  "  P
M?    'H   !V  @ =  2 '( &P!O ", ;@ J &P ,0!J #< :0 ] &< 0P!F
M $@ 9 !. &, 5 !A %H 8 !B %X :@!= '0 6P"  %H C !8 )L 5P"K %4
MP !5 -T 50#T %4 _P!4 /\ N00  *8)  "6#   B0\  '\/  !X#0  = H
M ' %  !O  , ;  , &H %0!H !X 9@ F &0 +0!B #, 8  Y %\ /P!> $4
M7 !+ %L 40!9 %@ 6 !? %8 : !5 '( 4P!^ %$ B@!/ )D 30"I $P O0!,
M -D 2P#N $H ^@!* /\ L0L  )\1  "/%   @Q8  'D6  !R%@  ;!0  &D0
M  !F"P  9@8& &0"$ !A AD 7P,A %T$*0!;!2\ 608V %@&/ !6!T( 50A(
M %,(3P!2"%8 4 E> $X)9P!-"7$ 2PE] $D)B@!'"9D 10BI $0'O0!"!M8
M00?K $$'^0!!!_\ K!(  )H6  "*&@  ?AL  '0<  !L'   9AH  &(8  !?
M%0  7A$  %T+" !;"Q0 6 T= %8.)0!4#RP 4Q S %$1.0!/$3\ 3A)& $P2
M30!+$E0 21-< $<39@!%$W$ 0Q-] $$3B@ _$YD /1*K #L1P  Y$-H .1#O
M #D0_  Y$/\ IQ<  )4:  "&'@  >B   ' A  !G(0  82   %P>  !9&P
M5QD  %86 P!4%0\ 4189 $\7(0!-%RD 3!@O $H9-@!(&3P 1QE# $4:2@!$
M&E( 0AI: $ :9  ^&F\ .QI[ #D:B0 W&I@ -1FI #,9O@ Q&-D ,1CP #(7
M_@ R%O\ HQL  )$>  "#(@  =R0  &PE  !D)0  720  %@C  !4(0  4AX
M % <  !-' L 2QT6 $D>'@!''B8 11\L $,?,P!"(#D 0"!  #\@2  ](4\
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M7@(I+&D")RQV B4LA $C*Y0!(2NF 1\JNP >*=4 'BGM 1XH_0(>)_\"F"8
M (<I  !Y*P  ;2T  &(N  !:+P  4B\  $TN  !(+@  0RT  #\N   [+P
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M !(]@  0/)  ##NA  H[M0 ).LX "CGH  LX^0 ,-_\ C3$  'TT  !O-0
M8S<  %DW  !0.   23@  $,Y   ].0  -CL  # ]   K/@  )D   "%""0 >
M0A( '$,: !M#(0 90RD %T,P !9$.  41$$ $D-+ !!#5@ -0V$ "T-N  E#
M?0 '0HP !$&>  ) L0 !/\L  C[D  0]]0 %//\ B34  'DX  !L.0  8#H
M %4[  !-.P  1CP  $ \   Z/0  ,S\  "U!   G0P  (44  !I'!  620T
M$TH6 !%*'0 /2B4 #4HL  M*-  )2CT "$I'  9)4@ $25T  4EJ  !)>0
M2(D  $>:  !&K@  1<<  $3B  !#\@  0_L A#H  '4\  !G/0  7#X  %(^
M  !*/P  0S\  #T_   W00  +T,  "A&   B2   '$H  !5-   -3P@ "% 1
M  50&0 #42$  E H  !0,   4#D  %!"  !030  4%D  %!F  !/=0  3X4
M $Z7  !-JP  3,,  $OA  !*\@  2?L ?SX  '!   !C00  6$(  $]"  !'
M0@  04(  #I#   R1@  *T@  "-+   <30  %E    Y2   &508  %<-  !7
M%0  6!P  %@C  !8*P  5S,  %<]  !72   5U0  %=A  !7<   5H$  %:3
M  !5J   4\   %+>  !1\P  4?T >D,  &M%  !>1@  5$8  $Q&  !%10
M/D8  #5)   M3   )4\  !U1   65   #E8   =9    7 0  %T*  !>$0
M7A<  %\>  !@)0  8"X  & W  !@0@  7T\  %]<  !?:P  7GP  %Z/  !=
MI   7+L  %K;  !:\@  6?X =$@  &9*  !:2@  44H  $I)  !"2@  .4T
M #!0   G4P  'E8  !99   .6P  !EX   !A    8P   &0&  !E#   9A(
M &<9  !H(   :2<  &DQ  !I/   :4D  &E7  !H9@  :'<  &>*  !FGP
M9;8  &35  !C\   8OT ;4X  &%.  !73@  3TX  $=.   ]40  ,U0  "I7
M   @6P  %EX   QB   %9    &<   !J    ;    &T   !O!@  < L  '$2
M  !R&   ="   '4H  !U,P  =4   '1/  !T7@  <W   '*$  !QF0  <+$
M &_/  !OZP  ;OL :%,  %U3  !44P  35(  $)5   V60  +%T  "%A   7
M90  #&D   -L    ;P   '$   !T    =@   '<   !Y    >@0  'P*  !]
M$0  ?Q@  ( @  ""*@  @C<  (%&  "!5P  @&@  (!]  !^D@  ?*H  'O&
M  ![Y@  >_< 8UD  %I8  !36   1UH  #M?   O8P  )&@  !AL   ,<
M G0   !W    >@   'T   !_    @0   (,   "%    A@   (@!  "*!P
MBPT  (X6  "0'P  DBH  )$Z  "03   D%\  (]S  ".B@  C*(  (N^  "*
MW@  B?, 8%X  %E=  !-8   0&4  #-J   G;P  &G0   YX   "?0   (
M  "#    A@   (D   "+    C0   (\   "1    DP   )0   "6    F 0
M )H+  "=%0  H!X  *(M  "@00  H%0  *!I  "@?P  GID  )VT  ";TP
MFNT 8&,  %-F  !&:P  .7   "QV   ??   $H$   6%    B0   (P   "/
M    D@   )4   "8    FP   )T   "?    H0   *,   "D    I@   *D
M  "L!P  L!   +0>  "T,0  LT<  +1;  "V<0  M(L  +.E  "QP0  K]T
M6FP  $UQ  ! =P  ,GT  "2#   7B0  "(X   "2    E@   )H   ">
MH0   *0   "F    J    *L   "M    KP   +$   "R    M    +<   "[
M    OP0  ,40  #*(0  R38  ,M-  #-9   S'X  ,J7  #(L   Q\8 57<
M $=]   ZA   *XL  !V1   .EP   9T   "A    I0   *@   "K    K@
M +    "S    M0   +<   "Z    O    +X   #!    P@   ,8   #*
MSP   -<#  #<%   WR8  .$_  #C60  Y7(  .6)  #FGP  YK$ _P   /\
M  #_    _P   /\ ! #_ !$ _P < /\ * #_ #, _P ] /D 1@#R $T \ !4
M .T 6P#K &$ Z0!F .< ; #E '( XP!X .$ ?@#? (4 W0". -H F #7 *0
MU "S -, S #0 .L S@#_ ,L _P#$ /\ N@#_ +4 _P"S /\ _P   /\   #_
M    _P   /H   #W  T ]  9 /, (P#O "T Z@ X .< 00#C $D WP!0 -P
M5@#: %P UP!A -0 9@#1 &P SP!R ,P > #* '\ QP"' ,4 D0#" )P OP"K
M +X OP"] .  NP#Z +H _P"W /\ KP#_ *L _P"H /\ _P   /\   #]
M\@   .H   #E  @ X@ 4 -H 'P#6 "@ U0 R -, / #. $0 R0!+ ,8 40##
M %8 P !< +X 80"] &8 NP!L +@ <@"W 'D M0"! +( B@"P )4 K@"B *P
MLP"M -$ JP#Q *D _P"H /\ HP#_ *  _P"> /\ _P   /H   #N    WP
M -8   #/  , Q@ / ,( &@#  "0 O0 M +L -@"X #X M0!% +, 2P"P %$
MKP!6 *T 6P"K &$ J@!F *@ ; "F ', I ![ *( @P"@ (X G@": )P J@"=
M ,( G #E )H _P"9 /\ EP#_ )0 _P"2 /\ ]P   .D   #:    RP   ,$
M  "X    L@ * *\ %0"K !\ J@ H *D , "G #@ I0!  *( 1@"@ $P G@!1
M )T 5@"; %L F@!A )@ 9P"6 &T E !U )( ?0"1 (< CP"3 (T H0"- +8
MC #6 (L ]@"+ /\ B@#_ (D _P"' /\ ZP   -@   #$    N    *\   "F
M    H@ % )X $ "; !D F@ B )@ *P"7 #, E0 Z ), 0 "1 $8 D !+ (X
M4 "- %8 BP!; (H 80"( &< AP!O (4 =P"# ($ @0", '\ F@!_ *T ?P#'
M 'X ZP!] /\ ?0#_ 'T _P!\ /\ W    ,8   "U    J0   *    "9
MDP   )  "@"- !0 BP = (H )0") "T B  T (8 .@"$ $$ @P!& ($ 2P"
M %  ?@!6 'T 7 ![ &( >@!J '@ <@!V 'P = "' '( DP!S *8 <@"\ '$
MW0!P /D < #_ '  _P!P /\ T    +D   "I    G    ),   "-    B
M (0 !0"!  \ ?P 8 'X ( !] "@ ?  O 'H -@!X #L =P!! '4 1@!T $L
M<@!1 '$ 5P!P %T ;@!D &P ;0!J '< : "" &< C@!F )\ 90"S &4 T !D
M .\ 8P#_ &, _P!D /\ P@   *X   "?    D0   (@   ""    ?@   'H
M 0!W  H =0 3 ', &P!R ", <  J &\ , !M #8 ;  \ &H 00!I $< : !,
M &8 4@!E %@ 8P!@ &$ :0!@ '( 7@!] %P B@!< )H 6@"L %D Q !8 .0
M6 #Y %@ _P!9 /\ MP   *4   "4    B $  '\   !Y    =    '$   !N
M  4 ;  . &H %P!H !X 9@ E &4 + !D #( 8@ W &  /0!? $( 70!( %P
M3@!; %4 60!< %< 90!6 &X 5 !Y %, AP!2 )4 4 "G $\ O !. -D 3@#S
M $X _P!. /\ KP   )T#  "-"   @0D  '@)  !P"   :P4  &@!  !F  $
M9  ) &( $@!@ !H 7@ A %P * !; "X 60 T %@ .0!6 #\ 50!% %0 2P!2
M %$ 40!9 $\ 8@!- &P 3 !W $H A !) ), 1P"C $8 M@!% -( 10#L $4
M_ !% /\ J08  )8+  "'#@  >Q$  '$2  !I$0  9 X  & +  !>"   70,$
M %L # !9 !4 5P = %4 ) !3 "H 4@ P %  -@!/ #P 3@%" $P!2 !+ D\
M20)7 $<"8 !% FH 1 )V $("@P!  I$ /@&A #T M  \ ,P / #G #L ]@ [
M /\ HPL  ) 2  ""%   =A8  &P7  !D%P  7A8  %H4  !7$0  50T  %0)
M!@!3!@\ 4088 $X'( !-""< 2P@M $H),P!("CD 1PH_ $4+1@!#"TX 0@M6
M $ +7P ^"VH / MV #D+@P W"Y( -0NB #0)M0 S",P ,0CD #$)]  Q"/T
MGQ   (P6  !^&0  <AL  &@<  !?'   61H  %09  !1&   3Q4  $X2  !-
M#PD 2P\3 $@0' !&$2, 11(J $,2, !!$S8 0!,] #X41  \%$P .A14 #@4
M7@ V%&D -!1U #(4@P O%)( +1.C "L2MP I$M  *1+I "D1]P J$?\ FA0
M (@:  !['0  ;A\  &0@  !;(   51\  % >  !,'0  21L  $@8  !&%P4
M1!<0 $(7& ! &"  /ADG #P9+0 Z&C0 .!HZ #<:0@ U&TH ,QM2 #$;7  O
M&V< +1MT "L;@0 H&Y  )AJB "09M0 B&<\ (ACI "(8^@ C%_\ EA@  (4=
M  !W(   :R(  & C  !8(P  42,  $PB  !((0  1"   $,=  ! '0$ /1X+
M #L>%0 Y'QT -Q\D #4?*@ S(#$ ,B X # @/P O(4@ +2%0 "LA6@ I(64
M)B%R "0A@  B((\ (""A !X?M  <'LT '![H !P=^0 <'?\ DQL  ((@  !T
M(P  :"4  %TF  !4)@  3B8  $@F  !$)0  0"0  #TC   Y(P  -R0( #0D
M$@ R)1H ,24A "\E*  M)BX *R8U "HF/0$H)D4!)B9. 20F6 $B)F0 ("9P
M !XF?P <)HX &26? !<DLP 6),P %B/G !8B^0 7(O\ CQ\  '\C  !Q)@
M92@  %HI  !1*0  2RD  $4I  ! *0  .RD  #<H   T*0  ,2H$ "XJ#@ L
M*Q< *BL> "DK)0 G+"P )2PS ",L.P$A+$,!("Q, !XL5P <+&( &BQO !<L
M?0 5*XT $RN> !$JL@ .*<L #BCF ! H^  1)_\ BR,  'PF  !N*0  8BL
M %<L  !.+   1RP  $(L   \+0  -RT  #(M   N+P  *R\! "@P"@ E,10
M(S$; "(Q(@ @,BD 'C(P !TR.  ;,D$ &3)* !<R50 5,F  $S)M !$R?  -
M,8L "S"<  DOKP '+\8 ""[@  DM]  *+/\ B"<  'DI  !K+   7BX  %0O
M  !++P  1#   #XP   Y,   -#   "XR   I-   )#4  "$V!P >-Q  '#<8
M !HW'P 9-R8 %S@M !4X-0 4.#X $CA( ! X4@ -.%X "C=J  @W>  &-X@
M!#:8  $UK   -,,  3/=  (R\  #,OP A"H  '4M  !H+P  6S$  %$R  !(
M,@  03,  #LS   V,P  ,30  "HV   E-P  (#D  !L[ P 7/0L %#T4 !(^
M&P 0/B, #CXJ  P^,@ */CH "#Y$  8]3@ $/5H  CUF   ]=0  /80  #R6
M   [J0  .L   #G=   X[P  -_D @"\  '$Q  !D,P  6#0  $TU  !%-@
M/C8  #DV   S-@  +C<  "<Z   A/   &SX  !9    /0P< "D00  =$&  %
M1!\ !$0F  )$+@ !1#8  $1   !$2@  0U8  $-C  !#<0  0X$  $*3  !!
MI@  0+T  #_;   ^\0  /?H ?#,  &TU  !?-P  5#@  $HY  !".0  /#D
M #8Y   P.@  *CP  "(^   <00  %T,  !%%   )2 8  DH,  !*%   2QL
M $LB  !+*@  2S(  $L[  !*1@  2E(  $I?  !*;0  2GX  $F0  !(I
M1KL  $79  !$\0  1/P =S@  &@Z  !;.P  4#P  $<\  ! /   .CP  #,]
M   L/P  )4$  !U$   71@  $4D   I+   "3@0  $\*  !0$0  41<  %(>
M  !3)0  4RT  %(V  !200  4DT  %%;  !1:0  47H  %&,  !1H0  3[D
M $W6  !,\   2_T <3T  &,_  !60   3$   $1    ^/P  -T   "]"   G
M10  'T@  !=+   130  "4\   -2    50(  %8'  !7#0  6!,  %H9  !;
M(   6R@  %LQ  !;/   6D@  %I6  !:90  678  %F(  !9G0  5[8  %75
M  !4[P  4_T :T(  %Y#  !21   240  $-#   [0P  ,D8  "I)   A3
M&$\  !!2   )50   E<   !:    7    %X#  !?"   8 T  &(4  !C&@
M9"(  &4K  !D-0  9$$  &1/  !C7P  8W   &*#  !BF   8;   %_0  !>
M[0  7?P 94@  %E(  !/2   2$<  $!'   V2@  +4T  "-1   :5   $%@
M  A:    70   &    !C    90   &<   !H P  :@@  &L-  !M%   ;AL
M ' C  !P+@  <#H  &](  !O6   ;FH  &U]  !LDP  :ZL  &K(  !IZ0
M:/L 7TT  %5-  !-3   1DP  #M/   P4P  )E8  !M:   17@  !F(   !E
M    :    &L   !N    <    '(   !T    =0   '<&  !Y"P  >A,  'P;
M  !^)   ?C   'X^  !]3P  ?&$  'QU  ![BP  >*,  '>_  !VX@  =?<
M6U,  %-2  !,40  0%0  #18   I70  '6$  !%F   %:@   &X   !Q
M=    '<   !Z    ?    'X   !_    @0   (,   "% P  APD  (D2  "+
M&P  CB8  (TT  "-10  BU@  (MM  "*@P  AYP  (:V  "$V   @_$ 65<
M %)6  !&6@  .5X  "QC   ?:0  $VX   9S    =P   'L   !^    @0
M (0   "&    B0   (L   "-    CP   )$   "3    E0   )@&  ";#@
MGAD  *$E  "@.   GDP  )UA  "=>   FY   )FK  "7R@  END 6%T  $Q@
M   _90  ,6H  "1P   6=@  "'L   "     A0   (@   "+    C@   )$
M  "3    E@   )@   ":    G    )\   "@    HP   *8   "I!   K T
M +$8  "S*@  L$   *]6  "P;0  L(4  *V@  "LO   J]T 4F8  $9K   X
M<0  *G@  !Q^   -A    (D   "-    D0   )4   "8    FP   )\   "B
M    I0   *@   "J    K0   *\   "Q    LP   +8   "Z    OP   ,<&
M  #,&   S"T  ,I%  #-7   SW0  ,N.  #)IP  Q\  37$  #]X   Q?@
M(X4  !6,   %D0   )8   ";    H    *0   "H    JP   *T   "P
ML@   +4   "W    N@   +P   "_    P0   ,4   #)    SP   -@   #>
M"P  Y!X  .(W  #D3P  YVD  .2#  #BFP  XK  _P   /\   #_    _P
M /\  @#_  T _P 9 /X ) #] "\ _0 Y /D 0P#U $L \0!2 .T 6 #J %X
MZ !C .8 : #D &X X@!S -\ >@#= (( V@"* -< E #4 *  T0"O ,X Q@#+
M .D S #_ ,8 _P"Z /\ M #_ *\ _P"K /\ _P   /\   #_    _P   /L
M  #X  D [P 5 .T ( #L "H Z@ T .4 /@#A $8 W0!- -H 4P#7 %D U !>
M -( 8P#0 &D S0!N ,L =0#( 'L Q0"$ ,( C0#  )D O0"G +H N@"X -H
MMP#[ +@ _P"N /\ J #_ *, _P"A /\ _P   /X   #Y    \    .D   #@
M  0 V@ 1 -8 ' #2 "8 T0 O -  . #+ $  QP!( ,0 3@#! %0 OP!9 +P
M7P"Z &0 N0!I +< < "U '8 L@!^ +  AP"M )( JP"@ *@ L "F ,H I #M
M *< _P"B /\ G0#_ )D _P"6 /\ _    /4   #F    W    -(   #&
MP0 + +T %@"[ "  N0 J +@ ,P"V #L LP!" +  2 "N $X K !3 *H 6 "H
M %T IP!C *4 :0"C '  H0!X )\ @0"= (L F@"8 )@ IP"6 +T E #> )8
M_P"5 /\ D0#_ (X _P"+ /\ \P   .4   #1    Q0   +@   "Q    K  &
M *D $0"G !L I0 D *4 +0"D #0 H0 [ )\ 0@"= $@ FP!- )D 4P"7 %@
ME@!= )0 8P"2 &H D0!R (\ >P"- (4 B@"2 (@ H "& +( A0#- (< ^ "'
M /\ A0#_ (( _P"  /\ Y    ,T   "^    L@   *<   "@    FP ! )@
M"P"6 !4 E  > ), )P"2 "\ D0 V (\ / "- $$ BP!' (H 3 "( %$ AP!7
M (8 70"$ &, @@!K ($ = !_ 'X ?0"+ 'L F !Y *D =P#  '@ ZP!X /\
M> #_ '8 _P!U /\ U    +X   "N    H    )@   "1    C0   (D !@"'
M !  A0 9 (0 (0"$ "D @P P ($ -@!_ #L ?@!  'P 10![ $L >0!1 '<
M5@!V %T = !D '( ;0!Q '< ;P"$ &T D0!L *( :@"V &L W0!J /L :@#_
M &H _P!J /\ Q0   +$   "@    E    (L   "%    @0   'T  @![  L
M>0 4 '@ ' !W ", =0 J ', , !Q #8 <  [ &\ 0 !M $4 ; !+ &L 40!I
M %@ 9P!? &8 : !D '( 8@!^ &  BP!? )L 7@"N %X S0!> /  70#_ %T
M_P!= /\ N0   *8   "5    B0   ($   ![    =@   '(   !P  < ;0 /
M &L %P!J !X :0 E &@ *P!F #$ 90 W &, / !B $$ 80!& %\ 30!> %,
M7 !: %L 8P!9 &T 5P!Y %8 A@!4 )4 5 "I %, P0!2 .4 4@#] %$ _P!1
M /\ KP   )L   ",    @0   '@   !Q    ;    &D   !F  ( 8P * &$
M$P!@ !H 7P A %X )P!< "T 6P R %D -P!8 #T 5P!" %4 2 !4 $\ 4@!6
M %$ 7P!/ &D 30!U $P @@!* )  2@"C $D N0!( -D 2 #T $< _P!( /\
MIP   )0   "% P  >04  ' %  !H!   8P(  %\   !=    6P & %D #0!7
M !4 5@ < %4 (P!3 "D 4@ N %$ - !/ #D 3@ ^ $T 10!+ $P 2@!3 $@
M7 !& &8 1 !Q $( ?@!" (T 00"> $  L@ _ ,T /@#K #X _@ ^ /\ H
M (X&  !_"0  <PL  &D,  !A"P  6PH  %<(  !5!0  5 $! %( "0!0 !$
M3P 8 $T 'P!, "4 2@ K $D , !( #8 1@ [ $4 0@!# $D 0@!0 $  60 ^
M &, .P!O #H ?  Y (L . "; #8 K@ U ,4 -0#D #4 ]P U /\ F@8  (D+
M  ![#P  ;A$  &02  !<$@  5A$  %$0  !.#0  3 H  $P&! !* PL 20$4
M $<!&P!% B$ 0P(G $(#+0!  S, /P0Y #T$0  \!4< .@5/ #@%6  V!6(
M- 5N #(%>P Q!8H +P29 "T$JP L L( + #? "P \@ L /T E0P  (01  !V
M%   :A8  %\6  !7%@  418  $P5  !(%   1A(  $4.  !$"P8 0PD. $$)
M%P _"AX /0HD #L+*@ Z"S$ . PW #8,/@ U#48 ,PU. #$-6  N#6, + UO
M "H-?0 H#8L )0V; "0,K0 C"L, (0K= " *[P @"OH D1   ($5  !S&
M9AH  %P:  !3&@  31H  $<:  !#&0  0!<  #\5   ^$@$ /!$) #H1$P X
M$AH -A,A #03*  S%"X ,10U "\4/  N%40 +!5- "H55P G%6$ )15N ",5
M?  @%8L 'A2< !P3KP :$\8 &1+A !H2\@ :$OT C10  'T8  !O&P  8AT
M %@=  !0'@  21X  $0=   _'0  .QP  #D:   W&   -1@% #,8#@ Q&1<
M+QD> "X:)0 L&BL *AHR "@;.@ G&T( )1M+ ",;50 A&V  'AML !P;>@ :
M&XD %QJ: !49K@ 3&<4 $QC@ !,8]0 4%_\ BA<  'H;  !L'@  7R   %4A
M  !-(0  1B$  $ A   [(0  -R   #0?   R'@  +QX" "T>"P K'Q0 *1\;
M "<@(@ E("@ )" P "(A-P @(4  'B%) !PA4P :(5X &"%K !4A>0 3((@
M$2"9  X?K  ,'L( "Q[=  P=\@ -'/\ AQH  '<>  !I(0  7",  %(D  !)
M)   0B0  #PD   W)   ,R,  # C   L(P  *20  "8D"  D)1$ (B48 " F
M'P ?)B8 '28M !LF-0 :)CT &"9' !8F40 4)EP $29I  XF=P +)H8 "266
M  @DJ0 &([\ !2/9  8B[@ '(?P A!T  '0A  !F)   624  $\F  !&)P
M/R<  #DG   T)P  ,"<  "PG   G*   (RD  " J!  =*PT &RL5 !HL'  8
M+", %BPJ !4L,@ 3+3L $2Q$  XL3P ,+%H "2QF  <L<P $+(,  BN3   J
MI@  *;L  "C8   G[  !)_@ @"   '$E  !B)P  5B@  $PI  !#*@  /"H
M #8J   Q*@  +2H  "DJ   B+0  'BX  !HO 0 7, D %#$2 !(R&0 0,B
M#C(G  PR+P *,S< "#)   8R2P $,E8  C%B   Q<   ,8   #"1   OHP
M+KD  "W6   M[   +/@ ?20  &TH  !?*@  4RP  $DL  ! +0  .2T  #0M
M   O+0  *RT  "8N   ?,   &S(  !8T   1-@8 "S@.  DX%@ '.!T !3@D
M  ,X*P ".#,  #@]   X1P  -U(  #=?   W;0  -WT  #>.   UH@  -+<
M #/4   R[0  ,OD >"@  &DK  !;+@  3R\  $4P   ],   -S   #$P   M
M+P  *#   "(R   <-   %S8  !(X   +.P4 !#T,   ^$P  /AH  #XA   ^
M*   /C   #\Y   ^0P  /D\  #U<   ]:@  /7H  #V,   \H   .K8  #G3
M   X[0  ./L ="T  &4O  !7,@  3#,  $(S   Z,P  -#,  # R   J,P
M)#4  !TW   7.0  $CP   L^   %0 0  $(*  !#$   1!8  $4=  !&)
M1BL  $8T  !&/@  14L  $18  !$9@  1'<  $2)  !#G0  0K0  $#2   _
M[@  /OP ;S(  & T  !3-0  2#8  #\V   X-@  ,S4  "TV   F.   'SH
M !@]   2/P  "T(   5$    1P(  $@'  !*#   2Q,  $P9  !.'P  3B<
M $XP  !..@  348  $Q3  !,8P  2W,  $N%  !+F@  2[(  $C1  !&[@
M1?T :3<  %LY  !..@  1#H  #TZ   W.0  ,#D  "@[   @/@  &$$  !)#
M   +1@  !4D   !+    3@   $\$  !1"0  4@X  %04  !6&P  5R(  %<K
M  !7-0  5D   %5.  !57@  5&\  %2!  !3E@  4Z\  %'/  !0[@  3?X
M8SP  %4]  !*/@  0CX  #L]   T/0  +#\  "-"   :10  $D@   M+   $
M3@   %$   !3    5@   %<   !9!0  6PD  %T/  !?%0  8!P  &$E  !A
M+P  8#H  &!(  !?6   7FH  %Y]  !=D@  7*H  %S*  !9[0  6/X 74(
M %%"  !'0@  0$$  #E!   O0P  )D<  !Q*   33@  "E$   -4    5P
M %H   !<    7P   &$   !B    9 0  &8)  !H$   :A8  &P>  !M*
M;#0  &M!  !J40  :F0  &EW  !HC   9Z4  &;"  !FYP  8_P 5T<  $U'
M  !&1@  /T4  #1(   I3   'U   !14   )6    5L   !>    80   &4
M  !G    :@   &P   !M    ;P   '$"  !S!P  =0T  '<6  !Z'P  >BL
M 'DX  !X2   =UL  '9O  !UA0  =)X  '*Z  !QWP  </@ 4TP  $Q+  !%
M2@  .4T  "U2   B5@  %EL   I?    9    &<   !K    ;@   '$   !T
M    =@   '@   !Z    ?    'X   "     @P4  (4,  "(%@  BB   (HN
M  "*/@  B5   (AE  "&>P  A90  (*O  "!T0  ?^\ 4E$  $M0   ^4P
M,E@  "5>   88@  "V@   !L    <0   '4   !Y    ?    '\   "!
MA    (8   "(    BP   (T   "/    D0   )0"  "7"@  FA4  )XB  "=
M,@  FT4  )E;  "8<@  EXH  )6E  "2P@  D>0 458  $59   W7@  *F0
M !QJ   .<    '8   ![    @    (,   "'    B@   (T   "0    D@
M )4   "7    F@   )P   "?    H0   *0   "H    K <  + 4  "T(@
MLC<  *].  "N90  K7X  *R7  "IL@  I]( 2V   #YE   P:P  (G(  !-Y
M   $?@   (4   "*    C@   )$   "5    F    )L   "=    H    *,
M  "E    J    *H   "M    KP   +(   "V    NP   ,$'  #(%   RBD
M ,9"  #%6@  QG(  ,>*  #"I0  P,$ 16L  #=R   I>0  &H    J'
MC0   )(   "7    F@   )X   "B    I@   *L   "N    L    +,   "V
M    N0   +P   "_    P@   ,8   #+    T0   -@   #C 0  Z14  .<N
M  #G1P  Z6   .IY  #GD@  Y:@ _P   /\   #_    _P   /\  0#_  D
M_P 6 /\ (0#] "P _  V /D 0 #U $@ \@!/ .\ 5@#L %P Z@!B .@ 9P#E
M &T XP!S .$ >0#> (  VP"( -@ D@#4 )\ T "O ,P Q@#( .@ Q0#_ +T
M_P"T /\ K #_ *< _P"D /\ _P   /\   #[    ^@   /H   #R  4 [@ 2
M .L '0#J "@ Z0 Q .8 .P#B $, W@!+ -L 40#8 %< U0!< -( 80#0 &<
MS0!L ,L <P#( 'H Q@"" ,, C #  )@ O "G +@ N@"U -L LP#Z +  _P"G
M /\ H0#_ )T _P": /\ _0   /<   #S    [P   .$   #<    U  , -(
M& #0 "( SP L ,\ -0#* #T Q@!$ ,, 2P#  %$ O0!6 +L 7 "Y &$ MP!G
M +4 ;0"S '0 L !] *X A@"L )( J0"@ *4 LP"C ,T H0#P )\ _P"; /\
ME@#_ )( _P"/ /\ ]0   .T   #D    U0   ,@   #     O  ' +D $P"W
M !T M@ F +4 +P"S #< L  ^ *T 1 "K $H J0!/ *@ 50"F %H I !@ *,
M9@"A &T GP!T )T ?@"; (D F "7 )8 J "3 ,  D #D (X _P", /\ B@#_
M (< _P"% /\ Z@   -P   #,    NP   +(   "K    IP ! *0 # "B !<
MH0 @ *$ * "A #  G@ W )P /0"9 $, EP!( )4 3 "3 %( D0!8 (\ 7@"-
M &4 C !M (H =@"( ($ A@". (4 G0"# +, @@#3 (  ]@!_ /\ ?0#_ 'L
M_P!Z /\ VP   ,<   "W    J0   *    ":    E@   )( !P"0 !$ CP :
M (\ (@"- "H BP Q (D -P"' #T A@!" (0 1@"# $L @@!0 (  5@!_ %X
M?0!F 'L ;P!Z 'H > "& '8 E0!T *D <@#_XO_B24-#7U!23T9)3$4 " K#
M '$ Z@!Q /\ <0#_ &\ _P!N /\ R@   +<   "E    F0   )$   "+
MAP   (,  P"!  L ?P 4 'X ' !] "0 ?0 K 'L ,0!Y #< >  \ '8 00!U
M $8 <P!+ '( 4 !P %< ;@!? &T :0!K ', :0!_ &< C0!E *  9 "V &,
MV@!C /T 9 #_ &, _P!C /\ O    *<   "8    C0   (0   !_    >@
M '8   !S  < <0 / '  %P!O !X ;@ E &T + !K #$ :0 W &@ / !G $$
M9@!& &0 3 !C %( 8@!9 &  9 !> &X 7 !Y %H AP!8 )D 5P"M %8 RP!7
M /, 5P#_ %@ _P!7 /\ L    )P   "-    @@   'H   !S    ;@   &H
M  !G  ( 90 * &0 $P!B !H 8@ @ &$ )P!? "P 7@ R %T -P!; #P 6@!!
M %D 1P!8 $T 5@!4 %4 7@!3 &D 40!T $\ @0!- )( 3 "E $L OP!, .@
M3 #_ $T _P!, /\ I@   ),   "%    >0   '    !I    8P   &    !=
M    6P & %D #@!8 !4 5P < %< (@!5 "@ 5  M %, ,P!2 #@ 40 ] $\
M0P!. $D 30!0 $L 6@!) &0 1P!P $4 ?0!# (T 00"? $( N !" -L 0@#X
M $( _P!" /\ G0   (L   !]    <@   &@   !@    6@   %<   !4
M4@ # %$ "@!/ !$ 3@ 8 $X '@!- "0 2P I $H +P!) #0 1P Y $8 /P!%
M $4 0P!- $$ 5@ _ &  /0!L #L >0 Y (D -P": #D L  Y ,X . #N #@
M_P X /\ E@   (4!  !W!   :P<  &$'  !9!P  4P8  $\$  !, @  2P
M $D !@!(  T 1P 4 $8 &@!% "  0P E $$ *P!  #  /P V #T /  \ $(
M.@!* #@ 4P V %T - !I #( =@ Q (8 ,0"7 #  J@ O ,, +P#C "\ ^0 O
M /\ D0$  ($&  !R"0  9@L  %P,  !4#0  30P  $D+  !%"0  0P8  $(#
M @!!  D 0  0 #X %@ ] !P .P B #H )P X "T -P S #4 .0 T $  ,@!(
M #  40 N %L +0!G "L =0 J (, * "3 "< I@ F +P )0#9 "8 \P F /\
MC08  'P+  !N#@  81   %<1  !/$@  21(  $,1  ! #P  /0T  #L+   Z
M" 0 .@4+ #@$$@ V!!D - 0? #,%)  Q!2H , 8P "X&-P M!CX *P=' "D'
M4  G!UL )0=F ",'=  A!X( 'P>2 !T&I  <!+D ' +4 !P [@ = /L B H
M 'D/  !J$P  7A0  %,5  !+%@  1!8  #\5   Z%   -Q,  #42   T#P
M,PP& #(+#0 P"Q4 +@P; "T,(@ K#2@ *0TO "@.-@ F#CX ) Y' "(.40 ?
M#EP '0]H !L/=@ 8#H4 %@Z5 !0-I@ 3#+H $PO3 !(*Z0 2"O8 A0X  '43
M  !G%@  6A<  % 8  !(&0  01D  #L9   V&   ,Q<  # 6   N%0  +1,!
M "L3"  J$Q$ *!08 "84'P D%24 (A4L "$5-  ?%3P '15% !L63P 9%EH
M%A9F !06=  1%80 #A64  P4I@ *$[H "1/4  D2ZP *$?D @A(  '(6  !C
M&0  5QH  $T;  !$'   /1T  #<<   S'   +QL  "P:   I&@  )QD  "49
M!0 C&0T (1H5 !\:'  =&R( '!LJ !H;,0 8&SH %AM# !0;30 2&U@ #QME
M  P;<@ )&X  !QN0  4:H@ $&;<  AC1  ,7Z  $%_8 ?Q4  &\9  !@'
M5!T  $H>  !!'P  .A\  #0?   P'P  +!X  "@>   E'@  (1X  !\> @ =
M'PH &B 2 !@@&0 7("  %2$G !,A+P 1(3< $"%!  TA2P *(54 ""%A  4A
M;@ #(7T  2".   ?H   'K4  !W/   <Z   '/4 >Q@  &L<  !='P  42
M $<A   ^(@  -R(  #$B   M(0  *2$  "4A   A(0  '2(  !DD   6) <
M$R8. !$F%@ /)AT #2<D  LG*P ))S0 !R<]  8F1P $)E(  29>   F;
M)GL  ":,   DG@  ([,  "+-   AZ0  (/8 >!P  &@?  !:(0  3B,  $0D
M   [)0  -"4  "\D   J)   )B0  "(D   ?)   &B8  !4H   1*@4 #"L,
M  DL%  '+!H !2PA  ,L*  !+#   "TY   L0P  +$X  "M;   K:0  *W@
M "N*   KG0  *+(  "?,   FZ   )?@ =!\  &0C  !6)0  2R8  $$G   X
M*   ,2<  "PG   H)@  )"8  " F   ;*   %BH  !(L   ,+@0 !C$*  (Q
M$0  ,A<  #(>   R)0  ,BT  #,U   S/P  ,DL  #%8   Q9@  ,78  #"'
M   PFP  +K$  "W,   KZ@  *_D <",  & F  !2*   1RH  #TJ   U*@
M+RH  "HI   F*0  (BD  !TJ   7+   $B\   PQ   ',P0  34)   V#@
M-Q4  #@;   Y(@  .2D  #DR   Y.P  .4<  #A4   W8P  -W,  #>%   V
MF0  -K   #3-   RZ@  ,?L :R<  %PJ  !.+   0RT  #HN   S+0  +2P
M "DK   D+   'BT  !@O   3,@  ##0   <V   !.0(  #L'   \#   /A(
M #\7  ! '@  0"4  $ N  !!.   04,  #]1   ^8   /7   #V#   ]EP
M/:\  #O-   Y[   ./P 9BL  %<O  !*,   0#$  #<Q   Q,   +"\  "8O
M   ?,0  &3,  !,U   ,.   !SH   $]    /P$  $$%  !#"0  1 X  $84
M  !(&@  22$  $DJ  !),P  23X  $A,  !'6P  16T  $5_  !%E   1*P
M $3,  !![0  /_X 8#$  %(S  !&-   /30  #4T   P,@  *C(  "(T   :
M-P  %#D   P\   &/P   $(   !$    1P   $D"  !*!@  3 H  $X0  !0
M%@  4AP  %,E  !3+@  4SD  %)&  !15@  3V@  $Y[  !.D   3:D  $W(
M  !,[0  2?\ 6C8  $TX  !".   .C@  #0V   N-@  )3@  !P[   4/@
M#$$   5$    1P   $H   !-    3P   %(   !4 0  5@4  %@*  !:$
M718  %\>  !>*   7C,  %U   !;4   6F(  %EW  !8C   5Z0  %?#  !6
MZ@  5?\ 5#P  $D\   _/   .3L  #(Z   H/0  'D   !5$   ,1P  !4L
M  !.    40   %0   !6    60   %L   !=    7P   &(%  !D"@  9Q$
M &D8  !K(@  :BT  &DZ  !H20  9EL  &5P  !DA@  8YX  &*[  !AY
M8?T 3T$  $5!   ^0   .#\  "U"   B10  %TH   Q.   $40   %4   !8
M    6P   %X   !A    9    &8   !H    :P   &T   !O P  <@D  '41
M  !W&@  >"4  '<R  !U00  =%0  '-I  !Q@   <)@  &^S  !MVP  ;?@
M2T8  $1%   ^1   ,D<  "9+   :4   #E4   ):    70   &$   !D
M9P   &L   !N    <0   ',   !U    =P   'D   !\    ?@   (('  "$
M$   AQL  (<H  "&-P  A$D  (->  ""=@  @(X  'ZI  !\S   >^\ 2DH
M $1)   W30  *U(  !Y7   27   !&$   !F    :@   &\   !R    =@
M 'D   !\    ?P   ($   "$    A@   (@   "*    C0   )    "3!@
MEQ$  )L=  ":*P  F3X  )A2  "6:@  E((  )*=  "1NP  C>  2D\  #U3
M   P6   (U\  !5D   &:@   '    !V    >@   '\   ""    A0   (D
M  ",    C@   )$   "4    E@   )@   ";    G@   *$   "E    J00
M *T0  "R'@  L#$  *Y&  "L7@  JG<  *B0  "GJP  H\H 1%D  #9?   I
M90  &FP   IS    >@   (    "%    B@   (X   "2    E0   )@   ";
M    G@   *$   "D    I@   *D   "L    KP   +(   "W    O    ,,!
M  #+#0  T"   ,LX  #&4@  Q&H  ,.#  ##G   O;< /64  "]L   A<P
M$7L   &"    B0   (\   "4    F    )P   "?    HP   *8   "H
MJP   *X   "Q    M    +<   "[    O@   ,(   #'    S@   -4   #@
M    YQ(  .<J  #A1P  XU\  .1W  #ECP  X:D _P   /\   #\    ^@
M /L   #^  @ _P 3 /\ 'P#^ "H _@ T /P /0#X $4 ]0!- /( 5 #O %H
M[0!@ .H 90#H &L Y0!Q ., > #@ '\ W0"( -H DP#6 *  T@"Q ,X S #(
M /$ Q #_ +8 _P"K /\ HP#_ *  _P"< /\ _@   /@   #T    \P   /0
M  #P  $ [0 - .L &@#J "0 Z@ N .@ . #C $  WP!' -P 30#9 %, U@!9
M -, 7@#1 &0 S@!J ,P < #) '@ QP"  ,0 B@#  )8 O0"G +H O0"V .(
ML0#_ *< _P"> /\ F #_ )8 _P"3 /\ ]@   .\   #K    YP   -T   #6
M    T@ ( -  % #. !\ S0 I ,T ,0#) #D Q@!  ,, 1@#  $L O !0 +D
M50"W %H M !A +( : "O '  K0!X *H @@"H (T I@"< *0 KP"B ,X H0#W
M )L _P"2 /\ C #_ (H _P"( /\ [    .0   #>    S@   ,(   "\
MN  " +4 #@"T !D M  B +( *@"N #( JP Y *@ 0 "F $4 I0!* *, 3P"B
M %0 H !9 )\ 7P"= &8 FP!O )D >@"6 (8 E "3 )( I "/ +T C0#E (L
M_P"& /\ @0#_ 'X _P!] /\ X    -8   #!    M0   *P   "F    H@
M *  " "= !( FP ; )L ) "; "P F  S )8 .0"4 #\ D@!$ )  20". $X
MC0!3 (L 60") %\ B !G (8 < "$ 'X @@"+ (  FP!_ +  ?0#2 'L _ !X
M /\ = #_ ', _P!R /\ T0   ,    "N    H@   )H   "4    D    (P
M P")  P B0 5 (@ '@"' "4 A@ L (0 ,P"" #D @0 ^ '\ 0P!^ $@ ?0!-
M 'L 4P!Z %D > !@ '< :0!U '0 <P"$ '  DP!N *8 ; #! &L [P!J /\
M9P#_ &< _P!F /\ PP   *P   "=    DP   (L   "%    @    'P   !Z
M  < >  0 '< & !W !\ =P F '4 +0!S #, <@ X '$ /0!P $( ;P!( &T
M30!L %0 :@!; &D 8P!G &T 90![ &( C !@ )T 7@"T %P WP!< /\ 6P#_
M %P _P!; /\ LP   )\   "1    A@   'T   !W    <0   &X   !K  (
M:@ * &D $P!I !H :0 A &@ * !G "X 90 S &, . !B #T 80!" %\ 2 !>
M $X 7 !5 %L 7@!: &< 6 !S %8 A0!4 )8 40"K $\ S@!/ /8 3P#_ %$
M_P!1 /\ I@   )0   "&    >P   '(   !J    90   &$   !?    7@ &
M %T #@!= !8 7  < %P (@!: "@ 6  M %< ,@!6 #@ 5  ] %, 0P!2 $D
M4 !0 $\ 60!- &( 3 !N $H ?P!( (\ 1@"B $0 P !# .H 1@#_ $< _P!'
M /\ G    (L   !^    <@   &<   !@    6@   %<   !5    4P # %(
M"@!2 !$ 40 7 %  '0!/ ", 3@ H $P +0!+ #, 20 X $@ /@!' $4 10!,
M $0 5 !" %X 00!I #\ >@ ] (H .@"= #D M@ X -T / #^ #P _P ] /\
ME    (0   !V    :@   %\   !7    4@   $X   !,    2@   $D !@!(
M  P 1P 3 $8 &0!& !\ 1  D $( *0!! "X /P T #X .@ \ $$ .P!( #D
M4  X %H -@!F #0 =0 R (4 ,0"8 #  KP Q -$ ,@#T #, _P S /\ C@
M 'X   !P    8P(  %D#  !1 P  2P(  $<   !$    0@   $   P _  D
M/@ / #T %0 \ !H .P @ #D )0 X "H -@ O #4 -@ S #T ,@!$ #  30 O
M %< +0!D "L <0 J ($ *0"3 "@ J0 I ,0 *0#I "D _P I /\ B    'D!
M  !J!0  7@<  %0(  !+"   10@  $ '   \!0  .@,  #@!   W  8 -@ +
M #4 $0 T !< ,P < #$ (0 O "8 +@ L "T ,@ K #H *@!! "@ 2@ G %0
M)0!A ", ;P B 'X (0"0 "  HP @ +L 'P#= !\ ]@ ? /\ A $  '0&  !F
M"   60L  $\,  !'#0  0 P  #H,   V"P  ,PD  #$(   P!@, , ,( "X!
M#0 M 1, *P$9 "H '@ H "0 )P$I "8 ,  D 3< (P$_ "$ 2  @ 5, '@%?
M !P ;0 ; 'P &0", !@ GP 7 +0 %@#1 !4 [0 6 /\ @ 4  ' )  !B#
M5@X  $L1  !#$0  /!$  #81   R$   +@\  "P-   J#   *0H$ "D("0 G
M!Q  )086 "0'&P B!R$ (0@G " (+@ >"#8 ' @^ !L(2  9"5( %@A> !0(
M;  2"'L $ B+  X&G0 -!;$ #0/+  T!Z  . /D ?0D  &T-  !>$   4A(
M $@4   _%0  .!4  #(4   N%   *A,  "<3   E$@  (Q$" "(.!0 A#@L
M( T2 !X.&0 <#A\ &PXF !D.+@ 7#C8 %0\_ !,020 0$%0 #1!@  H0;  )
M$'L !Q"+  8.G0 $#;   PS)  (+XP #"?, >@P  &D1  !;$P  3Q4  $47
M   \&   -1<  "\7   J%P  )A8  ",6   A%0  'Q4  !T4 @ ;% < &10.
M !<5%@ 6%1T %!4D !(5*P 0%C0 #18]  L61@ )%E  !A9<  06:0 "%G@
M !:(   5FP  $ZX  !+'   1XP  $?, =Q   &84  !8%@  3!@  $(:   Y
M&@  ,AH  "P:   G&@  (QD  " 9   =&   &Q@  !@9 0 5&00 $QH+ ! ;
M$P .&QH #!LA  H;*  (&R\ !ALX  0<0@ "&TT  1M9   ;9@  &W8  !N&
M   :F0  &:X  !?&   6XP  %?4 <Q,  &,7  !5&0  21L  #X=   V'0
M+QT  "D<   E'   (1P  !X;   ;&P  &!L  !4<   0'@, #!\)  D@$0 &
M(!< !2 >  ,A)  !(2P  "$U   A/@  (4D  "!6   @9   ('0  !^%   ?
MF   'JT  !S'   :Y0  &O8 ;Q8  %\:  !1'   1AX  #L?   S'P  +!\
M "<?   B'@  'QX  !P=   9'0  %1X  !$@   ,(@, !R0(  ,E#@  )14
M "8;   F(@  )BD  "8R   G.P  )T8  "94   E8@  )7(  "2$   DEP
M)*T  "'(   ?Y0  'O@ :QH  %L=  !.'P  0B$  #@B   P(@  *B$  "0A
M   A(   '1\  !H?   6(   $B(   PD   ()@,  R@(   J#   *Q,  "P8
M   L'P  +"8  "PO   M.   +4,  "U/   K7P  *G   "J"   IE@  *:P
M "C)   FZ   )/D 9QX  %<A  !*(P  /R4  #4E   M)   )R0  ",C   @
M(@  '"(  !<C   2)0  #2<   @I   #*P,  "T'   O"@  ,1   #,6   S
M'   ,R,  #0K   T-0  -$   #1,   R7   ,6T  #!_   PE   +ZL  "_)
M   LZP  *OP 8B(  %,E  !&)P  .R@  #(H   K)P  )B8  "(E   >)
M&"8  !,G   -*@  ""P   ,O    ,@$  #0$   V"   . P  #H2   [&
M.Q\  #LG   [,0  /#P  #Q(   [5P  .6D  #=]   WD@  -JH  #;)   U
M[   ,O\ 72<  $XI  !"*P  -RL  "\K   I*0  )2@  " H   :*0  %"L
M  TN   ',0   C,    V    .    #L"   ]!0  /PD  $$.  !#%   1!L
M $0C  !$+0  1#@  $1$  !$4@  064  #]Y   _C@  /J<  #W&   ][
M._\ 5RP  $HN   ^+P  -"\  "TM   I*P  (RL  !PM   5+P  #C(   <U
M   !.    #L    ]    0    $(   !% @  1P8  $D*  !+$   3A8  $X>
M  !.*   3C,  $X_  !.30  2V   $EU  !'BP  1Z0  $;$  !%ZP  1?\
M43$  $4R   Z,P  ,C(  "TP   G+P  'C$  !8T   .-P  !SH    ^
M00   $,   !&    20   $L   !.    4 (  %(&  !5"P  5Q(  %H9  !:
M(@  6BT  %DZ  !92   6%D  %5O  !2A@  4IX  %&\  !0Y@  4/\ 3#8
M $ W   X-@  ,C0  "LS   A-@  %SD   \]   '0    $0   !'    2@
M $T   !0    4P   %8   !8    6@   %T!  !@!0  8@L  &83  !H&P
M:"8  &@R  !G00  95$  &)H  !@@   7I@  %VU  !<WP  6_P 1SL  #T[
M   W.0  ,#@  "4[   :/P  #D,   9'    2P   $\   !3    5@   %D
M  !<    7P   &(   !D    9P   &D   !L    ;P0  '(+  !V%   =Q\
M '8K  !U.@  <TH  '!@  !N>   ;)(  &NL  !ITP  :/8 0T   #T_   V
M/0  *T   !Y%   22@  !4\   !3    6    %P   !?    8@   &4   !I
M    ;    &X   !Q    <P   '8   !Y    ?    '\#  "#"P  AA8  (<B
M  "%,0  @T(  (%7  !_;P  ?(H  'ND  !YQ@  =^T 0T0  #Q#   P1P
M)$L  !=1   )5P   %P   !@    90   &D   !L    <    ',   !W
M>@   'P   !_    @@   (0   "'    B@   (X   "1 0  E0H  )@7  "8
M)0  EC<  )1+  "28P  D'T  (Z7  ",M0  BMP 0TD  #9-   I4@  &U@
M  U>    9    &H   !O    =    '@   !\    @    (0   "'    B@
M (T   "0    D@   )4   "8    FP   )\   "C    IP   *P*  "R&
ML2D  *\^  "L50  J6\  *:)  "CI0  H<0 /%,  "]9   A8   $F8   )M
M    =    'H   "     A0   (H   "-    D0   )0   "8    FP   )X
M  "A    I    *<   "J    K0   +$   "V    O    ,,   #,"@  U!D
M - O  #+2   QF(  ,1[  #!E0  OJ\ -5\  "=F   8;@  !W8   !]
MA    (L   "1    E0   )H   "=    H0   *0   "G    JP   *X   "Q
M    M0   +@   "\    P0   ,4   #+    T@   -L   #D    [@@  / @
M  #K.P  Y5<  .1P  #DB   XZ  _@   /D   #U    ]    /4   #X  4
M_  1 /\ ' #_ "< _P Q /X .@#[ $( ^ !) /8 3P#S %0 \ !: .T 7P#I
M &0 Y@!J ., <@#? 'H W "$ -@ CP#4 )P T "L ,T QP#+ /  Q #_ +
M_P"C /\ FP#_ )4 _P"3 /\ ]P   /$   #L    ZP   .T   #O    [0 )
M .L %@#K "$ [  J .D - #A #P VP!# -@ 20#4 $X T@!4 -  60#. %X
MRP!C ,D :@#' '  Q !Y ,$ A0"^ )0 N@"D +< N0"S .  L #_ *( _P"8
M /\ D0#_ (P _P") /\ [@   .<   #B    X    -H   #4    SP $ ,X
M$ #+ !H QP D ,@ +0#% #4 P0 \ +X 0P"\ $@ N !- +8 4P"S %@ L0!=
M *\ 8P"L &H J@!R *@ >P"F (8 I "9 *$ K@"? ,T G0#W )4 _P"* /\
MA0#_ (( _P!_ /\ XP   -H   #4    R    +X   "X    M    *X "0"N
M !0 K@ > *T )@"J "\ IP V *0 / "B $( H0!' )\ 3 "> %( G !7 )L
M70"9 &0 EP!K )4 =0"3 '\ D0", (\ H@", +X B0#H (8 _P!_ /\ >0#_
M '8 _P!T /\ U0   ,H   "[    L    *@   "B    FP   )D  P"7  T
ME0 7 )8 ( "6 "@ E  O )$ -@"0 #P CP!! (X 1P"- $P BP!1 (H 5P"(
M %X AP!E (4 ;@"# 'D @0"% (  E !\ +, >0#7 '8 _@!Q /\ ; #_ &H
M_P!H /\ Q@   +4   "G    G0   )0   "-    B0   (4   "$  @ @P 1
M (0 &@"% ", A  J (( , "  #8 ?@ [ 'T 0 ![ $4 >0!+ '@ 4 !V %<
M=0!> ', 9P!Q '( ;P!^ &X C0!M *$ :@#% &8 \@!C /\ 7P#_ %T _P!=
M /\ MP   *4   "7    C    (0   !]    >    '4   !T  , =0 , '0
M%0!T !P =  C '( *0!P "X ;@ T &P .0!K #X :0!$ &@ 2@!F %$ 9 !8
M &( 80!A &L 7P!W %X A@!= )< 6P"W %D X@!6 /\ 4P#_ %( _P!2 /\
MJ0   )@   "*    ?P   '4   !N    :0   &<   !F    90 ' &0 #@!D
M !8 9  = &, (P!A "@ 7P M %T ,P!< #@ 6@ ] %D 0P!7 $D 5@!2 %0
M6P!2 &4 40!Q %  ?P!/ )  30"L $L T !) /D 1P#_ $< _P!' /\ G0
M (T   !_    <P   &D   !A    70   %L   !9    5P " %< "0!6 !$
M5@ 7 %8 '0!4 "( 4@ H %  + !. #$ 3  W $H / !) $, 2 !* $< 5 !&
M &  1 !K $, >@!" (D 0 "D #\ P@ ] .X / #_ #P _P _ /\ E    (0
M  !V    :0   %\   !7    4P   $\   !-    3    $L !0!*  L 20 2
M $@ & !& !T 1  B $, )P!! "P 0  R #X .  ] #X .P!% #H 3@ X %H
M-P!F #< =  V (0 - "< #, MP R .0 ,@#_ #( _P V /\ C    'T   !N
M    80   %<   !0    2@   $8   !#    00   $   @ ^  < /  - #P
M$P \ !@ .@ > #@ (P W "@ -@ M #0 ,P S #H ,@!! #  2@ O %8 +@!B
M "P <  K (  *@"6 "D K@ I -8 *0#[ "L _P M /\ A@   '8   !H
M6P   %$   !)    0@   #T    Z    -P   #4    T  0 ,P ) #, #@ S
M !0 ,0 : #  'P N "0 +0 I "P ,  K #8 *0 ^ "@ 1@ G %( )0!> "0
M;  C 'X (0"1 "$ J  A ,D (0#R "( _P D /\ @0   '$   !B    5@(
M $P#  !#!   / 0  #<#   S @  +P(  "T    L  ( +  & "L "P K !$
M*@ 6 "@ &P G "  )@ F "0 +  C #, (@ [ "$ 0P ? $\ '@!; !T :0 ;
M 'H &@", !H HP 9 +\ &0#E !D _P : /\ ?    &P   !>!   408  $<(
M   ^"   -P@  #$(   M"   *0<  "<&   F!   )0($ "0 "  C  P (P 3
M "$ &  @ !T 'P C !X *0 < #  &P X !H 00 9 $T %P!9 !8 9P 4 '<
M$@") !$ G0 1 +0 $0#6 !$ ]0 0 /\ >    &@$  !:"   30H  $,+   Z
M#   ,PP  "T,   H#   )0L  "(*   @"0  'P@# !X&!@ =!0H ' 0/ !L$
M%0 :!!H & 0@ !<$)@ 6!"X %00V !0#0  2 DL $0)7  X#9  + W0 "0*%
M  @!F  ( *X " #+  @ [  ( /\ =00  &4'  !6"P  2@T  #\/   V$
M+Q   "D0   E$   (0X  !X.   <#0  &@P" !@+!0 7"@< %PD, !4)$@ 4
M"1@ $PD> !$))  0"2P #@DU  P)/P *"4H " I6  4+8P ""G,   J#   )
ME@  !ZH   7#   #X@   /@ <0<  &$*  !3#0  1Q$  #P2   S$P  +!,
M "83   B$@  'A(  !L1   8$0  %A " !00!  2#P< $0X)  X.#@ -#Q4
M"Q <  H0(P ($"H !Q S  40/0 $$$@  A%4   180  $'$  !""   .E0
M#:H   O"   *WP  "?, ;@H  %T-  !0$0  1!0  #D5   P%0  *14  ",5
M   ?%0  &Q0  !@4   5$P  $Q,# !$2!0 /$@< "Q,(  D4#  '%1, !A49
M  05(  "%B<  18O   6.@  %D4  !91   57P  %6\  !6!   4E   $ZH
M !'$   /X@  #?8 :@T  %H1  !-%   0!<  #87   M&   )A@  "$7   =
M%P  &18  !86   4%0( $A0$  \5!0 +%@4 "!<'  09"@ !&A   !H6   ;
M'0  &R0  !LM   ;-@  &T(  !M.   ;7   &FT  !F    9E   &*H  !?%
M   5Y0  $_@ 9A$  %<4  !)%P  /1H  #,:   K&@  )!H  !\9   ;&
M%Q@  !47   3%@, $!<#  P8 P (&00 !!L&   ="0  'PT  " 4   @&P
M("(  "$J   A,P  (3\  "!,   @6@  'VP  !Y_   =DP  ':H  !S&   ;
MZ   &?L 8A4  %,8  !&&@  .AP  # =   H'   (AP  !T;   9&@  %QD
M !08 0 0&0  #!H   @< 0 $'@(  " $   B!P  )0L  "82   F&   )Q\
M "<G   G,0  )SL  "=)   G5P  )F@  "-]   CD0  (JD  "''   AZP
M'OX 7A@  $\;  !"'@  -A\  "T?   E'P  (!X  !P=   9&P  %AL  !$<
M   ,'0  "!\   ,A    (P   "8#   H!0  *PD  "T.   M%0  +AP  "XD
M   N+@  +C@  "Y&   N5   +60  "IZ   HD0  **@  "?'   G[   )_\
M61P  $L?   ^(@  ,R(  "HB   C(0  'R   !L>   7'@  $Q\   T@   (
M(@   R4    G    *0   "P!   O P  ,0<  #0+   V$@  -AD  #8A   V
M*@  -C4  #9"   V4   -F   #)W   PC@  +Z8  "[&   N[0  +O\ 5"$
M $8D   Y)@  +R4  "@D   B(P  'B$  !HA   4(@  #20   @F   "*0
M "P    N    ,0   #,    V 0  .04  #L)   ^#P  /Q8  #\>   _)P
M/S$  #\^   _3   /UP  #UP   YB@  -J0  #;#   U[0  -?\ 3R8  $$H
M   U*0  +2D  "8G   B)0  '20  !8F   .*   ""L   (M    ,0   #,
M   V    .0   #P    _    00(  $0&  !'"@  2A$  $H9  !+(0  2BP
M $HY  !*1P  25<  $AJ  !#A0  0*   $"^   _Z@  /O\ 22L  #PM   R
M+0  *RL  "8I   @*   &"H  !$L   (,    3,    W    .@   #T   !
M    0P   $8   !)    2P   $X!  !1!0  5 L  %<3  !7'   5B8  %8S
M  !600  55$  %1D  !/?P  3)H  $JW  !)Y0  2/\ 0S$  #@R   P,
M*BX  "0M   ;+P  $C(   DV   !.@   #X   !!    1    $@   !+
M3@   %$   !3    5@   %D   !< 0  7P8  &(,  !E%@  92   &0L  !D
M.P  8TL  &%=  !=>   69,  %:Q  !6VP  5?T /S8  #4U   P,P  *3$
M !XT   4.   "CP   !!    10   $D   !-    4    %,   !7    6@
M %T   !?    8@   &4   !G    :P   &X'  !R#P  =!D  '0F  !S-
M<T,  '%5  !M;P  :8D  &:H  !ES   9/4 .SH  #4X   O-P  (SH  !8_
M   *1    $@   !-    4@   %8   !:    7@   &$   !E    :    &L
M  !N    <0   '0   !W    >@   'X   ""!0  AP\  (D<  "'*@  A3L
M ().  !]9@  >H   '>>  !UO0  =.D .SX  #4\   I0   &T4   Q+
M4@   %8   !;    8    &0   !H    :P   &\   !S    =@   'D   !\
M    ?P   ((   "%    B0   (P   "1    E@8  )H2  ":(   ES$  )1$
M  "17   CG8  (N3  "(L   AMD .T(  "]&   A3   $U(   19    7P
M &4   !J    ;P   ',   !W    >@   'X   ""    A@   (D   ",
MCP   )$   "5    F    )P   "A    I@   *H%  "O%   KB0  *HX  "H
M3P  I6D  **%  "?H   G+\ -4T  "A3   960  "6$   !G    ;@   '0
M  !Z    ?P   (0   "(    C    )$   "5    F    )L   "?    H@
M *4   "H    K    +$   "W    O0   ,4   #-!   UA4  -$H  #,0
MQUH  ,%V  "]D   N:H +ED  "!A   0:    '    !W    ?P   (8   ",
M    D0   )8   ":    G@   *(   "F    J@   *X   "R    M0   +D
M  "^    PP   ,D   #0    V@   .,   #L    ] 0  /D7  #T,   [TP
M .EG  #F@0  XYD                       $#! 4&" D*"PT.#Q$2$Q06
M%Q@:&QP='R A(B0E)B@I*BLM+B\P,C,T-C<X.3L\/3Y 04)$149'24I+34Y/
M4%)35%576%E;7%U>8&%B8V5F9VEJ:VQN;W!Q<W1U=WAY>GQ]?H"!@H.%AH>(
MBHN,CH^0D9.4E9:8F9J<G9Z?H:*CI*:GJ*JKK*VOL+&SM+6VN+FZN[V^O\'"
MP\3&Q\C)R\S-S]#1TM35UM?9VMO=WM_@XN/DYN?HZ>OL[>[P\?+T]?;W^?K[
M_/[______________________________________________________P
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M______________________________________\
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M_VUF=#$      P0A   !                     0
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M^;Y'._/+34_LUE)EY>%5?-SF69'-WUVCP-=@L;+08KRFRF3&F\9FSX[!:->
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M;%'^66Q1_EEL4?Y9;%'^66Q1_EEL4?Y9;%'^66Q1_EEL4?Y9;-?$! #,V@8
MO?@>!J[_(Q">_R0;D/\G)H/_*C)W_R\\;?\S163_-TQ=_SI25_\^5E3_05E1
M_T1;4/]'7$[_2UU-_TY>3/]17TS_5%],_U1?3/]47TS_5%],_U1?3/]47TS_
M5%],_U1?3/]47TS_5%],_U1?3/]47TS_5%],_U1?3/]47_^>& 3_G2(*_YLL
M%?^6-B+_FD O_Z))/?^D5$W_HUY?_Z%H<?Z<<8+WEGJ2\(^"H.N'B:OG@9"T
MY'R8N>-ZG[SB>JB^X7JRO]-TL\'$;++"P&JRP\!JLL/ :K+#P&JRP\!JLL/
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MX7JRO]-TL\'$;++"P&JRP\!JLL/ :K+#P&JRP\!JLL/ :K+#P&JRP\!JLL/
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MP&JRP\!JLL/ :K+#P&JRP\!JLL/ :K+#P&JRP\!JLL/ :K+#P&JRP\!JLL/
M:K+#P&JRP_^>& 3_G2(*_YLL%?^6-B+_FD O_Z))/?^D5$W_HUY?_Z%H<?Z<
M<8+WEGJ2\(^"H.N'B:OG@9"TY'R8N>-ZG[SB>JB^X7JRO]-TL\'$;++"P&JR
MP\!JLL/ :K+#P&JRP\!JLL/ :K+#P&JRP\!JLL/ :K+#P&JRP\!JLL/ :K+#
MP&JRP_^>& 3_GB(*_YLL%/^7-B+_G$ N_Z1)//^G4DS_IUQ?_Z5F<?ZA<(/V
MG'B3[Y6 H>J-AZWEAHZWXH"5ON!]G<+??*;%VWNOQLERKLBZ:JW)N&NNR+AK
MKLBX:Z[(N&NNR+AKKLBX:Z[(N&NNR+AKKLBX:Z[(N&NNR+AKKLBX:Z[(N&NN
MR/^?& 3_GB(*_YPL%/^8-B+_GD M_Z9(._^J44O_JUI>_ZID<?ZG;8/UHW:5
M[IU^I.B5A+#CC8J[WX:1Q=R!F<O;@*3-SWJIS[QPJ-&Q;JK.KV^LS*]OK,RO
M;ZS,KV^LS*]OK,RO;ZS,KV^LS*]OK,RO;ZS,KV^LS*]OK,RO;ZS,KV^LS/^?
M& /_GR(*_YTL%/^9-B+_H#\L_ZA'.O^M4$O_KEE>_ZYB<?VM:H3UJ7.6[J1Z
MI>>>@K/AEH>_W(V-RMF&E=+6A*'6PWFCV+%QH]BI<ZC1IW.ISZ=SJ<^G<ZG/
MIW.ISZ=SJ<^G<ZG/IW.ISZ=SJ<^G<ZG/IW.ISZ=SJ<^G<ZG/IW.IS_^?& /_
MGR(*_YTL%/^9-B'_HC\K_ZI'.?^P3TK_LEA>_[)@<?RQ:(7TKW"7[:MWI^:F
M?;7@GH/"VI6)SM2,D-?-B)O;O(&AVZIWH=JB=Z;4H'>GTJ!WI]*@=Z?2H'>G
MTJ!WI]*@=Z?2H'>GTJ!WI]*@=Z?2H'>GTJ!WI]*@=Z?2H'>GTO^@& /_H"()
M_YXL$_^:-B'_I#\K_ZQ&./^S3DG_M5==_;9?<?JV9H7TM6V8[+)TJ.6N>;?>
MIG_%UJ"&S\J4C->_C)3<M8F?W:-]H-V:>Z/7F7NEU9E[I=69>Z75F7NEU9E[
MI=69>Z75F7NEU9E[I=69>Z75F7NEU9E[I=69>Z75F7NEU?^@& /_H"()_YXL
M$_^;-B#_I3XJ_ZU&./^U34G_N%9=^[I=<?B[9(7SNVN9Z[IPJN2V=;G;L'S%
MSJ>#SL*<B->TDH[=KI&=WYR$GM^3?Z+:DG^CUY)_H]>2?Z/7DG^CUY)_H]>2
M?Z/7DG^CUY)_H]>2?Z/7DG^CUY)_H]>2?Z/7DG^CU_^@%P/_H"()_YXL$_^<
M-B#_ICXI_Z]&-_^W34C]O%5<^KY<<?; 8H7QP6B9ZL)LJ^"_<KG4MWG$QZU_
MSKJDA=:LF8K>HI26XI2+G.&+@Z#<BX.AVHN#H=J+@Z':BX.AVHN#H=J+@Z':
MBX.AVHN#H=J+@Z':BX.AVHN#H=J+@Z':BX.AVO^A%P/_H2()_Y\L$_^>-A__
MJ#XH_[%&-O^Y3$?[OU1<]\-;<?/&88;NR66:YLQJJ]O'<+C-O7;#P+1\S;.K
M@=6DH(7=EIB.XXV3F^.$B9[?A(B@W(2(H-R$B*#<A(B@W(2(H-R$B*#<A(B@
MW(2(H-R$B*#<A(B@W(2(H-R$B*#<A(B@W/^A%P/_H2()_Y\L$_^?-A[_J3XH
M_[-%-OV\3$?XPU-;],A9<._-7H;JTF*;X=1GJM7/;;?'Q'/#N;IXS*RR?=6=
MJ('=C)^(XX>?F^-^D9[??H^?W7Z/G]U^CY_=?H^?W7Z/G]U^CY_=?H^?W7Z/
MG]U^CY_=?H^?W7Z/G]U^CY_=?H^?W?^A%P/_H2()_Z L$O^@-1[_JSXG_[1%
M-?J^2T;UQU):\,Y8<.O47(7EW6":VMIEJLW3:K? RW#"LL)US*6Z>=25L'W<
MAZJ%X86NG>%[G)_>>IF@W'J9H-QZF:#<>IF@W'J9H-QZF:#<>IF@W'J9H-QZ
MF:#<>IF@W'J9H-QZF:#<>IF@W/^A%P/_HB()_Z L$O^B-1W_K3TF_K=%,_?"
M2T3QS5%9[-56;^;?687=XEV9S]QBJ<+49[:US6O!J<APRYW#=-.-NGC:@[>#
MWH&\G-UYJJ';>*6BV7BEHMEXI:+9>*6BV7BEHMEXI:+9>*6BV7BEHMEXI:+9
M>*6BV7BEHMEXI:+9>*6BV?^B%P/_HB((_Z$L$O^D-1S_KSTD^[I$,O/&2D/M
MTT]7YM]4;N'I5H33Y5N8Q-Q?J+;48[6ISF; G,AIRI#$;-*#P'#8?+]]VGF_
MDMEVNJ/7=;2DUG6TI-9UM*36=;2DUG6TI-9UM*36=;2DUG6TI-9UM*36=;2D
MUG6TI-9UM*36=;2DUO^B%P+_HR((_Z(K$O^G-1K_LCTC][Y$,._,2D'GW$Y5
MX.E0;-GN5(+(YUJ6N=Y=I:O67[*=SV&]C\IBR(+%8]!WPFC5<\%UUG'"A]5O
MPYS3<<2DTG'$I-)QQ*32<<2DTG'$I-)QQ*32<<2DTG'$I-)QQ*32<<2DTG'$
MI-)QQ*32<<2DTO^C%P+_I"((_Z,K$?^J-1G]MCT@\L1$+>C323W?Y4M3V>].
M:\[R4H"]Z%B3KN!;H:#97:Z3TE^XALU?P7O)8<EQQF7-;<9QSFO&@,UJQY+,
M:<>7S&G'E\QIQY?,:<>7S&G'E\QIQY?,:<>7S&G'E\QIQY?,:<>7S&G'E\QI
MQY?,:<>7S/^D%@+_I2('_Z0K$?^N-!;XNSP=Z\M#*>#=1SG6ZDI3S?5-:L+T
M4'ZRZU:.H^-9G9;<6ZB*UERQ?M)=N73.7\!LS&3$:,MMQ6?,>L1FS(G#9<R.
MPV7,CL-ES([#9<R.PV7,CL-ES([#9<R.PV7,CL-ES([#9<R.PV7,CL-ES([#
M9<R.P_^E%@+_IB$'_Z8K$/^S-!/QPCP9X]1"(M;F1#K+\DA2P?Q+:+;V3GJG
M[E.)F>97EHS@6:&!VUJJ=M=;L6W47;9GTF*Y9-%JNF+2=;IATH*Y8=*&N&'2
MAKAATH:X8=*&N&'2AKAATH:X8=*&N&'2AKAATH:X8=*&N&'2AKAATH:X8=*&
MN/^G%0'_J"$&_ZHK#?>Z,P_GS#L3V.$](LSN0SO ^D91M/](9*KY2W6;\5&#
MCNI4CX/E5IEXX%>A;]U9IFC;6ZICV6"M7]EFKE[9<*Y=V7NM7-E_K5S9?ZU<
MV7^M7-E_K5S9?ZU<V7^M7-E_K5S9?ZU<V7^M7-E_K5S9?ZU<V7^M7-E_K?^I
M% '_JB$%_[(J">[$,@G:VS$.S>L\)<#X03NS_T).I_]%7YS]2&Z0]DU[A/!1
MAGKK4XYPYU65:>17FF/B6IU?X5Z?7.%CH%O@:Z!9X72@6>%WH%GA=Z!9X7>@
M6>%WH%GA=Z!9X7>@6>%WH%GA=Z!9X7>@6>%WH%GA=Z!9X7>@6>%WH/^K$P#_
MK2 $];LG!-_2*0+.YS(2P?8Z)K/_/3FF_S]*FO]!68__16>%^TER>O9->W'Q
M4()I[E*(8^Q5C%_K6(Y<ZER06NE@D5CI9Y%7Z6Z15^EQD5?I<9%7Z7&15^EQ
MD5?I<9%7Z7&15^EQD5?I<9%7Z7&15^EQD5?I<9%7Z7&15^EQD?^N$0#^LQX"
MYLH; -#D(P7"]#$5M/\U)J;_.#:9_SI$C?\]4H/_05YY_T1H</Q(<&CY3'9B
M]D]Z7O52?5OT57Y9\UF 5_-=@%;R8H%4\FB!5/-J@53S:H%4\VJ!5/-J@53S
M:H%4\VJ!5/-J@53S:H%4\VJ!5/-J@53S:H%4\VJ!5/-J@?NR#0#OP0\ T]\)
M ,3Q)@FU_RT6IO\O))C_,C*,_S4^@?\X2G?_/%1M_S]=9?]#9%__1VA;_TMK
M6/U.;E;]4F]4_%5P4_Q8<%+\77%1_&)Q4?QC<5'\8W%1_&-Q4?QC<5'\8W%1
M_&-Q4?QC<5'\8W%1_&-Q4?QC<5'\8W%1_&-Q4?QC<>RW!P#2S08 Q>\5 ;?^
M(PNH_R86F?\H(8S_*RV _R\X=?\S0FO_-TMC_SI27/\^5U?_05M4_T5=4?])
M7U#_3&!/_T]A3O]284W_5F%,_UIB2_]<8DO_7&)+_UQB2_]<8DO_7&)+_UQB
M2_]<8DO_7&)+_UQB2_]<8DO_7&)+_UQB2_]<8M+# @#'UP0 N?L7 ZK_' N;
M_QX4C?\A'H#_)"AT_RDR:?\M.V#_,4)9_S5'5/\X2U#_/$Y-_S]02_]"44K_
M15))_T=22/]*4T?_3E-&_U)41O]35$;_4U1&_U-41O]35$;_4U1&_U-41O]3
M5$;_4U1&_U-41O]35$;_4U1&_U-41O]35/^7%03_EB *_Y,I%/^.,R'_D3TL
M_Y=&./^:4$;_F5M7_Y9F:/^1<'C\BGJ&]H.#D_%\BY[N=Y2D['2=J.MTI:KK
M=*VKZG2UK.ASO:W=;K^NT6G K\EEO[#)9;^PR66_L,EEO[#)9;^PR66_L,EE
MO[#)9;^PR66_L,EEO[#)9;^PR66_L/^7%03_EB *_Y,I%/^.,R'_D3TL_Y=&
M./^:4$;_F5M7_Y9F:/^1<'C\BGJ&]H.#D_%\BY[N=Y2D['2=J.MTI:KK=*VK
MZG2UK.ASO:W=;K^NT6G K\EEO[#)9;^PR66_L,EEO[#)9;^PR66_L,EEO[#)
M9;^PR66_L,EEO[#)9;^PR66_L/^7%03_EB *_Y,I%/^.,R'_D3TL_Y=&./^:
M4$;_F5M7_Y9F:/^1<'C\BGJ&]H.#D_%\BY[N=Y2D['2=J.MTI:KK=*VKZG2U
MK.ASO:W=;K^NT6G K\EEO[#)9;^PR66_L,EEO[#)9;^PR66_L,EEO[#)9;^P
MR66_L,EEO[#)9;^PR66_L/^7%03_EB *_Y,I%/^.,R'_D3TL_Y=&./^:4$;_
MF5M7_Y9F:/^1<'C\BGJ&]H.#D_%\BY[N=Y2D['2=J.MTI:KK=*VKZG2UK.AS
MO:W=;K^NT6G K\EEO[#)9;^PR66_L,EEO[#)9;^PR66_L,EEO[#)9;^PR66_
ML,EEO[#)9;^PR66_L/^7%03_EB *_Y,I%/^.,R'_D3TL_Y=&./^:4$;_F5M7
M_Y9F:/^1<'C\BGJ&]H.#D_%\BY[N=Y2D['2=J.MTI:KK=*VKZG2UK.ASO:W=
M;K^NT6G K\EEO[#)9;^PR66_L,EEO[#)9;^PR66_L,EEO[#)9;^PR66_L,EE
MO[#)9;^PR66_L/^7%03_EB *_Y,I%/^.,R'_D3TL_Y=&./^:4$;_F5M7_Y9F
M:/^1<'C\BGJ&]H.#D_%\BY[N=Y2D['2=J.MTI:KK=*VKZG2UK.ASO:W=;K^N
MT6G K\EEO[#)9;^PR66_L,EEO[#)9;^PR66_L,EEO[#)9;^PR66_L,EEO[#)
M9;^PR66_L/^7%03_EB *_Y,I%/^.,R'_D3TL_Y=&./^:4$;_F5M7_Y9F:/^1
M<'C\BGJ&]H.#D_%\BY[N=Y2D['2=J.MTI:KK=*VKZG2UK.ASO:W=;K^NT6G
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MNK>A=;JWH76ZMZ%UNK>A=;JWH76ZM_^4$@3_DQP)_Y E$O^1+QO_FS@A_Z)
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MC*K/BH.JSH> K<F'@++#AX"RPX> LL.'@++#AX"RPX> LL.'@++#AX"RPX>
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MHW"1JIUUG:"6>JB5CWZQC(F$N(>'C[N$B)V[@XFLNW^'M[MZ@KFY?(&^L7R
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M.S+_8CHR_V(Z,O]B.C+_8CHR_V(Z,O]B.C+_8CHR_V(Z,O]B.L#"  "ST
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M54/_JU1#_[)30_^R4T/_LE-#_[)30_^R4T/_LE-#_[)30_^R4]JD  #,M
MPL,! +?1  "KY 0 H/\3 Y3_&@J)_R 2?O\D&W3_*25J_RPN8/\P-EC_,SQ1
M_S="2_\[14?_04A$_T=*0O].2T#_54L__UU+/O]F2CW_<$D\_WI)._^$2#K_
MDT<Z_YE&.O^91CK_F48Z_YE&.O^91CK_F48Z_YE&.O^91LZN  ##O0  N,P
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MCWZ#GXM]CJ&)?9JBAWVHHH9^MZ&$?LFA@7O,GH!ZT)> >=60@'G6D(!YUI"
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M=4S?Y7--U.IP3=3J<$W4ZG!-U.IP3=3J<$W4ZG!-U.IP3=3J</^% P+UF $
MUZ@  ,VV 0#$Q ( N](% +'L%0&H[B<'GN\P$Y/N-B")[3HN?NP^/'3K04EI
MZD548.I)7UCI3V92ZE9K3^I@;$WK;6Q,['MK3.V*:DONFFE+[ZIG2N^]9DGP
MU65([.ID2.SJ9$CLZF1([.ID2.SJ9$CLZF1([.ID2.SJ9/^/  #;H0  S[
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M/#7_HSPU_Z,\-?^C/#7_HSPU_Z,\-?^C/,JN  "_O   M,D  *?3  "9W
MCO0! 8/_"@5Y_Q$+;_\6$F7_&AE;_Q\@4_\C)DS_)RM&_RLO0?\P,CW_-30Z
M_SHV-_] -C3_1C<S_TTV,?]4-C#_7#4N_V4U+?]O-"S_>3,K_X8R*_^',BO_
MAS(K_X<R*_^',BO_AS(K_X<R*_^',L&X  "VQ0  J=   )O9  "-X   @?4
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M5T;D]U=&Y/=71N3W5T;D]U=&Y/=71N3W5^R/  #5H   RJX  ,"Z  "VQ@
MJ]$" *#=!0"8\QD#CO0D"H7S*Q1[\S ?<?(U*V;R.39=\3P_5/%!1T[R1TU*
M\D]01_-94D;S8U)%]'!11/5^4$3UC4Y#]IU-0_:N3$+WP$M!^-E)0?CL24'X
M[$E!^.Q)0?CL24'X[$E!^.Q)0?CL2=J9  #,J0  PK8  +C"  "LS0  H-8
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M<2$9_W$A&?]Q(;7   "GRP  F=(  (K:  !\X0  ;^<  &3Y  );_P &4O\
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M:U*H\&M2J/!K4JCP:U*H\&M2J/!K4JCP:_]U  /XB0  VI<  -"C  #'K@
MOK<  +7   "JR@8 H\TA IO-,0V2RCP<B<A$*X#%2CIWPDY';<!25&.^5U]:
MO%QG5+MD;%&[;VY0O'QM3[R+;$^]FVM.OJQI3;[!:$V^W6=-O?%E3;CV8DVV
M]V)-MO=B3;;W8DVV]V)-MO=B3;;W8O]^  '@CP  TYT  ,FI  # M   M[T
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M.I@L_SN@*_\[J"O_/*\J_SRW*O\]P"G_/LHI_S[6*?X_XRC\/^XH^D#W)_A
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M=5N$['%;A.QQ6X3L<5N$['%;A.QQ6X3L<?]E! ;_=P$!\X8  -J1  #2FP
MRJ,! ,*J  "YKA4 L:\L!:FM.Q&@JT4@F*A-+Y"E5#V(H5E*@)Y>5GB;8V%N
MEV=K991K=%Z2<GM:D7U]6)**?%B2F7M7DZEY5I.[>%:4TW=7E.MS5Y#M<%>-
M[VU7C>]M5XWO;5>-[VU7C>]M5XWO;?]I  3_?   X(H  -66  #-GP  Q*@
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M54NR_U5+LO]52[+_5?A^  #:C@  SIL  ,2G  "[L   LK@  *>_  "<Q@(
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M/T#6_SY UO\^0-;_/D#6_SY UO\^0-;_/MF/  #+G@  P*L  +BT  "MO0
MHL4  );+  "*TP$ ?]T& 'KH&0-RZ"0*:>@K$V#G,1U7YS8F3^8\+TGF0C5$
MYTHY0>=4.T#H7SL_Z6LZ/NEY.#[JB#<]ZYDV/>RK-#SLP#,[[=LR.^SQ,3KI
M_S$ZZ?\Q.NG_,3KI_S$ZZ?\Q.NG_,<^9  ##IP  NK(  +"\  "DQ   E\L
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M%QC_HA<8_Z(7&/^B%[>V  "KP   GL@  )#.  "!U   =-L  &CA  !=YP
M5?D  TW_  9&_P$*/O\&#CC_"Q$R_Q$4+O\5%BK_&Q<F_R 8(_\F&2#_*QD<
M_S$9&?\X&!;_01@3_TH7$?]5%@[_8!4+_VL4"?]W$P?_@1,'_X$3!_^!$P?_
M@1,'_X$3!_^!$ZZ^  "AQ@  DLT  (/4  !UVP  :.$  %SG  !1[  !2?P
M T'_  8Y_P ),_\ #"[_  XH_P,0)/\($B#_#!,=_Q(4&O\7%!?_'!03_R$4
M#_\G% K_+10'_S43 _\^$@#_1Q$ _U 1 /]9$ #_80\ _V$/ /]A#P#_80\
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M&13_+2$8_S4@&/\X(AG_.2<<_SHS(/\X/R3_-4PG_S19*?\S9RC_,W0H_S2
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MRG)7AN5O6(7P:UB"\V=8@?1F6('T9EB!]&98@?1F6('T9O]E  3^=@  WH0
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M5DZB_U1.H/]33J#_4TZ@_U-.H/]33J#_4_EV  #<A@  SY,  ,6>  "\I@
MLZT  *FS  "=N   D[L0 (Z])@*'O#0+@+H]%WBY1"-PMTHP9[5/.UZS4T57
ML5E-4;!@4TVP:55,L'552["#5$NQD5-*L:)12;&S4$FRRTY(L>9-2*_V2TBN
M_TI(KO]*2*[_2DBN_TI(KO]*2*[_2N1^  #4C0  R9H  +^D  "WK   K;,
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M)C;B_R8VXO\F-N+_)LJ9  "_I@  MK   *RY  "@P   D\4  (?+  ![T0
M<-@  &?I!P!A[Q4$6N\="E+P)!!+\"H71/ P'3[P-R$Z\#XD-_%')37R424T
M\UPD,_-I(S+T=R(Q](<A,/68'R_UJQXO]L =+O?9'"[W\1LN]O4:+O;U&B[V
M]1HN]O4:+O;U&L&D  "YKP  K[@  *._  "6Q@  B,L  'S1  !PUP  9=X
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M$O^M#[2U  "HO@  F\4  (S+  !^T0  <=@  &3>  !9XP  3N@  $?X  )
M_P %.?\ "#3_!0LN_PH.*?\0$"7_%1$B_QL2'_\A$QO_)A,7_RT3$_\T$@__
M/1(+_T<1"/]3$ 7_7P\"_VP. /]Y#0#_APP _XH, /^*# #_B@P _XH, /^*
M#*N]  "=Q   C\L  (#1  !RV   9-X  %CD  !-Z0  0^X  3O[  ,T_P %
M+O\ ""G_  HD_P ,(/\"#1S_!PX8_PL/%?\2#Q+_& \-_QP/"/\B#P3_*0\
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MU$B?,M)(IS+12; RSTFZ,LY)R#/,2MDSR$KI,\9+]S#$3/\NPDW_+,%-_RK
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MR6MH;^-H:G#U8FIP^EUJ;OQ::F[\6FIN_%IJ;OQ::F[\6O]9  7_:@ !ZG8
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M85:!^EU6?_Q;5G_\6U9__%M6?_Q;5G_\6_]D  'J=0  V8$  ,Z+  #%DP
MO9D  +.=  "IGP4 HJ$? )RA,0:5GST1C9Q''8::3BE_EU,U>)18/W"17$IH
MCV%48(QE7%F*;&-5B75F4XF!9E.*CV52BIYC48JN8E&+PF!0B]U>48KQ6U**
M_5A2B/]64HC_5E*(_U92B/]64HC_5O]I  #A>0  U(8  ,J0  #!F   N)X
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M/T6H_S]%J/\_1:C_/]Y^  #/C   Q)@  +NB  "RJ0  J*\  )VS  "1MP
M@[P  'R_$P!XOR8"<K\R"FN^.Q1CO$$>6[M'*%2Z3#%.N5(X2;A:/$:X8SY%
MN6\]1+E\/$2YBSM#NILY0KJL.$*ZPC=!NMXU0+CS-4"V_C4_M?\U/[7_-3^U
M_S4_M?\U/[7_-=:&  #(E   OJ   +:I  "MKP  HK4  )6Y  ")O0  ?<,
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M"@#_7@D _VT) /][" #_B0< _Y0' /^4!P#_E < _Y0' /^4!ZB[  ":P@
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MSE1]8>91?F+V3'YC_TA^9/]%?F3_1'YD_T1^9/]$?F3_1/]0  7_7@ !\FH
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M669L_%5G;/]19VS_4&=L_U!G;/]09VS_4/]8  +X:   WG,  --\  #*@P
MPH<  +J)  "RBPX JHPE :.+-0B<B4 3E89)'XZ"3RN'?U4V@7M:0'MX7DET
M=6-2;G)H66AP;U]E;GAB8FZ"8V!NCV-?;YQC76^K8UQOOF);;]9A77#N6UYQ
M^U=?</]37W#_4E]P_U)?</]27W#_4O];  'N:P  VW<  -"   #'AP  OHL
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M3$^%_TQ/A?],3X7_3/-I  #<>   SH0  ,2-  "[E   LYD  *F=  ";G@
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M*]"&  #$DP  NIX  +*F  "IK   GK$  )&T  "%MP  >+L  &O   !CQ!
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M#";JI@LFZKT*).O;"B/I\0DAYO\*(>;_"B'F_PHAYO\*(>;_"KJC  "SK
MJ;0  )RZ  "/O@  @<(  '3'  !HS   7-$  %+6  !(W   0.8  #OS"P(V
M\Q0%,?0;""ST(PHI]"H,)?4R#2/V.PT@]D4-'O=0#!SW70L9^&T*&/E^"1?Y
MD @6^J0'%?J[!A7ZU@84^_ %$_OT!1/[] 43^_0%$_OT!;6L  "KM   G[H
M )*_  "$Q   =LD  &G.  !=TP  4MD  $C=   ^X@  -NT  3'Z 0,L_P@%
M*/\0!R3_%@@@_QT)'/\D"AG_*PH5_S0*$O\^"0W_20D*_U8(!O]E!P3_=P8#
M_XD% O^<!0'_K00!_\($ ?_' P'_QP,!_\<# ?_' ZZS  "BN@  E,   (;%
M  !WR@  :M   %W5  !1VP  1^   #SD   SZ   +/(  2?]  ,B_P $'O\"
M!AK_" <7_PX'$_\5" [_&P@*_R((!?\J" '_- < _S\& /],!@#_6P4 _VL$
M /]\ P#_BP, _YH# /^= P#_G0, _YT# /^= Z6Z  "7P   B<8  'K,  !L
MT0  7M@  %'>  !&XP  .^<  #'K   H[@  (?<  1S_  ,8_P $%/\ !1'_
M  8,_P &"/\$!@3_"@< _Q$' /\8!@#_'P8 _RD% /\T!0#_000 _TX$ /];
M P#_: , _W8" /]X @#_> ( _W@" /]X O\,)Q+_$R02_Q0D$_\0)A/_""P3
M_P(V$O\!1!'_ %(0_P!?#O\ ; S_ '@+_P"""O\ BPG_ )((_P"9!_\ H ?_
M *8&_P&M!O\!M 7_ KP%_P+&!/\"TP3_ N$#_P+M _\"]@+_ OX"_0+_ OL"
M_P+[ O\"^P+_ OL"_P+[ O\"^P+_ O\1)1+_%B$2_Q<A$_\5(Q/_#2D3_PDT
M$_\(0A+_!U 1_P5=#_\#:@W_ G8,_P. "_\$B K_!9 )_P:7"/\'G@?_!Z0'
M_PBJ!O\)L0;_";H%_PK#!?\*T 3_"M\$_0KK _L*] /Y"OT#]PK_ _8*_P/V
M"O\#]@O_!/8+_P3V"_\$]@O_!/\5(A+_&AX2_QL=$O\:'Q/_%244_Q0Q%/\2
M/A3_$$P2_PY:$?\,9@__"W(-_PQ]#/\-A@O_#HT*_Q"4"?\0FPG_$:$(_Q*H
M"/\2KP?_$[<&_A3 !OT4S07Z%-L%]Q3G!?04\P3R%/P$\!7_!? 5_P7O%?\%
M[Q7_!>\5_P7O%?\%[Q7_!?\9'A+_'AD2_R 8$O\?&A+_'R(3_QXN%/\;.Q7_
M&4@4_QA6$O\78Q'_%F\/_Q9Y#O\8@@W]&(H,_!F1"_L:F KZ&YX*^1NE"?@<
MK GW'+0(]1V]"/0>R0?R'M@'[Q[E!NP>\0;J'OP'Z!__!^<?_P?E(/\(Y"#_
M".0@_PCD(/\(Y"#_"/\=&A+_(Q41_R<4$/\F%1#_*A\2_RDK%/\F-Q;_(T06
M_R%1%?XA7A/[(&H1^"!U$/8A?P_T(H<.\R..#?$DE0SP))L,[R6B"^XFJ0OM
M)K$*ZR>["NHHQPKI*-0)Y2CD">(H\0K@*/P*WBG_"]LJ_PO:*?\+V2G_"]DI
M_PO9*?\+V2G_"_\B%A'_*A(/_RX0#O\R% [_-1T/_S0F$O\Q,Q7_+3\7^BM,
M%_4J617Q*F84[BMQ$NPK>Q'J+(,0Z"V+$.8ND@_E+I@/Y"^?#N(OI@[A,*X.
MX#&X#MXQQ W=,=,-VC'C#M8R\0_3,OP/T#+_#\XR_P_-,O\/S#+_#\PR_P_,
M,O\/S#+_#_\H$Q#_,0T-_S8*#/\]$0O_0!H,_S\C#_\[+1+X-SH6\3-'&.LR
M5!CG,V$7XS1L%> U=A3>-G\4W#:'$]HWCA/9-Y43US><$]4XI!/4.*L3TCFU
M%-$YP!3/.<X4S3G?%,DZ[Q7&.OL5Q#K_%,([_Q3 ._\4P#K_$\ Z_Q/ .O\3
MP#K_$_\N$ [_-PD+_SX'"?]&#PC_2A<(_TD@"OA%*0[O0#03YSQ!%^$Z3AG<
M.UL9V#QG&-0]<1G2/7H9SSZ"&LT^B1K,/I :RC^7&L@_GAK'/Z8;Q4"O&\-
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MU#F25.DWD57X-)!6_S&/5O\OCU;_+H]6_RZ/5O\NCU;_+O]%  ;_40 "_%T
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M1'E>_D!Y7_\^>5__/'E?_SQY7_\\>5__//].  /]7   XF<  -AO  #.=0
MQW<  ,!W  "X>!0 L'DH JAX-@JA=4$5FG%)()1M4"N.:E8UB69</85C8D*!
M86A&?F!O27Q@=TMZ8(!,>6"*3'=@E4UU8*%-<V"O3G%?P4YP7]E/<&'O27%A
M_$5R8O]"<F+_0')B_T!R8O] <F+_0/]0  +V7P  WVH  -1S  #+>   PWL
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M25QL_TE<;/])7&S_2?]:  #C:0  U74  ,I]  #!@P  N(<  *^(  "FB ,
MGHD; )B)+0.2B#D+BX5"%86"22!_@$\J>'U4-')Z63UK=UU%9'1B35YR:51:
M<7%86'![659PAUE5<9585'&D5U-QM592<<Q54G+F451R]TU4<O]+57+_255R
M_TE5<O])57+_2?E>  #?;0  T7@  ,>!  "^AP  M8L  *N-  "@C0  F8X7
M )..*0*-C38)AXM $H&)1QQZADTF=(12,&V!5SIF?EM"7WQ@2EEZ9U%5>&]5
M4GAY5E%XAE50>9144'FC4D]YM5%.><M03GGE34]Y]DI/>?](4'C_1E!X_T90
M>/]&4'C_1NQB  #;<@  S7T  ,.&  "ZC   L9   *B2  ";D@  DY,1 (Z4
M)0&(DS,&@I$]#WR/11EUC4LC;XM0+&B)539AAEH^6H1?1E2"94Q0@6Y/3H%Y
M4$V!A4]-@I--3(*C2TR"M$I+@LM(2X+E1TN!]D1+@?]#2X#_0DN _T)+@/]"
M2X#_0N9H  #6=P  R8(  +^+  "VD0  KI4  *28  "4EP  C9D* (>:( ""
MF2\$?9@Z"W:60A5PE4D>:9-.*&*14S%;CU@Y58U=0%",9$5-BVU'2XMX1TJ+
MA49*C)-%28RC0TB,M$%(C,M 1XOF/T>*]CU'B?\\1XG_.T>)_SM'B?\[1XG_
M.^!O  #0?   Q(<  +N0  "SEP  JIL  )^>  "2GP  A: ! ("A& ![H2D"
M=J U"'"?/A!IG4498YM+(ER:4"M6F%8S4)=<.4R68SU)EFT^2)9X/D>6A3U'
MEI0[1I:C.466M3A$ELPW1)7F-4.4]S5#D_\T0Y+_-$.2_S1#DO\T0Y+_--IV
M  #+@P  P(X  +>6  "OG0  IJ$  )JD  "-I@  ?:<  ':H#0!SJ2$ ;JDO
M!&BH. MBIT 36Z5&'%6D3"1/HU(K2J)9,$>B83-%H6LT0Z%W,T.BA#)"HI(P
M0J*B+T&BM"U HLPL/Z'F*S^?]RL^G?\K/IW_*SZ=_RL^G?\K/IW_*])]  #%
MB@  NY4  +.=  "KHP  H*<  )2J  "(K   >JX  &VQ 0!GLA8 9+(F 5^R
M,0=9L3H-4[! %4VO1QQ(KDTB1*Y5)D&N72@_KF@H/JYT)SVN@28]KI D/*ZA
M(SNNLR$ZKLL@.JWF'SBK]R WJO\A-ZG_(3>I_R$WJ?\A-ZG_(<N&  "_D@
MMYP  *^D  "EJ0  FJT  (VP  " L@  =+4  &:X  !;O < 5[T: %2])P)/
MO3$'2KPY#46\0!- NT<8/+M0&SJ[61PYO&0;.+QP&C>\?ADVO(T8-KV>%S6]
MLA8TO,H4,[OF%#&Y]Q8PN/\7+[?_%R^W_Q<OM_\7+[?_%\./  "ZFP  LJ0
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M @KUV0$)]? !"//Y 0CS^0$(\_D!"//Y ;*K  "IL@  G+@  (^\  "!P
M<\4  &7)  !9S@  3M,  $/8   YW   +^$  "?E   C]  !(/T& AS^#@,9
M_A8$%?X=!!'^)04-_RX$"?\X! 7_1 0!_U$# /]A @#_= ( _X@! /^< 0#_
ML $ _\4  /_9  #_V0  _]D  /_9 *NR  "?N   DKT  (/"  !TQP  9\P
M %K1  !.U@  0]L  #C@   NY   )><  ![L   :^0 !%O\  A/_  ,/_P8#
M"_\-! ;_% 0"_QP$ /\D P#_+@, _SH" /]( @#_60$ _VP! /]^ 0#_CP
M_Y\  /^I  #_J0  _ZD  /^I **X  "5O@  AL,  '?)  !IS@  6]0  $[;
M  !"X   -^0  "WG   CZP  &NX  !3S   0_0 !"_\  @?_  (%_P # ?\
M P#_ P, _P@# /\1 P#_&0, _R," /\O @#_/@$ _TX! /]? 0#_;P  _WP
M /^%  #_A0  _X4  /^% /\()!#_"R(0_PHB$/\$)!#_ "H/_P U#O\ 0PS_
M %$+_P!>"?\ :P?_ '<&_P" !?\ B03_ ) $_P"7 _\ G0/_ *,"_P"I O\
MKP+_ +<!_P#  ?\ S '_ -L _P#I /\ \P#_ /T _0#_ /L _P#[ /\ ^P#_
M /L _P#[ /\ ^P#_ /\,(A#_#Q\0_PX>$/\*(1#_ "80_P R#_\ 0 W_ $X,
M_P!;"O\ : C_ '0'_P!^!O\ A@7_ (X$_P"4!/\ FP/_ *$#_P"G O\ K0+_
M +0"_P"] ?\ R0'^ -@!_0#F /L \0#X /P ]@#_ /4 _P#U /\!]0#_ ?4
M_P'U /\!]0#_ ?\1'Q#_%!L0_Q0:$/\0'!#_"B,0_P@P$/\&/0[_ TL-_P%8
M"_\ 90G_ ' (_P!Z!_\ @P;_ 8L%_P&1!/\"F 3_ YX#_P2D _X$JP/]!+("
M^P6Z OH$Q@'Y!=0!]@3B ?,%\ 'Q!?H![P;_ >X'_P'N!_\"[ G_ NP)_P+L
M"?\"[ G_ O\5&Q#_&180_QD5#_\6%@__%B 0_Q4L$/\2.1#_#D<._PQ4#/\*
M80K_"FP)_PIW"/T+@ ?[#(<&^@V.!?D-E07W#IL$]A"A!/40J /T$:\#\A&X
M _$1PP+P$=$"[1'@ NH2[@'G$_D"YA/_ ^04_P/A%O\$X!;_!. 6_P3@%O\$
MX!;_!/\:%A#_'A,/_Q\1#O\?% [_(AT/_R I$/\=-1#_&D(/_QA/#OP77 SX
M%F@*]A9S"?,7? CQ&(0'\!F+!NX:D@;M&Y@%[!N>!>H<I07I'*T$Z!RU!.8=
MP 3E'<X#XAW> ]\>[03<'_D%V2#_!=8@_P;5(/\&U"#_!M0@_P;4(/\&U"#_
M!O\?$P__) T-_R8*#/\K$ O_+1H,_RPD#O\H,!#])#T0]R)*#_(A5PWN(6,,
MZR)N"N@C> GF)( (Y"6'".(EC@?A)I4'WR:<!]XGHP;=)ZH&VRBS!MHHO@;8
M*,P&U2G=!M(J[ ?.*OD(RRK_"<DJ_PG(*O\)QBK_"L8J_PK&*O\*QBK_"O\E
M#@[_*P@+_R\%"?\W#@C_.!<)_S<@"_PS*P[T+C@0[2Q%$.<K4@_B*UX-WRUJ
M#-PN= O:+WT*V"^$"M4PBPK4,)$*TC&8"M QGPO/,J8+S3*O"\PRN0O*,\8,
MR#/7#,0SZ W!-/8-OS/_#KTT_PZ[,_\.NC/_#;HS_PVZ,_\-NC/_#?\K"@S_
M,@,)_SH#!O]!"@7_0Q,%_T$<!_0])@KJ.#$-XC0_$-PT3!#6-5D/TC9E#\\W
M;A#,.'<0RCA_$,@YAA'&.8P1Q3J3$<,ZFA'!.J$1P#NJ$KX[M!*].\ 2NSO0
M$K@[XQ.U._(3LSS^$[$[_Q.P._\2KCS_$JX\_Q*N//\2KCS_$O\Q!@K_.  '
M_T,!!/])!P/_2PX"]TH7 ^M&( 7@0"L(V#XY#- ]1Q++/E,5QCY>%L,_:!?
M/W$7OD!Y%[Q @!>Z0(<8N$&-&+=!E!BU09P8M$&D&;)!KAFP0KH9KT+*&JU"
MW1JJ0NX:J$+[&:9#_QBE0_\7I$/_%Z1#_Q>D0_\7I$/_%_\V 0C_/@ %_TD
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M+(M1_RF*4?\HBE'_)HI1_R:*4?\FBE'_)O]"  3_3@  ZU<  -U?  #58P
MSF0  ,I@ @# 8AD N&,K!+!@.0VI74,7HUI,(9U75"B:55LMEU1C,)14:C&3
M4W(RD5-Y,H]3@#*.4X@SC%.1,XM3FS2)4Z<TB%.T-893QC6%4]TVA%3Q,H-4
M_2^#5/\M@E3_*X)4_RN"5/\K@E3_*_]%  /]4@  XUP  -ED  #0:   R6H
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M.&U=_SAM7?\X;5W_./].  #G7   VF@  ,YP  #%=   O78  +5U  "L=0H
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M3EIGA4Y89Y).5V>A3E9GL4U49\9,5&?@2E5H]$96:/]#5VC_0%=H_T!7:/]
M5VC_0.]8  #=:   SW(  ,5Z  "\?P  LX(  *F#  "?@@  EX(5 )&#)P&+
M@C0'A7\^$']]11EY>TLB<WA0*VUV531G<UH\87%?0UMN94E7;6U-56QW3U-M
M@TY2;9!.46V?3%!MKTM/;L1*3V[?2%!N\T50;?Y"46W_0%%M_T!1;?] 46W_
M0.E=  #:;   S'8  ,%^  "XA   L(<  *:(  "9AP  DH<0 (R((P"'AS$%
M@84[#7N#0Q9U@4D?;W]/*&A]4S%B>E@Y7'A=0%9V8T92=&M*3W1U2TYT@4M-
M=8])376>2$QUKD9+=<-%2W7>0TMU\D%+=/X_3'3_/4QT_SU,=/\]3'3_/>5B
M  #5<   R'L  +Z#  "UB0  K(P  **.  "4C   C(T) (:-'@""C2T#?(PX
M"G:*01)PB$<;:H9-)&.$42Q=@E8U5X!;/%)^8D%.?6I$3'UU14M]@41*?HY#
M27Z>04E^KD!(?L,^1W[>/4=]\CM'?/XZ1WS_.4=\_SE'?/\Y1WS_.>!H  #0
M=@  Q(   +J(  "RC@  J9(  )^3  ".D@  AI," ("3& !\DRD!=I(U!W"1
M/0YJD$079(Y*'UZ,3R=8BU0O4HE:-DV(83M*AVD]2(=T/4>'@3Q'AXXZ1HB=
M.46(KC=%B,,V1(?>-4.&\C1#A?XS0X3_,D.$_S)#A/\R0X3_,MMN  #+>P
MP(8  +>.  "NE   I9<  )N9  "-F@  ?YH  'B:$0!TFR, ;YHP!&J9.0ID
MF$$27I9'&EB532)2E%(I39-8+TF28#-&D6DT19%T-$21@#)#DHXQ0Y*=+T*2
MKBY!DL0L0)'>*S^0\BL_C_XK/H[_*SZ._RL^CO\K/H[_*]1U  #&@@  NXP
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M#"RS\@XKLOX/*K#_$"JP_Q JL/\0*K#_$+^/  "VF0  KZ(  *>H  ";K0
MCZ\  (*R  !UM   9[8  %NY  !.O0  0L$! #O$#@ YQ1T -\4H C/%,00P
MQ3H'+L5$""S%3@DKQED(*L9E""G&<@<HQX(&)\>3!B7'I@4DQ[T$(\?;!"'$
M\04@POT''\#_"!_ _P@?P/\('\#_"+F8  "RH@  JJD  )^O  "3L@  A;4
M 'BX  !KN@  7KT  %+!  !'Q0  /,D  #'. 0 HU 8 )-82 "/6'@ AURD!
M']<T 1[80 $=V$L!'-E8 1O99@$9VG8 &-J( !;;G  4V[, $MO2 !'9[0 1
MU_H!$=7_ A'5_P(1U?\"$=7_ K2B  "MJ@  H[   ):T  ")N   >[L  &Z^
M  !AP0  5<4  $G)   ^S0  ,](  "K6   BVP  &^0% !GH$  7Z!H %.DD
M 1+I+@$0ZCD!#>I& 0KK4P (ZV, !NQT  3MB  ![)T  .NU  #KUP  ZO
M .G_  #I_P  Z?\  .G_ *^J  "FL0  F;8  (RZ  !^O0  <,$  &+%  !6
MR0  2LX  #[2   TU@  *ML  "+?   :XP  %.L  !'X P -^0L "OD4 0;Y
M' $"^28! /HQ 0#Z/@  ^DP  /E=  #Y<   ^(0  />9  #VKP  ]L<  /?D
M  #WY   ]^0  /?D *FQ  "=M@  C[L  (&_  !RQ   9,@  %?-  !*T@
M/M8  #/;   IWP  (.,  !CF   1Z@  "_$   ?[   $_P   ?\$ 0#_"@$
M_Q,! /\< 0#_)P  _S4  /]$  #_5@  _VD  /]]  #_D   _Z$  /^R  #_
MLP  _[,  /^S *"W  "2O   A,$  '3&  !FRP  6-$  $O6   ^W   ,N
M "CD   >YP  %>H   [N   &\    O<   #_    _P   /\  0#_  $ _P !
M /\( 0#_$@  _QT  /\J  #_.@  _TP  /]?  #_<0  _X   /^/  #_CP
M_X\  /^/ /\#(@[_!!\._P$?#O\ (@W_ "@,_P S"O\ 00C_ % &_P!=!?\
M:03_ '4#_P!^ O\ A0'_ (P!_P"3 ?\ F0#_ )\ _P"E /\ JP#_ +( _P"[
M /X Q@#\ -0 ^P#C /L \ #[ /H ^P#_ /L _P#Z /\ ^@#_ /H _P#Z /\
M^@#_ /\''P[_"!P._P8<#O\ '@W_ "0,_P Q"_\ /@G_ $T'_P!:!O\ 9@3_
M '(#_P![ O\ @P+_ (H!_P"0 ?\ E@'_ )P _P"B /X J0#\ +  ^@"X /D
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M _L ?0+X 80"]P&* ?4!D0'T 9<!\@&= /$!HP#O :H [@&R .P!O0#J <H
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M$J$]_Q*@/?\1GSW_$9\]_Q&?/?\1GSW_$?\S  ;_.@ "_T,  /%'  #D1P
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M)'U/_R1]3_\D?4__)/]   'L30  WED  --A  #*9   PF4  +MA  "S8!
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M0DUJJD%,:KU 2VK6/TQJ[CQ,:?PZ3&G_.$UI_SA-:?\X36G_..1=  #4:P
MQG0  +Q[  "T@0  JX,  *&$  "3@   BX$) (6!'0" @2P">X V"'5^/Q!O
M?$48:7I+(&1X4"A>=E0P6'19-U-R8#Q/<6A 37!R04MP?4%*<8H_2G&9/DEQ
MJ3U(<KP[1W+6.D=Q[3A'</LW1W#_-4=O_S5';_\U1V__->!B  #/;P  PWD
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M(3N,[2$ZBOLB.HG_(CF)_R(YB?\B.8G_(LYU  #!@0  MXH  *^2  "GEP
MGIH  )*;  "%G   =9P  &B<  !AG1( 7ITB %N=+@-6G#<(49L^#4R:11-'
MF4P90YA2'4"86A\^F&0@/)AO'SR8>QX[F(@=.IB7&SF8J!HXF+P9-Y?6&#:6
M[1@UE/L9-)/_&C23_QHTD_\:-)/_&L=]  "\B   M)$  *R8  "DG0  F:
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M Q:Y_P06N?\$%KG_!+:8  "OH0  IZ<  )RL  "0KP  @K(  '6T  !GM@
M6[@  $Z[  !"O@  -L(  "S&   BR@$ &\X) !C/%@ 6SR$ %<\L !30.  2
MT$0 $=!0 !#17@ -T6X "]%_  G0D@ (T*< !M#!  3/X0 %SO4 !<S_  7+
M_P %R_\ !<O_ +&A  "KJ   H*X  ).R  "&M0  >+@  &JZ  !=O0  4<
M $7#   YQP  +LL  "7/   <TP  %-8   O; @ %W0H  ]T7  +=(P  WB\
M -\\  #@2P  X%L  .%M  #A@   X90  .&J  #AQ   X>$  .'R  #A^
MX?@  .'X *VI  "CKP  E[,  (FW  ![N@  ;;T  %_!  !3Q   1L@  #K,
M   OT   )-0  !S9   4W   #-\   3B    ZP   .L&  #J$   Z1H  .DF
M  #K-   [44  .]6  #O:0  \'T  /"2  #QIP  \;P  /'3  #RWP  \M\
M /+? *:O  ":M0  C+D  'Z]  !OP   8<0  %3)  !'S0  .M$  "_5   D
MV@  &MX  !/B   *Y0   ^<   #I    \0   /<   #V    ]@8  /41  #U
M'   ]BL  /D]  #\4   _60  /UX  #^C   _IT  /^M  #_M   _[0  /^T
M )VU  "/N@  @;X  ''#  !CR   5<T  $C2   [V   +MP  "3@   9XP
M$.<   CJ   ![0   .\   #P    ]@   /X   #_    _P   /\   #_!0
M_Q(  /\A  #_,P  _T<  /]<  #_;P  _X   /^-  #_E   _Y0  /^4 /\
M'PS_ !T,_P ="_\ 'PK_ "0(_P R!_\ 0 7_ $X#_P!; O\ 9@'_ '$ _P!Z
M /\ @@#_ (D _P"0 /\ E@#_ )P _P"A /X IP#] *T _0"U /P OP#[ ,L
M^P#; /H [ #Z /@ ^@#_ /D _P#W /\ ]@#_ /8 _P#V /\ ]@#_ /\"' W_
M 1D,_P 9"_\ &PK_ "$)_P O!_\ /07_ $L$_P!8 O\ 8P'_ &X!_P!W /\
M?P#_ (< _@"- /P DP#Z )D ^0"> /@ I #W *L ]@"R /8 NP#U ,< ] #8
M /0 Z #S /4 \P#^ /$ _P#P /\ [P#_ .X _P#N /\ [@#_ /\&& W_!10,
M_P$4"_\ %@K_ !\)_P K"/\ .0;_ $<$_P!4 _\ 8 '_ &L!_P!T /T ? #Z
M (0 ]P"* /4 D #S )8 \@"; /$ H0#P *@ [P"O .X N #M ,0 [ #3 .L
MY #K /$ Z@#[ .@ _P#G /\ Y0#_ .4 _P#E /\ Y0#_ /\+% S_"A +_P<.
M"O\"$@K_ QP)_P H"/\ -0;_ $,$_P!0 _\ 7 +\ &<!^ !P /4 >0#R (
M[P"' .T C0#J ), Z0"8 .@ G@#G *4 Y@"L .0 M0#C ,  X@#/ .$ WP#@
M .X WP#Z -P _P#: /\ V0#_ -D _P#9 /\ V0#_ /\1#PS_$0D*_PT'"?\.
M#0G_$!D(_PPC"/\', ?_ SX%^@!+ _4 5P+Q &(![@!L .L =0#I 'T Y@"#
M ., B0#A (\ WP"5 -X FP#= *( VP"I -H!L@#9 ;X UP+, -4#W@#4!>\
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M$) ]_Q"0/?\0D#W_$/\Q  +].P  YT(  -Q*  #43   SDD  ,E"! #!1!D
MN$4I!+%#-PJK0D,/IT)-$:-"5A.A0EX4GD)F%)Q#;12;0W04F4-Z%9A#@166
M0X@5E4.0%9-#FA:20Z06D$.P%H]#P!>-0M47BT+J%XI"^A:(0O\6B$+_%8="
M_Q6'0O\5AT+_%?\T  'Q0   X4L  -92  #.5   QE,  ,%,  "Y3!0 L4XF
M JI,,PBD2CX/GTE(%)M(41>81UD9ED=@&91':!J21V\:D$=U&H]'?!N-1X0;
MC$>,&XI'E1R)1Z <AT>L'89'NQV$1] >@T?F'8%']QR 1_\;@$?_&G]'_QE_
M1_\9?T?_&?\Y  #J10  W5$  -%8  #(6P  P%L  +I4  "R4@\ JU4B :14
M, >=4CL.F$]$%9--31J03%0=C4M<'HM+8Q^)2VD@B$MP((9+>""%2W\A@TN(
M(8)+D2& 2YPB?TNH(GU*MR-\2LLD>DKC(WE+]2%X2_\@>$O_'GA*_QUX2O\=
M>$K_'?X]  #F3   V5<  ,U>  #$80  O&$  +1<  "L60H I5H? )Y:+068
M6#@,DE5!%(U221J)45 ?AD]7(H1/7B."3F4D@$YL)7].<R9]3GLF?$Z#)GI.
MC2=X3I@G=TZE*'5.LRES3L<I<DW?*7%.\R9P3O\D<$[_(W!._R)P3O\B<$[_
M(O9!  #C40  U5P  ,EB  # 9@  N&8  +!B  "G7@8 H%\; )I?*P.3738*
MC5L_$HA81AF$54T?@%13)'U26B9[4F H>5%G*G=1;RIU47<K=%& +')1B2QP
M494M;U&A+6U1L"YK4<,O:5#;+VE1\2MI4?XI:5'_)VE1_R9I4?\F:5'_)N]%
M  #?50  T6   ,9F  "]:@  M&H  *QG  "C8P( FV08 )5D* */8C0(B6 ]
M$(1=1!=_6DL>>UA1)'=65BAT55PK<51C+6]4:R]M5',P;%1\,6I4AC%H5)$R
M9E2>,F14K3-C5+\S8538-&%4[C!A5/TM853_*V)4_REB5/\I8E3_*>Q)  #<
M60  SF0  ,-J  "Z;@  L6X  *AL  ">:   EV@4 )%H)0&+9S$&A64[#8!B
M0A5[8$@<=EU.(W%;5"AM65DM:EA?,&A89S-E5V\T9%=X-6)7@C9@5XXV7E>;
M-UQ7JC=;5[PW65?4-UE7[31:5_LQ6EC_+EM8_RU;6/\M6UC_+>E.  #970
MRV<  ,!N  "W<0  KG(  *5Q  ":;   DFP0 (QM(@"';"\$@6HX"WQG0!-V
M948:<6),(6Q@42AH7E<N9%U<,F!<8S9>6VLX7%MU.5I;?SI86XLZ5UN9.E5;
MJ#I46[HZ4EO2.5-;ZS936_HS5%O_,51;_R]46_\O5%O_+^93  #580  R&L
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M,$-MYR]#;/@N0VO_+4-K_RU#:_\M0VO_+=IB  #*;@  OG<  +5^  "L@@
MHX4  )F%  ")@0  ?H   '> $0!S@2$ ;X N VI_-PAD?C\.7WQ%%5I[2AQ4
M>4\C3WA4*4MV6RY(=F,Q1G5M,41U>#%$=H4O0W:3+D)VHRQ!=K4K0';-*4!U
MYR@_=/@H/G/_*#YR_R@^<O\H/G+_*-1H  #%<P  NWP  +*#  "IB   H(H
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M$R^._Q0OCO\4+X[_%,)\  "XAP  L(\  *B6  "@F@  E9P  (F>  !\G@
M;9X  %Z?  !1H   2J$0 $>A'@!%H2D!0:$S!#V@.P<ZH$(*-I]*#32?4PXR
MGUP.,9]G#C"?<PTPGX$,+Y^/"RZ?H HLGK,)*Y[+""J<Y@@IFO@**)G_"R>8
M_PPGF/\,)YC_#+V%  "TCP  K)<  *6=  ";H0  CZ,  (*D  !UI0  9Z4
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M *Z@  "HIP  G:L  )"O  "#L@  =;0  &>V  !:N   3;L  $&^   TP0
M*<0  !_(   6S   #<X   31    TP@  -,3  #4'@  U2H  -8V  #71
MV5,  -ED  #9=P  V8L  -F@  #8N   U]4  -;K  #6]P  UO<  -;W *NG
M  "@K0  E+$  (:T  !XN   :KH  %R]  !/P   0L,  #;&   JR@  '\X
M !?2   .U0  !M@   #;    W0   -\   #@"@  X18  .,A  #E+P  YSX
M .I.  #K80  ZW4  .R*  #LH   [+8  .O-  #KX@  Z^(  .OB *.N  "7
ML@  B;8  'NZ  !LO0  7L$  %'%  !$R0  -LP  "O0   @U   %MD   S=
M   %X    .$   #D    Y@   .@   #I    ZP   .T*  #P%P  \B8  /4V
M  #X2   ^EP  /MQ  #\A@  _)D  /VI  #]M@  _;8  /VV )JT  "-N
M?KP  &_!  !@Q0  4\D  $7.   WT@  *]<  !_<   4WP  "^0   +G
MZ0   .L   #L    [0   /    #Q    \P   /4   #X    ^PP  /X<  #_
M+@  _T(  /]6  #_:@  _WT  /^+  #_EP  _Y<  /^7 /\ ' O_ !H*_P 8
M"?\ &P?_ "(&_P P!/\ /@+_ $L!_P!8 /\ 9 #_ &\ _P!X /\ ?P#_ (8
M_P", /\ D@#_ )< _@"< /X H@#] *@ _ "O /L N #[ ,0 ^@#3 /@ Y #V
M /0 ]0#_ /4 _P#U /\ ]0#_ /8 _P#V /\ ]@#_ /\ &0O_ !8*_P 5"?\
M%@?_ !\&_P M!/\ .P+_ $@!_P!5 /\ 80#_ &L _P!U /T ? #[ (, ^@")
M /D CP#Y )0 ^ "9 /< GP#V *4 ]0"L /0 M0#S ,  \@#. /  X #N /$
M[0#] .T _P#M /\ [0#_ .T _P#M /\ [0#_ /\!% O_ !(*_P 1"?\ $ C_
M !P&_P I!/\ . +_ $4!_P!1 /\ 70#\ &@ ^ !Q /4 >0#T (  \P"& /(
MBP#P )$ [P"6 .X G #M *( [ "I .L L0#J +L Z #) .8 W #D .T XP#Y
M ., _P#B /\ X@#_ .( _P#B /\ X@#_ /\%$ K_ PL)_P )"/\ #P?_ !D&
M_P E!/\ ,P/_ $ !_@!- /@ 60#S &0 [P!M .T =0#K 'P Z0"" .@ B #G
M (T Y@"3 .0 F #C )X X@"F .  K@#> +< W #% -H UP#8 .@ V #T -8
M_@#5 /\ U #_ -0 _P#3 /\ TP#_ /\*"0K_" 0(_P(!!_\&"@;_!A8%_P$A
M!/\ +@/\ #L!]0!( .X 5 #H %\ Y0!I ., <0#A '@ WP!^ -T A #; (H
MV@"/ -@ E0#6 )L U0"C -, JP#1 +4 SP#" ,T T@#, .0 R@#R ,D _@#'
M /\ Q0#_ ,0 _P#$ /\ Q #_ /\1 PC_#P &_Q  !?\4!@3_$Q$$_P\= _D(
M* +Q!#4!Z@%# ., 3P#= %H V@!D -<!; #4 G0 T@)Z -$#@ #/ X8 S0.,
M ,P$D@#*!)D R 2@ ,<%J #%!K, PP;  ,((T # ">0 O0SU +H._P"X#_\
MMQ#_ ;<0_P&W$/\!MQ#_ ?\7  ?_%@ $_QP  _\> 0+_'0H"^!D5 NX3(@'E
M#2X W@H\ -<+20#2#54 S@]? ,L1: #)$G  QA-V ,04?0#"%8, P1:) +\6
MCP"^%Y8 O!>= +H8I@"Y&+  MQF] +89S@"S&N$ L!SR :X<_P&L'/\"JAS_
M JD<_P*I'/\"J1S_ O\=  7_'@ "_R8  ?<G  #O)0$ [B + .,9& #9%24
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M  #E1   UT\  ,Q5  #"6   NE8  +-0  "K3 H I$T= )Y-+ 282S<*DTE
M#XY(21.+1U$6B498%X=&7QB%1F48@T9L&()&<QF 1GL9?T:#&7U&C!I\1I8:
M>D:C&WE&L1MW1L,<=4;:'71&\!MS1OX:<D;_&7)%_QAR1?\8<D7_&/ Y  #A
M2@  TU4  ,=;  "^70  MEP  *Y7  "F4@4 GU,: )A3* .24C0(C4\]#XA-
M112$3$P8@DM3&G]*6AQ]2F$=?$EG'7I);QYX278>=TE_'W5*B!]T2I,@<DJ?
M('!)K2%N2;\A;4G6(FQ)[2!K2?P>:DG_'6I)_QQJ2?\<:DG_'.Q   #=3P
MSUH  ,1@  "[8@  LF$  *E=  "@6 $ F5@6 )-9)@&-5S$'B%4Z#8-30A1_
M44D9>T]0''A.5A]V35P@=$UC(G)-:B)P37(C;TU[)&U-A"1K38\E:DV<)6A-
MJB9F3;LG9$S2)V-,ZR5C3?HC8TW_(6-,_R!C3/\@8TS_(.E%  #:5   S%X
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M,4Y7Y"].5_<L3U?_*D]7_RE/5O\H3U;_*.!3  #08   PVD  +AO  "O<@
MIG,  )QQ  "/:@  AFH% (!J& !\:B8!=VDQ!7)G.0ML94 29V-&&6)A2Q]>
M8%$E65Y6*E9=72]37&0Q45MM,T];>#-.6X0S3%R1,DM<H#)*7+(Q2%S(,$A<
MXR](6_8L25O_*TE;_RI)6_\I25O_*=Q8  #,9   P&T  +9R  "M=@  I'<
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M(#EN_R$Y;O\A.6[_(<]G  # <@  MGH  *V   "EA0  G(<  )&'  ""A
M=H(  &F! @!C@10 8($B %R!+@)8@#8'5'\]#$]^0Q%*?4D61GQ/&T)[5AX_
M>UX@/GMH(#U[<Q\\>X >.WN.'3I[G1LY>Z\:.'O%&3AZX!@V>?09-7?_&C1V
M_QLT=O\;-';_&\EN  "\>   LX   *J&  "BB@  F8T  (^-  "!C   <HH
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M![F$  "PC0  J94  **:  "8G0  C)\  '^@  !QH   8Z   %6A  !(HP
M.Z0  #"F"  LIA8 *Z8A "FF*P GIC0!):8] B.F1P(BIE$"(*9< A^F: $>
MIG8!'*:% 1NEE0 9I:@ %Z2^ !6DVP 6HO$!%J#^ 12>_P(4GO\"%)[_ K2-
M  "LE0  IIP  )VA  "2HP  A:4  '>F  !IIP  7*@  $ZI  !!JP  -*T
M "FO   ?L0, &;(0 !>R'  6LB8 %+(P !.R.P 1LD4 $+)1  VR70 +LFP
M";)\  BQC0 &L:  !+"U  .OSP #KND !*WX  2L_P $K/\ !*S_ *^6  "I
MG@  HJ,  ):G  ")J0  ?*L  &ZL  !@K0  4Z\  $:Q   YLP  +;4  "*X
M   8N@  #KP   6^"@ !OA8  +\A  "_*P  OS<  +]#  "_3P  OUX  +]N
M  "_@   OI,  +VH  "]P   O-T  +OO  "Z^0  NOL  +K[ *R?  "EI0
MFJD  (VL  " KP  <K$  &2R  !6M   2;<  #RY   PNP  )+X  !K!   1
MQ   !\8   #)    R@8  ,L0  #,&P  S24  ,XQ  #./@  STP  -!<  #0
M<   T(0  -"9  #/KP  SLD  ,[C  #-\@  S?0  ,WT *BF  "=JP  D:X
M (.Q  !UM   9K<  %FY  !,O   /K\  #+!   FQ   &\@  !++   (SP
M -    #3    U0   -<   #9!P  VQ(  -T=  #?*0  X3<  .1'  #E60
MY6\  .6&  #EG0  Y;(  .7*  #DWP  Y.,  .3C *"L  "4L   A[0  'BW
M  !IN@  6[X  $[!  ! Q0  ,\@  "?+   ;S@  $=,   ?8    VP   -P
M  #>    X    .(   #D    Y@   .D'  #L%   [R$  /(Q  #U0@  ]U4
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M )( _@"7 /X G0#] *, _ "J /D L@#W +P ]@#, /4 WP#T .\ ] #] /0
M_P#T /\ \P#_ /( _P#R /\ \@#_ /\ %0G_ !$(_P /!_\ $@7_ !T#_P K
M O\ . #_ $8 _P!3 /\ 7@#^ &@ _0!Q /P > #Z '\ ^0"% /@ B@#X (\
M]P"4 /8 F@#U *  \P"F /  K@#N +@ [0#' .P V0#K .L ZP#Z .H _P#I
M /\ Z #_ .@ _P#H /\ Z #_ /\ $0G_  T(_P +!O\ #@7_ !H#_P G O\
M- #_ $( _0!/ /D 6@#W &0 ]0!M /, =0#R 'L \0"! .\ AP#N (P [0"1
M .P E@#J )P Z "C .8 JP#D +4 XP#" .$ T@#@ .< WP#V -X _P#= /\
MW #_ -P _P#< /\ W #_ /\ "PG_  8'_P #!O\ # 7_ !<#_P C O\ , #[
M #X ] !* /$ 5@#N &  ZP!I .D <0#H '< Y@!] .4 @P#C (@ X@"- .
MDP#= )D VP"? -D IP#8 +$ U@"] -0 S0#3 .( T0#R -  _ #/ /\ S@#_
M ,T _P#- /\ S0#_ /\$! C_   &_P  !?\ !P3_ !0#_P ? ?T *@#R #@
MZ@!% .< 40#C %L X !D -X ; #< ', V@!Y -@ ?P#5 (0 TP"* -$ CP#/
M )4 S0"< ,P I #* *T R "Y ,< R0#% -P Q #L ,( ^ #! /\ P #_ +\
M_P"_ /\ OP#_ /\)  ;_!0 $_P@  _\* @+_!PT!_@$9 ?0 ) #F #$ X  _
M -L 2P#8 %8 U !? -$ : #. &\ S !U ,H >P#( ($ Q@"& ,0 C ## )(
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M O\9  '\(0  Z2<  . L  #8*P  TB0  ,\9" #'&AL OQXL +DA.@"T(T8
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M"H4XL@J$.,0+@CC:"X X[PQ^-_X,?3?_#'TW_PQ]-_\,?3?_#/,J  #D/
MUD8  ,M,  #!30  N4H  +)#  "K/0D I3\= )X_*P.9/C8'E#U!"I$]2@N.
M/5(,C#U9#(H]7PV(/68-ASUL#84]<PV$/7H.@CV"#H$]BPY_/94/?CVA#WP]
MK@][/;\0>3W6$7<][!%V/?P0=3S_$'4\_Q!T//\/=#S_#^\S  #?0P  T4T
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M(%Y(Y!]>2/8=74C_'%U(_QM=2/\:74C_&N1%  #44P  QEP  +MA  "R8P
MJ6(  *!>  "56   C54+ (A6'0""5BD#?50S"'A2.PUT4$(2<$](%VQ-3AII
M3%0<9TQ;'F5,8A]D3&D@8DQR(6!,?")?3(<B74R3(UM,H2-93+(D6$O')%9+
MX2-62_4A5DO_'U=+_QY72_\=5TO_'>%*  #05P  PV   +AD  "O9P  IF8
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M)$17_R-$5O\C1%;_(]97  #&8P  NVH  +%P  "H<P  GW,  )5Q  "&:P
M>V@  '1H#0!O:!T :V@I 6=G,@5B9CH+765 $%EC1A9484L<4&!0(4Q?5R5)
M7EXH1UYG*45><BE$7GXH0UZ+)T)>FB9!7ZLE0%^_)#]?VB,^7O B/EW^(CY<
M_R(^7/\B/ES_(M)<  ##9P  N&\  *YT  "F=P  G'@  ))W  "#<0  >&\
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M%,-M  "X=@  KWX  *>$  ">B   E8D  (N*  !]B   ;H8  &&$  !3@P4
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M A^5DP$>E*0!').Y !J3U  :D>T!&9#\ AB/_P,8CO\$&([_!+6#  "MC
MII,  )^8  "5FP  B9P  'N<  !MG   7YP  %"<  !#G0  -YX  "N@   C
MH0T (:$: !^A)  =H2T '*$W !NA0  9H4H &*%5 !:A80 4H&X $J!] !"@
MC0 .GZ  "YZT  F=S0 *G.@ "YKY  N9_P +F?\ "YG_ +",  "IE   HYH
M )J>  ".H   @:(  '2B  !FHP  6*,  $JD   \I@  ,*<  "6I   :JP
M$*P(  RL%  *K!\ ":PI  >L-  &K#X !*Q*  *L5@  K&0  *MS  "KA
MJI8  *FJ  "HP@  I]T  *?O  "F^0  IOX  *;^ *R5  "FG   GZ$  ).D
M  "&I@  >*@  &JH  !=J0  3ZL  $*L   UK@  *+   !ZR   4M   ";4
M  "W!P  MQ(  +@<  "X)@  N#$  +@\  "X2   N%8  +AF  "X>   N(H
M +>?  "VM0  M=$  +/J  "S]@  L_L  +/[ *F=  "CHP  EZ<  (JJ  !]
MK   ;JT  &"O  !3L   1;(  #BT   LMP  (+D  !:[   +O@   [\   #!
M    P@0  ,,-  #$&   Q2(  ,8M  #&.0  QT8  ,E5  #)9P  R7L  ,F0
M  #(I@  Q[\  ,;;  #%[0  Q?4  ,7U *:E  ";J0  CJP  (&O  !RL0
M8[,  %6U  !(N   .KH  "Z]   BOP  %\(   S%   #R    ,D   #,
MS@   ,\   #1!0  TQ   -4;  #7)P  V30  -M#  #>5   WV@  -]^  #?
ME   WZH  -_!  #?V   WN0  -[D )ZK  "2K@  A+$  '6U  !FMP  6+H
M $J]   \P   +\,  "/&   7R0  #,T   +1    U0   -4   #8    V@
M -P   #?    X0   .0$  #H$0  ZAX  .PM  #O/@  \5(  /)G  #S?P
M])4  /2I  #TN0  ],4  /3% )6P  "'LP  >;<  &J[  !;O@  3<(  #[&
M   PR@  ),T  !?1   *U0   =H   #>    X0   .$   #C    Y0   .<
M  #I    [    .\   #R    ]@8  /H5  #])0  _S<  /]-  #_9   _WP
M /^0  #_GP  _Z<  /^G /\ $P?_ !$&_P 1!/\ $P/_ !X!_P K /\ .0#_
M $@ _P!4 /\ 7@#_ &@ _P!Q /\ > #_ 'X _P"# /\ B0#_ (X _0"3 /L
MF #Y )X ]P"E /8 K0#U +< ] #$ /0 V #S .P \@#[ /  _P#O /\ [P#_
M .\ _P#P /\ \ #_ /\ $ ?_  P&_P +!/\ # /_ !L!_P G /\ -@#_ $0
M_P!0 /\ 6P#^ &4 _ !M /L = #Y 'L ^ "  /< A0#U (L ] "0 /( E0#P
M )L [P"B .T J@#L +, ZP"_ .H T@#I .8 YP#V .4 _P#E /\ Y0#_ .0
M_P#D /\ Y #_ /\ # ?_  <&_P &!/\ # /_ !<!_P D /\ ,@#\ #\ ^@!,
M /@ 5P#U &$ \P!I /$ <0#P '< [@!] .P @@#J (< Z ", .8 D@#E )<
MY "> .( I@#A *\ WP"[ -X RP#; .  V0#R -@ _P#8 /\ U@#_ -8 _P#7
M /\ UP#_ /\ !0?_   %_P  !/\ "0+_ !4!_P ? /D +0#S #L \ !' .X
M4@#K %P Z !E .8 ; #D ', X0!Y -\ ?@#= (, VP") -H C@#8 )0 U@":
M -0 H@#2 *H T0"V ,X Q0#, -D RP#M ,D ^P#( /\ R #_ ,@ _P#( /\
MR #_ /\   ;_   $_P   _\ !0+_ !$!_  : .X )P#I #4 Y@!" .( 30#?
M %< W !@ -D : #5 &\ T@!U -  >@#/ '\ S0"% ,L B@#* )  R "7 ,8
MG@#$ *< P@"R ,  OP"^ -, O0#H +P ]@"[ /\ N@#_ +D _P"X /\ N #_
M /\!  3_   #_P   ?\   #_  H \P 2 .0 ( #? "X V@ \ -4 2 #1 %(
MS0!; ,H 8P#' &H Q0!Q ,, =@#" 'P P "! +X A@"] (P NP"3 +D FP"W
M *0 M0"N +, O "R ,X L #A *\ \0"N /P JP#_ *H _P"J /\ J@#_ /\&
M  /_!@ !_0H  /((  #L @  Y@ ) -L & #4 "< S@ U ,D 0@#$ $T P !6
M +T 7@"[ &8 N0!L +< <@"U '@ M !] +( @P"P (D KP&0 *T"F "K J$
MJ@.L *@$N0"G!,H I0;? *,(\0"A"OX H K_ )\*_P">"O\ G@K_ /\*  '^
M$0  ZQ4  .,8  #=%   V H! -( #@#+ 1X PP0N +X'/ "Y"4< M0M1 +(,
M60"P#F$ K@YH *P0;@"J$'0 J1%Z *<1@ "F$H8 I!*- *,3E0"A$Y\ GQ2J
M )X5N "<%<D FA;? )@7\@"6%_\ E1C_ )07_P&4%_\!E!?_ ?\1  #O&@
MY"0  -HH  #1)@  RQ\  ,<4! # $!< N14G +,8-0"N&D( JAM, *<<5 "E
M'5P HQYC *$>:0"@'V\ GA]U )P@? ";((( FB"* )@@D@"7()L E2&F ),A
MM "2(<4 D"': (XB[P&,(OX"BR+_ HHB_P.)(?\#B2'_ _H8  #I)P  W3$
M -$U  #(-0  P3   +LF  "V'A$ KR(B *DE, "D)CT H2=' 9TH4 &;*5<!
MF2E> 9<I90&6*6L!E"IQ 9,J=P&1*GX!D"J% 8XJC@*-*I<"BRNB HDKKP*(
M*\ "ARO6 X0K[ 2"*_P$@2O_!8 J_P6 *O\%@"K_!?(B  #D,0  UCL  ,I
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M"W(WY0QQ-_<,;S?_#&\W_PQO-O\,;S;_#.DS  #90@  RTL  ,!/  "V4
MKDT  *9'  ">0   EST3 )$_(@&,/BX$B#XX!X0]00F!/$D+?SQ0"WT\5@Q[
M/%P,>CQC#'@\:@UV/'$-=3QY#7,\@@YR/(P.<#R7#F\\I0]M/+0/:SS)$&D\
MXA!H//409SS_$&<[_P]F._\/9CO_#^4Z  #52   QU$  +Q5  "S5@  JE,
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M&E%&_QE11O\844;_&-I)  #*5@  OET  +-A  "J8P  H6(  )=>  ",60
M@E0! 'Q3$P!W5"$ <E,L VY2- AI4#L,94Y!$6%-1Q1=3$T76TM3&EE+6AQ7
M2V$=54MJ'E1+=!]22W\?44N+($]+F2!-2ZD@3$N]($I+UB!*2^X>2DK]'4M*
M_QQ+2O\;2TK_&]=.  #'6@  NV$  +%E  "H9P  GV<  )5C  ")70  ?ED
M '=8#P!R6!X ;E@I FE7,@9D53D+8%0_$%Q2111844H855!0'%)/5QY03UX@
M3D]G(4U/<2)+3WPB2D^)(DA/ER)'3Z@A1D^[(41/U"%$3^T?1$[\'D1._QU%
M3O\<14[_'--2  #$70  N&0  *]I  "F:P  G6L  ))H  "&8@  >EX  ')=
M"P!M71H :5TF 61<+P1@6S<)7%D]#E=80Q-45D@74%5.'$U45!]*5%PA2%1E
M(D94;R-%5'HB1%2'(D-4EB%!5:8@0%6Y(#]5TQ\^5.P>/E/['CY3_QT^4O\=
M/E+_'=!7  #!80  MF@  *QM  "D<   FG   )!N  "":   =V0  &UB!@!G
M8A8 9&(C &!B+0-;834'5V [#%->01%/74<52UQ,&DA:4QU%6EH@0UIC(4%:
M;2% 6GD@/UJ&'SY;E1X]6Z4=/%NX'#I;TALY6NL;.5G[&SA8_QLX6/\;.%C_
M&\M<  "^9@  LVP  *IQ  "A=   F'4  (YS  " ;@  =6L  &=H 0!A:!(
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M#C%RD@TP<J,,+W*V"RURSPHL<>D+*V_Y#2IN_PXI;?\/*6W_#[YL  "T=0
MJWP  *.!  ";A0  DH8  (B&  !ZA   :X$  %V   !/?@  1GT- $-]&P!!
M?B4 /GTN 3M]-@0X?3T&-7Q$"#-\3 HQ?%4*+WQ>"BY\:0HM?'4)+'R#""M[
MD0<I>Z(&*'NU!2=ZS@4F>>D%)7CY!R1V_PDC=?\*(W7_"KIR  "P>P  J((
M *&(  "9BP  D(T  (2,  !VBP  9HD  %B(  !+AP  /88$ #>&$@ UAQX
M-(<G #&', $OAC@"+89 !"N&204IAE$%)X9;!":&9@0EAG,#)(6  R*%CP(A
MA: "'X2T 1Z$S $=@N@!'('Y QR _P0;?_\%&W__!;5Z  "M@P  I8H  )Z/
M  "6D@  BY,  '^3  !QD0  89   %.0  !&D   .)   "R0!P HD!0 )I >
M "21*  CD3$ (9$Z ""10P$>D$P!'9!6 !N08@ :D&X &)!\ !:/C  4CYT
M$HZQ !"-R0 0C.4 $8OW !&*_P$0B?\!$(G_ ;&"  "IB@  HY$  )R6  "2
MF   A9D  'B9  !JF   6Y<  $R8   _F   ,YD  ">9   ;FP8 %IL2 !6;
M'0 3FR8 $ILP !&;.0 .FT, #)M.  J;6@ (FV< !YIU  6:A0 #F98  )BJ
M  "7P0  EML  )7N  "4^@ !D_\  9/_ *V+  "GD@  H)@  )B<  "+G@
M?I\  '"?  !BG@  5)\  $:@   XH0  +*(  ""C   6I   "Z8$  .F#P
MIQH  *<D  "G+@  IS@  *9#  "F3P  IET  *9K  "E?   I8T  *2A  "B
MMP  H-,  )_K  "?]0  G_P  )_\ *J4  "DF@  G)\  )"B  "#HP  =:0
M &>E  !9I0  2Z8  #VH   PJ0  )*L  !FL   /K@  !:\   "P!   L0X
M +$8  "R(@  LBP  +(V  "R0@  LD\  +-?  "R<   LH(  +&6  "PJP
MK\4  *WC  "L\P  J_T  *O] *><  "@H@  E:4  (BG  !ZJ0  :ZH  %VK
M  !/K   0:X  #2P   GL@  '+0  !&V   'MP   +D   "Z    NP$  +P)
M  "]%   OAX  +\H  # ,P  P3\  ,).  ##8   PW,  ,*(  #"G@  P;4
M ,#1  "_YP  OO4  +[U *.C  "8IP  C*H  'ZL  !OK@  8+   %*R  !$
MM   -K8  "FX   =NP  $KT   ?     P@   ,,   #$    Q@   ,@   #*
M!   S T  ,X8  #0(P  TB\  -0\  #830  V6   -IV  #:C0  V:0  -B[
M  #8T@  V.<  -CG )NI  "/K   @:\  '*R  !CM   5;<  $>Y   XO
M*[\  !["   2Q0  !\@   #+    S@   ,X   #0    TP   -4   #8
MVP   -X$  #A$0  Y!T  .8J  #J.0  [4P  .]A  #P>   \8\  /&C  #P
MM0  \,<  /#' )*N  "%L0  =K4  &>X  !8NP  2;\  #K"   LQ@  '\D
M !/,   %T    -0   #8    W    -P   #>    X    .(   #E    Z
M .P   #O    \P4  /45  #X)   ^S8  /Y*  #_8   _W<  /^,  #_G
M_ZD  /^I /\ #P;_  P$_P + _\ #@'_ !H _P I /\ . #_ $4 _P!1 /\
M6P#_ &4 _P!M /\ = #_ 'H _@"  /P A0#[ (H ^0"/ /@ E #W )H ]P"A
M /8 J0#T +, \P"_ /( T0#O .< [@#Y .T _P#M /\ [0#_ .T _P#M /\
M[0#_ /\ # ;_  D$_P ( _\ "@'_ !< _P E /\ - #_ $$ _P!- /\ 6 #]
M &$ ^P!I /D <0#W '< ]0!] /, @@#Q (< \ ", .\ D0#N )< [0"= .P
MI0#J *X Z0"Z .8 R@#D .$ XP#T .$ _P#A /\ X0#_ .$ _P#? /\ W@#_
M /\ !@7_  ,$_P ! O\ "@'_ !0 _P A /T +P#Z #P ^ !) /8 4P#S %T
M\0!E .X ;0#K ', Z0!Y .< ?@#F (, Y0"( .0 C0#B ), X0"9 -\ H0#=
M *H V@"U -< Q #6 -H U #N -, _0#2 /\ T #_ ,T _P#, /\ RP#_ /\
M  7_   #_P   O\ !P'_ !  ^0 < /, *@#P #@ [0!$ .L 3P#H %D Y !A
M .$ :0#> &\ W !U -H >@#9 '\ UP"$ -4 B0#4 (\ T@"5 ,\ G0#- *8
MR@"P ,@ O@#' -( Q0#G ,0 ^0#  /\ O@#_ +T _P"] /\ O0#_ /\   3_
M   "_P   ?\  @#^  D [P 6 .D ) #E #( X0 _ -X 2@#: %0 U0!= -(
M9 #/ &L S0!Q ,L =@#* 'L R "  ,8 A0#$ (L P@"1 ,  F0"^ *$ O "L
M +H N0"X ,H M@#A +, \P"Q /\ L0#_ +  _P"P /\ L #_ /\   /_   !
M_P   /P   #S  ( Y0 / -\ '@#9 "L U  Y ,\ 1 #+ $\ QP!8 ,0 7P#"
M &8 OP!L +X <@"\ '< N@!\ +@ @@"V (< M0". +, E0"Q )X KP"H *T
MM "J ,4 J #; *< [@"F /H I0#_ *4 _P"D /\ I #_ /\   '_    \0
M .D   #A    VP ' -0 %@#- "4 QP R ,( /P"^ $D N@!2 +< 6@"U &$
MLP!G +$ ;0"O ', K@!X *P ?@"J (0 J0"* *< D@"E )L HP"E *$ L0"@
M ,$ G@#5 )T Z0"; /< F@'_ )D!_P"9 ?\ F '_ /\   #Q"   YA(  -T4
M  #5#@  SP4  ,D #0#" !P O0 J +< . "S $, KP%- *P#50"J!%P J 5C
M *8%:0"D!FX HP9T *$'>@"@!X  G@B' )P)CP";"9@ F0JC )<*KP"6"K\
ME O4 )(-Z@"1#OH CP__ (\/_P".#_\ C@__ /D)  #J&   WB$  -,D  #*
M(@  PQL  +X.  "Y!A0 L@HC *T.,0"H$3T I1)' *(33P"?%%< G15> )L5
M9 ":%FH F!9P )<6=@"5%WT E!>$ )(7C "1&)4 CQB@ (T8K ",&+P BAG1
M (@:Z "'&_D A1O_ 84;_P&$&O\!A!K_ ?(6  #D)0  UBX  ,HR  #!,0
MNBL  +0A  "N%@L J!D= *,<*P">'C< FQ]" )@@2P"5(%( DR%9 )$A7P"0
M(64 CB%L (TB<@"+(GD BB*  (@CB "'(Y$ A2.< (0CJ0""([@ @23- 7\D
MY %])/<"?"3_ GLD_P-[(_\#>R/_ ^TA  #>+P  SS@  ,,\  "[/   LS<
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M#&$V_PQA-O\+83;_"]\Y  #.1@  P4X  +91  "M4@  I5   )Q*  "30P
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M%M!.  #!6   MEX  *QC  "C9   FF,  )!@  "$6@  >54  '!2" !K4A@
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M&#E7D!<X5Z 6-U>R%397RA0U5^44-%7W%3-4_Q8S5/\6,U/_%L9;  "Y9
MKVH  *9O  "=<0  E'$  (IP  !\:P  <6@  &1E  !98@L 56(9 %-B) !/
M8BP"3&$T!4A@.@E%7T -05Y&$#Y>31,[7545.5U>%3A=:!4W7G04-EZ!$S5>
MCQ(T7I\1,UZQ$#)>R0\Q7>0/+USW$2Y:_Q(N6O\3+EG_$\)@  "V:0  K&\
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M A]VQ0$?=>(!'G/U QUR_P4<<?\&'''_!K5R  "L>@  I8$  )V&  "6B0
MC8H  (&)  !SAP  8X4  %6#  !(@@  .H$  "^!"@ L@1< *H$@ "B!*@ G
M@3( )8$Z 2.!0P$A@4P!((%6 1^!8 $=@6T!&X%Z !J B0 8@)D %G^L !1^
MPP 3?=\ %'ST !1[_P$4>O\"%'K_ K%Y  "I@0  HH@  )N-  "4CP  B)
M 'R/  !MC@  7HP  %"+  !"BP  -8L  "B*   ?BPL '(L7 !J+(  9BRD
M%XLR !:+.P 5BT4 $XM/ !&+6@ /BV< #8MU  J*A  (B90 !HBG  2'O0 $
MAM8 !(;L  6$^@ &@_\ !H/_ *V!  "FB0  H(\  )F3  "/E0  @Y8  '65
M  !FE   6),  $F3   [DP  +Y0  ".4   8E0  #)8*  F6%@ 'E2  !I8I
M  66,@ #E3P  I5'  "54P  E6   )5N  "4?0  DXX  ).@  "1M0  D-
M (_G  "/]   COL  ([^ *J*  "DD0  GI8  )69  ")FP  >YL  &V;  !>
MFP  4)L  $&;   TG   *)T  !R>   2GP  !J !  "@"P  H!8  * ?  "@
M*   H3(  *$]  "@20  H%8  *!E  "@=0  GX8  )Z8  "=K0  G,<  )KD
M  "9]   F?L  )G] *>3  "AF0  F9T  (Z?  "!H0  <J$  &2A  !5H@
M1Z(  #FD   LI0  (*8  !6G   *J    *D   "J 0  JPH  *L4  "K'0
MK"8  *PP  "M/   K4D  *U8  "M:   K7H  *R.  "JI   J;P  *C:  "G
M[P  IOH  *;] *2;  "=H   DJ,  (6E  !WI@  :*<  %JH  !+J0  /:H
M #"L   CK0  %Z\   NP   "L0   +,   "T    M0   +8%  "W$   N!D
M +DB  "Z+0  NSH  +Q(  "]60  O6P  +V   "\E0  NZP  +G(  "WY
MMO0  +;X *&B  "6I0  B:@  'NJ  !LJP  7:T  $^N  ! L   ,K(  "6T
M   8M@  #+@   *Z    O    +T   "^    P    ,$   ##    Q0@  ,<3
M  #*'0  S"D  ,XV  #11P  TEH  -)P  #3A@  TIP  -*S  #1R@  T>
M -'F )FH  "-J@  ?ZT  &^P  !@L0  4K,  $.V   TN   )[L  !J]   ,
MP    L,   #&    QP   ,@   #)    RP   ,X   #0    TP   -8!  #:
M#   WA@  .(E  #E,P  Z48  .M;  #L<@  [(H  .R@  #LLP  [,0  .S+
M )"L  ""KP  <[,  &2U  !5N   1KL  #>_   HP@  &\4   W(   !RP
M ,\   #2    U    -0   #6    V0   -L   #>    X0   .4   #I
M[04  /$2  #T(   ^#   /Q%  #^6P  _W(  /^(  #_F@  _Z@  /^M /\
M"P3_  D"_P ' ?\ " #_ !@ _P G /\ -0#_ $( _P!- /\ 6 #_ &$ _P!J
M /\ <0#\ '< ^P!] /H @@#Y (8 ^ "+ /< D0#V )< ]0"= /0 I0#S *X
M\0"Z .X RP#L .( ZP#V .L _P#J /\ Z #_ .4 _P#B /\ W@#_ /\ !P3_
M  0"_P # ?\ " #_ !0 _P C /\ ,0#_ #X _P!* /X 5 #[ %X ^ !F /4
M;@#S '0 \@!Y /  ?@#O (, [@"( .T C0#L ), ZP"9 .D H0#G *H Y "U
M .( Q0#@ -H WP#Q -X _P#: /\ U@#_ -0 _P#4 /\ U #_ /\  03_   "
M_P   ?\  P#_ !$ _@ > /L + #X #D ]@!% /0 4 #P %H [ !B .D :@#H
M '  Y@!U .4 >P#C '\ X@"$ .  B0#? (\ W0"5 -H G0#8 *4 U0"P -,
MO@#1 -( SP#K ,L _ #' /\ Q@#_ ,8 _P#& /\ Q@#_ /\   /_   "_P
M /\   #[  H ]  9 /  )P#M #0 Z@!  .< 2P#B %8 WP!> -P 90#: &P
MV !Q -8 =@#4 'L T@"  -$ A0#. (L S "1 ,H F #( *$ Q0"K ,, N #!
M ,L O0#C +H ]@"Y /\ N0#_ +D _P"Y /\ N #_ /\   +_   !_P   /\
M  #P  4 Z@ 3 .4 (@#A "\ W  [ -< 1P#3 %  T !9 ,T 8 #* &< R !M
M ,8 <@#$ '< P@!\ ,  @0"_ (< O0"- +L E "Y )T MP"G +, LP"P ,0
MKP#: *X \ "M /\ K #_ *P _P"K /\ JP#_ /\   '_    ^P   .\   #F
M    WP , -D &P#2 "@ S0 V ,D 00#% $L P@!4 +\ 6P"\ &( N@!H +@
M;0"V ', M !X +, ?0"Q (, KP") *T D "K )D J "B *8 K@"E +T HP#2
M *( Z0"A /D H #_ )\ _P"> /\ G@#_ /\   #V    [    .,   #;
MTP % ,P % #% "( P  O +P .P"X $4 M0!. +$ 5@"O %T K0!C *L :0"J
M &X J !S *8 >0"E '\ HP"% *$ C "? )4 G0"> )P J@": +@ F #, )<
MXP"5 /, E #^ ), _P"3 /\ D@#_ /H   #L!@  X0X  -<0  #."0  QP
M ,$ "P"[ !H M0 G +$ ,P"M #\ J0!( *8 4 "D %< H@!> *  9 "> &D
MG0!O )L =0": 'L F "! )8 B0"5 )$ DP"; )$!IP"/ ;4 C@+( (P#W@"+
M!?$ B0;^ (@'_P"'!_\ AP?_ /((  #E%P  V!\  ,PB  ##'@  O18  +<*
M  "Q !$ JP ? *8$+0"B!S@ GPA" )P)2P"9"E( EPM9 )8,7P"4#&4 D@QJ
M )$,< "0#7< C@U^ (P.A@"+#H\ B0Z: (@/I@"&$+4 A!#( (,1X "!$_0
M@!3_ '\4_P!^%/\ ?A/_ .T6  #>(P  T"P  ,0O  "[+   M"<  *T=  "H
M$08 H@\8 )P3)@"8%3( E18] )(710"0&$T C1A4 (P96@"*&6  B!EF (<:
M; "&&G, A!IZ (,;@@"!&XL @!N6 'X;H@!]&[$ >QS$ 'D<W !X'?$ =AW_
M 78=_P%U'?\!=1S_ ><A  #8+@  R#8  +XY  "U.   K3,  *8K  "?(0
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M"]0_  #%2@  N5   *]4  "F5   G%$  )-,  "*1@  @#\  '@[#@!T/!P
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M$T5#CQ1$0YX40D.P%$!"QA0_0N(3/T+V$S]!_Q) 0/\20$#_$LI-  "\5@
ML5P  *A@  "?80  EF   (Q<  " 5P  =5(  &E, @!C2Q( 7TL> %M+)P%8
M2B\$5$DU!U!(.PM-1T$-2T='$$A&3A)&1E441$9>%4-&:!5!1W,50$=_%3]'
MC14]1YP4/$>N%#I'Q!,Y1^ 3.4;U$SE&_Q,Y1?\3.47_$\=1  "Z6@  KV
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M"BU:P0DL6MT)*ECS"RE7_PTH5O\.*%7_#KU?  "R9P  J&T  *!Q  "8=
MCW0  (5R  !W;@  ;&P  %YI  !090  1F,, $-C&0!!8R, /F,K 3MB,@,X
M8CD%-6% "#-A1PDQ84\*+V%8"BYA8@HM8FX)+&)[""MBB0<I8ID'*&&K!B=A
MP 4F8=P%)5_R!R1=_PDC7/\*(US_"[ED  "O;   IG(  )YW  "6>0  C7H
M (-Y  !V=@  :7,  %MP  !-;0  /VL& #IJ$P X:AX -FHG #1J+P$Q:C8#
M+VH]!"UJ104K:DT&*6I6!BAJ8 4G:FP%)FIY!"1JAP,C:9<#(FFI B!IOP(?
M:-L!'F?Q QUE_@4=9/\&'&/_![5J  "L<@  I'@  )Q]  "4?P  BX   (*
M  !T?0  97H  %=X  !)=@  .W0  #%R#  N<A< +'(A "IS*0 H<S( )W,Y
M 25S00(C<TH"(G-3 B!S7@$?<VH!'7)W 1QRA0 :<I4 &'&G !=QO0 5<-D
M%F[P !9M_@$5;/\"%6S_ [%Q  "I>   H7\  )J$  "3A@  BH<  'Z&  !P
MA   8($  %*   !$?@  -GP  "I[ P B>Q  ('L: !Y[(P =?"L &WPT !I\
M/  8?$4 %WQ/ !5\6@ 4?&8 $GQS !![@@ ->Y( "WJD  EYN0 (>-( "'?K
M  IU^@ *=?\ "G3_ *YX  "F@   GX8  )B*  "1C0  AHT  'F,  !JB@
M6X@  $R'   _A@  ,88  "6%   9A00 $880 !"&&0 -AB, #(8K  J&-  )
MACX "(5(  :%4P $AF   H5M  "%?   A(P  (.>  ""L@  @,T  '_D  !_
M\P  ?OL  'W_ *J   "DB   G8T  )>1  ",DP  @),  '*2  !CD0  5)
M $6/   XCP  *X\  !^/   4CP  ") &  "0$0  D!H  ) C  "0+   D#8
M )!   "03   D%@  )!F  "/=0  CX8  (Z8  ",K   B\0  (GB  "(\@
MB/D  (?^ *>)  "AD   FY4  )*7  "&F   >)@  &J8  !;EP  3)<  #V7
M   PF   ))@  !B8   ,F0   IH   ":"   FA(  )H;  ":)   FRP  )LW
M  ";0@  FT\  )M=  ";;0  FGX  )F0  "8I   E[P  );9  "4\   D_H
M )/_ *21  "?EP  EYL  (N=  !^G@  ;YX  &">  !2G@  0Y\  #6@   H
MH   '*$  !"B   %HP   *0   "E    I08  *40  "F&   IB$  *<K  "G
M-@  IT(  *=1  "H8@  IW0  *>'  "FFP  I;(  *3.  "BZ0  HO8  *']
M **:  ";G@  D*$  (.B  !THP  9:0  %:D  !(I0  .:<  "NH   >J0
M$JH   :L    K    *X   "O    KP   + "  "Q"P  LA4  +,>  "T*
MM30  +9!  "W4@  MV4  +=Y  "UC@  M*8  +/   "SW0  LN\  +'W )^A
M  "3I   AJ8  'BH  !IJ0  6JH  $NK   \K0  +JX  ""P   4L@  ![0
M  "U    M@   +@   "Y    N@   +P   "]    OP0  , .  ##&   Q20
M ,<Q  #)00  RU0  ,UI  #-?@  S94  ,RL  #)Q@  R-X  ,?L ):F  "*
MJ0  ?*L  &VM  !>K@  3[   $"R   PM0  ([<  !:Y   'O    +X   #!
M    P0   ,,   #$    Q@   ,@   #*    S0   -    #3!P  V1,  -P?
M  #?+0  XT   .55  #F;   YX0  .B:  #GK@  Y[\  .?, (VK  " K0
M<;   &&R  !2M0  0[@  #.[   DO@  %\$   G#    QP   ,H   #-
MS@   ,\   #0    T0   -0   #8    W    .    #D    Z    .T,  #Q
M&P  ]"H  /@_  #[5@  _&X  /R%  #\F0  _*<  /RQ /\ !P+_  4!_P !
M /\ !@#_ !4 _P D /\ ,@#_ #X _P!* /\ 50#_ %\ _@!G /P ;@#[ '0
M^@!Z /D ?P#X (, ]P"( /8 C0#U ), ] "9 /( H0#O *H [0"V .P QP#J
M -X Z0#S .< _P#B /\ W@#_ -X _P#9 /\ U@#_ /\  @+_   !_P   /\
M P#_ !( _P @ /\ +0#_ #H _P!& /L 40#W %L ] !C /( :@#Q '  \ !V
M .X >P#M (  [ "$ .L B0#I (\ YP"6 .4 G0#C *8 X0"Q -\ P #= -4
MV@#L -0 _P#1 /\ T #_ -  _P#0 /\ S0#_ /\   +_   !_P   /\   #_
M  P ^P ; /@ *0#V #8 \P!" .\ 30#K %< Z0!? .< 9@#E &P XP!R .$
M=P#@ 'P W@"! -P A@#: (L V "2 -4 F0#3 *$ T0"L ,\ N0#+ ,T Q@#F
M ,0 ^@## /\ P@#_ ,( _P#" /\ P@#_ /\   '_    _P   /X   #V  <
M\0 6 .T (P#I #$ Y  ] .$ 2 #> %( VP!: -@ 8@#5 &@ TP!M -$ <P#/
M '@ S0!] ,L @@#) (< QP"- ,4 E0## )T P0"G +T M "Y ,4 MP#> +8
M\P"U /\ M #_ +0 _P"T /\ M #_ /\   '_    _P   /,   #K  ( Y0 0
M .  '@#9 "L U  X -$ 0P#. $T RP!5 ,@ 7 #% &, P@!I ,  ;@"_ ',
MO0!X +L ?0"Z (, N ") +8 D "S )@ L "B *X K@"L +T J@#4 *D ZP"H
M /P IP#_ *< _P"G /\ I@#_ /\   #_    \    .@   #@    V  * -
M& #+ "8 Q@ R ,( /0"_ $< O !0 +D 5P"V %X M !D +( :0"Q &X KP!T
M *T >0"L 'X J0"% *< C "F )0 I "= *( J "@ +< G@#* )T XP"< /8
MFP#_ )H _P": /\ F0#_ /\   #Q    YP   -T   #3    RP # ,0 $@"_
M !\ N@ K +4 -P"R $$ KP!* *P 4@"J %@ IP!? *8 9 "D &H H@!O *$
M= "? 'H G@"  )P AP": (\ F "9 )8 I "4 +$ DP## )$ W "0 /  CP#]
M (T _P", /\ C #_ /4   #H!   W L  - +  #'!@  P    +H "0"T !<
MK@ D *H +P"G #H HP!$ *$ 3 "> %, G !9 )H 7P"9 &4 EP!J )8 ;P"4
M '4 DP!\ )$ @P"/ (L C0"5 (L H "* *X B "_ (8 U0"$ .L @P#Y ((
M_P"" /\ @0#_ .T'  #@%0  T1T  ,8>  "]&@  MA$  + %  "J  X I0 <
M *  * "< #, F0 ] )8 1@"4 4T D@)4 ) #6@". U\ C01E (L$:P"*!'$
MB 5X (8%@ "%!H@ @P:2 ($&G@" !JP ?@:\ 'T'TP![">H >@OZ 'D+_P!X
M"_\ > O_ .<5  #8(@  R2H  +XK  "V*   KB,  *<9  "A# 0 FP44 )8)
M(@"2"RT CPPW (P.0 "*#T@ B!!/ (8050"$$5L @Q%A ($29P" $FT ?A)T
M 'T3? ![$X8 >A.0 '@3G !V$ZH =12\ ',4TP!Q%NL <!;\ &\6_P!O%O\
M;Q;_ .$A  #0+0  PS0  +@V  "O-   J"\  * G  "9'0  DA,, (T5' ")
M%R@ A1DR (,:.P"!&D, ?QM* 'T;4 ![&U8 >AQ< '@<8@!W'&D =1QQ ',=
M>0!R'8( <!V- &\=F0!M'J< ;!ZY &H>SP!H'^@ 9Q_Z 68?_P%F'O\"91[_
M MLI  #*-@  OCP  +,^  "J/0  HCD  )HS  "2*@  BB ' (4?%@"!(2,
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M!E8QD094,9\'4C&P!U$QQ@=/,>$(3C#U"$XP_PA.+_\(3B__",T_  "_2
MM$X  *I1  "A40  F$X  (Y(  "%0P  >SP  '(U" !L-18 :38A &4V*@)A
M-3(#7S4Y!5PU0 9:-$8&6#1,!U<T4P=5-%H(5#5B"%,U:PA1-78)4#6!"4XV
MC@E,-IT*2S:N"DDUPPM(-=X+1S7T"T<T_PM'-/\+1S/_"LI$  "\3   L5(
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M#C5#O0XT0]D-,T+P#C-"_P\S0?\/-$#_#\%0  "U6   JUX  *)A  "98P
MD&$  (9>  !Z60  ;E0  &)/  !72P8 4DH4 $]*'@!,2B<!24HN T5)- 9"
M2#H(/TA!"SU'1PT[1T\..4=7#S=(80\V2&P/-4AY#C1)A@XS298-,DFG##!)
MO LO2=@++DCO#"Y'_@XM1O\.+47_#KY4  "S7   J6(  *!F  "79P  CF8
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M QU9_ 4=6/\&'%C_![5C  "K:P  HW$  )MU  "3=P  BG<  (!V  !S<P
M9G   %AM  !*:@  /&<  #)E#  O91< +64@ "ME*  I93 !)V4X 25E0 (D
M94@"(F51 B%E6P(?968!'F5S 1UE@@$;99$ &F2C !ADMP 78]( %V+L !=@
M^P(68/\#%5__!+%I  "H<0  H'8  )E[  "1?0  B7X  ']]  !Q>@  8G<
M %1T  !&<@  .&\  "MN!0 D;1$ (FT: "%M(P ?;2L 'FTS !QM.P ;;40
M&6U- !AM6  6;6, %&UP !)M?P 0;8X #FR@  QKM  *:LT "VGH  QH^0 -
M9_\ #6;_ :YP  "F=P  GGT  )>!  "0A   AX4  'N#  !L@   77X  $]\
M  !!>@  ,W@  "=W   ;=@@ %G83 !1V'  2=B0 $78L  ]V-0 -=CX #'9(
M  IV4P (=EX !G9L  1V>@ "=8H  '6;  !TK@  <L<  ''A  !P\@  ;_P
M 6[_ *IW  "C?@  G(0  ):(  ".BP  @XH  ':)  !GAP  5X4  $F$   [
M@@  +H$  "&    6@   "8 )  2 %  "@!T  8 F  " +@  @#<  (!"  "
M30  @%D  (!F  !_=0  ?X4  'Z6  !]J0  >\$  'K>  !Y[P  >/D  'C^
M *=_  "AA@  FXP  )2/  "*D   ?9   &^/  !@C0  48P  $*+   TBP
M)XH  !N*   0B@  !(L#  "+#   BQ8  (L>  "+)P  BR\  (LZ  "*10
MBE$  (M?  "*;@  BGX  (F0  "'HP  AKL  (38  "#[P  @OL  (+_ *2(
M  "?C@  F9,  )"5  "#E@  =I4  &>4  !8E   29,  #J3   MDP  (),
M !24   (E    )4   "5!0  E0T  )46  "5'@  E2<  )8P  "6.P  E4@
M )96  "690  E78  )6(  "4G   D[(  )'.  "0Z0  CO@  (W_ **0  "=
ME@  E9D  (F:  ![FP  ;)L  %V:  !/F@  /YL  #&<   DG   %YT   J=
M    G@   )\   "@    H ,  * ,  "@%0  H1T  *$F  "A,   HCT  *)+
M  "B6P  HFP  *)_  "ADP  H*D  )_#  ">X0  G?(  )W\ *"8  "9G
MC9X  ("@  !QH0  8J$  %.A  !$H@  -:,  ">D   :I0  #:8   &G
MJ    *D   "J    JP   *L   "K!P  K!   *T9  "O(@  L"T  + [  "Q
M30  L6   +!T  "PB   L)X  *^V  "NTP  KND  *WV )R?  "1H@  A*0
M '6E  !FI@  5Z<  $BH   YJ0  *JL  !VL   .K@   J\   "Q    L0
M +,   "T    M0   +8   "W    N $  +H*  "]%   OQ\  ,$K  ##.P
MQ4T  ,=B  #&>   Q)   ,*H  #"P0  P=D  ,'K )2D  "(IP  >JD  &NJ
M  !;K   3*T  #RO   ML0  '[,  !&U   #MP   +H   "\    O    +X
M  "_    P0   ,,   #%    QP   ,H   #- P  T@T  -0;  #8*0  W#L
M -]0  #B9@  XGT  ..3  #AJ   X+P  -_1 (NI  !^K   ;JX  %^P  !0
ML@  0+4  #"W   @N@  $[T   2_    P@   ,4   #(    R    ,H   #+
M    S    ,\   #2    U@   -H   #>    XP   .D'  #M%@  \"4  /0Z
M  #V4@  ^&H  /F!  #YE0  ^J0  /FQ /\  @'_    _P   /\ ! #_ !(
M_P @ /\ +@#_ #L _P!' /\ 4@#^ %P _ !D /L :P#Z '$ ^ !V /< >P#V
M (  ]0"% /0 B@#R (\ \ "6 .X G@#M *< ZP"R .H P0#H -D Y #Q -X
M_P#; /\ W #_ -D _P#3 /\ T #_ /\   '_    _P   /\   #_  X _P <
M /\ *@#] #< ^@!# /< 3@#T %@ \@!@ /  9P#O &T [0!S .P > #J 'P
MZ0"! .< A@#E (P XP"2 .$ F@#@ *( W@"M -L NP#7 -$ T0#J ,X _0#-
M /\ S0#_ ,T _P#) /\ Q@#_ /\   '_    _P   /\   #]  D ^0 7 /4
M)0#Q #, [0 _ .L 20#H %, Y0!; ., 8@#A &D WP!N -T = #; '@ V0!]
M -8 @@#5 (@ TP". -$ E0#/ )X S0"H ,@ M0## ,D P0#B +\ ]P"_ /\
MO@#_ +X _P"^ /\ O #_ /\   #_    _P   /D   #R  0 [0 3 .@ ( #B
M "X W@ Z -P 1 #9 $X U0!6 -( 7@#0 &0 S0!J ,L ;P#) '0 R !Y ,8
M?@#$ (, PP") ,$ D0"^ )D N@"C +< KP"U ,  LP#7 +( \ "Q /\ L #_
M *\ _P"O /\ KP#_ /\   #_    ]P   .X   #F    X  - -@ ' #2 "@
MS@ T ,L /@#( $@ Q0!1 ,$ 60"_ %\ O0!E +L :@"Z &\ N !T +8 >0"U
M '\ L@"% +  C "N )0 K "> *H J0"H +@ I@#, *4 YP"C /H H@#_ *(
M_P"B /\ H@#_ /\   #V    [    .,   #:    T  ( ,D %@#$ "( P  N
M +P .0"X $( M@!+ +, 4P"Q %H KP!@ *T 90"K &H J0!P *< =0"F 'H
MI "  *, AP"A (\ GP"8 )T I "; +$ F0## )@ W0"7 /, E@#_ )4 _P"4
M /\ E #_ /D   #L    X0   -8   #,    Q  ! +X #P"X !P LP H *\
M,P"L #P J0!% *8 30"D %0 H@!: *  8 "> &4 G0!J )P < ": '4 F0![
M )< @@"5 (H DP"3 )$ GP"/ *L C0"\ (P TP"* .P B0#\ (D _P"( /\
MAP#_ /    #B @  U0@  ,D(  #! 0  N@   +, !P"M !4 J  A *0 + "@
M #8 G0 _ )L 1P"9 $X EP!4 )4 6@"3 &  D@!E )  :P"/ '  C0!W (L
M?@"* (8 B "/ (8 F@"$ *< @@"W ($ S0"  .8 ?@#V 'T _P!\ /\ ? #_
M .@'  #:%   RQL  , :  "X%@  L P  *H!  "D  P G@ 9 )H )0"6 "\
MDP Y )  00". $@ C !/ (H 50") %L AP!@ (8 9@"$ &P @@!R ($ >@!_
M (( ?0", 'P EP!Z *0 > "T '< R !U >$ = +S ',#_P!R _\ <@/_ .$5
M  #0(0  PR<  +DH  "P)0  J1\  *(5  ";" ( E0 1 )  '@", BD B0,S
M (8%.P"$!D, @@=) ( (4 !_"%8 ?0A; 'P)80!Z"6@ > EO '<*=@!U"G\
M<PJ* '(*E0!P"Z, ;PNS &T+R !K#>( :@[U &D._P!I#O\ : [_ -L@  #*
M+   OC$  +,S  "J,0  HBL  )LD  "3&0  C T' (<,%P"##B( ?Q M 'T1
M-0![$CT >1-$ '<42P!U%%$ <Q17 '(470!P%6, ;Q5K &T5<P!L%7P :A:'
M &@6DP!G%J$ 91:Q &,7QP!B&.$ 81CU & 8_P!?&/\ 7QC_ =0J  #%-
MN3H  *X\  "F.@  G34  )4O  "-)@  A1P! 'X7$0!Z&1T =QHH '0;,0!R
M&SD <!Q  &X<1P!L'4T :AU3 &D=60!G'6  9AYG &0>< !C'GD 81^$ & ?
MD !>'Y\ 7!^O %L@Q !9(-X 6"#S 5<@_P)7'_\"5Q__ L\R  # .P  M4$
M *M#  "B0@  F3X  )$X  "(,   ?R@  '<@"P!S(1D ;R(D &PB+0!J(S4
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M!T,QO =!,-8'03#O"$$O_@A!+_\(02[_",1"  "W2P  K5   *-2  ":4P
MD5   (A+  !^1@  =#\  &DX  !@- P 6S08 %@U(@!5-"H!4C0P T\S-P1-
M,ST%2S-#!DHS2@9(,U('1S1:!T4T8PA$-&T(0C5Y"$$UA@D_-94)/36F"3PU
MN@DZ-=0).C7M"3HT_0HZ,_\*.C/_"<%'  "U3P  JU0  *)7  "95P  CU4
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M!RA#^PDG0?\*)T'_"[E3  "N6P  I6   )QC  "49   BV,  (%@  !T6P
M:5@  %U4  !13P  14L) $%*%0 ^2AX .THF #E*+0(V2C,$-$HZ!3%)00<P
M24D(+DI1""U*6P@L2F8'*DMS!RE+@ 8H2Y %)TNA!29+M00D2\X$(TKI!2)(
M^@<B1_\((D;_";=8  "L7P  HV0  )MH  "2:0  B6@  ']F  !S8@  :%\
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M :UH  "E;P  G74  )9X  ".>@  AGL  'QZ  !N=P  7W0  %%Q  !$;@
M-6P  "AJ   <: D &6@3 !=H'  5:"0 %&@L !)H-  1:#T #FA'  UH40 +
M:%P "6AI  =H=P %9X<  V>7  )FJ@ !9<(  F3=  )C\  #8OT !&'_ *IO
M  "B=@  FWL  )1_  "-@0  A8(  'B   !J?0  6GH  $QX   ^=@  ,'0
M "-S   8<@  #'$+  EQ%0 '<1X !G$F  1Q+P #<3@  7%"  !Q3   <5@
M '%D  !P<P  <((  &^3  !OI@  ;KP  &S9  !J[0  :?@  &G^ *=V  "@
M?0  FH,  ).&  ",B   @8@  '.&  !DA   5($  $:    W?@  *GT  !Y\
M   2>P  !GL'  ![$   >QD  'LA  ![*0  >S$  'L[  !Z1P  >U(  'M?
M  !Z;@  >GX  'F.  !XH0  =[<  '73  !T[0  <_@  '+] *1^  ">A0
MF(H  )*-  "'C@  >HT  &R,  !=B@  3HD  #^(   QAP  )(8  !>&   +
MA@   (8!  "&"0  AA(  (4:  "%(@  ABD  (8S  "%/P  A4L  (58  "%
M9P  A'@  (.)  ""G   @;$  (#,  !_Z0  ??@  'W_ **'  "<C0  EY$
M (V3  "!DP  <Y,  &21  !5D   1I   #:0   ICP  '(\  !"/   $D
M )    "0 @  D D  ) 2  "0&@  D"$  )$J  "1-0  D$(  )%/  "17@
MD6\  )"!  "/E0  C:H  (S$  "*XP  B?0  (G] *"/  ";E   DY<  (:8
M  !XF0  :9@  %J7  !+EP  /)@  "V8   @F   $Y@   :9    F@   )L
M  ";    FP   )L(  ";$   FQ@  )P@  "=*@  G38  )U$  ">5   GF4
M )YX  "=C   G*(  )NY  ":U@  F.X  )?Y )Z7  "7FP  BYP  'Z>  !O
MG@  7YX  %">  !!G@  ,:   ".A   6H0  "*(   "C    I    *4   "F
M    I@   *8   "G P  IPL  *@4  "I'0  JBD  *HW  "K1P  K%D  *QL
M  "L@0  K)<  *NN  "JR0  J>,  *GQ )J>  "/H   @J(  '.C  !DHP
M5*0  $6E   UI@  )Z@  !FI   *J@   *L   "M    K0   *X   "P
ML0   +$   "R    LP   +4%  "W#P  N1D  +LE  "]-   OD@  +]>  "^
M=   OHH  +ZA  "]N0  O=,  +SE )*C  "%I0  =Z<  &BH  !8J0  2:H
M #BL   IK@  &[    RQ    LP   +4   "W    MP   +D   "Z    O
M +T   "_    P0   ,,   #&    RPD  ,X6  #2(P  U30  -E*  #<8
MW'@  -F1  #8J   UKT  -;0 (FG  ![J@  :ZP  %RN  !-KP  /+$  "RT
M   =MP  #;D   "[    O@   ,$   ##    PP   ,4   #&    R    ,H
M  #-    T    -0   #9    W0   .,#  #G$@  ZR(  .\U  #S3   ]60
M /9\  #VD0  ]Z(  /6O /\   #_    _P   /\  0#_  X _P = /\ *P#_
M #@ _P!$ /X 3P#\ %@ ^@!@ /D 9P#W &T ]@!S /4 > #S 'T \@"" /
MAP#O (P [0"3 .P F@#J *0 Z0"N .< O0#C -0 W0#O -H _P#9 /\ V0#_
M -, _P#. /\ R@#_ /\   #_    _P   /\   #_  L _P 9 /T )P#X #0
M]@!  /0 2@#Q %0 [P!< .T 8P#K &D Z0!O .< = #E 'D Y !^ .( @P#A
M (D X "/ -X E@#< )\ V@"I -0 MP#/ ,P S #G ,L ^P#* /\ R0#_ ,@
M_P## /\ P #_ /\   #_    _P   /\   #Z  8 ]@ 4 /  (@#K "\ Z0 [
M .< 10#C $\ X0!7 -T 7P#; &4 V0!K -8 < #5 '4 TP!Z -( ?P#0 (0
MSP"* ,T D@#* )H Q0"E ,( L0#  ,, O@#= +P ] "Z /\ N@#_ +H _P"X
M /\ M0#_ /\   #_    _0   /4   #N  $ Z  0 .$ '0#= "H V0 V -8
M0 #3 $H SP!2 ,L 6@#) &  QP!F ,4 :P#$ '  P@!U ,$ >P"_ (  O0"&
M +H C0"W )8 M0"? +, JP"Q +H KP#1 *T [ "L /\ K #_ *L _P"K /\
MJP#_ /\   #\    \@   .D   #A    V  * -$ &0#, "0 R  P ,4 .@#!
M $0 O@!- +L 5 "Y %L MP!A +4 9@"T &L L@!Q +  =@"N 'L K0"! *L
MB "I )  J "9 *8 I "D +, H@#& *  X0"? /@ G@#_ )T _P"= /\ G #_
M /X   #Q    Y@   -T   #2    R@ & ,, $P"^ !\ N0 J +8 -0"S #X
ML !& *T 3@"K %4 J !; *8 80"E &8 I !K *, < "A '8 H !\ )X @P"=
M (H FP"4 )D GP"7 *P E0"] ), U@"1 /  D #_ (\ _P"/ /\ CP#_ /0
M  #G    VP   ,X   #%    O@   +< # "R !D K0 D *D +@"F #@ HP!
M *  2 "> $\ G !5 )L 6P"9 &  F !F )< :P"5 '$ E !W )( ?@"0 (4
MC@"/ (P F0"* *8 B "V (8 S0"% .@ A #[ (0 _P"# /\ @P#_ .L   #=
M 0  S@8  ,0$  "[    LP   *T !0"G !( H@ > )X * ": #$ F  Z )4
M0@"3 $D D0!/ (\ 50". %L C !@ (L 9@") &L B !R (8 >0"$ ($ @@"*
M ($ E0!_ *( ?0"Q 'P Q0!Z .  >0#U 'D _P!W /\ =P#_ .,&  #2$P
MQ1@  +L7  "R$@  JP@  *0   ">  H F0 7 )0 (0"0 "L C0 T (H / "(
M $, A@!* (4 4 "# %4 @@!; (  80!_ &< ?0!M 'L =0!Z 'T > "& '8
MD0!T )X <@"M '$ P !P -H ;@#O &T _ !L /\ ; #_ -L5  #*(   OB0
M +0E  "K(0  HQL  )P1  "5!0  CP . (H &@"& "4 @P N (  -@!^ #X
M? !$ 'L 2@!Y %  > !6 '8!7 !T 6( <@)I '$"<0!O GD ;0.# &P#CP!J
M YP : .K &<#O@!E!-8 9 ;L &,'^P!B!_\ 8@?_ -,A  #$*@  N"\  *XP
M  "F+0  GB@  )8@  ".%@  APH% ($$$P!]!1X >@<H '<(,0!T"3@ <@H_
M '$*10!O"TL ;0Q1 &P,5P!J#%X : UE &<-;0!E#7< 8PZ! &(.C0!@#IL
M7@^K %T0OP!;$-D 6A'O %D2_0!9$O\ 61'_ ,TI  "_,@  M#<  *HY  "A
M-P  F3(  ) K  "((P  @!D  '@0"P!T$1@ <!(B &T3*P!K%#, :10Z &<5
M00!E%4< 9!9- &(64P!@%EH 7Q=A %T7:@!<%W, 6AA^ %D8B@!7&)@ 5AFH
M %09O !2&=4 4AKN %$:_@!1&?\!4!G_ <DQ  "[.@  L#\  *=   ">/P
ME3H  (PT  "#+0  >R0  '$<!0!L&1, :!H> &4;)P!C'"\ 81PV %\=/0!=
M'4, 7!U) %H>4 !8'E8 5QY> %4?9P!4'W$ 4A]\ %$@B !/()8 3B"F $P@
MN0!+(-,!2B#L 4D@_0))(/\"21__ L4W  "X/P  K40  *1&  ";10  DD$
M (D\  " -0  =BX  &PE 0!D(0X 82$: %XB(P!;(RL 62,R %<C.0!5(S\
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M!C,O^0<S+_\'-"[_![Q%  "Q30  IU(  )U4  "55   C%(  ().  !X2
M;4,  &$\  !6-@( 3C,. $LS&0!(,R$ 13,H 4(S+@(_,C0#/C([!#PS0@4[
M,TH&.3-2!C@T6P8V-&8&-35R!C,U?P8R-8X&,36?!B\UL@8N-<H&+37F!BTT
M^ <M,_\(+3+_"+I*  "N40  I58  )Q8  "36   BE<  (!3  !U3@  :DD
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M!K)7  "H7@  H&,  )=F  "/9@  AF8  'QD  !P7P  95T  %I9  !-5
M/T\  #)+"0 N2Q0 +$L< "I+)  H3"L )DPR 21,.@$C3$("(4Q* B!,5 (?
M3%\!'DUL 1Q->@$;38D &4V: !A,K0 73,4 %DOA !9*]0$62?\"%4C_ Z]<
M  "F8P  GF@  )9K  ".;   A6P  'MJ  !O9@  9&0  %=@  !)7   .U<
M "Y4!  F4@\ )%(8 ")2(  @4R@ 'U,O !U3-P <4S\ &E-( !E34@ 74UT
M%E-I !13=P 24X< $5.8  ]3JP -4L( #%'>  Y0]  /3_\!#T[_ :UA  "D
M:   G&T  )1P  "-<@  A'(  'IQ  !N;@  86L  %-G  !%8P  -V   "I=
M   >6@D &EH3 !A:'  76B, %5HK !1:,P 26CL $5I%  Y:3P ,6UH "EMF
M  E:=  '6H, !5J4  19I@ #6;T  U?8  17[0 %5OP !E7_ *IG  "B;@
MFG,  )-V  "+>   @W@  'IX  !K=   77$  $]N  !!:P  ,V@  "9F   9
M9 ( $&,,  QC%@ *8QX "6,F  =C+@ &8S< !&-   )C2P  8U8  &-B  !B
M<   8G\  &*0  !AH@  8+<  %_4  !=Z@  7/<  %S^ *=N  "?=   F'H
M ))]  "*?P  @H   '9]  !G>@  5W<  $EU   [<P  +7$  "!O   5;0
M"&T'  %L$   ;!D  &PA  !L*0  ;#$  &P[  !L1@  ;%$  &Q>  !K;
M:WL  &J+  !IG@  :+,  &?.  !FZ0  9/8  &3] *1U  "=?   EX$  )&$
M  ")A@  ?H4  '"#  !A@0  47X  $-\   T>P  )WD  !IX   .=P   G<#
M  !W#   =A0  '8<  !V(P  =BL  '8U  !V0   =4P  '59  !U9P  ='8
M '2'  !SF0  <JX  ''(  !OY@  ;O<  &[_ *)]  ";@P  EH@  )"+  "%
MC   >(L  &F)  !:AP  2X4  #N$   N@P  (((  !2!   '@0   ($   "!
M!P  @0X  ($6  " '0  @"0  ($M  " .   @$4  (!2  " 8   @'$  '^"
M  !^E0  ?:D  'S"  !ZX0  >?0  'C^ )^&  ":BP  E8\  (N1  !_D0
M<)#_XOV^24-#7U!23T9)3$4 "@H  &&.  !2C0  0HT  #.,   FC   &(L
M  N+    BP   (P   ",    C 8  (L.  "+%0  BQT  (PD  ",+@  C#L
M (Q)  ",6   C&@  (M[  "*CP  B:0  (>[  "&V0  A?$  (3[ )Z.  "9
MDP  D)4  (26  !VE@  9Y4  %>4  !(E   .)0  "J4   <E   #Y0   *5
M    E0   )8   "7    EP   )8$  "6"P  EQ,  )<;  "8)   F"\  )@^
M  "930  FEX  )EQ  "9A0  F)H  ):S  "4T0  D^H  )+X )R6  "5F0
MB9H  'N;  !LFP  7)L  $V;   ]FP  +IP  !^=   2G0  !)X   ">
MGP   *    "A    H0   *(   "A    H@@  *,1  "D&0  I2,  *8P  "F
M00  IU(  *AE  "H>@  J)   *>G  "FP@  I=T  *3N )B<  ",G@  ?Z
M '"A  !AH0  4:$  $&B   QHP  (Z0  !6E   &I@   *<   "I    J0
M *H   "L    K    *T   "N    K@   + !  "Q"@  M!0  +4A  "V,
MMT0  +A8  "Y;@  N80  +F;  "XL@  N,T  +CB )"A  "#HP  =:4  &6F
M  !6I@  1J<  #6I   EJP  %ZT   BN    KP   +$   "S    LP   +4
M  "V    MP   +D   "Z    NP   +T   #     Q 0  ,@0  #+'@  SRX
M -)$  #370  T78  -*-  #2HP  T;@  -', (>F  !YJ   ::H  %JK  !*
MK0  .:\  "FQ   :LP  ";8   "X    N@   +P   "_    O@   ,    #"
M    PP   ,8   #(    RP   ,X   #1    U@   -T   #B#0  YAT  .LP
M  #N1P  \E\  /)X  #PD   [J4  .ZT /\   #_    _P   /\   #_  H
M_P : /\ * #_ #4 _P!  /P 2P#Z %0 ^ !< /8 8P#T &H \@!O /  =0#N
M 'H [0!^ .P A #K (D Z@"/ .D EP#G *  Y@"K .$ N@#< -  V0#K -@
M_P#6 /\ U0#_ ,\ _P#( /\ Q #_ /\   #_    _P   /\   #_  < _@ 6
M /@ ) #U #  \P \ /$ 1@#N %  ZP!8 .@ 7P#E &8 XP!K .( <0#@ '4
MWP!Z -X @ #< (4 VP"+ -D D@#6 )L T0"F ,T M #+ ,< R@#B ,@ ^0#&
M /\ Q0#_ ,, _P"] /\ N@#_ /\   #_    _P   /T   #W  , \  1 .L
M'P#G "P Y0 V .( 00#> $L V@!3 -8 6P#4 &$ T@!G -  ; #/ '$ S0!V
M ,P >P#+ ($ R0"' ,4 C@#" )< P "A +X K0"\ +T N@#6 +@ \0"V /\
MM0#_ +4 _P"S /\ L #_ /\   #_    ^0   /$   #J    X0 - -P &@#7
M "8 TP R ,\ / #+ $4 R !. ,4 50## %P P0!B +\ 9P"^ &P O !Q +H
M=P"X 'P M0"" +0 B0"S )$ L0"; *\ IP"N +4 JP#+ *H Z "H /T IP#_
M *< _P"G /\ I #_ /\   #W    [0   .0   #:    T0 ' ,L %0#& "
MP@ L +X -@"[ #\ N !( +4 4 "S %8 L0!< *X 8@"M &< JP!L *H <0"I
M '< J !] *< A "E (L HP"5 *$ H "@ *T G@#! )P W ": /4 F #_ )<
M_P"7 /\ EP#_ /H   #M    X0   -4   #+    Q  # +T #P"X !P LP F
M +  , "M #H J@!" *< 2@"D %  HP!6 *$ 7 "@ &$ GP!F )T ; "< '$
MFP!W )D ?@"8 (8 E@"/ )0 F@"2 *< D "X (T T ", .P BP#_ (H _P"*
M /\ B@#_ .\   #B    U    ,@   "_    N    +$ "0"L !8 IP A *,
M*@"@ #, G0 \ )L 0P"9 $H EP!0 )4 5@"4 %L D@!A )$ 9@"0 &P C@!R
M (T >0"+ ($ B0"* (< E "% *$ @P"Q (( Q0"  ., ?P#X '\ _P!^ /\
M?@#_ .4   #5    R ,  +X!  "V    K@   *<  P"B  \ G0 : )@ )0"5
M "T D@ V )  /0"- $0 BP!* (H 4 "( %8 AP!; (4 80"$ &< @P!M ($
M= !_ 'P ?0"% 'P D !Z )P > "K '8 O@!U -H = #R ', _P!S /\ <@#_
M -P'  #,$0  P!4  +84  "M#@  I@4  )\   "8  @ DP 4 (X '@"+ "<
MAP O (4 -P"# #X @0!% '\ 2P!^ %  ? !6 'L 6P!Y &$ > !H '8 ;P!T
M '@ <@"! '  C !N )@ ;0"G &L N0!J -( :0#L &@ _ !G /\ 9@#_ -,5
M  #%'0  N2$  *\B  "F'@  GA<  )<-  "0 @  B@ , (4 %P"! "$ ?@ J
M 'L ,0!Y #D =P _ '4 10!S $L <0!1 '  5P!N %T ;0!C &L :P!I '0
M9P!^ &4 B0!D )4 8@"D &  M0!? ,X 7@#F %T ]@!< /\ 7 #_ ,T@  "_
M*   LRP  *HM  "A*@  F20  )$<  ")$P  @0@" 'P #P!W !H =  D '$
M+ !N 3, ; (Z &H"0 !I T8 9P1, &4%4@!D!5@ 8@9? & &9P!?!G  709[
M %L'A@!:!Y, 6 >C %8(M0!5",L 5 GE %,*]@!3"O\ 4@K_ ,<H  "Z,
MKS4  *8V  "=-   E"X  (PG  "#(   >Q<  ',,!P!N"!0 :@D> &<*)@!D
M"RX 8@PU & ,.P!?#4$ 70Y( %P.3@!:#U0 6!!< %<09 !5$&X 5!%Y %(1
MA0!0$I( 3Q*B $T2M0!,$LT 2Q/G $H3^0!*$_\ 2A/_ ,,P  "V.   K#P
M *(]  "9/   D3<  (@Q  !_*@  =B(  &T9  !E$@T 81,8 %X4(0!<%2D
M6A4P %@6-P!6%CT 51=$ %,72@!1%U$ 4!A8 $X880!-&&L 2QEV $H9@@!(
M&I  1QJ@ $4:L@!$&LH 0QKE $(:^0!"&O\!0AK_ ;\V  "S/@  J4(  *!$
M  "70@  CCX  (4Y  ![,@  <BL  &@C  !>&P@ 6AH4 %<;'0!4'"4 4APM
M % =,P!.'3D 31U  $L>1@!*'DT 2!Y5 $<?7@!%'V@ 1"!S $(@@ !!(8X
M/R&> 3XAL $\(<@!.B'D 3H@^ (Z(/\".A__ KT[  "Q0P  IT<  )U)  "5
M2   C$4  ((_  !Y.@  ;C(  &0K  !9) 0 4R$0 % A&@!-(B( 2R(I $DB
M+P!'(S8 12,\ $0C0P%")$H!0212 4 D6P$^)64!/"5Q 3LF?@$Y)HP".":<
M C8FKP(T)L8",R;B C,F]@,S)?\#,R3_!+I   "N1P  I4L  )M-  "33
MBDH  (!%  !V0   ;#H  &$S  !5+   32<+ $DG%@!&)QX 1"@E $$H+  _
M*#(!/2@X 3PH0 ([*4<".BE0 C@J60(W*F,#-2MO S,K? ,R*XH#,2N: R\K
MK0,M*\0#+"O@ RPJ]00M*O\$+2G_!;=$  "L2P  HU   )I2  "140  B$\
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M !LZ\@(:.?\#&CC_!+!1  "G5P  GEP  )5>  "-7P  A%X  'I;  !N5@
M8U,  %A/  !-2P  0$4  #) !P M/Q$ *S\9 "D_(0 G/R@ )3\O 2- -@$B
M0#X!($!' 1] 40$>0%L!'$%H 1M!=0 :080 &$&5 !=!J  50;X %$#: !4_
M\0$5/O\"%#W_ ZY6  "E7   G&$  )1C  ",9   @V,  'EA  !M70  8EH
M %A7  !+4@  /4T  #!( P F10T (T46 "%&'@ @1B4 'D8L !Q&-  ;1CP
M&D=% !A'3@ 71UD %4=E !-'<P 21X, $$>3  Y'I@ ,1KP "T;6  U%\  .
M1/X #D/_ :M;  "C80  FF8  )-H  "+:0  @FD  'AG  !L9   8F(  %5>
M  !'60  .54  "Q1   ?30@ &TT2 !E-&@ 732$ %DTI !1-,  333@ $4U"
M  ].3  -3E< "TYC  E.<0 (3H  !DZ0  5-H@ #3;<  TS1  1+Z0 %2OH
M!DK_ *E@  "@9@  F6L  )%N  "*;P  @6\  'AN  !L:P  7V@  %%D  !#
M8   -5T  "A9   ;5@, $E4,  Y5%0 ,51T "U4E  E5+0 (534 !E4^  15
M20 "550  55@  !5;0  57P  %6,  !4G@  4[,  %+.  !1Y@  4?4  %#^
M *9F  ">;   EW$  )!T  ")=@  @78  '=U  !I<@  6FX  $QK   ^:
M,&4  "-B   78   "UX'  1>$  !7AD  %XA  !>*0  7C$  %XZ  !>10
M7E   %U<  !=:@  77D  %R)  !<FP  6Z\  %K)  !9Y0  5_0  %?\ *1M
M  "<<P  EG@  (][  "(?0  @'T  '-[  !D>   574  $=R   X;P  *FT
M !UK   2:0  !6@$  !H#   :!4  &<<  !G)   9RP  &<U  !G0   9TL
M &98  !F90  974  &6%  !DEP  9*L  &+$  !AX@  8/4  %_] *%T  ";
M>@  E7\  (Z"  "'A   ?(,  &Z   !>?@  3WL  $!Y   Q=P  )'4  !=T
M   +<P   ',   !R"   <A   '(7  !Q'@  <28  '$N  !Q.@  <$8  '!2
M  !P8   <'   &^!  !NDP  ;:<  &R_  !KW@  :?,  &C^ )]\  "9@@
ME(8  (V)  "#B@  =H@  &>&  !7A   2((  #B    J?P  '7X  !!]   #
M?0   'T   !]!   ? H  'P2  !\&0  ?"   'PG  !\,@  >S\  'M,  ![
M6@  >VH  'I[  !YC@  >*(  '>Y  !VV   =?   '3\ )V$  "8B@  DXX
M (F/  !\CP  ;HT  %Z,  !/B@  /XD  #")   BB   %8<   >'    AP
M (@   "(    AP,  (<*  "'$0  AQ@  (<?  "'*   AS4  (=$  "'4@
MAV(  (=U  "&B   A)T  (.T  ""T   @>L  (#Z )N-  "7D@  CI0  (*4
M  !TE   9),  %62  !%D0  -9$  ":1   9D0  "I    "1    D0   )(
M  "2    D@   )(   "2!P  D@X  ),6  "4'@  E"D  ),X  "41P  E5@
M )5J  "4?P  DY8  )&N  "0R0  C^8  ([U )J5  "2EP  AI@  'F9  !I
MF0  6I@  $J8   ZF   *YD  !R9   -F0   )H   ":    FP   )P   "=
M    G0   )T   "=    G0,  )X+  "@$P  H1T  *(J  "A.@  HTP  *1?
M  "D<P  I(H  *.A  "BN@  H-L  )[O ):;  "*G   ?9X  &Z>  !>G@
M3IX  #Z?   NH   'Z$  !&B   "HP   *0   "E    I@   *<   "H
MJ0   *D   "J    J@   *L   "L!P  KA$  *\=  "Q*P  LCX  +12  "U
M9P  M7X  +65  "TK0  M,<  +/@ (Z?  "!H0  <J,  &.C  !3I   0Z4
M #*F   AJ   $ZH   .K    K    *T   "O    KP   +$   "R    LP
M +0   "V    M@   +@   "[    O@   ,(*  #%&0  QBL  ,A"  #*60
MS'   ,V'  #-G@  S;0  ,S* (2D  !VI@  9Z<  %>I  !'J@  -JP  "6N
M   6L   !K(   "T    M@   +@   "Z    N@   +P   "]    OP   ,$
M  ##    Q0   ,<   #+    SP   -<   #<!P  X1<  .4J  #I0@  ZUT
M .EX  #ICP  ZJ,  .JT /\   #_    _P   /\   #_  < _P 7 /\ )0#^
M #$ _0 \ /H 1P#W %  ] !9 /$ 8 #O &8 [0!L .P <0#K '8 Z@![ .@
M@ #G (8 Y@", .4 DP#B )P W0"G -D M@#7 ,H U0#F -0 _0#3 /\ T@#_
M ,H _P## /\ OP#_ /\   #_    _P   /\   #_  0 ^0 3 /4 (0#R "T
M\  W .T 0@#I $P Y0!4 .( 7 #@ &( W@!H -P ;0#; '( V@!W -@ ? #6
M ($ U0"( -$ CP#- )@ R@"B ,D KP#' ,$ Q@#; ,0 ]@#" /\ P0#_ +X
M_P"X /\ M0#_ /\   #_    _P   /H   #R    ZP . .8 ' #C "@ X  R
M -P /0#7 $< TP!/ -  5P#. %T S !C ,H : #) &T QP!R ,4 > #" 'T
MP "# +X B@"] )( NP"< +D J "X +@ M@#/ +0 [0"R /\ L0#_ +$ _P"M
M /\ J@#_ /\   #^    ]0   .T   #C    W  * -8 %@#1 "( S  N ,D
M-P#% $$ P@!* +\ 40"] %@ NP!> +@ 8P"V &@ M !M +, <P"R '@ L !^
M *\ A0"N (T K0"6 *L H@"I +  IP#$ *4 X@"D /L HP#_ *$ _P"@ /\
MG0#_ /X   #S    Z    -X   #3    S  $ ,4 $@#  !T NP H +@ ,@"U
M #L L@!# *\ 2P"L %( J@!8 *D 70"G &, I@!H *4 ;0"D '( HP!X *(
M?P"@ (< GP"0 )T FP"; *@ F0"Z )< U0"4 /( DP#_ ), _P"2 /\ D@#_
M /4   #G    V@   ,X   #%    O@   +< # "R !@ K@ B *H + "G #4
MI  ] *$ 10"? $P G@!2 )P 5P"; %P F0!B )@ 9P"7 &T E0!S )0 >0"3
M ($ D0"* (\ E0", *( B@"R (D R0"' .@ A@#^ (8 _P"% /\ A0#_ .H
M  #;    S0   ,(   "Z    L@   *P !P"F !, H0 = )X )@"; "\ F  W
M )8 /@"3 $4 D@!+ )  40". %8 C0!< (P 80"* &< B0!M (< = "% 'P
MA "% (( D "  )P ?@"K 'T P ![ -T >@#W 'D _P!Y /\ >0#_ -\   #/
M    PP   +D   "P    J    *(   "<  P EP 7 ), (0"/ "D C  Q (H
M.0"( #\ A@!% (0 2P"# %$ @0!6 (  7 !_ &$ ?0!H 'P ;P!Z '< > "
M '8 BP!T )< <@"F '$ N !O -, ;@#O &T _P!M /\ ;0#_ -4'  #'#@
MNQ(  + 1  "H"@  H0$  )D   "3  4 C@ 1 (D &P"% "0 @@ K '\ ,P!]
M #H >P!  'H 1@!X $L =@!1 '4 5@!S %P <0!C '  :@!N '( ; !\ &H
MAP!I ), 9P"B &4 L@!D ,L 8P#G &( ^P!A /\ 80#_ ,T4  "_&P  M!\
M *H>  "B&@  FA0  )()  "+    A0 ) (  % !\ !X >  F '4 +0!S #0
M<0 [ &\ 00!M $8 :P!, &H 40!H %< 9@!> &4 9@!C &X 80!X %\ @P!>
M )  7 "> %H KP!9 ,4 6 #B %< ]0!6 /\ 5@#_ ,<>  "Z)@  KRH  *4J
M  "=)@  E"   (P9  "$$   ?04  '< # !R !< ;@ @ &L * !H "\ 9@ U
M &0 .P!C $$ 80!' %\ 30!> %, 7 !: %H 80!8 &L 5P!U %4 @ !3 (T
M4@"< % !K0!/ <( 3@'< $T"\ !, OL 3 +_ ,(G  "U+@  JS(  *$S  "9
M,0  D"L  (<D  !_'0  =A0  &X)!0!H A  9 (9 &$#(@!>!"D 7 0P %H%
M-@!9!CP 5P9" %4'2 !4!T\ 4@A6 % (7@!/"6< 30ER $P*?@!*"HP 2 J;
M $<+K !%"L( 1 O< $,+\0!#"_X 0PO_ +XN  "R-@  ISH  )X[  "5.0
MC#0  (0N  !Z)P  <1\  &@6  !?# @ 6PL4 %@,' !5#20 4PTK %$.,0!/
M#C< 3@\^ $P01 !+$4L 21%3 $<16P!&$F4 1!-P $,3? !!$XH /Q2: #X4
MK  \%,( .Q3= #L4\P [%/\ .Q/_ +HU  "O/   I4   )M!  "3/P  BCL
M ($V  !W+P  ;2@  &,@  !:& ( 4Q0- $\4& !-%2  2Q4G $D6+0!'%C,
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M 24E\ (E)?\")B3_ [-#  "H2@  GTX  )9/  "-3@  A$P  'M(  !P0P
M9CT  %LW  !/,0  1"L! #LG"P X)Q4 -2<< #,G(P P)RD +R<P "XH-P$M
M*#\!*RE' 2HI40$I*EL!)RIG 28K= $D*X,!(RN3 2$KI0$@*[L!'BO6 !XK
M[P$?*OX"'RG_ [%'  "F3@  G5(  )53  ",4P  @U$  'E.  !N2   8T,
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M :I4  "A6@  F5\  )%A  ")80  @&$  '9>  !J6@  8%@  %95  !)4
M.TL  "Y&   A0@8 &D 0 !E %P 70!\ %4 F !1!+0 2034 $4$^  Y!2  ,
M05, "T)?  E";0 '0GP !D*,  1!G@ "0;(  D'+  - Y  %/_8 !C[_ *A9
M  "?7P  EV0  )!F  "(9P  ?V<  '5E  !I80  8%\  %-;  !%5@  -U(
M "I.   =2@$ %$<* !!'$P -2!L "T@C  I(*@ (2#( !T@[  5(10 #2%
M DE<  !):@  27D  $F)  !(FP  1ZX  $?'  !&X@  1?(  $3\ *5?  "=
M90  EFD  (YL  "';0  ?VT  '5L  !I:0  768  $]A  !!70  ,UH  "56
M   94P  #5 &  90$  #4!@  5 ?  !0)P  4"\  % X  !00@  4$X  %!9
M  !09P  4'8  %"&  !/F   3JP  $W$  !,X0  2_$  $O[ *-E  ";:P
ME&\  (UR  "&=   ?G0  '5S  !F;P  6&P  $IH   \9   +F$  "!?   4
M7   "%H$  !:#   614  %D<  !9(P  62L  %DT  !9/P  64H  %A6  !8
M8P  6'(  %B"  !7E   5J@  %7   !3W@  4O,  %+[ *%L  "9<@  DW8
M (UY  "&>@  ?GL  '%X  !B=0  4W(  $1O   U;   *&D  !IG   .9@
M F0!  !D"0  8Q$  &,8  !C'P  8B<  &(O  !B.@  8D8  &)2  !A7P
M86X  &!_  !?D   7J0  %V\  !<V@  6_(  %K] )YS  "8>0  DGT  (R
M  "%@@  >H   &M^  !<>P  3'@  #UV   O=   (7(  !1P   ';P   &\
M  !N!0  ;@P  &T3  !M&@  ;2$  &TH  !L,P  ;$   &M-  !K6@  :VH
M &IZ  !IC   :*   &>W  !FU0  9>\  &3\ )Q[  "7@0  D84  (N(  "!
MAP  <X4  &2#  !5@0  17\  #5]   G>P  &7H   MY    >0   'D   !Y
M    > <  '@-  !W%   =QL  '<B  !W*P  =S@  '9&  !V5   =F0  '5U
M  !TB   <YP  '*R  !QS@  <.P  &_[ )N#  "6B   D8P  (>-  !ZC
M:XL  %R)  !,B   /(8  "V%   ?A   $8,   .#    @P   (,   "#
M@P   (,&  ""#   @A,  ((:  "#(@  @R\  ((^  ""30  @EP  ()N  "!
M@@  @)<  'ZM  !]R   ?>8  'SW )F,  "5D   C)(  ("2  !QD0  8I
M %*/  !"C@  ,HX  "..   5C0  !XT   "-    C0   (X   ".    C@
M (X   ". P  C@D  (X1  "/&   CR,  (\Q  "/0@  D%(  )%D  "/>@
MCI   (VG  "+P0  BN   (KS )F4  "0E@  A)<  ':7  !GE@  5Y4  $>5
M   VE0  )Y4  !B6   )E@   )8   "7    EP   )@   "9    F0   )D
M  "9    F0   )H&  ";#@  G!<  )TC  "=-   GD8  )]8  "@;0  H(,
M )^<  "<N   F]D  )GO )29  "(FP  >YP  &R<  !<FP  2YL  #J<   J
MG0  &YX   R>    GP   *    "A    H@   *,   "D    I    *4   "E
M    I0   *8   "G @  J@H  *L7  "M)0  K3@  *]+  "Q8   L7<  +&/
M  "QJ   K\$  *_= (R>  !_GP  <*$  &"A  !0H0  /Z(  "ZD   >I0
M#J<   "H    J0   *H   "K    K    *T   "N    L    +$   "R
ML@   +,   "V    N    +L'  "]%@  OR<  ,$\  #%4@  QVH  ,B"  #(
MF0  R+$  ,?' (*C  !TI   9:4  %6F  !$IP  ,JD  "*L   2K0   J\
M  "Q    L@   +0   "V    M@   +@   "Y    NP   +T   "^    P0
M ,(   #%    R0   -    #5 @  VQ(  -XF  #@0   XEL  .1S  #EB@
MYJ   .:R /\   #_    _P   /\   #_  0 _P 4 /X (0#[ "T ^@ X /<
M0P#S $T [P!5 .T 70#K &, Z0!H .@ ;@#F ', Y0!W .0 ?0#C (( X0"(
M -T D #9 )D U@"C -0 L #3 ,0 T0#@ -  ^0#. /\ S0#_ ,4 _P"^ /\
MN@#_ /\   #_    _P   /\   #[  ( ]0 0 /$ '0#N "D [  S .@ /@#C
M $@ X !0 -T 6 #: %X V !D -8 :0#5 &X TP!S -$ > #. 'X RP"$ ,@
MC #' )0 Q@"= ,0 J@## +L P0#4 +\ \0"^ /\ O0#_ +D _P"T /\ L #_
M /\   #_    _0   /8   #L    YP + .( & #> "0 V0 O -4 .0#1 $,
MS0!+ ,H 4@#( %D Q@!? ,, 9 #! &D O@!O +P = "[ 'D N@!_ +D A@"X
M (X M@"7 +4 HP"S +( L0#( *\ YP"N /\ K0#_ *P _P"G /\ HP#_ /\
M  #Z    \0   .8   #=    U@ ' -  $P#* !\ Q@ J ,, ,P#  #P O !%
M +D 30"V %, LP!9 +$ 7P"P &0 KP!I *X ;@"M '0 K !Z *H @ "I (@
MJ "1 *8 G "D *L H@"] *$ V@"> /< G #_ )L _P": /\ F #_ /H   #N
M    XP   -8   #-    Q@ ! +\ #@"Z !D M@ D +( +@"O #8 K  _ *D
M1@"G $T I0!3 *0 60"B %X H0!C *  : "? &X G@!T )P >P"; (( F0"+
M )@ E@"6 *, DP"T )$ S0"/ .X C@#_ (T _P"- /\ C #_ /$   #B
MTP   ,@   #     N    +$ "0"L !4 J  > *0 * "A #$ GP X )P 0 ":
M $< F0!- )< 4@"6 %@ E != ), 8@"1 &@ D !N (\ =0"- 'T BP"% (D
MD "' )T A0"M (0 P@"" ., @0#[ (  _P"  /\ @ #_ .0   #4    R
M +T   "T    K0   *< ! "A  \ G  : )@ (@"5 "L DP S )  .@". $
MC !& (L 3 ") %$ B !7 (8 7 "% &( @P!H (( ;P"  '< ?P"  'T BP![
M )< >0"F '< N@!V -8 = #R '0 _P!S /\ <P#_ -@   #)    O@   +,
M  "K    HP   )T   "7  D D@ 4 (X '0"* "4 AP M (4 - "# #L @0!
M '\ 1@!^ $P ? !1 'L 5P!Y %P =P!C '8 :@!T '( <@![ '  A@!N )(
M;0"A &L LP!I ,L : #K &< _@!G /\ 9P#_ ,\%  #!#   M@\  *P-  "C
M!P  G    )0   ".  ( B0 - (0 %P"  "  ?0 G 'H +@!X #4 =@ [ '0
M00!R $8 <0!, &\ 40!M %< ; != &H 90!H &T 9@!W &0 @@!B (X 80"<
M %\ K0!= ,, 7 #B %P ]P!; /\ 6P#_ ,<3  "Z&0  KQP  *8;  "=%P
ME1   (T&  "&    @  & 'L $0!V !H <P B &\ *0!M "\ :P V &D / !G
M $$ 90!' &0 3 !B %( 8 !9 %X 8 != &D 6P!S %D ?@!7 (H 5@"8 %0
MJ0!3 +X 40#: %$ \P!1 /\ 4 #_ ,(=  "U)   JB<  *$G  "8(P  D!T
M (<6  !_#   > (  '$ "@!L !0 :  < &4 ) !B "H 8  P %X -@!= #P
M6P!" %D 2 !7 $X 5@!5 %0 7 !2 &4 40!O $\ >@!- (< 2P"5 $H I@!(
M +H 2 #4 $< [0!& /H 1@#_ +TF  "P+0  IC   )TP  "4+0  C"@  (,A
M  !Z&@  <A$  &D& @!C  P 7P 6 %L '@!8 "4 5@ K %0 ,0!3 #< 40 ]
M $\ 0P!. $D 3 %0 $H!6 !( F$ 1P)L $4#> !# X4 0024 $ $I  _ [@
M/0/1 #P#Z  \!/< / 3_ +DM  "M-   HS<  )HX  "1-@  B#$  '\K  !V
M)   ;1P  &04  !;"@4 504. %(%& !/!1\ 308F $L'+ !)!S( 1P@X $8(
M/P!$"44 0@E- $$*50 _"E\ /0MJ #L+=@ Z#(0 . R3 #8,I  U#+@ ,PS1
M #(,Z@ S#/D ,PS_ +8T  "J.@  H3X  )@^  "//   AC@  'TS  !S+
M:24  %\>  !6%@  30X( $D-$@!&#1H 1 XA $$.)P! #RX /A T #P0.@ [
M$4( .1)) #<24@ V$UP -!-G #,4=  Q%(( +Q62 "X5HP L%+@ *A32 "H5
M[  K%/L +!3_ +,Y  "H/P  GT,  )9$  "-0@  A#\  'HZ  !Q-   9RT
M %PF  !2'P  2!@# $$5#0 ^%18 .Q4= #D6)  W%BH -A8P #07-P S%SX
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M :Q&  "C3   FE   )%1  ")40  @$X  '9+  !K1@  8$$  %8\  !+-@
M0#$  #0L 0 J)PH )B83 "0G&@ B)R  (2<G !\H+P >*#8 '2D_ !PI20 ;
M*E0 &2I? !<K;0 6*WL %"N+ !,KG0 1*[( #RK+ ! JYP 1*OD $BG_ :I*
M  "A4   F%0  )!5  "(50  ?U0  '50  !I2P  7T<  %5#  !*/P  /SH
M #,U   F+P< ("T0 !XM%P <+1X &RXE !DN+  8+C0 %R\] !4O1P 4+U(
M$C!= ! P:P .,7H ##&*  HPFP ),*\ !S#'  @OX@ *+_< "R[_ *A.  "?
M5   EU@  (]:  "'6@  ?ED  '16  !H40  7DX  %1+  !)1P  /4(  # \
M   C-P0 &C0, !<S%  5-!L %#0B !(T*@ 1-3$ #S4Z  TU1  +-4\ "C9;
M  @V:  &-W< !3>'  ,VF0 !-JP  #;$  $UWP #-/( !#/_ *93  ">60
ME5T  (Y?  "&7P  ?5X  '-<  !G6   7E8  %12  !(3@  .D@  "U#   ?
M/P  %#L( ! Z$0 -.QD "SL@  D[)P (/"\ !CPX  4\0@ #/$T  3Q9   ]
M9@  /74  #V%   \E@  /*H  #O!   [W0  .N\  #GZ *18  "<7@  E&(
M (UD  "%90  ?&0  '-B  !G7P  7ET  %%9  !$5   -D\  "A+   ;1P
M$$0%  ="#0 $0Q8  D,=  !#)0  0RT  $0U  !#/P  0TH  $-6  !$8P
M1'(  $2"  !#E   0J<  $&^  !!W   0.\  #_Y *)>  ":8P  DV<  (QJ
M  "$:P  ?&L  ')I  !G9P  6V,  $U?   _6P  ,5<  "-3   74   "TT#
M  %,"P  2Q0  $P;  !,(@  2RH  $LR  !+/   2T@  $M3  !+8   2V\
M $M_  !*D0  2:4  $B\  !'V0  1O   $7Z *!D  "8:@  DFT  (MP  "$
M<@  ?'(  '-Q  !D;0  5FD  $AE   Y8@  *UX  !Y;   26   !58!  !6
M"0  51$  %47  !5'@  5"8  %0N  !4.0  5$0  %-0  !370  4VP  %-\
M  !2C@  4:(  %"Y  !.U@  3>\  $W\ )YJ  "7<   D70  (IW  "#>
M?'D  &]V  !?<P  4&\  $)L   S:0  )68  !=D   +8@   &$   !@!@
M7PT  %\4  !>&@  7B$  %XI  !=-   74   %U,  !<6@  7&@  %MY  !;
MB@  6IX  %BU  !7TP  5NX  %3\ )QR  "5=P  D'L  (I^  "#@   =WX
M &E[  !9>   274  #IS   L<   'FX  !%M   $:P   &L   !J @  :@@
M &D/  !I%0  :!P  &@C  !H+0  9SH  &='  !F50  9F0  &5T  !DA@
M8YH  &*P  !AS0  7^L  %[[ )IZ  "5?P  CX,  (F&  !_A0  <8,  &*!
M  !2?@  0GP  #)Z   D>   %G<   AV    =0   '4   !U    = ,  '0)
M  !S$   <Q8  ',=  !S)0  <C(  '%   !Q3@  <5X  '!O  !O@@  ;I8
M &VL  !LQP  :^8  &KY )B"  "4AP  CXL  (6+  !XB@  :8@  %F&  !)
MA0  .(,  "F"   ;@0  #8    !_    ?P   '\   !_    ?P   'X"  !^
M"   ?@X  'X6  !^'   ?B@  'TW  !]1P  ?E8  'UH  !\>P  >Y   'FF
M  !XP   >.   '?U )>+  "3CP  BI   'V0  !OCP  7XT  $^,   _BP
M+XL  ""*   1B@   XD   ")    B@   (H   "*    B@   (H   ")
MB@4  (H,  "+$P  BQT  (LK  "*/   BTT  (M?  "+<P  BHD  (B@  "'
MN0  AMH  (7Q )>2  ".E   @I4  '25  !DE   5),  $22   SDP  ))(
M !62   %D@   ),   "3    E    )4   "5    E0   )4   "5    E0
M )8!  "6"0  F!$  )D=  "9+@  F4   )M2  "<9@  FWX  )F8  "7L0
MEM   )7L )*8  "&F0  >9H  &F9  !9F0  29D  #>9   GF@  &)L   B;
M    FP   )P   "=    G@   )\   "@    H    *$   "A    H0   *(
M  "C    I04  *<1  "H'P  J#(  *I%  "L6@  K7$  *V)  "MH@  J[X
M *G@ (J<  !]G@  ;9\  %Z?  !.GP  /)\  "NA   ;H@  "J0   "E
MI0   *8   "G    J    *H   "K    K    *T   "M    K0   *X   "P
M    L@   +4#  "X$0  NR$  +PV  "_3   PF0  ,-\  ##E   PZP  ,+$
M ("A  !RHP  8J,  %*D  !!I0  +Z<  !ZI   .JP   *P   "N    KP
M +$   "R    LP   +0   "V    MP   +D   "Z    O    +T   #
MQ    ,H   #.    TA   -,D  #8/   W54  .!M  #AA0  X9P  .&P /\
M  #_    _P   /\   #_  $ _@ 1 /L '@#Y "D ]@ T /( 0 #N $D ZP!1
M .@ 60#F %\ Y !E ., :@#A &\ X !T -X >0#; '\ V "% -0 C0#2 )4
MT0"? -  JP#. +T S0#: ,L ]@#* /\ R0#_ ,$ _P"Z /\ M0#_ /\   #_
M    _P   /X   #V    \0 + .T &0#J "4 Y@ O .( .@#> $0 V@!, -<
M5 #4 %H T@!@ -  90#- &H R@!P ,@ =0#% 'H Q "! ,, AP#" (\ P0"9
M ,  I0"^ +0 O #- +H [ "Y /\ N #_ +4 _P"O /\ J@#_ /\   #_
M^@   /    #H    X@ ( -T % #6 "  T@ K ,\ - #+ #X QP!' ,0 3@#!
M %4 O@!; +L 8 "Y &4 N !J +< ;P"V '4 M0![ +0 @@"S (H L0"3 +
MG@"N *P K #! *L X0"I /L IP#_ *8 _P"A /\ G@#_ /\   #V    [
M .    #8    T  # ,D $ #$ !L P  E +T +P"Z #@ M0!  +( 2 "O $\
MK@!5 *P 6@"K %\ J@!E *D :@"H &\ IP!U *4 ? "D (0 HP"- *$ F "?
M *4 G@"W )L T@"8 /( EP#_ )< _P"5 /\ DP#_ /4   #I    W    -
M  #(    P    +D "P"T !8 L  @ *P *0"I #( I@ Z *0 0@"B $@ H0!.
M )\ 5 "> %D G !> )L 9 ": &D F0!O )< =@"6 'X E "' )( D0"0 )X
MC@"O (P Q@"* .@ B0#_ (@ _P"( /\ AP#_ .L   #;    S0   ,,   "Z
M    L@   *P !@"G !( H@ ; )\ ) "< "P F@ T )< .P"5 $( DP!( )(
M30"0 %, CP!8 (X 70", &, BP!I (D < "( '@ A@"! (0 BP"" )@ @ "H
M '\ O !] -P ? #X 'L _P!Z /\ >P#_ -T   #.    P@   +<   "O
MJ    *$  0"<  L EP 6 ), '@"0 "8 C0 N (L -0") #P AP!! (8 1P"$
M $T @P!2 ($ 5P"  %T ?@!C 'T :@![ '( >0![ '< A@!U )( <P"B '(
MM !P -  ;P#O &X _P!M /\ ;0#_ -(   #$    N    *\   "F    GP
M )@   "2  8 C0 1 (D &@"% "$ @@ H '\ +P!] #8 ?  \ 'H 00!X $<
M=P!, '4 4@!S %< <@!> '  90!N &T ; !V &H @0!H (T 9P"< &4 K@!C
M ,4 8@#E &$ _ !A /\ 8 #_ ,D$  "\"@  L0P  *<*  "?!   EP   )
M  ")    A  * '\ % ![ !P >  D '4 *0!R #  <  V &X / !L $$ :P!'
M &D 3 !G %( 9@!8 &0 8 !B &@ 8 !Q %X ? !< (D 6P"7 %D J !7 +T
M5@#; %4 ]0!5 /\ 50#_ ,(1  "U&   JQH  *(8  "9%   D0P  (D#  "!
M    >P $ '8 #0!Q !8 ;0 > &H )0!G "H 90 Q &, -P!A #P 7P!" %X
M2 !< $T 6@!4 %@ 6P!6 &, 50!M %, > !1 (4 3P"3 $X HP!, +< 2P#3
M $H [@!* /\ 2@#_ +P<  "P(@  IB4  )TD  "4(   BQH  (,3  !["@
M<P   &P !P!G !$ 8P 8 %\ ( != "8 6@ L %@ ,0!7 #< 50 ] %, 0P!2
M $D 4 !/ $X 5P!, %\ 2@!I $D =0!' ($ 10"0 $, H !" +, 00#, $
MZ0!  /H 0 #_ +@D  "L*P  HBX  )DN  "0*@  B"4  '\?  !V%P  ;0T
M &4#  !>  H 60 3 %8 &@!3 "$ 4  G $X + !- #( 2P X $D /@!( $0
M1@!+ $0 4P!" %P 0 !F #X <@ ] '\ .P"- #D G0 X +  -P#( #8 XP U
M /0 -0#^ +0L  "I,@  GS4  )8U  ".,P  A2X  'LH  !R(0  :1D  %\1
M  !7" , 4 $+ $P % !) !L 1P A $4 )P!# "T 00$S #\!.0 ^ D  / -'
M #H#3P X!%D -@5C #0%<  S!7T ,06, "\&G  N!:\ +03& "P%X  K!O(
M*P7] +$S  "F.   G3L  )0\  "+.@  @C4  'DP  !O*0  92(  %L;  !2
M%   20P% $('#0! !A4 /0<< #L((P Y""D -P@O #8)-0 T"3P ,@I$ # +
M3  O"U8 +0QA "L,;@ I#7P )PZ+ "4.G  D#;  (@W( "$.X@ B#O0 (PW_
M *XX  "D/0  FT$  ))!  "*0   @3P  '<W  !M,0  8RH  %DD  !.'0
M118  #L0!P V#1  - X7 #$.'@ P$"0 +A J "P0,0 K$3@ *1)! "@22@ F
M$U0 )1-? ",4;  A%7H 'Q6* !X5FP <%*\ &A3' !H4XP ;%?8 &Q3_ *P\
M  "B0@  F44  )%&  "(10  ?T(  '4]  !K.   83$  %8K  !+)0  01X
M #<9 @ P%0L +!43 "H5&@ H%B  )A8G "06+@ C%S4 (A@^ "$81P ?&5(
M'AE= !P::@ :&GD &1N( !<:F@ 5&JT %!K& !,:X@ 5&O8 %1K_ *I   "A
M1@  F$D  (]*  "'2@  ?D<  '1#  !I/@  7S@  %4R  !)+0  /R<  #0B
M   J'0< )1L/ "(;%@ @&QP 'QPC !X<*P <'3, &QT[ !H>10 9'E  %Q];
M !4?:  4('< $B"' ! @F  .(*P #!_#  P?WP .'_4 $![_ *A%  "?2@
MEDX  (Y/  "%3@  ?4P  '-(  !H0P  73\  %,Z  !(-   /3   #,K   H
M)0, 'R$+ !PA$P :(1H &"$A !<B*  6(C  %2,Y !,C0P 2(TX $"19  XE
M9P ,)74 "B:%  DEE@ '):D !27   8DVP ')/$ "2/_ *=)  "=3@  E5(
M (U3  "%4P  ?%$  ').  !F20  7$4  %)!  !(/0  /3@  #(S   F+@
M&B@) !8G$0 4)Q@ $B@? ! H)@ .*2X #2DV  LI0  **DL ""I7  8K9  %
M*W,  RR#  $KE   *Z<  "J]   JV   *>T  BG\ *5-  "<4@  E%8  (Q7
M  "$6   >U8  '%3  !E3P  7$P  %))  !(10  /$   "\Z   B-0  %C %
M  XN#0 ,+A8 "B\=  @O)  ',"P !3 T  0P/@ ",$D  3%5   Q8@  ,G$
M #*    QD@  ,:4  #"[   PUP  +^P  "[X *-2  ":5P  DEH  (M<  "#
M70  >EP  '!:  !E5@  6U,  %)0  !&3   .$8  "M!   >/0  $C@#  @U
M"P $-A0  C8;   W(@  -RH  #<R   W/   -T<  #=3   W8   .&X  #A^
M   XD   -Z,  #:Y   UU0  -.P  #3X *%7  "97   D6   (IB  ""8P
M>F(  '!@  !E70  7%L  %!7  !"4@  -$T  "=(   91   #4$"  ,^"@
M/A(  #X8   ^'P  /R<  #\P   _.0  /D0  #Y0   ^70  /VP  #]\   ^
MC@  /:$  #RW   [TP  .^T  #KX )]<  "78@  D&4  (EH  "":0  >6D
M '!G  !E90  66$  $M=   ]6   +U0  "%0   53   "$D   !("   1P\
M $<6  !''0  1R0  $<L  !&-@  1D(  $9.  !&6P  1FD  $9Y  !&BP
M19\  $.T  !"T0  0>P  $#Z )UC  "6:   CVP  (AN  "!<   >7   '!O
M  !B:P  5&<  $9C   W7P  *5L  !M8   .50   U,   !2!@  40P  %$3
M  !0&@  4"$  $\I  !/,P  3SX  $]+  !.6   3F8  $YV  !.B   39P
M $NR  !)SP  2.L  $?[ )MI  "4;P  CG(  (AU  "!=P  >G<  &QT  !=
M<   3FT  #]I   Q9@  (F,  !5A   (7@   %T   !< P  6PD  %L0  !:
M%@  61T  %DD  !9+@  6#H  %A&  !85   5V,  %=S  !6A0  59D  %2O
M  !2RP  4.H  $_[ )EQ  "3=@  C7H  (=\  "!?@  =7P  &9Y  !7=@
M1W,  #AP   I;0  &VL   UI   !:    &<   !F    9@4  &4*  !D$0
M9!@  &,?  !C*   8S0  &)!  !B3P  85X  &!O  !@@0  7I4  %VK  !<
MQ@  6^8  %GZ )=Y  "2?@  C8$  (B$  !]@P  ;X$  %]^  !/?   /WD
M "]W   A=0  $W,   5R    <@   '$   !Q    <    ' %  !O"@  ;Q$
M &X8  !N'P  ;BP  &TZ  !M20  ;5@  &QI  !J?   :9   &BF  !GP
M9N$  &7W ):!  "2A@  C8D  (.)  !VB   9H8  %:$  !&@@  -8   "9_
M   8?0  "7P   ![    >P   'P   ![    >P   'L   !Z!   >@H  'H1
M  !Z%P  >B(  'DQ  !Y00  >5$  'EB  !X=0  =HH  '6@  !SN0  <ML
M ''S ):)  "2C@  B(X  'N.  !MC0  78L  $V*   \B0  +(@  !R'   -
MA@   (8   "%    A@   (8   "&    A@   (8   "%    A0$  (4'  "&
M#@  AQ<  (8E  "%-P  AD<  (99  "&;0  A8,  (2:  ""LP  @=(  (#O
M ):1  "-DP  @),  '*3  !BD@  4I   $&0   PD   ()   !&/   "CP
M (\   "/    D    )$   "1    D0   )$   "1    D0   )$   "2!
ME H  )47  "5)P  E#L  )9-  "780  E7D  )22  "3JP  D<@  )#H )"6
M  "$EP  =I@  &>7  !7E@  1I8  #27   DF   %)@   28    F    )D
M  "9    F@   )L   "<    G0   )T   "=    G0   )X   "?    H
M *,*  "D&   I"P  *5   "H5   J6L  *F#  "GGP  I;X  */= (B;  ![
MG   :YP  %N<  !+G   .9T  "B>   8GP  !Z    "A    H@   *,   "C
M    I0   *8   "G    J    *D   "I    J0   *H   "K    K0   +$
M  "S"@  MAL  +8P  "Y1@  O5X  +YV  "^CP  OJ@  +[" 'Z?  !OH0
M8*$  %"B   ^HP  +*0  !NG   *J    *D   "J    K    *T   "N
MKP   +$   "R    M    +4   "V    N    +@   "[    O0   ,$   #&
M    R@L  ,T>  #1-@  UD\  -MH  #<@   W)@  -RN /\   #_    _P
M /\   #_    ^P , /@ &@#U "4 \0 P .T / #I $4 Y@!- .0 50#A %L
MWP!A -T 9@#; &L V !Q -0 =@#1 'P T "" ,X B0#- )$ S "; ,L IP#*
M +< R #2 ,8 \0#% /\ Q #_ +T _P"U /\ L0#_ /\   #_    _P   /D
M  #S    [0 ' .D %0#D "$ X  K -T -@#8 $  U !( -$ 3P#. %8 R@!<
M ,< 8@#$ &< P@!L ,$ <0#  '8 OP!\ +X @P"] (L O "5 +H H "Y *X
MMP#% +8 YP"T /\ LP#_ *\ _P"H /\ I #_ /\   #_    ]0   .L   #D
M    W0 % -4 $0#0 !P S  G ,D , #% #H P0!" +P 2@"Y %  MP!6 +4
M7 "T &$ LP!F +( :P"Q '$ L !W *\ ?@"N (4 K "/ *L F@"I *< J "Z
M *8 V0"C /< H0#_ *  _P"< /\ F0#_ /P   #R    Y0   -L   #2
MR@   ,, # "^ !< N@ A +< *P"S #, KP \ *T 0P"K $H J0!0 *@ 50"F
M %L I0!@ *0 90"C &L H@!Q *  > "? '\ G@"( )P DP": *  F "P )4
MRP"3 .X D@#_ )( _P"0 /\ C@#_ /    #B    U0   ,L   #"    N@
M +0 " "O !, J@ < *8 )0"D "T H@ U )\ /0"= $0 G !* )H 3P"9 %0
MEP!9 )8 7P"5 &4 DP!K )( <@"1 'D CP"" (P C0"* )D B0"I (< P "%
M .( A #] (, _P"# /\ @0#_ .0   #4    QP   +T   "T    K0   *<
M @"A  T G0 7 )H ( "7 "@ E  O )( -@"0 #T C@!# (T 20"+ $X B@!3
M (D 6 "' %X A@!E (0 :P"" ', @0!\ '\ AP!] ), >P"B 'D MP!X -4
M=@#U '4 _P!U /\ =0#_ -8   #)    O0   +(   "J    HP   )P   "7
M  @ D@ 3 (X &P"+ "( B  I (8 , "$ #< @@ ] (  0@!_ $@ ?0!- 'P
M4@!Z %@ >0!> '< 9@!U &T <P!W '$ @0!P (X ;@"= &P KP!J ,D :0#K
M &@ _P!G /\ 9P#_ ,P   "_    LP   *H   "A    F@   ),   "-  ,
MB  , (0 %@"  !X ?0 D 'H *@!X #$ =@ W '0 /0!S $( <0!' &\ 30!N
M %( ; !9 &H 8 !H &@ 9@!Q &0 ? !B (D 80"7 %\ J0!= ,  7 #@ %L
M^0!: /\ 6@#_ ,0"  "W"   K D  *,'  ": 0  D@   (L   "$    ?P '
M 'H $0!V !D <@ @ &\ )0!L "L :@ R &@ -P!G #T 90!" &, 2 !B $T
M8 !4 %X 6P!< &, 6@!L %@ =P!6 (0 50"2 %, HP!1 +@ 4 #5 $\ \@!.
M /\ 3@#_ +T0  "Q%@  IQ<  )T5  "5$0  C D  (0!  !]    =@ ! '$
M"@!L !, :  : &0 (0!A "8 7P L %T ,@!; #@ 6@ ] %@ 0P!6 $D 5 !/
M %( 5@!1 %X 3P!G $T <P!+ '\ 20". $< G@!& +$ 1 #+ $0 ZP!# /T
M0P#_ +<:  "L(   HB(  )DA  "0'0  AQ<  '\0  !W!P  ;@   &@ !0!B
M  T 7@ 5 %H &P!7 "( 5  G %( + !1 #( 3P X $T /@!, $0 2@!* $@
M4@!& %H 1 !D $( ;P!  'P /P"* #T F@ [ *T .@#% #D XP Y /@ .0#_
M +,C  "H*0  GRL  )8K  "-)P  A"$  'L<  !R%   :0H  &    !9  <
M5  / %  %@!- !P 2@ B $@ * !& "T 10 S $, .0!! #\ /P!& #T 30 [
M %8 .0!@ #< ;  V 'D -0"( #, F  Q *D ,0#  #  W0 P /, +P#_ *\K
M  "E,   G#,  ),S  "*,   @2L  '<E  !N'@  91<  %L.  !3!0  3  (
M $< $ !$ !< 00 = #X (P ] "D .P N #D -  W #L -0!" #, 2@ Q %,
M+P!> "X :@ L '< *P"% "D E@ G *@ )@"] "8 V0 E .X ) #Z *TQ  "C
M-P  F3D  )$Y  "(-P  ?S,  '4M  !L)@  8B   %<9  !.$0  10H" #X$
M"0 Z 1( -P 8 #4!'@ S 20 ,0(J "\",  N S< + ,^ "H$1P H!5  )@5;
M "0&9P C!W4 (0>$ !\(E0 =!Z< ' :] !H&U@ 9!^P &0CY *HW  "A/
MES\  (\_  "&/0  ?3H  ',T  !I+@  7R@  %4A  !+&@  010  #@-!  P
M" H +0<2 "L(&0 I"1\ )PDE "4)*P D"C, (@H[ " +1  ?#$X '0Q9 !L-
M9@ 9#G0 %PZ$ !4.E0 4#J@ $@V^ !$-V0 2#NX $PW[ *@[  "?0   ED,
M (U$  "%0@  ?$   '(Z  !H-0  7B\  %,I  !((P  /AP  #07   K$@4
M)! , "$/%  ?#QH 'A @ !P0*  ;$2\ &A$X !@200 7$TP %1-7 !,49  1
M%'( $!6"  T5DP +%:8 "16\  D4U@ *%.\ #!3] *8_  "=1   E$<  (Q(
M  "$1P  >T4  '%   !F.P  7#8  %(P  !'*P  /"4  #(@   I&P  'Q<(
M !H5$  8%18 %Q8= !46)0 4%RP $Q<U !(8/P 0&$D #1E5  L:8@ )&W
M"!N   8;D0 %&Z0  QJY  ,:TP $&>H !AG[ *5#  ";2   DTL  (M,  ""
M3   >4H  '!&  !E00  6SP  % W  !&,@  .RX  #$I   G)   '1\% !0;
M#  2&Q0 $!P;  X<(@ ,'2H "QXS  H>/0 ('T< !Q]3  4@8  #(&X  2%^
M   @CP  (*(  !^W   ?T0  '^D  ![W *-'  ":30  DE   (I1  ""4
M>$\  &],  !D1P  6D,  % _  !&.P  .S8  #$R   E+   &28"  XB"@ *
M(A( "",9  <C(  %)"@ !"0Q  (E.P !)44  "51   E7@  )FP  "=\   G
MC0  )J   "6U   DT   (^@  "/V *%,  "840  D50  (E5  "!5@  >%0
M &Y1  !C30  64H  %!'  !&0P  /#\  "XY   A,P  %2X   HJ"0 $*1
M 2H8   J'P  *R8  "LO   L.   *T,  "M/   L7   +&H  "UZ   LBP
M+)X  "NS   JS@  *>@  "CV )]0  "750  CU@  (A:  " 6P  =UH  &Y7
M  !B5   65$  %!.  !%2@  -T4  "H_   <.@  $38   4R"   ,@X  #(6
M   R'   ,B0  #(M   S-@  ,D$  #)-   R6@  ,V@  #-X   SB@  ,IT
M #&Q   PS   +^@  "[W )U5  "56P  CEX  (=@  !_8   =V   &U>  !C
M6P  6ED  $Y5  ! 4   ,DL  "5&   70@  "SX    [!P  .@T  #H4   Z
M&@  .B(  #HJ   Z,P  .CX  #E*   Y5P  .F8  #IV   ZB   .9L  #>P
M   VRP  ->@  #7X )Q;  "48   C60  (9F  !_9P  =V8  &UE  !C8P
M5U\  $E:   [5@  +5(  !]-   220  !D8   !$!@  0PL  $,2  !#&
M0A\  $(G  !",   0CP  $%(  !!50  06,  $%S  !!A0  0)D  #ZN   ]
MR0  /.<  #OY )IA  "39@  C&H  (9L  !_;@  =VX  &YL  !@:   4F4
M $1@   U7   )UD  !E5   ,4@   $\   !. P  30D  $P/  !,%0  2QP
M $LD  !*+0  2C@  $I%  !)4@  26   $EQ  !)@P  2)8  $>L  !%QP
M0^<  $+Y )AH  "2;0  C'$  (9S  !_=0  >'4  &IR  !;;@  3&H  #UF
M   N8P  (&   !)=   %6P   %D   !8    5P4  %8+  !6$0  51@  %0?
M  !4*   5#0  %-!  !33@  4ET  %)M  !1?P  49,  %"J  !-Q0  3.4
M $KY )9P  "1=   BW@  (5[  !_?   <WH  &1W  !4<P  17   #5M   G
M:@  &&@   EF    9    &,   !B    8@$  &$'  !@#   8!,  %\:  !>
M(@  7BX  %X[  !=20  75@  %QI  !;>P  6H\  %FE  !8P   5N(  %3X
M )5W  "0?   BX   (:"  ![@0  ;'\  %U\  !->0  /'<  "UT   ><@
M$'    %O    ;@   &X   !M    ;    &P!  !K!@  :@P  &H4  !J&@
M:28  &DT  !H0P  :%,  &=D  !F=@  98H  &2@  !BN@  8=P  &#U )2
M  "0A   BX@  (&(  !SA@  9(,  %2!  !$?P  ,GT  "-\   4>@  !7D
M  !X    >    '@   !X    =P   '<   !V    =@4  '4+  !U$P  =AP
M '4J  !T.P  =$L  '1<  !S<   <H0  '";  !NM   ;=0  &WQ )2(  "0
MC   AHT  'F,  !JB@  6HD  $J'   YA@  *84  !F$   )@P   ((   ""
M    @@   (,   "#    @@   ((   "!    @0   ($#  "!"@  @A$  ((?
M  "!,   @4(  ()3  ""9P  @'T  '^4  !]K0  ?,L  'OK )20  "+D0
M?I$  '"0  !@CP  3XX  #Z-   MC0  '8T   V,    C    (P   ",
MC0   (T   ".    C@   (X   ".    C0   (T   ".    D 4  ) 1  "0
M(0  CS8  )!)  "170  D7,  )"+  ".I0  C<$  (SD (Z5  ""E@  =)8
M &65  !4E   0Y0  #*4   AE0  $)4   "5    E0   )4   "6    EP
M )@   "9    F0   )D   "9    F0   )H   ";    G    )\$  "@$@
MH"4  *$Z  "C3P  I64  *.   "AFP  H+<  )_8 (:9  !XF@  :9H  %F:
M  !(F@  -IH  "6<   4G    YT   ">    G@   )\   "@    H0   *(
M  "D    I    *4   "E    I@   *8   "G    J0   *T   "O!   L14
M +$J  "T00  N%@  +EP  "YB0  N:,  +C" 'R>  !MGP  7I\  $Z?   [
MH   *:(  !>D   &I0   *8   "G    J0   *H   "K    K    *X   "O
M    L    +$   "R    LP   +,   "U    MP   +H   #     Q 4  ,@9
M  #*,   STD  -5B  #6>P  UI,  -:K /\   #_    _P   /\   #\
M^  ( /4 %@#P "( [0 L .D -P#E $$ X0!) -X 40#< %< V != -, 8P#1
M &@ S@!M ,P <@#, '@ R@!^ ,D A0#( (T QP"7 ,8 H@#$ +$ PP#) ,$
M[ #  /\ OP#_ +D _P"Q /\ JP#_ /\   #_    _@   /4   #O    Z0 $
M ., $@#> !X VP G -8 ,0#2 #L S@!$ ,D 2P#% %( P@!8 ,  70"^ &(
MO0!G +P ;0"[ '( N@!X +D ?P"X (< MP"0 +4 G "T *H L@"] +$ X "O
M /T K0#_ *D _P"C /\ GP#_ /\   #[    [P   .8   #?    U@ " ,\
M# #* !@ Q@ C ,, *P"^ #4 N0 ^ +8 10"T $P L@!2 +$ 5P"O %P K@!A
M *T 9P"L &P JP!R *H >0"H ($ IP"* *8 E0"D *( HP"S *  T0"= /,
MG #_ )P _P"7 /\ E #_ /@   #L    WP   -4   #,    Q    +T "0"X
M !, M  = +  )@"M "X J@ W *@ /P"F $4 I !+ *, 40"B %8 H !; )\
M80"> &8 G0!L )L <P": 'L F "$ )< C@"4 )L D@"K )  Q ". .D C0#_
M (P _P"+ /\ B #_ .L   #;    SP   ,4   "\    M0   *X ! "I !
MI0 8 *( (0"? "D G0 Q )H . "8 #\ EP!% )4 2@"4 %  D@!5 )$ 6@"0
M &  C@!F (T ;0"+ '4 B0!^ (< B "% )4 A "D (( N0"  -P ?P#Z 'X
M_P!] /\ ? #_ -X   #/    P@   +@   "P    J0   *(   "=  H F  4
M )4 &P"2 ", CP K (T ,@"+ #@ B0 ^ (@ 1 "& $D A0!. (0 5 "" %D
M@ !@ '\ 9P!] &\ ? !X 'H @@!X (\ =@"> '0 L0!R ,\ <0#R '  _P!O
M /\ ;P#_ -$   ##    N    *T   "E    G@   )@   "2  4 C0 . (D
M& "& !X @P E ($ *P!_ #( ?0 X 'L /0!Z $, > !( '< 3@!U %, <P!:
M '$ 80!P &D ;@!R &P ?0!J (D : "8 &8 J@!D ,, 8P#G &( _P!A /\
M80#_ ,<   "Z    KP   *8   "=    E0   (X   "(    @P ) '\ $@![
M !H >  ? '4 )@!R "P <  R &\ . !M #T :P!" &H 2 !H $X 9@!4 &0
M6P!B &, 8 !L %X =P!= (0 6P"2 %D I !7 +H 5@#; %4 ]P!4 /\ 5 #_
M +\!  "R!@  J 8  )\$  "6    C@   (8   "     >@ $ '4 # !Q !4
M;0 < &D (0!G "< 9  M &, ,P!A #@ 7P ^ %X 0P!< $D 6@!/ %@ 5@!6
M %X 5 !G %( <@!0 '\ 3P"- $T G@!+ +( 20#/ $@ [P!( /\ 2 #_ +@.
M  "L%   HQ4  )D3  "0#0  B 8  (    !X    <0   &L !P!G  \ 8@ 6
M %\ '0!< ", 60 G %< +0!6 #, 5  X %( /@!0 $0 3P!* $T 40!+ %D
M20!B $< ;0!% 'H 0P") $$ F0!  *P /@#& #T Y@ ] /P /0#_ +,9  "H
M'@  GB   )4>  ",&@  @Q0  'L-  !R!   :@   &,  @!=  H 6  1 %4
M%P!1 !T 3@ C $T * !+ "T 20 S $< . !& #\ 1 !% $( 30!  %4 /0!>
M #L :@ Z '< . "% #8 E0 U *@ ,P"^ #, WP R /8 ,@#_ *XB  "D)P
MFRD  )(H  "))   @!X  '<9  !N$0  90@  %P   !5  4 4  + $L $@!(
M !@ 1  = $( (P!  "@ /P M #T ,P [ #H .0!! #< 2  U %$ ,P!; #$
M9@ O '0 +@"" "T D@ K *0 *@"Y "H U@ I /  *0#_ *LI  "A+@  F#$
M (\P  "&+0  ?2@  '0A  !J'   810  %<+  !/ P  1P & $, #  ^ !,
M.P 9 #@ '@ V "0 -0 I #, +P Q #4 +P ] "T 1  K $X *0!8 "< 9  F
M '$ ) "  "( D  A *( 'P"V !\ T0 ? .P 'P#Z *DP  "?-0  EC<  (TW
M  "$-   >S   '(J  !H)   7AT  %07  !*#@  00@  #H!!P U  T ,@ 4
M "\ &0 M !\ *P E "D *P G #$ )0 Y ", 00 A $L 'P!5 !X 8@ < &\
M&@%^ !@!C@ 7 :  %@"T !4 S@ 4 .@ $P#W *8U  "=.@  E#P  (P\  "#
M.P  >C<  ' Q  !F*P  7"8  %(?  !'&   /A(  #0+ 0 L!@@ * ,. "4"
M%  C AH (0,@ !\#)@ =!"T ' 0U !H%/@ 8!4@ %P93 !0'7P 3!VT $0A]
M  X(C0 -!Z  "P>T  H&S  )!^4 "0?T *0Y  ";/@  DT$  (I!  ""0
M>#T  &XX  !E,@  6RP  % G  !%(0  .QL  #(6   I$0( ( P( !L)#@ 9
M"!4 %PD; !8)(@ 4"BH $PHR !$+.P /#$8 # U1  H.7@ (#VP !Q![  40
MC  $$)\  Q"S  $.RP !#>0  @WV *,]  "90@  D44  (E&  "!10  =T,
M &T^  !C.0  630  $\N  !$*0  .B0  # ?   G&@  '18# !01"  .#@X
M#1 7  P1'P +$2< "1(O  @3.0 '%$, !11/  ,57  !%FH  !9Y   6B@
M%IP  !6Q   5R0  %.,  !/S *%"  "81P  D$D  (A*  !_20  =D@  &U$
M  !B/P  6#H  $XU  !$,   .2P  # H   G(P  '1\  !$9!@ )%@T !A<5
M  48'0 #&"4  ADM  $:-P  &D$  !I-   ;6@  &V@  !QX   <B0  &YL
M !NO   :R   &>(  !CS )]&  "72P  CTT  (=/  !_3@  =DT  &Q)  !A
M10  5T$  $X]  !$.0  .C4  #$Q   E+   &24   P@!@ $'@P  !X4   >
M&P  'R,  !\K   @-0  ($   "!+   @6   (68  "%V   BAP  (9H  !^N
M   >Q@  'N,  !WS )Y*  "53P  CE(  (93  !^4P  =5(  &M/  !@2P
M5T@  $Y%  !%00  .ST  "TW   @,@  %"P   @G!@  )@P  "43   F&0
M)B$  "8I   G,@  )ST  "9)   G5@  )V0  "=T   HA0  )Y@  "6L   D
MQ0  (^,  "/U )Q/  "45   C58  (58  !]60  =5@  &M5  !@4@  5T\
M $]-  !$2   -D,  "D]   ;.   #C,   ,O!0  +@L  "T1   M%P  +1\
M "XG   N,   +CL  "U'   M5   +F(  "YR   NA   +9<  "RK   JQ
M*>(  "GV )I4  "360  C%P  (1>  !]7@  =%X  &M<  !@60  6%<  $U3
M   _3@  ,4D  "-$   6/P  "3L    X!0  -@H  #80   U%0  -1T  #4E
M   V+0  -3D  #5%   T4@  -&   #5P   U@@  -)4  #*J   QPP  ,.(
M "_V )A:  "27@  BV(  (1D  !]90  =60  &MC  !A80  55T  $A8   Y
M4P  *T\  !U+   01@  !$,   !  P  /P@  #\-   ^$P  /1H  #TB   ]
M*@  /38  #Q"   \3P  /%T  #QN   \@   /),  #JI   XP@  -^(  #;V
M )=@  "090  BF@  (-J  !];   =6P  &QK  !>9@  4&(  $)>   S6@
M)58  !=2   )3@   $P   !*    204  $@*  !($0  1Q<  $8>  !&)P
M13(  $4_  !%3   1%L  $1K  !$?0  1)$  $*G  ! P0  /N$  #WW )5G
M  "/;   B6\  (-Q  !]<P  =G,  &AP  !9;   2F@  #MD   L8   '5T
M  Y:   #6    %4   !4    4P(  %('  !2#   41,  % 9  !/(@  3RX
M $\[  !.20  3E<  $UH  !->@  38X  $ND  !*O@  1^   $7W )1N  "/
M<P  B78  (-Y  !]>@  <7@  &)U  !2<0  0FX  #-J   D9P  %F4   9C
M    80   &    !?    7@   %T#  !<"   6PT  %H5  !:'0  62@  %DU
M  !81   6%,  %=D  !6=@  5HH  %6@  !3N@  4=X  %#W )-V  ".>P
MB7X  (2!  !Y?P  :GP  %IY  !*=P  .70  "IQ   ;;P  #&T   !L
M:P   &H   !I    :0   &@   !G @  9@@  &8.  !E%@  92   &0N  !D
M/0  8TT  &->  !A<0  8(4  %^;  !>M   7=<  %OT ))_  ".@P  BH8
M '^&  !QA   8H$  %)_  !!?0  ,'H  "!Y   1=P   G8   !U    =0
M '0   !T    <P   ',   !R    <@$  '$'  !Q#@  <18  '$D  !P-0
M<$4  &]7  !O:@  ;7\  &N5  !JK@  :<X  &CO )*'  ".BP  A8L  '>*
M  !HB   6(8  $>%   V@P  )8(  !:!   &?P   '\   !^    ?P   '\
M  !_    ?P   'X   !^    ?0   'T   !]!0  ?@H  'X8  !]*0  ?3P
M 'U.  !]80  ?'<  'J.  !YIP  =\0  ';H )*/  ")D   ?)   &Z.  !=
MC0  38P  #N+   JBP  &HH   F)    B    (@   ")    B0   (H   "*
M    B@   (H   "*    B0   (H   "*    BP$  (P*  ",&P  BC$  (M$
M  ",5P  C6T  (N&  "*GP  B+L  (?> (V4  " E   <I0  &*3  !2D@
M09(  "^2   >D@  #)(   "2    D@   )(   "3    E    )4   "5
ME@   )8   "6    E0   )8   "7    F    )H   "<"P  G!\  )PU  ">
M2@  GV$  )Y[  "=E0  F[   )K2 (28  !VF   9Y@  %>8  !&EP  ,Y@
M "&9   1F@   )H   ";    FP   )P   "=    G@   )\   "@    H0
M *$   "B    H@   *(   "C    I0   *@   "K    K0X  *PE  "O.P
MLE(  +5J  "UA   LJ(  +#" 'J<  !KG0  6YT  $N=   YG@  )I\  !2A
M   "H@   *,   "D    I0   *8   "G    J0   *H   "L    K0   *T
M  "N    KP   *X   "P    L@   +4   "[    OP   ,(3  #$*P  R40
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M____________________________________________
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M^_S]_O]M9G0Q      ,!(0   0                    $
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M________?0          'I;____________________________L-@
M    !XC___________________________^V             'K_________
M__________________]=(            &;]________________________
M__^^<S           $WM____________________________X:%>*@4
M "[9_______________________________-E6=33EYUD*W5____________
M______________________KK[?O_________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_________________________________^[5Q+>KRO__________________
M_______________DH6]10#(C8.7______________________________]>+
M1@H     -[7_____________________________]I1'        %X______
M________________________OU\)         ''O____________________
M________DRD          %G8___________________________N:
M     $7$___________________________")            #&S________
M__________________^0             !NA________________________
M__\]              20_________________________^$
M  "!_________________________U\               !K____________
M_____________R(#              !1_O______________________JYYK
M*P             SY__________________________YOW(W$@        $6
MS/____________________________6[C&M95%UK>8B5VO______________
M___________________Z^?______________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M______#ATO'________________________________ILH]V9%5$,WC_____
M_________________________\5Z.Q$      $+/____________________
M________S'0G         !BA___________________________VB34
M      *%__________________________^_5             !N_O______
M__________________^2'             !9Z_______________________
M__AF              !'VO_______________________]8B
M   TR?_______________________Z\                ?N/__________
M_____________U4                (I?_______________________P
M                D_______________________E@
M@/______________________                    8_______________
M_______)                    0O______________________'T8J!0
M            +>______________________]/_=HF,Y&0       0X<+N?_
M___________________________1JXQ_?H:1G:JXQ?__________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________Z,NTH(]^;6+)_____________________________\2$5#0<
M!0    R3____________________________LV 7          !D^O______
M___________________*9A$            YR_______________________
M__^()P             1HO_______________________\I/
M    ?________________________Y<8                7___________
M_____________V,                 4/G_____________________X2,
M                0.O_____________________J0
M+=O_____________________5                   %\G_____________
M________                     +7___________________^@
M             )_____________________0                     (/_
M____________________                     'K_________________
M____*0                   ''_____________________@ D.
M         &O_____________________]\R_GG=7/288%!LD+SM'5'/_____
M________________________[=3,S-+;Y.WY________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________^N;4P:W!________
M_____________________^>TD'-;13$;!@!E^?______________________
M____KF(G           UR?________________________^M4
M   &F________________________])A @              </__________
M_____________XPB                1^W_____________________X$\
M                (<K_____________________J!D
M *K_____________________;                    (O_____________
M________)@                   &S____________________&
M             $[___________________^)                     #+_
M__________________^J                     "#R________________
M___4                     !?G____________________
M         !7C____________________)P                   !'<____
M________________:0                    O2____________________
MQ@                    ;+_____________________SP)!@
M      '(_____________________^S3OZB->&EA8&=P>H2/FJ78________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________YLJRG(=T
M7T=!T/__________________________RHI;.!L        $F___________
M______________^F3@0             :O_______________________[-+
M                /.3_____________________YF(
M$+G_____________________GB,                  )#_____________
M________7                    &S____________________E'P
M             $G___________________^?                     ";Q
M__________________]Z                      31________________
M__^5                      "S__________________^U
M          "7___________________:                      ""____
M________________                      !X____________________
M+0                    !V____________________9@
M      !S____________________J0                    !O________
M_____________QP                   !J_____________________X4
M                  !E______________________\Z)24;#0$    '$!DC
M+3==___________________________LV<O&R=#:X^KS_?______________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__________________________?BS;>@PO__________________________
M_]BOC7!6/R@0    <?________________________^\;3(%
M.^/______________________ZA&                "+'_____________
M________SDT                  (/_____________________>
M             %?____________________F+                    "[S
M__________________^3                      G0________________
M__]M                      "M__________________^)
M          "+__________________^H                      !I____
M_______________&                      !)___________________G
M                       M____________________"@
M       ;____________________-0                     4^_______
M____________9P                     3]?__________________H0
M                   3]?__________________Y0P
M   ,[____________________UT                    $Z?__________
M_________\8$                    X?____________________^&
M                U/______________________CW!K8U]<7V5O>(")D9JD
MU/__________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________]=B^IY%[94TS1?'_____________
M___________YL'U3,1(         #;G______________________[U>$P
M             (3_____________________RDD                  %'_
M____________________8                    "#B________________
M__^W#0                    "V__________________]?
M          "/__________________]U                      !I____
M______________^7                      !&__________________^U
M                       C___________________3
M        [?_________________R                        S/______
M____________&P                      L?__________________0@
M                    GO__________________;0
M    E?__________________G@                      D?__________
M________VP4                     D/___________________TH
M                CO___________________YP
MA_____________________]#                    >_______________
M_______''0                  :/______________________R28
M   ##!0<)"TU4?_________________________Y]_'M[?#U^___________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______WX<FQE\___________________________^&UDG1902H2     (K_
M______________________^>5R(              %3_________________
M____X%\$                 ![@____________________70
M          "M__________________^;                      !]____
M______________]1                      !2__________________]Z
M                       I__________________^B
M       #Z/_________________$                        Q?______
M___________C                        H___________________"0
M                    @?__________________*@
M    8O__________________3P                      2/__________
M________>                       ./__________________I@
M                ,/__________________V@4
M+?___________________T                      +/______________
M_____X<                     *____________________]@B
M            '_____________________^"                    #?__
M____________________5@                   /__________________
M_____V4                  -________________________^X9FEM<GB!
MB(V4GZ6MM=C_________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________^K/MI^';U4[(5;_________________________N(%4+Q
M         "#D_____________________YY"                  "N____
M________________> ,                   !Y__________________^8
M                      !'__________________]%
M       6]O________________]Y                        S/______
M__________^G                        I/_________________/
M                    ?O_________________S
M    6O__________________(                       -___________
M________00                      %?__________________8P
M                 /__________________A@
M .__________________K@                       -W_____________
M____W@T                      -/__________________T(
M             ,W__________________WX                      ,K_
M_________________\(-                     ,?_________________
M__]@                     +_____________________ )0
M         *S_____________________FQ$                  (______
M_________________Z8F                 &7_____________________
M___]?!0    "#!0<)BTS/$W_____________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________________________________DR:W_____
M______________________'$GGU@12L2      "N____________________
M__F84AT               !V____________________N#D
M      !"__________________^R$0                     /[?______
M__________\Z                        N_________________]T
M                    C?________________^H
M    8O_________________6                        .O__________
M________#                       $___________________,@
M                 /C_________________5P
M -?_________________>@                       +?_____________
M____G0                       )O_________________P@
M             (;_________________ZA@                      ';_
M_________________T<                      &W_________________
M_WX                      &C__________________[P&
M         &3___________________],                     %______
M______________^= 0                   %7_____________________
M8P                   #S_____________________WTX
M     !?______________________^UC                  #_________
M________________P5,   ,3'RP\4FR'J=3_________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_________________________________\25;UI024$Z,BHA%PXT________
M_____________X\O                   "Y?_________________U1
M                    L?________________\U
M    ?_________________]I                        4/__________
M______^H                        (O_________________<
M                 /K_________________%@
M -+_________________0@                       *W_____________
M____:@                       (G_________________CP
M             &?_________________LP                       $G_
M________________V 8                      ##_________________
M_RT                      !S__________________U<
M          ___________________X4                       ;_____
M_____________[D$                      #___________________A#
M                      #___________________^+
M      #____________________;/P                    #_________
M____________H!@                   #Y_____________________XX5
M                  #2______________________^O.@
M$C2__________________________YA=<7^/H;+$V?3_________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________________________________PY-G2R\;!O;>R
MJZ:G\/__________________^YEO43DG& H             :O__________
M______^,(0                      ._________________]2
M                #?________________^A
M .'________________@                         +;_____________
M____'0                       (O_________________3P
M             &/_________________>@                       #W_
M________________HP                       !G_________________
MR0                        #_________________[QT
M          #__________________T(                       #W____
M_____________VH                       #D_________________Y4
M                      #6_________________\,-
M      #,__________________A"                      #%________
M__________]_                      "____________________'*P
M                  "U____________________?0
M  "B____________________X5(                   "!____________
M_________]13                  !._______________________V?QP
M  D8)S='7'.+J,[__________________________^[2YO3_____________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M______________________________________W6NJ21AGUU;FAB75=234A%
M1__________________%?THA"                    ,/_____________
M__^/                         )C________________=
M             &[_________________'                        $3_
M________________5P                       !O_________________
MB0                        #_________________M0
M          #Z________________W@P                       #9____
M_____________S,                       "Z_________________UD
M                      "@_________________W\
M      ")_________________Z<                       !W________
M_________]$;                      !K__________________]*
M                  !B__________________^
M  !;__________________^\'P                    !3____________
M________9@                    !&____________________NC(
M               K_____________________Y4<
M______________________^8*@            LA.5A[________________
M________R6)=;'N*FZ["V//_____________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________________________________________\\.CA
MV];0S,C&P\/"Q>__________________V:6#:U=&."\G(!H3#08      $?_
M_______________4/P\                      ![_________________
M$@                        #_________________5
M          #X________________DP                        #2____
M____________QP                        "L________________\Q\
M                      "(_________________TD
M      !G_________________W                        !*________
M_________Y<                        P_________________[P%
M                   :_________________^,L
M   +__________________]7                        ____________
M______^&                        __________________^](
M                ___________________X70
M____________________H!D                     ________________
M____^6P                     _____________________]E;
M           :ZO_____________________A:@D #1DF-D=;<(BCP>7_____
M_____________________\C'VNKY________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________________________________?QK:GFY")A'YY
M='!L:VIL;WC_________________E&1"*!4$                  #/____
M____________30                        "G________________EP
M                      "!________________U
M      !<_________________RT                        X________
M_________UL                        5_________________X8
M                    _________________ZX
M    _________________]0>                        ____________
M______I$                        __________________]J
M                ^/________________^4
M[/_________________#)0                      X_______________
M___Y7                       V/__________________F1(
M            RO__________________WU<                     L___
M_________________ZDS                    B?__________________
M__^?,          ,(3A0;(RNXO______________________M5MG=X>5I;C-
MY/[_________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____^.WEXM_<VMC6U=;:X^O_________________[;J9?VYA5DU%/SHU,2PH
M)B4E)RE>________________G3 .                       I________
M________W                          &_________________S4
M                    _________________VH
M    _________________YD                         _/__________
M_____\,,                        X/_______________^PU
M                Q/________________]=
MK/________________^#                        F/______________
M__^J"P                      BO_________________3-0
M            ?___________________8P                      =/__
M________________F!$                     9O__________________
MU$\                     4?___________________Y4@
M        +O____________________!S"@             2*TAFD?______
M_______________D< \:*CE(6&A[DJS(Y___________________________
M_<'-WO#_____________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________________________________________KUL:Z
MKZ>AFY:3CXN)AXF-EJ&N________________]X%B2SDK'Q4.!P$
M    _________________S<                         Y?__________
M_____W<                         P________________ZP
M                I/_______________]HA
MA_________________],                        :O______________
M__]U                        4/________________^<
M            ./_________________#)                       )___
M_______________J2P                      &O__________________
M=0                      #O__________________HQH
M         /__________________U4\                      /______
M_____________XL7                     /___________________]9=
M                 !@S5_____________________^Y2      +&BL^5&Z*
MJ<KP________________________MVAZC)ZOPM/F____________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M______________[X\^_KY^7CYNGP^O___________________]6RFXM]<6EB
M7EE54DY+2DQ05E]JN?_______________XHV'@X
M9/_______________\                          1?______________
M__,R                        *O________________]B
M            #?________________^-                         /__
M______________^V%P                       /_________________<
M/@                       /__________________9
M         /__________________BP(                      /______
M____________M2P                      /__________________XUH
M                     /___________________XX8
M     /K__________________\E4                   2,OC_________
M__________^=,P         4*D->?)R\W/_____________________]CB\]
M3V!P@92JPM[______________________________\W:[/______________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____Z=G.Q;VVL:VJJ*:EIJFON<74WO_______________^>!;%Q/13TU+BDD
M'QP:&1D:'2(J-_________________\^                         /__
M______________]T                         /________________^D
M @                       /_________________/+P
M         /_________________W6                        .G_____
M____________?@                       -7_________________I!H
M                     ,3_________________S$,
M     +3_________________]FT                      *?_________
M_________YHD                     )/__________________\I7
M               %(Y7___________________^2*@          #"1 7GV=
MO.S____________________A=!4.(#! 469]EK'0\___________________
M________U8R8J[_1Y/G_________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__________________________[\^OC[_/_________________________3
MMZ:;DXN%?GEU<F]P<'-X?XR>K/________________^62C@J(1H2"P0
M         ,G________________ $P                       +#_____
M___________M1@                       )G_________________<@
M                     (3_________________F@\
M     &[_________________P3<                      %K_________
M________YUT                      $K__________________X4.
M                 #K__________________ZXW
M ";__________________]ED                   )*4O_____________
M______^5+@           !$N36R.LMG____________________6:PT  ! @
M,49==I&QT_;_________________________NF%G>HV?LLCB_?__________
M_____________________^OP____________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M______________'EW-;1S,?#P<# Q<G/U^7Z___________________UE(%R
M:6)<5U)-2DA'1TE,4UYOAJ;_________________71\0!0
M     "?_________________C                        !3_________
M________MRP                       #_________________WU0
M                  #__________________WP$
M  #__________________Z,K                      #_____________
M_____\A1                      #___________________!X$
M           <06+___________________^C/0            TK2VZ3N]?_
M___________________8;Q(    .'S-*8W^@P^?_____________________
M____L$U#5VM^DJC!W/K______________________________[Z[TN?\____
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________Y\F[L:JDGYR:F)B8FJ"EL+W3[/__________________O6-63$4^
M.34P+"HH)R@L,CE*:(O_________________W$8
M  #__________________W0                       #_____________
M_____YPC                      #__________________\-*
M              #__________________^EP!P                    #[
M__________________^6+                 XT7'__________________
M__^\4P           !4T57NDS>W____________________D?1\    &%RQ#
M77V>PNC_________________________LU(N0E9J?Y6NR^K_____________
M________________^*64K,+9[___________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________]_#LZ.7EX^+EZNWU____________________
M_____[:;D8J%@7Y]>GEZ>X"(E*.XVO3__________________YM".3$J)2(?
M&A42$! 2%!DH2'+D_________________[U                       "F
M_________________^1K                      "5________________
M__^2)P                  !BZD__________________^W30
M    !BU3>Y_?___________________<<1(          B)&;).ZYO______
M_______________^EC@    '&B]'8H2HSO;_________________________
MP6$B-TQB=HVHQ>;_____________________________^9Y\E:O#V_3_____
M______________________________WI____________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________BUL_)Q\7%Q<C&S-3;X_+_____________________
M__J8?'1N:FAG9VEG:W%X@Y*DPM_U__________________^-+R$:%!$."P8!
M       1,EZ.__________________^T20                 #,5V#____
M_______________;<!              )U)ZH\WK___________________^
ME#4         %#A?B;3:________________________ME8    /)#Q6<I"Y
MX?__________________________VGLG-DMB>I.PS>[_________________
M_____________ZMTB:&ZU.[___________________________________;3
MY___________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________XP+6OK*JMK;&WP,70V>/[_______________________O
MB6!95E1765UC96UU?I&HP^SY____________________ES4-"04"       =
M3'FBS/?_____________________O%P#       -,%>"K=C_____________
M____________W'\G  8<-$]LC:[6_____________________________)]#
M.U)KAJ' X________________________________\)]A:"ZUO;_________
M__________________________[.U//_____________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M______________________________/O[N[O]?S_____________________
M____________\Z^;FIN>I:ZZO,34YO__________________________]Y=4
M3$]46V5N@)? Y____________________________ZY4 !LV4G",J\OV____
M_________________________\IK/V-_G;S>_/______________________
M_________^>9@ZS(Y______________________________________;S/+_
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__________________________________________________\
M
M
M                                         /__________________
M____________________________________________________________
M____________________________________________________________
M________________________________    _^X (4%D;V)E &1      @,
M$ ,"! @               #_VP"$  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$" @(" @(" @(" @,# P,# P,# P,! 0$!
M 0$! 0$! 0(" 0(" P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# __" !0( *$"4 0!$0 "$0$#$0$$$0#_Q $3  $
M @$% 0$!            !P@) P0%!@H" 0L! 0 !! ,! 0             (
M!@<)"@,$!0(!$   !0,$ P " 00# 0     #! 4&!P$""! @, D -C@T-S41
M$A,5,Q07%A$  @(! P$$!@4&"04.! <  0(#! 41$@8A #$3!Q @,$$B%%%A
M,B,50K.T=86U<5(S)!9VAG>W8G*R<W2!L<)3@],T1(0E-3:6MD!CE-21H4-D
ME=4W$@ " 0,!! 0(!PP' PL$ P ! @,1! 4A #$2!A!!$P<@,%%A@2(R%'&1
M0E)R([.AL6*R,W.#=!6%M0B"DJ(D)75V\,&TT=)#4V.3-(0U%C= TY07H]25
M_]H #@0! 0(1 Q$$     /Y_Y[^   YGG]_:WYN3DZAZ]=Q<E$1V8JR7_1)(
M]6[?!_7[]?D?^9:_F:V4I$;O5'+>XX98Q\VRQ:S-USJTGO@    [!V:HV>0*
MYF46&KS7#R11+92JY==%D+U+I\+^?GY^QUY=J.;K32<0N]45MWC9ER@5M<8$
MQ\)UZ=W0    <WV*BVM_+E9/H<O5<3)-$EEZLE]T21?4NOPG[^_OY'OEVLYJ
MME*1&[U1BWF-R6L?ML\7<R=?ZU+;T    .Q]JK-CD'N;E+AF\5PLCL3V3JN7
M/1>_^G<_AOS\_/V-_*M)SE9Z3B!WNBENL:\N4&MMC%F'AN#P-T     9 +EY
M0X;S+WWV *P27ZUWN"    #HWG6XY;#[8[ Q9?&U:K$?.7S^?'Z !^OUD8NE
MEAA',7?3/E67OWI7-X<    (Y\JT_-X;;%8!;.X];8XL)H   ,A-S<IT,9DK
M[9^JQ2/ZMV>#    #H/FVRYC#K8O ?9K'-:W$Y-WX_  'U^_?YDENKEP@W,%
M?'//6CO/HW'XD    (T\FT/.X:+$:_\ 9_'_ &TQ>3(   :_UV?C-;?W8<JQ
MDNNSE\@D       Q_P!M,7LR8+([:V=MMAQ^9K!O^3T]'.)(78YJ?D/N?E5A
M4       QLVIQ&SGA,L!KN6IVWQT]0-?Z[/QFUD!L355R376RY08       8
M\;88JYJP=1ZUQ;8;#C\S6#?\GIZ.=.1.R94G(!<O*%#8      !C2M/B$G;"
MC8'7BM/H?/6^P ,VE_\ 8EJKDNNSE\@D   XSA\?7^_WD_.0Y?4T0  "@EM<
M8<Q8&XY:SUO?G\^/W.K(K9/J/D,N=E1A<        ,;-J<1LYX0X^ZZ%K0S>
M2"V+ZI9)KK9<H,        #'K;'%A-&"B.NM?;?Z_?IGDD;LPU"OW<K)Y#H
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MWWM/%+9K"98?#O8S C9D/3=+;<0H9.E121ZD 47MWC<EJS-6S Z))_KWCX
M  "C%N\;LM8!(UZP%Q@]%,HMKFD]N:VG1&X     &"B.NM=;C'I;'%?-'9.W
M5NQ]0\O=R^@7=_0N+Q0 '$<'A[FNE+Q0[M:*KYE]     #!Y'O7(MAC@M7B5
MG#E.;V=OZ@)=[DU!9.]>\7 @ =;ZE);[R_1$TV+]="\VV7,7+KO(!&'H7D[M
M0TN    \ZL7=4:[%1Z)@O)'W^\GY\?G'^AE@O/F[KMF"OCGFK1BELUA,L/AW
ML9@1LR'INEMN(4,G2HI(]2 (P\BSG/R3ZMW."UOKG^0   *,6[QNRU@$C7K
M7&#T4RBVN:3VYK:=$;@     >::)^H5>NNU+Q3[K=*O<A$6^A"3>TS3$
M     \WT5M2F\-7J0AIW^V=:3ACGT7RDVP*2@  &"6.FM5;G'O;+%G,\H^Q>
M;K_J1F!N=X_P   /.K%W5&NQ4>B8+R1+?MWSZW9FK)@]$H7;C&7+^K^\WSZ#
MI-;2],JZ4O%#NV'>QF!&S(>FZ6VXA0R=*BDCU( T?G@^OO\ ?O\ /O\ >3\
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M0E)O:;IC<>NI]1B        %(K?8Z96P 1JU>[D!G_DKM"4WN[<'(M%(
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MPH*HUE[KAC&QV2[O[$/F[3!/Y5X\X<G3$M.W1D1T^I)5&YUO9 K *_UM3ZE
MO^*9&BQ0TP"FMYLZ4.#.;)PQ*3MT;#2=#U5FSUZY(. !?ZZ<C48%[1T^XX4M
M,1LD5& WX5-%CQ;?G9]5:1K(KFBEZPY+#:FJ/].TC^!TQD^>M>QZ,;&G+O7H
MR+6MCUO[$/F[3!/Y5XLXIC'B:%-,3,4%7()99+$:$<M_1R-ANO%&S#PW%A;Q
MFLYR2 Y\8,8&SCRV=^:TQ#Q#".F,&,3CR(<\:Q4P8C;VCP933D!"RXQ"4H&.
M:==LQ#OF+M^=GU5KB/D>=@%_$#Y)4(^=I'\#IC)\]:]A;(M=./4*-ZUIP_O[
M$/F[3!/Y5XNR-\"+\W>,YJJKX=<;L%"B]C;%Y"27.B8Z8JL7'@#@[+7N*LRY
MXAHRBXUJ'8O0X<CG8[VFA/IL2BP%2+9"\P+>XK.R.WYV?57@88@PFG7[D]_T
M3'G:1_ Z8R?/6LUMZUV0^7 "*E]_8A\W:8)_*O%EHJ"*^2/F *  N9+<^:*G
M>K9.>8.H15>R<W=D[>+I4\^0>>'39HWYV?57D 4I6>,W\8;H>=?@ XY4?#3)
M<"=61VD?P.F,GSUJ8 "-%PQ Q@]_8A\W:8)_*O%E@G7IF1_F!+C+M[)?GS22
M[DG)WS!]?*-[)S=V3.(LK3UY!Q =3FC?G9]5>8__ +X>S,;LAM2>X4<<#R'Y
M&4CN>)GMG1*[8FF(],9/GK400,$.)E^QU1;O[$/F[3!/Y5XNQ]DBM^=O&VX%
M-J.&(9/0)BCWF[+V2*CRUXBK"BWEB&940IGCG8\W>@L%JR>_5.4)!\P(9(CO
MR.WYV?57F/\ ^^/,FH!1\@8[<" L-5<\_P"X;J4TQD^>M997[&K%N STL=N.
M&_L0^;M,$_E7BSRAX:4(5TQCR<<N.SEBZ8([F-!TD:4F#$R!+'8O+KB7X1[%
MY"27"2.E%(GOS/AL68H3TQCR;<F.SGC&6X_F%OZ/9^,^.$#+7+E4GU0TZ\H;
M&845;\[/JKS'_P#?&F>N,%'XA;,9/GK7/EZ6-+'#K2DP-#D'?V(?-VF"?RKQ
M5I2M,U,9C,*O71"<"\V%-NYWY,M\LOYZ9-+I=QNERO!4TPL.*A[&#@SJQC,1
MBZM&ZZ'(T%1M]@&2C?+K?8;DDK%GD_7K(2IIB'C6?GM]%RY<H7WYV?57F/\
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M>T3MI>0&4:H._&67HJS4S"%KEF9S+=EUUU]VR$V7<%;-C+N_NUBM<12;#_\
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M$#J8:X"Q4R='9,*"B7%BQ<F7V#@ F07M"EU+C90T1,<!(B=4C+)A2T.H000
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M:=.!_58_Q1X&5NR?R=O(WI"$C[NUI&6K);N\1]!XE_LLH]'B)?S\?WSTX?\
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M5OE$>RM34$K5410$ H -  -P Z@/$9C]%]A%T<O_ *[!]JO@?M;'Q4Q<[>L
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MUY(T9<[BUO?>^1!!UI ( 1N*D\6UWE>ZKF*QYMQ2<3=@0+#(!1J L4LCVTQ
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M6TF@!>"2-B/5)*D@Y/GCN/N+GF3D2(-)+9,H;*VB"I)58U5+^) #5H4CN%!
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M#:9<Z%N.I6.WOCJ5N/5CN')%T0S^\QY+ 9_&SV>;LYWAG@F1HY898V*O'(C
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MDDF@ %223UFOB,Q_GN-^T?I[EOWO_'LIXOOYO9F8NF>DM]:5X;2..T4:=06
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M>HT(T8$JRT925()V&+-Y+^S1*91%Q'LQ*5"&0)7A#E0%+ 5*JH)(44Z/Y?\
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M:U%DKR-<4]D^]SRPR !O=D.@M[*RMXX;.&-4CC10B(B *J(J@*JJH"JJ@
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MPX[C4%;G(<)!!X6XX;4'M)O5+]G"PD.<YSYQS$V0YHR5R\]S<2D%Y)7-2:*
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MRRNTDDDCDL[N[$L[LQ)9F)+$DDD^);.]U?/5]B+MR.T2-@]O/3<+BUE62VG
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MA5Y)'5$0;JL[$*HJ:5)&TXYB[Y,3<7Z5_N^/<Y*?BI[#)8B<1,?^W:)14<3
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M4>HVF!\I@<USJ_#M<W.5YVWX)F[W(Q>!_!,9) 22%CGBGT734LPW&->.>6G
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MXY2E4C1K$;V7 .D* K)VCX]Y?\7QG&L:H4S?)Q,]V_(FH6QE<I9:;)96R Q
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MF19(9X)HV:.6&6-@RLI*LI!!T]6+S@XACQ!Q3FE]X>4TZL>E?"<OG#V#>"(
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MH\G/UOS/]"X[Z?)G^[KB_P"ZX/4R&<BA,E[@7(,+R.%D7=*:5NP>/9*+O&D
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M*;+6KA95ZZG#T,>1NZC4Z  ZGMA^/8BN;>6SV4Q^&Q=52 UG(Y2W#1I5U)Z
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MM/SMB:"0#=X"GH(*M6"&M5K0Q5ZU:O$D->O7A18X8((8U6.*&*-0JJH"JH
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M\-BO8A=9(9X)HV62*:*10RLI#*P!!U[1<5Y7=@K^:G&J4:Y**0Q5_P"EF-A
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M+R3@LL:M(.BJT_&LQ9CC#Z?%(\5\ _DPCH.T0PGFAQRG<E 'X9R:P_%,B)2
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MX*SMBU.K&A>,D\ Z]3X=A95^@+M'::HK;H</3JT5 .J^+(GSL[=WVPUD(?\
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MY+'SO6NTIDGKS)WJZ^YE.JO&ZDJRD%64D$$$CM#DH-L5J/2#)4PVK5+BJ"X
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MB.O=O/9Y)':221F=W=BSN[$LSNS$LS,QU)/4GU3RW(PZ6;T318>.13NAHO\
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M="#T([-D<=$[\>O2DP,NY_PZ=_B-&=CJ1&3KX+$ZLHT)+*2?;+9N1R1<?HR
MW9^J?.2KM88ZLXT)>0$&1E_DT]X9EUB@@C2*&&-(H8HU"QQQ1J$CC11H%1$
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)ZJ/_ $(?8__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_01.jpg
<TEXT>
begin 644 image_01.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" !V ;(# 2(  A$! Q$!_\0
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M[=OPDNH)=!_:%UG4((2,V?B%EU"*1>ZMYX9N?4,&]"*\ HJ9T:53XXI^J.K
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MG;M.U#\_C<IJ8=.=+6/XK_,_H'@OQ<R_/JL<'F451KO1-?!)]E?6+?1-M/\
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M@U\/[/PK^Q*WBU+8+<^)?%-Y<S2[1N9(MD"#/7 \ML#L6;UK[78@<D5\L?\
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M\>V>CZ>K*S>'?#=Q]HNYAW62<KY<7_ /,R#U4UZE3,,'3C=S3]'=_@?E^7\
M\89EB%1IX*I'SG%PBO5RLOU[(_.-(9I!NCB9O]U:;TZU_2M\,/@U\+?@QX+M
M_A[\+_ VGZ+H]K"(H[.SMP Z@8RY.6D8CJSDL>Y-?F7_ ,%X?V+OAE\+K+P_
M^U!\,?#EIHK:UK']D>(K&QC$<-Q<M%+-%<! ,*Y6*17Q@'"G&=Q/'ALXIXBN
MJ?+:^SO_ %^I]AQ-X0YAP[D4LQCB8U7!)SBHN-DVDW%MOFLWK=1TU\C\W:**
M*]@_'PHHHH *^XO^""7QB3P%^UYJ'PTO[[R[7QMX=DMXHBP >[MV\^(^Y$8N
M !_M5\.UM?#GQ_XH^%7CW1_B5X*U)[/5M"U*&^T^X3^"6-PR_4<8(/!!(.0:
MPQ-'ZQAY4^Z/;X;SB60Y]A\P2;]G)-I;N.TE\XMH_IB[5\)_\%R?V-M8^.?P
M7L?C]X!L)+C7/ 4,S:E9PQEGNM+;#2,,<YA9=^/[C2'L*^I/V3_VE? _[67P
M-T7XR^!KR-DOK=4U.S5OGL+Q5'G6[CJ"K'CL5*L,@@UZ.Z*XVL,U\51J5,'B
M%*VL7M^:/[4S;+LMXPX=GAW*]*M%.,EK;9QDO1V=NNS/YA**_7K]M_\ X(9^
M!/C)KM]\2OV8=?L?".MWA,MUX?OHV_LNYE_B9"@9K8GJ0JLF>BKDFOAWQ/\
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MJI'K^'D<O$F0XSAK.*N Q"UB]'TE%_#)>37W.ZW05]X?\$JO^"K\W[-OV;X
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M /P6@_X*'?#G]I^[T?X!_!/4FU/P_P"&]4:_U37%4""^O1&T2"#NT:))(-Y
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M\,85(HU&%55&     !P!1I>DZ9HFFV^C:-IT%I9V<*PVMK:PK''#&H 5$50
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MRZD$=O:VL+222N>BJJ@DD^@H!)R=D5Z^E/\ @G=_P3F^(O[;WCR.]NX;C2/
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M^";7_!/#PC^PY\.FNM8-KJGCK6X5.OZW'#Q"G!%I 3R(E(R3QO8 D<*!]-
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<510,!0!P !P *DHHKR3]8VT04444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_1.jpg
<TEXT>
begin 644 image_1.jpg
M_]C_X  02D9)1@ ! @$!] 'T  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" "/ A # 2(  A$! Q$!_\0
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M%:2\W'9_+E]&?T"45X%^Q)_P40^!_P"VOX?$?A2_72O$]M!OU+PO?3#SXP,
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M9Z<_V96_NM.V(U//0L*F4HP5Y.R-\/AL3C*JI4(.<GLHIM_<M3@:*^L?#?\
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MVQKGY8HQ_!&HX51T ]>:Y:OL,!@:>#I]Y/=_UT/XZX\X\Q_&6/ZPP\'[D/\
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M1964>3M'5V8X5$'=F( ]:3:BKO8THT:N(JQITHN4I.R25VV^B2W9S=%?9?\
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MA*TBN-8N(DD\1:\T0$M_<8YYZB-3D*O0#GJ2:\_'X^."AIK)[+]6?HGA_P
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M_P"X4_SB?:=?&/\ P7?_ .3%O^YRT_\ ] GK[.KXQ_X+O_\ )BW_ '.6G_\
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M?^B6KY@KZ?\ ^".W_)_G@W_=NO\ T2U<^,_W6?H_R/I.#?\ DK,!_P!?J?\
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MK<IUATWQ+:F-LYZ>=%D  ?[!-?+OQ:_X)7?MJ?!Q9[WQ%\-[&ZL+<X;4=/\
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M'@=3I3C7SNKS6_Y=PO;_ +>GH_E%+_$>:?LQ?LE_!/\ 9(\#+X(^#_A9+4.
M;_4I\/=7KC^*23&3[+T'85Z7117@3G.I)RD[MG[[A,'A<!AHX?#04(15E%*R
)2] HHHJ3I/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067742410192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">333-08704<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ICON PLC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">South County Business Park<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Leopardstown<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin 18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">D18 X5R3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">ORDINARY SHARES, PAR VALUE &#8364;0.06 EACH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ICLR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity common stock, shares outstanding (in shares)</a></td>
<td class="nump">80,756,860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well Known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filler Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">U.S. GAAP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001060955<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">South County Business Park<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Leopardstown<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin 18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">D18 X5R3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Nigel Clerkin<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelEmailAddress', window );">Contact Personnel Email Address</a></td>
<td class="text">Nigel.Clerkin@iconplc.com<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CountryRegion', window );">Country Region</a></td>
<td class="text">353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">291-2000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelEmailAddress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Email address of contact personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelEmailAddress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CountryRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Region code of country</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CountryRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067747607744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor firm ID</a></td>
<td class="text">1116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor name</a></td>
<td class="text">KPMG<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor location</a></td>
<td class="text">Dublin, Ireland<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067742981248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 538,785<span></span>
</td>
<td class="nump">$ 378,102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments (Note 8)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,954<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for credit losses (Note 4)</a></td>
<td class="nump">1,401,989<span></span>
</td>
<td class="nump">1,790,322<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGrossCurrent', window );">Unbilled services (unbilled revenue)</a></td>
<td class="nump">1,286,274<span></span>
</td>
<td class="nump">951,936<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NontradeReceivablesCurrent', window );">Other receivables</a></td>
<td class="nump">79,487<span></span>
</td>
<td class="nump">65,797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepayments and other current assets</a></td>
<td class="nump">140,435<span></span>
</td>
<td class="nump">132,105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="nump">83,523<span></span>
</td>
<td class="nump">91,254<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">3,530,493<span></span>
</td>
<td class="nump">3,411,470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net (Note 9)</a></td>
<td class="nump">382,879<span></span>
</td>
<td class="nump">361,184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill (Note 10)</a></td>
<td class="nump">9,051,410<span></span>
</td>
<td class="nump">9,022,075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net (Note 11)</a></td>
<td class="nump">3,559,792<span></span>
</td>
<td class="nump">3,855,865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating right-of-use assets (Note 15)</a></td>
<td class="nump">147,602<span></span>
</td>
<td class="nump">140,333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other receivables</a></td>
<td class="nump">72,796<span></span>
</td>
<td class="nump">78,470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax asset (Note 20)</a></td>
<td class="nump">74,758<span></span>
</td>
<td class="nump">73,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue', window );">Investments in equity (Note 8)</a></td>
<td class="nump">57,948<span></span>
</td>
<td class="nump">46,804<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">16,877,678<span></span>
</td>
<td class="nump">16,989,863<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">173,025<span></span>
</td>
<td class="nump">131,584<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Unearned revenue (Note 4)</a></td>
<td class="nump">1,614,758<span></span>
</td>
<td class="nump">1,654,507<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities (Note 12)</a></td>
<td class="nump">923,603<span></span>
</td>
<td class="nump">915,399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">55,258<span></span>
</td>
<td class="nump">13,968<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Current bank credit lines, loan facilities and notes (Note 13)</a></td>
<td class="nump">29,762<span></span>
</td>
<td class="nump">110,150<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,796,406<span></span>
</td>
<td class="nump">2,825,608<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Non-current bank credit lines, loan facilities and notes, net (Note 13)</a></td>
<td class="nump">3,396,398<span></span>
</td>
<td class="nump">3,665,439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities (Note 15)</a></td>
<td class="nump">140,085<span></span>
</td>
<td class="nump">126,321<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Non-current other liabilities (Note 16)</a></td>
<td class="nump">83,470<span></span>
</td>
<td class="nump">45,998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Non-current income taxes payable</a></td>
<td class="nump">125,834<span></span>
</td>
<td class="nump">186,654<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability (Note 20)</a></td>
<td class="nump">812,486<span></span>
</td>
<td class="nump">899,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 17)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">7,354,679<span></span>
</td>
<td class="nump">7,749,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">80,756,860 shares issued and outstanding at December 31, 2024 and&#8232;82,495,086 shares issued and outstanding at December 31, 2023.</a></td>
<td class="nump">6,586<span></span>
</td>
<td class="nump">6,699<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">7,020,231<span></span>
</td>
<td class="nump">6,942,669<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OtherUndenominatedCapital', window );">Other undenominated capital (Note 18b)</a></td>
<td class="nump">1,304<span></span>
</td>
<td class="nump">1,162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss (Note 24)</a></td>
<td class="num">(229,929)<span></span>
</td>
<td class="num">(143,506)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">2,724,807<span></span>
</td>
<td class="nump">2,433,719<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders' Equity</a></td>
<td class="nump">9,522,999<span></span>
</td>
<td class="nump">9,240,743<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Shareholders&#8217; Equity</a></td>
<td class="nump">$ 16,877,678<span></span>
</td>
<td class="nump">$ 16,989,863<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OtherUndenominatedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other undenominated capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OtherUndenominatedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI) and investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481573/470-10-45-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481573/470-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NontradeReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of amounts currently receivable other than from customers. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NontradeReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067742080256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - &#8364; / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value (in EUR per share)</a></td>
<td class="nump">&#8364; 6<span></span>
</td>
<td class="nump">&#8364; 6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued (in shares)</a></td>
<td class="nump">80,756,860<span></span>
</td>
<td class="nump">82,495,086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding (in shares)</a></td>
<td class="nump">80,756,860<span></span>
</td>
<td class="nump">82,495,086<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743093280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 8,281,676<span></span>
</td>
<td class="nump">$ 8,120,176<span></span>
</td>
<td class="nump">$ 7,741,386<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Direct costs</a></td>
<td class="nump">5,845,319<span></span>
</td>
<td class="nump">5,719,949<span></span>
</td>
<td class="nump">5,527,045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">728,348<span></span>
</td>
<td class="nump">768,559<span></span>
</td>
<td class="nump">778,753<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">488,500<span></span>
</td>
<td class="nump">585,950<span></span>
</td>
<td class="nump">569,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Transaction and integration related (Note 6)</a></td>
<td class="nump">$ 29,574<span></span>
</td>
<td class="nump">44,176<span></span>
</td>
<td class="nump">39,695<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Restructuring (Note 19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring (Note 19)</a></td>
<td class="nump">$ 92,123<span></span>
</td>
<td class="nump">45,390<span></span>
</td>
<td class="nump">31,143<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">7,183,864<span></span>
</td>
<td class="nump">7,164,024<span></span>
</td>
<td class="nump">6,946,149<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">1,097,812<span></span>
</td>
<td class="nump">956,152<span></span>
</td>
<td class="nump">795,237<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">8,609<span></span>
</td>
<td class="nump">5,014<span></span>
</td>
<td class="nump">2,345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense (Note 13)</a></td>
<td class="num">(237,237)<span></span>
</td>
<td class="num">(336,699)<span></span>
</td>
<td class="num">(229,731)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest', window );">Income before income tax expense</a></td>
<td class="nump">869,184<span></span>
</td>
<td class="nump">624,467<span></span>
</td>
<td class="nump">567,851<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (Note 20)</a></td>
<td class="num">(77,710)<span></span>
</td>
<td class="num">(11,749)<span></span>
</td>
<td class="num">(59,411)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest', window );">Income before share of losses from equity method investments</a></td>
<td class="nump">791,474<span></span>
</td>
<td class="nump">612,718<span></span>
</td>
<td class="nump">508,440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of losses from equity method investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(383)<span></span>
</td>
<td class="num">(3,136)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 791,474<span></span>
</td>
<td class="nump">$ 612,335<span></span>
</td>
<td class="nump">$ 505,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per ordinary share (Note 23):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (USD per share)</a></td>
<td class="nump">$ 9.60<span></span>
</td>
<td class="nump">$ 7.46<span></span>
</td>
<td class="nump">$ 6.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (USD per share)</a></td>
<td class="nump">$ 9.53<span></span>
</td>
<td class="nump">$ 7.40<span></span>
</td>
<td class="nump">$ 6.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average number of ordinary shares outstanding (Note 23):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">82,482,764<span></span>
</td>
<td class="nump">82,101,813<span></span>
</td>
<td class="nump">81,532,320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">83,032,424<span></span>
</td>
<td class="nump">82,717,640<span></span>
</td>
<td class="nump">82,468,363<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) From Continuing Operations Before Equity Method Investments, Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes restructuring charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067740464800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Net Income (Loss) Attributable to Parent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 791,474<span></span>
</td>
<td class="nump">$ 612,335<span></span>
</td>
<td class="nump">$ 505,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="num">(84,927)<span></span>
</td>
<td class="nump">26,221<span></span>
</td>
<td class="num">(89,530)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Remeasurement of retirement benefit obligations</a></td>
<td class="num">(6,077)<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="nump">12,657<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gain / (loss) on cash flow hedge</a></td>
<td class="nump">4,581<span></span>
</td>
<td class="nump">1,567<span></span>
</td>
<td class="num">(3,728)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income</a></td>
<td class="nump">$ 705,051<span></span>
</td>
<td class="nump">$ 640,367<span></span>
</td>
<td class="nump">$ 424,703<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067740377680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Ordinary Shares</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Other Undenominated Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Retained Earnings</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,554,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 8,066,827<span></span>
</td>
<td class="nump">$ 6,640<span></span>
</td>
<td class="nump">$ 6,733,910<span></span>
</td>
<td class="nump">$ 1,134<span></span>
</td>
<td class="num">$ (90,937)<span></span>
</td>
<td class="nump">$ 1,416,080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Comprehensive income (net of tax):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">505,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">505,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="num">(89,530)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(89,530)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Remeasurement of retirement benefit obligations</a></td>
<td class="nump">12,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gain on cash flow hedge</a></td>
<td class="num">(3,728)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,728)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income</a></td>
<td class="nump">424,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of share options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">348,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of share options</a></td>
<td class="nump">35,828<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">35,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issue of restricted share units / performance share units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">241,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issue of restricted share units / performance share units</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share based compensation expense</a></td>
<td class="nump">70,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Share issuance costs</a></td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Share repurchase program, number of shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(420,530)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of ordinary shares</a></td>
<td class="num">(99,983)<span></span>
</td>
<td class="num">$ (28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(99,983)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ShareRepurchaseProgramBrokerCommission', window );">Share repurchase costs</a></td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,723,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="nump">8,497,963<span></span>
</td>
<td class="nump">$ 6,649<span></span>
</td>
<td class="nump">6,840,306<span></span>
</td>
<td class="nump">1,162<span></span>
</td>
<td class="num">(171,538)<span></span>
</td>
<td class="nump">1,821,384<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Comprehensive income (net of tax):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">612,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">612,335<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="nump">26,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Remeasurement of retirement benefit obligations</a></td>
<td class="nump">244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gain on cash flow hedge</a></td>
<td class="nump">1,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income</a></td>
<td class="nump">640,367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of share options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">535,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of share options</a></td>
<td class="nump">50,958<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">50,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issue of restricted share units / performance share units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issue of restricted share units / performance share units</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share based compensation expense</a></td>
<td class="nump">51,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Share issuance costs</a></td>
<td class="num">$ (16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Dec. 31, 2023</a></td>
<td class="nump">82,495,086<span></span>
</td>
<td class="nump">82,495,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2023</a></td>
<td class="nump">$ 9,240,743<span></span>
</td>
<td class="nump">$ 6,699<span></span>
</td>
<td class="nump">6,942,669<span></span>
</td>
<td class="nump">1,162<span></span>
</td>
<td class="num">(143,506)<span></span>
</td>
<td class="nump">2,433,719<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Comprehensive income (net of tax):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">791,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">791,474<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="num">(84,927)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(84,927)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Remeasurement of retirement benefit obligations</a></td>
<td class="num">(6,077)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,077)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gain on cash flow hedge</a></td>
<td class="nump">4,581<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,581<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income</a></td>
<td class="nump">705,051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of share options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">311,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of share options</a></td>
<td class="nump">36,178<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">36,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issue of restricted share units / performance share units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issue of restricted share units / performance share units</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share based compensation expense</a></td>
<td class="nump">41,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Share issuance costs</a></td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Share repurchase program, number of shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,179,699)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of ordinary shares</a></td>
<td class="num">(499,998)<span></span>
</td>
<td class="num">$ (142)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(499,998)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ShareRepurchaseProgramBrokerCommission', window );">Share repurchase costs</a></td>
<td class="num">$ (388)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Dec. 31, 2024</a></td>
<td class="nump">80,756,860<span></span>
</td>
<td class="nump">80,756,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2024</a></td>
<td class="nump">$ 9,522,999<span></span>
</td>
<td class="nump">$ 6,586<span></span>
</td>
<td class="nump">$ 7,020,231<span></span>
</td>
<td class="nump">$ 1,304<span></span>
</td>
<td class="num">$ (229,929)<span></span>
</td>
<td class="nump">$ 2,724,807<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ShareRepurchaseProgramBrokerCommission">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Repurchase Program, Broker Commission</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ShareRepurchaseProgramBrokerCommission</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067742038784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 791,474<span></span>
</td>
<td class="nump">$ 612,335<span></span>
</td>
<td class="nump">$ 505,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">488,500<span></span>
</td>
<td class="nump">585,950<span></span>
</td>
<td class="nump">569,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment', window );">Impairment of operating right-of-use assets and related property, plant and equipment</a></td>
<td class="nump">15,731<span></span>
</td>
<td class="nump">8,686<span></span>
</td>
<td class="nump">28,767<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Reduction in carrying value of operating right-of-use assets</a></td>
<td class="nump">39,787<span></span>
</td>
<td class="nump">41,546<span></span>
</td>
<td class="nump">45,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss on equity method investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">3,136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Acquisition-related gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,160)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of financing costs and debt discount</a></td>
<td class="nump">23,533<span></span>
</td>
<td class="nump">16,402<span></span>
</td>
<td class="nump">17,749<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation expense</a></td>
<td class="nump">45,870<span></span>
</td>
<td class="nump">55,667<span></span>
</td>
<td class="nump">70,523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred tax benefit</a></td>
<td class="num">(100,542)<span></span>
</td>
<td class="num">(85,403)<span></span>
</td>
<td class="num">(124,985)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Unrealized foreign exchange movements</a></td>
<td class="nump">6,911<span></span>
</td>
<td class="nump">19,706<span></span>
</td>
<td class="num">(13,009)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="nump">31,900<span></span>
</td>
<td class="nump">24,332<span></span>
</td>
<td class="nump">11,324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">349,309<span></span>
</td>
<td class="num">(83,296)<span></span>
</td>
<td class="num">(420,695)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset', window );">Unbilled revenue</a></td>
<td class="num">(339,921)<span></span>
</td>
<td class="nump">4,716<span></span>
</td>
<td class="num">(332,592)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Unearned revenue</a></td>
<td class="num">(37,743)<span></span>
</td>
<td class="nump">134,566<span></span>
</td>
<td class="nump">192,944<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other net assets</a></td>
<td class="num">(28,157)<span></span>
</td>
<td class="num">(168,403)<span></span>
</td>
<td class="nump">10,121<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">1,286,652<span></span>
</td>
<td class="nump">1,161,027<span></span>
</td>
<td class="nump">563,315<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows used in investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property, plant and equipment</a></td>
<td class="num">(168,060)<span></span>
</td>
<td class="num">(140,692)<span></span>
</td>
<td class="num">(142,160)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase of subsidiary undertakings (net of cash acquired)</a></td>
<td class="num">(84,159)<span></span>
</td>
<td class="num">(71,766)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromShortTermInvestments', window );">Movement of available for sale investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(241)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfLongtermInvestments', window );">Proceeds from investments in equity</a></td>
<td class="nump">2,690<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,906<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLongtermInvestments', window );">Purchase of investments in equity</a></td>
<td class="num">(17,261)<span></span>
</td>
<td class="num">(13,954)<span></span>
</td>
<td class="num">(5,612)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(266,790)<span></span>
</td>
<td class="num">(226,653)<span></span>
</td>
<td class="num">(145,867)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows used in financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">New Notes issue costs</a></td>
<td class="num">(12,679)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Drawdown of credit lines and loan facilities</a></td>
<td class="nump">2,317,480<span></span>
</td>
<td class="nump">370,000<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment of credit lines and loan facilities</a></td>
<td class="num">(2,677,763)<span></span>
</td>
<td class="num">(1,265,000)<span></span>
</td>
<td class="num">(875,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of equity compensation</a></td>
<td class="nump">36,187<span></span>
</td>
<td class="nump">50,973<span></span>
</td>
<td class="nump">35,844<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Share issue costs</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of ordinary shares</a></td>
<td class="num">(499,998)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(99,983)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_PaymentsForBrokerCommissionShareRepurchaseCosts', window );">Share repurchase costs</a></td>
<td class="num">(388)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(837,183)<span></span>
</td>
<td class="num">(844,043)<span></span>
</td>
<td class="num">(864,173)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate movements on cash</a></td>
<td class="num">(21,996)<span></span>
</td>
<td class="num">(997)<span></span>
</td>
<td class="num">(16,720)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase/(decrease) in cash and cash equivalents</a></td>
<td class="nump">160,683<span></span>
</td>
<td class="nump">89,334<span></span>
</td>
<td class="num">(463,445)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of year</a></td>
<td class="nump">378,102<span></span>
</td>
<td class="nump">288,768<span></span>
</td>
<td class="nump">752,213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of year</a></td>
<td class="nump">$ 538,785<span></span>
</td>
<td class="nump">$ 378,102<span></span>
</td>
<td class="nump">$ 288,768<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment, Operating Right-Of-Use Assets And Related Property, Plant And Equipment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_PaymentsForBrokerCommissionShareRepurchaseCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Broker Commission Share Repurchase Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_PaymentsForBrokerCommissionShareRepurchaseCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-5<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481956/830-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481926/830-20-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount paid (received) by the reporting entity through acquisition or sale and maturities of short-term investments with an original maturity that is three months or less which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireLongtermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireLongtermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfLongtermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, beyond the current operating cycle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfLongtermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743032768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Description of business</a></td>
<td class="text">Description of Business <div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc and its subsidiaries ("the Company" or "ICON") is a contract research organization ("CRO"), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process from compound selection to Phase I-IV clinical studies. Our mission is to improve the lives of patients by accelerating the development of our customers' drugs and devices through innovative solutions.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and have the operational flexibility to provide development serv</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ices on a stand-alone basis or as part of an integrated "full-service"  or a &#8220;blended-service&#8221; solution. At December&#160;31, 2024 we had approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">41,900</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> employees, in 106 locations in 55 countries. During the year ended December&#160;31, 2024, we derived 36.0%, 52.6% and 11.4% of our revenue in the United States, Europe and Rest of World, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON&#8217;s ordinary shares are traded on the NASDAQ Global Select Market under the symbol &#8220;ICLR&#8221;.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We began operations in 1990 and have expanded our business through internal growth, together with a number of strategic acquisitions to enhance our capabilities and expertise in certain areas of the clinical development process. We are incorporated in Ireland and our principal executive office is located at: South County Business Park, Leopardstown, Dublin 18, Republic of Ireland. The contact telephone number of this office is +353 1 2912000.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067741640720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant accounting policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant accounting policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accounting policies noted below were applied in the preparation of the accompanying financial statements of the Company and are in conformity with accounting principles generally accepted in the United States.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Basis of consolidation</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition, intangible assets acquired in a business combination, goodwill impairment and income taxation.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Disclosure of fair value of financial instruments</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on the net present value of estimated future cash flows. Debt is measured at amortized cost.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial instruments are measured at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 1: Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 2: Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 3: Inputs are generally unobservable and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Business combinations</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Accounting for contingent consideration, after the acquisition, depends on the classification of the contingent consideration. Equity-classified contingent consideration is not remeasured after the acquisition date and subsequent settlement is accounted for within equity. Contingent consideration, which is classified as a liability or an asset, is remeasured to fair value at each reporting date until the contingency is resolved. The changes in fair value are recognized in earnings, unless the arrangement is a derivative which has been designated as a hedging instrument in a cash flow hedging relationship, in which case, the changes are initially recognized in other comprehensive income/loss.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and any contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Foreign currencies and translation of subsidiaries</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's financial statements are prepared in United States dollars. The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income/loss. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Transactions in currencies other than the functional currency of the subsidiaries of the Company are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the subsidiaries of the Company are translated into the functional currency of that entity at exchange rates prevailing at the balance sheet date. Adjustments resulting from these translations are charged or credited to income. Foreign currency gains and losses on intercompany transactions classified as long-term investments are reported in other comprehensive income/loss as currency translation adjustments. Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts (credited) / charged</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,085)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,916&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,997)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Clinical trial service revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through / reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Laboratory services revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.    </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contracting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Consulting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Data services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the &#8220;units delivered&#8221; output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Commissions</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Reimbursable expenses</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. The Company includes reimbursed expenses in revenue and direct costs as the Company is primarily responsible for fulfilling the promise to provide the specified service, including integration of the related services into a combined output to the customer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Direct costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. Payments are made based on predetermined contractual arrangements. Timing of payments may differ from the timing of the expense.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Cash and cash equivalents</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Investments in debt, equity and other</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Available for sale investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies short-term investments as available for sale. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity.  Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses. Realized gains and losses are determined using specific identification.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Long term investments  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2024 and December&#160;31, 2023 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2024 and December&#160;31, 2023 qualify for the Net Asset Value ("NAV") practical expedient in ASC Topic 820, Fair value Measurements ("ASC 820"). Any increases or decreases in fair value are recognized in earnings in the period. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Investments in equity </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">which do not qualify for the NAV practical expedient are measured at cost, less impa</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">irment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Equity method investments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s investments that are not consolidated are accounted for under the equity method if the Company  exercises significant influence. These investments are classified as equity method investments on the Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of losses in equity investments in the Consolidated Statement of Operations. The Company reviews equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Accounts receivable, net and unbilled revenue</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the   Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accounts receivable early payment discounting</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">("ASC 860"). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Property, plant and equipment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, plant and equipment is stated at cost less accumulated depreciation. Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings &#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 - 8 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment &#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception and reassess if there are changes in terms and conditions of the contract. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December&#160;31, 2024 and December&#160;31, 2023, the Company did not account for any leases as finance leases. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Operating leases are included in operating right-of-use ("ROU") assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at the lease commencement date. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Subleases are accounted for as operating leases separately from the lease they relate to, but similar in manner as all other leases.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ROU assets for operating leases are occasionally reduced by impairment losses. The Company uses the long-lived assets impairment guidance in ASC Subtopic 360-10, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant, and  Equipment &#8211; Overall</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Intangible assets</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are measured at fair value at the date of acquisition and amortized on a straight-line basis over their respective estimated useful lives. The Company has no indefinite-lived intangible assets. The Company evaluates its intangible assets for impairment when indicators of impairment exist. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are amortized on a straight-line basis over their estimated useful lives, as set forth in the table below:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 - 23 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;3 - 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company periodically assesses the estimated useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Impairment of goodwill and long-lived assets</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill is tested for impairment annually, or more frequently, if an event or circumstance indicates that an impairment loss may have been incurred.  The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also chose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Fair value is determined through various valuation techniques including discounted cash flow models and third-party independent appraisals, as considered necessary. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Debt issuance costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Debt issuance costs relating to the Company&#8217;s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company&#8217;s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Derivative financial instruments</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has used derivative financial instruments to reduce exposures to interest rates. Derivatives are recorded on the Consolidated Balance Sheet at fair value at each balance sheet date utilizing pricing models for non-exchange-traded contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criteria for designating a derivative as a hedge include the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income and reclassify it </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Income taxes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the provision of income taxes in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of Global Intangible Low-Taxed Income ("GILTI") in the period it arises and has therefore not provided for deferred taxes in respect of this item.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Government grants</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the grant agreements, amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Research and development credits</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits may be recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Share-based compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC Topic 718, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Compensation &#8211; Stock Compensation </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">("ASC 718")</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Replacement awards</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Transaction and integration-related expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Transaction and integration-related expenses are the incremental costs directly attributable to completion and integration activities associated with the Company&#8217;s recent acquisitions. The costs consist of investment banking fees, advisory costs, professional fees, legal costs, retention agreements with employees, and ongoing integration activities offset by the remeasurement of liability-classified contingent consideration. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Restructuring</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Restructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company&#8217;s structure and facilitate improved long-term performance. Asset related impairment charges are taken when the fair value is less than the asset&#8217;s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Net income per ordinary share</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Impact of Recently Issued or Adopted Accounting Standards</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accounting pronouncements recently adopted</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-07, Segment Reporting &#8211; Improvements to Reportable Segment Disclosures (&#8220;ASU 2023-07&#8221;), which amends the guidance in ASC Topic 280, Segment Reporting (&#8220;Topic 280&#8221;). The amended guidance requires disclosure of significant segment expenses and other segment items on an annual and interim basis, as well as additional qualitative disclosures. Furthermore, all disclosures about a reportable segment&#8217;s profit or loss, which are currently required annually, will be mandated for interim periods. The Company adopted ASU 2023-07 effective January 1, 2024, which resulted in additional segment reporting related disclosures. Refer to note </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business Segment and Geographical Information</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:107%">Accounting pronouncements issued but not adopted as of December&#160;31, 2024</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following accounting pronouncements have been issued, but not yet adopted, as of December&#160;31, 2024:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, which requires disaggregated information about an entity&#8217;s effective tax rate reconciliation and additional discloses on income taxes paid. The new requirements are effective for annual periods beginning after December 15, 2024. The guidance is to be applied prospectively, with an option for retrospective application. The Company is currently evaluating the impact of this new guidance on disclosures within its consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which requires disaggregated disclosure of income statement expenses. The new standard requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement, as well as disclosures about selling expenses. The new requirements are effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Requirements are to be applied prospectively, with an option for retrospective application. The Company is currently evaluating the impact of this new guidance on disclosures within its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067742490192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disaggregation of Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text">Disaggregation of Revenue<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue disaggregated by customer concentration is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Top client</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">639,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">721,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">683,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 2-5</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,431,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,453,508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,506,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 6-10</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,306,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,188,943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,112,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 11-25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,774,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,743,539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,585,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,129,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,012,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,853,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,281,676&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$8,120,176</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$7,741,386</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There was no revenue from individual customers greater than 10% of consolidated revenue in the respective years. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our customers have similar profiles and economic characteristics, and therefore have similar degrees of risk and growth opportunities.  </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Billed services (accounts receivable)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,437,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,821,855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses (note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,664)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable (net)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,401,989&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,790,322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,286,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">951,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,688,263&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,742,258&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:47.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="12" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,286,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">951,936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (payments on account)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,614,758)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,654,507)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(328,484)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(702,571)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">374,087&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled revenue and therefore contract assets rather than accounts receivable when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right of set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Consolidated Balance Sheet.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support a clinical trial. The progress towards completion for clinical service contracts is measured </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">based on total project costs (including reimbursable costs). Amounts owed to investigators and others in respect of reimbursable expenses at December&#160;31, 2024 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and December&#160;31, 2023 were $369.2&#160;million </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and $333.0&#160;million (see note 12. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other liabilities</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services as at December&#160;31, 2024 increased by $334.3 million as compared to December&#160;31, 2023. Unearned revenue decreased by $39.7 million over the same period resulting in a decrease of $374.1 million in the net balance of unbilled services and unearned revenue or payments on account between December&#160;31, 2023 and December&#160;31, 2024. These fluctuations are primarily due to the timing of payments and invoicing related to the Company's clinical trial management contracts. Billings and payments are established by contractual provisions on the delivery of units/milestones including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contracts when a cost-based input method of revenue recognition is applied and revenue recognized e</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">xceeds the amount billed to the customer. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The credit loss expense recognized on the Company's receivables and unbilled services was $28.4&#160;million and $24.6&#160;million for the years ended December&#160;31, 2024 and 2023, respectively.</span></div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$15.9 billion (December&#160;31, 2023: $14.8 billion) of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations. The Company expects to recognize revenue on approximately 47% of the u</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">nsatisfied performance obligation over the next twelve months (December&#160;31, 2023:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> 52%)</span>, with the remainder recognized thereafter over the duration of the customer contracts.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743051088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)</a></td>
<td class="text">Disaggregation of Revenue<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue disaggregated by customer concentration is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Top client</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">639,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">721,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">683,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 2-5</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,431,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,453,508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,506,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 6-10</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,306,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,188,943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,112,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 11-25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,774,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,743,539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,585,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,129,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,012,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,853,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,281,676&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$8,120,176</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$7,741,386</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There was no revenue from individual customers greater than 10% of consolidated revenue in the respective years. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our customers have similar profiles and economic characteristics, and therefore have similar degrees of risk and growth opportunities.  </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Billed services (accounts receivable)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,437,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,821,855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses (note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,664)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable (net)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,401,989&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,790,322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,286,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">951,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,688,263&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,742,258&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:47.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="12" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,286,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">951,936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (payments on account)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,614,758)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,654,507)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(328,484)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(702,571)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">374,087&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled revenue and therefore contract assets rather than accounts receivable when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right of set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Consolidated Balance Sheet.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support a clinical trial. The progress towards completion for clinical service contracts is measured </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">based on total project costs (including reimbursable costs). Amounts owed to investigators and others in respect of reimbursable expenses at December&#160;31, 2024 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and December&#160;31, 2023 were $369.2&#160;million </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and $333.0&#160;million (see note 12. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Other liabilities</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services as at December&#160;31, 2024 increased by $334.3 million as compared to December&#160;31, 2023. Unearned revenue decreased by $39.7 million over the same period resulting in a decrease of $374.1 million in the net balance of unbilled services and unearned revenue or payments on account between December&#160;31, 2023 and December&#160;31, 2024. These fluctuations are primarily due to the timing of payments and invoicing related to the Company's clinical trial management contracts. Billings and payments are established by contractual provisions on the delivery of units/milestones including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contracts when a cost-based input method of revenue recognition is applied and revenue recognized e</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">xceeds the amount billed to the customer. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The credit loss expense recognized on the Company's receivables and unbilled services was $28.4&#160;million and $24.6&#160;million for the years ended December&#160;31, 2024 and 2023, respectively.</span></div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$15.9 billion (December&#160;31, 2023: $14.8 billion) of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations. The Company expects to recognize revenue on approximately 47% of the u</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">nsatisfied performance obligation over the next twelve months (December&#160;31, 2023:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> 52%)</span>, with the remainder recognized thereafter over the duration of the customer contracts.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067845621904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Allowances for Credit Losses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetAbstract', window );"><strong>Accounts Receivable, after Allowance for Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForCreditLossesTextBlock', window );">Allowance for Credit Losses</a></td>
<td class="text">Allowance for Credit Losses<div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company does business with most major international pharmaceutical companies. Provision for credit losses at December&#160;31, 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and December&#160;31, 2023 comprises:</span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts used during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,887)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts provided during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,664&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,533&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForCreditLossesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org/310/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForCreditLossesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743468400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combinations</a></td>
<td class="text">Business Combinations<div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">KCR S.A. Group Acquisition</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On August 19, 2024, the Company acquired the KCR S.A. Group ("KCR"), a CRO offering full service and functional services partnership ("FSP") clinical trial services, in exchange for consideration of $92.5&#160;million. The acquisition of KCR has been accounted for as a business combination in accordance with ASC 805 'Business Combinations' ('ASC 805'). </span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The net cash outflow was $76.4&#160;million comprising cash payments of $88.1&#160;million, net of cash acquired of $11.7&#160;million. The fair value of contingent consideration was initially measured at the date of acquisition at $4.3&#160;million and subsequently remeasured at $1.1&#160;million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The final purchase price allocation resulted in the recognition of goodwill of $43.4&#160;million and intangible assets of $45.1&#160;million. Goodwill arising in connection with the acquisition is primarily attributable to the assembled workforce of KCR and the expected synergies of the acquisition. The goodwill recognized is not deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Since August 19, 2024, KCR has earned revenue of $32.8&#160;million and net income of $1.8&#160;million which are included in the Group's Consolidated Statement of Operations for the year ended December 31, 2024. The pro-forma effect of the KCR acquisition if completed on January 1, 2023 would have resulted in revenue and net income for the fiscal year ended December 31, 2024 of $8,331.5&#160;million and $792.5&#160;million respectively and in revenue and net income for the fiscal year ended December 31, 2023 of $8,202.0&#160;million and $613.3&#160;million respectively.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">HumanFirst Inc.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On January 9, 2024, the Company acquired HumanFirst Inc. ("HumanFirst"), a life sciences technology company in exchange for consideration of $13.3&#160;million. The acquisition of HumanFirst has been accounted for as a business combination in accordance with ASC 805. </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The net cash outflow was $7.8&#160;million comprising initial cash payments of $11.8&#160;million, net of cash acquired of $4.0&#160;million. Deferred consideration of $1.4&#160;million remains unpaid as of December&#160;31, 2024. </span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The final purchase price allocation resulted in the recognition of goodwill of $2.7&#160;million and a developed technology intangible asset of $9.9&#160;million. Goodwill arising in connection with the acquisition is primarily attributable to the assembled workforce of HumanFirst. The goodwill recognized is not deductible for income tax purposes.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">BioTel Research LLC Acquisition</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On October 2, 2023, the Company acquired the entire outstanding equity interests of BioTel Research LLC (&#8220;BioTel&#8221;), a leading provider of medical imaging and cardiac safety monitoring services, from BioTelemetry Inc. in exchange for initial cash consideration of $68.1 million. Cash acquired amounted to $1.4&#160;million. The final purchase price allocation resulted in the recognition of intangible assets of $36.4 million and goodwill of $23.4 million. Goodwill arising in connection with the acquisition is primarily attributable to the assembled workforce of BioTel and the expected synergies of the acquisition. The goodwill recognized is deductible for income tax purposes.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">PRA Health Sciences, Inc. Acquisition</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021 (the "Merger Date"), the Company completed the acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of PRA Health Sciences ("the Acquisition" and "the Merger"). The Merger was accounted for as a business combination using the acquisition method of accounting in accordance with ASC 805.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022, the Company incurred approximately $23.5 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$16.4 million and $17.7 million of Merger-related financing fees which are included in the &#8220;Interest expense&#8221; line item in the Consolidated Statement of Operations. </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Oncacare Limited Acquisition</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 20, 2023, the Company completed the purchase of the majority investor's 51% majority voting share capital of Oncacare Limited ("Oncacare") for $5.1&#160;million, such that Oncacare and its subsidiaries became wholly-owned subsidiaries of the ICON Group. The Oncacare acquisition resulted in goodwill of $13.4 million and also gave rise to an acquisition-related gain of $6.2 million. </span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Transaction and Integration Costs</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the years ended December&#160;31, 2024, December&#160;31, 2023, and  December&#160;31, 2022, the Company incurred net Merger, transaction and integration related expenses of $29.6 million, $44.2 million and $39.7 million, respectively, which were accounted for separately from the business combination and expensed as incurred within the &#8220;Transaction and integration related&#8221; line item of the Consolidated Statement of Operations. The costs consist of investment banking fees, advisory costs, </span></div>professional fees, legal costs, retention agreements with employees, ongoing business combination and integration activities offset by the remeasurement of liability-classified contingent consideration.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743181728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value</a></td>
<td class="text">Fair Value<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company records certain assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy that prioritizes the inputs used to measure fair value is described below. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 1 &#8212; Quoted prices in active markets for identical assets or liabilities.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 2 &#8212; Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 3 &#8212; Unobservable inputs that are supported by little or no market activity. This includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable and accounts payable approximate fair value due to the short maturities of these instruments.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1,2</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,448&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,448&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">1</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Excludes investments in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">equity securities recorded at cost of $3.5 million which do not qualify for the NAV practical expedient.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> As at December&#160;31, 2023, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">3</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,804</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,804</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,758&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">2</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Certain investments qualify for the NAV practical expedient in ASC 820. Investments in equity consist of interests in funds and equity securities without readily determinable fair values. To determine the classification of investments in equity, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2024 and December&#160;31, 2023 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2024 and December&#160;31, 2023 qualify for the NAV practical expedient. Any increases or decreases in fair value are recognized in net income in the period. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">3</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents the fair value of highly liquid investments with maturities greater than three months, a minimum "A-" rated fixed term deposit and are based on quoted market prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">4</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents the fair value of the interest rate caps and the interest rate swap. </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Non-recurring Fair Value Measurements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain assets and liabilities are carried on the Consolidated Balance Sheet at cost and are not re-measured to fair value on a recurring basis. These assets include finite-lived intangible assets that are tested for impairment when a triggering event occurs and goodwill that is tested for impairment annually or when a triggering event occurs. As of December&#160;31, 2024, assets carried on the balance sheet and not re-measured to fair value on a recurring basis totaled approximately $12,614.7 million (December&#160;31, 2023: $12,878.0 million) and are identified as Level 3 assets. These assets are comprised of goodwill of $9,051.4 million (December&#160;31, 2023: $9,022.1 million), intangible assets of $3,559.8 million (December&#160;31, 2023: $3,855.9 million) and investments in equity recorded at cost of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$3.5 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s debt was $3,469.2&#160;million at December&#160;31, 2024 (December&#160;31, 2023: $3,793.5&#160;million). </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of the senior secured term loan facility</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, the 2026 Notes and the New Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions. The fair value of the senior secured revolving loan facility approximates its carrying value, due to the short term duration.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067845807600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">Investments<div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Investments in equity</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company entered into subscription agreements with a number of funds. During the year ended December&#160;31, 2024, net capital totaling $13.1 million (December&#160;31, 2023: $14.0 million) had been advanced under the terms of the subscription agreements. The Company determined that the interest in funds meets the definition of equity securities without readily determinable fair values. The Company therefore concluded that the interests held at December&#160;31, 2024 and December&#160;31, 2023 qualify for the NAV practical expedient in ASC 820. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There was a decrease in fair value of $3.3 million (December&#160;31, 2023: increase in fair value $0.2 million) recognized in net income during the year bringing the carrying value of the subscriptions to $54.4 million at December&#160;31, 2024.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2024, the Company had committed to future investments of $102.2 million in respect of these funds.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Investments in equity also include equity investments of $3.5 million </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(of which </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$1.5 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> was invested during the year ended December&#160;31, 2024) which do not qualify for the NAV practical expedient, and for which the measurement alternative has been applied.  Accordingly, these investments in equity are measured at cost, less impa</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">irment.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Available for sale investments </span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As at December&#160;31, 2024, the Company held available for sale investments amounting to $nil (December&#160;31, 2023: $2.0 million). Short-term investments comprise highly liquid investments with maturities of greater than three months and minimum "A-" rated fixed term deposits. The Company classifies its short- term investments as available for sale.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 940<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/940-320/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph b<br> -Publisher SEC<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/320/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/942-320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067741325440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment, net</a></td>
<td class="text">Property, Plant and Equipment, net<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Property, Plant and Equipment for the years ended December&#160;31, 2024 and 2023 is as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,072&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">689,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">550,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,034&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">928,894&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">781,067&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated depreciation and asset write offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(546,015)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(419,883)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment (net)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">382,879&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">361,184&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The depreciation expense recognized by the Company</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> was $138.2 million, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">$126.1 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> and $106.4 million for the years ended December&#160;31, 2024, 2023, and 2022, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company regularly updates its register of property, plant and equipment and during the year ended December&#160;31, 2024 and the year ended December&#160;31, 2023, certain fully depreciated assets were written off as they were no longer used by the Company.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067845826288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text">Goodwill<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in the carrying amount of goodwill for the years ended December&#160;31, 2024 and 2023 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,022,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,971,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current period acquisitions (note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange movement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,791)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,051,410&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,022,075&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">There were no impairment charges for the y</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">ear ended December&#160;31, 2024 or the year ended December&#160;31, 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067741165600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text">Intangible Assets<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Intangible Assets for the years ended December&#160;31, 2024 and 2023 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,129,501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,090,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">543,933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">541,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names &amp; brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,199,004&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,147,971&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,639,212)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,292,106)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net book value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,559,792&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,855,865&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The amortization expense recognized by the Company</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> was </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">$350.3 million, $459.9 million, and $463.1 million for the years ended December&#160;31, 2024, 2023, and 2022, respe</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">ctively. The decrease in amortization in the twelve months ended December&#160;31, 2024 is due to the order backlog and trade name intangible assets recognized in connection with the PRA merger amounting to </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">$500.0 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> and </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">$202.0 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> respectively as of the date of acquisition, becoming fully amortized on July 1, 2024.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On August 19, 2024, the Company acquired KCR. The acquisition resulted in the recognition of intangible assets of $45.1 million, comprising customer relationships of $41.4 million and order backlog of $3.7 million. These assets will be amortized over their expected useful lives of 13 years and 5 years respectively. In total, $1.3 million has been amortized in the period since the date of acquisition.  Refer to note 6. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Business Combinations</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On January 9, 2024, the Company acquired HumanFirst. The acquisition resulted in the recognition of a developed technology intangible asset of $9.9 million which will be amortized over its expected useful life of 5 years. In total, $2.0 million has been amortized in the period since the date of acquisition. Refer to note 6. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Business Combinations</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On October 2, 2023, the Co</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">mpany acquired BioTel Research LLC (&#8220;BioTel&#8221;). The acquisition resulted in the recognition of intangible assets of $36.4 million, comprising customer relationships of $12.5 million, order backlog of $3.9 million and developed technology assets of $20.0 million. These assets will be amortized over their expected useful lives of between 3 years and 16 years. $6.1 million has been amortized during the twelve months ended December&#160;31, 2024 (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">December&#160;31, 2023: </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$1.5 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">)</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">. Refer to note 6. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Business Combinations</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future intangible asset amortization expense for the years ended December 31, 2025 to December 31, 2029 is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235,011&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220,771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">208,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">195,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,039,878&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743027104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">Other Liabilities</a></td>
<td class="text">Other Liabilities<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Other Liabilities for the years ended December&#160;31, 2024 and 2023 is as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General trade and overhead liabilities*</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">531,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">463,882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Personnel related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">385,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-727">Other liabilities</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short term government grants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">923,603&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">915,399&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*includes amounts due to third parties in respect of accrued reimbursable investigator expenses of $369.2 million at December&#160;31, 2024 and $333.0 million at December&#160;31, 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067845697056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Bank Credit Lines, Loan Facilities and Notes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Bank credit lines, loan facilities and notes</a></td>
<td class="text">Bank credit lines, loan facilities and notes<div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company had the following debt outstanding as of December&#160;31, 2024 and </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate as of</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal amount as of</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.860&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">946,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,251,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes (the "2026 Notes")</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Revolving Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes (the "2027 Notes")*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes (the "2029 Notes")*</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes (the "2034 Notes")*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2034</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,446,450&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,806,213&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less current portion of debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29,762)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(110,150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,416,688&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,696,063&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less debt issuance costs and debt discount</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,290)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,624)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,396,398&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,665,439&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*Issued May 8, 2024</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company incurred interest costs from various financing arrangements during the years ended December&#160;31, 2024,  December&#160;31, 2023 and December&#160;31, 2022 as set out in the table below. These costs have been charged in the interest expense line of the Consolidated Statement of Operations. In the years ending December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022, the Company expensed $23.5 million,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$16.4 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and $17.7 million of transaction related financing costs, inclusive of the amortization of financing fees which were previously capitalized. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense on drawn facilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">311,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of merger related financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing costs*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total financing costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237,237&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">336,699&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229,731&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*Includes costs associated with the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">senior secured revolving loan facility.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the contractual maturities of the Company's debt obligations were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturities of debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,762&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">529,762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">779,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">857,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2029 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,446,450&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's primary financing arrangements are its senior secured credit facilities (the "Senior Secured Credit Facilities"), which consists of a senior secured term loan and a revolving credit facility; the 2026 Notes and the New Notes.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The New Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 8, 2024, ICON Investments Six Designated Activity Company (the "Issuer"), a wholly-owned subsidiary of ICON plc, issued $2&#160;billion senior secured notes ("the New Notes"). The New Notes were issued in aggregate principal amounts of: $750&#160;million 5.809% Senior Secured Notes due 2027 (the "2027 Notes"), $750&#160;million 5.849% Senior Secured Notes due 2029 (the "2029 Notes") and $500&#160;million 6.000% Senior Secured Notes due 2034 (the "2034 Notes"). </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The Company paid an underwriting discount of $6.8&#160;million on the New Notes being: 0.250% of the principal amount of the 2027 Notes, 0.350% of the principal amount of the 2029 Notes and 0.450% of the 2034 Notes. Further, the 2034 Notes were issued at a discount of $0.5&#160;million (issued at 99.896% of par). </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The proceeds from the issuance were used to repay a portion of the senior secured term loan outstanding under the Senior Secured Credit Facilities and to pay fees, costs and expenses related to the offering.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest on the New Notes is payable on May 8 and November 8 of each year, having commenced on November 8, 2024. Unless previously redeemed, the 2027 Notes will mature on May 8, 2027, the 2029 Notes will mature on May 8, 2029 and the 2034 Notes will mature on May 8, 2034.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The New Notes are guaranteed on a senior secured basis by ICON and its existing and future wholly owned subsidiaries, in each case that guarantee the obligations under our Senior Secured Credit Facilities and the 2026 Notes. The New Notes are the senior secured obligation of the Issuer and the Guarantors and rank equally in right of payment to all of the Issuer&#8217;s and Guarantors&#8217; existing and future senior debt and senior in right of payment to all of the Issuer's and Guarantors' existing and future subordinated debt. The New Notes and the guarantees are secured on a first-lien basis by substantially all of the existing and future assets of the Issuer and the Guarantors that also secure the Issuer&#8217;s and the Guarantors&#8217; obligations under the Senior Secured Credit Facilities and the 2026 Notes on a pari passu basis, subject to permitted liens, and the liens on the collateral securing the New Notes rank equally in priority with the liens on the collateral securing borrowings and guarantees under the Senior Secured Credit Facilities, the 2026 Notes and any other future pari passu first lien indebtedness.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Credit Facilities</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On July 1, 2021, the Company completed the acquisition of PRA Health Sciences, Inc. ("PRA") by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA, the parent of the PRA Health Sciences ("the Merger"). In conjunction with the completion of the Merger, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515&#160;million and a senior secured revolving loan facility in an initial aggregate principal amount of $300&#160;million (the "Senior Secured Credit Facilities"). On May 2, 2023, the Company agreed with its lenders to increase the aggregate principal amount of the senior secured revolving loan facility from $300&#160;million to $500&#160;million. The Senior Secured Credit Facilities and the 2026 Notes were issued at a discount of $27.6&#160;million.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR plus an applicable margin which is dependent on the Company's net leverage ratio. At </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, the applicable margin is 2.0% (which reflects the Third Amendment). The senior secured term loan facility is subject to a floor of 0.50%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reflecting the Third Amendment, the interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 0.45%, 0.10% or &#8211;% based on the Company&#8217;s current corporate family rating assigned by S&amp;P of BB (or lower), BB+ or BBB- (or higher), respectively, or (ii) Term SOFR plus an applicable margin of 1.45%, 1.10%, 0.85%, 0.65%, or 0.50% based on the Company&#8217;s current corporate family rating assigned by S&amp;P of BB (or lower), BB+, BBB-, BBB or BBB+ (or higher), respectively. In addition, lenders under the revolving loan facility are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Borrowers&#8217; (as defined in the Senior Secured Credit Facility) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON&#8217;s, the Borrowers&#8217; and each of the subsidiary guarantor&#8217;s assets (subject to certain exceptions), and the Senior Secured Credit Facilities will have a first-priority lien on such assets, which will rank pari passu with the lien securing the 2026 Notes and the New Notes subject to other permitted liens. The Company is permitted to make prepayments on the senior secured term loan without penalty.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Principal repayments, comprising mandatory and voluntary repayments, during the year ended December&#160;31, 2024 and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2023 were as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal repayments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(275,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(250,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,014,882)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(150,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 3</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,441)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(300,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 4</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,440)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(250,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total repayments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,304,763)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(950,000)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The voluntary repayments made during the year resulted in an accelerated charge associated with previously capitalized fees of $16.9&#160;million (December&#160;31, 2023: $7.9&#160;million). </span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">During the year ended December&#160;31, 2024, the Company drew down $318.0&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(December&#160;31, 2023: $370.0&#160;million) of the senior secured revolving loan facility and repaid $373.0&#160;million  (December&#160;31, 2023: $315.0&#160;million) as shown below. As at December&#160;31, 2024, $nil (December&#160;31, 2023: $55.0&#160;million) was drawn under the senior secured revolving loan facility.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Drawdown </span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Repayment</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Closing Balance</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 1, 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 2, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(80,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 3, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 4, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total drawdown / (repayments) in 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(315,000)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 1, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,000)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 2, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(193,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 3, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 4, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total drawdown / (repayments) in 2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">318,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(373,000)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">2026 Notes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In addition to the Senior Secured Credit Facilities, on July 1, 2021, a subsidiary of the Company issued $500&#160;million in aggregate principal amount of 2.875% senior secured notes (the "2026 Notes") in a private offering (the &#8220;Offering&#8221;). The 2026 Notes will mature on July 15, 2026. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Fair Value of Debt</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s debt was </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$3,469.2&#160;million</span> at December&#160;31, 2024 and (December&#160;31, 2023: $3,793.5&#160;million). The fair values of the senior secured term loan facility, the 2026 Notes and the New Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions. The fair value of the senior secured revolving loan facility approximates its carrying value due to the short term duration.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067846119040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivatives</a></td>
<td class="text">Derivatives<div style="text-align:justify;text-indent:14.4pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company previously entered into interest rate cap and swap agreements for purposes of managing its exposure to interest rate fluctuations.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On November 29, 2022, the Company entered into two interest rate cap agreements ("2022 Caps") with an initial total notional value of $2,101&#160;million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Caps began accruing on December 30, 2022 and the interest rate caps were due to expire on December 31, 2024. Under the terms of the interest rate caps, the Company had paid a fixed rate of 0.42% and received a variable rate equal to the amount that the three-month SOFR rate exceeds 4.75%. </span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On November 29, 2022, the Company entered into an interest rate swap agreement ("2022 Swap") with an initial notional value of $1,101&#160;million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Swap was due to begin accruing on December 31, 2024 and the interest rate swap was due to expire on September 30, 2026. Under the terms of the interest rate swap, the Company would have paid a fixed rate of 3.4% and would have received a variable rate of interest equal to the three-month SOFR on the 2022 Swap.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2022 Caps and the 2022 Swap were designated as cash flow hedges. G</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ains and losses were initially reported as a component of other comprehensive income/loss and subsequently recognized in net income.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">During the year, the Company&#8217;s exposure to interest rate fluctuations significantly reduced with the voluntary and mandatory repayments </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">f the senior secured term loan facility (refer to note 13. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:107%">Bank credit lines, loan facilities and notes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">). Given this reduction and the repricing of the Senior Secured Credit facilities, the Company </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">closed the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">2022 Caps and 2022 Swap agreements. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">At </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">December&#160;31, 2024, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">73%</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"> of the Company's outstanding debt is at a fixed interest rate (December&#160;31, 2023: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">13%)</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">During</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> the year ended December&#160;31, 2024, the Company recognized a gain of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$5.0&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">December&#160;31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">: $1.6 million) within other comprehensive income/loss after a reclassification of $13.9&#160;million (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">December&#160;31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">: $2.4&#160;million) from other comprehensive income/loss to the income statement.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">      The fair value of the Company&#8217;s derivative financial instruments at December&#160;31, 2024 amount to $nil. The fair value of the Company&#8217;s derivative financial instruments at December&#160;31, 2023 on a gross basis, are summarized in the following table:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.158%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notional</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest Rate Caps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,871&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,600,606&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest Rate Swap</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,100,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,701,212&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-5C<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/815/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067740102976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Operating Leases</a></td>
<td class="text">Operating Leases<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Lease costs recorded under operating leases for the years ended December&#160;31, 2024, 2023 and 2022 were as follows:</span></div><div style="margin-top:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,880&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from sub-leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,614)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,103)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,165)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating lease costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,852&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,717&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,715&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Of the total cost of $44.9 million incurred in the year ended December&#160;31, 2024 (December&#160;31, 2023, $45.7 million; December&#160;31, 2022, $52.7&#160;million), $37.2 million (December&#160;31, 2023, $37.9 million; December&#160;31, 2022, $48.3 million) is recorded within selling, general and administration costs and $7.7 million  (December&#160;31, 2023, $7.8 million; December&#160;31, 2022, $4.4 million) is recorded within direct costs. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Right-of-use assets obtained, in exchange for lease obligations, during the years ended December&#160;31, 2024 and December&#160;31, 2023 totaled $64.8 million and $37.7 million, respectively. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2024, 2023 and 2022, impairments of operating right-of-use assets were recognized within restructuring charges for $13.8 million, $8.7 million, and $28.4 million, respectively, as part of an office consolidation program (see note 19. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Charges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2024 were 6.56 years and 4.01%, respectively. The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2023 were 6.72 years and 3.29%, respectively.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable leases as of December&#160;31, 2024 were as follows:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:80.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Minimum rental payments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,931</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,445</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,257</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,156</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,838</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,047</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199,674</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,806)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176,868</span></td></tr></table></div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities are presented as current and non-current. As at </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, operating lease liabilities of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$36.8&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> have been included in <span style="-sec-ix-hidden:f-941"><span style="-sec-ix-hidden:f-942">Other liabilities</span></span> (December&#160;31, 2023: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> $36.4 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$140.1 million</span> million have been classified as Non-current Lease Liabilities (December&#160;31, 2023: $126.3 million).<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067740980320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-current other liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock', window );">Non-current other liabilities</a></td>
<td class="text">Non-current other liabilities<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Non-current other liabilities for the years ended December&#160;31, 2024 and 2023 is as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,470&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,998&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as noncurrent at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067856234432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Litigation</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We do not expect any litigation to have a materially adverse effect on our financial condition or results of operations. However, from time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has several non-cancelable operating leases, primarily for facilities, that expire over the next sixteen years. These leases generally contain renewal options and require the Company to pay all executory costs such as maintenance and insurance. See note 15.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Operating leases</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for rental expense pursuant to ASC 842 for the years ended December&#160;31, 2024, 2023 and 2022 and future minimum rental commitments as of December&#160;31, 2024.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067744289280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Share Capital</a></td>
<td class="text">Share Capital<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Holders of ordinary shares are entitled to receive such dividends as may be recommended by the Board of Directors of the Company and approved by the shareholders and/or such interim dividends as the Board of Directors of the Company may decide. On liquidation or a winding up of the Company, the par value of the ordinary shares are repaid out of the assets available for distribution among the holders of the ordinary shares of the Company. Holders of ordinary shares have no conversion or redemption rights. On a show of hands, every holder of an ordinary share present in person or proxy at a general meeting of shareholders shall have one vote, for each ordinary share held with no individual having more than one vote. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:29.25pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.02pt">Share based payments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024, 311,040 options were exercised at an average exercise price of $116.31 per share for total proceeds of $36.2 million. During the year ended December&#160;31, 2024, 120,458 ordinary shares were issued in respect of certain RSUs and 9,975 ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, 535,705 options were exercised at an average exercise price of $95.12 per share for total proceeds of $51.0 million. During the year ended December&#160;31, 2023, 188,800 ordinary shares were issued in respect of certain RSUs and 47,026 ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the year ended December&#160;31, 2022, 348,286 options were exercised at an average exercise price of $102.87 per share for total proceeds of $35.8 million. During the year ended December&#160;31, 2022, 195,029 ordinary shares were issued in respect of certain RSUs and 46,087 ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:29.25pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.02pt">Share Repurchase Program</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company can acquire up to 10% of its outstanding ordinary shares (by way of redemption), in accordance with Irish </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">law and the Company&#8217;s constitutional documents through open market share acquisitions. A resolution was passed at the Company&#8217;s Annual General Meeting (&#8220;AGM&#8221;) on July 23, 2024, which renewed the authorization for the Directors to purchase (buyback) up to 10% of the outstanding shares in the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 20, 2024, the Company's Board of Directors authorized a new buyback program of up to $500.0 million of the outstanding ordinary shares of the Company. On October 22, 2024, the Company's Board of Directors authorized an additional buyback program of up to $250.0 million of the outstanding ordinary shares of the Company. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All  ordinary  shares  that  are  redeemed  under  the  buyback  program  will  be canceled in accordance with the constitutional documents of the Company and the nominal value of these shares transferred to an undenominated capital fund as required under Irish Company law.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024, 2,179,699 ordinary shares were redeemed by the Company under this buyback program for a total consideration of $500.0 million.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No ordinary shares were redeemed by the Company during the year ended December&#160;31, 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, 420,530 ordinary shares were redeemed by the Company for total consideration of $100.0 million.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Under the repurchase program, a broker purchased or may purchase the Company's shares from time to time on the open market or in privately negotiated transactions in accordance with agreed terms and limitations. The program was and may be in the future designed to allow share repurchases during periods when the Company would ordinarily not be permitted to do so because it may be in possession of material non-public or price-sensitive information or due to applicable insider trading laws or self-imposed trading blackout periods. The Company's instructions to the broker in such cases were or may in the future be irrevocable and the trading decisions in respect of the repurchase program were made or will be made independently of and uninfluenced by the Company. The Company confirms that on entering the share repurchase plans it had no material non-public, price-sensitive or inside information regarding the Company or its securities. Furthermore, the Company will not enter into additional plans whilst in possession of such information. The timing and actual number of shares acquired by way of the redemption will be dependent on market conditions, legal and regulatory requirements and the other terms and limitations contained in the program. In addition, acquisitions under the program may be suspended or discontinued in certain circumstances in accordance with the agreed terms. Therefore, there can be no assurance as to the timing or number of shares that may be acquired under the program.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067741314656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring Charges</a></td>
<td class="text">Restructuring Charges<div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022, the Company incurred approximately $92.1&#160;million, $45.4&#160;million and $31.1&#160;million of restructuring charge in the Consolidated Statements of Operations under a restructuring plan adopted following a review of operations.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The restructuring plan reflected a workforce reduction of $74.5&#160;million (December&#160;31, 2023: $34.1&#160;million, December&#160;31, 2022: $2.7&#160;million) and an office consolidation program to optimize the Company's office footprint of $17.6&#160;million (December&#160;31, 2023: $11.3&#160;million, December&#160;31, 2022: $28.4&#160;million), being the impairment of operating right-off-use assets and related property plant and equipment of $15.7 million (December&#160;31, 2023: $8.7 million, December&#160;31, 2022: $28.4&#160;million) and onerous contract costs of $1.9&#160;million (December&#160;31, 2023: $2.6&#160;million, December&#160;31, 2022: $nil&#160;).</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,123&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,390&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2024, a total liability of $31.5 million (December&#160;31, 2023: $7.0 million) was recorded on the Consolidated Balance Sheet relating to restructuring activities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Charge during the year*</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51,917)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,474&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,999&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*The charge for the year ended December&#160;31, 2024 reflects the workforce reduction of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$74.5 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> (December&#160;31, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">: $34.1 million) and onerous contract costs of $1.9 million (December&#160;31, 2023: $2.6 million).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The closing provision of </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$31.5 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(December&#160;31, 2023: $7.0 million) reflects:</span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> (1) $27.7 million (December&#160;31, 2023: $4.0 million) of personnel related liabilities as a result of the workforce reduction; all of which have been classified as short-term within Other Liabilities, and</span></div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> (2) $3.8 million (December&#160;31, 2023: $3.0 million) of facilities related liabilities of which $1.4 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(December&#160;31, 2023: $1.0 million) is included within Other Liabilities and $2.4 million (December&#160;31, 2023: $2.0 million)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span>is included within Non-Current Other Liabilities.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/420/tableOfContent<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067741668448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's United States and Irish based subsidiaries file income tax returns in the United States and Ireland respectively. Other foreign subsidiaries are taxed separately under the laws of their respective countries.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The components of income before income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">736,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">624,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(304,546)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(352,532)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(270,440)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">437,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">352,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">869,184&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">624,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">567,851&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The components of income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income tax expense:</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current tax (benefit)/expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45,307)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42,428)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current tax expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178,252&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,152&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184,396&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax (benefit)/expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,663)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,166)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69,493)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(143,323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(118,475)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax benefit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100,542)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85,403)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(124,985)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense was allocated to the following components of other comprehensive income:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency impact on long term funding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,903)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retirement benefit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(895)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">647</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">301</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,190&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,147&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,622&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ireland's statutory trading income tax rate, the rate of our country of domicile, is 12.5%. The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes at Irish statutory rate of 12.5% (2023:12.5%; 2022:12.5%)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate differential from amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48,240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71,223)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Global Minimum Tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign and other income taxed at higher rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research &amp; development tax incentives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,041)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,868)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,608)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Movement in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,279)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,068)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effects of change in tax rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,691&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Decrease)/ increase in unrecognized tax benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,456)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54,347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investor tax expense on foreign subsidiary earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,995)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,385)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,487)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,756)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other and non-deductible expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,413)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(654)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,710&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,749&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,411&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deferred tax liabilities:</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,547&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating right-of-use-assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,014&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">901,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in foreign subsidiaries </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax liabilities recognized</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,002,493&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,073,114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss and tax credits carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,082&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303,720&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290,643&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38,955)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42,967)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets recognized</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,765&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,676&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Overall net deferred tax liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(737,728)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(825,438)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December&#160;31, 2024 Ireland subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available for offset against future tax liabilities, if any, of $15.6 million.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">At December&#160;31, 2024 U.S. subsidiaries had U.S. federal and state net operating loss ("NOL") carryforwards of approximately $8.0 million and $277.8 million, respectively. These NOLs are available for offset against future taxable income and the expiry dates are shown in the table below. The subsidiaries' ability to use the U.S. federal NOL carryforwards is limited on an annual basis due to change of ownership in 2014, 2017, 2019 and 2024 as defined by Section 382 of the Internal Revenue Code of 1986, as amended and expire between 2025 - 2037. The U.S. state NOL carryforwards are restricted by the state/entity in which they arose. As of December&#160;31, 2024, U.S subsidiaries also had disallowed interest carried forward of $317.0&#160;million </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(December&#160;31, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">: $204.0&#160;million) that can be carried forward indefinitely. The increase of $113.0&#160;million was recognized within the income tax expense. These carryforwards are available for offset against future taxable income in the event that the U.S subsidiaries have excess capacity for interest deductions in future years. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expected expiry dates of the US NOLs are as follows:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Federal<br/>NOL's</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">State<br/>NOL's</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025-2038</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">262,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2039-2043</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,035&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">277,828&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, we also have general business tax credit carryforwards of approximately $1.0 million that are available to reduce future U.S. federal and state income taxes. The general business tax credits are non-refundable and are due to expire between the years 2026-2038.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">At December&#160;31, 2024 other than those in the U.S. and Ireland, we had operating loss carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future taxable income, if any, of approximately $42.4 million. In addition, at December&#160;31, 2024 those subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward for up to 30 years, available to offset against future tax liabilities, if any, of  $2.7 million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The valuation allowance at December&#160;31, 2024 was $39.0 million (December&#160;31, 2023; $43.0 million). The net change in the total valuation allowance was a decrease of $4.0 million during 2024 and a decrease of $0.4 million during 2023. Of the total decrease of $4.0 million in 2024, an increase of $2.0&#160;million was in respect of an acquired entity, $5.3 million decrease was recognized within income tax expense and a decrease of $0.7 million was recognized in Other Comprehensive Income. Of the total decrease of $0.4 million in 2023, $1.1 million was recognized within income tax expenses and an increase of $0.7 million was recognized in Other Comprehensive Income.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The valuation allowances at December&#160;31, 2024 and December&#160;31, 2023 were primarily related to operating losses and tax credits carried forward that, in the judgment of management, are not more likely than not to be realized. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, loss utilization, projected future taxable income and tax planning strategies in making this assessment. In respect of deferred tax assets not subject to a valuation allowance, management considers that it is more likely than not that these deferred tax assets will be realized on the basis that there will be sufficient reversals of deferred tax liabilities and taxable income in future periods.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company has recognized a deferred tax liability of $35.0 million (2023: $52.4 million) for investments in foreign subsidiaries where the Company does not consider the earnings to be indefinitely reinvested. For the deferred tax liability not recognized in respect of temporary differences related to investments in foreign subsidiaries which are considered to be indefinitely reinvested, it is not practicable to calculate the exact unrecognized deferred tax liability. However it is not expected to be material as Ireland recently implemented a participation exemption in respect of distributions from foreign subsidiaries in EEA/treaty countries, in addition to the foreign tax credit regime at the statutory tax rate in the jurisdiction of the subsidiary, so that no material tax liability would be expected to arise in Ireland in the event these earnings were ever remitted. In addition, withholding taxes applicable to remittances from foreign subsidiaries would not be expected to be material given Ireland&#8217;s tax treaty network and the EU parent subsidiary directive.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at start of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,098&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease related to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,525)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(918)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,442)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lapse of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(65,417)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62,363)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(838)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,619&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160,016&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217,584&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The relevant statute of limitations for unrecognized tax benefits totaling $61.6 million could potentially expire during 2025. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in the balance of total unrecognized tax benefits at December&#160;31, 2024 were potential benefits of $101.6 million, which if recognized, would affect the effective rate on income from continuing operations. The balance of total unrecognized tax benefits at December&#160;31, 2023 and December&#160;31, 2022 included potential benefits which, if recognized, would affect the effective rate of income tax from continuing operations of $160.0 million and $217.6 million respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest and penalties recognized during the year ended December&#160;31, 2024 amounted to a net charge of $1.9 million (2023: $4.2 million, 2022: $7.1 million) and are included within the income tax expense. Total accrued interest and penalties as of December&#160;31, 2024 and December&#160;31, 2023 were $24.2 million and $27.1 million respectively and are included in closing income taxes payable at those dates.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our major tax jurisdictions are Ireland and the United States. We may potentially be subjected to tax audits in both our major jurisdictions. In Ireland, tax periods open to audit include the years ended December&#160;31, 2020, December&#160;31, 2021, December&#160;31, 2022, December&#160;31, 2023 and December&#160;31, 2024. In the United States, tax periods open to audit include the years ended December&#160;31, 2021, December&#160;31, 2022, December&#160;31, 2023 and December&#160;31, 2024. During such audits, local tax authorities may challenge the positions taken by us in our tax returns.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743810176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Equity Incentive Schemes and Stock Compensation Charges</a></td>
<td class="text">Equity Incentive Schemes and Stock Compensation Charges<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Share Options</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 21, 2008 the Company adopted the Employee Share Option Plan 2008 (the "2008 Employee Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any employee, or any Director holding a salaried office or employment with the Company or a Subsidiary for the purchase of ordinary shares. On the same date, the Company also adopted the Consultants Share Option Plan 2008 (the "2008 Consultants Plan"), pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any consultant, adviser or non-executive Director retained by the Company or any Subsidiary for the purchase of ordinary shares.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 14, 2017 both the 2008 Employee Plan and the 2008 Consultants Plan (together the "2008 Option Plans") were amended and restated in order to increase the number of options that can be issued under the 2008 Consultants Plan from 0.4 million to 1.0 million and to extend the date for options to be granted under the 2008 Option Plans. An aggregate of 6.0 million ordinary shares have been reserved under the 2008 Employee Plan, as reduced by any shares issued or to be issued pursuant to options granted under the 2008 Consultants Plan, under which a limit of 1.0 million shares applies. Further, the maximum number of ordinary shares with respect to which options may be granted under the 2008 Employee Option Plan, during any calendar year to any employee shall be 0.4 million ordinary shares. There is no individual limit under the 2008 Consultants Plan. No options may be granted under the 2008 Option Plans after February 14, 2027.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each option granted under the 2008 Option Plans is an employee stock option, or Nonqualified Stock Option ("NSO"), as described in Section 422 or 423 of the Internal Revenue Code. Each grant of an option under the 2008 Options Plans is evidenced by a Stock Option Agreement between the optionee and the Company. The exercise price is specified in each Stock Option Agreement, however option prices are not less than 100% of the fair market value of an ordinary share on the date the option is granted. Share option awards are granted with an exercise price equal to the market price of the Company's shares at date of grant. Share options typically vest over a period of <span style="-sec-ix-hidden:f-1226">four</span> to five years from date of grant and expire eight years from date of grant. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">PRA  Equity Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following represent the PRA equity incentive plans, that have been terminated as of July 1, 2021, as to grants of future awards.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, effective on July 1, 2021, each stock option and restricted stock unit under the PRA Plans was assumed by the Company and converted into a stock option or Restricted Share Unit exercisable for or payable in Ordinary Shares based on the ratio of the average trading price per Ordinary Share for the ten days prior to July 1, 2021, and the corresponding value of the Merger consideration for each PRA Share. Accordingly, the plans as detailed below were assumed by the Company.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PRA Health Sciences, Inc. 2020 Stock Incentive Plan  (the "2020 Plan&#8221;), 2018 Stock Incentive Plan (the "2018 Plan"), and 2014 Omnibus Incentive Plan (the "2014 Plan") were amended and restated and assumed by the Registrant effective as of July 1, 2021. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2020 Stock Incentive Plan, was approved by the PRA stockholders at their annual meeting on May 18, 2020. The 2020 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2020 Plan authorized the issuance of 2.5&#160;million shares of common stock plus all shares that remained available under the prior plan on May 18, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2018 Stock Incentive Plan (the &#8220;2018 Plan&#8221;), was approved by the PRA stockholders at their annual meeting on May 31, 2018. The 2018 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2018 Plan authorized the issuance of 2.0&#160;million shares of common stock plus all shares that remained available under the 2014 Plan on May 31, 2018 (which included shares carried over from the 2013 Plan).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On November 23, 2014, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2014 Plan for Key PRA Employees. The 2014 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The following table summarizes the transactions for the Company's share option plans for the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Granted<br/>Under Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,695,460&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.38&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229.94&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(348,286)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited/expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,698)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,378,119&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119.86&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,472&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232.48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(535,705)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited/expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,080)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">902,806&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142.96&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,380&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325.51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(311,040)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited/expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,854)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">622,292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170.52&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested and exercisable at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">426,497&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135.39&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average remaining contractual life of options outstanding and options exercisable at December&#160;31, 2024 was 3.91 years and 3.06 years respectively (2023: 4.42 years and 3.89 years respectively).</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The intrinsic value of options outstanding and options exercisable as of December&#160;31, 2024 was $34.0 million and $32.4 million, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The intrinsic value of options exercised during the years ended December&#160;31, 2024, 2023, and 2022, was $57.4 million, $80.4 million, and $41.9 million, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value of Stock Options Assumptions</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average fair value of options granted during the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022 was calculated using the Black-Scholes option pricing model. The weighted average fair values and assumptions were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115.76&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3 years</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected volatility is based on the historical volatility of our common stock over a period equal to the expected term of the options; the expected life represents the weighted average period of time that options granted are expected to be outstanding given consideration to vesting schedules and our historical experience of past vesting and termination patterns. The risk-free rate is based on the U.S. government zero-coupon bonds yield curve in effect at time of the grant for periods corresponding with the expected life of the option.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Restricted Share Units and Performance Share Units</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 23, 2013, the Company adopted the 2013 Employees Restricted Share Unit Plan (the "2013 RSU Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may select any employee, or any Director holding a salaried office or employment with the Company, or a Subsidiary to receive an award under the plan. On May 11, 2015, the 2013 RSU Plan was amended and restated in order to increase the number of shares that can be issued under the RSU Plan by 2.5 million shares. Further, on October 25, 2024, the 2013 RSU Plan was amended and restated effective as of November 6, 2024 in order to increase the number of shares that can be issued under the RSU Plan by a further 2.5&#160;million shares. Accordingly, an aggregate of 6.6 million ordinary shares have been reserved for issuance under the 2013 RSU Plan. The shares are awarded at par value and vest over a service period. Awards under the 2013 RSU Plan may be settled in cash or shares at the option of the Company. No awards may be granted under the 2013 RSU Plan after November 6, 2034.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 30 2019, the Company approved the 2019 Consultants and Directors Restricted Share Unit Plan (the &#8220;2019 Consultants RSU Plan&#8221;), which was effective as of May 16, 2019, pursuant to which the Compensation and Organization Committee of the Company&#8217;s Board of Directors may select any consultant, adviser or non-executive Director retained by the Company, or a Subsidiary to receive an award under the plan. 250,000 ordinary shares have been reserved for issuance under the 2019 Consultants RSU Plan. The awards are at par value and vest over a service period. Awards granted to non-executive directors vest over twelve months. No awards may be granted under the 2019 Consultants RSU Plan after May 16, 2029.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has awarded RSUs and PSUs to certain key individuals of the Group. The following table summarizes RSU and PSU activity for the year ended December&#160;31, 2024:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.599%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU Outstanding<br/>Number of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU<br/>Weighted Average<br/>Grant Date <br/>Fair Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU Outstanding<br/>Number<br/>of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU<br/>Weighted Average<br/>Grant Date Fair Value</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,256&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226.29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">621,011&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218.27&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,626&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325.51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">258,345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313.41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,975)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(120,458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">223.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(124,186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(111,309)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,721&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280.76&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">647,589&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251.36&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of RSUs vested for the year ended December&#160;31, 2024 totaled $26.9 million (2023: $35.4 million). The share price range for the year was $174.96 - $265.96 (2023: $159.33 - $265.96).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of PSUs vested for the year ended December&#160;31, 2024 totaled $1.8 million (2023: $7.5 million). The share price range for the year was $174.96 - $231.08 (2023: $159.33 - $166.51).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The PSUs vest based on service and specified EPS targets over the period 2022 &#8211; 2024, 2023 &#8211; 2025, and 2024 - 2026. Depending on the actual amount of EPS from 2022 to 2026, up to an additional 80,051 PSUs may also be granted.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Stock compensation expense</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations for the year ended December&#160;31, 2024 is stated after charging $45.9 million in respect of stock compensation expense (inclusive of employer related taxes). Stock compensation expense has been allocated as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,870&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,667&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,523&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, total unrecognized stock-based compensation expense related to outstanding non-vested stock-based compensation arrangements amounted to $108.1 million, which the Company expects to recognize over a weighted average period of 2.29 years.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The income tax expense for the year ended December&#160;31, 2024 reflects a net income tax benefit of $23.4 million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2024 was $10.1 million. The income tax expense for the year ended December&#160;31, 2023 reflects a net income tax benefit of $20.0 million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2023 was $10.9 million. The income tax expense for the year ended December&#160;31, 2022 reflects a net income tax benefit of $12.9 million in connection with stock compensation (including excess tax benefits) and the total tax benefit realized in connection with stock options exercised during 2022 was $7.7 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067742480160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographical Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segment and Geographical Information</a></td>
<td class="text">Business Segment and Geographical Information<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">The Company is a CRO providing outsourced services on a global basis to pharmaceutical, biotechnology, medical device and government and public health organizations. It specializes in the strategic development, management and analysis of programs that support all stages of the clinical development process - from compound selection to Phase I-IV clinical studies. The Company has the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and has the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" or &#8220;blended-service&#8221; solution. The Company has expanded through internal growth, together with a number of strategic acquisitions to enhance its expertise and capabilities in certain areas of the clinical development process. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%">The Company operates as one reportable segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries.  For each of the accounting periods presented herein, the Company determined that Chief Operating Decision Maker ('CODM') was comprised of the Chief Executive Officer and the Chief Financial Officer. As the Company is managed on a consolidated basis, the CODM evaluates performance and allocates resources based on consolidated net income. The CODM uses consolidated net income, as reported on the Consolidated Statement of Operations, to evaluate income generated from segment assets and for decisions related to the deployment of operating and capital resources.  The measure of segment assets is reported on the Consolidated Balance Sheet as total consolidated assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accounting policies of the reportable segment are the same as those described in Note 2. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. In the context of considerations around significant segment expenses, as the expense information that is regularly provided to the CODM is aligned with the respective consolidated expenses for direct costs and selling, general, and administrative expenses, as presented on the Consolidated Statement of Operations, such expense disclosures are not replicated here. Furthermore, as the Company consists of a single reportable segment, other quantitative disclosures, as required by Topic 280, are as presented on the Consolidated Statement of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues are allocated to individual entities based on where the work is performed in accordance with the Company's global transfer pricing model. Revenues and income from operations in Ireland are a function of our global contracting model and the Group&#8217;s transfer pricing model. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON Ireland acts as the Group entrepreneur under the Company&#8217;s global transfer pricing model given its role in the development and management of the Group, its ownership of key intellectual property and customer relationships, its key role in the mitigation of risks faced by the Group and its responsibility for maintaining the Company&#8217;s global network. ICON Ireland enters into the majority of the Company&#8217;s customer contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON Ireland remunerates other operating entities in the Group on the basis of an arm&#8217;s length return for the services they perform in each of their local territories. The arm&#8217;s length return for each ICON entity is established to ensure that each of ICON Ireland and the ICON entities that are involved in the conduct of services for customers, earn an appropriate return having regard to their respective functions performed, assets owned, and risks assumed in these intercompany transactions. The arm&#8217;s length return is reviewed annually to ensure that it is market appropriate. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The geographic split of revenue disclosed for each region outside Ireland is the arm&#8217;s length revenue attributable to these entities. The residual revenues of the Group, once each ICON entity has been paid its respective intercompany service fee, generally fall to be retained by ICON Ireland. As such, revenues and income from operations in Ireland are a function of this global transfer pricing model and comprise revenues of the Group after deducting the arm&#8217;s length revenues attributable to the activities performed outside Ireland.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no changes to the overall basis of segmentation or the measurement basis for the segment results since the prior year. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reportable geographic information at December&#160;31, 2024 and December&#160;31, 2023 and for the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022 is as follows:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a) The distribution of revenue by geographical area was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,793,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,377,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,984,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,560,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,574,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,618,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,985,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,283,790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,574,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">942,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">884,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,281,676&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,120,176&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,741,386&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b) The distribution of income from operations by geographical area was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">919,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">885,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">673,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216,768&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">254,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241,549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">314,982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sub-total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,448,104&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,416,006&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,258,324&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization on intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(350,292)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(459,854)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(463,087)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,097,812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">956,152&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">795,237&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c) The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span id="i85f7edaad3fa4a85a9148d91477e5119_6-1-1-1-401854"></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">530,481&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">501,517&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067741632912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Ordinary Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income Per Ordinary Share</a></td>
<td class="text">Net Income Per Ordinary Share<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There is no difference in net income used for basic and diluted net income per ordinary share.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for basic net income per ordinary share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,482,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,101,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,532,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive share options and other awards outstanding under share based compensation programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">549,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">615,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">936,043&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,032,424&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,717,640&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,468,363&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income per ordinary share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.53&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.40&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.13&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067744486240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">Accumulated Other Comprehensive Loss<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(234,075)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(149,148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remeasurement of retirement benefit obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,726&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,803&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain / (loss) on cash flow hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,161)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(229,929)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(143,506)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067741344768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Disclosure of Cash Flow Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Supplemental Disclosure of Cash Flow Information</a></td>
<td class="text">Supplemental Disclosure of Cash Flow Information<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">210,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for income taxes (net of refunds)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140,718&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163,778&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,322&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/230/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067741286064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Parties</a></td>
<td class="text">Related Parties <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">During the year, subsidiaries of the Company earned revenue of $0.3 million (December&#160;31, 2023: $0.2 million) from Corvus Pharmaceuticals. Dr. Linda Grais serves as a Director and shareholder</span><span style="color:#0094ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">of Corvus Pharmaceuticals. At December&#160;31, 2024, $0.1 million (December&#160;31, 2023: $0.1 million) was noted as due from Corvus Pharmaceuticals . </span></div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">During the year, subsidiaries of the Company earned revenu</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">e of $nil (December&#160;31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$0.05 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">) from Afimmune Limited. Dr. John Climax is Chief Executive Officer and a Director and shareholder of Afimmune Limited. At December&#160;31, 2024, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$0.1 million was no</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">ted as due from Afimmune Limited (December&#160;31, 2023: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$0.05 million</span>).<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743827776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Subsequent Events</span><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Company has evaluated subsequent events from the Balance Sheet date th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">rough February&#160;21, 2025, t</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">he date at which the consolidated financial statements were available to be issued. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">On February 18, 2025, the Company's Board of Directors authorized an additional buyback program of up to $750.0&#160;million of the outstanding ordinary shares of the Company. Along with unutilized amounts under the previous authorizations, this permits the Company to repurchase up to $1&#160;billion worth of ordinary shares. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">All ordinary shares that are redeemed under the buyback program will be canceled in accordance with the constitutional documents of the Company and the nominal value of these shares transferred to an undenominated capital fund as required under Irish Company law. Repurchases under the share buyback program may be effected from time to time in open market or privately negotiated transactions in accordance with agreed terms and limitations. The timing and amount of the repurchase transactions under this program will depend on a variety of factors, including market conditions and corporate and regulatory considerations. Depending upon results of operations, market conditions and the development of the economy, as well as other factors, generally we will consider share repurchases on an opportunistic basis from time to time.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Company has determined that there ar</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">e no other items t</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">o disclose.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067744412000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 791,474<span></span>
</td>
<td class="nump">$ 612,335<span></span>
</td>
<td class="nump">$ 505,304<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743470368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743655408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has a cybersecurity strategy and program designed to protect our information systems and data from an evolving cyber threat landscape. The cybersecurity program, overseen by the Chief Information Officer (CIO), has the support of executive leadership and the Board, and we have invested heavily in cybersecurity technologies to protect our environment. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Chief Information Officer (CIO), who reports to the CEO, has oversight responsibility for the cybersecurity strategy and program and has over a decade experience leading cybersecurity oversight. The Vice President of Cyber &amp; Information Security reports to the CIO and is responsible for the delivery of the cyber and information security strategy. The Vice President of Cyber &amp; Information Security as well as the overall security team have many years&#8217; experience and are all appropriately qualified. ICON&#8217;s cybersecurity processes are integrated into ICON&#8217;s overall risk management processes which are monitored by ICON&#8217;s executive leadership team and reported to the Board. The Chief Information Officer provides cybersecurity updates to the Board on a quarterly basis.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The underlying controls of the cyber risk management program are based on recognized best practices and standards for cybersecurity and information technology, including the National Institute of Standards and Technology (&#8220;NIST&#8221;) Cybersecurity Framework (&#8220;CSF&#8221;) and the International Organization Standardization (&#8220;ISO&#8221;) 27001 Information Security Management System Requirements. ICON has an enterprise-wide assessment, performed twice annually by a third party, of the Company&#8217;s cyber risk management program against ISO 27001. We also conduct an annual independent maturity review with a third party which is based on the NIST cybersecurity framework. ICON also maintains the Cyber Essentials certification.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has a dedicated Cybersecurity Operations Center that continuously monitors for threats and unauthorized access. The Cybersecurity Operations Center is staffed by appropriately qualified cyber and information security professionals. ICON has put in place controls and processes to inform and monitor the prevention, detection, mitigation, and remediation of cybersecurity incidents. These controls and procedures are designed to ensure prompt escalation of certain cybersecurity incidents so that decisions regarding public disclosure and reporting of such incidents can be made by executive management in a timely manner. The escalation processes are based on defined prioritization and severity assessment criteria.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text">ICON&#8217;s cybersecurity processes are integrated into ICON&#8217;s overall risk management processes which are monitored by ICON&#8217;s executive leadership team and reported to the Board.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text">The cybersecurity program, overseen by the Chief Information Officer (CIO), has the support of executive leadership and the Board, and we have invested heavily in cybersecurity technologies to protect our environment. <div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Chief Information Officer (CIO), who reports to the CEO, has oversight responsibility for the cybersecurity strategy and program and has over a decade experience leading cybersecurity oversight. The Vice President of Cyber &amp; Information Security reports to the CIO and is responsible for the delivery of the cyber and information security strategy. The Vice President of Cyber &amp; Information Security as well as the overall security team have many years&#8217; experience and are all appropriately qualified. ICON&#8217;s cybersecurity processes are integrated into ICON&#8217;s overall risk management processes which are monitored by ICON&#8217;s executive leadership team and reported to the Board. The Chief Information Officer provides cybersecurity updates to the Board on a quarterly basis.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">The Chief Information Officer (CIO), who reports to the CEO, has oversight responsibility for the cybersecurity strategy and program and has over a decade experience leading cybersecurity oversight.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">The Chief Information Officer provides cybersecurity updates to the Board on a quarterly basis.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Chief Information Officer (CIO), who reports to the CEO, has oversight responsibility for the cybersecurity strategy and program and has over a decade experience leading cybersecurity oversight. The Vice President of Cyber &amp; Information Security reports to the CIO and is responsible for the delivery of the cyber and information security strategy. The Vice President of Cyber &amp; Information Security as well as the overall security team have many years&#8217; experience and are all appropriately qualified. ICON&#8217;s cybersecurity processes are integrated into ICON&#8217;s overall risk management processes which are monitored by ICON&#8217;s executive leadership team and reported to the Board. The Chief Information Officer provides cybersecurity updates to the Board on a quarterly basis.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The underlying controls of the cyber risk management program are based on recognized best practices and standards for cybersecurity and information technology, including the National Institute of Standards and Technology (&#8220;NIST&#8221;) Cybersecurity Framework (&#8220;CSF&#8221;) and the International Organization Standardization (&#8220;ISO&#8221;) 27001 Information Security Management System Requirements. ICON has an enterprise-wide assessment, performed twice annually by a third party, of the Company&#8217;s cyber risk management program against ISO 27001. We also conduct an annual independent maturity review with a third party which is based on the NIST cybersecurity framework. ICON also maintains the Cyber Essentials certification.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON has a dedicated Cybersecurity Operations Center that continuously monitors for threats and unauthorized access. The Cybersecurity Operations Center is staffed by appropriately qualified cyber and information security professionals. ICON has put in place controls and processes to inform and monitor the prevention, detection, mitigation, and remediation of cybersecurity incidents. These controls and procedures are designed to ensure prompt escalation of certain cybersecurity incidents so that decisions regarding public disclosure and reporting of such incidents can be made by executive management in a timely manner. The escalation processes are based on defined prioritization and severity assessment criteria.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text">The Chief Information Officer (CIO), who reports to the CEO, has oversight responsibility for the cybersecurity strategy and program and has over a decade experience leading cybersecurity oversight. The Vice President of Cyber &amp; Information Security reports to the CIO and is responsible for the delivery of the cyber and information security strategy<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text">The Vice President of Cyber &amp; Information Security as well as the overall security team have many years&#8217; experience and are all appropriately qualified<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text">The Chief Information Officer provides cybersecurity updates to the Board on a quarterly basis.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067745335216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant accounting policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of consolidation</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Basis of consolidation</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition, intangible assets acquired in a business combination, goodwill impairment and income taxation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Disclosure of fair value of financial instruments</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Disclosure of fair value of financial instruments</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on the net present value of estimated future cash flows. Debt is measured at amortized cost.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial instruments are measured at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 1: Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 2: Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 3: Inputs are generally unobservable and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business combinations</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Business combinations</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Accounting for contingent consideration, after the acquisition, depends on the classification of the contingent consideration. Equity-classified contingent consideration is not remeasured after the acquisition date and subsequent settlement is accounted for within equity. Contingent consideration, which is classified as a liability or an asset, is remeasured to fair value at each reporting date until the contingency is resolved. The changes in fair value are recognized in earnings, unless the arrangement is a derivative which has been designated as a hedging instrument in a cash flow hedging relationship, in which case, the changes are initially recognized in other comprehensive income/loss.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and any contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Transaction and integration-related expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Transaction and integration-related expenses are the incremental costs directly attributable to completion and integration activities associated with the Company&#8217;s recent acquisitions. The costs consist of investment banking fees, advisory costs, professional fees, legal costs, retention agreements with employees, and ongoing integration activities offset by the remeasurement of liability-classified contingent consideration. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign currencies and translation of subsidiaries</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Foreign currencies and translation of subsidiaries</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's financial statements are prepared in United States dollars. The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income/loss. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Transactions in currencies other than the functional currency of the subsidiaries of the Company are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the subsidiaries of the Company are translated into the functional currency of that entity at exchange rates prevailing at the balance sheet date. Adjustments resulting from these translations are charged or credited to income. Foreign currency gains and losses on intercompany transactions classified as long-term investments are reported in other comprehensive income/loss as currency translation adjustments. Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts (credited) / charged</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,085)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,916&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,997)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Clinical trial service revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through / reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Laboratory services revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.    </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contracting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Consulting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Data services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the &#8220;units delivered&#8221; output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Commissions</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Reimbursable expenses and Direct costs</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Reimbursable expenses</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. The Company includes reimbursed expenses in revenue and direct costs as the Company is primarily responsible for fulfilling the promise to provide the specified service, including integration of the related services into a combined output to the customer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Direct costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. Payments are made based on predetermined contractual arrangements. Timing of payments may differ from the timing of the expense.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Cash and cash equivalents</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment in debt, equity and other</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Investments in debt, equity and other</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Available for sale investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies short-term investments as available for sale. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity.  Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses. Realized gains and losses are determined using specific identification.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Long term investments  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2024 and December&#160;31, 2023 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2024 and December&#160;31, 2023 qualify for the Net Asset Value ("NAV") practical expedient in ASC Topic 820, Fair value Measurements ("ASC 820"). Any increases or decreases in fair value are recognized in earnings in the period. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Investments in equity </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">which do not qualify for the NAV practical expedient are measured at cost, less impa</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">irment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Equity method investments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s investments that are not consolidated are accounted for under the equity method if the Company  exercises significant influence. These investments are classified as equity method investments on the Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of losses in equity investments in the Consolidated Statement of Operations. The Company reviews equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts receivable, net and unbilled revenue</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Accounts receivable, net and unbilled revenue</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the   Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accounts receivable early payment discounting</span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Transfers and Servicing </span>("ASC 860"). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, plant and equipment</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Property, plant and equipment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, plant and equipment is stated at cost less accumulated depreciation. Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings &#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 - 8 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment &#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div>Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception and reassess if there are changes in terms and conditions of the contract. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December&#160;31, 2024 and December&#160;31, 2023, the Company did not account for any leases as finance leases. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Operating leases are included in operating right-of-use ("ROU") assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at the lease commencement date. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Subleases are accounted for as operating leases separately from the lease they relate to, but similar in manner as all other leases.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ROU assets for operating leases are occasionally reduced by impairment losses. The Company uses the long-lived assets impairment guidance in ASC Subtopic 360-10, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant, and  Equipment &#8211; Overall</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Intangible assets</a></td>
<td class="text"><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Intangible assets</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are measured at fair value at the date of acquisition and amortized on a straight-line basis over their respective estimated useful lives. The Company has no indefinite-lived intangible assets. The Company evaluates its intangible assets for impairment when indicators of impairment exist. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are amortized on a straight-line basis over their estimated useful lives, as set forth in the table below:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 - 23 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;3 - 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company periodically assesses the estimated useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Impairment of goodwill and long-lived assets</a></td>
<td class="text"><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Impairment of goodwill and long-lived assets</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill is tested for impairment annually, or more frequently, if an event or circumstance indicates that an impairment loss may have been incurred.  The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also chose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Fair value is determined through various valuation techniques including discounted cash flow models and third-party independent appraisals, as considered necessary. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Debt issuance costs</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Debt issuance costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Debt issuance costs relating to the Company&#8217;s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company&#8217;s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative financial instruments</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Derivative financial instruments</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has used derivative financial instruments to reduce exposures to interest rates. Derivatives are recorded on the Consolidated Balance Sheet at fair value at each balance sheet date utilizing pricing models for non-exchange-traded contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criteria for designating a derivative as a hedge include the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income and reclassify it </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Income taxes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the provision of income taxes in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of Global Intangible Low-Taxed Income ("GILTI") in the period it arises and has therefore not provided for deferred taxes in respect of this item.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_GovernmentGrantsPolicyTextBlock', window );">Government grants</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Government grants</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the grant agreements, amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ResearchAndDevelopmentCreditsPolicyTextBlock', window );">Research and development credits</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Research and development credits</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits may be recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based compensation</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Share-based compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC Topic 718, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Compensation &#8211; Stock Compensation </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">("ASC 718")</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Replacement awards</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Transaction and integration-related expenses</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Business combinations</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Accounting for contingent consideration, after the acquisition, depends on the classification of the contingent consideration. Equity-classified contingent consideration is not remeasured after the acquisition date and subsequent settlement is accounted for within equity. Contingent consideration, which is classified as a liability or an asset, is remeasured to fair value at each reporting date until the contingency is resolved. The changes in fair value are recognized in earnings, unless the arrangement is a derivative which has been designated as a hedging instrument in a cash flow hedging relationship, in which case, the changes are initially recognized in other comprehensive income/loss.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and any contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Transaction and integration-related expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Transaction and integration-related expenses are the incremental costs directly attributable to completion and integration activities associated with the Company&#8217;s recent acquisitions. The costs consist of investment banking fees, advisory costs, professional fees, legal costs, retention agreements with employees, and ongoing integration activities offset by the remeasurement of liability-classified contingent consideration. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy', window );">Restructuring</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Restructuring</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Restructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company&#8217;s structure and facilitate improved long-term performance. Asset related impairment charges are taken when the fair value is less than the asset&#8217;s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net income per ordinary share</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Net income per ordinary share</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Impact of recently issued or adopted accounting standards</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Impact of Recently Issued or Adopted Accounting Standards</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accounting pronouncements recently adopted</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-07, Segment Reporting &#8211; Improvements to Reportable Segment Disclosures (&#8220;ASU 2023-07&#8221;), which amends the guidance in ASC Topic 280, Segment Reporting (&#8220;Topic 280&#8221;). The amended guidance requires disclosure of significant segment expenses and other segment items on an annual and interim basis, as well as additional qualitative disclosures. Furthermore, all disclosures about a reportable segment&#8217;s profit or loss, which are currently required annually, will be mandated for interim periods. The Company adopted ASU 2023-07 effective January 1, 2024, which resulted in additional segment reporting related disclosures. Refer to note </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business Segment and Geographical Information</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:107%">Accounting pronouncements issued but not adopted as of December&#160;31, 2024</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following accounting pronouncements have been issued, but not yet adopted, as of December&#160;31, 2024:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, which requires disaggregated information about an entity&#8217;s effective tax rate reconciliation and additional discloses on income taxes paid. The new requirements are effective for annual periods beginning after December 15, 2024. The guidance is to be applied prospectively, with an option for retrospective application. The Company is currently evaluating the impact of this new guidance on disclosures within its consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which requires disaggregated disclosure of income statement expenses. The new standard requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement, as well as disclosures about selling expenses. The new requirements are effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Requirements are to be applied prospectively, with an option for retrospective application. The Company is currently evaluating the impact of this new guidance on disclosures within its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_GovernmentGrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Government Grants, Policy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_GovernmentGrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ResearchAndDevelopmentCreditsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and Development Credits [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ResearchAndDevelopmentCreditsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost associated with exit or disposal activity or restructuring. Excludes entity newly acquired in business combination and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 12<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067845614400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant accounting policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ForeignCurrencyDisclosureTableTextBlock', window );">Adjustments resulting from foreign currency translations</a></td>
<td class="text">Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022 were as follows:<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts (credited) / charged</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,085)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,916&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,997)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock', window );">Estimated useful lives of assets</a></td>
<td class="text">Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings &#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 - 8 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment &#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 - 23 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;3 - 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Intangible Assets for the years ended December&#160;31, 2024 and 2023 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,129,501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,090,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">543,933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">541,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names &amp; brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,199,004&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,147,971&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,639,212)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,292,106)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net book value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,559,792&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,855,865&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ForeignCurrencyDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign Currency Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ForeignCurrencyDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Useful Lives For Property Plant Equipment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067741632000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disaggregation of Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue disaggregated by customer concentration is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Top client</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">639,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">721,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">683,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 2-5</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,431,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,453,508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,506,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 6-10</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,306,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,188,943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,112,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 11-25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,774,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,743,539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,585,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,129,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,012,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,853,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,281,676&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$8,120,176</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$7,741,386</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743836304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Accounts Receivables and Unbilled Revenue, and Unbilled Services and Unearned Revenue</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Billed services (accounts receivable)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,437,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,821,855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses (note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,664)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable (net)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,401,989&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,790,322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,286,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">951,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,688,263&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,742,258&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:47.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="12" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,286,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">951,936&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (payments on account)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,614,758)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,654,507)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(328,484)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(702,571)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">374,087&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067744280224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Allowances for Credit Losses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetAbstract', window );"><strong>Accounts Receivable, after Allowance for Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Schedule of Provision for Credit Losses</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company does business with most major international pharmaceutical companies. Provision for credit losses at December&#160;31, 2024</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and December&#160;31, 2023 comprises:</span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts used during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,887)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts provided during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,664&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,533&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743047520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis</a></td>
<td class="text">he fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1,2</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,448&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,448&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">1</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Excludes investments in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">equity securities recorded at cost of $3.5 million which do not qualify for the NAV practical expedient.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> As at December&#160;31, 2023, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">3</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,804</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,804</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,758&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">2</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Certain investments qualify for the NAV practical expedient in ASC 820. Investments in equity consist of interests in funds and equity securities without readily determinable fair values. To determine the classification of investments in equity, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2024 and December&#160;31, 2023 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2024 and December&#160;31, 2023 qualify for the NAV practical expedient. Any increases or decreases in fair value are recognized in net income in the period. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">3</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents the fair value of highly liquid investments with maturities greater than three months, a minimum "A-" rated fixed term deposit and are based on quoted market prices.</span></div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">4</span>Represents the fair value of the interest rate caps and the interest rate swap.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Fair Value, Assets Measured on Recurring Basis</a></td>
<td class="text">he fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1,2</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,448&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,448&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">1</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Excludes investments in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">equity securities recorded at cost of $3.5 million which do not qualify for the NAV practical expedient.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> As at December&#160;31, 2023, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">3</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,804</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,804</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,758&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">2</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Certain investments qualify for the NAV practical expedient in ASC 820. Investments in equity consist of interests in funds and equity securities without readily determinable fair values. To determine the classification of investments in equity, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2024 and December&#160;31, 2023 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2024 and December&#160;31, 2023 qualify for the NAV practical expedient. Any increases or decreases in fair value are recognized in net income in the period. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">3</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents the fair value of highly liquid investments with maturities greater than three months, a minimum "A-" rated fixed term deposit and are based on quoted market prices.</span></div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">4</span>Represents the fair value of the interest rate caps and the interest rate swap.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743684128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property Plant and Equipment, Net</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Property, Plant and Equipment for the years ended December&#160;31, 2024 and 2023 is as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,072&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">689,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">550,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,034&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">928,894&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">781,067&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated depreciation and asset write offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(546,015)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(419,883)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment (net)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">382,879&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">361,184&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067741318224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in the carrying amount of goodwill for the years ended December&#160;31, 2024 and 2023 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,022,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,971,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current period acquisitions (note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange movement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,791)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,051,410&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,022,075&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067741664560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8 - 23 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;3 - 5 years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Intangible Assets for the years ended December&#160;31, 2024 and 2023 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,129,501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,090,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">543,933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">541,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names &amp; brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,199,004&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,147,971&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,639,212)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,292,106)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net book value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,559,792&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,855,865&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Future Intangible Asset Amortization Expense</a></td>
<td class="text"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future intangible asset amortization expense for the years ended December 31, 2025 to December 31, 2029 is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235,011&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220,771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">208,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">195,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,039,878&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743836304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesTableTextBlock', window );">Schedule of Other Liabilities</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Other Liabilities for the years ended December&#160;31, 2024 and 2023 is as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General trade and overhead liabilities*</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">531,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">463,882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Personnel related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">385,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-727">Other liabilities</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short term government grants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">923,603&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">915,399&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*includes amounts due to third parties in respect of accrued reimbursable investigator expenses of $369.2 million at December&#160;31, 2024 and $333.0 million at December&#160;31, 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067740102448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Bank Credit Lines, Loan Facilities and Notes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Instruments</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company had the following debt outstanding as of December&#160;31, 2024 and </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate as of</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal amount as of</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.860&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">946,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,251,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes (the "2026 Notes")</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Revolving Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes (the "2027 Notes")*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes (the "2029 Notes")*</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes (the "2034 Notes")*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2034</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,446,450&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,806,213&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less current portion of debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29,762)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(110,150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,416,688&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,696,063&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less debt issuance costs and debt discount</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,290)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,624)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,396,398&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,665,439&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*Issued May 8, 2024</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Drawdown </span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Repayment</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Closing Balance</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 1, 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 2, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(80,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 3, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 4, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total drawdown / (repayments) in 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(315,000)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 1, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,000)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 2, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(193,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 3, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 4, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total drawdown / (repayments) in 2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">318,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(373,000)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock', window );">Schedule of Financing Cost</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense on drawn facilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">311,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of merger related financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing costs*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total financing costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">237,237&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">336,699&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229,731&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*Includes costs associated with the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">senior secured revolving loan facility.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt</a></td>
<td class="text"><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the contractual maturities of the Company's debt obligations were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturities of debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,762&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">529,762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">779,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">857,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2029 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,446,450&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock', window );">Schedule of Principal Payments on Debt Instrument</a></td>
<td class="text"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Principal repayments, comprising mandatory and voluntary repayments, during the year ended December&#160;31, 2024 and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;31, 2023 were as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal repayments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(275,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(250,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,014,882)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(150,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 3</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,441)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(300,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quarter 4</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,440)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(250,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total repayments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,304,763)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(950,000)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Financing Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Principal Payments on Debt Instrument</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-8<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067845815440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</a></td>
<td class="text">The fair value of the Company&#8217;s derivative financial instruments at December&#160;31, 2024 amount to $nil. The fair value of the Company&#8217;s derivative financial instruments at December&#160;31, 2023 on a gross basis, are summarized in the following table:<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.158%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notional</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest Rate Caps</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,871&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,600,606&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest Rate Swap</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,100,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,411&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,701,212&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067741633968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Costs</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Lease costs recorded under operating leases for the years ended December&#160;31, 2024, 2023 and 2022 were as follows:</span></div><div style="margin-top:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,880&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from sub-leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,614)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,103)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,165)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating lease costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,852&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,717&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,715&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Operating Lease Maturity</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable leases as of December&#160;31, 2024 were as follows:</span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:80.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Minimum rental payments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,931</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,445</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,257</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,156</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,838</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,047</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199,674</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,806)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176,868</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067845731312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-current other liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Non-current other liabilities</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Non-current other liabilities for the years ended December&#160;31, 2024 and 2023 is as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,470&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,998&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067744010496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Schedule of Restructuring Charges</a></td>
<td class="text"><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,123&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,390&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Reserve by Type of Cost</a></td>
<td class="text"><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Charge during the year*</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51,917)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending provision</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,474&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,999&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*The charge for the year ended December&#160;31, 2024 reflects the workforce reduction of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$74.5 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> (December&#160;31, 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">: $34.1 million) and onerous contract costs of $1.9 million (December&#160;31, 2023: $2.6 million).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067740722256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncomeBeforeIncomeTaxTableTextBlock', window );">Summary of Components of Income Before Provision for Income Taxes</a></td>
<td class="text"><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The components of income before income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">736,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">624,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(304,546)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(352,532)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(270,440)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">437,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">352,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">869,184&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">624,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">567,851&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Summary of Components of Provision for Income Taxes</a></td>
<td class="text"><div style="text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The components of income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income tax expense:</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current tax (benefit)/expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45,307)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42,428)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current tax expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178,252&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97,152&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184,396&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax (benefit)/expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,663)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,166)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(69,493)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(143,323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(118,475)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax benefit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100,542)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85,403)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(124,985)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense was allocated to the following components of other comprehensive income:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency impact on long term funding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,903)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retirement benefit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(895)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flow hedge</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">647</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">301</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,190&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,147&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,622&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Consolidated Reported Provision for Income Taxes and Statutory Rate</a></td>
<td class="text">The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes at Irish statutory rate of 12.5% (2023:12.5%; 2022:12.5%)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate differential from amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48,240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71,223)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Global Minimum Tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign and other income taxed at higher rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research &amp; development tax incentives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,041)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,868)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,608)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Movement in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,279)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,068)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effects of change in tax rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,691&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Decrease)/ increase in unrecognized tax benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,456)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54,347)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investor tax expense on foreign subsidiary earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,995)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,385)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,487)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,756)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other and non-deductible expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,413)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(654)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,710&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,749&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,411&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Tax Effects of Temporary Differences that Give Rise to Significant Portions of Deferred Tax Assets and Deferred Tax Liabilities</a></td>
<td class="text">The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deferred tax liabilities:</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,547&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating right-of-use-assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,014&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">901,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in foreign subsidiaries </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax liabilities recognized</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,002,493&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,073,114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss and tax credits carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,082&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303,720&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290,643&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38,955)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42,967)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets recognized</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,765&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,676&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Overall net deferred tax liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(737,728)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(825,438)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock', window );">Schedule of Expected Expiry Dates of NOL's</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expected expiry dates of the US NOLs are as follows:&#160;</span><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Federal<br/>NOL's</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">State<br/>NOL's</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025-2038</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">262,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2039-2043</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,035&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">277,828&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits Roll Forward</a></td>
<td class="text"><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at start of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,098&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease related to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,525)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(918)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,442)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to current year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lapse of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(65,417)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62,363)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(838)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,619&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160,016&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217,584&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncomeBeforeIncomeTaxTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Before Income Tax, Table</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncomeBeforeIncomeTaxTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067845704064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Transactions for Company's Share Option Plans</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The following table summarizes the transactions for the Company's share option plans for the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Granted<br/>Under Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,695,460&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.38&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229.94&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(348,286)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited/expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,698)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,378,119&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119.86&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,472&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232.48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(535,705)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited/expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,080)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">902,806&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142.96&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,380&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325.51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(311,040)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited/expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,854)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">622,292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170.52&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested and exercisable at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">426,497&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135.39&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of Weighted Average Fair Values and Assumptions Used</a></td>
<td class="text">The weighted average fair values and assumptions were as follows:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:57.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115.76&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3 years</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock', window );">Summary of RSU and PSU Activity</a></td>
<td class="text">The following table summarizes RSU and PSU activity for the year ended December&#160;31, 2024:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.599%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU Outstanding<br/>Number of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU<br/>Weighted Average<br/>Grant Date <br/>Fair Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU Outstanding<br/>Number<br/>of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU<br/>Weighted Average<br/>Grant Date Fair Value</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105,256&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226.29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">621,011&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218.27&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,626&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325.51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">258,345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313.41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,975)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(120,458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">223.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(124,186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(111,309)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,721&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280.76&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">647,589&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251.36&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock', window );">Schedule of Non-cash Stock Compensation Expense</a></td>
<td class="text">Stock compensation expense has been allocated as follows:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,870&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,667&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,523&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Non Cash Stock Compensation Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743092160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographical Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of Distribution of Net Revenue by Geographical Area</a></td>
<td class="text">The distribution of revenue by geographical area was as follows:<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,793,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,377,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,984,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,560,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,574,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,618,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,985,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,283,790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,574,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">942,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">884,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,281,676&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,120,176&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,741,386&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OperatingIncomeByGeographyTableTextBlock', window );">Schedule of Distribution of Income from Operations by Geographical Area</a></td>
<td class="text">The distribution of income from operations by geographical area was as follows:<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">919,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">885,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">673,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216,768&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">254,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241,549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">314,982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sub-total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,448,104&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,416,006&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,258,324&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization on intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(350,292)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(459,854)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(463,087)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,097,812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">956,152&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">795,237&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Schedule of Distribution of Net Revenue by Geographical Area</a></td>
<td class="text">The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span id="i85f7edaad3fa4a85a9148d91477e5119_6-1-1-1-401854"></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">530,481&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">501,517&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OperatingIncomeByGeographyTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Income by Geography.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OperatingIncomeByGeographyTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067741640720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Ordinary Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income per Ordinary Share</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for basic net income per ordinary share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,482,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,101,813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,532,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive share options and other awards outstanding under share based compensation programs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">549,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">615,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">936,043&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,032,424&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,717,640&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,468,363&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income per ordinary share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.53&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.40&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.13&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067741344768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income</a></td>
<td class="text"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(234,075)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(149,148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remeasurement of retirement benefit obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,726&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,803&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain / (loss) on cash flow hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,161)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(229,929)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(143,506)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067744288672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Disclosure of Cash Flow Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of Supplemental Disclosure of Cash Flow Information</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">210,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for income taxes (net of refunds)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140,718&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163,778&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,322&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743645536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of business (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>Employee </div>
<div>Location </div>
<div>Country</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityNumberOfEmployees', window );">Number of employees | Employee</a></td>
<td class="nump">41,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_NumberOfLocations', window );">Number of locations in which company operates | Location</a></td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfCountriesInWhichEntityOperates', window );">Number of countries in which company operates | Country</a></td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember', window );">Geographic Concentration Risk | United States | Net Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of company revenue (in percent)</a></td>
<td class="nump">36.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember', window );">Geographic Concentration Risk | Europe | Net Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of company revenue (in percent)</a></td>
<td class="nump">52.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember', window );">Geographic Concentration Risk | Rest of World | Net Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of company revenue (in percent)</a></td>
<td class="nump">11.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityNumberOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of persons employed by the Entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityNumberOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_NumberOfLocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Locations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_NumberOfLocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfCountriesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of countries in which the entity operates as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfCountriesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_OtherGeographicLocationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_OtherGeographicLocationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743687824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyAbstract', window );"><strong>Foreign Currency [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Amounts (credited) / charged</a></td>
<td class="num">$ (18,085)<span></span>
</td>
<td class="nump">$ 12,916<span></span>
</td>
<td class="num">$ (25,997)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482014/830-20-35-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481956/830-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481926/830-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481839/830-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067742585616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings &#160;</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">40 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Office furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory equipment &#160;</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Motor vehicles</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Computer equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Computer equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=iclr_ComputerEquipmentAndCapitalizedSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=iclr_ComputerEquipmentAndCapitalizedSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067742946704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">23 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember', window );">Order backlog | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember', window );">Order backlog | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names &amp; brands</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember', window );">Patient database</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology assets</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067742661760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 8,281,676<span></span>
</td>
<td class="nump">$ 8,120,176<span></span>
</td>
<td class="nump">$ 7,741,386<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=iclr_TopClientMember', window );">Top client</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">639,520<span></span>
</td>
<td class="nump">721,309<span></span>
</td>
<td class="nump">683,546<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=iclr_Clients25Member', window );">Clients 2-5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">1,431,873<span></span>
</td>
<td class="nump">1,453,508<span></span>
</td>
<td class="nump">1,506,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=iclr_Clients610Member', window );">Clients 6-10</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">1,306,604<span></span>
</td>
<td class="nump">1,188,943<span></span>
</td>
<td class="nump">1,112,636<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=iclr_Clients1125Member', window );">Clients 11-25</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">1,774,160<span></span>
</td>
<td class="nump">1,743,539<span></span>
</td>
<td class="nump">1,585,739<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=iclr_OtherCustomersMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 3,129,519<span></span>
</td>
<td class="nump">$ 3,012,877<span></span>
</td>
<td class="nump">$ 2,853,378<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=iclr_TopClientMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=iclr_TopClientMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=iclr_Clients25Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=iclr_Clients25Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=iclr_Clients610Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=iclr_Clients610Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=iclr_Clients1125Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=iclr_Clients1125Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=iclr_OtherCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=iclr_OtherCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743187488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Accounts Receivables and Unbilled Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ContractAssetsAbstract', window );"><strong>Contract Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BilledContractReceivables', window );">Billed services (accounts receivable)</a></td>
<td class="nump">$ 1,437,653<span></span>
</td>
<td class="nump">$ 1,821,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit losses (note 5)</a></td>
<td class="num">(35,664)<span></span>
</td>
<td class="num">(31,533)<span></span>
</td>
<td class="num">$ (20,562)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ContractsReceivableGross', window );">Accounts receivable (net)</a></td>
<td class="nump">1,401,989<span></span>
</td>
<td class="nump">1,790,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGrossCurrent', window );">Unbilled services (unbilled revenue)</a></td>
<td class="nump">1,286,274<span></span>
</td>
<td class="nump">951,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ContractsReceivableNet', window );">Accounts receivable and unbilled revenue, net</a></td>
<td class="nump">$ 2,688,263<span></span>
</td>
<td class="nump">$ 2,742,258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ContractAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ContractAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ContractsReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contracts Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ContractsReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ContractsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contracts Receivable, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ContractsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BilledContractReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts due for billed services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the Company and, at a minimum, one other party. An example would be amounts billed to customers under contracts or programs but not paid as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BilledContractReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067741550848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Unbilled Services and Unearned Revenue or Payments on Account (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGrossCurrent', window );">Unbilled services (unbilled revenue)</a></td>
<td class="nump">$ 1,286,274<span></span>
</td>
<td class="nump">$ 951,936<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent', window );">Change in unbilled services (unbilled revenue)</a></td>
<td class="nump">$ 334,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent', window );">Percentage change in unbilled services (unbilled revenue)</a></td>
<td class="nump">35.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Unearned revenue (payments on account)</a></td>
<td class="num">$ (1,614,758)<span></span>
</td>
<td class="num">(1,654,507)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent', window );">Change in unearned revenue (payments on account)</a></td>
<td class="nump">$ 39,749<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent', window );">Percentage change in unearned revenue (payments on account)</a></td>
<td class="num">(2.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable', window );">Net balance</a></td>
<td class="num">$ (328,484)<span></span>
</td>
<td class="num">$ (702,571)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable', window );">Change in net balance</a></td>
<td class="nump">$ 374,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent', window );">Percentage change in net balance</a></td>
<td class="num">(53.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Advance Payments Netted Against Unbilled Contracts Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in Advance Payments Netted Against Unbilled Contracts Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contract With Customer, Asset, Gross, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contract With Customer, Asset, Gross, Current, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contract with Customer, Liability, Gross, Current, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contracts With Customers, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067740437008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses', window );">Amounts due to third parties for reimbursable expenses</a></td>
<td class="nump">$ 369,200<span></span>
</td>
<td class="nump">$ 333,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent', window );">Change in unbilled services (unbilled revenue)</a></td>
<td class="nump">334,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent', window );">Change in unearned revenue (payments on account)</a></td>
<td class="nump">39,749<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable', window );">Decrease in net balance</a></td>
<td class="nump">374,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetCreditLossExpense', window );">Bad debt expense</a></td>
<td class="nump">28,400<span></span>
</td>
<td class="nump">24,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation, amount</a></td>
<td class="nump">$ 15,900,000<span></span>
</td>
<td class="nump">$ 14,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, remaining performance obligation (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, remaining performance obligation (in percent)</a></td>
<td class="nump">47.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction, period</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in Advance Payments Netted Against Unbilled Contracts Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contract With Customer, Asset, Gross, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Contracts With Customers, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetCreditLossExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetCreditLossExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067745205184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Allowances for Credit Losses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Opening provision</a></td>
<td class="nump">$ 31,533<span></span>
</td>
<td class="nump">$ 20,562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Amounts used during the year</a></td>
<td class="num">(24,887)<span></span>
</td>
<td class="num">(13,358)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AccountsReceivableCreditLossExpense', window );">Amounts provided during the year</a></td>
<td class="nump">28,417<span></span>
</td>
<td class="nump">24,550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments', window );">Foreign exchange</a></td>
<td class="nump">601<span></span>
</td>
<td class="num">(221)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Closing provision</a></td>
<td class="nump">$ 35,664<span></span>
</td>
<td class="nump">$ 31,533<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AccountsReceivableCreditLossExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Credit Loss Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AccountsReceivableCreditLossExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allowance For Doubtful Accounts Foreign Currency Translation Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067742646032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Narrative, KCR Acquisition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 19, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase of subsidiary undertakings (net of cash acquired)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,159<span></span>
</td>
<td class="nump">$ 71,766<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,051,410<span></span>
</td>
<td class="nump">9,051,410<span></span>
</td>
<td class="nump">9,022,075<span></span>
</td>
<td class="nump">$ 8,971,670<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_KCRS.AGroupMember', window );">KCR S.A Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, consideration transferred</a></td>
<td class="nump">$ 92,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to acquire businesses, net of cash acquired</a></td>
<td class="nump">76,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase of subsidiary undertakings (net of cash acquired)</a></td>
<td class="nump">88,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired from acquisition</a></td>
<td class="nump">11,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAssetsArisingFromContingenciesAmountRecognized', window );">Fair value of contingent consideration</a></td>
<td class="nump">4,300<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">43,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="nump">$ 45,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual', window );">Business combination, revenue of acquiree since acquisition date, actual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual', window );">Business combination, net income (loss) of acquiree since acquisition date, actual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Pro forma revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,331,500<span></span>
</td>
<td class="nump">8,202,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Pro forma net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 792,500<span></span>
</td>
<td class="nump">$ 613,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAssetsArisingFromContingenciesAmountRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount, measured at acquisition-date fair value, of all the assets acquired that arise from contingencies and were recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAssetsArisingFromContingenciesAmountRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_KCRS.AGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_KCRS.AGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067742324000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Narrative, HumanFirst Acquisition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 09, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase of subsidiary undertakings (net of cash acquired)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,159<span></span>
</td>
<td class="nump">$ 71,766<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,051,410<span></span>
</td>
<td class="nump">$ 9,022,075<span></span>
</td>
<td class="nump">$ 8,971,670<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_HumanFirstIncMember', window );">HumanFirst Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, consideration transferred</a></td>
<td class="nump">$ 13,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to acquire businesses, net of cash acquired</a></td>
<td class="nump">7,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase of subsidiary undertakings (net of cash acquired)</a></td>
<td class="nump">11,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired from acquisition</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="nump">$ 9,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479613/805-30-35-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_HumanFirstIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_HumanFirstIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067740465056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Narrative, Biotel Acquisition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 02, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Fair value of cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,159<span></span>
</td>
<td class="nump">$ 71,766<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,051,410<span></span>
</td>
<td class="nump">$ 9,022,075<span></span>
</td>
<td class="nump">$ 8,971,670<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_BiotelResearchLLCMember', window );">Biotel Research LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Fair value of cash consideration</a></td>
<td class="nump">$ 68,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired from acquisition</a></td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="nump">36,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 23,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_BiotelResearchLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_BiotelResearchLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067744271664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Narrative, PRA Acquisition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="nump">$ 237,237<span></span>
</td>
<td class="nump">$ 336,699<span></span>
</td>
<td class="nump">$ 229,731<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember', window );">PRA Health Sciences, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="nump">$ 23,500<span></span>
</td>
<td class="nump">$ 16,400<span></span>
</td>
<td class="nump">$ 17,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_PRAHealthSciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067741179648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Narrative, Oncacare Acquisition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 20, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,051,410<span></span>
</td>
<td class="nump">$ 9,022,075<span></span>
</td>
<td class="nump">$ 8,971,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 6,160<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_OncacareMember', window );">Oncacare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of share capital acquired</a></td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, consideration transferred</a></td>
<td class="nump">$ 5,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">13,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount', window );">Acquisition related costs</a></td>
<td class="nump">$ 6,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-5<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_OncacareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_OncacareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743626032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Transaction and Integration Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Integration related costs</a></td>
<td class="nump">$ 29,574<span></span>
</td>
<td class="nump">$ 44,176<span></span>
</td>
<td class="nump">$ 39,695<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067742999536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments (Note 8)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,954<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue', window );">Investments in equity (Note 8)</a></td>
<td class="nump">57,948<span></span>
</td>
<td class="nump">46,804<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCost', window );">Equity securities, FV-NI, cost</a></td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments (Note 8)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,954<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue', window );">Investments in equity (Note 8)</a></td>
<td class="nump">54,448<span></span>
</td>
<td class="nump">46,804<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">54,448<span></span>
</td>
<td class="nump">48,758<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=iclr_InterestRateCapAndInterestRateSwapMember', window );">Total derivatives designated as hedging instruments | Total derivatives designated as hedging instruments | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments (Note 8)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,954<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue', window );">Investments in equity (Note 8)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,954<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Total derivatives designated as hedging instruments | Total derivatives designated as hedging instruments | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments (Note 8)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue', window );">Investments in equity (Note 8)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Total derivatives designated as hedging instruments | Total derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Total derivatives designated as hedging instruments | Total derivatives designated as hedging instruments | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments (Note 8)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue', window );">Investments in equity (Note 8)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Total derivatives designated as hedging instruments | Total derivatives designated as hedging instruments | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember', window );">Other | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments (Note 8)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue', window );">Investments in equity (Note 8)</a></td>
<td class="nump">54,448<span></span>
</td>
<td class="nump">46,804<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">$ 54,448<span></span>
</td>
<td class="nump">46,804<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember', window );">Other | Total derivatives designated as hedging instruments | Total derivatives designated as hedging instruments | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br><br>Reference 28: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-22<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-10<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI) and investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iclr_InterestRateCapAndInterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iclr_InterestRateCapAndInterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743733824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair value - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCost', window );">Equity securities, FV-NI, cost</a></td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt at fair value</a></td>
<td class="nump">3,469.2<span></span>
</td>
<td class="nump">$ 3,793.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair value, nonrecurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">12,614.7<span></span>
</td>
<td class="nump">12,878.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillFairValueDisclosure', window );">Goodwill</a></td>
<td class="nump">9,051.4<span></span>
</td>
<td class="nump">9,022.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure', window );">Identifiable intangible assets, net</a></td>
<td class="nump">$ 3,559.8<span></span>
</td>
<td class="nump">$ 3,855.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067741956592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Debt securities, available for sale, cumulative amount advanced under subscription agreements</a></td>
<td class="nump">$ 13,100<span></span>
</td>
<td class="nump">$ 14,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi', window );">Increase (decrease) in equity securities, FV-NI</a></td>
<td class="num">(3,300)<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Carrying value of long-term investments in equity</a></td>
<td class="nump">54,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CommitmentToAcquireLongTermInvestments', window );">Commitment to acquire future long-term investments</a></td>
<td class="nump">102,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCost', window );">Equity securities, FV-NI, cost</a></td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi', window );">Payments to acquire equity securities, FV-NI</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available for sale investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,954<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_CommitmentToAcquireLongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitment To Acquire Long-Term Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_CommitmentToAcquireLongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 321<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479567/321-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 321<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479567/321-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743143872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property, Plant and Equipment, net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">$ 3,724<span></span>
</td>
<td class="nump">$ 3,724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings</a></td>
<td class="nump">66,132<span></span>
</td>
<td class="nump">70,072<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Computer equipment and software</a></td>
<td class="nump">689,979<span></span>
</td>
<td class="nump">550,119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Office furniture and fixtures</a></td>
<td class="nump">51,849<span></span>
</td>
<td class="nump">45,856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Laboratory equipment</a></td>
<td class="nump">55,111<span></span>
</td>
<td class="nump">56,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">62,034<span></span>
</td>
<td class="nump">55,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_VehiclesGross', window );">Motor vehicles</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total Cost</a></td>
<td class="nump">928,894<span></span>
</td>
<td class="nump">781,067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and asset write offs</a></td>
<td class="num">(546,015)<span></span>
</td>
<td class="num">(419,883)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment (net)</a></td>
<td class="nump">$ 382,879<span></span>
</td>
<td class="nump">$ 361,184<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_VehiclesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vehicles, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_VehiclesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067933548048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, net - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 138.2<span></span>
</td>
<td class="nump">$ 126.1<span></span>
</td>
<td class="nump">$ 106.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743092160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Schedule of Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Opening balance</a></td>
<td class="nump">$ 9,022,075<span></span>
</td>
<td class="nump">$ 8,971,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Current period acquisitions (note 6)</a></td>
<td class="nump">46,126<span></span>
</td>
<td class="nump">36,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign exchange movement</a></td>
<td class="num">(16,791)<span></span>
</td>
<td class="nump">13,655<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Closing balance</a></td>
<td class="nump">$ 9,051,410<span></span>
</td>
<td class="nump">$ 9,022,075<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) asset representing future economic benefit from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743057104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charge</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067742675216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">$ 5,199,004<span></span>
</td>
<td class="nump">$ 5,147,971<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(1,639,212)<span></span>
</td>
<td class="num">(1,292,106)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net book value</a></td>
<td class="nump">3,559,792<span></span>
</td>
<td class="nump">3,855,865<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">4,129,501<span></span>
</td>
<td class="nump">4,090,393<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember', window );">Order backlog</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">543,933<span></span>
</td>
<td class="nump">541,302<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names &amp; brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">204,588<span></span>
</td>
<td class="nump">204,653<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember', window );">Patient database</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">170,324<span></span>
</td>
<td class="nump">170,366<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total cost</a></td>
<td class="nump">$ 150,658<span></span>
</td>
<td class="nump">$ 141,257<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478859/928-340-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067742859808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Aug. 19, 2024</div></th>
<th class="th"><div>Jan. 09, 2024</div></th>
<th class="th"><div>Oct. 02, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350.3<span></span>
</td>
<td class="nump">$ 459.9<span></span>
</td>
<td class="nump">$ 463.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">23 years<span></span>
</td>
<td class="text">23 years<span></span>
</td>
<td class="text">23 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember', window );">Order backlog</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DecreaseInAmortisation', window );">Decrease in amortisation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember', window );">Order backlog | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember', window );">Order backlog | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names &amp; brands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DecreaseInAmortisation', window );">Decrease in amortisation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 202.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_HumanFirstIncMember', window );">HumanFirst Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_KCRS.AGroupMember', window );">KCR S.A Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_KCRS.AGroupMember', window );">KCR S.A Group | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_KCRS.AGroupMember', window );">KCR S.A Group | Order backlog</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_BiotelResearchLLCMember', window );">Biotel Research LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_BiotelResearchLLCMember', window );">Biotel Research LLC | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_BiotelResearchLLCMember', window );">Biotel Research LLC | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">16 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_BiotelResearchLLCMember', window );">Biotel Research LLC | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_BiotelResearchLLCMember', window );">Biotel Research LLC | Order backlog</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=iclr_BiotelResearchLLCMember', window );">Biotel Research LLC | Technology assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Value of intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DecreaseInAmortisation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease In Amortisation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DecreaseInAmortisation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_HumanFirstIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_HumanFirstIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_KCRS.AGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_KCRS.AGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=iclr_BiotelResearchLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=iclr_BiotelResearchLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067744636528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets - Future Intangible Asset Amortization Expense (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 235,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2026</a></td>
<td class="nump">220,771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2027</a></td>
<td class="nump">208,448<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2028</a></td>
<td class="nump">195,447<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2029</a></td>
<td class="nump">180,201<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet', window );">Total</a></td>
<td class="nump">$ 1,039,878<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite Lived Intangible Assets, Amortization Expense, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067742663248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">General trade and overhead liabilities</a></td>
<td class="nump">$ 531,560<span></span>
</td>
<td class="nump">$ 463,882<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Personnel related liabilities</a></td>
<td class="nump">225,822<span></span>
</td>
<td class="nump">385,499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">36,783<span></span>
</td>
<td class="nump">36,414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedUtilitiesCurrent', window );">Facility related liabilities</a></td>
<td class="nump">$ 8,547<span></span>
</td>
<td class="nump">11,078<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GovernmentAssistanceLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration', window );">Government Assistance, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="nump">$ 91,730<span></span>
</td>
<td class="nump">13,532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_RestructuringReserveAndOtherLiabilitiesCurrent', window );">Restructuring liabilities</a></td>
<td class="nump">29,120<span></span>
</td>
<td class="nump">4,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GovernmentAssistanceLiabilityCurrent', window );">Short term government grants</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="nump">923,603<span></span>
</td>
<td class="nump">915,399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses', window );">Amounts due to third parties for reimbursable expenses</a></td>
<td class="nump">$ 369,200<span></span>
</td>
<td class="nump">$ 333,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_RestructuringReserveAndOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Reserve And Other Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_RestructuringReserveAndOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedUtilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for utilities, such as electrical power, heating oil, natural gas, and water. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedUtilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GovernmentAssistanceLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability from government assistance, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483507/832-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GovernmentAssistanceLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GovernmentAssistanceLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes liability from government assistance, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483507/832-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GovernmentAssistanceLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481573/470-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067747605680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Bank Credit Lines, Loan Facilities and Notes - Schedule of Long-term Debt Instruments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>May 08, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jul. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 3,446,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,806,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_LongTermDebtCurrentMaturitiesGross', window );">Less current portion of debt</a></td>
<td class="num">(29,762)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110,150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_LongTermDebtExcludingCurrentMaturitiesGross', window );">Total long-term debt</a></td>
<td class="nump">3,416,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,696,063<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less debt issuance costs and debt discount</a></td>
<td class="num">(20,290)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,624)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt, net</a></td>
<td class="nump">$ 3,396,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,665,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Senior Secured Term Loan | Senior Secured Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="nump">6.329%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.86%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 946,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,251,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember', window );">Senior Secured Notes (the "2026 Notes") | Senior Secured Notes (the "2026 Notes")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember', window );">Senior Secured Notes (the "2026 Notes") | Senior Secured Notes (the "2027 Notes")*</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="nump">5.809%<span></span>
</td>
<td class="nump">5.809%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember', window );">Senior Secured Notes (the "2026 Notes") | Senior Secured Notes (the "2029 Notes")*</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="nump">5.849%<span></span>
</td>
<td class="nump">5.849%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember', window );">Senior Secured Notes (the "2026 Notes") | Senior Secured Notes (the "2034 Notes")*</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Senior Secured Revolving Loan | Senior Secured Revolving Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Senior Secured Revolving Loan | Senior Secured Revolving Loan | Senior Secured Revolving Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_LongTermDebtCurrentMaturitiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Current Maturities, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_LongTermDebtCurrentMaturitiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_LongTermDebtExcludingCurrentMaturitiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Excluding Current Maturities, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_LongTermDebtExcludingCurrentMaturitiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesDueMay2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesDueMay2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesDueMay2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesDueMay2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesDueMay2034Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesDueMay2034Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067736814352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Bank Credit Lines, Loan Facilities and Notes - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 08, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>May 02, 2023</div></th>
<th class="th"><div>Jul. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of financing costs and debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,533<span></span>
</td>
<td class="nump">$ 16,402<span></span>
</td>
<td class="nump">$ 17,749<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Drawdown of credit lines and loan facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,317,480<span></span>
</td>
<td class="nump">370,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Repayments of senior debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">373,000<span></span>
</td>
<td class="nump">315,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of credit facility, remaining borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">55,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,469,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,793,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,469,200<span></span>
</td>
<td class="nump">$ 3,793,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember', window );">Senior Secured Term Loan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember', window );">Senior Secured Term Loan | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior Secured Revolving Loan | Variable rate component one | Base rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior Secured Revolving Loan | Variable rate component one | Base rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior Secured Revolving Loan | Variable rate component one | Base rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior Secured Revolving Loan | Variable rate component two | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Standard &amp; Poor's, BB Rating</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior Secured Revolving Loan | Variable rate component two | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Standard &amp; Poor's, BB+ Rating</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior Secured Revolving Loan | Variable rate component two | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Standard &amp; Poor's, BBB- Rating</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior Secured Revolving Loan | Variable rate component two | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Standard &amp; Poor's, BBB Rating</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember', window );">Senior Secured Revolving Loan | Variable rate component two | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Standard &amp; Poor's, BBB+ Rating</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Senior Secured Term Loan | Senior Secured Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,515,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.329%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.86%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.329%<span></span>
</td>
<td class="nump">7.86%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid', window );">Accelerated charge on repayments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,900<span></span>
</td>
<td class="nump">$ 7,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Senior Secured Term Loan | Senior secured credit facility and senior secured notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember', window );">Senior Secured Notes (the "2026 Notes")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, principal amount</a></td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount paid</a></td>
<td class="nump">6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember', window );">Senior Secured Notes (the "2026 Notes") | Senior Secured Notes (the "2026 Notes")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.875%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember', window );">Senior Secured Notes (the "2026 Notes") | Senior Secured Notes (the "2027 Notes")*</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, principal amount</a></td>
<td class="nump">$ 750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="nump">5.809%<span></span>
</td>
<td class="nump">5.809%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.809%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DebtInstrumentDiscountRate', window );">Debt instrument, discount rate on underwriting (in percent)</a></td>
<td class="nump">0.00250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember', window );">Senior Secured Notes (the "2026 Notes") | Senior Secured Notes (the "2029 Notes")*</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, principal amount</a></td>
<td class="nump">$ 750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="nump">5.849%<span></span>
</td>
<td class="nump">5.849%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.849%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DebtInstrumentDiscountRate', window );">Debt instrument, discount rate on underwriting (in percent)</a></td>
<td class="nump">0.00350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember', window );">Senior Secured Notes (the "2026 Notes") | Senior Secured Notes (the "2034 Notes")*</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, principal amount</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount paid</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DebtInstrumentDiscountRate', window );">Debt instrument, discount rate on underwriting (in percent)</a></td>
<td class="nump">0.00450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed', window );">Debt instrument, redemption price, percentage of principal amount redeemed</a></td>
<td class="nump">99.896%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Senior Secured Revolving Loan | Senior Secured Revolving Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">6.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Senior Secured Revolving Loan | Senior Secured Revolving Loan | Senior Secured Revolving Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Drawdown of credit lines and loan facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 143,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 65,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 180,000<span></span>
</td>
<td class="nump">$ 318,000<span></span>
</td>
<td class="nump">$ 370,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DebtInstrumentDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DebtInstrumentDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of principal amount of debt redeemed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_VariableRateComponentAxis=iclr_VariableRateComponentOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_VariableRateComponentAxis=iclr_VariableRateComponentOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_VariableRateComponentAxis=iclr_VariableRateComponentTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_VariableRateComponentAxis=iclr_VariableRateComponentTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CreditRatingStandardPoorsAxis=srt_StandardPoorsBBRatingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CreditRatingStandardPoorsAxis=srt_StandardPoorsBBRatingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CreditRatingStandardPoorsAxis=srt_StandardPoorsBBPlusRatingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CreditRatingStandardPoorsAxis=srt_StandardPoorsBBPlusRatingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CreditRatingStandardPoorsAxis=srt_StandardPoorsBBBMinusRatingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CreditRatingStandardPoorsAxis=srt_StandardPoorsBBBMinusRatingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CreditRatingStandardPoorsAxis=srt_StandardPoorsBBBRatingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CreditRatingStandardPoorsAxis=srt_StandardPoorsBBBRatingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CreditRatingStandardPoorsAxis=srt_StandardPoorsBBBPlusRatingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CreditRatingStandardPoorsAxis=srt_StandardPoorsBBBPlusRatingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorSubordinatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesDueMay2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesDueMay2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesDueMay2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesDueMay2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesDueMay2034Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredNotesDueMay2034Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067742470592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Bank Credit Lines, Loan Facilities and Notes - Schedule of Finance Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense on drawn facilities</a></td>
<td class="nump">$ 206,198<span></span>
</td>
<td class="nump">$ 311,019<span></span>
</td>
<td class="nump">$ 209,189<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of merger related financing fees</a></td>
<td class="nump">23,533<span></span>
</td>
<td class="nump">16,402<span></span>
</td>
<td class="nump">17,749<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_InterestExpenseCreditOther', window );">Other financing costs</a></td>
<td class="nump">7,506<span></span>
</td>
<td class="nump">9,278<span></span>
</td>
<td class="nump">2,793<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Total financing costs</a></td>
<td class="nump">$ 237,237<span></span>
</td>
<td class="nump">$ 336,699<span></span>
</td>
<td class="nump">$ 229,731<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_InterestExpenseCreditOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Expense (Credit), Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_InterestExpenseCreditOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067740674064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Bank Credit Lines, Loan Facilities and Notes - Schedule of Maturities of Long-term Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 29,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2026</a></td>
<td class="nump">529,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2027</a></td>
<td class="nump">779,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2028</a></td>
<td class="nump">857,164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_LongTermDebtMaturityYearFiveAndThereafter', window );">2029 and thereafter</a></td>
<td class="nump">1,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 3,446,450<span></span>
</td>
<td class="nump">$ 3,806,213<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_LongTermDebtMaturityYearFiveAndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Maturity, Year Five And Thereafter</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_LongTermDebtMaturityYearFiveAndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067742585072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Bank Credit Lines, Loan Facilities and Notes - Schedule of Principal payments (Details) - Senior Secured Term Loan - Senior Secured Term Loan - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Principal repayments</a></td>
<td class="num">$ (7,440)<span></span>
</td>
<td class="num">$ (7,441)<span></span>
</td>
<td class="num">$ (2,014,882)<span></span>
</td>
<td class="num">$ (275,000)<span></span>
</td>
<td class="num">$ (250,000)<span></span>
</td>
<td class="num">$ (300,000)<span></span>
</td>
<td class="num">$ (150,000)<span></span>
</td>
<td class="num">$ (250,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Total repayments</a></td>
<td class="num">$ (2,304,763)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (950,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAnnualPrincipalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of annual principal payment for debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAnnualPrincipalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067741480816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Bank Credit Lines, Loan Facilities and Notes - Schedule of Movement on Debt Instrument (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Drawdown of credit lines and loan facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,317,480<span></span>
</td>
<td class="nump">$ 370,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment of credit lines and loan facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,677,763)<span></span>
</td>
<td class="num">(1,265,000)<span></span>
</td>
<td class="num">$ (875,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Senior Secured Revolving Loan | Senior Secured Revolving Loan | Senior Secured Revolving Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Drawdown of credit lines and loan facilities</a></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 143,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 65,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 180,000<span></span>
</td>
<td class="nump">318,000<span></span>
</td>
<td class="nump">370,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment of credit lines and loan facilities</a></td>
<td class="num">(75,000)<span></span>
</td>
<td class="num">(50,000)<span></span>
</td>
<td class="num">(193,000)<span></span>
</td>
<td class="num">(55,000)<span></span>
</td>
<td class="num">(85,000)<span></span>
</td>
<td class="num">(50,000)<span></span>
</td>
<td class="num">(80,000)<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
<td class="num">(373,000)<span></span>
</td>
<td class="num">(315,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 55,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 55,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=iclr_SeniorSecuredRevolvingLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067741823600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 29, 2022 </div>
<div>USD ($) </div>
<div>instrument</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PercentageOfDebtHedgedByInterestRateDerivatives', window );">Percentage of debt hedged by interest rate derivatives</a></td>
<td class="nump">73.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax</a></td>
<td class="nump">$ 13.9<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest Rate Caps | Total derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of interest rate derivatives held | instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,101.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative, fixed interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.42%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf', window );">Derivative, variable interest rate, reference rate in excess of</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,101.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative, fixed interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DerivativeVariableInterestRateReferenceRateInExcessOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative, Variable Interest Rate, Reference Rate In Excess Of</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DerivativeVariableInterestRateReferenceRateInExcessOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfInterestRateDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of interest rate derivative instruments held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfInterestRateDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480627/815-20-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PercentageOfDebtHedgedByInterestRateDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of an entity's outstanding debt that is designated as a hedged item in cash flow, fair value, or net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PercentageOfDebtHedgedByInterestRateDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743653968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details) - Total derivatives designated as hedging instruments - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest Rate Caps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,606<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,606<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=iclr_InterestRateCapAndInterestRateSwapMember', window );">Total derivatives designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,701,212<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=iclr_InterestRateCapAndInterestRateSwapMember', window );">Total derivatives designated as hedging instruments | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Liability</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,411<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1B<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-12<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br><br>Reference 30: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-22<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-10<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br><br>Reference 28: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-22<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-10<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=iclr_InterestRateCapAndInterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=iclr_InterestRateCapAndInterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743628736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases - Schedule of Lease Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">$ 46,466<span></span>
</td>
<td class="nump">$ 46,820<span></span>
</td>
<td class="nump">$ 53,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Income from sub-leases</a></td>
<td class="num">(1,614)<span></span>
</td>
<td class="num">(1,103)<span></span>
</td>
<td class="num">(1,165)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net operating lease costs</a></td>
<td class="nump">$ 44,852<span></span>
</td>
<td class="nump">$ 45,717<span></span>
</td>
<td class="nump">$ 52,715<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743644896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases Operating Leases - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net operating lease costs</a></td>
<td class="nump">$ 44,852<span></span>
</td>
<td class="nump">$ 45,717<span></span>
</td>
<td class="nump">$ 52,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for lease obligations</a></td>
<td class="nump">64,800<span></span>
</td>
<td class="nump">37,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Impairment of operating right-of-use assets and related property, plant and equipment</a></td>
<td class="nump">$ 13,800<span></span>
</td>
<td class="nump">$ 8,700<span></span>
</td>
<td class="nump">28,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">6 years 6 months 21 days<span></span>
</td>
<td class="text">6 years 8 months 19 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate (in percent)</a></td>
<td class="nump">4.01%<span></span>
</td>
<td class="nump">3.29%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">$ 36,783<span></span>
</td>
<td class="nump">$ 36,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other liabilities (Note 12)<span></span>
</td>
<td class="text">Other liabilities (Note 12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease, liability, noncurrent</a></td>
<td class="nump">$ 140,085<span></span>
</td>
<td class="nump">$ 126,321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net operating lease costs</a></td>
<td class="nump">37,200<span></span>
</td>
<td class="nump">37,900<span></span>
</td>
<td class="nump">48,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Direct costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net operating lease costs</a></td>
<td class="nump">$ 7,700<span></span>
</td>
<td class="nump">$ 7,800<span></span>
</td>
<td class="nump">$ 4,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479365/842-20-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067740640880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases Operating Leases - Operating Lease Maturity (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 42,931<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">38,445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">31,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">24,156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2029</a></td>
<td class="nump">17,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">45,047<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">199,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Lease imputed interest</a></td>
<td class="num">(22,806)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">$ 176,868<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067744020176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Non-current other liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">$ 83,470<span></span>
</td>
<td class="nump">$ 45,998<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Total</a></td>
<td class="nump">$ 83,470<span></span>
</td>
<td class="nump">$ 45,998<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067741043584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Narrative (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Non-cancelable operating leases for facilities expiration period</a></td>
<td class="text">16 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067741192576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 23, 2024</div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 22, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 20, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_NumberOfVotes', window );">Number of votes | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Total proceeds from exercise of stock options by employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,187<span></span>
</td>
<td class="nump">$ 50,973<span></span>
</td>
<td class="nump">$ 35,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Ordinary shares redeemed, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 499,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ShareRepurchaseProgramAxis=iclr_BuybackProgramMember', window );">Buyback program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Ordinary shares redeemed (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,179,699<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">420,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Ordinary shares redeemed, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ShareRepurchaseProgramAxis=iclr_BuybackProgramMember', window );">Buyback program | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_StockRepurchaseProgramAuthorizedPercentage', window );">Stock repurchase program, authorized percentage (in percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ShareRepurchaseProgramAxis=iclr_February2024Member', window );">February 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ShareRepurchaseProgramAxis=iclr_October2024Member', window );">October 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised by employees (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">311,040<span></span>
</td>
<td class="nump">535,705<span></span>
</td>
<td class="nump">348,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Average exercise price of option per share (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116.31<span></span>
</td>
<td class="nump">$ 95.12<span></span>
</td>
<td class="nump">$ 102.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Total proceeds from exercise of stock options by employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,200<span></span>
</td>
<td class="nump">$ 51,000<span></span>
</td>
<td class="nump">$ 35,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Ordinary shares issued in respect of certain RSUs previously awarded by the Company (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,458<span></span>
</td>
<td class="nump">188,800<span></span>
</td>
<td class="nump">195,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember', window );">Performance Share Unit (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">Ordinary shares issued in respect of certain PSUs previously awarded by the Company (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,975<span></span>
</td>
<td class="nump">47,026<span></span>
</td>
<td class="nump">46,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_NumberOfVotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Votes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_NumberOfVotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_StockRepurchaseProgramAuthorizedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program Authorized Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_StockRepurchaseProgramAuthorizedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ShareRepurchaseProgramAxis=iclr_BuybackProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ShareRepurchaseProgramAxis=iclr_BuybackProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ShareRepurchaseProgramAxis=iclr_February2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ShareRepurchaseProgramAxis=iclr_February2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ShareRepurchaseProgramAxis=iclr_October2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ShareRepurchaseProgramAxis=iclr_October2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067740993312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring charges - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring charges</a></td>
<td class="nump">$ 92,123<span></span>
</td>
<td class="nump">$ 45,390<span></span>
</td>
<td class="nump">$ 31,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="nump">74,500<span></span>
</td>
<td class="nump">34,100<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherRestructuringCosts', window );">Other restructuring costs</a></td>
<td class="nump">17,600<span></span>
</td>
<td class="nump">11,300<span></span>
</td>
<td class="nump">28,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment', window );">Impairment of operating right-of-use assets and related property, plant and equipment</a></td>
<td class="nump">15,731<span></span>
</td>
<td class="nump">8,686<span></span>
</td>
<td class="nump">28,767<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">31,474<span></span>
</td>
<td class="nump">6,999<span></span>
</td>
<td class="nump">6,022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=iclr_WorkforceReductionAndOfficeConsolidationProgramMember', window );">Workforce reduction and onerous contract cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment', window );">Impairment of operating right-of-use assets and related property, plant and equipment</a></td>
<td class="nump">15,700<span></span>
</td>
<td class="nump">8,700<span></span>
</td>
<td class="nump">28,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Onerous contract provision</a></td>
<td class="nump">1,900<span></span>
</td>
<td class="nump">2,600<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=iclr_PersonnelRelatedLiabilitiesMember', window );">Personnel related liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">27,700<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=iclr_FacilityLiabilityMember', window );">Facility liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">3,800<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveCurrent', window );">Restructuring reserve, current</a></td>
<td class="nump">1,400<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveNoncurrent', window );">Restructuring reserve, noncurrent</a></td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment, Operating Right-Of-Use Assets And Related Property, Plant And Equipment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=iclr_WorkforceReductionAndOfficeConsolidationProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=iclr_WorkforceReductionAndOfficeConsolidationProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=iclr_PersonnelRelatedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=iclr_PersonnelRelatedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=iclr_FacilityLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=iclr_FacilityLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067740082272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring charges - Schedule of Restructuring Charges (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring charges</a></td>
<td class="nump">$ 92,123<span></span>
</td>
<td class="nump">$ 45,390<span></span>
</td>
<td class="nump">$ 31,143<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067741046560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring charges - Schedule of Restructuring Reserve by Type of Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Opening provision</a></td>
<td class="nump">$ 6,999<span></span>
</td>
<td class="nump">$ 6,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charge during the year*</a></td>
<td class="nump">76,392<span></span>
</td>
<td class="nump">36,704<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_RestructuringReserveUtilizations', window );">Utilization</a></td>
<td class="num">(51,917)<span></span>
</td>
<td class="num">(35,727)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending provision</a></td>
<td class="nump">$ 31,474<span></span>
</td>
<td class="nump">$ 6,999<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_RestructuringReserveUtilizations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Reserve Utilizations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_RestructuringReserveUtilizations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482047/420-10-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067740437168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Income Before Provision for Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems', window );"><strong>Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income tax expense</a></td>
<td class="nump">$ 869,184<span></span>
</td>
<td class="nump">$ 624,467<span></span>
</td>
<td class="nump">$ 567,851<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems', window );"><strong>Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income tax expense</a></td>
<td class="nump">736,374<span></span>
</td>
<td class="nump">624,642<span></span>
</td>
<td class="nump">432,963<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems', window );"><strong>Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income tax expense</a></td>
<td class="num">(304,546)<span></span>
</td>
<td class="num">(352,532)<span></span>
</td>
<td class="num">(270,440)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems', window );"><strong>Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income tax expense</a></td>
<td class="nump">$ 437,356<span></span>
</td>
<td class="nump">$ 352,357<span></span>
</td>
<td class="nump">$ 405,328<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067739400352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Provision for Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current tax expense</a></td>
<td class="nump">$ 178,252<span></span>
</td>
<td class="nump">$ 97,152<span></span>
</td>
<td class="nump">$ 184,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax (benefit)/expense</a></td>
<td class="num">(100,542)<span></span>
</td>
<td class="num">(85,403)<span></span>
</td>
<td class="num">(124,985)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">77,710<span></span>
</td>
<td class="nump">11,749<span></span>
</td>
<td class="nump">59,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Income tax expense was allocated to the following components of other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax', window );">Currency impact on long term funding</a></td>
<td class="nump">1,728<span></span>
</td>
<td class="num">(3,903)<span></span>
</td>
<td class="nump">7,211<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Retirement benefit obligations</a></td>
<td class="num">(895)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Cash flow hedge</a></td>
<td class="nump">647<span></span>
</td>
<td class="nump">301<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity', window );">Total</a></td>
<td class="nump">79,190<span></span>
</td>
<td class="nump">8,147<span></span>
</td>
<td class="nump">66,622<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current tax expense</a></td>
<td class="nump">118,255<span></span>
</td>
<td class="nump">80,427<span></span>
</td>
<td class="nump">53,248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax (benefit)/expense</a></td>
<td class="num">(26,663)<span></span>
</td>
<td class="nump">45,253<span></span>
</td>
<td class="num">(6,166)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current tax expense</a></td>
<td class="num">(45,307)<span></span>
</td>
<td class="num">(42,428)<span></span>
</td>
<td class="nump">60,753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax (benefit)/expense</a></td>
<td class="num">(69,493)<span></span>
</td>
<td class="num">(143,323)<span></span>
</td>
<td class="num">(118,475)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current tax expense</a></td>
<td class="nump">105,304<span></span>
</td>
<td class="nump">59,153<span></span>
</td>
<td class="nump">70,395<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred tax (benefit)/expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax (benefit)/expense</a></td>
<td class="num">$ (4,386)<span></span>
</td>
<td class="nump">$ 12,667<span></span>
</td>
<td class="num">$ (344)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the tax effects of all items occurring during the period that have been charged or credited directly to other comprehensive income or to related components of shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481839/830-10-45-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481956/830-20-45-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-12<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_RestOfEuropeAndOtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067742665888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Taxes at Irish statutory rate of 12.5% (2023:12.5%; 2022:12.5%)</a></td>
<td class="nump">$ 108,648<span></span>
</td>
<td class="nump">$ 78,058<span></span>
</td>
<td class="nump">$ 70,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization', window );">Rate differential from amortization of intangible assets</a></td>
<td class="num">(48,240)<span></span>
</td>
<td class="num">(71,223)<span></span>
</td>
<td class="num">(59,330)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount', window );">Global Minimum Tax</a></td>
<td class="nump">16,719<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign and other income taxed at higher rates</a></td>
<td class="nump">49,703<span></span>
</td>
<td class="nump">35,778<span></span>
</td>
<td class="nump">52,464<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research &amp; development tax incentives</a></td>
<td class="num">(3,041)<span></span>
</td>
<td class="num">(3,868)<span></span>
</td>
<td class="num">(2,608)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Movement in valuation allowance</a></td>
<td class="num">(5,279)<span></span>
</td>
<td class="num">(1,068)<span></span>
</td>
<td class="num">(777)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Effects of change in tax rates</a></td>
<td class="nump">25,691<span></span>
</td>
<td class="nump">3,154<span></span>
</td>
<td class="num">(300)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount', window );">(Decrease)/ increase in unrecognized tax benefits</a></td>
<td class="num">(59,456)<span></span>
</td>
<td class="num">(54,347)<span></span>
</td>
<td class="nump">8,392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount', window );">Investor tax expense on foreign subsidiary earnings</a></td>
<td class="num">(7,995)<span></span>
</td>
<td class="nump">39,165<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Impact of stock compensation</a></td>
<td class="num">(9,385)<span></span>
</td>
<td class="num">(11,487)<span></span>
</td>
<td class="num">(8,756)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther', window );">Other and non-deductible expenses</a></td>
<td class="nump">10,345<span></span>
</td>
<td class="num">(2,413)<span></span>
</td>
<td class="num">(654)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 77,710<span></span>
</td>
<td class="nump">$ 11,749<span></span>
</td>
<td class="nump">$ 59,411<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Change in Unrecognized Tax Benefits, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Deferred Tax Provision On Unrepatriated Earnings, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to global intangible low-taxed income (GILTI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743616400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">$ 2,869<span></span>
</td>
<td class="nump">$ 7,547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Operating right-of-use-assets</a></td>
<td class="nump">15,633<span></span>
</td>
<td class="nump">16,108<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill', window );">Goodwill</a></td>
<td class="nump">43,390<span></span>
</td>
<td class="nump">39,014<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets', window );">Intangible assets</a></td>
<td class="nump">901,731<span></span>
</td>
<td class="nump">950,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Investments in foreign subsidiaries</a></td>
<td class="nump">34,983<span></span>
</td>
<td class="nump">52,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="nump">3,887<span></span>
</td>
<td class="nump">7,982<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities recognized</a></td>
<td class="nump">1,002,493<span></span>
</td>
<td class="nump">1,073,114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards', window );">Operating loss and tax credits carryforwards</a></td>
<td class="nump">164,904<span></span>
</td>
<td class="nump">124,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">7,869<span></span>
</td>
<td class="nump">9,082<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DeferredTaxAssetsOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">21,503<span></span>
</td>
<td class="nump">20,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">2,166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther', window );">Stock compensation</a></td>
<td class="nump">14,309<span></span>
</td>
<td class="nump">17,605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">78,428<span></span>
</td>
<td class="nump">84,928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DeferredTaxAssetContractWithCustomerLiability', window );">Unearned revenue</a></td>
<td class="nump">10,364<span></span>
</td>
<td class="nump">23,748<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther', window );">Other</a></td>
<td class="nump">6,298<span></span>
</td>
<td class="nump">8,774<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">303,720<span></span>
</td>
<td class="nump">290,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance for deferred tax assets</a></td>
<td class="num">(38,955)<span></span>
</td>
<td class="num">(42,967)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets recognized</a></td>
<td class="nump">264,765<span></span>
</td>
<td class="nump">247,676<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Overall net deferred tax liability</a></td>
<td class="num">$ (737,728)<span></span>
</td>
<td class="num">$ (825,438)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DeferredTaxAssetContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Contract With Customer, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DeferredTaxAssetContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DeferredTaxAssetsOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DeferredTaxAssetsOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Operating Loss And Tax Credits Carryforwards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Deferred Expense, Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from compensation and benefits, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479172/805-740-25-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479172/805-740-25-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067735728816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_TaxCreditCarryForwardExpirationPeriod', window );">Tax credit carry forward, expiration period</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance for deferred tax assets</a></td>
<td class="nump">$ 38,955<span></span>
</td>
<td class="nump">$ 42,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Net change in the total valuation allowance</a></td>
<td class="num">(4,000)<span></span>
</td>
<td class="num">(400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Investments in foreign subsidiaries</a></td>
<td class="nump">34,983<span></span>
</td>
<td class="nump">52,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit', window );">Unrecognized tax benefit, potentially expire in 2021</a></td>
<td class="nump">61,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Total unrecognized tax benefits net of potential benefits</a></td>
<td class="nump">101,600<span></span>
</td>
<td class="nump">160,000<span></span>
</td>
<td class="nump">$ 217,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Interest and penalties recognized as an expense</a></td>
<td class="nump">1,900<span></span>
</td>
<td class="nump">4,200<span></span>
</td>
<td class="nump">$ 7,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Total accrued interest and penalties</a></td>
<td class="nump">24,200<span></span>
</td>
<td class="nump">27,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=iclr_IncomeTaxBenefitMember', window );">Provision for income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Net change in the total valuation allowance</a></td>
<td class="num">(5,300)<span></span>
</td>
<td class="num">(1,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=iclr_TaxOfBusinessAcquiredMember', window );">Tax of business acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Net change in the total valuation allowance</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLocationAxis=us-gaap_OtherComprehensiveIncomeMember', window );">Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Net change in the total valuation allowance</a></td>
<td class="num">(700)<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Country</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Other non-U.S subsidiaries operating loss carryforwards for income tax</a></td>
<td class="nump">42,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland | Foreign Country</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration', window );">Ireland subsidiaries additional tax credit carryforward for income tax</a></td>
<td class="nump">15,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax', window );">Alternative minimum tax credit carry forwards</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Federal NOL's</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">8,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carry forward</a></td>
<td class="nump">317,000<span></span>
</td>
<td class="nump">$ 204,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_TaxCreditCarryForwardIncreaseDecreaseAmount', window );">Increase (decrease) tax credit carry forward</a></td>
<td class="nump">113,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Other non-U.S subsidiaries operating loss carryforwards for income tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | State NOL's</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">277,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Other non-U.S subsidiaries operating loss carryforwards for income tax</a></td>
<td class="nump">9,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember', window );">Other | Foreign Country</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration', window );">Ireland subsidiaries additional tax credit carryforward for income tax</a></td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_TaxCreditCarryForwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Credit Carry forward Expiration Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_TaxCreditCarryForwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_TaxCreditCarryForwardIncreaseDecreaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Credit Carry forward Increase (Decrease) , Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_TaxCreditCarryForwardIncreaseDecreaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible alternative minimum tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=iclr_IncomeTaxBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=iclr_IncomeTaxBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=iclr_TaxOfBusinessAcquiredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=iclr_TaxOfBusinessAcquiredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLocationAxis=us-gaap_OtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLocationAxis=us-gaap_OtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067740761808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Expected Expiry Dates of NOL's (Details) - United States<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">State NOL's</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Net operating loss carryforwards, not subject to expiration</a></td>
<td class="nump">$ 9,601<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">277,828<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">State NOL's | 2025-2038</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Net operating loss carryforwards, subject to expiration</a></td>
<td class="nump">262,170<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">State NOL's | 2039-2043</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Net operating loss carryforwards, subject to expiration</a></td>
<td class="nump">6,057<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">Federal NOL's</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Net operating loss carryforwards, not subject to expiration</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">8,035<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">Federal NOL's | 2025-2038</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Net operating loss carryforwards, subject to expiration</a></td>
<td class="nump">8,035<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">Federal NOL's | 2039-2043</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Net operating loss carryforwards, subject to expiration</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=iclr_TaxYear2025To2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=iclr_TaxYear2025To2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=iclr_TaxYear20392043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=iclr_TaxYear20392043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067742456704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Unrecognized Tax Benefits [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits at start of year</a></td>
<td class="nump">$ 160,016<span></span>
</td>
<td class="nump">$ 217,584<span></span>
</td>
<td class="nump">$ 202,065<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increase related to prior year tax positions</a></td>
<td class="nump">7,374<span></span>
</td>
<td class="nump">1,161<span></span>
</td>
<td class="nump">16,098<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decrease related to prior year tax positions</a></td>
<td class="num">(2,525)<span></span>
</td>
<td class="num">(918)<span></span>
</td>
<td class="num">(5,442)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase related to current year tax positions</a></td>
<td class="nump">2,171<span></span>
</td>
<td class="nump">4,552<span></span>
</td>
<td class="nump">5,701<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Lapse of statute of limitations</a></td>
<td class="num">(65,417)<span></span>
</td>
<td class="num">(62,363)<span></span>
</td>
<td class="num">(838)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits at end of year</a></td>
<td class="nump">$ 101,619<span></span>
</td>
<td class="nump">$ 160,016<span></span>
</td>
<td class="nump">$ 217,584<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067739093216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
<th class="th" colspan="1">252 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 25, 2024</div></th>
<th class="th"><div>Feb. 14, 2017</div></th>
<th class="th"><div>May 11, 2015</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>May 18, 2020</div></th>
<th class="th"><div>May 16, 2019</div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>Feb. 13, 2017</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average contractual term of options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 10 months 28 days<span></span>
</td>
<td class="text">4 years 5 months 1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable - weighted average remaining contractual life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 21 days<span></span>
</td>
<td class="text">3 years 10 months 20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options outstanding, intrinsic value (in USD)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable, intrinsic value (in USD)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Options exercised during period, intrinsic value (in USD)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,400<span></span>
</td>
<td class="nump">$ 80,400<span></span>
</td>
<td class="nump">$ 41,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,870<span></span>
</td>
<td class="nump">55,667<span></span>
</td>
<td class="nump">70,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized share-based compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 108,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized share-based compensation cost, period of recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 3 months 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Income tax benefit related to stock compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,400<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">12,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Cash tax benefit related to stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,100<span></span>
</td>
<td class="nump">10,900<span></span>
</td>
<td class="nump">$ 7,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iclr_The2020LegacyPRAPlanMember', window );">The 2020 Legacy PRA Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=iclr_The2018LegacyPRAPlanMember', window );">The 2018 Legacy PRA Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_ConsultantsStockPlan2008PlanMember', window );">Consultants Stock Plan, 2008 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted', window );">Limit of shares issued or to be issued pursuant to options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_EmployeeStockPlanTwentyZeroEightPlanMember', window );">Employee Stock Plan, 2008 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Maximum number of shares per employee (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_OptionPlans2008Member', window );">Option Plans 2008 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Percentage of option price for fair value of ordinary share (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Award date, prior to 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Shares expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Award date, prior to 2018 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Shares vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option | Award date, prior to 2018 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Shares vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_RestrictedStockUnitsTwentyThirteenMember', window );">Restricted Stock Units 2013</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="nump">6,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional number of ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember', window );">Consultants Restricted Stock Units 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Ordinary shares which have been reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember', window );">Consultants Restricted Stock Units 2019 | Non-executive director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Shares vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of stock units vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,900<span></span>
</td>
<td class="nump">$ 35,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare', window );">Share price of equity instruments other than options, vested in period (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 174.96<span></span>
</td>
<td class="nump">$ 159.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare', window );">Share price of equity instruments other than options, vested in period (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 265.96<span></span>
</td>
<td class="nump">$ 265.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember', window );">Performance Share Unit (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of stock units vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="nump">$ 7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember', window );">Performance Share Unit (PSUs) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare', window );">Share price of equity instruments other than options, vested in period (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 174.96<span></span>
</td>
<td class="nump">$ 159.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember', window );">Performance Share Unit (PSUs) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare', window );">Share price of equity instruments other than options, vested in period (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 231.08<span></span>
</td>
<td class="nump">$ 166.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceBasedGrantsMember', window );">PSUs Based on Service and EPS Targets | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems', window );"><strong>Compensation Related Costs Share Based Payments Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Stock units to be granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Compensation Related Costs Share Based Payments Disclosure [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Limit of Shares Issued or To Be Issued Pursuant to Options Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The highest quantity of shares an employee can purchase under the plan per period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iclr_The2020LegacyPRAPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iclr_The2020LegacyPRAPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=iclr_The2018LegacyPRAPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=iclr_The2018LegacyPRAPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_ConsultantsStockPlan2008PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_ConsultantsStockPlan2008PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_EmployeeStockPlanTwentyZeroEightPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_EmployeeStockPlanTwentyZeroEightPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_OptionPlans2008Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_OptionPlans2008Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=iclr_AwardDateAllYearsExcluding2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=iclr_AwardDateAllYearsExcluding2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_RestrictedStockUnitsTwentyThirteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_RestrictedStockUnitsTwentyThirteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=iclr_NonexecutiveDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=iclr_NonexecutiveDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_PerformanceBasedGrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_PerformanceBasedGrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743769792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details) - Stock Option and Award Plans - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Options Granted Under Plans</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">902,806<span></span>
</td>
<td class="nump">1,378,119<span></span>
</td>
<td class="nump">1,695,460<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">68,380<span></span>
</td>
<td class="nump">82,472<span></span>
</td>
<td class="nump">108,643<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(311,040)<span></span>
</td>
<td class="num">(535,705)<span></span>
</td>
<td class="num">(348,286)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Canceled/expired (in shares)</a></td>
<td class="num">(37,854)<span></span>
</td>
<td class="num">(22,080)<span></span>
</td>
<td class="num">(77,698)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">622,292<span></span>
</td>
<td class="nump">902,806<span></span>
</td>
<td class="nump">1,378,119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Vested and exercisable at end of period (in shares)</a></td>
<td class="nump">426,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (USD per share)</a></td>
<td class="nump">$ 142.96<span></span>
</td>
<td class="nump">$ 119.86<span></span>
</td>
<td class="nump">$ 110.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (USD per share)</a></td>
<td class="nump">325.51<span></span>
</td>
<td class="nump">232.48<span></span>
</td>
<td class="nump">229.94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (USD per share)</a></td>
<td class="nump">116.31<span></span>
</td>
<td class="nump">95.12<span></span>
</td>
<td class="nump">102.87<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Canceled/expired (USD per share)</a></td>
<td class="nump">238.51<span></span>
</td>
<td class="nump">196.20<span></span>
</td>
<td class="nump">143.08<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (USD per share)</a></td>
<td class="nump">170.52<span></span>
</td>
<td class="nump">$ 142.96<span></span>
</td>
<td class="nump">$ 119.86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Vested and exercisable at end of period (USD per share)</a></td>
<td class="nump">$ 135.39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_StockOptionAndAwardPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067740102208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details) - Employee Stock Option - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value (USD per share)</a></td>
<td class="nump">$ 115.76<span></span>
</td>
<td class="nump">$ 85.12<span></span>
</td>
<td class="nump">$ 68.42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Assumptions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (in percent)</a></td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (in percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate (in percent)</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">4.18%<span></span>
</td>
<td class="nump">1.86%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">4 years 3 months 18 days<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067742948416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember', window );">Performance Share Unit (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Outstanding number of shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at beginning of period (in shares) | shares</a></td>
<td class="nump">105,256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">48,626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares vested (in shares) | shares</a></td>
<td class="num">(9,975)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(124,186)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at ending of period (in shares) | shares</a></td>
<td class="nump">19,721<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at beginning of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 226.29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (USD per share) | $ / shares</a></td>
<td class="nump">325.51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Shares vested (USD per share) | $ / shares</a></td>
<td class="nump">177.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (USD per share) | $ / shares</a></td>
<td class="nump">260.42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at end of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 280.76<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Outstanding number of shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at beginning of period (in shares) | shares</a></td>
<td class="nump">621,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">258,345<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares vested (in shares) | shares</a></td>
<td class="num">(120,458)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(111,309)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at ending of period (in shares) | shares</a></td>
<td class="nump">647,589<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at beginning of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 218.27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (USD per share) | $ / shares</a></td>
<td class="nump">313.41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Shares vested (USD per share) | $ / shares</a></td>
<td class="nump">223.29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (USD per share) | $ / shares</a></td>
<td class="nump">241.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at end of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 251.36<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=iclr_PerformanceShareUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067740102048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total</a></td>
<td class="nump">$ 45,870<span></span>
</td>
<td class="nump">$ 55,667<span></span>
</td>
<td class="nump">$ 70,523<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Direct costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total</a></td>
<td class="nump">26,046<span></span>
</td>
<td class="nump">26,595<span></span>
</td>
<td class="nump">22,854<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Total</a></td>
<td class="nump">$ 19,824<span></span>
</td>
<td class="nump">$ 29,072<span></span>
</td>
<td class="nump">$ 47,669<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067742996176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographical Information - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of reporting segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067739025888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 8,281,676<span></span>
</td>
<td class="nump">$ 8,120,176<span></span>
</td>
<td class="nump">$ 7,741,386<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">2,793,045<span></span>
</td>
<td class="nump">2,377,104<span></span>
</td>
<td class="nump">1,984,567<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember', window );">Rest of Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">1,560,735<span></span>
</td>
<td class="nump">1,574,783<span></span>
</td>
<td class="nump">1,618,350<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">2,985,256<span></span>
</td>
<td class="nump">3,283,790<span></span>
</td>
<td class="nump">3,574,610<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 942,640<span></span>
</td>
<td class="nump">$ 884,499<span></span>
</td>
<td class="nump">$ 563,859<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_RestOfEuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067739444016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">$ 1,097,812<span></span>
</td>
<td class="nump">$ 956,152<span></span>
</td>
<td class="nump">$ 795,237<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization on intangible assets</a></td>
<td class="num">(350,300)<span></span>
</td>
<td class="num">(459,900)<span></span>
</td>
<td class="num">(463,100)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">1,448,104<span></span>
</td>
<td class="nump">1,416,006<span></span>
</td>
<td class="nump">1,258,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization on intangible assets</a></td>
<td class="num">(350,292)<span></span>
</td>
<td class="num">(459,854)<span></span>
</td>
<td class="num">(463,087)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">919,126<span></span>
</td>
<td class="nump">885,886<span></span>
</td>
<td class="nump">673,804<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember', window );">Rest of Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">216,768<span></span>
</td>
<td class="nump">154,626<span></span>
</td>
<td class="nump">254,955<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">241,549<span></span>
</td>
<td class="nump">314,982<span></span>
</td>
<td class="nump">260,890<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">$ 70,661<span></span>
</td>
<td class="nump">$ 60,512<span></span>
</td>
<td class="nump">$ 68,675<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_RestOfEuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067742081376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 530,481<span></span>
</td>
<td class="nump">$ 501,517<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">234,175<span></span>
</td>
<td class="nump">199,051<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember', window );">Rest of Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">88,556<span></span>
</td>
<td class="nump">94,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">145,391<span></span>
</td>
<td class="nump">159,245<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 62,359<span></span>
</td>
<td class="nump">$ 49,175<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_RestOfEuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_RestOfEuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=iclr_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=iclr_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067743109456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of ordinary shares outstanding for basic net income per ordinary share (in shares)</a></td>
<td class="nump">82,482,764<span></span>
</td>
<td class="nump">82,101,813<span></span>
</td>
<td class="nump">81,532,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive share options and other awards outstanding under share based compensation programs (in shares)</a></td>
<td class="nump">549,660<span></span>
</td>
<td class="nump">615,827<span></span>
</td>
<td class="nump">936,043<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share (in shares)</a></td>
<td class="nump">83,032,424<span></span>
</td>
<td class="nump">82,717,640<span></span>
</td>
<td class="nump">82,468,363<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067741320336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Net income per ordinary share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (USD per share)</a></td>
<td class="nump">$ 9.60<span></span>
</td>
<td class="nump">$ 7.46<span></span>
</td>
<td class="nump">$ 6.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (USD per share)</a></td>
<td class="nump">$ 9.53<span></span>
</td>
<td class="nump">$ 7.40<span></span>
</td>
<td class="nump">$ 6.13<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R121.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067742511024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss - Schedule of Accumulated Other Comprehensive income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Currency translation adjustments</a></td>
<td class="num">$ (234,075)<span></span>
</td>
<td class="num">$ (149,148)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Remeasurement of retirement benefit obligations</a></td>
<td class="nump">1,726<span></span>
</td>
<td class="nump">7,803<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_iclr_AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Gain / (loss) on cash flow hedge</a></td>
<td class="nump">2,420<span></span>
</td>
<td class="num">(2,161)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">&#160;Total</a></td>
<td class="num">$ (229,929)<span></span>
</td>
<td class="num">$ (143,506)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iclr_AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Loss, Cash Flow Hedge, Loss, Reclassification, After Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iclr_AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iclr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482736/825-10-45-5A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R122.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067853828128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Disclosure of Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">$ 196,622<span></span>
</td>
<td class="nump">$ 317,975<span></span>
</td>
<td class="nump">$ 210,918<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes (net of refunds)</a></td>
<td class="nump">$ 140,718<span></span>
</td>
<td class="nump">$ 163,778<span></span>
</td>
<td class="nump">$ 116,322<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R123.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067855790048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties (Details) - Subsidiaries - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=iclr_CorvusPharmaceuticalsMember', window );">Corvus Pharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Other receivables</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=iclr_AfimmuneLimitedMember', window );">Afimmune Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Other receivables</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=iclr_CorvusPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=iclr_CorvusPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_SubsidiaryOfCommonParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_SubsidiaryOfCommonParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=iclr_AfimmuneLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=iclr_AfimmuneLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R124.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45067740456768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details) - Subsequent event<br> $ in Millions</strong></div></th>
<th class="th">
<div>Feb. 18, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="nump">$ 1,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">February 2025</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="nump">$ 750.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ShareRepurchaseProgramAxis=iclr_February2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ShareRepurchaseProgramAxis=iclr_February2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>147
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MH IJW%']((Y?H<]G;O5*097[HJ/W33X$J.R4%JP/-@2,<#_BE_X>S@+B]$I
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MX1X&'\(08"Y;8R9XY/3ZD&',4T)].@<,,Q&$P-U*UFJEBX6JF_^@FZ[Y  G
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MVCSOHGX>ZG@>1. K+^12@,MBQF;[#H9J\%L&:,/@ O5ZC-GT&&#X&2 /$<>
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MMA<TC\1 E^B-XM3#:N?'<F?KC9U-BSRQ7,:"3/((HG,"'6746JQ7+8_61<8
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MN/,QRKQLX\J)9+NBL5DSB6U2,8RQ\P6N#/#[AC'Y.E$;U+WTZ']02P,$%
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M15/SYNC!;6X+#70+C)JN5*+/!A;_3=<>]# ;*(V!TC@43=6^M_KHD#M!QVV
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M]G(E12YK#8#OEQ6(W/Z#_H'#Z<3+_P-02P,$%     @ JXA56IUAH)V&!0
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MWX0<,N[3(%+K=N>KG;ZEW,47(86;]L0;=FLT6(@:1#2"1?#1 52^+V$9\[3
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MF*CLHH##9QV LQ--7,U,%,P&[\A( R!&OQ_WLEJ,"RX<0-OUY#+=?H\F(JM
M*DC#&K+T.#L&91.Z& 7L=,Y&QP$32BIIV:G+3:]26XO4O3G]<J2$B3$48;8
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M .^W"C6F>R %PZ?KN_\!4$L#!!0    ( *N(55I%SQL\!@D  (@7   9
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M0<$ ?@%E+9\<*;97[7.HH^<!SP[HZ _F15Z@\ZBXI]$CV*>NHX84+_2H =8
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MTM#\<LN"?ABHK -]7TMI#AL;H/L%3?\"4$L#!!0    ( *N(55J?UYHY! @
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M&!+ ^[G6KGZ@ YJO\1?_!E!+ P04    " "KB%5:HH^C\G8(   $&   &0
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M]*+C _1^:6W8+=A!=^>=_0]02P,$%     @ JXA56H=^!^[3 P  M @  !D
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M HU7H/-&:W<2O(/IC\KZ+U!+ P04    " "KB%5:[7'?MMH"  !3!@  &0
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M)B.MUJ"=-[&Y19-J@R9Q7+I#N;.:OG+"V<DGI?(U%V(46&)S>T&V0<Y:9'P
M&<5PK:0M#'R0.>:O"0*2T6F)MUIF\5'&2\QZD$0^Q&'</\*7=+DE#5_RC]R
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MIJ]^\1/O_!D?HLZ'Z#GTEP7J68CC!CZFXVZ%D#$IM[Q: BM%76D0BR.\44L
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M/+;WZ&^&VJF6-;?X6LM/HG+-,B@"J'##>^GN]/9/W-63>[Q22SM\83OZ9G$
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MOS='-QI0N]T^#3+N+A&4WK&)BOXH92ZKV/WP\9;])'@"BKF/)"9FX!L@OPT
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MU-R<-AG)&$R>86_F8I>E]%FT>_.,UL<]"]8PHSJ%KBJ" ,XAQ YD4[I7P=,
M!,T'=O\MW^YN/N!FBP4;PQX)\@X]\F+Q VZY6"R>T_@&H!V] $WN!%V*)@<+
MIXPE"/@4)X1-7"V1BQ*A8#,M7XA_@!09]?\DG46RT?]&T!]."TJUCL<Q572K
M3LB/^PJ69F!7%HEN_+ QDW0THX\:>8YX3:@(1C#NJD/8(^497RODEB;A^6<%
M5<L"]C)GFT3T*,BA@/;ZWYI!.DC5T;@PGEO#TC%'6I#4FM/RLR7@</G52+;;
MXK4;.<J%#9A9U^#YJ36IU1,L\22 H!\>6 WU ;AMY6LZ>QQIA7IZ[!.K&CO
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MFC $?^G0%0/TPK>"<&Y[E3:&/A6[:GW@1V<_^!DC7C&#?O2W?O5H_:7DK?Y
ML)FN/[-\1R@4CR)6L-2QIY.1/NVM'HIL1Y\++K.BR+;T<R.@'"B< .]7&2C(
M/. &]?>CK_X+4$L#!!0    ( *N(55HDQWD8U04  *D/   9    >&PO=V]R
M:W-H965T<R]S:&5E=#(R+GAM;,U7VW+;-A#]E1TE3NT9E2(I^1+']HPO39.9
MYC)VTCYT^@"12Q$3$F  4++[]=T%*(FR93M]Z$P?))'0[MG;V05PLM#FFRT1
M'=S6E;*G@]*YYG@TLEF)M;"1;E#1/X4VM7#T:F8CVQ@4N5>JJU$:QP>C6D@U
M.#OQ:Y_-V8EN7245?C9@V[H6YNX"*[TX'22#Y<*UG)6.%T9G)XV8X0VZK\UG
M0V^C%4HN:U16:@4&B]/!>7)\,6%Y+_"[Q(7M/0-',M7Z&[^\ST\',3N$%6:.
M$03]S/$2JXJ!R(WO'>9@99(5^\]+]+<^=HIE*BQ>ZNH/F;OR=' T@!P+T5;N
M6B_>81?//N-ENK+^&Q9!]H"$L]8Z77?*Y$$M5?@5MUT>>@I'\2,*::>0>K^#
M(>_EE7#B[,3H!1B6)C1^\*%Z;7).*B[*C3/TKR0]=W:%1LX%9\:>C!P!\O(H
MZY0O@G+ZB'*2P@>M7&GA%Y5CO@DP(D]6[J1+=R[2)Q&O,(M@G PAC=/)$WCC
M57ACCS=^-CQXKZPS+?')61 JAW>8SZ2:P3GS0CJ)%JZDS2IM6X/PY_F4Q(DS
M?VU+2S ZV6Z4^^C8-B+#TP$UBD4SQ\'9JQ?)0?SFB9 FJY F3Z$_5[$GE;>[
MUD.$+R7"I:X;H>Z ).92M[:Z \H:&LQ!*J?YBUZL R,<0B8:GT^[X(>900PY
MIH$!36L:;0E6%T1:)7S")?V)MTW(\P.XHFHSUPIN61O!)P4?]1SK*1I(7WM:
MI$-P/2<W/'.+K=ZMG=H=, )<BL8.]JC57$F^DPK57U3DC*-OI=DX/<Q%U2*[
M_C(=)G%"[5=5/$G(4"5KZ1Y$DI5"S2A:J;R+<V&DF%9XSR5"8,4;5))2=(-9
MR_Y?TA=!OA69K#P;(V)LIZ8#WLIUF.),\$3+3,L9I?^I<4*6QG'(DJ\):SW(
MAX4%+4#>>I_)?VEP$Z+KOPB^4EL;CT(8M2_C=LC-FI0BAT;(' 04\I:""W$7
M$$>3=,=[9L@8$8Y%5FGR4OB]]97P@*+6K7+T*%SPHJ1*_ESSS(&;3V^O.Y7;
M##&W,(D.]W?^-6=\_?OQ;!)Y29D;6MU"F2UD2?X_9&&G82'LLMC$&_D8;[JB
M/\(;>P]I39L;;-P&]0Y^D#<,N5F7A6ZKG-A#TWHK?<;1)+"G)_@HD4A^96^#
M5 ](=#]CD9^"ZVY;9J274M] :.5,D2FR;:D+;$G#BV9Y21L+5^17H#-1T*9-
MA:>@5^N80T/58*--IRX@HR1HQ8PCSS79,W[)8,E'H#DKTCN.&"L,W'9J*3#2
M\%B9GBGYMV<U*#K-!?$(KEK#M>8 [E"8C8R_>G&4)H=O?G0> P<L"YF)SF;>
M9F30]X3GL*ZH7>ELY_VC@9\+IXT/5-R% :PA4,$&0MN.T$P3RA(U5A$X?0>[
M=#QC$FGN,81D',&%4-\@"]SGG8W&3E^'MW VS/(6]J@"E#:NK;3!UW .[*I)
M3AF9^38(+FWOL37V)E?YH(#YO;G,V&N6K/>=",[=PU8;PN%X9VF]P_V)4M0Z
MZPB)7<MQ2I4D8+=JALWR[-Y''1]3JG;VX$'A:>K1&6V;%_VP>CP2,","^Y&V
M'\6K@;;[ &(,QS3UHH.E2)B2K/H<BPL*A>R0T4I8ZYGE:^3'Z#AZ_9S1-)JL
MC19&U\^:[&9 6 +*L_,5"BU?"&G6@WQ;G^3K\V0AE5 9[P&R?[+<4N?5-J;A
MI9+5?VEKS,.,"F<X5KJM2&*MH+8.=Z[E>&!KA:YH6'F"\,P\W@)U3D/+P6\T
M4T-'?ESN=;L>@TZ&Q%*[M]YZKIF1OA%>@@\C?4-/R?#H,/&_!W%,GX-["KY7
MEN+[DQAX PV"7_R!+.^=3S>';MF=X?M9Z9M.AY,D\;^'<3*D1=AV !_UKD\U
MFIF_)-)$YZ*%F]1J=74//0_7K[5XN,1^$&;&0[_"@E1C.I ,P(2+87AQNO&7
ML:EV=+7SCR7=I=&P /U?:!I>W0L;6-W.S_X!4$L#!!0    ( *N(55K,39'.
M[P0  (0,   9    >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;+576V_;-A3^
M*P=>-L2 (NLN.4T,).V*%5B7HNTV#,,>:(FRB4JD1E)QLU^_0U*6G?K2[F$O
M$DF=\_$[5U(W&R$_J36E&CZW#5>WD[76W?5LILHU;8GR14<Y?JF%;(G&J5S-
M5"<IJ:Q2V\RB(,AF+6%\LKBQ:^_DXD;TNF&<OI.@^K8E\NF>-F)S.PDGVX7W
M;+769F&VN.G(BGZ@^M?NG<39;$2I6$NY8H*#I/7MY"Z\OD^,O!7XC=&-VAN#
ML60IQ"<S>5/=3@)#B#:TU :!X.N1OJ1-8X"0QM\#YF3<TBCNC[?HKZWM:,N2
M*/I2-+^S2J]O)\4$*EJ3OM'OQ>8G.MB3&KQ2-,H^8>-D0Q0N>Z5%.R@C@Y9Q
M]R:?!S_L*13!"85H4(@L;[>19?F*:+*XD6(#TD@CFAE84ZTVDF/<!.6#EOB5
MH9Y>/'14$LWX"GZF:)RZF6E$-=]FY8!P[Q"B$PAA!&\%UVL%/_**5L\!9DAG
MY!1M.=U'9Q%?T=*'./0@"J+D#%X\VAA;O/@$GK,,_KQ;*BTQ#?XZ9J2#2(Y#
MF-*X5ATIZ>T$<U]1^4@GBQ^^"[/@Q1F"R4@P.8?^34'X;PCN!:506F'ME$)B
M:*#' $D0HVSC9+&T0:\I/%$B%5 31< 8T':)TMLXV&<,A%=F$,&&2@K$*#=8
MV.H:_D#M4\H'*_'!2@27C",-T2O<0TWAX3G-P98+2#(OR3(W**( !VGL%44
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MGXIZ#D+O=:7+ON3:PHL1*MF)B[VUR8_"WCC^WFC0'D1>H6K$ZX9C/LR<Q V
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MFR;--$X-,8#LCSK4IK*>BWZ[1_8QA<.;\0>1P!@6NE/?&@+N!8T8VU?;<X"
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M- #=WT'ZB56M/_<WRM(MP@]KNK:A=@:TOE7T:0\3%V"\"*[_!5!+ P04
M" "KB%5:JV?SS+ "  #U!0  &0   'AL+W=O<FMS:&5E=',O<VAE970S,BYX
M;6RE5-MNVS ,_17"&X8$,.I+G%N7!$C270JL6]%V&X9A#XK-Q%XM*9/DIOW[
M4;+CI4";A^[%(BGR\% T.=E)=:MS1 /WO!1ZZN7&;$^#0*<Y<J9/Y!8%W:RE
MXLR0JC:!WBIDF0OB91"'X2#@K!#>;.)LEVHVD94I"X&7"G3%.5,/"RSE;NI%
MWMYP56QR8PW!;+)E&[Q&\W5[J4@+6I2LX"AT(04H7$^]>72Z2*R_<_A6X$X?
MR& K64EY:Y7S;.J%EA"6F!J+P.BXPR66I04B&G\:3*]-:0,/Y3WZ>U<[U;)B
M&I>R_%YD)I]Z(P\R7+.J-%=R]Q&;>OH6+Y6E=E_8U;Z#L0=II8WD33 QX(6H
M3W;?O,-!P"A\)B!N F+'NT[D6)XQPV83)7>@K#>A6<&5ZJ*)7"%L4ZZ-HMN"
MXLQLGJ85KTIF,(,O)D<%2\FIO;E]]SN$3U+K26 HD_4/T@9U4:/&SZ!&,5Q(
M87(-[T2&V6. @"BV/.,]ST5\%/$,TQ/H13[$89P<P>NU=?<<7N^%=9^+5'*$
MCJV_Z\-G&@^YAAMV#S_G*VT4_4V_GGJ7.FOR=%8[8:=ZRU*<>I1+H[I#;_;F
M530(WQZI*6EK2HZAO[B7_X\*/Y I0-MKH$XA7Y&;[=8CI5,(,+FL-!.9[L*R
M4@I%^@#TFD)3 C>EV6_ZZ6GJC8;7T(E[B1\.^UTK1\G8CY)1%ZZ0(].50NMF
MVZ+0%(VV0H'K@JRKLM@X2 V1/XP',/1'80\^T)Z" #JE[2M0PI3I'-:TFR#'
M;(,0^TD<4F(_&D1=N)&&E8Y(//;'\;@ATO/[X:#[5,N"@U'DJ#9NX6A(925,
M/96MM=UI\WJ4_[G7"_&"J4U!]$M<4VAX,NQ[H.HE4RM&;MU@KZ2A->'$G/8R
M*NM ]VLIS5ZQ"=I-/_L+4$L#!!0    ( *N(55J?1C5#>P(  -\%   9
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M;"]W;W)K<VAE971S+W-H965T,S4N>&ULE5;;;MPV$/T50BW:%V-OMA/7W5W
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M]YBZ\Q,MP/M8*;L<$(/FD]O+?P-02P,$%     @ JXA56LUXG?;E+   EJ@
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MB^R7INXV/ONQ+ER1#G ?UAP6?J$+?WDQ.^)KMSK-'IPOLHNSBX<SXST(@'A
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MI(!4E/X!&R"+MZP+4):*GH.4GAQO; :E^PC+I>D12FS16V_F-7!#-:8!.3>
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M[X?3/^Y:5Y5FWJ.!F3 F@32SVJ*AQ)K11E_\?7)3PX(DYMK$TK&=0\;]'+2
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M2&\DSF110<9KI.JW9-6GRKDQ%T;>&?25C 8\9?-A$@O6&!P?O?_M UB4VD2
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M1BB%%"BB8,(((8J@8:-ZQ.A0P8\%_5%)163@>>TGN#Y:G6F=%HH-5-&..?E
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M <(.L-E :'F3^)MCZ;G1B(<SLE%AB](+ (IG&UO\MT*6"W$L&O-'*5TS^5;
MV\(I4(\<CA2$.XO48[_;-6 'J 87VGNT[-BBIE>2#CT14.8X=)?TH<!$Q<:;
M.]]6>RU&E-!GP7GPVT:Z=!/G+#=-Z.[@]6HXU6=GJ3M6XE[,E\R^UQ;(U&W
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MVREU/=,]O+H?IQO_V%EH1W'STQ6]5=&P .V76KOM#ROH7[_S_P!02P,$%
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M/$\''JCNWNH61J[<73&7AD;NS)*N>E0V@-XOI#2[A=V@__.8_ -02P,$%
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M>N7E'I18\5[:3^KP,Y[R21U?H:09GG 8?9/,@Z(W5C4G,"EH1#N^^=OI'"X
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M!LX-Q(Q60ZQ/XSZN.+H5U9K56[1B.=+07X@2PK:HE^#I@ ]1K33X@QE@RA
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M21H-%LM9M$A/SR=>/RC<2=S0UAX\DY4Q7[WPMIA%B0\(%>;.(PA>[O$"E?)
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M'UX\.\G2XS/BSADB+H>HY/;3.&:58[U".Q0"B-JT3,49>*ZE.H#_YVL,?F;
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M3H-1  6N6"WLO=I^PGT^%XXO5\+X+VP;W^0Z@+PV5E5[,"FHN&Q6]K)_AP/
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M1J,IW1/EFX1?&-FXPKR6ALJ\FY;45U%9 _J_D=(<%S9 UZF7_P-02P,$%
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M>ED4M;U[%H,41T*S&TT.OR=@7"Y@9Q*SSS?P)C!8HV\81<,=L#U-<$%,Z&:
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M( Z(NVK^+YJ.J=?V3C^O#?PAV.8*?LFDP@GP?5'7YK&##KJ?O/%_4$L#!!0
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MVW  WR^-\;M%,#!,LY-_ %!+ P04    " "KB%5:E'GF5$,#  #<!P  &0
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M_N0+EY+GU>6:T04K=8"ZO^1<'@9Z@;8G/OL?4$L#!!0    ( *N(55I)]*5
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M7B%!F@!\OA*XU;N)N73TE]+T!U!+ P04    " "KB%5:,R\1NZ,#   _#0
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MRQ-SCUTS'GD15G??UG9N-PG=B3]JS%ZP#AO682_K14KY%LHV+Z[D'Y[Q\OW
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M2P.\OQ%"UXLR0//--/\74$L#!!0    ( *N(55KT9V^S:P0  )D3   9
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M=L,F+6SR*EA;S.)UP,D129!&_B%OAU44QUXW;J_%[9W%U0=<WZ@,P7->8K:
M+KS>4>#$\P_@CFVN@\#O9DM;MO0LVYAR^<]SF1Z?RSA)H@.\#JN]T]OPN3OW
M=05B8=N81/;>:.Z]=K7ME$/;( [61[J#-@WOKTS3?N^P6! F$86YEO1N>KID
MHFEIS43QI>T*,ZYTC['#4G\%@# &^OF<<[6=F #M=T7V!U!+ P04    " "K
MB%5:\8+T.$<%   ](0  &0   'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6R]
M6EUOVS84_2N$5PP)D,6BK \[<PPDEM0&6X<@6;>'80^T3=M")=$E*;O]]Z,^
M+%L6S<;HQ5X24[KG\.H>D9>\U'C'^&>QIE2BKVF2B?O>6LK-7;\OYFN:$G'+
M-C13=Y:,IT2J)E_UQ893LBA!:=*W+<OKIR3.>I-Q>>V93\8LETF<T6>.1)ZF
MA'][I G;W?=P;W_A)5ZM97&A/QEOR(J^4OEI\\Q5J]^P+.*49B)F&>)T>=][
MP'<1'A: TN*OF.[$T6]4/,J,L<]%XVEQW[,*CVA"Y[*@(.K?EDYIDA1,RH\O
M-6FOZ;, 'O_>LT?EPZN'F1%!IRSY.U[(]7UOV$,+NB1Y(E_8[@.M'\@M^.8L
M$>5?M*MMK1Z:YT*RM 8K#](XJ_Z3KW4@C@#8.0.P:X!]"G#/  8U8' *\,X
MG!K@O-4EMP:X;P5X-< K8U\%JXQT0"29C#G;(5Y8*[;B1RE7B58!CK/BS7J5
M7-V-%4Y.'G.AK@B!IBR=Q1DIY!;H%_0'X9P4HM^@WZ8OZ&'^)8]%7+X,5P&5
M)$[$M3+[]!J@JW?7Z!V*,_3GFN6"9 LQ[DOE6M%!?UZ[,:W<L,^XX:"/+)-K
M@<)L01<:?&#&8]M T%<Q:0)C[P/S:!L9'_+5+<*C&V1;MJ-[(#,\H/-;-,!G
MX<&/P<.WPP<:>/1VN&V(Y:!YR08EW^![+]GQ:_3/[^H:>I(T%?]J7'RL*!T]
M93'AWHD-F=/[GII1!>5;VIO\_!/VK%]U8D&2!9!D(219!$36$MEI1'9,[)/G
MG,_7:HY';*GRU$S$BUBE*I2K\<@E^1QG*X&N,I4KU?TY$6N55-3+P.GB6J>^
ML:]+U8<D"RHRKR0K\O9V,G2P.QKWM\>R=JU\['M>VRKJ6EF-14L$MQ'!-8KP
MGK'%+DX274B-R$M#ZG8\'UDN=K#5?L*@LG._9Q?J[&S;\MV3B'7['8Y\[/EG
MXN8U<?.,<2MRW.OM WK/6;[1!<\(OS1XD&0!)%D(218!D;4$]1M!??B4XT.*
M#$D60)*%D&01$%E+Y&$C\M X:AN1YX?%ZXUJJ'V/2CIE$TE.,K&DG&N7E8_#
M[CQFN];)[#0UNG&IEI!D(219!$36TG+4:#DR+Q_(-[5AE0))ME\9H%FM+Q4W
M2+=RT DZZB02WW,Z@AI]N5102+(0DBP"(FL)BJW#UM+Z'U>$=6?'R@Z'N*.L
MV:=+I05E"T'9(BBVMKI'A0-L5'=ZK!A:<I96K2K7:A7$'04Q]KL*&ON]6$%(
MMA"4+8)B:RMH'Q2TC0I&).9H2Y*\'*$J;4HU)-4<W,Z@6B7MCI+.H"MDUPIW
M!FSP)JO0_"@7!QZ(K1WX0SD$&S?BQEU:#6V'MIO S#U</$A 2QJ@;!$46UNK
M0U4#F\L:3YDDV2J>)101M1)1"Q33Z@-W=_2.JTE2H!4)4+80E"V"8FNK=RB'
M8',]1+]#X'1+LVK6J\6D2-G-Z7$&0PLBZ4UQ])$3_4@%+:C@;@5D8 ^[LR5D
MIR$H6P3%UM;Z4,+!YAJ.7NMB?:FD92E%5PD3XOI'50>M!-5LQ_,%UH@.6N,!
M98N@V-JB'\H\V%A@F#QSALKSU?V@UFH&6M@!90MJMM:V9C# G1I$J#.T+=LZ
M-8R@_&LK<JC)8'-1YJ!(9^AIM8&L8$Q!V0+<K0[YFO)0J+'S\*"S((Z@O*N4
MZ1^=^J:4K\KS^6+VRS-9G7,V5YMO ![*D^^3ZT'Q;4!YFGR@J3XL^$CX*LX$
M2NA245JWOGK[>'567S4DVY1GRS,F)4O+GVM*U-:A,%#WEXS)?:/HH/EB8O(?
M4$L#!!0    ( *N(55J]0$"<100  $H6   9    >&PO=V]R:W-H965T<R]S
M:&5E=#<P+GAM;+U86V_;-AC]*X16# F011?+EI79!A)+73.L0]"TV\.P!UJB
M+2(2Z9)4W/[[D9(B2Y;"Q@"Q%UND> X_GD-]O"P.E#WQ#"$!OA4YX4LK$V)_
M8]L\R5 !^37=(R+?;"DKH)!%MK/YGB&85J BMSW'F=D%Q,1:+:JZ![9:T%+D
MF* '!GA9%)!]OT,Y/2PMUWJI^(1WF5 5]FJQASOTB,27_0.3);ME27&!",>4
M (:V2^O6O8E=7P&J%G]A=."=9Z"&LJ'T217NTZ7EJ(A0CA*A**#\>T9KE.>*
M2<;QM2&UVCX5L/O\POZ^&KP<S 9RM*;YWS@5V=*:6R!%6UCFXA,]?$#-@*:*
M+Z$YKW[!H6GK6" IN:!% Y81%)C4__!;(T0'( <Z#O :@'<*F+T"F#2 R5M[
M\!N _U; M %40[?KL5?"15# U8+1 V"JM613#Y7Z%5KJA8F:*(^"R;=8XL3J
MKN2RAG.PIL4&$ZC<X^ 7\"=D#"H/K\"'LH#D/69<@-OD:XDYKBR^B)" ..>7
MLO67QPA<O+L$[P FX'-&2PY)RA>VD!&J?NRDB69=1^.]$HWK@8^4B(R#F*0H
M[1/8<FCM^+R7\=UY6L;?(;D&3G@%/,?SQP+2PR.47(.)^RH\>CM\,@*/WP[W
M-&),6K,G%=_D1V9W??SG#UD'[@4J^+\C(=[5E/XXI<IC-WP/$[2T9*+BB#TC
M:_7S3^[,^75,;9-DD4FRV!!9SQ>_]<77L:\>2I9D,ML!NI49>\-QBF72!J7\
M!IB 3YCL.+@@<M60[Q/(,YE>I7\,I9=CAFG[.M>PFFQ6D:E%YWDU]]UIN+"?
MNTX,6P5N,)OU6\7#5D[;HJ?;M-5MJM7M-TK3 \[S,16TR'-5J,FFG<A#9^KZ
MKG.BPW0PPE!^N4XP/5%BV&X>!NXL>$6/6:O'3*M')U/?DV1,%2W^7%5,DD4F
MR6)#9#T3@M:$P'R2#4SZ8I(L,DD6&R+K^3)O?9EK/X[6E^2XT[F2!;GGE6FV
M*@+!(.%;Q-CIWJ-V:3[X;-W)Q#E) FMM&.?*;Y(L-D36DS]LY0_U:QS\+L\7
M@@-!7Y8OL&DL0?P*C"UO8QZ$@U0<S <6:$,YUP*39+$ALIX%KG/<[#O_XT:C
MZ:SKA>L.S=#'=*X;1MEB4VQ]/SJ'+U?KQ[JK,=@R6M2E>M48U=P=:.X[0\FU
MW9XMN4FVV!1;7W+O*+FGEUR>+^4\EZFHG_M'Q=92G;LL-VR]Y<,_M2XRVF=L
MBJTO]O&\Z6J/3=H->@/MSF0O&,YDHR=&HVRQ*;:^N,=#HZL_-=X3 <D.;W($
MH%Q#Y=*J6S?=X>DK#(=RFSP\1D;98E-LM=QVY\ZL0&Q775:JS6%)1'V]U-:V
M%Z*WU37@2?U:7916=W%'FOJ6]2-D.TPXR-%64CK7@9SKK+ZXK N"[JN;N0T5
M@A;58X:@S$BJ@7R_I52\%%0'[?7QZC]02P,$%     @ JXA56M4MJBJK P
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MQ*2WZR>2KE)CTOGZ<*:D;?I\@'W_.K5?&,5)_I!3^5#;^#]02P,$%     @
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M\[[5ZB>2-5VWLF%2]3[=<*?:4^#:0+TO&)-/$]T #0UO^B]02P,$%     @
MJXA56@@7"F]X @  J 8  !D   !X;"]W;W)K<VAE971S+W-H965T-SDN>&UL
MK55=3]LP%/TKEH<FD%CS28=8&XD2INV!J0*Q/4Q[<)/;QL*Q@^VV\.]W[:19
M00&AB9?$]_J>D_MAGTRV2M^9"L"2AUI(,Z65M<U9$)BB@IJ9D6I XLY2Z9I9
M-/4J,(T&5GI0+8(X#,=!S;BDV<3[YCJ;J+457,)<$[.N:Z8?9R#4=DHCNG-<
M\U5EG2/()@U;P0W8VV:NT0IZEI+7( U7DFA83NEY=):G+MX'_.2P-7MKXBI9
M*'7GC._EE(8N(1!06,? \+6!"Q#"$6$:]QTG[3_I@/OK'?M77SO6LF &+I3X
MQ4M;3>DI)24LV5K8:[7]!ET])XZO4,+X)]EVL2$EQ=I857=@S*#FLGVSAZX/
M>X!H_ (@[@#Q<T#Z B#I ,E; 6D'\*T.VE)\'W)F63;1:DNTBT8VM_#-]&@L
MGTLW]ANK<9<CSF9SC2=(V\=C,A=,6L)D22[OU[S!T=IC(O'@?2(_F-;,S8<<
MYF 9%^8(O;<W.3D\."('A$MRQ87 .9I)8#$KQQT470:S-H/XA0RBF%PI:2M#
M+F4)Y5." ,OI:XIW-<WB5QES*$8DB8Y)',;I0$(7;X<G _#\[?#XE6J2?D*)
MYTO^9T+D]_G"6(VWY\]0YUOF=)C9*<J9:5@!4XJ284!O@&8?/T3C\,M0U]Z3
M+'\GLB<=3?N.IJ^QXX20M.#,"<]0UUITU%X9IYN;+$I.1SC,S7X_AL+B\2AZ
M&I8/A87C4=J'M34$>W>X!KWR6FA(H=;2MD>_]_9R>^Y5YIE_AC+<JN8_FE;#
MKYA><6F(@"52AJ//)Y3H5A=;PZK&*\5"6=0=OZSP5P+:!>#^4BF[,]P'^I]3
M]A=02P,$%     @ JXA56@RKB[39 @  J <  !D   !X;"]W;W)K<VAE971S
M+W-H965T.# N>&ULK57;4MLP$/T5C<MT8*;@6VP#33Q#0F\/3!E2VH=.'X2]
MB37(4I#DA/Y]5[9Q<W%"'_IB2ZO=HW-6TNYP)=6C+@ ,>2ZYT".G,&9QZ;HZ
M*Z"D^DPN0.#*3*J2&IRJN:L7"FA>!Y7<#3PO=DO*A),.:]NM2H>R,IP)N%5$
M5V5)U>\Q<+D:.;[S8KAC\\)8@YL.%W0.4S#WBUN%,[=#R5D)0C,IB(+9R+GR
M+R>)]:\=OC-8Z;4QL4H>I'RTDR_YR/$L(>"0&8M \;>$"7!N@9#&4XOI=%O:
MP/7Q"_K'6CMJ>: :)I+_8+DI1LZY0W*8T8J;.[GZ#*V>R.)EDNOZ2U:-;YPX
M)*NTD64;C Q*)IH_?6[SL!;@QWL"@C8@V X8[ D(VX"P%MHPJV5=4T/3H9(K
MHJPWHME!G9LZ&M4P84]Q:A2N,HPSZ2<I\Q7CG)R2*=Z0O.) Y(QTYN-K,)1Q
M?8(.]]-K<GQT0HX($^1;(2M-1:Z'KD$>%LW-VCW'S9[!GCW]@-Q(80I-/H@<
M\DT %P5T*H(7%>/@(.(U9&<D]-^1P L&/80F_QX>'J 3=DD-:[SPM:3^O)/X
MQ?NVHBK_U9>I!FC0#V2?\*5>T Q&#KY1#6H)3OKVC1][[_M4_B>P#<V#3O/@
M$'KZ%>L*$W-\4YR*#/JT-@!Q#6"KRS*]\(+ 2Z*ANUR7L>MW?I'X<>)U?AL,
MHXYA=)#AI%(*A"$+4$SF6$">*J:9+2::' MI@,0G?;0;U&B-SB#V@WB+]*Y7
M&"?1'LIQ1SD^2!EO#M8A0> Y*ZB8 RGE$K"&FCZ>\0Z#4TS:A;]%=-?-#^,H
MZB>:=$23P[GE4K]R^DG/Z4?^P/>V^/7Y;=Z2AJ&[5O1*4/.Z%VB2R4J8IG)T
MUJ[=7-55=LL^QC;4=(V_,$T/NZ%JSO!V<)@AI'>68-94TQ>:B9&+NK0^2(.%
MNAX6V$I!60=<GTF\5NW$;M UY_0/4$L#!!0    ( *N(55J0.\JT80(  +H%
M   9    >&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;*U436_;, S]*X17#"VP
MU8Z=9D/G&,C'/GKH4#3H=AAV4&PF%BI+GJ3$W;\?)3MN6J39#KO$$LWW^/AB
M,FV4OC<EHH6'2D@S#DIKZ\LP-'F)%3/GJD9);U9*5\S25:]#4VMDA0=5(HRC
M:!16C,L@2WWL1F>IVEC!)=YH,)NJ8OKW%(5JQL$@V 5N^;JT+A!F:<W6N$![
M5]]HNH4]2\$KE(8K"1I7XV RN)P-7;Y/^,:Q,7MG<)TLE;IWEZMB'$1.$ K,
MK6-@]-CB#(5P1"3C5\<9]"4=</^\8__D>Z=>ELS@3(GOO+#E.'@?0($KMA'V
M5C5?L.OGPO'E2AC_"TV;>W$10+XQ5E4=F!147+9/]M#YL <8C%X Q!T@?@X8
MO@!(.D#B&VV5^;;FS+(LU:H![;*)S1V\-QY-W7#I_L6%U?26$\YFGY4J&BX$
MO(6O3&OF3(73.5K&A3FCZ-UB#J<G9W "7,(U99+Y)@TMU78,8=[5F;9UXA?J
M#&*X5M*6!C[* HNG!"&)[I7'.^73^"CC'/-S2 9O(([BX0%!LW^')T?D)+V1
MB>=+_F8DDP5<2<ODFB\%PL08M ;FW.1"F8U&^#%9&JOI^_UYR,:VRO!P%3?3
MEZ9F.8X#&EJ#>HM!]OK58!1].&3!?R)[8LBP-V1XC/W1$%[5C&N:? MYR?0:
M#[7=<HT\E]L\VRQ*P^U^+\<R6H'AWAA42(7<=C"0JXVT[7?51_L%-/%S]RP^
MI<74[I%'FG:K79-^+@T(7!%E=/Z.]H!N-T5[L:KVP[94ED;7'TM:KJA= KU?
M*65W%U>@7]?9'U!+ P04    " "KB%5:)H<,8P$$  #"$P  &0   'AL+W=O
M<FMS:&5E=',O<VAE970X,BYX;6R]6%V/FS@4_2L66U6MM#/8?(9I@C3-J-J1
MNMU19[K[L-H'!YS$&L"I;9)V?WUMPD!('-*H*"\)'_<<SKV^-@>/-XP_BR4A
M$GS+LT),K*64JQO;%LF2Y%A<LQ4IU)TYXSF6ZI0O;+'B!*<5*,]L!\+ SC$M
MK'A<77O@\9B5,J,%>>! E'F.^??W)&.;B86LEPN?Z6(I]04['J_P@CP2^67U
MP-69W;"D-">%H*P G,PGUBVZF3I0 ZJ(ORG9B)UCH%.9,?:L3^[3B06U(I*1
M1&H*K/[69$JR3#,I'5]K4JMYI@;N'K^P?ZB25\G,L"!3EOU#4[F<6",+I&2.
MRTQ^9IL_2)V0K_D2EHGJ%VSJ6&B!I!22Y358*<AIL?W'W^I"[ "0=P3@U #G
M9P%N#7"K1+?*JK3NL,3QF+,-X#I:L>F#JC856F5#"SV,CY*KNU3A9'Q?2%PL
MZ"PCX%8((@6X H^J5])276%S\($65)*KCZK6*3@,?G-')*:9>*M@7Q[OP)M7
M;\$K0 OPM&2EP$4JQK94,O7#[*26]'XKR3DBZ8XDU\!%OP,'.IX!/OUYN-N%
MVZHX386<ID).Q><>X;M-OI:4J^Q/E.+?CPH([B7)Q7^FI+=/\<Q/T;/U1JQP
M0B:6FHZ"\#6QXM>_H0"^,Y5@(+).0=RF(&X?>_S$),Y PH0TI;G%!A56KR'K
MV$=1!*$:R?5N!J8X+XQ"U,1UQ'F-.*]7W&V2E'F98:G&".>,2_H_UNN%2>J6
MR=^1<(4"-W*0LZ?5%.BH.!B8Q?J-6+]7[">U3.L5#JQQ5A*31/_@R:[O1V&T
MK] 0-_+]4>";!0:-P*!7X+1:@ A7"W96E5$LZ<HXI7MYSNWN@<@Z*8=-RN%%
MIGLX9$$&(NL49-049/0+TWUTT'B>FAH^1'L-:HB#$70CU]R@42,NZA7W%T^)
M?H\GSQE;F/3UPL\=AH'(.IDBV+ZIX44ZLW[,0#49BJU;E!W[@GZA.VOP;MOY
MGFHZ=Z\[C7'(A8ZY.U'K'5#OFSA^XC@EH, Y$> USE?OP(P?=46#.H2AV+J)
MMQX!N9=IUEXO<G91!F+K%J7U)JC?G)QHUD.;X4#/'XWVF]48%_A'EE+4NA'4
M;T<>U"N>%!*DZD-"?QH91?92G#T> [%U$V[=#0HNTZ2#NI^AV+I%:?T/ZG43
MIYHT/&@^%$+7V;?W1^*"(XX9M6X$G; C)%D63+WMOP-<C8Y192_'V0,R$%LW
MX];BH.@R73JH%QJ*K?M-WIHAI]=7G.C2&KS[=8E\&/C[2ZDI3OE7/]SK4GMG
M@T7O;OV)^8(6 F1DKH#P.E1]SK<;1ML3R5;5GLN,2?4!51TNB;("7 >H^W/&
MY,N)WL9IMNWB'U!+ P04    " "KB%5:G=45(.D+  !/OP  &0   'AL+W=O
M<FMS:&5E=',O<VAE970X,RYX;6RUW6]SVE86Q_&WHF$[G>[,UB"!L)TZGDFL
M^W?;;2=INP]V]H&"99L)(%>2XW:G+WX%)A:7B&M$OSQ);,SY2++/B:_R0^+B
M,2\^EG=95@6_SV>+\G7OKJKN7_7[Y>0NFZ?E27Z?+>JOW.3%/*WJ3XO;?GE?
M9.GUJF@^ZT>#P;@_3Z>+WN7%ZK&?BLN+_*&:31?93T50/LSG:?''VVR6/[[N
MA;W/#[R;WMY5RP?ZEQ?WZ6WV/JM^N?^IJ#_K/RO7TWFV**?Y(BBRF]>]-^$K
M.XZ6!:MG_#K-'LN-CX/EH7S(\X_+3\SUZ]Y@N4?9+)M42R*M__J4766SV5*J
M]^.W-=I[WN:R<//CS[I<'7Q],!_2,KO*9_^>7E=WKWMGO> ZNTD?9M6[_%%G
MZP.*E]XDGY6K/X/'I^>.1[U@\E!6^7Q=7._!?+IX^CO]??V-V"BHG?:":%T0
M[5LP7!<,MPO&.PI&ZX+1=L&N8XC7!?&^!>-UP7C?@M-UP>F^!6?K@K-]"\[7
M!>?[%H2#SS^YP:J#GG[DJWY)TBJ]O"CRQZ!8/K_VEA^LFFY57[?)=+&<C_=5
M47]U6M=5EV91I8O;Z8=9%KPIRZPJ@V^#?Z5%D2[;-O@FR:IT.BO_7C_ZR_LD
M^.:KOP=?!=-%\,-T-JO;N[SH5_5.+*G^9+W!MT\;C'9L<!C\D"^JNS(0B^OL
MNJ7^RE\_>JD^\=>'D0?HU]^]YV]A]/E;^#;RBDDV.0F&X3^":! -VPYH__)1
MV_'\M7+QU\KE7SMVM7]YU%*N_>5O'FY/@O!\Y\X;?[E-%R?!8'>Y]9?_.*GJ
M\JCMV)T^&CZ/XG#E#7>.8OWO^G0QK;)O9_7P70=?SN9_OJ]K E-E\_*_;:/W
MM(%1^P:6OVI?E??I)'O=JW^7EEGQ*>M=?OVW<#SXKJUM22PA,4%BDL04B6D2
M,R1F(<P9D]'SF(Q\^N6;>5Y4T_^EJ^55?E/_-GJ>DG0U)6V#X26[#@:))20F
MGK#PZ9?]<FG\Z7(8#T[J?YT^;;9\R]-&\?G)N?LTU?:T\? D=)^FR2,P)&8A
MS&G3^+E-8V^;7JU6;UE1GT3,5KU:WDWOR^#/>NFTF,X?YFU=ZA6[=BF))20F
M2$R2F"(Q36*&Q"R$.7,Q?IZ+\;%7.6-R3$@L(3%!8I+$%(EI$C,D9B',&9/3
MYS$YW7^5<Y\5T[SM7/>M%^DZ"OX].@O^R-*B;765'%HH#BV4Y'$K$M,D9DC,
M0IC3SF?/[7QVX&HH_7W7:L@K=NUM$DM(3)"8)#%%8IK$#(E9"'/FXOQY+LZ/
MO1HZ)\>$Q!(2$R0F24R1F"8Q0V(6PIPQ"0=-3#$@UD-^I>LTO+!/T7#WDNCP
M4G%XJ40/7Z&:1C6#:I;2W.;>R.!"[X_TQ^(Z6\:\DX^S_+:UK;WUG=N:U!)4
M$Z@F44VAFD8U@VJ6TMQYB)IYB(Z]*EIO@9H84DM03:":1#6%:AK5#*I92G,G
MIHF.0V_DM@S2BRPML^5K,]+54JE<+95:1P--B5$M036QUL8; 58\&&R%8>@F
M%:II5#.H9BG-[?@F!0[],;"S9O+':GZI<\.C\2^J"523J*903:.:035+:>YD
M-,%S&!]]]80FT:B6H)I -8EJ"M4TJAE4LY3F3DP328?>*&_O_UQ"@^<7]LGW
M?TN'5HJ#*R5Z[ K5-*H95+.4YG9VDR*'_@CUBU72[KC-+W7N;E)+4$V@FD0U
MA6H:U0RJ64IS)Z,)I,.SHZ^2T(0:U1)4$Z@F44VAFD8U@VJ6TMR)::+JT!OQ
M[;U*0@/I%_8I]JR2#JT4!U=*]-@5JFE4,ZAF*<V]?JL)ER-_I/IS-KE;Y/4*
MZ0_/)01^HVM?HUJ":@+5)*HI5-.H9E#-4IH[$TTF'87'7A]%:&J-:@FJ"523
MJ*903:.:035+:>[$-*EUY,WX]ET?^97.4^'?)\_ZZ.!*<7"E1(]=H9I&-8-J
MEM+<SF[2Y<B?+O]<I-=9L$CG61E\G<[OOPL^%.GBNGV9A*;+J):@FD UB6H*
MU32J&52SE.:.1A-#1Z.C+Y/0>!K5$E03J"913:&:1C6#:I;2W(EIXNG(?V%T
MEY<J^:G.HX'FT*@FUMKF2Y6B0;3U4B5TDPK5-*H95+.4YG9\$R]'2+SL5SHW
M^\'Q\L&5XN!*B1Z[0C6-:@;5+*6YG=W$RY$_7M8/\W0AIT59U>N>26M3HZDR
MJB6H)E!-HII"-8UJ!M4LI;D#T:3*T=%3Y0A-E5$M036!:A+5%*II5#.H9BG-
MG9@F58XZI,K[WL[+;W:>$?2JY[7FK.3==;Q -RA13:&:1C6#:I;2W)L]-J'S
MT!\Z_YK.'K+6C@_2R6\/TZ+U[J9O_6K7UD>U!-4$JDE44ZBF4<VL->>^?5_<
MW,]2VW2[OXF7A_Y+GO<\)_8KG;L=C9!13:":1#6%:AK5S M]MCN,M-1^N!/0
MQ,5#?TSZSZMWP?N3-X$J\H?[UMY'@V)42U!-H)I$-85J&M4,JEE*<^=AX^[7
MQ[_]-7O_:_8&V.P=L-E;8+/WP&9O@LW>!9N]#?8QLN=ADST/O4G=8:?.?K/S
MC(R^7&N&V_>;3M!M"E23J*903:.:035+:6[O-RGRT)\B'WKVC ;*J):@FD U
MB6H*U?1:V[J=_?9MZ@VZ44MI;OLWD?+0'Z4Z)P_!GT'[_55;)P!-F5$M036!
M:A+5%*II5#.H9BG-'90FH1Z>'OVL HVP42U!-8%J$M44JFE4,ZAF*<V=F";"
M'OIOU7WHR@J-K5$M036!:A+5%*KIM>:NK,*3T?;*"LVC*<UM_R:/'B)7.?N5
MSNV.)M"H)E!-HII"-?U"9X2[7[]HT!VQE.:^OUJ33(_\R?3VR<6+MR?V>UV'
M =425!.H)E%-H9I&-8-JEM+<^6BRZ]'1+XT>H;DVJB6H)E!-HII"-8UJ!M4L
MI;D3TV3=(W_6?> YA5_M/"5H HYJ M4DJBE4TVO-?8_2D].M4PITFY;2W.YO
MDNV1__+I/4\I_$KG;D?3:U03J"913:&:?J$S=K\ZR:#[82G-G8"-MVSV)]5O
MIWF5S8)W-9T6D[O@^^^O6B< S:91+4$U@6H2U12J:50SJ&8IS9V*)L,>'?U&
MW2,TST:U!-4$JDE44ZBF4<V@FJ4T=V*:V'O4X4KJ?5_QM#:W7J,4NRO.*_^6
M._<^FF2W'<%X^P4.$MVF0C6-:@;5+*6Y/=TDU"/_-=2'GANCJ32J):@F4$VB
MFD(UC6H&U>Q:<\_;QQM9H-O^3=P\\L?-+:<&_G?S\7N=&Q\-FE%-H)I$-85J
M&M4,JEE*<^>CR:-'1W^'Z!&:5:-:@FH"U22J*533J&90S5*:,S%Q$U_'R%M%
M^Y6N4X%J":H)5).HIE!-HYI!-?M"U[:^N,2=@":@COT7O>Y84^U^[Q^_UWD6
MT#@:U02J2513J*91S:":I31W/IHX.C[Z^TO':#2-:@FJ"523J*903:.:035+
M:>[$-!%VC$38?J7S5* 1-JH)5).HIE!-HYI!-?M"UX;CEQ=5388==\ZP.UUX
MY^<[SP8:;J.:0#6):@K5-*H95+.4YHY+$V['1P^W8S3<1K4$U02J2513J*91
MS:":I31W8IIP._:'VP<&@7ZU\Y2@,3BJ"523J*903:.:034;M[V<(MIX/87;
M_DT.'OMS\/;UU8O7'OG5SNV/YN"H)E!-HII"-8UJ!M4LI;E3TL3E\=%O,!ZC
M 3JJ):@F4$VBFD(UC6H&U2REN1/3!.BQ_[+=0Y=5:&B.:@FJ"523J*903:.:
M036[UL)H\_55&W=M=KI_W(3A8W^LV+ZJVNL-K_URUPE M035!*I)5%.HIE'-
MH)JE-'=2FM!\?/2KNL=HC(YJ":H)5).HIE!-HYI!-4MI[L0T,?KX*%=U^]7.
M4X)&YZ@F4$VBFD(UC6H&U>Q:<]]:<VM=U2_OLJQ*TBJ]O)AGQ6UVE<UF93#)
M'Q9UT7(BGA\-BNRFGHWPU9NHU__B\21\I<+EX_V&N;RX3V^S']+B=KHH@UEV
M4Y.#D].X%Q33V[OG3ZK\OE[_]8(/>57E\]6'=UEZG17+)]1?O\GKI=SZD^4&
M'O/BXVJW+_\/4$L#!!0    ( *N(55J&]M_>?P(  '@&   9    >&PO=V]R
M:W-H965T<R]S:&5E=#@T+GAM;(656V^;,!B&_XK%JJF5MG (IW8$*6W6K1>3
MJJ;=+J9=./ E6#68V29D^_6S#4590YJ;X-/[/>_K8).TC#^+ D"B74DK,;,*
M*>LKVQ99 246$U9#I6;6C)=8JB[?V*+F@',C*JGM.4YHEYA45IJ8L7N>)JR1
ME%1PSY%HRA+S/]= 63NS7.MEX(%L"JD'[#2I\0:6()_J>ZYZ]E E)R54@K *
M<5C/K+E[=1WK]6;!=P*MV&LCG63%V+/NW.4SR]&&@$(F=06L'ENX 4IU(67C
M=U_3&I!:N-]^J7YKLJLL*RS@AM$?))?%S(HME,,:-U0^L/8K]'D"72]C5)A?
MU/9K'0MEC9"L[,7*04FJ[HEW_3[L"3SOB,#K!9[QW8&,RP66.$TX:Q'7JU4U
MW3!1C5J9(Y7^4Y:2JUFB=#*]JR2N-F1% <V% "G01W3;R(8#>CV%YB7CDOS%
M9CL_[]1[(0"=+T!B0L4%.D.D0H\%:P2N<I'84MG3$#OKK5QW5KPC5A:03=#4
M_8 \Q_/1TW*!SL\N_B]CJW1#1&^(Z)FZTR-UOS"6MX12I&P=A!)H041&F=")
M?\Y70G+UHOP:<]]1_'&*/CQ7HL89S"QU.@3P+5CI^W=NZ'QZ(\-TR#!]JWJJ
MMB08\]2I0J/2YV^;>M/ <=W$WH[0_('FGZ*%8[1.%>S3/">*CM""@1:<HD5C
MM."0YL2^'X_3PH$6GJ+%8[3P@.9>!KX?C=.B@1:=HEV.T:)#6NQXSI&=C =:
M_";MD4E,QW#QP6OB.M/+.'J]E_;>1:+OY&^8;T@E$(6U4CJ32#GFW3W7=22K
MS=VR8E+=5*99J$\#<+U S:\9DR\=?5T-'YOT'U!+ P04    " "KB%5:QG"D
MNZD#  "V"P  &0   'AL+W=O<FMS:&5E=',O<VAE970X-2YX;6RM5MMNVS@0
M_15"6RQ:((TNE&0I:PM([*:[P!8UXEX>BGV@Y;%%E"*])&4G?[^DY"B.):M!
MNR^V*,T9GC/D7,9[(;^K D"C^Y)Q-7$*K;=7KJOR DJB+L46N/FR%K(DVBSE
MQE5;"615@TKF!IX7NR6AW,G&];NYS,:BTHQRF$NDJK(D\N$&F-A/'-]Y?'%'
M-X6V+]QLO"4;6(#^O)U+LW);+RM: E=4<"1A/7&N_:NI'UA ;?&%PEX=/2,K
M92G$=[OX:S5Q/,L(&.3:NB#F;P=38,QZ,CS^/3AUVCTM\/CYT?MM+=Z(61(%
M4\&^TI4N)D[BH!6L2<7TG=C_"0=!D?67"Z;J7[0_V'H.RBNE17D &P8EY<T_
MN3\$X@C@)V< P0$0G +",P!\ .!::,.LEC4CFF1C*?9(6FOCS3[4L:G11@WE
M]A@76IJOU.!T]E$7(-'?E"PIHYJ"0J]GH EEZ@UZBSXO9NCUJS?H%:(<?2I$
MI0A?J;&KS<X6[^:'76Z:78(SN\P@OT38OT"!%X0]\.G+X?@YW#5Z6]%!*SJH
M_>$7BYY1E3.A*@GHV_52:6FNUS]].AO'8;]CFW-7:DMRF#@FJ13('3C9[[_Y
ML?='G^K_R=FS&. V!GC(>_8>.$C"D)&Z F2.%8D=R,)4 L2> M,7@L9O7/NU
M56*71=B/8F_L[H[%=<W"&"=)T)H]HQVVM,-!VG.02G .S-001C3\D&WC+CJB
M$011$@0G;+MF.(G"-.UG&[5LHT&V'[<FQIKR#6)@:LV/N$9=$O$HP2=4^ZQ"
M/^QG&K=,XT&FMR2WQ!Y>&M:X<[HF7*,3IG&'J>][HZ2?Z:AE.AJ^N/:><M-)
M-+I6BBI-> X7;38_7*!I):7Y?($6VDBI+<4:W5)N+*FY\G.A:-U#OKV[U[8C
M+1F@=[PJZ\,2O#?QATDU%64X9M-!%S^9[DD;M>27"=XDG4--_1$^3>RD>ZHX
MPF?R.FWYI8/\[L 4W2K7E:RS99AGVLWIU ].>7:MPC3R^VGZWE._] :)+@HA
M-=(@2[1YNHD;2;CN;XQ>EX9_PK3/!I\A>M38_5\_\8./XYW3 ,?>:<WIL_,C
M?*X^^D^=V!]L<MEU*2H3.;2J &F!=$'E"FV)K+NRF5)-/:+ELI**V"2%>S.^
MJC-2@L[MQ7%JQME3*3UV&'M'=HT4]VBHLA/M!R(WE"M3R=<&Z%V.3#!D,R0V
M"RVV]9RU%-I,;?6C;:<@K8'YOA9"/R[LZ-:.ZME_4$L#!!0    ( *N(55K5
M<(O@3 8  ,4R   9    >&PO=V]R:W-H965T<R]S:&5E=#@V+GAM;+5;76_;
M-A3]*X16#,F0QB(IR7;G&%@M%<O0#D73;@_#'A2;B87*HBO220OLQX_ZB&1*
M-&O5-WE(],%[+GDN?<P32K-'GG\6:\8D^KI),W'EK*7<OAJ-Q'+--K&XY%N6
MJ3MW/-_$4IWF]R.QS5F\*H,VZ8BX;C#:Q$GFS&?EM??Y?,9W,DTR]CY'8K?9
MQ/FWURSECU<.=IXN?$CNU[*X,)K/MO$]NV'RT_9]KLY&#<HJV;!,)#Q#.;N[
M<G[#KR)*BX"RQ5\)>Q1[QZ@8RBWGGXN3Z]65XQ8]8BE;R@(B5G\>V(*E:8&D
M^O&E!G6:G$7@_O$3^IMR\&HPM[%@"Y[^G:SD^LJ9.&C%[N)=*C_PQ]]9/2"_
MP%OR5)2_T6/=UG70<B<DW]3!J@>;)*O^QE]K(O8"L'<@@-0!I!M #P30.H >
MF\&K [QC _PZH!SZJ!I[25P8RW@^R_DCRHO6"JTX*-DOHQ5?259,E!N9J[N)
MBI/SUW'V&2URMDHD>JONB0OTEL<9>A,ODS21"1,HSE;H3R[5T4MTHR;J:I<R
MQ.]4N^S^I63Y!H7L5J+K3,A\I^:0%.@L9#).4G&N0C[=A.CLQ3EZ@9(,?5SS
MG5" 8C:2JO=%'T;+NJ>OJYZ2 ST-V?(247R!B$L\0_C"'OXN_H;<R<'H\/CD
MU! >V</_V*67R*W"L1X^4@5KJD::JI$2CQ[LCD8X^J<H';J6;"/^-3%;H7EF
MM$*+7HEMO&17CA(;P?('YLQ__@D'[J\FGB'!0DBP" A,*PEM2D)MZ/./7,:I
MDJA;:2I %1N4L85V/\RIYP6>[\Y&#_O<6G,,Y=:0=.(&!%,]:0245*/-:VCS
MK+2]94(HG<OS8AIO>5Y^>RAQ.41DA>;OC>DEF8X#TN'1FG0HCX:<&+NX6[P(
M**G&H]_PZ!\Q_=)&D@_QY_?&0CT<!)-)AT!KMJ$$&I(&T\ -NA,1**E&8- 0
M&'Q_(A:LH42(79PM&5IR(:NOO_+Z*A%+OLN,M :&:>F2:??C;>W"4%8-.:GZ
M>'L=4H%R:J2.&U+'@V?E!<J8D<-Q7Z[H-*#3[M2TIAQ*HB%I$/@>G798!$JJ
ML3AI6)Q86;QA6<)S=,.43K(5^E@P62[2_D.';IGXM289N@B ! LAP2(@,*U2
MTZ924]!UV12R))!@(218! 2FE02[K<-QK1^?LBA)4Y0+=:S$B F)\E@R=*9L
MR9;E2W7KW.A**G1,]S3"O51?7J2C$0M[/X96X"FOJ^<=3X*.--4-IWH[W+32
M:=LSAOB$!6T=O"^<4]."UIYD,"?]K)3XN+^DA4JK<]?:,VRU&EW%KMSSF5PS
MY*AE05!=<,[[ GZHI;$$H*X.%"T$18N@T/1JMLX.4U!5QY N;@&*%H*B15!H
M>F%:[XCMYO%49?>,RDXF8[^K8J!^\NB\T3$M=>Y:OXB/,8P'Y=WO":WO%C]=
M8D!]XI%9(ZBL.G6M4\1VJPBE[N.GEK\82P!I%A>@:"$H6@2%II>S]:AX#"OO
MD 9T 8H6@J)%4&AZ85K;B^V^]U1YGQC%TY^XO87[L2W#NJ6VUNZ*TW,84-PZ
M4&QU4]_3]6E/8<>^2==!S:0A:X^UY_"(I/6(Q.X1H21]:I5T>R<&[\. VDU0
MM @*32]GZUT)AMT?@W2I"U"T$!0M@D+3"[.W;VDWQB=*>HW>%VJO*^E'MPSK
MEC9)MP_J1TEK_2<Y96N1]+?YC))N3S)X5O:S]EA[#G-(6G-([.802-*I9Y=T
M2&>X $4+0=$B*#2]G*U?)3ZLI$,ZTP4H6@B*%D&AZ85IW3"QN^%3)3TP_?<Z
MZ(K7,:U"4ZNN*#V'UR2MUR3';(@>E/+^;J3QOR[V)(-G8S]KC[7G,(*D-8)D
MT ;H!_; TX<DNS^P"ZK?-Q(-NA<*BA:"HD50:'KE6C=*8#=$">B.*"A:"(H6
M0:'I#ZNUAI<^ZZ8H->PY=A]E [6GU+P;&HP[3WY%4&EU7EOG2>V[IB=)U8](
MF;T_0S\QH&@A*%H$A:97MK6N%/:96PJZ/0N*%H*B15!H>F'V'KP]Z<G;[QK5
MA1U_,+?]A+[?W\."2EJ1-MI[ Z!XP>-=G-\K=4<INU/P[N58>82\>F>B.I%\
M6[X4<,NEY)OR<,WB%<N+!NK^'5>FMSXIWC-HWER9_P]02P,$%     @ JXA5
M6G^=-D%E%   X60! !D   !X;"]W;W)K<VAE971S+W-H965T.#<N>&ULS=UK
M<YM8@L;QKT)YIF:Z=]*Q0#<[D[BJ8^[7KJ1G]L76OB 2MJF6A 9A.YG:#S\@
M8>,C\#'$_][J?I&V)<X/A,03'?2(O+_/\M]V-TE2*%_7J\WNP\E-46S?G9[N
M%C?).MZ]S;;)IKSG*LO7<5'^FE^?[K9Y$B_W@]:K4VTTFIVNXW1S<O%^?]LO
M^<7[[+98I9ODEUS9W:[7<?[M8[+*[C^<J"</-WQ*KV^*ZH;3B_?;^#KYG!3_
MV/Z2E[^=/BK+=)UL=FFV4?+DZL/)S^J[:'Y6#=@O\<\TN=\]^5FI'LJ7+/NM
M^L59?C@955N4K))%41%Q^;^[Y#)9K2JIW(Y_U>C)XSJK@4]_?M#-_8,O'\R7
M>)=<9JO_3I?%S8>3LQ-EF5S%MZOB4W9O)_4#FE;>(EOM]G\J]_6RHQ-E<;LK
MLG4]N-R"=;HY_#_^6N^()P/4\3,#M'J =CQ@^LR <3U@?#Q@\LR 23U@TG?
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M:A&EB6G4U-\U>?W]#SR[_)ML>HGV[E%-1S4#U4Q4LU#-1C4'U5Q4\U#-1[4
MU4)4BRA-S,JFG:^=L=-+M&B/:CJJ&:AFHIJ%:C:J.:CFHIJ':CZJ!:@6HEI$
M:6)(-45[37ZA^%=.+]':/:KIJ&:@FHEJ%JK9J.:@FHMJ7JVUII?'WV=$UQJ@
M6HAJ$:6)_YIX4Z@?RPOU?^#9Y<>?)--+^<,:&H.HIJ.:@6HFJEFH9J.:@VHN
MJGFHYJ-:@&HAJD64)H9ET_<?J^CT<HQ6]U%-1S4#U4Q4LU#-1C4'U5Q4\U#-
M1[4 U4)4BRA-#"FM"2GYA>M?-[V4XX,C"RWRHYJ!:B:J6:AFHYJ#:BZJ>;76
M^HKD6?7/F#;_'<\VT8T(4"U$M8C2Q&QJ&OMC>6/_CSS;E$TVT:\*H)J.:@:J
MF:AFH9J-:@ZJN:CFH9J/:@&JA:@649J8E<VW"LH?T<GF! TI4M-1S4 U$]4L
M5+-1S4$U%]4\5/-1+4"U$-4B2A-#JNGSC^47Q'_E9!-M]Z.:CFH&JIFH9J&:
MC6H.JKFHYM5::[(Y.Z[*HJL-4"U$M8C2Q#1JBOMC>7'_CSR]E'5EY0]K< ZB
M7QE -0/53%2S4,U&-0?57%3S4,U'M0#50E2+*$T,R^9[!>,Y.[]$"_VHIJ.:
M@6HFJEFH9J.:@VHNJGFHYJ-:@&HAJD64)H944^@?RR^W_\KY)5KO1S4=U0Q4
M,U'-0C4;U1Q4<U'-J[76_+(UO42+^Z@6HEI$:6(8-<7]L;RX?S2]_#7)UP\S
MR^?NZDPEM,&/:CJJ&:AFHIJ%:C:J.:CFHIJ':CZJ!:@6HEI$:4)V39J>_V2$
MSO8F:+\>U714,U#-1#4+U6Q4<U#-134/U7Q4"U M1+6(TL20:OKU$_GU]/<A
ME3Z&U!MEFZ>;1;J-5TJ\SFXW16=2H25[5--1S4 U$]4L5+-1S4$U%]4\5/-1
M+4"U$-6B6IL]F1M/IVI5\WV<'8LAI#4A)._/MT(HW11)N45%OW-.<GUP'-6%
MYK%X#F VUL[%LP ZNEX#U4Q4LR;=)>_YV4S<)3:Z6@?57%3S>K],_+X[+T W
M,$2UJ-;.Q<>@/G/D-^WTB;R=_O-BD:R2ZBA?*HN;.+].JE/.>;*-OU5)L.L\
MW-%J>*T]335U=CX:'1_K:.<;U4Q4LSIVR+RU/VQTG0ZJN:CF]7N!^+UV6X!N
M6HAJ$:6)4="4KR?2WF2/4[V[^JY%^4=:*%?Q(EVEQ3<EWBS+^X1%-EF1=(<'
M606]1#4=U0Q4,U'-0C4;U1Q4<U'-0S4?U0)4"U$MHC0QVIK*]H2]!/L$+6FC
MFHYJ!JJ9J&:AFHUJ#JJYJ.:AFH]J :J%J!91FAA239-[(F]R[T-JF>X6U5E?
M91NGR\YH0GO3J*:CFH%J)JI9J&:CFH-J+JIYJ.:C6H!J(:I%M?9T<JO-9\^>
M^&T*T9-!%UH/JUF;\D-QDR@GVDB;'6XXZ3[IBW:C44U'-0/53%2S4,U&-0?5
M7%3S4,U'M0#50E2+*$W,JZ8;/6$O=CY!V]"HIJ.:@6HFJEFH9J.:@VHNJGFH
MYJ-:@&HAJD64)H94TYF>R#O3WU?I.6^_PSM<N4O\!.-2OO+!(826GU'-1#4+
MU6Q4<U#-134/U7Q4"U M1+6(TH00FC;EYZG\(N?]SB;5R/1)ZLS.6I$C7]70
MR$$U ]5,5+-0S48U!]5<5/-0S4>U -5"5(LH38R<ILH\E5>9>YY,:G]U;,AI
M)_DV#)W1H9J.:@:JF:AFH9J-:@ZJN:CFH9J/:@&JA:@649J8;%J3;!IZVFF*
M%J)134<U ]5,5+-0S48U!]5<5/-0S4>U -5"5(LH30RIILH]E5>YO^NTD]P<
MG%3H9;Y1S4 U$]4L5+-1S4$U%]4\5/-1+4"U$-6B:;LK/Q7/-8L9U'3(RQ\'
M9="P+Y+)]<%I=-".OR&DG<V/+B>CH^LU4,U$-:OW/K'1]3JHYJ*:UWN?^+V7
M#- M#%$MZO,HQ.._*5I/Y=?&IDX!S1^6_*_.F$#KV:BFHYJ!:B:J6:AFHYJ#
M:BZJ>:CFHUJ :B&J190F1EM3SY[.V'- :%$;U714,U#-1#4+U6Q4<U#-134/
MU7Q4"U M1+6(TL20:OK<4WF?^_O. <U;L\'YM*-Y)%_WX Q".]JH9J*:A6HV
MJCFHYJ*:AVH^J@6H%J):1&EB!C4=[:G\^M6O/0=TUCD[G9Z-SH_SJ.^2NGR+
M!V<-6K5&-:O6A,O$')_80?O3J.:BFM?[!>*_O-L"=--"5(LH33SBF\+S=&#A
M^;%WN#_BLXURNUDF^7V>5O\:T,L)<%B;.A&?MI$V/0X M J-:@:JF:AFH9J-
M:@ZJN:CFH9J/:@&JA:@649H03[.F"CV35Z&ID]+GTI/2\HT8>KX'U714,U#-
M1#4+U6Q4<U#-134/U7Q4"U M1+6(TL1H:RK7,Q4]*3U#V].HIJ.:@6HFJEFH
M9J.:@VHNJGFHYJ-:@&HAJD64)H:4UH34P*M+]SDI79LOGI26KWMP!J'E:%0S
M4<U"-1O5'%1S4<U#-1_5 E0+42VB-#&#FG+T;& Y>MA)Z5IOGTF<')^4[KVD
M+M_BP5F#UIM1S:HUV4EI=(4.JKFHYO5^@?@O[[8 W;00U2)*$X_XIHH\DY8B
MZ9/2]=I:)Z7'QR>EY9LU^ T)J1FH9J*:A6HVJCFHYJ*:AVH^J@6H%J):1&EB
M/#5-Z=G_2U-Z/)&?E$:;TJBFHYJ!:B:J6:AFHYJ#:BZJ>:CFHUJ :B&J190F
M1EO3E)ZQ3>D9VI1&-1W5#%0S4<U"-1O5'%1S4<U#-1_5 E0+42VB-#&DFJ;T
M['=H2L_:3>EIUS4:Y>L>G$%H4QK53%2S4,U&-0?57%3S4,U'M0#50E2+*$W,
MH*8I/?M=F]*SCM+JV]'L.(OZ+*7+MW1PQJ -:52SNO;'\<EHM"&-:BZJ>;U>
M'/[+NRQ -RM$M8C2Q*.\:4?/>K2C7[P2ZZQ]_>=I^WT%6GA&-0/53%2S4,U&
M-0?57%3S4,U'M0#50E2+*$U(G'E3>)[WN/8S]]%7O;;61U^3XX^^Y)LU-)Y0
MS4 U$]4L5+-1S4$U%]4\5/-1+4"U$-4B2A/CJ2DMS^77B6[%4YXLD_6V2,M@
MVN;I(GGS$$=Q]<_17[5.S>P').ND\XU4O?*C?L7Y^=GY\<Q(OIF#XPJM+Z.:
MB6H6JMFHYJ":BVH>JOFH%J!:B&H1I8EQI35Q):\O'WW^_BFYRU9WU?LF/XLW
M[<_GQ?L[$PJ].C2JZ:AFH)J):A:JV:CFH)J+:AZJ^:@6H%J(:A&EB2G6%*#G
M8_1#^3EZ86A4TU'-0#43U2Q4LU'-0347U3Q4\U$M0+40U2)*$T.JZ6S/I:7+
MUWX@)M<'9];DI4\]='2%!JJ9J&;5FCHZ^J1HKAU]=H:NUD$U%]6\EU\??M^]
M%J!;%J):1&EB)C1%Z?F@HO2PZ==W3<_0SC2JZ:AFH)J):A:JV:CFH)J+:AZJ
M^:@6H%J(:A&EB2G7=*;G;&=ZCG:F44U'-0/53%2S4,U&-0?57%3S4,U'M0#5
M0E2+*$T,J:8S/9=WIH/X:[J^72M?LKP<6[V'6L3EZM+B6V=$D57-2U334<U
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M*8!\OZ14["8J0/L/(?H/4$L#!!0    ( *N(55IV!4P]VP0  )H5   9
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M(ANL4X4[L$D2!*$=%@ZP\!@LML'",<S'86R'10,L.@9+;+!H!,.!'T9V6#S
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MB6.3U]+, 9K^ZR4/M-9HH%9WH-88M-8$BF;F>L^P<L<,"=07]#/YD175X.#
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M<WS.M7WO8,WXD\@ )'K.:2&&5B9E>6/;(LD@Q^*:E5"H+PO&<RS5E"]M47+
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MG82K2%GN((\#*F.+S32'ZRLV[D8M[L+ 0IZEF6S4"J91*_' <+")9C@<!KH
M"WX0* )+(@60-95<7RC*A8P-L,$ XO*:FBNRW+:FC.8.A@NCEI^65C%LN=FT
MVO1S$.[T<J/,#)\PL"A-RZ7TB%A]MKH6MHR&;:LGMF:&V8US3B.?.;=#J$F
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MBNKC'*,,EZJ!O#YC3#Q^43=8O]0V_A]02P,$%     @ JXA56KJ00659 P
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M4NSGCN\<%N[89JO-@KN8U70#]Z ?ZUN),[=3*5@%7#'!B83UW+GQK[.IP5O
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M'JKYJ!:@6HAJ$:7)3:!)ENGKN,H) NDZFC1#-1/5+%2S4<U!-1?5/%3S42U
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MGU;QKYU!H"%&5#-1S:HU*5;4U<\[H^T9Q.YR^F!PWM>W9Q!H\!#5/%3S42U
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MSE12K \QTVPZEF(+TJ")S7Q8,VTTR>>%V?:%EC3**4Y/;WZLN=[!;9%@878
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M ZX-U/R$,?G4T0O4+[SH/U!+ P04    " "KB%5:7)\BFS8"  #"!   &@
M 'AL+W=O<FMS:&5E=',O<VAE970Q,34N>&UL?51-CYLP$/TK%I6J5FIC(-FT
M2@$IV;3=/>PJ2M3V4/7@P #6&IO:)FS_??T!-)6RN8!G///FO6&&I!?R2=4
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M!WKX'9J$/,6WHAFO_J)#$VL9:%5R0?,&+$^0IT7]2;XT0IP!9*+# +L!V'V
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M6X-?"=VR<+^+HS !#UFUNXI5^@QPS 6+5WDYI!MY-:(I 1M&4_!M3U@9QZ_
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MH&R V5]*B=N)?4';X>-_4$L#!!0    ( *N(55KY' =QV@(  )H'   :
M>&PO=V]R:W-H965T<R]S:&5E=#$R,2YX;6RM56M/VS 4_2M6AB:0@#R;4M9&
M@E;;D/9 %+8/TSZXR4WCS8D[VVGAW^_:"5$I@2&T+ZT?]UR?<W)]/=X(^5L5
M )K<EKQ2$Z?0>G7JNBHMH*3J6*R@PIU<R))JG,JEJU82:&9!)7<#SXO=DK+*
M2<9V[5(F8U%KSBJXE$3594GEW3EPL9DXOG._<,66A38+;C)>T27,0=^L+B7.
MW"Y+QDJH%!,5D9!/G#/_=!J;>!OPC<%&;8V)4;(0XK>97&03QS.$@$.J30:*
M?VN8 N<F$=+XT^9TNB,-<'M\G_V]U8Y:%E3!5/#O+-/%Q#EQ2 8YK;F^$IN/
MT.H9F'RIX,K^DDT;ZSDDK94690M&!B6KFG]ZV_JP!?"C)P!!"PA>"@A;0&B%
M-LRLK!G5-!E+L2'21&,V,[#>6#2J897YBG,M<9<A3B=G:5J7-:<:,O)5%R#)
M5)18#X7Y4&L@GX12Y(C,L7JRF@,1.?D7A%6I*('LST!3QM4!PF_F,[*_=T#V
M<)-<%Z)6M,K4V-6HP/!PTY;M><,V>(+M#-)C$OJ')/""J <^?3D\? AWT;?.
MO* S+[#YPE>:=]$Z84P\."1?\%*B?]?TEOPX6R@ML89_]IG0G!KUGVKN]:E:
MT10F#IZE0*[!2=Z^\6/O79\E_RG9 X/"SJ#PN>S)M)82JO2.H-9*H5'VYF:_
ML*ZQ$^C>"F@RQC:CZ4'KY"@((V\X&+OK;5T]<7XT\J.3+NX!Y:BC'#U+^0I*
MH*J68 B:SR5!LW:V@ IRAJL+SI963*^"YH#!%C-_&,0[]!\'#4^\L)_[H.,^
M>);[!^S:Q"7[W-0;0:M3J@J28Z<F>'V7T$=V\(A'$ 7>#MG'04>!'_O];...
M;?S:TKL6FO(^MG%/<02C43#:(=P3YT?AP(MW*+M;G=.\6I^I7+)*$0XY(KWC
M(6J6S4O03+18V6:Z$!I;LQT6^'B"- &XGPNA[R>F/W?/<?(74$L#!!0    (
M *N(55J>I9AJOP(  )H'   :    >&PO=V]R:W-H965T<R]S:&5E=#$R,BYX
M;6RM56U/VS 0_BM6AB:0-O+:%E@;B39#XP,2HF/[,.V#FUP;B\3.;*=E_WYG
M)PTM!-1)?$G\<L_C>^[LN_%&R >5 VCR6!9<39Q<Z^K"=56:0TG5J:B X\Y2
MR))JG,J5JRH)-+.@LG #SQNZ)67<B<=V[5;&8U'K@G&XE43594GEWRD48C-Q
M?&>[<,=6N38+;CRNZ KFH.^K6XDSMV/)6 E<,<&)A.7$N?0ODH&QMP8_&&S4
MSI@8)0LA'LSD.ILXGG$("DBU8:#X6\,,BL(0H1M_6DZG.]( =\=;]BNK';4L
MJ(*9*'ZR3.<3Y\PA&2QI7>@[L?D&K1[K8"H*9;]DT]IZ#DEKI479@M&#DO'F
M3Q_;..P _.$K@* %!,\!T2N L 6$AP*B%A#9R#12;!P2JFD\EF)#I+%&-C.P
MP;1HE,^X2?M<2]QEB-/QO*ZJ C"/FA8D82HMA*HE$+$D,ZIR<H7W@ESSYGZ9
M1!TGH"DKU GY3.[G"3D^.B%'A''R/1>UHCQ38U>C8X;>35LGIHT3P2M.^ &Y
M$5SGBGSE&63[!"XJZF0%6UG3X$W&!-)3$OJ?2. %48]#L\/A80\\.1P>O*$F
M[)(46K[PD"0]I>5KLZ;(K\N%TA*?T.^^V#?<43^W*2L7JJ(I3!RL&PKD&ISX
MXP=_Z'WIB]M[DB7O1+87TZB+:?06>VS#6%&6$;S;>'\UX!FZ+WX-S]#RF"JZ
MCOWSX= D=KT;F9=FH3\Z'PWVS9*79H'OG?MGG=F>FD&G9O!?:E)1 M'T$10Y
MYM@\\#EC/:WQ=9[T21R\E!AYHQVG&HD]9L-P-'IFEO28H=U.P!J)[D[5*D&N
M;/57)!4UU\U+[U:[!G-IZ^JS]2DVGJ9//-$T7>N&RA7CBA2P1$KO=(2NR:83
M-!,M*EL;%T)CI;7#')LG2&. ^TLA]'9B#NC:<?P/4$L#!!0    ( *N(55J^
MRW0V[P(  %@*   :    >&PO=V]R:W-H965T<R]S:&5E=#$R,RYX;6RU5FU/
MVS 0_BM6AB:0!GEK0V%M)-IN&A)H50O;AVD?W.3:6"1V9SLI_/O93AKZ&K&M
M^Y+XY9['SUWNXNLN&7\2"8!$SUE*1<]*I%Q<V[:($LBPN& +H&IGQGB&I9KR
MN2T6''!L0%EJ>XX3V!DFU J[9FW$PR[+94HHC#@2>99A_M*'E"U[EFNM%L9D
MGDB]8(?=!9[#!.3C8L35S*Y98I(!%811Q&'6LV[<ZX'K:("Q^$9@*=;&2+LR
M9>Q)3V[CGN5H19!")#4%5J\"!I"FFDGI^%616O69&K@^7K%_-LXK9Z98P("E
MWTDLDY[5L5 ,,YRG<LR67Z!RJ*WY(I8*\T3+TC8(+!3E0K*L BL%&:'E&S]7
M@5@#N(< 7@7PM@&M P"_ OC&T5*9<6N()0Z[G"T1U]:*30],; Q:>4.H_HP3
MR=4N43@9CB'%$F(TPEP2$.AT"!*35)RA<S3)IX+$!'.]<8X>)T-T>G*&3A"A
MZ"%AN< T%EU;*AF:S(ZJ(_OED=Z!(UT/W3,J$X$^T1CB30);Z:^=\%9.]+U&
MQB%$%\AW/R#/\5I[! W>#O<;Y/AU3'W#USK -V"\R 4:)5CE602Y)!%.]P:J
MD4=7\+58*(:>I4I4 "_ "M^_<P/GXSXGCT2VX7*K=KEEV/TWI-$+>N"8"ES6
MZ8\[98IN)63BY[X0M(X9@B.1;82@78>@W?C5QU  S6'O=RZ1@4'J'VL1^H[3
MM8MU[;LVWIK-AJ2@EA0T2OHJ$^#J9QL!*? TW:^MI&BOG>ON:&NVV=!V66N[
M;-1V,R-9EJO4N",9D=N_@5):(\.?YL:1R#:<[=3.=OY3>72.&8(CD6V$X*H.
MP=5?E\?53GIM)^"N1?M _KG.Z\WG_'MU5!Q!8WGL,=J19Z_=T1GPN6E=!(I8
M3F5YT]6K=7MT8YJ"K?6^;IO,W?]*4_9<]YC/"14HA9FB="XN5;QXV<:4$\D6
MIA.8,JGZ"C-,5.L'7!NH_1EC<C71!]3-9/@;4$L#!!0    ( *N(55J%Z^$'
M20(  !T&   :    >&PO=V]R:W-H965T<R]S:&5E=#$R-"YX;6RU55%KVS 0
M_BO"*Z.%+G;<Q"V9;5B:E196" W='L8>%/L2BTB6*\EQMU^_D^R8;$O#&.N+
MI9/NOOL^G72.&ZDVN@ PY%GP4B=>84PU\7V=%2"H'L@*2MQ9226H05.M?5TI
MH+D+$MP/@R#R!66EE\9N;:[26-:&LQ+FBNA:"*J^3X'+)O&&WF[A@:T+8Q?\
M-*[H&A9@'JNY0LOO47(FH-1,ED3!*O$^#"?3R/H[A\\,&KTW)U;)4LJ-->[R
MQ LL(>"0&8M <=C"-7!N@9#&4X?I]2EMX/Y\AW[CM*.6)=5P+?D7EILB\:X\
MDL.*UMP\R.86.CUCBY=)KMV7-*UOA!FS6ALINF"T!2O;D3YWY[ 7$(8O!(1=
M0.AXMXD<RQDU-(V5;(BRWHAF)TZJBT9RK+1%61B%NPSC3+JHEQJ>:B@-^;C%
MKR:G,S"4<7U&WI&]7;"[Y(2PDMPSSO%$=>P;9&!Q_*S+-FVSA2]DNX'E@ RO
MSDD8A&/RN)B1TY.S7V%\%-"K"'L5H<.]^$L5Y.LG]"!W!H3^=HAF"S<Z#&<?
MPD17-(/$PYNN06W!2]^^&4;!^R-D+WJR%\?0TX61V08O=%6KK, +12HEUXJ*
M<T)K4TC%?D!.J)!U:0Y1;\$C!VZ?W#8=!D$0^]L#E$8]I=%12E@75>.;='4Y
ME/1H^#^>U[@G-_Z_Q1V_ MFH)QN]9G&C/XI[.?Z]MO[>:[>-\YZJ-2LUX;#"
MJ&!PB?I5VXQ:P\C*-8"E--A.W+3 _@W*.N#^2DJS,VQ/Z?\(Z4]02P,$%
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M:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " "KB%5:F&ON>7P(   I40
M#P   'AL+W=O<FMB;V]K+GAM;,6<77/:.!2&_XJ&J^Y,L['YL$VGZ4Q*2,M,
M&IC ]+8CC !-C<S*-FGZZU<V27N4N._NS0E7)+:!!]DZCW3T\?X^M]^7>?Y=
M_-AEIKCH;,MR_^[\O$BW:B>+O_.],N[,.K<[6;I_[>:\V%LE5\56J7*7G7>#
M(#K?26TZ']X_?=;,GM-_\E*EI<Z-.U@?^*K5??'[?/VO..A"+W6FRX>+3O-W
MICIBIXW>Z9]J==$).J+8YO>?<ZM_YJ:4V3RU>99==,+CB:_*ECI]<7A>0R[D
MLFB.E')Y)QW(12<*W >NM2W*YHKF\Z5C/"AW\?&_JLRO=58J>R5+]<GFU5Z;
M3?TQ[E><DY_1E,/3Z[$0W]G_4XSY>JU3=96GU4Z9\EB.5F4UH"FV>E]TA)$[
M==$9Y0=EZ]_COF"R.OZVTD&1DK+OM#MA)ZL&CP_ELEKI4DS,\<WN+,'J JPN
M+]9H>CN?WDRN+A?C*_'Q\N;R=C06\\_C\6). 'L L'<R0/%F)@ED'T#V7Q%R
MOG O7\:W#G!Z+::S\1V!' #(P<D@1],O,P(9 <CH9)#SSY>T)&, &9^N)"_G
MGPED B 37L@K5:16[^OC(E^+955HHXJ"P T!W) 7;E[M=M(^U&!SO3':O4V:
MTHDDS2M3:AJR Q2S ^8RU(7<;*S:R*=BO%,'92I% :%4N*UR++!"6)4J?9#N
MV]^*RKCV0*96PE,?DDS(;)G++,OOI4E5(=S[Q<BJ6H8W>5$H^D"&R#,ALV@^
M/E80,<IW2VV.%U XY)>063#74EOQ56;^DX=D$C+;9&(.JBCKB[Q"0NH(F=WA
MFLM[UYA]>"MF61--S$J,_ZGTOG[?6T$QD3Q"9GM\RO/5O:N@E =Y(F06Q<1U
M"LRF_E)QZ2JD?S^1(T)F24S+K;+B1LNF>Z.]4-%%6N@R:^&C--]_!;$Z:+QU
ML4P:<2W3FI1B(CETF>5PI:Q30MTU\TH.]C:813!U%=0=-1MQHZ0?_+LH^'>9
M@_]M;L[2REIWE<B;QRYK?^R0!+K<O8Q\M]/'D-O$MI'KSKNB5"9]!HF\T&7V
MPGPKK1(CN=>EI"&NB\S093;#G5.5K=*RLO6C-W*(&[_$D ^ZS#Z8F#3?*;&0
M/WPFY(0NLQ-J;98/PJ&YZUP $?/Z0]7QN9M[$0X9HLMLB%]MMKG:U)<V>)]4
MOK%RO]4IS6 @7_28?7&KZLQ/<Y=G+K1,[<JU+UWOIZDK%!+9HL??E:AVE3OA
M.@Y'\[IXL[=JJTSAG@"*B0S28S;(O-KO,U5?)#/A^F=IEA>5BSBN;S:2Q99B
MPJP5LU#NU+$D9](^4T@/*:3'K)!YM2S4/U5=5<:'9VWW'M)&CUD;,_D@#D5=
M/9JWN[A#;BZ%1!KI,6MDXFK"RE6,A96K6B2S/-.U>YNP,Z.][1X22H\[/?6P
M5+90KCU3Q_ [77P77Z21&W4,D103.:;'[!B8 _K6I9C(,;U3IJJ^]6@"&CFF
M?ZI4E7BSD$O:$NLCR_1/F;#R;GH?6:9_PH25*U"*B2S39[;,[[30\2ZKXB^*
M!D=$F$T#DS'^C4;>Z3-[YRD9TUI^R#5]=M<\R\JT$B+-])DU\R(]TTJ(#--G
M-@S,T_C/(#),G]DP)$_35H0#I)4!LU:>)VQ: 9%0!LQ"@9D;\89B(J$,F(7B
M9R#28P:BM3"13P;,/J&IB%8X9)0!LU%@3L*KS0,XRLYL%)B3\#&17P;,?H$Y
M";_>(,D,F"4#LQ)^:2+3#-C[,B KX6,BTPS83=,Z)T"\N5*EU+23$"'I1,S2
MP5VN/L5$ZHF8U8,Q!Q03J2=BSY@AS(AB(O=$S.X!'=CZZ:28R$(1LX5P!Y:F
M R)DH8C90AC3JT)PMA>SA3"F5X60A2)N"\%TP!7%1!:*N/L[;5-8Q)FXE;9N
MQ%-,9*'HM49MVC ]6<;(0C'W*#_$I#4]1A:*F2V$,6E-CY&%8F8+84Q:TV-D
MH?@4L\ <YL)*4T@ZHA@C"\6O-A_,L7UQ/7/7V&PZ&TZ;[AS%1!:*F2W48!X>
M,1^CT$$]-3?IX%.,+!2SY]I^S65KXZ28<-8QLX5P2M4+2,A",;.%,*87D)"%
M8F8+_<K\GC6)A%65-=VUEMEY";)0PFPA@OFR M'<3((DE#!+Z&6VVBM5BHDD
ME#!+J V3E"K%1!)*V--P+S&OJ[).*-2G*":24,(LH98!@+;G$@DHX4[&P1$
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M\?"/VY^N<5^WPTO_9"GJ;GX"4$L! A0#%     @ JXA56@=!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M" "KB%5:<1=1"^X    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    " "KB%5:F5R<(Q &  "<)P  $P
M    @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( *N(55JZ
MH]/VH08  %,?   8              " @0T(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    " "KB%5:0#9^ORL"  "H!0  &
M    @('D#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @
MJXA56BW6>?JV!P  U2$  !@              ("!11$  'AL+W=O<FMS:&5E
M=',O<VAE970S+GAM;%!+ 0(4 Q0    ( *N(55HBR-N$I0(  &X'   8
M          " @3$9  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M    " "KB%5:W"0DSV0&   F&P  &               @($,'   >&PO=V]R
M:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ JXA56H%/@3V< P  5PL
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M965T,3 N>&UL4$L! A0#%     @ JXA56N(CH2#W"   QA8  !D
M     ("!;V@  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *N(55K7-J]R>00  /\*   9              "
M@=R.  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ JXA5
M6H=^!^[3 P  M @  !D              ("!C),  'AL+W=O<FMS:&5E=',O
M<VAE970Q-RYX;6Q02P$"% ,4    " "KB%5:[7'?MMH"  !3!@  &0
M        @(&6EP  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0
M   ( *N(55KJ_%Y4G04  *@.   9              " @:>:  !X;"]W;W)K
M<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ JXA56GTOLP=& P  -0<
M !D              ("!>Z   'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q0
M2P$"% ,4    " "KB%5:W;I\21@.  !+*@  &0              @('XHP
M>&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( *N(55HDQWD8
MU04  *D/   9              " @4>R  !X;"]W;W)K<VAE971S+W-H965T
M,C(N>&UL4$L! A0#%     @ JXA56LQ-D<[O!   A P  !D
M ("!4[@  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " "K
MB%5:39+M0W$"  #&!0  &0              @(%YO0  >&PO=V]R:W-H965T
M<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( *N(55IV!Z@7QP,  $X(   9
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M970R.2YX;6Q02P$"% ,4    " "KB%5:IU2%@[8*  !C&P  &0
M    @(&'\0  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    (
M *N(55JB>WOMQ ,  !0*   9              " @73\  !X;"]W;W)K<VAE
M971S+W-H965T,S$N>&UL4$L! A0#%     @ JXA56JMG\\RP @  ]04  !D
M             ("!;P ! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"
M% ,4    " "KB%5:GT8U0WL"  #?!0  &0              @(%6 P$ >&PO
M=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( *N(55J'T5MCXP(
M #T'   9              " @0@& 0!X;"]W;W)K<VAE971S+W-H965T,S0N
M>&UL4$L! A0#%     @ JXA56N%@05YU!   'PH  !D              ("!
M(@D! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " "KB%5:
M+U#0"EX"  "!!@  &0              @('.#0$ >&PO=V]R:W-H965T<R]S
M:&5E=#,V+GAM;%!+ 0(4 Q0    ( *N(55H\I3,X$0(  -T$   9
M      " @6,0 0!X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%
M  @ JXA56L7 'M('"   ?BL  !D              ("!JQ(! 'AL+W=O<FMS
M:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " "KB%5:S7B=]N4L  "6J
M&0              @('I&@$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+
M 0(4 Q0    ( *N(55I// >UJP0   D+   9              " @05( 0!X
M;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ JXA56M3IB8CS
M @  2 8  !D              ("!YTP! 'AL+W=O<FMS:&5E=',O<VAE970T
M,2YX;6Q02P$"% ,4    " "KB%5:_PBG_I<#  "'"   &0
M@($14 $ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( *N(
M55I7G[!M[P(  (<&   9              " @=]3 0!X;"]W;W)K<VAE971S
M+W-H965T-#,N>&UL4$L! A0#%     @ JXA56M:=(=[K!   8Q4  !D
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M=#0X+GAM;%!+ 0(4 Q0    ( *N(55IXD03>"P8  #H0   9
M  " @3AJ 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @
MJXA56A,1D50' P  \P8  !D              ("!>G ! 'AL+W=O<FMS:&5E
M=',O<VAE970U,"YX;6Q02P$"% ,4    " "KB%5:O+.^=4\#  #*!P  &0
M            @(&X<P$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4
M Q0    ( *N(55JF!R$Z=@(  +$%   9              " @3YW 0!X;"]W
M;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ JXA56J+_SX0< P
MM0<  !D              ("!ZWD! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX
M;6Q02P$"% ,4    " "KB%5:@^$I?U0)  !6&   &0              @($^
M?0$ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( *N(55K;
M/KP(B@4  / -   9              " @<F& 0!X;"]W;W)K<VAE971S+W-H
M965T-34N>&UL4$L! A0#%     @ JXA56JPG+T!$!   V0H  !D
M     ("!BHP! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *N(55H*4$^^K (  .$&   9              "
M@;*= 0!X;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ JXA5
M6K]#OIDO P  /@\  !D              ("!E: ! 'AL+W=O<FMS:&5E=',O
M<VAE970V,BYX;6Q02P$"% ,4    " "KB%5:MR3G+%P#   !$0  &0
M        @('[HP$ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0
M   ( *N(55KKFS#= P0  !\7   9              " @8ZG 0!X;"]W;W)K
M<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @ JXA56DGTI4!% P  H H
M !D              ("!R*L! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q0
M2P$"% ,4    " "KB%5:,R\1NZ,#   _#0  &0              @(%$KP$
M>&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( *N(55KT9V^S
M:P0  )D3   9              " @1ZS 0!X;"]W;W)K<VAE971S+W-H965T
M-C<N>&UL4$L! A0#%     @ JXA56FTF\.[V @  8P@  !D
M ("!P+<! 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4    " "K
MB%5:\8+T.$<%   ](0  &0              @('MN@$ >&PO=V]R:W-H965T
M<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    ( *N(55J]0$"<100  $H6   9
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M970W-"YX;6Q02P$"% ,4    " "KB%5:-X[R:U$&  #@-@  &0
M    @(%UT@$ >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    (
M *N(55I&$1/&*0,  $<*   9              " @?W8 0!X;"]W;W)K<VAE
M971S+W-H965T-S8N>&UL4$L! A0#%     @ JXA56N=/M))O P  ] H  !D
M             ("!7=P! 'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6Q02P$"
M% ,4    " "KB%5:56C5F'P#  #\"@  &0              @($#X $ >&PO
M=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+ 0(4 Q0    ( *N(55H(%PIO> (
M *@&   9              " @;;C 0!X;"]W;W)K<VAE971S+W-H965T-SDN
M>&UL4$L! A0#%     @ JXA56@RKB[39 @  J <  !D              ("!
M9>8! 'AL+W=O<FMS:&5E=',O<VAE970X,"YX;6Q02P$"% ,4    " "KB%5:
MD#O*M&$"  "Z!0  &0              @(%UZ0$ >&PO=V]R:W-H965T<R]S
M:&5E=#@Q+GAM;%!+ 0(4 Q0    ( *N(55HFAPQC 00  ,(3   9
M      " @0WL 0!X;"]W;W)K<VAE971S+W-H965T.#(N>&UL4$L! A0#%
M  @ JXA56IW5%2#I"P  3[\  !D              ("!1? ! 'AL+W=O<FMS
M:&5E=',O<VAE970X,RYX;6Q02P$"% ,4    " "KB%5:AO;?WG\"  !X!@
M&0              @(%E_ $ >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+
M 0(4 Q0    ( *N(55K&<*2[J0,  +8+   9              " @1O_ 0!X
M;"]W;W)K<VAE971S+W-H965T.#4N>&UL4$L! A0#%     @ JXA56M5PB^!,
M!@  Q3(  !D              ("!^P(" 'AL+W=O<FMS:&5E=',O<VAE970X
M-BYX;6Q02P$"% ,4    " "KB%5:?YTV0644  #A9 $ &0
M@(%^"0( >&PO=V]R:W-H965T<R]S:&5E=#@W+GAM;%!+ 0(4 Q0    ( *N(
M55H)2.-5- ,  $()   9              " @1H> @!X;"]W;W)K<VAE971S
M+W-H965T.#@N>&UL4$L! A0#%     @ JXA56J-8QRS/ @  \0@  !D
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M=#DS+GAM;%!+ 0(4 Q0    ( *N(55I"/Y[YR (  "T(   9
M  " @8HU @!X;"]W;W)K<VAE971S+W-H965T.30N>&UL4$L! A0#%     @
MJXA56G8%3#W;!   FA4  !D              ("!B3@" 'AL+W=O<FMS:&5E
M=',O<VAE970Y-2YX;6Q02P$"% ,4    " "KB%5:?0H4:+P"  #2!P  &0
M            @(&;/0( >&PO=V]R:W-H965T<R]S:&5E=#DV+GAM;%!+ 0(4
M Q0    ( *N(55K+W_<Z1@(  *H%   9              " @8Y  @!X;"]W
M;W)K<VAE971S+W-H965T.3<N>&UL4$L! A0#%     @ JXA56@N@.&$: @
M< 0  !D              ("!"T," 'AL+W=O<FMS:&5E=',O<VAE970Y."YX
M;6Q02P$"% ,4    " "KB%5:J^M"5I,'  #G0   &0              @(%<
M10( >&PO=V]R:W-H965T<R]S:&5E=#DY+GAM;%!+ 0(4 Q0    ( *N(55K3
MGDLAGP0  +P7   :              " @29- @!X;"]W;W)K<VAE971S+W-H
M965T,3 P+GAM;%!+ 0(4 Q0    ( *N(55H=K&TU?P(  ,$&   :
M      " @?U1 @!X;"]W;W)K<VAE971S+W-H965T,3 Q+GAM;%!+ 0(4 Q0
M   ( *N(55IJ1^@=UP(  +T'   :              " @;14 @!X;"]W;W)K
M<VAE971S+W-H965T,3 R+GAM;%!+ 0(4 Q0    ( *N(55H?5;*7H@,  *41
M   :              " @<-7 @!X;"]W;W)K<VAE971S+W-H965T,3 S+GAM
M;%!+ 0(4 Q0    ( *N(55I8'(@8504  + >   :              " @9U;
M @!X;"]W;W)K<VAE971S+W-H965T,3 T+GAM;%!+ 0(4 Q0    ( *N(55H[
MO.XW^00  &P0   :              " @2IA @!X;"]W;W)K<VAE971S+W-H
M965T,3 U+GAM;%!+ 0(4 Q0    ( *N(55J-:<Y#W 0  &42   :
M      " @5MF @!X;"]W;W)K<VAE971S+W-H965T,3 V+GAM;%!+ 0(4 Q0
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M965T,3$P+GAM;%!+ 0(4 Q0    ( *N(55JAM", <P0  #P2   :
M      " @96, @!X;"]W;W)K<VAE971S+W-H965T,3$Q+GAM;%!+ 0(4 Q0
M   ( *N(55K?&F*&I ,  /<+   :              " @4"1 @!X;"]W;W)K
M<VAE971S+W-H965T,3$R+GAM;%!+ 0(4 Q0    ( *N(55IJS4LF=@0  -,3
M   :              " @1R5 @!X;"]W;W)K<VAE971S+W-H965T,3$S+GAM
M;%!+ 0(4 Q0    ( *N(55KZHQPW;@,  .T-   :              " @<J9
M @!X;"]W;W)K<VAE971S+W-H965T,3$T+GAM;%!+ 0(4 Q0    ( *N(55I<
MGR*;-@(  ,($   :              " @7"= @!X;"]W;W)K<VAE971S+W-H
M965T,3$U+GAM;%!+ 0(4 Q0    ( *N(55J$I1=![ ,  !H4   :
M      " @=Z? @!X;"]W;W)K<VAE971S+W-H965T,3$V+GAM;%!+ 0(4 Q0
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M965T,3(P+GAM;%!+ 0(4 Q0    ( *N(55KY' =QV@(  )H'   :
M      " @0ZS @!X;"]W;W)K<VAE971S+W-H965T,3(Q+GAM;%!+ 0(4 Q0
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M96QS+RYR96QS4$L! A0#%     @ JXA56IAK[GE\"   *5$   \
M     ( !/L," 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( *N(55H8ZBE1
M9@,  +](   :              "  >?+ @!X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<U!+ 0(4 Q0    ( *N(55IN$*BGI0(  +-%   3
M  "  87/ @!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    "$ (0 ;"0  %O2
$ @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>308</ContextCount>
  <ElementCount>501</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>104</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952151 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952152 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952153 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952154 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952155 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952156 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - Description of business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Descriptionofbusiness</Role>
      <ShortName>Description of business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Summary of Significant accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies</Role>
      <ShortName>Summary of Significant accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Disaggregation of Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DisaggregationofRevenue</Role>
      <ShortName>Disaggregation of Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Accountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilities</Role>
      <ShortName>Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Allowances for Credit Losses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AllowancesforCreditLosses</Role>
      <ShortName>Allowances for Credit Losses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Business Combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessCombinations</Role>
      <ShortName>Business Combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Fair Value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/FairValue</Role>
      <ShortName>Fair Value</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Property, Plant and Equipment, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/PropertyPlantandEquipmentnet</Role>
      <ShortName>Property, Plant and Equipment, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Other Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OtherLiabilities</Role>
      <ShortName>Other Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9952169 - Disclosure - Bank Credit Lines, Loan Facilities and Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotes</Role>
      <ShortName>Bank Credit Lines, Loan Facilities and Notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9952170 - Disclosure - Derivatives</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Derivatives</Role>
      <ShortName>Derivatives</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9952171 - Disclosure - Operating Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OperatingLeases</Role>
      <ShortName>Operating Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9952172 - Disclosure - Non-current other liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/Noncurrentotherliabilities</Role>
      <ShortName>Non-current other liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9952173 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9952174 - Disclosure - Share Capital</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/ShareCapital</Role>
      <ShortName>Share Capital</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9952175 - Disclosure - Restructuring Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RestructuringCharges</Role>
      <ShortName>Restructuring Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9952176 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9952177 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9952178 - Disclosure - Business Segment and Geographical Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation</Role>
      <ShortName>Business Segment and Geographical Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9952179 - Disclosure - Net Income Per Ordinary Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NetIncomePerOrdinaryShare</Role>
      <ShortName>Net Income Per Ordinary Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9952180 - Disclosure - Accumulated Other Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AccumulatedOtherComprehensiveLoss</Role>
      <ShortName>Accumulated Other Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9952181 - Disclosure - Supplemental Disclosure of Cash Flow Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation</Role>
      <ShortName>Supplemental Disclosure of Cash Flow Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9952182 - Disclosure - Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RelatedParties</Role>
      <ShortName>Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9952183 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Summary of Significant accounting policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies</Role>
      <ShortName>Summary of Significant accounting policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Summary of Significant accounting policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables</Role>
      <ShortName>Summary of Significant accounting policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Disaggregation of Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DisaggregationofRevenueTables</Role>
      <ShortName>Disaggregation of Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/DisaggregationofRevenue</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables</Role>
      <ShortName>Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/Accountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilities</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Allowances for Credit Losses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AllowancesforCreditLossesTables</Role>
      <ShortName>Allowances for Credit Losses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/AllowancesforCreditLosses</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Fair Value (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/FairValueTables</Role>
      <ShortName>Fair Value (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/FairValue</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Property, Plant and Equipment, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables</Role>
      <ShortName>Property, Plant and Equipment, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/PropertyPlantandEquipmentnet</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/GoodwillTables</Role>
      <ShortName>Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/Goodwill</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/IntangibleAssets</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Other Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OtherLiabilitiesTables</Role>
      <ShortName>Other Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/OtherLiabilities</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Bank Credit Lines, Loan Facilities and Notes (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesTables</Role>
      <ShortName>Bank Credit Lines, Loan Facilities and Notes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotes</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Derivatives (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DerivativesTables</Role>
      <ShortName>Derivatives (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/Derivatives</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Operating Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OperatingLeasesTables</Role>
      <ShortName>Operating Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/OperatingLeases</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Non-current other liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NoncurrentotherliabilitiesTables</Role>
      <ShortName>Non-current other liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/Noncurrentotherliabilities</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Restructuring charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RestructuringchargesTables</Role>
      <ShortName>Restructuring charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/IncomeTaxes</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Business Segment and Geographical Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables</Role>
      <ShortName>Business Segment and Geographical Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Net Income Per Ordinary Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables</Role>
      <ShortName>Net Income Per Ordinary Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/NetIncomePerOrdinaryShare</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/AccumulatedOtherComprehensiveLoss</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - Supplemental Disclosure of Cash Flow Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables</Role>
      <ShortName>Supplemental Disclosure of Cash Flow Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - Description of business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DescriptionofbusinessDetails</Role>
      <ShortName>Description of business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/Descriptionofbusiness</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails</Role>
      <ShortName>Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails</Role>
      <ShortName>Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails</Role>
      <ShortName>Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DisaggregationofRevenueDetails</Role>
      <ShortName>Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/DisaggregationofRevenueTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Accounts Receivables and Unbilled Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails</Role>
      <ShortName>Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Accounts Receivables and Unbilled Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Unbilled Services and Unearned Revenue or Payments on Account (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails</Role>
      <ShortName>Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Unbilled Services and Unearned Revenue or Payments on Account (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails</Role>
      <ShortName>Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - Allowances for Credit Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AllowancesforCreditLossesDetails</Role>
      <ShortName>Allowances for Credit Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/AllowancesforCreditLossesTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - Business Combinations - Narrative, KCR Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessCombinationsNarrativeKCRAcquisitionDetails</Role>
      <ShortName>Business Combinations - Narrative, KCR Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - Business Combinations - Narrative, HumanFirst Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessCombinationsNarrativeHumanFirstAcquisitionDetails</Role>
      <ShortName>Business Combinations - Narrative, HumanFirst Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - Business Combinations - Narrative, Biotel Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails</Role>
      <ShortName>Business Combinations - Narrative, Biotel Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - Business Combinations - Narrative, PRA Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails</Role>
      <ShortName>Business Combinations - Narrative, PRA Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - Business Combinations - Narrative, Oncacare Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails</Role>
      <ShortName>Business Combinations - Narrative, Oncacare Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9955546 - Disclosure - Business Combinations - Transaction and Integration Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessCombinationsTransactionandIntegrationCostsDetails</Role>
      <ShortName>Business Combinations - Transaction and Integration Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9955547 - Disclosure - Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails</Role>
      <ShortName>Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9955548 - Disclosure - Fair value - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/FairvalueNarrativeDetails</Role>
      <ShortName>Fair value - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9955549 - Disclosure - Investments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/InvestmentsNarrativeDetails</Role>
      <ShortName>Investments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9955550 - Disclosure - Property, Plant and Equipment, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails</Role>
      <ShortName>Property, Plant and Equipment, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>9955551 - Disclosure - Property, Plant and Equipment, net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/PropertyPlantandEquipmentnetNarrativeDetails</Role>
      <ShortName>Property, Plant and Equipment, net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>9955552 - Disclosure - Goodwill - Schedule of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails</Role>
      <ShortName>Goodwill - Schedule of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>9955553 - Disclosure - Goodwill - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/GoodwillNarrativeDetails</Role>
      <ShortName>Goodwill - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>9955554 - Disclosure - Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>9955555 - Disclosure - Intangible Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails</Role>
      <ShortName>Intangible Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>9955556 - Disclosure - Intangible Assets - Future Intangible Asset Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails</Role>
      <ShortName>Intangible Assets - Future Intangible Asset Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>9955557 - Disclosure - Other Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OtherLiabilitiesDetails</Role>
      <ShortName>Other Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/OtherLiabilitiesTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>9955558 - Disclosure - Bank Credit Lines, Loan Facilities and Notes - Schedule of Long-term Debt Instruments (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails</Role>
      <ShortName>Bank Credit Lines, Loan Facilities and Notes - Schedule of Long-term Debt Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>9955559 - Disclosure - Bank Credit Lines, Loan Facilities and Notes - Narrative (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails</Role>
      <ShortName>Bank Credit Lines, Loan Facilities and Notes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>9955560 - Disclosure - Bank Credit Lines, Loan Facilities and Notes - Schedule of Finance Cost (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofFinanceCostDetails</Role>
      <ShortName>Bank Credit Lines, Loan Facilities and Notes - Schedule of Finance Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>9955561 - Disclosure - Bank Credit Lines, Loan Facilities and Notes - Schedule of Maturities of Long-term Debt (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMaturitiesofLongtermDebtDetails</Role>
      <ShortName>Bank Credit Lines, Loan Facilities and Notes - Schedule of Maturities of Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>9955562 - Disclosure - Bank Credit Lines, Loan Facilities and Notes - Schedule of Principal payments (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofPrincipalpaymentsDetails</Role>
      <ShortName>Bank Credit Lines, Loan Facilities and Notes - Schedule of Principal payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>9955563 - Disclosure - Bank Credit Lines, Loan Facilities and Notes - Schedule of Movement on Debt Instrument (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails</Role>
      <ShortName>Bank Credit Lines, Loan Facilities and Notes - Schedule of Movement on Debt Instrument (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>9955564 - Disclosure - Derivatives - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DerivativesNarrativeDetails</Role>
      <ShortName>Derivatives - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>9955565 - Disclosure - Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails</Role>
      <ShortName>Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>9955566 - Disclosure - Operating Leases - Schedule of Lease Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OperatingLeasesScheduleofLeaseCostsDetails</Role>
      <ShortName>Operating Leases - Schedule of Lease Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>9955567 - Disclosure - Operating Leases Operating Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails</Role>
      <ShortName>Operating Leases Operating Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>9955568 - Disclosure - Operating Leases Operating Leases - Operating Lease Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails</Role>
      <ShortName>Operating Leases Operating Leases - Operating Lease Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>9955569 - Disclosure - Non-current other liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails</Role>
      <ShortName>Non-current other liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/NoncurrentotherliabilitiesTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>9955570 - Disclosure - Commitments and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>9955571 - Disclosure - Share Capital (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/ShareCapitalDetails</Role>
      <ShortName>Share Capital (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/ShareCapital</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>9955572 - Disclosure - Restructuring charges - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RestructuringchargesNarrativeDetails</Role>
      <ShortName>Restructuring charges - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>9955573 - Disclosure - Restructuring charges - Schedule of Restructuring Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringChargesDetails</Role>
      <ShortName>Restructuring charges - Schedule of Restructuring Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>9955574 - Disclosure - Restructuring charges - Schedule of Restructuring Reserve by Type of Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringReservebyTypeofCostDetails</Role>
      <ShortName>Restructuring charges - Schedule of Restructuring Reserve by Type of Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>9955575 - Disclosure - Income Taxes - Components of Income Before Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Components of Income Before Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>9955576 - Disclosure - Income Taxes - Components of Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Components of Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>9955577 - Disclosure - Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails</Role>
      <ShortName>Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>9955578 - Disclosure - Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>9955579 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>9955580 - Disclosure - Income Taxes - Expected Expiry Dates of NOL's (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails</Role>
      <ShortName>Income Taxes - Expected Expiry Dates of NOL's (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>9955581 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>9955582 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables</ParentRole>
      <Position>110</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>9955583 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>9955584 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>9955585 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>9955586 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails</Role>
      <ShortName>Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>114</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>9955587 - Disclosure - Business Segment and Geographical Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails</Role>
      <ShortName>Business Segment and Geographical Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>115</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>9955588 - Disclosure - Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails</Role>
      <ShortName>Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>116</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>9955589 - Disclosure - Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails</Role>
      <ShortName>Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>117</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>9955590 - Disclosure - Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails</Role>
      <ShortName>Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>118</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>9955591 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails</Role>
      <ShortName>Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>119</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>9955592 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails</Role>
      <ShortName>Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>120</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R121.htm</HtmlFileName>
      <LongName>9955593 - Disclosure - Accumulated Other Comprehensive Loss - Schedule of Accumulated Other Comprehensive income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails</Role>
      <ShortName>Accumulated Other Comprehensive Loss - Schedule of Accumulated Other Comprehensive income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>121</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R122.htm</HtmlFileName>
      <LongName>9955594 - Disclosure - Supplemental Disclosure of Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails</Role>
      <ShortName>Supplemental Disclosure of Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables</ParentRole>
      <Position>122</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R123.htm</HtmlFileName>
      <LongName>9955595 - Disclosure - Related Parties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/RelatedPartiesDetails</Role>
      <ShortName>Related Parties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/RelatedParties</ParentRole>
      <Position>123</Position>
    </Report>
    <Report instance="iclr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R124.htm</HtmlFileName>
      <LongName>9955596 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iconplc.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.iconplc.com/role/SubsequentEvents</ParentRole>
      <Position>124</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="20-F" isDefinitelyFs="true" isUsgaap="true" original="iclr-20241231.htm">iclr-20241231.htm</File>
    <File>iclr-20241231.xsd</File>
    <File>iclr-20241231_cal.xml</File>
    <File>iclr-20241231_def.xml</File>
    <File>iclr-20241231_lab.xml</File>
    <File>iclr-20241231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>iclr-20241231_g1.jpg</File>
    <File>iclr-20241231_g2.jpg</File>
    <File>iclr-20241231_g3.jpg</File>
    <File>iclr-20241231_g4.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="4">http://fasb.org/srt/2024</BaseTaxonomy>
    <BaseTaxonomy items="1265">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="15">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="47">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="1">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>154
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "iclr-20241231.htm": {
   "nsprefix": "iclr",
   "nsuri": "http://www.iconplc.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "iclr-20241231.htm"
     ]
    },
    "schema": {
     "local": [
      "iclr-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "iclr-20241231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "iclr-20241231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "iclr-20241231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "iclr-20241231_pre.xml"
     ]
    }
   },
   "keyStandard": 446,
   "keyCustom": 55,
   "axisStandard": 35,
   "axisCustom": 1,
   "memberStandard": 53,
   "memberCustom": 51,
   "hidden": {
    "total": 9,
    "http://xbrl.sec.gov/dei/2024": 4,
    "http://fasb.org/us-gaap/2024": 5
   },
   "contextCount": 308,
   "entityCount": 1,
   "segmentCount": 104,
   "elementCount": 901,
   "unitCount": 11,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 1265,
    "http://xbrl.sec.gov/dei/2024": 47,
    "http://xbrl.sec.gov/cyd/2024": 15,
    "http://fasb.org/srt/2024": 4,
    "http://xbrl.sec.gov/ecd/2024": 1
   },
   "report": {
    "R1": {
     "role": "http://www.iconplc.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.iconplc.com/role/AuditInformation",
     "longName": "0000002 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorFirmId",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorFirmId",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
     "longName": "9952151 - Statement - CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "longName": "9952152 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "eurPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "eurPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "longName": "9952153 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "longName": "9952154 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R7": {
     "role": "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY",
     "longName": "9952155 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "longName": "9952156 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.iconplc.com/role/Descriptionofbusiness",
     "longName": "9952157 - Disclosure - Description of business",
     "shortName": "Description of business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies",
     "longName": "9952158 - Disclosure - Summary of Significant accounting policies",
     "shortName": "Summary of Significant accounting policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.iconplc.com/role/DisaggregationofRevenue",
     "longName": "9952159 - Disclosure - Disaggregation of Revenue",
     "shortName": "Disaggregation of Revenue",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R12": {
     "role": "http://www.iconplc.com/role/Accountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilities",
     "longName": "9952160 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)",
     "shortName": "Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R13": {
     "role": "http://www.iconplc.com/role/AllowancesforCreditLosses",
     "longName": "9952161 - Disclosure - Allowances for Credit Losses",
     "shortName": "Allowances for Credit Losses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllowanceForCreditLossesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllowanceForCreditLossesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.iconplc.com/role/BusinessCombinations",
     "longName": "9952162 - Disclosure - Business Combinations",
     "shortName": "Business Combinations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.iconplc.com/role/FairValue",
     "longName": "9952163 - Disclosure - Fair Value",
     "shortName": "Fair Value",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.iconplc.com/role/Investments",
     "longName": "9952164 - Disclosure - Investments",
     "shortName": "Investments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.iconplc.com/role/PropertyPlantandEquipmentnet",
     "longName": "9952165 - Disclosure - Property, Plant and Equipment, net",
     "shortName": "Property, Plant and Equipment, net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.iconplc.com/role/Goodwill",
     "longName": "9952166 - Disclosure - Goodwill",
     "shortName": "Goodwill",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.iconplc.com/role/IntangibleAssets",
     "longName": "9952167 - Disclosure - Intangible Assets",
     "shortName": "Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.iconplc.com/role/OtherLiabilities",
     "longName": "9952168 - Disclosure - Other Liabilities",
     "shortName": "Other Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotes",
     "longName": "9952169 - Disclosure - Bank Credit Lines, Loan Facilities and Notes",
     "shortName": "Bank Credit Lines, Loan Facilities and Notes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.iconplc.com/role/Derivatives",
     "longName": "9952170 - Disclosure - Derivatives",
     "shortName": "Derivatives",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.iconplc.com/role/OperatingLeases",
     "longName": "9952171 - Disclosure - Operating Leases",
     "shortName": "Operating Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.iconplc.com/role/Noncurrentotherliabilities",
     "longName": "9952172 - Disclosure - Non-current other liabilities",
     "shortName": "Non-current other liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.iconplc.com/role/CommitmentsandContingencies",
     "longName": "9952173 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.iconplc.com/role/ShareCapital",
     "longName": "9952174 - Disclosure - Share Capital",
     "shortName": "Share Capital",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.iconplc.com/role/RestructuringCharges",
     "longName": "9952175 - Disclosure - Restructuring Charges",
     "shortName": "Restructuring Charges",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.iconplc.com/role/IncomeTaxes",
     "longName": "9952176 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges",
     "longName": "9952177 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation",
     "longName": "9952178 - Disclosure - Business Segment and Geographical Information",
     "shortName": "Business Segment and Geographical Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.iconplc.com/role/NetIncomePerOrdinaryShare",
     "longName": "9952179 - Disclosure - Net Income Per Ordinary Share",
     "shortName": "Net Income Per Ordinary Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLoss",
     "longName": "9952180 - Disclosure - Accumulated Other Comprehensive Loss",
     "shortName": "Accumulated Other Comprehensive Loss",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "iclr:AccumulatedOtherComprehensiveIncomeLossTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "iclr:AccumulatedOtherComprehensiveIncomeLossTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation",
     "longName": "9952181 - Disclosure - Supplemental Disclosure of Cash Flow Information",
     "shortName": "Supplemental Disclosure of Cash Flow Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.iconplc.com/role/RelatedParties",
     "longName": "9952182 - Disclosure - Related Parties",
     "shortName": "Related Parties",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.iconplc.com/role/SubsequentEvents",
     "longName": "9952183 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R37": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies",
     "longName": "9955511 - Disclosure - Summary of Significant accounting policies (Policies)",
     "shortName": "Summary of Significant accounting policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables",
     "longName": "9955512 - Disclosure - Summary of Significant accounting policies (Tables)",
     "shortName": "Summary of Significant accounting policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "iclr:ForeignCurrencyDisclosureTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "iclr:ForeignCurrencyDisclosureTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.iconplc.com/role/DisaggregationofRevenueTables",
     "longName": "9955513 - Disclosure - Disaggregation of Revenue (Tables)",
     "shortName": "Disaggregation of Revenue (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables",
     "longName": "9955514 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) (Tables)",
     "shortName": "Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.iconplc.com/role/AllowancesforCreditLossesTables",
     "longName": "9955515 - Disclosure - Allowances for Credit Losses (Tables)",
     "shortName": "Allowances for Credit Losses (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.iconplc.com/role/FairValueTables",
     "longName": "9955516 - Disclosure - Fair Value (Tables)",
     "shortName": "Fair Value (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables",
     "longName": "9955517 - Disclosure - Property, Plant and Equipment, net (Tables)",
     "shortName": "Property, Plant and Equipment, net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.iconplc.com/role/GoodwillTables",
     "longName": "9955518 - Disclosure - Goodwill (Tables)",
     "shortName": "Goodwill (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.iconplc.com/role/IntangibleAssetsTables",
     "longName": "9955519 - Disclosure - Intangible Assets (Tables)",
     "shortName": "Intangible Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.iconplc.com/role/OtherLiabilitiesTables",
     "longName": "9955520 - Disclosure - Other Liabilities (Tables)",
     "shortName": "Other Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesTables",
     "longName": "9955521 - Disclosure - Bank Credit Lines, Loan Facilities and Notes (Tables)",
     "shortName": "Bank Credit Lines, Loan Facilities and Notes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.iconplc.com/role/DerivativesTables",
     "longName": "9955522 - Disclosure - Derivatives (Tables)",
     "shortName": "Derivatives (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.iconplc.com/role/OperatingLeasesTables",
     "longName": "9955523 - Disclosure - Operating Leases (Tables)",
     "shortName": "Operating Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.iconplc.com/role/NoncurrentotherliabilitiesTables",
     "longName": "9955524 - Disclosure - Non-current other liabilities (Tables)",
     "shortName": "Non-current other liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.iconplc.com/role/RestructuringchargesTables",
     "longName": "9955525 - Disclosure - Restructuring charges (Tables)",
     "shortName": "Restructuring charges (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.iconplc.com/role/IncomeTaxesTables",
     "longName": "9955526 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "iclr:IncomeBeforeIncomeTaxTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "iclr:IncomeBeforeIncomeTaxTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables",
     "longName": "9955527 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges (Tables)",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables",
     "longName": "9955528 - Disclosure - Business Segment and Geographical Information (Tables)",
     "shortName": "Business Segment and Geographical Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables",
     "longName": "9955529 - Disclosure - Net Income Per Ordinary Share (Tables)",
     "shortName": "Net Income Per Ordinary Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossTables",
     "longName": "9955530 - Disclosure - Accumulated Other Comprehensive Loss (Tables)",
     "shortName": "Accumulated Other Comprehensive Loss (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables",
     "longName": "9955531 - Disclosure - Supplemental Disclosure of Cash Flow Information (Tables)",
     "shortName": "Supplemental Disclosure of Cash Flow Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.iconplc.com/role/DescriptionofbusinessDetails",
     "longName": "9955532 - Disclosure - Description of business (Details)",
     "shortName": "Description of business (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "dei:EntityNumberOfEmployees",
      "unitRef": "employee",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "dei:EntityNumberOfEmployees",
      "unitRef": "employee",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails",
     "longName": "9955533 - Disclosure - Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details)",
     "shortName": "Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails",
     "longName": "9955534 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details)",
     "shortName": "Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-46",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-46",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails",
     "longName": "9955535 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)",
     "shortName": "Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-52",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-57",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.iconplc.com/role/DisaggregationofRevenueDetails",
     "longName": "9955536 - Disclosure - Disaggregation of Revenue (Details)",
     "shortName": "Disaggregation of Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-59",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails",
     "longName": "9955537 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Accounts Receivables and Unbilled Revenue (Details)",
     "shortName": "Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Accounts Receivables and Unbilled Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:BilledContractReceivables",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:BilledContractReceivables",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails",
     "longName": "9955538 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Unbilled Services and Unearned Revenue or Payments on Account (Details)",
     "shortName": "Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Schedule of Unbilled Services and Unearned Revenue or Payments on Account (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ContractWithCustomerAssetGrossCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "iclr:IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails",
     "longName": "9955539 - Disclosure - Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Narrative (Details)",
     "shortName": "Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities) - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "us-gaap:OtherLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ContractWithCustomerAssetCreditLossExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.iconplc.com/role/AllowancesforCreditLossesDetails",
     "longName": "9955540 - Disclosure - Allowances for Credit Losses (Details)",
     "shortName": "Allowances for Credit Losses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.iconplc.com/role/BusinessCombinationsNarrativeKCRAcquisitionDetails",
     "longName": "9955541 - Disclosure - Business Combinations - Narrative, KCR Acquisition (Details)",
     "shortName": "Business Combinations - Narrative, KCR Acquisition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-76",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.iconplc.com/role/BusinessCombinationsNarrativeHumanFirstAcquisitionDetails",
     "longName": "9955542 - Disclosure - Business Combinations - Narrative, HumanFirst Acquisition (Details)",
     "shortName": "Business Combinations - Narrative, HumanFirst Acquisition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-82",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails",
     "longName": "9955543 - Disclosure - Business Combinations - Narrative, Biotel Acquisition (Details)",
     "shortName": "Business Combinations - Narrative, Biotel Acquisition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-85",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails",
     "longName": "9955544 - Disclosure - Business Combinations - Narrative, PRA Acquisition (Details)",
     "shortName": "Business Combinations - Narrative, PRA Acquisition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InterestExpenseNonoperating",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-87",
      "name": "us-gaap:InterestExpenseNonoperating",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails",
     "longName": "9955545 - Disclosure - Business Combinations - Narrative, Oncacare Acquisition (Details)",
     "shortName": "Business Combinations - Narrative, Oncacare Acquisition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-90",
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.iconplc.com/role/BusinessCombinationsTransactionandIntegrationCostsDetails",
     "longName": "9955546 - Disclosure - Business Combinations - Transaction and Integration Costs (Details)",
     "shortName": "Business Combinations - Transaction and Integration Costs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationIntegrationRelatedCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R75": {
     "role": "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
     "longName": "9955547 - Disclosure - Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details)",
     "shortName": "Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-101",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.iconplc.com/role/FairvalueNarrativeDetails",
     "longName": "9955548 - Disclosure - Fair value - Narrative (Details)",
     "shortName": "Fair value - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EquitySecuritiesFvNiCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-107",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.iconplc.com/role/InvestmentsNarrativeDetails",
     "longName": "9955549 - Disclosure - Investments - Narrative (Details)",
     "shortName": "Investments - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails",
     "longName": "9955550 - Disclosure - Property, Plant and Equipment, net (Details)",
     "shortName": "Property, Plant and Equipment, net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:Land",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:Land",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.iconplc.com/role/PropertyPlantandEquipmentnetNarrativeDetails",
     "longName": "9955551 - Disclosure - Property, Plant and Equipment, net - Narrative (Details)",
     "shortName": "Property, Plant and Equipment, net - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails",
     "longName": "9955552 - Disclosure - Goodwill - Schedule of Goodwill (Details)",
     "shortName": "Goodwill - Schedule of Goodwill (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.iconplc.com/role/GoodwillNarrativeDetails",
     "longName": "9955553 - Disclosure - Goodwill - Narrative (Details)",
     "shortName": "Goodwill - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails",
     "longName": "9955554 - Disclosure - Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details)",
     "shortName": "Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
     "longName": "9955555 - Disclosure - Intangible Assets - Narrative (Details)",
     "shortName": "Intangible Assets - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-116",
      "name": "iclr:DecreaseInAmortisation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R84": {
     "role": "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails",
     "longName": "9955556 - Disclosure - Intangible Assets - Future Intangible Asset Amortization Expense (Details)",
     "shortName": "Intangible Assets - Future Intangible Asset Amortization Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R85": {
     "role": "http://www.iconplc.com/role/OtherLiabilitiesDetails",
     "longName": "9955557 - Disclosure - Other Liabilities (Details)",
     "shortName": "Other Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:OtherSundryLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:OtherLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:OtherSundryLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:OtherLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R86": {
     "role": "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails",
     "longName": "9955558 - Disclosure - Bank Credit Lines, Loan Facilities and Notes - Schedule of Long-term Debt Instruments (Details)",
     "shortName": "Bank Credit Lines, Loan Facilities and Notes - Schedule of Long-term Debt Instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "iclr:LongTermDebtCurrentMaturitiesGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R87": {
     "role": "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
     "longName": "9955559 - Disclosure - Bank Credit Lines, Loan Facilities and Notes - Narrative (Details)",
     "shortName": "Bank Credit Lines, Loan Facilities and Notes - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AmortizationOfFinancingCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RepaymentsOfSeniorDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R88": {
     "role": "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofFinanceCostDetails",
     "longName": "9955560 - Disclosure - Bank Credit Lines, Loan Facilities and Notes - Schedule of Finance Cost (Details)",
     "shortName": "Bank Credit Lines, Loan Facilities and Notes - Schedule of Finance Cost (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InterestExpenseDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iclr:DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InterestExpenseDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iclr:DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R89": {
     "role": "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMaturitiesofLongtermDebtDetails",
     "longName": "9955561 - Disclosure - Bank Credit Lines, Loan Facilities and Notes - Schedule of Maturities of Long-term Debt (Details)",
     "shortName": "Bank Credit Lines, Loan Facilities and Notes - Schedule of Maturities of Long-term Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R90": {
     "role": "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofPrincipalpaymentsDetails",
     "longName": "9955562 - Disclosure - Bank Credit Lines, Loan Facilities and Notes - Schedule of Principal payments (Details)",
     "shortName": "Bank Credit Lines, Loan Facilities and Notes - Schedule of Principal payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "c-167",
      "name": "us-gaap:DebtInstrumentPeriodicPaymentPrincipal",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iclr:ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-167",
      "name": "us-gaap:DebtInstrumentPeriodicPaymentPrincipal",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iclr:ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R91": {
     "role": "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails",
     "longName": "9955563 - Disclosure - Bank Credit Lines, Loan Facilities and Notes - Schedule of Movement on Debt Instrument (Details)",
     "shortName": "Bank Credit Lines, Loan Facilities and Notes - Schedule of Movement on Debt Instrument (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProceedsFromLinesOfCredit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-184",
      "name": "us-gaap:RepaymentsOfLinesOfCredit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R92": {
     "role": "http://www.iconplc.com/role/DerivativesNarrativeDetails",
     "longName": "9955564 - Disclosure - Derivatives - Narrative (Details)",
     "shortName": "Derivatives - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PercentageOfDebtHedgedByInterestRateDerivatives",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PercentageOfDebtHedgedByInterestRateDerivatives",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R93": {
     "role": "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
     "longName": "9955565 - Disclosure - Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details)",
     "shortName": "Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "c-189",
      "name": "us-gaap:DerivativeAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-189",
      "name": "us-gaap:DerivativeAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R94": {
     "role": "http://www.iconplc.com/role/OperatingLeasesScheduleofLeaseCostsDetails",
     "longName": "9955566 - Disclosure - Operating Leases - Schedule of Lease Costs (Details)",
     "shortName": "Operating Leases - Schedule of Lease Costs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R95": {
     "role": "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails",
     "longName": "9955567 - Disclosure - Operating Leases Operating Leases - Narrative (Details)",
     "shortName": "Operating Leases Operating Leases - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R96": {
     "role": "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails",
     "longName": "9955568 - Disclosure - Operating Leases Operating Leases - Operating Lease Maturity (Details)",
     "shortName": "Operating Leases Operating Leases - Operating Lease Maturity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R97": {
     "role": "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails",
     "longName": "9955569 - Disclosure - Non-current other liabilities (Details)",
     "shortName": "Non-current other liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:OtherSundryLiabilitiesNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:OtherSundryLiabilitiesNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R98": {
     "role": "http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails",
     "longName": "9955570 - Disclosure - Commitments and Contingencies - Narrative (Details)",
     "shortName": "Commitments and Contingencies - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R99": {
     "role": "http://www.iconplc.com/role/ShareCapitalDetails",
     "longName": "9955571 - Disclosure - Share Capital (Details)",
     "shortName": "Share Capital (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "99",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "iclr:NumberOfVotes",
      "unitRef": "vote",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "iclr:NumberOfVotes",
      "unitRef": "vote",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R100": {
     "role": "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails",
     "longName": "9955572 - Disclosure - Restructuring charges - Narrative (Details)",
     "shortName": "Restructuring charges - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "100",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SeveranceCosts1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R101": {
     "role": "http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringChargesDetails",
     "longName": "9955573 - Disclosure - Restructuring charges - Schedule of Restructuring Charges (Details)",
     "shortName": "Restructuring charges - Schedule of Restructuring Charges (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "101",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R102": {
     "role": "http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringReservebyTypeofCostDetails",
     "longName": "9955574 - Disclosure - Restructuring charges - Schedule of Restructuring Reserve by Type of Cost (Details)",
     "shortName": "Restructuring charges - Schedule of Restructuring Reserve by Type of Cost (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "102",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:RestructuringReserve",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RestructuringCharges",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R103": {
     "role": "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
     "longName": "9955575 - Disclosure - Income Taxes - Components of Income Before Provision for Income Taxes (Details)",
     "shortName": "Income Taxes - Components of Income Before Provision for Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "103",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iclr:IncomeBeforeIncomeTaxTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "iclr:IncomeBeforeIncomeTaxTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R104": {
     "role": "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
     "longName": "9955576 - Disclosure - Income Taxes - Components of Provision for Income Taxes (Details)",
     "shortName": "Income Taxes - Components of Provision for Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "104",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R105": {
     "role": "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails",
     "longName": "9955577 - Disclosure - Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details)",
     "shortName": "Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "105",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R106": {
     "role": "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails",
     "longName": "9955578 - Disclosure - Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details)",
     "shortName": "Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "106",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R107": {
     "role": "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
     "longName": "9955579 - Disclosure - Income Taxes - Narrative (Details)",
     "shortName": "Income Taxes - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "107",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "iclr:TaxCreditCarryForwardExpirationPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "iclr:TaxCreditCarryForwardExpirationPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R108": {
     "role": "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
     "longName": "9955580 - Disclosure - Income Taxes - Expected Expiry Dates of NOL's (Details)",
     "shortName": "Income Taxes - Expected Expiry Dates of NOL's (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "108",
     "firstAnchor": {
      "contextRef": "c-233",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-236",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R109": {
     "role": "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails",
     "longName": "9955581 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details)",
     "shortName": "Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "109",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R110": {
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
     "longName": "9955582 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details)",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "110",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R111": {
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails",
     "longName": "9955583 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details)",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "111",
     "firstAnchor": {
      "contextRef": "c-262",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-258",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R112": {
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
     "longName": "9955584 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details)",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "112",
     "firstAnchor": {
      "contextRef": "c-199",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-199",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R113": {
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
     "longName": "9955585 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "113",
     "firstAnchor": {
      "contextRef": "c-270",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-270",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R114": {
     "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
     "longName": "9955586 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details)",
     "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "114",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-196",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R115": {
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails",
     "longName": "9955587 - Disclosure - Business Segment and Geographical Information - Narrative (Details)",
     "shortName": "Business Segment and Geographical Information - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "115",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R116": {
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
     "longName": "9955588 - Disclosure - Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details)",
     "shortName": "Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "116",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-222",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R117": {
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
     "longName": "9955589 - Disclosure - Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details)",
     "shortName": "Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "117",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-289",
      "name": "us-gaap:OperatingIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R118": {
     "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
     "longName": "9955590 - Disclosure - Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details)",
     "shortName": "Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "118",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:NoncurrentAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:NoncurrentAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R119": {
     "role": "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails",
     "longName": "9955591 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)",
     "shortName": "Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "119",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "unique": true
     }
    },
    "R120": {
     "role": "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails",
     "longName": "9955592 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details)",
     "shortName": "Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "120",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareBasic",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R121": {
     "role": "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails",
     "longName": "9955593 - Disclosure - Accumulated Other Comprehensive Loss - Schedule of Accumulated Other Comprehensive income (Details)",
     "shortName": "Accumulated Other Comprehensive Loss - Schedule of Accumulated Other Comprehensive income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "121",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R122": {
     "role": "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails",
     "longName": "9955594 - Disclosure - Supplemental Disclosure of Cash Flow Information (Details)",
     "shortName": "Supplemental Disclosure of Cash Flow Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "122",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InterestPaidNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InterestPaidNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R123": {
     "role": "http://www.iconplc.com/role/RelatedPartiesDetails",
     "longName": "9955595 - Disclosure - Related Parties (Details)",
     "shortName": "Related Parties (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "123",
     "firstAnchor": {
      "contextRef": "c-299",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-299",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R124": {
     "role": "http://www.iconplc.com/role/SubsequentEventsDetails",
     "longName": "9955596 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "124",
     "firstAnchor": {
      "contextRef": "c-308",
      "name": "srt:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-9",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-308",
      "name": "srt:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-9",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iclr-20241231.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/Noncurrentotherliabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current other liabilities",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Noncurrent [Text Block]",
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as noncurrent at the end of the reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r1028"
     ]
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/AllowancesforCreditLossesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Provision for Credit Losses",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r1214"
     ]
    },
    "iclr_AccountsReceivableCreditLossExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "AccountsReceivableCreditLossExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/AllowancesforCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts provided during the year",
        "label": "Accounts Receivable, Credit Loss Expense",
        "documentation": "Accounts Receivable, Credit Loss Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNetAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, after Allowance for Credit Loss [Abstract]",
        "label": "Accounts Receivable, after Allowance for Credit Loss [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, net of allowance for credit losses (Note 4)",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1211"
     ]
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedIncomeTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes payable",
        "label": "Accrued Income Taxes, Current",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r175"
     ]
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedIncomeTaxesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current income taxes payable",
        "label": "Accrued Income Taxes, Noncurrent",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r175"
     ]
    },
    "us-gaap_AccruedUtilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedUtilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Facility related liabilities",
        "label": "Accrued Utilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for utilities, such as electrical power, heating oil, natural gas, and water. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less accumulated depreciation and asset write offs",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r254",
      "r815"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails": {
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Remeasurement of retirement benefit obligations",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit)."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r6",
      "r25",
      "r126",
      "r1261"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails": {
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency translation adjustments",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses."
       }
      }
     },
     "auth_ref": [
      "r267",
      "r269",
      "r271",
      "r272",
      "r697"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss (Note 24)",
        "totalLabel": "Total",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r127",
      "r262",
      "r810",
      "r838",
      "r842"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "AccumulatedOtherComprehensiveIncomeLossTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "label": "Accumulated Other Comprehensive Income Loss [Text Block]",
        "documentation": "Disclosure of the components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r15",
      "r25",
      "r653",
      "r656",
      "r744",
      "r833",
      "r834",
      "r1184",
      "r1185",
      "r1186",
      "r1199",
      "r1200",
      "r1201",
      "r1202"
     ]
    },
    "iclr_AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails": {
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossScheduleofAccumulatedOtherComprehensiveincomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain / (loss) on cash flow hedge",
        "label": "Accumulated Other Comprehensive Loss, Cash Flow Hedge, Gain / (Loss), Reclassification, after Tax",
        "documentation": "Accumulated Other Comprehensive Loss, Cash Flow Hedge, Loss, Reclassification, After Tax"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r404",
      "r405",
      "r406",
      "r408",
      "r969"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1104"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r857",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1301",
      "r1376"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Address Type [Domain]",
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1117"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1117"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1117"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1117"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share based compensation expense",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r66",
      "r524"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Share issuance costs",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r157"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "AdvancePaymentsNettedAgainstUnbilledContractsReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net balance",
        "label": "Advance Payments Netted Against Unbilled Contracts Receivable",
        "documentation": "Advance Payments Netted Against Unbilled Contracts Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_AfimmuneLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "AfimmuneLimitedMember",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Afimmune Limited",
        "label": "Afimmune Limited [Member]",
        "documentation": "Afimmune Limited"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1162"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1075",
      "r1086",
      "r1096",
      "r1129"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1078",
      "r1089",
      "r1099",
      "r1132"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1163"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r1117"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r1079",
      "r1090",
      "r1100",
      "r1124",
      "r1133",
      "r1137",
      "r1145"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r1143"
     ]
    },
    "us-gaap_AllowanceForCreditLossesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForCreditLossesTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/AllowancesforCreditLosses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for Credit Losses",
        "label": "Allowance for Credit Losses [Text Block]",
        "documentation": "The entire disclosure for allowance for credit losses."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/AllowancesforCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange",
        "label": "Allowance For Doubtful Accounts Foreign Currency Translation Adjustments",
        "documentation": "Allowance For Doubtful Accounts Foreign Currency Translation Adjustments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails": {
       "parentTag": "iclr_ContractsReceivableGross",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails",
      "http://www.iconplc.com/role/AllowancesforCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Allowance for credit losses (note 5)",
        "periodStartLabel": "Opening provision",
        "periodEndLabel": "Closing provision",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r263",
      "r367",
      "r385",
      "r386",
      "r389",
      "r1343"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "presentation": [
      "http://www.iconplc.com/role/AllowancesforCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/AllowancesforCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amounts used during the year",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance."
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofFinanceCostDetails": {
       "parentTag": "us-gaap_InterestExpenseNonoperating",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofFinanceCostDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of financing costs and debt discount",
        "verboseLabel": "Amortization of merger related financing fees",
        "label": "Amortization of Debt Issuance Costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r470",
      "r1193",
      "r1324"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of intangible assets",
        "negatedTerseLabel": "Amortization on intangible assets",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r403",
      "r410",
      "r991"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r187",
      "r258",
      "r295",
      "r330",
      "r336",
      "r349",
      "r353",
      "r374",
      "r444",
      "r445",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r453",
      "r454",
      "r637",
      "r641",
      "r699",
      "r805",
      "r891",
      "r983",
      "r984",
      "r1028",
      "r1053",
      "r1252",
      "r1253",
      "r1332"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASSETS",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r264",
      "r295",
      "r374",
      "r444",
      "r445",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r453",
      "r454",
      "r637",
      "r641",
      "r699",
      "r1028",
      "r1252",
      "r1253",
      "r1332"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "terseLabel": "Total assets",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r673",
      "r674",
      "r1019"
     ]
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current assets:",
        "label": "Assets, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_AuditInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "AuditInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Audit Information [Abstract]",
        "documentation": "Audit Information"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.iconplc.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r1058",
      "r1059",
      "r1082"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.iconplc.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r1058",
      "r1059",
      "r1082"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://www.iconplc.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r1058",
      "r1059",
      "r1082"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Available for sale investments (Note 8)",
        "verboseLabel": "Available for sale investments",
        "label": "Debt Securities, Available-for-Sale, Current",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current."
       }
      }
     },
     "auth_ref": [
      "r370",
      "r390"
     ]
    },
    "iclr_AwardDateAllYearsExcluding2018Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "AwardDateAllYearsExcluding2018Member",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award date, prior to 2018",
        "label": "Award Date, All Years Excluding 2018 [Member]",
        "documentation": "Award Date, Prior to 2018 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AwardDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardDateAxis",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Date [Axis]",
        "label": "Award Date [Axis]",
        "documentation": "Information by date or year award under share-based payment arrangement is granted."
       }
      }
     },
     "auth_ref": [
      "r1262",
      "r1263",
      "r1264",
      "r1265",
      "r1266",
      "r1267",
      "r1268",
      "r1269",
      "r1270",
      "r1271",
      "r1272",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287"
     ]
    },
    "us-gaap_AwardDateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardDateDomain",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Date [Domain]",
        "label": "Award Date [Domain]",
        "documentation": "Date or year award under share-based payment arrangement is granted."
       }
      }
     },
     "auth_ref": [
      "r1262",
      "r1263",
      "r1264",
      "r1265",
      "r1266",
      "r1267",
      "r1268",
      "r1269",
      "r1270",
      "r1271",
      "r1272",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r1140"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r1141"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1136"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1136"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1136"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1136"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1136"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1136"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r527",
      "r528",
      "r529",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r1139"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1138"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r1137"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1137"
     ]
    },
    "us-gaap_BaseRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BaseRateMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Base rate",
        "label": "Base Rate [Member]",
        "documentation": "Minimum rate investor will accept."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BilledContractReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BilledContractReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails": {
       "parentTag": "iclr_ContractsReceivableGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Billed services (accounts receivable)",
        "label": "Billed Contracts Receivable",
        "documentation": "Amounts due for billed services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the Company and, at a minimum, one other party. An example would be amounts billed to customers under contracts or programs but not paid as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r761"
     ]
    },
    "iclr_BiotelResearchLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "BiotelResearchLLCMember",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Biotel Research LLC",
        "label": "Biotel Research LLC [Member]",
        "documentation": "Biotel Research LLC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BuildingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BuildingMember",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Buildings",
        "label": "Building [Member]",
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BuildingsAndImprovementsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Buildings",
        "label": "Buildings and Improvements, Gross",
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeHumanFirstAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeKCRAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Acquiree [Domain]",
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r624",
      "r1009",
      "r1010"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeHumanFirstAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeKCRAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Axis]",
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r70",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r624",
      "r1009",
      "r1010"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeHumanFirstAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeKCRAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Line Items]",
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r624"
     ]
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of share capital acquired",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeKCRAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pro forma net income (loss)",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period."
       }
      }
     },
     "auth_ref": [
      "r622",
      "r623"
     ]
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeKCRAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pro forma revenue",
        "label": "Business Acquisition, Pro Forma Revenue",
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period."
       }
      }
     },
     "auth_ref": [
      "r622",
      "r623"
     ]
    },
    "us-gaap_BusinessCombinationAssetsArisingFromContingenciesAmountRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationAssetsArisingFromContingenciesAmountRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeKCRAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of contingent consideration",
        "label": "Business Combination, Assets Arising from Contingencies, Amount Recognized",
        "documentation": "The amount, measured at acquisition-date fair value, of all the assets acquired that arise from contingencies and were recognized by the entity."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationBargainPurchaseGainRecognizedAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisition-related gain",
        "terseLabel": "Acquisition related costs",
        "label": "Business Combination, Bargain Purchase, Gain Recognized, Amount",
        "documentation": "In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r79",
      "r80",
      "r82",
      "r83",
      "r84"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeHumanFirstAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeKCRAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination, consideration transferred",
        "label": "Business Combination, Consideration Transferred",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r14"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeHumanFirstAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration",
        "label": "Business Combination, Contingent Consideration, Liability",
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r168",
      "r630",
      "r675",
      "r676",
      "r677"
     ]
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combinations",
        "label": "Business Combination Disclosure [Text Block]",
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r625"
     ]
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsTransactionandIntegrationCostsDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction and integration related (Note 6)",
        "verboseLabel": "Integration related costs",
        "label": "Business Combination, Integration Related Costs",
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeKCRAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination, net income (loss) of acquiree since acquisition date, actual",
        "label": "Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual",
        "documentation": "This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeKCRAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination, revenue of acquiree since acquisition date, actual",
        "label": "Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual",
        "documentation": "This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeHumanFirstAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeKCRAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets acquired",
        "verboseLabel": "Value of intangible assets acquired",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r72"
     ]
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combinations [Abstract]",
        "label": "Business Combinations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationsPolicy",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combinations",
        "verboseLabel": "Transaction and integration-related expenses",
        "label": "Business Combinations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r165",
      "r166",
      "r167"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Contact",
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r1059",
      "r1082"
     ]
    },
    "iclr_BuybackProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "BuybackProgramMember",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Buyback program",
        "label": "Buyback Program [Member]",
        "documentation": "Buyback Program [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalizedComputerSoftwareGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalizedComputerSoftwareGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer equipment and software",
        "label": "Capitalized Computer Software, Gross",
        "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software."
       }
      }
     },
     "auth_ref": [
      "r409",
      "r969"
     ]
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAcquiredFromAcquisition",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeHumanFirstAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeKCRAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash acquired from acquisition",
        "label": "Cash Acquired from Acquisition",
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business)."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r252",
      "r973"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents at beginning of year",
        "periodEndLabel": "Cash and cash equivalents at end of year",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r141",
      "r292"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase/(decrease) in cash and cash equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r141"
     ]
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental Disclosure of Cash Flow Information",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails",
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Change in net balance",
        "negatedLabel": "Decrease in net balance",
        "label": "Change in Advance Payments Netted Against Unbilled Contracts Receivable",
        "documentation": "Change in Advance Payments Netted Against Unbilled Contracts Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1115"
     ]
    },
    "iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage change in net balance",
        "label": "Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent",
        "documentation": "Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1112"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r1110"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfTreasuryStockTable",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Treasury Stock [Table]",
        "label": "Class of Treasury Stock [Table]",
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r60",
      "r61",
      "r62"
     ]
    },
    "iclr_Clients1125Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "Clients1125Member",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Clients 11-25",
        "label": "Clients 11-25 [Member]",
        "documentation": "Clients 11-25 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_Clients25Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "Clients25Member",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Clients 2-5",
        "label": "Clients 2-5 [Member]",
        "documentation": "Clients 2-5 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_Clients610Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "Clients610Member",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Clients 6-10",
        "label": "Clients 6-10 [Member]",
        "documentation": "Clients 6-10 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r1116"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1116"
     ]
    },
    "iclr_CommitmentToAcquireLongTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "CommitmentToAcquireLongTermInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitment to acquire future long-term investments",
        "label": "Commitment To Acquire Long-Term Investments",
        "documentation": "Commitment To Acquire Long-Term Investments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies (Note 17)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r179",
      "r808",
      "r877"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r437",
      "r438",
      "r956",
      "r1240",
      "r1248"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary Shares",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r1041",
      "r1042",
      "r1043",
      "r1045",
      "r1046",
      "r1047",
      "r1050",
      "r1199",
      "r1200",
      "r1202",
      "r1301",
      "r1373",
      "r1376"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, par value (in EUR per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r878"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, shares issued (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, shares outstanding (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r120",
      "r878",
      "r897",
      "r1376",
      "r1377"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "80,756,860 shares issued and outstanding at December 31, 2024 and\u202882,495,086 shares issued and outstanding at December 31, 2023.",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r809",
      "r1028"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1121"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1120"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1122"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1119"
     ]
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reimbursable expenses and Direct costs",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r160"
     ]
    },
    "iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Related Costs Share Based Payments Disclosure [Line Items]",
        "label": "Compensation Related Costs Share Based Payments Disclosure [Line Items]",
        "documentation": "Compensation Related Costs Share Based Payments Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "CompensationRelatedCostsShareBasedPaymentsDisclosureTable",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Related Costs Share Based Payments Disclosure [Table]",
        "label": "Compensation Related Costs Share Based Payments Disclosure [Table]",
        "documentation": "Compensation Related Costs Share Based Payments Disclosure [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total comprehensive income",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r275",
      "r277",
      "r283",
      "r800",
      "r821",
      "r822"
     ]
    },
    "iclr_ComputerEquipmentAndCapitalizedSoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "ComputerEquipmentAndCapitalizedSoftwareMember",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer equipment and software",
        "label": "Computer Equipment and Capitalized Software [Member]",
        "documentation": "Computer Equipment and Capitalized Software [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Domain]",
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r40",
      "r101",
      "r102",
      "r360",
      "r955"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Axis]",
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r40",
      "r101",
      "r102",
      "r360",
      "r844",
      "r955"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Axis]",
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r40",
      "r101",
      "r102",
      "r360",
      "r955",
      "r1172"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Percentage of company revenue (in percent)",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r40",
      "r101",
      "r102",
      "r360"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Domain]",
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r40",
      "r101",
      "r102",
      "r360",
      "r955"
     ]
    },
    "srt_ConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsAxis",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Axis]",
        "label": "Consolidation Items [Axis]",
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r212",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r298",
      "r330",
      "r338",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r353",
      "r354",
      "r355",
      "r444",
      "r445",
      "r446",
      "r447",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r983",
      "r984",
      "r1177",
      "r1178",
      "r1252",
      "r1253"
     ]
    },
    "srt_ConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsDomain",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Domain]",
        "label": "Consolidation Items [Domain]",
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r212",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r298",
      "r330",
      "r338",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r353",
      "r354",
      "r355",
      "r444",
      "r445",
      "r446",
      "r447",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r983",
      "r984",
      "r1177",
      "r1178",
      "r1252",
      "r1253"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r976"
     ]
    },
    "iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "ConsultantsRestrictedStockUnitsTwentyNineteenMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consultants Restricted Stock Units 2019",
        "label": "Consultants Restricted Stock Units Twenty Nineteen [Member]",
        "documentation": "Consultants Restricted Stock Units Twenty Nineteen [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_ConsultantsStockPlan2008PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "ConsultantsStockPlan2008PlanMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consultants Stock Plan, 2008 Plan",
        "label": "Consultants Stock Plan, 2008 Plan [Member]",
        "documentation": "Consultants Stock Plan, 2008 Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contact Personnel Email Address",
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contact Personnel Name",
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_ContractAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "ContractAssetsAbstract",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract Assets [Abstract]",
        "label": "Contract Assets [Abstract]",
        "documentation": "Contract Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accounts Receivables and Unbilled Revenue, and Unbilled Services and Unearned Revenue",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability."
       }
      }
     },
     "auth_ref": [
      "r1259"
     ]
    },
    "us-gaap_ContractWithCustomerAssetCreditLossExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerAssetCreditLossExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bad debt expense",
        "label": "Contract with Customer, Asset, Credit Loss Expense (Reversal)",
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r387",
      "r508",
      "r998"
     ]
    },
    "us-gaap_ContractWithCustomerAssetGrossCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerAssetGrossCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails": {
       "parentTag": "iclr_ContractsReceivableNet",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails": {
       "parentTag": "iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails",
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unbilled services (unbilled revenue)",
        "netLabel": "Unbilled services (unbilled revenue)",
        "label": "Contract with Customer, Asset, before Allowance for Credit Loss, Current",
        "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1257",
      "r1258"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails": {
       "parentTag": "iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable",
       "weight": -1.0,
       "order": 1.0
      },
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unearned revenue (Note 4)",
        "negatedTerseLabel": "Unearned revenue (payments on account)",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r489",
      "r490",
      "r510"
     ]
    },
    "iclr_ContractsReceivableGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "ContractsReceivableGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails": {
       "parentTag": "iclr_ContractsReceivableNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Accounts receivable (net)",
        "label": "Contracts Receivable, Gross",
        "documentation": "Contracts Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_ContractsReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "ContractsReceivableNet",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofAccountsReceivablesandUnbilledRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Accounts receivable and unbilled revenue, net",
        "label": "Contracts Receivable, Net",
        "documentation": "Contracts Receivable, Net"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_CorvusPharmaceuticalsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "CorvusPharmaceuticalsMember",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corvus Pharmaceuticals",
        "label": "Corvus Pharmaceuticals [Member]",
        "documentation": "Corvus Pharmaceuticals"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Direct costs",
        "label": "Cost of Goods and Services Sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r132",
      "r762"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Direct costs",
        "label": "Cost of Sales [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total costs and expenses",
        "label": "Costs and Expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostsAndExpensesAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Costs and expenses:",
        "label": "Costs and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring",
        "label": "Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cost associated with exit or disposal activity or restructuring. Excludes entity newly acquired in business combination and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r150"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Country Region",
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Axis]",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r443",
      "r1250"
     ]
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Domain]",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r443",
      "r1250",
      "r1251"
     ]
    },
    "srt_CreditRatingStandardPoorsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CreditRatingStandardPoorsAxis",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Rating, Standard &amp; Poor's [Axis]",
        "label": "Credit Rating, Standard &amp; Poor's [Axis]",
        "documentation": "Information by Standard and Poor's rating."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r189",
      "r190",
      "r989",
      "r1215",
      "r1299"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current tax expense",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r602",
      "r1197"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current tax (benefit)/expense:",
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer relationships",
        "label": "Customer Relationships [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1232",
      "r1234",
      "r1237",
      "r1238"
     ]
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1067",
      "r1156"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1067",
      "r1156"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1069",
      "r1158"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1069",
      "r1158"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1071",
      "r1160"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1069",
      "r1158"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1062",
      "r1151"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1063",
      "r1152"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1063",
      "r1152"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r1061",
      "r1150"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1061",
      "r1150"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r1061",
      "r1150"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1064",
      "r1153"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1066",
      "r1155"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1066",
      "r1155"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1067",
      "r1156"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1070",
      "r1159"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1068",
      "r1157"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1065",
      "r1154"
     ]
    },
    "us-gaap_DatabasesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DatabasesMember",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Patient database",
        "label": "Database Rights [Member]",
        "documentation": "Exclusive legal rights granted to the owner or licensee of collections of information stored in electronic form (such as on computer disks or files)."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1232",
      "r1234",
      "r1237",
      "r1238"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Disclosure [Abstract]",
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAnnualPrincipalPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAnnualPrincipalPayment",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofPrincipalpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Total repayments",
        "label": "Debt Instrument, Annual Principal Payment",
        "documentation": "Amount of annual principal payment for debt instrument."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofPrincipalpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r108",
      "r109",
      "r174",
      "r178",
      "r298",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r1026",
      "r1195",
      "r1241",
      "r1242",
      "r1243",
      "r1323",
      "r1325"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis spread on variable rate (in percent)",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMaturitiesofLongtermDebtDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total debt",
        "label": "Long-Term Debt, Gross",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r178",
      "r472"
     ]
    },
    "iclr_DebtInstrumentDiscountRate": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "DebtInstrumentDiscountRate",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, discount rate on underwriting (in percent)",
        "label": "Debt Instrument, Discount Rate",
        "documentation": "Debt Instrument, Discount Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, principal amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r718",
      "r719",
      "r993",
      "r994",
      "r1026"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, interest rate (in percent)",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r456"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofPrincipalpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r298",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r1026",
      "r1195",
      "r1323",
      "r1325"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofPrincipalpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r298",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r1026",
      "r1195",
      "r1241",
      "r1242",
      "r1243",
      "r1323",
      "r1325"
     ]
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofPrincipalpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Principal repayments",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "documentation": "Amount of the required periodic payments applied to principal."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accelerated charge on repayments",
        "label": "Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid",
        "documentation": "Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, redemption price, percentage of principal amount redeemed",
        "label": "Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed",
        "documentation": "Percentage of principal amount of debt redeemed."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofPrincipalpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r57",
      "r58",
      "r105",
      "r155",
      "r156",
      "r298",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r1026",
      "r1195",
      "r1323",
      "r1325"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentUnamortizedDiscount",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt discount paid",
        "label": "Debt Instrument, Unamortized Discount",
        "documentation": "Amount, after accumulated amortization, of debt discount."
       }
      }
     },
     "auth_ref": [
      "r1255",
      "r1322",
      "r1323",
      "r1325"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails": {
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less debt issuance costs and debt discount",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r461",
      "r473",
      "r717",
      "r718",
      "r719",
      "r993",
      "r994",
      "r1026"
     ]
    },
    "us-gaap_DebtPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt issuance costs",
        "label": "Debt, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "iclr_DecreaseInAmortisation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "DecreaseInAmortisation",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease in amortisation",
        "label": "Decrease In Amortisation",
        "documentation": "Decrease In Amortisation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax asset (Note 20)",
        "label": "Deferred Income Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r571",
      "r572"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax (benefit)/expense",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r207",
      "r1197"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax (benefit)/expense:",
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax liabilities recognized",
        "label": "Deferred Tax Liabilities, Gross",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r117",
      "r176",
      "r593"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liability (Note 20)",
        "label": "Deferred Income Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r571",
      "r572",
      "r806"
     ]
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax benefit",
        "label": "Deferred Income Taxes and Tax Credits",
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits."
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "iclr_DeferredTaxAssetContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "DeferredTaxAssetContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unearned revenue",
        "label": "Deferred Tax Asset, Contract With Customer, Liability",
        "documentation": "Deferred Tax Asset, Contract With Customer, Liability"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ireland subsidiaries additional tax credit carryforward for income tax",
        "label": "Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration",
        "documentation": "Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill."
       }
      }
     },
     "auth_ref": [
      "r1294"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax assets",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r594"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred tax assets recognized",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1292"
     ]
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNetAbstract",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets:",
        "label": "Deferred Tax Assets, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_DeferredTaxAssetsOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "DeferredTaxAssetsOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Deferred Tax Assets, Operating Lease, Liability",
        "documentation": "Deferred Tax Assets, Operating Lease, Liability"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating loss and tax credits carryforwards",
        "label": "Deferred Tax Assets Operating Loss And Tax Credits Carryforwards",
        "documentation": "Deferred Tax Assets Operating Loss And Tax Credits Carryforwards"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carryforwards",
        "totalLabel": "Net operating loss carryforwards",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1294"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-U.S subsidiaries operating loss carryforwards for income tax",
        "verboseLabel": "Net operating loss carryforwards, not subject to expiration",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates."
       }
      }
     },
     "auth_ref": [
      "r1294"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net operating loss carryforwards, subject to expiration",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates."
       }
      }
     },
     "auth_ref": [
      "r1294"
     ]
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment",
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r1294"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Alternative minimum tax credit carry forwards",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible alternative minimum tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1294"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock compensation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from compensation and benefits, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1294"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseOther",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1294"
     ]
    },
    "iclr_DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Other Liabilities",
        "documentation": "Deferred Tax Assets, Tax Deferred Expense, Other Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance for deferred tax assets",
        "terseLabel": "Valuation allowance for deferred tax assets",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r595"
     ]
    },
    "us-gaap_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Overall net deferred tax liability",
        "label": "Deferred Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1292"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities:",
        "label": "Deferred Tax Liabilities, Gross [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Deferred Tax Liabilities, Goodwill",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from goodwill."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r86",
      "r1294"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating right-of-use-assets",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements."
       }
      }
     },
     "auth_ref": [
      "r1294"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesOther",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Deferred Tax Liabilities, Other",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other."
       }
      }
     },
     "auth_ref": [
      "r1294"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesOtherFiniteLivedAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "label": "Deferred Tax Liabilities, Other Finite-Lived Assets",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r1294"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r1294"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments in foreign subsidiaries",
        "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences."
       }
      }
     },
     "auth_ref": [
      "r1294"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r49"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r49"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r330",
      "r341",
      "r353",
      "r983",
      "r984"
     ]
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeAssetNotionalAmount",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notional",
        "label": "Derivative Asset, Notional Amount",
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset."
       }
      }
     },
     "auth_ref": [
      "r940",
      "r943",
      "r945",
      "r948",
      "r1296",
      "r1297",
      "r1298"
     ]
    },
    "us-gaap_DerivativeAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Asset",
        "label": "Derivative Asset",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r266",
      "r673",
      "r674",
      "r685",
      "r698",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r884",
      "r885",
      "r940",
      "r944",
      "r946",
      "r947",
      "r949",
      "r950",
      "r975",
      "r1019",
      "r1022",
      "r1043",
      "r1304",
      "r1305",
      "r1306",
      "r1374"
     ]
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Contract [Domain]",
        "label": "Derivative Contract [Domain]",
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r867",
      "r869",
      "r883",
      "r884",
      "r885",
      "r887",
      "r888",
      "r889",
      "r890",
      "r892",
      "r893",
      "r894",
      "r895",
      "r910",
      "r911",
      "r912",
      "r913",
      "r916",
      "r917",
      "r918",
      "r919",
      "r940",
      "r941",
      "r946",
      "r949",
      "r1041",
      "r1043",
      "r1307",
      "r1308",
      "r1309",
      "r1310",
      "r1311",
      "r1312",
      "r1314",
      "r1315"
     ]
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeFixedInterestRate",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative, fixed interest rate",
        "label": "Derivative, Fixed Interest Rate",
        "documentation": "Fixed interest rate related to the interest rate derivative."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instrument [Axis]",
        "label": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r95",
      "r96",
      "r171",
      "r867",
      "r869",
      "r883",
      "r884",
      "r885",
      "r887",
      "r888",
      "r889",
      "r890",
      "r892",
      "r893",
      "r894",
      "r895",
      "r910",
      "r911",
      "r912",
      "r913",
      "r916",
      "r917",
      "r918",
      "r919",
      "r940",
      "r941",
      "r946",
      "r949",
      "r975",
      "r1041",
      "r1043",
      "r1307",
      "r1308",
      "r1309",
      "r1310",
      "r1311",
      "r1312",
      "r1314",
      "r1315"
     ]
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/Derivatives"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r646",
      "r659"
     ]
    },
    "us-gaap_DerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative instruments",
        "verboseLabel": "Liability",
        "label": "Derivative Liability",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r266",
      "r673",
      "r674",
      "r685",
      "r698",
      "r859",
      "r860",
      "r861",
      "r862",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r892",
      "r894",
      "r895",
      "r941",
      "r942",
      "r944",
      "r946",
      "r947",
      "r949",
      "r950",
      "r975",
      "r1304",
      "r1305",
      "r1306",
      "r1374"
     ]
    },
    "us-gaap_DerivativeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeLineItems",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative [Line Items]",
        "label": "Derivative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r659"
     ]
    },
    "us-gaap_DerivativeNotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeNotionalAmount",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative, notional amount",
        "label": "Derivative, Notional Amount",
        "documentation": "Nominal or face amount used to calculate payment on derivative."
       }
      }
     },
     "auth_ref": [
      "r1297",
      "r1298"
     ]
    },
    "us-gaap_DerivativeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeTable",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative [Table]",
        "label": "Derivative [Table]",
        "documentation": "Disclosure of information about derivative instrument or group of derivative instruments, including, but not limited to, type of derivative instrument, risk being hedged, notional amount, hedge designation, related hedged item, inception date, and maturity date."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r88",
      "r89",
      "r91",
      "r92",
      "r94",
      "r95",
      "r97",
      "r99",
      "r100",
      "r659"
     ]
    },
    "iclr_DerivativeVariableInterestRateReferenceRateInExcessOf": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "DerivativeVariableInterestRateReferenceRateInExcessOf",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative, variable interest rate, reference rate in excess of",
        "label": "Derivative, Variable Interest Rate, Reference Rate In Excess Of",
        "documentation": "Derivative, Variable Interest Rate, Reference Rate In Excess Of"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativesPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative financial instruments",
        "label": "Derivatives, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r88",
      "r89",
      "r92",
      "r98",
      "r297",
      "r315"
     ]
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DesignatedAsHedgingInstrumentMember",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total derivatives designated as hedging instruments",
        "label": "Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Line Items]",
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r509",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Table]",
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r509",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Disaggregation of Revenue",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r1260"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Incentive Schemes and Stock Compensation Charges",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r522",
      "r526",
      "r557",
      "r558",
      "r560",
      "r1012"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financing Cost",
        "label": "Disclosure Of Detailed Information About Financing Cost [Table Text Block]",
        "documentation": "Disclosure Of Detailed Information About Financing Cost"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Accounting Standard",
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r1059"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r1058",
      "r1059",
      "r1082"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r1058",
      "r1059",
      "r1082",
      "r1125"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Registration Statement",
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r1054"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Shell Company Report",
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r1059"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r1103"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1114"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income per ordinary share (Note 23):",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (USD per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r284",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r318",
      "r320",
      "r322",
      "r323",
      "r324",
      "r329",
      "r620",
      "r635",
      "r670",
      "r671",
      "r801",
      "r823",
      "r977"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (USD per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r284",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r320",
      "r322",
      "r323",
      "r324",
      "r329",
      "r620",
      "r635",
      "r670",
      "r671",
      "r801",
      "r823",
      "r977"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income per ordinary share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r326"
     ]
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareReconciliationAbstract",
     "presentation": [
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income per ordinary share:",
        "label": "Earnings Per Share Reconciliation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Income Per Ordinary Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r317",
      "r325",
      "r327",
      "r328"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange rate movements on cash",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r707"
     ]
    },
    "iclr_EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "(Decrease)/ increase in unrecognized tax benefits",
        "label": "Effective Income Tax Rate Reconciliation, Change in Unrecognized Tax Benefits, Amount",
        "documentation": "Effective Income Tax Rate Reconciliation, Change in Unrecognized Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investor tax expense on foreign subsidiary earnings",
        "label": "Effective Income Tax Rate Reconciliation, Deferred Tax Provision On Unrepatriated Earnings, Amount",
        "documentation": "Effective Income Tax Rate Reconciliation, Deferred Tax Provision On Unrepatriated Earnings, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationGiltiAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Global Minimum Tax",
        "label": "Effective Income Tax Rate Reconciliation, GILTI, Amount",
        "documentation": "Amount of reported income tax expense from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to global intangible low-taxed income (GILTI)."
       }
      }
     },
     "auth_ref": [
      "r1016",
      "r1289",
      "r1290"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Personnel related liabilities",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized share-based compensation cost, period of recognition",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized share-based compensation cost",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r1288"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax benefit related to stock compensation",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash tax benefit related to stock options exercised",
        "label": "Share-Based Payment Arrangement, Exercise of Option, Tax Benefit",
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r203"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Option",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_EmployeeStockPlanTwentyZeroEightPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "EmployeeStockPlanTwentyZeroEightPlanMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Plan, 2008 Plan",
        "label": "Employee Stock Plan, 2008 Plan [Member]",
        "documentation": "Employee Stock Plan, 2008 Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Country",
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Addresses, Address Type [Axis]",
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1056"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity common stock, shares outstanding (in shares)",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1056"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filler Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r1056"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r1165"
     ]
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of employees",
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1056"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r1056"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well Known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r1166"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1108"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1161"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r1161"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1161"
     ]
    },
    "us-gaap_EquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquipmentMember",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Laboratory equipment",
        "label": "Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityClassOfTreasuryStockLineItems",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r245",
      "r279",
      "r280",
      "r281",
      "r299",
      "r300",
      "r301",
      "r304",
      "r311",
      "r313",
      "r315",
      "r331",
      "r378",
      "r384",
      "r421",
      "r488",
      "r603",
      "r604",
      "r616",
      "r617",
      "r618",
      "r621",
      "r634",
      "r635",
      "r651",
      "r653",
      "r654",
      "r655",
      "r656",
      "r658",
      "r669",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r714",
      "r721",
      "r724",
      "r744",
      "r820",
      "r833",
      "r834",
      "r835",
      "r857",
      "r923"
     ]
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesFvNi",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Carrying value of long-term investments in equity",
        "label": "Equity Securities, FV-NI, Current",
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current."
       }
      }
     },
     "auth_ref": [
      "r259",
      "r696",
      "r974"
     ]
    },
    "us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments in equity (Note 8)",
        "label": "Equity Securities, FV-NI and without Readily Determinable Fair Value",
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI) and investment in equity security without readily determinable fair value."
       }
      }
     },
     "auth_ref": [
      "r696"
     ]
    },
    "us-gaap_EquitySecuritiesFvNiCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesFvNiCost",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/FairvalueNarrativeDetails",
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity securities, FV-NI, cost",
        "label": "Equity Securities, FV-NI, Cost",
        "documentation": "Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value."
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt securities, available for sale, cumulative amount advanced under subscription agreements",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "documentation": "Amount of investment in equity security without readily determinable fair value."
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1118"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1075",
      "r1086",
      "r1096",
      "r1129"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r1072",
      "r1083",
      "r1093",
      "r1126"
     ]
    },
    "srt_EuropeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "EuropeMember",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Europe",
        "label": "Europe [Member]",
        "documentation": "Continent of Europe."
       }
      }
     },
     "auth_ref": [
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1378",
      "r1379",
      "r1380",
      "r1381"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "srt_ExternalCreditRatingStandardPoorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ExternalCreditRatingStandardPoorsMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "External Credit Rating, Standard &amp; Poor's [Domain]",
        "label": "External Credit Rating, Standard &amp; Poor's [Domain]",
        "documentation": "Credit-ratings as used by Standard &amp; Poor's. Contact Standard &amp; Poor's for a complete list of ratings and their definitions."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_FacilityLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "FacilityLiabilityMember",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Facility liability",
        "label": "Facility Liability [Member]",
        "documentation": "Facility Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r673",
      "r674",
      "r685",
      "r1019"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r673",
      "r674",
      "r685",
      "r1019"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/FairValueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r1302",
      "r1303"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r463",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r672",
      "r674",
      "r675",
      "r676",
      "r677",
      "r684",
      "r685",
      "r687",
      "r754",
      "r755",
      "r756",
      "r993",
      "r994",
      "r1006",
      "r1007",
      "r1008",
      "r1019",
      "r1022"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Axis]",
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r673",
      "r674",
      "r675",
      "r677",
      "r1019",
      "r1305",
      "r1316"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/FairValue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r680",
      "r682",
      "r683",
      "r684",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r798",
      "r1019",
      "r1023"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r463",
      "r513",
      "r518",
      "r674",
      "r685",
      "r754",
      "r1006",
      "r1007",
      "r1008",
      "r1019"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r463",
      "r513",
      "r518",
      "r674",
      "r675",
      "r685",
      "r755",
      "r993",
      "r994",
      "r1006",
      "r1007",
      "r1008",
      "r1019"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r463",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r674",
      "r675",
      "r676",
      "r677",
      "r685",
      "r756",
      "r993",
      "r994",
      "r1006",
      "r1007",
      "r1008",
      "r1019",
      "r1022"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/FairValueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis",
        "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset."
       }
      }
     },
     "auth_ref": [
      "r1302",
      "r1303"
     ]
    },
    "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasuredAtNetAssetValuePerShareMember",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Fair Value Measured at Net Asset Value Per Share [Member]",
        "documentation": "Fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r513",
      "r672",
      "r687",
      "r1019"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Domain]",
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r673",
      "r674",
      "r675",
      "r677",
      "r1019",
      "r1305",
      "r1316"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails",
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r463",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r672",
      "r674",
      "r675",
      "r676",
      "r677",
      "r684",
      "r685",
      "r687",
      "r754",
      "r755",
      "r756",
      "r993",
      "r994",
      "r1006",
      "r1007",
      "r1008",
      "r1019",
      "r1022"
     ]
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsNonrecurringMember",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value, nonrecurring",
        "label": "Fair Value, Nonrecurring [Member]",
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r673",
      "r674",
      "r675",
      "r677",
      "r1019",
      "r1305"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring",
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r1019",
      "r1302",
      "r1303",
      "r1304",
      "r1305",
      "r1306",
      "r1316"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of fair value of financial instruments",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "iclr_February2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "February2024Member",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "February 2024",
        "label": "February 2024 [Member]",
        "documentation": "February 2024"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_February2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "February2025Member",
     "presentation": [
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "February 2025",
        "label": "February 2025 [Member]",
        "documentation": "February 2025"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization period",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accumulated amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r256",
      "r391",
      "r409",
      "r991"
     ]
    },
    "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNet",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Finite Lived Intangible Assets, Amortization Expense, Net",
        "documentation": "Finite Lived Intangible Assets, Amortization Expense, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r411",
      "r969",
      "r991"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r411",
      "r969",
      "r991"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r411",
      "r969",
      "r991"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r411",
      "r969",
      "r991"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": {
       "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r411",
      "r969",
      "r991"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r402",
      "r404",
      "r405",
      "r406",
      "r408",
      "r409",
      "r413",
      "r414",
      "r763",
      "r767",
      "r969"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Identifiable intangible assets, net",
        "label": "Finite-Lived Intangible Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of assets, excluding financial assets, that lack physical substance, having a limited useful life."
       }
      }
     },
     "auth_ref": [
      "r1302",
      "r1303",
      "r1313"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total cost",
        "label": "Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r409",
      "r767",
      "r991"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r402",
      "r404",
      "r405",
      "r406",
      "r408",
      "r409",
      "r413",
      "r414",
      "r969"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, net (Note 11)",
        "totalLabel": "Net book value",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r763",
      "r1234"
     ]
    },
    "us-gaap_ForeignCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCountryMember",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Country",
        "label": "Foreign Tax Jurisdiction [Member]",
        "documentation": "Designated foreign jurisdiction entitled to levy and collect income tax outside country of domicile."
       }
      }
     },
     "auth_ref": [
      "r574",
      "r575"
     ]
    },
    "us-gaap_ForeignCurrencyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyAbstract",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency [Abstract]",
        "label": "Foreign Currency [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_ForeignCurrencyDisclosureTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "ForeignCurrencyDisclosureTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments resulting from foreign currency translations",
        "label": "Foreign Currency Disclosure [Table Text Block]",
        "documentation": "Foreign Currency Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Amounts (credited) / charged",
        "label": "Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r701",
      "r703",
      "r704",
      "r706",
      "r920"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Unrealized foreign exchange movements",
        "label": "Unrealized Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r899",
      "r1051",
      "r1318",
      "r1319",
      "r1375"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currencies and translation of subsidiaries",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r700"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r1079",
      "r1090",
      "r1100",
      "r1133"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r1079",
      "r1090",
      "r1100",
      "r1133"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r1079",
      "r1090",
      "r1100",
      "r1133"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1079",
      "r1090",
      "r1100",
      "r1133"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1079",
      "r1090",
      "r1100",
      "r1133"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1113"
     ]
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FurnitureAndFixturesGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Office furniture and fixtures",
        "label": "Furniture and Fixtures, Gross",
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Office furniture and fixtures",
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeographicConcentrationRiskMember",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographic Concentration Risk",
        "label": "Geographic Concentration Risk [Member]",
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa)."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r955"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeHumanFirstAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeKCRAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Goodwill (Note 10)",
        "terseLabel": "Goodwill",
        "periodStartLabel": "Opening balance",
        "periodEndLabel": "Closing balance",
        "label": "Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r393",
      "r799",
      "r984",
      "r990",
      "r1020",
      "r1028",
      "r1217",
      "r1224"
     ]
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAcquiredDuringPeriod",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current period acquisitions (note 6)",
        "label": "Goodwill, Acquired During Period",
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination."
       }
      }
     },
     "auth_ref": [
      "r396",
      "r990"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined."
       }
      }
     },
     "auth_ref": [
      "r401",
      "r416",
      "r419"
     ]
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/Goodwill"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill Disclosure [Text Block]",
        "documentation": "The entire disclosure for goodwill."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r395",
      "r399",
      "r990"
     ]
    },
    "us-gaap_GoodwillFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill, Fair Value Disclosure",
        "documentation": "Fair value portion of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r1019",
      "r1020",
      "r1302",
      "r1303",
      "r1313"
     ]
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange movement",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) asset representing future economic benefit from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r398"
     ]
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/GoodwillNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill impairment charge",
        "label": "Goodwill, Impairment Loss",
        "documentation": "Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r394",
      "r397",
      "r400",
      "r990",
      "r1020"
     ]
    },
    "us-gaap_GoodwillRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillRollForward",
     "presentation": [
      "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Roll Forward]",
        "label": "Goodwill [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GovernmentAssistanceLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GovernmentAssistanceLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short term government grants",
        "label": "Government Assistance, Liability, Current",
        "documentation": "Amount of liability from government assistance, classified as current."
       }
      }
     },
     "auth_ref": [
      "r716"
     ]
    },
    "us-gaap_GovernmentAssistanceLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GovernmentAssistanceLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration",
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government Assistance, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "label": "Government Assistance, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes liability from government assistance, classified as current."
       }
      }
     },
     "auth_ref": [
      "r716"
     ]
    },
    "iclr_GovernmentGrantsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "GovernmentGrantsPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government grants",
        "label": "Government Grants [Policy Text Block]",
        "documentation": "Government Grants, Policy"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HedgingDesignationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HedgingDesignationAxis",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Axis]",
        "label": "Hedging Designation [Axis]",
        "documentation": "Information by designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r645"
     ]
    },
    "us-gaap_HedgingDesignationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HedgingDesignationDomain",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Domain]",
        "label": "Hedging Designation [Domain]",
        "documentation": "Designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "iclr_HumanFirstIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "HumanFirstIncMember",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeHumanFirstAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "HumanFirst Inc",
        "label": "HumanFirst Inc [Member]",
        "documentation": "HumanFirst Inc"
       }
      }
     },
     "auth_ref": []
    },
    "country_IE": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "IE",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ireland",
        "label": "IRELAND"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r1058",
      "r1059",
      "r1082"
     ]
    },
    "iclr_ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of operating right-of-use assets and related property, plant and equipment",
        "label": "Impairment, Operating Right-Of-Use Assets And Related Property, Plant And Equipment",
        "documentation": "Impairment, Operating Right-Of-Use Assets And Related Property, Plant And Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of goodwill and long-lived assets",
        "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_IncomeBeforeIncomeTaxTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "IncomeBeforeIncomeTaxTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Components of Income Before Provision for Income Taxes",
        "label": "Income Before Income Tax [Table Text Block]",
        "documentation": "Income Before Income Tax, Table"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before share of losses from equity method investments",
        "label": "Income (Loss) From Continuing Operations Before Equity Method Investments, Noncontrolling Interest",
        "documentation": "Income (Loss) From Continuing Operations Before Equity Method Investments, Noncontrolling Interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income before income tax expense",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r825",
      "r979",
      "r1204",
      "r1206",
      "r1207",
      "r1208",
      "r1209"
     ]
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share of losses from equity method investments",
        "negatedLabel": "Loss on equity method investments",
        "label": "Income (Loss) from Equity Method Investments",
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r129",
      "r181",
      "r330",
      "r342",
      "r353",
      "r373",
      "r817"
     ]
    },
    "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before income tax expense",
        "label": "Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax",
        "documentation": "Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r1186"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Income Location, Balance [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r422",
      "r423",
      "r429",
      "r678",
      "r681",
      "r686",
      "r828",
      "r830",
      "r907",
      "r969",
      "r1021",
      "r1345"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails",
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Income Location, Balance [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r423",
      "r429",
      "r678",
      "r681",
      "r686",
      "r828",
      "r830",
      "r907",
      "r969",
      "r1021",
      "r1345"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Jurisdiction [Axis]",
        "label": "Income Tax Jurisdiction [Axis]",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r574",
      "r575",
      "r584",
      "r599",
      "r1016",
      "r1293"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Jurisdiction [Domain]",
        "label": "Income Tax Jurisdiction [Domain]",
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r574",
      "r575",
      "r584",
      "r599",
      "r1016",
      "r1293"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityNameAxis",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority, Name [Axis]",
        "label": "Income Tax Authority, Name [Axis]",
        "documentation": "Information by name of taxing authority."
       }
      }
     },
     "auth_ref": [
      "r584",
      "r1293"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityNameDomain",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority, Name [Domain]",
        "label": "Income Tax Authority, Name [Domain]",
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": [
      "r584",
      "r1293"
     ]
    },
    "iclr_IncomeTaxBenefitMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "IncomeTaxBenefitMember",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for income taxes",
        "label": "Income Tax Benefit [Member]",
        "documentation": "Income Tax Benefit [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r296",
      "r566",
      "r574",
      "r580",
      "r581",
      "r582",
      "r590",
      "r597",
      "r608",
      "r610",
      "r611",
      "r612",
      "r852",
      "r1016"
     ]
    },
    "us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxEffectsAllocatedDirectlyToEquity",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Income Tax Effects Allocated Directly to Equity",
        "documentation": "The sum of the tax effects of all items occurring during the period that have been charged or credited directly to other comprehensive income or to related components of shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r573"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income tax expense (Note 20)",
        "totalLabel": "Income tax expense",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r208",
      "r314",
      "r315",
      "r330",
      "r343",
      "r353",
      "r573",
      "r574",
      "r609",
      "r826",
      "r1016"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax expense:",
        "label": "Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r569",
      "r570",
      "r590",
      "r591",
      "r596",
      "r601",
      "r850"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Movement in valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r579",
      "r1016",
      "r1289"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effects of change in tax rates",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates."
       }
      }
     },
     "auth_ref": [
      "r568",
      "r574",
      "r578",
      "r1016"
     ]
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign and other income taxed at higher rates",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r575",
      "r577",
      "r1016",
      "r1289"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Taxes at Irish statutory rate of 12.5% (2023:12.5%; 2022:12.5%)",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r574",
      "r1016"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rate differential from amortization of intangible assets",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible amortization."
       }
      }
     },
     "auth_ref": [
      "r1289",
      "r1290"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseOther",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other and non-deductible expenses",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r1016",
      "r1289",
      "r1290"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impact of stock compensation",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1016",
      "r1289",
      "r1290"
     ]
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Research &amp; development tax incentives",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit."
       }
      }
     },
     "auth_ref": [
      "r1016",
      "r1289",
      "r1290"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for income taxes (net of refunds)",
        "label": "Income Taxes Paid, Net",
        "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r291",
      "r598",
      "r599"
     ]
    },
    "us-gaap_IncomeTaxesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes receivable",
        "label": "Income Taxes Receivable, Current",
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r1182"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInContractWithCustomerAsset",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unbilled revenue",
        "label": "Increase (Decrease) in Contract with Customer, Asset",
        "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r1192"
     ]
    },
    "iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "IncreaseDecreaseInContractWithCustomerAssetGrossCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails": {
       "parentTag": "iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails",
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in unbilled services (unbilled revenue)",
        "label": "Increase (Decrease) In Contract With Customer, Asset, Gross, Current",
        "documentation": "Increase (Decrease) In Contract With Customer, Asset, Gross, Current"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage change in unbilled services (unbilled revenue)",
        "label": "Increase (Decrease) In Contract With Customer, Asset, Gross, Current, Percent",
        "documentation": "Increase (Decrease) In Contract With Customer, Asset, Gross, Current, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unearned revenue",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r760",
      "r1192"
     ]
    },
    "iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage change in unearned revenue (payments on account)",
        "label": "Increase (Decrease) In Contract With Customer, Liability, Gross, Current, Percent",
        "documentation": "Increase (Decrease) In Contract with Customer, Liability, Gross, Current, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "IncreaseDecreaseInContractsWithCustomersLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails": {
       "parentTag": "iclr_ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails",
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesScheduleofUnbilledServicesandUnearnedRevenueorPaymentsonAccountDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Change in unearned revenue (payments on account)",
        "label": "Increase (Decrease) In Contracts With Customers, Liability, Current",
        "documentation": "Increase (Decrease) In Contracts With Customers, Liability, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInEquitySecuritiesFvNi",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (decrease) in equity securities, FV-NI",
        "label": "Increase (Decrease) in Equity Securities, FV-NI",
        "documentation": "Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r286"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other net assets",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "documentation": "Amount of increase (decrease) in current liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r1192"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]",
        "label": "Indefinite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r402",
      "r412",
      "r417",
      "r991"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1079",
      "r1090",
      "r1100",
      "r1124",
      "r1133",
      "r1137",
      "r1145"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1143"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1060",
      "r1149"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1060",
      "r1149"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1060",
      "r1149"
     ]
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Assets",
        "label": "Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r401",
      "r415",
      "r418",
      "r968",
      "r969"
     ]
    },
    "iclr_InterestExpenseCreditOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "InterestExpenseCreditOther",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofFinanceCostDetails": {
       "parentTag": "us-gaap_InterestExpenseNonoperating",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofFinanceCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financing costs",
        "label": "Interest Expense (Credit), Other",
        "documentation": "Interest Expense (Credit), Other"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofFinanceCostDetails": {
       "parentTag": "us-gaap_InterestExpenseNonoperating",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofFinanceCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense on drawn facilities",
        "label": "Interest Expense, Debt",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r468",
      "r475",
      "r995",
      "r996"
     ]
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0,
       "order": 3.0
      },
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofFinanceCostDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofFinanceCostDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense (Note 13)",
        "terseLabel": "Interest expense",
        "totalLabel": "Total financing costs",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r1188"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for interest",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r285",
      "r289",
      "r290"
     ]
    },
    "iclr_InterestRateCapAndInterestRateSwapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "InterestRateCapAndInterestRateSwapMember",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails",
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total derivatives designated as hedging instruments",
        "label": "Interest Rate Cap And Interest Rate Swap [Member]",
        "documentation": "Interest Rate Cap And Interest Rate Swap"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestRateCapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestRateCapMember",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate Caps",
        "label": "Interest Rate Cap [Member]",
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount."
       }
      }
     },
     "auth_ref": [
      "r971"
     ]
    },
    "us-gaap_InterestRateSwapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestRateSwapMember",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate Swap",
        "label": "Interest Rate Swap [Member]",
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period."
       }
      }
     },
     "auth_ref": [
      "r971",
      "r1048",
      "r1049"
     ]
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InternalRevenueServiceIRSMember",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal NOL's",
        "label": "Internal Revenue Service (IRS) [Member]",
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentIncomeInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentIncomeInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Investment Income, Interest",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r330",
      "r339",
      "r353",
      "r983",
      "r1187"
     ]
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment in debt, equity and other",
        "label": "Investment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for investment in financial asset."
       }
      }
     },
     "auth_ref": [
      "r824",
      "r846",
      "r847",
      "r848",
      "r849",
      "r933",
      "r934"
     ]
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]",
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/Investments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "documentation": "The entire disclosure for investments in certain debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r183",
      "r211",
      "r369",
      "r371",
      "r692",
      "r693",
      "r1340"
     ]
    },
    "iclr_KCRS.AGroupMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "KCRS.AGroupMember",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeKCRAcquisitionDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "KCR S.A Group",
        "label": "KCR S.A Group [Member]",
        "documentation": "KCR S.A Group"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Land": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Land",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land",
        "label": "Land",
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale."
       }
      }
     },
     "auth_ref": [
      "r1179"
     ]
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesScheduleofLeaseCostsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails",
      "http://www.iconplc.com/role/OperatingLeasesScheduleofLeaseCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net operating lease costs",
        "verboseLabel": "Net operating lease costs",
        "label": "Lease, Cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r730",
      "r1027"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Lease Costs",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1328"
     ]
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseholdImprovementsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements, Gross",
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases [Abstract]",
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r729",
      "r738"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r728"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Operating Lease Maturity",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1329"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total future minimum lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Lease imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cancelable operating leases for facilities expiration period",
        "label": "Lessee, Operating Lease, Term of Contract",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1327"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r723"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r108",
      "r109",
      "r110",
      "r113",
      "r114",
      "r115",
      "r118",
      "r295",
      "r374",
      "r444",
      "r445",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r453",
      "r454",
      "r638",
      "r641",
      "r642",
      "r699",
      "r876",
      "r978",
      "r1053",
      "r1252",
      "r1332",
      "r1333"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities:",
        "label": "Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities and Shareholders\u2019 Equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r180",
      "r812",
      "r1028",
      "r1196",
      "r1213",
      "r1317"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r251",
      "r295",
      "r374",
      "r444",
      "r445",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r453",
      "r454",
      "r638",
      "r641",
      "r642",
      "r699",
      "r1028",
      "r1252",
      "r1332",
      "r1333"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities, Fair Value Disclosure",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r674",
      "r1302"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current liabilities:",
        "label": "Liabilities, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Limit of shares issued or to be issued pursuant to options granted (in shares)",
        "label": "Limit Of Shares Issued Or To Be Issued Pursuant To Options Granted",
        "documentation": "Limit of Shares Issued or To Be Issued Pursuant to Options Granted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum borrowing capacity",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r112"
     ]
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit facility, remaining borrowing capacity",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r112",
      "r443"
     ]
    },
    "us-gaap_LineOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Secured Revolving Loan",
        "label": "Line of Credit [Member]",
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LinesOfCreditCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LinesOfCreditCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current bank credit lines, loan facilities and notes (Note 13)",
        "label": "Line of Credit, Current",
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r174"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total long-term debt, net",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r178",
      "r462",
      "r474",
      "r993",
      "r994",
      "r1026",
      "r1341"
     ]
    },
    "iclr_LongTermDebtCurrentMaturitiesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "LongTermDebtCurrentMaturitiesGross",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails": {
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less current portion of debt",
        "label": "Long-term Debt, Current Maturities, Gross",
        "documentation": "Long-term Debt, Current Maturities, Gross"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_LongTermDebtExcludingCurrentMaturitiesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "LongTermDebtExcludingCurrentMaturitiesGross",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails": {
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total long-term debt",
        "label": "Long-term Debt, Excluding Current Maturities, Gross",
        "documentation": "Long-term Debt, Excluding Current Maturities, Gross"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/FairvalueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt at fair value",
        "label": "Long-Term Debt, Fair Value",
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission."
       }
      }
     },
     "auth_ref": [
      "r1302",
      "r1304",
      "r1305",
      "r1306"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMaturitiesofLongtermDebtDetails": {
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Long-Term Debt, Maturity, Year One",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r298",
      "r466"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMaturitiesofLongtermDebtDetails": {
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Long-Term Debt, Maturity, Year Four",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r298",
      "r466"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMaturitiesofLongtermDebtDetails": {
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Long-Term Debt, Maturity, Year Three",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r298",
      "r466"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMaturitiesofLongtermDebtDetails": {
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Long-Term Debt, Maturity, Year Two",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r298",
      "r466"
     ]
    },
    "iclr_LongTermDebtMaturityYearFiveAndThereafter": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "LongTermDebtMaturityYearFiveAndThereafter",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMaturitiesofLongtermDebtDetails": {
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029 and thereafter",
        "label": "Long-Term Debt, Maturity, Year Five And Thereafter",
        "documentation": "Long-Term Debt, Maturity, Year Five And Thereafter"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total long-term debt, net",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "us-gaap_LongTermDebtTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank credit lines, loan facilities and notes",
        "label": "Long-Term Debt [Text Block]",
        "documentation": "The entire disclosure for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "us-gaap_LongTermLineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermLineOfCredit",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current bank credit lines, loan facilities and notes, net (Note 13)",
        "label": "Long-Term Line of Credit, Noncurrent",
        "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r54",
      "r55"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofPrincipalpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r1241",
      "r1242",
      "r1243"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofPrincipalpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r56",
      "r1241",
      "r1242",
      "r1243"
     ]
    },
    "us-gaap_LossContingencyAccrualProvision": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingencyAccrualProvision",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Onerous contract provision",
        "label": "Loss Contingency Accrual, Provision",
        "documentation": "Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges."
       }
      }
     },
     "auth_ref": [
      "r1249"
     ]
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MachineryAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Laboratory equipment",
        "label": "Machinery and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Axis]",
        "label": "Customer [Axis]",
        "documentation": "Information by name or description of a single external customer or a group of external customers."
       }
      }
     },
     "auth_ref": [
      "r360",
      "r1001",
      "r1037",
      "r1040",
      "r1260",
      "r1344",
      "r1346",
      "r1347",
      "r1348",
      "r1349",
      "r1350",
      "r1351",
      "r1352",
      "r1353",
      "r1354",
      "r1355",
      "r1356",
      "r1357",
      "r1358",
      "r1359",
      "r1360",
      "r1361",
      "r1362",
      "r1363",
      "r1364",
      "r1365",
      "r1366",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371",
      "r1372"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r215",
      "r217",
      "r218",
      "r220",
      "r241",
      "r242",
      "r439",
      "r440",
      "r441",
      "r442",
      "r521",
      "r565",
      "r677",
      "r759",
      "r827",
      "r829",
      "r843",
      "r868",
      "r869",
      "r931",
      "r935",
      "r937",
      "r938",
      "r951",
      "r966",
      "r967",
      "r988",
      "r997",
      "r1011",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1038",
      "r1254",
      "r1334",
      "r1335",
      "r1336",
      "r1337",
      "r1338",
      "r1339"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1116"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1116"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r215",
      "r217",
      "r218",
      "r220",
      "r241",
      "r242",
      "r439",
      "r440",
      "r441",
      "r442",
      "r521",
      "r565",
      "r677",
      "r759",
      "r827",
      "r829",
      "r843",
      "r868",
      "r869",
      "r931",
      "r935",
      "r937",
      "r938",
      "r951",
      "r966",
      "r967",
      "r988",
      "r997",
      "r1011",
      "r1022",
      "r1023",
      "r1024",
      "r1038",
      "r1254",
      "r1334",
      "r1335",
      "r1336",
      "r1337",
      "r1338",
      "r1339"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1136"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1144"
     ]
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Domain]",
        "label": "Customer [Domain]",
        "documentation": "Single external customer or group of external customers."
       }
      }
     },
     "auth_ref": [
      "r360",
      "r1001",
      "r1037",
      "r1040",
      "r1260",
      "r1344",
      "r1346",
      "r1347",
      "r1348",
      "r1349",
      "r1350",
      "r1351",
      "r1352",
      "r1353",
      "r1354",
      "r1355",
      "r1356",
      "r1357",
      "r1358",
      "r1359",
      "r1360",
      "r1361",
      "r1362",
      "r1363",
      "r1364",
      "r1365",
      "r1366",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371",
      "r1372"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1117"
     ]
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://www.iconplc.com/role/Descriptionofbusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of business",
        "label": "Nature of Operations [Text Block]",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r195",
      "r209"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r288"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows used in financing activities:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r288"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows used in investing activities:",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r142",
      "r143"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows provided by operating activities:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income",
        "terseLabel": "Net income",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r143",
      "r182",
      "r249",
      "r274",
      "r276",
      "r281",
      "r295",
      "r303",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r314",
      "r315",
      "r321",
      "r374",
      "r444",
      "r445",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r453",
      "r454",
      "r620",
      "r635",
      "r671",
      "r699",
      "r819",
      "r900",
      "r921",
      "r922",
      "r1051",
      "r1252"
     ]
    },
    "us-gaap_NetIncomeLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Income (Loss) Attributable to Parent [Abstract]",
        "label": "Net Income (Loss) Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "documentation": "Disclosure of information about change in accounting principle or amendment to accounting standards or both. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards and other change in accounting principle."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r309",
      "r316",
      "r329",
      "r361",
      "r362",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r420",
      "r421",
      "r424",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r626",
      "r627",
      "r628",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r694",
      "r695",
      "r720",
      "r721",
      "r722",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r764",
      "r765",
      "r766",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r845"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impact of recently issued or adopted accounting standards",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1116"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r1079",
      "r1090",
      "r1100",
      "r1124",
      "r1133"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1107"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1106"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1144"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1144"
     ]
    },
    "us-gaap_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-lived assets",
        "label": "Long-Lived Assets",
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r359"
     ]
    },
    "iclr_NonexecutiveDirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "NonexecutiveDirectorMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-executive director",
        "label": "Non-executive Director [Member]",
        "documentation": "Non-executive Director [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NontradeReceivablesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NontradeReceivablesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables",
        "label": "Nontrade Receivables, Current",
        "documentation": "The sum of amounts currently receivable other than from customers. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1182"
     ]
    },
    "us-gaap_NumberOfCountriesInWhichEntityOperates": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfCountriesInWhichEntityOperates",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of countries in which company operates",
        "label": "Number of Countries in which Entity Operates",
        "documentation": "The number of countries in which the entity operates as of balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfInterestRateDerivativesHeld": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfInterestRateDerivativesHeld",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of interest rate derivatives held",
        "label": "Number of Interest Rate Derivatives Held",
        "documentation": "Number of interest rate derivative instruments held by the entity at the reporting date."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r91"
     ]
    },
    "iclr_NumberOfLocations": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "NumberOfLocations",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of locations in which company operates",
        "label": "Number of Locations",
        "documentation": "Number of Locations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reporting segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r984",
      "r1205"
     ]
    },
    "iclr_NumberOfVotes": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "NumberOfVotes",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of votes",
        "label": "Number Of Votes",
        "documentation": "Number Of Votes"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_October2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "October2024Member",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "October 2024",
        "label": "October 2024 [Member]",
        "documentation": "October 2024"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_OncacareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "OncacareMember",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Oncacare",
        "label": "Oncacare [Member]",
        "documentation": "Oncacare"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_OperatingIncomeByGeographyTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "OperatingIncomeByGeographyTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Distribution of Income from Operations by Geographical Area",
        "label": "Operating Income by Geography [Table Text Block]",
        "documentation": "Operating Income by Geography."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income from operations",
        "terseLabel": "Income from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r979",
      "r1204",
      "r1206",
      "r1207",
      "r1208",
      "r1209"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesScheduleofLeaseCostsDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesScheduleofLeaseCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease costs",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r731",
      "r1027"
     ]
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of operating right-of-use assets and related property, plant and equipment",
        "label": "Operating Lease, Impairment Loss",
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r1326"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r726"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails",
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "verboseLabel": "Operating lease liabilities, current",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r726"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r727"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities (Note 15)",
        "verboseLabel": "Operating lease, liability, noncurrent",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r726"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating right-of-use assets (Note 15)",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r725"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reduction in carrying value of operating right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r1193"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average discount rate (in percent)",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r735",
      "r1027"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining lease term",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r734",
      "r1027"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwardsLineItems",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Loss Carryforwards [Line Items]",
        "label": "Operating Loss Carryforwards [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwardsTable",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Loss Carryforwards [Table]",
        "label": "Operating Loss Carryforwards [Table]",
        "documentation": "Disclosure of information about operating loss carryforward. Includes, but is not limited to, tax authority, amount and expiration date of operating loss carryforward, and likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "us-gaap_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Segments",
        "label": "Operating Segments [Member]",
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r354",
      "r983",
      "r984"
     ]
    },
    "iclr_OptionPlans2008Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "OptionPlans2008Member",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Option Plans 2008",
        "label": "Option Plans 2008 [Member]",
        "documentation": "Option Plans 2008 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrderOrProductionBacklogMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrderOrProductionBacklogMember",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Order backlog",
        "label": "Order or Production Backlog [Member]",
        "documentation": "Order or production backlog arising from contract acquired in business combination, asset acquisition, and from joint venture formation."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1232",
      "r1234",
      "r1237",
      "r1238"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r257"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remeasurement of retirement benefit obligations",
        "verboseLabel": "Remeasurement of retirement benefit obligations",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax",
        "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r127",
      "r519"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency impact on long term funding",
        "label": "OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax",
        "documentation": "Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r7",
      "r702",
      "r705",
      "r713"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLocationAxis",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Comprehensive Income Location [Axis]",
        "label": "Other Comprehensive Income Location [Axis]",
        "documentation": "Information by location in other comprehensive income."
       }
      }
     },
     "auth_ref": [
      "r679",
      "r681",
      "r686"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLocationDomain",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Comprehensive Income Location [Domain]",
        "label": "Other Comprehensive Income Location [Domain]",
        "documentation": "Location in other comprehensive income."
       }
      }
     },
     "auth_ref": [
      "r679",
      "r681",
      "r686"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flow hedge",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r270"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Gain / (loss) on cash flow hedge",
        "terseLabel": "Gain on cash flow hedge",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r269"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r269",
      "r643",
      "r644",
      "r647"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r269",
      "r273"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency translation adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r820"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other comprehensive income, net of tax:",
        "terseLabel": "Comprehensive income (net of tax):",
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Retirement benefit obligations",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r6",
      "r7",
      "r126",
      "r169"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossTaxAbstract",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax expense was allocated to the following components of other comprehensive income:",
        "label": "Other Comprehensive Income (Loss), Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Comprehensive Income",
        "label": "Other Comprehensive Income (Loss) [Member]",
        "documentation": "Primary financial statement caption in which reported facts about other comprehensive income have been included."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "iclr_OtherCountriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "OtherCountriesMember",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Countries [Member]",
        "documentation": "Other Countries [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_OtherCustomersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "OtherCustomersMember",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Customers [Member]",
        "documentation": "Other Customers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_OtherGeographicLocationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "OtherGeographicLocationsMember",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rest of World",
        "label": "Other Geographic Locations [Member]",
        "documentation": "Other Geographic Locations [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails",
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts due to third parties for reimbursable expenses",
        "label": "Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses",
        "documentation": "Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities (Note 12)",
        "totalLabel": "Other liabilities",
        "label": "Other Liabilities, Current",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r1028"
     ]
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Liabilities Disclosure [Abstract]",
        "label": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Liabilities",
        "label": "Other Liabilities Disclosure [Text Block]",
        "documentation": "The entire disclosure for other liabilities."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r114",
      "r1239"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current other liabilities (Note 16)",
        "totalLabel": "Total",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_OtherLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Liabilities",
        "label": "Other Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of other liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNoncashIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other non-cash items",
        "label": "Other Noncash Income (Expense)",
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other."
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentotherliabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current other liabilities",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of other noncurrent liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r1116"
     ]
    },
    "us-gaap_OtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherReceivables",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables",
        "label": "Other Receivables",
        "documentation": "Amount due from parties in nontrade transactions, classified as other."
       }
      }
     },
     "auth_ref": [
      "r261",
      "r886",
      "r984",
      "r1342"
     ]
    },
    "us-gaap_OtherRestructuringCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherRestructuringCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other restructuring costs",
        "label": "Other Restructuring Costs",
        "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherSundryLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General trade and overhead liabilities",
        "label": "Other Sundry Liabilities, Current",
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r109"
     ]
    },
    "us-gaap_OtherSundryLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherSundryLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities",
        "label": "Other Sundry Liabilities, Noncurrent",
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r177"
     ]
    },
    "iclr_OtherUndenominatedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "OtherUndenominatedCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other undenominated capital (Note 18b)",
        "label": "Other Undenominated Capital",
        "documentation": "Other undenominated capital."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_OtherUndenominatedCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "OtherUndenominatedCapitalMember",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Undenominated Capital",
        "label": "Other Undenominated Capital [Member]",
        "documentation": "Other undenominated capital."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1077",
      "r1088",
      "r1098",
      "r1131"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1080",
      "r1091",
      "r1101",
      "r1134"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1080",
      "r1091",
      "r1101",
      "r1134"
     ]
    },
    "iclr_PRAHealthSciencesIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "PRAHealthSciencesIncMember",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PRA Health Sciences, Inc",
        "label": "PRA Health Sciences, Inc [Member]",
        "documentation": "PRA Health Sciences, Inc"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1105"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payables and Accruals [Abstract]",
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_PaymentsForBrokerCommissionShareRepurchaseCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "PaymentsForBrokerCommissionShareRepurchaseCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Share repurchase costs",
        "label": "Payments For Broker Commission Share Repurchase Costs",
        "documentation": "Payments For Broker Commission Share Repurchase Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForProceedsFromShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForProceedsFromShortTermInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Movement of available for sale investments",
        "label": "Payments for (Proceeds from) Short-Term Investments",
        "documentation": "The net amount paid (received) by the reporting entity through acquisition or sale and maturities of short-term investments with an original maturity that is three months or less which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r1189",
      "r1191",
      "r1194"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repurchase of ordinary shares",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfDebtIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "New Notes issue costs",
        "label": "Payments of Debt Issuance Costs",
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Share issue costs",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireBusinessesGross",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeHumanFirstAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeKCRAcquisitionDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of subsidiary undertakings (net of cash acquired)",
        "terseLabel": "Purchase of subsidiary undertakings (net of cash acquired)",
        "verboseLabel": "Fair value of cash consideration",
        "label": "Payments to Acquire Businesses, Gross",
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r629"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeHumanFirstAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeKCRAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments to acquire businesses, net of cash acquired",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_PaymentsToAcquireEquitySecuritiesFvNi": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireEquitySecuritiesFvNi",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/InvestmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments to acquire equity securities, FV-NI",
        "label": "Payments to Acquire Equity Securities, FV-NI",
        "documentation": "Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r286"
     ]
    },
    "us-gaap_PaymentsToAcquireLongtermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireLongtermInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of investments in equity",
        "label": "Payments to Acquire Long-Term Investments",
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term."
       }
      }
     },
     "auth_ref": [
      "r1190"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of property, plant and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1115"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1115"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1107"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r1117"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1106"
     ]
    },
    "us-gaap_PercentageOfDebtHedgedByInterestRateDerivatives": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PercentageOfDebtHedgedByInterestRateDerivatives",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of debt hedged by interest rate derivatives",
        "label": "Percentage of Debt Hedged by Interest Rate Derivatives",
        "documentation": "Percentage of an entity's outstanding debt that is designated as a hedged item in cash flow, fair value, or net investment hedge."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_PerformanceBasedGrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "PerformanceBasedGrantsMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PSUs Based on Service and EPS Targets",
        "label": "Performance Based Grants [Member]",
        "documentation": "Performance Based Grants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_PerformanceShareUnitMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "PerformanceShareUnitMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance Share Unit (PSUs)",
        "label": "Performance Share Unit [Member]",
        "documentation": "Performance Share Unit [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_PersonnelRelatedLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "PersonnelRelatedLiabilitiesMember",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Personnel related liabilities",
        "label": "Personnel Related Liabilities [Member]",
        "documentation": "Personnel Related Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1262",
      "r1263",
      "r1264",
      "r1265",
      "r1266",
      "r1267",
      "r1268",
      "r1269",
      "r1270",
      "r1271",
      "r1272",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1262",
      "r1263",
      "r1264",
      "r1265",
      "r1266",
      "r1267",
      "r1268",
      "r1269",
      "r1270",
      "r1271",
      "r1272",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1108"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1164"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1107"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayments and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1183"
     ]
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromLinesOfCredit",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Drawdown of credit lines and loan facilities",
        "label": "Proceeds from Lines of Credit",
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r1195"
     ]
    },
    "us-gaap_ProceedsFromSaleOfLongtermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleOfLongtermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from investments in equity",
        "label": "Proceeds from Sale of Long-Term Investments",
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, beyond the current operating cycle."
       }
      }
     },
     "auth_ref": [
      "r1169"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of equity compensation",
        "verboseLabel": "Total proceeds from exercise of stock options by employees",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r20"
     ]
    },
    "us-gaap_ProductInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProductInformationLineItems",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product Information [Line Items]",
        "label": "Product Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r274",
      "r276",
      "r287",
      "r295",
      "r303",
      "r311",
      "r314",
      "r315",
      "r374",
      "r444",
      "r445",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r453",
      "r454",
      "r620",
      "r635",
      "r636",
      "r639",
      "r640",
      "r671",
      "r699",
      "r802",
      "r818",
      "r856",
      "r900",
      "r921",
      "r922",
      "r1017",
      "r1018",
      "r1052",
      "r1186",
      "r1252"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Abstract]",
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r737"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, net",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r198",
      "r205",
      "r206"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Cost",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r253",
      "r816"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      },
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property, plant and equipment, net (Note 9)",
        "totalLabel": "Property, plant and equipment (net)",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r737",
      "r803",
      "r816",
      "r1028"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r198",
      "r205",
      "r814"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property Plant and Equipment, Net",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r737"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated Useful Life",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r1105"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1105"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r215",
      "r217",
      "r218",
      "r220",
      "r241",
      "r242",
      "r439",
      "r440",
      "r441",
      "r442",
      "r512",
      "r521",
      "r552",
      "r553",
      "r554",
      "r565",
      "r677",
      "r757",
      "r758",
      "r759",
      "r827",
      "r829",
      "r843",
      "r868",
      "r869",
      "r931",
      "r935",
      "r937",
      "r938",
      "r951",
      "r966",
      "r967",
      "r988",
      "r997",
      "r1011",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1038",
      "r1043",
      "r1244",
      "r1254",
      "r1305",
      "r1335",
      "r1336",
      "r1337",
      "r1338",
      "r1339"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r215",
      "r217",
      "r218",
      "r220",
      "r241",
      "r242",
      "r439",
      "r440",
      "r441",
      "r442",
      "r512",
      "r521",
      "r552",
      "r553",
      "r554",
      "r565",
      "r677",
      "r757",
      "r758",
      "r759",
      "r827",
      "r829",
      "r843",
      "r868",
      "r869",
      "r931",
      "r935",
      "r937",
      "r938",
      "r951",
      "r966",
      "r967",
      "r988",
      "r997",
      "r1011",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1038",
      "r1043",
      "r1244",
      "r1254",
      "r1305",
      "r1335",
      "r1336",
      "r1337",
      "r1338",
      "r1339"
     ]
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivablesPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, net and unbilled revenue",
        "label": "Receivable [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable."
       }
      }
     },
     "auth_ref": [
      "r364",
      "r365",
      "r366",
      "r368",
      "r1212"
     ]
    },
    "iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "ReconciliationOfProvisionOfIncomeTaxesLineItems",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Provision of Income Taxes [Line Items]",
        "label": "Reconciliation of Provision of Income Taxes [Line Items]",
        "documentation": "Reconciliation of Provision of Income Taxes [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_ReconciliationOfProvisionOfIncomeTaxesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "ReconciliationOfProvisionOfIncomeTaxesTable",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Provision of Income Taxes [Table]",
        "label": "Reconciliation of Provision of Income Taxes [Table]",
        "documentation": "Reconciliation of Provision of Income Taxes [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized Tax Benefits [Roll Forward]",
        "label": "Unrecognized Tax Benefits [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1072",
      "r1083",
      "r1093",
      "r1126"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Domain]",
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r520",
      "r748",
      "r749",
      "r807",
      "r813",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r896",
      "r898",
      "r930"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Axis]",
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r748",
      "r749",
      "r1331"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Domain]",
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Line Items]",
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r903",
      "r904",
      "r907"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transactions [Abstract]",
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Axis]",
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r520",
      "r748",
      "r749",
      "r807",
      "r813",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r896",
      "r898",
      "r930",
      "r1331"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/RelatedParties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Parties",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r745",
      "r746",
      "r747",
      "r749",
      "r750",
      "r853",
      "r854",
      "r855",
      "r905",
      "r906",
      "r907",
      "r927",
      "r929"
     ]
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfLinesOfCredit",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayment of credit lines and loan facilities",
        "label": "Repayments of Lines of Credit",
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r1195"
     ]
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfSeniorDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repayments of senior debt",
        "label": "Repayments of Senior Debt",
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period."
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "iclr_ResearchAndDevelopmentCreditsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "ResearchAndDevelopmentCreditsPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development credits",
        "label": "Research And Development Credits [Policy Text Block]",
        "documentation": "Research and Development Credits [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_RestOfEuropeAndOtherCountriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "RestOfEuropeAndOtherCountriesMember",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Rest Of Europe And Other Countries [Member]",
        "documentation": "Rest Of Europe And Other Countries [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_RestOfEuropeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "RestOfEuropeMember",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rest of Europe",
        "label": "Rest Of Europe [Member]",
        "documentation": "Rest Of Europe [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1073",
      "r1084",
      "r1094",
      "r1127"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r1074",
      "r1085",
      "r1095",
      "r1128"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1081",
      "r1092",
      "r1102",
      "r1135"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock Units (RSUs)",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_RestrictedStockUnitsTwentyThirteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "RestrictedStockUnitsTwentyThirteenMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock Units 2013",
        "label": "Restricted Stock Units Twenty Thirteen [Member]",
        "documentation": "Restricted Stock Units Twenty Thirteen [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring and Related Activities [Abstract]",
        "label": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringCharges"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Charges",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled."
       }
      }
     },
     "auth_ref": [
      "r425",
      "r426",
      "r428",
      "r431",
      "r436"
     ]
    },
    "us-gaap_RestructuringCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCharges",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Charge during the year*",
        "label": "Restructuring Charges",
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r432",
      "r433",
      "r1245"
     ]
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCostAndReserveAxis",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Type [Axis]",
        "label": "Restructuring Type [Axis]",
        "documentation": "Information by type of restructuring cost."
       }
      }
     },
     "auth_ref": [
      "r427",
      "r428",
      "r433",
      "r434"
     ]
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCostAndReserveLineItems",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Cost and Reserve [Line Items]",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r427",
      "r428",
      "r429",
      "r430",
      "r433",
      "r434",
      "r435"
     ]
    },
    "us-gaap_RestructuringCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails",
      "http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringChargesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Restructuring (Note 19)",
        "terseLabel": "Restructuring charges",
        "label": "Restructuring Costs",
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "label": "Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes restructuring charges."
       }
      }
     },
     "auth_ref": [
      "r1167",
      "r1168"
     ]
    },
    "us-gaap_RestructuringReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringReserve",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails",
      "http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring reserve",
        "periodStartLabel": "Opening provision",
        "periodEndLabel": "Ending provision",
        "label": "Restructuring Reserve",
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r434"
     ]
    },
    "iclr_RestructuringReserveAndOtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "RestructuringReserveAndOtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OtherLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring liabilities",
        "label": "Restructuring Reserve And Other Liabilities, Current",
        "documentation": "Restructuring Reserve And Other Liabilities, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringReserveCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringReserveCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring reserve, current",
        "label": "Restructuring Reserve, Current",
        "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset."
       }
      }
     },
     "auth_ref": [
      "r1180",
      "r1246",
      "r1247"
     ]
    },
    "us-gaap_RestructuringReserveNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringReserveNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring reserve, noncurrent",
        "label": "Restructuring Reserve, Noncurrent",
        "documentation": "Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset."
       }
      }
     },
     "auth_ref": [
      "r1181",
      "r1246",
      "r1247"
     ]
    },
    "us-gaap_RestructuringReserveRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringReserveRollForward",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Reserve [Roll Forward]",
        "label": "Restructuring Reserve [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_RestructuringReserveUtilizations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "RestructuringReserveUtilizations",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Utilization",
        "label": "Restructuring Reserve Utilizations",
        "documentation": "Restructuring Reserve Utilizations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained earnings",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r157",
      "r811",
      "r837",
      "r842",
      "r851",
      "r879",
      "r1028"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained Earnings",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r245",
      "r299",
      "r300",
      "r301",
      "r304",
      "r311",
      "r313",
      "r315",
      "r378",
      "r384",
      "r421",
      "r603",
      "r604",
      "r616",
      "r617",
      "r618",
      "r621",
      "r634",
      "r635",
      "r651",
      "r654",
      "r655",
      "r658",
      "r669",
      "r721",
      "r724",
      "r833",
      "r835",
      "r857",
      "r1376"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Contract with Customer [Abstract]",
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r330",
      "r337",
      "r338",
      "r347",
      "r353",
      "r356",
      "r358",
      "r360",
      "r507",
      "r509",
      "r762"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognition",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r970"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/Accountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilities",
      "http://www.iconplc.com/role/DisaggregationofRevenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue",
        "verboseLabel": "Accounts receivable, unbilled revenue (contract assets) and unearned revenue or payments on account (contract liabilities)",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r511"
     ]
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Distribution of Net Revenue by Geographical Area",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, remaining performance obligation, amount",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r201"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, remaining performance obligation, expected timing of satisfaction, period",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r202"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r202"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "presentation": [
      "http://www.iconplc.com/role/AccountsreceivableunbilledrevenuecontractassetsandunearnedrevenueorpaymentsonaccountcontractliabilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, remaining performance obligation (in percent)",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r1170"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Revenues",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r282",
      "r295",
      "r330",
      "r337",
      "r338",
      "r347",
      "r353",
      "r356",
      "r358",
      "r360",
      "r374",
      "r444",
      "r445",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r453",
      "r454",
      "r699",
      "r802",
      "r983",
      "r1252"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues [Abstract]",
        "label": "Revenues [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevolvingCreditFacilityMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Secured Revolving Loan",
        "label": "Revolving Credit Facility [Member]",
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets obtained in exchange for lease obligations",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r733",
      "r1027"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1144"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1144"
     ]
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Revenue",
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r360",
      "r1171"
     ]
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/AccumulatedOtherComprehensiveLossTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r1320",
      "r1321"
     ]
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "documentation": "Disclosure of information about acquired finite-lived intangible asset by major class."
       }
      }
     },
     "auth_ref": [
      "r404",
      "r405",
      "r406",
      "r408",
      "r969"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeBiotelAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeHumanFirstAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeKCRAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativeOncacareAcquisitionDetails",
      "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r70",
      "r624"
     ]
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Supplemental Disclosure of Cash Flow Information",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]",
        "label": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]",
        "documentation": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]",
        "label": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]",
        "documentation": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Components of Provision for Income Taxes",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r1295"
     ]
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-term Debt Instruments",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r57",
      "r58",
      "r105",
      "r155",
      "r156",
      "r993",
      "r995",
      "r1198",
      "r1323"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Tax Effects of Temporary Differences that Give Rise to Significant Portions of Deferred Tax Assets and Deferred Tax Liabilities",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1292"
     ]
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/DerivativesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income per Ordinary Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1203"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of Consolidated Reported Provision for Income Taxes and Statutory Rate",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r576",
      "r1016",
      "r1289"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsTables",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-Lived Intangible Assets",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r991",
      "r1233"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfGoodwillTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/GoodwillTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Goodwill",
        "label": "Schedule of Goodwill [Table Text Block]",
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule."
       }
      }
     },
     "auth_ref": [
      "r990",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226"
     ]
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Asset, Indefinite-Lived [Table]",
        "label": "Intangible Asset, Indefinite-Lived [Table]",
        "documentation": "Disclosure of information about indefinite-lived intangible asset. Excludes finite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r402",
      "r412",
      "r417",
      "r991"
     ]
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturities of Long-term Debt",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "ScheduleOfNonCashStockCompensationExpenseTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Non-cash Stock Compensation Expense",
        "label": "Schedule of Non Cash Stock Compensation Expense [Table Text Block]",
        "documentation": "Schedule of Non Cash Stock Compensation Expense."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Principal Payments on Debt Instrument",
        "label": "Schedule of Principal Payments on Debt Instrument [Table Text Block]",
        "documentation": "Schedule of Principal Payments on Debt Instrument"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfProductInformationTable",
     "presentation": [
      "http://www.iconplc.com/role/DescriptionofbusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nature of Operation, Product Information, Concentration of Risk [Table]",
        "label": "Nature of Operation, Product Information, Concentration of Risk [Table]",
        "documentation": "Disclosure of information about concentration risk of product within nature of operation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r737"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Table]",
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r104",
      "r903",
      "r904",
      "r907"
     ]
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Cost [Table]",
        "label": "Restructuring Cost [Table]",
        "documentation": "Disclosure of information about restructuring cost. Includes, but is not limited to, expected cost, cost incurred, statement of income caption that includes restructuring cost recognized, and amount of restructuring reserve."
       }
      }
     },
     "auth_ref": [
      "r427",
      "r428",
      "r429",
      "r430",
      "r433",
      "r434",
      "r435"
     ]
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restructuring Charges",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r149",
      "r150"
     ]
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restructuring Reserve by Type of Cost",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r151"
     ]
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Distribution of Net Revenue by Geographical Area",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r128"
     ]
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "documentation": "Disclosure of information about revenue from external customer and long-lived asset by geographical area. Long-lived asset excludes financial instrument, customer relationship with financial institution, mortgage and other servicing right, deferred policy acquisition cost, and deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r128"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r45",
      "r46"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r523",
      "r525",
      "r527",
      "r528",
      "r529",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555"
     ]
    },
    "iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of RSU and PSU Activity",
        "label": "Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block]",
        "documentation": "Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Transactions for Company's Share Option Plans",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r19",
      "r159"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Weighted Average Fair Values and Assumptions Used",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Unrecognized Tax Benefits Roll Forward",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r585",
      "r1015"
     ]
    },
    "iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated useful lives of assets",
        "label": "Schedule Of Useful Lives For Property Plant Equipment [Table Text Block]",
        "documentation": "Schedule Of Useful Lives For Property Plant Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Intangible Asset Amortization Expense",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r991",
      "r1235"
     ]
    },
    "us-gaap_SecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SecuredDebtMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofPrincipalpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Secured Term Loan",
        "label": "Secured Debt [Member]",
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg."
       }
      }
     },
     "auth_ref": [
      "r1300"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1055"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r1057"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/DescriptionofbusinessDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]",
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r216",
      "r219",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r358",
      "r359",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r861",
      "r864",
      "r866",
      "r932",
      "r936",
      "r939",
      "r952",
      "r954",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r972",
      "r1000",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1039",
      "r1043",
      "r1260",
      "r1344",
      "r1346",
      "r1347",
      "r1348",
      "r1349",
      "r1350",
      "r1351",
      "r1352",
      "r1353",
      "r1354",
      "r1355",
      "r1356",
      "r1357",
      "r1358",
      "r1359",
      "r1360",
      "r1361",
      "r1362",
      "r1363",
      "r1364",
      "r1365",
      "r1366",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371",
      "r1372"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting [Abstract]",
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Segment and Geographical Information",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r330",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r344",
      "r345",
      "r346",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r360",
      "r980",
      "r981",
      "r982",
      "r983",
      "r985",
      "r986",
      "r987"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general and administrative",
        "label": "Selling, General and Administrative Expense",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general and administrative",
        "label": "Selling, General and Administrative Expenses [Member]",
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior secured credit facility and senior secured notes",
        "label": "Senior Secured Credit Facility And Senior Secured Notes [Member]",
        "documentation": "Senior Secured Credit Facility And Senior Secured Notes"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_SeniorSecuredNotesDueMay2027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "SeniorSecuredNotesDueMay2027Member",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Secured Notes (the \"2027 Notes\")*",
        "label": "Senior Secured Notes Due May 2027 [Member]",
        "documentation": "Senior Secured Notes Due May 2027"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_SeniorSecuredNotesDueMay2029Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "SeniorSecuredNotesDueMay2029Member",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Secured Notes (the \"2029 Notes\")*",
        "label": "Senior Secured Notes Due May 2029 [Member]",
        "documentation": "Senior Secured Notes Due May 2029"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_SeniorSecuredNotesDueMay2034Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "SeniorSecuredNotesDueMay2034Member",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Secured Notes (the \"2034 Notes\")*",
        "label": "Senior Secured Notes Due May 2034 [Member]",
        "documentation": "Senior Secured Notes - 2034"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_SeniorSecuredNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "SeniorSecuredNotesMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Secured Notes (the \"2026 Notes\")",
        "label": "Senior Secured Notes [Member]",
        "documentation": "Senior Secured Notes"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_SeniorSecuredRevolvingLoanFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "SeniorSecuredRevolvingLoanFacilityMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofMovementonDebtInstrumentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Secured Revolving Loan",
        "label": "Senior Secured Revolving Loan Facility [Member]",
        "documentation": "Senior Secured Revolving Loan Facility"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeniorSubordinatedNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeniorSubordinatedNotesMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Secured Notes (the \"2026 Notes\")",
        "label": "Senior Subordinated Notes [Member]",
        "documentation": "A senior subordinated note is a bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior subordinated debt holders receive priority for [must receive] repayment [prior] relative to junior and unsecured (general) creditors. However senior subordinated notes are junior to Senior Notes and Senior bond holders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeveranceCosts1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeveranceCosts1",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Severance costs",
        "label": "Severance Costs",
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock compensation expense",
        "terseLabel": "Total",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r1012"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r544"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r544"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r542"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r542"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at beginning of period (in shares)",
        "periodEndLabel": "Outstanding at ending of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r539",
      "r540"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding number of shares [Roll Forward]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at beginning of period (USD per share)",
        "periodEndLabel": "Outstanding at end of period (USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r539",
      "r540"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Fair Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Shares vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r543"
     ]
    },
    "iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share price of equity instruments other than options, vested in period (in USD per share)",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of stock units vested",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash."
       }
      }
     },
     "auth_ref": [
      "r546"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares vested (USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r543"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assumptions:",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend yield (in percent)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r553"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility (in percent)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r552"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk free interest rate (in percent)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r554"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r523",
      "r525",
      "r527",
      "r528",
      "r529",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum number of shares per employee (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee",
        "documentation": "The highest quantity of shares an employee can purchase under the plan per period."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional number of ordinary shares which have been reserved for issuance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares which have been reserved for issuance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1014"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock units to be granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercised during period, intrinsic value (in USD)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r546"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Canceled/expired (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r535"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average fair value (USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r545"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options outstanding, intrinsic value (in USD)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r531",
      "r532"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options Granted Under Plans",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (USD per share)",
        "periodEndLabel": "Ending balance (USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r531",
      "r532"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and exercisable at end of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r548"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and exercisable at end of period (USD per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r548"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r527",
      "r528",
      "r529",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Average exercise price of option per share (USD per share)",
        "verboseLabel": "Exercised (USD per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Canceled/expired (USD per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired."
       }
      }
     },
     "auth_ref": [
      "r538"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (USD per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r535"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r522",
      "r530",
      "r549",
      "r550",
      "r551",
      "r552",
      "r555",
      "r561",
      "r562",
      "r563",
      "r564"
     ]
    },
    "srt_ShareRepurchaseProgramAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ShareRepurchaseProgramAxis",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Repurchase Program [Axis]",
        "label": "Share Repurchase Program [Axis]",
        "documentation": "Information by share repurchase program."
       }
      }
     },
     "auth_ref": [
      "r1256"
     ]
    },
    "iclr_ShareRepurchaseProgramBrokerCommission": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "ShareRepurchaseProgramBrokerCommission",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Share repurchase costs",
        "label": "Share Repurchase Program, Broker Commission",
        "documentation": "Share Repurchase Program, Broker Commission"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ShareRepurchaseProgramDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ShareRepurchaseProgramDomain",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Repurchase Program [Domain]",
        "label": "Share Repurchase Program [Domain]",
        "documentation": "Name of share repurchase program."
       }
      }
     },
     "auth_ref": [
      "r1256"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares expiration period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1013"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected life",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercisable, intrinsic value (in USD)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average contractual term of options outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable - weighted average remaining contractual life",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r548"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of option price for fair value of ordinary share (in percent)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant accounting policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r293"
     ]
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefit, potentially expire in 2021",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit",
        "documentation": "The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Unrecognized Tax Benefit, Reasonably Possible [Table]",
        "label": "Change in Unrecognized Tax Benefit, Reasonably Possible [Table]",
        "documentation": "Disclosure of information about unrecognized tax benefit for which significant change is reasonably possible within 12 months. Includes, but is not limited to, nature of uncertainty, nature of event that could cause significant change within 12 months, and estimate of range of reasonably possible change or statement of fact that estimate of range cannot be made."
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "srt_StandardPoorsBBBMinusRatingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StandardPoorsBBBMinusRatingMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Standard &amp; Poor's, BBB- Rating",
        "label": "Standard &amp; Poor's, BBB- Rating [Member]",
        "documentation": "BBB- credit rating as defined by the external credit rating agency, Standard &amp; Poor's."
       }
      }
     },
     "auth_ref": []
    },
    "srt_StandardPoorsBBBPlusRatingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StandardPoorsBBBPlusRatingMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Standard &amp; Poor's, BBB+ Rating",
        "label": "Standard &amp; Poor's, BBB+ Rating [Member]",
        "documentation": "BBB+ credit rating as defined by the external credit rating agency, Standard &amp; Poor's."
       }
      }
     },
     "auth_ref": []
    },
    "srt_StandardPoorsBBBRatingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StandardPoorsBBBRatingMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Standard &amp; Poor's, BBB Rating",
        "label": "Standard &amp; Poor's, BBB Rating [Member]",
        "documentation": "BBB credit rating as defined by the external credit rating agency, Standard &amp; Poor's."
       }
      }
     },
     "auth_ref": []
    },
    "srt_StandardPoorsBBPlusRatingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StandardPoorsBBPlusRatingMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Standard &amp; Poor's, BB+ Rating",
        "label": "Standard &amp; Poor's, BB+ Rating [Member]",
        "documentation": "BB+ credit rating as defined by the external credit rating agency, Standard &amp; Poor's."
       }
      }
     },
     "auth_ref": []
    },
    "srt_StandardPoorsBBRatingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StandardPoorsBBRatingMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Standard &amp; Poor's, BB Rating",
        "label": "Standard &amp; Poor's, BB Rating [Member]",
        "documentation": "BB credit rating as defined by the external credit rating agency, Standard &amp; Poor's."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State NOL's",
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r120",
      "r123",
      "r124",
      "r245",
      "r279",
      "r280",
      "r281",
      "r299",
      "r300",
      "r301",
      "r304",
      "r311",
      "r313",
      "r315",
      "r331",
      "r378",
      "r384",
      "r421",
      "r488",
      "r603",
      "r604",
      "r616",
      "r617",
      "r618",
      "r621",
      "r634",
      "r635",
      "r651",
      "r653",
      "r654",
      "r655",
      "r656",
      "r658",
      "r669",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r714",
      "r721",
      "r724",
      "r744",
      "r820",
      "r833",
      "r834",
      "r835",
      "r857",
      "r923"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/DescriptionofbusinessDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical",
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r216",
      "r219",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r358",
      "r359",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r861",
      "r864",
      "r866",
      "r932",
      "r936",
      "r939",
      "r952",
      "r954",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r972",
      "r1000",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1039",
      "r1043",
      "r1260",
      "r1344",
      "r1346",
      "r1347",
      "r1348",
      "r1349",
      "r1350",
      "r1351",
      "r1352",
      "r1353",
      "r1354",
      "r1355",
      "r1356",
      "r1357",
      "r1358",
      "r1359",
      "r1360",
      "r1361",
      "r1362",
      "r1363",
      "r1364",
      "r1365",
      "r1366",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371",
      "r1372"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r331",
      "r724",
      "r762",
      "r846",
      "r858",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r878",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r887",
      "r888",
      "r889",
      "r890",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r898",
      "r901",
      "r902",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r923",
      "r1044"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Comprehensive Income [Abstract]",
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r331",
      "r363",
      "r724",
      "r762",
      "r846",
      "r858",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r878",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r887",
      "r888",
      "r889",
      "r890",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r898",
      "r901",
      "r902",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r923",
      "r1044"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1076",
      "r1087",
      "r1097",
      "r1130"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares issued in respect of certain RSUs previously awarded by the Company (in shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r119",
      "r120",
      "r157"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of restricted share units / performance share units (in shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r119",
      "r120",
      "r157"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares issued in respect of certain PSUs previously awarded by the Company (in shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture",
        "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY",
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of share options (in shares)",
        "verboseLabel": "Options exercised by employees (in shares)",
        "negatedLabel": "Exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r119",
      "r120",
      "r157",
      "r536"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of restricted share units / performance share units",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r119",
      "r120",
      "r157"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of share options",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r120",
      "r123",
      "r124",
      "r157"
     ]
    },
    "iclr_StockOptionAndAwardPlansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "StockOptionAndAwardPlansMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Option and Award Plans",
        "label": "Stock Option And Award Plans [Member]",
        "documentation": "Stock Option And Award Plans [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails",
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase program, authorized amount",
        "label": "Share Repurchase Program, Authorized, Amount",
        "documentation": "Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": [
      "r1256"
     ]
    },
    "iclr_StockRepurchaseProgramAuthorizedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "StockRepurchaseProgramAuthorizedPercentage",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase program, authorized percentage (in percent)",
        "label": "Stock Repurchase Program Authorized Percentage",
        "documentation": "Stock Repurchase Program Authorized Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Share repurchase program, number of shares repurchased (in shares)",
        "terseLabel": "Ordinary shares redeemed (in shares)",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "documentation": "Number of shares that have been repurchased and retired during the period."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r119",
      "r120",
      "r157"
     ]
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY",
      "http://www.iconplc.com/role/ShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repurchase of ordinary shares",
        "terseLabel": "Ordinary shares redeemed, value",
        "label": "Stock Repurchased and Retired During Period, Value",
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital)."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r119",
      "r120",
      "r157"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Shareholders' Equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r123",
      "r124",
      "r146",
      "r880",
      "r897",
      "r924",
      "r925",
      "r1028",
      "r1053",
      "r1196",
      "r1213",
      "r1317",
      "r1376"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shareholders' Equity:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/ShareCapital"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Capital",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r294",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r660",
      "r926",
      "r928",
      "r953"
     ]
    },
    "us-gaap_SubleaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubleaseIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.iconplc.com/role/OperatingLeasesScheduleofLeaseCostsDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/OperatingLeasesScheduleofLeaseCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income from sub-leases",
        "label": "Sublease Income",
        "documentation": "Amount of sublease income excluding finance and operating lease expense."
       }
      }
     },
     "auth_ref": [
      "r732",
      "r1027"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Line Items]",
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r715",
      "r752"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r715",
      "r752"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Table]",
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r715",
      "r752"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r715",
      "r752"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.iconplc.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r715",
      "r752"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events [Abstract]",
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r751",
      "r753"
     ]
    },
    "us-gaap_SubsidiaryOfCommonParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiaryOfCommonParentMember",
     "presentation": [
      "http://www.iconplc.com/role/RelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiaries",
        "label": "Subsidiary of Common Parent [Member]",
        "documentation": "Refers to an entity under the control of the same parent as another entity (that is, a sister company)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SummaryOfOperatingLossCarryforwardsTextBlock",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Expected Expiry Dates of NOL's",
        "label": "Summary of Operating Loss Carryforwards [Table Text Block]",
        "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r1293"
     ]
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowElementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental Cash Flow Elements [Abstract]",
        "label": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1123"
     ]
    },
    "iclr_TaxCreditCarryForwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "TaxCreditCarryForwardExpirationPeriod",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credit carry forward, expiration period",
        "label": "Tax Credit Carry forward Expiration Period",
        "documentation": "Tax Credit Carry forward Expiration Period"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_TaxCreditCarryForwardIncreaseDecreaseAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "TaxCreditCarryForwardIncreaseDecreaseAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (decrease) tax credit carry forward",
        "label": "Tax Credit Carry forward Increase (Decrease) , Amount",
        "documentation": "Tax Credit Carry forward Increase (Decrease) , Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credit carry forward",
        "label": "Tax Credit Carryforward, Amount",
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "iclr_TaxOfBusinessAcquiredMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "TaxOfBusinessAcquiredMember",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax of business acquired",
        "label": "Tax of Business Acquired [Member]",
        "documentation": "Tax of Business Acquired"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TaxPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxPeriodAxis",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Period [Axis]",
        "label": "Tax Period [Axis]",
        "documentation": "Information by period subject to enacted tax law."
       }
      }
     },
     "auth_ref": [
      "r1291"
     ]
    },
    "us-gaap_TaxPeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxPeriodDomain",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Period [Domain]",
        "label": "Tax Period [Domain]",
        "documentation": "Identified tax period."
       }
      }
     },
     "auth_ref": [
      "r1291"
     ]
    },
    "iclr_TaxYear2025To2038Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "TaxYear2025To2038Member",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025-2038",
        "label": "Tax Year 2025 to 2038 [Member]",
        "documentation": "Tax Year 2025 to 2038"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_TaxYear20392043Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "TaxYear20392043Member",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2039-2043",
        "label": "Tax Year 2039 - 2043 [Member]",
        "documentation": "Tax Year 2039 - 2043"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Technology assets",
        "label": "Technology-Based Intangible Assets [Member]",
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1232",
      "r1234",
      "r1237",
      "r1238"
     ]
    },
    "iclr_TermLoanFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "TermLoanFacilityMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofLongtermDebtInstrumentsDetails",
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesScheduleofPrincipalpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Secured Term Loan",
        "label": "Term Loan Facility [Member]",
        "documentation": "Term Loan Facility"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_The2018LegacyPRAPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "The2018LegacyPRAPlanMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "The 2018 Legacy PRA Plan",
        "label": "The 2018 Legacy PRA Plan [Member]",
        "documentation": "The 2018 Plan"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_The2020LegacyPRAPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "The2020LegacyPRAPlanMember",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "The 2020 Legacy PRA Plan",
        "label": "The 2020 Legacy PRA Plan [Member]",
        "documentation": "The 2020 Legacy PRA Plan"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title and Position [Axis]",
        "label": "Title and Position [Axis]",
        "documentation": "Information by title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": [
      "r1210",
      "r1330"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title and Position [Domain]",
        "label": "Title and Position [Domain]",
        "documentation": "Title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_TopClientMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "TopClientMember",
     "presentation": [
      "http://www.iconplc.com/role/DisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Top client",
        "label": "Top Client [Member]",
        "documentation": "Top Client [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1115"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1122"
     ]
    },
    "us-gaap_TradeNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradeNamesMember",
     "presentation": [
      "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.iconplc.com/role/IntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails",
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade names &amp; brands",
        "label": "Trade Names [Member]",
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1234",
      "r1236",
      "r1237",
      "r1238"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1143"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r1145"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.iconplc.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r1146"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r1147"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r1147"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1145"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r1145"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r1148"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r1146"
     ]
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfRestructuringDomain",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Restructuring [Domain]",
        "label": "Type of Restructuring [Domain]",
        "documentation": "Identification of the types of restructuring costs."
       }
      }
     },
     "auth_ref": [
      "r427",
      "r428",
      "r433",
      "r434"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "US",
     "presentation": [
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails",
      "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails",
      "http://www.iconplc.com/role/DescriptionofbusinessDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails",
      "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails",
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "verboseLabel": "U.S.",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r1142"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unrecognized tax benefits at start of year",
        "periodEndLabel": "Unrecognized tax benefits at end of year",
        "label": "Unrecognized Tax Benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r567",
      "r585",
      "r1015"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Decrease related to prior year tax positions",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r586",
      "r1015"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total accrued interest and penalties",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r583",
      "r1015"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest and penalties recognized as an expense",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r583",
      "r1015"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase related to current year tax positions",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r587",
      "r1015"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase related to prior year tax positions",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r586",
      "r1015"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "crdr": "debit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Lapse of statute of limitations",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total unrecognized tax benefits net of potential benefits",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate."
       }
      }
     },
     "auth_ref": [
      "r589",
      "r1015"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r42",
      "r43",
      "r196",
      "r197",
      "r199",
      "r200"
     ]
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net change in the total valuation allowance",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r592"
     ]
    },
    "us-gaap_VariableRateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableRateAxis",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Axis]",
        "label": "Variable Rate [Axis]",
        "documentation": "Information by type of variable rate."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_VariableRateComponentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "VariableRateComponentAxis",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate Component [Axis]",
        "label": "Variable Rate Component [Axis]",
        "documentation": "Variable Rate Component"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_VariableRateComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "VariableRateComponentDomain",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate Component [Domain]",
        "label": "Variable Rate Component [Domain]",
        "documentation": "Variable Rate Component [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_VariableRateComponentOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "VariableRateComponentOneMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable rate component one",
        "label": "Variable Rate Component One [Member]",
        "documentation": "Variable Rate Component One"
       }
      }
     },
     "auth_ref": []
    },
    "iclr_VariableRateComponentTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "VariableRateComponentTwoMember",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable rate component two",
        "label": "Variable Rate Component Two [Member]",
        "documentation": "Variable Rate Component Two"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableRateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableRateDomain",
     "presentation": [
      "http://www.iconplc.com/role/BankCreditLinesLoanFacilitiesandNotesNarrativeDetails",
      "http://www.iconplc.com/role/DerivativesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Domain]",
        "label": "Variable Rate [Domain]",
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "auth_ref": []
    },
    "iclr_VehiclesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "VehiclesGross",
     "crdr": "debit",
     "calculation": {
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Motor vehicles",
        "label": "Vehicles, Gross",
        "documentation": "Vehicles, Gross"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VehiclesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VehiclesMember",
     "presentation": [
      "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Motor vehicles",
        "label": "Vehicles [Member]",
        "documentation": "Equipment used primarily for road transportation."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1111"
     ]
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "calculation": {
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of dilutive share options and other awards outstanding under share based compensation programs (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation."
       }
      }
     },
     "auth_ref": [
      "r1203"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average number of ordinary shares outstanding for diluted net income per ordinary share (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r319",
      "r324"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average number of ordinary shares outstanding (Note 23):",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average number of ordinary shares outstanding for basic net income per ordinary share (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r318",
      "r324"
     ]
    },
    "iclr_WorkforceReductionAndOfficeConsolidationProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iconplc.com/20241231",
     "localname": "WorkforceReductionAndOfficeConsolidationProgramMember",
     "presentation": [
      "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Workforce reduction and onerous contract cost",
        "label": "Workforce Reduction And Office Consolidation Program [Member]",
        "documentation": "Workforce Reduction And Office Consolidation Program"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r1109"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-7"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-8"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(j)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(k)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-12"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13",
   "SubTopic": "20",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-13"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "310",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/310/tableOfContent"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "420",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-10"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-13"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-14"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-2"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-3"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "37",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-37"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-3"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-4"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-6"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "30",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-5"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "30",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-6"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "740",
   "Section": "25",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479172/805-740-25-8"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "740",
   "Section": "25",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479172/805-740-25-9"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-5"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "25",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480238/815-25-50-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/230/tableOfContent"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-1"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/805/tableOfContent"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479613/805-30-35-1"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/815/tableOfContent"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r182": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r183": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/942-320/tableOfContent"
  },
  "r184": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r185": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r186": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r187": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r188": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-29"
  },
  "r189": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-29"
  },
  "r190": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-29"
  },
  "r191": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r192": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "321",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479567/321-10-45-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(1)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1403",
   "Paragraph": "b",
   "Publisher": "SEC"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column C",
   "Footnote": "5",
   "Publisher": "SEC"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column C",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(a)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column C",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column F",
   "Footnote": "7",
   "Publisher": "SEC"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(A)",
   "Publisher": "SEC"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(B)",
   "Publisher": "SEC"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(A)",
   "Publisher": "SEC"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(B)",
   "Publisher": "SEC"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(C)",
   "Publisher": "SEC"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 4",
   "Publisher": "SEC"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-7"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-12"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-15"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-19"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(n))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-6"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/320/tableOfContent"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-10"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481664/323-10-45-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-4"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-5"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477123/405-50-65-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/420/tableOfContent"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-15"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4E"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-5C"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480627/815-20-45-3"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482477/820-10-65-13"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482477/820-10-65-13"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-1A"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-5A"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/830/tableOfContent"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481839/830-10-45-17"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481839/830-10-45-9"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482014/830-20-35-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-5"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481926/830-20-50-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-21"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483507/832-10-50-3"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-5"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-2"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-2"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-3"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-12"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-6"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "12",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-12"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-19"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5A"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5A"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(1)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479294/326-20-55-15"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(1)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Subparagraph": "(ii)",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "1",
   "Publisher": "SEC"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(ii)",
   "Publisher": "SEC"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)",
   "Publisher": "SEC"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-9"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1208": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1209": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1210": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r1211": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r1212": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1213": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1214": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r1215": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r1216": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1217": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1218": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1219": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1220": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1221": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1222": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1223": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1224": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1225": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A"
  },
  "r1226": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r1227": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r1228": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1229": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1230": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1231": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1232": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1233": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1234": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1235": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1236": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1237": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1238": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1239": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405/tableOfContent"
  },
  "r1240": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1241": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1242": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1243": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1244": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1245": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482047/420-10-45-3"
  },
  "r1246": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r1247": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r1248": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1249": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r1250": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1251": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1252": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1253": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1254": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1255": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r1256": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r1257": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r1258": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-3"
  },
  "r1259": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r1260": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1261": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1262": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1263": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1264": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1265": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1266": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1267": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1268": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1269": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1270": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1271": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1272": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1273": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1274": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1275": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1276": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1277": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1278": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1279": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1280": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1281": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1282": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1283": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1284": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1285": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1286": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1287": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1288": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1289": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1290": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r1291": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r1292": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1293": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r1294": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1295": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1296": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r1297": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r1298": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B"
  },
  "r1299": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4K",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4K"
  },
  "r1300": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480682/815-20-25-6A"
  },
  "r1301": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1302": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1303": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1304": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1305": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1306": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1307": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1308": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1309": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1310": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1311": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1312": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1313": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1314": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1315": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1316": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1317": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1318": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-1"
  },
  "r1319": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481926/830-20-50-1"
  },
  "r1320": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r1321": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r1322": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r1323": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1324": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r1325": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1326": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479365/842-20-25-6"
  },
  "r1327": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1328": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1329": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1330": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r1331": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1332": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1333": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1334": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1335": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1336": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1337": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1338": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1339": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1340": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "940",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/940-320/tableOfContent"
  },
  "r1341": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1342": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1343": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1344": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1345": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1346": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1347": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1348": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1349": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1350": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1351": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1352": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1353": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1354": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1355": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1356": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1357": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1358": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1359": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1360": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1361": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1362": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1363": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1364": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1365": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1366": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1367": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1368": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1369": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1370": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1371": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1372": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1373": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1374": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1375": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1376": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1377": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1378": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1379": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1380": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1381": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>155
<FILENAME>0001060955-25-000016-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001060955-25-000016-xbrl.zip
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M&(T+SG&L=.($</G4% J,N1(QB2U0$MBI"^:*'G>X*42)A'DDY.U.IHX-O)B
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MSNA[S#4Z/N08C#>FRM%S: RG1D-!.^\;GB.<G"H$,*U]A\$AU;C5.N@0<+R
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M=0L'IU#U.;1V>AKE]M?^#_5?N_\@X+]02P,$%     @ JXA56FH6GQU5!0
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M+BSSO7/:Y5OXO;B&L^Z%/V/_#5!+ P04    " "KB%5:SC$'BQP+  !J-P
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M?@1P1(<,L0&>Y[L(\OQ4OSZ56)SJ(\/3\-57AC,<5Y?E\PO0LVB<Y<2Y^FX
M8X>M'A)\P&^$U.Y8O>AY'&]UK>(N.KXXCC9Z&QY'$1J+[R(^*6)Y"D+3>:Q
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M=I%8_:7P='RJ7.EMVI-O\UL(!VB J[Z04B@5\E&PKO!Q-_'=@OR+?1 !7"&
M@J$4N/*%KW/:.GWB=6[@^(W,\P27^HDO>Z>;$:TCZ'_DH"^>]S8?82_,:W20
M_=?^&D?K?XW6!EZC=3Q%C_L!B_@[> </Y0%61DQR$<'YV*=7>#?.+KEE8^+&
M1Q9Y],<_@.-A$Y3*:*:2TFJ='+R]/9K6&*^+>C7B/0XOX7(YXSC ,^5<DG4"
MRW?(!#J/X1#X]4"*X<C'PX8^&T3X=@7-7_\N/3@7Z'G90_0S99A$]"\ZML^3
M0,2T<(GO*0_,YT.@;!+QM^I?ZLM?7A>_,__&>TS=+X$U3-Y,G^OG7^_?KW0O
MGD2PR42)])YPD F/YR_]K*0\C.8]]NKKW:+'3OT>/WS/@W (7#SCMLMN3>$6
MKXNK?V('RWCK)S;;MK?FP-SAF/-IY@$6/[_2WZ[$/G[H*N4_\Y8?];<KW5([
M,;/O>*F^7.F&<$1U>31'_$;PUY7NAB9W1%;-[!5FWZ]TVX<PGD,7_&:E6TG>
MG[\\_>4R-]0J7A$%3"+S.2>CR_P+N [^W1,\<DBG\ID>TN7UWXO&V.2/TQ44
M[SZB \#\"RR5*'X/1R#9I8>-)OR?^5WV7;I,+[L47/!V,WN$^L;\VSSD=>&]
M9V]#:]W;H-]&D4G]TX.'?1_YPA7Q)XZ\['ABB&=]&.3-X O/ \4AN=1_0;_F
MXKN @P>O>9=(\%&E1*^'N?I&O[R>>?]T*])E[ 9QVA;PJ'+)XQEO9KYYSIL=
MV?5F[?+>[-B"-RNP;GMYUFV7Q[HGMFU#:_EM:)6W#:>VJ=?4G3&>U]6?"?IC
MX-.$ ?Q3*@UK+H//AV%P'X?NM_(U;$X F^4)X-F.;SF<=N3_@B?,A'<=7+*1
MB)F_*]O?V='M)VN28@=? \\X).#L[];N-QL[NOTI][MN,DQ\W'HBQHS@X\[0
M8NTNQIII<<=C!C:V=\6B0 1]N3,;OW:G9GNOMG:78.=YR@*KK[EV]V8?M; -
MA%N[][;+]KH-!%J[7[DOUKT-Q-I5[W?3OH -M-IUMWE3D8I6B<;<KOK*VPQ5
ME+C_K5UUEK<8JRAS^W?=/]YVK*),6EB7![3.KUS3QEN6XROSU7;="]YPK&([
MB;K6KKN\VX]5;(EPN^X*;RY6L24"[:K[N]U8Q9:(5?F_&R^5:57^[U;WOUWY
MOUO=_LK_M8<6E?^[I8VO$MHK64=;*D3>=5=^^T[BE@BWZ][]YIS$+1%HU[WX
M[3B)6R+6KGKT6TUH;XE6E4._G#%78E=/NW+HM[K_1Y5#O]7MKQQZ>VA1.?1;
MVGCK''H9Q=FF_\;#?L1& ^$R7VVX[L\__WH_=W.7INUE&+@<P7OP$+D3\MN[
M<=:UG*+5I$N8NOP)(K]D'>]XX Z&+/I67,P]\[F\XP\\2/AGOI]MU$?612^>
M8$G\^BJ)PM%3ZK9BS-UF3.NB,T\P9F:G9=\94)2G3JB*5W>;5ZT-5-VBHHSB
M\:T/-LM%X*%=-<)[S.*;=XGP$5MU9\PIZT).J"+N$/0L.ZL^B4 ,DV%9@K<4
M035\TG"4Q#Q*KX"KM=,H_LV]^[ 7/[)H=YP6ZV)6LXC-OE?$+H/8U@;+5E*H
M'Q+P3^,DXG#A!_$=_[8SONJQM?&RE4B0?KDS^VYMH&RE??\'!_/3WR%VMS8F
M]@$,B)A_% _<NP[@_?H(^WHA)8_EN_$G]J\PNO29G$R0)#(.ASRZX[YR0 9B
M]&(GY-G6C3U4MBX MQM47LJLL8?*UL6T7D3EF\CCT4T$ZM=+7"3S.^9^\\.G
MW+0?09RMBQ'M#*%W3**M#; \B]!?(N;QSVRX0^:1=:&6%Q'@/8L9CAK9G?VW
M+OKQ,@'@[B (0;6-:23 Y ]WABK6A2F4;L=-UZ9AOHCD2SBZ],5:?&$+@O G
MU@4LK"#&EB".K8MB6$&,[> 7G5@7VUA(#$4)V3K>3S5E70C""F)L24U9%RFP
M@AA;4E/6>?/+$..DV=A//66=RVT'-;:DJ*SSO^V@QI8TE77>^#+4:#;WU:3:
M+3=\<^38CJXZW2U'?'/DV-*8G=URQ55SC?EB+_75Z6[YXQNER)94UFXYY1NE
MR):TUI8\<YP-[,W/=NA"]CL^9")00XM[833$H=HW75_TF9K./.)NS+TO8@B7
MW/3NX5/98Y32O3?;I\CYRWIN7/="O _2Y-B0;[U/2MDOMX$696I.MQ1;V#MV
M.MI==BH1F>G4NN!(UL.A1K]>N'\F0@V+SQT<?[^\NZ]?_!:%R6C]EM798;.S
MG&55N/1%IX9U81(+Z%+0J(6M?I$(6!<#L6VKR],VUL4W+-CJYVN;TFS4,^L"
M'1;290O^]9EU$0_;Z+(=+_O,NKC'<G3Y/0%S]H.(9'P=N!N1F&7MIORE+Z*,
M=?$/*RBSGN/\S+JB _LVN\#9+]ILZXH*EMOL=R*,N7_')6>1._CX\7+M)T*S
M<=AH+7DBY"]]D=[943]Z ]0I!B[R&_XB<=A1!_GV[N)WSOQX<.\*'KA<;NHD
MWKCMNJ-N]18(M"4C=D>=\2T0:#N9H\Z.>N4W@<O<=6-T@,P<';8:91PEG1WU
MLM>WSY/:*;_3B[53X=(7,;^U+O8')J)_,#_A[\;I7W^'.Z(!-?[('[@_@9UB
M+KH.1DDLZ8KF2SMA9RSF$V<RB0C3[4/$_TQ -X[GK"1WJ;SC;A)%.P26U;'6
MQ2^#,UH59SR?,ZR-1Y3!&>V*,Y[/&=8&3Y[-&9H>WD7\F<?4;4P?W_+H?O"T
M45 QRP)FL3:6\R,2P]HX3V4'/B\"6!IG6!M@JNS +7.&M9&MR@[<+F<T&];&
MU"I#T$)NL38R^$-2HPH)+K.8]["G#RRF84XRCA)\%QQLD(L<7\.^1ES&=RSF
MEVQT$7CY3^X?V5-E6TLOYG?N]8''WG,I^@'+ MC98M47H+ZDOC9;=:6Z7B L
M592T$I9*6)84EBIP7 E+)2Q+"DL52Z_DIY*?Y\N/M>F%BC\K_@3^W.N,BT71
MT\]A$.U:.J[9V.NLRX_(':7J#GLS+YL:2V./J#;MS77L!C'*E(RFO:F$#4YX
ML4@X[$TF[ P]2I4/>^/5%@_&*94"]@9![9V,4RH![ VL[=IHG%+)8FV\QO*3
MPH(FU&;3WF"&;<>*%>2R-KI0%N#-OOE()0*Q-9O61@]V@_I;<LK*8X"6M1&+
M'<55*D\SMZR-7Y0+<+)O^KE$R)5FR]J8R2[QP+9"->6Q@;6AFEUB@RV[Q^5Q
M@[5AHPUSPY:FT)=*2VLC4!;0<@.#YDNEI;5AJZTCTMD0Z6A9&YBRBSRKP3F6
M1QYK U'O>3?."MWRHY]Y-/P8@A_*7.'#BLNR;CZ&03^&>^.#OXQ'O&C&W&.-
M"O?PRYW)_;:LC3/]H,0M,UW3MC:&-)>X]SP08:0W^S/HUZ>L_]+(2\]-NF'D
M"2JE7>;A]LAQV]J85$7JLJ7:VM#3<J2^XP^A_R""_N:5^$>PYFYZE[ (L3M'
M=-O:&%-%[[7(M[51) OHK6AI[EJD=OK@XD5[QFJEJA9K@UP5JUG :J5J-6MC
M<"L8J.\3_HF-86=.]]=4+56_6!O9JXB^/DG?O7CA J)W]I?HI4KZ[L41?TRB
MERGI1_L07S1$;Q_M+]'+E/2C?8@T_@A$+U72K8TYVK?O1X>-X\/&63G[ON.Q
MOQ_&@"Z5Z#L> /QA;*E2B;[CH;@?YE@ME>C[%!3;.Z)/UL;ER?[$#._\I2\J
MOCK:O0C:?M?G- \;I[D:R9>)_XY'RJKTR^ZPVH['YRI66W.L (^L<JKMCW<\
M*CC!#8&WO4*UW3O2CG<O.K@N>^4?+!*LZW-$@YU)V)L''@6B/X@_@!D;N*!C
M"#@V[$7I-]>!Q[\CE"Q^LWX+=QO='\?6AA8WQC&;;)>S@N36136)K'F!O0R'
MHS HDGWF]S=!B9CH6[>$YNLL[,Q=0@D]B]?7U4YH!:];%\RM>+TD7M]5CK0N
MTEQQY#:U[UY;&M8%V)_/ZU\>PQ^"U]?C'2TE&LKUA[O!T^[!"?98Y-V&820S
M<2E\_.Z=NG9/A<>ZW$,E/'LE/+=^(O=:@*S+[U0"M%<"] Z,MST7(>OR5I4(
M[9<([;/TG%B7BJND9[^D9]]-N),JGVE!LOKYG-!HE\8)59[2-DYH+\\)[3(Y
MP;KTY0_/"2#H1\OKA)/#=J,<3K NN??#<T)[>4YHE\D)UB75?GA.."J6M3VA
M$SJE<8)U*:<?GA/:RW-"NTQ.L"Y_\L-SPA%!*&_>B[0N$?##<T)[>4XH$TS[
MQ+IXMD5!L1^T#\.&.->I=9'BBB^MXLN58BTE\N7NQ5\KOK26+\N+ 9[N7C2X
MXLN-]E.VR\)>.MV]<'/%:AM6@=L(>9[N7O"[XLN-JL \J[U,!>Y>=+UBM0VK
MP&U$>$]W+]9?\>5&56"G-!6X>\F$BM4VJP*W$M ^W;W41L67U@:T2PS05(F6
MBB\7HGB6%J YJW(G%:M96)UX5N5.*KY<J )+"]"<5>F0BM4L+,8\JW(G%5\N
M5(&E!6C.JG1(Q6H6UIZ>[7CN9,\GPY<)OGMF<3HB$@\L%@\\(_B=D-^*^W\-
M;Q-Q&5/?-QN51?3?N=<']?*>2]$'JL)WQ<>:+[AW(?6UV2K72OS68;-YV.J4
M0WR+$P2K$A^;VG=GXZV-@']@(OH'\Q/^;IS^]7>X(XO<P?@C?^!^D03I1=?!
M*(DE7=$J2PH7<P'I_0GYOPB\%9EB#U1"F:,:SRR.@5?GP<R$<7G$[U@<E5[#
M>5!1OTA]:V._U:'T@W.FQ:'BBADVS0S6QF>O S<<\OL8=AA_^3%T9Q#AGOL^
M;/QO/ #]Y0,W7'A#$0@@ ['1U?<1W'83HPFWT3+8L3;@N4.TVU);7<?:H. .
MT:ZU/.U:9=+.VBC?4K2[#&5\T[MG_M[J16L#<9;19UNZS]IXG67TV99^LS9J
M=?'((F\Z;70U'/GAF /A0O?;S0A)MI>:K=6P-J0TAS)WX)A%P@4GB6CS-1"Q
MO+O_NJ?4L3;D,T$=\J1O>=0+HR$+7'X_8!%'VNPI7:P->%BCS[9C";0:UD8?
MK-)GVZ*.M?$%2_39MNAB;>S &GVV'<NYU; V,F"5/ML6=:R-"UBBS[9%%^OB
M 31H S?]CH^2R!TPR6^CL!^Q88Y [Y)QE[G?]!<O33O]8&.96PWK@@P_&-%/
M#UOMY8A>N/1%1&]:%[]8BN@?>#=*6#3&W5AW.T0+1"-]L1=D=EM-ZZ(12^WU
MC1N'\+L-;'6S<=AJE;/5U@48RM=E.WK,-*V+,-A'FBVYL4WKP@OVD69+%GG3
MV@@#.:R)&R<1]JN%,KX(//B,1P]YW^F/,/H&SI,+A/3@8DSA!=Y-KR=<?AD&
M,O2%1XF]_59]U@8C=I&(VU*2UL8L=I&(VU*GU@4X5B/B+8]D& 3<O^,^%KQ^
M%*R++<)BS:V9);;BM)K6Q1MV@P8E%ANW6M:Y_ZO1P'3&F[U_JD7>'NYO61<,
ML'GG2^5Y.V,#IL3M-X[G[F@@7*;;?MPP">)H?'Y]M6\&<<O.6,!62;$EL[9E
MI^^_55)LR3AM6>?K+TF*K_=[IZ"L\]BW3XIM*2CK_.[MDV);"LHZ[_D)4I#%
MBG;M3>\JB<(1QY!'/.#1)=%H+1Z;%>K+.A?;=D)M2;FUK?/#;2?4EE1?VSJW
M_>5F\I./*#9C?6'?+Y)X$$93L(4?PHB+?J!88'=",>U=#0@LL"Q>0-//;#A1
MDTJ #@'S[_@##Q)^SZ,'X?+KN_O=(?&N!AK60^*)UG%<!NAO;*[T_RN)A/2$
MNYZ2\'61=U>#%_LMP65&;=M[&!19FL1 W%O:K)SQ!9_]DS,LRSO^$K8:[;.7
MEK[:ST^EJHP]C.SL"C_MW?&SAZ&I<GBIW6DUCMJ59EJ)FW8MNK8WW+1W>FG7
MPG_K"9FO:7>/K(O9[7F<YFC78F^J?6:5J.@/3V+K0G%+ 5&98^JF]RZ1(N!2
M7KA_)B+BWG[FE8ZL"Z<M3Z94<M[Q@/?V%6'GR+J(F*&0UH?#4<0'^!U""R-%
M9D.[S;MZ3ZEF79#+6KG:4J+VR+JPT4[)U;:H9EV 9A'."+;A)#X:49(P8&Y]
M%K0:C3/\[SHMN>8I-KLWC\JQY*R+8EB\Y>URMMPZ=W_1EA<@J'"?OSS"3<?_
MFT?AE>@/XIWB]F-K8P';Y_;\ 3"YZ0L.@,E+7W0 '%L7.K!/-*R@D[7^_RPZ
M*> \I(9$\7EI;&<6]I (UH\]M#5B6QM%* TU<7TT7^U=D$@YQLT^\WU,K<BK
M[ZZ?>"+H XF?XN,7<5NSTSE=V@< ;BO/!SBV-B*R76Y;"MVLXK95N<W:2,[F
MN*WBB0F>L#9VA"9,5DJALAD#WFJT&A]YG[GCV[N+=;MCK<9AX_BP>5:..V9M
MO&?>3C?/-K;3S3/<Z9(2=L<[%>;)*3><D(57D/6^5L9NEI@?/=ZI$,_FMMN&
MUJ"3G8H!;4446B6*PLE.A72V) I;RK><[%089RNB4&9OQ,FN!%*V*0I;2NF?
M[$K887NB4&8!V<FN^-UI _7DL \5Z_\R$%',^;K#_,?D="WE"4]<^C*AL-83
MMI%*&AG]>$G5E;_T952RUHNVA4I3Z/7'Y2BQG7*J<]GD^33X+ *^;AHT.Z2B
M3LJAP4YYVF72X,F%8-K@BXA]?M.[#CSQ(+RD4/'^.0SX=^XF.'?\O8BX&X?1
MFL^QSO+&7:-$X^YTIUS^VXW,KUJ3CW.Z*^[^Q@>YK6O#=\J'WSAOE^FTG.Z*
M_[Y-WBYUPW?%*7_9AB]UDF^JXFA=I-P5AW\+I%S7X+IUD7)7H@+[*96E&@^[
M$CK83ZDLE90[%8QXAAUHJSR6JEIW*IJQ*2+NV/EXMN_1!ELEL4QU>K8K<8Q]
MD\12B;BKL9%W3'+OMPCCQ#M*QE(5JG5QEU51M_>S9N+,NO",97394EG7F76Q
M%LOHLJ7*TS/K B>E V/MJB:S+@YB'66VI<NL"VM81YEM:3/K8A5(F<O\;.1K
M()*< -2!=X3O@OZ]NNV>*K2.=3$(&XFS)9W6L2ZV8"-QMJ36.M;%#+8R8'--
MKGQGUUSYM>]NF?&N3N60;XR1*Q][8UR]:V[SVN'12]W=RO7=H-:HO-D-<K9U
M#FI6Q>+#CGNW8-&.OT0LD(P&5LAWX_PW$V,NDJX4GF#1^*9W&0Z'80 7P6-?
MFA]Z8DV%YH7H(9&W Q8-F<N3&+ED/]WG=L,Z][EBG=UP[ML-ZYS[BG6V=N"W
M&]9%$RINV)I%TFY8%_W8;6ZXZ(GA, GX1S$4\9X.<6DWK OJ5$QCOQ5B77BJ
M8IJMV!_6Q<XJ/MB*Y6%GE ]KE>_X*(G< 9/\-L+PTS"WW1]X-TJ W#CMN"PB
M(Q/Q/Q-8Y=4#_#'=8S1QP5II?$PX[:6@J;8;U@47]VG+7XOOYQ&7(? JE^J?
M \X\6H\G'M[^ G\0)<1IHWW6Z';/SESF'ITU3SJ]5O/LA!VQSE&C<^0>_Q^,
M$&2_D?'8!XH,17 XX#@VXKS=K!^/XC>/PHL'Y\U&XV\'A2MQ/8?,%_W@_%^)
M!-J,X7LY8L';7[K1:[BU^KMZPM1S<K]V8<=XM.#'Z_N9^=X-_3 Z_TN#_O>F
M!YM]V&-#X8_/?[J(!/-_JDE0PX<2B-)37TOQ;WY^!MM#_WI4.W8*/_9%P,T.
M-ENX:5\_7W^Y>N_<?[GX<G5OYQ+OKRZ_WEU_N;ZZ=RX^OW>N_OOR]XO/OUTY
MES>?/EW?WU_??+9SW7]<W/]^_?FW+S>?:\[[^F7=:36.CSK;7NO1C+6^H6=[
MW TCJFPY3P(06KSJX.W_*>5_VW[KV13Z<'/WR?D%M%00!I^3(=S#=;0RN^,]
M/#":!T[ \##PN#A_'[K)4.OF ])C/;@ ].7A!])UV5W>.G:^\*M/+/KFW 3\
MY[6MS_D:"#?TN//I?LY2.TLM-=W!]3Y\ECC &Z_,$W>\+V2LQ"?-%1XXU*P4
MPX'W/3[OB>_<@_7Z,N6>UL';__Q+Y_3HZ,TD ZWG[9=1!L_<>FN?.)N]\O2"
M!VJ".6!FRP1,'2<.G7M.GHW3;+WJ_NR$D?.J#__I.?& XW=))&+!I7/U'0SS
MH,^="S?&KYN=]I&=TG]S9Y'4ER5X%T&0,!\<I#":*6]QE*3BUM;B=K+[XK;Z
MPTM4LR]ZHB*8$Q'%9@M<&Z6M>>R\\G9;X#[ :^#B>T*Z\,ICSB*'@VGEG3_#
MZK@EI^M*13R+G.[!)X=#N,4 ?W;HL?$A/NN0!X;SCU81K<LDPHC1!UHU3K19
M]J'9\XX/WK[G+OFB__F7YDGC#<9HBB)7<S".MR.&TUZJ3@K?"12Y^>JS8*Z<
M;-E<L46%91NWC!K;=2VVE[Q_/^"^CT/#63!>DOM/2^7^E[$\+1_>D]8_BPGE
MLYFP;B,7OCA",?>EABSJB^ P#D?G+5C(5B4-\S5"8ES8^2!\[@!_P0&ZBK%P
M1?%=_+'ZK>'=LX.W[7;[L'%VVECAR,WMS>F<O8E9%Q:JK^^&$5#E$/;(9R/)
MS\U?WGA"CGPV/A<!O33]Z(V^>S>,XW!XCM'<!QY1M8I^"#U/?:T#O9U._;1Y
MB@(?1_#_GGFP#@/781-?3W_>.JMW6F<SOVK4FS,_GW>KYEG]['3V3[9X*WS!
M]NROS*U>TX:I30.R(,%_/6@?F(M'S,.!A><-ISF*]7W2RTZF+FN-ON.%TQPQ
M24)%O0W)$&4!KB]O/CNW7]]]O+YT/EY_HNCVY<VGVXO/_TSY//:6W@>];^9[
MDWV +Y^UE2M?ID5*"PEH*(<:$!VS>\]]VI+\,(/0/N]-2>HZR3QUXA.9E5<Q
MEZ(GDQNH]?N<W;."GV>_Z*NK[PP.9U3Q>$*;N!6<\DPZ]R/N8M[1<T3@B%@Z
MEP,6P;)_7H'5=XG$/PS76L68LQ7MJD9)QKDX--08)AVCL3]>SK.J]Y.'JQ/%
M?E+MZ8E"X0M?I3X*1\I__N6LU3Q](]5I(P+P(Z^"OB_D8)4#Y<?C"*N(7HZV
MO@[ U1Z%N82F:FX<7X9>,1 ,"W+/N==GT2@*'W1?;Q8);C9 PT?<9X%7*?A*
MP=M%JCU5\/^51$)ZPC4:OB#,& ^\B?HL$/^F?^^UK_":0DUV55NMKHPO/"_B
M4NK_?(3[-5/UVCQX>Q\F\< A_3QVWB42OI?2N671M^F<V\L?W4H?W3IX^Y&'
M(Q9Y,@X?@](>=@E_O8F^P"W31[4/WKY/NK"3#E:EEO2<VU#&S/_?8J3.-/VH
M(WA4\\SY[^.[=GEOI$[%Z7-3'Y?XL]R1>3SWR%PM.%\%9RVXU?+!V?(MAI),
M@;5:%':JZ%=:<O'X'$4B<,6(^4XZ"Q(^[@F7R_754;XHD;103;4*M1[P%7.Q
MN$2&0<#]?&RF>7+P]K/H<]^Y]'GT3<S0\)<#P7O.!Q$PV"'8H!O:EFC7=^7I
M8_>TQ&-WJ4=GQ^[9BX[=^0^;<>QVGG_LSG_.S&.WU7CVL;O@C58Z=EO-DHY=
M"QEZ4LROADSX>I?2]V]I<:]K<?^? NXX\MVZ&PZGDL;_G_-_K_)XVF^,-(79
M?H-1USZ>HO;A"K=%4D><%1@)[+>I6K,5[ODQ!!OG=A &$QGT%AAEK4X3&+71
MV(FBM?653&SW8,83JN;$W.<CI)(3$)EJ#D>6=D!X7X.#VV.N%$.LH5!?X^<.
MRXYT7?E#C(#IM1$)QL]/ED)H$^AD<Y4BLW<A5\,34?B61]Q#SSX.G2[/?[:@
MHEV5 UVX\?DR%2#'RAS=J$L!SGV]H>*7J_@4[4[]J'U2CB-P6N^<G)9R*UA5
MJ[/X5L\/L=D1>UJD<VC,.C(=9^[ <7TFY<LB3_:_LHI*?8D8OH(CQ\-NZ+^2
M+PRXV?_:GW6M A&:FQ)#T#N/ P&?9,JII-S^[N58M/H>-UM=$HO4R#C!<MOW
MUY\O[O[IW/]^<7=U7W-N+^Z<?UQ\_'KE_.=?SMHG1V] )YXX5Q>7OY>;4-F]
M;=22=4^"E>[A*984?+S[T3?'\)BI\56>_53B#KZ=<(/ O_Q\<?_^XG\YO_EA
M%YSZ>["UP$;"WE$>+]S6F3+<L7-_9R<2GF=8R<RPZL\VK'9M=V9SW^>;SU<[
M^TI/$AQD0Q]1".;+'2$=IFOK\?P.N[!$E4*;:53G:^R1]LO6KUFZ7?,Y8.5D
M6\Z+:)(74<)RP2Y?RE.Z#CS8L)@36;0S"$0*DQ@Q391AAA [,K58- F%E EV
MK^F2&#)8U54N&XD8]"*PBTL(2_ JH?L-"S+U;UT_E-S\0Z&EP*4/I#>Z8_J4
MY=L@TQ+_#Y&"4W*20"BMKA9W,*'IX<P"VTL,F2]_/;C^_&$Z!*:PGV@".$$(
MR9OLC8NM+K IAUY(QAS>$+@1& SNU4A/A,[!V[-&[?3XI'9VD@8_S%)G=K]T
MF?NM'X5@%!YJ^O;H?V_63&WGIL1>G&4?&L&>LFCLJ'V>CA5NA]^!S]P!![8<
M(N:#4+P89>7#I-T>N>\??@O"1U@>9S(,L)28&+^&[.QQ4#I#$:@"X[L$'+BC
MQO&,1B+0=_65DZ-_P,/_CL^^UX^^IB>GW=J-@[?_Y')NL*W<1K-E]S=M(-\X
MFSE*[YK_? YMV(FC-UMF=V1%(4T+'#)U8'0K6FV3G9HU8.3E!20(8_CDST2@
MXH:SOH<1174C65+/9]T!'K>+DALD7Y&E5U4@_PC])(A!]6+#6Y0F,MI-L%-"
MN_6&58?#XX"CQ3LI *^:/SL#. 60ZSV'^7[*^GF9Z')] =SS&6* ,N!X\!48
M8F0M1=SE9)8U6P[!"TCG%4;TX?]E N:9'(38XF+,JGC XLF%/S(Y+;;T8_T"
M/]<H(?"JI5ZP"^XO?-_]%[JYZ,[AI? C7(6^#TUSHT70(IF,G4[#\=A8KMZ>
MJ?$5[HQG@>6U2<:]K>K8VZ%C;^/*<I<T" H7R-50Q#%((H61HC! !]8?.QS\
MH;%SC7XM>A(/W'G/8J8ZGR<43':/_*&;MT?O>#_1+0WWAU^<5[A7IV]:[58]
M-5CA/ >],\+VN'4K'+7>5(]P^?/JUG%N8W!?M-)(M42[TA([I"5V05C)(?19
M! <S<UT0U@B!GHE_T1L,9GX*)G)P./T-'O_P"S@V,?+3=_I1^!@/#&#%EEWD
MY\ I1)?P<OUP5C&1PM2EUW;U15DTO7UT\/;C[#V=DET;6':;PEO]^;P_P8Z>
M%#\+.&F+)E+UI\U_?H838_K L(ICMW,N7<T^+;>\-:N>EN8M?J.7T(5V3X)K
MM8\W@:ZU](&T]:#F?.-).2#@M8PH:X6H'[VT_CY%LI48L <I"R,/ON+.HX [
M?*W?UYW?+BYN5XB"H@M'CAM(*H9#P;M)I,JF 1L0FF4^RJJ=I)[*C8W\,;X
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M2Z'YT^VXUS9=*OQG!V]38[2*8<\\>JL_5XB 72LK%S46\$+6CYSF6)W[U*T
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MD])G5<36=BJ=:GGLU)TO Z[SFWAD?L0$9]"OY'&/*%W)H^U4.FV8TJ!&W;F
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M 2^H'I@WWZ/@S]*();-.*N*/%#9<ZA849^*B[3 ><=RE!Y[+02/$X%#A/!>
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M:K\O0U[Y26)KD<8Y5JWNJI/-&&<N=EY'BURQ(AW;*HZU[Q;\=1X*@E)Q$]9
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M!JI0*RZES!1R<Q$>13KY8&9M1E RF#,E:\;@NR*6]4<,BTS/28@4KAVVG5#
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MC- 8=BBZ&H,"5I=AI&1<9Q")]909+]&8!X2X2K87+.*#6GU-ER'R48JUK P
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M3C-QUF4]-K=,KA<XCU8(2,N90$!9FJ-^F,>!A';12*K9UDA;6 2 N,]9+RN
MQFE+S,%,0J<H'@I"+7S#X8EO+19ZXB2;Y MI0;&!2@NI"*"HRE1U=K#,W8<6
M11%@NWJ@CZ(K,"Q&B@M1%.,14X[.;>T+Z>MR.L'_LY ;;<J.RV !*5]V<7*+
MM0"B#O\TP1AU\ML:)^]GG%***(<0/@H4()5^]H 7QK%? U]]P1<&NH.42DH,
M(M ,B8<':7([RIDVQ60I4;(%S*;Y%!+DUC@N*=,H,ZX22<DPAK'QOX^U60<Q
M>G#@@V-M?NM%<JW0C5QEH'SU93<_F$220%Q4M ,'(G@'A(_H3!JI'*>%^11F
M*L3T)7LBB""TY/ 5X:]HP=,@V;0N6XMI"64("(IDWWC6,-Y4ZGYZ1"1@ 3?;
MTQL_<6YX#PJ(M$@A2FHLU#8SK<"U)38.]4PY#TA8G4R-<__D;&$V\+B(KYX+
M&,M__L3?178^.[FK '&ROPZBF:=R\WK#(A3^BL)6^F3UU' 0 YACUQJ$ZYP!
MG.&Z;;@RY!)BDN@I+NJ#0JMU7</E'T%M]IX+3@8]0Z9I95$UD!X5=^6Q!!EB
MY92(RO3B8O+HQG\UHG;JW->YZ=#)JX 7KPZFA;\W7 .?#^RH;0P@I=#9<KI[
MO&"O\,\D66!5@-+@S_:ZBU0+34HM*5"GM S=F6RCJ=3/1B/>7QD-NGAVDB3?
M^;R!'403:B_:,]9AG+N-]_Y;^,A&H/>/D8"QOZ?E]2X&C=C_4YA%^I.X80[7
MX*/Z*$C8P= >4AAVO06\/8BG[9N$>/IV,O"G>\LDY/0P)Z,:&"0^G5G@-HT;
M.]R"I]7(7IN(S''NQ9T%CJNJ+\Q)%=0V47&6=1B!F+%$#1NMTQF/?EU[_KY$
M(O>R7!RE2H$DHRV"=9&7^9">NR(AM0C<LUTAM??T*'SGFGF[$2]+&WLO\'X)
M[4X(MSR>V41CC= K^>+'4HM#D>?J(O2Z =LREV#R<6>2#GP]*?K*0K5ID0\,
M;,LA?&27-'DAF0](\J3LV;+O"5N-%]V=& ^6[(N5D4Z5Y8]"CM18)SQK2 R,
MEOZQL7-<:NOPB3.$*KN"K>:)IT^2<MK@L\[-&Q\ O-=:>H+C-XO;:QL'70LJ
MN0G++WL36A]7HH+UC[HQMVHJ[G<GQGN[;!)+36R8OPXA&^&.,HLF\BXBSY_F
M@#N=!M!J"D'&*_;#;K;*:VK>^?H+(3CI7 8B: :)Z\E*;F8167'?!08^[$&"
MW6^=^/J$0+BUZ@X[MYV12.:=/F]5?P5O\(*)Z7+\7_?*IUN/GFT-A\^>C?+1
MXV?;3YY/=K:?/<D?Y\\?;SU_/-K]UZ/']Z[PW.MS2&2OCHM1+6/V U/^^-2]
M_WX'N>YW 8*!9?U:L4HW&2FA&: %]9"81F^ N[;J7(K>8B-:QX!T2L^*[S+,
MI2!K>;D6QSB!B$@NMT7>(-E/1NC0/GX*67!_PD[IA\%]=//MO0JJA3"4@&V6
MOJR0 3-:3J%0%G>Y7W@:(\1;ZORVYHRMG4*:_)HE5&IL28UB31N4%XD+?6Q1
MM4@;R9>5>GX>RJN+5"H:LD3"$WL]TV@MVFT57Z8G6LA0#IW]GI2Z]\<XFC2?
M"207QGHD.-&_-8YA2'Q9UH^B&X^_V-Q$R-C8G;^+95/UODO<CY5NK,;?0A)O
MV$MQ+OPT#FYU!-TQ7Q^';[,K,K0$,N;)_>.MIR4\#SO2):J4716=TA4PP9VU
M2-'FN6Z-BN9&,?9VA56_C<-ZV49KEH#^R&0G&HGN2R?9L6$LZ?@H/!?YM87[
MW+_3MLFOS+!UJV9>Y'"H_IS"2)BIE;-X3"D6/6?%#,0'B,FK:#Z3TKY>?HD4
M_-.3F"7!JGC0>-0L<!D=#MXVI:(;#!(^Q_F]!%VP6[5B8LBR2E",8D@&]KI7
M\O9>X0AJ;0M32*70J30;MVMT<7PS\2">^D@M7"A@>++-F[)&IB:PI(LA6EE3
M-QK!S-4B9#WKR1.8SN2N8W<#>X9J84@7:HO2&)9(7Z]:I]AH5-0U>FS$\BYZ
M1F]\3Y4P=+@&HN?@R02>AYON?)\Q&>HDT]&RAOXQZNB)NHWNH#(]0D.["%@K
M:D(KB5>28EH/.JE/O9C\&",WQU@ ZBC'(K@HY7I:#4$9>\3$]-27\UVXD&O+
M0>+=77G3NC9VB+ (Q?4_==7("\EQ0M?!6,!"@?JK+5@AOHO3GVSD0Z'[O+=*
M2!+8T:+L":'Z'3@E4GXKDC]<^-UB=1YT%IQ^AJ;<8%?&772U1C1HPJ'N+:EV
M@D=5!F+MCBY/"W(#-##V@B;%<1&=5"F)_4TWD/M:GCF=VVCHW-)*[(3-!EW&
MB%_&1%EZC%HL\7?!Z3SO/)EW"TN-$'SU>\&8K(K81PQ#H1=G_]U;W_CH#&\:
MOJ^[VHJ]*%N/M.B^_)T9.$\MVB(9%@Y6&<MDDY]4.7Q@/25O^I[]T%F=_5QN
MI&>*S_]CXS<K8L8P<2)4*,]=5;O@_-'60\)TNM_1K_L1\:E+/<8?MNMN)5E1
MX6I<\QE#6?OVT//NH\WLO52/M+NX9US\4!S7S<< ! *S6-IETQ;K'R]J]$](
MT[Q'^"X^JUZL2= $^51/=2XM(6%X,5!XT&X'T+K!_0S;<UXV[G-$\-^B;K/?
M>8N3N5J=8H[5$M&%Q8!'KA\T&6D&1SP38*FR$S?E:8DR530C QB7?40ZH]*Z
M8=O(WX2"AKWD%]1L//4 N3U0LYU;#36[TMWT&XX!X(P-A$D;*<$<C)=QX0D7
M4T+0X]&K,?&L8 "^W";XW&%VSWW@EH)NA>>GU5&NSJ]: ;UZ N3A2<03ZID!
M)59N\CD/?"&,P-Q]J8:ZRZK%GHMSM%-_&72K+RQB^[R]&YL#Y_K\.^)ND'.3
M)(OPSD+QMZZ$R&-<HM&[#6A&?[@+.B=BYB#ZQF?A>X'*;%>C5IMP?5E"$=VN
M_DJ:, %%+]B_0#0U*EN!H8S=J=)0J;N*("F6'_;\%^A/KTF<"I= (7-I%2'-
M'O7Q-W=6DD>?=?E[%X=D"Y',&2+*GNS;]>QN_]H^2%/0LQ@6197.MB<67:'P
M45O:<4*Z>G^)U-ZD4X0,4;);;:=Z_]T,XAKZ\,*<'U0I.PQ 6I0T*Z5N;E4<
MU(M2"EO8AR"N0\]#3"%&.-@D@C(&]M2I; -/]X+F >&6YLTTU>$&51B.1 OV
M2])OG!.$]?2S0%A?NX/X2Z"S7GG;\B[" X7?_JY>XW4XDZ]+^^I;:99I%E"O
M2&0J.IBB6-73++64^YQ1GT)+QV-D]'J8%OTGH20GVA"%;JO#NF$.BZ4]]&R7
M]5A;;13W8L5&[-I8RT=BHM&RT9P8>#M5'P/LDJVP )Y"VA\Y?[+/#2Z[J$<?
M-[,O"82_FK;[M^M2>D*>=>+G)YTZ%G9).<I)E#$7\GOX!J.\7?C+RMI@EF N
MF-(QP6#]RJ61Q2;\WOHX354W<"\0\"1? %$#&(QF)/UT =_"W4E_ JNJ."!2
ML4F%.AH/)S9-;;VP^!/Z]G*76?E)9&J%V6L@;8=POIHE7!>CD71&&W%P](M\
ML6@BB>?8@Q$GRWMH,NBRQNFOD=^%N\V;K_10"^25X&#A48;\BT(EA^54.OC]
M>_EF167VQC9 YS[:XHRS;"Q<'-)ARV<AUDW/P)#L8<Q3M=S,86OBJ6A]-P2Q
M(V.KUW3SPEP@1])Y>"T9J.1]W6GN?(%*0)HR(/JMO JJ I)12I]L6+AE<:2L
M!JM03Q)Z5"=1$M*O:U@O8/JJ EZ<6RMD99X5.1Y#6##A<&-X8,R,;?_:R#9=
MC=D0H'PYH9<N8Z(#V@Y64ZXQ M2:)KVE$67T4.*VH$58!MTO@-%UNZ658#RO
MXI!&CX$PXW*ZBO@'\48!V%JSBWS:"W37E=V+=K30YBKUV*^C)Q +-Q6?E 29
M%1([)WB.G)('27=3Y_RYM7OK[3*06W?X:D@\[75%W&/7T@DCO+%4G.(>LB,U
M5\"5_.4DX1-W\5:\RZ+S1:0K[ F<?66<YS^IZ U<\]3[UA*&6[W"7@A?IR\U
M'J0+)3 /"@&55TY4XJ]PF[^M#7%[#7<BE**&FLG."#>//*AQ9-DF9T%9X",>
MGS->%3+4V27AEZR./S;?;V9CE)O5U9X6"G4915^C,V -FFG [AZL+<=EWAAF
MS5W>G>.GK;WTGCZQ,/!5?FO*9',#IB##Z3*-D*99L6SJ#OEOU(V2V#OD/Q;'
MB-;QQ>CF>C&L7E,4\X]+ J4HRH@'G>0%^M91MN-^SWB34R-^7TFL  E@K-VG
MS]CM9&,BP^OK:A(QP35E*X(,P]IH*#[SZ+K-UN6,$4TEHF+*$*NCM!;A2'"5
M=J<.PO$54=:'RCZISR(:M323?<JA6D\6!?+-G]B$7(KT:_3CQAS13%4NXG/Q
M-;JD1TWMD<\D\6</-NKHV(HZ'(-(%M3>JZSFRT6;\$A'Y"UM$3UN3)(2C5E$
M2)Y$9?,<I270^/@K&:E*.BA[[DE;SY279,[]MV3&1%1@F3X*K:=E171#K!2#
M33@C'YW?':1K/X#CW[;JT;--%MC6Z^"%7[*=HK,=% CS3^)E,T'6FTS;6-0;
M/G/Q69*4M]O[#CG.GF%'O4/3G6/?,-D)<:W+$3ODH*@/FGSN9D%J6^5P&0N5
MN.M*^X0D/EKOHS#CA-K6?"IW3QA6LP=F9%[#80:'W1\54<OO%QZ^K;_YI[ON
MN)X]3-Q_0[.9OX,[4-QF':/K?O!^.J^E>;&UJRE^I>YU@])ZRB"5 G]ZIF'-
M>D^?4]Z),,F*)IV2GND#J$$*,IBG/(>_>]#_[8H/YFT\NN[.Z^<PMMZ1^YT[
M9U7RCWU,\<&@RL>$"XWJ(9DI9I=MNRS:A#+*3#BIU1:R> GIM]2;U70U;48U
M$FGJY$]^S?*V=H>DA4N'  PI^2=!_8MJH(P)W-T6_J<LSG\P7^@^+02IO"\X
M?8!./0_7U9D+Q/)(9[B_U[)L>V6QH=0LR1PS4CT3X2H^*GSX$\^.KZ:F#5NK
MTS' 3.TM#]S[9]M/!MG.UL[.(,1+$83!K0F6$O"WX$^^\YCGO1'=)UP@>W#O
M];N]>P]EG;I_8LFQB _3G&WO?N]L4U7.EC,^!]+A=?T1#HPRG]RASK8?W234
MV=7N'S/7@DH>U<V\]NPJ;C5^CZQ!V1:V%JMB(75$Q.O+QFVOME"DKC&>XI,E
MX4UNS1E7U<SM.1>\@/0>])T !2F*M]:+VTX=NLAD1IXGOQ]+Z$_L/$)23S,Q
M;=C9XW+,F$IL;G42&5GV(3 1<<)J"GX&<".3H^2%,Q=(VDB)[=$V-_ACGV%2
M[T@;-)PW4"ZL(N/A&.K]\Y5Y6W4UO%;<]3357QLEYKP0E32" \!QMUD1MJWB
M4S%:JMC+V ON>AXLFUM6QL39H/4+2X+L^QZ\Q>(B.%C',)VMXNK,ZTM\S.N0
MY[BT S&WSH3X1)&3#0/S-@+><8.\M*3 ?KWA7>$NN/Z^\^/OO7VY_^+>P^QG
MN?R>VPT;/R&\?NG"7PISW'-_^NFE^\B;>EQ,LW?+J2"\Q5E:^V!X:AR!XJM*
MB9QN'U9"R<Q)6 1TI[%G-[M:'3-N;#?>$E:,Z_EBW5W=(C%#(.>S4)K$WV=]
MFESQJE4%CY7G/G/_?#6W"OUEU)0\\FU5LO;%Q-*UKJR*"(,_]TV<B=MGU62$
M)4BP_,?_]^S1D\<_/MW=<L\_G8ILCC'DQGSY>6N<^!RU@KR/(H<:55."C$>L
MI01B?/]VG$)3#<GC0G0BZ"$7L3'M\6K=&Q [QCRWFUU9?8?PP6M4456!):II
M1H,-/3,PU<XWEG-<<M."1[DO0B#_Q.X;/3,<RV?(NWOX7UE)_DN6TG;V/WFU
M1/I:%A4<-+T>KE-41V53B\-71@=5IQ]=PAGI13 =.1]JMY+S.RJ%4RTVBWV/
MGAYB7DPD1 0J&8/9CA1,(U.*B$7PJE$EP,?!';E>BP Q"WU\#5?CHG2CJ2_<
MVW<;RMY+X%W*EA)8T9*)!#!\;MJM5(H@RCJE!;)TBVUF^4AKWVK/)MJ[X;FW
M<PQOV0I$V).,Y\>D05=US99C?U+X\1?CIS, 4^0N(,7ELCT=^Z->5Q_V1T%L
M6D+T3JRZQEV0&1E*.O RTL2.S;,Z^[V5<>"WZ%1J"<MS1O[ '1)!W\#KM_C"
M2$[B)#K3YQG@BO+4R-?X4=N+:0["!9F)DN'_^UW$*YDT%HJ+ZF!QJ"TU/!"4
M:"@>2BD=#<+6RJU;QS_<RE:TS)O;<E8X-MK"O%VP.A(E I.FZS4[N'\$[FSL
MA6SLARC2+%L!(,@.!I(3[*?D]>N*##'5!ZY2P1F[?R#CZ;8Y:GQ_@TC[:BRA
M;/5OWJ!_Z'&X%MBK2^=.39;52(_+BA*[U$[PDE.<0^2>06[0*E\[P*IMLB_Y
M,>?KB3ETB\)627#L(/!;+I:2[B>^Y42X6HA><_$,?<2F %]#X+AV?YQ/EVUZ
M@\#ZXDR:ORM3'%-GE448,V]/68G9_KH_T;PU2!#Y;VLO_;1TG[+73Q18%@9M
M)TRJ*0HD5Q:'K0B_MO:\-PCC<8YML^Z_/^LAZ2.1*E\H;7G*D*Q9J_.:GD6Z
M&D(CD\Q;24V!]N/ B,_P0R\K$P/+HC'"="4W<M$4X7J8_*BHPO.'ET+&85HK
MXAF_#2T/@ZQ%P.O&J)+//I"N"?>,K$EU_BH@0*WRA\5F,*X/T=8=MP][P.RW
MUG7UV8-CI82%7XFLB[-4_V:A^"0Q6V!ZDH$FTY4Z!VO-QF#E MJK%E&":9\*
M/=N+822C&%BK%G%G<L#1W_QC])KZ1%%-.Q_12@A?B0E K45WA)EE_FTF1]"M
MW:5_>O3HVM&Q,6[&06$BR*2!$$_RGV$:O#5M>[/D.%[V9@5Z.+,']VA'?][;
M^_W>PTBP%%DLG#3<>.Z_&]+K-,S;TAJS3=-;U7F']5AZ7)D_<]M6I'09 6J@
MVK-2LN5<R/UB5)>O$-3:>>N_!E=MH<E9B2QS*K:!I8O#Z.&JZ]?:AZ3"Y+D5
M[.:)*Q<>1"(E0[&V)ZV[GK]8^A(&)EQ6O@N-+5_:^5%>,EGJO?^6->"<2@)P
M)W8*V%#Y7'0$OD_I;56D9=7\7DD![(KI]USP4#;&4WE0UV,!3HMZDULO7/;.
MF2H673.H<?>70NK>F(HBUF/3,WQQ"[X-], S*(MWF[6'E-"KX@9]#JIYSX52
MP9=8\0B^\)I!XA@3!P\E9N<EZ+0[EY8H'1>=!DV"\]U SN@[+]L"B;HIZ^-Y
MI#KI/IF0"!A&2L4!_UJ.#V9>8]FNYTV,_P7-\S 7XYQVK*K/.TB:D)D1,LD4
MW_"/H(YE$1L-1KBK+\WN4L4#AP$5CB<E&+".@SR<%]+67'IV+ED .*2 (C@(
MD&-E6W:O,<9:5.5R+P MP4U?8"*/MYF]2,F<-8Q:I>D04BKXG'4X(_H(HNFE
M]C<"Z_;E&HC??3-[R\\A"3K39UFV(9'J5Y=1V%+!*)J37''IG)"D%->=$'6B
MCU#&XJ=UIHMQ=+U4FA'ULQ/MC1;VM*8YP=W4+5==B%K6F%L&I=M18UNY8W,8
MXI5+C&D"Y;,CKTR,HP)"9:9NG6%3L@^U]JKKTAO%=.-]WP*<MV"IPTI$-;12
M.3;TJ5GK: KW)XN $A]&:SHL_,* CKB=AF>Z!WU7M(9Q";-YM/3[5KE?.$:6
MDBZRY*"L5U<U. </>9_ S>Y1O7][1VO$Z78*&A"*<2?]'?B<%DUY<"#TQ?"(
M[/BFK4Q8?;K/SU8 _X)W$+[MQS<1PO=5ARP83ISXM?*&+(A&6'6+XN7&YE=^
M&W9!$B^=[6?5MV,7K*&K"'(W&ER5U"V=(DD\R<&N+X<"SRF$/P"UV-=G^=@K
M%%<D3 )N2]4F\\3XZS=7%7O.K5[_-1WA\U$-/=ZZL51#K]V?A^YG'#8W*!-_
M<:8_WS6.[E9H]TI*TO<-E-% K;A5V"],,Z "'-$Z!.EO$Q,YA7VQ#P$4\OYK
M)!"_G=#Q:K)JKR+5+Q3HXTCM#;D ?32G+CYZG4-#H#LPW=?R"("JW]H[: IE
M\8GQQP*22]:0AX)@ 6T*(&]8-\X+A',]=][()\9S;B5\]V2PM;V[Z9%_3+<
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MME[D"T\.%62ADW7.XN8)30V2E9K5\IX3#F;[-X5:R%[0:'>N_ ._CRJ# ,>
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MF@H8XD@\X!'T8:C-4+E!5'GFVILJ8R+ #'C'+Z" E56N8ZM2L?@C$F+/B@@
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M#G.6G[8(NB !AOC/#1GZH_!EW8@'GCX!<G9;=>R&^2@?%VBJ*X.6M M%PG+
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M)]&)43\9\TOR'DDG3Z<;)BJ3N:TQWLQ>Y:5TS,)H6=6#G5/LM56B'KE[5J
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MUBPKP/HXS^M\@X\/ZS"$PN$HVFY.M]>/0&:EM&K7F2N;_)U1PO.-)!)<4+>
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MOI&#]G:>$J\OE+5G45(055AJ5>U2K&(T-F*GD)U=JPCQP&"O66QL.$&J"J9
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MYP+,<42XQ@UDK"J3HHX)2-UBTAJR \)Z#W'N\I:=H=Z:<@WI36BB)G5Y-F^
M9E85VTS&^O)<V)N$HS:RW:9DRQDYFDJS!/$()/N24#] 5#98&8^I%(K^UMR.
MW\-.1TT\CDHXB^91HF_PAH"!3Y5+0ECJ^*:P28@)"H$B6]%MW9Y2A08KDB9N
M&5SW/E9@80AWBE<P2U'S.G++I(.T1MUP*6TW^5H'">>&XT+T_L1L(B4+\6'U
MR;I$I">QU>*J@C-G!A5GD^^]<K M"K:C?A3;Q5+ '6FQ%O5"&B, Y)>EH(^K
M<C#"V4F+&G:Z=<K\HZG1TLCD8D7^3L#UB1HW!']&)'19B3"C)KL'J$,J!EN$
M*[7#\+0,<4^J_A(95]&,3-/!H8ZY3"U!#P9/P$"1>&E6_J-ID\IT-[14::R5
M[%IPB>F$R)4O3MLR)AC629/H4UG,VA ,S%Q+PJ,,)!7KN9' ,!/$PS$]4>KL
M9$D^NGI.DV=)LJ?[G-D\<#Y-3(7(MH('M V;5WANZ'P7.?YM.EDF(AK]08%0
MK"&Y[NW9MD8'Z@7>O:<TGI:U[E;'I!_]<HXKR8Z;$V;E\M*/]OS]R_6@G#2<
M0U_M !.Q.B"_'H^B9?C%U#D.PEW#.=,+[;[@F$5XQK;W_KL02T_--^>%_C8R
M9$WX<_"_05XF9E. .M*^!#V-\U57CVNP$ULSIBP\,;UN*&#EB(77+D(+[\P+
MCVZU=+SXGD\W=B.^A=:G1C+\,Z <2=C<LGQ7MJDM"_E,37EJ O9-@[,2E4".
MHC78C.0$U<-( 2DFU2M7E+ZL.,2K* BO%1]M;!)R<,99$B1O.!E+PS#WJX70
MTR:UN-3EUU;1+RDE#0X>*ZR@^"UG/:VO*QE?-;KGC0N1396XD7H1*F\JBC1X
M=]<<.-)@  TCI\GTCC+*NUHU**IWL:O6H;G1_C19?JK&@_L#Q_GVRX'CW$[;
M_48X?P2[INJ-#JR(K S2TBE <>Q#*+7/*F%B5X[FH3^:,I1ZC)9"8F^N]@"!
M*)80-TR!AYP6&6[/]J09*TGZD(5/":A+:QX]@TJ3=GED#XS>(.OV,)N;I=6D
MK;NOH@4F<H])A+)C-60H$Y-2+E'Z3/V+]'V*(#BI#XV'$MZ 3UHK?381?FL\
MV=&, 3Q(GS)F@NJLH4M2?6'$PD1H!SIBF? >=XO'_@/]P]V$HDK^H$VB@%7N
MK2_W9ATV&E>KG6-<=G/B@<@PR8#*/)P90"Z3L%G1V8Y<H^SD)/+P0T%,C'X5
M317S1OYD\F/9SQ N\F;*=!N>IFSI#IX*$':^,H'>4Q'[ KFA-EF/-EFFZ-:E
MX$"2!Y+BT&QEU#MS(Q!3ELJKJU4\YD*^_2';VIH?26$&\-7,:L [03/H4/RT
M75+O-!JE*"2"3'<=G)'<!>3("RSKLFQ9]I:F1HJUKGQIHFV".S/K(I5 W2;>
MV^(87I]=&8/=F_8:*Z12"4 BA<;8Q4^9JN\(#QF<G3":)_"XHD2O7EB2_A"8
M8@Z#PQ=SRN!HT'R/I&NBYA2LG1&&-]+A28"<M L!$:2LJ_0QU;UTXX.!R-!G
M.PFW?5F!64?]'+'_KM[<)8\;J[0Z+Z>G]$MU>A[B:XV58\%!_.[[&P4?;1"]
M&;!CB_H-G1RA5$HEG)B(B[9&/ ?""*NWJ<'?VCFB*Z5MSZIA)G;8 $D&E,O<
MH[3WAY;2(A9-CJUQV>1&,U$39:)H)[$D%-M$$ONWA>,85TD(QT'+G":,D HP
M](D6F=25%L]%KF'-IGV.'?E)!7@.]E[_4NR5]QJ0MPPGO(H(UVL@["D+<[X#
MYF25D!!7E$::I6OUL5,Z40=8$[6EO2U]?N$HJ9F_*'F"17%680A.Z=E-O\O;
MC"*ED5$31 &-IN5^AWX5&+BK<B;.%8%A)]8,WBW'QM6%=UI4#5- TM[NOSQI
M<NH;%.C.XCL(\]3F"N@E*7T88? +L4-*FB];';%J07X*JV@'7R!<11^%GK9R
M%3*-ITDHK7&)H='P3HG[%QJ-66\9%D'$3Y+?'&MA(AURJ14-^@V5Z!Q48YVG
MO<2-)XW+X5+,,LKH&QP+27[ZF-)X0@?1L2L*O"YI4T[+2^D&9D )OT%YW$@!
M%IM9E[$7#C,:YGY<12L[LWA.@.^5N[-\QS?,<U2:,?L)V1(08C]4VEXTTOY,
MDN[@,&JW0'"%2)DF8$-A?.RS:A-F0,AZ0C3<;6Q^O7-F9(SAD+D7UWI!.J%D
M7[B6"8TLPTJ?LA2I],B3;; <8:-=*N82.$/8YYWBJ]>7<Y3*] ]?C1AL)*8Y
M_$QOJ[ $')>SLIX+81E[,C$5YY6F"'"96%[5)QG%Q#-3 G&_2Y.*D3=[[G:V
MN'#;GN)$-T;(83G0*L 1#*0D3G6_+)77*^5JQ79.K8J=1@-Z( TZ-BI)3*AE
M*SLGH,I7>OH#QXIL']5T(8L6T"!>.]961QGG@('[8;=0E)NK;:$%E%%T$[E1
MV?,3"WA&LR*O%M<7<EZ@@T/+>;3O#$\DG]7D2_#6G&_266.O1,QT&XRIZ(CO
MAXG ,;%G+(B";K.7ME2^V=F(X.4.#+^_5),W:60:=9 FX>6%W86F5N)<%'OU
MI1K E'EN"FUN@_^L@I%N5I6AK0@(4^ 8G/"^BZEZP)^FZ?O*@PU*"%1-,4-6
MV;  /2-**>=SL.N95@V&@'T]!)S_K@R^9,??9R"O6:AO*#@/^J^C)CSC%4OV
MR>/?MV:'__<E&WF21>Z* 1X-O)]-31A=>(\P<^$P7]&^N:][5RIQ-5K8XD_N
M*!M[*3MU>*6-;I>Y9^QLH*ZS+C1S^A141Y9#I,%UKT69[4'QU$Z#I!'-#K]@
M(CM8>S:>,5\V7HV43Y"E08W]  0J[5?Y=3B.L=T?GVEB+(4ED?A(DM=VFE%<
M +OVZ>.GSY+86=,N&BU(8E.'"]ZDH>82V4].U:A03AT,RH^H4\[IZVWI6^X?
M_QC%UF\%GS1?(.OQ8T<((@0=_YW<<]CPLJ/AV^[I$LS>._TUC@ =":?QIP*D
M3*6F!R*>4KLA1: >3[><G;15.,RE>LYR4*2LQJHT,BS?)PA94\P-H5I, @XZ
M3]&&$=8QO /1>G9[YWE#U9F[[=(B3_]+(XX;1NS83)KZ>5=.M-:LN(L7T[&,
M%KU2?)N$$X@:D.:L(W^&])8C"8Q!#FMDVWB<#:]564MS7 [:2G1>5Z?%[@0B
M(V*Q@J?Q6HYR>4AA3PY/N)QW(;2SA;BW^SHNO_%Y6;<"[\C6IS:@B=9W\)_P
MX:Q$-!TI,*X>HZN'*-C(-EQCNLJN[U<73!UXIGOU"Y"$#[%RUWMRJ#JFI.LQ
M'VVYD'YJO9(R.B*K7B&:IB>-:'^XD<-/S<2*$S1\IC!6ODS:%;[+-NT/GF)M
M6*Y*'((+KTW8[G(2//0T&']X9:3[:H#.)7=:8[1K.=*4B]NOE)?Q<ULD<4&\
M3 MB\/[#9Y:EL.%)='%\>N/P<*';<Z'[@X;Y[@$-\^^?JOD)0Y"W:*OF9+EP
M8*VU9GCT*78YN225]\6,KU!LT<@82Q-)X"C&&2O'R8B_J@M=G,5C:Y2"&7?R
M"T'C8GDR!3*_"?^[B@<C%!+0L!(/#\G/B!%>>_FR(!'%MC5(\\$C?==XZ%;H
MQ53/6"J$2L'H8)OJO;%NO/'M[3UU',:&NY/3([STM#J#.RLH<Q:7(S8/9:EE
M&X?,FN5'20=6TPX4CT[]5),*&!U_(,670X&ZTUH5W(+4!R=I*"GAI?/<C5#$
MG_X!/V1M3&]:R>\*$9?WJO\\B/S\U?*JYG=U51\S=M%L>#/A?-<?'F;GD\^.
MV?%14HNPJ7*$QL/HEJ:47+!&@BQ 0IW0'_"EA\G[Q)/G#@794%WEPM"1G[28
MN:M;Q3G<8Q+IWS:D'<G<;@M_X-W (@W"^QA)$;SV]/'3QVM90D:K@, W+NJ[
MK$XHG!0Y.XG&4WJ6E%#,?HR+O5KQPQK1[+P""+_M17I%_*)4U<T3^\:H6<\I
M$Q"5=2P"O\+PQE)'GD[-/2Q[]2<CJ6]=DT.-#0&X%=\DQL^:7'"9:.T=&T/F
MIU2VE7I1LL=,NE#F9'?Y11L&C8>T$<8>"Y-__>7'/8N31P6I1N%(O*GFQ6&P
M:6/TT0-]>5%%DE-)LP'X+2X124=!\G+2M*/<=Y5NJ;X.Z[95?5B,Q\V7W##0
MS"]C^F19CI+X5\T9^II#*A^"W9@I2;RP#MU1S L<1)-1;/UX=##B_#Y*67>I
MR;\IN[?%RZ8588*]*;5JMH\TRY R%R_J;CQMA /&IN7-WLL7,7UA3N' $=P=
M$UR/!SJ.^7[)-]EECG>/G\?+P,"\V[D=Z>E89Y?A#@M[%OQM\BA(1;)MI8M&
M#E 24:F V\CM&%AL(=&S?\ENEN;RM6133.C<_ )\(23!8:%\,[*]36VM"39=
M/45Y=U9-PG)@R+,_;OY>3NJ,^%$M9L?"*+_UW>/_"O&U+5^\Y'=/W5^^&<D0
MC)NS>6UMOK1^&^)+\KZDL"+2%*8F) $PW-D\.2LF;Y(BR13PU'&YJ ;KR)-F
MA#&; J<LF2'?"KI^:.2)U4G<]/FOPI2WY:*>@,L+\O0Q_M0JH/,V$V0[NP(P
M1EHR)^@L@RR+5@C_*X2(!B<?7@)M(4L<_6BFM!X3AN@$?:/>C==/;Y1LY5X,
MQ@?6*EG/9.]2LO;X*)F[*!>V_VLR??M[9D&+(W!'NHL<+:=&!UYW-UXD+,A$
M -Q,>%?C3/IXV^268KJ?1T?0^22FC2#8G2<_;'!O-C@FQ^[W+US=[L>FG*Y#
M6>^*M3%%B\C%H[BGD7 >U"2((Q&?EO1S]X_XQ<Z:CL_#<[?5A$[9M#'&(ZH-
M70:_=J?8E192G!RCO%JT&2[KLFQ3J?48_!/UJBPD #2SK4^6/G_Y]/&SQQ\T
MS<76\8L?NT<1PQZ>8CD1,X8U1$!4O%$LB84H[5HAU#NU5L19$J3M*(T*(YJ$
MM*7_XPG^"86:;X?1VI9G]@3$5#LUML3.2(1MUQIRA8.3A$4Q4UP/TA779RH+
M")P S=<P KQ?L8'GLE(!!N&2KBLQ[4+*V/49'#%JXBBAS4,J\XO)MX3U43R+
M1\"/33/QY@1M5-OL;'N8B!N8B#_'B3A0 DR/Z=7HPE/2/,S*#<S*D\=Q6HZ4
M:2/\6+!VURE7/,S!1YR#IVX.+,LF6+/E;.'%M8D';>8/LW(3LY).#@OW5.G\
M8?AO8OB_B\-_Z!G#C1WG;&-,]N5V,E\[;2^U7W]2A<!E&L6$2=?/#-YZ1-*)
M>^S*2$*MJ VW%3E("NTD<H4,28Y\M CFLR<-UCI4GWR3XZG_8NT@5P'M[W8P
M)V6J+H^D%8Y)=N2,4TPDE9MA8$8R+HO8&>>IJ- 0XF/L4I:'44X;@W;2"8S$
MS(/\L'!51_5L#1%QESAKI0@;U98F4%4;WA4<9\NV(SMI_EB^5LA 7_/4VIN6
MA"7X9J:ZK2)'8'37[9C7FR839/YQ-[!.SL\;T#^<E:FP\N-/":A?60,YJE95
M>P9N;' R@EC8^'R<'V PH0@4]2_^VA<5LYZCU(A$>U'JG]>:B:Q)C=U,VEN$
M#K=QG\L:L@:0#V5S\@]IW0=!A[!_H$#(55:%I5]>J$BUOT9*&EQ]M9NOD]SA
M^L(WFL71<N)^MLE>)0S8H0#PL!JN_LX4RL+L*6_C+G$'B@' 28=N)>5\6P]F
M?0W9'8$NF0K (CW< L] @F_V:.,)$E*/R/11WFW!KL#=UPJ7VWW-8H?SO87K
MW7[@ 0'Y2[%Q)'N7->"-E0 U(2D[X2H /7_R1Q!W5IV0%I*[O7(YA/!@\I&G
M1QA6(E.+?1*D:X/YO&2R5TVK4A*<A&F-=E?JE$_^[ M<J;/M4AK8>)PDZ([<
M4,H]VC0LU#[=7SY&4^*7G"3D/-VF8",\T!7!!F#A?HU,PXD#J:FPVX(I0>WZ
M:N#5PQQ\G#EXRBG0[ :VXMLZ;*.R[XMS%'ZCR_3VM_/H,H6=O397SQ[_0=-W
M?SHMOG_HM/CWJNP'\^)U<)Q!)25(+5:BQB*)\IS8F#>,M)TKD%!0S]_4<05?
MA+>5?OVL#CJORG9;"IZ)LTZNORWHW71JI4VCT;UX-+@-^]]8)"5+<KU^FW[[
M7U7;#*XMU_$/G'IIL<6^>>QN(6T6J>DASY-EQ"T,K*C\4'5>* \ML1%_5BO%
M=5XT)E'-M%P9 V I=*'A(B>)3,+N/08G;#=H1.3#IN'6L5JOY-WR),>UZ_(7
M+!LNEBM?[]_-CCT<=Q_GN)-*2V$G!7!TBZIXPLWPM/CQIQ_=#O_VR<[3_\#6
M>_G_@KGY7B!))?\5O%7L69*(/O@HGV?2G@VFZ^GCG<=73-?3I[]GNNY.YIIS
M^W,\PAZLTA>YP#=;I3_[9?[-XP>K=+LF;6B5KIFN>VF5?C'?5XS2@TWZ['-R
MY?(NQ^<I5!E44M("UV(0*0FI<03BE7E:\7<W(VH-<L0SFA@#5:\AC^N$7901
MDA*A,5J2VA;1NAN+:&^:3.7+2GS*IQ][ZVB#ULMU<G7BB%GB&Q7C<@HA[EYY
M$+7E!K\\EM-FI/_Q5(0RG34[;9I^T=;S7DI[I%YD2U3X[+!M^B:,L,?\:Q]2
ME+"5U1$ASO:],K4N97V"L85*N&_UN4DF.T@=;^YC^K1%VWGQWT+U4[R>5]I@
M<RNV,A\O;!%ID)3,P[CT'3_L#SJ^QK<@P;C))45"[L\PRM(H=7N&%4-WXX/P
M]>UY?QJ2&Q^ Y6(*RNB)+5ZQ3.S@-//DJTCH9RJZYK2_9$TTV S2B,;^8=##
M2B$]7._VC&UQN@P;SE[HQ@<YMP"PN#03R[Z>UO^R%)\-YNT9M=B,HEVB[(TN
MIZOXR#:@:M. /"\N:H@O-D;,JEPW&>F8:WF[VX[+0=;/F/-'#RNTAOQ#I$(L
MB>S"01<1LL)DJ+[NB.%.G%36RQH<GS%.T2??<T(]_ <2?]/^G(S#RJ/J+M_%
MZP^N?5H",\5'W6[FV_C_@^>TQQO\,#78=E.,$YHOX0+SI9<+0Q$,QH".6LLO
MPDHE?[D!?1#^%%Z6XVGI^,CD CQ67+R.,(I.'1NZU1]S$*4H6-OU"7G8M :L
MR$?>^6TO61U71 5CT/3UIQNK&MK,0\M/D$>XA9 VN+9@L+=*U<+?/2OMZ]3A
MUI1<NOO;"A07(\4CL$4WS$88DG&$C,5&?W:ZY>77& N$57)1Z1)26S8:?CIT
MWRK(,7!7G<WI_6%I 0TFF^SIDZO7,8DI2/\_!\QONG8KA[X#*\H,*I[6S-5!
M91D"7XH]]*)9>/Z^04PR>-B6REE@)\]5MH8WWM*W?W3'5\ZN&;NK[-+HNMDC
M:<6,D7<5UIVZ3$^^1XOH]M[KOQ^\B+.3SX-U6Z[U<S+RC"V&AL2)QLD%8;NQ
M@QR 0V%6<6X9),#[%8NBSO O3Q#FH7.=^JG\69QZ?#?,P.4\+=XGWU_[_E?=
M%3(C88:FNKU $HSWLJ[(JW[R\LU^1'+F3W['5^$K 0 ' W_)$%Y!<POJZE$X
M(FG8V> E"V:$!Q>5D"2DP<YEH!+SSD32&P,K*'!9*,1%:7=%D%7X!%7S%5(A
M_^!CB1D5R8JI*B<H1%'=""##BBJ,/K^0[JXDZG(BGD,J\.O'_V$H1\@/W_'9
M%D9GHPWJA9MW[\5AL05OGW3&Y',0A]#1+1S*V#]BK^_<'.J3D@  7*!.7>V4
M,5._;K(!FJ#3DY );$JFQHRDSDP>&1"$36FNSY$'$F?5N%N>;WM&%KQ_#*24
ME8I1JW4S[;&=V6"OU1WF4_$D8IM<W 2Y]R0WP@$ZP([R.ZDY7=.)>5- 5(/<
M@$_]00EQPF'Q_9.=;[[^CTB$X[!LTOD''PV46IS-]"#&^KEE0BBE!B4QR]:%
M0'-,S0;!_L,[KD]/%8\<?AV.$B>DLO:.X>TGX&@P#-#1_IXI)CQZ%"(D-B4X
M2XE$_$DUF;!W5&. 0=^&L0\*(AH9YK'QKHM6F%J[!/A?TQ-Z#TC]KB]?&DF2
MA'4B;)V)RW1>6Z!V](%M==H(X8$P5P3+";&OR#X':J'PU"K/,=5EKPHTDO$7
MZ+T9P\ZI(63J7V0(\7,T764L(<& AN5E''3"<&8>WB0]4 OYA(H4Z\'E:6<I
M9+6 CP<M)DQ[A,(+7<AC05320-N<K*[XSW*V^"&Y=&274!HAH544SK5)\/(Z
MR30AVQ]&"?_YY%O'82+5 ?EW^.QK]Y'>VB@),?JB_I.PX<^/]O=W7^'B/^_O
MORC&4(L")F\4'6*H2FEWPI4%%1=+[U-QJDMAM!\XMA*<LK]G< 4*6$RBM>)^
M#5YE;>J5!,_C992O/[UDTR;.1:T#*>7P;Y5NT@ME9:F=9%Y)<639SW$)Q2,Y
MO2QS"LW8O^1PB8NH7[CSK)%"3#/#BC#U#O7(3 -*6:+^(,COHQ1P/X^EN$V5
MW:M[? _F'6Q$.GZW;0K[L$5>%,Q^7:M0=<44/<S''YJ/7VGQL+/(%M]+S^##
MZ-_,Z!^*5R8NYW@U1B.;6F!MP[Q.)?C^="_\^;9V+SQLAX^Y'8XL,EN4R(-Y
M)I23E?, ^/%4M(2Y67)@RJ0Z+8.+QTBH608G=+NKI9+;+Y8;. X>)O-33&8D
M:!3+QOB"O,UT/J-K+M9$)NXM M@09/P7B@=5-;_.^#U,UD<]B*:E@*$(M2O"
M4XZKC(\QDI^7=1LU&1\FYT8FYYA)(N$IT3V%3!YN)OOFHII/P*^@I?(P0ZC"
M;,I6WMV4LDBJ=AD=03,_05\\CPPY(;161:9AY;$PM@L4 D[0=J9, DJ2<*Q?
MB&K"2ANC07XX4_ 8792#'O>6.)"@>I.<:ST?L-9:DN0-Z]63^(A=_GP4]]4L
M#G('3N(]GVP*ODOF@E31,9,!K54635==7WG **\9OLTZ&RH3S/8-=('\(\<N
M>TU,[GP\XHQ;2AXDDJ1_X20MFDLI)B7YW?LNTQ$\+$ ^I88[*X781\F_+Q*=
M3@1E1';7R,W*5*4Q_@JAC=,5LS0@.8##H%CVL"Q.6B#UVN*"Z2Q:0:64UYM>
MI6&LM41#;7T87[!URK[X,6;)KW%7/H/*X.==%;%T_G2 @-)RG=5!M^=">X*R
MQWG98JHGC18UC&X%-7 E#H(;#Z4": S(][F$K&=XI#\.,_J_GSP>A?=BWIH(
M*5?[LV1ANH+R-J$6S/)8V-IC?(3,9-UU%(;OELCJXICM>EDUI:!6F'/L1))^
M7%,2+M%9C<_#F0W6V=.RK1+%DJ+^(E7R2=GW4_E^L./U&/S\3/OKJ7#>=%7>
M6XU4]BD\@R$2SC#N6B$?>?[DS2P]+CUOY:'LFGLZ,Z]*K3 =RN\,97_23#MZ
M\4(0-IU6Y=E2]+;#[\,^FT_:LF:>PZ?S92#ES%:FO\CO-9?M#1!75<["Z'_]
M[>#M+V$VXK+0['YDZ,$K=XDSVKVSVH9%/9T"GE=VI 0V&(BRH$L_"=/7<'W/
MVEJ$_J84F>$3A)^>)7H>70-A;3W8 ,\8ODD9TO6:#(NS_65#DGB)%6^ =/M+
M&<M;':H\>VJA2K)LR.4D]KH8N; 4&<(4BM)5_27"S5J9H:7&-RZ!6"ROUZ9[
MF+:/.6T'\;0BOZB<5;!]XMHZ*&WTVL*?Q/9#3PW^VIWQ_J_P9S[>RK[CD(7=
M9,#I1L4#P+@?HY!/'+K?,6;(1<V[!>)VT8MXUWN&3.B."*=>!N.EMR5$-\J0
M^:[NU/%R[,(#0 )ND"#4F=?Q<"+=!M.V%J!?;=K>J/.W_6K\MRHLE"-5,"E>
M5H3^P><,*^95 ]#$+]6R%:PA >$6X[WZ)6E#W19+_M5?(;O3S!NF(5ZU.R%&
M':-50MX3/0  4:H<WPQ0+3B[DHD*_GP-/MU1\7/8-%!FJ" B!=?LA?+&<NOP
M>P;2H@N]NYS43D9;@I-KQI=C^\L+M/4('&391Q$9.U:BG.,,5(OA-<-.;J,0
M<4G(C/)$]>&B]1DYMXA@:9E:F'<8%@7%S%#ZF340LD/5 1$<PC$A()UC@K<-
M=,=>A7)*QLUXQ,VQV>R=^?U)988&[4.Z-L(7=G\^?HCXOS1[X%CEQ=B_:6N>
M3GMA,%NA@#T4KX<?'W#-A?6R%*%,H62M,Z7,PP.S#[?'.CPJM@L^65CDX=G[
M*L73;% \;QIBU?;-F1FED4  ?U85+]"BB#"WGC$G+ 589<>V<-=YB1ROVH_7
MQ(]7N'7N.6FR1-EX9?A5"+>+USQOK!/EJNO&(WL@W^2@Y9)Q/P_#@\Z!^!"6
M+ CWDX0B,8[GY-B5.LJX7)1CO1Y:95?#J^H[%*QK)BM:3BC=S#=[NBT-(VNW
MC7Z0- T@#S^+LEE2<!/WA(\E*.!^.3&,)JH-K? /BNA6]F!TY'%=5QG(49C,
MGX#R/2P:>??F]#2,3XDFE' XB/RI $2LQ^^T;KO@=[7A_7 ?Z/1RC6F&=4PE
M+:#_OMV>A25Z[EZ#.PMP_23Y:->1?EH1=C-'#)4*X%U+>V>F=WNQ\;JPW6 X
M5/9Y.-+^*30)7'2VC"7/',8%J8A_-*N*P%<]:$YP,&',)C4&@>\N>.GPCF4\
M28J^-:E2/F^: [RT@5 U1P2%RLE2$X6]0!K%MQ3 [B;P\L/I\66='O\WF)NP
MKG>3!K"/5#J:66: PY*Z/8?#SJ;G#JLXK-'R+*SY57B@,S/!!.NRNV_-@O?(
MK+.GH!+!U.YM/9UVLLD NA;*__&X$KQU*6)ZV!%,V0M?9W'13)< ?*#*6;Z5
MYB=ZBK)?ZC;NK$FY<D(5F]["N'!&\G!2^PWNG\:3786";/A7F%@T>$8;@GPO
M3:S%CJ/B^,W^*W2 <G^'X[$:G\_#K)RM1L4^7J*2(H!@S5^5&(0P-&-5D>1Y
MMD"7Q5+62QP;2.."YR3,'54J.'91Y%C93MOFM&+Z'N5<X<1'_!H"XR:/7G4=
M[A8'P/V1;P*Q- -I+>ZF1G<SU.NV'^0MVI>X:53=_="Q/Y^$D)Q4/0M=&.PW
MTA(S'H3-VJ1OB*>=%-G^]LFD:6\X(_01DF9W.Q'T1DM)<7LST++JGJJ#LIE3
MZG#<?DY(P1IKK6'2L7W1>H@<]5JEV4YPB1'5C_.B-;_%LE'P[Y:=R;_@:C4D
M4= :;#Z%N[M1N7056S<2ZQ9_;5>\<BVP[8:=#MG#!(_L%_14)&+I9]\_-G4G
M*Z0I<U]Z?[@Z5;&4@C7V>=B;:I.#MP<?6;HL:$Z-.?EH.;=%^:)$XZDR:YS6
MIY!P13>@RE.0%3 8O+!M12F^K%&?<255>]U7N- A<F7CMW_J&#IH@2Q<9H]=
M'Z=8=W)F7***.5#\/1$I<3MKSBJN"*!=EJ(N4DY7'>6_90CKTXK-L<6N]+L
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MEDJZE9# 3XX)KV>T,=4&^V"Y>$YA&$4S:"!!@KO2N$ \HL+E-WE0#A/8G8?
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M%-G"T_6T&I#:M1,EQ6!\'.Y!L1MF'"^KU*XSIY64C80?2PF.F%'R@ZL2%YN
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M>SV^=XW_GR7A\:@M?>;L67A>H"FX;$L)3S=P-F1=+<&Y$87QE8K_Y#_'Y<.
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M\[ALI%/^(;__L2K9-GWJP4@.YBBR-7R&H";$5#S8XT&/LQJ[[.!OR2X)-X4
MBS(>(F?PN'.WHX(O=Q-EAHPE&%D](5YP>TNHMFT'#O:15;.5KM>W3:D4*>^2
MV=Z.K6"SJNJ'3Y3*HVT\GT;V2")M7B[Z?.^/Z!GI[I--[;;@AK<V1PCQG3H\
M#[OG8^V>5T>?8X>(7C8T;Y49--IR+U'%*4?;'D^62'' ,T5$?0L\O[+P>ZH.
MM_SC^O;GN)[Y%4Z$47&*ZJNAFZX >$TV,9+N%,6Q+E/RFQ!H-1^K&(,V\<1@
M0.6V?*GG#1)?P6'P4!4G==XWBVUDY*;^$95A<1W&Y>M#$=(526>,.%)&H;.$
M1_7._@7R%\A%C2S2L,&T%Q_>CDR1B9T5S[UL(1:_UG)X#:'4PW[]L(CA&CKB
MF\L5;Q>[ED<;A:-6RXO1-<6SC31O!%Z1$=)Y1->6_-?^N\646L65!C?'8:WP
MGPP8MG:/]G9?[(,72L!?<$43&W;88Y?J#2N12-AD_Y^]-V].(\GZA;]*A:=[
M6HI 6("0D#S/1,ARMUO37O1*[NG[O/_<2""!;!=5="V2Z4]_SY)9E<4BL<@(
MBGSN';<-5%8N)W]G/^=>10DPK-<#KC!L[EX4MD.L(9#IT%E+D8K1OKL3S=*U
M4ZQB;H=.X\L0Q_:JZ;(0&"[$;>]-6+*6L/N(<+X6'G4QUF*5@C0"HJYH^TI>
MJB5SV1J3$3Z$&\B5%G2' KN'D98RLLY<+CGWI+6MR;D.\Y:.^,IL"Z8&>5Z>
MVBI'_M/UNYN?#H\V#XC<XBG6!CXM9]-45:S#O35\Z/HHU-Y17^/'EF1"$K-J
MSJ39YW9D;5*),0$*\WUE9,S+!C50?D)]-=/J>U2)B1"2=8 TH(@SW1R@#Z"E
M0]1]++'BC5+?CRW[R+V(5)AB3>Q>3T9<=7HJ--URM/"3I"AT%6 G F(NRAOI
MK>I=&X^@Z>%6:*@JZ+V2NQE<1B2'4%$W.^+EX/+Z4$>_DPR#Q5W47ZFT&S1\
M%)T!'*#W 9L<DAWCXX=#-+W)4?99Q?N$Y:O)R!+T4[0:W61UX2K>+^G??X^]
M#V%?=2JZ:!VLE>K;)3I.'4UYK'?=:2F*5F5VA_U76C(S1B^B\?H;VD739X^8
M!UGK03>TVD%D323H)RSM4:U/,TI.&VSXP8/04SIB57 &C]@%]Q4@8C12 1W=
ME[QZSSNC)9)L?1NV,:KK^@LZNB+@UE%*E0RUO/$^2WC?.U>%U;<K;]9%O'D4
M49^NJ:9)EM76=KF&=O65#%PHKTN7I"GD<WTA?T1>1L#<! .$%F+I@O(S39>L
M8E$?/-'K&5,'J3S\5G],%:P(]=#-U59YX7V["E2Q9Q/&^YMN+[EK+%O>=&LF
MW87%QA6%'5/"'NB9ET/Q-TJ07'@'L<7W*][=Y5V%V^?!)QCZGOI)H=4<=>?Y
M_'_VL)D<)?LQ^S&] /C\)WRO7#D#<XMZ/2[+;7KU:/]K@*5Y#"E3Y!4HO%\P
M7/O"TUJ%9JEYH(L5<FE5 ].N7)Y4YZ]4L<Q;L3KF:"TA\]X,-6?Q,RXB<CYE
M1V96,FLV=<1[E@/?#'A\H>2OH*OH@BI2J :@\_S-?8%U01+XF5529 2[1<99
MKMY$YA<9*+C';-J RP58@'&N[.')W:43K[-L&CV%_8ES^#'V(FZ?(;!K+&)6
M]H.V#."91_6BLMZM2P/'<*=&(<4<*-32L38G"B:Z 8\T-:0\3(L'%<@6(_-#
MSAI(%2%1@[(I]<OH7+%3K'+=UM15#JS^HKHF+U4V.WK@QE3#81KH-^SAL5%E
MLB^9;1,C/MA.801B4"BD3@WM<-FA0=HF!LSY22##PND.@!G!^SM\:)>Q$B:T
MA'X=R1@W6V=DCU*@D!C480)3>^B>Z+#MT408FY+0IA5.EC":=5/062YJJD.M
M'@L)T91.O">S)G<<0SH*T1\@=8DWV 4]5JX'921M/6^(<(JSZQYIZ AFEZD5
M[)73F.FF2]J#K[[*G*.#G"F& / ?&Z=-X-@#. SN0$L<._Q6]3ZRYY:%$JR,
MJV^..3XLCJNSW'4W*OT#OH&S<.EY9/&-MY0^/L/RT.,V5G.%]<+!;./5?9E:
M*K^$44&6A?]?V"F@C1Z&YX<S73+?;<XT_N(5.J\Q=;=V^EMQ[EM1S/EE&JB;
M"/^4PEA)J9I=GK14Q Q*%C(E#A.G3K8/ /LR*X!A?%#I*.2VFZ8.NF[0@&:9
MA$4'U,O"&*,M(MF1N<TG#W'4+O)BQ>**UU:A+;);O=/8,6#8DD(7 =779"-<
M+F)JGQQ6*O9$'S@JUQ9UF&6.^19D]  M:&@/#(F94U"53FHA&D +53]@)<#(
MZ,+V1VKENQ^QU?*!LO.Y#1Z+=WG9U8@JM:9$49F-0%':$I&*J9N:O6C2+M&1
MP%&!7O)46@_V0E(G>J "X/>)W7P8:T'!8@;X.CUVA0K81ET=8":RU5)Q?IZH
MB5PBIPRKD*HG3>Z">:#J_4'QH!1$1%O%-0HR@HX[(*EQD#J'+!&'X*^,286S
MA/5>D)J5XA3U4/!$5U?71QLA30X-T7&<HJ.9=-VA&.MP$[.5'.FK G3!H_V%
MXJWX[Z;@K,D7HJA2LJG !0WSS_&,O5<]*8_@7([T;%_A4*_8<47%:LFC[,>O
M\+R4NU?33$,W$XOYD.A$V<!+]@D?]"?Y59=9X@_&4D1(P*07<Z45*E0@C,TL
M*R*L"<>4$D8+.\9 8L?&F"N) CC#RP)6!+61K'#X<+Q(32.ALEZK'.XV,'&3
MH4DGQ)8MF/B&+T)C'\CG7)!Z]I YWX KI>W4F!0$4HC/-SR[61,OZJ:6"(^[
MUI9%-,B!Q<:#@K-41'V94"&X5SDXO,(NF), 07R#:+VGOI&1O0 6# 0;=S@!
M\I##Q.Q6CHN3&X*Y"+K?-P&HY )P>@NL6-:\6(\!:D*%'%CSH\C[\+G[;)=F
M?X3%L8'#A,5HM+38*-P(MEO9/#0)$RLA  -.8^\ [@]S76(J/<ZJHQB>>WW9
M5-0EN6;,CQQ6O5NIANTTBKG7#(VCB_L5"I$KJQ(ZQOQ%@NQSG J*W5F[.D>4
M1J 0;>T+Y+QB,M;%[&W#2*!N?H<[( '&.1@4XW292^&:N!]-9$\7^)U^A/P(
MA:5D+Q1F%[HZNFJ2B]$BZ$?4@(-%E.PR$W.R9!>6Y:>64\7(E8D54K\1B7(+
MFR2U$B=U3(;0U@G'^7*#))L9.5:,@ZYU1Z&"4#F*Z)QTFZ'<V:R-7]D 6CTP
M0\34CC-/#T@&82PGAC:'1^X#(VR:)&AK9CT?O8::YGV1\L%SG$TVH"9>2L]B
M909OMNCB&?#-4KU)L<_$VK!PQ;>"IIDO"2./)$<7Y=25A)B/'70VTG-L?P*%
MSK<U4&A7KO1'S(70/N'B56/29?ENB,JYH,;B!5!GESTO4#&+PKN&\@=]TSC&
MBWQ^#'+'.-;>0"_ N#ZV7(=IPD^0A$OQY/=:Z=2OURV;6 4S%UYR$X^N;B")
MC1>!D3W(+H<8%MMP<##@)/C;03UZ0L67&ONS89EQ'':45>W%^J4M88$$;7]#
M<I@@I+2E6%(;<WT,,TI9QC-<&14ZBM[/O-05KPV;!5,%=76H$EH\ZL2X--)O
ML:=E@''1W/R8VF=6[!I\\%=,%X^+^0OQ .W8?:XK3!IYE*+_L\M=O?+0::[,
M''NZ4Q3_+">%G^(\88$RDH[D<#00,:6T6NTJ67# A8FN_"OECBI3DBPITU9S
M%SMR>_-9W2]CG*3<+:O-:;F-DN@ONAHHB0TX*) 7>.QG<B9%'$)+<NI0#M%R
M;6A59C^U*G-1 R V;I'9DOHCXN4"$#I*PB-L8X0Y+Q,->9*\0Q._$";T%@L,
M<_0NRN[Y S_%1C[D%#4&$V"?C"@H#.N'*44B(84"KFTBC6_LF==J_;@0>?'_
MZ>*L."P1U"]AE XK6O;A9KLQ;0=/:_Y;.&,\\O.>MQH)BNN\RM;)08[4[D2"
M"*CKNR,:ZYRA9#HNVMI4G<H P*OBA  4?:/1U-&9@(PPZ(>(:=CQ,LV V?IA
MAX-*=/K4Q-%JHX85.$0F"LH+G'ACA69Z":B<Y*O-1YJ<'[<;E)@419D6>>,M
MC 24EMU2-]ZB E#9C\RL^:U(H+"G.8?Z;/7V6F4VS/>M04>^0+Z3A7YDG76[
M67U5?.93R$P.&=,=X(I 42%/<LG#].9-JBCK_WSW'DV.P%4IG%3'& C:8T-N
M/>QI3+'^IB57%^:@R", I,6QJ6%VM7[)MM"^6G8<*U+-Q#'JZN76!F$+R/PT
MID@ACR+KV#ZUBN?+/IU>WN!']^71I<FS6"<<LO+X1=*^%5UO+LX5*0K @6&H
M'8*YN;&QIL$70PR8X^U&Y[UN*63#'*5TL_TB+GR)P7Z<>(@9A*;I B46<\.%
MTCB^B?\PQ=(=N>7:&,OU0BZ7IO_%-O7,RC0%Z8],7]B=BE@";1F;4?KY5HH^
M*\6,N3IX2"?LY VM3 ,]DSQGYX/K(KQ;W=+"M7Q9JN7+^S#LYI4F;JBC Z8
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MH<%H<@KXF.;X' 67U<_3+>NX8JKR21@I#LM*T]PU9<;OWP,R[-XE)._@CTQ
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MU\PK^S=EL,]ZL3V:P"*NU&X=1H+'Z:SR?:9F[+ WOAC%\L+\Y4U7Q2-?C"\
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M:O-)!ZM"7 ;"'\.DG!SNH+T\T'XW'HX&83#.#(6F:A7Y,S%4%O[A0-V!>AE
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M>!UT<:$39_(?@01,JX8!Q"C$'A8SMIRQYS?X&L;X(M2# /+X,A J.W5<ZLT
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M ,<QXZ[O(@%_3B.O Q^C"([MP"3%1^%N=)&?A:.A;I$'FT-=P8 0<P+OJ6_
MT#!H2S);HRY2R"(I,@99,$A2YA0C9**(F]U4-W*B(BT R?+!>Y#R*]%GC!VE
M8#+(IN&P;[D\$/\TGT?AGN5MS; 7G-:U=>!66\0J"TCCND!PO ,U M:<P$M-
M.\.LJ:/AYTE(] Y'-"2V;=[-O]?-&_&&]OSP87)ZR7B$.PISH^Z",<?$":\;
M/@3911:)Z9O%3<ZR-RB\,Q@B1M%H8247&=IP\>$JP1"*0M" O<$L?1UU!QM7
M',AL-%;%X;.!&>=!;:(S4+"]!E4Z3/(HT,&RX>!XE7"?@/56>+'86E*-X&7=
MD.$MA$V+X91)SIJQE;J\DWU&)$7JG<HZW5D=WD9 CCAG[#_'.*@A-/;B%/%.
MX83A=4,IDXF'1TC#%(R8=^_;Q;BV1QGT%9X$;BX=":[T'C#47+, >V'"L838
M#W&W&H.UFHUEX]OJS6KM^.QYPK]JU=IYRPVU^:'JQXW-1]VM%Z;P\DV*6%;7
M#,&.MO-6CLHI^ACTY5TS,&?S>W+P+A(/ 0$X\MO#U_17#$]7W9?8ED>=$;.9
M"NWD)O?LDTR8FX  #_+,ZT4XW\8G>1"F"<[NL#B[_2)Q,EI_IC*&01@<T:&)
M+DHA).SLY[VWW&THR<IO;+'C'([]W))'V</)LSA@GX[>G,EX:ZU\Z%7B/[<E
M[/N1P.=5!995(T.-*>'%O6ES59.5?*5EBOEHG+4JM>,M[7RV=Z=!AM?Z&W<:
M6W$:M5:]<GJVI;&0>W<:[FYLTVD<U&N5\_/3Q9/YW4%\GX-H-EJ5L]8VEOXJ
M;0#E'6?VW^G,_BO.Y_\E<SF2+G.J$_/_*8:C-WFB_CX$YQTT*F=GS4JS]2+U
M=,JXHXW3XTJ]]1*=/<N[I[55A#NWI4^45JLT&PUWZU]2XG5[^@1O.JF?5F!'
M-TZE:UK?M+&W 6_NABFZP,DBN9*M<M-RU&Q+9>;=F1LTD <,K):;\HP[N!U$
M/<?DVZ@TSL\J)ZTEBEH^+W%M2%4K[0EJ <^<W@99S!IJHR.:ER6:VGFSTFBV
M'-$XHEF"5RPKH[OCVZ[C6\ONZH[OI8^OTFJ=51IG2Y3!?>$3W(MLPZ54$87M
M@M-8]E+?&TI!Q563@:!T.@JJA\.349S 8],Y'EENC5](6C+1Y)%)6JJ8/*X8
M\P/DO>#@\EDCQ0D&%/7'LW-X'EE6,B]G40R! !-3M;71FM4V_H?&6:M:RSZ?
M-YC)JW3=DD_KN],MN1QY<+>8\XHT'(2)]&I6*>'GG (-LU!A2AW\%GPU-:#Q
M6[CI$W6H-RG0TY0X08/<59@\UY6)4'Z6CV/EP*1)AFJ8GX9Y4(4=;F[%#G_.
M<A4_8+KX"^PGI2"F$87#SMU-DVV4 NS[2K1-PB(^[%-Y<Q%1<AJG"^U>MM#<
M8WLD?P@#J:>S@S:8@[PDK66"@]W9O9 #NNL)F9C&E"]S%(7W"HL4M,<S5VL5
M:8!?_%"K-ZU:#%2<H5)OK5+Z_P23*.WJ"<'"4P(!#%Y;.ZVM5GX>A2JS*LQ8
M7/+%A1U0\709![N.PT1RH24$=E7<26/<5P,L;0EWA7(H4<)/] 9/-@RHV,,G
M:J@E4JOTD]4?H1=CEAZFKH),F0(T1?1SSF_XGG4$MH_LJ:8]9=,.3(+PC,S/
M_#!%PO4:*#D1SD$$!:*QLEABG6#<Z:"0'7/RZCT]AP1STJC;#11$H=O%]#!I
M (S#EWE**X[1.#G)Q^!<]2>'@8L03 Q3.ZM7&V88N@BQS,@):"3U$WZZJWH@
M!\B@,TEF$WFVG/5+;\=$3<DE+TB]PI?@,T&>^)W@^>F<YB"E1 $L9 +2L%9N
M\LE:@LE\K>9!Q/S)R1F-XAW<R5&B,Q".^4<77K-.7U:\_\">V)_7].?<K,.,
M>N&=G.LO9@,(_.!,_V#J=0WK:?MUC6P:AU7O<JK?R>*;T>4;+$R+E ?89G-R
MDW10U"X1>;#D2Y&,:=MFO8@&!JF%$ZYQV PU]JM<3--(,EP( )5HNB*3X$'%
M#)XXO:$8 \I[K-_>2T 9X%J![ O]+VX30PRHDE6$"9$YZ(H6<6< [,#7E]$6
M./-L>D[0%[ Q:9=>0-?.2M*?D9,/]"307)3ZP#VSH0RUY2UY*J:40 8'E*?/
M#.@^5(@7M#O)0$5='E1+P)%4PW8:Q;ID0YSD-8WR\8K)_USM ,X?.!L6:;C2
MZ_5Z4D[6B "F1R-/5BMHD^CR>"4"6!N5$\$4ID1$?4EE.#P\R?KQFWQGZ8/:
M&^] 5OM5_4MX<4*% F00A?Q23@>K6+BG2Y_ J1.>PN$3'<$[L% "-B3"FB0X
M!Q:)? E?'U:\. 5@LDZV+6F8D>Q@-R1SP;&6"<DF4J!H :0&4@S2A*&/BK[[
MFB3C0FD$VL=B:0N;KL*VCT5<J%@)E8?AO9)=;0;ZA867BM& >3) TZ%>I*E_
M84,1E7"!5V=G6Z&/AJ$^&SB38FZ=!WPC-%V4"B!GKMU/LRY<F72L)]25-):Z
M5,=TH9T-[,)V&'L?VP2JV_9#_?34LGTNKJO,5%0>?1W*6_7ZBDW1%EO1<C7K
M[-)%OM#&X )G9QGQU+8"]PBC9A1E&HJN]+#PF1G/E##*:BKAM"?*-EU_P7L;
M":.,R(KW0^O$:BD'CYCB.0;=[*),.,%?4P#J7U04<S6EWZYNO?=1F'+WLQ]J
M)]7FO-'L<D^(,#!N,GX9:6;+0*,WH]35WH'&K$TH.DY:A?:'*X '%5B:@H^9
M+\:KV *M;R4+ARYV].3,"C4.^4H+FE_69)&US]/C7&U$X2$K:I9/'50O*B_U
MLN9B.EF4$\E?2B!WE\!_LGZ1),G_8MLD-T9PLXS(AW16QMP# A]LHO%M;,-.
M/NW;R%T-6[&A2S72A O(I3C##I8_K'J9,&M?"[@+NHY@UZM7:F?GV%AZR<5^
M44.8"D[J-@3V-6?9M>/%UKWQG9ZH24@;+W3I.JH\UY515E_VA^;Q<0Y;QLJ4
MR1@/DEJ7&LLD@(N%J6PZ8PNL?09:I\1ZK3+J*#XW9N!>.&+90!^TMBK+(*89
M[6)5ME79.>M$)6;<M-Q+C-;0)B\.Q8BM$HEQY9$ B0E?!K"U5?P6MBY@F].(
M99];G')QCKTY&GWYNK]7\^O^WLZI#%I!*TL6N0.W LN'SW/$;601\U;PC)=H
M;M[*=[U=UU>?/WE8:!%O62=2"9=L#7WM*GOPNE':+Y1MA;M$ 5*)^#KE.V2;
M5%8#F[T*"2Q1]&56+W5J1.+(,5K\BJX#R](M4&RZ-P5_C2&]IZ3?Q6&'(++@
M<S%6\>Q@I7/\?HR%5D7;5S'7.8U%3^IX+8D5/T5GC ^;59+1-:6WZE;?-%Q"
MQK<TT.9#U"$O4?"0;$G-C?D/802S02.ZC&@S9I? !3P9(E<#ZOA;FVCI%"@L
M#33E&,58-*4&,"QBR@BX\%!T9,J'0Z8SO5[81:R22Q 5Z",82'^DS;A#PJQ.
M1_IDRN;=MS8>/1"X<',!R:!+H7"QN)=P\^Y- >8A.DMY@+]207W/X6%?]625
M9O]3G!$-7%9C1S:U:-DB+;&O.]5;S;:5;+D UUAWEBDPQ8VAY6?DPL]Q'6AL
MPBZS$6(L_9SM1=C!XM/:'17"R>,/%(R'Y9UIB]&('^=U;['";!SR6?%;C/D;
MI)QNVLFF,'V0M*3BTME"CX^1GV""E'%Y 7EU^]'$ N<62-;W@D@*QX2[0&6#
M8<_P7-&OI&+RP)'WYV$@239&)T.8\%6DNX9;#J1/Q#1 >PI)<>EPQ-0WX-M"
M6X!\3NJ*9X&V><-'79#!J,:OD:7;V&A^* 4;:;H2224_='JK-NAH@_D,P6PA
MSK8_X86-XAZ\?'CA!OGKN_E"PA?@((4*\'-)14=*'V%VY'=U/KX,J^;JC'"_
MZ+YC/(D?HFPK_5@^8$%MYHH$-$%*8(5^I@JH8.3*04P0#R)BO@5:5H(["P":
MLS8J?M&50T&?HRT8>)72-E3X)[I<X&^QLJO_38C+'$E-3B81AP&PWS'PB:\:
MM ;(5X2'*$9, 9@Z,$MI84Z81IGGJJ+C7"JZ;P8'V8TK5O"U9;"V8J])$H=Y
M/(2ICXH!JOX,M;@EZ--E2Q:U4,A["\S<0)QVF[<OD(C';%5'QUN'( CWLY>B
M?=L*(V+1A78M?Q?R!]-OX 7MT"^O%/P\_[Y?&2'TD@-L<#-_UO7R-Q:,]S(W
M'"U87CWSA*1 *]PB(#=OYK04YX;.+)!M&@I^ =J&>WGT"W)WD._;DGD]"3LH
M@&''@'RC1_"B#LJ1QEA-'!S-P[G!1\M'C\^)HWXFGL2K_?1J=)%]]#D%@J-G
MJ2R_^"JSQ@FZ@4=LA!@MM0I&D<)-9Y,^=TJ@_D=:J<P"=BN94*,Q-8V,,(=[
M0CT59CYH6BW@6K)^0C-65$&\?I"^K]62F7/+G/6DG7#'K'@Z(J/J_4'=)R1M
M9G$[_DR[?0W5H 6 [!M&=)%PM$CK14$6'$%Q)FC9):&9T1+E.A]#)HH +EGA
M\Z@! S;N4%$G':+7O8/='"XY=, @'D:]L.J7V?%B^^24,>+8QZ?5"T):Q'QX
M$;*#"'^=HZ:1CO7D#2^D@9"<M %FE$8@]+'"23$5V<N9+'NA[U,N$"L=.C33
M)F^#0=;5F+?7J;8OY=3*+Q&CD4\,(ALV?FK@0IAHIJ5<(@Z@:10X<2(S2GL;
MBHATWW<*]PK;[I3(]#F;;9BV+;=Y.*)WE%L-OI!(<4?=>4KMT63#6D'#U$V)
M=*"40!FM[\M"K%,>V^.AL3SN*0Q*HO8NV"Q&54&7)PQ+??](#V<_1/YUC$;2
M,61%%=<[@'OKIUW&*[A^^8RR("*\)X5.40Q(=)EU\-@AW@+C9$"(?'PE5>\&
M,$;Q9>]);::E.ZR#C3+9%UNRP103NEF:M2'&PQ%:;(TBH0AE252%3W!1."PB
MI#'4%/KAY%VVBCL$&B@HX'0[K=,),KZJ_5'%V+D#NZ^<O5?9$(?:0I..6#J=
M:9\ //U3=C0462VH=%LE1!J)L5LJX%.)I X SK;/K X%; [-HA15M-; #3Q@
M;Y"A$A.,Q6W!XO@H&8#TU!^\+H0!&K9VJ$O+\V&9SEIHY2>;&$<,ZM?3ZX#'
M!,2$X]C8K9B/SOD]KL\@-!]+(% ^Y^VP'N-?6R/#@^F(A1.A32C,K4DZTD&1
M0!DLXO<1@F$)!^HPGP&'Q.%.'"C\W-!ASH:KWB:\5"^<NL<$0>FO=H\F"F5&
MZPHP2Q/\B'3)';6$D4X? R\R9VG\,G)FV(_04I:$H.!V8WM@"FDR]\/0:Z'E
ME\X![N;!HV2I&Z5)EA[,D9A,\_IJZ:!61KU8JX'Y71[S]X=SR:CJ?>3!;8I^
M;"&9\=-0-HN*+#T0%%X6;HCU:"92P\(DTGPFEOBBC<Y=:JFEH\20%^#<K8Y;
MMDA-8>DH\;+4/+'>)Q[2HM'$39X[QGPPU)N;+PPA2,D'XDSLD1A;?(<7V$$$
MRYS-]GMS5L6J5*0EQ3Q4V6YV6$3L(N@7=\Y@&T=+XU#T<NOQPGOR/(Q"'.W\
M!2T2C8WR>.Y(F5#\HM120T0R1:7Q'F#5-$D^=@TI--F^4.D(:8*N1/%N);J_
M;$?$!BVHFQT'?$_0#>L'&EM@U]\#HO#I^V'0/Z(&ELS$IIP2[&'(U5A^P[?"
MSU$>,[][8EX'#':4@$:=+%F"R6/X]2.D,6+:"*ML3/"3Y#W_"L>'AT4V745C
M!4^*,.C 1B5]WQ^76QYCPR,<UV;!^<NF\,?>#90>BZ\T^+_6VY_]3A5;XU%H
MT?9I;QW4-K01%^GR?1AVB81PHSX@G7^@<*!+LK=LH5HZ&T#,,O8I42IO5&R2
M/ A!D1_"#>J;@T7I"_,X5*0E%C2L<R+4PT &QJ. '-TV*AGK.FJRHS".J7UY
M/HX6(]A*;PV/F3?TRNS]K),R4'/D&%Y5S4=A<'9FLQF_R .,-U614C $M,C<
M&&AV0HV2;8X6STP#E?P$3!CFDRLB/C$2?(9R8$04C?&W6K&Y+3S,VGL;Y,F
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MVCGL*MCS?H3V'&/7$_2X%QT)Q4>59R2?J"H4EYJP7QH7HR4&<A38G(5:OE>
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M1);.Z5@-U59J: ?E'U@?/>L>Q>F7) (<Z0"DWK1N<!O:\RD*/]!6D*N#F')
MM;-=/R<&L/F6;&M#FHSJ+S7WG+03J484P63BPOMZ:]1O8F$(114@B8ZI1A-$
M<,T_BU$(.MB"56J+TY>[JVE4YIZBFBQ# (Z:QSH<-OK-_K9IK.UVH]O<3QIK
MOS'H[&>D;K?1[JY/B#V WUV1:!'2P?R8MN,G>[94D_6L-GAU>][[^R)UQKVD
MV6FFM[5-YN$*4#Q!<(R+5JSQ$0Q=>[&'M-C3A43/>HKM5^.VX7IJN]S61LG]
MO1;4K^BQDR;Q-FP8-[&X$\9U$GO87+3U\J)[J (#5=@V8_NCBON? $*[8F*\
MXS;1<+:?68?=(XH_'-!3F;/^Y-X*S[@&Y/X&EL C\/N$]MQMG?L.&<6S%G 2
MQ9\#XZ;]_V2'X<+XR?8FPKCHG3W#[O3.?8>,T)^YI+)_NQ^$/B&"_OK7_[(Z
M[3<^_,?JOB&=?#Y=&!?6RXOV<V#9FI?\3'?XJ[#'Q@=_+.:"/(S/2MMN*FW[
MEV#J@S;BSNSOY\[2^KO9E">TPV>G3+]+;H4OC(_.M7V;@.8!K+ES_JQY-^7C
MA';X[#CQ+XGG@EW\XR?A>IY4,LZ=674'Y[[#Y\2.4_?=KZX_MHWWH>U&A,B=
ME\:YLZO>;IA\0CM\8H9\L$NI\MU>^:!3_&?JQO8W=$'OJ%&<$*/J[F;LG= .
MGY@5'QF!W[IV.+/=L7&=^!A9,K5GY\ZANLUSWR%[Y*[&,]=WHSBT]:L4TW@/
M=A#&TU[#[B+A&7^U9_,W\!>G)-X()Q2Q'2Z6\7\IH/R(^D(A_GY-C% ;0U+U
M4#2KKX[I\+%X*\+26ZE<.-*<>0CT&TT+=XPQ,..2VS49["Q18,,>'14 JU4-
ML'[DVML 182@\",.U\,[R\_AK>VKGBSP=.;&L1"G ^%VU2!\A?7U3Q&2G:I!
M\E, XH%N;$SC!B27#7]1TNJ",/=] &(,[RC%*4*[6S5H2Z9[FER@5PUH;B:^
MM(CKJ1L9]GP>N#[G>-F1L>*RTC3 / &U'X?]Q?8Q/-EX,#!YZ9@VRQW(QR"W
MF@\G#QP@XXN&>0UVJ^<Z&Z! >;AAQ1/7/H8-([=PXS:TQPEE?5$NF&W\9#M3
M 4N0PGLF0N!W8W$;"MDI^'<?4"*,D"M> UZ)6V&\348>1>8;K>' :A@XC1P?
MT\'$GPELUEL8?R8 BHG+>6RVX4SM$)N&<?A_@LW99$K:E_OK!NNW/Z>H*S]V
M2',P:8XR&GR:O 8%39MRUN"$0>=!RKGU@A$8%M@3+70%BH[[ &.7;@D"/CQ0
MI.MR3N'$CF)C%MSA*YB4E\ !&+<!YLZA#(J%,_5A([<+S!"D+!+X\ /FF?EC
MT_@ V+O@C,/?_\D?X#]O)#"U<\$$.DJ>(SY!09-:\H01N;C6CW;H3('D6WU.
MTO"-((DC=RS2Z][TQ06^-L@?O0CO^*A7Q; 1/GV&<5 DP/<M Y# ]8KSWJ=#
M+,4(\1!_ #]#@*7+!YA8S697#K>2Z2VOB#YLM22\WB:A8IJQ.Q.,FVH24]\K
M+A$@$MSZE+V(>8CXE2?L,=#*U)VGT%6'<OWU,\PV!J80+N1TJX G#P>_NHJB
M /:O$C*O 1/1KC:^BD@0T'3U.C(NKF":E\;]U(5'H9")DM'2 B2>>HN&\0'4
M=&#B&9%I._1)W!#M\LX07CC.!]\/[GA5HX7Q98H>E']__G#]#JQO$]\&HQLA
M*7<Q"R),+YYXR!?P-.<BF'LI#8S<P)C3&$4(K>8]]KT=8B= ;<6 KM/ #T*4
M7)*!P?QO \);^->O]GTD#[R=GEB4 **$,:_4#<>PT3OA&:&"+QZ?F^TV(SZ"
M'-( D]_78 '[DHN[@3,3J$4N+Y+>?7L#RJ4'OXLQ?(1+>8>)G?/0C03].;.9
M9R##<,0<I\:$6)#N3HSIV!_@S6EVFKA(1_+N'$DB(7A1 "<R2_4P7($]OG.C
M (/0 E@A_OK[]5OC9I:$$[ M?DJ RD44&3?.- B\QH'RNY\@5VU+F;\48;WM
MAHZA!SV- %P"#?(+R70!XU?Q6UWF *%DC-\$"45"$'C6G1LDD;<L4)9T5I8&
M2EN%83H- Q<FEY1]3WGAQA>@:I>BETI9Z0V\#J-&4L9] O-O5A!4FZO32J)D
MJ\D#* Z($%/ZTZ&BS]QMP+(Q8Q0^4&)/4_5-?;^@Q[&L4<GEM,_5)_%/X8\]
ML1/DY?;2I:FA=.C/$4*M#O5MC5B6_BMQ$8Y4]0 405BQ-I5,C?TWC)\=E6F\
M9Y7J2QC\ 2J(ECG[9M47ZFA-9+!TQL@@OXK;Q+-!%BQ6?K@\AW%IO$O"8"[>
MT!C%#S[[#BMGZC43-W(O/*S$#T+DEAFWIA:HHR%)= /JU=2XFH2P2!K_"ODY
M4+]=<NHI[);//!N4H'P#0P7_AQ.DXW$V."TQ1R)3$$,HWG]JW#@-5OI G#?>
M-IBT2)O,9##@S,UB[(N%?/,C**^87@N_IS)#][EC\][R87YRL5H%WK48%[__
M\^6#J:\599%;RI-<.L/)YW:CGI%/T,BSN#5:?,%? 9]F5H'5815&#4J*#3#D
M,7%?QP:]+F0\_^>7C^^ERF6"<0.*DTBIY1WH:#!^",H=(V+*<(AB;,-/E$(4
M!LB0J%VX$PH[PL^!Q.=8-D6Z ]$3"-],W$D,-M0E=:+FE9B&DWC*C:@46AP1
M!V2QLPH(TO8PI;JNEL:2AH69#@<8V$=+,2WQLFI<&[W#_IW]FW!0%Y<FZ4QC
MA:E5B1GWCI(D$H(C,&N0-HW?W[Y?K? \GPHH@SP,JEP!I1)LX1_"]N(I4D=:
MDF$]!0Q (FF&M_"34)K>B('9<&:.'#R@ W0VH1,)QW2FMG_+Q27 3@I1A4+Y
M#?^Z#>V9+ &!$LB^!_B$ 4R7E1H"*-VC-\P) Q!AL\2+7;1/1TJHX2XC($>T
M8[$_%GJW\LM9Y[, @OQ5Q-%[$5]/A?--C#6RQ)6Z8V9$=GPY#6;(!M2623M"
MG33/"E*IK?GN;ASV-UU<L6\-X/E2F<&ZM*8KI/25G*?O7PDPM_30-(']D_#(
M3T7 34W*S+M7ZMCC22<"_7FLB*J7KM*7HM2:KD )L:IH"5IZV)[MS0K!9!4$
ML%L]:19ZDER9;;EL#"[?7]#EA<&CX3BE%D[.*B0SC/U9QEOT! 5S8B,W**%0
MPVX8VGBI4S5S%*+WAK0%JRD-'Z0#?'%)[]"L E9!)/L!"3DU)@G8$)+Z:8A)
MXCO2#Q2IQ2!GH5DSY89KJP''B'"$!7$V/V-D:C%CWAM"P!\3+]57Y@OBD78,
M!HQCS(%N?5ZH-# BY%)2A[L/0F_\([!(4-0%\ AVY#DBH0 @J5VXR,'>V:'G
MP@2\63 ZA2I+"*;)O[^DEEYJ2F@'T#"N(EJ(FO;GFR\Z &-ASTSM9$JMRLM2
MJQ+%@V[QI;!4TB)@3"/0CV& 6] VY\"T2,_DT*&Q\)!9+@@\2@D449"$3O82
M+ED=A.+HO%I066.NU8?J*ZP;#S5EQ&7PH U+MW<[5=UB=AL&O(!E9S0<T^^-
MFT9N)3@(X*F'U-)D_WON#H>@( 3IU&0_ G/ [U.HY':R3C))48,J_53,T$1<
MI+Z'*$[&=$\4*Q_J-0H>30:1 >N@8OU)'H8P;I+Y7__+:K??A*Y I6%,2O',
MI7_]%B0>T+K0EY?;F9I38FP@YH ;,Y<->IQ./;AS;UV/X@!0D@=@7/O2-8K;
M^\<"U&B?B?0W !"A/3D> +YFB>W+([Q17EM0-,@A!._=@$R$@]1O>"6"FMFS
M]_(&3UO"3]I98M_[96EZ!N[(+:7HBIS4$]W\@X;XBNV2/$AY8=F%7L$49]^G
M=D?7DZZ^?Q3%,/RQ,BL4$5%SRP[32PE<D\OW45C5#::0_/D+"QE<SI?[Z^R2
M14XK/!A7C(MO,P/,;@U#<:G>1$$,ZF<24MFW";!BDL<&UDE-K_V,[+I94J)6
M^71F?W=GR<R([P/Z*C+U783P+BJSJ8-KXJ8#=W/[);"5W<+@1M]]?'=%<)2<
MFAW"<O'( &C17$Z5YX+QF^@!6)I'R@X<E6_FFRE<[#$%W*1NYR^92.=WAU;Q
MB.3=(?!)NI"<V3Y[-$#=<0+@@U^!Y]U3ZP[CRZ_74MOW _\RN^(>:SCV*0A'
M81!\,_X!$@+@#<@#C!J6E)NW5$'#VL.@_+A> 7SO;KY^,',WICH?E$@]2WQD
MNQ*?5/G9XDIU:GAKWRV VP;.-UCP-P 2(6%F]DR0O!%C^*@^YM;T$];PC:;R
M@@X6IL5%YJ_G<+L9]U\1AX'+54Y6V%-V,4>BB_2_U5>D4BE@,VVA8A#*C345
MRL&TOOR_YQ+*0^;%JE3N,Q()A2UB#6]18/6I?ND$EX33 DMF%N(0)-GGKJIR
MD6;(D;3[JJ:%+.:M<-(?AHKFU@:%_)+ ^H -$6?+I$\3V-(-221-FC25H2,M
MJO2V:X6$XT*X ,8X*417J'!OOLIO=G!@L&& JP'U2IWL'PG"X"V<.)+8SP@H
M&9%D&S?W+A C$A0^&Y.'57+9>1C$:(T"U=TE'J8;8,5.9^IZXU#(:Y%(?$\X
M6,@+ 'G3D&E[1&HK7=/0\=%NR:IL*ZL2*XAG04:2WSGJ3C,-7TCC*?31N,.[
M=*C/0_@MBYB D=C\=18KKX!@4_8\0(<<#J#QIZOYW$.-6H[ FO2*4?YCD\GK
M\RHX2@.U6M?/KF;+QU'Z?V% 765 >-E)/ V(S1EHLU$H&7"ZS,J=VW-5&U8*
M.QE%H]Q<9,U(BQCCLD P <\DY)W;6$\]RH'5)?2SQW^@I8Z*^P18=4#NORQ"
M1/%HA&,"%K.\"=07C[<<7+T?Q&!&+SH]OKTQ?G(#&3.#RTT?TA_O/I.7;^*B
M^(-C(H\"_,(7#51?/G3O$-J9>7ZB7'!+UI^O@7"B>W[0&"A4>EC2VS>P W)7
M<JV^5%OT 0%W^'9-* \1(1WHVZ!J7P>9S)&XG<H;(+89^H$\^YZ49I Z1-N@
M@ SD[1>) YZW-"9/GT5?6":]".5GZ-6AT :Y0#*Y-3K*QI%M#5##P]@H8AOW
M"*"0KA607:!6Y4AV4: >=+G,;-<'5HM^F0PR&/UI@MX*E"Y9C>W\F;CRNM[4
MW@0.%(>)$]-V(^D<4 ]OTU2$7, >"AH$S)C#[1*66L!?T/$FKR=U\-#^D#=F
M :LCDNIZO"K"5P:3N1A#P7.G)>7%.'$4 P[TX,,\BF0<C,XD4DZID:Y%L)8\
M A!S+>^KSY]@>U$2\DZU\73D(0M!#L2^1-7=A.0U79ZH8)Z,?YK:C"#B8US*
M>*%8H@Q:P$.2Y\R7,*D+5H^Z=0J:$4.(*IGCD/)7J87#?F+0/&+"H=_2<-[E
M4=:_G],\5B^ A9Z4B"M- S-GFOT,A_2KO/>61MD2H7P8X65RD9+1PTC;5G9)
M&G+*"9=V%KU:PD 0&>>Z\UV#0HGE)(W]7GZD,H?CM7L'/.178"^Y^Z^Q"WH6
MQ9AFGDQ\:7V4>^,8!E %Q*.EE5:1!TP%5D[Y,HD%(G"FDGUMYAHK!,C#.*E#
M"X;-#XA(S4ZMG-ZV(I[M<^H_)\[GB>_(T+_D;D] 0'SPG88I[R2BJ9!>+AF<
MXG&TL(KP !-I8DL)HOGGF6U_AX,8<U"QNB$GQWL".ON":)V51W(7(/_(OI?6
MQ>\W9A;EAL%J$<:I_92/NY$;,5? )P\,W/GG_#I5:C9?R(2TO]1Y$QOO7>0Y
MZDI!;DW>*^'%N,CB<F@!LD@068JKHO"RG9H%&.KP4/=OY'3Y*0%VF]HGKES(
M/X0':.)C<)OX7CS*,HR1HI&TJ:(WZ>U/_\[8/[7A^D<0?'/GMKJ>9,R@@QC?
M8<0!H,]%BG]7H Z@M0NJED-F!ZEU+\M608R8F'V4%]%%=I\:7IF,PN-!2R0,
M\,H18?95CYROPX=ZPSI\:+N.,:'-G.3BQT\??OKZVX^E.+ONGG')A?%;Z/IE
M2M#F :QK\E"4KR +;]'E!_:_R6ET63<@S>H_?,.R*OMD2ZMAG2-(M@+ (]03
MJ[4VI'_I&NKK56HU*;G*,J"8K]=%@S.=A)U?O-K5HZ?29)QB/DI]!V0N4D=H
MSTE"2E6GF-'1', @P(-NI[I3&=-%<I$[[ );F>CPP&S2V5!T7:LLR&BC'5V%
MCITYY6A\=5_7[/-]'48VIV']J*IP(RHRK4<+7J6Y"JC*E2'7@I$_*,O^@S$W
MZCH/6=H=C(:Q$(X]1^+C:TE:""=MIEF2J@F5N@EE4,#9MH;#@7;0&%^2K8E=
M/_*^0&J6"N)D*.<LNIOW_U]1#U)ZBS$.DUOT7#@!1<XX:>ZZDT0RB@7CD-"C
M0LDVI%S#MK #F ;'>&J#4JU48]TK98.F$%*R0FS\QP4E!Q,N0&WV7>-]$(Q#
M-/PY,N=K@ 5+=#5['J*C%X/.@4UCLTKTFMJDJBD R^A1_Q; +GT&P60B,O=-
M>015JC'+*7"KGGV?@W$0?DO)'FQHEX)<,^_^/'4M(PM +/"UD!,F!KR'),4/
MO;W2 YWWEU_CM2  R 6<N\&@'O2ZX'$P7>N\Z$%G3HX2KH/P#G3/XKFGDC*C
M)NP?:E,Y$R<M":'!(;VGP/R4*TFM_XN!/]E.4 ,V/J8)*_149?W( !FV_G])
MWTDC:=#XERF.YRANMI3 ^4)^503(T_D/\K#9U)^NY_0IJ=EA;38=RY5E 93_
M5>>GY(J=46#?%%Y:?_<'Q RL2\GO+#688THI.K,0FVEBXC6F@K 5&<T%.GR!
M.:P.X<PM/>](UJSK;'%I?!]%R=IT,\4]>]$MIQ@:8"K8/VHU6HRD<7$%(G'F
M%D3WS<*/[5+^\BFX"QQ/S'(?O)1Q%C/N&3Q:Y/(&1NXM^AGD7=HEYZK[ 5X"
M8_AQ$L&*6#LB-AE,7 ;7^YM_%N&!3H:( Y2R0\Q<Z=)93:<*7R-7]@($\.\W
M-*)TXU ">J2%-.6=/2%7*91KR6QSZIEYA=?<H(?D@C.C1KK$S.&0*P/QKR2\
M\MQH571,+HYG\2W X,K<@2@#ZU?$0:5#FL9/BU"98O '[,/^9F9BH! XHT3)
M;R$@KN"$K&6A);?IV2-[9A?@OZSLZF**15,":@->YI-JE-_$N_ VP'('5.JA
MF'ER#?AJ@@;E <HZW\)@##K'/S]]_@]J?&8YVIG&OP4ZDFR9!D;=7\LPMXA&
MRK2](<9QK6)E:8#42EUQJYZ'S[-BXML:G&O*?CX'<#UXB5P"("3<[2IKDBY:
MK*LIDYFR867DHG[_C$G[A;'RF?'-H;19*,8H39ILF\7!D8F.[(A5^;+X)\EW
MIR# _DS(B4/.&7G]8\@Z'^4#1\()_'$66%D<F\+MBR-_$;X?+;P[$*JVK \#
MLH"'(F-0T) R.PZM$K\X-P R"7V>5RWT0ZIEM'K%Q:8+HM14O@S@K]7=Z;IS
MQ:7H=\[%DU&7J#AD(7.6I?TR8/XEW>I7D;SNI;1]W/PU8">:1E%:D,$T?K8=
M'$XYVK^$8"2&G*Z!Q#&/BBN<NM&F*_F5KLMI&!D(9K51QYC-IP$@HO2,7,C\
MB;$-#%QI*"^S?-Q04!D9^%?AI-(07(XMD%#']<DI"^^O+=#UDY['PPM7H:";
MU.H:]LUB32XP/1=I('5KJYP$5&#2I]K,*+12VS*+B"YN5$_1D8QAJ2K&[B60
M7$6TF$A-9>PX&IH=5_C.1O61<$78,CQ"V<SA8"K<@/QKY0HUS:02KL>"_"*I
M%FUB70BN1 '_AC-R(_Z#0TM@&QE:/U3\HPA2+KG1U$MN7)&+XU=R>6!X0C$L
MY\<L("=SG:2A.<Q5LG2Z5BD7S!M#:[3'+ 1#!4VB@_P7D''2$_,+.O>S4(>M
M2@_M329O]EVN]B%.]]"]_P&K5B[UB^9$TE0!/-*4^:*5PT:SA1O62P(?(<WW
MF!#.53M^ZT9.$D7X3T;F*]_V%E'9948UMK9M1I7 :%)Y+38/X*-MZF!6U4NV
M_C)2,ML-*EJ#/!/?(N34(*]=+(S%24XJO^@V0"<%L>0R+23G,,CF4^4+7M/
M,2E&)F@=,0<@XG)0=(*T0RF5#B*+1Z):<L_Q?>D#5(/N; ]#]-"S3DQ6;K.X
MD4E !0-L3#_"P )4TRX#].P@JQ?^G1L&OKJ]$!BWQP(*]()\S#6J1E)\"X!.
MMIPL!\&.6&J*/Q,4"SD@N$J!E_:\!/!,7C)HJS-B]'.10,=%A (C76!R7$1>
M0S?)^1R!%$K%.E6(H&PQ7=I7H3+!47!\<VPDSQ^[\##H%9/SZ(+F-1V3$=F>
MC:F]H"<'?A)1KK1^MGA5Z3,RJB*H<'QXDG0<!L6 H"YQ3VX;F)'PC6^<2FFG
M,"[-B%Y;T"74VG#X/(G(S_,[M"F+&+/]R"(=+=()-V$!Z[ 4?R)'4+IL+BT)
MB.&.$ZJ)F:%Q,/J#2QE$6?W0=Y^Q+*3@NJ-8$FDL-=X,L>4R0+\$R"EEL0["
M^7N_>;)!. >%BXYR-CK<HS3,F]*)<K0/2KI]FR:1,:/,4Q1FV6OTS]0OJ5AO
M7Y^2W@3]O/?B430'+(2<+&.0M#9:5"() P/#TF0JYARM"0,E&0#@]J%PWLKJ
MH5LJ:Y\+]U$IS$--BSMWT;8$!(/EBX0 (QO0>"XP*X><=",2RLP) 1M+[V'P
M3M]UW'E:%QB1E@78DCR*L. %TL?O<^365_/0]61Q_8[)*M'2_>&%^*Z\#)E+
M1*5YO22S>X[>69*M?D))?Z@(\I7*BV'3!(#R^J5?#(-!A-0 Y7":SD>NMH;Q
M'U10N9(.NY0*BR7)5I@/UR)KY[%WZP66@8;ISUYWRDHMIU*])&&/2@Z([W.J
M%Q#X%(C3LDSV[E(&)"BNH.6P+,V<R4LXH>H*TLBLMLO0#$!22E3B"C:ID4$7
M?++$6"31=J$T$EARN]=YTVXSJES0$J3J!0/> 8G<8OZ3#//% =&O]-IXT>X.
MS-; >BDQP5O3,.F,#GI%B8TMJF+<%XDKUVBC-93V'$6]R&32E'0ET4VXJOF+
M#A\:'XS+?OVS/X5R?NX'<8$U:VJ-,B9(&9$,W0\,5"V0;SMXV>".5#FM$"T:
MF(!5>*"=D9C:WB2UD#=T!*"Y45SJCSG)>XRC>EH%Y-U2<8U4LB+L_BD6R[&:
MSU))^2V(*5TSFN85;OPCI$Q4+ VIF]8RHHWUZU3+*+IQ4E?(BO&)&;&IR/&H
M*MKAU4A%L2Z' )&5[L+6;6Q2$'X3L0HT571 EQA8HA?O4[1+#\R+C\B.GY-+
M"NAT'-S[]._4;EYA#LL$)A7QQ"7KL$T#5N_-W?)M1ZDC8!L"62VYBU# 3>%@
MI)=AV4FU8DZ]Z%OJ7:*T3'2PR='FF,+HQYH%5>($TY?-=\+3(/'&6.PW=E=?
M,FN@@OW3L1>1@_ABYM4))+W)[.:1B.\Q0&O0_0N!J]6&?^!)*TM.G4\6R5)^
M4H=J%5$=:OT42-"2V)?]/? 2OM /P5P5C\X7:+FZV>K=DCK9(1>O"]';X]-_
MX153U<Y:\9F9T]=D-$$:V-Z6NCR2B@KHGE/!W&UM[TK&%QVLK6S_(5\IZP^I
M)D+>=U+EEAV?IG:''&&I*2.8RPS$KU@'P.5B9V1-_NY3F#2&/6@L47MF/L)%
M^F&BKW_5>GF"B+C:0NI<L Z\'T]11YD"*MA\XH913);O.,'ZHC,A])9 .0<.
MOQ^AI$&,929.<V*\!3-\OK/ 8@=EKB(YEO)<945>$H*> E#A<]U=ZWA!Q"DS
M>%N?KX;QH[PI2 /?Q^PSH&&!F,4]['M*YIT&S9F]2"&*MR&7\#$#LM!U*;\'
M^,Q$(.*Z,3TB%/R6&T58PB&S")9.2;K: /&T5;A%>*< B&1B@W30X:D*S.*4
M@1ATH2/X@ $H7)LG]=S3W8J/:(1<GPY,KJ?@ML>1T,&1^DO\>+6771TCHU 4
MRX*O- #QLO3(2,6@( D*R3&I;(<C"UF[FO%5T*E@4U[,R"QCT^2<?R3C6ZHT
M>^X23!9487?."I9B7"#GL)IOOMS\3DJYU7JCVHJ1OU9)/BXX"A(E2NC* H\;
MT(-[JN(_9"7&+<2CY ?V#&O3X>EWS$[7XH/%8E^Q["'&_ &>6TVSWQPPT]#4
M+(6 H9A@2<@H5TTY3]S:54W$Z2QXES&F0);W5U=?.#:>@J;>?;E)-6NJR(4C
M\5U82:5&JV5<KJC(6F/5X[%J22^*,51RI5:TA%DML]EMKL&LCCD8U(CUM(A%
ME[C+ADM1U<K<\227;*Q$YU#-/>7JD1I/F0JW[ 6ZY0A75&= ,_F.:0%% \X-
ME4].%S$F5]2@(Y<]/;6AI:1+]Y-;CKQ6%YK4QYWAI:\N]O,C@G@?"T%M&C5!
M792HFVY;$\I2!FMR%@,:N1H0F?5<T5!&\Z7^@7+SO\%1O>E<9,BZ*C2 [F2<
M@$A?M4E%@*:Z(7P<!9X[)D_>#19O4C[LK'K(^7O4?J/^E(CH"^,*ZQHQ6Z$*
M()GW/SIWAD!9=4@JZ/>E3&,9SHQ9 QH<T'BV,S!Q4 />I@5YG1 C4^DR6UZ-
M1.K"A!13VX@UL,.WN=+\6MYKF 6Z^M@_27!X"]"8+YS,X<:,P\%:/&,L4 &O
M<Q9M*D1PJ:!)AVF?)V0'8)P@#TK"*)&Q3)^N;MY>_<OX"L857VEWK6[S8O3R
MHKVFF]JN*/!\(D5:58T4R=<9:Y>&&Q\S]%6[Y]PDOG=I^;MT2&T_=8[T33*C
M8KEY3RT)PDOC?Y>=;4R9RN.V+^#\_;]YRI3&0'*&F![FV?-(O%;_> ., P3L
MXK7KTT[HHS?YN1 I0=DD+[_$)4(K?BSQ=3AL6+TAHFP<PO^/U<02FQL F5<E
MOP\:G4&_]%&ST2K_9,50W49[4/YDVY'ZC6:S:B.UF@VKLZ]%]=N]/8TT&+3W
M,M*@T;:Z>QJIT[?V-M)ZU'Q%J,[H#@2%%/@_/[1_6)V6Z3A"3"9O)#%2 H0U
MCPW26PW%H.33.)B7/)3)$_#DN]'*\W<<KDBG,W<\]L216#Y)K$_V3,C4!K S
M?+2V/.)02KBGG"H>5P1PK$$\/>A0-E0/.B&N\.F!<T/7C'L SZD"X">\47S&
M^__"+AKB);I3XAF#!-U>;)8Z9>IUS4(*+"0949Q+#:!5 $(W_"5=GTDRVRM6
MG2I85&Q:ZM'Y68A]<.+U2$2;/S\<HTBV]=BUM5HMJYWL@3:;"#6I\C^?J3?%
M%ACEF*CR0A(<#+T3M>4!5(.@!D$-@II3U "JB>C0.'(4W:TB\#N,$W1+/R=?
M11PKRE>58M>#U4BE71&O=CA;86NOYO$!E;O4*@+ VB< FL:FI'-\*+1,J]TI
MI)5+8#P$@,(9TR:;FV[QU=;P/A6($CNRBJV':Y@^"DO;S1J>>X1GNW42X#P7
M%ML>=FMX'P^YS>; .@EXGPI$.Z>A(9P'^G;,KK4C>W[ RGOL<4B+JA!7V>I2
MR-=>S=7#^IZK/?JI?_^<8?\H)\S2Y,_4@Y%/+]?\%TM947^K'1BU \,Z#>7D
M5.!9NR]JF)X"3%N#DP#GF3#9SFD8U&<"[>9IN(M.!9ZGQ'[/ X.M3O^4/!A6
M[<&HDA7]U-\_9]C7'HP]L+]B:1?R8?R\MNS=WVI?1NW+Z+6&)Z&DG H\3TGQ
M.Q68]G?4[&IPEC.^TP#G>?#7OM6NH7TT:%]T![V7%8?TJ<#RE"39>6!OJUUI
M%\:NAITLG;/2M-MSCHFJN?:T*0*_[9Q=_:3 *S?.C@R[G2VSXX)N<U9R9/BU
MS&&_?\!6QJODQ5:L:[NSV@B1-V1L>!I;B)A]+[2R:",%?HTX->)LRZ]K;E,C
MS99(T^_5./,D.'.V:H]E6KUFC50U4NT7J7K-5HU4M73;#FTZG1IGSIP1'=(_
MN *IS&&S>UYXM8_J(+OY,U]1>>^-"L?+7W Q^*><GE&MU6YTR_V/>L^'2W[M
MF)7Y_V; _RVU3L3JF#-L"CHVQ&SN!8M" VS9605>_.S$ ?:$0V<<-Q2E/LQ4
MRD,^4G7:C3@(OG$3'FJW4]*"$=LT7/_\>76GA1,!ZM^,TMV% AO6<:>U(G0:
M!M8F37S9A^D1C0NYZ1,\F0@WEJW1Y6)P$8ZP(]FP8X3-E:CUAC'W''G40I0M
M#]>>>-3I _L &4XHQBYUS* 6?K*#7+X#R,1XT6ST#("JA[V9C0_4G!%>2SN[
MNI$<"/OPX:A3;-4DO[34EVFW:9A-ML'C[E825F-NDB7[P;K!>#7^')YJGU'G
MA?8)=U[HM+J[=%[H#O;4>:';VD\/AUYC.-C/FO8W$G9>L/;3Y:#?Z.]MI$%_
M/]T@!HUVJ_R+'?HE[ FA8*1>I^Z\L*6F7'=>J#LO' (XW'G!V -\3A4"=>N%
MNO5"W7JA;KUP2 #5K1?JU@MUZX6Z]4(UKG+J>N$U"&H0U)T%:@!5#$ U"*J@
MNU4$?L\T[;]NO;!YMG][)0">3X:9V1J>1AWV4X+H:>13GPQ$K;H46=UXX409
MK&5VZ\KU1ZU<W^OV3@+>)P/1&GV/6!W$M':%=UVV\ Q&/_7OGS/LZ[*%ARI;
MN*)>8>V_>/;^B^Z@MK7W:AL.3L,X/!5X]D^CV-NI@+-V71S5D]GLURT7C@?O
MX;!N,%O7*SQE#+;,9F]'CE%7+*PK%IY7Q<+=K+.J%C<X>L7"?G]P7I4-3J9B
MQDFC3;=&FQIMMD:;88TT-=)LB30]J\:9)\&9LU5ZVF:O51?!K)%JKTC5-7N=
M&JEJZ;8EVM3U"L^>$1V_7N'0;#?/C!=5J%[A1E7))&0Z5J./!;14^9O75'C-
MO1-O5&$GA)S^H01$,_O$'L&NDGCU)TM.N6-6YNM;>1CH_SM-P]CF]JVX'(7"
M_G9I3V"%KVWOWEY$"&2]R)GK7Q8 5]SS:N ?O3#<*A*T]*(!5-EQ*<U](U0Z
MW3)VG>TV6C@P63CPAR>H8=>RK*UKV T;G>9^BI?U&MW><"\C#1O-?F]?E>>Z
MW?UL;W^+.N^1!HW6<#T:U)7GRBO/5:^R3UU<[@1JTG!QN6=<X4A6G^9"C5QG
MC>6Y45=:JRNMU976ZDIK3U1I;5)76MM#I;52$[2NM%:7!ZK+ ]4@.!0(:C*I
M 50345UF;$_PJT2:[L%@47ZA=NW:(4SU,0E#>Q_NB7TEX1X9##MWI3]@SL>1
M0? $*39;7KX_*F>IAF8-S<-#L^8#-:RWR8%N'C5-](PY1+L[J#XDSP!C>[O"
M^2!)H?(8#N-CK+;BOE0<^&"6X-GJ[EOOOK)4V3*M]K:EY@J5LHX1-GL:L&QO
M*Y-K2.ZIPLL3 /(LB+\]W+:J<@WIG1#:; ZVK8E1,X<]E:*M47:W&LI=:T<V
M7"F-_0Q<[5__^E]6I_W&A_]8W3?D<Y]/:Y][[7,_ 5];#<T:FE6%9LT':EAO
M(W9:1ZWC>L8<HM4_:CN)9XNQ[5T+8U=*@S\3G_LOP=0WKCUW9G^O7>[/V.6^
MF\BNO4$U-&MHUGR@AO5Q5/>:0ZRH3[]M%$>-L+O=@-:^]TIH[K\$,-%[.[2G
MB[_5'O?:XUY]OT4-S1J:585FS0=J6&_3..T$0K-/ Y!';>'U;/&UU=TQ*Z-2
M6OL9^-O?);?"%\9'Y]J^37:KO%:[V\^#)D_&S59#LX9F5:%9\X$:UK6[_2DT
MRE/(*3H#C&UW=L382FGNY^!O3SQ7&)]__"1<[X E.L]6<3\?8_ID'&TU-&MH
M5A6:-1^H85V'N#^%XFZ= "3/ &/;[5[M<J^"XHXA[K^Z_M@VWH>VNUMA]-KG
M?AY$>3*^MAJ:-32K"LV:#]2PKGWN3Z&ZMX;5A^098&R[O6-)I$JI[F?@<[_R
M?6'\9^K&]C<1_JT.<Z^][B?@;:NA64.SJM"L^4 -ZW.$]4E <]<8[!IICP+F
M2BGO>8-B%,1Q,'O=AFG'03+R1+%IU<-=T5JYAY71^]<UX7R\H_ZH<#NRH5 .
MN3WY^ \+N JPCG+H4=%Y!;XC2ME'^!H>/*F'D?@8[J#'+K.Z*--NU@A3(\SF
M"--NU?CR%/ARKA*K/>S6"%4CU+X0"JOKUPA52[2M>%"K-ZA1IN9!^T*HOMD<
MG!M"K7(K'0C?R.'T*K9A)?#?L7OW]_^&_U&[F=GAK>MKBWXC?\%EX)]R;L:O
M=JO1S2/)'TD4NY,%_^3Z8^''KR^M_CP^DI_/PO/ZFV%\C+!Z<5H'S0A%[(9B
M;$S"8&;$4V'\%-CAV A\XY?$6QA6VS300=(PC/28SQ,T?R/0Y*[/C7L[,NSY
M/'#]&$ 4!VL!M 0?7OW?_WL4(G:5/MS7UFB8U[!JSW4VV.Q-,H,C6@!_G<V%
M']FQ"]LAS#<NC?\5=F@(.(:Q\58X8C82(=-YNT5;;6^WT0*6($YTZ6AY/L4L
MF*8!#IX]C\1K]8\W8S>:>_;BM>O3-NBC-WF,0W0JDC2B$C]^<^^.X^GKX;#1
MLJR__)#ZE.7$_+35 +"\*OE]V.@T6Z6/FHWRWU<-U6MT>\.]C#1L-/N]O8S4
M:C:ZW?UL;W^+.N^1!HW6<#T:'"9J21.:CPYIFKGCL2>.J=Y\LF>[5?XY*&S*
MKR^.#QWDV-6#3JFN=7S@W-@>BKH]P.=4(7 -4M[V%R2>4=R#L&>!#D#PX] =
M)2C_GS& KCS/"$"U"W,*44U1JR@J&<4[WS8_"P!-[5!<CNQ(C(GH]HQ5IPJ6
MMV!H.G$04HA4_TUD3(38+;=P&R3:P(MPBL#D> _$KNM5V'68S-6-X-9$J!6=
M>&<_=45]@R\DP<'0>P@0JD%0@Z FDQI -1$=&$>.HKA4!'[/,5/OVK5#FQK
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M^'QBE?HG%ZMTE*JW5W2SSH[ 6/-A+0<WGD43M,VW6UYNE8M.<\[]. N Y!H
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MU.RTZAJ75(-5XT?1JCD(M4=4W0ID)D'7L:,IHJ.:.*:O6$86:*8!)\FKBM1
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MX;E Y[@='7!*5Y_//1=HB _H9[9EF'6I$L>KK21BG/"/.>I;*>=1BUVC&^C
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M&MV;C,E33TS5<)EV57_?H8XK&I92][<:=M=T!5')5^N\M>X;)<^SV+W\+JO
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MNX$'D+^#=0Z4(I65NB-:R0@#5WI (?ZT]T.OB4M":,8/%^O@'!%3G;6UU7*
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M /9D]EID\H74B_!0%B+ @ B@I[+P6$I*WW$=MGP=X# :U-<X3XQ8M\PR*5+
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MQH@60I4I5BV WAKU1CMQ UX$Q1<#Q4?ON</\JEW@)DI@]&1!*!0&Q;$Q*(X
M-5%7I(E=Q!^[+6(7=*T'FD ^**0%8B7 7V-=I5 !M<*55%0H$$T!2<R9>6;V
M7Z2PV"\G".7\'DSK"86W J60*-E_I4X_L\94<U(T[@)7E"17&B<B@8 1(+*%
M&/85MUH0X /9>F=,6B,>>"1A*FA^"U(/OG@%R$'B. 05 SG41' +N@Y?<  ?
M;V3"??X63='AT*]O]1P?32+;P1SFS].KS[2Z2F;4::4H5&1BFU'%Q+9$D00O
M^:QV@)NIYK>MG]\6Y QP&[\^P*U5D_%M<:[_P$/<3D%')B:Q<72MS"2V0,U.
MXWY4G6:GE?WR(+P5E2OQ:J.:KC)3VE+3=591E/(&\]K&^KSV>/NA,);YQH?"
MI'*=]4R-P^+N[[[=?KEZN/FB?;[Z=O7]^D:[__WFYN%^[8(3,UMXF7Q(3DK$
M[8B]@37%,WL1L(_R+Y_0V9C9+Q\=EY9!%WU*3X3!?08K2>@!@B1$'?YUS *7
M3<X&H0__&\LGBZ\OX:L/V<\[O4NKG_]5\]+(_7S=K0SKTFA:U=VJ\^JM/M!;
M\C<%8N*F$-+1VCIN\'W!!?@D-@*WR5B$&J4*-&0C6<3_T5S\THQTI2^6_V:V
MP%L<2/TT><L#ZNJ(^\+Q8=[<QR4<[-4STMA,8B]I+4,GQ9:$7BI!"2%>*\0X
M*S*U4F0J+#.B]Z$RF>$4/R11KN[ODTI[E5DZ>WIY;K*.S!#O*!+*X=R"]^4X
M04A.P?V>.^/QC!U235X+7%1^0/]81DN<NSTHJL[V*;Q;O^.N*FSE937ZLU]+
M#L;:C:B( W-@3_8L-9].['615VYJ-=#0^>_[7Z7>JX9<6P02M/4Z)"CRPI4[
MQC]N8D:X"J]MW\?Z@']ABUY1$%"K,6BW>GJWUUX# 5IF0Z1L;;TQ'Q0OGPDO
M6T?@Y79CT.KV=*-IUH27*W*L:FR?KIYL9V;+NJH -D0 $_ $U#M"CNV]7^N9
MF,6(D2OM)R@=&S1]1-6OGG\/-(U+BKZP81C_2_BW:3F9.+_8^.)OYGLY(M(1
M< GFI[(B\@JK%E3W;YT9-JC*4LRP66EV&P-#[[>MFO##^;OT5W*F D<<PYW5
M-9=1C9B-N+*4 23@8)]A2=+,PS(IH4NMW73IMI[3"8K/)ETJR/TSHO9W%NXH
M*SV4%:L)\M+KU\3%4 RP47]6R !]9(!NOZFW3.5C'HH7_G2'SFP63?=@Y33A
M&3L2F^('7G:."(X/"7_SP<+L)A'=)DJ$V>OH9K<N+H3BA(VG[WUP@M$8]-M@
M&EOKALDH5[)JEKBC0OC8C\Q$A=^Z:[!!(WXG.1BSV#78E?G-QJ#;UZU>MR9>
M@=K[33JPNKUO-0:=-GB%==G[#7I/UAC!0MDJJY3]U?D[HS^P[/XEGD#)>Y%&
MJ42S\DL+:6$BJ3.^X1.XKMPQF37R1W8520N\4JNI6ZW262WEDQY('^^!"]K
M!2U3-YIUX8+S]TAO"9-""^U?+!G@5'YI(8W(J?B 1(S=DZ+<WVD,>BV]C55_
MM7!+U+9O4H&5;'L7CN&&;I9/Z!PY/KEUI66-M>$#AT)_U3FLA@YG4093[(U/
M7!=L2EN5<7QZC0%H_A8XP/W2VG\G<:RJX$O)P%G+P*;,71D9Z*,,6(:A6]UF
M[65 &,F5-DK#Y*UCNQT6FKB2]:&;PUU_MNT%WSWW8E1]BT%APJ^[_OR/FS]\
MQ!Y"H$/$@^+H$5@DO\  ':^JX<GBOBJ;*1J4XY3]@72]<L<WDJK?65%5W&N"
M*NZ9>J^KBF9JL_T;HW'5;;\!V]\Q=*-WZD?2T]&+OWG>^-F9S83V,YJJ5J:8
M^I,$+,KK9F/0UYMM\#J-JKQ.E7K8M[+;=;-;M-FFJ3>[*L-PN Q#:+N/CH#\
M8HA4&;MYAJ'\O&**[BL"/+)O./DZIBP_>.]@ZBT*/+7[>K=?E_I8Q0*;U%^U
M+(!->'JOW=9[G;JTE)Z_OW<7(? 2*2Z\R04BT E@0J$;V\H)+*8;(ZI^8W;
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M-'),6\HQ+:8DOR%A[R;71.9=9<1J#,R^WJU-!;':]DWZL9)MQTH0HZD;[;I
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M@,(N&XN!53]FL&R0FS_A8ISL^#<;_V8[+LH?O%< U/NR].&_/^#%O/'. H:
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M2NW$Y )89LAF#B/ZPFX_,W*//)>@/&RQ<1HN;(&? *<'VK,33HG0[-<"W<*
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M R=GL GC]2_ITFHST;_42V;C#9Z+#CW79C^=X*\?S,</P,0:T8M=F/&;8;U
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M18L%?DE&,D*-8;@BYGA:-N[$+$VRT0N_$=CS)YECY4)&3OQ*="3!)/A.MH^
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M A+(I"OO$2V7'N\S68N7;/EXLOVH# Y.[U/O60-&Q93>2)O I9X?)& !$J_
M2^[P[K"]E&*#R\=+4?5'R;+D_HJ2%=C3@&'V><83,3GIW1H4'>Q5.J[NK[5.
MLQ.C-!#@TBB!$8%8QB%;!!^U=\9[64/T$M47(LW?!>\E-IR4CT_:.W/EUPOF
MDSTF6+CA#!N7>6MHZEYP8>M]7-:SF@+F_4GP(^M]5."4_YNH,BKWL4'VN2@M
M[]KOX_K!" GA&4NZWA'P[GM>7LM3N@'<*I@XHF4U_T% &STJB91X-Q+5*HNV
M@%6+Q*Y482;8>U4J:]G%O#=+MJ;?/JU<)*4$.<_8J!DFBNVJ<I7O3\6X6/0R
M6RMPDFO'H@;>F2.8P"6[C+K@)$;TBI@*N-)<Y?[.D1.B!6Q)9(3$*GA#7A*S
M@-LG7AI G5(L>"^*W:EB&@L,7G^52^T'B(I#)0MDL*,LO%1#44OBV(''NK!X
M6;LH1!_V,%E@SNT38?T[0>K3!/!*FA3@DD_A]C[^,V5YQ5.6@2AE<?RQ?$_M
M772W69HHT2W>I\'S4]Y#-$4 7(?_A>>*RJZL"LSTH?N,_)I8.T:OAZ4,O#B%
M3BZB'/Q=Z(59Z>(UG7807 C,T _PC3,?+OV $OX2_N:]%C4JDZ;CW70V_ T'
M#-!/H^?3\RXUZ:"F>Q4B1I6-*((M5)_<-GURO5KUR:TK&^E1V<CZYK=6;O.;
MM>D =DBMO,[#"6*=*T&<O$>?>BF\9\26E57MY*RB)$93+83@C2+O-MF5%6%A
MV )A0WX%;@)I8A)>H22HRXB0 #%T,A8:.^"@N"EIUM:+<Z;C1,+NH=E91#C:
MY#EZ(,"V$/[,.I0+TQA\RQ[-WHK_DJ_FT<_6^8 +/>6KQ[C>:,P"X8%(TX$V
M/A(PZ6Q[(^#S@+ONHHE0&GI@1!PL0IW]L<66E9U@(',<B=@RH7SF'*ISVR6C
MGKQT%]HSEZE1R,TB=4MF.A^CQ7"0O>R290-BK!OH#!9%*#@.-6(T8,!@L=:+
M$OTSN=Y#JH>$1'^-CDO#\D3=A]*:XAB8F4 +'+'$1J#W-J8>D,2K76KW*P['
M)G<@N8MCAD-^\IS!/.P@.:YHC3:6*UWC?SY,XQ:45+?BG($;/.9#EQ#M4.CE
MZ%'1>5N"]7&7<07?R*797E2='[G3O)N4#(F3N(]H&0P"B6T:[>F$QSRX0Y=A
M:WP#"C7S$N$G#\DNEYLDCI,$0N9H@=RMPQ,XT(>"^C$SZG)OMJ-SKEE#'$<?
MJ!N908]ON\ 3 0/&49'@8<$2 UAH:.<$11DRLCQ25K6IA]I &K^,G^DGX&*%
MU I:C-'7'(GA1N(KA!F! X"'/:N"H*E.V;A9(\DW$CURBTV!_SN0?:R-,93Q
M.U02):SAR?@*KYK'9,P:&VD),1#96>I-)-2(!ALLV!CGF FK)\%$Z8@:A?@3
M^*1\JE1&X&FTU*5VE0[^K7N6.,EQ^8[NE;9Q$9YRI'T=\E.%")$X)>6(GZ!G
M+_%LL%S9R%/("34"O^9=$T(YBG5RZ4]%(M+!\T*1W[JR5'&)D]TD;U[@<&C@
M*(<>L6\%1QZ!1;E#?&VW^,SKL9FM8R75G4IC FTXCZ8/? *5\1TNJJ(SI,"3
M?'M"^R65X'N#XIK)Z4;P*I3[Y%PE6]GMV0O8+G+2XF-1'#5!B);Q!2&JT-A3
M"3D2Y6(E1%>(XPD>*3/,#Q<O"22/&"^,.13,?F;L+^S:IRPC_@5DYS]+VP=!
MG[U<:K>31)Z,''B&@9FYYS/>GXC HG!3DH#$2XD#DNA*3+VM"&K'9V*=RU@4
M]<Z['4\5<$3XUT\XL;3+"9EQEZ[H$/0X_-X<(T6V1$5).<9\09Q\&%;:3B=R
MB-D9O(= )M3I5$ ^1 2Q@_N%HS )*6&LN>S1"QT1.HC<B8@!^(_BLXQ(NP<$
M?> MPPMO<K'P1@C@)B-?L%:YR7KJO8?.C$\DM<=/G'2)HQH/PLD#6[P2X0+Q
MK^-N6 QS8($"'9M)KL\R2/;Z^#(,UVR*5\"V #]L&[58=Q/N"$?Q"9RSRL>L
MID,5PC.^=0FAA )*/DOQ0"P=B1&R]AI1U7G)A!8@0#>_(WZ=YJK(F@>QVQY9
M=2X1^',QW([#7$51#SG8%3B91X0Q$"%] 5J*Y\=J,ADON=1N.+]'X5^6;.<5
M?)K(64<G?#'M0 Q?X?%E_J4,%<3^O404S^0'WQZW7T>C[R(TI7A4SW(!1R@,
M-I#>DJ/"8S=,QM4$&<E!6RU.2MW8FX3,C6X? <:G DZ@HW&4LXPAR=E\DL5Q
M7@6\/-@K$!1XRI\R+KOR+'V-@*P4B9!=1FAX9%84&6&$-1SF#9H6]8"8-AQW
MOF-ACS#"(@Y,=TL826)R$3'-I81-L&VO>_&/\ 2)XQ/-5X[C<0D67M'S::BZ
M))AH1JB7"?+%1$IDY07 NBN$6<2]A+^M)VP8:09&[=1C/3?@&*&MB,C3:DP\
MGPJ9R-3A-<1;5A"IVD5,' M$_!6)(F,B1G7-L)5+R  6#\P<O(H#S;M/B/^F
MN9Y[,9= &I102?,L03$&4<F?@#@(A)-'X/K\A!B;%/FD?R0NRP1#8\<HJ7*R
M0(/<2 U1\Z XW<:)D8R9Q,P)NL[B9:1K&$$)"M/+\2A3,[X2U,F,)1#KD$PL
MG+)L1$N^:K *K1BLRTC80:*6RQZ"J-/<=5Y3%L7WHH,_5B5R]*^E2W3//#K:
MG+G]@KL#DC)AC@A]HVZ-XQ!<JERL>$D](+T=48(M0Z=$@<S;.W<#S\U!+G*!
M8<]8"QEM'- L\RQ4Q!OP<F8NG[QP.I6)3<N!1+*4[+4>#&JEK(I7D25\ZRD'
MT&'$JAPY)<Z RLT1ZXN'6:W< !<H0"S%09N+V+I(MQ-$M9IQ3A<'HG#S*")7
M2;QX$1?@:-\(0$4A]S'&];#.F'\^9-&S*47%,D"4^;T<:ZN9=I6[-U0%U3^%
M*BBJ:,JK<VH7!?F^EK$8''+/L[77*!MKVUTJG@E[\,:6G(*E0X&U[95S<]^,
M8VGQ">KKIH#)PYL$WT+%&#=Z1 X\SX;-'+I.G$C(!XA.8[+T(U+S$D\T6<R[
MXD+*F%KB,=':2=''A:2B=I8O4&C9V!7%,,P<]"@_ RXPQR@GITV6LXG#8S6)
M:I)D%(:.$?PU,)'/?;)D<%>>[1()3UG:$!?VH,=M"[!6M#X\L+)Z--J/3U0;
M ?N2V*6SD*OD"_'<=2!*M6+%B44L@3=RB"'8?#'S7AB>]UV&,XXY0/@4I$D<
MS"/Q0^X4J:H+R4_R\F39NV#]U9\6KI \-;?R%<4FD$P%7+!(;"15A,CMB]]$
MN4R447PUH0H27]*>!O*L["W]9*$4>87X6:7]%)B;7?=R49C$XV5%C(]+HFF[
MI)WQ&8& @\1YYC*30E,"L!J$2ALI7OLCTO<2FCDZRP$)$FF49  O&0H#8D:I
MK8A[\2B9GD.;S( EXCEU@%S&N9M7[AC_N(GG;J[S<JR*9UD?6 GC6W+;OC)G
MM*@1.2U-L?:UXY99^8LI7 :NPLR!'XU3F*0D_1*3?76(*8YPE#CF_#S&,\@^
M988$PC$*8-0K&P\P#>2X)UZ6L>6L^-*,?QN]VUIF/^U>]=O$YE'0?XAI;3XY
M)C*AI^**% PW7;TZ(OC</8/D22*"&P[X$.(<L.$@9Z(R/XZLQ20&:8[CO3K7
M#4N7]Z5A/3HA(J,FX(#(22SC1,T$NHJ>*W)EY A.O1D<H()_1)-@M"OW)8(3
MX$4!X3-C;FS1D96SL>><E4=.$9S7[-'(Y^.2@!Q,W&7U!3[PU:,SDGJO%$(Z
MRU9;1 <_.3!BE#>E_239KFB'CH=GRU6&.X?P]R[RY_"!S,1P?&[0$BMWI_:3
M* F4;;OIU@5^F22?OM(4X+@38'MRJ=%[]CA&-F4]QXE9!8C:$W"$<U%&+V1>
MS$S" F=[C%&"J!V#U$$\%"8=H$@P/1T!9*)WY=W@FWQ8[O7PVRUMCM%L2I_
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MEA=-UL@,!$HM],EASZ^].8TYAQ]S.:9N802$$I,UX\8+/@W'\4?+.5:*\K3
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M.G/,9G)ZB../+V!W"&=\S!:,!(!\/=L!GXKG.1,DB^!.+_E(#,D#8W+"&$V
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M2/H,:*8A7>OF JFJ84?GY7M/\!=SZZ$M_;BH*:4REG/;X4IZ"9KSA3S=I:U
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M)XQ[VTSSUB=C0Y4[F>8M26-=LOKX*+GZK=RC*L;8)1<#?$:Z_M11III;!\V
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M;L[1XZ2Q[.3UM?W,7LRR[GG#8!ZG157A$B@&Z".*@\2CPM=#DE]6PR5=+0K
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M9<^.@/OH=Z/\A 7V): WW#E]\@)6X<W@HW#/@K\F ?RJ]T!WM8#E>C.X&RH
M0E@,VRT^PF8 #<CYS_B@'?:96VVZ87R8'=$G5AUM#3"_2I=1C=DOK AA#YP3
MV("3G.%!5U0\:#JWHG+E2^+.]UOUKI,;A#M8@^/-8-%T]D" =\/_@>>6S16P
MX?YQD,6#!WPTQS<]@M0^\U>X9/HK<-V./Q\+Q0*&M/ICGQD"QQ0&NP@TN0,
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MY-=XQ[_Q)W=Q'OKHUA(GFC0NMP2>^I*[W)9!MR7+XW)4+[UEL4)@=7Y7'ZF
M_(SR\5/Z:]V1,XYJ%#7-&I<[V$Y]?4?>J84[-35M;#7P;67DJG*^YBG'?LHL
M'7".@9ZZ/-D^T+,_,8@NIH2>=P=M#-9^[@ CC\! U#R95[BO/"I)4Y3&VQ"(
M= J6'*C'+JG[L^\]_"#!"J%W6V)UY>A>0IFAZM98KLGM)"*R/G[:C?!43[%;
M&7=K6%6<7MCMZ_'I)=^/0B0D'6 ;$L_!^3LHQ9(HH.O;&%2>T3A_?T032V/
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M)(W>LA"/+X3Q-)P%SIK>G_T0$))+!=D"J"J<.@PBB*94Q\*'F 9!4'H\$SN
MAZ$\JPO 8,H0*!)OAD5,\+O'M)QW0 F]6\'A5YK6&"51MGB9IS$@.MT2ADC4
MK>&1I0W*C6"4;?Z(8;$YK'U.6!89?RK3[]64LGMF/DO,8XX]/&*2'6?,$K"X
MR)G3[87BD YDR/4(([@:=#/LM/Q@H_J@=>QFDZ=". 7X6UDWLY_[P'_VDU?E
M>U=QDHY^M[*';$BJ+39VV&I[VG:1L?^NC-'MI,*CRL1#;0G(?$,13/&?R2M%
MF[-*@F $_:B:H&['YNA64[=%2&L%PO@<#DRU35KI])V'F>^BX5@JEE)G$>6+
M[E#U B^MG"CB2:>8EMWEHYYM!6$-ES@S-WCSGOX6/O>'?S<#?@E($JW(F<15
M3(. S!-YBZ! X0!*=4UF$>=V$'C<9!PT7]H_7UT@"G?EIUE8_MH1:&"/:+/2
M$&T^:?")GN K. P65ND%K],U'6:I%"_GJ_U,+SWET!WUF@(>M]0R+W#40Z'V
M':-B$&Z;UL(VM_$UO^"Y3Q/S.]K:(JLYIC4#2=1ME56? ).!V>\QF+ E+(WY
M/.NUZY YR*B[&>:48(TNJXP.24WR"2-]::$ 3T")@DO"D-8P](<J635%%UF8
MRQ&^NP>"Z!%53([/7WKMCG-12JVR :-WVH>9:EM*XC<L$^H9;S\=FP8=*%=W
M:\EW/9 T)R3ET:WGN&4A>9+ 3NM]E=>/[4W;HCECX3N&]&]H2#]_64DU2XOB
M;RQ[J:O_IK)VIP+PS?8'WIS"<Q,T 7$CE):+H8$2]>V2FCA*3?@.WWM!E;A6
M?25NF_2/D:9_SE.Y>Y0SJW9+K;89I*\!=E)%SU]=V\/L$=J :^2,;5DA12UG
MA12UG!5*'BX*]/&4E=,?H"'[DR:+Z!)O.SJ?BE/1-O=_F.ER]"Q-&CIC^A7%
M\-8;2^UBM*O#K88U_2*-7SM4Q"Y\U_6?<EC+G9N(M_\?S7EFPHXVS,(9NO8Z
M)&^2O[R=.^':M9_?.!X]%/JEM]S*XA*RHB6%KH6]S26 98U-34$AP%'8^ ]S
M^3"&0_YK^75#&:NR6OG69"Q5OE[W*$D:ZXK1W:.LK8\Z% G\4(#I/DPD+(G<
M23[\)B2T?PB>>+$+O-CJ/=D.P]?3XU *Q[$O/'AGP(1'0[&L/@T,=M72@W[
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M0W.%=+K:*<V9++5;IKGV27--/=XR+5RF5)F #MHO5.MHH7D#;^'\)/.;?Y/
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M\LD/YB#Z,\XV1[?1DU\>X%!!7!E-O4+?2!;>VVMTC>C4,1N=0A DH'XBFH0
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M&.C$8"L>U<K83@W*/5S8OK7U>FOKT0;-SM[:NL(Q[;8+6D/*J0=(.>7L&MT
M^NNJ+HZD,CX^H4;?($;W-+JA@KS3AW*)4FQ5H6\0HAV%;N"T0'E88K4=HM /
M@;K:.86.Y6RF*9I2F2U[0H6N=46A8[>KD4B]<$^LT4]S*7U*Q<'YI?AG#2Y3
M#N R_?P*!5U$S105LPQ&)U4H>L<5"KJ(DC(T2Z:)M:Q1=LQ .TBCH(NH;QG3
M5DNC'()UHVL:980NHJ6+4LF<GY-JE%%'-,H(TP(-42I#^#DURG6'A.^['1+^
MRI9Q,)ECVX,O?*[@M8>%\RDO$U1T$Y[*$2_QZK+FK#+L9E"FUN@*AAA[1>"$
MOK=Q-/<#'/R93"@#Y50VI&RDH$(JCBA#)L3T,S^.PLCF5Y&;[/L*N/')?L:/
MKN[R7M-H7GN" XDI X4NI#X%3CBO<Z5SRK-R[2>2N3G)\I__QU3DT=N0AF)&
MH!IP:Z"/I_XDYND7T3SPXX<Y)BUYPL(.?K HT=YTU#QB% Z%6Q1K&#7"<WZB
MP9MA8O^4O>_6\_#*[K?DRO*/Y,KR%7Y D=[>_O8'_4U^^QJS$O\[!MF(KAF/
MN/*L0,HD8GP[=@(#'H%)4U)6E]*8391RYJO[^!E3:EX?"M+R\'P;(%6K04I7
MTSF0)MA,DB*/IB@Z)F[N/.$CNP]BY$Y%2O&0H\!?P[*<!#L[ ,$6 #5" H%L
M^BM\FH.AGO$IKX7R<=HMQT(81#NAP+N"RB7FYP@#&I*T):)1!HA=>0M NCN@
M!A;)HTEZ .4P39:G P/'MD5!^2@4Q$'!>ML4[&*R^5&Y[=9UA1554K+PG%1*
MO"%]" [E5$@F#1+!,FQDX #EB(^ZQ^XOF ;+[>!-Y8G?K=1#)>E+E KK+QS\
M8#Y'*&3I4B-P>,,9"P*>265[M$S^'6SP..%9:<(L]JA[59*(.DUVP[5Y^DI0
MGV<)[5S*)<$!5Z'R7I<$*Q$PO?6F7\%2",J<N]H>G %"0I1'EFA8^SJU&=[7
M';0$+]'<"0N"<49I;CS,@>AVIDGM1/U8A[PC>KX?M?Z.K%(F-$>[U$XU_-=\
M(L1HB3-Y@&>Z_4DG88#:D-[K,N @2,^<GVQZ\V\6^&5H-K&_64,83VO<D_2R
ML-V8G[S77<FQ9"'VIP"#6E?WO3"J@M JIMM4V.UH\]A,V)D8SZPI["X,LS+.
M0/XS44R4))UZP(EJ$D$OW0?^#_A 1D5,*<:4[>RSZQY"@H!B[9N?%.?EH@3P
M),Q4#IQ'L+7 ?_?8@Q\Y9'>17<;I'999@O9#P/!C+%@DE8'. @RU)-2 ,:=4
MNV*D 3^0I,(G[G!253)E(9Q#8OMA*\ D<K$B19B*O"6A!0L.V9I'+3SYL3M-
M60 KM+#$$MX$7X E1?SA4U\(?2QSM&,L5(QRRUGZ(;PF3%@@K;VDDK!E?.\Z
M$Y[$[4P8G+"'X91'_!YGWR2#?!H3H>WE$CY/Z>P.9RTD)+DN6$:)GPR9.[MQ
M%O!23F7ZY;T+]@@FQR>;Y!1<'2H\+ KBY#3P0.&W"2Y@ U0 ,"%:$>,G %FG
M-.X5K.Q'GR\OM<[3%2 ?A^EAY\+?Y;CD[UG84WH9N0[WR;^1BY:,6,E]YEGR
M:*P#O8#- 3Z%R'E^JRAA9@Y"BCP8H"WE+J4R?1,;PM*U<<61,+>Q^7O9X8F%
MHR/4X^&L'6+ 'NQ@FKXI70]^%NO9V 0GVCL,3N9C'&"]*>:PB^LX1#)0>2^N
M&2LR_+P[SM?Z-'?<,"K"+BGBR-;#R0*,2WTXT?>91!B.XQ&OK' @3,.Y1-8D
M!,K/+"MI2(\G.Q>D:R(!LO+A4$QJ>WFUWT/LVE3/E_A;JYIWDB%4<%O*^VD5
M(?<?HY4<& J?5M$)<2TTF=GF*WPEW!G&X9+K<%X<DA41X</3FZJ)$X +BC&"
M"2N5511^S,DKHFW 9ND)!N3TXOL 0G:8E"A2 0UGM>088 T%\F<5Q?=L=12%
M_72B"FY4JPJN(_D-%=5S5MWJ.;IQ!0E*NH0,$1?UW"W(U,>-/L;%0CJSI'[-
ME(N%=&LO$=X#0A[VZ O1CE%>D>/(EUFR^,:9CR>O>25KZ9.W=REKN5-$ JO*
M(\B+<X>WHTEJ\'XZ"VXCU4N/WVX@K^'E/59.UQU08<(Q6DI)(_NU 15BO57O
MR-=H8=4J-NPIF9"PMFHZJ5H+-XZ^< TK4':1FU]#YD7!A$3!ZBK(HZ9!9&A_
M \7)L@#J7=:V(U$B]L:3T(H ->HO\;N\>S99" )F*+"GC=8?&^V/.A0&.%_[
MAQ)Z@BW@L@G-$P)O(O@!H)B0"<5-[OI5,3O\8FHZ 28&85"N#4)],!YIPV+&
M]#H(VYGDL$,6--V*@>EZN\57N;RNN94=TJ'I5L"\4H;%5*.UG;Q.N]GXLQEF
M%TXR28"+3XU?L#HQ57$!N-YP[I.OS7P_ J^&M^9O$YG4DZT%,6E2\ZYB"N89
M$-K6EG#,FUPR?>0,2&UI2Y8$B#5W:>'7(K@VJ5OL !#!/6<<>:LN.50U?P/H
MO,'H2EK:3YXDF=D(;?AP]$SREL]J0\=RF3ZJ9N"QXLPIP>-3ML:L<\M77-[=
M[,^0W=+25O;_EV1=7W!9\.,/Z:+*Z"4#!/02%A?:!;0B5YS_D;<'IJ2Y97<M
M81O]T./OKB8GJ'MQ L'6]UB ;=$F25.FI.-1:QC.VD'Y8;CJ+_A,LWAL%[;\
M2'&ZVEO$D5?#XB7J,21R)8"/M3?,)=FE;8X-WX/VMO6^T +CR'/<BFV]'A;\
M_QJ]A"9S,&Y==C>KB(N00BD&0JSBH*/R":7ER<J#4P_CH?LC7B9:9QJ/(0U'
MFM+:"!UY^PB=,SU**?]56X-]NME&?L?0%:O1_CHQ5^5_\-[[ P;&6AFP<_"<
MIH8S:CHZM>BP(4ZE;:6+Y+@R6JD]K?:FE=+* *3KG8:UAV#NIV&52^Z2+:<Q
MVO,>^=>2$'EA$%:=75[3 (EK&@2Q'G0L-#X^-)*U&@!AF7@+)LI*57BN"?6/
M-#&E!V[W@:L?';A\Z)AJM34BJ =N#]S"!4+[P(4527@3+LI:5T1N0YOYV./R
M3H\7FIA7=VAA/\?K"/2X<&%R;/,-5B2W9;^UR]2MJL^>PWH..Y.="2M2VC(T
M>P[K.>SR..P$!K':ED%\9@ZK&$*YEL'>:OW"R^N.;%Y"=V2J$2BK'% OKG*
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M 897;"L<)# IU_*C X]EOSN/;,K9H3X;C 9C2Y+%D=JW%.L,( X2DFT!P@1
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MV7QCG)LT1<$G:(J:&K<4<_8 <E^Q[WZ,EN>4#05:<V+7TF"[9/VEZPY7"V<
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MA:RM_9V5 3]YL#7&$>XODREV80T;U@F%9((.[QX_F5,[[8=Z1MU!)FV9R:6
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M52. G"@O@$BTRTX(GYV^,2L@A=^"NOSIK%[(#YZM;7O]W"FX _CU/98\&E8
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M*Y,8>F0 ,G:,H#H),D:#L6ZHHJEW!1G]C(Z*&1W]B(Z^K?F11W2<1.*8H(O
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MXL@P.Y(WTY_\[C*O5D[>&(QE71.-YC9F?_(G*^)JY>2QF!].WM*[4MIYM9&
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M6\ #..-LO:BN&%#Z.0$U(D#)DBR:LMH#ZBH 99P34"8 2A9U51%5I?&HEE,
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M(18^^!YD^[WM_1"%S\/;(=VMV-.%@]<A 069!?N!3@T/9O/#O_O>%(CT#M9
M% T%"E9%> ?#O[>GU6E996;GQVUF9QXYO<79ZYIKTS7*_V_O;'L3-X(X_E56
M.K4ZG0)XUP_@5CJ)DDL4-9=&(57[+C+V<EAU,+4A"=^^.[NV,6# 1 FVT[DW
MQUT29]?>^7EV9G;^Z;O&P'=-V7?-E<R5+B)>_B53_)(XVXUUQ>"=X#V(21C3
M/!)WC(M1PH&B;6B>B6LN9;Y?_2LM@TB0FF3>):&C\H!E"%@$[ <&;)ZNZJ-
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M6$4<KN*0&]T=<NN,0F\I_IK,'X.O_P%02P,$%     @ JXA56BF?70U7'0
MNV(! !$   !I8VQR+3(P,C0Q,C,Q+GAS9.U=6W/;.+)^GU^!XY>=K8KB6YS$
MJ<ELR;*=N-:Q?"0YLWM>IB 2E+"A" U(VM;\^H,&KQ)(@J"LA+/4/$PL$MWH
M[J\! HT&\,L_GA<N>B3<I\S[>'#\^N@ $<]B-O5F'P\>)M>]]P?_^/6GGW[Y
MGU[O7Q>C6W3)K'!!O  -.,$!L=$3#>8HF!/T&^/?Z"-&]RX.',87O=ZODFS
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MU!-M[/2XL0Q90S&3(:';4H;"IE$&BHY2_O:W%2-M9\9BQ)1&8A2WVYI8) 0
MPIE)A3ZQ7L_8XZ'%0B_@JSJ-H8@D^6'2#-:9K>P>=GI^.#42867'U:?DC26P
M"36I.BD.?S2NDUBV29U)<?BCH$[L>2R0]/ D?K9<4L]AT0/Q"%KKAZ3)CHB3
M?$.4KVC\S3T^/S\_E&_%YT828VYQYI+JPH=+SI:$!Y3X^2^P9##GQ/EX -_A
M7O*M^'W)R6LA25)$J6"]WX'7H@;BB\^5U/<V4RAA 4WOXX$O<'!)9*(VZV\3
MQU1_04(]^E^AO8NGIMH+$N+^Y16WL&NJN""Q0K>)UP/Y1+Q'U/YX,&!B G&
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M%BC'HT-6O\#>MWCH#<.V6X:]:VS%=A!=[!T+:D-1CY<6'V7B#WS3$3UP?H6
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M8?2^:#T\X1F'N]:XRH72#D$U#I?+:/<S=C,[,6> _?FURY[,.T$3CEKXE&!
MGGO^#7,05("@AH[VA",BO?H><X, P0:1%A E*! S0#&'#ME['$Y]\D<H%+AZ
M-%B#5<BT-E<F_!D+%/'HE-7K9#S>LQVD4:9,JQ$[.SLNZ+;JIE.BGY-JNI1
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MHCKS/E:&FJ'FZJ5VF1.3Z&Y40W*VB7E#+!(ZY3.?P^+\Z$"9G'1.G,40 "%
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M^R7!Y#-WAF<<K=>L!=E8M(ZS'+@646LT6<DK.^Z,;E"=R!Z*432RZR?2%2>
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MGL7IO]<=U-ZT]CUO9G'Z*N:SV8C3\MML<;$"XZ:#QJJ#];2MDU6B_@&Q$UH
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MNPCI2F+M"[4EE4/18)4#YD5S:B,X%GE6+,6$(&U*VE'[#O?!.23C:SA<VU>
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M:'$HV3/A07CT$V*0U"6N+R,85&NA^XGXJLHX8(I[NE:R'I)VHJU<%EM878/
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M>6YJ"2 S>1"]AV$,*:UD@#3OC1$[VMEG/V]_I#B'O_WI_P%02P,$%     @
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M ?TMG*[,WVW@]I2)V!'J8;(2O5&_O8HUX^T1J%N2W"LZ%L#D(N@ME 8<O7A
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M/]<2QS>39_EK%=:["T_W-UR0H)Y](FG.%W^_\)<OE_/^TI4>&1EM0"?!92E
MN>C!J<A AXR2,QVDV"Z)UQ'(]ZER0[+7PSVMC7OPBQGF\>(7VH@OSOI11(8B
MD,T;9:VJC%BO''E'1[T30J'G[8O%MD?WW2E?SP3V%]B_7V CC20$)22] &+9
M[;?Z-"% ;<7@E57(FE<^;P7LNU6P]K3=U2T]B&Y=#48<R8(Y&7_1!U!Q&\#I
M;,!$E3Q7T3A>#J%E5Q!_Z%L/5-[5/'/PZ![]@_$T\Y&QF3M;$MBH#2CC:)\N
M,@ 3TEDOA';ZT<7U+K#_T-4AR;^KQ/9H\J*C6U[6H\Z,COC3S8W>%O2/[.B/
M[.CCD.&/[.AWD1W]D41Z^F;0CR32CR328PGP_T@B_4@B_4@B_4@B/4F5^Y%$
M^I%$^I%$^I%$.EH%^Y%$^I%$>G3Z]B.)]"@"?C^22,>:1'I^-B<)D1<^/8WC
MR?D\@\M$Q'^\>/\L_=?9>+Y\2H=[<7L\I7O:INO2&N5;5C"N/>Y**8OR.CM#
MYZ>RF?0A:/"LMJKC3&4?8M#!-]X,[L/3;J;<FJ?,GW^[]J?S<+A(F31>,4A2
MT_JQ*'"F#LU@/ 2M2TG8VM?8%>-0>8YF>K)Y?EP/I!PZ1W&/]);W;[S@7%LF
M(9'0:K<#$IP,"+:4H+GWDH76Z;4-4 [?M[P/^J?M:>BAH>LZ6/7;&:Z:]6\#
ML*?);P^".\RLMR94;J$>W7DXB,)87[)F@H/0EMP1<D7 :^O!!'0F2Y.B;7UR
M'4A1'IC6=A@]V47\K;-%9#M^^/.SO\ZF9U\N^K&0'U&R3 &$)0S*ZECSI ),
MX<8:6FOF\2$;>?U'#^]R-9;]M)G@>IB7ML9%>$&'XI@^??F'C[,PF1><S9!\
MMYQ4R<H:D,CKN1@-D.,H(1J%5G)6^.U<7[,W?AM\CT)3VEBLO='2@PJM$D$?
MIQ=OR0H\UMS0V_(BS#]?_":/4O(\D9\/62VG4B@.W@D+POL84D#C96L5V@7?
M$:E0;[3T8&S<@W59(3'R#K-"@:!92:""<^!4<I"MMLXQE E;3_=\"-/WH2J[
MB[^',7W75;5V\KHF@)$D/0VJCI#CCJ"YPNJ4*0-6"\8"^6Z)M=Y0[H%S1$K1
M2N@]I/+7G([GDS:>S0CAY-.JVQM]BY-T6>[W'M/TTV3\W[3?,6\T"NZ U%?7
M6@16NW=RT,%QA20LY+9_2V8WT$>D6\,2V$.&_Z_3:?Y]?'(R"H:A5RK5=C9U
M@F7%H94!+8*(67-7?.OM9_7L(]*'O<390W)]C5Y>Z=R;3&?DN(S#Y6"?U?;X
M;)*OUQ;/YV>GUP?SS$?2D,=8^P0'JV*=T9[)R9/D+Z(QG%O'-;;.>/:TE"-2
MNL= =@]I^C7+>C>;OJ[)VC>39<[V?*7+?.[;LHIL?!A/$EY/"-;^76EQ%DY&
M0AN2LG0D9*EHKV4!//)89PS0]X*GD%C_VMMM$<>MMP,2O#$GW[?&O@JS6G@P
M?SNKE7Y;K2NY(AW3"ECQ=)JP*" 4E2%EQLE8"%G( ;;=)FOY[O2W9[KOJK'K
M(6,R7RWLXFTDQRD6S*B ^U+C+"*!$YFL6.2FI!*-BGU%4.^!=83*U8J$NWKB
M^]23WW#Q9I*FIUB5?A1XX$K6"JTZ^E,A2Q!#61;0<X]2&N1Z0&VY >X[T9G]
M"5D3)NVA-?R])5Y_.SL-D]?CV7PQ0!';O0_KN99M^X4.4=+&K?+<9 4EZ&I.
M90LQ902'*F7.BHQB@$W^$L_@)6TZU.&R]/+9D&IV-/CS*V8A,Z882JN:#[IX
MDB5MN^A)YY*V74AY["5MT;F49,AU:G(XORCK@U'DM @4D84BL/6=AJ=>TK83
M_5N6M.U"PT$JE+8!^*.D;6<J=RY5VH>'@RB,"*PD[CU$9/26%*L@>*?(OO/&
M!BS6V[[20D^CI*U?/=E%_*U+VJY,2++W+VJSC.;1EUK7Q1(MF?%(JY4(VCJI
ML\E$QG;WS==\^*/PG[K(?]I0>(<N;$-?T$=&"S>.L#J'0'^TD- (KYPNNODE
MR2=<V-;%;NV-ED,7ML7H?5*$E=D:?)36DKI[!6AY(9O+%\9:7[-XPH5M752H
M-UH.4=C&6$HQ$2HC:V559LNF&!(DDD'NF)8^I>'4YC$6MO6D*KN+?^#"MI03
M7QZ=S$55YZ46B-P'"*J$K$4)1C1O0O)D"MNZ*$4KH0]3V'99!K6X<4Y>]G4:
M659T"2J 5T@[G,D.?&)DN17)G+9,86Y=&KL'S"/2G[Y)ZK-<S6:#/)-)'TUT
MH%*- $7MZ0L=BI9'M*:ULCS2<K4N&K"7.)]0N1I/-EAR!"%K*>E4S Q\YA*"
MB"JX9!R3?5T9/NYRM<;;SN!D;RQ7&RRE^7P\7>#) .G,C0_J.96YW0*'2&,*
MZP*WF.G,2J2LA6FRC;6#&&(T4F7O4E^&Q:-(8]J8F=8L0;&BCIU/@M;O/!@5
M.'-.TLG=>OU/,HVYBYYT3F/N0LIC3V/JJ,E$,!J8QD [KRQD.$@&-A;C(F<\
ML-9Y\J>>QMR)_BW3F+O0<)"LU#8 ?Z0Q=Z9RY_34/CP<IC.'32E8F8#SY>6H
M%&J6+H"VEDE4W!LOCT-1]DQC]JLGNXB_=1KSW'Q\CW.DS_S\RR\O+K)QKEB6
MR<< %ZR@C9,%VCB] 2.*BHIY9)X]9"_?]X!'X6AUX6':6(C#YJ/.H]F)HRZ6
M%]"Z%L$FH2&@MR $RS$E*2UK?5'GB243NMBJ3<7?@WK<%]?.WA:ND@8LI=ZK
MM QB= EL#6P+7WB.X;M-)G11BE9"[]%.:!TP*A9)E6,$DR*IN3(2?/&N=B4V
M)M7+C\WG=7T?T<$N>O@8R.XA07H9:6>!7IGE=?"2:T=_E\%A*I!3TMH'79*/
MC97ND28NNFC)7N+<F.<<+.C[[OVS 2*^ZY_2<[AWBZ4-$>M-+/+B/!U5Z HH
MZSEXTJ_ZG7:<!<;,47=AQN@TDS*"L_6ELDZ D]*!D9%SEFRBW_Z(]>ZF)YUC
MO;N0\MACO8:3)Z"R!')(9=UP)3A-QRH*1LYIDFCC$"&9IQ3KW8G^+6.]N]!P
MD-#=-@!_Q'IWIG+G&-X^/!PF.>!=#D)P0%5O9'CAP=>A,(Q[(:5(1N#W'>OM
M5T]V$7_K6"_9CG_#<++X_"&-<9)P?G7Y@C/ON::#N6C%0*')$#RC?=I;EH+-
MJ/)VX=[-SW@4;E$7-J;M1=E#5(^<<9SA?'$QVNZWZ63Z95E>./DT<EEK::P&
M(3PMEV.!H$,!$URPVAAG9>MK*_? >10*T<94;27TC?HPF.O\=I)""C-\R,EL
MX#_?\ZB>G>AM%SF$)\V$X19]!NGJ%A1$!L\%JS,"=;VW%!4;X KIX3SIZ'*1
M"CD(2WX!';>UTKF./V")C'DRX"UO'4EXDI[T+GK2V9/>A93'[DG3,2Y"[45M
MA1"@3'$01$(PUL?$B^!"M(X$/W5/>B?ZM_2D=Z'A(([1-@!_>-([4[FSA[0/
M#P=1F)(8:I<2\*C(4<00P'G#06*TT@1>DAX@!OZ(/>E^]607\;?VI%<&Y(7+
MI[@QF>< ]$P#]6X6>++V08;DL\/:I-H^9"JO^=Q'X2!UD?JTC<AZ[/9P;:%7
M@Y/?EG],J^NV\NHNL]\CEQQY\:6 R(E\1%];^0GK0,N"F@PQH\P LQ&W0/HH
M5*>-\3H 58=N)^(R<Q9S@ASJR\!, L]\'1'/M146+6'NOT+FJ;03::%,S6GI
MP0*Y&G(@:$7&UW,T:%"69XA,*9 J<ZU]H?^V-C0>:2U+%^KW$F</)4IK5/!Y
MF'TBV;P[FZ7/88Y_I>^OBK'.1YF,1':<V^CKC4O:S^@KA.A]-:8R^6I:R]XZ
M0>^&](A49@"J!BF6>AW&LW^$DS,ROL+\;+:,NTS+Y4^GY=?P?Z:S9:5?N"KP
M^Y9. OTH=XC_MGEP]VAP#P)H%!N^Q'!19WFCOO(";7Y;=>QL-B-#A_[";]/)
M;/7'YV$^GE\INTF1VV0C!)X9*;NI5\4=@I"U28DO.JG6"9ZF"^BZM[8 <QX"
M(^,14S02N#>6S$=;N]HAF8]:&LYR#"ZU/G.;@1\J7GTXW;V]41^&]\<2^;Y<
M_?-OE]_^;4P6+9U1WW[!KWAR7MA@G3:6D41U75K!"+ZH!%8Y$KS*@H7>-H=[
MD1TJ+GX@K=FDN^W8Z\$967>"SN_B755#;0&VIUCZ3D /$U?O@_%-2M4;70?7
ML>A\M'6FJ*[3T)6@MR\4$T%'P63T(67=NAO"(]"M!T+QCTZU=F&I3Y5Z,_ER
MMI@O)<!7A5K99*Y"!A<S^6K)&(@% S!MDT2I!%.M/>I[X SO-O=(Y":5Z<A"
M#W':==#$!309';TGI4",D2Q2J>A4%S&").=>).-U:![MOP?.]Z8@^[ PT XB
M+Z 5:05Z4E:12UVRDA!K#:G57%@58LG-V__? ^=[4Y!]6.@AGGM;"/G9XC=<
M+%V*Y8_?X>S#YZO$IP^8,G<%@I<%5.0,O#&9]CN7L_0JB-*;SFR%\+M0H_9<
M]=#=]R7.QE^7!:MO)O/%[*S*Y?UX_L^E"<<=BNQ5!F5K<461"J)2"-9'[J.4
MP9O6YN]]>+YO'[X94SWL3U?8:M?A64B+C_0O+UZF;;#UY*C?A^LP?GD[%C>J
M1R,*>K!S[L48T7 E@X:45.TAX")$6SBP0LB=$!EUZP*%X=7C =?Z,-JQB^1;
M5[FMBFK>AP6^"%]HZ[S^DP^_AR\7YZ1PE@LZ*T%P7ML4TW>U$S!H1\:7XHZ%
M\&"J<*<G#F^CM"-IVK>$>_"2_X;Y$YV6+W$^_G2>!U]JO1+>*1U2K8@QH)06
M$'/4(&R.Y)YEY7WK",IZ)-^W]=& G1ZLU[NH+MZ6;7#U9'-LPG08>Z,%;P^J
M0@>A]V!E;,0G@E0V10=.*W*U:..$J)V&XCPS,=$9FEJW(AQ6&1ZP+H;4A5UD
MW8NE>0Z(O._Y!<8KBVIUWBE>HK,,4"S'L]L"GMQ[2+5TSPC'I&M=?K$%K.'-
MCC8<WC$XVQ+09UC^^;=K0:'7,_RO,YRD;^?OAD<R?90%$7(@B'6VJ*B7]SW]
M1VH61&H]\&H+6-^W*=*:MQYF&ZV+-EX"7)V66T <L'[A%KR#5RVTH7:+O'(+
M7@8J5+@--2INE)6,4!KZ8@M!+;H SW64I"DLVM8ADX.ISO9%"0?3G%WH&*JT
MY7(O7K4+#]SIDFFG]9:#$CR?#\O.PM*9[@1Z,4A%RRU<CR,AU(G0;4I8NK#1
M@P5T<8S'^3+8-,K),Y^2)"N/:U"A]J=R/H"E'Z+@-OGF5\1N(CB@%AR\O+@#
M%WUHQM<P/JF6VNOI[$,XP0]UQ4NAO,2XN/K3"Y(#*?9(%X=):;+GZKQ!E6(!
MYTH$SC3+&$F[9>N.;SM"'%ZWNC!Z6SEZI*.'D^C5?YV-%]^N8+W^^MN8WIS_
M'"\^3\\6[S'D\<FWE[C V>EXLES6ZC4<F<B\RN0)FH+D$WJ9(%IZHW3F+!3#
MM5"M.ZGLC_9)Z]1 )/60;3X7PB6<E^-YO0E!._5(DE[3(5H;CPM%P((AO;<D
M%'3*A:2<RJ:7$VP-F">M'&U$W$/$__ID@-5"8XE&9H' M"8KBH< 'GFI4]-C
M3)K7GHB-65\#XWLV7KJRTFNMP35P(Y=B+D*2XB*+H*(P=99Z(8.[(*<C4GG>
M7Y'!-2##*TMGBC96%.PKWQY(OP9EW=[%<RI<US8PC&PCE5*&6)("C,RQ[*S0
MMK5Q<3^BIZ\&#27>@Z6PSL9Y,9TO1AB<9L4G*'1<@=*TV<5D(B1FA-+9"Y]:
M5Q5LPO(]GQM-^-FH-ZW;&WRM,KML\-JQ9<'Z#VO3AF +H(^RM0!CB9&=2JRS
M2!:K1K)=61"08E F6N-Y<^?O2%L+V&**5L6 5HBTI=?.5)&,]L0]!N4S#[>[
MQ3T*23[AU@*[Z&Y_K05VX?T1MA;8F+J)-KK,;0%FO*-U&0XNDS$1'!DH,@EI
M^TM;'',>?B=]V2,/OPMOATJB;@'Q1QZ^([7[9%/WX.5 *B2=,2($!EH'<J"8
M<A"4Y,"=30E]9E[]R,,/ISF[T#%4'O[Z_GN1_,T<;2K:@Y)(CA.W'&(=S<R%
MX*AEI'TY#9&*OPOM<6;C=Z)UFVQ\1T[Z+4F\K[6&<J;PZ .=VK9&]EV &'4"
MQE5RA96@9>N ]_?29:F10=2*O0'NDM]_$WH;L#^Z++5DO%,KG'WH.GB7)4&'
M?I2R@"STNBE7NV\$GD +(:1@G.GTH\O2P55K%Y8&[I%B,RU3.P>Z"!*"SZ:V
MWD4(1CNM,@LI#-%EZ8GT2-F)R!UZI.S"0F_%C.N24+Y60D3R-[BNY2H<'3C&
M.1CCT7KCO7'-B],>3U7(XPESMF&H!]59M6U?!RVC1:R7E+RI_5DRO2A.I-JE
M7T83--?.MNYH>@^<[UE]6K'4Q^%4:<!?QE^Q7JX/DT]C\B4VJSOMCP5C#I!R
M+?OV*8++VI(43&08Z)>Y>>/GG1!^SVK6(Y=#5C@P79C3AD20:SB#OJ\O0ZH3
M**Q)RC*.K:-+QUKAT$6;FO#31QWE=/+I(\Y.:_WX56$O2UB4XAK(D!.@A!7@
MBD?(6KF86!'<MNY&N1;(]ZPQW9G9>*&U94',[;UQ-0!T6N[90#O4S'1Z7O>R
MFG;+;51YLQI"=L_CK_0QFN0EJ1#D8OCYW/$H+$)B5K"D A?9M?: =L#7;B#T
MPT]]_FTYA^5%';MR'O(E)=,^%@_.+VO-K(' ZE4_C*EHU-QSW5@XG0 /51_3
MFX9M'AW=-WV/IN1ELTBO+W 9X?,B6L=C@IB=K9+-X%.F[3^JI*0G"[-]LF=[
M>(>?-]V[SFSO'W3B;EBW] KH;^%TU6-N&[A])7MV@WJ@=$]?U&^O8LUX>PSJ
M5B+3K@1 [Y9=EF.U:15YTG202.9%9LW#]H]!S1[*_#Q6+=N!KAZTZ\79?#$]
MQ=E[/%DVJ9I_'G^9K_KW)Z>E4K5'0[U[%)(&$H &XQPJB[P(T;I-TSUP#N"]
M]DGEM!\>>HCCOZV?\W;V;C;-9^E\DF;ZY\ET5=PCE0Y&F *TQ C*TY>@HP7#
MC0R9*9E*Z[#K_8B.6U$:LM'#=O)Q%C+6E:YTUY./8HITD.O\965(BT/4!FQA
M/BM!AF)N[0;>QG#<^M!)XGTTK0^+$,/\$DZ]J&BS6EYD\_5FNP1R S*HHIDO
M@5S:V#I(<@O"<?/?1=X]1, _8OH\F=)^].TY@;J[_'.0RCC,3!A@J BDH</,
M*\? 9H*:,RO(6GO?6P$[;E5ISTT?31XW"^2OL^E\/A(R>Y,XJU.").$K"%$R
M!C(49U44Q;#6_88?PG2 IB1#11&;TM%';?=F?,]2.CL].UEVRSV=SA;C_UY:
MUJ-2R+^+-2DH"YE(G!L@RZB ]06=9%J@'S#TMP'E]ZE2+2@;-@3S&RY&<5EF
MY9#0\=K1V3"(2&"-9=%IPU1L?\'Z7D3?I_+L2L4@'0[N@&S0Z.#!SVR?F!VD
M[<&;R07:A\-T5\KD#4?G."F3D+4^MB0()6:P0EET*@6E6E<2[H.S73+V@:>?
MIV(".0%8"QM(XY&D0E^"X@ZBXT(P8T*VK8O_=T,X5+JU=YW:G'9M3M1CR;,^
M/YN3J.;SY:8_'U^.O'!"^I*EA^ CF8(\TBEM#)+_Z7S,D1?1_,;)!BB'SY^V
M)W_:GH0>3*5UL,YM@Y4'NPW GM*A#X([3 *T"95;J$=W'@ZB,'6:.+T,!-35
M.);0!7R=*LT-2T9++!&'V%8&4)0'4IB'T9-=Q-]ZCN'?SD[#Y/5X-E^\F:15
M=W<1#2^Y@'2Q#CGQ#GS6"#IDH;6T='2SARSH31\^O./46/[3AL)K&*U9XOF/
M%^\__/G97V?3LR^7R:I8LI8,=(SDK;%0("9!+F$JRIF<BE5F*RKO?/11$=E-
M<*W?R>?CZ0)/WN,<Z_7'7WYY<8%)Z^I\._*U18KDU=?AV^@U:)7DLBP,8]J*
MS T/."I*6PBQCRX&NQ3)!$^8(J?%:E.=I$PZR#1(SA(7F#CZYO?+GU(%9>\>
M0%]D#:M7Z[-<6\#]43+9 _5=B]GVX.T1E$PR&01&@AU]S9F'1+NN9*7.9;2T
MO^M(&_LQJEG+DLD!M6P7N@8NF=31^6#%LNU#K*.G$KCE9;6BT:'VW*36HS*>
M=,GD3E3N4#*Y"P_#ETPR[8V5&4%@<&3E:08AFP)6LJ"ME(&GUOO-4R^9[*(H
M#=GHHV1RJZH<$3SRA 8P%@+I$AF*6CH@1Z-X)S$+V;H9YI%43'71G/;<]&!<
MWZD Y<5%S02OM]X%*/2AIJ\T9)MSC"H)CZVWEZ=7<]M)+;I(O&'1Y7RV&+VG
MI>+2!,.<E'(\@W5(:FABIA59"<;K'$RV&L5692CTJ=<HIS]=T7WC@4?L8N\O
MV#[8O5"R;6#LXA1OPW/[M_EA)[>#\&_3UT%R#4_ZVW"R$U;JPFA[J)=ZT&CP
M/'HP%J47)7K"^A0(W. ^MN=O%X$UYNU7DM3IV>EE>#8+@3Q""H'<"N<<.*RC
M>6PHNC:8<=N-!G^ N1L/'>XH[23V:0N9-73%ED#"']>!B**#-0J2,@F4# J<
M3 Z2C)&A8!KU5G6_#Y%W_:%/D+R]9=:#;W2]"+@>]S?/]Y&R+A46."3KR;=/
M(4&(T=#>(JV73AGRWQH;NO<C&M[L';R^K2$EK1/,+S'-D/RT-Y-SD//SXG&C
M-!K!2'V-K(,1; 1??33KLJQ-R6E[NM5^:T-B<OWG'S'GK:3:8]G0B^EI'$^6
MD-YCFGZ:C/^;)))QLAB7<;AVL>"\/OUF!S+ZW=GI=0&2F%2B;2T'VNLXN87H
M/(0Z5",H+[P()CC=^LY[3TLY8KU\3$HP:+;T[W,L9R>_C N.;/*2_J. K&B2
M&]/DT<:D(4?%5>$BD7DU6,[J"M=WH'7-Z=D8,VAY$>5YF/SS!2G_>%&E,/]E
M&B:O0[IX!T+MN[C :_WW:K_$Q46_Q#>3^6)VMFQ_WN'62EL W:^X]"B01O=A
M;C[J2GE5Y%A*5B!]O3_%-8-H:(\J0@1?F*#_M&Y"NP%*]W'BUS_V/%[G399<
MJ0S!*J0WAYP/5R2Y,+3WUH;F!G/K$W@-C*'NI[3@^.X0\6Y2?2SW3*Z_<A_I
MWRSC29899V.QD%(JH*(EP=!7B,P6:9DCMZ-UV=DZ'(<*?G?F=DU?W$XR[F/>
M_"U,JV+++5#U5!2V'M%A:K^Z,_: "G00]W#*P(T@V\(7,*7.1W<Y >V8'GC4
M.?C M7:MS=\AE>"!RJRA=& 7*?? _;+!.^8*ZC*3(X-1/H-DK*Y1)/"^1IMH
M#[3DLSFN6O=NN -B>!>G!3NWKZEV$FT/)5,?<#*>SCZ<1?K ZLOCN0&^2K![
MSE$C@A&^+K4.$-1!@&/HC4'-O&IM%-X+Z$ATH)7(^]CWR11^6\X=M%5G(BZR
M%XR<Z"1KR8:7$$P= D ^-FHEC?>M6XG=17$4S'<4;A]MXV[8M<OS+!2O8E0*
M1' 2E"0#U_E<(&E1I)0L2].ZY.TNBF.Q\SO*MW?&KU5F;8.K)SM_$Z;#6/I=
M.;M7!3H*O(<=?S.^VO3.<0,R.06J) %T-D7 7-"PF)'Q?C>" ]_#&$P/=I!S
MZUNE=3;/M1#LMU4STU**"\*#U,:"XLY!# 1.HZ']KM"2Y:UHSX;<[?K/'_XP
M;R/\:5O)M4[$7QB6YR[&=9NR+J4DFT%DC/7><H!H:C&82-)P:8L2;BLZ-SWA
M& AM(KW6[^<-4._QZ_3DZWCR:8W>A<"SMK7_K*OEML75<2!< /U($T29@N6[
M4WS/$X^.\E;2;6BS;=#+EV?X:_A&U-D+>%$GLDAS!(-U6'%FC#8=$<&YZDQR
M)UC0>[[?MY]U=+1WEVC#VO.'X/G5*4/+$Z'4DDY%=@CJ!"''6)L%VQ2+"BD]
MF!C>\EE'3O@^$FW8?OD!>%)=P#.&[ I1QU#DY3W?)"$24C IB6BBM26%CH2O
MGG7<A.\ET;N$Z\ZWF9=!H-4QLW0NBF#62$9K+-'7*[,6/+D5$$3AD1N)S+6>
MV7 7Q;$$7CK*MX<6_3<176CX-IAZ"KJLPW.8@$M7KNZEOH.@^VABL Z;+LK9
MG!T=.R&!BMY M"E#<IQ.)&4-N^UM/R'R'PBR#,']+O+M@?-+Q^(FN%5/L:BL
M1V/H-1&"5FM+O3#"P&@R1#"*Y&/KU.J]@(8__KMS-NU+X#TD7&\>=&\F"YSA
M?/$^+/##HN8"W]&92;\(GW"4A'6NN P^>@O*(0./*, %SW5A))[<>J3@]N@.
M;2;^TD/-7C,V>M>;%V$V^U8GMY].SR:+D79<6F<E"%=OG05&?DQA!NB-D081
M=>RY-/4FGF/4C0X2;QT4K)GICQ>9Z1=GLQFA^S4LSF;+$NKS\3".U<90)4 (
MY#0ISNKLPF+JS0J!M'FB*=N% Q]^UM,FNP^!MHX 7H?WZH]T<I;KV;8>I]+H
M!28'6B0Z-RVC_8J1RVQ\%@ZUP<C+SL0_\- CTX"6(N[!C[RY]K]/POG-4,PO
MQ_-4]Z9W,SP=GYT^FRS+S-[,YV=ADO#%='X^J\4@\\$P3@=7O5N<ZKCP8B1H
MG:5/+B;3/,S0$?+3UJ]#\-;#@+CK;\AOTTDZ?S=&HF!.)7$(EDQJE>D<#/0>
M )*S%FC+-*R7@N"[2(Y#21I(>6.P<O!K;2V&+NWWH(&NJ0TRGFF3FHF4#1D=
M H32$E3M?!;1(03!7=28$LO-)[P.=QU-U98ULI!][4L=ONT".*8X<)\4!I4%
M*ZW#(H_P.MHN'&]S'6T7J3[JZVC:AU@W11#6DON5,@<O10#K$WH6E/?-NZ _
M]NMH.W&[S76T760\W VD;5!]K]?1=F)LNZM(^XA[.&4@&R@[2ULCB[+&<E.I
M.F^!#"(3F&9)"/F$E6"?ZV@]Z, N4A[D.IK!.F*)*2BV E*8( IA::%::5U\
M]N'[N8ZV$SL/7D?;1;2#7T=C*7I6YR;A<DQ+L0C>HX+,K227P1996K=Y?QK7
MT;KI0"N1#W,=S1NR=!ROMVQY[8VG#,3H%01NK/>2J]C\?M)=%$?!?$?A#G,=
M32G%6&$.F)<!5%QZ/X9#"$$CYR6W;S;XN*^C=;'S.\IWR.MHV^#Z7J^C[<39
MMM>0]A'XD-?1#.FWU\Y =M[4&?.D]Z%6:"OE+)F\DL76D>;'?AVM%SW81<X#
M74=3BJ,0& "-<4!K)I\&0X1(3HW7M,ZT92O11W\=;2?A;W$=;1?)]7H=[;[;
M-<D+D:TC3P-+=5EU@%!KLXP/EBOAF=7;C99]@G>7]B:\%^GV>GWM5JGG)&^\
M<>>]94Y;#Y%<45"ZEEJ54$"@%%KH4K#$W15BZ^<?G7KT(_G^+[JM?%!1BO<L
M@9'!DP;+ J$.N2L^6W)3#,MVW\LO1TKXOM(;\"K;ZJ8=.E]\B09*J)=Q"B\0
MG=/@<A&>IZR=M'N2^XCO+C:DN9-$A[O*=GG33H7JO=:K7$QR4"K19A.S!VM%
M445FCK$SX8_O[F(?A.\CT897V;:]:2=,+)8'"9EG@F=* "]9O<:E(N,BH'*R
M(^&/\.YB#X3O)=&[A)L>[BXJ1LN5I'B!O U0-H4Z;49 *#I+6G?*O/55A<=]
M=[%+E*ZC?(>ZN[@-IN_Q[N).7&US?VT?00]U=S$5IKGU :0BPU)9LCABBG)Y
MN8J.'R9U_I[N+C;G?A?Y#GYWD=':7*U(E3G49D?"@5,9P3)>:.\+*$WK:T=/
MX>[B3ISM='=Q%X&W#N?](\R60UWJY;@7T],OT\DJ#&V9,MZF"%I4#Y.':G]Z
M"2GQ:(J21FFSE8&W\1%/_61O*,#6'MM:5)>]R!_&M?Z$WX7@0QS?+0EYD.,.
MTFP=D+T/GXFT@=2>-]Z(.GY),_"6><@1;;WSRKW?SD\;G.4-Y_0A2-Y%B(.0
M^W:R&DTI&0],,%L#@1E4;687+ N0O- FU>9V>;LN8?<_9[A#N"T9#S*\GR0'
M.88__CY=A0:DS<AT@%R'ABJL?3,*V:/)*&>$]2R7[7)I]S_G:$G>3Y(]6-[7
MT9UO5\IP%5"!L)F4SCJ$J) !$R99C80V;35G?@=C^S:&IVZ&-9%M#\W KN-9
M&0M;(.HIN'(7S6%"*]U8NH?R#B+N^45?!7R0NZ!E F0BTOF2$D1#QTTLK* R
MF@GAGRCI#X14^N9\%\GV=Y7A[5><3<:?/B]>CR=ADLC;7W:<F9;9Y6_J>,T_
M/OP>OM3?K$:#I"A-+A&REN3]HZ0M3P1#IFODF5O!^6T_N]6UA_T #Q^.Z<KX
M^NL1 ]#5PU6*YV&.U]!HX5)61@#G-M2&-0@N!$%R\-S&A-YGUEAY;B)X\MK0
M0: -MY+Y;#%Z'R:?SK='422/2G+0B?P/)309J<%K<D>L]4D()>-6ER'H4Z\Q
M2G^Z8O/& Y^Z!;B_]!KF42]!K#R-+6#L8NMM0V;[=_)APZZ#\&_3UT%R?;R+
MEZ56TBE6. 2I!2C/%?@B!>2B&>;DHXY;M60X-($;C+3V_.TBL,:\_1K^&)^>
MG:Y*:%Q.*&*"8'0!I6H[-SJE01L=D_*"3,VMTI@/,'?CH<,=B)W$/FTALX;V
MS1((B>H*2$DN%*$B%.T=*.-]74ZIH^69C2(DM=ULXH?(N_[0)TC>WC)K_.:=
M9S;)DB)#^L,B3'*8Y7?3Z6R^W%92,MQ)'0!EIE.=C&7P7'APV:?H@M4^;C5R
M\@$R[P5Q#%9..RG?I=]VH?_5'PMRFL+)1H"K>PM;0&QH%6T):WB+J2&1TV%8
M:+Q?; O5NJQ8E@J"P Q*UC<E)P%&(7KIR?]F^:DKRCV6V6'U9!?A-]:/&W">
M/S_'N,K4)91%YPRRVJ?*"E;'JT:P7@FFO;&)M;#([X$PK*'0"UW3]K)N; _>
M@O7NY&Q^ UH(,9)Y8Z%86JGBO-18C0+!M=-<IICX5GV"=E.#VS".6A4ZR;S?
M'>$YF;ZWP%E#FYXVM/\52]NAB*RV[V8$TR<RJ(0G*[B]0MP%<M0JT5'N#>\7
MK@-W$U>.EAE7ZIT9)*=*6XBR%GB4Y$WBM&C9PG:X#\-QJ\+>TFYXFV$=KCO;
M%K=165Y'@MDZP#774VRIH5@0N5 .51^:\%V=%=VDWD-SZV?GO;A#E?#;<IGF
M6_;>'CF!TIO:;=DH7?<L2W9-%%"<SM%X'HIOW8'H/CR'ON/V2Y/NM,TDWONH
ME=<AX<70CZBS0,$21,;K14N)X-!Z,)9V+VNY%*%UN\E-6(Y#"YI(NO<F1/>.
M!>(Q>&.P@)2,=)4E!5&Q&HY-@:R=%++J5R>>QI"F=EK2C(W>NYFMF?$P*LZ9
MS$J"S%*-NV=)!K /$*)402=ARG8IPKW590VH8]22KK)OW0GC)KH5I*K#(V01
M$Y,9O*D=>X.L-23H0,@0I#).Q"V[6VU^QM-FN*4 >S >;R)[CQE/OU3AOIN-
M$U[M36\+_8",G"_AY/R0JW\33S&/,K,R!D9.L<, *BG"+U$ ,U$'GW+VJ=_.
M=KMC?MH*=1#F>J@;_^5: ]?+FZ+G.?KGT]EL^GNUJ,,7^LWBVT@ZVN"$3>!"
M3=?;K"%P\N*\TKK.PRQ6MBXJW@7?<6A4;XSTT,;CYOJ?A_EX_N'+#$-^.[E>
M.<E'GHN2T"/8D--%[L@I"]EFF8-(.IM^6_!NQG8<6M,+$PW3]NMQT@8YGN9Q
M>A>^+<L5<'8Z?QY.3J:T@5[\:/H<WX5Q'B5N>#'" *9:;8*^!H"Y@53(S?<B
ME6BV*NK86X.VQWJ,&M434W<US'75L'>S:4+,\]<DI2J)^6HS'3$OT&MA07..
MH$0=?Z>BA&"]+5B2#ZKUV,*-8(Y#1]K(^JX2^.Y-1[Z<:R4A.N^&59<_8K0\
MGZ( S)+,_)@S.%EJJWO4@OX7>6JM >N1' ?]#:2\)O+6.?BZSH)ZCU5*9#K=
MM:&XR\(Z)D!K<@!5T61#.<W!)TN.'RU?N"&LVLT(CT-9>F1EC1(U&1>U&J/Y
M.HQG_P@G9SA"E;-VAH-EM2+!:04>>0"GG6>^7NCO=5;I)9 C48G.,E[#O#C0
MJ-(/Z3/FLQ.<7KGZJ]VQ[^&E6SQZH'&FNPJAYP&G-CE;LF:0I"'WV+ "00JR
M0C*/43!-VMFZM=R  TZEE:*$PH%IKFM_4'+E))VXM$TF%8,-I>=Q%H]BP.DN
M'&\SX'07J:[+&SZ: :>V6(.H$&12M(_F@G7(/$)B/'FCHPFRM<?\V ><[L3M
M-@-.=Y'Q<#,MMT'UO0XXW8FQ[89;[B/NX90AL*Q+\*4FM#BA\W4RFR&=-V1C
M6>^PR-8=-A_[@-,>=& 7*??7%>3:%$[+ U.UQ:= GPB0*^!M=J!2*CZPY+-I
MW:SA\0XXW8F=!P><[B+:WFO+E@I=:#6HZKDF*H[S=*(2X%!'%QQ+S/5;$G),
M!WU'^0XYX7 ;7-_KA,.=.-MVLMT^ A]RPB%R@;(H!IARJ+VNR!DB-%"8CK3K
M%:%9ZUCF8Y]PV(L>["+G@28<UL9#V9,I4PP*4)CKN#8ZZ(J+BO['Z5=',N%P
M)^%O,>%P%\GU?I[?2K1>AM%&7-5^"RQ""M&#8BZ!RZXV2V$R,BF1;]?5H%4"
M_!+9H36CCU!0$Q;ZM_TFD[-P<@GN NR(1V=9$@FX29)V/&' 15D@"8VJ7M,6
MV*^FK,=UC'K2@(&-Q\,!,QB_3K\N Y33R:V:V<$2&0\A&#R?L9-(>DYK!,Z8
M<H&#59;T%U--BPH/(FJ6+,H@=>L^S@.F-8S@KDBKR457!I1?7O5- 8(G*\[G
M0B=\ZQZECS"ML0O'VZ0U=I'J8TEKK)F.A"DP:VD_C;Z.KT':M;TBD]Z&5*RA
MTYF[UJK_N*?$[<3KPU/B=I'O4 /"ML'T/4Z)VXFK;2:%[2/HH92 <2=<]A%T
MK*V0<[80G)7 69(Q66:2:7U)\C%/B6O._2[R'7Q*G*LC3[U78%(FKTMX 9$;
M0PX[N5R2!XRQ=5CK*4R)VXFSG:;$[2+P85(<*=K@F#/D:0=RJ>H5*:^B!1:L
MSI8A8Z5?F_>8#OZ.\ATRQ;$-KN\UQ;$39]N&MO<1^) I#I:,0)UH:V*U\T\V
M&KQSM/U97W(*]%+XUHGMQY[BZ$4/=I%SZQ3'C0'FER?5FM!]T,;&8@JDZ!PH
M+FD[C+03!IZD9.B\Y-O-#=WVB8<.8NY+T,;Q\*VDVX,5L+9VAVP:Y@(9.0PM
MK57E! Y+!BY2%)I> MO<#WCL58U=+('.,F[8Y>*!(IYM4'VO58T[,;9=1=L^
MXAZNJE$*Y71! TZ1;T(.2@*?%/F_2 XQYH1)M'8''GM58P\ZL(N4^^#^VI6Q
MU<0(ST5(5D%),9*I0[M>H",*!,?D2U0<<Y^7]1Y97>-._-QS'V\/X?9PWF^^
M35PD%T6%!-S6$\YJ.N$4V26&H>31LVQXZ_813^#F=I<441M9]Z $U^\4WP1F
M51'*> 3/M:ME/QFB(&67R0JG9$$O6V_Y&\$<AQ*TD75/A_[J8NC(9J9"EAE,
M=+5CB8K@=#20O2E<QT#[4NN7__KSCX/JO26Z,=;7LCSE)<[&7\-B_!7GOX79
M;/E=AUJ3^SZN>^'(UF";58&LGG>E"CGJ0MLS,<A)'Q2/%IRKE>Z6O#V>,O.E
M?<O0.S"ZQ_A6'WGNR#J#0JHL(2&3H$PPX$4H$*T5V; @HVG=GN,6A.&J/KIQ
M>C>*M[\D'TNUQ]4:KC74&\__N71N0F(8<PB030UQ128@.')N+"J)27N#D?>F
M&G?Q'"[\TX'GC3K34=Z]1/]7V%Z0LLU"NG&;:PMLO:6$-N,Z5%JH%8L;U:,1
M!4.KB0]DS3C&@,EJY7#$V@+>@6?:6RN#2\U[M0RO'@\FBPZA';M(O@>MN-[>
M^T7X<A'<R%ZXR&,$R4($1=2!+SQ!T,DD483'[>;U[* .:X$<PI]HQ=6TM:![
M""#<:.[^^R4J$17Y-LZ#"9I0&?*;O-0%A&!H&=E6*H8>Z;]"<J3\[RGJUIGC
M6RKY;)(W@)2*D99B !MJZ!1I&R1G6H,Q+)-_+.HU[JTRQ]L^\0AX[T_"/504
M_0WSI_'DTTN<CS]-ED-BEH<>2Z&@9!'09E+.Z#0XH0+4/F:6<RF+:KT/K$=R
M#"Y$ QD/POQEQ<3#N'IR'#9A.HS3T(*W!U6A@]![, HWXI,&/1IZ=Y:6BG*<
M@;-<0.%DJ?"<C79;36M[M,KP@(LPI"[L(NM>W,5S0)B?S2\P7KE%JVG54G!E
MLX'@&=;+X(H@F@Q*F""R5RAY^PX*#\(:WGCXO^V]67-;.;(N^G[_2YZ->7BY
M$2Z7J[=/N,L.V]4=Y[XP,"1LGI;)VB3E+O>OOPF2FD5I+1)KD9(<W>&R+5G\
MD/D!R$SDT$:'=[S&M@H8P'VXWBU_LQ&D52FI"$Q'\I)9X81'<;#96VT3TM79
MNK?.;0S/P50X2*X#))E=QW-Q4W5 -)!Y<!?-<0R#P[3T@,H/$/$ %\$]R"R+
MD=>KSF&I9UO(X#G/X)CAUC$;BFGM%XRE]$<,@*%UWD>RP[7&>_\=%[/IEZ^K
MRT&A:W=U7A:77WD[R_A7=6#K5RY2HJ2LH\;)#(J!W&13>X@)^H5ENI14S;_B
MK8/(!P$>WU X5./WM]L;05T#& ^73<Q_^7'YV_^>XH(^Y.N/=_@=SS;U&HQK
MLF,"%)$YF5",1.-1 6,EQ>2T<<W' 7=#]AP,C0%T<)<I!T_\NX3V=PQ+(OPZ
M"^LNWHN:K Y@![),>@$]CM$RA,9WD6HP=0UP\_4#K<FQ+T%;$+$Z=\)HB#G0
MU9^,#<IA\LTG4Y\ MQZQC4Z.6GVT-"2EWL[^/%\MUQ(0%]5B1M8'!0$BU\')
M@CF(*5A(T5M>H@XIM\[>>@#.^(;0@(K<19D#M3" !?3[>47QOEQ_$[J6,/G?
M>)8G3"6%: L(F>ID=D+GK.40@XDI8K3.M9[*T0'6,=_GWC5) FPM^T$:.US
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M&*SR*F$JK=^,^V)\SNQIK*$!\J0>Q/OK=+D.(-7:@6VCFHGTL3Z2&<#@+>T
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MG^'[<N/3UI]T5N?EU<]=;E[AO>1.>5$@V5#SU$(=2% <)*6D82[KI%O7<?:
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MNH$2&=KKL-6/7^F<7\[+[^_?+=NT:G[TQS=MW=QO,8U:.>^.'%^CGN.851+
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M?OQ_N)B_F7[YNKH&4YB<E9<,R PIH +MM)B-)]2)K!,N!,NA$VFZ?^9+)\]
MVFE]XKS_<]TGD< L*[4O$DY=;27F(ZU:D?&*.M4^(P)JI)DER7SIV#?ZWA__
MTJEQN,P'J!RYP=<-PBTPARXDF21Y,BR *IGH*72]JPNY,MJ1#%I7SN\$\X*I
MTU91#9.#UYS^B+5A7.W\L,;UQZQV,UJ?>)^_3A<KQ N0G >Z%Z.!DKFN5IZ
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M<B\&H"Q7B_.UU-^OON+B\]<PN^'OW-CJOX7I8K/+C<ZIQ&B <:Y &8?@6-+
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M^Y$Y\.#8]SZZ>"ICL[NLZ>?8]UYCWWO19(SYV?OH^*GPUZ6BF/*13/7J,)B
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M:.+D'[#WWGD'BVR :I_:W?=\L:A==#8!M(*9F:(CV!S8=L9?H,7*:)7BQO.
MV,6\Z>&"W\9PHE'+0]SK@\0\2A'.1SPC,R]_""0 7!X06KS_!QT>#>P L%$
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M>W<^8/0]_HB&[K[<[9+)W7UH_,.O-=N_KK]$.@W^W__G_P=02P,$%     @
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M\-\^,.\!BCU  -A!X1T&=E'@X5/@8<H!&,@E(1[VP"D/;Q<^ >%NHCU[B4E
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M1J DA"]3CW/?[8N1/R]*L'L*V.G !Y!ERG77WM["_-ZZX-9E:;_; =3C'TV
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MS7'%:M;(91Q])G _!FB5&,  LE(B!<\4CY=J7*+H04ZTW9"/69!-Q@#OOV*
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MD@2:= ^*TY;&):2E!,W0Y!198S/28ZD4D"%_AFE$85=.G_]A?PUA+5E:X@1
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MGGOE4Y<W,B"-9PS J6;D?Y0TK4'S$0Z[R/F+!<"58JF',-U.(^</8CCENEB
MDDE3Z6UDRE.ODGEU<%-A7E5!MD-6\XSGCN2S]U2[2"8OP9N]=6%>,Z>(,WSK
M!GSP@S=SP1V3:%)<XNMS,TXD:(A[;ZI/8+-Y3'@9/,KP274<>??EY(".^_;Y
M,QTJ "7>["+OR3TIMR.VFDI-T_X%;:O!,?-;IYH-SCT8\6!H5FVQLRQP\2>Z
MYP]\3UOSP_;&L^(/]7_+!Q_&UMO88);Y#KEJ_%56K\TEAF@6QNOU;[Y>K(S;
MM?#AD:S\&E&3=_[PIJ&R^#G2E9*<HYR5Z_:^\5W*F%,6A!M#_.-!!4E../XD
M6?,[M?:IC5?I^C[[;2[C)T$AJL0WO+95A'/?K]LMJYJ(14T7:-U4.9/=1P^:
M-^1U8LH,B>X_&W)6.)6H/"-O)U.,T2 "3GJL*3MUR1Y,7;]>FZK0+8&-W=^G
M2T./A7V$X1-?^1,&:7=!G3NVM2Z.U/S$?"#:UOOHHK)85WFL':R+![RG2J0.
M;X$LAQ#J?DG)]D0R/W@ [GOA.'4V&E*&*=KLO2*LJ\K<30M9>R.!V,'+D#^C
MSEEKS+$ O')7,F6YQV=^!^F.1A[Y=(;C7%\D1XJK&_H'.-G(S0M2?2H\,S*[
M5S_HO-_+&KT%S!:0OVD,=*]O1!5S=DO4+EI1TS$V39L _:[V5GY5IZ5]C#^L
M>:"QH2>C6/W'^O8I 5'XUX4_0;Z.$JZ_H><L-V?.UPB]N1AMR/<JYXI;.>VN
M6/G&GAL%5X^\0@@N6SBU7#U2IAIU]Z7R,6\)X[$GB-_J[SCR[4P?I'OF$$A*
ML>6TWWZ^Z$Q![?!2?9^%AR.W&#HLP&#F@!X]+-^<WASN\.%)G.*KQ;L7S$YP
MR4YR]^$JZ"!&5EG,R>F)M6G)BF^F_<(?:?>;:UNP4']O4Z-)42TY50Z>[R,Y
MJ<^L+P:977T:51"0H*D)]^0EY2F>?5#2('="+/'V9$'VI_I]SGR]0;1! !P]
M1%TM)9]\'5F4[O7\=TVB[3LH!-P%D:-[#4+.3S!B;06CL5+.X5V*G0+*37_=
MZF?QRDI;0PC/!6A8FCB!,=B=[U1BV6KP=,S"[A1SG4N&1,I/U_^+=QL;%A9:
MM"9BQ7:$>L/JS@[^E)VD9&L':RK)EA$M</C3L::E:(%7*L0?ZHH6@YXG!%S_
M>+MU4CE@WT2Q<P_R3-X_?A)]CVL1J55&/E4Y=T,\)\ Q%Y2-[0FGV,YAMD3F
M,8<F[QT=[DJ>_B3@7%8=T).1O3VY6T%4ACF[P^Q]P*U5ALU 8$/NZN !N1B1
M:7A:Z)U<I"IW[$%@WXA<UFS #4[YC.B!&P-6I\>O8CYCWX .SE!LF;7_B-A(
M%O>REXK;*":GWS/??7W<,NBQ;OVZ/O*YGQ^;<NX=F)8AWE)FW.9#\VL4?DS=
M\N--.2'2U(A:V+[SG7O['9Y3ZV)\&MA!8[H][2CD<O;5!\9!Z(*5D;>(!_C/
MBL$CAN=?M7N<X9(..&L/^3*%(^73_+^X7-3-7XI^96EO%Q5X3;22]R#89W\A
M#3M2]YT1Z1&QSYP9%EV?=0SE&U%UN1F:9AS\$ISB;'+R$-']_J]=\.1-Y4F"
MR? %XQGJ$#7X4^$CW8L N6<+ *1"KP^MS<^A"7UZ<L/\6V&P')]2O*C=@/"6
MYI$%2?1KCC78&?H#2O^\85A2M(OS](3>Z2\>$UZ7>47*48B%:F0J6&G0?8CD
MSC60R#&56+P94[X#N>)SS_!+B^=\E.@)C89H/4H#R*@ZIK6,F.IN@'OAZ#%U
M%_?HHZM=::J=$=I3W'39X6#'E/C&W0A/3N<E)_FK!TV^/MGMO'2<&CLQD4[,
MKPW^AE8U#)/H]C7NH[( Y"8V=K)PF&!>B46MYL 7KNQ8URY@8_A!/!#>AO0-
M6>#6!'QUA9_[RE!%U.,[NAQ!SY]YS!+JUZPU-LP'(\*+YI<IR3XUVF79)3HT
MP_\\<<%P,]C$>O%S-POPXAJ6*+ QD1N>W=K;+]>[+V7]X9] 9N0AL3'\FGCL
MI:AI;>[6C.N;KH"&Q;0A#D=PD5-:=KXC];JH5T; FQ= .K'JJRVL.Y1W#]@J
M,U[E'Y8UH';N6OE[B]=5)3(]S!\7M3ODZ=KQ$R+PE=-Z3VI&G*?7F=OPB23:
MH*5.3QM!/'DC2M3>"Y$F'WKM47R0!+N@<! UD/^P3TTFP2L8EDW_>'EG&\;;
MYTC-3,L'I+5NG_JK6Q\WK1F+_'HDG-Z:.PZI_$5!$IR)G1M1D"5?GHD'_>7+
MT-C?[$!9&9PW@^U_)NXZK&'GPL'+H \L0)E=4M*G5].W8WE_2GU:7WWONWKD
MN^L95"1 W2\.DF;M%OUERS(N(K $4GTB,B,J1%T:=8L7#]V2:JE3]/D2CTX#
M,B2C,<AAT*ZY@@MU@8V??R36Q%4[&B^-K#0Y**-'A)IV)Q)V4)2CM9>GG,O@
M5RWMQ5//1GI)!\*RI7XHG/Q^E , U&A!6O6/_\Z$^,N'7.^&EGRNG8:C?Y4N
M8609WU"+810XHYT%(/YX0%PJN #VA!IE&$\\CMR"I[_Z$=[5=Y6A3AU2]'XT
M.M[M[BZEX<+#'Z=[_&3X(8GH #:58:(N(.P8V9XQ_-.6CM,7*K_I]GW>W'NT
MF;8Q5 +\:LJ(#9PDU0^<G^R5%_EB5-^Z-UP7@A-LBZI1GQOC\BNHSG(LCBZ:
MMM860C[4H.=XH(1\_)L?AY;FN^L/96XLC4^U@=TVV7SFYZ:=39>>O'"B;9SC
MBX396+NH<>6S'PI"CH >H:BD01)*?BF)IS>9V6MH3!(Z\)HU@H'H/(RL'8_*
MC#X$S,>YM/))VYELV2L6[GV^(91X1D:</.YPG3===LOL]^DU]_[<YEOIQSL^
M^V(&R.7+R)]&,%%D"W87 D>33T.I"N!-R/P/HT6ORFU["A9C9%+YQC7;= 6[
M=?2?HJ@%2MJ%$LV'08$J2^A@YI55\ZSTF^7%I;'+B5HBY[5FOFZ];_^[84X3
MRIW$P\[^PI$?9V=N^;, ]=#[,B[YI1,.E=45X2-3Q\P=4R[+#*5Q+CQ["N51
MD_AMZ<MG+=F_G=4S<T-H]6L8^5 EYB-2&O%L&"GE$V[1F6,7HA_5.YKGS=P^
MW]X@EFX#E*9X'*ZPYM1HJU4(J9I<SF^N21#,/-7,T&- /ILF(KNHD/1,NMB
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M*X54B(B6D.]'@O9-B7OOM'2V;QIH_%7?>#P^(J3J,UL>=BE8X61L:[K)G4W
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MD5H0[YMCZ*90;9Y0DRAIE9E0)76MYY'WFCE*$+KXV2>;60,Z,'6TA+7&'$A
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MZEDES2D>;A@[BSZ"<C@M:'C:'(Z4*H%/T%KV?I3$?A5[#YSZ>X2G67BO_J_
M?.T-VJS,.X7C7(]]7@XH3)1["/UX\1XGU83>FTC1=R=_QY^)[BJ"33I%8YML
M7^NPV?BW5]!'^K[;6)H](B]9,L1OY9S3.3SDUQ<6H.]7Z>*.[5%CJ4;C)U/H
M>1]<JPP@NPDE"GN%?S!H-N?PQX$V;?'V4/WZ&2W_!76"95#48O(;4NVD=#'<
ME^^)B];CXTQ8IC-EOVV\O#G 9WV\29.,OGX_]\@+[K,\=]\/[;;%Z:[DNSLH
MC&+>& ;E2KF<7=*>JPM9^WSN5*AM G+CUPM*)"X".0R!Q#>)G@S1+$GX43=B
MEO'RWH?"&XI[$VY2V+O#&]0SJ$+BCO]_7:*#76:.4'\FH7FVMD[9@%6/]YL6
MOKS>S'#57K)\,KR,#$J>%Q'F<)M^JAWFSX2A40.U@[.*FR3^YE.@K2T_L_3^
MB%NN%HVN^^+"?.VKWS_</&8 ?&@:E,( *@E@^@U#DI_X@=[1H;9G#[TH"M(%
M-4\<6Z"DH%NKG-I;7B&R] *S(S"2)E9B216,%*:HH<LB"]"H$IOR!B@RU+$0
M_7VG7?U@O@Y&6<#[UIW?^-,XXE#5CWD/=WS9X &.^CLZ&QO[EX2I@H.:TX#]
MB!>G:\Q'OIW)%*E)>ZTKMWVH4$.I5]V?8-GW:YX$J1;YW-=LO)3->\%;A[Y4
MGOSL9;B.U4+JLUNOHX*?'CFK05IC:B(_TF4(ZFV1:IP93N6?:OB+F_YXQ)X$
MR>H^55(/NR#:6E:*/K4Z?O)]EN-M%5<12*=S[ +S@#?K:HZ18?J%EQ9JI][T
M[*_Z@/YU32[?#F,!7K"IR(^T.BTBI@#U?YXFLU$&--/3B&*T:[9#(]9RD[+K
M=T0<T>R,Y<"&6P&/'VJ+3&X(@_>7XZ%25[<-=WMK$1,+.R+K*&XU;;>\];B7
MNDKAO%!QV9BJB-5C*![='3-^P?RI$;2CK71364+! M<%U4=%G6?5W:.1"<8%
M?DBL-1:V8B)P]4_/=0.(YVICN%>DZ;0+A;^>FMTLPVVQ2GUB;3?@+AZR?3?%
M?I+,L:?.J0:J@0C350?8>,1+!*ROW[V_?>/9BP+Q[:X ^3XOWB5T\97,'X:S
M$S0]/8]RW*4O91MQWET_XX4B68#C%RR]&M0W9J /EG)O3\64_L7?^C5@,E*,
M>I<V5&IDN3+TKUOP]=[_(T-A9\%C6(5<8O9_6\H%#E$,Q"DY])8H<UWN)\XV
MKN<]Z6SN0YT>I3HT8(LVO?VN\XN*#V]+N]A'RI:4/#G,HSWE<'$QFN[YM]M7
MLM[J#/0LW1*_E+<J>CZU0$#1<$I,1Y[RB[ZQ@UXQ?>I\XV^;>&>.38946<+(
M7[9-ZEF XAWZ11: IW3JE5-8CB/?B^5GRY$_&ZU^7E3Z>]%!>>&3$@9&B5@0
MJ#DZFV]A^>GPFQ>, <5#B^+7G5"S]QTF%/IP@<S1Y-+$ND,#>8]FK=9/PJ:,
M!!;V+C)YN_-UP25KZX.9B7-.!N%_0OY2$S/=\YSX%7'QZMU3S<%F]I_H72MQ
MA@O)1-![[''8?%MH5OB\V1L/N(1I==I%19ZV)<V>.Y*GVSD!2-YEK'4=B6BZ
MN4_(:(2=5N/W?)';Z9&T-UW;=#R_DU[-?:<'-09-]1JJ,:U"!B2U)KQ^X)-D
M7ZW>.CC+WT13E2G&!+\1MZJ0>]BU"PI8C$>[HAZ:]F)+%>M5#4/(193 IGFC
MC%MI5BUY(:BQ+XP1+M]1/_>X$Z!IS',6(+@ #Z339\ZQK11"AR=3$FB:/D*M
MHH=PI?Z^._K=PQEYE_)UCMV1^ZI>]QR<)KRV'A"LHOS&B2=2XOQ69CE$WTR0
MCRO/J&^15^V#.B05OM/[GJD2/\_9E*IJ5!G?-72I.W]NV_ZA'=KK,;NH'\:\
MJPV0'Z]+9T20;-[0C;)D#TQF*S5(D_GTQ+)\H=:5]Y]L)/3XVP>T*^EZA#@$
M% _)+[@)E"B%5495J>7=;<T>XA.#U.-6HDA$:L+FOK>Q>DO7MEVBXQFST5U=
MR &F /KZS6,]V*&UVU*C%KF,'L['W$(<_\RU"\0H9]Y5L<2%PCM\@K1_P+ZN
M@HXA>:80SPCG$W^\+!V4YK6KKC)I?V3 >Q[E6^BV>6(KD&0?LCF,)[=V2T_<
MI9D9!2JT=&5I[4L\LXUY8;FS&9*I;8_O6"8]\<4E[<K?W @Z^1O[,!@:Y1_"
M OPNSE%V5Q5E&B?.+01'F<?6_,1,'B@N[&^NO)BM/6/(XV/7D7BV@F856<R_
MFQ!Z\F_;<JO.$1Y#Y9ZCB!W*^XF+;DQ4*O++>K)^5G7FE.,^></3X6VP\@M7
M'4^Q[ .%A RZ*O[/^W*::E.5?8:,KEB9/G/FMAQ*1<R\TSA)Z)-6F;6?3()\
M!]8NAL]Z0_1XU8",[9>H&YJT6SU"IT]M7[KG/=[PCOQ<U33/9Z?EDP]_HV!6
MY5L.B12)!!47]\8;J'&;8P$;?G5(1K%"SG4Z;X9C49%)3:V<;LS\L[Y9$.5<
M(.6)S+3N*W]>X6+ZJ65$#]A]"<;C$\X"M"0O+6-RNAQJJS^UBY%7OHN^XP*H
M HXZ(=0HJ-^(!P1Q<ZW$=[+'= M VQH"K59%I'J1]H6)+VN#+$#^%LP6^5=4
M)+QICD'.+Q3*UR+@4 SYR!?:#")LKZ"]<RQCCX[E(E R!6.ZDR$BC'@Z\.?8
M3[_/_"I3?:":.'APD)[W>%'L^]434/-EYF7DWV2KD6_2O1^O)/<^BO*63FBN
MGO\&:A1([9AZ+Q[];D$<UX_"I&?@>P]$P&$&NM,KJ_$=^+<A)61'1!FMM\N_
M4S?O1M:?BK#O:?RO%J-:3\K%'1<K$FC8Q^@RT$Q)??Q.&U_[K:5;5AHCT[NW
MH5?;&W5)C]V)4Q:HLNP0FW[DU5.C3Z2<$AW?TOPN'+*SI0094W 1H,X).@N0
M!J]>"#O(^[Q+MS#R:V%RKNW4(C)IK]BPU[L)1-I29 :7$0V; IP,N=GNOYTI
M[Y*VW,B?4 M[/HE2P_7,_(FAAR!DV=$ZB%J%6WX>S@I8=H,Z)E7N%^UY^H$:
M>@.K0EJZ;7Q>H#<%WWP_MDR*]YI$)YRWLP_E\B/3P;U:;LP ^#9PS/1>A"[E
MGJW'KR-5'_<L_XXNOEL"T#^9ZILIM:Y2:K(YA5]>NIOU=\$3-5JM]T8].&D>
M7+'CE9JU?>M5.POP+D@*"I%M\6,7=] A=##S\"#1[*&+U[?,RCCA!%_+N!;W
M4:Y#;9J\8\2%?&$B*,C-7U?7K(1HKL1U6] Y\^H8F@\Y/*T4WPP[&QUQ/HHL
M<D$M-:(_ZT42]-TX%B](N.Z\A=[U]\['"#D9YOET6M7%EM>V$'<325.7%$KP
M#EH1,$K.7,2USVK2?G$JL4U2B$50P<R*%6'_>4S71L>S+@L7K\T #CR*;#:0
M3_0/,&R]J4#.4 GC-Y ['SW)_4G(\>@W$8U9CRWK( RRI^X0[K4U]_>6[/;R
MI8JB*]?.+A1R<C*/'%^S3H@TLKSQMI)J)5QRRB N^V]RT<$,P7BN;*=QAD\_
M8TIQ_-)%W3>>I>]O.2A!NHY?W/7EC+?T=C&"63#'QL7=?4SO##<"5:9)^=YG
MJNVBOH$>-H,7HX<G3KC?IT_(-^:)2CWYD5<%<F3^1>T^>,D"%'Z>H7)Y;@W/
M0XM!]+BOV$T)16:@B+^GZQ!EC&IMQES2Z_NOYO=?8F.='R,?>55_CB$ZTUCE
M46?5DWTA;E<3*C>Q^,N(>< %"=?VH_+_5V>SCH.13LI1Z(T4O1P[%F[1)6UK
M3 <+!EWTYQ%@*I0)Y#S8/)C</W<=PI^HVCZQZ-LVM)#"!"V&DUF ]S,E06W-
M$?='RG*6!TLO-]\OG-7WT&B0,KC[2WF%$RNRT5I:?6Q8055/7"ENV2[(L%H8
MN ++I!HDN:2O>?EY_K0!6^@\/?X)=?(7 #A0];LWP7'HP#)>)CORUY*)M:Q:
M+=8>%2+ML!AU>0Z47L%?XD+=G7 G@5(1-$(;V;N*8@LDUR6I)2>^Z^%.?JZV
M\5+M*L)50TFH\)CK\473B834>?TS,\W3H"&/;V6G7?PYZ@^(]F)BDY[TW#0%
M8>L5G.W;% 4G?2TI.3T/I(.M.E D=Q,SICK_<5H*O]46HG"A:SPZ[GM]U]O>
MUZZ _5%7^=5.F+#E73*.I^GB.*%22_2C, BGL XK.5-V)880KW5?*9ID7_K9
M+_?2"Q8@1DIP/4?T%?KTYWF)CZV:'L[=H$<^&V1//*;9D,<2[I>7_,':X%>!
M],K)+R8G57(:9I'*F!C(31^#MGHL-RD5:"#/3N!:8HI<%YBO8GMT.-2*,/T/
M*/SD>!8@;FS>97^6!>CGQJF?N+T/B0B].933;R)V_N?T2MK:TW;?WV83[9_B
M'\:F9G-RU7M27]9U0HOVWY_1_I;[?O!; @-IH&K:!@&Q4=<_C3#,"+5J@]7_
MO?' J*B]B6(N$&0\WDK^LRP3B)"TG86='EOU<_N:E\]QO+OI&.KKV'_]E?R6
MK,'$BNDJ]'<M*>Y'YL_,KV;0PV/1ZLA1I%J\)CX_)'A+_-7*L&6[:P=JZ0/J
MQ']U*<Y&DPAS.ZW^?BN8P[4EY)HANQK*'^FQXD2OL\WO/%;<F2AUG]A5OX6B
MM@WK!(E7H'@'WM37=H.KFS%(1AK6P1\5^E2[V?JR8W#$\BTO<E]<\&KTA;#U
ML\(Q24<^^0JLK'[%.OR[YCO*^%HC_;)H0>A31;P AVK3,<ELE/%TE4P(]9:U
M*!X2F'TW/,S%_B2B=H*=*L_%4W :EG$Y5[9CL/7V%4Y/;%+.O8&[S[$ XZ=F
M3U!@XN9_8L635(XV'3S[O+3U4_U\X7JVL+ _R'B>X<O!2[U&^'8OHAEZDF[L
M*!72\C$^2UL[TC<<=8OW &?EX=!3!A%3:;AW(M0@+3:N2KL/6^1"CTE>800:
M,J,>T( 5F!BHS<P!2*&7=@S-$$P@@]PL24CY3244H\6O9&^%_(%MZO9Y-/4
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MVP3MT*RVR>+[;#.@68 B3%KN*G:TEWDO3>(?B$01KQ2L?Y/?4\M@['XE:;,
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MG]GE&$)MC,,8 -QR&?+SQO_QWO,%V:'1#=1BN.S/N9D-_$KP&R,P"WJ\Z$/
M#=AKTQ9LL0L](>B?;@Z;C!M7X*T3&YIC^Q[T&U^=!Z-DP?:[S\L[KKGN<N@<
M3;$#0>J-FF_D'_A.2LR<_F1AUD'I6!SQZ$;IX?P8RJEX%N!0WO>M6W[*J8K&
M)VY5@X KV'^GU%;[@4A.2GE;LI13E<)GQ=L/MP2\*N]?2OIUB4V)KU1<WQ=8
MR0R TD0IVR.J 7J-IEPYK@-"&X_;&,_'?Z^JUYM<]#X:@\<A)AZLTE=DTK6Y
MK1X7;,:PG2+8DO*OJ96+HI]F0^WP#.8%]WD0XW ^"X"_+<.4JILO "XHMAQG
M\E),/(^&@_/O^B8*69C]7^R]>3R4[_LW/*4HE%12E"D4DJ1("9/ZV$/('E,D
M6\B^&RW(.B$IQ<@NRV0OVQ192IKL^S)DWT:VP9BYKVOL/I^^W^_O_CW/_=SW
M<_?'^7J=YKJNXSR.][&<QWE>I^/2V?)=PJ;\ EUC6^+XS:&LGR-NGC>15%=.
MQ_X<*< ^1^#"Q(\!R>Q)().GTB=#NI.;,'>QC]VY"%9HTUF6T6?J#;/GDP_?
M"XGUOG\?\3CX0M5=$VB.I_\KJ02<WQ,:^\P/6DI=*<G$X69Q5N+U&G<>DUGA
M<%'AH$^6[.5<+=$['!@CHAY:6P4N#KQ.,%=^#O>L+,PR]'YEK<O OIAUC!_7
MN>OKSBVGXY%(]<O2I$=P[DB;P-!9AE$8SD=4%A\YKVDPR55K*-^UWR9K*Q2*
MIS8 ($=[)YO"MG3W3[4)A+D((K,Q=X;CWA-D]YM:WRH,/\_FW7L/T5,_$OK+
M:"1H@J7Q:AV:R)^H^$XZ\7UX=:QY<K^!V0F7<Y#WL]?LV(LRT[1]DLZ-9(17
MIS[VYJWGA2E7RNO93/24-W10$6R2/D2H*A?YI-[KKFC3]:)CF)7@&H*,PQD'
MV<Y/,'CC!:L<5-XI?]1Q^<!H-;9EZY-JF[H2Z.NK5,JJ5GWC/]V#-*I0.1')
MXD$X,X_=37WO_7/?&%Z!3>W30!BB6 F5Y<S.G_,ZDL^_B6W^',0NOW?K7>O[
M5SWI9=1$C0C):8L)HEQ<ON),G;);G<)8;OJYY[M$/\Q ]/@K$:E?6^X\?O]S
MO9:7[L5:!9,Z@EF= 5M)35''XK/QO<-=B\$\VZ/RW@=,-(6U$U]H?!8:AV=@
M2Y-AU$-A>FSU_3KFPLI!A@^[I5J"E )B]S6=H0MV9*5)XHA/N1GS9J*9SQ$W
M8=9RZ42*F[<D^Z^HZ8KA&W;M+DKX[Z%62:9ARLV:K6F#)\*B9F;%'V&4+CL*
M-2V*J_CK_^QX,B<_\S5?5M3J32O/]N[:V1P18LT[Z/Q.-,JF$SQ>/]RH.Z%1
M;NTJ/?$])NULUGVY*SJ?^T\]32RF&I/F:@LOQR=XGR;J=BM<DDK7;10..25?
M3GLI?8:*<X%V*OKU+>07JQ#-@CNOV8*-.F#;4K6Q.'Y/@WN]*1PA**DY[P%)
M1Z51("\[UDF/:,SJG&=IK,MS\Q?10YD;6N3SC49K&L EE3U@Q^!\[BVP7T?P
MY8LN0([X)M5:E8#-K3+X\CQQ)GW2<10>!=^"6X!](D/H3@B\ I8"L[4'2-ES
M<_ W\&V8G\$$55(!1ZH5*QOSKF$]RXK1@9DC+LJ25GS8'W?2PF'G[ 84BCXD
M?G:.^^PW)Y"&G4'DR</\]9B#KWH*GQ @37)P+RI H:)G =],1[>^^':_[;OE
ML2D>KJKR=\>]<3?U_-YBHX8/L$0DE5:]'K1B)$-,#IY9E)Y$*W7[S.U^?\_
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MDR3=IB>$<:=1$ZS%]GD'GYDP:GW+:/UB21O$]D/J1Y3'%GK$88UGB)*#S?1
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M_:<"?%ZD,@,XA!09#A5TKM4@Q+[QNX:3O!C=MJZ87"[4E?IK;B$C:6_64[O
MB\P3R+1E*N!@%#3HDSV6@36-[YOS'#G4SD4FWC#90/Y:6A8U>#2,>U L^OR;
M$RM7@>N ZOZSF*/]G#/\>R0.VW"X%1EJW42B'KK/H,8,X*/R=5J]O=T>7:2:
M=HA[OM\[HVMF9] RP11.G /2^8VS!JAO4UUGX/PY#X^[A?K<!\QW"]^\'@/C
M7>!2O6TO?2MK>*7A^N?@)K,\40_CJ6X"C+)?E@H<1S)2@2$6%'G_*:*K$16
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M 8LOS4DO##7Y^+\J>I-;<P@%:+(4Q_T;R)<%M_/RGLY9U#PDMAI>?0@EZYJ
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M, ,>?8VC(F.&U$O1I?F7:?4()#JJ*Y)_$?0>V A:^8C >\BR&@?9)POT,TT
M5H-I3 OT*/; A0'07XA8M[Q$(8;*L[,+/+^.%+@(6K=4HL#ST>7!@H7((@B3
M,!](C)6U^%JS^EDP! +*X^L]*8BG(B7G\A]+,9F<0(2JO(+&14>[9>RY.?U2
M_IKS@4FA*-/O:?V=^'BMRUX@& >,@RC2"IL)@('X"?-H,.J6K^XH/<QR02+H
MJR-JJFK6I'*FM&,:WT-ED.F<4E>D,J,6Y,U?JNG%%!?W7]RZ3U$E3579$38!
M_523QSZ+]<)U]P!@^LPTB@ <UE9!8%_0$I2=GX #"MB!IJ]F6*6Y<,,\ +"
MH>BIBJU9M)(=HBY9QA$W$(%=NCF$0.Q;!$4[X4C 21UE<68(?T Q JS]_G%
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MU1LPGW'4<V6%N'%#U.#U3S2?TVH_6NE+8LH\&&!BZS@J"\N/ T!+Y@<M+<L
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MT<VW4%W[<=*PKJ#T8^W4AI =I<>".R#9P0K<3\H9P)]*;I 49Q)(-83GW4R
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M\2)SNQKGD":EP.LYM:L7G5XU-9-NNJ@+!6 L$"U4#]Q-N3['"0^E7P25LQ'
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M,=]M9'!D'^_>C4Y7S)Y8. =<Y+Y-T=^[>/<S@0=RK\ML7O2E3_+='Q-]*X2
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MXC2C<%!-9DA]C8<.* J((S.I8P2]WM4V>5@:)J^N.:\&1&B=C/])!.2B<P^
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M!X%X:R#?LS)L?1+4";1LIOQ[H2')'3IRQVI)Y?['UQMPY,.J]\_]O]DS&BR
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MY"6!4UFT]V,F@";3D 84"6&S4Z6D><FF6M.CYF[,:!\K_>E42!F]1DJ@R]C
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MGC===XC&I=23#7VCG5^T6>/JDK6A9@?'XD88&F2!OJX^9CJO.<VL<301\(>
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MC#0Q(!NL@&A'IK$CV)JJ%&,YPJ>;5Z;-S<ZVID\8:-Q_QP[U H>O$=8)IPM
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M"W"W75=@L9B4$I[D.G-&B3)!*HMC5'0;^MT=UHK8BP_!?+8)ZCP#RTUV(UU
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MQ^P@3['YT/,D_<S<9E?\SKKG+"A2GYV 2E0[#PE <)+3_1-Z]HU,%A!>"C2
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M=^OSBY?XQN,I567R?CDRY$0<Z$@BG&S:;)47'+0.7('7U#"708=VH#V"96'
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MNO;X)B"?%U4B5"=,UA)ADC+9;Y1N,F-J,;^[>#TOPD2B:(X!PT6H(_6/;M$
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M'OO1S(D;/.>JD:AK$.8]&Q09HEP1':XU1YXS.3)$(95_]N>]65C76G#S0(2
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M!!^()J113PA^6)T1(:CG$5FMZ.;L(PQ?"Y/K.S?>%_5IOSY?TYH1YG)@:$A
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M[M1P[M/?L\HZO6<<@A?WZD;^YDBD-B+FO5Z4H_XV0*4.@%*&7!RC>:Q<?(^
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M_I_6#O&,O;=Q>*J7(I0@C3)[MSG\@VZ)USCL\;%=6$ZH*$&A!+_!@V5EY[=
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M&^Y*S&1<6VS*0>;<8MBG!(NM HFFPSRKC.<>_W#KSJ<4%6K*B$W8'MBX$J$
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M4LV2U/48DV(PVTF 7'9E:WV9'G.[PR^:4OUP\W>6R)H (H,2T*VKE:S^>=^
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M6K,%NH_I.Q7\3@&E>_[MX-%Y .O[*3__TC908P)N2J_5/T;\VZ8<X);;F]J
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M6U4WY2IAEM(^ 5*P0O^F4$'BY3X//MGT6<S2J<:^3CQFHS5L\(GM"Z3'+(^
MUG.:1@ECR#X_CO#:/17,3XGNONUMO194 )#RL4TEL:7V*@D$Z@),OG%66\?.
MIQ6NT*OUK<MI#B04;N<$[?QGDE4EOIE<3]H(<OB_>'O/J*;"=6LT@H)TI$@G
M" A(%:1*2$2EB4B37B(B(B @(A A)!3I34!  8G2D2:]$R 4:2)=0DU"+Y*
M0(0 %_=WSCU[?^.</;YQQS?NC_=',D;6REKK?9_YS&<][YRWAJFH]41 EG>2
MZK7F;)9[9@LI$!)UVR%T*X=T>6ZE??A9J\@(15FN!LJM5V(HK/^\ ML0.WVI
M@JK(,-,[LO=$Q Q]EHM=<#MDV;(AS9N/O9+1-QQ1XOGL)K71I"82LDKS^+[)
MI9IN%G6]+=NL<J)?9ZOB<46K2FBNZV5>\4@XIUBR<[DM5E<ZR[FN^E:V>Y/-
M!9LK>A 1X]*0X9_KD_N+8Y.8*$(OF-U-GB+J]IF*_-7UNB(./B0UJ'S+@V&9
MJF$V/G.%JHGE##5\T,%P.QSP(DP'HP#;[K(7K[:[W3&L=+%$)GTJ5*$.)2&5
M>JF"(=YW1U,(&$M1/P*U9BQ,R]':(08/6XM(]NKSPG9(D_I6.RI+4 =\)9VO
M<(SUO5WA+=7O>NI2JVBL*2X\ACEYH86E$WI^#RH(\[L_0A@ED&A#RO*234:G
MV#U3:P?38#OG3$7+:"Q1&:FRFRK<=B(SK4P4J\E6$;WBGV04[E?#@H"SOH_>
ME;%S62,O.H/<?XW?UH]U^*H>_;MBI/7N<0P<0F+7(A5$)<% SOD4T?BIQ\/5
MIP#@@JN+ZK6DHH.<6^<SSU6'VQ>(M3:= O;&NZIX9*VL!%#_O;I)"2H,N7/=
M%CE9C%QUL<:F4=YXH#>*D3?L:=RJ Q^D(S$ZR8BQ]*Y30,0IP!D8=3,U+= K
MWU4YG6EQXB UJ=KTCG!GEY6 KI/(V*6?^R7 GZA.Z_(8B!,J EM;5S3G=K-T
M/#-.8_^S^A!H0/PMU8Z:="> 5OP3=8T+8A*UXX;FA&S:MIP"A@V@G"<#:*()
M*AQRX>0\&=)N/1>&[R\UU:V%.:=W?,?J<E>7_;E](*F+8?XB-5"@;?8L(&-F
M^'E@!:EJ/Y58US:K?W=$B4_ N]/^ZD1=+0JWS?B3;_KHC6::3X+D]1P-2_;P
M-G4#6%J7(?84H$TN.E*C/(9>K(L&,1$\&7[2-(SNN?F-^D@)CTA87!"H/>"_
M+E)_+AP^N9]T_/D)*:T3\B8]JPD/Y8&#R-1X=XYUMO6;W&X!'V0S!H6E(D('
M1!T>#[@U10P=Z2_XTZ_>A%*4W+-"\]>MQ1)>X]Z7*V88>#W5;]A"#--QT7[_
M\RW9_QO=EO"D ;_B0X[<FE- B(G../H\TG/^(EEG81[SCI0IJ-0:[Z;ZW)/B
MY9,W*)NQ_X-O(.Y7KON.KG)FBL7:6)#7-I(;[3ITGL(S_LKN\K*&39>]Q,1C
M]K4Y 6)IVG1YF<,*VYOSLC/7NA_H,E4+E$+IR3&$@XAFIZ/S9(N%VHQL-RX@
MNY*^/I^^ .V19.#(%]N2&!_V=S]7-WB$BL2E_0$&?KZU=<B*H2T]')J/<J]V
M3)SH=!#\' XZ$:FK#JA7G*[_7*=C!:J15OBA+-_+1GK+?4V2]65+T]J,^=AA
M#RYARW@!'3W'2WI0D-?S90V;%BZ<9 ?%-+843-6HWXH<#(^L6-QZ=/&QPG5=
MI3XX\+B!PD>JW>F%J^&@/&4?A%!;Z4O+28EKC8ZWXY<\9,^71'=Q7#>3P92]
M@ ER$D_XT+$H0; :W)VX__%U ?QF(S&P.]FIT*[M+$>=9HMDY4F$NDB"4O]$
M$I967](:'M'-N6$A%/;EPX,.<[0KZ:[\!KO+C\B##[(IJ#Z^@*3;L8+U74Z2
MBOB,.L^WF[Y<4*+Q?(1R;87K%LY3L"[D2>.1,&P,]AI=,?-+\E[?$!H0<IW=
MKT][U I9C=YJ*H9?)5<13P$=]@)$1$6I"[:3:#=[MCI>UP?>&Z]52<XO6Q![
M&XYA/_ #T [6P\5)(EV" N24(R7#PO7#[81F/U(6PY"Z5=UX^B\;.9:[8CXN
MRNZL77RRG8 DS62 V'5PQG%!S0:0@9R\?X><$B"*:?>W?=$;4-SNL8OQB$V-
M+[E7[&/4*:O"6L C-'D',Q*;\^N $M(S!F1#N@W1PN6@C%;0-7O1,8H-7DIW
M^SF<+\_E*<%J9^HE_)N* \^+MI"IOM:9+<>'KSRGH;B3&N)TM[UL_+1-%:I]
M%6A-G-U+:B_&.H4$.;P&;)P,4].*@X#G2<[QBO,AZ-IJ"#](A_FS'S&G&\$1
M/FU(4FIY4]5>4"5]]>Z7HN4K#I=O$_RV6][+I<"-PC<(8J5'VA1WXLG'@'\\
MLEQ_@]3//N=3SQX9.YU,<,JEVE3CQ2ROX[D((4=^#;6K/@7(']*![(2$:?UV
M("?X(CGM8:@NN0)73M?C<&$S2_K'\YROB8;8A5B,^ZN=+9>["14=2_>BP!XI
MZ\F('R=TY#M'&F2NKO2R'#R3ON%X]1%W]7O/Y*WTY2+1M\7:L5]\>U]@4I]O
M27MG:2->DY.Y$T[H!)YPWDX@Z_RN:NL1VV%$?:_WQ/*U^7?G'8%/^L!*T1!6
M9(<\KE1LZ.CI0<<O"Z/1[*2Y'\?9PM3NDB*>[V.I./P*-HMZ\RKK+8^D%K:W
MS'"06$'),9!DHT5D,P]^0P(\*1[1#"T0 ),^B2+VN+RIFN,+0"O<90Q&_ZC#
M@T((%J@'Q,EXN XN3FP1.T^NT_D1BS5H*N*K&URF GR#^+UMBPVY08!4 2,H
M,B3J_8(ZDE^(4D(4BJW:D&G-1 0VW]6X"A-8C)O<O,8XH2>RT&=X. ;X]5@^
M;LX ;W@)QK#06H5W*P^;9VL5H;"12KA,[X'Y-PYOS&D&>L<*"U^!W58[9[;T
M&L;O%>V%,5UQ06+.'6;@H!QK"!7BW <\$QM)B4G$M$Z_R::PG4IWQL,TY!R_
M8$3BCX589O1_J2;U()T-.6$]W?,7X%*EY*-[O'(Q<C*Q::F/Q2(\O[=S=\_D
M*%QXW!(C^%'JYS\K+S5(R-K>LW]LD]*L=?9EU"E@ 7)XL61]^%_%E_AU2$[K
M77)_]3G;M*'1S>KN!!:&]4.FC7[.U")GF7?;YZBT]%AS.$7Y69FU-7FH6A$3
MZ$>0".N5MCA:G$9W'I[SAZ*=WIY-P+=?I5VX%,ILW_='/TT/2L +(#F0]\8I
MX'*K(DQEP2)\:^\4P.\&^>G_\,#%B7-HZFG]P$#)>M-C'8>=''X"/R(P6[=2
MNPSM$ZXS6N/)\S"_(<T(]&5WWXV8-]F]S4 QTMOCL_/&I!L/EY1L+<9)#UQP
M,K+RY9(^/Z#Z0I7?_\\9<48NH)!,S5IX)M?]21.2<WCU1]\%6]<3WA]*WFYY
MZP_X_+8_8V=/ 6&ZU&0OJ/[P/:4O.D_5J_K/,NF!DW/D!F+9$.Y7>>YQ&@;K
MKZVXO3FYD_OUV>1C16E-0)BT&N-%<2&2O7<NH@U!,]KL@Y/CF247]]P\!40U
MJ[VHTBS<2!^9[7W)&:K#D4<0TLX,L]P'?JC4:R_/?_;%;+W+6EH)Y+> WBQ=
M* ]!,E'N+-B!YC=.!"?+EAM;0^UA^;N@GR,J]T6?-=%WJPIE)@_=?\$K3F%'
MX_(3"]<>NSMV'?:$*Q:CZUQ.F,>5<L!Q[O+N4Y;*SD6.(3V^NL^76\KQD]T)
M-!0&XFPKFA#G?,1R+VM+.KOA2'J2YT/*!XOGNIO@AXZ9C@E#U7J7=<<G?WW]
M=NB;@QU/:,X84P)[D;@V^8@;G8)@$FU4SCC((GL:%F]PN!WQV\ZAY/>LC7I,
MU#"'NA1;9Z'700;@R;A^ EE\'C-='N(%EP[TZ[J#N;Y18!_<-5Z'%7[7/?S'
MM9LJ'R2O*E1K."<2?>@1#:ZP>(HQ?OLI7E1S^.&Y/Z:KV5_]F_Y.MUO/8/^]
M1I'96>RGA O]E:A9%2MU@^ZP9?PO<;##YASR<\PEBJ))3L+&'V.=FL!SRT"V
M$RSX&@EU1DFI<?.;?W"02[9D$PRT.M#4=JSD?<F0!^.'6-8[K)?IP)J8R[:+
MU/8.),R^5,:^-)&IIZL\% $AR>17?.H_CXTKR_-FQ[P^EV@44M$=_.Y&B/$!
MU8UYGOV$Z1L+Y9U(LK4@+1E'3!H1<.[*X@S;DJVVRLAH,K'%/:R,P%NEO&/M
M5)U.DNH#2\"UC[,A[A!F.8R ^D)6 ;%*>^QJ[,;-R4C>5[&WXTO#7*[$+#%^
M2M$4805P\PRIS\Y[MW)5UO8,0X@_$X%\<'KB;S /EQ?EP<BD,5<_<NDX]'H4
M_6N$\:Z:ZE%_[*LMZ\;Y+4WO@I/19#AO)3%B/^6 (K)=JEF$="D!OPKF+A&T
MT7HS8\'73VI2+;]TG ]F)Z?AN#H]I_J[6IF)\0T$3T8*./1([-?0G3H5BXZK
MNH0[2PD?8H00MP"<[2*2KL (WSD5<O 9L>"H(D<54E1(*F_@,I!P7NP$P;)"
MJL:7-=O79+A'2GE[EDN4J8%'U'0Y=2#B(G:CXL[^\^-JA*@;X@:YH0RN2UQ)
M7DA@F=5-3UGDC:6",)9(@:>?!%L$CGY;YVC,LJ0>!?A=1A.-#$P-1RDJ^&TN
MN. $Z!HQIU/%Q<T1_\='5SP1W@9O<*HVF^=_0N,^G="GT/3]',F.=J$\SL;H
M[+HNV9-%.B>\*;?&KXY50]ABA%\]$DFUB>P\T-\I^'!4 Z .Z;*D3K1/)$X3
M"GI86"@R1*Z.;48X\Z3BMN J:?K9P2$Z6G%%$!B-O7")9P)WU5 ^.LS]$T$]
M9)MP34UXB5LC<0O(BW8]!?RUO&=3+ ^?HR?:G1'/\LCTL(J6FQIA,[YOK:?W
M6)0Z@U-!0;K?1/)U9QH(?/N'M:,4:I+DABU19B7BY J96:)@K)DGH%#L2;S>
MI?.)=M+/RU#-IO7B/":JC]PRR2DX0WX*U7%%'GG*8:'%$:\2YG-,I0$T#\6P
M?M@NR1<TFA6H>/D]MYU'('RY]SS3'(1DN+#=Z1E_B>)#'O1>T/#$])8\,S^4
MBVB6\WIJ8]ZHE35373G]29;[HAXV0'Z=RPL^$-G!Z[NGX6E^!HJ)KEG<1%1H
MLS>>)21]+H$XWVG +U6N7$X]<%5B "]E]/GC.?.?OX;_1*L ;EIXXY#3=RP]
MX^8NDY$$5!AO.>8WZ8F!<FBAO>M;V^9UCK?BX4K'&('ZZ88/EH4B/"(8I(MA
M6.N-28@#-"@+. H7*7?E_97AD\>W)3MID&63892:%*'0^<6.*HOYUN)D"6(T
MBY8$C(2X)4RAK49^,YD:C;S***X=4V+05W.JJV1:<K^A6UQS(_0@DI:8DWYG
M*?]WG?<G4L166+D!B;WK;%Y;$+\<X7/(=R5A(8?SEA&&T5@3NNL= I:#0MB%
M+P _$0"SMTXDTA-%M7H*J#)(Z^9S8[I].+*S>R2KP>6:UP%UB K17C("Q'8U
M]&VU]7;!BPBHJ:0AW'R/7'3=/&OK>1@*?Y*,5Y^J,61T;65W*SK/=F]';]&V
MA%VGXN4ZP]=O.[U&[?7[2!8X\UCSA2,>I*,;!% -Y9A9MXX:VX-0/3L<7%2P
MEI+02J433UV^\^)+]+T>X1>+<D*_./)\F3\J)FZ@&"'/SC@F.;F'5R>BV9.H
M;D>T*ZN@2^^W&ZVY6#.H<<NDS=: ZD*HT",/\20%P&(@+30=2 T_1P R46!$
M/\HU(!W%AARPX-M\I!/]:CXRD2%0PN:72;\GW\OM:E6FU&3I^K99:-XI(,^6
M[UEW]4/[8(MJR!_Z.W^WL&H7CF^QG-Q^>PIH0R<60,*2]<F1RY1_<54N+?]7
M7; /S[4,XS++.\O#YGC(73BK9B7\UHTCZ-UTW>6DR:%4@8$(2;^[?1C:'Y-O
M;?XJ]R&=-U[GI("!.0K7'= 6:(>>+]6+K($7129+ ]FUSG?G9I=\^ ;+P+&$
M-#LM/ /QE<"<'[00.R]&T7Q8#(L&A-(MN;?'%HI2O>%GDY+"J6SN$K<7GJL4
M+: 8;9ZY!P1[O:C4!XV<HXCIV:$\ QMZ[/$M;-'2LJ^M>U%L)\/H2H']/-P9
MU$J3#18D7@W1VKD-;QQVMX!K6F26+_ZH_&/Z;:36\4IEY@L:-;'6G+%6!K*Z
M%3DM&WZK901T"N!:G<C_WF-Z]'!CL?-.2*OEH[C.2L;*E>4>![L6#LLZ<X.K
M/PEP%:)?A^ ETDHDW"5W#>A(DHND*BL(W"]"#5'SZ:1^-_8*/KBU9A] 0$[M
M8SH@#""??(HL,2'BUYXGF^%^__&-+G;;F2EHP_/6S?YWC^DD'Q8R<F3Z"*YI
M*;Q>S%I9,8\X$B9CNB;GZ'[@R5>S*<"1W[-/YRTG]E8I=QLS)[ME0?46\"2A
M/YEOI/OH:/W.HVK!,A0ZHER/NW('IN<F[X9O*EM-5R5?T<*SJ307]<\^XB+\
M_/$I<\-Z4ER2(\EJY9<H*L3Y&/@%2,B>G:1Z.:/ALU3# MHGQO0 SCO7+OB&
MV6M^$]%P>U]SG-'*;T41K2<[>>)J8MJY6);U\TJ7>KYW&\O>;W7..!@WG%L%
MK$V.2N0_S1,M]1Z NQS=H-P@ARV@6<BFG8*<$28_*!!ZF[472IW],B6NP532
MO4)I%\QNI*IA55[15%+<CX 4(7*<9ZXF'GC!!GH*>(+5<7!6F+7%2+;S;L4K
MIZIQ+IH)J%0AK?<E)7@S)[%J<N%(NN8K1$_,*>!G%M,/]U<"JNCW:YY).ZW7
M>?6X4U_2^HH2U?"-6(E/J=-^_^).ZXD_2WX_GP+*??[Z958H_I<Q7RGZKV1,
MQ$G+Y"G@MFM6P7UDT(F.G!8'$K6[]?OW7_FF/Z,$OZT-8O$"-.HJ\:3(I\BM
M<:G)O;'R1^G(TVK5\W2".G>9UC^E"G3Y_=U@ZV)(C1A.OSKQ>>'XMD[ZX#M[
ME\FOD66E,2^;)D4Y52$*20H7OVOF>1LZ*S:4?J[#)X2<,)$*$D :! TW[2-D
M) 5R"A#J+VC\8#[SZ_O=>R=6:FK]UU;5%LSK$N#4N+\>26QCH!OX0"6E0#:R
M1'U-XI2*^Z,^/RF:\]?/NZMQ<_XPOI_U]#4D&NT$"0,K$\-#<7'>':SK-[5#
M+]:.WDVS$ RLOG-B58+7O&:?>;FG?Z2FE>MD",T"9ERKFP S$TOC$RX0IWRG
M CZ(FZ*2]*X^??K L.\!S8,+_IP<)1:@])JA"]"?.@LWW0A6T A?L>U!A3]/
MUY=*Z_Q?TT"E/(^N^AY9.)+T]U^0W4AYTFG=]FR5X^E=Y\UWBGO=I8WC$Z.N
M/'$/A7BK_N9<4[R,+?%"[9Z1 U5%6@W]N<,LMT+$X"F J48N;(VX#J6?UEGH
M3'0ZZ:])MZ2^^?71EJB'0(:04\R3@T%[4EW;$#5%>P2NE@^+N'LR7$'<')YQ
M23S^ FO]3BI\J*9C\A,0B/<W-VQ#8:4Z3@'5P% ?*/NJ\F%X6MY:W<A/6P$G
MX:A049<K\)SZGYP]HOMJW,MEL"9":O+9'3ZW=B+[H]H=B1=+#O39?\;5;@[!
MLKT%M3EU+PD:/>O;/A^:(A*:] PR)]X [#*<0N/0W2VF#\::G7$PGS@=0ZCL
MW*JM@:=DV58[P]UU.TW1L.=!>B)%Y7IF%S];_(JG53L.&-&>>RSUJ R7>>E;
M@>F5WA8^>HGLD-O_FR'WEW_1'N/@!$;Q05G1BTI<QR^@QW3%[\M0?Z=T]G\Z
MPGIS2CG>.\M2'*Q.A%L;1N&0HCDKF\#:G;D)JT>U/ ,CDFQ%/44 A-)G*X1$
MH#V$:;W\T]7J=#SVWG.VW_)A!3_O.W14?FP*^LX-]!HT3IH%OD<R@K1([/MO
M1GP,N8#8X&8I$O46.P.$JM?W^>-T+;[L.*.!J/!%+_;@X/KDM^!M<@!)JM/^
MW#'*'61(^F%#AMJ,+#B-Y^^*)$+=4N)O"3F;[#"AA)FMOG(\H2=+=<_S(5A@
M7S2T^PG(-G<=+7)993]_)<R>^E$:6Y5 Y?4;Q1YJ_)4#+$8/%FA-3P'T-OB>
M&,A"9E$NU-)UDO=C>&UCUL?/,]K+Q+5(9>G;"BK\-T#1S0*?W&F%S)_]_J*E
M)[4:J+-P"IC.:$-(D&BB\N=6YZ2)<67-> T^:Y)8XKX!Q/CQB];[GW^R:G*+
M2BQZI^,HUT@B]G_KAV'PAR-R/K/6*QU8BS#S0QF.N6\3;QM[GG3EA&4\KIBA
M!(%WO7N5EL\FE4ZW._5^)]EO83L<Q:CX4=^(%)O^L69P*;<1_C6!)??9ZK(+
M_1MN:2X)W84@[R _N$CNC!VR70LA[U*!QLKF$A6F12JZ#ZY;2HBB3$/_['UI
MH,\T.P1JD9WW\XBHZ%; .I3K^>]C)Y"*@T!G)7;H_&UBY/MB=\UK#W(2,KWL
MU8_N(F;3P$QDBX6$2V21#FQ):!=.M&ZL1DKHQ[16P[N>'5VSL@<S7Y[$\B?Y
M6PP!F1'*S^8XC\-!@4244>7X:,^^2R _]OJH&-/Y![ATER=2E4JW;-2_J7$#
M%LU7NN-DUSW)XI-M<?92-C$Q!D#CFL86-UA,Y&,I5=F?0,D5:O'8M^K1&3$_
MNV6W&W[;0GB:U?';6$?<.Q43N"D1%;D7)_QZ"WX-[E@UTB>'':O9R]]9-EUJ
MHCJW1D>@:03R(:9;:8@),4JEU ;#S6:$@(\7S^8NGM"1KM=<-_KB 7R-H1#@
MKB8B]"C^4S .N]+)1(M'43A4%CRC0?*%2)=G?B>\C<H']O<3/>@;HU6^K7._
MS'UY[G"O9'MJ$G\2<<3=11)I0W.6[+G+V=5/>BC)@#>.E*U&K:,2C<_+1H6+
MYK_T+=_V>JMY;C:T0(#/8@><38)NV2U &"C,H?AF=GM8:$>R'O^]5^_?#K5,
M/YW0$Z!*\>#1.^^SW* /G.[!;4W&@.1S9ES 4B,EE/MKEU/*UZTUZT8]/O8%
ML9D_^DZM4.1C\BGS%];/XAM"C.R"AT2@B0\2+AOB-93MZ.T"NJZOUZ:#ULTV
MMZ8(9N:F?>Q5Z@^8Y=_>L*\Z>JZ=2+EZG)G"(2Q;D1^4$T0[-1JL];/EG;+_
M^I '*6VK8F&>@8RQ)\Y]P)7SP.8V,"M/*[QP!GQ;OH<!C"%5:C[=RK5>.Y32
M&=Z]\G (>[,&*:+=&AE-D0L\_IPS3[.S^.2)C]/CLI)<*N[K0J3M[][0\_!G
M]627!<,X^^OCFZ  $L,^G#10]W29,#1JO_U@XOT-E0SZ6P.BYJ*H.=7[Z%G@
M=: YHAO-VBI$N4^6<B^AZ'Q53L?8Z7&V8+#'B=ON(?F]6&E WOOZ!<#M$%I%
M,:U[QK$<21HCT1+%:@S_M(76PHZPW>)X"CC+.*?<$H>1BTH.IP#HI5/ ZNW&
M;6#@!I ,/.FW.,M--R*(HB\5C;4":#,[T-QP+AS+U-E4:=4@?Q#O-N3?.&$?
MPY,$1G[>R6G;D:YX76:5<;GJT2_"-DL>8@AA>0J %.R4AR"=MJ?T=4E+J.XC
MN2@TBU--H&$G%W *FUJ:]UZ.C5;V;FV5;D;0^1">!QHOZ<JLAU^ZB#2Q*%T0
MHT1#B8;EK-,PTVXD%X%XAKXU=HX+3R,\DG^Z8A=\+#_0+ MQ&KTW./I:W-%]
MK\QM1&=K[4MY^&C/#APXD;RP81?C0XK8SZ59D/NP]#J_DPD''RCS(ZBNJ')^
MH] 2D9W;+&1G/')SBB!SPQ*EXZZ\,]IQHIC4\724TB!\Y;%+QSOJ%0M 71^\
M\_MM&1@D_!3P]& 4SN6PT(2>2K,:!\OI!"X:X&4>+!_#U:4%'<#>0Q>P0E<N
MVA4%=[_4F[;ROG=-(J/>-#-W:3&PAI2QWQ3:!E8@^H6"!'!6""%859>Y6Z'+
M?E1A5X&-4I6G1#?>R$):Y"47_]9BR*V;@GS'A?E51&ALS7P4E(6B2>PSI->^
MVJ3_^\B@9B3)S'QB5;+G15=MV7"\U8O7JCL)V "<>81@PH([;2>*R@<))'OJ
MCV2/YI"X@LN6DQ^.?F"5>U=;FI8D'?2P7ZJP5WQYJ3FF WD.(4MY<)8J0-L;
M;1$*HV!>6Q<BLN-&'D7/R4!W[@Z(;?,,VZ2-(I?L>]/N)/GQ%J@5-*07Z'4?
M"1[GGDPW?D>IA"EY"L"OCE%8%H"<A@*UB?@H)9A'NT+<#T6B9'B8%<+S?29C
M8CWCQ$JW'+:J"\VB= I@M7F&I-V3\;SS(V<^ "_@;1ZA68E\5W%T8T96%@ (
M,5H1^7R>?<<B]!3@+ #IBEN ,KH@J\!%G\BU="()7?;"I">'F=8/GP71IH\3
M6F)U-S4?Y7S^<PL">V6]@I%CM:'XDBO$$_XV4N%[(I6L%F/:_;_&SKA<_EJ7
M+JR7FYC*G:B9<#58TKB>IQ?EHLZU6>2-A"X'_&HY@KGX(BO'4=WN4AU^O&],
M71GR![-G[6-\H^TZE:]>Q 6U"6VMSF-BS?&(B8-6/K)-.5R+'$;<.>-Q)Y?K
MHK%V?(-CCYN:QRG'7>R]MT#AN)<"];-9 *4=<8JDH0":PAZ/I$51D=_!LB>[
MIN=U;FKU8.U!OW;9KG]XA0DDRK>O1!^6[[>0^?# .'1E2WPPCJQ"CC"X[!^K
MS Y)G63BT+(7R73X.ACT\T\0K8!6D4'Q_&=F#OS(+@\..BUB$]$#9OV!N J7
M'&OEFX)U-9?2/LQX&$YR?K<UQ;]:6'KNZ@_ U"-;*OE408$%2*2@,%%E:YST
M!WYMP68;Z%9GW.GXM:8Y_+OHPYVZYJJ^%Z'+W&V/>^K\]U'TB&$H5ZLH+*/=
MGR6BE=5-D#7N'I!SO55Y]&KXQ-1#P,;3CH<*27?"'JN7/61,'SS.HK#C-;CV
ML>2MLO6;-$4.V:[&-C$:#]:_ZVZ514XE\L<V05M]L^3U=O4*$)\:'N7E5?_R
M+]\</-*U0HP(<HS77/RM7L[D>JBTNX9-3?93&'CTX2%_<9 *LVZOT<N"Z/T;
M4)&3-@0MB2O4AR6V%,]$;?8CS8CT,$TYPJ0R=<;VKGZBL">U_XZ:8(O;!O(4
M8/;*M"FZH==,8G!GD\,W.WX\9^J#S'<47H6":4U";M9T3;K\DZ0=)K['0X0<
M*]4'UD ,@*F/<ZK[ Y"7UW89-FZ9CYJ-+NZ4+9B\-+,L,FG]SLVXPK/<8A^=
M<[&W:Q:H#F<Y#CVY#+] 4D2(C,CLR;C9U/76MD[\,C%U3PQQ?'C7J).-FE5W
M\W59# 9=F?"F^0:DZX-[#9/+--[HO9O@<V(B[8<5CR.P,)_7?L31T:%LP,K4
M:MX3FV(UNUJ8W>2FWT+3T!1^:&$L/:NYE;L&M<7PJH[UN,XO:W3GY,& AS=%
M0'ZOM#P:6@4)!\O"_-K]E2L"BVUL8";+#,5B%:E77PN*7LRV&\X,H7DPBS:V
MK]&ZS%6=YMU_QCR^G_"2#0F&D8)71\KVI#:&>.<"ZTQ"C9/$@_G@@[5*EF-A
MQT?'>!@U"JK4>I:;P>%*C4VM(?-F)(\TG-L&NG:6?!-C)?]L5S\QQ(&N_I6M
M0ST6T THSU_-_N9:4K8'8NA&51@&@ZP(D2"S?%=[$:)L8:WQ6A7JHBOTD7[&
M$S.MZ%NL'YLN<81)I1B/Q8XSB>^SDU]_HFB0YD->]9^%BI]DMVYVFQG;J=)%
MD\!8C%"B5E.S5I"J4??M%7IPS6\G#JM7P!J4=]?B<3+EJE@+L<[L9GRU!T+
M2L<QMS!+)CE;N/!&@I3TB]!?*8=FIX $5!7D#?I91B K+(1@,K(G<'EQYJ?K
M(?_:A9F[>\8BV@2/VRJW-&]I+JQ,/,N7^]LUG (+W7]U!CS18!GR#;QR09'K
M@;TPL>9S=<T%'*LMO(PQ62CF:L+[G@,GFEMM6Y9@ON,$$ M.OSPZ>6IF?4B\
M4[?LRMC Z&U$7S*/?@Q<9R>V#W%R8GR3@/+.3GD;H.>GNOT&RO *%7(*8/Z=
M0//,CRO-VCZU4E1AG3E.G28Q\Y?$EQ;;W\;=4A79T4_L?VU*C8+T3@&R\T2Y
MM;_-Q7C#/[Y_J_7W]/$Z9G(X74QVM-37Y=5_[)"+5;GVNP>,2N"H-J%>WE+?
MIR>_SJ?PD=(P=\?@=\2B\*7&2C;]'YQ#MUX,E/.=8[]X^\NR/$;D14_F6^W9
M4\"FYT+ *H)5J&E")@WWVF+X#?MM]#.I)7D52..?G6$I@0PUO_V>)F/3OKC
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M0[;^G017$'FSNDDYR-O3T"6<$P7B8T02 NHZ8!/5$P"IF*C%]7_Q=C=9%QE
M\\32)7$&O=B*Q[!B[@ <B[I)T[2 L1ARH1T98,6(98K3WJYC#'F0)\N8)C/1
M/:5!)*(Q!3+TG +9#\MU85C'EU @6%& B?;?)@$5:7;_OOOI 07R2^(9!(VE
MH]7J@N*@FO2]_G%>8_+\R_3G#2K<ZGH&*IBM>Z3<'B=&>K%U"?6I'*$)8%=@
MD/I,@5@-4""M!4-K(.\+0!3)'HFV?>.9]PVC?!UH+0/[^@9V(9!:H7QP3D]T
M.6SBL-7E($-4_!Q9P6R^J;@ >-^A0"HYP9'=FESAV>8ID;9K6Y]"S6YBUU?B
M "(XC+WP_)W_>Q\W;?1^P3Q3^174I)RVH&F)6=\_@LR?;R65:5(@"(ZYY4Z1
MU'X1^JS<M*.KPP:8&!7M5SFEK#N;06 _]7H[:Z5K&*_IT/50(9PC)&Y66N%U
M#,]'ZTWZ;M)F,S7?9;UHU+YJ \]#;;K>@3. ]SA8-7KHK5*P8A[8!7]X+-_W
MF-L<P@[O!I"MY4-K5<FSTF9+"])DO/5X\ .-7'IFZ1Y[[,2@P^9PVRHG9GT-
M;*RDTR698SV!U-)^3_JS.)DDKLA9)67-OZ7]62A7VT%U5]ZDMS\3*]: Z%IQ
M"3FT)]PZ2*#L+ZJH*JD4:1)LG5[YM]2H=]] Z=H'WM-X22M0QC&XA6)<Q9,D
ME%;]!>Q?]H<U/5G!*/RF&[Z'#Y4ZX'.L"&=L(F+RP@-DA2=6Q4#&I<@*6QNC
M#J2)$H  =403,H!6^G_)[/SO4 "_LJDL^)9^<#;=TSZ?+777U.M&(IPW<(I?
MI&5L5, +VAC5,_C$<HZYK?I7DM5ME$6$&I9UB:<&-B%TX/S)'FD2=$<.TCEV
MI5,@U=AN[ 0(1_A5*9 Z_1,B_$E:<5Y<*\Q?_G1+&ZPEB*_!H6<@A4$I$&;X
M2S?!WJ;<5FT3!I((V0M P!8ED21]*!ZSLK".!\%K&P5"T',2P\V.]4RDY00!
MS$ %.*S0=0X8((PB&FRLD8C([]84"#%#)N;^ZH-9IPX#I3\7HKHU:ZZF]UXR
MKC+3(J!X!" QR-8@0 5$5B')OV0=;OE-X579?Z0%JA+S/"TFX9XADTB<V<S0
M$LB&(I(ID)&T/V7_THW!2JQ!0=D9]FO;D+]DKS-N4M/;N,D! POY?O,]B *O
M@;W_M;!0?'WO ++[&G G;AAZP,:3)U>J;JXXBO%\FW^%462C%^.D3?-*6+N9
M<5[_Y4:+VWN5_,XTV.#SSY6D]9=T:TKM=M9*RD+^T-I90VLUR !H[QIR:0:<
MW$,X4]H\])T;IB&Y9+0;V/Y\Y! ]P+0U+0]5M4UF;GE$==5[B+1!G>321.W9
MU-Z'_YN?GOF#B"-CNQRV/'RM.##;JKB#.R50+::)7^S-@>^W2^]W3'"TV4DD
ME\"IW/S]'U3=ULPD_WV,?ORHG^JU>G:MT7F43>*6,IFEIEKT+2T[X*X&?]G+
MU[U.K-[^/VO=MG\\A3H,YG^?[ LK'&P94;C*&KGO,*OKC:</US3-.@K*,D.G
M+$)$/_94?5. K&!2&\D?I40/V-8U[A,P;S/ YHIC)X( >>RHZNJQ-1(X4QIB
M2+;?)E!.K:M.P#7M) SRMAFRE8'D@:Q'S6HLK(-3#B5.;&OEP<U.D+*2E4V!
MVDH*) %*7*1 PJ ],4-+8-UXS C)"0HUO:WK-U1"*LB/O2D0>1AAC +A@/TL
M3]XK*!^]F!?&[+5Y9!-P1XXV 9(_"PMW7V.P@HU9<@BO_:R8]=;"N B@,D V
M-DKJ+VRIV-;"9$9!Q4*!1#^SSAS:4K.?Q3DU@/J) A$1ZIQC_",^Z,_;4K97
MVL7L')(CU8J2)@3O*Z JKJ2PQ+],D772-9V1@;*!6F7+/L L@F"@BZB28<E[
MOZ'/CU?G'$ZK*D/P\#2I.)">VN>"\HM>9X;5O].\'O(LPZG8G"6DCP)Y)'T=
M''@X*00]JDKB+6T@;2"_ZX$U=U-1;$E=Q+ZO2RK"XNB[8!,@0^1+);;]DE7H
MZU476#2Y7I2Y\)??440E%]3Z,EB]=$#2A#8_G829/VV=C=GZ,[*:,PO9F@HH
MPPE)DPKQ\#&D8ZBRW99?DX%# ^: -VQ1&!G&>F%V&BFR^<10Q';+KU!\X QT
M:0I4P;HDZU(&*]UULV^WVXS,MO[\2PN5OWC)HAN!T;_3\M@&TCJHA*E-%PN:
MS7"U%&4%E,[^OIO&]I= ELGM\H(9_=/7(C_9%O)'<\=]5O)E8QSZ6D"Z]=J&
MHRB%J>N+1VX6+YV#_L1)+[1G7&;\Z50IY?K/(W_= 1FE,M[_XSWP<^S%_'L[
M (,UMH)KW5M_AFV5 V>>?[%XV/RZ3\IM2RMO4#O<R,;U]PY'O0B"G!+$IK J
M5[]:CRG]Y,.+_&@#W5BC^M1B<LH:9%TZ![,9:VPEF[X+B7)9!KI)<^V?0&Y%
M2\_KNI_$JVQ'3/79%INV8Y;G'_R?NLWXXS;FM]L:[ZANT'N_AX0S&EVHN/5[
M2+A77R5#B2NVQVU%'BG'L^5?^@!ALY+J=B]3+^ODZ)YM6R^CV;/N._/$1;%3
MKT^?\=[T(\M9B\@.W&0VDJ@L9;:^ HYH*%6P!3- HX@!+L$)&-V^:@KDR+F*
M: V$^+R$$)CRTLIO*1__FC*YKV;]J1<'53CY0KI!X83K@W4V(P53A9//$T/:
M *?G)5 ,%;)@+VESJ3+S[Y%=>"<&G!T)F>#LP*X?ILX.9:DKOG:."^."Q([2
M=_EK3T=54KI+FRB0PYYWAU;!B6:9(U&&XKGQS83L>V%7WMQ069-.SV:%HS%Z
M*PLJ?S'K8O D7C5Q&U'1<_JWDO(_WZXX4XM>G*/&WXZ>^,,A0FC=H)*G9?%#
M1I_$(\;J%\U=7?W4J'L/IU/9O62L;U)YZ\2K"^*_,.'I<5791W_%:>&Q_/_W
M:'?,K+3"W!@,3Z,J 68IFPT#Y$5!XA@)ZN!KR@;O=(JT3K#Q2>V"IEQGGE!H
M=97CM4X*4=[6V7D_098">5IKME*%7#Z>,U\BSF(=T_<\A:OHRWI$L%]4A:J,
M8NI@Z?U%[737EBMZQNF]_.%)H%W ,78B)\ 9Q2?XPWK\G <59K8,XZJALS94
MLQ<B8@8<5C  O)&+?%2S]W@:NS0#VC=&DO7J.\""IYYJC#YNFQ\*S.["OTMN
MR86V(%7=HE" PYJZ_&??KRTQDFQ,KM_8_&@3ID$ZN:P\96J^9:'B+>9"O4C
MWW!B<?$2KW>9T6?M5T+<K87N;86M9HSLEUE"9(3_$F78:B0W_MN OO\:Y,G<
M8C[UA[8T3\I* Y^0;I?>IR&:TQ&NYZIXFPOR(0%X9L*ZWVG<X,JR_4@)*ACY
M8^$&1=Z=F6K<Q?!DN3]>5S-$Y#JI^X92]#?6L2K:J!7FD&^KML>G"LV;A7YT
MGS\%(H;\<Q=+%;:->)T J<.V?6SZ;PSBPU?^7Q4N](6-MOX^6C!+W?4;D[)0
MTD-PK'Y;V]);?F':?Z4@Y,)C_L?:@4Y^D#TYHK>]"'^]57QK3(Y!6$MR^CRO
MZ\N/*O6C_8/)F_+HI6;L0I096C]9M^]RV_0#R?DSBAU6?6\VY;$_[JCV@APP
MP0Y4T[%-/53QVOV2QSNMM5!]U0,Y$8<<.H[*!ZVZ?#^P+OD#"PSG\[<6LJ^F
M*[:*DY8<-K^W_2V=.;576"P\5I,5.P5_YOJWA#]4A]]GU%\5KQ &#LW]&Q$3
M?4\V]=!6,8!',7G1^F\)?^ 5.@GY36VT3=0L2&U;SX+V0Q/Z1\)5*5! JNZH
MHFW._:UR7[T3X.OC0VN?DL&F71.1Z(JA0*"TY*%I$3W/:Z9QG&]J\]YQP@6\
M0CHPN4U\HT'JZ_&G>G ($&KS6F-G?*E$JJ1O&F%IZ>B4<>E+U<G,[P]+#KUK
M&1]]>-VL5QJ[-.$(@O(XDLC,9*-PK&8"L_NGSN@(JL6/\@('W VZ-D7U2L0-
MK2^]!T&])L",E9=[X26S>J+- );G@)QH&07(TD3MK<G#W=T8K!3KJ.YBS072
M^C?DT%NJ'W5+ZM:#N-F)GE1E8^!3!2AO<JC-9:H/:DMJ&1S(Z#>ISM@ME13Z
M);F\7% ^^G8\L]/F\34 ,0^CKE5!MZ:>"+J_ZO2#?5@,@GT=WT#>H,*7GZFY
M\/,\+=XASOJM6QK(]%OJZ-]2)W#7]+:^BU4E!61A9TJ1DQ<KU&V;ERO.+BKH
M-"=\=5%^N>_.8U_HJ6G;KRSEGW6O7OZ\\D[;,503E'2#PY/;;2[X+UT/$H0)
MFH./TQIV':Z>;*,]KBSP/5+N\)2)B<?$+[LL]%RLSO)=/57*"+ <3 9%W^Z'
MP^F']]0?_-?*274V$3/&A;(]M,<V/=&?G2D0_#L7Z/HH58RE?WAW3W*K N[]
MR"%Z"J3.X+0R5YI"!7Q<%DF\+HLB$8JH[JP?_MU?"LA\D12NQS.8NL0-^^5Y
M;0J$CA;\EW"6ZL$CZ'_65A5F<-!=#T?_HPHF1],6IY.HNQ.V9J"'K*[J0$Z$
M%9/Q0R1])R;M1O_^#H!Z4N67QV&XF].PI?I^@.@ ")>$"(U=F)M&G@:5\]:G
MH;\VW+B.Z<'KU178"U G;GT\M9WDA'1+,_Q ,,I0%^8_E'60#N*XY-7-;[!E
METAR-#-')^?EB32;;KAYBJEQ/8WZ 7&^P$DU'17;YH8Z*MR8Q2X$47OJ"S4F
M !^0#@Y9'@4RN:=<^.V^,U^R!5FR6IH EK=4R+)JME;SFS.[ \0S@TT $0D(
MO^\3N:KGM*F^)B=.-(S%D#9[D4,,OW>Q+I4L>8EOXJB>^U%KL.\*T$Y@[@'I
M5 !3$4.FOH,,;' A2"+7P-\KH> 0YIP-D='R^C?.ST61EJ#?_=@0/R!P>EWN
M[/K1)Q.N3I'>(I]$O@"'*9#/!D O<G;E2(A:UZNQ$P*]D[9?GVD5'%QY_(U)
MI^W\/F51)LBS;3X4_,>F[C_,YS_]06VP8]I6BU;4A4 'SR^-'52S#ZV=X[33
MJ[_0 )4"98M._ HX7UB1:]7@A*NR'5KDZD#.C)N1#W1RS(>Q%;S\DEZ7_!64
M<<LI]%+U D"$4Y=^;GA:D?!E8,\S@CV/D4S*[+GDTR*8 LZ8IG;81, 0&8^F
M#E#><NLZS@V<,8+@C#&]J\Q3S3L[XFE&.EEQ!G WH4"&]OT^0EOK,/Y,>Y:/
MY]\BM\''HW2:/G/9<R/Q)KH>$AD/GSSLK9CQMOWLPP$"-D^'C54'\CZ1]@#'
MCI G64\LLJI##$4D=B4]#X%</F']^I_]D,Q4H$5S=?=M&YZ3A>T. L61)UZV
MLPOOD8&L*:Z\'Q!ID0>G!>\,AL@ ^(HD!4CI7+,2XTM.X:R=!$=;-I?::&CD
M;WK%Q1S4O6*P8U2%%)A4!F32-&^,*96 .'"Z 7 W]M'XK:OV=:)(^/>D&.IL
MY A1S(3\_RR1?ABL[GEI]%>C!J;&A5<.-%P[O;TS6S.-JK&+IPRI:PG+C-KR
MDOPL;2GR^NKJQUV+#;^?C9*\$LEB6G:^82D-BQ,H!KYCGX)$Y].6C9R72Y(O
MBQZ_*W]I]'B,$F@$'T7V QY-ZPP@F#^BX; ^(?X=5E_2*%SQY I0>.8O[PNM
MGF;(OD(=6@'0*"<\ )1^X/@_TN8\"%%XHC2C*PLCJHMB)U[]J 7L9UK;5TDH
M\T,;'2VHGYFBMB2=$$KNJ57\UY=?_.?RG\,.79 ,?BBP.UC[Z>E/#=D:'IG*
MYD?#+SVH<T.\1J(*G9[#")L.%(@)ZWKGPA%DPR*R^S2I6>EMR;IFIX>LO>7"
M7[8/TU-;\[^O _Z_+/]NFRU>4_BHND2MT$?N%@7;V/19Y.C&$% JOO1F2IDO
M^7'<7>[(11FFI(=3&L966<= ?;)36T,9LMT'W0XIH8+%A-NY0Z_L:(I'#6QI
M:X<\AX#=9.&1DOB7T3?.515H@G.)NYBT%+,(!5F_P',*Y!OUH_$8<^=LD@?:
M\"5(B*O50: E/T8*HK+C?<=^3VT\QN3%%M3UUAF)CS1"MLH@>:F<]V])NV64
M>>IY5]+CH6"N0TLM9A^I?/:/E%(MVJJYP=XV5JI;<E3]F=()U.VWH?_MI?^M
M]=R3J]H<=9KY):8&*4([(Q3G1!UY\O:#BOSV/^IS4:9_/"Y_?-ANB_#?HE6A
M,HF1_:HEU^^$&]PYOW[^]).(;ZC+/3F,#6:+;*' >W'@46<%FW#4F)4B7W+J
M0>O8(7S\=1!)T:$^(:EH>HOQT*_1-@WJO.F!-,YP@VV72K7S)O3_1VE ])D@
M#5UK_"U17U1U=3='O9Y]0X[XYX*DB'/:&J;J<Z*%+"%"KV]M=_#D7WCMO.FI
MC;(Q/$%%C5>VA14T7Y^'G#_&KYM.?TJ&K%'/XJD_^SRO3DZ=1T+[ I>O%]HS
MF\K"X-1>@*U54UOXV;T!4-%H)=("OH6AAFF9//I70&L6,0G#OP,9Y3IUP0\A
M_CN;A('6%$1?=%0ZB=:&1[-[VR3^!Q*"1#%;3X$6Y(EH*E9!+@3\P1-3J?V.
MWL2!';\T#7*[E8R@UU1J!_*[B8!6,A[[@]O]DKVI-\AC%0NUEJ$@C462J.N4
ME:R_T]@MV6>VIH%<HBN#Q_]/#:;RSBW9>ZR 7'&C4^D+$G<3I(M+U1, T8P*
MHW_)'*,(DF*H89HGPZ^-HV)0NA^9F_W6FQ,=VHU!8"N2#8G3]?/3;"R< 7>Y
MM36$1P6&K<9SPCP-(JRQB^SO*) < O78;X7[M0?7Y-ZMF%SJ!^4I77;;8S3_
ME:M\Z9?U^(J#?_HA1^[5"PR.JX)Z>%EH^\/+C("2(9*,4*6>2TLQ<(:OT]^E
M0'XL^@N)08\H2-<B%\5MT"LSXH"O;;7(  E,R+?ZDQOSO4WXO.+(^3HI1$3W
MZ;:Q)K92NHGH2>1>"F1<A *YAUWU?'S/3G54X9"6W!<A[IE7RP';'9#YG[C>
M%LK&=NP8B5TC!4E!-]9!/*HDI8+YA;BM).+C(WK AB9NXUK2W-&%D*) GBX/
MK<P.;1PQ2#VX,@ZC1WY7D"9[20./HJ=J*CRB*\_$>H4J,UT[_D^K(?7!YU'$
M-(A]](0BV-%/R=U4='N>>;+Y:_E$'7(16OK;?J^=9:>P[!.CL$ +;67FF82C
MV\G+->PCZD:]P@T8X&?+5T@2I!XCPX F>YGQ>A>1O8)AY%(?"*0%I7'44U[)
M!M3WK#<3D9-\:=U,BDP.!J/4HSTOMNDB]2<)#0#L)CB30DG3:X]AHQNPC7'8
MRXRS,,(Z+=G9;,*@7)T"@8(E4D'F'4#2694HL2*1EA32,;[M63]JMJ"6G$FB
M0&3]4D&#@9I!;DQB6]X:2> (_/G+*6^64S#G-OZA+&1!&;UGD$36Y>SI*H+T
M8/&/%]%\1=>&(U3QO0'*3 8>(\[;5H0:*OM*VKP;W9JRX@NLL^Y,L^+#>]2C
M&ML^]:^\</*@DN -_CVZCLG K^N6Y>*$@R>M\"];0&F8Y=F[G33\_@X-/3?5
M;,P T\9M<AL<DZ"8>,_OO]&(_L=F L!4@,:=YS'[N1+8)6KGWO331!HE3TQ3
M((?_DT'D/%<\#OZR:6>F\QG*@!9_*BE$F.'\OSS6;*OBEHT^7V:V?LT8+?D4
M AQN:E-F3A\)2EVG0&!DFT4LHT\'[ ""DW"V'P?DC@3D$EQJWRFQ)*RZG:1K
M+F[<HWWXB?TW6"C6<.4R*9/\3IX3!K;F'CHX\L;+(Q3()7RI;5&>RE4=#5OW
M%-HAWYH$">7CLPXJ^Y/=8$H^XCYM4 9%&J0EBMO]D36RS\>JIZ%G7NQ I>G
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MF[J:FR>)#C6>*=A' H3H^L*T>%D1(4QS9F#/=>9:'7L!WU,0^16ID2XD7F?
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ME,[$9@'>[O"V@T>(),/ER%]/J Y/VWGF5> Q>/3TC?2A0GA8N:8MOGL86J/
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M/@B/'TNWBULM^C;*WN?M91"+8"<GEM\EQ+;C5DMNX?-G@?V$X^AC P#5TW1
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MX$XW0;I@WLZ%W!(N) 9.A*,U/Z=!(;;3LE(L\;90D L#^8*DN1NYJ2((A=/
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MY,1^0>LVU_D7-J>]B0QY38KG6MWW9P(2XDVWDS:"%^UY4WSWQG:>-+IT.>Z
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M_R;HN_\FZ/Q_"!K\%T$GZW$(6LZL\^//I7=9+:WYP1?U!7!M]K<P@3O?6>N
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MG*->S _$8-]E@;F B(3(QQPC/F=M2^V@-W5L(*X&\R7"1$*ZON/H-W4DH]J
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M<T,TY:X1?!?P<6P T*BN5\L4!_F)::.<6-S7_]E:>6Q.P7I11M)0*C;+?(_
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M;C[ZGIGH(N1_TL!?L_Y7&GC@_VL:.&?R]MPC-B)<PP?-[0)L46%3 2(6T">
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M2[H$9?CN[?"AQB.36_P%G%G7-81^]'#E^BJ=5B6:7"W\5ZTK"=RN<)I&GEN
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M8CFN.^'A0F)"Y.L+#W@4A;JS5!CAU!>S!X#)/7ZD-^5&?I1D9!K46N1WO46
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M%VFR*8HV8OB[0E^W@F3R);B^/_D4O0$"/WNZB4W499L13L^D+6?<1>L"X3;
M<9KG^9'9KZM^N'/TPQK%!X_5R.>-J7AK<SQQT0]LNWS!2SF2?H*6D*Q+3,.*
MH8[/PZ4#())0(0!ST6I(S^WAVD#]U>ZU^O2UM_Q5QIW.7)VB3AIG;W$S#@)Q
MM WZ9^K+Y0R<.FVC!R[X_9VW#89S95:J<52Q/DTFYWBXVI>EXC/V]RO,KA[C
M>%D\M8;61OE2[=;Z:I!8 I;O1SOPJF3@1.F[.'(,8F%TX(Y3T!4Y/QF%$YNK
M%VXIA,0=Y-A\ET#&3.S0GPTAC*]1XNN9A1W*4W.#LC5E%A2+(4251O$#;H_+
M8LK*\6I/8@Z?BN#Z@!=D#<$E4-Q[J@RO49PZA>G8/ROT'6<36(I$4,1J_;U;
M;<3#79.BGXC(73)]]5Q:PK7L=!'$'*CLQC0NI5 []D$4M3E)72.3(.+E*/>%
MSM. Y?0DH98_PU]CHJ$O)D8GH[U_#34Z3*#M$+!2^Z!YK %<%">@BQ:C;?EN
M^1^FNR)_*SA7*]V^ETG0;I&WB+%_%2N$NW]AX&\/Q2<>YM/".N)O0&HF$(^A
M(FG05^76S#PR@9;:/.0&-S[8?RB[F<C[NTO^YF-._LNGT6QB'W-S(/ -NL?]
M8*RJMEK^,QU+2U.EW9"&U' 'R/.B@S3Q]0AU+$-D *KK.M<#2=PPAF;VZ%Y(
M%7<(H7L^OMVPA@T1E4L]OG" O8Z.@Y/)P#DR&+@<)C:*\E0JX&]M'.Z25IQN
MY<Y\8%D1?=*CF%?[J&P9_K0Q]WS4_[1+=;GP7^U2;;#_3^U2F6'NVQQ;&XRC
M(O]GCD#:Q0V8-_ZO 2(>0E?SP^_:R-S#4.TU_^K DR?W0466F,U3CIG_7AW&
M9**_%@H .O.VW$Y "MW6T?9;U=W?Z_N@6CT)XP^>S>?#IIL6+Q\3>A+<!XHR
MH6U1E.JIY618HK$M>8[/WUUW?&W^0,^YH76OEIPEGUM)V:EB$Z7-6IQQ#C5Y
MN!MD.]*6!0!_@[(H6+!,\*F>7"%63B.Y(#Q3!2ITRSN1-]H\AH6/"KV(^FW@
MN50):R"N5W/A]^2!#(IFIUM4XYFU/[ZZD3-AH0-/5OP7^>L2WRE<[57+?/?@
MB?'T'VED>"^1CT6\QX",:(;!,PJU@!U*)-/0;HTH"$OU[LA:_5OD>4S,81^$
MBPN_E:GQ@"->^9B<;,K>.50@EI[$'KG=+^P1C:K;PXC& *,K88%!KI^L7X\>
MC[<M^##AHFVJ.']$^^$8H0?#SQJ3/0.<)>.E_W4\,YK?"50B12F0&84RZ4NS
MD6%)QMFM[4_^#J@E#=X]=C!:?ROCR%"0QP?V]>5F2^YS^]H0Y"3^NNZ%ZL\6
MIH(IJJN(>'PSMJM:<UXPXUU H<YPJ*WCA:'B6'OJEY$!L;>BG[4.91UJ,')+
MIUX7=2L?$33E<GBY#SITH"Z#?JH=(+[]:0X1]JN7$=OH^?1%$A.@%@-3T3I8
MY7/OZ8OLFZDYHE=AG*R)'5D!.-LGNDG4$7=%7^@L5#J#KXM9*#@SYV50BIN?
M./,UN"T-^%NYK,Q\B0JK8+-  Y3U.[-7-_LHZH[] C1!,+CA;,%:245%A#^7
MW3/^5_>T<9Y%->_9JV+^%883/K^*7,1%OB[!WMH[AXQ<]]4STY\-9'W!ZABQ
MW*8>[(/$'FR92L.387?3KE'$&2)SO7@)XZ/K9(28DRN/4FJ?3&=MNTUB<;9I
MIK/,Q:;%Z?+%X&^Q:6RX')JC1P./ N:)R>XZ0%[Y)'#-H8[UK07 E",?"%LT
M/-%QW0>506;S+GN$<YA^713=<G]*_=4+/<">:VO&91P[7"L]K0 *EP)1*UN6
MGED\2ZW-/!(\A^[7)G!^)UR._;V1()E37,SZ#!7%#ZEA&OX$P+E=[/P\O]V\
MU'3!,T-A[S.(X<O9A5+8!PE8[%F[K!:>:J95L(B&/.WY I">W%EP^M[5ED?'
M'NE-M,GU?GYX4#KUA>?!">9SM"[# 9@L07D#KI0TS&4J6T"#.=TU<L53==O/
M>B<QB+I6]P+O=&MQR0=OQDB@[<V(1,@AABUU9R&A1YP-8 A2;F^.K&*A#7;=
MCLL5* T-<+6P/%6K5!AM<WR"X[/GTDRJL$ 8EFHC87P602/0TQNH3;D1KWS!
M8>4VI7Z[207K$,^94,],W,:LUV@F"X6=%?3EM&,==IW'R_04 _4N6(H!R5@!
M04F[^G6K>V["887>UBG_98X4B\A0S)A1(6F-YZ^C8#3'!<?U6!IG/XUQDM:4
M1\62FQ__L=:]/CYGD>*('_V]P/E9_N3'\XD'2F3!GW%-%VX2 26[#)Q>*1!"
M 3_2#&,:CO=;$1[B8LWR%\7^%'-H_Q(+K\M0W^R\=21 @:X,O"5G3/JX L54
M3TKAAS( XEQ+.S%66S8;,%SZLJ/4\XQI%L&XX$;&[ZV8^^=N@3/?<ZQB#K ,
M4>>IV'6.**K4@OKLRQIDLJW.GD_/K-K0>ES=ZMBK/#?O:&DK%=(R[P'6^BZC
M%#?8!1/&^&))? OC_7@0^X%8)#QBP.9G[E]/<2LP;1K1N"*1W.4C?:FB%!.F
MVI#NW'^=]P,9(NJ"'H%3KZ2I]G=P9X9A.!AGJ6N[4<3$^7-TU\H57-^_YNHH
MM<Y4:2&I)_?,3#37V))166#/&3.Q#-DLC%9#BE,(O6P."&_J** 64 Q2R#1H
M D63YUQ4R4V-EX>* BV/'OAU.XWC[V<#X;O>Q\^IB XC'2D[*2P%](R[!C4H
MHUH7)F@L0-X+&UWS;'R4LW"CQ>/[TM5"CT=2!KSS02GERL98QM%(Z]RN?+L>
M<+J8V+KZ<@]"V'5Z]F\$_VY83TE(N<S][A.[1I'+/JS#!')D,P![Q[@T=ELK
M8$Y$;X\H3&S)&@C:U)XB/!TUCP^C9T5#:S)^#[\5+U7_[[^'_/_)IW\YE8*U
M-I7V89QJ5V6A-;F_#^^#DDKV07&.I1ABWS*3CF78/L@[ZH'5T:$'KP5CJ!7;
M-7\!W#ZHX]^!Q2Q1]^Q]$$P<NT/"T/1(@?\.!/O($L3W0;PU%]EJ "+^?">4
MS5X"ZMT/:5@<?3=Y)3F]>UQS 1LO"P9>(@(0"^##/]&JS8W>6;/JB,OQ?^0]
M3CN+W;A5$GU6=.3*A>)/CG0[X/@^Z#RB$P+83.R#:!6_<")40M<<?W50( Y"
M-@%WYXQ?5BR4 =O&?SWKQ,\5EG9=)%T[X,WKZ#.!D/F,'KP@,@]G50)P=^_"
M$U_4ZU?[%+N>>V 3!O4ONEO(V'(QQ/1@#OON@Z;Z>[I)ZKET1H92/3T0JK(/
M:GC9'!20JKF1-#TY]^(WM''DBJF$NS3U:\8\4VS8\IMNFSKX0N/5IEWTRZ G
MKMVE*4<2HT^E9B%EK"O$T")LU(L-TEM'6%$7TPK+WXJ$O;4KG;20&2N6/W#]
MXR?Q+^@+AXB8ARLJ1>!TELAD /MNV'7G0%J*&Q!)@8"0KEVMBOF7'_E0UHV=
M_1W#G]9'['"I]V4+:]N''1QX$M("?C^6DPQ2?4K#=\,Y&3:^4GTL ?8MD_,Y
M$B\WEW9%+*8CX7I2,G9V+K]4BOCAO$@#4ZK&DWS'^ 9U@QZ2A_" 5ZF+50#O
MT^@+YT&<G>NDO#=(S1X2FVWO@X3=?5V\QA-#@7PI$Y< E=G?DY#C.6<O;EB<
M/0N*#OD2]-WTF#U2N6>L0^4#S=B0*T\\22-P;"S*P^A,WX_W,3Q)2WSM3VZA
M2C([2Z@),3C8O(RT'UKBVS91<"7&,G?-T/;%@_<)GEL&N9)OIB-?A%6OJG#R
M65$=$QH$$(YCH>V<-L-Z@;<S_ZCN&9VAM'3<.:A@*Q\])'IPX4'PTV0X+Z#:
M,\M=UU)/G8TM ]!#%/+OI5B;^O3)$WFT5@>GSD-?N9PV@[\$73&5OE'3A4T8
M<]= B+H"XCT.+!4?#=*TBTGK;(Y"CL[!.>S]@-*Q4!.C7A>OKP65?O36LI?W
MVI3K<7'>R3>V[]PRD^UUB#O*T8<,G\?W[(.X_23+<HO8UW%1RJNP_#8WZ==J
MT8XS",X^Y>#T'91Y0?%(9ZID_@)9,T;36,&';,V0(O_%J7K_.M&4H)3+Z=3=
ME<)U@??NU6-9/#).^;]^%G%9@FYR/++W-XQJJO31*UW'.3X(>97N&O'-\$+Y
M&R]CH34+%_;Z)7(Q9*C@GI2!&N,3\P@!P/UWV)3:KOY3A/?F23ERONY5*\Y8
MMQ/I&9[E-]UONCB[3MUT_ZC<FG,L6S;B0$7"DV@^_=$; \N\W&:./XMXQW,>
M[,95C37;$T("M(\MQM\1S%+E%_4R/F*F<-#QN>8:EFH%V;0RYM@'/6[/V =)
MUCB]CCZ-.SF/!R/%;=QT>ES$\LA,O<L.1.OZ=)+0]H41S17;9O9S6T?="*$@
M0V7T(<+3G>K*8YX-:0BEQT?.VYZ6FN3@Y+VL?0CQW52Z.0U]#&E <6O'R9ZF
MYB106@(G&K1^N=PQ2!$RN9@D^AZ=_98\Q_^3!?Z^WO"2V[KNNV[E[28I&<-)
MN1BMG[5%O-PF<?[LR\"26(<9QK2F1K%&"NP TJ=7$F?*\T?FVH7F#RV70GO3
MX^)/:\6Z;"'!/3K("D+O$#+D(D;8V;7 R.UVE8=!#E5Z265)M5UD"?%,&D5(
MMPW5M><2?/1OB!=_76_[KBNC8_EA])W+UI4"N_IT;MS+)'6UJ@IC@N*+^CLO
ML"X*5+N$5[30PI.VW)<R>C>G^$[JE=2GNK=WG..Y-!7^["-W4/ 3 01[Z5DE
M0WD9)K3^9K:5=AR #WQ,'F3UQC_?HOU+-\>P\(7_LK(OP'8>)F!+*= 4@27H
MYM).I.$GU<-R:Q-GS3B^>J0'MGV'AO\UXUR"EK5*JG FC-_=!C]NA:6@O(J!
MD^\:3Q8;[#Z3%1^B!-HY(+LZ2?IYBUVW7A48SX?5\#)S&"=J&.;_TI@6YI(9
MD#=();?[LW.F5%;:.]=$O6.A@*FVC:'@E=)GG(T?9.%7]9_^"3S*P?^-$,*?
M:2,Y>#3YRNC(D4](N?3Y<=$2A@ 07/33L"FAE &C-A6\7NVR+"XC_6SZ[NKN
M>4;$\FW3)4R#X-D_[WXG@XK+5_1=+N<BRB:=NWS*7;N;J)-3O;4]1_T/5,AS
M-%X'@3BCS[P+Z-X'<>$XYJ."%ERH&X]P!D4!XAR/2?&Y)5-3-VU:%ILO)!Y;
MGA[WL0"%N.L"P63-)'W[261S-\D@^2X9H6T4%6 7OZF+L*]3!47U76T%8/-&
M&_P3R/L+7;(R+=3UQX,A/L6#)5.-I;A/@N/I\@5"\4L]()Z!Y?RU-T7\4G.'
M ,Q5FEY"XN\&=?U?O88HA$!AM=X+1'B@5(R,PO-WVPX'8SB6E9H=2]6/<K#I
M%<:&9EF@GU>UTI3?]/),;U/N-\5O'W5>:)^6V_ZMFDM%=/XC.8)A2B/&)^?!
M_$A/^SN;I VK[]75)[Q@W2ZZUS+ZV_)5#BBE7JAZUY89S]LD&)4QUE(#9O #
M"#)$2 9C#D21 \7=3R2-ZC+%2'RO73?0?XX8F/Q=:JM@PV*?.]\WXX@R 9W>
M5K$\BHR6EW-<8:6/S&>HQXO*M<P+T^T95YXZZD6!+]/$G@:7^9.BFLK+IH^G
M1QI]S''R@O^N.RV7;BB4_)V-)%*(:*R &D,GC-P"E0$N0P3=+C6+2YY_*%-!
MLCGUHK)!WB2U<]OC\+%W"7VR['N&O+9Y#62<&T:9%5^\/E"^FA,\/=4TQ+MD
M<.@RS\$[P<DS[$MN S;SOKK, Y]@7$BT$0S\A?Y2]N!0D=!*W3+4J^YQKVWA
M_6CIL8P4'!\9GVAH1X<G&YN4(I]>FE7<$ZOQ$ITV(EA.RF=F_DJ>8^.,L0S;
M%U!&0U_SR'#!%7?)88,\**%XTB+@L.=HDV71G?D["XV&"UU0V1;:'5F5 K-A
M)9I>>VU]@DODF2\_[(6MD[RG<$K61F;]U@OY;.-.HRS^.75'E+9;N-FPWH>&
MMM+VX1\C=Q=: FSB8&K?Q:\MMJP-QICXL4Y2@V(7JI5LE7OS-5Y2!#3,)=;"
M;"[\OA4R\>R)J(E=T)]F"]#]CL/ [?F-^/=?P(^-E5\!+B<_;GE^UYVX.V:N
M$]-]0F+UX>ZX/3:<]))-J)XUV',*.GE\>$3=L=L'%>XHL [B&;9A1KX,OTP5
M2]?BW']U:^7[(&(?D4EG_P*AUK#IT5^ +9 [QMF,ZAT6NNTS^X]MZ>Y)$QBJ
M,S 66@.ST<BF4'XPLOL$AAB9!9N%L_X/]MXSJJGW6Q>-@C0ITCNH5*F"]!91
M:2("2F]1 >E-6H! *-([*"B]]R)=D"*$(B*]2D\0Z1 $0H00[N+WW_?L<<^Y
M^XQ]SI<S]ADXQO0+Z\EZUWKGG,_SO.]*%F]+S.E8E*$EYNZV)'3Y^0;%=?49
MA^-A+LY0G^WLNNJNCY*(2C""DUBIIF,0/^)T=63>!7_\<75W82]C.F_T/O7.
M,N@NZ+#*8 FI%NR(DRS%OJ$BMKT!]=-[O]8Q9CFV;*K9S!:\)Z0LI=YW/>GK
MFNUA54L4Z/=K(&WE2UL5)1:91E^G(O)9A)+LT'5V(?95PI&0>5Q9_J^YKJ#9
M"FQ=IR]QO(?AF()6KET[UYAYBNJGR1VNEJ"/3_7>)3[^Q1'.9K!#=R6H&I 1
M6?S-8R*>F01:D[L>/CU3F8I'&>Z*[Q!,233?GSC?E37C$)B.@$D70.O4/H\U
M#(H,&(]5&3IBI#$;"C0QAU:N^F'^#@; R'",Z+VN#DJ/OX" (87:J*';8N)_
M:SCDS:C8T#8=1_7FT!Y5#-/!Z+%^*['.P@[= 03HH8Z*1Z!XG4D)/[_TMWU/
MU->-+ F8JA:C0&M%:,ZPHGVMU,AL1)HF-JEW:3NE96"FV^5FX)J8FM3">K8\
M+B?H@//Y,UL\&?HX[,C)5&],@EU:<Z(ADL'I\9_O0S*OVSP)!7]LYGQ#<%_M
M/I+\H@)2VYL^J+[;?)82<'UQ?M#='1W]-9615C9)HP ]F"Y?PYW"W9.DP<=]
M5/T\+U V_AI.$AV/\+-S:N5#FC-V8<8RQQ[F;8S\S.=T8ZF"LZQ_?!2E&VC]
M0IEB2;%MTX2?('BTG0 G@5Z+F.YF,40,D]GYGM183SH>:MI6!2GB)F.DW)8D
MYVMW9;9]HY*B0#WH^&# !"JRV5DPC]0O70BS#\9V4FZSB+8XX\;;04D^?&Q3
M8;G%LYN-R<:+<RH^=G),J\$>5&Q1JF2U621<-4?E>CK$M$C.X&PJ)<[-L<UV
M1N".P:1+OQ=:M8T>^OEI9&KK6$@0QI=6QM_ BB(6!5K'JB7;B($Y/DP/\BXV
M@QCW*:0\)W]E9/SNPU+0@0@5?9L*Z 7TR]=V5FP(X#ZLL?F(6<-(B4&4=HT]
M1M<<T>KAE'2'F>-S$?;AURP6K/<_QSQ'M&B'>2S\UJY9QXB9=!D=.266,!\I
M0JO"HD#8I:]@4N>&X;EQ3%#;OF'(ZPD%VLIU7ZU6:9;>=];C+M^523P,$A6:
M'[^7U<VXX2^XZ4*,I4) *.L;QQ7N( ?Y$')N[G?J1K?SZL-]-N>X=,3]'?*
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MF=ENJ-70)R['A[:38VWHNRVHT&&A2/4J(XG]]31'*8<[[-=)WC^T7&SYSD]
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M9T$712(76'9F-6/!&N,O&YH^_GQP3\&MQ(!'7R])%D0YJ=8%)L)=01_K?IZ
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MZD? ^?@B=@]VF2@SGKXL>;[A3P84)$]M,.UMD %"KJMDP/D61<[DFX"W@+M
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MJ4N+-\UDXV7J\:#(;U\$]V79\-$%9[L[9BP\_7V7-/7E ';7U2GTVL56ZZ<
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MK@*.RST%H"I%N0UBTV!L[_1=ZE[EQ?.U4J,3?#F>>*.!I"$*\C@Z3(#+PM^
M9A4PM(<]3-<#'#M#^5MPR*@Z$>0/E6\:K[,PID/35BL&+;L? 31QM%B!R76F
M#JIZ9O/X"2&<^_>R$A2!BJ^R(Z*PJ]X9'M=<&$$3?U3-7A=P&KKE9L)</O_8
M'^.!4M37#DDW4@EA>(\>$!.Q01T?6GRW^EV!YAO"Y.A[P8 _S&$)3[CJOX3B
M^XZ.%.G_,A%%U&(]>$MQBR:&>M[2)A,U[8_O?;RH0N3DIDCO$@7R21'*0J>
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M"C_'C0;2C09"_*BB+PX%(D+*K$5YA7$D!ZX ^S=<+0^\N81*GRO0'YQ360L
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MIE!Q>'0K"#@!+;]/8)^-EGPZ<8?(\=FRY%S'-6'WV-\R_D;J/,_/]"L4T_!
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M'0 T43!&TG@R(;-!]RLYI(L:X[KSS';*#><1_I&CBJI6IP>]?R>*:/68_1:
MZ4\@C@O-UM"0?K\^<P7S/?'[NF <5/R[#QBK"XH55[UHY-&4ZZBP JVY+0TV
M^)421C$)F8.S._^\/,1U->OC3\UGQSPSG[A?5.=[B>@1:(3-481)N1C$Y 5,
M1E-M+A=:KO?V!4B@O<S9 <6'NA#1O>?>2^HGO31A%\RL\6/8L=?4<V[:)OB(
MYH LZT_'P?P1<?=9CNM,B>+>8UX4H34F/X[^"O0'K7@4BG4@X:0P*KT>IGZ3
M72\P%_J3K#L@F (=_-GBE"ST5?F\+__<4[IX1*'[V C\C+O*A3E&$9IP4W)N
MP:,JZZTG!?X@.#,='%RL&N+LX[M7NQ4 T93#%^( 0*AOY]9;WL1V#/T8_ICH
M,GJ_19GI/07C$QG_#9?/_NL <):J!CT 8%1_E?EAP!=F7 (LVP337OY\Z*O:
MD_6XI%/3_GWW?/S7F5Y?/1;+[(J)%>/OGZ!![X=%&@/4LFDO#^H \-7XL$/8
M[%\=PA2\,\4^T[)V6">0RT_LKUU@=0L+'[7.."8H##TYW 56L!)RO=<[O[!T
M3]HK]/4SOE.R%=[LN4;*TCOH\L,+"2JH*?ATZ^%@5FQ]]_8!@&755Z*W-$OY
M9<3HVC4C0>'GGT4+IJ%TG"H\B)CE0%%M6K[?SC=**^3D<(I J\AK&EW*(>*(
M$?OO@H'D>U#8-V;W7K<"B]!1[H[74NGG0G+?AFW5W1CI5GO/.MJ F$-3+@2T
MP!F#[9RPJDY6#02_A9>A;LJ!ZZ.,T/F3[/[WOS\L!,14J:IWP$*"Y?:+FL2"
MA2KBNMI@LDUA!K?8Q3U#K;]$G_7/_L[%#UK#UDN=.VPRK*8 C>Y L;R^8!"M
M>2S=H"Q4A,N^?&WZX\Y<].\FM*58LNS GG;JG&NSARFR(627[ (;L;3]@CAF
MLZQDO=*#:[2<R2JKC.HDRWNIU\$WPA>=5<J//;_U&"2@HL1"$;2TW0_I. !D
M1:.+7%/J1K-4J3F!:EEPKU^ZI:5/7 23$(3K-P6';^RRN,GYWID2B@W+87HB
MK7@Z:]/ZK7/1?6^K\LY.^X7717DC"4LP*K0'A ]WJUTETA\ MJW,?A\ ;' !
M9(]@CZ;RY$D(T+H'(BOG(SSA\5RTC:L_)=-W-0V_"<[5XHLIF$V=E>T<ZO3Q
M$<[WR@78"R(Z$^)D5M>M(U]5@TSA<YGPBF0D@1&3&_F\TFT;T9$)?+V&U[AN
M5[HVMF\E#)+1;/W$>[QPT[JY2VK<#-/5!;EP\]7.B4)GR_DLS9$^A+BSY"O
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M_M7;_>*&"N.<JMUC"3>G@H>6.B0R2N[N-Q!0J%F4I-2%BT3(S;[2PQ503 I
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MY+]" >\@ZN%S6<"*[5EZ%5[.4(I\@7SUZ\KQ73UOSRF'LO(^QE!%,Q^&PA6
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MI![:1,P)IW@B_NF/;.OK-2]I FU2'E%;<BEKE"L'@ @_$OH <*>KTY;$7W\
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M<Q8R9;NOZO,0\@_<!A *F46(1"Y0_VWUAMG5+>'-X+CSQW*X:(2!&/L<8N"
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M0).@X0%/$QS_+\!Z <"*^A%9%=X"<H0/@^+P',59L$B_@^4'3TQ@"M:D\9>
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M+EUMW9VBZ*+;)8!IN'CR*4Z>7*D!)Q>^Y=M]<UEN%@&DH(&BJ)>HNFV3G"Y
M)!*G7!_@LGH,50T2!Q^)FGH?9FL4W!4>*&C2G.+))SDMJ@QWA):M3DT^R4]H
M#%4@U"R6V^N8'!UJ9J:1EKXV.5R<'Q54"J#(Y-%3%:[1I;OC-!A@7QJ7$Y>S
M' S+ _&-H+0C!1+B1W*@2:74Y--L+7'6J$C=* /QY,05X(_HTT3$OUJB!B)U
M9&$ZLO@,F+-;)ZKHT,V<SSW[;UT!0U+ZI YM#7E1N-Q,?_A+N/A1S/1*(Z8/
MR(FTEAB"XWII"3"I([ZL6SSM%G.X^%TH.7RS-B=P7-4JHRQH.W  5^ (J<FG
MN)Y3VZ]G1"$%LM=S."Y0#"E SK54@,(J]@[-#@V^DX;(B0R/KGT9%>^L&+.B
MG#DYG[L)-15L?(8FS)7:&EI<NL\2-12L-2N)PV5\1A4[P3?L1#=!/)5EN&\R
M00Y\Q#/7R\W>WMKYO&%4WJ$^?/,.N;[]QGUZ:6;';![W[0VZ(WZG@HTJT1@J
M2]3C.!MTNSR7[\!R3.CJL>3P?=-^MVPI/DT2 ']MJ_BTM;4*Q.\NF_6A&+%*
M;=U][(8:_&OYVM*KLN1%:UX8&>Z+\4L%!  &Z4SZ5(FX[GW[\"\-B4XZ$LN5
M%+;+E_3LO\OD&^3X?30U^2I7@IRVAE3J!?0;I&14??"&$5.">/+MW<-[NW4D
M8J6Z%6?=-2<3B+T#%Z6C(WYG3Z@R(2?3A(4DB!,43U]+)7AI:XC*>.TE *]M
MO[$OH^JHL&$)B%;/ZCL7]M]B2T6.W !^*7@3,ZB>V6RILV:W9HV4?,/7<[8)
MW\<>%"]:HQ)QZM5(]@N2';8^!5EIOK-9?T5^U.M*#23*3ZLA,+.&MWZ''#+&
ML[MVN#U752[[B!\>7YWKHF*?5_@P7_><+;[93IF=.G;?O\;FX+: FXC^]1;9
MN]WNOF&'1IRIU/(Z?_'D0D<DCM-F::I/1K7@2=Q2TK&H<SR#0F/G!L^F#:<N
M^RZD=7"?@^T.L>M,)[5V3@0K3()4QSI.P;F1:YN6)MYY!K]N?(WO&I>5_JEY
MA7<OC[M .QTZ1=2A7A@,+6ZDU!Z*M9=<GU<E8'7J\R?G\4M-WQ_54<7(!Y[9
MIOI+)BSY[BZZ\\B3+=_35JUK\;3-M%YSV,T><<MN^?1J[^<223[3V* 'IJ!_
M(!\@32CJK2!.7.O+'Z5#>Y]EYVP!K0AE<R,U\3ZH@39J>4CL=].]&,I#)=#;
M]N>J\;Q[?R US6QRW?##&D.-Q=')X1(G06:#&'EGHR2?X4Y1_73C+@B,O03N
MPV$%TL3:C&J)$70$ HE0P;_Z-AI_IX!C[T _2]'(OG4%1"ZS<($$02!-$II)
MDZR,:?1';M*.Y,1E?CFY!A#30NG,<40S'21Q$&2Z%2M!%HB>_1D=E"-'*)!&
M+#*GVQ$$-/!,QF<?$(IU<U65Y#0790)AY973:&Y>+#Z3EGPD-TBRAJ)I>983
M^"SGR]2>32"H_JPJOW$S)M0PN*&Z=T*_?E!(G.G@#3TS']8'C-LK(&5L0"F#
MA)74/YUETR3%1M)NL;$HC2ME>U"\IE93=2AIS4+8Y8[;_ .?V7W=N#&!O)<J
M+'QZ2W&86U9P7G")HD$7'7J,/;LQ/UJ3D_V#XK%"7):G]6:=../S S_S!0]-
M#F68C>E,8JZ0EJFRW*/*#-K1H3"%SI5+]K\[_?;ADQ'EU6SF^=EV%?#1Q@OJ
M8A6]N>9ZV_57YD7?&^1P.X!WYHZ(\"@)P/7EDH_K+T.JCC#GYYY\YA==XBRW
M>?"9XFJ,T9G:'X).]83!XC3S1R'.S'=?XT(A3MQEKYH2'>D+D;UC[B>6;,Y/
M&.G!7UGZH2/[9_#*'A6]3R&91PAYX<N[J^Q/'^!>S)T:$M(88S*6,!:DV%1^
M3ETY,'@0&T95/[=>,/3UI>\?M<)_R(BR)0H3K0;P^TI!6+RJ"BYZH#W(V>QS
MW*+MV(H/U&6%+7*-N&;+V->[;L1=&Z[QO'YP2X*)J%_ZY_Z8"3JDX0^7XNH&
M7C<R40^OO)B9?$3#M^SBZ.V-VT,_*;%'_[A56XE;"C==EW4JY,G[\H+0,D#1
M3,\_I_/D"CGS!&?QEG:MWD4GVG8,1%1NKH@P2:R\6OE!YD#W^PC1 <W@*U/E
MS!3G*2G*0$MIR/T7^LU3SLK>F?8QMH3^,VYQJX])\/\<VE7Q<3!?J.+RT<5*
M:YMJ>X@OZ=!IX\!%E.TM:DRCCCZ9)]C*R@I^RL1]%]KK<?G=J\GE6X9KFS1[
MJ[.12A&9FJ8'3Z-T*WOMW9XX>25YB&C7WWXJ=+5I,%JI_6&&I?:[O&0U57O#
MS3))^Z_C<V[TOZAL:=!W=7Y,,21'O<8)JN[SQBS18*T_=SY=PD/\G,N1%PF3
M':\Q9+WMVO+/8YJS,9+]CYV(:EG?'[$Z]*9FMF^=.GM_^Q@GN3^I&5/O;%SI
MXWP\M^;8L7[)?M'@NSVO2M>H\03GZO.NWF44\EEX9,B_YJ')'>L4Q[*&O20%
MK_;R\_@E/J0SB-13<N,YZ_ U^[\?^&X5I_7\D.TR#<\>O"52W<CE$Q5!?'*@
M-G0$O]7RN_G+,OF?9T*9[6X\_ KYW>]O1#A*FK<'G/-.'#C?YC/!)YVK)7I0
M><T>C7'>F[3.R=<V?.VCCALNU6::I;I7OK#9>+\>_S-08*0]?+2Q'COF\84.
M.1!YS>KPWS7O=N6]K3K<O2QIQY06VV'M[8=L/6X&^/.(T9S398VU7P]N,;P3
M=KOKP,%8D'NRKDJ#O+6<K]M%Y22:-IC\J^]D?KFQ$RUXCCM!7**I:\>OW !U
MFX'>#(S= IM33Z:9Z1RXQ<8(?,EM:#W7X#/> ^)Z-XAX"4:/=0Q-,[O80/V>
MK>%H:;R#SB<?FD2;#[1EJ=3@WS.3#NY *-'TEV9@CDW]FG[Z&=#EH.V.!-H5
MG6'.4DG(Z=;W9"0JSY'DT"X-@UFB>]A PI(&J='D))H2JW>4@D7OP*Y+*+N3
MQG=R0#$&XNP)+P#B@$(\FYNZ==$TS)G3[51]=P>JW-_I513D^/5:#+),-=-)
MF1G-Z%JHDONLT99V,X!N.KVN,J)#'!VK4],0S*=3Z\;NAHMGQ^*RF*]^[QIY
M,[ #4ZY_'O?3XS.N9TR?MLIY/*\92XUM7 Q_%:NF0WNR@CG\+B&::XP1DBT=
MJCQ+"@A>3H?>29+#:*<E<2,ZM5D7*=:!!W<.DL@I]Y+#M[Q3K_FG0E7//PA3
M^=T0O=K==.CAS08ZI.V:F<)#/71]%1T:-[L9]K-M,^C,@@1V+Y2O_S?+5W8U
M'.);12 ]V)<7?>/1*ROYVW6E'^\O1@Y,Q.#Q?IO&"LEN83B[S*BSX\<%JYT?
M'2YS?:S!NK'!2_CTH?="&++@S]<:GR0VU$QR)_+J\QAEWMER1!)KR?-,=5-&
M%V[E"SGR^!M3C@Y].^8?#8H6.I5G;(CWG=F;<1?A9FE*W>#>58T^A9<EL\*Q
M+N^OV4PD3#B,N=">JTJ0B4VTL%"J1H:S;T+:J1BK@%5B?B\>>9Z\<EEKO.4I
ML2YL[!6YO$C-N50E*OS>Z(6ZW*F!W#?U@3):FIO.-HJUWNY*&$:RM^OJZ[^8
MI'2L,MW,<V/C:'RV9*Y:[1C_DQR\0.#1_*+$@;XW43#3BX*/'A.U;_'+7AQN
MQ5&<,AN^/"O \VK</W?+X)"L>#2;!N9[0_T-<L;8S4(*;C#,<O#(9<?:9U(/
MO=99$H:C(P;EKK!'G&Q5;RF\ S<\;K)LHZJ+/R4'#5/2Y3GCV;7S M*4.A\+
M?%(;IICJ;^TJ^W!E7/.\X-=C]BMO")C7Y6N3#@15-B!?5R;XC$61W^@Y</F
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MWU_ 4A1P(:BQ30-H"O./8^$/?5OFU3F\#1F!5A,+!.!9+-,XBH0(98PJ,U5
M23O7C[R-HE-' L16TQBY,$*!D0M]6!J!#-$GR)B21FU8!/_-R/\@28"1V3:H
MA_GAA?_))BQ@4^BOHVYM$0@)%'&;;OV;)/"<6O0:7&T 7#*_.]AUS<&H'[Q8
M]R^C LC'4K=HKYUU/W1DJH#\//_7[ (1<+3-#1O B%X' SC_I?]2:<W#DX"'
MN7^5&[\\/++F8:  2 *2W!\JA?XA'1,#Y+<L1GXS[:,]$&&<JO]?\*C]A<?S
M#?3YF_ _ ^4GX9T9A&<4#9!U1[]B>8QB'#VJFO]0;$V\4=V"WJ(QXXPX@F"<
M$8PCW/(? JUA]NYOX2OQ:WY6_TEX (ZW?RL4\1_!C]@ _OS_#OS$WPQ;I[#2
MFF70-<NT?VUTZQ>0JG\!R2#6RO^.6+]P[/\_,>1'#OC-_'=_D_I7O%C]IWAA
M/ ;%BS3Y(]NL2VKX4Y(IK3=>/G8(7='+$[YOX*EQP^<9Q>=+2[. ">7-)$WB
M]V@M4FB_LC1[CRE8'+IKK.QRPO6N$LM<IZ#1".RL(+..5\]YON05.@@XLI5@
M;-I3J7+GO71>5&NUI'PMU#J$'EC916N$9,:G$L!5NZN;4#8DVXMU!>9I@JP-
M$(B$Y;W^W?&X=Y/F9YH"R)FP/F+JDAPQ_6'*(./Y.!S8)@<@4J(<Q;H-A,+=
M)+_(X23&X=MC IP\JDT2)U+)XD^3_5^EL0:,N[76>\6 YUM+"DE[R1(DYPK:
M3M@3%*^@K< ^+P&YDQHWXN?S;ET\<RWD-*7(J9(I@ #O ! A4LZ1OO?30>QU
M)5;%(PD\<<<?][#>U.(2]+T8FC#F8=2$SC8*&B)R54G4']S\=)R7A:)M-S4X
M>&)I!Y0?Y'[#<RO3RXO-[W4,='NN!INJJ^1NE[3#UTN\JU+%%")JCL1-N7RG
MM?(B'G1\H# 11BL*V*/Y'![6YZRT+\QS:V:&OW(7I2;JAW9E5N-IU\SY?IT'
MO:B],QYH#XG4"1>EZM'JV@ YMYG4[*%P;8)F(X30$\^@/]=C1A.U'I.W@@'W
M;QW KB=6HWH@*)4@GV&K#2\!XEY@$/<I0)YI(I8**E+XF6RA X5>0-">E-[Y
MZ\A#O Y-^48["3!W'KVZ?2U0_O?B()-J0/R>DF7D@#,TODR@.U_83.C[YP";
MVBA_I21 +?G,"A/UYE?HV"&XWPKD'*K"#=E'N_</$G])ARM\UVP>0^U'?>C
M4;?4KB5M,,FA 5CQC:T"]>LTVB@]=615;#4./ 1>C#T![/:"D3D. $'9@4>M
M;D(B_CF8_Q#OU:<.,4B@W*=EWH(L[&6DJ3< :BI /7H2NO-GF@K](1X,B%]/
MV[%CB1,NT#"6U?J7J'_@7S.?HO S=F$D!^S&92_%?BW[W6V3&]<Q%$!L4."'
MV\Y")H__Y0 F ()?V>,/#1@.2%EW &JC WSX?B:+GPZ /%YO/GXZX"  I>)?
M4#)NL_N9W_[8Z >43Z"M7J.T!U:,L\SO!Y-8 ";].LPV[M,R[\WAK>LW!TCX
ML-+PI\-_00<X'+/!VI\./T7+'(7^\EP!Y1=PQWYX[I<+=F[T7,-_<,&/R/ES
MIY\ND%Y$;T"E[9<U/PCF2OJ)BO5_0 5%43 *QHXQ#0#GE<.:G^ ,-5'?6"K@
M&_D%IM[ZS7&NI"[:/37>WQSGP^A=P8^QO_L-")P-.&[8> W&OH5-A+:-*'+]
M!4<N%<2X+?<G(PLH0(=X$K(3M8&0?^:1#?H :02^9B;F1R7Q[UED@S[O_I;]
M*XG\WZ#XF4/&:J!V_I23O)!]2)8*C\78=-RCTT;B2-SLCH<)#CV3,<3EJ=%^
M;+#Y[F+BK;*\I(^M4Z7AY/+PCQ"QBU GY;U!0?Q #;U]L.AZ8<,#Z*XC-#ZO
M<]\7;=TMMK^X5N#O2&[GN><ZA$\6ZF;JS$SQ#3*2%X",>%P1/(AYDL:K&+OT
M;#C1_LCME63;\8X>N9&[0K?CPIH3#Y09]@=YZAL5^'3V;LHAH<BG;#]V"-_I
MF+")>7.Q&CQ#*76G.4GZ"3XR\FT^?=Y1WPP&VWOZBDU3HM1@YS$5Z #U3)52
MU=N(I*OU[VP4PK>]RKZOK1+D"9[_QDMV+L=N]N&A??402&H+G4H@YH:^#?QJ
MO__I4E3E@GZRQ'WJ"$N[.T:5>L]+RE(AB&* 5SW?J1R+8!NW5[E^::O^39'(
M9?[^1R$7=LG5*.(YD'[FQ43=7,]4&SF>682P[.?ISS50%_92%\'GFS/B)NHK
M;H1J['T,?QPB%'G^S6RMJTMX3U=J28]2?"UXVB+56F)HK)>3L!1K@Q4_G3/K
M>ZH<\^7+"6X!90.@/LY0,5:ZW<E"8P+*&YQM&1T$3^-@?(7Y$MWU(II"0]V?
MA1+:2XX OE6[#S!B'D7LA *+3  RFH'HH*XB+,6MB'?]ZT&RLRS0M-<MHTEV
ML'T F[D >I;>19&F(83V>"E@BR.,+>8 4G42;-;[_.FZ6AI*KA?U<TLF((Z'
M@3C.0O^]Q&/#$NA?2U 5UY&YM'L%@#&U:\8 ,;R ?0;-E9->H30@ 697$A'4
M32Y@"@M09(9\!Y*'_V#?ZN8Q" D,U(\"&);7Z+7O11UNPN=7XHE_O@_$[MXJ
M[,+6;U""()RF; Y6ETYMI%VD===A1^=5\1O?U:0<EP[$CNU\A>I784#45PK=
M3M$DRBJW?4NSS-.6#933DL4]Z*B6O4M.3G+5I]7"=^&#/HV[S851#M\51!E<
M+4 B"Y4%@R7-O8U9DT05U1?/ ]U@,:!3X.#L!IVXJOK^T4EN$,QNX\/9/-24
M[<F316Y?N7W3E-]M_\+^U1 )A17#0+#ZQ.N0[;>NOA'&BW_209F%_H(EZP]8
MF&Y#?\"R;?3;=YKW.P;XHNLN;B"H]JV;R_P-]=-<T4 48"Z0KM?LA6!T;T\V
MQ:",DB@)U/P7J(91DB#QSZT3-VYBOIOFH>]!=AU-^A=@_[.D)!ND>P5O;J#\
MUHSO"RN+;&]YYOHO]'M$? ,[:WY\G>VHCE.J&Q7AOAQAMP0GV<$9S.0[Q6 F
M=HV9)0R:'7](!_D< EB4W3_S]KB5159*A2>O,AZ;;,Q@]KE_5.%:5V6VLH_B
M%OICMW6> [LACVN^HU0)4HMO_T>FCOS!U+6P:U Y14!5]O(0(C'^TM/70\\7
M[,[2E_Q2=S8PWT>OX6!T)82E2&< O:V3%$5KY5Y(#>,)48_3WH67P)FK:V96
M+&G:9>Z842A*?EW89-5G'WKZ=ZK'_DEUA36J\S>VH@'?)',MS5C10=".&:#X
M^"WB-L3Y3[VS!SC6?J> 3G<S#.M92Q__:MD_"85ZQSGT_!2%BQ!8B=UU++ >
MII$=X*EL=%@R_$+*8U;N>]MK^@->Z"5RNH5E\W<I5,+"([6TEC1? SW5AHUN
M_TY3ADEMCV0CKX,O.FK!&#&.([NOIY[0'ZF'[^0_#HYG9*_C/ZTB>!RF ODM
M\&>R8JS@0OV/"];R#F1IA '4B]F_/L# R0Q P?X73OT+Z[_GK*706T4,4 K_
MM,7]-UL>_OA!9CWQS*\%^6_>2ERGW5J0(X PV:D.60NK0B"L1CP;&)D&-<;&
MR#3KI$2L4QR'ZM99\\&[)(8VTFMTA)8N36*"S)E)S[ 6I/O].^43(N[0FIJ^
M27[;(Y/OI'"''>D@\ZWMD<]W=":29)K3*T*HZK(UW]I\CBP_<T9EA]-9IUV*
MGUFVA'3/&V+1Z;;=:MLR2/[ ^5[=QY[-N;?#M%VU'OU<[8H5C^)B-=4O],RD
M@1@9[,'GJGEYQYGZKHKKX<ZH'1\BL+?LF[KR"2ACEZ,UCN+J>XZ%GRN[O&M/
MG58IB%TKV;2\M6U/>>6^X"_ARD\=S7'D Z1]?;@^@6,2VI_WC7RIT_)4T8V-
MC&3YLJU!IRZ9P&]T*:F&ZPCNZ\"=N2HCWVVSA\*FH-NA-\&L7LJ$>G1 B=39
M-N/@MEG)HA-IWRP?[M_B8#FF^[U/?CP*+8@G= :B=B 53G^WLURY[BM%S/+P
MF;TV&?]P?M+4KW*60V<0PVO#94<'Y85H/.B5AXIK%(E!(IT>WMMZMZBDJ3<^
MN8=Z_83HU!TM#0GM#F?H\>45%]5 &N_#2O3"]N] EEA[;*L-> _JFZ@Z'83=
M@R)^(7:*+1TC<U)3@,(<_6%)^H^WH0/O5+0 -L5QT2C OS@)W.W$]J8I2.?S
MOI75ANL =UX11:F;7>!DHNCZ<]Y^%U;D%F!>C;Y&:P9J]8963RZ*/(L_=&PO
M$$]]_FO/5&T6% :XJQL(I#O@!3X2GZ4W9=$.S9;!SB_&5S%^4QV$K6X9PRX/
MKCU"=N-RY#2')Z_W0[(!4%U#KT[!_]SM&:KB(C*"=E])FDJ* (AM%/)=,\/O
MOVL#(.%S8UT; P ;EJ6W"C0?N7;L#RC2^&B4VA]/:EPS/@M!G@?.#WZ,P.M0
M2_:R=2B#?D&I 4 IN_X PHT;K&%9\1%E8XD:Q?_T$^MW[&P=]I>?)'ZM9CCJ
MZ#KPI 9+0';"FFPX>?X'\'X_@*]C .\$ "_P"QH4H5GM%S0W?D!#6H=F91T:
MO=^A@5#DP3^A>;$.S<;UD?AG_T"3V0ZDWG=>/VE2\P.;A!_$6-,/P_\Z.B-Y
MHV?AJUMO_^99U!CGFBM0ZY[E=@-/7T!0J+<R&&Z,IMTW!MP8_>,1K;\6PVF*
MYLKJ@K]LY5FC@0B@JR%#5Y&?-/AM_08:5*_3X#?9D#_7_TY*XD;5X1M5?[&N
M.C5(^7?.:#-<SO4[9Z37_?:?. .DRS6W[_E!&B_&#L4 :;3_C31^E=@%-H T
ME>ND@3"62_]:_HLU#0!KKJ]Y!9"^@" 3I7^RYI_E0+BJKNDN]Z?NVO^C[D$;
M=5?_G?"_6P_HGK2.)/H/)$< )"\CU!2L>R5#M!'[2**:K?:W^(3G!BO<AO9U
M.X&XA_CO?\:()K:-A]KX?!'8+2U;5:NE.UE_J&3$S\N.&NNBHUV>*ZA,LA3.
M53(5>=/L<I7=*FM+E.3#=ZQ*&)4=#VR'^^9+,?DE6T@Q9EPXMQPI<M?.2]3P
MP7T\._-V)://K.Z=A(M2; DNYB!2QF#<YF[QSDXX]&GJ2TF=^>JB9=8O4-;Q
M! 5W7<W:6T@E\6<R64)?WJS<B*J9B5DT4T[T9]P'$QY-0BE-J2E"LB_IJ7N%
M46TXJF=A;Q4\0#0/1F@(A:0 W<PGU%@%O!B['34413I#*]N'7A6Q)6A7HN=.
M3* 7R:*T('ER%R&:IH5X!)W:;4T'O38LMD-4[!W\! ;XX2M@Q:%GKK64 &<\
M,<:0#AKJ<8&2>::Q"U$3)=_^GH<QXT8-5O;CZ*""Y@6H*&,NV7:L !(7DDY>
M0M%!X41"'S^J2OLM'31^R;6TS9L,I8-JD(Q'0UD>B:.#DO2:M0>L&FG"WK!T
MJ#UTY43#7E0^H-*;#%0PTM4S=#J9#A+E&T2LCC+^^-W(3T^3I+>@.7*U@1*4
M <5'CY0'B*6%\O\S?QK- 7JF[PLD@Q:MDULY@%?C,:#SA]W0%[R1;W[=]?+C
MHC@"'\F;U?HY??O;E7<H(JSY^CU6L:2R2=+%S7K:H8YM K=QV,F3VW\,\?[;
M!9+H1/6_Z@! M"6K1M1"P%H1W;21KT57W#& ^@\>HFJ.4>.Q4W @&9[M,)*'
M#9X978'85V#+JCPTZ:#SFE6H\^3D?E%*8@5.$Q1*TFI[2%N,])*"NWIMH8.>
MN9,F:=6N /<_I!B2U=XM#U!VP*B>:%HX$CW9&2"&.4FY\_L<KECB'&6LBHF5
M,4NX-EWU\Y8>9@Z]$,>G*%ZSMT\!8PQV_;JO1T-.G>GW6Y$ ;">!%X4>C?;C
M]?N!=YX_V C@A@N<B+H)C>T?Q7V[2P<%6!.G::'N<):V7F@FF!+6%XI=DL+2
M(GK:REHJ((,-PRN0M]_HH###O8VH51/5OB5>.BCB'0&(_K?1\%5-5;<^/M10
M!K*OC7QSE@[2E'>$?FR@Q,'N0R>3^FAA#6:YU;,KDN9 H?BQI8\68M,82NQ+
MGKB;OTP)L$:U 61\DQCP.D"B$:KP:RCVYW78L=H[4V-M&JU39@:JQ"RR?@<2
MPX8RU4U07Q"'/CY;!,2AIVFWP  %^O7V[W:^ 1S]ZN;S[>J0T33N-S_&ZL7^
MXY6R_T2,&A:)4@I!@U>;Z2#@U1F3>#0=M%443BI957-$DS3MYT-72?F89] X
M;^#(W2K&")LWJ/9"!! ?7/)SKG>Y40-GJ<Y* %Z^"(,I5#N,I@7#H6!3[Z +
M.L-.EUMIY:@Y+9H*JET<3-U[US1N%TV8!@]K> X$I06T0IHJY:_.871J?N _
MT):E!9H!4T(%HB;3<N>BBFC+2Q'$-C^O6S[)!B:3$IXU!E/.98*MP:;W"A_,
M\+NSY'HL@-M?X6% :^*:0],W>CJ!9?&R'83PVQSM)#E?/)N'C:[-BV<.V+\C
MR)WK&O-19W.;BZ[)#4/>U////UN=@*;DF\^1$)1>S3R?Y@*!T("2?>-JTH^/
MYNZC:>,.\&?MW32'3A#WSE],5RZC@S[1(EA\[;,Q DC?K&-YERU8:_@/[J\0
M3Y_;K. )KEM,7UX*P7XBN)=+L56$UV+K8EK[:FF''N]B4V@23Z1M-0NM3IUF
MA;!>-9\TYRT@&L:-IER9*K/8=VG@ZS9\CH>S*2'E1+E,2'UF;V7_G6QB))%S
M\&7"-C/EKA>]TUUFX6HW2=\)6VF\XU$%O='O4':WC7:DC$3RX25EWT0.1&*+
M9R3<!S!3W^W3D!K2>Y&%5^W!.B^V?'_]+.A)37EA8= 1I!!FBY$G,= \'[)Y
M1E*(8#43G%BS$QLFV;9KL,>KV6I';.WH/59\";O$&?R^",_!AHXN337!!]K/
M&_D4ZXMSS&)V"[+>4YH6T5J%G&\Q?(?GZ$F?=JZ-,GKP^%#VE:81O;=O$MZW
M]!7'95%@QT@)9/FK2%39'!)='M,T:>RU?>1S!,?3K+ME+BZ@74IA(??F.]&$
MY:6;'YM5A,!/*+?2<OPM[@0*.TIH[C[73@F:W7] Z_-^SQ#G*U%TT+:2 ZCR
MY.A+L<81Y[]=>VP=>ZZD(.:@$(_PD\]=4:,@O'+QY%C?D[:"'6@VEZ[)6;#.
MH/<.R3UI:<]KSLH\_71M=^D.*-3.3RDSX*)^2>%C+NGRMI=$>3%/>>Y#B8>F
MNDH*S#H@REYP:KQ!F9I :&4!<RHU-R&G3R;6^H8A.9W'Q] 4'Z\4(F%;BLT\
M@L8C'G>Z/T'EWLPL+# 0NON^Y,)Y87%<V\QF#_R)=* )\]E_6VUK7V<[4I!\
M_MNM3(1(4I[OV4WH.]=]EZGXIS+QFISLT8XBF"F/N>J1X^0M@?FZ[+Q.[*JR
M.Z5M#<)LTZ;T:^^P<1T?[U6K^=H[EZEC[ZG,OS@ZE3308UDAUXN$5>VQR<U@
MWE3T.>F!D8#!$.0P!68\ [6"L5MW0BN6BK*;]\S,4"E=[RX_BW7CN>@G< (T
M/WD%DN$%'*7;,$^>45N*3G.]@^QOF(,D09<4K7C! 9O&I*.'A?EW1G*:KMS:
MKMR)<[@*8\W@OJ##>_[(AUNO'6JC.FFW^^W4-I,0<%*^].-C=-!N+<_D8/G9
MX)X/8>=J19]SX"*Y0;>*700/4Z,H,@-P]HDV(W.10L_:V^8CW)<T%#;%W7NK
ML$>7^11_S&=JM(O]F3.D^G<F$X8*Q[E8+L11"M]=L-.,X^YYP*QQ:B0?$1KH
M/"@=:ASWY/GC\,'>5LF7[ZUV:T(,5F-Z%P5TU57WJ*B9<JH4#R8_UG6*#3#R
ML$[N]MCJ-Y4[@ ;?=HOV42":C.>Z@VZ>>!O 82@D<NI.5\9TP*"/DA=3Z("9
M;Q3FK8V^#:].7;SF;.F\T-,'I4-W2GW5XB3:*#K]?<Q>/-]<;L^H2'OCM<=-
MOO@>VGFGL)1G1??RIL^EK!Z>!G20K48X[.&J@2JV(TDI:$LY^ZS8BBPE7\"Q
M,=/7NB!L.?W%N*5LD?!1U[9/0;=T#X\-=2YZB/I\3B16H? \*JJE90$X;CHH
M_7*#ES%A!F-)8#I=F$^4:DVX67,K$Q;>RW%NGNL+TY8>7'YZ(-ZOGBQ+N@->
M&;4 *J*4/MY$3W1';L71:CFAM_&IX2R'U!15+IWJBJ9<Z./3T;WBE];"/=4Y
MVX4Z\SR#^IPB/8 %=\!)DU7ZUNY<)AJ?S0Z<=>/IR*^X$?JJR@G"6P(J(W1I
M9K>Y!)N0#<['E5^_^/KLECW<G -M(:_<.6>UB2R7"+./IH1(P?TK/<*06^&V
M,@)3=J6N+A!WH29%JD0X:9J06\Y2ZHAL.)^IY/ZT=6Y%+(VUGDTIN$0/<GC3
MW%$6W<B+:09QSJHT//_-JP^16E3C<%T9F/GM>G>'9>Q;/ZE^.JCCX?G0\IS.
MOI"BDYW\[JP?#EP5\JO=(9O0>U)C]II$-*F>K)9;$2?>9]:8#9D.9K[^WLJ*
M#]\M^^$\Y4-R6V])-*GV;L*9 3:)>LN*:#6))L/+5B%U#G-SR7OX%70[QC^G
M@P>KB^]@F1P^6!#,9L(2M1#;'FLY[*_*F^=\)NL@'0^JEFLX,1+@^C[_,-S-
M7%FL]&*"89#E!R&7-KE(<K&BW5>N ?14O54Z\C1D#RGW:H1&Q@N5,7QPE&I8
M?,A,__WX;?@$SFDZB+4$,HX%>X'3U!-M)=*M<\.UG+=^B710>977721XZ67
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M\EZO%SM#B54@CG]N ?MQ:;8%;+C!ZY\KY.<],9!70&D$9?>6T9S\EV+ZGTL
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MU+:TCC\4\4Z=!AI !W)-JIX1K!0+]4E+]/4KRG:ZT/3AUH2H?_D4I]-F!V\
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MW6"#F#5Z&%4Q=30/NV)*S9E"Q(.)'%"4#?HW3"'" K%[F1W8#Z#W-;LBK*A
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MT_J6&\S!VVB@^7M0@TN*?S8QH/FO4ICLX3^[6#'#S/? TT"02]]H<4S)>Q#
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M09?C@(\CASX?V?<\]9TVM(&3S9M8'W#^/NI)NL0*5]*N?1KDPIR^!8E90*Q
M.=OO;*&F;*Z&8*[^).">MIB-OZQ4Q+ZC(QW^\SB&\CTL($\>]PQQFG&2S37O
MH].0%9).X ;0*29$5 &AW,4W)$-)Y\_MB^[0)0'OJ%3G.'H#_33?*CVC)^5?
M%>5S&<3IRP,5*72.)&5L#/V_0HXL%8+S,7LY&L+)V\6<';H"G WH^8W5SGHJ
M7#A=W;5K Z'(X% 'PSQD@819GH3 ;2J4/M8'#?X^["3.VYC=A^QE)*3P'X3V
M86^=\KO?^#?]:LV_VG>ZEV(+SN@(:;GO\>M%(2*85(,<4 *M?]6'ESK.N4)
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M/5)C517P]_52$'R^BX"XIS!^),2:D(=8K^HWE^PX?8K401&3! &*X77^0!2
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MOC\#%H4*1I%>7\1<_-'0T@=CM:'_BU_V12BV07*<;NU#D=;,)2SQY'=B\U:
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M!4'%=L)/XQ$S$>.F9RL" =S!@@ UD@#.WII$T(>?.H)\K#3L]&YBS3O%2J+
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MFR1&;IM/?@&!F86)]U[/313OC7%\T=UNS&D.33B=#/I6YW"$OVW?D;^<W+F
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MEH"D\F93LP_.\T\CDJZ1 7 G:&<56V7:F?V]54P\IPFAA<"Y0FN7\U=")6P
MZ-4O/(>'MC2;FH\VBHMW,8M9A[@S*3<LV5GI2E"1H?SZ-$1F]9LC50_%Q[E?
M6I^6'KK!I&RWLGFBM=-DH')2A':RNMV%Y$E EZ5C;V99&AQ*.+D\1"UEG22F
MRWQ.E3Y/S%B:I&;FZI4(QHP\ZYX>#GP]$91IMU<OJT3MJYVTF\XU@X5[P=&1
MH2@EIHPKOE+:V;319:>9LDEI>NA:!V2$FII1@K9><JBQU?DJ\5;3QXW*F+/
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MCH]#" "=&MV4=FKX6!0TBO=(05WJ(1]DZP=XALN58(F2OI)+/E@.__"NQHU
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MSNDSXH)/\K]>XASHK)/9F<Y38W4X!%[WC@6A2- )JG2IW8N=QX\Y//Z^SH+
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M<Z+-K9Z<)OK$@_\^T\S+Z/JW^ALGQ8ZMX=)14L'72 *-"R[#2Y<S_KQXX/+
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M6?EJK8>YK]&QSLJ[KQN=-ZQNU-JG&W2^RJ0 _XP"+Y%M75A99UX4N=-NT]7
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ME6M;_<7B\,?'.A6>7Z_:Y#!]&-GTJT\S%&ZN<M>-6[A99!L6_<YE95G%*TH
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MK,$W1X5$SR.HK!AD"E!#/078L2$F>)YP[T6!P4\#B%W,)_$X3N Y!A5E:\P
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MX"UQ/T@B4$=K$5CN)9!Z3+^=-5E^CHQ[DVT",Y*8PV9A:]]KI%Z#M7F->N\
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MT@%WB+"V7-2S:E(HA%WOA04CJ$8;3XN=I-E_'#<[?#5<D3>Q=L3Q,IWH^5\
M=2.#8L_?0.372+]:2F2Z$'^1-7G2(_LG2+/+YGL.#"Y%.ISI[[4G@V5,!2/-
M]D@R--MP:=+)/**X*) HQ$NT&^(GFH4DNHZQ1WALE-?Y"%,"2DT*B)Y=$:8#
M?:KDL7$"<!PF2Q$S%>L>CS2/M5-^B_O?@NE-!+.MGAUL'>,X'Q@7E24+^MTL
M,X#]Q#(&,W:FVT["5?F(/[@H1 3C(=@;N8^]7R1U'^4]B7BG(&(>[,4?T?IT
M(=H !-Q+CX%XI8!GNI!*A&<0F=)@YT(8&L6 [NES#(GZ&HF:!&?4P']*?9JV
MAAR"#-X"30,#G;CA%R.;XE@& $L'P)+XD)/L!B"#)DVIU!XOL1Q;S'"=I%]@
M]A]>(<T@;!E"V#%*O3EA: 1!%9S\ R(W\E3EHHZG0NLN3Y027!4XVYR&B$U^
MR0Z+J,AZA4"*K$]HAUK[(=8X0KT2Z<[)!\)C(P@B%&6V5Y_^LXG<9QF/3B2'
M[].CC+& FI&8FC64]]M \QGGF\'PWTQ/$<'P*XJW^4RPGXH3-4U2D2G\W P^
MMO;5)"027[=?N\XHSP=3/I-A/.Y@<\A(8UU?-8#IZ&\%D*">!8YM!]I Z20C
MI2, _5,V"M4?+*!3_8>,F)/]:BJSR6_'*1]O?)_$ ^#SG#,V,S4*>B4HL^EN
M\924I0CQ81Q,L08N1G0;(942&"..;7]R4<\G0"T&X]L/+FJ2E\E.,T _" :X
M23&)T^S4(&L24H6(>I160Y9[SF ,%_47T,<8:=(LX[)_9#61-WDR;].H8P43
M]NZ!@E5X:K:#1(/!=.1H!A\M!$7#G]SZ]$#1.")%\POYC%^+_!B_"%^3!EJA
MX/752-Z@KR+@KN8,/G%$%A##B7 $)!SFOX<S@JL0>(!8)!ZZ_CYI: S8WY&>
MQ'EM.78P"JE$ N(Q\!O$4C-;'Z"N#Z%.3<,5A*C;!QA+B7%&E 0>S6%66IH6
MM')VMA+9(W:8''E(3DQY'NPYT2 ,&MX1,OP"FR6>9AD&:&RMK*B9BV;)&%X>
MV"L^IE-*W;-V ?L"\S7],'L_*2LS(]L*4Y1[8<?Q$Z7*O@8+J0).U\LNGGXE
M;A/6XJ/;)RN0FK$YCJ@J&I(:6.&QTF0E^GSG5_^MUAS+$2A&1==^;ZX)CJSV
M]4F W >;@S16V3[_(I*(18^%]YK#MX57>M4=Y;1AL%B[$>Q*-IIF6/9P8RU;
M@FAY(9+S8855E\H1T7FAX9E7-XZ*]U@+L9,_R9<VW'MH&;/^5GJ^AERBE/GU
MSI:,])M6<J'M/EUU8U(/N:BEZO2E@]MV[U1/!VMZ,'(C*U7Z2MBCD\!<!81P
MR!]@F0TKLKU/0CQ_V3"R1MEP(__!""8KA:&J47 3\*G()\H0C"M^DLS;0+0U
M,O "$A<E$0>O=J'*L-D7H(F(#2P+%@QMPPP,(1+64H;&+H'BC&*#AF-7W8NV
M?@>1[R/=E)$4#]KI,C8H"4(P**&Y_PYP9CB57T)G>0CV, W'!H&W01\<)C-/
M46Z1AB@@WIL<I*$2:$6DY5!'(4!['>P^2GN^8+*(I Y&!\Q%J8#=2YH'2.,^
M>G0,J<T$ZW?PUVEH"=/0A&=!\]Z-80M"L(KU66=<+Q=5UD?FP([T>+BF$#R[
M@<!B(_8W)IZ"+IS"='SB;PD>\X1 _M:0][?:[.VCQ89CS*\ NP)P<),;?B;S
MMM5$9*^6,X'M\:_8GD*_A691#^J(%PY4]QK#OD N:@QYHP'I"[)3RTQA"/>M
ME6&/04PQ((H[@;U]X!<T:%H193FFHW622N<V0OTH98CEQ!?2WZR0S/:>P(KA
M1T-/12.RMW-1(-S $ZC9DHNBYV):_.$-$-EK4N/:NUP4#@N1V\H0XN)F:(KI
MDROPY23XS# <V,#XH1'#J0]/4?=K^,'P5!!L4H7:F2H<>DK*?$X8:D/F=4YR
MST1:4X;HG#3S9&QK0PX13/F8' Q"?&B6Q\ 4:] %4S%&]$K8$\.;4=1QB.T5
MV:/?,%.4_6HVL#O/5J1/J1C%2?,VG"(-JA?5XB0CA24\D2=8*/S6,@-_R?-7
M4=P65P\ ][8BW:Q"\C18@2"'"=:6Q/XSV+]6Z11<T",9)3,L@LD&A$\$KQSG
M&$%V8%U!UB6PKIA\!PIZSU3PGU7JEC5EL31X-Z4/-\!?0<$#+_>GD%WSC&A@
MW?M=.*=)4_3P>LAWWJ<Y\%:]GFHM3JK/C%S/\G*=31QVVA]T/,_^\(20_L<!
M'X0>X!!@;,.>+"U.VLQP-O\EW$D"@(9E\:A/AP:&D+//!N#YJ<+@7 6+_W,(
MF5<0P_7Q3#'#<%T0/_-2_TF7E&"RG86GL$$7$2>7<3A@Q1OY6*C)(<Z$AOL%
M6O@4<6(\XL3 (BA!7&D_:8P>$XBO:0=?TS;L>@@W0X8&T@06!-QEB%>FWAO
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MM"Q$ZDW#@5\+V72^#3H495& GH (..-TI(E,(()TW(YIDLR> FEH0U50?[,
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M"2.!L\PC]M"LA($[XMD=( &&-*HH@U4)S"U=H8=11[\U KN6;$^W=X3!0>:
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MK3;U3)"T]\!IP3=AG<3/,-SK5D^8Z/*J,Z_+897%?)G [CE_$M]=P%\ZU<=
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M!=W8)B;9FTA9;#0!61JY50?^M\PI,3YP#M7&@I;";9UU/>BL:@5ZZL 0^1-
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M@KF^1V/[.C/;I,2MWN]7#5E7]"F $$\=B59&9"H6:?7S0#]OGV.#C/$LD?#
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MMT7:D]*O11Y).ZSJV5UUK+ "8>88S=GLIYM<?A#],EG^(T=#T>?4U-=]E)E
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M3@?O/F&O93 ZARW34'LX%U7F3,B^5\U[KKY]N]L51?MU9X=QF_)16U8R5V8
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M:L^^,0#9J119?V*B7C3^%ME=@\VV<QZE,%9=1?N$=F9W2.;QO.T2A^U& AF
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MYOT/GOO[_VP.<9QZG=R(2PR'2T>T97,.LT3E\K]_TMUTY]V^+AAG+P\)H_<
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M58;K:(<]54O:9Y 3ZUM[T2IR+ [!ZFY.EXEWR%AJ]QC#J'572L]='#][-C=
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M6%O:B P APV$QH_&0PHA!%,O/FCV1;+%?&;6A<?U@R[I)K*=U_+R^=*=7SQ
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MKWQ2>]3,)_43?5*45.(UAB2]&H"%$0]P^SEVDE*H-1'CH<&',AEOFNR9FLY
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MBZ>H4D2>AX3CS!>-J8,7>POE66^E>CF=^O'],<=9CX5'>OMG6]>TX1Y!K+C
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MLJ"JBEZ_:>>/U>VC:6VQ9@CWA 0**?S3T6_KVRCQ)1@+A3\F6&QR$9B.\TA
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M#6+(*7C5@G$2)!E)V(7$ 6<&$(1SB(YTNK ;,8(R(4,_P4K,7?/7HOA>6#Y
M-(.L#4X8Q(\0$W\ACW$$Z:*NW]>;1-&#E4)R"TS54>KJUL$6%9?  .Q/73R2
M3=*=GWY=>;&I)U=QV>R36W=J(]CG=;[]^9Q8O0/U0 \!:/<7<G2)+G])(G.9
M2DUZ')U+C"KI84KYS@#,<J57OQK:6 CQG+B-_8AHZ1@!U;/2B+K_Y3YGJ"M3
M1=)JO>NDO1,#<$' C+X!.F@'$LJKP%NM# #,>/.S<)_NU\U<C^#T?R_T[T#5
M+T/O"&=6QU<M0?Z]S+\#"4^<^$O^E_PO^5_RO^1_R?^2_R7_2_Z7_"_Y7_*_
MY'_)_Y+_)?]?F#S&>E>&;#E1</"4 6B"?OZC%G8F]Z9F0/B,,Z44^7Y$I])Q
M0\SHP7IA3LQ8CP3(=E2R035O9BTCOL7:TJKE@(>'75#2NW"JC0X8C80A&(#3
MBN1$[SD&X%5:'<NG#G&J+KQZ)U7Y^HSBS%R833?P'E3_!2G%>,OW&512G>]Q
M&&LTVAT]D6E'RU5SN]986</=Q%']H?WKZHN4W;@Y_3D7WW*,T(_3H0S !I8!
M.#5&GQG<H&H15:"QREN<>MR1[I..$SJZ&;2F\ 8\_1R:X-F/T^TP0%]R3UOW
M+0BRYZRSG'+B7].Y*IDPYY'4]*WJJ*<8\S!,8J#-G'0['ZRUY+,!Q,K$M%&P
M(<*JN70, \!4:?-@/N*7M>DFK]S#R.FFO.RJ7 : N8*0B7Y9^9P!P++2&T,^
M'.2CE"; M7OKK-H>IP]$NAB ^;1_'5?P)R(7,9M(;W0DYY*\R19?5G9M)\D<
MN@9QWSIF=*>?!:F'^D GBI/)[\$D3F4& !EY7,2ZHLC$G67JY_Q*K8QWV._=
M&WA+![/X>U?C;A8"3OQA?1KCSVGQ+N3+_P#[[_S'F9A0GT9EY7_''EE"H"/J
MOY5#9/]7)71Q()4;@/]\+,'_5E:3OZJDTC[8[!F961]P<O2E^(#]*Z;6>HD@
MS*07W'>+$\[%_86P*1K7E!78P #X)VA2H5Y.\B WCLB<_/J*M);Y^2RUVDOS
MKXKKA%_YHVR#'[$4WG$3^%R2[#'.$RKQL3*P/>1\$*M>9;SVXOCNV:UF]Z9\
MPI921,^0IUH_27!!"6]-$6?;O/IBV'0IW" X0YPS+R;@1\VC,/'4MY__<\,D
MJP@*YZYK<Y[8YC36#F7*YCI</78BGL[<Z MFPA?67(C_#%$-X9'89225"TW3
M;4$?5(%IE64-,L2<8+X:2BHX?2D60M#[@*4PX>1?RGD^CPH+[WY%=ME'_>&B
M5!&8J.P0NG;_&_3^O@L#\-D @D!-<Y:#VI^^9P!JAP[ISZUOY-2";262R*D,
MP&5EQ/H\8H^[K*X6^!:R<S*:WL3# &BZ=Z%^=4>W)2KFQ$CTJ-[['^ _F_\0
M2P #' <,DRYTK&?51\GO?V;-I-^D3V8+$%C?2"NH \'(-HO1#1.K*V'EDLAI
M!@!*X.HC@TCT07^69P(R[$'P,'YQ7O&Z^.Z28.5N&2:NW?3H_6[T>#\^BX9Y
MJZ:1D=LL^:>!QWCKFM6KW4O9YS (7WLL#LP!NT0K0%4&;6TO$^PKA!U.;";+
MJ ;<*L$OSD4DA&('#"[HG!,[@\.V,P  <I S[[?!E,=FSLA?(VCN,$1Q4(7N
M'ZJ2=&,8@JLI4?"9>;W4CL=E!R0LIHUL0S35(=?F3+O7\62,WIJJ^IFL/=E0
MN,:4#R-2;"R#8N<9@%^TDRT3S#YK]CPQ4S9K/(.MC:F7"E+3!*7!R[9>&R <
M6-AF1C/?VJU4[-6,7EYM ]2CV>G"I^"LVDU;MA;QI]..1W3@4BA[3S[S\Q>#
M"6E8(]2>[K3]7E/3%#^5\H-6T71S[2B?'E]@8[UF_7[PP\;HS&_YS\R:RL#0
MA/V9:?@0Y!+U L'Y.+A AF"S7&M*/ACW']:<W*352,GU]7KE(Y.T?TJ>9Y51
MNZ-\HPHS]<8]-\+BS?Q[?3"M(89]!=]L\[.1[E%Z7]_//]8-(5N8TSZC75G/
MN09DBX^4),]J_?0?%R7=U1GO-(XC9JQK*,,<B;IM_>,HO5$_#WD5>.Z2S7J\
MX'7M:.<35Z*G3Q?1=-R-Z\T]L0^1FS$FKZ>>#>>@G&LT/I A1.A]<JT#(NSS
M1\>*RI^WZ7ZQE7=.%@JG3KB@W<D2I"M$F43)_=@P&:.A"?!IPQ?]84&CE%1!
MF9,]?:<#@!QH]WY^<B).'1-!Y[8LG4K;&E# L2HN.H%D!0FY7\'Y*A_$0UV,
MLKN/ALWD7</,%8O%>J9+TK:[?U,$]JEN$@OH"$B53.P5\KOL,^3,@M*H+_+!
M+WH7#A\FCMW:8BUUIP^#JJ2+")-MW#.<A-?&MM ?-S\N!5%G90*GM>TW$*5/
M]U6:!DSM_'=4T%6WZ,U8CW%5FU**Y1&BL-]S_S?5DAR.O$!E*@I*-M!I2N@1
MO]4Q)I7,!.EHND]DVE0E5LPCHUN"BK431M?V)"PA_:[_)/AH\C7/':",(/'V
ME[$(QWJT .0K,K#$\VFUS6-77B: DPK_T)IO1%R^<V;U$G#B?;'.BTC\->Y]
M&^%B@@1>%"30('*]EOO3D3OFQ1]>QS#:&=^,/7CHLOKZ,FH\&M<*A9SQ]^)8
M)[H=P;CENQPI+#^:>1^!ZE0IV/@I^#":ITD".I%.E>CE%;HYG':!Y7-J"\G9
ML^WH$2&YR,0[YH?=F*Y<@2ZKT6.!]WEU4I"LQ#HWB270>#3I\ZB&:%#X=DNV
M=*5!F ^7 R>Q?3%Z N[X=+QX=6H?%!5Z?J%4Q\RI4WZH]9D;;O5;)4E-"1^X
MZ32/B@C)65F:\(!:=SA653_)N1SB*8:N"K9/_]<&5Y$RN8:0%A[N:A]AT2C;
M[Q!;0>>&%/Q^63ZA@)113Y3.SRLK<+JV-CNI&Z"DI18$E YQ]#VTR"='X N:
MD8EPONB[1*Z\&=9Z%]V8?0^.L[]VJ[#*)LJ'C=#Q!/[W3YDZ>S)&RI BBV*)
M;6:E)AHCFNVKW#6'3<M8.#,Q(16_S6*Y7B?UJVYH:\C/4R5B^L&&9BG:?2<Q
MDLY'P/Z"O,8&<H<L9*1'X5D+,SLMV6I<Q=R$WIS<166XT(HUI*EFQ-,[,/4!
M&\KMX30V3;=E9?"\RW."$2O7LN[Y=7W[7DIQ\9^#;\YL+4/1-?;4M 'LD>YT
M8X4]!S&%E%=-UB)R@ F5$X+8[4!.DT-BSR7I XF(]?BJ#G@? U#UM0@WRPL\
M3=X95&4)T)6=[!'9J7G )%N7_1J?&+*#GC2E&RFU_EPEJ8)I@OL#6N?<Z7T_
M5GUC^3[Z/E5OXAJ?EB$SS2*7&8!2 X@4? 18J1M+9R/OWAV$@11+ M+?G;O&
M\4OH[6S"Q3")$0TUV+T1NO!Q\"3>3OY35L3\2$ZA?.MAQ0V0# Z:N+9;"=Q]
M'H*TSP\IQQX<R^Q?ZBINN361BZFCRG^XG1U> K:@KPBL&%9FZD.B#BJ7'((S
MP'^]CY(:C+NO]_RIWKK]E<]4=W(L\0+)=A1FX.3!G8_3+&Q,Z[:Q18T3,OO^
MA)Y1PQZ_\0_4FX;@S^3!^P3[3UC"E(*Q^\/J&:_TB\1=%S*\:AS\S]3UA7UK
M8;OGTSJE7$8R:2&;J-0J2O_W*O!$QJ0^F<C3ZONE;Z=QRCS\T/F$SQJO8 AL
M-C^T1I-L@6FZ2FXOL:*/'8]P Y8KE4O#FY\I6JLKGM4_KH :UI-2[/HW-2F/
ME)K'I?Q8SIS=HAKXA)LN29M,GVM)6<-\Q[AW?>7K'(I7'J\*8P X0I3)0_'N
MJ07^?(I53?8N Z"%P%Q4"%D:,N&"1[;NEX_"'N<LWZ][H3M1\E!_+?C7$[AM
M G2EGPT69.= "AS6N!QDC#?X4!I;XOO9Z[KQR]_=V>-"1VS&IDPF6=5N*QZZ
M"E^L#/QP*.>2C5!M8"E,8AXX48$'ML6S5!XG&2M):R%3,J+I2J,DQ%7MR+'/
M+GQ]6TTC$_3NXRZC]+;!'W\(X\$KYU!",>(U&<H-M>P/FJ4$6#\CVMT+7A6?
M[3*:\'0Q4&HU_W2YK+;:PPV.&?THW,0 1)?*[*UO0H1AYK1"-?]BF&T= =@:
M:N"M6%+J.=@7TROYYIQW\MW'O")B15R07^A*E_;$L[ 'WPG];4(L9:5E?*<2
M68IF.9^_N'8ZR(GISI'Q/G]# ];&'CN,F!A#N'6Z0"=(@_2"<3\3$VQVJ.9_
M>*[P_Z_]$Z"X:B]DV7!G_B3<U"_NJ\X^:!K8U3!)S=@KO<'*%B14*G+GH\-.
MU][AJ]_TU$:A\53#I.6CA"+?;U,*6+F*<CS?7.CY:0*(]"DC.2Q-AZ)R/(@O
MZCT,"8-^S% *UV,;+BZZ7"2X/-@(;:[S"X%'>'Q_^E48"K3=H\EJWZ@%/\HT
M?NMB0IB.0LD9^EX\,'ZIB>%<\7L_N#?NL;=H:1O^J :D] QZWR^7:[:KYHXG
M2<W"LJ:AIBE9E=8!IR3X9N,G2LE0^W3MX:<.(@(!JJ(/B1%3H5@+XLUFX8Z)
M%68]P<QSP&D14 _\ZT\&X.+*SKKU^T<Y2[>:\]53?7N#=V)?;R14#N<&^"'8
M_7[BDV?HBB<6-6PHGYS NV5BAQ;^Q)OTVS:JBD\<S:775%\ :/*V4C?1 M]-
MR8^,M;F2_B7X_UWF'[NOTUX,@#$!1=LT90 \)/;DT&H,P%PI ["FP<4 -'Y#
M;.;[SX/B.3"]#,#4-QA:P98!"#=@ '[7$GGH324,P-XYZ/8^):<)\']_O8"#
M:JY60.M#]N\^&]#FZ@F9MTUL0QV>:#U65!>.DX$J_Y'?5'T&X)T@:)^ /KI@
M_AA^QE9#-+B4T]C^Z<2_;0_QOYMQ@2WK,UIUF^JJ(S8M+C6+)FG6"SM$BDJ'
M.KX$J=3JSO<W@HS5$]\U,!%WFX^=1<RVVATB4TN&T2><FI6>KZQ+0"=S]M/S
MO_"GF+$?X*/'C0P'PF0KAE PB:)#E?B>>HC![N@3D0[8KY!"WI,ILZ6AF';4
M6$0KZ%+5>I:+WG ^87.QFT\L1OG^N_J4[M._)\ :.;5>YQB 9G6_+)!YU+H]
M470BM<2KMF0NHIL]E%NLX(]%HWZ3\*?4!X;M"'%B*B%HXH^?^V!<_F"@ 7C]
MR)$_JK0("OG.,>6>*%JCH9]3V;;M.CIWZL[V#K[4#_W=;K&.*M3XLI<WDW(/
M,KTE0%^Y@QF::.QNAS#O03AA*@T$JX@-:P52R[A(#;[K<?,]C=>LI4'I+<"Q
M1C@7>6>H3:L]!:+KVF?RQWJ#W?,>6G;JKAI)J#ASTJ1()T^@PG,=_&M/H_A-
M;FRNB<3'&X4U"(SI<:[RM)AWB;Q;VM?%_&Y\RD,](.5F.+Q1%P<=9P">@R8X
M'I/-%="L*[<FX[6,WTQU^KX(U^0,OOE/1(</J]A@G5<XZ$=O03."WUWC2G2;
MO#LJF./^D^1A'0ZI>M4(P5$TA@$8Q^B2B2Z.!TK);B&E[\19%EP%.<54K8R4
M^Q JWU)7P)P%4@X.-Y75[ 3KS-Q63;9WMV<P74#^!E;\ AG,% .#$L^HWU/-
MO6#C^EUOY_O3I-1'Q:F\&]X9&PUGT<2735?P8CT_UQD .YZ],B28]G+#>>AZ
MA TQ^TNA?OG[BDEND6K0S'G+Y159^UP" T!Z44'P:@F#_E*JFYKH2"_BT7 9
M;Y/B)O:=P6?KA(R.R"K4<IJAW,2J*N\4.I&14/$N;I,(ZZXMNDLZO"7P[.Q9
M-5T/YK5T#Q^<PI22(P8#?(G*:CKKVB0]3)=:YP^,@AE#Y]7#XM9<FDX%C_G6
MGC%.@*YN1X+*U2#,L+"GN!M4*\7AV_+!Y1.T=S(?.VYAO('Y[C!K6IP?\(V]
M:'H;OT8I*$K1*N$0WB^\%[@U&\0EUB1.<W[M/GQ0B;3QV+ENR6RV8MR@^)6T
M5(7U.Q)FP;%&AC1](488,@"O:W#HJ&TU0S<UH&3/R@;7*S/>N'^".F[6M$O\
MIHI1W+2+@EZ>W>!X%.4S*#XA(@)(? *V/F*:8P VG')@=X@*]E=']H,;]+ZU
M3,[OYH[S@PX21<N/L$@Z-OLJV?];$$[J9'N&$:K ?90HHEVZNBH@KK/192/)
M!-_W6_^6&BRR+:&84S,55_QD69=Y;5B??<G0KB;4(W!JAE8/\Y^?UIKW1'[5
M++2Q7[,(=%/_T7[#ISS!JHX@FP!-'=B9_2ZU=.<0R0#HG-\!Q6@PD4WGD-'N
M,'D<FFR@9A"L\#P!?2/\2O+X7:-SJWTA%U6QPT F.%LG'C5^N[6E+K(MPX*4
MK- 4F-J8:N $-]$MV,F_=I[SBO-&_@C7.?..9VO5J=.J5JITL?=4D:JZ!MK;
MAH"T5W%-CGF1@JFG]8#ORFKHYPYPAE>'FINN#BW6U52C#?(_OD[@K SJV IY
M93]/,)V+1#9OGYPF0REWU].P<@W):G_.[O ^*3NAYH_B)Z9OG,Q=RQAI/XB&
MZ7GG:*IRWTZ^)VJY$WSBU:E$!TN5/7>*OD^ 2: 1QO9%4(G2=Y21X&#<\Q$&
MP'3@V'-US]>\:;IN'P35'#(7"NU-,AQI#/_68[%=\R%W_WICQ7<1 K7>(AYV
MEO8!IDY0+&BL_IGR>/0K6 I5<#>3AU*86X"]WI@.DE7?S:Y:PI)@#$"=!TI^
MMOG;6A;QG'B '6@.*0JA#V7(Q#9)@.> ;X0O#7DHN&XY5BD%)A_FVX9U+)[I
M.8J8+7U*'T16++<<IY@@-/'BVS#AV**;4=4U4<N]"8N)A,AG>FO!3%P;_SK3
MUA'-3'4<1E=%#D\(5]^UDM[$6UC=I>\(.E*6&M*/^V&X_Z^:+NR,;& 52_)W
MZZ=C(8XU7&LFQ??4*N*FI.HT0MFB.L#96?KZ^:2TF-FB932S=%4OE*1)3GI2
MJI86(/^+M)Y\[VN@?O%FY*E$1,@^FBS& +S94]807@]QL)UL+M&%N63V/BD9
MD'M9D/WYTFQ6&-?<;)2]$$$FPJ*5WSP[:?4:GU.,YL\^RZ<?^WT0#RWZZ-*T
MEW[037>;619RPK)63>K;V_$\'T28"BU."?K/#3<8\J_Y+1R:!MKI)S!Q1:3R
M#V-5CYMG<]:9]CP8V!9;#^&ECX]*S4=902@Z(\*N9\RZ\KS@*OA:4JG,I"4#
MT*$;%*@.QT Q!=O(F".#.<@&:AX5'NA1A/&^7E$F]R-V_4W+V5=K;#[>^[VF
MY$Z*Q 0,0HXL"/KJQ6:8W^G":7S!<O-^S*1@=2 /;Y_WT/?B!.GW4)W^Z3@/
MWYL?/:\'N4V'[B:GU@LS4<(2Q7#IKQ<1J1J=!XE&HGS4XC$T5(;;S87DY&^P
MXIABG/#'YJJRE$Q/_"^2(%)_JTD-WJ\B@_&0[E-=_Z@PK=^#K)B]]ZJKV,&'
M2^S="U42ZNH@XHF0N%_F!T4$UXP[CR%;PC@U3O>Y'J4YT'</EY/E?I&S=M'E
M9,B8K:W$,_7WG*G:C9L>%Q#EGZ<ILNMD/@; J%'P"0/0S=M_^*^]33CZ=BX@
M.()*#.6N0)5)T4^4GF+^:<HEBQ'L)^=F7TJK2=:]SVCCF#)0G=([^X:Z]DWG
M#_@@9+DQZ#WPNU "$C=?9!E4C<."]=H&)B\\LKO[_/5T?=*V;DTNR(-/O\O&
M5>QUNZFE50N/WY"AG;_:;/MG!J US/H(\=QJCL0 6 BY4,.2@1?I8Z-U44T@
MW",9R2V;7J8S "X]X7%S:GR83#&\BY11@+%LN@9D,Q1JL=<.I&5+<989FYU
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M6&+D@<'?.PC\KR>U>_A*4E[X(\G$/WN,>/$&;?Q(8JD [>_C"L3AZ=@YBN9
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MY4XJ2]W/5[O/KO$@G2SZ+3 (O:PL.*=KHU%3)W?CR>1-+5&6I(>^LKNQ7T#
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MZ_5M$%,K78 -BK:$IXOUKZ7[\=Q)L^VIBM]2[B6."(C30<I\1JMA/D]X!$D
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M9ZK;0_MHT44=W05_X8M<%N&XW\Z7EMZ #RE89-?:&-IFSR#'2!D"#K1J.>^
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M7]R&?9G6,W4/\@L+3%\3PP!#H#>0W\[?9&J9?+;"QHI)0V5<AELEX56*@20
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M%E8LJN'J81ABI@&"Q&CE4?5XAYX6$H#><IBS=$\EHT .8M7;I1_&XC:>*W[
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M_9#E-7ZD47-0T[(T1:Q5>IXN->*PJ?=-/EY3=%E_5M5.<-GE6)$* 0YQ#N+
M'IJ@-L9=_*]CA'*78S^,UB%BBQHR,+ISG5V-H)A6L67(MO<?>^-<ZW N=\=?
MB0N\W(]6*]K[AGR6R1*]-9_2N-!16#[5J "1>5J!.D]E?1G@9"_)L<HBV;@3
M>.F_G\OPO>)' NPGDP"\UU=%S\K;3I+L1R1( %<X\7K0\^U^T+I-. D __3W
M2]4(=#I1\S"N;5^*S$CSEUJJ#,@-B:+4">'6),!H>BH"R@)=+\?.$SO!N1=*
M>_-2H'/RWGT9.O,.0F#QM;PJ@6761:N3 !HV\QMMAR\/4;HD@%84PE!/U2\"
ML'V>*C&B= [_T>;@<G.'E3?$PV1?LDF0WQ3+I533V-,=4"O+36=_;BIZ6G)*
MK#D]1*8>^]#]Q9GQ881P87\^V*%M]3-*N9) !_O])@<2ZV2? I4.@,[G]F;L
M!0!1L&Y+Q>"M44G?<N1D+<OGR+4%^;C!QWU]Y5KX^.4M^!&\7/F..OKF"ZR!
MM8.=2,*J$L\;H,U$AKB-V-9#[8^I//&^W)Y]2(N&> $?34T/I!?RT EK3U2G
M!8?"XDI7#;X4P \.SUJ82I2]T.D=D+L^5V=%/,L>:&F]<PKQ]$R4\014)EUU
MA3R=P3[E<,> /[RT_;/H(',WFLOVJX&$6#UEN<2XU+S/D50C(=>SH'XJ'RVA
M_F:UAF_R\9?1BU4W\6N]$ZQ]*&A4>3,0)V*Z)ZU9YNT :^JN?RO(PGRU]^MB
M;D>K<>MK,Z:G6:4-^7K"(LG(UN\X:F43E2N1Q9>7N8MERC)-]VIS78]E(HG7
ML/,=&7H3-<(W;$M3G'WUIK1#)T.2P.AR7?514;S*]^[71;-#@;Z\-ZEOMB1L
MS"^U-A"^*#]TR+U3&J!BC9!+UY-N-> >N5-N_'@E'P"XYT30YMU?7A56Z,Q%
M9>W>>EHY9%=B_O*OSN_1]ZX9*>/:-$]Y,J<ZU:K%;IFC:LK\%2XPBI_?5HOI
M?U.4G/MXZ#^WEQ[8E NR!U8M)YPT76W.[*R2%"B,#/\K%06:->8]*5?I;&6<
M5#0J%4DMG&V9^CH?^>$5I_SI"?R;\BWBGU8!M$WW9X\6S6=%8Z=4B7<77QOA
ME!FS-7^R@+RI7)4<BC([:_WHD':P_G<Q3/,G9TV)+ZS.PBS,CN?HUHR/A8PY
M#0JC8GU3S%/A3O+B=XU"NWH8?U:E<V6$ML#AACZLQ)%6D&WY6Q+@HY>G&;2M
M851C#<0G?/S>W]CE8Q =MJG7N,PSWW9L8?ZJX%:3D.TSV7L2MVC\<Y$<Z)$N
M3@:T]7+X25H(F\3;.^]\SN3$1;G9T6%<G(BZ9BI@E[;6:G@FO>4V\<8X5]1E
M<!-+N>(GV3>EFB$+=S3Z\0X@I)#C^U&XWE-%3,UA7=[D!9?N?O/E"OW.<?=T
MGD,'E]T3R]+SDN[E&XI&*RY59,FR?33/TQF)2#1YJQ;TNT&#?;-E<QGC$=Z[
MXCG_)*]F),YY-:[]2[!/YI"^D5P'_BON] +LC8Y^NEQU4"@V:36U%2+HS9IE
M^T%S3_%5/:7@M)+LC[/E6U+ST-GB /WT;YX5-@RY=D<3<3U&^EYK+D_]P9E@
M\6[$CGZ*8V[UAG])B_"6\U:QNL"OE3WCV$.>_?.TX=^&>/A<;U\&Y,,ITKV+
MB?5A;N&"Q:[Q0;^06'E )8S*=5ON<*P.KX+B[55F&E_"D+7G%R<KMIQG%@]G
ME)X]?08TO1!=Z28!\%RYE%(NK+X:WJ5+!/B+^L04.FE5FQNT8KV_YR>F1/>W
MT%5=K8KH\&]Y>U7"^Z*.TX_:DKZ_$1B01ETU##_<EMMLD?]2)')JK__1EU]!
M\ZSIT(7,1;3X?\W%R8^G*QGYS KRD+DMBBXS@&LESJ47G#2W[24*5=38E+]/
M:;_%LGXQK=-6=9@P-[% 1ZMS2V/C5>/5Q:S A2V6P[&6XU50!%)1 J?JL]G1
M?5?AM6-2GNA][Q2WMF#[5669H#^<O)7HM*95@OQ+)X\]NRD>0> AI=K ?-U6
MDZBN2O3H.]EF-=Z952LVMQ[391OGD<'^C<^*(DSS;S8$CS65D75@$H"K!V^Q
MP@%M3YY7+=\9LSM\?U-U\Y8*X+T?$+9EW+9JC,TGWH9@-6B3'VRW@K,Q1=8W
MJV2I6$:D3L[(KJ,C 3I06*/5;!O-Q]-EBK1-:H@8_NL/<L_,[$ '4Z)(O?+.
M5;J(1KI0(;J4*H$(5<52,0 #L,2*B"W^EFE4OJ,?"U9(UC_2<D.S"+/+EYGT
MXV2[95L/S()X!QB@N67 K6C3B_RUA%(2P([FIDX%EC=_Q $V]TO!?)Z2^\6/
MBJLRW#:,JT!47H!GZRAHE:-1V$-&M<[N\BOV)%K 5JO@-F3./3?8]-$.,=D>
M=$0_==A[&,E:UTD"A%\X#<>(SUDN*KH&YK]RBZGBI0AF4?2$A[2ON3+8CA6J
M/MSB%W99#TKX_.K]Y-YDB44-Z_O0,Z<I$F ]H*(D@!Y=&U5L^G(!&[2%E/FK
M] %'I> G<;4-;H^S[P$6J(CN):H*LT4;];2I/Y^H!P9V"TXN%\OB'?:4_!'*
M987$84PK?]QHS9<3[,OG?=?N*%,X>ASH/O<W5H_ ZT+72(!9F-&$9X/QQ6E9
MN=$Z7TE]"0<,\(J32G,WW"5VPXCWVE&QF])AT%XE;IA__;.(C6;6QN#J<&U-
M$PA4?P[Y10+0X#76^KDMZ#0S3JU6UYD-#;9??I(P51;""J^)4NYLXEZ.6H>,
MZK#:+EH;C10_=;5<15T)"'1'3<SMB&U?W(U+?V2?SM?S1N.\X&92V8+U!W;P
M#^&F?E0"I+8%S6XIF*' ELASXIIW7!%YF;\''-UL[ ZABWRO*<(_-U=WAA?\
M$RNBKG([W,!94T>FJ1+B=3B!3>Y0IIC&^WJ@;$W?3A]\8'H+>$!XB0+);[_%
M4JW->#ZL<*$U_]+A,I#*!Y;M>^]U=@K_%L2V0(96"^'+YE1UO95,SY)6WLSP
M#LO/ZZ?M7 GVWOMM:(,NT"T2H$[X="^AKN9;'*+^:)(6Z 6^ 2#>UFEUBM:L
ML1=+X)%Q<H'JO3X*8//@ V>U%*H.%98Y+X[P$K+O9SY&VT0*BRH*@B)%'L2J
M\U3SWZP6NKY^^$K!*GI=RH5R+P>$#4/8GG#0OD(M]AW:' D^+HQG.(Z7?Z^K
M>48WN[6)'4+3<:R#+L1^3+?G!,D%:)%Y$1)+//TA8 5[VN(WFM#\C6FZK!$R
M.)9VB3F:V?Y.\H9[QDZ@Z-3RIH]()NIF;V--<[(9UB\P,8GN\PZ+K*PLM9J?
M5[G@B]%#CVQ-;>6C*0?_F>7?#KZW(FAVHB\R5;"C""4#3$)RIXM;_E,9 Y,R
M6%H]!6.DT\QB%KQ<KAAOL#K/88 I'U7MTFN,$7/KZXSPU&=27@O%@I]+/%>5
MCY?]7"+K7@(YL!%^GD]CG)1VUWDW("%CV:]BI;:-HMG;-S].1Y3.7*K88N6N
MWGUSF_O7%R^,==I0O5U$IE'$I)3% P=!?F:!?A$JWEJ)C LZ3"1V$I%P"7O4
MJSU:?G=JC%G?EZ&K;"O)]W)B+[NK&;!&>'X72.715,QH=, 3_O3K^YLB]GR;
M/OTZ$36QOO8MPOX%%@$P2N8WC/R_,Y*F,%50K]Y>WW;05L;%'L8=-9QHA2I:
MZ[KKI\@Z53\DVG]/?Q]\D)>D#.EH?5Y1DW1Q=--V9$2BU%[W'3<%?@^9?1=$
M'31(I/D9\2)GM7#BH6':D[1E?O85&PI#UG'E[X18OJ<';GX\D\)$-7,%;7]?
MA(#)4T'C"YD:^,2FLKP/5 =-]:L"H0U^$M.9<>3T-@;P+%9'^@Y@6%TQ^AS(
M/,+,> ;N.OS8AFHH&!>ABBRJ^].EBL]\SV*1P+<VC8;'*CJMXJ WL"7Z8V5P
M4/7]ZL]=(HHMF20 =8Y[[ZK!IS?WY7624C=::L[ #I78!!I]QGR3GM%1B*[O
MO/^#PTX0Y1":OL<T*(J>02-30I9XK5<HJ/7T%!BC:(8ZQOAK"7/27!&5NIK
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M'L+&/*)R )*O<D%5=3-9,BIS)V@DXQBM[.+&Q<-F"D)\Y7;I-B#: 3IC([W
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M@!O/\;__<,1.64?UUE.P(<W,5(XQ7ZL:_OZ"J8+VLMV+FG)37FE%# ?[I6>
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M6R*)>3D7SCDFM)#HX";!.:/ZU_7W?LD9(!A:1=]V!O@' 81=(<^0]@N5\K[
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MG@U^JOIU@ JYT'&Y$I=1F%6M%E+<2Q!6*RB85GR2J/'S-3F;74U7ZK,@I^;
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M]96#MS+K>X<Y3#OY65% ?87[AM JRY"@,X #Z!]XL]:>#)AY/?=NDM%+F$"
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M;\WIL,[1$G]NW-3V]OC%[51\&1V-,79O6.Z<NOS&]_  %5]'17*!5-=& HR
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M8==&K>>H=6]?R?@)FN ,:U>(;SH]I?3[P#[=Z@T-]AD(>"5EZJ''H\SEV\J
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MET#OT4MLV*J7Y0;J9F__<FCV?.$N9GN> B2HY5$C#CHXK1)H)D&*$=Y#0II
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M&RI+";Q8.9?#8&+T[.@JB]-JRP,3\91/=:F?]#]92"=*M'3061EK+]W%>.]
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M,W=^+GQ5QM7VX58#1U(^5Z=JS<57U7Z4F[4=30A ECCKBZ#,G9<2+(NL[TU
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M+]FE6/"948##.[!+!T5D)=78]?D3,K-L!F$_W:'M%*!5_GZP\R9U]?.# GQ
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MZC#[%[72[V$FQ&&G4YSIP1A&D4D_HX4]3"G)?  E@S@^S]KH)5:W]QVM;%=
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MKN!+Y=ZU)1\_\F;LYMTG.1%NF@^AV</*Z^WD+B01=H)^;+16 J030E_';EC
M.<J/WFOTH&>D?SNR<2@DG>PS%[<"YO#\\</OK&V;4#JRI<YVTOJY[><ZC-N=
M9G>V1PK3;AQ7.Y!?Z2SO<0]Z_"IWWG(C1\*_]KRN$DE16(O<=K2=ZK01,#:6
M$GUM_<;.!%(@VS%4%2WK@ZG5*H#F!57//;J]-9+.TL/4AF)E%QYHNILNY^F[
M6?VJZH$ZF^GYWV2S?!3.CB*'JMQ!=4.(8/@>(@R^YH3<=X1F)>W.48 C[A3
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M@D;V3$+/P6IV%'A=#??LOW;O '@:0;R<0GII!2*W@.$'@M6HDJ6_-.F(48#
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MJ<,G':FM'-E4X60>N=<7'+"_AWR$=<.4VJ^Y+I0G"DRG:(L+/)97*A-^V:0
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MX+YY;+@?#Y(+*__>\J?4Z!)\\Y(T16$G7W%MLVRRLSI5!PX_$!_"43D/&6_
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M![;P#.\&@(_-XV%_ #S!O]6_P1/Z(T^)S1>'V0,$?^@ 5UK6&0$B[)$,6S8
M  HEQO4_VL0)3G""$YS@!"?_3<70WMG*Q<>#Y9&=BZ<+BZ*5O:>+.XN@ )\
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MO )S^%IM<:* G_Q*&?QBY3"+E:QB*F>CF>5P!0,4*=6_-"D,(29]F%L)*\,
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M,E[NS,ZN\U062_)(,R_1'32K\+Q#PA;,D0]$%*FG-+-\/E026+$PF:*$)([
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M*I)C1%I)*1<TE+J&H323*!+ RA(*&"#0,,D15)D5817)T^)#@U\Z/7W7/+W
M]N#"<2SC@V6!(XG62LXR1/]@LY+<2^K[$GPQT$+=_,8O]'3#[0!?.<9A5D[X
M)_9(E**-ZKD[9+-Z_["/4/>KHV_WQ<7@DXW0 ]"BN9],3ON$SJ3+MNUTF6$+
M:/=7D!P&^.(3A@%VZ:%H6>4+<1"L<94)@0$N+J=B )@N!C#X?9TO:"/4\*)_
M6VXGO>$Z!@A=V#M!X=>!,<"+80RPMPY&5%T$8@#Y'7(,,">"O=@/=N0BB-9J
M@_[7+@./D<%/4W\%SBH&W,( 5SL7=LZ((% ,@)># 19&H*UNR'/TRQG0[TU+
M,0#R"+0^8WF1^@9:3&=^ *XZ;PA'*J 98)VSA]=V,0 :7PL#=.;^$_31NLY3
M,+9;ID*-RU"WDT"JW;!_M%_[GZ 7^,+V@VZAJZRAO>B%[3,>!#G2&0R"#DBW
M8OMR%=L\<\8_0?_MQ@L%E&L/!OB$ZIP^_%>\KXTN6@9W(\/.$'$80/@<5KL*
M?_U/?/:?X%$FO=#8/?*C5AZT[0G(9]#\RG]VV7\"/ZO\B $XY_^+1.,8PS&&
M8PS'&(XQ'&,XQG",X1C#,89C#,<8CC$<8SC&<(SA&,,QAF,,QQB.,1QC.,9P
MC.$8PS&&8PS'&(ZQ_V6,:6%=)OXWE^6TG[LCMZPN:_#<\]PN()A+[>P#]Z3^
MZ1+1]@F3<ZUMV^D/AFT5C94N;RW[4Q'30F:0_<5HB0M5=-R('0:HS/KPD1[^
M>INE<\9?NCSAT-I\Q:@_[("6YUSZ3,13=[XP/Z.RO#+?]J>>X3N(R7$YTF->
MXRU' 4>D*XIU9,ZN<WZ!"[R3?Q0),ODZ=G=H1[.ALK$\-BYQ1C^:8?4>:YW#
MN#'2Q^&KVY%R8UBGA9O:(?<=/V&E<!?C^XKN19J(0]U[RY_E"2FU_QNDR(?/
MYQ[A)R4'.B;OY<#*R,,FU=>ET%G74I]73RW?;+@/#KGNWCE.LC<;-5MND+"+
M-%UM8!9T0+.:9D8F-]O-;D6?? 0AF*2C!RYTY^&TCF;BHXLC1WU*3FI[&& I
M,R>$*)DUBM(?( QT-FPM+ZDH,)D.FT>1!_^ Y(?BU4AX]>ONFB\'TNSQ'_\:
M*2<7&V[V9E-_L00M<XDV@^9SJ,%'*P/QX)]E-!:N>G2(AVZ8CCH?J>Z[CNF4
MAAP_@FAO LRCD8I!L<'?7:NXLI1(4&>HE<6/F[,,'U5KCIAJ/<]?A7/!]>T@
M_8_2P^]<V^1*#[^$4*34)0W!FF[Z9^D1#0E7^HLJ;45*PI9PKB]\E-J*>*[I
MX5PX)9S2_RE*K['G!4A^[NZ\\VHDF@F$*XXZ'Q9$[!]_^^;2>?)B719&%:MH
MR^V:6R3JM6ROF;DF9R<-9ELG#TVM6"[*.C5($?I&7_Y5 CU01LJX+OM80NE"
M#"UZY/,RB-4.1%%6DFM'_T%\8)>)<EXEZ;PX)TZNS7 ISA%BWI[8^>K(KESV
MYJ,DS7I8YON4C/-"*:%=H9S@\%.RUE!7Y.NEL)/;2&B3W [/_*8!5>ZS>B2:
M<_V(-V!ME^>X>#C _]CI9EL1=>P\]2VV5!:3&="QZGD4M ;"F6-*GO8^N O>
MNV>D-BX5]=EN(O7K7,EX0$M,45C<V-*ZNN)M7K>4%UC+@?]7DXZ.J.!>E!W>
M4. ,A&K?98OW_%%W=K</@I_HB5,UT!J8_V!<,&6O;3II]-R3<5\<Z@B"#4'X
M>I'JK2=F9I5>S,[;&9Q>F0^E+DE)>V_31+_2&VM[_$-U7>L4 X#5SM&@;MGR
M$DC(]J%6WJD/I=O-K+Z7+>KF9>>^^((V=]M*F55=H <7>5SIC>JJH/<.)Q;8
M6?%_P?<1S5#".HO1VJ9]?//:YNF3AIO]NS]6-,KC+GB=?^SQ"/L.1<1(H<[@
M\RX3MHBML;!R"<^=:ZWVN:I.K%,_2M4_+G+=K^2-ND8NNI>Z84"3&MUB,I5S
MFAJ(SK8,3"W3?6?0:+X/EK'+D7&BC(@BJ8DIS)$D\"Y*)8!X73Q98+JIJ-$T
M.Z/H_!@:\O@%+_*2%L+<0BHZ1%Q[L_P41$HBG*>O#6N;CE#C.0R$6F.C(1G;
MEHK3SHOC! SPKIASP783-4=.>G%WCSDO&^)-:K+A: "QN=&E5J$L4Q\0*<?5
M,II'[_:Z>+H&^NE$M$J<3NE#?H_;-\,-M'++B,Y!= =4LU$-13F$ 6R@H0E2
M3IG?(&;3F9"X=W_8O'NTL>Q;?A>>,,EQ6LM\33?&\ =C'!W[PBP:[W14T;N1
M7H0'1':AL\>1D&U2E!52-!A%2QE#X1W\*V5QC,JLG#Z\7&+$1-2C':Z(6%=+
M3OG1K$AIT"F!'4:A?TP,V%F"A&>\T1I*L)HBA_S$]PF^MI9G%"GW^ '?YA<!
M3V!)9;/S )[6(!8 [!*%!E$C8_6& R2O%J'*"U3)6AYK=G2M),!3VE?T7#_F
M(FRIIRJ=&X77!4S!;SJ?9D7FL&<P[/BO[<O1I,,P@'D6U2&S[?<S;/#P\%(X
M5X93$W:R K )7S--D5([]S\$%[J]1>[5UN/8<Y()KDL)MB?8.CV5/\=_DKI;
MYCCVV*VY_GNF$_CWQ]J=)[R=-ECS!?\AIE'QQOHCKGT9>^K1_W_HHS-P2=O@
M^>%&O9HN55;AF X&<+_RG:+#WU_/AWK86'6IC^Q]=T1<-$EJ&X5V'\/DZO!$
M?T)2W'AX.%>^,!;CXS^V6(R--K*"VD7_4Z^P]5^P=]@CO+\DG4%GV>/?#?RN
MO_2OIRPO?]- ^ C6H01_H_WO*2KA#Z=<Y=AZBCV^^9.6_YA,>!4&L <^N,5^
MO0QVV<EF^6=>?=[9@!U>NM?_R:158_K[L@SETJK-DZ_8<ANV&\#_YL2R3^G%
M!"4Y6SBV0^5FQJN#KR!;5CPCWQ1Z/3:)@8;>45WW)]H9..@+B%1>.X*+@Q(&
M>^](Z5/7@RS'O@NKG3YQ<5%<&_6TW?A@ZR-Z.Z#Q_/9%$)32)">X[IY;HV%E
M1!+#)X;EZK=*WH+;Z\)'^..QA^--G6"4WX4N77#!J\+5$>.,,Q!_YU"OG5(]
MC3^:+#[<(4*WX,WAOTGE_S6)P $1)!3PL!RI.R>-<G;Z9OIR<:*ID]ES\UK[
MF:OJL>Z3MHA+!P-[YMB'Q?+^MM8%E[=":P:Q-$-ELC_S\7KJ3E$;000$V"=.
MD/'Q?@!^KZ!V-IJJX%#.$=S[TS X3N5"2W$# P![D9:&]6-'ZD7JCZK\:Z?R
MC.VS@XI[W;4VSL@=<A2ISCTM:(N-BLA7[%5'G'5\7+"1$O?;?QC^_[5D;IYU
MFQ\^E)[3S',LFKFEP^L#?NQI?HK_&#I&B;X?JSYZZR?O4B)^-5N*B3<&\).D
M%T/I#9=A%<8QP-CO_QKFV-- B,QU8.9&?OI2&Q^KN4<PS.+\ZHYJ$VB7/?8
MWH1ZEYNO$9AZ ,[6]U(?'X;:F^Q6[X5MX2&@R =R@I#$=L/G0D\8JB!-4UPW
M -F73HV[]%N-EF"2S_[S\^MWJ\.42V,6?"S8GHF:=R>CJ4;1TRG48FC6W9,W
M,<(5Z].;2T\EKC*X/#R/9H/.BDZA6^6HT/V[<N5PE1#KD>*+#S9HKGE&"@R
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M^E#S-VTZ><;)GJ&H?KSTA **4VC8BEGIN>S%-1!]>:0.0U)W&4JNA= VA<#
MDJV$I$KV:S&49/;FVYR0+.[1)S$"+18."XY*(52^PMUVQ?#YA)##60+D@<&
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M/$)I6E?VKL<-:_8YYK4&][A1N7TGU1&+\<L>&CC1>L,LLUNYV3PWS?JS7_&
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M0F>8Y0#EY4L_B@+0P+(P'/;NC[#^R%(#KB=*-WFL0VB^=R7R9<)90"^=*PD
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MGA$X!51_Q2G8GZ=Z2K0 P?%W%Q/ZUIYZY=$KFSF+7T3L/<2E?J]PME[*XYU
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MA?+VF2&G>2J1EYC;"=:-!I>_)C0T4#]\_T_MJ/[_^!#K8\QS_#@9LMIUNUZ
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M?D4$!P'[\3+\2$<QV=1.RI2/$P[#6I_#E00Y^T]X/T9;OJH77#S:AIOA6;'
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M-4!^<CU"L2K"Y+<0KKA@,YJ>5_WNY-^'_M].65$(P@BL,A[/U9#6S2[24!F
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MW\QA=#6P%C*3.USH<H\NWRE!\7-QY%,,(UV/)E&*%7UN9+H6/68^X[22M5C
MI?1+/L_'4JE2F\7R.2@3MHOG*^$YG-;.WF!1(TYK(IP\(U[\N -%&;@;]*0E
MY.KGC46/1\?^,SR[C881%Z:O.$U,J18>X:)C1L6?2RU]D;: A]W 2K%;Z 96
M;]AO_(S^[";W9$T?Y5(T"5![=]?8:ZZBI%B1(2")?Z6T;(C5V]]9\:_ZW63Y
M_O2,TWFYK5/874*/W,LIL=XGJ)+LT:KJS];UOLDY'N^/J3[4#D6N>MSUD=CW
M1;.\&X6RY>.EQI0O^A]+/*/JGYWM"62U!G8J%_9DX<+1#A!,-C:ES*"Y:H'#
MU\;(+"B'ZO4UX'S4N-__FVZB"M\(1Q]?544CO3=KG%[FVB5!+$,&R13>V4,3
M$U<EIOS2:*K&^FN[F9V9R]_&FQ0S@Y%+O8KR?Z[G9;5STM8PU&XPLT-#%L&4
M\^A1\I=2%O;9+\;U.Z_8WA7#69"?V!Q7.U$^(P'FP9A^C$+*Z?B3SB.IM6_\
M'A7QF2)UP\2W6W1.$4I'\'TF-&5;S3/+?&RX=574:TZ)T*1;6FYM[OQR*5UT
MQW.J_)K=EL=* RL:TQ%D:<M\IJM?!W_.61SUOT1PC,M1$7I:.!O08KF'D?MF
M?TY]]>]4Z*?$Z3LZ]ZI__TZ;F9.^^G5'D#"]2'5JK'R,:C=0-E3QA BG?6@(
M8^!M?5CNR/9NKBO$HK;EOV,$M?\?,!5>TY(K8S',*GSF8W5V9=@C3A\G^0=8
MZ]03;JXPSCAU3?SV\O&>\7LM9Z_MO-6*Z/;.C61^.0H]F88T9<-^PTO@)_^V
M_6L [34@@O30G?0:T,/<HHWN$/5_B29ZQCM0:/10X15C0H/OY.)=O#9:MZ/1
MMPXJ6Z*4]\:E_^1.%*,P*U&BT2EW?>-N7S7?;$1CDHC1W+L_RFL _0%J=59W
ML<F@UHGL*$18FDY&LQJ_E;5:"Q'EMV\&"2\7R\\10>[[Q)A"K(1XC)\S*W-=
MD,8V#;M#:?O5=(+//N<G7TO7J18'%.@3,$S:).?(P/:Y74U;?^YD\]R[()^
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M<3-5%@U1P:8C6\"UBKBD70%\<QQXXVQ[R\N.6S_*:1*OV.X2;,^=]#,G9(@
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M\NRB4.ZIG=PS3%S1QM+:NR%1W]"JT,%GMWL^%W>U_G2<(:U5/UE'4.$?V!$
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M.ZS'6@AU4Q99,X<(.PZ8-'D5G$ F8"^1HGF-*(TO:;MA,UA#C@.EU@)AA1O
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M@I7CV=7W ;>RT'5H3%8J8Y11:Y2.ZT8-=6-[K$_8JR>".)-"UT^;B:&8*[V
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M1)L6K\C/!#&CG_T*141<&R8FR/15F+#Q'$W5FC[\U4])>6M!;0:7IH97)C
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M;_/)5\4%Q"&@W"OWT#'=E^"MZWO@]9C'''H@G@P_6W_^1H1\3-MT# :]AR[
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M7*R8?V"2Q9*TX>*#DP*/[-0V)^'U81Z1!1FMAF'[#\I&Z3'-F0OOQNOS%P7
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MG+6(=^&Q0(R1'-IN;"^XKV8A^,42KV6?-PGAUK-58C0PM>.ZV?=E7/^<F-3
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MOA\R8<KK,&9";LGXLT\+)LYFZ(P><%Y#_*. <O6Y5!U#L1)T\2VD6Y/?Y#$
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MX4111U%R9*\3C%5"<R/;7:HFE^^\?R%S^<Y%/1_>B]\QJTA*)KQ*)5WR3K4
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M\?:Q ;G2DK1EC:&5.1M@&8D<NSPCM9?U%4E"=^, [L_"&;7N1GYS*YYC]M7
M@-J<2C.H-LKL,RQOW=TG&5RGJ;J="V,O\85?,S]KY_ 6Q$0L5?F%,!U::@S^
MEP/,_?<<(&^!'DI21T2U8::2IE OE5:ZJZ8X_D#0SCN^+R+?V)Y.YZNPX'WU
M4"L :PS'%=V JQODQC,8>%L_M:^RA$V;<5%R[OC1\95G*)T4[,XI3&;+HOL7
MC%<M0EI#+TX78C/,85ST<IU7 3ST#?S-4QBU&HDGLZ[R5@F]KRZ^X%!"RQVA
MDAE"H>=# <X8T 53JM\N-N93[Z55H3*Y*60OZ@+51.9[!F)3<;&+LBI5-1BQ
M4>R6@E4I3-8=A!9C1LY#>I:BLZ/3QDF?1I0EQCM&R[6_00*6+&7, #EEX#GA
M^)NOPCS@VCTCTQ:K)H0;&))J56";T_):V-8T>^B%VLOQ;%%8)I=GH)K:;'<]
M,!CZ9(],R-106)67B<T2\GYGE]QX'Z.0CV*U]S,QJO?9?H*RC;&Y+EIQF04@
MT@2,M_)/U^3)3+5D:%?FZWK+VZ=_?Y7;_4@FZA)>$Z/5FK^4V%H[TI?,*>V9
M".D@K$A<5CUJ=Z\-V3;"R+ZH@%AC;G]ZT!S#;*C=C[_*3;X>:*ZD]$ZO:<&^
M?U(SSK2N(G)#.E*4DM)&K2C.QRREUBFR_G$V+A-TQ\1^C,-,^;7PTBN!3V7Q
MTC-?/%]+'^;+66'(+'!!?I?G0MWHAAV_:?%)<T;0!/7-/RQX^%!3=-/TD+;Z
M9W9.W[>XA+[)K(Q-\53YE)1EGY)$23PKJM=_@9#M5"];T)]C^O/Z-K.5Z:V/
M Q\-D/)*#K@I5&)$([L=AP;F5LUDQ <7GD]3B@S3,L!H&D)ERX":H3UUX7:.
MAJM'58X*X^=<]?&.+.UM/P54!1K1(<SH*:SD %0:LRH=,DN:G&&/^"AX%&FD
MNLI6V7[B@<(3 1GV/(5!3.^7>5LDWDUWNQ7HJ8G&VLO>/U!<2%;WBC%,RXIG
M>"B32LOQ1<F-\!#7C ("U_-S(9/3DT%Q[XY[;J@P <;O N,?2UT.X6YPJ=")
MOZ[/F2LU4QQR_="N16_A?I;@2.L8GN<D_&]$D$D["FB4]=Q<."LP6IN]6P/[
M*YHVRI6S!O1;'8#/#?HJ3W5\GX\YF$]:4*LZW"AA,&JF$(!&TCOCV[V4:)L%
M$->D3U7_WOD[0"5;?J>TN3ZHO?U.=25FT2;!CLW(=,?F2\SOOPOW;)(4K-DI
M9P(R><IQUSF7,^)&46@[JZ:B\"6@MD9FRIBRH$&AZ[ OZ%3#5PV]7&10-7L_
M&>+90>MT#^:.K"M+.+.O)@E:VZA0\X?E,?W:&-:6R6</T!,%)L%LGS(#5$;K
M9V'["6:!.JM8;<3W#;DA5IX]F4&7;1?_?K7D[I-5]3K8SN"BB?I70SG7)\NL
ME'D<T2^TS?9@,<L0Q=[P'+KL]+S#&4EL$2[EQT1Q+2ZD7V]>OKU(1T'^AD,7
M_IU7B7K''#W>$D,EA[@-&0./GD%_7XV\)7VIXP/O"4H<.6#ZH.F57<_DDSB]
MN@FVH.<]S 8LL<7WZ\S"IHF 0R*@WYMDP$4\D5KH,,_7<R8)\M>^^;A:WPO/
MCRC_Y5HMMW14\A"V08K:3HM*(-W(>.\*D_=+(P=#C\Y4G$AS4R%^$D>/D@R'
M,G>\^B/>M2UHN"-1YI# <G2/Y7;V$?]H30&O?I9FO1=?N_A$9(1WC1?O0&S8
M3H6\;#NP(J--B]YNU])OD?=UQ1>':$%V]7=-F(#NNM+M5*;5 XLP<T$T$1!4
M(B>="[EC8EM]C5W=NE19D3^ Q2HN'=J *U&&=4@)B$OM*:<Z-"*?EN)J8UWC
MC21GSRZO>9]Y$V@G/#E0].$$EBE5AX5M;Y16U9<=R+O/8H\R%J]O-*ON/%JI
MZ>;WCK,;C>)ZEB_4:[J:95["!AV,F[9PRY*)8O;5Q$BV039-^JGL'?*FC0-^
ME@:+C5^[]('JT0:YMH&O)2:PG0BX+5;S?O<V1,?>X$4W=R0W3.Q"2SSY\@M/
M"I^C$AE8Z$*>2L(?\YU)AS4[ 6MVW^E#YI4Y,#P/[#.?$3DKC?.SKTH60L@9
MJ+=,_BX4@VQ])PWJG<4:/KZ"/SGF+/&O<S9*E/Z+P#LBA=7-N8JC-L3MB8:*
M6:Z823J6,QC/O.7!>[-6-'M]B]V;FJ3E!.4$\.NMG;9RZND3@ALK+<V#B@?=
MPR^SUB)$&'XK\\XVJ B#7;^AG:+$=T-JX\8(;,,6&G7)'#>ZF/CO? H 4US=
M*#S6%[Z#2]'%!%>[%F[2:_CE36\_G'Y8D#!94-CR06'C(\[ BC:W-+=O8Z_$
M9G3R:^VAF;A2UYY0&AFFW=V<CS3A*9EM\[,VDZ<3)]\[EE3MLMB3\=QE"2+_
M+G\ZQJPD/9BKHZ8;,3G5^:)8)]7TWOW8V9E'J]+K?=#XM4;:L^^-]SPE>@7%
MYNY,G\4HT#%GJW\@__:0]ZX/&<E8:-C3N%SC^Z-C;CL:S-=(NZ^=$K;G+J]E
M<9:KP(F#]1;;8 2JT%*M-Z0L/T;A;RHOX)CV)CB]C&8FTJ9C?K?%J&ZH[FBA
M5)64* 19'E:24@T_)558V^MD[/Z[0P\9_\N^:ACAUJ229?1._OTDKC_:(I%2
M4\XZSTZ;#GH,/&!R^@6X(>,,\"B<B0C03N6)61C0J_I#X_SM%N!BF6VAGET'
M=$2)%%*SU:F,]<["4I8;2"%U/A/&[YK*DPD#_ ="T/DZ#Q$@-Z8]#PQ.Y\ E
M%=R@I%PO,ZOAZ$V-^-E"^60'JGVPE-XTJL\WE$4O$Z,JM#*<-PP7)R6LE+5*
MZ3I/KMITJ5<1?PM\1F<F6+]V!I#%N%K80WL193ATR(2O[F*>XJ8GI=W+<:L*
M(L"NCE%>5OC7^H0OY5G2 2A(Y''>[.51.36PH <[_LL=:<.X R+ <\]K[1;_
MI+Y+._15*H:L+5?Q^C8;'($GP[(!%SP7.$L-1[P.S!#SGX&YOGIQVA:WH3'_
MH=_'_M]!A\D)6 R06%$*IO-X"<MRL98"W#K$""/G)A':F,N''8'S4UUBV^SW
M;9>'OTLE;+*PABLL>M]^+,=&3KL!K/)HZ\+SSJ=84!IV+9M!@D:-+BP[##F2
M0N-%@:SUVD8F/3M3=G[9TDE:L$#;*7C-5#9.-Y^R9)%V3&EH)",>8^YED&:Q
MA1<M/]5P6@M095*Q<;=VE^:*U/2)\2-4NM^DU*ZM%FU]Y2%&5E3:\CL+ Z]I
M)(/VG( "*L(<P&T)(O:-G$E/@[@O+)*NSJO'\]7/2_LY(F5.3YZ$?M=W)G]$
M3CL&6TS6LY?Q]/;M<FMH1/4WH:W>:G"!:77C&QP@9T<V2X&\!G<#KLX'0,85
M;A(&T[EP%EY.$%<7H<J%YD\Q+0M=(E&&7Y=*Y"F[O=:<528R:!JOX"P6TU/D
MO",^N9]$FRKF-WVTCBCMT,)06J/6O.#]0!:<Z N<WV*ORN/A,7J#=UO3V8M*
M=VG=%#[=]E<T3Z!\T+PZO*Q<)+\\=/A\S^78&A2\T=' E+[K=BP&3?,4;I\D
MZ299J^)UZL];0D/>DLX^^:Q?60+DE1S'6H&EI+/]GI*Q=T$V?WS]I#:Q6ADD
MX''U6B=K==[=TP+PM/#=2 EW$%^ *KQW7^Y2&5X]$SOC#2QY,Y'J^IS%A5D^
MH^!^9GT6@<EG(<%_"5+=YT+(="*PUT5=Q?6K8$9CDG\$^29'!(K>3:*-H]/M
M; 5  CR]A[-Z=6X*BWGKE7ZUWUO*T99<&D H/4B_PM]?KXK9;(+>'A-Z'V'1
M]F!B0Z+]Z4\QG3LY'UYUZDA34**TU>+5^A-23:!J*Y6%@ZTE]H/:YH[(3!TP
M\SP\;)8*%^8EGQOB]O60=SZJ-T8L8LQ^E?$XSH.]MJXP=%MP*1D\P6)O-(X%
MO$G6S95YMY1J[)>.RC5.,_11>Z<I/_0G';87?:KE*T)&4"[TUSJ\0P1@:(?L
M@31R@CDX!4I:,\CMQ]^??_]>^W(\5KI)OV-%C@W0?Z4J@9Z*F5?7_M3V4!H5
MV=*?U%%D;+)1<2C+Q-_Z?G>*<J'R<.[+2<1,<@RM=4VY7X@4DN\:J\_'H60L
M*[-AV5C%FO#!9A[\;:X9QO31P@ RCP.FCZY$CV*'IYUFK@!9@]MG7N3E./X>
MR$RNV%B1#8#Q?+LD7[@ FLHBJ&$3B8"7SQ 'OH='K[8MKA%F@'O@"L3I124B
M(&L57KB0<<R '""HM&%"\+"<C:@2PDTBH(L#K77V48 (.'@"MC)U:D8<<T*O
M$0$_N3((H6I;A2N;1  =%+ZO +]&V-7"\^]=Y\G\*=-"8KWXWX$KE7=9,%J9
M'YB-&N^BL2F+?D)^L@:E@2_*OCK$W/AT*W=_=W?8((=F<=IL=*E;)'DYIE9!
M"Q=_>GO"/*D$3Y]W%J ;>Y8&_8T!OHG=%4;5;8A8B'N.+5"&*[#5I7D\KJOX
MJ(7WXV.\BWS;^0F^F6%_IFC_)KHH5#_N@=QM9<@&VE<UO)6+*1WO>W3:'X)$
M1Y+33>?-WMF;V@%QY,&'@#2^9&C*L*.JK(44*OYWUE516WO4&\;RV03QE63D
MENQ\84N_9=[&)(0-=E_U-I0B"93FI\_&UZ*%BW;!:\':G,UE,M#9V8V[F[L*
MC)F-C35G'Q??>K&)>1ZO_AY27(+>@65Q;U'ZU&]ATNJX7T^ZDAU[5:XA0\LF
M_'OZFXF Z&7U(%=;(J 'WNZ?M.='>^B!?R!/!)S=DIC#"3L1I%5(S:/_VM(G
M_+1"[.^C_9>T3N I_OT9?W>*^,\['?TW]E$Y:4X@J<^_9%_\"XZK\<=X\'$&
MSX %V+^5;,[_#\J!" C $@&HN'_5+F)TPN/QP&/R<[)SLG.R<[)SLG.R<[)S
MLG.R<[)SLO\59&?_!YDY 8FQ6/'-4O(S(P(H*/V( ,6(:L*-*2(@4OM?;2"Y
MA+G](_1K(D!_WZ8!^#]XE$3 B.\4P9? C^^/LX47(A8^[B+67*J(@&8??TPW
MZ%\T1RFJ"5 H)3[P#-R+6.U?1/P^5H:=U!$8V$X)(<Q.>/IJ(H EZU\TSU[V
M^*^NSA,!G:!SKG.N<ZYSKG.N<Z[_IUR(?Q=7'0%*H/AW'-^_9Y]_[/-WSG7.
M=<YUSG7.=<YUSG7.=<YUSG7.]3_*103\G^^>0P0$DS?NHOB=93.V_INW$(-H
M#Y>KMRB9.I\3Q&V>.Y>NUUT%68@1 7SK!T[C-LU8'^87(Y4.2DA]HSL\_?,T
M&7COG_EMO]Z#Z^X3M YE[- )$,G=QRHC\#^X=[7]5WQY,4YMC+=M96[.;+UU
MP4:DFW(0)B6H#WNA'STML#XXOX6;P<A6.IWGN>P^;:?J@1L42<@%V('4JV?Z
M.N)7"QX &. WJ-MAO:_R\7/'POL*4=>:=C8,"Q >QX@]!2T<Y)1R:LH+G"XQ
M#!V<!F[-2)7E#BR=(M>^^6GXR2\@*-:A=P87A][[7!7;9 CIN5GK8'K$/9QA
M?E@\F] H3/_UM<O@"ER6H++F25%X+:%CW-/H:/,HPMB-2] +6?*_]>=I)'#H
M^D K-NS6^P<_*%PX*Q?/%Q<.'S(N7Q%4Z&:@4GG\Y0THJ@]$ 18^E?!\!Z+&
MVZ-[*]8;KUI#JB_9G.F(P@ERA6"$?=M[W.'BZQGFK2V$5GD;*!VB@I5/8L<M
M_"ATBYE<H-\L!W4RG06#?G7NW@3>PUU6?RT5,"+>H#5\=D6?")#*:;_JJ@5'
M5H.@>PP3)^ .8+53R.M*#'VP6]Z?:T+;RU7Q'S:7R\I6"03)90O;:K5C4>QA
MTI64A:N1<AW)"R$E%SLH]VD/I"\MLW0DFVG%+2:[I.L;G D>9PAZ4ALGMD+%
M_[@]TV3K.V%L_&YZA[*4D7Q\;,-JRD;K*Q$P)+&*AG<5>LY"0K/"%U5>%A[*
M\Q_&H B/W_F/B>(+USQ+> VRN$97N]"F<R,8$3-0)SX1Y#DV-U?ZA0@(XW_K
M<U:+(@*>T**OG78T$L["_9=@4T3 V $1<$+KG:I.!+#C3N"=>U(J!.5R<ZU]
M^;&TRN/64QW_+B^,UBEI<IQHT4*C3L"KE-ND_^7:;+<X'/Q;[W01GK*@3Y@2
M1B/^G/2)$P$N@03,VMS/*'R4.3L1\-.;"%AKMGB-2P&A(S<R#C>Y"0$0%'Q<
MA: "IR("QJ7]#U["2^LU2.P[A42 ^:#_VOW2?B)@R9X(V!XJ#/9?4D-LH_9\
M(D6'(D>&(.:"H_5ND(5MZC?5M^T2>NRL+-\R]D@:O+SR;LO_$;G]BG_"%<@6
M:-RFJ6HS:Q/*7Q/$6><3]?/1[U\\L.^I\-/V./\F_H/G/;1:9$&&GY%)':,@
MONZ?;JXLEBW*I@5@1*:"!1$0Y+IHZQ8AJEG_I_*FQ*9V3>3DN/FDZM7HB8!P
M1[)1A*8O_\*I_W5/)_6!XBN"10Y9U5HZM(^ZCJ1Z;1OJ70&LM%5?6CFD[BXQ
M)3V"]Y0_7_QA^RV'39]Y"]H3^T9LSTM3.U$T<>F&9B;L>'_C;UVL?]R*1_^L
M+I,X]U"Q# S@(,1K^^T*R@$8) -[))G#G#_\@LQ#NS9-"2#I=MXX;YPW_E_<
M*/X[JU]*)O.2-MFVR\ N<0G2O'B0">,!_&_&A9OW5N+VGXU/P0 X+>PTNM4.
M1%U4::5\VSY!?1_[4%GM)YX&>3P6C>?!?$!3MCF06;SZ^G;G<0H9=_=+G><^
MV];(!K_-4R5?;A!=([#'RE[;S4?R5#],\D+JQ>O4:TW1ZZG4@PAIH:+5H9V5
MRE_!SX1>?D$*"%U]8R5EQ3%V=VS3BXX]75;XI.((5GZPUM^"2[P!%NREXTL>
MU$KR/E39E,CPNO4=<K.W(DR,FKV+)?1=4?:;VWXB^(T1WVMH;FS!L *](3(3
M8C"X:0X,7P0*AF2\E:?WH*A'%RE+KU;ZL4).7_H^3!_KC36JJ8YEW'OS\VN5
MW\,"E4V+:^&=F!KC2)' .&^Q$FAB(H:-C%E54Y_&:D2>$N)49W&), &5"VFW
MH+XWZ/#&2/#@V?-;/9W[X\%?H("[)\$')9N+R.UBVMDDA93Y,"-4^B.]C6I[
M^I>'$=+2!X+AWDS'?';9?Q^744FPNV8=/9Y@S1GC.KU$<#MD <4:? =O2L7;
M#+@=*O##7$\8"M3)/_G.F*S_+>5_!?^0\ "7LY#&^Z)6W8^YFQR_K]A !&!&
MQ$]<?2^N[W\<ZG%:MG@([? G=Q1COH:'%"HMF]I3>7G[/E>P^I2:1'F*,_6A
M( )H_4!\.Y\361_3+F#H)!B*[,-9A\6.#Q7"@LK6%QX>JV56%$#VJD*60C!,
MIZM8?JY&BDAO>^JH <B"F8=:XN,QMYL2;E/B\:U3M2</12Q61''@(2*@M+]#
M@[SE1.C[@MF[$T$A<"VDSB0LY!KUCKZ!!O+#8]/],3>_D-O:^1:"FLF-_9K(
M%G2[O:?IQ"GXS4[):<;K$_ *27D\?MB+0;5;>5][:='VF &4!Z^2<\,<-2M<
M'K2JJQD3%+:^\;6HZ(>1=7P=X!N:,K\)WC?'@$M?[4CG&W&;JM3+>/'+)UAI
MK2[J!HZ"TM</TKKPELMP-,U+*6\2.8!)EPE2HT$?+*7"/1Q#3RBQ)!T4O=GF
MC[UE<<; O^5$[=]95T 29A49)]?@D?ZO@,=L]4I$P,MED@H(:&S'2.+#DG//
M?%2)@&_)>_N[QTR(T_=8G WA*0)'=0PB D;A"(2EU%/_2]M7B8"$Q$0*_]TB
M?S4<.1Z4 PTD(//HYQUC6G&Y-:!CQI #>,&B^^A%_EX@5?.ZW*!35_IX@X;,
M%YVQ9>[MA7_XDHSG.,<Y:%Z0L6#,^3'E6*L!!4%1>_<RH<^+M*;,G2B*V'EG
MKN?A1$!#:I0O0+X*MMZZ:+]@SU=A91TI9WXK6"8V*S1*S.CX;^'(B:Q%8.!2
M;!\:/QE?D)& >@ZR-6#[KN<$1-_E#TUI5N (4&1)!X[H/ XO-.IFWN./MBA\
M0S9L'?N:"'@/U<>*X<JI:$\G[;5V%"Y6DRWD\@\6#.Z/X:-^.]W"W\00 3 A
MN4+@]0VC_I.>/(U:_SF=[2N-\3C94R9C''1ORA"3C=[P</FRGO-$TB3KEC(6
MM"ER-FUYMF"ALTWV[6)"/=Z&"B7RXCW*-G?*O_[P(>%.T_Q*0=]^S&[UM.+U
MT!%M/;Z\)NT_NE]]<Y-C8,>ZVS%5H23G'7N6Z"9\!S+&QH_^=,/5Q75_=CTE
M0<*F@R)4];HJ0V>G-&-7'__R)CP$RE=:2[>/@X!A#E,7Y<,_E/9)H=(;"@]U
M4DK]:T%\)].45(L/XN)YVU6%ZW'/D9^<:S;Z*N[/SZZN.K7Z3]ATS,K7!^T<
M'/O*YE G"8M?[99B)##46'-'UK!Z;;DW2D/[91H#%WOD02T*#,-.!RE^"IRG
MSV^+-;[]]7IKBWR6^Q(!\!+ OYMZX8_VQW65DYXP;'>!6D_N8R(@'P<LK)7T
M\.G)WP-M0=!';8V4F,@ZA>KO<W;.ZJ\Y(M5KC,@>.#M? UIT-_[ T+S3^&Y/
M]31GR<>+5H\B1BV=7QWPG@8<$H[48@P]^1VCI=5T(H<0#+;X=)+-.3EF7IOQ
MU0*=1;C[G@CX!#+L\TX!;^,\X#7^5OV4&^8,.-D<NY/*\!.WK7?3=-6_GL3P
MB$HSLLT'XL9*'-@"PBG5#EPI-JI>*6GGT\1L>7E9W!KHQE!2:3I43RO]+7N\
M</A1B4;WG]0;I3U)M9'R0DQ#SM_ +WP&E/<;]P&W^%>KX..WA0E-T?YKQYL;
MI!RF+'+@'XV1>T4$L.=[9VTB OWWGN&I2<E/'71V.WX"S(QV(J@" _RWKMD0
M 9EWZOB.:XF ]HQ"?']ABW\=*?M?QP? >(IN_?P'$*WG.,?_UW ^E<]QCO_%
M**O7+Y(,P4L6V'\&IHX:E$V'[D=,W:X2G<KQ30 Y0?"4N"P'9#7V(VKJS,S;
M4ZZ:.DIC >7CE=6!7,')56E'WC=X-Z7<7V8+CT!N8_R)@"=NI41 3: _IO:]
M?W7[9"=%^HV/L34:JA_QH/<0DL\#NPH?'^'@^W+P0S@O$9"!""19NBU[_F56
M?NS^D$VZ^#">R\V.$21J/%.T1/FR.PD.Q?E@%%O]J2M6&M#8[,1"MDM_ON@8
MJC)>^!,>OM^O&!@ Z6U;KJEG6BG6R#ESEW_+YO01J1Y+J2TY97,D^O/O0]+[
M6B__9Q6#4)QLI#ZK!2W![?RQE\*( )5^"_=_P\*>-#*2?'>X'W#)5XO!O[/
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MM _G_F4EG0B<)"FS1#6#L)?*B8"!:V;QOC/^B_TC!)N1!=#,.A$0!'VL1&-
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MB(!.8R2A#OF?V'O/@":#;ETTB@B"@$CO*"I*[QVB(EU >B?2I/=>HR*]1$!
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MC;X^5W;@>\?F7(]%BMBG 9S9Q4UW'XYR?_+H:@TV%40)MBY*0PT;&CXBMK$
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MR+U0O#"X4%>@U=',9E"<R5]#SD_F]?D>R=,&C:)6>CGJXD!&Q9L%W'WOO[L
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M'GG8:X<8EF8S5 T-EWUU$'[]A+Z$(X]+VW']BNS)1 -[L8WK>5UHLJ<]C;J
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MU._6;WM?(QQ-"'=*$=61R <?^P>?R24J>PU,J>WTX=$H*L"\\&&N3T7ZL).
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MC)!@[+JR <5\9L&\&H^:4P@))4F[Y=FK/A:C$86,WXK8:'#WE%B &VZ@7O#
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M0I9-*>]AC?:#^2O L2XCJ33!AF)YL*=#':PN$K/: U$1=8-<BT)N;G3P'1;
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MGY=[=ZA.NJGX$N2!ST)EC[D;(7S> 16%+MTJFQ,W-MGV/M=YHS2-GF-3@@J
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M*PEDKR\3)JD[\X?\;]*458O)5XU[4>_I);;H8#P[6*)NT#O8,O0,9JQW&/@
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M)1A4(-@V-?\N29 =QHP@=I=(Y\@1$Z)4D[%W_G]\Z]Y_7620@*Q(=K+7N _
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M&LU["<'<^[ZC5JRZ^L6H8*^)UA^D&DZ7L%Z\4)442Y#$\:,B'F+VM+S! HZ
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M3)8:X&)D> 1JRS="=%0>)%>/=<WJ.Z\Z-[]!\>$?"9@4'\,M!AK<>5\VB\Y
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MN9.R59 2D9&Y</I+O$5EO!%6BC8LW9(T7NAH=E)-/$EV3K>[R@8\,Y4[Z#)
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M4&17VCNZB@1(T<4QXS::1J\!2)(.&&T/7?U5A913(6RQ_;+G4B1S6&9UL?Q
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MT&3_^J$_[VDNVM4!*2M(#K_(SXL0\G$=*F:W%CY)5:81.*M+*MN'WL*PN+8
MYJV)M7T*&^W\2_K>M>*92G%LK57[]P\[]*JZ4SS)97B):J*^MKJ8['EKMCS
MUE\#VKS:;2@?"YB"VY?<-,4T\)+;H:>2:/W65-Z*<(\8Y2,+B1J>5K.YU ;#
M^X[G6DI\#K'F@CV)[_;<WOR"3#U4"I#+TPA,W!M!&M'_L6M4+)K=K@[6TYUG
M_4)&ZCP _,2VZ"MJ0VK5?.=_L??>84U]R]YXK"B*B-);5% ZB(#T1$"Z@'1$
MBHAT 0&!@(%01)0J(" @1'HG J&72!>07D+OO2;4 "'YA6\YY]SGN>^Y[[GO
MO>?<WWW\8P+[6;/W7FO69];,[#UK-K*7JFB?/R(GJ8JM@?:8;CL'C"G!4TQ5
M6;$R]54OCST[N$N_;YZQZ/3%VW76FQ_KECPK;;;+M*^%(X]H!BGU7WM@NF4=
M8OM\52$MM9U^GSK';*N:145XA:L_*?YEQ.ID,9BV<@.,HCIFK YLAF^)K:)(
MDTH*$U,9J\"D.(4*V75J=,7.NSC*^8?VCP<-/BZM;(/E8"I3Q1R(OW9-X"VF
MA&Q+M08R.W$VL&^^M:PJC9:]=:>1JZ=+N[66?W7TCG#M[S5@B #TW$E1$+7C
M#-3L; ,1L-%U$HNV5G/DR"7C$AZARB^;E29:>/GS^;@TN0'IO6_83$A%J=A+
M6YH6?7B8Y'SN:%0P3&-?C<:FTZ#2157U/&N-V+SK4MGF?:343&T4+ID(8-<3
M.)RW(P*2;T-'3:IFP4$CBN]!S 6!MK&W,/+D?EB?"MF*34)K9DBF>'_:3.GS
MMD+JI6DLMT-'B]P/_4/]'B* C B8^V@"&VW917QQ%D('[2( >)U>J- 4%](N
MK<(N6VJ-OD<%WQ#FKMTBJYWV25]'7=$DB;4Z77?8&>D$OXP\LM=N\10I&=+S
MS1C3K;R68T )_2B&,,8=SW0\;=BKM$A*E(IY-?;A<K&L6^%H&3E3UFJ2=.[W
M/,?%/H%G5:51;>6^C>^/W;Z)D_7UUO2B9T4#H,9IE\#40QZ*;,Y(!8/M\.HT
MBN_;R\V>\2TTZK9([JUM^=>213_EN<SLS#P../CBINGHM(W;+)*><'PD I@*
M+<$?$)FU%W%NLPVU9T),;KZSRV:<:VZ(/@NHP%,#F\MCL.X-E)?NEO<@,_H%
MZ#X3 >XWR<=E?M: OFKC!8YD>4Q6M%9[))XJEZT5CBC0*XB/1RIQ@ 7 )N=<
M9M+UJ=04J-=BO3I_EHH9U:)$/%>T/6UR3/*PC:8"!I>.A[$']WDF4=:;!]=V
M)@]) >\QW6V(>J&[Y<2=JJKB;5 ]FH^;C/Y5>K&?M.*MFNLSBTU\/"V,Y])#
M_<8NFE5<B^(^1W^A?76EOC*GWCE?0=F^8M',B3I["OMZGN_%SK944NV'XR^P
M.>5^U.HQ:L?(=;M4*!R1[ME2;QHDH>@'E70W]RZC$$8K/#-[T&"C>R9RXNM@
MQ9\OBN+^\J*H$6*GKT;60JN_Q5(HYWDYL.?2=/B<FN?^.M7T00D?A]H@7]3/
ML#[G]N(O;%/O#D^#L2L8U>R'Z'L_OJZ[6P)"F%GC:%90E"!1V#,;[++$?'5L
MC" BEGGIE(6Z[Q/E@T]7A)[,</9K!=C:;DA?R4/1R#[.]V^45'!47/ 0*)LZ
MSS,$)<,D/!J0NGB_K.##>NNDL#.[KU* CHO?A;EW8+FG:J0(+O?>1# ]Q7?Q
MK9@.;$37>/-$22M>'==,$"@FM/?=B.Q2)0)B0CDH!;[>>$4WBCA='*V"BV5\
M/3,[7K1L]NJ)9Z+AKKGFZ+CJ+L<Q7.3'2REC]V?KA0+)C68)X'O,OO ,(J M
M!P_!( _!P7/]]9;MC\G;5L2>G/9I\^H4VHQ:-G&R<^6+[M>_JM1C]'"Z5WZ%
MGAEC-XH'8T>5!Y%=:T0 K<VT/^<UE8@/-Z/&DN>\&3;52R0^\>3LH$45 OP;
MNYNF:E/?P]G4L5[2E)=W6@QW[^!N[7E?)(SWNVIGMC-3.-W.'9T/W->6?,>4
M23_U15_7<68SP)"E9?3ERU[5K^X%HT\NZNU- ,CZ:.KPCW E[K-I3R4A\>W*
M"N/S0J?[J+K+RKYU27=R[D5CKX>87=$=7#+5K7N6K6(0%)26U,:WO"UU5'9P
M+%V1GEJQ"O?D&5Z!QDU"+Y_LJL@D GXKS:W]6V[5RI^Y507ZTX@/]M#;?^9F
M*9_:0G-$W_ N<9EI(45B]C-*)QE7SU5U@_?;J#<NKP_!-\FWQDD617W$X- :
MG7D<MK3]9@Q=N(HJ)@+P456(P\,H(D#&\*"RQF7:O<D>6.=-G:!6HYJ1F.EQ
MZ@--K TYF61-[H]C2=AAMIE-FTA.!<^=AGL(]0Q*B@N2R!))#7_PEM;.GYN2
MP.ML)Y%L(BF2-2=%LK;3WJRK>Q-TV'>).<:!]_?FVSW,^;;9.%MFZDN]^2$C
M#2V, ]'C?FV%38[S0''9+QL<81KYXMJ?"@L3D=^T$&H6UU,FJ^??,/-Q;*>G
M9H)#/1.&#OR7!0*=%6<U_(N6558X5#U>)AR_6[1:TD%WQI:Z,WJ-E98)"HM2
MB2N&-I-_F27;+?#_#@*A,.>ST+1?-1PY_R8R-"ETPEZ?1H68/]EM%[BS"J"-
M'P[&#DEYG$1TV%LYSW*4L[85C,.17[X=U+)^L="43:,I&4[]Z4V#XX6,-K8[
M2JD?OA9$QO*F^7W-)A>]<M R12$Z$_MN!W41EXP<%TRW"+MM T53!(K_):23
M[Z\5AK@T,*H.X334&O,C\^<]-/V/9Y,,"#0SHK%1*Z):XT9M?6./YN<B*OA;
M4#B]':\:VX*T@53[L,N&]6:O>AJT(A-5QUM?>C'\G;UMJ!.S O[#K(!?4LDF
M)]VEX]1)(@+6XF=J&7$Q??4F_"7]FU(-]M?*;XFTSBO1 PT74E6<ZON##:N2
MWITD]H6QYKW(IV%*U/^W^]T*B( I,A)HX'^ 9DL@&'2WD!0R)_<+[_X&NNN<
MVN5"9=D$3$'JM.-O:*+Y#4UQBW]%4R@W,@/SRL\PER:PZ7&8HV%Q;&5?_Y;$
M.HB$^U;5/_<].GDGHHYU>Z#2Z/5J@5D*29VJ*_;K[3%;S4\7%#3#FP(\2U*.
M0U+*"K<-#"/"[MU[X\+2M7[[WX!OO18 :Y6L( (0O]6TY<15S-H!F>WTW-TN
M<2KEXXL7.;4_-F);=VEZH'RX_%2<0'VQ35GVZSZIS1N"MXK6;SY8="]$W$KG
M#C]W(3V_9U?8Z1-;PD#>_ 9RK4L:8U(03QDLG'MP92BY7.[FCNP#\X/K)NU'
M#R'>]JK*?:[!+[;9D&-%:XL7<#=K?<+QGK6P-;'U/@S"$.>!K3HZHQ&NC.:;
MJRX,A98O/KC$_9J\3>/G5Z?XU<:>K$SR_H$Q3U8WXZ!D;M=OD$#KUB5\U^T]
M/*#I#9T/X=JR9Z:OY>!NCY.#^L%L!/O(0^ZOB_322N8[MTJ?-DY>U-.MH;W+
M]-%EGB]AE@U>%5IC%XE+P :9TAO"+)9?M5IEO&!@*/=PZG[VB@QW)?K3JEZC
M<]];HS?%A@9&K";I>C6ZOZW%DI3##1I(PH^!S0AP;[S3A?%V7C.Y4_!<UL_+
M)O;_%T\*Y.'3A'3>)(V1EP[G[_@PLTK<!:4FU:)"/4VR9X$!M?P?)VQ+Y_G?
MGPN6X58:8F%(7?5=?=)VO6'FMMZK!8W" ?42*0?3R](2;5]2*SU-%R!=;_%@
MIYGPJT^6!Y<Z>W^(EHH])%LP7R/;0;PY3DYM\5FOT=L3(@+":IPE IO6R>I+
M[PWC!!0-+#^:%<R' ^4ZGW2!&R%9>#.LN1(VL&$ZPR@8L0[COW_/0ZY-B/^>
M,Z5<UX*$CDZHX4!V_US1HSQ)DJZY8B8&5)Q-!1X*K)%TC(TUEX2JX)-2"7.@
MN[!6I4$B8#4%ME22B[H =<W$T>FB*OII+963J;X&G&'>(*O(HP3:#1+N8-U2
MLPW):/<OITO5^==SBN-S2Z_&#L[?1Q;.ZR&4YX67LM^TUEPFEY9VD0?.FL"U
M%Y"@: Q[\&R7O]4C91JKIU:%XHOF6?77UT,S:AVKBQ/4*^-'%NZ\@QBD-C><
M4Y)>3<50AF]6G\L1:2KZL+YPRJK4X8QOM__0]I)W],J^Z=5:)DB%UJIA,=7$
MN;KM_"\5+3(50A&[X&A(H>Y=7?9^HU3^EF$=R,M)2G6AG&0M\I$U='8S_@QF
M[! >$JM-7H_64'B.FT[\E&7:^@'/#1L1#6=Y C<&"9ULAB.X=L/#XEF#O<S,
M4H9$:H.98I*4DLD-[,4N^ ^41BIW&4Z!>''U+<T3M\M0WZZ]9RLQ4(J6+96K
MF'JQ)R(<;?BY2<^IJ- @SHS30JN^+[N#)W>T8@U,R1[>3')QPQ(6.*/MY[X]
M5W"[2V;3TIV-^.+*)S&K5)O4N76GK,(W2$+4G "#USC@*%M& GU<Y9SL/N3/
MD49OOO6#3"ZI):ED50BO@G.?Y32/-2W:*M"QOS,S'A?X[75KRT&3".-GB4CH
MEY[89]&/0/;O,AGZ'V?3V+O!A)KQ3--/X0P0OU&UTG,/ ^^IT(&TKN3!NK1X
M'&>L&LJ]@4:&#RN_UL9,"7F8J-<'24:5+W*('0)5=BQQ-5.H\\M;BM.)=]LE
MW<*NDY=525XFN,Y,L&-9-H-*/NPR'4BUSHD!K%[:2G"'??>NWIU#RW/IYSY-
M&BM4/,\=<^G2NSU;[][<E80B(D"PEF4P';-189XM]S.F-R\!5GUJ'D85@4/W
M) EC7IA(#^#9<I\&Q'<K,5J>>>>#^%RQ=YL4"YU!?,X=J67"O^RKEIQ^ZB6D
M^S0V:3R.:O9Q@YFX4>*X@M/.Z>*6WJPQV]YQ:\>(F:S;4O>YC@JZ%H(FD?H?
M:M%Y3ZP+0>8E&A(69 1#47+*<A/8E.ZBR;E![0:"0*_CG.3S=Z[;]'MR6X7X
M#SE)MP;3L+157MDJ]-(_\^\,$F@(-'@R8("5=]+NL.*59!FMC7 .AE!7;%$C
M?^C3'J",=_<$ URWYZ5(L,ZV7I=S&QTB9D@2=>*K'NQC]\AH5H%7"&*HP)=L
MO;L)'@*\J<81'0Q,LR9M,N"[9U EKYTAP=.W&R?MWH@]G-L0O*3\@&/\P2@1
ML(*0",F90A='2XY:AB<W:S58]AG$GSQ<R%AS E\A7!F#+"J5__L/%UY5-GTR
M=,AVMZ-H&65[IQ!J=0D)NG+OO/H]ET/]7-SB;)I[O/8RB+'T#2>#FU>VCRQ=
MN3P+J,8KM^4-$4 R?*M$ &@7';#7ZYQH?'T),AS8OZR0R"RT$#EAS+ 3VT1Y
M<*L'AF8R/;[($WB<*/)C#:KV)E/RG&AWKB)\QGK+Z4 (6 ^?U?C=2&>0C+3L
MG[%?VCX1\ +]Z8F)6N:$G(L=CYP4/WN8_%0V<XBW;GM@0QO$HR^R^.6NTW"H
MA-BA09#Z"A>'8^.FMQC$<E$!6S*P'!H:C;TFSP\R'FK@]W*^>$AE\H;9GC?H
M?7IB&(VBRTA-EQQN/L5NQ'!Y@K>OKLV7S4-6Z4O8O*?_3M=@_DGBCOOOB3L=
MD)/$G8I7L&%^ - W)_-]O@)K:Y]]BMW4W<]MB.LJU>9TN1JND_T3F/$*G!TF
M8+Z:B5^+K/R%&?(#<"-Y?U[G"/T1__OG93S7/L%F TDF^#%4 9?N-;M,2P%_
MT<=FWS,:ILKLM2#=Q>';)[T"\ZW&*_4=NZF&.W[L;PY9-EM1S]@2S@Y)?]\R
MG?T8=_-%=6?"7BAF#;M**S%F;3BHY-W%I=O9HJ7$L4))D#01R]H2DS^7^!X@
MX.RIWUL+PL793,-H*9@,"I]V,"YT&+]_,*]L2<;MC:D/:BG%MM1O7E%Q1(X*
MOQEH%XBV/>J?Q:GZD$W92=V_E2]!%>SO%2_RLPC/S\$@$5095IE9D9\N.TGA
M??F' \H%8C\A&_8*.GQQ*'/,0N90_Q/^TD$MN\WD[\4I\K' &=?-\ *VD,SA
MUT-/7^L=M/*%.)B/325)6F%S3"F@JG;30#K#%7<_.<=K8B##N:VT*Z"2ZKN[
M;+*I\?OIV>VF0(4,B;<V5=J9CCB7G.-4\-R;OY:ZZ-B!'UQZ D._)D4! :ZF
MM%)F%K..U^2R#/)RR4=YV1\EJ\N)2W?M!SCK7><KV:TNN&@PIR^VZN/L9 R!
ME$^G,CB:_V@9"'C4[/K\&,W7!3MYNZ#9BUK%P)9*$4D\ P0^O$8OU.GK\)/E
MU5>WWTVI-%O7AU8]\?+22/=04SA]+5-&0:5+&[I7(Z4@E)106:38@]IV!.]3
M$DKF3<^[(KL)-PV$\ZY)Y@^FA^=Z37:<O&<'X@SC9?%<()9AE[W)P@/QK>:.
MX=TNE2T''<PKF:DPCPZ7Z2R5Q[GJ=FZ=:RTL%_0:]-(V6VEPK!U'\A 3R"Z/
ML3?[I&W/)8^@D+5GRGJ@1F;8=WE(Z^SH4)+8/L(:X]CR7E]-3;1Q+_]U A2%
M;$YN0&@D:I@B8"J]IM>@[,@XQUM% 8MDMT2048!P>3;'>4V%?"-AZ4_+90[-
MN+S[=(*YNZ3EPJ-,;:U3NQY^-AV-YQ9)&-<X8K]K0_6B;$SJJYA+VZP4/(/2
M<QX$S!$(WY$/B9'QHM=2N"(:[K)^B'Z*99M]5,M5Z,6C'+"&7)!\$?W^FA)J
M_/NTXG;3*^]K)PD0:AFF8^=/$B#""[U?<G6=*=S+7VZNSE;K7^W>+A2YJX.E
M-@\<4!CKW>AZ\F^?.?V>_R#3)^5QY]_+?T"?H2.G"D%:@5SU$J'VRGWNAD E
MJ-0?Z0\3)^D/G:6/: ]/0UB?+VXC]#"()GLV>9S='5\)H^-O#4[T@BF?VHNC
M%]V/9*M#H.5L6<M=F=+ANWEW/RVDZ\<YN"U XK7?T45,1MMZ41TI<N U1YZ&
M^>TJ+C(1 0'0S1!TMR&X!4BQ*L'KEL16^N+3C2>1JDZ\6L#'YST/J9J=.CS(
M&ODTE ;P:M(3'R@CGBU]#GU.Y1MP)H"U8:3X>UNZ6.4]_[[L G=F$+=34U].
MXEK^ 'V?C7XI)BZ].(GS0:O;^W6&)9>@;-(*O[MLTC-+! 2/<'RHIG1-,U1T
MYO_RD+KUZ@6WRL)%4)!=,[@KWU.86ST%BBV<-G^U\VI;,Q7THEM3GJ;?HTZ>
M6@N0$L3Y#U$J_JCG4%]C2N#4)&13CW9PI<=00::\LFZ4<??[KOF03J?M)Z.Y
MM="EGNSW\>EJQL6FT\"&06QI.4>EW'&4=5W&3D3E6]:ONZ#FVK10739=W5.*
M9TYG01QEBC"=L5?@9G11CM<PDE%C46/Q X@/3<]-;KDO=Q\G<+6;Q73/F5X?
M#S5TI=:G6@^@UGQP[G\I71A(0%CKF;#WW?[6SS<X,R+CER?..K4'FHWO2XEW
MX%]UMJ 1*V\U%IH7> ^_N L\JW;[IPSB=0B^C+M"T+];B>P1#/(*LFET<_9
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MN<79DE)%11 968*5!;9(4YX68%%SI1,/.VP;@>X2[H24>;<<Z/OT/%ZNVXA
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MM]G,@3P K]R.;(77D]7A>0VSG#.Q&W.NPLBZ(-/\9^Y74J)PV?\BQ^9C3Q.
MCX:YE]<IUIO&@_W+*5,N*(0TVD \&*>[ER_4@" "+J+>IYZ#YC(\* YHH8]\
M=4%,^J-H<I.1&5>5/+T>0I62U3:R<->BL=7QDBI;GM/7L9\MIQZL*.\T01NP
MJ01R2DS#]).D=M5J1\;5PCFO6,57@TL3X4Y^_H13U6%3^HN4S5TCQ3.B+<$?
M]!LEUF(.):\7R_<5GXL/P5:<NB,K;?SY6$+_(^QPM2_3;Y6$XR=SB;.R][>M
M^D@XGDJ&TX)N>Y16NJ4"_9 9LVN'=_3<@.M&S+6PL2'I*G2':!F:,7H.K>_2
MZNHJ1!=I\Z6JBC6M< [>G)Q20]\70I,2'I?[/O?)1-I)E3?DW;^M,/;O$D-*
MT -^2@<UMTD*;Q'<XM0Q$3 "O3EC=WPU=@(C?^?(0^-8^$,9FS>WW?N43Y&1
MR% VK<?NP<5@F=JK) #K\-^Z^P2JC!GY^>5,KC6,A]+==Y2L/]HLY%5FNA<*
M@YHU]0,)VF3LUQ'8B@8U]5]_;#RR"B94/AQZ303X<G9X4^B.TQGV0R6S9;*6
M1?<E+)//.+Y;Z;0,,NC**?HH<\@XG>W_MI:"87.Z.&<G+^?H!^&M@K3-P($[
M!D@@MYF!7;QDSS,CXHLUB2F7R7GBRX(W#Z%E9A\'#TE%*F\>4F+@L^Y^M?>M
M42,FE.C\DA>/+P^NJ!@]C1I12KB,TKK[YKJ)A<KU="S;ZMWR%?K\&[MK[DAM
MZT.T^%)8RD>M[G^PNM;_#^AFVHP/B[Q@,0X=CW<X_EK-< 3&N99HT-C*<KT@
M6XNWKV6OJC(;$>[2T!/33%*:^:(=A707^C*KSJ_MIIAFK,&"I.3M+)3U*:[Z
M<N[Q/67IW!G8B "!7'FZZTS)8 !F@5-*/Y]?<]>&/A%TG@AX$6;)-A0P!^WX
M@0@'6V^.2K8 D32->]?4)X"8L,UQZQBMJ^PFS>[?[R7AQ#27DS2ZB(!%4.VQ
MW6"JO^I$'!8WMMR&:5@BQ=,1:*@*+G^F*WCBAI=54^7\8(FG\_5.J.(%#DGS
M$#--KT^GC$*I]=/IL]:@R$RN]GCU-7 BM:;.@W_X/4@3M19@N<,3_7UR)+!E
MLGAWI>S=KEN4LM4D*!CZJ#3*,[%&,WS_H]^K>Y"Z+4-N"QH1&UL[];QED+6D
MT)[DGM-Q>34E=O5';R8,IR!EU$"F5/O1/K'JX-JSB^!Q,8?J5VI>K/FF7>PO
M>W[DI>5R_3#KI^J4]TH\$B*ID7RU/&9W#0_&4H]!X WF+S57Y"A@UA*G&^&3
MG+.28=BD3%\3W9<< C5G5C%/>J.3WQ]U]>-[T=)3X<S68"HI21L$Q$ZG;% X
M./VGOEY7.5#WQE:>!,T-4M!POJS#H[1T<4!!107+(B_LM?%I1?Z?M\DA5,GZ
M5+\V4Z;*+($#;X!!U&U>&K,C\ TD]R)Q!-WM*R_BCA09KQB'?V4YQ0&XKG9G
M/.+:IV<5:6MA]1I5IAS>/9.8QX[G\2R1B_*8[O!F$%<X)W:TG1!H/0Y^PWGT
MDQ)S1^/LM8Q:J>,,L"."#F\=N?T0T]<U+7"^5KOU ];#K0;L=>MX0+I'3/Q&
MS*HICQM!=T6S[C@GL'6V. -Q&3SAR=$L$#XAAEO/\ZIJ.NPO*V2C+>N;_ND6
M,XYRIQ?K%!OS-A^+WZZU3JE1:I(WY&A53\M1C7=8X_PC>/N'31/!=1)_$[<^
MZ^A;V=,/O9G?85;C6U[DLF X;HZ,B-3YXE1UZAV$+?\5]8FO\+.7YK;:MOPP
M/ ]5'(ZG%J@C FA-T ^QSQNF-JG;W\KQPI=$U;HOS(%?)?T@I%YN1 ^NWEDA
M0%JF<3N(+"+ $CZ*;@:>->Q30,<[TD+N2=U QFV[6L-WZA56R/#;T## .0ET
M[%.RP;C=<MY5Z^>@[=VMF')$@"E=-0\VH4'0;N+ZP/0 ;\)I7>U2 R##UIQ<
MV]T=L.9'F8*?Z)@^]9^'0VU"*IJ>5U(2\,8V_4%_U&C\)U#:'1_:(!M'VT8L
M/ 0)!N"\5XVPM-GVJ<OW@VOM<C/)4UD N^;=G&>C?,Y;]VO9<F^:VZK[(TP&
MMA'K#$<.$*:ITUT9'U#3M['/@/RAYC=8-8F C*UG[P-++VV!C)C1/TR1:#RU
ME0EV#.T-Q+W<QKDT9 JVYGX;?N,F^0F\U20MN)TT[ZQ7RQNI&#VBS)(6$;;@
MQE[('JG,OBN.4 ^[GF 8V#;KDL[40)F[X;G9HC&2.4.V?NKUZ@R%P:AU\KY<
M\M!&6,]=YXN/E2,"][]$+?LV>9 -1@;MFM/7&7(>D$=GZAGUN9/0I?LYX#^A
M<F1@0N6*-PM4 ZM?;TJEF ]1?5K5(W+VNX!#P\L<\=%;=[E7(-.^S%;,^GSR
MJD&1Q?SW7D%[>N"9L&($GCI3%OLI9@386'X#TUPP]'#P)L?:==$C#_;O7JT\
M_9&IIVO'BBN##ND7RR(L_1Y2,K^OB^[WD3LMX2>)WNXQ.3@2)PRSBATG%=PL
M+(,?O:FWV.8/\+HYDI3!<.61XG+TKI93^/U2*NEG7NJ7))SV!1D/X$C91).G
M&(&]((SI^KEI;#;$5'/<A='?/=W()];M+1'@=0^R8W%;P[Q?/^L^ '%'N6E$
M<4@VC5LQ_LJ2*W5/V*<5!=]_JOEDTV4QURWNWFE/E-.J]M?X5BK'CM:_]W[V
M V ^[@/@U&K\V1&5M8H[;E@30>S17@&&8VT[\QM:()10N5PY*??MYL:+'4L6
M-HV]! ; ^F4%GKFN$5* J^'D>AL="+JF],S'4ARO)FPJ202@D2_%@.OE74:G
M?%JF[+6UJ@=++@4?RVZ\.1H-O-?AXL*CS![B&6,Y%[7BI>8I_"K,\.?!%P<7
M1I-YBB<;DTBR]7PLV6S?F$&[.RD>F7S'SLX?G-%6]\+TT)[S1ON.F,FI$0HH
M$; S$\0S&,)VSCIUUDXOT<9%QYUR\01VYWXOPOJ/1)5IIYZR7L>ZE4T9NXT:
M8O9RW5-68A8%39ZH]/RH6!&3\A/C=K[0*6_>H_(CJ[5I')@"+R;%E]/\:27=
M!-ZGO%=>!<^HTM?*>GH3:)8)>'/F\(^7XX\69=#"1,!UF_N5&5%>CMDV99H?
MGE66?%1FSO&\]TU,!'_@S;#71++5CB,N+:;%G?F+$!>M;61<VJ1KJLF"JO+Q
M4P>%%B+ 7HGCC#@#66?^6PT#H(9?9[K&>*-MU2[829X/8KJV>/040H)?GZXP
M*7(K@JHRORE 7BIC]33/;89<RSQZ<%ILC.Z&?CF_^*;)HY2I=7:O:(EO^302
M#DN103*J6K;_\E>X_W6O@N]PGM*P-<=4[ BWY[[/MY^+]Z"E-]?:9/M(HW,Y
M4GD*(&VW';S72 JB?-MSI3?]:FEM*<^]O\-#!%P;+44G9%FO)^"T!TTR$\OI
M+0<3N73=%&EYZ#0N7O&H\>1?1'H/$ %E&1\PQ@YXD6E@\2KA_F/SZ _C=IFB
M&A,?O6U.$0$Q=GUD3BR4\RVAU4X(O *69;!FQMYP\<G AOJ+RDJO%@8Q718:
M10L YY)8GN+SGZK7?JHK@[7AVP15N_%T!>'8N(,](19].I[6Y2%)37F:;H_D
M_XQY_EM*-T'EWZ:^O /W)0*0="$H*])0*;3K1X(5SX:@7O8N'JP+4+-&WO'T
M>45_M4':0^1PX$C4>\"$ZC@5"195C3T2;;R/]?=*-E:26M( %"5)_=C&/W-G
M(%>BP<49>C-B[^=.K;NU/^D1N13*HU/\4?7<>.ZGUV9+7I)7(3>^H%E>2MGR
MY'>9GXG3J9>4?@Z3L0OK7SFXO@<^KD"B0F/V:FFQ;QI2<<MT[:&$.<8D,@,B
MH(HCSXNPA8TV+1 R89[F=N@%$=[=2KK%O#/>?<B5"U=QE>G^[X<1(R<@ T3C
M.1,HJ0/TQ)GO-1^C;F#T1Z$TF,$-2135BP8OA&)@4./BYYE.N?:ALG$-MZ-*
M[4SN@AYQ)_IXB,$;E9#=KI'PO0X,:FW=C#_.<7Z5(!PM=#Z<^HM,1'3D=."8
MT579XP7ZYE-C8$YO'N@SK&DS@EH5 2G3B]6N9L\3/![B^T@$G%7NH<L\$]4_
M-X?FRK*E,RQ9VX]%WYLP,5+J[7"2C(U4Y.#]V1*IW,J^VZ&/\ R]T(/./B"(
MWLT-CBGH62,-Y'62TO]S.M5V2_IM:KON*ZAI6%,X-9X%^U"""'CKZH',E[E;
M0+T@^?;'P>T0S,HK,;9O;&=/@_50%O!1[08P\O87"34B('9ZDTD!7ML[!QL?
M?^:\M^:-V?R&;^]Z?$E_MD3#W,,I8T+.W4:JM.RQ1"MU=X5BJ.\/"[,?;%EL
M&3R1!2RZA@Z>Y;SU&13+>9ZIA[2F-1H(?Y1Y^"A!@#9!X"Q>K3H,;23Y_!OV
M;+G2IH8,\] T^X[#F==B4F7C0>HN(]4JG^;51A27Z*%J4CKBRT6&7"F)3UC,
M_@FA*>$U8,7\\?"9;G3K9"G9>E,ZE**D M,2\,+_"78N2/> \OSG"T=;1(#G
M(^8\F.P0/<4K_P2DNB<N" (1[W=3S/#N,2WA> NS8B'K&K0Z<JMP8EUEN3(A
ML]B%OCRYW2GE=RE)[,9I!9XMT]FR=;I9C9'KC8J/L?>_UK?1W>E2*KMM;T]V
MQ#7^S<.M'6CF(Z9! \DUP):B//)71Z*;\W--Q"/?5&7R;F@X: "N .@! ![N
MFA$Q5T7]"@S]6EL&UU8^&VGE.2F+WE)3>J7_]R+R_WDGU\BS5U/5Q.<E#MQL
MN.@#E;$I@+CHE/?LOM$;IQC(C39;H7R>F:Q=Q\QX+'L<!79,!,X<#N.>-G<X
M?L5U%#*+,ERTRV;UX>J\IGU<_ZIE(\DMO$U%]^C[#MN701IKA9QM:5Y64,$5
M_;#Q\"4'J20U9=-X>.$DGIH<1LD$/@?5JGV3R#O# Z3J;$H:_18VM?MB^0,E
M#_X),V*9)KU?/T)>^%I:]P_?7J6A>T41'V589,Y7<W]*5R:!1LS(6,I(/+NH
M@]HOIE!2]I_P*%L8L&)W.9_-RO%,_,'V7N8QHEK\2,PZH^>1(3ID([4C*:S@
M00AK9*?BF,SR0.7ER]^RFCI&[HC8R;YE7I%D0^&&L:/UIJ>@W".+0:ZG3I?.
MEQ2^/5]1_1%V5CE)@XUO7\'C%NH.V(9R9+89C#3)PIITCH #S#^6%/C:W10,
M 4:G.Q2A4#*=@$60/99GQOV#-S^D8+'1A'O@3O^N..YGX$7RN1FQ_E<YDJ?"
M%AG$I4K>O+[;%EN]#[H$C-=I AG84,'>NJ>E!&WL2-W]H]3[L_^'!?@,OPUC
MR89_MN$*H^O8H7>RW8V82[E/+CLW3F':&CXJYGN'>;>B,)J<4@\'3:[ALITH
M8K*:GB.QK&=?J6N<<A#T98*5WLTL-WI!L.O--],+L<UWE_SVN:U<W(4D.V!W
M_SW>KTIY# 8O:,3/LKY+1[1.#I/MK0^ *+KLIC48.YSR(#??AUUZ]S.6T:#K
MG&?L>W?U7+ST_;(5QT"H3 8N5PDY*!R\ZJ7ZJ#I$S=[5[@9D3J[;CQ*\V%O-
MB$Q77OG_F'OOJ":[/ETX*@H(@@I()RB]2^_$1A<B74&("HB @""=D A(;P("
M@D"D=R)=$8AT 1'ITIOTEE!"2#WQG?G..C/G/3/SG7F>]7U_[!76RIW%O??^
ME>OZE;UA86'=(]VWT//5Y=I"4D\"_[^/E?UWAY 00,ILK%[=B-WH,VI4.K>F
MICZ^*&=UL5WWLFB_O.P"X)R^ LGP7OWP<VD9CZIKM;6-\8692TYT27FA#S(2
M 0!Z0?19V%WR%*+!9ZW'Z(D' \YRU54&,-D;X2@$-$\ROI.@?H?N[,4C0D_6
MV;EX3LO4I+5EV3=M(ZM!A]H4P+0Z=J$5U^7CL\A\=@9<C.-3$O/TSM#WL>0=
M](E-8"\E#/PX37P5Y$T4LSDL0,*R548LHT]^"%PR8P$Y*U%ER<7K_X9]_K/Q
MCX-4L,>7IP9Y?GX;,N*FU;^82O56_ FO^8[P-@16\NS&\MD:-'.GZQ P2N[J
MB&+O- -\\O&[G!1?)G]8Y(5C"D!^PVJ/\460)5NI3MEQ E%8KH@)BIXN ^5^
MVC0@4@"D<+C;VL0/!'I^B2DW&[P2ICM>Q?V^ZGK#@2P568;%5\". <1?4L=+
MR0%(1*G1B&\27HF=A=%"RU_.0*P\1Z78TNG^WU9;K3?*!1!+OJ[7+WL^/UG_
M*^O=:0&I;EH1D1CB(*D)Y#:I8>,9C-Y;Q.;UYNH,G*NLF$(1X9<Z;K.<(1>7
M/*7Q6->ZFSZ5*F:1FM05V]5!RQ2P]Q-%> Z; U?4'[^"<;E(\>4HWR[UCQA"
M3]!R/'/[Y0W>T]/"TO$X-'[]<'2XI1]?9X4RR"RH9#F(LQ0O$G<WHWIRR^(_
M-V)\_8OZ;6[P^&T,MQZ08B@ #S&-Z^-V-+CTDKHIU6FFC"6&=,GQ[-?RC8(]
M&U=5C2-75F",'U[V&/05JHS%9TR&=YFW@Z?,8*U.A\H,%2$/[JM][/NH2A,8
MDX:2H0 >(Z9]B&<\'=$40,]$%U'ZMW:1RTBUB+%(@2GP9"F(A8Q4$?&8):G'
MAU7==K?DI.&3M3MKX/Z^%J33MK2Q+'9P>S7Z65%BRW#V_>RVOR\B8'KO=*:K
M@\RR'I'ZRM:M%TE-5,[9L7@J +VU2/Y@9?>\HWS+$CGP1H/CR>-A#TO@R^*Y
M%<5B(RI>$19A8912-H7+R*WM5!-\=!<46]#L'?UC[SLKN*1T[X>'&(%J=3G7
MO&>]X&'%<P14AI^RZ=R,D69GS<.'!JOZPDFQZM6":4\"D_4'[5R4GIP\5<](
M%)F8KQ0*.BPI,_A&7&./*XU%4"GT8FB,:&4"X%]O__E+I-IJ E2-W$$%HRWW
MI]MSKN<$ZWZMO:Y7I!K@G0>/!M#4W<FYY[WYZ;?RMU$F?VQ%F5F\]E/OQ:W1
MCL$ILR#@SX38\DE7O%M58=%L1W#Q;&?MS9?NB\NI' YR26TTEZRV]EFP\J0:
MF=;3KB;^'ITOC8+0Y/V'3<''([:)<MWJN1I-3,T?.7_LC<\*F-=.>$_;ZH*;
M8K#MNT*9#%$\&E[Y%_KZ.DKXPQ"%_FRE:F#;Q*&/]W_97QW@Q><=L0X95S#?
M^1L;S]Y].*M9FJ 'Z4YM 9T_D<#^(M54MM)NF.+,VALOV>*P^_R&)4Q-#Y^?
M$WSCEQ1R<@\?(? 'QY9L)P0>+4:&E2KG2<(F@0U%"#30Z'V''5<RKV%/H^RR
MTWSL74O.RP:J_6^\J@F[[M>Y]^&=?/RC1(M*NRVNKL.IG-* JVFKNZNW]@W6
M2@53=K;5?$L4-8T/K$>E/8X82I'(J@+GXL^?O/8-MKV^?_?2%\S1[RT;VQO*
M*Y61/ZCP52N2\TN;I6*JJI3O?V&P]@U@&:EXJ+S]G@!QG:]-:$JS>AILW\;N
M!2]ROIF T]]2X%Q?;D(#<]LZF'.>E62Q:3MS#U5J:(QN?)&G6OVO.2H_R0+^
M$#"&/5*1P\>6#P^28R@!TWCS)Y1]_<VFPA]*5Q6!8J4 '"%3^;:D]]"'/)P^
M,G3S>J"ZPS?SD=E7_!_<Z*D%L"4"$G^A3N.FM7'QB[;JG7:\J$2S89GE@T>?
MH[(N95V\^?LZ?VCQFYNT-%;A=F%YQ,2AZRHX>X$IP]R?0WIBKF^/_GX8^_]F
M.,37^V_9@3$VV *<(QK<>>^9G1Q&&:M4ZNG26-V!9<@X8%#/:UC/<P0JN%\W
M]M_X5I2WDG?'N$"LROF+P/AZ!8H1%PO&^$4>#KS4_T2P2R^=Z@IRUNH&RW%>
M5%,:!\25TM*<EO_&5JK7<G3SOTC</IPM67W,XY@16K:OOV/L/G:R10&</4]"
MY@P@6]G\Y7 5WS4JX::-4#>:1U,"3&MDZTLCNWZ/J%9P+#E&!7/_W6/GII03
M/C>"+VS2E&@^)@VE7^C?]A?_8=28GK;772[^QE^@0KPCX8?.[@UKW%3*(06@
M-6KU<Z2H5.(.<9HE*N=:?JER29")-EOIM[\AK,'/QM'=%L)?^DT\@&]Y#G4/
M_@@U+4L6M+:!:F!:T!YL4UV-1J-/[;^8Q.N*_C[*N/$CL"D4?#6:V%+.Y9[K
M4[!Y96+<ZO+DG/6WVMN>#&_]LXTM4B/Y0T_1!%HJEHH/U<X<7O?O7=A\V>->
M0@ZW1$!DR9VH>F]@G4C8M.%X88(,SSI&M#4.D+<O&<XNFA^2\NIK\+C AT<2
M&UEDQ8/AV+!:D'Z^-=M",5/^>E&,S\U/?P>(>3NQ8-J;W1PXT4T!-")W_.?I
MO)^BE5][^.(&32.5E5]D-62<8:([3&T["2HCSAH\W6@;38Y1K>:(>ES:E#+)
MYTJ P29K)-/G&9H9X!^EUQ5W+&=/#EWU?GD?ODD\!K5 <F Y* /+I[Z2/2]E
M>P53<&LM0L$7Q V2:T"*74^*8TK6^/_<CA7UWZ1'_W2<1MT /0)-RQY.4L4J
MG*R*FG7 A=T:DP:^>Y\W]6U^5O/2E^ Y'24R_*>F*]?;98L'V9\>FJ/KV?2@
M@^L^N@,(EV"H$>$4;&(8:C2\C M:9IB7[PJ$@M;91Y0'2[[FISX)['OU<C8]
M)S>:8!$T,6A>M-&?BBA8Q%SL'+'@[Q4ML+;^OOEWI,DNCMC,CZ<V6?T -CCM
MF+D15'%2;G4],6O=3<W/FWS*W[3/JBE^CR6-:0!@!YX_%<V?K FQVEO7B=X<
M?3_$%T3P@TWJ+FHA9$(TV -IX]R7*0#CEO :[V_W'<YJ%KWPWRT_\)& I-7H
M#<LZ<WRI[I>_K*_Y(V@LWL:R9:+>L,70I"D33]ZWS%G:7(S5EXSS^MYY))@U
M9H#G4D@5<OQ\4J7,J>%H[.SVD[JCZRI_[-I_S=3\UP?W<PXL$DD%D:CI:QYA
M39U\#!B?9?T%UPU/CY?R+*1T>6 S_0:]R"JPW7A!"PN[40@9KBD]:RJEM]FQ
M)!)14M:12V*<[DLIZ^6.U+W7UW?S+/@6W8Z9U1J0R#*!;4F><P6&:\FWS'L(
M7_NI2/]>B".+04<K$L?L\9GT$Z3#&O="'J)I^KY80OXP2UJ<H\S%4_!/EE1L
M+&GJ[XB[7BUJW#(@AAPA^4E%J&?Q MB7.!_/*KL3O\#Z[D?#=>-0[@S,_"=M
M#LG9"%K3LRI=O9.<HZ5<]UZ^K]&]0'""C3<@:@=?=V?D&UZ82*C72_Q5.<TH
M):#!'<V*I>$M@V%H2\P@;Z9^5 <O\5KNF8_NKJ)&/82<=Z6K>)J3OUQ^\"ZG
M6' \,8'H64G4P[@7+H$O0?1+MKA>MSX_Z-U*8&4*N=$>S@/XP B0.-<:&LYF
MH.6TBB-Z5Z>0-_]<PK>I\?'OJ %#YH$<@%,=9J0LZ .LX5K:<1O7VWS"K<[+
M<[?YM(;HMC=E4X%01IZ+!= ]@Y9@@N7+T%(^2P^=NH\'%OS;0Z1SN""[$2(X
M_X'+E,5O*[S;MJ%FRW=&3J'X"(N073K%0LA;T$?X3H!(NU0@\VE<U3%9--O
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MDX.G"#M5@BCQ1>3R?%L+L%-*O*'Z/"G6,MI_TO>5APH/X&MYG"_45W'[H=5
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M.:K1,?>0LWR!NU?\[-8LN-]']E*QM(UM4D3_6E3QCGFR54/Q[R,V+&*G%,.
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M\6*/RD("=V>[U28V:%]1  Z(UY":^0Z59F=,F:&F_?U'RFW^C U#?3J+'C3
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M#&N#MTG!?T]8D3O\$'UJDO0S^)TFJUX*@ >TD)=S'L>&N6V-UJE<; DR&55
M"?9Z.O#O0P9"5=.Y?].&OV'2O>>Z)4X$4Y<AANIQEXDW*8!/</+[G1+NGR1!
M4B;<#7F>/)(C.>;-2WMK7*$\6ZM_9UB_E,Y7[B3F'3=O@E='@XKBX;GJ4N'$
M@CG(MWA!WX_-VZ6CX::=C,=+*"GX0M+\OO6?PX*?G%  P^]<#_=Z@/M"_F'D
MMF,@7JKDS-(>+@C>@<"S$$U&:J9A\"UX=N!Q+,H='DFFPPDM#D8U9?DE40#M
MVBSZA>MB*^\WL)\MO\W66X M1<YH]@+(PEC0(&=7(',(D7-Y?DJDBTLWO([!
M$'%Q\XJ2H9NKQV=+"<,[7@%/KYJ<415,&2,DG[TB\HZ0KT>=+FK2L%1\$\$H
M+>6-?9SAIEB8Z6BW9G\C)$'.\Y,OW]$QO ,4Q>74!3ZS/B<YM-P4>W>LLFN@
MR4Y[Q?!CLEQ_RL;F39[0EY WF>E$%L2R763EL[3&'-Z$I8Y[+1'#-B2E%6G+
MG^JO'))NSK'=['W^R#YGC'!U,?M<?WO3N?=Y&Q])"..1RB>U#;&$I.Y<-CC@
M[+6D8BJCN?Z/6ML^!$X<0<R2#J$N6SV*G#H[L5G_S\HOOKR =VE(;I&&\/F'
MH']659$%&Z  ]CT@C*!MJQ'08;+X8>#O],Y!NT3T\GIHC&BITO\Q-BAV0>G5
MM=;F,'!MSN:J>>@<C;-#VJW3>26]3\ W ,@.YBF)I=%Y[E997'I7PB#6L#R,
M+<Z=;G_';.6U??74F8N@Z'<3&U9$5OLE#,X3?27X\H_EWC&BQ=61-V(=#(^4
M'W[$BD4-DGS93KB)*GMX*V1HL>MW7/,!RX#0+4WERS&BR+LGU__C_CIG9SZ>
M,>+-50K <<.OZ4VD1P;6T"^]_X=G]H=E%5"J1&[!2I[\LZI$,MM$K!J"8>L^
M!? 1.D\T,F]%P[X4?S*L9#:I]Y)O"'IP<7GBC4KIJNT%S2R"/%\,Y"%&W]SI
M3P5*Y[_P:G ,>^:=! 5GAZ30,M'>)_X IC6%"+F8D3&B8CDN6$"M*#6XF)[^
M4OU*;1>*]\:,>J"E(_V,E['T=]&\&(?_Q7@/_Z.!Z^Q_=!;0V\!ADQM .^I&
M*[4J B/G.0K1:;F>*^MD\9NG:9]+^I6FT%, (:$80EKB,,H*GTD.4F@QWM(>
MK51DX)P;QPX[? I=DH^(N?.H[RL^])SFUK'K@D=G.3P.>%Y#=@FG%%;Z0.)'
M4E;4VL.";Z#9)%OX>4SUVQ/KS,W@5MWHM;!\Z?>!O+^*S;35FD<V__OI,@,#
M '<A3 $V"^%,[&9.G$)-.AW4:9XA"UU1-S9I;M!Z'L9S>?C*;Q\+L %)EH34
MDH&WI^+HEXQ\YY:W\?6=\$F\ZYD(PMU)"\=C[7F187E(%*'Q,MCZZ+KY[LSD
MONJN@/;-P(]Y,1+C6@K_46Z";1=>??8P$+YC@<8_N)7J^OD)=Y/CSLI-W$JX
MOZ,K#M3%GG,>8Q>_=$%CIV48^;CU]1IN^<6RUJ1=<*V)XL"5A!B6W^6<ODXS
M<+2E*R=+)P7 A#3>$[91_V8UXM5\AZSBB;?Z6H\?(=A 08VD*M!339$N/CK+
M,9F*]BVNYR;2CI_B<A]48JB4=9(G/4HFD)B9R=Z8NI3$I7HIIDFEC9&)2==D
MT*/2:]%QU\M'M_2]F>NEG2O#M0)YJ?X"$XKX> ([['LF>X@68+/IF/K/F9WE
M#2OAG7W^]>4.&<^W\^/>'4="WBST7MT](QW P6U14E+>6LS'3*]A/F-68PL>
M8*;%?;%" Z.?*Y+.HS?P+;$G#<<27*KQ'W5N^ CD:NJR[>+37U, S^#3:D8R
M-LU#]<R7IW]]?52'RN0.UOJ5K[3J:+^2?]DSN255M]"(($_41!?OG"78]KKC
MS2UAC,I6F176:J>CW'ZF,-($ON1;G#FM/C$*;U3>B5]"A-B)CVC0+^BY*92B
M:I>;$:9ILPZRY?)YVJS/E0"G':H9F6YP3+U\O:FH\"%=.6,VLJ-;0<BT;EYH
MQW$4[<%(U8'KK9*;/^++['#P#NSO12*A,?.>9IH"?]+N<K$U_F 9$2*$LR?0
M;.6P(N[96KH!;T=\GY.TNY_BD!07/N/9PQMDM=H8"W*1B<U1>6 _!N-WK=66
MZ1>\,F'DRA+$L315$&3/AA=;'J3?Y&/Y0S=GUJ?B9,X5NBU&<:URGF+F3M?G
MO<\7)W>3[\.$IJ-ZUT EGB_A_/V 6V6Y[.C=P6@*8"$'M>\+8^PA[K=2/9MJ
M^0A\H2Q'_$LSKF4QD>EDVWOK IL'C7K"O-J# DN5H^G+,)]5.!K\G$ITK?W5
MR9\A5)\(6*TJ)Y^'4P B0JX4P"-N"(E;T7V"8'"H8B_"4UDXKMMOQSXTW0D3
M'/9^0[AP]%LIMSK+X\5GDBM6&5N" R[!8Q TSXFGT.0]HY^+-K'^NY?Q 5>C
M)CLCG]]V<(?A8N-.O=Z"),#8Q@<CFDWR-Q<9XXOG;OM>,F;@^&WU%;_3HU6/
MKR0$N_!)-.%.%?H/+JY%^01K27"7(*7=ZR1.W(C3G$\>KP*E0AP9GVA]39G*
M9RT<9.!:<6=@?E!_[&&_4DU%1DA<38L/!7 NC * 3,")\9![L$Y(S7RGS&2C
M.4;!3GA<P7"6V3)".&':L"GG5CI=Y[EI0=%S%N\N,QFS"\00IT!UNEW4->DU
MPJ0O+S$T4P#K@RMV7]! '5(^Z-FGHU*H&$:BL_3<&P&6@1+_Y'U6/Z]?=ZXF
MV)S7IWU%MY;IDV^5-B98P6&->S9F'*^JO!DX&$)FVQBB2L^]^B]G:-P<BV:-
MJJ)\XUN?I_7*905&2Y]A/M8.HMVI)H@0]4D%Q,<?!A=)3K=JT;OI#O:&MJ:;
M_O,[DML.*2ZWMD+S9"= 8L@,D /)SQ871'C9483;LW8SZV077K[3.EKE,3#I
M&D)W*3>C5])/)RDDA_Y,?2"0R)K2";P,XX;>&U)$,OM_Z9P2B5!T4WU"7[0Y
MTG9ZMGNPQ5?@54%N=&UWP*%BK!FVVB1P^G:57.&16DV6[>=ZPY=1%$"D%?&!
M71,%$.9)7=-&"'5-78B7<&Q+8#KR=S\48[-?4/'FB&++2ISI_7[!(5+FHVDK
MN6L\I;Z 1Z].OPIB[@/CGB7&S(([]SB6R1W'<*)7RW(;Z@+<>9 ;*I2XQ(OH
M;/&:Z!BDF;CJT6P1P-C.T>C^-D+]%C$^[$O2#]F8\0IQ?:2SX,O'KHN+8OW,
MQE;UC:HR.)$J^&)%,S<%\' /=9C@[OI?$'8(&@P^49<YAS_QF\?K*I\,^,#1
M9A3 B:H$A "8HF[T9%DE>;B%D?6S5Z_H4=*^L@K5F/_4\O\/JXGL\@^H'\>(
M7\7+ND0Q2 )><7:L)^7#YAI!PG2N\UK/56[!YV@E%4L10FZ+*S9!:>8#P>J@
M!U(/J?;HZL;U$D#^<+,OGP@ZU<5G"EVD!]*=<P&T'M@<>9[(V8$ CJD@(Z!]
MTI+,P$UBH@]KW1CKYOX@\K^=_A434_EPUCWUQ(("."N'HP(R^N*N<A#-??"J
M,XP]4?F4S4I0[ZU:[X5MH]A-CF\2ARG+M)VN,J]1C%#]I:VE5N.4IP<5[B^$
M4C@20.6?M?FV)=!PNW$DU+!RDZNU4-W61?GXLNW#'R2'U%^UC:-I(ABD+BTX
M\^%>[O[)JD!R9EYC$)[U65X,-C'R__B&XJ[JJD<,[W9V'B6O+MVNOQK-4 N\
M 5"MG,=9:4GRP-ME*N$+K1YDX:+5I->%Z/RLO":9/]]0 +GVUE15^P.K9(@2
MR"L4P,_J?WTT70Y8^WZ29X4-;HDFEWY0T"]S;@QT_:9\;?8KAIWOPW7.,C8=
M-X7M]AC1(OY_Z5+Z.0P%E?F'_+:5,6H>S=&0+RRX("^J*<?*8QIX0;OE$D+;
MR,]9,[RS8>)ZKX<GR_-DL3?E DQT_(=K)^8*;>7/VO]GTR-;I<>BIONRH9N!
M%/N]8!4!?6QG_9OV2R\_[4W'7:@\,6UM$-/N=W 8TGU,AC.]O:?W7ZTM/V1^
MA6"K:CU/M$&OQ>[$UEDJ VS;(_E\OL0G%X^6JASR\XT1\O,W?9O&WSN7_/J1
M;FGUH@!MQ-G7RRWJ^"B8CC^Q$JXYAJ?N/\T$KGE."\='YFK]=% //G]7LMM&
MTHWGRBO2.<&XH#L2_=TC36:Z8[_]$QXT,3M5'[6/E)8;(_D)]_[;C7QOAF[0
MK<40=_[<W0)].N,-C+"&GFR4;Y;%]_B$RNF2ZKQ01]^/D3]M@QY036(LO&Q3
MOK(R/(XJ7^"K[3U<8D_MMP'"*%J8#%2G!5>/D>F$2:,D1<:07#[Q@[+:[5WL
M0P+F)MOU\V'% UI./T]FMEBV2P@*1^F_O31O:**X#$21SW$7_W=<+\-;JAF3
ML$XJP>5B? \6K+;+G98->;5X3;? (W5C-C:1HHFK'$]4!7YJP<^?T)+Y6I;:
M$+A<A>>^%(!A6@L%@.VF4I]SGRD Y 4@!: [;?4;&7AP_?"QB;)@L)UC/#(R
M2\# TE)W%HX^VKORIW:&71>(/:+*\"2D!M%CN#?%O2B*>9I?9+.A#'J>^7-Z
M6EWM\>F%E<]K/C AJRTPD44UG<R9CL SSE( HNN=0Z_YL^[5-#L&'F6Y&!K*
M'W1@C=$5?(JD?#)PPTI/J-'-1-HA_NUUG]><,6_\^:.^:75.K%, .RT$%7_J
MNR95HUM3%HUL=$>\@]7TJSRNCDD_3?R1$5IQ]_2=A6V(?#)\)1?Y S@ITY5&
MIB<5P(";C5YT;NEF-LY"3Z=*:L^]KN7[&I A\I.+8$4^_[@,>A.MAXZ,:19;
M@E]\9BTAV>2#&_91K<Q]4,-WQ4>'4U)C_CWP*VTAV^>6"DE)@6(>7B>%J=8&
M#0B9%X)QX//9H[4GHZI0)U=:OY,2R&=PJ 6G]EG[-K(2:MC']0&2+TCO\*0P
M0R#FSFF]Z>_QUQE._^($RENM.)/RM"1*>HB2>YR!+Y'490')M?0O3'3,3[DN
M(T.E-<P64=%\5XVD)=+J(3O,+',W#N3.2O8>7#1W[_92I?$MKS0NAS0G"]!#
M+IQOS#4VFCS2X%HV'R/30AW&GJ)GMS:FD)'U-E\,;=+B!9]AU3N-)RPY)9*^
M'2IN9B:&P)]Y3(MO&6%X=R/A2RH[;N&5#?F>%UH1[D.[3R7?-]?!;-(>YM!^
M )!BR:R_B"](A<D37?O9+E/=ZO%/3MR%Y(-;S7V ZI?](I)O]*C.G!JTQ@=A
METAUS;9HC^Z?_BQ?G=T*#"^\]5-6*QC?DE@Y:%!):KN1>T,HZGG*JW,S[U-U
MBCEN!HW/9HT^:QM*=1EVR<;J1N-LR/1A&'M+T:EZ<L@B 9[^(G-C[:WW>G6I
MV49_0D[J4<^.R$(Z+IA LTF^\JG%UMB(7;NZ6AEFUR:3JB!.]S K>*C;]<"F
M"UZWUH7@H^<?:PY&SG0I?QMO.#;R8,T >?=<&>/'7X+D [F:%8,6* "<B.24
M4C&W=ND#?U?CB%7ES>3(L$!$[C>B1$X-0N'AU-BA)B-W1U^VQ2T9MTE,(Y$%
M#D*/-LF0_.VH.E-T)[/Z3P$^56ERJ-CUHT4Q.=2%&2=RS@I;-(3::C^@ +2Y
M$.3S5(<E @K>(J4[4P ?,M>G68KM!T<(\N0YK3S2:]#O7J@1!6#K R9=EMB?
M1RGB4PGGN@]@75J">B>^[\T9CO8M45+P=)?K% #/SZ? 71S\]E'LPG%T%9&7
M:@+G;%W:GS:@:M%S^4)UZR^&^EM?Q&EV7(2?)V8+[ \JXA,794ZTQWI(L>DH
MO)8U\9,=*I[#=FU38]Q()X:\<=Q(O.QAF@&UQ9S[JHS7&%>JK:$ ZI+URO%Z
MKM_W-+B=EY XT97Q6$_@>R?E.+NE9P2U\HQ9</64[K(=%:G29%, R>'+*,+9
M-@H@W^A%8'H,/]J#R!KA9KE!++]/A/SNOZI"5X,0K<9R[P>'E%  Z2.-]O[3
MF^]@;I\3J2 F]*-_]_9FZQETGEYO<87\IE<W\V6]^[J< F,W4H![F402[3[R
M)P0G?APF YM= %_I86F)3-7*4(@]MD^YIM=V_,B1 FB]  L6SW+B9&M@QQGT
MG'.&5P[4_I*"N^Q%*\'I1A8KK$<9%BWJTWHK?]=$Z N&]%\.G[D,F+DA$0K@
M$#B=BP,2;A#-<99,(>@]TXQSN9ZKV4KS1C$[NT_%V5\-U:Z=_W0^*"@+;Q4*
M?WR,T=V> '6UF'7-HQ-O7B@<HQHA;[S'^]6.2X\*0.\^R7Q<<%.=R:D_'"2R
M(!81D<VT:&$*8"E[##E57WG#5GXF?%;PRAMYL1C97[4ZWSW[H:](0R9J;Y=I
M^ZH\=!EBRJTOE8KPRL %?N_08AEP6\MB6K.>B^!MC-><ZXS+\<\[VP.]DN^_
MO\+_9JH_;-RNI2X_ 5/<#HSE V)04<WZ^3VDM&'0+X5Y);]TJ SGK>T2]DC-
M,U:#H$OPA3P@AX9SF6UOP98LSE _*3'%OJB-6T[8^,S=S8<-:DEU++\\X^&_
MD)U4;]I%,,<9[]EBKM0OJ;OQ/)R?T<H-$-SP +Y9I[,4E+:[8P=J,3.;#E+^
M/JPSRD=O%5/,J3]?.OSGDF4VW6X/^H9SQJ&G5-9BHYO(3@>*AR B2\2)-VK2
M>!?3;3EOUO(VT?$.:+@U@+KU%6MD=O;7M8-$/3AVR?H8CA,Y :*[\6ND8!<(
M7LR5WC4R9-+P[H_R?7C227#5U@19:+S^ L0T>_>(^V1N=77QQVH ;ZP\S(%<
MCXTD7BYN?^,"885"ENCSF972"WO<Z!UI[<%73R)SIQF8\[EP\).)&0C: ''%
M9@/%0GR\N.%P?V7,^UO58\9?3#_U;IIL_LIXSQ?C6GL)_F3;?S(X1TDZ>/ .
MJ0ST>#!F'DB6=R&+UTX0E:_$#76X%5O/V\U$\X=?/%UH.1NZ>EM@@>5XZ]M[
M,KT]QO$F:'KN@LA'Y48JA3,'N25R02UQ1H3;_C%]$STPZ>$ZJ9OI)L/+#>-5
M]J_;-Y7%Q5M9)4,F/#BF1VBLJ/K4H0VU_ %?=/+OIP!HCR%$K^JB<A4)_?L[
MG:-MA "Q$>C$+@Q!#,2]+#<BG'?5XL/X=+46+EU@OY'@O">576B5.2IQ$I)M
MD; (_*X'#"C'_#GS"]'7BL0<MX.G0#=Q(C+Q4##FC-7[=JM Z$O;7W/^F3L%
M^T[G\\2>)'U\T/RU4/5WJN(^_'&WQ$,%5;/Q-6%'"XLLH(2E[<V2O)@MC7O_
M#G&<JET8O.*B=0;CGKBD*>PA8#J\N]S<",5\YE!B+E%IXVT3:('M0F4QV&S,
M[:]JS#&'#>=Z+.L,7S_\W:UWDB]"Z)M^2RA%?LW=&4?IH192*0!VFWL_H;KH
M)>S"EXTU@I61I>HU]D>U_(<6;_*9 ^(#?O5!AU:UT@4[@]2J4B;)3O.O_@'H
M6 E_^4D-!9K.SI4W@+$0M"G#E3K21PTG 2?VZ[_NHL#5MQ #%PRINC<]=G4$
MY>K!(/BC%%ON^C^8>\^H)KNU6S@*BJ" ((A("2I($Q"17B+Z  ("@O06%>E"
M!*1#@B*]!%! :I0B("72I8:.@-(A]!8Z!!)*"*3PY=GG_7'*>_;^SMGGQ_OC
M'AGC'O?(O7*ME6O.N=:ZYIJX7.M#NA_+0%5R_?O WE(8L^,(V7<1R-?J/O]B
M]'5\LM<]^">#*Y7?=@EIO.^P;,AH*!>1<+3HVV' XE=KP+-S$$A$7KWW1O!"
M2P70P;J(8/=DP 'VZ.+),%H>M]M=+]]! YIUJAB.,M@P+*OK_?.]_@+_]_9*
MT=[$B2*^XMQ?>4Z<QS3Z< XZFF/#NIB-J O:D(043,^[E(@CR%#4H^769]G)
MQ ;:$^>)NX[X!DS'1LY,Z7Q$D#(#P3YSB-*S?.G)<.@,E[(Z+V?<XRT]]H'T
M[3O33YMKJ\%-*C'73LH!,"5J#"1!*W_FR_J/'\"C/U!N:#>0>9682WI,!.KH
M^ORLJD'IZ>S3K9@+W#2="3PO5G3X1AF]$[:L)Q37X0'/RK$'%S%PW(TB+Z.W
MN<CL:*J>-VQ;WI^<B^RN_(49V4.BYXE"WMT(DG1_&K .O3,"]UMTA^U^?_UY
M)S@*''4*P!F"CU5@D: CUE/ 2' U%)U.5J>@9.E'4:ZHR,I;NQ<]W%B",57A
M]T!G/^=%)V)!N,>[QQ)JTJ> \J!3P,83V1-?#/R8O5']%/"<!*=<'3NF?2E]
M/ W"1C! $M< ]5,[N "J< I(%.\ $EA_G@*&W+0,2^%K+BACT$(2]'SU")2=
MB.R,XR(_D56UVC[[J&=/((K;8R,U_0F<H $U0V\;D-D)LG""6=7SNP/%<S*!
M6;V@!(Y)MIF3"7YGIYR\P?\B.^3I[V?5Y9?I+G7'ES9?(\OBI:)W0IP.,AC=
M/[SV2QS3[SBI= -W_6,WE&',QW6H,:SU8?,=^0[XU!6C$8G5_?O(BP6$)V(%
M< 7>&3E0$VI9;8CI.*ED,R"YO[QP%FS[!,WE:]0X\H1B,QGEH+:<296U;$[/
M]!=( HEVF'A_[\W=Y##4</+ZIPNRT# :I AVO2(6=1F0=5"$/93*UH$RE?$&
MM7()26FCW?B)![<Y5GXZ!31UK]+(& =H(7_*MQT4F7T35])\MA[U4;,YI:<L
MU<B8_=/+AO?'6MS=3\;Y$&3.F'8O6/=N.]:(!;82=N")W^I%JHWAP5A#6G?<
MP M3V]&PD[OH%-9GPSG77#S?^XQ.U;A&AVD+24A- I$!"D1A$M3OHE&VA-#Y
M?$AD08HY.[.9?N*[B6FTXK/8> O]X0N]": [:G>"%$:A;$&:Z$;@]T2AG8^>
M+^X5MB1?8.8-\6&)+843BK> 1"&YU*(>O%?GU"==D:'%(;6!-Q/*EP94]*X&
M.K[VI'(C56@H&3MK,4,=G1/0M?9/F)SL]JJE!O@SS<)F7A7FDKZ7I4],<[_6
M9%%($]<A'*J]RFF>IM HV0+"AU^,"(-@3@'1V0(?VRWI<<$5%T5>Q9^_NGS>
MHB#]@:GLB_X91WKV%IPR"12!^G&4_7:DS$KO[6-U;[EB:,Q/;XC,3;7@@&!Q
M_Y?/LW+*WK3?*18ITBZ<;R@_[M,ZWD@GH0F?:6T+]O-Z0/0*QNR&U5?_.0S+
M*F_*>))B7Z]=VBTA>$5DH+?NM1RV!?C9CF$-/ EKG6<B.R_%O9Q?JHU\A=M)
M9OZ2U.]41L__JK-%3%L3 WD1GZQ39<\@DJ9+9Q3G-)R]NT,:R &Y(B<+6DX!
M9TX!]JKG(:S.<P[E_B63,4TOMZ,DOYV?\Q'_>>GF*[KR![QG/35=E^!GMTRI
M?/C:B$/7'ZOC[8:U]9\T[TVS:SBT[+QAAG9#1[+9B"^6D!_J-;/PPK:ICW!Y
MOC5[5K;="I&-?1SO96<,*S])!O@@^T"1M@PX#EB5!C)<A?7[GQ+BS<V3MG'Q
M797'.Q5W'KY6&[S'G?D6PSD04?SGZK< BQ2NB;'8HNEO6>X!:]@1DK&?#"%V
M..B&V^+C:H7EX6]U21C2P\F7UQ+M+E9%O*:TI]-$8CVE'F4/.T_M#S#X(!DD
M+OEMSV7$NMN#\M6S(E:S/'GJK*3:<0\R$WJ5!I\,75(\SG.<N#^%=:.[/.$)
MV'@.WJHD.18V+>'W!@\8!?BC)9FR,.5K=C<L_;*UD8%Z\?K1E)NG@'!AXAD<
MPX.*>F+=$AHU*OGS[-)&Z4T?WMKD2^ F@;>"Y9M*5S00VS"2/'1PRF8I2 3_
M*MVA]!+4*7Y\1YM<+0SH@WB0_J1A!)!UMRM/1N4KRU$$/>^=62^?YH)5+.=,
MT"NB^I+4NV:E)APRJC1%?%TKC0//_K(NJK+&?,!;H;M0(/2]-%B3VHFJ (?"
MG$ 1:A+CC0].?HS>GVYW<^-'*'5=\[_199S+[@L$N\R9V%WS:HH7\].I=JF7
MML7CQSB/UOY>MP6%P2X$B19L@8$J5LPIY4$9(W]9X2&\%KS(GK3;WABA"T_]
MVED,8*S;NB0EL@]N=G:@G2^XI.SY&>A(_J:>SPU/-</[,C)W&>C??1+.O-ZS
M]'75IUNL5*@>Y;H)?6DV"\/I(R:1K4".*AO7KFRQD5- 3=E!TV.+J0D;N2WU
MR"2]77Z0'S3H192MDB-]4"H&&2X/8Z+>L25*=;+<3-5'Z;H6880,<X0>)S-2
MK\8EO^MZHP&MA?ZBLA*M:/*2?NOJ/%.0NE3D6XMJ.HG1O1G&6*_/@Z\97BZX
M,7D,6 Y<L=#DWV@V"UOKD%5+'22_' 58;26<!R2'8/A81\A46=OF/$IA\W7R
M65SJ>[M1M6O$KN# CF$79UY"DBWCPQ:CA]C:/NL78PRV,M''D.'ZHKYTT6S-
MVQ]S#3NI9_ZVTQ7Y9_6P;U=1FJ"%9,352P0U$:*7K[2$NR:RH%@.JBG.N\GZ
M!2+RCCIMMJ8:T+U=C%>F<K)V#USP"[<(*C[C)R&5%L]A]8=4=^T44,\#&SOG
MA8Y0E8/K2I4>!OWE ,5(**7QN*]-WS\Y;C]8^#>YV)EK(VJX@FKCT4.>8*!>
M?7-#\O.JZJB"%+/UR.^ZT@3 ]<!BQ@;QRGUQ*E,<_OG6//M]"&!*EQKQI970
MT/EL?-/^G#&<\')*B^+C0GQ?CXQN5OE)1.!O=32+UUVJ<$'OS=YQ&[_OH'R%
M>K;!C'I6/!F9E\NOXWQK;\8>4F*6I?_WD5H32_^\-+R5.R\G :@'[0'5?"LE
M*?6>W"ZEGYI_]\TGL>2K^-K48W^I\TM<V>N/Z??N:DL<0B*K09,,A*1D[R:[
MIT-5<2X+*>G^!<$WU^L6CKO%*N1OK2K7OWDCOK<4O9+-?R]HR,>Q5$NZ2!]1
MD6F<.XDH:N;!S6_[XVXN@=BL7.>XQZ2P5*<RH(E28V%[0A_]ZX6[VZTRZZYK
MD"F:.MU#8!R2Y4,;N2%>>40=S5/ DX:Z8TFI%H&PJ;QCCV5';J$?==._0'Q#
M?]W=E$K7WZZO^[3"ZJ@O)O[K@#6$1L<AS>?)QH-D>\>SLSR,W.X25G3][T;S
M(B^L^Y2W;K=XMW*>,..Y;"F?8:^SI+3'JD\!W(\6LUS&0:*2DE(Y(U)?G^SL
MO=H/U5Q@?WSK#7U6Z3XOU7K(Q"@Z\]/'2NEVN_R'+!G1G\":T'>3SJ *@VW4
M6UE2< !FR3=*XD*@N$9=/,7TJ8+]WMB-:RJA-UXJB">=\_E#<B6K$;$D!2)2
M$Q]?;;<P?V5S'#TN[4P23KZBW-P_W<:+LYOQZS%5 +P#?QXUA9G&-@O[0'B'
MW]07T.><\,^3KA'W'Q(=21I$QPZHT*C=\(&K<<,5V\<EK1>M=&(2OAO<:?$@
MHA^1@H(,<-V=R/BK)VL?JLT/LT3?1DK$=1C6G[G9(VK?7JARWG9V:_5$'.;0
M5*#846YD[ANQ$1C1%-Q'$J#.7@>])_,!VV'1'CW>BU5QI:\/Y4*QHGP-0=_F
M_'"Z&N\?",B=F8[+O;7X7:1(1Y;S\X^)HD7' 0/JF1-0,74 5KX;*\5C6TF,
M>O%E6F?5= 2K\HB><0!RV][Y\JLUIRZEMTLE1!+A-]& I$"6^=@*II=8&O46
MB%NV?A!+2-FKM;!/>53O+/U>^N>;,P*7S%:;.-^W2U5-:WG]SGQ&N#]JM1EW
M#ETMA ZO21V)>VY-^6$;<1.L[(._O=B/G5D;1VE2^:!38$:4$R1\8V$^;KRF
MYGI*IX5#8U1<5E]82[;H4P=&154?C+ K[P+4Q=!R-/=ZE/#@<KN=V(N,FJ*=
MM!-%"$F)V@WE&<T==Z?>FMQ,<>G%//G8\4:/BR^ZC;Z@<'-R@?6I'V2:CK ^
M%.2\4$OTP-5S2P3)X6-<9Q_3V(M0[=.SK1"@26S(F3L<"VYT].CV3Z8>[7F[
M\EXY_K%UO*+J&JK8.NQ\>03\OE0XK H<'J2Q9*-^O_3ZN'*Y[.CWWX664W_9
M<ESIN\NGC-;X_]N/D+_[L>^PB&*S>&*[^'?FO/RO5C/.!1?3\CN*^&/N&K'X
M.Y%_Y[6%7]+$G]<E?EQ/S[N#YF)^#U"\+(G?ZVFX)]M A&!V6?V^]4EXY8$?
M!11E,IY5N!,Q&2(6'%7RO3L[(VKR0PGN,-?0%P0=S[*8 XZ[J6CE;)Q4?\@)
MY"$Y[7SY]-9O]I$X5"#44G9?V0GZ+6MLD-:^2_^.H<"CJ?2 9W&R\+[,07['
M%A3.A#7&K6!=C9OH;2\I-,J[B=XL0 @Q/C8FR43Q;%U _NG"QF>)3\)>LT8A
M<+1_NA/DFBN;[NJ$U2R?T@"#^'(KZ4??=J<%C7PZ-+HTQ["RZ#@#TQPX*<VW
MC=:KZ#HY#&T8/M-8_W]:1*GJ1= Z!7Q,)7J< EY$PM*0(ZBI8L+/*DJJ>Y L
M)SK\&YZ5,&Q][[-[![]9DAWO"H_B?G"]V:KP-IQ&V:5Q\]3VNZ< I1,DE6GZ
M%' #& X\[#.B^E2OCD=G.7T+5CN?M[[@8ES0] =.#)1+ JUFV,(6)D'$L5NP
M5HNJT@*J1/4:E?DC\$0,I1#':SIODNLZL40=[SHBLQTP8/U)3RVI(^GH"$AI
M(T@RY/[GV^^2K!)!:4W)%1<TNF>1B,(3;V0ERAXXL=\&XH,"B*F=J:> J3V_
MI/Z=O>&NN:Y%=D5N"8S?:+%HC]0-/BW+H5Z.&\N>;9R53..6/=2(KOMFZ[1Q
M_!(5"J0_N'@1%=\L4\LOT!C1KZ0S3\F^ULU]H8@TZ9,9UQ*&K6WR\47\0+88
MQ/-?K4<1S9:NEO^$BZ0JN>=!OL3K]]WW3/$XF"D=/-A"C'_=4THQL2D=(X&?
M[?-'S^'1H=X&$;;WQH-D2O\J=PDP&9FR%F,W26.=,PHHVE159V@6G_V[<&ZB
MW922)X@P1S4'7VRM\3R^![[)D+WZ_(S3DM&;N]?L?PF\ EP+C5LQDH;+!/ '
MJ\CJ)*M^,FL,&A7?-2 *3H7C(SHNP]:ZT*< 36V;\'*<,$$.YYY#Y1I7T6+:
M\BA_K_UMW-'YQANFQ%M:I+SG_C="6OG3&,9HL9MT $T>+7%%>\<Q6!I<]KO5
M<?4J]IO-_>A]2>[/Q9QGK"^W%"/IO>GH5#C+V9+E:E3)+&"C^)OWW.[75M8=
M5Y*,/4B/@[2!A_P--,D>WEC6%$I(JM;=G<KH3AE^I24?Y1@7G<G+_>--H#?2
M@U)+^Z%2=-0!$.M;9DC;WN:P+=@%89>*/1(7NT!. X:PO?$,/2RK-KIK&#.;
MK?'DSJ92M>E0 (++4#<>E15<2U*C=E'IB5DDR7GR@[&5,;1-;>C31-/Q#5/V
MY_.5*Q,&N/C#?)W$;V7] =><EUYA#+X5=+PUL\=!VDQM58C5"[LL+GKWS%U.
MFDKC6M\1M%=ZQ(HY!7EYI=?&FP]&40OIS2RUQ,K7T/GOYD&*Y<.=*^0C7^W5
M <]7"?ZZMP?9."_+R-T[ [#S,14S#9-W<'M$9W:%2RR8+^VX<@OL1F0E=.&
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MU.+ZFP"_;#1^GY][>!YS;BGD+.^E</',2T4MLA\7$:&G@ J&UB9W$+N-'\D
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M[BN^(/*%NE!Q" O"-:&/$;-;WJX6<+DXMDAXZUN>;7-5Z7!>Y3&66+<PC8R
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M]=7CWN(][A !/9>YNTF5[+T<WS19[89_V%&B0 X2YU)L'G6^]/N,2VT6#./
M%)[S05CO@R]0Q\![GD!VV+:J[RD@E]G?QI'IRHKM\9@9\*&L8--[][7-@6B0
M"RTW@"K0(6N#S=?C9,Q1)A)NWYSNV(=;1 *T/=[>X\E9J95) '1)@S^KB>$=
M<C$0+A?HK?%\*ZR!48-KP[>@[PV5[N(A?K8>(9H,=/DO36G KG++&T_7K<00
M_CKK9?VXU&)YO";WA5=O&B)_+3@*3UR?RQ(9:JQ5D+[6^[E'4TY;(DD5@Q'&
M)F,04[HM*6IT_'S5/V*PT@."2DQ/NI9O)I3[OZK]Q<@,-P'K[)\"F*F]""ZR
M\:\:($OC WJ$C^ZT7-5#A>X!N;%N5:]X@WQH%/DAWK%]@$@37,'7T0]POP.R
M&PJ1DU\@*>(Q1['GDUS3:E*F+H;&\EL8 Q2!HG[%5"9_O*/E_A6=RD$59382
M'.*TKY,[T_N[@$H$8L(4>W6/# </I#F<VDR[C-U-)X$NT&X8D\H+')+@^Q.'
M@$L,7^S\67_74JBW_V9-(L?V3!Z\V5Z!_G @@ RQIO("]ZF!Z&VN;2D,DBM(
MFWBFR.]CEV5U?V4AV,77[=R?MN_4%</+8F(A7Q\5+P 4_T#5I%QB58\+//>%
M@?;J[1#5@5$$452>G(X,0VW+V)\"\FHYCUMQ"*I.:BCL'S=RAU%:_S *VG.9
MXSR@3E:< H8MMO9#%[7(R5+G3P$3#GVG *U\YPCJE>//J^#=1-TJ@R;00LD,
M$;982PF:.P6L7QZC88=6^[05^!P1U<W^5RG,-^A^H?5>SZ7'%7<9AM)-?AW&
MFH")XO+D$#4>&'ILE_J.V0>$TW5SX!D("2"DEZB-V97UVC \1=(+6>%OG +$
M5M";O=U%G%SIS>XQ!VI&1 Q.&(/N,HBVO8G7S%U0]=S"^NI+A(IAPV?-(W,-
M&T*N .,-C+2[B1"2,AE&M,+$\70J"8=4]P4_TOMI@>XSX7\9NJ\)=3=)%=-Z
MH^=C*T++B1^"WN+@48?!["=;6M$DO8:4_K=NTNJL/)_<93:K,UC)'!\Q;AU1
M'&:6*DG*YTSTI'79]0%T*MD!9D^":X6JRE=US*5<L;SY?[PV6(EBCN^PA^ P
M-2Y\0!N7X8BLM,/O!Y>>9\L) JU5G.%/:DMEJ(RT( O6=OT9/06\+J!&6A[W
M$=*(3:1'Q- 6X 2*HU'^-GQQ.N;GA#6?8%O<O?!7ZB*"CH!,;P6U\.8X6FL-
M3P$]XOA:2K@Q;)F^Q)&+5S5CT]>PB*DN*?.9I;<: _$(3_>4^!4?V@F].2HI
M^-,U[J%]K:EGFPAG;_=U&A<M9-AT18,6LO@%&X9@+C"6B>D_@CXG3=4K^;]=
MWE3<M&KL2]P>+"*+KX'98;\ZO\/0HZ@3;N1;VIMAM#?/^EW<HGWF<7%.&XE/
M5"_[??;O-9_H057YG )PQN+F-!GE1.**EC7+:"<,Z_0J.NP7/#58^ +E/) B
ML^>"<-\:P5N4>MA!MAB.%BPS<J;MQU/ RY5:ZB=K- K6*F9 MD!RT8::WRE@
M0\6D&W3DE-W$>GR]G^JXJI9_"KAQ$7&R.7_"]OW0CA:'A# TQ1M"N3 6<("I
M4+.$76$2R2D,^6>+ME_VI]5&C4X!G%(W$#\1%8@.36(^"404[V#_[=@8>*ZZ
M(3'>HN##YSR[=8N$6O(%LU)T*PRG XX\3VIMOH=[O9LZ@K0;Q;;S^SS)X&6U
M=WIWT@/V/T)FE/)K5T&_OBO&_AA$)%09&8T+^_T[;M"Q,F %Z#Q-E\/;YR<1
M':*7FDUV?@ZM#SY?2)1\DHL/$P+&!?/.BN\;4)DJ\1?F_?I:YRZ&&\QL$#Q=
M4IE8F05+[!X$C[VT.P6XB>>R\@=$\3O86TTL%@@U=[=6&6H$ [\>)_POK]7Q
MF$I*P+[)B:]B:1RY;*C>[?*_BZ+HI?_!U_B?7OE4M@>,-/3^'P]2)3I$G^D^
M7GV'^ '&Z:,B([K!E>X?'>]_LQI@F='->VR^9_C8#[5P4Y%-BQ3>G(W\#28*
M&<#C4_%<G=FL:7B6TN>IN/,J_C_N&A4?:FO_[7EU\KJYB83N?WFKQS#WX'<-
MLJ:MDS"8%.VTI5_F-?+O3-.Q%?\!.4M%%BP:M Q<(V8K!L44*S/H6LC$6FM'
M?@4=X8>;1.O-VN9Q)I!(O3RR*@X1NN@I."Z53?!^-B[" 2B8:/P.PV:Y::H<
MLBMXC 7'\WMIK9HNS0:0#G/BYYJIC=XYS1_=6/NRM_]92/]C#>KS?UN#"G2L
M0X[.3^D20H@0W$,8:P'\P/G0;#3%IW+O+;&L\4<V."UK6VXMX.T6W(5<04FD
M$9]5-9Z_LS=P#6P":[4"+=_ M5/K7,#]XXU3@R;B77=.8IDMGK:,%G&.[L"Q
M>)(BAOH7:9Y\V0J&?PMK#X+V^ZVUHIN.J2TU!S0J1UY%2?WA1([=F,U$3',>
MK8 ]-A%5NQVLS&1#XD@9\6.;G*>Y$Y>S^P]UH?H6X[P+\#U1 ?M/!\A!(%%H
MNQA"DM\RJIT%7YZ5)DM@_T!-S#:UR%<<J7K/.D$$[B8:XIB+>4@;YB7MV)H9
M#EQ=)<GL^RYIP:NEHOF5QLG/2@P$CZ;R1V;D/T\W5MOM?3DPL08P/#@7+/JW
ME1O^W$X&24.O0%VF-#L_3S_U\HZRU0NM1_#=LQ<&<H&6QU>;"VE9S 76,VA.
M"X?D[BE W7*JRJS<:;FUWX"'&VSZ"[:0=_7-)'4T_7=B=_G.6Y)HOH#G[YN,
M"%@R!Y3S<*"K5!\VF4I@&+F/9.U]2S&R41O0U?U\K^1V)D/=)[9?#I1C>L^+
M9Y7,>E XH]__<+L"GH1-TF!1 FP.G7I:V\DZ$:B/9_G\;4=D:<2[I*71_\D[
MB_*),Z+"@W0;UO>(SO-V4P4[HYV](+9CPX\]('F5;!2-J)=)@W.!.!U4M%)\
MKN/2P!FPC6IG<K16T<90@V./Z<N/8FL)>9\S^,Y(!GP$9\[-_MRB!HOOLA*%
MSK_S$(XG>Y<>0PA6P4H\4C) 47^A>7B+QBD ;F8K)CZIG-O36R"RA'$OZ$=4
MR9.S4N-@VTXTIJR%GJ:QZ:!30-MG7#AL705TD.U"C"'$?[:DCMDJ)=>9D_64
M@5\R9(]8R9RF7)#WV>RIP ;P93&9@"MNBG0'LK%56>)9!ZC0:)#DUJ$!09XV
M>,^-@[;0%E0CLQ7?,D7.DTK2C8U*YU/ #V9,?Y@:NF"+ZP*K3=[O+U1E[1,V
M2XR<;8&</M(40BHA[U+2:"-XJ9D;@R0+^@!/5,5W$$0Q9,?%V2LMT,NXK+P]
M=;<R&P,O_Y5R_E<^FQF&(9OYWYA#Y^X&FK71%+<4.=.L'42Z1ANY%/[D0P29
MDP9""4%R:_"*>=CZ4^/1N*W6>[CA-RVFM6^#Z$LTU?N5,"J.Y+\GI V(6@BB
M-^6($GV"IL;6(WOQX*)3P 74RC6EB/^XE\M9%?RX%RJ&6G3LGO^/6E@[JC\8
MML$[MD7+"N!(R[@!.%EBX?-:DNIMM#YU+(E3P<(A1?N647N=221FY#?$<@](
M%"Z@Q3X4MI5\1$W\8P,F<])1]770U):KJ!,Y%U[C<C%*](=,SQZ+W5O+T\J3
M!]._)+'V@:[%OA8OTF]/#55DOF=]R?IH KWI2^9@!Q.U079-PB9-)O)NO@6V
MYR_&52C=%70L8&G'(WN_4PPI/XF4\ -K[U- E $U1 1)UGE]#^MD9E#>!FL5
M#:)SY4_%P*[WL3=-Z_'#W5<T[4P,[WP!:DIP4?!@;NH0XHHL, 9Q7>79$L]6
M>+9<4]+%^S,Z[6X\'%$<;^F<Z#%%=P+224@JH^Z2E2L\K%D61_3F2@EHFU=Z
MY?AJ,,_%X[#6A8PEQBRZHNB(^QVVP%&VI",]5/KX PQ]<F+X[IN T/7@]7QG
ML^3.Z*"?3&*J^G""/_%K(1E(;%U$L&WL5SDS3VGY7GMYU=7Q>457BW=ODJ;?
M)0X"LA&U4(S8TR%STC)DZBE@B!6<!60A2WAAX/Q^@0^JWNO&Q.E0>4SBI??Y
M=LZ</&?WFKA$0 Z!B6+CL$43HCCH@!M"N7Q@HCO=7N=G)E5H%C-![LF)%D?9
M%O3_O8'_\G^&TD:4^:ZD:(9E* +6*@Z]R>>Z"(]2 :HT?!O<35D])WSM_:)V
M"__[Q\N*IP#WYB7D+RFB,! ^$ IS5E76\YUV7.)1K)JDXZ=[M]H%;<B9 ,TC
MT8D4\37\TY5":-0G4\)/X^RMASJBYR0\^2?^'3(1D?^2V-<QGGT1%U^[=!%3
MTZ=;F4Z >NQIADT?/+.2./("W_E[6:E9H/;]*<"!1%%BF/1=$O_UMDI\]/:3
M"N!7\VA82Z>SOLJ(H2*>4S5.U* "=#M(%SGGA^RP+*LMU%Z=WS3SG+-^'%"5
MI.@#RKC^)Q>'U0@6&S(G?]/K^=M7W/CQ?]*L)JWF_^F(!HZ0_V;QH9YW-R?:
M5N/,"Y'<:HX+_]>6Y$T&PTG1#X(/:<"01XQT"]+ @.@&1/=VL)@QK)TP0.65
MEJ3JI"V01' ]2 "XXAD(?^'Q--&@Z<=CZKB'?37*WK;\,6RO#.39V93ZF_D4
M<(:3Y-\', GA7+2[U6>T571R7M=JZL4Q<%*0-DXB3_Z?'\;Y?W+]%S 3XI:Y
M@'&P"S-,,E _1+:< F*@=T&7H2)^E1UU=])KBCS\^6'A\HG14@L-6HO@:E 5
M(H;U'?4,D61IH9)6>N":2(^83<:(<I\"FB==<<6#+YNL+T%%@4"$\3@'Q3QN
M/%H$:?(ZR.]?;7P2/^"B,BH73CGO!1G)^SZ=/D_M8W)(N/T&(C..4BLL<1DA
M)'K437_H"#:M*':=. 1.)1EG$.*(B8+N%;=<:U_=2U"G+*ZK(R5SHH?%DP6]
MC%-59AK"W@)9&VU [:< /J)O!V'(?W_])*SII+VQ\&-O(OB%ZKLNT/6U]6]C
M8U&QF9:N7T]6\.*M(!::COX*OG@06$K7*6I?[(S:N+K7=55[VU8#?(\G\B)=
M:'6PX@/C1'2K&^W!M!.N=UXE9"UBD5T!T7.R3W?9JK0\D4%AW][S<K;FV5I,
MMAI3N+/$BL5-GV@-1;.'ZL#((LG=,LBD[>:2:XIAB$-B)KPC'1/'V#T;6P)W
M^?9"LY*0[%0@>41AG01/HC#=-"#DV3A!AS:>+2KP\VUS/I??8,W&X2O]$Y9]
M=\WK4JY]QJK@,F4'!@QR7HR!GR.V6P]*1F?$21)<%;D?BW7)B]<9O'FXS(96
M.XS1L!'C_U.3O7JM)+#SH;1'912)$9)'O$)8IF14Z?%5=VG&\UBL7GUVH_Y'
M0[QJ;,4M.LJ:K2:WE< ><] 9/&BA";Y-(IGX@=O&KV?69WTPF[+OM;'>-CO.
MUVNM6;AT#]6L=((>,#8J4!]Q']"TO07D?1CSYBBY&F5W\(S*5%MDZ<(/)+Z1
M*%O\*>X5F,CQ+O+XQH'L/FC;G_1$FR1'_BM]]404HB)>G#.]F3(86X\5S/NE
M=/6A5>B8182UV;LAD^MB]RD9]XKC,_$@B_!8&L*7DD3)=RB5[JA%11PH3J(*
M^W+%#.N;[AE3N-9RYLD@EV;\ P"?,?[7[0HH![5U[BPETSL&QA^DB6\J^W8_
ME>MJG_]U"XMV,43RM%=Y\KLI8X]]NU!PFD_MQXF^U6D]H<:?7<3,(G(GE[R7
M[9-7/].U5UK.K;SLIBL0' >;9=49'RBAJD0421:&UG/UX,$3&&&=\MT-Y"3%
M:>Y$Y;D':^/[VO!94O 2PCWMQZ5.EKM?+HG<4GCIU\\P!,+I8/6'NQ=]8X=7
M=WA\W5Y<L'AE(GS$.&BVFLR95RAL,)F;G?U"84FM7-;'B1@5ZA?Z[%:">[X*
M+[S9=0;T/#"R%.9J<+9/)>J2#J16^]8Y.LI93!T245B:S^^DD&E<'*CTO;3&
M5XW&Q]\CP.K!I+^<C:S^\/UV79Q^8RE\Z0P7EV \<X \F7UW:3>"#')=0M!O
MGF0U9Q2!;3J#7TKFLY7V/[/[GO1@1JZ 3U][VW5_+[IGJ$G*T:M"8>V25:<0
MZA%V=UJ<((#K;C4XLYFMB*-6%^J\&OWHGOKV:=[37]UB>8!N5TY =G=FMNL2
MT$6D5+2S3<Y]34ZL2MP@F^UOF^]JQ7^Y/%2$6LAHECT%?# CI):/9.%9FEYX
M%/#NR8M%C5*\6$ +)B<[XKAG"P/1 ^^:)8CR'><-)%65S:I_?EKCCK,W6B!Q
M_E+K0@5@UA)M;\O)I3O.+)LH%NKP?5[4U;/T]E\;^7<\&R_,BN-!A'%\*ED8
M6+4&EV*K57<,I*1=&P!8%8:5GP+HM$ X,<H7_%4D0\0!GY9)O4)->4W2ZC-J
MKZC="1,5>NAFA+$:0WKSU.Y+[JSZK\)VE<L=0%&R&\]S=Q6!X@CCJAMZ <FT
MC$A@C6+Z[P]4!<:+Y(XG$$!64"X:IQ)?G)^,:>.7Q:>^;U216,*M9!'RBZR=
M'SH*?7FXT_JT4EHXDZZG3)=Z%;W]5PEH4$46C0IS+R>> G)I_'A+Q>H4(#)6
M>PHHO]EW"OBK$YQDB]#9*WI&:/S3LSY0UO6R^5M1&\?23LHZQ6A8A8_$&V1?
M?UT.SA5Q/M=O6B!\RN)@8W+Z2RQ[1L;0 U4ELS^(ZOEM'G_<([V,SF;6NGIT
MD$#9N;&F%F;O@O=^#F* ))5,]Q;QQ,P]U^7+.GLLK$\#HRDT'?<>2G;.P'2W
M4GQ;H7<3O6.PG%=[P=7VZ3MMK^S5;T./>6RN'?%X]?34)Z0 Y_37V\(L%3\2
M9-['UM^'&LL_H\(&%K5M:KN0$7]P!4OH&!4A4OO5CX5]],S"=W!K;Y\$]W*
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MDAFD=T^SY V 727:2A"S$QTU'J8J^,?I^=:2R8;F.IG\!8JP)-%AS,A7P-U
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M?IO\N'UI<#D_HMA"7E^^?"^.\^3<H@%1D+)\XJ*W!(J\.P6N((^?N&<Z_J5
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M?\V#-L.EXP^)* U/DYQ-;6UE\T/<Y_7%#9U/&_NW!T9. 40?WU:#$[Y&W5-
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M1-3BG^.Q[+JMXX1#9@'FZ:@[?Q1'\*X514*J]E2-&GBS.MI%3 *;&GD/?2K
M<4?ET:-^!Y>M[:R0 4S  ]VO&N<$+&-;WUJ]GK<_YB*SP:E:*W$TP,8=5FH4
MZA>!Q+Q.YB!X=Z#/;XJ[-XAA,TSN5]?&Z]PS#^E]*&C3'R]_JS(9.!,L_]EG
MEW&_.K*P24TB@@;8T5?6_[N:@*+P[N^/_>_)':3\G36W]:*RLILN6[?\4K0L
M$_O:$K4$=[S3IO&0-O!EJ!PZ\Z!E<I\8ZJ\,>URQNEOYA+#(EQLWP;##4:6I
M8+BH(#D>IL%6+).'>4:I12^NJUZ#C_T"'NER0/Z7"J<A_ZAPNI I2+A5C#OO
MNF(ZNL\2:V)4=[V@H3Z^X?O%+R>UE/$ \ATJ-T&O?+[4:\R\WU<D0\#XQ\SB
MK+FF78I*C_ZWUGRCCR%,.0G'J@^$":8H]\$#U3+Z(W)QU*LBVC1 ^<LI&D!;
MW.T/8L(#ZQ0&=P-/=,##5$4S3" 50^^1WB_[.,UL$"=9"BM&DBZME/%YJ5\Q
M64Z-(?MB01%!7UTS;X]N^VX^N,&YZ@V7UKG1P73=2^]^[]W.VI)2Z6<- [YG
M)2J/:S<DGK\B6$YI#G3S!!5?>'!0TE2VI*OQ54D \;2M[WLL3FQ@'Q0+GT^C
M ;A\^(*"W<\,MK8K0M(C/!8:HB:B?*<)/?-%&_?%-L#F1Z%$".7C/?@$5S/L
M!F&E;0:L>[5D-%W<0FFS1.S-.5N#^[N"?F<O#'0;&3$60[7R8--PWDHKI0W9
MN8L>@J$O9PZ,4\:D:("Y[AN.F"9OZT#"9?HDAXE:JLE%D\&%;AV7/^;4I1[H
M\WL9WPTS\!YFU6O)&BS5]_K]QYU7CSF46%E4+:&2X($K:!/QB$)SD#6PP2QG
M]QIE=^:CE32QF@WU/D\33A;_M/W*$IST&Q9)G0ZG2OH_/G*!' %0O1>FD2M6
MR(@F:=)N!S^?+J,%X27JJW/YQI1-H-_@0]E7R#OR\\85>3#C.MZ/4-N"JU^#
M?V$Q'@6DL=4#,ELAW9-]), IX0AJ4CODHQK\TM ^M6H\X#:.*TZ5=W5W(@#2
M'E3VQD&Y"?IM]4"736G^?-L%Z3 &U1&C+VN/DKF?>UYJ&2$F6EVPH$,:<8R&
MR*#W!" HR&4J%^;8!-:ERCVD+/=U8FK6RFSU@#AD57&%>U#RJ@+W(ZG]YZ^8
MSM5TFI/A3J+MZ8))=)3O]\'0%-<]4#B\4J[-XUU:L!G=H1W%(9[_@FQH8TTY
M$,:7:AQ.'5SSGLVNXM;52/7QF2?X_.EQ+?'@CH>ZDR10Y-.$6CPZ\N;W= /.
M@9G %+;*!'8H;MG!,/X!8]RT4^DKF2'R0U(RUB,J#;NN*CHJ+M.H^Q=B7NR2
M,=*2#RI/O.[K1)@OBV3+Z6MKI)HD91RKO(T2*I;ZWSX54_CH,-=9^WTKDB#P
M1.Q#=4UY+8/*HMDP#? G"_+9NNH@G,SF;[ #]<5M@D $0H$%)H8&\#(&'AO7
MWM4Y>$*4^N2%G8>EBBFFDP8Z"U%(D,;_1U+^OW SU4JGN7LG=N!D]C$3=SFB
M8^*T+*A2)MK"%M1PYM"3!H@OWM$AH:]25.E=4.9J;4*/!F==#FD 2-DA/;9[
MS1K]S0P_?&.]=1[VYV^1R62">^"U["B12OR_RB7YQZ6-?C((/RK^ QJ'SX<5
M=-  <2E^08WE]7AJ H.K/_X;CR/SP\[+_ L9J0)U[U>'G12\U+K3!_*$AY[A
MZI4@$R@JTSK6(Z;N";\ 07>QZ2)^>NV[><Z#NIT=:;)KB4;*.][W-HF2#^,?
MF?1S 2O@&W#\I..0LB[VO.JQP;M#:8W"@(3V%A#W;,I6.ACJSK"L[-,I0[<V
MUR@%,AX77)]"1?%YNZN11/N:T9?NIKFYH+M3Q2>9R_JYRX>E8G"O0!E(_\*N
M,J&'OJG2R0E;H\7O?_9.&.;GCFXB\S-O4%[#6*#V^(VCU!8(>V?^M/JK[^-K
M#(85YV,V$LQZBVB -X2DG<QD/&L':RCU)@F(<T.QD+)_6<RV[[8K!Z?Q?(R\
M[A 9P1,_3^Q[<.KD61:\/W8[ L84L TF:(2+3_(4!S)FO#0]E/-DDVN_ME5R
M1B7N[+77&I/(:O\.3.@<K^JY5;955:$?-838G$>%+J/EK0*]2STY?6]-C$2X
M)Q]QV%[X\_HKHBI'AF=&6A%IW/$T63./J7/+:26/XP^:$08@87"_E_-<YF<4
MQ=1#%.\E+CG6QIV/:@L3"&3XS/_IC\@'0L$[&3" 5&R(7ZXZ.>4Z^6+3PYNY
MZ_OI>-_6DP_((M6?%.3G#-M]EK_DC\:T9U>2I1?6Z50<D*357]GU;C*SR)\C
M.??% H.NP+O[IGBI7PHRTU!'2@;9&W]NE:$CS5[1<Z1A^WN@G#X&W3.!WKH<
M$Q@Y5A:PJI,FM]24^]7[@^7@ +^+F@^]H<%8<!2_8.A]?%F"=ZGKT!V'ZA\,
M87QFGR*,]!-2;!D%,M5"! K@S5(P*6NS3_GP"ZL[.)!3S3!O[>K/.SSB00=%
MR::/L([#^*KBV\*>=:HZQ8HO,[R+UV1_<'K>.T@UR+W8EGMR:X/C/J;H1J,.
MCG6CG" Q;X6>4M9?6-&]_4IM1'31(OI%4MBY]1[[O5DNF8)C<3(#H: =P^UR
MA'GO0T+Y4!B,OJ<^3=0IQ#J/_9J+O_)6[U*=4[[2H.^-+\L?<>^+-HWD^()9
M"#CB,P+K!F$>S>S:)-3T0_%'_;T_DPZH/C%.F9C7@T[G.F%GG][OG%6X0F"F
MT&7ZVS=4#-V"$')(4JQG7+ZM2:TFS:CT_/;E/?&HQ ;<IQYH"$G)E,1GYLU#
M.%QG^4>PIC*ZXDN;+P5,3%AN?+YX5I _1$14Q<,%*(V2; DQ+\WAT:A%J 6M
M-,]-F&!-.N5/KX0U*&_F%K,KENY%>[A_GM]T7"),7WMAVVCRUT,Z0.T'-W3;
MT62!H_IW,T0+E0<ICZA]#H\M">MQ;AKF:7XOEM^S7C)0'@BMSMKQY:C" 4^O
MHUG)#[RS Y*TZP:JW+R/IRRZ?D@RYEQ0,!R6[%*)=26+DHRPX)@F4?!YDO&@
MTHRUIGV&;8I]I-^U7KZ^^V01:P>W?.]@!04O"\/X[$:X%B4))K2.9*N",[A0
MN8,S_#5W:(!*60QPHO1QQ/?K@;L5-RUY&6IP;Q*LLTIH@&9IJI2+HLZL15EH
M<5>4Q89?4*CH9FA_8,)7^Z.7J]MF=?T6%?GRHH]'<&>@66J^LT"2#@[(&;#:
MP)-'\J-NMU_J&=#)#U03#/NPT-#2=LI(9?RU4MH1%Y4OF9!T?,^*E:1!WI$F
M@C;/L,5ED!L_K53PO]OML/S:HO3]SH*;D<D[GD/@+7T+J@(>&*%ZE92X?I^@
MFNR9XTJ<@TTN27KV<6LN?,"]-WC0>:;<O32OL29J]FQFX)(GKZ=ZWJ?QSZ<!
M7EJW7PL/)YG\>3Z/$S>NNI'=E([_FY^/DXC9&_?(']Q0OLO>;,9E67]7I_+@
M;G8]2B_F!'';%,T.LH%$HYE] GTM?I_A<])Y(P?VSM8EOF&.R\OY&2_$??-M
M/*#[QG?B\%157_7;-J%=>24@2%]GK$!F3963DM80@F,-2T.TJ8CH5"-;ZJ#^
M;!B_L00!X9;Z7"66E_* /8Z2W.RRB=_,AH63;QL18ME-J:20OV>WD.H)+"V<
ML]??8IX,;&[EF&V6[KO]B,(Z=YV2-%*?2!@*9,R\CV(FO9GG\UZ 1U>QG@M(
M['(Y&@D5QKS\GOO&7\A!*3[>JZ0 %?1Q^!U2U"SOB8JYOL%G\R<KSME1_<O_
M-JGQV(W*!"Z607=X<+K4MEC^X0_DSU>*^ !+3".E-)72<>OL"K>A%(@M]*E.
MY%HUCY7):M%!LYY^$:6MD9?2F\JE>X@L$]'+9[9648.N'CG__QV3__EFRF#B
MZ$A<]+$8]%&-\20$S#E! Y1]%X0<J\!N$3 [>WNH<1!):+: R#IAV/9TBR[+
M>NN%5&MJM$#$#)CJW[HZ8<&F-[= T@O>$Y!+'!-,DU%"J,>'__(T2M0(*^FF
M)Q"/@0FL4!V#$13!2E0/-=C$91X=,ZM,\LW3R2=!VNM^A-K<ZUC8W! W%W31
M9+9\T^Q>6$O4M]Q?K8M?TLA[W=;)8C*I!7GTF7";'&..I(3TT@!9:11Y-(A0
MG O<%Z?[^9Q1M+A#\I9@H+UCHM:5"D[!1+!@9N!R_1E2+ZY(F:ZXSJ8'5!M[
MG#N\,7<L-(.>:/CFQ>48Y)A?*B<#O/&MIK _64N&<"M.>A#] #V?"-^Y2$+2
M ):5<RN^$*3J;.;<8!WR%!E,@+>J-WHP!R09X'>M3W&)%4Q76OO-M/O;E<G)
M@F:+2QD->//EA=?/6\L(5FH\.M:%=[>1GVS3 !ST!A20R2JPSV13DHW$ILNQ
M(,D#C.\H+6CU]?2P*YR<MJRXPI(;;"WK<*Y'?9F/Z?0K#7-RQ,A^] S<J'%X
M7^F31Q5+=V9P=/1[T9VNQ11'A<5$/;<:DO?Q0Z@Z2<>1"+M$@.7DF'8M/W(L
M$PP-[+#H]16^,F__IN^,FW"E@U!GJH^?C>>'5;WL8DZ<M$6']5F"_T8T :49
M_32M WS)><?"]5NW_;;@!:DKXE;L":UW<&/<ZY!LX.4&Q@4@2<CDYPS0'-]7
M? 99-EZ>,NKR06GB5X_RE-;/Q3O7%8 SQH XUJ6Y-M9(V"U249EX%;;1%F<Q
M8GP=4%,[>46=1?(I.P @2M?%T<WPB\HZ>)PQ=1#?U%CHS#7./&3:-\"EW\?+
MVJ#XRDN>7>]#;O;007RAW9T![X+>(*_5X0,2:/XSD"=W3.!;"(_NVX&/9X:G
M#".FRC2Y)UD_O1G;NKPOLS\643EW$D:7DM^/G0_HQGBL0<OO>V.E/V>W &1-
M_(O'^(,V_06I8.$+)?=!%ZU@,W-\*%%8%Q54>\F..ZYE4$$1'F)[_F@LEE3<
MGC866U6T#[_H.A8T6G"7LC2S\5LT1DJ3!W%?NH7(^^SX:M558LR$[;<:Y^Z%
M^6DD++R$VEZZ#!N!L%HA?DV&EI-M$QM15.9J&N FH@5"/ $\TA>#NBW,77+-
MO#Q:ZAO"20V1>%9EB[>VT+1+O'4MIOA"^"E$1R74A<#2-L<F<U8":HB"K!^\
M:E]LE\U2TB9T)OJ=['R3",:9UWE,WB'*XR)UF(3/N\Y@!N$3MZGZZUC0$7Z4
M!MCC=MNU6\"0/X!9:(!QXS$:0$/,Q1G)W>"[@&+I72B]39]BR(5#XV<ALK.K
MB6?,I 1/,SIVD]?CJ^K2.M9XT@.O\D18:O%&^'UX[G7%KD9Y93+*9XE+0HIP
MI6;D62+DQ-$CNJ2U:<;#6V<#CD,PU&CM>?JPS%6.(N;+X7A,^X&GV:IY[C).
MIZ[AQ<,DQ;!$1K&6\!.:&)YJ?QN(0, 0=BQ65=!BTH)4W'94$'&]RL]98%C<
M6I_GX@EA5B\E;&,K,9@2L85VQKP[H(H.0"$>-D5FL[KVDVKM"<^W(LIR>P0/
M_1GU#T!76Y[A]!""U-TR^;1D0N;4A:H?LQIE9!LZ*5NN>P=\73Y8Z*C**PM]
M1;5=/?HUJ"96!A:*2_CFPSV?D7M!U6X7:$WY0 ,XQ#+0=9),QEQT@XY=$?0!
M@:V[8'7TQY=#YZA\LU/W8S?\.E/BPP!0=/LNS'\5SJLJ3%:,)8.<<.#+SFYV
M O<G7=!IH(KOO.SCX.ZWDB8 3TS0 7J<I85ZEU1[K#U..C!M&*X*%CO)O5@_
MLL]M;2>(8FGG5;6[G$)9WG!Z'3Z9G2LL[%[K[+.P;C-[0SSY5OZ<5:K7 9G#
M$!&7R3V#..2R/8)W_NXTWY<@W9[KA+.2[Y/LO/$6'1(,EIWG^DVG9KY-%9KU
M7&D0R+3R!_$-QX0,69^GCX\P(185!7+1>K%YR^Q]>-[4ZM +!1;QU5LVR*>W
M ,=OE4QZ\+\%+PN6*VD(VDLI\G((Q#_8Q 0-LAMIW[72,Z^I#NOLR_7575\.
M>4,PI#(A";=;8=?J^%DLP)Q_8J9*/\ZHN7E%@6<2[(5S$4;*<:]8.39I@'(:
M8$,#]'/&8!TKT;9>JLK2*^+2]-MN1:39/DPST64)).[W$L!0><962YX!ASY'
MG9SC:;A9D)<1WL9S\$:CETAZWNBYV>0\4[XOTPU5HWQ1O4XVK]+QX"35&XR^
M&"$W.XFF7YOIN-+QQN1:W 4EI+EU7T-.SVQHG "#NO7H9[YC'T7DY"Z6&$U(
MPJGG?"6Y]O& +IBKI\C>XK$Y46,D^EM:"+"4\3EFM]KQO@('D4)WFK%6UVB
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M29KJ6[JBWKX.Q'_3O"F7?+ 94J3@/?CL$:A)DPXX,^,7[Q1[%-<-K,5TS"=
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MX_OZ3Q@6K.#+45%T@ N*&XJ\];5N%.80ZA>0Z\SOZI8OJMND^D1JA0ZH32=
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M/E[(9TQ75YHR'5!1"SRRXPB[8J%S=>B/\2(G)<7G!'R"NX\.N"/AAZB1HGR
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MLRY.A,+)BF%MBA1+?"QTM3MK@V31MJ.W>_/MIG%,[CT_)<V7!69X W&5FX.
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MF5X>\:7.#UG1UJ]^BN[7J!FQ[AJMGKE4KKZ35%G<1WK/,9[2<MJ&Q$(XIT/
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M'H=)4C^!7*]Z=/[)4&%(O?*E^LK&T=\IAD5UZ0<?0M(3$,>>W8=]8G(*/M1
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M<W" Z_]!VGN'-15UZ:-15*1+DTY4.@A(1UI$!01%1'J-BD@3(M);@B*]1$!
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M65_8<'CB<>-GDLQK,F!JFW:A+7[NG5G[B*W#-FJD\*)DX-39QW]U]_^!G3L
M$MAI%_J)7UTSW0(1WF.'Q(6Y/W5D0%?1@1O2ED*Y<Z>=FHG)QQ;!(CO^L6GK
M_ <1%.Z2![U[ LP+^ Q: I[+D,86G5ZGP, ]#=__+N'&"T0/Y=Y>X&ATS<>9
MM7DCG<>D%YR3A>PBJ1<2M(%>;"\3!QX!=,\W;QE,"BR&_YH#Z8>@4CJN5D[L
M#3+S.)M.!PJNO.Q,$'O[PW?>BO^;9PD=B<;*+]^*8(]YQ$%?^&/6,=35YXKL
M>\<_/]2M(@:&]/U."&P"OS2NH?=W)4N=N;O2)>.*RVR<4B03X(!8HU[^4"X+
MO>,-]\.)B[IZ7D&I2?!O;2-Y.C3'D??2:US]^0IVU<F "T1(*#]#8B?I_'B)
MFOY2M.^X55$  N[!I@-LUKWQI%RG_S%@^O:* Y#'BT+4SLRVR("=0SXRH&U@
MDO$,S!\I^7I";U0H;AY_?7SX#LG8%[0P=U":&R5Q$(+NL.5_FS0RWGD[EO;-
M2KJ"FWV -ZV8%4+(*T.4L6H75.ZP<P9RW(_J79II^/J5CWM\^.'<W;W1TM2(
M6]]_F#/7-HA< *9X^?XL'8%/BOQ*7K@ LR<#K@8:C2W1:>2QG47,>B<ZO8X3
ML/5W@\G#G_18'Z\M4;M.;:X>7;U1E5<^EL&!?T9JXX;LX"DP]S$%IRD$/32O
MY'@_\<2*#)!L_+@56&,3=:OAG5':P3:84J&S[>-[6(KO!E>%[T2CP!=]XU:L
MG=$*_9GN\HVUAS2I\V]!4Z]:3L*0TEZ[+(=M*FLY.5NWJJJS"F9UG=SICN/,
M9W,*3RX8/U\7\7WH"?D\6$#-/0JEN1'+KI!>7#/Q9.9.QLM#E2YN)M2+-Q?]
M.>) #J!(,,,Q TM7NP9+4SER/-?1<]O\BY1@O==,DE;DYQ6(K?IV7H_6UH"X
M_+J"+X))*;LYO((8#%6Q=7+QS:"1V0,@&NMCBSVNW%EW>7APK,;+S\2.(LFC
M@1%0ONVWCB3A(8B\Y&.91$@ 3<S/?B4IZ$'&'UDFA.CHA_1$*5__RK'U2RE9
M[[0\,YE(?+AP5$H$:E!-.E^W:)M5H(>OV"U"[WLO;QW5.QL^Y,XVYL8A2FCA
MW3=T$G$@"F$H6/<S.(>8;F.2M!)O]:*0OD HW-)-3T7QD>-H0N.+J74VLT&5
M]1T.3&_;F07R:\N!S?W(Y@<[TH@2X4?>DPE7/7:RBEI+;[K)-TPAI"57*^M"
M_[QME955D4UC?^9W(6 X9EDZ=-;+T3B'\* RB!K/ >U3X=B51$&8-^OW"K]O
MOMGT=I_M//.+D*O0&&GP_[FYBYM((KBB)0O:F*)MQ=%Y'PYM+#9.ABVU%'K
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M[<V0I7*WC4;CL;=QK1C5A]%&0X$<GO4OD?(^EC%E4SF%7/1%$A*W-'[D>B+
M#($7*-&T51H.IL_&9(:55/KNJ3TLN*FD->PH=&--[MU-^Q3OVYT>NQUVXO$5
ME4G]T[[.A9U&(:OU*M(S=E@C],E.YSP#-V-1X5;F#.SU(;+RD8-#XHKK3!E'
M:=K4&;W9'_8S'@K3@^#) -KFU%+2U,1ZDC;_8^.1^&K[Q_+NLA_8*5&"?=3O
M7RZ0:[$U&MV!W3LRU K\@O]OHX:159Y*%(#02@$NX=".>@0\\E@Z"GII1'A4
M'J$9VUF5/]51;Z5;EE)GPB7$&SO0.CTEL@J27M]JD+BDW<9HDJ)FE[5(4H>E
MPW3ZNDMI<.EX9@(WKLQ/B%2ZN.TB^?112O/07/%<Y-8?@>M\R&E[D>-\ [%3
MH6S2.!G U0AZE9P,8VG4EAR]:%+;[(1]-WC^]!J3F\P[:X-8DI!O#<ID1<E6
M B-5A%*-T.ZV,FI(<.=47E*2H96;B<GL1!JZP18389>%OZSH!W1Z;RT<]*OB
MGQ8=]96!$)[\% SX_D4@$WIWQ8?#6V4AXNXY?+J1X75...K&13CHT?)T=+C8
M*1@-62R-(JG@?@^T-;.-O&K*, -7VLC>JJF(R;#_TG7YF\,L^I+N>>1;C8N$
MZ\/-%PE2@XT<N3*I#(J\#SU_L^\)O["T,(=5MB]Z<_(!$ -4!!!ZH<V571Y&
MY^C-?2FUP&=J1W)<Z!7IT)7*PS^QS]/8VLD< YY1;?%!LH!> 8$;_I[ZZG@+
MR94KV7M.W//&M9,Y=1#18-5U=IS1X$G7Q.%Z#1E@B\S!EGYIEH"UJI$8 RW&
M][PBCXKV&9U3'MO7U0Y*W3]OIF[=N84)4]<UN7#RC;ON%)Y%FE[@)B@M?@72
M;-JJ-50,O7Y^%=O#5\GOZ0XXG_WGR>_S[X*5WBAOQD!KH(/<Y2YD0#D$?JS<
M*="$#EK][9&9M,L5?E@JA!X@L"PO9KSS8SN)1@&O9+,\4LG(9@=NK^@P$UTV
MT^U:5(2;%GF0%^<LXI=Z$;<K"R4%XA.O]@%35L.HWYPRRJ4-7X"II2-IB;W$
M,.3*")0RIB?5D4>>2=VPMFKH^0.#T'TD&N)%(=?%I=^@_#@F;9S=XJ[T+Q)_
MC8L-CWY$FRM]0F5,=&T9S^<$/Q'$>;VNNW,2AV 2;1T:9%H[+B\=9>E:G*)B
M[>V2YYPO)++SIUSNGL#A1\0:V\ =8X=D]C,3DRH>'M>GG:C^@WG5AH<?'//?
MOZ1/$*"7_:EV1;.5_X@-ILX/P&";T,A.;D@D0>&[;KZ+I6>&:]-OP)L'U\(N
M7/FM*6X<\O%!::D7!"?!T;Z]P$1,&&C+X!TYUH';.=.P#3_+4!)TO?XDZ///
M%??IYI^8"0*K]&)IK().4U7EN)IH_\Q*N&:3<2B\_%%"*']OL"IM8@L,K<_T
M'DH[^J*A;J3*@+V7>3:ZU#8<?GM ICV^R*N3\XK[\/O74&/<B![%Q\3)!PQ$
MS0N'/!VMW#4PQ/-LGZ1)=O1HNT9G/*#C.5?I^J3!MY/:$,^'^R%]"3JRP.AU
M>^4@BS0>-Y3K=KYXL4472]P7J;$D?L/%HO^>/\2N!E#C0#%PBZDI<@O']0_%
M_OS0^3;#(N;]Y\V#L_CYQE<@G/!"BV.Z+8A^0:!PEM/YY%K(E@:T\E?7*-5'
M0&D7#"<V\0X2*(=_#-XN_]7['/60QZ7!*?B4*SORF2?_8GLN&=!<T 3]=8\S
MC WNT3Q&5Q=GOERGWO<6R*[!B ,M@\-F[F(RPB&(S9F:3L'?/73+/,OQ#UZ^
M]KG@U:5WZ1A$T\Q.L,7XM!JP,5W!R9DG:HT%YK_+-1\V25"\]NFEEWA+DM%[
ME6#MRY>0VLC%K^#*\#BHDF\#BKTF+E!'$>G.ATCORVYTU^*]IE8DW+VL9=+C
M>/BN_Z)G#1"M!PJI<)9\DUH0_>Q#]7YY?I:;'7_+9[IETD7;);0(U@3GA5=5
M[^L*J2Q<&BU9NGJB$KLZFJ@O_SSDV<HN;PSAA]AYG3]@]%/0%*L1+GB(\ 1M
M'[+@/.[]B\_!H,:ZUYV6*<'3L+>>/HPJX4<MONJT:(F)TP7)U*CK4((+,*H?
MJOHJ,G=QK.BUIUJ,3[? M<(+O/'=@F9'>G,2OTB2T [8Y69Y6^LME?70[(IQ
M-\9-!1OQ>RYO^N:^0KIWW,=&4U^L@M3^ZO3E!3HG:J884+5%>O96.D?GE]79
MRGQL=DC*('1J!^FP'^3G%6XURV'8.XZ/)BR;JPIGO[SZ4G'SA%750:.X/2-$
M+95HE4BB :%]YVBTJY:%X&\T[B[,N)Z]G'$CNDQ#F4A=E( #I9X7SEK*I.L@
MEH?0_7!F4>C[!31V^-T9$!C5Y)=[5:V+1+.+%U\(/(?6(C6AHAT7,? (4SDA
M)#U6L??PYDU8LWGR:_]K6W6EN<U"@:!A#7%?)FMT<@-39I[S>)^K++RQ;M4F
MB,M<0FS'F'OS:N/V\GJ7.A/6#TV#@4045_'L2KKE5/D>U0ZMTN.KJ_D&[02H
M,X@,5!M0">@@N&(A"N8 YK7>L+U>&;^3JNT*,C6?V3D97+\^2 8$<,ZF&Q]O
MT:P%7L18=8+IW'+KT/ H!3#CP^N7GA?,J^DJRL%EC)<PF2CVL\P@2GP]1TPE
MB3D>.&E(^7U]E))2B;GTX42&->2]J4(*]<+W69G=NL6%R1JL'2XOV]P7V9;!
M$F(\M!_2R''U+(GPIK?J-^O/WPW>Y;++5&DKW#["76N@,,_,J(5JZG87!JXJ
M=7#'=!&_6Y7$%\'WOV[<\>-,B\CAY.HR"CXG2'NXP.,+(5U9X'8Y.U>+!V--
ML]SML+&A:@OBVOHS 0YN[C,*^.-%9+@&,\[P6\_SI5AJ??3XYYS (OOSOW@<
M\0>WN%Y08V1$YI%4S<(N'WV_HG2BCJ/-6*R<N:OF9A_EG$O636\]N[)06B4C
M=Y1#HF$E P2_=@&Q/ ;$*TE_,UN>PE8F>$AMWIF_]=:1BXDJO,F@<X&ZA0]"
M+YY$V#,[X.*O?7 @G=T$T9[EH$Y:]^D(;]&1Z('HG=Q1^9 W*1J/C!I%_CS:
M5?T8,HL93GF:W'6X#1["F_7"T+NPX'38$D<3I8RF 3*  VPH/4\0Y3;5N$L9
MO"'0'A\8?Z.$$PI.9^5'DA]\X3@^]8:?-)K>>0W6G%LANE\7_E3B@!\UOZ\S
M*O@>)58,0=B+"3Y&\,8_*/BH\^1WD-\%LZ/7<[=+K^-:\2*!DKCU-Q,9-]&(
MIDY$#02;][6I:J)Z/286M\-[BPL5'?V)4/!7Q_U;)G\E Y_G9*"/T!_']_*I
MV%_3J)< N_U&K31\W>UCWHDPWX*.U(%8@J9/B6^X4?VX@DO-H4ACXZ<>@;1S
M/>J7 +SNP=3/P3\.*942A3+I>ZSE5RU?-KI]8-=<)=':+^L:20R8^$Z0)(9J
M,!"$1[^-'@W0,1B9O OI"$ \<IOBY TS@<2;\VO27E9GX& T6H?AA#-WDG[X
M:L!PEO/290$2,]&OPN^6U=J4Y[K=.KG))&[Q]H=JD8RZ*?)N>(W\**?(8<'P
M?V0)2!P4D&@+R  1NF^P202$#,C[EU*)!G0J9( G]#N1Z>_VH)7Y9D[89&D^
M;%/09.-X'5@!(WR=:&/"LQ\-$ 6CFOCKA#!R$SD$Y;-KV5'B^N__42J=8A?R
M4[V$ %!K6*O)T8+(LEEH*7;1VI&.,4C/^A$,^ZTT2N+H'HEV*"M3>JFY)/)7
MU7$N_/B*+-.P'F&_-*M-=5AGK2[7S]WC\-_2'@3_BQ=/=]@,AZ,NL7EE1UU@
M,]2Z]>^Z 4G!_[X,<>W_*(RT*&='B=%3KOI?%D5%B7)2+ME$_,<]/+.CJ-^<
M_#_J/C&#Y[3XOO]3;0!F6YD$%J2^(K*"5.?9&U:/H=]A^H%HJB<#-C2+#BJ.
M2B<7<"(9X<1HO+BOZ=T&(63R :9K?$W+B P(O$'R:HV%-:SN!3'J\*!*I^0V
MA?)RV:J6,J'_<G_2_X==S]48W=+^QC10BI/0_KKFB&3P BB'H<[.NQ./WX63
MHDO[+8DFE#F4[XB$X*ARP-FO]$'@T"]-S$M?'E!B;K79JAD%1H$0 9,Z_CKK
M7_ZX1D.=+K(I64I4HO^Y+\7\/XIR;KP(B$P0C<]-FA07IR\3^495ARV=,)CD
M:,UD)0$#A5(>X$)<+H;%% L-%>^]!+E6QY;;"%D_?Y)89YS^VZ(5\(PI_=^4
ML"\<#;"ZI)ZTJ]M.J[9E=R=;OO:X9A^U&+Q_:P#S8Y=JQ$_]3JD\L1+D8L!,
ML,+L(9;2I4BN$JVIZLN6;2YNJQI3@H\U,UY<GJ636K6-.H]I$&[<ZIM(H=#3
M#;0S)^U##B,SR12/7?BT0V<%M&OALB 2Y["HKG&YBJ[3JFC;]Y?F\YOAD7DQ
M#,,LNB8]M)>?^$X7'!BUVUX;;;0H ;MP=QQ-QQ4&2!BX>[V9R=!1UP6M_USF
M+!V5GAS!?AHF YQ@X3X+#(W0ZTB,X%5]B(I-6JSE".?"_HWW2B?]O/P-$-(
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M1T]?(]%/R0""=_,],B L"H<@ [14.\$XC08R8/D3K$TKT)0,R$Y?EB8 Y\@
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M/*M<MB/LHEPN>80F^HO.?P$I[GR\?<&.>FU_^O%!T#WL!UR20K>$-$'0_T.
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M<^7O3[8 ;RU+:YP D4I>$QNYCL"1MU\ \G2"EW'6%X#^H6#21E4,+0\9(9V
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M91<H5Q;9@A>E<25%V0'F@"MO7@P]YJ+3W (7$1\@,TC^--1^?I L^0TJ*UF
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M,EW)OV(S1KV6E)WP.:#6%%ZG>/[OW#-3/XU3,X'K['EWGBC_*20T-X>L'GP
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MP[ /8#K?@W >R8E@\34%@:J)W0+!^='W7_QN5O7H+:GU/.'VLEPF;Y7RAZ^
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M.S]KU^>+CH%[)SD)],2>>@YCOGZZS'.WAC<[M7S_4)Z9#5[>J?\$.<-N!EX
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M?-DBB^6D$_H31$7RSO%@ED<C%*X<1]@@W%.Y9ZPBKP26[]Z!B9%/LYNXOPX
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M*^MDY][)UJW#ELJDJLX>]<7\^VP6HEO_VT9<_Q]""XZ"-R@1<Y*ZD\"[U&>
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MPL\ 5PE&IZOP[Q9_TB9(O*[K/)X(DB^8=.'1#9%5SMT3@J4[C(,L[*Y!/ZI
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M3#>7?"+_#8W_OR-W[,H)4A!)6#R8OT4$-1DW\-6]KAGYO3_.!?GRJD9V^([
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M 5NV1TG ?$E$E!DH,@R!5<)9XP4QB#Z>H6[X6RW#$:) ''5;*FKNGFR74+F
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M [1]_JRLUYMFMV;IYK]YMU+,ISFNVI81CO=@GGEX;$SNS49]$2WRX6I-[>*
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MC2ZF$[2_M1_U0,HHWF<3+W &H"?3(][6<:E5!/5$2A>: ^4#\X U)6CNPC-
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M)MA5)B*J[EFU!?PZU).$IP"+6IWHDF_9_:-UQ2H*FPZ1<[(FO, '^M>%3JG
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M.8G\'&/33;R).>(X;%#!YI5]9]S_0R)(P094';3(E\)&GO/YWCQ <-ZP*4K
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M4F<./>IA41EI^F(9O?3,N-,EL.9UF:JBY"6C*#(K0]Z8=%@.,<8P2+_/;:_
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M\^*NH\%-?%>Z4K0&I$P>A[I,M)P%<:WRB3[;^F+E.;''DJJVL^MH9%&&18Y
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M;3ZIL3'QOWRWYW^3T4Y>]S6J0BY%>_^PHRNM"4E7DSZ2;'_Q2ID'R> ?"HO
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M_Z<U=16716#%TG44-S3*3SC//DG1/3_'GGW"),OX.<"_Q[OTQUD8F@S5:4\
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M'*JJ]_2<L<;=W];>*5_9!UKP*_R.>Q(7(%GA5E=8W2O)$F#L,O4Q,4B#&,3
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M B!>8 6(!>B#MY[HN;Q&T34]RNGT(A_[E.IIZPZ2;H,M@V^T;0K H#B*>@(
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M4%RD!_#;+E=;_VPBMB2FO'2]PL$>;5_S)7KZ >UE=9K3CST:5A2+W0$^ON;
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MJJ0NZUWM)>&97<5L=",K:&AC*\B/L_RB4)9EBX,;F3$ALCWRS+KB:SFE&RO
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M810],S'IX/C]63%$V@M6A+^#W7B$HV\4W+M)+?GVI^-"S^CO.DU:L*7T?)U
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M VE(0D/@NTA9\$W]_X](';39,&\HH?K/_RHG-.1"Q-A>X.,46R$Y!M:= <N
MIVJ@["0FE;:J'/1._H>7=1,$)2%CPL5-]8"3.TJZ@"%=OZ>1+CEQ3NUO70 Q
M\FEN_'>?%[F1>TF<P@24/@$JI*P/O\N1S-:V$&=2@\3I TOO,@PN#SFR>GN'
M6YYYD:+2]I[U_@1RD-A'*12?0W]--O**[[\YCZXR@Q(H^51(YF/2./YZ']G
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MA\=1)'''WV>%XMZ7_#J)ZQ*'"BSM,""16=H*&]2Z$7_%QIS-^SR@3N&*.J.
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M2].6IPQ)TY:&]+I3XS-V_H!5@\E700":EC4 U!B!0/"' =61!AN8MM:?ZA@
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M1(2+MM?U) 9%.Y1I#?16V[0GP35]NV![]%*GOZT8.FQO'GO306XQTS^*]YX
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M:;GP4.)OUKV0!2XO0]-CUF/SO4J*:DA&HTCM;P^(?%EMP<0(T.JZJBBEZ0]
MQZF6T<[%WLZ92A^15D"MV.]MHP2%[&'H!)S^..$CB%T.3+_IX3GK6VIVP&73
MSW.(*>'^!-B>A[)N@:I'=VU W0G7"F(ASL7UX9#;_1-:Q:82PE':,FR04B\T
M]-6E3XR Z[V(O8@?9$"G#M[&>NM6]+>S>SLV/YVX4''OH')[0+21Y T="A2A
M]&BS9 H4V_QEK+H]54L<X^P3B/,-BA1_8!;O[2)MZ!.OJ,M4$H4P5HCEC<D.
M*2 ($Y-/=J9^B[4X^C5]JT]->X5]-#_<N?*?6!P)0' 1\\@ !R)XF:NKV'*!
MQ[4SS3C0:"G0RB$D092[F$$)@.RCI@ZQI1O5\#GG)++@!(M O133XM_-:5"W
M$RB?Z>S_GYPG6"^\('M3[9-Q4@J/2:.B?\0PRY:R"[-.0\.9O_H+XB<H[2:0
MNXW/Y5PR<A&KHF<C?<"/YRY.6*=YJ4$CXBVUWOIRE()%'_0P0@X6 Q5WN]D;
M-!@V?IS2:)I2-O5':YSU<F;TWAL^=D%O'<52"A./P)#> 1&DGS) PI?0EA)L
M$T;S(!KTVH-=SU=4MTXAO'.!CJ>RYSI=S3OZ?0_O[BEU9U.O)W>+V2%-[-&?
M)PO\:HF&^598)9PT)JW+W+^=CF D8%YQ(3Q^<_Y1O/:OZD>H(>OE4Y.9#^-M
M-S W0X*0-C"C,=\[+3%$]14]O4@RH/FVM-GYH?*Y_6Q;+(5K K?-Y<$U5VNC
MS:R"6B600K',K-@]1X%WJPRN\<2:6X]AS@BN8HFQ#2MYZJ+:L"B"CE Q_)Z+
MMX+/-RY.Q5@6+\_0CP@W>56#Z#OEU>NAS4OOX=>65D9[1J\%.-FY6I5\/W7P
MBGG+M;91*9++Z$W];KF]']%,T3[I9 #]D!]4 ',RQ-<2@1?Z^8GZE]21U#G\
M[GTRP+&$<WSU@U-)JAVT/CI,OF;AG -<O]&SU0+"//S9)!0A%0VC<YOZ(O2@
M=/?72V/0W\<=YSH'-L)[ \@84 R,"B*,,7FDOSY^)S?-G2XX=5GR$AD0*/!'
M>L['/)Y@1DR%*D.>X&)6)%GF<7<_;/LGZ7/*ESA^3E", \W :"^#<=>"C?#2
M$%&,;\)/&R?D3'<9S?'.*]DYJU?;'*>S0S0OZ-WQ%C89H5YQ@_$IW6?\[ -J
MAN4%ADRQ99$YEM^>9LU86=D?HN)E1T].6$_\=S'XF[.XN8YV=";AX32XJXWU
M]1#Z47RBCMA#I70=[I>*AXK+J=QK6G0!=W%N@?D$\(>?Z9]>(]@L$W12<FQU
MG#\&3?I3JT14LF(IQNY#=Q+.HZ/M"MKVB]F,;H.S4^KLK?=FE^-N&9YJ85'$
ME./RZ&2W0LW] $5N.>6WVRO2M(1TJV:9LK;+I"'8#4G&"%4@RBH3U(WXLI<K
MVV]FH?3SH@.=,+ZP2Y&]5#(&7.D7AT[ NDVU&!7-VXRBU)109J\EGLTJMVX_
M*BTTYY>64A3F@[O@,!P_$BW8PTT^=?&AWY$!H%_MFFWB =,[*T#"C9\[,^-G
MIS,WS>B\I'<$HH+IW?OFJYB#AYWNC'S3D6VG,;D67V#Z*\DX]FWE,JP2MKN$
M-$Q()8DG=U>Y7'V;7W>3#+#+M.__I&OE]VQCG]'@!(Z_;B4(WS/-L^IK=M"#
M<>[S95S-I2K _1.;4K!5((:-N,-(O++2$H&]2P8DUU6<+Y$!FT5W?QDN/;EC
M5,#ZH8BUQ'UWB%B/N@&=7!2,:S##7P<]=+M:WH4M)GZ%T* E\#_U"Q9<=.Q*
MEEJ4/]>G73248)5>2W.AM[-I?<<@FD2L:U_=)FB>4,+L^&O7!=!R ?CP BZ8
M# "SP<\O/1,ZN/1EPX#Y>5-UW+PM/'!WB;9%%EW>A_7 R']#EKW;/D42ID]W
M"EV,90,K^1]&]0M)>1?UGQFBP-S#Z*5ELS+,3D<;.WJ]O<AED77:J*R\/-4[
MJ<NO._*].#/:8&J+8!. <"%^@ZW^;+L-FXFO)0-R\]L U2UPPY;P[5FM\'6.
MFX_S; NWO=F#K^89,!Q5WQN2-GI6<9I?.D4&\"2X$Q'J@+^0B[@H)[L<M<E%
MX.2;Z?5IO7SZ[>64%#K !;XP]TQN6DP9M68S1J*Q8.LF$P<"L<]?&RH]E>M'
MFW-TNXU +/@>@8TD)A 4,#=[Y8*UGSP^R#\\N\-UJN"5X.C5@->TO461NO^1
M7YNFH'=I;RZR?HO$6:_@L/>+F'V8R$B\UM=BFBLBI]_H'D]O<%&FKS-3<-]@
MV*\"7D?]$T@%'3T'AQT3&3:,FS&\V4VNJ4T-9G$O-6FM7FC<]^?G1C.%0;H7
M7/_"7!.BG%82^F!,VTSZ&\[3,K!7SS]YMST1*!+='7& X5@#)GS+G,&)8)_A
MOE\9E;)8W3%+R4^?C32=Q;_V&:(2BLX5R(#+TJ,$$2#-*1D0-7M,!I0SSPPM
M52)^>C! (!B_UOR >+W-O=TW9NO\]E)Q]5\O9B055!X?(_)AR_G@P\<0RO"R
MHPR"W,.9-%B'-!FPFA?03NJ@?)H3YMG3\-L-Z!251]M8<TON[3@AYAUL-P@]
MB'SCL]W.#K$C)ER;&NHR&$,VF:;M(ONU/A6G^8E<4 $ LO*;2N!_ZI>7>CUH
M%EU M*HFE%@>5VQVL"<E]J5?)['OR]?S4-D,WI3#^CVKE9)1-NCO+*7&YJ]Y
M>-X""3AM<LKC91_F0I[PI_ BX4:$"26<>[C,R(-Y/<1R$DG#@3D&@@E>LSVV
M\F;\V?R)<&S<LQS%KED?[F,7I,O+MOS"<K,]:'O@&N@JA'6YD'37)0N(JRU<
M"/#1KX@.>)5TY<6./W?T-P8F(K""(F9!->;A)%97^%6(K!.&RK9I7%64M9O:
ML+G^%:-8*#73A\BY4L>$!1[1(SRVMSY^!IN*F7W4_&RA=Q56\[NWF^0 [VW+
M);:<$5/;N"D]8%!%P=/=8A=AI?M+/F]84.'9406_TA.@3;NCT7+M5V9QR2M3
M&^$0@/#T;KFO<.TXHY .:OZ!M  ]_44=/H",H>[Y[!)6#J>--N_$6J;U&G(^
MEN,*XZBI@_^*\;MB)O=(5J\&TV)?IS'L30:@]4%7YUR!K!#-%;J/%@[C]];T
M@A>,=>9#44LOE8GL,Q;X1] ^V$V2',1Z1O6Q9(WYQ (A3ETTYB]K=MV3CS8_
M9*X$OI2=2K L3H:0AG_U=]%\U+MVDJ>79?Q.(O(-K,K\)QD0WZ2/)_!C2G^[
MRH^=A4X[<S[_*8 :BM:T>.80TL"K$AJ B"%X+;?:(T>C3R09=NK<'$N<#]G7
M(P^5+W(8>CX+O\1[GWJ\K1FGAF<BV.(L,"I=4.%0,N!AU#W\G\7EAS"A+3ZQ
M2Y6H7QO>-X%Q0+0)@G;V;T!UA^VM<#FK5JWQE7'ODM.6\+A/<!/\.E!#3?'M
MMO=HHLKWGA?$<M;IMZT9$^8VG*JG6!MBW+ZZ_%8RKJ [/38+B'80VZ[6K#'T
MKT!BJPF%,>&7_S!EO%<4:M4CL8SNIJU<TPBP?X+IZ:FKV[T=O^?A,#M^X_VE
M!&#2?/S[TW-S,-[95@<=A#5&IX4<6Z@/7T/-.2=GN#GS1=\^P%5_7-A)Y=DY
M^@J+*%?<!H$V'K'L!(V8/5H1?"BQ]KWHKGRRVQE6?7,:]$*-[B>(NB6H%/?!
MJ*5]YEZ0ZV"K\O:X8S0-\K%"][C6LQ25^BM<"0O+*%84O!+^$W:- ,&$M^<'
M)!XDS?9VN+_$TW<*S3O0C=Q'49_-3,)H(8$PU %.>";::;+\VM1Z9K:+I:ON
M4F#J':O!A>U'CE>"4'*K</03T-G=+$DRH$(7MKE6:)Q>(+_8]Z;BC_-+]*_K
M-0[Q.1WME?Z=B M;#S96EJ*0XR?BNL[IO9T'9M']#P$O^0=>T@W4.]O_9F;C
M=CB#18"<8!%M@L3R\C;NK:;4O,( 8R[_S_-]/AS)P]>C:'.C&T1HJ KL9XJ.
MX+,;/6F\$L0?+1ZJ$RUC?Y?:,J_:=SM3[V,+=Q5$@47"K7X@M"'B3,D-2&HI
M)P..C4K6/K]87?7&6ZM9/Y.JS$TRKCW_2@9<)S$10#@/O%E[:&VF%MX0+=@8
M.6^K(W2&8GQ=%;P6>^C %SPQW;:%80N'LNCC[\PZ6X:W^S-VKM75,6T7[PI)
M1_WN]5G;$-+(V8?%0>[BW\$&QG#UI$8+,F!+S/38J9OQ3,O@&QE@:P8\M^)Y
MM++Z?6Y^KW/DGLM+YU[:L7:*AU@%TD/I"&RX1+RV"XEF_"38Y"EZ:/;=<,[2
M0Y\J[4PFR]=S;^U5V?C7V ]W>F&O$\) Z#R2Q,XB6^30.82A^OF@].6LA4D9
MAU-^%9V?:_H^8 :(FS]ZJ2^=,6K7V_UM2?_^ RI2Y?VS3WB9-1@G7IM$J[ \
M"&8-,.P L;P-E7 3C!/+RU+-1.O23Q_L7I"!RHA[E(IH*N2HUG(&E KJ=-[5
ME3CW<^H'7H9R#V-<5^K#"<(<O@E&S:8-2:"63W<D11D]H[N#5EJIL9TXH^7V
MT'8FL19Q)(='?KKH?9]"N=T=H;Y/28FQMU&T5/[(GB!MP@W_GW[G7IBT[CWP
MFYN<-LW/[WNBUI[<246V+]_AWQB;;7N,*T(-PJ.6F%H>KGPKZ]0WQFP\LX=+
MJ*[<(P/>?S<EW-'_5:+GX*C\-"<D)NETG4*:WK7S! [<PW*()V8O+>R8B=-:
MM^S>J:S38%V85Y-6G]TGZB)'GIUPA"Z."S/8 Z<Z&1Q$T-QW4MO/C7J#F9\]
M&]IF_Q3-$LXAX"GJO)12$_C%U\#T=@DX=6.R:707A9<ET#=\T,5%H8+PQ&!3
MSB#?0(9YBN(OKH_+XNL"!D9UL*N)&HQB%2A7'^V:20/3MCCZ7",V[(&R$I-_
M1=DEFFDP:GBK!=YNH37\:X@JZ!6'D@'=IXO,Z8L;SQN"!O;E[J[4=*G<2!!?
M"J"JF/L),)]8JIS9_8#R"(%=%\8H1/JZW>5KJ$@:KL%SY*;\^>>6?R NJSCM
M6#-#2KX:FNQ4'"^\RQI )N4?MPT13C",'P]:^%%T!PPNZ#.V\V"4Q;S6EY\.
MW@7._(E]U^*UU43WP9% M '\FB7NFW:RSHQ$"VAY4WR]<?K$QGA%X37:Y*7V
MIVP=KH%7_4^O^)P:CH+KWKJR[3FB+AO5!!</D81FF6$F8&,RH$.?8!Z41Y!#
MYT>XR7:Y%2^UI(E$\+ITOB^N+YQ'5F[GC-=^SA.F<_9)9HS(-F"/,%9X^H[[
M-)QT$3K0)MYFR."L+IUT8/&YU,A@-D<@J9'] AU?U)^L7P7"AX@,D OB;]8!
MU@MC^EG:MJX$N6#*JT<WP"+V/G\!HTO-%;YV%G$MZ\-W#+MC@&/\XZ\YB<]E
M9)C9>96H*U%RY\(4A4+?I-R^.X<F XPS1*U'BZR4((=T?X>&1[/YH,\LGVVP
M!LW'C/4BMT?_%O[B+ %R_7LN.,!W:9;KG[5]]R3&T=$]-/BAR5<Z;5>&7:K8
MN!$#S_='\8\!B2<&K7@UTB"0ICPBG&"'$AT@/)!*5K%Y/'R#"9YI%UL*\8.^
MC\W2? NN?/<OD_R?G=Y%Y=I'G!DQA2YT C%=P5G,E<)-!UJ*)S[@S'=A>[U%
MP3Z!_JII;.;,]ZH-1?<#N9,LOC97"B2?%!R8)IM7/:@58^#,R+M\=]0F"%@,
MKHK813FBG7I(MV<(TBM76_26$ZX_MZK[%KA>,D1;?=-,Y&+%1OA3E= K2H0I
M7 \9(.A#^3]8[C:*1(@2W5W""1XD2.:3 1_[.B8&UYW18I:9I4XD"UGFI)!=
M+Z:^ES0D$=P@BHV0,LI%J;HWG@S0%2C05)Q*<D2M&>1?B2TJ$6U5X0X+\M@U
M)P.$[R^#SL\IL4UG#<&,<"-&4Y3<IBHU1<^;P+94:VL-0[+4&8GK\&(U!1+M
M6R_,T4,RH-*%@1*+CWQ-8:\0?[7OXY!X$*ZK.\^7IL7.,=#7,=]J;K[TJ6J4
M&UUW.8?A%9VK EGA9; .@_;5MM=@K+@5):CJ3_T+(1/F'HRD0:CRU/4K0>*O
ML*M7-G6?S\F#=%?=BJ5?G[-/A%F/E[J(EL'X/TY03# 9\/=H>7O.&<8*@:1'
M1']]-C]KM7#OZ<]N)RY^XVTE_(B6%L,5E_;>I3\>':= >DG58'0".-FTJJ8^
MJ%%L%NG^(XL%J!2N"8AXRK[W9C54<1,J/%6KU^ICW#SI2Q<E<5"^%A2U+ZB2
MKL.>-&18I HO@T92/-4)C4<;5\"27F9LJN?VW=M:?6N\#HHO0 =AQ>F9<J-#
M]F%90#8C9&N27LY.]MD.DDC]%&/07+!Y;EJRN&U^E-?:VF+_5< ;0#6! )<%
M=Q20NN&T)#J<UNASW Q**QR[Z7:S+IG=CC&VZG9Q33+3PGN>0)YK@:>$&TZ=
M%:[M0/=:E<C3\KC<81\J/PN;<3[8091@.2-V&C-U&@]Z/7J3[NM0W:Q^Q_C>
M[=%!%B_/G\'6C>JKTTF?B_5-#'J?.8]WV64)Y09FSNK]/K\R@]7"W<"</IP4
MQ(%0>C%NKR;9\&I= [<E#'D=9(J'B@TO]&H<NZ<<@3J!5UW:+A"+55F1"]YC
MI;YN*MW34M8/^A3ME%^$*HIH755:O:Y]I='P(^BF7'LH5*42\RIDM958K -,
M?,O>)=/$>I?/F(:#[X2[4*UD#,*%L3+'C>&M ^AZ+/=:X]J*?,JW*G_=PSTQ
MJM"Q-U44Z\X R.ALJEVFE8V;.KXUW37S=CUG4*6LKG*['?W,\$QTD?6 #&"F
M&(R<M5(5\%__CB-HCS[&(G>2#$ *WAR6&/.$._6W2L7F=_6.OINC2/X?L $;
M-(+XOH^4D-IZ<Y!DY$(&G*P)DS)FJXR]"JXDZ#[+-N&*W#"O<MKPF$&<J9.F
M3A"=L+\>'8MRQ"2(/D;T:9HQ^+IS77KLF)B"B/BI1NQ RA]OBNA%))$!O>V:
M("?XF;9V F@76 ;;S"^/WNL1E>T?O/N@3$?+94L3?HUP"V=21G#&8#.1-K1R
M>)LQ<8'QX,& 9Q</ZRLXEKV] :O1>&I+8B9E2!^$G-+\(#S M!+)@$BC"PU1
MML9&T:LW6%O>V"^'7_ASS'-_HQMF!X[A!':"X@<"5SA051.^5C1O\UN_UO6]
M&17P%FW<;8QQ5KNRFW4!D4L&O#;$"2_T]7AP;+?)H0VCQ?G3GL-J!^R+KASJ
M50R\7M?H<_7C"A@XJ_"4+A$>_;60N!":S6'7FJ=X=P2O'KD*L<#3$U1QV>CS
MTQ[0)54K^1*YAI=B$L(W>F2_7^IJIA,PYEX-_#JB#>#I6@?^34.&?\6XHOK"
M"1PKP%JKK=D/-N*C?^>U9;[LY7T"/%;LTE*._XK04J<E_@#9S]EX;SRI:1FK
M*9F*77)Y]^8ZV*I*N]E56F2=3Z%>C.7HP )6L7!\7K 7LCPW-Z Z]^UK+4U^
M,L#=KZI18/GM:G)?F3.;'(V<:$YJKO.S[K$/!;_F3M,>IA-+VY@WX9=(]UQX
M;Z*/;'3R.]P\9(*K[@N$92KP/@B9/#?/(PU11.WP:$\"71_*@W/G&M+CBLR]
ML3-'LY45P1''>92#$=ISB$91&'"]!U[_*H;BVH%[L6\_]5P[W*K+_NQ0?F(Z
M N(\-<3=-8_.14MV@JEP=)IT=KG;QA5)B]SOW?9NBB>^<UNX#<1=G/ 5O-/)
MM)"N3?= SHNU6 L3WK]6"F4D]7%.'>*\)_K8](K[%RUMN;:,++X!+HCVK/*^
M"P[<LQ7'/R/U4@3*P>J.'UL9 J>\?I]YB1T[_'I#Q?@I@Y0&<B;T?K^M[%'(
M\5XT49Z8?J*CK@;MA JA3R.!>X?.=:?I][P?RRQKTNJ[]Q$+3WNIB3[@=\;&
M.<X^-C?N_Q[Z7*3LPJR[A9#8& !6>OQL9R! <47% ?[=5;8]=FXY>H6W*E->
MPJ2=PJ5H'-VE^?V.$:YUQ&AU#H)HP^0)(E9=QHWQ<3II78U-VZI6)[=6AUWK
M4*;(F2/9E35.:SXV(S,GC0(YFR.\ANO?/D*, O#<U-76$>\>4(7O@=?TQ<:M
M'H@IO]TIF-/J$V4Q*N32V*7S@)5P%OD85(>FI(3I/\U^'W_;<SUE=O+\ XF]
M8%F[CY%^R1HBC(%4;/MMI1P>7!MZW0WY$6 =&%W@O"$Z?Q1K_I-7 CV2O=S.
MO-UTI8PQL6@KS=C2NB]CY9%;V8=Y!\^%GN!_,S +4^YB(&<]U]>YCN'X)TW1
MCM>Z *Q]P&>L@]!%HU)0K7_\%.NSFU4>G^V3'2\(8P0F\@),L6X+[HXQ<2(X
MQ96<RVQ!SI5'1);6(M$:],7_7QRTH!3>3+SD$@\(&XMSOJ.XL,+%WG[0F +"
MNA!'$9WPOU63B]#?2_0KP&,9YWUHC&<L3,/UU(H@VMM+>(V'?,"9G+ Z3T[M
M&2#NG7_ZO\E-\O]QN7!-(3J8!3!VG(,N,-*X1KA#N#OYE I&"Z+U90$L=29T
M9FH"%-#_YU]ZX8S==@SS@>5WJ Y1V+JQD1C\@X Z54CR(.LO.%A&X"7LX$<7
M&G$+40Q:_KYXTTUAQ2RL_,=>A,D$(<EK^C$83O![1"A9>X>]V]PABQ9;B<E)
M* ."_B73F\1T_O<MT/_ZUO1? @,^CO^Q"_K_N)CH*Z>_9O_\G_F/_D=Y]OYN
MS;8;_<7_D67FOQ)U_$=>\/]*T7<9.+@8?8?J> ZKB"MRP]Q ,GS+UU%TL]>(
M$I/(%KY6J74+\D[F#L>)&2(+YB+YE[_;CU=FLL5P>4%(WTESTL&UJ/2-^5ML
M5;W$)?M4LS>)]?F/?P)N'!5T+47.D@&=2\P/RP.\STH1_&<67E_6'VBM^I($
M%:EYO_-^-_^;14,)(!&;;/+2VBL(1O!S\.6NX7RW])O\;1PI:>IP>377N,ZW
M:\-4Q[1*X73W.K7I$M+$<JK5S=&PW0T,5^]LC=]-6Y;),@7YF:;)LJS9JWT/
MAO;9\GW"!HXOS6P)=\(CS@U_>H35S=YOCG,KO154LG,6W^.OY.S@H<G3RJHM
MS+J:7D!@H4).E57+98;7P]1_F\G5Q4LG_ZD& ?R727)'U'V&LQ,]0(X]*YUX
MUM^JBL]EG;&'-P//4"/)5)XH/D#.C "5KF[9JV0SK4E7QT8Q1[-88IYV91?$
M%Q?>SM(F&A#171DJ+E$PYU(J!?EHQ.T0WUT<SC\Y0Y$J%;!XZN@V>O4(E8C&
MW_M9?TIXGTA^O0Y_4XT8$SU*;."!J1/( $MLPE\8:JW])XS5)>U=7-D4-KG0
M,M*QOD:T?<C\,G"=[P45WP[!M-72/_HQ6B:CZP]JP6549Y$,D-V#QQD_)] 1
MTT[*5'2&/*VV* HZM059/P2I6C)J:5]V32%&$.Y[H!+^8G>Z_'_JIKOU],(%
M'JW6,"=(.?TYB\_YZ[I!!LS&8$O'20H!VGJ_W^K+/IWX'GJTYR]TK-6,S7Y&
MY2JO91.U]=M< 2\&_3T-ON#K%ERK)SK\T&#J5F2@WWV]*'O[&N07K]JEXW*8
M Q'^]=A7-AHXF^B5MO_9[13N0@B8WH->)0V_2ZG+(('_'F\>NS)XSF4^$NF:
MORM)!ER0.\M>!I_QM*C,4[3-7/P[,J#,\I1Q-@>;4X';R=E\IQ5G%U3PQ\):
MQ]>S_AOU5Z&%Q)39ON_.RF3 NQ;&KJ:DUXM\$W(TIEFB>H7E/.8<M[BEJ4"Z
MB['<+PZ:5;EW>/188S_D$_LM^[;-]\SF8$XPCD^PM:&W9$!Y%/@SO"O!!:^
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M#C)CW=I7M]@T7TI(VA.Y8U0<]>+,3N<;CHW?*1F/IK ;+GJJ.LB<>Y[KF9E
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M+GV-9TV9E8Q-V*AQ3992\!9].>FJAQW!&\2<>;DDPFO#].R[*T%QNP5E)E[
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ML?'8=+RE\.OAW>AH"X46^7N3AS:N+8S<MQH123.A'+:@J7:GJ99:B3T^2\S
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MPBY*_EHRZMB$X'JB26B(:6A+>$M_OY%M6GW6Z_Q*9//Q(D,G#4BV!AS!<'T
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MB#Q^;HTHL$:6_7K=M[=_>MM[':9H%AF9M.') Y; *;+ *>8SD4L 7HN#O);
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MH=FQ$*T%XW]/I_ED&AQ8 =XO07,5P?LJ?YL*H)S554 G<D()LT ZIZHT8/"
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M@ /Z17\M<#"QP!C8(  '%P__&@C P #_^2SZ !@3"_OW21(  P0&8V!B8..
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MMP 5V ^%H#]:TK'?+:E-H]=0?]+06&Z6,VSTQ^D8&[E5RW#K*Y4!G[PS6)^
M<QR7!ZB)?OAU\TXBJ?8!E97 23FDS\*+][29#GO13X(N_!!\M/*1J,XD46.0
MW++70GJJ9?!U@_+4I1%RT$.(5SF:DF[GOHPE"O!'%V"18>AM3^.^O+$7J'<2
MT[!-$WKD1GR <S$DAK"%G<;UE7>O"%[JGV3_/N/Z[] 0_AM"I@.=9&@;"$>&
M7@WJD.2BXYX06=0Z$-+^8<,MJ?X#DF%M[V"M\]AW*"IP(%HPJ92 @7+'NTN0
MR*;<F&:5KW>OL,ON9;"0:\\,WAY%K^+&R.J@>T:X14'0'3BC@]?2]"TUJ!I&
M&K-HJF/,'B2>\V"_W\';-B4\H6*WC'3A>!?OBX:2@\UQT*C2ZD/PX:$\KSE[
M\P]M"Q#%IK1'=?KCQ]9[2AXSQ"MN7+"0&D3 V=YEEO"2Y>.E5_I?J/E]31HF
M+4O/< [K^Z$EG4DR#)3O*/CN*;2RL&G1>#8R+<(_'5=$R8QMZK$8E6$9EJGO
M490:^WB3Q.""JV_R"ZD&=*Z('VT*2-MB/.L,>79CW]IPT;Y)\&(\ FEFSO16
M-?&VC]6INX0#W0=$9BU)AB,\!<^Y><W5UI4$GV]H*4[(0V"]3:O7V_*)?4J7
M3:S176O!CTX3ZC?E(\##4&ZSO&;&@ON7C7&6(\EAM6'K\/2@AW>"[HC(9<EI
M+W"JG6M!C<E%HB/..I<''KP?;,=T#^?<PM;7JO-M4]2UGMR)A6GT#9W7^QDL
M+)CIR1\M2PLV2WJ=_?=KLF&PW[\_]MJ6N.E9&T*Z9.%"@3NRJ*D_?T]KAM//
ML@<L:Q\4,/$4V%N2FZOY4343K/]Y?NCT[DR%]//,YD,4T LK4H\_'YGO.5Q0
MWQ,IF.K5_#G<JM(BM[C\!.XBT/!)8UF@B_-#.<T=X:T54B:E9YN09![]^[$&
M'Q.J!KG.*[Z+Z=V^?J#37T+<2U4HU"5^@F>6G3=T9"5T9QV>&:1Y_+6?6U>%
M^FUA#HW:S%3'S9O/:0YP8FV&QWMI#J>WIXS4SKPE!"0?>6PHGM"QX)W92$AU
M/?6-5KP<II$1(W!\-TL3DA)00A6,9QDV8 (M]"5XWS.33 ^^#F^0[I)P;;\'
M624^R7<[1;?J>\Q_]*U"HU">0&,>UV:YRY /.%WAR/>%6A/+WR<.$:]SD6:A
MJ2*MV.!CLL]0P2>!U&D%#-&-90G21OCLDG:\,^%^S[OT-B-M(\]=?1X6OP]P
M&E\)]OQ1\4L\*FEXLM"8C[HOPNBB".$1X'I]&2V?28IT&E6H7\)7G54IT#Z-
M:5(=O:1[3)#=]?_BVH\4A^P?W&,OO?L&\6'%;?<$&I,M _W4D>FR'?"HQ[@5
MFQC_I,Z6!D> 9TR8_>CSX7)I1W%KH02C4RXO4ZR>M<-^I<OGCBQZL8LSNTS7
MNGWHX 4-6VI]W;DK94@V S?MYY7OJAMZ2TG/M;T?R# N5$*X_.XB;@\LK0W$
M;.T5T%YDTPLFE3<_;VG8'LKH%6Y0H'\>7Z47M[SRRWDQT<ZKI18LI]U\$<A\
M;O?6-<N?;S4[/2E[Y<4+Y+$2& [H_,AG$%91],].D!H\+#S,(U5DS]UA:UMA
MF?KR A,+6^P?;$AN\@(<WI0V:9/CH.'%$]GSF9S/*^J<;)(PMAL;]P[WNL -
M-?KM[43$3/ :OOV!>!0@VV-W)#&B;A##D$=[F;L0G_BA@"BC1<RGRL.OV$EO
ML] ZT4AGECBT"ZQM.,_*_E%CH!</=#D<KN)Z/V;$O"YJN%?1'Y)>FGUF[4RP
MC^^#-[<!'0*E6[U%NI\)U4D)5\C1VX27R24]]B$-#<UI84:4S<L=U=)>QIS!
M>9:\F)4LV]'Q*#"Q+L3ZO4H?@^*ED$#&R)(N#H/(.L=8;"]FT>C*X&E(.')@
M,AD%]+Q' 1$H8 &ZBDBA4UF&O3L.&H/]Z:#OV"_S0)U=5N L0<]31HXD$+><
M.F/,?)8]6(V7%X9\E;>1UZ3[EXU&IOOI'CT^?@:Y]N3"AL: ?M*29'P\+WDN
M.>%U7IP\"DCHAF-<9^M8[%3AS6/>AG.3R=^64 \'Y.XI9M/N4XM/O7N+$V>[
MMX'U,*C8#%XG\+@@=)&0:VHM:?9X+3(HBYCS<X3\/O%Z6#+,)(46(<UA5G2O
M/B9:\^NTM)DEP9[EQ(7I*\.M\:"Z9<C@@3"RC,'PU-<X4;?!CYC@L_9K>PN^
M4-^RK<OWN3J5YXEJE"[-1ER#]4I<2:]G7C"W -O$THC^*,PNE2FNO8!GI[!H
M"QR-#QB=-9 SN_Q=D^K;2*PSPH'=BX^:58YORE.:L]![:[R$^,_3RH^K/WY/
M*ZGXEE$ +VM] A>MX.Y\:Z7?F!M!9I0X;0 S>TKK8:[*2N0TO%Y;!DH9M FC
MIW\(C[^]D';VI%=OG5/>M?.GQ"8LIR?RPZ15BP!AHQ,LK3[EW%^/KZ@EG"S3
MSY-E["<Q?:*=EL3G68ZZ#W4)4=?4+TGQFWO1VC!\Y]Q>:WBZK%;%1B$MT))R
M5M SM\@ @1#1PQV2_ RF?:TBBPIDB*FJBDWVQU+@<FW?J59I(HPS_9]RJ&<3
MD(GV$O'AFHCR%2--4ZQ'MS&R)_Q_'J(#S4>MIJP(F-I950'2K)QQ6A4_9D(=
M^4D]<#SMO3#L*_26+XRGL8PQCK6 BB W1)WVV3U?\8FH&W1D%U 7SE%AWZ/0
M/OVHVF#)YXOHQ#*^W"&(STV[M-]SI]\Z3O5G3S&,R-2'KE#RI@3E74@O%>NG
M+H[?J;9@L\F^1Y(9H;(\P,,]V(_IR%[,CFWX<XF45"[4Q3(%S[-]WA7S2)X3
MKA*RE(Q7.YTNP+-4882S\J(O2(*$>-]/ "&_7#WM_O:VJOWY]93%;T,OGB0<
MIQX]*,SPKBXGD ]VBO.X$5Z^PW\FR>/^/-ZHJ8!I^DED:I*XW^<EWDO]R^O[
M"*?'W+-EO*PY[@7.,(%NFBGEVVR@17BYZ %QTMLQ69[=Z@ESKS,(:1Q9 1LO
M*"5;YO@&WTKD/$*0B8$M%NI%9-KQ@RC<8D'L.XR7;.3YU^FN]:=Z0=GT81D)
M,<K,]57V:0:?W2AU_Y:+J.7RR4)CWS8=H7-.$;\JQ[C:U ;EI:EC1F%6Q%G!
MZDC(2H0AS3+]DQ<?= :=SC^FO?>T_ IE?>)@G\S.'*EGJ$N0M_U;.<P'D(2;
MHP/\OFJ(UD=!-BRWM'D?BG?#;[;?W>_PW]K0@83#O:#1:.'@MWAWNP+@R^R'
M7\A4 U7H2H>-9(2W/;"]5Q<'0UU].%;KW@6EO,Q908<_3N/$^S.<TH*,0RG)
M#(P+:HA/R_!O@FF!VE[ZB4N=1=APQU/;=USN'S?JF7V>^+#1;B>=WZ-ZGH+>
M>T5F>L\]"W>[GFMKW_%]_I+MGP3%CM;\W:B9G].9+K4F&[YF1.9^!HOOG)0)
M!W-;;Q)*2%@M$E%D]\IH7((Y4H;7C#BTI?UC78YC7JGK5]'])9P^KN]?A@\-
MA@5J4^@F+O6^884[^B[1Z*\.^>9O?]G6%N;A.E3DPN$U=]G33RJAVC!8BF.=
MSM3=[<37676[A<Q*U-A\]/9% 8,%GLC%_V'ON^.:;):V8T410024'GKO14"!
MB @(2.\@TD&D"4@5B(CTWIN"2.^"2)$2E=X$!>F]29,2:B D7U#1A,?SOL_Y
M3GM^[_$O?[OW[ES7S,[,SNY]!\4;Z4E4@A/E)A)?#U8(=I84?CB71UYA6U@O
MHYZGDZX0<CW1SE:\EIP9],NPE+]D)1!@O6 ]-7GM(^3ZM1=VTPT0(F;M(NMH
M4:'S5LWU>#CWTF[K0W%<$TF,1!.?#M[-!G$TTC'*,^@R)4T:>X+8S!A=SN'A
M-R6_]F)L& \FK*SE@BY'&W:*L:X*S7_>P#L2':]37/O0<&LK^P_1;42BS#NV
M:N&:)A5S'Z^3F[C"/O=BON &0"5[Y2VMY<K$BK?]L&!3!9ML&Z58J(H1FU27
M?:65FBBB$;6MZ<;*,);WI>U7*R!"/RR_*85AL<C)>PTH#XZ#.;44W:&*WGZR
M^!ZL2.&C;F+=@7LD<'3DT9H :C459.@W!)6NJ81R/$[82YGTX<G(&[ A'.X9
M;J[Q34,$>.HSQFDORVA$$GS,;*21JQ L6I'R]IV'Q)CTO:I\F+EYN]*=!I++
M1N 0^<%F#G1IOWA3IR/S/Z*TRZS78ZY02<#O$XJJ+@OQILL^39VGZYYX&W5O
M3ER1M0.+C#LUU5#/[(N\6]>TS2H>7J@OKM[+EJKL)6$>[F@AK17G5]7*M*V7
ML6:)@VY5? KLV4]SW=OZX:7.ML[7*I8:?U$G-L</>I\%GL8*#%_:R\O4_##9
M0\LM<VG^U#R>7\O;3*-(XB:F%Q:AK<Q&_ $2M&4LV7 ADR'K9[-^4VJ68#;-
MA ZJS'O1='L,R;E'$IEF4<>$2$$Y#K[ ^7&P4V,HT#)GN Q00!F$NPMMN#I:
M$2ZS^5E1:N@L&*=<KEOV.O@Q_(,K>+H 7F \O?AJS\SMI%78!R1 \/E]F]:U
M])N1IW/K4"2_B$.$3SIV4$8^]-_?ZJP^Y8S02D[DO'ML8MVB-$&HJ=8X[<J]
M-Y0NY<7).5%A0Y9SF;HS0X-2FD [_5G$$[UD4?["@8$GD):F51NKSW*VYVI*
M_:%ET9#:(82HVS:B@]2VL&+U+;..Z=>S47 OWZE7)>-,0^XQ%!H OL'8<RCU
M Y-;3T<AEJ[3P@MD=[Q,JJRS9D.OX0_H3<<%>]T"48$,+A6VC?%:^034/']O
MZ'?M:-:SHP]QWYAP]&$;:(.G(=WITNYW5TQ<[Z4[)W1]F<YPG$])':=:M1,9
M??7$1+[?"U6)(P&ZT=,;V>WQ<^]*IBP4RF+\N[*30OTBZ]NV/'ILHZ^8_06.
MFO\WF]$+E#<K*Y(T;LSG+;:X,(P5T6Z^I+HAC) 3;O,_ECU/F1VW?/6? JJY
M_+0DWD%3C9I(?_RUYPMU"H2+8,*]5X)M]5+5WMH>>KI#9<L L>%X+W"==*MS
M;6Y(A%12Q\TNOHTN6DV5Q:S,CKJ]_:]?#8X<$;OH6=272[;V/I(C]V@::[.7
M#\TSJWI?.V$[6[ZQ>=OXAM31G4X/L<Z,CR)ZNL[0\48'_DR6O0@W.Y5+G]+K
M;$<OQLZ9DJB\_$];_G?S=_-W\W?S=_-W\W?S=_-W\W?S=_-W\U_>O-Y%I--Q
M(K?ZII7NO-'=914R#=>X@<KNAD\C&9<*-KA?.64'_W[X^^'OA_]''B9=RO4L
M(++Y_TD5FCGOMHFLCU_Y:R6PW\W_7%,#ZUWTMEK5WSDW)Y'?CDGGKZ'![^9?
MI6FE'9>3(<T^\7=,50NY1Z3EB?M7TN+?TM1\7_&YG"]S797O);AF@MP/A@3$
M"W&3642]D0U-YC#<3BN*8O2C2ZY\N.?L[-9GFS2%!+0BS+W:L&^RK^*5!+_D
M; /+%=.I&!O3/3'6^@60;Q4DY(U=_"?"!+4^ID)O>?X[#.'$Z4S0WGBC-3K3
M.^(G<%0F :0/\0S=[*ZKG&KU%VCZ;[\_O^U[2@;^]TQ09J@@Y/_K\/\W-8M&
M12P^7WMEIK!,O&.+!.0-(SSU,AGQK>QC3SE%NN6]QJ%ZD;<D)//97J6:=0Q4
M1D*F*>4=;DQ&C)?,EYI:/!]3&^17^^F8_OR@S4YHQR"[?W4" VLWB>7K=2Z=
MP#)K;B+UZ6N.KBH&*J.L&2/L^5@Y+BV#-\\T!_(^;/([(X1USWESQ_RQ9*?I
MT9,=:Z0]3J>I(LZ[NK;6 3/2W+>=-8,\H[UN>=V5*X 5C(H]BZ^AW5228@!)
M;30?L:2G)BSN6J/L,=V?,BQB,H'W\73MNSICG(29.2NE=/OK:AR-A>].2 ]2
M#<C1:R39OGKI::V%!#@B 49&S34R3LWW7O "M+_0MBO>?<'_,2*<F2J>"6(&
M4?$G?*[.S@1N:S4%O99./[:9*A.Z;5C!<9*22NX^4&#0HBZ/?34DJS;0?;2+
MQNCF)#<#/BQS1L?]&C#W^D:,4 W_Q+LG:MU+$I=WIU\03DZ'7>'-)VN/>3U)
M6.9AF1I.KNLXMRO#DTIJ=_QQ!3-,1E:(AN%=4BQOBZ=OHT3AX&@Z=_2&9J^$
MKE/[I9U3E)5*H?UBE<#4<^PFU(09P+9$=?WBO"+53K[L>H5]91OK< J$CC_C
M"1,;PB^GI1J( @=:78V*!ZSCD=PEMKT;+M>PFSUW*_:T0<-Y1WA'J5P_P^F!
M:\E'X!;;QN7$SIY1?:.-6<]B&'""/_AH-)>0R? G7QZ\LSS'S<ZYN\3=#,FX
M(=E'\M"K&-[PJL*6W'/<J*OG-O^.&.UR[3O/,)XJ+XN_EB/_ZYN>&2SY$;)_
M>LJ'>M5BIK^4 O^6YALD@%LAV]:(9)?]$A*PHA2ZW3==-/\A,F[K95MV=5^.
MTDS?XU)[+\2._18S+3VE)7W3"_]I7A>/S#=X*68 C[R7VPEX'[:7C<&Q.X)E
M93J^VQE1)SE<O3/?I/:Q\YQG?T&F[90_6[1@R\<3\.B22/<F[9"Q6(:Q#@F\
MNH?$*BW 7KW4]!JX^7:RPRF8\13IZM/J%E"L*WA.U#5J,JJX:%QWFVG0YA.4
MV*2TJ8&SNW4CF$;$D,%'2<U@W6M"I$']K "^)>W5&J<NZR_I_ \<8EB0@ C\
M["UKGMKVYXR&5Q+@KZ [(]?*G !"@,935I_PI;./U;VRC;]E6]V%!%QV<=5U
MDSA_C@:7]&[$:27Y*" H(YXXP4QPE8>)2L?DU$.6X(=D1\*L7+82EVC*NO-&
MSHLHP^DGG";:<H14^DIU*"4:XI\3@02^]%Q1U7]&P)5]#/QBNS;!#FH6KIW&
MD/,,J']2=8H+U&)>7QU4,'Q!PPB*G])JUMY8WZP"W9+?8]-3*2=/#_<+J7RL
M5#J:.R7RGH>_V#9P@U=.7"%469PPAX38&@^VT>*9,<'NB]"3'W![.?=>^EP9
M4S-"$@G@\HB,D74?L/UB*PU/>5Z0GC5<Y14AQ<NETA7O-'%CD[P&'A5\\MP%
MV2XS3VO"U(>J >=<\:,J;I)!F_;4EKY(]07H^<ZQ058S= 2 0$5O^*N:@/[/
M(6/>E3R4MS;9A$^ 6PKZVHD[KLRTN;4_XZ@^=NV-'>V8T2Y['Q*@9_F0;YAI
M]83NT18YT1'!#/WW7OX&NG-=A:5'XP).AYR4_VLY^+^\F9,;(>O\9V=I#W.Q
M)/T77@ 8Z"5<"-(/F>%6?W05"9#:O=]*U15F9?E2'B(GR9_ JW:/V%U(J[^$
M[/I$##,L/">0[))89>MNR>T9B,4*W#SR8?&GL$Y9>$?&4TY)KJ2<<!\D0*?[
M&I@\2BZ&A^B"Q-2"IZW),4X%.8TYI3H$+36'5=@4P9- @007Y6-9#.DT]Z/3
M5#-;Q,O@Q*WIKP0_7*Q+G0(S2N0-L&68?\II:27S5A2G]/+_(NZC_-SO6J.Z
M&!+ TL,)NU.!!(1[(>XTV98Z>YA@F:=IS_64C:I%3S$(G(_E3V4!>;!.6/2>
M[<>Y"B"5 [&#)I/Q=D$P01C)FEEH!/ ]Z1"B2OU"T'EI,=.PY?H3KN W3[@I
ME(3(G@V!8U9:0!]-8DQ%7"K.;.$MA)[?=E\$MY.>K?%WTH^9/?_RZ+ TB/Q^
M-K^H$%/BB0(E0,!-)$ 0,L*'! 2U(@'GW(AAQ>W-2=/RXNT@#JO@GGA;T@W3
M:*FVNE2.9(&+Q"]41EL6POD?,<U[?ZIQ"_3(("%9LZQOCC6Q:L-K]5U(J!YJ
MW52[;K9G\Q#<X,LNG$!;%:@7.[ILFH($D$ F76QCJ8+<6D5:GO@FNUQP*'O=
M_328R&1*X86+=*M)D^#*9[K-Y=9-41LQT+F-.1HUS2Z;NWM"9-R6W 32UF[>
MMFG,[J(S5S5L"1*R-U=V>^GKW?KNX3=E(F36\->(7L0_Q#TME2DOOO,(]]JU
M^'>WQ$!-I?]MP9##>)-9U_M/3LKIF?-47:'^CY/^=S=SFL=TO)DF<MX\PKMG
MJXYU(?3!U"9(A;*ZB&[GYITY*.@+O'*ZE+Z],17WAM?GP H/PJ+89)C:F:U5
M8D$I5^<.NSU@R\MY@L#AZX\6]KI9-XV0 %#F9W_^%S?\&:8"X:@@"G$;701-
M3>C[\DU-1<#<.:K*CML<]ZBN"D_S)OQX8SC,+M./T=6C 'KE17 =#>?&X!?W
MFQ=Z.O XO=,3QR;PM+$]:#+?Z#\[;VS2Q /FN"/][.H+AO7A1%C<!NCS()5<
M:8,P3=R+CP55*;S-YL!\*^JI#\<DQ1$*L/6^[>G8ND^2C"8Z$#Z]NP&&KUY%
M7+*JEJX!)$V4( &BC2< &=>AIW8YF1'^7=.O0B>C)UV3GJ3=IX4,>P6T4I,2
M!D!%XQFBS<AY<3FJ*MC%YA<EQ\([Q\*+X[!/VSQ9)YE*8%W@(KU3RN0X5?EE
M.QEB&:5PK<%6^-VGM5?=7GY%B=U;_:R("N(56"')DLRK4.;;(\3+H1=?:VBL
MYUZ_KJ(FIE*SY[0<<9X\CC@2HKK<[HHS8E:L:G):D$:>* N'!1M*V4A-(%&L
M-'%JF6/T]A"W3I,ZUT4S=?6I42HYKG,DUY.R\%JM<*W.]Z>6WV8S9CNA5LKB
MM2F]TGQS$,=VG.Q9QH>"JOPK'<9)>><IE<6T><H"D(#D5Y>PR&KNI!(8J']N
MUW@=$??%RCCX_4A:;4!F>:'>6M_D54:_)#$A:&R,;VS*F (S\5HX$A ?V@'?
MG3*V>F+T+M;EBGBB7$55A-I$<7,+KYJP+S.>H?FF[ZVHX*Y3DOXF_3KV>-#8
MV.GBI(U,&2F^:+ENZ&UE9XI2@YYXX^"NF[37TU\[5'^.D+T>3A:H7!_IN3>A
M\0KT\G0V]T4\KJ#7:Q*;61E7=+1H30>[$\=.+QU)!W<8/7IH4J= E>0BVUK;
M6KIPXNXGML]%1N,[Q3R7WG./G^Z12/QKQ-"_+UB?WW\7W?=G)^5;QQ$I'*7X
M3Y/^CS7)X&]?/:@D4>9G:_0F$C,TITGR8J2TTCKQN+4UG-A*7_TX5P"76-^C
M<ZKXX<+]C1$FGI%_$>)_M::J?)QR)?:?G*26WW4T>TS\/T[Z=_,OV/P'/2EZ
M0=2DK+/>+(QYL5H3"2@B&S_:%W]JS5 #^$2]Z4YX4VW=JMZ$7<?9S 9L/6B%
M 1+@!ADI=^-S?COZH[5M,8D%;IGVW8,B :Z3XX5!%$@ :PQPJW5O(=2GALL)
M7G #/*JP52!*NKT_BQH)< <=S)KRW5O_/HL,"8ANQMN=0VPTUNH17T%HT(&6
M,W=[@6?=])=AM\*0@)KDY5MN_*M>D&G;6L0.N-IVY<.^B,F?(O:!0X!;73^
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M!D 8!D 3.L 4!H =A@(5Z"OPY]'N_4!K6D+!E1_ &3NA\(8.\'BN)*(@RGY
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MR0DG,'H]!$Z@D%6 F>IM,S0ZE*/\]7+,STEW'-C1Q,UKHR-U8]+(QB2IC*[
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MI%)@J-,SWA 24(-*3P]MYH(?;RLCS&%$K,$T#Y1:;@RK.IGHBT*Y2QG)4]N
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M.^OSI:<ZNE)Y$JM'Q(NPBIJ@=D;48=RL9"<WWF!KJ5\E]E1ZZ=1ZVF'5'Q(
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M4N7/@&$;BX)+"+1?)F6I>JU1@T,T<*T=BP7.+$D+Y\[HZ)("\O44NRO.;-E
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M3?4S>OGQ-'F;M"CO:''UX;J;/\B!<QSXZ+O.2ZDC:T?I=1K@&^KG>K#1!O3
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M(>16/:[NE!8=M[CA7;K('<89I#.I!_<E.]L7YEFRB\5Y7-TSA+&Z C3#9J\
M/:E(XY%?HF0Y+1+WX<,QTECGZ4>]#Y-H4*R@IUM_)Q%]^U3W^"'-"MU-2593
M8:Q*>H5L];3F+%W S.'IQVF[9DM\$JE<;%W3KB& %S1J^DK\;-/=L5C:1+UW
M]AVVC,^Q?>#>>V*R!@W-V 0ORF.:KP!=(5:TZL*16[0')W6+@R8G63 DW14@
M[(,%<FWO_15  =.PP?;5E:C ?$&PG#/"3[,C1$Z4#-W9U=O@ BY:C>NQHM?1
M27@J_L5:K/1AW03D*[#(?/O[7?\O3:%$SIKE#Z*P.U:=:W@%R"O(79%Z*:;O
MYX_$;?I@EK+[B6;1_==/U>(7]_*N #<NTYQ#MF$2L(R?F&Y5+Y/&[*]!L:1R
M +='8VVB%N21:\,"=N09P407:O7!YY>O9;?,V8]&JIYY<EOS&(M@HJ&AR: D
M/G%WWM4F<4W'H0_9FLUA!AW[^(_/<B(G]O>7JS>@H4G6%@-_[9;+IH(O)Z?1
MIB_+_6F24TX[RC^C7AI%E-!J7P%\E[ T#&8L99BQ?RG]+7L+]JT?TP)ME396
ML_FF,6/P'PX.JC4.KZ<TQ!(.4V-Y60&6EV44!<53XII#Y4&.ZUVW-HP#5RNY
M-C5&?YK["'ZPZ)MO^P3OI"H4H3EM;K?967AS20.^EL!H<X?TM/;^HMUPJEC7
MG"C;K;['E0ZJ:!%+1BJW.FNA82;"DHS5-B9Y8@Z/ IBU0D^Z11EH]8$_'OJK
M(6+(6UCWU,&D#O/MNH!-!$1+L":W%XV\%K.:>F1Z\Z(,#>IS<_%@*"PI.+-6
MU;U3!L!1CVA9 A5:?'2[H]J:G/_-SJ*4R>M@V=;MOMNK]@2ZF"GTQ)Q.,5@M
M_W6@P;,.^1@9N7G4%M$3G2*[M;(]2=Y/?43UX-F@GE1Y37:WR-8RX:9T+\9P
M)AV/O+(>Y1(QK3@+C"-V 0NO !97@+N&M6*9-/)34* [-PIV,=@A@%5AZF+#
MK\49FP0/Y3$8GN-I#!,(M5F#768*K^S>W81+V'>W4E%5$_H]R3/\'XHH$V2(
MHX%:!V[%4'&#.J87PP!R74':2]3M7R00LVQL>@WHXW.S1! KG:Y8VW6HABF[
M14Z@D<>LMGF2LLSV$/EW?6$O+(_%6/+OAZ\Y1 IX7:B2L&X:ANIQ903GK&&"
M_LFZ:IW($JH_C6']EOHF$.5,&P%K0WOQ'%X!+BHN<] .4???;AY<WGQQRYE/
MZ.P [Q&\2[((PN80-.H0D$WO?S\+.%16]C@\)9(VZU,?^7A*I :+;=Y[JIM'
MVXV6&@ W29J*L8Z8NR_YOUR_'TZC#7[LH%IXP[0U@(EF4YT@2K:)HO;4_UZ&
MB7"_YX)%:-P^X64:XVU7[!;/R!)S%Q\:2UFIJT27&5R61_'7X<2F]89I<0Y_
M6!T3I"&-A<UJGYL&6K]]>5MRU99@FEUMT@*%PY7">D>-6U+DGZ./#4SY-7P"
M46X/M?^ ?IWY8:T?.@[G,2Q-Y(?<:NKYP'7_'6TNE_F/(28KBR?9VQ@?6%<&
M9\*[3T<(]"3D]I]6G5"V6PUJ#E.@:'I0*5 $FQ\XS=Q8ND?6.Z97SX=;050_
MS[(T&PE"3:)32E4R1D8$8W3IU88)HD(V:9:#VT@WMW@6W\.H4U>6E;=/@\:_
M,)XX8!KVA<F;*&,4>#CM[-P'Y!_DY>(7N6D]>DY'M$H"6X.7\\8P 6\5J8?]
M),?51PC>RKVO:/7$H$Y0FP*[LW ]N@SX)Q:4C=X9,3(^(;)D*\4GY7(#AO6;
M)/&1:LZEM29<,)>.)^>H)N$9:.+#!,MRD1-<8"O,FH+?[DLW_53>X\'O)^:+
MT#-3%]1MYC@?J7MQ3VA_-(PF]0^-1\=G.%SS]]Q:M'QR_TA :4-H64Q+ I6Y
MU5QK6\ADRR$+N0&B>Y$@%DC[D>$5C>PQ*?=WP@UVU$=9 ?.TU-I$V\4]RQQ!
MK )8PEFI@%-03L@0:Y%;E"^@!$..I%48M)<^F 0=&K(\MP=;!0*3D:??(Z&N
M9B'SGVU, \OX$$:V#^N>'.H$T#%VO08;:S^TR3S7Z\4<7 &&L>Z1I+=<?G3?
M[ /P&^LYXAPUMLTX".H0@KEU;,-/(ZU</2EC3$@_.PS+$>OB<[#9^UG:-0X$
M!T5#E@=M&1](7 %F$Y9<8;PK)55;6L- "L;OMTCYN_"$K146M&D0U*S_$D3X
M\_=N]LE<U\C7T\'?RCJFG:<3X*SX6)*RD_)'(3^.OO7_B?00;2 /[+?[+QWL
MTD:%6]&^K/N#Q_6(91G#2B_&6A-B_J2;$4?():[ ]C5]X9M='OEC>7;H6<7
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MR]4<%U--#@%^\QSPH8-WIY,5/W[)4=5#,7M\G0[EP^MS"BN!GV8:&A>9I'5
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MJ+&'03B7>IT[4O8'6N4MSHA_I9!%;AL0-'.Z)KZ$(HAKW48Y/69=,N6]BGR
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MUGB=A8;'H"MA<5> /[*S<<]*?F-%S^&K#1=CB[^S>.[^_LG?TSH6T\![2E>
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MLW].U6A58S6PT)[BRPJX4BF46ZO'42TS>.RW[R'BF36:/<;_,(HUZ?4J0\G
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ML@EK/[.2QNQBX"+"DD"$039Z))O,EAGXZ RDO9]Y+F1T@6_^>N4B 1"?C4]
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M7/+\/B'3US=$>'3_V_HWZBKBW9DPY\%H^-K-/^,;E#(UQ"=SQL3S"\6)X=6
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ME;H0#\3WF2'V\*-G?O9-(//D1.6>BLRHK[+H9RXJ9 1W4"L3>;+-G?"VV(=
MB,HHGHR$,GG>BH$#SZO<<3\EK-?L:/,U'<Z6'\2N"J&2_#8-U6K-JC^B)F?3
M>DDS!."/ I"T)-><.UG[<F"?UJR4JVKG9;4T R%"PKQ]-VJ:)XL"8)6*$XY#
M^QV((BPN?_SE'+G6%@SJO0Q>CD=*/4L:'AU<4RNAB,J2/O+^ 7F7':P2!4@1
MA-87L (]OSDY3OWRH0<=A6'6U2]"*Z %F\S\!4?A#?GYAE?POIH%N&?3DD\
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MG;O),W!#@=I5C9AGI$KP2UU,267Y]0&//EQJ@T3,=U6:?O;U?G)"2PA"G49
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MZM\V. WQ'E@[!JGU?6SB@@+<EA!Z\QCH=<G&1;7JX>P9PXZ+)K?# \48Q5$
M@;GG'N4CQULD1L\J3G?%7J=0'S_S6GNJ"4KWQ#+&WQ9<D.E=LX)\6\G\C,"T
M2'G6J(S=32&2D, N5*9"_#/[06V]%I 9:];%]RB .[UB4("%LG@!"L LA@(8
M"<':.*1.JTW"V2&B[G7&XDBZX]]%@0LHP,8H"F !\E)TZQ@8+B^,)59PI;LA
M!T-OK)(ZK/,EVRN4A1%0)!S8C-X)!RB2+#JI @4AO>C%R<\;R99/OVB#.3W/
M:EE\2\C^4MB?7EO\72=X=A0_AE3U]>6N>2,Y\@V[YIUT%T.?AI_BN6#!!/B0
M#,SJI2O/K#K,ATAX4TWR.LM'"^#BF9&\ K\19&@_^70Q=?SU5<^5@^CT]#H1
MH&DNL_-L[C"1^- 2XMAWKML-/7R7CY/(#1),_&")5;VDD,YD=R\3_N'<*#>[
M]NE!\;ZR;.&Y]!?=4?"NC3$4P P8<%X@4DJZMMRX8^W&K*+?N@ZDC3)#SY8N
M%1(V%GSNV2'JGN1L&:NP><G2 R'PL?5G:.^ R@WX/(/"@S<H-_I1 %.N*6NB
M*-.E3_6LZS!(FS$LL-;W!8MU['>(!3 :1))&IJAEX>%>8#Z1;B08JYR^7/7*
M5]*.AMHN46;AD,=K[3BJB7"#YP>FZV06)?5"I</2?Q @\[68/B::49$[QY6S
M#KCD=#F=<Y^6IB$<I%1AO&8L?%"9G9%T:EYHQ>SB^ZI:?Z^I,-];TI6Q9LS%
M0?J/Z.W%!ZO4+?1+:3/>4,M0+J=I2.5KK&D(L:?3M[,. ^=/5M<GTHH!HPW\
M&V1KUSY!@T6=S%[?>3I)4Q+?3<AJ.R6_X9@W;3#*+R) *__HVG/6(T\*-.W"
M]%4D&\"4:7>=["2?T-%TN;_D KG97+G=^,@IM>=VC(Y]&KD\Q XT7755H%)1
MINEBJY"(?'V3OU7^)$\W$[BQ(ZOL6^;J@7_UW=U_ZRARPD>N%%/'^%0*2+\A
M4^?X-^R3$PS_FT].F*VVJOSFU/Z%8)%QE Q]G0>>X(5C'IU@.=+PS0A8]Q$R
MEV^+^0ERX9B$:M&?[US_KJ)9\46J8--VN1- +VU9%1@*X(O]QIPR0\LHV%+L
M%B(;=YW'BK[.8QS5'G(2 ,6,9 S/WJI+</W3IPND9.A<2W4=6OHH0)X(#945
MU![_NC0H(YIQQ-$\_+DF92W3+9./GY47I\.XV>^245UEF!=;;1^QH!F&"@BQ
M1FC02[UD AP_+M:]RNF]?*-?S?^+^J/T#=L1V[S&9P;^5BL\O:][Z86Y-=5?
M1:O: D4X[NM<.'+ E<?6,.72?:H$()/W/LNZJ;ZZ:YQ&(F_.@^X4%O_T8COB
M)/*34>N,6:T4T_.TE@17PC.S0V$4-A3AA[/<4T;!C:>@0#+92"(P;YNOXY1<
M$,5[QVJ+GE$U,?=71R3M!Y77#5.,WYC2-7[G8O#R'K6\J_\T3K[%(+%AX&EE
MP^&(Q,](,^DC'.=8CW5#CI!X[W.H*[<3[%VN"V;(F'3\P5/!V2PBSX\",('B
M-PR:4(![:X;YH)#*K"&$8S%I=RSM'1-74[]:()1U' 7064(!>MS#!8V'YU,E
MT5W2/9VY*CHC5EXE*[^7#&:7AU'T.YH97# OJPZ%PH._NJD3]IY(DIUD;0N=
MDY(%AC"W(DH$L[Y69X(SX]]4/U$Y%AGLD.@*_QFHQ'L80)5ZVW(V(^U"28Y4
MLIMQA! C(;LZ'5&_I@K"2FW \XFLJ&:2U>#"B*V'Y@L-W5"KK[ FF-G7.!7%
M^S8&=:]O;YRALA\H#UG)UX&<*Z%KO!7BGR[DFKIT3O.Y&6=6*O>C %'_CZ+V
M\;:(^>7(M]%-B0G?!T96\E//S'=&2-+'Y,A=EH&F(V/NN<M(!HBE"R[/T6,.
MY<&"7E]?!(U?K'./Y<VXLS#43(!(+-L?;QT7\E2D@S62J[R-\T?NGR;Q^]?Z
M1KHBFO!*W F*!_DC,D]!TJ#R@*,3F9BUSD6_Q^=]KW9(4\'3V+%]LUWL@JJJ
M^S18EFJOJA[+F[-@#0#\_"XF2R/XYW>OPIZE()\[<;%H&XFE2GOVNXER&)B9
ME\:"P)#!=!@(GGOB:\]@G)W;/$=I4-*EU71VA/!S$2F])A%3S39^AZ8)1-.4
MP8;Q,UEJ(T-(V*ODGX$#MJ<Z Q\(%J[)R9SC?9!<JI#A!].\#)8^I05E2&'M
M!%)LR+.7MCO&+8/$D"]]FWCDK[HZSIQ-?JH84>,FIUO+<'>:Y-,9?UAFU,I\
M"5O$OCH^E0^]?;'R8,+[)[7\BRWR?AP>#.I@',O_ZD^9;VM\;C^(R8]^1)IC
MQ<AR[1VK[L#U",<11,M/-;=(_^S#/]Y%?1N:_):I4:AW6N:V58C N<9;Z:[>
M2U_5R\ ,J^G&;\SV6V8Z#9ZWU"^/TG14]?[PVIL#S3=/<W1Q2O-VA9NKS:HF
M;,2-M)>/J?DT;;-!C%?BW+XN?L*HPUE-EQ;-HAZLF1&I-Q8I93MRBG<PO?2)
M_C9]@,U?<R)]CD[RFDM1W9UK5\H_,P3?4=5KJ ^R+'9Z*$:1>7"0F]0EZA&4
M3R1G?#CAD,SW"<.SWX\L&,FXWET_.X%496$.Y"I*6*M,6%.5%Y!LC=8I(FH(
M)HRX9*A _\[UM8JP?4?(I[/%2FRFUO&GJ$JGOJL=?W>;"A92"R-A(OFF(VIA
M87M/)D5_-3U K\$ZH._;-UJ_)-:^!-"^T+E<OZ+),^'1PP6:#-P*T@RVE@.&
M;/SFP>U(E3]\DPBNF&5DX9E<H8<"C&H>;.9,A+,^M<(>WZ3Y1XYO4INDB-R.
MG:YZ?PI9*[JT.!!\9\65,_[&FK4_B8??>^^U#:DF3]M@]0$QK__2D[K,:(SC
M?K+G2E^$M@:Z4&:""TY?&S%O;R.YX,YM6';G/O4%RS9CS2"S.6E$P?"3]^IB
M-F#7SY<V&.V_/O+>&+Z5H=,W-Q&=Q$AZS;14PS#ZOW)-6GNW"J1P32;U\[<+
MMX%5QEGNKV/OJY\RS[SE0;1FP'&-]M*T]B>7&>&3P:YQLGGLA<:?>1_W-@J6
MN]-+LH OJ-%1SIIVF!K\-XA7R61"-(X9272\N*CFRG@#R/2T()K-A2#<B<JT
MUBGDK@I:4%M@3'PZK4C+BU6DF/])O'5MW2%.\WRUF1$"Z&?W'_ V/E](T. R
M6;*JLN>_P^(#GUKS<!.8NYZO^3Y0D5 @,)3SYYAEN\;SL^.@-*5GN14\)WNZ
M>B6D2/56JUO$0NY(_K7C#1_,X\XQJ.FHQ#]_$.!&.!L48G9P5K3U-&5R/<=8
M2H9=J&K9.&9-%+<Y\(S\'SBN=I\W/OTVW^B]_4=S>;D/3QR?DT4!QA9Z)I:9
MB56ON',5C7[QBN:,&I5ZF4(&A;F,=C/><WP!%A/\%VO1?[QH3*5H0BW'L;3/
MT>$BS3=$T8C<V\;1.3=3E[A9XU'0!++UYG"MJK7(G)W08P7#[NPF6E.-!Z,?
MHS5LE/;1WM0U29H1F9PGMOQ^3,+'>)@K P7@&-7ACQ%X^TY2[6L&J;%<M)*M
M:%I/C&WJ@M3G8[DT5T5&PX:C_M5=L/]PL9>W^BZ8SYY5KW"CF_UM;"Y7)G@(
MV:O-LRKQ_%  SS15=JKA9'I-S%4R;L^W2>.B;R8_F\^K((*G!:4S=&]H39UO
M:>T6H_3YB@+<>:5=(%SQO6FT?ZDVR$Y[8;&=7!WD>KC'['K%681H ]]]K[.*
M0T7<_^K^SG^^^,$FP?71K'=27\%3VT;QTM>]4I2\UA1%W\J*E.H8&GL.>  N
M4&Q$+=^?@0+("F1MS\97<;A*D.(N5+QKOPQ>>-\YMAYVFK17?)ZE5XKP3#[L
ME/V:>>V,TITSTNT(XSNG5LRN-_L!NC)%WAW\]^: OUY4CW(//0F'*5 ]2K0)
M=;]%(%:GV"@DZ?I>EE4CZW1 =ICQZA19&2((AOQ$I'5)^]--*5/Y?^A-YNJ<
MB*K"D\1L('[/,'-YF;>%\#==*I\?U6?JMG]"G.):?);N<;8>]T!]<Q3 PQH8
MPS< S<<^<C\2U!_-^HVZ'^QDO+L(4;P&JA5% 4K$@3'<N\O1?"4L8^Y^6W @
M<5V/L]\VZ-$%_EH48'\[TCI]_\-7:Z*UR&OAR,.?L,6H#<:][>*X]@Q$A]&A
M5>DEFW#$9R$$I2D\LY!BQGF\2PAN80SCA"Z:N[!WSS;D&"_40>94P*,U<TKY
M??'6>*[UH1CJ\1]Q1?+1&DF,<.MNX8\[A2%*';L- 6\;(J;KA7;4GHIO&ZQ;
MS']3@;R=3O+PU3+Q)ED%%]/NV:0M5T5Q#X"=BN-VBT>M/=LT]6VAR(QS\Y8Q
MU!CI^#W:UOQ_31IIAL4.W90.#J!;E9[4V73%I3ETR#6V31/5B>^>3=YDREH7
MFK1+NAD-]6H+*IME[)'J9KBJ]=%Z$W?H357*3_^P97,DG_J,<PL_GF7=2RVT
M?R[C_%.&0]+8A91R:R<2//61SG=\<XD^>-%@+346S\+#![RHOZ.8S3I:,)D#
MPC+V7CSP"%COW()Y/C5.+S7Z$O9TG\[G+8.%=9L0K<6IV]INI"?"T]:*MO"*
M8]%X*Z"%&JP'CJR!HF93,,_VYL6:%<&-!=3% &IC1U$$WP32RGB[ JNA[9$1
MFKXNEKZQVN+U\6N;"+)2OU-6I[CSMDZC5W(P_:YZ[6S--PU-J&'2<;/ &E<1
MCM?O1@24[N4=;<6^ZRW^V:$N%9/+ZJ5Q(7 F1\.((%(/,ZG1G/#[.9=0@.!+
MX#QSI(C1"<2/G)Q8G$<J^1R05H:I0)P_Z%*A\+01RTWC814N\8@VS!U7C'<\
MK=U,"M615OF=N"#FR(H8<:.M[?Z)[=W%2A?O@_:NM!HFBN+02KX*UM'L;TV8
M,)%^PD$Y[8$JNKQ+>%)_"UF)"NU8#5SGC'F?>25XVK(-7@]5.A.Z46>[$;JC
MD0[3V):"M^%@NYM&(=K"(BN\H@J^2F#4K/YFWTN2T,7K4UMJ>8Q$$&T/6F,Q
MT;4!^^CZ@4ZG&S5A(H6V(,$%(XLVGA<GJT2'QGVH!C??PFUK%0".A.(H/D>K
M^:B_)6Q\%'2Z<A 'A58K(X?. 8O-XA&8)SK'ZA,1F>D(QIO8(L3*^%H6+F?0
MSCI??!QIUSF;NH5W HTG\=.Y-16O[RA:7_1*]G(*GDXY][S2HGO;(]MM%?%H
MS.)<C%]2L'XY7\R-Q=PRZ(22#Q:C=A.#;Q \NI&V-H+C93I(C<-TW(UI?'V+
MIXPYBS &,VT34\;<[2:B+[MO6\2E1@93DYZNOR4BB^VSHP('DKX)PB(*9D(;
M:S6U@H\+O3&F[-SV$V<\BVBQ)*9#(PV^G4(I &/(FB(^<O/4\U T<?>@;18^
M0&&LR"6\+8/<B*]HC(;F34PV<!W&^ V>+8>A^X@"(]%],(E'B^OS WFKLZ$%
MG7I!Z#Z,?/ XQ/?LOH347RN3AF+[SS:B\ZT*S=O_]\M%,G4YL;,R%)6@J)AV
MMQ<E]42ZQE?.K6M$_SQ_>66,C\8.-##@ZRD5&1W,2).+.<G\%;T+6;/(%0^S
MHCQ*KCV9."[9% 3FS]@X*2IK$6 SDN,/]FD!Z@C>;EDM?U3O_CIGTRG2Z:-8
M-VW7.!O78YUPUF;3"3,0])*R?GWM01?.;ST@] *Y4K"TG(O+D2](:TRHEC8V
MR_CVC5WMSA/K=K@<NX=HQX2N::4/&[J *7@&)E\2?T*P86!N6S1%IQA$K0N?
M"YL<8W_#$;B#8Q26H_L61[$]'&[OX? #S:$-YK%+/G>S_Z??Q\M&'M_)@1S-
M 04X:K#-TQO-$_1<8,L0>8PAY31;AL9A#!TDQI.XBR.UAT0!0FZO6;^FUF:7
M6N-!1IR:2A^\&B^\FK=XT!-;H+?W0##PX9G^HQ!BNGA_B>/\Y;&GRZ>&+=LW
M4V-O%W]J;%QGYTGQ<5? NU1ARZ4-LYLH%)L>%'NX&2D=/ S+,AZ'&H^C5(1/
M +9MBU<W34[%FWQV,\!\>)O!#_ 6^."-CN^-_3]77H!0VK)B6_G/O<JE=RNW
M=DV3=/;I/&U'DX+\<F- KL7YPJ,)G>2T^A2&FO(G#0^XX03!A#'*(V&JEN[*
MV^\0UA3@JSLU(7VAC_RN=/(:&:% %31*#\X9_TVDNC"L(63P7>) L=*S6H8T
MF#?(]SC>)W838/(H/-=K1%CRH"LN^!A5?,)9G+L$]:['>U/ $^L7R'L962L\
M_7;<9+QF6C8:BYV.40!:.;S9?4TLK*<155CGW&7%>FM#9&#1&".7"O)]LY,&
MT@SK^6)RK#>0$7/P]%',4@;R[?]SL<1%=LSP&3JT3002B4U5X9UL@S!LA^CV
M".FC '0EO\/6;YNMVB@1AH;?;K8WL#1J=K)%B[5"*J_N])HPUK7F6ZYU:UO<
MA_%MI?UOI6[ME3(>DMSI6UP>,FS[EGR+1N,>&FT@_^._86N%L-JA 8KUT.E-
M#Y&QBL&&L,QV1MW- ;,-F,_".T,8#1^ Y6JSB<0D:S6$"SHCWHWLC&LWT4[#
MKNY("2R^HL122=DH;@,P7X@!6Q"!O$<[&[/DMT*@1[$JJRJQ_/VP"ARP"OSL
M)CS1++#;DZ$(C#.&34%79&0MY[%C*> &SL@@?VQ6T6&-=/IMSR3,6H[IB;:[
M$FOW&4_,]@#-"XH72I_O9D4OZ!A>V_"8Q%/8!>\,FR&'FQG#Z;"Y@A%#TP\$
MU;+MH>]*CL@4PI! .Q^[ 8- /Z&O%K;$$BN8^]#Q;0=M$\/40* _=DJE^TA'
MH0"L\FC'^F(=B\Z#8NX99]@:ZQ8),5A\?M\0;!=0/:CFJ_<. ]6[9^%Z1W<A
M/\<@AS[90=--#B,EO$,*+?0*!> [N*6,>I[(R7CA4]P.MQ@?=1;KB\A(7+V?
MX84""$1">W)D>.:)'!52X95C!DP<#Y20ZW(5L@-M$VD4##=Y(CEN<;1B7E[^
M=QW4;CKB=Z3T^7NGGRHF_^_%]__OQ?=ZO_3B^WAWE?/ZEK&?SJ$OME$ \1%Z
MIH]"AC5,_X'S) 74)FM%B2W=K^OSD%+OZ\DH9ZVX2: F:$GM>.QKWAW0"8)Y
MSSPNJW!68!+H_O:K[:G$'+#>0J<1&>;-Z_8I>G'MN "A\S$ YVI<TF"3J_U#
MMS84T_D9-DO0<&+X],6][MZ;"2>*R0QMS"N+\>F$U74:DQ[8O]G8_\EP(^"9
M?BGFW?%DV->W,V#R'SVT<"G-VX"MTB_%Y*(\VN%H4N@,QPZ-5GY#^SC<V"!%
M:^77KR!657YQ>[ \^YFO$M5I7-[@/:>7@KF#>D/79,=+3[:3<3/3< VMO+W4
MFP8'H ?%'QX:P524AM^0QR=OZLT=&<L[C8>^J;/9;P<9-)T$3 ('8'-2OT*
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M3ZX#U@^4H^4_PT2+>=)N &?,"^&U*.&@#$U/'V%C_YX:SCEL?RWP0EA V 7
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MM.9ON##<-.'G1%MZ%^HAA-:0D?%-?\3Z>*/R75"8?@D"(\CJ4E_5394HF'Z
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MS,'2;GK2<1]K0(3E##1FWH];$(OLW_!):V9<OD-TNRZNJ9O*G(/W*Y^XTJE
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M@I7Y\,3S X8;[F,"#J5H'48@V+'9XJ7"%:V"6?VH4%[?USP\7OJ+>.GX)^.
MP0?,Y,[TK1ZA4A%I.94;6#XA^\40 ^][ZW$*[#.?_?6V*CX\3T5R(B&\<3UU
MQ(O]?@- NY*\TIOV:?!CBPHD]2LE?: OAQ?"VCG54Y&K&@^6+J98;8FFAE$,
M=51G>'O%Z?B[PYU^V9SV1S:T5%POD6%";"(( 5S,.)%[[Y$ZT8EW4D*4O"]&
M?L.?G(<Z78=-+WW](R82P?5I8!=FQ74;2 .^-<9]Z#V^#9*2%$W=0C5)QT22
M[1!T9]!8[*BV3_J,ALDRZ#66-FE&"ZS:E<@"PO<SCJBGMVUXO5OOV7HR%/M
MBU<A/N&T?A$JK]$?$_,PR7_.VXCXV("[8!<=\+S^CHCB-'R!.H]!++R>I!;;
M>L[.%XB?R2H1\N@E18%%-Z,7_PLI1ROZ#GE-9"8Q^"OF]-(%0#L92VXR/,M0
M6')SPD-L?Z [QF5Y$;8XG2RPH!Z\V&K4K]NF?4J]7T\OGK] Y9K4<H=5%EG(
ML,AD-Q'=K![> 4$\;W*IDXG22>CA1>+9HY 7@ CU]6>NL-;!W4?G.PVL)ZX8
MGO@DDQ(/"2)7[JZL=*NQ6;>C#KM,4$B4Q1%N/9 9")[0GCNY81 =R$8PF;%W
MVNGTSKKV_-KM00Z[Y::%/N;,"@7ORC%S/(^C;\8)"+9 *C[Q-*&P%3"P@[#"
MMMR3SCI3YW#)MOE<0(J(%N( BU78H073',VVUPXX=T_H617CR2K23/8"%I@,
M%'@J,%ZNNY%S"N/G\P"]^_N-,\U%A78^]VX5IVU(2BFG-*H'4@W2 C;IK4"K
M.0O3+T?GAQ1+WN 6\*)LW.HD JF2LDJ!+VF UC%*" @%-E)UQC[$F1',041G
M?G\?O$<8P2UPW[GH[ (@#1PO?<3;Z,G!OJ/=:=GOL%G;OX>^FNW="F#Q393_
MI+Z9N@@YDDZV+3=DAX)6"3U(Q=;GR@;-/3N=3!70:2B+Q).3UAMIZEZ)O;P.
M7HQ7\N2*\WK:=RZ]MV< G\0^N/[)CE6=( 9?33(^1_-9@'"1OQ/X:^FY8R:U
M.#[6I3UX?JKM+!AXZ8G/!/:VJG%56]>4]AVRSP:VRR/UD(_I TI<4#M?M)RY
M P/RU,]EX"?"0H:!90'WF7R"<;A&:5*!?:P)8_"5VXDL)W7:P_K'MF8EK1R2
M-3J>:%C7OZ&29#'ZI-A[VSP7F,PY2_C2\9Y\9\QTB_ZYR.;?'$SSTQ=U-9P7
M '=4_P4 ]RUL>&Z],R_:,57X7WFD_\%IC@KGBZB#O(RA8<&)C:,+P*=SZ9%Z
MK_V?2F!?-A:/&[0DX5&HRLEI+I$8T?&A0^_S4F;/J3Y>3D_5"OAP+1^%=3?T
MA[_@<3 0([[? JO0L-.;9>%T-F"D#\K0()A$^>_=35.O>!@)[RM=H!XT@>.\
ML&=W&L/9T-.0)IP*/-X?:AE CRB4RQ:*2@>RNNDN6EE[AWLKS#,*19\E8\I/
M<3;A;N*#-9A,C;ND0+J3M*^S*";C)$W-(Q9OV"^>UMT*+<#U/YS+YF<6LL0J
MZVC55#S:+&Y[_@E/)TEZ_-7>4([F8N3UJ0UK9CZ6?61D!_$#!<+\'&)BYV9=
M<6%3%<M<E@,(_PE4LB]EG6T/J:PN7E"OT.TNQ<(^VX8;M)P[GRT?$KEWS6H>
MC%;EIA._L<XH]Q+_'K]85FE9=SPF#^U)H686WP %^JN:CIM5=E)&A:),!2]U
M1E&#"< T@WA2&J+E#=[/:D+>^F\PWFULC#^@5[PIR[REH0-LH2KAR14+7X3E
M[#T^4LC([= X3:LBT?0WG*9AF/STNDF-?$!4RVXXER<A(B9=^W/BJE&Y!UO.
MIX6BM"0I@MY*Y1O409P+I7X]L=B98M2I^R'1=S=PNAJ!\$\![$+1L./$M 1S
M3]JMYI.=9]902X_-8=C8A@7VQ*DS2:E<YZUYCKJL&\E]-1I^?" &)W[J@#S:
M>$EASVR'C3R]5MOE>3=KF@U%%/FNL9<Z!#%/@;M\OA1@&[IIX><OM44A4J?5
M=J9!5>3:9W=]*+$[<<\@X1EM8Y62R--:*=8[3Y@K@,1IRT&4L$S71HI"6CJT
M=>P3IZU&<I B56%O$9J4/0*(6R2GD41KTJJ5*_HJ,HD6ZAD@DMJP)74S)K#"
MF*C!2>F-_BEBI10'QU4VG.-5JJAH&LLTVZG[44D2K27'RC?CZ.LTW=52KKF2
MG9]56^K,WS@)<HNO\ NZS)GBZ$;%%\?<\IUJ9$\C3[FQ,4Z5&&Y*ZR^2_7V6
M_G1I1!>R/4RI$QVD^_ ^S;/U9U"U:^%;,XPQ/'4JZI\C)MP?Y,=L?)Q<4C69
MJ[!<O*9.THE6RN75*T[#9:+<\,F0U?RTL5]4\N7](V.^7LFEZ,41"OEN&.S%
MMHSA)T.;KQ.Q#74!P_*WQ'=Y6^6\!40PI]7)"'04D]8_<(ZYWTIGYR\)+LXX
M?[L+VY=:?D?%06%/FW,VP+(%THV>W58T*8LU#8]HTW%4@@O3JDA\%_;BDZ.P
MXO40-4$JF;S8Z%-.><Y6Y&JU1Q&@X!KMTC!S3F&F)LM[=YKLZ_#ZU/B+LPKU
MY53C$XWOK>U"W-$C1[:<4_><QY(AUZ*Q2&G0N?L2G@KYY*#X:TIITZW>$W-U
MM35,+$>9:A639;/3Y/OZ6K_F2<5Y,;P&&2%[1,BJC[TM;FJJ8.11.YYP=Y@=
M;T(KN$N!XM%R[AQF))50 FDFT/.8X;2Z:#8G7.X$[8LH'].M+R2;]=;"Q5!M
MX-V-<E=>1<(:4E.HGQ+T^Z"KQ%-)R)%!:"F%M _Z-T9"]WNYE?[RUE$CLR1E
MYYCZA$(.@LXYM=9'1.8^WRYG0*@@8N/C$9LZD_7._L [C%Q6?O@P>7=WG[N'
MHDZ$5HA6G$7KR[H;'#&=GQ&XC.BNFQ]2W:0Y9"#3H-200).FL:10C $0OFB&
M!LNI;0)NB;\1!B)C-V1QOLBC_H.\]$2!PN?//J$^-,J75#-CP#*(04GLSN%)
M 8C#6YCFY<<#@W4'!JFQ5R*.4 +_-_V$PM'\E!8<#]1OM0*3B]\WXC6.U%!P
M5;)\B=8N54IP0*?@613QY,LMN#NP)#]!,(E@4[=_1+?"X X<@$[ME"@H6>3;
MWWWGN92X7S,=,N5NU65%&$S$T\,^]37-O*][Y')M"/=*87C+:,C# ATKGTY=
M+TR]0::I,7&BST:8!BYU@>>T'%W;-[;Z?+_LT\);*V)I1SWNXZ)'JNV82CRI
M"22OG]CG/K"("A?;R8E&<&\=8:>Q1Q<R#6ZP:^X\[=40I-XI9('WI=$+<Y#O
MTVE1GCF2\P1E*9*[8D2SU'QZVFL@7A5R^7LI5C>3%GW&1^O7>C]"#4,B/VW"
MZF6]^=-&A!\)H']M:=2'SBLP]Z%944<[KSZ7Y(;C493=P)(2+-\;\N/AH6P]
M;0]AJ!9;J'+.Y$X^E;49EI H-;_\L8]$10ZY-FE)@<VSC72<76#PJ)-1[QW"
M)A%G/_3HU622J.1%B]?<4-_PB/%+JQVJMC$1JNYSDXY72);UK,8-OO;PB-*_
MS!&D==]^OU@GGD-4<F E@MRN._V=X(%\8T=*KO$\P4K)!<"?MR+/!=+B2OWM
M+'$VOG93H>;64NTH[8G7RG)\.-*[ 3[20VOQ*H'!?>@XJ_R(.DL0;*.5C^QF
MNZ8Q[;0R^.# )XI'3&.VNBP^!@,0.051UQ,6NO0L6QM6![%O1="6%YGVK+43
M\VA :23TB\$E.-#IQ,<1#%XJ3':?"DQZ2M6&C+X_H;V'CQ31IDKB3<CZDN.J
MDCW;FO\D3F6]SJU8DN31$N]\XC+)\B/8(N5)"3=>:D2>@.94&,%FB;8;I7X/
MC >J.D.C(&:O>QNNBT4^JBEG$$\E>M)R<N"5BOD&HL+<WC3Y3&5(2Y9*];H]
M@NK2BL);(,5"UNBQB7+#ZB\E.#]C;XB/W#ERCB12=Y AN)6D4M?]])VX[M?7
M86'GO#UK:MB 21.?V)P"R:48/=$DGB]Y;\)\#;:>E!P19LF3+K%"G9M=$^FU
MI[_-X%B\\PKB!3.$&^ 6U6ZHJH]G/M2N9!HNH3%K,Q(.:2UXZCE_?#P(@?9K
M0!K&;ST;H'2[7MQ=GYD 5=:.\;RW._@VD51-93E>)A?4E814<S2EOG?#,-C@
M=?_T+D5V^H":S1)I0N:&QF?##F56;P4;H:31/ +<W >9>%E/6C&%C=O2;&:C
M9](,KFOV4/;A*^Q!+$)8PJ(@HA^D9@<(N#7[48;.W\?IW+;QSH7"S^4_*0G>
M/U!T8=94<L Z$;\ B";V:2[:I^5G[H7*P!Y[>>];,D,:JE%S5$^7XN?GK!;5
M?4$#6!5V.$(/7I#$B?JD+*=),3AY-UCW,VHFT&:8F,S9O374LW0W9;8+28T<
MI&J&E I9%])+%A\;QE6R[<8K50HF1B<'2&,4@K3.**2YA$+PUHZD9A:D&:QQ
M7I(0:?:9E7*D*HA*%E#06[P%!^DVYDXI.VM2%+F:TN?(G7E2$#&*Q0\GIHG*
M1Q+3AXR[NZ*#RX09\AP(/O(.O#MYXKIGO<@<X\IE\RQ\D&\D^^[FN[S>S)N9
M:_.@2&?+$SJKCS='-I^RX,.VQC(?]C7?E!QQ6SXC3*EZOLCK]H_7G*!XL!0_
MZ203+IS+#AI,G&TJ2"Z0QA8E]FG6@K@$847^ILH)M,^LMHE_VH/VMQ7+W[1^
M+[!]^='3T7IQO*Q?2=1(0,H:\YVKZ/'KI%5XH=MQ&1N^11#+2>M8FFAV=I03
M^Z8_6\F=]N>93>C$%.JY;T$,//XBN?O/YI2L,PWB%%T43R'[+'Y40KFLUWS'
MMQR_M*06-<H9XDN[2)(N[ P9>V"^APF'%FM-QY>QNF,[@&RV-H;.^)XW'<,P
M5.(&^H1!L2[=OJLZG#6:G$61>7$9MUC\]$\M8]5O<;IFW$KU6=C0^+!--FOE
MR:_A"993,^\VI<#N)YKX#IKBQ>OC[88/M@0U>M-K';D&*J$F/%HY;EL.QBMG
M^?&+D^P.U@8+<,FY49P&+;0JZ[8K1[[0O<=6)&C2^5Z)D#9-V)J1/&C4^5A$
MH5W9\MF#T3I-GVT;UQQ%.I<A&:73L%G5<UO*[GM234?4K]28OO%V)P(><<GJ
M43@^.<8O+GKH,?O4]PN]UKX5,:YUSX!?\VA,<>:#9R)-?8[EBTF$HOS][T7-
M)<Y&FYHCT^6T O =[+NDC5]!=\=5K#$0KPTD%_H9DV9\R!C\H@:@&J[[E PG
MJ=8U7NFL1.7E.H7NTZ-6+E$8K10E#" 3]*H:0LZBV!^"$=PS5E&_Q4X1A$[3
M?)H]UL@?9D@19N%XO('/%[8M7,V1CT\!88G$*TXZ0N=+>EW%VM793>]5W,PT
MC7#Y/+ O;;@14-R?)2UI@@QCX96CR<+3@+DM)R=-B.$,#;2L0'V#U7<'7*8+
MNJ&+>;=V6$Y0Y3[^4D.AVS"EG:W:P3X2C]456/?_H^ZMXZKJMK;AC2 E7=+=
MW:%T=W=((QT;I*1!&C;=C8" TAT"DIL-2DE(R2:4$C;=?.H=1SWGOI]SGN_W
MO,_[_KD7B[5FC#GF&&N.Z[KR3N222'2FIJWUS?'BO);+A1AEFX4_U*TCN XF
MZ-2_CK?M)-K"(RZ.GR.2#G5[C!)*3G2%^E#6EFWM'@K[Z/O( HT9EMS$]L2(
M</KB5A%-,IE*EL2KW8M#>N'0*O QA8]:H]'RT1-G$"/<:Z6;P'A+R8>7N?$&
M%QPO*W<LB3*V?B53_^^0]E2<E7!A06I)8J,($AP\53 SS#L>\53= IA!VQD1
M1*2Y-5.R%J4MVVDGE!?4S\]0_=<^[H^TE@V&B::$/)QDA;!&G 0SS)*"N0HE
M9E 66D"^#T=\P[Q*_'D,==NQ5U935Z-  C0:":KE\*7V2&H!EFYC(.RT86&)
MP<'D7OY<%:_'WOYR+YRA$8'MCH-WI!X+OB.]EKG[RL'B#$%"FB)>%6MEH<%F
M=+!F+:IAFCJ/"NWCF)/&[B2UF43-/-IXBK=-)6*)4TGHID[4^2V V$K9FMVQ
M.(GP=>Y8EFH;&P1%1@=LJ88[PR#L!:XD"""!;D4U9[T=[92A31QS:5Y)I):S
MF8608F(I\IE('84>EB")B]2=R84)&@"]P\=\^,-ZI:?NAN5D%Y*JG5\3::_V
MD>8(":*GZ#;S=;X;)**7E/&]!9#&PI'.URMR+[CK=KZG29N5)5F%DV%\JME9
MQQ6%T^0^C";HNU.X/BK!&N,;GEK"SW!L52<-2487E;C7P+")6?EVHG0UF2*#
M@:'7(LM/E<@-XR!;Q<<NP >LOGCQ-2-^+JNQMIZYFK<.5['%-8S@^@)5S#X[
MIPZ;!KBZ/H3\(LRDJ9S8\$+F]0/.$DR@?QTB0_1\<0JRZ_$BX^27FS)J\'3^
MKO4$ 5/O(#N\W?KQ8@D,8[T53A$0^&'$.TKF7<Z*"*3ZV-O9C+$T/"1&:A9D
M;TF(Y?0XC3L.,ZDK%42H?PM("832T*1GVV1OBAZ)-!X7"51*4E2375QZ@@DA
MR<:/ =YM)0^JBIX@K8^AISRUW@<ANQZLP=!+==NFO+@BJY!4;P$< ZT*P8C0
MM4'.A)5L)W\GJ[*)1XZ!&8'&WM;L=JMA2&4>]%$5,??I;B!/2@T$W7A7(-U>
M6Z"TBVF!8VV<M9E..-@R,W8Z ^5;  S#UH5K"WMI_VC4SG!'SM![K;9O,%NW
MF#)7+ZLIM;*OUI=[1X#L%&D]1%W /(^U=F4E">>#MY,S/-7U;-7E+8#I FB%
M0VS).. I%##0F'V<I4$KVW G8L$/%F:K83P'E]I/?O'J]?/BF;OZ?K> <+TW
MEN A(?,$WY0GZ#9\H/$@=;*HDUY"DKHW/D&DG/+N=#,_A)1W7?X&OZ]G\;(2
M$K@86"?6RPD\]+QP*8-F6V-8_G[C_S1E]3]A]?XGB*3"?X!(-G')_T-2XOOG
MU+\DK5[Y&;;^"VFU1=KOOU^1?J\"^=6A_0,'_!/8]EL7?T+&XOW#27X'"%>4
M-(0PZ(K (7T11*YY2Q_)&/=H_]'P!)LX[_:,&:(D]@K>7)8%D!M9N+;PGW"5
M/Z,3OQ,\E*89%K$&Q$+ +!JJQ4PI C4;4HQ51/=0Q[?&9N&//9RMM))/+NOH
M$4VUS""$_H!E'W%]!9PD&S0Y9U$Q;X@5IAP)$0CVX5I/X^+RSEU\.7Q3N!#L
M%>MTADB_-DK@(%GOSQCZORE7^\7EN_P K?Q%F^07YLV?'_(-0_]@_/AY;6SQ
M'07:736 ,#"J>ZCUS!T9E8G]T<>'_\(6?MY:_@6OYX]M9CY8/C7= >V/D'8L
MOL[>/"N=D\KX(P:+FD35,_]W\$#??C:VF>D((_]^61OTEF)/Z#QV9-)?M=KT
M>KE/^%( 1/DO'O 31]V?/-%_)4/PG^&'=6&Z XCF/YQV_<^3JGV[V?4WY/Z?
M+NBON:=_5L/XU6D%_P./^ZO<!=,/IWN_8N+_ Q;T_VE6A[^CCOK?HX'5D3>S
M>X=W%Q02G1/%-YIB85VSO!!UC2EVN7D+^&AT824L?PK*]@H6VX"LZ2J5JB"O
MC;? ES-W![RD-CM&4R62<\<]8#2N+?D.Q-11</J =8\)[IEVHB+(,9*RGI-K
M0^A "\SY?:"^P>$K"INMU=?5<&R)L_4^)=:"\^&JF.<[U6A[_J!%UWSJV<S[
MA%G^%:&62QDULG#F,*)P_].I V6R_S^&/P-/^1,ROB3@)Q9:2P*)WUEF=+NK
MF%__U@3?\6=BCP 2:V\UN#98EFK,S9;^BO[DFT_1,9P;ETJE4I,M++P \@OQ
M<%&:.)8DF7U[E\F.5>P=C2#ZD((O_G6DXDVD0#),L*I\%FY_,((G=00M>@WE
MH,7TGW;X_6#B]V4"!REEAC)%5V<A!HWW(%5!L\T0YQ3IA:?-+?Z&:,+RKQ:5
M*1X;5U&(6A"^$(Y= J)Q(D71QBW O^OJ7J RB' /_35>5U: C*0^,7H.EG\_
MM_B\012(+T/_3\@Q\XL$WJ!4A."IX,E/B6U6U$IIB-:L<- '68ZB.4[>*H;?
M*'/8@A]EE/1IX3W$UXY'3,$I2!#@)1/U1BF5I#W0^A/<^IM\S8_+XR>@YG]P
MPOG#]O!'6%!!_9"(%E_; M,50RX2L>>.+T5RMEJJ &-W8(6K&\+9M[''3+;_
M<4G[U330QR*+(F@!^(="A-KT#<DRL'R_,$7R/\<>M?G:$Y>H[>_88U-6-HP1
M9!$OO&[TYR%"+]^$_YOZ!_\%$]+_FDR!UC)#8"?+@<O[C"Q0R0=;L0YRZ*Z6
M:1[3<YV$(+(@\IYXSGX<Q,7[_*5N*4&)%Z"EX'SCO!7%ATEE+R"RC''=;M;E
M.<^(J*D/^B816"3)?*;;&6\!+"[;"4)!7?0KQ2D5E6X!>T\;,=F4+/(*H>"%
MPE=B<+$\*,27,^Q)^H,$?3YT)YYJ?CTT^)9IPY+4D"@0T9"W139X[3R]4-;\
MDNHU1Q_:(''PQ@Y&B.5YV?#[CHEGU,U(%C2%%))KKL[6>X[3J/%B6S=!(34'
M4S.56XZ5<SD3K8[UR%F7.8Z^"E:D1G ;9>6V.)O%R0#MFXFL6,YA^E[^-/UF
MX?8W&&_!>QFT%B^!8'EI S?8JA FFE;X@6.WHWK-=<+R_:T1EQ%, 3,/W!M0
MV\2\"->7=2S,9Z-R_8V,+%V+F3@9D5!7MQ6>="2:C6@01.L!;P.<-E>YB/=Q
MJ:[[O3)*.WJ)=(E 2_>77=J2BA?&-]B7QJ_9N^+AC!^_3J;B0 :N0.>[*G*;
MT]?;9!(9I9( 7Y@63DKEU[%Y]:64F((9C_7:#IY/?S;&-WNPST>S/R0G2)_]
MN"A%CF!P03.2RFZ6.;KV,Z)5LNIK+FY>W)ZU.9!F<%=*<_]%/>XA_.C<C:0_
M[-10S<OF1%E30I8HE0C%F<Q3^3'12I+7)],]K1NNZFW'ODF@Z.GC#Q3J-R\N
MAS%Z(5J/JLOKJFW<%=?K1J@=OKC![.@2W!R1LO)*"I1*XY7AM"X5[3E[&;/1
M/AA8$/AXA='E)B_5R/?KKR<E1-:M?D==EM;[R-KV4%9BO]=^_WK+1G *?ND3
M1(IKP2]X$=VMH+.C_![^VD<L>[M..Y/.NIX4+.N%23:NV# 4@D"R(:5+@AIW
MDF-R,NXA2*2^V\&J( A%UX1NA!Y:0"ELZZ!U,$\#O;?B2(B)%-4(%%^O8OD/
M=3*^!C4N/T4Y 3]'_'^Z_O\"^%?8]>80<75_(BCM%9[>4J88(>^-II[1TPL^
MM_7,0F8 .J102R-R!!6BP#AC],5$+'4C2BGDE6JABGR?S5WN"?E[LY<)#SQS
M/H3B2<(!FF[F'#^]6;7H Q(C7P:RJ' BP#2]4 ?B3K68A(* Q<]3VB,2M2(@
M[O+RE(Q:DL9C5O%FA(-*-.LF6\1I(/IL58_"S[UN2>$2HBH&KDKW^?-5K")5
MY:&#D63;74=O&+I0,:AI!L>R/+-+FYY?8079F<9<O>7)!]2UU)*6AAH&Y/W1
MB-EA8Y88["%;FE=7U;S=.#H*GU\&T!QI,7]M@^7W-BBQOS(<CQ8L1NL@9^N-
M$"0D9MSFX%#R[CC1V3&>9$[3(,O)\;53-J7:J%<?6Y\<I =4'[*OH@%1N"!E
M:2+OV/?38QO[/9G!?!2GX1S'71L=;R*F \G>+G.<:IS>--0M2R6MXT^$<5%B
M0'/?V5M_HD2,B2 3?@Y'IE/EU\B*^N<2B.W>F6-C+>*P_*)S\#;[.(I 4C=Z
MV2KW[6*X'.]G+1%V=FJZIGZB2M9*[D/7(6M2;8IZJ4;/_>$5G9K/:S90' ()
M4B.$YI%;P)[2+:#V%A 9VXXY02JB-QU X:H= \%I0>O7[(3/HIAR)>W)F) _
M+-R3V'J@G>4&-S!82!*:)FMAG,6](MA:.;B^:8VJ&\:Y;KA3?/4R>!C>;%+^
M_1."MD\08#<\JB!]/ERUL:RZ@9(2X]Z[A1=^E7SHJ$D/7HC=/QHZZTE?IUO_
MTM#T%ERU(,MOV73N4?*&K2\,[1VJ* 4KA$.SLA4^L8S9VRF5M%M(8V+H%/.I
MTCJX%8\2%36-8:7L'68T\^R-H9ZIBXR(E%12-Y(]OEA#:?&W<0:'Z/?G/5+D
M)W;80DR,GBS?X=;, /%W>,>KE9#?Z*7<T2[6JLN]!>CJK&(*T&[238!:J@\&
M\JP2%'3@%.XJG+5Y$O(H/N.96*4W-G(LKMX<F)N#,*&-UCR,VWZMA+>CE_RH
M&#N*>QZHN[W-W';1KP!E&GQ3AL'\JGUV2_"EFQY[G($MSF*U2.K3^[P#!M*>
MQKX^WXRA[A8@D]0--$.]!7!_X1RD3";-H .Y0SJ8#.Q>^1*6B,)I/LQ/4]3"
M-D>3]3+!WEZWRWCRR!1L&L,$"TWA31)9VE:DC>U3K"DDP<X$S(?(..I^C79^
M31P<S7Z)PO^(Q\J[4F\!7;\5:R;GEES<.&T1CXP/;Y$&$05=PF+AX( V"8GW
MIXIWG+/U0G32@2$5RQ(WF=H1<'CKDH]Y:>DF*U3,GX,#-8/4GUC6C$0IRW0/
MAJVM1;8<[-24N^H$;7?/4'*'S+'Q?C-')9K8WP0AC%4$@Q[U\)/KI9P^,H68
M'( (A;I2T]/;)LH+;5%T\6A>0'J:,32X>+48A5M9HPEAZK[NO$(*P_#I9+R1
MG1&=G+632V^8WO<S%T747AIH/Z>U5%7FRG'+/0UH:%JTXO^B#5(M3KBNF/*
MJ+AAG!((&R.E/KH%6! /JCX]E"9[D-?+P(1\:#<8N[86'\@Z#,>L4SZG>@NH
M9(%))7G4;<HM=$$\$1404@%,E"$![+GA:'6%R@VS.S OQNTVGR9/H':XS2S9
MP/$R7;PN4[6H*([J?-+LP4+)B$5X2J7>RO+GP7Y\NZN&JNS:YC1L[D)#1FK%
MTSM=CQUQ*&=F:V(C"/&;Q1HY&AL=FI!#GJ\_GQ$@X.3AQ>4_Z"LNU)3;">W:
M&O93WPC0?63*6_=0+O&:$Y-Y(M,+Z\Z"Q!TU3.UW5QP<BB6!:>TW+\OZR9U-
MUZW7#Q5+GQ58O&24TT@/=<8KLK M7['XVPSO9_ZFO\OP8O\5K6^2FL=T4V(*
M+U_I\DX]UKU$SZ3$>,&9U2P3E^I1W#OZB1^?KI<1LK.Z#Y';+SUNPH+H7!=J
M'?9$SCI.#93L&=Q/?^YZ#]_P%L!5V+>&)IN3M[(GN6Q7;2;N-E-(QNV6D*P-
MRW WM7X.]A5BNP/ZX!2.HBS#V?<8W+Y(KL0U-%9]R/1B@.<NSQOSKH5B:XO3
MLFC4LS.TE)(W,\A$.]C)/@'Z/30Q6B^TM%)C@SLVUQZ"6O5&Q98#:RD&$=F5
MCTWU>C!?O0R>>4^91YWCQPQ4KXKSJ;HV@4 /CN+A+"I--W@%,<2'[,!?R(_8
M3K).$)#(?+$G&8A0>-\11?">S"M8-WN?L^F'&NX\>#+/-7+:;$XJ%Q2#PCB1
MV3H6NCG1L&>*7G<CUMBS'W^CLOCYP*# JP!A(O?*#1=AXAUV4%V7D0'^'Z]V
ME6SC'O7:^O*D-()N^'!.K]926;E;WYS[_FGYLIVF_I<W%8&VSIP#%LJ/(WNS
M7WJ4O2XW!#RHG;5DBGS)172@TSJVUOSH*7=\B0J0VJP^#1[;[QKL:0C]5SOZ
MSTFS,>?_73FU;GWS!21LK=+T@[L,!4]"X@K!'+);5HWPL-T-*<7>F=C'6T ]
M(ZRKF",Y]]QT<_6;GH]H")7F4@-]2(->N1A;36SS%?<Y9UIVF"FI*(ZB.UVW
MFE_NS5$UN$O7PEXTW:[@9O]I-(?&=$&\GFZS+E4&P?K43/7<\$J\-*:>[%5;
M)(H\J=D7KRXQH,&+K81%#L(5[*SK@O<W\!QA:*H'S??8;4>TS6@^!=;RS'PQ
M?&CD@61CF!] 97=Q$*O1*M_:EID((GTZN*CXR-!BS+A\\TW#:;'YZ%O1$V(I
MUR&QX@O47931W)>''/-S$ON;UZ[6I)JQ!G8@1*$1]_6S\]JIS&)G\83NZ<[M
MS.=&93B4LQO#?D/+IA>U+O-WNG9:-KHPRV(@)^V+!C!AEAN.27DQ(9/[V1.?
M(P$ZNRU51F7Q,TNK#AO*9[ZHN@<YI>O6S4YCA2Z)FU= H7[MCGE>S56< 1_7
M5V/+6Y[U(UTN5D@MF]=ND*T4BSBACX-"\7Y=%+SA'S9?Y<B701%;,RPM<I5M
MS+PC>"^EIT@T.A4( 2H.@Z5#?@HCR@D?@RGBG2?54M9':!VJ.;92D#+X$-M3
M@\50DRHZ@TS:K%L*J$E-=+6$R#_:8@(?;-\(P6X! U*W ))UC9O]RRZM5+$O
M--<N9R4&[(;H(MY90&#9.HQB)?'.@1\)VH@KZI;#GM:!%(5!>JV4QE%L6EEZ
M?\1C"@-R%1]IY$Z#<EUIND#<*ZXI%ZF.JHC)0;&-0=@I+;?J1#,_;2U?M>^&
M&7Y].3<MC-PQU"1Y.ZU&>=GE"<-@]=$(JU2X9DSS5#XN*;W/P95?^GD%AR&4
M3@25\G+V8[<]PU+ AN$LS"KR +2D+;SJ\<A%J8@23J\)VBHB[/GZY)4?.!]3
M0O&U=LK"RZ;=-CRV Q&Q>#G!BO1LFVAC"_UW[ 0-_/QIOPPKUY_#.KW[ROC[
ML&8RPE"?J&<&0]%"WW[17$&>#4.Z(:K'5!9A6-IMEY[JN8F\'%[FJ9Y)8TFE
M<'1S.8XXSV\G%4VR7(@S@R$ XXM>L_B-+&O+OY+;X:"_!>C? C(O]U>.<?D?
M]';3Q+08G-8NC'I\^8\8$=%T7+L3EGX1GN;_(2W_SIJFI>\AIB/E6XL:9/LH
MS.]D&$/Q<X"JH\<)1S0%WRU@!79S$W&#><GIW36>#DY?[RK#/ );3U'H632B
MJWW04@\P<.6'J@K3-XEN%%Q*;7"FR&7Y?W+92[^6N 7@?$VF#L[:10*GQ2HO
M%/<$%P1HX[N0Q:=.^2AZ$>%&SNMFY&=!BDT[588/B1@#74!CWC/'JU3NY&NK
MB836>]6M:N!8?XN'^'R7 V1R],2X6V=\:\M[[R[*CF.?D"867MR@",\X\62B
MG$6]<J>5?2:(DYD(W<KSF;"8>%;5(P&_H6JQ.? 68D+3_TB)?;8Q]LG.T2T@
MRAPT[;]<'CNZ CKN,JH*7"*\!:Q2W0+B:BD,3@-*TD^Y;IJWO9*[NL2V\J>Y
MWH$]Q$Q[EE1OKFX!%8'A0N?L$=MGM(>+O%^L&*#TC2,)C%K!3)GDM*<CX[XS
MV*&7BHT7^K%];^P9H#O'4M%NA_![&H?68+M.T>@@P$./*C7 AP^-R?3&(G?*
MTN@$[M&BM^$QK 6.K+FCEOO43Y!3,9)KIV]^L%BZHQR9PEM,;#V9CREI;*P?
M-G  O[146/(J*QR'9D^1J?S\8^Q9&U9.1MC=*/@ORL=_I ]%% 977D*9@6V@
MKN.&4T22NU [<'1^>E]@.''K%9:599B>EJEO?O+\:?]3?#X*3]*KC,^O*PXD
MSMVO/_^&A#A*B^.8%B,CX[B<#EQE^J9)+YH?\5GK^M/Y+:#$]-&+=F$9PTH)
MJ'>5',7DH>.4:51S^@+^WM%@2X 7#C576:_)X'A";#<^EI*SLJSL@2(-6,]0
M1DD_1("3,&B1Y:3&\B)&^".:6_'3P_.7TU^(V K$/:W++P!EV[VQOL_U/R5B
M!>U1E"^9M-@6YH2.2Y /Q,5KV+"4)F+GMQ\7=+2L&3-T.IR2UG-,K&ZJO:1F
M]7PM!DO\.GF.8:]!04Z#UWOG$]>,9,"5LLQS\EAMO^!2HUAU#'X?(OEE?_H\
MBQ:;:(!J/SR%NT0*E 2RM+%EI6S^Y5K1T\F(26+G3;[O2OHTH?C-UM>X<:JD
MI)\7]H !/S8_:G;R<Y6B%?SC;#1)S:@[05N*8A*3$]/6HA7USG=*C^<'F<#4
M<@P,:K&2INH,+90-[T[KK[,#29L"Y7H&^Z_W^FY2NG1N+M2.YV]H@;- \D_W
M!=YS^%Q.!G++;;TCSMLJWK/,.(N#A[D?2W["7A,]*-ZH3)JX\,<' #PWC?.P
M&QNWUH$KG_']&JER%."=GZ&<4QP*D195/'(\*HM41$I]".'.T+0AD]3VAZNQ
M(9#K]"@+4SX/:*A42[D8>K^<L+P!/$?/$;:"P6]$'3*6]%Y3P+ 3^H_"%[]E
M=D"]]!;G?I-?C_!8?B; 8])I"MU&(RAT6(Q#E,YZ3 @C7M]3%I,([!\/[+D%
MV.A ?2B2DS\&*E+P)=O>)*4=6_#B%]@G'[QA\$>E"W\&D]M(6W]+[;(>N#>S
M%JAKN;'VR2Z@*XO^PDB"YL! ""A<KJC;?CHDK=@FH+Q:;V'\;C4K=;J>U"W#
M:>J%2X-1^;4/5>PBN,H@"(1VE\_)A6\*SKX<BV]M,$Z5-LAOFBMEU0CY-&50
MHE[)QID;R:)LY5$*K$HK2?H(V+"/S?#^J8>$CR&EP5(!ODG49Y9EMA$?) I%
M 886M@><#.G3-.N&,VG'E[#5FRBY$/:SU4,YDX%TK1X82[,<LT2YR2V ]"4.
M') >H02]9Z^:-MNXU2$J/]U"VR_<RA*/E/2 .U'9XVE:TI(5?:&>RW.*S901
M[=#4<.DW4BU,!K> #N MX*68X5K),2+6S9='L N\AJ'2/'II:&TR[*'3D1[:
M$"+DNT%5EC/N8O2PE2*]UW7Z7-[I"1L^D$\$@WMB94W512602F\!G8$[\V=K
MZT=7Q%RW !\8([K6[]HV$/.AISF.71JG^9T/#JVW62*GQK02RX!^[A1HOJT7
MK=DK4I_%%M_=%%ZK)(&_ABBOQ+XN9[WCJ@FCK>F#X2X':Z3>J^W8TP24-][F
M3)A %81=>"2M%C[(4#,B-Q<_KA*;<_+%!%Q+X>K%0:;EA]!TM)O73/[1MX!"
M3<]UA&$5>_@G-UWA<K&@%_S>U+(KE$'3?45JRW##N6W8::L5<X/O^@.>=[&Y
M&1%^S2=^.-;Y58WDQ\WLWU6I8A:=5[IX$WY,8WAB4S@\4ED(I(F)-!F$Z@1*
MW@+Z:P-[ FWD0$/U^X$E%%FH7^:W!D%T3FV%+R!P35&#$2]$U]&2C1C9B#\,
M;M_1[:J?[B(PW^NSFW?J%GS]+AJ1!2*/22='Z[&N&-!1$T40+.RV%(VQ<;U7
M@JFR)5C]*!=1G^8-4Y$63VIQ->]I;NL[:AJ*N:K5S\/%S&OW$H5M9#?$==XG
M:G[@?#6$R.O2A2!:!&&\@_WJ5-I>]XZ,_+6,#*HH 6\Y;&C Q*Z9_B' #:YN
M\<%[-BD:Q6>$FCD1IJ16+H6R@I&SW'A^8R\VIB<J:ST+19<WN/W6)C Q1-I2
M2C]\G.=\LL5]P-8;VZ(2-OE[IL/4#X:\]S>]JQ)09'L6G<<B ?4A)3PG,+@I
M-.G=,WA:UK'[U@>;\&;4BT*6*Q5X%W? RMGJKHD!/ELQZD*0I>SEOM06ZT$0
M)<L3$K73)-/CB&WCQ(M0X^^ ,68?3Q<)>A< YB($4<**9S(/F^9L*VF41]6'
MB_9R_:-6B$(Z[[8IZ'T6'TR'XBEI,7EWZUS_$";5Z0N?)(N)_>M4 -Q\"5!_
M8-0WRK>R%87\^?B ^6PY;/< 3+CG1$,%_XS"T@U_1#0LKCM4?1'TCB6!<A9(
M1<6X3Y9:,$G7B#;VH(4Z#"TJ07B>)G;P,^5S!"UN$_?:[U02A/\/)3U_'')_
M&DY^>1_UK60TV>R8QX@Q=+6^=EQ>UM/STRB)?Z&<.\T0.S5<1J,0QL9K(6U@
M1I"@4G*R"M$0I"]\+2^P\:Y/(5W=?5S9OH#A1*VS]=IAA2J<5:M)Y'NK40=W
M]1ZU&)@UZY@IEJ_!E9-P&,=32I?L73ME949)$2(E+.]XI5<1$%;!<]XMII+@
M+2_V&&2D'5QJ,X@<I,MSFU_3ONJLH&L6M+G9DI#TPXPGK:$O(3</3^=\]B90
M.9&BP DJG+6B[&_;Y;*N'!%#<T4_'\@&<%S#/ZD^-+DP1C:DYC<<P]:YY$7J
M141.['<\;I5N07OXVCC5!8W<_(X49;0Z8\\%::QWK9,NT;M0'4TH=KJ1OC/5
M6)%'5%]2"]0@8#B6%Y@@7T (DU+!H?8N82]$6M]5H<1$6UX<8C)=%W+6Q]4$
M<:YNNB,O,!R!\5V*YC_4)'Z2%7?H#Q@_H2YC$:*CDJ1K>^#G*JR90>F!KK\%
M>>);SX<M<*<!@(& NI(F2JBWFL7U"7>$WI/DNI]VBE"X2O9CO?JU4"J&U,(V
M=W9*YZ<]%6=G_)>6XKT)"4F-2_GW'0<!L.3UBYSS$6^NN+U^R#5/U<]_%Q>V
M.@\HR1D,)5RZ,NZ:? @^O><B]-BL.&HQ#DEC-;X EZQ]1H*+:"'.:>9C^,%)
M!>\<,_1%;PRF"VF>OEM<ED?K%9/+T([&7H'1T$+:BG0 TB[<R@PSS$HL;#[%
M8Q9<FZ#W(?P0\46Z,%7$94L_'$Q42%B=>J0U+5?7_$&8:$;%>=VN=2HQ/V)D
M>_DK9+:5Q!YBQ,NY;1LZ2HO ,.!IBLY<Z BEO!6VXEU",:G4P1B"]^9#X)Z*
M<C=DR*M7 EB?-1Y(0Q6,W5B[K&6)A>1IU=&\"TNCL(4UTZ:Q DRGD@#[H]<+
MH=4'.<VL*.5R&6X-K6'.N!=6D2"%YEH7C0T]C1;IQ>QNL@,DVI*:. $T0E@>
MDS+6 PSK)6]G+8XK2PH8_: *!-I9Y&QY4;S'F,\XU&P[!AXG5!0IG[FZ/NA8
M#9O=K@\(B^I[8_I&.N-+F;=+B1WF+MEKDRZTT3!OF0>.<\(*1%Z%P($(LW__
M'./;\>ML=T([O, /%UW[,W[D^D73)/E=FZ!RA=?\D/ >XZ'JU;)K,RZ3+)H@
MG [?=>G^B",@N.MI[?20HF3<[N22[GG5RN-$1:S>( J4JF-'UVB2TV(#*B;4
MY0DQ)<]35-9<%-*8$(+VR97=*/(:ORY#2ZH5[)F8=/"25HN13\4:(]3+4@W-
M/8:$/5Z2>]DI=_WAL^:L*LEX!D_>_4'!VKK/:S1L)W.T(^G&N>=U*\[T%5B]
MD8LJ?NXD@,+VVFEY12.7^BIVO#GJ.T)(Y89[:C%-E+[@@VLE)DQDC [CU_8?
M/&J7YZ\?R2$/+Z0TJQTNTW!:LE.UV]"0)NROV8::$Q6Q$FNG<+,\A(?I1A=_
M@@)?IG.!P9.1YF+J#%U%)NL*TRA_-+&=L[8^HC@AMGG>*ID[%^BS\30U3=O*
MS#;T"=]2&=>W;K>S&?<D<(D@;4HO$C[Y2,M.DY9BMH@A*0"RKUD4)9.K.+.>
MGLZ$CEM:QWU?U+Z,O7)4RV:$,#D$^2AHHF5KVE9N=-GI*>.)6X&9/O^VAL9)
MNPVMQ"K=!ZL$P2*.I]?V>KCE]=((0$S-[PLL@;S.+T-1Z@U\]?UMKU0&??K*
MA&^+2YAKA-6Q30@9XM\D98L3629K 4"8RHV02AYF)<@5NF.6KL0H0%<A>-%8
M;>^^'4G^-7?1E(L*_)H6;,\?19^^?V%UUXOD9H@B7(<P&17X. &MPX3_,I6C
M8<@Y![)=32#<O/C,OS*$AU+OGG!&,4__@(!I(*T 00^UJPA/C4O#XM.G,P@2
M.,N5K.'<SZ2O1:Z&<0USK<(!SW'PIN G=X[!JWA6XWGB _B+%[E%;VM[!2W@
MF!E1MD_:+!,,HC\F8'_[7,T?RACM84,)4/UD/K:>>3=DLHQ2&2>J/E=WOY4&
M)"!<V2BPESKD*PK7A@//=@05*V&?6A"NP[*_5XO@=_!-S/ ^4ZO24L 1Q#C7
M.O[KB['@I0R).8S+"(LYGJ:^2.!Z%BAP_&#BB9&">N)03=&,>]O)@-04+@I<
MO-0KT-@K2UJOIIM0P;A08/EG(#<B-[32<<!2T!7WC9.><C0ZL_@HI<UGP>O4
M:J"K\K!E,JLD88F-KE\KE<;$\(X8)60H3ZJLWSCO($:>FHC]Y'7 ,1MPW-*2
M>JAZ-*HH*]'D%&R9^% +71H@+"D^][ERPR$U3?H/"Z()4U_NS*L0'\+RQ9R(
M:N/<#A)R(RW0"/40@O,^J42?7'FW]9KH26.I;8/WG*4SL*70^C,B+Y#L!!D:
M3YB("V0F)MW&<P^GQ$G!_[9Y@=<(+/?L)X?@'MZX;"NQZK-&JG9S7OMXM IF
MC&+O(;_C'*;/G9.GG'1KN:1AZ6,4V)+GH?7Q!]O\INGR,^]5L-&_1H1KJ;$K
MU[R]AW478VW,8Y@[!L,F(Q+B05^TL@X4N)L5L0D>3+ ;<I9;4C_G+Y6Z[-0D
MG)Q"!C>2F+GC>N/8[W[P!?9A,--TZLD?\6ZP;"':(  _AWYH)5IHX^GMB;TV
MRNO$613=]0 ;Z!_$QJ/)N4&Y-S$XH989_<P;0OB6Q9*#26\[1&YF%A-AF.Z/
M0W&O+%(X.(JC96SOXC-U'6(OK*WBR%56:A_ 49I/[LHN&4E4Y.O0(JM]T)OW
MJZ#MM6^F=HLW54\@^UC92TM0 \$19!OTW!Q*\#1-APTE*-RMH^>,+<*4OOM\
MJRF)B2;17,+D[?8\&\T4J;>\-Y \L-QP0'Z/[1K1-98D54TJ,8$K_3Z_*[7K
M1_IF[4F+4.4$'GFB-@PQ:X>%'!QZRV1A2<&X3--6M/@T+XG6.QU1:P_\=, N
MC(UWJ)+V'"ZG&MMU9+E9*H$6MF5NWRQ$A"G<&^ =C#A<EOG)8+T"2PZ[A0_6
M$ZEN79&0TO3%13K7(MZL[XYF2%G58"E:R-!I%0J SG_YE4U,0$)XM&G-:G5P
MKV!RR^=8(D +)%%:JD3"N6?)VIID[(F8K/1(7EPHGH7CD&;">YH\=]H8_7>]
MBA[D@M[(>(3>15JMZ.G\,;C$+\&#R[O^[P?[1$;BD8\R2M@\SYVC*XC#'@F#
M=LT'B3=F\BE3X<;<%>M.T;]K'/ZC%/472;Z_J];_+X78M=KGGSG(3V$/\4/;
M;V8<!R./[XL"$0$^-PW)W*0(NIE -FL]YZ"]A(2:Q7AC6KR)0[7HE9&\.IBE
MZ4'$>$H4=J.0^R 1.3OEZV-HW@*K(Q+\^.M)?_+C'A(DCY$!]0(?IHO$K1>%
M\V'1@E-'YA'>!/S<P3:1!I^ERBIQ(#2),O"N(OMSZ4F"EK'N."P>D*$E'H2!
M:!6=#@PB>$_L:+-X% Z06OC8H8].T +SL:!@U.?$>,Z%X6N(,)A[E$T[1#"N
MISJ>U"*43 +1R(OZR;TUI<@U!.YG^*77;R6Y>*4\%8(%\SFFZWYJ=)A\7'DL
M;$ N)I*CT[NL^1X)7/>12\.R7*>K;,]BRH@U*E)26LHF+\<]3DUYRN;Q:VZM
M&J=P:C1EA3+]U$:%L;K<("W3QI,VL[0U5F9JBT'HA/&0JU8@IS$*K:XD.I8S
MNE?Y,%=<SLA!'4OKH\\R+S55S<F_[D_<U"OU5BW /0_?#ZDCX[-]%G&M]?ZE
M.TA-6&AQ:=S4V"LDR>^M$\*WQ%2&Y! +-V<^A>NBUT:@/2,#^=(/$QZ5'A.K
M3R%&9\_04%LW\G>CR<5$7X-)ZWQ?&O4EGVZ(SW73#R_H_U8)_==UC7^OK5*K
MJ[/>]:5KCF(E0\BGW5]@$J92%\'U^XTZN*5X56_^W0C(P:.[PAOKCU->BARQ
M)?=#HLS2B]Q'79==D3XG+N02_^(!/X58'?]:D*?4E^[*LR3->BV>T4]OP9J(
MTOKHR+WAW/(>+@'J V1')WV%+9Y)UQSYRU'NI,=L+Y"8N7KA^_O44NG:2HLO
M-+5H'-'O"M_GIL* 4R5P?,W; OI([[XL4?H&-L_EF6QCP22S_YF'5%:+$F+O
M;IU$6&09FV0]\OU3]W\H:?4?:8+\477VQQFYXZ\UJYH_W?C?E+3ZI2C^)TFK
M?_&0?REI];U T>P?]_Y44&[,I?MSD=U?TC7\4F7_8]7O?R$$X?(W@((?!ZTV
MF.VG<^?_.XKX_F6//1G_',6_JAW_CW*/KY.I,T?PMZ;G\DLE.1OT'Z;WDR+O
MSZ;7Q,G]1U/UOSF37^.7'V?9\I>MYZ>BRHX?M)\(?ZX5^5UH[A]HC)\ZIO1O
M?K_[&_;=7QBE4'_J']W/U>H_UR?\NXK!L]V_R-[\_#7Q?UG([Y=Z>3R!/Q^K
M7_(/G_M3R<9_4,+W-6RMV(FQ_.':!^@0^\^3_Z/0G^X TS],\V_YPF>[TWYW
M4M_\7HO%/R%6\'_P>R9_#09R[?_3,]S]IPC\QUFW_+E_WZJ@?U@9/W?\O\7S
M](L G>;?/>27$.\O/603Y\_"A;^8\/\B1PZ/TN3;8NJ!A\>B\*W#9:)PSK*D
M<JQADD_]J^AC!TBT32-L//%I3T?DH4(B6F)(#LGJG.1HXDXCS67;2J^:BSUB
M8/[I=\)(<0?<+@H/5-G$I\C1"ER&:N<O3<N'QG//LO0&>8K9J9RS686%"$^I
M=SM:W3R$J(DI<.X?)Z8J\5J^'PI/<R>@N1 ]HEL/2V.(C=:^7$],2&>@H&>R
MY*.2CQ%!?+HRS$OKO2-F0(1B'>N3MN-KMW8?^^SLQ=)FG3ZQ?(G#Y'5'C@T=
MN/+K/UP\XS928Q]FHY4,G;*Y*V X4;G4[C5"9$TJOO1VB]C &PC"?)%HW)&Q
M98?3WF >P(M0\V(6LXQ'6/SN:9M;B'3&]&H^?9>,TN;%@EJIF.WNU"0FX6OR
MRH^0B/BF/?M!I;1;P&4)FUK[GN"PA? X"*WNFOH]1X/!R[M6DDCQ??[0%IH$
MI43K9#7AIT.4T,AAR1>T>4'689/QU%:V])H^]AM\:Y:\%RB7P57J/-+'[AC)
ME/=[3^EJ^WZC-'_,09_#R3JF3'-PW/=2G:IBQPL/MFUHS< J>[(>QPJFE$MO
MO?>T#&SF/52B:D 4!;0#1^N/RFO1-QSL%$U+,XK(FFD]><7<N7WX0W\U?^]O
M7YH:R84TN=EDY')@,4]8,,'GM]R8Z"X+<<D0/:YJ&J*R,;4%=&!A%D-EDD<F
MX#5%*WLX+@^"R6P"X%3(AZ\]@C"3&'FV@6C#1D;20(6D!.Y\.E,#@L6^D+%9
M1FV!Q&[[]"$1AQKA5.T)>%A2^(/;:IJ4!D%4^QA#'6DN,CEUQ#%N0KP^)-$E
M+\V[?UBL[(O.0=?E),7(+:!/54Y@PN#S+: #M%HH9;\][ /8WA*XDE^#7=,L
M$+O'Y'2]##B2/+=8C^!0GMQ@.=5MQ206V>V52]C[.G!)?>9T^EARZL!]IS<I
MRBIX*O&I[(77$VEE6O-[0L:E-*/MY$36%S)%8KW-I->B2*DL4UHNOI-4J[)5
M\X%,#U=6EC^&AZHDK1#KX.M<RA:[%%?IV\"59JRD!">08-B:L=2 &Z@Y&DYK
MG'%0^5@40R\J$V+[6@6L^MR(DTC^6G'NY]V^EWJ6[">7^E>T) :?,G;N:]W5
MNYPB#8)IS>^/ZC*Y/HV9W*J-;<=\X=Q]:'^(%OK6=!ET++<M%%6V#O-LVZO^
MF#:WB;.,.O <1!ZZ)^3QM<-]X416%Y*Y7]>1;!*3INN I'&&&M'@,:K=2Q,:
MG,1]W#[B^"[VSAK8O1+!(5(3,FN+T]$W7%J*$P4!'=94Y YHCZE>M$V ]U"0
MF<77O.#-#P<TL3<B+7DN_+="E9,GC[WS*$8/>8=@,:4!>)7134_RLNE.3^W5
MMBYA*7T^+[F4&";N+]GAS$8//?^FB4A(P\6N7!:N?U-0[&!S^CC6[*MU$"$?
M.H2AC<IYZ R$BM2L#=D*,P;J .$918S6RW*\J#ATUFNVTUHZ)JG6(2%"KKSG
MT=?OJ[2@@YV0JY>7K]=:QP9L99"W,$P\H=C&DVJ<2K15I3I0;U2 0Z/JN2PE
M8+[S[50FCN SQ_#Z">O7^'$*Y")(2T!@!H@_PSQ-[3G3XJR"E1UUJJ E%;OR
MX]C>K7O)*DDR>CJT7-"&+P$FKFY!B='2=Y!$%9L?D$Y7CHX]@\W>O(2G3*=W
MGQR^,R1><3#[!&+L;)=PL-Z#_]'N$/^RTKBX'_0T_=SNE&XGG%L"C^:%D)<
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MQJZ%)$:Q-@:5A.[![]Z[!;QI%@/? M"Z9I#BR$],D_.]/N! *FT:+.(9>U]
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M"I'5I<\BWET-*'&M/83H)FBDW *R<$[>E]A\&FWU._@"IZ/*-$KM/$Q]<^:
MP[3:E\6TU+A<+9$0Z\<YG\P01]7HH7;LQ RUP*$(IP,P(J:>;]!^:^\NCWE.
M4_@XN0.%:L:\?#H)C'1LNLRYQ3L":\7"#1(BZ2^ R@F:<*5U'<).WZ7B74\2
MC<*10KXYN<.9BCW"N-#O;GE/COE0ZE)G?9 6S<J1;TB-5-F*U>N4JS<S_KO>
M^W^;S:G2Z'N\K2N"*)VUF&-A8TM/L9(-6KL%A)MNIWK7 @-91/<:6+,AA]TE
MF;: \L7 *NP4/"4UQAB:+TK 3]C_G.<^MI\0LI-WEBV.FIT)F$,>U@$WN3[+
M3M<:+V\D=+2P+:"+V1GQG-_ODQY:2%F+%\SH?;I5MWH-53M^=^44YO]X8<!T
M$7,[H-E'Z7+OA.',,CMI4[0ZM..W#)=K%.R1K]>SI(6?\1O\HY4]>>N,TN;]
M>N*UJC3Q#DO-"40:@+>:,\$0/6G*M]0FCZUP3UR%O_STLBZ6"]_9ILJ*&-5K
M(G-GU89/>%-K.I^ ,#KQE&O(N[8O[Q8PW09U+S62K=V9T,F,,#U<!I "!<:Y
MTY\!D&!4#2(:T%3M)!T0#L:U)W@MB*H249/.!&-X.@WZX33H,^'DERI96>A;
M[!7P(UM_2PVOU""+.TD5<"6,0-?(THXYE,0#:9]GU[8K[B?16?EG%-L)_;54
MS>J.XN<!I:NX2WU1.*DR)%F3Z5V.*M)S\JLYXI$%L<U-WD[K!J3\[U$QV46
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M*;4KI!O11GOA8T3\2),QZ2EMJB%KZ! CH?>3M"*&?I;IUSH?;QWZI4\%:TD
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M$)QRYX!D8CK=CIRHT6EFI::78%RMIZ5EHD51%@J=#BGUQ9_46JDP+6F(/R?
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M6Q( JY/EZI!"NTUM+"54H<ECS9=N=/]CN"(Z.=8C7UA.)VVF9?P; 1[C,J*
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MX<&L_HAL-?&4 JCM8GR%F60CK"W4JHO1RT4)D6^ M$]19!.9]#^\P-G+2@O
M'[3N[TQ7?O9!L+H/K#18'8WABC8W$F""G+>1,&^\Y'8SL>6M=7\+(I2F?G>V
M#06@(CQT2E0\:%I&:'"A !60K?K)&/<CP64LZLACI#/G:B[&&AVIFG\JF4!-
M8-=0+N0RHV_A^KL\MMP5O+:4DK37G[/%GS**98Q&LMG9L)$.$R7NZ7\T&;UV
M1I^55].G7B*4[%)%"@>ZVG0[<[_H8\=S&]-E?EU2U)[FJT"]MHW>ZOH0N:9W
M ES%#>T<688!$S>H-%*U$Z=J.P9B.*: %2A K45EVI=KUV_07%2UPUZ$:GXP
M*)I(V:#G5/+RR_$3\/0L[JA27(DUFKG'H.!J<#<VJGZQ_@UOTT5(Y=M^RXFT
ML9:*W1RH7XYP62["_QH*T'\!_&:E4S-7Q;'/;]ESC>!QNB\%YTLPF/=X1?>J
M;1/B?$<<60DV1,QMM50;7KO P3HMD1+XQG0NR7]-X^#)RZ<N$\087HY@!M;W
MG\N?66@'$!+G][DO[+_P3Z,:N\?1//W6PJLM5C9C/D0U6NEY;>@:56(LK<43
M#;PVO(K[;DS%?=W,U]DD?2[NH@!XK;3.&^Z*C5UU:R"(]WF=]:GK;?/-DTK5
MCY#)8C:30O(4$56R.&MR:XHPAFE6_?O.,^&*S3[8I+J/;NYG:-P(PL =XZEG
MOH]@L$8>K0IWL5" %-=1<11 =,G%APO4#9K3G%?7IWQ6'']ENK\ZEK.^J7P/
M8M7I<GN7QS/",M@'JVV;950G\<';J$XJS1'3B63QEI;^+];7L)] BKEK0M['
MQ.T9%@V[?GE,,0F'X(4NLRJR]/UVGHEW#>M$JJ(*B^@(]0MV &91QF5"TD<N
M 7WB0#S(:GH<^-GLMTJPN&W-=!-2F$<L^LGC<ZGC3C;<OQ18# N\S<9VF:RM
M0XE^DL]'^2  R-FUF<BKPN-R>.?:##:O"RLX)5VZZ>$<WEVV65YODT2QB$1#
MQ'0JUY@MM2\9Z+T-A62V2:OOFG1ZFY \,O/.@:>*PV+\]/B9BYII5_@F8^JV
M%Y,UQ*Y4QG2I:M3Y:N#&ZG:$K^MX!UX!!ZNX$,7;!7.%<+&QUI[# ?,^+8M2
M?7Y!UZKH:(@Z6)7LAT+N:23A*%R[7,GQ>>^Y[;"@L'YUP1G..#$9/."+)!'-
M1O,H21TX3J.>ZP6"/J3CHR8;XI%(11Y-C89XF](B"0*+H%6Y76E3AR)Z1OF.
M>T[=N?P2?(/XCZBG-D=*2P/F6V0[FL%/7(4G.ASET\]#T*VW%/,CNP^:O@69
ME2OYWAS93YE%=((+]C_V@]\G0*'8+[@U>=&0=Z #8=Q[6!]XT0&0?!.]35^O
M61>RMA306]E[$[ (-$M[\T M*\^;%9<Y![_,#]B05N6QI37EK#9QI3VVA #6
MQ+S/)*;9) \G?0X/7,VET66E97YC*6D<MIE"1XIOO[*@'P,]@^N= A:FKH_2
MC1)FEJC7?93FXSG%.^?W6C0)W&L1#O>@I9E%WH5-;L91%&BN &G3T3^ ,A;G
M#G09=K61X"B0'@**7#F?"AF,MC%Z\=N!^,\L+_K?_H2</N7^EEV*\^>"^_2/
M@U._"W_LV=0/BQ#[AY#Y3I_AU"7>@0VY,2][NTQW@%8QT*\9#HP'?);DRE3>
MN%!>G)/8Z&[6$R-_=2F&!?XY0PPMAT*]HY)P6H%7G#U/=[]54Y2MEJG2A\A;
M@M^80ED=EP'#'9LK&>C\(9@_H6<76'!8+UGJ2I /2A(9TH:>BZ&3>.[8L%&V
M0]VNZ#%?.(]- :RO0XM(ZN6TP6 GFH:I.'$+Y<1SO0QQOO7^'CSX^DS#7-@H
M"]&S>Y@B\F3T:OA6YKU%:O'*CQ"1;A'FLLE(E@[#GLR^L;[(1QE/LU& FYQ!
MS6>./LC ^#6Y<.,$X'PWG@-5 'R4KLH7 _M\+DD&Y3A_6&EG5O\E'^\@/1T*
M,[ MXEFBB@([K*4MPBIJ3,<\:Q"6*2J>>@%@7U;@%Y'O2CHH;OC4^7',LQ%;
M.I$EMBTFMQ8K8=WQ6^77Q&+D[KBLJ:F&LSORJ!<ET*F;Q+-[%#GX:*6WIV4:
M>%/+ M+\_69>7TZO9^.I^:1)>'Y3.W;/I<,U(#Y'R^L.E6$[* QZR=(#_>+H
MDKLS,(K-;)U;E6_L2Z%8*SQ#HIR8#3H38Z-:>%IW)TZQ1T\N>BO^I;RPQ.1!
ML=\.X+ 9K3#,6C49#?P>)N[1(#'')^D6:S@]&&(CW@MA17VMP,R"7Y:4M*'[
MMD6B[FC#619Y\&P2;+!*!:'+- E":&%7VY11J8=?"<Q%3.RE;X@UNY#XX4 ]
M,15;_%[8L%>H^":+I2_LF@7E2\U<,V_AGU6]R[2OL!!B_V ?:W9W I(M$I%>
M\\2'YJ-P8EBG"SU'.L'H(/#<<*%Q,SWE(OKVX\W7>-T(^+WU-<J+_@=#I@])
M?9J\Y29'1Q697YM+^[AG"U)<F4S$P]VX)?<QLS(>F*;R,1=T84H,<)Y EU-[
M/J2J/_-!>ZMG?LJ%J'@J?H#"DFNGS+-7=.02+83B"8\IKA[ @,"(Q0XM'ME.
MS-N;;D8Z%^\R 0YDMZ.N"'G$^31GS/D/6;V'>6%X+RAJAEU_HNC#Z.]N(9.J
M23GL>I&I>O])?@7#>6:R75*3-69X  \.QLP2 6)EZ'G\NDY.H6!HU(1S9V=2
MAV\L!_LM-Y@Z8915C&.= /\P6YT1,.X.8=MX493NHX[>#<FM$E:;ZM>.&N=X
MG3G<]P7(26&O::,O+\>,0%E<];1(>YL$L!H;DDM+4DT4NW$MQ$LBO7&LHJF,
M\Z9Z@I9TDY)@&#=OI?&S]]VR(G]24 7-LF99)Z/5F*GG2F:K%'K+5ZRS,+RD
M_WG!P%C"$_G2S/YB@H1ND2OS7B%YQ=LL2Y/$T(65F,B[#NET??)GN'7.5X9\
M?.0)S0Y" ?C$+&S?6R:P:4\F\@47U]EF3*"G:Z6'^1<.B2MT)>2J!6C39*=8
M:'*8B^63@^P?%>I>H$U]::&PNZ=C] P%\!#=3V^8+IV17!:AUSE:JSEQ&1?[
MD>_:JO-9TQA)"D7VF)!_'H8^@ F9#\PFQ,BTD HP'_1*>ESU9.&DFE)Q!>8)
M,31Q!G$Y3L^V6]@ZY.2U.R[UZ!_X5 RL(),L.'KQ0J+0%9]D>D6/7_[U9]!?
M)GB\9I"  E2A %;@8+/IF:7-,<T6D7;:'WDT]32.]KIG_^;/RJL%O>AYX[+?
M;V?Z.:, 7MV=-C:/Y^]ZHP#+2*;9H1HO[*^?_!;!*UZ<C%%!U+281AS0YL$A
M\GT+\,X""M HNM5^*+9#&.<! <VJSNC#\KL8+_2(8^=R]2$\Y0!?I)3$,]T%
M$CN?";0&[<#&CG;GC[=LV#+FW%,(5[ KLO;;=M91@,*Q-6"BY;YBA9C7\?JK
M+094[[1%>*CL1G-U\Q!L5/P]L\2#-*-:H@X6AV$Y_US'>,=!-X4&26@/G#C^
MN;J+8;WPNEW*?5%Z'8;UP!2_&G3/A1P8.X&S_?3*)"*7E[_MBT"KE1V58@MT
M_6Q;+I4-J<5\JJ_6!+.$@AS^XB??F4CB,O0B\G/Y_ATFNRNR^QND!#+XD'NO
M^^W>7>>?P9K ?FK'G5E<6;%+CO944OFR=;*KR[YE-22[P3F=E*V!=WU#N%FW
M1FAKL,_S_:Z?F,"B!2';=1UKJB1?JSR[3R8=[27&)+DO<7E&E"ZCU?O$SU+G
M(B+XS:%6K-'1:+3M"6\P9+RI'F!<BO:1GHIM=61 ;](FI>WWAOH]&+5]'3LZ
M42AV",C#__24<)+//)I_8B?G&J["3=;;<V/P@B([[A?$;DYK+]"@!$\C2\1*
M//V2'8;R&MR0&_0[7;4BT#T_3O:4\,4:XGLK$=.3,92'!@2@]E;=M.9P-/SI
M].5"\!050CVNZYT4"M#W(6/?%6RP>=[K=O^R.#>EO^D=]KV0 UG:IJ"P'78E
MN2DNQ=U*ILGU)TWUZ*_I/F5 NMG<6@N>VMJH&[0PY-O/W78ADM4+.L/BV[;:
M;AZ1]!C)+BCB@A==J#6D:K2^6*IB%>2F*!&@<QE>; /0*\^N54C02203)1FS
MNK,/_K* "V0YGY^(4<Q5[3NDE4[;N.=;J%;L:6A-7VW:R5)G4+>?.<Y0@@)@
M^$J":-N[Z3D.WMRMDD@E'8L9S#AL).IA,K*>[WPW=N$0-+L4/RG%-+DK[OUL
M7-J23OEH[RB1U'JS2@@%@,6>20]#9%HC%'=MZ)]Z^_%\+NW2J&[$ 7,_BYI#
MF\=E"(#-B))\S"2/)A3<(;N1C@+081SME!B0(NVSB+$&T<FC]?;AG%]\CB$2
M:?JU1ID;D*%'LK&A>ZMCOVU%O:8%N?$9G O6L9%BR+]QM.F8G4=&F'Y$ <+D
MYLO5BQ1I5P_5S@<6N:@%L4Z04OG0;$Q=2FIC$1668RK8)+8D[7#G+ ->7S;Z
M DNMD</QN<Z433EY,_'P@^,K%,"3#04P 5^WY"V46ND_VAU5I&^%''S<QP.9
MEJ5@Y@C(HDVI@-6B=)N8@+"T%"DV\2G:/<18GFY'"EE"*5<I 8#Z[);-92VS
MKG@EK9&$.'4.)95[?K'/K'//G9NU&5*MBIO0![6Q<[A(WPO4E\B@L"/M")==
MTNF3R!/2\!6&!WU4RI$-IFJD>=7Q/$DJQO+Y38\<OZCB.RP4\'.]I235OGWM
M0"GQSX\E;E"0TI?S+DJ/H !M4J!=*'C*IPHTRN Q[W(3T0PN0 '(%G[;?$:
M:Z16^DJ1DZ!^%"#<(Q8T&HA\AK"DT^Q=N_%N'P7H CW3;/>X4+A:^?21Y\#8
MX3O:\?? ##JR!C82)),*>.)RE(_8TN$6K=U4[-J4?M.Z8%41Y&A+R5'<AOXL
M_X$982@:EF[.<#L*0#M<ZXDNUC"MB%@@[]RY BU" 49QP -._7LA#(4W5OJ6
M!< NA L,.[#L$.KY8KEECX!(\$?TC%W?(4A\$@GVFO@G,T$%%A0 [= O*$.E
M1G3@K>R!FMWZI-VNC=I4T]F[NZZ>R175L(/X!R$#*]>E6A6FU_&482[.;P\#
MT2 M[98((%C(O7(FS#PYEN(Y;],'C:DB[?C)MSB5XM>?6&4P,]KB5Q+V54MO
M2+PAY7(3974*>1[9K1'XI8V'Z$S+)1.K+'ZJQ]B.,M99J?H&))\[L2DP@7P,
M^-Y:VX.(76L@1YCB9"OE%(2E^%WN.BN&V[1J*#[Z.EWRO>GB;I+);GFQ-(,9
M4J/+;D\_JRY$4\O(1Y4M*JZ-32>M2W&%$&H4^HDAC6B/[.EAO%Y-&7+#^&O4
M_B1W;->6XMK'(F7$J*;+P4.*SAVY]CM'BNM"OCG\D$2*7+U7;U3;A&A&H !K
MG.#XJ2T>W4\Y2++IH2ZYBA1B+^RV9>EYDOV>RP2+;2OB5O* J6D)'?;.9^NW
M?SLS_5VV9_GL'"$S-*#_)4 7PK4.X(W-:!V-!&Y<K%=51QZ"=]F0%6+8SGOL
MK>D;61L<=M:"]&K*['F74Y/(^I03IGVS8&5W73XJB;&(/1 (JL!)=&/^>*>Q
M )QII!6WW?L,FV\"1-C+?OOQ><A!)YC(OW2]II<APOG&XBB50RE:AP<UM;+2
MRJL5DQE)99ZS+>=W7,(Q)ITM FC2K"^]?'Z5<CV\L![1\F8_9XL'SWAZ!>&P
MQ:  \ICW2 1751P?T.'53*V8\/;&[=<7U/.^JHY2M; UG539A6P'B_NR*%^R
M8*>R7(%GW)KVRG0NK-%C" LCRU:YYD\CW*3,;!M.IU_;J2_*]!RYI+3RM>QS
MDX+V6 K>%(2U+5K^UJ5S[V8,%87 H>0[[6O37Z?-Q7TW8 M^XXCVT7"Z8G2I
MDO[E:UH?[+V!,[NQGZ-O-HU+A_GJ?,EP0ZX>#[/;L5^K=&97H@!N# M^97<#
M-T=*+A#/MVBW'6U#!40G.OSD7RNV^6/,0^0E&60\:57YQL/62$8'7:TPM48'
MS7J3TC@7L1:$$.;R0_&++Y6*_"5!P526FSW\L_3LYZ_D>$R'Q4#EX9F'7)PJ
M5AE)^HOLF=&7\:O8J*<KREXK-1:=?P;<R_UXZ)IZ,UQNSR_GHC8]G@O$!6%K
M@H&0XN0.&SZTVV"8$? ZDE*.^@&T@Z&9PRMA7*(N!9'4(+-YM-FD,;VGGV_
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MH3#5/5Y0\=@$QD]]_(\]9CA2+FP/<62@. S'!@IA/4Q//U)^P$_E_X>>'P^
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MALU5J:74KZ,TJTD/7=OM2TH7((==.ZEVM\>,P3-.-5.JCOM3*("@[RRUD<<
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MNM87YMPTYTEOSVO>'68(M5;V%.?M+/]1<0MO;23I'L39'T)_.XV#&I5H@-9
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MP:7$JL-UE0G#W!Y5<>^3*HWO27CKL39(!YYCD/3\2_S1_H*(#(S/6QS@,0[
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M2SJM9X^TF/YD(RJ+[Y%_1J;+[2@')Y*O/$]&6H5V=*WHE79EX!:#R0Q==;5
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MH=C%VP7/ D#X&6_4]DJB3HFUS5'<2$;C*RQ^BRI]QKE\]"/A1OVLZ)=^Z)8
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MM[W?5MV@FXXQ""\J VUTZ(HTEG>'Q?R'O;?_2 P&Z,&GSW_M-L[J7"5?EUO
MR&7*%9F),((LSU7SEPZWFQZ6HQQSQ/S;9J?7Q???ED3N73M94.4"Y7H)J#7V
M[P^N#7<RS[\ H5\B1L;3DS6V1Q@8(JXY? ^/+"E^L-^YF)Q4TN95.Q6'%AU
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M1K0;I:DWD>C9<4L95W@%NE?1MBE;X=L<+E<52PB]@ILE*B"_9U&K*%S;Z0[
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MEG'K7'>L%D.GB,;  \]X[[RT#TZ'J9Z0'5=MS+ALF^CI;>' 49?>KD?*==P
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MJF8L+H42?!RRX#NB-O;(M8P2"6B?8S_82TNGG)21)^"#)S9A:>^8HC8P<J"
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M5,TT&?5IA AIE.,P#^H3PV^G;S+G9)!;95W!=@9/I]U+I93HONF-E%+(=W/
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M7LUP%W+=;I5Y5*@U:S5#)L>VB5\C6$= Y\'@5M^W@N2+[Q&4#!:R$O&(%W>
MP4'XO4)F9(C%//7_((1(!9UYW 'XW+_$"IWX@E_PPO?N '%@V/X=@!?:X:Q2
M5,1\NEI*G$ PP6XAJ_-><44$?QH><&_+AX9I\&V=J*!<XHN@2O+0?_NE*>=6
M^8W[*R5Z[@#LON54M3_YUWGE)"J\B45_'HKQ#H]D.W)O+I<2^-M)4:[&%8I7
M4\2\V9]*(]?(7:!"FR UUADVA8!3Z+Y%+DL(%^6R%QV&%C\'/H.JI31!0IQ)
MHTV,/J:CZ3&PRCS';WM %4QNG4KIC[*LS>[;R7Z)OR1?12$"=%+,9;HH\Y<C
MT*!6*"WY?KU-):$5NDC$V?,^)^:I=IR&BAKZXQP6'$- O2$;&*3?N$^J,%M8
MF (I[%#X4=)ZRT#(&R7A_S=B8H_FOU4GSO4*4VF_SE8KBQ[>YT^YRHA2JUMR
M,^W]\;G78@$G@(I<L5N G[ EER1$,L/^/>>G^I2U_9W$0(?Q)_VO57]FKD$/
M5H1EJ6R6$@[Z\,+GJM#-0"W4SY0'ZAY@GA+%91W-&P>'.O7DGA]^^M9X0FK;
M'T;ICGLAB?A+!KOV*X/MN\]@@8\UNUM&<29DA?_S*H.&;HV7.?\3Q?G^1G?%
M:!*8?((]>HM2O"#YSD,RK)^R_BX]+U-72"K=U4\97)^GNKW*/,!S@;UVSJ;#
MXW,:.M0+;'_<EG],AG_@*! NJMC: N\/G-7K44R^"MUVW_MT?M3:=ZU#;XTC
M.N2O8:QXM)6M35,C<*@G !!?\3^LU\C?L@C)N>8UY4982)6.S;Y#]50[]@_:
ME2D6O ,\M7K T>4E(: 0EVMM:/Q4,,A:$S_\!J\A(4[02S!V51X\AC'07<KP
M#:]A0+6@V?SL\95Y;'^LJ9;3RP0)*"+STFFF3>'2EUD\Z?HD=<?MVM*%/E&*
MA7TIT5ZU;2S-Z!]E-SIR$-6KW?D[P.0@/)M,#6)4=!87]7BX293(Y^4.TTW?
MO5?Q+Q[3/_4X<;>!&?Y?O7$JF)18C$/^B_6UBMG]0*UCFG_[LYX+I.:F9^U[
MS?=1FO%2+J8P&\V:7Y>EPRIO(?>3.YH)P1 ?IS/6$=86M5/-]_>_N3-LR."#
MB7F](&]>C%;!DQ&J:'%C\>B!^"+G0<+6,&S2/&CBD6DD+V'UA(;@)2&B[26I
MK3 VXRG[&X3&%*)&QDY?R=Y6A&#-#B[#ZF^(\\$[*N%IL-T+*&1'P &3O5(.
M:?H.4$D-(EEUG;!T=*-BGJ*$_MS967ZK<%!*&-/;,*T6(G!E-]M]M#W6S]^+
MWSD)REJL,%:F9+6WQ!V=[Q2\24/C'A5I4+C<);D9!\*M[@ QAC0Q+2 F?ZU[
M?\][!QB0NW?L=M&PZH=*IM"TVT/024RWP4[2]F10YKW!44:_=VVC@G)7AJ"X
MD^7V4Z;AJ0./#Q??OU3@)^.KR4EU6_ $EXO495!@IDR#-I2I>WFHBN@80".I
M[7CQH%"Y _:A]1@6A*E^E/&STA:UN0<@D^+D7#;3AWG^O)!HR2++3+KAI /=
MAH;5&0LL"8T"?UH99D"-XOF ]F2J.*V? NB6'_BKJ=X"UX;]KZYZRK FQ 7>
MU4!W5;W:]EQ>%O-L]U8P:(O2](1_9% 0Y@=DLNT^Z0&=Q)I>96UZ??"/R\S;
M&1^QGR70UXE%*;\#Z$CX<W5LY Y,AI_(IN^F@;DXMSZJ:@N_=WZ26QC,4M.K
M<A_EN##:L)20QOR(@*_.:!S8;FAJDCJ;].^W++?RA.J/9ZIV"W>OVMX!MIC@
M]@LX3FTP4>C;6T@2@A<\4!DK\WEXFRSQ>^ZP-<:I32)->*Q]9/*Q9[F$OYF_
M2+0?PP+2(+E\1]!V5)1H<>Z&,/OK8OFK]'>%R>+GPR,ZY'66U M:IWGP-QQ=
MKO?1TQC^=IMXW;&JV([UD_/;; _GL.FR9YB 1^))2M%O4%NHVV273G,@1?;?
MB=YI<-)MRFB>:!UU];:XE)+.:6WS A5+LS<3.1A2+?61!\?N "D'#&!*?$B;
M> X\'IAZB5FI-VRC3.JA(7H2[U?3MUU:URP<1VC' %W;Z1]/^:8@K!TKA#L:
M+Q8.PD"IAN38)?(M5)"&BY8@?.\ L3%IU_=^ATF7CDJF@6N&$/VOIP:VS,OV
M,KTL$<+UX &1>Q'Y1D 6\(H@I3 /]\RFX%3MHH #\$P\,.JG\,NZ1@LQ]1*1
MG;71T=8?23,J+!1A+\L*L!R.IZK 2\,9D7:A=#Y%=P!^EZUIYX)F""'C-Y )
M58&IVU>L;?,&L8$AS!A(7H67%75S\O*@HEJ^F"_(+C./[MUG&^F"T5=KQAY^
M)6)I>^5,R/>1!ANB7XS5KF4R@?+",?7DG!K$(B?*HO7ZG.(DAGLB"X<RO32Q
MT:XQ1O%!#A8/1$*<*FLG49#2UXTGOG'K"WGBOG<''VA!V\3D4^J#7^4QW#9<
M>4)=B&F*S:R):)3U.3K5 Y8GK/KR)T!B#,4,F\#4#>96>%>4?+U#U(!U9FCX
MAPXO8&VWU=QJ&$/_2YNB<&E]&=M,U)V8PN7]2U088#4,7Q'Q]2H],BZ^&OFY
M:'VT/,GC8^M5S:[VZ:W7T[18J("R4IK5"H>4(:3AH4"F \_8"GR;>)G;-<$-
M1 W=X/%8_G>&<>R_TY#Y?\):&+9VU)B@[(#F244R79O49-AHZ63Z-T*G^<VT
M1QN6CQ$:QI4GLI(I"P>RJYMY<^Q;N.A(5JO6L6LC!N"9O2HVEAAE=%K#(U!X
ML>JH>4J<NCN36@PKPM ^3[^.NT=W-BJ%Z*-VA#5CUI2W)<_'#2%RW/F#Q?&I
M8UN:YROS0L >*=,B N0(I3-,Y:X"CM4&K#'+ES'&F,'<IC^6IS:9W(Q2'.?>
M\MB;W%N<V/Z6+T"82+07'=.L^$,XY,;5-^^\6GA.?1*2X1-\$:.KDJ0UN16+
M/SRF-BE7:P#AYC=.#NEU7D_U5UML*C*6HRYBB>9^%O>3>SP42:<'M/_KV!?H
M5(AC;_,.0#)XUK V3E%G*9!=ZAK[!3S?*,<:ILO%4P0<]* ]?5C^IN[]HOL@
M;_.109+4URHR_UP8 %UG_S&<Q<*!/%NMJ;]GJ:>"30[/ %SG<?FZ]WD88<7X
M@RRH$RPK:=-2%#RAE"O[X8F)3TWF\OA]'@5$T+M/#O>E\5XH6XB\$I4VYN0>
M*'I-)"9_H_5# 0817OYQ6.Q&E:R;*+,D:7*5IYY9@0$(R3]D4?[^3GM2^$>G
MTHN_YIBCO,+7_N6RE3 W#X$E=@>]G%%,5F:BF+=K97!W21^!47P&,?CJ-(%P
M81/ZYLX!_GI%L=R::2]-M."NJ ;;_>0_Z8]#\'R^ Y";42ZH[L$838QF5B]5
MI%Y^+HDA$@:I*#R7DGP:J-Z%++22S>"V@%=\D-E_^NA$ZA&P<>,.H!:?MQ$<
M$)Y!!1$HU5> 9.UG&[%K%C-_+6==]Z6/;.6G\)QC?(,+<!OZD;/_-+;&SI4Z
MXYD>S(V7"/M8]PC-^*/+\L70(PH+*US"N--WI$69M &86'6)N424"G!WS\6&
M4R^(T<8_]MWE/Q//)PN,Z:LN<-7O #/.]T_3*#@D=-E]@TOV=# 1+V-D>;$>
MNHFVN_'Z\/D3:/I(]G+ZU26V;]Z.SSA#7YI' L%#-I*R?G"REE_FP]Z!]!&)
M(DH<K^2T4\9#O0,UQ;<8=6UW $NV[&P1 6L!FJN#\8[>"N,/=H+9=6-5[3KO
MOYZQR9J6=FD!#G;D\S9>/-:;W@RIYB1>)5(W$/:>NHW*:Z\FQQ$NUK&EZ68#
MYB0/#NB*@@?X>\4=7:%7M<#1GY==P(P[0+B@L;@*(U<9GZJ@_8OB@POH<'WX
M)Z;>A!2',UW6\-KML>G!K<YX6)%&=X.U _,WO:'5_%3TO=?SVX GAB56XLEY
MAC--V YRJ7N&^=;,ED5I8LWY10FFIR+4J$TC&BC>G@BKC[NE""7@9?ZOOI%K
MS$.[=M?O-6V3[!:375B)=-M0*1K\SY[4ZYJ7]47X:N9]<6E!'[X#&&R[-=L_
M9<S5NY]T['DGL>"K-5JO9JD]6*7_/YC7KEDQ:(>OG6SVK_@?Y?\XI(C;H*F9
MC$"2+O%^4+*FEOI3/\2&IV&@.KB'E.O2V>[D<6NU8K-#>WICUJGC':#D?_CM
M3#^85&G?I(( 4KH0ODF!YSN6#4W3=AK>I0 GVQHNXX./(=]NK4C7#=),:'0+
M\M'+U]:0\LFDAW)@U&(G]]F>CRILZ][_9#%0*?'Z26U<EIAFK.JDZ>./ K:'
MM:U_]IW1[20$E^?:DKGK0%.BO 1[%#C]B<OCJ[P=D6O&IDX&Y,+K X[O'?_?
ME%OK!>RNJ^'=,P2+UP?$U&24R37NL3?@7G_2(<=LV?>2;N4'BYT= \+Y$5LU
MG\Y +YO GLR^8)QPI-H1B4-DF=VE]@AB-H?!0*F/=3QLT.=3"=O3)7< %45Q
M97V%;3L2K]*#7'T,CF(AGF_)S'A O$6;TJ'U6GU\9O<5H3FC-;LXAFM6A4^Y
MH)$[0)TJ5J;3F97<LRR&#C_57PM2_^7]1)U)4/#M]E_Z03\8<\Q>B7UH2HSO
M 7,#T]7A.RK<ML+!LZ.>O=%N"GMQSJ^>L12VF^E;6(E>VI^H0\O(5'DANCAO
M?[SXV_+-O1ISNTOXJ]I7%+ZPL.V+(%FS!WX,8HCG_LP9[:\ZRM9M^@W[ILOP
MA?I@B/?5[1-W(_/*SX+#(*$F>OG-)LT3]W.,8R3%2/CW^ &*AIQR$E@_XO0^
MV"0#;>E\CDGU5X'?!V2>UO=1=MP=@/%7EW7*].X=KIMY\!:%?],HTW 1.K]-
MI?63B[;]\8_$BD%?$[#B[V,?%+.AJ-S[*#:#*_NG (6NW@>"!#<@ 6M>9*G3
MQ9-V/Q&,.1UXJ-2^UFFVALS[^C$':CU8'K13NF;KG=@<TU1W(K8,_]<)N.6O
M]KZJ@CS7XBY<7\&KZ> M6G!?J(D1Z2F>U>E@UM*H,BJ ^7"U-(YHJ_8.\ [.
M1\738IG$A$IOFM%E;*S(,$V]&BDR=9'4X >LO,\@JS(;) <?J<#;*CM_9(=.
M!"F3L[KZ9R>^"PU^C5SD&T'Q8PG3Z(W4OG=)G6^?F%H?^I$P>)J>Z<J<FI91
MKHT-ZIR_&%LIVB:YFJ QB?SHQ+9?1D'8BEE@2XCNAWEWNFS+J>\<@KK-441X
MP;\PSTMHM(7 D**2+;'>14\RDM@D('%ZV>7CY9#\98ME8&6$-4)E1@![UJHS
MG!5U86A3X;A4ZM+:':4H(7KH5I7M](.ZC!?O9XG CP\#OKK? 4*K3:E4T%1L
M$L7^^>&]W%_UP4Z7.P"I(8(Q0T=%1><A&-6%_SX!M^>Z&D;_;H2_/0+^M=@I
MTK4,9+IU"")__>2Q,@E"6 [!,WH'>/PK%/RUWHM0NFU#*%PO,234J,X@[:Q=
M';7 ;?+.%1+%TJ6^7Z5PC==<UH('!&Z=HD4X_1V+_M9Y65MF^2+BDKJ9P*MV
MH%_A=^NV$67BQ'!&3^/^<K YU$3[#A"!DRK;"=)BA1'LGL7Q-H:_.+A.H?1T
MW[G<V%R@PM^\*NI^"MI:0WB#QSI(%^R?WJOYWT3SE(ZGT+?;/V_&F?Z2)^E2
M1@4EHD!]M+4)#!_+TLMWW:C=3I.Q!X9BOK*$^NL;7R/B35>@BP:Q8FQS@WO?
M$[=P33";%6"=Y;1R1!5Y46EE<@%86KJ[1J'<*]E'2OZ]IQH'/?P1&K1E%>\*
MOLL0$EU!;0"-T7U.]51 T6>W<*&W2+HACXX?/!1PNF2"Q5*18Y!Q2J3JPM)V
M%)K28B$+?L][ ['D%%,?>-Y^J"8HI>/':<$,2SF,2_Q GPB)[,L0GFWD1]*%
MV%VM)VRRYXL)_TC^=_61&.^_4T82@2^T7;]/37R]^67MF)$O1:HR)7L28V+L
M"5''E OA11Z0/![IH$8E=S.'6WI*K&Z+F!21!'..-^P<*#3A%*#13CL,7"UH
M8<H?SKCD'WPX1[\%/;A/6\G8*V619G.NAA[>>Q99'PK'/L\B)8_1[K0TMQ6F
MBFP-H8<3ZI*$<QNE!G> EB0^PBD<V4M5WZ.*XMFBEUB9Z=LF)OTK]XDK#7Z=
MTY"S!#M\[GZ,%_5@%HX[ /*0VSL(OZ0E++ 0E)D?ZJ,:%R,/B)G9_]8Y2)5.
M:Y>K=Q*%#>8\0X>.:2P;?Q.7<%1=T"HOA\V19<DRNV*S<.U,I./_+-VV^YXX
M:@K9-LAS&U9RG(LTS!/(M88WM;6WOPU&H8PV33 3ABY/O_Z^843K0^NI(,J+
M-T9A;E?";F]?N5\F3B.#-"27]49=_3G"8 77XHLATVUFW/_!WEO'1=EU>^.C
M- I(2DE+2K<T2)=TAZ2TH'0,"-+=C4B7((VD=$J7H'1+S #"P##SF_M^XISW
MG/?$YWZ><^OYO?.7?F=OUOI>:Z^]UMI[7_&#0.^<'+&R7%@3E7FC?BJP:2<0
MOU#BHW>C/P 2N2'M>?E\U$LR:OB4MNL_"N&5<:-YH/$/<$!!'$2()W^T17Z/
MFH3IMX^[_]FO=^,^U;L>0P1F4G6H,BU5588WWLO[(\:V_W?)9G</G3_%ISR;
M*,NG5F/%X2&"]G1*]:K8'96J?]-MP05\71]IIVOO2+R)3OS@(;8PLQE8_,XE
M2S<MSJI;(;T"-[HXC,H>A^FE-PQFO6IC[XNF!0>@ B1BY4,$+FN/+;_WC:EM
MG@L+)"_IGUK/->9S4"<&#^(RMY[=I)#AWZ-XR,OA/.6WZ%[0;Q%T64#0ZRK3
M @B82IJPL,#NMQ&-_RA7)Q -J\3IV^NOUT)85I^2P8AT<"#I(5BNB+&B7)YO
M(*F)-?/6%"/*,ZD)*P9F04M1S;K+10%H[RE.?Y2OD3>V+G_I0G"K!S\9YAV<
M%AL+#_./[UO$:SZ5N&V^JI8"HSC68[L^I.>PSY1//^(SO#&53MD7H+E!+R!@
M_^U!.P?O_?-"@HPX6D/'-D]$CLL&WJ6D38OTG:C:]DUMOH]82@<([/1)I,6I
M\>T=AGZDC_Z:?^YOXV1]8["4-!WSO. 9K)14LI@G(8U/^YOCQUR\<MXY<K2U
MOL<LJ"[][6TO7H3*646^$G?\^!JOG&V*G!C1PLUPW-\.=5W#9I0L_#@%^IZN
M2$C\;#)Y8FV[BUQM^_0&.M(U.O,#NP2&"0!2QF$Z@:R_#2Q&9>8,[;LYL31^
MV!ZI<I(VEGB($4^IX;EWS<I#1R.@9&/\M0!2>_!$,_6X3W%3GLCI*F J6T5*
M?W0@42/10=[.9^:+C%O0,.%<#M[H*R',1HV$.(9NH*CIYP-Z)67:\N]M4D5L
M_8A+C\.T7:<Z>W"<_IZSV"B#JK:$BEV6:-U>X':.?\TL-R_#ET.ST2;R(=T<
M"(__Z]M5$JN2)[W8!BHCF2)0(' @K'(&PLEYR>H&15QWP*/6B2E(Q]%SU3I%
M_?!\S7)UPYMRMX/CL!!N$(ZF/\1[Z[(AX(D*R)CETI\'33?'S^?\BH>0[VLD
MG8FGU6//%'>VJ/0O8-.G_6NPN=&G,WX2$I1!\;O+M'2>"D >T7ZF-KDF<Q6
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M4<ILLD?D63\>NH<UF[?HJ=2:L]23,B0,/<_W3 Z@>8\)SS*MFIN>=3F,"4[
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M6;JZKX6/HN!6!N'FN@6?0=ZV]HA8.<\]^7)!](+O'1IQ66E9:7W K;#K43@
ME P']!*BFSH$I_6%[CKRL9T3..(O8HFC$E=O&'>8OMV0GV:JLA<\*.F?:GE7
M6CW>Y2\<BM9*Y^"9%F"\F''4\T/61D)A _J2DW9Q_AG)TY6S.CB@( ^2%789
M<!<8M7%E.I3.,;D1( T'^"+<#)&8&9=X:]W<O3J*[:HAL9_M LI>4G"C<M*1
M!*<(X@SBSS-'JW-M?;:X5#+9YAQ9<'KGG6_11M1$LDSN\0 .,%42QGHF2G,'
MFSKEXK/)6ADW:.<[^5NGT^JU,&;+P#,?.8N6SS\_&OU!:(8:4($&ZB;FG;$]
MTV:]N#'@T0\I8;.*^U"S Q)4ZV%$(=!2R[ D >EFR&!3I9>K^UOO.HN/[P\/
M%IOGWRJ69>G%.Q_<]3D3-O\:QI =:>WX-<@DLOBQK<SI4"@:1:)%;R>?Q#<L
M<3M$M4AF)5R_N=G?^1"XL0'SA@-&1W/E*L5,BY*%G?_PE_JZ)#@EOET&."&\
MT7$XC\DL+FOEE'B!^>M-,+A+D\"OZL,O8.%_.L0_Q=N"^A206;JHCIN4%UY.
M?X #'EN#AM3X0%C<DQ 3,<]$<7$)XH CB8%'(!GU0 .)5&@4572WG.CF QSF
M"C#U &OR80=IB%:[I8*J!?W=E/RCQZ]%MLRG7Q7TLD08P@SNV)%(\4O7V+\X
MX3\8N;0>>-C<@T;U/,<742&>]1Y*5 RDB%,1%Q%QFLKTH+H]53D!431:)PNK
ML(W")&]8:#-)L ]_I%1(^]G_3NH1R-7YWH]O,BTM[[X:$U*_TO5 !.NG>*T,
M-H_1Z?%%ASGEH)TWA(\_U\ZP\)D^"*=+V3I>2Q!^I,6\MB:0ZQTV,GDP2" M
MA5[>4SJ\P4&RUQ-#-XD8=%F5NJNVYJ23DY*G\J;RY]:)0\^*A;Q4OQQSP\P8
M2[?ULX)S%O!U+#<.H]TT;<.B7B0-0)Q<7TCF6J^+WA&& T)1F-9Q8TRQ1$=$
MIUZ5GJ7W:F S7P^!A&-56Q+B<$?5S9+4Y[;.-FT,@GW\ NE]ID+?9;QRYN"[
MM'*H<(,P+DE'*BZGL<8,I##C,#.+.DQ3\3)<2M^>BAO>O:-._P.K%[H81 VB
MS#55U4??.VJ' *\L//)F-X;S\+"G(N]7TZZE##Q$7UQ;%W0LOQKBG'P7KZ/_
M-+J0W$VA$>4EQ.[17<,O3S&<C9.#3@WG3T83DMI[A!0V-3[>W^IJ<'W8@T$S
MPWJ3>9TT3_\H;2CYQ=Q6]K9(:JU^2%<%0(J(YHP>NT9,"_S)RF+NN)=ZT=70
M+WPT**V])Q5W$Y4ZI8[[<E-28FASI9)#N<^<B\1E"PY@EWU;AG\T<"B\#ZQC
M3F[.;I:4\DP7;:?ZF,VP$#,;IB,QO81JW5T7F(3E,N*07OYAN W/9-$!UGM;
M@K*S%Y?SM>\B4ZIH$E6HOYSHUMYP\AV$>[$E7V:M1;VQS11-N@K0X"SKCB3(
M]G[%,'^(1VDI3J1^GZP>_(!==]E(HC<?U;9!TE1"3L]WZ47L3-=[(-N67"4/
M)_GA<'G/$08/NM[=53%\$$P_-#HL[:(P+C8%@-NE[8\8/SS\O,!!:#6"_P0^
M:<MIQ?TJH7. 5MG)<!$'XZY,H*9L&<Q@P&-K([Z$7K/(&P<J2&8^I*K9C<VZ
M,0AK>&?HD[P*A8 .?C26<(+;W$1]E^@C![!MMX"<L,#POO$<_7:[@=+;.>JA
M<IKKMI@OL"4A>4/<!V$S6MVF(5/Y'9:7FP7B)+Q]O?WSX"_;AH\2JV]->]@#
M/]#@(28<BCS")(U!6Y=G#&M4FT>C/HC9*;[XI*AW2_HVRWUH!6(.Y57Y=!ZM
MZ,7A@2&:;9WDUKF,,].KQYYSBZE/M[B^8OPVS40/)"I&8@*HB*JTJTWE!SA3
ME7$?<9UDU2-LFIJY1X"^1D-4Q8IY03U 3W92ERLN(.X7[,M\]NV%!77=T" <
M$$27X1(NDNG'XED[SNYM(W8+4VMHZ5#X6!WO5O*PL=H3VJX<:Z=?(9;]T;V]
M%4=_89K7U:5=4_R2#%I8F)A>CAGAJ/=$5@N_>*#QS.&L_]:Q,I&;AN:B3U/+
M:N/#<%GMY)45.[$W]JLA](>/FJ_EM]W0$D>QO^MP3S^FSE7A8EY.(GD(R8>=
M*)ZJ7Z:/T(Z5,#'R0]C@ &KJTW&8C168_]G^^:/\D3]^Q_8MB#?LHN?4Y3+8
M1AOR&.KW#0Y(?_])S7V[T-=<0=&M<>#7,O+_.-2EWP;2OJ_9?KX4$G:HK6-T
M1=G!6T+NU=RD.![/R;&;]!D;-SBI73ST[=!EX"N'DXAM@]S@MP/Y WL#6EJZ
MEK.Q&BRNPD_#L&WC;7ZEJ_HSX$>6NT^X]KG*1<Y:8&8#3+W]*54-U";-4^G!
M#@K?L^[_M9^RS<RHHRSZ &WO<*I Y<!;4J$DA=L."<HU;!^T1U0-6<0A7%T%
M/"I__DT2&!9ELEN=[_SC5((<T63HTGZZ/9'P3_);X;MR!:7=I2M3 UU6S>G3
MG<K4M^((_LT_L;^Y*H@Q'A6\O*GY'?NWC9;=#1[RNZPYLM3%@ >U3@XU^3]C
M*\N#M5&A]W78;<V]>G"GK6M"L6XH-]<^+KK:V7A0G\E>'DIDZ[0X!K%GL1\N
MZ['*):7.MXP3H8IVWE57/1_;KO7WR&[(;LANR&[_KW73%6$,F(&L%1I:NCC2
M4+B#AK1NZ]3D+U000"?@ "\&2 E4Q3I^>SHIB1R: @?$Q?UV-,;+XTU><^Z#
M6 _]X<]-5 .@;7" [QJD"2I5Q^J7$R#N AS5,_]%,B$2_ESX,XK>7^;BD? G
MPI^R(RY"K-7<;&3-L8GV0+$;[3OIL#3=",9L)Q=9A)'[6YC'P1G>09:CC_K.
M8Y6/Q]M^PU),F1R%R\,K<BL5O.B8L;&W9D;A 'P#&'T+'!#0N1+V*>Z%)20"
M#A!JA<J_A-T .ZG1Q3X!N25V[@/#CX KU1<;JP/-G-M,T/5CT(/QZW,8U(_T
M @W:"P=DF_Q-2%PPU6IG>MYI5&>OI\3Q_#7HQ'+Y_BDAS-7S,G;GY@K11_RN
M[VN8!? S!T+W,AS0:78\@%!L-JH.Z5M9%\F[.+BYO.0^NH,D@B2")((D@B2"
M)((D@B2")((D@B2")((D@B2")((D@B3RAX@845FU4!_-7Y]X<1]A_?Z+EHG(
M>-U2WK<I63@@R*4-J#*0F\J4^EE7S+'@W/ES?8Z%F(%P?X"]3_4XOS!WMDU4
M6U^R-0G^HI;O!]V?<6/-0L4H=*OZ@;0,0=[7_)*K,82)U _'CO+N SJ*MAN\
MF\<Q-TF_V3Z>_^D[@DCXLV YK](LM7*\0HZ\QKI(= 4#:A_)=P-<WF<'<YX.
M7E%T_JG$9&/#HHRY'WG628AK'RW\Z8<&J%35;DZTB5*SV@FGQ8LV0J![HE]J
M1T(9(*(NCSUC?B53(N&?#\^ (]=)C]#POG\H&3R^.LA4-;;7VSSS(3-V:*[-
MGF^5^QE1E^U4\'J,\ZJ$A^M&JG_&G^!"-.ZQ8,(O8S(D_#F>BC=2?;0)!^@'
M5$[;0\+>3KB)_WB6.>_\4P[#'@;8P '>17" ]K8<=:G0E[AWICL).W)@CE_+
M9DCX)T/3((C[S7+> =YLII,9UQDYKORW45[#PY^0]:M'5X[Y.O>S!WO.,2@T
MSI27P:*[WV1_+6O]2Q'EM#5VYVPS5-R8N:A"S023BGZ &[QYTM>BSW79_[ZQ
M41D.8!V'(18I(7! UNF=TP SE^\>9D-PP-2UA'TR')#ZOF UF7!U9."R4<%^
MX&GO+IZB?[3ZT^G":>,!Y@*\@64;/QO&1X_+-H3&%.^D\HO\:Q(ZW]D#6NCD
M#5^:-QRHR65@4>$[KE'187@77H\&J-]@D";-[.C>41/U>0U,O[3A> 2C+7]9
MM^>'[^D[S_FEOXY_7N0_O<!B'_$@CKJ1J9(>I9GI*KNKVN@,.7%GM4=,G-.3
M=TKWCDL4+!*S4U.*;V2!L0986%$X!C2NN02A0PWE7Y;XES G=-(G[D:(THT(
M]0Y.V.)#T._H4.LGAXHXZLCZ8;#.\X=IJD\]F)B4HY_G;/;?D\AHRWWEND_O
M%I=?K3,:+0Q5C1,DU"@Z::((Y<]XW[!03M?]Z1P#OY]U 'HQJ"1--V)%8_.<
MUY=SQ!WE8HK C_#912:L<DY9;UG<>9_\%E1^\V!EQ)W^@H?\4@SSNHNZ@G1_
M7 -LL(MQDI>%V?'!%X-[D+E'P#4^OF;/%@5%%B_)X;\SU!)/IB641FO &\.=
MQ&Q*+&*LHCR52:LD*U'4$;1$GAEM=5<880/C>9R+&VI\%^+"NI3?'GY?*9V^
MY&__(INA=@<AK;+.""RX6VKHHI=&[B=J9UCSP)N:<GYCQC6SNN'+UN2E*T]G
MW8]2[Y<(_RBAY_')9NZS&TB3Q#O%H\PUAI&5.WPJ KWYZF+<:2\#=#@7IGH\
M'TQ<K03B&RW-I76^N]&M<,27G_2WF[Q*<T34_>6DB%YMSA9Y[+)!>0CC VL7
M8S%HUS"K+"73Y#;VI]>KF!VF4FZ\344+F!B7F]4X*\JMM\:98-G10_LO"HA+
MJ$P $J.B;MDM4%[M3?.IR^ZCIO=F#;2=#5?9<0\</D7.%WEEVFBKWVM"=UUC
M\"1_.E3SK^RFY8\RXN9@!;I\ZE\B4>J5/3"2;.EVLBKL[79L/0DSZL;H/5(/
M7\?X*I-Y6B'V:0D'U7=8J\H;[?O,T)V7*&Z%&F6'&VD;,Q&.'JYNN]&R QZT
M6?>?_G-&H2PW[JUR)?BL[&2J@>_ ,*"R@%$C+BLI"FOD[$QZ_['OWA1I8<G#
M(KM.#;.-5&EIBQY=!4K;D%J)$\$KB3E_LPNSBH$XB&B9J5D/5R?W_MK[AK$%
MF/KT +#'KZVZ/6+[T^Q_/K%^(8BL3/X!:&"[-7X]L0**A@-ZD_BOJDLVKKZ^
M#]N7F+VAY3O]5BV0NTOG]K:L2MQ;+O.VY%)*Y0@S?K<=TZ3?,7]K$._+Z$Q^
MG[@7+YD8L_&;! E)WDM>-=VM_GQEWM[$>:T!E;SVA/*BJ(N3Z?G6SVYLQ%PX
MGWXE?))D$(!_1FT7)TO6-!1O26(*Q"5,GK!1AO@Z)^LEM.1FE4*97YI RCQ%
MX@9[7S)]MPRP A?LYMT3+9!H6/7#M;$8Y?']ZN'/W=?)%9<UF&W.6]C6@?O,
M2_-="LPR!4<-RN#^WFE'?F^=H+TZ[=#2T"EBYJ%^:%\X\0E(0LY&S9CNJX>0
M:P+5V<YHK@XY085/=A0YVL; LYF;@O3+.J^PI+0\U=6HULN F1Y9,%:+U,,>
M(E2]\ -U-Q]K87X^>Y$6TGICZ9U:CF,P6)BHH2TD=[E4ZDH;VXJ^G.8JV+&>
M)DX*\L&$$;WI8P2E1D@IIL3!W<\9S8DB414#A&2!P&SQ'RZ0&-AI-=2*&G1_
MS"9M_S*@Q/W]E?QYIY0%E0FXYR DWNOM_HWG"8H V<N[SB7HV5O@!]]+8#J'
MG8OG%'EC0!VV=(G,M!<>>0EQ;((G%AT6X)Y=*P)OVMV-<\KQOG0K=^^SG?OI
MQ[*0_TOTK>8 WIT5^'L$Y*^#=B@,7#T)(5"_5V_2D;DMVO#DAG8D-ARO,M_O
MTZ:,>:B^?NW[[U4_RC::C.M(2L)G,NN>7V(0>2J+UFWE32_#Q"F%8..LX.KF
MDY%3FY,#6PKU$E"U3R%X'KS+1FVH'DC.>>^6B_^!^@"W=?D1KN,KD:O8L?V5
M- O^+>?>FINT8CA H9AKUFPF.Y.<*OA4KQ[:$A7S,"$*#DB0Q/B&-:BL[8/N
M.A%;N))$?BJ8FB7SK)/!I7:E:]N9\AO]^QD[*+7;.*>WO:IK'/4;C"\OK\(B
M>M*8^P?0L[<O/&NK(7J-<(#MC#.0_T;[O7F O<FG+P%RHI4KGR(@P2/5[_@I
M7DE8#P!W7SZ+8A[<KUL5BDOSL2OPICXKO"-1IJ9SZ36?3U]-NY9L-?."BOS:
MN-)0G4!4[T? S( ZM%6-_@#7.V]1"=N?@7R+9Y9Z#?<)'_UEW-"M;76&@&B9
M1RH&\E]P9O >U"X;QO+*%H@G]5!J6%-I@B]VK6UV1F:P?323JUM HY00/_4W
MK>P">)@O6POS/IOJ;ENU[2Q04?H!3!M@9$G!@LQ:$>73)IN=;_Q(29Q,".RV
M*F9K6F+EKVDFKMU0]7;?:Z2*:M .3X]*FZ>Z[*AS#%7Z.)%L^C$0-N =VM2I
M)TL??K6OH:RW:!VKX\BQHK74I7VJUTFN#2/EPF59Z7N<2!L7 L'(L#G<SHEL
M9P/# 2HD)U>]?IJ$G1"VIH,QCF(/AY8]/OU+R[YO_7Z3VQ$NUE9R;.2Y-"Q%
M=LN((:"C&Q<T*ITA(T</--D""HCGT1ADI\>9ZCB+;W0(UV#AM+S/TS2WE[>2
MSVDP<M*F[U[.=O1X=G)#\TJBFK8D)-]CL6+H;K*%YV51[O_A]1PCZ9:N-7:?
MS6B_#0.W3)=N\C1:H//GFBW!B(" 80<A!=<!T=FV.1^)ATHQ)5+%2FB,0@U"
MY?7RU%R]8\\&Y, 2>PJZK@^%]=8V3$-BV\)"M9(TNKP<#MVX[4050&:+UUKL
M$N!#H3B3<1[QX:=:Q^@M3QKD+V62<#!A])V)5!?@O929)^<R,TTZUQ\W-\J7
M/,IV5:_4!D\A+^]P]M"#09<*UV50M^HQJM7- #FQK>#]CY9V;GSJ,Y[?Y2VS
M%%14]%]E<&<CLFQ%W(B-U(D2Z8RC7NS7,6_*+O*.D\.';^F3.\:_Q$:!MV\S
M6[E]HX\1WZ>>3WF@<82S(4,%3OL$\?A6@$65@!O]N.EL)+;"*?1(]!7CA0A=
M-1S H17$)>)6_&E7ZDJ2S-A=[D:JT0??-.G4_#6=40P>ZU3.P5J6T2N=R2R[
M_X^]]PQKJNO61H,@6!!$0*J$WGOO0>DU]-Z;-$% FD""@C2!T'M'.DH1!*0J
MTH-TJ8*TT%L "2$)!Y_G_7;YRO6=:U_G.GM_Y[S_,O-CK3'FN,<][C'G6G,M
M9Y1$R61P!U>-&2#Z6FORJZ%J ;IC^[Y\;@49W1PR3WE?'KLQV#!SQ8E93&6P
MOW5_98\63T/K.(7EL\Z\-,Y]+"=^!-]+^46O4_L0],!2-HL.9]DP4,5:=5]3
M@M9@]DYV2B8TFW)P[M'MSQV?]\). M+7QK @K7J^H?;*2]F7NJ3TS80&R?O]
M4[^HW6J#L;<C81>0IWK7-/H!8U+!L'XZU.!6[7+-HL;\SNU) < ,;ZVFUXHV
MR(H>' 5QC5OTWR2J[B!M#>/\_' C3M\P07-*3WT^PH\!>R(>1$1*);CKO2H;
M0O4U&'=K5-+U@6M^0:6(YG#:=<C+@0\]FX:.M'2V##RKR?I-6/A#< Q.="47
M!(N,R2NH&SS?_/ 7\[.,M;5IWT+X*-]FO?. J'ULJXBTATN/)U6>XJ7E*97
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M?>"R^LY@-B&KH5<RZ4F>N(<OX<CE9![YZ+#K??7P-M)YBNV%2GA(MB>+=[G
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MU@&]:,_"1$C0V+TEW5B^+_B6=4J4#G74M]\/];&KO.8^5\[^$J3QQKBQ\GA
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M369I@74(8OJN%=8,3I@4]79#VJ9Z!9USMJR&:][BU1P$'3I"][I6[^7<4YV
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M&Z0?*[$]2TI?15URKP>BA1S@5CU0W$:G9KO[QL06S)S02"F [6>(HVA:RJ\
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MW#6'/DWA;0A5%JT[F1[)CD!9WHL25+_\0J/4.)Z2=L]QE<?A4+_MI'1ZD*B
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M?*D_TLIU0YZ#J0O$39'#P E# :_\"W@#;6NI3D]AX79RG)(R(7E6UJKL9)N
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MMG]1_+D@@AGZ@QGGD3/Z<NIS $%<V"-3\6X4Z5JFN8>]17["L%GJ6J'T0I?
M%6#)##3CA7J]5OGGU(X/;[?D3\X)FI'G:A:1KHLF,7>:CG<MVXRD3Z/HE*/I
MDK8'1RZB&'.*T6*E('=8?(@WIJ)6#'.\BHLU0;1=/GNBG'SG-;1]O@ \*M!#
MHV3822)>]CR+$/10R6^N+$;_*Y$1L'&("^RYK&.'L@4NJ<F0TBKAQ7*LDLL,
M.'ZNA[['VR%P%BWK=3/$(#,3V26#3'V<B>OSY5^8-O^;EXI%FFS _6>?.TBG
MH-7H)Q:;I.<?;#*O -%Q;403]*$F/Z"/'N2XCGSDJ35BBH+3(AX_Y/H6UZ+=
M01G2[U1;:!%&@9*?DH>#/HKB*(X+-,?B4"=W"A;04Z5()?W*8'6-F2^M7&B5
M*T#MK2FRLXA'C#)K:2&F2^%%.=5=*M YUI;C-2S4V'E]4*_E\Z)D8'D/?^X<
M419F":W5&8&GH,NCM\KS>%_K6T^8EK?ZZ)2;CD@/[9R%<;QLO]-9OFB28?,P
M;![(UR#(08%Z*3)$&!(2ZGX0L'$%N!SF0.]? >Y;^H%TSR%IXZ%$2Y!?R3A+
M:,>]*P#U*$9=A,/H% .U>%.$AIU!U31#5G!GPR? 8[(,6[0BK H]NE;">_+G
M,D#T[I_WQ[LG0U5_HA6;?F#QE^17XY&1[]E+/$>9JGDHZ0QLJZ ))ODW'A3^
M+!WR44I91N/?:O[A./VAT%6-51KOL79KW!R]/5E: +!UHI]K6#(K -8A@QF^
MU O)03F+IU3GU/XY>DYKW0F9ENFHZ^AV ^S/W'9Y#YETN>TU."A6]B8!6JHY
MA'.4O@@.?F-@5*L=O?48J*,I+D Z_9 V!"?6YRH?7QXO84!&$FM>P$+#<B25
ME&P9>'@\\JV7E%2 M.M &[. "!@OO7W+6HG0G[EICV@E$R48\Y;?NES7FQ;6
M:S*B)<:#)P6D).NOM\?#!M'+QQQ=SKE!@V!O%XTO'HBA/U)7[B2[@1TNQ7[C
M%J53=I:3M[I_G9[8/"P)M1O>%7I9"3ZW 4ZOG-H*172F6)_&K$?-T#& 93N3
M')-B2;C5F<!>'@M]W3\W$8_94X6?>?ZOI%'>OYY25#5]BL)%!<U= 7J/L+PV
M\*Y#K:[=W)'>4YCO^ZE0G_/2K.#84=%][XE%98>[2(KJ-'KW2Y5.J>ITH5Y?
MIJ4>H94:;WFTH[2L@?77X9?%[Y*T.T<[Q.&R$4KH1Y%,7'T-@H?#!>=%76LT
M5X 8=@^_O^ ?^C?\[1! J<X<J5A*<R[4COQD "Y+A_>&_7!*@:'W<*08HG93
MQG'JO?&^,O5-M_/5TUDL!TM8IN:;_"H65DGLLEM&,N^#[X1MWL;TT?)W2EZ&
M(,UC:!@ />IXU+E1HWNZ$R&7?/"=Y)N_]AZ&5\W8=?U?U+UG5%-KMS8<!$&0
M7I0>.DJ5*B!5D ZA(UVJTJ4*" D*"B@0>H>(]"XBO4M)("!(D2*=@!3I(*$D
MO,']E+W/&<\YSSCC?<?WG9_KSBIWF?.:UYSK7E<V^T#:@*G7@K9)Q>.T%##?
M5Q^2K:X2A"80Z2I7;2)]1T5I@\1=1:XQL9A5I1W=.DRB:=IW%%?"&D(>#7K<
M8LBAVGLFO4]J'WE.SYQC;Z6YPILC\XHY0.A(@LOO6/H3?32'/?7:%Z\$.P/F
M)D(UOW*;.2G)K[10SQU:DO,-']+[5*QY[8G5*98)\I'#!ZX'C#/T!O>)[BRZ
M_C2.42"5,6QD59]0&Z'(V$%B3+3& F;&[:_1>,S?/.PL"8VJ_C;Z'N%T38ZO
M;>SE_K[-'2O!3Q$+U'=H:=]/0#J<C.Q$U"*?28G%#\KC(R.+L$\.B/=WK@F.
MJXZO#_O2,KR-N/G6.S&[>&C!R%:S+D$X2Y!I3(_+0)&S!D]/556Y(V4F727&
MZ.YJ'/A/[BK\VUU?_.&NNK7S=X4B^!]07QE?8>?)K+L E(E4+^Q=3=SV\7%1
MI>FBVE'&6MF<%O_:^KX,Y*R^ "@$YY2*JV0<BGVPW5,Z,52Y,R^3$S>Q-P7!
MMZR1U H]<!ZU+8\XO6V3+4%1.5,KWQ^,O[:)GA >A;^6Q\RX6Z)_;$]QU]>[
MIEQ[6=X;ZJ0AT?@TCX93:2/#_?WZ,'?%:-D-M#$(LA^ROIQQ&QF]]V##J_L^
M!PU;@;5;?<,8B]NB8O5HG%PFU-,EP!&M;2<U=/>F(8,VVHO)Y]&S;^YV6TRC
M"1F,3B.B2S?6BLCQ'RCS?#O<&0 >9V(R+@#,(\YM56&CKF#H6VOK+(OUSDEO
MDLJ9X"<_GZ[<E#D.070$>-FT[_#)ZQT8-757,.<ZP].6;NMT%"TG#(4K/K0M
M',O*#]O1;SJXYSQA]XU;G]+1 +#Y)5DA5MUV"4JUVFL>1KP+X(-/AYWWU3V<
MDP;,AN%C>Y,P@4YQ/Y5UV\25CIN101/CCT2^W]\2.@)+6%O_F+1/9>E'/1 B
M;1$I5DF<0YPW<H]_;I^@Q:MG>06*41R0?<^YYB]%N@+F)!L1=VAN?Q*)F;Z7
M(]\_AG_DU!M(:AOR1,;M8?A'^D,"3-1$ANPR3^K=O&OFMYA+^<=,8'Q.DLPX
M;\LL'F?V7HQQ2[.VKOB5-5),PD#,!KDK_':OTIA^]TO+3)06E"IN^S[6Y@+0
M\A%2.;]WM6\#G+N-$307?G<V-$-M\R?W=MAH@T$WGW[Z+1](_+K]!]%():D^
MWY[!=2./[FWOK ""94?$8*G42A?C@<EY[PMK^I7"\X:)J2388OQ(!I?8Q/7(
MU(S*UU$K9S0^BI95',$N3_)6&CKCLFH6'<-)I="G!QAUB$!@[9%9N.$K7N]P
M$DI%A<^-LI,$5^%+$T5C60F+R8%<;> +0!#TM"R=T;.@ZQL& NBMD?C62@T?
MK)MNN<__ =_=6GF1ZQF![Z#*AW["A<,[8UVW%C.644C7#];?[A?U,"7@,@4X
M$93]TTL(/X,GOO6RF^$A*<S"PCE&@Z/B6]FW]VU3V4ODK&P;YS3P3A[35>@=
MF-#NRUDC=^OLJT]NB1&1"]]8X77^;STN]9\0[/];C^>48@D-3JI!XMC5R 7@
ML?!&<+/P,03OE#E88>[<\=3J) )["#TBVI1:!\/>;+:UXUA\K0)ZA>*($S?U
M0G9=9T-1&"%_T#:8ZJRK7?C(3%A_V<<XFDVG.=AFE$6;0">VKDG@]:.PD;(M
M.[#CMX(QKB<HMM)[5Z>SU]/1U9%O691+QQS%Q(.HD0K_3 T8<:G!EM\ER2M5
M1ZXPW4&\0XP1Y/Q\\.P7TP*P+>4\G7'T/EQAI& %(LH2W-KZN:1THK#;EPU:
MQ)UY,V+C+9D\A'%94N14UKE^DW+M8X'\@R1HQZKG369A1-,<!04;]##LSE]X
MKO[WO4'_2Y[K_N_P7,'S.G5$W-:&43#Z+$0.'-UL^OR9U#3@[H[VU=5<>W;1
M=RF"N"DN""F9YUL,?]T+S8SO22#RZI9-8VU^FBHF]IZ6J)05WN;N]9+PK$E@
MA#J>S33!)J5A^_/_I-X2'+$Q_>@V]A2X.[9R^N5)[\G=G2#[]9[Z VN;S/IT
M[;RV1I%=$XAFN)YIS+T5'I'FZ9E<Z7%/[7K$+^+'^%8-9>0JP*OZK?*!+XKC
MXQ?(1_]#%./;];^N-.[Z8?X(550(<.NZ\:'?R.4-T5#3_4G-RI<O%37PB]@G
MCE::G--)Y!@ETL+)8LM+W16=ZZB0W2(/EY<H=%4 %%\M.ZF6TUD=IQG0 =TM
M[PM6R */5N*= 'M%2M5D5I&G=W[TBHR+C*Q*OU@Z-Z?1/C#L"SQZ5,IQ-5Z1
M*58B]URT;_&*K%5@K?T8C3QY)C3AP<D+MP^6XP^DV>P/2H!=HI]ZE_>>^E67
MG'6)'OA_\(T,?_.N4=:H_N>8!X1TXE$$0Y%G"7+Q.O.W0$\CC)R'N1]AM/$K
M27&\IA I[ZZNU )ZT8"OC6RR):M]$H$9=P'"U$C=,4Y/N. @#EF?C+KHFE$^
M_%64)]C[SGW"T8E@] ,?2PEZU5+42*J=Y4L[CY! BSSD_91J:S$H?_?U%PXC
MD@2J- KW=N;/<"JY5?#$XPQON#X<6 TR^R2S JO@HTVGK5MX*77$M'/_SG)J
MA QA%W/U7O6>NM%+HK^GITB_$'F%W#RERX^=BZH"&]U#M-3UGN:IFK<.*@,/
M-B-8KY<DKD9/QS/!J>:HF@ANOS-C>L^'\CX;I .;61MX@UXU7Z/WVCM27%=(
M(U3E]R6ZHN  IMU%\A96%>3=J!NJ2KB.W*)QX7N$_9G";U5R5O=]!^D]3U0&
MVW+NLA8N2KD ^$#2:$^'JW2OV[0L%YZ"^2M.L7A2,H>C*B6V^*70:4?:HGK/
M(I&6.Q0[7,Q#?TU%;AU=$6,TM*OE P=JJ],PRY9+BQ$^' +*W!9>@9TU8R+.
M/=-EVF# X<4G"F\73XW.8=CCH?U$K*X0\P5 !0ST%F^?TUK&KK'5TL4<B7(7
MD;N:'YYQ))]Z(^8CZGVT.Z1#+,M#!MJM;[Y1^K1DDEE2X'JXI3VQO(B]ZYX)
M/<\6L9%R>;U%Y_0J+\EP68[B ! LID @I=O;53;NL 30Y&(]LA'<M#$.A;M?
M_]0\CAX/? ZSC4?&KGASI"\@NQC#->1^)B(3K"SY,5Z*3%Z31N@QTJY^#OD(
M^]"!^<@NW^9?(U7FM^I4,T<Y8!^Y"MT>LTJ98=TQL9G,7V2S1%".-JYL!W.U
M0MF=G&Q$)F2UP41[ SJ2(H)#:K;E_5[#+.Y$)XY_5T);R;B<A='?U0+E0$\-
MJ_O[)G'&^FG#AUS5!=Z!C[OPK,QW[6CZ.()HCM]+5,DAG>^I45I?"\B(&91!
M>:UWO\HIW]\D==0O)<%Z?]11G?*DU2_./ROS5^#PIN>R%R(<-")87*(0KK79
M/\1W.5H?+-M?:&2YE([(KQG&$,V?7KF)Q/HD8!=4C%7<]=Z1?7N9QYL*B/8L
MLR;3SVH(XF:%U#T4<GF?E21R,@9=3&>T]T(W!$V.81:C5WTJ_D>[ =\'UF,6
MH)>B7]T^H+!-A9NY8Q< ?WD*60.C,;_!YJ%"T^J92:\CK2KA&A.YMJQ"'M$5
M7>WNQ:.'Z%P%=:US7)9'X/V%:F9TB?7@0#]!F;V,&A35AZ=-7.=^XORKX$3X
MW#UCT ;TMFD8<K/K\ -&^6SB F#6;NUFCY")SAIJR=W_G9*TXN]OGC4J? .6
MB4^WV:Z),T-;TYQJOU<+#U(<OP1E0+I[S<C=I:5%JOILT.@+0 [D0(PWOHS"
MM,21W*+:6&7]%?^'?W?@YK-W^'(([N&:=RF00\=MP$Q(-Y-H4=_$\NKQ>8\_
ML4UZ^YPS9%PZ/F*#7#)O+;41%?BUY2WN\I*=?XK9B/A=ZBAN^R=N H$--<+B
M)_JU<%.3ZST!VW('%A%W7[/TYFG[4+KCXG"R*^_9'G@Y72&3Y<M-%,5SFY0>
M.0U^75]FL,4^EGZC\N4:WU"0HV3B<[DA::Y\O).04F%*%R)@5W"Q[I5[9.M]
M4OL,9O*9.\I@)^CV;_6*=+E+D0Z7/\0P.8[FT:N\I_&0WD9KA1UY[OJ[QYRS
MP.'.0^'C]T T K;'GBD+TSB^J16Q 3V*F.N'B&+';'BP#&'Y&S]Q\;QK#T."
M56JZ&=?G@B$Z?_!+X<=._%@L-==47BJM-L72MT LROP!7:GO!F1<_P&.Q[OY
M?NY+9'%K4 P]-\0?+,MS9%4_N++N81_WE37S L!/L9DF$VUI!U=SS!\0R9!]
M$UA^0N9W4^S^8F"PBL'[H@9.N$CU1L #RA^.7Z-R;N4\^7[O84LFOECMP^WG
M-^222$M5?@A^C?:MGHT,U/3Q <?./FP&IJM*?QC@H]OVDW'V<B":/Z:#_*.:
MBR,];^4\)W9![?]D)TV7A4O7MO@=_V8<>>^^ !@(HR>8(7/!FJM8U/.\4TI@
M"LS%!L?GF.M-O_Z!Y.%?VY>+(<M<[27[ [#9<\Y31B]("-:W7:OE6*2^Q93%
MV#AB&,XBU3#1*M/5=2<X8@[F.AUPX$#,W4RNU4K1;BQ/)"*"[.32^#)(,=!-
M_T[PO(PP!E\K"/_N(X:(O@?72J2]!IQ<R*A&U6@]>==-SAMNV2<D'4E#/H]Z
M]C:R&$]N/\XME?M5DK]^]^W3CU8:NU?\5VIH/N %.3R6>CJF+!"P[V7Y9>XP
M\X 9DO];>8EG(%MX= ^CR]J\P;HS8E@U -TVQ$#08ZN2J>G'TAD[^<_GO"[+
MZL))*"N#P0IEKZ<,H!CZ1)N4PT%5VTYYWMQ1JD0@D15VW$;@Q,4*+T.#2Y_E
M+G[N,==($F*U7]2-\.<G-#FU!D?*R=+L$;]? C6C!'J2?+DFA'X=$5U\8&6I
MO40:Z!/8YF'ME0/^!U\M^W/)@%\"P@$*$>LO#Q6[02=H=0&87'S]3@6O271M
M19J!9'[^-'&+=3C09/+T"_D*])4ZD 0S]58Z8&3J2P\0"1\+'K%!FJ >R\G#
M<3&)L6H1=U\*I78<>.2?FA0W61W<PR1LEP?C>;2#'729GZ*):%A!%.R\+>$[
M UB]$',;ZROY4G0EN[3%OPKM;;^P23FL;HC#V9=B/*K*U',LJD^K'SDX\H-8
M;9Z<UR,^[P]%Y=R_8[^P>3IQ(N7SD>,*03L=Z.3Y7M57;09LNZE@NO,S^/J/
M]L%G*9^:RP*U4SUTE$@*&HW0+T;=&!Y3\[%+B7SA607?B'/EQ/13H/MN;F@C
MX9CY#FPJOO#Q/#TVW&;59OHM:KZ+?\3O;^JUG(?"Z%6%2PW+WBD3T(X\>SO%
M,>^L\$C>R5/#T3B2H*SZ"X!))EBBSZ42[L-"IK]3:\6KT6+Q*F$#%$I3+YB6
M'7I]E%.ZZ_5[!GMXXIM5_^/\^;1E##MDF1Y'^24=UB\5BY\>S>L=@Q.RP0X0
M;]@F[DE%(I]:AAH')D(XYU+ EANR+ MR]-Y D8E=C)E_J:14ECOI6MJYH8*4
MS-JWEW-RC1D4R8%W3\Y6I.2\EX1TBZ/U%ED@M2_7/E[[$17;H1X.^Z4L&7B7
M:,:*A], VA+R\V!(AC8CSHRS@%+$)><[<#&C55Z)#&H:6/;96Y]%T///Y4 9
M6/'S=DUQ&Z5C6 -W>VI&T_>4%X/2E$CK'[D,_J4W-[P.S10;8&'M*]8:FWXV
M:LFN5FBT(1PX2')@T\<JO)8KV^GI_-B+V>L62;F<O8FM9DP][[L*[P%5@RC>
MA?&,.^&A4$A)2F#.MXUU/7.)FV!+$,UTDO2+\.X0CU%]!@0%69_3+W]1-4X?
M+^:L&-=&@M$U>*3FH]C=%AXIQ+T, 8O]9<R:)[H7LJ21/OU;Z='Z#Z5'@8.(
MLPGA 4BWJE78.KE\V:9";*0.]99;H087G2*8[8'_/5^DJ J"DO$IXKYBCO8/
MF_T$UQ>.=0Y6)?53MEAXFZO(JM2OY.:6:=N, A*C_?:4>>3,2L:#7-IWO-"!
M1.U8MSRA#M'1!2DW1/69I\C[#3(O[*;]Y[:Q*^VO? 269)GE+.E_X O?5/[H
MO JY)5\A7(5GP$PRAB8Q>FYXJRM+\6E?WYASK'(/XZR-2;QLO?V170>BWR1'
MMNWKB6?\JQ48C6SX(WCGQ%'S_@4 LY*(\;]4'/]C*=;:PG84GMI? %*/^:\.
MTH\F) -EPL[%A V$A C?&"L$Z)QWHOJ$*TESDU3'!#1FG]SR =[PHI\P%99,
M^F)I1663IL)D5*3K"DHE1#B#\[8Q[#46AQ20-7Z(T*1<2Y35":S'!%9VR6^0
MN7-<@=C07O:O7%^WWVDX&ZP](/-?%1-'T415+A_+=(8O9:DTP^>RL(Z8XC:=
M<S&@QOC 'Q[#X\UQTC3 =X=:D)BH!D\'$WNBCAFH1Z'B).Y\AZT;[->G9"H*
M>CWMEV>5\\=OY%WKRA2.6G_+(D]!N"*C<1BBZ&*>EN1K-W9R#0$,'8B"A[&
MI1L"BI8<EXXQ_39ID!WU"X >N"9A!*-P0V:^:@'F MGK!VZH70"H+7LBCF$T
MIY8_83/GG,?A>4AK&ZA!>!]I;/V5]R^*\;:&32)^I#-XIS&R&4:%7<ORX(IZ
M/@5,V=IQ3\,XOX@F*U62.+D 6';U/P*GVK^4YCS*3J-(KZ1>756%_DS\WOB.
M ,,KV:!$=6.MEIHZG9T?.:/VK[Z3? SYN]Z22^UE"C+G#]D+5M#$F"*$0_C[
MN?08WAI$M%US47E@*) A)LU@(ZE0=:+S29S\"V-1#.!7I:/=X!+C4['U6';_
M+WX/'1OJE!XI,AF$4[S,CG5E4TRMF$41ZK/>7. +-/]L08_(/E$'<9J@C QM
M+1GRN4)DTYT7'LFI(BG/&VD;_W".3#)37 3R*%(^ CY;)XY("\XXS5I]:!90
MC=X (\EB#=]*A;Y'/1[)2EB*"2P[^;(B_MWXDZ$)NTDVNLCG,#H6\%B()ZB$
M].G"<<@;:_5V+03CX"#]/B"@C&Q]OZLX*FJ9U#>1.JHW&#M.QHLP^*Y;Q2E,
M\&B<Q3PSIMU:-RA.=3#@DY-HC1&E?,CX-ZRQB@15F(&,MQS$Q*PPXEK->)%9
MDO;P6@[VK]@W>(E]\.!P/2MRWRJ:S^V#];N53BZ>$8]M\BKESNH<S+&)ST-$
M%GGI_0N88J[>+6;*ZH)+J7C<]6>H1F7520"?0]*4,72W&U9QM*+:C=&S;"';
M<UCN O#NG8( "C!0.[/+%MQHBDNWVV W8O!.VX %>!![WE2/E%5-6E$Q$A9T
M8ON"]R3"$7IM^TD6.?%>CJ7&3H9L2W#/Y^?^AKM[FV,F[V%@>UODHB4N7MT)
M.+IE4)&EA3I3/:)G(!8 ;'?KX<7'[ZW42+TH?'T^0H&$_J.^YOB[ON9W"BR^
M )@>AM=\ >Y8MHM< *@8_"GRI4ZKRK$R OMU>:?R*\!J60O4=X@'\]>E*-6<
M8&JBA4,DEE%ST%O^JQZH4?_!H("'W\V\;'MJV/+CV.:;$G*ZOL(<.H5@\S:+
MZVDHR$<RBGJV!^ W*]+V/=3XB45IX9T"$P-SAB$N#S)XS?4H(F&MZI6N3U?I
M>RBW_1CMD_94/EZ7EJ^\010G/@-.U#T<T+@^0Y:%SBA.;)6%67U(Z'4RJ[?3
M\L:Z'#.TP=G9:Y!.+\*AU#:I4D.ZYY\O (&0J:J]09[,#;2<9/T:.O=P"+T"
M/.*Z#'*Z.#JGMN8*QPQ]M@G4@ @I_$.L,O&W6.7G88S::7O^+5>;O:^X5"'J
M L"(JKX /-L5\+X /,<^Q1!7K7K^(3Z9Y"QSKJ"5^/L5D$XY5<$'?2=%,&=(
MV\061LZ'U8AWTWN!N%=6W@]3=EY6..1D59E54WNKH)&2*-A'6VN=>'0YR3-Z
M9Z?NMGU)96HQ8N=C.I>)/*!Z7JR 7(IDF[R2058V/^?@N*C-8=_'E?ITMRFT
MP[NJWDOSUX"E&9J(V,=G/=BPAYKJ65V?<Y&X5SVW$6?<=F"P38QW0\+CQZU-
M^E3=BG\ILR(E+E^GI53<' [YL4TLO +_QTM$T=]O41K,_PLS$)T?H#A.43B:
MP+)-O2@\A38?-EOA;'AY6_ $[##Q,Z9$_&F+^@EC&;C<&S\V6..SJELP\*JP
M4*#6H?AGC6PMQLAQU[;OV1U;EM(^ 2]#CS]T%NX6>'/VL5^^IQN#C%OVCX8(
MW:C?1'/=2 RQ&D<4FY"!&!E'15$"AE51BVRM-XV'V0\$-'_U&,6&DY"=OBX*
M'E-F[W8!*2>2^H3::LJ;[0<WR;9]BOT$^!F^4Q_THCXXQ7+)+M2V:"1++1*6
M *HXB2+;U\[,]S50 [>4'*^@]UA)Y"RU&^&17#)NV8%Y2/B )6^]HP(%:^L#
ME]O'J_+,;72]NDYY1%"#5WQ3W6V@3Y[Z+^(2.LA_/@ P, !9+<0B&9]X#@J=
M?\29!N3#!2!F?\L&!%WS^@3$4=C;\HG>=4U0'G'6O#<7@(H^2*R#MJ4\7@]<
MB+D.D@71XCQXEK0R7F!FQY%UOYY34R\;EU%T=:8IZOLS9HL@W#AD>TB^K_?0
M[I,4M[0\V1"EC_F"N0#XR"Y'T%$(MW#;I'@#G,RW RCE+<M.#SA-1Y>6UBC&
M<4\%9HC?%I]B5"NZZ<^OO&.SG"[E34S"@A]1_/F1VQ%W\C\)W1U?'*A-;>(2
M':/XFX/?;/5#XY^HRZ61>/Y\UJ'@(W@BRN9B6W]9A?44E PU7UI,"I8-^DGD
M#?H:(6E#,WI#)IB5K-_-_C!TK.J;_M<"S>"P6[C@.,=ZS33>+PO,HR2\3O#C
M0'CKP;[G8MJI;J53^Z54(C 7 L>9U%@J5K+_(R1PCPP-:91?!R>%]<MPR12[
M-.?W@UFYR$HF"H*.!LI/2&5(GOI.YB664.\[9%R-P>2_TUY\3U<!X@B^/;\S
M()L0_GIF-I;>(>J():T^I])@"77J*ZY7KN9/AZ5ER"XB4'MF6AZ7]&O;/CUM
M,_-_5'XE2O1KV&$_S>\V>?4 X@SR3!M4#7;BC;Z'$;*]A?;62]T?2T$[HN7@
M/:?[RJ:HCK6[DS]C#H3R;KQR/U(??%A%\HP$/ K,,7W#R]7PUC\P^LX"RUC$
M_H-3:\5O'D_@<?@]#SU!*2!]&II>>F<>;IKH$TPI(RBNH"[;6M7Z6F>I3.U=
M)G!+TA%;3,;>VH"C4S%;\%E9Q7EII LG8;XO*@A;7J-#3O6X3+?F5GKN5[D)
MR'(:; .78C.N2E[F\8.#&,2QVB';!4"@?7;^I\)R<(WIZ/(IH^]OXS1Y>P%@
M 9ZL70#VZFP2S]I#O:HAS[%>&+X+0-H%8.<^SD)P"T4=')NZCL86FN\40TP/
MDS;_N>4IYG++DT?S.NLQ^)_@ C<\HGBV;O4'ME"L_#@;@8PIE#N9E*VC&V2$
MJQ8JRC;P=<8&*H;IJA"]>)A >C4HCDK5]"E0"-]LQB!YO]W8V(E.,:BZ(J,/
M&B$V3--;C!TE1][*JN]]$*Q@8%JAX5/X/5&N8[6C.$9?GN]LCVC5^Z>=6&JA
M I.0I*& UQ$(O $L4=Y'_E%K[=NXW+5C'8;&A=*(C?EY#6PSI#O6C1WQ/%O7
MIO@,>6^X$'3'C,D\=#%@%.52L;^>T1*Z!*-IN80M%I<X\[MQ&$+AP.Y>O$F1
ML[[I,,&^DO;<O!NQ,:A2Q35!&A?^-1(UD^MCAS'U\R'[,ZF+IXW8;UD22Z>!
MGL?\@0/%;="Q,UI=FXU]B7-1>ODP:[<CXZ7K*_5S?<%#KGZ^Q8*,;]N%>*.V
M-)F[/MO)U]L71Z.(7J-JGM]CX(QO;(C55:V=>>E\:-_-?4<MP)J&V8%ED#;Q
M[P,;R+Y$F:>_489?]C^56>?GM):/P^O-7TL?$9I%/40"'KJ#P@V+Y?9_.D2Z
M+:\ 5C@LV^V>^:Q\;Y6.&"NP9Y&YAP]Z]\90Y/5#Y"93X\=.*> LTE,TZJ"@
MX\T 5S=#9LSM\ZXMJJT)]E#+<F^W<<U<@Q\?6U^*UY$(("BZ/>NG,>U%E?<M
M0-^^ ++LNW[83+?W-[G]<IQ>1]XS>&,1#W@&%^]NB\N6EU9%?\&>/=J7>JO'
M77=E*?\L*/TC4]?Y_/"Z[I3"$$:@_C_D@&F,P2^96"LG3,-1[V7,B?X^^#]7
MT%_OSU4VA:#*V-\WWRE9NV:OB=KO>G.EZ4YGDC+7BPW07%5%(+5%X[3ZFUT?
MQ-@V?R-B>2SRC1S#RM=TS64C?5;O5AV9*;>Q\>)W9WRC/@><["]Y#)8?EZ:%
MRXJL_.+_DUTC?K^;%#C\G72*"/-> %J]@H?.55;!D/RF"N%O"BPT"@.0X]P_
M4FAYPP(<ARA!3(0HXSA$M>R0G^[_"'UX,R%SURX /V#G:N)H^9J](!;0L?U"
MY&A+IEML*E6U WX<P1C-)(:!^$<R?0K"^=&U-!1<MJL27C;SOO$"H*:L&5O8
M_@0+]'>RZ[5E:4RU@MU!BD#4=5K).+]C26PVDZQM>J2#I2"$NG><\;MV4D^7
M R&TL<P*8;BL^CS$#".S6[QLW>(R=GYGHS+OR5?C_D;?LX<FN1A<\"B?KY+4
M1[%(ZCZ>TSN1K/_?L>W66)W7U9N!V(2%) /8XJ#>YO9"9(:C77<&TIY_ 0CS
MW$Q&>VT#>>89;;ZD#C0?;L'/3D%H26S#92L7>@3KV^9($&LO87C_7O3'BGQ&
M%5 )TJL&L:6;E0;[YLT!\,9+[^,<@&5\S[YOT43,DD:>E5:_V:VB%F>FC4SG
M79K)B/XH7/BE1Y)9B_6>[_="#H"GIC<UW^ S\W!O>H0C%Z7+M0UR];>NA,D>
MGOG-1<4_Q]81*47SH2IJB=*7-Y@[%.8_<?=UL6S)%"7/BV0N?B8A73R8VGTX
M80HIZA )ZEO?MLUQ&B<L>3I"4?/+%*./"5J%TTIQZL+T$[OC;^LZ2%4LA>NT
M%0@6YWOTR])%8LSP 8&O$2@1E#JZ>/#I!&&E%O"&A$*L.@DJC%/(XZ5_/7M<
MLNUP2>Y9+Y>-.#']-E-#T_.\?E6!(.,HWKT. '/B;0:?68,?^BD_#=2<\(/$
M;F "" @""0T0C@.)>[[_<K3?7=<%^=>;!8/VN%V/;46H5R,'X/&<,R-6+9X;
MA(^.>.-XDT%6ISO0:QQQ7$IMK5N65G)?5SAOR/%U)Z*7 ,PI!J(_FOV//5U<
MF41A^QK ,AK*P'('>\2HZ4V0MROG#845:H@U!YNWF3HRO2XW^YUL7+(\V_ B
MQS"7&K>SA+0C>X::@ QU=_S^/'L'D>( *GX#["KDZ=#,AACH]D5I@5LX.&3C
M;Z?[2#;]9621U_:)4Y2%'&!OF'C&VJ2UU1(2KFU+2EW[%&:97"EQV^,5E[_M
MP@!H$Q&)AY!D?FW9IT WO%%C4440/PY)-@L]>]'QB.(.M:CFO2O@)]K5)52N
M$.[LD+L.5=9<%<[[B+0H'T>&M'VNY\D7@'^:8]SN\HR\3HYX>[9PNK*EM=RW
M?3%<0+Z5>+I_G\W;]G<?OV&U9$X]^JQ;-,Q'5Z(B4R6B!P*IY?J%5OJXQK+[
MI'D(IEO;\@0__'W%:?ZVXJ!!50WMPG(->=[@.-J.S-6FN?4M'7N[HA[<?.)%
MRHXRT.]/F1YF%32>0H=.&EEM0KQE\9,)K;DJ?YY_TWC.5<[E9+>49*?AWN09
MKD(6YZ31/#MQ=\1J=,S?!3>%ACLXHT_H=[+LDS_ZNB':VY;13##C11JP,^&1
MMHO?RN7 9IRQ77OK\1,*+FY0I+@TAV!H/'-R_MA*TFMGY@]K6M1JR. (  N^
M6():R4EY8VO"SS!.,:K1>,'3W<C(?95"QX'IS6Q5BVH-EC2RM0&+HR4V3@2/
M&6EC EA@J ]K2A7T+(9GC#?FMF[9K[)S,0N8Q,SM&>=/1V:"/ =UN*5:>UT<
M%LF9*X>X ,A/)19% .;+(LJ0<,%&0NETC]8;$F;) <1 J*YL!LS/FQF_03(@
M8>7Q:MV\?LJ85\R4T?;]:OS=S[BUK$;8(^+WE!VFOT(*G(J ^FBTMPNXI2KT
M&>'\#:L?J^%(QGA]E\3[+29JUQ<80L_*XNX0O7-CX)(D.)^]423 5HI8!.G1
MA[I.N"S@?M!/4'X$&M2=WMJBN#65-))L8#2ZUD<?Y6./6PCQC\X9WF9]3G):
MC+#V:[0O-68J/O=8S_W2LMF>3<48J&T@TL(&LYSL$7&;;T^$VEO\/8_28!.A
M*N1*HNFIHII GDX:SV*DVVVFC]"K=@HFBAVLMA^E20-I#O03#&]?OF>;Y[IZ
MA^>DS&)#=#I6I)DO&V'"!F:XM!2O/X88IIUISF&E:98:=B\9:] -;69C(U*<
M]*:IYEU=/V+P,.)O%HU],Z .5.K&/5-[H([K?&RA\;F]T:4Y$>U^MJ.0%(F'
M<N_/]XD1/;;KRKO!]2: ^0J;6Z*H3H)Y8UO"=DY>C6$1ASD,3$7%JH6S:J[R
MU_ZA^_>-T&'*X6_M<&ZKE?G/<<53X<<Y7IY4TGG/(@ZA^6'-:!BS3'QS,#(^
M=K'Y;5&3;+X=O.!A H1911&5KH[,V8@I[E]?3[7+EO*6]5^OUV:^LIW.'/ZF
MQNI;'FT%,2H_;(D,A[J/R+Q-8489"UZ!+!%A8E3HK-!0YE W:6XAA_/A1GO#
M@-Q_%9R,MSQ1-56%/Y,WNY,KY,WPJ83<EL585:#>[>O?H<>'L%UWC#<K\_.(
MOIK>U(." [Z[,M'U=@GW[C!]Q06'OFO7]DD=XRZCPV:(JH6^^FQ2 #_5:?4=
MHK2'O[VTP4_C78D&B^NWZ,_M<KOT^,.W^M@1L R$L$.='6*@/"B9B^8PFH?M
M0#$]=J%*1_=AGRWG:SEU>\.#>2* W!55#?*BU8@$9=PJ:VP_D[YS^X7DL.PS
M^EPZGC+QO+?J*\'718 X&P?XDA5Q00T/[CO&J&?^V;%0EW#>YR"ZJH'.[2Q<
MYOD6E6J48=N3[]UV-0W:U(@'D"'L2E"S PV6U-Y^;$W^T_1$BUKR5P<;X6$1
M.T>4@@1]X1,0-Q>0\HFW@P5 '57F ^&>E5-S*M+5QMU;1250-&F@,<&\KBUA
M]*S>\0)@%'_Z 6?*]KCI>Y5H*=%9E@#OB0$M1]+U$:I:3EA8M>:N,(EF&)1J
M9H307Y['R:J:HB.FJR4M "^Q-SQ>O!*GLVVX(Q#XT#4W"BRK/IU< 8Y/:ZP)
M"&'>DH?U;AKE8!^Y7N]TCR]U-<VM *Q1C*8UN3W?NWG/(LD4@/[ /"W#LYM+
M0U@D\6$I00;G*D0+WH2  [Q/#DDX7S'0*HII5>Q6.+@2&((.4./A4&'::%H]
MU6H*BAW4S8IR"4$3J 3R&.*FZK@8-?W5E#%K0CDZX1X%H1/GGC0>0!KP72 A
M5134X[(A^C[(=I)7EQG*<KHURHKW3)WA&IU3<X5C[?=I5OV:VP5\^25%7\.[
MM3(X<>/+>)X:WYC"O6FMDF/,BAYFNAW/<UK5U)ZPC_.949S/))\L4%&ATG_3
M@_':PQ38;+/P:7[51G<WJ^ME/!'&V<1D0WP7:SG]&$8"%X(4XQ.4GRM(Z,C[
MICR:D'#@79:0F&\-6HAC"S+K".//62X3:=EWF0.XK5P1E>=&F8$#*V/!P'*/
MK94":NRVQ?/I@ZOGYG+O:F+"I)EU[GF:\'YNH_?J_F+IR% HHMS%E$*'0QH7
MJ=Z?I<_8'[Y .W7CL&94C1W*H=;SU_$EX,)^KZ@(RMEA5!Q5DS 0E"*A *:\
M33"W8KZLG[+F%3^5Y($OPKEW&4W%?H?=MSS[O9G.)3T]T.LOS.]RR&M?];DN
M7H"/^OEI][72K'"0>_Z)ZR%SNUEC,H@R8 R]-7_D)+N/#GO-CH2'?9;U2:0X
M$"J6,)M^<';OZ@GII%T$H$@?QAO%<=\XG9SCTTV0FTNT$;J$\\A!G2CS%@*>
M4-!;)(C(0_R498C"/ ;@L,#)6].R[R37V]WEU\2(.<3_9_M& @Y,NUE_N_N?
M[37\-W]R2:G?-YL8]=<\6M+\!A,@Y+ <_1W@DZR0"1HE]Q*\C3HR5<")J5 *
M??0%0)@3U,S9(3WLML?=/S18..;H<(BLIT"A C"S(HLW?5N<2G'$*=I0G#<A
M@>*/B,GE;=S8_C?LY!$\W<>QEG1-7,@5G-D0G7VC_K/#4]5NOHH*CU5)]#<?
M,_@'IB9P3!)3]1FL8K6J=E@R,4Z\.%]41/5?VJY^K#(#:?Y+,B46I3XJ-[P"
MB\QUH?6->Q(RWMPEQY>6]N7R+"O6/ '7];(/.G!*>"S&?STLE&6=D_U*^81?
M,6>2!&'XLSZ),/42B4 4L[D:9T>-X1%*"K FKU,D@,,8I948W1ZRQ?_1IX</
M*JMDR#E,\;L2#8]6+/$;@C-?F^$ 3B^Z)T;WAX!+\U,<MI7RZ9@XJ]V([T??
ML)/?6+'[C6VQWWYS+AJ>/(&WZS75.A'4\-A9R?4X2OP@-VGB2^\KLS@1V%QO
MYK[DI* 4'@[+K[\7*X4;V3O317E4Q0;B@P5SX7\DB+P[WIQ9WRR;[V2O:1QE
M#RKZ';-P/#CD2Y[@9'[L .&A$XZG7.)ZP3]QO?>NHV$C23=%%RZJOHI5QH6'
M-]FMH],Y^M6&(Z7J"J]Q%+8Z.CK0;>R@ME, 5<-:$ .:>_K",L[!L=&HKCUA
MXC<\&E_R-\K U_KI4([[6:.??B0FP+LSLM@,J;4;2\WG^Q[;Z$SQ3T3QFP=_
MH/\[G?R'M1EK$]>KL4>.:Q \8V)6KR5,_C'FV$C[S(F5M!O;$AG*'&:+LQ)8
M1A)-;2-I>!GY*QV*.5$5&\DKJO=>;POEK.W'OV5-MM,X?PH@XNI7M3PV?FN4
M0;?T4<H&,$ T:TD(."1]K4'V0N'N@Q+D-;Z/4H9CA&R,1],-I'AKM YQDS0'
M%G^ANY_MN >I<*-0:RSVS'_Q-N]C]4:_.D_SMI<(D2,-VR2W[I\(#]=5$9YC
MOEV71 L2KMB\3K/0<W*5#M9'8@S<K"KG8]SIA;)I"<$:)9=[A7@S"OX$@?_@
MU/\1 ^^]5-4@^XF[-KF0.RT!9*"C<7EQVY,7I0-E'>KG05ZHL;.R^ 66SIKN
M5'X%B;_Z,<XT)GN=9*-85VYZHQ)<=%%9F5?<J6Z4B'.^02P&X]\!5K'A0'92
M5-V-^"0W_2UC]A>-RBVJOZ"B@S;>*A-G'"[G6<HC'<3[VW3/)W"<?""LO[[M
M,?=S/SX]YK8)=XQ\UA4.V=]9EA97Y[^='?]9T5+EP/.L$WBI!!BY"B/Z!A96
M+L'^#*;W>X49*OQZWQ*N^4'?''^BKDM2--ICT*(X_(>J2)-6/&GX53K>1X16
MOLMX3^:'38$[Z0H+3*>.8*[G\,'FSM0#QWTAS%4O[$DB%J^]4/ZR-9@!(FG#
MT0\13'VK36$N?.Z>QM@6.ZKTQ89BI.N(8L<&XX0)K(:R;8CZR.]']-5>=O%_
MU_])DOSEEJYTGG3^_[GYKP\F:;[RN^F_/@MW+W^^N?_4X\L&NO]^A?]+2=Q_
MX_K?A[5OZO]5;VO?--,VT][]VQ7EQI,%+7K_W8#^K;[]Z\.K_[>T"O]=J<O_
MH+&9XWZI('ZY.7"/>73A=*AGS4]A%AI&-7P.YXE"J-+N%TVS7%OSL4VD[!L<
M6_SB9>6G:&95FU@>]2MIS%0P*>#535;J.Y(,PN?EKM 5Z+;G2=6==GZ@ KQS
M"AQD]?4,8M&^8F\)$8#X0 8?8DWD(="7V-_MYK8GSZ4;$YYY?AJS/^".-2ZE
MY6".H6V(ABZ771]3:(4<91ZM]LN&%?8-G/4#>;Y==GQ80:B].1%C>UJC4[;*
M&J:$.)MZ[6K53'T^C!L"UTG1N;9CW.IH8B+C>?(%  H]^7$!$!,-9/QP%)2B
MM]),9Z2;9H!;]W]OCHPK1J^4+"A?@@K@O.4"\'SQI/Y<J88O.!LL[PD9,'V4
M?)*)64W%&*;3@]\MN\A'/<]1RV9"_/]"I_+_P\,K?Y[@1_]3G_CW#LMA?8RT
M064U6DWO@!11+D=G-43Z<1WNXU/K=Z+#]WQ!/ZE'!\BXK@!>*3P!%%7<>W:R
MRA5=;=10,13ZVA5*9CBTXXXMXU1]MM0#7M;^KC)9KR2UFW#O3:Q.&/M^40I$
M1^0QEVJK\Q@,+RVP)B"XL9E,$M8C&4@(\O$K7"=;IS50LXG(EG>8N!/:)_?S
M?'VJ_V'UZ9/@"L<?R5NUB%8+37[_Y5\:NYQU]*N7@H^'NP-2[SJHO\YB) RL
M\[VN%.95=DFVW*\8?IK@6F9ZH\HE %$ ,K_#AI52>8&*4H'G],<4:49MT#[*
M#MR3?;;>KLULMS'%[' ]S^JPOR5^9:6%?((J09[Z51C M?_3NO74B^)^>TO>
MMMG*1$#R7NS&V<.YZB*YI!@C1UUMZG>ABG)E$V(B ^H^?E->:32UU\4CZJH3
M-L\^X8* $<WI1R=%']=+,143'8]A1BF^8'K#:W?[HJ*@$J'>D[9V48E:&>Q]
M>4_;N!]2C,?1$!6[2Z%D_A!K:LL6<&&)?\FH_R:'I_4N@CBLMNZRC_N^3;X?
MJB15KY_WJ /!'(^.2+SB&XE08S*^-55<JHY[).IG>V+XI=$.VW@G[(A"G8I+
MI;(83A-[K#KOD8-VZ.H7$5&4X.AWN>JE#2/TY:2\I.#2Y)']QL% 1FN4TT4L
M'BI(PY,HKIRHNA#P-WF;O-5I+W5?!2Z>AR/_URWM7VSV)K5!YEA9/9%VOO*4
M;MVFJ'C2R=^RC<7=HX:0XL9QJ9;XF7X@1Z^Z7C>Y6IW-[:=OO;S@T:$#%X 5
M*S@6>TYT-.BY"O5I/(_$^K3_O0E^H-8(X5#(FE\Y5#!-\26X2WTS;NV)1;"?
M:K?F6@1QW+F?K7G$<16V!MPRI1;G.R4-"U1&3<^^^=^H-\^VOQJ>ZG)\DR#2
M?A,T+<\0E<H.+91%?N@,5V<86B?96GT>,$1;&UUT8B1XC,-WYH@PSB\/8*L<
MTHJF&5N&&F%Z]7?]WU71:'#NGD!@VI3IT0W<N[?[WHA!H\B:/R?/E@IE,[]0
M$V._6BQ-M;=EW7@+@0X/!!=21^Z^#]KS.7E7E*SS7CA?V0=[%COXJXW5Z (@
MX_@N*!8C+8XX)2JJ&K<^K-^ =BO<6-*A*WX""I5^1NF%!LD8P713)KU]'5D%
M\BG@@#39-X[1\#0%;G>J;A_VVQLDL-D7R!1XG1K/<G9@S6<79==]O3%Z\<K[
MN\R9"P52.[^<MQ*@;)^#AW2^('-'5K.\U6>J+@7M'HGA%ZO_%NIA2"K)G41-
MG_!]GY;[FN\R<*FD^H$!;S#)SA%A\4S2P!P7Z*)_JU3AL0MI72I<\3:%E,K#
M9%\I/=W U_-F*E).^QB_'+F/\?#E(+_-6J>@S#0P80D+%)KU\#"V4A9D<J)C
MD3N@T5./_0).X#!\#QV3A=/E5]'7A;]R,M\#?G1>3%:CBB-ZHW/PA4-](;:W
MD<,7O74^$ON2^XTQG2%K!X;)@<LQ/,Q?]CL;9S'!T]WXF<^*E6ZS?'PZHD\F
M,E47(6EEACN%)CP4>M->"$\UU"LD8[S7NJ&ZM("':3?_Y4].1'K3(H@=W$^.
MR]6;B2XV5VMF<FX50%^^!"V&QDE_C-9N%&KX]-Q0@RX)?8?S:(F+@JN?1[;G
M-M_^I-_G3MI3E;U8U;OXW66&1PY2\("3>F8#%@I$\9^E&KET?%P!R$>- JB$
M?'Y6B15%,*-?U6M912[%G%<._]!RT\@'@+@M,HD%%5I4;8Z2H!/QU-0H,TU"
MV4[B'_'N!AL+Y6_HG_)$X[&HQ=IM.*CX[_CX>E&GG/U,4"I$/I7F$!-^4\*Y
M.Y!W1SIND=0[90&8P/S&S=O=W:Z\RKA&_7#-@207Z=%!KO9X(VB5@$L;<>[K
MW_B(\%;&W 7 @G;@V*C_R$(<JOM:L92Y[B< Y0\NJGQT7V4 "E=S30'8157L
M'%7#2A4HSRVBQ$UR<^4!JYZ4?BV\V7R@(BTW:1E1Z T#HN50;=8'HKWV \"$
M>TC1<H/Q]V+DO O7D5U!>BMFKV)]YXO$GT%OS)0.3\N%62/>L3NB6M:(W_&V
MRCCL:X5+++U(9[)>&J606%OM?7:;X:$:*T\$=(H%&ZC+G*5H-MMN^/:EZNOO
M(7TZ=3#!WQISI8FG-6P(M70O>WPA1=C+K&%QHK<OBSI?D5-Z)M+0L+H$\@C]
M/Z06IFH,2:_T#70 QU+$^2_<4E;Y(4(CDDKBA^@3X O^Z>R#:PR.<VOW;E];
MF(R][;=-HN?J?QSQJOM:J?^/FY]-Y^>YO/KO]:HM=3M%_\I2/(CM\VC,S^8Q
M9)  .EOT@)13[6'T]4R2PM=&6,GD+>*-5&V72G^K/P[41C)X$Z'>(>'V$US?
M*HYN\^6%&;\RTCM7[@Y !83)X\\\^YOH*^A$$3H1KLYZZ92TV8'VRJ?'Q2.J
M/7*2M\9<? @,POWD_ <LIZ1<H/H>'C *ELGOX1.MM]QEC+T85,F#A&D0&!8?
MWFCC[Q$='L7S?@)::G$WC.UN;E&2$0UU$<==H^+-J]AB71N1<%) O828\"CZ
M/.Q&QM55"EI/?ATKV7VDMME-&2CPWG[(X8=!G=''^J?OQ!BD)>Z*VVMF];Z0
M]6;](<:E"*?9.1MA1CYE(/A5+'Z8&+GJR%8KS^?E7I86FB,JFQW^7I8M: ]<
MIY#NT3I9*K!NB/<WX=L0T3:1.:9@Z6? A"U&$8$]?I(PCBL4]Z^3,I"IG+WQ
MNIX4LKSSP)7QN88/W_WP4/CB@S5Y9?988TJ-D[J5%V)QD9O#W#[WAUF%KLD3
MZ*TL?(]68IZE5;7O4>+ZQ92ED8\7G"PDX%"+W6/X+9L;&2>;?NF#U]GKG3<[
M;KPK>5<!V-G_K,.FDJ/SUI1_PTM6(2,".@^E1.70F'[U:PU/M9G-NWN*6ZT.
M!R+1M YD'+?N$W/\GDZBCC?,<9+=+Z4_TI\W] XW1F$\#<(6/2REH%.[54%.
M#/U2I3V&'^@IKN[F" G+:P=T*RTK]W\J"D(;B@E.F#XP.SQQ?V7%H/;V-K"*
M@XN"8Z#C$N=O/7)]28?G)'?E#:S!(:K235%T4O@O2X471TS%^_[NPW@KNV6&
MV/A0#=I5"&RN3=I$9.CY/&H^Z25GK?O!@=+W*8U+P3O#$R6%,@%1_$R51XX(
MZ@(N)\Z>%P1^1/8)A)/QEA.=;L<\D9>X"#&YHKB:UHU,+*I[;J]V*3(+K*)4
MNA32EOA# .S_-<'_$AQ5H.%J4?0HGO(!Q1;>_'1ZV=@ $&0:F-=KOWF/4*G$
M^KHZZ](@W=O@!ZE8[AT0:7=T )1TY@3YFB>@0_*@U48I4_>*1LD>C#'C:%YR
MN)_[0^!Y@R.%45.!6=R2W+U^2,,'%,PE=EZ=!U;LE"I_<"(GF>GF+SMG-XCT
MR2Q*=VI/^1BW+_QSCVB=2**I^L,S<_S&Z[G1:F7#OB4*&I&)Z 6>/?"]D:N/
MSR$2>'__N%O:(W4=_<FUK?UE2,D% 'X+4@(\U_"Y 9P+!JW[?(3X[$+G6$X@
MI7U!4*:,<MLK[M^7L&D;CSC<_&J_.H@1L";;N +;6E(';MZ?5MZ-8GA I&1U
M <!+]XKL866?6=!5$T=3"'$@9+^NXJ\,QUF4QI2-OEL?G1>YL[3G8>!SQ'!.
M$DW]_0(@WEG^G3;+X!$%(UF8?^[Q3JH:,5P8Q,L8%+GR2FOC02!'I\"":SV=
M+2)LH?1NT1#[Y2?+9$WJU[I1\A"[UXD_ICP>&\4)$SWZQ&+23'8!L-8,>D0X
M(.)*6J!:_"[X+%\PO'3M%A=!G(PW"\3:HC ]+N]KGEFDXN1&?^$88:8M<XLR
M7:P\VR%*$8"A&Z!BE8Y?M<J%141K]?-9ZTW K,UNX#KFRT0Y/@G-(P^V9S%D
M$;)/8Q7NR14?DI!-A9F0O&<SH\5K6#8'=@GD4'+V3&2:R"F)+:PWG'!A_4<[
M6XR5E-ELT!P]D-<.SBOK\WD191'E>-_:#;G&K4'"*O%FW0]SRFGK=5>SO]A^
M_IB9[B]-W$7%;(<E?TUT(%@F..#(3;=LS-\J:6O3L*3>(ZPQI2B]:$AK,(3T
MC4U@:36'PH">155?4UWZOC?V#N.U!ST2EKC.0)Q,4.V)F>7?TCTQ)>62% ^>
MB16(NQ?+CNHX^A[>F)Y-^4Y.[Y?<@6LTY=W9KTYQ25%76A+.:^'_]I\"_WN'
MAR <XVVAN@ ,*:!CG7=#'B\=RL"VX9T_ AL"?_P^JP:*!-4*]T&6W<8W3H.M
MYOZV(P\XUWXZ>'I@SZHTYK :LD*1Z/J[!O._XW].WM2.K+0PYZG:FAL;Q=OD
M\8M1K5K8QQJ@B$TP>#[8TT3LU?9"M1YHP$G-+N_YZ+[R[$.-QR!]!M?1.(YV
ML*XH-6KB%KT/;41?;<WU"\"LL]?5M:&]D&W(0X;*V!.*YJ-[@5NO)>9/)\%N
M+/?+/18H\_=V-$?7$1E.Q&N('<AR^LUS1X6]-EOX6=<V1K<7,@,_G:^8:-\;
M>(L5A:'GZ7',.&2^Y#%F %)Q^O574^K:H#27GO2!X_UG2QKNV(T55>; :_N>
ML2 *2CFWB>F)I-HHOXCG@=\S1&GV\.JU?98IK^A_]QMUE-:(KJ>-/U' ;+Y=
MA2SQBM9@N#M',/9[7X%%ZV]+7$0YM]]K,$3$X!['7&JX$%JY,$\*YC&@"%1P
MB<W[H17EP,.S$'I. B@@TD2C<HLBF3[TE<7+)RJ_CTBK+3X*C:4M[S!05NII
M9\X1<+HAXVL+NX54JS(*J:P24XR;S'NIT/*TMBSX^#(9X;DR4*B6&.R-#%>C
ME'=*='B]ZBK=LU9Q,RFX!.F"AL LWZ5%J84MX4(L<0", *9S 8AUNP!L5FUJ
M(V#'\<?@>@K@L<$Q=+BG1GK\HS 'I-5UWW,\+0-6,+F&;<^X:[3?[3/(F9F6
ME&K?_:&XC"7VQ$B,DBA_WZ.OB%!E#YZN9C9)(6C1)ZNS*48NFU=$< X9^LZ7
MU&)V+;MU:S?B!<VMT]8^S\3R:QI"QM((&*DK5G_GT'%JI0'*/@X?Z;*7^2C-
M*2AT) 5+S!--W&._KOD\P-$[5E32/?ICF /-RL>;^J/O1_T(R %1D4&L+VO/
MI4D_BHE%P'A*/DOMOUT9%/MFJA]KL)NC_ZVD*T;J5_&&=S28@3:P43I8ST.V
MR5BD2MR%4\_/*1K.9JY^K0 4(W:7-$#M'@N+Q_M@IPVHB9K78Z_\+F;))R[(
M?C, G<!SSS0[_70>"."G([%]9*S(#G^YNX??PYSKW0H.G[SOT)'*/^2^U1&E
M>-9U2S40+U9I6\ 5:9ZQ/O"3LJ7 F>[JDV"?N^)2IUOCWYSWG]+4YD2'J:0:
MI#@Z2P<YQ 9WZ,/;9L%F47'V^!X>753]#L*I%GHUX4IE7OI*)N(GO;J:JKCH
M-+W$+SD'V=9KPOFN^95?=8</([C<7PCH*!O!F&MNL+D8K([#]!Y\OD=N4_'0
M"B@XU?M53T=" [RH%C$G*K&$F+]5YQ5 22B[,DY6$-@3<6N'7T#[MN85I7-1
MG\YO3#?*@_*0/(N0%8S\)^?1,(-VD3##PW/#]Z?8J]?O9A69ENOT2B@0/"*7
M57-+Z^ 'AVP]-N8__"ESU4;^<_4,H;[NDTJP'R?:P;=W><^Q@DXXH$XB_4MM
MVB9P;R ,XW6:/^BOL,.-\[EEX6/]8VP=2R:1[H ?%+VJA&W &#BU X\3CL%%
M7JEGQ6<7 //:RH)3,5T-6O+@*;UL=((%I*D1GUPV/%#L3YZ7_J\][^5YZP4@
M"'0:<11=;WQX;BZN8--UQ&UM,\95DZSB9B1VR^49'7*_6]US=6DA/?J5'[O8
M05L1>T,"-7R4^4EK6W]6$0CO,X4IKVG<'OW<=_==D-^U;>XWG$4?#E^^"5]B
M2FV%?&E\2T,)BAK\DA:/_WG%BEKPF5'*$P)3KP])$B;W;^NG/US :V!ISF*>
M(H:2*WKFVC-D;;+\/^%71KY!+-WO1+M15'KW:Z])Z_=1C=V-%E7X#-9J5[2\
M +3E7P!>>*Z'70)J40?L -1')$OFT6-)9SM&I9R"'YRAK>U_NSYQF=JJFT(S
M\? 5%UA:U4=?R"3)$K[\'M\XKD_\55.J"^;$[2K>]I-^#[4YO73)_"&-C^X&
M <O>3^"M8,3,Z%K_8R& NG>U(BKNJO1XI:=#7*2!412(_IN$'[.:;EC0JC@!
MX(@29%$D)O"19IT:X/W.Z.CL67.=5GI<>6?KW=*]U=O&+F & 1555<[4.W!Q
M[7>\[ 9-<E3FV,I?E-_+U=Y^NMT'GUY64J1PWV_1HQ9M_W%C8$J;$P^X&C-\
M*G>P\<'R@=C-ZPSQ6HQQIC,[B7U4Q"IP]_77M[/BLQQ;KU\/3G_.)EK$L_2A
MF6]LF#&F8P^N3U6-C5-->.P%^6P4G.=[;%K]*?KA^?UR#07;%F^S#DH)]&R5
M#J? R^,?QW0L]@/D*[F1N^'&]X6]EN:X4-5+0/U5N)"WA\BT; G-J:IKY @3
M7;R^D<^M6V9G":;UHW&+@$09]^6DT%AVODVKM>-/#0E?;/V)^7O>"S?'K(6L
M)WNI:#\-MAAP\$)VKQL'C\P:8A;K3OHN #32P?*-P<QNL-FN\YW6V%6+2H=Z
MA;U!$'H LB289G_6A;$9^UF &<;6;]J;96P:@H3GN<-?JQI\H3U5)#D/B>H7
M[4:8#O9WBN#[.=4=%Z84&<1WAXUOVL3F@E??%>H+DY),]4/?Z)RVR:9N?$-Z
MEK I*3K$E&QK3G#B!V"O2MMQ)ID&FYP462<PY-QZ^)[?LV-/ .ZMP;38%4WU
MV-?%AXJ3?FO;91JU^6ND?)XV#JK/C*E4^$3<#26_W\CRIM=:G(O[R[V7Z]NZ
M+]P9>S[54.C/_VK (N@5]QP\XZ:3D)VABS\$^PR')28:XRQF:+@,6 FD5^X'
M4>IBGJ[T I9BNT4ZTQ"[H*?^LW0KKB*/?61!3>7>MX_UD.>B# 4]]/%S3+Z[
MBUGOGT/GJ-W5!J@W@'BR=EN,/TN)M!&OV5E.CQO,Q-*W1AO%F]L;Q]0MN)/9
M]*X07 7[\6.\(WM%3C=F2G0#%9JIJ=8M^%U-1FKC7'//QA/>Z$@_Y<P]]99"
M+!_N%P;:<\;^& !6.YCGS^=-_1_VWCNJZ6];] VB(DJ1HG0"A-Y#!P,!Z;U+
M$>F@@(" ]!*D!H2$W@6D%P%!Z54IH8I*EQZ:]-Y)N.!OWW/V&>^\<<_=Y^X[
MWA[C_9?U'=]\UUQUSKG6^LR%45QF7>B+=RW$J788P@]<* &JDL29DH@XOVWM
M4?GIEF>,L?',M.4L]^3,W20Q75S,$UMJ_PZ.:F)WN020(X7H4Y<CLEW6*N,$
M7OQ>B>'T.>QC"R&I0>4+6PTK ;4KA\DGU8<44DONC&T$=0:H4T'#U7+<%E P
MA-,32 "]_3&FYTGE,I[K]PZOQYSO\:X[WM+)+G'1OHOK"NL"76YO;(!%K2A4
M3V8D)UIQJ,8 /D:USU._T#F/. DQK3\LM3W@(94/%;DM;-%];-GFG+@P+U4<
M^[RY5I16D^!FB.(K3M&:O361J&/VKX9*Z*U\59"C^MD0"RF($\G49:G[1O#V
MPG#DQ).?XL\_R5B^:*O]<'\WKOK$?U6-E$%I]^)1JAP9SCSLG<G/]0$-;=RG
MTZ7)16#!Z#&46SW52W.^R ?+"WV,\^!NXEANF""=[_^%W2,?_035Y4>WPD3N
M]I84CA<B*POLK/TX)GR4<+* =R3;%XN7!A@O:A!.S*9X/@'=4L)"YU7BM@)9
M2C;!)&W$5.1) 99&ROS*":,,'+4;\;.+'GV?JW"=RD4:;@XW\$-^-; Z+FJ"
M68I$]M)NV(<<%*\)/BWNT"QZ5$;O I1KN?-.<6]1;>G]JQ)/M*)F;+>BONRK
M"4G"] BUC4WSO9<L[TI0Q;\-$8$$.3KB??&4*%6Z2T!UV&^)BF*_3]UV/6DM
MN#$, 4WCBZ&R(1)1XGP,L=OG$Z+I386\99Q]).3H!_74.B';)\L/";[>>%LU
MO(J0M2!99G\RJ\%>&*,OO[2@J!W3X>2Y?9ZZ0BM6Y.T_SWGQ*0978,RM[<W>
MDME8*G5+%@6%=$!%^*JTV7C/4E]^?5PH090\T87R[(ZXM;4 *L13Z!O>S9-!
M7N;C 7I3*<MYR4:.2:1I3C7-N:W('XS/Z0_&QW(6GNQX\$CG.4XA0^A[Y\\^
M6GHO6[EKQ&WB3#/5R;[0:AWZFY$KQO']W+O]R4T!$DC/V>[C5R4!3\GDG\A+
M2= 07#DJLI-ZG/3+W9O*"W2[:&UXRO%L3W<X2,2A,Q><F);]9G^KO':OA+$H
MBCIV*';]K&I 2$P^LTRB/\<V7.[XRF]&6,***2X<4L:OG*:39-&_@JT$_QU"
M.' -]]C]B763;\QW\1JVDGL=Z2% <PN+T]6)V3Y%'>3Z';H=JG;G :N*9G=X
M49Q#;R/H+P'UC0:\5!W'.,=)JD6:(L74?18,] RAL]NW0VQII=\4AUL)<@>J
MDDAK.!W\5JL5Q5'Z70)WV&R(WOO1#M)&_C+6I 5UBE\$8I3Q$@Y>5"/DWXV^
MLA>+$9$\,Z@PZ1N(:<\NQ%6'VS1W)\<S?>=VWF2Y\9SP?IF]-]F\QB4@P&(Q
M@5F$II& OX=L[1'86=(DO[/GX/>+]X:(#:X+=L%'&G<06Q5&C!R;4RA!\)CH
M/[8]__^6;+XQ^<VCZG'LMY!=P -.*ON<Q%EA-DT&)UZL1!'E&\:CIV9H=5',
M'G31V&K>>OM<Y>2D-1W;\>A"N>#*LE"\>*OFQ_WN$F!G!J38AXV'PR*$9H^[
M+P&Q=LC0^-9-K@4TUOG\_O8N:SKV%+C' [Z^PB_?S\]LX!)@^6#S8LGJN2[I
M@PI3]E*SND4-_+[4<R.4/@(2ZAL\Z&1S^"Z](_XX8Q)'9F7QY:],Y>L80/\*
M=QY>&63J-?D\V7E.O1(_#(LJ?L3PDR[C6KM2[C'[Z?\=,Q-[#2FH7=C!),P$
MPO_#<6XE.<5XDP*;_OCK"WMLL"8-2+U:!RI#+C+#E)/#PMGC,>$)2PM>\*['
M";. '#KY"U=Z3ZV+*%"C92[2__35(-E(EX11<(]HH_[>0*ZTDF#?42 F\1+@
ML"LN!_/EY7W3EV@W9W6A\WCF$H 2X#OIA2WX9<":I+:'1Z!;5ACGT?79DV7Y
M2P"5YH5SU)_GG[#+T%&,TU6Y$=9FNPE7(^KDC_.L^M?[VWV#QU=%*H(9HJXL
M;0/9PXO[])I7QC?Z-.LDHL\-PY*K>HA$R;6K#R=K#%L_%])EAFN&&E[[O:_0
M@<>W+[S%!-*W09M:PY!D%]I02U,ES:]MD;K5GCV*VJ2B%I+,;P[>TI%?]!2T
MYW.[\.[K5,4H [G%"IX_+U20B'+INJDX,A*S7C,FH'B_JB*W#>;QPF$;&R >
M$=5!AOIVUDCP(Y5D!YOV>Q,DGS8S,V\MG"8WP=43B%-L]LXE4]J&>I%8N#/R
ML0#I&7QI7^7#?52A">ZP4O8EX NK&<^>XO39E.'=3BALS3(U<RT5& N=J3X5
M7>N7U/RY\1IF-L UUCH3T;H N@1T(,R0J_1SZ.6S?(S5<160,9X_D_Y]?.$,
M%&%I[S$OY812;"7W2VC*?6V#>*KO&B=)+5)L!O>H^'%L0.0BIYJRUJ[.11KZ
M Y(LFV>O [VQA_-LO-OKS<)1I2#*H+8']%#'?FD;C2GB>4Q9V$@"*=]%!G8/
MZ$C)'>&=+,4R*[113 V)!4N1,2ERL5#QAOKGBS]U7>+:>> (/W[0VZ6DYE-<
M-]\3=<;;X%2ZPH$?]" SRV@VD>/(?_4@0*A[CB83F)]4=&;5><A4D;9@'":^
M25=20FKXHS>FO9D+:YEZ9V>!59!^0?T3NH^$VWHO!T?VJ>&T#,V IU!E#C+$
M)SQ>U&)XL3]'Z3[@@CH7/] F3@=(X2TEXN"-K=#\X(A"(6L7#H9H5T;H>57S
M\<),@#K37 J-WG&J23;R[I;63GET@0^V7@TRV^<>W4)%VDI_^TV?3\UC3&<H
M>/?VHMX)4FG)P.L20+?9Q&S;<@DX2:(KA?G_B6=#*EX9SKA%E,LW[+\43R.[
M_$BL0T^@79_C6>^Y?_MN/R_?7=M3"IOVA05:R,(/XCQOW>]+PK_G28,KA9@Q
M5.++S>\'*AZF-1N)X+0RW!]3D\Z>&Z:GB:+.*D2_HQC;X=85G-;EN&C#GD%/
M.EIW6?OI1$';'FFS13 ]_Z6WRVZEMFG&?"G<+264^+F0!'H,[ UH4O@39OBD
M@<(]RNOD1"(D%?+.8Q,U!)J*U6RICU] -7^E-HK72_5NF.>>C^RAB5=LC%W0
MW!17 %BKG4^]TPNQHK4J%.;Z][$7ASP.GSY+&3Q/N00\/6R\FH16H6O 4?"(
M/_3!=PP,[WK5C0TC>]8E45&(;@!6S,6LJG>]Z,&Z7P(B"'JS0%NOP/ZR,V2S
M$#O7LO9O>F?/HVEJ)W!/;'DSK4(42[-*N[RB&AR/.367>AR_#ICW=[>1=1:U
M8<C;!()K%!1OYNIT*.,-@!-7$+W:L)G,9$[7I0-8[5B-#GO_*S^3(&MP7^<)
M/_>OAH<[_Q1S3@'U8?#^W:INP#A@ P ,T'/I. "RSB?)GB#[RS&/7+#8>"QA
M:[G4-1\B]0?SDAGX&]# 6KC=!RA7EXNOUZML%-'A?CNB9'%@;4//J/:>]P:S
MA "=F3R&5WV@L*NB,?O\Q?11OY+UW,'@\H; _*Z_UW&+5?TMBR7Q+9KC2"N9
MHW?8^WA#2:K\M+7'0K+J'&[C[BQTT)189U LM!Y^9PRC<E]S(9% ,3"X?VN6
M>Z'CIBNBK]K!X;<U*UOB@I7>BXEQ%TD)VOO\(!^\LI^N* :I>"8);79'#PX>
M1OE, [N4/?"G/7W3$7IQB+72F73YF4,_@>7-"+0D3X4PYJWS25M6*2UD"6/9
MD*F%+?),E.H<O#"'C2"<7+ ?GXER7 +T:A???U/6<W_Q3,\K*YQ.D1%CWJ#>
M@RW&$.TEYOXR[:KBT-VEYF? A.VB("'9#KL-JSE6,:936'3,%*;F-&LL538^
MF-<FQ3N.*T+LGJGM;. <4YGD.NIDN94$WL*);BF?%8LMOS=?5@>SG'ZD%#?S
M:YZZX+F^LYK3%YGQK*PPJGXJN0,Z;21)%"OQL(-UZQ/RRK_YL"^O?5B__^G#
M6ET'P-D66C0<KCQ4SHE,TVX2Q(4K,K:L.'RU@3_!5HS&!0367P+\E2\!-V:'
M!/P,CY'IH7.:IX6+[TZ-)S:C?N-=35 -!.PS!Q4!J<@TZ9U+@,BQV^L?8#1M
M_E,& Z6&9OO! 2VG;1YIW/J3!@S5<UJK@[$ZH1/=U,-G[BPB8Y;./\'*LE\R
M>7G4$>L)5E)!D+>)*0%';-_8S81?D*H*]MU-)4%<X#%]$#&7GBW7)-*Z19=V
M*(8?F^!)K^I8AGCCR*6^T\-_\(/XU\*Y7)3R+C-7S%0.>,<"Q.LZCJ?YTOW\
MQ2^^2$/%@M5S$YAUE,Q.GG/LS#"JZ\K7I8,;+6'P-Q<I*  H\N>IO&+#B$#<
M5I,DDT $Y98J+:6:)NT1KO](4Z/GX<26#?9%GKU?]W6,&O@^P8XJ0C?9SQK%
M+786L>:/4.W#&&^GQBU]*@\U;'G2"QEP]H9T,+B1%!:NCH53P^)K9U,,U:1G
M*LH:U>5<J1S=?]:+2B4<'1$"?\4HT<N;O0UOG\F<?H4?_&A5CWP!W*4HV/F\
MYY[%R[$TWSSS3_CU+MJZ&J :(U"[Y"4@;>1.JB6#\QJ&J#IP[:CU"8WF/=(B
M#^["3<+SX"CDS;J&!U%^AJ]@Y)K,K*E+WH4N:\4(?ONM!?A=B2O_-@6G9B7W
MB20DXO NG;+ZZP$E>Y_LV( >;HK%RH\7/LN0^2^(5MJI#]X0M;'M\Y1W@Y/.
MJ1CO3'&)8C?N>+.ZL^+/,0']VK73+18+%%V0OLH!7B#!L0+[.V^G ICQR**7
M&=I,/65W]R9NC2SP#JW #92OK9. 5[:UI6_$8[-VX;)*AV+K0]HWM/*#$UM&
MZJ[=,3:K-\(%U75)HR1MGWC?._^^(FO'B$ /Q5/K2!=\J-BX?2#.1QH1A24,
M(.S0I#L]'Q*C=J].7Z^>1QV;5DP>/M)II3B]V(LWD0U>>/9-SZN.!>U:5O'N
MX\9XP_-_ZH'$OY)Z04ME2.:_8,#N&&(1[5@DRS4M>@GPVIA=)YVM8&+"8]6Y
M1A4+5XWJ=@Z!H1RH>)?"4*[@0+?LOHY$_:PT,FX[YP?RLB4#3NS7:)8ML&C)
M]M_0+-D^00W[CGBTNJNY[@WEY4]W2<SREA;:AP.@?=U#6]VOB%[30)1=/^W;
M55,920ILMI^*TT,]U;SDI_FH2OY0@ /_3@'BTR8Z.2_^!5_WO UH@L.1?T13
M+:M8_(S=G("-, =\4)-9KOP;@[%<K@HD=8B[D9)*-F .\:34BHS73]/^-T+.
M#$"':]<#&K[XGFJEPZJN8$0Q]-PRG8@%2=?@.,3 </M@_ \2_?3)?V ,U.3J
M<P3!BTK'W*K)T?5AC.NFTIGZ4B=*>-;X]YU+/46=/;R5^KL22DF[LC3^ ITS
MMVJ;?)\MV.IBE4&'EI;$0EVVD&AAE]?'"E5@*W1'UA@<3AO+0>4F4DG[OD@(
M5->N)I.GE]:T1\0#BITS*C[;^\, _G?YG/\==^U?(%#KW^\2\KA[?W<A%:/'
M2<NJX)RC:U^<1G>[0P5";'GM/<6MM$6*QC1Z0=Q>N%K5$)G=0K5H(CNT\+-'
M&?_QZ0LW39*2U:GE!@]M*JLVZM!B-'&TA)5LVBYU^;MOM0V^NKTBG#[Z5Z.D
M(_"::.^S?9^:_0?!#WXLE<%LC .>XHF39>3NB%-7EE3NN"LC O\/%$Y$H"2N
M>0_C1[;E,+:D%=91>.VP30UY](1B4"7N3C<E;K_(-8D7X&#9$O>0M_P+\LG-
MH( ,-1GI5)H@8PH$>2$KNNM#M1!;1Q0$="52J7:/<,F75Z.H./"375W9$W.F
MTZJH*,][UFX<?R=!R]^(Y8.2N,*=-DN6@01KJ^Z?L:Y=A14(Y>B<+/TT^3EK
MU]9>H^)C ZXYNB^?%V-_#0[@)PDSS8_8!KHHTQ)?B;[>VX_SFT9!F4CNXONW
M9=DGPFSU/6_4K7^=\)J.[REP^NG%P ANX@Z 8Y&L6\[,C<*QJ<A3N3]].OZ:
M@:^A^H7;@Z^++@@GY8&S0I*GS)3=,0N?=$\CH!4 ..T?*H[K6R$7OQMHCXXF
MMNB4EA8W\>9)7..G?=G&9.9X'4_FQ5/A>(=_BQ6 EL]30JAN.><U8G<G6D=9
M6DUQ2.C5\@5YK1-KCC7MO14Z-56*&;"4,7_ 9IZ$*C5])][,WZ,*W-+9W,J3
M[7YP@.OS:VI'D_E+M6M8KE6D3-Y3![*/[Q-7YWNN!ELK@2=QO/-;OA5@JHQ-
M-&?9ZXT< 52@\#W=#B#UZ^[ORX/PD==;[G_/AS'C7M.N3R5F5C<UV<>+5_69
M@>VD.,N5?^5.(K"F\ZV):KQB+XG9?P('()K]ZP^<7?/K3%7S;XSXUZM)0<$6
M$G'O2M+%D?'*74O-]0Z .)..P')^G/G,/_6X3 M'&J[^'PR8^2F#TF*I"XSE
MV[>-]HN"O\A#JNL&DEW\]>.^O<#D7= UI8XW'P/&2WE)=4VI:WGRVJLK;[F^
MQ*_^.24T3-"Q2VZ<]MV+ *"C%K'\NYR:.M12_*XP(2>$B-DX@J2G:(D_IE<)
M])Z&5NDSKDEBNG9BAM*S>@2R>P^H:8*\4U+@9[LU</R+-FWK&N4\"ZG)B6UD
MW[F^19E 9ID&=(UNO]4V[;E'\<0<57I#YGPG)2C'VMG&8>ISY/U*3BYYYN\&
M9;>%;A!$3*@R?Z%P+E&W%T.!BG:>F$-Q8_CQ4@@K>]@W\$]+L._J+@&P*UOP
M]NP8:!Y5YY?J]2=^""'/9._41$KK/JGR^9XEP\M1:^7&:?>N]SS=N8W\.[9L
MAW,DN#%J!=<LWFAS;-W(Y/PY35;XTGQX"!^5I,94.E(KB?7/X"60@0H&=M!'
MD(%\H<(<A7:#;"S("&%Q!HXWS/NO=5(T69A)IEZZ,'TG=-6K;XE;/T?97@(,
MX\]V[KSI2;CZ?%P535A0/F69/#&92O D_L,W('H5+\.<G.'\$!<C6KY 2[SI
MZX %CG\"%@RC&[WL'Z3</M=C-EA9".EXR&3MREO3%/=]5,2&[539;"0"GOQ'
MY7 ?JGOK[94YS-3911_J9VDE+6I/IW@)DIWM7>DI H0LK_7%\/R[LFYK%L/7
MG"\"=N.83BMOHEY]3-MZ5:F7-%^0;<L&SQD>#6XSOY%*13;@_A?.QP-+B#W[
M2!D\ /ZC=3\)H>))-2.$Q:3SR/S&GDY+5I: ==%YR)' 0.\" ?#B^MO">F$/
M;K^KTNX"B*[A3)T>?N?_*N?RWTJ:_PT\>O-?_<M_68O]H\E_@: \_^%K#_Z3
MS^L^< =?/?MZ]?1_5;&A?Y";_\<;_^RF_\^D_M_L"?\P+_>/[+1[Q.:U5+#E
M4P&^9[TMF&5P+>Z7-G+NA"]!&,&7 /RL8TSK1=0E(-TU"W@F<"H.3,(F0(<8
MMR^J>>)\6N^AIA<@@:>+"RE*8Z#E,4E(ME@-J,DIP586_K>\BJ:?JCIRRI+%
M& ("Z-,O5A,?6UJV>Y@\IYKG_?FZ8"1KZ#&N5M;;9JG@J&4&[L*'@C'?96+5
M$<;?4PN3;>*FIN^^HJM=&DU<O7 -3L!_52^+ U[XG;BTQ?E([Z>9*F>Y#/?[
MW\UO=B?+]?$C]IQ[X OCQ\9X/"^NBT;=\%3H-CHW$*:156ULP+E T;[DV$XU
MO[#Z.JC/6-^1)WKH@\,(7-LTD365BI[DY0(]Z-EZQ8>!A&@RK42(NH1CD #Z
M82HJ<"<S>O5('<;4\9F@*Z@9G% G_X&QR^OQ*ZS6BYXGF0"%#BI1/"P>N,D7
M2^67T9X/.GF_CXG4/37_FM_L18@C9% LM"&R'D=5<6*S9_[Z@"\2*!0OD,%F
M631Q4!/$G!';]?B+(BSD^Q@GV<V48U%::SG5YEM)GW,.FL6KQ1^29]N6B;\>
M)]N>3_SF=Z//"?*<<?[.<XV;P9,O4Z8_1#X-)?H_WR?^M4C<?_(4_O\G_SW)
MLD=\/@P=>?EU&,/;)W]X<8^Z?\RXYZ*DS)%V3XD#/ZH<0X64AM)^&:B'TV[^
MLBMGDL- .)Z\S7VG5LE-*D2;YW8..ELZ%7CE.\A&]I"/K)O(!O@P_7G 3(*
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M--Y#K05G+ES#QEX%TD,0.HR/-M.2B'33'K[_:+[B3N2BA[041!VC/7,^<F"
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M88\A@''"O7IT0M?*]-0D$N("5)*RWE<1FK;Y/*$6R4G]/K%!(!,EP(:,THU
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M;8K)3U:7!,MY,V*,K%3RR(0;\1[+$H6XM\GO6S-;U:G;[CM.]77TVFT H%Z
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MP:8P/:N=E)8+#6V*7K>O^#]U?*+;T.1KB20O\RJAO:$@1EL?X 6MU7+_PY:
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M'6?SWPR(&\-(X#_00 \_V1151K,]#UD@GZ!;>?Y"W7:A"%&OA^MGL:KBJ;I
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MMX0\>= :?G-:A>Q8%MZ")HU>!PC^OH269N?CLZ7_?%1P8*0 *A=W0U$9W,C
M<,V HOZBZ)40K'$,WE3A%N\^!5N%L*S@*$<4O_IVQFG2+-SXOC_AT+4H.WC"
MDNC@.\5Z:+R*L9O0'!-R-M/'0=11M0K/5;DUO8[,G(;+-Z=U*\3PN>LOQF=L
MONZ;">,[PKZ1+\H-B3>D]8Y,RXC$.VKIK5#JMX!NAF+XF/B,+;V_]DTX#B7!
M)?+-$>R&<8;CKN4<//XDYU"X7<<^7L,7C?/4/J!)^\.$R\: S+.6_NQ]HZOT
M&X:8HDU3X/2QZ9H':DB?IVK."C>OZ8=Z]SY"L(]YV/TF1_B48<]RD,*M!P]9
M(#;-NSL]N8/TVT:K/R$\-4C2&'),\7'S P_/V"$(L&XBR8>F#?Y))Q+__XI_
MBW!^;_K6J-?X[_YG4.95]E=*E;]RL/P9^LO^]U7\L^3YOXO/3GRL=9H+#LPM
MC:I;.WP7L&*>\K'KJ?,;(9K\%2I:@@A&[W6M,1:9.Z_B%C!L:+:&\&MW[,B0
M&+V 3F3K33%-IF<4?MH013NBB,.UH,I03567@Y@6VQ- X_H^HQ&R?:I0LYT.
M<+",DD]82%WC P"7],?\A@43<>CN$^P(EZXR!VNDB_N$6WZ#[+&EP=-?39",
MBVL1Z$6Y8I[^"$$C"?#E2$M5U:=;?3M69\L//Z7GER!P ;<;"V-'< H?9=@L
MIYE<S'J_Q2'"WAJM(+]FS/A@NRSVM0V97 EN](WU:4C)GYQ\+MU!L(LF"_5=
MB^VA0Y9QN<4"[*TY+0W\38/Z 6PYF)0GI!+(0Z1E'UVU.9QUP.%,Y\,4#1;-
M-[3.?HLW:W6BSKM+X7W8RWM:B6$I[FPH<&KAV*-<S9SYL@C84FP6D<2@N%&X
MQ3?(L3SRITJ(-7NO;-J!S#,I*6 '+?^AHV@3S=(J8=6Z",T/4RWOF,\T$M?;
MBPCF)7P:LKR,5-?=UQ29I]@4F\\M3-YC-I4,2A,]&E-*9>[PU/$7VS3RD3XE
MH)/"WBHQN@5D?^6QP%BW$A43Z5_IH??.;@JUZ9U@]M%/*QAG.$ED8+('DQ;-
M*UAJ8*6VW>#;2*C6Q%"''<L9;L-LF'#($NY5:'H^Z'@5$."741.NGV#B1GX(
M.763LT5%I;F%TXL;0*O0$Q+EWY,U6O$(/3K2D)CG$9=EIZDL.X0RKO.,@X>'
M19'>OINT*D71U](:/-Z0?3.J@24,G4!&F>6M[(9LKB>EB'[H(C#R=/Q@2&,0
M//SU:K6U[20X8=AMF$2.B1S$G$ 0IM\=L)2,2_L$#ZQ#+ZR^82IGX'L2(PC
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M0!%Z]<Q5:H%@Z^83^#+OVGDB C9"1N1S4T2\>ST-K-.9AM=+'[IF4:Z*U,<
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M4OBH\M\MB+W[YU(OPM^//TMQ2RV<0QU_1XL.9#.;P=(7CTF_,4%M;@'>!;<
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MQ^8S.D\G=\8"OK!E_$S$%(8YM /9H*;N[#$\%JJ.+D+S 20SX=LI_H:KG0?
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M2;]0HT1&)9:6'P!#= \ G$"/TZB^<\Z\W<+S$(.GX&?/[!E6-&7<&@0VIAX
M;X%+'>BVF-8E:M&JD(Y']L??QV4DP^;]]-8YE7(O%JG=TLZ5S@30OU')H( \
M9R%]QQ-1VU1W:LR#\/DK^!?=DMNY!T#>96FPA_NENUXCXCV^C2Y6J9!!B8=$
M8O0J<^%?A*B1$/J%R.7]6PREHI >[)^/?BI(#/K(R%FAF^M[N,;]^]MOP:X_
M79>MZZ2KZ-&C()HNG?-"D$Q(;LB*@]HYUIYR#=:T1,AWERDX,7RU*NC\;5O6
M<_;&'&MK3/M!'8>3[V' 3,,2*=X(;IU$.MUL.__DWN:.#=RA4.^U9ZFD+6*W
MUEI1Z"4]!YN6(Z G4Y($WSB]>.TLH_9?'-]+3%EW-[DL?TB475\L;;/L#(JS
MQV5_<9%7;J-H1 NNCT#_BFH5K!9^%K0;,\R.R EREH;7]G_Q+3*?V[7\E!9Q
M75MHTOHFMJ4X$BG\^))JWS7>70)T$3REQ"=5$O]+-98#M 1UOU5_VI4%IU+J
M-!C$JONN@]!2SE_*.>:K4Q;@!#CWC9$M+% N_?Q(XN"JGTUEX$4E)^&S9[Q%
MG#1]L-A6+AMTU8J^/4T5LJ>:[6\34G*#]A6\>EGZ *@,T>^OO@EF_K.7]X%*
M2"CQ &$904X-G&?3A7R<U0W_LJ%M[W:)U?TN\!J/81+O6UC&M69AK?7ON8#I
M1(G#TX[3/"!4,F8J;>K6>IL:):IG*)&..>?LR>?=BQL9G+%G)";&TVR#DI0;
M,%ZJ6"UZ>7OW*[I86DU"-9F-T6=-*Z)QY"RD$?092S/%KPO[>#[T1SRE/X#9
M-3U)19*<9[[K_A>'='@Z2(((3_K\CKCUU;-FFRPKKBW].+=-N]&,"BBP QQA
MZ"SDED*I6Q/DPAC%*T>27C6?6:,QMVDA)^6XC1<I$SST8HN*6Z52Z=ROSX\,
MT>1Y\[L' $^O^?8 K5#DX+S=A]%7889O[E\F<-ATQJ!P([H9P-^5)DI4FHV^
MP&%O7I/3BEX=X?BICPL/ ##M ^#3 V"LP^<-US:\L&7P>/V^7#RD\57N8>ZN
M.096:9':(W"&]L3;-RS*0I9Z/25:O#14:IB+SM%W ^[.DOO86H>.B5F[5ZT.
M235K:7X!&G"R9PK^B'(/ .U]#SIV7ZAT5%@P>:BUJUV_0E=[.]U:@G+<:5J9
M!$XV<J!;?,#%M8A44G]^Q?A3*D*)+6'EMI3&/?VTLRI(]^=W1A@\W:]O)Y,X
MAXDTTRG+RA"W1_MJ>$X> -[BF":(+ZWO?58&.(MM*3+NQ^FI"AQI'1WWK%#Y
M-/0Z^3(U2ALDZ6]I^PC$7Z)NXM)C)GP8,$-*TC6'B>F2F>.)(NC8@H@XU"XD
MK*[NA>L'$9S+#+L"K^DH<2T'+2UM5:@@J)"AE7%MEDWIR?7#:?<1J,2@1&,-
MH9E:"97J V N?8?TS5!F$I\]*>F$Y#+;S2U,3G_()DD\D?$)F!B(L#'-\V&J
MMJ4"YP5*.<0W,OY2@C6X)'T4;XA=$7Z@[&XYZJML?YL-:S2_$7@5VP*UQ6K3
MR,G>&N*8V8J*HL.GU)_X/[J<J?KCW%!_"KEU\R/ <,I<:T/1AB4BZ3@HT=']
M(\;Z_7!U<$[S R#3])KU 3")$L6U'12:]=LFB^V/\&8F^++L9&RIE<)DI!"#
MEH2354)-%/JX3#'$H<)D[T3N$D'GFT!0++V@62%2J#%,16A.=<\?]Z5:;.L&
M76R@AFHQ.:X$=^8@3OH;#4T5P"4XIH+XZ7S*LI^;^ >"8JKHRG,5![DR@T))
M"$_Z44YA>&/F(Q"Y);3$H]+P)8_".PQI5?</I)-W*5*I..EMP&N>]'5$C83K
MU+A3\J$ )6]6PK)[ GQUMA84,$VT=MF1TQ=G;-&.HKNYU<?O'P"Q>.=6[T^S
MSN-,*M(EJBFLQ(S%=4QJ:#^$5$M2-9 X\1SHN\2:SEB6!$*\(+-Z\?UN5G47
M80-8$.YZ!S-GWJNNVN*R>*H=^ [11)9V;XY1<JSQREO;7I)75$B/_9#3X@9&
MJ/V<%3'.\WQ#.MM,\^._J'U3!ZYBRN?WJC"QRT\^.F[*\XL,QC,0?<V!*^ V
MCA5;:B-.T_SQD%/70W-(S;6Y<.P;GYZF^X$?5@J9C1RB&R9EI?8H\J)R0/2*
MN63*9(K$EB<B!R\@=&62W$82_.ZY=0)+?54)7$ZH3)>=WF"FT+HKOIA$*(;B
MBZZR$0*0XCF8BV=)'QY#6H!T0N76SZZ1Q1W]*ET8-^\Z<=BDI3NVB#X?4]*1
M5>%1;RY,G,7U&#/%@[<__N,)$%96.>)0(OS&XIS$FXN.LF^O7I'VY>/E@&SE
M?IQUG,X]1<:3G66[K796++UU5&864$/PM9&LVMO]>18WBT[$Z6]/JA\ W0*K
MPA+05^Q1LUSANFH'ZS\'7O:>3[+TXP\OL*K1S9!A(\_%QQ=762->I%?.P+_(
MO9"1(Z+DZ!K6&&_1CW^W:'!_A"!_F%<F>/L\VUURMMHP1">2/#SN&\8#H%:]
M5]U94]4_&*;2FP'F/4DZ#S?)^@5K*TTASRQ%AC/)2^$ZGVV\VV]0\ 0TEZVK
M9DFU..;Y:GU(XV#KV/L$!!T%[G*&8#KZ&$Y)*$!.+IA<SN7ZCR 0MS7 L_W)
MC10.VQE$C1P+&RCQ9);)HOD()XY#++D[SJ'66RKEE&3<VM(Z.9 C;3GQZ'$J
M"59FRV[#EJ%=7P#9OO2!W++#+/?)!@ZYM 5%9"%?N2_#'DI/'2,@S@\IH$4<
M"[=RJ!T"QY6(,])HP*5;/VIERSFH2OE>\JVY1>[6T_N:36 ^*LE/X?9MHE,1
MP.^@0-FNA@M\;YT_1+4<++(T"3^Z\S1KLXQ[+^9'-9LG=.*9!@O:#X<D9SLY
M/?H^^'5U ,9(YY[5?]9Q$ZH..I HLOG+$43NFZTCN=^=L-.WD;MZ7'C/1UQX
M*#$&9Y7HE)B!/UJQHJPEG.":.[L*:3)M2>2(C\K=$XS'4BQ%R2RVJ[=X.B7$
MM(FAMIZYQ8]W8#L9]HKT4*TY)Z+-Q[$'W7W\ =!$!F,?E!,_VK80%)[U[+V@
MR"-2';W[A)2%MU@KL>+/K.?O+$Q9P<V#C=20A>,]#[5F=CU=IRK#$LQ.W4SQ
M0>A*R$E/#^JVFV7DP3E3.FLAAYJNR."M#A?QPSE%I,C?I^V./F5V:6[^Z6)K
M =_[1=9>#=AK;-$7 LD%_Z]=@_J?'9C]G0WW/[Z&<0G.OJXTN/G-!Y4:&&6X
MU/#M?*2#<1?NW<_F]Z6_KKA3MDZ&3::ED=YE/ "2DJZW'P"\0#_2]^?^F>I;
M703:JMF:_]O7:G3J)A&JUGYM;S8 ?JT_ M:OV^ZD/K &O@T6=PF!Z)EE7.?!
M85EPK1SBX'<;]N(Q 07R;\F&_W:G,\'!%,Z8,E#UB0X?H;MFH0?9TG+PXXMM
M9QNC>VH<A-<O/M#TJ]8'#I[7Z+1Z5DD?C9A^3C]:K+=$U^'D:AS+#&9&Q0%7
M,TZ.K7;A&,E\8(47&'+?V+KC?NH9F+3R$G&%/*%UZCX_UQJDU8F+>80_">6[
MBBF_1JSH?15\,?Q=R$]&SUVOR"^F.7E86]3E(J7I+KO]<M/(4?A.A,#L3(Y*
M\*G3CR*%).];%36T<:_1NZ<W,1RKN>LWM+05'K7UC5[X8=Q1N2=%#73#+N/F
MQ%>TLBL0ZZS!?!7==>%3IIS'+?W]? [L9E7JBP35+'PB,'%V/6RIDELCR/65
ME24UO<!MJHK:&..>Q'-\_>*#FJF[+_-IZ'R^,4WK5E-NF,2).)M%[QQ \AS:
MF/5"36F*]]V91H'!VK-1@F\"C*N,]FQ/V;\-X6A7K6$$CS08^(R@DA:[C,4W
M(=)0LV6"^7O4SFK'!"E%JXYFFHM#9\+[,85<T2RSF&+HZ$'RIY9VKLTT?GB:
M"0:N]%IEP/QLW[$.H18F<E^'Y<UD1)!;CC,B@ZE@W>=0#S3%?K-SZ*HJB+L;
M[>8%)OC4R-1(IGN<]&NVH?938AV%K/UB3[ ;=&TUY] 6G+^YF$R!H)&#2>I1
MZA=^YJC9#\JJ1IMIWFBD8':8Y=F.BP]?@EE\_3G'UMN)6PDY6535U]0%)\<2
MMT].:+;4^>DEM2X#HRW7Z2\[7@*/HX=ZL^Q(9W>F,H1.SK7>.*B*X)A$]K@5
MB .QW(Q>=O/0F*J7=1)VWO!FJA-SE[#LR)%G#TFV>Y#+31*=6DCKMK4IK%[?
M?Z/:VV=)OZ*':S(,WPU3*4N*???"XH_;CM4BQB+1M4'Y<<Q?H=)';AD5@1/X
M34R-)+[&S=1"I]9>HA1F5P7*LI_)TZJ?#Q8Z0G-S_SJ0DDJG,-,G5_KS074^
MFX';7.P9__>4/P1ZE<052<^VAQ_VOO,F/X:![5.X5IEO[E83^?-<<TY<++<6
M8TL-.!.OBJIHEV[SPEOOX8TD0+F?NV\J4,:^<W87M2@N08R!S6 VP_?6:9(&
M/9"^X,*/U^UG$Z0/BJY\H"T;8&/1D+6P#=$8#403Q%-5@X42",5H7HD>6&Y&
MTI\I'N-P?4:9E#9"40N8[SU+,';ZS-;!,1$X<*,E2( L>*O1-@^NB%9;7=F
M?G%+,TJ2Z;\S:_T(-T"*&:YX=B(AU\]ZQ+67\G/=GHMS0XN21Q&[5>Q&FTI.
M:=0U"QQN5.U6" ]ZB>?7*U(8&^#I<V]_W !1AS&]EI^DI8B"1?16(@1,U#D8
M!1F'FA%H:^ $C\;W4?*@$'%:9A5^I&L^Y/?'065*L):Z\"/%.1O?TNQ_%4WJ
M$ED>A1Z%K2ON+FK"D* K("<KP_<47$/1)N$M_W&);.5'(:R5IQI)!XNOYOD,
MF5RZXCN! >R \*Q-$!3-S77K* FO)4%.Y *9.4+2"S#3]QI$KNR79]2!="W_
M1@M".KN;I;<!BD4J<QA/,PD'(;,'$S?P;8]!\ZH74F96G+9(!SUP(43[F7SF
M/^611[[$4SF>^J$5G4'3D@1L+0ZCUTFDN7UZY^Y[[)H',SC90P>AXHN$T?:/
M63!'X TT%<-S<W&NR./?ST-CRH?M[46!T1EL"]=+"]QG4-DX_Z$N]TL.M?7D
M9\&<5JL!0GM7JM\ /M2>#=SU.:Z3M98Q2*B?RMA4SR[ 3'&)HH+'=J#"_BQL
M*J0T8#[!Z* /&;E>&KV:L/\>X1Y][EOB.X[+<1A1J.D+FGD,G=A\F<R1;3RT
MC)88F@9=LK95J0BSOLK4"IWG13CXJ2#U@"=(C;G<=\%^:<PQ:)SXC&:^8<$K
M3K'28S]*@"'\W@U)I"'D T>HB]&3A=?)/MQ$5R<O^(UUSNW04[UV #LHKR'9
MDI+JKDU6PACI\ME>#9/N-]V^=S1V)L9L^T"AQBN+G&TPM("UM(;+[25R&6RH
MK\W0O9DN^E7#PM-)^R Q#UQB7^N!?:"]\L8GX\7;U#$J#3@)<$S5*$ W8^&M
M#_A$/EXK(3:8/"(W3],FIQYOW0(FM9+!/R#MC+>L((Q%1+P8H&;X!6<)^]2P
M9.3NO"S8(HHG$$$ EV\[V%;)3Q)O)<WAV51N_VEJGF/U,V9(ON_ 8Q0L3JWT
M>;G= EN!QAO<8C#V3MU48.*U]M$\%#G.6TP>=3T92NEP&#C]A1>C6PE-<&&C
MBZH\',GUT%U@U#^/G =!<.Q)L5_H6:(D8'C5CJP(#+3 L^_/AYZB%%OU.L7.
MG43.X]SRB%:=X).HO583)J*VE_&)![![0]?KL[MR/Y"FY9CI?IH=E9,;+7@1
M_O?DO]2JD0 VV]+F$.J#YK&F@U6R)P9MA@;'(M^%]E/3BTZG079?]30_(7L
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MMM_I-.V>WGTNR/V*S^K^@&H[Z,=;3[L8<F_/[0$2^@U=3O_*S6?HE%0DC"&
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MBO24.I&V,Q"UXQLRAH:GT%U'TS/?V&6JT109;<XF84.SB)@7OAZGKXTCX3P
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M5S\@Q PGZ>['.>PSHJA*@NX5EN=.0^E/OK'A3-)U3*Q/J#(^J29EGEOCHN/
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M%_QG\$YYWPL:.W6C(+(RU-Q+(!W%WK#22QTMH-+WB.B!9QAC01$LP8?DCH*
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M]GK\_G__3,*Z9E-MX7O?R5_)4[+W?45Y;P#AO%:J"55](_L7$3NX>^3C.B*
MS)#HNV9-.78_B8Q^-]1X8-W(+:Z9$*741,MIPC8HNP,JON)B/AH[4J;8._E6
M>R7I3#8K=9CJ)DU9D_A/(T3C:+]$3,&HV9U);+=B>3L!_ARP(&@Y>8@PC'N,
MU()]%"<)P<:-T2A&. GODLE8^/R:>UT_YHVOZ_Y];=L".K6POYNN =>],\QB
M8')U>9W<R7!Z=%+&7'U::?E&N#5!WB(W:G1'QAQ;2?_]]]5V'A]*IC\7BLD;
MA37"F[R[*#]S!PT__][ R&"%Y&5)I@ER%YCK^4KBJY Q'(;O!?(EC=RE3KA
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MTCZD/Z"G#)\HP,)U'Q&8O2BA(4<_([;R/HQW8$1-CK1VM,AWIZL=;N7X2ES
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MR-.QG[%Q PB/ZOH$)>^3H06@<Y%&LC+QR,DVDGN-3'I5.T)"CY'@468H 1-
ML%2)Q@/B$45]/KF7;#0KL'O<%Q 5@M=$C/?:+.0NVX@XO,[V4ZR[NEKUL(+&
MHU[V%1NWG/L)@&+VQ[KI+X\1L*M<&<\@G]1/WC&\KB3,^T8&"8QZVW\PKQ'7
M5Z5,N0*@N0IPLN_U)DW5A^GK!6D8<],W& I$E4_*,Q9?O[A-W<^GN42#KY=&
M!UY;QY7R'ZWW(3.N,(E8<)V,Y2M]\,9[^_+-#2 ];(_P+?8RS5F-^2,WF-F0
M5^:8BJ',EUF9!MB0'_DA98;O#4#^VMV!0955X7[-&7)'P)6>R@_A"?X0WB?*
M$PC^=^$QM"@_F%1QFG]QLIO2=3=2B"XA$M5/3EPEUT;$PF&DUTG(DPN5<QJ"
MG(AW4&0*-U=B-8;;=C^=N(\+NUI/HQ5<C%<[%?3M;Z]P %#5+C74 2N\UE!P
M%0!23^P_,2,]0U=F L[[!"GC!G4,Q\8PW0#J]/T(696D]0= $'#PS^(\?Q?4
M^C;TQF #+O!VW-T:9WX6^"=-L;,'M 1 5;<&CUQ%5@K#K5^5_CP2^GWB],@N
MYTGN<C^ IR6 .(,I;'E-@/3N=C#R::X H/"L"P4[=*J)1,L%I2K&PG*"T($@
M/LD:!W?KT[ P"N%=OS[#&4EU _DW90,06G&YZ?T<\E"E+;%+B2\J#9;]-(XC
MDGZSP7T=V.:1$W6@*@9C[MPJ_1L 6@N;,Y8V38;$DP4_]:ZQVLHE:6"J8N"7
M.]2:$_".ON5"YL4VV]UDJZ$5F@QIO>WK1U%!^84!E2;HTK>)G<')R3/00J%(
M8$<Y_45XW^8#6^&4BOTMG$.=IB!K^14+VWE_2PD16I[37,*W1'$3P!4U9Z!Z
MO4G8AR:]B?TAJUK2Q6+H:WP5[E7E\J_VRZG'0SV4;&OZ,,4GET>O5A6(H%4'
M U8C*_<+Z49/'^V:V[5,EPQ6KW$P(,<UI)]-J143Z;8%O /2EZS@R==WJ,#W
MQU>OA.U-[+PL5B^][ M92VS3LR<$?'G 0N.%?C45>KX\R+%GTR8&KB>%M@V?
ME2I=5WF#(L?=026EQCRE5?H!:"WXSFC:-$3J+\F.)#[O3+).%UW<"Q8P]-N
MI*E6*#\]Z,^KW4[3&&%PD&26V1A__"'%_YMSLJ597&Q-;*\S>48UZ0.<<TB1
M]<#96XW!T<R9B^#/")9XQ2[3O 10O&KK^U0!0+#(79X; /,5<,!.5JQ5SCZ
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M;:,9S:R\O6^"]C'+GU.K/[%];!=,' ^%>4>BIA+?4YD>5F\\GYC>$!WG1=3
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M+&*XM21[.!*:4<Z1!1E(^',.+,]] 9O[_IU*1S<A[@R/19*;5>7G$=$O^"?
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MK?=P'EQ-')M _$N/1+MHRS;2J%A$%W5N -HW@!@#T%7'2_4!E"(](<IX^OP
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M,^5S2X\;9LP?MUA5]UL,\):S@5GR7H$^BU_6R'*#M&OQU4(L!2O>1C 3^=T
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M\?]P]]9Q<2A9_FA#\. 6W*UQFD @. 1W=Z<)3G -[L'=@KN[! M!&DV"NTN
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MXS)&[69"[W(\6Q_+S>!V]RJ<=+]J_1D(,"TR."K&$?NNU^3?X.U*WK^XG7P
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M@4,^ RJ"'LRP508R^ N^[>.^%4(ZJS%C;+Y[!F%OB6^WKA\S]G*,24Q<^P=
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M+?OC_$4;B3SL%6L/1W'B*%Q%7:<UE<R$3\ZF<6Q//$RAVI0V^22,2"%0OLM
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MWX'<,2F]^E+I9_RTH1=M6"1X.%F(0_M)$A6<D)I+:BF6G 9#,-M0JF.%,B+
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M'XDI*X[5.UN]<-02H/(QFY*OAN&&9TN K>^NF7ZO[#"D>4DN)5(H'<>"E\U
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MBS4.#:Y?.1)DT7&_L]6W'C116A;P16W?)KD2KVODZU#];H&7Z$C>"$U#WMK
M];&@FVQ\NE)58Z42&*.SZ:CXDQ PO[QC;)!&H>_Y-IJ,DFJEXWXKOY@EW:1M
M\4T;XG<QO2K0&G>P;/D7'45E29R92K?!(5?WD$&&^@KFMD&B>O>SX78CCUZZ
MKRG-H^XBSP'.3W*&7L>.AG/')!]7^DE_%5Q!KK;/NHXW-VWHJVMTMT>ME>J%
M5^!7EY0_&?B\03V@#C>O:5R2\3("MK@LLP>2X!_V/%S?[)5DD;^X6['JV58^
MER-NAFC?V]WAO8E6*TT((TZI ]5,=VDJS>LGYG1E;S\3;*W17%:6-564MCN4
M-<?H>-?YL)/+">NJ3'*15XV7/4$OAE FT).+TTVQ<BD[-IB1E I/#0ZS82[:
M+S<US:BS5R,J[:XZL@^+1J_9.L]W?5+A0L+0<1DD65 39RG168;JZUL:F"15
M*W3-, 5=B9!^M]#+1?X<#/0W<[H0OG,2@EF#.S/#=OO94'L;F;NO B6F<4H'
M;_4CZ(K;K(<C++]%O@Q-WV299Y*<K%6( %T9N0'N-&WP)TB]D)H:',&]H?Z,
M24)D*!%-;R#9@+)EI8,[U\/K/$F\D"=:P'/+*1OS2:NT_B.#9"(05"=)>$[>
M>)0PKA3V&BY1E1[O.?IPO:6 FX\Z> PC]'@,:-YR\2)OKK]0"]!<L9)U%_R(
M=C<U:#9$/^%S3C<C7NY-2:.TZEQMV(65817;V)BBDY;FSABD"+/R+<##/1@M
M8+ZRX-":5"8D+"L40H],@*Z)&V2>XO6]1>LK5=1\QCVO#_"8*"QWBJ*@V7Z/
MCWU'6BC:2&Y.\ *YJO2-"FXD- _F_^'NK>/B6K*][R:X.P&"TT#CT'@@N+N[
M!1J"$YP0)!""NUMPU^ 0( 1MH"&":P@:W D.#R0G<\[,G'OOW/>Y<V>>]Q\^
MU/[TKKUWU5JKJO;^KE^)4(]P@0=RX6GB5MO"J[7_H?=\_^UB2F%UGU.BQ$C.
M(]]+&$F5-;J%@X]I<;X\SIVY++KH##/:8SL]WX1M#*>_E#_58$XX+>@.M]DX
M^DB=X,U@\US5-.,T&H^5R"TQ^1FM]FT$]HC 'L/1TR>Z4+7M9'Y##EB[#<%<
MMR'XC]X',T\/5)\^'B=B'>;1WN_D@AN@YGT9<);MIU'F4>6=*X!Q&].E&BKK
MEZM!CA3M0<8N6-XT4_JOOY0<UZ$-"&!/7P\&'NR'B7#CV^B_VIW0Y6$4@U8X
M"S#TVLO5L:D&^E26?JI"@DONJ*4GB9 B[[17M=DDVN_-/CWN/WWO'**4S9#Q
M08&S1""2D>0!BUHC:7&S/AA+,]MF5;)F'[/W:KT>U=%'-HG))T[)]O"Z6>]U
MMTRSO?+PVC2'VV9,X"EF((*MS::Q E[0_N:II=B@P%ZXA8V'5]'X)V;0LHCM
M!1@?U@NZ_*14::0)1G#%%!.U'0&"MR7UIQ,S\^W]U>$9K^)C@HS)FU\AZM4[
M$=, 450T1I<O;Z,]:[%UZ<KF_>D'*YZ55TRX,MJ$Q:$^*I1^249+?I+Z]NYO
M5V/+?+*9YI5$"LF^K2.G)1".[8X3$B5\9=0_7K\"AWX,@9L-UXG6*7V5".\_
MW$+V<Z!3/M3@HZ*"4_7MZU-A)YH-N,N?"ZMNMP7+SE)D'PFX"P6A(L6:%!(]
M6HK4:O5:^7+GZTHEY)H#00+(; MEXB(8T>%F!6]9X5**):=,>%)+KVBK87<)
M<B]E:\ND9U*2VK]-I_J%B:21_.CRD7T[9-&'%EQ]E@'V;DF%XWE1@[=Q* &<
M8O_9WM"F.+U<'CO2]E2#95]T!2==S,BH?L;9Y9WY!TM+&(6-@'[N2MLQC6[)
M=SF>JH_G*[T>N!3+TQ5!Y7:)"6@3A5=8>M%\@/R7LK:"667\7MJO:U+N4K*7
MW"6#I"8/6(.C?=EYZNS2.OOWB1,:H[];?.,0O.T:6_IQS$X"-X3OPI32J):+
M!.*LX@<GFTSA\DYD7L<#WX2ID)WCMA^>;+ .)$XG5'!"[_9 !4DP!@89YS$A
M!T[C\KT-'B>3S0O'.J[:@Q7%A^QCQLE3;:*S'4B7?WD$_DA,X81:1[=]:(RC
M!/C-ULV4<N]K8?B3PZNJDA[!I(V*PY4*ID+^L<27?^>W]'\Y7_MO*O3\'?[.
MK>"Y7U=L'%PL&/&6!$. ?HQ^G$*L6TULLUN#W@6/.;G9'CYE\!=G_T<1]%:M
M\A]5[VN7_#GA_5]1XO]W$/&?U_Y#L_UG_@ Y5N4^.[XT?/9CP_XH,T27D\+1
MG6.&%@+[%UN\)"3+7*OY.<Z!@G];L;T27V<QK$UM)QA?5(A @SU3@S7>B@4J
M\3=J\+\8B3(EJ6VF^SD;6$ML01)8<O5R]<$Q3@2J7OL$_1G=82L[!FJU;;R!
M,7!5AQ9/L^[!%23SL;K.IE>BRO9-&=OHZ?_S .8_Y>[_ W;?6SU%UH*;%HB-
MM:!V R@RJ2!J'U(Z9( **U; <?<ZZT7*#5K+PIQ[+*7^NA+//Z80./[*G/B3
M/OG_C1_]I[7K_B61Y5].I/\WBA4_DW+^6RH4=]W_SY2LOUVXY5]Y$E7A8"*-
M55J8=?7VH8OVDT0D/I*>BI+B-(C]T_,;2@T_N?&+UBN)B /$4PD$KC(&]Q[J
MOEO53/J(ZA_6J)82%XUZ)U%,RSTGLKFE79==);\JS>)++4M4<<[+?K)WT=[(
MLI=WN5O-7?"\(%V5#&?@>43@_M/=0:I (G-J_,=6;#.A#H+:S>[\3FG+,4$#
MJEM:KG(;. \U1X"(B9JMC40?5$E'VC_'97@J 8LMK/YY=O#_@*>45E14OS4-
ME\^B;&<)]!RB:RG3KG-@G2!Y__ZS=H5]Y B"ON;IU6FGD&4B)'0]KJBZ4#),
M?/8/[\)<287BL0Q ^^:*_5%X'BN[%LI-GY<#G:>"P]*66.@%KV#R1-J6^TT5
MS/*[B9U(E@& 1CV]]-[%N@KF=QS^J=G9^D&:P69E>2JJK\B'P*+Z56\;>,O5
M2M063GZPWNJ_L=Y:SVVYG$E>">-J&#9P@-N!P[=GP1DRI6(BB8M8ML.,#ID/
M#@XLY%QR(F+<:3EE[XAEHZ2TB>Q$*KCQ9F].D@-9HA!2?,IIE?8+\#S@)' 8
M:Z>_?(C,NR;T?5<:H\0?4KMTFFIY-\JMI0E)[++-X':5'BX.SI16%Q!KFH.(
M7SP?3P#G"Q+J*(#7( 2Y:91D=:*QW6FJ S&_>/F3),O!5S8.S T&_,0N<F@D
MZO@HW$]2)<9$A8$W ,6!*#RIK8%D<M2/4TSSM,'OA17DO&-3(HE5HZ8BI%S,
M&FE^[U?MZ=G9-V*CI\M+%+1R>MR6]$Q> 3)S+\*X7S7_1V:@5Z&/4S[WP"E)
M'HG[^7!!8LX_0@["C)@48OO0V,/MN&CX(^+EXZSBJ(KSL ^4G&7@*'R7A]%
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MJ.5C!;>'YU4FJR)3*<V^>;MF^@L,1497#T^W39+0>):+Z^IU\[13TX*W<F\
M#L94 "3),X1A+MDD7DO<$N30T]!+\"4]WSHY'LY;D<GT*Y6OSAE"!3NB\K6H
M819Y[ROU)C6I5E3(8%TX=ID1 17OJC>K]1JE9ZX,,UR<2)-I&K[DF#9P:ICU
M- A/.IL3+WVSD0*>O>@1_+1\M)38BNAQ1C9IRD-"]!B+9Y6R)LOC^XJOP Y*
M'?G<YA?2YC,+_-0L7N"TB([+>K>@$_*MSZ6<F^] =-:E),$N)82$2^,I3CJH
M]6@T!H\OV$_]#%]U#;GKV+YJ:I;.(1?^E%-Y]@0G ;IN7.)>8**U>0F]X+K/
M/NJSQOHT?J3R^K6W>Q4,D?1 TZ'LMOLVLDXGP. KSA/?_&2;7X28TV\].LBP
M= <L\F_<SN.2#7[39EZBS#6^ 8RV_5WV@8M?:V[6T+Y?UESH]>YB&]X:8>H+
M^8-MQ9[(+X-JO.-Q*NQXL@ZK+1$-'.!$-R6F%H-N/^N/D598BGM8!XE&3B]9
M)-&P'@D]A!SNT.ZH-PY2VON-4I9_'76A6&'4?LRI["CRY38(C]\ TFJ%_41/
MKAN,\.S>FV7,1XM_X7XD5[4I N4Z\#*%!U>5"#%WC6+XXBIS%PA?UC)&S>KT
MRR>^GL6)[S", WF1O[L,9,#MDR/*R^,KI\"_$,];!1-[-)T4VV ?R9*T-"\*
M2U3M=U#>Y2%K;4]S.CP2E5UIIR1KX.EH]Y,\4@]Z[FJJ99R]/7*^XI0 -RGW
M@ \AUS;[/:[&I^,+?C,'C]/E-BWN#1^+LL71BP/=Z]I]V=5X!?VTX\H;@%"'
MT"2][?5!V@V K^O:S]?B!A!_6K/VI<1$FAW-#RZ8?800] C\KE2CV\_!?/$\
MN V.M[9H/#,3^=325:3U=C4KK.2BV\%S>/^D?4MF?W!(96P/8O0K9NK"+JIW
MKVP_XS)+OH%N(-$$97@_7\F'!@GI[,F_+AC%>0/169G)N19 D0=L </=PSJ*
MS'B1D^:5^?E23XOE0BM-JY6\N[Y/7(F=?["\G;:[T&SK7!3[C8GL5PKXIERT
MJR?\E[R]!C5=XT'[PI4+V\*LGIU_,Y/N7K'QV&;*0=D4RFM2$WDMAG?SO@:!
MHP&OWM;1D^BW#?E>DIBK,ZE^ZK8TS2OA'GA1*RM3GUW[&H?T4N'\$-@5(/HL
M2#9'I,#U_9%CX!4MVV))UJ/X,?O$]K5#8/!W8<*SK,/+I^+"E+@[HE/RL^/3
M*L?!FX:!O]FBY@ATG'59;)3T.N\2K'NE2BT#O%W-Y;E>B6QZAW)K$59"S*%0
M7SFX.ZZ8^\)$36\J+'M3^7HJ/HH(E3Y O#[C#7.QE)D-2/?B>(;5/X3&_[1
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MIPCI4L83R+V91U?M1/'B@<AC%3> ^>!KA-O5!'0A^/!=MUV5R]/X?FRD93%
M&NZL!DM"8(2MFX1M+0D=U1$!/.,'!WD=*1MC*H@OY\0"04D_RJR/=$ >]ZM0
MDD!(TJ('34"ZQ:FDV/09D-K[9ZN#7_.-[8E*K,W/LW\\M=#US7X1.9+ ,Z)3
M;>-S%AOA];$G9C5!B3HVU"%_-P7,JTOO=LSJRS:T=Y<RENJ]?ZGGZEZ\+(&S
M)7,$93SJ4= 7.Z7_D0#Z]""Y67Q&<&U:1%[56C\ S)%22<+42L0TQGO@J%+C
M%7OM.V7G%/TU;EBQ*PK*(<#ICOB_\#*^-,:0IWFY,)B!A'@'KT8&C <MX1'
MLT=+FE"R>4:=4R#RH9E_L"M.LYETXIWXIPC2[O<:L9<BQB9+"FV\+V\]VT-
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MC5.[=U)+K7*N!YV3@E" "^R54 *O&' ?)JCT/52$RY!>\E KE?!/Q3G_O36
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M620)9\B:S(UN% 1';&YP8<LF%3%_3F3F/;H%*+;W("4',A;QY%N<TJ'JS^I
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M?!$IA&AEV6_I.  ,74A=K^J."4-V%_$C&EQOELR1)_[-,ZMAFZ%PWQ73_A[
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MJ+BX+V92;H("U(E9B*#PH*=-=1.+2JS@FC2Y<I3G]2W'4%8/4WH](#A;?9"
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M987&>T6696B)"6BMUC*T>?'?AH-5-R$9F7,X@;?RD@\X-E D/(8;1.-1T1;
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M5% V;6UZ4GXQF&]\'&+6N!A'(%E3FGS.E:?]+9ODEPT -B#U<*&NF<A(X/#
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M$H4]FG>C ]/"JRX-ZNU]WT+Z"60FA;*[BUW\^(I.-[U:M,^^WK!64[(K*F1
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M/XR%)H&>PI!_"T986Y_G6HUS(FMG,M>7/J8=#*J"S[A[@LXW#Y42FH9$K1]
M8-^F!9L4\DM9/SU69 L(8,\A&N%\_I;OB)TBH-1J(+J:E0AED*#?=L%X8D\[
MQP*J;&RX\JY^35!W\-H25&JO)'SUNI/1J]=IUEO&;3W!UUA%@"XW@:<CJP=8
M8^9(%)Z)6)FI<28W<L#G6;-@36V] ;VN(<_,-AA\,&HG2,C9D9,!B.B>Y$7V
MB*EK&T M@^M,5-  #A#!R@T5-0&J#[+8>5*'U"N%(/IVL" I5=\TIR9DP9Y)
MJJYKD7%\+>>5U[T_BUGS.U@%20>N#$EO,*"Z&U@9!LT+#[B;-+^GTV9C"QNM
ML:,2X\[NHK!L'%L.3)E8JJL)H@$V#KYM<-:+5=X+@C.1CN:!HXZGFSEGG,-R
M7P+=]M9"@NBHW QV@<.70)Z6S6&S&P)9,@G=R'&6+2PS,_;UCX$OGW-_T^K;
MVR<B?WXH$SE$,'Z/R62):_1E^I4K5-NCO:2DC5NKSV47_LMIC88@XRO7-@HE
M(+IM/OL$OKX)'Q.D*/\C3A); W,L]RC0 !.@A:T5_&-2'M3+ ?8G8-\_!_,<
M7CNV3XI$?.F9V(5XH"C,BYC'8Z+9-]& 7./4!D)&?>1(!22.Z-1._J;56G@N
M=/S$W\\^4>YVH9:*$1,:T(3-??^MO34.@>JL_63^,*:']?TT17$#VD7L/F:V
M&"]5LF]F)GDF'DS?AH/7\4A<]8"V!-0V1#1JUSF^K#P&*5A/B%(>WS- OGW+
M=LM+EFS(#CG5G>* Y03,9F]8[P^BT XE][6*65GIN<AAMG[GGY8#T'<@R4UZ
M8'$S_)J:$@D=AK[=M; @X7-G\X8^ZOFGX1_F#N40R[Z%!"C]J@8D.P5F.)D4
MN8IP@;^K:\>[&;#LI/&FP'R_<AH?.T71V<B&+#4#'=@"GT,J,3SPC,+FCFPT
MVS?Y0Q;$L5IH8]C<%!9M=ZKR9#*YC$SPS=L0L>45):M4M6)JE?4"J0#G-/(W
MRQ)TPF"_=WL:\8HD^;K.L@,$^OH=>O[Y6GP^'-8XJIG-SSGBIKP=GU5\OIWA
M[H8&\$]L:BAT%,79$:&<'E46$Z6M&\SM/Q9(PA(^M6*8[9[TJ$,# HYU)Y5&
M3P@V,@>O2>1$!X=.M5 (#6,UTO"T%!=)*N(/EA8/I[P@27$HL!G3WPD(>HEL
MGTL<>053NTR6$. /3F+"4 $=%*R6'P/U3P(DI23TO^HG< [V2.4G1?),]I(<
M@83-OPS9A)Q6242O1_EC7*@%\(U<,_]@C6/B]71.ZX-8#3\7M#]-?XKENH#F
MT9[8\E9*=$E:++?#_>)M)Q\.;?V,_,>[#\E#(R>1 U(QH]M[T PQESH+8? B
M-I3YBH>J9)'3WA3"8KA-A5K3547WKM_H#2L:QC##"E&Y)!CWH:29:.OU+W6#
M+!S9,F/P./!?O]^%G.ANMV ,?5&2BP;TD8T,$OY@><^HN']$C#\"9AG[6GAT
MJR73%.5@8=9 _!8-&/$61@,BK-*IZ5I\K:Y[?+Y8R%?=]F LJ:3V^4XWMS6,
M*YL%D+'TRUQ'*>0JUZ8DZ[97EN,IR\I#$C5D\%(9KEV:C1L_&+GY.4B-@.Y^
MT4IXT$@2-5%P$C,1!MLH!:>IA61:#*-U[0.^G> X/>[,@;,J'\J)Z/DK[NE;
MO@U&"M*^Q;,@5]E#SG@!&<80-&I.Z?.\0W8E )<QA>O.>P^6MV]:9\H,+<M>
MZ7]X/B;Y32(,AE&3&M-'/6G8";$OOQA,?&*8K<LP"W)8D6%;HEW.0CERIE/3
MU_3=U-0^O':HJQ?1R[[-2.U\M ND3NZ_I@"P,?&R!I;X+>XH6A"]M+U'!*63
M>@1=S5 G3\,DU.U,@AO"M@^NVV!7Q1,&(32EXH-[KV$!;'*#REGRZ')9RD)?
M.6%.ZQPW))HK?AV+4]BAL0:9;1Q'P0:[GQN".8R_AJR%\A%M!K.;R1\^&HQZ
MQ;U?6/FQX7L@^15SG*QQO+S/2OT>'% 3(\OU+4_M72JM,*(BR>.GA+Z:#'-I
MJHJG>K&F.7E4GKW;TX\?X,I/J=(=P);7;=?QCZ^TP7SZ1@&K9'&M[I&MO)(>
MA7;(C=+ZAXK-&L?NPN8[;(P%9VP2P>MA_D07'!*>5]//PD!'+S1N[<K>(0.[
MM:-U-=U33-;,XTRF@H:'=K/UA?D(3]/9?!TWZ1G=E'@L/SJ%Z^=)^;O']\?T
MAH<I,ZAUG@E316!7ON$/:9>)OGF/U21/R8L);R!Z79/DFP[0@18WOX1Y/.7?
MU4:,K_Z!J"???[O4R'^=R6BC?2>SV2X7"'\$2XU@M@7+TS%=?JH+RH?>EW7F
MNXY9[S?[V8R:Z3%Q)]TZP?N."X3'($,*X1WJEKQ&@SZ5N<^3>>GX1CW*AM)\
MSX?4&,SG4UR2@YR60[3XYZ!QQBAF#?!;7 D^: M(P-S9OKF#[IE%K%1(EM*/
MU3]E88H&^']" ^(;T8#^0<'-P%$>;7WD\+3ME4_R,+LF1O$F&J![B$G8#/%*
MPG#A1P.$]BA\0\BEQTCF#IR"*-(^1:[B\G/F97;9,(4W\U>Q5HT%L[>E/BD^
MJ]^07R0[U39PG;N0B@__5>>/S\$3-G?ZGVHC,C2!:SE-Q>$W:,BM!36F&I\P
M-0HS[:J.%6I6#99^%N_1$B1I\E0J5R:YAZ>T)KLM4!R/UX=!>$>C)8]I,N#"
MNY0N0:V)H*GIFB."+BQ]E##-))CSF'=,??1 2Q;;5(G]-#<?DQ"'[AJVP:'W
M;&UA.L)3[0=KI=0$K*]&??-*YPG'O*J 8::SUHDCH1HIT5E"*0[CQN-9IIW^
M7L/#SJ8>LNUH@*&2TI7HAA#>W9;RZIK>X%=G97(R\)"=F'8CH2D%#-Y8NT;'
M_-SX_>-UE>R:Q'"[<#,&[DS%,[#?WZ_F('*;SO?9K+/S0M]&"K 5:>D$OORR
M0_30CNE_R7]=C_33SQR9V3 -+ KP2,?JJ/KW-=PWUBO-(D#^*8A#F^%^\4IP
MT <0[H^YO4%7-&64*:;9VW@GD^NA:Y=;8-O^5NH:J6J%+@&\?-,Z7 EZ%IN+
MPL5>2_>E;^B[1=8!CTMX7MALJ*Q(Q78N,/]&.8V?4LUS4.O/93K\ @U61Z3W
M;&D/4H 6O_XA&#BN'O[CFQO="*>5E5$?;]EK!W0T"8/"5>X(Y0W$6'%J!+[K
MD@$;/^^#L^D=ULFH*\,P\=EN8#?VA\ F_HVUI4.7>,?H:L2\]UCD7"G**6A;
M_)FTPXV&"1)[,IHZ\A6/G+K= 8N>,TL4@O9T:+7*RP24%Y>6QS=FG_E'9$J/
M0=D!NY]<VEWZI43EN4FYWQLOS?PS\>?/#0U:VYV-30@GTR/U/\E67NVX!N^-
M#@W?-86*K::&#>&SB1;3-I5"Z<EO(JP9KNEF"OQ)NOU_!RN7*?<?:E.#2QXT
MGF&^5I+KO=DV4;GVAO&I/_54.^?5#QKN':[F?S3VPE)*K@(C;1D[ON_3:H_:
MQ-'B[QHP:H@*F)DTP-" ]-QS66^V,C8_'-1'@D_BH%(H?].[5CS]#)?,LQU+
MRN5A6^$$;*P3L/X1J#='PF,-MXB-?ZPC[Z?+]!/^F6!S RO*.BA6]_H;;O*%
MAX'E-#0;Q_8\&L;MCNG<^;R@6I6&6NE/%A ?ZH'])"]M#)O.-GBGPALS5F'L
M]2>G3M+#*/#N:&E8STL;_2R3#U<>0:+WT::D)H5FD&/C^=/]$8G,:--4AT[+
M06G?Y1!\-""DY/+T?.0\5A6>-'9+.(*O5_+^E>VI(8G$?GF!F+=>6VJ.9X^V
MEW?^L0PMD UH@!\!TM9]NJ/V_?C \'BVO:#Z'W/'OA\-$("L"**:4-U#?>-M
MM**)\,G1/P4#?\(_#![OC: !)\EHP*#2I7KN&'+)/'\ATD;H#ZC#@:M]R'FY
M(;W#NS,6+_'1X]!WUY6Z[1?2DF]",7O*;*4^.HX&1E:6>)$*0UB/KNRQR'HT
M8/4.&C#4ALJ^#_55)I0U-^VIVF#(D,*]*9VH0F5;]:1B%&BI)NKO_:F\RB*C
M@BED'.O#O8E!M9?%5(3^81'<O_7L*74K>?46 _]ED?*8=8W'CPX;=^/1+F(%
M#(I4S_J[M!T?E?J +7!,,[9,'S/A.[ D[T8*&$;<G ^;IF9WOAI0MTR_9S$X
M061PINO%D\['*57VDJ2R3"=?^(C5.K='U!D'#6W=7CTUF-KTN#'[3?G?5K2A
MF;-REX2-D?V^SD,4^:WREKGG B:4:O%1;]]:SD6+Q+7@LC_GR '^;J Y^/PK
MY ?7Q8[$XZR&UU.4XQ@Q3N,99"IZL9FR_@DNE, ^V,=(&B7TVX>+&=V6G_+7
M#T@B5"P64/UO$BK=Y[D*)Z7INEV50M6<? V1?0RVUWBN=%N?,7 O!KAIA@9H
M4-MT,T;3NPMMN3@P*ZD=P<N=$?4JA'IXQ?OEOVM3<7%+T(+=M]1'M]'.Z#'!
M&&Y,\LU.L[_CYQT9>-G?\K/RU0?[%$E=JNP3B=XV2GP(*7O*^LV6UK]EH143
MOI.FL#M8W7-02.D):75U:F\>94@,'7?5DEE+,XDW1U_URV):V7XJ=6U,Y>\A
MM/R1,_9_M>+70NH)2*XGA<;FNV40>Y5J.XBIDL1*F% HKPLPR)1,-"K8TQO<
MZ9_ Z&#Z3L%48^'X87Y"+3YC:UQM#F8." UV5?E-5/H<37Z;NKN.9=K^8HI4
MG6%J)<TXIRX"+#(,6TJWE3O<-4F:00LZZJYS5N&Y:J)(81_4:19*$7(T=)"X
M#XVFKS]:<('T*&L?3S?L#%_#<9N8U_O12X>(<4"5)&! U_B!QFQ8>DIG0QPG
MV\704,RU.#G;U*^&;XQ)E5$A'6!>)2TI"4I0H "U? \9(98^2\;Z#<8,/ G'
M5I$:_E_Y4!_+R(]3E,D2C#?,^G+ L.%OF :0E1&)ZOTWJ>M@%' I F5R3+'+
MRS?^4COHWW_Z3TO7U=K/:0AQ*/7!M-8UB0@*21' N*MF;.1NOV1GI+2C?%U[
MZ6F88Y=W7=Z**'E&0><DALT)KFIYIV'7!_M&C/*$B7LAWG:DYTH8=+K/PX>9
M?S6>NQZQ. _PDKAMBW!5CV&<_=*FNLO1@OO.EM*>5C=)"^>'5[TJU-.Y\IWD
MPT8DC-8$.D_+:W_M4W7F]_?/WC+JC?ESA*KN33QFR?">2<]4CJ\>6G;X5 4>
M6L>K6\SWR%$QQ$IU "RE/JUF.%3/[<?D<@L^@M>V7 PJJ)!@NIIL-:T:?U#^
M18PM*7\11S;UVS)J[?21_41R!.V]Z?I?#@<+JV+ZGV'G&&W(3R#*18<.L$P)
MF#(F?R=?Y-4M\ +N!*S*88O\Z;H@PS<WV6Y,Q^.6E%'Z3KF(9'[[5K@5JE2>
M?62(E;9:]$:38Z>&G2N)PC"E<_*MOG9*/Y59"_6_8J/Y_\'#KO]Q3*8["0V@
M,$/1Y32\?_]IPQ8.+4?.="9$KY%B,)9>[7T-F:?TH$@*6E"HTP/?@JRXR7L8
M%S(]'! /I$"^F5KN6J,-;28:8'9Y,B/)._]YQPL-X,GW#10>1<S.N:;5UYI^
MO\7C=H]]1.[K3;7<-D8+R4,Z2KS2-,8P1"?"<-.7_7^Q]]91<7UKFG#A$MR"
M!7<+A1,*"G=W=PCN$" X! CN[NXNP0GN[AJD"! @:$*A0WYW[O2=[O[6]/JZ
M>U;/FOF+M4\=3KU[O_J<VN^SGS3-C'JQ;R%D[+87<*2+US)-[Z^_&]*7G2'_
MXG<SIQVM(Y&P$M+XLEQY6-O'PS(4:82&DQ;+1:3J[ 4U\K(K#D,J-3<SNK70
MK[)$" O'ZI:ZO,Y([FN/$WPMY;2(&-B.'G/_H80T,?^G?#2B,_0SY+-[7,.0
M.G+RN M=:?Y:P*TE&V-X4Y_ZE0+N>.*/*DV$:J'Y-TD^4^]E34$;P4SFN'Z:
M!D-,:';^2<#:W3P_?J4H0L] ZCE0/4\EIQXKC@1\74)!EL<)9HP>8WBDI862
MUM5PROX5F@RIA(CFOE<" H.4L2L<Z:U<-)$:ZD.'W)>)<=LC.V5P]?1#N_/>
M]5+W:F)*2X=]MKOI,H_+MGZGL4MRD8GXT5A)4ZUCKD.;)P7B>-[(WD-EA[.J
M&1)4CO@)56HOZ?9K6#C.JY^LTZ43+9>U!"ZPN:O<7-62NG3(+:::-Y68K*/V
MI2146@M,/Y25B#N )'-=#YR *<C 'I&C(VB.RS8:5UF:&IC>2T.P;[;%(S"#
M>'1[H%]$2^)(@U7\4HD;_:#^89@K!'=?HV^M]K"^C,%4G4+:HCKS$.M>_99+
MN<R;,P/N\M@?C6.$*I&=9.DATKV0,;[7_(T.NO75"GD_X3Z."KOJ*:YPIKY+
M'*MU!VZ=4?KHF"AH3H&#T9_I)S4^(@]XC'#Y0AE,6CJ$!A(>8+//6(S@8QJS
M$CG&,(>SK_#4.-Z24[,O:6K)(WIB.E4;5>Q_0LJ[F$#+'/=3Y&H[JW:ER:A)
MI4D=@_MDJ1M#5WA"[$%S>@G]1I;NK3)R<@E:X5<<-#SZ+NBM@(BI2U'<AG![
M+('N@SRIR7=![+3+&@L5NT(UL'%VY'@[@(ZJKAK4L9"+UD%'B6V2E2_O./5D
MJ.V80BALI/<9KJ!2 /^^@CG5++=D6G)DW.(%;K,Y%"2;D&K'CS0D#DHIA2<3
M42:Y*A'*-+,B&@BYVEA=PB+@E'0&F"@$_DQ!@66-X^V@^.=F+L1NLHO(7WF8
M:#5]--6II+*!?>)R."*7:,S3(3%3LK0]_\E&<O\:57"*(RZ6FRYQO6=<KL,!
M;!+,4:V>.!Q?K+>#F,-5H\X)VQ]%:VAV.=!M8*$CF]!7&$A?.H'6@+MG0:3[
MWA?J[&XY$AR<2@,(.54LNE01B2,2,:7#Z7H_CFMU6=TQ6^1$).X.MHI#$NE>
MY9N0UJ-D5CQ]!C [TN'3<8/')FR? :A%%E(O@L)'&EPNW*' 6N2!+4*/_;):
M.''V)V1GO<D3Z9:IK'<9\&54"5NIA-&;\6[W+>+$Y]#*W]A#S;S>N5+BO3R/
M=_ 6%DSZ>0*.C#V_U,_0T(B 5-09)!,W@WLJ;'MU% *!H3.FS?B9<C"CS=*7
MU3T.I\$U.F2JGXZB*S0\TOKZU^XQ1[&"5;*#9?1P*;$[&3]N')PT9Z'T-%3C
M=Q;_ _Z3HM'KX[W;?1_CX0'4=^\ABUL%G8=8CB*43 J" > 8W"3X]( $6V*6
M=JZ<I'')8BDGJ7!^NY> DL8SR=U3XQ>MI#9[S2>A"'J4]0'9&H5V\T<2[_[X
MV!31PI\/Y;!W(,BA"E1/IHQTJ2BS+RL=?ILB@JL0JA[;\E#?F<V?@^J?G';Y
M $,>(WP $TMH]BXTY\XME%'JM6'A6\1UF*8KB4OTI;H@==0RO]&X>*,X0%:%
MCK@V44!$ZT-C1_HJ)L*>F"9]I$OM*J62K*.NN:)Q#/L@?4CO(*:R-%C2''U=
M\]^5>VKU_V%K':=1;N[7H=%)^LPK2^V5VJ(.G'=9C;UHG3R<![G<K>FHKX4[
M84B(EYJ>TMTH>U<)SPN:<L<[NA3@ Y@8CXYQ4.X ]/ - <'L.)L?QG$/:5!2
MS693W<&*BB^6,"([LZ88RU;WE,4\VIX+ ,F,RO[EYJY0#0\$VS<^_-S^NUP/
M+K&$W+>!$3;$;AFV:<6J->^"TP'KQCRC7,^ %]->Q!#-H\J3E@8[H<OG'< $
MIJ%X=.W_B(9W28(-F<\@KO:'Y7 >H8FGT.&->VJ[T;IK+3RZ<C"L%=+XUESZ
MIES6@LCF=TO;XEGX/VP(_#8]ZT+K^F2P>:PJPX!:83!VQ<7"3^R&=%$B;P$#
M,@8::$FG2KOBC0^VWV/O8H::2XKJ9XJTV)<\NE[K[!P^&H5D>]TU[6_TC%;;
MR@]R#RZM*>A27_K_C:;*,1@L,9+B9?:#O(C^KK9T^G?R39OSWC$F9*NY1-&]
MCY6C8A/)-V_#]O=EWQ"0FY_[%?*O5_.F'_=#0LSL @&"F--D>HD30!IG? 2]
M^ -IO/PW@1/RKCNLV,F@<9%+_;5S5UQ)/EX"-&WRG#&/B55S;!>T<CH"#(MK
MQHO+ZZ,G#<^GSI9?+9H9T-@Q#J@;8W+<534L ;U#E[HGQ&F$?C3*PIK@#XW-
M2A.S">243PG>!V*N@_ZNWH:\S79^G7L.I%JPFSVFEN?WOGFA.WNM@+)VH#,,
M]TF9MEN'WR2_D1IC/TQ7VE]:_!=:6&(APW;0Z'1^J4.873MO_[$EOT/D%:1K
M<Z%.RO7(Q51#D,UMH^RVS1\MA@K ;?6)4^]?S3J$+UEGP:*K,U)WEF:VA%V0
M:%!H4/JVW1V.!SL5JY6&1(FEA^4GVP(_:C+^[O[E?0"_R@0<''O<CW>D:\QW
MKM689@OLO_[RV3H28?.YFW_L8N*&0A]([;)6'.-[]HIR?\C\V><_.GK=,I[(
M?Y6;G3N>P&(5\34U68:ZC>AS+#F)O)G#Y726Z96QK5<A3+DA_:XFX30YXHX%
MV>M,:+\H,?ZX>(_Q[/RCVB/&:F:,OD@W7=]?FP^FGP&,]GL).D1EYAJD@H'T
M\>1AVVGI4Y/\1%HI/VMN4-['G"(5%97=6F$\(EVA6H)Z 6KJ :0YX K)> 6J
MX78DXY[C4*X'3C,R164Q\X3KZ;%H,G[L,VW8G2^L_I8!Q+'9_FA]TVPQ0J+Y
MX(/HP:I!\T\:,)O()A3D[^9Z)+%#L"=!KWRN[;G[2?3>$:7W$7] WVPY<1YV
M/JBK&SL!M=*V9-E]-E*NK!8!V9P,.,K^/A]#.]-7L-1;'\\<O6)=J=_/R<>O
MU@M;A2Q'>V.B35T@./.3ZNF^-IHQGZ&YMF#2#>R&E<ZO#2<C8AB/= NV^I%+
MJV!O>S,W>A17+:R73!K LZ?XQ \3A]L7PWKT=M8-I7EX!W8IURH[V>\]/2/R
ME0S7&$O/VYJF])WDH(;/9JR]B0.N)!F!2:0%PLWI06E^MH,_Y!R:83L_*8FH
M=F2%8I0-#?H,[H\^=%9<)C$-Q_9JS]QL57!2$<%GPE=O&5R:;YE()E!%5'CF
MF$<?&8XYYXC@<Q2%2GR3+N,2E!)+:;3%-U_CA3PNU01)H):ME\?-%0X%X";)
M,43JI+WB[J'<M!HQ=ZH*KJ2L%C(.<!IF2!#_:OX,2,Y BTOTE+USB I0OZSE
M_E5Z<@LA*IZMI3Q,]3/U,M7S(CM/OMY, J! ?OFIG^XE#K+[,H:TT]R1QY^Y
M-]]0PRA?O^="@BP\$9DW(#=RPF!7^.EO'I694QH(EU^/TF#&PP'&4.&_2E_;
MT]ZDIR"/H"WFV\Q;L*Z0H[6H[A!,9"AI71X<0=ACZ,,1<DH#:FTNJOVB*@?Q
M[?CZZ1_:+ZO:S6L%DIFE0B,4O%@"<+^0^-#?61!9(I>TC<WY3RBQR#E2;^%T
M9S8$P("ZI\>R.UTFU)#FQG .OS8RML6M>S'99AK5A"K)(]K@;)2%!+<2>UR,
M*0ICOL)@/8++L^*PO?0&XJ.+;A-1**OUDI-F%?>WRY3\!'71%L\TFG;G6\@&
M>2X>*2X^UJ*)G^@&-Y>J^ND8% 4!>Q=<6%!VA=Q5>L;:M*((G4,0N_8SLU&\
M1N#H/<24A=P!^WMQ,G%QC(A_,6;]+W.1]D/Q2R[:?P9$Y5Y4'"#Z.? H6H$G
M?;GDXPWHG@%UPRL/<@]^#WR8XGN"!$]J1[NT*4<MY,;D)A>\Y_U9U_J?WD";
MGZZ&7Q *>$]SQ/@@RF?K0X&7BZ][1%\S7.6?4MURS!2T/E'.L]##QG9]S:&B
M#Z-*31-_C05&J[) "$]CT7IK9Y%"GM*:6D86D;R!1,.[ 5,ZG_:='=W2F#.6
MRIKCB&!ND./"A)H\[5MFU. H&W6C_.0+3'.\Z=GV59M[C/%K!5\>#8?-ZX^,
MZQFT*+;7"RKHE,1Q\U^]*)/?A;O4KXN3PL4>+6+X<NKRU"NN7$69-..QEWR8
MD3_ V!+'WG7<]5 <)27@,86D_,YE9$(ND9)9<Z:SV+E6(U]EP,X@FJ";D!9(
M9L4!P]WY4-?9HMH?/-^ ^P?1!$R\(L>B]'^K%?T@?/,"Q/;73<:O2WSBMS/\
M?QJ_K*?MW3IU6 +PTF16UH0RU11=:L)2SG:I\RE8:WYIYZ-3XJ%]SY[=\N[U
M6):5G=Y#=0-!2XE::]F]3U@?F'@O;54_S(/V^R-%Y!/ST]DWJ<EN\B6.!]7K
M^TP*CQ>W2?\M.K0DX/Y8@'1/.'Q3HA*BT_+%0=LN1[1-VRS;LRXQ%D]UXPFH
MLB@,_9DNQ-!NO_>J^+)Z.+6TA45M(4'D*"(!COGM^HJ]ZCLM,B"%5CC>]REB
MBX-J$):B"<9&$"'TXD2)3?B)R)"#"H5@B ;1H!+J(+>.T*C:75!E(T,?K9I\
M:KA%%$NT4%TF&]VY/-[">;06U/\:CN.URG1JJ7*T89+@.TN[<&#+I1V5SYZU
MZT?O>*6CS_I4;TO'PP8&4"^W:_5C. "KV!1(<E!KCP3D8<2R<F,E?&A"X7F-
M$+LA>\BR3Z1K 7W9C@Z2IIBNUE >:9(+"@<N OV\VRBW#+QR+9U@S^=S(A,0
M:!57/N+^<NEL$BU),Z]<G:9U0_B!(SZ- -8$X0!,-PE9U$J."^4B?46^5$B/
M%B0354TQKO.?]^:ZZ^-ES^,^^"*^1_6@$<S[FI[')&V2Y;\4J>:_6GLR^(.T
MQ;\_8MM@&@*7N@4Y_$@[5IURKO<F4VP/*BE=7W'CRT=DQQ)?ECV9?!G[YHE.
M@ VB9?[''H_T.XZ1CA%-6]:;B; *3H1?^P>EYU_C3@C>6_(>]'#H"^Y_,K?
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M"]\.,/ (*YNF_R$*RK7:LNR\S#)A,S%#!JDWJT<LS)#OI"4$Y%+-F-*.QNE
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M0^]AYQF0F*XNE'AA0B8]/6FO*:>"YUROO)'^)4,SJ?3'R Y!E E1T29/?I&
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MCWL7%G<]PU&G^C$!G%IS7=HMG"ZM034J_"\*@<0^9 L8Z=PQ7[GXE,56>.\
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M*#40QU_.U8Y.9YMQ'KV6[5E)K#84#!/WRDI+C"@?C[J,GZ;BI9;PM";FS$5
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MD4%J@+L'238YKBU7"/ER\7(!F&1,5J1N^2>8/G5F0 $7<RH1,2],?07@&[-
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MO5]LE?TE]QY_#M.05,N N]UL)][RA@S5I%IL]9/WL0)_^ %_:[C;M[<Z2.X
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MDL%DI@2$*X)M6&I ZTN/E-%&;:0W^D]1U!WZUCE6*M5&,R:/L<MVM)'W?12
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M&P,I._X@7V/4,,?,O>M?!W6F3O&\WC.AH"4L>.5]$?]9X87;EI7!S38&85I
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MOM?\AA+4_067>4$U*:%DQ8:JJ0::1]F[#PR8Z?IE6B>N."HB2@*,!/0Y4+C
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M.#_EB7R/L4_(LB$AI8H4[1&_PEHE,OC^C=79 C,Z^44G^A5%85JD%FS]P2I
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M[DBWDEWY@E')XKL]G>E2,,$@.X=T4Z<J G@'H*:&?[D5&O<ZM4V.#IGJOTT
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MTV9'C\/3[L.'K"J5M=]!H/7,K]&9M?$\C]1\1FZ='&H7B;0^^=FDEQUP?YH
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M<=X:OI.<H*5K$'W1F,^RP[>C(K\\I$Q=F&&'^:P_XTM($4ONVPZ!D17FK#O
MU/QM0M^6M]T= +?_5(12$BORKY'(_97E__](-/GC[UR?%K=N*VR"$UEP[168
M<M8* BH8DISPS_K< =+K$.\R0NZ;P+=S;'L'R!;EG[_-&0A/0X/3G_M3KV9>
MVJ#I8HO7\>5FE-S^W?P;+E"1F@Z\!:0W,UL>9_#0(QW5&7THC6C5( 5@O0W%
M6AHC\T+X0VL6 *B?Y1WQ[ 6/3X :UFHGE-G%SOM#?:S,FO#RQ6Y2Q7K..X
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M<1ZF8S V1&%"+L2P;,:]1Y4I'@5A)C#<BKCBJ#748XV[_9/UZ&=?QD(NDN\
MZ^PA P0"" 22PCGWAY?/EMA[J(2?@\[M?@AUGFT4SM9/5#V.FM\R)W^(H^<0
MR&+JO0N?NB&')C\T9M@1,I3;^W+%S7E>U<\_U[KC.]Y&1F_^#.3J/=D#?91
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MD8BG<OOU,C,F,1T1S8KJ*/T^26._;FR^S0@BNC) B(FBI2';HSO/LP6X,MH
M; R$<+WF*A".O>[E=;\#@&>,@DF3,W:P4S:&NZ]O+]3AU"=$XPTPK-71G-O[
M)$PK9$C^_M5NF>U^+;(YS2&7:]27P]Q(]9/["*!SQH6LB5-]09<7H8"^(S<L
M)) O*%(4;+[<[QTVEUP4P:NK69E] $?R[OP?]MXR+JJWWQ<>0"4$29&2[NX0
MI+N[!>EN44!@0)"&H5M"8NB2%D0E!F9 NA$D!J2$&4+  <[@7?]]W__G.?O%
M/OOL^_,Y+]>:65?\\ON[UKJ^EP/9\+ ^TY&=OMEFTGT1@5<6<]VBO[(0GR)U
MF^UP$"76SKJEF4(YZ\)2XG$^DE-&>8?E"C&J%Z\9/VT.'B_&BG"I/$IWC0A5
M '_&7BBNO:>O1*=A-K=WN+<@ 9)'E78H9AK*>&2HHS*[HM>$",6=!^/:D%]*
MG((]B5[5#-2-'#:1GJI?UA4LVFNNV:FND<%00Z0MS9_GL+CPJ/R_8UP#'"#@
M\6S$)D^%%%F<X_2P$UU&KLI,'96O-$74RJ[H2E5'8JXA1S6#?=#!FQH2X[@
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MI30K$S$8="\R# AC#\V/CL(4ER<TF'&<?:.Y/_1A4-AHH6<C/)68>".98Z=
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MF4@Q3I]=JVEI"@9I!C=2%U'3H?][*80769A\#>CSH0RQ(O--7X45&9@C:25
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M1Z4!BX;9HE*)7 -:[MY;C3"HG\P*2$E^.]^'I[,E(Z!1(UB*"-)Y&.R&,(#
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M&>H'F[AM'^'I4LT&S;[=*+Y'UJ>/I=9E@:MO8F6#XRE2YC(91'LN<1>7<;S
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MU\+F,.V3E7PX3N++$_20&/NH*I2!7N=%#?1GP70=^8:_WZVE?*BAA*OCS;X
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M-PER#8A3MNVNYFJZL1+9PT9PE(5)6Q,AQ?$:$+C#,=1RX2M2XL+!=7R-J-(
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MB6'566E5<>OUTY$M&_GF? EFR;C"H@=CVN.5YX PJ82^H4C&]WQL2!!*_4O
M?O@-4-UP6PLDJ7,DU7JHZZW.LOI.)Q>M8WZZ=A-GTMH4''2S:#699E%-0T$
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M+VO'2]SC[U(4*,N_$#]O86&.))?5).IKI%.P[G68OWKAP/OF=X[>B9U*;QT
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MF6KN[L;[#\S5(FW:0D0T]$^DBE'N?&R,GWC5H/M.Z]'O!CH!+\+#?W0<_"+
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M)<&3?J.E,T%Y"?*<8@%7'FOO4QI=3,;"<>.8BT;-K>J4 BJL;N9N,_$>'/'
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M7T;2,_9P-J=@ >4B^HQ'1&B].P#ENV594>0-)ZJ$TVF+/V*_^B4&UNW:VMZ
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M;TEN5M67"P=Y 9)^_IRS)9[KJ]=!V4_KUKEB&VZ_3TO<G?(YTK$A\:P4[."
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M$/G2Y>,,1Q"E)(3$HPQZP@\Q\PEBJ5&+#'W2(]OTC@' O]/V]O&Q>#8(#;&
M4L\ CP.0F4'M>;@ /4H]&V"##Z 8Z2Y W%><TY??<4TZ#<*O4K5.'Y!C=>T,
M1CA[%]D:,OE#_UD7N+;5PV+!^LO9IE+$C)/8\[' T$O# ** ,TAX$, H1HE'
M$<N\P,CA/).?L;W*,WM"G(NV\19U; S/V,OV?ISZ>?6'5<>'K>PGY0'V+%Z
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M20PMZD):(>&L0*09]8DK15I!LU\RTFX8<V=@HY7M+:>%7%->KA;L,W[DNN[
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MV_+G( B#5$K,/<_3/0ACG'D\PDF0I''NQ2%-03/71RE.G?6C'EF5I<*B:CE
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M/RKRZQO_^".P3:UG=^_-Z7[__OTO1?E4MR.\-^7F)*8\%!%.9!9APIHQN;'
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M0F4"ID)BD0M"9)*R2()FC@S0FMK"V]#L%75MR#>Y=TV9A,UTN2'\S%2!(U2
MKC07@%@VQAP4U6D/S..4WJ#=Y:#(QSM;#C]B>1_8^KJU&<'6?Y'B3HKWVQ[?
MNG?J1UD5SU1W5:T77L"EK\>;L8CJ&>YZAIR?<RQYE,>>)P-)C*+[EO1G]?P+
MG:E[WS"D?<A%QQ+2J<_JEUNF@#<&(.*&MX?I< 1&#O<@;)*=_[*%<,--VY+W
MHP&$\-N%'1"N;AI ZO/>.NR@>74#L5S&3D']K-O<E8V#O*Z+>JU/H4U*T\N'
M-IMIJQBO\\[E09<WJ[KIE_?IS[4LZZ;U;_GTT,TV6'@\8((QI;<"3C$AQ,-9
M+@-,_2P*69*2, -E'D["Y<3*;L<SVC%]@;9L*W._9?P"[=T-MLRC#??H]QW_
MJ"< \.(TS:LVTY]O_@)A6O8MWQU8)4^*K2/%/0V/LZKW26$^/ 2F)69?N+=S
MBV]S$(,LR)1=2G N$X*)K_Y(0VW"\I000;.4911:EO>:S,3*NKE(]6(ZT"3-
M$8S,E.3YD@.#B'"AK2K@3LODL+[M")'9J]=."WJL-FW@TW8;M)?.T+6 CCA+
MF"<X3IDN,(MBB=6]+%4;- Q(+&(OI*![V"L*$V_+ZTWV5Y/. ;0$7\-AM@W/
M$A*V _NI4 Z;3(]*XFC?O5Y_UBUW4KS#W7;Z@Y8NW(='6E3-T5NI7?RXJNGR
M.M=._L;'WV9K7Y5\^:2^OG?*<.M\_NTO;E;+@K^T?^Z2(W+B1Q'/*([3F.I6
M0R'6.:'8Y\13&S7+$PZK!77/X\2;?<>QODK?K5;BCV*Y;.M%=?QDV<1/;!KI
M3/&^#%W-;_L68-JH_P(JM&%7OXQ>_&K3P&?+--IQO?UERS+ZO?NOTVX>,T#K
MRB4^ 8?SNM*G@_B5"WY"4A9C5!1BJU+J05?*#GOY^"1O5YO15ODGG0;$&\L+
M4$(#6')B/=MQ@C:L(/'4S(+<=%C4LS5V_(P.:SL+O&$M.B%N,,WH&#+8M! X
M '8C00!TYIO[ 1=^;[B'Q>.6A4/;=I;OG^JBE'5]R?_Q5+3>F/K]2^]?3:;@
M(J(L4.87PUGLZ>+\S,,LC%+L9T%"DS1)N ?J9@1E8.KX?R_#>\,0ZG-TH0-6
MO1]TJ<E ?PL8=K-KVY1@ M,&G.,(+ZBQ!,-5F0R4_+S%+Y;@O"IIL5W'MG%(
MJ>M?*BF*]6:2)F>$IH'$/"6)4D@TQC3-8NS1R,LI\R,2@U(/7I.86N6</S9S
M !XSQ7&>T##5H&DU]70-M0G<1Z>%<=;[XQ6!F1M^G!+P=9>/DY^TJ!0[VN7Z
MH%B&>8&4E.>8<!E@PD2$4R8\+,*,Y'&<A30,C*O!# A.O3F?'AZT(W>DX?M-
MM7I6:DX=8[H4>-?^W=3W:PSO\':> C2@+^94'_RS*KA,D %4:3E&R*X2ZQ12
M%ZCAQ%'%%4#4P:HJDW7FJYP"2+57'05YSM*>DG?ZJ_!-/NH)3^7=KJE92H67
M$X(S3[=1R ."61!ZF,>ITHA,I)D$A;1.$9K\LM*015NZUB'GDT@9FCH.Y >:
M-#:BPZV6$;E<62>GR,QKA8P(^\K:&/N\W::]%']_JM=-E^+;U:5H)^K2I6ZJ
M>E5VG0^;*-Q573])H?_4B2VZ[JI>1&K[\H!0G&5";6Q&8K7%TT1705 9>SQC
M(7#6QCGL&'W]SQG"T42T4='1;.H>@5&ML] V4PZ3(VC747['E7;"[OAJNC?K
MSJD=:Q==9+WE[@)M^&L*+1TF1;N R9$^.HN56766"] .]9J3-6T3J=MX]64I
M#J-3QZ-5"T[C5/@)Q812I>8$9S@-B8=CW_>(\*3GAQXL21K(P=3Q_%U<V"9H
M#P?43*=-"A-,D?W<SW$X$D9_H\BZ-4+.DH6A]&=.!+:$YW62K^U"\!&WG\JU
MSAR6NI_D\JH4\L__1[XL L]/@BB-L>?3'.L24YP2R7 HO##DPA>YQTSGW!ZE
M,+&*:6FBCBAJJ")%UGSD[7%<AC6)$VEAF@(L*&@$[J P5G-PCZ\XVS#<08'Z
M$W&'/VAW$_BUK"1?W97%?S<SM+JQA?763W(CU95$]YQH]WU3U'7)>:4N)(N,
M>$GFDP G>21T$";%+$Y2=3M(0L+3,,D9J+_+&;Q,O'7;]J>TI;4K_M0GX>.&
M*=B%X1S<S:X.,Z$)4PU]IAH/\8:MB[[;>,O:YJ[1PMUQY^[NX  B1[>(<SB9
M]3[A ++#FX6+)>V4W_7Z7E;?I)ZZP]=/5=<<JU[0V.<\$ &F(O8QR3,?L\3W
M<2X%D8&?)3Z+((KM!)V)E59#%55]LC:>FU,@F6DA!Z+#-$PK]1Y%UQZ4$9D<
MJ8135&;=[B.B'F[EL8_;AE=TKL3W)];V5UY+\76UEO4F%215]_]4601!(#Q,
M@MS#F2 I]KD(DM2/HIQDL!C+ +5YLT(:PNB= A7]B_I^Q.T/_@7:3'H0/M/
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M)@D+<"K2$/MI2#TA)2,QR,]C1G;BS=4RH9VS?,.&;L+XAV:D2;ZAY0M:=;S
MSD5#6,W.2/=@P?;K#J</KW'J.CQ=C\$$/CQA4CLZ2 V)SGJHPH X/&"!3]MI
MD4UJ[8?5 ]-%X$HO?5B5.A:M#O1-\GCSX^TPZ(40F1<G:8QI((@ZE!..TRB@
M.,HRPB@5PHM "<86/$Q]O=Z25]JD1Q^F2FRP-=,K$R,&4S+;[.P>-Q>H!^$>
M0[V9]NXTSAEX.%(_-AS,JHO.@.A0,9VS%#REY:I=[U:GRRP+KO3@3;7B7U?K
M2[%Z7$MXJ9+Q@A,KF8X/M$DDV7#35#=HEJ1X4H_K7BFH8\T\;<8<M6&-,QE@
M4/\V&*L)ZIW 0%BEZ)A3F2U[!RQX/[$'_O#Y$\8^4][HG6_R@1:E^L:\7U75
MZ@_=RXH^JM^ID];CG*9I(C&CTE.&49[C+)4A3K+82X,X]P+/*,75COS$NN5+
M-ZF+MY.Z\HZ?"U1M.$)LPQ+B'4_V$\L,X#9U*DX%(M31N#?I[/,6ORTS:,L-
M^C"&WUEST,QAF&!&F@'Q-YN?9@[,T&PUP"IV:JDK.ZD_KZIO\E%]W^ZIG@6K
M+D\/J[(I\%YPZ2<^)Q&6>2HQX2+$C) 0BRB5-.5Y0#P&&T0R3M1H[YPS;F1'
M5V^DML=8]8)J7?  ],D80&BF7AS!8J52-K2;2J-]<%KZ[>@0=TK$7%A'BL.
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MEF*19$*=T$&(HYSKUA]!C-- A)@(/XQ(FI#< U7 GB8U\8G\L:@D7]MT]!A
MQVSKN)$9&O.HU_IT;*@V%^\-7:0).ZRH&!7.54'%:4+SUE.,"ORJG&+\">OA
M5FV'25E_DUP6SY0MY2(,N4\S7X]\])6]G*<>IK['L,^R+/'\T$_C"#C(ZC65
MB7=KUTUUK8FB:DL5/+OJ"#QF>_9LH6';==<]5LF[(WBQF4?E= ;5:<'<S9LZ
M0F/NV5*GQ3PR1VK@PY9=:MI:Z/IVU552G6R"L<C"D(7$CW'$=05&1!.U=;T
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M),@\RE*!/9HK2R?+&,[TJ(Y0!'G,"0F$!/4E/5A_8HUV0Q4X2IN)CBJP N4
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MA)++./!!(68+'B96!&U;;=:TU>8]GEQT/!_&UDPC3(P83%,<[4'>:U/^>\L
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M_55NOJW$OIN1Y<'-9JV1#7H[,;PR)QEM5^Z^?D%[5E##B_UAS@J<RX<[W[C
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M?VU&/POWZY0QWI&E87DAW%]\X%B/<>.@WPZ/@76;-#8.KCY'C'GF</K98N-
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M\$/L+7WZ?=WK_;$_^=CZB):KC/>MUL31]_5!*]@]?<\N)%!8I\.<S?J3G>H
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MC;7I#0/, BXQIZP0D<J8 E[00ZB/?1QN>)FA^X:;6D'H 3_ LS (6LMC\5B
M 4_('5:_]+ Z9*5KF:4-2L.-S].Q"PJ^#LH@VM.>F5U@>79\=EK$P><S096/
M*[I\3WD=R&OU(,[R+(WCV$QYYYA$DN$\2B*L5$&CHI 1L6M.-4!C=$.R-$>J
MKY)O3:IL'3PR3 !<D3/86'AJUTL,LP0[Z5!'\;*^6\L+<+*NE]O-G7HNOR=G
M:5B@0;?HS*/3.4##O!^X.A<^ZN;4O*.5:?MMAJ[4B2]?I.%:K]^DS71-?I(@
M4"$A.9:)3$W3$X*+- UPE,5Q)(5@+ )Y,W9D1[8^G^2F&\GW:++/#LJK@ U
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M0L4N7'"-K+!]XLU.P'>7!'1HQ75:"F]MMXZ6G[C%UFGAGK?3.O,Y;Y>@[20
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M-)S,T-# Q&9B\BTMQ0P9CM#[H<[-8*OC"H8GLP,F/ZG=<07GV/ XK^-F>4P
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MN4#?-!NP+= &2[O-R3-"L&UC#TY''AGZJ,< ^ML0.&#C#1#7DUFUH3BIP0-
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M9@S6U6;^;FM<EO9;$J4A"Z6@6.4LQ204*:8B#S'/LI#3F*9$1C9VX'CAD4U
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M[_'3;[W4G?(-SU;MV+R^!SOC, &Z,/O1!W:'WNP<QFOT1\W8.&D+5X+C:[Z
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ML\V.\?<6[/RA2;$%6LD3C2%FNR;4#7O(J \Z8'#65H:B/8^CMHUP@VN\CA)
M?EZZV80;?!9]*!P7=O#)/JZ6]W>R>C!=<][]X(NMT&3:(OQ?Z69;U2TF?ZE6
MZ_6<YC1.62 P8SPTH5DS7#@6F(I(J:)@(9?V?AJ \,@F\&YEHI$+S0_63S\@
MH3D">#(0!"T<NI%P@9FOCSLP#!LSM&,$=4TP]JS,4,W,2(@!_,&1D'/S$7TB
M"/,A'6 8]"LAZTWG:SI(>>!_NCSO8%[K26T;\_6Y6]WP?VW+2G:4/RS-#."Z
M/F4NF I%FF98AHG A$<"YZFY^4J$C..4BT):77H!:(YL5/=,H,T*T88-I+:F
MRJ!G:\L]0P #8HFJA;7UCQ7,T/9@NENAE@-4&P_# _HP)CX V^H?)S>SZ@,O
MF#F%23YH22V7FLZ(PF0[L)_ 1]V.\Y_DG[TNR=5JJ7_D34E?W3/YJ?EG[W(Q
MR662A@6.(^V7$EH$. ]XA"5+25PG&T4)Y/0.96!DHVK&VO!-4T%G:L473ZBL
MBWXTJHB*U:/)(J?[%M_K#5T*6@E@BT8P[';']3'!A%E=S0GJ=T(_X&76=$9_
M0G^T_Q[EEM,5#$]G;S#Y28_:KN <GZR=UX&9JW6UF=^5FX4THU!$^;T46[HP
M-R?U@"G3(O5;^7BW>J?9V#RU9?L\$U2Q0F$2$GV6YC3'C)( IW&1BB+CH<BL
M+)4#[;&/TX:;>MC@[6I=IY@ VR6XP#EL@48&"69\7/"Q-B]72#ID6?2R/:NB
M_VMO45PH3F),KH"BLR/7+.$[:WK]^NE7^H]5]69!U^N;'Z5VW_,HS?(\QE&4
M,TR21.&"BAQG:4%8FN9I&H(R)0&TQ[Z4&,H<7INIRS4[J.8'_6$X K9B@>!L
MY]V,A![,MG@%SF/R]5D(1L_!?D[Y)TG%/@N)?4;V^26\&Q_M1FT?MO6XS'Z!
MPYRP6&2F)C%A8:3=&,9Q'E*)%8U"07F:!)F )8#!F1@]#ZQ'%]$>86\FYQRZ
M5UN>:Q ;P0#-4!_*&QLH?1JA"VB,;XO.,?"SF*0+  $LTZ65W S48;/=HXF^
M?3KO?IC">SD/I4HR1F),@Y1CDB<)+N)86ZL@"5A!BS21H"D\4 9&]I.^2+'E
M]0FB7").J^K)A#-VV1R#H^)AQ@N,O)WI&A-/F.%ZUL'[2P?9;GKX##5==4J.
M=L#[LUNN4'BR6F#RD]HL5W".+9;S.O B\+8O!*1E=^^1D0T'K&5W7Y1AO;Y"
M"IBZ=JU2_+7O/L&V4X5W?YW)JKM/,-^O[#[U9WC;KR;,\<',A*#:^'V7;^F&
MME?F\UPJ&B<TPQ&),TSB.,0%RV(<A"))TXQR:5?)?8G0R(K1D$8]VF:\"^V2
M-NR[A V"-:Q$/B& :96K]*"F8C:B.?48&UQXLI9C-N+U.Y!9?=XA\^3+KL=F
MW1SP-]-'\^Y/O>C3W;>RVDBY[*HO6!$D!1&8"'-G6H0)SE/M(XLL2!C/>)YF
M5@69(*JC.\:[!J--._2:$10%80Q(H["&<%B?1P,&IMQG,&F80!T7+K4<UC@!
M$D[&P,LMY<07;K"T$ZC\@XDGUHM-EWH"E>\@^03\L%NXP72&_JQJ8OJT5_=5
M[;KA2Y71@,<X39((DT#_@Y(DQV&<DBABA1)<0>(*9RF-?5=K6JRO%#J@[-C=
M_CQ:=K$ +QC 3**C^."S_471/!WBS].9]+1^4=SC8_GE!QSSQ[;&"GQ6NV/_
M5WG?I#[^_^2]:X_<.)(N_%>$<X#=[H/B'ETHB=S]5+[U&L=M%VSW+!;](<%K
M6=-9F37*++=K?_U+4LI,Y4TB*4K5@Q?8[:DJ2XR+%*%@,.*),BYP65(!!$YC
M %&L#+C08.M%DE E,V.Y4V+P*J6I-_*&;E,1]JC3%[KJJR7M6/1U55=VYAM$
M V[F>Q#^D+W[,B2\>Z76D&"A2K*NTIFW]FI(W+,BJ\$;/'8O.US&/2+CE3E[
MBTR6E$G)04EUY;P0#. DX2#%)24\3\LXM4(?=Z(ZL5$?WN:E05I8MG0KX5($
M;JU"B]W+%(IQL_4]:&H7+?7ZV,TI].2P>YE"7WZ[EU!Z<]N]N,K?NWNQ7FR^
MW8NK?$>[%^>;/9&DJPVYOZ]UP8-Z871X94!LOA*Z% LA45)FK 0<20%@F:4
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M\S49IPPQF0*$2 $@$CD@*!:@0#&3.4I34D+[\9['BT_]-6NH12G(7090GBC
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MHY13Y^*UAN=D@BLE:1_TT]\-R< )AISP&+!<2 #+1 *<90)04<JT*,LX*:U
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M_PND7JCF_[K0UXO^>^X)4>'\FM3ULPH.;A]T ^ "0\&PS!&0"<JU42-]@IP
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M*4LH!ZPL"8 %B0$JI0 %YV6."B9A+JT;$"Z2F/S#G&&@J3ELBB^KPB(I,%I
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M[(&.9]RY?==[]&*W*QLGK9O7V0FJD5]4H%AWY#8 ,,&^^</"33# ;\Y88%C
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M4%&#&_%YPP<OQ9S%$7ZK>)P/=@$/]0'F>J7Q1U:B/3LJ\P26,:4@C[%R.(F
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M@7A1PI3%Q,HF+6A-GJW5-30-==/A8.A'A@&'JOT!??5;:& MN*9T.PJX/5:
M#Q+S@"8<FA;":<2O4V&<9MR:$^QD[>U(&%ABOC8$.UF.>@\L;QF7.+PC%?\H
MM@M9Q*2DDH%2L!3 N&" Q#0!A4RS,B:X9*E7TK!=?^I80D]C>E2D(KFN]1Q0
M0]LO1;C3B%MZT$-.S]2@IG03O?W!ED]<;Q6ZF$*[BVZB \K8+=M6W_M3IMYY
MQ!.I ^<0=ZN_2/[P1+1KN</3RT;F#=^O'I^VFP_BNU@F[<=! PV(F B E($J
MRZ0($)TJD#EB0DA<0DF]\H7GM":V4D,J2CP3@A=4XY@('">PF[D>, 8T-*FF
M>Q.U\@?\3#J(&#K]=X'2RZ3]KHM\-=W7<XOO="C%\VK;E(%\KC9_O'I^)5;L
MVP.I_S"S M*<<YS"%"2E,EW(\AR@7$(@I" ,I<J\$\=Y4/T$I]^['\A'FGZT
M)S\TB,!/@7:F'E(MSEM[;XUX3':R$S/8+*<!<C-/;[(3_GQ>D^5](U##=-5G
M+;Z)U:;Z+G1MV(/0**+OUK6H[E<-9!%[_EJK*)ZP-K WORT-5[?\[T\;,U)*
MA12?Y%?R8Y%#S JB\<5DB8#:W6@$HJ0 3!#,DR2C+'9R'-.P.;6[:3G20&4[
M)B*RY\(#H"S\@[)S4"^O?C>WUD"B'3$<-1Q'/VF>?[Z)6K:C_4/J,&Z21QW6
MHP/O-Y'BWG1ND1^!<=4FTV](0+;P3,Z/Y#:9HB]"P$U'S<_CWVXV8KM'-H08
MQI@D"<@%T8Y:"$"82 #EDK$$)D3"Q 4J[FAU)__JBPRWFUA!#&4WIWJL"SM?
MZ"VAFPMKR$R X7B1_T NXGCM62W[HEBG!GGYHI%U[I^DSN.]6Z[_W-S2C?K6
ML^T"910RA&.0EB@!$"(.<)['(!$IRG@F*2N<LA]]Q"8_5=G5B:NOGLE8&NIJ
M=]#2]RV*OZ0W.Q,,I0W7TQ5O1?A7T/=(&+J>_A*IEZFN[Q'Z:JU]WSU^!JYG
MIY@A*CM<%(;4%Q%)9<DZ&9+&!&#"&,AI1LN")SD45@-KKZP_L1F;"4+-,"&_
M$L=3==B9Z@@AW:S313YG<[PB12 +/%U]5J.[(MJIG5V[S/<83X?!:LVVAKF=
M:-1,HWZJ5O?M.=!Z=?@T0"@QQ$(J_5$(H$00T(*6Z@LK,T*00,CUJ,^9AXE-
MM-VAZJEK;0>!Y8C7,6JU/2^<5%FN9XI&3]KB6W:BGUJ&U,;^P%-T8&J2C_0(
MI00[<G3G8.9C26\5G1]=^B_EB;)^CJ)8Z6%KC\WXTLTG>5=7*U8]DN7[E897
M_*H>JUB4&)4XERF(TTPYJI1@0%*U <@8Y"D6I,#"*??IQ\;$ODJ]BJ4C$+N?
M-NW\T_0Z<G-1 \BHAGI Z/91TH>"=/=C8EZH]U&*.H. '[>:GU,ZP&$_T&IE
M_-U=O7ZG1U._7YD)U>:@2'P7JR?Q2=ZR?SQ5BNH7Q8@POS33(-^H;=,MVSZ1
MY2*&>9ZFL 1%J5%N<N6O,([5OB81!>0D2RBQFN$T&8<3N[(]<CL[,'P3U0U_
M>J]/6@ZCC6:Q^;7A,>**R1OU%\VFFSL,_QSM/.6+/ATW)]J!U.\\&,5M9-B-
M.OS>1)\/S^OV^'EUN([>F.=UV_^\G/WO9#H-Y)K#\S>KUYY,O:<.?3I"?KY>
M?UC>KU0L^W0 $2EPPFB!8I P#0'*,@YHQCD@F*<0%4F,W<;L7J Q=4*9?1/\
M:6E,U<1)VUV<%!T8\1RR>TEC=GYQI!X<4\FG*OCJI0)G1]4C9"!7<XG"K,ZB
M1\13<^^[U/-,Z!NIQ2NR:89PJEUJ<X1;U^KAFRSUJ^?#)7=-F&@JY)MZ^<TO
MZD(]U[M)M?V7J.Z_;06__:XVMO?"_*/V+?N"P(4@:C\I" .,I*D*W0H*$%>A
M6YR7O(0YC5&*%^INNK8^:)I7 A<3Z\IA;6D[#B+2L!!)7>'ZW4S1^NFW+V^B
M1U%'&RW1SX['6#,_:LN3L;_NXW/TD)I+8-B,NJ)$'5DBJO$?#]>U\C2]/3=M
MM\]&SR?60D75JCT@N(GV;T4K67.)B0X[8]8"'N>]S&,)=4(X,_?S'CJ^S*,Y
M.\=\(3;&#([X(EB;\_BO:OMM_;3]+ BOEL]OA([H5 "M/JA[BK</NM%\D8@T
M+5@F0)%(#&#!=(,(02I\E4E:Y R3S"G9X,W)Q$&NB>4V>[9NU/>'5$O-A^GU
MVI"EVH>RIX<G7>7U743$,!41_IVHUY9'3RNN/TQ/]#"!A=RKO88)#'V&6/@\
M++MOSBR/P.WKT0[#./ 4_=DP%;5<15VVHF[72\-:Z*$9([03=+"&#Q\O,'QC
MA+HN#^@8LZ O!O)_B>7R_ZW6?ZZ^"+)9KP1_O]D\B7J!2Y(*IF<)QLC4QI>
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M*%><Y1#0HDP DV4:)XDD$I/%=KTE2SM7W$?,R;WN23H$!NJ6B+<,Z&$PT?)
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M;S:W=;513+TQ$,A-:*8N_"2_DA^+LHAS2',(,,HD@&I3#D@N&<A$2>,X*;E
MPOD =R)F)_:!GU7L:Y[D#FZI%MNJ_8TV?$=KNJSN30S@<RX\U4.$I$P+GL9
MEC%6'Z<R SC3,;**B%E!LP3F<O%=U'3]S_88NTS__^!!.E0&_ 4>CD])P1';
M43MF]"?-U,\W42M U$I@:GEO(LUU>TG4<AXUK+=IDIN(2&7O&G0H<#G"Q$H.
M6<<P%:OS%T!,K/2+E1-3TQSQY?_RM.+U<Z>TXZ/295N1"T69$H)*(!%3CC^3
M%"#,4H"+6) 4I@4LG0X7APC.4GNU6J_ Z/+E0=4YN-I "O%QEPWI8RBU _7
MWLY"SI >JX_<_%['0OB+GL/F/C_K?_6DW(K8;)1OHM6JB57:P3]EPE"FRZ2E
MGB,"-:0M,EC8DLHD2S4@H1.ZP752$UO\CG#$.I3=++U'37E"*2Z8BHNQVM+
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M5!M\G0!HH!Y#;_4#/LI ._Z7>4#A-_X;VYW_*:3C3;03*FJEVB<'(B/7C&F
M\ ]CKFQ 0,[_6DF!\(_$.3<P 0M_-23B=^M:BFJKX95;+%N:%23)4 H8)#F
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M@95@41^7.-V#B/U29NR9X::=W'L!H]5-Q.H_54A\D(,HSGD/6KK*A%$0A/:
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M@JF,-]OEAA.*97+@K-Z'!U!**(A:<F!1><6<3$FTCFRW4]/-_('3@:F1W'N
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M0=F)5-,#T'U"$L]EFE].R3"_6[[T67"REL9;NJIGF^K#WM3TS:S.;W@SOKS
MI3P&3@NC=$I +).HG2G@9,D021KT6XRU;VYP"CZZ+7\X"9 [5W??(+_<M!1
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MG][\[>S]ZS>?/K_Y?_]X]^5_M\RW;OCZ*=.M#S'3/MNZHZ%]<$J8& ,PA8+
MR#3$0K_D4H2$!"C-?..-O!=AQX_,6"WRI;Y)&+@4-+-D;0,SY(JP2#_SUD!.
MCGNG3#;-VP3<IJ WN=1&6+@_->-@>?? ];NF?BF1:F4GXUI-^^+'<#:(-E"
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M(1T3K1LT/X:^[J>F/*TK<@JU'0O*+VW]Y0=97!X<)$AAHO)@O+*UFZ( ET0
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M;K6@3@8=KVHEA[Z02VX"!!\3.*E\]CFP$%N;GX=H.KX08O/W-[8L<C+045V
M.6):9<7 "U';.AK-O:-0)[7..#V"O*[+'AIBYWZUPVF4U%/[\_DRSO"_+NE+
M;[[C@=V([WVCC8^TB[!FCM#M16Z&L2E9Y]4F\!AJ WSM('HLD*0*TM7KZ>;O
M4+;1<G1^^\YWUXY/&Z0114!&F^KQ&>D@M;FRF[Q#:3)O7=6QE9BN79H&.+B7
MRVXB^-[:C7W& 5_-23W,JCQJA:>;<;R9J=//.D:9K"//%HSRM0 Y!_!%1E#)
MT4'$LDG-*[5/-^OXUGSQQ<=_KC7X]U)[:PMHVG]UA#B#4!CY]9DV@%")V]*:
MTUWT=)Y@:H&(^Z]:&BF@F8$Z'$Q_S/"LO)G-AQ?DNLT&+''ROT( 6SQ1;S29
M;Y4L>..=TSFA;_YZXS8%>P%&/#/ '"'D'D#D>J+(67D['(=Q&M;JB>L&'\L-
M,'#*HY E0,$ZA]'D4ONOT7'O.48F9&K?S&8OPO8"E'QF@&JODA[@;--8K14G
M,H7(A;9@>/4E&3E\7@4$F404AOX_BM:S@[93LQ>BU#-#5"/A]P!&;R=3)!_T
MU>+-?+J=Y1CGQ2]'Z_RMCW,4.7H?H7A7V]8ZBBVX]V LYSHHC'2BMS9AAQ*[
M%PCU,P/ATZBN!QA]8+KQ7>X25ZD$H\%994!E[\"GDB G1SM11%UXZX[4CZ-P
M+S2:9X;&$RJI!Q#<5M]\+YY10CH6-6BIZS@3RR$J%& Q<$>.;.T(USR@W(NT
MO4!GGQGH3J&6/J MS+[6#A#TG_H*YGL8W?BI:[5DF'4,J$#[+$ )CQ",E<!0
MH]0E:<3FR8M]"-L+:>ZY(:VY2GJ LYOA<'<9B<5IPX6BH-LX4'7N7$A"@F:8
M%"\L8SC=F+]#\.2?&9[:B+X'&+J9)']_-T03-%E<,+K4M^":K*XT&8H4RIE@
MF+:M#=1V:O;+K;)G!J-&TN\!CK8.<[O+5XG2%4E"*L0'"2D*B,0+;9><<S*B
M,-&Z7F-?VO;#V'-+X)]$,SU W+)YZK)GZCU6"IG9Q%,=WY7)8:Q59>@42/1&
M)%F(G-8WUCO(V0]7SRW/WTK^/8#2CH%/=W]]G284)07#B2.N:^=P!.]T@N1,
ME RMUJ+U,/M'$[D?[)[;;<!I==4#,+Z[^!:&TVJ@SZ:OA[-ODUD8G94Z0N/]
M\#OF*U;3Z+).>-[,\]W]*!@&60('86H+59DM!%9\;9JA5="6=-&\+TM[-O8#
M]'.[C.A:WSV ?)T+<R_#Z!AS11N@XZ(FN4L=JY<1K.=>>\D"_6ECR&X@8S_(
M/;>KAV/EW0O(7(^ZN<N)53$G&2GDIDU X(\(49A"'HB)3'FFD+>.6[=3LQ^
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M#%GX0*$.2[4,3T-F10DIZEMMW[Q0\F&Z&CX26:VP62=W]Q4SZ+1# 5C?%JA
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M\ZE0.] U;;AY?'3LG.8X4%2=EM'\,EN%KU^7=6S0>K'N9@+WD$7 3W]BDU7
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MV-UOF";0VAHA[9AXN-)9G(?3-IW/#[WFE4?KTURN.#LG32J"0!V!\TR'2B:
M2S6V*!E&Z]!GL]-L^7UZH'<A;)H8[E@JI[TL!FB<\U$4S>]X?L*#*SP2BZ*4
MGIYE@\0=Q8&)R*0OVHJ[T\%V5S/T^=.$=H^E9/9E8#,5\\+C'%OW^#,N?\S2
MQF.^_,1/VT_\>/6)&_)>4MQCT %?9!RDG4B/'!?1*H9@@H#"L@$EB@#Z@:?K
M7'P4)?(H6H]9.E*UZ&XO&%."E>3))N*I[F>*"0+Y8\"5R=D[3@JQ=&M-3!YB
MV0<]AUD8^\AGZM3QNWE:8ECA+WCYO^_FNYU1^D1/<F:0K:<SFF2A%MY"R/0F
M>Y^*];OY.@<2,&WN<$RL'4TL+Q1Z'W&9ZE&=](9%%T&X.K]>U.*[(!3H+)C)
M7 91=BMG&D;'M*UFO0+Q$"%U$$)\Z&SO-[;3S^T=<\BCS'02[>MT<_H38J8_
MM#,N6@S<N6,\OW?IFG;8RU2O[R#I=!)0?/R.K6X>=77OK!A$YHYKP"1KYVCF
MX$,=NQ^E29[NF1-BH I\FH)I)[],J/P:"J9[$#YXW1Y2]BPF[25=/6,UG;K4
M)5A2<3#(I<RA).%:VH1/T;(3,,U?$)BC"&MJ2_%5_E$S2=M@Q.]X3KA_]37,
MYJOS;13C@5C?"?%/B-J0H5F==:E$771.=H@QAN6",>H=BY\/)& G%-H7B\)C
MB&7"%,]E"/E;G1/R;G[H6;7(Z_' P$R--6OMP;O$R#731G+EA<4=E^8-(V0G
M*+H7"\5CBFGP@]T2F;-#C[Q]!\@V9D'*!*AE38?% #YI ;YHGC7G@J<=D]9-
MZ-D)I_Z%X_2H0OOWKM3]/2R71.J/%U"#>X_4%Y15>IK-1\X/98DZ!HZ;^9M)
M.HC):\@B.6M('>OFM8)'R@]MON83UH:GNL<%EV6Q/*NJY$,\G5UV$OSZYW=,
M]9V9G=&_\J%\II^N2EB/Y]Y,G$K1"AD8))U\'9R1("C!0%JE<Y#,N=1ZK'4;
MRE]&AFD?_#W2MW%,"7<0=QU\ZL_G87G^"UE7Z]$.)D23O"G >!6 U?5Y5A)8
M5"6EX*4UK8>!M3U!%S@_*@9;7X/# ?%7N [OKWK(%+,Z"$O*1T4-*AMR;&KI
M4_ F,HT^NN9MG^VH[R+)^Z*OP6% F#K>MV[(?G]M7;XZJV8G.4N5H5\67[[-
MEODCW6_ZU=O%\A/.SN+%<E5_67DQ7^'J).04BO <G%D/U>26G+.,$+/VS MI
M>?0[N;7#:7GAROQ "-UKL#^>/*>&[Z'%&\8YX5(R((LBKQZKII!%$'^3%:Y(
M[:7:";,ON:9F4J >0W+]HO.9I"83)I@D/+U<)=!#%@TXH02Y-:XH.FZQ;K>)
M4:-FF\<NM>D4GPUEUTE">FA(W\AH SH)+DL!RD4/3D4&.F24G.D@Q6X3[8Z1
M>1F[+F=2U!Y3DD/!.VY3V!NB9G;^GEZ.C6%S$I&A"*FF#NJT[8AU&Y%W9-<X
M(11ZWGX$\.[4=5'>,Q5T1Q;F2PDSG&@DIBDAZ;J)NC"4KW-= >HV7*^L0M9\
MLOY.A'51XC,U.-N+\*7@<I,*#5_Q1!;,R?A0YQ;5P6\V@-/9@(DJ>:ZB<;QU
M0>Z>)'91"/0BL'J@6%\*:I_B,OT'LT7F)\9F[FQ)8*.N/1R.WI,B S AG?5"
M:*>[RUYL:.^BRNA%X+PU$'JM\MA. 5D1"ZX-)EP-*<=X[C.;U$WL17BC H?[
M\U'(1[I**P?KM&4$AZPRN4&!D1N4" XR6,FML4'+UEG[)PDZSKR>3XO34Q+!
M'V&93V2R1:O"(.N:QN,V0HPB@C1"D<F-5BG>F@/[$CEMM+\=@@Z;YW.HM#IX
MOW<<6(3HG?990ZJ.GJH5]/0#TM%T)FD(/EXWOX7MQD>-![QQX7'8<*E]9'4P
M K^O7^MUO<$1<?C?R]DY?BAE=5*T5TYH!D:B!(4.:^FR!):,#IIGDUWK4;M[
MDCAM7JE'9!XFO4ECFY<='_=.<C\(QI0-**T #(),9T-&M"-#%ASY;,0XQ=..
MBT5V^+)I,T+'0=8HC)\Z"?D4Z^A'./LZOTQ=I9]?EF&^.KT4:O[GQ>I\G3PX
MT4*JB,D"<YI.:UF=2RDX2)^3\*JDF'>;@C68E&D3/,<$X5&%]G),0N$U=RIF
M\+)84"F1#@\FUM6F6=O Z(]IW))I\S<]/KQ[R6J@2?CK/(\65WE]L9K-<;5Z
MLSB+L_GZTZY[,/[OFT^OTO]<S%:S^O,!D98#OJ5%[&7HX1I%8QXBX]J5%G6<
M3B*H^LCIL?4!0B3%9B(RD3A&&W=:M[G//.HGZ!FJZ:Y7EF^_Y0:35Z]_WOBG
MRZI6D;+33C%(4M<MK$6!,R)!8#P$K4M)V#IOO2^-TSK$S=!S5]&-*JH.'MT'
M3K6NX?>"<VV9A*1,J NY-.GP@&!+(4?)>\E"Z\#+(Z1,"ZQQY7]W.'P#872*
MJ?K7)>)V>9@O9'20*2JT);O $:>\MAY,0&>R-"G:UOKL6:+Z4&"#1+\#G Z7
MP]1.+)DBG__/J[\M%Q??-TOCHG8ERQ1 6%LG"^M8Z]4%F,*--<2;S'>;]G#O
MH_O#P@"Y+9HQL4_=<IU'+C7$[.B>1&5)]YI EX5E 8[7N=4A!AW\^&KE?1\-
M55._7(>)I2.(W; EWQ#'9B2N]3^LHRV7E/&3G%3)RAJ0R"O3HH'(M(1H%%K)
M6>%WR_3'\$P>I:\[178@*AZ!6W,1=0"_;<'VE\5&Z6\/B[6&^T-Y$U;?-K_)
M)REYGJP7D)4@[>T5!^^$!>%]#"F@\;(U_/:A;UH-.!K\1A-1W_"[7!GC'6:%
M D'7V@857%T9DQQDJZUS#&5"/![D)MS4,R7,]A=%!]"Z>2WJ6(\;##N1=">"
M2@BDC>DHKC (* Q8+>H:/BR)M59D3Y S;9)I-$"U$D '6'K  MCLL5G2B>9?
MMV-CZ*\X3U==T)\P+;[.9_]+>IEYHU%P!W15=.US8A"=Y*"#XPJ)N<CM^);;
M?D1/FV(ZICDWHC [0._?%HO\Q^ST]"08AEZI5&>C8+5-B6ZM#&@11,R:N^);
MJ[WM=T_;T3,:E@YB;0>0>. .7./[72:6SLJL^NF;F[%1XZ_F^>:HA]7JXHS^
M=1+D_.MLO594&NL+&@?!JIIX39F\>NG!H#&<6\<UMNYO&.DHT[;U'%/Y'5WP
M?>+_XW+QMK9RO)NO.SHN.;/N]OA0M@'1S[-YPILIZCJ$*IU?A-,3H0U)I8Z#
M4U+1F\ ">.2UR"'3WP5/(;5> ]G\$-.V^!P3\T<4]HM!^Z]A65N:5A^6M?)P
M)SXD5Z1C6@$KGEX]%@6$HC*DS#@91"$+>01UW^0LTPXGGAC[(XN^HRMP,RNQ
M9<3FYI-3&@MF5,!]J;$SD<")3%8^<E-2B4;%L:+K3Y"U6U"=O5ADMI)(YR#[
M'<_?S=/B#.L-.PD\<"5KTZG1=#!D"6(HZRDHW*.4!KD^(M1N$;<;X%YN&J>M
M=#IMSGVRSO+O%V=A_G:V7)T?H9;TR2\;O:1T]Z,>H[(T>@PLA PQ2ZQ%T!X"
MCX:>3Y]MU$J$YMM=NZHLU606>$[WU894*TF"OQQ5%C)CBJ&T*K3N9_L+59;N
M@Y[!E:7[B*K/IW==T1:=2TD2SY26X7)ZHP]&D;LF4$06BL"Q;MS+KBS=2_X[
M5I;N(XQ.,76[,DX$5A+W'B(R8E*Q"H)WB@P%;VS 8KT=*ZOSPBI+]Q+]WI6E
M^\AAZLK2:XN$+,Y-6:31//I22RI9(A8Q'HD[I..U=5)GDS.6W>99/O#A_>%A
M@.P6#1G9IX:Y]G6X59Z;K* $78.,V4),&<%A73K*BHSB".&(*WI>6'UIX_?K
M,+%T!+&=BA?1%_21T5TTCJZ/JQ,+(MW*A$9XY731S:?M_47J2_="Q9#ZTGU$
MU '\]BI>C-'[1-X,,%MCRM+:NEI9 5I>Z!K[PECK-K"_2'WI$/B-)J*^X7=9
MU,A82C'1*8RL18V9K>=/2Y!([X-C6OK4NM?W!=>7C@2S_471 ;2>*F],.?&U
M!<I<)#YQ52#RV@BL2LA:E&!$\\G?+[*^= B@6@F@ RP]; %<5B">W[(%KK8_
MG%A6= DJ@%=(FMAD!SXQ<IZ*9'44H,+<NC+^ #([KB%M;[*U$U@'F+PJ;;39
M(,_DD4<3':A4G:BH/?U!#[_E$:UI#;074#4Z!#T'L;8#2(Q5/,B3#39Q#UE+
M22]_9N SEQ!$5,$EXUCSZ;?_?E6CC=7=T07_$A/MKV>+<SP]0I+]T2\:/<&^
MVQ&/D5S/GA&63)VT8SD!O"YJ8]:!BYJA*3HSTSJYW%5RW<;,M&8)BA5TF402
MY#\Y#T8%SIR39&6T?J?_0LGU?= S.+F^CZ@Z>O?O)O5TU&2C& U,8R#U+0M9
M+I*!C<6XR!D/;*P;][*3ZWO)?\?D^C["Z!13=\;.V)2"E0DX7W?9I5!3Q@&T
MM4RBXMYX>01TO8#D^EZBWW]LTQYRF#JY?FF-?"*Q$ W?WK]_L\D+NV)93G5@
M<K""+AP+=.&\ 2.*BHIY9)X]9X ]]07]X6* #!>-&=JGMKGVC(1U@5O,X,D#
M!U68IK-H!S'$:*3*WJ6Q(FE_@41[X[?L,+%T +%G\QN)HRZ6%]"ZUJXGH2&@
MMR $RS$E*2UKW2'8)-4T34)]+^GOFVK:1Q0'0^L'+N/B",FF[&WA*FG 4FKK
MN640HTM@:[)#^,)S#)TEFZ9)D@^!5"L!=*"HQ@KF%8MT<6($DR)=*F4D^.)=
M7?%H3*K]X>FO%,6=)@,_!,,]"+X#_%]E7UB@Z[F>U%%R7>GL,CA,!7)*6ON@
M2_*Q,6#W2FQ-DY(?@K"#6/L2 _L?/[TZ0E3_X6\9/:2_P^&.$<_7F*U5Y%A@
MS5JI&.NLX%IYQD.T*DA"T1&&"TP7S\?H-).23FWK1;2.'"LI'1@9.6?))OKM
M?^+Y+= S.)Z_CZ@Z> $?BR,:3DZ0RA*"K>G8Z"0X38Q#P;C32:*-QXBXOKQX
M_E[RWS&>OX\P.L74[1BD]BX'(3B@JBU@7GCP=><[XUY(*9(1^)]X_OZBWSN>
MOX\<IH[GDRGR=PRGY]\^IQG6C=W7K5Z<><^U2E"T8N1UFPS!,P3RQED*-J/*
MNX7T'_^._M Q0)*+]FSM4^U<NS*)15Z<UX#H"JEES\&35U/_IAUG@3'SGPT-
MQWK4#A-+!Q![-Z?/PM7Y9A?K[XOYXONZN'?^]<1EK67=QBJ$IQO(L4#0H8 )
M+EAMC+.R=</<$^1TIZ\.E/EB' &\Q$##AWD*B=A_A&C#$U\U>LAAUV,>(^Z
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M?#Y(R,OO5&N#MN%2ZK3XYMW\!Z[.+V/_#<IOGOJX%@4X.Y/;J 3GQO=5T1/
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MZQS.PQX$?U5$(9UBA4.06H#R7($O4D NFF%./NJXTWJ>740_Y3LR0%AWQ7T
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M(*TS+;PV/KFBV5;Y6,\IA+J38K<*H>XBY0["::]?3>J(,6>"@LPM+9<09>W
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M&B@FU1&AQ9/;BPD,DN245:CB8'.'[J&GAS/M<)UO!:4]%- %F.BS9N'L _[
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M3*1]U/(S*6N#1@Y&![ZNJ@I,T@*/3FC&D%9&ZUJ@YU++SY0*(<0$TE?WV+,
M3NI<&S<)$7W67C1/^_UW+?^.F!VNEG\7]7?@==TN\8V<,YY$A,SKE'+)B7@O
M+$0K;"P!56:M8Q;/LI9_)Q \6LN_BT8Z@-/^@GNDQ%>I5+P)&FI#87+SBH6@
MLP$T/%F&V40\NL=^XK7\.\'J&+7\N^BX YQ?=0"[SH&_K!MGW&8I#&CI1+U+
MMK3TO0;C? XN,*]8Z]2%!XGI/-E@<)P\U+;M(*5U@+X&+GL.*2$+"8Q'XM@[
M"5Z2WUZGC :;G<K]E#J_>6[%_H>8!T?6_2FC?9N$@]6+OY-[<3TP)T3)-$<+
MS&H+M/(5>$YGH]-2.1YJ!GQO%P0[LMCYN= 8P8/6;[:%TVG<E#\DH"N>;\2Y
MZ 3_&YY_G>?YV?S+SRM?73N90]:ZEI+4[JO:02@J0/2&&5_H1&?=K+'MV3K1
M1+*1U]5 L#GED^L^D5S>;_Q]?D8?<S8]__F!]IF)-*5(C@&D-@GJ4 82B39
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M09*IN%F'TM(9P6MA'O+LT]"GZYA1<\^2\M+0CA BL:^B E^X!\=ET226F/V
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M(>U+3M/7E*ZW+XO/(:HE"G92-HQY,08 =%?*LH->NP.)LSI1ET PAGHP+]0
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MVS@P1@3 1B]Y" ;5.H+@D3BP$^U3 F$7$ 8%PZ=RE==Z8^$[D6!GV:>'PE-
MS(J$F@CKEPIVC'U6'#2.MMV$H5REFT?A-47"MD2XD^M3HF$/'D9P=?OK)2UU
M4M42"'<N?0I3W6@80=3->J.8!HKVHN!.F4\AIXV $;0\,K(NTSIEU=5R>?6*
MTFSV^88!N7#GQ*<0-HC-/V,[>%%D*1$&+,J"7' [^*B9"VP']YNA?3OX?5,G
M/J)A7[A;_JQ-DZUX^EZTKKGWN'1#MHX'>3O>:5'$"WPSK$O/;T6]557/>K]Z
M*X8L_\_D>0"_RT?T[1?R!T85^]__^7]02P,$%     @ JXA56JV%62.7#0
MDVD! !X   !I8V]N+65X,C)G=6%R86YT;W)S8VAE9'5L92YH=&WMG>]7XC@7
MQ]\_?T4>Y^PLGB,(^'/4]1P&&&47D4-QYME]\YS01LE:&C9MU>Y?OS=M011P
MT!U'AG[GQ6";_DAN[B<W29-[C_K!P#T^Z@ON'/_GZ+_Y/*LI.QP(+V"V%CP0
M#@M]Z5VQ+X[PKUD^GUY55<-(RZM^P,K%\@[[HO2UO.%)>B #5QR/GG.TF1P?
M;<8O.>HI)SH^<N0-D\XO:[*TNULN%2][^Z62O;UM[_"]+;Z[NV672V*W[&SO
M_[^T1K?2Y<D]?A"YXI>U@?3R?6'>?[!7'@:'M]()^@>E8O&GM0?7!>(NR'-7
M7GD'<6XI]5)1V=)D6[E*'[PKQO\.34K^D@^D&QW\W)4#X;.6N&4=->#>SQL^
M]_R\+[2\3"[TY=^"WD@OCP]OT]S0<USIB5'N2F63I?I=7_8DR:I<*!UMFNM'
M99HJV42.;9*>T&^49>OBH]6H-2J=W]G)1:53:77/.Q:KM&JL85D7]0X[_S1*
MJ-=KS*I7+SJ-;J.>7%/Y]*G1;%2Z=/CE]-RJ3Z97SYM-2NE4FHT_'B30$Q\*
M9PG%TJB>MUBC];EN=<_JK:[%K,;_6*UN-4Y:5"8J>+7;^-SH_DZE/&M76K\_
MNT $B#Y>Y*X_0S^0E]&KRV%[IARZ?<$NE>NJ6],X^&'/EX[D6M(;U"6+I31T
M[0V6"^C"]^_VR^7B854-AMR+XJ/2X3KC6K"KD&ON!4K?W]?P;H0?F*;#9Y:\
M8S7A4WGCIJAB!_)&!A&;>%1I[]!_\)J&[X="C]^R4]@O?OB)6<*32M./'6IZ
M4DL%E%4G%*;]VMLP5VU_Y:H/C'L.VRV08)^\<&M[5'W?MF)*"U7,^W<[^X?/
MYVBVVAT?!;SGBM'-/:4=H?-4%)</?7$P^N/0D?[0Y=&!].(,Q3<=#KB^HF:Z
MIX) #0YV*/<W0@?2YFZ:@3@O2?)] QZ+ES(54'8"9_3F-+D0)VT&SG3:;K&P
MN[<U-[E8*,U->^JQI==Y;'FGL+6SO=!C-V-))-(@@?ND][^L;:V-;AARQR$$
M#\K#.T8:PLSO5F%OC\0]4=>NN)P2?R+Y[]^.QO7;JIS538-_;V;&RI<*Y(FR
M%DU)UQ:Z-!7+X93>/Y;&0#J.*]Y(&E:7C <[)Z/:/273^BM91*O6(%-"S2$)
MJ=&JGG?:YYU*<H(NZYQ46HT_XN,'<ON*LJ0 !VI(*D9$,E^YTF&C KY<E^B)
MW]\0%<<&^<15/>ZR+O58_5!'[(+:H8$T%B,U%-]6N591C%JXQKP]1YM^R'(:
M=:G2>9,;UA&^X-KNLV:B+J_:!OT8\DGT(!-J<*I<DW%_NKE@4(0L*<)T>]#6
M:DA9C&CP<2-<-8PG1'*I3-;17&1,2RJV+6BH8YL1*^H^6W4?MQ#GU!KP0"J/
M&HGY9@,ZD56=^"0][MEF*@Q*D6FE&'<ETB$I&@OHA=&+9G@G!CT5ZBMF%=Z_
M*Y>W#YDNN 5HP;UD,J$(=:[=B+7[W!?,$OI&VL+?8,UF%6/.XZZXX_ZJ:\%'
MP6WEL8]2^;84GBTV6,.S"ZC^XQJ9@UL:8JVZ!LR;@VQ6H0.9TH$F[RD:0B@=
M39@"TQA #[*B!V?*%7;H<GU6HX&!'J+J,U/U<1-P8=T/$=$-R%3]MS4U^-90
MF#5- M8_2U5?.Z]:Z0P1#'ZZ((@>\ZO0OHA6O?(G/R91\X]6/ZE_I8,^JW*M
M*(VON@Y,COY4J&U!#PYNE;[>@"&(^T8NG5-RY2>#'DX%3*Y\AAIDJ#_0[E38
MJ> NM8!6,BF(B8",J4!'6.G2HS[7 VZ+,,X7)H8RJ@]6TBU(6H6XKUCQN!M1
MYGST$;*E"=%@V%=>-+80R@W-LA,_GC!4R1H4J$-6U.&1?1A_/JKXOK(E#V J
M1I+Z+,T&-+GR@\FX]YA.(J/N,]8:4-TWS'XV+UV*B,Y!INJ_T[8>+S6$!F1.
M ]I43GISJ@&H_TS5OXJ8T8'Q9V34?H9JO]IIH>%?M.HW8\<4Q__>*\9W+E;L
MV*/BNDP:UR9.[(=$A8$?T!^FO1=_A<8IBF^<D<@@]<$2/.FAQ:2F&Q$V3.*?
MP@Y8H.+S\48%GDPQ^"*@IYA/<SU!C]HP2N+2(%.3M/X6\>7W_E9B5RQOX&]E
MCL^311SJ3#J1&BI?FE(?F'T)9E'&7+=2J4^3XOTMO.>;:9GYMWQ_!T:SU6BF
M_ZGD_[Z^Q_Y*Y'M:\.L\OZ2\'G#WED?^VK-\<,T5_X_H7F9KO_"A.#_YI7Y@
MM@KE\OZW?^K+,_M46KE0VO_VF2V9Q[ZQ*YSO8:R>\(.3^S?^7];?V''.F[H1
M.O_2JG>R+(!VO5.MM[JLW:S73NHU. -ZEO^X>Y<.<!"TB&B'KOV6@OHZBV\G
M'_/_J@\VGW:>]%HP_;"26@*G$2!F"?3@"3]30&;Y?&J F253!/#SK?EYW?T&
M*PS08M4_,4F6WI\W%Q^4"WMFGFIT+O9(GYY\H]G 9RG--&S)=%ZVD5O<XP^H
M6WFS]0QE@.EZY;D%\+%\E?R$I]4Q*E-N5H$*4,D>*KEF!P0LEP=W<+$$53^V
M$],Z\& A--AY]G0DX%EA>&;X, <:0 -H+!I#"+2@$P98  O&[,#BF5[>:3 _
M3@$0L!X9QV2^#_S<Y?MWVWN'U_'_?-+[24WZMJ)BR/32=9:+W<4#I[?R)PZ4
MWK:,\P()Y$8;X( &T,@F&O.K'70\%M-C#^0 8]7!F!MVXG'W*\&(JDF;SRFC
MN^3H\G7 !)@R#--4[ [P\&I-#4#"@N7Y05-F<(>ER=A- [:>Q=940!IPA0D%
M=/5FNME"5P]0P+0\K]LV*\[)7)A@9^9^3@94@.KK0:18SHG'UKUTA#T.(S#5
M4*^SW"C>$OB;9_ !W0IW[Z;B,;+<?3Q"=/#0P<LF%K,B5>8>!FH$'( CFW 8
MG^L?A1Z$#M]X_ZZT6SQL!@[QD9X#& N&M,NN5XS=G96'9%35S!'4,MI]0>H@
M)O7AKU P2[LL5^4>!S7+$0@2T+QI$6=$@V55>O>@)SDC(\/)RHR. <QR!,0#
M,DNN ^PT]*ZXCN[33'2)FK@1KAJ:J6B6=-_2R\ 5N )7BW#5"+@;,:N0['.+
MCP /X'D1/',#-&4N3$\987H0I@=A>I:EM5K #IZ).VDK,H3Q7$>A&?]6"^PS
M6<4D#6819A%]2K#TXX;^!CE+/35LUO_TA39N=WSVL? Y7L8P/@-D,+>^N@A]
M6/BC;=L$JRWO% _)OE0*9%5R="8$'>B<K3(?"[>0_M,FIAU25A7K4!\L7?:0
M+ N:. ^48&@R#]("HYSX+9*3&8J'.+GT&/C $@&@10"J4SFI*[==.N0;<6?N
M@BBRAEQZ8 @,@:'I*2)FW0I'>*SRD4")_P0I( 6DQ!,#XXK/=?M<)B&HJJKP
M8'7W. 788(R3=6@L$KAK7,I8D2?T542_?B &/AO'%[GPXM_?Z")'#0 -; VP
MB?=M6P'7R2[M*F7G4FD,_('' @+*PLZZ%F5,2^Z.704"$2 "1!Z8$+,EN^%Y
MZB8>V/MP_0Y.P,DL-RX-\ZBJ B  !(#,<%[Q8';X3#BQ+G2%W4_<653)N(1N
MP)]RU0:"0%!V"6ISS5U7N&P7-@:$@)#97R&3D&^3VZU'NC ['D"B.":X57ZL
M-!=6!8%'P!@86\QG",P18O2 "\/%V(\K@%BTV0 4*PY%1]A"WI@M^AC8HTL%
M2E[LOA+<3(A,1<RLI(/G=$#R(*P[&,&R24 S7C>91.M(.MZQ=_6*Q]V(,@=>
MIH4UBELR&J<8!UYFS4,<<U4E 0Z!RRKC$GJ^"-BI=%WP@;$*$'EA(PEL@ VP
M>8D2L-QG:=Q88@'R7+]CS/P#+*L,R^QZAU%YZFL3B%AA(AY/=X*'6>[62!3T
MYE1&F!!>=2;:HTB:")@..P$FYC>#(&*!9@-<K# 7\7*\$T7Y\>(EP28B4SOL
MN=*>FL?".!R+&3//RV0\9G7)/FKI!VHT#.\*SQ.^+V!-9@:N!AC9 :/:Y]H5
MQ(:7LF&I$#'+ 0@ F01$!8%(^6@I#3[ !_@8\V&Z5E(PXZI+VBDE#9>.E$0@
M%?"1<3Y.I7VM= 3K 3I>1@<"O8X"O6XAT"L"O2+0Z[(T5X\,78>[)A6&#H8.
MW<!I.I1]';$S%7H!" $A(&2*$(ORX_="#)7 !_B8P<<7Z=*PY>K^2PT  2
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MM62%G6DJQK;%&A;8'^R<G=/(IZU<[CF@ W1DZ</[G$[7V"U/[J+P6V&=->5
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M'I^#Q4+[ EE;X_DS1_'A[J/X12L*>%X0?C/Z>=1XAU,3[&EF98['*8JQE+P
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M4NA:@7WKH/[4]K5!!1_(F\_U#[N 1[=P9:UPUQVC7>84!!%%69<Y0!#74 @
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M+70%%U]1:-<Z*9[PY[?O1'7X\U;B?LCB,>N*.L]2-1,N/RG2>6E3(ZFCEH5
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MLSB"_LEN'Z*_2Y#<IIRH(OJ,[9/VMH;'_/#WS]N#7UX==[H7-+EMHCSIG_E
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MZ>O_!U!+ 0(4 Q0    ( *N(55J5KDVO_ <  "=    3              "
M 0    !E>&AI8FET,3(Q+3(P,C0N:'1M4$L! A0#%     @ JXA56FH6GQU5
M!0  V2   !,              ( !+0@  &5X:&EB:70Q,C(M,C R-"YH=&U0
M2P$"% ,4    " "KB%5:D#K=H<,#  !J"P  $P              @ &S#0
M97AH:6)I=#$V,2TR,#(T+FAT;5!+ 0(4 Q0    ( *N(55K.,0>+' L  &HW
M   2              "  :<1  !E>&AI8FET,C(M,C R-"YH=&U02P$"% ,4
M    " "KB%5:TN\19\4"  !?"   $P              @ 'S'   97AH:6)I
M=#(S,2TR,#(T+FAT;5!+ 0(4 Q0    ( *N(55J(XTI3AP@$ 'F6*@ 1
M          "  >D?  !I8VQR+3(P,C0Q,C,Q+FAT;5!+ 0(4 Q0    ( *N(
M55HIGUT-5QT  +MB 0 1              "  9\H! !I8VQR+3(P,C0Q,C,Q
M+GAS9%!+ 0(4 Q0    ( *N(55H+?O)(FC$  ,GN 0 5              "
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M &EC;'(M,C R-#$R,S%?9S,N:G!G4$L! A0#%     @ JXA56M20/SO[C08
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M;&EC>6%S=7!D+FAT;5!+ 0(4 Q0    ( *N(55H-V%?&WBL  &<X 0 >
M          "  <>[' !I8V]N<&QC<VAA<F5T<F%D:6YG<&]L:6-Y82YH=&U0
52P4&     !( $@"Z!   X><<

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>iclr-20241231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2024"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iclr="http://www.iconplc.com/20241231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="iclr-20241231.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">iclr:OtherUndenominatedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherGeographicLocationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iclr:ComputerEquipmentAndCapitalizedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">iclr:ComputerEquipmentAndCapitalizedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:TopClientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients25Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients610Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:Clients1125Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">iclr:OtherCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:KCRS.AGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-19</startDate>
            <endDate>2024-08-19</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:KCRS.AGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-19</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:KCRS.AGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:KCRS.AGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-19</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:KCRS.AGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:KCRS.AGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:HumanFirstIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-09</startDate>
            <endDate>2024-01-09</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:HumanFirstIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:HumanFirstIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-09</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-02</startDate>
            <endDate>2023-10-02</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-02</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:PRAHealthSciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:OncacareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-20</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:OncacareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-20</startDate>
            <endDate>2023-04-20</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:KCRS.AGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-19</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:KCRS.AGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-19</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:HumanFirstIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-09</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-02</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-02</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-02</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-02</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-02</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">iclr:BiotelResearchLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-02</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesDueMay2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesDueMay2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesDueMay2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesDueMay2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesDueMay2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesDueMay2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-08</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesDueMay2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-08</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesDueMay2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-08</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesDueMay2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-08</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesDueMay2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-08</startDate>
            <endDate>2024-05-08</endDate>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-02</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CreditRatingStandardPoorsAxis">srt:StandardPoorsBBRatingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CreditRatingStandardPoorsAxis">srt:StandardPoorsBBPlusRatingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CreditRatingStandardPoorsAxis">srt:StandardPoorsBBBMinusRatingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CreditRatingStandardPoorsAxis">srt:StandardPoorsBBBRatingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CreditRatingStandardPoorsAxis">srt:StandardPoorsBBBPlusRatingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="iclr:VariableRateComponentAxis">iclr:VariableRateComponentTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredRevolvingLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">iclr:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorSubordinatedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-01</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-29</instant>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-29</instant>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">iclr:InterestRateCapAndInterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-23</startDate>
            <endDate>2024-07-23</endDate>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">iclr:February2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-20</instant>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">iclr:October2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-22</instant>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">iclr:BuybackProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:WorkforceReductionAndOfficeConsolidationProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:WorkforceReductionAndOfficeConsolidationProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:WorkforceReductionAndOfficeConsolidationProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:PersonnelRelatedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:PersonnelRelatedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:FacilityLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">iclr:FacilityLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeAndOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2025To2038Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear2025To2038Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear20392043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">iclr:TaxYear20392043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:TaxOfBusinessAcquiredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:IncomeTaxBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">iclr:IncomeTaxBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-02-14</instant>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-02-13</instant>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:EmployeeStockPlanTwentyZeroEightPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-02-14</instant>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsStockPlan2008PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-02-14</startDate>
            <endDate>2017-02-14</endDate>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:EmployeeStockPlanTwentyZeroEightPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-02-14</startDate>
            <endDate>2017-02-14</endDate>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:OptionPlans2008Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-02-14</startDate>
            <endDate>2017-02-14</endDate>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">iclr:AwardDateAllYearsExcluding2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1997-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">iclr:AwardDateAllYearsExcluding2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1997-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">iclr:AwardDateAllYearsExcluding2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1997-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:The2020LegacyPRAPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-18</instant>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">iclr:The2018LegacyPRAPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:StockOptionAndAwardPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:RestrictedStockUnitsTwentyThirteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-05-11</startDate>
            <endDate>2015-05-11</endDate>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:RestrictedStockUnitsTwentyThirteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-25</startDate>
            <endDate>2024-10-25</endDate>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:RestrictedStockUnitsTwentyThirteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-25</instant>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsRestrictedStockUnitsTwentyNineteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-16</instant>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">iclr:NonexecutiveDirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:ConsultantsRestrictedStockUnitsTwentyNineteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceShareUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">iclr:PerformanceBasedGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:RestOfEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">iclr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:CorvusPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:CorvusPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:CorvusPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:CorvusPharmaceuticalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">iclr:AfimmuneLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:SubsidiaryOfCommonParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">iclr:February2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-18</instant>
        </period>
    </context>
    <context id="c-308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001060955</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-18</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="eurPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="employee">
        <measure>iclr:Employee</measure>
    </unit>
    <unit id="location">
        <measure>iclr:Location</measure>
    </unit>
    <unit id="country">
        <measure>iclr:Country</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="instrument">
        <measure>iclr:instrument</measure>
    </unit>
    <unit id="vote">
        <measure>iclr:vote</measure>
    </unit>
    <unit id="segment">
        <measure>iclr:segment</measure>
    </unit>
    <dei:AmendmentFlag contextRef="c-1" id="f-40">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-41">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-42">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-43">0001060955</dei:EntityCentralIndexKey>
    <us-gaap:RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration contextRef="c-1" id="f-159">http://fasb.org/us-gaap/2024#RestructuringCosts</us-gaap:RestructuringIncurredCostStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:GovernmentAssistanceLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration contextRef="c-3" id="f-727">http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent</us-gaap:GovernmentAssistanceLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-3" id="f-941">http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-4" id="f-942">http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-253" id="f-1226">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType contextRef="c-1" id="f-1">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="c-1" id="f-2">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-3">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-4">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-5">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-6">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport contextRef="c-1" id="f-7">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-8">333-08704</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-9">ICON PLC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-10">L2</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-11">South County Business Park</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-12">Leopardstown</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-13">Dublin 18</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-14">D18 X5R3</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="c-1" id="f-15">IE</dei:EntityAddressCountry>
    <dei:ContactPersonnelName contextRef="c-2" id="f-16">Nigel Clerkin</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1 contextRef="c-2" id="f-17">South County Business Park</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-2" id="f-18">Leopardstown</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-2" id="f-19">Dublin 18</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="c-2" id="f-20">D18 X5R3</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="c-2" id="f-21">IE</dei:EntityAddressCountry>
    <dei:ContactPersonnelEmailAddress contextRef="c-2" id="f-22">Nigel.Clerkin@iconplc.com</dei:ContactPersonnelEmailAddress>
    <dei:CountryRegion contextRef="c-2" id="f-23">353</dei:CountryRegion>
    <dei:CityAreaCode contextRef="c-2" id="f-24">1</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-2" id="f-25">291-2000</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-26">ORDINARY SHARES, PAR VALUE &#x20ac;0.06 EACH</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-27">ICLR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-28">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-29" unitRef="shares">80756860</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-30">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-32">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-33">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-34">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-35">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-36">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-37">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:DocumentAccountingStandard contextRef="c-1" id="f-38">U.S. GAAP</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany contextRef="c-1" id="f-39">false</dei:EntityShellCompany>
    <dei:AuditorFirmId contextRef="c-1" id="f-44">1116</dei:AuditorFirmId>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c-1" id="f-45">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="c-1" id="f-46">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ICON has a cybersecurity strategy and program designed to protect our information systems and data from an evolving cyber threat landscape. The cybersecurity program, overseen by the Chief Information Officer (CIO), has the support of executive leadership and the Board, and we have invested heavily in cybersecurity technologies to protect our environment. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Chief Information Officer (CIO), who reports to the CEO, has oversight responsibility for the cybersecurity strategy and program and has over a decade experience leading cybersecurity oversight. The Vice President of Cyber &amp;amp; Information Security reports to the CIO and is responsible for the delivery of the cyber and information security strategy. The Vice President of Cyber &amp;amp; Information Security as well as the overall security team have many years&#x2019; experience and are all appropriately qualified. ICON&#x2019;s cybersecurity processes are integrated into ICON&#x2019;s overall risk management processes which are monitored by ICON&#x2019;s executive leadership team and reported to the Board. The Chief Information Officer provides cybersecurity updates to the Board on a quarterly basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The underlying controls of the cyber risk management program are based on recognized best practices and standards for cybersecurity and information technology, including the National Institute of Standards and Technology (&#x201c;NIST&#x201d;) Cybersecurity Framework (&#x201c;CSF&#x201d;) and the International Organization Standardization (&#x201c;ISO&#x201d;) 27001 Information Security Management System Requirements. ICON has an enterprise-wide assessment, performed twice annually by a third party, of the Company&#x2019;s cyber risk management program against ISO 27001. We also conduct an annual independent maturity review with a third party which is based on the NIST cybersecurity framework. ICON also maintains the Cyber Essentials certification.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ICON has a dedicated Cybersecurity Operations Center that continuously monitors for threats and unauthorized access. The Cybersecurity Operations Center is staffed by appropriately qualified cyber and information security professionals. ICON has put in place controls and processes to inform and monitor the prevention, detection, mitigation, and remediation of cybersecurity incidents. These controls and procedures are designed to ensure prompt escalation of certain cybersecurity incidents so that decisions regarding public disclosure and reporting of such incidents can be made by executive management in a timely manner. The escalation processes are based on defined prioritization and severity assessment criteria.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="c-1" id="f-47">The cybersecurity program, overseen by the Chief Information Officer (CIO), has the support of executive leadership and the Board, and we have invested heavily in cybersecurity technologies to protect our environment. &lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Chief Information Officer (CIO), who reports to the CEO, has oversight responsibility for the cybersecurity strategy and program and has over a decade experience leading cybersecurity oversight. The Vice President of Cyber &amp;amp; Information Security reports to the CIO and is responsible for the delivery of the cyber and information security strategy. The Vice President of Cyber &amp;amp; Information Security as well as the overall security team have many years&#x2019; experience and are all appropriately qualified. ICON&#x2019;s cybersecurity processes are integrated into ICON&#x2019;s overall risk management processes which are monitored by ICON&#x2019;s executive leadership team and reported to the Board. The Chief Information Officer provides cybersecurity updates to the Board on a quarterly basis.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock contextRef="c-1" id="f-49">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Chief Information Officer (CIO), who reports to the CEO, has oversight responsibility for the cybersecurity strategy and program and has over a decade experience leading cybersecurity oversight. The Vice President of Cyber &amp;amp; Information Security reports to the CIO and is responsible for the delivery of the cyber and information security strategy. The Vice President of Cyber &amp;amp; Information Security as well as the overall security team have many years&#x2019; experience and are all appropriately qualified. ICON&#x2019;s cybersecurity processes are integrated into ICON&#x2019;s overall risk management processes which are monitored by ICON&#x2019;s executive leadership team and reported to the Board. The Chief Information Officer provides cybersecurity updates to the Board on a quarterly basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The underlying controls of the cyber risk management program are based on recognized best practices and standards for cybersecurity and information technology, including the National Institute of Standards and Technology (&#x201c;NIST&#x201d;) Cybersecurity Framework (&#x201c;CSF&#x201d;) and the International Organization Standardization (&#x201c;ISO&#x201d;) 27001 Information Security Management System Requirements. ICON has an enterprise-wide assessment, performed twice annually by a third party, of the Company&#x2019;s cyber risk management program against ISO 27001. We also conduct an annual independent maturity review with a third party which is based on the NIST cybersecurity framework. ICON also maintains the Cyber Essentials certification.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ICON has a dedicated Cybersecurity Operations Center that continuously monitors for threats and unauthorized access. The Cybersecurity Operations Center is staffed by appropriately qualified cyber and information security professionals. ICON has put in place controls and processes to inform and monitor the prevention, detection, mitigation, and remediation of cybersecurity incidents. These controls and procedures are designed to ensure prompt escalation of certain cybersecurity incidents so that decisions regarding public disclosure and reporting of such incidents can be made by executive management in a timely manner. The escalation processes are based on defined prioritization and severity assessment criteria.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-48">The Chief Information Officer (CIO), who reports to the CEO, has oversight responsibility for the cybersecurity strategy and program and has over a decade experience leading cybersecurity oversight. The Vice President of Cyber &amp;amp; Information Security reports to the CIO and is responsible for the delivery of the cyber and information security strategy</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-50">The Chief Information Officer (CIO), who reports to the CEO, has oversight responsibility for the cybersecurity strategy and program and has over a decade experience leading cybersecurity oversight.</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="c-1" id="f-51">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock contextRef="c-1" id="f-52">The Vice President of Cyber &amp;amp; Information Security as well as the overall security team have many years&#x2019; experience and are all appropriately qualified</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="c-1" id="f-54">ICON&#x2019;s cybersecurity processes are integrated into ICON&#x2019;s overall risk management processes which are monitored by ICON&#x2019;s executive leadership team and reported to the Board.</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="c-1" id="f-53">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-57">The Chief Information Officer provides cybersecurity updates to the Board on a quarterly basis.</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-56">The Chief Information Officer provides cybersecurity updates to the Board on a quarterly basis.</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag contextRef="c-1" id="f-55">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="c-1" id="f-58">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="c-1" id="f-59">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="c-1" id="f-60">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-61" unitRef="usd">8281676000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dei:AuditorName contextRef="c-1" id="f-62">KPMG</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-63">Dublin, Ireland</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-64" unitRef="usd">538785000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-65" unitRef="usd">378102000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-3" decimals="-3" id="f-66" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-4" decimals="-3" id="f-67" unitRef="usd">1954000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-3" decimals="-3" id="f-68" unitRef="usd">1401989000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-4" decimals="-3" id="f-69" unitRef="usd">1790322000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent contextRef="c-3" decimals="-3" id="f-70" unitRef="usd">1286274000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent contextRef="c-4" decimals="-3" id="f-71" unitRef="usd">951936000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:NontradeReceivablesCurrent contextRef="c-3" decimals="-3" id="f-72" unitRef="usd">79487000</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:NontradeReceivablesCurrent contextRef="c-4" decimals="-3" id="f-73" unitRef="usd">65797000</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-3" id="f-74" unitRef="usd">140435000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-75" unitRef="usd">132105000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:IncomeTaxesReceivable contextRef="c-3" decimals="-3" id="f-76" unitRef="usd">83523000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable contextRef="c-4" decimals="-3" id="f-77" unitRef="usd">91254000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:AssetsCurrent contextRef="c-3" decimals="-3" id="f-78" unitRef="usd">3530493000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-79" unitRef="usd">3411470000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-80" unitRef="usd">382879000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-81" unitRef="usd">361184000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill contextRef="c-3" decimals="-3" id="f-82" unitRef="usd">9051410000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-83" unitRef="usd">9022075000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-3" decimals="-3" id="f-84" unitRef="usd">3559792000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-4" decimals="-3" id="f-85" unitRef="usd">3855865000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-3" decimals="-3" id="f-86" unitRef="usd">147602000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-87" unitRef="usd">140333000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-3" decimals="-3" id="f-88" unitRef="usd">72796000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-89" unitRef="usd">78470000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-3" decimals="-3" id="f-90" unitRef="usd">74758000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-4" decimals="-3" id="f-91" unitRef="usd">73662000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue contextRef="c-3" decimals="-3" id="f-92" unitRef="usd">57948000</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue contextRef="c-4" decimals="-3" id="f-93" unitRef="usd">46804000</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:Assets contextRef="c-3" decimals="-3" id="f-94" unitRef="usd">16877678000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-95" unitRef="usd">16989863000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-3" decimals="-3" id="f-96" unitRef="usd">173025000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-97" unitRef="usd">131584000</us-gaap:AccountsPayableCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-3" decimals="-3" id="f-98" unitRef="usd">1614758000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-3" id="f-99" unitRef="usd">1654507000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-100" unitRef="usd">923603000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-101" unitRef="usd">915399000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-3" decimals="-3" id="f-102" unitRef="usd">55258000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-4" decimals="-3" id="f-103" unitRef="usd">13968000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LinesOfCreditCurrent contextRef="c-3" decimals="-3" id="f-104" unitRef="usd">29762000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LinesOfCreditCurrent contextRef="c-4" decimals="-3" id="f-105" unitRef="usd">110150000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-106" unitRef="usd">2796406000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-107" unitRef="usd">2825608000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermLineOfCredit contextRef="c-3" decimals="-3" id="f-108" unitRef="usd">3396398000</us-gaap:LongTermLineOfCredit>
    <us-gaap:LongTermLineOfCredit contextRef="c-4" decimals="-3" id="f-109" unitRef="usd">3665439000</us-gaap:LongTermLineOfCredit>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-3" decimals="-3" id="f-110" unitRef="usd">140085000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-111" unitRef="usd">126321000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-3" decimals="-3" id="f-112" unitRef="usd">83470000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-113" unitRef="usd">45998000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent contextRef="c-3" decimals="-3" id="f-114" unitRef="usd">125834000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent contextRef="c-4" decimals="-3" id="f-115" unitRef="usd">186654000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-3" decimals="-3" id="f-116" unitRef="usd">812486000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-4" decimals="-3" id="f-117" unitRef="usd">899100000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:CommitmentsAndContingencies contextRef="c-3" decimals="-3" id="f-118" unitRef="usd">0</us-gaap:CommitmentsAndContingencies>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" decimals="-3" id="f-119" unitRef="usd">0</us-gaap:CommitmentsAndContingencies>
    <us-gaap:Liabilities contextRef="c-3" decimals="-3" id="f-120" unitRef="usd">7354679000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-121" unitRef="usd">7749120000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-122"
      unitRef="eurPerShare">6</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-123"
      unitRef="eurPerShare">6</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-124" unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-125" unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-126" unitRef="shares">80756860</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="INF" id="f-127" unitRef="shares">80756860</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="INF" id="f-128" unitRef="shares">82495086</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-129" unitRef="shares">82495086</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-3" decimals="-3" id="f-130" unitRef="usd">6586000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-131" unitRef="usd">6699000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-3" decimals="-3" id="f-132" unitRef="usd">7020231000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-4" decimals="-3" id="f-133" unitRef="usd">6942669000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <iclr:OtherUndenominatedCapital contextRef="c-3" decimals="-3" id="f-134" unitRef="usd">1304000</iclr:OtherUndenominatedCapital>
    <iclr:OtherUndenominatedCapital contextRef="c-4" decimals="-3" id="f-135" unitRef="usd">1162000</iclr:OtherUndenominatedCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-3" decimals="-3" id="f-136" unitRef="usd">-229929000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-3" id="f-137" unitRef="usd">-143506000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-3" id="f-138" unitRef="usd">2724807000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-139" unitRef="usd">2433719000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-140" unitRef="usd">9522999000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-141" unitRef="usd">9240743000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="-3" id="f-142" unitRef="usd">16877678000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-143" unitRef="usd">16989863000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-144" unitRef="usd">8281676000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-3" id="f-145" unitRef="usd">8120176000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-3" id="f-146" unitRef="usd">7741386000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-3" id="f-147" unitRef="usd">5845319000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-5" decimals="-3" id="f-148" unitRef="usd">5719949000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-6" decimals="-3" id="f-149" unitRef="usd">5527045000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-150" unitRef="usd">728348000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-5" decimals="-3" id="f-151" unitRef="usd">768559000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-6" decimals="-3" id="f-152" unitRef="usd">778753000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:DepreciationAndAmortization contextRef="c-1" decimals="-3" id="f-153" unitRef="usd">488500000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-5" decimals="-3" id="f-154" unitRef="usd">585950000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-6" decimals="-3" id="f-155" unitRef="usd">569513000</us-gaap:DepreciationAndAmortization>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts contextRef="c-1" decimals="-3" id="f-156" unitRef="usd">29574000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts contextRef="c-5" decimals="-3" id="f-157" unitRef="usd">44176000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts contextRef="c-6" decimals="-3" id="f-158" unitRef="usd">39695000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:RestructuringCosts contextRef="c-1" decimals="-3" id="f-160" unitRef="usd">92123000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts contextRef="c-5" decimals="-3" id="f-161" unitRef="usd">45390000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts contextRef="c-6" decimals="-3" id="f-162" unitRef="usd">31143000</us-gaap:RestructuringCosts>
    <us-gaap:CostsAndExpenses contextRef="c-1" decimals="-3" id="f-163" unitRef="usd">7183864000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-5" decimals="-3" id="f-164" unitRef="usd">7164024000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-6" decimals="-3" id="f-165" unitRef="usd">6946149000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-166" unitRef="usd">1097812000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-3" id="f-167" unitRef="usd">956152000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-6" decimals="-3" id="f-168" unitRef="usd">795237000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest contextRef="c-1" decimals="-3" id="f-169" unitRef="usd">8609000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-5" decimals="-3" id="f-170" unitRef="usd">5014000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-6" decimals="-3" id="f-171" unitRef="usd">2345000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpenseNonoperating contextRef="c-1" decimals="-3" id="f-172" unitRef="usd">237237000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-5" decimals="-3" id="f-173" unitRef="usd">336699000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-6" decimals="-3" id="f-174" unitRef="usd">229731000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-175" unitRef="usd">869184000</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-176" unitRef="usd">624467000</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest contextRef="c-6" decimals="-3" id="f-177" unitRef="usd">567851000</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-178" unitRef="usd">77710000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-3" id="f-179" unitRef="usd">11749000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-180" unitRef="usd">59411000</us-gaap:IncomeTaxExpenseBenefit>
    <iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-181" unitRef="usd">791474000</iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest>
    <iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-182" unitRef="usd">612718000</iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest>
    <iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest contextRef="c-6" decimals="-3" id="f-183" unitRef="usd">508440000</iclr:IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-184" unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-5" decimals="-3" id="f-185" unitRef="usd">-383000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-6" decimals="-3" id="f-186" unitRef="usd">-3136000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-187" unitRef="usd">791474000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-188" unitRef="usd">612335000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-189" unitRef="usd">505304000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-190"
      unitRef="usdPerShare">9.60</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-191"
      unitRef="usdPerShare">7.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-192"
      unitRef="usdPerShare">6.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-193"
      unitRef="usdPerShare">9.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-194"
      unitRef="usdPerShare">7.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-195"
      unitRef="usdPerShare">6.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-196" unitRef="shares">82482764</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="0" id="f-197" unitRef="shares">82101813</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="0" id="f-198" unitRef="shares">81532320</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-199" unitRef="shares">83032424</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="0" id="f-200" unitRef="shares">82717640</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="0" id="f-201" unitRef="shares">82468363</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-202" unitRef="usd">791474000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-5" decimals="-3" id="f-203" unitRef="usd">612335000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-6" decimals="-3" id="f-204" unitRef="usd">505304000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-1" decimals="-3" id="f-205" unitRef="usd">-84927000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-5" decimals="-3" id="f-206" unitRef="usd">26221000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-6" decimals="-3" id="f-207" unitRef="usd">-89530000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax contextRef="c-1" decimals="-3" id="f-208" unitRef="usd">-6077000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax contextRef="c-5" decimals="-3" id="f-209" unitRef="usd">244000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax contextRef="c-6" decimals="-3" id="f-210" unitRef="usd">12657000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-1" decimals="-3" id="f-211" unitRef="usd">4581000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-5" decimals="-3" id="f-212" unitRef="usd">1567000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-6" decimals="-3" id="f-213" unitRef="usd">-3728000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-214" unitRef="usd">705051000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-5" decimals="-3" id="f-215" unitRef="usd">640367000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-6" decimals="-3" id="f-216" unitRef="usd">424703000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesIssued contextRef="c-7" decimals="INF" id="f-217" unitRef="shares">81554683</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-7" decimals="-3" id="f-218" unitRef="usd">6640000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-3" id="f-219" unitRef="usd">6733910000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-3" id="f-220" unitRef="usd">1134000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-3" id="f-221" unitRef="usd">-90937000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-11" decimals="-3" id="f-222" unitRef="usd">1416080000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-12" decimals="-3" id="f-223" unitRef="usd">8066827000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-13" decimals="-3" id="f-224" unitRef="usd">505304000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-225" unitRef="usd">505304000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-14" decimals="-3" id="f-226" unitRef="usd">-89530000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-6" decimals="-3" id="f-227" unitRef="usd">-89530000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax contextRef="c-14" decimals="-3" id="f-228" unitRef="usd">12657000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax contextRef="c-6" decimals="-3" id="f-229" unitRef="usd">12657000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-14" decimals="-3" id="f-230" unitRef="usd">-3728000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-6" decimals="-3" id="f-231" unitRef="usd">-3728000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-6" decimals="-3" id="f-232" unitRef="usd">424703000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-15"
      decimals="INF"
      id="f-233"
      unitRef="shares">348286</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-15" decimals="-3" id="f-234" unitRef="usd">21000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-16" decimals="-3" id="f-235" unitRef="usd">35807000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-6" decimals="-3" id="f-236" unitRef="usd">35828000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-15"
      decimals="INF"
      id="f-237"
      unitRef="shares">241116</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-15" decimals="-3" id="f-238" unitRef="usd">16000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-6" decimals="-3" id="f-239" unitRef="usd">16000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-16" decimals="-3" id="f-240" unitRef="usd">70606000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-6" decimals="-3" id="f-241" unitRef="usd">70606000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-16" decimals="-3" id="f-242" unitRef="usd">17000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-6" decimals="-3" id="f-243" unitRef="usd">17000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="c-15"
      decimals="INF"
      id="f-244"
      unitRef="shares">420530</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-15" decimals="-3" id="f-245" unitRef="usd">28000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-17" decimals="-3" id="f-246" unitRef="usd">-28000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-13" decimals="-3" id="f-247" unitRef="usd">99983000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-6" decimals="-3" id="f-248" unitRef="usd">99983000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <iclr:ShareRepurchaseProgramBrokerCommission contextRef="c-6" decimals="-3" id="f-249" unitRef="usd">17000</iclr:ShareRepurchaseProgramBrokerCommission>
    <iclr:ShareRepurchaseProgramBrokerCommission contextRef="c-6" decimals="-3" id="f-250" unitRef="usd">17000</iclr:ShareRepurchaseProgramBrokerCommission>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-18"
      decimals="INF"
      id="f-251"
      unitRef="shares">81723555</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-18" decimals="-3" id="f-252" unitRef="usd">6649000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-3" id="f-253" unitRef="usd">6840306000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-3" id="f-254" unitRef="usd">1162000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="-3" id="f-255" unitRef="usd">-171538000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="-3" id="f-256" unitRef="usd">1821384000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-23" decimals="-3" id="f-257" unitRef="usd">8497963000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-24" decimals="-3" id="f-258" unitRef="usd">612335000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-259" unitRef="usd">612335000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-25" decimals="-3" id="f-260" unitRef="usd">26221000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-5" decimals="-3" id="f-261" unitRef="usd">26221000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax contextRef="c-25" decimals="-3" id="f-262" unitRef="usd">244000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax contextRef="c-5" decimals="-3" id="f-263" unitRef="usd">244000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-25" decimals="-3" id="f-264" unitRef="usd">1567000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-5" decimals="-3" id="f-265" unitRef="usd">1567000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-5" decimals="-3" id="f-266" unitRef="usd">640367000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-26"
      decimals="INF"
      id="f-267"
      unitRef="shares">535705</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-26" decimals="-3" id="f-268" unitRef="usd">35000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-27" decimals="-3" id="f-269" unitRef="usd">50923000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-5" decimals="-3" id="f-270" unitRef="usd">50958000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-26"
      decimals="INF"
      id="f-271"
      unitRef="shares">235826</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-26" decimals="-3" id="f-272" unitRef="usd">15000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-5" decimals="-3" id="f-273" unitRef="usd">15000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-27" decimals="-3" id="f-274" unitRef="usd">51456000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-5" decimals="-3" id="f-275" unitRef="usd">51456000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-27" decimals="-3" id="f-276" unitRef="usd">16000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-5" decimals="-3" id="f-277" unitRef="usd">16000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-28"
      decimals="INF"
      id="f-278"
      unitRef="shares">82495086</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-3" id="f-279" unitRef="usd">6699000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-3" id="f-280" unitRef="usd">6942669000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-30" decimals="-3" id="f-281" unitRef="usd">1162000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-31" decimals="-3" id="f-282" unitRef="usd">-143506000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-32" decimals="-3" id="f-283" unitRef="usd">2433719000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-284" unitRef="usd">9240743000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-33" decimals="-3" id="f-285" unitRef="usd">791474000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-286" unitRef="usd">791474000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-34" decimals="-3" id="f-287" unitRef="usd">-84927000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-1" decimals="-3" id="f-288" unitRef="usd">-84927000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax contextRef="c-34" decimals="-3" id="f-289" unitRef="usd">-6077000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax contextRef="c-1" decimals="-3" id="f-290" unitRef="usd">-6077000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-34" decimals="-3" id="f-291" unitRef="usd">4581000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-1" decimals="-3" id="f-292" unitRef="usd">4581000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-293" unitRef="usd">705051000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-35"
      decimals="INF"
      id="f-294"
      unitRef="shares">311040</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-35" decimals="-3" id="f-295" unitRef="usd">20000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-36" decimals="-3" id="f-296" unitRef="usd">36158000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-1" decimals="-3" id="f-297" unitRef="usd">36178000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c-35"
      decimals="INF"
      id="f-298"
      unitRef="shares">130433</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-35" decimals="-3" id="f-299" unitRef="usd">9000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-1" decimals="-3" id="f-300" unitRef="usd">9000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-36" decimals="-3" id="f-301" unitRef="usd">41426000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-302" unitRef="usd">41426000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-36" decimals="-3" id="f-303" unitRef="usd">22000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-1" decimals="-3" id="f-304" unitRef="usd">22000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="c-35"
      decimals="INF"
      id="f-305"
      unitRef="shares">2179699</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-35" decimals="-3" id="f-306" unitRef="usd">142000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-37" decimals="-3" id="f-307" unitRef="usd">-142000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-33" decimals="-3" id="f-308" unitRef="usd">499998000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-1" decimals="-3" id="f-309" unitRef="usd">499998000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <iclr:ShareRepurchaseProgramBrokerCommission contextRef="c-1" decimals="-3" id="f-310" unitRef="usd">388000</iclr:ShareRepurchaseProgramBrokerCommission>
    <iclr:ShareRepurchaseProgramBrokerCommission contextRef="c-1" decimals="-3" id="f-311" unitRef="usd">388000</iclr:ShareRepurchaseProgramBrokerCommission>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-38"
      decimals="INF"
      id="f-312"
      unitRef="shares">80756860</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity contextRef="c-38" decimals="-3" id="f-313" unitRef="usd">6586000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-39" decimals="-3" id="f-314" unitRef="usd">7020231000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-40" decimals="-3" id="f-315" unitRef="usd">1304000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-41" decimals="-3" id="f-316" unitRef="usd">-229929000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-42" decimals="-3" id="f-317" unitRef="usd">2724807000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-318" unitRef="usd">9522999000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-319" unitRef="usd">791474000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-5" decimals="-3" id="f-320" unitRef="usd">612335000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-6" decimals="-3" id="f-321" unitRef="usd">505304000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-322" unitRef="usd">488500000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-5" decimals="-3" id="f-323" unitRef="usd">585950000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-6" decimals="-3" id="f-324" unitRef="usd">569513000</us-gaap:DepreciationDepletionAndAmortization>
    <iclr:ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-325" unitRef="usd">15731000</iclr:ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment>
    <iclr:ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment contextRef="c-5" decimals="-3" id="f-326" unitRef="usd">8686000</iclr:ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment>
    <iclr:ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment contextRef="c-6" decimals="-3" id="f-327" unitRef="usd">28767000</iclr:ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-1" decimals="-3" id="f-328" unitRef="usd">39787000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-5" decimals="-3" id="f-329" unitRef="usd">41546000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-6" decimals="-3" id="f-330" unitRef="usd">45215000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-331" unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-5" decimals="-3" id="f-332" unitRef="usd">-383000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-6" decimals="-3" id="f-333" unitRef="usd">-3136000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount contextRef="c-1" decimals="-3" id="f-334" unitRef="usd">0</us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount>
    <us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount contextRef="c-5" decimals="-3" id="f-335" unitRef="usd">6160000</us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount>
    <us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount contextRef="c-6" decimals="-3" id="f-336" unitRef="usd">0</us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-1" decimals="-3" id="f-337" unitRef="usd">23533000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-5" decimals="-3" id="f-338" unitRef="usd">16402000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-6" decimals="-3" id="f-339" unitRef="usd">17749000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-340" unitRef="usd">45870000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-5" decimals="-3" id="f-341" unitRef="usd">55667000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-6" decimals="-3" id="f-342" unitRef="usd">70523000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="c-1" decimals="-3" id="f-343" unitRef="usd">-100542000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="c-5" decimals="-3" id="f-344" unitRef="usd">-85403000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="c-6" decimals="-3" id="f-345" unitRef="usd">-124985000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="c-1" decimals="-3" id="f-346" unitRef="usd">-6911000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="c-5" decimals="-3" id="f-347" unitRef="usd">-19706000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="c-6" decimals="-3" id="f-348" unitRef="usd">13009000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-1" decimals="-3" id="f-349" unitRef="usd">-31900000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-5" decimals="-3" id="f-350" unitRef="usd">-24332000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-6" decimals="-3" id="f-351" unitRef="usd">-11324000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-3" id="f-352" unitRef="usd">-349309000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-5" decimals="-3" id="f-353" unitRef="usd">83296000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-6" decimals="-3" id="f-354" unitRef="usd">420695000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset contextRef="c-1" decimals="-3" id="f-355" unitRef="usd">339921000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset contextRef="c-5" decimals="-3" id="f-356" unitRef="usd">-4716000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset contextRef="c-6" decimals="-3" id="f-357" unitRef="usd">332592000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-1" decimals="-3" id="f-358" unitRef="usd">-37743000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-5" decimals="-3" id="f-359" unitRef="usd">134566000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-6" decimals="-3" id="f-360" unitRef="usd">192944000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="c-1" decimals="-3" id="f-361" unitRef="usd">-28157000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="c-5" decimals="-3" id="f-362" unitRef="usd">-168403000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="c-6" decimals="-3" id="f-363" unitRef="usd">10121000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-364" unitRef="usd">1286652000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-5" decimals="-3" id="f-365" unitRef="usd">1161027000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-6" decimals="-3" id="f-366" unitRef="usd">563315000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-367" unitRef="usd">168060000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-5" decimals="-3" id="f-368" unitRef="usd">140692000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-6" decimals="-3" id="f-369" unitRef="usd">142160000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-1" decimals="-3" id="f-370" unitRef="usd">84159000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-5" decimals="-3" id="f-371" unitRef="usd">71766000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-6" decimals="-3" id="f-372" unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsForProceedsFromShortTermInvestments contextRef="c-1" decimals="-3" id="f-373" unitRef="usd">0</us-gaap:PaymentsForProceedsFromShortTermInvestments>
    <us-gaap:PaymentsForProceedsFromShortTermInvestments contextRef="c-5" decimals="-3" id="f-374" unitRef="usd">241000</us-gaap:PaymentsForProceedsFromShortTermInvestments>
    <us-gaap:PaymentsForProceedsFromShortTermInvestments contextRef="c-6" decimals="-3" id="f-375" unitRef="usd">1000</us-gaap:PaymentsForProceedsFromShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfLongtermInvestments contextRef="c-1" decimals="-3" id="f-376" unitRef="usd">2690000</us-gaap:ProceedsFromSaleOfLongtermInvestments>
    <us-gaap:ProceedsFromSaleOfLongtermInvestments contextRef="c-5" decimals="-3" id="f-377" unitRef="usd">0</us-gaap:ProceedsFromSaleOfLongtermInvestments>
    <us-gaap:ProceedsFromSaleOfLongtermInvestments contextRef="c-6" decimals="-3" id="f-378" unitRef="usd">1906000</us-gaap:ProceedsFromSaleOfLongtermInvestments>
    <us-gaap:PaymentsToAcquireLongtermInvestments contextRef="c-1" decimals="-3" id="f-379" unitRef="usd">17261000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:PaymentsToAcquireLongtermInvestments contextRef="c-5" decimals="-3" id="f-380" unitRef="usd">13954000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:PaymentsToAcquireLongtermInvestments contextRef="c-6" decimals="-3" id="f-381" unitRef="usd">5612000</us-gaap:PaymentsToAcquireLongtermInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-382" unitRef="usd">-266790000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-5" decimals="-3" id="f-383" unitRef="usd">-226653000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-6" decimals="-3" id="f-384" unitRef="usd">-145867000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="c-1" decimals="-3" id="f-385" unitRef="usd">12679000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="c-5" decimals="-3" id="f-386" unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="c-6" decimals="-3" id="f-387" unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-1" decimals="-3" id="f-388" unitRef="usd">2317480000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-5" decimals="-3" id="f-389" unitRef="usd">370000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-6" decimals="-3" id="f-390" unitRef="usd">75000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-1" decimals="-3" id="f-391" unitRef="usd">2677763000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-5" decimals="-3" id="f-392" unitRef="usd">1265000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-6" decimals="-3" id="f-393" unitRef="usd">875000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-1" decimals="-3" id="f-394" unitRef="usd">36187000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-5" decimals="-3" id="f-395" unitRef="usd">50973000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-6" decimals="-3" id="f-396" unitRef="usd">35844000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-1" decimals="-3" id="f-397" unitRef="usd">22000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-5" decimals="-3" id="f-398" unitRef="usd">16000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-6" decimals="-3" id="f-399" unitRef="usd">17000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-3" id="f-400" unitRef="usd">499998000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-5" decimals="-3" id="f-401" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-6" decimals="-3" id="f-402" unitRef="usd">99983000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <iclr:PaymentsForBrokerCommissionShareRepurchaseCosts contextRef="c-1" decimals="-3" id="f-403" unitRef="usd">388000</iclr:PaymentsForBrokerCommissionShareRepurchaseCosts>
    <iclr:PaymentsForBrokerCommissionShareRepurchaseCosts contextRef="c-5" decimals="-3" id="f-404" unitRef="usd">0</iclr:PaymentsForBrokerCommissionShareRepurchaseCosts>
    <iclr:PaymentsForBrokerCommissionShareRepurchaseCosts contextRef="c-6" decimals="-3" id="f-405" unitRef="usd">17000</iclr:PaymentsForBrokerCommissionShareRepurchaseCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-406" unitRef="usd">-837183000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-5" decimals="-3" id="f-407" unitRef="usd">-844043000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-6" decimals="-3" id="f-408" unitRef="usd">-864173000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-3" id="f-409" unitRef="usd">-21996000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-410" unitRef="usd">-997000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-6" decimals="-3" id="f-411" unitRef="usd">-16720000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-412" unitRef="usd">160683000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-5" decimals="-3" id="f-413" unitRef="usd">89334000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-6" decimals="-3" id="f-414" unitRef="usd">-463445000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-415" unitRef="usd">378102000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-23" decimals="-3" id="f-416" unitRef="usd">288768000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-12" decimals="-3" id="f-417" unitRef="usd">752213000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-418" unitRef="usd">538785000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-419" unitRef="usd">378102000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-23" decimals="-3" id="f-420" unitRef="usd">288768000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NatureOfOperations contextRef="c-1" id="f-421">Description of Business &lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ICON plc and its subsidiaries ("the Company" or "ICON") is a contract research organization ("CRO"), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process from compound selection to Phase I-IV clinical studies. Our mission is to improve the lives of patients by accelerating the development of our customers' drugs and devices through innovative solutions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and have the operational flexibility to provide development serv&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ices on a stand-alone basis or as part of an integrated "full-service"  or a &#x201c;blended-service&#x201d; solution. At December&#160;31, 2024 we had approximately &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;41,900&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; employees, in 106 locations in 55 countries. During the year ended December&#160;31, 2024, we derived 36.0%, 52.6% and 11.4% of our revenue in the United States, Europe and Rest of World, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ICON&#x2019;s ordinary shares are traded on the NASDAQ Global Select Market under the symbol &#x201c;ICLR&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We began operations in 1990 and have expanded our business through internal growth, together with a number of strategic acquisitions to enhance our capabilities and expertise in certain areas of the clinical development process. We are incorporated in Ireland and our principal executive office is located at: South County Business Park, Leopardstown, Dublin 18, Republic of Ireland. The contact telephone number of this office is +353 1 2912000.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <dei:EntityNumberOfEmployees contextRef="c-3" decimals="0" id="f-422" unitRef="employee">41900</dei:EntityNumberOfEmployees>
    <iclr:NumberOfLocations
      contextRef="c-3"
      decimals="INF"
      id="f-423"
      unitRef="location">106</iclr:NumberOfLocations>
    <us-gaap:NumberOfCountriesInWhichEntityOperates
      contextRef="c-3"
      decimals="INF"
      id="f-424"
      unitRef="country">55</us-gaap:NumberOfCountriesInWhichEntityOperates>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-43" decimals="3" id="f-425" unitRef="number">0.360</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-44" decimals="3" id="f-426" unitRef="number">0.526</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-45" decimals="3" id="f-427" unitRef="number">0.114</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-428">Summary of Significant Accounting Policies&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The accounting policies noted below were applied in the preparation of the accompanying financial statements of the Company and are in conformity with accounting principles generally accepted in the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition, intangible assets acquired in a business combination, goodwill impairment and income taxation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Disclosure of fair value of financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on the net present value of estimated future cash flows. Debt is measured at amortized cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Financial instruments are measured at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 1: Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 2: Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 3: Inputs are generally unobservable and typically reflect management&#x2019;s estimates of assumptions that market participants would use in pricing the asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business combinations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Accounting for contingent consideration, after the acquisition, depends on the classification of the contingent consideration. Equity-classified contingent consideration is not remeasured after the acquisition date and subsequent settlement is accounted for within equity. Contingent consideration, which is classified as a liability or an asset, is remeasured to fair value at each reporting date until the contingency is resolved. The changes in fair value are recognized in earnings, unless the arrangement is a derivative which has been designated as a hedging instrument in a cash flow hedging relationship, in which case, the changes are initially recognized in other comprehensive income/loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and any contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign currencies and translation of subsidiaries&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's financial statements are prepared in United States dollars. The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income/loss. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Transactions in currencies other than the functional currency of the subsidiaries of the Company are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the subsidiaries of the Company are translated into the functional currency of that entity at exchange rates prevailing at the balance sheet date. Adjustments resulting from these translations are charged or credited to income. Foreign currency gains and losses on intercompany transactions classified as long-term investments are reported in other comprehensive income/loss as currency translation adjustments. Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts (credited) / charged&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,085)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,997)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Clinical trial service revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through / reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Laboratory services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.    &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contracting services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consulting services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Data services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the &#x201c;units delivered&#x201d; output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commissions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reimbursable expenses&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. The Company includes reimbursed expenses in revenue and direct costs as the Company is primarily responsible for fulfilling the promise to provide the specified service, including integration of the related services into a combined output to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Direct costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. Payments are made based on predetermined contractual arrangements. Timing of payments may differ from the timing of the expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in debt, equity and other&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Available for sale investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies short-term investments as available for sale. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity.  Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses. Realized gains and losses are determined using specific identification.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long term investments  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2024 and December&#160;31, 2023 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2024 and December&#160;31, 2023 qualify for the Net Asset Value ("NAV") practical expedient in ASC Topic 820, Fair value Measurements ("ASC 820"). Any increases or decreases in fair value are recognized in earnings in the period. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Investments in equity &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;which do not qualify for the NAV practical expedient are measured at cost, less impa&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;irment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity method investments &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s investments that are not consolidated are accounted for under the equity method if the Company  exercises significant influence. These investments are classified as equity method investments on the Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of losses in equity investments in the Consolidated Statement of Operations. The Company reviews equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts receivable, net and unbilled revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the   Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts receivable early payment discounting&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transfers and Servicing &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;("ASC 860"). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment is stated at cost less accumulated depreciation. Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.716%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Buildings &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2 - 8 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Laboratory equipment &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Motor vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is a lease at inception and reassess if there are changes in terms and conditions of the contract. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December&#160;31, 2024 and December&#160;31, 2023, the Company did not account for any leases as finance leases. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Operating leases are included in operating right-of-use ("ROU") assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at the lease commencement date. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Subleases are accounted for as operating leases separately from the lease they relate to, but similar in manner as all other leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ROU assets for operating leases are occasionally reduced by impairment losses. The Company uses the long-lived assets impairment guidance in ASC Subtopic 360-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property, Plant, and  Equipment &#x2013; Overall&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Intangible assets are measured at fair value at the date of acquisition and amortized on a straight-line basis over their respective estimated useful lives. The Company has no indefinite-lived intangible assets. The Company evaluates its intangible assets for impairment when indicators of impairment exist. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Intangible assets are amortized on a straight-line basis over their estimated useful lives, as set forth in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.716%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8 - 23 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3 - 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Technology assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company periodically assesses the estimated useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of goodwill and long-lived assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Goodwill is tested for impairment annually, or more frequently, if an event or circumstance indicates that an impairment loss may have been incurred.  The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also chose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Fair value is determined through various valuation techniques including discounted cash flow models and third-party independent appraisals, as considered necessary. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"&gt;Debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Debt issuance costs relating to the Company&#x2019;s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company&#x2019;s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has used derivative financial instruments to reduce exposures to interest rates. Derivatives are recorded on the Consolidated Balance Sheet at fair value at each balance sheet date utilizing pricing models for non-exchange-traded contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criteria for designating a derivative as a hedge include the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income and reclassify it &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the provision of income taxes in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of Global Intangible Low-Taxed Income ("GILTI") in the period it arises and has therefore not provided for deferred taxes in respect of this item.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Government grants&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Under the grant agreements, amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and development credits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Research and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits may be recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC Topic 718, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation &#x2013; Stock Compensation &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;("ASC 718")&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Replacement awards&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transaction and integration-related expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Transaction and integration-related expenses are the incremental costs directly attributable to completion and integration activities associated with the Company&#x2019;s recent acquisitions. The costs consist of investment banking fees, advisory costs, professional fees, legal costs, retention agreements with employees, and ongoing integration activities offset by the remeasurement of liability-classified contingent consideration. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"&gt;Restructuring&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Restructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company&#x2019;s structure and facilitate improved long-term performance. Asset related impairment charges are taken when the fair value is less than the asset&#x2019;s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"&gt;Net income per ordinary share&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Impact of Recently Issued or Adopted Accounting Standards&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting pronouncements recently adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In November 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-07, Segment Reporting &#x2013; Improvements to Reportable Segment Disclosures (&#x201c;ASU 2023-07&#x201d;), which amends the guidance in ASC Topic 280, Segment Reporting (&#x201c;Topic 280&#x201d;). The amended guidance requires disclosure of significant segment expenses and other segment items on an annual and interim basis, as well as additional qualitative disclosures. Furthermore, all disclosures about a reportable segment&#x2019;s profit or loss, which are currently required annually, will be mandated for interim periods. The Company adopted ASU 2023-07 effective January 1, 2024, which resulted in additional segment reporting related disclosures. Refer to note &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;22. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Segment and Geographical Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:107%"&gt;Accounting pronouncements issued but not adopted as of December&#160;31, 2024&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following accounting pronouncements have been issued, but not yet adopted, as of December&#160;31, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, which requires disaggregated information about an entity&#x2019;s effective tax rate reconciliation and additional discloses on income taxes paid. The new requirements are effective for annual periods beginning after December 15, 2024. The guidance is to be applied prospectively, with an option for retrospective application. The Company is currently evaluating the impact of this new guidance on disclosures within its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which requires disaggregated disclosure of income statement expenses. The new standard requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement, as well as disclosures about selling expenses. The new requirements are effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Requirements are to be applied prospectively, with an option for retrospective application. The Company is currently evaluating the impact of this new guidance on disclosures within its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-429">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-430">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition, intangible assets acquired in a business combination, goodwill impairment and income taxation.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c-1" id="f-431">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Disclosure of fair value of financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on the net present value of estimated future cash flows. Debt is measured at amortized cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Financial instruments are measured at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 1: Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 2: Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 3: Inputs are generally unobservable and typically reflect management&#x2019;s estimates of assumptions that market participants would use in pricing the asset or liability.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:BusinessCombinationsPolicy contextRef="c-1" id="f-432">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business combinations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Accounting for contingent consideration, after the acquisition, depends on the classification of the contingent consideration. Equity-classified contingent consideration is not remeasured after the acquisition date and subsequent settlement is accounted for within equity. Contingent consideration, which is classified as a liability or an asset, is remeasured to fair value at each reporting date until the contingency is resolved. The changes in fair value are recognized in earnings, unless the arrangement is a derivative which has been designated as a hedging instrument in a cash flow hedging relationship, in which case, the changes are initially recognized in other comprehensive income/loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and any contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transaction and integration-related expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Transaction and integration-related expenses are the incremental costs directly attributable to completion and integration activities associated with the Company&#x2019;s recent acquisitions. The costs consist of investment banking fees, advisory costs, professional fees, legal costs, retention agreements with employees, and ongoing integration activities offset by the remeasurement of liability-classified contingent consideration. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c-1" id="f-433">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign currencies and translation of subsidiaries&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's financial statements are prepared in United States dollars. The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income/loss. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Transactions in currencies other than the functional currency of the subsidiaries of the Company are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the subsidiaries of the Company are translated into the functional currency of that entity at exchange rates prevailing at the balance sheet date. Adjustments resulting from these translations are charged or credited to income. Foreign currency gains and losses on intercompany transactions classified as long-term investments are reported in other comprehensive income/loss as currency translation adjustments. Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts (credited) / charged&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,085)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,997)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <iclr:ForeignCurrencyDisclosureTableTextBlock contextRef="c-1" id="f-434">Amounts charged or credited to the Consolidated Statements of Operations for the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022 were as follows:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts (credited) / charged&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,085)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,997)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iclr:ForeignCurrencyDisclosureTableTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-1" decimals="-3" id="f-435" unitRef="usd">18085000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-5" decimals="-3" id="f-436" unitRef="usd">-12916000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-6" decimals="-3" id="f-437" unitRef="usd">25997000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-438">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Clinical trial service revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through / reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Laboratory services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.    &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contracting services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consulting services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Data services revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the &#x201c;units delivered&#x201d; output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commissions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="c-1" id="f-439">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reimbursable expenses&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. The Company includes reimbursed expenses in revenue and direct costs as the Company is primarily responsible for fulfilling the promise to provide the specified service, including integration of the related services into a combined output to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Direct costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. Payments are made based on predetermined contractual arrangements. Timing of payments may differ from the timing of the expense.&lt;/span&gt;&lt;/div&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-440">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock contextRef="c-1" id="f-441">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in debt, equity and other&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Available for sale investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies short-term investments as available for sale. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity.  Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses. Realized gains and losses are determined using specific identification.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long term investments  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2024 and December&#160;31, 2023 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2024 and December&#160;31, 2023 qualify for the Net Asset Value ("NAV") practical expedient in ASC Topic 820, Fair value Measurements ("ASC 820"). Any increases or decreases in fair value are recognized in earnings in the period. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Investments in equity &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;which do not qualify for the NAV practical expedient are measured at cost, less impa&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;irment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity method investments &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s investments that are not consolidated are accounted for under the equity method if the Company  exercises significant influence. These investments are classified as equity method investments on the Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of losses in equity investments in the Consolidated Statement of Operations. The Company reviews equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="c-1" id="f-442">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts receivable, net and unbilled revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the   Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts receivable early payment discounting&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transfers and Servicing &lt;/span&gt;("ASC 860"). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows.</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c-1" id="f-443">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment is stated at cost less accumulated depreciation. Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.716%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Buildings &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2 - 8 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Laboratory equipment &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Motor vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <iclr:ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock contextRef="c-1" id="f-444">Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below:&#160;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.716%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Buildings &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2 - 8 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Laboratory equipment &#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Motor vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iclr:ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-46" id="f-445">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-47" id="f-446">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-48" id="f-447">P8Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-49" id="f-448">P8Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-50" id="f-449">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-51" id="f-450">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c-1" id="f-451">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is a lease at inception and reassess if there are changes in terms and conditions of the contract. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December&#160;31, 2024 and December&#160;31, 2023, the Company did not account for any leases as finance leases. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Operating leases are included in operating right-of-use ("ROU") assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at the lease commencement date. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Subleases are accounted for as operating leases separately from the lease they relate to, but similar in manner as all other leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ROU assets for operating leases are occasionally reduced by impairment losses. The Company uses the long-lived assets impairment guidance in ASC Subtopic 360-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property, Plant, and  Equipment &#x2013; Overall&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy contextRef="c-1" id="f-452">&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Intangible assets are measured at fair value at the date of acquisition and amortized on a straight-line basis over their respective estimated useful lives. The Company has no indefinite-lived intangible assets. The Company evaluates its intangible assets for impairment when indicators of impairment exist. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Intangible assets are amortized on a straight-line basis over their estimated useful lives, as set forth in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.716%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8 - 23 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3 - 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Technology assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company periodically assesses the estimated useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c-1" id="f-453">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.716%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8 - 23 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3 - 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Technology assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Intangible Assets for the years ended December&#160;31, 2024 and 2023 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,129,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,090,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;543,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;541,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade names &amp;amp; brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Technology assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;141,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,199,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,147,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,639,212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,292,106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net book value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,559,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,855,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-52" id="f-454">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-53" id="f-455">P23Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-54" id="f-456">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-55" id="f-457">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-56" id="f-458">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-57" id="f-459">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-58" id="f-460">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock contextRef="c-1" id="f-461">&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of goodwill and long-lived assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Goodwill is tested for impairment annually, or more frequently, if an event or circumstance indicates that an impairment loss may have been incurred.  The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also chose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Fair value is determined through various valuation techniques including discounted cash flow models and third-party independent appraisals, as considered necessary. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <us-gaap:DebtPolicyTextBlock contextRef="c-1" id="f-462">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"&gt;Debt issuance costs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Debt issuance costs relating to the Company&#x2019;s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company&#x2019;s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="c-1" id="f-463">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative financial instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has used derivative financial instruments to reduce exposures to interest rates. Derivatives are recorded on the Consolidated Balance Sheet at fair value at each balance sheet date utilizing pricing models for non-exchange-traded contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criteria for designating a derivative as a hedge include the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income and reclassify it &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-464">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the provision of income taxes in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of Global Intangible Low-Taxed Income ("GILTI") in the period it arises and has therefore not provided for deferred taxes in respect of this item.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <iclr:GovernmentGrantsPolicyTextBlock contextRef="c-1" id="f-465">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Government grants&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Under the grant agreements, amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.&lt;/span&gt;&lt;/div&gt;</iclr:GovernmentGrantsPolicyTextBlock>
    <iclr:ResearchAndDevelopmentCreditsPolicyTextBlock contextRef="c-1" id="f-466">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and development credits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Research and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits may be recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.&lt;/span&gt;&lt;/div&gt;</iclr:ResearchAndDevelopmentCreditsPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c-1" id="f-467">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC Topic 718, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation &#x2013; Stock Compensation &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;("ASC 718")&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Replacement awards&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy contextRef="c-1" id="f-468">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"&gt;Restructuring&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Restructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company&#x2019;s structure and facilitate improved long-term performance. Asset related impairment charges are taken when the fair value is less than the asset&#x2019;s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.&lt;/span&gt;&lt;/div&gt;</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c-1" id="f-469">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%"&gt;Net income per ordinary share&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-470">&lt;div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Impact of Recently Issued or Adopted Accounting Standards&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting pronouncements recently adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In November 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-07, Segment Reporting &#x2013; Improvements to Reportable Segment Disclosures (&#x201c;ASU 2023-07&#x201d;), which amends the guidance in ASC Topic 280, Segment Reporting (&#x201c;Topic 280&#x201d;). The amended guidance requires disclosure of significant segment expenses and other segment items on an annual and interim basis, as well as additional qualitative disclosures. Furthermore, all disclosures about a reportable segment&#x2019;s profit or loss, which are currently required annually, will be mandated for interim periods. The Company adopted ASU 2023-07 effective January 1, 2024, which resulted in additional segment reporting related disclosures. Refer to note &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;22. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Segment and Geographical Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:107%"&gt;Accounting pronouncements issued but not adopted as of December&#160;31, 2024&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following accounting pronouncements have been issued, but not yet adopted, as of December&#160;31, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures, which requires disaggregated information about an entity&#x2019;s effective tax rate reconciliation and additional discloses on income taxes paid. The new requirements are effective for annual periods beginning after December 15, 2024. The guidance is to be applied prospectively, with an option for retrospective application. The Company is currently evaluating the impact of this new guidance on disclosures within its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which requires disaggregated disclosure of income statement expenses. The new standard requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement, as well as disclosures about selling expenses. The new requirements are effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Requirements are to be applied prospectively, with an option for retrospective application. The Company is currently evaluating the impact of this new guidance on disclosures within its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c-1" id="f-471">Disaggregation of Revenue&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue disaggregated by customer concentration is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Top client&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;639,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;721,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;683,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 2-5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,431,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,453,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,506,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 6-10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,306,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,188,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,112,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 11-25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,774,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,743,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,585,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,129,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,012,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,853,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,281,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$8,120,176&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$7,741,386&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;There was no revenue from individual customers greater than 10% of consolidated revenue in the respective years. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our customers have similar profiles and economic characteristics, and therefore have similar degrees of risk and growth opportunities.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable and unbilled revenue are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.461%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Billed services (accounts receivable)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,437,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,821,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses (note 5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35,664)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,533)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable (net)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,401,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,790,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unbilled services (unbilled revenue)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,286,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;951,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable and unbilled revenue, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,688,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,742,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.769%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.769%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.769%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.773%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$ Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;% Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="12" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unbilled services (unbilled revenue)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,286,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;951,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;334,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue (payments on account)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,614,758)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,654,507)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(328,484)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(702,571)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;374,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(53.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled revenue and therefore contract assets rather than accounts receivable when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right of set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Consolidated Balance Sheet.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support a clinical trial. The progress towards completion for clinical service contracts is measured &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;based on total project costs (including reimbursable costs). Amounts owed to investigators and others in respect of reimbursable expenses at December&#160;31, 2024 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;and December&#160;31, 2023 were $369.2&#160;million &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;and $333.0&#160;million (see note 12. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other liabilities&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unbilled services as at December&#160;31, 2024 increased by $334.3 million as compared to December&#160;31, 2023. Unearned revenue decreased by $39.7 million over the same period resulting in a decrease of $374.1 million in the net balance of unbilled services and unearned revenue or payments on account between December&#160;31, 2023 and December&#160;31, 2024. These fluctuations are primarily due to the timing of payments and invoicing related to the Company's clinical trial management contracts. Billings and payments are established by contractual provisions on the delivery of units/milestones including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contracts when a cost-based input method of revenue recognition is applied and revenue recognized e&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;xceeds the amount billed to the customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The credit loss expense recognized on the Company's receivables and unbilled services was $28.4&#160;million and $24.6&#160;million for the years ended December&#160;31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$15.9 billion (December&#160;31, 2023: $14.8 billion) of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations. The Company expects to recognize revenue on approximately 47% of the u&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;nsatisfied performance obligation over the next twelve months (December&#160;31, 2023:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; 52%)&lt;/span&gt;, with the remainder recognized thereafter over the duration of the customer contracts.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-472">&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue disaggregated by customer concentration is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Top client&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;639,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;721,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;683,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 2-5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,431,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,453,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,506,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 6-10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,306,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,188,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,112,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Clients 11-25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,774,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,743,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,585,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,129,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,012,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,853,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,281,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$8,120,176&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$7,741,386&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-59" decimals="-3" id="f-473" unitRef="usd">639520000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-60" decimals="-3" id="f-474" unitRef="usd">721309000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-61" decimals="-3" id="f-475" unitRef="usd">683546000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-62" decimals="-3" id="f-476" unitRef="usd">1431873000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-63" decimals="-3" id="f-477" unitRef="usd">1453508000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-64" decimals="-3" id="f-478" unitRef="usd">1506087000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-65" decimals="-3" id="f-479" unitRef="usd">1306604000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-66" decimals="-3" id="f-480" unitRef="usd">1188943000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-67" decimals="-3" id="f-481" unitRef="usd">1112636000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-68" decimals="-3" id="f-482" unitRef="usd">1774160000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-69" decimals="-3" id="f-483" unitRef="usd">1743539000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-70" decimals="-3" id="f-484" unitRef="usd">1585739000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-71" decimals="-3" id="f-485" unitRef="usd">3129519000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-72" decimals="-3" id="f-486" unitRef="usd">3012877000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-73" decimals="-3" id="f-487" unitRef="usd">2853378000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-488" unitRef="usd">8281676000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-3" id="f-489" unitRef="usd">8120176000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-3" id="f-490" unitRef="usd">7741386000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock contextRef="c-1" id="f-491">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable and unbilled revenue are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.461%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Billed services (accounts receivable)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,437,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,821,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses (note 5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35,664)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(31,533)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable (net)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,401,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,790,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unbilled services (unbilled revenue)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,286,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;951,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts receivable and unbilled revenue, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,688,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,742,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.769%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.769%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.769%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.773%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$ Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;% Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="12" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands, except percentages)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unbilled services (unbilled revenue)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,286,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;951,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;334,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue (payments on account)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,614,758)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,654,507)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(328,484)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(702,571)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;374,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(53.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:BilledContractReceivables contextRef="c-3" decimals="-3" id="f-492" unitRef="usd">1437653000</us-gaap:BilledContractReceivables>
    <us-gaap:BilledContractReceivables contextRef="c-4" decimals="-3" id="f-493" unitRef="usd">1821855000</us-gaap:BilledContractReceivables>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-3" decimals="-3" id="f-494" unitRef="usd">35664000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-4" decimals="-3" id="f-495" unitRef="usd">31533000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <iclr:ContractsReceivableGross contextRef="c-3" decimals="-3" id="f-496" unitRef="usd">1401989000</iclr:ContractsReceivableGross>
    <iclr:ContractsReceivableGross contextRef="c-4" decimals="-3" id="f-497" unitRef="usd">1790322000</iclr:ContractsReceivableGross>
    <us-gaap:ContractWithCustomerAssetGrossCurrent contextRef="c-3" decimals="-3" id="f-498" unitRef="usd">1286274000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent contextRef="c-4" decimals="-3" id="f-499" unitRef="usd">951936000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <iclr:ContractsReceivableNet contextRef="c-3" decimals="-3" id="f-500" unitRef="usd">2688263000</iclr:ContractsReceivableNet>
    <iclr:ContractsReceivableNet contextRef="c-4" decimals="-3" id="f-501" unitRef="usd">2742258000</iclr:ContractsReceivableNet>
    <us-gaap:ContractWithCustomerAssetGrossCurrent contextRef="c-3" decimals="-3" id="f-502" unitRef="usd">1286274000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <us-gaap:ContractWithCustomerAssetGrossCurrent contextRef="c-4" decimals="-3" id="f-503" unitRef="usd">951936000</us-gaap:ContractWithCustomerAssetGrossCurrent>
    <iclr:IncreaseDecreaseInContractWithCustomerAssetGrossCurrent contextRef="c-1" decimals="-3" id="f-504" unitRef="usd">334338000</iclr:IncreaseDecreaseInContractWithCustomerAssetGrossCurrent>
    <iclr:IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent contextRef="c-1" decimals="3" id="f-505" unitRef="number">0.351</iclr:IncreaseDecreaseInContractWithCustomerAssetGrossCurrentPercent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-3" decimals="-3" id="f-506" unitRef="usd">1614758000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-3" id="f-507" unitRef="usd">1654507000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent contextRef="c-1" decimals="-3" id="f-508" unitRef="usd">-39749000</iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent>
    <iclr:IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent contextRef="c-1" decimals="3" id="f-509" unitRef="number">-0.024</iclr:IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent>
    <iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable contextRef="c-3" decimals="-3" id="f-510" unitRef="usd">-328484000</iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable>
    <iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable contextRef="c-4" decimals="-3" id="f-511" unitRef="usd">-702571000</iclr:AdvancePaymentsNettedAgainstUnbilledContractsReceivable>
    <iclr:ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable contextRef="c-1" decimals="-3" id="f-512" unitRef="usd">-374087000</iclr:ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable>
    <iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent contextRef="c-1" decimals="3" id="f-513" unitRef="number">-0.532</iclr:ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent>
    <iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses contextRef="c-3" decimals="-5" id="f-514" unitRef="usd">369200000</iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses>
    <iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses contextRef="c-4" decimals="-5" id="f-515" unitRef="usd">333000000</iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses>
    <iclr:IncreaseDecreaseInContractWithCustomerAssetGrossCurrent contextRef="c-1" decimals="-5" id="f-516" unitRef="usd">334300000</iclr:IncreaseDecreaseInContractWithCustomerAssetGrossCurrent>
    <iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent contextRef="c-1" decimals="-5" id="f-517" unitRef="usd">-39700000</iclr:IncreaseDecreaseInContractsWithCustomersLiabilityCurrent>
    <iclr:ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable contextRef="c-1" decimals="-5" id="f-518" unitRef="usd">-374100000</iclr:ChangeInAdvancePaymentsNettedAgainstUnbilledContractsReceivable>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense contextRef="c-1" decimals="-5" id="f-519" unitRef="usd">28400000</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense contextRef="c-5" decimals="-5" id="f-520" unitRef="usd">24600000</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-3" decimals="-8" id="f-521" unitRef="usd">15900000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-4" decimals="-8" id="f-522" unitRef="usd">14800000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c-74" decimals="2" id="f-523" unitRef="number">0.47</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-75" id="f-524">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 contextRef="c-74" id="f-525">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c-75" decimals="2" id="f-526" unitRef="number">0.52</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:AllowanceForCreditLossesTextBlock contextRef="c-1" id="f-527">Allowance for Credit Losses&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company does business with most major international pharmaceutical companies. Provision for credit losses at December&#160;31, 2024&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; and December&#160;31, 2023 comprises:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts used during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,887)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13,358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts provided during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Closing provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AllowanceForCreditLossesTextBlock>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock contextRef="c-1" id="f-528">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company does business with most major international pharmaceutical companies. Provision for credit losses at December&#160;31, 2024&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; and December&#160;31, 2023 comprises:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts used during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,887)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13,358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts provided during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Closing provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-4" decimals="-3" id="f-529" unitRef="usd">31533000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-23" decimals="-3" id="f-530" unitRef="usd">20562000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs contextRef="c-1" decimals="-3" id="f-531" unitRef="usd">24887000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs contextRef="c-5" decimals="-3" id="f-532" unitRef="usd">13358000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <iclr:AccountsReceivableCreditLossExpense contextRef="c-1" decimals="-3" id="f-533" unitRef="usd">28417000</iclr:AccountsReceivableCreditLossExpense>
    <iclr:AccountsReceivableCreditLossExpense contextRef="c-5" decimals="-3" id="f-534" unitRef="usd">24550000</iclr:AccountsReceivableCreditLossExpense>
    <iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments contextRef="c-1" decimals="-3" id="f-535" unitRef="usd">601000</iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments>
    <iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments contextRef="c-5" decimals="-3" id="f-536" unitRef="usd">-221000</iclr:AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-3" decimals="-3" id="f-537" unitRef="usd">35664000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-4" decimals="-3" id="f-538" unitRef="usd">31533000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="c-1" id="f-539">Business Combinations&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;KCR S.A. Group Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On August 19, 2024, the Company acquired the KCR S.A. Group ("KCR"), a CRO offering full service and functional services partnership ("FSP") clinical trial services, in exchange for consideration of $92.5&#160;million. The acquisition of KCR has been accounted for as a business combination in accordance with ASC 805 'Business Combinations' ('ASC 805'). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The net cash outflow was $76.4&#160;million comprising cash payments of $88.1&#160;million, net of cash acquired of $11.7&#160;million. The fair value of contingent consideration was initially measured at the date of acquisition at $4.3&#160;million and subsequently remeasured at $1.1&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The final purchase price allocation resulted in the recognition of goodwill of $43.4&#160;million and intangible assets of $45.1&#160;million. Goodwill arising in connection with the acquisition is primarily attributable to the assembled workforce of KCR and the expected synergies of the acquisition. The goodwill recognized is not deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Since August 19, 2024, KCR has earned revenue of $32.8&#160;million and net income of $1.8&#160;million which are included in the Group's Consolidated Statement of Operations for the year ended December 31, 2024. The pro-forma effect of the KCR acquisition if completed on January 1, 2023 would have resulted in revenue and net income for the fiscal year ended December 31, 2024 of $8,331.5&#160;million and $792.5&#160;million respectively and in revenue and net income for the fiscal year ended December 31, 2023 of $8,202.0&#160;million and $613.3&#160;million respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;HumanFirst Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On January 9, 2024, the Company acquired HumanFirst Inc. ("HumanFirst"), a life sciences technology company in exchange for consideration of $13.3&#160;million. The acquisition of HumanFirst has been accounted for as a business combination in accordance with ASC 805. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The net cash outflow was $7.8&#160;million comprising initial cash payments of $11.8&#160;million, net of cash acquired of $4.0&#160;million. Deferred consideration of $1.4&#160;million remains unpaid as of December&#160;31, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The final purchase price allocation resulted in the recognition of goodwill of $2.7&#160;million and a developed technology intangible asset of $9.9&#160;million. Goodwill arising in connection with the acquisition is primarily attributable to the assembled workforce of HumanFirst. The goodwill recognized is not deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;BioTel Research LLC Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On October 2, 2023, the Company acquired the entire outstanding equity interests of BioTel Research LLC (&#x201c;BioTel&#x201d;), a leading provider of medical imaging and cardiac safety monitoring services, from BioTelemetry Inc. in exchange for initial cash consideration of $68.1 million. Cash acquired amounted to $1.4&#160;million. The final purchase price allocation resulted in the recognition of intangible assets of $36.4 million and goodwill of $23.4 million. Goodwill arising in connection with the acquisition is primarily attributable to the assembled workforce of BioTel and the expected synergies of the acquisition. The goodwill recognized is deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;PRA Health Sciences, Inc. Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On July 1, 2021 (the "Merger Date"), the Company completed the acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of PRA Health Sciences ("the Acquisition" and "the Merger"). The Merger was accounted for as a business combination using the acquisition method of accounting in accordance with ASC 805.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022, the Company incurred approximately $23.5 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$16.4 million and $17.7 million of Merger-related financing fees which are included in the &#x201c;Interest expense&#x201d; line item in the Consolidated Statement of Operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Oncacare Limited Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On April 20, 2023, the Company completed the purchase of the majority investor's 51% majority voting share capital of Oncacare Limited ("Oncacare") for $5.1&#160;million, such that Oncacare and its subsidiaries became wholly-owned subsidiaries of the ICON Group. The Oncacare acquisition resulted in goodwill of $13.4 million and also gave rise to an acquisition-related gain of $6.2 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;Transaction and Integration Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In the years ended December&#160;31, 2024, December&#160;31, 2023, and  December&#160;31, 2022, the Company incurred net Merger, transaction and integration related expenses of $29.6 million, $44.2 million and $39.7 million, respectively, which were accounted for separately from the business combination and expensed as incurred within the &#x201c;Transaction and integration related&#x201d; line item of the Consolidated Statement of Operations. The costs consist of investment banking fees, advisory costs, &lt;/span&gt;&lt;/div&gt;professional fees, legal costs, retention agreements with employees, ongoing business combination and integration activities offset by the remeasurement of liability-classified contingent consideration.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-76" decimals="-5" id="f-540" unitRef="usd">92500000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-76" decimals="-5" id="f-541" unitRef="usd">76400000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-76" decimals="-5" id="f-542" unitRef="usd">88100000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:CashAcquiredFromAcquisition contextRef="c-76" decimals="-5" id="f-543" unitRef="usd">11700000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:BusinessCombinationAssetsArisingFromContingenciesAmountRecognized contextRef="c-77" decimals="-5" id="f-544" unitRef="usd">4300000</us-gaap:BusinessCombinationAssetsArisingFromContingenciesAmountRecognized>
    <us-gaap:BusinessCombinationAssetsArisingFromContingenciesAmountRecognized contextRef="c-78" decimals="-5" id="f-545" unitRef="usd">1100000</us-gaap:BusinessCombinationAssetsArisingFromContingenciesAmountRecognized>
    <us-gaap:Goodwill contextRef="c-77" decimals="-5" id="f-546" unitRef="usd">43400000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-77" decimals="-5" id="f-547" unitRef="usd">45100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual contextRef="c-79" decimals="-5" id="f-548" unitRef="usd">32800000</us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual contextRef="c-79" decimals="-5" id="f-549" unitRef="usd">1800000</us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="c-80" decimals="-5" id="f-550" unitRef="usd">8331500000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="c-80" decimals="-5" id="f-551" unitRef="usd">792500000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="c-81" decimals="-5" id="f-552" unitRef="usd">8202000000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="c-81" decimals="-5" id="f-553" unitRef="usd">613300000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-82" decimals="-5" id="f-554" unitRef="usd">13300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-82" decimals="-5" id="f-555" unitRef="usd">7800000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-82" decimals="-5" id="f-556" unitRef="usd">11800000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:CashAcquiredFromAcquisition contextRef="c-82" decimals="-5" id="f-557" unitRef="usd">4000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-83" decimals="-5" id="f-558" unitRef="usd">1400000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:Goodwill contextRef="c-84" decimals="-5" id="f-559" unitRef="usd">2700000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-84" decimals="-5" id="f-560" unitRef="usd">9900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-85" decimals="-5" id="f-561" unitRef="usd">68100000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:CashAcquiredFromAcquisition contextRef="c-85" decimals="-5" id="f-562" unitRef="usd">1400000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-86" decimals="-5" id="f-563" unitRef="usd">36400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill contextRef="c-86" decimals="-5" id="f-564" unitRef="usd">23400000</us-gaap:Goodwill>
    <us-gaap:InterestExpenseNonoperating contextRef="c-87" decimals="-5" id="f-565" unitRef="usd">23500000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-88" decimals="-5" id="f-566" unitRef="usd">16400000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-89" decimals="-5" id="f-567" unitRef="usd">17700000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c-90" decimals="2" id="f-568" unitRef="number">0.51</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-91" decimals="-5" id="f-569" unitRef="usd">5100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:Goodwill contextRef="c-90" decimals="-5" id="f-570" unitRef="usd">13400000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount contextRef="c-91" decimals="-5" id="f-571" unitRef="usd">6200000</us-gaap:BusinessCombinationBargainPurchaseGainRecognizedAmount>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts contextRef="c-1" decimals="-5" id="f-572" unitRef="usd">29600000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts contextRef="c-5" decimals="-5" id="f-573" unitRef="usd">44200000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts contextRef="c-6" decimals="-5" id="f-574" unitRef="usd">39700000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-575">Fair Value&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company records certain assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy that prioritizes the inputs used to measure fair value is described below. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 1 &#x2014; Quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 2 &#x2014; Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt"&gt;Level 3 &#x2014; Unobservable inputs that are supported by little or no market activity. This includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable and accounts payable approximate fair value due to the short maturities of these instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.574%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;1,2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Excludes investments in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;equity securities recorded at cost of $3.5 million which do not qualify for the NAV practical expedient.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; As at December&#160;31, 2023, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,804&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,804&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;4&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Certain investments qualify for the NAV practical expedient in ASC 820. Investments in equity consist of interests in funds and equity securities without readily determinable fair values. To determine the classification of investments in equity, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2024 and December&#160;31, 2023 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2024 and December&#160;31, 2023 qualify for the NAV practical expedient. Any increases or decreases in fair value are recognized in net income in the period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Represents the fair value of highly liquid investments with maturities greater than three months, a minimum "A-" rated fixed term deposit and are based on quoted market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;4&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Represents the fair value of the interest rate caps and the interest rate swap. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-recurring Fair Value Measurements &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certain assets and liabilities are carried on the Consolidated Balance Sheet at cost and are not re-measured to fair value on a recurring basis. These assets include finite-lived intangible assets that are tested for impairment when a triggering event occurs and goodwill that is tested for impairment annually or when a triggering event occurs. As of December&#160;31, 2024, assets carried on the balance sheet and not re-measured to fair value on a recurring basis totaled approximately $12,614.7 million (December&#160;31, 2023: $12,878.0 million) and are identified as Level 3 assets. These assets are comprised of goodwill of $9,051.4 million (December&#160;31, 2023: $9,022.1 million), intangible assets of $3,559.8 million (December&#160;31, 2023: $3,855.9 million) and investments in equity recorded at cost of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$3.5 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the Company&#x2019;s debt was $3,469.2&#160;million at December&#160;31, 2024 (December&#160;31, 2023: $3,793.5&#160;million). &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair values of the senior secured term loan facility&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, the 2026 Notes and the New Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions. The fair value of the senior secured revolving loan facility approximates its carrying value, due to the short term duration.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="c-1" id="f-577">he fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.574%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;1,2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Excludes investments in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;equity securities recorded at cost of $3.5 million which do not qualify for the NAV practical expedient.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; As at December&#160;31, 2023, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,804&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,804&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;4&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Certain investments qualify for the NAV practical expedient in ASC 820. Investments in equity consist of interests in funds and equity securities without readily determinable fair values. To determine the classification of investments in equity, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2024 and December&#160;31, 2023 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2024 and December&#160;31, 2023 qualify for the NAV practical expedient. Any increases or decreases in fair value are recognized in net income in the period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Represents the fair value of highly liquid investments with maturities greater than three months, a minimum "A-" rated fixed term deposit and are based on quoted market prices.&lt;/span&gt;&lt;/div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;4&lt;/span&gt;Represents the fair value of the interest rate caps and the interest rate swap.</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock contextRef="c-1" id="f-576">he fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:37.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.574%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;1,2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Excludes investments in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;equity securities recorded at cost of $3.5 million which do not qualify for the NAV practical expedient.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; As at December&#160;31, 2023, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available for sale securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,804&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,804&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Derivative instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;4&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Certain investments qualify for the NAV practical expedient in ASC 820. Investments in equity consist of interests in funds and equity securities without readily determinable fair values. To determine the classification of investments in equity, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December&#160;31, 2024 and December&#160;31, 2023 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December&#160;31, 2024 and December&#160;31, 2023 qualify for the NAV practical expedient. Any increases or decreases in fair value are recognized in net income in the period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Represents the fair value of highly liquid investments with maturities greater than three months, a minimum "A-" rated fixed term deposit and are based on quoted market prices.&lt;/span&gt;&lt;/div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;4&lt;/span&gt;Represents the fair value of the interest rate caps and the interest rate swap.</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue contextRef="c-92" decimals="-3" id="f-578" unitRef="usd">0</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue contextRef="c-93" decimals="-3" id="f-579" unitRef="usd">0</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue contextRef="c-94" decimals="-3" id="f-580" unitRef="usd">0</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue contextRef="c-95" decimals="-3" id="f-581" unitRef="usd">54448000</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue contextRef="c-96" decimals="-3" id="f-582" unitRef="usd">54448000</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-92" decimals="-3" id="f-583" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-93" decimals="-3" id="f-584" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-94" decimals="-3" id="f-585" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-95" decimals="-3" id="f-586" unitRef="usd">54448000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-96" decimals="-3" id="f-587" unitRef="usd">54448000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNiCost contextRef="c-3" decimals="-5" id="f-588" unitRef="usd">3500000</us-gaap:EquitySecuritiesFvNiCost>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-97" decimals="-3" id="f-589" unitRef="usd">1954000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-98" decimals="-3" id="f-590" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-99" decimals="-3" id="f-591" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-100" decimals="-3" id="f-592" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-101" decimals="-3" id="f-593" unitRef="usd">1954000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue contextRef="c-97" decimals="-3" id="f-594" unitRef="usd">0</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue contextRef="c-98" decimals="-3" id="f-595" unitRef="usd">0</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue contextRef="c-99" decimals="-3" id="f-596" unitRef="usd">0</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue contextRef="c-100" decimals="-3" id="f-597" unitRef="usd">46804000</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue contextRef="c-101" decimals="-3" id="f-598" unitRef="usd">46804000</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-97" decimals="-3" id="f-599" unitRef="usd">1954000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-98" decimals="-3" id="f-600" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-99" decimals="-3" id="f-601" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-100" decimals="-3" id="f-602" unitRef="usd">46804000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-101" decimals="-3" id="f-603" unitRef="usd">48758000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities contextRef="c-102" decimals="-3" id="f-604" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-103" decimals="-3" id="f-605" unitRef="usd">2411000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-104" decimals="-3" id="f-606" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-105" decimals="-3" id="f-607" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-106" decimals="-3" id="f-608" unitRef="usd">2411000</us-gaap:DerivativeLiabilities>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-97" decimals="-3" id="f-609" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-98" decimals="-3" id="f-610" unitRef="usd">2411000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-99" decimals="-3" id="f-611" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-100" decimals="-3" id="f-612" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-101" decimals="-3" id="f-613" unitRef="usd">2411000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-107" decimals="-5" id="f-614" unitRef="usd">12614700000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-108" decimals="-5" id="f-615" unitRef="usd">12878000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:GoodwillFairValueDisclosure contextRef="c-107" decimals="-5" id="f-616" unitRef="usd">9051400000</us-gaap:GoodwillFairValueDisclosure>
    <us-gaap:GoodwillFairValueDisclosure contextRef="c-108" decimals="-5" id="f-617" unitRef="usd">9022100000</us-gaap:GoodwillFairValueDisclosure>
    <us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure contextRef="c-107" decimals="-5" id="f-618" unitRef="usd">3559800000</us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure>
    <us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure contextRef="c-108" decimals="-5" id="f-619" unitRef="usd">3855900000</us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNiCost contextRef="c-3" decimals="-5" id="f-620" unitRef="usd">3500000</us-gaap:EquitySecuritiesFvNiCost>
    <us-gaap:LongTermDebtFairValue contextRef="c-3" decimals="-5" id="f-621" unitRef="usd">3469200000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="c-4" decimals="-5" id="f-622" unitRef="usd">3793500000</us-gaap:LongTermDebtFairValue>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="c-1" id="f-623">Investments&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in equity&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company entered into subscription agreements with a number of funds. During the year ended December&#160;31, 2024, net capital totaling $13.1 million (December&#160;31, 2023: $14.0 million) had been advanced under the terms of the subscription agreements. The Company determined that the interest in funds meets the definition of equity securities without readily determinable fair values. The Company therefore concluded that the interests held at December&#160;31, 2024 and December&#160;31, 2023 qualify for the NAV practical expedient in ASC 820. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;There was a decrease in fair value of $3.3 million (December&#160;31, 2023: increase in fair value $0.2 million) recognized in net income during the year bringing the carrying value of the subscriptions to $54.4 million at December&#160;31, 2024.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2024, the Company had committed to future investments of $102.2 million in respect of these funds.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Investments in equity also include equity investments of $3.5 million &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;(of which &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$1.5 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt; was invested during the year ended December&#160;31, 2024) which do not qualify for the NAV practical expedient, and for which the measurement alternative has been applied.  Accordingly, these investments in equity are measured at cost, less impa&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;irment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%"&gt;Available for sale investments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As at December&#160;31, 2024, the Company held available for sale investments amounting to $nil (December&#160;31, 2023: $2.0 million). Short-term investments comprise highly liquid investments with maturities of greater than three months and minimum "A-" rated fixed term deposits. The Company classifies its short- term investments as available for sale.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount contextRef="c-3" decimals="-5" id="f-624" unitRef="usd">13100000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount contextRef="c-4" decimals="-5" id="f-625" unitRef="usd">14000000.0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi contextRef="c-1" decimals="-5" id="f-626" unitRef="usd">-3300000</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi contextRef="c-5" decimals="-5" id="f-627" unitRef="usd">200000</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-3" decimals="-5" id="f-628" unitRef="usd">54400000</us-gaap:EquitySecuritiesFvNi>
    <iclr:CommitmentToAcquireLongTermInvestments contextRef="c-3" decimals="-5" id="f-629" unitRef="usd">102200000</iclr:CommitmentToAcquireLongTermInvestments>
    <us-gaap:EquitySecuritiesFvNiCost contextRef="c-3" decimals="-5" id="f-630" unitRef="usd">3500000</us-gaap:EquitySecuritiesFvNiCost>
    <us-gaap:PaymentsToAcquireEquitySecuritiesFvNi contextRef="c-1" decimals="-5" id="f-631" unitRef="usd">1500000</us-gaap:PaymentsToAcquireEquitySecuritiesFvNi>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-3" decimals="-5" id="f-632" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-4" decimals="-5" id="f-633" unitRef="usd">2000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c-1" id="f-634">Property, Plant and Equipment, net&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Property, Plant and Equipment for the years ended December&#160;31, 2024 and 2023 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;689,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;550,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Motor vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;928,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;781,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and asset write offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(546,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(419,883)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment (net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;382,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;361,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;The depreciation expense recognized by the Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt; was $138.2 million, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;$126.1 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt; and $106.4 million for the years ended December&#160;31, 2024, 2023, and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company regularly updates its register of property, plant and equipment and during the year ended December&#160;31, 2024 and the year ended December&#160;31, 2023, certain fully depreciated assets were written off as they were no longer used by the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-635">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Property, Plant and Equipment for the years ended December&#160;31, 2024 and 2023 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;689,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;550,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Motor vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;928,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;781,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and asset write offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(546,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(419,883)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment (net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;382,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;361,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:Land contextRef="c-3" decimals="-3" id="f-636" unitRef="usd">3724000</us-gaap:Land>
    <us-gaap:Land contextRef="c-4" decimals="-3" id="f-637" unitRef="usd">3724000</us-gaap:Land>
    <us-gaap:BuildingsAndImprovementsGross contextRef="c-3" decimals="-3" id="f-638" unitRef="usd">66132000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross contextRef="c-4" decimals="-3" id="f-639" unitRef="usd">70072000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:CapitalizedComputerSoftwareGross contextRef="c-3" decimals="-3" id="f-640" unitRef="usd">689979000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross contextRef="c-4" decimals="-3" id="f-641" unitRef="usd">550119000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:FurnitureAndFixturesGross contextRef="c-3" decimals="-3" id="f-642" unitRef="usd">51849000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross contextRef="c-4" decimals="-3" id="f-643" unitRef="usd">45856000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:MachineryAndEquipmentGross contextRef="c-3" decimals="-3" id="f-644" unitRef="usd">55111000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross contextRef="c-4" decimals="-3" id="f-645" unitRef="usd">56217000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:LeaseholdImprovementsGross contextRef="c-3" decimals="-3" id="f-646" unitRef="usd">62034000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross contextRef="c-4" decimals="-3" id="f-647" unitRef="usd">55000000</us-gaap:LeaseholdImprovementsGross>
    <iclr:VehiclesGross contextRef="c-3" decimals="-3" id="f-648" unitRef="usd">65000</iclr:VehiclesGross>
    <iclr:VehiclesGross contextRef="c-4" decimals="-3" id="f-649" unitRef="usd">79000</iclr:VehiclesGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-3" decimals="-3" id="f-650" unitRef="usd">928894000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-4" decimals="-3" id="f-651" unitRef="usd">781067000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-3" decimals="-3" id="f-652" unitRef="usd">546015000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-653" unitRef="usd">419883000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-654" unitRef="usd">382879000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-655" unitRef="usd">361184000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c-1" decimals="-5" id="f-656" unitRef="usd">138200000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-5" decimals="-5" id="f-657" unitRef="usd">126100000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-6" decimals="-5" id="f-658" unitRef="usd">106400000</us-gaap:Depreciation>
    <us-gaap:GoodwillDisclosureTextBlock contextRef="c-1" id="f-659">Goodwill&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The change in the carrying amount of goodwill for the years ended December&#160;31, 2024 and 2023 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.461%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,022,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,971,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current period acquisitions (note 6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange movement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,791)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Closing balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,051,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,022,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;There were no impairment charges for the y&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;ear ended December&#160;31, 2024 or the year ended December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="c-1" id="f-660">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The change in the carrying amount of goodwill for the years ended December&#160;31, 2024 and 2023 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.461%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,022,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,971,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current period acquisitions (note 6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange movement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,791)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Closing balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,051,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,022,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-661" unitRef="usd">9022075000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-23" decimals="-3" id="f-662" unitRef="usd">8971670000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-1" decimals="-3" id="f-663" unitRef="usd">46126000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-5" decimals="-3" id="f-664" unitRef="usd">36750000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-1" decimals="-3" id="f-665" unitRef="usd">-16791000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss contextRef="c-5" decimals="-3" id="f-666" unitRef="usd">13655000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill contextRef="c-3" decimals="-3" id="f-667" unitRef="usd">9051410000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-668" unitRef="usd">9022075000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-1" decimals="-5" id="f-669" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-5" decimals="-5" id="f-670" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="c-1" id="f-671">Intangible Assets&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Intangible Assets for the years ended December&#160;31, 2024 and 2023 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,129,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,090,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Order backlog&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;543,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;541,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade names &amp;amp; brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Technology assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;141,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,199,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,147,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,639,212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,292,106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net book value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,559,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,855,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;The amortization expense recognized by the Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt; was &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;$350.3 million, $459.9 million, and $463.1 million for the years ended December&#160;31, 2024, 2023, and 2022, respe&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;ctively. The decrease in amortization in the twelve months ended December&#160;31, 2024 is due to the order backlog and trade name intangible assets recognized in connection with the PRA merger amounting to &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;$500.0 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt; and &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;$202.0 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt; respectively as of the date of acquisition, becoming fully amortized on July 1, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;On August 19, 2024, the Company acquired KCR. The acquisition resulted in the recognition of intangible assets of $45.1 million, comprising customer relationships of $41.4 million and order backlog of $3.7 million. These assets will be amortized over their expected useful lives of 13 years and 5 years respectively. In total, $1.3 million has been amortized in the period since the date of acquisition.  Refer to note 6. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%"&gt;Business Combinations&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;On January 9, 2024, the Company acquired HumanFirst. The acquisition resulted in the recognition of a developed technology intangible asset of $9.9 million which will be amortized over its expected useful life of 5 years. In total, $2.0 million has been amortized in the period since the date of acquisition. Refer to note 6. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%"&gt;Business Combinations&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;On October 2, 2023, the Co&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;mpany acquired BioTel Research LLC (&#x201c;BioTel&#x201d;). The acquisition resulted in the recognition of intangible assets of $36.4 million, comprising customer relationships of $12.5 million, order backlog of $3.9 million and developed technology assets of $20.0 million. These assets will be amortized over their expected useful lives of between 3 years and 16 years. $6.1 million has been amortized during the twelve months ended December&#160;31, 2024 (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;December&#160;31, 2023: &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$1.5 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;)&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;. Refer to note 6. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%"&gt;Business Combinations&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Future intangible asset amortization expense for the years ended December 31, 2025 to December 31, 2029 is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;235,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;208,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;195,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;180,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,039,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-109" decimals="-3" id="f-672" unitRef="usd">4129501000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-110" decimals="-3" id="f-673" unitRef="usd">4090393000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-111" decimals="-3" id="f-674" unitRef="usd">543933000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-112" decimals="-3" id="f-675" unitRef="usd">541302000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-56" decimals="-3" id="f-676" unitRef="usd">204588000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-113" decimals="-3" id="f-677" unitRef="usd">204653000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-57" decimals="-3" id="f-678" unitRef="usd">170324000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-114" decimals="-3" id="f-679" unitRef="usd">170366000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-58" decimals="-3" id="f-680" unitRef="usd">150658000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-115" decimals="-3" id="f-681" unitRef="usd">141257000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-3" decimals="-3" id="f-682" unitRef="usd">5199004000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-4" decimals="-3" id="f-683" unitRef="usd">5147971000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-3" decimals="-3" id="f-684" unitRef="usd">1639212000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-4" decimals="-3" id="f-685" unitRef="usd">1292106000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-3" decimals="-3" id="f-686" unitRef="usd">3559792000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-4" decimals="-3" id="f-687" unitRef="usd">3855865000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-5" id="f-688" unitRef="usd">350300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-5" decimals="-5" id="f-689" unitRef="usd">459900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-6" decimals="-5" id="f-690" unitRef="usd">463100000</us-gaap:AmortizationOfIntangibleAssets>
    <iclr:DecreaseInAmortisation contextRef="c-116" decimals="-5" id="f-691" unitRef="usd">500000000.0</iclr:DecreaseInAmortisation>
    <iclr:DecreaseInAmortisation contextRef="c-117" decimals="-5" id="f-692" unitRef="usd">202000000.0</iclr:DecreaseInAmortisation>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-77" decimals="-5" id="f-693" unitRef="usd">45100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-118" decimals="-5" id="f-694" unitRef="usd">41400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-119" decimals="-5" id="f-695" unitRef="usd">3700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-118" id="f-696">P13Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-119" id="f-697">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-79" decimals="-5" id="f-698" unitRef="usd">1300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-84" decimals="-5" id="f-699" unitRef="usd">9900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-84" id="f-700">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-120" decimals="-5" id="f-701" unitRef="usd">2000000.0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-86" decimals="-5" id="f-702" unitRef="usd">36400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-121" decimals="-5" id="f-703" unitRef="usd">12500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-122" decimals="-5" id="f-704" unitRef="usd">3900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles contextRef="c-123" decimals="-5" id="f-705" unitRef="usd">20000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-124" id="f-706">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-125" id="f-707">P16Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-126" decimals="-5" id="f-708" unitRef="usd">6100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-127" decimals="-5" id="f-709" unitRef="usd">1500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="c-1" id="f-710">&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Future intangible asset amortization expense for the years ended December 31, 2025 to December 31, 2029 is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;235,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;208,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;195,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;180,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,039,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c-3" decimals="-3" id="f-711" unitRef="usd">235011000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c-3" decimals="-3" id="f-712" unitRef="usd">220771000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c-3" decimals="-3" id="f-713" unitRef="usd">208448000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c-3" decimals="-3" id="f-714" unitRef="usd">195447000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c-3" decimals="-3" id="f-715" unitRef="usd">180201000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <iclr:FiniteLivedIntangibleAssetsAmortizationExpenseNet contextRef="c-3" decimals="-3" id="f-716" unitRef="usd">1039878000</iclr:FiniteLivedIntangibleAssetsAmortizationExpenseNet>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock contextRef="c-1" id="f-717">Other Liabilities&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Other Liabilities for the years ended December&#160;31, 2024 and 2023 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General trade and overhead liabilities*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;531,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;463,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Personnel related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;385,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Facility related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-727"&gt;Other liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restructuring liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Short term government grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;923,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;915,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;*includes amounts due to third parties in respect of accrued reimbursable investigator expenses of $369.2 million at December&#160;31, 2024 and $333.0 million at December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <us-gaap:OtherLiabilitiesTableTextBlock contextRef="c-1" id="f-718">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Other Liabilities for the years ended December&#160;31, 2024 and 2023 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General trade and overhead liabilities*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;531,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;463,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Personnel related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;385,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Facility related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-727"&gt;Other liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restructuring liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Short term government grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;923,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;915,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;*includes amounts due to third parties in respect of accrued reimbursable investigator expenses of $369.2 million at December&#160;31, 2024 and $333.0 million at December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:OtherLiabilitiesTableTextBlock>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-719" unitRef="usd">531560000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-720" unitRef="usd">463882000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-721" unitRef="usd">225822000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-722" unitRef="usd">385499000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-3" id="f-723" unitRef="usd">36783000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-724" unitRef="usd">36414000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccruedUtilitiesCurrent contextRef="c-3" decimals="-3" id="f-725" unitRef="usd">8547000</us-gaap:AccruedUtilitiesCurrent>
    <us-gaap:AccruedUtilitiesCurrent contextRef="c-4" decimals="-3" id="f-726" unitRef="usd">11078000</us-gaap:AccruedUtilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-728" unitRef="usd">91730000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-729" unitRef="usd">13532000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <iclr:RestructuringReserveAndOtherLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-730" unitRef="usd">29120000</iclr:RestructuringReserveAndOtherLiabilitiesCurrent>
    <iclr:RestructuringReserveAndOtherLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-731" unitRef="usd">4951000</iclr:RestructuringReserveAndOtherLiabilitiesCurrent>
    <us-gaap:GovernmentAssistanceLiabilityCurrent contextRef="c-3" decimals="-3" id="f-732" unitRef="usd">41000</us-gaap:GovernmentAssistanceLiabilityCurrent>
    <us-gaap:GovernmentAssistanceLiabilityCurrent contextRef="c-4" decimals="-3" id="f-733" unitRef="usd">43000</us-gaap:GovernmentAssistanceLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-734" unitRef="usd">923603000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-735" unitRef="usd">915399000</us-gaap:OtherLiabilitiesCurrent>
    <iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses contextRef="c-3" decimals="-5" id="f-736" unitRef="usd">369200000</iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses>
    <iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses contextRef="c-4" decimals="-5" id="f-737" unitRef="usd">333000000.0</iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses>
    <us-gaap:LongTermDebtTextBlock contextRef="c-1" id="f-738">Bank credit lines, loan facilities and notes&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company had the following debt outstanding as of December&#160;31, 2024 and &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Principal amount as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;946,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,251,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Notes (the "2026 Notes")&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Revolving Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Notes (the "2027 Notes")*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;May 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Notes (the "2029 Notes")*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;May 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Notes (the "2034 Notes")*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;May 2034&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,446,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,806,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less current portion of debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29,762)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(110,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,416,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,696,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less debt issuance costs and debt discount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,624)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,396,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,665,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;*Issued May 8, 2024&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company incurred interest costs from various financing arrangements during the years ended December&#160;31, 2024,  December&#160;31, 2023 and December&#160;31, 2022 as set out in the table below. These costs have been charged in the interest expense line of the Consolidated Statement of Operations. In the years ending December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022, the Company expensed $23.5 million,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$16.4 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;and $17.7 million of transaction related financing costs, inclusive of the amortization of financing fees which were previously capitalized. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense on drawn facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;206,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;311,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;209,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of merger related financing fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other financing costs*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;237,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;336,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;*Includes costs associated with the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;senior secured revolving loan facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, the contractual maturities of the Company's debt obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.473%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturities of debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;529,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;779,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;857,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2029 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,446,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's primary financing arrangements are its senior secured credit facilities (the "Senior Secured Credit Facilities"), which consists of a senior secured term loan and a revolving credit facility; the 2026 Notes and the New Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;The New Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On May 8, 2024, ICON Investments Six Designated Activity Company (the "Issuer"), a wholly-owned subsidiary of ICON plc, issued $2&#160;billion senior secured notes ("the New Notes"). The New Notes were issued in aggregate principal amounts of: $750&#160;million 5.809% Senior Secured Notes due 2027 (the "2027 Notes"), $750&#160;million 5.849% Senior Secured Notes due 2029 (the "2029 Notes") and $500&#160;million 6.000% Senior Secured Notes due 2034 (the "2034 Notes"). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;The Company paid an underwriting discount of $6.8&#160;million on the New Notes being: 0.250% of the principal amount of the 2027 Notes, 0.350% of the principal amount of the 2029 Notes and 0.450% of the 2034 Notes. Further, the 2034 Notes were issued at a discount of $0.5&#160;million (issued at 99.896% of par). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;The proceeds from the issuance were used to repay a portion of the senior secured term loan outstanding under the Senior Secured Credit Facilities and to pay fees, costs and expenses related to the offering.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Interest on the New Notes is payable on May 8 and November 8 of each year, having commenced on November 8, 2024. Unless previously redeemed, the 2027 Notes will mature on May 8, 2027, the 2029 Notes will mature on May 8, 2029 and the 2034 Notes will mature on May 8, 2034.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The New Notes are guaranteed on a senior secured basis by ICON and its existing and future wholly owned subsidiaries, in each case that guarantee the obligations under our Senior Secured Credit Facilities and the 2026 Notes. The New Notes are the senior secured obligation of the Issuer and the Guarantors and rank equally in right of payment to all of the Issuer&#x2019;s and Guarantors&#x2019; existing and future senior debt and senior in right of payment to all of the Issuer's and Guarantors' existing and future subordinated debt. The New Notes and the guarantees are secured on a first-lien basis by substantially all of the existing and future assets of the Issuer and the Guarantors that also secure the Issuer&#x2019;s and the Guarantors&#x2019; obligations under the Senior Secured Credit Facilities and the 2026 Notes on a pari passu basis, subject to permitted liens, and the liens on the collateral securing the New Notes rank equally in priority with the liens on the collateral securing borrowings and guarantees under the Senior Secured Credit Facilities, the 2026 Notes and any other future pari passu first lien indebtedness.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Secured Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;On July 1, 2021, the Company completed the acquisition of PRA Health Sciences, Inc. ("PRA") by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA, the parent of the PRA Health Sciences ("the Merger"). In conjunction with the completion of the Merger, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515&#160;million and a senior secured revolving loan facility in an initial aggregate principal amount of $300&#160;million (the "Senior Secured Credit Facilities"). On May 2, 2023, the Company agreed with its lenders to increase the aggregate principal amount of the senior secured revolving loan facility from $300&#160;million to $500&#160;million. The Senior Secured Credit Facilities and the 2026 Notes were issued at a discount of $27.6&#160;million.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR plus an applicable margin which is dependent on the Company's net leverage ratio. At &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2024&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, the applicable margin is 2.0% (which reflects the Third Amendment). The senior secured term loan facility is subject to a floor of 0.50%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reflecting the Third Amendment, the interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 0.45%, 0.10% or &#x2013;% based on the Company&#x2019;s current corporate family rating assigned by S&amp;amp;P of BB (or lower), BB+ or BBB- (or higher), respectively, or (ii) Term SOFR plus an applicable margin of 1.45%, 1.10%, 0.85%, 0.65%, or 0.50% based on the Company&#x2019;s current corporate family rating assigned by S&amp;amp;P of BB (or lower), BB+, BBB-, BBB or BBB+ (or higher), respectively. In addition, lenders under the revolving loan facility are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Borrowers&#x2019; (as defined in the Senior Secured Credit Facility) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON&#x2019;s, the Borrowers&#x2019; and each of the subsidiary guarantor&#x2019;s assets (subject to certain exceptions), and the Senior Secured Credit Facilities will have a first-priority lien on such assets, which will rank pari passu with the lien securing the 2026 Notes and the New Notes subject to other permitted liens. The Company is permitted to make prepayments on the senior secured term loan without penalty.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Principal repayments, comprising mandatory and voluntary repayments, during the year ended December&#160;31, 2024 and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.461%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Principal repayments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(275,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(250,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,014,882)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(150,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,441)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(300,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(250,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total repayments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,304,763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(950,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The voluntary repayments made during the year resulted in an accelerated charge associated with previously capitalized fees of $16.9&#160;million (December&#160;31, 2023: $7.9&#160;million). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;During the year ended December&#160;31, 2024, the Company drew down $318.0&#160;million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;(December&#160;31, 2023: $370.0&#160;million) of the senior secured revolving loan facility and repaid $373.0&#160;million  (December&#160;31, 2023: $315.0&#160;million) as shown below. As at December&#160;31, 2024, $nil (December&#160;31, 2023: $55.0&#160;million) was drawn under the senior secured revolving loan facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Drawdown &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Repayment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Closing Balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;180,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(100,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 2, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(80,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 3, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 4, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(85,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total drawdown / (repayments) in 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(315,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 2, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(193,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 3, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 4, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(75,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total drawdown / (repayments) in 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;318,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(373,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;2026 Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;In addition to the Senior Secured Credit Facilities, on July 1, 2021, a subsidiary of the Company issued $500&#160;million in aggregate principal amount of 2.875% senior secured notes (the "2026 Notes") in a private offering (the &#x201c;Offering&#x201d;). The 2026 Notes will mature on July 15, 2026. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%"&gt;Fair Value of Debt&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the Company&#x2019;s debt was &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$3,469.2&#160;million&lt;/span&gt; at December&#160;31, 2024 and (December&#160;31, 2023: $3,793.5&#160;million). The fair values of the senior secured term loan facility, the 2026 Notes and the New Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions. The fair value of the senior secured revolving loan facility approximates its carrying value due to the short term duration.</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="c-1" id="f-739">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company had the following debt outstanding as of December&#160;31, 2024 and &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest rate as of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Principal amount as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;946,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,251,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Notes (the "2026 Notes")&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Revolving Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Notes (the "2027 Notes")*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;May 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Notes (the "2029 Notes")*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;May 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Senior Secured Notes (the "2034 Notes")*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;May 2034&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,446,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,806,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less current portion of debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(29,762)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(110,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,416,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,696,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less debt issuance costs and debt discount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,624)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,396,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,665,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;*Issued May 8, 2024&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Drawdown &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Repayment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Closing Balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;180,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(100,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 2, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(80,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 3, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 4, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(85,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total drawdown / (repayments) in 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;370,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(315,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(55,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 2, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(193,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 3, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 4, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(75,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total drawdown / (repayments) in 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;318,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(373,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-128" decimals="5" id="f-740" unitRef="number">0.06329</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-129" decimals="5" id="f-741" unitRef="number">0.07860</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-128" decimals="-3" id="f-742" unitRef="usd">946450000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-129" decimals="-3" id="f-743" unitRef="usd">3251213000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-130" decimals="5" id="f-744" unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-131" decimals="5" id="f-745" unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-130" decimals="-3" id="f-746" unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-131" decimals="-3" id="f-747" unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-132" decimals="5" id="f-748" unitRef="number">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-133" decimals="5" id="f-749" unitRef="number">0.06720</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-134" decimals="-3" id="f-750" unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-135" decimals="-3" id="f-751" unitRef="usd">55000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-136" decimals="5" id="f-752" unitRef="number">0.05809</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-137" decimals="5" id="f-753" unitRef="number">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-136" decimals="-3" id="f-754" unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-137" decimals="-3" id="f-755" unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-138" decimals="5" id="f-756" unitRef="number">0.05849</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-139" decimals="5" id="f-757" unitRef="number">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-138" decimals="-3" id="f-758" unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-139" decimals="-3" id="f-759" unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-140" decimals="5" id="f-760" unitRef="number">0.06000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-141" decimals="5" id="f-761" unitRef="number">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-140" decimals="-3" id="f-762" unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-141" decimals="-3" id="f-763" unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-3" decimals="-3" id="f-764" unitRef="usd">3446450000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-4" decimals="-3" id="f-765" unitRef="usd">3806213000</us-gaap:DebtInstrumentCarryingAmount>
    <iclr:LongTermDebtCurrentMaturitiesGross contextRef="c-3" decimals="-3" id="f-766" unitRef="usd">29762000</iclr:LongTermDebtCurrentMaturitiesGross>
    <iclr:LongTermDebtCurrentMaturitiesGross contextRef="c-4" decimals="-3" id="f-767" unitRef="usd">110150000</iclr:LongTermDebtCurrentMaturitiesGross>
    <iclr:LongTermDebtExcludingCurrentMaturitiesGross contextRef="c-3" decimals="-3" id="f-768" unitRef="usd">3416688000</iclr:LongTermDebtExcludingCurrentMaturitiesGross>
    <iclr:LongTermDebtExcludingCurrentMaturitiesGross contextRef="c-4" decimals="-3" id="f-769" unitRef="usd">3696063000</iclr:LongTermDebtExcludingCurrentMaturitiesGross>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="c-3" decimals="-3" id="f-770" unitRef="usd">20290000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="c-4" decimals="-3" id="f-771" unitRef="usd">30624000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-3" decimals="-3" id="f-772" unitRef="usd">3396398000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-4" decimals="-3" id="f-773" unitRef="usd">3665439000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:InterestExpenseNonoperating contextRef="c-87" decimals="-5" id="f-774" unitRef="usd">23500000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-88" decimals="-5" id="f-775" unitRef="usd">16400000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-89" decimals="-5" id="f-776" unitRef="usd">17700000</us-gaap:InterestExpenseNonoperating>
    <iclr:DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock contextRef="c-1" id="f-777">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense on drawn facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;206,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;311,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;209,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization of merger related financing fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other financing costs*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total financing costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;237,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;336,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;*Includes costs associated with the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;senior secured revolving loan facility.&lt;/span&gt;&lt;/div&gt;</iclr:DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock>
    <us-gaap:InterestExpenseDebt contextRef="c-1" decimals="-3" id="f-778" unitRef="usd">206198000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="c-5" decimals="-3" id="f-779" unitRef="usd">311019000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="c-6" decimals="-3" id="f-780" unitRef="usd">209189000</us-gaap:InterestExpenseDebt>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-1" decimals="-3" id="f-781" unitRef="usd">23533000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-5" decimals="-3" id="f-782" unitRef="usd">16402000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-6" decimals="-3" id="f-783" unitRef="usd">17749000</us-gaap:AmortizationOfFinancingCosts>
    <iclr:InterestExpenseCreditOther contextRef="c-1" decimals="-3" id="f-784" unitRef="usd">7506000</iclr:InterestExpenseCreditOther>
    <iclr:InterestExpenseCreditOther contextRef="c-5" decimals="-3" id="f-785" unitRef="usd">9278000</iclr:InterestExpenseCreditOther>
    <iclr:InterestExpenseCreditOther contextRef="c-6" decimals="-3" id="f-786" unitRef="usd">2793000</iclr:InterestExpenseCreditOther>
    <us-gaap:InterestExpenseNonoperating contextRef="c-1" decimals="-3" id="f-787" unitRef="usd">237237000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-5" decimals="-3" id="f-788" unitRef="usd">336699000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-6" decimals="-3" id="f-789" unitRef="usd">229731000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="c-1" id="f-790">&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, the contractual maturities of the Company's debt obligations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.473%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.783%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturities of debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;529,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;779,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;857,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2029 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,446,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="c-3" decimals="-3" id="f-791" unitRef="usd">29762000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="c-3" decimals="-3" id="f-792" unitRef="usd">529762000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="c-3" decimals="-3" id="f-793" unitRef="usd">779762000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour contextRef="c-3" decimals="-3" id="f-794" unitRef="usd">857164000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <iclr:LongTermDebtMaturityYearFiveAndThereafter contextRef="c-3" decimals="-3" id="f-795" unitRef="usd">1250000000</iclr:LongTermDebtMaturityYearFiveAndThereafter>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-3" decimals="-3" id="f-796" unitRef="usd">3446450000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-142" decimals="-9" id="f-797" unitRef="usd">2000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-143" decimals="-6" id="f-798" unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-143" decimals="5" id="f-799" unitRef="number">0.05809</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-144" decimals="-6" id="f-800" unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-144" decimals="5" id="f-801" unitRef="number">0.05849</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-145" decimals="-6" id="f-802" unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-145" decimals="5" id="f-803" unitRef="number">0.06000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-142" decimals="-5" id="f-804" unitRef="usd">6800000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <iclr:DebtInstrumentDiscountRate contextRef="c-143" decimals="5" id="f-805" unitRef="number">0.00250</iclr:DebtInstrumentDiscountRate>
    <iclr:DebtInstrumentDiscountRate contextRef="c-144" decimals="5" id="f-806" unitRef="number">0.00350</iclr:DebtInstrumentDiscountRate>
    <iclr:DebtInstrumentDiscountRate contextRef="c-145" decimals="5" id="f-807" unitRef="number">0.00450</iclr:DebtInstrumentDiscountRate>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-145" decimals="-5" id="f-808" unitRef="usd">500000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed contextRef="c-146" decimals="5" id="f-809" unitRef="number">0.99896</us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-147" decimals="-6" id="f-810" unitRef="usd">5515000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-148" decimals="-6" id="f-811" unitRef="usd">300000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-148" decimals="-6" id="f-812" unitRef="usd">300000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-149" decimals="-6" id="f-813" unitRef="usd">500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-150" decimals="-5" id="f-814" unitRef="usd">27600000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-147" decimals="2" id="f-815" unitRef="number">0.0100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-151" decimals="2" id="f-816" unitRef="number">0.020</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-152" decimals="3" id="f-817" unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-153" decimals="4" id="f-818" unitRef="number">0.0045</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-154" decimals="4" id="f-819" unitRef="number">0.0010</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-155" decimals="4" id="f-820" unitRef="number">0</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-156" decimals="4" id="f-821" unitRef="number">0.0145</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-157" decimals="4" id="f-822" unitRef="number">0.0110</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-158" decimals="4" id="f-823" unitRef="number">0.0085</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-159" decimals="4" id="f-824" unitRef="number">0.0065</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-160" decimals="4" id="f-825" unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <iclr:ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock contextRef="c-1" id="f-826">&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Principal repayments, comprising mandatory and voluntary repayments, during the year ended December&#160;31, 2024 and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.461%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Principal repayments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(275,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(250,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,014,882)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(150,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,441)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(300,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Quarter 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(250,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total repayments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,304,763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(950,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iclr:ScheduleOfPrincipalPaymentsOnDebtInstrumentTableTextBlock>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="c-161" decimals="-3" id="f-827" unitRef="usd">275000000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="c-162" decimals="-3" id="f-828" unitRef="usd">250000000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="c-163" decimals="-3" id="f-829" unitRef="usd">2014882000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="c-164" decimals="-3" id="f-830" unitRef="usd">150000000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="c-165" decimals="-3" id="f-831" unitRef="usd">7441000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="c-166" decimals="-3" id="f-832" unitRef="usd">300000000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="c-167" decimals="-3" id="f-833" unitRef="usd">7440000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="c-168" decimals="-3" id="f-834" unitRef="usd">250000000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment contextRef="c-128" decimals="-3" id="f-835" unitRef="usd">2304763000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment contextRef="c-129" decimals="-3" id="f-836" unitRef="usd">950000000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid contextRef="c-128" decimals="-5" id="f-837" unitRef="usd">16900000</us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid>
    <us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid contextRef="c-129" decimals="-5" id="f-838" unitRef="usd">7900000</us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-169" decimals="-5" id="f-839" unitRef="usd">318000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-170" decimals="-5" id="f-840" unitRef="usd">370000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfSeniorDebt contextRef="c-1" decimals="-5" id="f-841" unitRef="usd">373000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt contextRef="c-5" decimals="-5" id="f-842" unitRef="usd">315000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-3" id="f-843" unitRef="usd" xsi:nil="true"/>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-4" decimals="-5" id="f-844" unitRef="usd">55000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-171" decimals="-3" id="f-845" unitRef="usd">180000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-171" decimals="-3" id="f-846" unitRef="usd">100000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:LongTermDebt contextRef="c-172" decimals="-3" id="f-847" unitRef="usd">80000000</us-gaap:LongTermDebt>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-173" decimals="-3" id="f-848" unitRef="usd">50000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-173" decimals="-3" id="f-849" unitRef="usd">80000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:LongTermDebt contextRef="c-174" decimals="-3" id="f-850" unitRef="usd">50000000</us-gaap:LongTermDebt>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-175" decimals="-3" id="f-851" unitRef="usd">75000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-175" decimals="-3" id="f-852" unitRef="usd">50000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:LongTermDebt contextRef="c-176" decimals="-3" id="f-853" unitRef="usd">75000000</us-gaap:LongTermDebt>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-177" decimals="-3" id="f-854" unitRef="usd">65000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-177" decimals="-3" id="f-855" unitRef="usd">85000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:LongTermDebt contextRef="c-135" decimals="-3" id="f-856" unitRef="usd">55000000</us-gaap:LongTermDebt>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-170" decimals="-3" id="f-857" unitRef="usd">370000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-170" decimals="-3" id="f-858" unitRef="usd">315000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-178" decimals="-3" id="f-859" unitRef="usd">50000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-178" decimals="-3" id="f-860" unitRef="usd">55000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:LongTermDebt contextRef="c-179" decimals="-3" id="f-861" unitRef="usd">50000000</us-gaap:LongTermDebt>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-180" decimals="-3" id="f-862" unitRef="usd">143000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-180" decimals="-3" id="f-863" unitRef="usd">193000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:LongTermDebt contextRef="c-181" decimals="-3" id="f-864" unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-182" decimals="-3" id="f-865" unitRef="usd">50000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-182" decimals="-3" id="f-866" unitRef="usd">50000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:LongTermDebt contextRef="c-183" decimals="-3" id="f-867" unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-184" decimals="-3" id="f-868" unitRef="usd">75000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-184" decimals="-3" id="f-869" unitRef="usd">75000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:LongTermDebt contextRef="c-134" decimals="-3" id="f-870" unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-169" decimals="-3" id="f-871" unitRef="usd">318000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-169" decimals="-3" id="f-872" unitRef="usd">373000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-185" decimals="-6" id="f-873" unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-185" decimals="5" id="f-874" unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtFairValue contextRef="c-3" decimals="-5" id="f-875" unitRef="usd">3469200000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="c-4" decimals="-5" id="f-876" unitRef="usd">3793500000</us-gaap:LongTermDebtFairValue>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="c-1" id="f-877">Derivatives&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company previously entered into interest rate cap and swap agreements for purposes of managing its exposure to interest rate fluctuations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On November 29, 2022, the Company entered into two interest rate cap agreements ("2022 Caps") with an initial total notional value of $2,101&#160;million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Caps began accruing on December 30, 2022 and the interest rate caps were due to expire on December 31, 2024. Under the terms of the interest rate caps, the Company had paid a fixed rate of 0.42% and received a variable rate equal to the amount that the three-month SOFR rate exceeds 4.75%. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On November 29, 2022, the Company entered into an interest rate swap agreement ("2022 Swap") with an initial notional value of $1,101&#160;million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Swap was due to begin accruing on December 31, 2024 and the interest rate swap was due to expire on September 30, 2026. Under the terms of the interest rate swap, the Company would have paid a fixed rate of 3.4% and would have received a variable rate of interest equal to the three-month SOFR on the 2022 Swap.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The 2022 Caps and the 2022 Swap were designated as cash flow hedges. G&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ains and losses were initially reported as a component of other comprehensive income/loss and subsequently recognized in net income.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;During the year, the Company&#x2019;s exposure to interest rate fluctuations significantly reduced with the voluntary and mandatory repayments &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;o&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;f the senior secured term loan facility (refer to note 13. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:107%"&gt;Bank credit lines, loan facilities and notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;). Given this reduction and the repricing of the Senior Secured Credit facilities, the Company &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;closed the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;2022 Caps and 2022 Swap agreements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;At &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;December&#160;31, 2024, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;73%&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt; of the Company's outstanding debt is at a fixed interest rate (December&#160;31, 2023: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;13%)&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;During&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt; the year ended December&#160;31, 2024, the Company recognized a gain of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$5.0&#160;million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt; (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;December&#160;31, 2023&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;: $1.6 million) within other comprehensive income/loss after a reclassification of $13.9&#160;million (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;December&#160;31, 2023&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;: $2.4&#160;million) from other comprehensive income/loss to the income statement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:14.4pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;      The fair value of the Company&#x2019;s derivative financial instruments at December&#160;31, 2024 amount to $nil. The fair value of the Company&#x2019;s derivative financial instruments at December&#160;31, 2023 on a gross basis, are summarized in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.128%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.158%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,600,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest Rate Swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,100,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,701,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="c-186"
      decimals="INF"
      id="f-878"
      unitRef="instrument">2</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:DerivativeNotionalAmount contextRef="c-186" decimals="-6" id="f-879" unitRef="usd">2101000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate contextRef="c-186" decimals="4" id="f-880" unitRef="number">0.0042</us-gaap:DerivativeFixedInterestRate>
    <iclr:DerivativeVariableInterestRateReferenceRateInExcessOf contextRef="c-186" decimals="4" id="f-881" unitRef="number">0.0475</iclr:DerivativeVariableInterestRateReferenceRateInExcessOf>
    <us-gaap:DerivativeNotionalAmount contextRef="c-187" decimals="-6" id="f-882" unitRef="usd">1101000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate contextRef="c-187" decimals="3" id="f-883" unitRef="number">0.034</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:PercentageOfDebtHedgedByInterestRateDerivatives contextRef="c-3" decimals="2" id="f-884" unitRef="number">0.73</us-gaap:PercentageOfDebtHedgedByInterestRateDerivatives>
    <us-gaap:PercentageOfDebtHedgedByInterestRateDerivatives contextRef="c-4" decimals="2" id="f-885" unitRef="number">0.13</us-gaap:PercentageOfDebtHedgedByInterestRateDerivatives>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-1" decimals="-5" id="f-886" unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-5" decimals="-5" id="f-887" unitRef="usd">1600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-1" decimals="-5" id="f-888" unitRef="usd">13900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax contextRef="c-5" decimals="-5" id="f-889" unitRef="usd">2400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock contextRef="c-1" id="f-890">The fair value of the Company&#x2019;s derivative financial instruments at December&#160;31, 2024 amount to $nil. The fair value of the Company&#x2019;s derivative financial instruments at December&#160;31, 2023 on a gross basis, are summarized in the following table:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.128%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.158%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,600,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest Rate Swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,100,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,701,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeLiabilities contextRef="c-188" decimals="-3" id="f-891" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssets contextRef="c-189" decimals="-3" id="f-892" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities contextRef="c-189" decimals="-3" id="f-893" unitRef="usd">1871000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssetNotionalAmount contextRef="c-189" decimals="-3" id="f-894" unitRef="usd">1600606000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssets contextRef="c-190" decimals="-3" id="f-895" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities contextRef="c-190" decimals="-3" id="f-896" unitRef="usd">540000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssetNotionalAmount contextRef="c-190" decimals="-3" id="f-897" unitRef="usd">1100606000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssets contextRef="c-191" decimals="-3" id="f-898" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities contextRef="c-191" decimals="-3" id="f-899" unitRef="usd">2411000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssetNotionalAmount contextRef="c-192" decimals="-3" id="f-900" unitRef="usd">2701212000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-901">Operating Leases&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Lease costs recorded under operating leases for the years ended December&#160;31, 2024, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from sub-leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,614)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Of the total cost of $44.9 million incurred in the year ended December&#160;31, 2024 (December&#160;31, 2023, $45.7 million; December&#160;31, 2022, $52.7&#160;million), $37.2 million (December&#160;31, 2023, $37.9 million; December&#160;31, 2022, $48.3 million) is recorded within selling, general and administration costs and $7.7 million  (December&#160;31, 2023, $7.8 million; December&#160;31, 2022, $4.4 million) is recorded within direct costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Right-of-use assets obtained, in exchange for lease obligations, during the years ended December&#160;31, 2024 and December&#160;31, 2023 totaled $64.8 million and $37.7 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2024, 2023 and 2022, impairments of operating right-of-use assets were recognized within restructuring charges for $13.8 million, $8.7 million, and $28.4 million, respectively, as part of an office consolidation program (see note 19. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring Charges&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2024 were 6.56 years and 4.01%, respectively. The weighted average remaining lease term and weighted-average discount rate at December&#160;31, 2023 were 6.72 years and 3.29%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under non-cancelable leases as of December&#160;31, 2024 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:80.168%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.632%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Minimum rental payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,931&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,445&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,257&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,156&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,838&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,047&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;199,674&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lease imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,806)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;176,868&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities are presented as current and non-current. As at &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, operating lease liabilities of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$36.8&#160;million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; have been included in &lt;span style="-sec-ix-hidden:f-941"&gt;&lt;span style="-sec-ix-hidden:f-942"&gt;Other liabilities&lt;/span&gt;&lt;/span&gt; (December&#160;31, 2023: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; $36.4 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;) and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$140.1 million&lt;/span&gt; million have been classified as Non-current Lease Liabilities (December&#160;31, 2023: $126.3 million).</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-902">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Lease costs recorded under operating leases for the years ended December&#160;31, 2024, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from sub-leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,614)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-3" id="f-903" unitRef="usd">46466000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-5" decimals="-3" id="f-904" unitRef="usd">46820000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-6" decimals="-3" id="f-905" unitRef="usd">53880000</us-gaap:OperatingLeaseCost>
    <us-gaap:SubleaseIncome contextRef="c-1" decimals="-3" id="f-906" unitRef="usd">1614000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome contextRef="c-5" decimals="-3" id="f-907" unitRef="usd">1103000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome contextRef="c-6" decimals="-3" id="f-908" unitRef="usd">1165000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost contextRef="c-1" decimals="-3" id="f-909" unitRef="usd">44852000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-5" decimals="-3" id="f-910" unitRef="usd">45717000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-6" decimals="-3" id="f-911" unitRef="usd">52715000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-1" decimals="-5" id="f-912" unitRef="usd">44900000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-5" decimals="-5" id="f-913" unitRef="usd">45700000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-6" decimals="-5" id="f-914" unitRef="usd">52700000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-193" decimals="-5" id="f-915" unitRef="usd">37200000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-194" decimals="-5" id="f-916" unitRef="usd">37900000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-195" decimals="-5" id="f-917" unitRef="usd">48300000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-196" decimals="-5" id="f-918" unitRef="usd">7700000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-197" decimals="-5" id="f-919" unitRef="usd">7800000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-198" decimals="-5" id="f-920" unitRef="usd">4400000</us-gaap:LeaseCost>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-5" id="f-921" unitRef="usd">64800000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-5" decimals="-5" id="f-922" unitRef="usd">37700000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseImpairmentLoss contextRef="c-1" decimals="-5" id="f-923" unitRef="usd">13800000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss contextRef="c-5" decimals="-5" id="f-924" unitRef="usd">8700000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss contextRef="c-6" decimals="-5" id="f-925" unitRef="usd">28400000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-3" id="f-926">P6Y6M21D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-3" decimals="4" id="f-927" unitRef="number">0.0401</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-4" id="f-928">P6Y8M19D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-4" decimals="4" id="f-929" unitRef="number">0.0329</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-930">&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under non-cancelable leases as of December&#160;31, 2024 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:80.168%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.632%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Minimum rental payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,931&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,445&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,257&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,156&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,838&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,047&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;199,674&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lease imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,806)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;176,868&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-3" decimals="-3" id="f-931" unitRef="usd">42931000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-3" decimals="-3" id="f-932" unitRef="usd">38445000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-3" decimals="-3" id="f-933" unitRef="usd">31257000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-3" decimals="-3" id="f-934" unitRef="usd">24156000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c-3" decimals="-3" id="f-935" unitRef="usd">17838000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-3" decimals="-3" id="f-936" unitRef="usd">45047000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-3" decimals="-3" id="f-937" unitRef="usd">199674000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-3" decimals="-3" id="f-938" unitRef="usd">22806000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-3" decimals="-3" id="f-939" unitRef="usd">176868000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-5" id="f-940" unitRef="usd">36800000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-5" id="f-943" unitRef="usd">36400000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-3" decimals="-5" id="f-944" unitRef="usd">140100000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-5" id="f-945" unitRef="usd">126300000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock contextRef="c-1" id="f-946">Non-current other liabilities&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Non-current other liabilities for the years ended December&#160;31, 2024 and 2023 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock contextRef="c-1" id="f-947">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The carrying amount of Non-current other liabilities for the years ended December&#160;31, 2024 and 2023 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:OtherSundryLiabilitiesNoncurrent contextRef="c-3" decimals="-3" id="f-948" unitRef="usd">83470000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-949" unitRef="usd">45998000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-3" decimals="-3" id="f-950" unitRef="usd">83470000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-951" unitRef="usd">45998000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-952">Commitments and Contingencies&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We do not expect any litigation to have a materially adverse effect on our financial condition or results of operations. However, from time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has several non-cancelable operating leases, primarily for facilities, that expire over the next sixteen years. These leases generally contain renewal options and require the Company to pay all executory costs such as maintenance and insurance. See note 15.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt; Operating leases&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; for rental expense pursuant to ASC 842 for the years ended December&#160;31, 2024, 2023 and 2022 and future minimum rental commitments as of December&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-3" id="f-953">P16Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-954">Share Capital&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Holders of ordinary shares are entitled to receive such dividends as may be recommended by the Board of Directors of the Company and approved by the shareholders and/or such interim dividends as the Board of Directors of the Company may decide. On liquidation or a winding up of the Company, the par value of the ordinary shares are repaid out of the assets available for distribution among the holders of the ordinary shares of the Company. Holders of ordinary shares have no conversion or redemption rights. On a show of hands, every holder of an ordinary share present in person or proxy at a general meeting of shareholders shall have one vote, for each ordinary share held with no individual having more than one vote. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:29.25pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.02pt"&gt;Share based payments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2024, 311,040 options were exercised at an average exercise price of $116.31 per share for total proceeds of $36.2 million. During the year ended December&#160;31, 2024, 120,458 ordinary shares were issued in respect of certain RSUs and 9,975 ordinary shares were issued in respect of PSUs previously awarded by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2023, 535,705 options were exercised at an average exercise price of $95.12 per share for total proceeds of $51.0 million. During the year ended December&#160;31, 2023, 188,800 ordinary shares were issued in respect of certain RSUs and 47,026 ordinary shares were issued in respect of PSUs previously awarded by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the year ended December&#160;31, 2022, 348,286 options were exercised at an average exercise price of $102.87 per share for total proceeds of $35.8 million. During the year ended December&#160;31, 2022, 195,029 ordinary shares were issued in respect of certain RSUs and 46,087 ordinary shares were issued in respect of PSUs previously awarded by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:29.25pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.02pt"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company can acquire up to 10% of its outstanding ordinary shares (by way of redemption), in accordance with Irish &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;law and the Company&#x2019;s constitutional documents through open market share acquisitions. A resolution was passed at the Company&#x2019;s Annual General Meeting (&#x201c;AGM&#x201d;) on July 23, 2024, which renewed the authorization for the Directors to purchase (buyback) up to 10% of the outstanding shares in the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On February 20, 2024, the Company's Board of Directors authorized a new buyback program of up to $500.0 million of the outstanding ordinary shares of the Company. On October 22, 2024, the Company's Board of Directors authorized an additional buyback program of up to $250.0 million of the outstanding ordinary shares of the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;All  ordinary  shares  that  are  redeemed  under  the  buyback  program  will  be canceled in accordance with the constitutional documents of the Company and the nominal value of these shares transferred to an undenominated capital fund as required under Irish Company law.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2024, 2,179,699 ordinary shares were redeemed by the Company under this buyback program for a total consideration of $500.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;No ordinary shares were redeemed by the Company during the year ended December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2022, 420,530 ordinary shares were redeemed by the Company for total consideration of $100.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Under the repurchase program, a broker purchased or may purchase the Company's shares from time to time on the open market or in privately negotiated transactions in accordance with agreed terms and limitations. The program was and may be in the future designed to allow share repurchases during periods when the Company would ordinarily not be permitted to do so because it may be in possession of material non-public or price-sensitive information or due to applicable insider trading laws or self-imposed trading blackout periods. The Company's instructions to the broker in such cases were or may in the future be irrevocable and the trading decisions in respect of the repurchase program were made or will be made independently of and uninfluenced by the Company. The Company confirms that on entering the share repurchase plans it had no material non-public, price-sensitive or inside information regarding the Company or its securities. Furthermore, the Company will not enter into additional plans whilst in possession of such information. The timing and actual number of shares acquired by way of the redemption will be dependent on market conditions, legal and regulatory requirements and the other terms and limitations contained in the program. In addition, acquisitions under the program may be suspended or discontinued in certain circumstances in accordance with the agreed terms. Therefore, there can be no assurance as to the timing or number of shares that may be acquired under the program.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <iclr:NumberOfVotes contextRef="c-1" decimals="INF" id="f-955" unitRef="vote">1</iclr:NumberOfVotes>
    <iclr:NumberOfVotes contextRef="c-1" decimals="INF" id="f-956" unitRef="vote">1</iclr:NumberOfVotes>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-199"
      decimals="INF"
      id="f-957"
      unitRef="shares">311040</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-199"
      decimals="2"
      id="f-958"
      unitRef="usdPerShare">116.31</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-199" decimals="-5" id="f-959" unitRef="usd">36200000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-200"
      decimals="INF"
      id="f-960"
      unitRef="shares">120458</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="c-201"
      decimals="INF"
      id="f-961"
      unitRef="shares">9975</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-202"
      decimals="INF"
      id="f-962"
      unitRef="shares">535705</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-202"
      decimals="2"
      id="f-963"
      unitRef="usdPerShare">95.12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-202" decimals="-5" id="f-964" unitRef="usd">51000000.0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-203"
      decimals="INF"
      id="f-965"
      unitRef="shares">188800</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="c-204"
      decimals="INF"
      id="f-966"
      unitRef="shares">47026</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-205"
      decimals="INF"
      id="f-967"
      unitRef="shares">348286</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-205"
      decimals="2"
      id="f-968"
      unitRef="usdPerShare">102.87</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-205" decimals="-5" id="f-969" unitRef="usd">35800000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-206"
      decimals="INF"
      id="f-970"
      unitRef="shares">195029</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="c-207"
      decimals="INF"
      id="f-971"
      unitRef="shares">46087</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <iclr:StockRepurchaseProgramAuthorizedPercentage contextRef="c-208" decimals="2" id="f-972" unitRef="number">0.10</iclr:StockRepurchaseProgramAuthorizedPercentage>
    <iclr:StockRepurchaseProgramAuthorizedPercentage contextRef="c-209" decimals="2" id="f-973" unitRef="number">0.10</iclr:StockRepurchaseProgramAuthorizedPercentage>
    <srt:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-210" decimals="-6" id="f-974" unitRef="usd">500000000.0</srt:StockRepurchaseProgramAuthorizedAmount1>
    <srt:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-211" decimals="-6" id="f-975" unitRef="usd">250000000.0</srt:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="c-212"
      decimals="INF"
      id="f-976"
      unitRef="shares">2179699</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-212" decimals="-5" id="f-977" unitRef="usd">500000000.0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="c-213"
      decimals="INF"
      id="f-978"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="c-214"
      decimals="INF"
      id="f-979"
      unitRef="shares">420530</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-214" decimals="-5" id="f-980" unitRef="usd">100000000.0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock contextRef="c-1" id="f-981">Restructuring Charges&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;In the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022, the Company incurred approximately $92.1&#160;million, $45.4&#160;million and $31.1&#160;million of restructuring charge in the Consolidated Statements of Operations under a restructuring plan adopted following a review of operations.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The restructuring plan reflected a workforce reduction of $74.5&#160;million (December&#160;31, 2023: $34.1&#160;million, December&#160;31, 2022: $2.7&#160;million) and an office consolidation program to optimize the Company's office footprint of $17.6&#160;million (December&#160;31, 2023: $11.3&#160;million, December&#160;31, 2022: $28.4&#160;million), being the impairment of operating right-off-use assets and related property plant and equipment of $15.7 million (December&#160;31, 2023: $8.7 million, December&#160;31, 2022: $28.4&#160;million) and onerous contract costs of $1.9&#160;million (December&#160;31, 2023: $2.6&#160;million, December&#160;31, 2022: $nil&#160;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2024, a total liability of $31.5 million (December&#160;31, 2023: $7.0 million) was recorded on the Consolidated Balance Sheet relating to restructuring activities. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.461%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Charge during the year*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Utilization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(51,917)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;*The charge for the year ended December&#160;31, 2024 reflects the workforce reduction of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$74.5 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; (December&#160;31, 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;: $34.1 million) and onerous contract costs of $1.9 million (December&#160;31, 2023: $2.6 million).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The closing provision of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$31.5 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(December&#160;31, 2023: $7.0 million) reflects:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; (1) $27.7 million (December&#160;31, 2023: $4.0 million) of personnel related liabilities as a result of the workforce reduction; all of which have been classified as short-term within Other Liabilities, and&lt;/span&gt;&lt;/div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; (2) $3.8 million (December&#160;31, 2023: $3.0 million) of facilities related liabilities of which $1.4 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(December&#160;31, 2023: $1.0 million) is included within Other Liabilities and $2.4 million (December&#160;31, 2023: $2.0 million)&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;is included within Non-Current Other Liabilities.</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringCosts contextRef="c-1" decimals="-5" id="f-982" unitRef="usd">92100000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts contextRef="c-5" decimals="-5" id="f-983" unitRef="usd">45400000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts contextRef="c-6" decimals="-5" id="f-984" unitRef="usd">31100000</us-gaap:RestructuringCosts>
    <us-gaap:SeveranceCosts1 contextRef="c-1" decimals="-5" id="f-985" unitRef="usd">74500000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="c-5" decimals="-5" id="f-986" unitRef="usd">34100000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="c-6" decimals="-5" id="f-987" unitRef="usd">2700000</us-gaap:SeveranceCosts1>
    <us-gaap:OtherRestructuringCosts contextRef="c-1" decimals="-5" id="f-988" unitRef="usd">17600000</us-gaap:OtherRestructuringCosts>
    <us-gaap:OtherRestructuringCosts contextRef="c-5" decimals="-5" id="f-989" unitRef="usd">11300000</us-gaap:OtherRestructuringCosts>
    <us-gaap:OtherRestructuringCosts contextRef="c-6" decimals="-5" id="f-990" unitRef="usd">28400000</us-gaap:OtherRestructuringCosts>
    <iclr:ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment contextRef="c-215" decimals="-5" id="f-991" unitRef="usd">15700000</iclr:ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment>
    <iclr:ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment contextRef="c-216" decimals="-5" id="f-992" unitRef="usd">8700000</iclr:ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment>
    <iclr:ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment contextRef="c-217" decimals="-5" id="f-993" unitRef="usd">28400000</iclr:ImpairmentOperatingRightOfUseAssetsAndRelatedPropertyPlantAndEquipment>
    <us-gaap:LossContingencyAccrualProvision contextRef="c-215" decimals="-5" id="f-994" unitRef="usd">1900000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision contextRef="c-216" decimals="-5" id="f-995" unitRef="usd">2600000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision contextRef="c-217" decimals="-5" id="f-996" unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock contextRef="c-1" id="f-997">&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringCosts contextRef="c-1" decimals="-3" id="f-998" unitRef="usd">92123000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts contextRef="c-5" decimals="-3" id="f-999" unitRef="usd">45390000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts contextRef="c-6" decimals="-3" id="f-1000" unitRef="usd">31143000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts contextRef="c-1" decimals="-3" id="f-1001" unitRef="usd">92123000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts contextRef="c-5" decimals="-3" id="f-1002" unitRef="usd">45390000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts contextRef="c-6" decimals="-3" id="f-1003" unitRef="usd">31143000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringReserve contextRef="c-3" decimals="-5" id="f-1004" unitRef="usd">31500000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-4" decimals="-5" id="f-1005" unitRef="usd">7000000.0</us-gaap:RestructuringReserve>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock contextRef="c-1" id="f-1006">&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.461%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Opening provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Charge during the year*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Utilization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(51,917)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(35,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending provision&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;*The charge for the year ended December&#160;31, 2024 reflects the workforce reduction of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$74.5 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; (December&#160;31, 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;: $34.1 million) and onerous contract costs of $1.9 million (December&#160;31, 2023: $2.6 million).&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve contextRef="c-4" decimals="-3" id="f-1007" unitRef="usd">6999000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-23" decimals="-3" id="f-1008" unitRef="usd">6022000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges contextRef="c-1" decimals="-3" id="f-1009" unitRef="usd">76392000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges contextRef="c-5" decimals="-3" id="f-1010" unitRef="usd">36704000</us-gaap:RestructuringCharges>
    <iclr:RestructuringReserveUtilizations contextRef="c-1" decimals="-3" id="f-1011" unitRef="usd">51917000</iclr:RestructuringReserveUtilizations>
    <iclr:RestructuringReserveUtilizations contextRef="c-5" decimals="-3" id="f-1012" unitRef="usd">35727000</iclr:RestructuringReserveUtilizations>
    <us-gaap:RestructuringReserve contextRef="c-3" decimals="-3" id="f-1013" unitRef="usd">31474000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-4" decimals="-3" id="f-1014" unitRef="usd">6999000</us-gaap:RestructuringReserve>
    <us-gaap:SeveranceCosts1 contextRef="c-1" decimals="-5" id="f-1015" unitRef="usd">74500000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="c-5" decimals="-5" id="f-1016" unitRef="usd">34100000</us-gaap:SeveranceCosts1>
    <us-gaap:LossContingencyAccrualProvision contextRef="c-215" decimals="-5" id="f-1017" unitRef="usd">1900000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision contextRef="c-216" decimals="-5" id="f-1018" unitRef="usd">2600000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:RestructuringReserve contextRef="c-3" decimals="-5" id="f-1019" unitRef="usd">31500000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-4" decimals="-5" id="f-1020" unitRef="usd">7000000.0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-218" decimals="-5" id="f-1021" unitRef="usd">27700000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-219" decimals="-5" id="f-1022" unitRef="usd">4000000.0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-220" decimals="-5" id="f-1023" unitRef="usd">3800000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve contextRef="c-221" decimals="-5" id="f-1024" unitRef="usd">3000000.0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveCurrent contextRef="c-220" decimals="-5" id="f-1025" unitRef="usd">1400000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:RestructuringReserveCurrent contextRef="c-221" decimals="-5" id="f-1026" unitRef="usd">1000000.0</us-gaap:RestructuringReserveCurrent>
    <us-gaap:RestructuringReserveNoncurrent contextRef="c-220" decimals="-5" id="f-1027" unitRef="usd">2400000</us-gaap:RestructuringReserveNoncurrent>
    <us-gaap:RestructuringReserveNoncurrent contextRef="c-221" decimals="-5" id="f-1028" unitRef="usd">2000000.0</us-gaap:RestructuringReserveNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-1029">Income Taxes &lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company's United States and Irish based subsidiaries file income tax returns in the United States and Ireland respectively. Other foreign subsidiaries are taxed separately under the laws of their respective countries.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The components of income before income tax expense are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;736,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;624,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;432,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(304,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(352,532)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(270,440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;437,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;352,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;405,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;869,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;624,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;567,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The components of income tax expense are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Income tax expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current tax (benefit)/expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(45,307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42,428)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;178,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;184,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax (benefit)/expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(69,493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(143,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(118,475)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(100,542)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(85,403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(124,985)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense was allocated to the following components of other comprehensive income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency impact on long term funding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,903)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Retirement benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(895)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;647&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;301&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Ireland's statutory trading income tax rate, the rate of our country of domicile, is 12.5%. The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Taxes at Irish statutory rate of 12.5% (2023:12.5%; 2022:12.5%)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rate differential from amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(48,240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(71,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(59,330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Global Minimum Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign and other income taxed at higher rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research &amp;amp; development tax incentives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,041)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,868)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Movement in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effects of change in tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(Decrease)/ increase in unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(59,456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(54,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investor tax expense on foreign subsidiary earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,995)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impact of stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,756)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other and non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating right-of-use-assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;901,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in foreign subsidiaries &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,002,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,073,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating loss and tax credits carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;164,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;290,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Valuation allowance for deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38,955)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42,967)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;247,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Overall net deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(737,728)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(825,438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2024 Ireland subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available for offset against future tax liabilities, if any, of $15.6 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;At December&#160;31, 2024 U.S. subsidiaries had U.S. federal and state net operating loss ("NOL") carryforwards of approximately $8.0 million and $277.8 million, respectively. These NOLs are available for offset against future taxable income and the expiry dates are shown in the table below. The subsidiaries' ability to use the U.S. federal NOL carryforwards is limited on an annual basis due to change of ownership in 2014, 2017, 2019 and 2024 as defined by Section 382 of the Internal Revenue Code of 1986, as amended and expire between 2025 - 2037. The U.S. state NOL carryforwards are restricted by the state/entity in which they arose. As of December&#160;31, 2024, U.S subsidiaries also had disallowed interest carried forward of $317.0&#160;million &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;(December&#160;31, 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;: $204.0&#160;million) that can be carried forward indefinitely. The increase of $113.0&#160;million was recognized within the income tax expense. These carryforwards are available for offset against future taxable income in the event that the U.S subsidiaries have excess capacity for interest deductions in future years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The expected expiry dates of the US NOLs are as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Federal&lt;br/&gt;NOL's&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;State&lt;br/&gt;NOL's&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025-2038&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;262,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2039-2043&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;277,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In addition, we also have general business tax credit carryforwards of approximately $1.0 million that are available to reduce future U.S. federal and state income taxes. The general business tax credits are non-refundable and are due to expire between the years 2026-2038.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;At December&#160;31, 2024 other than those in the U.S. and Ireland, we had operating loss carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future taxable income, if any, of approximately $42.4 million. In addition, at December&#160;31, 2024 those subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward for up to 30 years, available to offset against future tax liabilities, if any, of  $2.7 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The valuation allowance at December&#160;31, 2024 was $39.0 million (December&#160;31, 2023; $43.0 million). The net change in the total valuation allowance was a decrease of $4.0 million during 2024 and a decrease of $0.4 million during 2023. Of the total decrease of $4.0 million in 2024, an increase of $2.0&#160;million was in respect of an acquired entity, $5.3 million decrease was recognized within income tax expense and a decrease of $0.7 million was recognized in Other Comprehensive Income. Of the total decrease of $0.4 million in 2023, $1.1 million was recognized within income tax expenses and an increase of $0.7 million was recognized in Other Comprehensive Income.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The valuation allowances at December&#160;31, 2024 and December&#160;31, 2023 were primarily related to operating losses and tax credits carried forward that, in the judgment of management, are not more likely than not to be realized. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, loss utilization, projected future taxable income and tax planning strategies in making this assessment. In respect of deferred tax assets not subject to a valuation allowance, management considers that it is more likely than not that these deferred tax assets will be realized on the basis that there will be sufficient reversals of deferred tax liabilities and taxable income in future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The Company has recognized a deferred tax liability of $35.0 million (2023: $52.4 million) for investments in foreign subsidiaries where the Company does not consider the earnings to be indefinitely reinvested. For the deferred tax liability not recognized in respect of temporary differences related to investments in foreign subsidiaries which are considered to be indefinitely reinvested, it is not practicable to calculate the exact unrecognized deferred tax liability. However it is not expected to be material as Ireland recently implemented a participation exemption in respect of distributions from foreign subsidiaries in EEA/treaty countries, in addition to the foreign tax credit regime at the statutory tax rate in the jurisdiction of the subsidiary, so that no material tax liability would be expected to arise in Ireland in the event these earnings were ever remitted. In addition, withholding taxes applicable to remittances from foreign subsidiaries would not be expected to be material given Ireland&#x2019;s tax treaty network and the EU parent subsidiary directive.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at start of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Decrease related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(918)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lapse of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(65,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(62,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The relevant statute of limitations for unrecognized tax benefits totaling $61.6 million could potentially expire during 2025. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Included in the balance of total unrecognized tax benefits at December&#160;31, 2024 were potential benefits of $101.6 million, which if recognized, would affect the effective rate on income from continuing operations. The balance of total unrecognized tax benefits at December&#160;31, 2023 and December&#160;31, 2022 included potential benefits which, if recognized, would affect the effective rate of income tax from continuing operations of $160.0 million and $217.6 million respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Interest and penalties recognized during the year ended December&#160;31, 2024 amounted to a net charge of $1.9 million (2023: $4.2 million, 2022: $7.1 million) and are included within the income tax expense. Total accrued interest and penalties as of December&#160;31, 2024 and December&#160;31, 2023 were $24.2 million and $27.1 million respectively and are included in closing income taxes payable at those dates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our major tax jurisdictions are Ireland and the United States. We may potentially be subjected to tax audits in both our major jurisdictions. In Ireland, tax periods open to audit include the years ended December&#160;31, 2020, December&#160;31, 2021, December&#160;31, 2022, December&#160;31, 2023 and December&#160;31, 2024. In the United States, tax periods open to audit include the years ended December&#160;31, 2021, December&#160;31, 2022, December&#160;31, 2023 and December&#160;31, 2024. During such audits, local tax authorities may challenge the positions taken by us in our tax returns.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <iclr:IncomeBeforeIncomeTaxTableTextBlock contextRef="c-1" id="f-1030">&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;The components of income before income tax expense are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;736,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;624,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;432,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(304,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(352,532)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(270,440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;437,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;352,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;405,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income before income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;869,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;624,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;567,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iclr:IncomeBeforeIncomeTaxTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-222" decimals="-3" id="f-1031" unitRef="usd">736374000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-223" decimals="-3" id="f-1032" unitRef="usd">624642000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-224" decimals="-3" id="f-1033" unitRef="usd">432963000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-225" decimals="-3" id="f-1034" unitRef="usd">-304546000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-226" decimals="-3" id="f-1035" unitRef="usd">-352532000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-227" decimals="-3" id="f-1036" unitRef="usd">-270440000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-228" decimals="-3" id="f-1037" unitRef="usd">437356000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-229" decimals="-3" id="f-1038" unitRef="usd">352357000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-230" decimals="-3" id="f-1039" unitRef="usd">405328000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-1040" unitRef="usd">869184000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-5" decimals="-3" id="f-1041" unitRef="usd">624467000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="c-6" decimals="-3" id="f-1042" unitRef="usd">567851000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c-1" id="f-1043">&lt;div style="text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The components of income tax expense are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Income tax expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current tax (benefit)/expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;53,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(45,307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42,428)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total current tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;178,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;184,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax (benefit)/expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(69,493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(143,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(118,475)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(100,542)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(85,403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(124,985)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense was allocated to the following components of other comprehensive income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency impact on long term funding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,903)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Retirement benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(895)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;647&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;301&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-222" decimals="-3" id="f-1044" unitRef="usd">118255000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-223" decimals="-3" id="f-1045" unitRef="usd">80427000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-224" decimals="-3" id="f-1046" unitRef="usd">53248000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-225" decimals="-3" id="f-1047" unitRef="usd">-45307000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-226" decimals="-3" id="f-1048" unitRef="usd">-42428000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-227" decimals="-3" id="f-1049" unitRef="usd">60753000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-228" decimals="-3" id="f-1050" unitRef="usd">105304000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-229" decimals="-3" id="f-1051" unitRef="usd">59153000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-230" decimals="-3" id="f-1052" unitRef="usd">70395000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1053" unitRef="usd">178252000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-5" decimals="-3" id="f-1054" unitRef="usd">97152000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-1055" unitRef="usd">184396000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-222" decimals="-3" id="f-1056" unitRef="usd">-26663000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-223" decimals="-3" id="f-1057" unitRef="usd">45253000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-224" decimals="-3" id="f-1058" unitRef="usd">-6166000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-225" decimals="-3" id="f-1059" unitRef="usd">-69493000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-226" decimals="-3" id="f-1060" unitRef="usd">-143323000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-227" decimals="-3" id="f-1061" unitRef="usd">-118475000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-228" decimals="-3" id="f-1062" unitRef="usd">-4386000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-229" decimals="-3" id="f-1063" unitRef="usd">12667000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-230" decimals="-3" id="f-1064" unitRef="usd">-344000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1065" unitRef="usd">-100542000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-5" decimals="-3" id="f-1066" unitRef="usd">-85403000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-1067" unitRef="usd">-124985000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1068" unitRef="usd">77710000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-3" id="f-1069" unitRef="usd">11749000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-1070" unitRef="usd">59411000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax contextRef="c-1" decimals="-3" id="f-1071" unitRef="usd">1728000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax contextRef="c-5" decimals="-3" id="f-1072" unitRef="usd">-3903000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax contextRef="c-6" decimals="-3" id="f-1073" unitRef="usd">7211000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax contextRef="c-1" decimals="-3" id="f-1074" unitRef="usd">895000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax contextRef="c-5" decimals="-3" id="f-1075" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax contextRef="c-6" decimals="-3" id="f-1076" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax contextRef="c-1" decimals="-3" id="f-1077" unitRef="usd">647000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax contextRef="c-5" decimals="-3" id="f-1078" unitRef="usd">301000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax contextRef="c-6" decimals="-3" id="f-1079" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity contextRef="c-1" decimals="-3" id="f-1080" unitRef="usd">79190000</us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity>
    <us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity contextRef="c-5" decimals="-3" id="f-1081" unitRef="usd">8147000</us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity>
    <us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity contextRef="c-6" decimals="-3" id="f-1082" unitRef="usd">66622000</us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c-1" id="f-1083">The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Taxes at Irish statutory rate of 12.5% (2023:12.5%; 2022:12.5%)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rate differential from amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(48,240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(71,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(59,330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Global Minimum Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign and other income taxed at higher rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research &amp;amp; development tax incentives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,041)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,868)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Movement in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effects of change in tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(Decrease)/ increase in unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(59,456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(54,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investor tax expense on foreign subsidiary earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,995)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impact of stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8,756)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other and non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="-3" id="f-1084" unitRef="usd">108648000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-5" decimals="-3" id="f-1085" unitRef="usd">78058000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-6" decimals="-3" id="f-1086" unitRef="usd">70980000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization contextRef="c-1" decimals="-3" id="f-1087" unitRef="usd">-48240000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization contextRef="c-5" decimals="-3" id="f-1088" unitRef="usd">-71223000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization contextRef="c-6" decimals="-3" id="f-1089" unitRef="usd">-59330000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization>
    <us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount contextRef="c-1" decimals="-3" id="f-1090" unitRef="usd">16719000</us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount contextRef="c-5" decimals="-3" id="f-1091" unitRef="usd">0</us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount contextRef="c-6" decimals="-3" id="f-1092" unitRef="usd">0</us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-1" decimals="-3" id="f-1093" unitRef="usd">49703000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-5" decimals="-3" id="f-1094" unitRef="usd">35778000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-6" decimals="-3" id="f-1095" unitRef="usd">52464000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="c-1" decimals="-3" id="f-1096" unitRef="usd">3041000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="c-5" decimals="-3" id="f-1097" unitRef="usd">3868000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="c-6" decimals="-3" id="f-1098" unitRef="usd">2608000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-1" decimals="-3" id="f-1099" unitRef="usd">-5279000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-5" decimals="-3" id="f-1100" unitRef="usd">-1068000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-6" decimals="-3" id="f-1101" unitRef="usd">-777000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="c-1" decimals="-3" id="f-1102" unitRef="usd">25691000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="c-5" decimals="-3" id="f-1103" unitRef="usd">3154000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="c-6" decimals="-3" id="f-1104" unitRef="usd">-300000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <iclr:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount contextRef="c-1" decimals="-3" id="f-1105" unitRef="usd">-59456000</iclr:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount>
    <iclr:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount contextRef="c-5" decimals="-3" id="f-1106" unitRef="usd">-54347000</iclr:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount>
    <iclr:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount contextRef="c-6" decimals="-3" id="f-1107" unitRef="usd">8392000</iclr:EffectiveIncomeTaxRateReconciliationChangeInUnrecognizedTaxBenefitsAmount>
    <iclr:EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount contextRef="c-1" decimals="-3" id="f-1108" unitRef="usd">-7995000</iclr:EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount>
    <iclr:EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount contextRef="c-5" decimals="-3" id="f-1109" unitRef="usd">39165000</iclr:EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount>
    <iclr:EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount contextRef="c-6" decimals="-3" id="f-1110" unitRef="usd">0</iclr:EffectiveIncomeTaxRateReconciliationDeferredTaxProvisionOnUnrepatriatedEarningsAmount>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-1" decimals="-3" id="f-1111" unitRef="usd">-9385000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-5" decimals="-3" id="f-1112" unitRef="usd">-11487000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-6" decimals="-3" id="f-1113" unitRef="usd">-8756000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther contextRef="c-1" decimals="-3" id="f-1114" unitRef="usd">10345000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther contextRef="c-5" decimals="-3" id="f-1115" unitRef="usd">-2413000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther contextRef="c-6" decimals="-3" id="f-1116" unitRef="usd">-654000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1117" unitRef="usd">77710000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-3" id="f-1118" unitRef="usd">11749000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-1119" unitRef="usd">59411000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c-1" id="f-1120">The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating right-of-use-assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;901,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;950,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in foreign subsidiaries &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,002,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,073,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating loss and tax credits carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;164,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;124,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;303,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;290,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Valuation allowance for deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38,955)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42,967)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;247,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Overall net deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(737,728)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(825,438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-3" decimals="-3" id="f-1121" unitRef="usd">2869000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-1122" unitRef="usd">7547000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-3" decimals="-3" id="f-1123" unitRef="usd">15633000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-4" decimals="-3" id="f-1124" unitRef="usd">16108000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill contextRef="c-3" decimals="-3" id="f-1125" unitRef="usd">43390000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill contextRef="c-4" decimals="-3" id="f-1126" unitRef="usd">39014000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets contextRef="c-3" decimals="-3" id="f-1127" unitRef="usd">901731000</us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets>
    <us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets contextRef="c-4" decimals="-3" id="f-1128" unitRef="usd">950055000</us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings contextRef="c-3" decimals="-3" id="f-1129" unitRef="usd">34983000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings contextRef="c-4" decimals="-3" id="f-1130" unitRef="usd">52408000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="c-3" decimals="-3" id="f-1131" unitRef="usd">3887000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="c-4" decimals="-3" id="f-1132" unitRef="usd">7982000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-3" decimals="-3" id="f-1133" unitRef="usd">1002493000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-4" decimals="-3" id="f-1134" unitRef="usd">1073114000</us-gaap:DeferredIncomeTaxLiabilities>
    <iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards contextRef="c-3" decimals="-3" id="f-1135" unitRef="usd">164904000</iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards>
    <iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards contextRef="c-4" decimals="-3" id="f-1136" unitRef="usd">124150000</iclr:DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="c-3" decimals="-3" id="f-1137" unitRef="usd">7869000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-1138" unitRef="usd">9082000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <iclr:DeferredTaxAssetsOperatingLeaseLiability contextRef="c-3" decimals="-3" id="f-1139" unitRef="usd">21503000</iclr:DeferredTaxAssetsOperatingLeaseLiability>
    <iclr:DeferredTaxAssetsOperatingLeaseLiability contextRef="c-4" decimals="-3" id="f-1140" unitRef="usd">20190000</iclr:DeferredTaxAssetsOperatingLeaseLiability>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="c-3" decimals="-3" id="f-1141" unitRef="usd">45000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="c-4" decimals="-3" id="f-1142" unitRef="usd">2166000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther contextRef="c-3" decimals="-3" id="f-1143" unitRef="usd">14309000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther contextRef="c-4" decimals="-3" id="f-1144" unitRef="usd">17605000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther>
    <iclr:DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities contextRef="c-3" decimals="-3" id="f-1145" unitRef="usd">78428000</iclr:DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities>
    <iclr:DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities contextRef="c-4" decimals="-3" id="f-1146" unitRef="usd">84928000</iclr:DeferredTaxAssetsTaxDeferredExpenseOtherLiabilities>
    <iclr:DeferredTaxAssetContractWithCustomerLiability contextRef="c-3" decimals="-3" id="f-1147" unitRef="usd">10364000</iclr:DeferredTaxAssetContractWithCustomerLiability>
    <iclr:DeferredTaxAssetContractWithCustomerLiability contextRef="c-4" decimals="-3" id="f-1148" unitRef="usd">23748000</iclr:DeferredTaxAssetContractWithCustomerLiability>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther contextRef="c-3" decimals="-3" id="f-1149" unitRef="usd">6298000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther contextRef="c-4" decimals="-3" id="f-1150" unitRef="usd">8774000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-3" decimals="-3" id="f-1151" unitRef="usd">303720000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-4" decimals="-3" id="f-1152" unitRef="usd">290643000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-3" decimals="-3" id="f-1153" unitRef="usd">38955000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-4" decimals="-3" id="f-1154" unitRef="usd">42967000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-3" decimals="-3" id="f-1155" unitRef="usd">264765000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-4" decimals="-3" id="f-1156" unitRef="usd">247676000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilities contextRef="c-3" decimals="-3" id="f-1157" unitRef="usd">737728000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities contextRef="c-4" decimals="-3" id="f-1158" unitRef="usd">825438000</us-gaap:DeferredTaxLiabilities>
    <iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration contextRef="c-231" decimals="-5" id="f-1159" unitRef="usd">15600000</iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-232" decimals="-5" id="f-1160" unitRef="usd">8000000.0</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-233" decimals="-5" id="f-1161" unitRef="usd">277800000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-232" decimals="-5" id="f-1162" unitRef="usd">317000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-234" decimals="-5" id="f-1163" unitRef="usd">204000000</us-gaap:TaxCreditCarryforwardAmount>
    <iclr:TaxCreditCarryForwardIncreaseDecreaseAmount contextRef="c-232" decimals="-5" id="f-1164" unitRef="usd">113000000</iclr:TaxCreditCarryForwardIncreaseDecreaseAmount>
    <us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock contextRef="c-1" id="f-1165">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The expected expiry dates of the US NOLs are as follows:&#160;&lt;/span&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Federal&lt;br/&gt;NOL's&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;State&lt;br/&gt;NOL's&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025-2038&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;262,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2039-2043&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;277,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c-235" decimals="-3" id="f-1166" unitRef="usd">8035000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c-236" decimals="-3" id="f-1167" unitRef="usd">262170000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c-237" decimals="-3" id="f-1168" unitRef="usd">0</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="c-238" decimals="-3" id="f-1169" unitRef="usd">6057000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration contextRef="c-232" decimals="-3" id="f-1170" unitRef="usd">0</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration contextRef="c-233" decimals="-3" id="f-1171" unitRef="usd">9601000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-232" decimals="-3" id="f-1172" unitRef="usd">8035000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-233" decimals="-3" id="f-1173" unitRef="usd">277828000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax contextRef="c-239" decimals="-5" id="f-1174" unitRef="usd">1000000.0</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration contextRef="c-240" decimals="-5" id="f-1175" unitRef="usd">42400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <iclr:TaxCreditCarryForwardExpirationPeriod contextRef="c-1" id="f-1176">P30Y</iclr:TaxCreditCarryForwardExpirationPeriod>
    <iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration contextRef="c-241" decimals="-5" id="f-1177" unitRef="usd">2700000</iclr:DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-3" decimals="-5" id="f-1178" unitRef="usd">39000000.0</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-4" decimals="-5" id="f-1179" unitRef="usd">43000000.0</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-1" decimals="-5" id="f-1180" unitRef="usd">-4000000.0</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-5" decimals="-5" id="f-1181" unitRef="usd">-400000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-1" decimals="-5" id="f-1182" unitRef="usd">-4000000.0</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-242" decimals="-5" id="f-1183" unitRef="usd">2000000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-243" decimals="-5" id="f-1184" unitRef="usd">-5300000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-244" decimals="-5" id="f-1185" unitRef="usd">-700000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-5" decimals="-5" id="f-1186" unitRef="usd">-400000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-245" decimals="-5" id="f-1187" unitRef="usd">-1100000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-246" decimals="-5" id="f-1188" unitRef="usd">700000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings contextRef="c-3" decimals="-5" id="f-1189" unitRef="usd">35000000.0</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings contextRef="c-4" decimals="-5" id="f-1190" unitRef="usd">52400000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="c-1" id="f-1191">&lt;div style="margin-bottom:10pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at start of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Decrease related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(918)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Lapse of statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(65,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(62,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;217,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-4" decimals="-3" id="f-1192" unitRef="usd">160016000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-23" decimals="-3" id="f-1193" unitRef="usd">217584000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-12" decimals="-3" id="f-1194" unitRef="usd">202065000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-1" decimals="-3" id="f-1195" unitRef="usd">7374000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-5" decimals="-3" id="f-1196" unitRef="usd">1161000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-6" decimals="-3" id="f-1197" unitRef="usd">16098000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-1" decimals="-3" id="f-1198" unitRef="usd">2525000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-5" decimals="-3" id="f-1199" unitRef="usd">918000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-6" decimals="-3" id="f-1200" unitRef="usd">5442000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-1" decimals="-3" id="f-1201" unitRef="usd">2171000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-5" decimals="-3" id="f-1202" unitRef="usd">4552000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-6" decimals="-3" id="f-1203" unitRef="usd">5701000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-1" decimals="-3" id="f-1204" unitRef="usd">65417000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-5" decimals="-3" id="f-1205" unitRef="usd">62363000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c-6" decimals="-3" id="f-1206" unitRef="usd">838000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-3" decimals="-3" id="f-1207" unitRef="usd">101619000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-4" decimals="-3" id="f-1208" unitRef="usd">160016000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-23" decimals="-3" id="f-1209" unitRef="usd">217584000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit contextRef="c-3" decimals="-5" id="f-1210" unitRef="usd">61600000</us-gaap:SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-3" decimals="-5" id="f-1211" unitRef="usd">101600000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-4" decimals="-5" id="f-1212" unitRef="usd">160000000.0</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-23" decimals="-5" id="f-1213" unitRef="usd">217600000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c-1" decimals="-5" id="f-1214" unitRef="usd">1900000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c-5" decimals="-5" id="f-1215" unitRef="usd">4200000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c-6" decimals="-5" id="f-1216" unitRef="usd">7100000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c-3" decimals="-5" id="f-1217" unitRef="usd">24200000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c-4" decimals="-5" id="f-1218" unitRef="usd">27100000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-1219">Equity Incentive Schemes and Stock Compensation Charges&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Options&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On July 21, 2008 the Company adopted the Employee Share Option Plan 2008 (the "2008 Employee Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any employee, or any Director holding a salaried office or employment with the Company or a Subsidiary for the purchase of ordinary shares. On the same date, the Company also adopted the Consultants Share Option Plan 2008 (the "2008 Consultants Plan"), pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any consultant, adviser or non-executive Director retained by the Company or any Subsidiary for the purchase of ordinary shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On February 14, 2017 both the 2008 Employee Plan and the 2008 Consultants Plan (together the "2008 Option Plans") were amended and restated in order to increase the number of options that can be issued under the 2008 Consultants Plan from 0.4 million to 1.0 million and to extend the date for options to be granted under the 2008 Option Plans. An aggregate of 6.0 million ordinary shares have been reserved under the 2008 Employee Plan, as reduced by any shares issued or to be issued pursuant to options granted under the 2008 Consultants Plan, under which a limit of 1.0 million shares applies. Further, the maximum number of ordinary shares with respect to which options may be granted under the 2008 Employee Option Plan, during any calendar year to any employee shall be 0.4 million ordinary shares. There is no individual limit under the 2008 Consultants Plan. No options may be granted under the 2008 Option Plans after February 14, 2027.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Each option granted under the 2008 Option Plans is an employee stock option, or Nonqualified Stock Option ("NSO"), as described in Section 422 or 423 of the Internal Revenue Code. Each grant of an option under the 2008 Options Plans is evidenced by a Stock Option Agreement between the optionee and the Company. The exercise price is specified in each Stock Option Agreement, however option prices are not less than 100% of the fair market value of an ordinary share on the date the option is granted. Share option awards are granted with an exercise price equal to the market price of the Company's shares at date of grant. Share options typically vest over a period of &lt;span style="-sec-ix-hidden:f-1226"&gt;four&lt;/span&gt; to five years from date of grant and expire eight years from date of grant. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;PRA  Equity Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following represent the PRA equity incentive plans, that have been terminated as of July 1, 2021, as to grants of future awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Pursuant to the Merger Agreement, effective on July 1, 2021, each stock option and restricted stock unit under the PRA Plans was assumed by the Company and converted into a stock option or Restricted Share Unit exercisable for or payable in Ordinary Shares based on the ratio of the average trading price per Ordinary Share for the ten days prior to July 1, 2021, and the corresponding value of the Merger consideration for each PRA Share. Accordingly, the plans as detailed below were assumed by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;PRA Health Sciences, Inc. 2020 Stock Incentive Plan  (the "2020 Plan&#x201d;), 2018 Stock Incentive Plan (the "2018 Plan"), and 2014 Omnibus Incentive Plan (the "2014 Plan") were amended and restated and assumed by the Registrant effective as of July 1, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The 2020 Stock Incentive Plan, was approved by the PRA stockholders at their annual meeting on May 18, 2020. The 2020 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2020 Plan authorized the issuance of 2.5&#160;million shares of common stock plus all shares that remained available under the prior plan on May 18, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The 2018 Stock Incentive Plan (the &#x201c;2018 Plan&#x201d;), was approved by the PRA stockholders at their annual meeting on May 31, 2018. The 2018 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2018 Plan authorized the issuance of 2.0&#160;million shares of common stock plus all shares that remained available under the 2014 Plan on May 31, 2018 (which included shares carried over from the 2013 Plan).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On November 23, 2014, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2014 Plan for Key PRA Employees. The 2014 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;The following table summarizes the transactions for the Company's share option plans for the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.981%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.859%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Granted&lt;br/&gt;Under Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,695,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(348,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(77,698)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,378,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(535,705)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;196.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;902,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;142.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;325.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(311,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37,854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;238.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;622,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested and exercisable at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;426,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The weighted average remaining contractual life of options outstanding and options exercisable at December&#160;31, 2024 was 3.91 years and 3.06 years respectively (2023: 4.42 years and 3.89 years respectively).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The intrinsic value of options outstanding and options exercisable as of December&#160;31, 2024 was $34.0 million and $32.4 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The intrinsic value of options exercised during the years ended December&#160;31, 2024, 2023, and 2022, was $57.4 million, $80.4 million, and $41.9 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair value of Stock Options Assumptions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The weighted average fair value of options granted during the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022 was calculated using the Black-Scholes option pricing model. The weighted average fair values and assumptions were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Expected volatility is based on the historical volatility of our common stock over a period equal to the expected term of the options; the expected life represents the weighted average period of time that options granted are expected to be outstanding given consideration to vesting schedules and our historical experience of past vesting and termination patterns. The risk-free rate is based on the U.S. government zero-coupon bonds yield curve in effect at time of the grant for periods corresponding with the expected life of the option.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Share Units and Performance Share Units&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On April 23, 2013, the Company adopted the 2013 Employees Restricted Share Unit Plan (the "2013 RSU Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may select any employee, or any Director holding a salaried office or employment with the Company, or a Subsidiary to receive an award under the plan. On May 11, 2015, the 2013 RSU Plan was amended and restated in order to increase the number of shares that can be issued under the RSU Plan by 2.5 million shares. Further, on October 25, 2024, the 2013 RSU Plan was amended and restated effective as of November 6, 2024 in order to increase the number of shares that can be issued under the RSU Plan by a further 2.5&#160;million shares. Accordingly, an aggregate of 6.6 million ordinary shares have been reserved for issuance under the 2013 RSU Plan. The shares are awarded at par value and vest over a service period. Awards under the 2013 RSU Plan may be settled in cash or shares at the option of the Company. No awards may be granted under the 2013 RSU Plan after November 6, 2034.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On April 30 2019, the Company approved the 2019 Consultants and Directors Restricted Share Unit Plan (the &#x201c;2019 Consultants RSU Plan&#x201d;), which was effective as of May 16, 2019, pursuant to which the Compensation and Organization Committee of the Company&#x2019;s Board of Directors may select any consultant, adviser or non-executive Director retained by the Company, or a Subsidiary to receive an award under the plan. 250,000 ordinary shares have been reserved for issuance under the 2019 Consultants RSU Plan. The awards are at par value and vest over a service period. Awards granted to non-executive directors vest over twelve months. No awards may be granted under the 2019 Consultants RSU Plan after May 16, 2029.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Company has awarded RSUs and PSUs to certain key individuals of the Group. The following table summarizes RSU and PSU activity for the year ended December&#160;31, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.116%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.599%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;PSU Outstanding&lt;br/&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;PSU&lt;br/&gt;Weighted Average&lt;br/&gt;Grant Date &lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;RSU Outstanding&lt;br/&gt;Number&lt;br/&gt;of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;RSU&lt;br/&gt;Weighted Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;226.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;621,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;325.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;258,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;313.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,975)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(120,458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;223.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(124,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;260.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(111,309)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;241.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;647,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;251.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair value of RSUs vested for the year ended December&#160;31, 2024 totaled $26.9 million (2023: $35.4 million). The share price range for the year was $174.96 - $265.96 (2023: $159.33 - $265.96).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair value of PSUs vested for the year ended December&#160;31, 2024 totaled $1.8 million (2023: $7.5 million). The share price range for the year was $174.96 - $231.08 (2023: $159.33 - $166.51).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The PSUs vest based on service and specified EPS targets over the period 2022 &#x2013; 2024, 2023 &#x2013; 2025, and 2024 - 2026. Depending on the actual amount of EPS from 2022 to 2026, up to an additional 80,051 PSUs may also be granted.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock compensation expense&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Income from operations for the year ended December&#160;31, 2024 is stated after charging $45.9 million in respect of stock compensation expense (inclusive of employer related taxes). Stock compensation expense has been allocated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Direct costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, total unrecognized stock-based compensation expense related to outstanding non-vested stock-based compensation arrangements amounted to $108.1 million, which the Company expects to recognize over a weighted average period of 2.29 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The income tax expense for the year ended December&#160;31, 2024 reflects a net income tax benefit of $23.4 million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2024 was $10.1 million. The income tax expense for the year ended December&#160;31, 2023 reflects a net income tax benefit of $20.0 million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2023 was $10.9 million. The income tax expense for the year ended December&#160;31, 2022 reflects a net income tax benefit of $12.9 million in connection with stock compensation (including excess tax benefits) and the total tax benefit realized in connection with stock options exercised during 2022 was $7.7 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-247"
      decimals="-5"
      id="f-1220"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-248"
      decimals="-5"
      id="f-1221"
      unitRef="shares">1000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-249"
      decimals="-5"
      id="f-1222"
      unitRef="shares">6000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <iclr:LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted
      contextRef="c-250"
      decimals="-5"
      id="f-1223"
      unitRef="shares">1000000.0</iclr:LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="c-251"
      decimals="-5"
      id="f-1224"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="c-252"
      decimals="INF"
      id="f-1225"
      unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-254" id="f-1227">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-255" id="f-1228">P8Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-256"
      decimals="INF"
      id="f-1229"
      unitRef="shares">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-257"
      decimals="INF"
      id="f-1230"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-1231">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%"&gt;The following table summarizes the transactions for the Company's share option plans for the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.981%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.859%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Granted&lt;br/&gt;Under Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,695,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;108,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;229.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(348,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(77,698)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,378,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(535,705)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;196.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;902,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;142.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;325.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(311,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37,854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;238.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;622,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested and exercisable at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;426,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-258"
      decimals="INF"
      id="f-1232"
      unitRef="shares">1695460</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-258"
      decimals="2"
      id="f-1233"
      unitRef="usdPerShare">110.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-259"
      decimals="INF"
      id="f-1234"
      unitRef="shares">108643</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-259"
      decimals="2"
      id="f-1235"
      unitRef="usdPerShare">229.94</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-259"
      decimals="INF"
      id="f-1236"
      unitRef="shares">348286</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-259"
      decimals="2"
      id="f-1237"
      unitRef="usdPerShare">102.87</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c-259"
      decimals="INF"
      id="f-1238"
      unitRef="shares">77698</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-259"
      decimals="2"
      id="f-1239"
      unitRef="usdPerShare">143.08</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-260"
      decimals="INF"
      id="f-1240"
      unitRef="shares">1378119</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-260"
      decimals="2"
      id="f-1241"
      unitRef="usdPerShare">119.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-261"
      decimals="INF"
      id="f-1242"
      unitRef="shares">82472</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-261"
      decimals="2"
      id="f-1243"
      unitRef="usdPerShare">232.48</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-261"
      decimals="INF"
      id="f-1244"
      unitRef="shares">535705</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-261"
      decimals="2"
      id="f-1245"
      unitRef="usdPerShare">95.12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c-261"
      decimals="INF"
      id="f-1246"
      unitRef="shares">22080</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-261"
      decimals="2"
      id="f-1247"
      unitRef="usdPerShare">196.20</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-262"
      decimals="INF"
      id="f-1248"
      unitRef="shares">902806</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-262"
      decimals="2"
      id="f-1249"
      unitRef="usdPerShare">142.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-263"
      decimals="INF"
      id="f-1250"
      unitRef="shares">68380</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-263"
      decimals="2"
      id="f-1251"
      unitRef="usdPerShare">325.51</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-263"
      decimals="INF"
      id="f-1252"
      unitRef="shares">311040</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-263"
      decimals="2"
      id="f-1253"
      unitRef="usdPerShare">116.31</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c-263"
      decimals="INF"
      id="f-1254"
      unitRef="shares">37854</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-263"
      decimals="2"
      id="f-1255"
      unitRef="usdPerShare">238.51</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-264"
      decimals="INF"
      id="f-1256"
      unitRef="shares">622292</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-264"
      decimals="2"
      id="f-1257"
      unitRef="usdPerShare">170.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="c-264"
      decimals="INF"
      id="f-1258"
      unitRef="shares">426497</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="c-264"
      decimals="2"
      id="f-1259"
      unitRef="usdPerShare">135.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-1260">P3Y10M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-1261">P3Y21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-5" id="f-1262">P4Y5M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-5" id="f-1263">P3Y10M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-3" decimals="-5" id="f-1264" unitRef="usd">34000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-3" decimals="-5" id="f-1265" unitRef="usd">32400000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-1" decimals="-5" id="f-1266" unitRef="usd">57400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-5" decimals="-5" id="f-1267" unitRef="usd">80400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-6" decimals="-5" id="f-1268" unitRef="usd">41900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-1269">The weighted average fair values and assumptions were as follows:&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-199"
      decimals="2"
      id="f-1270"
      unitRef="usdPerShare">115.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-202"
      decimals="2"
      id="f-1271"
      unitRef="usdPerShare">85.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-205"
      decimals="2"
      id="f-1272"
      unitRef="usdPerShare">68.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-199"
      decimals="2"
      id="f-1273"
      unitRef="number">0.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-202"
      decimals="2"
      id="f-1274"
      unitRef="number">0.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-205"
      decimals="2"
      id="f-1275"
      unitRef="number">0.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-199"
      decimals="INF"
      id="f-1276"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-202"
      decimals="INF"
      id="f-1277"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-205"
      decimals="INF"
      id="f-1278"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-199"
      decimals="4"
      id="f-1279"
      unitRef="number">0.0420</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-202"
      decimals="4"
      id="f-1280"
      unitRef="number">0.0418</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-205"
      decimals="4"
      id="f-1281"
      unitRef="number">0.0186</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-199" id="f-1282">P4Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-202" id="f-1283">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-205" id="f-1284">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="c-265"
      decimals="-5"
      id="f-1285"
      unitRef="shares">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="c-266"
      decimals="-5"
      id="f-1286"
      unitRef="shares">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-267"
      decimals="-5"
      id="f-1287"
      unitRef="shares">6600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-268"
      decimals="INF"
      id="f-1288"
      unitRef="shares">250000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-269" id="f-1289">P12M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <iclr:ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock contextRef="c-1" id="f-1290">The following table summarizes RSU and PSU activity for the year ended December&#160;31, 2024:&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.116%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.599%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;PSU Outstanding&lt;br/&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;PSU&lt;br/&gt;Weighted Average&lt;br/&gt;Grant Date &lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;RSU Outstanding&lt;br/&gt;Number&lt;br/&gt;of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;RSU&lt;br/&gt;Weighted Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;226.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;621,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;218.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;325.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;258,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;313.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9,975)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(120,458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;223.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(124,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;260.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(111,309)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;241.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;647,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;251.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iclr:ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-270"
      decimals="INF"
      id="f-1291"
      unitRef="shares">105256</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-270"
      decimals="2"
      id="f-1292"
      unitRef="usdPerShare">226.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-271"
      decimals="INF"
      id="f-1293"
      unitRef="shares">621011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-271"
      decimals="2"
      id="f-1294"
      unitRef="usdPerShare">218.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-201"
      decimals="INF"
      id="f-1295"
      unitRef="shares">48626</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-201"
      decimals="2"
      id="f-1296"
      unitRef="usdPerShare">325.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-200"
      decimals="INF"
      id="f-1297"
      unitRef="shares">258345</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-200"
      decimals="2"
      id="f-1298"
      unitRef="usdPerShare">313.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-201"
      decimals="INF"
      id="f-1299"
      unitRef="shares">9975</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-201"
      decimals="2"
      id="f-1300"
      unitRef="usdPerShare">177.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-200"
      decimals="INF"
      id="f-1301"
      unitRef="shares">120458</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-200"
      decimals="2"
      id="f-1302"
      unitRef="usdPerShare">223.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-201"
      decimals="INF"
      id="f-1303"
      unitRef="shares">124186</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-201"
      decimals="2"
      id="f-1304"
      unitRef="usdPerShare">260.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-200"
      decimals="INF"
      id="f-1305"
      unitRef="shares">111309</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-200"
      decimals="2"
      id="f-1306"
      unitRef="usdPerShare">241.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-272"
      decimals="INF"
      id="f-1307"
      unitRef="shares">19721</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-272"
      decimals="2"
      id="f-1308"
      unitRef="usdPerShare">280.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-273"
      decimals="INF"
      id="f-1309"
      unitRef="shares">647589</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-273"
      decimals="2"
      id="f-1310"
      unitRef="usdPerShare">251.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-200" decimals="-5" id="f-1311" unitRef="usd">26900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-203" decimals="-5" id="f-1312" unitRef="usd">35400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="c-274"
      decimals="2"
      id="f-1313"
      unitRef="usdPerShare">174.96</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="c-275"
      decimals="2"
      id="f-1314"
      unitRef="usdPerShare">265.96</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="c-276"
      decimals="2"
      id="f-1315"
      unitRef="usdPerShare">159.33</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="c-277"
      decimals="2"
      id="f-1316"
      unitRef="usdPerShare">265.96</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-201" decimals="-5" id="f-1317" unitRef="usd">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-204" decimals="-5" id="f-1318" unitRef="usd">7500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="c-278"
      decimals="2"
      id="f-1319"
      unitRef="usdPerShare">174.96</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="c-279"
      decimals="2"
      id="f-1320"
      unitRef="usdPerShare">231.08</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="c-280"
      decimals="2"
      id="f-1321"
      unitRef="usdPerShare">159.33</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare
      contextRef="c-281"
      decimals="2"
      id="f-1322"
      unitRef="usdPerShare">166.51</iclr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-282"
      decimals="INF"
      id="f-1323"
      unitRef="shares">80051</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-5" id="f-1324" unitRef="usd">45900000</us-gaap:ShareBasedCompensation>
    <iclr:ScheduleOfNonCashStockCompensationExpenseTableTextBlock contextRef="c-1" id="f-1325">Stock compensation expense has been allocated as follows:&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Direct costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iclr:ScheduleOfNonCashStockCompensationExpenseTableTextBlock>
    <us-gaap:ShareBasedCompensation contextRef="c-196" decimals="-3" id="f-1326" unitRef="usd">26046000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-197" decimals="-3" id="f-1327" unitRef="usd">26595000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-198" decimals="-3" id="f-1328" unitRef="usd">22854000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-193" decimals="-3" id="f-1329" unitRef="usd">19824000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-194" decimals="-3" id="f-1330" unitRef="usd">29072000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-195" decimals="-3" id="f-1331" unitRef="usd">47669000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-1332" unitRef="usd">45870000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-5" decimals="-3" id="f-1333" unitRef="usd">55667000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-6" decimals="-3" id="f-1334" unitRef="usd">70523000</us-gaap:ShareBasedCompensation>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions contextRef="c-3" decimals="-5" id="f-1335" unitRef="usd">108100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-1" id="f-1336">P2Y3M14D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-1" decimals="-5" id="f-1337" unitRef="usd">23400000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions contextRef="c-1" decimals="-5" id="f-1338" unitRef="usd">10100000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-5" decimals="-5" id="f-1339" unitRef="usd">20000000.0</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions contextRef="c-5" decimals="-5" id="f-1340" unitRef="usd">10900000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-6" decimals="-5" id="f-1341" unitRef="usd">12900000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions contextRef="c-6" decimals="-5" id="f-1342" unitRef="usd">7700000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-1343">Business Segment and Geographical Information&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"&gt;The Company is a CRO providing outsourced services on a global basis to pharmaceutical, biotechnology, medical device and government and public health organizations. It specializes in the strategic development, management and analysis of programs that support all stages of the clinical development process - from compound selection to Phase I-IV clinical studies. The Company has the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and has the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" or &#x201c;blended-service&#x201d; solution. The Company has expanded through internal growth, together with a number of strategic acquisitions to enhance its expertise and capabilities in certain areas of the clinical development process. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:124%"&gt;The Company operates as one reportable segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries.  For each of the accounting periods presented herein, the Company determined that Chief Operating Decision Maker ('CODM') was comprised of the Chief Executive Officer and the Chief Financial Officer. As the Company is managed on a consolidated basis, the CODM evaluates performance and allocates resources based on consolidated net income. The CODM uses consolidated net income, as reported on the Consolidated Statement of Operations, to evaluate income generated from segment assets and for decisions related to the deployment of operating and capital resources.  The measure of segment assets is reported on the Consolidated Balance Sheet as total consolidated assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The accounting policies of the reportable segment are the same as those described in Note 2. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. In the context of considerations around significant segment expenses, as the expense information that is regularly provided to the CODM is aligned with the respective consolidated expenses for direct costs and selling, general, and administrative expenses, as presented on the Consolidated Statement of Operations, such expense disclosures are not replicated here. Furthermore, as the Company consists of a single reportable segment, other quantitative disclosures, as required by Topic 280, are as presented on the Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenues are allocated to individual entities based on where the work is performed in accordance with the Company's global transfer pricing model. Revenues and income from operations in Ireland are a function of our global contracting model and the Group&#x2019;s transfer pricing model. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ICON Ireland acts as the Group entrepreneur under the Company&#x2019;s global transfer pricing model given its role in the development and management of the Group, its ownership of key intellectual property and customer relationships, its key role in the mitigation of risks faced by the Group and its responsibility for maintaining the Company&#x2019;s global network. ICON Ireland enters into the majority of the Company&#x2019;s customer contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;ICON Ireland remunerates other operating entities in the Group on the basis of an arm&#x2019;s length return for the services they perform in each of their local territories. The arm&#x2019;s length return for each ICON entity is established to ensure that each of ICON Ireland and the ICON entities that are involved in the conduct of services for customers, earn an appropriate return having regard to their respective functions performed, assets owned, and risks assumed in these intercompany transactions. The arm&#x2019;s length return is reviewed annually to ensure that it is market appropriate. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The geographic split of revenue disclosed for each region outside Ireland is the arm&#x2019;s length revenue attributable to these entities. The residual revenues of the Group, once each ICON entity has been paid its respective intercompany service fee, generally fall to be retained by ICON Ireland. As such, revenues and income from operations in Ireland are a function of this global transfer pricing model and comprise revenues of the Group after deducting the arm&#x2019;s length revenues attributable to the activities performed outside Ireland.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;There have been no changes to the overall basis of segmentation or the measurement basis for the segment results since the prior year. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reportable geographic information at December&#160;31, 2024 and December&#160;31, 2023 and for the years ended December&#160;31, 2024, December&#160;31, 2023 and December&#160;31, 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;a) The distribution of revenue by geographical area was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,793,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,377,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,984,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,560,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,574,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,618,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,985,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,283,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,574,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;942,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;884,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;563,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,281,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,120,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,741,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;b) The distribution of income from operations by geographical area was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;919,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;885,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;673,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;216,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;254,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;241,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;314,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;260,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sub-total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,448,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,416,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,258,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization on intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(350,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(459,854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(463,087)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,097,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;956,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;795,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;c) The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.461%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;234,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;199,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span id="i85f7edaad3fa4a85a9148d91477e5119_6-1-1-1-401854"&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;530,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;501,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-1344"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock contextRef="c-1" id="f-1345">The distribution of revenue by geographical area was as follows:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,793,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,377,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,984,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,560,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,574,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,618,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,985,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,283,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,574,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;942,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;884,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;563,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,281,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,120,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,741,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-222" decimals="-3" id="f-1346" unitRef="usd">2793045000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-223" decimals="-3" id="f-1347" unitRef="usd">2377104000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-224" decimals="-3" id="f-1348" unitRef="usd">1984567000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-283" decimals="-3" id="f-1349" unitRef="usd">1560735000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-284" decimals="-3" id="f-1350" unitRef="usd">1574783000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-285" decimals="-3" id="f-1351" unitRef="usd">1618350000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-225" decimals="-3" id="f-1352" unitRef="usd">2985256000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-226" decimals="-3" id="f-1353" unitRef="usd">3283790000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-227" decimals="-3" id="f-1354" unitRef="usd">3574610000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-286" decimals="-3" id="f-1355" unitRef="usd">942640000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-287" decimals="-3" id="f-1356" unitRef="usd">884499000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-288" decimals="-3" id="f-1357" unitRef="usd">563859000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-1358" unitRef="usd">8281676000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-3" id="f-1359" unitRef="usd">8120176000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-3" id="f-1360" unitRef="usd">7741386000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <iclr:OperatingIncomeByGeographyTableTextBlock contextRef="c-1" id="f-1361">The distribution of income from operations by geographical area was as follows:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;919,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;885,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;673,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;216,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;254,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;241,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;314,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;260,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sub-total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,448,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,416,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,258,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortization on intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(350,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(459,854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(463,087)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,097,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;956,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;795,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iclr:OperatingIncomeByGeographyTableTextBlock>
    <us-gaap:OperatingIncomeLoss contextRef="c-222" decimals="-3" id="f-1362" unitRef="usd">919126000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-223" decimals="-3" id="f-1363" unitRef="usd">885886000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-224" decimals="-3" id="f-1364" unitRef="usd">673804000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-283" decimals="-3" id="f-1365" unitRef="usd">216768000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-284" decimals="-3" id="f-1366" unitRef="usd">154626000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-285" decimals="-3" id="f-1367" unitRef="usd">254955000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-225" decimals="-3" id="f-1368" unitRef="usd">241549000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-226" decimals="-3" id="f-1369" unitRef="usd">314982000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-227" decimals="-3" id="f-1370" unitRef="usd">260890000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-286" decimals="-3" id="f-1371" unitRef="usd">70661000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-287" decimals="-3" id="f-1372" unitRef="usd">60512000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-288" decimals="-3" id="f-1373" unitRef="usd">68675000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-289" decimals="-3" id="f-1374" unitRef="usd">1448104000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-290" decimals="-3" id="f-1375" unitRef="usd">1416006000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-291" decimals="-3" id="f-1376" unitRef="usd">1258324000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-289" decimals="-3" id="f-1377" unitRef="usd">350292000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-290" decimals="-3" id="f-1378" unitRef="usd">459854000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-291" decimals="-3" id="f-1379" unitRef="usd">463087000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-1380" unitRef="usd">1097812000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-3" id="f-1381" unitRef="usd">956152000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-6" decimals="-3" id="f-1382" unitRef="usd">795237000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock contextRef="c-1" id="f-1383">The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.461%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;234,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;199,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rest of Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span id="i85f7edaad3fa4a85a9148d91477e5119_6-1-1-1-401854"&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;530,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;501,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:NoncurrentAssets contextRef="c-292" decimals="-3" id="f-1384" unitRef="usd">234175000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-293" decimals="-3" id="f-1385" unitRef="usd">199051000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-294" decimals="-3" id="f-1386" unitRef="usd">88556000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-295" decimals="-3" id="f-1387" unitRef="usd">94046000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-239" decimals="-3" id="f-1388" unitRef="usd">145391000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-296" decimals="-3" id="f-1389" unitRef="usd">159245000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-297" decimals="-3" id="f-1390" unitRef="usd">62359000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-298" decimals="-3" id="f-1391" unitRef="usd">49175000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-3" decimals="-3" id="f-1392" unitRef="usd">530481000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-4" decimals="-3" id="f-1393" unitRef="usd">501517000</us-gaap:NoncurrentAssets>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-1394">Net Income Per Ordinary Share&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Basic net income per ordinary share has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;There is no difference in net income used for basic and diluted net income per ordinary share.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average number of ordinary shares outstanding for basic net income per ordinary share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,482,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,101,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,532,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive share options and other awards outstanding under share based compensation programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;549,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;615,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;936,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average number of ordinary shares outstanding for diluted net income per ordinary share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83,032,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,717,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,468,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income per ordinary share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-1395">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average number of ordinary shares outstanding for basic net income per ordinary share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,482,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,101,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81,532,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive share options and other awards outstanding under share based compensation programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;549,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;615,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;936,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average number of ordinary shares outstanding for diluted net income per ordinary share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83,032,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,717,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,468,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income per ordinary share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-1396" unitRef="shares">82482764</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="0" id="f-1397" unitRef="shares">82101813</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="0" id="f-1398" unitRef="shares">81532320</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="c-1" decimals="0" id="f-1399" unitRef="shares">549660</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="c-5" decimals="0" id="f-1400" unitRef="shares">615827</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="c-6" decimals="0" id="f-1401" unitRef="shares">936043</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-1402" unitRef="shares">83032424</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="0" id="f-1403" unitRef="shares">82717640</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="0" id="f-1404" unitRef="shares">82468363</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-1405"
      unitRef="usdPerShare">9.60</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-1406"
      unitRef="usdPerShare">7.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-1407"
      unitRef="usdPerShare">6.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-1408"
      unitRef="usdPerShare">9.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-1409"
      unitRef="usdPerShare">7.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-1410"
      unitRef="usdPerShare">6.13</us-gaap:EarningsPerShareDiluted>
    <iclr:AccumulatedOtherComprehensiveIncomeLossTextBlock contextRef="c-1" id="f-1411">Accumulated Other Comprehensive Loss&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(234,075)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(149,148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remeasurement of retirement benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain / (loss) on cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(229,929)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(143,506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</iclr:AccumulatedOtherComprehensiveIncomeLossTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-1412">&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(234,075)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(149,148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remeasurement of retirement benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain / (loss) on cash flow hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(229,929)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(143,506)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="c-3" decimals="-3" id="f-1413" unitRef="usd">-234075000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="c-4" decimals="-3" id="f-1414" unitRef="usd">-149148000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax contextRef="c-3" decimals="-3" id="f-1415" unitRef="usd">-1726000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax contextRef="c-4" decimals="-3" id="f-1416" unitRef="usd">-7803000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <iclr:AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-3" decimals="-3" id="f-1417" unitRef="usd">2420000</iclr:AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax>
    <iclr:AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-4" decimals="-3" id="f-1418" unitRef="usd">-2161000</iclr:AccumulatedOtherComprehensiveLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-3" decimals="-3" id="f-1419" unitRef="usd">-229929000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-3" id="f-1420" unitRef="usd">-143506000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock contextRef="c-1" id="f-1421">Supplemental Disclosure of Cash Flow Information&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;196,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;317,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;210,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for income taxes (net of refunds)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;140,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;163,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock contextRef="c-1" id="f-1422">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.620%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;196,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;317,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;210,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for income taxes (net of refunds)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;140,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;163,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-3" id="f-1423" unitRef="usd">196622000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-5" decimals="-3" id="f-1424" unitRef="usd">317975000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-6" decimals="-3" id="f-1425" unitRef="usd">210918000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-1" decimals="-3" id="f-1426" unitRef="usd">140718000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-5" decimals="-3" id="f-1427" unitRef="usd">163778000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-6" decimals="-3" id="f-1428" unitRef="usd">116322000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c-1" id="f-1429">Related Parties &lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;During the year, subsidiaries of the Company earned revenue of $0.3 million (December&#160;31, 2023: $0.2 million) from Corvus Pharmaceuticals. Dr. Linda Grais serves as a Director and shareholder&lt;/span&gt;&lt;span style="color:#0094ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;of Corvus Pharmaceuticals. At December&#160;31, 2024, $0.1 million (December&#160;31, 2023: $0.1 million) was noted as due from Corvus Pharmaceuticals . &lt;/span&gt;&lt;/div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;During the year, subsidiaries of the Company earned revenu&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;e of $nil (December&#160;31, 2023&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$0.05 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;) from Afimmune Limited. Dr. John Climax is Chief Executive Officer and a Director and shareholder of Afimmune Limited. At December&#160;31, 2024, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$0.1 million was no&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;ted as due from Afimmune Limited (December&#160;31, 2023: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$0.05 million&lt;/span&gt;).</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:Revenues contextRef="c-299" decimals="-3" id="f-1430" unitRef="usd">300000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-300" decimals="-3" id="f-1431" unitRef="usd">200000</us-gaap:Revenues>
    <us-gaap:OtherReceivables contextRef="c-301" decimals="-3" id="f-1432" unitRef="usd">100000</us-gaap:OtherReceivables>
    <us-gaap:OtherReceivables contextRef="c-302" decimals="-3" id="f-1433" unitRef="usd">100000</us-gaap:OtherReceivables>
    <us-gaap:Revenues contextRef="c-303" decimals="-3" id="f-1434" unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-304" decimals="-3" id="f-1435" unitRef="usd">50000.00</us-gaap:Revenues>
    <us-gaap:OtherReceivables contextRef="c-305" decimals="-3" id="f-1436" unitRef="usd">100000</us-gaap:OtherReceivables>
    <us-gaap:OtherReceivables contextRef="c-306" decimals="-3" id="f-1437" unitRef="usd">50000.00</us-gaap:OtherReceivables>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-1438">&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Subsequent Events&lt;/span&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;The Company has evaluated subsequent events from the Balance Sheet date th&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;rough February&#160;21, 2025, t&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;he date at which the consolidated financial statements were available to be issued. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;On February 18, 2025, the Company's Board of Directors authorized an additional buyback program of up to $750.0&#160;million of the outstanding ordinary shares of the Company. Along with unutilized amounts under the previous authorizations, this permits the Company to repurchase up to $1&#160;billion worth of ordinary shares. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;All ordinary shares that are redeemed under the buyback program will be canceled in accordance with the constitutional documents of the Company and the nominal value of these shares transferred to an undenominated capital fund as required under Irish Company law. Repurchases under the share buyback program may be effected from time to time in open market or privately negotiated transactions in accordance with agreed terms and limitations. The timing and amount of the repurchase transactions under this program will depend on a variety of factors, including market conditions and corporate and regulatory considerations. Depending upon results of operations, market conditions and the development of the economy, as well as other factors, generally we will consider share repurchases on an opportunistic basis from time to time.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;The Company has determined that there ar&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;e no other items t&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;o disclose.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <srt:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-307" decimals="-5" id="f-1439" unitRef="usd">750000000</srt:StockRepurchaseProgramAuthorizedAmount1>
    <srt:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-308" decimals="-9" id="f-1440" unitRef="usd">1000000000</srt:StockRepurchaseProgramAuthorizedAmount1>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
